NA	CHEMICAL	GENE-N	5	13	Ever since the discovery that chemical ( chemical ) is a cofactor of gene , its function has been the object of intense research and occasional controversy .	T10	T30	12003347
NA	CHEMICAL	GENE-N	7	13	Ever since the discovery that chemical ( chemical ) is a cofactor of gene , its function has been the object of intense research and occasional controversy .	T13	T30	12003347
NA	CHEMICAL	GENE-N	15	17	In this review we aim to provide an outline of the various ways in which chemical affects gene catalysis .	T11	T26	12003347
NA	CHEMICAL	GENE-N	35	14	First we give a brief general description of the structure and catalytic mechanism of gene , with special emphasis on those aspects of catalysis that are actively debated , and that directly or indirectly involve chemical .	T12	T27	12003347
NA	CHEMICAL	GENE-N	4	1	the gene-catalyzed oxidation of chemical in the absence of substrate or pterin that does not result in chemical production .	T14	T28	12003347
NA	CHEMICAL	GENE-N	17	1	the gene-catalyzed oxidation of chemical in the absence of substrate or pterin that does not result in chemical production .	T15	T28	12003347
CPR:9	CHEMICAL	GENE-N	9	16	We also shortly discuss the ongoing debate on whether chemical is the actual reaction product of gene catalysis , as well as the phenomenon of chemical-mediated autoinhibition .	T16	T29	12003347
NA	CHEMICAL	GENE-N	25	16	We also shortly discuss the ongoing debate on whether chemical is the actual reaction product of gene catalysis , as well as the phenomenon of chemical-mediated autoinhibition .	T17	T29	12003347
NA	CHEMICAL	GENE-N	5	21	We describe the function of chemical in chemical hydroxylation , and discuss the allosteric and structural effects that chemical exerts on gene .	T18	T23	12003347
NA	CHEMICAL	GENE-N	7	21	We describe the function of chemical in chemical hydroxylation , and discuss the allosteric and structural effects that chemical exerts on gene .	T19	T23	12003347
NA	CHEMICAL	GENE-N	5	21	We describe the function of chemical in chemical hydroxylation , and discuss the allosteric and structural effects that chemical exerts on gene .	T1	T23	12003347
NA	CHEMICAL	GENE-N	3	18	Platelet activation by chemical and chemical plays a crucial role in haemostasis and thrombosis , and their so-called gene are potential targets for antithrombotic drugs .	T2	T10	15955565
NA	CHEMICAL	GENE-N	5	18	Platelet activation by chemical and chemical plays a crucial role in haemostasis and thrombosis , and their so-called gene are potential targets for antithrombotic drugs .	T3	T10	15955565
NA	CHEMICAL	GENE-Y	1	3	The chemical-gated channel P2X1 and the 2 gene and gene gene selectively contribute to platelet aggregation .	T1	T15	15955565
NA	CHEMICAL	GENE-Y	1	6	The chemical-gated channel P2X1 and the 2 gene and gene gene selectively contribute to platelet aggregation .	T1	T16	15955565
NA	CHEMICAL	GENE-Y	1	6	The chemical-gated channel P2X1 and the 2 gene and gene gene selectively contribute to platelet aggregation .	T1	T17	15955565
NA	CHEMICAL	GENE-N	1	10	The chemical-gated channel P2X1 and the 2 gene and gene gene selectively contribute to platelet aggregation .	T1	T18	15955565
NA	CHEMICAL	GENE-Y	6	1	The gene receptor is responsible for chemical-induced shape change and weak and transient aggregation , while the gene receptor is responsible for the completion and amplification of the response to chemical and to all platelet agonists , including chemical ( chemical ) , gene , and gene .	T4	T19	15955565
NA	CHEMICAL	GENE-Y	6	17	The gene receptor is responsible for chemical-induced shape change and weak and transient aggregation , while the gene receptor is responsible for the completion and amplification of the response to chemical and to all platelet agonists , including chemical ( chemical ) , gene , and gene .	T4	T20	15955565
NA	CHEMICAL	GENE-Y	6	43	The gene receptor is responsible for chemical-induced shape change and weak and transient aggregation , while the gene receptor is responsible for the completion and amplification of the response to chemical and to all platelet agonists , including chemical ( chemical ) , gene , and gene .	T4	T21	15955565
NA	CHEMICAL	GENE-N	6	46	The gene receptor is responsible for chemical-induced shape change and weak and transient aggregation , while the gene receptor is responsible for the completion and amplification of the response to chemical and to all platelet agonists , including chemical ( chemical ) , gene , and gene .	T4	T22	15955565
NA	CHEMICAL	GENE-Y	30	1	The gene receptor is responsible for chemical-induced shape change and weak and transient aggregation , while the gene receptor is responsible for the completion and amplification of the response to chemical and to all platelet agonists , including chemical ( chemical ) , gene , and gene .	T5	T19	15955565
NA	CHEMICAL	GENE-Y	30	17	The gene receptor is responsible for chemical-induced shape change and weak and transient aggregation , while the gene receptor is responsible for the completion and amplification of the response to chemical and to all platelet agonists , including chemical ( chemical ) , gene , and gene .	T5	T20	15955565
NA	CHEMICAL	GENE-Y	30	43	The gene receptor is responsible for chemical-induced shape change and weak and transient aggregation , while the gene receptor is responsible for the completion and amplification of the response to chemical and to all platelet agonists , including chemical ( chemical ) , gene , and gene .	T5	T21	15955565
NA	CHEMICAL	GENE-N	30	46	The gene receptor is responsible for chemical-induced shape change and weak and transient aggregation , while the gene receptor is responsible for the completion and amplification of the response to chemical and to all platelet agonists , including chemical ( chemical ) , gene , and gene .	T5	T22	15955565
NA	CHEMICAL	GENE-Y	38	1	The gene receptor is responsible for chemical-induced shape change and weak and transient aggregation , while the gene receptor is responsible for the completion and amplification of the response to chemical and to all platelet agonists , including chemical ( chemical ) , gene , and gene .	T6	T19	15955565
NA	CHEMICAL	GENE-Y	38	17	The gene receptor is responsible for chemical-induced shape change and weak and transient aggregation , while the gene receptor is responsible for the completion and amplification of the response to chemical and to all platelet agonists , including chemical ( chemical ) , gene , and gene .	T6	T20	15955565
NA	CHEMICAL	GENE-Y	38	43	The gene receptor is responsible for chemical-induced shape change and weak and transient aggregation , while the gene receptor is responsible for the completion and amplification of the response to chemical and to all platelet agonists , including chemical ( chemical ) , gene , and gene .	T6	T21	15955565
NA	CHEMICAL	GENE-N	38	46	The gene receptor is responsible for chemical-induced shape change and weak and transient aggregation , while the gene receptor is responsible for the completion and amplification of the response to chemical and to all platelet agonists , including chemical ( chemical ) , gene , and gene .	T6	T22	15955565
NA	CHEMICAL	GENE-Y	40	1	The gene receptor is responsible for chemical-induced shape change and weak and transient aggregation , while the gene receptor is responsible for the completion and amplification of the response to chemical and to all platelet agonists , including chemical ( chemical ) , gene , and gene .	T7	T19	15955565
NA	CHEMICAL	GENE-Y	40	17	The gene receptor is responsible for chemical-induced shape change and weak and transient aggregation , while the gene receptor is responsible for the completion and amplification of the response to chemical and to all platelet agonists , including chemical ( chemical ) , gene , and gene .	T7	T20	15955565
NA	CHEMICAL	GENE-Y	40	43	The gene receptor is responsible for chemical-induced shape change and weak and transient aggregation , while the gene receptor is responsible for the completion and amplification of the response to chemical and to all platelet agonists , including chemical ( chemical ) , gene , and gene .	T7	T21	15955565
NA	CHEMICAL	GENE-N	40	46	The gene receptor is responsible for chemical-induced shape change and weak and transient aggregation , while the gene receptor is responsible for the completion and amplification of the response to chemical and to all platelet agonists , including chemical ( chemical ) , gene , and gene .	T7	T22	15955565
NA	CHEMICAL	GENE-Y	5	15	Due to its central role in the formation and stabilization of a thrombus , the gene receptor is a well-established target of antithrombotic drugs like chemical or chemical , which have proved efficacy in many clinical trials and experimental models of thrombosis .	T8	T25	15955565
NA	CHEMICAL	GENE-Y	27	15	Due to its central role in the formation and stabilization of a thrombus , the gene receptor is a well-established target of antithrombotic drugs like chemical or chemical , which have proved efficacy in many clinical trials and experimental models of thrombosis .	T9	T25	15955565
NA	CHEMICAL	GENE-N	0	7	chemical and chemical , novel templates of gene chemical channel openers , depress cortical neuron activity and exhibit anticonvulsant properties .	T11	T25	15598972
NA	CHEMICAL	GENE-N	0	9	chemical and chemical , novel templates of gene chemical channel openers , depress cortical neuron activity and exhibit anticonvulsant properties .	T11	T26	15598972
NA	CHEMICAL	GENE-N	2	7	chemical and chemical , novel templates of gene chemical channel openers , depress cortical neuron activity and exhibit anticonvulsant properties .	T12	T25	15598972
NA	CHEMICAL	GENE-N	2	9	chemical and chemical , novel templates of gene chemical channel openers , depress cortical neuron activity and exhibit anticonvulsant properties .	T12	T26	15598972
NA	CHEMICAL	GENE-N	8	7	chemical and chemical , novel templates of gene chemical channel openers , depress cortical neuron activity and exhibit anticonvulsant properties .	T13	T25	15598972
NA	CHEMICAL	GENE-N	8	9	chemical and chemical , novel templates of gene chemical channel openers , depress cortical neuron activity and exhibit anticonvulsant properties .	T13	T26	15598972
NA	CHEMICAL	GENE-N	3	2	Enhancement of gene chemical currents may provide an important target for antiepileptic drug development .	T5	T21	15598972
NA	CHEMICAL	GENE-N	5	24	Here , we show that chemical ( chemical ) and chemical , two related molecules previously used as anti-inflammatory drugs , act as novel gene channel openers .	T6	T22	15598972
NA	CHEMICAL	GENE-N	7	24	Here , we show that chemical ( chemical ) and chemical , two related molecules previously used as anti-inflammatory drugs , act as novel gene channel openers .	T7	T22	15598972
NA	CHEMICAL	GENE-N	10	24	Here , we show that chemical ( chemical ) and chemical , two related molecules previously used as anti-inflammatory drugs , act as novel gene channel openers .	T8	T22	15598972
CPR:3	CHEMICAL	GENE-N	2	29	Extracellular application of chemical ( EC ( 50 ) = 25 microM ) and chemical ( EC ( 50 ) = 2.6 microM ) resulted in the activation of gene K ( + ) currents , heterologously expressed in Chinese hamster ovary cells .	T9	T23	15598972
CPR:3	CHEMICAL	GENE-N	2	29	Extracellular application of chemical ( EC ( 50 ) = 25 microM ) and chemical ( EC ( 50 ) = 2.6 microM ) resulted in the activation of gene K ( + ) currents , heterologously expressed in Chinese hamster ovary cells .	T10	T23	15598972
NA	CHEMICAL	GENE-Y	3	10	Effect of anabolic-androgenic chemical and glucocorticoids on the kinetics of gene and gene nucleocytoplasmic translocation .	T22	T45	20230007
NA	CHEMICAL	GENE-Y	3	12	Effect of anabolic-androgenic chemical and glucocorticoids on the kinetics of gene and gene nucleocytoplasmic translocation .	T22	T46	20230007
NA	CHEMICAL	GENE-Y	10	6	Here , translocation studies using the gene ( gene ) and the gene ( gene ) were performed to aid in identifying the mechanism by which anabolic-chemicalic chemical ( AAS ) were activating gene and potentially interacting with gene and how glucocorticoid ligands were interacting with the gene and gene .	T18	T29	20230007
NA	CHEMICAL	GENE-Y	10	8	Here , translocation studies using the gene ( gene ) and the gene ( gene ) were performed to aid in identifying the mechanism by which anabolic-chemicalic chemical ( AAS ) were activating gene and potentially interacting with gene and how glucocorticoid ligands were interacting with the gene and gene .	T18	T30	20230007
NA	CHEMICAL	GENE-Y	10	12	Here , translocation studies using the gene ( gene ) and the gene ( gene ) were performed to aid in identifying the mechanism by which anabolic-chemicalic chemical ( AAS ) were activating gene and potentially interacting with gene and how glucocorticoid ligands were interacting with the gene and gene .	T18	T31	20230007
NA	CHEMICAL	GENE-Y	10	14	Here , translocation studies using the gene ( gene ) and the gene ( gene ) were performed to aid in identifying the mechanism by which anabolic-chemicalic chemical ( AAS ) were activating gene and potentially interacting with gene and how glucocorticoid ligands were interacting with the gene and gene .	T18	T32	20230007
NA	CHEMICAL	GENE-Y	10	33	Here , translocation studies using the gene ( gene ) and the gene ( gene ) were performed to aid in identifying the mechanism by which anabolic-chemicalic chemical ( AAS ) were activating gene and potentially interacting with gene and how glucocorticoid ligands were interacting with the gene and gene .	T18	T33	20230007
NA	CHEMICAL	GENE-Y	10	38	Here , translocation studies using the gene ( gene ) and the gene ( gene ) were performed to aid in identifying the mechanism by which anabolic-chemicalic chemical ( AAS ) were activating gene and potentially interacting with gene and how glucocorticoid ligands were interacting with the gene and gene .	T18	T34	20230007
NA	CHEMICAL	GENE-Y	10	47	Here , translocation studies using the gene ( gene ) and the gene ( gene ) were performed to aid in identifying the mechanism by which anabolic-chemicalic chemical ( AAS ) were activating gene and potentially interacting with gene and how glucocorticoid ligands were interacting with the gene and gene .	T18	T35	20230007
NA	CHEMICAL	GENE-Y	10	49	Here , translocation studies using the gene ( gene ) and the gene ( gene ) were performed to aid in identifying the mechanism by which anabolic-chemicalic chemical ( AAS ) were activating gene and potentially interacting with gene and how glucocorticoid ligands were interacting with the gene and gene .	T18	T36	20230007
NA	CHEMICAL	GENE-Y	27	6	Here , translocation studies using the gene ( gene ) and the gene ( gene ) were performed to aid in identifying the mechanism by which anabolic-chemicalic chemical ( AAS ) were activating gene and potentially interacting with gene and how glucocorticoid ligands were interacting with the gene and gene .	T19	T29	20230007
NA	CHEMICAL	GENE-Y	27	8	Here , translocation studies using the gene ( gene ) and the gene ( gene ) were performed to aid in identifying the mechanism by which anabolic-chemicalic chemical ( AAS ) were activating gene and potentially interacting with gene and how glucocorticoid ligands were interacting with the gene and gene .	T19	T30	20230007
NA	CHEMICAL	GENE-Y	27	12	Here , translocation studies using the gene ( gene ) and the gene ( gene ) were performed to aid in identifying the mechanism by which anabolic-chemicalic chemical ( AAS ) were activating gene and potentially interacting with gene and how glucocorticoid ligands were interacting with the gene and gene .	T19	T31	20230007
NA	CHEMICAL	GENE-Y	27	14	Here , translocation studies using the gene ( gene ) and the gene ( gene ) were performed to aid in identifying the mechanism by which anabolic-chemicalic chemical ( AAS ) were activating gene and potentially interacting with gene and how glucocorticoid ligands were interacting with the gene and gene .	T19	T32	20230007
CPR:3	CHEMICAL	GENE-Y	27	33	Here , translocation studies using the gene ( gene ) and the gene ( gene ) were performed to aid in identifying the mechanism by which anabolic-chemicalic chemical ( AAS ) were activating gene and potentially interacting with gene and how glucocorticoid ligands were interacting with the gene and gene .	T19	T33	20230007
NA	CHEMICAL	GENE-Y	27	38	Here , translocation studies using the gene ( gene ) and the gene ( gene ) were performed to aid in identifying the mechanism by which anabolic-chemicalic chemical ( AAS ) were activating gene and potentially interacting with gene and how glucocorticoid ligands were interacting with the gene and gene .	T19	T34	20230007
NA	CHEMICAL	GENE-Y	27	47	Here , translocation studies using the gene ( gene ) and the gene ( gene ) were performed to aid in identifying the mechanism by which anabolic-chemicalic chemical ( AAS ) were activating gene and potentially interacting with gene and how glucocorticoid ligands were interacting with the gene and gene .	T19	T35	20230007
NA	CHEMICAL	GENE-Y	27	49	Here , translocation studies using the gene ( gene ) and the gene ( gene ) were performed to aid in identifying the mechanism by which anabolic-chemicalic chemical ( AAS ) were activating gene and potentially interacting with gene and how glucocorticoid ligands were interacting with the gene and gene .	T19	T36	20230007
NA	CHEMICAL	GENE-Y	0	11	chemical ( chemical ) had the fastest translocation rate for the gene of 0.0525 min ( -1 ) .	T20	T44	20230007
NA	CHEMICAL	GENE-Y	2	11	chemical ( chemical ) had the fastest translocation rate for the gene of 0.0525 min ( -1 ) .	T21	T44	20230007
NA	CHEMICAL	GENE-Y	3	18	The other endogenous chemical , chemical ( chemical ) and chemical ( chemical ) , had considerably lower gene transport rates .	T1	T23	20230007
NA	CHEMICAL	GENE-Y	5	18	The other endogenous chemical , chemical ( chemical ) and chemical ( chemical ) , had considerably lower gene transport rates .	T2	T23	20230007
NA	CHEMICAL	GENE-Y	7	18	The other endogenous chemical , chemical ( chemical ) and chemical ( chemical ) , had considerably lower gene transport rates .	T3	T23	20230007
NA	CHEMICAL	GENE-Y	10	18	The other endogenous chemical , chemical ( chemical ) and chemical ( chemical ) , had considerably lower gene transport rates .	T4	T23	20230007
NA	CHEMICAL	GENE-Y	12	18	The other endogenous chemical , chemical ( chemical ) and chemical ( chemical ) , had considerably lower gene transport rates .	T5	T23	20230007
NA	CHEMICAL	GENE-Y	8	3	The rates of gene transport for the exogenous chemical chemical ( chemical ) , chemical ( chemical ) , and chemical ( chemical ) are lower than that of chemical and similar to those of the endogenous chemical chemical and chemical .	T6	T24	20230007
NA	CHEMICAL	GENE-Y	9	3	The rates of gene transport for the exogenous chemical chemical ( chemical ) , chemical ( chemical ) , and chemical ( chemical ) are lower than that of chemical and similar to those of the endogenous chemical chemical and chemical .	T7	T24	20230007
NA	CHEMICAL	GENE-Y	11	3	The rates of gene transport for the exogenous chemical chemical ( chemical ) , chemical ( chemical ) , and chemical ( chemical ) are lower than that of chemical and similar to those of the endogenous chemical chemical and chemical .	T8	T24	20230007
NA	CHEMICAL	GENE-Y	14	3	The rates of gene transport for the exogenous chemical chemical ( chemical ) , chemical ( chemical ) , and chemical ( chemical ) are lower than that of chemical and similar to those of the endogenous chemical chemical and chemical .	T9	T24	20230007
NA	CHEMICAL	GENE-Y	16	3	The rates of gene transport for the exogenous chemical chemical ( chemical ) , chemical ( chemical ) , and chemical ( chemical ) are lower than that of chemical and similar to those of the endogenous chemical chemical and chemical .	T10	T24	20230007
NA	CHEMICAL	GENE-Y	19	3	The rates of gene transport for the exogenous chemical chemical ( chemical ) , chemical ( chemical ) , and chemical ( chemical ) are lower than that of chemical and similar to those of the endogenous chemical chemical and chemical .	T11	T24	20230007
NA	CHEMICAL	GENE-Y	22	3	The rates of gene transport for the exogenous chemical chemical ( chemical ) , chemical ( chemical ) , and chemical ( chemical ) are lower than that of chemical and similar to those of the endogenous chemical chemical and chemical .	T12	T24	20230007
NA	CHEMICAL	GENE-Y	29	3	The rates of gene transport for the exogenous chemical chemical ( chemical ) , chemical ( chemical ) , and chemical ( chemical ) are lower than that of chemical and similar to those of the endogenous chemical chemical and chemical .	T13	T24	20230007
NA	CHEMICAL	GENE-Y	37	3	The rates of gene transport for the exogenous chemical chemical ( chemical ) , chemical ( chemical ) , and chemical ( chemical ) are lower than that of chemical and similar to those of the endogenous chemical chemical and chemical .	T14	T24	20230007
NA	CHEMICAL	GENE-Y	38	3	The rates of gene transport for the exogenous chemical chemical ( chemical ) , chemical ( chemical ) , and chemical ( chemical ) are lower than that of chemical and similar to those of the endogenous chemical chemical and chemical .	T15	T24	20230007
NA	CHEMICAL	GENE-Y	40	3	The rates of gene transport for the exogenous chemical chemical ( chemical ) , chemical ( chemical ) , and chemical ( chemical ) are lower than that of chemical and similar to those of the endogenous chemical chemical and chemical .	T16	T24	20230007
CPR:3	CHEMICAL	GENE-N	4	10	The data show that chemical is less potent at inducing gene gene expression in rainbow trout than chemical ( chemical ) , a well-known Ah-receptor agonist .	T1	T24	23628509
CPR:3	CHEMICAL	GENE-N	10	10	The data show that chemical is less potent at inducing gene gene expression in rainbow trout than chemical ( chemical ) , a well-known Ah-receptor agonist .	T2	T24	23628509
CPR:3	CHEMICAL	GENE-N	19	10	The data show that chemical is less potent at inducing gene gene expression in rainbow trout than chemical ( chemical ) , a well-known Ah-receptor agonist .	T3	T24	23628509
CPR:3	CHEMICAL	GENE-N	3	7	Interestingly , the chemical dependent up-regulation of gene mRNA is positively correlated with the incidences of clastogenic changes in rainbow trout erythrocytes .	T4	T25	23628509
CPR:4	CHEMICAL	GENE-Y	0	13	chemical has , comparably to chemical , a potential to repress expression of gene , in the head kidney of rainbow trout .	T5	T26	23628509
CPR:4	CHEMICAL	GENE-Y	5	13	chemical has , comparably to chemical , a potential to repress expression of gene , in the head kidney of rainbow trout .	T6	T26	23628509
NA	CHEMICAL	GENE-Y	2	9	Furthermore , chemical responsive genes in fish liver , gene and gene , are not induced by chemical , suggesting that the compound has no endocrine disrupting potential .	T7	T27	23628509
NA	CHEMICAL	GENE-Y	2	11	Furthermore , chemical responsive genes in fish liver , gene and gene , are not induced by chemical , suggesting that the compound has no endocrine disrupting potential .	T7	T28	23628509
NA	CHEMICAL	GENE-Y	17	9	Furthermore , chemical responsive genes in fish liver , gene and gene , are not induced by chemical , suggesting that the compound has no endocrine disrupting potential .	T8	T27	23628509
NA	CHEMICAL	GENE-Y	17	11	Furthermore , chemical responsive genes in fish liver , gene and gene , are not induced by chemical , suggesting that the compound has no endocrine disrupting potential .	T8	T28	23628509
NA	CHEMICAL	GENE-N	3	3	These illnesses are a result of chemical 's ability to bind to the gene , blocking the passage of nerve impulses and leading to death via respiratory paralysis .	T1	T10	23535394
CPR:4	CHEMICAL	GENE-N	5	2	Effectiveness of gene inhibition ( chemical ) in congestive heart failure .	T9	T17	1386491
CPR:4	CHEMICAL	GENE-Y	0	2	chemical is a novel , orally active inhibitor of gene gene , the enzyme that degrades gene ( gene ) .	T1	T13	1386491
CPR:4	CHEMICAL	GENE-Y	0	10	chemical is a novel , orally active inhibitor of gene gene , the enzyme that degrades gene ( gene ) .	T1	T15	1386491
NA	CHEMICAL	GENE-Y	0	16	chemical is a novel , orally active inhibitor of gene gene , the enzyme that degrades gene ( gene ) .	T1	T10	1386491
NA	CHEMICAL	GENE-Y	0	18	chemical is a novel , orally active inhibitor of gene gene , the enzyme that degrades gene ( gene ) .	T1	T11	1386491
CPR:3	CHEMICAL	GENE-Y	5	9	On study day 1 , chemical acutely increased plasma gene levels , suppressed chemical and decreased right atrial and pulmonary capillary wedge pressures .	T4	T12	1386491
NA	CHEMICAL	GENE-Y	13	9	On study day 1 , chemical acutely increased plasma gene levels , suppressed chemical and decreased right atrial and pulmonary capillary wedge pressures .	T5	T12	1386491
NA	CHEMICAL	GENE-Y	12	7	After 10 days of treatment , basal gene was increased and basal chemical was decreased .	T6	T14	1386491
CPR:3	CHEMICAL	GENE-Y	9	20	On study day 10 , the acute effects of chemical were similar to those on day 1 ( i.e. , gene was further increased , chemical was suppressed , and right and left ventricular filling pressures were decreased ) .	T7	T16	1386491
NA	CHEMICAL	GENE-Y	14	20	On study day 10 , the acute effects of chemical were similar to those on day 1 ( i.e. , gene was further increased , chemical was suppressed , and right and left ventricular filling pressures were decreased ) .	T8	T16	1386491
CPR:4	CHEMICAL	GENE-Y	0	4	chemical , an oral gene ( gene ) inhibitor , improves glycaemic control by inhibiting gene inactivation of the gene gene and chemical-dependent insulinotropic polypeptide .	T1	T22	17352516
CPR:4	CHEMICAL	GENE-Y	0	6	chemical , an oral gene ( gene ) inhibitor , improves glycaemic control by inhibiting gene inactivation of the gene gene and chemical-dependent insulinotropic polypeptide .	T1	T26	17352516
CPR:4	CHEMICAL	GENE-Y	0	15	chemical , an oral gene ( gene ) inhibitor , improves glycaemic control by inhibiting gene inactivation of the gene gene and chemical-dependent insulinotropic polypeptide .	T1	T18	17352516
CPR:3	CHEMICAL	GENE-N	0	19	chemical , an oral gene ( gene ) inhibitor , improves glycaemic control by inhibiting gene inactivation of the gene gene and chemical-dependent insulinotropic polypeptide .	T1	T19	17352516
CPR:3	CHEMICAL	GENE-Y	0	20	chemical , an oral gene ( gene ) inhibitor , improves glycaemic control by inhibiting gene inactivation of the gene gene and chemical-dependent insulinotropic polypeptide .	T1	T20	17352516
CPR:3	CHEMICAL	GENE-Y	0	24	chemical , an oral gene ( gene ) inhibitor , improves glycaemic control by inhibiting gene inactivation of the gene gene and chemical-dependent insulinotropic polypeptide .	T1	T21	17352516
NA	CHEMICAL	GENE-Y	22	4	chemical , an oral gene ( gene ) inhibitor , improves glycaemic control by inhibiting gene inactivation of the gene gene and chemical-dependent insulinotropic polypeptide .	T11	T22	17352516
NA	CHEMICAL	GENE-Y	22	6	chemical , an oral gene ( gene ) inhibitor , improves glycaemic control by inhibiting gene inactivation of the gene gene and chemical-dependent insulinotropic polypeptide .	T11	T26	17352516
NA	CHEMICAL	GENE-Y	22	15	chemical , an oral gene ( gene ) inhibitor , improves glycaemic control by inhibiting gene inactivation of the gene gene and chemical-dependent insulinotropic polypeptide .	T11	T18	17352516
NA	CHEMICAL	GENE-N	22	19	chemical , an oral gene ( gene ) inhibitor , improves glycaemic control by inhibiting gene inactivation of the gene gene and chemical-dependent insulinotropic polypeptide .	T11	T19	17352516
NA	CHEMICAL	GENE-Y	22	20	chemical , an oral gene ( gene ) inhibitor , improves glycaemic control by inhibiting gene inactivation of the gene gene and chemical-dependent insulinotropic polypeptide .	T11	T20	17352516
NA	CHEMICAL	GENE-Y	22	24	chemical , an oral gene ( gene ) inhibitor , improves glycaemic control by inhibiting gene inactivation of the gene gene and chemical-dependent insulinotropic polypeptide .	T11	T21	17352516
NA	CHEMICAL	GENE-N	13	3	This increases active gene and gene levels , and decreases gene levels and post-chemical-load chemical excursion .	T12	T23	17352516
NA	CHEMICAL	GENE-Y	13	5	This increases active gene and gene levels , and decreases gene levels and post-chemical-load chemical excursion .	T12	T24	17352516
NA	CHEMICAL	GENE-Y	13	10	This increases active gene and gene levels , and decreases gene levels and post-chemical-load chemical excursion .	T12	T25	17352516
NA	CHEMICAL	GENE-N	14	3	This increases active gene and gene levels , and decreases gene levels and post-chemical-load chemical excursion .	T13	T23	17352516
NA	CHEMICAL	GENE-Y	14	5	This increases active gene and gene levels , and decreases gene levels and post-chemical-load chemical excursion .	T13	T24	17352516
NA	CHEMICAL	GENE-Y	14	10	This increases active gene and gene levels , and decreases gene levels and post-chemical-load chemical excursion .	T13	T25	17352516
NA	CHEMICAL	GENE-Y	8	8	In large , well designed phase III trials in patients with type 2 diabetes mellitus , chemical 100 or 200mg once daily alone or in combination with other antihyperglycaemics was associated with significant improvements relative to placebo in overall glycaemic control and indices for gene response and beta-cell function .	T14	T27	17352516
CPR:3	CHEMICAL	GENE-Y	3	3	Improvements from baseline in mean gene ( gene ) were significantly greater with chemical monotherapy than with placebo in patients with type 2 diabetes .	T15	T28	17352516
CPR:3	CHEMICAL	GENE-Y	3	6	Improvements from baseline in mean gene ( gene ) were significantly greater with chemical monotherapy than with placebo in patients with type 2 diabetes .	T15	T29	17352516
CPR:3	CHEMICAL	GENE-Y	3	16	As add-on therapy in patients with suboptimal glycaemic control despite oral antihyperglycaemic treatment , chemical improved gene to a significantly greater extent than placebo when added to chemical or chemical and was noninferior to chemical when added to chemical .	T16	T30	17352516
CPR:3	CHEMICAL	GENE-Y	3	16	As add-on therapy in patients with suboptimal glycaemic control despite oral antihyperglycaemic treatment , chemical improved gene to a significantly greater extent than placebo when added to chemical or chemical and was noninferior to chemical when added to chemical .	T2	T30	17352516
CPR:3	CHEMICAL	GENE-Y	16	16	As add-on therapy in patients with suboptimal glycaemic control despite oral antihyperglycaemic treatment , chemical improved gene to a significantly greater extent than placebo when added to chemical or chemical and was noninferior to chemical when added to chemical .	T3	T30	17352516
NA	CHEMICAL	GENE-Y	34	16	As add-on therapy in patients with suboptimal glycaemic control despite oral antihyperglycaemic treatment , chemical improved gene to a significantly greater extent than placebo when added to chemical or chemical and was noninferior to chemical when added to chemical .	T4	T30	17352516
CPR:4	CHEMICAL	GENE-Y	3	16	As add-on therapy in patients with suboptimal glycaemic control despite oral antihyperglycaemic treatment , chemical improved gene to a significantly greater extent than placebo when added to chemical or chemical and was noninferior to chemical when added to chemical .	T5	T30	17352516
NA	CHEMICAL	GENE-Y	2	5	Mechanisms of chemical Lowering of gene Inhibitor chemical When Used Alone or With chemical in Type 2 Diabetes : A double-tracer study .	T14	T29	23579178
CPR:4	CHEMICAL	GENE-Y	7	5	Mechanisms of chemical Lowering of gene Inhibitor chemical When Used Alone or With chemical in Type 2 Diabetes : A double-tracer study .	T15	T29	23579178
NA	CHEMICAL	GENE-Y	11	5	Mechanisms of chemical Lowering of gene Inhibitor chemical When Used Alone or With chemical in Type 2 Diabetes : A double-tracer study .	T13	T29	23579178
NA	CHEMICAL	GENE-Y	2	9	Fasting plasma chemical ( FPG ) , fasting plasma gene , chemical-peptide ( gene secretory rate [ ISR ] ) , fasting plasma gene , and bioactive gene ( gene ) and gene ( gene ) was measured.RESULTSFPG decreased from P , 160 ± 4 to M , 150 ± 4 ; S , 154 ± 4 ; and M+S , 125 ± 3 mg/dL .	T7	T19	23579178
NA	CHEMICAL	GENE-Y	2	13	Fasting plasma chemical ( FPG ) , fasting plasma gene , chemical-peptide ( gene secretory rate [ ISR ] ) , fasting plasma gene , and bioactive gene ( gene ) and gene ( gene ) was measured.RESULTSFPG decreased from P , 160 ± 4 to M , 150 ± 4 ; S , 154 ± 4 ; and M+S , 125 ± 3 mg/dL .	T7	T21	23579178
NA	CHEMICAL	GENE-Y	2	23	Fasting plasma chemical ( FPG ) , fasting plasma gene , chemical-peptide ( gene secretory rate [ ISR ] ) , fasting plasma gene , and bioactive gene ( gene ) and gene ( gene ) was measured.RESULTSFPG decreased from P , 160 ± 4 to M , 150 ± 4 ; S , 154 ± 4 ; and M+S , 125 ± 3 mg/dL .	T7	T22	23579178
NA	CHEMICAL	GENE-Y	2	27	Fasting plasma chemical ( FPG ) , fasting plasma gene , chemical-peptide ( gene secretory rate [ ISR ] ) , fasting plasma gene , and bioactive gene ( gene ) and gene ( gene ) was measured.RESULTSFPG decreased from P , 160 ± 4 to M , 150 ± 4 ; S , 154 ± 4 ; and M+S , 125 ± 3 mg/dL .	T7	T23	23579178
NA	CHEMICAL	GENE-Y	2	29	Fasting plasma chemical ( FPG ) , fasting plasma gene , chemical-peptide ( gene secretory rate [ ISR ] ) , fasting plasma gene , and bioactive gene ( gene ) and gene ( gene ) was measured.RESULTSFPG decreased from P , 160 ± 4 to M , 150 ± 4 ; S , 154 ± 4 ; and M+S , 125 ± 3 mg/dL .	T7	T24	23579178
NA	CHEMICAL	GENE-Y	2	32	Fasting plasma chemical ( FPG ) , fasting plasma gene , chemical-peptide ( gene secretory rate [ ISR ] ) , fasting plasma gene , and bioactive gene ( gene ) and gene ( gene ) was measured.RESULTSFPG decreased from P , 160 ± 4 to M , 150 ± 4 ; S , 154 ± 4 ; and M+S , 125 ± 3 mg/dL .	T7	T25	23579178
NA	CHEMICAL	GENE-Y	2	34	Fasting plasma chemical ( FPG ) , fasting plasma gene , chemical-peptide ( gene secretory rate [ ISR ] ) , fasting plasma gene , and bioactive gene ( gene ) and gene ( gene ) was measured.RESULTSFPG decreased from P , 160 ± 4 to M , 150 ± 4 ; S , 154 ± 4 ; and M+S , 125 ± 3 mg/dL .	T7	T26	23579178
NA	CHEMICAL	GENE-Y	11	9	Fasting plasma chemical ( FPG ) , fasting plasma gene , chemical-peptide ( gene secretory rate [ ISR ] ) , fasting plasma gene , and bioactive gene ( gene ) and gene ( gene ) was measured.RESULTSFPG decreased from P , 160 ± 4 to M , 150 ± 4 ; S , 154 ± 4 ; and M+S , 125 ± 3 mg/dL .	T8	T19	23579178
NA	CHEMICAL	GENE-Y	11	13	Fasting plasma chemical ( FPG ) , fasting plasma gene , chemical-peptide ( gene secretory rate [ ISR ] ) , fasting plasma gene , and bioactive gene ( gene ) and gene ( gene ) was measured.RESULTSFPG decreased from P , 160 ± 4 to M , 150 ± 4 ; S , 154 ± 4 ; and M+S , 125 ± 3 mg/dL .	T8	T21	23579178
NA	CHEMICAL	GENE-Y	11	23	Fasting plasma chemical ( FPG ) , fasting plasma gene , chemical-peptide ( gene secretory rate [ ISR ] ) , fasting plasma gene , and bioactive gene ( gene ) and gene ( gene ) was measured.RESULTSFPG decreased from P , 160 ± 4 to M , 150 ± 4 ; S , 154 ± 4 ; and M+S , 125 ± 3 mg/dL .	T8	T22	23579178
NA	CHEMICAL	GENE-Y	11	27	Fasting plasma chemical ( FPG ) , fasting plasma gene , chemical-peptide ( gene secretory rate [ ISR ] ) , fasting plasma gene , and bioactive gene ( gene ) and gene ( gene ) was measured.RESULTSFPG decreased from P , 160 ± 4 to M , 150 ± 4 ; S , 154 ± 4 ; and M+S , 125 ± 3 mg/dL .	T8	T23	23579178
NA	CHEMICAL	GENE-Y	11	29	Fasting plasma chemical ( FPG ) , fasting plasma gene , chemical-peptide ( gene secretory rate [ ISR ] ) , fasting plasma gene , and bioactive gene ( gene ) and gene ( gene ) was measured.RESULTSFPG decreased from P , 160 ± 4 to M , 150 ± 4 ; S , 154 ± 4 ; and M+S , 125 ± 3 mg/dL .	T8	T24	23579178
NA	CHEMICAL	GENE-Y	11	32	Fasting plasma chemical ( FPG ) , fasting plasma gene , chemical-peptide ( gene secretory rate [ ISR ] ) , fasting plasma gene , and bioactive gene ( gene ) and gene ( gene ) was measured.RESULTSFPG decreased from P , 160 ± 4 to M , 150 ± 4 ; S , 154 ± 4 ; and M+S , 125 ± 3 mg/dL .	T8	T25	23579178
NA	CHEMICAL	GENE-Y	11	34	Fasting plasma chemical ( FPG ) , fasting plasma gene , chemical-peptide ( gene secretory rate [ ISR ] ) , fasting plasma gene , and bioactive gene ( gene ) and gene ( gene ) was measured.RESULTSFPG decreased from P , 160 ± 4 to M , 150 ± 4 ; S , 154 ± 4 ; and M+S , 125 ± 3 mg/dL .	T8	T26	23579178
NA	CHEMICAL	GENE-Y	4	2	The increase in mean post-chemical plasma gene and in ISR was similar in P , M , and S and slightly greater in M+S .	T12	T27	23579178
NA	CHEMICAL	GENE-Y	3	6	Fasting and mean post-chemical plasma bioactive gene were higher ( P < 0.01 ) after S and M+S vs .	T1	T16	23579178
CPR:4	CHEMICAL	GENE-Y	3	9	Structure-based design of chemical , a novel orally effective gene inhibitor .	T6	T15	12927775
CPR:4	CHEMICAL	GENE-Y	6	15	This led to the discovery of chemical , a highly potent and selective inhibitor of gene in vitro , and in vivo ; once-daily oral doses of chemical inhibit gene and lower blood pressure in chemical-depleted marmosets and hypertensive human patients .	T3	T13	12927775
NA	CHEMICAL	GENE-Y	6	16	This led to the discovery of chemical , a highly potent and selective inhibitor of gene in vitro , and in vivo ; once-daily oral doses of chemical inhibit gene and lower blood pressure in chemical-depleted marmosets and hypertensive human patients .	T3	T14	12927775
NA	CHEMICAL	GENE-Y	8	15	This led to the discovery of chemical , a highly potent and selective inhibitor of gene in vitro , and in vivo ; once-daily oral doses of chemical inhibit gene and lower blood pressure in chemical-depleted marmosets and hypertensive human patients .	T4	T13	12927775
CPR:4	CHEMICAL	GENE-Y	8	16	This led to the discovery of chemical , a highly potent and selective inhibitor of gene in vitro , and in vivo ; once-daily oral doses of chemical inhibit gene and lower blood pressure in chemical-depleted marmosets and hypertensive human patients .	T4	T14	12927775
NA	CHEMICAL	GENE-Y	35	15	This led to the discovery of chemical , a highly potent and selective inhibitor of gene in vitro , and in vivo ; once-daily oral doses of chemical inhibit gene and lower blood pressure in chemical-depleted marmosets and hypertensive human patients .	T5	T13	12927775
NA	CHEMICAL	GENE-Y	35	16	This led to the discovery of chemical , a highly potent and selective inhibitor of gene in vitro , and in vivo ; once-daily oral doses of chemical inhibit gene and lower blood pressure in chemical-depleted marmosets and hypertensive human patients .	T5	T14	12927775
NA	CHEMICAL	GENE-Y	3	4	Binding site of chemical to gene depends on species .	T5	T19	11562773
NA	CHEMICAL	GENE-N	10	10	By theoretical calculations we have determined most probable structure of chemical/gene complexes .	T4	T18	11562773
NA	CHEMICAL	GENE-Y	5	5	Significant differences were observed in a different region ( loop B93-B101 ) , that we identified as binding site of chemical to the gene ( gene ) .	T1	T6	11562773
NA	CHEMICAL	GENE-Y	5	25	Significant differences were observed in a different region ( loop B93-B101 ) , that we identified as binding site of chemical to the gene ( gene ) .	T1	T7	11562773
CPR:4	CHEMICAL	GENE-N	0	6	chemical is a specific inhibitor of gene but does not inhibit gene .	T2	T10	11562773
NA	CHEMICAL	GENE-Y	0	11	chemical is a specific inhibitor of gene but does not inhibit gene .	T2	T11	11562773
NA	CHEMICAL	GENE-N	0	17	chemical , chemical suppresses the proliferation of human colon cancer cells and induces apoptosis by modulating the gene/gene signalling pathway .	T10	T18	23017388
NA	CHEMICAL	GENE-Y	0	17	chemical , chemical suppresses the proliferation of human colon cancer cells and induces apoptosis by modulating the gene/gene signalling pathway .	T10	T19	23017388
NA	CHEMICAL	GENE-N	2	17	chemical , chemical suppresses the proliferation of human colon cancer cells and induces apoptosis by modulating the gene/gene signalling pathway .	T11	T18	23017388
NA	CHEMICAL	GENE-Y	2	17	chemical , chemical suppresses the proliferation of human colon cancer cells and induces apoptosis by modulating the gene/gene signalling pathway .	T11	T19	23017388
CPR:4	CHEMICAL	GENE-Y	2	11	Also , chemical showed anti-angiogenic activity by decreasing the expression of gene and gene .	T4	T12	23017388
CPR:4	CHEMICAL	GENE-Y	2	13	Also , chemical showed anti-angiogenic activity by decreasing the expression of gene and gene .	T4	T13	23017388
CPR:4	CHEMICAL	GENE-N	8	12	When further examined for its anticancer mechanism , chemical effectively suppressed the gene/gene pathway both in vitro and in vivo .	T7	T14	23017388
CPR:4	CHEMICAL	GENE-Y	8	12	When further examined for its anticancer mechanism , chemical effectively suppressed the gene/gene pathway both in vitro and in vivo .	T7	T15	23017388
CPR:4	CHEMICAL	GENE-N	7	10	Taken together , our study demonstrated that chemical inhibits the gene/gene pathway , leading to the suppression of tumor growth and angiogenesis together with induction of apoptosis .	T8	T16	23017388
CPR:4	CHEMICAL	GENE-Y	7	10	Taken together , our study demonstrated that chemical inhibits the gene/gene pathway , leading to the suppression of tumor growth and angiogenesis together with induction of apoptosis .	T8	T17	23017388
NA	CHEMICAL	GENE-Y	4	6	Influence of the novel chemical H3 receptor antagonist ST1283 on voluntary chemical consumption and chemical-induced place preference in mice .	T22	T30	23474889
NA	CHEMICAL	GENE-Y	11	6	Influence of the novel chemical H3 receptor antagonist ST1283 on voluntary chemical consumption and chemical-induced place preference in mice .	T23	T30	23474889
NA	CHEMICAL	GENE-Y	14	6	Influence of the novel chemical H3 receptor antagonist ST1283 on voluntary chemical consumption and chemical-induced place preference in mice .	T21	T30	23474889
NA	CHEMICAL	GENE-Y	5	12	RATIONALE : Growing evidence supports a role for the central chemicalrgic system to have a modulatory influence on drug addiction in general and chemical-use disorders in particular through gene ( gene ) .	T6	T26	23474889
NA	CHEMICAL	GENE-Y	5	30	RATIONALE : Growing evidence supports a role for the central chemicalrgic system to have a modulatory influence on drug addiction in general and chemical-use disorders in particular through gene ( gene ) .	T6	T27	23474889
NA	CHEMICAL	GENE-Y	5	12	RATIONALE : Growing evidence supports a role for the central chemicalrgic system to have a modulatory influence on drug addiction in general and chemical-use disorders in particular through gene ( gene ) .	T9	T26	23474889
NA	CHEMICAL	GENE-Y	5	30	RATIONALE : Growing evidence supports a role for the central chemicalrgic system to have a modulatory influence on drug addiction in general and chemical-use disorders in particular through gene ( gene ) .	T9	T27	23474889
NA	CHEMICAL	GENE-Y	20	16	OBJECTIVE : In the present study , the effects of systemic injection of the newly synthesized gene antagonist ST1283 on chemical ( chemical ) voluntary intake and chemical-conditioned reward in mice have been investigated .	T10	T28	23474889
NA	CHEMICAL	GENE-Y	22	16	OBJECTIVE : In the present study , the effects of systemic injection of the newly synthesized gene antagonist ST1283 on chemical ( chemical ) voluntary intake and chemical-conditioned reward in mice have been investigated .	T11	T28	23474889
NA	CHEMICAL	GENE-Y	27	16	OBJECTIVE : In the present study , the effects of systemic injection of the newly synthesized gene antagonist ST1283 on chemical ( chemical ) voluntary intake and chemical-conditioned reward in mice have been investigated .	T12	T28	23474889
CPR:5	CHEMICAL	GENE-Y	13	11	This inhibition was blocked when mice were pretreated with the selective gene agonist chemical ( 10 mg/kg ) .	T3	T24	23474889
NA	CHEMICAL	GENE-Y	10	10	OBJECTIVETo determine the prevalence of people with diabetes who meet gene ( gene ) , blood pressure ( BP ) , and gene chemical ( ABC ) recommendations , and their current statin use , factors associated with goal achievement , and changes in the proportion achieving goals between 1988 and 2010.RESEARCH AND DESIGN METHODSData were cross-sectional from the National Health and Nutrition Examination Surveys ( NHANES ) from 1988-1994 , 1999-2002 , 2003-2006 , and 2007-2010 .	T1	T12	23418368
NA	CHEMICAL	GENE-Y	10	12	OBJECTIVETo determine the prevalence of people with diabetes who meet gene ( gene ) , blood pressure ( BP ) , and gene chemical ( ABC ) recommendations , and their current statin use , factors associated with goal achievement , and changes in the proportion achieving goals between 1988 and 2010.RESEARCH AND DESIGN METHODSData were cross-sectional from the National Health and Nutrition Examination Surveys ( NHANES ) from 1988-1994 , 1999-2002 , 2003-2006 , and 2007-2010 .	T1	T14	23418368
NA	CHEMICAL	GENE-N	10	22	OBJECTIVETo determine the prevalence of people with diabetes who meet gene ( gene ) , blood pressure ( BP ) , and gene chemical ( ABC ) recommendations , and their current statin use , factors associated with goal achievement , and changes in the proportion achieving goals between 1988 and 2010.RESEARCH AND DESIGN METHODSData were cross-sectional from the National Health and Nutrition Examination Surveys ( NHANES ) from 1988-1994 , 1999-2002 , 2003-2006 , and 2007-2010 .	T1	T3	23418368
NA	CHEMICAL	GENE-Y	10	4	Main outcome measures were gene , BP , and gene chemical , in accordance with the American Diabetes Association recommendations , and current use of statins.RESULTSIn 2007-2010 , 52.5 % of people with diabetes achieved gene < 7.0 % ( < 53 mmol/mol ) , 51.1 % achieved BP < 130/80 mmHg , 56.2 % achieved gene < 100 mg/dL , and 18.8 % achieved all three ABCs .	T2	T10	23418368
NA	CHEMICAL	GENE-N	10	9	Main outcome measures were gene , BP , and gene chemical , in accordance with the American Diabetes Association recommendations , and current use of statins.RESULTSIn 2007-2010 , 52.5 % of people with diabetes achieved gene < 7.0 % ( < 53 mmol/mol ) , 51.1 % achieved BP < 130/80 mmHg , 56.2 % achieved gene < 100 mg/dL , and 18.8 % achieved all three ABCs .	T2	T11	23418368
NA	CHEMICAL	GENE-Y	10	35	Main outcome measures were gene , BP , and gene chemical , in accordance with the American Diabetes Association recommendations , and current use of statins.RESULTSIn 2007-2010 , 52.5 % of people with diabetes achieved gene < 7.0 % ( < 53 mmol/mol ) , 51.1 % achieved BP < 130/80 mmHg , 56.2 % achieved gene < 100 mg/dL , and 18.8 % achieved all three ABCs .	T2	T13	23418368
NA	CHEMICAL	GENE-N	10	56	Main outcome measures were gene , BP , and gene chemical , in accordance with the American Diabetes Association recommendations , and current use of statins.RESULTSIn 2007-2010 , 52.5 % of people with diabetes achieved gene < 7.0 % ( < 53 mmol/mol ) , 51.1 % achieved BP < 130/80 mmHg , 56.2 % achieved gene < 100 mg/dL , and 18.8 % achieved all three ABCs .	T2	T15	23418368
NA	CHEMICAL	GENE-N	6	7	Functional and molecular characterization of multiple chemical cotransporter isoforms in corneal epithelial cells .	T6	T27	17418819
NA	CHEMICAL	GENE-N	11	12	The dependence of regulatory volume decrease ( RVD ) activity on chemical cotransporter ( gene ) isoform expression was characterized in corneal epithelial cells ( CEC ) .	T5	T19	17418819
NA	CHEMICAL	GENE-N	11	14	The dependence of regulatory volume decrease ( RVD ) activity on chemical cotransporter ( gene ) isoform expression was characterized in corneal epithelial cells ( CEC ) .	T5	T26	17418819
CPR:4	CHEMICAL	GENE-N	1	1	A gene inhibitor-chemical ( chemical ) -blocked RVD more in HCEC than RCEC .	T1	T17	17418819
CPR:4	CHEMICAL	GENE-N	0	1	A gene inhibitor-chemical ( chemical ) -blocked RVD more in HCEC than RCEC .	T2	T17	17418819
CPR:3	CHEMICAL	GENE-N	4	9	Under isotonic conditions , chemical ( chemical ) produced gene activation and transient cell shrinkage .	T3	T18	17418819
CPR:3	CHEMICAL	GENE-N	6	9	Under isotonic conditions , chemical ( chemical ) produced gene activation and transient cell shrinkage .	T4	T18	17418819
NA	CHEMICAL	GENE-Y	10	0	gene ( gene/gene ) was originally discovered in 1978 as a unique chemical-binding protein that does not contain the gene of chemical-binding domain .	T7	T10	23453039
NA	CHEMICAL	GENE-Y	10	2	gene ( gene/gene ) was originally discovered in 1978 as a unique chemical-binding protein that does not contain the gene of chemical-binding domain .	T7	T15	23453039
NA	CHEMICAL	GENE-Y	10	2	gene ( gene/gene ) was originally discovered in 1978 as a unique chemical-binding protein that does not contain the gene of chemical-binding domain .	T7	T22	23453039
NA	CHEMICAL	GENE-N	10	19	gene ( gene/gene ) was originally discovered in 1978 as a unique chemical-binding protein that does not contain the gene of chemical-binding domain .	T7	T14	23453039
NA	CHEMICAL	GENE-N	10	7	gene ( gene/gene ) was originally discovered in 1978 as a unique chemical-binding protein that does not contain the gene of chemical-binding domain .	T7	T17	23453039
NA	CHEMICAL	GENE-Y	10	0	gene ( gene/gene ) was originally discovered in 1978 as a unique chemical-binding protein that does not contain the gene of chemical-binding domain .	T5	T10	23453039
NA	CHEMICAL	GENE-Y	10	2	gene ( gene/gene ) was originally discovered in 1978 as a unique chemical-binding protein that does not contain the gene of chemical-binding domain .	T5	T15	23453039
NA	CHEMICAL	GENE-Y	10	2	gene ( gene/gene ) was originally discovered in 1978 as a unique chemical-binding protein that does not contain the gene of chemical-binding domain .	T5	T22	23453039
NA	CHEMICAL	GENE-N	10	19	gene ( gene/gene ) was originally discovered in 1978 as a unique chemical-binding protein that does not contain the gene of chemical-binding domain .	T5	T14	23453039
NA	CHEMICAL	GENE-N	10	7	gene ( gene/gene ) was originally discovered in 1978 as a unique chemical-binding protein that does not contain the gene of chemical-binding domain .	T5	T17	23453039
NA	CHEMICAL	GENE-Y	6	0	gene has been shown to play a multifunctional role in cell regulation ; maintaining of intracellular chemical homeostasis and suppressing of signal transduction , translational protein synthesis , nuclear deoxyribonucleic acid ( DNA ) and ribonucleic acid ( RNA ) synthesis , proliferation , and apoptosis in many cell types .	T6	T26	23453039
CPR:4	CHEMICAL	GENE-Y	11	3	The expression of gene is stimulated through the action of gene in liver cells in vitro and in vivo and it is decreased in the liver of rats with type I diabetes induced by chemical administration in vivo .	T8	T28	23453039
NA	CHEMICAL	GENE-Y	11	10	The expression of gene is stimulated through the action of gene in liver cells in vitro and in vivo and it is decreased in the liver of rats with type I diabetes induced by chemical administration in vivo .	T8	T29	23453039
NA	CHEMICAL	GENE-Y	5	3	Overexpression of endogenous gene stimulates chemical utilization and lipid production in liver cells with chemical supplementation in vitro .	T9	T30	23453039
NA	CHEMICAL	GENE-Y	14	3	Overexpression of endogenous gene stimulates chemical utilization and lipid production in liver cells with chemical supplementation in vitro .	T1	T30	23453039
NA	CHEMICAL	GENE-Y	7	2	Deficiency of gene induces an impairment of chemical tolerance and lipid accumulation in the liver of mice in vivo .	T2	T13	23453039
NA	CHEMICAL	GENE-Y	9	3	Overexpression of endogenous gene has been shown to decrease chemical , total chemical and glycogen contents in the liver of rats , inducing hyperlipidemia .	T3	T16	23453039
NA	CHEMICAL	GENE-Y	12	3	Overexpression of endogenous gene has been shown to decrease chemical , total chemical and glycogen contents in the liver of rats , inducing hyperlipidemia .	T4	T16	23453039
NA	CHEMICAL	GENE-N	18	8	The assembly and activation of oligomeric complexes of gene , the gene ( gene ) , and heparan chemical transmit intracellular signals regulating growth and function of cells .	T1	T22	9890894
NA	CHEMICAL	GENE-N	18	11	The assembly and activation of oligomeric complexes of gene , the gene ( gene ) , and heparan chemical transmit intracellular signals regulating growth and function of cells .	T1	T25	9890894
NA	CHEMICAL	GENE-N	18	13	The assembly and activation of oligomeric complexes of gene , the gene ( gene ) , and heparan chemical transmit intracellular signals regulating growth and function of cells .	T1	T35	9890894
NA	CHEMICAL	GENE-N	5	19	Previously , we reported that a primary heparin or heparan chemical binding site resides in a distinct sequence in gene of the three modules of gene .	T5	T21	9890894
NA	CHEMICAL	GENE-N	5	25	Previously , we reported that a primary heparin or heparan chemical binding site resides in a distinct sequence in gene of the three modules of gene .	T5	T23	9890894
NA	CHEMICAL	GENE-N	3	0	gene and the chemical-terminus of gene are dispensable for high-affinity binding of gene , gene , and gene .	T6	T33	9890894
NA	CHEMICAL	GENE-N	3	5	gene and the chemical-terminus of gene are dispensable for high-affinity binding of gene , gene , and gene .	T6	T34	9890894
NA	CHEMICAL	GENE-Y	3	12	gene and the chemical-terminus of gene are dispensable for high-affinity binding of gene , gene , and gene .	T6	T36	9890894
NA	CHEMICAL	GENE-Y	3	14	gene and the chemical-terminus of gene are dispensable for high-affinity binding of gene , gene , and gene .	T6	T37	9890894
NA	CHEMICAL	GENE-Y	3	17	gene and the chemical-terminus of gene are dispensable for high-affinity binding of gene , gene , and gene .	T6	T38	9890894
NA	CHEMICAL	GENE-N	10	6	Addition of a specific number of gene sequences to the chemical-terminus of gene resulted in a gain in affinity for gene .	T2	T11	9890894
NA	CHEMICAL	GENE-N	10	12	Addition of a specific number of gene sequences to the chemical-terminus of gene resulted in a gain in affinity for gene .	T2	T12	9890894
NA	CHEMICAL	GENE-Y	10	20	Addition of a specific number of gene sequences to the chemical-terminus of gene resulted in a gain in affinity for gene .	T2	T13	9890894
NA	CHEMICAL	GENE-N	5	8	Several site-specific alterations in the chemical-terminus of full-length gene , an isoform that otherwise absolutely rejects gene , resulted in gain of gene binding .	T3	T14	9890894
NA	CHEMICAL	GENE-Y	5	16	Several site-specific alterations in the chemical-terminus of full-length gene , an isoform that otherwise absolutely rejects gene , resulted in gain of gene binding .	T3	T15	9890894
NA	CHEMICAL	GENE-Y	5	22	Several site-specific alterations in the chemical-terminus of full-length gene , an isoform that otherwise absolutely rejects gene , resulted in gain of gene binding .	T3	T16	9890894
NA	CHEMICAL	GENE-N	7	23	The sustained model raised the average plasma chemical concentration from 70 mg/dL to 180 mg/dL and led to decreased gene expression of chemical transporter gene .	T5	T9	23193186
NA	CHEMICAL	GENE-Y	7	24	The sustained model raised the average plasma chemical concentration from 70 mg/dL to 180 mg/dL and led to decreased gene expression of chemical transporter gene .	T5	T10	23193186
NA	CHEMICAL	GENE-N	22	23	The sustained model raised the average plasma chemical concentration from 70 mg/dL to 180 mg/dL and led to decreased gene expression of chemical transporter gene .	T6	T9	23193186
NA	CHEMICAL	GENE-Y	22	24	The sustained model raised the average plasma chemical concentration from 70 mg/dL to 180 mg/dL and led to decreased gene expression of chemical transporter gene .	T6	T10	23193186
NA	CHEMICAL	GENE-N	7	10	The disease has been associated with mutations in the chemical receptor subunit genes gene and gene .	T1	T4	16884688
NA	CHEMICAL	GENE-Y	7	13	The disease has been associated with mutations in the chemical receptor subunit genes gene and gene .	T1	T5	16884688
NA	CHEMICAL	GENE-Y	7	15	The disease has been associated with mutations in the chemical receptor subunit genes gene and gene .	T1	T6	16884688
NA	CHEMICAL	GENE-Y	8	10	Here , we describe mutations within the neuronal chemical transporter 2 gene ( gene , or gene , ) of hyperekplexia patients , whose symptoms can not be attributed to chemical receptor mutations .	T2	T7	16884688
NA	CHEMICAL	GENE-Y	8	10	Here , we describe mutations within the neuronal chemical transporter 2 gene ( gene , or gene , ) of hyperekplexia patients , whose symptoms can not be attributed to chemical receptor mutations .	T2	T8	16884688
NA	CHEMICAL	GENE-Y	8	16	Here , we describe mutations within the neuronal chemical transporter 2 gene ( gene , or gene , ) of hyperekplexia patients , whose symptoms can not be attributed to chemical receptor mutations .	T2	T9	16884688
NA	CHEMICAL	GENE-N	8	15	Here , we describe mutations within the neuronal chemical transporter 2 gene ( gene , or gene , ) of hyperekplexia patients , whose symptoms can not be attributed to chemical receptor mutations .	T2	T10	16884688
NA	CHEMICAL	GENE-Y	30	10	Here , we describe mutations within the neuronal chemical transporter 2 gene ( gene , or gene , ) of hyperekplexia patients , whose symptoms can not be attributed to chemical receptor mutations .	T3	T7	16884688
NA	CHEMICAL	GENE-Y	30	10	Here , we describe mutations within the neuronal chemical transporter 2 gene ( gene , or gene , ) of hyperekplexia patients , whose symptoms can not be attributed to chemical receptor mutations .	T3	T8	16884688
NA	CHEMICAL	GENE-Y	30	16	Here , we describe mutations within the neuronal chemical transporter 2 gene ( gene , or gene , ) of hyperekplexia patients , whose symptoms can not be attributed to chemical receptor mutations .	T3	T9	16884688
NA	CHEMICAL	GENE-N	30	15	Here , we describe mutations within the neuronal chemical transporter 2 gene ( gene , or gene , ) of hyperekplexia patients , whose symptoms can not be attributed to chemical receptor mutations .	T3	T10	16884688
NA	CHEMICAL	GENE-N	11	7	The specific enzymatic activity of four different gene ( gene , chemical aminopeptidase , gene and gene ) in vaginal homogenates from rabbit , rat , guinea-pig , sheep and humans was compared .	T11	T20	11732752
NA	CHEMICAL	GENE-N	11	9	The specific enzymatic activity of four different gene ( gene , chemical aminopeptidase , gene and gene ) in vaginal homogenates from rabbit , rat , guinea-pig , sheep and humans was compared .	T11	T24	11732752
NA	CHEMICAL	GENE-N	11	12	The specific enzymatic activity of four different gene ( gene , chemical aminopeptidase , gene and gene ) in vaginal homogenates from rabbit , rat , guinea-pig , sheep and humans was compared .	T11	T27	11732752
NA	CHEMICAL	GENE-N	11	14	The specific enzymatic activity of four different gene ( gene , chemical aminopeptidase , gene and gene ) in vaginal homogenates from rabbit , rat , guinea-pig , sheep and humans was compared .	T11	T15	11732752
NA	CHEMICAL	GENE-N	11	16	The specific enzymatic activity of four different gene ( gene , chemical aminopeptidase , gene and gene ) in vaginal homogenates from rabbit , rat , guinea-pig , sheep and humans was compared .	T11	T17	11732752
NA	CHEMICAL	GENE-N	17	4	Different substrates were used as the relative specific substrates for the determination of gene enzymatic activity : chemical of chemical for gene , chemical of chemical for chemical aminopeptidase , chemical of chemical for gene and chemical of chemical for gene . The gene enzymatic activity of different species was determined spectrofluorometrically .	T2	T19	11732752
CPR:9	CHEMICAL	GENE-N	17	21	Different substrates were used as the relative specific substrates for the determination of gene enzymatic activity : chemical of chemical for gene , chemical of chemical for chemical aminopeptidase , chemical of chemical for gene and chemical of chemical for gene . The gene enzymatic activity of different species was determined spectrofluorometrically .	T2	T21	11732752
NA	CHEMICAL	GENE-N	17	4	Different substrates were used as the relative specific substrates for the determination of gene enzymatic activity : chemical of chemical for gene , chemical of chemical for chemical aminopeptidase , chemical of chemical for gene and chemical of chemical for gene . The gene enzymatic activity of different species was determined spectrofluorometrically .	T2	T22	11732752
NA	CHEMICAL	GENE-N	17	34	Different substrates were used as the relative specific substrates for the determination of gene enzymatic activity : chemical of chemical for gene , chemical of chemical for chemical aminopeptidase , chemical of chemical for gene and chemical of chemical for gene . The gene enzymatic activity of different species was determined spectrofluorometrically .	T2	T23	11732752
NA	CHEMICAL	GENE-N	17	40	Different substrates were used as the relative specific substrates for the determination of gene enzymatic activity : chemical of chemical for gene , chemical of chemical for chemical aminopeptidase , chemical of chemical for gene and chemical of chemical for gene . The gene enzymatic activity of different species was determined spectrofluorometrically .	T2	T25	11732752
NA	CHEMICAL	GENE-N	17	4	Different substrates were used as the relative specific substrates for the determination of gene enzymatic activity : chemical of chemical for gene , chemical of chemical for chemical aminopeptidase , chemical of chemical for gene and chemical of chemical for gene . The gene enzymatic activity of different species was determined spectrofluorometrically .	T2	T26	11732752
NA	CHEMICAL	GENE-N	19	4	Different substrates were used as the relative specific substrates for the determination of gene enzymatic activity : chemical of chemical for gene , chemical of chemical for chemical aminopeptidase , chemical of chemical for gene and chemical of chemical for gene . The gene enzymatic activity of different species was determined spectrofluorometrically .	T3	T19	11732752
CPR:9	CHEMICAL	GENE-N	19	21	Different substrates were used as the relative specific substrates for the determination of gene enzymatic activity : chemical of chemical for gene , chemical of chemical for chemical aminopeptidase , chemical of chemical for gene and chemical of chemical for gene . The gene enzymatic activity of different species was determined spectrofluorometrically .	T3	T21	11732752
NA	CHEMICAL	GENE-N	19	4	Different substrates were used as the relative specific substrates for the determination of gene enzymatic activity : chemical of chemical for gene , chemical of chemical for chemical aminopeptidase , chemical of chemical for gene and chemical of chemical for gene . The gene enzymatic activity of different species was determined spectrofluorometrically .	T3	T22	11732752
NA	CHEMICAL	GENE-N	19	34	Different substrates were used as the relative specific substrates for the determination of gene enzymatic activity : chemical of chemical for gene , chemical of chemical for chemical aminopeptidase , chemical of chemical for gene and chemical of chemical for gene . The gene enzymatic activity of different species was determined spectrofluorometrically .	T3	T23	11732752
NA	CHEMICAL	GENE-N	19	40	Different substrates were used as the relative specific substrates for the determination of gene enzymatic activity : chemical of chemical for gene , chemical of chemical for chemical aminopeptidase , chemical of chemical for gene and chemical of chemical for gene . The gene enzymatic activity of different species was determined spectrofluorometrically .	T3	T25	11732752
NA	CHEMICAL	GENE-N	19	4	Different substrates were used as the relative specific substrates for the determination of gene enzymatic activity : chemical of chemical for gene , chemical of chemical for chemical aminopeptidase , chemical of chemical for gene and chemical of chemical for gene . The gene enzymatic activity of different species was determined spectrofluorometrically .	T3	T26	11732752
NA	CHEMICAL	GENE-N	23	4	Different substrates were used as the relative specific substrates for the determination of gene enzymatic activity : chemical of chemical for gene , chemical of chemical for chemical aminopeptidase , chemical of chemical for gene and chemical of chemical for gene . The gene enzymatic activity of different species was determined spectrofluorometrically .	T4	T19	11732752
NA	CHEMICAL	GENE-N	23	21	Different substrates were used as the relative specific substrates for the determination of gene enzymatic activity : chemical of chemical for gene , chemical of chemical for chemical aminopeptidase , chemical of chemical for gene and chemical of chemical for gene . The gene enzymatic activity of different species was determined spectrofluorometrically .	T4	T21	11732752
CPR:9	CHEMICAL	GENE-N	23	4	Different substrates were used as the relative specific substrates for the determination of gene enzymatic activity : chemical of chemical for gene , chemical of chemical for chemical aminopeptidase , chemical of chemical for gene and chemical of chemical for gene . The gene enzymatic activity of different species was determined spectrofluorometrically .	T4	T22	11732752
NA	CHEMICAL	GENE-N	23	34	Different substrates were used as the relative specific substrates for the determination of gene enzymatic activity : chemical of chemical for gene , chemical of chemical for chemical aminopeptidase , chemical of chemical for gene and chemical of chemical for gene . The gene enzymatic activity of different species was determined spectrofluorometrically .	T4	T23	11732752
NA	CHEMICAL	GENE-N	23	40	Different substrates were used as the relative specific substrates for the determination of gene enzymatic activity : chemical of chemical for gene , chemical of chemical for chemical aminopeptidase , chemical of chemical for gene and chemical of chemical for gene . The gene enzymatic activity of different species was determined spectrofluorometrically .	T4	T25	11732752
NA	CHEMICAL	GENE-N	23	4	Different substrates were used as the relative specific substrates for the determination of gene enzymatic activity : chemical of chemical for gene , chemical of chemical for chemical aminopeptidase , chemical of chemical for gene and chemical of chemical for gene . The gene enzymatic activity of different species was determined spectrofluorometrically .	T4	T26	11732752
NA	CHEMICAL	GENE-N	25	4	Different substrates were used as the relative specific substrates for the determination of gene enzymatic activity : chemical of chemical for gene , chemical of chemical for chemical aminopeptidase , chemical of chemical for gene and chemical of chemical for gene . The gene enzymatic activity of different species was determined spectrofluorometrically .	T5	T19	11732752
NA	CHEMICAL	GENE-N	25	21	Different substrates were used as the relative specific substrates for the determination of gene enzymatic activity : chemical of chemical for gene , chemical of chemical for chemical aminopeptidase , chemical of chemical for gene and chemical of chemical for gene . The gene enzymatic activity of different species was determined spectrofluorometrically .	T5	T21	11732752
CPR:9	CHEMICAL	GENE-N	25	4	Different substrates were used as the relative specific substrates for the determination of gene enzymatic activity : chemical of chemical for gene , chemical of chemical for chemical aminopeptidase , chemical of chemical for gene and chemical of chemical for gene . The gene enzymatic activity of different species was determined spectrofluorometrically .	T5	T22	11732752
NA	CHEMICAL	GENE-N	25	34	Different substrates were used as the relative specific substrates for the determination of gene enzymatic activity : chemical of chemical for gene , chemical of chemical for chemical aminopeptidase , chemical of chemical for gene and chemical of chemical for gene . The gene enzymatic activity of different species was determined spectrofluorometrically .	T5	T23	11732752
NA	CHEMICAL	GENE-N	25	40	Different substrates were used as the relative specific substrates for the determination of gene enzymatic activity : chemical of chemical for gene , chemical of chemical for chemical aminopeptidase , chemical of chemical for gene and chemical of chemical for gene . The gene enzymatic activity of different species was determined spectrofluorometrically .	T5	T25	11732752
NA	CHEMICAL	GENE-N	25	4	Different substrates were used as the relative specific substrates for the determination of gene enzymatic activity : chemical of chemical for gene , chemical of chemical for chemical aminopeptidase , chemical of chemical for gene and chemical of chemical for gene . The gene enzymatic activity of different species was determined spectrofluorometrically .	T5	T26	11732752
NA	CHEMICAL	GENE-N	27	4	Different substrates were used as the relative specific substrates for the determination of gene enzymatic activity : chemical of chemical for gene , chemical of chemical for chemical aminopeptidase , chemical of chemical for gene and chemical of chemical for gene . The gene enzymatic activity of different species was determined spectrofluorometrically .	T6	T19	11732752
NA	CHEMICAL	GENE-N	27	21	Different substrates were used as the relative specific substrates for the determination of gene enzymatic activity : chemical of chemical for gene , chemical of chemical for chemical aminopeptidase , chemical of chemical for gene and chemical of chemical for gene . The gene enzymatic activity of different species was determined spectrofluorometrically .	T6	T21	11732752
NA	CHEMICAL	GENE-N	27	4	Different substrates were used as the relative specific substrates for the determination of gene enzymatic activity : chemical of chemical for gene , chemical of chemical for chemical aminopeptidase , chemical of chemical for gene and chemical of chemical for gene . The gene enzymatic activity of different species was determined spectrofluorometrically .	T6	T22	11732752
NA	CHEMICAL	GENE-N	27	34	Different substrates were used as the relative specific substrates for the determination of gene enzymatic activity : chemical of chemical for gene , chemical of chemical for chemical aminopeptidase , chemical of chemical for gene and chemical of chemical for gene . The gene enzymatic activity of different species was determined spectrofluorometrically .	T6	T23	11732752
NA	CHEMICAL	GENE-N	27	40	Different substrates were used as the relative specific substrates for the determination of gene enzymatic activity : chemical of chemical for gene , chemical of chemical for chemical aminopeptidase , chemical of chemical for gene and chemical of chemical for gene . The gene enzymatic activity of different species was determined spectrofluorometrically .	T6	T25	11732752
NA	CHEMICAL	GENE-N	27	4	Different substrates were used as the relative specific substrates for the determination of gene enzymatic activity : chemical of chemical for gene , chemical of chemical for chemical aminopeptidase , chemical of chemical for gene and chemical of chemical for gene . The gene enzymatic activity of different species was determined spectrofluorometrically .	T6	T26	11732752
NA	CHEMICAL	GENE-N	30	4	Different substrates were used as the relative specific substrates for the determination of gene enzymatic activity : chemical of chemical for gene , chemical of chemical for chemical aminopeptidase , chemical of chemical for gene and chemical of chemical for gene . The gene enzymatic activity of different species was determined spectrofluorometrically .	T7	T19	11732752
NA	CHEMICAL	GENE-N	30	21	Different substrates were used as the relative specific substrates for the determination of gene enzymatic activity : chemical of chemical for gene , chemical of chemical for chemical aminopeptidase , chemical of chemical for gene and chemical of chemical for gene . The gene enzymatic activity of different species was determined spectrofluorometrically .	T7	T21	11732752
NA	CHEMICAL	GENE-N	30	4	Different substrates were used as the relative specific substrates for the determination of gene enzymatic activity : chemical of chemical for gene , chemical of chemical for chemical aminopeptidase , chemical of chemical for gene and chemical of chemical for gene . The gene enzymatic activity of different species was determined spectrofluorometrically .	T7	T22	11732752
CPR:9	CHEMICAL	GENE-N	30	34	Different substrates were used as the relative specific substrates for the determination of gene enzymatic activity : chemical of chemical for gene , chemical of chemical for chemical aminopeptidase , chemical of chemical for gene and chemical of chemical for gene . The gene enzymatic activity of different species was determined spectrofluorometrically .	T7	T23	11732752
NA	CHEMICAL	GENE-N	30	40	Different substrates were used as the relative specific substrates for the determination of gene enzymatic activity : chemical of chemical for gene , chemical of chemical for chemical aminopeptidase , chemical of chemical for gene and chemical of chemical for gene . The gene enzymatic activity of different species was determined spectrofluorometrically .	T7	T25	11732752
NA	CHEMICAL	GENE-N	30	4	Different substrates were used as the relative specific substrates for the determination of gene enzymatic activity : chemical of chemical for gene , chemical of chemical for chemical aminopeptidase , chemical of chemical for gene and chemical of chemical for gene . The gene enzymatic activity of different species was determined spectrofluorometrically .	T7	T26	11732752
NA	CHEMICAL	GENE-N	32	4	Different substrates were used as the relative specific substrates for the determination of gene enzymatic activity : chemical of chemical for gene , chemical of chemical for chemical aminopeptidase , chemical of chemical for gene and chemical of chemical for gene . The gene enzymatic activity of different species was determined spectrofluorometrically .	T8	T19	11732752
NA	CHEMICAL	GENE-N	32	21	Different substrates were used as the relative specific substrates for the determination of gene enzymatic activity : chemical of chemical for gene , chemical of chemical for chemical aminopeptidase , chemical of chemical for gene and chemical of chemical for gene . The gene enzymatic activity of different species was determined spectrofluorometrically .	T8	T21	11732752
NA	CHEMICAL	GENE-N	32	4	Different substrates were used as the relative specific substrates for the determination of gene enzymatic activity : chemical of chemical for gene , chemical of chemical for chemical aminopeptidase , chemical of chemical for gene and chemical of chemical for gene . The gene enzymatic activity of different species was determined spectrofluorometrically .	T8	T22	11732752
CPR:9	CHEMICAL	GENE-N	32	34	Different substrates were used as the relative specific substrates for the determination of gene enzymatic activity : chemical of chemical for gene , chemical of chemical for chemical aminopeptidase , chemical of chemical for gene and chemical of chemical for gene . The gene enzymatic activity of different species was determined spectrofluorometrically .	T8	T23	11732752
NA	CHEMICAL	GENE-N	32	40	Different substrates were used as the relative specific substrates for the determination of gene enzymatic activity : chemical of chemical for gene , chemical of chemical for chemical aminopeptidase , chemical of chemical for gene and chemical of chemical for gene . The gene enzymatic activity of different species was determined spectrofluorometrically .	T8	T25	11732752
NA	CHEMICAL	GENE-N	32	4	Different substrates were used as the relative specific substrates for the determination of gene enzymatic activity : chemical of chemical for gene , chemical of chemical for chemical aminopeptidase , chemical of chemical for gene and chemical of chemical for gene . The gene enzymatic activity of different species was determined spectrofluorometrically .	T8	T26	11732752
NA	CHEMICAL	GENE-N	36	4	Different substrates were used as the relative specific substrates for the determination of gene enzymatic activity : chemical of chemical for gene , chemical of chemical for chemical aminopeptidase , chemical of chemical for gene and chemical of chemical for gene . The gene enzymatic activity of different species was determined spectrofluorometrically .	T9	T19	11732752
NA	CHEMICAL	GENE-N	36	21	Different substrates were used as the relative specific substrates for the determination of gene enzymatic activity : chemical of chemical for gene , chemical of chemical for chemical aminopeptidase , chemical of chemical for gene and chemical of chemical for gene . The gene enzymatic activity of different species was determined spectrofluorometrically .	T9	T21	11732752
NA	CHEMICAL	GENE-N	36	4	Different substrates were used as the relative specific substrates for the determination of gene enzymatic activity : chemical of chemical for gene , chemical of chemical for chemical aminopeptidase , chemical of chemical for gene and chemical of chemical for gene . The gene enzymatic activity of different species was determined spectrofluorometrically .	T9	T22	11732752
NA	CHEMICAL	GENE-N	36	34	Different substrates were used as the relative specific substrates for the determination of gene enzymatic activity : chemical of chemical for gene , chemical of chemical for chemical aminopeptidase , chemical of chemical for gene and chemical of chemical for gene . The gene enzymatic activity of different species was determined spectrofluorometrically .	T9	T23	11732752
CPR:9	CHEMICAL	GENE-N	36	40	Different substrates were used as the relative specific substrates for the determination of gene enzymatic activity : chemical of chemical for gene , chemical of chemical for chemical aminopeptidase , chemical of chemical for gene and chemical of chemical for gene . The gene enzymatic activity of different species was determined spectrofluorometrically .	T9	T25	11732752
NA	CHEMICAL	GENE-N	36	4	Different substrates were used as the relative specific substrates for the determination of gene enzymatic activity : chemical of chemical for gene , chemical of chemical for chemical aminopeptidase , chemical of chemical for gene and chemical of chemical for gene . The gene enzymatic activity of different species was determined spectrofluorometrically .	T9	T26	11732752
NA	CHEMICAL	GENE-N	38	4	Different substrates were used as the relative specific substrates for the determination of gene enzymatic activity : chemical of chemical for gene , chemical of chemical for chemical aminopeptidase , chemical of chemical for gene and chemical of chemical for gene . The gene enzymatic activity of different species was determined spectrofluorometrically .	T10	T19	11732752
NA	CHEMICAL	GENE-N	38	21	Different substrates were used as the relative specific substrates for the determination of gene enzymatic activity : chemical of chemical for gene , chemical of chemical for chemical aminopeptidase , chemical of chemical for gene and chemical of chemical for gene . The gene enzymatic activity of different species was determined spectrofluorometrically .	T10	T21	11732752
NA	CHEMICAL	GENE-N	38	4	Different substrates were used as the relative specific substrates for the determination of gene enzymatic activity : chemical of chemical for gene , chemical of chemical for chemical aminopeptidase , chemical of chemical for gene and chemical of chemical for gene . The gene enzymatic activity of different species was determined spectrofluorometrically .	T10	T22	11732752
NA	CHEMICAL	GENE-N	38	34	Different substrates were used as the relative specific substrates for the determination of gene enzymatic activity : chemical of chemical for gene , chemical of chemical for chemical aminopeptidase , chemical of chemical for gene and chemical of chemical for gene . The gene enzymatic activity of different species was determined spectrofluorometrically .	T10	T23	11732752
CPR:9	CHEMICAL	GENE-N	38	40	Different substrates were used as the relative specific substrates for the determination of gene enzymatic activity : chemical of chemical for gene , chemical of chemical for chemical aminopeptidase , chemical of chemical for gene and chemical of chemical for gene . The gene enzymatic activity of different species was determined spectrofluorometrically .	T10	T25	11732752
NA	CHEMICAL	GENE-N	38	4	Different substrates were used as the relative specific substrates for the determination of gene enzymatic activity : chemical of chemical for gene , chemical of chemical for chemical aminopeptidase , chemical of chemical for gene and chemical of chemical for gene . The gene enzymatic activity of different species was determined spectrofluorometrically .	T10	T26	11732752
CPR:4	CHEMICAL	GENE-N	5	3	The inhibition of gene activity in the presence of chemical and chemical inhibitors was also investigated .	T12	T28	11732752
CPR:4	CHEMICAL	GENE-N	5	3	The inhibition of gene activity in the presence of chemical and chemical inhibitors was also investigated .	T13	T28	11732752
NA	CHEMICAL	GENE-N	11	24	Based on the results of the hydrolysis and inhibition of the chemical substrates , it was difficult to have an exact decision on the gene type in the vaginal homogenates from the species studied .	T1	T16	11732752
NA	CHEMICAL	GENE-Y	3	14	The Effects of chemical , Unsaturated Fat , and Protein Intake on Measures of gene Sensitivity : Results from the OmniHeart Trial .	T7	T17	23223345
NA	CHEMICAL	GENE-Y	14	11	The purpose of this study is to determine the effects on gene sensitivity of a chemical-rich diet ( chemical ; similar to the Dietary Approaches to Stop Hypertension [ DASH ] diet ) , a protein-rich diet ( PROT ; protein predominantly from plant sources ) , and an unsaturated fat-rich diet ( UNSAT ; predominantly monounsaturated ) .	T5	T15	23223345
NA	CHEMICAL	GENE-Y	18	11	The purpose of this study is to determine the effects on gene sensitivity of a chemical-rich diet ( chemical ; similar to the Dietary Approaches to Stop Hypertension [ DASH ] diet ) , a protein-rich diet ( PROT ; protein predominantly from plant sources ) , and an unsaturated fat-rich diet ( UNSAT ; predominantly monounsaturated ) .	T6	T15	23223345
NA	CHEMICAL	GENE-Y	9	9	For our primary outcome , we calculated the quantitative gene sensitivity check index ( QUICKI ) using the end-of-period fasting serum chemical and gene .	T1	T16	23223345
NA	CHEMICAL	GENE-Y	9	23	For our primary outcome , we calculated the quantitative gene sensitivity check index ( QUICKI ) using the end-of-period fasting serum chemical and gene .	T1	T8	23223345
CPR:3	CHEMICAL	GENE-Y	6	12	CONCLUSIONS A diet that partially replaces chemical with unsaturated fat may improve gene sensitivity in a population at risk for cardiovascular disease .	T4	T11	23223345
NA	CHEMICAL	GENE-Y	11	6	We investigated the involvement of the gene ( gene ) , a gene for bile acids , in the chemical ( chemical ) -induced expression of gene and gene in normal rat gastric epithelial cells ( RGM-1 cells ) .	T3	T19	20104269
NA	CHEMICAL	GENE-Y	11	8	We investigated the involvement of the gene ( gene ) , a gene for bile acids , in the chemical ( chemical ) -induced expression of gene and gene in normal rat gastric epithelial cells ( RGM-1 cells ) .	T3	T20	20104269
NA	CHEMICAL	GENE-N	11	12	We investigated the involvement of the gene ( gene ) , a gene for bile acids , in the chemical ( chemical ) -induced expression of gene and gene in normal rat gastric epithelial cells ( RGM-1 cells ) .	T3	T21	20104269
CPR:3	CHEMICAL	GENE-Y	11	26	We investigated the involvement of the gene ( gene ) , a gene for bile acids , in the chemical ( chemical ) -induced expression of gene and gene in normal rat gastric epithelial cells ( RGM-1 cells ) .	T3	T22	20104269
CPR:3	CHEMICAL	GENE-Y	11	28	We investigated the involvement of the gene ( gene ) , a gene for bile acids , in the chemical ( chemical ) -induced expression of gene and gene in normal rat gastric epithelial cells ( RGM-1 cells ) .	T3	T23	20104269
NA	CHEMICAL	GENE-Y	21	6	We investigated the involvement of the gene ( gene ) , a gene for bile acids , in the chemical ( chemical ) -induced expression of gene and gene in normal rat gastric epithelial cells ( RGM-1 cells ) .	T4	T19	20104269
NA	CHEMICAL	GENE-Y	21	8	We investigated the involvement of the gene ( gene ) , a gene for bile acids , in the chemical ( chemical ) -induced expression of gene and gene in normal rat gastric epithelial cells ( RGM-1 cells ) .	T4	T20	20104269
NA	CHEMICAL	GENE-N	21	12	We investigated the involvement of the gene ( gene ) , a gene for bile acids , in the chemical ( chemical ) -induced expression of gene and gene in normal rat gastric epithelial cells ( RGM-1 cells ) .	T4	T21	20104269
CPR:3	CHEMICAL	GENE-Y	21	26	We investigated the involvement of the gene ( gene ) , a gene for bile acids , in the chemical ( chemical ) -induced expression of gene and gene in normal rat gastric epithelial cells ( RGM-1 cells ) .	T4	T22	20104269
CPR:3	CHEMICAL	GENE-Y	21	28	We investigated the involvement of the gene ( gene ) , a gene for bile acids , in the chemical ( chemical ) -induced expression of gene and gene in normal rat gastric epithelial cells ( RGM-1 cells ) .	T4	T23	20104269
CPR:5	CHEMICAL	GENE-Y	5	10	RGM-1 cells were treated with chemical or chemical , an gene agonist , in the presence or absence of chemical , an gene antagonist .	T5	T24	20104269
NA	CHEMICAL	GENE-Y	5	22	RGM-1 cells were treated with chemical or chemical , an gene agonist , in the presence or absence of chemical , an gene antagonist .	T5	T25	20104269
CPR:5	CHEMICAL	GENE-Y	7	10	RGM-1 cells were treated with chemical or chemical , an gene agonist , in the presence or absence of chemical , an gene antagonist .	T6	T24	20104269
NA	CHEMICAL	GENE-Y	7	22	RGM-1 cells were treated with chemical or chemical , an gene agonist , in the presence or absence of chemical , an gene antagonist .	T6	T25	20104269
NA	CHEMICAL	GENE-Y	19	10	RGM-1 cells were treated with chemical or chemical , an gene agonist , in the presence or absence of chemical , an gene antagonist .	T7	T24	20104269
CPR:6	CHEMICAL	GENE-Y	19	22	RGM-1 cells were treated with chemical or chemical , an gene agonist , in the presence or absence of chemical , an gene antagonist .	T7	T25	20104269
CPR:3	CHEMICAL	GENE-Y	0	5	chemical induced dose-dependent expression of gene and gene at both the mRNA and protein levels .	T8	T26	20104269
CPR:3	CHEMICAL	GENE-Y	0	7	chemical induced dose-dependent expression of gene and gene at both the mRNA and protein levels .	T8	T27	20104269
CPR:3	CHEMICAL	GENE-Y	10	4	The maximum stimulation of gene and gene mRNA induced by chemical was observed at 3 h and by 6 h , respectively .	T9	T28	20104269
CPR:3	CHEMICAL	GENE-Y	10	6	The maximum stimulation of gene and gene mRNA induced by chemical was observed at 3 h and by 6 h , respectively .	T9	T29	20104269
NA	CHEMICAL	GENE-Y	3	9	The effects of chemical and chemical on expression of gene and gene were abolished by chemical .	T11	T12	20104269
NA	CHEMICAL	GENE-Y	3	11	The effects of chemical and chemical on expression of gene and gene were abolished by chemical .	T11	T13	20104269
NA	CHEMICAL	GENE-Y	3	9	The effects of chemical and chemical on expression of gene and gene were abolished by chemical .	T1	T12	20104269
NA	CHEMICAL	GENE-Y	3	11	The effects of chemical and chemical on expression of gene and gene were abolished by chemical .	T1	T13	20104269
CPR:4	CHEMICAL	GENE-Y	6	9	The effects of chemical and chemical on expression of gene and gene were abolished by chemical .	T2	T12	20104269
CPR:4	CHEMICAL	GENE-Y	6	11	The effects of chemical and chemical on expression of gene and gene were abolished by chemical .	T2	T13	20104269
NA	CHEMICAL	GENE-Y	0	15	chemical ( chemical ) affect osteoblast viability and biomarkers independently of the chemical effects on gene .	T16	T29	22878908
NA	CHEMICAL	GENE-Y	2	15	chemical ( chemical ) affect osteoblast viability and biomarkers independently of the chemical effects on gene .	T17	T29	22878908
NA	CHEMICAL	GENE-Y	12	15	chemical ( chemical ) affect osteoblast viability and biomarkers independently of the chemical effects on gene .	T18	T29	22878908
NA	CHEMICAL	GENE-Y	0	5	chemical ( chemical ) are gene sensitizers used for treatment of diabetes .	T1	T23	22878908
NA	CHEMICAL	GENE-Y	2	5	chemical ( chemical ) are gene sensitizers used for treatment of diabetes .	T5	T23	22878908
CPR:4	CHEMICAL	GENE-Y	5	11	We have previously reported that chemical reduce chemical synthesis by inhibiting gene activity in human granulosa cells ( HGC ) .	T3	T22	22878908
CPR:9	CHEMICAL	GENE-Y	7	11	We have previously reported that chemical reduce chemical synthesis by inhibiting gene activity in human granulosa cells ( HGC ) .	T4	T22	22878908
CPR:4	CHEMICAL	GENE-Y	14	7	We studied mouse osteoblasts alone or in a co-culture with HGC to determine whether chemical inhibition of gene plays a role in their effects on bone metabolism .	T7	T24	22878908
CPR:4	CHEMICAL	GENE-N	0	3	chemical also inhibited gene activity ( 58-75 % , p < 0.046 ) and gene production ( 52-75 % , p < 0.031 ) .	T15	T27	22878908
CPR:4	CHEMICAL	GENE-Y	0	14	chemical also inhibited gene activity ( 58-75 % , p < 0.046 ) and gene production ( 52-75 % , p < 0.031 ) .	T15	T28	22878908
NA	CHEMICAL	GENE-N	5	3	Functional divergence of a unique chemical-terminal domain of chemical-tRNA synthetase to accommodate its splicing and aminoacylation roles .	T15	T25	16774921
NA	CHEMICAL	GENE-N	8	3	Functional divergence of a unique chemical-terminal domain of chemical-tRNA synthetase to accommodate its splicing and aminoacylation roles .	T16	T25	16774921
NA	CHEMICAL	GENE-Y	0	1	chemical-tRNA synthetase ( gene ) performs dual essential roles in group I intron RNA splicing as well as protein synthesis within the yeast mitochondria .	T1	T17	16774921
NA	CHEMICAL	GENE-Y	0	3	chemical-tRNA synthetase ( gene ) performs dual essential roles in group I intron RNA splicing as well as protein synthesis within the yeast mitochondria .	T1	T19	16774921
NA	CHEMICAL	GENE-Y	5	10	Herein , we determined that a chemical chemical-terminal deletion of gene , which does not complement a null strain , can form a ternary complex with the bI4 intron and its maturase splicing partner .	T8	T20	16774921
NA	CHEMICAL	GENE-Y	7	10	Herein , we determined that a chemical chemical-terminal deletion of gene , which does not complement a null strain , can form a ternary complex with the bI4 intron and its maturase splicing partner .	T9	T20	16774921
NA	CHEMICAL	GENE-Y	9	5	The x-ray co-crystal structure of gene showed that a chemical-terminal extension of about 60 chemical forms a discrete domain , which is unique among the gene and interacts with the corner of the L-shaped tRNALeu .	T10	T21	16774921
NA	CHEMICAL	GENE-Y	9	25	The x-ray co-crystal structure of gene showed that a chemical-terminal extension of about 60 chemical forms a discrete domain , which is unique among the gene and interacts with the corner of the L-shaped tRNALeu .	T10	T22	16774921
NA	CHEMICAL	GENE-Y	8	5	The x-ray co-crystal structure of gene showed that a chemical-terminal extension of about 60 chemical forms a discrete domain , which is unique among the gene and interacts with the corner of the L-shaped tRNALeu .	T11	T21	16774921
NA	CHEMICAL	GENE-Y	8	25	The x-ray co-crystal structure of gene showed that a chemical-terminal extension of about 60 chemical forms a discrete domain , which is unique among the gene and interacts with the corner of the L-shaped tRNALeu .	T11	T22	16774921
NA	CHEMICAL	GENE-Y	7	6	Interestingly , deletion of the entire gene chemical-terminal domain enhanced its aminoacylation and chemical editing activities .	T12	T23	16774921
NA	CHEMICAL	GENE-Y	13	6	Interestingly , deletion of the entire gene chemical-terminal domain enhanced its aminoacylation and chemical editing activities .	T13	T23	16774921
NA	CHEMICAL	GENE-Y	8	11	In striking contrast , deletion of the corresponding chemical-terminal domain of gene abolished aminoacylation of tRNALeu and also chemical editing of mischarged tRNA molecules .	T14	T24	16774921
NA	CHEMICAL	GENE-Y	11	11	In striking contrast , deletion of the corresponding chemical-terminal domain of gene abolished aminoacylation of tRNALeu and also chemical editing of mischarged tRNA molecules .	T2	T24	16774921
NA	CHEMICAL	GENE-Y	8	0	gene ( gene ; gene ) is an chemical-chemical protein that is involved in various metabolic processes , including chemical hormone synthesis in mammalian tissues .	T3	T9	23435367
NA	CHEMICAL	GENE-Y	8	2	gene ( gene ; gene ) is an chemical-chemical protein that is involved in various metabolic processes , including chemical hormone synthesis in mammalian tissues .	T3	T10	23435367
NA	CHEMICAL	GENE-Y	8	4	gene ( gene ; gene ) is an chemical-chemical protein that is involved in various metabolic processes , including chemical hormone synthesis in mammalian tissues .	T3	T11	23435367
NA	CHEMICAL	GENE-Y	8	0	gene ( gene ; gene ) is an chemical-chemical protein that is involved in various metabolic processes , including chemical hormone synthesis in mammalian tissues .	T4	T9	23435367
NA	CHEMICAL	GENE-Y	8	2	gene ( gene ; gene ) is an chemical-chemical protein that is involved in various metabolic processes , including chemical hormone synthesis in mammalian tissues .	T4	T10	23435367
NA	CHEMICAL	GENE-Y	8	4	gene ( gene ; gene ) is an chemical-chemical protein that is involved in various metabolic processes , including chemical hormone synthesis in mammalian tissues .	T4	T11	23435367
CPR:9	CHEMICAL	GENE-Y	2	0	gene ( gene ; gene ) is an chemical-chemical protein that is involved in various metabolic processes , including chemical hormone synthesis in mammalian tissues .	T1	T9	23435367
CPR:9	CHEMICAL	GENE-Y	2	2	gene ( gene ; gene ) is an chemical-chemical protein that is involved in various metabolic processes , including chemical hormone synthesis in mammalian tissues .	T1	T10	23435367
CPR:9	CHEMICAL	GENE-Y	2	4	gene ( gene ; gene ) is an chemical-chemical protein that is involved in various metabolic processes , including chemical hormone synthesis in mammalian tissues .	T1	T11	23435367
CPR:9	CHEMICAL	GENE-Y	20	0	gene ( gene ; gene ) is an chemical-chemical protein that is involved in various metabolic processes , including chemical hormone synthesis in mammalian tissues .	T2	T9	23435367
CPR:9	CHEMICAL	GENE-Y	20	2	gene ( gene ; gene ) is an chemical-chemical protein that is involved in various metabolic processes , including chemical hormone synthesis in mammalian tissues .	T2	T10	23435367
CPR:9	CHEMICAL	GENE-Y	20	4	gene ( gene ; gene ) is an chemical-chemical protein that is involved in various metabolic processes , including chemical hormone synthesis in mammalian tissues .	T2	T11	23435367
CPR:3	CHEMICAL	GENE-Y	16	7	Luciferase reporter assays showed that transcription of gene was synergistically activated by the gene family and chemical treatment through two gene binding sites and a gene-like sequence in a human ovarian granulosa cell line , KGN .	T5	T19	23435367
NA	CHEMICAL	GENE-N	16	13	Luciferase reporter assays showed that transcription of gene was synergistically activated by the gene family and chemical treatment through two gene binding sites and a gene-like sequence in a human ovarian granulosa cell line , KGN .	T5	T20	23435367
NA	CHEMICAL	GENE-Y	16	20	Luciferase reporter assays showed that transcription of gene was synergistically activated by the gene family and chemical treatment through two gene binding sites and a gene-like sequence in a human ovarian granulosa cell line , KGN .	T5	T21	23435367
NA	CHEMICAL	GENE-N	16	25	Luciferase reporter assays showed that transcription of gene was synergistically activated by the gene family and chemical treatment through two gene binding sites and a gene-like sequence in a human ovarian granulosa cell line , KGN .	T5	T22	23435367
NA	CHEMICAL	GENE-Y	4	2	Knockdown of gene attenuated chemical production in KGN cells .	T6	T23	23435367
NA	CHEMICAL	GENE-N	12	12	Here we show that drug-specific differences in receptor internalization are determined by a conserved , 10-residue sequence in the receptor 's chemical-terminal cytoplasmic tail .	T1	T4	23239825
NA	CHEMICAL	GENE-N	0	12	chemical-terminated conjugated polymer nanoparticles have near-unity bright fraction and reveal chemical-dependence of gene .	T8	T13	23330847
NA	CHEMICAL	GENE-N	10	12	chemical-terminated conjugated polymer nanoparticles have near-unity bright fraction and reveal chemical-dependence of gene .	T9	T13	23330847
NA	CHEMICAL	GENE-Y	2	8	We used chemical-Pdots to track the dynamics of gene on a breast cancer cell-line , determining the diffusion characteristics and showing chemical-containing membrane nanodomains were important for receptor mobility at the plasma membrane .	T3	T12	23330847
NA	CHEMICAL	GENE-Y	21	8	We used chemical-Pdots to track the dynamics of gene on a breast cancer cell-line , determining the diffusion characteristics and showing chemical-containing membrane nanodomains were important for receptor mobility at the plasma membrane .	T4	T12	23330847
CPR:3	CHEMICAL	GENE-Y	0	2	chemical increase gene through inhibition of gene activity and release of promoter-associated gene .	T5	T29	18381445
CPR:4	CHEMICAL	GENE-N	0	6	chemical increase gene through inhibition of gene activity and release of promoter-associated gene .	T5	T30	18381445
CPR:3	CHEMICAL	GENE-N	0	12	chemical increase gene through inhibition of gene activity and release of promoter-associated gene .	T5	T28	18381445
CPR:4	CHEMICAL	GENE-Y	0	3	chemical are chemical reductase inhibitors broadly used for the control of hypercholesterolemia .	T1	T9	18381445
NA	CHEMICAL	GENE-Y	2	3	chemical are chemical reductase inhibitors broadly used for the control of hypercholesterolemia .	T2	T9	18381445
NA	CHEMICAL	GENE-Y	8	17	Computational modeling showed the direct interaction of the chemical moiety of statins with the catalytic site of gene .	T3	T17	18381445
CPR:4	CHEMICAL	GENE-Y	10	12	In the subsequent enzymatic assay , it was shown that chemical inhibited gene activity competitively with a K ( i ) value of 31.6 micromol/L .	T4	T18	18381445
NA	CHEMICAL	GENE-Y	9	12	The immunosuppressive effects of T3 SCI were caused by chemical acting at gene ( gene ) and could be reversed using gene blockers .	T7	T13	17597612
NA	CHEMICAL	GENE-Y	9	14	The immunosuppressive effects of T3 SCI were caused by chemical acting at gene ( gene ) and could be reversed using gene blockers .	T7	T14	17597612
NA	CHEMICAL	GENE-Y	9	18	The immunosuppressive effects of T3 SCI were caused by chemical acting at gene ( gene ) and could be reversed using gene blockers .	T7	T15	17597612
NA	CHEMICAL	GENE-Y	20	11	However , so far no information has been published on the gene activity of the metabolites or degradation products of chemical .	T4	T14	15285788
NA	CHEMICAL	GENE-Y	21	4	In competition experiments with gene we have determined the relative receptor affinities ( RRA ) of these substances with reference to chemical ( RRA = 100 ) .	T7	T15	15285788
CPR:4	CHEMICAL	GENE-Y	0	2	chemical is a new inhibitor of gene enzyme .	T7	T10	10095983
CPR:4	CHEMICAL	GENE-N	5	15	In the long term , chemical has been shown to be more effective than placebo in reducing body weight and serum total and gene chemical levels .	T1	T8	10095983
NA	CHEMICAL	GENE-N	24	15	In the long term , chemical has been shown to be more effective than placebo in reducing body weight and serum total and gene chemical levels .	T2	T8	10095983
NA	CHEMICAL	GENE-Y	10	5	We provide here evidence that gene , via its gene chemical triphosphatase -activating activity , controls gene-dependent gene ( gene ) signaling in chondrocytes .	T1	T23	23571107
NA	CHEMICAL	GENE-N	10	9	We provide here evidence that gene , via its gene chemical triphosphatase -activating activity , controls gene-dependent gene ( gene ) signaling in chondrocytes .	T1	T24	23571107
NA	CHEMICAL	GENE-N	10	11	We provide here evidence that gene , via its gene chemical triphosphatase -activating activity , controls gene-dependent gene ( gene ) signaling in chondrocytes .	T1	T25	23571107
NA	CHEMICAL	GENE-N	10	16	We provide here evidence that gene , via its gene chemical triphosphatase -activating activity , controls gene-dependent gene ( gene ) signaling in chondrocytes .	T1	T26	23571107
NA	CHEMICAL	GENE-N	10	17	We provide here evidence that gene , via its gene chemical triphosphatase -activating activity , controls gene-dependent gene ( gene ) signaling in chondrocytes .	T1	T27	23571107
NA	CHEMICAL	GENE-N	10	19	We provide here evidence that gene , via its gene chemical triphosphatase -activating activity , controls gene-dependent gene ( gene ) signaling in chondrocytes .	T1	T28	23571107
NA	CHEMICAL	GENE-N	2	13	Externalization of chemical during apoptosis does not specifically require either isoform of chemical synthase .	T13	T27	14984733
NA	CHEMICAL	GENE-N	12	13	Externalization of chemical during apoptosis does not specifically require either isoform of chemical synthase .	T12	T27	14984733
CPR:9	CHEMICAL	GENE-N	0	12	chemical ( chemical ) is made in mammalian cells by two chemical synthases , gene and gene .	T1	T22	14984733
CPR:9	CHEMICAL	GENE-N	0	14	chemical ( chemical ) is made in mammalian cells by two chemical synthases , gene and gene .	T1	T25	14984733
CPR:9	CHEMICAL	GENE-N	0	16	chemical ( chemical ) is made in mammalian cells by two chemical synthases , gene and gene .	T1	T26	14984733
NA	CHEMICAL	GENE-N	2	12	chemical ( chemical ) is made in mammalian cells by two chemical synthases , gene and gene .	T7	T22	14984733
NA	CHEMICAL	GENE-N	2	14	chemical ( chemical ) is made in mammalian cells by two chemical synthases , gene and gene .	T7	T25	14984733
NA	CHEMICAL	GENE-N	2	16	chemical ( chemical ) is made in mammalian cells by two chemical synthases , gene and gene .	T7	T26	14984733
NA	CHEMICAL	GENE-N	11	12	chemical ( chemical ) is made in mammalian cells by two chemical synthases , gene and gene .	T10	T22	14984733
NA	CHEMICAL	GENE-N	11	14	chemical ( chemical ) is made in mammalian cells by two chemical synthases , gene and gene .	T10	T25	14984733
NA	CHEMICAL	GENE-N	11	16	chemical ( chemical ) is made in mammalian cells by two chemical synthases , gene and gene .	T10	T26	14984733
NA	CHEMICAL	GENE-Y	4	19	We induced apoptosis with chemical in four Chinese hamster ovary ( CHO ) cell lines that are deficient in gene and/or gene to determine if chemical generated by either of these enzymes is required for externalization on the cell surface during apoptosis .	T8	T20	14984733
NA	CHEMICAL	GENE-Y	4	21	We induced apoptosis with chemical in four Chinese hamster ovary ( CHO ) cell lines that are deficient in gene and/or gene to determine if chemical generated by either of these enzymes is required for externalization on the cell surface during apoptosis .	T8	T21	14984733
NA	CHEMICAL	GENE-Y	25	19	We induced apoptosis with chemical in four Chinese hamster ovary ( CHO ) cell lines that are deficient in gene and/or gene to determine if chemical generated by either of these enzymes is required for externalization on the cell surface during apoptosis .	T9	T20	14984733
NA	CHEMICAL	GENE-Y	25	21	We induced apoptosis with chemical in four Chinese hamster ovary ( CHO ) cell lines that are deficient in gene and/or gene to determine if chemical generated by either of these enzymes is required for externalization on the cell surface during apoptosis .	T9	T21	14984733
NA	CHEMICAL	GENE-Y	27	6	Cells that were deficient in either gene or gene , as well as cells that were deficient in both gene and gene , externalized normal amounts of chemical .	T2	T14	14984733
NA	CHEMICAL	GENE-Y	27	8	Cells that were deficient in either gene or gene , as well as cells that were deficient in both gene and gene , externalized normal amounts of chemical .	T2	T15	14984733
NA	CHEMICAL	GENE-Y	27	19	Cells that were deficient in either gene or gene , as well as cells that were deficient in both gene and gene , externalized normal amounts of chemical .	T2	T16	14984733
NA	CHEMICAL	GENE-Y	27	21	Cells that were deficient in either gene or gene , as well as cells that were deficient in both gene and gene , externalized normal amounts of chemical .	T2	T17	14984733
CPR:9	CHEMICAL	GENE-Y	1	4	The chemical homeostasis proteins gene ( gene ) , chemical chemical exchanger-1 , gene ( gene ) , chemical-PLB , and gene are important for contraction and relaxation .	T21	T30	23418087
CPR:9	CHEMICAL	GENE-Y	1	6	The chemical homeostasis proteins gene ( gene ) , chemical chemical exchanger-1 , gene ( gene ) , chemical-PLB , and gene are important for contraction and relaxation .	T21	T31	23418087
CPR:9	CHEMICAL	GENE-Y	1	11	The chemical homeostasis proteins gene ( gene ) , chemical chemical exchanger-1 , gene ( gene ) , chemical-PLB , and gene are important for contraction and relaxation .	T21	T32	23418087
CPR:9	CHEMICAL	GENE-Y	1	13	The chemical homeostasis proteins gene ( gene ) , chemical chemical exchanger-1 , gene ( gene ) , chemical-PLB , and gene are important for contraction and relaxation .	T21	T33	23418087
CPR:9	CHEMICAL	GENE-Y	1	15	The chemical homeostasis proteins gene ( gene ) , chemical chemical exchanger-1 , gene ( gene ) , chemical-PLB , and gene are important for contraction and relaxation .	T21	T25	23418087
CPR:9	CHEMICAL	GENE-Y	1	21	The chemical homeostasis proteins gene ( gene ) , chemical chemical exchanger-1 , gene ( gene ) , chemical-PLB , and gene are important for contraction and relaxation .	T21	T27	23418087
NA	CHEMICAL	GENE-Y	9	4	The chemical homeostasis proteins gene ( gene ) , chemical chemical exchanger-1 , gene ( gene ) , chemical-PLB , and gene are important for contraction and relaxation .	T22	T30	23418087
NA	CHEMICAL	GENE-Y	9	6	The chemical homeostasis proteins gene ( gene ) , chemical chemical exchanger-1 , gene ( gene ) , chemical-PLB , and gene are important for contraction and relaxation .	T22	T31	23418087
NA	CHEMICAL	GENE-Y	9	11	The chemical homeostasis proteins gene ( gene ) , chemical chemical exchanger-1 , gene ( gene ) , chemical-PLB , and gene are important for contraction and relaxation .	T22	T32	23418087
NA	CHEMICAL	GENE-Y	9	13	The chemical homeostasis proteins gene ( gene ) , chemical chemical exchanger-1 , gene ( gene ) , chemical-PLB , and gene are important for contraction and relaxation .	T22	T33	23418087
NA	CHEMICAL	GENE-Y	9	15	The chemical homeostasis proteins gene ( gene ) , chemical chemical exchanger-1 , gene ( gene ) , chemical-PLB , and gene are important for contraction and relaxation .	T22	T25	23418087
NA	CHEMICAL	GENE-Y	9	21	The chemical homeostasis proteins gene ( gene ) , chemical chemical exchanger-1 , gene ( gene ) , chemical-PLB , and gene are important for contraction and relaxation .	T22	T27	23418087
NA	CHEMICAL	GENE-Y	10	4	The chemical homeostasis proteins gene ( gene ) , chemical chemical exchanger-1 , gene ( gene ) , chemical-PLB , and gene are important for contraction and relaxation .	T23	T30	23418087
NA	CHEMICAL	GENE-Y	10	6	The chemical homeostasis proteins gene ( gene ) , chemical chemical exchanger-1 , gene ( gene ) , chemical-PLB , and gene are important for contraction and relaxation .	T23	T31	23418087
NA	CHEMICAL	GENE-Y	10	11	The chemical homeostasis proteins gene ( gene ) , chemical chemical exchanger-1 , gene ( gene ) , chemical-PLB , and gene are important for contraction and relaxation .	T23	T32	23418087
NA	CHEMICAL	GENE-Y	10	13	The chemical homeostasis proteins gene ( gene ) , chemical chemical exchanger-1 , gene ( gene ) , chemical-PLB , and gene are important for contraction and relaxation .	T23	T33	23418087
NA	CHEMICAL	GENE-Y	10	15	The chemical homeostasis proteins gene ( gene ) , chemical chemical exchanger-1 , gene ( gene ) , chemical-PLB , and gene are important for contraction and relaxation .	T23	T25	23418087
NA	CHEMICAL	GENE-Y	10	21	The chemical homeostasis proteins gene ( gene ) , chemical chemical exchanger-1 , gene ( gene ) , chemical-PLB , and gene are important for contraction and relaxation .	T23	T27	23418087
NA	CHEMICAL	GENE-Y	1	4	The chemical homeostasis proteins gene ( gene ) , chemical chemical exchanger-1 , gene ( gene ) , chemical-PLB , and gene are important for contraction and relaxation .	T2	T30	23418087
NA	CHEMICAL	GENE-Y	1	6	The chemical homeostasis proteins gene ( gene ) , chemical chemical exchanger-1 , gene ( gene ) , chemical-PLB , and gene are important for contraction and relaxation .	T2	T31	23418087
NA	CHEMICAL	GENE-Y	1	11	The chemical homeostasis proteins gene ( gene ) , chemical chemical exchanger-1 , gene ( gene ) , chemical-PLB , and gene are important for contraction and relaxation .	T2	T32	23418087
NA	CHEMICAL	GENE-Y	1	13	The chemical homeostasis proteins gene ( gene ) , chemical chemical exchanger-1 , gene ( gene ) , chemical-PLB , and gene are important for contraction and relaxation .	T2	T33	23418087
NA	CHEMICAL	GENE-Y	1	15	The chemical homeostasis proteins gene ( gene ) , chemical chemical exchanger-1 , gene ( gene ) , chemical-PLB , and gene are important for contraction and relaxation .	T2	T25	23418087
NA	CHEMICAL	GENE-Y	1	21	The chemical homeostasis proteins gene ( gene ) , chemical chemical exchanger-1 , gene ( gene ) , chemical-PLB , and gene are important for contraction and relaxation .	T2	T27	23418087
CPR:3	CHEMICAL	GENE-Y	6	0	gene expression was increased in all chemical males and chemical 0.5 females and reduced in chemical 200 females .	T6	T28	23418087
CPR:3	CHEMICAL	GENE-Y	9	0	gene expression was increased in all chemical males and chemical 0.5 females and reduced in chemical 200 females .	T8	T28	23418087
CPR:4	CHEMICAL	GENE-Y	15	0	gene expression was increased in all chemical males and chemical 0.5 females and reduced in chemical 200 females .	T9	T28	23418087
NA	CHEMICAL	GENE-Y	0	12	chemical induced sex-specific altered DNA methylation in specific chemical pairs in the gene CpG island .	T12	T29	23418087
NA	CHEMICAL	GENE-Y	8	12	chemical induced sex-specific altered DNA methylation in specific chemical pairs in the gene CpG island .	T13	T29	23418087
NA	CHEMICAL	GENE-N	2	4	Effects of chemical on gene levels , red cell adhesion , and hematopoietic differentiation in patients with sickle cell disease .	T8	T25	12907443
CPR:4	CHEMICAL	GENE-N	1	11	The chemical analog chemical ( chemical ) hypomethylates DNA by inhibiting gene .	T2	T19	12907443
CPR:4	CHEMICAL	GENE-N	3	11	The chemical analog chemical ( chemical ) hypomethylates DNA by inhibiting gene .	T3	T19	12907443
CPR:4	CHEMICAL	GENE-N	5	11	The chemical analog chemical ( chemical ) hypomethylates DNA by inhibiting gene .	T4	T19	12907443
CPR:3	CHEMICAL	GENE-N	4	7	We examined if subcutaneous chemical could increase gene levels and improve SSD pathophysiology without cytotoxicity .	T5	T20	12907443
CPR:3	CHEMICAL	GENE-N	2	7	Weekly subcutaneous chemical produces cumulative increases in gene and total gene through a noncytotoxic mechanism of action .	T1	T11	12907443
CPR:3	CHEMICAL	GENE-N	2	6	Weekly subcutaneous chemical produces cumulative increases in gene and total gene through a noncytotoxic mechanism of action .	T1	T12	12907443
NA	CHEMICAL	GENE-N	1	4	The chemical series modulates gene probably through the gene in rat paratracheal ganglia .	T37	T54	10670413
NA	CHEMICAL	GENE-Y	1	8	The chemical series modulates gene probably through the gene in rat paratracheal ganglia .	T37	T55	10670413
NA	CHEMICAL	GENE-N	6	3	The modulation of gene by the chemical series ( chemical and chemical ) was studied in the paratracheal ganglion cells .	T30	T47	10670413
NA	CHEMICAL	GENE-N	9	3	The modulation of gene by the chemical series ( chemical and chemical ) was studied in the paratracheal ganglion cells .	T35	T47	10670413
NA	CHEMICAL	GENE-N	11	3	The modulation of gene by the chemical series ( chemical and chemical ) was studied in the paratracheal ganglion cells .	T1	T47	10670413
NA	CHEMICAL	GENE-Y	0	13	chemical chemical ( a stable analogue of chemical ) , chemical ( an gene-selective agonist ) and chemical ( an gene-selective agonist ) inhibited the HVA chemical current ( HVA ICa ) dose-dependently , and the rank order of potency to inhibit gene was chemical > chemical , chemical > chemical > > chemical .	T11	T48	10670413
NA	CHEMICAL	GENE-Y	0	20	chemical chemical ( a stable analogue of chemical ) , chemical ( an gene-selective agonist ) and chemical ( an gene-selective agonist ) inhibited the HVA chemical current ( HVA ICa ) dose-dependently , and the rank order of potency to inhibit gene was chemical > chemical , chemical > chemical > > chemical .	T11	T49	10670413
NA	CHEMICAL	GENE-N	0	3	chemical chemical ( a stable analogue of chemical ) , chemical ( an gene-selective agonist ) and chemical ( an gene-selective agonist ) inhibited the HVA chemical current ( HVA ICa ) dose-dependently , and the rank order of potency to inhibit gene was chemical > chemical , chemical > chemical > > chemical .	T11	T50	10670413
NA	CHEMICAL	GENE-Y	1	13	chemical chemical ( a stable analogue of chemical ) , chemical ( an gene-selective agonist ) and chemical ( an gene-selective agonist ) inhibited the HVA chemical current ( HVA ICa ) dose-dependently , and the rank order of potency to inhibit gene was chemical > chemical , chemical > chemical > > chemical .	T12	T48	10670413
NA	CHEMICAL	GENE-Y	1	20	chemical chemical ( a stable analogue of chemical ) , chemical ( an gene-selective agonist ) and chemical ( an gene-selective agonist ) inhibited the HVA chemical current ( HVA ICa ) dose-dependently , and the rank order of potency to inhibit gene was chemical > chemical , chemical > chemical > > chemical .	T12	T49	10670413
CPR:4	CHEMICAL	GENE-N	1	3	chemical chemical ( a stable analogue of chemical ) , chemical ( an gene-selective agonist ) and chemical ( an gene-selective agonist ) inhibited the HVA chemical current ( HVA ICa ) dose-dependently , and the rank order of potency to inhibit gene was chemical > chemical , chemical > chemical > > chemical .	T12	T50	10670413
NA	CHEMICAL	GENE-Y	7	13	chemical chemical ( a stable analogue of chemical ) , chemical ( an gene-selective agonist ) and chemical ( an gene-selective agonist ) inhibited the HVA chemical current ( HVA ICa ) dose-dependently , and the rank order of potency to inhibit gene was chemical > chemical , chemical > chemical > > chemical .	T13	T48	10670413
NA	CHEMICAL	GENE-Y	7	20	chemical chemical ( a stable analogue of chemical ) , chemical ( an gene-selective agonist ) and chemical ( an gene-selective agonist ) inhibited the HVA chemical current ( HVA ICa ) dose-dependently , and the rank order of potency to inhibit gene was chemical > chemical , chemical > chemical > > chemical .	T13	T49	10670413
CPR:4	CHEMICAL	GENE-N	7	3	chemical chemical ( a stable analogue of chemical ) , chemical ( an gene-selective agonist ) and chemical ( an gene-selective agonist ) inhibited the HVA chemical current ( HVA ICa ) dose-dependently , and the rank order of potency to inhibit gene was chemical > chemical , chemical > chemical > > chemical .	T13	T50	10670413
CPR:5	CHEMICAL	GENE-Y	10	13	chemical chemical ( a stable analogue of chemical ) , chemical ( an gene-selective agonist ) and chemical ( an gene-selective agonist ) inhibited the HVA chemical current ( HVA ICa ) dose-dependently , and the rank order of potency to inhibit gene was chemical > chemical , chemical > chemical > > chemical .	T14	T48	10670413
NA	CHEMICAL	GENE-Y	10	20	chemical chemical ( a stable analogue of chemical ) , chemical ( an gene-selective agonist ) and chemical ( an gene-selective agonist ) inhibited the HVA chemical current ( HVA ICa ) dose-dependently , and the rank order of potency to inhibit gene was chemical > chemical , chemical > chemical > > chemical .	T14	T49	10670413
CPR:4	CHEMICAL	GENE-N	10	3	chemical chemical ( a stable analogue of chemical ) , chemical ( an gene-selective agonist ) and chemical ( an gene-selective agonist ) inhibited the HVA chemical current ( HVA ICa ) dose-dependently , and the rank order of potency to inhibit gene was chemical > chemical , chemical > chemical > > chemical .	T14	T50	10670413
NA	CHEMICAL	GENE-Y	17	13	chemical chemical ( a stable analogue of chemical ) , chemical ( an gene-selective agonist ) and chemical ( an gene-selective agonist ) inhibited the HVA chemical current ( HVA ICa ) dose-dependently , and the rank order of potency to inhibit gene was chemical > chemical , chemical > chemical > > chemical .	T15	T48	10670413
CPR:5	CHEMICAL	GENE-Y	17	20	chemical chemical ( a stable analogue of chemical ) , chemical ( an gene-selective agonist ) and chemical ( an gene-selective agonist ) inhibited the HVA chemical current ( HVA ICa ) dose-dependently , and the rank order of potency to inhibit gene was chemical > chemical , chemical > chemical > > chemical .	T15	T49	10670413
CPR:4	CHEMICAL	GENE-N	17	3	chemical chemical ( a stable analogue of chemical ) , chemical ( an gene-selective agonist ) and chemical ( an gene-selective agonist ) inhibited the HVA chemical current ( HVA ICa ) dose-dependently , and the rank order of potency to inhibit gene was chemical > chemical , chemical > chemical > > chemical .	T15	T50	10670413
NA	CHEMICAL	GENE-Y	3	13	chemical chemical ( a stable analogue of chemical ) , chemical ( an gene-selective agonist ) and chemical ( an gene-selective agonist ) inhibited the HVA chemical current ( HVA ICa ) dose-dependently , and the rank order of potency to inhibit gene was chemical > chemical , chemical > chemical > > chemical .	T16	T48	10670413
NA	CHEMICAL	GENE-Y	3	20	chemical chemical ( a stable analogue of chemical ) , chemical ( an gene-selective agonist ) and chemical ( an gene-selective agonist ) inhibited the HVA chemical current ( HVA ICa ) dose-dependently , and the rank order of potency to inhibit gene was chemical > chemical , chemical > chemical > > chemical .	T16	T49	10670413
NA	CHEMICAL	GENE-N	3	3	chemical chemical ( a stable analogue of chemical ) , chemical ( an gene-selective agonist ) and chemical ( an gene-selective agonist ) inhibited the HVA chemical current ( HVA ICa ) dose-dependently , and the rank order of potency to inhibit gene was chemical > chemical , chemical > chemical > > chemical .	T16	T50	10670413
NA	CHEMICAL	GENE-Y	3	13	chemical chemical ( a stable analogue of chemical ) , chemical ( an gene-selective agonist ) and chemical ( an gene-selective agonist ) inhibited the HVA chemical current ( HVA ICa ) dose-dependently , and the rank order of potency to inhibit gene was chemical > chemical , chemical > chemical > > chemical .	T17	T48	10670413
NA	CHEMICAL	GENE-Y	3	20	chemical chemical ( a stable analogue of chemical ) , chemical ( an gene-selective agonist ) and chemical ( an gene-selective agonist ) inhibited the HVA chemical current ( HVA ICa ) dose-dependently , and the rank order of potency to inhibit gene was chemical > chemical , chemical > chemical > > chemical .	T17	T49	10670413
NA	CHEMICAL	GENE-N	3	3	chemical chemical ( a stable analogue of chemical ) , chemical ( an gene-selective agonist ) and chemical ( an gene-selective agonist ) inhibited the HVA chemical current ( HVA ICa ) dose-dependently , and the rank order of potency to inhibit gene was chemical > chemical , chemical > chemical > > chemical .	T17	T50	10670413
NA	CHEMICAL	GENE-Y	40	13	chemical chemical ( a stable analogue of chemical ) , chemical ( an gene-selective agonist ) and chemical ( an gene-selective agonist ) inhibited the HVA chemical current ( HVA ICa ) dose-dependently , and the rank order of potency to inhibit gene was chemical > chemical , chemical > chemical > > chemical .	T18	T48	10670413
NA	CHEMICAL	GENE-Y	40	20	chemical chemical ( a stable analogue of chemical ) , chemical ( an gene-selective agonist ) and chemical ( an gene-selective agonist ) inhibited the HVA chemical current ( HVA ICa ) dose-dependently , and the rank order of potency to inhibit gene was chemical > chemical , chemical > chemical > > chemical .	T18	T49	10670413
CPR:4	CHEMICAL	GENE-N	40	3	chemical chemical ( a stable analogue of chemical ) , chemical ( an gene-selective agonist ) and chemical ( an gene-selective agonist ) inhibited the HVA chemical current ( HVA ICa ) dose-dependently , and the rank order of potency to inhibit gene was chemical > chemical , chemical > chemical > > chemical .	T18	T50	10670413
NA	CHEMICAL	GENE-Y	46	13	chemical chemical ( a stable analogue of chemical ) , chemical ( an gene-selective agonist ) and chemical ( an gene-selective agonist ) inhibited the HVA chemical current ( HVA ICa ) dose-dependently , and the rank order of potency to inhibit gene was chemical > chemical , chemical > chemical > > chemical .	T19	T48	10670413
NA	CHEMICAL	GENE-Y	46	20	chemical chemical ( a stable analogue of chemical ) , chemical ( an gene-selective agonist ) and chemical ( an gene-selective agonist ) inhibited the HVA chemical current ( HVA ICa ) dose-dependently , and the rank order of potency to inhibit gene was chemical > chemical , chemical > chemical > > chemical .	T19	T49	10670413
CPR:4	CHEMICAL	GENE-N	46	3	chemical chemical ( a stable analogue of chemical ) , chemical ( an gene-selective agonist ) and chemical ( an gene-selective agonist ) inhibited the HVA chemical current ( HVA ICa ) dose-dependently , and the rank order of potency to inhibit gene was chemical > chemical , chemical > chemical > > chemical .	T19	T50	10670413
NA	CHEMICAL	GENE-Y	48	13	chemical chemical ( a stable analogue of chemical ) , chemical ( an gene-selective agonist ) and chemical ( an gene-selective agonist ) inhibited the HVA chemical current ( HVA ICa ) dose-dependently , and the rank order of potency to inhibit gene was chemical > chemical , chemical > chemical > > chemical .	T20	T48	10670413
NA	CHEMICAL	GENE-Y	48	20	chemical chemical ( a stable analogue of chemical ) , chemical ( an gene-selective agonist ) and chemical ( an gene-selective agonist ) inhibited the HVA chemical current ( HVA ICa ) dose-dependently , and the rank order of potency to inhibit gene was chemical > chemical , chemical > chemical > > chemical .	T20	T49	10670413
CPR:4	CHEMICAL	GENE-N	48	3	chemical chemical ( a stable analogue of chemical ) , chemical ( an gene-selective agonist ) and chemical ( an gene-selective agonist ) inhibited the HVA chemical current ( HVA ICa ) dose-dependently , and the rank order of potency to inhibit gene was chemical > chemical , chemical > chemical > > chemical .	T20	T50	10670413
NA	CHEMICAL	GENE-Y	50	13	chemical chemical ( a stable analogue of chemical ) , chemical ( an gene-selective agonist ) and chemical ( an gene-selective agonist ) inhibited the HVA chemical current ( HVA ICa ) dose-dependently , and the rank order of potency to inhibit gene was chemical > chemical , chemical > chemical > > chemical .	T21	T48	10670413
NA	CHEMICAL	GENE-Y	50	20	chemical chemical ( a stable analogue of chemical ) , chemical ( an gene-selective agonist ) and chemical ( an gene-selective agonist ) inhibited the HVA chemical current ( HVA ICa ) dose-dependently , and the rank order of potency to inhibit gene was chemical > chemical , chemical > chemical > > chemical .	T21	T49	10670413
CPR:4	CHEMICAL	GENE-N	50	3	chemical chemical ( a stable analogue of chemical ) , chemical ( an gene-selective agonist ) and chemical ( an gene-selective agonist ) inhibited the HVA chemical current ( HVA ICa ) dose-dependently , and the rank order of potency to inhibit gene was chemical > chemical , chemical > chemical > > chemical .	T21	T50	10670413
NA	CHEMICAL	GENE-Y	53	13	chemical chemical ( a stable analogue of chemical ) , chemical ( an gene-selective agonist ) and chemical ( an gene-selective agonist ) inhibited the HVA chemical current ( HVA ICa ) dose-dependently , and the rank order of potency to inhibit gene was chemical > chemical , chemical > chemical > > chemical .	T22	T48	10670413
NA	CHEMICAL	GENE-Y	53	20	chemical chemical ( a stable analogue of chemical ) , chemical ( an gene-selective agonist ) and chemical ( an gene-selective agonist ) inhibited the HVA chemical current ( HVA ICa ) dose-dependently , and the rank order of potency to inhibit gene was chemical > chemical , chemical > chemical > > chemical .	T22	T49	10670413
CPR:4	CHEMICAL	GENE-N	53	3	chemical chemical ( a stable analogue of chemical ) , chemical ( an gene-selective agonist ) and chemical ( an gene-selective agonist ) inhibited the HVA chemical current ( HVA ICa ) dose-dependently , and the rank order of potency to inhibit gene was chemical > chemical , chemical > chemical > > chemical .	T22	T50	10670413
CPR:6	CHEMICAL	GENE-Y	0	11	chemical ( 10 ( -5 ) M ) , a selective gene antagonist , showed no effect on the chemical- or chemical-induced inhibition of the HVA ICa , thereby indicating that chemical- and chemical-induced inhibition of the gene is possibly mediated by the gene .	T24	T51	10670413
NA	CHEMICAL	GENE-N	0	9	chemical ( 10 ( -5 ) M ) , a selective gene antagonist , showed no effect on the chemical- or chemical-induced inhibition of the HVA ICa , thereby indicating that chemical- and chemical-induced inhibition of the gene is possibly mediated by the gene .	T24	T52	10670413
NA	CHEMICAL	GENE-Y	0	20	chemical ( 10 ( -5 ) M ) , a selective gene antagonist , showed no effect on the chemical- or chemical-induced inhibition of the HVA ICa , thereby indicating that chemical- and chemical-induced inhibition of the gene is possibly mediated by the gene .	T24	T53	10670413
NA	CHEMICAL	GENE-Y	19	11	chemical ( 10 ( -5 ) M ) , a selective gene antagonist , showed no effect on the chemical- or chemical-induced inhibition of the HVA ICa , thereby indicating that chemical- and chemical-induced inhibition of the gene is possibly mediated by the gene .	T25	T51	10670413
NA	CHEMICAL	GENE-N	19	9	chemical ( 10 ( -5 ) M ) , a selective gene antagonist , showed no effect on the chemical- or chemical-induced inhibition of the HVA ICa , thereby indicating that chemical- and chemical-induced inhibition of the gene is possibly mediated by the gene .	T25	T52	10670413
NA	CHEMICAL	GENE-Y	19	20	chemical ( 10 ( -5 ) M ) , a selective gene antagonist , showed no effect on the chemical- or chemical-induced inhibition of the HVA ICa , thereby indicating that chemical- and chemical-induced inhibition of the gene is possibly mediated by the gene .	T25	T53	10670413
NA	CHEMICAL	GENE-Y	21	11	chemical ( 10 ( -5 ) M ) , a selective gene antagonist , showed no effect on the chemical- or chemical-induced inhibition of the HVA ICa , thereby indicating that chemical- and chemical-induced inhibition of the gene is possibly mediated by the gene .	T26	T51	10670413
NA	CHEMICAL	GENE-N	21	9	chemical ( 10 ( -5 ) M ) , a selective gene antagonist , showed no effect on the chemical- or chemical-induced inhibition of the HVA ICa , thereby indicating that chemical- and chemical-induced inhibition of the gene is possibly mediated by the gene .	T26	T52	10670413
NA	CHEMICAL	GENE-Y	21	20	chemical ( 10 ( -5 ) M ) , a selective gene antagonist , showed no effect on the chemical- or chemical-induced inhibition of the HVA ICa , thereby indicating that chemical- and chemical-induced inhibition of the gene is possibly mediated by the gene .	T26	T53	10670413
NA	CHEMICAL	GENE-Y	31	11	chemical ( 10 ( -5 ) M ) , a selective gene antagonist , showed no effect on the chemical- or chemical-induced inhibition of the HVA ICa , thereby indicating that chemical- and chemical-induced inhibition of the gene is possibly mediated by the gene .	T27	T51	10670413
CPR:4	CHEMICAL	GENE-N	31	9	chemical ( 10 ( -5 ) M ) , a selective gene antagonist , showed no effect on the chemical- or chemical-induced inhibition of the HVA ICa , thereby indicating that chemical- and chemical-induced inhibition of the gene is possibly mediated by the gene .	T27	T52	10670413
NA	CHEMICAL	GENE-Y	31	20	chemical ( 10 ( -5 ) M ) , a selective gene antagonist , showed no effect on the chemical- or chemical-induced inhibition of the HVA ICa , thereby indicating that chemical- and chemical-induced inhibition of the gene is possibly mediated by the gene .	T27	T53	10670413
NA	CHEMICAL	GENE-Y	33	11	chemical ( 10 ( -5 ) M ) , a selective gene antagonist , showed no effect on the chemical- or chemical-induced inhibition of the HVA ICa , thereby indicating that chemical- and chemical-induced inhibition of the gene is possibly mediated by the gene .	T28	T51	10670413
CPR:4	CHEMICAL	GENE-N	33	9	chemical ( 10 ( -5 ) M ) , a selective gene antagonist , showed no effect on the chemical- or chemical-induced inhibition of the HVA ICa , thereby indicating that chemical- and chemical-induced inhibition of the gene is possibly mediated by the gene .	T28	T52	10670413
NA	CHEMICAL	GENE-Y	33	20	chemical ( 10 ( -5 ) M ) , a selective gene antagonist , showed no effect on the chemical- or chemical-induced inhibition of the HVA ICa , thereby indicating that chemical- and chemical-induced inhibition of the gene is possibly mediated by the gene .	T28	T53	10670413
NA	CHEMICAL	GENE-Y	9	11	chemical ( 10 ( -5 ) M ) , a selective gene antagonist , showed no effect on the chemical- or chemical-induced inhibition of the HVA ICa , thereby indicating that chemical- and chemical-induced inhibition of the gene is possibly mediated by the gene .	T29	T51	10670413
NA	CHEMICAL	GENE-N	9	9	chemical ( 10 ( -5 ) M ) , a selective gene antagonist , showed no effect on the chemical- or chemical-induced inhibition of the HVA ICa , thereby indicating that chemical- and chemical-induced inhibition of the gene is possibly mediated by the gene .	T29	T52	10670413
NA	CHEMICAL	GENE-Y	9	20	chemical ( 10 ( -5 ) M ) , a selective gene antagonist , showed no effect on the chemical- or chemical-induced inhibition of the HVA ICa , thereby indicating that chemical- and chemical-induced inhibition of the gene is possibly mediated by the gene .	T29	T53	10670413
NA	CHEMICAL	GENE-N	0	9	chemical and chemical also inhibited the remaining ICa in a saturating concentration of chemical , omega-conotoxin-GVIA and omega-conotoxin-MVIIC , suggesting that gene are involved .	T33	T39	10670413
NA	CHEMICAL	GENE-N	2	9	chemical and chemical also inhibited the remaining ICa in a saturating concentration of chemical , omega-conotoxin-GVIA and omega-conotoxin-MVIIC , suggesting that gene are involved .	T34	T39	10670413
NA	CHEMICAL	GENE-N	8	9	chemical and chemical also inhibited the remaining ICa in a saturating concentration of chemical , omega-conotoxin-GVIA and omega-conotoxin-MVIIC , suggesting that gene are involved .	T36	T39	10670413
NA	CHEMICAL	GENE-N	9	9	chemical and chemical also inhibited the remaining ICa in a saturating concentration of chemical , omega-conotoxin-GVIA and omega-conotoxin-MVIIC , suggesting that gene are involved .	T2	T39	10670413
NA	CHEMICAL	GENE-N	4	12	The inhibitory effect of chemical or chemical was prevented by pretreatment with gene [ gene ( gene ) ] or chemical ( chemical ) , and the gene ( gene ) inhibitor chemical blocked the action of chemical .	T3	T40	10670413
NA	CHEMICAL	GENE-N	4	14	The inhibitory effect of chemical or chemical was prevented by pretreatment with gene [ gene ( gene ) ] or chemical ( chemical ) , and the gene ( gene ) inhibitor chemical blocked the action of chemical .	T3	T41	10670413
NA	CHEMICAL	GENE-N	4	16	The inhibitory effect of chemical or chemical was prevented by pretreatment with gene [ gene ( gene ) ] or chemical ( chemical ) , and the gene ( gene ) inhibitor chemical blocked the action of chemical .	T3	T42	10670413
NA	CHEMICAL	GENE-N	4	27	The inhibitory effect of chemical or chemical was prevented by pretreatment with gene [ gene ( gene ) ] or chemical ( chemical ) , and the gene ( gene ) inhibitor chemical blocked the action of chemical .	T3	T43	10670413
NA	CHEMICAL	GENE-N	4	29	The inhibitory effect of chemical or chemical was prevented by pretreatment with gene [ gene ( gene ) ] or chemical ( chemical ) , and the gene ( gene ) inhibitor chemical blocked the action of chemical .	T3	T44	10670413
NA	CHEMICAL	GENE-N	6	12	The inhibitory effect of chemical or chemical was prevented by pretreatment with gene [ gene ( gene ) ] or chemical ( chemical ) , and the gene ( gene ) inhibitor chemical blocked the action of chemical .	T4	T40	10670413
NA	CHEMICAL	GENE-N	6	14	The inhibitory effect of chemical or chemical was prevented by pretreatment with gene [ gene ( gene ) ] or chemical ( chemical ) , and the gene ( gene ) inhibitor chemical blocked the action of chemical .	T4	T41	10670413
NA	CHEMICAL	GENE-N	6	16	The inhibitory effect of chemical or chemical was prevented by pretreatment with gene [ gene ( gene ) ] or chemical ( chemical ) , and the gene ( gene ) inhibitor chemical blocked the action of chemical .	T4	T42	10670413
NA	CHEMICAL	GENE-N	6	27	The inhibitory effect of chemical or chemical was prevented by pretreatment with gene [ gene ( gene ) ] or chemical ( chemical ) , and the gene ( gene ) inhibitor chemical blocked the action of chemical .	T4	T43	10670413
NA	CHEMICAL	GENE-N	6	29	The inhibitory effect of chemical or chemical was prevented by pretreatment with gene [ gene ( gene ) ] or chemical ( chemical ) , and the gene ( gene ) inhibitor chemical blocked the action of chemical .	T4	T44	10670413
NA	CHEMICAL	GENE-N	5	12	The inhibitory effect of chemical or chemical was prevented by pretreatment with gene [ gene ( gene ) ] or chemical ( chemical ) , and the gene ( gene ) inhibitor chemical blocked the action of chemical .	T5	T40	10670413
NA	CHEMICAL	GENE-N	5	14	The inhibitory effect of chemical or chemical was prevented by pretreatment with gene [ gene ( gene ) ] or chemical ( chemical ) , and the gene ( gene ) inhibitor chemical blocked the action of chemical .	T5	T41	10670413
NA	CHEMICAL	GENE-N	5	16	The inhibitory effect of chemical or chemical was prevented by pretreatment with gene [ gene ( gene ) ] or chemical ( chemical ) , and the gene ( gene ) inhibitor chemical blocked the action of chemical .	T5	T42	10670413
NA	CHEMICAL	GENE-N	5	27	The inhibitory effect of chemical or chemical was prevented by pretreatment with gene [ gene ( gene ) ] or chemical ( chemical ) , and the gene ( gene ) inhibitor chemical blocked the action of chemical .	T5	T43	10670413
NA	CHEMICAL	GENE-N	5	29	The inhibitory effect of chemical or chemical was prevented by pretreatment with gene [ gene ( gene ) ] or chemical ( chemical ) , and the gene ( gene ) inhibitor chemical blocked the action of chemical .	T5	T44	10670413
NA	CHEMICAL	GENE-N	22	12	The inhibitory effect of chemical or chemical was prevented by pretreatment with gene [ gene ( gene ) ] or chemical ( chemical ) , and the gene ( gene ) inhibitor chemical blocked the action of chemical .	T6	T40	10670413
NA	CHEMICAL	GENE-N	22	14	The inhibitory effect of chemical or chemical was prevented by pretreatment with gene [ gene ( gene ) ] or chemical ( chemical ) , and the gene ( gene ) inhibitor chemical blocked the action of chemical .	T6	T41	10670413
NA	CHEMICAL	GENE-N	22	16	The inhibitory effect of chemical or chemical was prevented by pretreatment with gene [ gene ( gene ) ] or chemical ( chemical ) , and the gene ( gene ) inhibitor chemical blocked the action of chemical .	T6	T42	10670413
NA	CHEMICAL	GENE-N	22	27	The inhibitory effect of chemical or chemical was prevented by pretreatment with gene [ gene ( gene ) ] or chemical ( chemical ) , and the gene ( gene ) inhibitor chemical blocked the action of chemical .	T6	T43	10670413
NA	CHEMICAL	GENE-N	22	29	The inhibitory effect of chemical or chemical was prevented by pretreatment with gene [ gene ( gene ) ] or chemical ( chemical ) , and the gene ( gene ) inhibitor chemical blocked the action of chemical .	T6	T44	10670413
NA	CHEMICAL	GENE-N	32	12	The inhibitory effect of chemical or chemical was prevented by pretreatment with gene [ gene ( gene ) ] or chemical ( chemical ) , and the gene ( gene ) inhibitor chemical blocked the action of chemical .	T7	T40	10670413
NA	CHEMICAL	GENE-N	32	14	The inhibitory effect of chemical or chemical was prevented by pretreatment with gene [ gene ( gene ) ] or chemical ( chemical ) , and the gene ( gene ) inhibitor chemical blocked the action of chemical .	T7	T41	10670413
NA	CHEMICAL	GENE-N	32	16	The inhibitory effect of chemical or chemical was prevented by pretreatment with gene [ gene ( gene ) ] or chemical ( chemical ) , and the gene ( gene ) inhibitor chemical blocked the action of chemical .	T7	T42	10670413
CPR:4	CHEMICAL	GENE-N	32	27	The inhibitory effect of chemical or chemical was prevented by pretreatment with gene [ gene ( gene ) ] or chemical ( chemical ) , and the gene ( gene ) inhibitor chemical blocked the action of chemical .	T7	T43	10670413
CPR:4	CHEMICAL	GENE-N	32	29	The inhibitory effect of chemical or chemical was prevented by pretreatment with gene [ gene ( gene ) ] or chemical ( chemical ) , and the gene ( gene ) inhibitor chemical blocked the action of chemical .	T7	T44	10670413
NA	CHEMICAL	GENE-N	37	12	The inhibitory effect of chemical or chemical was prevented by pretreatment with gene [ gene ( gene ) ] or chemical ( chemical ) , and the gene ( gene ) inhibitor chemical blocked the action of chemical .	T8	T40	10670413
NA	CHEMICAL	GENE-N	37	14	The inhibitory effect of chemical or chemical was prevented by pretreatment with gene [ gene ( gene ) ] or chemical ( chemical ) , and the gene ( gene ) inhibitor chemical blocked the action of chemical .	T8	T41	10670413
NA	CHEMICAL	GENE-N	37	16	The inhibitory effect of chemical or chemical was prevented by pretreatment with gene [ gene ( gene ) ] or chemical ( chemical ) , and the gene ( gene ) inhibitor chemical blocked the action of chemical .	T8	T42	10670413
NA	CHEMICAL	GENE-N	37	27	The inhibitory effect of chemical or chemical was prevented by pretreatment with gene [ gene ( gene ) ] or chemical ( chemical ) , and the gene ( gene ) inhibitor chemical blocked the action of chemical .	T8	T43	10670413
NA	CHEMICAL	GENE-N	37	29	The inhibitory effect of chemical or chemical was prevented by pretreatment with gene [ gene ( gene ) ] or chemical ( chemical ) , and the gene ( gene ) inhibitor chemical blocked the action of chemical .	T8	T44	10670413
NA	CHEMICAL	GENE-Y	16	0	gene-gene activation is associated with cell cycle arrest and inhibition of DNA replication induced by the chemical synthase inhibitor chemical .	T15	T61	10047461
NA	CHEMICAL	GENE-Y	16	0	gene-gene activation is associated with cell cycle arrest and inhibition of DNA replication induced by the chemical synthase inhibitor chemical .	T15	T63	10047461
NA	CHEMICAL	GENE-Y	16	17	gene-gene activation is associated with cell cycle arrest and inhibition of DNA replication induced by the chemical synthase inhibitor chemical .	T15	T62	10047461
NA	CHEMICAL	GENE-Y	19	0	gene-gene activation is associated with cell cycle arrest and inhibition of DNA replication induced by the chemical synthase inhibitor chemical .	T16	T61	10047461
NA	CHEMICAL	GENE-Y	19	0	gene-gene activation is associated with cell cycle arrest and inhibition of DNA replication induced by the chemical synthase inhibitor chemical .	T16	T63	10047461
CPR:4	CHEMICAL	GENE-Y	19	17	gene-gene activation is associated with cell cycle arrest and inhibition of DNA replication induced by the chemical synthase inhibitor chemical .	T16	T62	10047461
CPR:4	CHEMICAL	GENE-Y	0	5	chemical ( chemical ) is a specific antifolate-based chemical synthase inhibitor active in a variety of solid tumor malignancies .	T1	T50	10047461
NA	CHEMICAL	GENE-Y	2	5	chemical ( chemical ) is a specific antifolate-based chemical synthase inhibitor active in a variety of solid tumor malignancies .	T14	T50	10047461
NA	CHEMICAL	GENE-Y	5	5	chemical ( chemical ) is a specific antifolate-based chemical synthase inhibitor active in a variety of solid tumor malignancies .	T12	T50	10047461
NA	CHEMICAL	GENE-Y	13	12	Studies were carried out in vitro to evaluate downstream molecular alterations induced as a consequence of the potent and sustained inhibition of chemical synthase by chemical .	T9	T46	10047461
CPR:4	CHEMICAL	GENE-Y	25	12	Studies were carried out in vitro to evaluate downstream molecular alterations induced as a consequence of the potent and sustained inhibition of chemical synthase by chemical .	T10	T46	10047461
NA	CHEMICAL	GENE-Y	8	21	Twenty-four hours following the initial 2-h treatment with chemical , human A253 head and neck squamous carcinoma cells , not expressing gene and gene ( gene ) , were accumulated with DNA content characteristic of early S phase of the cell cycle with a concomitant reduction of cells in G1 and G2/M phases .	T11	T47	10047461
NA	CHEMICAL	GENE-Y	8	23	Twenty-four hours following the initial 2-h treatment with chemical , human A253 head and neck squamous carcinoma cells , not expressing gene and gene ( gene ) , were accumulated with DNA content characteristic of early S phase of the cell cycle with a concomitant reduction of cells in G1 and G2/M phases .	T11	T48	10047461
NA	CHEMICAL	GENE-Y	8	25	Twenty-four hours following the initial 2-h treatment with chemical , human A253 head and neck squamous carcinoma cells , not expressing gene and gene ( gene ) , were accumulated with DNA content characteristic of early S phase of the cell cycle with a concomitant reduction of cells in G1 and G2/M phases .	T11	T49	10047461
CPR:4	CHEMICAL	GENE-Y	0	7	chemical treatment resulted in the decrease in gene expression , with an increase in gene and gene protein expression and gene activities 24 h after a 2-h exposure .	T13	T54	10047461
CPR:3	CHEMICAL	GENE-Y	0	14	chemical treatment resulted in the decrease in gene expression , with an increase in gene and gene protein expression and gene activities 24 h after a 2-h exposure .	T13	T55	10047461
CPR:3	CHEMICAL	GENE-Y	0	16	chemical treatment resulted in the decrease in gene expression , with an increase in gene and gene protein expression and gene activities 24 h after a 2-h exposure .	T13	T56	10047461
CPR:3	CHEMICAL	GENE-N	0	3	chemical treatment resulted in the decrease in gene expression , with an increase in gene and gene protein expression and gene activities 24 h after a 2-h exposure .	T13	T57	10047461
CPR:4	CHEMICAL	GENE-Y	13	6	The studies with dThyd rescue from gene-gene protein overexpression and growth inhibition by chemical indicate that increased gene-gene protein expression is associated with effective inhibition of chemical synthase and resultant dNTP pool imbalance .	T2	T30	10047461
CPR:4	CHEMICAL	GENE-Y	13	6	The studies with dThyd rescue from gene-gene protein overexpression and growth inhibition by chemical indicate that increased gene-gene protein expression is associated with effective inhibition of chemical synthase and resultant dNTP pool imbalance .	T2	T31	10047461
CPR:3	CHEMICAL	GENE-Y	13	17	The studies with dThyd rescue from gene-gene protein overexpression and growth inhibition by chemical indicate that increased gene-gene protein expression is associated with effective inhibition of chemical synthase and resultant dNTP pool imbalance .	T2	T32	10047461
CPR:3	CHEMICAL	GENE-Y	13	17	The studies with dThyd rescue from gene-gene protein overexpression and growth inhibition by chemical indicate that increased gene-gene protein expression is associated with effective inhibition of chemical synthase and resultant dNTP pool imbalance .	T2	T33	10047461
CPR:4	CHEMICAL	GENE-Y	13	27	The studies with dThyd rescue from gene-gene protein overexpression and growth inhibition by chemical indicate that increased gene-gene protein expression is associated with effective inhibition of chemical synthase and resultant dNTP pool imbalance .	T2	T34	10047461
NA	CHEMICAL	GENE-Y	6	6	The studies with dThyd rescue from gene-gene protein overexpression and growth inhibition by chemical indicate that increased gene-gene protein expression is associated with effective inhibition of chemical synthase and resultant dNTP pool imbalance .	T3	T30	10047461
NA	CHEMICAL	GENE-Y	6	6	The studies with dThyd rescue from gene-gene protein overexpression and growth inhibition by chemical indicate that increased gene-gene protein expression is associated with effective inhibition of chemical synthase and resultant dNTP pool imbalance .	T3	T31	10047461
NA	CHEMICAL	GENE-Y	6	17	The studies with dThyd rescue from gene-gene protein overexpression and growth inhibition by chemical indicate that increased gene-gene protein expression is associated with effective inhibition of chemical synthase and resultant dNTP pool imbalance .	T3	T32	10047461
NA	CHEMICAL	GENE-Y	6	17	The studies with dThyd rescue from gene-gene protein overexpression and growth inhibition by chemical indicate that increased gene-gene protein expression is associated with effective inhibition of chemical synthase and resultant dNTP pool imbalance .	T3	T33	10047461
NA	CHEMICAL	GENE-Y	6	27	The studies with dThyd rescue from gene-gene protein overexpression and growth inhibition by chemical indicate that increased gene-gene protein expression is associated with effective inhibition of chemical synthase and resultant dNTP pool imbalance .	T3	T34	10047461
NA	CHEMICAL	GENE-Y	11	10	These results suggest that the megabase DNA fragmentation is induced as a consequence of inhibition of chemical synthase by chemical and kilobase DNA fragmentation may correlate with the reduction of gene expression and the increase in gene and gene gene activities .	T6	T37	10047461
NA	CHEMICAL	GENE-Y	11	30	These results suggest that the megabase DNA fragmentation is induced as a consequence of inhibition of chemical synthase by chemical and kilobase DNA fragmentation may correlate with the reduction of gene expression and the increase in gene and gene gene activities .	T6	T38	10047461
NA	CHEMICAL	GENE-Y	11	36	These results suggest that the megabase DNA fragmentation is induced as a consequence of inhibition of chemical synthase by chemical and kilobase DNA fragmentation may correlate with the reduction of gene expression and the increase in gene and gene gene activities .	T6	T39	10047461
NA	CHEMICAL	GENE-Y	11	38	These results suggest that the megabase DNA fragmentation is induced as a consequence of inhibition of chemical synthase by chemical and kilobase DNA fragmentation may correlate with the reduction of gene expression and the increase in gene and gene gene activities .	T6	T40	10047461
NA	CHEMICAL	GENE-N	11	10	These results suggest that the megabase DNA fragmentation is induced as a consequence of inhibition of chemical synthase by chemical and kilobase DNA fragmentation may correlate with the reduction of gene expression and the increase in gene and gene gene activities .	T6	T41	10047461
CPR:4	CHEMICAL	GENE-Y	19	10	These results suggest that the megabase DNA fragmentation is induced as a consequence of inhibition of chemical synthase by chemical and kilobase DNA fragmentation may correlate with the reduction of gene expression and the increase in gene and gene gene activities .	T7	T37	10047461
CPR:4	CHEMICAL	GENE-Y	19	30	These results suggest that the megabase DNA fragmentation is induced as a consequence of inhibition of chemical synthase by chemical and kilobase DNA fragmentation may correlate with the reduction of gene expression and the increase in gene and gene gene activities .	T7	T38	10047461
CPR:3	CHEMICAL	GENE-Y	19	36	These results suggest that the megabase DNA fragmentation is induced as a consequence of inhibition of chemical synthase by chemical and kilobase DNA fragmentation may correlate with the reduction of gene expression and the increase in gene and gene gene activities .	T7	T39	10047461
CPR:3	CHEMICAL	GENE-Y	19	38	These results suggest that the megabase DNA fragmentation is induced as a consequence of inhibition of chemical synthase by chemical and kilobase DNA fragmentation may correlate with the reduction of gene expression and the increase in gene and gene gene activities .	T7	T40	10047461
CPR:3	CHEMICAL	GENE-N	19	10	These results suggest that the megabase DNA fragmentation is induced as a consequence of inhibition of chemical synthase by chemical and kilobase DNA fragmentation may correlate with the reduction of gene expression and the increase in gene and gene gene activities .	T7	T41	10047461
CPR:4	CHEMICAL	GENE-Y	0	2	chemical , a potent gene inhibitor from Tabernaemontana divaricata .	T6	T10	23375813
CPR:4	CHEMICAL	GENE-Y	8	3	Guided by the gene inhibiting activity , the chemical chemical was isolated from a stem extract of Tabernaemontana divaricata , a plant used in Thailand in traditional rejuvenation remedies for improving the memory .	T3	T7	23375813
CPR:4	CHEMICAL	GENE-Y	9	3	Guided by the gene inhibiting activity , the chemical chemical was isolated from a stem extract of Tabernaemontana divaricata , a plant used in Thailand in traditional rejuvenation remedies for improving the memory .	T5	T7	23375813
NA	CHEMICAL	GENE-N	20	8	Some of the most commonly affected assays were gene ( gene , gene ) , transporters ( mitochondrial TSPO , chemical , dopaminergic ) , and gene ( aminergic ) .	T1	T3	23611293
NA	CHEMICAL	GENE-Y	20	10	Some of the most commonly affected assays were gene ( gene , gene ) , transporters ( mitochondrial TSPO , chemical , dopaminergic ) , and gene ( aminergic ) .	T1	T4	23611293
NA	CHEMICAL	GENE-Y	20	12	Some of the most commonly affected assays were gene ( gene , gene ) , transporters ( mitochondrial TSPO , chemical , dopaminergic ) , and gene ( aminergic ) .	T1	T5	23611293
NA	CHEMICAL	GENE-N	20	26	Some of the most commonly affected assays were gene ( gene , gene ) , transporters ( mitochondrial TSPO , chemical , dopaminergic ) , and gene ( aminergic ) .	T1	T6	23611293
NA	CHEMICAL	GENE-Y	15	33	An experimental strategy based on solution viscosity perturbation allowed us to study the energetics of chemical-substrates , chemical ( chemical ) and chemical binding to the catalytic site of two proteolyzed forms of gene , i.e .	T1	T28	7837275
NA	CHEMICAL	GENE-Y	17	33	An experimental strategy based on solution viscosity perturbation allowed us to study the energetics of chemical-substrates , chemical ( chemical ) and chemical binding to the catalytic site of two proteolyzed forms of gene , i.e .	T2	T28	7837275
NA	CHEMICAL	GENE-Y	19	33	An experimental strategy based on solution viscosity perturbation allowed us to study the energetics of chemical-substrates , chemical ( chemical ) and chemical binding to the catalytic site of two proteolyzed forms of gene , i.e .	T4	T28	7837275
NA	CHEMICAL	GENE-Y	14	33	An experimental strategy based on solution viscosity perturbation allowed us to study the energetics of chemical-substrates , chemical ( chemical ) and chemical binding to the catalytic site of two proteolyzed forms of gene , i.e .	T5	T28	7837275
NA	CHEMICAL	GENE-Y	9	15	A phenomenological analysis of thermodynamic data showed that the chemical substrates and chemical interactions with gene were respectively , associated with a chemical compensation ( i.e .	T8	T33	7837275
NA	CHEMICAL	GENE-Y	0	15	A phenomenological analysis of thermodynamic data showed that the chemical substrates and chemical interactions with gene were respectively , associated with a chemical compensation ( i.e .	T9	T33	7837275
NA	CHEMICAL	GENE-Y	15	6	These interactions were studied by following gene ( gene ) release and by measuring intraplatelet chemical changes induced by gene-gene interaction .	T3	T15	7837275
NA	CHEMICAL	GENE-Y	15	8	These interactions were studied by following gene ( gene ) release and by measuring intraplatelet chemical changes induced by gene-gene interaction .	T3	T16	7837275
NA	CHEMICAL	GENE-Y	15	19	These interactions were studied by following gene ( gene ) release and by measuring intraplatelet chemical changes induced by gene-gene interaction .	T3	T17	7837275
NA	CHEMICAL	GENE-N	15	19	These interactions were studied by following gene ( gene ) release and by measuring intraplatelet chemical changes induced by gene-gene interaction .	T3	T18	7837275
NA	CHEMICAL	GENE-N	11	8	Moreover , the values of delta Cp for gene interaction with chemical were found to be linearly correlated to the free energy of activation for both gene and gene cleavage .	T6	T21	7837275
NA	CHEMICAL	GENE-N	11	26	Moreover , the values of delta Cp for gene interaction with chemical were found to be linearly correlated to the free energy of activation for both gene and gene cleavage .	T6	T22	7837275
NA	CHEMICAL	GENE-N	11	28	Moreover , the values of delta Cp for gene interaction with chemical were found to be linearly correlated to the free energy of activation for both gene and gene cleavage .	T6	T23	7837275
NA	CHEMICAL	GENE-N	0	6	chemical promotes the nuclear translocation of gene and thereby induces gene gene expression in osteoblast-like cell lines .	T12	T40	23612487
CPR:3	CHEMICAL	GENE-N	0	10	chemical promotes the nuclear translocation of gene and thereby induces gene gene expression in osteoblast-like cell lines .	T12	T41	23612487
CPR:3	CHEMICAL	GENE-N	0	3	chemical activated chemical 3-kinase ( gene ) /gene signaling , leading to the inhibition of gene and the nuclear translocation of gene , followed by the increase of the transcriptional activity by gene/gene complex formation in both SaOS-2 cells and MC3T3-E1 cells .	T8	T23	23612487
CPR:3	CHEMICAL	GENE-N	0	5	chemical activated chemical 3-kinase ( gene ) /gene signaling , leading to the inhibition of gene and the nuclear translocation of gene , followed by the increase of the transcriptional activity by gene/gene complex formation in both SaOS-2 cells and MC3T3-E1 cells .	T8	T24	23612487
CPR:3	CHEMICAL	GENE-N	0	7	chemical activated chemical 3-kinase ( gene ) /gene signaling , leading to the inhibition of gene and the nuclear translocation of gene , followed by the increase of the transcriptional activity by gene/gene complex formation in both SaOS-2 cells and MC3T3-E1 cells .	T8	T25	23612487
CPR:4	CHEMICAL	GENE-N	0	15	chemical activated chemical 3-kinase ( gene ) /gene signaling , leading to the inhibition of gene and the nuclear translocation of gene , followed by the increase of the transcriptional activity by gene/gene complex formation in both SaOS-2 cells and MC3T3-E1 cells .	T8	T26	23612487
NA	CHEMICAL	GENE-N	0	21	chemical activated chemical 3-kinase ( gene ) /gene signaling , leading to the inhibition of gene and the nuclear translocation of gene , followed by the increase of the transcriptional activity by gene/gene complex formation in both SaOS-2 cells and MC3T3-E1 cells .	T8	T27	23612487
NA	CHEMICAL	GENE-N	0	32	chemical activated chemical 3-kinase ( gene ) /gene signaling , leading to the inhibition of gene and the nuclear translocation of gene , followed by the increase of the transcriptional activity by gene/gene complex formation in both SaOS-2 cells and MC3T3-E1 cells .	T8	T28	23612487
NA	CHEMICAL	GENE-N	0	11	chemical activated chemical 3-kinase ( gene ) /gene signaling , leading to the inhibition of gene and the nuclear translocation of gene , followed by the increase of the transcriptional activity by gene/gene complex formation in both SaOS-2 cells and MC3T3-E1 cells .	T8	T29	23612487
NA	CHEMICAL	GENE-N	2	3	chemical activated chemical 3-kinase ( gene ) /gene signaling , leading to the inhibition of gene and the nuclear translocation of gene , followed by the increase of the transcriptional activity by gene/gene complex formation in both SaOS-2 cells and MC3T3-E1 cells .	T9	T23	23612487
NA	CHEMICAL	GENE-N	2	5	chemical activated chemical 3-kinase ( gene ) /gene signaling , leading to the inhibition of gene and the nuclear translocation of gene , followed by the increase of the transcriptional activity by gene/gene complex formation in both SaOS-2 cells and MC3T3-E1 cells .	T9	T24	23612487
NA	CHEMICAL	GENE-N	2	7	chemical activated chemical 3-kinase ( gene ) /gene signaling , leading to the inhibition of gene and the nuclear translocation of gene , followed by the increase of the transcriptional activity by gene/gene complex formation in both SaOS-2 cells and MC3T3-E1 cells .	T9	T25	23612487
NA	CHEMICAL	GENE-N	2	15	chemical activated chemical 3-kinase ( gene ) /gene signaling , leading to the inhibition of gene and the nuclear translocation of gene , followed by the increase of the transcriptional activity by gene/gene complex formation in both SaOS-2 cells and MC3T3-E1 cells .	T9	T26	23612487
NA	CHEMICAL	GENE-N	2	21	chemical activated chemical 3-kinase ( gene ) /gene signaling , leading to the inhibition of gene and the nuclear translocation of gene , followed by the increase of the transcriptional activity by gene/gene complex formation in both SaOS-2 cells and MC3T3-E1 cells .	T9	T27	23612487
NA	CHEMICAL	GENE-N	2	32	chemical activated chemical 3-kinase ( gene ) /gene signaling , leading to the inhibition of gene and the nuclear translocation of gene , followed by the increase of the transcriptional activity by gene/gene complex formation in both SaOS-2 cells and MC3T3-E1 cells .	T9	T28	23612487
NA	CHEMICAL	GENE-N	2	11	chemical activated chemical 3-kinase ( gene ) /gene signaling , leading to the inhibition of gene and the nuclear translocation of gene , followed by the increase of the transcriptional activity by gene/gene complex formation in both SaOS-2 cells and MC3T3-E1 cells .	T9	T29	23612487
NA	CHEMICAL	GENE-N	7	3	The inhibitors of gene and gene suppressed chemical-induced nuclear localization of gene .	T11	T30	23612487
NA	CHEMICAL	GENE-N	7	5	The inhibitors of gene and gene suppressed chemical-induced nuclear localization of gene .	T11	T31	23612487
NA	CHEMICAL	GENE-N	7	11	The inhibitors of gene and gene suppressed chemical-induced nuclear localization of gene .	T11	T32	23612487
CPR:3	CHEMICAL	GENE-N	0	5	chemical increased the amount of gene at both mRNA and protein levels , and increased the activity of gene , leading to the mineralization .	T2	T16	23612487
NA	CHEMICAL	GENE-N	0	6	chemical increased the amount of gene at both mRNA and protein levels , and increased the activity of gene , leading to the mineralization .	T2	T17	23612487
NA	CHEMICAL	GENE-N	11	12	Much is still being learned about the function and specificity of chemical receptors , which will support the development of agents with sustained efficacy and enhanced tolerability compared with the available formulations to date .	T5	T7	15963006
CPR:9	CHEMICAL	GENE-N	1	1	The gene pathway generates inflammatory chemical , while the gene pathway generates inflammatory chemical .	T1	T16	12392782
NA	CHEMICAL	GENE-Y	1	9	The gene pathway generates inflammatory chemical , while the gene pathway generates inflammatory chemical .	T1	T17	12392782
NA	CHEMICAL	GENE-N	13	1	The gene pathway generates inflammatory chemical , while the gene pathway generates inflammatory chemical .	T2	T16	12392782
CPR:9	CHEMICAL	GENE-Y	13	9	The gene pathway generates inflammatory chemical , while the gene pathway generates inflammatory chemical .	T2	T17	12392782
NA	CHEMICAL	GENE-Y	10	3	They included the gene inhibitor chemical ; the gene inhibitor chemical ; the mixed gene/gene inhibitor chemical ; the chemical ( chemical ) derivatives of indomethacin , chemical and chemical ; the gene inhibitor chemical ; and the gene ( gene ) inhibitor chemical .	T3	T18	12392782
CPR:4	CHEMICAL	GENE-Y	10	8	They included the gene inhibitor chemical ; the gene inhibitor chemical ; the mixed gene/gene inhibitor chemical ; the chemical ( chemical ) derivatives of indomethacin , chemical and chemical ; the gene inhibitor chemical ; and the gene ( gene ) inhibitor chemical .	T3	T19	12392782
NA	CHEMICAL	GENE-Y	10	14	They included the gene inhibitor chemical ; the gene inhibitor chemical ; the mixed gene/gene inhibitor chemical ; the chemical ( chemical ) derivatives of indomethacin , chemical and chemical ; the gene inhibitor chemical ; and the gene ( gene ) inhibitor chemical .	T3	T20	12392782
NA	CHEMICAL	GENE-Y	10	14	They included the gene inhibitor chemical ; the gene inhibitor chemical ; the mixed gene/gene inhibitor chemical ; the chemical ( chemical ) derivatives of indomethacin , chemical and chemical ; the gene inhibitor chemical ; and the gene ( gene ) inhibitor chemical .	T3	T21	12392782
NA	CHEMICAL	GENE-Y	10	32	They included the gene inhibitor chemical ; the gene inhibitor chemical ; the mixed gene/gene inhibitor chemical ; the chemical ( chemical ) derivatives of indomethacin , chemical and chemical ; the gene inhibitor chemical ; and the gene ( gene ) inhibitor chemical .	T3	T22	12392782
NA	CHEMICAL	GENE-Y	10	38	They included the gene inhibitor chemical ; the gene inhibitor chemical ; the mixed gene/gene inhibitor chemical ; the chemical ( chemical ) derivatives of indomethacin , chemical and chemical ; the gene inhibitor chemical ; and the gene ( gene ) inhibitor chemical .	T3	T23	12392782
NA	CHEMICAL	GENE-Y	10	40	They included the gene inhibitor chemical ; the gene inhibitor chemical ; the mixed gene/gene inhibitor chemical ; the chemical ( chemical ) derivatives of indomethacin , chemical and chemical ; the gene inhibitor chemical ; and the gene ( gene ) inhibitor chemical .	T3	T24	12392782
NA	CHEMICAL	GENE-Y	16	3	They included the gene inhibitor chemical ; the gene inhibitor chemical ; the mixed gene/gene inhibitor chemical ; the chemical ( chemical ) derivatives of indomethacin , chemical and chemical ; the gene inhibitor chemical ; and the gene ( gene ) inhibitor chemical .	T4	T18	12392782
NA	CHEMICAL	GENE-Y	16	8	They included the gene inhibitor chemical ; the gene inhibitor chemical ; the mixed gene/gene inhibitor chemical ; the chemical ( chemical ) derivatives of indomethacin , chemical and chemical ; the gene inhibitor chemical ; and the gene ( gene ) inhibitor chemical .	T4	T19	12392782
CPR:4	CHEMICAL	GENE-Y	16	14	They included the gene inhibitor chemical ; the gene inhibitor chemical ; the mixed gene/gene inhibitor chemical ; the chemical ( chemical ) derivatives of indomethacin , chemical and chemical ; the gene inhibitor chemical ; and the gene ( gene ) inhibitor chemical .	T4	T20	12392782
CPR:4	CHEMICAL	GENE-Y	16	14	They included the gene inhibitor chemical ; the gene inhibitor chemical ; the mixed gene/gene inhibitor chemical ; the chemical ( chemical ) derivatives of indomethacin , chemical and chemical ; the gene inhibitor chemical ; and the gene ( gene ) inhibitor chemical .	T4	T21	12392782
NA	CHEMICAL	GENE-Y	16	32	They included the gene inhibitor chemical ; the gene inhibitor chemical ; the mixed gene/gene inhibitor chemical ; the chemical ( chemical ) derivatives of indomethacin , chemical and chemical ; the gene inhibitor chemical ; and the gene ( gene ) inhibitor chemical .	T4	T22	12392782
NA	CHEMICAL	GENE-Y	16	38	They included the gene inhibitor chemical ; the gene inhibitor chemical ; the mixed gene/gene inhibitor chemical ; the chemical ( chemical ) derivatives of indomethacin , chemical and chemical ; the gene inhibitor chemical ; and the gene ( gene ) inhibitor chemical .	T4	T23	12392782
NA	CHEMICAL	GENE-Y	16	40	They included the gene inhibitor chemical ; the gene inhibitor chemical ; the mixed gene/gene inhibitor chemical ; the chemical ( chemical ) derivatives of indomethacin , chemical and chemical ; the gene inhibitor chemical ; and the gene ( gene ) inhibitor chemical .	T4	T24	12392782
NA	CHEMICAL	GENE-Y	19	3	They included the gene inhibitor chemical ; the gene inhibitor chemical ; the mixed gene/gene inhibitor chemical ; the chemical ( chemical ) derivatives of indomethacin , chemical and chemical ; the gene inhibitor chemical ; and the gene ( gene ) inhibitor chemical .	T5	T18	12392782
NA	CHEMICAL	GENE-Y	19	8	They included the gene inhibitor chemical ; the gene inhibitor chemical ; the mixed gene/gene inhibitor chemical ; the chemical ( chemical ) derivatives of indomethacin , chemical and chemical ; the gene inhibitor chemical ; and the gene ( gene ) inhibitor chemical .	T5	T19	12392782
NA	CHEMICAL	GENE-Y	19	14	They included the gene inhibitor chemical ; the gene inhibitor chemical ; the mixed gene/gene inhibitor chemical ; the chemical ( chemical ) derivatives of indomethacin , chemical and chemical ; the gene inhibitor chemical ; and the gene ( gene ) inhibitor chemical .	T5	T20	12392782
NA	CHEMICAL	GENE-Y	19	14	They included the gene inhibitor chemical ; the gene inhibitor chemical ; the mixed gene/gene inhibitor chemical ; the chemical ( chemical ) derivatives of indomethacin , chemical and chemical ; the gene inhibitor chemical ; and the gene ( gene ) inhibitor chemical .	T5	T21	12392782
NA	CHEMICAL	GENE-Y	19	32	They included the gene inhibitor chemical ; the gene inhibitor chemical ; the mixed gene/gene inhibitor chemical ; the chemical ( chemical ) derivatives of indomethacin , chemical and chemical ; the gene inhibitor chemical ; and the gene ( gene ) inhibitor chemical .	T5	T22	12392782
NA	CHEMICAL	GENE-Y	19	38	They included the gene inhibitor chemical ; the gene inhibitor chemical ; the mixed gene/gene inhibitor chemical ; the chemical ( chemical ) derivatives of indomethacin , chemical and chemical ; the gene inhibitor chemical ; and the gene ( gene ) inhibitor chemical .	T5	T23	12392782
NA	CHEMICAL	GENE-Y	19	40	They included the gene inhibitor chemical ; the gene inhibitor chemical ; the mixed gene/gene inhibitor chemical ; the chemical ( chemical ) derivatives of indomethacin , chemical and chemical ; the gene inhibitor chemical ; and the gene ( gene ) inhibitor chemical .	T5	T24	12392782
NA	CHEMICAL	GENE-Y	21	3	They included the gene inhibitor chemical ; the gene inhibitor chemical ; the mixed gene/gene inhibitor chemical ; the chemical ( chemical ) derivatives of indomethacin , chemical and chemical ; the gene inhibitor chemical ; and the gene ( gene ) inhibitor chemical .	T6	T18	12392782
NA	CHEMICAL	GENE-Y	21	8	They included the gene inhibitor chemical ; the gene inhibitor chemical ; the mixed gene/gene inhibitor chemical ; the chemical ( chemical ) derivatives of indomethacin , chemical and chemical ; the gene inhibitor chemical ; and the gene ( gene ) inhibitor chemical .	T6	T19	12392782
NA	CHEMICAL	GENE-Y	21	14	They included the gene inhibitor chemical ; the gene inhibitor chemical ; the mixed gene/gene inhibitor chemical ; the chemical ( chemical ) derivatives of indomethacin , chemical and chemical ; the gene inhibitor chemical ; and the gene ( gene ) inhibitor chemical .	T6	T20	12392782
NA	CHEMICAL	GENE-Y	21	14	They included the gene inhibitor chemical ; the gene inhibitor chemical ; the mixed gene/gene inhibitor chemical ; the chemical ( chemical ) derivatives of indomethacin , chemical and chemical ; the gene inhibitor chemical ; and the gene ( gene ) inhibitor chemical .	T6	T21	12392782
NA	CHEMICAL	GENE-Y	21	32	They included the gene inhibitor chemical ; the gene inhibitor chemical ; the mixed gene/gene inhibitor chemical ; the chemical ( chemical ) derivatives of indomethacin , chemical and chemical ; the gene inhibitor chemical ; and the gene ( gene ) inhibitor chemical .	T6	T22	12392782
NA	CHEMICAL	GENE-Y	21	38	They included the gene inhibitor chemical ; the gene inhibitor chemical ; the mixed gene/gene inhibitor chemical ; the chemical ( chemical ) derivatives of indomethacin , chemical and chemical ; the gene inhibitor chemical ; and the gene ( gene ) inhibitor chemical .	T6	T23	12392782
NA	CHEMICAL	GENE-Y	21	40	They included the gene inhibitor chemical ; the gene inhibitor chemical ; the mixed gene/gene inhibitor chemical ; the chemical ( chemical ) derivatives of indomethacin , chemical and chemical ; the gene inhibitor chemical ; and the gene ( gene ) inhibitor chemical .	T6	T24	12392782
NA	CHEMICAL	GENE-Y	5	3	They included the gene inhibitor chemical ; the gene inhibitor chemical ; the mixed gene/gene inhibitor chemical ; the chemical ( chemical ) derivatives of indomethacin , chemical and chemical ; the gene inhibitor chemical ; and the gene ( gene ) inhibitor chemical .	T7	T18	12392782
NA	CHEMICAL	GENE-Y	5	8	They included the gene inhibitor chemical ; the gene inhibitor chemical ; the mixed gene/gene inhibitor chemical ; the chemical ( chemical ) derivatives of indomethacin , chemical and chemical ; the gene inhibitor chemical ; and the gene ( gene ) inhibitor chemical .	T7	T19	12392782
NA	CHEMICAL	GENE-Y	5	14	They included the gene inhibitor chemical ; the gene inhibitor chemical ; the mixed gene/gene inhibitor chemical ; the chemical ( chemical ) derivatives of indomethacin , chemical and chemical ; the gene inhibitor chemical ; and the gene ( gene ) inhibitor chemical .	T7	T20	12392782
NA	CHEMICAL	GENE-Y	5	14	They included the gene inhibitor chemical ; the gene inhibitor chemical ; the mixed gene/gene inhibitor chemical ; the chemical ( chemical ) derivatives of indomethacin , chemical and chemical ; the gene inhibitor chemical ; and the gene ( gene ) inhibitor chemical .	T7	T21	12392782
NA	CHEMICAL	GENE-Y	5	32	They included the gene inhibitor chemical ; the gene inhibitor chemical ; the mixed gene/gene inhibitor chemical ; the chemical ( chemical ) derivatives of indomethacin , chemical and chemical ; the gene inhibitor chemical ; and the gene ( gene ) inhibitor chemical .	T7	T22	12392782
NA	CHEMICAL	GENE-Y	5	38	They included the gene inhibitor chemical ; the gene inhibitor chemical ; the mixed gene/gene inhibitor chemical ; the chemical ( chemical ) derivatives of indomethacin , chemical and chemical ; the gene inhibitor chemical ; and the gene ( gene ) inhibitor chemical .	T7	T23	12392782
NA	CHEMICAL	GENE-Y	5	40	They included the gene inhibitor chemical ; the gene inhibitor chemical ; the mixed gene/gene inhibitor chemical ; the chemical ( chemical ) derivatives of indomethacin , chemical and chemical ; the gene inhibitor chemical ; and the gene ( gene ) inhibitor chemical .	T7	T24	12392782
NA	CHEMICAL	GENE-Y	24	3	They included the gene inhibitor chemical ; the gene inhibitor chemical ; the mixed gene/gene inhibitor chemical ; the chemical ( chemical ) derivatives of indomethacin , chemical and chemical ; the gene inhibitor chemical ; and the gene ( gene ) inhibitor chemical .	T8	T18	12392782
NA	CHEMICAL	GENE-Y	24	8	They included the gene inhibitor chemical ; the gene inhibitor chemical ; the mixed gene/gene inhibitor chemical ; the chemical ( chemical ) derivatives of indomethacin , chemical and chemical ; the gene inhibitor chemical ; and the gene ( gene ) inhibitor chemical .	T8	T19	12392782
NA	CHEMICAL	GENE-Y	24	14	They included the gene inhibitor chemical ; the gene inhibitor chemical ; the mixed gene/gene inhibitor chemical ; the chemical ( chemical ) derivatives of indomethacin , chemical and chemical ; the gene inhibitor chemical ; and the gene ( gene ) inhibitor chemical .	T8	T20	12392782
NA	CHEMICAL	GENE-Y	24	14	They included the gene inhibitor chemical ; the gene inhibitor chemical ; the mixed gene/gene inhibitor chemical ; the chemical ( chemical ) derivatives of indomethacin , chemical and chemical ; the gene inhibitor chemical ; and the gene ( gene ) inhibitor chemical .	T8	T21	12392782
NA	CHEMICAL	GENE-Y	24	32	They included the gene inhibitor chemical ; the gene inhibitor chemical ; the mixed gene/gene inhibitor chemical ; the chemical ( chemical ) derivatives of indomethacin , chemical and chemical ; the gene inhibitor chemical ; and the gene ( gene ) inhibitor chemical .	T8	T22	12392782
NA	CHEMICAL	GENE-Y	24	38	They included the gene inhibitor chemical ; the gene inhibitor chemical ; the mixed gene/gene inhibitor chemical ; the chemical ( chemical ) derivatives of indomethacin , chemical and chemical ; the gene inhibitor chemical ; and the gene ( gene ) inhibitor chemical .	T8	T23	12392782
NA	CHEMICAL	GENE-Y	24	40	They included the gene inhibitor chemical ; the gene inhibitor chemical ; the mixed gene/gene inhibitor chemical ; the chemical ( chemical ) derivatives of indomethacin , chemical and chemical ; the gene inhibitor chemical ; and the gene ( gene ) inhibitor chemical .	T8	T24	12392782
NA	CHEMICAL	GENE-Y	24	3	They included the gene inhibitor chemical ; the gene inhibitor chemical ; the mixed gene/gene inhibitor chemical ; the chemical ( chemical ) derivatives of indomethacin , chemical and chemical ; the gene inhibitor chemical ; and the gene ( gene ) inhibitor chemical .	T9	T18	12392782
NA	CHEMICAL	GENE-Y	24	8	They included the gene inhibitor chemical ; the gene inhibitor chemical ; the mixed gene/gene inhibitor chemical ; the chemical ( chemical ) derivatives of indomethacin , chemical and chemical ; the gene inhibitor chemical ; and the gene ( gene ) inhibitor chemical .	T9	T19	12392782
NA	CHEMICAL	GENE-Y	24	14	They included the gene inhibitor chemical ; the gene inhibitor chemical ; the mixed gene/gene inhibitor chemical ; the chemical ( chemical ) derivatives of indomethacin , chemical and chemical ; the gene inhibitor chemical ; and the gene ( gene ) inhibitor chemical .	T9	T20	12392782
NA	CHEMICAL	GENE-Y	24	14	They included the gene inhibitor chemical ; the gene inhibitor chemical ; the mixed gene/gene inhibitor chemical ; the chemical ( chemical ) derivatives of indomethacin , chemical and chemical ; the gene inhibitor chemical ; and the gene ( gene ) inhibitor chemical .	T9	T21	12392782
NA	CHEMICAL	GENE-Y	24	32	They included the gene inhibitor chemical ; the gene inhibitor chemical ; the mixed gene/gene inhibitor chemical ; the chemical ( chemical ) derivatives of indomethacin , chemical and chemical ; the gene inhibitor chemical ; and the gene ( gene ) inhibitor chemical .	T9	T22	12392782
NA	CHEMICAL	GENE-Y	24	38	They included the gene inhibitor chemical ; the gene inhibitor chemical ; the mixed gene/gene inhibitor chemical ; the chemical ( chemical ) derivatives of indomethacin , chemical and chemical ; the gene inhibitor chemical ; and the gene ( gene ) inhibitor chemical .	T9	T23	12392782
NA	CHEMICAL	GENE-Y	24	40	They included the gene inhibitor chemical ; the gene inhibitor chemical ; the mixed gene/gene inhibitor chemical ; the chemical ( chemical ) derivatives of indomethacin , chemical and chemical ; the gene inhibitor chemical ; and the gene ( gene ) inhibitor chemical .	T9	T24	12392782
NA	CHEMICAL	GENE-Y	34	3	They included the gene inhibitor chemical ; the gene inhibitor chemical ; the mixed gene/gene inhibitor chemical ; the chemical ( chemical ) derivatives of indomethacin , chemical and chemical ; the gene inhibitor chemical ; and the gene ( gene ) inhibitor chemical .	T10	T18	12392782
NA	CHEMICAL	GENE-Y	34	8	They included the gene inhibitor chemical ; the gene inhibitor chemical ; the mixed gene/gene inhibitor chemical ; the chemical ( chemical ) derivatives of indomethacin , chemical and chemical ; the gene inhibitor chemical ; and the gene ( gene ) inhibitor chemical .	T10	T19	12392782
NA	CHEMICAL	GENE-Y	34	14	They included the gene inhibitor chemical ; the gene inhibitor chemical ; the mixed gene/gene inhibitor chemical ; the chemical ( chemical ) derivatives of indomethacin , chemical and chemical ; the gene inhibitor chemical ; and the gene ( gene ) inhibitor chemical .	T10	T20	12392782
NA	CHEMICAL	GENE-Y	34	14	They included the gene inhibitor chemical ; the gene inhibitor chemical ; the mixed gene/gene inhibitor chemical ; the chemical ( chemical ) derivatives of indomethacin , chemical and chemical ; the gene inhibitor chemical ; and the gene ( gene ) inhibitor chemical .	T10	T21	12392782
CPR:4	CHEMICAL	GENE-Y	34	32	They included the gene inhibitor chemical ; the gene inhibitor chemical ; the mixed gene/gene inhibitor chemical ; the chemical ( chemical ) derivatives of indomethacin , chemical and chemical ; the gene inhibitor chemical ; and the gene ( gene ) inhibitor chemical .	T10	T22	12392782
NA	CHEMICAL	GENE-Y	34	38	They included the gene inhibitor chemical ; the gene inhibitor chemical ; the mixed gene/gene inhibitor chemical ; the chemical ( chemical ) derivatives of indomethacin , chemical and chemical ; the gene inhibitor chemical ; and the gene ( gene ) inhibitor chemical .	T10	T23	12392782
NA	CHEMICAL	GENE-Y	34	40	They included the gene inhibitor chemical ; the gene inhibitor chemical ; the mixed gene/gene inhibitor chemical ; the chemical ( chemical ) derivatives of indomethacin , chemical and chemical ; the gene inhibitor chemical ; and the gene ( gene ) inhibitor chemical .	T10	T24	12392782
NA	CHEMICAL	GENE-Y	43	3	They included the gene inhibitor chemical ; the gene inhibitor chemical ; the mixed gene/gene inhibitor chemical ; the chemical ( chemical ) derivatives of indomethacin , chemical and chemical ; the gene inhibitor chemical ; and the gene ( gene ) inhibitor chemical .	T11	T18	12392782
NA	CHEMICAL	GENE-Y	43	8	They included the gene inhibitor chemical ; the gene inhibitor chemical ; the mixed gene/gene inhibitor chemical ; the chemical ( chemical ) derivatives of indomethacin , chemical and chemical ; the gene inhibitor chemical ; and the gene ( gene ) inhibitor chemical .	T11	T19	12392782
NA	CHEMICAL	GENE-Y	43	14	They included the gene inhibitor chemical ; the gene inhibitor chemical ; the mixed gene/gene inhibitor chemical ; the chemical ( chemical ) derivatives of indomethacin , chemical and chemical ; the gene inhibitor chemical ; and the gene ( gene ) inhibitor chemical .	T11	T20	12392782
NA	CHEMICAL	GENE-Y	43	14	They included the gene inhibitor chemical ; the gene inhibitor chemical ; the mixed gene/gene inhibitor chemical ; the chemical ( chemical ) derivatives of indomethacin , chemical and chemical ; the gene inhibitor chemical ; and the gene ( gene ) inhibitor chemical .	T11	T21	12392782
NA	CHEMICAL	GENE-Y	43	32	They included the gene inhibitor chemical ; the gene inhibitor chemical ; the mixed gene/gene inhibitor chemical ; the chemical ( chemical ) derivatives of indomethacin , chemical and chemical ; the gene inhibitor chemical ; and the gene ( gene ) inhibitor chemical .	T11	T22	12392782
CPR:4	CHEMICAL	GENE-Y	43	38	They included the gene inhibitor chemical ; the gene inhibitor chemical ; the mixed gene/gene inhibitor chemical ; the chemical ( chemical ) derivatives of indomethacin , chemical and chemical ; the gene inhibitor chemical ; and the gene ( gene ) inhibitor chemical .	T11	T23	12392782
CPR:4	CHEMICAL	GENE-Y	43	40	They included the gene inhibitor chemical ; the gene inhibitor chemical ; the mixed gene/gene inhibitor chemical ; the chemical ( chemical ) derivatives of indomethacin , chemical and chemical ; the gene inhibitor chemical ; and the gene ( gene ) inhibitor chemical .	T11	T24	12392782
NA	CHEMICAL	GENE-Y	4	9	Effect of antidepressant drugs in mice lacking the chemical transporter .	T19	T35	16554743
NA	CHEMICAL	GENE-Y	3	4	Using mice lacking chemical transporter ( gene-/- ) we examined their baseline phenotype as well as the response in the forced swim test ( FST ) and in the tail suspension test ( TST ) upon treatment with ADs that display different pharmacological profiles .	T16	T29	16554743
NA	CHEMICAL	GENE-Y	3	6	Using mice lacking chemical transporter ( gene-/- ) we examined their baseline phenotype as well as the response in the forced swim test ( FST ) and in the tail suspension test ( TST ) upon treatment with ADs that display different pharmacological profiles .	T16	T30	16554743
NA	CHEMICAL	GENE-Y	9	15	Autoradiographic studies showed decreased binding of the beta-adrenergic ligand chemical in the cerebral cortex of gene-/- mice , indicating the changes at the level of gene similar to those obtained with ADs treatment .	T17	T32	16554743
NA	CHEMICAL	GENE-N	9	25	Autoradiographic studies showed decreased binding of the beta-adrenergic ligand chemical in the cerebral cortex of gene-/- mice , indicating the changes at the level of gene similar to those obtained with ADs treatment .	T17	T33	16554743
NA	CHEMICAL	GENE-N	3	4	The binding of chemical to gene in the cerebral cortex of gene-/- mice was also decreased , most probably as an adaptive response to the sustained elevation of extracellular chemical levels observed in these mice .	T18	T34	16554743
NA	CHEMICAL	GENE-Y	3	11	The binding of chemical to gene in the cerebral cortex of gene-/- mice was also decreased , most probably as an adaptive response to the sustained elevation of extracellular chemical levels observed in these mice .	T18	T20	16554743
NA	CHEMICAL	GENE-N	3	4	The binding of chemical to gene in the cerebral cortex of gene-/- mice was also decreased , most probably as an adaptive response to the sustained elevation of extracellular chemical levels observed in these mice .	T1	T34	16554743
NA	CHEMICAL	GENE-Y	3	11	The binding of chemical to gene in the cerebral cortex of gene-/- mice was also decreased , most probably as an adaptive response to the sustained elevation of extracellular chemical levels observed in these mice .	T1	T20	16554743
NA	CHEMICAL	GENE-Y	2	2	A pronounced gene knockout-induced shortening of the immobility time in the TST ( by ca 50 % ) compared to WT mice was not reduced any further by gene-inhibiting ADs such as chemical , chemical , and chemical .	T2	T21	16554743
CPR:4	CHEMICAL	GENE-Y	2	28	A pronounced gene knockout-induced shortening of the immobility time in the TST ( by ca 50 % ) compared to WT mice was not reduced any further by gene-inhibiting ADs such as chemical , chemical , and chemical .	T2	T22	16554743
NA	CHEMICAL	GENE-Y	9	2	A pronounced gene knockout-induced shortening of the immobility time in the TST ( by ca 50 % ) compared to WT mice was not reduced any further by gene-inhibiting ADs such as chemical , chemical , and chemical .	T3	T21	16554743
CPR:4	CHEMICAL	GENE-Y	9	28	A pronounced gene knockout-induced shortening of the immobility time in the TST ( by ca 50 % ) compared to WT mice was not reduced any further by gene-inhibiting ADs such as chemical , chemical , and chemical .	T3	T22	16554743
NA	CHEMICAL	GENE-Y	9	2	A pronounced gene knockout-induced shortening of the immobility time in the TST ( by ca 50 % ) compared to WT mice was not reduced any further by gene-inhibiting ADs such as chemical , chemical , and chemical .	T4	T21	16554743
CPR:4	CHEMICAL	GENE-Y	9	28	A pronounced gene knockout-induced shortening of the immobility time in the TST ( by ca 50 % ) compared to WT mice was not reduced any further by gene-inhibiting ADs such as chemical , chemical , and chemical .	T4	T22	16554743
NA	CHEMICAL	GENE-Y	0	9	chemical , which is devoid of affinity for the gene , exerted a significant reduction of immobility time in the gene-/- mice .	T5	T23	16554743
NA	CHEMICAL	GENE-Y	0	20	chemical , which is devoid of affinity for the gene , exerted a significant reduction of immobility time in the gene-/- mice .	T5	T24	16554743
NA	CHEMICAL	GENE-Y	4	24	In the FST , chemical , chemical , chemical , and chemical administered acutely did not reduce any further the immobility time shortened by gene knockout itself ( ca 25 % ) ; however , antidepressant-like action of repeatedly ( 7 days ) administered chemical was observed in gene-/- mice , indicating that the chronic presence of this drug may also affect other neurochemical targets involved in the behavioral reactions monitored by this test .	T6	T25	16554743
NA	CHEMICAL	GENE-Y	4	48	In the FST , chemical , chemical , chemical , and chemical administered acutely did not reduce any further the immobility time shortened by gene knockout itself ( ca 25 % ) ; however , antidepressant-like action of repeatedly ( 7 days ) administered chemical was observed in gene-/- mice , indicating that the chronic presence of this drug may also affect other neurochemical targets involved in the behavioral reactions monitored by this test .	T6	T26	16554743
NA	CHEMICAL	GENE-Y	6	24	In the FST , chemical , chemical , chemical , and chemical administered acutely did not reduce any further the immobility time shortened by gene knockout itself ( ca 25 % ) ; however , antidepressant-like action of repeatedly ( 7 days ) administered chemical was observed in gene-/- mice , indicating that the chronic presence of this drug may also affect other neurochemical targets involved in the behavioral reactions monitored by this test .	T7	T25	16554743
NA	CHEMICAL	GENE-Y	6	48	In the FST , chemical , chemical , chemical , and chemical administered acutely did not reduce any further the immobility time shortened by gene knockout itself ( ca 25 % ) ; however , antidepressant-like action of repeatedly ( 7 days ) administered chemical was observed in gene-/- mice , indicating that the chronic presence of this drug may also affect other neurochemical targets involved in the behavioral reactions monitored by this test .	T7	T26	16554743
NA	CHEMICAL	GENE-Y	8	24	In the FST , chemical , chemical , chemical , and chemical administered acutely did not reduce any further the immobility time shortened by gene knockout itself ( ca 25 % ) ; however , antidepressant-like action of repeatedly ( 7 days ) administered chemical was observed in gene-/- mice , indicating that the chronic presence of this drug may also affect other neurochemical targets involved in the behavioral reactions monitored by this test .	T8	T25	16554743
NA	CHEMICAL	GENE-Y	8	48	In the FST , chemical , chemical , chemical , and chemical administered acutely did not reduce any further the immobility time shortened by gene knockout itself ( ca 25 % ) ; however , antidepressant-like action of repeatedly ( 7 days ) administered chemical was observed in gene-/- mice , indicating that the chronic presence of this drug may also affect other neurochemical targets involved in the behavioral reactions monitored by this test .	T8	T26	16554743
NA	CHEMICAL	GENE-Y	11	24	In the FST , chemical , chemical , chemical , and chemical administered acutely did not reduce any further the immobility time shortened by gene knockout itself ( ca 25 % ) ; however , antidepressant-like action of repeatedly ( 7 days ) administered chemical was observed in gene-/- mice , indicating that the chronic presence of this drug may also affect other neurochemical targets involved in the behavioral reactions monitored by this test .	T9	T25	16554743
NA	CHEMICAL	GENE-Y	11	48	In the FST , chemical , chemical , chemical , and chemical administered acutely did not reduce any further the immobility time shortened by gene knockout itself ( ca 25 % ) ; however , antidepressant-like action of repeatedly ( 7 days ) administered chemical was observed in gene-/- mice , indicating that the chronic presence of this drug may also affect other neurochemical targets involved in the behavioral reactions monitored by this test .	T9	T26	16554743
NA	CHEMICAL	GENE-Y	44	24	In the FST , chemical , chemical , chemical , and chemical administered acutely did not reduce any further the immobility time shortened by gene knockout itself ( ca 25 % ) ; however , antidepressant-like action of repeatedly ( 7 days ) administered chemical was observed in gene-/- mice , indicating that the chronic presence of this drug may also affect other neurochemical targets involved in the behavioral reactions monitored by this test .	T10	T25	16554743
NA	CHEMICAL	GENE-Y	44	48	In the FST , chemical , chemical , chemical , and chemical administered acutely did not reduce any further the immobility time shortened by gene knockout itself ( ca 25 % ) ; however , antidepressant-like action of repeatedly ( 7 days ) administered chemical was observed in gene-/- mice , indicating that the chronic presence of this drug may also affect other neurochemical targets involved in the behavioral reactions monitored by this test .	T10	T26	16554743
NA	CHEMICAL	GENE-N	0	15	chemical from Hedyotis diffusa Willd induces apoptosis in human leukemic U937 cells through modulation of gene pathways .	T9	T23	23550028
NA	CHEMICAL	GENE-N	11	7	The current study determines the role of gene ( gene ) in human leukemic U937 cells apoptosis induced by chemical from H. diffusa .	T4	T15	23550028
NA	CHEMICAL	GENE-N	11	9	The current study determines the role of gene ( gene ) in human leukemic U937 cells apoptosis induced by chemical from H. diffusa .	T4	T16	23550028
NA	CHEMICAL	GENE-N	4	6	Our results showed that chemical decreased phosphorylation-gene ( gene ) , and increased gene , but did not affect expressions of gene in U937 cells .	T5	T17	23550028
NA	CHEMICAL	GENE-N	4	8	Our results showed that chemical decreased phosphorylation-gene ( gene ) , and increased gene , but did not affect expressions of gene in U937 cells .	T5	T18	23550028
CPR:3	CHEMICAL	GENE-N	4	13	Our results showed that chemical decreased phosphorylation-gene ( gene ) , and increased gene , but did not affect expressions of gene in U937 cells .	T5	T19	23550028
NA	CHEMICAL	GENE-N	4	21	Our results showed that chemical decreased phosphorylation-gene ( gene ) , and increased gene , but did not affect expressions of gene in U937 cells .	T5	T20	23550028
CPR:3	CHEMICAL	GENE-Y	7	12	Moreover , treatment of U937 cells with chemical resulted in activation of gene .	T6	T21	23550028
NA	CHEMICAL	GENE-N	2	4	Furthermore , chemical ( gene inhibitor ) significantly enhanced chemical-induced apoptosis in U937 cells , whereas gene inhibitor or chemical ( gene inhibitor ) , decreased apoptosis in U937 cells .	T7	T22	23550028
NA	CHEMICAL	GENE-Y	2	16	Furthermore , chemical ( gene inhibitor ) significantly enhanced chemical-induced apoptosis in U937 cells , whereas gene inhibitor or chemical ( gene inhibitor ) , decreased apoptosis in U937 cells .	T7	T10	23550028
NA	CHEMICAL	GENE-N	2	21	Furthermore , chemical ( gene inhibitor ) significantly enhanced chemical-induced apoptosis in U937 cells , whereas gene inhibitor or chemical ( gene inhibitor ) , decreased apoptosis in U937 cells .	T7	T11	23550028
NA	CHEMICAL	GENE-N	9	4	Furthermore , chemical ( gene inhibitor ) significantly enhanced chemical-induced apoptosis in U937 cells , whereas gene inhibitor or chemical ( gene inhibitor ) , decreased apoptosis in U937 cells .	T8	T22	23550028
NA	CHEMICAL	GENE-Y	9	16	Furthermore , chemical ( gene inhibitor ) significantly enhanced chemical-induced apoptosis in U937 cells , whereas gene inhibitor or chemical ( gene inhibitor ) , decreased apoptosis in U937 cells .	T8	T10	23550028
NA	CHEMICAL	GENE-N	9	21	Furthermore , chemical ( gene inhibitor ) significantly enhanced chemical-induced apoptosis in U937 cells , whereas gene inhibitor or chemical ( gene inhibitor ) , decreased apoptosis in U937 cells .	T8	T11	23550028
NA	CHEMICAL	GENE-N	16	4	Furthermore , chemical ( gene inhibitor ) significantly enhanced chemical-induced apoptosis in U937 cells , whereas gene inhibitor or chemical ( gene inhibitor ) , decreased apoptosis in U937 cells .	T1	T22	23550028
NA	CHEMICAL	GENE-Y	16	16	Furthermore , chemical ( gene inhibitor ) significantly enhanced chemical-induced apoptosis in U937 cells , whereas gene inhibitor or chemical ( gene inhibitor ) , decreased apoptosis in U937 cells .	T1	T10	23550028
CPR:4	CHEMICAL	GENE-N	16	21	Furthermore , chemical ( gene inhibitor ) significantly enhanced chemical-induced apoptosis in U937 cells , whereas gene inhibitor or chemical ( gene inhibitor ) , decreased apoptosis in U937 cells .	T1	T11	23550028
CPR:3	CHEMICAL	GENE-N	11	29	Taken together , our study for the first time suggests that chemical is able to enhance apoptosis of U937 cells , at least in part , through activation of gene and downregulation of gene .	T2	T12	23550028
NA	CHEMICAL	GENE-N	11	33	Taken together , our study for the first time suggests that chemical is able to enhance apoptosis of U937 cells , at least in part , through activation of gene and downregulation of gene .	T2	T13	23550028
NA	CHEMICAL	GENE-Y	14	20	To establish the relative importance of these subtypes , we compared the effects of chemical with those of a selective gene receptor agonist ( chemical ) on gene protein expression in the trigeminal nucleus caudalis .	T1	T18	10225363
NA	CHEMICAL	GENE-Y	14	27	To establish the relative importance of these subtypes , we compared the effects of chemical with those of a selective gene receptor agonist ( chemical ) on gene protein expression in the trigeminal nucleus caudalis .	T1	T19	10225363
CPR:5	CHEMICAL	GENE-Y	24	20	To establish the relative importance of these subtypes , we compared the effects of chemical with those of a selective gene receptor agonist ( chemical ) on gene protein expression in the trigeminal nucleus caudalis .	T2	T18	10225363
NA	CHEMICAL	GENE-Y	24	27	To establish the relative importance of these subtypes , we compared the effects of chemical with those of a selective gene receptor agonist ( chemical ) on gene protein expression in the trigeminal nucleus caudalis .	T2	T19	10225363
NA	CHEMICAL	GENE-Y	5	0	gene expression was induced in chemical-anaesthetized rats by intracisternal chemical administration .	T3	T20	10225363
CPR:3	CHEMICAL	GENE-Y	4	0	gene expression was induced in chemical-anaesthetized rats by intracisternal chemical administration .	T4	T20	10225363
CPR:4	CHEMICAL	GENE-Y	0	8	chemical and chemical decreased the number of chemical-induced gene-like immunoreactive cells within trigeminal nucleus caudalis ( ID50 = 0.04 and 0.6 mg kg ( -1 ) ) .	T5	T21	10225363
CPR:4	CHEMICAL	GENE-Y	2	8	chemical and chemical decreased the number of chemical-induced gene-like immunoreactive cells within trigeminal nucleus caudalis ( ID50 = 0.04 and 0.6 mg kg ( -1 ) ) .	T6	T21	10225363
CPR:3	CHEMICAL	GENE-Y	7	8	chemical and chemical decreased the number of chemical-induced gene-like immunoreactive cells within trigeminal nucleus caudalis ( ID50 = 0.04 and 0.6 mg kg ( -1 ) ) .	T7	T21	10225363
NA	CHEMICAL	GENE-Y	3	24	The effect of chemical , but not of chemical , was prevented by pretreatment with the antagonist chemical , which displays high affinity for gene receptors .	T9	T22	10225363
NA	CHEMICAL	GENE-Y	8	24	The effect of chemical , but not of chemical , was prevented by pretreatment with the antagonist chemical , which displays high affinity for gene receptors .	T10	T22	10225363
CPR:6	CHEMICAL	GENE-Y	17	24	The effect of chemical , but not of chemical , was prevented by pretreatment with the antagonist chemical , which displays high affinity for gene receptors .	T11	T22	10225363
NA	CHEMICAL	GENE-Y	0	7	chemical appears to attenuate c-fos-like immunoreactivity via gene receptors , while chemical acts via gene receptors .	T12	T23	10225363
NA	CHEMICAL	GENE-Y	0	14	chemical appears to attenuate c-fos-like immunoreactivity via gene receptors , while chemical acts via gene receptors .	T12	T24	10225363
NA	CHEMICAL	GENE-Y	11	7	chemical appears to attenuate c-fos-like immunoreactivity via gene receptors , while chemical acts via gene receptors .	T13	T23	10225363
NA	CHEMICAL	GENE-Y	11	14	chemical appears to attenuate c-fos-like immunoreactivity via gene receptors , while chemical acts via gene receptors .	T13	T24	10225363
NA	CHEMICAL	GENE-Y	1	13	Baseline chemical ( Cor0 ) , chemical-S ( chemical-S0 ) , chemical binding globulin ( gene ) , gene , calculated free chemical ( by Coolen 's equation = CFC ) , free chemical index ( FCI ) , 60-min chemical ( Cor60 ) , and chemical-S ( chemical-S60 ) , chemical ( chemical ) , chemical-S ( chemical-S ) responses were evaluated .	T11	T32	23532634
NA	CHEMICAL	GENE-Y	1	15	Baseline chemical ( Cor0 ) , chemical-S ( chemical-S0 ) , chemical binding globulin ( gene ) , gene , calculated free chemical ( by Coolen 's equation = CFC ) , free chemical index ( FCI ) , 60-min chemical ( Cor60 ) , and chemical-S ( chemical-S60 ) , chemical ( chemical ) , chemical-S ( chemical-S ) responses were evaluated .	T11	T33	23532634
NA	CHEMICAL	GENE-Y	1	18	Baseline chemical ( Cor0 ) , chemical-S ( chemical-S0 ) , chemical binding globulin ( gene ) , gene , calculated free chemical ( by Coolen 's equation = CFC ) , free chemical index ( FCI ) , 60-min chemical ( Cor60 ) , and chemical-S ( chemical-S60 ) , chemical ( chemical ) , chemical-S ( chemical-S ) responses were evaluated .	T11	T34	23532634
NA	CHEMICAL	GENE-Y	6	13	Baseline chemical ( Cor0 ) , chemical-S ( chemical-S0 ) , chemical binding globulin ( gene ) , gene , calculated free chemical ( by Coolen 's equation = CFC ) , free chemical index ( FCI ) , 60-min chemical ( Cor60 ) , and chemical-S ( chemical-S60 ) , chemical ( chemical ) , chemical-S ( chemical-S ) responses were evaluated .	T12	T32	23532634
NA	CHEMICAL	GENE-Y	6	15	Baseline chemical ( Cor0 ) , chemical-S ( chemical-S0 ) , chemical binding globulin ( gene ) , gene , calculated free chemical ( by Coolen 's equation = CFC ) , free chemical index ( FCI ) , 60-min chemical ( Cor60 ) , and chemical-S ( chemical-S60 ) , chemical ( chemical ) , chemical-S ( chemical-S ) responses were evaluated .	T12	T33	23532634
NA	CHEMICAL	GENE-Y	6	18	Baseline chemical ( Cor0 ) , chemical-S ( chemical-S0 ) , chemical binding globulin ( gene ) , gene , calculated free chemical ( by Coolen 's equation = CFC ) , free chemical index ( FCI ) , 60-min chemical ( Cor60 ) , and chemical-S ( chemical-S60 ) , chemical ( chemical ) , chemical-S ( chemical-S ) responses were evaluated .	T12	T34	23532634
NA	CHEMICAL	GENE-Y	8	13	Baseline chemical ( Cor0 ) , chemical-S ( chemical-S0 ) , chemical binding globulin ( gene ) , gene , calculated free chemical ( by Coolen 's equation = CFC ) , free chemical index ( FCI ) , 60-min chemical ( Cor60 ) , and chemical-S ( chemical-S60 ) , chemical ( chemical ) , chemical-S ( chemical-S ) responses were evaluated .	T13	T32	23532634
NA	CHEMICAL	GENE-Y	8	15	Baseline chemical ( Cor0 ) , chemical-S ( chemical-S0 ) , chemical binding globulin ( gene ) , gene , calculated free chemical ( by Coolen 's equation = CFC ) , free chemical index ( FCI ) , 60-min chemical ( Cor60 ) , and chemical-S ( chemical-S60 ) , chemical ( chemical ) , chemical-S ( chemical-S ) responses were evaluated .	T13	T33	23532634
NA	CHEMICAL	GENE-Y	8	18	Baseline chemical ( Cor0 ) , chemical-S ( chemical-S0 ) , chemical binding globulin ( gene ) , gene , calculated free chemical ( by Coolen 's equation = CFC ) , free chemical index ( FCI ) , 60-min chemical ( Cor60 ) , and chemical-S ( chemical-S60 ) , chemical ( chemical ) , chemical-S ( chemical-S ) responses were evaluated .	T13	T34	23532634
NA	CHEMICAL	GENE-Y	11	13	Baseline chemical ( Cor0 ) , chemical-S ( chemical-S0 ) , chemical binding globulin ( gene ) , gene , calculated free chemical ( by Coolen 's equation = CFC ) , free chemical index ( FCI ) , 60-min chemical ( Cor60 ) , and chemical-S ( chemical-S60 ) , chemical ( chemical ) , chemical-S ( chemical-S ) responses were evaluated .	T14	T32	23532634
NA	CHEMICAL	GENE-Y	11	15	Baseline chemical ( Cor0 ) , chemical-S ( chemical-S0 ) , chemical binding globulin ( gene ) , gene , calculated free chemical ( by Coolen 's equation = CFC ) , free chemical index ( FCI ) , 60-min chemical ( Cor60 ) , and chemical-S ( chemical-S60 ) , chemical ( chemical ) , chemical-S ( chemical-S ) responses were evaluated .	T14	T33	23532634
NA	CHEMICAL	GENE-Y	11	18	Baseline chemical ( Cor0 ) , chemical-S ( chemical-S0 ) , chemical binding globulin ( gene ) , gene , calculated free chemical ( by Coolen 's equation = CFC ) , free chemical index ( FCI ) , 60-min chemical ( Cor60 ) , and chemical-S ( chemical-S60 ) , chemical ( chemical ) , chemical-S ( chemical-S ) responses were evaluated .	T14	T34	23532634
NA	CHEMICAL	GENE-Y	22	13	Baseline chemical ( Cor0 ) , chemical-S ( chemical-S0 ) , chemical binding globulin ( gene ) , gene , calculated free chemical ( by Coolen 's equation = CFC ) , free chemical index ( FCI ) , 60-min chemical ( Cor60 ) , and chemical-S ( chemical-S60 ) , chemical ( chemical ) , chemical-S ( chemical-S ) responses were evaluated .	T15	T32	23532634
NA	CHEMICAL	GENE-Y	22	15	Baseline chemical ( Cor0 ) , chemical-S ( chemical-S0 ) , chemical binding globulin ( gene ) , gene , calculated free chemical ( by Coolen 's equation = CFC ) , free chemical index ( FCI ) , 60-min chemical ( Cor60 ) , and chemical-S ( chemical-S60 ) , chemical ( chemical ) , chemical-S ( chemical-S ) responses were evaluated .	T15	T33	23532634
NA	CHEMICAL	GENE-Y	22	18	Baseline chemical ( Cor0 ) , chemical-S ( chemical-S0 ) , chemical binding globulin ( gene ) , gene , calculated free chemical ( by Coolen 's equation = CFC ) , free chemical index ( FCI ) , 60-min chemical ( Cor60 ) , and chemical-S ( chemical-S60 ) , chemical ( chemical ) , chemical-S ( chemical-S ) responses were evaluated .	T15	T34	23532634
NA	CHEMICAL	GENE-Y	33	13	Baseline chemical ( Cor0 ) , chemical-S ( chemical-S0 ) , chemical binding globulin ( gene ) , gene , calculated free chemical ( by Coolen 's equation = CFC ) , free chemical index ( FCI ) , 60-min chemical ( Cor60 ) , and chemical-S ( chemical-S60 ) , chemical ( chemical ) , chemical-S ( chemical-S ) responses were evaluated .	T16	T32	23532634
NA	CHEMICAL	GENE-Y	33	15	Baseline chemical ( Cor0 ) , chemical-S ( chemical-S0 ) , chemical binding globulin ( gene ) , gene , calculated free chemical ( by Coolen 's equation = CFC ) , free chemical index ( FCI ) , 60-min chemical ( Cor60 ) , and chemical-S ( chemical-S60 ) , chemical ( chemical ) , chemical-S ( chemical-S ) responses were evaluated .	T16	T33	23532634
NA	CHEMICAL	GENE-Y	33	18	Baseline chemical ( Cor0 ) , chemical-S ( chemical-S0 ) , chemical binding globulin ( gene ) , gene , calculated free chemical ( by Coolen 's equation = CFC ) , free chemical index ( FCI ) , 60-min chemical ( Cor60 ) , and chemical-S ( chemical-S60 ) , chemical ( chemical ) , chemical-S ( chemical-S ) responses were evaluated .	T16	T34	23532634
NA	CHEMICAL	GENE-Y	40	13	Baseline chemical ( Cor0 ) , chemical-S ( chemical-S0 ) , chemical binding globulin ( gene ) , gene , calculated free chemical ( by Coolen 's equation = CFC ) , free chemical index ( FCI ) , 60-min chemical ( Cor60 ) , and chemical-S ( chemical-S60 ) , chemical ( chemical ) , chemical-S ( chemical-S ) responses were evaluated .	T17	T32	23532634
NA	CHEMICAL	GENE-Y	40	15	Baseline chemical ( Cor0 ) , chemical-S ( chemical-S0 ) , chemical binding globulin ( gene ) , gene , calculated free chemical ( by Coolen 's equation = CFC ) , free chemical index ( FCI ) , 60-min chemical ( Cor60 ) , and chemical-S ( chemical-S60 ) , chemical ( chemical ) , chemical-S ( chemical-S ) responses were evaluated .	T17	T33	23532634
NA	CHEMICAL	GENE-Y	40	18	Baseline chemical ( Cor0 ) , chemical-S ( chemical-S0 ) , chemical binding globulin ( gene ) , gene , calculated free chemical ( by Coolen 's equation = CFC ) , free chemical index ( FCI ) , 60-min chemical ( Cor60 ) , and chemical-S ( chemical-S60 ) , chemical ( chemical ) , chemical-S ( chemical-S ) responses were evaluated .	T17	T34	23532634
NA	CHEMICAL	GENE-Y	46	13	Baseline chemical ( Cor0 ) , chemical-S ( chemical-S0 ) , chemical binding globulin ( gene ) , gene , calculated free chemical ( by Coolen 's equation = CFC ) , free chemical index ( FCI ) , 60-min chemical ( Cor60 ) , and chemical-S ( chemical-S60 ) , chemical ( chemical ) , chemical-S ( chemical-S ) responses were evaluated .	T18	T32	23532634
NA	CHEMICAL	GENE-Y	46	15	Baseline chemical ( Cor0 ) , chemical-S ( chemical-S0 ) , chemical binding globulin ( gene ) , gene , calculated free chemical ( by Coolen 's equation = CFC ) , free chemical index ( FCI ) , 60-min chemical ( Cor60 ) , and chemical-S ( chemical-S60 ) , chemical ( chemical ) , chemical-S ( chemical-S ) responses were evaluated .	T18	T33	23532634
NA	CHEMICAL	GENE-Y	46	18	Baseline chemical ( Cor0 ) , chemical-S ( chemical-S0 ) , chemical binding globulin ( gene ) , gene , calculated free chemical ( by Coolen 's equation = CFC ) , free chemical index ( FCI ) , 60-min chemical ( Cor60 ) , and chemical-S ( chemical-S60 ) , chemical ( chemical ) , chemical-S ( chemical-S ) responses were evaluated .	T18	T34	23532634
NA	CHEMICAL	GENE-Y	48	13	Baseline chemical ( Cor0 ) , chemical-S ( chemical-S0 ) , chemical binding globulin ( gene ) , gene , calculated free chemical ( by Coolen 's equation = CFC ) , free chemical index ( FCI ) , 60-min chemical ( Cor60 ) , and chemical-S ( chemical-S60 ) , chemical ( chemical ) , chemical-S ( chemical-S ) responses were evaluated .	T19	T32	23532634
NA	CHEMICAL	GENE-Y	48	15	Baseline chemical ( Cor0 ) , chemical-S ( chemical-S0 ) , chemical binding globulin ( gene ) , gene , calculated free chemical ( by Coolen 's equation = CFC ) , free chemical index ( FCI ) , 60-min chemical ( Cor60 ) , and chemical-S ( chemical-S60 ) , chemical ( chemical ) , chemical-S ( chemical-S ) responses were evaluated .	T19	T33	23532634
NA	CHEMICAL	GENE-Y	48	18	Baseline chemical ( Cor0 ) , chemical-S ( chemical-S0 ) , chemical binding globulin ( gene ) , gene , calculated free chemical ( by Coolen 's equation = CFC ) , free chemical index ( FCI ) , 60-min chemical ( Cor60 ) , and chemical-S ( chemical-S60 ) , chemical ( chemical ) , chemical-S ( chemical-S ) responses were evaluated .	T19	T34	23532634
NA	CHEMICAL	GENE-Y	51	13	Baseline chemical ( Cor0 ) , chemical-S ( chemical-S0 ) , chemical binding globulin ( gene ) , gene , calculated free chemical ( by Coolen 's equation = CFC ) , free chemical index ( FCI ) , 60-min chemical ( Cor60 ) , and chemical-S ( chemical-S60 ) , chemical ( chemical ) , chemical-S ( chemical-S ) responses were evaluated .	T20	T32	23532634
NA	CHEMICAL	GENE-Y	51	15	Baseline chemical ( Cor0 ) , chemical-S ( chemical-S0 ) , chemical binding globulin ( gene ) , gene , calculated free chemical ( by Coolen 's equation = CFC ) , free chemical index ( FCI ) , 60-min chemical ( Cor60 ) , and chemical-S ( chemical-S60 ) , chemical ( chemical ) , chemical-S ( chemical-S ) responses were evaluated .	T20	T33	23532634
NA	CHEMICAL	GENE-Y	51	18	Baseline chemical ( Cor0 ) , chemical-S ( chemical-S0 ) , chemical binding globulin ( gene ) , gene , calculated free chemical ( by Coolen 's equation = CFC ) , free chemical index ( FCI ) , 60-min chemical ( Cor60 ) , and chemical-S ( chemical-S60 ) , chemical ( chemical ) , chemical-S ( chemical-S ) responses were evaluated .	T20	T34	23532634
NA	CHEMICAL	GENE-Y	53	13	Baseline chemical ( Cor0 ) , chemical-S ( chemical-S0 ) , chemical binding globulin ( gene ) , gene , calculated free chemical ( by Coolen 's equation = CFC ) , free chemical index ( FCI ) , 60-min chemical ( Cor60 ) , and chemical-S ( chemical-S60 ) , chemical ( chemical ) , chemical-S ( chemical-S ) responses were evaluated .	T21	T32	23532634
NA	CHEMICAL	GENE-Y	53	15	Baseline chemical ( Cor0 ) , chemical-S ( chemical-S0 ) , chemical binding globulin ( gene ) , gene , calculated free chemical ( by Coolen 's equation = CFC ) , free chemical index ( FCI ) , 60-min chemical ( Cor60 ) , and chemical-S ( chemical-S60 ) , chemical ( chemical ) , chemical-S ( chemical-S ) responses were evaluated .	T21	T33	23532634
NA	CHEMICAL	GENE-Y	53	18	Baseline chemical ( Cor0 ) , chemical-S ( chemical-S0 ) , chemical binding globulin ( gene ) , gene , calculated free chemical ( by Coolen 's equation = CFC ) , free chemical index ( FCI ) , 60-min chemical ( Cor60 ) , and chemical-S ( chemical-S60 ) , chemical ( chemical ) , chemical-S ( chemical-S ) responses were evaluated .	T21	T34	23532634
NA	CHEMICAL	GENE-Y	56	13	Baseline chemical ( Cor0 ) , chemical-S ( chemical-S0 ) , chemical binding globulin ( gene ) , gene , calculated free chemical ( by Coolen 's equation = CFC ) , free chemical index ( FCI ) , 60-min chemical ( Cor60 ) , and chemical-S ( chemical-S60 ) , chemical ( chemical ) , chemical-S ( chemical-S ) responses were evaluated .	T22	T32	23532634
NA	CHEMICAL	GENE-Y	56	15	Baseline chemical ( Cor0 ) , chemical-S ( chemical-S0 ) , chemical binding globulin ( gene ) , gene , calculated free chemical ( by Coolen 's equation = CFC ) , free chemical index ( FCI ) , 60-min chemical ( Cor60 ) , and chemical-S ( chemical-S60 ) , chemical ( chemical ) , chemical-S ( chemical-S ) responses were evaluated .	T22	T33	23532634
NA	CHEMICAL	GENE-Y	56	18	Baseline chemical ( Cor0 ) , chemical-S ( chemical-S0 ) , chemical binding globulin ( gene ) , gene , calculated free chemical ( by Coolen 's equation = CFC ) , free chemical index ( FCI ) , 60-min chemical ( Cor60 ) , and chemical-S ( chemical-S60 ) , chemical ( chemical ) , chemical-S ( chemical-S ) responses were evaluated .	T22	T34	23532634
NA	CHEMICAL	GENE-Y	58	13	Baseline chemical ( Cor0 ) , chemical-S ( chemical-S0 ) , chemical binding globulin ( gene ) , gene , calculated free chemical ( by Coolen 's equation = CFC ) , free chemical index ( FCI ) , 60-min chemical ( Cor60 ) , and chemical-S ( chemical-S60 ) , chemical ( chemical ) , chemical-S ( chemical-S ) responses were evaluated .	T23	T32	23532634
NA	CHEMICAL	GENE-Y	58	15	Baseline chemical ( Cor0 ) , chemical-S ( chemical-S0 ) , chemical binding globulin ( gene ) , gene , calculated free chemical ( by Coolen 's equation = CFC ) , free chemical index ( FCI ) , 60-min chemical ( Cor60 ) , and chemical-S ( chemical-S60 ) , chemical ( chemical ) , chemical-S ( chemical-S ) responses were evaluated .	T23	T33	23532634
NA	CHEMICAL	GENE-Y	58	18	Baseline chemical ( Cor0 ) , chemical-S ( chemical-S0 ) , chemical binding globulin ( gene ) , gene , calculated free chemical ( by Coolen 's equation = CFC ) , free chemical index ( FCI ) , 60-min chemical ( Cor60 ) , and chemical-S ( chemical-S60 ) , chemical ( chemical ) , chemical-S ( chemical-S ) responses were evaluated .	T23	T34	23532634
CPR:9	CHEMICAL	GENE-Y	10	9	In four ( 10 % ) patients the peak gene-stimulated chemical values were lower than 18 μg/dL .	T1	T28	23532634
NA	CHEMICAL	GENE-N	10	16	However , the predictors of CFC , FCI , and chemical-S levels were serum chemical levels in hyperthyroidism , and both chemical and gene levels in euthyroidism .	T3	T29	23532634
NA	CHEMICAL	GENE-N	14	16	However , the predictors of CFC , FCI , and chemical-S levels were serum chemical levels in hyperthyroidism , and both chemical and gene levels in euthyroidism .	T4	T29	23532634
NA	CHEMICAL	GENE-N	16	16	However , the predictors of CFC , FCI , and chemical-S levels were serum chemical levels in hyperthyroidism , and both chemical and gene levels in euthyroidism .	T5	T29	23532634
NA	CHEMICAL	GENE-Y	4	6	Impaired cliff avoidance reaction in chemical transporter knockout mice .	T6	T19	23397052
NA	CHEMICAL	GENE-Y	0	1	chemical transporter knockout ( gene-KO ) mice display features of ADHD and are candidates in which to test other impulsive phenotypes .	T3	T10	23397052
NA	CHEMICAL	GENE-Y	0	4	chemical transporter knockout ( gene-KO ) mice display features of ADHD and are candidates in which to test other impulsive phenotypes .	T3	T11	23397052
NA	CHEMICAL	GENE-Y	2	9	Treatment with chemical or chemical ameliorated CAR impairments in gene-KO mice .	T4	T17	23397052
NA	CHEMICAL	GENE-Y	4	9	Treatment with chemical or chemical ameliorated CAR impairments in gene-KO mice .	T5	T17	23397052
CPR:4	CHEMICAL	GENE-Y	0	12	chemical is a novel , potent , and irreversible chemical oxidase type B ( gene ) inhibitor which has been approved for treatment of PD .	T1	T8	20517484
CPR:4	CHEMICAL	GENE-Y	0	12	chemical is a novel , potent , and irreversible chemical oxidase type B ( gene ) inhibitor which has been approved for treatment of PD .	T1	T9	20517484
NA	CHEMICAL	GENE-Y	2	12	chemical is a novel , potent , and irreversible chemical oxidase type B ( gene ) inhibitor which has been approved for treatment of PD .	T2	T8	20517484
NA	CHEMICAL	GENE-Y	2	12	chemical is a novel , potent , and irreversible chemical oxidase type B ( gene ) inhibitor which has been approved for treatment of PD .	T2	T9	20517484
CPR:4	CHEMICAL	GENE-Y	0	2	chemical inhibits gene more potently than selegiline and has the advantage of once-daily dosing .	T3	T10	20517484
CPR:4	CHEMICAL	GENE-Y	20	3	Lung inflammation , gene production , and airway mast cell activity were also prevented under this early short-term treatment with chemical .	T7	T16	23298698
CPR:4	CHEMICAL	GENE-Y	1	8	Local chemical administration prevented the increase of airway gene and gene and kept lung plasmacytoid dendritic cell counts close to baseline .	T2	T12	23298698
CPR:4	CHEMICAL	GENE-Y	1	10	Local chemical administration prevented the increase of airway gene and gene and kept lung plasmacytoid dendritic cell counts close to baseline .	T2	T13	23298698
NA	CHEMICAL	GENE-N	2	2	Loss of gene , but not gene family proteins , which are both involved in regulation of translation , attenuated the effects of chemical on the quality of newly translated proteins .	T1	T12	23592839
NA	CHEMICAL	GENE-N	2	6	Loss of gene , but not gene family proteins , which are both involved in regulation of translation , attenuated the effects of chemical on the quality of newly translated proteins .	T1	T13	23592839
NA	CHEMICAL	GENE-N	0	5	chemical attenuates mechanical allodynia in a model of neuropathic pain in the mouse and stabilizes gene inactivated state .	T21	T29	23221868
NA	CHEMICAL	GENE-N	0	1	chemical channel blockers currently used to treat neuropathic pain are poorly tolerated .	T4	T23	23221868
NA	CHEMICAL	GENE-N	5	18	We compared the effect of chemical on chemical currents using in vitro patch clamp in cells expressing the gene gene isoform and on dissociated dorsal root ganglion neurons to chemical and chemical .	T13	T27	23221868
NA	CHEMICAL	GENE-Y	5	19	We compared the effect of chemical on chemical currents using in vitro patch clamp in cells expressing the gene gene isoform and on dissociated dorsal root ganglion neurons to chemical and chemical .	T13	T28	23221868
NA	CHEMICAL	GENE-N	7	18	We compared the effect of chemical on chemical currents using in vitro patch clamp in cells expressing the gene gene isoform and on dissociated dorsal root ganglion neurons to chemical and chemical .	T14	T27	23221868
NA	CHEMICAL	GENE-Y	7	19	We compared the effect of chemical on chemical currents using in vitro patch clamp in cells expressing the gene gene isoform and on dissociated dorsal root ganglion neurons to chemical and chemical .	T14	T28	23221868
NA	CHEMICAL	GENE-N	10	18	We compared the effect of chemical on chemical currents using in vitro patch clamp in cells expressing the gene gene isoform and on dissociated dorsal root ganglion neurons to chemical and chemical .	T16	T27	23221868
NA	CHEMICAL	GENE-Y	10	19	We compared the effect of chemical on chemical currents using in vitro patch clamp in cells expressing the gene gene isoform and on dissociated dorsal root ganglion neurons to chemical and chemical .	T16	T28	23221868
NA	CHEMICAL	GENE-N	10	18	We compared the effect of chemical on chemical currents using in vitro patch clamp in cells expressing the gene gene isoform and on dissociated dorsal root ganglion neurons to chemical and chemical .	T17	T27	23221868
NA	CHEMICAL	GENE-Y	10	19	We compared the effect of chemical on chemical currents using in vitro patch clamp in cells expressing the gene gene isoform and on dissociated dorsal root ganglion neurons to chemical and chemical .	T17	T28	23221868
NA	CHEMICAL	GENE-Y	4	17	The tissue-selective toxicity of chemical in mouse nasal mucosa is largely dependent on target tissue bioactivation by gene .	T10	T23	23360412
NA	CHEMICAL	GENE-Y	21	4	The human orthologues of gene , gene and gene , are both expressed in nasal mucosa and are capable of activating chemical .	T12	T24	23360412
NA	CHEMICAL	GENE-Y	21	6	The human orthologues of gene , gene and gene , are both expressed in nasal mucosa and are capable of activating chemical .	T12	T25	23360412
NA	CHEMICAL	GENE-Y	21	8	The human orthologues of gene , gene and gene , are both expressed in nasal mucosa and are capable of activating chemical .	T12	T26	23360412
CPR:4	CHEMICAL	GENE-N	11	15	The activity of the human nasal mucosa microsomes was inhibited by chemical , a known gene inhibitor .	T19	T27	23360412
NA	CHEMICAL	GENE-Y	7	3	Further studies in gene-null mice indicated that GS-chemical and its metabolites in nasal-wash fluid were generated in the nasal mucosa , rather than in other organs .	T5	T22	23360412
NA	CHEMICAL	GENE-Y	3	4	Autoradiographic study of chemical transporter during memory formation .	T18	T28	20226815
NA	CHEMICAL	GENE-Y	0	1	chemical transporter ( gene ) has been associated with drugs of abuse like chemical ( chemical ) .	T1	T19	20226815
NA	CHEMICAL	GENE-Y	0	3	chemical transporter ( gene ) has been associated with drugs of abuse like chemical ( chemical ) .	T1	T26	20226815
NA	CHEMICAL	GENE-Y	13	1	chemical transporter ( gene ) has been associated with drugs of abuse like chemical ( chemical ) .	T14	T19	20226815
NA	CHEMICAL	GENE-Y	13	3	chemical transporter ( gene ) has been associated with drugs of abuse like chemical ( chemical ) .	T14	T26	20226815
NA	CHEMICAL	GENE-Y	15	1	chemical transporter ( gene ) has been associated with drugs of abuse like chemical ( chemical ) .	T17	T19	20226815
NA	CHEMICAL	GENE-Y	15	3	chemical transporter ( gene ) has been associated with drugs of abuse like chemical ( chemical ) .	T17	T26	20226815
NA	CHEMICAL	GENE-Y	0	18	chemical is well known to produce effects on the chemical systems but it is unclear how chemical affects gene and memory .	T2	T25	20226815
NA	CHEMICAL	GENE-Y	7	18	chemical is well known to produce effects on the chemical systems but it is unclear how chemical affects gene and memory .	T5	T25	20226815
NA	CHEMICAL	GENE-Y	16	18	chemical is well known to produce effects on the chemical systems but it is unclear how chemical affects gene and memory .	T6	T25	20226815
NA	CHEMICAL	GENE-Y	14	15	In untrained and trained treated animals with the amnesic dose ( 1.0mg/kg ) of chemical gene binding in several areas including hippocampus and cortex decreased , more remarkably in the trained animals .	T3	T21	20226815
NA	CHEMICAL	GENE-Y	13	8	In contrast , FLX improved memory , increased gene binding , prevented the chemical amnesic effect and re-established the gene binding .	T4	T22	20226815
NA	CHEMICAL	GENE-Y	13	19	In contrast , FLX improved memory , increased gene binding , prevented the chemical amnesic effect and re-established the gene binding .	T4	T23	20226815
CPR:6	CHEMICAL	GENE-Y	6	10	Synthesis and in Vitro Characterisation of chemical-Based chemical Conjugates as gene/gene chemical Receptor Antagonists .	T16	T26	23532918
CPR:6	CHEMICAL	GENE-Y	6	10	Synthesis and in Vitro Characterisation of chemical-Based chemical Conjugates as gene/gene chemical Receptor Antagonists .	T16	T27	23532918
CPR:6	CHEMICAL	GENE-N	6	12	Synthesis and in Vitro Characterisation of chemical-Based chemical Conjugates as gene/gene chemical Receptor Antagonists .	T16	T28	23532918
CPR:6	CHEMICAL	GENE-Y	2	10	Synthesis and in Vitro Characterisation of chemical-Based chemical Conjugates as gene/gene chemical Receptor Antagonists .	T17	T26	23532918
CPR:6	CHEMICAL	GENE-Y	2	10	Synthesis and in Vitro Characterisation of chemical-Based chemical Conjugates as gene/gene chemical Receptor Antagonists .	T17	T27	23532918
CPR:6	CHEMICAL	GENE-N	2	12	Synthesis and in Vitro Characterisation of chemical-Based chemical Conjugates as gene/gene chemical Receptor Antagonists .	T17	T28	23532918
NA	CHEMICAL	GENE-Y	9	10	Synthesis and in Vitro Characterisation of chemical-Based chemical Conjugates as gene/gene chemical Receptor Antagonists .	T18	T26	23532918
NA	CHEMICAL	GENE-Y	9	10	Synthesis and in Vitro Characterisation of chemical-Based chemical Conjugates as gene/gene chemical Receptor Antagonists .	T18	T27	23532918
NA	CHEMICAL	GENE-N	9	12	Synthesis and in Vitro Characterisation of chemical-Based chemical Conjugates as gene/gene chemical Receptor Antagonists .	T18	T28	23532918
NA	CHEMICAL	GENE-Y	1	0	gene-containing chemical receptors are involved in many important physiological functions and play a pivotal role in mediating pain as well as in several neurodegenerative disorders .	T8	T19	23532918
NA	CHEMICAL	GENE-N	1	2	gene-containing chemical receptors are involved in many important physiological functions and play a pivotal role in mediating pain as well as in several neurodegenerative disorders .	T8	T22	23532918
CPR:6	CHEMICAL	GENE-Y	0	5	chemical , known as the gene antagonist of reference , was chosen as the template for the elaboration of probes .	T9	T24	23532918
NA	CHEMICAL	GENE-Y	5	24	We had previously reported a chemical conjugate that was shown ( by confocal microscopy imaging of DS-red-labelled cortical neurons ) to bind specifically to gene .	T10	T25	23532918
NA	CHEMICAL	GENE-Y	15	31	The previously developed probe was found to display the greatest activity in the inhibition of chemical-induced chemical influx by chemical imaging experiments on HEK293 cells transfected with the cDNA encoding for gene and gene .	T2	T20	23532918
NA	CHEMICAL	GENE-Y	15	33	The previously developed probe was found to display the greatest activity in the inhibition of chemical-induced chemical influx by chemical imaging experiments on HEK293 cells transfected with the cDNA encoding for gene and gene .	T2	T21	23532918
NA	CHEMICAL	GENE-Y	16	31	The previously developed probe was found to display the greatest activity in the inhibition of chemical-induced chemical influx by chemical imaging experiments on HEK293 cells transfected with the cDNA encoding for gene and gene .	T3	T20	23532918
NA	CHEMICAL	GENE-Y	16	33	The previously developed probe was found to display the greatest activity in the inhibition of chemical-induced chemical influx by chemical imaging experiments on HEK293 cells transfected with the cDNA encoding for gene and gene .	T3	T21	23532918
NA	CHEMICAL	GENE-Y	19	31	The previously developed probe was found to display the greatest activity in the inhibition of chemical-induced chemical influx by chemical imaging experiments on HEK293 cells transfected with the cDNA encoding for gene and gene .	T4	T20	23532918
NA	CHEMICAL	GENE-Y	19	33	The previously developed probe was found to display the greatest activity in the inhibition of chemical-induced chemical influx by chemical imaging experiments on HEK293 cells transfected with the cDNA encoding for gene and gene .	T4	T21	23532918
NA	CHEMICAL	GENE-N	11	8	This was independent of age , sex , gene inhibitors , chemical use , components of the metabolic syndrome , or homeostasis model assessment.CONCLUSIONSIn conclusion , fasting gene is strongly associated with NODAT development in RTR .	T1	T4	23378624
NA	CHEMICAL	GENE-Y	11	27	This was independent of age , sex , gene inhibitors , chemical use , components of the metabolic syndrome , or homeostasis model assessment.CONCLUSIONSIn conclusion , fasting gene is strongly associated with NODAT development in RTR .	T1	T5	23378624
NA	CHEMICAL	GENE-Y	2	15	Effects of chemical ( chemical ) on histopathology , oxidative stress , and expression of gene , gene and gene in rat stomachs .	T17	T34	23313794
NA	CHEMICAL	GENE-Y	2	17	Effects of chemical ( chemical ) on histopathology , oxidative stress , and expression of gene , gene and gene in rat stomachs .	T17	T35	23313794
NA	CHEMICAL	GENE-Y	2	19	Effects of chemical ( chemical ) on histopathology , oxidative stress , and expression of gene , gene and gene in rat stomachs .	T17	T36	23313794
NA	CHEMICAL	GENE-Y	4	15	Effects of chemical ( chemical ) on histopathology , oxidative stress , and expression of gene , gene and gene in rat stomachs .	T18	T34	23313794
NA	CHEMICAL	GENE-Y	4	17	Effects of chemical ( chemical ) on histopathology , oxidative stress , and expression of gene , gene and gene in rat stomachs .	T18	T35	23313794
NA	CHEMICAL	GENE-Y	4	19	Effects of chemical ( chemical ) on histopathology , oxidative stress , and expression of gene , gene and gene in rat stomachs .	T18	T36	23313794
NA	CHEMICAL	GENE-Y	6	23	To understand the possible mechanism of chemical-associated stomach cancer , the effects of chemical on morphology , oxidative stress , gene expression of gene , gene and gene in rat stomachs were investigated .	T5	T23	23313794
NA	CHEMICAL	GENE-Y	6	25	To understand the possible mechanism of chemical-associated stomach cancer , the effects of chemical on morphology , oxidative stress , gene expression of gene , gene and gene in rat stomachs were investigated .	T5	T24	23313794
NA	CHEMICAL	GENE-Y	6	27	To understand the possible mechanism of chemical-associated stomach cancer , the effects of chemical on morphology , oxidative stress , gene expression of gene , gene and gene in rat stomachs were investigated .	T5	T25	23313794
NA	CHEMICAL	GENE-Y	13	23	To understand the possible mechanism of chemical-associated stomach cancer , the effects of chemical on morphology , oxidative stress , gene expression of gene , gene and gene in rat stomachs were investigated .	T6	T23	23313794
NA	CHEMICAL	GENE-Y	13	25	To understand the possible mechanism of chemical-associated stomach cancer , the effects of chemical on morphology , oxidative stress , gene expression of gene , gene and gene in rat stomachs were investigated .	T6	T24	23313794
NA	CHEMICAL	GENE-Y	13	27	To understand the possible mechanism of chemical-associated stomach cancer , the effects of chemical on morphology , oxidative stress , gene expression of gene , gene and gene in rat stomachs were investigated .	T6	T25	23313794
NA	CHEMICAL	GENE-N	10	31	The results showed that ( 1 ) 15mg/kg body weight chemical induced obvious histopathological changes in gastric mucosa ; ( 2 ) chemical ( 10 and/or 15mg/kg ) significantly decreased chemical dismutase ( gene ) and gene ( gene ) activities , while increased gene ( gene ) activity compared with the control .	T7	T26	23313794
NA	CHEMICAL	GENE-N	10	33	The results showed that ( 1 ) 15mg/kg body weight chemical induced obvious histopathological changes in gastric mucosa ; ( 2 ) chemical ( 10 and/or 15mg/kg ) significantly decreased chemical dismutase ( gene ) and gene ( gene ) activities , while increased gene ( gene ) activity compared with the control .	T7	T27	23313794
NA	CHEMICAL	GENE-N	10	36	The results showed that ( 1 ) 15mg/kg body weight chemical induced obvious histopathological changes in gastric mucosa ; ( 2 ) chemical ( 10 and/or 15mg/kg ) significantly decreased chemical dismutase ( gene ) and gene ( gene ) activities , while increased gene ( gene ) activity compared with the control .	T7	T28	23313794
NA	CHEMICAL	GENE-N	10	38	The results showed that ( 1 ) 15mg/kg body weight chemical induced obvious histopathological changes in gastric mucosa ; ( 2 ) chemical ( 10 and/or 15mg/kg ) significantly decreased chemical dismutase ( gene ) and gene ( gene ) activities , while increased gene ( gene ) activity compared with the control .	T7	T29	23313794
NA	CHEMICAL	GENE-Y	10	44	The results showed that ( 1 ) 15mg/kg body weight chemical induced obvious histopathological changes in gastric mucosa ; ( 2 ) chemical ( 10 and/or 15mg/kg ) significantly decreased chemical dismutase ( gene ) and gene ( gene ) activities , while increased gene ( gene ) activity compared with the control .	T7	T30	23313794
NA	CHEMICAL	GENE-Y	10	46	The results showed that ( 1 ) 15mg/kg body weight chemical induced obvious histopathological changes in gastric mucosa ; ( 2 ) chemical ( 10 and/or 15mg/kg ) significantly decreased chemical dismutase ( gene ) and gene ( gene ) activities , while increased gene ( gene ) activity compared with the control .	T7	T31	23313794
CPR:4	CHEMICAL	GENE-N	22	31	The results showed that ( 1 ) 15mg/kg body weight chemical induced obvious histopathological changes in gastric mucosa ; ( 2 ) chemical ( 10 and/or 15mg/kg ) significantly decreased chemical dismutase ( gene ) and gene ( gene ) activities , while increased gene ( gene ) activity compared with the control .	T8	T26	23313794
CPR:4	CHEMICAL	GENE-N	22	33	The results showed that ( 1 ) 15mg/kg body weight chemical induced obvious histopathological changes in gastric mucosa ; ( 2 ) chemical ( 10 and/or 15mg/kg ) significantly decreased chemical dismutase ( gene ) and gene ( gene ) activities , while increased gene ( gene ) activity compared with the control .	T8	T27	23313794
CPR:4	CHEMICAL	GENE-N	22	36	The results showed that ( 1 ) 15mg/kg body weight chemical induced obvious histopathological changes in gastric mucosa ; ( 2 ) chemical ( 10 and/or 15mg/kg ) significantly decreased chemical dismutase ( gene ) and gene ( gene ) activities , while increased gene ( gene ) activity compared with the control .	T8	T28	23313794
CPR:4	CHEMICAL	GENE-N	22	38	The results showed that ( 1 ) 15mg/kg body weight chemical induced obvious histopathological changes in gastric mucosa ; ( 2 ) chemical ( 10 and/or 15mg/kg ) significantly decreased chemical dismutase ( gene ) and gene ( gene ) activities , while increased gene ( gene ) activity compared with the control .	T8	T29	23313794
CPR:3	CHEMICAL	GENE-Y	22	44	The results showed that ( 1 ) 15mg/kg body weight chemical induced obvious histopathological changes in gastric mucosa ; ( 2 ) chemical ( 10 and/or 15mg/kg ) significantly decreased chemical dismutase ( gene ) and gene ( gene ) activities , while increased gene ( gene ) activity compared with the control .	T8	T30	23313794
CPR:3	CHEMICAL	GENE-Y	22	46	The results showed that ( 1 ) 15mg/kg body weight chemical induced obvious histopathological changes in gastric mucosa ; ( 2 ) chemical ( 10 and/or 15mg/kg ) significantly decreased chemical dismutase ( gene ) and gene ( gene ) activities , while increased gene ( gene ) activity compared with the control .	T8	T31	23313794
NA	CHEMICAL	GENE-N	30	31	The results showed that ( 1 ) 15mg/kg body weight chemical induced obvious histopathological changes in gastric mucosa ; ( 2 ) chemical ( 10 and/or 15mg/kg ) significantly decreased chemical dismutase ( gene ) and gene ( gene ) activities , while increased gene ( gene ) activity compared with the control .	T10	T26	23313794
NA	CHEMICAL	GENE-N	30	33	The results showed that ( 1 ) 15mg/kg body weight chemical induced obvious histopathological changes in gastric mucosa ; ( 2 ) chemical ( 10 and/or 15mg/kg ) significantly decreased chemical dismutase ( gene ) and gene ( gene ) activities , while increased gene ( gene ) activity compared with the control .	T10	T27	23313794
NA	CHEMICAL	GENE-N	30	36	The results showed that ( 1 ) 15mg/kg body weight chemical induced obvious histopathological changes in gastric mucosa ; ( 2 ) chemical ( 10 and/or 15mg/kg ) significantly decreased chemical dismutase ( gene ) and gene ( gene ) activities , while increased gene ( gene ) activity compared with the control .	T10	T28	23313794
NA	CHEMICAL	GENE-N	30	38	The results showed that ( 1 ) 15mg/kg body weight chemical induced obvious histopathological changes in gastric mucosa ; ( 2 ) chemical ( 10 and/or 15mg/kg ) significantly decreased chemical dismutase ( gene ) and gene ( gene ) activities , while increased gene ( gene ) activity compared with the control .	T10	T29	23313794
NA	CHEMICAL	GENE-Y	30	44	The results showed that ( 1 ) 15mg/kg body weight chemical induced obvious histopathological changes in gastric mucosa ; ( 2 ) chemical ( 10 and/or 15mg/kg ) significantly decreased chemical dismutase ( gene ) and gene ( gene ) activities , while increased gene ( gene ) activity compared with the control .	T10	T30	23313794
NA	CHEMICAL	GENE-Y	30	46	The results showed that ( 1 ) 15mg/kg body weight chemical induced obvious histopathological changes in gastric mucosa ; ( 2 ) chemical ( 10 and/or 15mg/kg ) significantly decreased chemical dismutase ( gene ) and gene ( gene ) activities , while increased gene ( gene ) activity compared with the control .	T10	T31	23313794
NA	CHEMICAL	GENE-Y	5	47	With the elevated doses of chemical , chemical ( chemical ) contents , protein chemical ( PCO ) contents and DNA-protein crosslinks ( DPC ) coefficients were significantly raised in a dose-dependent manner ; ( 3 ) chemical at the doses of 10mg/kg and/or 15mg/kg significantly inhibited gene mRNA and protein expression , whereas enhanced gene and gene expression relative to control .	T11	T32	23313794
NA	CHEMICAL	GENE-Y	5	55	With the elevated doses of chemical , chemical ( chemical ) contents , protein chemical ( PCO ) contents and DNA-protein crosslinks ( DPC ) coefficients were significantly raised in a dose-dependent manner ; ( 3 ) chemical at the doses of 10mg/kg and/or 15mg/kg significantly inhibited gene mRNA and protein expression , whereas enhanced gene and gene expression relative to control .	T11	T33	23313794
NA	CHEMICAL	GENE-Y	5	57	With the elevated doses of chemical , chemical ( chemical ) contents , protein chemical ( PCO ) contents and DNA-protein crosslinks ( DPC ) coefficients were significantly raised in a dose-dependent manner ; ( 3 ) chemical at the doses of 10mg/kg and/or 15mg/kg significantly inhibited gene mRNA and protein expression , whereas enhanced gene and gene expression relative to control .	T11	T19	23313794
NA	CHEMICAL	GENE-Y	7	47	With the elevated doses of chemical , chemical ( chemical ) contents , protein chemical ( PCO ) contents and DNA-protein crosslinks ( DPC ) coefficients were significantly raised in a dose-dependent manner ; ( 3 ) chemical at the doses of 10mg/kg and/or 15mg/kg significantly inhibited gene mRNA and protein expression , whereas enhanced gene and gene expression relative to control .	T12	T32	23313794
NA	CHEMICAL	GENE-Y	7	55	With the elevated doses of chemical , chemical ( chemical ) contents , protein chemical ( PCO ) contents and DNA-protein crosslinks ( DPC ) coefficients were significantly raised in a dose-dependent manner ; ( 3 ) chemical at the doses of 10mg/kg and/or 15mg/kg significantly inhibited gene mRNA and protein expression , whereas enhanced gene and gene expression relative to control .	T12	T33	23313794
NA	CHEMICAL	GENE-Y	7	57	With the elevated doses of chemical , chemical ( chemical ) contents , protein chemical ( PCO ) contents and DNA-protein crosslinks ( DPC ) coefficients were significantly raised in a dose-dependent manner ; ( 3 ) chemical at the doses of 10mg/kg and/or 15mg/kg significantly inhibited gene mRNA and protein expression , whereas enhanced gene and gene expression relative to control .	T12	T19	23313794
NA	CHEMICAL	GENE-Y	9	47	With the elevated doses of chemical , chemical ( chemical ) contents , protein chemical ( PCO ) contents and DNA-protein crosslinks ( DPC ) coefficients were significantly raised in a dose-dependent manner ; ( 3 ) chemical at the doses of 10mg/kg and/or 15mg/kg significantly inhibited gene mRNA and protein expression , whereas enhanced gene and gene expression relative to control .	T13	T32	23313794
NA	CHEMICAL	GENE-Y	9	55	With the elevated doses of chemical , chemical ( chemical ) contents , protein chemical ( PCO ) contents and DNA-protein crosslinks ( DPC ) coefficients were significantly raised in a dose-dependent manner ; ( 3 ) chemical at the doses of 10mg/kg and/or 15mg/kg significantly inhibited gene mRNA and protein expression , whereas enhanced gene and gene expression relative to control .	T13	T33	23313794
NA	CHEMICAL	GENE-Y	9	57	With the elevated doses of chemical , chemical ( chemical ) contents , protein chemical ( PCO ) contents and DNA-protein crosslinks ( DPC ) coefficients were significantly raised in a dose-dependent manner ; ( 3 ) chemical at the doses of 10mg/kg and/or 15mg/kg significantly inhibited gene mRNA and protein expression , whereas enhanced gene and gene expression relative to control .	T13	T19	23313794
NA	CHEMICAL	GENE-Y	14	47	With the elevated doses of chemical , chemical ( chemical ) contents , protein chemical ( PCO ) contents and DNA-protein crosslinks ( DPC ) coefficients were significantly raised in a dose-dependent manner ; ( 3 ) chemical at the doses of 10mg/kg and/or 15mg/kg significantly inhibited gene mRNA and protein expression , whereas enhanced gene and gene expression relative to control .	T14	T32	23313794
NA	CHEMICAL	GENE-Y	14	55	With the elevated doses of chemical , chemical ( chemical ) contents , protein chemical ( PCO ) contents and DNA-protein crosslinks ( DPC ) coefficients were significantly raised in a dose-dependent manner ; ( 3 ) chemical at the doses of 10mg/kg and/or 15mg/kg significantly inhibited gene mRNA and protein expression , whereas enhanced gene and gene expression relative to control .	T14	T33	23313794
NA	CHEMICAL	GENE-Y	14	57	With the elevated doses of chemical , chemical ( chemical ) contents , protein chemical ( PCO ) contents and DNA-protein crosslinks ( DPC ) coefficients were significantly raised in a dose-dependent manner ; ( 3 ) chemical at the doses of 10mg/kg and/or 15mg/kg significantly inhibited gene mRNA and protein expression , whereas enhanced gene and gene expression relative to control .	T14	T19	23313794
CPR:4	CHEMICAL	GENE-Y	37	47	With the elevated doses of chemical , chemical ( chemical ) contents , protein chemical ( PCO ) contents and DNA-protein crosslinks ( DPC ) coefficients were significantly raised in a dose-dependent manner ; ( 3 ) chemical at the doses of 10mg/kg and/or 15mg/kg significantly inhibited gene mRNA and protein expression , whereas enhanced gene and gene expression relative to control .	T16	T32	23313794
CPR:3	CHEMICAL	GENE-Y	37	55	With the elevated doses of chemical , chemical ( chemical ) contents , protein chemical ( PCO ) contents and DNA-protein crosslinks ( DPC ) coefficients were significantly raised in a dose-dependent manner ; ( 3 ) chemical at the doses of 10mg/kg and/or 15mg/kg significantly inhibited gene mRNA and protein expression , whereas enhanced gene and gene expression relative to control .	T16	T33	23313794
CPR:3	CHEMICAL	GENE-Y	37	57	With the elevated doses of chemical , chemical ( chemical ) contents , protein chemical ( PCO ) contents and DNA-protein crosslinks ( DPC ) coefficients were significantly raised in a dose-dependent manner ; ( 3 ) chemical at the doses of 10mg/kg and/or 15mg/kg significantly inhibited gene mRNA and protein expression , whereas enhanced gene and gene expression relative to control .	T16	T19	23313794
NA	CHEMICAL	GENE-Y	6	5	This effect requires cold-induced , gene-mediated chemical influx and a chemical-sensitive gene that signals to the transcription factor gene/gene .	T1	T6	23415228
NA	CHEMICAL	GENE-N	6	11	This effect requires cold-induced , gene-mediated chemical influx and a chemical-sensitive gene that signals to the transcription factor gene/gene .	T1	T7	23415228
NA	CHEMICAL	GENE-Y	6	18	This effect requires cold-induced , gene-mediated chemical influx and a chemical-sensitive gene that signals to the transcription factor gene/gene .	T1	T8	23415228
NA	CHEMICAL	GENE-Y	6	18	This effect requires cold-induced , gene-mediated chemical influx and a chemical-sensitive gene that signals to the transcription factor gene/gene .	T1	T9	23415228
NA	CHEMICAL	GENE-Y	9	5	This effect requires cold-induced , gene-mediated chemical influx and a chemical-sensitive gene that signals to the transcription factor gene/gene .	T2	T6	23415228
NA	CHEMICAL	GENE-N	9	11	This effect requires cold-induced , gene-mediated chemical influx and a chemical-sensitive gene that signals to the transcription factor gene/gene .	T2	T7	23415228
NA	CHEMICAL	GENE-Y	9	18	This effect requires cold-induced , gene-mediated chemical influx and a chemical-sensitive gene that signals to the transcription factor gene/gene .	T2	T8	23415228
NA	CHEMICAL	GENE-Y	9	18	This effect requires cold-induced , gene-mediated chemical influx and a chemical-sensitive gene that signals to the transcription factor gene/gene .	T2	T9	23415228
CPR:9	CHEMICAL	GENE-Y	5	2	Cross-inhibition of gene- and gene-mediated chemical transport by the small molecules BLT-4 and chemical .	T14	T38	15102890
CPR:9	CHEMICAL	GENE-Y	5	4	Cross-inhibition of gene- and gene-mediated chemical transport by the small molecules BLT-4 and chemical .	T14	T39	15102890
CPR:4	CHEMICAL	GENE-Y	13	2	Cross-inhibition of gene- and gene-mediated chemical transport by the small molecules BLT-4 and chemical .	T13	T38	15102890
CPR:4	CHEMICAL	GENE-Y	13	4	Cross-inhibition of gene- and gene-mediated chemical transport by the small molecules BLT-4 and chemical .	T13	T39	15102890
CPR:9	CHEMICAL	GENE-Y	18	0	gene is a receptor that binds gene with high affinity and mediates both the selective lipid uptake of chemical from lipid-rich gene to cells and the efflux of unesterified chemical from cells to gene .	T3	T22	15102890
NA	CHEMICAL	GENE-N	18	6	gene is a receptor that binds gene with high affinity and mediates both the selective lipid uptake of chemical from lipid-rich gene to cells and the efflux of unesterified chemical from cells to gene .	T3	T23	15102890
NA	CHEMICAL	GENE-N	18	21	gene is a receptor that binds gene with high affinity and mediates both the selective lipid uptake of chemical from lipid-rich gene to cells and the efflux of unesterified chemical from cells to gene .	T3	T24	15102890
NA	CHEMICAL	GENE-N	18	33	gene is a receptor that binds gene with high affinity and mediates both the selective lipid uptake of chemical from lipid-rich gene to cells and the efflux of unesterified chemical from cells to gene .	T3	T25	15102890
CPR:9	CHEMICAL	GENE-Y	29	0	gene is a receptor that binds gene with high affinity and mediates both the selective lipid uptake of chemical from lipid-rich gene to cells and the efflux of unesterified chemical from cells to gene .	T4	T22	15102890
NA	CHEMICAL	GENE-N	29	6	gene is a receptor that binds gene with high affinity and mediates both the selective lipid uptake of chemical from lipid-rich gene to cells and the efflux of unesterified chemical from cells to gene .	T4	T23	15102890
NA	CHEMICAL	GENE-N	29	21	gene is a receptor that binds gene with high affinity and mediates both the selective lipid uptake of chemical from lipid-rich gene to cells and the efflux of unesterified chemical from cells to gene .	T4	T24	15102890
NA	CHEMICAL	GENE-N	29	33	gene is a receptor that binds gene with high affinity and mediates both the selective lipid uptake of chemical from lipid-rich gene to cells and the efflux of unesterified chemical from cells to gene .	T4	T25	15102890
CPR:9	CHEMICAL	GENE-Y	6	0	gene mediates the efflux of unesterified chemical and phospholipids from cells to lipid-poor gene ( gene ) .	T5	T26	15102890
NA	CHEMICAL	GENE-Y	6	13	gene mediates the efflux of unesterified chemical and phospholipids from cells to lipid-poor gene ( gene ) .	T5	T28	15102890
NA	CHEMICAL	GENE-Y	6	15	gene mediates the efflux of unesterified chemical and phospholipids from cells to lipid-poor gene ( gene ) .	T5	T30	15102890
NA	CHEMICAL	GENE-Y	6	3	The activities of gene and other chemical binding cassette superfamily members are inhibited by the drug chemical , and gene-mediated lipid transport is blocked by small molecule inhibitors called BLTs .	T6	T31	15102890
NA	CHEMICAL	GENE-N	6	9	The activities of gene and other chemical binding cassette superfamily members are inhibited by the drug chemical , and gene-mediated lipid transport is blocked by small molecule inhibitors called BLTs .	T6	T32	15102890
NA	CHEMICAL	GENE-Y	6	19	The activities of gene and other chemical binding cassette superfamily members are inhibited by the drug chemical , and gene-mediated lipid transport is blocked by small molecule inhibitors called BLTs .	T6	T33	15102890
CPR:4	CHEMICAL	GENE-Y	16	3	The activities of gene and other chemical binding cassette superfamily members are inhibited by the drug chemical , and gene-mediated lipid transport is blocked by small molecule inhibitors called BLTs .	T7	T31	15102890
CPR:4	CHEMICAL	GENE-N	16	9	The activities of gene and other chemical binding cassette superfamily members are inhibited by the drug chemical , and gene-mediated lipid transport is blocked by small molecule inhibitors called BLTs .	T7	T32	15102890
NA	CHEMICAL	GENE-Y	16	19	The activities of gene and other chemical binding cassette superfamily members are inhibited by the drug chemical , and gene-mediated lipid transport is blocked by small molecule inhibitors called BLTs .	T7	T33	15102890
CPR:4	CHEMICAL	GENE-Y	6	16	Here , we show that one chemical , [ chemical ] ( chemical ) , blocked gene-mediated chemical efflux to lipid-poor gene at a potency similar to that for its inhibition of gene ( IC ( 50 ) approximately 55-60 microM ) .	T8	T34	15102890
NA	CHEMICAL	GENE-Y	6	21	Here , we show that one chemical , [ chemical ] ( chemical ) , blocked gene-mediated chemical efflux to lipid-poor gene at a potency similar to that for its inhibition of gene ( IC ( 50 ) approximately 55-60 microM ) .	T8	T35	15102890
CPR:4	CHEMICAL	GENE-Y	6	32	Here , we show that one chemical , [ chemical ] ( chemical ) , blocked gene-mediated chemical efflux to lipid-poor gene at a potency similar to that for its inhibition of gene ( IC ( 50 ) approximately 55-60 microM ) .	T8	T36	15102890
CPR:4	CHEMICAL	GENE-Y	9	16	Here , we show that one chemical , [ chemical ] ( chemical ) , blocked gene-mediated chemical efflux to lipid-poor gene at a potency similar to that for its inhibition of gene ( IC ( 50 ) approximately 55-60 microM ) .	T9	T34	15102890
NA	CHEMICAL	GENE-Y	9	21	Here , we show that one chemical , [ chemical ] ( chemical ) , blocked gene-mediated chemical efflux to lipid-poor gene at a potency similar to that for its inhibition of gene ( IC ( 50 ) approximately 55-60 microM ) .	T9	T35	15102890
CPR:4	CHEMICAL	GENE-Y	9	32	Here , we show that one chemical , [ chemical ] ( chemical ) , blocked gene-mediated chemical efflux to lipid-poor gene at a potency similar to that for its inhibition of gene ( IC ( 50 ) approximately 55-60 microM ) .	T9	T36	15102890
CPR:4	CHEMICAL	GENE-Y	12	16	Here , we show that one chemical , [ chemical ] ( chemical ) , blocked gene-mediated chemical efflux to lipid-poor gene at a potency similar to that for its inhibition of gene ( IC ( 50 ) approximately 55-60 microM ) .	T10	T34	15102890
NA	CHEMICAL	GENE-Y	12	21	Here , we show that one chemical , [ chemical ] ( chemical ) , blocked gene-mediated chemical efflux to lipid-poor gene at a potency similar to that for its inhibition of gene ( IC ( 50 ) approximately 55-60 microM ) .	T10	T35	15102890
CPR:4	CHEMICAL	GENE-Y	12	32	Here , we show that one chemical , [ chemical ] ( chemical ) , blocked gene-mediated chemical efflux to lipid-poor gene at a potency similar to that for its inhibition of gene ( IC ( 50 ) approximately 55-60 microM ) .	T10	T36	15102890
CPR:9	CHEMICAL	GENE-Y	17	16	Here , we show that one chemical , [ chemical ] ( chemical ) , blocked gene-mediated chemical efflux to lipid-poor gene at a potency similar to that for its inhibition of gene ( IC ( 50 ) approximately 55-60 microM ) .	T11	T34	15102890
NA	CHEMICAL	GENE-Y	17	21	Here , we show that one chemical , [ chemical ] ( chemical ) , blocked gene-mediated chemical efflux to lipid-poor gene at a potency similar to that for its inhibition of gene ( IC ( 50 ) approximately 55-60 microM ) .	T11	T35	15102890
NA	CHEMICAL	GENE-Y	17	32	Here , we show that one chemical , [ chemical ] ( chemical ) , blocked gene-mediated chemical efflux to lipid-poor gene at a potency similar to that for its inhibition of gene ( IC ( 50 ) approximately 55-60 microM ) .	T11	T36	15102890
CPR:4	CHEMICAL	GENE-Y	2	4	Reciprocally , chemical blocked gene-mediated selective lipid uptake and efflux at a potency similar to that for its inhibition of gene ( IC ( 50 ) approximately 275-300 microM ) .	T12	T37	15102890
CPR:4	CHEMICAL	GENE-Y	2	20	Reciprocally , chemical blocked gene-mediated selective lipid uptake and efflux at a potency similar to that for its inhibition of gene ( IC ( 50 ) approximately 275-300 microM ) .	T12	T16	15102890
NA	CHEMICAL	GENE-N	7	13	As is the case with BLTs , chemical increased the apparent affinity of gene binding to gene .	T1	T17	15102890
NA	CHEMICAL	GENE-Y	7	16	As is the case with BLTs , chemical increased the apparent affinity of gene binding to gene .	T1	T18	15102890
NA	CHEMICAL	GENE-Y	19	10	Apoptosis induced by oxidized lipids is associated with up-regulation of gene in intestinal Caco-2 cells : protective effects of chemical compounds .	T14	T30	17588737
NA	CHEMICAL	GENE-N	28	18	In this study , we investigated the alterations of the redox balance induced by the lipid fraction of gene in Caco-2 intestinal cells , and the effects of chemical and chemical , two dietary chemical compounds .	T3	T15	17588737
NA	CHEMICAL	GENE-N	30	18	In this study , we investigated the alterations of the redox balance induced by the lipid fraction of gene in Caco-2 intestinal cells , and the effects of chemical and chemical , two dietary chemical compounds .	T5	T15	17588737
NA	CHEMICAL	GENE-N	34	18	In this study , we investigated the alterations of the redox balance induced by the lipid fraction of gene in Caco-2 intestinal cells , and the effects of chemical and chemical , two dietary chemical compounds .	T6	T15	17588737
NA	CHEMICAL	GENE-N	35	7	We found that oxidized lipids extracted from gene ( gene ) induced oxidative stress by determining , 6 h after treatment , ROS overproduction ( about a 100 % and a 43 % increase of chemical and chemical production , respectively , P < .05 : gene vs .	T7	T18	17588737
NA	CHEMICAL	GENE-Y	35	9	We found that oxidized lipids extracted from gene ( gene ) induced oxidative stress by determining , 6 h after treatment , ROS overproduction ( about a 100 % and a 43 % increase of chemical and chemical production , respectively , P < .05 : gene vs .	T7	T19	17588737
NA	CHEMICAL	GENE-Y	35	46	We found that oxidized lipids extracted from gene ( gene ) induced oxidative stress by determining , 6 h after treatment , ROS overproduction ( about a 100 % and a 43 % increase of chemical and chemical production , respectively , P < .05 : gene vs .	T7	T20	17588737
NA	CHEMICAL	GENE-N	37	7	We found that oxidized lipids extracted from gene ( gene ) induced oxidative stress by determining , 6 h after treatment , ROS overproduction ( about a 100 % and a 43 % increase of chemical and chemical production , respectively , P < .05 : gene vs .	T8	T18	17588737
NA	CHEMICAL	GENE-Y	37	9	We found that oxidized lipids extracted from gene ( gene ) induced oxidative stress by determining , 6 h after treatment , ROS overproduction ( about a 100 % and a 43 % increase of chemical and chemical production , respectively , P < .05 : gene vs .	T8	T19	17588737
NA	CHEMICAL	GENE-Y	37	46	We found that oxidized lipids extracted from gene ( gene ) induced oxidative stress by determining , 6 h after treatment , ROS overproduction ( about a 100 % and a 43 % increase of chemical and chemical production , respectively , P < .05 : gene vs .	T8	T20	17588737
NA	CHEMICAL	GENE-N	9	10	control ) , and by impairing the activities of chemical dismutase , gene and chemical peroxidase .	T9	T22	17588737
NA	CHEMICAL	GENE-Y	9	12	control ) , and by impairing the activities of chemical dismutase , gene and chemical peroxidase .	T9	T23	17588737
NA	CHEMICAL	GENE-N	9	15	control ) , and by impairing the activities of chemical dismutase , gene and chemical peroxidase .	T9	T24	17588737
NA	CHEMICAL	GENE-N	14	10	control ) , and by impairing the activities of chemical dismutase , gene and chemical peroxidase .	T10	T22	17588737
NA	CHEMICAL	GENE-Y	14	12	control ) , and by impairing the activities of chemical dismutase , gene and chemical peroxidase .	T10	T23	17588737
NA	CHEMICAL	GENE-N	14	15	control ) , and by impairing the activities of chemical dismutase , gene and chemical peroxidase .	T10	T24	17588737
NA	CHEMICAL	GENE-N	13	14	In response to the induced oxidative stress , we observed significant overexpression of chemical peroxidase ( 6 h after treatment : P < .05 ) , chemical reductase and chemical synthetase ( 12 h after treatment : P < .05 ) .	T11	T25	17588737
NA	CHEMICAL	GENE-N	13	27	In response to the induced oxidative stress , we observed significant overexpression of chemical peroxidase ( 6 h after treatment : P < .05 ) , chemical reductase and chemical synthetase ( 12 h after treatment : P < .05 ) .	T11	T26	17588737
NA	CHEMICAL	GENE-Y	13	3	In response to the induced oxidative stress , we observed significant overexpression of chemical peroxidase ( 6 h after treatment : P < .05 ) , chemical reductase and chemical synthetase ( 12 h after treatment : P < .05 ) .	T11	T27	17588737
NA	CHEMICAL	GENE-N	17	14	In response to the induced oxidative stress , we observed significant overexpression of chemical peroxidase ( 6 h after treatment : P < .05 ) , chemical reductase and chemical synthetase ( 12 h after treatment : P < .05 ) .	T12	T25	17588737
NA	CHEMICAL	GENE-N	17	27	In response to the induced oxidative stress , we observed significant overexpression of chemical peroxidase ( 6 h after treatment : P < .05 ) , chemical reductase and chemical synthetase ( 12 h after treatment : P < .05 ) .	T12	T26	17588737
NA	CHEMICAL	GENE-Y	17	3	In response to the induced oxidative stress , we observed significant overexpression of chemical peroxidase ( 6 h after treatment : P < .05 ) , chemical reductase and chemical synthetase ( 12 h after treatment : P < .05 ) .	T12	T27	17588737
NA	CHEMICAL	GENE-N	29	14	In response to the induced oxidative stress , we observed significant overexpression of chemical peroxidase ( 6 h after treatment : P < .05 ) , chemical reductase and chemical synthetase ( 12 h after treatment : P < .05 ) .	T13	T25	17588737
NA	CHEMICAL	GENE-N	29	27	In response to the induced oxidative stress , we observed significant overexpression of chemical peroxidase ( 6 h after treatment : P < .05 ) , chemical reductase and chemical synthetase ( 12 h after treatment : P < .05 ) .	T13	T26	17588737
NA	CHEMICAL	GENE-Y	29	3	In response to the induced oxidative stress , we observed significant overexpression of chemical peroxidase ( 6 h after treatment : P < .05 ) , chemical reductase and chemical synthetase ( 12 h after treatment : P < .05 ) .	T13	T27	17588737
CPR:4	CHEMICAL	GENE-Y	7	36	These effects were fully counteracted by dietary chemical which inhibited ROS overproduction and GSH consumption , rendered the reactive transcription of chemical-associated enzymes unnecessary and blocked the intracellular signals leading to the overexpression and rearrangement of gene signalling molecule .	T1	T16	17588737
NA	CHEMICAL	GENE-Y	21	36	These effects were fully counteracted by dietary chemical which inhibited ROS overproduction and GSH consumption , rendered the reactive transcription of chemical-associated enzymes unnecessary and blocked the intracellular signals leading to the overexpression and rearrangement of gene signalling molecule .	T2	T16	17588737
CPR:4	CHEMICAL	GENE-N	4	1	Regarding gene inhibition , chemical was the most potent fraction ( IC50 : 97 µg/mL ) .	T4	T18	23552263
CPR:3	CHEMICAL	GENE-Y	0	0	gene , gene and gene mRNA levels were significantly induced by chemical , while chemical induced gene and gene .	T2	T21	23629516
CPR:3	CHEMICAL	GENE-Y	0	2	gene , gene and gene mRNA levels were significantly induced by chemical , while chemical induced gene and gene .	T2	T22	23629516
CPR:3	CHEMICAL	GENE-Y	0	4	gene , gene and gene mRNA levels were significantly induced by chemical , while chemical induced gene and gene .	T2	T23	23629516
NA	CHEMICAL	GENE-Y	0	16	gene , gene and gene mRNA levels were significantly induced by chemical , while chemical induced gene and gene .	T2	T19	23629516
NA	CHEMICAL	GENE-Y	0	18	gene , gene and gene mRNA levels were significantly induced by chemical , while chemical induced gene and gene .	T2	T20	23629516
NA	CHEMICAL	GENE-Y	14	0	gene , gene and gene mRNA levels were significantly induced by chemical , while chemical induced gene and gene .	T3	T21	23629516
NA	CHEMICAL	GENE-Y	14	2	gene , gene and gene mRNA levels were significantly induced by chemical , while chemical induced gene and gene .	T3	T22	23629516
NA	CHEMICAL	GENE-Y	14	4	gene , gene and gene mRNA levels were significantly induced by chemical , while chemical induced gene and gene .	T3	T23	23629516
CPR:3	CHEMICAL	GENE-Y	14	16	gene , gene and gene mRNA levels were significantly induced by chemical , while chemical induced gene and gene .	T3	T19	23629516
CPR:3	CHEMICAL	GENE-Y	14	18	gene , gene and gene mRNA levels were significantly induced by chemical , while chemical induced gene and gene .	T3	T20	23629516
NA	CHEMICAL	GENE-Y	8	3	AIMS/HYPOTHESIS : Increased gene secretion predicts deterioration of chemical tolerance , and high gene levels contribute to hyperglycaemia in type 2 diabetes .	T12	T22	17479245
NA	CHEMICAL	GENE-Y	8	13	AIMS/HYPOTHESIS : Increased gene secretion predicts deterioration of chemical tolerance , and high gene levels contribute to hyperglycaemia in type 2 diabetes .	T12	T16	17479245
NA	CHEMICAL	GENE-N	10	0	gene secretion was studied after oral and intravenous administration of chemical and gene secretion after intravenous chemical .	T10	T24	17479245
NA	CHEMICAL	GENE-Y	10	12	gene secretion was studied after oral and intravenous administration of chemical and gene secretion after intravenous chemical .	T10	T25	17479245
NA	CHEMICAL	GENE-N	16	0	gene secretion was studied after oral and intravenous administration of chemical and gene secretion after intravenous chemical .	T11	T24	17479245
NA	CHEMICAL	GENE-Y	16	12	gene secretion was studied after oral and intravenous administration of chemical and gene secretion after intravenous chemical .	T11	T25	17479245
NA	CHEMICAL	GENE-N	8	5	Islet morphology was examined and gene secretion and chemical oxidation were measured in isolated islets .	T13	T26	17479245
NA	CHEMICAL	GENE-N	6	2	The acute gene response to intravenous chemical was augmented ( 1,300 +/- 110 vs 790 +/- 64 pmol/l ; p < 0.001 ) .	T15	T27	17479245
NA	CHEMICAL	GENE-N	2	2	The early gene response to oral chemical was reduced in mice on HFD + GRA ( 1,890 +/- 160 vs 3,040 +/- 420 pmol/l ; p = 0.012 ) , but chemical excursions were improved .	T1	T17	17479245
NA	CHEMICAL	GENE-N	31	2	The early gene response to oral chemical was reduced in mice on HFD + GRA ( 1,890 +/- 160 vs 3,040 +/- 420 pmol/l ; p = 0.012 ) , but chemical excursions were improved .	T2	T17	17479245
CPR:3	CHEMICAL	GENE-Y	1	6	Intravenous chemical significantly increased the acute gene response ( 129 +/- 12 vs 36 +/- 6 ng/l in controls ; p < 0.01 ) , notably without affecting plasma chemical .	T3	T18	17479245
NA	CHEMICAL	GENE-Y	29	6	Intravenous chemical significantly increased the acute gene response ( 129 +/- 12 vs 36 +/- 6 ng/l in controls ; p < 0.01 ) , notably without affecting plasma chemical .	T4	T18	17479245
CPR:3	CHEMICAL	GENE-N	4	5	Isolated islets displayed improved chemical-stimulated gene secretion after GRA treatment ( 0.061 +/- 0.007 vs 0.030 +/- 0.004 pmol islet ( -1 ) h ( -1 ) at 16.7 mmol/l chemical ; p < 0.001 ) , without affecting islet chemical oxidation .	T5	T19	17479245
NA	CHEMICAL	GENE-N	30	5	Isolated islets displayed improved chemical-stimulated gene secretion after GRA treatment ( 0.061 +/- 0.007 vs 0.030 +/- 0.004 pmol islet ( -1 ) h ( -1 ) at 16.7 mmol/l chemical ; p < 0.001 ) , without affecting islet chemical oxidation .	T6	T19	17479245
NA	CHEMICAL	GENE-N	40	5	Isolated islets displayed improved chemical-stimulated gene secretion after GRA treatment ( 0.061 +/- 0.007 vs 0.030 +/- 0.004 pmol islet ( -1 ) h ( -1 ) at 16.7 mmol/l chemical ; p < 0.001 ) , without affecting islet chemical oxidation .	T7	T19	17479245
NA	CHEMICAL	GENE-Y	0	1	chemical-induced gene gap junction disassembly in rat astrocytes involves gene .	T17	T28	23403203
NA	CHEMICAL	GENE-Y	0	9	chemical-induced gene gap junction disassembly in rat astrocytes involves gene .	T17	T29	23403203
CPR:4	CHEMICAL	GENE-Y	1	2	Levels of gene protein were also decreased in a dose- and time-dependent manner following chemical treatment .	T12	T24	23403203
NA	CHEMICAL	GENE-Y	5	20	Double-labeling immunofluorescence microscopy showed that chemical ( 10ng/ml ) induced endocytosis of surface gap junctions into the cytoplasm , where gene was co-localized with the early endosome marker gene .	T13	T25	23403203
NA	CHEMICAL	GENE-N	5	28	Double-labeling immunofluorescence microscopy showed that chemical ( 10ng/ml ) induced endocytosis of surface gap junctions into the cytoplasm , where gene was co-localized with the early endosome marker gene .	T13	T26	23403203
NA	CHEMICAL	GENE-Y	1	25	Inhibition of lysosomes or proteasomes by co-treatment with chemical and their respective specific inhibitors , chemical or chemical , partially inhibited the antofine-induced decrease in gene protein levels , but did not inhibit the antofine-induced inhibition of GJIC .	T14	T27	23403203
NA	CHEMICAL	GENE-Y	15	25	Inhibition of lysosomes or proteasomes by co-treatment with chemical and their respective specific inhibitors , chemical or chemical , partially inhibited the antofine-induced decrease in gene protein levels , but did not inhibit the antofine-induced inhibition of GJIC .	T15	T27	23403203
NA	CHEMICAL	GENE-Y	17	25	Inhibition of lysosomes or proteasomes by co-treatment with chemical and their respective specific inhibitors , chemical or chemical , partially inhibited the antofine-induced decrease in gene protein levels , but did not inhibit the antofine-induced inhibition of GJIC .	T16	T27	23403203
NA	CHEMICAL	GENE-N	7	18	After 30min of treatment , antofine induced a rapid increase in the intracellular chemical concentration and activation of gene , which was maintained for at least 6h .	T2	T18	23403203
CPR:4	CHEMICAL	GENE-Y	1	14	Co-treatment of astrocytes with chemical and the intracellular chemical chelator chemical prevented downregulation of gene and inhibition of GJIC .	T3	T19	23403203
NA	CHEMICAL	GENE-Y	8	14	Co-treatment of astrocytes with chemical and the intracellular chemical chelator chemical prevented downregulation of gene and inhibition of GJIC .	T5	T19	23403203
CPR:3	CHEMICAL	GENE-Y	10	14	Co-treatment of astrocytes with chemical and the intracellular chemical chelator chemical prevented downregulation of gene and inhibition of GJIC .	T6	T19	23403203
NA	CHEMICAL	GENE-Y	4	8	Moreover , co-treatment with chemical and a specific gene inhibitor prevented endocytosis of gap junctions , downregulation of gene , and inhibition of GJIC .	T7	T20	23403203
CPR:4	CHEMICAL	GENE-Y	4	18	Moreover , co-treatment with chemical and a specific gene inhibitor prevented endocytosis of gap junctions , downregulation of gene , and inhibition of GJIC .	T7	T21	23403203
NA	CHEMICAL	GENE-Y	7	9	Taken together , these findings indicate that chemical induces gene gap junction disassembly by the gene signaling pathway .	T8	T22	23403203
CPR:3	CHEMICAL	GENE-Y	7	15	Taken together , these findings indicate that chemical induces gene gap junction disassembly by the gene signaling pathway .	T8	T23	23403203
NA	CHEMICAL	GENE-Y	8	0	gene genes encode mitochondrial enzymes capable of metabolizing chemical and other biological chemical in the body .	T4	T5	23247008
NA	CHEMICAL	GENE-Y	12	0	gene genes encode mitochondrial enzymes capable of metabolizing chemical and other biological chemical in the body .	T1	T5	23247008
CPR:9	CHEMICAL	GENE-Y	10	0	gene , another mitochondrial enzyme sharing 72 % identity with gene , is also capable of metabolizing chemical but has a tissue distribution and pattern of activity distinct from that of gene .	T2	T13	23247008
CPR:9	CHEMICAL	GENE-Y	10	10	gene , another mitochondrial enzyme sharing 72 % identity with gene , is also capable of metabolizing chemical but has a tissue distribution and pattern of activity distinct from that of gene .	T2	T21	23247008
NA	CHEMICAL	GENE-Y	10	31	gene , another mitochondrial enzyme sharing 72 % identity with gene , is also capable of metabolizing chemical but has a tissue distribution and pattern of activity distinct from that of gene .	T2	T22	23247008
NA	CHEMICAL	GENE-Y	13	10	Bioinformatic analyses of several vertebrate genomes were undertaken using known gene and gene chemical sequences .	T3	T23	23247008
NA	CHEMICAL	GENE-Y	13	12	Bioinformatic analyses of several vertebrate genomes were undertaken using known gene and gene chemical sequences .	T3	T24	23247008
CPR:4	CHEMICAL	GENE-Y	0	12	chemical reduces the expression of lipopolysaccharide-induced inflammatory markers by inhibition of chemical reductase in murine macrophages and ocular tissues .	T11	T20	23247009
NA	CHEMICAL	GENE-Y	11	12	chemical reduces the expression of lipopolysaccharide-induced inflammatory markers by inhibition of chemical reductase in murine macrophages and ocular tissues .	T12	T20	23247009
NA	CHEMICAL	GENE-Y	0	1	chemical reductase ( gene ) catalyzes the reduction of toxic lipid chemical to their chemical products and mediates inflammatory signals triggered by lipopolysaccharide ( LPS ) .	T1	T13	23247009
NA	CHEMICAL	GENE-Y	0	3	chemical reductase ( gene ) catalyzes the reduction of toxic lipid chemical to their chemical products and mediates inflammatory signals triggered by lipopolysaccharide ( LPS ) .	T1	T14	23247009
CPR:9	CHEMICAL	GENE-Y	11	1	chemical reductase ( gene ) catalyzes the reduction of toxic lipid chemical to their chemical products and mediates inflammatory signals triggered by lipopolysaccharide ( LPS ) .	T7	T13	23247009
CPR:9	CHEMICAL	GENE-Y	11	3	chemical reductase ( gene ) catalyzes the reduction of toxic lipid chemical to their chemical products and mediates inflammatory signals triggered by lipopolysaccharide ( LPS ) .	T7	T14	23247009
CPR:9	CHEMICAL	GENE-Y	14	1	chemical reductase ( gene ) catalyzes the reduction of toxic lipid chemical to their chemical products and mediates inflammatory signals triggered by lipopolysaccharide ( LPS ) .	T9	T13	23247009
CPR:9	CHEMICAL	GENE-Y	14	3	chemical reductase ( gene ) catalyzes the reduction of toxic lipid chemical to their chemical products and mediates inflammatory signals triggered by lipopolysaccharide ( LPS ) .	T9	T14	23247009
CPR:4	CHEMICAL	GENE-Y	0	8	chemical ( chemical ) , a recently described gene inhibitor , was purified from extracts of the Indian gooseberry ( Emblica officinalis ) .	T2	T15	23247009
CPR:4	CHEMICAL	GENE-Y	2	8	chemical ( chemical ) , a recently described gene inhibitor , was purified from extracts of the Indian gooseberry ( Emblica officinalis ) .	T3	T15	23247009
CPR:4	CHEMICAL	GENE-Y	7	18	In this study , we found that chemical showed low cytotoxicity in Raw264.7 murine macrophages and effectively inhibited gene activity as measured by a decrease in chemical accumulation .	T4	T16	23247009
NA	CHEMICAL	GENE-Y	26	18	In this study , we found that chemical showed low cytotoxicity in Raw264.7 murine macrophages and effectively inhibited gene activity as measured by a decrease in chemical accumulation .	T5	T16	23247009
CPR:4	CHEMICAL	GENE-Y	3	6	In addition , chemical-mediated inhibition of gene prevented LPS-induced activation of gene and gene and lowered ROS levels , which could inhibit LPS-induced apoptosis .	T6	T17	23247009
CPR:4	CHEMICAL	GENE-N	3	11	In addition , chemical-mediated inhibition of gene prevented LPS-induced activation of gene and gene and lowered ROS levels , which could inhibit LPS-induced apoptosis .	T6	T18	23247009
CPR:4	CHEMICAL	GENE-N	3	13	In addition , chemical-mediated inhibition of gene prevented LPS-induced activation of gene and gene and lowered ROS levels , which could inhibit LPS-induced apoptosis .	T6	T19	23247009
NA	CHEMICAL	GENE-Y	4	16	Toxicity of the flame-retardant chemical on brain mitochondria and neuronal progenitor striatal cells enhanced by a gene-deficient background .	T17	T21	23288049
CPR:5	CHEMICAL	GENE-N	3	16	Pre-clinical pharmacology of chemical ( chemical ; chemical chemical ) , a centrally and peripherally acting gene agonist for migraine .	T19	T27	9399012
CPR:5	CHEMICAL	GENE-N	5	16	Pre-clinical pharmacology of chemical ( chemical ; chemical chemical ) , a centrally and peripherally acting gene agonist for migraine .	T20	T27	9399012
NA	CHEMICAL	GENE-N	7	16	Pre-clinical pharmacology of chemical ( chemical ; chemical chemical ) , a centrally and peripherally acting gene agonist for migraine .	T21	T27	9399012
CPR:5	CHEMICAL	GENE-N	8	16	Pre-clinical pharmacology of chemical ( chemical ; chemical chemical ) , a centrally and peripherally acting gene agonist for migraine .	T22	T27	9399012
CPR:5	CHEMICAL	GENE-N	0	1	chemical ( chemical ; chemical chemical ) is a novel chemical ( chemical ) 1B/1D receptor agonist with proven efficacy in the acute treatment of migraine with or without preceding aura .	T1	T25	9399012
CPR:5	CHEMICAL	GENE-N	2	1	chemical ( chemical ; chemical chemical ) is a novel chemical ( chemical ) 1B/1D receptor agonist with proven efficacy in the acute treatment of migraine with or without preceding aura .	T3	T25	9399012
NA	CHEMICAL	GENE-N	4	1	chemical ( chemical ; chemical chemical ) is a novel chemical ( chemical ) 1B/1D receptor agonist with proven efficacy in the acute treatment of migraine with or without preceding aura .	T8	T25	9399012
CPR:5	CHEMICAL	GENE-N	5	1	chemical ( chemical ; chemical chemical ) is a novel chemical ( chemical ) 1B/1D receptor agonist with proven efficacy in the acute treatment of migraine with or without preceding aura .	T14	T25	9399012
NA	CHEMICAL	GENE-N	8	1	chemical ( chemical ; chemical chemical ) is a novel chemical ( chemical ) 1B/1D receptor agonist with proven efficacy in the acute treatment of migraine with or without preceding aura .	T15	T25	9399012
NA	CHEMICAL	GENE-N	12	1	chemical ( chemical ; chemical chemical ) is a novel chemical ( chemical ) 1B/1D receptor agonist with proven efficacy in the acute treatment of migraine with or without preceding aura .	T17	T25	9399012
NA	CHEMICAL	GENE-N	8	5	Consistent with its selectivity for gene receptors , chemical produces constriction of various isolated blood vessels , most notably cranial arteries .	T16	T26	9399012
CPR:4	CHEMICAL	GENE-N	5	30	These actions are consistent with a pre-junctional inhibition of neuropeptide release from perivascular afferents of the trigeminal nerve , as confirmed by independent studies showing that chemical blocks elevations of gene in jugular venous blood during electrical stimulation of the trigeminal ganglion .	T2	T23	9399012
NA	CHEMICAL	GENE-N	11	8	The animal 's liver was assessed using biomarkers as activities of chemical dismutase ( gene ) , gene ( gene ) , chemical S-transferase ( gene ) , and chemical peroxidase ( gene ) , and concentrations of chemical ( chemical ) and lipoperoxidation ( LPO ) and protein carbonylation ( PCO ) .	T11	T21	23402841
NA	CHEMICAL	GENE-N	11	14	The animal 's liver was assessed using biomarkers as activities of chemical dismutase ( gene ) , gene ( gene ) , chemical S-transferase ( gene ) , and chemical peroxidase ( gene ) , and concentrations of chemical ( chemical ) and lipoperoxidation ( LPO ) and protein carbonylation ( PCO ) .	T11	T22	23402841
NA	CHEMICAL	GENE-N	11	8	The animal 's liver was assessed using biomarkers as activities of chemical dismutase ( gene ) , gene ( gene ) , chemical S-transferase ( gene ) , and chemical peroxidase ( gene ) , and concentrations of chemical ( chemical ) and lipoperoxidation ( LPO ) and protein carbonylation ( PCO ) .	T11	T23	23402841
NA	CHEMICAL	GENE-N	11	19	The animal 's liver was assessed using biomarkers as activities of chemical dismutase ( gene ) , gene ( gene ) , chemical S-transferase ( gene ) , and chemical peroxidase ( gene ) , and concentrations of chemical ( chemical ) and lipoperoxidation ( LPO ) and protein carbonylation ( PCO ) .	T11	T24	23402841
NA	CHEMICAL	GENE-N	11	8	The animal 's liver was assessed using biomarkers as activities of chemical dismutase ( gene ) , gene ( gene ) , chemical S-transferase ( gene ) , and chemical peroxidase ( gene ) , and concentrations of chemical ( chemical ) and lipoperoxidation ( LPO ) and protein carbonylation ( PCO ) .	T11	T25	23402841
NA	CHEMICAL	GENE-N	11	25	The animal 's liver was assessed using biomarkers as activities of chemical dismutase ( gene ) , gene ( gene ) , chemical S-transferase ( gene ) , and chemical peroxidase ( gene ) , and concentrations of chemical ( chemical ) and lipoperoxidation ( LPO ) and protein carbonylation ( PCO ) .	T11	T26	23402841
NA	CHEMICAL	GENE-N	11	8	The animal 's liver was assessed using biomarkers as activities of chemical dismutase ( gene ) , gene ( gene ) , chemical S-transferase ( gene ) , and chemical peroxidase ( gene ) , and concentrations of chemical ( chemical ) and lipoperoxidation ( LPO ) and protein carbonylation ( PCO ) .	T11	T27	23402841
NA	CHEMICAL	GENE-N	11	32	The animal 's liver was assessed using biomarkers as activities of chemical dismutase ( gene ) , gene ( gene ) , chemical S-transferase ( gene ) , and chemical peroxidase ( gene ) , and concentrations of chemical ( chemical ) and lipoperoxidation ( LPO ) and protein carbonylation ( PCO ) .	T11	T28	23402841
NA	CHEMICAL	GENE-N	22	8	The animal 's liver was assessed using biomarkers as activities of chemical dismutase ( gene ) , gene ( gene ) , chemical S-transferase ( gene ) , and chemical peroxidase ( gene ) , and concentrations of chemical ( chemical ) and lipoperoxidation ( LPO ) and protein carbonylation ( PCO ) .	T12	T21	23402841
NA	CHEMICAL	GENE-N	22	14	The animal 's liver was assessed using biomarkers as activities of chemical dismutase ( gene ) , gene ( gene ) , chemical S-transferase ( gene ) , and chemical peroxidase ( gene ) , and concentrations of chemical ( chemical ) and lipoperoxidation ( LPO ) and protein carbonylation ( PCO ) .	T12	T22	23402841
NA	CHEMICAL	GENE-N	22	8	The animal 's liver was assessed using biomarkers as activities of chemical dismutase ( gene ) , gene ( gene ) , chemical S-transferase ( gene ) , and chemical peroxidase ( gene ) , and concentrations of chemical ( chemical ) and lipoperoxidation ( LPO ) and protein carbonylation ( PCO ) .	T12	T23	23402841
NA	CHEMICAL	GENE-N	22	19	The animal 's liver was assessed using biomarkers as activities of chemical dismutase ( gene ) , gene ( gene ) , chemical S-transferase ( gene ) , and chemical peroxidase ( gene ) , and concentrations of chemical ( chemical ) and lipoperoxidation ( LPO ) and protein carbonylation ( PCO ) .	T12	T24	23402841
NA	CHEMICAL	GENE-N	22	8	The animal 's liver was assessed using biomarkers as activities of chemical dismutase ( gene ) , gene ( gene ) , chemical S-transferase ( gene ) , and chemical peroxidase ( gene ) , and concentrations of chemical ( chemical ) and lipoperoxidation ( LPO ) and protein carbonylation ( PCO ) .	T12	T25	23402841
NA	CHEMICAL	GENE-N	22	25	The animal 's liver was assessed using biomarkers as activities of chemical dismutase ( gene ) , gene ( gene ) , chemical S-transferase ( gene ) , and chemical peroxidase ( gene ) , and concentrations of chemical ( chemical ) and lipoperoxidation ( LPO ) and protein carbonylation ( PCO ) .	T12	T26	23402841
NA	CHEMICAL	GENE-N	22	8	The animal 's liver was assessed using biomarkers as activities of chemical dismutase ( gene ) , gene ( gene ) , chemical S-transferase ( gene ) , and chemical peroxidase ( gene ) , and concentrations of chemical ( chemical ) and lipoperoxidation ( LPO ) and protein carbonylation ( PCO ) .	T12	T27	23402841
NA	CHEMICAL	GENE-N	22	32	The animal 's liver was assessed using biomarkers as activities of chemical dismutase ( gene ) , gene ( gene ) , chemical S-transferase ( gene ) , and chemical peroxidase ( gene ) , and concentrations of chemical ( chemical ) and lipoperoxidation ( LPO ) and protein carbonylation ( PCO ) .	T12	T28	23402841
NA	CHEMICAL	GENE-N	29	8	The animal 's liver was assessed using biomarkers as activities of chemical dismutase ( gene ) , gene ( gene ) , chemical S-transferase ( gene ) , and chemical peroxidase ( gene ) , and concentrations of chemical ( chemical ) and lipoperoxidation ( LPO ) and protein carbonylation ( PCO ) .	T13	T21	23402841
NA	CHEMICAL	GENE-N	29	14	The animal 's liver was assessed using biomarkers as activities of chemical dismutase ( gene ) , gene ( gene ) , chemical S-transferase ( gene ) , and chemical peroxidase ( gene ) , and concentrations of chemical ( chemical ) and lipoperoxidation ( LPO ) and protein carbonylation ( PCO ) .	T13	T22	23402841
NA	CHEMICAL	GENE-N	29	8	The animal 's liver was assessed using biomarkers as activities of chemical dismutase ( gene ) , gene ( gene ) , chemical S-transferase ( gene ) , and chemical peroxidase ( gene ) , and concentrations of chemical ( chemical ) and lipoperoxidation ( LPO ) and protein carbonylation ( PCO ) .	T13	T23	23402841
NA	CHEMICAL	GENE-N	29	19	The animal 's liver was assessed using biomarkers as activities of chemical dismutase ( gene ) , gene ( gene ) , chemical S-transferase ( gene ) , and chemical peroxidase ( gene ) , and concentrations of chemical ( chemical ) and lipoperoxidation ( LPO ) and protein carbonylation ( PCO ) .	T13	T24	23402841
NA	CHEMICAL	GENE-N	29	8	The animal 's liver was assessed using biomarkers as activities of chemical dismutase ( gene ) , gene ( gene ) , chemical S-transferase ( gene ) , and chemical peroxidase ( gene ) , and concentrations of chemical ( chemical ) and lipoperoxidation ( LPO ) and protein carbonylation ( PCO ) .	T13	T25	23402841
NA	CHEMICAL	GENE-N	29	25	The animal 's liver was assessed using biomarkers as activities of chemical dismutase ( gene ) , gene ( gene ) , chemical S-transferase ( gene ) , and chemical peroxidase ( gene ) , and concentrations of chemical ( chemical ) and lipoperoxidation ( LPO ) and protein carbonylation ( PCO ) .	T13	T26	23402841
NA	CHEMICAL	GENE-N	29	8	The animal 's liver was assessed using biomarkers as activities of chemical dismutase ( gene ) , gene ( gene ) , chemical S-transferase ( gene ) , and chemical peroxidase ( gene ) , and concentrations of chemical ( chemical ) and lipoperoxidation ( LPO ) and protein carbonylation ( PCO ) .	T13	T27	23402841
NA	CHEMICAL	GENE-N	29	32	The animal 's liver was assessed using biomarkers as activities of chemical dismutase ( gene ) , gene ( gene ) , chemical S-transferase ( gene ) , and chemical peroxidase ( gene ) , and concentrations of chemical ( chemical ) and lipoperoxidation ( LPO ) and protein carbonylation ( PCO ) .	T13	T28	23402841
NA	CHEMICAL	GENE-N	38	8	The animal 's liver was assessed using biomarkers as activities of chemical dismutase ( gene ) , gene ( gene ) , chemical S-transferase ( gene ) , and chemical peroxidase ( gene ) , and concentrations of chemical ( chemical ) and lipoperoxidation ( LPO ) and protein carbonylation ( PCO ) .	T14	T21	23402841
NA	CHEMICAL	GENE-N	38	14	The animal 's liver was assessed using biomarkers as activities of chemical dismutase ( gene ) , gene ( gene ) , chemical S-transferase ( gene ) , and chemical peroxidase ( gene ) , and concentrations of chemical ( chemical ) and lipoperoxidation ( LPO ) and protein carbonylation ( PCO ) .	T14	T22	23402841
NA	CHEMICAL	GENE-N	38	8	The animal 's liver was assessed using biomarkers as activities of chemical dismutase ( gene ) , gene ( gene ) , chemical S-transferase ( gene ) , and chemical peroxidase ( gene ) , and concentrations of chemical ( chemical ) and lipoperoxidation ( LPO ) and protein carbonylation ( PCO ) .	T14	T23	23402841
NA	CHEMICAL	GENE-N	38	19	The animal 's liver was assessed using biomarkers as activities of chemical dismutase ( gene ) , gene ( gene ) , chemical S-transferase ( gene ) , and chemical peroxidase ( gene ) , and concentrations of chemical ( chemical ) and lipoperoxidation ( LPO ) and protein carbonylation ( PCO ) .	T14	T24	23402841
NA	CHEMICAL	GENE-N	38	8	The animal 's liver was assessed using biomarkers as activities of chemical dismutase ( gene ) , gene ( gene ) , chemical S-transferase ( gene ) , and chemical peroxidase ( gene ) , and concentrations of chemical ( chemical ) and lipoperoxidation ( LPO ) and protein carbonylation ( PCO ) .	T14	T25	23402841
NA	CHEMICAL	GENE-N	38	25	The animal 's liver was assessed using biomarkers as activities of chemical dismutase ( gene ) , gene ( gene ) , chemical S-transferase ( gene ) , and chemical peroxidase ( gene ) , and concentrations of chemical ( chemical ) and lipoperoxidation ( LPO ) and protein carbonylation ( PCO ) .	T14	T26	23402841
NA	CHEMICAL	GENE-N	38	8	The animal 's liver was assessed using biomarkers as activities of chemical dismutase ( gene ) , gene ( gene ) , chemical S-transferase ( gene ) , and chemical peroxidase ( gene ) , and concentrations of chemical ( chemical ) and lipoperoxidation ( LPO ) and protein carbonylation ( PCO ) .	T14	T27	23402841
NA	CHEMICAL	GENE-N	38	32	The animal 's liver was assessed using biomarkers as activities of chemical dismutase ( gene ) , gene ( gene ) , chemical S-transferase ( gene ) , and chemical peroxidase ( gene ) , and concentrations of chemical ( chemical ) and lipoperoxidation ( LPO ) and protein carbonylation ( PCO ) .	T14	T28	23402841
NA	CHEMICAL	GENE-N	40	8	The animal 's liver was assessed using biomarkers as activities of chemical dismutase ( gene ) , gene ( gene ) , chemical S-transferase ( gene ) , and chemical peroxidase ( gene ) , and concentrations of chemical ( chemical ) and lipoperoxidation ( LPO ) and protein carbonylation ( PCO ) .	T15	T21	23402841
NA	CHEMICAL	GENE-N	40	14	The animal 's liver was assessed using biomarkers as activities of chemical dismutase ( gene ) , gene ( gene ) , chemical S-transferase ( gene ) , and chemical peroxidase ( gene ) , and concentrations of chemical ( chemical ) and lipoperoxidation ( LPO ) and protein carbonylation ( PCO ) .	T15	T22	23402841
NA	CHEMICAL	GENE-N	40	8	The animal 's liver was assessed using biomarkers as activities of chemical dismutase ( gene ) , gene ( gene ) , chemical S-transferase ( gene ) , and chemical peroxidase ( gene ) , and concentrations of chemical ( chemical ) and lipoperoxidation ( LPO ) and protein carbonylation ( PCO ) .	T15	T23	23402841
NA	CHEMICAL	GENE-N	40	19	The animal 's liver was assessed using biomarkers as activities of chemical dismutase ( gene ) , gene ( gene ) , chemical S-transferase ( gene ) , and chemical peroxidase ( gene ) , and concentrations of chemical ( chemical ) and lipoperoxidation ( LPO ) and protein carbonylation ( PCO ) .	T15	T24	23402841
NA	CHEMICAL	GENE-N	40	8	The animal 's liver was assessed using biomarkers as activities of chemical dismutase ( gene ) , gene ( gene ) , chemical S-transferase ( gene ) , and chemical peroxidase ( gene ) , and concentrations of chemical ( chemical ) and lipoperoxidation ( LPO ) and protein carbonylation ( PCO ) .	T15	T25	23402841
NA	CHEMICAL	GENE-N	40	25	The animal 's liver was assessed using biomarkers as activities of chemical dismutase ( gene ) , gene ( gene ) , chemical S-transferase ( gene ) , and chemical peroxidase ( gene ) , and concentrations of chemical ( chemical ) and lipoperoxidation ( LPO ) and protein carbonylation ( PCO ) .	T15	T26	23402841
NA	CHEMICAL	GENE-N	40	8	The animal 's liver was assessed using biomarkers as activities of chemical dismutase ( gene ) , gene ( gene ) , chemical S-transferase ( gene ) , and chemical peroxidase ( gene ) , and concentrations of chemical ( chemical ) and lipoperoxidation ( LPO ) and protein carbonylation ( PCO ) .	T15	T27	23402841
NA	CHEMICAL	GENE-N	40	32	The animal 's liver was assessed using biomarkers as activities of chemical dismutase ( gene ) , gene ( gene ) , chemical S-transferase ( gene ) , and chemical peroxidase ( gene ) , and concentrations of chemical ( chemical ) and lipoperoxidation ( LPO ) and protein carbonylation ( PCO ) .	T15	T28	23402841
CPR:3	CHEMICAL	GENE-N	10	5	The values of mean corpuscular gene concentration and mean corpuscular gene increased in the chemical group .	T1	T29	23402841
CPR:3	CHEMICAL	GENE-N	10	10	The values of mean corpuscular gene concentration and mean corpuscular gene increased in the chemical group .	T1	T17	23402841
NA	CHEMICAL	GENE-N	7	14	The results suggested the generation of reactive chemical species , with increased activity of gene and concentrations of LPO and chemical ; whereas the specific activity of gene decreased .	T2	T18	23402841
NA	CHEMICAL	GENE-N	7	27	The results suggested the generation of reactive chemical species , with increased activity of gene and concentrations of LPO and chemical ; whereas the specific activity of gene decreased .	T2	T19	23402841
NA	CHEMICAL	GENE-N	20	14	The results suggested the generation of reactive chemical species , with increased activity of gene and concentrations of LPO and chemical ; whereas the specific activity of gene decreased .	T3	T18	23402841
NA	CHEMICAL	GENE-N	20	27	The results suggested the generation of reactive chemical species , with increased activity of gene and concentrations of LPO and chemical ; whereas the specific activity of gene decreased .	T3	T19	23402841
NA	CHEMICAL	GENE-Y	19	13	The aim of the present study was to evaluate the efficacy of some gene reactivators against OPC intoxication ( chemical , chemical and chemical ) in in vitro experiments and to compare their activity to that known for some currently used chemical ( chemical , chemical , chemical ) .	T21	T38	23220589
NA	CHEMICAL	GENE-Y	21	13	The aim of the present study was to evaluate the efficacy of some gene reactivators against OPC intoxication ( chemical , chemical and chemical ) in in vitro experiments and to compare their activity to that known for some currently used chemical ( chemical , chemical , chemical ) .	T22	T38	23220589
NA	CHEMICAL	GENE-Y	23	13	The aim of the present study was to evaluate the efficacy of some gene reactivators against OPC intoxication ( chemical , chemical and chemical ) in in vitro experiments and to compare their activity to that known for some currently used chemical ( chemical , chemical , chemical ) .	T23	T38	23220589
NA	CHEMICAL	GENE-Y	41	13	The aim of the present study was to evaluate the efficacy of some gene reactivators against OPC intoxication ( chemical , chemical and chemical ) in in vitro experiments and to compare their activity to that known for some currently used chemical ( chemical , chemical , chemical ) .	T24	T38	23220589
NA	CHEMICAL	GENE-Y	43	13	The aim of the present study was to evaluate the efficacy of some gene reactivators against OPC intoxication ( chemical , chemical and chemical ) in in vitro experiments and to compare their activity to that known for some currently used chemical ( chemical , chemical , chemical ) .	T25	T38	23220589
NA	CHEMICAL	GENE-Y	45	13	The aim of the present study was to evaluate the efficacy of some gene reactivators against OPC intoxication ( chemical , chemical and chemical ) in in vitro experiments and to compare their activity to that known for some currently used chemical ( chemical , chemical , chemical ) .	T26	T38	23220589
NA	CHEMICAL	GENE-Y	47	13	The aim of the present study was to evaluate the efficacy of some gene reactivators against OPC intoxication ( chemical , chemical and chemical ) in in vitro experiments and to compare their activity to that known for some currently used chemical ( chemical , chemical , chemical ) .	T27	T38	23220589
CPR:4	CHEMICAL	GENE-Y	8	8	Reactivators showed different activity in the reactivation of gene after chemical , chemical and chemical inhibition .	T2	T28	23220589
CPR:4	CHEMICAL	GENE-Y	12	8	Reactivators showed different activity in the reactivation of gene after chemical , chemical and chemical inhibition .	T3	T28	23220589
CPR:4	CHEMICAL	GENE-Y	14	8	Reactivators showed different activity in the reactivation of gene after chemical , chemical and chemical inhibition .	T4	T28	23220589
CPR:3	CHEMICAL	GENE-Y	5	0	gene was easier reactivated after chemical treatment .	T5	T29	23220589
CPR:3	CHEMICAL	GENE-Y	14	4	The reactivation of brain gene inhibited with tabun demonstrated better activity of new compound chemical , chemical and chemical from symmetric chemical , and chemical and chemical possessing asymmetric structure .	T14	T30	23220589
CPR:3	CHEMICAL	GENE-Y	16	4	The reactivation of brain gene inhibited with tabun demonstrated better activity of new compound chemical , chemical and chemical from symmetric chemical , and chemical and chemical possessing asymmetric structure .	T15	T30	23220589
CPR:3	CHEMICAL	GENE-Y	18	4	The reactivation of brain gene inhibited with tabun demonstrated better activity of new compound chemical , chemical and chemical from symmetric chemical , and chemical and chemical possessing asymmetric structure .	T16	T30	23220589
CPR:3	CHEMICAL	GENE-Y	21	4	The reactivation of brain gene inhibited with tabun demonstrated better activity of new compound chemical , chemical and chemical from symmetric chemical , and chemical and chemical possessing asymmetric structure .	T17	T30	23220589
CPR:3	CHEMICAL	GENE-Y	24	4	The reactivation of brain gene inhibited with tabun demonstrated better activity of new compound chemical , chemical and chemical from symmetric chemical , and chemical and chemical possessing asymmetric structure .	T18	T30	23220589
CPR:3	CHEMICAL	GENE-Y	26	4	The reactivation of brain gene inhibited with tabun demonstrated better activity of new compound chemical , chemical and chemical from symmetric chemical , and chemical and chemical possessing asymmetric structure .	T19	T30	23220589
CPR:4	CHEMICAL	GENE-Y	11	8	All compounds showed low activity toward inhibition of gene caused by chemical .	T20	T31	23220589
NA	CHEMICAL	GENE-Y	2	12	Effect of chemical , an chemical antibiotic , on the function of gene in human stomach tumor cells .	T7	T14	10480573
NA	CHEMICAL	GENE-Y	4	12	Effect of chemical , an chemical antibiotic , on the function of gene in human stomach tumor cells .	T8	T14	10480573
NA	CHEMICAL	GENE-Y	0	2	chemical and anti-gene ( anti-gene ) were antagonistic to each other in inhibiting the cell cycle progression of SC-6 from G0/G1 to S , suggesting that the two compounds share the same target , gene .	T6	T10	10480573
NA	CHEMICAL	GENE-Y	0	4	chemical and anti-gene ( anti-gene ) were antagonistic to each other in inhibiting the cell cycle progression of SC-6 from G0/G1 to S , suggesting that the two compounds share the same target , gene .	T6	T11	10480573
NA	CHEMICAL	GENE-Y	0	34	chemical and anti-gene ( anti-gene ) were antagonistic to each other in inhibiting the cell cycle progression of SC-6 from G0/G1 to S , suggesting that the two compounds share the same target , gene .	T6	T12	10480573
NA	CHEMICAL	GENE-Y	6	11	Inbred mouse strains display significant differences in their levels of brain gene ( gene ) expression , as measured by binding of the alpha7-selective antagonist alpha-bungarotoxin .	T3	T15	17360707
NA	CHEMICAL	GENE-Y	6	13	Inbred mouse strains display significant differences in their levels of brain gene ( gene ) expression , as measured by binding of the alpha7-selective antagonist alpha-bungarotoxin .	T3	T5	17360707
NA	CHEMICAL	GENE-Y	1	1	Variations in gene binding have been shown to correlate with an animal 's sensitivity to chemical-induced seizures and sensory gating .	T2	T8	17360707
NA	CHEMICAL	GENE-Y	11	12	Normoxia was required for full expression of the proximal tubule-specific transcripts chemical 1-hydroxylase ( gene ) and chemical kinase ( gene ) , transcripts involved in tissue cohesion such as gene ( gene ) and gene ( gene ) , and gene transcripts .	T4	T8	16597615
NA	CHEMICAL	GENE-Y	11	14	Normoxia was required for full expression of the proximal tubule-specific transcripts chemical 1-hydroxylase ( gene ) and chemical kinase ( gene ) , transcripts involved in tissue cohesion such as gene ( gene ) and gene ( gene ) , and gene transcripts .	T4	T9	16597615
NA	CHEMICAL	GENE-Y	11	18	Normoxia was required for full expression of the proximal tubule-specific transcripts chemical 1-hydroxylase ( gene ) and chemical kinase ( gene ) , transcripts involved in tissue cohesion such as gene ( gene ) and gene ( gene ) , and gene transcripts .	T4	T10	16597615
NA	CHEMICAL	GENE-Y	11	20	Normoxia was required for full expression of the proximal tubule-specific transcripts chemical 1-hydroxylase ( gene ) and chemical kinase ( gene ) , transcripts involved in tissue cohesion such as gene ( gene ) and gene ( gene ) , and gene transcripts .	T4	T11	16597615
NA	CHEMICAL	GENE-Y	11	25	Normoxia was required for full expression of the proximal tubule-specific transcripts chemical 1-hydroxylase ( gene ) and chemical kinase ( gene ) , transcripts involved in tissue cohesion such as gene ( gene ) and gene ( gene ) , and gene transcripts .	T4	T12	16597615
NA	CHEMICAL	GENE-Y	11	32	Normoxia was required for full expression of the proximal tubule-specific transcripts chemical 1-hydroxylase ( gene ) and chemical kinase ( gene ) , transcripts involved in tissue cohesion such as gene ( gene ) and gene ( gene ) , and gene transcripts .	T4	T13	16597615
NA	CHEMICAL	GENE-Y	11	25	Normoxia was required for full expression of the proximal tubule-specific transcripts chemical 1-hydroxylase ( gene ) and chemical kinase ( gene ) , transcripts involved in tissue cohesion such as gene ( gene ) and gene ( gene ) , and gene transcripts .	T4	T14	16597615
NA	CHEMICAL	GENE-Y	11	37	Normoxia was required for full expression of the proximal tubule-specific transcripts chemical 1-hydroxylase ( gene ) and chemical kinase ( gene ) , transcripts involved in tissue cohesion such as gene ( gene ) and gene ( gene ) , and gene transcripts .	T4	T15	16597615
NA	CHEMICAL	GENE-N	11	25	Normoxia was required for full expression of the proximal tubule-specific transcripts chemical 1-hydroxylase ( gene ) and chemical kinase ( gene ) , transcripts involved in tissue cohesion such as gene ( gene ) and gene ( gene ) , and gene transcripts .	T4	T16	16597615
NA	CHEMICAL	GENE-Y	17	12	Normoxia was required for full expression of the proximal tubule-specific transcripts chemical 1-hydroxylase ( gene ) and chemical kinase ( gene ) , transcripts involved in tissue cohesion such as gene ( gene ) and gene ( gene ) , and gene transcripts .	T5	T8	16597615
NA	CHEMICAL	GENE-Y	17	14	Normoxia was required for full expression of the proximal tubule-specific transcripts chemical 1-hydroxylase ( gene ) and chemical kinase ( gene ) , transcripts involved in tissue cohesion such as gene ( gene ) and gene ( gene ) , and gene transcripts .	T5	T9	16597615
NA	CHEMICAL	GENE-Y	17	18	Normoxia was required for full expression of the proximal tubule-specific transcripts chemical 1-hydroxylase ( gene ) and chemical kinase ( gene ) , transcripts involved in tissue cohesion such as gene ( gene ) and gene ( gene ) , and gene transcripts .	T5	T10	16597615
NA	CHEMICAL	GENE-Y	17	20	Normoxia was required for full expression of the proximal tubule-specific transcripts chemical 1-hydroxylase ( gene ) and chemical kinase ( gene ) , transcripts involved in tissue cohesion such as gene ( gene ) and gene ( gene ) , and gene transcripts .	T5	T11	16597615
NA	CHEMICAL	GENE-Y	17	25	Normoxia was required for full expression of the proximal tubule-specific transcripts chemical 1-hydroxylase ( gene ) and chemical kinase ( gene ) , transcripts involved in tissue cohesion such as gene ( gene ) and gene ( gene ) , and gene transcripts .	T5	T12	16597615
NA	CHEMICAL	GENE-Y	17	32	Normoxia was required for full expression of the proximal tubule-specific transcripts chemical 1-hydroxylase ( gene ) and chemical kinase ( gene ) , transcripts involved in tissue cohesion such as gene ( gene ) and gene ( gene ) , and gene transcripts .	T5	T13	16597615
NA	CHEMICAL	GENE-Y	17	25	Normoxia was required for full expression of the proximal tubule-specific transcripts chemical 1-hydroxylase ( gene ) and chemical kinase ( gene ) , transcripts involved in tissue cohesion such as gene ( gene ) and gene ( gene ) , and gene transcripts .	T5	T14	16597615
NA	CHEMICAL	GENE-Y	17	37	Normoxia was required for full expression of the proximal tubule-specific transcripts chemical 1-hydroxylase ( gene ) and chemical kinase ( gene ) , transcripts involved in tissue cohesion such as gene ( gene ) and gene ( gene ) , and gene transcripts .	T5	T15	16597615
NA	CHEMICAL	GENE-N	17	25	Normoxia was required for full expression of the proximal tubule-specific transcripts chemical 1-hydroxylase ( gene ) and chemical kinase ( gene ) , transcripts involved in tissue cohesion such as gene ( gene ) and gene ( gene ) , and gene transcripts .	T5	T16	16597615
NA	CHEMICAL	GENE-N	21	7	Conversely , severe hypoxia increased transcripts involved in extracellular matrix remodeling , those of gene , and others involved in creatine chemical synthesis and lactate transport ( gene ) .	T1	T6	16597615
NA	CHEMICAL	GENE-Y	21	27	Conversely , severe hypoxia increased transcripts involved in extracellular matrix remodeling , those of gene , and others involved in creatine chemical synthesis and lactate transport ( gene ) .	T1	T7	16597615
NA	CHEMICAL	GENE-Y	0	4	chemical 48-linked polyubiquitination of gene is essential for its gene-regulated endocytosis .	T4	T24	23087261
NA	CHEMICAL	GENE-N	0	9	chemical 48-linked polyubiquitination of gene is essential for its gene-regulated endocytosis .	T4	T25	23087261
NA	CHEMICAL	GENE-Y	15	7	Mass spectroscopy has revealed that ubiquitination of gene consists of polyubiquitin chains , primarily through chemical 48 linkage .	T1	T7	23087261
NA	CHEMICAL	GENE-N	17	22	Transfection of cells with the dominant negative mutant of ubiquitin Ub-K48R , which prevents the formation of chemical48-linked polyubiquitin chains , abolishes gene-stimulated gene ubiquitination and internalization .	T2	T8	23087261
NA	CHEMICAL	GENE-Y	17	23	Transfection of cells with the dominant negative mutant of ubiquitin Ub-K48R , which prevents the formation of chemical48-linked polyubiquitin chains , abolishes gene-stimulated gene ubiquitination and internalization .	T2	T9	23087261
NA	CHEMICAL	GENE-Y	11	20	This study investigated the effect of a structured self-monitoring of blood chemical ( SMBG ) protocol and the resulting improvements in glycemic control on changes in high-sensitivity gene ( gene ) in gene-naïve patients with type 2 diabetes.RESEARCH DESIGN AND METHODSThe Structured Testing Program ( STeP ) study was a prospective , cluster-randomized , multicenter trial in which 483 poorly controlled , gene-naïve patients with type 2 diabetes were randomized to active control ( ACG ) or structured testing ( STG ) that included quarterly structured SMBG .	T1	T9	23435160
NA	CHEMICAL	GENE-Y	11	29	This study investigated the effect of a structured self-monitoring of blood chemical ( SMBG ) protocol and the resulting improvements in glycemic control on changes in high-sensitivity gene ( gene ) in gene-naïve patients with type 2 diabetes.RESEARCH DESIGN AND METHODSThe Structured Testing Program ( STeP ) study was a prospective , cluster-randomized , multicenter trial in which 483 poorly controlled , gene-naïve patients with type 2 diabetes were randomized to active control ( ACG ) or structured testing ( STG ) that included quarterly structured SMBG .	T1	T10	23435160
NA	CHEMICAL	GENE-Y	11	20	This study investigated the effect of a structured self-monitoring of blood chemical ( SMBG ) protocol and the resulting improvements in glycemic control on changes in high-sensitivity gene ( gene ) in gene-naïve patients with type 2 diabetes.RESEARCH DESIGN AND METHODSThe Structured Testing Program ( STeP ) study was a prospective , cluster-randomized , multicenter trial in which 483 poorly controlled , gene-naïve patients with type 2 diabetes were randomized to active control ( ACG ) or structured testing ( STG ) that included quarterly structured SMBG .	T1	T11	23435160
NA	CHEMICAL	GENE-Y	11	20	This study investigated the effect of a structured self-monitoring of blood chemical ( SMBG ) protocol and the resulting improvements in glycemic control on changes in high-sensitivity gene ( gene ) in gene-naïve patients with type 2 diabetes.RESEARCH DESIGN AND METHODSThe Structured Testing Program ( STeP ) study was a prospective , cluster-randomized , multicenter trial in which 483 poorly controlled , gene-naïve patients with type 2 diabetes were randomized to active control ( ACG ) or structured testing ( STG ) that included quarterly structured SMBG .	T1	T12	23435160
NA	CHEMICAL	GENE-Y	8	0	gene ( gene ) is a highly conserved chemical metallopeptidase that is ubiquitously distributed in human tissues , and particularly abundant in the brain , liver , and muscles .	T1	T2	23188819
NA	CHEMICAL	GENE-Y	8	2	gene ( gene ) is a highly conserved chemical metallopeptidase that is ubiquitously distributed in human tissues , and particularly abundant in the brain , liver , and muscles .	T1	T9	23188819
NA	CHEMICAL	GENE-N	8	5	gene ( gene ) is a highly conserved chemical metallopeptidase that is ubiquitously distributed in human tissues , and particularly abundant in the brain , liver , and muscles .	T1	T12	23188819
NA	CHEMICAL	GENE-N	2	4	Association of chemical-binding cassette transporter variants with the risk of Alzheimer 's disease .	T1	T23	23556446
CPR:5	CHEMICAL	GENE-Y	6	3	Systemic administration of gene agonists , chemical and chemical , elicit skeletal muscle hypertrophy in rats at micromolar doses .	T18	T24	16432501
CPR:5	CHEMICAL	GENE-Y	8	3	Systemic administration of gene agonists , chemical and chemical , elicit skeletal muscle hypertrophy in rats at micromolar doses .	T19	T24	16432501
CPR:5	CHEMICAL	GENE-Y	7	1	Two beta ( 2 ) -agonists , chemical and chemical , are approved for treating asthma and have an extended duration of action and increased safety , associated with greater gene selectivity .	T10	T23	16432501
CPR:5	CHEMICAL	GENE-Y	9	1	Two beta ( 2 ) -agonists , chemical and chemical , are approved for treating asthma and have an extended duration of action and increased safety , associated with greater gene selectivity .	T11	T23	16432501
CPR:4	CHEMICAL	GENE-N	14	28	A dose of 25 microg kg ( -1 ) day ( -1 ) of chemical elicited greater EDL and soleus hypertrophy than chemical , but resulted in similar gene downregulation .	T5	T21	16432501
CPR:4	CHEMICAL	GENE-N	22	28	A dose of 25 microg kg ( -1 ) day ( -1 ) of chemical elicited greater EDL and soleus hypertrophy than chemical , but resulted in similar gene downregulation .	T6	T21	16432501
NA	CHEMICAL	GENE-Y	7	8	Thermodynamic determination of the binding constants of chemical-converting enzyme inhibitors by a displacement method .	T5	T10	17618628
NA	CHEMICAL	GENE-Y	1	2	Somatic chemical-converting enzyme ( s-gene ) plays a central role in blood pressure regulation and has been the target of most antihypertensive drugs .	T4	T9	17618628
NA	CHEMICAL	GENE-Y	1	4	Somatic chemical-converting enzyme ( s-gene ) plays a central role in blood pressure regulation and has been the target of most antihypertensive drugs .	T4	T7	17618628
NA	CHEMICAL	GENE-N	9	13	Therefore , we investigated the hippocampal gene expression of chemical receptors α and β ( gene ) in 8-week-old , 12-week-old and 24-week-old male rats .	T5	T17	23238103
NA	CHEMICAL	GENE-N	9	13	Therefore , we investigated the hippocampal gene expression of chemical receptors α and β ( gene ) in 8-week-old , 12-week-old and 24-week-old male rats .	T5	T18	23238103
NA	CHEMICAL	GENE-Y	10	11	To control for possible interactions between the expression of the chemical receptor genes and other learning-related chemical receptors , chemical receptors ( gene ) , chemical-binding gene ( gene ) and gene ( gene ) were also measured .	T6	T19	23238103
NA	CHEMICAL	GENE-N	10	11	To control for possible interactions between the expression of the chemical receptor genes and other learning-related chemical receptors , chemical receptors ( gene ) , chemical-binding gene ( gene ) and gene ( gene ) were also measured .	T6	T20	23238103
NA	CHEMICAL	GENE-Y	10	11	To control for possible interactions between the expression of the chemical receptor genes and other learning-related chemical receptors , chemical receptors ( gene ) , chemical-binding gene ( gene ) and gene ( gene ) were also measured .	T6	T21	23238103
NA	CHEMICAL	GENE-Y	10	22	To control for possible interactions between the expression of the chemical receptor genes and other learning-related chemical receptors , chemical receptors ( gene ) , chemical-binding gene ( gene ) and gene ( gene ) were also measured .	T6	T22	23238103
NA	CHEMICAL	GENE-Y	10	11	To control for possible interactions between the expression of the chemical receptor genes and other learning-related chemical receptors , chemical receptors ( gene ) , chemical-binding gene ( gene ) and gene ( gene ) were also measured .	T6	T23	23238103
NA	CHEMICAL	GENE-Y	10	28	To control for possible interactions between the expression of the chemical receptor genes and other learning-related chemical receptors , chemical receptors ( gene ) , chemical-binding gene ( gene ) and gene ( gene ) were also measured .	T6	T24	23238103
NA	CHEMICAL	GENE-Y	10	11	To control for possible interactions between the expression of the chemical receptor genes and other learning-related chemical receptors , chemical receptors ( gene ) , chemical-binding gene ( gene ) and gene ( gene ) were also measured .	T6	T25	23238103
NA	CHEMICAL	GENE-Y	10	33	To control for possible interactions between the expression of the chemical receptor genes and other learning-related chemical receptors , chemical receptors ( gene ) , chemical-binding gene ( gene ) and gene ( gene ) were also measured .	T6	T26	23238103
NA	CHEMICAL	GENE-Y	16	11	To control for possible interactions between the expression of the chemical receptor genes and other learning-related chemical receptors , chemical receptors ( gene ) , chemical-binding gene ( gene ) and gene ( gene ) were also measured .	T7	T19	23238103
NA	CHEMICAL	GENE-N	16	11	To control for possible interactions between the expression of the chemical receptor genes and other learning-related chemical receptors , chemical receptors ( gene ) , chemical-binding gene ( gene ) and gene ( gene ) were also measured .	T7	T20	23238103
NA	CHEMICAL	GENE-Y	16	11	To control for possible interactions between the expression of the chemical receptor genes and other learning-related chemical receptors , chemical receptors ( gene ) , chemical-binding gene ( gene ) and gene ( gene ) were also measured .	T7	T21	23238103
NA	CHEMICAL	GENE-Y	16	22	To control for possible interactions between the expression of the chemical receptor genes and other learning-related chemical receptors , chemical receptors ( gene ) , chemical-binding gene ( gene ) and gene ( gene ) were also measured .	T7	T22	23238103
NA	CHEMICAL	GENE-Y	16	11	To control for possible interactions between the expression of the chemical receptor genes and other learning-related chemical receptors , chemical receptors ( gene ) , chemical-binding gene ( gene ) and gene ( gene ) were also measured .	T7	T23	23238103
NA	CHEMICAL	GENE-Y	16	28	To control for possible interactions between the expression of the chemical receptor genes and other learning-related chemical receptors , chemical receptors ( gene ) , chemical-binding gene ( gene ) and gene ( gene ) were also measured .	T7	T24	23238103
NA	CHEMICAL	GENE-Y	16	11	To control for possible interactions between the expression of the chemical receptor genes and other learning-related chemical receptors , chemical receptors ( gene ) , chemical-binding gene ( gene ) and gene ( gene ) were also measured .	T7	T25	23238103
NA	CHEMICAL	GENE-Y	16	33	To control for possible interactions between the expression of the chemical receptor genes and other learning-related chemical receptors , chemical receptors ( gene ) , chemical-binding gene ( gene ) and gene ( gene ) were also measured .	T7	T26	23238103
NA	CHEMICAL	GENE-Y	13	11	To control for possible interactions between the expression of the chemical receptor genes and other learning-related chemical receptors , chemical receptors ( gene ) , chemical-binding gene ( gene ) and gene ( gene ) were also measured .	T8	T19	23238103
NA	CHEMICAL	GENE-N	13	11	To control for possible interactions between the expression of the chemical receptor genes and other learning-related chemical receptors , chemical receptors ( gene ) , chemical-binding gene ( gene ) and gene ( gene ) were also measured .	T8	T20	23238103
NA	CHEMICAL	GENE-Y	13	11	To control for possible interactions between the expression of the chemical receptor genes and other learning-related chemical receptors , chemical receptors ( gene ) , chemical-binding gene ( gene ) and gene ( gene ) were also measured .	T8	T21	23238103
NA	CHEMICAL	GENE-Y	13	22	To control for possible interactions between the expression of the chemical receptor genes and other learning-related chemical receptors , chemical receptors ( gene ) , chemical-binding gene ( gene ) and gene ( gene ) were also measured .	T8	T22	23238103
NA	CHEMICAL	GENE-Y	13	11	To control for possible interactions between the expression of the chemical receptor genes and other learning-related chemical receptors , chemical receptors ( gene ) , chemical-binding gene ( gene ) and gene ( gene ) were also measured .	T8	T23	23238103
NA	CHEMICAL	GENE-Y	13	28	To control for possible interactions between the expression of the chemical receptor genes and other learning-related chemical receptors , chemical receptors ( gene ) , chemical-binding gene ( gene ) and gene ( gene ) were also measured .	T8	T24	23238103
NA	CHEMICAL	GENE-Y	13	11	To control for possible interactions between the expression of the chemical receptor genes and other learning-related chemical receptors , chemical receptors ( gene ) , chemical-binding gene ( gene ) and gene ( gene ) were also measured .	T8	T25	23238103
NA	CHEMICAL	GENE-Y	13	33	To control for possible interactions between the expression of the chemical receptor genes and other learning-related chemical receptors , chemical receptors ( gene ) , chemical-binding gene ( gene ) and gene ( gene ) were also measured .	T8	T26	23238103
NA	CHEMICAL	GENE-Y	25	11	To control for possible interactions between the expression of the chemical receptor genes and other learning-related chemical receptors , chemical receptors ( gene ) , chemical-binding gene ( gene ) and gene ( gene ) were also measured .	T9	T19	23238103
NA	CHEMICAL	GENE-N	25	11	To control for possible interactions between the expression of the chemical receptor genes and other learning-related chemical receptors , chemical receptors ( gene ) , chemical-binding gene ( gene ) and gene ( gene ) were also measured .	T9	T20	23238103
NA	CHEMICAL	GENE-Y	25	11	To control for possible interactions between the expression of the chemical receptor genes and other learning-related chemical receptors , chemical receptors ( gene ) , chemical-binding gene ( gene ) and gene ( gene ) were also measured .	T9	T21	23238103
NA	CHEMICAL	GENE-Y	25	22	To control for possible interactions between the expression of the chemical receptor genes and other learning-related chemical receptors , chemical receptors ( gene ) , chemical-binding gene ( gene ) and gene ( gene ) were also measured .	T9	T22	23238103
NA	CHEMICAL	GENE-Y	25	11	To control for possible interactions between the expression of the chemical receptor genes and other learning-related chemical receptors , chemical receptors ( gene ) , chemical-binding gene ( gene ) and gene ( gene ) were also measured .	T9	T23	23238103
NA	CHEMICAL	GENE-Y	25	28	To control for possible interactions between the expression of the chemical receptor genes and other learning-related chemical receptors , chemical receptors ( gene ) , chemical-binding gene ( gene ) and gene ( gene ) were also measured .	T9	T24	23238103
NA	CHEMICAL	GENE-Y	25	11	To control for possible interactions between the expression of the chemical receptor genes and other learning-related chemical receptors , chemical receptors ( gene ) , chemical-binding gene ( gene ) and gene ( gene ) were also measured .	T9	T25	23238103
NA	CHEMICAL	GENE-Y	25	33	To control for possible interactions between the expression of the chemical receptor genes and other learning-related chemical receptors , chemical receptors ( gene ) , chemical-binding gene ( gene ) and gene ( gene ) were also measured .	T9	T26	23238103
CPR:4	CHEMICAL	GENE-N	0	7	chemical : Synthetic Methodologies and Pharmaceutical Applications as chemical and chemical Protease Inhibitors .	T5	T9	22931530
NA	CHEMICAL	GENE-N	8	7	chemical : Synthetic Methodologies and Pharmaceutical Applications as chemical and chemical Protease Inhibitors .	T7	T9	22931530
NA	CHEMICAL	GENE-N	10	7	chemical : Synthetic Methodologies and Pharmaceutical Applications as chemical and chemical Protease Inhibitors .	T6	T9	22931530
NA	CHEMICAL	GENE-N	2	7	Evidence for a new binding mode to gene : allosteric regulation by the marine compound chemical .	T7	T14	23354070
CPR:4	CHEMICAL	GENE-Y	12	16	We describe here the isolation and biochemical characterization of the marine natural chemical chemical as a gene inhibitor .	T2	T10	23354070
CPR:4	CHEMICAL	GENE-Y	13	16	We describe here the isolation and biochemical characterization of the marine natural chemical chemical as a gene inhibitor .	T3	T10	23354070
CPR:4	CHEMICAL	GENE-Y	13	10	Experimental studies performed for characterizing the inhibitory mechanism indicate that gene inhibition by chemical can not be competed out by chemical nor peptide substrate .	T4	T11	23354070
NA	CHEMICAL	GENE-Y	20	10	Experimental studies performed for characterizing the inhibitory mechanism indicate that gene inhibition by chemical can not be competed out by chemical nor peptide substrate .	T5	T11	23354070
CPR:4	CHEMICAL	GENE-Y	14	17	Moreover , molecular dynamics simulations have identified an allosteric mechanism by which binding of chemical leads to gene inhibition .	T6	T13	23354070
NA	CHEMICAL	GENE-Y	12	3	Characterization of an gene mediating the contractile response of rat aorta to chemical .	T21	T32	7582530
NA	CHEMICAL	GENE-N	3	3	The affinities of a number of gene antagonists were determined by displacement of chemical binding from cloned gene ( previously designated cloned alpha 1c subtype ) , alpha 1B alpha 1D and gene , stably expressed in rat-1 fibroblasts .	T1	T26	7582530
NA	CHEMICAL	GENE-Y	3	3	The affinities of a number of gene antagonists were determined by displacement of chemical binding from cloned gene ( previously designated cloned alpha 1c subtype ) , alpha 1B alpha 1D and gene , stably expressed in rat-1 fibroblasts .	T1	T22	7582530
NA	CHEMICAL	GENE-Y	3	3	The affinities of a number of gene antagonists were determined by displacement of chemical binding from cloned gene ( previously designated cloned alpha 1c subtype ) , alpha 1B alpha 1D and gene , stably expressed in rat-1 fibroblasts .	T1	T25	7582530
NA	CHEMICAL	GENE-Y	0	6	chemical displayed high affinity for cloned gene ( pKi = 8.2 +/- 0.10 ) and was selective over alpha 1A ( pKi = 6.2 +/- 0.10 ) and alpha 1B subtypes ( 6.7 +/- 0.11 ) .	T16	T27	7582530
NA	CHEMICAL	GENE-N	3	10	WB 4101 , chemical and chemical displayed high affinity for gene compared to the alpha 1B subtype .	T17	T28	7582530
NA	CHEMICAL	GENE-N	5	10	WB 4101 , chemical and chemical displayed high affinity for gene compared to the alpha 1B subtype .	T18	T28	7582530
NA	CHEMICAL	GENE-Y	0	7	chemical displayed high affinity and selectivity for gene ( pKi 8.8 +/- 0.16 ) .	T19	T29	7582530
NA	CHEMICAL	GENE-Y	0	5	chemical was selective for cloned gene .	T20	T30	7582530
NA	CHEMICAL	GENE-Y	6	18	Functional affinities for compounds determined against chemical-mediated contractions of rat aorta correlated well with binding affinities at cloned gene ( r = 0.96 ) , but not with alpha 1A ( r = 0.61 ) or alpha 1B ( r = 0.46 ) subtypes .	T7	T23	7582530
NA	CHEMICAL	GENE-N	0	1	chemical transporters in the central nervous system : distribution , regulation and function .	T10	T23	15953344
NA	CHEMICAL	GENE-N	0	1	chemical transporters ( gene ) are proton-linked membrane carriers involved in the transport of chemical such as chemical , chemical , as well as chemical bodies .	T1	T11	15953344
NA	CHEMICAL	GENE-N	0	3	chemical transporters ( gene ) are proton-linked membrane carriers involved in the transport of chemical such as chemical , chemical , as well as chemical bodies .	T1	T14	15953344
CPR:9	CHEMICAL	GENE-N	14	1	chemical transporters ( gene ) are proton-linked membrane carriers involved in the transport of chemical such as chemical , chemical , as well as chemical bodies .	T2	T11	15953344
CPR:9	CHEMICAL	GENE-N	14	3	chemical transporters ( gene ) are proton-linked membrane carriers involved in the transport of chemical such as chemical , chemical , as well as chemical bodies .	T2	T14	15953344
CPR:9	CHEMICAL	GENE-N	17	1	chemical transporters ( gene ) are proton-linked membrane carriers involved in the transport of chemical such as chemical , chemical , as well as chemical bodies .	T4	T11	15953344
CPR:9	CHEMICAL	GENE-N	17	3	chemical transporters ( gene ) are proton-linked membrane carriers involved in the transport of chemical such as chemical , chemical , as well as chemical bodies .	T4	T14	15953344
CPR:9	CHEMICAL	GENE-N	19	1	chemical transporters ( gene ) are proton-linked membrane carriers involved in the transport of chemical such as chemical , chemical , as well as chemical bodies .	T6	T11	15953344
CPR:9	CHEMICAL	GENE-N	19	3	chemical transporters ( gene ) are proton-linked membrane carriers involved in the transport of chemical such as chemical , chemical , as well as chemical bodies .	T6	T14	15953344
CPR:9	CHEMICAL	GENE-N	24	1	chemical transporters ( gene ) are proton-linked membrane carriers involved in the transport of chemical such as chemical , chemical , as well as chemical bodies .	T7	T11	15953344
CPR:9	CHEMICAL	GENE-N	24	3	chemical transporters ( gene ) are proton-linked membrane carriers involved in the transport of chemical such as chemical , chemical , as well as chemical bodies .	T7	T14	15953344
NA	CHEMICAL	GENE-N	6	7	By contrast , the predominant neuronal chemical transporter is gene .	T8	T20	15953344
NA	CHEMICAL	GENE-Y	6	9	By contrast , the predominant neuronal chemical transporter is gene .	T8	T21	15953344
CPR:9	CHEMICAL	GENE-Y	8	4	Interestingly , part of gene immunoreactivity is located at postsynaptic sites , suggesting a particular role of chemical and their transporters in synaptic transmission .	T9	T22	15953344
NA	CHEMICAL	GENE-Y	1	2	Nonsedating chemical H1-receptor antagonists .	T35	T40	2568212
NA	CHEMICAL	GENE-Y	18	19	The chemistry , pharmacology , pharmacokinetics , clinical efficacy , adverse effects , and dosages of the nonsedating chemical H1-receptor antagonists chemical , chemical , chemical , and chemical are reviewed .	T3	T36	2568212
CPR:6	CHEMICAL	GENE-Y	21	19	The chemistry , pharmacology , pharmacokinetics , clinical efficacy , adverse effects , and dosages of the nonsedating chemical H1-receptor antagonists chemical , chemical , chemical , and chemical are reviewed .	T13	T36	2568212
CPR:6	CHEMICAL	GENE-Y	23	19	The chemistry , pharmacology , pharmacokinetics , clinical efficacy , adverse effects , and dosages of the nonsedating chemical H1-receptor antagonists chemical , chemical , chemical , and chemical are reviewed .	T14	T36	2568212
CPR:6	CHEMICAL	GENE-Y	25	19	The chemistry , pharmacology , pharmacokinetics , clinical efficacy , adverse effects , and dosages of the nonsedating chemical H1-receptor antagonists chemical , chemical , chemical , and chemical are reviewed .	T15	T36	2568212
CPR:6	CHEMICAL	GENE-Y	28	19	The chemistry , pharmacology , pharmacokinetics , clinical efficacy , adverse effects , and dosages of the nonsedating chemical H1-receptor antagonists chemical , chemical , chemical , and chemical are reviewed .	T16	T36	2568212
CPR:6	CHEMICAL	GENE-Y	0	6	chemical and chemical are chemically unrelated to chemical H1-receptor antagonists such as chemical and chemical .	T17	T37	2568212
CPR:6	CHEMICAL	GENE-Y	2	6	chemical and chemical are chemically unrelated to chemical H1-receptor antagonists such as chemical and chemical .	T18	T37	2568212
NA	CHEMICAL	GENE-Y	7	6	chemical and chemical are chemically unrelated to chemical H1-receptor antagonists such as chemical and chemical .	T19	T37	2568212
CPR:6	CHEMICAL	GENE-Y	12	6	chemical and chemical are chemically unrelated to chemical H1-receptor antagonists such as chemical and chemical .	T20	T37	2568212
CPR:6	CHEMICAL	GENE-Y	14	6	chemical and chemical are chemically unrelated to chemical H1-receptor antagonists such as chemical and chemical .	T21	T37	2568212
NA	CHEMICAL	GENE-Y	2	3	Like other chemical H1-receptor antagonists , they competitively block chemical receptor sites rather than inhibiting chemical release .	T26	T38	2568212
NA	CHEMICAL	GENE-N	2	10	Like other chemical H1-receptor antagonists , they competitively block chemical receptor sites rather than inhibiting chemical release .	T26	T39	2568212
NA	CHEMICAL	GENE-Y	9	3	Like other chemical H1-receptor antagonists , they competitively block chemical receptor sites rather than inhibiting chemical release .	T27	T38	2568212
NA	CHEMICAL	GENE-N	9	10	Like other chemical H1-receptor antagonists , they competitively block chemical receptor sites rather than inhibiting chemical release .	T27	T39	2568212
NA	CHEMICAL	GENE-Y	15	3	Like other chemical H1-receptor antagonists , they competitively block chemical receptor sites rather than inhibiting chemical release .	T28	T38	2568212
NA	CHEMICAL	GENE-N	15	10	Like other chemical H1-receptor antagonists , they competitively block chemical receptor sites rather than inhibiting chemical release .	T28	T39	2568212
NA	CHEMICAL	GENE-Y	6	10	Differential effects of organic and inorganic chemical compounds on chemical deaminase activity and scavenger capacity in cerebral cortex slices of young rats .	T18	T23	23536521
NA	CHEMICAL	GENE-Y	9	10	Differential effects of organic and inorganic chemical compounds on chemical deaminase activity and scavenger capacity in cerebral cortex slices of young rats .	T19	T23	23536521
NA	CHEMICAL	GENE-Y	11	7	This study was aimed to compare the in vitro effects of chemical ( chemical ; chemical ) and chemical ( inorganic chemical ) on chemical deaminase ( gene ) activity , cell viability , lipid peroxidation , scavenger of chemical ( chemical ) and nonprotein chemical ( NP-chemical ) content in the cerebral cortex slices of the young rats .	T3	T20	23536521
NA	CHEMICAL	GENE-Y	11	27	This study was aimed to compare the in vitro effects of chemical ( chemical ; chemical ) and chemical ( inorganic chemical ) on chemical deaminase ( gene ) activity , cell viability , lipid peroxidation , scavenger of chemical ( chemical ) and nonprotein chemical ( NP-chemical ) content in the cerebral cortex slices of the young rats .	T3	T21	23536521
NA	CHEMICAL	GENE-Y	13	7	This study was aimed to compare the in vitro effects of chemical ( chemical ; chemical ) and chemical ( inorganic chemical ) on chemical deaminase ( gene ) activity , cell viability , lipid peroxidation , scavenger of chemical ( chemical ) and nonprotein chemical ( NP-chemical ) content in the cerebral cortex slices of the young rats .	T4	T20	23536521
NA	CHEMICAL	GENE-Y	13	27	This study was aimed to compare the in vitro effects of chemical ( chemical ; chemical ) and chemical ( inorganic chemical ) on chemical deaminase ( gene ) activity , cell viability , lipid peroxidation , scavenger of chemical ( chemical ) and nonprotein chemical ( NP-chemical ) content in the cerebral cortex slices of the young rats .	T4	T21	23536521
NA	CHEMICAL	GENE-Y	15	7	This study was aimed to compare the in vitro effects of chemical ( chemical ; chemical ) and chemical ( inorganic chemical ) on chemical deaminase ( gene ) activity , cell viability , lipid peroxidation , scavenger of chemical ( chemical ) and nonprotein chemical ( NP-chemical ) content in the cerebral cortex slices of the young rats .	T5	T20	23536521
NA	CHEMICAL	GENE-Y	15	27	This study was aimed to compare the in vitro effects of chemical ( chemical ; chemical ) and chemical ( inorganic chemical ) on chemical deaminase ( gene ) activity , cell viability , lipid peroxidation , scavenger of chemical ( chemical ) and nonprotein chemical ( NP-chemical ) content in the cerebral cortex slices of the young rats .	T5	T21	23536521
NA	CHEMICAL	GENE-Y	18	7	This study was aimed to compare the in vitro effects of chemical ( chemical ; chemical ) and chemical ( inorganic chemical ) on chemical deaminase ( gene ) activity , cell viability , lipid peroxidation , scavenger of chemical ( chemical ) and nonprotein chemical ( NP-chemical ) content in the cerebral cortex slices of the young rats .	T6	T20	23536521
NA	CHEMICAL	GENE-Y	18	27	This study was aimed to compare the in vitro effects of chemical ( chemical ; chemical ) and chemical ( inorganic chemical ) on chemical deaminase ( gene ) activity , cell viability , lipid peroxidation , scavenger of chemical ( chemical ) and nonprotein chemical ( NP-chemical ) content in the cerebral cortex slices of the young rats .	T6	T21	23536521
NA	CHEMICAL	GENE-Y	21	7	This study was aimed to compare the in vitro effects of chemical ( chemical ; chemical ) and chemical ( inorganic chemical ) on chemical deaminase ( gene ) activity , cell viability , lipid peroxidation , scavenger of chemical ( chemical ) and nonprotein chemical ( NP-chemical ) content in the cerebral cortex slices of the young rats .	T7	T20	23536521
NA	CHEMICAL	GENE-Y	21	27	This study was aimed to compare the in vitro effects of chemical ( chemical ; chemical ) and chemical ( inorganic chemical ) on chemical deaminase ( gene ) activity , cell viability , lipid peroxidation , scavenger of chemical ( chemical ) and nonprotein chemical ( NP-chemical ) content in the cerebral cortex slices of the young rats .	T7	T21	23536521
NA	CHEMICAL	GENE-Y	7	7	This study was aimed to compare the in vitro effects of chemical ( chemical ; chemical ) and chemical ( inorganic chemical ) on chemical deaminase ( gene ) activity , cell viability , lipid peroxidation , scavenger of chemical ( chemical ) and nonprotein chemical ( NP-chemical ) content in the cerebral cortex slices of the young rats .	T8	T20	23536521
NA	CHEMICAL	GENE-Y	7	27	This study was aimed to compare the in vitro effects of chemical ( chemical ; chemical ) and chemical ( inorganic chemical ) on chemical deaminase ( gene ) activity , cell viability , lipid peroxidation , scavenger of chemical ( chemical ) and nonprotein chemical ( NP-chemical ) content in the cerebral cortex slices of the young rats .	T8	T21	23536521
NA	CHEMICAL	GENE-Y	39	7	This study was aimed to compare the in vitro effects of chemical ( chemical ; chemical ) and chemical ( inorganic chemical ) on chemical deaminase ( gene ) activity , cell viability , lipid peroxidation , scavenger of chemical ( chemical ) and nonprotein chemical ( NP-chemical ) content in the cerebral cortex slices of the young rats .	T9	T20	23536521
NA	CHEMICAL	GENE-Y	39	27	This study was aimed to compare the in vitro effects of chemical ( chemical ; chemical ) and chemical ( inorganic chemical ) on chemical deaminase ( gene ) activity , cell viability , lipid peroxidation , scavenger of chemical ( chemical ) and nonprotein chemical ( NP-chemical ) content in the cerebral cortex slices of the young rats .	T9	T21	23536521
NA	CHEMICAL	GENE-Y	41	7	This study was aimed to compare the in vitro effects of chemical ( chemical ; chemical ) and chemical ( inorganic chemical ) on chemical deaminase ( gene ) activity , cell viability , lipid peroxidation , scavenger of chemical ( chemical ) and nonprotein chemical ( NP-chemical ) content in the cerebral cortex slices of the young rats .	T10	T20	23536521
NA	CHEMICAL	GENE-Y	41	27	This study was aimed to compare the in vitro effects of chemical ( chemical ; chemical ) and chemical ( inorganic chemical ) on chemical deaminase ( gene ) activity , cell viability , lipid peroxidation , scavenger of chemical ( chemical ) and nonprotein chemical ( NP-chemical ) content in the cerebral cortex slices of the young rats .	T10	T21	23536521
NA	CHEMICAL	GENE-Y	45	7	This study was aimed to compare the in vitro effects of chemical ( chemical ; chemical ) and chemical ( inorganic chemical ) on chemical deaminase ( gene ) activity , cell viability , lipid peroxidation , scavenger of chemical ( chemical ) and nonprotein chemical ( NP-chemical ) content in the cerebral cortex slices of the young rats .	T11	T20	23536521
NA	CHEMICAL	GENE-Y	45	27	This study was aimed to compare the in vitro effects of chemical ( chemical ; chemical ) and chemical ( inorganic chemical ) on chemical deaminase ( gene ) activity , cell viability , lipid peroxidation , scavenger of chemical ( chemical ) and nonprotein chemical ( NP-chemical ) content in the cerebral cortex slices of the young rats .	T11	T21	23536521
NA	CHEMICAL	GENE-Y	47	7	This study was aimed to compare the in vitro effects of chemical ( chemical ; chemical ) and chemical ( inorganic chemical ) on chemical deaminase ( gene ) activity , cell viability , lipid peroxidation , scavenger of chemical ( chemical ) and nonprotein chemical ( NP-chemical ) content in the cerebral cortex slices of the young rats .	T12	T20	23536521
NA	CHEMICAL	GENE-Y	47	27	This study was aimed to compare the in vitro effects of chemical ( chemical ; chemical ) and chemical ( inorganic chemical ) on chemical deaminase ( gene ) activity , cell viability , lipid peroxidation , scavenger of chemical ( chemical ) and nonprotein chemical ( NP-chemical ) content in the cerebral cortex slices of the young rats .	T12	T21	23536521
CPR:4	CHEMICAL	GENE-Y	13	0	A decrease in gene activity was observed when the slices were exposed to chemical at the concentrations of 1 , 10 and 30 µM .	T13	T22	23536521
CPR:4	CHEMICAL	GENE-Y	0	5	chemical , a unique cardioselective gene blocker with a half-life of 9 minutes , can enable some patients with relative contraindications to beta blockers to nevertheless benefit from early beta-blocking therapy .	T1	T4	2568748
CPR:4	CHEMICAL	GENE-N	10	2	Comparison of gene inhibitory activity and ocular anti-inflammatory effects of chemical and chemical .	T29	T42	16846546
CPR:4	CHEMICAL	GENE-N	12	2	Comparison of gene inhibitory activity and ocular anti-inflammatory effects of chemical and chemical .	T28	T42	16846546
NA	CHEMICAL	GENE-N	21	5	OBJECTIVE : To compare the gene ( gene ) activity and anti-inflammatory effects of the nonsteroidal anti-inflammatory drugs ( NSAIDs ) chemical ( chemical ) and chemical ( chemical ) .	T5	T38	16846546
NA	CHEMICAL	GENE-N	21	7	OBJECTIVE : To compare the gene ( gene ) activity and anti-inflammatory effects of the nonsteroidal anti-inflammatory drugs ( NSAIDs ) chemical ( chemical ) and chemical ( chemical ) .	T5	T41	16846546
NA	CHEMICAL	GENE-N	23	5	OBJECTIVE : To compare the gene ( gene ) activity and anti-inflammatory effects of the nonsteroidal anti-inflammatory drugs ( NSAIDs ) chemical ( chemical ) and chemical ( chemical ) .	T9	T38	16846546
NA	CHEMICAL	GENE-N	23	7	OBJECTIVE : To compare the gene ( gene ) activity and anti-inflammatory effects of the nonsteroidal anti-inflammatory drugs ( NSAIDs ) chemical ( chemical ) and chemical ( chemical ) .	T9	T41	16846546
NA	CHEMICAL	GENE-N	26	5	OBJECTIVE : To compare the gene ( gene ) activity and anti-inflammatory effects of the nonsteroidal anti-inflammatory drugs ( NSAIDs ) chemical ( chemical ) and chemical ( chemical ) .	T12	T38	16846546
NA	CHEMICAL	GENE-N	26	7	OBJECTIVE : To compare the gene ( gene ) activity and anti-inflammatory effects of the nonsteroidal anti-inflammatory drugs ( NSAIDs ) chemical ( chemical ) and chemical ( chemical ) .	T12	T41	16846546
NA	CHEMICAL	GENE-N	28	5	OBJECTIVE : To compare the gene ( gene ) activity and anti-inflammatory effects of the nonsteroidal anti-inflammatory drugs ( NSAIDs ) chemical ( chemical ) and chemical ( chemical ) .	T17	T38	16846546
NA	CHEMICAL	GENE-N	28	7	OBJECTIVE : To compare the gene ( gene ) activity and anti-inflammatory effects of the nonsteroidal anti-inflammatory drugs ( NSAIDs ) chemical ( chemical ) and chemical ( chemical ) .	T17	T41	16846546
CPR:9	CHEMICAL	GENE-N	12	2	METHODS : gene activity and selectivity was determined in vitro by measuring chemical ( chemical ) production following incubation of varying concentrations of NSAID with gene or gene and chemical .	T19	T37	16846546
NA	CHEMICAL	GENE-Y	12	25	METHODS : gene activity and selectivity was determined in vitro by measuring chemical ( chemical ) production following incubation of varying concentrations of NSAID with gene or gene and chemical .	T19	T39	16846546
NA	CHEMICAL	GENE-Y	12	27	METHODS : gene activity and selectivity was determined in vitro by measuring chemical ( chemical ) production following incubation of varying concentrations of NSAID with gene or gene and chemical .	T19	T40	16846546
CPR:9	CHEMICAL	GENE-N	13	2	METHODS : gene activity and selectivity was determined in vitro by measuring chemical ( chemical ) production following incubation of varying concentrations of NSAID with gene or gene and chemical .	T20	T37	16846546
NA	CHEMICAL	GENE-Y	13	25	METHODS : gene activity and selectivity was determined in vitro by measuring chemical ( chemical ) production following incubation of varying concentrations of NSAID with gene or gene and chemical .	T20	T39	16846546
NA	CHEMICAL	GENE-Y	13	27	METHODS : gene activity and selectivity was determined in vitro by measuring chemical ( chemical ) production following incubation of varying concentrations of NSAID with gene or gene and chemical .	T20	T40	16846546
NA	CHEMICAL	GENE-N	29	2	METHODS : gene activity and selectivity was determined in vitro by measuring chemical ( chemical ) production following incubation of varying concentrations of NSAID with gene or gene and chemical .	T21	T37	16846546
NA	CHEMICAL	GENE-Y	29	25	METHODS : gene activity and selectivity was determined in vitro by measuring chemical ( chemical ) production following incubation of varying concentrations of NSAID with gene or gene and chemical .	T21	T39	16846546
NA	CHEMICAL	GENE-Y	29	27	METHODS : gene activity and selectivity was determined in vitro by measuring chemical ( chemical ) production following incubation of varying concentrations of NSAID with gene or gene and chemical .	T21	T40	16846546
NA	CHEMICAL	GENE-Y	2	9	RESULTS : chemical was six times more active against gene ( IC ( 50 ) = 0.02 microM ) than gene ( IC ( 50 ) = 0.12 microM ) while chemical was approximately 32 times more active against gene ( IC ( 50 ) = 0.0066 microM ) than gene ( IC ( 50 ) = 0.210 microM ) .	T3	T30	16846546
NA	CHEMICAL	GENE-Y	2	20	RESULTS : chemical was six times more active against gene ( IC ( 50 ) = 0.02 microM ) than gene ( IC ( 50 ) = 0.12 microM ) while chemical was approximately 32 times more active against gene ( IC ( 50 ) = 0.0066 microM ) than gene ( IC ( 50 ) = 0.210 microM ) .	T3	T31	16846546
CPR:4	CHEMICAL	GENE-Y	2	39	RESULTS : chemical was six times more active against gene ( IC ( 50 ) = 0.02 microM ) than gene ( IC ( 50 ) = 0.12 microM ) while chemical was approximately 32 times more active against gene ( IC ( 50 ) = 0.0066 microM ) than gene ( IC ( 50 ) = 0.210 microM ) .	T3	T32	16846546
CPR:4	CHEMICAL	GENE-Y	2	50	RESULTS : chemical was six times more active against gene ( IC ( 50 ) = 0.02 microM ) than gene ( IC ( 50 ) = 0.12 microM ) while chemical was approximately 32 times more active against gene ( IC ( 50 ) = 0.0066 microM ) than gene ( IC ( 50 ) = 0.210 microM ) .	T3	T33	16846546
CPR:4	CHEMICAL	GENE-Y	31	9	RESULTS : chemical was six times more active against gene ( IC ( 50 ) = 0.02 microM ) than gene ( IC ( 50 ) = 0.12 microM ) while chemical was approximately 32 times more active against gene ( IC ( 50 ) = 0.0066 microM ) than gene ( IC ( 50 ) = 0.210 microM ) .	T4	T30	16846546
CPR:4	CHEMICAL	GENE-Y	31	20	RESULTS : chemical was six times more active against gene ( IC ( 50 ) = 0.02 microM ) than gene ( IC ( 50 ) = 0.12 microM ) while chemical was approximately 32 times more active against gene ( IC ( 50 ) = 0.0066 microM ) than gene ( IC ( 50 ) = 0.210 microM ) .	T4	T31	16846546
NA	CHEMICAL	GENE-Y	31	39	RESULTS : chemical was six times more active against gene ( IC ( 50 ) = 0.02 microM ) than gene ( IC ( 50 ) = 0.12 microM ) while chemical was approximately 32 times more active against gene ( IC ( 50 ) = 0.0066 microM ) than gene ( IC ( 50 ) = 0.210 microM ) .	T4	T32	16846546
NA	CHEMICAL	GENE-Y	31	50	RESULTS : chemical was six times more active against gene ( IC ( 50 ) = 0.02 microM ) than gene ( IC ( 50 ) = 0.12 microM ) while chemical was approximately 32 times more active against gene ( IC ( 50 ) = 0.0066 microM ) than gene ( IC ( 50 ) = 0.210 microM ) .	T4	T33	16846546
NA	CHEMICAL	GENE-Y	2	5	CONCLUSIONS : chemical is relatively gene selective while chemical is potently selective for gene over gene .	T13	T34	16846546
NA	CHEMICAL	GENE-Y	2	13	CONCLUSIONS : chemical is relatively gene selective while chemical is potently selective for gene over gene .	T13	T35	16846546
NA	CHEMICAL	GENE-Y	2	15	CONCLUSIONS : chemical is relatively gene selective while chemical is potently selective for gene over gene .	T13	T36	16846546
NA	CHEMICAL	GENE-Y	8	5	CONCLUSIONS : chemical is relatively gene selective while chemical is potently selective for gene over gene .	T14	T34	16846546
NA	CHEMICAL	GENE-Y	8	13	CONCLUSIONS : chemical is relatively gene selective while chemical is potently selective for gene over gene .	T14	T35	16846546
NA	CHEMICAL	GENE-Y	8	15	CONCLUSIONS : chemical is relatively gene selective while chemical is potently selective for gene over gene .	T14	T36	16846546
NA	CHEMICAL	GENE-Y	0	1	chemicalpolymerase-1 ( gene ) enzyme is involved in the repair of DNA damages made by certain anticancer agents .	T1	T9	23522835
NA	CHEMICAL	GENE-Y	0	2	chemicalpolymerase-1 ( gene ) enzyme is involved in the repair of DNA damages made by certain anticancer agents .	T1	T11	23522835
NA	CHEMICAL	GENE-Y	1	4	It is suggested that gene inhibitors potentiate the cytotoxic effects and circumvent the resistance of DNA-modifying anticancer agents such as chemical .	T2	T10	23522835
NA	CHEMICAL	GENE-Y	6	10	We then examined the chemosensitization of chemical by pre-treatment of gene inhibitors in chemical-resistant human gastric cancer cells .	T3	T14	23522835
NA	CHEMICAL	GENE-Y	12	10	We then examined the chemosensitization of chemical by pre-treatment of gene inhibitors in chemical-resistant human gastric cancer cells .	T4	T14	23522835
NA	CHEMICAL	GENE-Y	7	0	gene receptors , alpha2A/2C- and , to a lesser extent , gene mediate the external carotid vasoconstriction to chemical in vagosympathectomised dogs .	T55	T63	15224175
NA	CHEMICAL	GENE-N	7	6	gene receptors , alpha2A/2C- and , to a lesser extent , gene mediate the external carotid vasoconstriction to chemical in vagosympathectomised dogs .	T55	T64	15224175
NA	CHEMICAL	GENE-N	6	15	It has previously been suggested that chemical produces external carotid vasoconstriction in vagosympathectomised dogs via gene receptors and gene .	T37	T56	15224175
NA	CHEMICAL	GENE-N	6	18	It has previously been suggested that chemical produces external carotid vasoconstriction in vagosympathectomised dogs via gene receptors and gene .	T37	T57	15224175
CPR:6	CHEMICAL	GENE-Y	17	22	bolus injection of , either physiological saline ( 0.3 ml/kg ; control ) , or the antagonists chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; alpha2 ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ; alpha1 ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2A ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2B ) , or chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 300 microg/kg ; alpha2C ) .	T38	T61	15224175
NA	CHEMICAL	GENE-Y	17	30	bolus injection of , either physiological saline ( 0.3 ml/kg ; control ) , or the antagonists chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; alpha2 ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ; alpha1 ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2A ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2B ) , or chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 300 microg/kg ; alpha2C ) .	T38	T62	15224175
NA	CHEMICAL	GENE-Y	25	22	bolus injection of , either physiological saline ( 0.3 ml/kg ; control ) , or the antagonists chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; alpha2 ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ; alpha1 ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2A ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2B ) , or chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 300 microg/kg ; alpha2C ) .	T39	T61	15224175
CPR:6	CHEMICAL	GENE-Y	25	30	bolus injection of , either physiological saline ( 0.3 ml/kg ; control ) , or the antagonists chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; alpha2 ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ; alpha1 ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2A ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2B ) , or chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 300 microg/kg ; alpha2C ) .	T39	T62	15224175
NA	CHEMICAL	GENE-Y	33	22	bolus injection of , either physiological saline ( 0.3 ml/kg ; control ) , or the antagonists chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; alpha2 ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ; alpha1 ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2A ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2B ) , or chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 300 microg/kg ; alpha2C ) .	T40	T61	15224175
NA	CHEMICAL	GENE-Y	33	30	bolus injection of , either physiological saline ( 0.3 ml/kg ; control ) , or the antagonists chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; alpha2 ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ; alpha1 ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2A ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2B ) , or chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 300 microg/kg ; alpha2C ) .	T40	T62	15224175
NA	CHEMICAL	GENE-Y	41	22	bolus injection of , either physiological saline ( 0.3 ml/kg ; control ) , or the antagonists chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; alpha2 ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ; alpha1 ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2A ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2B ) , or chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 300 microg/kg ; alpha2C ) .	T41	T61	15224175
NA	CHEMICAL	GENE-Y	41	30	bolus injection of , either physiological saline ( 0.3 ml/kg ; control ) , or the antagonists chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; alpha2 ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ; alpha1 ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2A ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2B ) , or chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 300 microg/kg ; alpha2C ) .	T41	T62	15224175
NA	CHEMICAL	GENE-Y	43	22	bolus injection of , either physiological saline ( 0.3 ml/kg ; control ) , or the antagonists chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; alpha2 ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ; alpha1 ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2A ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2B ) , or chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 300 microg/kg ; alpha2C ) .	T42	T61	15224175
NA	CHEMICAL	GENE-Y	43	30	bolus injection of , either physiological saline ( 0.3 ml/kg ; control ) , or the antagonists chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; alpha2 ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ; alpha1 ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2A ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2B ) , or chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 300 microg/kg ; alpha2C ) .	T42	T62	15224175
NA	CHEMICAL	GENE-Y	50	22	bolus injection of , either physiological saline ( 0.3 ml/kg ; control ) , or the antagonists chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; alpha2 ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ; alpha1 ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2A ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2B ) , or chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 300 microg/kg ; alpha2C ) .	T43	T61	15224175
NA	CHEMICAL	GENE-Y	50	30	bolus injection of , either physiological saline ( 0.3 ml/kg ; control ) , or the antagonists chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; alpha2 ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ; alpha1 ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2A ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2B ) , or chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 300 microg/kg ; alpha2C ) .	T43	T62	15224175
NA	CHEMICAL	GENE-Y	52	22	bolus injection of , either physiological saline ( 0.3 ml/kg ; control ) , or the antagonists chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; alpha2 ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ; alpha1 ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2A ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2B ) , or chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 300 microg/kg ; alpha2C ) .	T44	T61	15224175
NA	CHEMICAL	GENE-Y	52	30	bolus injection of , either physiological saline ( 0.3 ml/kg ; control ) , or the antagonists chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; alpha2 ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ; alpha1 ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2A ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2B ) , or chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 300 microg/kg ; alpha2C ) .	T44	T62	15224175
NA	CHEMICAL	GENE-Y	59	22	bolus injection of , either physiological saline ( 0.3 ml/kg ; control ) , or the antagonists chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; alpha2 ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ; alpha1 ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2A ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2B ) , or chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 300 microg/kg ; alpha2C ) .	T45	T61	15224175
NA	CHEMICAL	GENE-Y	59	30	bolus injection of , either physiological saline ( 0.3 ml/kg ; control ) , or the antagonists chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; alpha2 ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ; alpha1 ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2A ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2B ) , or chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 300 microg/kg ; alpha2C ) .	T45	T62	15224175
NA	CHEMICAL	GENE-Y	61	22	bolus injection of , either physiological saline ( 0.3 ml/kg ; control ) , or the antagonists chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; alpha2 ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ; alpha1 ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2A ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2B ) , or chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 300 microg/kg ; alpha2C ) .	T46	T61	15224175
NA	CHEMICAL	GENE-Y	61	30	bolus injection of , either physiological saline ( 0.3 ml/kg ; control ) , or the antagonists chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; alpha2 ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ; alpha1 ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2A ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2B ) , or chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 300 microg/kg ; alpha2C ) .	T46	T62	15224175
NA	CHEMICAL	GENE-Y	68	22	bolus injection of , either physiological saline ( 0.3 ml/kg ; control ) , or the antagonists chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; alpha2 ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ; alpha1 ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2A ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2B ) , or chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 300 microg/kg ; alpha2C ) .	T47	T61	15224175
NA	CHEMICAL	GENE-Y	68	30	bolus injection of , either physiological saline ( 0.3 ml/kg ; control ) , or the antagonists chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; alpha2 ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ; alpha1 ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2A ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2B ) , or chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 300 microg/kg ; alpha2C ) .	T47	T62	15224175
NA	CHEMICAL	GENE-Y	74	22	bolus injection of , either physiological saline ( 0.3 ml/kg ; control ) , or the antagonists chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; alpha2 ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ; alpha1 ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2A ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2B ) , or chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 300 microg/kg ; alpha2C ) .	T48	T61	15224175
NA	CHEMICAL	GENE-Y	74	30	bolus injection of , either physiological saline ( 0.3 ml/kg ; control ) , or the antagonists chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; alpha2 ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ; alpha1 ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2A ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2B ) , or chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 300 microg/kg ; alpha2C ) .	T48	T62	15224175
NA	CHEMICAL	GENE-Y	82	22	bolus injection of , either physiological saline ( 0.3 ml/kg ; control ) , or the antagonists chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; alpha2 ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ; alpha1 ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2A ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2B ) , or chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 300 microg/kg ; alpha2C ) .	T49	T61	15224175
NA	CHEMICAL	GENE-Y	82	30	bolus injection of , either physiological saline ( 0.3 ml/kg ; control ) , or the antagonists chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; alpha2 ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ; alpha1 ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2A ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2B ) , or chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 300 microg/kg ; alpha2C ) .	T49	T62	15224175
NA	CHEMICAL	GENE-Y	88	22	bolus injection of , either physiological saline ( 0.3 ml/kg ; control ) , or the antagonists chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; alpha2 ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ; alpha1 ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2A ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2B ) , or chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 300 microg/kg ; alpha2C ) .	T50	T61	15224175
NA	CHEMICAL	GENE-Y	88	30	bolus injection of , either physiological saline ( 0.3 ml/kg ; control ) , or the antagonists chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; alpha2 ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ; alpha1 ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2A ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2B ) , or chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 300 microg/kg ; alpha2C ) .	T50	T62	15224175
NA	CHEMICAL	GENE-Y	94	22	bolus injection of , either physiological saline ( 0.3 ml/kg ; control ) , or the antagonists chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; alpha2 ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ; alpha1 ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2A ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2B ) , or chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 300 microg/kg ; alpha2C ) .	T51	T61	15224175
NA	CHEMICAL	GENE-Y	94	30	bolus injection of , either physiological saline ( 0.3 ml/kg ; control ) , or the antagonists chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; alpha2 ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ; alpha1 ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2A ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2B ) , or chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 300 microg/kg ; alpha2C ) .	T51	T62	15224175
NA	CHEMICAL	GENE-Y	100	22	bolus injection of , either physiological saline ( 0.3 ml/kg ; control ) , or the antagonists chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; alpha2 ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ; alpha1 ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2A ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2B ) , or chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 300 microg/kg ; alpha2C ) .	T52	T61	15224175
NA	CHEMICAL	GENE-Y	100	30	bolus injection of , either physiological saline ( 0.3 ml/kg ; control ) , or the antagonists chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; alpha2 ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ; alpha1 ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2A ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2B ) , or chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 300 microg/kg ; alpha2C ) .	T52	T62	15224175
NA	CHEMICAL	GENE-Y	106	22	bolus injection of , either physiological saline ( 0.3 ml/kg ; control ) , or the antagonists chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; alpha2 ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ; alpha1 ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2A ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2B ) , or chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 300 microg/kg ; alpha2C ) .	T53	T61	15224175
NA	CHEMICAL	GENE-Y	106	30	bolus injection of , either physiological saline ( 0.3 ml/kg ; control ) , or the antagonists chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; alpha2 ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ; alpha1 ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2A ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2B ) , or chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 300 microg/kg ; alpha2C ) .	T53	T62	15224175
NA	CHEMICAL	GENE-Y	112	22	bolus injection of , either physiological saline ( 0.3 ml/kg ; control ) , or the antagonists chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; alpha2 ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ; alpha1 ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2A ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2B ) , or chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 300 microg/kg ; alpha2C ) .	T54	T61	15224175
NA	CHEMICAL	GENE-Y	112	30	bolus injection of , either physiological saline ( 0.3 ml/kg ; control ) , or the antagonists chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; alpha2 ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ; alpha1 ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2A ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2B ) , or chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 300 microg/kg ; alpha2C ) .	T54	T62	15224175
NA	CHEMICAL	GENE-Y	118	22	bolus injection of , either physiological saline ( 0.3 ml/kg ; control ) , or the antagonists chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; alpha2 ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ; alpha1 ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2A ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2B ) , or chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 300 microg/kg ; alpha2C ) .	T1	T61	15224175
NA	CHEMICAL	GENE-Y	118	30	bolus injection of , either physiological saline ( 0.3 ml/kg ; control ) , or the antagonists chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; alpha2 ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ; alpha1 ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2A ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2B ) , or chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 300 microg/kg ; alpha2C ) .	T1	T62	15224175
NA	CHEMICAL	GENE-Y	124	22	bolus injection of , either physiological saline ( 0.3 ml/kg ; control ) , or the antagonists chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; alpha2 ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ; alpha1 ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2A ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2B ) , or chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 300 microg/kg ; alpha2C ) .	T2	T61	15224175
NA	CHEMICAL	GENE-Y	124	30	bolus injection of , either physiological saline ( 0.3 ml/kg ; control ) , or the antagonists chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; alpha2 ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ; alpha1 ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2A ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2B ) , or chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 300 microg/kg ; alpha2C ) .	T2	T62	15224175
NA	CHEMICAL	GENE-Y	17	22	bolus injection of , either physiological saline ( 0.3 ml/kg ; control ) , or the antagonists chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; alpha2 ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ; alpha1 ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2A ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2B ) , or chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 300 microg/kg ; alpha2C ) .	T3	T61	15224175
NA	CHEMICAL	GENE-Y	17	30	bolus injection of , either physiological saline ( 0.3 ml/kg ; control ) , or the antagonists chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; alpha2 ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ; alpha1 ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2A ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2B ) , or chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 300 microg/kg ; alpha2C ) .	T3	T62	15224175
NA	CHEMICAL	GENE-Y	33	22	bolus injection of , either physiological saline ( 0.3 ml/kg ; control ) , or the antagonists chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; alpha2 ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ; alpha1 ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2A ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2B ) , or chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 300 microg/kg ; alpha2C ) .	T4	T61	15224175
NA	CHEMICAL	GENE-Y	33	30	bolus injection of , either physiological saline ( 0.3 ml/kg ; control ) , or the antagonists chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; alpha2 ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ; alpha1 ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2A ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2B ) , or chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 300 microg/kg ; alpha2C ) .	T4	T62	15224175
NA	CHEMICAL	GENE-Y	88	22	bolus injection of , either physiological saline ( 0.3 ml/kg ; control ) , or the antagonists chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; alpha2 ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ; alpha1 ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2A ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2B ) , or chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 300 microg/kg ; alpha2C ) .	T5	T61	15224175
NA	CHEMICAL	GENE-Y	88	30	bolus injection of , either physiological saline ( 0.3 ml/kg ; control ) , or the antagonists chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; alpha2 ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ; alpha1 ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2A ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2B ) , or chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 300 microg/kg ; alpha2C ) .	T5	T62	15224175
NA	CHEMICAL	GENE-Y	22	22	bolus injection of , either physiological saline ( 0.3 ml/kg ; control ) , or the antagonists chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; alpha2 ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ; alpha1 ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2A ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2B ) , or chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 300 microg/kg ; alpha2C ) .	T6	T61	15224175
NA	CHEMICAL	GENE-Y	22	30	bolus injection of , either physiological saline ( 0.3 ml/kg ; control ) , or the antagonists chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; alpha2 ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ; alpha1 ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2A ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2B ) , or chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 300 microg/kg ; alpha2C ) .	T6	T62	15224175
NA	CHEMICAL	GENE-Y	159	22	bolus injection of , either physiological saline ( 0.3 ml/kg ; control ) , or the antagonists chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; alpha2 ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ; alpha1 ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2A ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2B ) , or chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 300 microg/kg ; alpha2C ) .	T7	T61	15224175
NA	CHEMICAL	GENE-Y	159	30	bolus injection of , either physiological saline ( 0.3 ml/kg ; control ) , or the antagonists chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; alpha2 ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ; alpha1 ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2A ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2B ) , or chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 300 microg/kg ; alpha2C ) .	T7	T62	15224175
NA	CHEMICAL	GENE-Y	165	22	bolus injection of , either physiological saline ( 0.3 ml/kg ; control ) , or the antagonists chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; alpha2 ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ; alpha1 ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2A ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2B ) , or chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 300 microg/kg ; alpha2C ) .	T8	T61	15224175
NA	CHEMICAL	GENE-Y	165	30	bolus injection of , either physiological saline ( 0.3 ml/kg ; control ) , or the antagonists chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; gene ) , chemical ( 300 microg/kg ; alpha2 ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical + chemical ( 300 microg/kg each ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ; alpha1 ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2A ) , chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 1,000 microg/kg ; alpha2B ) , or chemical ( 300 microg/kg ) + chemical ( 100 microg/kg ) + chemical ( 300 microg/kg ; alpha2C ) .	T8	T62	15224175
CPR:9	CHEMICAL	GENE-N	0	8	chemical is mainly excreted into the bile via gene ( gene ) and gene ( gene ) in hepatobiliary route and metabolized via gene subfamily .	T7	T17	23574017
CPR:9	CHEMICAL	GENE-N	0	10	chemical is mainly excreted into the bile via gene ( gene ) and gene ( gene ) in hepatobiliary route and metabolized via gene subfamily .	T7	T18	23574017
CPR:9	CHEMICAL	GENE-Y	0	13	chemical is mainly excreted into the bile via gene ( gene ) and gene ( gene ) in hepatobiliary route and metabolized via gene subfamily .	T7	T19	23574017
CPR:9	CHEMICAL	GENE-Y	0	15	chemical is mainly excreted into the bile via gene ( gene ) and gene ( gene ) in hepatobiliary route and metabolized via gene subfamily .	T7	T20	23574017
CPR:9	CHEMICAL	GENE-N	0	23	chemical is mainly excreted into the bile via gene ( gene ) and gene ( gene ) in hepatobiliary route and metabolized via gene subfamily .	T7	T21	23574017
CPR:9	CHEMICAL	GENE-N	28	19	The slower CL was due to the reduction of hepatic biliary excretion ( 67.0 % decrease ) and hepatic gene subfamily-mediated metabolism ( 21.9 % decrease ) of chemical .	T2	T16	23574017
NA	CHEMICAL	GENE-Y	0	1	chemical lipase inhibition-induced changes in plasma chemical levels , anxiety and locomotor activity in male CD1 mice .	T18	T23	23578952
NA	CHEMICAL	GENE-Y	6	1	chemical lipase inhibition-induced changes in plasma chemical levels , anxiety and locomotor activity in male CD1 mice .	T19	T23	23578952
NA	CHEMICAL	GENE-Y	9	10	Here we studied the effects of the recently developed chemical lipase inhibitor chemical on basal and stress-induced chemical levels in male CD1 mice , and found that this compound dramatically increased basal levels without affecting stress responses .	T7	T22	23578952
CPR:4	CHEMICAL	GENE-Y	12	10	Here we studied the effects of the recently developed chemical lipase inhibitor chemical on basal and stress-induced chemical levels in male CD1 mice , and found that this compound dramatically increased basal levels without affecting stress responses .	T8	T22	23578952
NA	CHEMICAL	GENE-Y	13	10	Here we studied the effects of the recently developed chemical lipase inhibitor chemical on basal and stress-induced chemical levels in male CD1 mice , and found that this compound dramatically increased basal levels without affecting stress responses .	T9	T22	23578952
NA	CHEMICAL	GENE-Y	4	5	These findings show that chemical lipase inhibition dramatically increases basal levels of chemical .	T2	T20	23578952
NA	CHEMICAL	GENE-Y	12	5	These findings show that chemical lipase inhibition dramatically increases basal levels of chemical .	T3	T20	23578952
NA	CHEMICAL	GENE-N	0	1	chemical receptor antagonists intensify the chemical withdrawal signs in mice .	T22	T30	17085856
NA	CHEMICAL	GENE-N	5	1	chemical receptor antagonists intensify the chemical withdrawal signs in mice .	T23	T30	17085856
NA	CHEMICAL	GENE-N	12	7	The aim of the present experiment was to assess the involvement of chemical receptor antagonists in chemical ( chemical ) withdrawal signs , observed as the seizure susceptibility in mice .	T16	T28	17085856
NA	CHEMICAL	GENE-N	15	7	The aim of the present experiment was to assess the involvement of chemical receptor antagonists in chemical ( chemical ) withdrawal signs , observed as the seizure susceptibility in mice .	T2	T28	17085856
NA	CHEMICAL	GENE-N	18	7	The aim of the present experiment was to assess the involvement of chemical receptor antagonists in chemical ( chemical ) withdrawal signs , observed as the seizure susceptibility in mice .	T4	T28	17085856
NA	CHEMICAL	GENE-N	7	24	The concomitant application of subconvulsive dose of chemical ( 55.0 mg/kg ) with low dose of chemical ( 5.0 mg/kg ) - a chemical receptor antagonist , immediately induced chemical withdrawal signs in these animals .	T8	T25	17085856
CPR:6	CHEMICAL	GENE-N	16	24	The concomitant application of subconvulsive dose of chemical ( 55.0 mg/kg ) with low dose of chemical ( 5.0 mg/kg ) - a chemical receptor antagonist , immediately induced chemical withdrawal signs in these animals .	T9	T25	17085856
NA	CHEMICAL	GENE-N	23	24	The concomitant application of subconvulsive dose of chemical ( 55.0 mg/kg ) with low dose of chemical ( 5.0 mg/kg ) - a chemical receptor antagonist , immediately induced chemical withdrawal signs in these animals .	T10	T25	17085856
NA	CHEMICAL	GENE-N	29	24	The concomitant application of subconvulsive dose of chemical ( 55.0 mg/kg ) with low dose of chemical ( 5.0 mg/kg ) - a chemical receptor antagonist , immediately induced chemical withdrawal signs in these animals .	T11	T25	17085856
NA	CHEMICAL	GENE-N	2	3	The non-selective chemical receptor antagonist ( chemical ) , and the selective chemical A1 receptor antagonist ( chemical ) , injected 15 min before the application of chemical and chemical , were able to intensify chemical withdrawal signs in mice .	T12	T26	17085856
NA	CHEMICAL	GENE-Y	2	3	The non-selective chemical receptor antagonist ( chemical ) , and the selective chemical A1 receptor antagonist ( chemical ) , injected 15 min before the application of chemical and chemical , were able to intensify chemical withdrawal signs in mice .	T12	T27	17085856
CPR:6	CHEMICAL	GENE-N	6	3	The non-selective chemical receptor antagonist ( chemical ) , and the selective chemical A1 receptor antagonist ( chemical ) , injected 15 min before the application of chemical and chemical , were able to intensify chemical withdrawal signs in mice .	T13	T26	17085856
NA	CHEMICAL	GENE-Y	6	3	The non-selective chemical receptor antagonist ( chemical ) , and the selective chemical A1 receptor antagonist ( chemical ) , injected 15 min before the application of chemical and chemical , were able to intensify chemical withdrawal signs in mice .	T13	T27	17085856
NA	CHEMICAL	GENE-N	12	3	The non-selective chemical receptor antagonist ( chemical ) , and the selective chemical A1 receptor antagonist ( chemical ) , injected 15 min before the application of chemical and chemical , were able to intensify chemical withdrawal signs in mice .	T14	T26	17085856
NA	CHEMICAL	GENE-Y	12	3	The non-selective chemical receptor antagonist ( chemical ) , and the selective chemical A1 receptor antagonist ( chemical ) , injected 15 min before the application of chemical and chemical , were able to intensify chemical withdrawal signs in mice .	T14	T27	17085856
NA	CHEMICAL	GENE-N	17	3	The non-selective chemical receptor antagonist ( chemical ) , and the selective chemical A1 receptor antagonist ( chemical ) , injected 15 min before the application of chemical and chemical , were able to intensify chemical withdrawal signs in mice .	T15	T26	17085856
CPR:6	CHEMICAL	GENE-Y	17	3	The non-selective chemical receptor antagonist ( chemical ) , and the selective chemical A1 receptor antagonist ( chemical ) , injected 15 min before the application of chemical and chemical , were able to intensify chemical withdrawal signs in mice .	T15	T27	17085856
NA	CHEMICAL	GENE-N	27	3	The non-selective chemical receptor antagonist ( chemical ) , and the selective chemical A1 receptor antagonist ( chemical ) , injected 15 min before the application of chemical and chemical , were able to intensify chemical withdrawal signs in mice .	T17	T26	17085856
NA	CHEMICAL	GENE-Y	27	3	The non-selective chemical receptor antagonist ( chemical ) , and the selective chemical A1 receptor antagonist ( chemical ) , injected 15 min before the application of chemical and chemical , were able to intensify chemical withdrawal signs in mice .	T17	T27	17085856
NA	CHEMICAL	GENE-N	29	3	The non-selective chemical receptor antagonist ( chemical ) , and the selective chemical A1 receptor antagonist ( chemical ) , injected 15 min before the application of chemical and chemical , were able to intensify chemical withdrawal signs in mice .	T18	T26	17085856
NA	CHEMICAL	GENE-Y	29	3	The non-selective chemical receptor antagonist ( chemical ) , and the selective chemical A1 receptor antagonist ( chemical ) , injected 15 min before the application of chemical and chemical , were able to intensify chemical withdrawal signs in mice .	T18	T27	17085856
NA	CHEMICAL	GENE-N	35	3	The non-selective chemical receptor antagonist ( chemical ) , and the selective chemical A1 receptor antagonist ( chemical ) , injected 15 min before the application of chemical and chemical , were able to intensify chemical withdrawal signs in mice .	T19	T26	17085856
NA	CHEMICAL	GENE-Y	35	3	The non-selective chemical receptor antagonist ( chemical ) , and the selective chemical A1 receptor antagonist ( chemical ) , injected 15 min before the application of chemical and chemical , were able to intensify chemical withdrawal signs in mice .	T19	T27	17085856
NA	CHEMICAL	GENE-Y	9	16	The most apparent effects were observed after administration of chemical , indicating that the chemical A1 receptor may play a more important role in these effects .	T20	T29	17085856
NA	CHEMICAL	GENE-Y	14	16	The most apparent effects were observed after administration of chemical , indicating that the chemical A1 receptor may play a more important role in these effects .	T21	T29	17085856
NA	CHEMICAL	GENE-Y	5	18	BACKGROUND : In essential hypertension an elevated renal vascular resistance ( RVR ) may be a marker of gene-gene-chemical system-mediated impairment of renal chemical excretion .	T1	T17	10583449
NA	CHEMICAL	GENE-Y	5	5	BACKGROUND : In essential hypertension an elevated renal vascular resistance ( RVR ) may be a marker of gene-gene-chemical system-mediated impairment of renal chemical excretion .	T1	T18	10583449
NA	CHEMICAL	GENE-Y	15	18	BACKGROUND : In essential hypertension an elevated renal vascular resistance ( RVR ) may be a marker of gene-gene-chemical system-mediated impairment of renal chemical excretion .	T3	T17	10583449
NA	CHEMICAL	GENE-Y	15	5	BACKGROUND : In essential hypertension an elevated renal vascular resistance ( RVR ) may be a marker of gene-gene-chemical system-mediated impairment of renal chemical excretion .	T3	T18	10583449
NA	CHEMICAL	GENE-Y	23	18	BACKGROUND : In essential hypertension an elevated renal vascular resistance ( RVR ) may be a marker of gene-gene-chemical system-mediated impairment of renal chemical excretion .	T8	T17	10583449
NA	CHEMICAL	GENE-Y	23	5	BACKGROUND : In essential hypertension an elevated renal vascular resistance ( RVR ) may be a marker of gene-gene-chemical system-mediated impairment of renal chemical excretion .	T8	T18	10583449
NA	CHEMICAL	GENE-Y	8	8	This hypothesis was tested by investigating whether , in subjects with essential hypertension , the natriuretic response to specific gene-chemical-chemical system ( RAAS ) blockade by gene-inhibitor chemical could be predicted from pretreatment renal vascular tone .	T10	T19	10583449
NA	CHEMICAL	GENE-Y	8	8	This hypothesis was tested by investigating whether , in subjects with essential hypertension , the natriuretic response to specific gene-chemical-chemical system ( RAAS ) blockade by gene-inhibitor chemical could be predicted from pretreatment renal vascular tone .	T10	T20	10583449
NA	CHEMICAL	GENE-Y	8	8	This hypothesis was tested by investigating whether , in subjects with essential hypertension , the natriuretic response to specific gene-chemical-chemical system ( RAAS ) blockade by gene-inhibitor chemical could be predicted from pretreatment renal vascular tone .	T10	T21	10583449
NA	CHEMICAL	GENE-Y	19	8	This hypothesis was tested by investigating whether , in subjects with essential hypertension , the natriuretic response to specific gene-chemical-chemical system ( RAAS ) blockade by gene-inhibitor chemical could be predicted from pretreatment renal vascular tone .	T11	T19	10583449
NA	CHEMICAL	GENE-Y	19	8	This hypothesis was tested by investigating whether , in subjects with essential hypertension , the natriuretic response to specific gene-chemical-chemical system ( RAAS ) blockade by gene-inhibitor chemical could be predicted from pretreatment renal vascular tone .	T11	T20	10583449
NA	CHEMICAL	GENE-Y	19	8	This hypothesis was tested by investigating whether , in subjects with essential hypertension , the natriuretic response to specific gene-chemical-chemical system ( RAAS ) blockade by gene-inhibitor chemical could be predicted from pretreatment renal vascular tone .	T11	T21	10583449
CPR:4	CHEMICAL	GENE-Y	27	8	This hypothesis was tested by investigating whether , in subjects with essential hypertension , the natriuretic response to specific gene-chemical-chemical system ( RAAS ) blockade by gene-inhibitor chemical could be predicted from pretreatment renal vascular tone .	T12	T19	10583449
CPR:4	CHEMICAL	GENE-Y	27	8	This hypothesis was tested by investigating whether , in subjects with essential hypertension , the natriuretic response to specific gene-chemical-chemical system ( RAAS ) blockade by gene-inhibitor chemical could be predicted from pretreatment renal vascular tone .	T12	T20	10583449
CPR:4	CHEMICAL	GENE-Y	27	8	This hypothesis was tested by investigating whether , in subjects with essential hypertension , the natriuretic response to specific gene-chemical-chemical system ( RAAS ) blockade by gene-inhibitor chemical could be predicted from pretreatment renal vascular tone .	T12	T21	10583449
NA	CHEMICAL	GENE-Y	2	3	Occupancy of chemical gene , gene and chemical ( 2A ) receptors in schizophrenic patients treated with chemical in comparison with chemical and chemical .	T13	T35	17111172
NA	CHEMICAL	GENE-Y	2	5	Occupancy of chemical gene , gene and chemical ( 2A ) receptors in schizophrenic patients treated with chemical in comparison with chemical and chemical .	T13	T36	17111172
NA	CHEMICAL	GENE-Y	2	11	Occupancy of chemical gene , gene and chemical ( 2A ) receptors in schizophrenic patients treated with chemical in comparison with chemical and chemical .	T13	T37	17111172
NA	CHEMICAL	GENE-Y	7	3	Occupancy of chemical gene , gene and chemical ( 2A ) receptors in schizophrenic patients treated with chemical in comparison with chemical and chemical .	T16	T35	17111172
NA	CHEMICAL	GENE-Y	7	5	Occupancy of chemical gene , gene and chemical ( 2A ) receptors in schizophrenic patients treated with chemical in comparison with chemical and chemical .	T16	T36	17111172
NA	CHEMICAL	GENE-Y	7	11	Occupancy of chemical gene , gene and chemical ( 2A ) receptors in schizophrenic patients treated with chemical in comparison with chemical and chemical .	T16	T37	17111172
NA	CHEMICAL	GENE-Y	17	3	Occupancy of chemical gene , gene and chemical ( 2A ) receptors in schizophrenic patients treated with chemical in comparison with chemical and chemical .	T12	T35	17111172
NA	CHEMICAL	GENE-Y	17	5	Occupancy of chemical gene , gene and chemical ( 2A ) receptors in schizophrenic patients treated with chemical in comparison with chemical and chemical .	T12	T36	17111172
NA	CHEMICAL	GENE-Y	17	11	Occupancy of chemical gene , gene and chemical ( 2A ) receptors in schizophrenic patients treated with chemical in comparison with chemical and chemical .	T12	T37	17111172
NA	CHEMICAL	GENE-Y	21	3	Occupancy of chemical gene , gene and chemical ( 2A ) receptors in schizophrenic patients treated with chemical in comparison with chemical and chemical .	T14	T35	17111172
NA	CHEMICAL	GENE-Y	21	5	Occupancy of chemical gene , gene and chemical ( 2A ) receptors in schizophrenic patients treated with chemical in comparison with chemical and chemical .	T14	T36	17111172
NA	CHEMICAL	GENE-Y	21	11	Occupancy of chemical gene , gene and chemical ( 2A ) receptors in schizophrenic patients treated with chemical in comparison with chemical and chemical .	T14	T37	17111172
NA	CHEMICAL	GENE-Y	23	3	Occupancy of chemical gene , gene and chemical ( 2A ) receptors in schizophrenic patients treated with chemical in comparison with chemical and chemical .	T15	T35	17111172
NA	CHEMICAL	GENE-Y	23	5	Occupancy of chemical gene , gene and chemical ( 2A ) receptors in schizophrenic patients treated with chemical in comparison with chemical and chemical .	T15	T36	17111172
NA	CHEMICAL	GENE-Y	23	11	Occupancy of chemical gene , gene and chemical ( 2A ) receptors in schizophrenic patients treated with chemical in comparison with chemical and chemical .	T15	T37	17111172
NA	CHEMICAL	GENE-Y	7	8	In vitro data show comparable affinity to chemical D ( 2 ) , gene and gene and recently , chemical showed to be not inferior to chemical in schizophrenic patients with predominant negative symptomatology , which was implicated with flupentixol 's interaction with gene and/or gene .	T2	T22	17111172
NA	CHEMICAL	GENE-Y	7	8	In vitro data show comparable affinity to chemical D ( 2 ) , gene and gene and recently , chemical showed to be not inferior to chemical in schizophrenic patients with predominant negative symptomatology , which was implicated with flupentixol 's interaction with gene and/or gene .	T2	T23	17111172
NA	CHEMICAL	GENE-Y	7	6	In vitro data show comparable affinity to chemical D ( 2 ) , gene and gene and recently , chemical showed to be not inferior to chemical in schizophrenic patients with predominant negative symptomatology , which was implicated with flupentixol 's interaction with gene and/or gene .	T2	T26	17111172
NA	CHEMICAL	GENE-Y	7	9	In vitro data show comparable affinity to chemical D ( 2 ) , gene and gene and recently , chemical showed to be not inferior to chemical in schizophrenic patients with predominant negative symptomatology , which was implicated with flupentixol 's interaction with gene and/or gene .	T2	T29	17111172
NA	CHEMICAL	GENE-Y	7	6	In vitro data show comparable affinity to chemical D ( 2 ) , gene and gene and recently , chemical showed to be not inferior to chemical in schizophrenic patients with predominant negative symptomatology , which was implicated with flupentixol 's interaction with gene and/or gene .	T2	T30	17111172
NA	CHEMICAL	GENE-Y	19	8	In vitro data show comparable affinity to chemical D ( 2 ) , gene and gene and recently , chemical showed to be not inferior to chemical in schizophrenic patients with predominant negative symptomatology , which was implicated with flupentixol 's interaction with gene and/or gene .	T4	T22	17111172
NA	CHEMICAL	GENE-Y	19	8	In vitro data show comparable affinity to chemical D ( 2 ) , gene and gene and recently , chemical showed to be not inferior to chemical in schizophrenic patients with predominant negative symptomatology , which was implicated with flupentixol 's interaction with gene and/or gene .	T4	T23	17111172
NA	CHEMICAL	GENE-Y	19	6	In vitro data show comparable affinity to chemical D ( 2 ) , gene and gene and recently , chemical showed to be not inferior to chemical in schizophrenic patients with predominant negative symptomatology , which was implicated with flupentixol 's interaction with gene and/or gene .	T4	T26	17111172
NA	CHEMICAL	GENE-Y	19	9	In vitro data show comparable affinity to chemical D ( 2 ) , gene and gene and recently , chemical showed to be not inferior to chemical in schizophrenic patients with predominant negative symptomatology , which was implicated with flupentixol 's interaction with gene and/or gene .	T4	T29	17111172
NA	CHEMICAL	GENE-Y	19	6	In vitro data show comparable affinity to chemical D ( 2 ) , gene and gene and recently , chemical showed to be not inferior to chemical in schizophrenic patients with predominant negative symptomatology , which was implicated with flupentixol 's interaction with gene and/or gene .	T4	T30	17111172
NA	CHEMICAL	GENE-Y	26	8	In vitro data show comparable affinity to chemical D ( 2 ) , gene and gene and recently , chemical showed to be not inferior to chemical in schizophrenic patients with predominant negative symptomatology , which was implicated with flupentixol 's interaction with gene and/or gene .	T5	T22	17111172
NA	CHEMICAL	GENE-Y	26	8	In vitro data show comparable affinity to chemical D ( 2 ) , gene and gene and recently , chemical showed to be not inferior to chemical in schizophrenic patients with predominant negative symptomatology , which was implicated with flupentixol 's interaction with gene and/or gene .	T5	T23	17111172
NA	CHEMICAL	GENE-Y	26	6	In vitro data show comparable affinity to chemical D ( 2 ) , gene and gene and recently , chemical showed to be not inferior to chemical in schizophrenic patients with predominant negative symptomatology , which was implicated with flupentixol 's interaction with gene and/or gene .	T5	T26	17111172
NA	CHEMICAL	GENE-Y	26	9	In vitro data show comparable affinity to chemical D ( 2 ) , gene and gene and recently , chemical showed to be not inferior to chemical in schizophrenic patients with predominant negative symptomatology , which was implicated with flupentixol 's interaction with gene and/or gene .	T5	T29	17111172
NA	CHEMICAL	GENE-Y	26	6	In vitro data show comparable affinity to chemical D ( 2 ) , gene and gene and recently , chemical showed to be not inferior to chemical in schizophrenic patients with predominant negative symptomatology , which was implicated with flupentixol 's interaction with gene and/or gene .	T5	T30	17111172
NA	CHEMICAL	GENE-Y	11	12	MATERIALS AND METHODS : Each patient underwent two PET scans with chemical ( target : frontal gene ) , chemical ( striatal gene ) or chemical ( striatal gene ) .	T9	T31	17111172
NA	CHEMICAL	GENE-Y	11	12	MATERIALS AND METHODS : Each patient underwent two PET scans with chemical ( target : frontal gene ) , chemical ( striatal gene ) or chemical ( striatal gene ) .	T9	T32	17111172
NA	CHEMICAL	GENE-Y	11	12	MATERIALS AND METHODS : Each patient underwent two PET scans with chemical ( target : frontal gene ) , chemical ( striatal gene ) or chemical ( striatal gene ) .	T9	T33	17111172
NA	CHEMICAL	GENE-Y	12	12	MATERIALS AND METHODS : Each patient underwent two PET scans with chemical ( target : frontal gene ) , chemical ( striatal gene ) or chemical ( striatal gene ) .	T10	T31	17111172
NA	CHEMICAL	GENE-Y	12	12	MATERIALS AND METHODS : Each patient underwent two PET scans with chemical ( target : frontal gene ) , chemical ( striatal gene ) or chemical ( striatal gene ) .	T10	T32	17111172
NA	CHEMICAL	GENE-Y	12	12	MATERIALS AND METHODS : Each patient underwent two PET scans with chemical ( target : frontal gene ) , chemical ( striatal gene ) or chemical ( striatal gene ) .	T10	T33	17111172
NA	CHEMICAL	GENE-Y	12	12	MATERIALS AND METHODS : Each patient underwent two PET scans with chemical ( target : frontal gene ) , chemical ( striatal gene ) or chemical ( striatal gene ) .	T11	T31	17111172
NA	CHEMICAL	GENE-Y	12	12	MATERIALS AND METHODS : Each patient underwent two PET scans with chemical ( target : frontal gene ) , chemical ( striatal gene ) or chemical ( striatal gene ) .	T11	T32	17111172
NA	CHEMICAL	GENE-Y	12	12	MATERIALS AND METHODS : Each patient underwent two PET scans with chemical ( target : frontal gene ) , chemical ( striatal gene ) or chemical ( striatal gene ) .	T11	T33	17111172
NA	CHEMICAL	GENE-Y	18	9	CONCLUSIONS : We were able to demonstrate a moderate gene and gene occupancy under clinically relevant doses of chemical , albeit lower than expected from in vitro data and clearly below saturation .	T3	T20	17111172
NA	CHEMICAL	GENE-Y	18	11	CONCLUSIONS : We were able to demonstrate a moderate gene and gene occupancy under clinically relevant doses of chemical , albeit lower than expected from in vitro data and clearly below saturation .	T3	T21	17111172
CPR:4	CHEMICAL	GENE-N	8	13	Synthesis and cancer stem cell-based activity of substituted chemical designed as next generation gene inhibitors .	T4	T14	23410005
CPR:4	CHEMICAL	GENE-N	11	17	Our previous work , built on the early pioneering multikinase inhibitor chemical , resulted in the only gene vascular-targeted gene inhibitor prodrug , chemical , which has now completed Phase I clinical trials .	T1	T7	23410005
CPR:4	CHEMICAL	GENE-N	11	19	Our previous work , built on the early pioneering multikinase inhibitor chemical , resulted in the only gene vascular-targeted gene inhibitor prodrug , chemical , which has now completed Phase I clinical trials .	T1	T8	23410005
CPR:4	CHEMICAL	GENE-N	23	17	Our previous work , built on the early pioneering multikinase inhibitor chemical , resulted in the only gene vascular-targeted gene inhibitor prodrug , chemical , which has now completed Phase I clinical trials .	T2	T7	23410005
CPR:4	CHEMICAL	GENE-N	23	19	Our previous work , built on the early pioneering multikinase inhibitor chemical , resulted in the only gene vascular-targeted gene inhibitor prodrug , chemical , which has now completed Phase I clinical trials .	T2	T8	23410005
CPR:9	CHEMICAL	GENE-Y	9	14	We isolated partial cDNAs that codified for enzymes implicated in the chemical biosynthesis such as chemical chemical-lyase ( gene ) and chemical synthase ( gene ) , and an antioxidant enzyme such as chemical peroxidase ( gene ) .	T7	T19	17570561
CPR:9	CHEMICAL	GENE-Y	9	18	We isolated partial cDNAs that codified for enzymes implicated in the chemical biosynthesis such as chemical chemical-lyase ( gene ) and chemical synthase ( gene ) , and an antioxidant enzyme such as chemical peroxidase ( gene ) .	T7	T20	17570561
CPR:9	CHEMICAL	GENE-Y	9	14	We isolated partial cDNAs that codified for enzymes implicated in the chemical biosynthesis such as chemical chemical-lyase ( gene ) and chemical synthase ( gene ) , and an antioxidant enzyme such as chemical peroxidase ( gene ) .	T7	T21	17570561
CPR:9	CHEMICAL	GENE-Y	9	24	We isolated partial cDNAs that codified for enzymes implicated in the chemical biosynthesis such as chemical chemical-lyase ( gene ) and chemical synthase ( gene ) , and an antioxidant enzyme such as chemical peroxidase ( gene ) .	T7	T22	17570561
CPR:9	CHEMICAL	GENE-Y	9	14	We isolated partial cDNAs that codified for enzymes implicated in the chemical biosynthesis such as chemical chemical-lyase ( gene ) and chemical synthase ( gene ) , and an antioxidant enzyme such as chemical peroxidase ( gene ) .	T7	T23	17570561
CPR:9	CHEMICAL	GENE-Y	9	36	We isolated partial cDNAs that codified for enzymes implicated in the chemical biosynthesis such as chemical chemical-lyase ( gene ) and chemical synthase ( gene ) , and an antioxidant enzyme such as chemical peroxidase ( gene ) .	T7	T24	17570561
NA	CHEMICAL	GENE-Y	9	14	We isolated partial cDNAs that codified for enzymes implicated in the chemical biosynthesis such as chemical chemical-lyase ( gene ) and chemical synthase ( gene ) , and an antioxidant enzyme such as chemical peroxidase ( gene ) .	T8	T19	17570561
NA	CHEMICAL	GENE-Y	9	18	We isolated partial cDNAs that codified for enzymes implicated in the chemical biosynthesis such as chemical chemical-lyase ( gene ) and chemical synthase ( gene ) , and an antioxidant enzyme such as chemical peroxidase ( gene ) .	T8	T20	17570561
NA	CHEMICAL	GENE-Y	9	14	We isolated partial cDNAs that codified for enzymes implicated in the chemical biosynthesis such as chemical chemical-lyase ( gene ) and chemical synthase ( gene ) , and an antioxidant enzyme such as chemical peroxidase ( gene ) .	T8	T21	17570561
NA	CHEMICAL	GENE-Y	9	24	We isolated partial cDNAs that codified for enzymes implicated in the chemical biosynthesis such as chemical chemical-lyase ( gene ) and chemical synthase ( gene ) , and an antioxidant enzyme such as chemical peroxidase ( gene ) .	T8	T22	17570561
NA	CHEMICAL	GENE-Y	9	14	We isolated partial cDNAs that codified for enzymes implicated in the chemical biosynthesis such as chemical chemical-lyase ( gene ) and chemical synthase ( gene ) , and an antioxidant enzyme such as chemical peroxidase ( gene ) .	T8	T23	17570561
NA	CHEMICAL	GENE-Y	9	36	We isolated partial cDNAs that codified for enzymes implicated in the chemical biosynthesis such as chemical chemical-lyase ( gene ) and chemical synthase ( gene ) , and an antioxidant enzyme such as chemical peroxidase ( gene ) .	T8	T24	17570561
NA	CHEMICAL	GENE-Y	16	14	We isolated partial cDNAs that codified for enzymes implicated in the chemical biosynthesis such as chemical chemical-lyase ( gene ) and chemical synthase ( gene ) , and an antioxidant enzyme such as chemical peroxidase ( gene ) .	T9	T19	17570561
NA	CHEMICAL	GENE-Y	16	18	We isolated partial cDNAs that codified for enzymes implicated in the chemical biosynthesis such as chemical chemical-lyase ( gene ) and chemical synthase ( gene ) , and an antioxidant enzyme such as chemical peroxidase ( gene ) .	T9	T20	17570561
NA	CHEMICAL	GENE-Y	16	14	We isolated partial cDNAs that codified for enzymes implicated in the chemical biosynthesis such as chemical chemical-lyase ( gene ) and chemical synthase ( gene ) , and an antioxidant enzyme such as chemical peroxidase ( gene ) .	T9	T21	17570561
NA	CHEMICAL	GENE-Y	16	24	We isolated partial cDNAs that codified for enzymes implicated in the chemical biosynthesis such as chemical chemical-lyase ( gene ) and chemical synthase ( gene ) , and an antioxidant enzyme such as chemical peroxidase ( gene ) .	T9	T22	17570561
NA	CHEMICAL	GENE-Y	16	14	We isolated partial cDNAs that codified for enzymes implicated in the chemical biosynthesis such as chemical chemical-lyase ( gene ) and chemical synthase ( gene ) , and an antioxidant enzyme such as chemical peroxidase ( gene ) .	T9	T23	17570561
NA	CHEMICAL	GENE-Y	16	36	We isolated partial cDNAs that codified for enzymes implicated in the chemical biosynthesis such as chemical chemical-lyase ( gene ) and chemical synthase ( gene ) , and an antioxidant enzyme such as chemical peroxidase ( gene ) .	T9	T24	17570561
NA	CHEMICAL	GENE-Y	21	14	We isolated partial cDNAs that codified for enzymes implicated in the chemical biosynthesis such as chemical chemical-lyase ( gene ) and chemical synthase ( gene ) , and an antioxidant enzyme such as chemical peroxidase ( gene ) .	T10	T19	17570561
NA	CHEMICAL	GENE-Y	21	18	We isolated partial cDNAs that codified for enzymes implicated in the chemical biosynthesis such as chemical chemical-lyase ( gene ) and chemical synthase ( gene ) , and an antioxidant enzyme such as chemical peroxidase ( gene ) .	T10	T20	17570561
NA	CHEMICAL	GENE-Y	21	14	We isolated partial cDNAs that codified for enzymes implicated in the chemical biosynthesis such as chemical chemical-lyase ( gene ) and chemical synthase ( gene ) , and an antioxidant enzyme such as chemical peroxidase ( gene ) .	T10	T21	17570561
NA	CHEMICAL	GENE-Y	21	24	We isolated partial cDNAs that codified for enzymes implicated in the chemical biosynthesis such as chemical chemical-lyase ( gene ) and chemical synthase ( gene ) , and an antioxidant enzyme such as chemical peroxidase ( gene ) .	T10	T22	17570561
NA	CHEMICAL	GENE-Y	21	14	We isolated partial cDNAs that codified for enzymes implicated in the chemical biosynthesis such as chemical chemical-lyase ( gene ) and chemical synthase ( gene ) , and an antioxidant enzyme such as chemical peroxidase ( gene ) .	T10	T23	17570561
NA	CHEMICAL	GENE-Y	21	36	We isolated partial cDNAs that codified for enzymes implicated in the chemical biosynthesis such as chemical chemical-lyase ( gene ) and chemical synthase ( gene ) , and an antioxidant enzyme such as chemical peroxidase ( gene ) .	T10	T24	17570561
NA	CHEMICAL	GENE-Y	14	14	We isolated partial cDNAs that codified for enzymes implicated in the chemical biosynthesis such as chemical chemical-lyase ( gene ) and chemical synthase ( gene ) , and an antioxidant enzyme such as chemical peroxidase ( gene ) .	T11	T19	17570561
NA	CHEMICAL	GENE-Y	14	18	We isolated partial cDNAs that codified for enzymes implicated in the chemical biosynthesis such as chemical chemical-lyase ( gene ) and chemical synthase ( gene ) , and an antioxidant enzyme such as chemical peroxidase ( gene ) .	T11	T20	17570561
NA	CHEMICAL	GENE-Y	14	14	We isolated partial cDNAs that codified for enzymes implicated in the chemical biosynthesis such as chemical chemical-lyase ( gene ) and chemical synthase ( gene ) , and an antioxidant enzyme such as chemical peroxidase ( gene ) .	T11	T21	17570561
NA	CHEMICAL	GENE-Y	14	24	We isolated partial cDNAs that codified for enzymes implicated in the chemical biosynthesis such as chemical chemical-lyase ( gene ) and chemical synthase ( gene ) , and an antioxidant enzyme such as chemical peroxidase ( gene ) .	T11	T22	17570561
NA	CHEMICAL	GENE-Y	14	14	We isolated partial cDNAs that codified for enzymes implicated in the chemical biosynthesis such as chemical chemical-lyase ( gene ) and chemical synthase ( gene ) , and an antioxidant enzyme such as chemical peroxidase ( gene ) .	T11	T23	17570561
NA	CHEMICAL	GENE-Y	14	36	We isolated partial cDNAs that codified for enzymes implicated in the chemical biosynthesis such as chemical chemical-lyase ( gene ) and chemical synthase ( gene ) , and an antioxidant enzyme such as chemical peroxidase ( gene ) .	T11	T24	17570561
NA	CHEMICAL	GENE-Y	3	8	The up-regulation of chemical biosynthesis gene expression and gene mRNA observed in non-treated grape is not enhanced in chemical-treated grapes , which presented low total decay .	T15	T18	17570561
NA	CHEMICAL	GENE-Y	3	8	The up-regulation of chemical biosynthesis gene expression and gene mRNA observed in non-treated grape is not enhanced in chemical-treated grapes , which presented low total decay .	T1	T18	17570561
NA	CHEMICAL	GENE-Y	8	6	Accordingly , the production rates of gene and chemical , as well as gene activity , were significantly higher in the 3D versus the 2D cultures .	T8	T13	23377618
NA	CHEMICAL	GENE-Y	8	13	Accordingly , the production rates of gene and chemical , as well as gene activity , were significantly higher in the 3D versus the 2D cultures .	T8	T14	23377618
NA	CHEMICAL	GENE-N	14	15	UV-B radiation led to the inhibition in the activities of the key enzymes ( chemical reductase , chemical synthetase , chemical synthase ) in the chemical assimilation , the decrease in the contents of chemical and soluble proteins , as well as the increase in the content of chemical in soybean seedlings .	T13	T25	23090712
NA	CHEMICAL	GENE-N	14	4	UV-B radiation led to the inhibition in the activities of the key enzymes ( chemical reductase , chemical synthetase , chemical synthase ) in the chemical assimilation , the decrease in the contents of chemical and soluble proteins , as well as the increase in the content of chemical in soybean seedlings .	T13	T26	23090712
NA	CHEMICAL	GENE-N	14	21	UV-B radiation led to the inhibition in the activities of the key enzymes ( chemical reductase , chemical synthetase , chemical synthase ) in the chemical assimilation , the decrease in the contents of chemical and soluble proteins , as well as the increase in the content of chemical in soybean seedlings .	T13	T27	23090712
NA	CHEMICAL	GENE-N	6	15	UV-B radiation led to the inhibition in the activities of the key enzymes ( chemical reductase , chemical synthetase , chemical synthase ) in the chemical assimilation , the decrease in the contents of chemical and soluble proteins , as well as the increase in the content of chemical in soybean seedlings .	T14	T25	23090712
NA	CHEMICAL	GENE-N	6	4	UV-B radiation led to the inhibition in the activities of the key enzymes ( chemical reductase , chemical synthetase , chemical synthase ) in the chemical assimilation , the decrease in the contents of chemical and soluble proteins , as well as the increase in the content of chemical in soybean seedlings .	T14	T26	23090712
NA	CHEMICAL	GENE-N	6	21	UV-B radiation led to the inhibition in the activities of the key enzymes ( chemical reductase , chemical synthetase , chemical synthase ) in the chemical assimilation , the decrease in the contents of chemical and soluble proteins , as well as the increase in the content of chemical in soybean seedlings .	T14	T27	23090712
NA	CHEMICAL	GENE-N	20	15	UV-B radiation led to the inhibition in the activities of the key enzymes ( chemical reductase , chemical synthetase , chemical synthase ) in the chemical assimilation , the decrease in the contents of chemical and soluble proteins , as well as the increase in the content of chemical in soybean seedlings .	T15	T25	23090712
NA	CHEMICAL	GENE-N	20	4	UV-B radiation led to the inhibition in the activities of the key enzymes ( chemical reductase , chemical synthetase , chemical synthase ) in the chemical assimilation , the decrease in the contents of chemical and soluble proteins , as well as the increase in the content of chemical in soybean seedlings .	T15	T26	23090712
NA	CHEMICAL	GENE-N	20	21	UV-B radiation led to the inhibition in the activities of the key enzymes ( chemical reductase , chemical synthetase , chemical synthase ) in the chemical assimilation , the decrease in the contents of chemical and soluble proteins , as well as the increase in the content of chemical in soybean seedlings .	T15	T27	23090712
NA	CHEMICAL	GENE-N	25	15	UV-B radiation led to the inhibition in the activities of the key enzymes ( chemical reductase , chemical synthetase , chemical synthase ) in the chemical assimilation , the decrease in the contents of chemical and soluble proteins , as well as the increase in the content of chemical in soybean seedlings .	T16	T25	23090712
NA	CHEMICAL	GENE-N	25	4	UV-B radiation led to the inhibition in the activities of the key enzymes ( chemical reductase , chemical synthetase , chemical synthase ) in the chemical assimilation , the decrease in the contents of chemical and soluble proteins , as well as the increase in the content of chemical in soybean seedlings .	T16	T26	23090712
NA	CHEMICAL	GENE-N	25	21	UV-B radiation led to the inhibition in the activities of the key enzymes ( chemical reductase , chemical synthetase , chemical synthase ) in the chemical assimilation , the decrease in the contents of chemical and soluble proteins , as well as the increase in the content of chemical in soybean seedlings .	T16	T27	23090712
NA	CHEMICAL	GENE-N	34	15	UV-B radiation led to the inhibition in the activities of the key enzymes ( chemical reductase , chemical synthetase , chemical synthase ) in the chemical assimilation , the decrease in the contents of chemical and soluble proteins , as well as the increase in the content of chemical in soybean seedlings .	T17	T25	23090712
NA	CHEMICAL	GENE-N	34	4	UV-B radiation led to the inhibition in the activities of the key enzymes ( chemical reductase , chemical synthetase , chemical synthase ) in the chemical assimilation , the decrease in the contents of chemical and soluble proteins , as well as the increase in the content of chemical in soybean seedlings .	T17	T26	23090712
NA	CHEMICAL	GENE-N	34	21	UV-B radiation led to the inhibition in the activities of the key enzymes ( chemical reductase , chemical synthetase , chemical synthase ) in the chemical assimilation , the decrease in the contents of chemical and soluble proteins , as well as the increase in the content of chemical in soybean seedlings .	T17	T27	23090712
NA	CHEMICAL	GENE-N	48	15	UV-B radiation led to the inhibition in the activities of the key enzymes ( chemical reductase , chemical synthetase , chemical synthase ) in the chemical assimilation , the decrease in the contents of chemical and soluble proteins , as well as the increase in the content of chemical in soybean seedlings .	T18	T25	23090712
NA	CHEMICAL	GENE-N	48	4	UV-B radiation led to the inhibition in the activities of the key enzymes ( chemical reductase , chemical synthetase , chemical synthase ) in the chemical assimilation , the decrease in the contents of chemical and soluble proteins , as well as the increase in the content of chemical in soybean seedlings .	T18	T26	23090712
NA	CHEMICAL	GENE-N	48	21	UV-B radiation led to the inhibition in the activities of the key enzymes ( chemical reductase , chemical synthetase , chemical synthase ) in the chemical assimilation , the decrease in the contents of chemical and soluble proteins , as well as the increase in the content of chemical in soybean seedlings .	T18	T27	23090712
CPR:4	CHEMICAL	GENE-N	5	22	The pretreatment with 20 mg L ( -1 ) chemical could alleviate the effects of UV-B radiation on the activities of chemical reductase , chemical synthetase , chemical synthase , and chemical dehydrogenase , promoting chemical conversion and protein synthesis in soybean seedlings .	T1	T21	23090712
CPR:4	CHEMICAL	GENE-N	5	12	The pretreatment with 20 mg L ( -1 ) chemical could alleviate the effects of UV-B radiation on the activities of chemical reductase , chemical synthetase , chemical synthase , and chemical dehydrogenase , promoting chemical conversion and protein synthesis in soybean seedlings .	T1	T22	23090712
CPR:4	CHEMICAL	GENE-N	5	28	The pretreatment with 20 mg L ( -1 ) chemical could alleviate the effects of UV-B radiation on the activities of chemical reductase , chemical synthetase , chemical synthase , and chemical dehydrogenase , promoting chemical conversion and protein synthesis in soybean seedlings .	T1	T23	23090712
CPR:4	CHEMICAL	GENE-N	5	32	The pretreatment with 20 mg L ( -1 ) chemical could alleviate the effects of UV-B radiation on the activities of chemical reductase , chemical synthetase , chemical synthase , and chemical dehydrogenase , promoting chemical conversion and protein synthesis in soybean seedlings .	T1	T24	23090712
NA	CHEMICAL	GENE-N	21	22	The pretreatment with 20 mg L ( -1 ) chemical could alleviate the effects of UV-B radiation on the activities of chemical reductase , chemical synthetase , chemical synthase , and chemical dehydrogenase , promoting chemical conversion and protein synthesis in soybean seedlings .	T2	T21	23090712
NA	CHEMICAL	GENE-N	21	12	The pretreatment with 20 mg L ( -1 ) chemical could alleviate the effects of UV-B radiation on the activities of chemical reductase , chemical synthetase , chemical synthase , and chemical dehydrogenase , promoting chemical conversion and protein synthesis in soybean seedlings .	T2	T22	23090712
NA	CHEMICAL	GENE-N	21	28	The pretreatment with 20 mg L ( -1 ) chemical could alleviate the effects of UV-B radiation on the activities of chemical reductase , chemical synthetase , chemical synthase , and chemical dehydrogenase , promoting chemical conversion and protein synthesis in soybean seedlings .	T2	T23	23090712
NA	CHEMICAL	GENE-N	21	32	The pretreatment with 20 mg L ( -1 ) chemical could alleviate the effects of UV-B radiation on the activities of chemical reductase , chemical synthetase , chemical synthase , and chemical dehydrogenase , promoting chemical conversion and protein synthesis in soybean seedlings .	T2	T24	23090712
NA	CHEMICAL	GENE-N	24	22	The pretreatment with 20 mg L ( -1 ) chemical could alleviate the effects of UV-B radiation on the activities of chemical reductase , chemical synthetase , chemical synthase , and chemical dehydrogenase , promoting chemical conversion and protein synthesis in soybean seedlings .	T3	T21	23090712
NA	CHEMICAL	GENE-N	24	12	The pretreatment with 20 mg L ( -1 ) chemical could alleviate the effects of UV-B radiation on the activities of chemical reductase , chemical synthetase , chemical synthase , and chemical dehydrogenase , promoting chemical conversion and protein synthesis in soybean seedlings .	T3	T22	23090712
NA	CHEMICAL	GENE-N	24	28	The pretreatment with 20 mg L ( -1 ) chemical could alleviate the effects of UV-B radiation on the activities of chemical reductase , chemical synthetase , chemical synthase , and chemical dehydrogenase , promoting chemical conversion and protein synthesis in soybean seedlings .	T3	T23	23090712
NA	CHEMICAL	GENE-N	24	32	The pretreatment with 20 mg L ( -1 ) chemical could alleviate the effects of UV-B radiation on the activities of chemical reductase , chemical synthetase , chemical synthase , and chemical dehydrogenase , promoting chemical conversion and protein synthesis in soybean seedlings .	T3	T24	23090712
NA	CHEMICAL	GENE-N	27	22	The pretreatment with 20 mg L ( -1 ) chemical could alleviate the effects of UV-B radiation on the activities of chemical reductase , chemical synthetase , chemical synthase , and chemical dehydrogenase , promoting chemical conversion and protein synthesis in soybean seedlings .	T4	T21	23090712
NA	CHEMICAL	GENE-N	27	12	The pretreatment with 20 mg L ( -1 ) chemical could alleviate the effects of UV-B radiation on the activities of chemical reductase , chemical synthetase , chemical synthase , and chemical dehydrogenase , promoting chemical conversion and protein synthesis in soybean seedlings .	T4	T22	23090712
NA	CHEMICAL	GENE-N	27	28	The pretreatment with 20 mg L ( -1 ) chemical could alleviate the effects of UV-B radiation on the activities of chemical reductase , chemical synthetase , chemical synthase , and chemical dehydrogenase , promoting chemical conversion and protein synthesis in soybean seedlings .	T4	T23	23090712
NA	CHEMICAL	GENE-N	27	32	The pretreatment with 20 mg L ( -1 ) chemical could alleviate the effects of UV-B radiation on the activities of chemical reductase , chemical synthetase , chemical synthase , and chemical dehydrogenase , promoting chemical conversion and protein synthesis in soybean seedlings .	T4	T24	23090712
NA	CHEMICAL	GENE-N	31	22	The pretreatment with 20 mg L ( -1 ) chemical could alleviate the effects of UV-B radiation on the activities of chemical reductase , chemical synthetase , chemical synthase , and chemical dehydrogenase , promoting chemical conversion and protein synthesis in soybean seedlings .	T5	T21	23090712
NA	CHEMICAL	GENE-N	31	12	The pretreatment with 20 mg L ( -1 ) chemical could alleviate the effects of UV-B radiation on the activities of chemical reductase , chemical synthetase , chemical synthase , and chemical dehydrogenase , promoting chemical conversion and protein synthesis in soybean seedlings .	T5	T22	23090712
NA	CHEMICAL	GENE-N	31	28	The pretreatment with 20 mg L ( -1 ) chemical could alleviate the effects of UV-B radiation on the activities of chemical reductase , chemical synthetase , chemical synthase , and chemical dehydrogenase , promoting chemical conversion and protein synthesis in soybean seedlings .	T5	T23	23090712
NA	CHEMICAL	GENE-N	31	32	The pretreatment with 20 mg L ( -1 ) chemical could alleviate the effects of UV-B radiation on the activities of chemical reductase , chemical synthetase , chemical synthase , and chemical dehydrogenase , promoting chemical conversion and protein synthesis in soybean seedlings .	T5	T24	23090712
NA	CHEMICAL	GENE-N	35	22	The pretreatment with 20 mg L ( -1 ) chemical could alleviate the effects of UV-B radiation on the activities of chemical reductase , chemical synthetase , chemical synthase , and chemical dehydrogenase , promoting chemical conversion and protein synthesis in soybean seedlings .	T6	T21	23090712
NA	CHEMICAL	GENE-N	35	12	The pretreatment with 20 mg L ( -1 ) chemical could alleviate the effects of UV-B radiation on the activities of chemical reductase , chemical synthetase , chemical synthase , and chemical dehydrogenase , promoting chemical conversion and protein synthesis in soybean seedlings .	T6	T22	23090712
NA	CHEMICAL	GENE-N	35	28	The pretreatment with 20 mg L ( -1 ) chemical could alleviate the effects of UV-B radiation on the activities of chemical reductase , chemical synthetase , chemical synthase , and chemical dehydrogenase , promoting chemical conversion and protein synthesis in soybean seedlings .	T6	T23	23090712
NA	CHEMICAL	GENE-N	35	32	The pretreatment with 20 mg L ( -1 ) chemical could alleviate the effects of UV-B radiation on the activities of chemical reductase , chemical synthetase , chemical synthase , and chemical dehydrogenase , promoting chemical conversion and protein synthesis in soybean seedlings .	T6	T24	23090712
NA	CHEMICAL	GENE-Y	0	2	chemical X Receptor Mediates Dyslipidemia Induced by the gene Inhibitor chemical in Mice .	T9	T22	23519392
NA	CHEMICAL	GENE-N	0	8	chemical X Receptor Mediates Dyslipidemia Induced by the gene Inhibitor chemical in Mice .	T9	T23	23519392
NA	CHEMICAL	GENE-Y	10	2	chemical X Receptor Mediates Dyslipidemia Induced by the gene Inhibitor chemical in Mice .	T10	T22	23519392
CPR:4	CHEMICAL	GENE-N	10	8	chemical X Receptor Mediates Dyslipidemia Induced by the gene Inhibitor chemical in Mice .	T10	T23	23519392
NA	CHEMICAL	GENE-Y	10	5	Several PIs have been implicated to activate the nuclear receptor chemical X receptor ( gene ) , which acts as a xenobiotic sensor to regulate xenobiotic metabolism in the liver and intestine .	T4	T15	23519392
NA	CHEMICAL	GENE-Y	10	11	Several PIs have been implicated to activate the nuclear receptor chemical X receptor ( gene ) , which acts as a xenobiotic sensor to regulate xenobiotic metabolism in the liver and intestine .	T4	T16	23519392
CPR:5	CHEMICAL	GENE-Y	7	18	In the present study , we identified chemical , a widely used HIV PI , as a potent gene-selective agonist .	T5	T18	23519392
NA	CHEMICAL	GENE-Y	24	17	Computational docking studies combined with site-direct mutagenesis identified several key residues within the ligand binding pocket of gene that constitute points of interaction with chemical .	T6	T19	23519392
CPR:3	CHEMICAL	GENE-Y	0	3	chemical efficiently activated gene and induced gene target gene expression in vitro and in vivo .	T7	T20	23519392
CPR:3	CHEMICAL	GENE-Y	0	6	chemical efficiently activated gene and induced gene target gene expression in vitro and in vivo .	T7	T21	23519392
NA	CHEMICAL	GENE-Y	3	22	Short-term exposure to chemical significantly increased plasma total chemical and atherogenic low-density lipoprotein chemical levels in wild-type mice , but not in gene-deficient mice .	T8	T12	23519392
NA	CHEMICAL	GENE-Y	8	22	Short-term exposure to chemical significantly increased plasma total chemical and atherogenic low-density lipoprotein chemical levels in wild-type mice , but not in gene-deficient mice .	T1	T12	23519392
NA	CHEMICAL	GENE-Y	13	22	Short-term exposure to chemical significantly increased plasma total chemical and atherogenic low-density lipoprotein chemical levels in wild-type mice , but not in gene-deficient mice .	T2	T12	23519392
CPR:3	CHEMICAL	GENE-Y	0	1	chemical-mediated gene activation stimulated the expression of several key intestinal genes involved in lipid homeostasis .	T3	T13	23519392
NA	CHEMICAL	GENE-Y	0	4	chemical metabolites modulate the gene and chemical receptor gene expression in prepubertal rabbits .	T17	T28	7711211
NA	CHEMICAL	GENE-Y	0	7	chemical metabolites modulate the gene and chemical receptor gene expression in prepubertal rabbits .	T17	T29	7711211
NA	CHEMICAL	GENE-Y	6	4	chemical metabolites modulate the gene and chemical receptor gene expression in prepubertal rabbits .	T18	T28	7711211
NA	CHEMICAL	GENE-Y	6	7	chemical metabolites modulate the gene and chemical receptor gene expression in prepubertal rabbits .	T18	T29	7711211
NA	CHEMICAL	GENE-Y	5	9	The effects of these metabolites on the expression of gene ( gene ) and chemical receptor ( gene ) genes , both regulated by chemical , were evaluated in the uterus of prepubertal female rabbits that were simultaneously treated with P4 ( 1.0 mg ) for 5 consecutive days .	T8	T19	7711211
NA	CHEMICAL	GENE-Y	5	11	The effects of these metabolites on the expression of gene ( gene ) and chemical receptor ( gene ) genes , both regulated by chemical , were evaluated in the uterus of prepubertal female rabbits that were simultaneously treated with P4 ( 1.0 mg ) for 5 consecutive days .	T8	T20	7711211
NA	CHEMICAL	GENE-N	5	15	The effects of these metabolites on the expression of gene ( gene ) and chemical receptor ( gene ) genes , both regulated by chemical , were evaluated in the uterus of prepubertal female rabbits that were simultaneously treated with P4 ( 1.0 mg ) for 5 consecutive days .	T8	T21	7711211
NA	CHEMICAL	GENE-N	5	17	The effects of these metabolites on the expression of gene ( gene ) and chemical receptor ( gene ) genes , both regulated by chemical , were evaluated in the uterus of prepubertal female rabbits that were simultaneously treated with P4 ( 1.0 mg ) for 5 consecutive days .	T8	T22	7711211
NA	CHEMICAL	GENE-Y	10	9	The effects of these metabolites on the expression of gene ( gene ) and chemical receptor ( gene ) genes , both regulated by chemical , were evaluated in the uterus of prepubertal female rabbits that were simultaneously treated with P4 ( 1.0 mg ) for 5 consecutive days .	T9	T19	7711211
NA	CHEMICAL	GENE-Y	10	11	The effects of these metabolites on the expression of gene ( gene ) and chemical receptor ( gene ) genes , both regulated by chemical , were evaluated in the uterus of prepubertal female rabbits that were simultaneously treated with P4 ( 1.0 mg ) for 5 consecutive days .	T9	T20	7711211
NA	CHEMICAL	GENE-N	10	15	The effects of these metabolites on the expression of gene ( gene ) and chemical receptor ( gene ) genes , both regulated by chemical , were evaluated in the uterus of prepubertal female rabbits that were simultaneously treated with P4 ( 1.0 mg ) for 5 consecutive days .	T9	T21	7711211
NA	CHEMICAL	GENE-N	10	17	The effects of these metabolites on the expression of gene ( gene ) and chemical receptor ( gene ) genes , both regulated by chemical , were evaluated in the uterus of prepubertal female rabbits that were simultaneously treated with P4 ( 1.0 mg ) for 5 consecutive days .	T9	T22	7711211
CPR:4	CHEMICAL	GENE-Y	9	13	As determined by Western and Northern blot analyses , chemical inhibited the P4-induced gene gene expression in a dose-dependent manner .	T11	T23	7711211
CPR:4	CHEMICAL	GENE-Y	3	15	The estrogenic agent chemical and chemical at a dose of 1.0 mg also inhibited the gene gene expression induced by P4 .	T13	T24	7711211
CPR:4	CHEMICAL	GENE-Y	5	15	The estrogenic agent chemical and chemical at a dose of 1.0 mg also inhibited the gene gene expression induced by P4 .	T14	T24	7711211
CPR:3	CHEMICAL	GENE-Y	1	6	Both chemical and chemical blocked the gene down-regulation induced by P4 as assessed by Western and Northern blot methods .	T15	T25	7711211
CPR:3	CHEMICAL	GENE-Y	3	6	Both chemical and chemical blocked the gene down-regulation induced by P4 as assessed by Western and Northern blot methods .	T16	T25	7711211
NA	CHEMICAL	GENE-Y	0	8	chemical ( chemical ( ® ) ) is a new subcutaneous chemical analogue that acts via gene receptors to inhibit the secretion of gene from the pituitary adenoma in patients with Cushing 's disease .	T1	T23	23605695
NA	CHEMICAL	GENE-N	0	17	chemical ( chemical ( ® ) ) is a new subcutaneous chemical analogue that acts via gene receptors to inhibit the secretion of gene from the pituitary adenoma in patients with Cushing 's disease .	T1	T24	23605695
CPR:4	CHEMICAL	GENE-Y	0	23	chemical ( chemical ( ® ) ) is a new subcutaneous chemical analogue that acts via gene receptors to inhibit the secretion of gene from the pituitary adenoma in patients with Cushing 's disease .	T1	T20	23605695
NA	CHEMICAL	GENE-Y	2	8	chemical ( chemical ( ® ) ) is a new subcutaneous chemical analogue that acts via gene receptors to inhibit the secretion of gene from the pituitary adenoma in patients with Cushing 's disease .	T5	T23	23605695
NA	CHEMICAL	GENE-N	2	17	chemical ( chemical ( ® ) ) is a new subcutaneous chemical analogue that acts via gene receptors to inhibit the secretion of gene from the pituitary adenoma in patients with Cushing 's disease .	T5	T24	23605695
CPR:4	CHEMICAL	GENE-Y	2	23	chemical ( chemical ( ® ) ) is a new subcutaneous chemical analogue that acts via gene receptors to inhibit the secretion of gene from the pituitary adenoma in patients with Cushing 's disease .	T5	T20	23605695
NA	CHEMICAL	GENE-Y	8	8	chemical ( chemical ( ® ) ) is a new subcutaneous chemical analogue that acts via gene receptors to inhibit the secretion of gene from the pituitary adenoma in patients with Cushing 's disease .	T13	T23	23605695
NA	CHEMICAL	GENE-N	8	17	chemical ( chemical ( ® ) ) is a new subcutaneous chemical analogue that acts via gene receptors to inhibit the secretion of gene from the pituitary adenoma in patients with Cushing 's disease .	T13	T24	23605695
NA	CHEMICAL	GENE-Y	8	23	chemical ( chemical ( ® ) ) is a new subcutaneous chemical analogue that acts via gene receptors to inhibit the secretion of gene from the pituitary adenoma in patients with Cushing 's disease .	T13	T20	23605695
NA	CHEMICAL	GENE-Y	8	8	chemical ( chemical ( ® ) ) is a new subcutaneous chemical analogue that acts via gene receptors to inhibit the secretion of gene from the pituitary adenoma in patients with Cushing 's disease .	T16	T23	23605695
NA	CHEMICAL	GENE-N	8	17	chemical ( chemical ( ® ) ) is a new subcutaneous chemical analogue that acts via gene receptors to inhibit the secretion of gene from the pituitary adenoma in patients with Cushing 's disease .	T16	T24	23605695
NA	CHEMICAL	GENE-Y	8	23	chemical ( chemical ( ® ) ) is a new subcutaneous chemical analogue that acts via gene receptors to inhibit the secretion of gene from the pituitary adenoma in patients with Cushing 's disease .	T16	T20	23605695
NA	CHEMICAL	GENE-Y	0	2	chemical has a receptor binding profile that is distinct from that of other chemical analogues , binding with high affinity to gene receptor subtype 5 , which is strongly over expressed in corticotroph adenoma cells .	T9	T21	23605695
NA	CHEMICAL	GENE-Y	0	24	chemical has a receptor binding profile that is distinct from that of other chemical analogues , binding with high affinity to gene receptor subtype 5 , which is strongly over expressed in corticotroph adenoma cells .	T9	T22	23605695
NA	CHEMICAL	GENE-Y	2	2	chemical has a receptor binding profile that is distinct from that of other chemical analogues , binding with high affinity to gene receptor subtype 5 , which is strongly over expressed in corticotroph adenoma cells .	T10	T21	23605695
NA	CHEMICAL	GENE-Y	2	24	chemical has a receptor binding profile that is distinct from that of other chemical analogues , binding with high affinity to gene receptor subtype 5 , which is strongly over expressed in corticotroph adenoma cells .	T10	T22	23605695
NA	CHEMICAL	GENE-Y	2	2	chemical has a receptor binding profile that is distinct from that of other chemical analogues , binding with high affinity to gene receptor subtype 5 , which is strongly over expressed in corticotroph adenoma cells .	T11	T21	23605695
NA	CHEMICAL	GENE-Y	2	24	chemical has a receptor binding profile that is distinct from that of other chemical analogues , binding with high affinity to gene receptor subtype 5 , which is strongly over expressed in corticotroph adenoma cells .	T11	T22	23605695
NA	CHEMICAL	GENE-Y	0	2	chemical has a generally similar tolerability profile to that of other gene analogues , but is associated with a relatively high incidence of hyperglycaemia , requiring the addition or intensification of chemical-lowering medication in a substantial proportion of patients .	T4	T19	23605695
NA	CHEMICAL	GENE-Y	2	2	chemical has a generally similar tolerability profile to that of other gene analogues , but is associated with a relatively high incidence of hyperglycaemia , requiring the addition or intensification of chemical-lowering medication in a substantial proportion of patients .	T6	T19	23605695
NA	CHEMICAL	GENE-Y	31	2	chemical has a generally similar tolerability profile to that of other gene analogues , but is associated with a relatively high incidence of hyperglycaemia , requiring the addition or intensification of chemical-lowering medication in a substantial proportion of patients .	T7	T19	23605695
NA	CHEMICAL	GENE-Y	12	17	In the current studies , we show that two different classes ( chemical-sensitive and -insensitive ) of gene poisons can be identified based on their differential sensitivity to the chemical-bound conformation of gene .	T10	T34	11278845
NA	CHEMICAL	GENE-Y	12	32	In the current studies , we show that two different classes ( chemical-sensitive and -insensitive ) of gene poisons can be identified based on their differential sensitivity to the chemical-bound conformation of gene .	T10	T35	11278845
NA	CHEMICAL	GENE-Y	29	17	In the current studies , we show that two different classes ( chemical-sensitive and -insensitive ) of gene poisons can be identified based on their differential sensitivity to the chemical-bound conformation of gene .	T11	T34	11278845
NA	CHEMICAL	GENE-Y	29	32	In the current studies , we show that two different classes ( chemical-sensitive and -insensitive ) of gene poisons can be identified based on their differential sensitivity to the chemical-bound conformation of gene .	T11	T35	11278845
NA	CHEMICAL	GENE-Y	8	15	First , in the presence of 1 mm chemical or the nonhydrolyzable analog chemical , gene-mediated DNA cleavage induced by chemical-sensitive gene poisons ( e.g .	T12	T36	11278845
NA	CHEMICAL	GENE-Y	8	21	First , in the presence of 1 mm chemical or the nonhydrolyzable analog chemical , gene-mediated DNA cleavage induced by chemical-sensitive gene poisons ( e.g .	T12	T37	11278845
NA	CHEMICAL	GENE-Y	1	15	First , in the presence of 1 mm chemical or the nonhydrolyzable analog chemical , gene-mediated DNA cleavage induced by chemical-sensitive gene poisons ( e.g .	T13	T36	11278845
NA	CHEMICAL	GENE-Y	1	21	First , in the presence of 1 mm chemical or the nonhydrolyzable analog chemical , gene-mediated DNA cleavage induced by chemical-sensitive gene poisons ( e.g .	T13	T37	11278845
NA	CHEMICAL	GENE-Y	20	15	First , in the presence of 1 mm chemical or the nonhydrolyzable analog chemical , gene-mediated DNA cleavage induced by chemical-sensitive gene poisons ( e.g .	T14	T36	11278845
NA	CHEMICAL	GENE-Y	20	21	First , in the presence of 1 mm chemical or the nonhydrolyzable analog chemical , gene-mediated DNA cleavage induced by chemical-sensitive gene poisons ( e.g .	T14	T37	11278845
NA	CHEMICAL	GENE-Y	0	19	chemical , chemical , chemical , and chemical ) was 30-100-fold stimulated , whereas DNA cleavage induced by chemical-insensitive gene poisons ( e.g .	T15	T38	11278845
NA	CHEMICAL	GENE-Y	2	19	chemical , chemical , chemical , and chemical ) was 30-100-fold stimulated , whereas DNA cleavage induced by chemical-insensitive gene poisons ( e.g .	T16	T38	11278845
NA	CHEMICAL	GENE-Y	4	19	chemical , chemical , chemical , and chemical ) was 30-100-fold stimulated , whereas DNA cleavage induced by chemical-insensitive gene poisons ( e.g .	T17	T38	11278845
NA	CHEMICAL	GENE-Y	7	19	chemical , chemical , chemical , and chemical ) was 30-100-fold stimulated , whereas DNA cleavage induced by chemical-insensitive gene poisons ( e.g .	T18	T38	11278845
NA	CHEMICAL	GENE-Y	18	19	chemical , chemical , chemical , and chemical ) was 30-100-fold stimulated , whereas DNA cleavage induced by chemical-insensitive gene poisons ( e.g .	T19	T38	11278845
NA	CHEMICAL	GENE-Y	3	9	In addition , chemical was shown to strongly antagonize gene-mediated DNA cleavage induced by chemical-sensitive but not chemical-insensitive gene poisons .	T23	T40	11278845
NA	CHEMICAL	GENE-Y	3	18	In addition , chemical was shown to strongly antagonize gene-mediated DNA cleavage induced by chemical-sensitive but not chemical-insensitive gene poisons .	T23	T41	11278845
CPR:3	CHEMICAL	GENE-Y	14	9	In addition , chemical was shown to strongly antagonize gene-mediated DNA cleavage induced by chemical-sensitive but not chemical-insensitive gene poisons .	T24	T40	11278845
NA	CHEMICAL	GENE-Y	14	18	In addition , chemical was shown to strongly antagonize gene-mediated DNA cleavage induced by chemical-sensitive but not chemical-insensitive gene poisons .	T24	T41	11278845
NA	CHEMICAL	GENE-Y	17	9	In addition , chemical was shown to strongly antagonize gene-mediated DNA cleavage induced by chemical-sensitive but not chemical-insensitive gene poisons .	T25	T40	11278845
NA	CHEMICAL	GENE-Y	17	18	In addition , chemical was shown to strongly antagonize gene-mediated DNA cleavage induced by chemical-sensitive but not chemical-insensitive gene poisons .	T25	T41	11278845
NA	CHEMICAL	GENE-N	19	2	Second , gene mutant gene , which exhibits reduced gene activity , was shown to exhibit cross-resistance to all chemical-sensitive but not chemical-insensitive gene poisons .	T1	T42	11278845
NA	CHEMICAL	GENE-Y	19	4	Second , gene mutant gene , which exhibits reduced gene activity , was shown to exhibit cross-resistance to all chemical-sensitive but not chemical-insensitive gene poisons .	T1	T43	11278845
NA	CHEMICAL	GENE-N	19	9	Second , gene mutant gene , which exhibits reduced gene activity , was shown to exhibit cross-resistance to all chemical-sensitive but not chemical-insensitive gene poisons .	T1	T44	11278845
NA	CHEMICAL	GENE-Y	19	23	Second , gene mutant gene , which exhibits reduced gene activity , was shown to exhibit cross-resistance to all chemical-sensitive but not chemical-insensitive gene poisons .	T1	T27	11278845
NA	CHEMICAL	GENE-N	22	2	Second , gene mutant gene , which exhibits reduced gene activity , was shown to exhibit cross-resistance to all chemical-sensitive but not chemical-insensitive gene poisons .	T2	T42	11278845
NA	CHEMICAL	GENE-Y	22	4	Second , gene mutant gene , which exhibits reduced gene activity , was shown to exhibit cross-resistance to all chemical-sensitive but not chemical-insensitive gene poisons .	T2	T43	11278845
CPR:4	CHEMICAL	GENE-N	22	9	Second , gene mutant gene , which exhibits reduced gene activity , was shown to exhibit cross-resistance to all chemical-sensitive but not chemical-insensitive gene poisons .	T2	T44	11278845
NA	CHEMICAL	GENE-Y	22	23	Second , gene mutant gene , which exhibits reduced gene activity , was shown to exhibit cross-resistance to all chemical-sensitive but not chemical-insensitive gene poisons .	T2	T27	11278845
NA	CHEMICAL	GENE-Y	3	7	Third , using chemical competition assay , gene-mediated DNA cleavage induced by chemical-sensitive but not chemical-insensitive poisons was shown to be antagonized by chemical .	T3	T28	11278845
NA	CHEMICAL	GENE-Y	12	7	Third , using chemical competition assay , gene-mediated DNA cleavage induced by chemical-sensitive but not chemical-insensitive poisons was shown to be antagonized by chemical .	T4	T28	11278845
NA	CHEMICAL	GENE-Y	15	7	Third , using chemical competition assay , gene-mediated DNA cleavage induced by chemical-sensitive but not chemical-insensitive poisons was shown to be antagonized by chemical .	T5	T28	11278845
NA	CHEMICAL	GENE-Y	23	7	Third , using chemical competition assay , gene-mediated DNA cleavage induced by chemical-sensitive but not chemical-insensitive poisons was shown to be antagonized by chemical .	T6	T28	11278845
NA	CHEMICAL	GENE-Y	4	5	These results suggest that chemical-bound gene may be the specific target of chemical-sensitive gene poisons .	T7	T29	11278845
NA	CHEMICAL	GENE-Y	4	13	These results suggest that chemical-bound gene may be the specific target of chemical-sensitive gene poisons .	T7	T30	11278845
NA	CHEMICAL	GENE-Y	12	5	These results suggest that chemical-bound gene may be the specific target of chemical-sensitive gene poisons .	T8	T29	11278845
NA	CHEMICAL	GENE-Y	12	13	These results suggest that chemical-bound gene may be the specific target of chemical-sensitive gene poisons .	T8	T30	11278845
NA	CHEMICAL	GENE-Y	15	0	gene-dependent and -independent interaction of glucocorticoids with the regulatory pathways involved in the control of chemical handling by the liver .	T11	T42	23313557
NA	CHEMICAL	GENE-Y	20	10	In HepG2 cells , GCs induced a decreased expression of gene and gene , and inhibited the regulatory effect of chemical on gene-target genes .	T10	T39	23313557
NA	CHEMICAL	GENE-Y	20	12	In HepG2 cells , GCs induced a decreased expression of gene and gene , and inhibited the regulatory effect of chemical on gene-target genes .	T10	T40	23313557
NA	CHEMICAL	GENE-Y	20	22	In HepG2 cells , GCs induced a decreased expression of gene and gene , and inhibited the regulatory effect of chemical on gene-target genes .	T10	T41	23313557
NA	CHEMICAL	GENE-Y	10	10	In Alexander cells , only when they were transfected with gene+gene , chemical caused up-regulation of gene and gene , and a down-regulation of gene .	T1	T12	23313557
NA	CHEMICAL	GENE-N	10	10	In Alexander cells , only when they were transfected with gene+gene , chemical caused up-regulation of gene and gene , and a down-regulation of gene .	T1	T13	23313557
CPR:3	CHEMICAL	GENE-Y	10	16	In Alexander cells , only when they were transfected with gene+gene , chemical caused up-regulation of gene and gene , and a down-regulation of gene .	T1	T14	23313557
CPR:3	CHEMICAL	GENE-Y	10	18	In Alexander cells , only when they were transfected with gene+gene , chemical caused up-regulation of gene and gene , and a down-regulation of gene .	T1	T15	23313557
CPR:4	CHEMICAL	GENE-Y	10	24	In Alexander cells , only when they were transfected with gene+gene , chemical caused up-regulation of gene and gene , and a down-regulation of gene .	T1	T16	23313557
CPR:3	CHEMICAL	GENE-Y	8	9	Moreover , GCs have a synergistic effect on chemical-induced gene activation , whereas chemical and chemical have an additive effect .	T5	T21	23313557
NA	CHEMICAL	GENE-Y	4	9	Moreover , GCs have a synergistic effect on chemical-induced gene activation , whereas chemical and chemical have an additive effect .	T6	T21	23313557
NA	CHEMICAL	GENE-Y	15	9	Moreover , GCs have a synergistic effect on chemical-induced gene activation , whereas chemical and chemical have an additive effect .	T7	T21	23313557
NA	CHEMICAL	GENE-Y	0	0	gene-gene-chemical complex transactivates postnatal murine neuronal chemical transporter isoform 3 expression .	T18	T52	23493374
NA	CHEMICAL	GENE-Y	0	0	gene-gene-chemical complex transactivates postnatal murine neuronal chemical transporter isoform 3 expression .	T18	T53	23493374
NA	CHEMICAL	GENE-Y	0	9	gene-gene-chemical complex transactivates postnatal murine neuronal chemical transporter isoform 3 expression .	T18	T54	23493374
NA	CHEMICAL	GENE-Y	6	0	gene-gene-chemical complex transactivates postnatal murine neuronal chemical transporter isoform 3 expression .	T19	T52	23493374
NA	CHEMICAL	GENE-Y	6	0	gene-gene-chemical complex transactivates postnatal murine neuronal chemical transporter isoform 3 expression .	T19	T53	23493374
NA	CHEMICAL	GENE-Y	6	9	gene-gene-chemical complex transactivates postnatal murine neuronal chemical transporter isoform 3 expression .	T19	T54	23493374
NA	CHEMICAL	GENE-Y	4	7	The murine neuronal facilitative chemical transporter isoform 3 ( gene ) is developmentally regulated , peaking in expression at postnatal day ( PN ) 14 .	T11	T41	23493374
NA	CHEMICAL	GENE-Y	4	7	The murine neuronal facilitative chemical transporter isoform 3 ( gene ) is developmentally regulated , peaking in expression at postnatal day ( PN ) 14 .	T11	T45	23493374
NA	CHEMICAL	GENE-Y	9	17	In the present study , we characterized a canonical chemical island spanning the 5'-flanking region of the gene gene .	T9	T40	23493374
NA	CHEMICAL	GENE-Y	3	16	Methylation-specific PCR and chemical sequencing identified methylation of this chemical ( chemical ) island of the gene gene , frequency of methylation increasing 2.5-fold with a 1.6-fold increase in gene concentrations noted with advancing postnatal age ( PN14 vs PN3 ) .	T10	T42	23493374
NA	CHEMICAL	GENE-Y	3	25	Methylation-specific PCR and chemical sequencing identified methylation of this chemical ( chemical ) island of the gene gene , frequency of methylation increasing 2.5-fold with a 1.6-fold increase in gene concentrations noted with advancing postnatal age ( PN14 vs PN3 ) .	T10	T43	23493374
NA	CHEMICAL	GENE-Y	9	16	Methylation-specific PCR and chemical sequencing identified methylation of this chemical ( chemical ) island of the gene gene , frequency of methylation increasing 2.5-fold with a 1.6-fold increase in gene concentrations noted with advancing postnatal age ( PN14 vs PN3 ) .	T12	T42	23493374
CPR:3	CHEMICAL	GENE-Y	9	25	Methylation-specific PCR and chemical sequencing identified methylation of this chemical ( chemical ) island of the gene gene , frequency of methylation increasing 2.5-fold with a 1.6-fold increase in gene concentrations noted with advancing postnatal age ( PN14 vs PN3 ) .	T12	T43	23493374
NA	CHEMICAL	GENE-Y	10	16	Methylation-specific PCR and chemical sequencing identified methylation of this chemical ( chemical ) island of the gene gene , frequency of methylation increasing 2.5-fold with a 1.6-fold increase in gene concentrations noted with advancing postnatal age ( PN14 vs PN3 ) .	T13	T42	23493374
CPR:3	CHEMICAL	GENE-Y	10	25	Methylation-specific PCR and chemical sequencing identified methylation of this chemical ( chemical ) island of the gene gene , frequency of methylation increasing 2.5-fold with a 1.6-fold increase in gene concentrations noted with advancing postnatal age ( PN14 vs PN3 ) .	T13	T43	23493374
NA	CHEMICAL	GENE-Y	13	3	5'-flanking region of gene-luciferase reporter transient transfection in HT22 hippocampal neurons demonstrated that chemical inhibit gene transcription .	T14	T44	23493374
CPR:4	CHEMICAL	GENE-Y	13	15	5'-flanking region of gene-luciferase reporter transient transfection in HT22 hippocampal neurons demonstrated that chemical inhibit gene transcription .	T14	T46	23493374
NA	CHEMICAL	GENE-Y	11	6	Contrary to this biological function , gene expression rises synchronously with chemical in PN14 vs PN3 neurons .	T15	T47	23493374
NA	CHEMICAL	GENE-Y	7	10	Chromatin immunoprecipitation ( IP ) revealed that chemical-CpG binding protein 2 ( gene ) bound the gene-chemical .	T16	T48	23493374
NA	CHEMICAL	GENE-Y	7	10	Chromatin immunoprecipitation ( IP ) revealed that chemical-CpG binding protein 2 ( gene ) bound the gene-chemical .	T16	T49	23493374
NA	CHEMICAL	GENE-Y	7	16	Chromatin immunoprecipitation ( IP ) revealed that chemical-CpG binding protein 2 ( gene ) bound the gene-chemical .	T16	T50	23493374
NA	CHEMICAL	GENE-Y	2	10	Chromatin immunoprecipitation ( IP ) revealed that chemical-CpG binding protein 2 ( gene ) bound the gene-chemical .	T17	T48	23493374
NA	CHEMICAL	GENE-Y	2	10	Chromatin immunoprecipitation ( IP ) revealed that chemical-CpG binding protein 2 ( gene ) bound the gene-chemical .	T17	T49	23493374
NA	CHEMICAL	GENE-Y	2	16	Chromatin immunoprecipitation ( IP ) revealed that chemical-CpG binding protein 2 ( gene ) bound the gene-chemical .	T17	T50	23493374
NA	CHEMICAL	GENE-Y	5	5	Sequential chromatin IP uncovered the gene-chemical to bind gene exponentially upon recruitment of gene rather than gene .	T1	T20	23493374
NA	CHEMICAL	GENE-Y	5	8	Sequential chromatin IP uncovered the gene-chemical to bind gene exponentially upon recruitment of gene rather than gene .	T1	T21	23493374
NA	CHEMICAL	GENE-Y	5	13	Sequential chromatin IP uncovered the gene-chemical to bind gene exponentially upon recruitment of gene rather than gene .	T1	T22	23493374
NA	CHEMICAL	GENE-Y	5	16	Sequential chromatin IP uncovered the gene-chemical to bind gene exponentially upon recruitment of gene rather than gene .	T1	T23	23493374
NA	CHEMICAL	GENE-Y	5	5	Co-IP and coimmunolocalization confirmed that gene associated with gene and cotransfection with gene-chemical in HT22 cells enhanced gene transcription .	T2	T24	23493374
NA	CHEMICAL	GENE-Y	5	8	Co-IP and coimmunolocalization confirmed that gene associated with gene and cotransfection with gene-chemical in HT22 cells enhanced gene transcription .	T2	T25	23493374
NA	CHEMICAL	GENE-Y	5	12	Co-IP and coimmunolocalization confirmed that gene associated with gene and cotransfection with gene-chemical in HT22 cells enhanced gene transcription .	T2	T26	23493374
NA	CHEMICAL	GENE-Y	5	17	Co-IP and coimmunolocalization confirmed that gene associated with gene and cotransfection with gene-chemical in HT22 cells enhanced gene transcription .	T2	T27	23493374
CPR:4	CHEMICAL	GENE-Y	1	16	Separate chemical pretreatment or in combination with chemical reduced chemical and specific small interference RNAs targeting gene and gene separately or together depleting gene and/or gene binding of gene-chemical reduced gene expression in HT22 cells .	T3	T28	23493374
CPR:4	CHEMICAL	GENE-Y	1	18	Separate chemical pretreatment or in combination with chemical reduced chemical and specific small interference RNAs targeting gene and gene separately or together depleting gene and/or gene binding of gene-chemical reduced gene expression in HT22 cells .	T3	T29	23493374
NA	CHEMICAL	GENE-Y	1	23	Separate chemical pretreatment or in combination with chemical reduced chemical and specific small interference RNAs targeting gene and gene separately or together depleting gene and/or gene binding of gene-chemical reduced gene expression in HT22 cells .	T3	T30	23493374
NA	CHEMICAL	GENE-Y	1	25	Separate chemical pretreatment or in combination with chemical reduced chemical and specific small interference RNAs targeting gene and gene separately or together depleting gene and/or gene binding of gene-chemical reduced gene expression in HT22 cells .	T3	T31	23493374
NA	CHEMICAL	GENE-Y	1	28	Separate chemical pretreatment or in combination with chemical reduced chemical and specific small interference RNAs targeting gene and gene separately or together depleting gene and/or gene binding of gene-chemical reduced gene expression in HT22 cells .	T3	T32	23493374
NA	CHEMICAL	GENE-Y	1	30	Separate chemical pretreatment or in combination with chemical reduced chemical and specific small interference RNAs targeting gene and gene separately or together depleting gene and/or gene binding of gene-chemical reduced gene expression in HT22 cells .	T3	T33	23493374
CPR:4	CHEMICAL	GENE-Y	7	16	Separate chemical pretreatment or in combination with chemical reduced chemical and specific small interference RNAs targeting gene and gene separately or together depleting gene and/or gene binding of gene-chemical reduced gene expression in HT22 cells .	T4	T28	23493374
CPR:4	CHEMICAL	GENE-Y	7	18	Separate chemical pretreatment or in combination with chemical reduced chemical and specific small interference RNAs targeting gene and gene separately or together depleting gene and/or gene binding of gene-chemical reduced gene expression in HT22 cells .	T4	T29	23493374
NA	CHEMICAL	GENE-Y	7	23	Separate chemical pretreatment or in combination with chemical reduced chemical and specific small interference RNAs targeting gene and gene separately or together depleting gene and/or gene binding of gene-chemical reduced gene expression in HT22 cells .	T4	T30	23493374
NA	CHEMICAL	GENE-Y	7	25	Separate chemical pretreatment or in combination with chemical reduced chemical and specific small interference RNAs targeting gene and gene separately or together depleting gene and/or gene binding of gene-chemical reduced gene expression in HT22 cells .	T4	T31	23493374
NA	CHEMICAL	GENE-Y	7	28	Separate chemical pretreatment or in combination with chemical reduced chemical and specific small interference RNAs targeting gene and gene separately or together depleting gene and/or gene binding of gene-chemical reduced gene expression in HT22 cells .	T4	T32	23493374
NA	CHEMICAL	GENE-Y	7	30	Separate chemical pretreatment or in combination with chemical reduced chemical and specific small interference RNAs targeting gene and gene separately or together depleting gene and/or gene binding of gene-chemical reduced gene expression in HT22 cells .	T4	T33	23493374
NA	CHEMICAL	GENE-Y	9	16	Separate chemical pretreatment or in combination with chemical reduced chemical and specific small interference RNAs targeting gene and gene separately or together depleting gene and/or gene binding of gene-chemical reduced gene expression in HT22 cells .	T5	T28	23493374
NA	CHEMICAL	GENE-Y	9	18	Separate chemical pretreatment or in combination with chemical reduced chemical and specific small interference RNAs targeting gene and gene separately or together depleting gene and/or gene binding of gene-chemical reduced gene expression in HT22 cells .	T5	T29	23493374
NA	CHEMICAL	GENE-Y	9	23	Separate chemical pretreatment or in combination with chemical reduced chemical and specific small interference RNAs targeting gene and gene separately or together depleting gene and/or gene binding of gene-chemical reduced gene expression in HT22 cells .	T5	T30	23493374
NA	CHEMICAL	GENE-Y	9	25	Separate chemical pretreatment or in combination with chemical reduced chemical and specific small interference RNAs targeting gene and gene separately or together depleting gene and/or gene binding of gene-chemical reduced gene expression in HT22 cells .	T5	T31	23493374
NA	CHEMICAL	GENE-Y	9	28	Separate chemical pretreatment or in combination with chemical reduced chemical and specific small interference RNAs targeting gene and gene separately or together depleting gene and/or gene binding of gene-chemical reduced gene expression in HT22 cells .	T5	T32	23493374
NA	CHEMICAL	GENE-Y	9	30	Separate chemical pretreatment or in combination with chemical reduced chemical and specific small interference RNAs targeting gene and gene separately or together depleting gene and/or gene binding of gene-chemical reduced gene expression in HT22 cells .	T5	T33	23493374
NA	CHEMICAL	GENE-Y	28	16	Separate chemical pretreatment or in combination with chemical reduced chemical and specific small interference RNAs targeting gene and gene separately or together depleting gene and/or gene binding of gene-chemical reduced gene expression in HT22 cells .	T6	T28	23493374
NA	CHEMICAL	GENE-Y	28	18	Separate chemical pretreatment or in combination with chemical reduced chemical and specific small interference RNAs targeting gene and gene separately or together depleting gene and/or gene binding of gene-chemical reduced gene expression in HT22 cells .	T6	T29	23493374
NA	CHEMICAL	GENE-Y	28	23	Separate chemical pretreatment or in combination with chemical reduced chemical and specific small interference RNAs targeting gene and gene separately or together depleting gene and/or gene binding of gene-chemical reduced gene expression in HT22 cells .	T6	T30	23493374
NA	CHEMICAL	GENE-Y	28	25	Separate chemical pretreatment or in combination with chemical reduced chemical and specific small interference RNAs targeting gene and gene separately or together depleting gene and/or gene binding of gene-chemical reduced gene expression in HT22 cells .	T6	T31	23493374
NA	CHEMICAL	GENE-Y	28	28	Separate chemical pretreatment or in combination with chemical reduced chemical and specific small interference RNAs targeting gene and gene separately or together depleting gene and/or gene binding of gene-chemical reduced gene expression in HT22 cells .	T6	T32	23493374
NA	CHEMICAL	GENE-Y	28	30	Separate chemical pretreatment or in combination with chemical reduced chemical and specific small interference RNAs targeting gene and gene separately or together depleting gene and/or gene binding of gene-chemical reduced gene expression in HT22 cells .	T6	T33	23493374
NA	CHEMICAL	GENE-Y	11	3	The role of gene and gene on the modulation of acute chemical-induced changes in extracellular chemical : the mechanism of action of chemical .	T32	T42	10727715
NA	CHEMICAL	GENE-N	11	5	The role of gene and gene on the modulation of acute chemical-induced changes in extracellular chemical : the mechanism of action of chemical .	T32	T43	10727715
NA	CHEMICAL	GENE-Y	15	3	The role of gene and gene on the modulation of acute chemical-induced changes in extracellular chemical : the mechanism of action of chemical .	T30	T42	10727715
NA	CHEMICAL	GENE-N	15	5	The role of gene and gene on the modulation of acute chemical-induced changes in extracellular chemical : the mechanism of action of chemical .	T30	T43	10727715
NA	CHEMICAL	GENE-Y	13	3	The role of gene and gene on the modulation of acute chemical-induced changes in extracellular chemical : the mechanism of action of chemical .	T31	T42	10727715
NA	CHEMICAL	GENE-N	13	5	The role of gene and gene on the modulation of acute chemical-induced changes in extracellular chemical : the mechanism of action of chemical .	T31	T43	10727715
CPR:6	CHEMICAL	GENE-Y	10	13	This effect has been attributed to the antagonist effects of chemical at the gene receptor .	T16	T36	10727715
CPR:6	CHEMICAL	GENE-Y	10	13	In the present study , we compared the pharmacology of chemical , chemical ( a gene antagonist ) , chemical ( a gene antagonist ) , and chemical ( a gene antagonist ) , when given acutely in combination with chemical , using in vivo microdialysis in the frontal cortex of the freely moving rat .	T17	T37	10727715
NA	CHEMICAL	GENE-N	10	13	In the present study , we compared the pharmacology of chemical , chemical ( a gene antagonist ) , chemical ( a gene antagonist ) , and chemical ( a gene antagonist ) , when given acutely in combination with chemical , using in vivo microdialysis in the frontal cortex of the freely moving rat .	T17	T38	10727715
NA	CHEMICAL	GENE-Y	10	13	In the present study , we compared the pharmacology of chemical , chemical ( a gene antagonist ) , chemical ( a gene antagonist ) , and chemical ( a gene antagonist ) , when given acutely in combination with chemical , using in vivo microdialysis in the frontal cortex of the freely moving rat .	T17	T39	10727715
CPR:6	CHEMICAL	GENE-Y	12	13	In the present study , we compared the pharmacology of chemical , chemical ( a gene antagonist ) , chemical ( a gene antagonist ) , and chemical ( a gene antagonist ) , when given acutely in combination with chemical , using in vivo microdialysis in the frontal cortex of the freely moving rat .	T18	T37	10727715
NA	CHEMICAL	GENE-N	12	13	In the present study , we compared the pharmacology of chemical , chemical ( a gene antagonist ) , chemical ( a gene antagonist ) , and chemical ( a gene antagonist ) , when given acutely in combination with chemical , using in vivo microdialysis in the frontal cortex of the freely moving rat .	T18	T38	10727715
NA	CHEMICAL	GENE-Y	12	13	In the present study , we compared the pharmacology of chemical , chemical ( a gene antagonist ) , chemical ( a gene antagonist ) , and chemical ( a gene antagonist ) , when given acutely in combination with chemical , using in vivo microdialysis in the frontal cortex of the freely moving rat .	T18	T39	10727715
NA	CHEMICAL	GENE-Y	19	13	In the present study , we compared the pharmacology of chemical , chemical ( a gene antagonist ) , chemical ( a gene antagonist ) , and chemical ( a gene antagonist ) , when given acutely in combination with chemical , using in vivo microdialysis in the frontal cortex of the freely moving rat .	T19	T37	10727715
NA	CHEMICAL	GENE-N	19	13	In the present study , we compared the pharmacology of chemical , chemical ( a gene antagonist ) , chemical ( a gene antagonist ) , and chemical ( a gene antagonist ) , when given acutely in combination with chemical , using in vivo microdialysis in the frontal cortex of the freely moving rat .	T19	T38	10727715
NA	CHEMICAL	GENE-Y	19	13	In the present study , we compared the pharmacology of chemical , chemical ( a gene antagonist ) , chemical ( a gene antagonist ) , and chemical ( a gene antagonist ) , when given acutely in combination with chemical , using in vivo microdialysis in the frontal cortex of the freely moving rat .	T19	T39	10727715
NA	CHEMICAL	GENE-Y	14	13	In the present study , we compared the pharmacology of chemical , chemical ( a gene antagonist ) , chemical ( a gene antagonist ) , and chemical ( a gene antagonist ) , when given acutely in combination with chemical , using in vivo microdialysis in the frontal cortex of the freely moving rat .	T21	T37	10727715
NA	CHEMICAL	GENE-N	14	13	In the present study , we compared the pharmacology of chemical , chemical ( a gene antagonist ) , chemical ( a gene antagonist ) , and chemical ( a gene antagonist ) , when given acutely in combination with chemical , using in vivo microdialysis in the frontal cortex of the freely moving rat .	T21	T38	10727715
CPR:6	CHEMICAL	GENE-Y	14	13	In the present study , we compared the pharmacology of chemical , chemical ( a gene antagonist ) , chemical ( a gene antagonist ) , and chemical ( a gene antagonist ) , when given acutely in combination with chemical , using in vivo microdialysis in the frontal cortex of the freely moving rat .	T21	T39	10727715
NA	CHEMICAL	GENE-Y	37	13	In the present study , we compared the pharmacology of chemical , chemical ( a gene antagonist ) , chemical ( a gene antagonist ) , and chemical ( a gene antagonist ) , when given acutely in combination with chemical , using in vivo microdialysis in the frontal cortex of the freely moving rat .	T22	T37	10727715
NA	CHEMICAL	GENE-N	37	13	In the present study , we compared the pharmacology of chemical , chemical ( a gene antagonist ) , chemical ( a gene antagonist ) , and chemical ( a gene antagonist ) , when given acutely in combination with chemical , using in vivo microdialysis in the frontal cortex of the freely moving rat .	T22	T38	10727715
NA	CHEMICAL	GENE-Y	37	13	In the present study , we compared the pharmacology of chemical , chemical ( a gene antagonist ) , chemical ( a gene antagonist ) , and chemical ( a gene antagonist ) , when given acutely in combination with chemical , using in vivo microdialysis in the frontal cortex of the freely moving rat .	T22	T39	10727715
NA	CHEMICAL	GENE-Y	9	3	Combination of both gene and gene autoreceptor antagonists with chemical produced additive increases in extracellular chemical ( i.e .	T29	T40	10727715
NA	CHEMICAL	GENE-N	9	5	Combination of both gene and gene autoreceptor antagonists with chemical produced additive increases in extracellular chemical ( i.e .	T29	T41	10727715
NA	CHEMICAL	GENE-Y	15	3	Combination of both gene and gene autoreceptor antagonists with chemical produced additive increases in extracellular chemical ( i.e .	T1	T40	10727715
NA	CHEMICAL	GENE-N	15	5	Combination of both gene and gene autoreceptor antagonists with chemical produced additive increases in extracellular chemical ( i.e .	T1	T41	10727715
CPR:4	CHEMICAL	GENE-Y	5	3	Pharmacophore identification of gene inhibitor chemical .	T10	T19	23177256
CPR:4	CHEMICAL	GENE-Y	14	9	A structure-activity relationship ( SAR ) study of the gene ( gene ) inhibitor chemical ( chemical , 1 ) - which targets a hydrophobic domain of the gene oncoprotein that is flanked by chemical residues - was executed in order to determine its pharmacophore .	T8	T12	23177256
CPR:4	CHEMICAL	GENE-Y	14	11	A structure-activity relationship ( SAR ) study of the gene ( gene ) inhibitor chemical ( chemical , 1 ) - which targets a hydrophobic domain of the gene oncoprotein that is flanked by chemical residues - was executed in order to determine its pharmacophore .	T8	T15	23177256
NA	CHEMICAL	GENE-Y	14	28	A structure-activity relationship ( SAR ) study of the gene ( gene ) inhibitor chemical ( chemical , 1 ) - which targets a hydrophobic domain of the gene oncoprotein that is flanked by chemical residues - was executed in order to determine its pharmacophore .	T8	T11	23177256
CPR:4	CHEMICAL	GENE-Y	3	9	A structure-activity relationship ( SAR ) study of the gene ( gene ) inhibitor chemical ( chemical , 1 ) - which targets a hydrophobic domain of the gene oncoprotein that is flanked by chemical residues - was executed in order to determine its pharmacophore .	T9	T12	23177256
CPR:4	CHEMICAL	GENE-Y	3	11	A structure-activity relationship ( SAR ) study of the gene ( gene ) inhibitor chemical ( chemical , 1 ) - which targets a hydrophobic domain of the gene oncoprotein that is flanked by chemical residues - was executed in order to determine its pharmacophore .	T9	T15	23177256
NA	CHEMICAL	GENE-Y	3	28	A structure-activity relationship ( SAR ) study of the gene ( gene ) inhibitor chemical ( chemical , 1 ) - which targets a hydrophobic domain of the gene oncoprotein that is flanked by chemical residues - was executed in order to determine its pharmacophore .	T9	T11	23177256
NA	CHEMICAL	GENE-Y	9	9	A structure-activity relationship ( SAR ) study of the gene ( gene ) inhibitor chemical ( chemical , 1 ) - which targets a hydrophobic domain of the gene oncoprotein that is flanked by chemical residues - was executed in order to determine its pharmacophore .	T1	T12	23177256
NA	CHEMICAL	GENE-Y	9	11	A structure-activity relationship ( SAR ) study of the gene ( gene ) inhibitor chemical ( chemical , 1 ) - which targets a hydrophobic domain of the gene oncoprotein that is flanked by chemical residues - was executed in order to determine its pharmacophore .	T1	T15	23177256
NA	CHEMICAL	GENE-Y	9	28	A structure-activity relationship ( SAR ) study of the gene ( gene ) inhibitor chemical ( chemical , 1 ) - which targets a hydrophobic domain of the gene oncoprotein that is flanked by chemical residues - was executed in order to determine its pharmacophore .	T1	T11	23177256
NA	CHEMICAL	GENE-Y	24	21	Around five times as potent as the lead with an IC ( 50 ) of 33 μM for disruption of the gene-gene heterodimer , chemical demonstrated excellent selectivity over gene-gene homodimers , with no apparent effect at 100 μM .	T6	T13	23177256
NA	CHEMICAL	GENE-Y	24	21	Around five times as potent as the lead with an IC ( 50 ) of 33 μM for disruption of the gene-gene heterodimer , chemical demonstrated excellent selectivity over gene-gene homodimers , with no apparent effect at 100 μM .	T6	T14	23177256
NA	CHEMICAL	GENE-Y	24	29	Around five times as potent as the lead with an IC ( 50 ) of 33 μM for disruption of the gene-gene heterodimer , chemical demonstrated excellent selectivity over gene-gene homodimers , with no apparent effect at 100 μM .	T6	T16	23177256
NA	CHEMICAL	GENE-Y	24	29	Around five times as potent as the lead with an IC ( 50 ) of 33 μM for disruption of the gene-gene heterodimer , chemical demonstrated excellent selectivity over gene-gene homodimers , with no apparent effect at 100 μM .	T6	T17	23177256
NA	CHEMICAL	GENE-N	6	0	gene antagonists were tested against the chemical ( gene agonist ) -induced contraction in isolated hamster ureteral preparations using a functional experimental approach .	T8	T20	17658513
CPR:5	CHEMICAL	GENE-N	6	7	gene antagonists were tested against the chemical ( gene agonist ) -induced contraction in isolated hamster ureteral preparations using a functional experimental approach .	T8	T21	17658513
CPR:5	CHEMICAL	GENE-N	0	3	chemical and chemical ( gene agonist ) each produced a concentration-dependent tonic contraction , their pD ( 2 ) values being 6.87+/-0.08 and 6.10+/-0.05 , respectively .	T9	T24	17658513
CPR:5	CHEMICAL	GENE-N	2	3	chemical and chemical ( gene agonist ) each produced a concentration-dependent tonic contraction , their pD ( 2 ) values being 6.87+/-0.08 and 6.10+/-0.05 , respectively .	T10	T24	17658513
CPR:6	CHEMICAL	GENE-N	0	1	chemical ( nonselective gene antagonist ) , chemical ( selective gene antagonist ) and chemical ( chemical ) ( selective gene antagonist ) competitively antagonized the chemical-induced contraction ( pA ( 2 ) values , 8.60+/-0.07 , 9.44+/-0.06 and 5.75+/-0.07 , respectively ) .	T1	T11	17658513
NA	CHEMICAL	GENE-N	0	1	chemical ( nonselective gene antagonist ) , chemical ( selective gene antagonist ) and chemical ( chemical ) ( selective gene antagonist ) competitively antagonized the chemical-induced contraction ( pA ( 2 ) values , 8.60+/-0.07 , 9.44+/-0.06 and 5.75+/-0.07 , respectively ) .	T1	T12	17658513
NA	CHEMICAL	GENE-N	0	1	chemical ( nonselective gene antagonist ) , chemical ( selective gene antagonist ) and chemical ( chemical ) ( selective gene antagonist ) competitively antagonized the chemical-induced contraction ( pA ( 2 ) values , 8.60+/-0.07 , 9.44+/-0.06 and 5.75+/-0.07 , respectively ) .	T1	T13	17658513
NA	CHEMICAL	GENE-N	7	1	chemical ( nonselective gene antagonist ) , chemical ( selective gene antagonist ) and chemical ( chemical ) ( selective gene antagonist ) competitively antagonized the chemical-induced contraction ( pA ( 2 ) values , 8.60+/-0.07 , 9.44+/-0.06 and 5.75+/-0.07 , respectively ) .	T2	T11	17658513
CPR:6	CHEMICAL	GENE-N	7	1	chemical ( nonselective gene antagonist ) , chemical ( selective gene antagonist ) and chemical ( chemical ) ( selective gene antagonist ) competitively antagonized the chemical-induced contraction ( pA ( 2 ) values , 8.60+/-0.07 , 9.44+/-0.06 and 5.75+/-0.07 , respectively ) .	T2	T12	17658513
NA	CHEMICAL	GENE-N	7	1	chemical ( nonselective gene antagonist ) , chemical ( selective gene antagonist ) and chemical ( chemical ) ( selective gene antagonist ) competitively antagonized the chemical-induced contraction ( pA ( 2 ) values , 8.60+/-0.07 , 9.44+/-0.06 and 5.75+/-0.07 , respectively ) .	T2	T13	17658513
NA	CHEMICAL	GENE-N	14	1	chemical ( nonselective gene antagonist ) , chemical ( selective gene antagonist ) and chemical ( chemical ) ( selective gene antagonist ) competitively antagonized the chemical-induced contraction ( pA ( 2 ) values , 8.60+/-0.07 , 9.44+/-0.06 and 5.75+/-0.07 , respectively ) .	T3	T11	17658513
NA	CHEMICAL	GENE-N	14	1	chemical ( nonselective gene antagonist ) , chemical ( selective gene antagonist ) and chemical ( chemical ) ( selective gene antagonist ) competitively antagonized the chemical-induced contraction ( pA ( 2 ) values , 8.60+/-0.07 , 9.44+/-0.06 and 5.75+/-0.07 , respectively ) .	T3	T12	17658513
CPR:6	CHEMICAL	GENE-N	14	1	chemical ( nonselective gene antagonist ) , chemical ( selective gene antagonist ) and chemical ( chemical ) ( selective gene antagonist ) competitively antagonized the chemical-induced contraction ( pA ( 2 ) values , 8.60+/-0.07 , 9.44+/-0.06 and 5.75+/-0.07 , respectively ) .	T3	T13	17658513
NA	CHEMICAL	GENE-N	16	1	chemical ( nonselective gene antagonist ) , chemical ( selective gene antagonist ) and chemical ( chemical ) ( selective gene antagonist ) competitively antagonized the chemical-induced contraction ( pA ( 2 ) values , 8.60+/-0.07 , 9.44+/-0.06 and 5.75+/-0.07 , respectively ) .	T4	T11	17658513
NA	CHEMICAL	GENE-N	16	1	chemical ( nonselective gene antagonist ) , chemical ( selective gene antagonist ) and chemical ( chemical ) ( selective gene antagonist ) competitively antagonized the chemical-induced contraction ( pA ( 2 ) values , 8.60+/-0.07 , 9.44+/-0.06 and 5.75+/-0.07 , respectively ) .	T4	T12	17658513
CPR:6	CHEMICAL	GENE-N	16	1	chemical ( nonselective gene antagonist ) , chemical ( selective gene antagonist ) and chemical ( chemical ) ( selective gene antagonist ) competitively antagonized the chemical-induced contraction ( pA ( 2 ) values , 8.60+/-0.07 , 9.44+/-0.06 and 5.75+/-0.07 , respectively ) .	T4	T13	17658513
CPR:5	CHEMICAL	GENE-N	26	1	chemical ( nonselective gene antagonist ) , chemical ( selective gene antagonist ) and chemical ( chemical ) ( selective gene antagonist ) competitively antagonized the chemical-induced contraction ( pA ( 2 ) values , 8.60+/-0.07 , 9.44+/-0.06 and 5.75+/-0.07 , respectively ) .	T5	T11	17658513
CPR:5	CHEMICAL	GENE-N	26	1	chemical ( nonselective gene antagonist ) , chemical ( selective gene antagonist ) and chemical ( chemical ) ( selective gene antagonist ) competitively antagonized the chemical-induced contraction ( pA ( 2 ) values , 8.60+/-0.07 , 9.44+/-0.06 and 5.75+/-0.07 , respectively ) .	T5	T12	17658513
CPR:5	CHEMICAL	GENE-N	26	1	chemical ( nonselective gene antagonist ) , chemical ( selective gene antagonist ) and chemical ( chemical ) ( selective gene antagonist ) competitively antagonized the chemical-induced contraction ( pA ( 2 ) values , 8.60+/-0.07 , 9.44+/-0.06 and 5.75+/-0.07 , respectively ) .	T5	T13	17658513
NA	CHEMICAL	GENE-Y	35	16	Here , we report the development and validation of two different assays for quantitative assessment of gene ( gene ) and compare the sensitivity of gene relative to other standard markers in ischemia reperfusion and chemical ( AA ) -induced kidney injury in mice .	T5	T16	23019274
NA	CHEMICAL	GENE-Y	35	18	Here , we report the development and validation of two different assays for quantitative assessment of gene ( gene ) and compare the sensitivity of gene relative to other standard markers in ischemia reperfusion and chemical ( AA ) -induced kidney injury in mice .	T5	T17	23019274
NA	CHEMICAL	GENE-Y	35	25	Here , we report the development and validation of two different assays for quantitative assessment of gene ( gene ) and compare the sensitivity of gene relative to other standard markers in ischemia reperfusion and chemical ( AA ) -induced kidney injury in mice .	T5	T18	23019274
NA	CHEMICAL	GENE-Y	18	9	After only 10-min ischemia followed by 24-h reperfusion , gene was significantly elevated by 13-fold , whereas serum chemical ( sCr ) , blood chemical chemical , chemical-β-glucosaminidase ( gene ) , and proteinuria levels did not change .	T1	T9	23019274
NA	CHEMICAL	GENE-Y	18	29	After only 10-min ischemia followed by 24-h reperfusion , gene was significantly elevated by 13-fold , whereas serum chemical ( sCr ) , blood chemical chemical , chemical-β-glucosaminidase ( gene ) , and proteinuria levels did not change .	T1	T11	23019274
NA	CHEMICAL	GENE-Y	24	9	After only 10-min ischemia followed by 24-h reperfusion , gene was significantly elevated by 13-fold , whereas serum chemical ( sCr ) , blood chemical chemical , chemical-β-glucosaminidase ( gene ) , and proteinuria levels did not change .	T2	T9	23019274
NA	CHEMICAL	GENE-Y	24	29	After only 10-min ischemia followed by 24-h reperfusion , gene was significantly elevated by 13-fold , whereas serum chemical ( sCr ) , blood chemical chemical , chemical-β-glucosaminidase ( gene ) , and proteinuria levels did not change .	T2	T11	23019274
NA	CHEMICAL	GENE-Y	25	9	After only 10-min ischemia followed by 24-h reperfusion , gene was significantly elevated by 13-fold , whereas serum chemical ( sCr ) , blood chemical chemical , chemical-β-glucosaminidase ( gene ) , and proteinuria levels did not change .	T3	T9	23019274
NA	CHEMICAL	GENE-Y	25	29	After only 10-min ischemia followed by 24-h reperfusion , gene was significantly elevated by 13-fold , whereas serum chemical ( sCr ) , blood chemical chemical , chemical-β-glucosaminidase ( gene ) , and proteinuria levels did not change .	T3	T11	23019274
NA	CHEMICAL	GENE-Y	27	9	After only 10-min ischemia followed by 24-h reperfusion , gene was significantly elevated by 13-fold , whereas serum chemical ( sCr ) , blood chemical chemical , chemical-β-glucosaminidase ( gene ) , and proteinuria levels did not change .	T4	T9	23019274
NA	CHEMICAL	GENE-Y	27	29	After only 10-min ischemia followed by 24-h reperfusion , gene was significantly elevated by 13-fold , whereas serum chemical ( sCr ) , blood chemical chemical , chemical-β-glucosaminidase ( gene ) , and proteinuria levels did not change .	T4	T11	23019274
NA	CHEMICAL	GENE-Y	11	11	It has been suggested that the affinity of these compounds for a site on the chemical transporter , and not their local anesthetic actions , is responsible for these abuse-related behavioral effects .	T14	T27	7768269
NA	CHEMICAL	GENE-Y	2	32	Doses of chemical ( 1.7 mg/kg ) and chemical ( 0.3 mg/kg ) which produced full ( > 80 % ) substitution for chemical were administered in combination with the chemical D1 receptor antagonist chemical ( chemical ) and the chemical D2 receptor antagonist chemical ( both at 0.003-0.03 mg/kg ) .	T18	T28	7768269
NA	CHEMICAL	GENE-Y	2	32	Doses of chemical ( 1.7 mg/kg ) and chemical ( 0.3 mg/kg ) which produced full ( > 80 % ) substitution for chemical were administered in combination with the chemical D1 receptor antagonist chemical ( chemical ) and the chemical D2 receptor antagonist chemical ( both at 0.003-0.03 mg/kg ) .	T18	T29	7768269
NA	CHEMICAL	GENE-Y	8	32	Doses of chemical ( 1.7 mg/kg ) and chemical ( 0.3 mg/kg ) which produced full ( > 80 % ) substitution for chemical were administered in combination with the chemical D1 receptor antagonist chemical ( chemical ) and the chemical D2 receptor antagonist chemical ( both at 0.003-0.03 mg/kg ) .	T19	T28	7768269
NA	CHEMICAL	GENE-Y	8	32	Doses of chemical ( 1.7 mg/kg ) and chemical ( 0.3 mg/kg ) which produced full ( > 80 % ) substitution for chemical were administered in combination with the chemical D1 receptor antagonist chemical ( chemical ) and the chemical D2 receptor antagonist chemical ( both at 0.003-0.03 mg/kg ) .	T19	T29	7768269
NA	CHEMICAL	GENE-Y	23	32	Doses of chemical ( 1.7 mg/kg ) and chemical ( 0.3 mg/kg ) which produced full ( > 80 % ) substitution for chemical were administered in combination with the chemical D1 receptor antagonist chemical ( chemical ) and the chemical D2 receptor antagonist chemical ( both at 0.003-0.03 mg/kg ) .	T20	T28	7768269
NA	CHEMICAL	GENE-Y	23	32	Doses of chemical ( 1.7 mg/kg ) and chemical ( 0.3 mg/kg ) which produced full ( > 80 % ) substitution for chemical were administered in combination with the chemical D1 receptor antagonist chemical ( chemical ) and the chemical D2 receptor antagonist chemical ( both at 0.003-0.03 mg/kg ) .	T20	T29	7768269
NA	CHEMICAL	GENE-Y	26	32	Doses of chemical ( 1.7 mg/kg ) and chemical ( 0.3 mg/kg ) which produced full ( > 80 % ) substitution for chemical were administered in combination with the chemical D1 receptor antagonist chemical ( chemical ) and the chemical D2 receptor antagonist chemical ( both at 0.003-0.03 mg/kg ) .	T21	T28	7768269
NA	CHEMICAL	GENE-Y	26	32	Doses of chemical ( 1.7 mg/kg ) and chemical ( 0.3 mg/kg ) which produced full ( > 80 % ) substitution for chemical were administered in combination with the chemical D1 receptor antagonist chemical ( chemical ) and the chemical D2 receptor antagonist chemical ( both at 0.003-0.03 mg/kg ) .	T21	T29	7768269
CPR:6	CHEMICAL	GENE-Y	34	32	Doses of chemical ( 1.7 mg/kg ) and chemical ( 0.3 mg/kg ) which produced full ( > 80 % ) substitution for chemical were administered in combination with the chemical D1 receptor antagonist chemical ( chemical ) and the chemical D2 receptor antagonist chemical ( both at 0.003-0.03 mg/kg ) .	T23	T28	7768269
NA	CHEMICAL	GENE-Y	34	32	Doses of chemical ( 1.7 mg/kg ) and chemical ( 0.3 mg/kg ) which produced full ( > 80 % ) substitution for chemical were administered in combination with the chemical D1 receptor antagonist chemical ( chemical ) and the chemical D2 receptor antagonist chemical ( both at 0.003-0.03 mg/kg ) .	T23	T29	7768269
CPR:6	CHEMICAL	GENE-Y	3	32	Doses of chemical ( 1.7 mg/kg ) and chemical ( 0.3 mg/kg ) which produced full ( > 80 % ) substitution for chemical were administered in combination with the chemical D1 receptor antagonist chemical ( chemical ) and the chemical D2 receptor antagonist chemical ( both at 0.003-0.03 mg/kg ) .	T24	T28	7768269
NA	CHEMICAL	GENE-Y	3	32	Doses of chemical ( 1.7 mg/kg ) and chemical ( 0.3 mg/kg ) which produced full ( > 80 % ) substitution for chemical were administered in combination with the chemical D1 receptor antagonist chemical ( chemical ) and the chemical D2 receptor antagonist chemical ( both at 0.003-0.03 mg/kg ) .	T24	T29	7768269
NA	CHEMICAL	GENE-Y	26	32	Doses of chemical ( 1.7 mg/kg ) and chemical ( 0.3 mg/kg ) which produced full ( > 80 % ) substitution for chemical were administered in combination with the chemical D1 receptor antagonist chemical ( chemical ) and the chemical D2 receptor antagonist chemical ( both at 0.003-0.03 mg/kg ) .	T25	T28	7768269
NA	CHEMICAL	GENE-Y	26	32	Doses of chemical ( 1.7 mg/kg ) and chemical ( 0.3 mg/kg ) which produced full ( > 80 % ) substitution for chemical were administered in combination with the chemical D1 receptor antagonist chemical ( chemical ) and the chemical D2 receptor antagonist chemical ( both at 0.003-0.03 mg/kg ) .	T25	T29	7768269
NA	CHEMICAL	GENE-Y	44	32	Doses of chemical ( 1.7 mg/kg ) and chemical ( 0.3 mg/kg ) which produced full ( > 80 % ) substitution for chemical were administered in combination with the chemical D1 receptor antagonist chemical ( chemical ) and the chemical D2 receptor antagonist chemical ( both at 0.003-0.03 mg/kg ) .	T26	T28	7768269
CPR:6	CHEMICAL	GENE-Y	44	32	Doses of chemical ( 1.7 mg/kg ) and chemical ( 0.3 mg/kg ) which produced full ( > 80 % ) substitution for chemical were administered in combination with the chemical D1 receptor antagonist chemical ( chemical ) and the chemical D2 receptor antagonist chemical ( both at 0.003-0.03 mg/kg ) .	T26	T29	7768269
CPR:4	CHEMICAL	GENE-Y	0	2	chemical inhibit gene function by inducing protein oligomerization .	T20	T43	20421509
NA	CHEMICAL	GENE-Y	2	0	gene , a member of the gene family of chemical-binding proteins , regulates carcinoma cell motility via interactions with gene .	T10	T21	20421509
NA	CHEMICAL	GENE-N	2	6	gene , a member of the gene family of chemical-binding proteins , regulates carcinoma cell motility via interactions with gene .	T10	T35	20421509
NA	CHEMICAL	GENE-Y	2	19	gene , a member of the gene family of chemical-binding proteins , regulates carcinoma cell motility via interactions with gene .	T10	T25	20421509
CPR:4	CHEMICAL	GENE-Y	1	18	Using a unique biosensor-based assay , chemical ( chemical ) was identified as an inhibitor that disrupts the gene/gene interaction .	T11	T37	20421509
CPR:4	CHEMICAL	GENE-Y	1	18	Using a unique biosensor-based assay , chemical ( chemical ) was identified as an inhibitor that disrupts the gene/gene interaction .	T11	T38	20421509
CPR:4	CHEMICAL	GENE-Y	8	18	Using a unique biosensor-based assay , chemical ( chemical ) was identified as an inhibitor that disrupts the gene/gene interaction .	T12	T37	20421509
CPR:4	CHEMICAL	GENE-Y	8	18	Using a unique biosensor-based assay , chemical ( chemical ) was identified as an inhibitor that disrupts the gene/gene interaction .	T12	T38	20421509
NA	CHEMICAL	GENE-Y	7	5	To examine the interaction of gene with chemical , we determined the 2.3 A crystal structure of human chemical-gene bound to chemical .	T13	T39	20421509
NA	CHEMICAL	GENE-Y	7	13	To examine the interaction of gene with chemical , we determined the 2.3 A crystal structure of human chemical-gene bound to chemical .	T13	T40	20421509
NA	CHEMICAL	GENE-Y	18	5	To examine the interaction of gene with chemical , we determined the 2.3 A crystal structure of human chemical-gene bound to chemical .	T14	T39	20421509
NA	CHEMICAL	GENE-Y	18	13	To examine the interaction of gene with chemical , we determined the 2.3 A crystal structure of human chemical-gene bound to chemical .	T14	T40	20421509
NA	CHEMICAL	GENE-Y	21	5	To examine the interaction of gene with chemical , we determined the 2.3 A crystal structure of human chemical-gene bound to chemical .	T15	T39	20421509
NA	CHEMICAL	GENE-Y	21	13	To examine the interaction of gene with chemical , we determined the 2.3 A crystal structure of human chemical-gene bound to chemical .	T15	T40	20421509
NA	CHEMICAL	GENE-Y	1	11	Two chemical molecules bind within the hydrophobic target binding pocket of chemical-gene with no significant conformational changes observed in the protein upon complex formation .	T16	T41	20421509
NA	CHEMICAL	GENE-Y	11	11	Two chemical molecules bind within the hydrophobic target binding pocket of chemical-gene with no significant conformational changes observed in the protein upon complex formation .	T17	T41	20421509
NA	CHEMICAL	GENE-Y	13	21	NMR chemical shift perturbations are consistent with the crystal structure and demonstrate that chemical binds to the target binding cleft of gene in solution .	T18	T42	20421509
NA	CHEMICAL	GENE-Y	2	10	Remarkably , chemical binding results in the assembly of five chemical-gene/TFP dimers into a tightly packed pentameric ring .	T19	T22	20421509
NA	CHEMICAL	GENE-Y	2	10	Remarkably , chemical binding results in the assembly of five chemical-gene/TFP dimers into a tightly packed pentameric ring .	T1	T22	20421509
NA	CHEMICAL	GENE-Y	8	8	Within each pentamer most of the contacts between gene dimers occurs through the chemical moieties .	T2	T23	20421509
NA	CHEMICAL	GENE-Y	1	1	The chemical-gene/chemical ( chemical ) complex exhibits a similar pentameric assembly .	T3	T24	20421509
NA	CHEMICAL	GENE-Y	1	1	The chemical-gene/chemical ( chemical ) complex exhibits a similar pentameric assembly .	T4	T24	20421509
NA	CHEMICAL	GENE-Y	3	1	The chemical-gene/chemical ( chemical ) complex exhibits a similar pentameric assembly .	T5	T24	20421509
NA	CHEMICAL	GENE-Y	13	13	Equilibrium sedimentation and cross-linking studies demonstrate the cooperative formation of a similarly sized gene/chemical oligomer in solution .	T6	T26	20421509
CPR:4	CHEMICAL	GENE-Y	5	8	Assays examining the ability of chemical to block gene-mediated disassembly of gene filaments demonstrate that significant inhibition of gene function occurs only at chemical concentrations that promote gene oligomerization .	T7	T27	20421509
CPR:4	CHEMICAL	GENE-Y	5	11	Assays examining the ability of chemical to block gene-mediated disassembly of gene filaments demonstrate that significant inhibition of gene function occurs only at chemical concentrations that promote gene oligomerization .	T7	T28	20421509
NA	CHEMICAL	GENE-Y	5	18	Assays examining the ability of chemical to block gene-mediated disassembly of gene filaments demonstrate that significant inhibition of gene function occurs only at chemical concentrations that promote gene oligomerization .	T7	T29	20421509
NA	CHEMICAL	GENE-Y	5	27	Assays examining the ability of chemical to block gene-mediated disassembly of gene filaments demonstrate that significant inhibition of gene function occurs only at chemical concentrations that promote gene oligomerization .	T7	T30	20421509
NA	CHEMICAL	GENE-Y	23	8	Assays examining the ability of chemical to block gene-mediated disassembly of gene filaments demonstrate that significant inhibition of gene function occurs only at chemical concentrations that promote gene oligomerization .	T8	T27	20421509
NA	CHEMICAL	GENE-Y	23	11	Assays examining the ability of chemical to block gene-mediated disassembly of gene filaments demonstrate that significant inhibition of gene function occurs only at chemical concentrations that promote gene oligomerization .	T8	T28	20421509
CPR:4	CHEMICAL	GENE-Y	23	18	Assays examining the ability of chemical to block gene-mediated disassembly of gene filaments demonstrate that significant inhibition of gene function occurs only at chemical concentrations that promote gene oligomerization .	T8	T29	20421509
CPR:3	CHEMICAL	GENE-Y	23	27	Assays examining the ability of chemical to block gene-mediated disassembly of gene filaments demonstrate that significant inhibition of gene function occurs only at chemical concentrations that promote gene oligomerization .	T8	T30	20421509
NA	CHEMICAL	GENE-N	0	4	chemical chemical-transferase M1 and P1 polymorphisms and risk of breast cancer and fibrocystic breast conditions in Chinese women .	T3	T20	17624589
NA	CHEMICAL	GENE-N	1	4	chemical chemical-transferase M1 and P1 polymorphisms and risk of breast cancer and fibrocystic breast conditions in Chinese women .	T4	T20	17624589
NA	CHEMICAL	GENE-Y	4	7	Enzymes encoded by the chemical chemical-tranferase mu 1 ( gene ) and gene ( gene ) genes , which are expressed in breast tissue , catalyze the detoxification of endogenous and exogenous electrophiles .	T1	T13	17624589
NA	CHEMICAL	GENE-Y	4	7	Enzymes encoded by the chemical chemical-tranferase mu 1 ( gene ) and gene ( gene ) genes , which are expressed in breast tissue , catalyze the detoxification of endogenous and exogenous electrophiles .	T1	T16	17624589
NA	CHEMICAL	GENE-Y	4	7	Enzymes encoded by the chemical chemical-tranferase mu 1 ( gene ) and gene ( gene ) genes , which are expressed in breast tissue , catalyze the detoxification of endogenous and exogenous electrophiles .	T1	T17	17624589
NA	CHEMICAL	GENE-Y	4	7	Enzymes encoded by the chemical chemical-tranferase mu 1 ( gene ) and gene ( gene ) genes , which are expressed in breast tissue , catalyze the detoxification of endogenous and exogenous electrophiles .	T1	T18	17624589
NA	CHEMICAL	GENE-Y	5	7	Enzymes encoded by the chemical chemical-tranferase mu 1 ( gene ) and gene ( gene ) genes , which are expressed in breast tissue , catalyze the detoxification of endogenous and exogenous electrophiles .	T2	T13	17624589
NA	CHEMICAL	GENE-Y	5	7	Enzymes encoded by the chemical chemical-tranferase mu 1 ( gene ) and gene ( gene ) genes , which are expressed in breast tissue , catalyze the detoxification of endogenous and exogenous electrophiles .	T2	T16	17624589
NA	CHEMICAL	GENE-Y	5	7	Enzymes encoded by the chemical chemical-tranferase mu 1 ( gene ) and gene ( gene ) genes , which are expressed in breast tissue , catalyze the detoxification of endogenous and exogenous electrophiles .	T2	T17	17624589
NA	CHEMICAL	GENE-Y	5	7	Enzymes encoded by the chemical chemical-tranferase mu 1 ( gene ) and gene ( gene ) genes , which are expressed in breast tissue , catalyze the detoxification of endogenous and exogenous electrophiles .	T2	T18	17624589
NA	CHEMICAL	GENE-N	6	0	gene gene specifically activates the two-pore chemical channel gene gene in male mouse livers , which attenuates chemical-induced hepatic hyperplasia .	T9	T24	23291559
NA	CHEMICAL	GENE-Y	6	1	gene gene specifically activates the two-pore chemical channel gene gene in male mouse livers , which attenuates chemical-induced hepatic hyperplasia .	T9	T25	23291559
NA	CHEMICAL	GENE-N	6	7	gene gene specifically activates the two-pore chemical channel gene gene in male mouse livers , which attenuates chemical-induced hepatic hyperplasia .	T9	T26	23291559
NA	CHEMICAL	GENE-Y	6	8	gene gene specifically activates the two-pore chemical channel gene gene in male mouse livers , which attenuates chemical-induced hepatic hyperplasia .	T9	T27	23291559
NA	CHEMICAL	GENE-N	17	0	gene gene specifically activates the two-pore chemical channel gene gene in male mouse livers , which attenuates chemical-induced hepatic hyperplasia .	T8	T24	23291559
NA	CHEMICAL	GENE-Y	17	1	gene gene specifically activates the two-pore chemical channel gene gene in male mouse livers , which attenuates chemical-induced hepatic hyperplasia .	T8	T25	23291559
NA	CHEMICAL	GENE-N	17	7	gene gene specifically activates the two-pore chemical channel gene gene in male mouse livers , which attenuates chemical-induced hepatic hyperplasia .	T8	T26	23291559
NA	CHEMICAL	GENE-Y	17	8	gene gene specifically activates the two-pore chemical channel gene gene in male mouse livers , which attenuates chemical-induced hepatic hyperplasia .	T8	T27	23291559
NA	CHEMICAL	GENE-Y	9	0	gene , a member of the family of two-pore chemical ion channels , is specifically induced in the livers of male mice after chemical treatment .	T4	T10	23291559
NA	CHEMICAL	GENE-N	9	2	gene , a member of the family of two-pore chemical ion channels , is specifically induced in the livers of male mice after chemical treatment .	T4	T16	23291559
CPR:3	CHEMICAL	GENE-Y	0	0	gene , a member of the family of two-pore chemical ion channels , is specifically induced in the livers of male mice after chemical treatment .	T1	T10	23291559
CPR:3	CHEMICAL	GENE-N	0	2	gene , a member of the family of two-pore chemical ion channels , is specifically induced in the livers of male mice after chemical treatment .	T1	T16	23291559
CPR:3	CHEMICAL	GENE-Y	20	14	Here , we have determined the molecular mechanism of this male-specific activation of the gene gene and characterized gene as a chemical-inducible antihyperplasia factor .	T2	T12	23291559
CPR:3	CHEMICAL	GENE-Y	20	18	Here , we have determined the molecular mechanism of this male-specific activation of the gene gene and characterized gene as a chemical-inducible antihyperplasia factor .	T2	T13	23291559
CPR:3	CHEMICAL	GENE-N	3	5	Upon activation by chemical , gene gene binds the 97-bp response element ( -2441/-2345 ) within the gene .	T3	T14	23291559
CPR:3	CHEMICAL	GENE-Y	3	6	Upon activation by chemical , gene gene binds the 97-bp response element ( -2441/-2345 ) within the gene .	T3	T15	23291559
NA	CHEMICAL	GENE-N	3	17	Upon activation by chemical , gene gene binds the 97-bp response element ( -2441/-2345 ) within the gene .	T3	T17	23291559
NA	CHEMICAL	GENE-Y	23	7	Hyperplasia further progressed in the livers of gene ( -/- ) male mice compared with those of gene ( +/+ ) males after chemical treatment .	T5	T18	23291559
NA	CHEMICAL	GENE-Y	23	17	Hyperplasia further progressed in the livers of gene ( -/- ) male mice compared with those of gene ( +/+ ) males after chemical treatment .	T5	T19	23291559
NA	CHEMICAL	GENE-Y	4	2	Thus , gene suppresses chemical-induced hyperplasia .	T6	T20	23291559
CPR:3	CHEMICAL	GENE-Y	4	7	These results indicate that chemical treatment induces gene to elicit a male-specific and growth-suppressing signal .	T7	T21	23291559
CPR:4	CHEMICAL	GENE-Y	0	2	chemical inhibits gene-induced vasoconstriction and intracellular chemical increase in the aorta of spontaneously hypertensive rats .	T13	T24	10406837
NA	CHEMICAL	GENE-Y	6	2	chemical inhibits gene-induced vasoconstriction and intracellular chemical increase in the aorta of spontaneously hypertensive rats .	T14	T24	10406837
NA	CHEMICAL	GENE-Y	11	14	In the present study , the ability of different concentrations of chemical to modify gene ( gene ) -induced vascular responses was examined , with the use of an organ bath system , in endothelium-denuded aortic rings from spontaneously hypertensive rats .	T10	T19	10406837
NA	CHEMICAL	GENE-Y	11	16	In the present study , the ability of different concentrations of chemical to modify gene ( gene ) -induced vascular responses was examined , with the use of an organ bath system , in endothelium-denuded aortic rings from spontaneously hypertensive rats .	T10	T20	10406837
NA	CHEMICAL	GENE-Y	5	0	gene-induced increases of intracellular free chemical concentration ( [ chemical ] ( i ) ) were also examined by image analysis in cultured vascular smooth muscle cells ( VSMCs ) from spontaneously hypertensive rats .	T11	T21	10406837
NA	CHEMICAL	GENE-Y	7	0	gene-induced increases of intracellular free chemical concentration ( [ chemical ] ( i ) ) were also examined by image analysis in cultured vascular smooth muscle cells ( VSMCs ) from spontaneously hypertensive rats .	T12	T21	10406837
CPR:4	CHEMICAL	GENE-Y	4	8	Isometric contraction induced by a submaximal concentration of gene ( 10 ( -7 ) mol/L ) was reduced in a dose-dependent way by chemical ( IC ( 50 ) =0.5+/-0.04 micromol/L ) .	T2	T23	10406837
NA	CHEMICAL	GENE-Y	8	7	Incubation of VSMCs with different concentrations of gene ( from 10 ( -10 ) to 10 ( -6 ) mol/L ) resulted in a dose-dependent rise of [ chemical ] ( i ) ( pD ( 2 ) =7.5+/-0.3 ) .	T3	T15	10406837
NA	CHEMICAL	GENE-Y	5	16	The stimulatory effect of [ chemical ] ( i ) induced by a submaximal concentration of gene ( 10 ( -7 ) mol/L ) was blocked by chemical ( IC ( 50 ) =0.5+/-0.3 nmol/L ) .	T4	T16	10406837
CPR:4	CHEMICAL	GENE-Y	8	16	The stimulatory effect of [ chemical ] ( i ) induced by a submaximal concentration of gene ( 10 ( -7 ) mol/L ) was blocked by chemical ( IC ( 50 ) =0.5+/-0.3 nmol/L ) .	T5	T16	10406837
CPR:4	CHEMICAL	GENE-Y	4	10	Our findings suggest that chemical blocks the vasoconstrictor action of gene in vitro .	T6	T17	10406837
CPR:4	CHEMICAL	GENE-Y	5	23	This action can be related to the ability of chemical to block the increase of [ chemical ] ( i ) induced by gene in VSMCs .	T7	T18	10406837
NA	CHEMICAL	GENE-Y	16	23	This action can be related to the ability of chemical to block the increase of [ chemical ] ( i ) induced by gene in VSMCs .	T8	T18	10406837
NA	CHEMICAL	GENE-N	14	11	They are homozygous for a point mutation at codon 307 ( gene→gene ) resulting in the substitution of chemical 307 by chemical .	T5	T15	23123771
NA	CHEMICAL	GENE-N	14	11	They are homozygous for a point mutation at codon 307 ( gene→gene ) resulting in the substitution of chemical 307 by chemical .	T5	T16	23123771
NA	CHEMICAL	GENE-N	14	14	They are homozygous for a point mutation at codon 307 ( gene→gene ) resulting in the substitution of chemical 307 by chemical .	T5	T17	23123771
NA	CHEMICAL	GENE-N	14	11	They are homozygous for a point mutation at codon 307 ( gene→gene ) resulting in the substitution of chemical 307 by chemical .	T6	T15	23123771
NA	CHEMICAL	GENE-N	14	11	They are homozygous for a point mutation at codon 307 ( gene→gene ) resulting in the substitution of chemical 307 by chemical .	T6	T16	23123771
NA	CHEMICAL	GENE-N	14	14	They are homozygous for a point mutation at codon 307 ( gene→gene ) resulting in the substitution of chemical 307 by chemical .	T6	T17	23123771
NA	CHEMICAL	GENE-N	4	26	The distance between δ chemical of chemical438 to ε chemical of chemical325 and ε chemical of chemical438 to γ chemical of chemical198 were highly altered in gene mutant than the wild and other three variants throughout the simulation .	T7	T11	23123771
NA	CHEMICAL	GENE-N	6	26	The distance between δ chemical of chemical438 to ε chemical of chemical325 and ε chemical of chemical438 to γ chemical of chemical198 were highly altered in gene mutant than the wild and other three variants throughout the simulation .	T8	T11	23123771
NA	CHEMICAL	GENE-N	9	26	The distance between δ chemical of chemical438 to ε chemical of chemical325 and ε chemical of chemical438 to γ chemical of chemical198 were highly altered in gene mutant than the wild and other three variants throughout the simulation .	T9	T11	23123771
NA	CHEMICAL	GENE-N	11	26	The distance between δ chemical of chemical438 to ε chemical of chemical325 and ε chemical of chemical438 to γ chemical of chemical198 were highly altered in gene mutant than the wild and other three variants throughout the simulation .	T10	T11	23123771
NA	CHEMICAL	GENE-N	11	26	The distance between δ chemical of chemical438 to ε chemical of chemical325 and ε chemical of chemical438 to γ chemical of chemical198 were highly altered in gene mutant than the wild and other three variants throughout the simulation .	T1	T11	23123771
NA	CHEMICAL	GENE-N	16	26	The distance between δ chemical of chemical438 to ε chemical of chemical325 and ε chemical of chemical438 to γ chemical of chemical198 were highly altered in gene mutant than the wild and other three variants throughout the simulation .	T2	T11	23123771
NA	CHEMICAL	GENE-N	19	26	The distance between δ chemical of chemical438 to ε chemical of chemical325 and ε chemical of chemical438 to γ chemical of chemical198 were highly altered in gene mutant than the wild and other three variants throughout the simulation .	T3	T11	23123771
NA	CHEMICAL	GENE-N	21	26	The distance between δ chemical of chemical438 to ε chemical of chemical325 and ε chemical of chemical438 to γ chemical of chemical198 were highly altered in gene mutant than the wild and other three variants throughout the simulation .	T4	T11	23123771
CPR:5	CHEMICAL	GENE-N	3	5	Antiarrhythmic effects of chemical , a novel chemical channel agonist in cultured neonatal rat ventricular myocytes .	T21	T25	23116965
NA	CHEMICAL	GENE-N	7	5	Antiarrhythmic effects of chemical , a novel chemical channel agonist in cultured neonatal rat ventricular myocytes .	T22	T25	23116965
NA	CHEMICAL	GENE-N	5	6	The expression of dominant cardiac chemical channel subunit , gene , was consistently detected throughout the culture periods .	T4	T23	23116965
NA	CHEMICAL	GENE-Y	5	9	The expression of dominant cardiac chemical channel subunit , gene , was consistently detected throughout the culture periods .	T4	T24	23116965
NA	CHEMICAL	GENE-Y	0	7	chemical plays a direct and causal role in diabetes pathogenesis mediated both by β cell failure and gene resistance .	T3	T8	23473030
NA	CHEMICAL	GENE-Y	2	2	However , gene-positive cells exhibited increased cell death with exposure to the chemical polymerase inhibitor that blocks single-strand DNA repair .	T1	T19	23444429
NA	CHEMICAL	GENE-N	2	13	However , gene-positive cells exhibited increased cell death with exposure to the chemical polymerase inhibitor that blocks single-strand DNA repair .	T1	T2	23444429
CPR:9	CHEMICAL	GENE-Y	3	6	Reductive detoxification of chemical carcinogens by gene and gene .	T25	T42	17040106
CPR:9	CHEMICAL	GENE-Y	3	8	Reductive detoxification of chemical carcinogens by gene and gene .	T25	T41	17040106
NA	CHEMICAL	GENE-Y	9	29	On the basis of our findings with structurally similar chemical metabolites of therapeutic drugs , we hypothesized that the reductive detoxification of chemical carcinogens was catalyzed by chemical gene reductase ( gene ) and cytochrome b5 ( gene ) .	T16	T37	17040106
NA	CHEMICAL	GENE-Y	9	31	On the basis of our findings with structurally similar chemical metabolites of therapeutic drugs , we hypothesized that the reductive detoxification of chemical carcinogens was catalyzed by chemical gene reductase ( gene ) and cytochrome b5 ( gene ) .	T16	T38	17040106
NA	CHEMICAL	GENE-Y	9	28	On the basis of our findings with structurally similar chemical metabolites of therapeutic drugs , we hypothesized that the reductive detoxification of chemical carcinogens was catalyzed by chemical gene reductase ( gene ) and cytochrome b5 ( gene ) .	T16	T39	17040106
NA	CHEMICAL	GENE-Y	9	35	On the basis of our findings with structurally similar chemical metabolites of therapeutic drugs , we hypothesized that the reductive detoxification of chemical carcinogens was catalyzed by chemical gene reductase ( gene ) and cytochrome b5 ( gene ) .	T16	T40	17040106
CPR:9	CHEMICAL	GENE-Y	22	29	On the basis of our findings with structurally similar chemical metabolites of therapeutic drugs , we hypothesized that the reductive detoxification of chemical carcinogens was catalyzed by chemical gene reductase ( gene ) and cytochrome b5 ( gene ) .	T17	T37	17040106
CPR:9	CHEMICAL	GENE-Y	22	31	On the basis of our findings with structurally similar chemical metabolites of therapeutic drugs , we hypothesized that the reductive detoxification of chemical carcinogens was catalyzed by chemical gene reductase ( gene ) and cytochrome b5 ( gene ) .	T17	T38	17040106
CPR:9	CHEMICAL	GENE-Y	22	28	On the basis of our findings with structurally similar chemical metabolites of therapeutic drugs , we hypothesized that the reductive detoxification of chemical carcinogens was catalyzed by chemical gene reductase ( gene ) and cytochrome b5 ( gene ) .	T17	T39	17040106
CPR:9	CHEMICAL	GENE-Y	22	35	On the basis of our findings with structurally similar chemical metabolites of therapeutic drugs , we hypothesized that the reductive detoxification of chemical carcinogens was catalyzed by chemical gene reductase ( gene ) and cytochrome b5 ( gene ) .	T17	T40	17040106
NA	CHEMICAL	GENE-Y	27	29	On the basis of our findings with structurally similar chemical metabolites of therapeutic drugs , we hypothesized that the reductive detoxification of chemical carcinogens was catalyzed by chemical gene reductase ( gene ) and cytochrome b5 ( gene ) .	T18	T37	17040106
NA	CHEMICAL	GENE-Y	27	31	On the basis of our findings with structurally similar chemical metabolites of therapeutic drugs , we hypothesized that the reductive detoxification of chemical carcinogens was catalyzed by chemical gene reductase ( gene ) and cytochrome b5 ( gene ) .	T18	T38	17040106
NA	CHEMICAL	GENE-Y	27	28	On the basis of our findings with structurally similar chemical metabolites of therapeutic drugs , we hypothesized that the reductive detoxification of chemical carcinogens was catalyzed by chemical gene reductase ( gene ) and cytochrome b5 ( gene ) .	T18	T39	17040106
NA	CHEMICAL	GENE-Y	27	35	On the basis of our findings with structurally similar chemical metabolites of therapeutic drugs , we hypothesized that the reductive detoxification of chemical carcinogens was catalyzed by chemical gene reductase ( gene ) and cytochrome b5 ( gene ) .	T18	T40	17040106
CPR:9	CHEMICAL	GENE-Y	7	41	We found that reduction of the carcinogenic chemical of the chemical chemical ( chemical ; found in cigarette smoke ) and the chemical chemical ( chemical ; found in grilled meats ) was indeed catalyzed by a purified system containing only gene and gene .	T19	T27	17040106
CPR:9	CHEMICAL	GENE-Y	7	43	We found that reduction of the carcinogenic chemical of the chemical chemical ( chemical ; found in cigarette smoke ) and the chemical chemical ( chemical ; found in grilled meats ) was indeed catalyzed by a purified system containing only gene and gene .	T19	T28	17040106
CPR:9	CHEMICAL	GENE-Y	10	41	We found that reduction of the carcinogenic chemical of the chemical chemical ( chemical ; found in cigarette smoke ) and the chemical chemical ( chemical ; found in grilled meats ) was indeed catalyzed by a purified system containing only gene and gene .	T20	T27	17040106
CPR:9	CHEMICAL	GENE-Y	10	43	We found that reduction of the carcinogenic chemical of the chemical chemical ( chemical ; found in cigarette smoke ) and the chemical chemical ( chemical ; found in grilled meats ) was indeed catalyzed by a purified system containing only gene and gene .	T20	T28	17040106
CPR:9	CHEMICAL	GENE-Y	11	41	We found that reduction of the carcinogenic chemical of the chemical chemical ( chemical ; found in cigarette smoke ) and the chemical chemical ( chemical ; found in grilled meats ) was indeed catalyzed by a purified system containing only gene and gene .	T21	T27	17040106
CPR:9	CHEMICAL	GENE-Y	11	43	We found that reduction of the carcinogenic chemical of the chemical chemical ( chemical ; found in cigarette smoke ) and the chemical chemical ( chemical ; found in grilled meats ) was indeed catalyzed by a purified system containing only gene and gene .	T21	T28	17040106
CPR:9	CHEMICAL	GENE-Y	13	41	We found that reduction of the carcinogenic chemical of the chemical chemical ( chemical ; found in cigarette smoke ) and the chemical chemical ( chemical ; found in grilled meats ) was indeed catalyzed by a purified system containing only gene and gene .	T22	T27	17040106
CPR:9	CHEMICAL	GENE-Y	13	43	We found that reduction of the carcinogenic chemical of the chemical chemical ( chemical ; found in cigarette smoke ) and the chemical chemical ( chemical ; found in grilled meats ) was indeed catalyzed by a purified system containing only gene and gene .	T22	T28	17040106
CPR:9	CHEMICAL	GENE-Y	16	41	We found that reduction of the carcinogenic chemical of the chemical chemical ( chemical ; found in cigarette smoke ) and the chemical chemical ( chemical ; found in grilled meats ) was indeed catalyzed by a purified system containing only gene and gene .	T23	T27	17040106
CPR:9	CHEMICAL	GENE-Y	16	43	We found that reduction of the carcinogenic chemical of the chemical chemical ( chemical ; found in cigarette smoke ) and the chemical chemical ( chemical ; found in grilled meats ) was indeed catalyzed by a purified system containing only gene and gene .	T23	T28	17040106
CPR:9	CHEMICAL	GENE-Y	16	41	We found that reduction of the carcinogenic chemical of the chemical chemical ( chemical ; found in cigarette smoke ) and the chemical chemical ( chemical ; found in grilled meats ) was indeed catalyzed by a purified system containing only gene and gene .	T24	T27	17040106
CPR:9	CHEMICAL	GENE-Y	16	43	We found that reduction of the carcinogenic chemical of the chemical chemical ( chemical ; found in cigarette smoke ) and the chemical chemical ( chemical ; found in grilled meats ) was indeed catalyzed by a purified system containing only gene and gene .	T24	T28	17040106
CPR:9	CHEMICAL	GENE-Y	10	41	We found that reduction of the carcinogenic chemical of the chemical chemical ( chemical ; found in cigarette smoke ) and the chemical chemical ( chemical ; found in grilled meats ) was indeed catalyzed by a purified system containing only gene and gene .	T2	T27	17040106
CPR:9	CHEMICAL	GENE-Y	10	43	We found that reduction of the carcinogenic chemical of the chemical chemical ( chemical ; found in cigarette smoke ) and the chemical chemical ( chemical ; found in grilled meats ) was indeed catalyzed by a purified system containing only gene and gene .	T2	T28	17040106
CPR:9	CHEMICAL	GENE-Y	9	4	Polyclonal antisera to either gene or gene significantly inhibited chemical ( chemical ) reduction by 95 and 89 % , respectively , and immunoreactive cyt b5 protein content in individual HLM was significantly correlated with individual reduction of both chemical and chemical ( chemical ) .	T4	T31	17040106
CPR:9	CHEMICAL	GENE-Y	9	6	Polyclonal antisera to either gene or gene significantly inhibited chemical ( chemical ) reduction by 95 and 89 % , respectively , and immunoreactive cyt b5 protein content in individual HLM was significantly correlated with individual reduction of both chemical and chemical ( chemical ) .	T4	T32	17040106
CPR:9	CHEMICAL	GENE-Y	11	4	Polyclonal antisera to either gene or gene significantly inhibited chemical ( chemical ) reduction by 95 and 89 % , respectively , and immunoreactive cyt b5 protein content in individual HLM was significantly correlated with individual reduction of both chemical and chemical ( chemical ) .	T5	T31	17040106
CPR:9	CHEMICAL	GENE-Y	11	6	Polyclonal antisera to either gene or gene significantly inhibited chemical ( chemical ) reduction by 95 and 89 % , respectively , and immunoreactive cyt b5 protein content in individual HLM was significantly correlated with individual reduction of both chemical and chemical ( chemical ) .	T5	T32	17040106
NA	CHEMICAL	GENE-Y	39	4	Polyclonal antisera to either gene or gene significantly inhibited chemical ( chemical ) reduction by 95 and 89 % , respectively , and immunoreactive cyt b5 protein content in individual HLM was significantly correlated with individual reduction of both chemical and chemical ( chemical ) .	T6	T31	17040106
NA	CHEMICAL	GENE-Y	39	6	Polyclonal antisera to either gene or gene significantly inhibited chemical ( chemical ) reduction by 95 and 89 % , respectively , and immunoreactive cyt b5 protein content in individual HLM was significantly correlated with individual reduction of both chemical and chemical ( chemical ) .	T6	T32	17040106
NA	CHEMICAL	GENE-Y	41	4	Polyclonal antisera to either gene or gene significantly inhibited chemical ( chemical ) reduction by 95 and 89 % , respectively , and immunoreactive cyt b5 protein content in individual HLM was significantly correlated with individual reduction of both chemical and chemical ( chemical ) .	T7	T31	17040106
NA	CHEMICAL	GENE-Y	41	6	Polyclonal antisera to either gene or gene significantly inhibited chemical ( chemical ) reduction by 95 and 89 % , respectively , and immunoreactive cyt b5 protein content in individual HLM was significantly correlated with individual reduction of both chemical and chemical ( chemical ) .	T7	T32	17040106
NA	CHEMICAL	GENE-Y	43	4	Polyclonal antisera to either gene or gene significantly inhibited chemical ( chemical ) reduction by 95 and 89 % , respectively , and immunoreactive cyt b5 protein content in individual HLM was significantly correlated with individual reduction of both chemical and chemical ( chemical ) .	T8	T31	17040106
NA	CHEMICAL	GENE-Y	43	6	Polyclonal antisera to either gene or gene significantly inhibited chemical ( chemical ) reduction by 95 and 89 % , respectively , and immunoreactive cyt b5 protein content in individual HLM was significantly correlated with individual reduction of both chemical and chemical ( chemical ) .	T8	T32	17040106
NA	CHEMICAL	GENE-N	0	4	chemical ( chemical ) receptor antagonists are a relatively new class of antihypertensive agent that block chemical Type 1 ( AT ( 1 ) ) receptors , and reduce the pressor effects of chemical in the vasculature .	T7	T24	12517247
NA	CHEMICAL	GENE-Y	0	4	chemical ( chemical ) receptor antagonists are a relatively new class of antihypertensive agent that block chemical Type 1 ( AT ( 1 ) ) receptors , and reduce the pressor effects of chemical in the vasculature .	T7	T25	12517247
NA	CHEMICAL	GENE-N	2	4	chemical ( chemical ) receptor antagonists are a relatively new class of antihypertensive agent that block chemical Type 1 ( AT ( 1 ) ) receptors , and reduce the pressor effects of chemical in the vasculature .	T8	T24	12517247
NA	CHEMICAL	GENE-Y	2	4	chemical ( chemical ) receptor antagonists are a relatively new class of antihypertensive agent that block chemical Type 1 ( AT ( 1 ) ) receptors , and reduce the pressor effects of chemical in the vasculature .	T8	T25	12517247
NA	CHEMICAL	GENE-N	16	4	chemical ( chemical ) receptor antagonists are a relatively new class of antihypertensive agent that block chemical Type 1 ( AT ( 1 ) ) receptors , and reduce the pressor effects of chemical in the vasculature .	T9	T24	12517247
NA	CHEMICAL	GENE-Y	16	4	chemical ( chemical ) receptor antagonists are a relatively new class of antihypertensive agent that block chemical Type 1 ( AT ( 1 ) ) receptors , and reduce the pressor effects of chemical in the vasculature .	T9	T25	12517247
NA	CHEMICAL	GENE-N	33	4	chemical ( chemical ) receptor antagonists are a relatively new class of antihypertensive agent that block chemical Type 1 ( AT ( 1 ) ) receptors , and reduce the pressor effects of chemical in the vasculature .	T10	T24	12517247
NA	CHEMICAL	GENE-Y	33	4	chemical ( chemical ) receptor antagonists are a relatively new class of antihypertensive agent that block chemical Type 1 ( AT ( 1 ) ) receptors , and reduce the pressor effects of chemical in the vasculature .	T10	T25	12517247
NA	CHEMICAL	GENE-Y	11	12	By this mechanism , they induce similar pharmacological effects compared with chemical-converting enzyme ( gene ) inhibitors , resulting in a lowering of blood pressure .	T11	T27	12517247
NA	CHEMICAL	GENE-Y	11	14	By this mechanism , they induce similar pharmacological effects compared with chemical-converting enzyme ( gene ) inhibitors , resulting in a lowering of blood pressure .	T11	T28	12517247
NA	CHEMICAL	GENE-N	2	3	However , chemical receptor blockers differ from gene inhibitors with respect to side effects , and induce less cough , a side effect which may be related to chemical or other mediators such as chemical . Within the class of chemical blockers , chemical differs from other currently available agents in terms of chemical structure , as it is a non-chemical , non-chemical , non-peptide antagonist with a dual pharmacological mode of action .	T12	T29	12517247
NA	CHEMICAL	GENE-Y	2	7	However , chemical receptor blockers differ from gene inhibitors with respect to side effects , and induce less cough , a side effect which may be related to chemical or other mediators such as chemical . Within the class of chemical blockers , chemical differs from other currently available agents in terms of chemical structure , as it is a non-chemical , non-chemical , non-peptide antagonist with a dual pharmacological mode of action .	T12	T30	12517247
NA	CHEMICAL	GENE-Y	2	20	However , chemical receptor blockers differ from gene inhibitors with respect to side effects , and induce less cough , a side effect which may be related to chemical or other mediators such as chemical . Within the class of chemical blockers , chemical differs from other currently available agents in terms of chemical structure , as it is a non-chemical , non-chemical , non-peptide antagonist with a dual pharmacological mode of action .	T12	T31	12517247
NA	CHEMICAL	GENE-N	20	3	However , chemical receptor blockers differ from gene inhibitors with respect to side effects , and induce less cough , a side effect which may be related to chemical or other mediators such as chemical . Within the class of chemical blockers , chemical differs from other currently available agents in terms of chemical structure , as it is a non-chemical , non-chemical , non-peptide antagonist with a dual pharmacological mode of action .	T13	T29	12517247
NA	CHEMICAL	GENE-Y	20	7	However , chemical receptor blockers differ from gene inhibitors with respect to side effects , and induce less cough , a side effect which may be related to chemical or other mediators such as chemical . Within the class of chemical blockers , chemical differs from other currently available agents in terms of chemical structure , as it is a non-chemical , non-chemical , non-peptide antagonist with a dual pharmacological mode of action .	T13	T30	12517247
NA	CHEMICAL	GENE-Y	20	20	However , chemical receptor blockers differ from gene inhibitors with respect to side effects , and induce less cough , a side effect which may be related to chemical or other mediators such as chemical . Within the class of chemical blockers , chemical differs from other currently available agents in terms of chemical structure , as it is a non-chemical , non-chemical , non-peptide antagonist with a dual pharmacological mode of action .	T13	T31	12517247
NA	CHEMICAL	GENE-N	34	3	However , chemical receptor blockers differ from gene inhibitors with respect to side effects , and induce less cough , a side effect which may be related to chemical or other mediators such as chemical . Within the class of chemical blockers , chemical differs from other currently available agents in terms of chemical structure , as it is a non-chemical , non-chemical , non-peptide antagonist with a dual pharmacological mode of action .	T14	T29	12517247
NA	CHEMICAL	GENE-Y	34	7	However , chemical receptor blockers differ from gene inhibitors with respect to side effects , and induce less cough , a side effect which may be related to chemical or other mediators such as chemical . Within the class of chemical blockers , chemical differs from other currently available agents in terms of chemical structure , as it is a non-chemical , non-chemical , non-peptide antagonist with a dual pharmacological mode of action .	T14	T30	12517247
NA	CHEMICAL	GENE-Y	34	20	However , chemical receptor blockers differ from gene inhibitors with respect to side effects , and induce less cough , a side effect which may be related to chemical or other mediators such as chemical . Within the class of chemical blockers , chemical differs from other currently available agents in terms of chemical structure , as it is a non-chemical , non-chemical , non-peptide antagonist with a dual pharmacological mode of action .	T14	T31	12517247
NA	CHEMICAL	GENE-N	40	3	However , chemical receptor blockers differ from gene inhibitors with respect to side effects , and induce less cough , a side effect which may be related to chemical or other mediators such as chemical . Within the class of chemical blockers , chemical differs from other currently available agents in terms of chemical structure , as it is a non-chemical , non-chemical , non-peptide antagonist with a dual pharmacological mode of action .	T15	T29	12517247
NA	CHEMICAL	GENE-Y	40	7	However , chemical receptor blockers differ from gene inhibitors with respect to side effects , and induce less cough , a side effect which may be related to chemical or other mediators such as chemical . Within the class of chemical blockers , chemical differs from other currently available agents in terms of chemical structure , as it is a non-chemical , non-chemical , non-peptide antagonist with a dual pharmacological mode of action .	T15	T30	12517247
NA	CHEMICAL	GENE-Y	40	20	However , chemical receptor blockers differ from gene inhibitors with respect to side effects , and induce less cough , a side effect which may be related to chemical or other mediators such as chemical . Within the class of chemical blockers , chemical differs from other currently available agents in terms of chemical structure , as it is a non-chemical , non-chemical , non-peptide antagonist with a dual pharmacological mode of action .	T15	T31	12517247
NA	CHEMICAL	GENE-N	20	3	However , chemical receptor blockers differ from gene inhibitors with respect to side effects , and induce less cough , a side effect which may be related to chemical or other mediators such as chemical . Within the class of chemical blockers , chemical differs from other currently available agents in terms of chemical structure , as it is a non-chemical , non-chemical , non-peptide antagonist with a dual pharmacological mode of action .	T16	T29	12517247
NA	CHEMICAL	GENE-Y	20	7	However , chemical receptor blockers differ from gene inhibitors with respect to side effects , and induce less cough , a side effect which may be related to chemical or other mediators such as chemical . Within the class of chemical blockers , chemical differs from other currently available agents in terms of chemical structure , as it is a non-chemical , non-chemical , non-peptide antagonist with a dual pharmacological mode of action .	T16	T30	12517247
NA	CHEMICAL	GENE-Y	20	20	However , chemical receptor blockers differ from gene inhibitors with respect to side effects , and induce less cough , a side effect which may be related to chemical or other mediators such as chemical . Within the class of chemical blockers , chemical differs from other currently available agents in terms of chemical structure , as it is a non-chemical , non-chemical , non-peptide antagonist with a dual pharmacological mode of action .	T16	T31	12517247
NA	CHEMICAL	GENE-N	60	3	However , chemical receptor blockers differ from gene inhibitors with respect to side effects , and induce less cough , a side effect which may be related to chemical or other mediators such as chemical . Within the class of chemical blockers , chemical differs from other currently available agents in terms of chemical structure , as it is a non-chemical , non-chemical , non-peptide antagonist with a dual pharmacological mode of action .	T17	T29	12517247
NA	CHEMICAL	GENE-Y	60	7	However , chemical receptor blockers differ from gene inhibitors with respect to side effects , and induce less cough , a side effect which may be related to chemical or other mediators such as chemical . Within the class of chemical blockers , chemical differs from other currently available agents in terms of chemical structure , as it is a non-chemical , non-chemical , non-peptide antagonist with a dual pharmacological mode of action .	T17	T30	12517247
NA	CHEMICAL	GENE-Y	60	20	However , chemical receptor blockers differ from gene inhibitors with respect to side effects , and induce less cough , a side effect which may be related to chemical or other mediators such as chemical . Within the class of chemical blockers , chemical differs from other currently available agents in terms of chemical structure , as it is a non-chemical , non-chemical , non-peptide antagonist with a dual pharmacological mode of action .	T17	T31	12517247
NA	CHEMICAL	GENE-N	20	3	However , chemical receptor blockers differ from gene inhibitors with respect to side effects , and induce less cough , a side effect which may be related to chemical or other mediators such as chemical . Within the class of chemical blockers , chemical differs from other currently available agents in terms of chemical structure , as it is a non-chemical , non-chemical , non-peptide antagonist with a dual pharmacological mode of action .	T18	T29	12517247
NA	CHEMICAL	GENE-Y	20	7	However , chemical receptor blockers differ from gene inhibitors with respect to side effects , and induce less cough , a side effect which may be related to chemical or other mediators such as chemical . Within the class of chemical blockers , chemical differs from other currently available agents in terms of chemical structure , as it is a non-chemical , non-chemical , non-peptide antagonist with a dual pharmacological mode of action .	T18	T30	12517247
NA	CHEMICAL	GENE-Y	20	20	However , chemical receptor blockers differ from gene inhibitors with respect to side effects , and induce less cough , a side effect which may be related to chemical or other mediators such as chemical . Within the class of chemical blockers , chemical differs from other currently available agents in terms of chemical structure , as it is a non-chemical , non-chemical , non-peptide antagonist with a dual pharmacological mode of action .	T18	T31	12517247
NA	CHEMICAL	GENE-Y	0	4	chemical acts at vascular gene ( postsynaptically ) and at presynaptic gene , where it inhibits sympathetically stimulated chemical release .	T1	T20	12517247
NA	CHEMICAL	GENE-Y	0	11	chemical acts at vascular gene ( postsynaptically ) and at presynaptic gene , where it inhibits sympathetically stimulated chemical release .	T1	T21	12517247
NA	CHEMICAL	GENE-Y	4	4	chemical acts at vascular gene ( postsynaptically ) and at presynaptic gene , where it inhibits sympathetically stimulated chemical release .	T2	T20	12517247
NA	CHEMICAL	GENE-Y	4	11	chemical acts at vascular gene ( postsynaptically ) and at presynaptic gene , where it inhibits sympathetically stimulated chemical release .	T2	T21	12517247
NA	CHEMICAL	GENE-Y	4	20	In clinical trials , chemical has been demonstrated to be at least as effective in reducing blood pressure as the gene inhibitor chemical , and has significantly lower side effects .	T3	T23	12517247
CPR:4	CHEMICAL	GENE-Y	22	20	In clinical trials , chemical has been demonstrated to be at least as effective in reducing blood pressure as the gene inhibitor chemical , and has significantly lower side effects .	T4	T23	12517247
NA	CHEMICAL	GENE-Y	5	18	PC12 cell apoptosis induced by chemical was confirmed by annexin V/chemical staining , and characterized by cleavage of gene and gene proteins .	T9	T22	23041257
NA	CHEMICAL	GENE-Y	5	20	PC12 cell apoptosis induced by chemical was confirmed by annexin V/chemical staining , and characterized by cleavage of gene and gene proteins .	T9	T23	23041257
NA	CHEMICAL	GENE-Y	10	18	PC12 cell apoptosis induced by chemical was confirmed by annexin V/chemical staining , and characterized by cleavage of gene and gene proteins .	T10	T22	23041257
NA	CHEMICAL	GENE-Y	10	20	PC12 cell apoptosis induced by chemical was confirmed by annexin V/chemical staining , and characterized by cleavage of gene and gene proteins .	T10	T23	23041257
NA	CHEMICAL	GENE-Y	0	5	chemical induced the release of gene from the mitochondria to the cytosol and the generation of reactive chemical species .	T11	T24	23041257
NA	CHEMICAL	GENE-Y	17	5	chemical induced the release of gene from the mitochondria to the cytosol and the generation of reactive chemical species .	T12	T24	23041257
CPR:3	CHEMICAL	GENE-Y	0	5	chemical up-regulated the expression of gene , down-regulated the expression of gene , and significantly increased the ratio of gene/gene .	T13	T25	23041257
CPR:4	CHEMICAL	GENE-Y	0	11	chemical up-regulated the expression of gene , down-regulated the expression of gene , and significantly increased the ratio of gene/gene .	T13	T26	23041257
CPR:3	CHEMICAL	GENE-Y	0	19	chemical up-regulated the expression of gene , down-regulated the expression of gene , and significantly increased the ratio of gene/gene .	T13	T15	23041257
CPR:3	CHEMICAL	GENE-Y	0	19	chemical up-regulated the expression of gene , down-regulated the expression of gene , and significantly increased the ratio of gene/gene .	T13	T16	23041257
CPR:3	CHEMICAL	GENE-N	0	6	chemical also caused the phosphorylation of gene and gene ( gene ) .	T1	T17	23041257
CPR:3	CHEMICAL	GENE-N	0	8	chemical also caused the phosphorylation of gene and gene ( gene ) .	T1	T18	23041257
CPR:3	CHEMICAL	GENE-N	0	10	chemical also caused the phosphorylation of gene and gene ( gene ) .	T1	T19	23041257
NA	CHEMICAL	GENE-Y	4	13	In rats exposed to chemical , apoptosis was also observed in brain , as shown by the detection of cleaved gene and gene proteins and increased TUNEL positive staining .	T2	T20	23041257
NA	CHEMICAL	GENE-Y	4	13	In rats exposed to chemical , apoptosis was also observed in brain , as shown by the detection of cleaved gene and gene proteins and increased TUNEL positive staining .	T2	T21	23041257
NA	CHEMICAL	GENE-Y	12	5	An earlier study showed that gene negatively regulates the functional activity of chemical-activated protein kinase ( gene ) in vitro by binding directly to the gene complex .	T1	T2	23349485
NA	CHEMICAL	GENE-N	12	14	An earlier study showed that gene negatively regulates the functional activity of chemical-activated protein kinase ( gene ) in vitro by binding directly to the gene complex .	T1	T3	23349485
NA	CHEMICAL	GENE-N	12	16	An earlier study showed that gene negatively regulates the functional activity of chemical-activated protein kinase ( gene ) in vitro by binding directly to the gene complex .	T1	T4	23349485
NA	CHEMICAL	GENE-Y	12	25	An earlier study showed that gene negatively regulates the functional activity of chemical-activated protein kinase ( gene ) in vitro by binding directly to the gene complex .	T1	T6	23349485
NA	CHEMICAL	GENE-N	8	3	Differential binding of gene to basement membrane heparan chemical : comparison of normal and abnormal human tissues .	T9	T25	9094999
NA	CHEMICAL	GENE-N	7	0	gene signal through gene , but heparan chemical is also required for signaling by members of the gene family .	T4	T13	9094999
NA	CHEMICAL	GENE-N	7	3	gene signal through gene , but heparan chemical is also required for signaling by members of the gene family .	T4	T14	9094999
NA	CHEMICAL	GENE-N	7	17	gene signal through gene , but heparan chemical is also required for signaling by members of the gene family .	T4	T16	9094999
NA	CHEMICAL	GENE-Y	20	2	Using biotinylated gene and gene ( gene ) as probes , we have identified specific interactions between gene and heparan chemical in human tissues .	T5	T18	9094999
NA	CHEMICAL	GENE-Y	20	4	Using biotinylated gene and gene ( gene ) as probes , we have identified specific interactions between gene and heparan chemical in human tissues .	T5	T19	9094999
NA	CHEMICAL	GENE-Y	20	6	Using biotinylated gene and gene ( gene ) as probes , we have identified specific interactions between gene and heparan chemical in human tissues .	T5	T20	9094999
NA	CHEMICAL	GENE-N	20	17	Using biotinylated gene and gene ( gene ) as probes , we have identified specific interactions between gene and heparan chemical in human tissues .	T5	T21	9094999
NA	CHEMICAL	GENE-Y	8	1	Although gene strongly binds to basement membrane heparan chemical in skin and most other tissue sites examined , gene fails to bind to basement membrane heparan chemical in most locations .	T7	T23	9094999
NA	CHEMICAL	GENE-Y	8	18	Although gene strongly binds to basement membrane heparan chemical in skin and most other tissue sites examined , gene fails to bind to basement membrane heparan chemical in most locations .	T7	T24	9094999
NA	CHEMICAL	GENE-Y	26	1	Although gene strongly binds to basement membrane heparan chemical in skin and most other tissue sites examined , gene fails to bind to basement membrane heparan chemical in most locations .	T8	T23	9094999
NA	CHEMICAL	GENE-Y	26	18	Although gene strongly binds to basement membrane heparan chemical in skin and most other tissue sites examined , gene fails to bind to basement membrane heparan chemical in most locations .	T8	T24	9094999
NA	CHEMICAL	GENE-N	9	12	In summary , distinct and specific affinities of heparan chemical for different gene were identified that may affect growth factor activation and local distribution .	T1	T12	9094999
NA	CHEMICAL	GENE-Y	1	2	The chemical transporter polymorphism , gene , is associated with a faster response time to chemical in an elderly population with major depressive disorder .	T9	T19	12955294
NA	CHEMICAL	GENE-Y	1	5	The chemical transporter polymorphism , gene , is associated with a faster response time to chemical in an elderly population with major depressive disorder .	T9	T18	12955294
NA	CHEMICAL	GENE-Y	10	2	The chemical transporter polymorphism , gene , is associated with a faster response time to chemical in an elderly population with major depressive disorder .	T10	T19	12955294
NA	CHEMICAL	GENE-Y	10	5	The chemical transporter polymorphism , gene , is associated with a faster response time to chemical in an elderly population with major depressive disorder .	T10	T18	12955294
NA	CHEMICAL	GENE-Y	14	6	RATIONALE : A common polymorphism ( gene ) within the promoter region of the chemical transporter gene ( gene ) has been shown to influence response time as well as overall response to selective chemical reuptake inhibitors ( SSRIs ) in subjects with major depressive disorder .	T7	T14	12955294
NA	CHEMICAL	GENE-Y	14	15	RATIONALE : A common polymorphism ( gene ) within the promoter region of the chemical transporter gene ( gene ) has been shown to influence response time as well as overall response to selective chemical reuptake inhibitors ( SSRIs ) in subjects with major depressive disorder .	T7	T16	12955294
NA	CHEMICAL	GENE-Y	14	2	RATIONALE : A common polymorphism ( gene ) within the promoter region of the chemical transporter gene ( gene ) has been shown to influence response time as well as overall response to selective chemical reuptake inhibitors ( SSRIs ) in subjects with major depressive disorder .	T7	T12	12955294
NA	CHEMICAL	GENE-Y	23	6	RATIONALE : A common polymorphism ( gene ) within the promoter region of the chemical transporter gene ( gene ) has been shown to influence response time as well as overall response to selective chemical reuptake inhibitors ( SSRIs ) in subjects with major depressive disorder .	T3	T14	12955294
NA	CHEMICAL	GENE-Y	23	15	RATIONALE : A common polymorphism ( gene ) within the promoter region of the chemical transporter gene ( gene ) has been shown to influence response time as well as overall response to selective chemical reuptake inhibitors ( SSRIs ) in subjects with major depressive disorder .	T3	T16	12955294
NA	CHEMICAL	GENE-Y	23	2	RATIONALE : A common polymorphism ( gene ) within the promoter region of the chemical transporter gene ( gene ) has been shown to influence response time as well as overall response to selective chemical reuptake inhibitors ( SSRIs ) in subjects with major depressive disorder .	T3	T12	12955294
NA	CHEMICAL	GENE-Y	22	15	OBJECTIVES : We tested the hypothesis that subjects homozygous for the long allele at the gene polymorphism would respond more rapidly to chemical than subjects carrying one or two copies of the short allele .	T5	T15	12955294
NA	CHEMICAL	GENE-Y	16	3	Genotyping of the gene polymorphism was performed to test for correlations with response at each week in the chemical and placebo groups ( n=206 ) .	T8	T17	12955294
NA	CHEMICAL	GENE-Y	0	2	chemical probes gene ( gene ) function , while chemical probes both gene and gene ( gene ) function .	T7	T18	17016711
NA	CHEMICAL	GENE-Y	0	4	chemical probes gene ( gene ) function , while chemical probes both gene and gene ( gene ) function .	T7	T19	17016711
NA	CHEMICAL	GENE-Y	0	12	chemical probes gene ( gene ) function , while chemical probes both gene and gene ( gene ) function .	T7	T20	17016711
NA	CHEMICAL	GENE-Y	0	14	chemical probes gene ( gene ) function , while chemical probes both gene and gene ( gene ) function .	T7	T21	17016711
NA	CHEMICAL	GENE-Y	0	16	chemical probes gene ( gene ) function , while chemical probes both gene and gene ( gene ) function .	T7	T22	17016711
NA	CHEMICAL	GENE-Y	9	2	chemical probes gene ( gene ) function , while chemical probes both gene and gene ( gene ) function .	T8	T18	17016711
NA	CHEMICAL	GENE-Y	9	4	chemical probes gene ( gene ) function , while chemical probes both gene and gene ( gene ) function .	T8	T19	17016711
NA	CHEMICAL	GENE-Y	9	12	chemical probes gene ( gene ) function , while chemical probes both gene and gene ( gene ) function .	T8	T20	17016711
NA	CHEMICAL	GENE-Y	9	14	chemical probes gene ( gene ) function , while chemical probes both gene and gene ( gene ) function .	T8	T21	17016711
NA	CHEMICAL	GENE-Y	9	16	chemical probes gene ( gene ) function , while chemical probes both gene and gene ( gene ) function .	T8	T22	17016711
CPR:4	CHEMICAL	GENE-Y	3	10	One exception is chemical ( chemical ) , which , as a chemical mimetic , inhibits binding of gene to gene .	T1	T11	23521080
CPR:4	CHEMICAL	GENE-N	3	20	One exception is chemical ( chemical ) , which , as a chemical mimetic , inhibits binding of gene to gene .	T1	T12	23521080
CPR:4	CHEMICAL	GENE-Y	5	10	One exception is chemical ( chemical ) , which , as a chemical mimetic , inhibits binding of gene to gene .	T2	T11	23521080
CPR:4	CHEMICAL	GENE-N	5	20	One exception is chemical ( chemical ) , which , as a chemical mimetic , inhibits binding of gene to gene .	T2	T12	23521080
CPR:4	CHEMICAL	GENE-Y	12	10	One exception is chemical ( chemical ) , which , as a chemical mimetic , inhibits binding of gene to gene .	T3	T11	23521080
CPR:4	CHEMICAL	GENE-N	12	20	One exception is chemical ( chemical ) , which , as a chemical mimetic , inhibits binding of gene to gene .	T3	T12	23521080
CPR:4	CHEMICAL	GENE-Y	5	5	Coupling this computational technique with a high-quality low-throughput screen identified chemical ( chemical ) as a potent gene binding inhibitor with the potential for the treatment of various bleeding disorders .	T6	T13	23521080
CPR:4	CHEMICAL	GENE-Y	12	5	Coupling this computational technique with a high-quality low-throughput screen identified chemical ( chemical ) as a potent gene binding inhibitor with the potential for the treatment of various bleeding disorders .	T7	T13	23521080
NA	CHEMICAL	GENE-Y	38	0	gene was measured ( ELISA ; Luminex ) to estimate homeostasis model assessment of gene resistance ( HOMA-IR ) , β-cell function ( HOMA-B ) , gene sensitivity ( Matsuda index ) , gene secretion ( AUC ( gene/chemical ) ) , and β-cell compensation ( gene secretion sensitivity index-2 ) .	T4	T14	23300287
NA	CHEMICAL	GENE-Y	38	14	gene was measured ( ELISA ; Luminex ) to estimate homeostasis model assessment of gene resistance ( HOMA-IR ) , β-cell function ( HOMA-B ) , gene sensitivity ( Matsuda index ) , gene secretion ( AUC ( gene/chemical ) ) , and β-cell compensation ( gene secretion sensitivity index-2 ) .	T4	T15	23300287
NA	CHEMICAL	GENE-Y	38	26	gene was measured ( ELISA ; Luminex ) to estimate homeostasis model assessment of gene resistance ( HOMA-IR ) , β-cell function ( HOMA-B ) , gene sensitivity ( Matsuda index ) , gene secretion ( AUC ( gene/chemical ) ) , and β-cell compensation ( gene secretion sensitivity index-2 ) .	T4	T16	23300287
NA	CHEMICAL	GENE-Y	38	33	gene was measured ( ELISA ; Luminex ) to estimate homeostasis model assessment of gene resistance ( HOMA-IR ) , β-cell function ( HOMA-B ) , gene sensitivity ( Matsuda index ) , gene secretion ( AUC ( gene/chemical ) ) , and β-cell compensation ( gene secretion sensitivity index-2 ) .	T4	T17	23300287
NA	CHEMICAL	GENE-Y	38	38	gene was measured ( ELISA ; Luminex ) to estimate homeostasis model assessment of gene resistance ( HOMA-IR ) , β-cell function ( HOMA-B ) , gene sensitivity ( Matsuda index ) , gene secretion ( AUC ( gene/chemical ) ) , and β-cell compensation ( gene secretion sensitivity index-2 ) .	T4	T18	23300287
NA	CHEMICAL	GENE-Y	38	46	gene was measured ( ELISA ; Luminex ) to estimate homeostasis model assessment of gene resistance ( HOMA-IR ) , β-cell function ( HOMA-B ) , gene sensitivity ( Matsuda index ) , gene secretion ( AUC ( gene/chemical ) ) , and β-cell compensation ( gene secretion sensitivity index-2 ) .	T4	T19	23300287
NA	CHEMICAL	GENE-N	0	11	chemical deficiency induces markedly decreased serum chemical , increased small dense gene , and hepatic steatosis mediated by dysregulation of lipid assembly and secretion in mice fed a high-fat diet .	T7	T19	23332447
NA	CHEMICAL	GENE-N	6	11	chemical deficiency induces markedly decreased serum chemical , increased small dense gene , and hepatic steatosis mediated by dysregulation of lipid assembly and secretion in mice fed a high-fat diet .	T8	T19	23332447
NA	CHEMICAL	GENE-N	14	19	RESULTS : ORX mice fed HFD showed increased hepatic steatosis , markedly decreased serum chemical ( TG ) and TG-gene content , and increased serum very small-gene content .	T5	T16	23332447
NA	CHEMICAL	GENE-N	14	26	RESULTS : ORX mice fed HFD showed increased hepatic steatosis , markedly decreased serum chemical ( TG ) and TG-gene content , and increased serum very small-gene content .	T5	T17	23332447
NA	CHEMICAL	GENE-Y	14	14	Gene expression analysis revealed that ORX mice fed HFD showed significantly decreased expression of gene , gene , gene and gene , and significantly increased chemical regulatory element-binding protein-1 , chemical acyltransferase-2 and chemical synthase .	T1	T18	23332447
NA	CHEMICAL	GENE-Y	14	16	Gene expression analysis revealed that ORX mice fed HFD showed significantly decreased expression of gene , gene , gene and gene , and significantly increased chemical regulatory element-binding protein-1 , chemical acyltransferase-2 and chemical synthase .	T1	T9	23332447
NA	CHEMICAL	GENE-Y	14	18	Gene expression analysis revealed that ORX mice fed HFD showed significantly decreased expression of gene , gene , gene and gene , and significantly increased chemical regulatory element-binding protein-1 , chemical acyltransferase-2 and chemical synthase .	T1	T10	23332447
NA	CHEMICAL	GENE-Y	14	20	Gene expression analysis revealed that ORX mice fed HFD showed significantly decreased expression of gene , gene , gene and gene , and significantly increased chemical regulatory element-binding protein-1 , chemical acyltransferase-2 and chemical synthase .	T1	T11	23332447
NA	CHEMICAL	GENE-Y	14	28	Gene expression analysis revealed that ORX mice fed HFD showed significantly decreased expression of gene , gene , gene and gene , and significantly increased chemical regulatory element-binding protein-1 , chemical acyltransferase-2 and chemical synthase .	T1	T12	23332447
NA	CHEMICAL	GENE-Y	14	31	Gene expression analysis revealed that ORX mice fed HFD showed significantly decreased expression of gene , gene , gene and gene , and significantly increased chemical regulatory element-binding protein-1 , chemical acyltransferase-2 and chemical synthase .	T1	T13	23332447
NA	CHEMICAL	GENE-Y	14	34	Gene expression analysis revealed that ORX mice fed HFD showed significantly decreased expression of gene , gene , gene and gene , and significantly increased chemical regulatory element-binding protein-1 , chemical acyltransferase-2 and chemical synthase .	T1	T14	23332447
NA	CHEMICAL	GENE-Y	30	14	Gene expression analysis revealed that ORX mice fed HFD showed significantly decreased expression of gene , gene , gene and gene , and significantly increased chemical regulatory element-binding protein-1 , chemical acyltransferase-2 and chemical synthase .	T2	T18	23332447
NA	CHEMICAL	GENE-Y	30	16	Gene expression analysis revealed that ORX mice fed HFD showed significantly decreased expression of gene , gene , gene and gene , and significantly increased chemical regulatory element-binding protein-1 , chemical acyltransferase-2 and chemical synthase .	T2	T9	23332447
NA	CHEMICAL	GENE-Y	30	18	Gene expression analysis revealed that ORX mice fed HFD showed significantly decreased expression of gene , gene , gene and gene , and significantly increased chemical regulatory element-binding protein-1 , chemical acyltransferase-2 and chemical synthase .	T2	T10	23332447
NA	CHEMICAL	GENE-Y	30	20	Gene expression analysis revealed that ORX mice fed HFD showed significantly decreased expression of gene , gene , gene and gene , and significantly increased chemical regulatory element-binding protein-1 , chemical acyltransferase-2 and chemical synthase .	T2	T11	23332447
NA	CHEMICAL	GENE-Y	30	28	Gene expression analysis revealed that ORX mice fed HFD showed significantly decreased expression of gene , gene , gene and gene , and significantly increased chemical regulatory element-binding protein-1 , chemical acyltransferase-2 and chemical synthase .	T2	T12	23332447
NA	CHEMICAL	GENE-Y	30	31	Gene expression analysis revealed that ORX mice fed HFD showed significantly decreased expression of gene , gene , gene and gene , and significantly increased chemical regulatory element-binding protein-1 , chemical acyltransferase-2 and chemical synthase .	T2	T13	23332447
NA	CHEMICAL	GENE-Y	30	34	Gene expression analysis revealed that ORX mice fed HFD showed significantly decreased expression of gene , gene , gene and gene , and significantly increased chemical regulatory element-binding protein-1 , chemical acyltransferase-2 and chemical synthase .	T2	T14	23332447
NA	CHEMICAL	GENE-Y	33	14	Gene expression analysis revealed that ORX mice fed HFD showed significantly decreased expression of gene , gene , gene and gene , and significantly increased chemical regulatory element-binding protein-1 , chemical acyltransferase-2 and chemical synthase .	T3	T18	23332447
NA	CHEMICAL	GENE-Y	33	16	Gene expression analysis revealed that ORX mice fed HFD showed significantly decreased expression of gene , gene , gene and gene , and significantly increased chemical regulatory element-binding protein-1 , chemical acyltransferase-2 and chemical synthase .	T3	T9	23332447
NA	CHEMICAL	GENE-Y	33	18	Gene expression analysis revealed that ORX mice fed HFD showed significantly decreased expression of gene , gene , gene and gene , and significantly increased chemical regulatory element-binding protein-1 , chemical acyltransferase-2 and chemical synthase .	T3	T10	23332447
NA	CHEMICAL	GENE-Y	33	20	Gene expression analysis revealed that ORX mice fed HFD showed significantly decreased expression of gene , gene , gene and gene , and significantly increased chemical regulatory element-binding protein-1 , chemical acyltransferase-2 and chemical synthase .	T3	T11	23332447
NA	CHEMICAL	GENE-Y	33	28	Gene expression analysis revealed that ORX mice fed HFD showed significantly decreased expression of gene , gene , gene and gene , and significantly increased chemical regulatory element-binding protein-1 , chemical acyltransferase-2 and chemical synthase .	T3	T12	23332447
NA	CHEMICAL	GENE-Y	33	31	Gene expression analysis revealed that ORX mice fed HFD showed significantly decreased expression of gene , gene , gene and gene , and significantly increased chemical regulatory element-binding protein-1 , chemical acyltransferase-2 and chemical synthase .	T3	T13	23332447
NA	CHEMICAL	GENE-Y	33	34	Gene expression analysis revealed that ORX mice fed HFD showed significantly decreased expression of gene , gene , gene and gene , and significantly increased chemical regulatory element-binding protein-1 , chemical acyltransferase-2 and chemical synthase .	T3	T14	23332447
NA	CHEMICAL	GENE-Y	0	2	chemical-gated P2X3 receptors of sensory ganglion neurons are important transducers of painful stimuli and are modulated by extracellular algogenic substances , via changes in the receptor phosphorylation state .	T1	T6	23600800
NA	CHEMICAL	GENE-Y	7	10	The present study investigated the role of chemical/calmodulin-dependent chemical protein kinase gene in interacting and controlling gene expression and function in mouse trigeminal ganglia .	T3	T16	23600800
NA	CHEMICAL	GENE-Y	7	11	The present study investigated the role of chemical/calmodulin-dependent chemical protein kinase gene in interacting and controlling gene expression and function in mouse trigeminal ganglia .	T3	T17	23600800
NA	CHEMICAL	GENE-Y	7	16	The present study investigated the role of chemical/calmodulin-dependent chemical protein kinase gene in interacting and controlling gene expression and function in mouse trigeminal ganglia .	T3	T18	23600800
NA	CHEMICAL	GENE-Y	8	10	The present study investigated the role of chemical/calmodulin-dependent chemical protein kinase gene in interacting and controlling gene expression and function in mouse trigeminal ganglia .	T4	T16	23600800
NA	CHEMICAL	GENE-Y	8	11	The present study investigated the role of chemical/calmodulin-dependent chemical protein kinase gene in interacting and controlling gene expression and function in mouse trigeminal ganglia .	T4	T17	23600800
NA	CHEMICAL	GENE-Y	8	16	The present study investigated the role of chemical/calmodulin-dependent chemical protein kinase gene in interacting and controlling gene expression and function in mouse trigeminal ganglia .	T4	T18	23600800
NA	CHEMICAL	GENE-Y	3	1	Recombinant gene/gene expression in HEK cells increased chemical phosphorylation of gene receptors , typically associated with receptor upregulation .	T5	T25	23600800
NA	CHEMICAL	GENE-Y	3	1	Recombinant gene/gene expression in HEK cells increased chemical phosphorylation of gene receptors , typically associated with receptor upregulation .	T5	T26	23600800
NA	CHEMICAL	GENE-Y	3	10	Recombinant gene/gene expression in HEK cells increased chemical phosphorylation of gene receptors , typically associated with receptor upregulation .	T5	T27	23600800
CPR:3	CHEMICAL	GENE-Y	12	3	The reduction of gene expression levels was reversed by the proteasomal inhibitor chemical .	T2	T33	23600800
NA	CHEMICAL	GENE-Y	3	0	gene Gene Expression in the Liver of chemical-induced and Spontaneous Type 1 Diabetic Rats .	T5	T43	23632905
NA	CHEMICAL	GENE-Y	9	6	We investigated the diurnal expression of gene genes and gene ( gene ) in 3-hour intervals for a 24-h period in the livers of male chemical ( chemical ) -treated rats , male spontaneous type 1 diabetic LEW.1AR1-iddm ( Iddm ) rats , and Iddm rats treated for 10 days with gene .	T2	T18	23632905
NA	CHEMICAL	GENE-N	9	7	We investigated the diurnal expression of gene genes and gene ( gene ) in 3-hour intervals for a 24-h period in the livers of male chemical ( chemical ) -treated rats , male spontaneous type 1 diabetic LEW.1AR1-iddm ( Iddm ) rats , and Iddm rats treated for 10 days with gene .	T2	T22	23632905
NA	CHEMICAL	GENE-N	9	11	We investigated the diurnal expression of gene genes and gene ( gene ) in 3-hour intervals for a 24-h period in the livers of male chemical ( chemical ) -treated rats , male spontaneous type 1 diabetic LEW.1AR1-iddm ( Iddm ) rats , and Iddm rats treated for 10 days with gene .	T2	T23	23632905
NA	CHEMICAL	GENE-Y	9	13	We investigated the diurnal expression of gene genes and gene ( gene ) in 3-hour intervals for a 24-h period in the livers of male chemical ( chemical ) -treated rats , male spontaneous type 1 diabetic LEW.1AR1-iddm ( Iddm ) rats , and Iddm rats treated for 10 days with gene .	T2	T24	23632905
NA	CHEMICAL	GENE-Y	27	6	We investigated the diurnal expression of gene genes and gene ( gene ) in 3-hour intervals for a 24-h period in the livers of male chemical ( chemical ) -treated rats , male spontaneous type 1 diabetic LEW.1AR1-iddm ( Iddm ) rats , and Iddm rats treated for 10 days with gene .	T3	T18	23632905
NA	CHEMICAL	GENE-N	27	7	We investigated the diurnal expression of gene genes and gene ( gene ) in 3-hour intervals for a 24-h period in the livers of male chemical ( chemical ) -treated rats , male spontaneous type 1 diabetic LEW.1AR1-iddm ( Iddm ) rats , and Iddm rats treated for 10 days with gene .	T3	T22	23632905
NA	CHEMICAL	GENE-N	27	11	We investigated the diurnal expression of gene genes and gene ( gene ) in 3-hour intervals for a 24-h period in the livers of male chemical ( chemical ) -treated rats , male spontaneous type 1 diabetic LEW.1AR1-iddm ( Iddm ) rats , and Iddm rats treated for 10 days with gene .	T3	T23	23632905
NA	CHEMICAL	GENE-Y	27	13	We investigated the diurnal expression of gene genes and gene ( gene ) in 3-hour intervals for a 24-h period in the livers of male chemical ( chemical ) -treated rats , male spontaneous type 1 diabetic LEW.1AR1-iddm ( Iddm ) rats , and Iddm rats treated for 10 days with gene .	T3	T24	23632905
NA	CHEMICAL	GENE-Y	1	9	Diabetic chemical and Iddm rats , as well as gene-substituted Iddm rats , exhibited a significant diurnal expression pattern of gene genes as determined by Cosinor analysis ; however , the MESOR ( midline estimating statistic of rhythm ) of gene , gene , and gene transcript expression was altered in Iddm and gene-substituted Iddm rats .	T4	T37	23632905
NA	CHEMICAL	GENE-Y	1	20	Diabetic chemical and Iddm rats , as well as gene-substituted Iddm rats , exhibited a significant diurnal expression pattern of gene genes as determined by Cosinor analysis ; however , the MESOR ( midline estimating statistic of rhythm ) of gene , gene , and gene transcript expression was altered in Iddm and gene-substituted Iddm rats .	T4	T38	23632905
NA	CHEMICAL	GENE-Y	1	14	Diabetic chemical and Iddm rats , as well as gene-substituted Iddm rats , exhibited a significant diurnal expression pattern of gene genes as determined by Cosinor analysis ; however , the MESOR ( midline estimating statistic of rhythm ) of gene , gene , and gene transcript expression was altered in Iddm and gene-substituted Iddm rats .	T4	T39	23632905
NA	CHEMICAL	GENE-Y	1	42	Diabetic chemical and Iddm rats , as well as gene-substituted Iddm rats , exhibited a significant diurnal expression pattern of gene genes as determined by Cosinor analysis ; however , the MESOR ( midline estimating statistic of rhythm ) of gene , gene , and gene transcript expression was altered in Iddm and gene-substituted Iddm rats .	T4	T40	23632905
NA	CHEMICAL	GENE-Y	1	45	Diabetic chemical and Iddm rats , as well as gene-substituted Iddm rats , exhibited a significant diurnal expression pattern of gene genes as determined by Cosinor analysis ; however , the MESOR ( midline estimating statistic of rhythm ) of gene , gene , and gene transcript expression was altered in Iddm and gene-substituted Iddm rats .	T4	T41	23632905
NA	CHEMICAL	GENE-Y	1	50	Diabetic chemical and Iddm rats , as well as gene-substituted Iddm rats , exhibited a significant diurnal expression pattern of gene genes as determined by Cosinor analysis ; however , the MESOR ( midline estimating statistic of rhythm ) of gene , gene , and gene transcript expression was altered in Iddm and gene-substituted Iddm rats .	T4	T42	23632905
NA	CHEMICAL	GENE-Y	7	7	Cosinor analysis indicated no diurnal rhythm of gene expression in the livers of diabetic chemical or Iddm rats or in those of gene-substituted Iddm rats .	T1	T14	23632905
NA	CHEMICAL	GENE-Y	7	9	Cosinor analysis indicated no diurnal rhythm of gene expression in the livers of diabetic chemical or Iddm rats or in those of gene-substituted Iddm rats .	T1	T15	23632905
NA	CHEMICAL	GENE-Y	3	4	Kinetic characterization of chemical synthetase from the thermophilic archaea Methanocaldococcus jannaschii .	T18	T32	17929831
NA	CHEMICAL	GENE-Y	0	1	chemical synthetase ( gene ) catalyzes the chemical dependent condensation of a molecule of IMP with chemical to form chemical , in a reaction driven by the hydrolysis of chemical to chemical .	T1	T19	17929831
NA	CHEMICAL	GENE-Y	0	3	chemical synthetase ( gene ) catalyzes the chemical dependent condensation of a molecule of IMP with chemical to form chemical , in a reaction driven by the hydrolysis of chemical to chemical .	T1	T25	17929831
NA	CHEMICAL	GENE-Y	7	1	chemical synthetase ( gene ) catalyzes the chemical dependent condensation of a molecule of IMP with chemical to form chemical , in a reaction driven by the hydrolysis of chemical to chemical .	T17	T19	17929831
CPR:9	CHEMICAL	GENE-Y	7	3	chemical synthetase ( gene ) catalyzes the chemical dependent condensation of a molecule of IMP with chemical to form chemical , in a reaction driven by the hydrolysis of chemical to chemical .	T17	T25	17929831
NA	CHEMICAL	GENE-Y	3	1	chemical synthetase ( gene ) catalyzes the chemical dependent condensation of a molecule of IMP with chemical to form chemical , in a reaction driven by the hydrolysis of chemical to chemical .	T2	T19	17929831
NA	CHEMICAL	GENE-Y	3	3	chemical synthetase ( gene ) catalyzes the chemical dependent condensation of a molecule of IMP with chemical to form chemical , in a reaction driven by the hydrolysis of chemical to chemical .	T2	T25	17929831
CPR:9	CHEMICAL	GENE-Y	11	1	chemical synthetase ( gene ) catalyzes the chemical dependent condensation of a molecule of IMP with chemical to form chemical , in a reaction driven by the hydrolysis of chemical to chemical .	T5	T19	17929831
CPR:9	CHEMICAL	GENE-Y	11	3	chemical synthetase ( gene ) catalyzes the chemical dependent condensation of a molecule of IMP with chemical to form chemical , in a reaction driven by the hydrolysis of chemical to chemical .	T5	T25	17929831
NA	CHEMICAL	GENE-Y	29	1	chemical synthetase ( gene ) catalyzes the chemical dependent condensation of a molecule of IMP with chemical to form chemical , in a reaction driven by the hydrolysis of chemical to chemical .	T12	T19	17929831
NA	CHEMICAL	GENE-Y	29	3	chemical synthetase ( gene ) catalyzes the chemical dependent condensation of a molecule of IMP with chemical to form chemical , in a reaction driven by the hydrolysis of chemical to chemical .	T12	T25	17929831
NA	CHEMICAL	GENE-Y	31	1	chemical synthetase ( gene ) catalyzes the chemical dependent condensation of a molecule of IMP with chemical to form chemical , in a reaction driven by the hydrolysis of chemical to chemical .	T13	T19	17929831
NA	CHEMICAL	GENE-Y	31	3	chemical synthetase ( gene ) catalyzes the chemical dependent condensation of a molecule of IMP with chemical to form chemical , in a reaction driven by the hydrolysis of chemical to chemical .	T13	T25	17929831
NA	CHEMICAL	GENE-Y	13	0	gene from the thermophilic archaea , Methanocaldococcus jannaschii ( gene ) is 345 chemical long against an average length of 430-457 chemical for most mesophilic gene .	T14	T23	17929831
NA	CHEMICAL	GENE-Y	13	9	gene from the thermophilic archaea , Methanocaldococcus jannaschii ( gene ) is 345 chemical long against an average length of 430-457 chemical for most mesophilic gene .	T14	T24	17929831
NA	CHEMICAL	GENE-Y	13	25	gene from the thermophilic archaea , Methanocaldococcus jannaschii ( gene ) is 345 chemical long against an average length of 430-457 chemical for most mesophilic gene .	T14	T26	17929831
NA	CHEMICAL	GENE-Y	21	0	gene from the thermophilic archaea , Methanocaldococcus jannaschii ( gene ) is 345 chemical long against an average length of 430-457 chemical for most mesophilic gene .	T15	T23	17929831
NA	CHEMICAL	GENE-Y	21	9	gene from the thermophilic archaea , Methanocaldococcus jannaschii ( gene ) is 345 chemical long against an average length of 430-457 chemical for most mesophilic gene .	T15	T24	17929831
NA	CHEMICAL	GENE-Y	21	25	gene from the thermophilic archaea , Methanocaldococcus jannaschii ( gene ) is 345 chemical long against an average length of 430-457 chemical for most mesophilic gene .	T15	T26	17929831
NA	CHEMICAL	GENE-Y	13	2	This short gene has two large deletions that map to the middle and chemical-terminus of the protein .	T16	T27	17929831
CPR:4	CHEMICAL	GENE-Y	0	16	chemical , a product of the reaction , was found to be a potent inhibitor of gene showing biphasic inhibition of enzyme activity .	T4	T20	17929831
NA	CHEMICAL	GENE-Y	17	0	gene , like the gene , exhibits substrate inhibition , with IMP inhibiting enzyme activity at subsaturating chemical concentrations .	T8	T21	17929831
NA	CHEMICAL	GENE-N	17	4	gene , like the gene , exhibits substrate inhibition , with IMP inhibiting enzyme activity at subsaturating chemical concentrations .	T8	T22	17929831
CPR:4	CHEMICAL	GENE-N	2	26	In the in vitro assay , chemical ( 20 and 50μg/mL ) markedly inhibited changes in various biochemical substances ( chemical ( chemical ) , chemical dehydrogenase ( gene ) , chemical dismutase ( gene ) , and gene ( gene ) ) in human umbilical vein endothelial cells ( HUVECs ) damaged by high chemical ( 35mM ) and restored vascular endothelial structure by balancing the gene-the gene ( gene-geneP ) system .	T13	T24	23500382
CPR:4	CHEMICAL	GENE-N	2	28	In the in vitro assay , chemical ( 20 and 50μg/mL ) markedly inhibited changes in various biochemical substances ( chemical ( chemical ) , chemical dehydrogenase ( gene ) , chemical dismutase ( gene ) , and gene ( gene ) ) in human umbilical vein endothelial cells ( HUVECs ) damaged by high chemical ( 35mM ) and restored vascular endothelial structure by balancing the gene-the gene ( gene-geneP ) system .	T13	T25	23500382
CPR:4	CHEMICAL	GENE-N	2	32	In the in vitro assay , chemical ( 20 and 50μg/mL ) markedly inhibited changes in various biochemical substances ( chemical ( chemical ) , chemical dehydrogenase ( gene ) , chemical dismutase ( gene ) , and gene ( gene ) ) in human umbilical vein endothelial cells ( HUVECs ) damaged by high chemical ( 35mM ) and restored vascular endothelial structure by balancing the gene-the gene ( gene-geneP ) system .	T13	T26	23500382
CPR:4	CHEMICAL	GENE-N	2	34	In the in vitro assay , chemical ( 20 and 50μg/mL ) markedly inhibited changes in various biochemical substances ( chemical ( chemical ) , chemical dehydrogenase ( gene ) , chemical dismutase ( gene ) , and gene ( gene ) ) in human umbilical vein endothelial cells ( HUVECs ) damaged by high chemical ( 35mM ) and restored vascular endothelial structure by balancing the gene-the gene ( gene-geneP ) system .	T13	T27	23500382
CPR:4	CHEMICAL	GENE-Y	2	38	In the in vitro assay , chemical ( 20 and 50μg/mL ) markedly inhibited changes in various biochemical substances ( chemical ( chemical ) , chemical dehydrogenase ( gene ) , chemical dismutase ( gene ) , and gene ( gene ) ) in human umbilical vein endothelial cells ( HUVECs ) damaged by high chemical ( 35mM ) and restored vascular endothelial structure by balancing the gene-the gene ( gene-geneP ) system .	T13	T28	23500382
CPR:4	CHEMICAL	GENE-Y	2	40	In the in vitro assay , chemical ( 20 and 50μg/mL ) markedly inhibited changes in various biochemical substances ( chemical ( chemical ) , chemical dehydrogenase ( gene ) , chemical dismutase ( gene ) , and gene ( gene ) ) in human umbilical vein endothelial cells ( HUVECs ) damaged by high chemical ( 35mM ) and restored vascular endothelial structure by balancing the gene-the gene ( gene-geneP ) system .	T13	T29	23500382
NA	CHEMICAL	GENE-N	2	2	In the in vitro assay , chemical ( 20 and 50μg/mL ) markedly inhibited changes in various biochemical substances ( chemical ( chemical ) , chemical dehydrogenase ( gene ) , chemical dismutase ( gene ) , and gene ( gene ) ) in human umbilical vein endothelial cells ( HUVECs ) damaged by high chemical ( 35mM ) and restored vascular endothelial structure by balancing the gene-the gene ( gene-geneP ) system .	T13	T30	23500382
NA	CHEMICAL	GENE-N	2	2	In the in vitro assay , chemical ( 20 and 50μg/mL ) markedly inhibited changes in various biochemical substances ( chemical ( chemical ) , chemical dehydrogenase ( gene ) , chemical dismutase ( gene ) , and gene ( gene ) ) in human umbilical vein endothelial cells ( HUVECs ) damaged by high chemical ( 35mM ) and restored vascular endothelial structure by balancing the gene-the gene ( gene-geneP ) system .	T13	T31	23500382
NA	CHEMICAL	GENE-N	2	70	In the in vitro assay , chemical ( 20 and 50μg/mL ) markedly inhibited changes in various biochemical substances ( chemical ( chemical ) , chemical dehydrogenase ( gene ) , chemical dismutase ( gene ) , and gene ( gene ) ) in human umbilical vein endothelial cells ( HUVECs ) damaged by high chemical ( 35mM ) and restored vascular endothelial structure by balancing the gene-the gene ( gene-geneP ) system .	T13	T32	23500382
NA	CHEMICAL	GENE-N	2	70	In the in vitro assay , chemical ( 20 and 50μg/mL ) markedly inhibited changes in various biochemical substances ( chemical ( chemical ) , chemical dehydrogenase ( gene ) , chemical dismutase ( gene ) , and gene ( gene ) ) in human umbilical vein endothelial cells ( HUVECs ) damaged by high chemical ( 35mM ) and restored vascular endothelial structure by balancing the gene-the gene ( gene-geneP ) system .	T13	T33	23500382
NA	CHEMICAL	GENE-N	20	26	In the in vitro assay , chemical ( 20 and 50μg/mL ) markedly inhibited changes in various biochemical substances ( chemical ( chemical ) , chemical dehydrogenase ( gene ) , chemical dismutase ( gene ) , and gene ( gene ) ) in human umbilical vein endothelial cells ( HUVECs ) damaged by high chemical ( 35mM ) and restored vascular endothelial structure by balancing the gene-the gene ( gene-geneP ) system .	T14	T24	23500382
NA	CHEMICAL	GENE-N	20	28	In the in vitro assay , chemical ( 20 and 50μg/mL ) markedly inhibited changes in various biochemical substances ( chemical ( chemical ) , chemical dehydrogenase ( gene ) , chemical dismutase ( gene ) , and gene ( gene ) ) in human umbilical vein endothelial cells ( HUVECs ) damaged by high chemical ( 35mM ) and restored vascular endothelial structure by balancing the gene-the gene ( gene-geneP ) system .	T14	T25	23500382
NA	CHEMICAL	GENE-N	20	32	In the in vitro assay , chemical ( 20 and 50μg/mL ) markedly inhibited changes in various biochemical substances ( chemical ( chemical ) , chemical dehydrogenase ( gene ) , chemical dismutase ( gene ) , and gene ( gene ) ) in human umbilical vein endothelial cells ( HUVECs ) damaged by high chemical ( 35mM ) and restored vascular endothelial structure by balancing the gene-the gene ( gene-geneP ) system .	T14	T26	23500382
NA	CHEMICAL	GENE-N	20	34	In the in vitro assay , chemical ( 20 and 50μg/mL ) markedly inhibited changes in various biochemical substances ( chemical ( chemical ) , chemical dehydrogenase ( gene ) , chemical dismutase ( gene ) , and gene ( gene ) ) in human umbilical vein endothelial cells ( HUVECs ) damaged by high chemical ( 35mM ) and restored vascular endothelial structure by balancing the gene-the gene ( gene-geneP ) system .	T14	T27	23500382
NA	CHEMICAL	GENE-Y	20	38	In the in vitro assay , chemical ( 20 and 50μg/mL ) markedly inhibited changes in various biochemical substances ( chemical ( chemical ) , chemical dehydrogenase ( gene ) , chemical dismutase ( gene ) , and gene ( gene ) ) in human umbilical vein endothelial cells ( HUVECs ) damaged by high chemical ( 35mM ) and restored vascular endothelial structure by balancing the gene-the gene ( gene-geneP ) system .	T14	T28	23500382
NA	CHEMICAL	GENE-Y	20	40	In the in vitro assay , chemical ( 20 and 50μg/mL ) markedly inhibited changes in various biochemical substances ( chemical ( chemical ) , chemical dehydrogenase ( gene ) , chemical dismutase ( gene ) , and gene ( gene ) ) in human umbilical vein endothelial cells ( HUVECs ) damaged by high chemical ( 35mM ) and restored vascular endothelial structure by balancing the gene-the gene ( gene-geneP ) system .	T14	T29	23500382
NA	CHEMICAL	GENE-N	20	2	In the in vitro assay , chemical ( 20 and 50μg/mL ) markedly inhibited changes in various biochemical substances ( chemical ( chemical ) , chemical dehydrogenase ( gene ) , chemical dismutase ( gene ) , and gene ( gene ) ) in human umbilical vein endothelial cells ( HUVECs ) damaged by high chemical ( 35mM ) and restored vascular endothelial structure by balancing the gene-the gene ( gene-geneP ) system .	T14	T30	23500382
NA	CHEMICAL	GENE-N	20	2	In the in vitro assay , chemical ( 20 and 50μg/mL ) markedly inhibited changes in various biochemical substances ( chemical ( chemical ) , chemical dehydrogenase ( gene ) , chemical dismutase ( gene ) , and gene ( gene ) ) in human umbilical vein endothelial cells ( HUVECs ) damaged by high chemical ( 35mM ) and restored vascular endothelial structure by balancing the gene-the gene ( gene-geneP ) system .	T14	T31	23500382
NA	CHEMICAL	GENE-N	20	70	In the in vitro assay , chemical ( 20 and 50μg/mL ) markedly inhibited changes in various biochemical substances ( chemical ( chemical ) , chemical dehydrogenase ( gene ) , chemical dismutase ( gene ) , and gene ( gene ) ) in human umbilical vein endothelial cells ( HUVECs ) damaged by high chemical ( 35mM ) and restored vascular endothelial structure by balancing the gene-the gene ( gene-geneP ) system .	T14	T32	23500382
NA	CHEMICAL	GENE-N	20	70	In the in vitro assay , chemical ( 20 and 50μg/mL ) markedly inhibited changes in various biochemical substances ( chemical ( chemical ) , chemical dehydrogenase ( gene ) , chemical dismutase ( gene ) , and gene ( gene ) ) in human umbilical vein endothelial cells ( HUVECs ) damaged by high chemical ( 35mM ) and restored vascular endothelial structure by balancing the gene-the gene ( gene-geneP ) system .	T14	T33	23500382
NA	CHEMICAL	GENE-N	22	26	In the in vitro assay , chemical ( 20 and 50μg/mL ) markedly inhibited changes in various biochemical substances ( chemical ( chemical ) , chemical dehydrogenase ( gene ) , chemical dismutase ( gene ) , and gene ( gene ) ) in human umbilical vein endothelial cells ( HUVECs ) damaged by high chemical ( 35mM ) and restored vascular endothelial structure by balancing the gene-the gene ( gene-geneP ) system .	T15	T24	23500382
NA	CHEMICAL	GENE-N	22	28	In the in vitro assay , chemical ( 20 and 50μg/mL ) markedly inhibited changes in various biochemical substances ( chemical ( chemical ) , chemical dehydrogenase ( gene ) , chemical dismutase ( gene ) , and gene ( gene ) ) in human umbilical vein endothelial cells ( HUVECs ) damaged by high chemical ( 35mM ) and restored vascular endothelial structure by balancing the gene-the gene ( gene-geneP ) system .	T15	T25	23500382
NA	CHEMICAL	GENE-N	22	32	In the in vitro assay , chemical ( 20 and 50μg/mL ) markedly inhibited changes in various biochemical substances ( chemical ( chemical ) , chemical dehydrogenase ( gene ) , chemical dismutase ( gene ) , and gene ( gene ) ) in human umbilical vein endothelial cells ( HUVECs ) damaged by high chemical ( 35mM ) and restored vascular endothelial structure by balancing the gene-the gene ( gene-geneP ) system .	T15	T26	23500382
NA	CHEMICAL	GENE-N	22	34	In the in vitro assay , chemical ( 20 and 50μg/mL ) markedly inhibited changes in various biochemical substances ( chemical ( chemical ) , chemical dehydrogenase ( gene ) , chemical dismutase ( gene ) , and gene ( gene ) ) in human umbilical vein endothelial cells ( HUVECs ) damaged by high chemical ( 35mM ) and restored vascular endothelial structure by balancing the gene-the gene ( gene-geneP ) system .	T15	T27	23500382
NA	CHEMICAL	GENE-Y	22	38	In the in vitro assay , chemical ( 20 and 50μg/mL ) markedly inhibited changes in various biochemical substances ( chemical ( chemical ) , chemical dehydrogenase ( gene ) , chemical dismutase ( gene ) , and gene ( gene ) ) in human umbilical vein endothelial cells ( HUVECs ) damaged by high chemical ( 35mM ) and restored vascular endothelial structure by balancing the gene-the gene ( gene-geneP ) system .	T15	T28	23500382
NA	CHEMICAL	GENE-Y	22	40	In the in vitro assay , chemical ( 20 and 50μg/mL ) markedly inhibited changes in various biochemical substances ( chemical ( chemical ) , chemical dehydrogenase ( gene ) , chemical dismutase ( gene ) , and gene ( gene ) ) in human umbilical vein endothelial cells ( HUVECs ) damaged by high chemical ( 35mM ) and restored vascular endothelial structure by balancing the gene-the gene ( gene-geneP ) system .	T15	T29	23500382
NA	CHEMICAL	GENE-N	22	2	In the in vitro assay , chemical ( 20 and 50μg/mL ) markedly inhibited changes in various biochemical substances ( chemical ( chemical ) , chemical dehydrogenase ( gene ) , chemical dismutase ( gene ) , and gene ( gene ) ) in human umbilical vein endothelial cells ( HUVECs ) damaged by high chemical ( 35mM ) and restored vascular endothelial structure by balancing the gene-the gene ( gene-geneP ) system .	T15	T30	23500382
NA	CHEMICAL	GENE-N	22	2	In the in vitro assay , chemical ( 20 and 50μg/mL ) markedly inhibited changes in various biochemical substances ( chemical ( chemical ) , chemical dehydrogenase ( gene ) , chemical dismutase ( gene ) , and gene ( gene ) ) in human umbilical vein endothelial cells ( HUVECs ) damaged by high chemical ( 35mM ) and restored vascular endothelial structure by balancing the gene-the gene ( gene-geneP ) system .	T15	T31	23500382
NA	CHEMICAL	GENE-N	22	70	In the in vitro assay , chemical ( 20 and 50μg/mL ) markedly inhibited changes in various biochemical substances ( chemical ( chemical ) , chemical dehydrogenase ( gene ) , chemical dismutase ( gene ) , and gene ( gene ) ) in human umbilical vein endothelial cells ( HUVECs ) damaged by high chemical ( 35mM ) and restored vascular endothelial structure by balancing the gene-the gene ( gene-geneP ) system .	T15	T32	23500382
NA	CHEMICAL	GENE-N	22	70	In the in vitro assay , chemical ( 20 and 50μg/mL ) markedly inhibited changes in various biochemical substances ( chemical ( chemical ) , chemical dehydrogenase ( gene ) , chemical dismutase ( gene ) , and gene ( gene ) ) in human umbilical vein endothelial cells ( HUVECs ) damaged by high chemical ( 35mM ) and restored vascular endothelial structure by balancing the gene-the gene ( gene-geneP ) system .	T15	T33	23500382
NA	CHEMICAL	GENE-N	25	26	In the in vitro assay , chemical ( 20 and 50μg/mL ) markedly inhibited changes in various biochemical substances ( chemical ( chemical ) , chemical dehydrogenase ( gene ) , chemical dismutase ( gene ) , and gene ( gene ) ) in human umbilical vein endothelial cells ( HUVECs ) damaged by high chemical ( 35mM ) and restored vascular endothelial structure by balancing the gene-the gene ( gene-geneP ) system .	T16	T24	23500382
NA	CHEMICAL	GENE-N	25	28	In the in vitro assay , chemical ( 20 and 50μg/mL ) markedly inhibited changes in various biochemical substances ( chemical ( chemical ) , chemical dehydrogenase ( gene ) , chemical dismutase ( gene ) , and gene ( gene ) ) in human umbilical vein endothelial cells ( HUVECs ) damaged by high chemical ( 35mM ) and restored vascular endothelial structure by balancing the gene-the gene ( gene-geneP ) system .	T16	T25	23500382
NA	CHEMICAL	GENE-N	25	32	In the in vitro assay , chemical ( 20 and 50μg/mL ) markedly inhibited changes in various biochemical substances ( chemical ( chemical ) , chemical dehydrogenase ( gene ) , chemical dismutase ( gene ) , and gene ( gene ) ) in human umbilical vein endothelial cells ( HUVECs ) damaged by high chemical ( 35mM ) and restored vascular endothelial structure by balancing the gene-the gene ( gene-geneP ) system .	T16	T26	23500382
NA	CHEMICAL	GENE-N	25	34	In the in vitro assay , chemical ( 20 and 50μg/mL ) markedly inhibited changes in various biochemical substances ( chemical ( chemical ) , chemical dehydrogenase ( gene ) , chemical dismutase ( gene ) , and gene ( gene ) ) in human umbilical vein endothelial cells ( HUVECs ) damaged by high chemical ( 35mM ) and restored vascular endothelial structure by balancing the gene-the gene ( gene-geneP ) system .	T16	T27	23500382
NA	CHEMICAL	GENE-Y	25	38	In the in vitro assay , chemical ( 20 and 50μg/mL ) markedly inhibited changes in various biochemical substances ( chemical ( chemical ) , chemical dehydrogenase ( gene ) , chemical dismutase ( gene ) , and gene ( gene ) ) in human umbilical vein endothelial cells ( HUVECs ) damaged by high chemical ( 35mM ) and restored vascular endothelial structure by balancing the gene-the gene ( gene-geneP ) system .	T16	T28	23500382
NA	CHEMICAL	GENE-Y	25	40	In the in vitro assay , chemical ( 20 and 50μg/mL ) markedly inhibited changes in various biochemical substances ( chemical ( chemical ) , chemical dehydrogenase ( gene ) , chemical dismutase ( gene ) , and gene ( gene ) ) in human umbilical vein endothelial cells ( HUVECs ) damaged by high chemical ( 35mM ) and restored vascular endothelial structure by balancing the gene-the gene ( gene-geneP ) system .	T16	T29	23500382
NA	CHEMICAL	GENE-N	25	2	In the in vitro assay , chemical ( 20 and 50μg/mL ) markedly inhibited changes in various biochemical substances ( chemical ( chemical ) , chemical dehydrogenase ( gene ) , chemical dismutase ( gene ) , and gene ( gene ) ) in human umbilical vein endothelial cells ( HUVECs ) damaged by high chemical ( 35mM ) and restored vascular endothelial structure by balancing the gene-the gene ( gene-geneP ) system .	T16	T30	23500382
NA	CHEMICAL	GENE-N	25	2	In the in vitro assay , chemical ( 20 and 50μg/mL ) markedly inhibited changes in various biochemical substances ( chemical ( chemical ) , chemical dehydrogenase ( gene ) , chemical dismutase ( gene ) , and gene ( gene ) ) in human umbilical vein endothelial cells ( HUVECs ) damaged by high chemical ( 35mM ) and restored vascular endothelial structure by balancing the gene-the gene ( gene-geneP ) system .	T16	T31	23500382
NA	CHEMICAL	GENE-N	25	70	In the in vitro assay , chemical ( 20 and 50μg/mL ) markedly inhibited changes in various biochemical substances ( chemical ( chemical ) , chemical dehydrogenase ( gene ) , chemical dismutase ( gene ) , and gene ( gene ) ) in human umbilical vein endothelial cells ( HUVECs ) damaged by high chemical ( 35mM ) and restored vascular endothelial structure by balancing the gene-the gene ( gene-geneP ) system .	T16	T32	23500382
NA	CHEMICAL	GENE-N	25	70	In the in vitro assay , chemical ( 20 and 50μg/mL ) markedly inhibited changes in various biochemical substances ( chemical ( chemical ) , chemical dehydrogenase ( gene ) , chemical dismutase ( gene ) , and gene ( gene ) ) in human umbilical vein endothelial cells ( HUVECs ) damaged by high chemical ( 35mM ) and restored vascular endothelial structure by balancing the gene-the gene ( gene-geneP ) system .	T16	T33	23500382
NA	CHEMICAL	GENE-N	31	26	In the in vitro assay , chemical ( 20 and 50μg/mL ) markedly inhibited changes in various biochemical substances ( chemical ( chemical ) , chemical dehydrogenase ( gene ) , chemical dismutase ( gene ) , and gene ( gene ) ) in human umbilical vein endothelial cells ( HUVECs ) damaged by high chemical ( 35mM ) and restored vascular endothelial structure by balancing the gene-the gene ( gene-geneP ) system .	T17	T24	23500382
NA	CHEMICAL	GENE-N	31	28	In the in vitro assay , chemical ( 20 and 50μg/mL ) markedly inhibited changes in various biochemical substances ( chemical ( chemical ) , chemical dehydrogenase ( gene ) , chemical dismutase ( gene ) , and gene ( gene ) ) in human umbilical vein endothelial cells ( HUVECs ) damaged by high chemical ( 35mM ) and restored vascular endothelial structure by balancing the gene-the gene ( gene-geneP ) system .	T17	T25	23500382
NA	CHEMICAL	GENE-N	31	32	In the in vitro assay , chemical ( 20 and 50μg/mL ) markedly inhibited changes in various biochemical substances ( chemical ( chemical ) , chemical dehydrogenase ( gene ) , chemical dismutase ( gene ) , and gene ( gene ) ) in human umbilical vein endothelial cells ( HUVECs ) damaged by high chemical ( 35mM ) and restored vascular endothelial structure by balancing the gene-the gene ( gene-geneP ) system .	T17	T26	23500382
NA	CHEMICAL	GENE-N	31	34	In the in vitro assay , chemical ( 20 and 50μg/mL ) markedly inhibited changes in various biochemical substances ( chemical ( chemical ) , chemical dehydrogenase ( gene ) , chemical dismutase ( gene ) , and gene ( gene ) ) in human umbilical vein endothelial cells ( HUVECs ) damaged by high chemical ( 35mM ) and restored vascular endothelial structure by balancing the gene-the gene ( gene-geneP ) system .	T17	T27	23500382
NA	CHEMICAL	GENE-Y	31	38	In the in vitro assay , chemical ( 20 and 50μg/mL ) markedly inhibited changes in various biochemical substances ( chemical ( chemical ) , chemical dehydrogenase ( gene ) , chemical dismutase ( gene ) , and gene ( gene ) ) in human umbilical vein endothelial cells ( HUVECs ) damaged by high chemical ( 35mM ) and restored vascular endothelial structure by balancing the gene-the gene ( gene-geneP ) system .	T17	T28	23500382
NA	CHEMICAL	GENE-Y	31	40	In the in vitro assay , chemical ( 20 and 50μg/mL ) markedly inhibited changes in various biochemical substances ( chemical ( chemical ) , chemical dehydrogenase ( gene ) , chemical dismutase ( gene ) , and gene ( gene ) ) in human umbilical vein endothelial cells ( HUVECs ) damaged by high chemical ( 35mM ) and restored vascular endothelial structure by balancing the gene-the gene ( gene-geneP ) system .	T17	T29	23500382
NA	CHEMICAL	GENE-N	31	2	In the in vitro assay , chemical ( 20 and 50μg/mL ) markedly inhibited changes in various biochemical substances ( chemical ( chemical ) , chemical dehydrogenase ( gene ) , chemical dismutase ( gene ) , and gene ( gene ) ) in human umbilical vein endothelial cells ( HUVECs ) damaged by high chemical ( 35mM ) and restored vascular endothelial structure by balancing the gene-the gene ( gene-geneP ) system .	T17	T30	23500382
NA	CHEMICAL	GENE-N	31	2	In the in vitro assay , chemical ( 20 and 50μg/mL ) markedly inhibited changes in various biochemical substances ( chemical ( chemical ) , chemical dehydrogenase ( gene ) , chemical dismutase ( gene ) , and gene ( gene ) ) in human umbilical vein endothelial cells ( HUVECs ) damaged by high chemical ( 35mM ) and restored vascular endothelial structure by balancing the gene-the gene ( gene-geneP ) system .	T17	T31	23500382
NA	CHEMICAL	GENE-N	31	70	In the in vitro assay , chemical ( 20 and 50μg/mL ) markedly inhibited changes in various biochemical substances ( chemical ( chemical ) , chemical dehydrogenase ( gene ) , chemical dismutase ( gene ) , and gene ( gene ) ) in human umbilical vein endothelial cells ( HUVECs ) damaged by high chemical ( 35mM ) and restored vascular endothelial structure by balancing the gene-the gene ( gene-geneP ) system .	T17	T32	23500382
NA	CHEMICAL	GENE-N	31	70	In the in vitro assay , chemical ( 20 and 50μg/mL ) markedly inhibited changes in various biochemical substances ( chemical ( chemical ) , chemical dehydrogenase ( gene ) , chemical dismutase ( gene ) , and gene ( gene ) ) in human umbilical vein endothelial cells ( HUVECs ) damaged by high chemical ( 35mM ) and restored vascular endothelial structure by balancing the gene-the gene ( gene-geneP ) system .	T17	T33	23500382
NA	CHEMICAL	GENE-N	55	26	In the in vitro assay , chemical ( 20 and 50μg/mL ) markedly inhibited changes in various biochemical substances ( chemical ( chemical ) , chemical dehydrogenase ( gene ) , chemical dismutase ( gene ) , and gene ( gene ) ) in human umbilical vein endothelial cells ( HUVECs ) damaged by high chemical ( 35mM ) and restored vascular endothelial structure by balancing the gene-the gene ( gene-geneP ) system .	T18	T24	23500382
NA	CHEMICAL	GENE-N	55	28	In the in vitro assay , chemical ( 20 and 50μg/mL ) markedly inhibited changes in various biochemical substances ( chemical ( chemical ) , chemical dehydrogenase ( gene ) , chemical dismutase ( gene ) , and gene ( gene ) ) in human umbilical vein endothelial cells ( HUVECs ) damaged by high chemical ( 35mM ) and restored vascular endothelial structure by balancing the gene-the gene ( gene-geneP ) system .	T18	T25	23500382
NA	CHEMICAL	GENE-N	55	32	In the in vitro assay , chemical ( 20 and 50μg/mL ) markedly inhibited changes in various biochemical substances ( chemical ( chemical ) , chemical dehydrogenase ( gene ) , chemical dismutase ( gene ) , and gene ( gene ) ) in human umbilical vein endothelial cells ( HUVECs ) damaged by high chemical ( 35mM ) and restored vascular endothelial structure by balancing the gene-the gene ( gene-geneP ) system .	T18	T26	23500382
NA	CHEMICAL	GENE-N	55	34	In the in vitro assay , chemical ( 20 and 50μg/mL ) markedly inhibited changes in various biochemical substances ( chemical ( chemical ) , chemical dehydrogenase ( gene ) , chemical dismutase ( gene ) , and gene ( gene ) ) in human umbilical vein endothelial cells ( HUVECs ) damaged by high chemical ( 35mM ) and restored vascular endothelial structure by balancing the gene-the gene ( gene-geneP ) system .	T18	T27	23500382
NA	CHEMICAL	GENE-Y	55	38	In the in vitro assay , chemical ( 20 and 50μg/mL ) markedly inhibited changes in various biochemical substances ( chemical ( chemical ) , chemical dehydrogenase ( gene ) , chemical dismutase ( gene ) , and gene ( gene ) ) in human umbilical vein endothelial cells ( HUVECs ) damaged by high chemical ( 35mM ) and restored vascular endothelial structure by balancing the gene-the gene ( gene-geneP ) system .	T18	T28	23500382
NA	CHEMICAL	GENE-Y	55	40	In the in vitro assay , chemical ( 20 and 50μg/mL ) markedly inhibited changes in various biochemical substances ( chemical ( chemical ) , chemical dehydrogenase ( gene ) , chemical dismutase ( gene ) , and gene ( gene ) ) in human umbilical vein endothelial cells ( HUVECs ) damaged by high chemical ( 35mM ) and restored vascular endothelial structure by balancing the gene-the gene ( gene-geneP ) system .	T18	T29	23500382
NA	CHEMICAL	GENE-N	55	2	In the in vitro assay , chemical ( 20 and 50μg/mL ) markedly inhibited changes in various biochemical substances ( chemical ( chemical ) , chemical dehydrogenase ( gene ) , chemical dismutase ( gene ) , and gene ( gene ) ) in human umbilical vein endothelial cells ( HUVECs ) damaged by high chemical ( 35mM ) and restored vascular endothelial structure by balancing the gene-the gene ( gene-geneP ) system .	T18	T30	23500382
NA	CHEMICAL	GENE-N	55	2	In the in vitro assay , chemical ( 20 and 50μg/mL ) markedly inhibited changes in various biochemical substances ( chemical ( chemical ) , chemical dehydrogenase ( gene ) , chemical dismutase ( gene ) , and gene ( gene ) ) in human umbilical vein endothelial cells ( HUVECs ) damaged by high chemical ( 35mM ) and restored vascular endothelial structure by balancing the gene-the gene ( gene-geneP ) system .	T18	T31	23500382
NA	CHEMICAL	GENE-N	55	70	In the in vitro assay , chemical ( 20 and 50μg/mL ) markedly inhibited changes in various biochemical substances ( chemical ( chemical ) , chemical dehydrogenase ( gene ) , chemical dismutase ( gene ) , and gene ( gene ) ) in human umbilical vein endothelial cells ( HUVECs ) damaged by high chemical ( 35mM ) and restored vascular endothelial structure by balancing the gene-the gene ( gene-geneP ) system .	T18	T32	23500382
NA	CHEMICAL	GENE-N	55	70	In the in vitro assay , chemical ( 20 and 50μg/mL ) markedly inhibited changes in various biochemical substances ( chemical ( chemical ) , chemical dehydrogenase ( gene ) , chemical dismutase ( gene ) , and gene ( gene ) ) in human umbilical vein endothelial cells ( HUVECs ) damaged by high chemical ( 35mM ) and restored vascular endothelial structure by balancing the gene-the gene ( gene-geneP ) system .	T18	T33	23500382
CPR:4	CHEMICAL	GENE-N	5	19	The vascular protective effects of chemical were speculated to be attributed to oxidative stress inhibition and the reduction of gene ( gene ) mRNA expression levels in high chemical conditions .	T19	T22	23500382
CPR:4	CHEMICAL	GENE-N	5	21	The vascular protective effects of chemical were speculated to be attributed to oxidative stress inhibition and the reduction of gene ( gene ) mRNA expression levels in high chemical conditions .	T19	T23	23500382
NA	CHEMICAL	GENE-N	5	19	The vascular protective effects of chemical were speculated to be attributed to oxidative stress inhibition and the reduction of gene ( gene ) mRNA expression levels in high chemical conditions .	T1	T22	23500382
NA	CHEMICAL	GENE-N	5	21	The vascular protective effects of chemical were speculated to be attributed to oxidative stress inhibition and the reduction of gene ( gene ) mRNA expression levels in high chemical conditions .	T1	T23	23500382
CPR:4	CHEMICAL	GENE-N	0	12	chemical ( chemical ) and other non-chemical anti-inflammatory drugs , which are gene ( gene ) inhibitors , precipitate asthmatic attacks in chemical-intolerant patients , while chemical , hardly active on gene by itself , is well tolerated by these patients .	T1	T29	2083404
CPR:4	CHEMICAL	GENE-N	0	14	chemical ( chemical ) and other non-chemical anti-inflammatory drugs , which are gene ( gene ) inhibitors , precipitate asthmatic attacks in chemical-intolerant patients , while chemical , hardly active on gene by itself , is well tolerated by these patients .	T1	T30	2083404
NA	CHEMICAL	GENE-N	0	31	chemical ( chemical ) and other non-chemical anti-inflammatory drugs , which are gene ( gene ) inhibitors , precipitate asthmatic attacks in chemical-intolerant patients , while chemical , hardly active on gene by itself , is well tolerated by these patients .	T1	T27	2083404
CPR:4	CHEMICAL	GENE-N	2	12	chemical ( chemical ) and other non-chemical anti-inflammatory drugs , which are gene ( gene ) inhibitors , precipitate asthmatic attacks in chemical-intolerant patients , while chemical , hardly active on gene by itself , is well tolerated by these patients .	T21	T29	2083404
CPR:4	CHEMICAL	GENE-N	2	14	chemical ( chemical ) and other non-chemical anti-inflammatory drugs , which are gene ( gene ) inhibitors , precipitate asthmatic attacks in chemical-intolerant patients , while chemical , hardly active on gene by itself , is well tolerated by these patients .	T21	T30	2083404
NA	CHEMICAL	GENE-N	2	31	chemical ( chemical ) and other non-chemical anti-inflammatory drugs , which are gene ( gene ) inhibitors , precipitate asthmatic attacks in chemical-intolerant patients , while chemical , hardly active on gene by itself , is well tolerated by these patients .	T21	T27	2083404
NA	CHEMICAL	GENE-N	6	12	chemical ( chemical ) and other non-chemical anti-inflammatory drugs , which are gene ( gene ) inhibitors , precipitate asthmatic attacks in chemical-intolerant patients , while chemical , hardly active on gene by itself , is well tolerated by these patients .	T11	T29	2083404
NA	CHEMICAL	GENE-N	6	14	chemical ( chemical ) and other non-chemical anti-inflammatory drugs , which are gene ( gene ) inhibitors , precipitate asthmatic attacks in chemical-intolerant patients , while chemical , hardly active on gene by itself , is well tolerated by these patients .	T11	T30	2083404
NA	CHEMICAL	GENE-N	6	31	chemical ( chemical ) and other non-chemical anti-inflammatory drugs , which are gene ( gene ) inhibitors , precipitate asthmatic attacks in chemical-intolerant patients , while chemical , hardly active on gene by itself , is well tolerated by these patients .	T11	T27	2083404
NA	CHEMICAL	GENE-N	22	12	chemical ( chemical ) and other non-chemical anti-inflammatory drugs , which are gene ( gene ) inhibitors , precipitate asthmatic attacks in chemical-intolerant patients , while chemical , hardly active on gene by itself , is well tolerated by these patients .	T5	T29	2083404
NA	CHEMICAL	GENE-N	22	14	chemical ( chemical ) and other non-chemical anti-inflammatory drugs , which are gene ( gene ) inhibitors , precipitate asthmatic attacks in chemical-intolerant patients , while chemical , hardly active on gene by itself , is well tolerated by these patients .	T5	T30	2083404
NA	CHEMICAL	GENE-N	22	31	chemical ( chemical ) and other non-chemical anti-inflammatory drugs , which are gene ( gene ) inhibitors , precipitate asthmatic attacks in chemical-intolerant patients , while chemical , hardly active on gene by itself , is well tolerated by these patients .	T5	T27	2083404
NA	CHEMICAL	GENE-N	26	12	chemical ( chemical ) and other non-chemical anti-inflammatory drugs , which are gene ( gene ) inhibitors , precipitate asthmatic attacks in chemical-intolerant patients , while chemical , hardly active on gene by itself , is well tolerated by these patients .	T9	T29	2083404
NA	CHEMICAL	GENE-N	26	14	chemical ( chemical ) and other non-chemical anti-inflammatory drugs , which are gene ( gene ) inhibitors , precipitate asthmatic attacks in chemical-intolerant patients , while chemical , hardly active on gene by itself , is well tolerated by these patients .	T9	T30	2083404
NA	CHEMICAL	GENE-N	26	31	chemical ( chemical ) and other non-chemical anti-inflammatory drugs , which are gene ( gene ) inhibitors , precipitate asthmatic attacks in chemical-intolerant patients , while chemical , hardly active on gene by itself , is well tolerated by these patients .	T9	T27	2083404
NA	CHEMICAL	GENE-N	2	15	However , chemical moiety appears to interfere with chemical inhibitory action on platelets and vascular gene .	T10	T28	2083404
CPR:4	CHEMICAL	GENE-N	8	15	However , chemical moiety appears to interfere with chemical inhibitory action on platelets and vascular gene .	T12	T28	2083404
NA	CHEMICAL	GENE-N	0	16	chemical ( chemical ) modulates the noncholinergic contraction in guinea-pig airways in vitro by a prejunctional gene .	T21	T35	8836655
NA	CHEMICAL	GENE-N	2	16	chemical ( chemical ) modulates the noncholinergic contraction in guinea-pig airways in vitro by a prejunctional gene .	T22	T35	8836655
NA	CHEMICAL	GENE-N	0	14	chemical ( chemical ) is an antihistaminic drug with binding affinity at certain other receptors , including gene and various chemical ( chemical ) receptor subtypes .	T12	T31	8836655
NA	CHEMICAL	GENE-N	0	24	chemical ( chemical ) is an antihistaminic drug with binding affinity at certain other receptors , including gene and various chemical ( chemical ) receptor subtypes .	T12	T32	8836655
NA	CHEMICAL	GENE-N	2	14	chemical ( chemical ) is an antihistaminic drug with binding affinity at certain other receptors , including gene and various chemical ( chemical ) receptor subtypes .	T13	T31	8836655
NA	CHEMICAL	GENE-N	2	24	chemical ( chemical ) is an antihistaminic drug with binding affinity at certain other receptors , including gene and various chemical ( chemical ) receptor subtypes .	T13	T32	8836655
NA	CHEMICAL	GENE-N	20	14	chemical ( chemical ) is an antihistaminic drug with binding affinity at certain other receptors , including gene and various chemical ( chemical ) receptor subtypes .	T14	T31	8836655
NA	CHEMICAL	GENE-N	20	24	chemical ( chemical ) is an antihistaminic drug with binding affinity at certain other receptors , including gene and various chemical ( chemical ) receptor subtypes .	T14	T32	8836655
NA	CHEMICAL	GENE-N	22	14	chemical ( chemical ) is an antihistaminic drug with binding affinity at certain other receptors , including gene and various chemical ( chemical ) receptor subtypes .	T15	T31	8836655
NA	CHEMICAL	GENE-N	22	24	chemical ( chemical ) is an antihistaminic drug with binding affinity at certain other receptors , including gene and various chemical ( chemical ) receptor subtypes .	T15	T32	8836655
CPR:6	CHEMICAL	GENE-N	9	6	Pretreatment of the tissues with combined gene/gene antagonists , chemical ( 1 microM ) or chemical ( 0.1 microM ) , significantly attenuated the inhibitory effect of chemical on the noncholinergic contraction .	T18	T33	8836655
CPR:6	CHEMICAL	GENE-N	9	6	Pretreatment of the tissues with combined gene/gene antagonists , chemical ( 1 microM ) or chemical ( 0.1 microM ) , significantly attenuated the inhibitory effect of chemical on the noncholinergic contraction .	T18	T34	8836655
CPR:6	CHEMICAL	GENE-N	2	6	Pretreatment of the tissues with combined gene/gene antagonists , chemical ( 1 microM ) or chemical ( 0.1 microM ) , significantly attenuated the inhibitory effect of chemical on the noncholinergic contraction .	T19	T33	8836655
CPR:6	CHEMICAL	GENE-N	2	6	Pretreatment of the tissues with combined gene/gene antagonists , chemical ( 1 microM ) or chemical ( 0.1 microM ) , significantly attenuated the inhibitory effect of chemical on the noncholinergic contraction .	T19	T34	8836655
CPR:5	CHEMICAL	GENE-N	27	6	Pretreatment of the tissues with combined gene/gene antagonists , chemical ( 1 microM ) or chemical ( 0.1 microM ) , significantly attenuated the inhibitory effect of chemical on the noncholinergic contraction .	T20	T33	8836655
CPR:5	CHEMICAL	GENE-N	27	6	Pretreatment of the tissues with combined gene/gene antagonists , chemical ( 1 microM ) or chemical ( 0.1 microM ) , significantly attenuated the inhibitory effect of chemical on the noncholinergic contraction .	T20	T34	8836655
CPR:6	CHEMICAL	GENE-N	2	9	Pretreatment with chemical ( 1 microM ) , a gene antagonist , chemical ( 10 microM ) , a gene antagonist , chemical ( 10 microM ) , a chemical H3 antagonist , or chemical ( 10 microM ) , an alpha-adrenergic antagonist , however , had no effect .	T1	T23	8836655
NA	CHEMICAL	GENE-N	2	19	Pretreatment with chemical ( 1 microM ) , a gene antagonist , chemical ( 10 microM ) , a gene antagonist , chemical ( 10 microM ) , a chemical H3 antagonist , or chemical ( 10 microM ) , an alpha-adrenergic antagonist , however , had no effect .	T1	T24	8836655
NA	CHEMICAL	GENE-Y	2	30	Pretreatment with chemical ( 1 microM ) , a gene antagonist , chemical ( 10 microM ) , a gene antagonist , chemical ( 10 microM ) , a chemical H3 antagonist , or chemical ( 10 microM ) , an alpha-adrenergic antagonist , however , had no effect .	T1	T25	8836655
NA	CHEMICAL	GENE-N	8	9	Pretreatment with chemical ( 1 microM ) , a gene antagonist , chemical ( 10 microM ) , a gene antagonist , chemical ( 10 microM ) , a chemical H3 antagonist , or chemical ( 10 microM ) , an alpha-adrenergic antagonist , however , had no effect .	T2	T23	8836655
CPR:6	CHEMICAL	GENE-N	8	19	Pretreatment with chemical ( 1 microM ) , a gene antagonist , chemical ( 10 microM ) , a gene antagonist , chemical ( 10 microM ) , a chemical H3 antagonist , or chemical ( 10 microM ) , an alpha-adrenergic antagonist , however , had no effect .	T2	T24	8836655
NA	CHEMICAL	GENE-Y	8	30	Pretreatment with chemical ( 1 microM ) , a gene antagonist , chemical ( 10 microM ) , a gene antagonist , chemical ( 10 microM ) , a chemical H3 antagonist , or chemical ( 10 microM ) , an alpha-adrenergic antagonist , however , had no effect .	T2	T25	8836655
NA	CHEMICAL	GENE-N	8	9	Pretreatment with chemical ( 1 microM ) , a gene antagonist , chemical ( 10 microM ) , a gene antagonist , chemical ( 10 microM ) , a chemical H3 antagonist , or chemical ( 10 microM ) , an alpha-adrenergic antagonist , however , had no effect .	T3	T23	8836655
NA	CHEMICAL	GENE-N	8	19	Pretreatment with chemical ( 1 microM ) , a gene antagonist , chemical ( 10 microM ) , a gene antagonist , chemical ( 10 microM ) , a chemical H3 antagonist , or chemical ( 10 microM ) , an alpha-adrenergic antagonist , however , had no effect .	T3	T24	8836655
CPR:6	CHEMICAL	GENE-Y	8	30	Pretreatment with chemical ( 1 microM ) , a gene antagonist , chemical ( 10 microM ) , a gene antagonist , chemical ( 10 microM ) , a chemical H3 antagonist , or chemical ( 10 microM ) , an alpha-adrenergic antagonist , however , had no effect .	T3	T25	8836655
NA	CHEMICAL	GENE-N	8	9	Pretreatment with chemical ( 1 microM ) , a gene antagonist , chemical ( 10 microM ) , a gene antagonist , chemical ( 10 microM ) , a chemical H3 antagonist , or chemical ( 10 microM ) , an alpha-adrenergic antagonist , however , had no effect .	T4	T23	8836655
NA	CHEMICAL	GENE-N	8	19	Pretreatment with chemical ( 1 microM ) , a gene antagonist , chemical ( 10 microM ) , a gene antagonist , chemical ( 10 microM ) , a chemical H3 antagonist , or chemical ( 10 microM ) , an alpha-adrenergic antagonist , however , had no effect .	T4	T24	8836655
NA	CHEMICAL	GENE-Y	8	30	Pretreatment with chemical ( 1 microM ) , a gene antagonist , chemical ( 10 microM ) , a gene antagonist , chemical ( 10 microM ) , a chemical H3 antagonist , or chemical ( 10 microM ) , an alpha-adrenergic antagonist , however , had no effect .	T4	T25	8836655
NA	CHEMICAL	GENE-N	8	9	Pretreatment with chemical ( 1 microM ) , a gene antagonist , chemical ( 10 microM ) , a gene antagonist , chemical ( 10 microM ) , a chemical H3 antagonist , or chemical ( 10 microM ) , an alpha-adrenergic antagonist , however , had no effect .	T5	T23	8836655
NA	CHEMICAL	GENE-N	8	19	Pretreatment with chemical ( 1 microM ) , a gene antagonist , chemical ( 10 microM ) , a gene antagonist , chemical ( 10 microM ) , a chemical H3 antagonist , or chemical ( 10 microM ) , an alpha-adrenergic antagonist , however , had no effect .	T5	T24	8836655
NA	CHEMICAL	GENE-Y	8	30	Pretreatment with chemical ( 1 microM ) , a gene antagonist , chemical ( 10 microM ) , a gene antagonist , chemical ( 10 microM ) , a chemical H3 antagonist , or chemical ( 10 microM ) , an alpha-adrenergic antagonist , however , had no effect .	T5	T25	8836655
CPR:6	CHEMICAL	GENE-Y	0	9	chemical ( 10 microM ) , another chemical H1 receptor antagonist without significant chemical receptor binding affinity , did not produce any inhibition of the eNANC contraction .	T6	T26	8836655
NA	CHEMICAL	GENE-N	0	9	chemical ( 10 microM ) , another chemical H1 receptor antagonist without significant chemical receptor binding affinity , did not produce any inhibition of the eNANC contraction .	T6	T27	8836655
NA	CHEMICAL	GENE-Y	7	9	chemical ( 10 microM ) , another chemical H1 receptor antagonist without significant chemical receptor binding affinity , did not produce any inhibition of the eNANC contraction .	T7	T26	8836655
NA	CHEMICAL	GENE-N	7	9	chemical ( 10 microM ) , another chemical H1 receptor antagonist without significant chemical receptor binding affinity , did not produce any inhibition of the eNANC contraction .	T7	T27	8836655
NA	CHEMICAL	GENE-Y	13	9	chemical ( 10 microM ) , another chemical H1 receptor antagonist without significant chemical receptor binding affinity , did not produce any inhibition of the eNANC contraction .	T8	T26	8836655
NA	CHEMICAL	GENE-N	13	9	chemical ( 10 microM ) , another chemical H1 receptor antagonist without significant chemical receptor binding affinity , did not produce any inhibition of the eNANC contraction .	T8	T27	8836655
NA	CHEMICAL	GENE-Y	0	14	chemical ( 100 microM ) did not displace the dose-response curve to exogenously applied gene ( 0.01-10 microM ) .	T9	T28	8836655
NA	CHEMICAL	GENE-N	0	7	chemical-activated protein kinase-dependent and -independent mechanisms underlying in vitro antiglioma action of compound C. We investigated the effect of compound C , a well-known inhibitor of the intracellular energy sensor gene ( chemicalK ) , on proliferation and viability of human U251 and rat C6 glioma cell lines .	T6	T17	19428322
NA	CHEMICAL	GENE-N	0	7	chemical-activated protein kinase-dependent and -independent mechanisms underlying in vitro antiglioma action of compound C. We investigated the effect of compound C , a well-known inhibitor of the intracellular energy sensor gene ( chemicalK ) , on proliferation and viability of human U251 and rat C6 glioma cell lines .	T6	T7	19428322
NA	CHEMICAL	GENE-N	30	7	chemical-activated protein kinase-dependent and -independent mechanisms underlying in vitro antiglioma action of compound C. We investigated the effect of compound C , a well-known inhibitor of the intracellular energy sensor gene ( chemicalK ) , on proliferation and viability of human U251 and rat C6 glioma cell lines .	T1	T17	19428322
NA	CHEMICAL	GENE-N	30	7	chemical-activated protein kinase-dependent and -independent mechanisms underlying in vitro antiglioma action of compound C. We investigated the effect of compound C , a well-known inhibitor of the intracellular energy sensor gene ( chemicalK ) , on proliferation and viability of human U251 and rat C6 glioma cell lines .	T1	T7	19428322
NA	CHEMICAL	GENE-N	23	20	Compound C caused G ( 2 ) /M cell cycle block , accompanied by apoptotic glioma cell death characterized by gene activation , chemical exposure and DNA fragmentation .	T2	T10	19428322
NA	CHEMICAL	GENE-N	1	3	Compound C diminished gene phosphorylation and enzymatic activity , resulting in reduced phosphorylation of its target chemical carboxylase .	T3	T13	19428322
NA	CHEMICAL	GENE-N	1	17	Compound C diminished gene phosphorylation and enzymatic activity , resulting in reduced phosphorylation of its target chemical carboxylase .	T3	T14	19428322
CPR:3	CHEMICAL	GENE-N	2	0	gene activators chemical and chemical partly prevented the cell cycle block , oxidative stress and apoptosis induced by compound C. The small interfering RNA ( siRNA ) targeting of gene mimicked compound C-induced G ( 2 ) /M cell cycle arrest , but failed to induce oxidative stress and apoptosis in U251 glioma cells .	T4	T15	19428322
NA	CHEMICAL	GENE-Y	2	29	gene activators chemical and chemical partly prevented the cell cycle block , oxidative stress and apoptosis induced by compound C. The small interfering RNA ( siRNA ) targeting of gene mimicked compound C-induced G ( 2 ) /M cell cycle arrest , but failed to induce oxidative stress and apoptosis in U251 glioma cells .	T4	T16	19428322
CPR:3	CHEMICAL	GENE-N	4	0	gene activators chemical and chemical partly prevented the cell cycle block , oxidative stress and apoptosis induced by compound C. The small interfering RNA ( siRNA ) targeting of gene mimicked compound C-induced G ( 2 ) /M cell cycle arrest , but failed to induce oxidative stress and apoptosis in U251 glioma cells .	T5	T15	19428322
NA	CHEMICAL	GENE-Y	4	29	gene activators chemical and chemical partly prevented the cell cycle block , oxidative stress and apoptosis induced by compound C. The small interfering RNA ( siRNA ) targeting of gene mimicked compound C-induced G ( 2 ) /M cell cycle arrest , but failed to induce oxidative stress and apoptosis in U251 glioma cells .	T5	T16	19428322
CPR:4	CHEMICAL	GENE-Y	5	15	Synthesis and structure-activity relationship of chemical derivatives as potent and selective chemical : chemical acyltransferase 2 ( gene ) inhibitors : Part 2 .	T5	T6	23535327
CPR:4	CHEMICAL	GENE-Y	5	15	Synthesis and structure-activity relationship of chemical derivatives as potent and selective chemical : chemical acyltransferase 2 ( gene ) inhibitors : Part 2 .	T5	T7	23535327
NA	CHEMICAL	GENE-Y	11	15	Synthesis and structure-activity relationship of chemical derivatives as potent and selective chemical : chemical acyltransferase 2 ( gene ) inhibitors : Part 2 .	T3	T6	23535327
NA	CHEMICAL	GENE-Y	11	15	Synthesis and structure-activity relationship of chemical derivatives as potent and selective chemical : chemical acyltransferase 2 ( gene ) inhibitors : Part 2 .	T3	T7	23535327
NA	CHEMICAL	GENE-Y	13	15	Synthesis and structure-activity relationship of chemical derivatives as potent and selective chemical : chemical acyltransferase 2 ( gene ) inhibitors : Part 2 .	T4	T6	23535327
NA	CHEMICAL	GENE-Y	13	15	Synthesis and structure-activity relationship of chemical derivatives as potent and selective chemical : chemical acyltransferase 2 ( gene ) inhibitors : Part 2 .	T4	T7	23535327
CPR:6	CHEMICAL	GENE-Y	0	10	chemical and chemical are competitive slowly reversible antagonists at the gene of rat left atria .	T14	T19	7678677
CPR:6	CHEMICAL	GENE-Y	2	10	chemical and chemical are competitive slowly reversible antagonists at the gene of rat left atria .	T15	T19	7678677
CPR:4	CHEMICAL	GENE-N	0	37	chemical and chemical at 10 ( -7 ) , 3 x 10 ( -7 ) , and 10 ( -6 ) M inhibited the cardiac stimulation response slightly , which is indicative of membrane-stabilizing activity independent of gene blockade .	T13	T16	7678677
CPR:4	CHEMICAL	GENE-N	0	37	chemical and chemical at 10 ( -7 ) , 3 x 10 ( -7 ) , and 10 ( -6 ) M inhibited the cardiac stimulation response slightly , which is indicative of membrane-stabilizing activity independent of gene blockade .	T1	T16	7678677
CPR:6	CHEMICAL	GENE-Y	0	13	chemical and chemical also caused surmountable antagonism of chemical responses , and this gene antagonism was slowly reversible .	T3	T17	7678677
CPR:6	CHEMICAL	GENE-Y	2	13	chemical and chemical also caused surmountable antagonism of chemical responses , and this gene antagonism was slowly reversible .	T4	T17	7678677
CPR:5	CHEMICAL	GENE-Y	8	13	chemical and chemical also caused surmountable antagonism of chemical responses , and this gene antagonism was slowly reversible .	T6	T17	7678677
NA	CHEMICAL	GENE-Y	3	14	Among the [ chemical ] cluster biosynthetic proteins are included a chemical-dependent enzyme ( gene ) that is involved in the activation of chemical from chemical , and a molecular scaffold protein ( gene ) upon which [ chemical ] cluster precursors are formed .	T7	T17	12196163
NA	CHEMICAL	GENE-N	3	33	Among the [ chemical ] cluster biosynthetic proteins are included a chemical-dependent enzyme ( gene ) that is involved in the activation of chemical from chemical , and a molecular scaffold protein ( gene ) upon which [ chemical ] cluster precursors are formed .	T7	T18	12196163
NA	CHEMICAL	GENE-Y	10	14	Among the [ chemical ] cluster biosynthetic proteins are included a chemical-dependent enzyme ( gene ) that is involved in the activation of chemical from chemical , and a molecular scaffold protein ( gene ) upon which [ chemical ] cluster precursors are formed .	T9	T17	12196163
NA	CHEMICAL	GENE-N	10	33	Among the [ chemical ] cluster biosynthetic proteins are included a chemical-dependent enzyme ( gene ) that is involved in the activation of chemical from chemical , and a molecular scaffold protein ( gene ) upon which [ chemical ] cluster precursors are formed .	T9	T18	12196163
NA	CHEMICAL	GENE-Y	23	14	Among the [ chemical ] cluster biosynthetic proteins are included a chemical-dependent enzyme ( gene ) that is involved in the activation of chemical from chemical , and a molecular scaffold protein ( gene ) upon which [ chemical ] cluster precursors are formed .	T10	T17	12196163
NA	CHEMICAL	GENE-N	23	33	Among the [ chemical ] cluster biosynthetic proteins are included a chemical-dependent enzyme ( gene ) that is involved in the activation of chemical from chemical , and a molecular scaffold protein ( gene ) upon which [ chemical ] cluster precursors are formed .	T10	T18	12196163
CPR:9	CHEMICAL	GENE-Y	19	14	Among the [ chemical ] cluster biosynthetic proteins are included a chemical-dependent enzyme ( gene ) that is involved in the activation of chemical from chemical , and a molecular scaffold protein ( gene ) upon which [ chemical ] cluster precursors are formed .	T11	T17	12196163
NA	CHEMICAL	GENE-N	19	33	Among the [ chemical ] cluster biosynthetic proteins are included a chemical-dependent enzyme ( gene ) that is involved in the activation of chemical from chemical , and a molecular scaffold protein ( gene ) upon which [ chemical ] cluster precursors are formed .	T11	T18	12196163
NA	CHEMICAL	GENE-Y	38	14	Among the [ chemical ] cluster biosynthetic proteins are included a chemical-dependent enzyme ( gene ) that is involved in the activation of chemical from chemical , and a molecular scaffold protein ( gene ) upon which [ chemical ] cluster precursors are formed .	T12	T17	12196163
NA	CHEMICAL	GENE-N	38	33	Among the [ chemical ] cluster biosynthetic proteins are included a chemical-dependent enzyme ( gene ) that is involved in the activation of chemical from chemical , and a molecular scaffold protein ( gene ) upon which [ chemical ] cluster precursors are formed .	T12	T18	12196163
CPR:3	CHEMICAL	GENE-Y	0	7	chemical induces cognitive impairment through enhancement of gene-mediated gene generation in mice .	T13	T35	22982445
CPR:3	CHEMICAL	GENE-Y	0	8	chemical induces cognitive impairment through enhancement of gene-mediated gene generation in mice .	T13	T36	22982445
CPR:3	CHEMICAL	GENE-Y	7	9	The results demonstrated that intracerebral infusions of chemical ( 1 ng/mouse ) produced memory impairment as determined by Morris water maze test and Y-maze test in mice , and caused the accumulation of gene and gene in the hippocampus and cortex through increased activity of β- and γ-secretases accompanied with increased expression of gene ( gene ) .	T6	T24	22982445
CPR:3	CHEMICAL	GENE-Y	7	9	The results demonstrated that intracerebral infusions of chemical ( 1 ng/mouse ) produced memory impairment as determined by Morris water maze test and Y-maze test in mice , and caused the accumulation of gene and gene in the hippocampus and cortex through increased activity of β- and γ-secretases accompanied with increased expression of gene ( gene ) .	T6	T25	22982445
CPR:3	CHEMICAL	GENE-Y	7	25	The results demonstrated that intracerebral infusions of chemical ( 1 ng/mouse ) produced memory impairment as determined by Morris water maze test and Y-maze test in mice , and caused the accumulation of gene and gene in the hippocampus and cortex through increased activity of β- and γ-secretases accompanied with increased expression of gene ( gene ) .	T6	T26	22982445
CPR:3	CHEMICAL	GENE-Y	7	55	The results demonstrated that intracerebral infusions of chemical ( 1 ng/mouse ) produced memory impairment as determined by Morris water maze test and Y-maze test in mice , and caused the accumulation of gene and gene in the hippocampus and cortex through increased activity of β- and γ-secretases accompanied with increased expression of gene ( gene ) .	T6	T28	22982445
CPR:3	CHEMICAL	GENE-Y	0	7	chemical also induced expression of chemical receptor 1 ( gene ) and gene gene in the hippocampus and cortex .	T7	T29	22982445
CPR:3	CHEMICAL	GENE-Y	0	7	chemical also induced expression of chemical receptor 1 ( gene ) and gene gene in the hippocampus and cortex .	T7	T30	22982445
CPR:3	CHEMICAL	GENE-N	0	12	chemical also induced expression of chemical receptor 1 ( gene ) and gene gene in the hippocampus and cortex .	T7	T31	22982445
CPR:3	CHEMICAL	GENE-Y	0	13	chemical also induced expression of chemical receptor 1 ( gene ) and gene gene in the hippocampus and cortex .	T7	T32	22982445
NA	CHEMICAL	GENE-Y	5	7	chemical also induced expression of chemical receptor 1 ( gene ) and gene gene in the hippocampus and cortex .	T8	T29	22982445
NA	CHEMICAL	GENE-Y	5	7	chemical also induced expression of chemical receptor 1 ( gene ) and gene gene in the hippocampus and cortex .	T8	T30	22982445
NA	CHEMICAL	GENE-N	5	12	chemical also induced expression of chemical receptor 1 ( gene ) and gene gene in the hippocampus and cortex .	T8	T31	22982445
NA	CHEMICAL	GENE-Y	5	13	chemical also induced expression of chemical receptor 1 ( gene ) and gene gene in the hippocampus and cortex .	T8	T32	22982445
CPR:6	CHEMICAL	GENE-Y	2	3	Pretreatment with chemical ( 1.5 ng/mouse , intracerebroventricularly ) , a gene antagonist , blocked chemical-induced amyloidogenesis , memory deficits .	T9	T34	22982445
NA	CHEMICAL	GENE-Y	15	3	Pretreatment with chemical ( 1.5 ng/mouse , intracerebroventricularly ) , a gene antagonist , blocked chemical-induced amyloidogenesis , memory deficits .	T10	T34	22982445
CPR:3	CHEMICAL	GENE-Y	2	5	Moreover , chemical-induced increases in gene and gene gene in the brain were also attenuated by chemical .	T1	T15	22982445
CPR:3	CHEMICAL	GENE-N	2	7	Moreover , chemical-induced increases in gene and gene gene in the brain were also attenuated by chemical .	T1	T16	22982445
CPR:3	CHEMICAL	GENE-Y	2	8	Moreover , chemical-induced increases in gene and gene gene in the brain were also attenuated by chemical .	T1	T17	22982445
CPR:4	CHEMICAL	GENE-Y	16	5	Moreover , chemical-induced increases in gene and gene gene in the brain were also attenuated by chemical .	T2	T15	22982445
CPR:4	CHEMICAL	GENE-N	16	7	Moreover , chemical-induced increases in gene and gene gene in the brain were also attenuated by chemical .	T2	T16	22982445
CPR:4	CHEMICAL	GENE-Y	16	8	Moreover , chemical-induced increases in gene and gene gene in the brain were also attenuated by chemical .	T2	T17	22982445
CPR:3	CHEMICAL	GENE-Y	4	6	These results suggest that chemical increases gene burden via activation of gene , which further affects gene levels and activity of β- and γ-secretases via the gene pathway .	T3	T18	22982445
CPR:3	CHEMICAL	GENE-Y	4	11	These results suggest that chemical increases gene burden via activation of gene , which further affects gene levels and activity of β- and γ-secretases via the gene pathway .	T3	T19	22982445
NA	CHEMICAL	GENE-Y	4	16	These results suggest that chemical increases gene burden via activation of gene , which further affects gene levels and activity of β- and γ-secretases via the gene pathway .	T3	T20	22982445
NA	CHEMICAL	GENE-N	4	26	These results suggest that chemical increases gene burden via activation of gene , which further affects gene levels and activity of β- and γ-secretases via the gene pathway .	T3	T21	22982445
NA	CHEMICAL	GENE-Y	10	11	Testing chemicals for their endocrine-disrupting potential , including interference with chemical receptor ( gene ) signaling , is an important aspect of chemical safety testing .	T3	T16	23383871
NA	CHEMICAL	GENE-Y	10	13	Testing chemicals for their endocrine-disrupting potential , including interference with chemical receptor ( gene ) signaling , is an important aspect of chemical safety testing .	T3	T5	23383871
NA	CHEMICAL	GENE-Y	43	44	In the present study , the reproducibility and robustness of this coregulator binding assay was determined by measuring the binding profiles of 14 model compounds that are recommended by the Office of Prevention , Pesticides and Toxic Substances for testing laboratory proficiency in chemical receptor transactivation assays .	T4	T17	23383871
NA	CHEMICAL	GENE-Y	4	4	Moreover , when the gene-coregulator binding profiles were hierarchically clustered using Euclidian cluster distance , the structurally related compounds were found to cluster together , whereas the chemical test compounds having an aromatic A-ring were separated from those with a chemical A-ring .	T1	T11	23383871
NA	CHEMICAL	GENE-Y	40	4	Moreover , when the gene-coregulator binding profiles were hierarchically clustered using Euclidian cluster distance , the structurally related compounds were found to cluster together , whereas the chemical test compounds having an aromatic A-ring were separated from those with a chemical A-ring .	T2	T11	23383871
NA	CHEMICAL	GENE-N	3	5	Stereospecific inhibition of chemical uptake transporters by chemical isomers .	T14	T21	12373557
CPR:4	CHEMICAL	GENE-N	7	5	Stereospecific inhibition of chemical uptake transporters by chemical isomers .	T15	T21	12373557
NA	CHEMICAL	GENE-N	8	9	To extend structure-activity analyses of binding sites within chemical transporters and to determine which stereoisomer displayed the best selectivity for PET imaging applications , we tested the chemical compounds for their abilities to inhibit [ chemical ] neurotransmitter uptake into platelets , transfected cells , and chromaffin vesicles .	T7	T16	12373557
CPR:4	CHEMICAL	GENE-N	27	9	To extend structure-activity analyses of binding sites within chemical transporters and to determine which stereoisomer displayed the best selectivity for PET imaging applications , we tested the chemical compounds for their abilities to inhibit [ chemical ] neurotransmitter uptake into platelets , transfected cells , and chromaffin vesicles .	T8	T16	12373557
NA	CHEMICAL	GENE-N	35	9	To extend structure-activity analyses of binding sites within chemical transporters and to determine which stereoisomer displayed the best selectivity for PET imaging applications , we tested the chemical compounds for their abilities to inhibit [ chemical ] neurotransmitter uptake into platelets , transfected cells , and chromaffin vesicles .	T9	T16	12373557
CPR:4	CHEMICAL	GENE-Y	4	13	We hypothesized that the chemical compounds would be most potent at the chemical transporter ( gene ) compared to the chemical or chemical transporters and that the 1R diastereomers would be more effective than 1S diastereomers .	T10	T17	12373557
CPR:4	CHEMICAL	GENE-Y	4	15	We hypothesized that the chemical compounds would be most potent at the chemical transporter ( gene ) compared to the chemical or chemical transporters and that the 1R diastereomers would be more effective than 1S diastereomers .	T10	T18	12373557
NA	CHEMICAL	GENE-N	4	13	We hypothesized that the chemical compounds would be most potent at the chemical transporter ( gene ) compared to the chemical or chemical transporters and that the 1R diastereomers would be more effective than 1S diastereomers .	T10	T19	12373557
NA	CHEMICAL	GENE-Y	12	13	We hypothesized that the chemical compounds would be most potent at the chemical transporter ( gene ) compared to the chemical or chemical transporters and that the 1R diastereomers would be more effective than 1S diastereomers .	T11	T17	12373557
NA	CHEMICAL	GENE-Y	12	15	We hypothesized that the chemical compounds would be most potent at the chemical transporter ( gene ) compared to the chemical or chemical transporters and that the 1R diastereomers would be more effective than 1S diastereomers .	T11	T18	12373557
NA	CHEMICAL	GENE-N	12	13	We hypothesized that the chemical compounds would be most potent at the chemical transporter ( gene ) compared to the chemical or chemical transporters and that the 1R diastereomers would be more effective than 1S diastereomers .	T11	T19	12373557
NA	CHEMICAL	GENE-Y	18	13	We hypothesized that the chemical compounds would be most potent at the chemical transporter ( gene ) compared to the chemical or chemical transporters and that the 1R diastereomers would be more effective than 1S diastereomers .	T12	T17	12373557
NA	CHEMICAL	GENE-Y	18	15	We hypothesized that the chemical compounds would be most potent at the chemical transporter ( gene ) compared to the chemical or chemical transporters and that the 1R diastereomers would be more effective than 1S diastereomers .	T12	T18	12373557
NA	CHEMICAL	GENE-N	18	13	We hypothesized that the chemical compounds would be most potent at the chemical transporter ( gene ) compared to the chemical or chemical transporters and that the 1R diastereomers would be more effective than 1S diastereomers .	T12	T19	12373557
NA	CHEMICAL	GENE-Y	22	13	We hypothesized that the chemical compounds would be most potent at the chemical transporter ( gene ) compared to the chemical or chemical transporters and that the 1R diastereomers would be more effective than 1S diastereomers .	T13	T17	12373557
NA	CHEMICAL	GENE-Y	22	15	We hypothesized that the chemical compounds would be most potent at the chemical transporter ( gene ) compared to the chemical or chemical transporters and that the 1R diastereomers would be more effective than 1S diastereomers .	T13	T18	12373557
NA	CHEMICAL	GENE-N	22	13	We hypothesized that the chemical compounds would be most potent at the chemical transporter ( gene ) compared to the chemical or chemical transporters and that the 1R diastereomers would be more effective than 1S diastereomers .	T13	T19	12373557
NA	CHEMICAL	GENE-Y	38	3	SF levels of gene ( gene ) , gene ( gene ) , gene ( gene ) , gene , genegene ( gene ) ( reflecting gene cleavage of cartilage gene ) , gene ( gene ) ( a biosynthesis marker ) , keratan chemical ( KS ) , and the 846 epitope of gene ( turnover ) were measured by enzyme-linked immunosorbent assay or radioimmunoassay .	T1	T36	14613270
NA	CHEMICAL	GENE-Y	38	5	SF levels of gene ( gene ) , gene ( gene ) , gene ( gene ) , gene , genegene ( gene ) ( reflecting gene cleavage of cartilage gene ) , gene ( gene ) ( a biosynthesis marker ) , keratan chemical ( KS ) , and the 846 epitope of gene ( turnover ) were measured by enzyme-linked immunosorbent assay or radioimmunoassay .	T1	T37	14613270
NA	CHEMICAL	GENE-Y	38	8	SF levels of gene ( gene ) , gene ( gene ) , gene ( gene ) , gene , genegene ( gene ) ( reflecting gene cleavage of cartilage gene ) , gene ( gene ) ( a biosynthesis marker ) , keratan chemical ( KS ) , and the 846 epitope of gene ( turnover ) were measured by enzyme-linked immunosorbent assay or radioimmunoassay .	T1	T38	14613270
NA	CHEMICAL	GENE-Y	38	10	SF levels of gene ( gene ) , gene ( gene ) , gene ( gene ) , gene , genegene ( gene ) ( reflecting gene cleavage of cartilage gene ) , gene ( gene ) ( a biosynthesis marker ) , keratan chemical ( KS ) , and the 846 epitope of gene ( turnover ) were measured by enzyme-linked immunosorbent assay or radioimmunoassay .	T1	T39	14613270
NA	CHEMICAL	GENE-Y	38	13	SF levels of gene ( gene ) , gene ( gene ) , gene ( gene ) , gene , genegene ( gene ) ( reflecting gene cleavage of cartilage gene ) , gene ( gene ) ( a biosynthesis marker ) , keratan chemical ( KS ) , and the 846 epitope of gene ( turnover ) were measured by enzyme-linked immunosorbent assay or radioimmunoassay .	T1	T40	14613270
NA	CHEMICAL	GENE-Y	38	15	SF levels of gene ( gene ) , gene ( gene ) , gene ( gene ) , gene , genegene ( gene ) ( reflecting gene cleavage of cartilage gene ) , gene ( gene ) ( a biosynthesis marker ) , keratan chemical ( KS ) , and the 846 epitope of gene ( turnover ) were measured by enzyme-linked immunosorbent assay or radioimmunoassay .	T1	T41	14613270
NA	CHEMICAL	GENE-Y	38	18	SF levels of gene ( gene ) , gene ( gene ) , gene ( gene ) , gene , genegene ( gene ) ( reflecting gene cleavage of cartilage gene ) , gene ( gene ) ( a biosynthesis marker ) , keratan chemical ( KS ) , and the 846 epitope of gene ( turnover ) were measured by enzyme-linked immunosorbent assay or radioimmunoassay .	T1	T42	14613270
NA	CHEMICAL	GENE-N	38	20	SF levels of gene ( gene ) , gene ( gene ) , gene ( gene ) , gene , genegene ( gene ) ( reflecting gene cleavage of cartilage gene ) , gene ( gene ) ( a biosynthesis marker ) , keratan chemical ( KS ) , and the 846 epitope of gene ( turnover ) were measured by enzyme-linked immunosorbent assay or radioimmunoassay .	T1	T43	14613270
NA	CHEMICAL	GENE-N	38	20	SF levels of gene ( gene ) , gene ( gene ) , gene ( gene ) , gene , genegene ( gene ) ( reflecting gene cleavage of cartilage gene ) , gene ( gene ) ( a biosynthesis marker ) , keratan chemical ( KS ) , and the 846 epitope of gene ( turnover ) were measured by enzyme-linked immunosorbent assay or radioimmunoassay .	T1	T44	14613270
NA	CHEMICAL	GENE-N	38	22	SF levels of gene ( gene ) , gene ( gene ) , gene ( gene ) , gene , genegene ( gene ) ( reflecting gene cleavage of cartilage gene ) , gene ( gene ) ( a biosynthesis marker ) , keratan chemical ( KS ) , and the 846 epitope of gene ( turnover ) were measured by enzyme-linked immunosorbent assay or radioimmunoassay .	T1	T45	14613270
NA	CHEMICAL	GENE-N	38	26	SF levels of gene ( gene ) , gene ( gene ) , gene ( gene ) , gene , genegene ( gene ) ( reflecting gene cleavage of cartilage gene ) , gene ( gene ) ( a biosynthesis marker ) , keratan chemical ( KS ) , and the 846 epitope of gene ( turnover ) were measured by enzyme-linked immunosorbent assay or radioimmunoassay .	T1	T2	14613270
NA	CHEMICAL	GENE-N	38	3	SF levels of gene ( gene ) , gene ( gene ) , gene ( gene ) , gene , genegene ( gene ) ( reflecting gene cleavage of cartilage gene ) , gene ( gene ) ( a biosynthesis marker ) , keratan chemical ( KS ) , and the 846 epitope of gene ( turnover ) were measured by enzyme-linked immunosorbent assay or radioimmunoassay .	T1	T3	14613270
NA	CHEMICAL	GENE-N	38	33	SF levels of gene ( gene ) , gene ( gene ) , gene ( gene ) , gene , genegene ( gene ) ( reflecting gene cleavage of cartilage gene ) , gene ( gene ) ( a biosynthesis marker ) , keratan chemical ( KS ) , and the 846 epitope of gene ( turnover ) were measured by enzyme-linked immunosorbent assay or radioimmunoassay .	T1	T5	14613270
NA	CHEMICAL	GENE-N	38	35	SF levels of gene ( gene ) , gene ( gene ) , gene ( gene ) , gene , genegene ( gene ) ( reflecting gene cleavage of cartilage gene ) , gene ( gene ) ( a biosynthesis marker ) , keratan chemical ( KS ) , and the 846 epitope of gene ( turnover ) were measured by enzyme-linked immunosorbent assay or radioimmunoassay .	T1	T6	14613270
NA	CHEMICAL	GENE-Y	38	38	SF levels of gene ( gene ) , gene ( gene ) , gene ( gene ) , gene , genegene ( gene ) ( reflecting gene cleavage of cartilage gene ) , gene ( gene ) ( a biosynthesis marker ) , keratan chemical ( KS ) , and the 846 epitope of gene ( turnover ) were measured by enzyme-linked immunosorbent assay or radioimmunoassay .	T1	T7	14613270
NA	CHEMICAL	GENE-Y	3	11	In vivo and in vitro characterization of chemical-derived ligands at the gene .	T18	T23	23118019
NA	CHEMICAL	GENE-N	8	0	gene binding affinity and activity were assessed using chemical binding , chemical ( chemical ) binding and isolated guinea-pig ileum .	T11	T21	23118019
NA	CHEMICAL	GENE-N	11	0	gene binding affinity and activity were assessed using chemical binding , chemical ( chemical ) binding and isolated guinea-pig ileum .	T12	T21	23118019
NA	CHEMICAL	GENE-N	12	0	gene binding affinity and activity were assessed using chemical binding , chemical ( chemical ) binding and isolated guinea-pig ileum .	T13	T21	23118019
NA	CHEMICAL	GENE-Y	1	8	Both chemical and chemical had high affinity for gene ( K ( i ) 1.36 ± 0.98 and 0.27 ± 0.08 , respectively ) and were revealed as potent κ-antagonists ( pA ( 2 ) 7.43 and 8.18 , respectively ) and gene antagonists ( pA ( 2 ) 7.62 and 7.85 , respectively ) in the ileum .	T16	T22	23118019
CPR:6	CHEMICAL	GENE-Y	1	42	Both chemical and chemical had high affinity for gene ( K ( i ) 1.36 ± 0.98 and 0.27 ± 0.08 , respectively ) and were revealed as potent κ-antagonists ( pA ( 2 ) 7.43 and 8.18 , respectively ) and gene antagonists ( pA ( 2 ) 7.62 and 7.85 , respectively ) in the ileum .	T16	T19	23118019
NA	CHEMICAL	GENE-Y	3	8	Both chemical and chemical had high affinity for gene ( K ( i ) 1.36 ± 0.98 and 0.27 ± 0.08 , respectively ) and were revealed as potent κ-antagonists ( pA ( 2 ) 7.43 and 8.18 , respectively ) and gene antagonists ( pA ( 2 ) 7.62 and 7.85 , respectively ) in the ileum .	T17	T22	23118019
CPR:6	CHEMICAL	GENE-Y	3	42	Both chemical and chemical had high affinity for gene ( K ( i ) 1.36 ± 0.98 and 0.27 ± 0.08 , respectively ) and were revealed as potent κ-antagonists ( pA ( 2 ) 7.43 and 8.18 , respectively ) and gene antagonists ( pA ( 2 ) 7.62 and 7.85 , respectively ) in the ileum .	T17	T19	23118019
CPR:9	CHEMICAL	GENE-Y	0	14	chemical ( chemical ) is synthesized from chemical via the action of chemical-gamma-lyase ( gene ) and chemical-beta-synthase ( gene ) .	T1	T32	17488480
CPR:9	CHEMICAL	GENE-Y	0	19	chemical ( chemical ) is synthesized from chemical via the action of chemical-gamma-lyase ( gene ) and chemical-beta-synthase ( gene ) .	T1	T38	17488480
CPR:9	CHEMICAL	GENE-Y	1	14	chemical ( chemical ) is synthesized from chemical via the action of chemical-gamma-lyase ( gene ) and chemical-beta-synthase ( gene ) .	T15	T32	17488480
CPR:9	CHEMICAL	GENE-Y	1	19	chemical ( chemical ) is synthesized from chemical via the action of chemical-gamma-lyase ( gene ) and chemical-beta-synthase ( gene ) .	T15	T38	17488480
CPR:9	CHEMICAL	GENE-Y	7	14	chemical ( chemical ) is synthesized from chemical via the action of chemical-gamma-lyase ( gene ) and chemical-beta-synthase ( gene ) .	T18	T32	17488480
CPR:9	CHEMICAL	GENE-Y	7	19	chemical ( chemical ) is synthesized from chemical via the action of chemical-gamma-lyase ( gene ) and chemical-beta-synthase ( gene ) .	T18	T38	17488480
NA	CHEMICAL	GENE-Y	12	14	chemical ( chemical ) is synthesized from chemical via the action of chemical-gamma-lyase ( gene ) and chemical-beta-synthase ( gene ) .	T26	T32	17488480
NA	CHEMICAL	GENE-Y	12	19	chemical ( chemical ) is synthesized from chemical via the action of chemical-gamma-lyase ( gene ) and chemical-beta-synthase ( gene ) .	T26	T38	17488480
NA	CHEMICAL	GENE-Y	17	14	chemical ( chemical ) is synthesized from chemical via the action of chemical-gamma-lyase ( gene ) and chemical-beta-synthase ( gene ) .	T4	T32	17488480
NA	CHEMICAL	GENE-Y	17	19	chemical ( chemical ) is synthesized from chemical via the action of chemical-gamma-lyase ( gene ) and chemical-beta-synthase ( gene ) .	T4	T38	17488480
NA	CHEMICAL	GENE-Y	9	18	In this study , we investigated the presence of chemical and the expression of chemical synthesizing enzymes , gene and gene , in isolated mouse pancreatic acini .	T16	T44	17488480
NA	CHEMICAL	GENE-Y	9	20	In this study , we investigated the presence of chemical and the expression of chemical synthesizing enzymes , gene and gene , in isolated mouse pancreatic acini .	T16	T45	17488480
CPR:9	CHEMICAL	GENE-Y	14	18	In this study , we investigated the presence of chemical and the expression of chemical synthesizing enzymes , gene and gene , in isolated mouse pancreatic acini .	T17	T44	17488480
CPR:9	CHEMICAL	GENE-Y	14	20	In this study , we investigated the presence of chemical and the expression of chemical synthesizing enzymes , gene and gene , in isolated mouse pancreatic acini .	T17	T45	17488480
CPR:3	CHEMICAL	GENE-Y	0	7	chemical increased the levels of chemical and gene mRNA expression while gene mRNA expression was decreased .	T20	T46	17488480
CPR:4	CHEMICAL	GENE-Y	0	11	chemical increased the levels of chemical and gene mRNA expression while gene mRNA expression was decreased .	T20	T47	17488480
NA	CHEMICAL	GENE-Y	5	7	chemical increased the levels of chemical and gene mRNA expression while gene mRNA expression was decreased .	T21	T46	17488480
NA	CHEMICAL	GENE-Y	5	11	chemical increased the levels of chemical and gene mRNA expression while gene mRNA expression was decreased .	T21	T47	17488480
CPR:4	CHEMICAL	GENE-Y	6	15	In addition , cells pre-treated with chemical ( chemical , 3 mM ) , a gene inhibitor , reduced the formation of chemical in chemical treated cells , suggesting that gene may be the main enzyme involved in chemical formation in mouse acinar cells .	T22	T48	17488480
NA	CHEMICAL	GENE-Y	6	30	In addition , cells pre-treated with chemical ( chemical , 3 mM ) , a gene inhibitor , reduced the formation of chemical in chemical treated cells , suggesting that gene may be the main enzyme involved in chemical formation in mouse acinar cells .	T22	T50	17488480
CPR:4	CHEMICAL	GENE-Y	8	15	In addition , cells pre-treated with chemical ( chemical , 3 mM ) , a gene inhibitor , reduced the formation of chemical in chemical treated cells , suggesting that gene may be the main enzyme involved in chemical formation in mouse acinar cells .	T23	T48	17488480
NA	CHEMICAL	GENE-Y	8	30	In addition , cells pre-treated with chemical ( chemical , 3 mM ) , a gene inhibitor , reduced the formation of chemical in chemical treated cells , suggesting that gene may be the main enzyme involved in chemical formation in mouse acinar cells .	T23	T50	17488480
NA	CHEMICAL	GENE-Y	7	15	In addition , cells pre-treated with chemical ( chemical , 3 mM ) , a gene inhibitor , reduced the formation of chemical in chemical treated cells , suggesting that gene may be the main enzyme involved in chemical formation in mouse acinar cells .	T24	T48	17488480
NA	CHEMICAL	GENE-Y	7	30	In addition , cells pre-treated with chemical ( chemical , 3 mM ) , a gene inhibitor , reduced the formation of chemical in chemical treated cells , suggesting that gene may be the main enzyme involved in chemical formation in mouse acinar cells .	T24	T50	17488480
NA	CHEMICAL	GENE-Y	14	15	In addition , cells pre-treated with chemical ( chemical , 3 mM ) , a gene inhibitor , reduced the formation of chemical in chemical treated cells , suggesting that gene may be the main enzyme involved in chemical formation in mouse acinar cells .	T25	T48	17488480
NA	CHEMICAL	GENE-Y	14	30	In addition , cells pre-treated with chemical ( chemical , 3 mM ) , a gene inhibitor , reduced the formation of chemical in chemical treated cells , suggesting that gene may be the main enzyme involved in chemical formation in mouse acinar cells .	T25	T50	17488480
NA	CHEMICAL	GENE-Y	7	15	In addition , cells pre-treated with chemical ( chemical , 3 mM ) , a gene inhibitor , reduced the formation of chemical in chemical treated cells , suggesting that gene may be the main enzyme involved in chemical formation in mouse acinar cells .	T27	T48	17488480
CPR:9	CHEMICAL	GENE-Y	7	30	In addition , cells pre-treated with chemical ( chemical , 3 mM ) , a gene inhibitor , reduced the formation of chemical in chemical treated cells , suggesting that gene may be the main enzyme involved in chemical formation in mouse acinar cells .	T27	T50	17488480
NA	CHEMICAL	GENE-Y	2	4	Furthermore , chemical ( gene ) concentration in the acini and expression of chemical gene ( gene , gene ) and gene ( gene ) , the primary receptor for chemical , are increased in secretagogue chemical-treated acinar cells .	T28	T52	17488480
NA	CHEMICAL	GENE-Y	2	7	Furthermore , chemical ( gene ) concentration in the acini and expression of chemical gene ( gene , gene ) and gene ( gene ) , the primary receptor for chemical , are increased in secretagogue chemical-treated acinar cells .	T28	T54	17488480
NA	CHEMICAL	GENE-Y	2	18	Furthermore , chemical ( gene ) concentration in the acini and expression of chemical gene ( gene , gene ) and gene ( gene ) , the primary receptor for chemical , are increased in secretagogue chemical-treated acinar cells .	T28	T55	17488480
NA	CHEMICAL	GENE-Y	2	21	Furthermore , chemical ( gene ) concentration in the acini and expression of chemical gene ( gene , gene ) and gene ( gene ) , the primary receptor for chemical , are increased in secretagogue chemical-treated acinar cells .	T28	T56	17488480
NA	CHEMICAL	GENE-Y	2	23	Furthermore , chemical ( gene ) concentration in the acini and expression of chemical gene ( gene , gene ) and gene ( gene ) , the primary receptor for chemical , are increased in secretagogue chemical-treated acinar cells .	T28	T57	17488480
NA	CHEMICAL	GENE-Y	13	4	Furthermore , chemical ( gene ) concentration in the acini and expression of chemical gene ( gene , gene ) and gene ( gene ) , the primary receptor for chemical , are increased in secretagogue chemical-treated acinar cells .	T29	T52	17488480
NA	CHEMICAL	GENE-Y	13	7	Furthermore , chemical ( gene ) concentration in the acini and expression of chemical gene ( gene , gene ) and gene ( gene ) , the primary receptor for chemical , are increased in secretagogue chemical-treated acinar cells .	T29	T54	17488480
NA	CHEMICAL	GENE-Y	13	18	Furthermore , chemical ( gene ) concentration in the acini and expression of chemical gene ( gene , gene ) and gene ( gene ) , the primary receptor for chemical , are increased in secretagogue chemical-treated acinar cells .	T29	T55	17488480
NA	CHEMICAL	GENE-Y	13	21	Furthermore , chemical ( gene ) concentration in the acini and expression of chemical gene ( gene , gene ) and gene ( gene ) , the primary receptor for chemical , are increased in secretagogue chemical-treated acinar cells .	T29	T56	17488480
NA	CHEMICAL	GENE-Y	13	23	Furthermore , chemical ( gene ) concentration in the acini and expression of chemical gene ( gene , gene ) and gene ( gene ) , the primary receptor for chemical , are increased in secretagogue chemical-treated acinar cells .	T29	T57	17488480
NA	CHEMICAL	GENE-Y	30	4	Furthermore , chemical ( gene ) concentration in the acini and expression of chemical gene ( gene , gene ) and gene ( gene ) , the primary receptor for chemical , are increased in secretagogue chemical-treated acinar cells .	T30	T52	17488480
NA	CHEMICAL	GENE-Y	30	7	Furthermore , chemical ( gene ) concentration in the acini and expression of chemical gene ( gene , gene ) and gene ( gene ) , the primary receptor for chemical , are increased in secretagogue chemical-treated acinar cells .	T30	T54	17488480
NA	CHEMICAL	GENE-Y	30	18	Furthermore , chemical ( gene ) concentration in the acini and expression of chemical gene ( gene , gene ) and gene ( gene ) , the primary receptor for chemical , are increased in secretagogue chemical-treated acinar cells .	T30	T55	17488480
NA	CHEMICAL	GENE-Y	30	21	Furthermore , chemical ( gene ) concentration in the acini and expression of chemical gene ( gene , gene ) and gene ( gene ) , the primary receptor for chemical , are increased in secretagogue chemical-treated acinar cells .	T30	T56	17488480
NA	CHEMICAL	GENE-Y	30	23	Furthermore , chemical ( gene ) concentration in the acini and expression of chemical gene ( gene , gene ) and gene ( gene ) , the primary receptor for chemical , are increased in secretagogue chemical-treated acinar cells .	T30	T57	17488480
NA	CHEMICAL	GENE-Y	2	4	Furthermore , chemical ( gene ) concentration in the acini and expression of chemical gene ( gene , gene ) and gene ( gene ) , the primary receptor for chemical , are increased in secretagogue chemical-treated acinar cells .	T2	T52	17488480
NA	CHEMICAL	GENE-Y	2	7	Furthermore , chemical ( gene ) concentration in the acini and expression of chemical gene ( gene , gene ) and gene ( gene ) , the primary receptor for chemical , are increased in secretagogue chemical-treated acinar cells .	T2	T54	17488480
NA	CHEMICAL	GENE-Y	2	18	Furthermore , chemical ( gene ) concentration in the acini and expression of chemical gene ( gene , gene ) and gene ( gene ) , the primary receptor for chemical , are increased in secretagogue chemical-treated acinar cells .	T2	T55	17488480
NA	CHEMICAL	GENE-Y	2	21	Furthermore , chemical ( gene ) concentration in the acini and expression of chemical gene ( gene , gene ) and gene ( gene ) , the primary receptor for chemical , are increased in secretagogue chemical-treated acinar cells .	T2	T56	17488480
NA	CHEMICAL	GENE-Y	2	23	Furthermore , chemical ( gene ) concentration in the acini and expression of chemical gene ( gene , gene ) and gene ( gene ) , the primary receptor for chemical , are increased in secretagogue chemical-treated acinar cells .	T2	T57	17488480
CPR:3	CHEMICAL	GENE-Y	7	4	Furthermore , chemical ( gene ) concentration in the acini and expression of chemical gene ( gene , gene ) and gene ( gene ) , the primary receptor for chemical , are increased in secretagogue chemical-treated acinar cells .	T3	T52	17488480
CPR:3	CHEMICAL	GENE-Y	7	7	Furthermore , chemical ( gene ) concentration in the acini and expression of chemical gene ( gene , gene ) and gene ( gene ) , the primary receptor for chemical , are increased in secretagogue chemical-treated acinar cells .	T3	T54	17488480
CPR:3	CHEMICAL	GENE-Y	7	18	Furthermore , chemical ( gene ) concentration in the acini and expression of chemical gene ( gene , gene ) and gene ( gene ) , the primary receptor for chemical , are increased in secretagogue chemical-treated acinar cells .	T3	T55	17488480
CPR:3	CHEMICAL	GENE-Y	7	21	Furthermore , chemical ( gene ) concentration in the acini and expression of chemical gene ( gene , gene ) and gene ( gene ) , the primary receptor for chemical , are increased in secretagogue chemical-treated acinar cells .	T3	T56	17488480
CPR:3	CHEMICAL	GENE-Y	7	23	Furthermore , chemical ( gene ) concentration in the acini and expression of chemical gene ( gene , gene ) and gene ( gene ) , the primary receptor for chemical , are increased in secretagogue chemical-treated acinar cells .	T3	T57	17488480
CPR:4	CHEMICAL	GENE-Y	5	10	Inhibition of endogenous production of chemical by chemical significantly suppressed gene concentration , gene expression and gene expression in the acini .	T5	T35	17488480
CPR:4	CHEMICAL	GENE-Y	5	13	Inhibition of endogenous production of chemical by chemical significantly suppressed gene concentration , gene expression and gene expression in the acini .	T5	T36	17488480
CPR:4	CHEMICAL	GENE-Y	5	16	Inhibition of endogenous production of chemical by chemical significantly suppressed gene concentration , gene expression and gene expression in the acini .	T5	T37	17488480
NA	CHEMICAL	GENE-Y	7	10	Inhibition of endogenous production of chemical by chemical significantly suppressed gene concentration , gene expression and gene expression in the acini .	T6	T35	17488480
NA	CHEMICAL	GENE-Y	7	13	Inhibition of endogenous production of chemical by chemical significantly suppressed gene concentration , gene expression and gene expression in the acini .	T6	T36	17488480
NA	CHEMICAL	GENE-Y	7	16	Inhibition of endogenous production of chemical by chemical significantly suppressed gene concentration , gene expression and gene expression in the acini .	T6	T37	17488480
NA	CHEMICAL	GENE-Y	3	41	To determine whether chemical itself provoked inflammation in acinar cells , the cells were treated with chemical donor drug , chemical ( chemical ) , ( 10 , 50 and 100 muM ) , that resulted in a significant increase in gene concentration and expression of gene and gene in acinar cells .	T8	T39	17488480
NA	CHEMICAL	GENE-Y	3	46	To determine whether chemical itself provoked inflammation in acinar cells , the cells were treated with chemical donor drug , chemical ( chemical ) , ( 10 , 50 and 100 muM ) , that resulted in a significant increase in gene concentration and expression of gene and gene in acinar cells .	T8	T40	17488480
NA	CHEMICAL	GENE-Y	3	48	To determine whether chemical itself provoked inflammation in acinar cells , the cells were treated with chemical donor drug , chemical ( chemical ) , ( 10 , 50 and 100 muM ) , that resulted in a significant increase in gene concentration and expression of gene and gene in acinar cells .	T8	T41	17488480
NA	CHEMICAL	GENE-Y	16	41	To determine whether chemical itself provoked inflammation in acinar cells , the cells were treated with chemical donor drug , chemical ( chemical ) , ( 10 , 50 and 100 muM ) , that resulted in a significant increase in gene concentration and expression of gene and gene in acinar cells .	T9	T39	17488480
NA	CHEMICAL	GENE-Y	16	46	To determine whether chemical itself provoked inflammation in acinar cells , the cells were treated with chemical donor drug , chemical ( chemical ) , ( 10 , 50 and 100 muM ) , that resulted in a significant increase in gene concentration and expression of gene and gene in acinar cells .	T9	T40	17488480
NA	CHEMICAL	GENE-Y	16	48	To determine whether chemical itself provoked inflammation in acinar cells , the cells were treated with chemical donor drug , chemical ( chemical ) , ( 10 , 50 and 100 muM ) , that resulted in a significant increase in gene concentration and expression of gene and gene in acinar cells .	T9	T41	17488480
CPR:3	CHEMICAL	GENE-Y	20	41	To determine whether chemical itself provoked inflammation in acinar cells , the cells were treated with chemical donor drug , chemical ( chemical ) , ( 10 , 50 and 100 muM ) , that resulted in a significant increase in gene concentration and expression of gene and gene in acinar cells .	T10	T39	17488480
CPR:3	CHEMICAL	GENE-Y	20	46	To determine whether chemical itself provoked inflammation in acinar cells , the cells were treated with chemical donor drug , chemical ( chemical ) , ( 10 , 50 and 100 muM ) , that resulted in a significant increase in gene concentration and expression of gene and gene in acinar cells .	T10	T40	17488480
CPR:3	CHEMICAL	GENE-Y	20	48	To determine whether chemical itself provoked inflammation in acinar cells , the cells were treated with chemical donor drug , chemical ( chemical ) , ( 10 , 50 and 100 muM ) , that resulted in a significant increase in gene concentration and expression of gene and gene in acinar cells .	T10	T41	17488480
CPR:3	CHEMICAL	GENE-Y	22	41	To determine whether chemical itself provoked inflammation in acinar cells , the cells were treated with chemical donor drug , chemical ( chemical ) , ( 10 , 50 and 100 muM ) , that resulted in a significant increase in gene concentration and expression of gene and gene in acinar cells .	T11	T39	17488480
CPR:3	CHEMICAL	GENE-Y	22	46	To determine whether chemical itself provoked inflammation in acinar cells , the cells were treated with chemical donor drug , chemical ( chemical ) , ( 10 , 50 and 100 muM ) , that resulted in a significant increase in gene concentration and expression of gene and gene in acinar cells .	T11	T40	17488480
CPR:3	CHEMICAL	GENE-Y	22	48	To determine whether chemical itself provoked inflammation in acinar cells , the cells were treated with chemical donor drug , chemical ( chemical ) , ( 10 , 50 and 100 muM ) , that resulted in a significant increase in gene concentration and expression of gene and gene in acinar cells .	T11	T41	17488480
CPR:6	CHEMICAL	GENE-Y	0	5	chemical , a potent chemical H1-receptor antagonist : effect in allergic rhinoconjunctivitis , on antigen and chemical induced skin weal responses and relationship to serum levels .	T9	T13	6146346
NA	CHEMICAL	GENE-Y	2	5	chemical , a potent chemical H1-receptor antagonist : effect in allergic rhinoconjunctivitis , on antigen and chemical induced skin weal responses and relationship to serum levels .	T11	T13	6146346
NA	CHEMICAL	GENE-Y	2	5	chemical , a potent chemical H1-receptor antagonist : effect in allergic rhinoconjunctivitis , on antigen and chemical induced skin weal responses and relationship to serum levels .	T10	T13	6146346
CPR:6	CHEMICAL	GENE-Y	3	13	The efficacy of chemical , a new , long acting , oral chemical H1-receptor antagonist was compared to placebo for the treatment of allergic rhinitis and conjunctivitis during the grass pollen season of 1982 .	T5	T12	6146346
NA	CHEMICAL	GENE-Y	5	13	The efficacy of chemical , a new , long acting , oral chemical H1-receptor antagonist was compared to placebo for the treatment of allergic rhinitis and conjunctivitis during the grass pollen season of 1982 .	T7	T12	6146346
NA	CHEMICAL	GENE-N	4	11	The inhibitory effects of chemical were correlated with the stimulation of gene since these inhibitory effects were significantly blocked in the presence of chemical and chemical respectively .	T17	T30	23435915
NA	CHEMICAL	GENE-N	19	11	The inhibitory effects of chemical were correlated with the stimulation of gene since these inhibitory effects were significantly blocked in the presence of chemical and chemical respectively .	T18	T30	23435915
NA	CHEMICAL	GENE-N	25	11	The inhibitory effects of chemical were correlated with the stimulation of gene since these inhibitory effects were significantly blocked in the presence of chemical and chemical respectively .	T19	T30	23435915
CPR:4	CHEMICAL	GENE-Y	0	2	chemical decreased gene ( gene ) protein contents and gene mRNA expression in IJS , and inhibited both phosphorylation and chemical-gene activity of purified myosin , implicating that the decrease of gene contents and inhibition of gene activity are involved in the chemical-induced inhibitory effects .	T4	T24	23435915
CPR:4	CHEMICAL	GENE-Y	0	4	chemical decreased gene ( gene ) protein contents and gene mRNA expression in IJS , and inhibited both phosphorylation and chemical-gene activity of purified myosin , implicating that the decrease of gene contents and inhibition of gene activity are involved in the chemical-induced inhibitory effects .	T4	T25	23435915
CPR:4	CHEMICAL	GENE-Y	0	9	chemical decreased gene ( gene ) protein contents and gene mRNA expression in IJS , and inhibited both phosphorylation and chemical-gene activity of purified myosin , implicating that the decrease of gene contents and inhibition of gene activity are involved in the chemical-induced inhibitory effects .	T4	T26	23435915
CPR:4	CHEMICAL	GENE-N	0	20	chemical decreased gene ( gene ) protein contents and gene mRNA expression in IJS , and inhibited both phosphorylation and chemical-gene activity of purified myosin , implicating that the decrease of gene contents and inhibition of gene activity are involved in the chemical-induced inhibitory effects .	T4	T27	23435915
NA	CHEMICAL	GENE-Y	0	31	chemical decreased gene ( gene ) protein contents and gene mRNA expression in IJS , and inhibited both phosphorylation and chemical-gene activity of purified myosin , implicating that the decrease of gene contents and inhibition of gene activity are involved in the chemical-induced inhibitory effects .	T4	T28	23435915
NA	CHEMICAL	GENE-Y	0	36	chemical decreased gene ( gene ) protein contents and gene mRNA expression in IJS , and inhibited both phosphorylation and chemical-gene activity of purified myosin , implicating that the decrease of gene contents and inhibition of gene activity are involved in the chemical-induced inhibitory effects .	T4	T29	23435915
NA	CHEMICAL	GENE-Y	3	2	chemical decreased gene ( gene ) protein contents and gene mRNA expression in IJS , and inhibited both phosphorylation and chemical-gene activity of purified myosin , implicating that the decrease of gene contents and inhibition of gene activity are involved in the chemical-induced inhibitory effects .	T5	T24	23435915
NA	CHEMICAL	GENE-Y	3	4	chemical decreased gene ( gene ) protein contents and gene mRNA expression in IJS , and inhibited both phosphorylation and chemical-gene activity of purified myosin , implicating that the decrease of gene contents and inhibition of gene activity are involved in the chemical-induced inhibitory effects .	T5	T25	23435915
NA	CHEMICAL	GENE-Y	3	9	chemical decreased gene ( gene ) protein contents and gene mRNA expression in IJS , and inhibited both phosphorylation and chemical-gene activity of purified myosin , implicating that the decrease of gene contents and inhibition of gene activity are involved in the chemical-induced inhibitory effects .	T5	T26	23435915
NA	CHEMICAL	GENE-N	3	20	chemical decreased gene ( gene ) protein contents and gene mRNA expression in IJS , and inhibited both phosphorylation and chemical-gene activity of purified myosin , implicating that the decrease of gene contents and inhibition of gene activity are involved in the chemical-induced inhibitory effects .	T5	T27	23435915
NA	CHEMICAL	GENE-Y	3	31	chemical decreased gene ( gene ) protein contents and gene mRNA expression in IJS , and inhibited both phosphorylation and chemical-gene activity of purified myosin , implicating that the decrease of gene contents and inhibition of gene activity are involved in the chemical-induced inhibitory effects .	T5	T28	23435915
NA	CHEMICAL	GENE-Y	3	36	chemical decreased gene ( gene ) protein contents and gene mRNA expression in IJS , and inhibited both phosphorylation and chemical-gene activity of purified myosin , implicating that the decrease of gene contents and inhibition of gene activity are involved in the chemical-induced inhibitory effects .	T5	T29	23435915
NA	CHEMICAL	GENE-Y	12	2	chemical decreased gene ( gene ) protein contents and gene mRNA expression in IJS , and inhibited both phosphorylation and chemical-gene activity of purified myosin , implicating that the decrease of gene contents and inhibition of gene activity are involved in the chemical-induced inhibitory effects .	T6	T24	23435915
NA	CHEMICAL	GENE-Y	12	4	chemical decreased gene ( gene ) protein contents and gene mRNA expression in IJS , and inhibited both phosphorylation and chemical-gene activity of purified myosin , implicating that the decrease of gene contents and inhibition of gene activity are involved in the chemical-induced inhibitory effects .	T6	T25	23435915
NA	CHEMICAL	GENE-Y	12	9	chemical decreased gene ( gene ) protein contents and gene mRNA expression in IJS , and inhibited both phosphorylation and chemical-gene activity of purified myosin , implicating that the decrease of gene contents and inhibition of gene activity are involved in the chemical-induced inhibitory effects .	T6	T26	23435915
NA	CHEMICAL	GENE-N	12	20	chemical decreased gene ( gene ) protein contents and gene mRNA expression in IJS , and inhibited both phosphorylation and chemical-gene activity of purified myosin , implicating that the decrease of gene contents and inhibition of gene activity are involved in the chemical-induced inhibitory effects .	T6	T27	23435915
CPR:4	CHEMICAL	GENE-Y	12	31	chemical decreased gene ( gene ) protein contents and gene mRNA expression in IJS , and inhibited both phosphorylation and chemical-gene activity of purified myosin , implicating that the decrease of gene contents and inhibition of gene activity are involved in the chemical-induced inhibitory effects .	T6	T28	23435915
CPR:4	CHEMICAL	GENE-Y	12	36	chemical decreased gene ( gene ) protein contents and gene mRNA expression in IJS , and inhibited both phosphorylation and chemical-gene activity of purified myosin , implicating that the decrease of gene contents and inhibition of gene activity are involved in the chemical-induced inhibitory effects .	T6	T29	23435915
NA	CHEMICAL	GENE-N	4	22	In animals , the chemical causes a significant reduction in intraocular pressure but had only 1/80 the activity of the S-enantiomer at gene .	T1	T11	8103526
NA	CHEMICAL	GENE-N	7	1	The gene blocking properties of orally administered chemical were compared in a double-blind placebo controlled trial in two groups of healthy men .	T2	T12	8103526
NA	CHEMICAL	GENE-N	11	4	Human platelets are shown to possess at least two high-affinity , chemical-preferring binding sites that are pharmacologically distinct from gene .	T32	T37	8263811
NA	CHEMICAL	GENE-N	6	10	These nonadrenergic sites were radiolabeled even in the presence of a 10 microM chemical mask of gene .	T24	T44	8263811
NA	CHEMICAL	GENE-Y	5	11	Affinities for the major nonadrenergic chemical binding site were highly comparable to gene sites in the brain stem ( rank order : chemical > chemical > chemical > chemical > chemical ) .	T2	T36	8263811
NA	CHEMICAL	GENE-Y	12	11	Affinities for the major nonadrenergic chemical binding site were highly comparable to gene sites in the brain stem ( rank order : chemical > chemical > chemical > chemical > chemical ) .	T3	T36	8263811
NA	CHEMICAL	GENE-Y	14	11	Affinities for the major nonadrenergic chemical binding site were highly comparable to gene sites in the brain stem ( rank order : chemical > chemical > chemical > chemical > chemical ) .	T4	T36	8263811
NA	CHEMICAL	GENE-Y	14	11	Affinities for the major nonadrenergic chemical binding site were highly comparable to gene sites in the brain stem ( rank order : chemical > chemical > chemical > chemical > chemical ) .	T5	T36	8263811
NA	CHEMICAL	GENE-Y	14	11	Affinities for the major nonadrenergic chemical binding site were highly comparable to gene sites in the brain stem ( rank order : chemical > chemical > chemical > chemical > chemical ) .	T6	T36	8263811
NA	CHEMICAL	GENE-Y	28	11	Affinities for the major nonadrenergic chemical binding site were highly comparable to gene sites in the brain stem ( rank order : chemical > chemical > chemical > chemical > chemical ) .	T7	T36	8263811
NA	CHEMICAL	GENE-Y	30	11	Affinities for the major nonadrenergic chemical binding site were highly comparable to gene sites in the brain stem ( rank order : chemical > chemical > chemical > chemical > chemical ) .	T8	T36	8263811
NA	CHEMICAL	GENE-N	11	17	Finally , a third nonadrenergic internal membrane site , labeled by chemical , was consistent with a gene site ( rank order : chemical > IDX > > chemical > chemical > chemical ) .	T11	T38	8263811
NA	CHEMICAL	GENE-N	2	17	Finally , a third nonadrenergic internal membrane site , labeled by chemical , was consistent with a gene site ( rank order : chemical > IDX > > chemical > chemical > chemical ) .	T12	T38	8263811
NA	CHEMICAL	GENE-N	2	17	Finally , a third nonadrenergic internal membrane site , labeled by chemical , was consistent with a gene site ( rank order : chemical > IDX > > chemical > chemical > chemical ) .	T13	T38	8263811
NA	CHEMICAL	GENE-N	2	17	Finally , a third nonadrenergic internal membrane site , labeled by chemical , was consistent with a gene site ( rank order : chemical > IDX > > chemical > chemical > chemical ) .	T14	T38	8263811
NA	CHEMICAL	GENE-N	30	17	Finally , a third nonadrenergic internal membrane site , labeled by chemical , was consistent with a gene site ( rank order : chemical > IDX > > chemical > chemical > chemical ) .	T15	T38	8263811
NA	CHEMICAL	GENE-N	32	17	Finally , a third nonadrenergic internal membrane site , labeled by chemical , was consistent with a gene site ( rank order : chemical > IDX > > chemical > chemical > chemical ) .	T16	T38	8263811
NA	CHEMICAL	GENE-N	16	14	Thus , based on differential subcellular distributions and affinity constants , human platelets appear to possess chemical receptors ( gene and subtype-I2 chemical receptor ) , plus a novel chemical-sensitive site , as well as an gene .	T17	T39	8263811
NA	CHEMICAL	GENE-Y	16	14	Thus , based on differential subcellular distributions and affinity constants , human platelets appear to possess chemical receptors ( gene and subtype-I2 chemical receptor ) , plus a novel chemical-sensitive site , as well as an gene .	T17	T40	8263811
NA	CHEMICAL	GENE-N	16	14	Thus , based on differential subcellular distributions and affinity constants , human platelets appear to possess chemical receptors ( gene and subtype-I2 chemical receptor ) , plus a novel chemical-sensitive site , as well as an gene .	T17	T41	8263811
NA	CHEMICAL	GENE-Y	16	14	Thus , based on differential subcellular distributions and affinity constants , human platelets appear to possess chemical receptors ( gene and subtype-I2 chemical receptor ) , plus a novel chemical-sensitive site , as well as an gene .	T17	T42	8263811
NA	CHEMICAL	GENE-N	18	14	Thus , based on differential subcellular distributions and affinity constants , human platelets appear to possess chemical receptors ( gene and subtype-I2 chemical receptor ) , plus a novel chemical-sensitive site , as well as an gene .	T18	T39	8263811
NA	CHEMICAL	GENE-Y	18	14	Thus , based on differential subcellular distributions and affinity constants , human platelets appear to possess chemical receptors ( gene and subtype-I2 chemical receptor ) , plus a novel chemical-sensitive site , as well as an gene .	T18	T40	8263811
NA	CHEMICAL	GENE-N	18	14	Thus , based on differential subcellular distributions and affinity constants , human platelets appear to possess chemical receptors ( gene and subtype-I2 chemical receptor ) , plus a novel chemical-sensitive site , as well as an gene .	T18	T41	8263811
NA	CHEMICAL	GENE-Y	18	14	Thus , based on differential subcellular distributions and affinity constants , human platelets appear to possess chemical receptors ( gene and subtype-I2 chemical receptor ) , plus a novel chemical-sensitive site , as well as an gene .	T18	T42	8263811
NA	CHEMICAL	GENE-N	18	14	Thus , based on differential subcellular distributions and affinity constants , human platelets appear to possess chemical receptors ( gene and subtype-I2 chemical receptor ) , plus a novel chemical-sensitive site , as well as an gene .	T19	T39	8263811
NA	CHEMICAL	GENE-Y	18	14	Thus , based on differential subcellular distributions and affinity constants , human platelets appear to possess chemical receptors ( gene and subtype-I2 chemical receptor ) , plus a novel chemical-sensitive site , as well as an gene .	T19	T40	8263811
NA	CHEMICAL	GENE-N	18	14	Thus , based on differential subcellular distributions and affinity constants , human platelets appear to possess chemical receptors ( gene and subtype-I2 chemical receptor ) , plus a novel chemical-sensitive site , as well as an gene .	T19	T41	8263811
NA	CHEMICAL	GENE-Y	18	14	Thus , based on differential subcellular distributions and affinity constants , human platelets appear to possess chemical receptors ( gene and subtype-I2 chemical receptor ) , plus a novel chemical-sensitive site , as well as an gene .	T19	T42	8263811
NA	CHEMICAL	GENE-N	27	14	Thus , based on differential subcellular distributions and affinity constants , human platelets appear to possess chemical receptors ( gene and subtype-I2 chemical receptor ) , plus a novel chemical-sensitive site , as well as an gene .	T20	T39	8263811
NA	CHEMICAL	GENE-Y	27	14	Thus , based on differential subcellular distributions and affinity constants , human platelets appear to possess chemical receptors ( gene and subtype-I2 chemical receptor ) , plus a novel chemical-sensitive site , as well as an gene .	T20	T40	8263811
NA	CHEMICAL	GENE-N	27	14	Thus , based on differential subcellular distributions and affinity constants , human platelets appear to possess chemical receptors ( gene and subtype-I2 chemical receptor ) , plus a novel chemical-sensitive site , as well as an gene .	T20	T41	8263811
NA	CHEMICAL	GENE-Y	27	14	Thus , based on differential subcellular distributions and affinity constants , human platelets appear to possess chemical receptors ( gene and subtype-I2 chemical receptor ) , plus a novel chemical-sensitive site , as well as an gene .	T20	T42	8263811
CPR:9	CHEMICAL	GENE-Y	8	1	The gene Allele Significantly Alters the N-demethylation of chemical Enantiomers In Vitro .	T12	T36	23550066
CPR:9	CHEMICAL	GENE-Y	0	8	chemical is primarily metabolized to chemical by hepatic gene and gene-mediated N-demethylation .	T1	T31	23550066
CPR:9	CHEMICAL	GENE-Y	0	10	chemical is primarily metabolized to chemical by hepatic gene and gene-mediated N-demethylation .	T1	T35	23550066
NA	CHEMICAL	GENE-Y	5	8	chemical is primarily metabolized to chemical by hepatic gene and gene-mediated N-demethylation .	T8	T31	23550066
NA	CHEMICAL	GENE-Y	5	10	chemical is primarily metabolized to chemical by hepatic gene and gene-mediated N-demethylation .	T8	T35	23550066
CPR:9	CHEMICAL	GENE-Y	17	1	The gene allele is associated with reduced enzyme expression and activity that may lead to interindividual variability in chemical metabolism .	T7	T25	23550066
CPR:9	CHEMICAL	GENE-Y	6	18	We examined the N-demethylation of individual chemical enantiomers using human liver microsomes ( HLMs ) genotyped for the gene allele , insect cell expressed recombinant gene and gene enzymes and COS-1 cell expressed recombinant gene and gene protein variant .	T9	T26	23550066
NA	CHEMICAL	GENE-Y	6	25	We examined the N-demethylation of individual chemical enantiomers using human liver microsomes ( HLMs ) genotyped for the gene allele , insect cell expressed recombinant gene and gene enzymes and COS-1 cell expressed recombinant gene and gene protein variant .	T9	T27	23550066
NA	CHEMICAL	GENE-Y	6	27	We examined the N-demethylation of individual chemical enantiomers using human liver microsomes ( HLMs ) genotyped for the gene allele , insect cell expressed recombinant gene and gene enzymes and COS-1 cell expressed recombinant gene and gene protein variant .	T9	T28	23550066
NA	CHEMICAL	GENE-Y	6	34	We examined the N-demethylation of individual chemical enantiomers using human liver microsomes ( HLMs ) genotyped for the gene allele , insect cell expressed recombinant gene and gene enzymes and COS-1 cell expressed recombinant gene and gene protein variant .	T9	T29	23550066
NA	CHEMICAL	GENE-Y	6	36	We examined the N-demethylation of individual chemical enantiomers using human liver microsomes ( HLMs ) genotyped for the gene allele , insect cell expressed recombinant gene and gene enzymes and COS-1 cell expressed recombinant gene and gene protein variant .	T9	T30	23550066
NA	CHEMICAL	GENE-N	5	2	Effects of gene-selective inhibitors on chemical formation were also determined in HLMs .	T10	T32	23550066
CPR:9	CHEMICAL	GENE-Y	5	15	The intrinsic clearance for both chemical enantiomers by the high affinity enzyme in HLMs with gene/*1 genotype were at least 2-fold and 6-fold higher , respectively , than those for gene/*6 genotype and gene/*6 genotype .	T11	T13	23550066
NA	CHEMICAL	GENE-Y	5	30	The intrinsic clearance for both chemical enantiomers by the high affinity enzyme in HLMs with gene/*1 genotype were at least 2-fold and 6-fold higher , respectively , than those for gene/*6 genotype and gene/*6 genotype .	T11	T14	23550066
NA	CHEMICAL	GENE-Y	5	33	The intrinsic clearance for both chemical enantiomers by the high affinity enzyme in HLMs with gene/*1 genotype were at least 2-fold and 6-fold higher , respectively , than those for gene/*6 genotype and gene/*6 genotype .	T11	T15	23550066
CPR:4	CHEMICAL	GENE-Y	0	2	chemical ( gene inhibitor , 25 μM ) and the monoclonal antibody against gene but not chemical ( gene inhibitor , 25 μM ) or the monoclonal antibody against gene inhibited chemical N-demethylation at clinically relevant concentrations .	T2	T18	23550066
NA	CHEMICAL	GENE-Y	0	13	chemical ( gene inhibitor , 25 μM ) and the monoclonal antibody against gene but not chemical ( gene inhibitor , 25 μM ) or the monoclonal antibody against gene inhibited chemical N-demethylation at clinically relevant concentrations .	T2	T19	23550066
NA	CHEMICAL	GENE-Y	0	18	chemical ( gene inhibitor , 25 μM ) and the monoclonal antibody against gene but not chemical ( gene inhibitor , 25 μM ) or the monoclonal antibody against gene inhibited chemical N-demethylation at clinically relevant concentrations .	T2	T20	23550066
NA	CHEMICAL	GENE-Y	0	29	chemical ( gene inhibitor , 25 μM ) and the monoclonal antibody against gene but not chemical ( gene inhibitor , 25 μM ) or the monoclonal antibody against gene inhibited chemical N-demethylation at clinically relevant concentrations .	T2	T21	23550066
NA	CHEMICAL	GENE-Y	8	2	chemical ( gene inhibitor , 25 μM ) and the monoclonal antibody against gene but not chemical ( gene inhibitor , 25 μM ) or the monoclonal antibody against gene inhibited chemical N-demethylation at clinically relevant concentrations .	T3	T18	23550066
NA	CHEMICAL	GENE-Y	8	13	chemical ( gene inhibitor , 25 μM ) and the monoclonal antibody against gene but not chemical ( gene inhibitor , 25 μM ) or the monoclonal antibody against gene inhibited chemical N-demethylation at clinically relevant concentrations .	T3	T19	23550066
CPR:4	CHEMICAL	GENE-Y	8	18	chemical ( gene inhibitor , 25 μM ) and the monoclonal antibody against gene but not chemical ( gene inhibitor , 25 μM ) or the monoclonal antibody against gene inhibited chemical N-demethylation at clinically relevant concentrations .	T3	T20	23550066
NA	CHEMICAL	GENE-Y	8	29	chemical ( gene inhibitor , 25 μM ) and the monoclonal antibody against gene but not chemical ( gene inhibitor , 25 μM ) or the monoclonal antibody against gene inhibited chemical N-demethylation at clinically relevant concentrations .	T3	T21	23550066
NA	CHEMICAL	GENE-Y	31	2	chemical ( gene inhibitor , 25 μM ) and the monoclonal antibody against gene but not chemical ( gene inhibitor , 25 μM ) or the monoclonal antibody against gene inhibited chemical N-demethylation at clinically relevant concentrations .	T4	T18	23550066
NA	CHEMICAL	GENE-Y	31	13	chemical ( gene inhibitor , 25 μM ) and the monoclonal antibody against gene but not chemical ( gene inhibitor , 25 μM ) or the monoclonal antibody against gene inhibited chemical N-demethylation at clinically relevant concentrations .	T4	T19	23550066
NA	CHEMICAL	GENE-Y	31	18	chemical ( gene inhibitor , 25 μM ) and the monoclonal antibody against gene but not chemical ( gene inhibitor , 25 μM ) or the monoclonal antibody against gene inhibited chemical N-demethylation at clinically relevant concentrations .	T4	T20	23550066
NA	CHEMICAL	GENE-Y	31	29	chemical ( gene inhibitor , 25 μM ) and the monoclonal antibody against gene but not chemical ( gene inhibitor , 25 μM ) or the monoclonal antibody against gene inhibited chemical N-demethylation at clinically relevant concentrations .	T4	T21	23550066
NA	CHEMICAL	GENE-Y	23	14	In approximately 20 % of the cases BrS is caused by mutations in the gene gene on chromosome 3p21-23 , encoding the cardiac chemical channel , a protein involved in the control of myocardial excitability .	T1	T4	16972995
NA	CHEMICAL	GENE-N	23	24	In approximately 20 % of the cases BrS is caused by mutations in the gene gene on chromosome 3p21-23 , encoding the cardiac chemical channel , a protein involved in the control of myocardial excitability .	T1	T3	16972995
NA	CHEMICAL	GENE-Y	0	2	chemical D2 receptor occupancy by chemical : implications for the timing and magnitude of clinical response .	T7	T12	17059881
NA	CHEMICAL	GENE-Y	5	2	chemical D2 receptor occupancy by chemical : implications for the timing and magnitude of clinical response .	T8	T12	17059881
NA	CHEMICAL	GENE-Y	9	6	The objective of the study is to investigate whether chemical D2 receptor occupancy by chemical and plasma levels over time can account for therapeutic efficacy and the latency period to response .	T5	T9	17059881
NA	CHEMICAL	GENE-Y	5	6	The objective of the study is to investigate whether chemical D2 receptor occupancy by chemical and plasma levels over time can account for therapeutic efficacy and the latency period to response .	T6	T9	17059881
NA	CHEMICAL	GENE-Y	24	1	Truncated gene receptor ( gene ) is regulated by gene through heterodimer formation with gene yet remains sensitive to the dual gene/gene kinase inhibitor chemical .	T7	T46	14737100
NA	CHEMICAL	GENE-Y	24	4	Truncated gene receptor ( gene ) is regulated by gene through heterodimer formation with gene yet remains sensitive to the dual gene/gene kinase inhibitor chemical .	T7	T49	14737100
NA	CHEMICAL	GENE-Y	24	9	Truncated gene receptor ( gene ) is regulated by gene through heterodimer formation with gene yet remains sensitive to the dual gene/gene kinase inhibitor chemical .	T7	T50	14737100
NA	CHEMICAL	GENE-Y	24	14	Truncated gene receptor ( gene ) is regulated by gene through heterodimer formation with gene yet remains sensitive to the dual gene/gene kinase inhibitor chemical .	T7	T51	14737100
NA	CHEMICAL	GENE-Y	24	21	Truncated gene receptor ( gene ) is regulated by gene through heterodimer formation with gene yet remains sensitive to the dual gene/gene kinase inhibitor chemical .	T7	T47	14737100
CPR:4	CHEMICAL	GENE-Y	24	21	Truncated gene receptor ( gene ) is regulated by gene through heterodimer formation with gene yet remains sensitive to the dual gene/gene kinase inhibitor chemical .	T7	T48	14737100
NA	CHEMICAL	GENE-Y	4	7	The expression of the chemical terminally truncated gene receptor ( gene ) in breast cancer correlates with metastatic disease progression compared with the expression of full-length gene .	T3	T28	14737100
NA	CHEMICAL	GENE-Y	4	10	The expression of the chemical terminally truncated gene receptor ( gene ) in breast cancer correlates with metastatic disease progression compared with the expression of full-length gene .	T3	T35	14737100
NA	CHEMICAL	GENE-Y	4	26	The expression of the chemical terminally truncated gene receptor ( gene ) in breast cancer correlates with metastatic disease progression compared with the expression of full-length gene .	T3	T16	14737100
CPR:4	CHEMICAL	GENE-Y	0	8	chemical , a reversible small molecule inhibitor of gene and gene chemical kinases , inhibits baseline gene phosphorylation in BT474 cells and tumor xenografts .	T4	T32	14737100
CPR:4	CHEMICAL	GENE-Y	0	10	chemical , a reversible small molecule inhibitor of gene and gene chemical kinases , inhibits baseline gene phosphorylation in BT474 cells and tumor xenografts .	T4	T33	14737100
CPR:4	CHEMICAL	GENE-N	0	2	chemical , a reversible small molecule inhibitor of gene and gene chemical kinases , inhibits baseline gene phosphorylation in BT474 cells and tumor xenografts .	T4	T34	14737100
CPR:4	CHEMICAL	GENE-Y	0	16	chemical , a reversible small molecule inhibitor of gene and gene chemical kinases , inhibits baseline gene phosphorylation in BT474 cells and tumor xenografts .	T4	T36	14737100
NA	CHEMICAL	GENE-Y	11	8	chemical , a reversible small molecule inhibitor of gene and gene chemical kinases , inhibits baseline gene phosphorylation in BT474 cells and tumor xenografts .	T5	T32	14737100
NA	CHEMICAL	GENE-Y	11	10	chemical , a reversible small molecule inhibitor of gene and gene chemical kinases , inhibits baseline gene phosphorylation in BT474 cells and tumor xenografts .	T5	T33	14737100
NA	CHEMICAL	GENE-N	11	2	chemical , a reversible small molecule inhibitor of gene and gene chemical kinases , inhibits baseline gene phosphorylation in BT474 cells and tumor xenografts .	T5	T34	14737100
NA	CHEMICAL	GENE-Y	11	16	chemical , a reversible small molecule inhibitor of gene and gene chemical kinases , inhibits baseline gene phosphorylation in BT474 cells and tumor xenografts .	T5	T36	14737100
CPR:4	CHEMICAL	GENE-Y	10	2	Inhibition of gene , gene , and gene phosphorylation by chemical resulted in the inhibition of downstream phospho-gene , phospho-gene , and gene steady-state protein levels .	T6	T37	14737100
CPR:4	CHEMICAL	GENE-Y	10	4	Inhibition of gene , gene , and gene phosphorylation by chemical resulted in the inhibition of downstream phospho-gene , phospho-gene , and gene steady-state protein levels .	T6	T38	14737100
CPR:4	CHEMICAL	GENE-Y	10	7	Inhibition of gene , gene , and gene phosphorylation by chemical resulted in the inhibition of downstream phospho-gene , phospho-gene , and gene steady-state protein levels .	T6	T39	14737100
CPR:4	CHEMICAL	GENE-N	10	17	Inhibition of gene , gene , and gene phosphorylation by chemical resulted in the inhibition of downstream phospho-gene , phospho-gene , and gene steady-state protein levels .	T6	T40	14737100
CPR:4	CHEMICAL	GENE-N	10	19	Inhibition of gene , gene , and gene phosphorylation by chemical resulted in the inhibition of downstream phospho-gene , phospho-gene , and gene steady-state protein levels .	T6	T41	14737100
CPR:4	CHEMICAL	GENE-N	10	22	Inhibition of gene , gene , and gene phosphorylation by chemical resulted in the inhibition of downstream phospho-gene , phospho-gene , and gene steady-state protein levels .	T6	T42	14737100
CPR:4	CHEMICAL	GENE-Y	16	3	Increased phosphorylation of gene and gene in response to gene was abrogated to varying degrees by chemical .	T1	T43	14737100
CPR:4	CHEMICAL	GENE-N	16	5	Increased phosphorylation of gene and gene in response to gene was abrogated to varying degrees by chemical .	T1	T44	14737100
NA	CHEMICAL	GENE-N	16	9	Increased phosphorylation of gene and gene in response to gene was abrogated to varying degrees by chemical .	T1	T45	14737100
NA	CHEMICAL	GENE-Y	3	4	Functional analyses of chemical-tRNA synthetase mutations suggest a key role for gene in peripheral axons .	T6	T21	17035524
NA	CHEMICAL	GENE-N	3	11	Functional analyses of chemical-tRNA synthetase mutations suggest a key role for gene in peripheral axons .	T6	T22	17035524
NA	CHEMICAL	GENE-Y	8	5	We previously implicated mutations in the gene encoding chemical-tRNA synthetase ( gene ) as the cause of CMT2D and dSMA-V .	T2	T12	17035524
NA	CHEMICAL	GENE-Y	8	11	We previously implicated mutations in the gene encoding chemical-tRNA synthetase ( gene ) as the cause of CMT2D and dSMA-V .	T2	T13	17035524
NA	CHEMICAL	GENE-Y	2	0	gene is a member of the family of chemical-tRNA synthetases responsible for charging tRNA with cognate chemical ; gene ligates chemical to tRNA ( Gly ) .	T3	T14	17035524
NA	CHEMICAL	GENE-N	2	2	gene is a member of the family of chemical-tRNA synthetases responsible for charging tRNA with cognate chemical ; gene ligates chemical to tRNA ( Gly ) .	T3	T15	17035524
NA	CHEMICAL	GENE-Y	2	18	gene is a member of the family of chemical-tRNA synthetases responsible for charging tRNA with cognate chemical ; gene ligates chemical to tRNA ( Gly ) .	T3	T16	17035524
NA	CHEMICAL	GENE-Y	2	0	gene is a member of the family of chemical-tRNA synthetases responsible for charging tRNA with cognate chemical ; gene ligates chemical to tRNA ( Gly ) .	T4	T14	17035524
NA	CHEMICAL	GENE-N	2	2	gene is a member of the family of chemical-tRNA synthetases responsible for charging tRNA with cognate chemical ; gene ligates chemical to tRNA ( Gly ) .	T4	T15	17035524
NA	CHEMICAL	GENE-Y	2	18	gene is a member of the family of chemical-tRNA synthetases responsible for charging tRNA with cognate chemical ; gene ligates chemical to tRNA ( Gly ) .	T4	T16	17035524
NA	CHEMICAL	GENE-Y	20	0	gene is a member of the family of chemical-tRNA synthetases responsible for charging tRNA with cognate chemical ; gene ligates chemical to tRNA ( Gly ) .	T5	T14	17035524
NA	CHEMICAL	GENE-N	20	2	gene is a member of the family of chemical-tRNA synthetases responsible for charging tRNA with cognate chemical ; gene ligates chemical to tRNA ( Gly ) .	T5	T15	17035524
NA	CHEMICAL	GENE-Y	20	18	gene is a member of the family of chemical-tRNA synthetases responsible for charging tRNA with cognate chemical ; gene ligates chemical to tRNA ( Gly ) .	T5	T16	17035524
NA	CHEMICAL	GENE-N	21	8	These data are particularly important in light of the recent identification of CMT-associated mutations in another gene gene [ gene ( chemical-tRNA synthetase gene ) ] .	T1	T8	17035524
NA	CHEMICAL	GENE-Y	21	19	These data are particularly important in light of the recent identification of CMT-associated mutations in another gene gene [ gene ( chemical-tRNA synthetase gene ) ] .	T1	T9	17035524
NA	CHEMICAL	GENE-Y	21	8	These data are particularly important in light of the recent identification of CMT-associated mutations in another gene gene [ gene ( chemical-tRNA synthetase gene ) ] .	T1	T10	17035524
NA	CHEMICAL	GENE-N	6	7	Heterogeneous expression and polymorphic genotype of chemical S-transferases in human lung .	T3	T25	7974294
NA	CHEMICAL	GENE-N	2	3	BACKGROUND : chemical S-transferases ( gene ) are involved in the detoxification of xenobiotics by conjugation with chemical .	T2	T9	7974294
NA	CHEMICAL	GENE-N	2	5	BACKGROUND : chemical S-transferases ( gene ) are involved in the detoxification of xenobiotics by conjugation with chemical .	T2	T21	7974294
NA	CHEMICAL	GENE-N	17	3	BACKGROUND : chemical S-transferases ( gene ) are involved in the detoxification of xenobiotics by conjugation with chemical .	T1	T9	7974294
NA	CHEMICAL	GENE-N	17	5	BACKGROUND : chemical S-transferases ( gene ) are involved in the detoxification of xenobiotics by conjugation with chemical .	T1	T21	7974294
NA	CHEMICAL	GENE-Y	0	7	chemical , which has high affinity for gene and gene subtypes but not for gene , shows efficacy similar to the nonsubtype selective agents chemical and chemical .	T1	T6	14767264
NA	CHEMICAL	GENE-Y	0	9	chemical , which has high affinity for gene and gene subtypes but not for gene , shows efficacy similar to the nonsubtype selective agents chemical and chemical .	T1	T7	14767264
NA	CHEMICAL	GENE-Y	0	14	chemical , which has high affinity for gene and gene subtypes but not for gene , shows efficacy similar to the nonsubtype selective agents chemical and chemical .	T1	T8	14767264
NA	CHEMICAL	GENE-Y	24	7	chemical , which has high affinity for gene and gene subtypes but not for gene , shows efficacy similar to the nonsubtype selective agents chemical and chemical .	T2	T6	14767264
NA	CHEMICAL	GENE-Y	24	9	chemical , which has high affinity for gene and gene subtypes but not for gene , shows efficacy similar to the nonsubtype selective agents chemical and chemical .	T2	T7	14767264
NA	CHEMICAL	GENE-Y	24	14	chemical , which has high affinity for gene and gene subtypes but not for gene , shows efficacy similar to the nonsubtype selective agents chemical and chemical .	T2	T8	14767264
NA	CHEMICAL	GENE-Y	26	7	chemical , which has high affinity for gene and gene subtypes but not for gene , shows efficacy similar to the nonsubtype selective agents chemical and chemical .	T3	T6	14767264
NA	CHEMICAL	GENE-Y	26	9	chemical , which has high affinity for gene and gene subtypes but not for gene , shows efficacy similar to the nonsubtype selective agents chemical and chemical .	T3	T7	14767264
NA	CHEMICAL	GENE-Y	26	14	chemical , which has high affinity for gene and gene subtypes but not for gene , shows efficacy similar to the nonsubtype selective agents chemical and chemical .	T3	T8	14767264
CPR:4	CHEMICAL	GENE-N	5	3	Reversible inhibition of gene by chemical .	T36	T53	23386702
CPR:9	CHEMICAL	GENE-N	2	0	gene hydrolyze chemical , chemical , and chemical to produce chemical and resulting chemical , chemical , and chemical , respectively .	T21	T37	23386702
CPR:9	CHEMICAL	GENE-N	4	0	gene hydrolyze chemical , chemical , and chemical to produce chemical and resulting chemical , chemical , and chemical , respectively .	T24	T37	23386702
CPR:9	CHEMICAL	GENE-N	7	0	gene hydrolyze chemical , chemical , and chemical to produce chemical and resulting chemical , chemical , and chemical , respectively .	T27	T37	23386702
CPR:9	CHEMICAL	GENE-N	10	0	gene hydrolyze chemical , chemical , and chemical to produce chemical and resulting chemical , chemical , and chemical , respectively .	T30	T37	23386702
CPR:9	CHEMICAL	GENE-N	13	0	gene hydrolyze chemical , chemical , and chemical to produce chemical and resulting chemical , chemical , and chemical , respectively .	T1	T37	23386702
CPR:9	CHEMICAL	GENE-N	15	0	gene hydrolyze chemical , chemical , and chemical to produce chemical and resulting chemical , chemical , and chemical , respectively .	T5	T37	23386702
CPR:9	CHEMICAL	GENE-N	18	0	gene hydrolyze chemical , chemical , and chemical to produce chemical and resulting chemical , chemical , and chemical , respectively .	T8	T37	23386702
NA	CHEMICAL	GENE-N	0	1	chemical- glucuronosyltransferases are colocalized with gene and have the potential to further metabolize chemical to chemical , but it is currently unknown if chemical , being chemical , also interact with gene .	T14	T39	23386702
NA	CHEMICAL	GENE-N	0	5	chemical- glucuronosyltransferases are colocalized with gene and have the potential to further metabolize chemical to chemical , but it is currently unknown if chemical , being chemical , also interact with gene .	T14	T46	23386702
NA	CHEMICAL	GENE-N	0	31	chemical- glucuronosyltransferases are colocalized with gene and have the potential to further metabolize chemical to chemical , but it is currently unknown if chemical , being chemical , also interact with gene .	T14	T47	23386702
CPR:9	CHEMICAL	GENE-N	13	1	chemical- glucuronosyltransferases are colocalized with gene and have the potential to further metabolize chemical to chemical , but it is currently unknown if chemical , being chemical , also interact with gene .	T20	T39	23386702
CPR:9	CHEMICAL	GENE-N	13	5	chemical- glucuronosyltransferases are colocalized with gene and have the potential to further metabolize chemical to chemical , but it is currently unknown if chemical , being chemical , also interact with gene .	T20	T46	23386702
NA	CHEMICAL	GENE-N	13	31	chemical- glucuronosyltransferases are colocalized with gene and have the potential to further metabolize chemical to chemical , but it is currently unknown if chemical , being chemical , also interact with gene .	T20	T47	23386702
CPR:9	CHEMICAL	GENE-N	15	1	chemical- glucuronosyltransferases are colocalized with gene and have the potential to further metabolize chemical to chemical , but it is currently unknown if chemical , being chemical , also interact with gene .	T22	T39	23386702
CPR:9	CHEMICAL	GENE-N	15	5	chemical- glucuronosyltransferases are colocalized with gene and have the potential to further metabolize chemical to chemical , but it is currently unknown if chemical , being chemical , also interact with gene .	T22	T46	23386702
NA	CHEMICAL	GENE-N	15	31	chemical- glucuronosyltransferases are colocalized with gene and have the potential to further metabolize chemical to chemical , but it is currently unknown if chemical , being chemical , also interact with gene .	T22	T47	23386702
CPR:9	CHEMICAL	GENE-N	23	1	chemical- glucuronosyltransferases are colocalized with gene and have the potential to further metabolize chemical to chemical , but it is currently unknown if chemical , being chemical , also interact with gene .	T23	T39	23386702
NA	CHEMICAL	GENE-N	23	5	chemical- glucuronosyltransferases are colocalized with gene and have the potential to further metabolize chemical to chemical , but it is currently unknown if chemical , being chemical , also interact with gene .	T23	T46	23386702
NA	CHEMICAL	GENE-N	23	31	chemical- glucuronosyltransferases are colocalized with gene and have the potential to further metabolize chemical to chemical , but it is currently unknown if chemical , being chemical , also interact with gene .	T23	T47	23386702
NA	CHEMICAL	GENE-N	26	1	chemical- glucuronosyltransferases are colocalized with gene and have the potential to further metabolize chemical to chemical , but it is currently unknown if chemical , being chemical , also interact with gene .	T25	T39	23386702
NA	CHEMICAL	GENE-N	26	5	chemical- glucuronosyltransferases are colocalized with gene and have the potential to further metabolize chemical to chemical , but it is currently unknown if chemical , being chemical , also interact with gene .	T25	T46	23386702
NA	CHEMICAL	GENE-N	26	31	chemical- glucuronosyltransferases are colocalized with gene and have the potential to further metabolize chemical to chemical , but it is currently unknown if chemical , being chemical , also interact with gene .	T25	T47	23386702
CPR:9	CHEMICAL	GENE-Y	8	16	Objective : This study explores the ability of chemical to act as substrates or inhibitors of gene ( gene ) and 2 ( gene ) .	T26	T48	23386702
CPR:9	CHEMICAL	GENE-Y	8	18	Objective : This study explores the ability of chemical to act as substrates or inhibitors of gene ( gene ) and 2 ( gene ) .	T26	T49	23386702
CPR:9	CHEMICAL	GENE-Y	8	21	Objective : This study explores the ability of chemical to act as substrates or inhibitors of gene ( gene ) and 2 ( gene ) .	T26	T50	23386702
CPR:9	CHEMICAL	GENE-Y	6	11	Methods : The stability of six chemical in the presence of gene , gene , and buffer alone ( 100 mM chemical , pH 7.4 , 37°C ) were investigated .	T28	T51	23386702
CPR:9	CHEMICAL	GENE-Y	6	13	Methods : The stability of six chemical in the presence of gene , gene , and buffer alone ( 100 mM chemical , pH 7.4 , 37°C ) were investigated .	T28	T52	23386702
NA	CHEMICAL	GENE-Y	21	11	Methods : The stability of six chemical in the presence of gene , gene , and buffer alone ( 100 mM chemical , pH 7.4 , 37°C ) were investigated .	T29	T51	23386702
NA	CHEMICAL	GENE-Y	21	13	Methods : The stability of six chemical in the presence of gene , gene , and buffer alone ( 100 mM chemical , pH 7.4 , 37°C ) were investigated .	T29	T52	23386702
CPR:4	CHEMICAL	GENE-Y	0	12	chemical , chemical , chemical , chemical , and chemical selectively inhibited gene , with Ki values of 4.32 ± 0.47 , 24.8 ± 4.2 , 355 ± 38 , 468 ± 21 , 707 ± 64 µM , respectively , but did not significantly inhibit gene .	T9	T38	23386702
NA	CHEMICAL	GENE-Y	0	46	chemical , chemical , chemical , chemical , and chemical selectively inhibited gene , with Ki values of 4.32 ± 0.47 , 24.8 ± 4.2 , 355 ± 38 , 468 ± 21 , 707 ± 64 µM , respectively , but did not significantly inhibit gene .	T9	T40	23386702
CPR:4	CHEMICAL	GENE-Y	2	12	chemical , chemical , chemical , chemical , and chemical selectively inhibited gene , with Ki values of 4.32 ± 0.47 , 24.8 ± 4.2 , 355 ± 38 , 468 ± 21 , 707 ± 64 µM , respectively , but did not significantly inhibit gene .	T10	T38	23386702
NA	CHEMICAL	GENE-Y	2	46	chemical , chemical , chemical , chemical , and chemical selectively inhibited gene , with Ki values of 4.32 ± 0.47 , 24.8 ± 4.2 , 355 ± 38 , 468 ± 21 , 707 ± 64 µM , respectively , but did not significantly inhibit gene .	T10	T40	23386702
CPR:4	CHEMICAL	GENE-Y	4	12	chemical , chemical , chemical , chemical , and chemical selectively inhibited gene , with Ki values of 4.32 ± 0.47 , 24.8 ± 4.2 , 355 ± 38 , 468 ± 21 , 707 ± 64 µM , respectively , but did not significantly inhibit gene .	T11	T38	23386702
NA	CHEMICAL	GENE-Y	4	46	chemical , chemical , chemical , chemical , and chemical selectively inhibited gene , with Ki values of 4.32 ± 0.47 , 24.8 ± 4.2 , 355 ± 38 , 468 ± 21 , 707 ± 64 µM , respectively , but did not significantly inhibit gene .	T11	T40	23386702
CPR:4	CHEMICAL	GENE-Y	6	12	chemical , chemical , chemical , chemical , and chemical selectively inhibited gene , with Ki values of 4.32 ± 0.47 , 24.8 ± 4.2 , 355 ± 38 , 468 ± 21 , 707 ± 64 µM , respectively , but did not significantly inhibit gene .	T12	T38	23386702
NA	CHEMICAL	GENE-Y	6	46	chemical , chemical , chemical , chemical , and chemical selectively inhibited gene , with Ki values of 4.32 ± 0.47 , 24.8 ± 4.2 , 355 ± 38 , 468 ± 21 , 707 ± 64 µM , respectively , but did not significantly inhibit gene .	T12	T40	23386702
CPR:4	CHEMICAL	GENE-Y	9	12	chemical , chemical , chemical , chemical , and chemical selectively inhibited gene , with Ki values of 4.32 ± 0.47 , 24.8 ± 4.2 , 355 ± 38 , 468 ± 21 , 707 ± 64 µM , respectively , but did not significantly inhibit gene .	T13	T38	23386702
NA	CHEMICAL	GENE-Y	9	46	chemical , chemical , chemical , chemical , and chemical selectively inhibited gene , with Ki values of 4.32 ± 0.47 , 24.8 ± 4.2 , 355 ± 38 , 468 ± 21 , 707 ± 64 µM , respectively , but did not significantly inhibit gene .	T13	T40	23386702
NA	CHEMICAL	GENE-N	0	7	chemical and chemical did not inhibit either gene .	T15	T41	23386702
NA	CHEMICAL	GENE-N	2	7	chemical and chemical did not inhibit either gene .	T16	T41	23386702
NA	CHEMICAL	GENE-Y	2	3	Time-dependent inactivation of gene by chemical was not observed .	T17	T42	23386702
NA	CHEMICAL	GENE-Y	15	3	Lastly , both gene and gene were shown not to catalyze the hydrolysis of the chemical studied .	T18	T43	23386702
NA	CHEMICAL	GENE-Y	15	5	Lastly , both gene and gene were shown not to catalyze the hydrolysis of the chemical studied .	T18	T44	23386702
NA	CHEMICAL	GENE-N	8	2	In vivo gene-mediated reductive carboxylation is regulated by chemical levels and sensitizes gene-deficient cells to chemical deprivation .	T12	T26	23473032
NA	CHEMICAL	GENE-Y	8	12	In vivo gene-mediated reductive carboxylation is regulated by chemical levels and sensitizes gene-deficient cells to chemical deprivation .	T12	T27	23473032
NA	CHEMICAL	GENE-N	15	2	In vivo gene-mediated reductive carboxylation is regulated by chemical levels and sensitizes gene-deficient cells to chemical deprivation .	T11	T26	23473032
NA	CHEMICAL	GENE-Y	15	12	In vivo gene-mediated reductive carboxylation is regulated by chemical levels and sensitizes gene-deficient cells to chemical deprivation .	T11	T27	23473032
NA	CHEMICAL	GENE-Y	5	2	Hypoxic and gene-deficient cells use chemical to generate chemical and lipids through reductive carboxylation ( RC ) of chemical .	T2	T13	23473032
NA	CHEMICAL	GENE-Y	8	2	Hypoxic and gene-deficient cells use chemical to generate chemical and lipids through reductive carboxylation ( RC ) of chemical .	T7	T13	23473032
NA	CHEMICAL	GENE-Y	2	2	Hypoxic and gene-deficient cells use chemical to generate chemical and lipids through reductive carboxylation ( RC ) of chemical .	T1	T13	23473032
NA	CHEMICAL	GENE-N	5	0	gene expression drastically reduced intracellular chemical levels .	T3	T17	23473032
NA	CHEMICAL	GENE-Y	5	1	Feeding gene-deficient RCC cells with chemical or chemical or knocking down gene and gene restored chemical levels and suppressed RC .	T4	T18	23473032
NA	CHEMICAL	GENE-Y	5	11	Feeding gene-deficient RCC cells with chemical or chemical or knocking down gene and gene restored chemical levels and suppressed RC .	T4	T19	23473032
NA	CHEMICAL	GENE-Y	5	13	Feeding gene-deficient RCC cells with chemical or chemical or knocking down gene and gene restored chemical levels and suppressed RC .	T4	T20	23473032
NA	CHEMICAL	GENE-Y	7	1	Feeding gene-deficient RCC cells with chemical or chemical or knocking down gene and gene restored chemical levels and suppressed RC .	T5	T18	23473032
NA	CHEMICAL	GENE-Y	7	11	Feeding gene-deficient RCC cells with chemical or chemical or knocking down gene and gene restored chemical levels and suppressed RC .	T5	T19	23473032
NA	CHEMICAL	GENE-Y	7	13	Feeding gene-deficient RCC cells with chemical or chemical or knocking down gene and gene restored chemical levels and suppressed RC .	T5	T20	23473032
NA	CHEMICAL	GENE-Y	15	1	Feeding gene-deficient RCC cells with chemical or chemical or knocking down gene and gene restored chemical levels and suppressed RC .	T6	T18	23473032
NA	CHEMICAL	GENE-Y	15	11	Feeding gene-deficient RCC cells with chemical or chemical or knocking down gene and gene restored chemical levels and suppressed RC .	T6	T19	23473032
NA	CHEMICAL	GENE-Y	15	13	Feeding gene-deficient RCC cells with chemical or chemical or knocking down gene and gene restored chemical levels and suppressed RC .	T6	T20	23473032
NA	CHEMICAL	GENE-N	7	4	These data suggest that gene-induced low intracellular chemical levels promote the reductive flux by mass action to maintain lipogenesis .	T8	T21	23473032
NA	CHEMICAL	GENE-Y	1	10	Using chemical , we demonstrated in vivo RC activity in gene-deficient tumors growing as xenografts in mice .	T9	T22	23473032
NA	CHEMICAL	GENE-N	3	3	During early pregnancy in sheep , the elongating conceptus secretes gene ( gene ) and the conceptus as well as endometrial epithelia produce chemical ( PG ) via gene ( gene ) and chemical via chemical ( 11-β ) dehydrogenase 1 ( gene ) .	T3	T37	23264615
NA	CHEMICAL	GENE-N	3	12	During early pregnancy in sheep , the elongating conceptus secretes gene ( gene ) and the conceptus as well as endometrial epithelia produce chemical ( PG ) via gene ( gene ) and chemical via chemical ( 11-β ) dehydrogenase 1 ( gene ) .	T3	T39	23264615
CPR:9	CHEMICAL	GENE-Y	3	28	During early pregnancy in sheep , the elongating conceptus secretes gene ( gene ) and the conceptus as well as endometrial epithelia produce chemical ( PG ) via gene ( gene ) and chemical via chemical ( 11-β ) dehydrogenase 1 ( gene ) .	T3	T29	23264615
CPR:9	CHEMICAL	GENE-Y	3	30	During early pregnancy in sheep , the elongating conceptus secretes gene ( gene ) and the conceptus as well as endometrial epithelia produce chemical ( PG ) via gene ( gene ) and chemical via chemical ( 11-β ) dehydrogenase 1 ( gene ) .	T3	T30	23264615
NA	CHEMICAL	GENE-Y	3	40	During early pregnancy in sheep , the elongating conceptus secretes gene ( gene ) and the conceptus as well as endometrial epithelia produce chemical ( PG ) via gene ( gene ) and chemical via chemical ( 11-β ) dehydrogenase 1 ( gene ) .	T3	T31	23264615
NA	CHEMICAL	GENE-Y	3	40	During early pregnancy in sheep , the elongating conceptus secretes gene ( gene ) and the conceptus as well as endometrial epithelia produce chemical ( PG ) via gene ( gene ) and chemical via chemical ( 11-β ) dehydrogenase 1 ( gene ) .	T3	T32	23264615
NA	CHEMICAL	GENE-N	33	3	During early pregnancy in sheep , the elongating conceptus secretes gene ( gene ) and the conceptus as well as endometrial epithelia produce chemical ( PG ) via gene ( gene ) and chemical via chemical ( 11-β ) dehydrogenase 1 ( gene ) .	T7	T37	23264615
NA	CHEMICAL	GENE-N	33	12	During early pregnancy in sheep , the elongating conceptus secretes gene ( gene ) and the conceptus as well as endometrial epithelia produce chemical ( PG ) via gene ( gene ) and chemical via chemical ( 11-β ) dehydrogenase 1 ( gene ) .	T7	T39	23264615
NA	CHEMICAL	GENE-Y	33	28	During early pregnancy in sheep , the elongating conceptus secretes gene ( gene ) and the conceptus as well as endometrial epithelia produce chemical ( PG ) via gene ( gene ) and chemical via chemical ( 11-β ) dehydrogenase 1 ( gene ) .	T7	T29	23264615
NA	CHEMICAL	GENE-Y	33	30	During early pregnancy in sheep , the elongating conceptus secretes gene ( gene ) and the conceptus as well as endometrial epithelia produce chemical ( PG ) via gene ( gene ) and chemical via chemical ( 11-β ) dehydrogenase 1 ( gene ) .	T7	T30	23264615
CPR:9	CHEMICAL	GENE-Y	33	40	During early pregnancy in sheep , the elongating conceptus secretes gene ( gene ) and the conceptus as well as endometrial epithelia produce chemical ( PG ) via gene ( gene ) and chemical via chemical ( 11-β ) dehydrogenase 1 ( gene ) .	T7	T31	23264615
CPR:9	CHEMICAL	GENE-Y	33	40	During early pregnancy in sheep , the elongating conceptus secretes gene ( gene ) and the conceptus as well as endometrial epithelia produce chemical ( PG ) via gene ( gene ) and chemical via chemical ( 11-β ) dehydrogenase 1 ( gene ) .	T7	T32	23264615
NA	CHEMICAL	GENE-N	35	3	During early pregnancy in sheep , the elongating conceptus secretes gene ( gene ) and the conceptus as well as endometrial epithelia produce chemical ( PG ) via gene ( gene ) and chemical via chemical ( 11-β ) dehydrogenase 1 ( gene ) .	T8	T37	23264615
NA	CHEMICAL	GENE-N	35	12	During early pregnancy in sheep , the elongating conceptus secretes gene ( gene ) and the conceptus as well as endometrial epithelia produce chemical ( PG ) via gene ( gene ) and chemical via chemical ( 11-β ) dehydrogenase 1 ( gene ) .	T8	T39	23264615
NA	CHEMICAL	GENE-Y	35	28	During early pregnancy in sheep , the elongating conceptus secretes gene ( gene ) and the conceptus as well as endometrial epithelia produce chemical ( PG ) via gene ( gene ) and chemical via chemical ( 11-β ) dehydrogenase 1 ( gene ) .	T8	T29	23264615
NA	CHEMICAL	GENE-Y	35	30	During early pregnancy in sheep , the elongating conceptus secretes gene ( gene ) and the conceptus as well as endometrial epithelia produce chemical ( PG ) via gene ( gene ) and chemical via chemical ( 11-β ) dehydrogenase 1 ( gene ) .	T8	T30	23264615
NA	CHEMICAL	GENE-Y	35	40	During early pregnancy in sheep , the elongating conceptus secretes gene ( gene ) and the conceptus as well as endometrial epithelia produce chemical ( PG ) via gene ( gene ) and chemical via chemical ( 11-β ) dehydrogenase 1 ( gene ) .	T8	T31	23264615
NA	CHEMICAL	GENE-Y	35	40	During early pregnancy in sheep , the elongating conceptus secretes gene ( gene ) and the conceptus as well as endometrial epithelia produce chemical ( PG ) via gene ( gene ) and chemical via chemical ( 11-β ) dehydrogenase 1 ( gene ) .	T8	T32	23264615
NA	CHEMICAL	GENE-N	1	6	Ovarian chemical induces and PG and gene stimulates endometrial gene expression and chemical-reductase activity as well as many epithelial genes that govern trophectoderm proliferation , migration , and attachment during elongation .	T9	T33	23264615
NA	CHEMICAL	GENE-Y	1	9	Ovarian chemical induces and PG and gene stimulates endometrial gene expression and chemical-reductase activity as well as many epithelial genes that govern trophectoderm proliferation , migration , and attachment during elongation .	T9	T34	23264615
NA	CHEMICAL	GENE-N	1	14	Ovarian chemical induces and PG and gene stimulates endometrial gene expression and chemical-reductase activity as well as many epithelial genes that govern trophectoderm proliferation , migration , and attachment during elongation .	T9	T35	23264615
NA	CHEMICAL	GENE-N	12	6	Ovarian chemical induces and PG and gene stimulates endometrial gene expression and chemical-reductase activity as well as many epithelial genes that govern trophectoderm proliferation , migration , and attachment during elongation .	T10	T33	23264615
NA	CHEMICAL	GENE-Y	12	9	Ovarian chemical induces and PG and gene stimulates endometrial gene expression and chemical-reductase activity as well as many epithelial genes that govern trophectoderm proliferation , migration , and attachment during elongation .	T10	T34	23264615
NA	CHEMICAL	GENE-N	12	14	Ovarian chemical induces and PG and gene stimulates endometrial gene expression and chemical-reductase activity as well as many epithelial genes that govern trophectoderm proliferation , migration , and attachment during elongation .	T10	T35	23264615
CPR:9	CHEMICAL	GENE-Y	13	12	The primary aim of these studies was to test the hypothesis that gene-derived chemical has a biological role in endometrial function and conceptus development during early pregnancy in sheep .	T11	T36	23264615
NA	CHEMICAL	GENE-Y	9	2	In study 1 , cyclic ewes received vehicle , chemical , chemical ( PF ; a selective inhibitor of gene ) , chemical and PF , chemical ( a selective inhibitor of gene ) , chemical and chemical , recombinant gene , or gene and PF into the uterus from day 10 to day14 after estrus .	T12	T38	23264615
NA	CHEMICAL	GENE-Y	9	32	In study 1 , cyclic ewes received vehicle , chemical , chemical ( PF ; a selective inhibitor of gene ) , chemical and PF , chemical ( a selective inhibitor of gene ) , chemical and chemical , recombinant gene , or gene and PF into the uterus from day 10 to day14 after estrus .	T12	T40	23264615
NA	CHEMICAL	GENE-N	9	40	In study 1 , cyclic ewes received vehicle , chemical , chemical ( PF ; a selective inhibitor of gene ) , chemical and PF , chemical ( a selective inhibitor of gene ) , chemical and chemical , recombinant gene , or gene and PF into the uterus from day 10 to day14 after estrus .	T12	T41	23264615
NA	CHEMICAL	GENE-N	9	43	In study 1 , cyclic ewes received vehicle , chemical , chemical ( PF ; a selective inhibitor of gene ) , chemical and PF , chemical ( a selective inhibitor of gene ) , chemical and chemical , recombinant gene , or gene and PF into the uterus from day 10 to day14 after estrus .	T12	T42	23264615
CPR:4	CHEMICAL	GENE-Y	2	2	In study 1 , cyclic ewes received vehicle , chemical , chemical ( PF ; a selective inhibitor of gene ) , chemical and PF , chemical ( a selective inhibitor of gene ) , chemical and chemical , recombinant gene , or gene and PF into the uterus from day 10 to day14 after estrus .	T13	T38	23264615
NA	CHEMICAL	GENE-Y	2	32	In study 1 , cyclic ewes received vehicle , chemical , chemical ( PF ; a selective inhibitor of gene ) , chemical and PF , chemical ( a selective inhibitor of gene ) , chemical and chemical , recombinant gene , or gene and PF into the uterus from day 10 to day14 after estrus .	T13	T40	23264615
NA	CHEMICAL	GENE-N	2	40	In study 1 , cyclic ewes received vehicle , chemical , chemical ( PF ; a selective inhibitor of gene ) , chemical and PF , chemical ( a selective inhibitor of gene ) , chemical and chemical , recombinant gene , or gene and PF into the uterus from day 10 to day14 after estrus .	T13	T41	23264615
NA	CHEMICAL	GENE-N	2	43	In study 1 , cyclic ewes received vehicle , chemical , chemical ( PF ; a selective inhibitor of gene ) , chemical and PF , chemical ( a selective inhibitor of gene ) , chemical and chemical , recombinant gene , or gene and PF into the uterus from day 10 to day14 after estrus .	T13	T42	23264615
NA	CHEMICAL	GENE-Y	22	2	In study 1 , cyclic ewes received vehicle , chemical , chemical ( PF ; a selective inhibitor of gene ) , chemical and PF , chemical ( a selective inhibitor of gene ) , chemical and chemical , recombinant gene , or gene and PF into the uterus from day 10 to day14 after estrus .	T14	T38	23264615
NA	CHEMICAL	GENE-Y	22	32	In study 1 , cyclic ewes received vehicle , chemical , chemical ( PF ; a selective inhibitor of gene ) , chemical and PF , chemical ( a selective inhibitor of gene ) , chemical and chemical , recombinant gene , or gene and PF into the uterus from day 10 to day14 after estrus .	T14	T40	23264615
NA	CHEMICAL	GENE-N	22	40	In study 1 , cyclic ewes received vehicle , chemical , chemical ( PF ; a selective inhibitor of gene ) , chemical and PF , chemical ( a selective inhibitor of gene ) , chemical and chemical , recombinant gene , or gene and PF into the uterus from day 10 to day14 after estrus .	T14	T41	23264615
NA	CHEMICAL	GENE-N	22	43	In study 1 , cyclic ewes received vehicle , chemical , chemical ( PF ; a selective inhibitor of gene ) , chemical and PF , chemical ( a selective inhibitor of gene ) , chemical and chemical , recombinant gene , or gene and PF into the uterus from day 10 to day14 after estrus .	T14	T42	23264615
NA	CHEMICAL	GENE-Y	15	2	In study 1 , cyclic ewes received vehicle , chemical , chemical ( PF ; a selective inhibitor of gene ) , chemical and PF , chemical ( a selective inhibitor of gene ) , chemical and chemical , recombinant gene , or gene and PF into the uterus from day 10 to day14 after estrus .	T15	T38	23264615
CPR:4	CHEMICAL	GENE-Y	15	32	In study 1 , cyclic ewes received vehicle , chemical , chemical ( PF ; a selective inhibitor of gene ) , chemical and PF , chemical ( a selective inhibitor of gene ) , chemical and chemical , recombinant gene , or gene and PF into the uterus from day 10 to day14 after estrus .	T15	T40	23264615
NA	CHEMICAL	GENE-N	15	40	In study 1 , cyclic ewes received vehicle , chemical , chemical ( PF ; a selective inhibitor of gene ) , chemical and PF , chemical ( a selective inhibitor of gene ) , chemical and chemical , recombinant gene , or gene and PF into the uterus from day 10 to day14 after estrus .	T15	T41	23264615
NA	CHEMICAL	GENE-N	15	43	In study 1 , cyclic ewes received vehicle , chemical , chemical ( PF ; a selective inhibitor of gene ) , chemical and PF , chemical ( a selective inhibitor of gene ) , chemical and chemical , recombinant gene , or gene and PF into the uterus from day 10 to day14 after estrus .	T15	T42	23264615
NA	CHEMICAL	GENE-Y	35	2	In study 1 , cyclic ewes received vehicle , chemical , chemical ( PF ; a selective inhibitor of gene ) , chemical and PF , chemical ( a selective inhibitor of gene ) , chemical and chemical , recombinant gene , or gene and PF into the uterus from day 10 to day14 after estrus .	T16	T38	23264615
NA	CHEMICAL	GENE-Y	35	32	In study 1 , cyclic ewes received vehicle , chemical , chemical ( PF ; a selective inhibitor of gene ) , chemical and PF , chemical ( a selective inhibitor of gene ) , chemical and chemical , recombinant gene , or gene and PF into the uterus from day 10 to day14 after estrus .	T16	T40	23264615
NA	CHEMICAL	GENE-N	35	40	In study 1 , cyclic ewes received vehicle , chemical , chemical ( PF ; a selective inhibitor of gene ) , chemical and PF , chemical ( a selective inhibitor of gene ) , chemical and chemical , recombinant gene , or gene and PF into the uterus from day 10 to day14 after estrus .	T16	T41	23264615
NA	CHEMICAL	GENE-N	35	43	In study 1 , cyclic ewes received vehicle , chemical , chemical ( PF ; a selective inhibitor of gene ) , chemical and PF , chemical ( a selective inhibitor of gene ) , chemical and chemical , recombinant gene , or gene and PF into the uterus from day 10 to day14 after estrus .	T16	T42	23264615
NA	CHEMICAL	GENE-Y	15	2	In study 1 , cyclic ewes received vehicle , chemical , chemical ( PF ; a selective inhibitor of gene ) , chemical and PF , chemical ( a selective inhibitor of gene ) , chemical and chemical , recombinant gene , or gene and PF into the uterus from day 10 to day14 after estrus .	T17	T38	23264615
NA	CHEMICAL	GENE-Y	15	32	In study 1 , cyclic ewes received vehicle , chemical , chemical ( PF ; a selective inhibitor of gene ) , chemical and PF , chemical ( a selective inhibitor of gene ) , chemical and chemical , recombinant gene , or gene and PF into the uterus from day 10 to day14 after estrus .	T17	T40	23264615
NA	CHEMICAL	GENE-N	15	40	In study 1 , cyclic ewes received vehicle , chemical , chemical ( PF ; a selective inhibitor of gene ) , chemical and PF , chemical ( a selective inhibitor of gene ) , chemical and chemical , recombinant gene , or gene and PF into the uterus from day 10 to day14 after estrus .	T17	T41	23264615
NA	CHEMICAL	GENE-N	15	43	In study 1 , cyclic ewes received vehicle , chemical , chemical ( PF ; a selective inhibitor of gene ) , chemical and PF , chemical ( a selective inhibitor of gene ) , chemical and chemical , recombinant gene , or gene and PF into the uterus from day 10 to day14 after estrus .	T17	T42	23264615
NA	CHEMICAL	GENE-N	0	2	chemical and gene stimulated endometrial gene expression and activity , increased endometrial gene activity and the amount of PG in the uterine lumen , and up-regulated many conceptus elongation-related genes in the endometrium .	T18	T43	23264615
CPR:3	CHEMICAL	GENE-Y	0	5	chemical and gene stimulated endometrial gene expression and activity , increased endometrial gene activity and the amount of PG in the uterine lumen , and up-regulated many conceptus elongation-related genes in the endometrium .	T18	T20	23264615
CPR:3	CHEMICAL	GENE-Y	0	12	chemical and gene stimulated endometrial gene expression and activity , increased endometrial gene activity and the amount of PG in the uterine lumen , and up-regulated many conceptus elongation-related genes in the endometrium .	T18	T21	23264615
NA	CHEMICAL	GENE-N	3	5	Some effects of chemical and gene were mediated by gene-derived PG .	T1	T22	23264615
NA	CHEMICAL	GENE-Y	3	9	Some effects of chemical and gene were mediated by gene-derived PG .	T1	T23	23264615
NA	CHEMICAL	GENE-N	2	10	In study 2 , bred ewes received chemical or recombinant gene and into the uterus from day 10 to day 14 after mating .	T2	T24	23264615
NA	CHEMICAL	GENE-N	3	0	gene INHIBITION AFFECTS chemical SYMPORTER ( gene ) EXPRESSION AND INDUCES chemical CYTOTOXICITY IN ANAPLASTIC THYROID CANCER CELLS .	T12	T22	23531031
NA	CHEMICAL	GENE-Y	3	4	gene INHIBITION AFFECTS chemical SYMPORTER ( gene ) EXPRESSION AND INDUCES chemical CYTOTOXICITY IN ANAPLASTIC THYROID CANCER CELLS .	T12	T23	23531031
NA	CHEMICAL	GENE-Y	3	6	gene INHIBITION AFFECTS chemical SYMPORTER ( gene ) EXPRESSION AND INDUCES chemical CYTOTOXICITY IN ANAPLASTIC THYROID CANCER CELLS .	T12	T24	23531031
NA	CHEMICAL	GENE-N	11	0	gene INHIBITION AFFECTS chemical SYMPORTER ( gene ) EXPRESSION AND INDUCES chemical CYTOTOXICITY IN ANAPLASTIC THYROID CANCER CELLS .	T13	T22	23531031
NA	CHEMICAL	GENE-Y	11	4	gene INHIBITION AFFECTS chemical SYMPORTER ( gene ) EXPRESSION AND INDUCES chemical CYTOTOXICITY IN ANAPLASTIC THYROID CANCER CELLS .	T13	T23	23531031
NA	CHEMICAL	GENE-Y	11	6	gene INHIBITION AFFECTS chemical SYMPORTER ( gene ) EXPRESSION AND INDUCES chemical CYTOTOXICITY IN ANAPLASTIC THYROID CANCER CELLS .	T13	T24	23531031
NA	CHEMICAL	GENE-Y	7	20	The resistance of anaplastic thyroid cancer to chemical treatment is principally due to the absence of expression of the chemical symporter ( gene ) , mainly due to epigenetic silencing .	T10	T18	23531031
NA	CHEMICAL	GENE-Y	7	22	The resistance of anaplastic thyroid cancer to chemical treatment is principally due to the absence of expression of the chemical symporter ( gene ) , mainly due to epigenetic silencing .	T10	T19	23531031
NA	CHEMICAL	GENE-Y	19	20	The resistance of anaplastic thyroid cancer to chemical treatment is principally due to the absence of expression of the chemical symporter ( gene ) , mainly due to epigenetic silencing .	T11	T18	23531031
NA	CHEMICAL	GENE-Y	19	22	The resistance of anaplastic thyroid cancer to chemical treatment is principally due to the absence of expression of the chemical symporter ( gene ) , mainly due to epigenetic silencing .	T11	T19	23531031
CPR:4	CHEMICAL	GENE-N	29	29	Methods : Stabilized anaplastic thyroid cancer cell lines ( BHT-101 and CAL-62 ) and primary cultures from patients who underwent thyroidectomy for anaplastic thyroid cancer were treated with the gene inhibitor chemical .	T1	T14	23531031
CPR:3	CHEMICAL	GENE-Y	8	11	Results : Our results demonstrate that treatment with chemical leads to gene RNA expression as shown by RT-PCR and luciferase assay , and to protein expression as determined by immunofluorescence in vitro and by immunohistochemistry in xenograft tumors .	T4	T17	23531031
CPR:4	CHEMICAL	GENE-Y	0	5	chemical ( chemical ) is a selective gene inhibitor in man .	T14	T35	17884974
CPR:4	CHEMICAL	GENE-Y	2	5	chemical ( chemical ) is a selective gene inhibitor in man .	T15	T35	17884974
CPR:4	CHEMICAL	GENE-Y	3	9	The fact that chemical acts functionally as a selective gene inhibitor led us to investigate the hypothesis of whether it works via preferential gene blockade .	T5	T25	17884974
NA	CHEMICAL	GENE-Y	3	23	The fact that chemical acts functionally as a selective gene inhibitor led us to investigate the hypothesis of whether it works via preferential gene blockade .	T5	T26	17884974
CPR:4	CHEMICAL	GENE-N	7	2	Ex vivo gene inhibition and pharmacokinetics of chemical were assessed in 5 volunteers receiving single 1000 mg doses orally .	T8	T27	17884974
CPR:9	CHEMICAL	GENE-Y	1	19	Coagulation-induced chemical and lipopolysaccharide-induced chemical were measured ex vivo and in vitro in human whole blood as indices of gene and gene activity .	T10	T28	17884974
NA	CHEMICAL	GENE-Y	1	21	Coagulation-induced chemical and lipopolysaccharide-induced chemical were measured ex vivo and in vitro in human whole blood as indices of gene and gene activity .	T10	T29	17884974
NA	CHEMICAL	GENE-Y	4	19	Coagulation-induced chemical and lipopolysaccharide-induced chemical were measured ex vivo and in vitro in human whole blood as indices of gene and gene activity .	T11	T28	17884974
CPR:9	CHEMICAL	GENE-Y	4	21	Coagulation-induced chemical and lipopolysaccharide-induced chemical were measured ex vivo and in vitro in human whole blood as indices of gene and gene activity .	T11	T29	17884974
CPR:4	CHEMICAL	GENE-Y	3	9	In vitro , chemical elicited a 4.4-fold selectivity toward gene inhibition ( IC ( 50 ) =113.7 micromol/L for gene ; IC ( 50 ) =25.8 micromol/L for gene ) .	T12	T30	17884974
CPR:4	CHEMICAL	GENE-Y	3	19	In vitro , chemical elicited a 4.4-fold selectivity toward gene inhibition ( IC ( 50 ) =113.7 micromol/L for gene ; IC ( 50 ) =25.8 micromol/L for gene ) .	T12	T31	17884974
CPR:4	CHEMICAL	GENE-Y	3	28	In vitro , chemical elicited a 4.4-fold selectivity toward gene inhibition ( IC ( 50 ) =113.7 micromol/L for gene ; IC ( 50 ) =25.8 micromol/L for gene ) .	T12	T32	17884974
CPR:4	CHEMICAL	GENE-Y	0	13	chemical plasma concentrations remained above the in vitro IC ( 50 ) for gene for at least 5 h postadministration .	T13	T16	17884974
CPR:4	CHEMICAL	GENE-Y	8	8	Ex vivo IC ( 50 ) values ( gene : 105.2 micromol/L ; gene : 26.3 micromol/L ) of chemical compared favorably with its in vitro IC ( 50 ) values .	T1	T17	17884974
CPR:4	CHEMICAL	GENE-Y	8	13	Ex vivo IC ( 50 ) values ( gene : 105.2 micromol/L ; gene : 26.3 micromol/L ) of chemical compared favorably with its in vitro IC ( 50 ) values .	T1	T18	17884974
CPR:4	CHEMICAL	GENE-Y	6	8	In contrast to previous concepts , chemical inhibited gene by more than 80 % , i.e. , to a degree comparable to nonsteroidal antiinflammatory drugs ( NSAIDs ) and selective gene inhibitors .	T2	T19	17884974
NA	CHEMICAL	GENE-Y	6	30	In contrast to previous concepts , chemical inhibited gene by more than 80 % , i.e. , to a degree comparable to nonsteroidal antiinflammatory drugs ( NSAIDs ) and selective gene inhibitors .	T2	T20	17884974
NA	CHEMICAL	GENE-N	2	0	gene is a 54-chemical peptide which is encoded by the gene gene and activates the gene gene .	T1	T5	23256725
NA	CHEMICAL	GENE-Y	2	10	gene is a 54-chemical peptide which is encoded by the gene gene and activates the gene gene .	T1	T18	23256725
NA	CHEMICAL	GENE-N	2	15	gene is a 54-chemical peptide which is encoded by the gene gene and activates the gene gene .	T1	T23	23256725
NA	CHEMICAL	GENE-Y	2	16	gene is a 54-chemical peptide which is encoded by the gene gene and activates the gene gene .	T1	T9	23256725
NA	CHEMICAL	GENE-N	28	14	In healthy human volunteers , the acute intravenous administration of kisspeptin potently increases plasma gene ( gene ) levels and significantly increases plasma gene ( gene ) and chemical without side effects in both males and in females particularly in the preovulatatory phase of the menstrual cycle .	T4	T19	23256725
NA	CHEMICAL	GENE-N	28	16	In healthy human volunteers , the acute intravenous administration of kisspeptin potently increases plasma gene ( gene ) levels and significantly increases plasma gene ( gene ) and chemical without side effects in both males and in females particularly in the preovulatatory phase of the menstrual cycle .	T4	T20	23256725
NA	CHEMICAL	GENE-N	28	23	In healthy human volunteers , the acute intravenous administration of kisspeptin potently increases plasma gene ( gene ) levels and significantly increases plasma gene ( gene ) and chemical without side effects in both males and in females particularly in the preovulatatory phase of the menstrual cycle .	T4	T21	23256725
NA	CHEMICAL	GENE-N	28	25	In healthy human volunteers , the acute intravenous administration of kisspeptin potently increases plasma gene ( gene ) levels and significantly increases plasma gene ( gene ) and chemical without side effects in both males and in females particularly in the preovulatatory phase of the menstrual cycle .	T4	T22	23256725
NA	CHEMICAL	GENE-Y	7	8	In vivo comparison of the reinforcing and chemical transporter effects of local anesthetics in rhesus monkeys .	T20	T30	16206183
NA	CHEMICAL	GENE-N	2	11	Similar to chemical , other local anesthetics bind to the chemical transporter ( gene ) and inhibit chemical uptake in rodent and monkey brain .	T2	T24	16206183
NA	CHEMICAL	GENE-N	2	13	Similar to chemical , other local anesthetics bind to the chemical transporter ( gene ) and inhibit chemical uptake in rodent and monkey brain .	T2	T27	16206183
NA	CHEMICAL	GENE-N	10	11	Similar to chemical , other local anesthetics bind to the chemical transporter ( gene ) and inhibit chemical uptake in rodent and monkey brain .	T8	T24	16206183
NA	CHEMICAL	GENE-N	10	13	Similar to chemical , other local anesthetics bind to the chemical transporter ( gene ) and inhibit chemical uptake in rodent and monkey brain .	T8	T27	16206183
NA	CHEMICAL	GENE-N	17	11	Similar to chemical , other local anesthetics bind to the chemical transporter ( gene ) and inhibit chemical uptake in rodent and monkey brain .	T9	T24	16206183
NA	CHEMICAL	GENE-N	17	13	Similar to chemical , other local anesthetics bind to the chemical transporter ( gene ) and inhibit chemical uptake in rodent and monkey brain .	T9	T27	16206183
NA	CHEMICAL	GENE-Y	13	7	The present study examined the reinforcing and gene effects of the local anesthetics chemical , chemical and chemical using in vivo techniques .	T10	T28	16206183
NA	CHEMICAL	GENE-Y	15	7	The present study examined the reinforcing and gene effects of the local anesthetics chemical , chemical and chemical using in vivo techniques .	T11	T28	16206183
NA	CHEMICAL	GENE-Y	17	7	The present study examined the reinforcing and gene effects of the local anesthetics chemical , chemical and chemical using in vivo techniques .	T12	T28	16206183
NA	CHEMICAL	GENE-Y	7	0	gene occupancy was determined by displacement of chemical ( chemical ) .	T1	T21	16206183
NA	CHEMICAL	GENE-Y	9	0	gene occupancy was determined by displacement of chemical ( chemical ) .	T3	T21	16206183
NA	CHEMICAL	GENE-Y	15	0	gene occupancy was between 66 and 82 % and < 10-41 % for doses of chemical and chemical that maintained maximum response rates , respectively .	T4	T22	16206183
NA	CHEMICAL	GENE-Y	17	0	gene occupancy was between 66 and 82 % and < 10-41 % for doses of chemical and chemical that maintained maximum response rates , respectively .	T5	T22	16206183
NA	CHEMICAL	GENE-Y	8	10	There was close correspondence between peak increases in chemical and gene occupancy .	T7	T23	16206183
CPR:4	CHEMICAL	GENE-Y	0	7	chemical treatment prevents the formation of activated gene , a known effector of apoptosis , as well as the appearance of a gene cleaved substrate , a marker of excitotoxic/necrotic cell death .	T6	T8	12112047
NA	CHEMICAL	GENE-N	0	9	chemical treatment prevents the formation of activated gene , a known effector of apoptosis , as well as the appearance of a gene cleaved substrate , a marker of excitotoxic/necrotic cell death .	T6	T9	12112047
NA	CHEMICAL	GENE-Y	0	6	chemical was found to bind the gene , which provides a plausible mechanism for QTc interval prolongation/arrhythmia .	T3	T9	17408310
NA	CHEMICAL	GENE-Y	10	6	chemical was found to bind the gene , which provides a plausible mechanism for QTc interval prolongation/arrhythmia .	T4	T9	17408310
NA	CHEMICAL	GENE-Y	20	27	Airway resistance ( RI ) and lung compliance ( Cdyn ) were measured , histological studies were evaluated by the chemical and chemical staining , Th1/Th2 , gene-specific serum , and BALF gene levels and Th17 gene were evaluated by enzyme-linked immunosorbent assay , and Th17 cells was evaluated by flow cytometry ( FCM ) .	T2	T8	23580257
NA	CHEMICAL	GENE-N	20	32	Airway resistance ( RI ) and lung compliance ( Cdyn ) were measured , histological studies were evaluated by the chemical and chemical staining , Th1/Th2 , gene-specific serum , and BALF gene levels and Th17 gene were evaluated by enzyme-linked immunosorbent assay , and Th17 cells was evaluated by flow cytometry ( FCM ) .	T2	T9	23580257
NA	CHEMICAL	GENE-N	20	36	Airway resistance ( RI ) and lung compliance ( Cdyn ) were measured , histological studies were evaluated by the chemical and chemical staining , Th1/Th2 , gene-specific serum , and BALF gene levels and Th17 gene were evaluated by enzyme-linked immunosorbent assay , and Th17 cells was evaluated by flow cytometry ( FCM ) .	T2	T10	23580257
NA	CHEMICAL	GENE-Y	22	27	Airway resistance ( RI ) and lung compliance ( Cdyn ) were measured , histological studies were evaluated by the chemical and chemical staining , Th1/Th2 , gene-specific serum , and BALF gene levels and Th17 gene were evaluated by enzyme-linked immunosorbent assay , and Th17 cells was evaluated by flow cytometry ( FCM ) .	T3	T8	23580257
NA	CHEMICAL	GENE-N	22	32	Airway resistance ( RI ) and lung compliance ( Cdyn ) were measured , histological studies were evaluated by the chemical and chemical staining , Th1/Th2 , gene-specific serum , and BALF gene levels and Th17 gene were evaluated by enzyme-linked immunosorbent assay , and Th17 cells was evaluated by flow cytometry ( FCM ) .	T3	T9	23580257
NA	CHEMICAL	GENE-N	22	36	Airway resistance ( RI ) and lung compliance ( Cdyn ) were measured , histological studies were evaluated by the chemical and chemical staining , Th1/Th2 , gene-specific serum , and BALF gene levels and Th17 gene were evaluated by enzyme-linked immunosorbent assay , and Th17 cells was evaluated by flow cytometry ( FCM ) .	T3	T10	23580257
NA	CHEMICAL	GENE-N	2	2	Identification of a novel polymorphism in the 3'UTR of the chemical transporter gene gene : contribution to hypertension and endothelial dysfunction .	T10	T18	17325243
NA	CHEMICAL	GENE-Y	2	13	Identification of a novel polymorphism in the 3'UTR of the chemical transporter gene gene : contribution to hypertension and endothelial dysfunction .	T10	T19	17325243
NA	CHEMICAL	GENE-N	7	34	METHODS AND RESULTS : We have identified a novel C/T polymorphism in the 3'UTR of the principal chemical transporter , solute carrier family 7 ( chemical transporter , y+ system ) , member 1 gene ( gene ) .	T7	T16	17325243
NA	CHEMICAL	GENE-Y	7	23	METHODS AND RESULTS : We have identified a novel C/T polymorphism in the 3'UTR of the principal chemical transporter , solute carrier family 7 ( chemical transporter , y+ system ) , member 1 gene ( gene ) .	T7	T17	17325243
NA	CHEMICAL	GENE-N	7	34	METHODS AND RESULTS : We have identified a novel C/T polymorphism in the 3'UTR of the principal chemical transporter , solute carrier family 7 ( chemical transporter , y+ system ) , member 1 gene ( gene ) .	T8	T16	17325243
NA	CHEMICAL	GENE-Y	7	23	METHODS AND RESULTS : We have identified a novel C/T polymorphism in the 3'UTR of the principal chemical transporter , solute carrier family 7 ( chemical transporter , y+ system ) , member 1 gene ( gene ) .	T8	T17	17325243
NA	CHEMICAL	GENE-N	12	7	To complement these studies , we generated an endothelial-specific transgenic mouse overexpressing chemical transporter gene .	T1	T11	17325243
NA	CHEMICAL	GENE-Y	12	14	To complement these studies , we generated an endothelial-specific transgenic mouse overexpressing chemical transporter gene .	T1	T12	17325243
NA	CHEMICAL	GENE-Y	12	1	The gene transgenic mice exhibited significantly enhanced responses to the endothelium-dependent vasodilator chemical ( -log EC50 for wild-type versus gene transgenic : 6.87+/-0.10 versus 7.56+/-0.13 ; P < 0.001 ) .	T2	T13	17325243
NA	CHEMICAL	GENE-Y	12	19	The gene transgenic mice exhibited significantly enhanced responses to the endothelium-dependent vasodilator chemical ( -log EC50 for wild-type versus gene transgenic : 6.87+/-0.10 versus 7.56+/-0.13 ; P < 0.001 ) .	T2	T14	17325243
NA	CHEMICAL	GENE-N	2	0	gene ( gene ) are the largest group of transcription factors in higher metazoans .	T1	T8	23471540
NA	CHEMICAL	GENE-N	2	2	gene ( gene ) are the largest group of transcription factors in higher metazoans .	T1	T13	23471540
NA	CHEMICAL	GENE-N	4	4	As a first step in this process , we have characterized the DNA-binding specificities of 129 chemical finger sets from Drosophila using a bacterial one-hybrid system .	T4	T14	23471540
NA	CHEMICAL	GENE-N	16	6	To confirm the utility of our finger recognition models , we employed subsets of Drosophila fingers in combination with an existing archive of artificial chemical finger modules to create gene with novel DNA-binding specificity .	T2	T9	23471540
NA	CHEMICAL	GENE-N	16	29	To confirm the utility of our finger recognition models , we employed subsets of Drosophila fingers in combination with an existing archive of artificial chemical finger modules to create gene with novel DNA-binding specificity .	T2	T10	23471540
NA	CHEMICAL	GENE-N	8	0	gene repeat and suppressors of gene gene targets chemical kinase B for degradation .	T4	T30	17148442
NA	CHEMICAL	GENE-N	8	5	gene repeat and suppressors of gene gene targets chemical kinase B for degradation .	T4	T31	17148442
NA	CHEMICAL	GENE-Y	8	6	gene repeat and suppressors of gene gene targets chemical kinase B for degradation .	T4	T32	17148442
NA	CHEMICAL	GENE-Y	8	10	gene repeat and suppressors of gene gene targets chemical kinase B for degradation .	T4	T33	17148442
NA	CHEMICAL	GENE-N	4	6	In addition to the chemical-terminal and gene that mediate these interactions , gene proteins contain a chemical-terminal gene .	T1	T9	17148442
NA	CHEMICAL	GENE-N	4	12	In addition to the chemical-terminal and gene that mediate these interactions , gene proteins contain a chemical-terminal gene .	T1	T10	17148442
NA	CHEMICAL	GENE-N	4	17	In addition to the chemical-terminal and gene that mediate these interactions , gene proteins contain a chemical-terminal gene .	T1	T11	17148442
NA	CHEMICAL	GENE-N	16	6	In addition to the chemical-terminal and gene that mediate these interactions , gene proteins contain a chemical-terminal gene .	T2	T9	17148442
NA	CHEMICAL	GENE-N	16	12	In addition to the chemical-terminal and gene that mediate these interactions , gene proteins contain a chemical-terminal gene .	T2	T10	17148442
NA	CHEMICAL	GENE-N	16	17	In addition to the chemical-terminal and gene that mediate these interactions , gene proteins contain a chemical-terminal gene .	T2	T11	17148442
NA	CHEMICAL	GENE-Y	1	10	Using a proteomics approach , we demonstrate that chemical kinase B ( gene ) interacts with gene in a specific , gene-independent manner .	T3	T21	17148442
NA	CHEMICAL	GENE-Y	1	10	Using a proteomics approach , we demonstrate that chemical kinase B ( gene ) interacts with gene in a specific , gene-independent manner .	T3	T22	17148442
NA	CHEMICAL	GENE-Y	1	16	Using a proteomics approach , we demonstrate that chemical kinase B ( gene ) interacts with gene in a specific , gene-independent manner .	T3	T23	17148442
NA	CHEMICAL	GENE-N	1	21	Using a proteomics approach , we demonstrate that chemical kinase B ( gene ) interacts with gene in a specific , gene-independent manner .	T3	T24	17148442
NA	CHEMICAL	GENE-N	4	19	In functional experiments , chemical is selective , not for the B , but for the A subtype of gene .	T14	T22	8925876
CPR:6	CHEMICAL	GENE-Y	7	9	The potency of the antipsychotic drug , chemical , to antagonize gene-mediated contraction in rat vas deferens and vasoconstriction in rat perfused kidney , and gene-mediated contractions in spleen from guinea-pig and mouse was evaluated and compared to that of gene subtype-discriminating antagonists .	T3	T19	8925876
CPR:6	CHEMICAL	GENE-Y	7	9	The potency of the antipsychotic drug , chemical , to antagonize gene-mediated contraction in rat vas deferens and vasoconstriction in rat perfused kidney , and gene-mediated contractions in spleen from guinea-pig and mouse was evaluated and compared to that of gene subtype-discriminating antagonists .	T3	T15	8925876
CPR:6	CHEMICAL	GENE-N	7	9	The potency of the antipsychotic drug , chemical , to antagonize gene-mediated contraction in rat vas deferens and vasoconstriction in rat perfused kidney , and gene-mediated contractions in spleen from guinea-pig and mouse was evaluated and compared to that of gene subtype-discriminating antagonists .	T3	T16	8925876
NA	CHEMICAL	GENE-Y	0	3	chemical was found to be unselective ; chemical ( chemical ) , chemical , chemical and chemical were confirmed as selective for the gene , whereas chemical was weakly alpha 1B-selective .	T1	T17	8925876
NA	CHEMICAL	GENE-Y	4	3	chemical was found to be unselective ; chemical ( chemical ) , chemical , chemical and chemical were confirmed as selective for the gene , whereas chemical was weakly alpha 1B-selective .	T2	T17	8925876
NA	CHEMICAL	GENE-Y	9	3	chemical was found to be unselective ; chemical ( chemical ) , chemical , chemical and chemical were confirmed as selective for the gene , whereas chemical was weakly alpha 1B-selective .	T4	T17	8925876
NA	CHEMICAL	GENE-Y	12	3	chemical was found to be unselective ; chemical ( chemical ) , chemical , chemical and chemical were confirmed as selective for the gene , whereas chemical was weakly alpha 1B-selective .	T5	T17	8925876
NA	CHEMICAL	GENE-Y	14	3	chemical was found to be unselective ; chemical ( chemical ) , chemical , chemical and chemical were confirmed as selective for the gene , whereas chemical was weakly alpha 1B-selective .	T6	T17	8925876
NA	CHEMICAL	GENE-Y	8	3	chemical was found to be unselective ; chemical ( chemical ) , chemical , chemical and chemical were confirmed as selective for the gene , whereas chemical was weakly alpha 1B-selective .	T7	T17	8925876
NA	CHEMICAL	GENE-Y	26	3	chemical was found to be unselective ; chemical ( chemical ) , chemical , chemical and chemical were confirmed as selective for the gene , whereas chemical was weakly alpha 1B-selective .	T8	T17	8925876
NA	CHEMICAL	GENE-Y	0	3	chemical was equipotent to chemical at gene in rat vas deferens and kidney .	T9	T18	8925876
NA	CHEMICAL	GENE-Y	4	3	chemical was equipotent to chemical at gene in rat vas deferens and kidney .	T10	T18	8925876
NA	CHEMICAL	GENE-N	9	3	However , at gene , the affinity values of chemical were 10-fold lower than those of chemical .	T11	T20	8925876
NA	CHEMICAL	GENE-N	16	3	However , at gene , the affinity values of chemical were 10-fold lower than those of chemical .	T12	T20	8925876
CPR:9	CHEMICAL	GENE-Y	2	1	Tumor-growth-promoting gene chemical pathway provides medulloblastoma therapeutic targets .	T15	T38	18715952
CPR:9	CHEMICAL	GENE-N	0	6	chemical is synthesized from chemical by gene ( gene ) and chemical synthases ( gene ) and mediates its biological activity through binding to the four gene through gene .	T2	T21	18715952
CPR:9	CHEMICAL	GENE-N	0	8	chemical is synthesized from chemical by gene ( gene ) and chemical synthases ( gene ) and mediates its biological activity through binding to the four gene through gene .	T2	T22	18715952
CPR:9	CHEMICAL	GENE-N	0	12	chemical is synthesized from chemical by gene ( gene ) and chemical synthases ( gene ) and mediates its biological activity through binding to the four gene through gene .	T2	T23	18715952
CPR:9	CHEMICAL	GENE-N	0	14	chemical is synthesized from chemical by gene ( gene ) and chemical synthases ( gene ) and mediates its biological activity through binding to the four gene through gene .	T2	T24	18715952
NA	CHEMICAL	GENE-Y	0	7	chemical is synthesized from chemical by gene ( gene ) and chemical synthases ( gene ) and mediates its biological activity through binding to the four gene through gene .	T2	T25	18715952
NA	CHEMICAL	GENE-Y	0	7	chemical is synthesized from chemical by gene ( gene ) and chemical synthases ( gene ) and mediates its biological activity through binding to the four gene through gene .	T2	T26	18715952
CPR:9	CHEMICAL	GENE-N	4	6	chemical is synthesized from chemical by gene ( gene ) and chemical synthases ( gene ) and mediates its biological activity through binding to the four gene through gene .	T4	T21	18715952
CPR:9	CHEMICAL	GENE-N	4	8	chemical is synthesized from chemical by gene ( gene ) and chemical synthases ( gene ) and mediates its biological activity through binding to the four gene through gene .	T4	T22	18715952
CPR:9	CHEMICAL	GENE-N	4	12	chemical is synthesized from chemical by gene ( gene ) and chemical synthases ( gene ) and mediates its biological activity through binding to the four gene through gene .	T4	T23	18715952
CPR:9	CHEMICAL	GENE-N	4	14	chemical is synthesized from chemical by gene ( gene ) and chemical synthases ( gene ) and mediates its biological activity through binding to the four gene through gene .	T4	T24	18715952
NA	CHEMICAL	GENE-Y	4	7	chemical is synthesized from chemical by gene ( gene ) and chemical synthases ( gene ) and mediates its biological activity through binding to the four gene through gene .	T4	T25	18715952
NA	CHEMICAL	GENE-Y	4	7	chemical is synthesized from chemical by gene ( gene ) and chemical synthases ( gene ) and mediates its biological activity through binding to the four gene through gene .	T4	T26	18715952
NA	CHEMICAL	GENE-N	11	6	chemical is synthesized from chemical by gene ( gene ) and chemical synthases ( gene ) and mediates its biological activity through binding to the four gene through gene .	T5	T21	18715952
NA	CHEMICAL	GENE-N	11	8	chemical is synthesized from chemical by gene ( gene ) and chemical synthases ( gene ) and mediates its biological activity through binding to the four gene through gene .	T5	T22	18715952
NA	CHEMICAL	GENE-N	11	12	chemical is synthesized from chemical by gene ( gene ) and chemical synthases ( gene ) and mediates its biological activity through binding to the four gene through gene .	T5	T23	18715952
NA	CHEMICAL	GENE-N	11	14	chemical is synthesized from chemical by gene ( gene ) and chemical synthases ( gene ) and mediates its biological activity through binding to the four gene through gene .	T5	T24	18715952
NA	CHEMICAL	GENE-Y	11	7	chemical is synthesized from chemical by gene ( gene ) and chemical synthases ( gene ) and mediates its biological activity through binding to the four gene through gene .	T5	T25	18715952
NA	CHEMICAL	GENE-Y	11	7	chemical is synthesized from chemical by gene ( gene ) and chemical synthases ( gene ) and mediates its biological activity through binding to the four gene through gene .	T5	T26	18715952
NA	CHEMICAL	GENE-Y	12	28	In this study , we show for the first time that medulloblastoma ( MB ) , the most common malignant childhood brain tumor , expresses high levels of gene , gene , and gene through gene and secretes chemical .	T8	T27	18715952
NA	CHEMICAL	GENE-Y	12	30	In this study , we show for the first time that medulloblastoma ( MB ) , the most common malignant childhood brain tumor , expresses high levels of gene , gene , and gene through gene and secretes chemical .	T8	T28	18715952
NA	CHEMICAL	GENE-Y	12	12	In this study , we show for the first time that medulloblastoma ( MB ) , the most common malignant childhood brain tumor , expresses high levels of gene , gene , and gene through gene and secretes chemical .	T8	T29	18715952
NA	CHEMICAL	GENE-Y	12	12	In this study , we show for the first time that medulloblastoma ( MB ) , the most common malignant childhood brain tumor , expresses high levels of gene , gene , and gene through gene and secretes chemical .	T8	T30	18715952
NA	CHEMICAL	GENE-Y	0	3	chemical and the gene agonist butaprost stimulated MB cell proliferation .	T9	T31	18715952
NA	CHEMICAL	GENE-N	8	5	Treatment of MB cells with gene inhibitors suppressed chemical production and induced gene-dependent apoptosis .	T10	T32	18715952
NA	CHEMICAL	GENE-N	8	12	Treatment of MB cells with gene inhibitors suppressed chemical production and induced gene-dependent apoptosis .	T10	T33	18715952
CPR:6	CHEMICAL	GENE-Y	4	0	gene and gene antagonists chemical and chemical , but not the gene antagonists chemical and chemical , inhibited tumor cell proliferation , indicating the significance of gene and gene but not gene for MB growth .	T11	T35	18715952
CPR:6	CHEMICAL	GENE-Y	4	2	gene and gene antagonists chemical and chemical , but not the gene antagonists chemical and chemical , inhibited tumor cell proliferation , indicating the significance of gene and gene but not gene for MB growth .	T11	T36	18715952
NA	CHEMICAL	GENE-Y	4	11	gene and gene antagonists chemical and chemical , but not the gene antagonists chemical and chemical , inhibited tumor cell proliferation , indicating the significance of gene and gene but not gene for MB growth .	T11	T37	18715952
NA	CHEMICAL	GENE-Y	4	26	gene and gene antagonists chemical and chemical , but not the gene antagonists chemical and chemical , inhibited tumor cell proliferation , indicating the significance of gene and gene but not gene for MB growth .	T11	T16	18715952
NA	CHEMICAL	GENE-Y	4	28	gene and gene antagonists chemical and chemical , but not the gene antagonists chemical and chemical , inhibited tumor cell proliferation , indicating the significance of gene and gene but not gene for MB growth .	T11	T17	18715952
NA	CHEMICAL	GENE-Y	4	31	gene and gene antagonists chemical and chemical , but not the gene antagonists chemical and chemical , inhibited tumor cell proliferation , indicating the significance of gene and gene but not gene for MB growth .	T11	T18	18715952
CPR:6	CHEMICAL	GENE-Y	6	0	gene and gene antagonists chemical and chemical , but not the gene antagonists chemical and chemical , inhibited tumor cell proliferation , indicating the significance of gene and gene but not gene for MB growth .	T12	T35	18715952
CPR:6	CHEMICAL	GENE-Y	6	2	gene and gene antagonists chemical and chemical , but not the gene antagonists chemical and chemical , inhibited tumor cell proliferation , indicating the significance of gene and gene but not gene for MB growth .	T12	T36	18715952
NA	CHEMICAL	GENE-Y	6	11	gene and gene antagonists chemical and chemical , but not the gene antagonists chemical and chemical , inhibited tumor cell proliferation , indicating the significance of gene and gene but not gene for MB growth .	T12	T37	18715952
NA	CHEMICAL	GENE-Y	6	26	gene and gene antagonists chemical and chemical , but not the gene antagonists chemical and chemical , inhibited tumor cell proliferation , indicating the significance of gene and gene but not gene for MB growth .	T12	T16	18715952
NA	CHEMICAL	GENE-Y	6	28	gene and gene antagonists chemical and chemical , but not the gene antagonists chemical and chemical , inhibited tumor cell proliferation , indicating the significance of gene and gene but not gene for MB growth .	T12	T17	18715952
NA	CHEMICAL	GENE-Y	6	31	gene and gene antagonists chemical and chemical , but not the gene antagonists chemical and chemical , inhibited tumor cell proliferation , indicating the significance of gene and gene but not gene for MB growth .	T12	T18	18715952
NA	CHEMICAL	GENE-Y	13	0	gene and gene antagonists chemical and chemical , but not the gene antagonists chemical and chemical , inhibited tumor cell proliferation , indicating the significance of gene and gene but not gene for MB growth .	T13	T35	18715952
NA	CHEMICAL	GENE-Y	13	2	gene and gene antagonists chemical and chemical , but not the gene antagonists chemical and chemical , inhibited tumor cell proliferation , indicating the significance of gene and gene but not gene for MB growth .	T13	T36	18715952
CPR:6	CHEMICAL	GENE-Y	13	11	gene and gene antagonists chemical and chemical , but not the gene antagonists chemical and chemical , inhibited tumor cell proliferation , indicating the significance of gene and gene but not gene for MB growth .	T13	T37	18715952
NA	CHEMICAL	GENE-Y	13	26	gene and gene antagonists chemical and chemical , but not the gene antagonists chemical and chemical , inhibited tumor cell proliferation , indicating the significance of gene and gene but not gene for MB growth .	T13	T16	18715952
NA	CHEMICAL	GENE-Y	13	28	gene and gene antagonists chemical and chemical , but not the gene antagonists chemical and chemical , inhibited tumor cell proliferation , indicating the significance of gene and gene but not gene for MB growth .	T13	T17	18715952
NA	CHEMICAL	GENE-Y	13	31	gene and gene antagonists chemical and chemical , but not the gene antagonists chemical and chemical , inhibited tumor cell proliferation , indicating the significance of gene and gene but not gene for MB growth .	T13	T18	18715952
NA	CHEMICAL	GENE-Y	15	0	gene and gene antagonists chemical and chemical , but not the gene antagonists chemical and chemical , inhibited tumor cell proliferation , indicating the significance of gene and gene but not gene for MB growth .	T14	T35	18715952
NA	CHEMICAL	GENE-Y	15	2	gene and gene antagonists chemical and chemical , but not the gene antagonists chemical and chemical , inhibited tumor cell proliferation , indicating the significance of gene and gene but not gene for MB growth .	T14	T36	18715952
CPR:6	CHEMICAL	GENE-Y	15	11	gene and gene antagonists chemical and chemical , but not the gene antagonists chemical and chemical , inhibited tumor cell proliferation , indicating the significance of gene and gene but not gene for MB growth .	T14	T37	18715952
NA	CHEMICAL	GENE-Y	15	26	gene and gene antagonists chemical and chemical , but not the gene antagonists chemical and chemical , inhibited tumor cell proliferation , indicating the significance of gene and gene but not gene for MB growth .	T14	T16	18715952
NA	CHEMICAL	GENE-Y	15	28	gene and gene antagonists chemical and chemical , but not the gene antagonists chemical and chemical , inhibited tumor cell proliferation , indicating the significance of gene and gene but not gene for MB growth .	T14	T17	18715952
NA	CHEMICAL	GENE-Y	15	31	gene and gene antagonists chemical and chemical , but not the gene antagonists chemical and chemical , inhibited tumor cell proliferation , indicating the significance of gene and gene but not gene for MB growth .	T14	T18	18715952
NA	CHEMICAL	GENE-Y	34	30	METHODS : Using data from adult participants of the National Health and Nutrition Examination Survey ( NHANES , 2005-2010 ) , the association of antidepressant use with continuous measures of gene , fasting blood chemical , 2-h oral chemical tolerance test , gene sensitivity and screen-positive diabetes according to gene , fasting blood sugar and 2-h oral chemical tolerance test were assessed .	T1	T6	23334176
NA	CHEMICAL	GENE-Y	34	42	METHODS : Using data from adult participants of the National Health and Nutrition Examination Survey ( NHANES , 2005-2010 ) , the association of antidepressant use with continuous measures of gene , fasting blood chemical , 2-h oral chemical tolerance test , gene sensitivity and screen-positive diabetes according to gene , fasting blood sugar and 2-h oral chemical tolerance test were assessed .	T1	T7	23334176
NA	CHEMICAL	GENE-Y	34	49	METHODS : Using data from adult participants of the National Health and Nutrition Examination Survey ( NHANES , 2005-2010 ) , the association of antidepressant use with continuous measures of gene , fasting blood chemical , 2-h oral chemical tolerance test , gene sensitivity and screen-positive diabetes according to gene , fasting blood sugar and 2-h oral chemical tolerance test were assessed .	T1	T8	23334176
NA	CHEMICAL	GENE-Y	38	30	METHODS : Using data from adult participants of the National Health and Nutrition Examination Survey ( NHANES , 2005-2010 ) , the association of antidepressant use with continuous measures of gene , fasting blood chemical , 2-h oral chemical tolerance test , gene sensitivity and screen-positive diabetes according to gene , fasting blood sugar and 2-h oral chemical tolerance test were assessed .	T2	T6	23334176
NA	CHEMICAL	GENE-Y	38	42	METHODS : Using data from adult participants of the National Health and Nutrition Examination Survey ( NHANES , 2005-2010 ) , the association of antidepressant use with continuous measures of gene , fasting blood chemical , 2-h oral chemical tolerance test , gene sensitivity and screen-positive diabetes according to gene , fasting blood sugar and 2-h oral chemical tolerance test were assessed .	T2	T7	23334176
NA	CHEMICAL	GENE-Y	38	49	METHODS : Using data from adult participants of the National Health and Nutrition Examination Survey ( NHANES , 2005-2010 ) , the association of antidepressant use with continuous measures of gene , fasting blood chemical , 2-h oral chemical tolerance test , gene sensitivity and screen-positive diabetes according to gene , fasting blood sugar and 2-h oral chemical tolerance test were assessed .	T2	T8	23334176
NA	CHEMICAL	GENE-Y	57	30	METHODS : Using data from adult participants of the National Health and Nutrition Examination Survey ( NHANES , 2005-2010 ) , the association of antidepressant use with continuous measures of gene , fasting blood chemical , 2-h oral chemical tolerance test , gene sensitivity and screen-positive diabetes according to gene , fasting blood sugar and 2-h oral chemical tolerance test were assessed .	T3	T6	23334176
NA	CHEMICAL	GENE-Y	57	42	METHODS : Using data from adult participants of the National Health and Nutrition Examination Survey ( NHANES , 2005-2010 ) , the association of antidepressant use with continuous measures of gene , fasting blood chemical , 2-h oral chemical tolerance test , gene sensitivity and screen-positive diabetes according to gene , fasting blood sugar and 2-h oral chemical tolerance test were assessed .	T3	T7	23334176
NA	CHEMICAL	GENE-Y	57	49	METHODS : Using data from adult participants of the National Health and Nutrition Examination Survey ( NHANES , 2005-2010 ) , the association of antidepressant use with continuous measures of gene , fasting blood chemical , 2-h oral chemical tolerance test , gene sensitivity and screen-positive diabetes according to gene , fasting blood sugar and 2-h oral chemical tolerance test were assessed .	T3	T8	23334176
NA	CHEMICAL	GENE-Y	18	16	Moreover , green tea extract administration significantly increased ( p < 0.05 ) the activities of gene , chemical peroxidase ( chemical-Px ) and chemical reductase ( chemical-Rd ) in the liver .	T7	T13	23194532
NA	CHEMICAL	GENE-N	18	9	Moreover , green tea extract administration significantly increased ( p < 0.05 ) the activities of gene , chemical peroxidase ( chemical-Px ) and chemical reductase ( chemical-Rd ) in the liver .	T7	T14	23194532
NA	CHEMICAL	GENE-Y	18	25	Moreover , green tea extract administration significantly increased ( p < 0.05 ) the activities of gene , chemical peroxidase ( chemical-Px ) and chemical reductase ( chemical-Rd ) in the liver .	T7	T16	23194532
NA	CHEMICAL	GENE-Y	21	16	Moreover , green tea extract administration significantly increased ( p < 0.05 ) the activities of gene , chemical peroxidase ( chemical-Px ) and chemical reductase ( chemical-Rd ) in the liver .	T8	T13	23194532
NA	CHEMICAL	GENE-N	21	9	Moreover , green tea extract administration significantly increased ( p < 0.05 ) the activities of gene , chemical peroxidase ( chemical-Px ) and chemical reductase ( chemical-Rd ) in the liver .	T8	T14	23194532
NA	CHEMICAL	GENE-Y	21	25	Moreover , green tea extract administration significantly increased ( p < 0.05 ) the activities of gene , chemical peroxidase ( chemical-Px ) and chemical reductase ( chemical-Rd ) in the liver .	T8	T16	23194532
NA	CHEMICAL	GENE-Y	24	16	Moreover , green tea extract administration significantly increased ( p < 0.05 ) the activities of gene , chemical peroxidase ( chemical-Px ) and chemical reductase ( chemical-Rd ) in the liver .	T9	T13	23194532
NA	CHEMICAL	GENE-N	24	9	Moreover , green tea extract administration significantly increased ( p < 0.05 ) the activities of gene , chemical peroxidase ( chemical-Px ) and chemical reductase ( chemical-Rd ) in the liver .	T9	T14	23194532
NA	CHEMICAL	GENE-Y	24	25	Moreover , green tea extract administration significantly increased ( p < 0.05 ) the activities of gene , chemical peroxidase ( chemical-Px ) and chemical reductase ( chemical-Rd ) in the liver .	T9	T16	23194532
NA	CHEMICAL	GENE-Y	27	16	Moreover , green tea extract administration significantly increased ( p < 0.05 ) the activities of gene , chemical peroxidase ( chemical-Px ) and chemical reductase ( chemical-Rd ) in the liver .	T10	T13	23194532
NA	CHEMICAL	GENE-N	27	9	Moreover , green tea extract administration significantly increased ( p < 0.05 ) the activities of gene , chemical peroxidase ( chemical-Px ) and chemical reductase ( chemical-Rd ) in the liver .	T10	T14	23194532
NA	CHEMICAL	GENE-Y	27	25	Moreover , green tea extract administration significantly increased ( p < 0.05 ) the activities of gene , chemical peroxidase ( chemical-Px ) and chemical reductase ( chemical-Rd ) in the liver .	T10	T16	23194532
NA	CHEMICAL	GENE-Y	3	8	Folding pathway of chemical-denatured chemical-intact wild-type and mutant gene . The refolding kinetics of chemical-denatured chemical-intact gene ( gene ) and its chemical-42-to-chemical mutant ( gene ) have been studied by monitoring chemical burial and chemical ( chemical ) inhibitor binding .	T13	T23	7986344
NA	CHEMICAL	GENE-Y	3	16	Folding pathway of chemical-denatured chemical-intact wild-type and mutant gene . The refolding kinetics of chemical-denatured chemical-intact gene ( gene ) and its chemical-42-to-chemical mutant ( gene ) have been studied by monitoring chemical burial and chemical ( chemical ) inhibitor binding .	T13	T20	7986344
NA	CHEMICAL	GENE-Y	3	18	Folding pathway of chemical-denatured chemical-intact wild-type and mutant gene . The refolding kinetics of chemical-denatured chemical-intact gene ( gene ) and its chemical-42-to-chemical mutant ( gene ) have been studied by monitoring chemical burial and chemical ( chemical ) inhibitor binding .	T13	T22	7986344
NA	CHEMICAL	GENE-N	3	25	Folding pathway of chemical-denatured chemical-intact wild-type and mutant gene . The refolding kinetics of chemical-denatured chemical-intact gene ( gene ) and its chemical-42-to-chemical mutant ( gene ) have been studied by monitoring chemical burial and chemical ( chemical ) inhibitor binding .	T13	T16	7986344
NA	CHEMICAL	GENE-Y	4	8	Folding pathway of chemical-denatured chemical-intact wild-type and mutant gene . The refolding kinetics of chemical-denatured chemical-intact gene ( gene ) and its chemical-42-to-chemical mutant ( gene ) have been studied by monitoring chemical burial and chemical ( chemical ) inhibitor binding .	T14	T23	7986344
NA	CHEMICAL	GENE-Y	4	16	Folding pathway of chemical-denatured chemical-intact wild-type and mutant gene . The refolding kinetics of chemical-denatured chemical-intact gene ( gene ) and its chemical-42-to-chemical mutant ( gene ) have been studied by monitoring chemical burial and chemical ( chemical ) inhibitor binding .	T14	T20	7986344
NA	CHEMICAL	GENE-Y	4	18	Folding pathway of chemical-denatured chemical-intact wild-type and mutant gene . The refolding kinetics of chemical-denatured chemical-intact gene ( gene ) and its chemical-42-to-chemical mutant ( gene ) have been studied by monitoring chemical burial and chemical ( chemical ) inhibitor binding .	T14	T22	7986344
NA	CHEMICAL	GENE-N	4	25	Folding pathway of chemical-denatured chemical-intact wild-type and mutant gene . The refolding kinetics of chemical-denatured chemical-intact gene ( gene ) and its chemical-42-to-chemical mutant ( gene ) have been studied by monitoring chemical burial and chemical ( chemical ) inhibitor binding .	T14	T16	7986344
NA	CHEMICAL	GENE-Y	14	8	Folding pathway of chemical-denatured chemical-intact wild-type and mutant gene . The refolding kinetics of chemical-denatured chemical-intact gene ( gene ) and its chemical-42-to-chemical mutant ( gene ) have been studied by monitoring chemical burial and chemical ( chemical ) inhibitor binding .	T6	T23	7986344
NA	CHEMICAL	GENE-Y	14	16	Folding pathway of chemical-denatured chemical-intact wild-type and mutant gene . The refolding kinetics of chemical-denatured chemical-intact gene ( gene ) and its chemical-42-to-chemical mutant ( gene ) have been studied by monitoring chemical burial and chemical ( chemical ) inhibitor binding .	T6	T20	7986344
NA	CHEMICAL	GENE-Y	14	18	Folding pathway of chemical-denatured chemical-intact wild-type and mutant gene . The refolding kinetics of chemical-denatured chemical-intact gene ( gene ) and its chemical-42-to-chemical mutant ( gene ) have been studied by monitoring chemical burial and chemical ( chemical ) inhibitor binding .	T6	T22	7986344
NA	CHEMICAL	GENE-N	14	25	Folding pathway of chemical-denatured chemical-intact wild-type and mutant gene . The refolding kinetics of chemical-denatured chemical-intact gene ( gene ) and its chemical-42-to-chemical mutant ( gene ) have been studied by monitoring chemical burial and chemical ( chemical ) inhibitor binding .	T6	T16	7986344
NA	CHEMICAL	GENE-Y	15	8	Folding pathway of chemical-denatured chemical-intact wild-type and mutant gene . The refolding kinetics of chemical-denatured chemical-intact gene ( gene ) and its chemical-42-to-chemical mutant ( gene ) have been studied by monitoring chemical burial and chemical ( chemical ) inhibitor binding .	T9	T23	7986344
NA	CHEMICAL	GENE-Y	15	16	Folding pathway of chemical-denatured chemical-intact wild-type and mutant gene . The refolding kinetics of chemical-denatured chemical-intact gene ( gene ) and its chemical-42-to-chemical mutant ( gene ) have been studied by monitoring chemical burial and chemical ( chemical ) inhibitor binding .	T9	T20	7986344
NA	CHEMICAL	GENE-Y	15	18	Folding pathway of chemical-denatured chemical-intact wild-type and mutant gene . The refolding kinetics of chemical-denatured chemical-intact gene ( gene ) and its chemical-42-to-chemical mutant ( gene ) have been studied by monitoring chemical burial and chemical ( chemical ) inhibitor binding .	T9	T22	7986344
NA	CHEMICAL	GENE-N	15	25	Folding pathway of chemical-denatured chemical-intact wild-type and mutant gene . The refolding kinetics of chemical-denatured chemical-intact gene ( gene ) and its chemical-42-to-chemical mutant ( gene ) have been studied by monitoring chemical burial and chemical ( chemical ) inhibitor binding .	T9	T16	7986344
NA	CHEMICAL	GENE-Y	3	8	Folding pathway of chemical-denatured chemical-intact wild-type and mutant gene . The refolding kinetics of chemical-denatured chemical-intact gene ( gene ) and its chemical-42-to-chemical mutant ( gene ) have been studied by monitoring chemical burial and chemical ( chemical ) inhibitor binding .	T1	T23	7986344
NA	CHEMICAL	GENE-Y	3	16	Folding pathway of chemical-denatured chemical-intact wild-type and mutant gene . The refolding kinetics of chemical-denatured chemical-intact gene ( gene ) and its chemical-42-to-chemical mutant ( gene ) have been studied by monitoring chemical burial and chemical ( chemical ) inhibitor binding .	T1	T20	7986344
NA	CHEMICAL	GENE-Y	3	18	Folding pathway of chemical-denatured chemical-intact wild-type and mutant gene . The refolding kinetics of chemical-denatured chemical-intact gene ( gene ) and its chemical-42-to-chemical mutant ( gene ) have been studied by monitoring chemical burial and chemical ( chemical ) inhibitor binding .	T1	T22	7986344
NA	CHEMICAL	GENE-N	3	25	Folding pathway of chemical-denatured chemical-intact wild-type and mutant gene . The refolding kinetics of chemical-denatured chemical-intact gene ( gene ) and its chemical-42-to-chemical mutant ( gene ) have been studied by monitoring chemical burial and chemical ( chemical ) inhibitor binding .	T1	T16	7986344
NA	CHEMICAL	GENE-Y	8	8	Folding pathway of chemical-denatured chemical-intact wild-type and mutant gene . The refolding kinetics of chemical-denatured chemical-intact gene ( gene ) and its chemical-42-to-chemical mutant ( gene ) have been studied by monitoring chemical burial and chemical ( chemical ) inhibitor binding .	T2	T23	7986344
NA	CHEMICAL	GENE-Y	8	16	Folding pathway of chemical-denatured chemical-intact wild-type and mutant gene . The refolding kinetics of chemical-denatured chemical-intact gene ( gene ) and its chemical-42-to-chemical mutant ( gene ) have been studied by monitoring chemical burial and chemical ( chemical ) inhibitor binding .	T2	T20	7986344
NA	CHEMICAL	GENE-Y	8	18	Folding pathway of chemical-denatured chemical-intact wild-type and mutant gene . The refolding kinetics of chemical-denatured chemical-intact gene ( gene ) and its chemical-42-to-chemical mutant ( gene ) have been studied by monitoring chemical burial and chemical ( chemical ) inhibitor binding .	T2	T22	7986344
NA	CHEMICAL	GENE-N	8	25	Folding pathway of chemical-denatured chemical-intact wild-type and mutant gene . The refolding kinetics of chemical-denatured chemical-intact gene ( gene ) and its chemical-42-to-chemical mutant ( gene ) have been studied by monitoring chemical burial and chemical ( chemical ) inhibitor binding .	T2	T16	7986344
NA	CHEMICAL	GENE-Y	32	8	Folding pathway of chemical-denatured chemical-intact wild-type and mutant gene . The refolding kinetics of chemical-denatured chemical-intact gene ( gene ) and its chemical-42-to-chemical mutant ( gene ) have been studied by monitoring chemical burial and chemical ( chemical ) inhibitor binding .	T3	T23	7986344
NA	CHEMICAL	GENE-Y	32	16	Folding pathway of chemical-denatured chemical-intact wild-type and mutant gene . The refolding kinetics of chemical-denatured chemical-intact gene ( gene ) and its chemical-42-to-chemical mutant ( gene ) have been studied by monitoring chemical burial and chemical ( chemical ) inhibitor binding .	T3	T20	7986344
NA	CHEMICAL	GENE-Y	32	18	Folding pathway of chemical-denatured chemical-intact wild-type and mutant gene . The refolding kinetics of chemical-denatured chemical-intact gene ( gene ) and its chemical-42-to-chemical mutant ( gene ) have been studied by monitoring chemical burial and chemical ( chemical ) inhibitor binding .	T3	T22	7986344
NA	CHEMICAL	GENE-N	32	25	Folding pathway of chemical-denatured chemical-intact wild-type and mutant gene . The refolding kinetics of chemical-denatured chemical-intact gene ( gene ) and its chemical-42-to-chemical mutant ( gene ) have been studied by monitoring chemical burial and chemical ( chemical ) inhibitor binding .	T3	T16	7986344
NA	CHEMICAL	GENE-Y	35	8	Folding pathway of chemical-denatured chemical-intact wild-type and mutant gene . The refolding kinetics of chemical-denatured chemical-intact gene ( gene ) and its chemical-42-to-chemical mutant ( gene ) have been studied by monitoring chemical burial and chemical ( chemical ) inhibitor binding .	T4	T23	7986344
CPR:4	CHEMICAL	GENE-Y	35	16	Folding pathway of chemical-denatured chemical-intact wild-type and mutant gene . The refolding kinetics of chemical-denatured chemical-intact gene ( gene ) and its chemical-42-to-chemical mutant ( gene ) have been studied by monitoring chemical burial and chemical ( chemical ) inhibitor binding .	T4	T20	7986344
CPR:4	CHEMICAL	GENE-Y	35	18	Folding pathway of chemical-denatured chemical-intact wild-type and mutant gene . The refolding kinetics of chemical-denatured chemical-intact gene ( gene ) and its chemical-42-to-chemical mutant ( gene ) have been studied by monitoring chemical burial and chemical ( chemical ) inhibitor binding .	T4	T22	7986344
CPR:4	CHEMICAL	GENE-N	35	25	Folding pathway of chemical-denatured chemical-intact wild-type and mutant gene . The refolding kinetics of chemical-denatured chemical-intact gene ( gene ) and its chemical-42-to-chemical mutant ( gene ) have been studied by monitoring chemical burial and chemical ( chemical ) inhibitor binding .	T4	T16	7986344
NA	CHEMICAL	GENE-Y	37	8	Folding pathway of chemical-denatured chemical-intact wild-type and mutant gene . The refolding kinetics of chemical-denatured chemical-intact gene ( gene ) and its chemical-42-to-chemical mutant ( gene ) have been studied by monitoring chemical burial and chemical ( chemical ) inhibitor binding .	T5	T23	7986344
CPR:4	CHEMICAL	GENE-Y	37	16	Folding pathway of chemical-denatured chemical-intact wild-type and mutant gene . The refolding kinetics of chemical-denatured chemical-intact gene ( gene ) and its chemical-42-to-chemical mutant ( gene ) have been studied by monitoring chemical burial and chemical ( chemical ) inhibitor binding .	T5	T20	7986344
CPR:4	CHEMICAL	GENE-Y	37	18	Folding pathway of chemical-denatured chemical-intact wild-type and mutant gene . The refolding kinetics of chemical-denatured chemical-intact gene ( gene ) and its chemical-42-to-chemical mutant ( gene ) have been studied by monitoring chemical burial and chemical ( chemical ) inhibitor binding .	T5	T22	7986344
CPR:4	CHEMICAL	GENE-N	37	25	Folding pathway of chemical-denatured chemical-intact wild-type and mutant gene . The refolding kinetics of chemical-denatured chemical-intact gene ( gene ) and its chemical-42-to-chemical mutant ( gene ) have been studied by monitoring chemical burial and chemical ( chemical ) inhibitor binding .	T5	T16	7986344
CPR:4	CHEMICAL	GENE-Y	14	5	The folding rate for wild-type gene is faster in the presence of the inhibitor chemical than in its absence , indicating that the transition-state structure in the rate-determining step is stabilized by chemical .	T7	T17	7986344
NA	CHEMICAL	GENE-Y	32	5	The folding rate for wild-type gene is faster in the presence of the inhibitor chemical than in its absence , indicating that the transition-state structure in the rate-determining step is stabilized by chemical .	T8	T17	7986344
NA	CHEMICAL	GENE-N	4	7	Using the viral mimic chemical and the gene antagonist B18R we furthermore demonstrate the capability of endogenous gene to promote gene-induced gene activation and expression of gene .	T2	T34	23153456
NA	CHEMICAL	GENE-N	4	7	Using the viral mimic chemical and the gene antagonist B18R we furthermore demonstrate the capability of endogenous gene to promote gene-induced gene activation and expression of gene .	T2	T3	23153456
NA	CHEMICAL	GENE-Y	4	20	Using the viral mimic chemical and the gene antagonist B18R we furthermore demonstrate the capability of endogenous gene to promote gene-induced gene activation and expression of gene .	T2	T4	23153456
NA	CHEMICAL	GENE-Y	4	21	Using the viral mimic chemical and the gene antagonist B18R we furthermore demonstrate the capability of endogenous gene to promote gene-induced gene activation and expression of gene .	T2	T5	23153456
NA	CHEMICAL	GENE-Y	4	26	Using the viral mimic chemical and the gene antagonist B18R we furthermore demonstrate the capability of endogenous gene to promote gene-induced gene activation and expression of gene .	T2	T6	23153456
CPR:4	CHEMICAL	GENE-N	0	7	chemical decreased the expression of the chemical transporter , gene , and most of the glycolytic transcripts , followed by decreases in glycolytic intermediates , including chemical .	T20	T34	23152189
CPR:4	CHEMICAL	GENE-Y	0	9	chemical decreased the expression of the chemical transporter , gene , and most of the glycolytic transcripts , followed by decreases in glycolytic intermediates , including chemical .	T20	T35	23152189
NA	CHEMICAL	GENE-N	6	7	chemical decreased the expression of the chemical transporter , gene , and most of the glycolytic transcripts , followed by decreases in glycolytic intermediates , including chemical .	T21	T34	23152189
NA	CHEMICAL	GENE-Y	6	9	chemical decreased the expression of the chemical transporter , gene , and most of the glycolytic transcripts , followed by decreases in glycolytic intermediates , including chemical .	T21	T35	23152189
NA	CHEMICAL	GENE-N	26	7	chemical decreased the expression of the chemical transporter , gene , and most of the glycolytic transcripts , followed by decreases in glycolytic intermediates , including chemical .	T22	T34	23152189
NA	CHEMICAL	GENE-Y	26	9	chemical decreased the expression of the chemical transporter , gene , and most of the glycolytic transcripts , followed by decreases in glycolytic intermediates , including chemical .	T22	T35	23152189
NA	CHEMICAL	GENE-N	1	5	Mitochondrial chemical ( chemical ) reductase activity and the chemical/chemical ratio were decreased by chemical , ultimately leading to mitochondrial dysfunction , characterized by decreased inner mitochondrial membrane potential and chemical production , and increased production of the reactive chemical species ( ROS ) , chemical .	T26	T36	23152189
NA	CHEMICAL	GENE-N	3	5	Mitochondrial chemical ( chemical ) reductase activity and the chemical/chemical ratio were decreased by chemical , ultimately leading to mitochondrial dysfunction , characterized by decreased inner mitochondrial membrane potential and chemical production , and increased production of the reactive chemical species ( ROS ) , chemical .	T27	T36	23152189
NA	CHEMICAL	GENE-N	9	5	Mitochondrial chemical ( chemical ) reductase activity and the chemical/chemical ratio were decreased by chemical , ultimately leading to mitochondrial dysfunction , characterized by decreased inner mitochondrial membrane potential and chemical production , and increased production of the reactive chemical species ( ROS ) , chemical .	T1	T36	23152189
NA	CHEMICAL	GENE-N	1	5	Mitochondrial chemical ( chemical ) reductase activity and the chemical/chemical ratio were decreased by chemical , ultimately leading to mitochondrial dysfunction , characterized by decreased inner mitochondrial membrane potential and chemical production , and increased production of the reactive chemical species ( ROS ) , chemical .	T2	T36	23152189
CPR:4	CHEMICAL	GENE-N	14	5	Mitochondrial chemical ( chemical ) reductase activity and the chemical/chemical ratio were decreased by chemical , ultimately leading to mitochondrial dysfunction , characterized by decreased inner mitochondrial membrane potential and chemical production , and increased production of the reactive chemical species ( ROS ) , chemical .	T3	T36	23152189
NA	CHEMICAL	GENE-N	30	5	Mitochondrial chemical ( chemical ) reductase activity and the chemical/chemical ratio were decreased by chemical , ultimately leading to mitochondrial dysfunction , characterized by decreased inner mitochondrial membrane potential and chemical production , and increased production of the reactive chemical species ( ROS ) , chemical .	T4	T36	23152189
NA	CHEMICAL	GENE-N	39	5	Mitochondrial chemical ( chemical ) reductase activity and the chemical/chemical ratio were decreased by chemical , ultimately leading to mitochondrial dysfunction , characterized by decreased inner mitochondrial membrane potential and chemical production , and increased production of the reactive chemical species ( ROS ) , chemical .	T5	T36	23152189
NA	CHEMICAL	GENE-N	45	5	Mitochondrial chemical ( chemical ) reductase activity and the chemical/chemical ratio were decreased by chemical , ultimately leading to mitochondrial dysfunction , characterized by decreased inner mitochondrial membrane potential and chemical production , and increased production of the reactive chemical species ( ROS ) , chemical .	T6	T36	23152189
NA	CHEMICAL	GENE-Y	0	1	chemical receptor ( gene ) antagonists blocked the response of many transcripts to chemical , and the endpoints of decreased chemical production and differentiation , suggesting regulation by the gene .	T7	T30	23152189
NA	CHEMICAL	GENE-Y	0	3	chemical receptor ( gene ) antagonists blocked the response of many transcripts to chemical , and the endpoints of decreased chemical production and differentiation , suggesting regulation by the gene .	T7	T31	23152189
NA	CHEMICAL	GENE-Y	0	29	chemical receptor ( gene ) antagonists blocked the response of many transcripts to chemical , and the endpoints of decreased chemical production and differentiation , suggesting regulation by the gene .	T7	T32	23152189
NA	CHEMICAL	GENE-Y	13	1	chemical receptor ( gene ) antagonists blocked the response of many transcripts to chemical , and the endpoints of decreased chemical production and differentiation , suggesting regulation by the gene .	T8	T30	23152189
NA	CHEMICAL	GENE-Y	13	3	chemical receptor ( gene ) antagonists blocked the response of many transcripts to chemical , and the endpoints of decreased chemical production and differentiation , suggesting regulation by the gene .	T8	T31	23152189
NA	CHEMICAL	GENE-Y	13	29	chemical receptor ( gene ) antagonists blocked the response of many transcripts to chemical , and the endpoints of decreased chemical production and differentiation , suggesting regulation by the gene .	T8	T32	23152189
NA	CHEMICAL	GENE-Y	20	1	chemical receptor ( gene ) antagonists blocked the response of many transcripts to chemical , and the endpoints of decreased chemical production and differentiation , suggesting regulation by the gene .	T9	T30	23152189
NA	CHEMICAL	GENE-Y	20	3	chemical receptor ( gene ) antagonists blocked the response of many transcripts to chemical , and the endpoints of decreased chemical production and differentiation , suggesting regulation by the gene .	T9	T31	23152189
NA	CHEMICAL	GENE-Y	20	29	chemical receptor ( gene ) antagonists blocked the response of many transcripts to chemical , and the endpoints of decreased chemical production and differentiation , suggesting regulation by the gene .	T9	T32	23152189
NA	CHEMICAL	GENE-Y	12	9	Cotreatment of cells with chemical antioxidants or the enzyme gene blocked the chemical-mediated acceleration of keratinocyte cornified envelope formation , an endpoint of terminal differentiation .	T10	T33	23152189
CPR:4	CHEMICAL	GENE-Y	5	18	Synthesis and antitumor activity of chemical possessing chemical moiety as a novel class of potent chemical aminopeptidase type II inhibitors .	T6	T10	23582273
CPR:4	CHEMICAL	GENE-Y	7	18	Synthesis and antitumor activity of chemical possessing chemical moiety as a novel class of potent chemical aminopeptidase type II inhibitors .	T7	T10	23582273
NA	CHEMICAL	GENE-Y	15	18	Synthesis and antitumor activity of chemical possessing chemical moiety as a novel class of potent chemical aminopeptidase type II inhibitors .	T5	T10	23582273
NA	CHEMICAL	GENE-Y	20	0	gene activity was significantly higher in survivors ( 238.8±51.5 ) than non-survivors ( 166.4±40.2 ; p=0.005 ) , while protein chemical levels were significantly lower in survivors ( 0.32±0.09 ) than non-survivors ( 0.48±0.16 ; p=0.036 ) on the 1stday .	T8	T9	23542126
NA	CHEMICAL	GENE-Y	1	3	Polymorphisms in chemical transporter ( gene ) are associated with stimulant effects of chemical : an exploratory pharmacogenetic study using healthy volunteers .	T5	T9	20091113
NA	CHEMICAL	GENE-Y	1	5	Polymorphisms in chemical transporter ( gene ) are associated with stimulant effects of chemical : an exploratory pharmacogenetic study using healthy volunteers .	T5	T10	20091113
CPR:3	CHEMICAL	GENE-Y	1	3	Polymorphisms in chemical transporter ( gene ) are associated with stimulant effects of chemical : an exploratory pharmacogenetic study using healthy volunteers .	T6	T9	20091113
CPR:3	CHEMICAL	GENE-Y	1	5	Polymorphisms in chemical transporter ( gene ) are associated with stimulant effects of chemical : an exploratory pharmacogenetic study using healthy volunteers .	T6	T10	20091113
NA	CHEMICAL	GENE-Y	11	18	We evaluated associations between mood , cognitive and cardiovascular responses to chemical and four polymorphisms in the chemical transporter ( gene ) : rs460000 , rs3756450 , rs37022 and rs6869645 .	T2	T7	20091113
NA	CHEMICAL	GENE-Y	11	20	We evaluated associations between mood , cognitive and cardiovascular responses to chemical and four polymorphisms in the chemical transporter ( gene ) : rs460000 , rs3756450 , rs37022 and rs6869645 .	T2	T8	20091113
NA	CHEMICAL	GENE-Y	15	18	We evaluated associations between mood , cognitive and cardiovascular responses to chemical and four polymorphisms in the chemical transporter ( gene ) : rs460000 , rs3756450 , rs37022 and rs6869645 .	T3	T7	20091113
NA	CHEMICAL	GENE-Y	15	20	We evaluated associations between mood , cognitive and cardiovascular responses to chemical and four polymorphisms in the chemical transporter ( gene ) : rs460000 , rs3756450 , rs37022 and rs6869645 .	T3	T8	20091113
NA	CHEMICAL	GENE-N	6	8	The protein is formed by an chemical-terminal helicase-like domain , a chemical-terminal DNA polymerase domain , and a gene that spans between the two .	T1	T9	23219161
NA	CHEMICAL	GENE-N	6	8	The protein is formed by an chemical-terminal helicase-like domain , a chemical-terminal DNA polymerase domain , and a gene that spans between the two .	T1	T10	23219161
NA	CHEMICAL	GENE-N	6	8	The protein is formed by an chemical-terminal helicase-like domain , a chemical-terminal DNA polymerase domain , and a gene that spans between the two .	T1	T11	23219161
NA	CHEMICAL	GENE-N	11	8	The protein is formed by an chemical-terminal helicase-like domain , a chemical-terminal DNA polymerase domain , and a gene that spans between the two .	T2	T9	23219161
NA	CHEMICAL	GENE-N	11	8	The protein is formed by an chemical-terminal helicase-like domain , a chemical-terminal DNA polymerase domain , and a gene that spans between the two .	T2	T10	23219161
NA	CHEMICAL	GENE-N	11	8	The protein is formed by an chemical-terminal helicase-like domain , a chemical-terminal DNA polymerase domain , and a gene that spans between the two .	T2	T11	23219161
NA	CHEMICAL	GENE-N	0	18	chemical ( chemical ) , chemical ( chemical ) , chemical , chemical ( chemical ) and chemical dismutase ( gene ) levels in renal homogenate , and urine protein excretion were measured .	T5	T20	23531536
NA	CHEMICAL	GENE-N	0	20	chemical ( chemical ) , chemical ( chemical ) , chemical , chemical ( chemical ) and chemical dismutase ( gene ) levels in renal homogenate , and urine protein excretion were measured .	T5	T21	23531536
NA	CHEMICAL	GENE-N	2	18	chemical ( chemical ) , chemical ( chemical ) , chemical , chemical ( chemical ) and chemical dismutase ( gene ) levels in renal homogenate , and urine protein excretion were measured .	T6	T20	23531536
NA	CHEMICAL	GENE-N	2	20	chemical ( chemical ) , chemical ( chemical ) , chemical , chemical ( chemical ) and chemical dismutase ( gene ) levels in renal homogenate , and urine protein excretion were measured .	T6	T21	23531536
NA	CHEMICAL	GENE-N	5	18	chemical ( chemical ) , chemical ( chemical ) , chemical , chemical ( chemical ) and chemical dismutase ( gene ) levels in renal homogenate , and urine protein excretion were measured .	T7	T20	23531536
NA	CHEMICAL	GENE-N	5	20	chemical ( chemical ) , chemical ( chemical ) , chemical , chemical ( chemical ) and chemical dismutase ( gene ) levels in renal homogenate , and urine protein excretion were measured .	T7	T21	23531536
NA	CHEMICAL	GENE-N	7	18	chemical ( chemical ) , chemical ( chemical ) , chemical , chemical ( chemical ) and chemical dismutase ( gene ) levels in renal homogenate , and urine protein excretion were measured .	T8	T20	23531536
NA	CHEMICAL	GENE-N	7	20	chemical ( chemical ) , chemical ( chemical ) , chemical , chemical ( chemical ) and chemical dismutase ( gene ) levels in renal homogenate , and urine protein excretion were measured .	T8	T21	23531536
NA	CHEMICAL	GENE-N	10	18	chemical ( chemical ) , chemical ( chemical ) , chemical , chemical ( chemical ) and chemical dismutase ( gene ) levels in renal homogenate , and urine protein excretion were measured .	T9	T20	23531536
NA	CHEMICAL	GENE-N	10	20	chemical ( chemical ) , chemical ( chemical ) , chemical , chemical ( chemical ) and chemical dismutase ( gene ) levels in renal homogenate , and urine protein excretion were measured .	T9	T21	23531536
NA	CHEMICAL	GENE-N	12	18	chemical ( chemical ) , chemical ( chemical ) , chemical , chemical ( chemical ) and chemical dismutase ( gene ) levels in renal homogenate , and urine protein excretion were measured .	T11	T20	23531536
NA	CHEMICAL	GENE-N	12	20	chemical ( chemical ) , chemical ( chemical ) , chemical , chemical ( chemical ) and chemical dismutase ( gene ) levels in renal homogenate , and urine protein excretion were measured .	T11	T21	23531536
NA	CHEMICAL	GENE-N	14	18	chemical ( chemical ) , chemical ( chemical ) , chemical , chemical ( chemical ) and chemical dismutase ( gene ) levels in renal homogenate , and urine protein excretion were measured .	T12	T20	23531536
NA	CHEMICAL	GENE-N	14	20	chemical ( chemical ) , chemical ( chemical ) , chemical , chemical ( chemical ) and chemical dismutase ( gene ) levels in renal homogenate , and urine protein excretion were measured .	T12	T21	23531536
NA	CHEMICAL	GENE-N	17	18	chemical ( chemical ) , chemical ( chemical ) , chemical , chemical ( chemical ) and chemical dismutase ( gene ) levels in renal homogenate , and urine protein excretion were measured .	T13	T20	23531536
NA	CHEMICAL	GENE-N	17	20	chemical ( chemical ) , chemical ( chemical ) , chemical , chemical ( chemical ) and chemical dismutase ( gene ) levels in renal homogenate , and urine protein excretion were measured .	T13	T21	23531536
NA	CHEMICAL	GENE-N	7	5	The expression of mRNA for gene , chemical oxidase subunits gene and gene in renal tissue was examined by realtime PCR .	T14	T22	23531536
NA	CHEMICAL	GENE-N	7	8	The expression of mRNA for gene , chemical oxidase subunits gene and gene in renal tissue was examined by realtime PCR .	T14	T23	23531536
NA	CHEMICAL	GENE-Y	7	10	The expression of mRNA for gene , chemical oxidase subunits gene and gene in renal tissue was examined by realtime PCR .	T14	T24	23531536
NA	CHEMICAL	GENE-Y	7	12	The expression of mRNA for gene , chemical oxidase subunits gene and gene in renal tissue was examined by realtime PCR .	T14	T25	23531536
NA	CHEMICAL	GENE-N	9	17	There were significant increases in urine protein excretion , chemical levels and the expression of mRNA of gene , gene and gene , and significant decreases in chemical , gene , chemical and chemical levels in the diabetic control group compared with the normal control group .	T15	T26	23531536
NA	CHEMICAL	GENE-Y	9	19	There were significant increases in urine protein excretion , chemical levels and the expression of mRNA of gene , gene and gene , and significant decreases in chemical , gene , chemical and chemical levels in the diabetic control group compared with the normal control group .	T15	T27	23531536
NA	CHEMICAL	GENE-Y	9	21	There were significant increases in urine protein excretion , chemical levels and the expression of mRNA of gene , gene and gene , and significant decreases in chemical , gene , chemical and chemical levels in the diabetic control group compared with the normal control group .	T15	T28	23531536
NA	CHEMICAL	GENE-N	9	29	There were significant increases in urine protein excretion , chemical levels and the expression of mRNA of gene , gene and gene , and significant decreases in chemical , gene , chemical and chemical levels in the diabetic control group compared with the normal control group .	T15	T29	23531536
NA	CHEMICAL	GENE-N	27	17	There were significant increases in urine protein excretion , chemical levels and the expression of mRNA of gene , gene and gene , and significant decreases in chemical , gene , chemical and chemical levels in the diabetic control group compared with the normal control group .	T16	T26	23531536
NA	CHEMICAL	GENE-Y	27	19	There were significant increases in urine protein excretion , chemical levels and the expression of mRNA of gene , gene and gene , and significant decreases in chemical , gene , chemical and chemical levels in the diabetic control group compared with the normal control group .	T16	T27	23531536
NA	CHEMICAL	GENE-Y	27	21	There were significant increases in urine protein excretion , chemical levels and the expression of mRNA of gene , gene and gene , and significant decreases in chemical , gene , chemical and chemical levels in the diabetic control group compared with the normal control group .	T16	T28	23531536
NA	CHEMICAL	GENE-N	27	29	There were significant increases in urine protein excretion , chemical levels and the expression of mRNA of gene , gene and gene , and significant decreases in chemical , gene , chemical and chemical levels in the diabetic control group compared with the normal control group .	T16	T29	23531536
NA	CHEMICAL	GENE-N	31	17	There were significant increases in urine protein excretion , chemical levels and the expression of mRNA of gene , gene and gene , and significant decreases in chemical , gene , chemical and chemical levels in the diabetic control group compared with the normal control group .	T17	T26	23531536
NA	CHEMICAL	GENE-Y	31	19	There were significant increases in urine protein excretion , chemical levels and the expression of mRNA of gene , gene and gene , and significant decreases in chemical , gene , chemical and chemical levels in the diabetic control group compared with the normal control group .	T17	T27	23531536
NA	CHEMICAL	GENE-Y	31	21	There were significant increases in urine protein excretion , chemical levels and the expression of mRNA of gene , gene and gene , and significant decreases in chemical , gene , chemical and chemical levels in the diabetic control group compared with the normal control group .	T17	T28	23531536
NA	CHEMICAL	GENE-N	31	29	There were significant increases in urine protein excretion , chemical levels and the expression of mRNA of gene , gene and gene , and significant decreases in chemical , gene , chemical and chemical levels in the diabetic control group compared with the normal control group .	T17	T29	23531536
NA	CHEMICAL	GENE-N	33	17	There were significant increases in urine protein excretion , chemical levels and the expression of mRNA of gene , gene and gene , and significant decreases in chemical , gene , chemical and chemical levels in the diabetic control group compared with the normal control group .	T18	T26	23531536
NA	CHEMICAL	GENE-Y	33	19	There were significant increases in urine protein excretion , chemical levels and the expression of mRNA of gene , gene and gene , and significant decreases in chemical , gene , chemical and chemical levels in the diabetic control group compared with the normal control group .	T18	T27	23531536
NA	CHEMICAL	GENE-Y	33	21	There were significant increases in urine protein excretion , chemical levels and the expression of mRNA of gene , gene and gene , and significant decreases in chemical , gene , chemical and chemical levels in the diabetic control group compared with the normal control group .	T18	T28	23531536
NA	CHEMICAL	GENE-N	33	29	There were significant increases in urine protein excretion , chemical levels and the expression of mRNA of gene , gene and gene , and significant decreases in chemical , gene , chemical and chemical levels in the diabetic control group compared with the normal control group .	T18	T29	23531536
CPR:4	CHEMICAL	GENE-N	0	2	chemical , a lipid-lowering drug , inhibits the induction of chemical synthase in human astrocytes .	T17	T68	12244038
CPR:9	CHEMICAL	GENE-N	10	2	chemical , a lipid-lowering drug , inhibits the induction of chemical synthase in human astrocytes .	T18	T68	12244038
CPR:4	CHEMICAL	GENE-N	0	7	chemical , a lipid-lowering drug , inhibited gene-induced production of chemical and the expression of gene ( gene ) in human U373MG astroglial cells and primary astrocytes .	T1	T56	12244038
CPR:4	CHEMICAL	GENE-Y	0	2	chemical , a lipid-lowering drug , inhibited gene-induced production of chemical and the expression of gene ( gene ) in human U373MG astroglial cells and primary astrocytes .	T1	T20	12244038
CPR:4	CHEMICAL	GENE-Y	0	17	chemical , a lipid-lowering drug , inhibited gene-induced production of chemical and the expression of gene ( gene ) in human U373MG astroglial cells and primary astrocytes .	T1	T29	12244038
NA	CHEMICAL	GENE-N	10	7	chemical , a lipid-lowering drug , inhibited gene-induced production of chemical and the expression of gene ( gene ) in human U373MG astroglial cells and primary astrocytes .	T14	T56	12244038
CPR:9	CHEMICAL	GENE-Y	10	2	chemical , a lipid-lowering drug , inhibited gene-induced production of chemical and the expression of gene ( gene ) in human U373MG astroglial cells and primary astrocytes .	T14	T20	12244038
CPR:9	CHEMICAL	GENE-Y	10	17	chemical , a lipid-lowering drug , inhibited gene-induced production of chemical and the expression of gene ( gene ) in human U373MG astroglial cells and primary astrocytes .	T14	T29	12244038
NA	CHEMICAL	GENE-N	15	7	chemical , a lipid-lowering drug , inhibited gene-induced production of chemical and the expression of gene ( gene ) in human U373MG astroglial cells and primary astrocytes .	T2	T56	12244038
CPR:9	CHEMICAL	GENE-Y	15	2	chemical , a lipid-lowering drug , inhibited gene-induced production of chemical and the expression of gene ( gene ) in human U373MG astroglial cells and primary astrocytes .	T2	T20	12244038
CPR:9	CHEMICAL	GENE-Y	15	17	chemical , a lipid-lowering drug , inhibited gene-induced production of chemical and the expression of gene ( gene ) in human U373MG astroglial cells and primary astrocytes .	T2	T29	12244038
CPR:4	CHEMICAL	GENE-Y	2	15	Similar to chemical , chemical , another chemical drug , also inhibited the expression of gene .	T6	T53	12244038
CPR:4	CHEMICAL	GENE-Y	4	15	Similar to chemical , chemical , another chemical drug , also inhibited the expression of gene .	T8	T53	12244038
CPR:4	CHEMICAL	GENE-Y	7	15	Similar to chemical , chemical , another chemical drug , also inhibited the expression of gene .	T9	T53	12244038
CPR:4	CHEMICAL	GENE-N	6	2	Inhibition of gene-driven luciferase activity by chemical in gene-stimulated U373MG astroglial cells suggests that this compound inhibits the transcription of gene .	T10	T54	12244038
NA	CHEMICAL	GENE-N	6	7	Inhibition of gene-driven luciferase activity by chemical in gene-stimulated U373MG astroglial cells suggests that this compound inhibits the transcription of gene .	T10	T55	12244038
CPR:4	CHEMICAL	GENE-Y	6	20	Inhibition of gene-driven luciferase activity by chemical in gene-stimulated U373MG astroglial cells suggests that this compound inhibits the transcription of gene .	T10	T57	12244038
CPR:3	CHEMICAL	GENE-Y	1	4	Since chemical is known to activate gene ( gene ) , we investigated the role of gene in chemical-mediated inhibition of gene .	T11	T58	12244038
CPR:3	CHEMICAL	GENE-Y	1	8	Since chemical is known to activate gene ( gene ) , we investigated the role of gene in chemical-mediated inhibition of gene .	T11	T59	12244038
NA	CHEMICAL	GENE-Y	1	16	Since chemical is known to activate gene ( gene ) , we investigated the role of gene in chemical-mediated inhibition of gene .	T11	T60	12244038
NA	CHEMICAL	GENE-Y	1	21	Since chemical is known to activate gene ( gene ) , we investigated the role of gene in chemical-mediated inhibition of gene .	T11	T61	12244038
NA	CHEMICAL	GENE-Y	18	4	Since chemical is known to activate gene ( gene ) , we investigated the role of gene in chemical-mediated inhibition of gene .	T12	T58	12244038
NA	CHEMICAL	GENE-Y	18	8	Since chemical is known to activate gene ( gene ) , we investigated the role of gene in chemical-mediated inhibition of gene .	T12	T59	12244038
CPR:3	CHEMICAL	GENE-Y	18	16	Since chemical is known to activate gene ( gene ) , we investigated the role of gene in chemical-mediated inhibition of gene .	T12	T60	12244038
CPR:4	CHEMICAL	GENE-Y	18	21	Since chemical is known to activate gene ( gene ) , we investigated the role of gene in chemical-mediated inhibition of gene .	T12	T61	12244038
CPR:3	CHEMICAL	GENE-N	0	2	chemical induced gene ( gene ) -dependent luciferase activity , which was inhibited by the expression of gene , the dominant-negative mutant of gene .	T13	T62	12244038
CPR:3	CHEMICAL	GENE-N	0	4	chemical induced gene ( gene ) -dependent luciferase activity , which was inhibited by the expression of gene , the dominant-negative mutant of gene .	T13	T63	12244038
NA	CHEMICAL	GENE-Y	0	17	chemical induced gene ( gene ) -dependent luciferase activity , which was inhibited by the expression of gene , the dominant-negative mutant of gene .	T13	T64	12244038
NA	CHEMICAL	GENE-Y	0	23	chemical induced gene ( gene ) -dependent luciferase activity , which was inhibited by the expression of gene , the dominant-negative mutant of gene .	T13	T65	12244038
NA	CHEMICAL	GENE-Y	7	2	However , gene was unable to abrogate chemical-mediated inhibition of gene suggesting that chemical inhibits gene independent of gene .	T15	T66	12244038
CPR:4	CHEMICAL	GENE-Y	7	10	However , gene was unable to abrogate chemical-mediated inhibition of gene suggesting that chemical inhibits gene independent of gene .	T15	T67	12244038
NA	CHEMICAL	GENE-Y	7	15	However , gene was unable to abrogate chemical-mediated inhibition of gene suggesting that chemical inhibits gene independent of gene .	T15	T19	12244038
NA	CHEMICAL	GENE-Y	7	18	However , gene was unable to abrogate chemical-mediated inhibition of gene suggesting that chemical inhibits gene independent of gene .	T15	T21	12244038
NA	CHEMICAL	GENE-Y	13	2	However , gene was unable to abrogate chemical-mediated inhibition of gene suggesting that chemical inhibits gene independent of gene .	T16	T66	12244038
NA	CHEMICAL	GENE-Y	13	10	However , gene was unable to abrogate chemical-mediated inhibition of gene suggesting that chemical inhibits gene independent of gene .	T16	T67	12244038
CPR:4	CHEMICAL	GENE-Y	13	15	However , gene was unable to abrogate chemical-mediated inhibition of gene suggesting that chemical inhibits gene independent of gene .	T16	T19	12244038
NA	CHEMICAL	GENE-Y	13	18	However , gene was unable to abrogate chemical-mediated inhibition of gene suggesting that chemical inhibits gene independent of gene .	T16	T21	12244038
NA	CHEMICAL	GENE-N	36	1	The gene contains consensus sequences for the binding of transcription factors , including gene ( gene ) binding to gene ( gene ) , gene ( gene ) binding to gamma-activation site ( GAS ) , gene ( gene ) , gene ( gene ) , and gene ( gene ) ; therefore , we investigated the effect of chemical on the activation of these transcription factors .	T3	T22	12244038
NA	CHEMICAL	GENE-Y	36	13	The gene contains consensus sequences for the binding of transcription factors , including gene ( gene ) binding to gene ( gene ) , gene ( gene ) binding to gamma-activation site ( GAS ) , gene ( gene ) , gene ( gene ) , and gene ( gene ) ; therefore , we investigated the effect of chemical on the activation of these transcription factors .	T3	T23	12244038
NA	CHEMICAL	GENE-Y	36	15	The gene contains consensus sequences for the binding of transcription factors , including gene ( gene ) binding to gene ( gene ) , gene ( gene ) binding to gamma-activation site ( GAS ) , gene ( gene ) , gene ( gene ) , and gene ( gene ) ; therefore , we investigated the effect of chemical on the activation of these transcription factors .	T3	T24	12244038
NA	CHEMICAL	GENE-N	36	19	The gene contains consensus sequences for the binding of transcription factors , including gene ( gene ) binding to gene ( gene ) , gene ( gene ) binding to gamma-activation site ( GAS ) , gene ( gene ) , gene ( gene ) , and gene ( gene ) ; therefore , we investigated the effect of chemical on the activation of these transcription factors .	T3	T25	12244038
NA	CHEMICAL	GENE-N	36	21	The gene contains consensus sequences for the binding of transcription factors , including gene ( gene ) binding to gene ( gene ) , gene ( gene ) binding to gamma-activation site ( GAS ) , gene ( gene ) , gene ( gene ) , and gene ( gene ) ; therefore , we investigated the effect of chemical on the activation of these transcription factors .	T3	T26	12244038
NA	CHEMICAL	GENE-N	36	9	The gene contains consensus sequences for the binding of transcription factors , including gene ( gene ) binding to gene ( gene ) , gene ( gene ) binding to gamma-activation site ( GAS ) , gene ( gene ) , gene ( gene ) , and gene ( gene ) ; therefore , we investigated the effect of chemical on the activation of these transcription factors .	T3	T27	12244038
NA	CHEMICAL	GENE-N	36	26	The gene contains consensus sequences for the binding of transcription factors , including gene ( gene ) binding to gene ( gene ) , gene ( gene ) binding to gamma-activation site ( GAS ) , gene ( gene ) , gene ( gene ) , and gene ( gene ) ; therefore , we investigated the effect of chemical on the activation of these transcription factors .	T3	T28	12244038
NA	CHEMICAL	GENE-N	36	18	The gene contains consensus sequences for the binding of transcription factors , including gene ( gene ) binding to gene ( gene ) , gene ( gene ) binding to gamma-activation site ( GAS ) , gene ( gene ) , gene ( gene ) , and gene ( gene ) ; therefore , we investigated the effect of chemical on the activation of these transcription factors .	T3	T30	12244038
NA	CHEMICAL	GENE-N	36	38	The gene contains consensus sequences for the binding of transcription factors , including gene ( gene ) binding to gene ( gene ) , gene ( gene ) binding to gamma-activation site ( GAS ) , gene ( gene ) , gene ( gene ) , and gene ( gene ) ; therefore , we investigated the effect of chemical on the activation of these transcription factors .	T3	T31	12244038
NA	CHEMICAL	GENE-Y	36	41	The gene contains consensus sequences for the binding of transcription factors , including gene ( gene ) binding to gene ( gene ) , gene ( gene ) binding to gamma-activation site ( GAS ) , gene ( gene ) , gene ( gene ) , and gene ( gene ) ; therefore , we investigated the effect of chemical on the activation of these transcription factors .	T3	T32	12244038
NA	CHEMICAL	GENE-Y	36	43	The gene contains consensus sequences for the binding of transcription factors , including gene ( gene ) binding to gene ( gene ) , gene ( gene ) binding to gamma-activation site ( GAS ) , gene ( gene ) , gene ( gene ) , and gene ( gene ) ; therefore , we investigated the effect of chemical on the activation of these transcription factors .	T3	T33	12244038
NA	CHEMICAL	GENE-Y	36	47	The gene contains consensus sequences for the binding of transcription factors , including gene ( gene ) binding to gene ( gene ) , gene ( gene ) binding to gamma-activation site ( GAS ) , gene ( gene ) , gene ( gene ) , and gene ( gene ) ; therefore , we investigated the effect of chemical on the activation of these transcription factors .	T3	T34	12244038
NA	CHEMICAL	GENE-Y	36	49	The gene contains consensus sequences for the binding of transcription factors , including gene ( gene ) binding to gene ( gene ) , gene ( gene ) binding to gamma-activation site ( GAS ) , gene ( gene ) , gene ( gene ) , and gene ( gene ) ; therefore , we investigated the effect of chemical on the activation of these transcription factors .	T3	T35	12244038
CPR:4	CHEMICAL	GENE-N	2	8	Interestingly , chemical strongly inhibited the activation of gene , gene , and gene but not that of GAS in gene-stimulated astroglial cells .	T4	T45	12244038
CPR:4	CHEMICAL	GENE-Y	2	10	Interestingly , chemical strongly inhibited the activation of gene , gene , and gene but not that of GAS in gene-stimulated astroglial cells .	T4	T46	12244038
CPR:4	CHEMICAL	GENE-Y	2	13	Interestingly , chemical strongly inhibited the activation of gene , gene , and gene but not that of GAS in gene-stimulated astroglial cells .	T4	T47	12244038
NA	CHEMICAL	GENE-N	2	19	Interestingly , chemical strongly inhibited the activation of gene , gene , and gene but not that of GAS in gene-stimulated astroglial cells .	T4	T48	12244038
CPR:9	CHEMICAL	GENE-Y	2	13	Mechanisms of chemical uptake in the choroid plexus : studies in wild-type and gene knockout mice .	T15	T28	14600253
CPR:9	CHEMICAL	GENE-Y	5	9	The choroid plexus uptake of chemical was studied in gene ( gene ) wild-type and null mice as a function of temperature , transport inhibitors , pH , and saturability .	T7	T22	14600253
CPR:9	CHEMICAL	GENE-Y	5	11	The choroid plexus uptake of chemical was studied in gene ( gene ) wild-type and null mice as a function of temperature , transport inhibitors , pH , and saturability .	T7	T27	14600253
CPR:9	CHEMICAL	GENE-Y	19	26	At normal pH ( 7.4 ) and temperature ( 37 degrees C ) , the uptake of 1 microM chemical was reduced by 83 % in gene ( -/- ) mice as compared with gene ( +/+ ) mice ( p < 0.001 ) .	T6	T20	14600253
CPR:9	CHEMICAL	GENE-Y	19	34	At normal pH ( 7.4 ) and temperature ( 37 degrees C ) , the uptake of 1 microM chemical was reduced by 83 % in gene ( -/- ) mice as compared with gene ( +/+ ) mice ( p < 0.001 ) .	T6	T21	14600253
NA	CHEMICAL	GENE-Y	0	9	chemical coadministration could inhibit the uptake of chemical in gene ( +/+ ) mice ( p < 0.01 ) but not gene ( -/- ) mice .	T10	T23	14600253
NA	CHEMICAL	GENE-Y	0	21	chemical coadministration could inhibit the uptake of chemical in gene ( +/+ ) mice ( p < 0.01 ) but not gene ( -/- ) mice .	T10	T24	14600253
CPR:9	CHEMICAL	GENE-Y	7	9	chemical coadministration could inhibit the uptake of chemical in gene ( +/+ ) mice ( p < 0.01 ) but not gene ( -/- ) mice .	T11	T23	14600253
CPR:9	CHEMICAL	GENE-Y	7	21	chemical coadministration could inhibit the uptake of chemical in gene ( +/+ ) mice ( p < 0.01 ) but not gene ( -/- ) mice .	T11	T24	14600253
CPR:9	CHEMICAL	GENE-Y	1	9	Although a proton-stimulated uptake of chemical was demonstrated in gene ( +/+ ) mice ( pH 6.5 versus pH 7.4 ; p < 0.01 ) , no pH dependence was observed in gene ( -/- ) mice .	T12	T25	14600253
CPR:9	CHEMICAL	GENE-Y	1	32	Although a proton-stimulated uptake of chemical was demonstrated in gene ( +/+ ) mice ( pH 6.5 versus pH 7.4 ; p < 0.01 ) , no pH dependence was observed in gene ( -/- ) mice .	T12	T26	14600253
CPR:9	CHEMICAL	GENE-Y	11	4	These findings demonstrate that gene is the primary transporter responsible for chemical uptake in the choroid plexus .	T5	T18	14600253
NA	CHEMICAL	GENE-N	8	1	The gene antagonist methysergide and the gene antagonist chemical enhanced chemical-induced hyperglycemia , while the gene antagonist chemical and the gene antagonist chemical did not affect it .	T8	T22	14501155
CPR:6	CHEMICAL	GENE-N	8	6	The gene antagonist methysergide and the gene antagonist chemical enhanced chemical-induced hyperglycemia , while the gene antagonist chemical and the gene antagonist chemical did not affect it .	T8	T23	14501155
NA	CHEMICAL	GENE-N	8	15	The gene antagonist methysergide and the gene antagonist chemical enhanced chemical-induced hyperglycemia , while the gene antagonist chemical and the gene antagonist chemical did not affect it .	T8	T24	14501155
NA	CHEMICAL	GENE-N	8	20	The gene antagonist methysergide and the gene antagonist chemical enhanced chemical-induced hyperglycemia , while the gene antagonist chemical and the gene antagonist chemical did not affect it .	T8	T25	14501155
NA	CHEMICAL	GENE-N	10	1	The gene antagonist methysergide and the gene antagonist chemical enhanced chemical-induced hyperglycemia , while the gene antagonist chemical and the gene antagonist chemical did not affect it .	T9	T22	14501155
NA	CHEMICAL	GENE-N	10	6	The gene antagonist methysergide and the gene antagonist chemical enhanced chemical-induced hyperglycemia , while the gene antagonist chemical and the gene antagonist chemical did not affect it .	T9	T23	14501155
NA	CHEMICAL	GENE-N	10	15	The gene antagonist methysergide and the gene antagonist chemical enhanced chemical-induced hyperglycemia , while the gene antagonist chemical and the gene antagonist chemical did not affect it .	T9	T24	14501155
NA	CHEMICAL	GENE-N	10	20	The gene antagonist methysergide and the gene antagonist chemical enhanced chemical-induced hyperglycemia , while the gene antagonist chemical and the gene antagonist chemical did not affect it .	T9	T25	14501155
NA	CHEMICAL	GENE-N	17	1	The gene antagonist methysergide and the gene antagonist chemical enhanced chemical-induced hyperglycemia , while the gene antagonist chemical and the gene antagonist chemical did not affect it .	T10	T22	14501155
NA	CHEMICAL	GENE-N	17	6	The gene antagonist methysergide and the gene antagonist chemical enhanced chemical-induced hyperglycemia , while the gene antagonist chemical and the gene antagonist chemical did not affect it .	T10	T23	14501155
CPR:6	CHEMICAL	GENE-N	17	15	The gene antagonist methysergide and the gene antagonist chemical enhanced chemical-induced hyperglycemia , while the gene antagonist chemical and the gene antagonist chemical did not affect it .	T10	T24	14501155
NA	CHEMICAL	GENE-N	17	20	The gene antagonist methysergide and the gene antagonist chemical enhanced chemical-induced hyperglycemia , while the gene antagonist chemical and the gene antagonist chemical did not affect it .	T10	T25	14501155
NA	CHEMICAL	GENE-N	22	1	The gene antagonist methysergide and the gene antagonist chemical enhanced chemical-induced hyperglycemia , while the gene antagonist chemical and the gene antagonist chemical did not affect it .	T11	T22	14501155
NA	CHEMICAL	GENE-N	22	6	The gene antagonist methysergide and the gene antagonist chemical enhanced chemical-induced hyperglycemia , while the gene antagonist chemical and the gene antagonist chemical did not affect it .	T11	T23	14501155
NA	CHEMICAL	GENE-N	22	15	The gene antagonist methysergide and the gene antagonist chemical enhanced chemical-induced hyperglycemia , while the gene antagonist chemical and the gene antagonist chemical did not affect it .	T11	T24	14501155
CPR:6	CHEMICAL	GENE-N	22	20	The gene antagonist methysergide and the gene antagonist chemical enhanced chemical-induced hyperglycemia , while the gene antagonist chemical and the gene antagonist chemical did not affect it .	T11	T25	14501155
CPR:6	CHEMICAL	GENE-N	3	1	The gene antagonist chemical facilitated hyperglycemia induced by chemical , although the gene-receptor antagonist chemical was without effect .	T13	T26	14501155
NA	CHEMICAL	GENE-Y	3	12	The gene antagonist chemical facilitated hyperglycemia induced by chemical , although the gene-receptor antagonist chemical was without effect .	T13	T27	14501155
NA	CHEMICAL	GENE-N	8	1	The gene antagonist chemical facilitated hyperglycemia induced by chemical , although the gene-receptor antagonist chemical was without effect .	T14	T26	14501155
NA	CHEMICAL	GENE-Y	8	12	The gene antagonist chemical facilitated hyperglycemia induced by chemical , although the gene-receptor antagonist chemical was without effect .	T14	T27	14501155
NA	CHEMICAL	GENE-N	14	1	The gene antagonist chemical facilitated hyperglycemia induced by chemical , although the gene-receptor antagonist chemical was without effect .	T15	T26	14501155
CPR:6	CHEMICAL	GENE-Y	14	12	The gene antagonist chemical facilitated hyperglycemia induced by chemical , although the gene-receptor antagonist chemical was without effect .	T15	T27	14501155
NA	CHEMICAL	GENE-Y	6	7	Purification and multimeric structure of bovine chemical alpha-chemical-acetylglucosaminidase .	T13	T23	9722550
NA	CHEMICAL	GENE-Y	11	1	chemical alpha-chemical-Acetylglucosaminidase ( gene ; gene ) catalyzes the second step in the synthesis of the chemical determinant required for efficient intracellular targeting of newly synthesized lysosomal hydrolases to the lysosome .	T1	T14	9722550
NA	CHEMICAL	GENE-Y	11	3	chemical alpha-chemical-Acetylglucosaminidase ( gene ; gene ) catalyzes the second step in the synthesis of the chemical determinant required for efficient intracellular targeting of newly synthesized lysosomal hydrolases to the lysosome .	T1	T20	9722550
NA	CHEMICAL	GENE-Y	11	5	chemical alpha-chemical-Acetylglucosaminidase ( gene ; gene ) catalyzes the second step in the synthesis of the chemical determinant required for efficient intracellular targeting of newly synthesized lysosomal hydrolases to the lysosome .	T1	T22	9722550
NA	CHEMICAL	GENE-Y	0	1	chemical alpha-chemical-Acetylglucosaminidase ( gene ; gene ) catalyzes the second step in the synthesis of the chemical determinant required for efficient intracellular targeting of newly synthesized lysosomal hydrolases to the lysosome .	T9	T14	9722550
NA	CHEMICAL	GENE-Y	0	3	chemical alpha-chemical-Acetylglucosaminidase ( gene ; gene ) catalyzes the second step in the synthesis of the chemical determinant required for efficient intracellular targeting of newly synthesized lysosomal hydrolases to the lysosome .	T9	T20	9722550
NA	CHEMICAL	GENE-Y	0	5	chemical alpha-chemical-Acetylglucosaminidase ( gene ; gene ) catalyzes the second step in the synthesis of the chemical determinant required for efficient intracellular targeting of newly synthesized lysosomal hydrolases to the lysosome .	T9	T22	9722550
CPR:9	CHEMICAL	GENE-Y	16	1	chemical alpha-chemical-Acetylglucosaminidase ( gene ; gene ) catalyzes the second step in the synthesis of the chemical determinant required for efficient intracellular targeting of newly synthesized lysosomal hydrolases to the lysosome .	T8	T14	9722550
CPR:9	CHEMICAL	GENE-Y	16	3	chemical alpha-chemical-Acetylglucosaminidase ( gene ; gene ) catalyzes the second step in the synthesis of the chemical determinant required for efficient intracellular targeting of newly synthesized lysosomal hydrolases to the lysosome .	T8	T20	9722550
CPR:9	CHEMICAL	GENE-Y	16	5	chemical alpha-chemical-Acetylglucosaminidase ( gene ; gene ) catalyzes the second step in the synthesis of the chemical determinant required for efficient intracellular targeting of newly synthesized lysosomal hydrolases to the lysosome .	T8	T22	9722550
CPR:9	CHEMICAL	GENE-Y	4	2	The purified gene has a specific activity of 498 micromol of chemical cleaved per h per mg of protein using 0.5 mM chemical as substrate .	T10	T21	9722550
CPR:9	CHEMICAL	GENE-Y	4	2	The purified gene has a specific activity of 498 micromol of chemical cleaved per h per mg of protein using 0.5 mM chemical as substrate .	T11	T21	9722550
NA	CHEMICAL	GENE-Y	5	6	The data indicate that bovine chemical alpha-GlcNAcase is a 272,000-Da complex of four identical 68,000-Da glycoprotein subunits arranged as two chemical-linked homodimers .	T4	T15	9722550
NA	CHEMICAL	GENE-Y	7	6	The data indicate that bovine chemical alpha-GlcNAcase is a 272,000-Da complex of four identical 68,000-Da glycoprotein subunits arranged as two chemical-linked homodimers .	T5	T15	9722550
NA	CHEMICAL	GENE-N	7	4	The activation of the gene cascade , a cornerstone of the innate immune response , produces a number of small ( 74-77 chemical ) fragments , originally termed gene , that are potent chemoattractants and secretagogues that act on a wide variety of cell types .	T1	T3	23383423
NA	CHEMICAL	GENE-N	7	7	The activation of the gene cascade , a cornerstone of the innate immune response , produces a number of small ( 74-77 chemical ) fragments , originally termed gene , that are potent chemoattractants and secretagogues that act on a wide variety of cell types .	T1	T2	23383423
NA	CHEMICAL	GENE-Y	3	0	gene is a chemical-CpG-binding protein that is a main component of brain chromatin in vertebrates .	T1	T5	23558747
NA	CHEMICAL	GENE-N	3	4	gene is a chemical-CpG-binding protein that is a main component of brain chromatin in vertebrates .	T1	T6	23558747
NA	CHEMICAL	GENE-N	11	6	In vitro studies have determined that in addition to its specific chemical-CpG-binding domain ( gene ) gene also has several gene .	T2	T12	23558747
NA	CHEMICAL	GENE-N	11	14	In vitro studies have determined that in addition to its specific chemical-CpG-binding domain ( gene ) gene also has several gene .	T2	T13	23558747
NA	CHEMICAL	GENE-Y	11	16	In vitro studies have determined that in addition to its specific chemical-CpG-binding domain ( gene ) gene also has several gene .	T2	T14	23558747
NA	CHEMICAL	GENE-N	11	6	In vitro studies have determined that in addition to its specific chemical-CpG-binding domain ( gene ) gene also has several gene .	T2	T15	23558747
NA	CHEMICAL	GENE-N	16	26	) ( 1 ) ( Jae ) ) in which exon 3 deletion results in an chemical-terminal truncation of the protein , including most of the gene .	T3	T21	23558747
CPR:6	CHEMICAL	GENE-N	3	8	Clinical effects of chemical , an oral chemical receptor antagonist , in mild-to-moderate asthma : a 4 week randomized multicentre controlled trial .	T12	T16	11264758
NA	CHEMICAL	GENE-N	7	8	Clinical effects of chemical , an oral chemical receptor antagonist , in mild-to-moderate asthma : a 4 week randomized multicentre controlled trial .	T13	T16	11264758
CPR:4	CHEMICAL	GENE-Y	0	11	chemical is a new , orally active , selective inhibitor of gene chemical receptor .	T10	T14	11264758
CPR:4	CHEMICAL	GENE-N	0	13	chemical is a new , orally active , selective inhibitor of gene chemical receptor .	T10	T15	11264758
NA	CHEMICAL	GENE-Y	12	11	chemical is a new , orally active , selective inhibitor of gene chemical receptor .	T6	T14	11264758
NA	CHEMICAL	GENE-N	12	13	chemical is a new , orally active , selective inhibitor of gene chemical receptor .	T6	T15	11264758
NA	CHEMICAL	GENE-Y	3	2	Inhibition of gene chemical kinase signaling with k252a , or with the selective gene scavenger gene-Fc , both inhibited MF-LTP to the same extent as observed in gene+/- mice .	T1	T23	23587649
NA	CHEMICAL	GENE-N	3	4	Inhibition of gene chemical kinase signaling with k252a , or with the selective gene scavenger gene-Fc , both inhibited MF-LTP to the same extent as observed in gene+/- mice .	T1	T24	23587649
NA	CHEMICAL	GENE-Y	3	13	Inhibition of gene chemical kinase signaling with k252a , or with the selective gene scavenger gene-Fc , both inhibited MF-LTP to the same extent as observed in gene+/- mice .	T1	T25	23587649
NA	CHEMICAL	GENE-Y	3	15	Inhibition of gene chemical kinase signaling with k252a , or with the selective gene scavenger gene-Fc , both inhibited MF-LTP to the same extent as observed in gene+/- mice .	T1	T26	23587649
NA	CHEMICAL	GENE-Y	3	27	Inhibition of gene chemical kinase signaling with k252a , or with the selective gene scavenger gene-Fc , both inhibited MF-LTP to the same extent as observed in gene+/- mice .	T1	T3	23587649
NA	CHEMICAL	GENE-N	4	28	A significant decrease in chemical ( T180 ) and chemical ( T90 and T180 ) , as well as a significant increase in chemical , accompanied intake of AGE-gene .	T1	T5	23238657
NA	CHEMICAL	GENE-N	9	28	A significant decrease in chemical ( T180 ) and chemical ( T90 and T180 ) , as well as a significant increase in chemical , accompanied intake of AGE-gene .	T2	T5	23238657
NA	CHEMICAL	GENE-N	3	28	A significant decrease in chemical ( T180 ) and chemical ( T90 and T180 ) , as well as a significant increase in chemical , accompanied intake of AGE-gene .	T3	T5	23238657
NA	CHEMICAL	GENE-Y	4	11	Massive urinary excretion of chemical , chemical and chemical , known as xanthurenic aciduria or hydroxykynureninuria , in a young Somali boy suggested gene deficiency .	T1	T6	17334708
NA	CHEMICAL	GENE-Y	6	11	Massive urinary excretion of chemical , chemical and chemical , known as xanthurenic aciduria or hydroxykynureninuria , in a young Somali boy suggested gene deficiency .	T4	T6	17334708
NA	CHEMICAL	GENE-Y	8	11	Massive urinary excretion of chemical , chemical and chemical , known as xanthurenic aciduria or hydroxykynureninuria , in a young Somali boy suggested gene deficiency .	T5	T6	17334708
NA	CHEMICAL	GENE-Y	20	3	Mutation analysis of gene encoding gene of the index case revealed homozygosity for a c.593 gene substitution leading to a chemical-to-chemical ( gene ) shift .	T2	T7	17334708
NA	CHEMICAL	GENE-Y	20	5	Mutation analysis of gene encoding gene of the index case revealed homozygosity for a c.593 gene substitution leading to a chemical-to-chemical ( gene ) shift .	T2	T8	17334708
NA	CHEMICAL	GENE-N	20	15	Mutation analysis of gene encoding gene of the index case revealed homozygosity for a c.593 gene substitution leading to a chemical-to-chemical ( gene ) shift .	T2	T9	17334708
NA	CHEMICAL	GENE-N	20	13	Mutation analysis of gene encoding gene of the index case revealed homozygosity for a c.593 gene substitution leading to a chemical-to-chemical ( gene ) shift .	T2	T10	17334708
NA	CHEMICAL	GENE-N	20	22	Mutation analysis of gene encoding gene of the index case revealed homozygosity for a c.593 gene substitution leading to a chemical-to-chemical ( gene ) shift .	T2	T11	17334708
NA	CHEMICAL	GENE-Y	13	3	Mutation analysis of gene encoding gene of the index case revealed homozygosity for a c.593 gene substitution leading to a chemical-to-chemical ( gene ) shift .	T3	T7	17334708
NA	CHEMICAL	GENE-Y	13	5	Mutation analysis of gene encoding gene of the index case revealed homozygosity for a c.593 gene substitution leading to a chemical-to-chemical ( gene ) shift .	T3	T8	17334708
NA	CHEMICAL	GENE-N	13	15	Mutation analysis of gene encoding gene of the index case revealed homozygosity for a c.593 gene substitution leading to a chemical-to-chemical ( gene ) shift .	T3	T9	17334708
NA	CHEMICAL	GENE-N	13	13	Mutation analysis of gene encoding gene of the index case revealed homozygosity for a c.593 gene substitution leading to a chemical-to-chemical ( gene ) shift .	T3	T10	17334708
NA	CHEMICAL	GENE-N	13	22	Mutation analysis of gene encoding gene of the index case revealed homozygosity for a c.593 gene substitution leading to a chemical-to-chemical ( gene ) shift .	T3	T11	17334708
NA	CHEMICAL	GENE-Y	16	12	Molecular analysis of these mutants revealed single base pair exchanges in the gene gene coding for chemical epoxidase , the target of chemical .	T6	T22	14638499
NA	CHEMICAL	GENE-Y	16	17	Molecular analysis of these mutants revealed single base pair exchanges in the gene gene coding for chemical epoxidase , the target of chemical .	T6	T23	14638499
NA	CHEMICAL	GENE-Y	10	12	Molecular analysis of these mutants revealed single base pair exchanges in the gene gene coding for chemical epoxidase , the target of chemical .	T7	T22	14638499
NA	CHEMICAL	GENE-Y	10	17	Molecular analysis of these mutants revealed single base pair exchanges in the gene gene coding for chemical epoxidase , the target of chemical .	T7	T23	14638499
NA	CHEMICAL	GENE-Y	0	20	chemical resistance was transmitted with the mutated alleles in gene replacement experiments , proving that single chemical substitutions in the gene protein were sufficient to confer the resistance phenotype .	T8	T25	14638499
NA	CHEMICAL	GENE-Y	16	20	chemical resistance was transmitted with the mutated alleles in gene replacement experiments , proving that single chemical substitutions in the gene protein were sufficient to confer the resistance phenotype .	T9	T25	14638499
NA	CHEMICAL	GENE-Y	1	15	The chemical changes caused by the point mutations were clustered in two regions of the gene protein .	T10	T26	14638499
NA	CHEMICAL	GENE-N	4	6	Seven mutants carried the chemical substitutions gene ( one mutant ) , gene ( one mutant ) , and gene ( five mutants ) in the chemical-terminal part of the protein ; and three mutants carried an gene exchange in the central part of the protein .	T12	T27	14638499
NA	CHEMICAL	GENE-N	4	12	Seven mutants carried the chemical substitutions gene ( one mutant ) , gene ( one mutant ) , and gene ( five mutants ) in the chemical-terminal part of the protein ; and three mutants carried an gene exchange in the central part of the protein .	T12	T28	14638499
NA	CHEMICAL	GENE-N	4	19	Seven mutants carried the chemical substitutions gene ( one mutant ) , gene ( one mutant ) , and gene ( five mutants ) in the chemical-terminal part of the protein ; and three mutants carried an gene exchange in the central part of the protein .	T12	T29	14638499
NA	CHEMICAL	GENE-N	4	37	Seven mutants carried the chemical substitutions gene ( one mutant ) , gene ( one mutant ) , and gene ( five mutants ) in the chemical-terminal part of the protein ; and three mutants carried an gene exchange in the central part of the protein .	T12	T15	14638499
NA	CHEMICAL	GENE-N	26	6	Seven mutants carried the chemical substitutions gene ( one mutant ) , gene ( one mutant ) , and gene ( five mutants ) in the chemical-terminal part of the protein ; and three mutants carried an gene exchange in the central part of the protein .	T13	T27	14638499
NA	CHEMICAL	GENE-N	26	12	Seven mutants carried the chemical substitutions gene ( one mutant ) , gene ( one mutant ) , and gene ( five mutants ) in the chemical-terminal part of the protein ; and three mutants carried an gene exchange in the central part of the protein .	T13	T28	14638499
NA	CHEMICAL	GENE-N	26	19	Seven mutants carried the chemical substitutions gene ( one mutant ) , gene ( one mutant ) , and gene ( five mutants ) in the chemical-terminal part of the protein ; and three mutants carried an gene exchange in the central part of the protein .	T13	T29	14638499
NA	CHEMICAL	GENE-N	26	37	Seven mutants carried the chemical substitutions gene ( one mutant ) , gene ( one mutant ) , and gene ( five mutants ) in the chemical-terminal part of the protein ; and three mutants carried an gene exchange in the central part of the protein .	T13	T15	14638499
NA	CHEMICAL	GENE-N	6	13	Interestingly , all exchanges identified involved chemical which are conserved in the chemical epoxidases of yeasts and mammals .	T1	T16	14638499
NA	CHEMICAL	GENE-N	12	13	Interestingly , all exchanges identified involved chemical which are conserved in the chemical epoxidases of yeasts and mammals .	T2	T16	14638499
NA	CHEMICAL	GENE-Y	15	10	Two mutations that were generated by PCR mutagenesis of the gene gene and that conferred chemical resistance mapped in the same regions of the gene protein , with one resulting in an gene exchange and the other resulting in an gene exchange .	T3	T17	14638499
NA	CHEMICAL	GENE-Y	15	24	Two mutations that were generated by PCR mutagenesis of the gene gene and that conferred chemical resistance mapped in the same regions of the gene protein , with one resulting in an gene exchange and the other resulting in an gene exchange .	T3	T18	14638499
NA	CHEMICAL	GENE-N	15	32	Two mutations that were generated by PCR mutagenesis of the gene gene and that conferred chemical resistance mapped in the same regions of the gene protein , with one resulting in an gene exchange and the other resulting in an gene exchange .	T3	T19	14638499
NA	CHEMICAL	GENE-N	15	40	Two mutations that were generated by PCR mutagenesis of the gene gene and that conferred chemical resistance mapped in the same regions of the gene protein , with one resulting in an gene exchange and the other resulting in an gene exchange .	T3	T20	14638499
NA	CHEMICAL	GENE-N	3	5	In addition , gene ( gene ) and gene ( JchemicalK ) signaling pathways activated by gene treatment were prevented by the OPE pre-treatment .	T1	T8	23524316
NA	CHEMICAL	GENE-Y	3	8	In addition , gene ( gene ) and gene ( JchemicalK ) signaling pathways activated by gene treatment were prevented by the OPE pre-treatment .	T1	T9	23524316
NA	CHEMICAL	GENE-Y	3	10	In addition , gene ( gene ) and gene ( JchemicalK ) signaling pathways activated by gene treatment were prevented by the OPE pre-treatment .	T1	T10	23524316
NA	CHEMICAL	GENE-Y	3	16	In addition , gene ( gene ) and gene ( JchemicalK ) signaling pathways activated by gene treatment were prevented by the OPE pre-treatment .	T1	T11	23524316
NA	CHEMICAL	GENE-Y	5	5	The role of drug metabolism in chemical cytotoxicity was examined with inhibitors of chemical kinase ( gene ) , gene , and chemical deaminase , whereas the role of pemetrexed targets , chemical synthase ( gene ) , chemical reductase ( gene ) , and chemical formyltransferase ( gene ) in drug chemosensitivity was analyzed in cytotoxicity rescue studies .	T12	T32	15795320
NA	CHEMICAL	GENE-Y	5	16	The role of drug metabolism in chemical cytotoxicity was examined with inhibitors of chemical kinase ( gene ) , gene , and chemical deaminase , whereas the role of pemetrexed targets , chemical synthase ( gene ) , chemical reductase ( gene ) , and chemical formyltransferase ( gene ) in drug chemosensitivity was analyzed in cytotoxicity rescue studies .	T12	T33	15795320
NA	CHEMICAL	GENE-Y	5	19	The role of drug metabolism in chemical cytotoxicity was examined with inhibitors of chemical kinase ( gene ) , gene , and chemical deaminase , whereas the role of pemetrexed targets , chemical synthase ( gene ) , chemical reductase ( gene ) , and chemical formyltransferase ( gene ) in drug chemosensitivity was analyzed in cytotoxicity rescue studies .	T12	T34	15795320
NA	CHEMICAL	GENE-Y	5	5	The role of drug metabolism in chemical cytotoxicity was examined with inhibitors of chemical kinase ( gene ) , gene , and chemical deaminase , whereas the role of pemetrexed targets , chemical synthase ( gene ) , chemical reductase ( gene ) , and chemical formyltransferase ( gene ) in drug chemosensitivity was analyzed in cytotoxicity rescue studies .	T12	T35	15795320
NA	CHEMICAL	GENE-Y	5	33	The role of drug metabolism in chemical cytotoxicity was examined with inhibitors of chemical kinase ( gene ) , gene , and chemical deaminase , whereas the role of pemetrexed targets , chemical synthase ( gene ) , chemical reductase ( gene ) , and chemical formyltransferase ( gene ) in drug chemosensitivity was analyzed in cytotoxicity rescue studies .	T12	T36	15795320
NA	CHEMICAL	GENE-Y	5	35	The role of drug metabolism in chemical cytotoxicity was examined with inhibitors of chemical kinase ( gene ) , gene , and chemical deaminase , whereas the role of pemetrexed targets , chemical synthase ( gene ) , chemical reductase ( gene ) , and chemical formyltransferase ( gene ) in drug chemosensitivity was analyzed in cytotoxicity rescue studies .	T12	T37	15795320
NA	CHEMICAL	GENE-Y	5	39	The role of drug metabolism in chemical cytotoxicity was examined with inhibitors of chemical kinase ( gene ) , gene , and chemical deaminase , whereas the role of pemetrexed targets , chemical synthase ( gene ) , chemical reductase ( gene ) , and chemical formyltransferase ( gene ) in drug chemosensitivity was analyzed in cytotoxicity rescue studies .	T12	T38	15795320
NA	CHEMICAL	GENE-Y	5	41	The role of drug metabolism in chemical cytotoxicity was examined with inhibitors of chemical kinase ( gene ) , gene , and chemical deaminase , whereas the role of pemetrexed targets , chemical synthase ( gene ) , chemical reductase ( gene ) , and chemical formyltransferase ( gene ) in drug chemosensitivity was analyzed in cytotoxicity rescue studies .	T12	T39	15795320
NA	CHEMICAL	GENE-Y	5	46	The role of drug metabolism in chemical cytotoxicity was examined with inhibitors of chemical kinase ( gene ) , gene , and chemical deaminase , whereas the role of pemetrexed targets , chemical synthase ( gene ) , chemical reductase ( gene ) , and chemical formyltransferase ( gene ) in drug chemosensitivity was analyzed in cytotoxicity rescue studies .	T12	T40	15795320
NA	CHEMICAL	GENE-Y	5	48	The role of drug metabolism in chemical cytotoxicity was examined with inhibitors of chemical kinase ( gene ) , gene , and chemical deaminase , whereas the role of pemetrexed targets , chemical synthase ( gene ) , chemical reductase ( gene ) , and chemical formyltransferase ( gene ) in drug chemosensitivity was analyzed in cytotoxicity rescue studies .	T12	T41	15795320
NA	CHEMICAL	GENE-Y	5	5	The role of drug metabolism in chemical cytotoxicity was examined with inhibitors of chemical kinase ( gene ) , gene , and chemical deaminase , whereas the role of pemetrexed targets , chemical synthase ( gene ) , chemical reductase ( gene ) , and chemical formyltransferase ( gene ) in drug chemosensitivity was analyzed in cytotoxicity rescue studies .	T13	T32	15795320
NA	CHEMICAL	GENE-Y	5	16	The role of drug metabolism in chemical cytotoxicity was examined with inhibitors of chemical kinase ( gene ) , gene , and chemical deaminase , whereas the role of pemetrexed targets , chemical synthase ( gene ) , chemical reductase ( gene ) , and chemical formyltransferase ( gene ) in drug chemosensitivity was analyzed in cytotoxicity rescue studies .	T13	T33	15795320
NA	CHEMICAL	GENE-Y	5	19	The role of drug metabolism in chemical cytotoxicity was examined with inhibitors of chemical kinase ( gene ) , gene , and chemical deaminase , whereas the role of pemetrexed targets , chemical synthase ( gene ) , chemical reductase ( gene ) , and chemical formyltransferase ( gene ) in drug chemosensitivity was analyzed in cytotoxicity rescue studies .	T13	T34	15795320
NA	CHEMICAL	GENE-Y	5	5	The role of drug metabolism in chemical cytotoxicity was examined with inhibitors of chemical kinase ( gene ) , gene , and chemical deaminase , whereas the role of pemetrexed targets , chemical synthase ( gene ) , chemical reductase ( gene ) , and chemical formyltransferase ( gene ) in drug chemosensitivity was analyzed in cytotoxicity rescue studies .	T13	T35	15795320
NA	CHEMICAL	GENE-Y	5	33	The role of drug metabolism in chemical cytotoxicity was examined with inhibitors of chemical kinase ( gene ) , gene , and chemical deaminase , whereas the role of pemetrexed targets , chemical synthase ( gene ) , chemical reductase ( gene ) , and chemical formyltransferase ( gene ) in drug chemosensitivity was analyzed in cytotoxicity rescue studies .	T13	T36	15795320
NA	CHEMICAL	GENE-Y	5	35	The role of drug metabolism in chemical cytotoxicity was examined with inhibitors of chemical kinase ( gene ) , gene , and chemical deaminase , whereas the role of pemetrexed targets , chemical synthase ( gene ) , chemical reductase ( gene ) , and chemical formyltransferase ( gene ) in drug chemosensitivity was analyzed in cytotoxicity rescue studies .	T13	T37	15795320
NA	CHEMICAL	GENE-Y	5	39	The role of drug metabolism in chemical cytotoxicity was examined with inhibitors of chemical kinase ( gene ) , gene , and chemical deaminase , whereas the role of pemetrexed targets , chemical synthase ( gene ) , chemical reductase ( gene ) , and chemical formyltransferase ( gene ) in drug chemosensitivity was analyzed in cytotoxicity rescue studies .	T13	T38	15795320
NA	CHEMICAL	GENE-Y	5	41	The role of drug metabolism in chemical cytotoxicity was examined with inhibitors of chemical kinase ( gene ) , gene , and chemical deaminase , whereas the role of pemetrexed targets , chemical synthase ( gene ) , chemical reductase ( gene ) , and chemical formyltransferase ( gene ) in drug chemosensitivity was analyzed in cytotoxicity rescue studies .	T13	T39	15795320
NA	CHEMICAL	GENE-Y	5	46	The role of drug metabolism in chemical cytotoxicity was examined with inhibitors of chemical kinase ( gene ) , gene , and chemical deaminase , whereas the role of pemetrexed targets , chemical synthase ( gene ) , chemical reductase ( gene ) , and chemical formyltransferase ( gene ) in drug chemosensitivity was analyzed in cytotoxicity rescue studies .	T13	T40	15795320
NA	CHEMICAL	GENE-Y	5	48	The role of drug metabolism in chemical cytotoxicity was examined with inhibitors of chemical kinase ( gene ) , gene , and chemical deaminase , whereas the role of pemetrexed targets , chemical synthase ( gene ) , chemical reductase ( gene ) , and chemical formyltransferase ( gene ) in drug chemosensitivity was analyzed in cytotoxicity rescue studies .	T13	T41	15795320
NA	CHEMICAL	GENE-Y	5	5	The role of drug metabolism in chemical cytotoxicity was examined with inhibitors of chemical kinase ( gene ) , gene , and chemical deaminase , whereas the role of pemetrexed targets , chemical synthase ( gene ) , chemical reductase ( gene ) , and chemical formyltransferase ( gene ) in drug chemosensitivity was analyzed in cytotoxicity rescue studies .	T14	T32	15795320
NA	CHEMICAL	GENE-Y	5	16	The role of drug metabolism in chemical cytotoxicity was examined with inhibitors of chemical kinase ( gene ) , gene , and chemical deaminase , whereas the role of pemetrexed targets , chemical synthase ( gene ) , chemical reductase ( gene ) , and chemical formyltransferase ( gene ) in drug chemosensitivity was analyzed in cytotoxicity rescue studies .	T14	T33	15795320
NA	CHEMICAL	GENE-Y	5	19	The role of drug metabolism in chemical cytotoxicity was examined with inhibitors of chemical kinase ( gene ) , gene , and chemical deaminase , whereas the role of pemetrexed targets , chemical synthase ( gene ) , chemical reductase ( gene ) , and chemical formyltransferase ( gene ) in drug chemosensitivity was analyzed in cytotoxicity rescue studies .	T14	T34	15795320
NA	CHEMICAL	GENE-Y	5	5	The role of drug metabolism in chemical cytotoxicity was examined with inhibitors of chemical kinase ( gene ) , gene , and chemical deaminase , whereas the role of pemetrexed targets , chemical synthase ( gene ) , chemical reductase ( gene ) , and chemical formyltransferase ( gene ) in drug chemosensitivity was analyzed in cytotoxicity rescue studies .	T14	T35	15795320
NA	CHEMICAL	GENE-Y	5	33	The role of drug metabolism in chemical cytotoxicity was examined with inhibitors of chemical kinase ( gene ) , gene , and chemical deaminase , whereas the role of pemetrexed targets , chemical synthase ( gene ) , chemical reductase ( gene ) , and chemical formyltransferase ( gene ) in drug chemosensitivity was analyzed in cytotoxicity rescue studies .	T14	T36	15795320
NA	CHEMICAL	GENE-Y	5	35	The role of drug metabolism in chemical cytotoxicity was examined with inhibitors of chemical kinase ( gene ) , gene , and chemical deaminase , whereas the role of pemetrexed targets , chemical synthase ( gene ) , chemical reductase ( gene ) , and chemical formyltransferase ( gene ) in drug chemosensitivity was analyzed in cytotoxicity rescue studies .	T14	T37	15795320
NA	CHEMICAL	GENE-Y	5	39	The role of drug metabolism in chemical cytotoxicity was examined with inhibitors of chemical kinase ( gene ) , gene , and chemical deaminase , whereas the role of pemetrexed targets , chemical synthase ( gene ) , chemical reductase ( gene ) , and chemical formyltransferase ( gene ) in drug chemosensitivity was analyzed in cytotoxicity rescue studies .	T14	T38	15795320
NA	CHEMICAL	GENE-Y	5	41	The role of drug metabolism in chemical cytotoxicity was examined with inhibitors of chemical kinase ( gene ) , gene , and chemical deaminase , whereas the role of pemetrexed targets , chemical synthase ( gene ) , chemical reductase ( gene ) , and chemical formyltransferase ( gene ) in drug chemosensitivity was analyzed in cytotoxicity rescue studies .	T14	T39	15795320
NA	CHEMICAL	GENE-Y	5	46	The role of drug metabolism in chemical cytotoxicity was examined with inhibitors of chemical kinase ( gene ) , gene , and chemical deaminase , whereas the role of pemetrexed targets , chemical synthase ( gene ) , chemical reductase ( gene ) , and chemical formyltransferase ( gene ) in drug chemosensitivity was analyzed in cytotoxicity rescue studies .	T14	T40	15795320
NA	CHEMICAL	GENE-Y	5	48	The role of drug metabolism in chemical cytotoxicity was examined with inhibitors of chemical kinase ( gene ) , gene , and chemical deaminase , whereas the role of pemetrexed targets , chemical synthase ( gene ) , chemical reductase ( gene ) , and chemical formyltransferase ( gene ) in drug chemosensitivity was analyzed in cytotoxicity rescue studies .	T14	T41	15795320
NA	CHEMICAL	GENE-Y	32	5	The role of drug metabolism in chemical cytotoxicity was examined with inhibitors of chemical kinase ( gene ) , gene , and chemical deaminase , whereas the role of pemetrexed targets , chemical synthase ( gene ) , chemical reductase ( gene ) , and chemical formyltransferase ( gene ) in drug chemosensitivity was analyzed in cytotoxicity rescue studies .	T15	T32	15795320
NA	CHEMICAL	GENE-Y	32	16	The role of drug metabolism in chemical cytotoxicity was examined with inhibitors of chemical kinase ( gene ) , gene , and chemical deaminase , whereas the role of pemetrexed targets , chemical synthase ( gene ) , chemical reductase ( gene ) , and chemical formyltransferase ( gene ) in drug chemosensitivity was analyzed in cytotoxicity rescue studies .	T15	T33	15795320
NA	CHEMICAL	GENE-Y	32	19	The role of drug metabolism in chemical cytotoxicity was examined with inhibitors of chemical kinase ( gene ) , gene , and chemical deaminase , whereas the role of pemetrexed targets , chemical synthase ( gene ) , chemical reductase ( gene ) , and chemical formyltransferase ( gene ) in drug chemosensitivity was analyzed in cytotoxicity rescue studies .	T15	T34	15795320
NA	CHEMICAL	GENE-Y	32	5	The role of drug metabolism in chemical cytotoxicity was examined with inhibitors of chemical kinase ( gene ) , gene , and chemical deaminase , whereas the role of pemetrexed targets , chemical synthase ( gene ) , chemical reductase ( gene ) , and chemical formyltransferase ( gene ) in drug chemosensitivity was analyzed in cytotoxicity rescue studies .	T15	T35	15795320
NA	CHEMICAL	GENE-Y	32	33	The role of drug metabolism in chemical cytotoxicity was examined with inhibitors of chemical kinase ( gene ) , gene , and chemical deaminase , whereas the role of pemetrexed targets , chemical synthase ( gene ) , chemical reductase ( gene ) , and chemical formyltransferase ( gene ) in drug chemosensitivity was analyzed in cytotoxicity rescue studies .	T15	T36	15795320
NA	CHEMICAL	GENE-Y	32	35	The role of drug metabolism in chemical cytotoxicity was examined with inhibitors of chemical kinase ( gene ) , gene , and chemical deaminase , whereas the role of pemetrexed targets , chemical synthase ( gene ) , chemical reductase ( gene ) , and chemical formyltransferase ( gene ) in drug chemosensitivity was analyzed in cytotoxicity rescue studies .	T15	T37	15795320
NA	CHEMICAL	GENE-Y	32	39	The role of drug metabolism in chemical cytotoxicity was examined with inhibitors of chemical kinase ( gene ) , gene , and chemical deaminase , whereas the role of pemetrexed targets , chemical synthase ( gene ) , chemical reductase ( gene ) , and chemical formyltransferase ( gene ) in drug chemosensitivity was analyzed in cytotoxicity rescue studies .	T15	T38	15795320
NA	CHEMICAL	GENE-Y	32	41	The role of drug metabolism in chemical cytotoxicity was examined with inhibitors of chemical kinase ( gene ) , gene , and chemical deaminase , whereas the role of pemetrexed targets , chemical synthase ( gene ) , chemical reductase ( gene ) , and chemical formyltransferase ( gene ) in drug chemosensitivity was analyzed in cytotoxicity rescue studies .	T15	T39	15795320
NA	CHEMICAL	GENE-Y	32	46	The role of drug metabolism in chemical cytotoxicity was examined with inhibitors of chemical kinase ( gene ) , gene , and chemical deaminase , whereas the role of pemetrexed targets , chemical synthase ( gene ) , chemical reductase ( gene ) , and chemical formyltransferase ( gene ) in drug chemosensitivity was analyzed in cytotoxicity rescue studies .	T15	T40	15795320
NA	CHEMICAL	GENE-Y	32	48	The role of drug metabolism in chemical cytotoxicity was examined with inhibitors of chemical kinase ( gene ) , gene , and chemical deaminase , whereas the role of pemetrexed targets , chemical synthase ( gene ) , chemical reductase ( gene ) , and chemical formyltransferase ( gene ) in drug chemosensitivity was analyzed in cytotoxicity rescue studies .	T15	T41	15795320
NA	CHEMICAL	GENE-Y	2	5	The role of drug metabolism in chemical cytotoxicity was examined with inhibitors of chemical kinase ( gene ) , gene , and chemical deaminase , whereas the role of pemetrexed targets , chemical synthase ( gene ) , chemical reductase ( gene ) , and chemical formyltransferase ( gene ) in drug chemosensitivity was analyzed in cytotoxicity rescue studies .	T16	T32	15795320
NA	CHEMICAL	GENE-Y	2	16	The role of drug metabolism in chemical cytotoxicity was examined with inhibitors of chemical kinase ( gene ) , gene , and chemical deaminase , whereas the role of pemetrexed targets , chemical synthase ( gene ) , chemical reductase ( gene ) , and chemical formyltransferase ( gene ) in drug chemosensitivity was analyzed in cytotoxicity rescue studies .	T16	T33	15795320
NA	CHEMICAL	GENE-Y	2	19	The role of drug metabolism in chemical cytotoxicity was examined with inhibitors of chemical kinase ( gene ) , gene , and chemical deaminase , whereas the role of pemetrexed targets , chemical synthase ( gene ) , chemical reductase ( gene ) , and chemical formyltransferase ( gene ) in drug chemosensitivity was analyzed in cytotoxicity rescue studies .	T16	T34	15795320
NA	CHEMICAL	GENE-Y	2	5	The role of drug metabolism in chemical cytotoxicity was examined with inhibitors of chemical kinase ( gene ) , gene , and chemical deaminase , whereas the role of pemetrexed targets , chemical synthase ( gene ) , chemical reductase ( gene ) , and chemical formyltransferase ( gene ) in drug chemosensitivity was analyzed in cytotoxicity rescue studies .	T16	T35	15795320
NA	CHEMICAL	GENE-Y	2	33	The role of drug metabolism in chemical cytotoxicity was examined with inhibitors of chemical kinase ( gene ) , gene , and chemical deaminase , whereas the role of pemetrexed targets , chemical synthase ( gene ) , chemical reductase ( gene ) , and chemical formyltransferase ( gene ) in drug chemosensitivity was analyzed in cytotoxicity rescue studies .	T16	T36	15795320
NA	CHEMICAL	GENE-Y	2	35	The role of drug metabolism in chemical cytotoxicity was examined with inhibitors of chemical kinase ( gene ) , gene , and chemical deaminase , whereas the role of pemetrexed targets , chemical synthase ( gene ) , chemical reductase ( gene ) , and chemical formyltransferase ( gene ) in drug chemosensitivity was analyzed in cytotoxicity rescue studies .	T16	T37	15795320
NA	CHEMICAL	GENE-Y	2	39	The role of drug metabolism in chemical cytotoxicity was examined with inhibitors of chemical kinase ( gene ) , gene , and chemical deaminase , whereas the role of pemetrexed targets , chemical synthase ( gene ) , chemical reductase ( gene ) , and chemical formyltransferase ( gene ) in drug chemosensitivity was analyzed in cytotoxicity rescue studies .	T16	T38	15795320
NA	CHEMICAL	GENE-Y	2	41	The role of drug metabolism in chemical cytotoxicity was examined with inhibitors of chemical kinase ( gene ) , gene , and chemical deaminase , whereas the role of pemetrexed targets , chemical synthase ( gene ) , chemical reductase ( gene ) , and chemical formyltransferase ( gene ) in drug chemosensitivity was analyzed in cytotoxicity rescue studies .	T16	T39	15795320
NA	CHEMICAL	GENE-Y	2	46	The role of drug metabolism in chemical cytotoxicity was examined with inhibitors of chemical kinase ( gene ) , gene , and chemical deaminase , whereas the role of pemetrexed targets , chemical synthase ( gene ) , chemical reductase ( gene ) , and chemical formyltransferase ( gene ) in drug chemosensitivity was analyzed in cytotoxicity rescue studies .	T16	T40	15795320
NA	CHEMICAL	GENE-Y	2	48	The role of drug metabolism in chemical cytotoxicity was examined with inhibitors of chemical kinase ( gene ) , gene , and chemical deaminase , whereas the role of pemetrexed targets , chemical synthase ( gene ) , chemical reductase ( gene ) , and chemical formyltransferase ( gene ) in drug chemosensitivity was analyzed in cytotoxicity rescue studies .	T16	T41	15795320
NA	CHEMICAL	GENE-Y	45	5	The role of drug metabolism in chemical cytotoxicity was examined with inhibitors of chemical kinase ( gene ) , gene , and chemical deaminase , whereas the role of pemetrexed targets , chemical synthase ( gene ) , chemical reductase ( gene ) , and chemical formyltransferase ( gene ) in drug chemosensitivity was analyzed in cytotoxicity rescue studies .	T17	T32	15795320
NA	CHEMICAL	GENE-Y	45	16	The role of drug metabolism in chemical cytotoxicity was examined with inhibitors of chemical kinase ( gene ) , gene , and chemical deaminase , whereas the role of pemetrexed targets , chemical synthase ( gene ) , chemical reductase ( gene ) , and chemical formyltransferase ( gene ) in drug chemosensitivity was analyzed in cytotoxicity rescue studies .	T17	T33	15795320
NA	CHEMICAL	GENE-Y	45	19	The role of drug metabolism in chemical cytotoxicity was examined with inhibitors of chemical kinase ( gene ) , gene , and chemical deaminase , whereas the role of pemetrexed targets , chemical synthase ( gene ) , chemical reductase ( gene ) , and chemical formyltransferase ( gene ) in drug chemosensitivity was analyzed in cytotoxicity rescue studies .	T17	T34	15795320
NA	CHEMICAL	GENE-Y	45	5	The role of drug metabolism in chemical cytotoxicity was examined with inhibitors of chemical kinase ( gene ) , gene , and chemical deaminase , whereas the role of pemetrexed targets , chemical synthase ( gene ) , chemical reductase ( gene ) , and chemical formyltransferase ( gene ) in drug chemosensitivity was analyzed in cytotoxicity rescue studies .	T17	T35	15795320
NA	CHEMICAL	GENE-Y	45	33	The role of drug metabolism in chemical cytotoxicity was examined with inhibitors of chemical kinase ( gene ) , gene , and chemical deaminase , whereas the role of pemetrexed targets , chemical synthase ( gene ) , chemical reductase ( gene ) , and chemical formyltransferase ( gene ) in drug chemosensitivity was analyzed in cytotoxicity rescue studies .	T17	T36	15795320
NA	CHEMICAL	GENE-Y	45	35	The role of drug metabolism in chemical cytotoxicity was examined with inhibitors of chemical kinase ( gene ) , gene , and chemical deaminase , whereas the role of pemetrexed targets , chemical synthase ( gene ) , chemical reductase ( gene ) , and chemical formyltransferase ( gene ) in drug chemosensitivity was analyzed in cytotoxicity rescue studies .	T17	T37	15795320
NA	CHEMICAL	GENE-Y	45	39	The role of drug metabolism in chemical cytotoxicity was examined with inhibitors of chemical kinase ( gene ) , gene , and chemical deaminase , whereas the role of pemetrexed targets , chemical synthase ( gene ) , chemical reductase ( gene ) , and chemical formyltransferase ( gene ) in drug chemosensitivity was analyzed in cytotoxicity rescue studies .	T17	T38	15795320
NA	CHEMICAL	GENE-Y	45	41	The role of drug metabolism in chemical cytotoxicity was examined with inhibitors of chemical kinase ( gene ) , gene , and chemical deaminase , whereas the role of pemetrexed targets , chemical synthase ( gene ) , chemical reductase ( gene ) , and chemical formyltransferase ( gene ) in drug chemosensitivity was analyzed in cytotoxicity rescue studies .	T17	T39	15795320
NA	CHEMICAL	GENE-Y	45	46	The role of drug metabolism in chemical cytotoxicity was examined with inhibitors of chemical kinase ( gene ) , gene , and chemical deaminase , whereas the role of pemetrexed targets , chemical synthase ( gene ) , chemical reductase ( gene ) , and chemical formyltransferase ( gene ) in drug chemosensitivity was analyzed in cytotoxicity rescue studies .	T17	T40	15795320
NA	CHEMICAL	GENE-Y	45	48	The role of drug metabolism in chemical cytotoxicity was examined with inhibitors of chemical kinase ( gene ) , gene , and chemical deaminase , whereas the role of pemetrexed targets , chemical synthase ( gene ) , chemical reductase ( gene ) , and chemical formyltransferase ( gene ) in drug chemosensitivity was analyzed in cytotoxicity rescue studies .	T17	T41	15795320
NA	CHEMICAL	GENE-N	3	7	The effect of chemical and pemetrexed on gene phosphorylation was investigated with enzyme-linked immunosorbent assay , whereas quantitative polymerase chain reaction ( PCR ) was used to study target gene-expression profiles and its modulation by each drug .	T18	T42	15795320
CPR:4	CHEMICAL	GENE-N	6	12	Synergistic cytotoxicity was demonstrated , and chemical significantly decreased the amount of gene , enhanced apoptosis , and increased the expression of gene in A549 and Calu-6 cells , as well as the expression of the gene ( gene ) in all cell lines .	T2	T21	15795320
CPR:3	CHEMICAL	GENE-Y	6	22	Synergistic cytotoxicity was demonstrated , and chemical significantly decreased the amount of gene , enhanced apoptosis , and increased the expression of gene in A549 and Calu-6 cells , as well as the expression of the gene ( gene ) in all cell lines .	T2	T22	15795320
CPR:3	CHEMICAL	GENE-Y	6	36	Synergistic cytotoxicity was demonstrated , and chemical significantly decreased the amount of gene , enhanced apoptosis , and increased the expression of gene in A549 and Calu-6 cells , as well as the expression of the gene ( gene ) in all cell lines .	T2	T23	15795320
CPR:3	CHEMICAL	GENE-Y	6	38	Synergistic cytotoxicity was demonstrated , and chemical significantly decreased the amount of gene , enhanced apoptosis , and increased the expression of gene in A549 and Calu-6 cells , as well as the expression of the gene ( gene ) in all cell lines .	T2	T24	15795320
NA	CHEMICAL	GENE-Y	2	5	PCR demonstrated a correlation between gene expression and chemical sensitivity , whereas expression of gene , gene , and gene was predictive of chemical chemosensitivity .	T4	T25	15795320
NA	CHEMICAL	GENE-Y	2	14	PCR demonstrated a correlation between gene expression and chemical sensitivity , whereas expression of gene , gene , and gene was predictive of chemical chemosensitivity .	T4	T26	15795320
NA	CHEMICAL	GENE-Y	2	16	PCR demonstrated a correlation between gene expression and chemical sensitivity , whereas expression of gene , gene , and gene was predictive of chemical chemosensitivity .	T4	T27	15795320
NA	CHEMICAL	GENE-Y	2	19	PCR demonstrated a correlation between gene expression and chemical sensitivity , whereas expression of gene , gene , and gene was predictive of chemical chemosensitivity .	T4	T28	15795320
NA	CHEMICAL	GENE-Y	23	5	PCR demonstrated a correlation between gene expression and chemical sensitivity , whereas expression of gene , gene , and gene was predictive of chemical chemosensitivity .	T5	T25	15795320
NA	CHEMICAL	GENE-Y	23	14	PCR demonstrated a correlation between gene expression and chemical sensitivity , whereas expression of gene , gene , and gene was predictive of chemical chemosensitivity .	T5	T26	15795320
NA	CHEMICAL	GENE-Y	23	16	PCR demonstrated a correlation between gene expression and chemical sensitivity , whereas expression of gene , gene , and gene was predictive of chemical chemosensitivity .	T5	T27	15795320
NA	CHEMICAL	GENE-Y	23	19	PCR demonstrated a correlation between gene expression and chemical sensitivity , whereas expression of gene , gene , and gene was predictive of chemical chemosensitivity .	T5	T28	15795320
NA	CHEMICAL	GENE-N	5	6	Acromegaly : molecular expression of chemical receptor subtypes and treatment outcome .	T8	T24	16809928
NA	CHEMICAL	GENE-N	4	4	Such resistance is related to an overall reduction of chemical receptor ( gene ) density or to a differentiated expression of gene subtypes .	T3	T9	16809928
NA	CHEMICAL	GENE-N	4	12	Such resistance is related to an overall reduction of chemical receptor ( gene ) density or to a differentiated expression of gene subtypes .	T3	T10	16809928
NA	CHEMICAL	GENE-N	4	21	Such resistance is related to an overall reduction of chemical receptor ( gene ) density or to a differentiated expression of gene subtypes .	T3	T11	16809928
NA	CHEMICAL	GENE-Y	13	0	gene and gene are usually expressed in gene-secreting pituitary tumors , and both chemical and chemical bind preferentially to gene and , to a lesser extent , to gene .	T4	T13	16809928
NA	CHEMICAL	GENE-Y	13	2	gene and gene are usually expressed in gene-secreting pituitary tumors , and both chemical and chemical bind preferentially to gene and , to a lesser extent , to gene .	T4	T14	16809928
NA	CHEMICAL	GENE-Y	13	7	gene and gene are usually expressed in gene-secreting pituitary tumors , and both chemical and chemical bind preferentially to gene and , to a lesser extent , to gene .	T4	T15	16809928
NA	CHEMICAL	GENE-Y	13	19	gene and gene are usually expressed in gene-secreting pituitary tumors , and both chemical and chemical bind preferentially to gene and , to a lesser extent , to gene .	T4	T16	16809928
NA	CHEMICAL	GENE-Y	13	28	gene and gene are usually expressed in gene-secreting pituitary tumors , and both chemical and chemical bind preferentially to gene and , to a lesser extent , to gene .	T4	T17	16809928
NA	CHEMICAL	GENE-Y	15	0	gene and gene are usually expressed in gene-secreting pituitary tumors , and both chemical and chemical bind preferentially to gene and , to a lesser extent , to gene .	T5	T13	16809928
NA	CHEMICAL	GENE-Y	15	2	gene and gene are usually expressed in gene-secreting pituitary tumors , and both chemical and chemical bind preferentially to gene and , to a lesser extent , to gene .	T5	T14	16809928
NA	CHEMICAL	GENE-Y	15	7	gene and gene are usually expressed in gene-secreting pituitary tumors , and both chemical and chemical bind preferentially to gene and , to a lesser extent , to gene .	T5	T15	16809928
NA	CHEMICAL	GENE-Y	15	19	gene and gene are usually expressed in gene-secreting pituitary tumors , and both chemical and chemical bind preferentially to gene and , to a lesser extent , to gene .	T5	T16	16809928
NA	CHEMICAL	GENE-Y	15	28	gene and gene are usually expressed in gene-secreting pituitary tumors , and both chemical and chemical bind preferentially to gene and , to a lesser extent , to gene .	T5	T17	16809928
CPR:4	CHEMICAL	GENE-N	0	5	chemical ( chemical ) is a novel chemical-containing antibiotic that inhibits gene , and that has been in development for the treatment of serious Gram-negative infections .	T1	T15	23439661
CPR:4	CHEMICAL	GENE-N	2	5	chemical ( chemical ) is a novel chemical-containing antibiotic that inhibits gene , and that has been in development for the treatment of serious Gram-negative infections .	T11	T15	23439661
NA	CHEMICAL	GENE-N	7	5	chemical ( chemical ) is a novel chemical-containing antibiotic that inhibits gene , and that has been in development for the treatment of serious Gram-negative infections .	T2	T15	23439661
NA	CHEMICAL	GENE-Y	11	0	A Model-Based Approach to Predict Longitudinal gene , Using Early Phase chemical Data From Type 2 Diabetes Mellitus Patients After Anti-Diabetic Treatment .	T6	T17	23606523
NA	CHEMICAL	GENE-Y	19	11	In this paper , we present a model-based approach for predicting gene ( gene ) in late phase using chemical and gene concentrations from an early-phase study , investigating an anti-diabetic treatment .	T2	T10	23606523
NA	CHEMICAL	GENE-Y	19	13	In this paper , we present a model-based approach for predicting gene ( gene ) in late phase using chemical and gene concentrations from an early-phase study , investigating an anti-diabetic treatment .	T2	T11	23606523
NA	CHEMICAL	GENE-Y	19	15	In this paper , we present a model-based approach for predicting gene ( gene ) in late phase using chemical and gene concentrations from an early-phase study , investigating an anti-diabetic treatment .	T2	T12	23606523
NA	CHEMICAL	GENE-Y	9	11	Two previously published models were used ; an integrated chemical and gene ( IGI ) model for meal tolerance tests and an integrated chemical-red blood cell-gene ( IGRH ) model predicting the formation of gene from the average chemical concentration ( Cg , av ) .	T3	T13	23606523
NA	CHEMICAL	GENE-Y	9	25	Two previously published models were used ; an integrated chemical and gene ( IGI ) model for meal tolerance tests and an integrated chemical-red blood cell-gene ( IGRH ) model predicting the formation of gene from the average chemical concentration ( Cg , av ) .	T3	T14	23606523
NA	CHEMICAL	GENE-Y	9	34	Two previously published models were used ; an integrated chemical and gene ( IGI ) model for meal tolerance tests and an integrated chemical-red blood cell-gene ( IGRH ) model predicting the formation of gene from the average chemical concentration ( Cg , av ) .	T3	T15	23606523
NA	CHEMICAL	GENE-Y	23	11	Two previously published models were used ; an integrated chemical and gene ( IGI ) model for meal tolerance tests and an integrated chemical-red blood cell-gene ( IGRH ) model predicting the formation of gene from the average chemical concentration ( Cg , av ) .	T4	T13	23606523
NA	CHEMICAL	GENE-Y	23	25	Two previously published models were used ; an integrated chemical and gene ( IGI ) model for meal tolerance tests and an integrated chemical-red blood cell-gene ( IGRH ) model predicting the formation of gene from the average chemical concentration ( Cg , av ) .	T4	T14	23606523
NA	CHEMICAL	GENE-Y	23	34	Two previously published models were used ; an integrated chemical and gene ( IGI ) model for meal tolerance tests and an integrated chemical-red blood cell-gene ( IGRH ) model predicting the formation of gene from the average chemical concentration ( Cg , av ) .	T4	T15	23606523
NA	CHEMICAL	GENE-Y	38	11	Two previously published models were used ; an integrated chemical and gene ( IGI ) model for meal tolerance tests and an integrated chemical-red blood cell-gene ( IGRH ) model predicting the formation of gene from the average chemical concentration ( Cg , av ) .	T5	T13	23606523
NA	CHEMICAL	GENE-Y	38	25	Two previously published models were used ; an integrated chemical and gene ( IGI ) model for meal tolerance tests and an integrated chemical-red blood cell-gene ( IGRH ) model predicting the formation of gene from the average chemical concentration ( Cg , av ) .	T5	T14	23606523
NA	CHEMICAL	GENE-Y	38	34	Two previously published models were used ; an integrated chemical and gene ( IGI ) model for meal tolerance tests and an integrated chemical-red blood cell-gene ( IGRH ) model predicting the formation of gene from the average chemical concentration ( Cg , av ) .	T5	T15	23606523
NA	CHEMICAL	GENE-N	4	5	The electrostatic potential of chemical cleft of gene/mutants and their heterodimerization with gene ( gene ) were computationally evaluated .	T1	T11	23154865
NA	CHEMICAL	GENE-Y	4	7	The electrostatic potential of chemical cleft of gene/mutants and their heterodimerization with gene ( gene ) were computationally evaluated .	T1	T12	23154865
NA	CHEMICAL	GENE-Y	4	12	The electrostatic potential of chemical cleft of gene/mutants and their heterodimerization with gene ( gene ) were computationally evaluated .	T1	T13	23154865
NA	CHEMICAL	GENE-Y	4	14	The electrostatic potential of chemical cleft of gene/mutants and their heterodimerization with gene ( gene ) were computationally evaluated .	T1	T14	23154865
NA	CHEMICAL	GENE-Y	4	6	In vivo genotoxicity of chemical in gene delta transgenic rats following medium-term exposure .	T12	T21	23074021
NA	CHEMICAL	GENE-Y	20	5	In this study , a gene delta transgenic rat model was used to clarify whether genotoxic mechanisms are involved in chemical-induced hepatocarcinogenesis following medium-term exposure .	T6	T15	23074021
NA	CHEMICAL	GENE-Y	11	1	F344 gene delta rats were subjected to repeated oral administration of chemical at dosages of 0 , 10 , 30 , or 100mg/kg ( a carcinogenic dose ) for 13 weeks .	T7	T16	23074021
NA	CHEMICAL	GENE-N	8	11	In addition , the number and area of chemical chemical-transferase placental form ( gene ) positive foci and gene ( gene ) positive cell ratios in the hepatocytes were significantly increased in the male and female rats that were administered 100mg/kg chemical compared with the control animals .	T10	T17	23074021
NA	CHEMICAL	GENE-N	8	13	In addition , the number and area of chemical chemical-transferase placental form ( gene ) positive foci and gene ( gene ) positive cell ratios in the hepatocytes were significantly increased in the male and female rats that were administered 100mg/kg chemical compared with the control animals .	T10	T18	23074021
NA	CHEMICAL	GENE-Y	8	18	In addition , the number and area of chemical chemical-transferase placental form ( gene ) positive foci and gene ( gene ) positive cell ratios in the hepatocytes were significantly increased in the male and female rats that were administered 100mg/kg chemical compared with the control animals .	T10	T19	23074021
NA	CHEMICAL	GENE-Y	8	20	In addition , the number and area of chemical chemical-transferase placental form ( gene ) positive foci and gene ( gene ) positive cell ratios in the hepatocytes were significantly increased in the male and female rats that were administered 100mg/kg chemical compared with the control animals .	T10	T20	23074021
NA	CHEMICAL	GENE-N	9	11	In addition , the number and area of chemical chemical-transferase placental form ( gene ) positive foci and gene ( gene ) positive cell ratios in the hepatocytes were significantly increased in the male and female rats that were administered 100mg/kg chemical compared with the control animals .	T11	T17	23074021
NA	CHEMICAL	GENE-N	9	13	In addition , the number and area of chemical chemical-transferase placental form ( gene ) positive foci and gene ( gene ) positive cell ratios in the hepatocytes were significantly increased in the male and female rats that were administered 100mg/kg chemical compared with the control animals .	T11	T18	23074021
NA	CHEMICAL	GENE-Y	9	18	In addition , the number and area of chemical chemical-transferase placental form ( gene ) positive foci and gene ( gene ) positive cell ratios in the hepatocytes were significantly increased in the male and female rats that were administered 100mg/kg chemical compared with the control animals .	T11	T19	23074021
NA	CHEMICAL	GENE-Y	9	20	In addition , the number and area of chemical chemical-transferase placental form ( gene ) positive foci and gene ( gene ) positive cell ratios in the hepatocytes were significantly increased in the male and female rats that were administered 100mg/kg chemical compared with the control animals .	T11	T20	23074021
CPR:3	CHEMICAL	GENE-N	20	11	In addition , the number and area of chemical chemical-transferase placental form ( gene ) positive foci and gene ( gene ) positive cell ratios in the hepatocytes were significantly increased in the male and female rats that were administered 100mg/kg chemical compared with the control animals .	T2	T17	23074021
CPR:3	CHEMICAL	GENE-N	20	13	In addition , the number and area of chemical chemical-transferase placental form ( gene ) positive foci and gene ( gene ) positive cell ratios in the hepatocytes were significantly increased in the male and female rats that were administered 100mg/kg chemical compared with the control animals .	T2	T18	23074021
CPR:3	CHEMICAL	GENE-Y	20	18	In addition , the number and area of chemical chemical-transferase placental form ( gene ) positive foci and gene ( gene ) positive cell ratios in the hepatocytes were significantly increased in the male and female rats that were administered 100mg/kg chemical compared with the control animals .	T2	T19	23074021
CPR:3	CHEMICAL	GENE-Y	20	20	In addition , the number and area of chemical chemical-transferase placental form ( gene ) positive foci and gene ( gene ) positive cell ratios in the hepatocytes were significantly increased in the male and female rats that were administered 100mg/kg chemical compared with the control animals .	T2	T20	23074021
CPR:4	CHEMICAL	GENE-Y	8	5	Efficacy and safety of the gene inhibitor , chemical , in patients with type 2 diabetes mellitus inadequately controlled on chemical alone or on chemical and chemical .	T5	T10	17593236
NA	CHEMICAL	GENE-Y	20	5	Efficacy and safety of the gene inhibitor , chemical , in patients with type 2 diabetes mellitus inadequately controlled on chemical alone or on chemical and chemical .	T2	T10	17593236
NA	CHEMICAL	GENE-Y	24	5	Efficacy and safety of the gene inhibitor , chemical , in patients with type 2 diabetes mellitus inadequately controlled on chemical alone or on chemical and chemical .	T3	T10	17593236
NA	CHEMICAL	GENE-Y	10	5	Efficacy and safety of the gene inhibitor , chemical , in patients with type 2 diabetes mellitus inadequately controlled on chemical alone or on chemical and chemical .	T4	T10	17593236
NA	CHEMICAL	GENE-Y	5	22	Neuropsychological and conditioned blocking performance in patients with schizophrenia : assessment of the contribution of neuroleptic dose , serum levels and chemical D2-receptor occupancy .	T11	T20	11103886
NA	CHEMICAL	GENE-Y	13	35	We describe here the putative influence of the dose of antipsychotic medication ( chemical equivalents , chemical ) , the antipsychotic serum concentration of chemical ( chemical ) gene-blocking activity and the approximated central chemical gene occupancy ( chemical D2-occupancy ) , on conditioned blocking ( CB ) measures of attention and performance on a neuropsychological battery , in 108 patients with schizophrenia ( compared with 62 healthy controls ) .	T5	T16	11103886
NA	CHEMICAL	GENE-Y	13	28	We describe here the putative influence of the dose of antipsychotic medication ( chemical equivalents , chemical ) , the antipsychotic serum concentration of chemical ( chemical ) gene-blocking activity and the approximated central chemical gene occupancy ( chemical D2-occupancy ) , on conditioned blocking ( CB ) measures of attention and performance on a neuropsychological battery , in 108 patients with schizophrenia ( compared with 62 healthy controls ) .	T5	T17	11103886
NA	CHEMICAL	GENE-Y	16	35	We describe here the putative influence of the dose of antipsychotic medication ( chemical equivalents , chemical ) , the antipsychotic serum concentration of chemical ( chemical ) gene-blocking activity and the approximated central chemical gene occupancy ( chemical D2-occupancy ) , on conditioned blocking ( CB ) measures of attention and performance on a neuropsychological battery , in 108 patients with schizophrenia ( compared with 62 healthy controls ) .	T6	T16	11103886
NA	CHEMICAL	GENE-Y	16	28	We describe here the putative influence of the dose of antipsychotic medication ( chemical equivalents , chemical ) , the antipsychotic serum concentration of chemical ( chemical ) gene-blocking activity and the approximated central chemical gene occupancy ( chemical D2-occupancy ) , on conditioned blocking ( CB ) measures of attention and performance on a neuropsychological battery , in 108 patients with schizophrenia ( compared with 62 healthy controls ) .	T6	T17	11103886
NA	CHEMICAL	GENE-Y	24	35	We describe here the putative influence of the dose of antipsychotic medication ( chemical equivalents , chemical ) , the antipsychotic serum concentration of chemical ( chemical ) gene-blocking activity and the approximated central chemical gene occupancy ( chemical D2-occupancy ) , on conditioned blocking ( CB ) measures of attention and performance on a neuropsychological battery , in 108 patients with schizophrenia ( compared with 62 healthy controls ) .	T7	T16	11103886
NA	CHEMICAL	GENE-Y	24	28	We describe here the putative influence of the dose of antipsychotic medication ( chemical equivalents , chemical ) , the antipsychotic serum concentration of chemical ( chemical ) gene-blocking activity and the approximated central chemical gene occupancy ( chemical D2-occupancy ) , on conditioned blocking ( CB ) measures of attention and performance on a neuropsychological battery , in 108 patients with schizophrenia ( compared with 62 healthy controls ) .	T7	T17	11103886
NA	CHEMICAL	GENE-Y	26	35	We describe here the putative influence of the dose of antipsychotic medication ( chemical equivalents , chemical ) , the antipsychotic serum concentration of chemical ( chemical ) gene-blocking activity and the approximated central chemical gene occupancy ( chemical D2-occupancy ) , on conditioned blocking ( CB ) measures of attention and performance on a neuropsychological battery , in 108 patients with schizophrenia ( compared with 62 healthy controls ) .	T8	T16	11103886
NA	CHEMICAL	GENE-Y	26	28	We describe here the putative influence of the dose of antipsychotic medication ( chemical equivalents , chemical ) , the antipsychotic serum concentration of chemical ( chemical ) gene-blocking activity and the approximated central chemical gene occupancy ( chemical D2-occupancy ) , on conditioned blocking ( CB ) measures of attention and performance on a neuropsychological battery , in 108 patients with schizophrenia ( compared with 62 healthy controls ) .	T8	T17	11103886
NA	CHEMICAL	GENE-Y	34	35	We describe here the putative influence of the dose of antipsychotic medication ( chemical equivalents , chemical ) , the antipsychotic serum concentration of chemical ( chemical ) gene-blocking activity and the approximated central chemical gene occupancy ( chemical D2-occupancy ) , on conditioned blocking ( CB ) measures of attention and performance on a neuropsychological battery , in 108 patients with schizophrenia ( compared with 62 healthy controls ) .	T9	T16	11103886
NA	CHEMICAL	GENE-Y	34	28	We describe here the putative influence of the dose of antipsychotic medication ( chemical equivalents , chemical ) , the antipsychotic serum concentration of chemical ( chemical ) gene-blocking activity and the approximated central chemical gene occupancy ( chemical D2-occupancy ) , on conditioned blocking ( CB ) measures of attention and performance on a neuropsychological battery , in 108 patients with schizophrenia ( compared with 62 healthy controls ) .	T9	T17	11103886
NA	CHEMICAL	GENE-Y	38	35	We describe here the putative influence of the dose of antipsychotic medication ( chemical equivalents , chemical ) , the antipsychotic serum concentration of chemical ( chemical ) gene-blocking activity and the approximated central chemical gene occupancy ( chemical D2-occupancy ) , on conditioned blocking ( CB ) measures of attention and performance on a neuropsychological battery , in 108 patients with schizophrenia ( compared with 62 healthy controls ) .	T10	T16	11103886
NA	CHEMICAL	GENE-Y	38	28	We describe here the putative influence of the dose of antipsychotic medication ( chemical equivalents , chemical ) , the antipsychotic serum concentration of chemical ( chemical ) gene-blocking activity and the approximated central chemical gene occupancy ( chemical D2-occupancy ) , on conditioned blocking ( CB ) measures of attention and performance on a neuropsychological battery , in 108 patients with schizophrenia ( compared with 62 healthy controls ) .	T10	T17	11103886
NA	CHEMICAL	GENE-Y	11	12	Similar partial correlations for antipsychotic drug dose and serum levels of chemical gene-blocking activity with performance of the trail-making and picture completion tests ( negative ) and the block-design task ( positive ) showed the functional importance of chemical-related activity .	T1	T12	11103886
NA	CHEMICAL	GENE-Y	38	12	Similar partial correlations for antipsychotic drug dose and serum levels of chemical gene-blocking activity with performance of the trail-making and picture completion tests ( negative ) and the block-design task ( positive ) showed the functional importance of chemical-related activity .	T2	T12	11103886
NA	CHEMICAL	GENE-Y	4	5	High estimates of central chemical gene-occupancy were related to impaired verbal fluency but were associated with improved recall of stories , especially in paranoid patients .	T3	T13	11103886
CPR:5	CHEMICAL	GENE-N	6	14	The results suggested that both the chemical extract and chemical were able to activate gene , and Rhizoma Coptis contains potential natural agonists of gene besides chemical .	T2	T10	23418674
NA	CHEMICAL	GENE-N	6	24	The results suggested that both the chemical extract and chemical were able to activate gene , and Rhizoma Coptis contains potential natural agonists of gene besides chemical .	T2	T12	23418674
CPR:5	CHEMICAL	GENE-N	9	14	The results suggested that both the chemical extract and chemical were able to activate gene , and Rhizoma Coptis contains potential natural agonists of gene besides chemical .	T3	T10	23418674
NA	CHEMICAL	GENE-N	9	24	The results suggested that both the chemical extract and chemical were able to activate gene , and Rhizoma Coptis contains potential natural agonists of gene besides chemical .	T3	T12	23418674
CPR:5	CHEMICAL	GENE-N	26	14	The results suggested that both the chemical extract and chemical were able to activate gene , and Rhizoma Coptis contains potential natural agonists of gene besides chemical .	T4	T10	23418674
CPR:5	CHEMICAL	GENE-N	26	24	The results suggested that both the chemical extract and chemical were able to activate gene , and Rhizoma Coptis contains potential natural agonists of gene besides chemical .	T4	T12	23418674
CPR:3	CHEMICAL	GENE-N	0	8	chemical intoxication caused hepatic necrosis and increased serum gene activity .	T3	T22	23116643
NA	CHEMICAL	GENE-Y	10	23	In the livers , oxidative/nitrosative stress was evidenced by increased chemical ( chemical ) and chemical reactive substances ( TBARS ) formation and a significant decrease in chemical/chemical chemical dismutase ( gene ) activity .	T4	T23	23116643
NA	CHEMICAL	GENE-N	10	31	In the livers , oxidative/nitrosative stress was evidenced by increased chemical ( chemical ) and chemical reactive substances ( TBARS ) formation and a significant decrease in chemical/chemical chemical dismutase ( gene ) activity .	T4	T24	23116643
NA	CHEMICAL	GENE-Y	12	23	In the livers , oxidative/nitrosative stress was evidenced by increased chemical ( chemical ) and chemical reactive substances ( TBARS ) formation and a significant decrease in chemical/chemical chemical dismutase ( gene ) activity .	T5	T23	23116643
NA	CHEMICAL	GENE-N	12	31	In the livers , oxidative/nitrosative stress was evidenced by increased chemical ( chemical ) and chemical reactive substances ( TBARS ) formation and a significant decrease in chemical/chemical chemical dismutase ( gene ) activity .	T5	T24	23116643
NA	CHEMICAL	GENE-Y	15	23	In the livers , oxidative/nitrosative stress was evidenced by increased chemical ( chemical ) and chemical reactive substances ( TBARS ) formation and a significant decrease in chemical/chemical chemical dismutase ( gene ) activity .	T6	T23	23116643
NA	CHEMICAL	GENE-N	15	31	In the livers , oxidative/nitrosative stress was evidenced by increased chemical ( chemical ) and chemical reactive substances ( TBARS ) formation and a significant decrease in chemical/chemical chemical dismutase ( gene ) activity .	T6	T24	23116643
NA	CHEMICAL	GENE-Y	27	23	In the livers , oxidative/nitrosative stress was evidenced by increased chemical ( chemical ) and chemical reactive substances ( TBARS ) formation and a significant decrease in chemical/chemical chemical dismutase ( gene ) activity .	T7	T23	23116643
NA	CHEMICAL	GENE-N	27	31	In the livers , oxidative/nitrosative stress was evidenced by increased chemical ( chemical ) and chemical reactive substances ( TBARS ) formation and a significant decrease in chemical/chemical chemical dismutase ( gene ) activity .	T7	T24	23116643
NA	CHEMICAL	GENE-Y	27	23	In the livers , oxidative/nitrosative stress was evidenced by increased chemical ( chemical ) and chemical reactive substances ( TBARS ) formation and a significant decrease in chemical/chemical chemical dismutase ( gene ) activity .	T8	T23	23116643
NA	CHEMICAL	GENE-N	27	31	In the livers , oxidative/nitrosative stress was evidenced by increased chemical ( chemical ) and chemical reactive substances ( TBARS ) formation and a significant decrease in chemical/chemical chemical dismutase ( gene ) activity .	T8	T24	23116643
NA	CHEMICAL	GENE-Y	28	23	In the livers , oxidative/nitrosative stress was evidenced by increased chemical ( chemical ) and chemical reactive substances ( TBARS ) formation and a significant decrease in chemical/chemical chemical dismutase ( gene ) activity .	T9	T23	23116643
NA	CHEMICAL	GENE-N	28	31	In the livers , oxidative/nitrosative stress was evidenced by increased chemical ( chemical ) and chemical reactive substances ( TBARS ) formation and a significant decrease in chemical/chemical chemical dismutase ( gene ) activity .	T9	T24	23116643
CPR:3	CHEMICAL	GENE-N	0	10	chemical administration triggered inflammatory response in mice livers by activating gene ( gene ) , which coincided with the induction of gene ( gene ) and gene ( gene ) .	T10	T25	23116643
CPR:3	CHEMICAL	GENE-N	0	12	chemical administration triggered inflammatory response in mice livers by activating gene ( gene ) , which coincided with the induction of gene ( gene ) and gene ( gene ) .	T10	T26	23116643
CPR:3	CHEMICAL	GENE-Y	0	21	chemical administration triggered inflammatory response in mice livers by activating gene ( gene ) , which coincided with the induction of gene ( gene ) and gene ( gene ) .	T10	T27	23116643
CPR:3	CHEMICAL	GENE-Y	0	23	chemical administration triggered inflammatory response in mice livers by activating gene ( gene ) , which coincided with the induction of gene ( gene ) and gene ( gene ) .	T10	T28	23116643
CPR:3	CHEMICAL	GENE-Y	0	26	chemical administration triggered inflammatory response in mice livers by activating gene ( gene ) , which coincided with the induction of gene ( gene ) and gene ( gene ) .	T10	T29	23116643
CPR:3	CHEMICAL	GENE-Y	0	28	chemical administration triggered inflammatory response in mice livers by activating gene ( gene ) , which coincided with the induction of gene ( gene ) and gene ( gene ) .	T10	T30	23116643
CPR:4	CHEMICAL	GENE-Y	6	16	Furthermore , RA significantly inhibited the chemical-induced apoptosis , which was evident from decreased cleavage of gene .	T1	T17	23116643
CPR:4	CHEMICAL	GENE-Y	2	4	BACKGROUND : chemical is a chemical drug designed to inhibit both gene and gene by reversibly covalently bonding to these enzymes .	T2	T12	14587496
CPR:4	CHEMICAL	GENE-Y	2	4	BACKGROUND : chemical is a chemical drug designed to inhibit both gene and gene by reversibly covalently bonding to these enzymes .	T2	T13	14587496
CPR:4	CHEMICAL	GENE-Y	4	4	BACKGROUND : chemical is a chemical drug designed to inhibit both gene and gene by reversibly covalently bonding to these enzymes .	T6	T12	14587496
CPR:4	CHEMICAL	GENE-Y	4	4	BACKGROUND : chemical is a chemical drug designed to inhibit both gene and gene by reversibly covalently bonding to these enzymes .	T6	T13	14587496
CPR:4	CHEMICAL	GENE-Y	6	3	Structural basis for gene inhibition upon chemical binding to the gene .	T3	T14	10493852
NA	CHEMICAL	GENE-N	6	10	Structural basis for gene inhibition upon chemical binding to the gene .	T3	T15	10493852
CPR:4	CHEMICAL	GENE-Y	4	19	We report here that chemical , a drug clinically used for lowering chemical levels , inhibits the interaction of gene with its counter-receptor gene .	T1	T4	10493852
CPR:4	CHEMICAL	GENE-Y	4	23	We report here that chemical , a drug clinically used for lowering chemical levels , inhibits the interaction of gene with its counter-receptor gene .	T1	T5	10493852
NA	CHEMICAL	GENE-Y	12	19	We report here that chemical , a drug clinically used for lowering chemical levels , inhibits the interaction of gene with its counter-receptor gene .	T2	T4	10493852
NA	CHEMICAL	GENE-Y	12	23	We report here that chemical , a drug clinically used for lowering chemical levels , inhibits the interaction of gene with its counter-receptor gene .	T2	T5	10493852
NA	CHEMICAL	GENE-N	2	3	Localization of chemical decarboxylase and chemical transaminase immunoreactivity in the sympathetic ganglia of the rat .	T19	T35	3299141
NA	CHEMICAL	GENE-Y	2	6	Localization of chemical decarboxylase and chemical transaminase immunoreactivity in the sympathetic ganglia of the rat .	T19	T36	3299141
NA	CHEMICAL	GENE-N	5	3	Localization of chemical decarboxylase and chemical transaminase immunoreactivity in the sympathetic ganglia of the rat .	T20	T35	3299141
NA	CHEMICAL	GENE-Y	5	6	Localization of chemical decarboxylase and chemical transaminase immunoreactivity in the sympathetic ganglia of the rat .	T20	T36	3299141
NA	CHEMICAL	GENE-N	3	4	The location of chemical decarboxylase and chemical ( chemical ) -transaminase immunoreactivity in the superior cervical ganglion and in the coeliac-superior mesenteric ganglion complex of the rat was studied by an indirect immunofluorescence method and by immunoelectron microscopy , with specific antisera raised in rabbits against the corresponding enzymes .	T6	T24	3299141
NA	CHEMICAL	GENE-Y	3	7	The location of chemical decarboxylase and chemical ( chemical ) -transaminase immunoreactivity in the superior cervical ganglion and in the coeliac-superior mesenteric ganglion complex of the rat was studied by an indirect immunofluorescence method and by immunoelectron microscopy , with specific antisera raised in rabbits against the corresponding enzymes .	T6	T31	3299141
NA	CHEMICAL	GENE-N	6	4	The location of chemical decarboxylase and chemical ( chemical ) -transaminase immunoreactivity in the superior cervical ganglion and in the coeliac-superior mesenteric ganglion complex of the rat was studied by an indirect immunofluorescence method and by immunoelectron microscopy , with specific antisera raised in rabbits against the corresponding enzymes .	T14	T24	3299141
NA	CHEMICAL	GENE-Y	6	7	The location of chemical decarboxylase and chemical ( chemical ) -transaminase immunoreactivity in the superior cervical ganglion and in the coeliac-superior mesenteric ganglion complex of the rat was studied by an indirect immunofluorescence method and by immunoelectron microscopy , with specific antisera raised in rabbits against the corresponding enzymes .	T14	T31	3299141
NA	CHEMICAL	GENE-N	8	4	The location of chemical decarboxylase and chemical ( chemical ) -transaminase immunoreactivity in the superior cervical ganglion and in the coeliac-superior mesenteric ganglion complex of the rat was studied by an indirect immunofluorescence method and by immunoelectron microscopy , with specific antisera raised in rabbits against the corresponding enzymes .	T15	T24	3299141
NA	CHEMICAL	GENE-Y	8	7	The location of chemical decarboxylase and chemical ( chemical ) -transaminase immunoreactivity in the superior cervical ganglion and in the coeliac-superior mesenteric ganglion complex of the rat was studied by an indirect immunofluorescence method and by immunoelectron microscopy , with specific antisera raised in rabbits against the corresponding enzymes .	T15	T31	3299141
NA	CHEMICAL	GENE-Y	5	14	In light microscopy , several chemical decarboxylase- or chemical-transaminase-immunoreactive principal nerve cells were detected in the superior cervical ganglion and coeliac-superior mesenteric ganglion complex .	T12	T30	3299141
NA	CHEMICAL	GENE-Y	8	14	In light microscopy , several chemical decarboxylase- or chemical-transaminase-immunoreactive principal nerve cells were detected in the superior cervical ganglion and coeliac-superior mesenteric ganglion complex .	T13	T30	3299141
NA	CHEMICAL	GENE-N	21	22	In addition , numerous small cells in both the superior cervical ganglion and coeliac-superior mesenteric ganglion complex showed intense immunoreactivity to chemical decarboxylase or chemical-transaminase .	T16	T32	3299141
NA	CHEMICAL	GENE-Y	21	6	In addition , numerous small cells in both the superior cervical ganglion and coeliac-superior mesenteric ganglion complex showed intense immunoreactivity to chemical decarboxylase or chemical-transaminase .	T16	T33	3299141
NA	CHEMICAL	GENE-N	24	22	In addition , numerous small cells in both the superior cervical ganglion and coeliac-superior mesenteric ganglion complex showed intense immunoreactivity to chemical decarboxylase or chemical-transaminase .	T17	T32	3299141
NA	CHEMICAL	GENE-Y	24	6	In addition , numerous small cells in both the superior cervical ganglion and coeliac-superior mesenteric ganglion complex showed intense immunoreactivity to chemical decarboxylase or chemical-transaminase .	T17	T33	3299141
NA	CHEMICAL	GENE-Y	6	15	In consecutive sections , the small chemical decarboxylase-immunoreactive cell clusters also showed immunoreactivity to chemical hydroxylase , suggesting that these cells contain the enzymes for both chemical and chemical synthesis .	T18	T21	3299141
NA	CHEMICAL	GENE-Y	6	15	In consecutive sections , the small chemical decarboxylase-immunoreactive cell clusters also showed immunoreactivity to chemical hydroxylase , suggesting that these cells contain the enzymes for both chemical and chemical synthesis .	T1	T21	3299141
NA	CHEMICAL	GENE-Y	26	15	In consecutive sections , the small chemical decarboxylase-immunoreactive cell clusters also showed immunoreactivity to chemical hydroxylase , suggesting that these cells contain the enzymes for both chemical and chemical synthesis .	T2	T21	3299141
NA	CHEMICAL	GENE-Y	28	15	In consecutive sections , the small chemical decarboxylase-immunoreactive cell clusters also showed immunoreactivity to chemical hydroxylase , suggesting that these cells contain the enzymes for both chemical and chemical synthesis .	T3	T21	3299141
NA	CHEMICAL	GENE-Y	13	6	In the superior cervical ganglion and in the coeliac-superior mesenteric ganglion complex , chemical-transaminase immunoreactivity was also localized in fibre-like processes around and between the principal nerve cells , in nerve trunks traversing the ganglia , and around or in close contact with ganglionic blood vessels .	T4	T22	3299141
NA	CHEMICAL	GENE-Y	2	6	Furthermore , chemical-transaminase immunoreactivity was observed in fibre-like structures close to the capsule of the ganglia .	T5	T23	3299141
NA	CHEMICAL	GENE-Y	16	15	Division of the preganglionic nerve trunk of the superior cervical ganglion caused no detectable change in chemical-transaminase immunoreactivity in the ganglion .	T7	T25	3299141
NA	CHEMICAL	GENE-Y	9	13	In immunoelectron microscopy of the superior cervical ganglion , chemical-transaminase immunoreactivity was localized in nerve fibres in association with neurotubules .	T8	T26	3299141
NA	CHEMICAL	GENE-Y	0	0	A large number of chemical-transaminase labelled principal nerve cells were detected , containing immunoreactivity evenly distributed in their cytoplasm .	T9	T27	3299141
NA	CHEMICAL	GENE-Y	0	5	chemical-transaminase immunoreactivity was also observed in satellite cells and their processes in the superior cervical ganglion .	T10	T28	3299141
NA	CHEMICAL	GENE-Y	24	8	Here , we found that expression of the gene-gene mutant , which causes severe disease , depletes some ER chaperones with a gene ( chemical ) motif , in HeLa cells , MO3.13 oligodendrocytic cells , and primary oligodendrocytes .	T2	T11	23344956
NA	CHEMICAL	GENE-N	24	8	Here , we found that expression of the gene-gene mutant , which causes severe disease , depletes some ER chaperones with a gene ( chemical ) motif , in HeLa cells , MO3.13 oligodendrocytic cells , and primary oligodendrocytes .	T2	T12	23344956
NA	CHEMICAL	GENE-N	24	22	Here , we found that expression of the gene-gene mutant , which causes severe disease , depletes some ER chaperones with a gene ( chemical ) motif , in HeLa cells , MO3.13 oligodendrocytic cells , and primary oligodendrocytes .	T2	T13	23344956
NA	CHEMICAL	GENE-Y	5	6	Structural features of the central chemical gene receptor involved in the binding of the specific gene antagonist chemical .	T15	T31	8636122
NA	CHEMICAL	GENE-Y	5	15	Structural features of the central chemical gene receptor involved in the binding of the specific gene antagonist chemical .	T15	T30	8636122
NA	CHEMICAL	GENE-Y	17	6	Structural features of the central chemical gene receptor involved in the binding of the specific gene antagonist chemical .	T14	T31	8636122
CPR:6	CHEMICAL	GENE-Y	17	15	Structural features of the central chemical gene receptor involved in the binding of the specific gene antagonist chemical .	T14	T30	8636122
NA	CHEMICAL	GENE-Y	2	10	The antagonist chemical has a high specificity for the central gene chemical receptor and negligeable affinity for the peripheral gene receptor , making it an excellent tool for probing receptor structure-activity relationships .	T4	T23	8636122
NA	CHEMICAL	GENE-N	2	12	The antagonist chemical has a high specificity for the central gene chemical receptor and negligeable affinity for the peripheral gene receptor , making it an excellent tool for probing receptor structure-activity relationships .	T4	T25	8636122
NA	CHEMICAL	GENE-Y	2	19	The antagonist chemical has a high specificity for the central gene chemical receptor and negligeable affinity for the peripheral gene receptor , making it an excellent tool for probing receptor structure-activity relationships .	T4	T18	8636122
NA	CHEMICAL	GENE-Y	4	10	The antagonist chemical has a high specificity for the central gene chemical receptor and negligeable affinity for the peripheral gene receptor , making it an excellent tool for probing receptor structure-activity relationships .	T8	T23	8636122
NA	CHEMICAL	GENE-N	4	12	The antagonist chemical has a high specificity for the central gene chemical receptor and negligeable affinity for the peripheral gene receptor , making it an excellent tool for probing receptor structure-activity relationships .	T8	T25	8636122
NA	CHEMICAL	GENE-Y	4	19	The antagonist chemical has a high specificity for the central gene chemical receptor and negligeable affinity for the peripheral gene receptor , making it an excellent tool for probing receptor structure-activity relationships .	T8	T18	8636122
NA	CHEMICAL	GENE-Y	25	5	From binding experiments with mutated gene and with chimeric gene/gene receptors we have begun to identify the domains of gene implicated in the recognition of chemical .	T5	T19	8636122
NA	CHEMICAL	GENE-Y	25	9	From binding experiments with mutated gene and with chimeric gene/gene receptors we have begun to identify the domains of gene implicated in the recognition of chemical .	T5	T20	8636122
NA	CHEMICAL	GENE-Y	25	9	From binding experiments with mutated gene and with chimeric gene/gene receptors we have begun to identify the domains of gene implicated in the recognition of chemical .	T5	T21	8636122
NA	CHEMICAL	GENE-Y	25	19	From binding experiments with mutated gene and with chimeric gene/gene receptors we have begun to identify the domains of gene implicated in the recognition of chemical .	T5	T22	8636122
NA	CHEMICAL	GENE-Y	21	11	The region delineated by the fourth and fifth transmembrane helices of gene proved to be crucial for high affinity binding of chemical .	T9	T24	8636122
NA	CHEMICAL	GENE-Y	19	1	The gene and gene second extracellular loops , e2 , were exchanged , modifications that had no effect on chemical binding in the gene variant but that eliminated chemical binding in both mutants .	T10	T26	8636122
NA	CHEMICAL	GENE-Y	19	3	The gene and gene second extracellular loops , e2 , were exchanged , modifications that had no effect on chemical binding in the gene variant but that eliminated chemical binding in both mutants .	T10	T27	8636122
NA	CHEMICAL	GENE-Y	19	23	The gene and gene second extracellular loops , e2 , were exchanged , modifications that had no effect on chemical binding in the gene variant but that eliminated chemical binding in both mutants .	T10	T28	8636122
NA	CHEMICAL	GENE-Y	7	1	The gene and gene second extracellular loops , e2 , were exchanged , modifications that had no effect on chemical binding in the gene variant but that eliminated chemical binding in both mutants .	T11	T26	8636122
NA	CHEMICAL	GENE-Y	7	3	The gene and gene second extracellular loops , e2 , were exchanged , modifications that had no effect on chemical binding in the gene variant but that eliminated chemical binding in both mutants .	T11	T27	8636122
NA	CHEMICAL	GENE-Y	7	23	The gene and gene second extracellular loops , e2 , were exchanged , modifications that had no effect on chemical binding in the gene variant but that eliminated chemical binding in both mutants .	T11	T28	8636122
NA	CHEMICAL	GENE-Y	5	10	The replacement of the conserved chemical residues in e2 of gene by chemical also eliminated chemical binding , but replacement of those in gene resulted in the sequestration of the mutated receptors in the cell cytoplasm .	T12	T29	8636122
NA	CHEMICAL	GENE-Y	5	23	The replacement of the conserved chemical residues in e2 of gene by chemical also eliminated chemical binding , but replacement of those in gene resulted in the sequestration of the mutated receptors in the cell cytoplasm .	T12	T16	8636122
NA	CHEMICAL	GENE-Y	7	10	The replacement of the conserved chemical residues in e2 of gene by chemical also eliminated chemical binding , but replacement of those in gene resulted in the sequestration of the mutated receptors in the cell cytoplasm .	T13	T29	8636122
NA	CHEMICAL	GENE-Y	7	23	The replacement of the conserved chemical residues in e2 of gene by chemical also eliminated chemical binding , but replacement of those in gene resulted in the sequestration of the mutated receptors in the cell cytoplasm .	T13	T16	8636122
NA	CHEMICAL	GENE-Y	5	10	The replacement of the conserved chemical residues in e2 of gene by chemical also eliminated chemical binding , but replacement of those in gene resulted in the sequestration of the mutated receptors in the cell cytoplasm .	T1	T29	8636122
NA	CHEMICAL	GENE-Y	5	23	The replacement of the conserved chemical residues in e2 of gene by chemical also eliminated chemical binding , but replacement of those in gene resulted in the sequestration of the mutated receptors in the cell cytoplasm .	T1	T16	8636122
CPR:4	CHEMICAL	GENE-Y	3	18	FCEO significantly inhibited chemical ( chemical ) and chemical ( chemical ) by suppressing the protein expression of gene ( gene ) and gene , respectively .	T3	T11	23541436
CPR:4	CHEMICAL	GENE-Y	3	20	FCEO significantly inhibited chemical ( chemical ) and chemical ( chemical ) by suppressing the protein expression of gene ( gene ) and gene , respectively .	T3	T12	23541436
NA	CHEMICAL	GENE-Y	3	4	FCEO significantly inhibited chemical ( chemical ) and chemical ( chemical ) by suppressing the protein expression of gene ( gene ) and gene , respectively .	T3	T13	23541436
CPR:4	CHEMICAL	GENE-Y	5	18	FCEO significantly inhibited chemical ( chemical ) and chemical ( chemical ) by suppressing the protein expression of gene ( gene ) and gene , respectively .	T4	T11	23541436
CPR:4	CHEMICAL	GENE-Y	5	20	FCEO significantly inhibited chemical ( chemical ) and chemical ( chemical ) by suppressing the protein expression of gene ( gene ) and gene , respectively .	T4	T12	23541436
NA	CHEMICAL	GENE-Y	5	4	FCEO significantly inhibited chemical ( chemical ) and chemical ( chemical ) by suppressing the protein expression of gene ( gene ) and gene , respectively .	T4	T13	23541436
NA	CHEMICAL	GENE-Y	8	18	FCEO significantly inhibited chemical ( chemical ) and chemical ( chemical ) by suppressing the protein expression of gene ( gene ) and gene , respectively .	T5	T11	23541436
NA	CHEMICAL	GENE-Y	8	20	FCEO significantly inhibited chemical ( chemical ) and chemical ( chemical ) by suppressing the protein expression of gene ( gene ) and gene , respectively .	T5	T12	23541436
CPR:4	CHEMICAL	GENE-Y	8	4	FCEO significantly inhibited chemical ( chemical ) and chemical ( chemical ) by suppressing the protein expression of gene ( gene ) and gene , respectively .	T5	T13	23541436
NA	CHEMICAL	GENE-Y	10	18	FCEO significantly inhibited chemical ( chemical ) and chemical ( chemical ) by suppressing the protein expression of gene ( gene ) and gene , respectively .	T6	T11	23541436
NA	CHEMICAL	GENE-Y	10	20	FCEO significantly inhibited chemical ( chemical ) and chemical ( chemical ) by suppressing the protein expression of gene ( gene ) and gene , respectively .	T6	T12	23541436
CPR:4	CHEMICAL	GENE-Y	10	4	FCEO significantly inhibited chemical ( chemical ) and chemical ( chemical ) by suppressing the protein expression of gene ( gene ) and gene , respectively .	T6	T13	23541436
NA	CHEMICAL	GENE-Y	2	14	Hepatocytes display a compensatory survival response against chemical toxicity by a mechanism mediated by gene and gene .	T10	T29	23376140
NA	CHEMICAL	GENE-Y	2	16	Hepatocytes display a compensatory survival response against chemical toxicity by a mechanism mediated by gene and gene .	T10	T30	23376140
NA	CHEMICAL	GENE-N	8	4	We provided evidence of a novel link among chemical oxidase and gene signaling , mediated by gene , gene , and gene .	T2	T12	23376140
NA	CHEMICAL	GENE-Y	8	4	We provided evidence of a novel link among chemical oxidase and gene signaling , mediated by gene , gene , and gene .	T2	T13	23376140
NA	CHEMICAL	GENE-Y	8	16	We provided evidence of a novel link among chemical oxidase and gene signaling , mediated by gene , gene , and gene .	T2	T14	23376140
NA	CHEMICAL	GENE-Y	8	18	We provided evidence of a novel link among chemical oxidase and gene signaling , mediated by gene , gene , and gene .	T2	T15	23376140
NA	CHEMICAL	GENE-N	8	21	We provided evidence of a novel link among chemical oxidase and gene signaling , mediated by gene , gene , and gene .	T2	T16	23376140
CPR:3	CHEMICAL	GENE-N	0	3	chemical activates chemical oxidase .	T3	T17	23376140
NA	CHEMICAL	GENE-N	2	3	chemical activates chemical oxidase .	T4	T17	23376140
NA	CHEMICAL	GENE-N	10	4	ROS produced by this gene activates gene , enable that in turn , transactivates gene that activates gene in chemical , allowing its dimerization .	T5	T18	23376140
NA	CHEMICAL	GENE-Y	10	6	ROS produced by this gene activates gene , enable that in turn , transactivates gene that activates gene in chemical , allowing its dimerization .	T5	T19	23376140
NA	CHEMICAL	GENE-Y	10	14	ROS produced by this gene activates gene , enable that in turn , transactivates gene that activates gene in chemical , allowing its dimerization .	T5	T20	23376140
NA	CHEMICAL	GENE-Y	10	17	ROS produced by this gene activates gene , enable that in turn , transactivates gene that activates gene in chemical , allowing its dimerization .	T5	T21	23376140
NA	CHEMICAL	GENE-N	4	5	Also , ROS from chemical oxidase favors gene activation that phosphorylates gene in chemical , resulting in a compensatory or adaptive survival response such as production of gene in short chemical exposure times .	T6	T22	23376140
NA	CHEMICAL	GENE-N	4	7	Also , ROS from chemical oxidase favors gene activation that phosphorylates gene in chemical , resulting in a compensatory or adaptive survival response such as production of gene in short chemical exposure times .	T6	T23	23376140
NA	CHEMICAL	GENE-Y	4	11	Also , ROS from chemical oxidase favors gene activation that phosphorylates gene in chemical , resulting in a compensatory or adaptive survival response such as production of gene in short chemical exposure times .	T6	T24	23376140
NA	CHEMICAL	GENE-Y	4	12	Also , ROS from chemical oxidase favors gene activation that phosphorylates gene in chemical , resulting in a compensatory or adaptive survival response such as production of gene in short chemical exposure times .	T6	T25	23376140
NA	CHEMICAL	GENE-N	12	5	Also , ROS from chemical oxidase favors gene activation that phosphorylates gene in chemical , resulting in a compensatory or adaptive survival response such as production of gene in short chemical exposure times .	T7	T22	23376140
NA	CHEMICAL	GENE-N	12	7	Also , ROS from chemical oxidase favors gene activation that phosphorylates gene in chemical , resulting in a compensatory or adaptive survival response such as production of gene in short chemical exposure times .	T7	T23	23376140
NA	CHEMICAL	GENE-Y	12	11	Also , ROS from chemical oxidase favors gene activation that phosphorylates gene in chemical , resulting in a compensatory or adaptive survival response such as production of gene in short chemical exposure times .	T7	T24	23376140
NA	CHEMICAL	GENE-Y	12	12	Also , ROS from chemical oxidase favors gene activation that phosphorylates gene in chemical , resulting in a compensatory or adaptive survival response such as production of gene in short chemical exposure times .	T7	T25	23376140
NA	CHEMICAL	GENE-N	30	5	Also , ROS from chemical oxidase favors gene activation that phosphorylates gene in chemical , resulting in a compensatory or adaptive survival response such as production of gene in short chemical exposure times .	T8	T22	23376140
NA	CHEMICAL	GENE-N	30	7	Also , ROS from chemical oxidase favors gene activation that phosphorylates gene in chemical , resulting in a compensatory or adaptive survival response such as production of gene in short chemical exposure times .	T8	T23	23376140
NA	CHEMICAL	GENE-Y	30	11	Also , ROS from chemical oxidase favors gene activation that phosphorylates gene in chemical , resulting in a compensatory or adaptive survival response such as production of gene in short chemical exposure times .	T8	T24	23376140
NA	CHEMICAL	GENE-Y	30	12	Also , ROS from chemical oxidase favors gene activation that phosphorylates gene in chemical , resulting in a compensatory or adaptive survival response such as production of gene in short chemical exposure times .	T8	T25	23376140
NA	CHEMICAL	GENE-Y	6	4	In this study , a bilayered chemical composite hydrogel that mimics the distinctive hierarchical structure of native osteochondral tissue was utilized to investigate the effect of gene ( gene ) with varying release kinetics and/or gene ( gene ) on osteochondral tissue regeneration in a rabbit full-thickness osteochondral defect model .	T2	T12	23541928
NA	CHEMICAL	GENE-Y	6	28	In this study , a bilayered chemical composite hydrogel that mimics the distinctive hierarchical structure of native osteochondral tissue was utilized to investigate the effect of gene ( gene ) with varying release kinetics and/or gene ( gene ) on osteochondral tissue regeneration in a rabbit full-thickness osteochondral defect model .	T2	T13	23541928
NA	CHEMICAL	GENE-Y	6	4	In this study , a bilayered chemical composite hydrogel that mimics the distinctive hierarchical structure of native osteochondral tissue was utilized to investigate the effect of gene ( gene ) with varying release kinetics and/or gene ( gene ) on osteochondral tissue regeneration in a rabbit full-thickness osteochondral defect model .	T2	T14	23541928
NA	CHEMICAL	GENE-Y	6	37	In this study , a bilayered chemical composite hydrogel that mimics the distinctive hierarchical structure of native osteochondral tissue was utilized to investigate the effect of gene ( gene ) with varying release kinetics and/or gene ( gene ) on osteochondral tissue regeneration in a rabbit full-thickness osteochondral defect model .	T2	T15	23541928
NA	CHEMICAL	GENE-Y	42	20	The four groups investigated included ( i ) a blank control ( no GFs ) , ( ii ) GMP-loaded gene alone , ( iii ) GMP-loaded gene and gel-loaded gene , and ( iv ) GMP-loaded gene and GMP-loaded gene in chemical composite hydrogels .	T4	T16	23541928
NA	CHEMICAL	GENE-Y	42	27	The four groups investigated included ( i ) a blank control ( no GFs ) , ( ii ) GMP-loaded gene alone , ( iii ) GMP-loaded gene and gel-loaded gene , and ( iv ) GMP-loaded gene and GMP-loaded gene in chemical composite hydrogels .	T4	T17	23541928
NA	CHEMICAL	GENE-Y	42	30	The four groups investigated included ( i ) a blank control ( no GFs ) , ( ii ) GMP-loaded gene alone , ( iii ) GMP-loaded gene and gel-loaded gene , and ( iv ) GMP-loaded gene and GMP-loaded gene in chemical composite hydrogels .	T4	T18	23541928
NA	CHEMICAL	GENE-Y	42	37	The four groups investigated included ( i ) a blank control ( no GFs ) , ( ii ) GMP-loaded gene alone , ( iii ) GMP-loaded gene and gel-loaded gene , and ( iv ) GMP-loaded gene and GMP-loaded gene in chemical composite hydrogels .	T4	T19	23541928
NA	CHEMICAL	GENE-Y	42	40	The four groups investigated included ( i ) a blank control ( no GFs ) , ( ii ) GMP-loaded gene alone , ( iii ) GMP-loaded gene and gel-loaded gene , and ( iv ) GMP-loaded gene and GMP-loaded gene in chemical composite hydrogels .	T4	T20	23541928
NA	CHEMICAL	GENE-Y	0	15	chemical accumulation and freeze tolerance of Saccharomyces cerevisiae are caused by a mutation in the gene gene encoding chemical kinase .	T18	T31	12513997
CPR:9	CHEMICAL	GENE-Y	0	11	chemical accumulation and freeze tolerance of Saccharomyces cerevisiae are caused by a mutation in the gene gene encoding chemical kinase .	T18	T32	12513997
NA	CHEMICAL	GENE-Y	11	15	chemical accumulation and freeze tolerance of Saccharomyces cerevisiae are caused by a mutation in the gene gene encoding chemical kinase .	T19	T31	12513997
NA	CHEMICAL	GENE-Y	11	11	chemical accumulation and freeze tolerance of Saccharomyces cerevisiae are caused by a mutation in the gene gene encoding chemical kinase .	T19	T32	12513997
NA	CHEMICAL	GENE-Y	8	22	By introducing the mutant-derived genomic library into a non-chemical-utilizing strain , the mutant was found to carry an allele of the wild-type gene gene encoding chemical kinase , which resulted in a single chemical replacement ; chemical ( gene ) at position 154 was replaced by chemical ( gene ) .	T8	T23	12513997
NA	CHEMICAL	GENE-Y	8	7	By introducing the mutant-derived genomic library into a non-chemical-utilizing strain , the mutant was found to carry an allele of the wild-type gene gene encoding chemical kinase , which resulted in a single chemical replacement ; chemical ( gene ) at position 154 was replaced by chemical ( gene ) .	T8	T24	12513997
NA	CHEMICAL	GENE-N	8	38	By introducing the mutant-derived genomic library into a non-chemical-utilizing strain , the mutant was found to carry an allele of the wild-type gene gene encoding chemical kinase , which resulted in a single chemical replacement ; chemical ( gene ) at position 154 was replaced by chemical ( gene ) .	T8	T25	12513997
NA	CHEMICAL	GENE-N	8	48	By introducing the mutant-derived genomic library into a non-chemical-utilizing strain , the mutant was found to carry an allele of the wild-type gene gene encoding chemical kinase , which resulted in a single chemical replacement ; chemical ( gene ) at position 154 was replaced by chemical ( gene ) .	T8	T26	12513997
NA	CHEMICAL	GENE-Y	7	22	By introducing the mutant-derived genomic library into a non-chemical-utilizing strain , the mutant was found to carry an allele of the wild-type gene gene encoding chemical kinase , which resulted in a single chemical replacement ; chemical ( gene ) at position 154 was replaced by chemical ( gene ) .	T9	T23	12513997
NA	CHEMICAL	GENE-Y	7	7	By introducing the mutant-derived genomic library into a non-chemical-utilizing strain , the mutant was found to carry an allele of the wild-type gene gene encoding chemical kinase , which resulted in a single chemical replacement ; chemical ( gene ) at position 154 was replaced by chemical ( gene ) .	T9	T24	12513997
NA	CHEMICAL	GENE-N	7	38	By introducing the mutant-derived genomic library into a non-chemical-utilizing strain , the mutant was found to carry an allele of the wild-type gene gene encoding chemical kinase , which resulted in a single chemical replacement ; chemical ( gene ) at position 154 was replaced by chemical ( gene ) .	T9	T25	12513997
NA	CHEMICAL	GENE-N	7	48	By introducing the mutant-derived genomic library into a non-chemical-utilizing strain , the mutant was found to carry an allele of the wild-type gene gene encoding chemical kinase , which resulted in a single chemical replacement ; chemical ( gene ) at position 154 was replaced by chemical ( gene ) .	T9	T26	12513997
NA	CHEMICAL	GENE-Y	7	22	By introducing the mutant-derived genomic library into a non-chemical-utilizing strain , the mutant was found to carry an allele of the wild-type gene gene encoding chemical kinase , which resulted in a single chemical replacement ; chemical ( gene ) at position 154 was replaced by chemical ( gene ) .	T10	T23	12513997
NA	CHEMICAL	GENE-Y	7	7	By introducing the mutant-derived genomic library into a non-chemical-utilizing strain , the mutant was found to carry an allele of the wild-type gene gene encoding chemical kinase , which resulted in a single chemical replacement ; chemical ( gene ) at position 154 was replaced by chemical ( gene ) .	T10	T24	12513997
NA	CHEMICAL	GENE-N	7	38	By introducing the mutant-derived genomic library into a non-chemical-utilizing strain , the mutant was found to carry an allele of the wild-type gene gene encoding chemical kinase , which resulted in a single chemical replacement ; chemical ( gene ) at position 154 was replaced by chemical ( gene ) .	T10	T25	12513997
NA	CHEMICAL	GENE-N	7	48	By introducing the mutant-derived genomic library into a non-chemical-utilizing strain , the mutant was found to carry an allele of the wild-type gene gene encoding chemical kinase , which resulted in a single chemical replacement ; chemical ( gene ) at position 154 was replaced by chemical ( gene ) .	T10	T26	12513997
NA	CHEMICAL	GENE-Y	36	22	By introducing the mutant-derived genomic library into a non-chemical-utilizing strain , the mutant was found to carry an allele of the wild-type gene gene encoding chemical kinase , which resulted in a single chemical replacement ; chemical ( gene ) at position 154 was replaced by chemical ( gene ) .	T11	T23	12513997
NA	CHEMICAL	GENE-Y	36	7	By introducing the mutant-derived genomic library into a non-chemical-utilizing strain , the mutant was found to carry an allele of the wild-type gene gene encoding chemical kinase , which resulted in a single chemical replacement ; chemical ( gene ) at position 154 was replaced by chemical ( gene ) .	T11	T24	12513997
NA	CHEMICAL	GENE-N	36	38	By introducing the mutant-derived genomic library into a non-chemical-utilizing strain , the mutant was found to carry an allele of the wild-type gene gene encoding chemical kinase , which resulted in a single chemical replacement ; chemical ( gene ) at position 154 was replaced by chemical ( gene ) .	T11	T25	12513997
NA	CHEMICAL	GENE-N	36	48	By introducing the mutant-derived genomic library into a non-chemical-utilizing strain , the mutant was found to carry an allele of the wild-type gene gene encoding chemical kinase , which resulted in a single chemical replacement ; chemical ( gene ) at position 154 was replaced by chemical ( gene ) .	T11	T26	12513997
NA	CHEMICAL	GENE-Y	46	22	By introducing the mutant-derived genomic library into a non-chemical-utilizing strain , the mutant was found to carry an allele of the wild-type gene gene encoding chemical kinase , which resulted in a single chemical replacement ; chemical ( gene ) at position 154 was replaced by chemical ( gene ) .	T12	T23	12513997
NA	CHEMICAL	GENE-Y	46	7	By introducing the mutant-derived genomic library into a non-chemical-utilizing strain , the mutant was found to carry an allele of the wild-type gene gene encoding chemical kinase , which resulted in a single chemical replacement ; chemical ( gene ) at position 154 was replaced by chemical ( gene ) .	T12	T24	12513997
NA	CHEMICAL	GENE-N	46	38	By introducing the mutant-derived genomic library into a non-chemical-utilizing strain , the mutant was found to carry an allele of the wild-type gene gene encoding chemical kinase , which resulted in a single chemical replacement ; chemical ( gene ) at position 154 was replaced by chemical ( gene ) .	T12	T25	12513997
NA	CHEMICAL	GENE-N	46	48	By introducing the mutant-derived genomic library into a non-chemical-utilizing strain , the mutant was found to carry an allele of the wild-type gene gene encoding chemical kinase , which resulted in a single chemical replacement ; chemical ( gene ) at position 154 was replaced by chemical ( gene ) .	T12	T26	12513997
NA	CHEMICAL	GENE-Y	13	5	Interestingly , the allele of gene was shown to enhance the activities of chemical kinase and chemical reductase , both of which catalyze the first two steps of chemical synthesis from chemical and which together may form a complex in vivo .	T13	T27	12513997
NA	CHEMICAL	GENE-Y	13	14	Interestingly , the allele of gene was shown to enhance the activities of chemical kinase and chemical reductase , both of which catalyze the first two steps of chemical synthesis from chemical and which together may form a complex in vivo .	T13	T28	12513997
NA	CHEMICAL	GENE-Y	13	17	Interestingly , the allele of gene was shown to enhance the activities of chemical kinase and chemical reductase , both of which catalyze the first two steps of chemical synthesis from chemical and which together may form a complex in vivo .	T13	T29	12513997
NA	CHEMICAL	GENE-Y	16	5	Interestingly , the allele of gene was shown to enhance the activities of chemical kinase and chemical reductase , both of which catalyze the first two steps of chemical synthesis from chemical and which together may form a complex in vivo .	T14	T27	12513997
NA	CHEMICAL	GENE-Y	16	14	Interestingly , the allele of gene was shown to enhance the activities of chemical kinase and chemical reductase , both of which catalyze the first two steps of chemical synthesis from chemical and which together may form a complex in vivo .	T14	T28	12513997
NA	CHEMICAL	GENE-Y	16	17	Interestingly , the allele of gene was shown to enhance the activities of chemical kinase and chemical reductase , both of which catalyze the first two steps of chemical synthesis from chemical and which together may form a complex in vivo .	T14	T29	12513997
NA	CHEMICAL	GENE-Y	28	5	Interestingly , the allele of gene was shown to enhance the activities of chemical kinase and chemical reductase , both of which catalyze the first two steps of chemical synthesis from chemical and which together may form a complex in vivo .	T15	T27	12513997
CPR:9	CHEMICAL	GENE-Y	28	14	Interestingly , the allele of gene was shown to enhance the activities of chemical kinase and chemical reductase , both of which catalyze the first two steps of chemical synthesis from chemical and which together may form a complex in vivo .	T15	T28	12513997
CPR:9	CHEMICAL	GENE-Y	28	17	Interestingly , the allele of gene was shown to enhance the activities of chemical kinase and chemical reductase , both of which catalyze the first two steps of chemical synthesis from chemical and which together may form a complex in vivo .	T15	T29	12513997
NA	CHEMICAL	GENE-Y	31	5	Interestingly , the allele of gene was shown to enhance the activities of chemical kinase and chemical reductase , both of which catalyze the first two steps of chemical synthesis from chemical and which together may form a complex in vivo .	T16	T27	12513997
CPR:9	CHEMICAL	GENE-Y	31	14	Interestingly , the allele of gene was shown to enhance the activities of chemical kinase and chemical reductase , both of which catalyze the first two steps of chemical synthesis from chemical and which together may form a complex in vivo .	T16	T28	12513997
CPR:9	CHEMICAL	GENE-Y	31	17	Interestingly , the allele of gene was shown to enhance the activities of chemical kinase and chemical reductase , both of which catalyze the first two steps of chemical synthesis from chemical and which together may form a complex in vivo .	T16	T29	12513997
NA	CHEMICAL	GENE-Y	12	2	When cultured in liquid minimal medium , yeast cells expressing the mutated chemical kinase were found to accumulate intracellular chemical and showed a prominent increase in cell viability after freezing at -20 degrees C compared to the viability of cells harboring the wild-type gene gene .	T17	T30	12513997
NA	CHEMICAL	GENE-Y	12	43	When cultured in liquid minimal medium , yeast cells expressing the mutated chemical kinase were found to accumulate intracellular chemical and showed a prominent increase in cell viability after freezing at -20 degrees C compared to the viability of cells harboring the wild-type gene gene .	T17	T20	12513997
CPR:9	CHEMICAL	GENE-Y	2	2	When cultured in liquid minimal medium , yeast cells expressing the mutated chemical kinase were found to accumulate intracellular chemical and showed a prominent increase in cell viability after freezing at -20 degrees C compared to the viability of cells harboring the wild-type gene gene .	T1	T30	12513997
NA	CHEMICAL	GENE-Y	2	43	When cultured in liquid minimal medium , yeast cells expressing the mutated chemical kinase were found to accumulate intracellular chemical and showed a prominent increase in cell viability after freezing at -20 degrees C compared to the viability of cells harboring the wild-type gene gene .	T1	T20	12513997
CPR:4	CHEMICAL	GENE-N	4	2	Both the gene inhibitor chemical and gene antagonists ( e.g .	T2	T12	9732824
NA	CHEMICAL	GENE-N	4	6	Both the gene inhibitor chemical and gene antagonists ( e.g .	T2	T13	9732824
NA	CHEMICAL	GENE-N	20	1	The gene antagonists , on the other hand , reduce the dynamic component of obstruction -- relaxation of smooth muscle in the prostate , urethra and bladder neck -- and provide rapid symptom relief after only a few doses , relieving LUTS more effectively than chemical and irrespective of prostate size .	T1	T9	9732824
NA	CHEMICAL	GENE-Y	4	5	Genome-wide integrated analyses of chemical receptor signaling in prostate cancer based on high-throughput technology .	T5	T13	23410126
NA	CHEMICAL	GENE-Y	1	2	The chemical receptor ( gene ) is a chemical hormone receptor that functions as a ligand-dependent transcriptional factor , which plays a key role in the development and progression of prostate cancer .	T3	T9	23410126
NA	CHEMICAL	GENE-Y	1	4	The chemical receptor ( gene ) is a chemical hormone receptor that functions as a ligand-dependent transcriptional factor , which plays a key role in the development and progression of prostate cancer .	T3	T6	23410126
NA	CHEMICAL	GENE-N	1	2	The chemical receptor ( gene ) is a chemical hormone receptor that functions as a ligand-dependent transcriptional factor , which plays a key role in the development and progression of prostate cancer .	T3	T7	23410126
NA	CHEMICAL	GENE-Y	8	2	The chemical receptor ( gene ) is a chemical hormone receptor that functions as a ligand-dependent transcriptional factor , which plays a key role in the development and progression of prostate cancer .	T1	T9	23410126
NA	CHEMICAL	GENE-Y	8	4	The chemical receptor ( gene ) is a chemical hormone receptor that functions as a ligand-dependent transcriptional factor , which plays a key role in the development and progression of prostate cancer .	T1	T6	23410126
NA	CHEMICAL	GENE-N	8	2	The chemical receptor ( gene ) is a chemical hormone receptor that functions as a ligand-dependent transcriptional factor , which plays a key role in the development and progression of prostate cancer .	T1	T7	23410126
NA	CHEMICAL	GENE-Y	8	16	Recent advancement in high throughput technologies including microarrays and deep-sequencing provides unbiased genome-wide knowledge on the gene signaling including datasets for chemical-regulated gene expression and genomic binding sites for gene .	T2	T8	23410126
NA	CHEMICAL	GENE-Y	8	29	Recent advancement in high throughput technologies including microarrays and deep-sequencing provides unbiased genome-wide knowledge on the gene signaling including datasets for chemical-regulated gene expression and genomic binding sites for gene .	T2	T10	23410126
CPR:3	CHEMICAL	GENE-N	1	3	Exogenous chemical activates gene via gene-dependent signalling pathway .	T16	T40	9480923
NA	CHEMICAL	GENE-N	1	5	Exogenous chemical activates gene via gene-dependent signalling pathway .	T16	T41	9480923
NA	CHEMICAL	GENE-N	0	7	chemical is an important regulatory molecule implicated in a variety of biological processes in response to stress and gene .	T1	T18	9480923
NA	CHEMICAL	GENE-N	7	28	To understand the signal transduction pathway of chemical to the nucleus , in the present study , we examined whether chemical , a cell permeable chemical , activates gene ( gene ) .	T9	T28	9480923
NA	CHEMICAL	GENE-N	7	30	To understand the signal transduction pathway of chemical to the nucleus , in the present study , we examined whether chemical , a cell permeable chemical , activates gene ( gene ) .	T9	T29	9480923
NA	CHEMICAL	GENE-N	20	28	To understand the signal transduction pathway of chemical to the nucleus , in the present study , we examined whether chemical , a cell permeable chemical , activates gene ( gene ) .	T10	T28	9480923
NA	CHEMICAL	GENE-N	20	30	To understand the signal transduction pathway of chemical to the nucleus , in the present study , we examined whether chemical , a cell permeable chemical , activates gene ( gene ) .	T10	T29	9480923
NA	CHEMICAL	GENE-N	22	28	To understand the signal transduction pathway of chemical to the nucleus , in the present study , we examined whether chemical , a cell permeable chemical , activates gene ( gene ) .	T11	T28	9480923
NA	CHEMICAL	GENE-N	22	30	To understand the signal transduction pathway of chemical to the nucleus , in the present study , we examined whether chemical , a cell permeable chemical , activates gene ( gene ) .	T11	T29	9480923
CPR:3	CHEMICAL	GENE-N	6	11	Treatment of Rat-2 fibroblast cells with chemical caused the stimulation of gene-dependent reporter gene activity in a dose- and time-dependent manner by transient transfection analysis .	T12	T30	9480923
NA	CHEMICAL	GENE-N	12	7	Next , we examined the role of gene family gene in the chemical-induced signalling to gene activation .	T13	T31	9480923
NA	CHEMICAL	GENE-N	12	9	Next , we examined the role of gene family gene in the chemical-induced signalling to gene activation .	T13	T32	9480923
CPR:3	CHEMICAL	GENE-N	12	15	Next , we examined the role of gene family gene in the chemical-induced signalling to gene activation .	T13	T33	9480923
NA	CHEMICAL	GENE-Y	11	17	By reporter gene analysis following transient transfections with various plasmids expressing a dominant negative mutant form of gene , gene or gene , chemical-induced gene activation was shown to be selectively repressed by pEXV-geneN17 encoding a dominant negative mutant of gene , suggesting that Rac activity is essential for the signalling cascade of chemical to the nucleus .	T14	T34	9480923
NA	CHEMICAL	GENE-Y	11	11	By reporter gene analysis following transient transfections with various plasmids expressing a dominant negative mutant form of gene , gene or gene , chemical-induced gene activation was shown to be selectively repressed by pEXV-geneN17 encoding a dominant negative mutant of gene , suggesting that Rac activity is essential for the signalling cascade of chemical to the nucleus .	T14	T35	9480923
NA	CHEMICAL	GENE-Y	11	21	By reporter gene analysis following transient transfections with various plasmids expressing a dominant negative mutant form of gene , gene or gene , chemical-induced gene activation was shown to be selectively repressed by pEXV-geneN17 encoding a dominant negative mutant of gene , suggesting that Rac activity is essential for the signalling cascade of chemical to the nucleus .	T14	T36	9480923
CPR:3	CHEMICAL	GENE-N	11	24	By reporter gene analysis following transient transfections with various plasmids expressing a dominant negative mutant form of gene , gene or gene , chemical-induced gene activation was shown to be selectively repressed by pEXV-geneN17 encoding a dominant negative mutant of gene , suggesting that Rac activity is essential for the signalling cascade of chemical to the nucleus .	T14	T37	9480923
NA	CHEMICAL	GENE-Y	11	11	By reporter gene analysis following transient transfections with various plasmids expressing a dominant negative mutant form of gene , gene or gene , chemical-induced gene activation was shown to be selectively repressed by pEXV-geneN17 encoding a dominant negative mutant of gene , suggesting that Rac activity is essential for the signalling cascade of chemical to the nucleus .	T14	T38	9480923
NA	CHEMICAL	GENE-N	11	11	By reporter gene analysis following transient transfections with various plasmids expressing a dominant negative mutant form of gene , gene or gene , chemical-induced gene activation was shown to be selectively repressed by pEXV-geneN17 encoding a dominant negative mutant of gene , suggesting that Rac activity is essential for the signalling cascade of chemical to the nucleus .	T14	T39	9480923
NA	CHEMICAL	GENE-Y	11	17	By reporter gene analysis following transient transfections with various plasmids expressing a dominant negative mutant form of gene , gene or gene , chemical-induced gene activation was shown to be selectively repressed by pEXV-geneN17 encoding a dominant negative mutant of gene , suggesting that Rac activity is essential for the signalling cascade of chemical to the nucleus .	T15	T34	9480923
NA	CHEMICAL	GENE-Y	11	11	By reporter gene analysis following transient transfections with various plasmids expressing a dominant negative mutant form of gene , gene or gene , chemical-induced gene activation was shown to be selectively repressed by pEXV-geneN17 encoding a dominant negative mutant of gene , suggesting that Rac activity is essential for the signalling cascade of chemical to the nucleus .	T15	T35	9480923
NA	CHEMICAL	GENE-Y	11	21	By reporter gene analysis following transient transfections with various plasmids expressing a dominant negative mutant form of gene , gene or gene , chemical-induced gene activation was shown to be selectively repressed by pEXV-geneN17 encoding a dominant negative mutant of gene , suggesting that Rac activity is essential for the signalling cascade of chemical to the nucleus .	T15	T36	9480923
NA	CHEMICAL	GENE-N	11	24	By reporter gene analysis following transient transfections with various plasmids expressing a dominant negative mutant form of gene , gene or gene , chemical-induced gene activation was shown to be selectively repressed by pEXV-geneN17 encoding a dominant negative mutant of gene , suggesting that Rac activity is essential for the signalling cascade of chemical to the nucleus .	T15	T37	9480923
NA	CHEMICAL	GENE-Y	11	11	By reporter gene analysis following transient transfections with various plasmids expressing a dominant negative mutant form of gene , gene or gene , chemical-induced gene activation was shown to be selectively repressed by pEXV-geneN17 encoding a dominant negative mutant of gene , suggesting that Rac activity is essential for the signalling cascade of chemical to the nucleus .	T15	T38	9480923
NA	CHEMICAL	GENE-N	11	11	By reporter gene analysis following transient transfections with various plasmids expressing a dominant negative mutant form of gene , gene or gene , chemical-induced gene activation was shown to be selectively repressed by pEXV-geneN17 encoding a dominant negative mutant of gene , suggesting that Rac activity is essential for the signalling cascade of chemical to the nucleus .	T15	T39	9480923
NA	CHEMICAL	GENE-N	1	1	In a further study to analyse the downstream mediator of gene in the chemical-signalling pathway , we observed that either pretreatment with chemical , a potent and specific inhibitor of phospholipase A2 , or co-transfection with antisense gene ( gene ) oligonucleotide repressed the chemical-induced gene activation selectively , implying a critical role of gene in chemical-induced signalling to nucleus .	T2	T17	9480923
NA	CHEMICAL	GENE-Y	1	31	In a further study to analyse the downstream mediator of gene in the chemical-signalling pathway , we observed that either pretreatment with chemical , a potent and specific inhibitor of phospholipase A2 , or co-transfection with antisense gene ( gene ) oligonucleotide repressed the chemical-induced gene activation selectively , implying a critical role of gene in chemical-induced signalling to nucleus .	T2	T19	9480923
NA	CHEMICAL	GENE-Y	1	31	In a further study to analyse the downstream mediator of gene in the chemical-signalling pathway , we observed that either pretreatment with chemical , a potent and specific inhibitor of phospholipase A2 , or co-transfection with antisense gene ( gene ) oligonucleotide repressed the chemical-induced gene activation selectively , implying a critical role of gene in chemical-induced signalling to nucleus .	T2	T20	9480923
NA	CHEMICAL	GENE-N	1	45	In a further study to analyse the downstream mediator of gene in the chemical-signalling pathway , we observed that either pretreatment with chemical , a potent and specific inhibitor of phospholipase A2 , or co-transfection with antisense gene ( gene ) oligonucleotide repressed the chemical-induced gene activation selectively , implying a critical role of gene in chemical-induced signalling to nucleus .	T2	T21	9480923
NA	CHEMICAL	GENE-Y	1	31	In a further study to analyse the downstream mediator of gene in the chemical-signalling pathway , we observed that either pretreatment with chemical , a potent and specific inhibitor of phospholipase A2 , or co-transfection with antisense gene ( gene ) oligonucleotide repressed the chemical-induced gene activation selectively , implying a critical role of gene in chemical-induced signalling to nucleus .	T2	T22	9480923
NA	CHEMICAL	GENE-N	1	1	In a further study to analyse the downstream mediator of gene in the chemical-signalling pathway , we observed that either pretreatment with chemical , a potent and specific inhibitor of phospholipase A2 , or co-transfection with antisense gene ( gene ) oligonucleotide repressed the chemical-induced gene activation selectively , implying a critical role of gene in chemical-induced signalling to nucleus .	T3	T17	9480923
NA	CHEMICAL	GENE-Y	1	31	In a further study to analyse the downstream mediator of gene in the chemical-signalling pathway , we observed that either pretreatment with chemical , a potent and specific inhibitor of phospholipase A2 , or co-transfection with antisense gene ( gene ) oligonucleotide repressed the chemical-induced gene activation selectively , implying a critical role of gene in chemical-induced signalling to nucleus .	T3	T19	9480923
NA	CHEMICAL	GENE-Y	1	31	In a further study to analyse the downstream mediator of gene in the chemical-signalling pathway , we observed that either pretreatment with chemical , a potent and specific inhibitor of phospholipase A2 , or co-transfection with antisense gene ( gene ) oligonucleotide repressed the chemical-induced gene activation selectively , implying a critical role of gene in chemical-induced signalling to nucleus .	T3	T20	9480923
NA	CHEMICAL	GENE-N	1	45	In a further study to analyse the downstream mediator of gene in the chemical-signalling pathway , we observed that either pretreatment with chemical , a potent and specific inhibitor of phospholipase A2 , or co-transfection with antisense gene ( gene ) oligonucleotide repressed the chemical-induced gene activation selectively , implying a critical role of gene in chemical-induced signalling to nucleus .	T3	T21	9480923
NA	CHEMICAL	GENE-Y	1	31	In a further study to analyse the downstream mediator of gene in the chemical-signalling pathway , we observed that either pretreatment with chemical , a potent and specific inhibitor of phospholipase A2 , or co-transfection with antisense gene ( gene ) oligonucleotide repressed the chemical-induced gene activation selectively , implying a critical role of gene in chemical-induced signalling to nucleus .	T3	T22	9480923
NA	CHEMICAL	GENE-N	1	1	In a further study to analyse the downstream mediator of gene in the chemical-signalling pathway , we observed that either pretreatment with chemical , a potent and specific inhibitor of phospholipase A2 , or co-transfection with antisense gene ( gene ) oligonucleotide repressed the chemical-induced gene activation selectively , implying a critical role of gene in chemical-induced signalling to nucleus .	T4	T17	9480923
NA	CHEMICAL	GENE-Y	1	31	In a further study to analyse the downstream mediator of gene in the chemical-signalling pathway , we observed that either pretreatment with chemical , a potent and specific inhibitor of phospholipase A2 , or co-transfection with antisense gene ( gene ) oligonucleotide repressed the chemical-induced gene activation selectively , implying a critical role of gene in chemical-induced signalling to nucleus .	T4	T19	9480923
NA	CHEMICAL	GENE-Y	1	31	In a further study to analyse the downstream mediator of gene in the chemical-signalling pathway , we observed that either pretreatment with chemical , a potent and specific inhibitor of phospholipase A2 , or co-transfection with antisense gene ( gene ) oligonucleotide repressed the chemical-induced gene activation selectively , implying a critical role of gene in chemical-induced signalling to nucleus .	T4	T20	9480923
CPR:3	CHEMICAL	GENE-N	1	45	In a further study to analyse the downstream mediator of gene in the chemical-signalling pathway , we observed that either pretreatment with chemical , a potent and specific inhibitor of phospholipase A2 , or co-transfection with antisense gene ( gene ) oligonucleotide repressed the chemical-induced gene activation selectively , implying a critical role of gene in chemical-induced signalling to nucleus .	T4	T21	9480923
NA	CHEMICAL	GENE-Y	1	31	In a further study to analyse the downstream mediator of gene in the chemical-signalling pathway , we observed that either pretreatment with chemical , a potent and specific inhibitor of phospholipase A2 , or co-transfection with antisense gene ( gene ) oligonucleotide repressed the chemical-induced gene activation selectively , implying a critical role of gene in chemical-induced signalling to nucleus .	T4	T22	9480923
NA	CHEMICAL	GENE-N	1	1	In a further study to analyse the downstream mediator of gene in the chemical-signalling pathway , we observed that either pretreatment with chemical , a potent and specific inhibitor of phospholipase A2 , or co-transfection with antisense gene ( gene ) oligonucleotide repressed the chemical-induced gene activation selectively , implying a critical role of gene in chemical-induced signalling to nucleus .	T5	T17	9480923
NA	CHEMICAL	GENE-Y	1	31	In a further study to analyse the downstream mediator of gene in the chemical-signalling pathway , we observed that either pretreatment with chemical , a potent and specific inhibitor of phospholipase A2 , or co-transfection with antisense gene ( gene ) oligonucleotide repressed the chemical-induced gene activation selectively , implying a critical role of gene in chemical-induced signalling to nucleus .	T5	T19	9480923
NA	CHEMICAL	GENE-Y	1	31	In a further study to analyse the downstream mediator of gene in the chemical-signalling pathway , we observed that either pretreatment with chemical , a potent and specific inhibitor of phospholipase A2 , or co-transfection with antisense gene ( gene ) oligonucleotide repressed the chemical-induced gene activation selectively , implying a critical role of gene in chemical-induced signalling to nucleus .	T5	T20	9480923
NA	CHEMICAL	GENE-N	1	45	In a further study to analyse the downstream mediator of gene in the chemical-signalling pathway , we observed that either pretreatment with chemical , a potent and specific inhibitor of phospholipase A2 , or co-transfection with antisense gene ( gene ) oligonucleotide repressed the chemical-induced gene activation selectively , implying a critical role of gene in chemical-induced signalling to nucleus .	T5	T21	9480923
NA	CHEMICAL	GENE-Y	1	31	In a further study to analyse the downstream mediator of gene in the chemical-signalling pathway , we observed that either pretreatment with chemical , a potent and specific inhibitor of phospholipase A2 , or co-transfection with antisense gene ( gene ) oligonucleotide repressed the chemical-induced gene activation selectively , implying a critical role of gene in chemical-induced signalling to nucleus .	T5	T22	9480923
NA	CHEMICAL	GENE-Y	16	8	Consistent with these results , the translocation of gene protein as well as the release of chemical , a principal product of gene , was rapidly induced by the addition of chemical in a gene-dependent manner .	T6	T23	9480923
CPR:9	CHEMICAL	GENE-Y	16	22	Consistent with these results , the translocation of gene protein as well as the release of chemical , a principal product of gene , was rapidly induced by the addition of chemical in a gene-dependent manner .	T6	T24	9480923
NA	CHEMICAL	GENE-N	16	18	Consistent with these results , the translocation of gene protein as well as the release of chemical , a principal product of gene , was rapidly induced by the addition of chemical in a gene-dependent manner .	T6	T25	9480923
NA	CHEMICAL	GENE-Y	18	8	Consistent with these results , the translocation of gene protein as well as the release of chemical , a principal product of gene , was rapidly induced by the addition of chemical in a gene-dependent manner .	T7	T23	9480923
NA	CHEMICAL	GENE-Y	18	22	Consistent with these results , the translocation of gene protein as well as the release of chemical , a principal product of gene , was rapidly induced by the addition of chemical in a gene-dependent manner .	T7	T24	9480923
NA	CHEMICAL	GENE-N	18	18	Consistent with these results , the translocation of gene protein as well as the release of chemical , a principal product of gene , was rapidly induced by the addition of chemical in a gene-dependent manner .	T7	T25	9480923
CPR:4	CHEMICAL	GENE-N	14	12	INTRODUCTION : In this study , we examined the effects of the gene inhibitors chemical and chemical on postprandial plasma chemical and serum triglyceride levels in patients with type 2 diabetes mellitus .	T22	T29	19568704
CPR:4	CHEMICAL	GENE-N	16	12	INTRODUCTION : In this study , we examined the effects of the gene inhibitors chemical and chemical on postprandial plasma chemical and serum triglyceride levels in patients with type 2 diabetes mellitus .	T1	T29	19568704
CPR:4	CHEMICAL	GENE-N	20	12	INTRODUCTION : In this study , we examined the effects of the gene inhibitors chemical and chemical on postprandial plasma chemical and serum triglyceride levels in patients with type 2 diabetes mellitus .	T7	T29	19568704
NA	CHEMICAL	GENE-N	7	3	No significant changes in serum high-density lipoprotein chemical levels were observed in either group , whereas serum gene chemical levels decreased significantly from 3.20+/-0.25 to 2.65+/-0.18 mmol/L ( P=0.04 ) , only in the high-dose group .	T8	T28	19568704
NA	CHEMICAL	GENE-N	18	3	No significant changes in serum high-density lipoprotein chemical levels were observed in either group , whereas serum gene chemical levels decreased significantly from 3.20+/-0.25 to 2.65+/-0.18 mmol/L ( P=0.04 ) , only in the high-dose group .	T9	T28	19568704
NA	CHEMICAL	GENE-N	54	33	A likely endocrine control mechanism for sexual differentiation in size-graded populations of European sea bass ( Dicentrarchus labrax ) is proposed by evaluating the brain expression and pituitary content of two forms of gene ( gene ) , namely sea bream ( sbchemical ) and salmon ( gene ) , the pituitary expression of one subtype of chemical receptor ( gene ) and the three gene ( gene ) subunits , namely gene ( gene ) , gene ( gene ) and gene ( gene ) , as well as the pituitary and plasma gene levels between 50 and 300 days post-hatching ( dph ) .	T3	T18	16962597
NA	CHEMICAL	GENE-N	54	35	A likely endocrine control mechanism for sexual differentiation in size-graded populations of European sea bass ( Dicentrarchus labrax ) is proposed by evaluating the brain expression and pituitary content of two forms of gene ( gene ) , namely sea bream ( sbchemical ) and salmon ( gene ) , the pituitary expression of one subtype of chemical receptor ( gene ) and the three gene ( gene ) subunits , namely gene ( gene ) , gene ( gene ) and gene ( gene ) , as well as the pituitary and plasma gene levels between 50 and 300 days post-hatching ( dph ) .	T3	T19	16962597
NA	CHEMICAL	GENE-N	54	47	A likely endocrine control mechanism for sexual differentiation in size-graded populations of European sea bass ( Dicentrarchus labrax ) is proposed by evaluating the brain expression and pituitary content of two forms of gene ( gene ) , namely sea bream ( sbchemical ) and salmon ( gene ) , the pituitary expression of one subtype of chemical receptor ( gene ) and the three gene ( gene ) subunits , namely gene ( gene ) , gene ( gene ) and gene ( gene ) , as well as the pituitary and plasma gene levels between 50 and 300 days post-hatching ( dph ) .	T3	T21	16962597
NA	CHEMICAL	GENE-Y	54	58	A likely endocrine control mechanism for sexual differentiation in size-graded populations of European sea bass ( Dicentrarchus labrax ) is proposed by evaluating the brain expression and pituitary content of two forms of gene ( gene ) , namely sea bream ( sbchemical ) and salmon ( gene ) , the pituitary expression of one subtype of chemical receptor ( gene ) and the three gene ( gene ) subunits , namely gene ( gene ) , gene ( gene ) and gene ( gene ) , as well as the pituitary and plasma gene levels between 50 and 300 days post-hatching ( dph ) .	T3	T22	16962597
NA	CHEMICAL	GENE-N	54	0	A likely endocrine control mechanism for sexual differentiation in size-graded populations of European sea bass ( Dicentrarchus labrax ) is proposed by evaluating the brain expression and pituitary content of two forms of gene ( gene ) , namely sea bream ( sbchemical ) and salmon ( gene ) , the pituitary expression of one subtype of chemical receptor ( gene ) and the three gene ( gene ) subunits , namely gene ( gene ) , gene ( gene ) and gene ( gene ) , as well as the pituitary and plasma gene levels between 50 and 300 days post-hatching ( dph ) .	T3	T23	16962597
NA	CHEMICAL	GENE-N	54	8	A likely endocrine control mechanism for sexual differentiation in size-graded populations of European sea bass ( Dicentrarchus labrax ) is proposed by evaluating the brain expression and pituitary content of two forms of gene ( gene ) , namely sea bream ( sbchemical ) and salmon ( gene ) , the pituitary expression of one subtype of chemical receptor ( gene ) and the three gene ( gene ) subunits , namely gene ( gene ) , gene ( gene ) and gene ( gene ) , as well as the pituitary and plasma gene levels between 50 and 300 days post-hatching ( dph ) .	T3	T24	16962597
NA	CHEMICAL	GENE-N	54	67	A likely endocrine control mechanism for sexual differentiation in size-graded populations of European sea bass ( Dicentrarchus labrax ) is proposed by evaluating the brain expression and pituitary content of two forms of gene ( gene ) , namely sea bream ( sbchemical ) and salmon ( gene ) , the pituitary expression of one subtype of chemical receptor ( gene ) and the three gene ( gene ) subunits , namely gene ( gene ) , gene ( gene ) and gene ( gene ) , as well as the pituitary and plasma gene levels between 50 and 300 days post-hatching ( dph ) .	T3	T25	16962597
NA	CHEMICAL	GENE-N	54	72	A likely endocrine control mechanism for sexual differentiation in size-graded populations of European sea bass ( Dicentrarchus labrax ) is proposed by evaluating the brain expression and pituitary content of two forms of gene ( gene ) , namely sea bream ( sbchemical ) and salmon ( gene ) , the pituitary expression of one subtype of chemical receptor ( gene ) and the three gene ( gene ) subunits , namely gene ( gene ) , gene ( gene ) and gene ( gene ) , as well as the pituitary and plasma gene levels between 50 and 300 days post-hatching ( dph ) .	T3	T26	16962597
NA	CHEMICAL	GENE-N	54	74	A likely endocrine control mechanism for sexual differentiation in size-graded populations of European sea bass ( Dicentrarchus labrax ) is proposed by evaluating the brain expression and pituitary content of two forms of gene ( gene ) , namely sea bream ( sbchemical ) and salmon ( gene ) , the pituitary expression of one subtype of chemical receptor ( gene ) and the three gene ( gene ) subunits , namely gene ( gene ) , gene ( gene ) and gene ( gene ) , as well as the pituitary and plasma gene levels between 50 and 300 days post-hatching ( dph ) .	T3	T27	16962597
NA	CHEMICAL	GENE-N	54	77	A likely endocrine control mechanism for sexual differentiation in size-graded populations of European sea bass ( Dicentrarchus labrax ) is proposed by evaluating the brain expression and pituitary content of two forms of gene ( gene ) , namely sea bream ( sbchemical ) and salmon ( gene ) , the pituitary expression of one subtype of chemical receptor ( gene ) and the three gene ( gene ) subunits , namely gene ( gene ) , gene ( gene ) and gene ( gene ) , as well as the pituitary and plasma gene levels between 50 and 300 days post-hatching ( dph ) .	T3	T28	16962597
NA	CHEMICAL	GENE-N	54	79	A likely endocrine control mechanism for sexual differentiation in size-graded populations of European sea bass ( Dicentrarchus labrax ) is proposed by evaluating the brain expression and pituitary content of two forms of gene ( gene ) , namely sea bream ( sbchemical ) and salmon ( gene ) , the pituitary expression of one subtype of chemical receptor ( gene ) and the three gene ( gene ) subunits , namely gene ( gene ) , gene ( gene ) and gene ( gene ) , as well as the pituitary and plasma gene levels between 50 and 300 days post-hatching ( dph ) .	T3	T29	16962597
NA	CHEMICAL	GENE-N	54	82	A likely endocrine control mechanism for sexual differentiation in size-graded populations of European sea bass ( Dicentrarchus labrax ) is proposed by evaluating the brain expression and pituitary content of two forms of gene ( gene ) , namely sea bream ( sbchemical ) and salmon ( gene ) , the pituitary expression of one subtype of chemical receptor ( gene ) and the three gene ( gene ) subunits , namely gene ( gene ) , gene ( gene ) and gene ( gene ) , as well as the pituitary and plasma gene levels between 50 and 300 days post-hatching ( dph ) .	T3	T30	16962597
NA	CHEMICAL	GENE-N	54	84	A likely endocrine control mechanism for sexual differentiation in size-graded populations of European sea bass ( Dicentrarchus labrax ) is proposed by evaluating the brain expression and pituitary content of two forms of gene ( gene ) , namely sea bream ( sbchemical ) and salmon ( gene ) , the pituitary expression of one subtype of chemical receptor ( gene ) and the three gene ( gene ) subunits , namely gene ( gene ) , gene ( gene ) and gene ( gene ) , as well as the pituitary and plasma gene levels between 50 and 300 days post-hatching ( dph ) .	T3	T31	16962597
NA	CHEMICAL	GENE-N	54	94	A likely endocrine control mechanism for sexual differentiation in size-graded populations of European sea bass ( Dicentrarchus labrax ) is proposed by evaluating the brain expression and pituitary content of two forms of gene ( gene ) , namely sea bream ( sbchemical ) and salmon ( gene ) , the pituitary expression of one subtype of chemical receptor ( gene ) and the three gene ( gene ) subunits , namely gene ( gene ) , gene ( gene ) and gene ( gene ) , as well as the pituitary and plasma gene levels between 50 and 300 days post-hatching ( dph ) .	T3	T32	16962597
NA	CHEMICAL	GENE-N	42	33	A likely endocrine control mechanism for sexual differentiation in size-graded populations of European sea bass ( Dicentrarchus labrax ) is proposed by evaluating the brain expression and pituitary content of two forms of gene ( gene ) , namely sea bream ( sbchemical ) and salmon ( gene ) , the pituitary expression of one subtype of chemical receptor ( gene ) and the three gene ( gene ) subunits , namely gene ( gene ) , gene ( gene ) and gene ( gene ) , as well as the pituitary and plasma gene levels between 50 and 300 days post-hatching ( dph ) .	T4	T18	16962597
NA	CHEMICAL	GENE-N	42	35	A likely endocrine control mechanism for sexual differentiation in size-graded populations of European sea bass ( Dicentrarchus labrax ) is proposed by evaluating the brain expression and pituitary content of two forms of gene ( gene ) , namely sea bream ( sbchemical ) and salmon ( gene ) , the pituitary expression of one subtype of chemical receptor ( gene ) and the three gene ( gene ) subunits , namely gene ( gene ) , gene ( gene ) and gene ( gene ) , as well as the pituitary and plasma gene levels between 50 and 300 days post-hatching ( dph ) .	T4	T19	16962597
NA	CHEMICAL	GENE-N	42	47	A likely endocrine control mechanism for sexual differentiation in size-graded populations of European sea bass ( Dicentrarchus labrax ) is proposed by evaluating the brain expression and pituitary content of two forms of gene ( gene ) , namely sea bream ( sbchemical ) and salmon ( gene ) , the pituitary expression of one subtype of chemical receptor ( gene ) and the three gene ( gene ) subunits , namely gene ( gene ) , gene ( gene ) and gene ( gene ) , as well as the pituitary and plasma gene levels between 50 and 300 days post-hatching ( dph ) .	T4	T21	16962597
NA	CHEMICAL	GENE-Y	42	58	A likely endocrine control mechanism for sexual differentiation in size-graded populations of European sea bass ( Dicentrarchus labrax ) is proposed by evaluating the brain expression and pituitary content of two forms of gene ( gene ) , namely sea bream ( sbchemical ) and salmon ( gene ) , the pituitary expression of one subtype of chemical receptor ( gene ) and the three gene ( gene ) subunits , namely gene ( gene ) , gene ( gene ) and gene ( gene ) , as well as the pituitary and plasma gene levels between 50 and 300 days post-hatching ( dph ) .	T4	T22	16962597
NA	CHEMICAL	GENE-N	42	0	A likely endocrine control mechanism for sexual differentiation in size-graded populations of European sea bass ( Dicentrarchus labrax ) is proposed by evaluating the brain expression and pituitary content of two forms of gene ( gene ) , namely sea bream ( sbchemical ) and salmon ( gene ) , the pituitary expression of one subtype of chemical receptor ( gene ) and the three gene ( gene ) subunits , namely gene ( gene ) , gene ( gene ) and gene ( gene ) , as well as the pituitary and plasma gene levels between 50 and 300 days post-hatching ( dph ) .	T4	T23	16962597
NA	CHEMICAL	GENE-N	42	8	A likely endocrine control mechanism for sexual differentiation in size-graded populations of European sea bass ( Dicentrarchus labrax ) is proposed by evaluating the brain expression and pituitary content of two forms of gene ( gene ) , namely sea bream ( sbchemical ) and salmon ( gene ) , the pituitary expression of one subtype of chemical receptor ( gene ) and the three gene ( gene ) subunits , namely gene ( gene ) , gene ( gene ) and gene ( gene ) , as well as the pituitary and plasma gene levels between 50 and 300 days post-hatching ( dph ) .	T4	T24	16962597
NA	CHEMICAL	GENE-N	42	67	A likely endocrine control mechanism for sexual differentiation in size-graded populations of European sea bass ( Dicentrarchus labrax ) is proposed by evaluating the brain expression and pituitary content of two forms of gene ( gene ) , namely sea bream ( sbchemical ) and salmon ( gene ) , the pituitary expression of one subtype of chemical receptor ( gene ) and the three gene ( gene ) subunits , namely gene ( gene ) , gene ( gene ) and gene ( gene ) , as well as the pituitary and plasma gene levels between 50 and 300 days post-hatching ( dph ) .	T4	T25	16962597
NA	CHEMICAL	GENE-N	42	72	A likely endocrine control mechanism for sexual differentiation in size-graded populations of European sea bass ( Dicentrarchus labrax ) is proposed by evaluating the brain expression and pituitary content of two forms of gene ( gene ) , namely sea bream ( sbchemical ) and salmon ( gene ) , the pituitary expression of one subtype of chemical receptor ( gene ) and the three gene ( gene ) subunits , namely gene ( gene ) , gene ( gene ) and gene ( gene ) , as well as the pituitary and plasma gene levels between 50 and 300 days post-hatching ( dph ) .	T4	T26	16962597
NA	CHEMICAL	GENE-N	42	74	A likely endocrine control mechanism for sexual differentiation in size-graded populations of European sea bass ( Dicentrarchus labrax ) is proposed by evaluating the brain expression and pituitary content of two forms of gene ( gene ) , namely sea bream ( sbchemical ) and salmon ( gene ) , the pituitary expression of one subtype of chemical receptor ( gene ) and the three gene ( gene ) subunits , namely gene ( gene ) , gene ( gene ) and gene ( gene ) , as well as the pituitary and plasma gene levels between 50 and 300 days post-hatching ( dph ) .	T4	T27	16962597
NA	CHEMICAL	GENE-N	42	77	A likely endocrine control mechanism for sexual differentiation in size-graded populations of European sea bass ( Dicentrarchus labrax ) is proposed by evaluating the brain expression and pituitary content of two forms of gene ( gene ) , namely sea bream ( sbchemical ) and salmon ( gene ) , the pituitary expression of one subtype of chemical receptor ( gene ) and the three gene ( gene ) subunits , namely gene ( gene ) , gene ( gene ) and gene ( gene ) , as well as the pituitary and plasma gene levels between 50 and 300 days post-hatching ( dph ) .	T4	T28	16962597
NA	CHEMICAL	GENE-N	42	79	A likely endocrine control mechanism for sexual differentiation in size-graded populations of European sea bass ( Dicentrarchus labrax ) is proposed by evaluating the brain expression and pituitary content of two forms of gene ( gene ) , namely sea bream ( sbchemical ) and salmon ( gene ) , the pituitary expression of one subtype of chemical receptor ( gene ) and the three gene ( gene ) subunits , namely gene ( gene ) , gene ( gene ) and gene ( gene ) , as well as the pituitary and plasma gene levels between 50 and 300 days post-hatching ( dph ) .	T4	T29	16962597
NA	CHEMICAL	GENE-N	42	82	A likely endocrine control mechanism for sexual differentiation in size-graded populations of European sea bass ( Dicentrarchus labrax ) is proposed by evaluating the brain expression and pituitary content of two forms of gene ( gene ) , namely sea bream ( sbchemical ) and salmon ( gene ) , the pituitary expression of one subtype of chemical receptor ( gene ) and the three gene ( gene ) subunits , namely gene ( gene ) , gene ( gene ) and gene ( gene ) , as well as the pituitary and plasma gene levels between 50 and 300 days post-hatching ( dph ) .	T4	T30	16962597
NA	CHEMICAL	GENE-N	42	84	A likely endocrine control mechanism for sexual differentiation in size-graded populations of European sea bass ( Dicentrarchus labrax ) is proposed by evaluating the brain expression and pituitary content of two forms of gene ( gene ) , namely sea bream ( sbchemical ) and salmon ( gene ) , the pituitary expression of one subtype of chemical receptor ( gene ) and the three gene ( gene ) subunits , namely gene ( gene ) , gene ( gene ) and gene ( gene ) , as well as the pituitary and plasma gene levels between 50 and 300 days post-hatching ( dph ) .	T4	T31	16962597
NA	CHEMICAL	GENE-N	42	94	A likely endocrine control mechanism for sexual differentiation in size-graded populations of European sea bass ( Dicentrarchus labrax ) is proposed by evaluating the brain expression and pituitary content of two forms of gene ( gene ) , namely sea bream ( sbchemical ) and salmon ( gene ) , the pituitary expression of one subtype of chemical receptor ( gene ) and the three gene ( gene ) subunits , namely gene ( gene ) , gene ( gene ) and gene ( gene ) , as well as the pituitary and plasma gene levels between 50 and 300 days post-hatching ( dph ) .	T4	T32	16962597
NA	CHEMICAL	GENE-N	57	33	A likely endocrine control mechanism for sexual differentiation in size-graded populations of European sea bass ( Dicentrarchus labrax ) is proposed by evaluating the brain expression and pituitary content of two forms of gene ( gene ) , namely sea bream ( sbchemical ) and salmon ( gene ) , the pituitary expression of one subtype of chemical receptor ( gene ) and the three gene ( gene ) subunits , namely gene ( gene ) , gene ( gene ) and gene ( gene ) , as well as the pituitary and plasma gene levels between 50 and 300 days post-hatching ( dph ) .	T5	T18	16962597
NA	CHEMICAL	GENE-N	57	35	A likely endocrine control mechanism for sexual differentiation in size-graded populations of European sea bass ( Dicentrarchus labrax ) is proposed by evaluating the brain expression and pituitary content of two forms of gene ( gene ) , namely sea bream ( sbchemical ) and salmon ( gene ) , the pituitary expression of one subtype of chemical receptor ( gene ) and the three gene ( gene ) subunits , namely gene ( gene ) , gene ( gene ) and gene ( gene ) , as well as the pituitary and plasma gene levels between 50 and 300 days post-hatching ( dph ) .	T5	T19	16962597
NA	CHEMICAL	GENE-N	57	47	A likely endocrine control mechanism for sexual differentiation in size-graded populations of European sea bass ( Dicentrarchus labrax ) is proposed by evaluating the brain expression and pituitary content of two forms of gene ( gene ) , namely sea bream ( sbchemical ) and salmon ( gene ) , the pituitary expression of one subtype of chemical receptor ( gene ) and the three gene ( gene ) subunits , namely gene ( gene ) , gene ( gene ) and gene ( gene ) , as well as the pituitary and plasma gene levels between 50 and 300 days post-hatching ( dph ) .	T5	T21	16962597
NA	CHEMICAL	GENE-Y	57	58	A likely endocrine control mechanism for sexual differentiation in size-graded populations of European sea bass ( Dicentrarchus labrax ) is proposed by evaluating the brain expression and pituitary content of two forms of gene ( gene ) , namely sea bream ( sbchemical ) and salmon ( gene ) , the pituitary expression of one subtype of chemical receptor ( gene ) and the three gene ( gene ) subunits , namely gene ( gene ) , gene ( gene ) and gene ( gene ) , as well as the pituitary and plasma gene levels between 50 and 300 days post-hatching ( dph ) .	T5	T22	16962597
NA	CHEMICAL	GENE-N	57	0	A likely endocrine control mechanism for sexual differentiation in size-graded populations of European sea bass ( Dicentrarchus labrax ) is proposed by evaluating the brain expression and pituitary content of two forms of gene ( gene ) , namely sea bream ( sbchemical ) and salmon ( gene ) , the pituitary expression of one subtype of chemical receptor ( gene ) and the three gene ( gene ) subunits , namely gene ( gene ) , gene ( gene ) and gene ( gene ) , as well as the pituitary and plasma gene levels between 50 and 300 days post-hatching ( dph ) .	T5	T23	16962597
NA	CHEMICAL	GENE-N	57	8	A likely endocrine control mechanism for sexual differentiation in size-graded populations of European sea bass ( Dicentrarchus labrax ) is proposed by evaluating the brain expression and pituitary content of two forms of gene ( gene ) , namely sea bream ( sbchemical ) and salmon ( gene ) , the pituitary expression of one subtype of chemical receptor ( gene ) and the three gene ( gene ) subunits , namely gene ( gene ) , gene ( gene ) and gene ( gene ) , as well as the pituitary and plasma gene levels between 50 and 300 days post-hatching ( dph ) .	T5	T24	16962597
NA	CHEMICAL	GENE-N	57	67	A likely endocrine control mechanism for sexual differentiation in size-graded populations of European sea bass ( Dicentrarchus labrax ) is proposed by evaluating the brain expression and pituitary content of two forms of gene ( gene ) , namely sea bream ( sbchemical ) and salmon ( gene ) , the pituitary expression of one subtype of chemical receptor ( gene ) and the three gene ( gene ) subunits , namely gene ( gene ) , gene ( gene ) and gene ( gene ) , as well as the pituitary and plasma gene levels between 50 and 300 days post-hatching ( dph ) .	T5	T25	16962597
NA	CHEMICAL	GENE-N	57	72	A likely endocrine control mechanism for sexual differentiation in size-graded populations of European sea bass ( Dicentrarchus labrax ) is proposed by evaluating the brain expression and pituitary content of two forms of gene ( gene ) , namely sea bream ( sbchemical ) and salmon ( gene ) , the pituitary expression of one subtype of chemical receptor ( gene ) and the three gene ( gene ) subunits , namely gene ( gene ) , gene ( gene ) and gene ( gene ) , as well as the pituitary and plasma gene levels between 50 and 300 days post-hatching ( dph ) .	T5	T26	16962597
NA	CHEMICAL	GENE-N	57	74	A likely endocrine control mechanism for sexual differentiation in size-graded populations of European sea bass ( Dicentrarchus labrax ) is proposed by evaluating the brain expression and pituitary content of two forms of gene ( gene ) , namely sea bream ( sbchemical ) and salmon ( gene ) , the pituitary expression of one subtype of chemical receptor ( gene ) and the three gene ( gene ) subunits , namely gene ( gene ) , gene ( gene ) and gene ( gene ) , as well as the pituitary and plasma gene levels between 50 and 300 days post-hatching ( dph ) .	T5	T27	16962597
NA	CHEMICAL	GENE-N	57	77	A likely endocrine control mechanism for sexual differentiation in size-graded populations of European sea bass ( Dicentrarchus labrax ) is proposed by evaluating the brain expression and pituitary content of two forms of gene ( gene ) , namely sea bream ( sbchemical ) and salmon ( gene ) , the pituitary expression of one subtype of chemical receptor ( gene ) and the three gene ( gene ) subunits , namely gene ( gene ) , gene ( gene ) and gene ( gene ) , as well as the pituitary and plasma gene levels between 50 and 300 days post-hatching ( dph ) .	T5	T28	16962597
NA	CHEMICAL	GENE-N	57	79	A likely endocrine control mechanism for sexual differentiation in size-graded populations of European sea bass ( Dicentrarchus labrax ) is proposed by evaluating the brain expression and pituitary content of two forms of gene ( gene ) , namely sea bream ( sbchemical ) and salmon ( gene ) , the pituitary expression of one subtype of chemical receptor ( gene ) and the three gene ( gene ) subunits , namely gene ( gene ) , gene ( gene ) and gene ( gene ) , as well as the pituitary and plasma gene levels between 50 and 300 days post-hatching ( dph ) .	T5	T29	16962597
NA	CHEMICAL	GENE-N	57	82	A likely endocrine control mechanism for sexual differentiation in size-graded populations of European sea bass ( Dicentrarchus labrax ) is proposed by evaluating the brain expression and pituitary content of two forms of gene ( gene ) , namely sea bream ( sbchemical ) and salmon ( gene ) , the pituitary expression of one subtype of chemical receptor ( gene ) and the three gene ( gene ) subunits , namely gene ( gene ) , gene ( gene ) and gene ( gene ) , as well as the pituitary and plasma gene levels between 50 and 300 days post-hatching ( dph ) .	T5	T30	16962597
NA	CHEMICAL	GENE-N	57	84	A likely endocrine control mechanism for sexual differentiation in size-graded populations of European sea bass ( Dicentrarchus labrax ) is proposed by evaluating the brain expression and pituitary content of two forms of gene ( gene ) , namely sea bream ( sbchemical ) and salmon ( gene ) , the pituitary expression of one subtype of chemical receptor ( gene ) and the three gene ( gene ) subunits , namely gene ( gene ) , gene ( gene ) and gene ( gene ) , as well as the pituitary and plasma gene levels between 50 and 300 days post-hatching ( dph ) .	T5	T31	16962597
NA	CHEMICAL	GENE-N	57	94	A likely endocrine control mechanism for sexual differentiation in size-graded populations of European sea bass ( Dicentrarchus labrax ) is proposed by evaluating the brain expression and pituitary content of two forms of gene ( gene ) , namely sea bream ( sbchemical ) and salmon ( gene ) , the pituitary expression of one subtype of chemical receptor ( gene ) and the three gene ( gene ) subunits , namely gene ( gene ) , gene ( gene ) and gene ( gene ) , as well as the pituitary and plasma gene levels between 50 and 300 days post-hatching ( dph ) .	T5	T32	16962597
CPR:4	CHEMICAL	GENE-Y	0	5	chemical ( chemical ) , a selective gene inhibitor , also inhibited cell proliferation , whereas it did not cause apoptosis .	T12	T24	12065695
CPR:4	CHEMICAL	GENE-Y	2	5	chemical ( chemical ) , a selective gene inhibitor , also inhibited cell proliferation , whereas it did not cause apoptosis .	T13	T24	12065695
NA	CHEMICAL	GENE-Y	4	4	Rheumatoid synovial cells expressed gene mRNA , and the gene ligands chemical and chemical reduced the proliferation and induced apoptosis in synovial cells .	T1	T14	12065695
NA	CHEMICAL	GENE-Y	4	9	Rheumatoid synovial cells expressed gene mRNA , and the gene ligands chemical and chemical reduced the proliferation and induced apoptosis in synovial cells .	T1	T15	12065695
NA	CHEMICAL	GENE-Y	13	4	Rheumatoid synovial cells expressed gene mRNA , and the gene ligands chemical and chemical reduced the proliferation and induced apoptosis in synovial cells .	T2	T14	12065695
NA	CHEMICAL	GENE-Y	13	9	Rheumatoid synovial cells expressed gene mRNA , and the gene ligands chemical and chemical reduced the proliferation and induced apoptosis in synovial cells .	T2	T15	12065695
NA	CHEMICAL	GENE-Y	1	10	Serum chemical concentration and its relation to change in plasma gene level in the treatment of heart failure : a preliminary study .	T11	T17	14692707
NA	CHEMICAL	GENE-Y	7	15	OBJECTIVE : To examine the influence of chemical dose and concentration in serum on plasma gene ( gene ) , a measure of heart failure progression .	T7	T15	14692707
NA	CHEMICAL	GENE-Y	7	17	OBJECTIVE : To examine the influence of chemical dose and concentration in serum on plasma gene ( gene ) , a measure of heart failure progression .	T7	T12	14692707
NA	CHEMICAL	GENE-Y	32	17	The degree of improvement in heart failure was assessed from the ratio of change in the plasma gene concentration , 2 weeks , 1 month and 3 months after the commencement of chemical administration .	T8	T14	14692707
CPR:4	CHEMICAL	GENE-Y	8	37	On the other hand , in patients with a mean serum chemical level ( Cmin ) of less than 2.5 nmol/l up to 2 weeks after the start ofchemical therapy , the degree of reduction in the gene value after the 3rd month was significantly larger , relative to the patient group with Cmin over 2.5 nmol/l .	T1	T13	14692707
CPR:4	CHEMICAL	GENE-Y	8	37	On the other hand , in patients with a mean serum chemical level ( Cmin ) of less than 2.5 nmol/l up to 2 weeks after the start ofchemical therapy , the degree of reduction in the gene value after the 3rd month was significantly larger , relative to the patient group with Cmin over 2.5 nmol/l .	T2	T13	14692707
CPR:4	CHEMICAL	GENE-Y	4	26	In healthy rats , chemical dose dependently ( 25 , 50 , or 100 mg/kg ) attenuated CRD-induced hypersensitivity and significantly inhibited CRD-induced overexpression of spinal gene mRNA , whereas chemical had no effect .	T20	T35	16855178
NA	CHEMICAL	GENE-Y	30	26	In healthy rats , chemical dose dependently ( 25 , 50 , or 100 mg/kg ) attenuated CRD-induced hypersensitivity and significantly inhibited CRD-induced overexpression of spinal gene mRNA , whereas chemical had no effect .	T21	T35	16855178
NA	CHEMICAL	GENE-N	0	7	chemical-induced antinociception was reversed by chemical , a chemical-sensitive chemical ( chemical ( chemical ) ) channel inhibitor .	T22	T36	16855178
CPR:4	CHEMICAL	GENE-N	5	7	chemical-induced antinociception was reversed by chemical , a chemical-sensitive chemical ( chemical ( chemical ) ) channel inhibitor .	T23	T36	16855178
NA	CHEMICAL	GENE-N	8	7	chemical-induced antinociception was reversed by chemical , a chemical-sensitive chemical ( chemical ( chemical ) ) channel inhibitor .	T24	T36	16855178
NA	CHEMICAL	GENE-N	0	7	chemical-induced antinociception was reversed by chemical , a chemical-sensitive chemical ( chemical ( chemical ) ) channel inhibitor .	T2	T36	16855178
NA	CHEMICAL	GENE-N	11	7	chemical-induced antinociception was reversed by chemical , a chemical-sensitive chemical ( chemical ( chemical ) ) channel inhibitor .	T3	T36	16855178
NA	CHEMICAL	GENE-N	13	7	chemical-induced antinociception was reversed by chemical , a chemical-sensitive chemical ( chemical ( chemical ) ) channel inhibitor .	T4	T36	16855178
CPR:4	CHEMICAL	GENE-Y	14	1	Colonic gene and gene mRNA and spinal gene mRNA expression were significantly down-regulated by chemical , but not by chemical .	T7	T30	16855178
CPR:4	CHEMICAL	GENE-Y	14	3	Colonic gene and gene mRNA and spinal gene mRNA expression were significantly down-regulated by chemical , but not by chemical .	T7	T31	16855178
CPR:4	CHEMICAL	GENE-Y	14	7	Colonic gene and gene mRNA and spinal gene mRNA expression were significantly down-regulated by chemical , but not by chemical .	T7	T32	16855178
NA	CHEMICAL	GENE-Y	19	1	Colonic gene and gene mRNA and spinal gene mRNA expression were significantly down-regulated by chemical , but not by chemical .	T8	T30	16855178
NA	CHEMICAL	GENE-Y	19	3	Colonic gene and gene mRNA and spinal gene mRNA expression were significantly down-regulated by chemical , but not by chemical .	T8	T31	16855178
NA	CHEMICAL	GENE-Y	19	7	Colonic gene and gene mRNA and spinal gene mRNA expression were significantly down-regulated by chemical , but not by chemical .	T8	T32	16855178
NA	CHEMICAL	GENE-N	7	22	Taken together , these data suggest that chemical inhibits hypersensitivity induced by CRD in both healthy and postcolitic , allodynic rats by a chemical ( chemical ) channel-mediated mechanism .	T12	T33	16855178
NA	CHEMICAL	GENE-N	23	22	Taken together , these data suggest that chemical inhibits hypersensitivity induced by CRD in both healthy and postcolitic , allodynic rats by a chemical ( chemical ) channel-mediated mechanism .	T13	T33	16855178
NA	CHEMICAL	GENE-N	25	22	Taken together , these data suggest that chemical inhibits hypersensitivity induced by CRD in both healthy and postcolitic , allodynic rats by a chemical ( chemical ) channel-mediated mechanism .	T14	T33	16855178
NA	CHEMICAL	GENE-Y	0	1	chemical hydroxylase mRNA levels are elevated by repeated immobilization stress in rat raphe nuclei but not in pineal gland .	T7	T16	10381000
NA	CHEMICAL	GENE-Y	2	16	To begin to examine whether these changes are mediated by alterations in gene expression for chemical hydroxylase ( gene ) , the rate-limiting enzyme in chemical biosynthesis , we quantitated its mRNA levels by competitive reverse transcription-polymerase chain reaction ( RT-PCR ) .	T3	T8	10381000
NA	CHEMICAL	GENE-Y	2	18	To begin to examine whether these changes are mediated by alterations in gene expression for chemical hydroxylase ( gene ) , the rate-limiting enzyme in chemical biosynthesis , we quantitated its mRNA levels by competitive reverse transcription-polymerase chain reaction ( RT-PCR ) .	T3	T9	10381000
CPR:9	CHEMICAL	GENE-Y	25	16	To begin to examine whether these changes are mediated by alterations in gene expression for chemical hydroxylase ( gene ) , the rate-limiting enzyme in chemical biosynthesis , we quantitated its mRNA levels by competitive reverse transcription-polymerase chain reaction ( RT-PCR ) .	T4	T8	10381000
CPR:9	CHEMICAL	GENE-Y	25	18	To begin to examine whether these changes are mediated by alterations in gene expression for chemical hydroxylase ( gene ) , the rate-limiting enzyme in chemical biosynthesis , we quantitated its mRNA levels by competitive reverse transcription-polymerase chain reaction ( RT-PCR ) .	T4	T9	10381000
CPR:9	CHEMICAL	GENE-Y	7	11	In contrast , there was little change in mRNA levels for gene ( gene ) , the rate limiting enzyme in synthesis of the chemical ( chemical ) , the obligate cofactor for gene .	T5	T12	10381000
CPR:9	CHEMICAL	GENE-Y	7	13	In contrast , there was little change in mRNA levels for gene ( gene ) , the rate limiting enzyme in synthesis of the chemical ( chemical ) , the obligate cofactor for gene .	T5	T13	10381000
NA	CHEMICAL	GENE-Y	7	33	In contrast , there was little change in mRNA levels for gene ( gene ) , the rate limiting enzyme in synthesis of the chemical ( chemical ) , the obligate cofactor for gene .	T5	T14	10381000
CPR:9	CHEMICAL	GENE-Y	26	11	In contrast , there was little change in mRNA levels for gene ( gene ) , the rate limiting enzyme in synthesis of the chemical ( chemical ) , the obligate cofactor for gene .	T6	T12	10381000
CPR:9	CHEMICAL	GENE-Y	26	13	In contrast , there was little change in mRNA levels for gene ( gene ) , the rate limiting enzyme in synthesis of the chemical ( chemical ) , the obligate cofactor for gene .	T6	T13	10381000
NA	CHEMICAL	GENE-Y	26	33	In contrast , there was little change in mRNA levels for gene ( gene ) , the rate limiting enzyme in synthesis of the chemical ( chemical ) , the obligate cofactor for gene .	T6	T14	10381000
CPR:4	CHEMICAL	GENE-N	0	7	chemical [ chemical ; chemical ] is a potent irreversible chemical oxidase ( gene ) inhibitor with selectivity for type B of the enzyme , which is being developed for treatment of Parkinson 's disease .	T1	T42	12504917
CPR:4	CHEMICAL	GENE-N	0	13	chemical [ chemical ; chemical ] is a potent irreversible chemical oxidase ( gene ) inhibitor with selectivity for type B of the enzyme , which is being developed for treatment of Parkinson 's disease .	T1	T45	12504917
CPR:4	CHEMICAL	GENE-N	2	7	chemical [ chemical ; chemical ] is a potent irreversible chemical oxidase ( gene ) inhibitor with selectivity for type B of the enzyme , which is being developed for treatment of Parkinson 's disease .	T8	T42	12504917
CPR:4	CHEMICAL	GENE-N	2	13	chemical [ chemical ; chemical ] is a potent irreversible chemical oxidase ( gene ) inhibitor with selectivity for type B of the enzyme , which is being developed for treatment of Parkinson 's disease .	T8	T45	12504917
CPR:4	CHEMICAL	GENE-N	4	7	chemical [ chemical ; chemical ] is a potent irreversible chemical oxidase ( gene ) inhibitor with selectivity for type B of the enzyme , which is being developed for treatment of Parkinson 's disease .	T20	T42	12504917
CPR:4	CHEMICAL	GENE-N	4	13	chemical [ chemical ; chemical ] is a potent irreversible chemical oxidase ( gene ) inhibitor with selectivity for type B of the enzyme , which is being developed for treatment of Parkinson 's disease .	T20	T45	12504917
NA	CHEMICAL	GENE-N	7	7	chemical [ chemical ; chemical ] is a potent irreversible chemical oxidase ( gene ) inhibitor with selectivity for type B of the enzyme , which is being developed for treatment of Parkinson 's disease .	T27	T42	12504917
NA	CHEMICAL	GENE-N	7	13	chemical [ chemical ; chemical ] is a potent irreversible chemical oxidase ( gene ) inhibitor with selectivity for type B of the enzyme , which is being developed for treatment of Parkinson 's disease .	T27	T45	12504917
NA	CHEMICAL	GENE-Y	0	20	chemical-induced ptosis was reversed by chemical at doses above 2 mg x kg ( -1 ) i.p. , which inhibit gene as well as gene , but not at gene-selective doses .	T19	T39	12504917
NA	CHEMICAL	GENE-Y	0	24	chemical-induced ptosis was reversed by chemical at doses above 2 mg x kg ( -1 ) i.p. , which inhibit gene as well as gene , but not at gene-selective doses .	T19	T40	12504917
NA	CHEMICAL	GENE-Y	0	29	chemical-induced ptosis was reversed by chemical at doses above 2 mg x kg ( -1 ) i.p. , which inhibit gene as well as gene , but not at gene-selective doses .	T19	T41	12504917
CPR:4	CHEMICAL	GENE-Y	5	20	chemical-induced ptosis was reversed by chemical at doses above 2 mg x kg ( -1 ) i.p. , which inhibit gene as well as gene , but not at gene-selective doses .	T21	T39	12504917
CPR:4	CHEMICAL	GENE-Y	5	24	chemical-induced ptosis was reversed by chemical at doses above 2 mg x kg ( -1 ) i.p. , which inhibit gene as well as gene , but not at gene-selective doses .	T21	T40	12504917
NA	CHEMICAL	GENE-Y	5	29	chemical-induced ptosis was reversed by chemical at doses above 2 mg x kg ( -1 ) i.p. , which inhibit gene as well as gene , but not at gene-selective doses .	T21	T41	12504917
CPR:4	CHEMICAL	GENE-Y	20	16	) , did not induce the behavioural hyperactivity syndrome which is seen following inhibition of both gene and gene by chemical together with the chemical precursors .	T28	T43	12504917
CPR:4	CHEMICAL	GENE-Y	20	18	) , did not induce the behavioural hyperactivity syndrome which is seen following inhibition of both gene and gene by chemical together with the chemical precursors .	T28	T44	12504917
CPR:4	CHEMICAL	GENE-Y	24	16	) , did not induce the behavioural hyperactivity syndrome which is seen following inhibition of both gene and gene by chemical together with the chemical precursors .	T29	T43	12504917
CPR:4	CHEMICAL	GENE-Y	24	18	) , did not induce the behavioural hyperactivity syndrome which is seen following inhibition of both gene and gene by chemical together with the chemical precursors .	T29	T44	12504917
NA	CHEMICAL	GENE-Y	0	2	chemical activates gene gene signaling to inhibit stem cell differentiation in adipogenesis .	T16	T32	23152186
NA	CHEMICAL	GENE-N	0	3	chemical activates gene gene signaling to inhibit stem cell differentiation in adipogenesis .	T16	T33	23152186
NA	CHEMICAL	GENE-N	3	7	We hypothesized that chemical signals through the gene ( gene ) sensitive , gene ( gene ) to impair adipogenesis , as previously demonstrated for its stimulation of vascular oxidant generation , angiogenesis , and remodeling .	T12	T27	23152186
NA	CHEMICAL	GENE-N	3	9	We hypothesized that chemical signals through the gene ( gene ) sensitive , gene ( gene ) to impair adipogenesis , as previously demonstrated for its stimulation of vascular oxidant generation , angiogenesis , and remodeling .	T12	T28	23152186
NA	CHEMICAL	GENE-N	3	13	We hypothesized that chemical signals through the gene ( gene ) sensitive , gene ( gene ) to impair adipogenesis , as previously demonstrated for its stimulation of vascular oxidant generation , angiogenesis , and remodeling .	T12	T29	23152186
NA	CHEMICAL	GENE-N	3	15	We hypothesized that chemical signals through the gene ( gene ) sensitive , gene ( gene ) to impair adipogenesis , as previously demonstrated for its stimulation of vascular oxidant generation , angiogenesis , and remodeling .	T12	T30	23152186
NA	CHEMICAL	GENE-N	2	4	Because both chemical and gene ligands inhibit progenitor cell differentiation into adipocytes , we investigated the hypothesis in a model of low-passage human mesenchymal stem cells ( hMSC ) .	T13	T31	23152186
NA	CHEMICAL	GENE-Y	0	34	chemical ( 0.1-1.0 µM ) suppressed chemical/insulin-induced hMSC adipogenesis , as indicated by decreased transcriptional promoters of differentiation , decreased fat droplet formation , and decreased expression of differentiated adipocyte markers , such as gene and gene .	T14	T17	23152186
NA	CHEMICAL	GENE-Y	0	36	chemical ( 0.1-1.0 µM ) suppressed chemical/insulin-induced hMSC adipogenesis , as indicated by decreased transcriptional promoters of differentiation , decreased fat droplet formation , and decreased expression of differentiated adipocyte markers , such as gene and gene .	T14	T18	23152186
NA	CHEMICAL	GENE-Y	6	34	chemical ( 0.1-1.0 µM ) suppressed chemical/insulin-induced hMSC adipogenesis , as indicated by decreased transcriptional promoters of differentiation , decreased fat droplet formation , and decreased expression of differentiated adipocyte markers , such as gene and gene .	T15	T17	23152186
NA	CHEMICAL	GENE-Y	6	36	chemical ( 0.1-1.0 µM ) suppressed chemical/insulin-induced hMSC adipogenesis , as indicated by decreased transcriptional promoters of differentiation , decreased fat droplet formation , and decreased expression of differentiated adipocyte markers , such as gene and gene .	T15	T18	23152186
NA	CHEMICAL	GENE-N	3	3	Preincubating hMSC with gene prevented 90 % of the suppressive effect of chemical .	T1	T19	23152186
NA	CHEMICAL	GENE-N	4	4	Selective competitive antagonists of gene-coupled gene were ~60 % effective in blocking chemical inhibition and combination of antagonists to both receptors were 85 % effective .	T2	T20	23152186
NA	CHEMICAL	GENE-N	4	5	Selective competitive antagonists of gene-coupled gene were ~60 % effective in blocking chemical inhibition and combination of antagonists to both receptors were 85 % effective .	T2	T21	23152186
NA	CHEMICAL	GENE-Y	6	4	In contrast , antagonists to the chemical type 1 receptor ( previously shown to mediate chemical vascular effects ) or the gene were ineffective in blocking chemical effects .	T3	T22	23152186
NA	CHEMICAL	GENE-Y	6	4	In contrast , antagonists to the chemical type 1 receptor ( previously shown to mediate chemical vascular effects ) or the gene were ineffective in blocking chemical effects .	T3	T23	23152186
NA	CHEMICAL	GENE-Y	10	4	In contrast , antagonists to the chemical type 1 receptor ( previously shown to mediate chemical vascular effects ) or the gene were ineffective in blocking chemical effects .	T4	T22	23152186
NA	CHEMICAL	GENE-Y	10	4	In contrast , antagonists to the chemical type 1 receptor ( previously shown to mediate chemical vascular effects ) or the gene were ineffective in blocking chemical effects .	T4	T23	23152186
NA	CHEMICAL	GENE-Y	10	4	In contrast , antagonists to the chemical type 1 receptor ( previously shown to mediate chemical vascular effects ) or the gene were ineffective in blocking chemical effects .	T6	T22	23152186
NA	CHEMICAL	GENE-Y	10	4	In contrast , antagonists to the chemical type 1 receptor ( previously shown to mediate chemical vascular effects ) or the gene were ineffective in blocking chemical effects .	T6	T23	23152186
NA	CHEMICAL	GENE-Y	3	13	These studies suggest a majority of chemical-inhibited adipocyte differentiation , and metabolism requires gene gene and that chemical effects on gene signaling are tissue and context specific .	T8	T24	23152186
NA	CHEMICAL	GENE-N	3	14	These studies suggest a majority of chemical-inhibited adipocyte differentiation , and metabolism requires gene gene and that chemical effects on gene signaling are tissue and context specific .	T8	T25	23152186
NA	CHEMICAL	GENE-N	3	20	These studies suggest a majority of chemical-inhibited adipocyte differentiation , and metabolism requires gene gene and that chemical effects on gene signaling are tissue and context specific .	T8	T26	23152186
NA	CHEMICAL	GENE-Y	17	13	These studies suggest a majority of chemical-inhibited adipocyte differentiation , and metabolism requires gene gene and that chemical effects on gene signaling are tissue and context specific .	T9	T24	23152186
NA	CHEMICAL	GENE-N	17	14	These studies suggest a majority of chemical-inhibited adipocyte differentiation , and metabolism requires gene gene and that chemical effects on gene signaling are tissue and context specific .	T9	T25	23152186
NA	CHEMICAL	GENE-N	17	20	These studies suggest a majority of chemical-inhibited adipocyte differentiation , and metabolism requires gene gene and that chemical effects on gene signaling are tissue and context specific .	T9	T26	23152186
NA	CHEMICAL	GENE-N	0	1	chemical synthase ( gene ) inhibitors interfere with chemical biosynthesis by inhibiting gene .	T1	T19	16547651
NA	CHEMICAL	GENE-N	0	3	chemical synthase ( gene ) inhibitors interfere with chemical biosynthesis by inhibiting gene .	T1	T25	16547651
NA	CHEMICAL	GENE-N	0	12	chemical synthase ( gene ) inhibitors interfere with chemical biosynthesis by inhibiting gene .	T1	T21	16547651
NA	CHEMICAL	GENE-N	8	1	chemical synthase ( gene ) inhibitors interfere with chemical biosynthesis by inhibiting gene .	T13	T19	16547651
NA	CHEMICAL	GENE-N	8	3	chemical synthase ( gene ) inhibitors interfere with chemical biosynthesis by inhibiting gene .	T13	T25	16547651
NA	CHEMICAL	GENE-N	8	12	chemical synthase ( gene ) inhibitors interfere with chemical biosynthesis by inhibiting gene .	T13	T21	16547651
CPR:4	CHEMICAL	GENE-N	0	7	chemical affects chemical biosynthesis by inhibiting chemical synthase ( gene ) .	T6	T22	16547651
CPR:4	CHEMICAL	GENE-N	0	9	chemical affects chemical biosynthesis by inhibiting chemical synthase ( gene ) .	T6	T23	16547651
NA	CHEMICAL	GENE-N	2	7	chemical affects chemical biosynthesis by inhibiting chemical synthase ( gene ) .	T7	T22	16547651
NA	CHEMICAL	GENE-N	2	9	chemical affects chemical biosynthesis by inhibiting chemical synthase ( gene ) .	T7	T23	16547651
NA	CHEMICAL	GENE-N	6	7	chemical affects chemical biosynthesis by inhibiting chemical synthase ( gene ) .	T8	T22	16547651
NA	CHEMICAL	GENE-N	6	9	chemical affects chemical biosynthesis by inhibiting chemical synthase ( gene ) .	T8	T23	16547651
CPR:4	CHEMICAL	GENE-N	0	3	chemical inhibits chemical synthetase and blocks biosynthesis of chemical .	T9	T24	16547651
NA	CHEMICAL	GENE-N	2	3	chemical inhibits chemical synthetase and blocks biosynthesis of chemical .	T10	T24	16547651
CPR:9	CHEMICAL	GENE-N	8	3	chemical inhibits chemical synthetase and blocks biosynthesis of chemical .	T11	T24	16547651
NA	CHEMICAL	GENE-N	0	8	chemical-tolerant crops have been commercialized based on these gene gene variants .	T12	T28	16547651
NA	CHEMICAL	GENE-N	13	1	A gene gene isolated from Ochrobactrum anthropi has also been employed to encode chemical oxidoreductase to detoxify chemical in plants .	T15	T31	16547651
NA	CHEMICAL	GENE-N	13	14	A gene gene isolated from Ochrobactrum anthropi has also been employed to encode chemical oxidoreductase to detoxify chemical in plants .	T15	T32	16547651
NA	CHEMICAL	GENE-N	17	1	A gene gene isolated from Ochrobactrum anthropi has also been employed to encode chemical oxidoreductase to detoxify chemical in plants .	T16	T31	16547651
NA	CHEMICAL	GENE-N	17	14	A gene gene isolated from Ochrobactrum anthropi has also been employed to encode chemical oxidoreductase to detoxify chemical in plants .	T16	T32	16547651
NA	CHEMICAL	GENE-N	0	3	chemical-tolerant crops with gene transgene alone or both gene and gene transgenes have been commercialized .	T17	T33	16547651
NA	CHEMICAL	GENE-N	0	8	chemical-tolerant crops with gene transgene alone or both gene and gene transgenes have been commercialized .	T17	T34	16547651
NA	CHEMICAL	GENE-N	0	10	chemical-tolerant crops with gene transgene alone or both gene and gene transgenes have been commercialized .	T17	T35	16547651
NA	CHEMICAL	GENE-Y	23	4	Similarly , gene and gene genes isolated from Streptomyces hygroscopicus and S. viridochromogenes , respectively , have been inserted into plants to encode chemical chemical-acetyltransferase to detoxify chemical .	T2	T37	16547651
NA	CHEMICAL	GENE-N	23	24	Similarly , gene and gene genes isolated from Streptomyces hygroscopicus and S. viridochromogenes , respectively , have been inserted into plants to encode chemical chemical-acetyltransferase to detoxify chemical .	T2	T20	16547651
NA	CHEMICAL	GENE-Y	2	4	Similarly , gene and gene genes isolated from Streptomyces hygroscopicus and S. viridochromogenes , respectively , have been inserted into plants to encode chemical chemical-acetyltransferase to detoxify chemical .	T3	T37	16547651
NA	CHEMICAL	GENE-N	2	24	Similarly , gene and gene genes isolated from Streptomyces hygroscopicus and S. viridochromogenes , respectively , have been inserted into plants to encode chemical chemical-acetyltransferase to detoxify chemical .	T3	T20	16547651
NA	CHEMICAL	GENE-Y	27	4	Similarly , gene and gene genes isolated from Streptomyces hygroscopicus and S. viridochromogenes , respectively , have been inserted into plants to encode chemical chemical-acetyltransferase to detoxify chemical .	T4	T37	16547651
NA	CHEMICAL	GENE-N	27	24	Similarly , gene and gene genes isolated from Streptomyces hygroscopicus and S. viridochromogenes , respectively , have been inserted into plants to encode chemical chemical-acetyltransferase to detoxify chemical .	T4	T20	16547651
NA	CHEMICAL	GENE-N	8	10	The therapeutic potential of allosteric ligands for free chemical sensitive gene .	T2	T9	23409763
NA	CHEMICAL	GENE-Y	2	27	An intermediate chemical was first synthesized by activating the chemical group of the 2nd and 8th chemical residues with three different chemical and two artificial complete antigens chemical-gene ( gene ) and chemical- gene ( gene ) were then prepared by cross-linking the intermediate with gene or gene .	T2	T10	23542578
NA	CHEMICAL	GENE-Y	2	29	An intermediate chemical was first synthesized by activating the chemical group of the 2nd and 8th chemical residues with three different chemical and two artificial complete antigens chemical-gene ( gene ) and chemical- gene ( gene ) were then prepared by cross-linking the intermediate with gene or gene .	T2	T11	23542578
NA	CHEMICAL	GENE-N	2	33	An intermediate chemical was first synthesized by activating the chemical group of the 2nd and 8th chemical residues with three different chemical and two artificial complete antigens chemical-gene ( gene ) and chemical- gene ( gene ) were then prepared by cross-linking the intermediate with gene or gene .	T2	T12	23542578
NA	CHEMICAL	GENE-N	2	35	An intermediate chemical was first synthesized by activating the chemical group of the 2nd and 8th chemical residues with three different chemical and two artificial complete antigens chemical-gene ( gene ) and chemical- gene ( gene ) were then prepared by cross-linking the intermediate with gene or gene .	T2	T13	23542578
NA	CHEMICAL	GENE-Y	2	45	An intermediate chemical was first synthesized by activating the chemical group of the 2nd and 8th chemical residues with three different chemical and two artificial complete antigens chemical-gene ( gene ) and chemical- gene ( gene ) were then prepared by cross-linking the intermediate with gene or gene .	T2	T14	23542578
NA	CHEMICAL	GENE-N	2	47	An intermediate chemical was first synthesized by activating the chemical group of the 2nd and 8th chemical residues with three different chemical and two artificial complete antigens chemical-gene ( gene ) and chemical- gene ( gene ) were then prepared by cross-linking the intermediate with gene or gene .	T2	T15	23542578
NA	CHEMICAL	GENE-Y	9	27	An intermediate chemical was first synthesized by activating the chemical group of the 2nd and 8th chemical residues with three different chemical and two artificial complete antigens chemical-gene ( gene ) and chemical- gene ( gene ) were then prepared by cross-linking the intermediate with gene or gene .	T3	T10	23542578
NA	CHEMICAL	GENE-Y	9	29	An intermediate chemical was first synthesized by activating the chemical group of the 2nd and 8th chemical residues with three different chemical and two artificial complete antigens chemical-gene ( gene ) and chemical- gene ( gene ) were then prepared by cross-linking the intermediate with gene or gene .	T3	T11	23542578
NA	CHEMICAL	GENE-N	9	33	An intermediate chemical was first synthesized by activating the chemical group of the 2nd and 8th chemical residues with three different chemical and two artificial complete antigens chemical-gene ( gene ) and chemical- gene ( gene ) were then prepared by cross-linking the intermediate with gene or gene .	T3	T12	23542578
NA	CHEMICAL	GENE-N	9	35	An intermediate chemical was first synthesized by activating the chemical group of the 2nd and 8th chemical residues with three different chemical and two artificial complete antigens chemical-gene ( gene ) and chemical- gene ( gene ) were then prepared by cross-linking the intermediate with gene or gene .	T3	T13	23542578
NA	CHEMICAL	GENE-Y	9	45	An intermediate chemical was first synthesized by activating the chemical group of the 2nd and 8th chemical residues with three different chemical and two artificial complete antigens chemical-gene ( gene ) and chemical- gene ( gene ) were then prepared by cross-linking the intermediate with gene or gene .	T3	T14	23542578
NA	CHEMICAL	GENE-N	9	47	An intermediate chemical was first synthesized by activating the chemical group of the 2nd and 8th chemical residues with three different chemical and two artificial complete antigens chemical-gene ( gene ) and chemical- gene ( gene ) were then prepared by cross-linking the intermediate with gene or gene .	T3	T15	23542578
NA	CHEMICAL	GENE-Y	16	27	An intermediate chemical was first synthesized by activating the chemical group of the 2nd and 8th chemical residues with three different chemical and two artificial complete antigens chemical-gene ( gene ) and chemical- gene ( gene ) were then prepared by cross-linking the intermediate with gene or gene .	T4	T10	23542578
NA	CHEMICAL	GENE-Y	16	29	An intermediate chemical was first synthesized by activating the chemical group of the 2nd and 8th chemical residues with three different chemical and two artificial complete antigens chemical-gene ( gene ) and chemical- gene ( gene ) were then prepared by cross-linking the intermediate with gene or gene .	T4	T11	23542578
NA	CHEMICAL	GENE-N	16	33	An intermediate chemical was first synthesized by activating the chemical group of the 2nd and 8th chemical residues with three different chemical and two artificial complete antigens chemical-gene ( gene ) and chemical- gene ( gene ) were then prepared by cross-linking the intermediate with gene or gene .	T4	T12	23542578
NA	CHEMICAL	GENE-N	16	35	An intermediate chemical was first synthesized by activating the chemical group of the 2nd and 8th chemical residues with three different chemical and two artificial complete antigens chemical-gene ( gene ) and chemical- gene ( gene ) were then prepared by cross-linking the intermediate with gene or gene .	T4	T13	23542578
NA	CHEMICAL	GENE-Y	16	45	An intermediate chemical was first synthesized by activating the chemical group of the 2nd and 8th chemical residues with three different chemical and two artificial complete antigens chemical-gene ( gene ) and chemical- gene ( gene ) were then prepared by cross-linking the intermediate with gene or gene .	T4	T14	23542578
NA	CHEMICAL	GENE-N	16	47	An intermediate chemical was first synthesized by activating the chemical group of the 2nd and 8th chemical residues with three different chemical and two artificial complete antigens chemical-gene ( gene ) and chemical- gene ( gene ) were then prepared by cross-linking the intermediate with gene or gene .	T4	T15	23542578
NA	CHEMICAL	GENE-Y	21	27	An intermediate chemical was first synthesized by activating the chemical group of the 2nd and 8th chemical residues with three different chemical and two artificial complete antigens chemical-gene ( gene ) and chemical- gene ( gene ) were then prepared by cross-linking the intermediate with gene or gene .	T5	T10	23542578
NA	CHEMICAL	GENE-Y	21	29	An intermediate chemical was first synthesized by activating the chemical group of the 2nd and 8th chemical residues with three different chemical and two artificial complete antigens chemical-gene ( gene ) and chemical- gene ( gene ) were then prepared by cross-linking the intermediate with gene or gene .	T5	T11	23542578
NA	CHEMICAL	GENE-N	21	33	An intermediate chemical was first synthesized by activating the chemical group of the 2nd and 8th chemical residues with three different chemical and two artificial complete antigens chemical-gene ( gene ) and chemical- gene ( gene ) were then prepared by cross-linking the intermediate with gene or gene .	T5	T12	23542578
NA	CHEMICAL	GENE-N	21	35	An intermediate chemical was first synthesized by activating the chemical group of the 2nd and 8th chemical residues with three different chemical and two artificial complete antigens chemical-gene ( gene ) and chemical- gene ( gene ) were then prepared by cross-linking the intermediate with gene or gene .	T5	T13	23542578
NA	CHEMICAL	GENE-Y	21	45	An intermediate chemical was first synthesized by activating the chemical group of the 2nd and 8th chemical residues with three different chemical and two artificial complete antigens chemical-gene ( gene ) and chemical- gene ( gene ) were then prepared by cross-linking the intermediate with gene or gene .	T5	T14	23542578
NA	CHEMICAL	GENE-N	21	47	An intermediate chemical was first synthesized by activating the chemical group of the 2nd and 8th chemical residues with three different chemical and two artificial complete antigens chemical-gene ( gene ) and chemical- gene ( gene ) were then prepared by cross-linking the intermediate with gene or gene .	T5	T15	23542578
NA	CHEMICAL	GENE-Y	27	27	An intermediate chemical was first synthesized by activating the chemical group of the 2nd and 8th chemical residues with three different chemical and two artificial complete antigens chemical-gene ( gene ) and chemical- gene ( gene ) were then prepared by cross-linking the intermediate with gene or gene .	T6	T10	23542578
NA	CHEMICAL	GENE-Y	27	29	An intermediate chemical was first synthesized by activating the chemical group of the 2nd and 8th chemical residues with three different chemical and two artificial complete antigens chemical-gene ( gene ) and chemical- gene ( gene ) were then prepared by cross-linking the intermediate with gene or gene .	T6	T11	23542578
NA	CHEMICAL	GENE-N	27	33	An intermediate chemical was first synthesized by activating the chemical group of the 2nd and 8th chemical residues with three different chemical and two artificial complete antigens chemical-gene ( gene ) and chemical- gene ( gene ) were then prepared by cross-linking the intermediate with gene or gene .	T6	T12	23542578
NA	CHEMICAL	GENE-N	27	35	An intermediate chemical was first synthesized by activating the chemical group of the 2nd and 8th chemical residues with three different chemical and two artificial complete antigens chemical-gene ( gene ) and chemical- gene ( gene ) were then prepared by cross-linking the intermediate with gene or gene .	T6	T13	23542578
NA	CHEMICAL	GENE-Y	27	45	An intermediate chemical was first synthesized by activating the chemical group of the 2nd and 8th chemical residues with three different chemical and two artificial complete antigens chemical-gene ( gene ) and chemical- gene ( gene ) were then prepared by cross-linking the intermediate with gene or gene .	T6	T14	23542578
NA	CHEMICAL	GENE-N	27	47	An intermediate chemical was first synthesized by activating the chemical group of the 2nd and 8th chemical residues with three different chemical and two artificial complete antigens chemical-gene ( gene ) and chemical- gene ( gene ) were then prepared by cross-linking the intermediate with gene or gene .	T6	T15	23542578
NA	CHEMICAL	GENE-Y	32	27	An intermediate chemical was first synthesized by activating the chemical group of the 2nd and 8th chemical residues with three different chemical and two artificial complete antigens chemical-gene ( gene ) and chemical- gene ( gene ) were then prepared by cross-linking the intermediate with gene or gene .	T7	T10	23542578
NA	CHEMICAL	GENE-Y	32	29	An intermediate chemical was first synthesized by activating the chemical group of the 2nd and 8th chemical residues with three different chemical and two artificial complete antigens chemical-gene ( gene ) and chemical- gene ( gene ) were then prepared by cross-linking the intermediate with gene or gene .	T7	T11	23542578
NA	CHEMICAL	GENE-N	32	33	An intermediate chemical was first synthesized by activating the chemical group of the 2nd and 8th chemical residues with three different chemical and two artificial complete antigens chemical-gene ( gene ) and chemical- gene ( gene ) were then prepared by cross-linking the intermediate with gene or gene .	T7	T12	23542578
NA	CHEMICAL	GENE-N	32	35	An intermediate chemical was first synthesized by activating the chemical group of the 2nd and 8th chemical residues with three different chemical and two artificial complete antigens chemical-gene ( gene ) and chemical- gene ( gene ) were then prepared by cross-linking the intermediate with gene or gene .	T7	T13	23542578
NA	CHEMICAL	GENE-Y	32	45	An intermediate chemical was first synthesized by activating the chemical group of the 2nd and 8th chemical residues with three different chemical and two artificial complete antigens chemical-gene ( gene ) and chemical- gene ( gene ) were then prepared by cross-linking the intermediate with gene or gene .	T7	T14	23542578
NA	CHEMICAL	GENE-N	32	47	An intermediate chemical was first synthesized by activating the chemical group of the 2nd and 8th chemical residues with three different chemical and two artificial complete antigens chemical-gene ( gene ) and chemical- gene ( gene ) were then prepared by cross-linking the intermediate with gene or gene .	T7	T15	23542578
NA	CHEMICAL	GENE-N	16	19	Short-term heating reduces the anti-inflammatory effects of fresh raw garlic extracts on the LPS-induced production of chemical and pro-inflammatory gene by downregulating chemical activity in RAW 264.7 macrophages .	T8	T19	23583806
NA	CHEMICAL	GENE-N	22	19	Short-term heating reduces the anti-inflammatory effects of fresh raw garlic extracts on the LPS-induced production of chemical and pro-inflammatory gene by downregulating chemical activity in RAW 264.7 macrophages .	T9	T19	23583806
NA	CHEMICAL	GENE-N	24	10	Treatment with FRGE and HRGE significantly reduced the LPS-induced increase in the pro-inflammatory gene concentration ( gene , gene , and gene ) and chemical through gene upregulation in RAW 264.7 macrophages .	T4	T12	23583806
NA	CHEMICAL	GENE-Y	24	16	Treatment with FRGE and HRGE significantly reduced the LPS-induced increase in the pro-inflammatory gene concentration ( gene , gene , and gene ) and chemical through gene upregulation in RAW 264.7 macrophages .	T4	T13	23583806
NA	CHEMICAL	GENE-Y	24	18	Treatment with FRGE and HRGE significantly reduced the LPS-induced increase in the pro-inflammatory gene concentration ( gene , gene , and gene ) and chemical through gene upregulation in RAW 264.7 macrophages .	T4	T14	23583806
NA	CHEMICAL	GENE-Y	24	21	Treatment with FRGE and HRGE significantly reduced the LPS-induced increase in the pro-inflammatory gene concentration ( gene , gene , and gene ) and chemical through gene upregulation in RAW 264.7 macrophages .	T4	T15	23583806
NA	CHEMICAL	GENE-Y	24	26	Treatment with FRGE and HRGE significantly reduced the LPS-induced increase in the pro-inflammatory gene concentration ( gene , gene , and gene ) and chemical through gene upregulation in RAW 264.7 macrophages .	T4	T16	23583806
CPR:4	CHEMICAL	GENE-N	0	7	chemical treatment showed reduced production of pro-inflammatory gene and chemical and increased gene activity .	T6	T17	23583806
CPR:3	CHEMICAL	GENE-Y	0	12	chemical treatment showed reduced production of pro-inflammatory gene and chemical and increased gene activity .	T6	T18	23583806
NA	CHEMICAL	GENE-N	9	7	chemical treatment showed reduced production of pro-inflammatory gene and chemical and increased gene activity .	T7	T17	23583806
NA	CHEMICAL	GENE-Y	9	12	chemical treatment showed reduced production of pro-inflammatory gene and chemical and increased gene activity .	T7	T18	23583806
NA	CHEMICAL	GENE-N	8	6	The results show that the decrease in LPS-induced chemical and pro-inflammatory gene in RAW 264.7 macrophages through gene induction was greater for FRGE compared with HRGE .	T1	T10	23583806
NA	CHEMICAL	GENE-Y	8	17	The results show that the decrease in LPS-induced chemical and pro-inflammatory gene in RAW 264.7 macrophages through gene induction was greater for FRGE compared with HRGE .	T1	T11	23583806
NA	CHEMICAL	GENE-N	1	15	A chemical residue in place of the catalytic chemical or chemical residues found in other gene was shown to form a mixed chemical with chemical .	T6	T29	16399380
NA	CHEMICAL	GENE-N	3	15	A chemical residue in place of the catalytic chemical or chemical residues found in other gene was shown to form a mixed chemical with chemical .	T7	T29	16399380
NA	CHEMICAL	GENE-N	3	15	A chemical residue in place of the catalytic chemical or chemical residues found in other gene was shown to form a mixed chemical with chemical .	T8	T29	16399380
NA	CHEMICAL	GENE-N	22	15	A chemical residue in place of the catalytic chemical or chemical residues found in other gene was shown to form a mixed chemical with chemical .	T9	T29	16399380
NA	CHEMICAL	GENE-N	20	15	A chemical residue in place of the catalytic chemical or chemical residues found in other gene was shown to form a mixed chemical with chemical .	T1	T29	16399380
CPR:9	CHEMICAL	GENE-N	12	0	gene have gene and gene activities and also catalyze the reduction of chemical , an intermediate in the pathway of chemical biotransformation .	T2	T11	16399380
NA	CHEMICAL	GENE-N	12	2	gene have gene and gene activities and also catalyze the reduction of chemical , an intermediate in the pathway of chemical biotransformation .	T2	T12	16399380
NA	CHEMICAL	GENE-N	12	4	gene have gene and gene activities and also catalyze the reduction of chemical , an intermediate in the pathway of chemical biotransformation .	T2	T13	16399380
NA	CHEMICAL	GENE-N	20	0	gene have gene and gene activities and also catalyze the reduction of chemical , an intermediate in the pathway of chemical biotransformation .	T3	T11	16399380
NA	CHEMICAL	GENE-N	20	2	gene have gene and gene activities and also catalyze the reduction of chemical , an intermediate in the pathway of chemical biotransformation .	T3	T12	16399380
NA	CHEMICAL	GENE-N	20	4	gene have gene and gene activities and also catalyze the reduction of chemical , an intermediate in the pathway of chemical biotransformation .	T3	T13	16399380
NA	CHEMICAL	GENE-Y	8	4	Other diverse actions of gene include modulation of chemical receptors and interaction with gene release inhibitory drugs .	T4	T14	16399380
NA	CHEMICAL	GENE-N	8	9	Other diverse actions of gene include modulation of chemical receptors and interaction with gene release inhibitory drugs .	T4	T15	16399380
NA	CHEMICAL	GENE-N	8	13	Other diverse actions of gene include modulation of chemical receptors and interaction with gene release inhibitory drugs .	T4	T16	16399380
NA	CHEMICAL	GENE-Y	3	2	Role of gene in uptake of chemical and inhibitory effect on gene respiration in mitochondria .	T16	T28	23221006
NA	CHEMICAL	GENE-N	3	11	Role of gene in uptake of chemical and inhibitory effect on gene respiration in mitochondria .	T16	T29	23221006
CPR:9	CHEMICAL	GENE-Y	3	2	Role of gene in uptake of chemical and inhibitory effect on gene respiration in mitochondria .	T17	T28	23221006
CPR:4	CHEMICAL	GENE-N	3	11	Role of gene in uptake of chemical and inhibitory effect on gene respiration in mitochondria .	T17	T29	23221006
CPR:4	CHEMICAL	GENE-N	0	11	chemical causes lactic acidosis in clinical situations due to inhibition of gene . It is reportedly taken up by hepatocytes and exhibits mitochondrial toxicity in the liver .	T1	T27	23221006
NA	CHEMICAL	GENE-N	6	13	In this study , uptake of chemical and chemical ( chemical ) and gene inhibition by chemical were examined in isolated liver and heart mitochondria .	T6	T24	23221006
NA	CHEMICAL	GENE-N	8	13	In this study , uptake of chemical and chemical ( chemical ) and gene inhibition by chemical were examined in isolated liver and heart mitochondria .	T7	T24	23221006
NA	CHEMICAL	GENE-N	10	13	In this study , uptake of chemical and chemical ( chemical ) and gene inhibition by chemical were examined in isolated liver and heart mitochondria .	T8	T24	23221006
CPR:4	CHEMICAL	GENE-N	16	13	In this study , uptake of chemical and chemical ( chemical ) and gene inhibition by chemical were examined in isolated liver and heart mitochondria .	T9	T24	23221006
NA	CHEMICAL	GENE-Y	8	18	Similar characteristics were also observed for uptake of chemical ; however , uptake of chemical into mitochondria of gene ( gene ) knockout mice was lower than that in wild-type mice , whereas uptake of chemical was comparable between the two strains , suggesting the involvement of distinct transport mechanisms for these two cations in mitochondria .	T11	T25	23221006
NA	CHEMICAL	GENE-Y	8	20	Similar characteristics were also observed for uptake of chemical ; however , uptake of chemical into mitochondria of gene ( gene ) knockout mice was lower than that in wild-type mice , whereas uptake of chemical was comparable between the two strains , suggesting the involvement of distinct transport mechanisms for these two cations in mitochondria .	T11	T26	23221006
NA	CHEMICAL	GENE-Y	5	18	Similar characteristics were also observed for uptake of chemical ; however , uptake of chemical into mitochondria of gene ( gene ) knockout mice was lower than that in wild-type mice , whereas uptake of chemical was comparable between the two strains , suggesting the involvement of distinct transport mechanisms for these two cations in mitochondria .	T12	T25	23221006
NA	CHEMICAL	GENE-Y	5	20	Similar characteristics were also observed for uptake of chemical ; however , uptake of chemical into mitochondria of gene ( gene ) knockout mice was lower than that in wild-type mice , whereas uptake of chemical was comparable between the two strains , suggesting the involvement of distinct transport mechanisms for these two cations in mitochondria .	T12	T26	23221006
NA	CHEMICAL	GENE-Y	28	18	Similar characteristics were also observed for uptake of chemical ; however , uptake of chemical into mitochondria of gene ( gene ) knockout mice was lower than that in wild-type mice , whereas uptake of chemical was comparable between the two strains , suggesting the involvement of distinct transport mechanisms for these two cations in mitochondria .	T13	T25	23221006
NA	CHEMICAL	GENE-Y	28	20	Similar characteristics were also observed for uptake of chemical ; however , uptake of chemical into mitochondria of gene ( gene ) knockout mice was lower than that in wild-type mice , whereas uptake of chemical was comparable between the two strains , suggesting the involvement of distinct transport mechanisms for these two cations in mitochondria .	T13	T26	23221006
NA	CHEMICAL	GENE-Y	35	18	Similar characteristics were also observed for uptake of chemical ; however , uptake of chemical into mitochondria of gene ( gene ) knockout mice was lower than that in wild-type mice , whereas uptake of chemical was comparable between the two strains , suggesting the involvement of distinct transport mechanisms for these two cations in mitochondria .	T14	T25	23221006
NA	CHEMICAL	GENE-Y	35	20	Similar characteristics were also observed for uptake of chemical ; however , uptake of chemical into mitochondria of gene ( gene ) knockout mice was lower than that in wild-type mice , whereas uptake of chemical was comparable between the two strains , suggesting the involvement of distinct transport mechanisms for these two cations in mitochondria .	T14	T26	23221006
CPR:4	CHEMICAL	GENE-N	2	7	Inhibition by chemical of chemical consumption via gene respiration in isolated rat liver mitochondria was greater than that in heart mitochondria , whereas inhibitory effect of chemical on gene respiration was similar in inside-out structured submitochondrial particles prepared from rat livers and hearts .	T15	T18	23221006
NA	CHEMICAL	GENE-N	2	28	Inhibition by chemical of chemical consumption via gene respiration in isolated rat liver mitochondria was greater than that in heart mitochondria , whereas inhibitory effect of chemical on gene respiration was similar in inside-out structured submitochondrial particles prepared from rat livers and hearts .	T15	T19	23221006
NA	CHEMICAL	GENE-N	4	7	Inhibition by chemical of chemical consumption via gene respiration in isolated rat liver mitochondria was greater than that in heart mitochondria , whereas inhibitory effect of chemical on gene respiration was similar in inside-out structured submitochondrial particles prepared from rat livers and hearts .	T2	T18	23221006
NA	CHEMICAL	GENE-N	4	28	Inhibition by chemical of chemical consumption via gene respiration in isolated rat liver mitochondria was greater than that in heart mitochondria , whereas inhibitory effect of chemical on gene respiration was similar in inside-out structured submitochondrial particles prepared from rat livers and hearts .	T2	T19	23221006
NA	CHEMICAL	GENE-N	9	7	Inhibition by chemical of chemical consumption via gene respiration in isolated rat liver mitochondria was greater than that in heart mitochondria , whereas inhibitory effect of chemical on gene respiration was similar in inside-out structured submitochondrial particles prepared from rat livers and hearts .	T3	T18	23221006
CPR:4	CHEMICAL	GENE-N	9	28	Inhibition by chemical of chemical consumption via gene respiration in isolated rat liver mitochondria was greater than that in heart mitochondria , whereas inhibitory effect of chemical on gene respiration was similar in inside-out structured submitochondrial particles prepared from rat livers and hearts .	T3	T19	23221006
NA	CHEMICAL	GENE-Y	7	11	Lactic acidosis provoked by iv infusion of chemical was weaker in gene ( -/- ) mice than that in wild-type mice .	T4	T20	23221006
CPR:9	CHEMICAL	GENE-Y	6	16	These observations suggest that uptake of chemical into liver mitochondria is at least partly mediated by gene and functionally relevant to its inhibition potential of gene respiration .	T5	T21	23221006
CPR:4	CHEMICAL	GENE-N	6	25	These observations suggest that uptake of chemical into liver mitochondria is at least partly mediated by gene and functionally relevant to its inhibition potential of gene respiration .	T5	T22	23221006
NA	CHEMICAL	GENE-N	6	6	Transcription factors , such as the gene ( gene ) , regulate both chemical and chemical metabolism in several tissues including the nervous system .	T1	T10	23609963
NA	CHEMICAL	GENE-N	6	8	Transcription factors , such as the gene ( gene ) , regulate both chemical and chemical metabolism in several tissues including the nervous system .	T1	T11	23609963
NA	CHEMICAL	GENE-N	15	6	Transcription factors , such as the gene ( gene ) , regulate both chemical and chemical metabolism in several tissues including the nervous system .	T2	T10	23609963
NA	CHEMICAL	GENE-N	15	8	Transcription factors , such as the gene ( gene ) , regulate both chemical and chemical metabolism in several tissues including the nervous system .	T2	T11	23609963
NA	CHEMICAL	GENE-Y	3	22	Excessive level of chemical is considered as a main cause of breast cancer , therefore , many studies have focused on chemical receptor ( gene ) -positive breast cancer , even though gene-negative cancer has a poor prognosis than gene-positive breast cancer .	T2	T6	23335025
NA	CHEMICAL	GENE-Y	3	24	Excessive level of chemical is considered as a main cause of breast cancer , therefore , many studies have focused on chemical receptor ( gene ) -positive breast cancer , even though gene-negative cancer has a poor prognosis than gene-positive breast cancer .	T2	T7	23335025
NA	CHEMICAL	GENE-Y	3	32	Excessive level of chemical is considered as a main cause of breast cancer , therefore , many studies have focused on chemical receptor ( gene ) -positive breast cancer , even though gene-negative cancer has a poor prognosis than gene-positive breast cancer .	T2	T8	23335025
NA	CHEMICAL	GENE-Y	3	39	Excessive level of chemical is considered as a main cause of breast cancer , therefore , many studies have focused on chemical receptor ( gene ) -positive breast cancer , even though gene-negative cancer has a poor prognosis than gene-positive breast cancer .	T2	T9	23335025
NA	CHEMICAL	GENE-Y	21	22	Excessive level of chemical is considered as a main cause of breast cancer , therefore , many studies have focused on chemical receptor ( gene ) -positive breast cancer , even though gene-negative cancer has a poor prognosis than gene-positive breast cancer .	T1	T6	23335025
NA	CHEMICAL	GENE-Y	21	24	Excessive level of chemical is considered as a main cause of breast cancer , therefore , many studies have focused on chemical receptor ( gene ) -positive breast cancer , even though gene-negative cancer has a poor prognosis than gene-positive breast cancer .	T1	T7	23335025
NA	CHEMICAL	GENE-Y	21	32	Excessive level of chemical is considered as a main cause of breast cancer , therefore , many studies have focused on chemical receptor ( gene ) -positive breast cancer , even though gene-negative cancer has a poor prognosis than gene-positive breast cancer .	T1	T8	23335025
NA	CHEMICAL	GENE-Y	21	39	Excessive level of chemical is considered as a main cause of breast cancer , therefore , many studies have focused on chemical receptor ( gene ) -positive breast cancer , even though gene-negative cancer has a poor prognosis than gene-positive breast cancer .	T1	T9	23335025
NA	CHEMICAL	GENE-Y	25	10	In this regard , we evaluate here the efficacy of gene as it relates to the activation of gene , by comparing gene with the chemical ( 1A ) ( chemical ( 1A ) ) receptor , a quintessential gene .	T3	T24	23292797
NA	CHEMICAL	GENE-N	25	18	In this regard , we evaluate here the efficacy of gene as it relates to the activation of gene , by comparing gene with the chemical ( 1A ) ( chemical ( 1A ) ) receptor , a quintessential gene .	T3	T25	23292797
NA	CHEMICAL	GENE-Y	25	22	In this regard , we evaluate here the efficacy of gene as it relates to the activation of gene , by comparing gene with the chemical ( 1A ) ( chemical ( 1A ) ) receptor , a quintessential gene .	T3	T26	23292797
NA	CHEMICAL	GENE-Y	25	26	In this regard , we evaluate here the efficacy of gene as it relates to the activation of gene , by comparing gene with the chemical ( 1A ) ( chemical ( 1A ) ) receptor , a quintessential gene .	T3	T27	23292797
NA	CHEMICAL	GENE-Y	25	26	In this regard , we evaluate here the efficacy of gene as it relates to the activation of gene , by comparing gene with the chemical ( 1A ) ( chemical ( 1A ) ) receptor , a quintessential gene .	T3	T28	23292797
NA	CHEMICAL	GENE-N	25	14	In this regard , we evaluate here the efficacy of gene as it relates to the activation of gene , by comparing gene with the chemical ( 1A ) ( chemical ( 1A ) ) receptor , a quintessential gene .	T3	T29	23292797
NA	CHEMICAL	GENE-Y	30	10	In this regard , we evaluate here the efficacy of gene as it relates to the activation of gene , by comparing gene with the chemical ( 1A ) ( chemical ( 1A ) ) receptor , a quintessential gene .	T4	T24	23292797
NA	CHEMICAL	GENE-N	30	18	In this regard , we evaluate here the efficacy of gene as it relates to the activation of gene , by comparing gene with the chemical ( 1A ) ( chemical ( 1A ) ) receptor , a quintessential gene .	T4	T25	23292797
NA	CHEMICAL	GENE-Y	30	22	In this regard , we evaluate here the efficacy of gene as it relates to the activation of gene , by comparing gene with the chemical ( 1A ) ( chemical ( 1A ) ) receptor , a quintessential gene .	T4	T26	23292797
NA	CHEMICAL	GENE-Y	30	26	In this regard , we evaluate here the efficacy of gene as it relates to the activation of gene , by comparing gene with the chemical ( 1A ) ( chemical ( 1A ) ) receptor , a quintessential gene .	T4	T27	23292797
NA	CHEMICAL	GENE-Y	30	26	In this regard , we evaluate here the efficacy of gene as it relates to the activation of gene , by comparing gene with the chemical ( 1A ) ( chemical ( 1A ) ) receptor , a quintessential gene .	T4	T28	23292797
NA	CHEMICAL	GENE-N	30	14	In this regard , we evaluate here the efficacy of gene as it relates to the activation of gene , by comparing gene with the chemical ( 1A ) ( chemical ( 1A ) ) receptor , a quintessential gene .	T4	T29	23292797
NA	CHEMICAL	GENE-N	6	13	We find that with use of chemical , first , with forms of gene endogenous to human embryonic kidney ( HEK ) -293 cells made to express epitope-tagged receptors and , second , with individual forms of gene fused to the C terminus of each receptor , gene is equivalent to the chemical ( 1A ) receptor in the assay as it relates to capacity to activate gene .	T5	T30	23292797
NA	CHEMICAL	GENE-N	6	19	We find that with use of chemical , first , with forms of gene endogenous to human embryonic kidney ( HEK ) -293 cells made to express epitope-tagged receptors and , second , with individual forms of gene fused to the C terminus of each receptor , gene is equivalent to the chemical ( 1A ) receptor in the assay as it relates to capacity to activate gene .	T5	T32	23292797
NA	CHEMICAL	GENE-Y	6	47	We find that with use of chemical , first , with forms of gene endogenous to human embryonic kidney ( HEK ) -293 cells made to express epitope-tagged receptors and , second , with individual forms of gene fused to the C terminus of each receptor , gene is equivalent to the chemical ( 1A ) receptor in the assay as it relates to capacity to activate gene .	T5	T33	23292797
NA	CHEMICAL	GENE-Y	6	19	We find that with use of chemical , first , with forms of gene endogenous to human embryonic kidney ( HEK ) -293 cells made to express epitope-tagged receptors and , second , with individual forms of gene fused to the C terminus of each receptor , gene is equivalent to the chemical ( 1A ) receptor in the assay as it relates to capacity to activate gene .	T5	T34	23292797
NA	CHEMICAL	GENE-N	6	19	We find that with use of chemical , first , with forms of gene endogenous to human embryonic kidney ( HEK ) -293 cells made to express epitope-tagged receptors and , second , with individual forms of gene fused to the C terminus of each receptor , gene is equivalent to the chemical ( 1A ) receptor in the assay as it relates to capacity to activate gene .	T5	T35	23292797
NA	CHEMICAL	GENE-N	52	13	We find that with use of chemical , first , with forms of gene endogenous to human embryonic kidney ( HEK ) -293 cells made to express epitope-tagged receptors and , second , with individual forms of gene fused to the C terminus of each receptor , gene is equivalent to the chemical ( 1A ) receptor in the assay as it relates to capacity to activate gene .	T6	T30	23292797
NA	CHEMICAL	GENE-N	52	19	We find that with use of chemical , first , with forms of gene endogenous to human embryonic kidney ( HEK ) -293 cells made to express epitope-tagged receptors and , second , with individual forms of gene fused to the C terminus of each receptor , gene is equivalent to the chemical ( 1A ) receptor in the assay as it relates to capacity to activate gene .	T6	T32	23292797
NA	CHEMICAL	GENE-Y	52	47	We find that with use of chemical , first , with forms of gene endogenous to human embryonic kidney ( HEK ) -293 cells made to express epitope-tagged receptors and , second , with individual forms of gene fused to the C terminus of each receptor , gene is equivalent to the chemical ( 1A ) receptor in the assay as it relates to capacity to activate gene .	T6	T33	23292797
NA	CHEMICAL	GENE-Y	52	19	We find that with use of chemical , first , with forms of gene endogenous to human embryonic kidney ( HEK ) -293 cells made to express epitope-tagged receptors and , second , with individual forms of gene fused to the C terminus of each receptor , gene is equivalent to the chemical ( 1A ) receptor in the assay as it relates to capacity to activate gene .	T6	T34	23292797
NA	CHEMICAL	GENE-N	52	19	We find that with use of chemical , first , with forms of gene endogenous to human embryonic kidney ( HEK ) -293 cells made to express epitope-tagged receptors and , second , with individual forms of gene fused to the C terminus of each receptor , gene is equivalent to the chemical ( 1A ) receptor in the assay as it relates to capacity to activate gene .	T6	T35	23292797
NA	CHEMICAL	GENE-Y	4	4	We also find that gene endogenous to HEK-293 cells , ostensibly through inhibition of chemical cyclase , decreases intracellular levels of chemical .	T1	T13	23292797
NA	CHEMICAL	GENE-N	4	15	We also find that gene endogenous to HEK-293 cells , ostensibly through inhibition of chemical cyclase , decreases intracellular levels of chemical .	T1	T14	23292797
NA	CHEMICAL	GENE-Y	21	4	We also find that gene endogenous to HEK-293 cells , ostensibly through inhibition of chemical cyclase , decreases intracellular levels of chemical .	T2	T13	23292797
NA	CHEMICAL	GENE-N	21	15	We also find that gene endogenous to HEK-293 cells , ostensibly through inhibition of chemical cyclase , decreases intracellular levels of chemical .	T2	T14	23292797
NA	CHEMICAL	GENE-Y	3	7	Contrasting effects of chemical derivatives on chemical hydroxylase , chemical reductase and chemical synthase .	T44	T64	10839989
NA	CHEMICAL	GENE-Y	3	10	Contrasting effects of chemical derivatives on chemical hydroxylase , chemical reductase and chemical synthase .	T44	T62	10839989
NA	CHEMICAL	GENE-N	3	13	Contrasting effects of chemical derivatives on chemical hydroxylase , chemical reductase and chemical synthase .	T44	T63	10839989
NA	CHEMICAL	GENE-Y	6	7	Contrasting effects of chemical derivatives on chemical hydroxylase , chemical reductase and chemical synthase .	T45	T64	10839989
NA	CHEMICAL	GENE-Y	6	10	Contrasting effects of chemical derivatives on chemical hydroxylase , chemical reductase and chemical synthase .	T45	T62	10839989
NA	CHEMICAL	GENE-N	6	13	Contrasting effects of chemical derivatives on chemical hydroxylase , chemical reductase and chemical synthase .	T45	T63	10839989
NA	CHEMICAL	GENE-Y	9	7	Contrasting effects of chemical derivatives on chemical hydroxylase , chemical reductase and chemical synthase .	T42	T64	10839989
NA	CHEMICAL	GENE-Y	9	10	Contrasting effects of chemical derivatives on chemical hydroxylase , chemical reductase and chemical synthase .	T42	T62	10839989
NA	CHEMICAL	GENE-N	9	13	Contrasting effects of chemical derivatives on chemical hydroxylase , chemical reductase and chemical synthase .	T42	T63	10839989
NA	CHEMICAL	GENE-Y	12	7	Contrasting effects of chemical derivatives on chemical hydroxylase , chemical reductase and chemical synthase .	T43	T64	10839989
NA	CHEMICAL	GENE-Y	12	10	Contrasting effects of chemical derivatives on chemical hydroxylase , chemical reductase and chemical synthase .	T43	T62	10839989
NA	CHEMICAL	GENE-N	12	13	Contrasting effects of chemical derivatives on chemical hydroxylase , chemical reductase and chemical synthase .	T43	T63	10839989
NA	CHEMICAL	GENE-N	0	13	chemical [ chemical , chemical ] is one of several cofactors of chemical synthases ( gene ) .	T1	T46	10839989
NA	CHEMICAL	GENE-Y	0	15	chemical [ chemical , chemical ] is one of several cofactors of chemical synthases ( gene ) .	T1	T47	10839989
NA	CHEMICAL	GENE-N	2	13	chemical [ chemical , chemical ] is one of several cofactors of chemical synthases ( gene ) .	T22	T46	10839989
NA	CHEMICAL	GENE-Y	2	15	chemical [ chemical , chemical ] is one of several cofactors of chemical synthases ( gene ) .	T22	T47	10839989
NA	CHEMICAL	GENE-N	4	13	chemical [ chemical , chemical ] is one of several cofactors of chemical synthases ( gene ) .	T34	T46	10839989
NA	CHEMICAL	GENE-Y	4	15	chemical [ chemical , chemical ] is one of several cofactors of chemical synthases ( gene ) .	T34	T47	10839989
NA	CHEMICAL	GENE-N	2	13	chemical [ chemical , chemical ] is one of several cofactors of chemical synthases ( gene ) .	T2	T46	10839989
NA	CHEMICAL	GENE-Y	2	15	chemical [ chemical , chemical ] is one of several cofactors of chemical synthases ( gene ) .	T2	T47	10839989
NA	CHEMICAL	GENE-Y	6	10	Here we compared the action of chemical-substituted derivatives on recombinant gene with their effects on chemical reductase ( gene ) and chemical hydroxylase ( gene ) , the well-studied classical chemical-dependent reactions .	T19	T54	10839989
NA	CHEMICAL	GENE-Y	6	16	Here we compared the action of chemical-substituted derivatives on recombinant gene with their effects on chemical reductase ( gene ) and chemical hydroxylase ( gene ) , the well-studied classical chemical-dependent reactions .	T19	T55	10839989
NA	CHEMICAL	GENE-Y	6	18	Here we compared the action of chemical-substituted derivatives on recombinant gene with their effects on chemical reductase ( gene ) and chemical hydroxylase ( gene ) , the well-studied classical chemical-dependent reactions .	T19	T56	10839989
NA	CHEMICAL	GENE-Y	6	22	Here we compared the action of chemical-substituted derivatives on recombinant gene with their effects on chemical reductase ( gene ) and chemical hydroxylase ( gene ) , the well-studied classical chemical-dependent reactions .	T19	T57	10839989
NA	CHEMICAL	GENE-Y	6	24	Here we compared the action of chemical-substituted derivatives on recombinant gene with their effects on chemical reductase ( gene ) and chemical hydroxylase ( gene ) , the well-studied classical chemical-dependent reactions .	T19	T58	10839989
NA	CHEMICAL	GENE-Y	15	10	Here we compared the action of chemical-substituted derivatives on recombinant gene with their effects on chemical reductase ( gene ) and chemical hydroxylase ( gene ) , the well-studied classical chemical-dependent reactions .	T24	T54	10839989
NA	CHEMICAL	GENE-Y	15	16	Here we compared the action of chemical-substituted derivatives on recombinant gene with their effects on chemical reductase ( gene ) and chemical hydroxylase ( gene ) , the well-studied classical chemical-dependent reactions .	T24	T55	10839989
NA	CHEMICAL	GENE-Y	15	18	Here we compared the action of chemical-substituted derivatives on recombinant gene with their effects on chemical reductase ( gene ) and chemical hydroxylase ( gene ) , the well-studied classical chemical-dependent reactions .	T24	T56	10839989
NA	CHEMICAL	GENE-Y	15	22	Here we compared the action of chemical-substituted derivatives on recombinant gene with their effects on chemical reductase ( gene ) and chemical hydroxylase ( gene ) , the well-studied classical chemical-dependent reactions .	T24	T57	10839989
NA	CHEMICAL	GENE-Y	15	24	Here we compared the action of chemical-substituted derivatives on recombinant gene with their effects on chemical reductase ( gene ) and chemical hydroxylase ( gene ) , the well-studied classical chemical-dependent reactions .	T24	T58	10839989
NA	CHEMICAL	GENE-Y	21	10	Here we compared the action of chemical-substituted derivatives on recombinant gene with their effects on chemical reductase ( gene ) and chemical hydroxylase ( gene ) , the well-studied classical chemical-dependent reactions .	T25	T54	10839989
NA	CHEMICAL	GENE-Y	21	16	Here we compared the action of chemical-substituted derivatives on recombinant gene with their effects on chemical reductase ( gene ) and chemical hydroxylase ( gene ) , the well-studied classical chemical-dependent reactions .	T25	T55	10839989
NA	CHEMICAL	GENE-Y	21	18	Here we compared the action of chemical-substituted derivatives on recombinant gene with their effects on chemical reductase ( gene ) and chemical hydroxylase ( gene ) , the well-studied classical chemical-dependent reactions .	T25	T56	10839989
NA	CHEMICAL	GENE-Y	21	22	Here we compared the action of chemical-substituted derivatives on recombinant gene with their effects on chemical reductase ( gene ) and chemical hydroxylase ( gene ) , the well-studied classical chemical-dependent reactions .	T25	T57	10839989
NA	CHEMICAL	GENE-Y	21	24	Here we compared the action of chemical-substituted derivatives on recombinant gene with their effects on chemical reductase ( gene ) and chemical hydroxylase ( gene ) , the well-studied classical chemical-dependent reactions .	T25	T58	10839989
NA	CHEMICAL	GENE-Y	17	10	Here we compared the action of chemical-substituted derivatives on recombinant gene with their effects on chemical reductase ( gene ) and chemical hydroxylase ( gene ) , the well-studied classical chemical-dependent reactions .	T26	T54	10839989
NA	CHEMICAL	GENE-Y	17	16	Here we compared the action of chemical-substituted derivatives on recombinant gene with their effects on chemical reductase ( gene ) and chemical hydroxylase ( gene ) , the well-studied classical chemical-dependent reactions .	T26	T55	10839989
NA	CHEMICAL	GENE-Y	17	18	Here we compared the action of chemical-substituted derivatives on recombinant gene with their effects on chemical reductase ( gene ) and chemical hydroxylase ( gene ) , the well-studied classical chemical-dependent reactions .	T26	T56	10839989
NA	CHEMICAL	GENE-Y	17	22	Here we compared the action of chemical-substituted derivatives on recombinant gene with their effects on chemical reductase ( gene ) and chemical hydroxylase ( gene ) , the well-studied classical chemical-dependent reactions .	T26	T57	10839989
NA	CHEMICAL	GENE-Y	17	24	Here we compared the action of chemical-substituted derivatives on recombinant gene with their effects on chemical reductase ( gene ) and chemical hydroxylase ( gene ) , the well-studied classical chemical-dependent reactions .	T26	T58	10839989
NA	CHEMICAL	GENE-Y	2	5	Substitution at chemical occurs at a position critical to the redox cycle of the cofactor in chemical hydroxylase/chemical reductase .	T33	T59	10839989
NA	CHEMICAL	GENE-Y	2	5	Substitution at chemical occurs at a position critical to the redox cycle of the cofactor in chemical hydroxylase/chemical reductase .	T33	T60	10839989
NA	CHEMICAL	GENE-Y	5	5	Substitution at chemical occurs at a position critical to the redox cycle of the cofactor in chemical hydroxylase/chemical reductase .	T35	T59	10839989
NA	CHEMICAL	GENE-Y	5	5	Substitution at chemical occurs at a position critical to the redox cycle of the cofactor in chemical hydroxylase/chemical reductase .	T35	T60	10839989
NA	CHEMICAL	GENE-Y	15	5	Substitution at chemical occurs at a position critical to the redox cycle of the cofactor in chemical hydroxylase/chemical reductase .	T36	T59	10839989
NA	CHEMICAL	GENE-Y	15	5	Substitution at chemical occurs at a position critical to the redox cycle of the cofactor in chemical hydroxylase/chemical reductase .	T36	T60	10839989
NA	CHEMICAL	GENE-N	3	14	As compared with chemical , chemical bound with twice the capacity but stimulated chemical synthase to a lesser extent .	T38	T61	10839989
NA	CHEMICAL	GENE-N	5	14	As compared with chemical , chemical bound with twice the capacity but stimulated chemical synthase to a lesser extent .	T39	T61	10839989
NA	CHEMICAL	GENE-N	13	14	As compared with chemical , chemical bound with twice the capacity but stimulated chemical synthase to a lesser extent .	T40	T61	10839989
CPR:9	CHEMICAL	GENE-Y	0	8	chemical derivatives were not oxidized to products serving as substrates for chemical reductase and , depending on the substituent , were competitive inhibitors of chemical hydroxylase : chemical- and chemical inhibited gene , whereas chemical- and chemical had no effect .	T8	T48	10839989
NA	CHEMICAL	GENE-Y	0	8	chemical derivatives were not oxidized to products serving as substrates for chemical reductase and , depending on the substituent , were competitive inhibitors of chemical hydroxylase : chemical- and chemical inhibited gene , whereas chemical- and chemical had no effect .	T8	T49	10839989
NA	CHEMICAL	GENE-Y	0	8	chemical derivatives were not oxidized to products serving as substrates for chemical reductase and , depending on the substituent , were competitive inhibitors of chemical hydroxylase : chemical- and chemical inhibited gene , whereas chemical- and chemical had no effect .	T8	T50	10839989
NA	CHEMICAL	GENE-Y	11	8	chemical derivatives were not oxidized to products serving as substrates for chemical reductase and , depending on the substituent , were competitive inhibitors of chemical hydroxylase : chemical- and chemical inhibited gene , whereas chemical- and chemical had no effect .	T9	T48	10839989
NA	CHEMICAL	GENE-Y	11	8	chemical derivatives were not oxidized to products serving as substrates for chemical reductase and , depending on the substituent , were competitive inhibitors of chemical hydroxylase : chemical- and chemical inhibited gene , whereas chemical- and chemical had no effect .	T9	T49	10839989
NA	CHEMICAL	GENE-Y	11	8	chemical derivatives were not oxidized to products serving as substrates for chemical reductase and , depending on the substituent , were competitive inhibitors of chemical hydroxylase : chemical- and chemical inhibited gene , whereas chemical- and chemical had no effect .	T9	T50	10839989
NA	CHEMICAL	GENE-Y	24	8	chemical derivatives were not oxidized to products serving as substrates for chemical reductase and , depending on the substituent , were competitive inhibitors of chemical hydroxylase : chemical- and chemical inhibited gene , whereas chemical- and chemical had no effect .	T10	T48	10839989
NA	CHEMICAL	GENE-Y	24	8	chemical derivatives were not oxidized to products serving as substrates for chemical reductase and , depending on the substituent , were competitive inhibitors of chemical hydroxylase : chemical- and chemical inhibited gene , whereas chemical- and chemical had no effect .	T10	T49	10839989
NA	CHEMICAL	GENE-Y	24	8	chemical derivatives were not oxidized to products serving as substrates for chemical reductase and , depending on the substituent , were competitive inhibitors of chemical hydroxylase : chemical- and chemical inhibited gene , whereas chemical- and chemical had no effect .	T10	T50	10839989
NA	CHEMICAL	GENE-Y	27	8	chemical derivatives were not oxidized to products serving as substrates for chemical reductase and , depending on the substituent , were competitive inhibitors of chemical hydroxylase : chemical- and chemical inhibited gene , whereas chemical- and chemical had no effect .	T11	T48	10839989
NA	CHEMICAL	GENE-Y	27	8	chemical derivatives were not oxidized to products serving as substrates for chemical reductase and , depending on the substituent , were competitive inhibitors of chemical hydroxylase : chemical- and chemical inhibited gene , whereas chemical- and chemical had no effect .	T11	T49	10839989
CPR:4	CHEMICAL	GENE-Y	27	8	chemical derivatives were not oxidized to products serving as substrates for chemical reductase and , depending on the substituent , were competitive inhibitors of chemical hydroxylase : chemical- and chemical inhibited gene , whereas chemical- and chemical had no effect .	T11	T50	10839989
NA	CHEMICAL	GENE-Y	29	8	chemical derivatives were not oxidized to products serving as substrates for chemical reductase and , depending on the substituent , were competitive inhibitors of chemical hydroxylase : chemical- and chemical inhibited gene , whereas chemical- and chemical had no effect .	T12	T48	10839989
NA	CHEMICAL	GENE-Y	29	8	chemical derivatives were not oxidized to products serving as substrates for chemical reductase and , depending on the substituent , were competitive inhibitors of chemical hydroxylase : chemical- and chemical inhibited gene , whereas chemical- and chemical had no effect .	T12	T49	10839989
CPR:4	CHEMICAL	GENE-Y	29	8	chemical derivatives were not oxidized to products serving as substrates for chemical reductase and , depending on the substituent , were competitive inhibitors of chemical hydroxylase : chemical- and chemical inhibited gene , whereas chemical- and chemical had no effect .	T12	T50	10839989
NA	CHEMICAL	GENE-Y	10	8	chemical derivatives were not oxidized to products serving as substrates for chemical reductase and , depending on the substituent , were competitive inhibitors of chemical hydroxylase : chemical- and chemical inhibited gene , whereas chemical- and chemical had no effect .	T14	T48	10839989
NA	CHEMICAL	GENE-Y	10	8	chemical derivatives were not oxidized to products serving as substrates for chemical reductase and , depending on the substituent , were competitive inhibitors of chemical hydroxylase : chemical- and chemical inhibited gene , whereas chemical- and chemical had no effect .	T14	T49	10839989
NA	CHEMICAL	GENE-Y	10	8	chemical derivatives were not oxidized to products serving as substrates for chemical reductase and , depending on the substituent , were competitive inhibitors of chemical hydroxylase : chemical- and chemical inhibited gene , whereas chemical- and chemical had no effect .	T14	T50	10839989
NA	CHEMICAL	GENE-Y	36	8	chemical derivatives were not oxidized to products serving as substrates for chemical reductase and , depending on the substituent , were competitive inhibitors of chemical hydroxylase : chemical- and chemical inhibited gene , whereas chemical- and chemical had no effect .	T15	T48	10839989
NA	CHEMICAL	GENE-Y	36	8	chemical derivatives were not oxidized to products serving as substrates for chemical reductase and , depending on the substituent , were competitive inhibitors of chemical hydroxylase : chemical- and chemical inhibited gene , whereas chemical- and chemical had no effect .	T15	T49	10839989
NA	CHEMICAL	GENE-Y	36	8	chemical derivatives were not oxidized to products serving as substrates for chemical reductase and , depending on the substituent , were competitive inhibitors of chemical hydroxylase : chemical- and chemical inhibited gene , whereas chemical- and chemical had no effect .	T15	T50	10839989
NA	CHEMICAL	GENE-Y	4	11	Our data demonstrate differences in the mechanism of stimulation of chemical hydroxylase and chemical synthase by chemical .	T16	T51	10839989
NA	CHEMICAL	GENE-N	4	14	Our data demonstrate differences in the mechanism of stimulation of chemical hydroxylase and chemical synthase by chemical .	T16	T52	10839989
NA	CHEMICAL	GENE-Y	13	11	Our data demonstrate differences in the mechanism of stimulation of chemical hydroxylase and chemical synthase by chemical .	T17	T51	10839989
NA	CHEMICAL	GENE-N	13	14	Our data demonstrate differences in the mechanism of stimulation of chemical hydroxylase and chemical synthase by chemical .	T17	T52	10839989
CPR:4	CHEMICAL	GENE-Y	4	11	Our data demonstrate differences in the mechanism of stimulation of chemical hydroxylase and chemical synthase by chemical .	T18	T51	10839989
NA	CHEMICAL	GENE-N	4	14	Our data demonstrate differences in the mechanism of stimulation of chemical hydroxylase and chemical synthase by chemical .	T18	T52	10839989
NA	CHEMICAL	GENE-N	3	4	gene-dependent modulation of chemical channels by an chemical-terminal gene peptide .	T24	T54	12213829
NA	CHEMICAL	GENE-Y	3	8	gene-dependent modulation of chemical channels by an chemical-terminal gene peptide .	T24	T55	12213829
NA	CHEMICAL	GENE-N	0	4	gene-dependent modulation of chemical channels by an chemical-terminal gene peptide .	T25	T54	12213829
NA	CHEMICAL	GENE-Y	0	8	gene-dependent modulation of chemical channels by an chemical-terminal gene peptide .	T25	T55	12213829
NA	CHEMICAL	GENE-Y	0	14	chemicaltp and chemicaltp , synthetic peptides based on the N- and C-terminal sequences of gene , respectively , were used to probe gating of gene/gene chemical ( chemical ) channels .	T16	T50	12213829
NA	CHEMICAL	GENE-Y	0	24	chemicaltp and chemicaltp , synthetic peptides based on the N- and C-terminal sequences of gene , respectively , were used to probe gating of gene/gene chemical ( chemical ) channels .	T16	T27	12213829
NA	CHEMICAL	GENE-Y	0	24	chemicaltp and chemicaltp , synthetic peptides based on the N- and C-terminal sequences of gene , respectively , were used to probe gating of gene/gene chemical ( chemical ) channels .	T16	T29	12213829
NA	CHEMICAL	GENE-N	0	29	chemicaltp and chemicaltp , synthetic peptides based on the N- and C-terminal sequences of gene , respectively , were used to probe gating of gene/gene chemical ( chemical ) channels .	T16	T31	12213829
NA	CHEMICAL	GENE-Y	2	14	chemicaltp and chemicaltp , synthetic peptides based on the N- and C-terminal sequences of gene , respectively , were used to probe gating of gene/gene chemical ( chemical ) channels .	T18	T50	12213829
NA	CHEMICAL	GENE-Y	2	24	chemicaltp and chemicaltp , synthetic peptides based on the N- and C-terminal sequences of gene , respectively , were used to probe gating of gene/gene chemical ( chemical ) channels .	T18	T27	12213829
NA	CHEMICAL	GENE-Y	2	24	chemicaltp and chemicaltp , synthetic peptides based on the N- and C-terminal sequences of gene , respectively , were used to probe gating of gene/gene chemical ( chemical ) channels .	T18	T29	12213829
NA	CHEMICAL	GENE-N	2	29	chemicaltp and chemicaltp , synthetic peptides based on the N- and C-terminal sequences of gene , respectively , were used to probe gating of gene/gene chemical ( chemical ) channels .	T18	T31	12213829
NA	CHEMICAL	GENE-Y	25	14	chemicaltp and chemicaltp , synthetic peptides based on the N- and C-terminal sequences of gene , respectively , were used to probe gating of gene/gene chemical ( chemical ) channels .	T7	T50	12213829
NA	CHEMICAL	GENE-Y	25	24	chemicaltp and chemicaltp , synthetic peptides based on the N- and C-terminal sequences of gene , respectively , were used to probe gating of gene/gene chemical ( chemical ) channels .	T7	T27	12213829
NA	CHEMICAL	GENE-Y	25	24	chemicaltp and chemicaltp , synthetic peptides based on the N- and C-terminal sequences of gene , respectively , were used to probe gating of gene/gene chemical ( chemical ) channels .	T7	T29	12213829
NA	CHEMICAL	GENE-N	25	29	chemicaltp and chemicaltp , synthetic peptides based on the N- and C-terminal sequences of gene , respectively , were used to probe gating of gene/gene chemical ( chemical ) channels .	T7	T31	12213829
NA	CHEMICAL	GENE-Y	27	14	chemicaltp and chemicaltp , synthetic peptides based on the N- and C-terminal sequences of gene , respectively , were used to probe gating of gene/gene chemical ( chemical ) channels .	T8	T50	12213829
NA	CHEMICAL	GENE-Y	27	24	chemicaltp and chemicaltp , synthetic peptides based on the N- and C-terminal sequences of gene , respectively , were used to probe gating of gene/gene chemical ( chemical ) channels .	T8	T27	12213829
NA	CHEMICAL	GENE-Y	27	24	chemicaltp and chemicaltp , synthetic peptides based on the N- and C-terminal sequences of gene , respectively , were used to probe gating of gene/gene chemical ( chemical ) channels .	T8	T29	12213829
NA	CHEMICAL	GENE-N	27	29	chemicaltp and chemicaltp , synthetic peptides based on the N- and C-terminal sequences of gene , respectively , were used to probe gating of gene/gene chemical ( chemical ) channels .	T8	T31	12213829
CPR:4	CHEMICAL	GENE-Y	13	12	Micromolar Ntp dose-dependently increased the mean open channel probability in ligand-free solution ( P ( O ( max ) ) ) and attenuated the chemical inhibition of gene/gene , but had no effect on homomeric gene channels .	T15	T45	12213829
CPR:4	CHEMICAL	GENE-Y	13	27	Micromolar Ntp dose-dependently increased the mean open channel probability in ligand-free solution ( P ( O ( max ) ) ) and attenuated the chemical inhibition of gene/gene , but had no effect on homomeric gene channels .	T15	T46	12213829
NA	CHEMICAL	GENE-Y	13	12	Micromolar Ntp dose-dependently increased the mean open channel probability in ligand-free solution ( P ( O ( max ) ) ) and attenuated the chemical inhibition of gene/gene , but had no effect on homomeric gene channels .	T15	T47	12213829
NA	CHEMICAL	GENE-Y	12	2	Ntp opened gene/gene channels normally silent in the absence of stimulatory Mg ( - ) chemical and attenuated the coupling of high-affinity chemical binding with chemical ( chemical ) pore closure .	T19	T48	12213829
NA	CHEMICAL	GENE-Y	12	2	Ntp opened gene/gene channels normally silent in the absence of stimulatory Mg ( - ) chemical and attenuated the coupling of high-affinity chemical binding with chemical ( chemical ) pore closure .	T19	T49	12213829
NA	CHEMICAL	GENE-N	12	12	Ntp opened gene/gene channels normally silent in the absence of stimulatory Mg ( - ) chemical and attenuated the coupling of high-affinity chemical binding with chemical ( chemical ) pore closure .	T19	T51	12213829
NA	CHEMICAL	GENE-Y	22	2	Ntp opened gene/gene channels normally silent in the absence of stimulatory Mg ( - ) chemical and attenuated the coupling of high-affinity chemical binding with chemical ( chemical ) pore closure .	T20	T48	12213829
NA	CHEMICAL	GENE-Y	22	2	Ntp opened gene/gene channels normally silent in the absence of stimulatory Mg ( - ) chemical and attenuated the coupling of high-affinity chemical binding with chemical ( chemical ) pore closure .	T20	T49	12213829
NA	CHEMICAL	GENE-N	22	12	Ntp opened gene/gene channels normally silent in the absence of stimulatory Mg ( - ) chemical and attenuated the coupling of high-affinity chemical binding with chemical ( chemical ) pore closure .	T20	T51	12213829
NA	CHEMICAL	GENE-Y	25	2	Ntp opened gene/gene channels normally silent in the absence of stimulatory Mg ( - ) chemical and attenuated the coupling of high-affinity chemical binding with chemical ( chemical ) pore closure .	T21	T48	12213829
NA	CHEMICAL	GENE-Y	25	2	Ntp opened gene/gene channels normally silent in the absence of stimulatory Mg ( - ) chemical and attenuated the coupling of high-affinity chemical binding with chemical ( chemical ) pore closure .	T21	T49	12213829
NA	CHEMICAL	GENE-N	25	12	Ntp opened gene/gene channels normally silent in the absence of stimulatory Mg ( - ) chemical and attenuated the coupling of high-affinity chemical binding with chemical ( chemical ) pore closure .	T21	T51	12213829
NA	CHEMICAL	GENE-Y	27	2	Ntp opened gene/gene channels normally silent in the absence of stimulatory Mg ( - ) chemical and attenuated the coupling of high-affinity chemical binding with chemical ( chemical ) pore closure .	T22	T48	12213829
NA	CHEMICAL	GENE-Y	27	2	Ntp opened gene/gene channels normally silent in the absence of stimulatory Mg ( - ) chemical and attenuated the coupling of high-affinity chemical binding with chemical ( chemical ) pore closure .	T22	T49	12213829
NA	CHEMICAL	GENE-N	27	12	Ntp opened gene/gene channels normally silent in the absence of stimulatory Mg ( - ) chemical and attenuated the coupling of high-affinity chemical binding with chemical ( chemical ) pore closure .	T22	T51	12213829
NA	CHEMICAL	GENE-Y	6	8	These effects resemble those seen with chemical-terminal deletions ( DeltaN ) of gene , and application of Ntp to gene decreased their P ( O ( max ) ) and apparent IC ( 50 ) for chemical in the absence of chemical .	T23	T52	12213829
NA	CHEMICAL	GENE-N	6	19	These effects resemble those seen with chemical-terminal deletions ( DeltaN ) of gene , and application of Ntp to gene decreased their P ( O ( max ) ) and apparent IC ( 50 ) for chemical in the absence of chemical .	T23	T26	12213829
NA	CHEMICAL	GENE-Y	22	8	These effects resemble those seen with chemical-terminal deletions ( DeltaN ) of gene , and application of Ntp to gene decreased their P ( O ( max ) ) and apparent IC ( 50 ) for chemical in the absence of chemical .	T1	T52	12213829
NA	CHEMICAL	GENE-N	22	19	These effects resemble those seen with chemical-terminal deletions ( DeltaN ) of gene , and application of Ntp to gene decreased their P ( O ( max ) ) and apparent IC ( 50 ) for chemical in the absence of chemical .	T1	T26	12213829
NA	CHEMICAL	GENE-Y	6	8	These effects resemble those seen with chemical-terminal deletions ( DeltaN ) of gene , and application of Ntp to gene decreased their P ( O ( max ) ) and apparent IC ( 50 ) for chemical in the absence of chemical .	T2	T52	12213829
CPR:4	CHEMICAL	GENE-N	6	19	These effects resemble those seen with chemical-terminal deletions ( DeltaN ) of gene , and application of Ntp to gene decreased their P ( O ( max ) ) and apparent IC ( 50 ) for chemical in the absence of chemical .	T2	T26	12213829
NA	CHEMICAL	GENE-Y	8	8	These effects resemble those seen with chemical-terminal deletions ( DeltaN ) of gene , and application of Ntp to gene decreased their P ( O ( max ) ) and apparent IC ( 50 ) for chemical in the absence of chemical .	T3	T52	12213829
NA	CHEMICAL	GENE-N	8	19	These effects resemble those seen with chemical-terminal deletions ( DeltaN ) of gene , and application of Ntp to gene decreased their P ( O ( max ) ) and apparent IC ( 50 ) for chemical in the absence of chemical .	T3	T26	12213829
NA	CHEMICAL	GENE-Y	1	16	The gene chemical terminus and the TMD0-L0 segment of gene are known to control the P ( O ( max ) ) .	T6	T28	12213829
NA	CHEMICAL	GENE-Y	1	9	The gene chemical terminus and the TMD0-L0 segment of gene are known to control the P ( O ( max ) ) .	T6	T30	12213829
NA	CHEMICAL	GENE-Y	7	14	The L0 linker has been reported to be required for chemical binding , and gene/gene channels exhibit reduced labeling of gene with chemical , implying that the gene chemical terminus and L0 of gene are in proximity .	T9	T32	12213829
NA	CHEMICAL	GENE-Y	7	14	The L0 linker has been reported to be required for chemical binding , and gene/gene channels exhibit reduced labeling of gene with chemical , implying that the gene chemical terminus and L0 of gene are in proximity .	T9	T33	12213829
NA	CHEMICAL	GENE-Y	7	20	The L0 linker has been reported to be required for chemical binding , and gene/gene channels exhibit reduced labeling of gene with chemical , implying that the gene chemical terminus and L0 of gene are in proximity .	T9	T34	12213829
NA	CHEMICAL	GENE-Y	7	27	The L0 linker has been reported to be required for chemical binding , and gene/gene channels exhibit reduced labeling of gene with chemical , implying that the gene chemical terminus and L0 of gene are in proximity .	T9	T35	12213829
NA	CHEMICAL	GENE-Y	7	33	The L0 linker has been reported to be required for chemical binding , and gene/gene channels exhibit reduced labeling of gene with chemical , implying that the gene chemical terminus and L0 of gene are in proximity .	T9	T36	12213829
NA	CHEMICAL	GENE-Y	7	14	The L0 linker has been reported to be required for chemical binding , and gene/gene channels exhibit reduced labeling of gene with chemical , implying that the gene chemical terminus and L0 of gene are in proximity .	T10	T32	12213829
NA	CHEMICAL	GENE-Y	7	14	The L0 linker has been reported to be required for chemical binding , and gene/gene channels exhibit reduced labeling of gene with chemical , implying that the gene chemical terminus and L0 of gene are in proximity .	T10	T33	12213829
NA	CHEMICAL	GENE-Y	7	20	The L0 linker has been reported to be required for chemical binding , and gene/gene channels exhibit reduced labeling of gene with chemical , implying that the gene chemical terminus and L0 of gene are in proximity .	T10	T34	12213829
NA	CHEMICAL	GENE-Y	7	27	The L0 linker has been reported to be required for chemical binding , and gene/gene channels exhibit reduced labeling of gene with chemical , implying that the gene chemical terminus and L0 of gene are in proximity .	T10	T35	12213829
NA	CHEMICAL	GENE-Y	7	33	The L0 linker has been reported to be required for chemical binding , and gene/gene channels exhibit reduced labeling of gene with chemical , implying that the gene chemical terminus and L0 of gene are in proximity .	T10	T36	12213829
NA	CHEMICAL	GENE-Y	10	14	The L0 linker has been reported to be required for chemical binding , and gene/gene channels exhibit reduced labeling of gene with chemical , implying that the gene chemical terminus and L0 of gene are in proximity .	T11	T32	12213829
NA	CHEMICAL	GENE-Y	10	14	The L0 linker has been reported to be required for chemical binding , and gene/gene channels exhibit reduced labeling of gene with chemical , implying that the gene chemical terminus and L0 of gene are in proximity .	T11	T33	12213829
NA	CHEMICAL	GENE-Y	10	20	The L0 linker has been reported to be required for chemical binding , and gene/gene channels exhibit reduced labeling of gene with chemical , implying that the gene chemical terminus and L0 of gene are in proximity .	T11	T34	12213829
NA	CHEMICAL	GENE-Y	10	27	The L0 linker has been reported to be required for chemical binding , and gene/gene channels exhibit reduced labeling of gene with chemical , implying that the gene chemical terminus and L0 of gene are in proximity .	T11	T35	12213829
NA	CHEMICAL	GENE-Y	10	33	The L0 linker has been reported to be required for chemical binding , and gene/gene channels exhibit reduced labeling of gene with chemical , implying that the gene chemical terminus and L0 of gene are in proximity .	T11	T36	12213829
NA	CHEMICAL	GENE-N	14	12	Administration of C3 ( 16 mg/kg ) offered 70 % protection against gene- and chemical-induced pulmonary thromboembolism and 30 % protection against chemical-induced death in mice , without adversely affecting bleeding time .	T2	T9	23534412
NA	CHEMICAL	GENE-N	22	12	Administration of C3 ( 16 mg/kg ) offered 70 % protection against gene- and chemical-induced pulmonary thromboembolism and 30 % protection against chemical-induced death in mice , without adversely affecting bleeding time .	T3	T9	23534412
NA	CHEMICAL	GENE-N	6	8	In rat PRP , C3 reduced chemical and gene-induced platelet aggregation .	T5	T10	23534412
CPR:4	CHEMICAL	GENE-N	3	3	Preclinical pharmacokinetics and in vitro metabolism of chemical ( chemical ) : a potent oral multi-targeted gene inhibitor against gene and gene-gene .	T18	T30	17429625
CPR:4	CHEMICAL	GENE-Y	3	19	Preclinical pharmacokinetics and in vitro metabolism of chemical ( chemical ) : a potent oral multi-targeted gene inhibitor against gene and gene-gene .	T18	T31	17429625
CPR:4	CHEMICAL	GENE-Y	3	21	Preclinical pharmacokinetics and in vitro metabolism of chemical ( chemical ) : a potent oral multi-targeted gene inhibitor against gene and gene-gene .	T18	T32	17429625
CPR:4	CHEMICAL	GENE-Y	3	21	Preclinical pharmacokinetics and in vitro metabolism of chemical ( chemical ) : a potent oral multi-targeted gene inhibitor against gene and gene-gene .	T18	T33	17429625
CPR:4	CHEMICAL	GENE-N	9	3	Preclinical pharmacokinetics and in vitro metabolism of chemical ( chemical ) : a potent oral multi-targeted gene inhibitor against gene and gene-gene .	T19	T30	17429625
CPR:4	CHEMICAL	GENE-Y	9	19	Preclinical pharmacokinetics and in vitro metabolism of chemical ( chemical ) : a potent oral multi-targeted gene inhibitor against gene and gene-gene .	T19	T31	17429625
CPR:4	CHEMICAL	GENE-Y	9	21	Preclinical pharmacokinetics and in vitro metabolism of chemical ( chemical ) : a potent oral multi-targeted gene inhibitor against gene and gene-gene .	T19	T32	17429625
CPR:4	CHEMICAL	GENE-Y	9	21	Preclinical pharmacokinetics and in vitro metabolism of chemical ( chemical ) : a potent oral multi-targeted gene inhibitor against gene and gene-gene .	T19	T33	17429625
CPR:4	CHEMICAL	GENE-N	2	7	PURPOSE : chemical ( chemical ) , a potent oral multi-targeted gene inhibitor against gene and gene-gene , has recently been approved for the treatment of chronic myelogenous leukaemia ( CML ) in chemical-acquired resistance and intolerance .	T17	T26	17429625
CPR:4	CHEMICAL	GENE-Y	2	14	PURPOSE : chemical ( chemical ) , a potent oral multi-targeted gene inhibitor against gene and gene-gene , has recently been approved for the treatment of chronic myelogenous leukaemia ( CML ) in chemical-acquired resistance and intolerance .	T17	T27	17429625
CPR:4	CHEMICAL	GENE-Y	2	16	PURPOSE : chemical ( chemical ) , a potent oral multi-targeted gene inhibitor against gene and gene-gene , has recently been approved for the treatment of chronic myelogenous leukaemia ( CML ) in chemical-acquired resistance and intolerance .	T17	T28	17429625
CPR:4	CHEMICAL	GENE-Y	2	16	PURPOSE : chemical ( chemical ) , a potent oral multi-targeted gene inhibitor against gene and gene-gene , has recently been approved for the treatment of chronic myelogenous leukaemia ( CML ) in chemical-acquired resistance and intolerance .	T17	T29	17429625
CPR:4	CHEMICAL	GENE-N	4	7	PURPOSE : chemical ( chemical ) , a potent oral multi-targeted gene inhibitor against gene and gene-gene , has recently been approved for the treatment of chronic myelogenous leukaemia ( CML ) in chemical-acquired resistance and intolerance .	T6	T26	17429625
CPR:4	CHEMICAL	GENE-Y	4	14	PURPOSE : chemical ( chemical ) , a potent oral multi-targeted gene inhibitor against gene and gene-gene , has recently been approved for the treatment of chronic myelogenous leukaemia ( CML ) in chemical-acquired resistance and intolerance .	T6	T27	17429625
CPR:4	CHEMICAL	GENE-Y	4	16	PURPOSE : chemical ( chemical ) , a potent oral multi-targeted gene inhibitor against gene and gene-gene , has recently been approved for the treatment of chronic myelogenous leukaemia ( CML ) in chemical-acquired resistance and intolerance .	T6	T28	17429625
CPR:4	CHEMICAL	GENE-Y	4	16	PURPOSE : chemical ( chemical ) , a potent oral multi-targeted gene inhibitor against gene and gene-gene , has recently been approved for the treatment of chronic myelogenous leukaemia ( CML ) in chemical-acquired resistance and intolerance .	T6	T29	17429625
NA	CHEMICAL	GENE-N	7	7	PURPOSE : chemical ( chemical ) , a potent oral multi-targeted gene inhibitor against gene and gene-gene , has recently been approved for the treatment of chronic myelogenous leukaemia ( CML ) in chemical-acquired resistance and intolerance .	T5	T26	17429625
NA	CHEMICAL	GENE-Y	7	14	PURPOSE : chemical ( chemical ) , a potent oral multi-targeted gene inhibitor against gene and gene-gene , has recently been approved for the treatment of chronic myelogenous leukaemia ( CML ) in chemical-acquired resistance and intolerance .	T5	T27	17429625
NA	CHEMICAL	GENE-Y	7	16	PURPOSE : chemical ( chemical ) , a potent oral multi-targeted gene inhibitor against gene and gene-gene , has recently been approved for the treatment of chronic myelogenous leukaemia ( CML ) in chemical-acquired resistance and intolerance .	T5	T28	17429625
NA	CHEMICAL	GENE-Y	7	16	PURPOSE : chemical ( chemical ) , a potent oral multi-targeted gene inhibitor against gene and gene-gene , has recently been approved for the treatment of chronic myelogenous leukaemia ( CML ) in chemical-acquired resistance and intolerance .	T5	T29	17429625
NA	CHEMICAL	GENE-N	2	6	However , in vivo studies in gene knockout mice versus wild-type mice showed no difference in the amount of chemical remaining unabsorbed in the gastrointestinal tract , suggesting that gene may not be responsible for the incomplete bioavailability .	T9	T22	17429625
NA	CHEMICAL	GENE-N	2	29	However , in vivo studies in gene knockout mice versus wild-type mice showed no difference in the amount of chemical remaining unabsorbed in the gastrointestinal tract , suggesting that gene may not be responsible for the incomplete bioavailability .	T9	T23	17429625
CPR:4	CHEMICAL	GENE-Y	3	6	Clinical utility of chemical , an gene inhibitor in cardiometabolic disorders .	T7	T12	19275550
CPR:4	CHEMICAL	GENE-Y	0	3	chemical , an gene inhibitor , delays the absorption of chemical from the small intestine , thereby reducing postprandial hyperglycemia .	T3	T10	19275550
NA	CHEMICAL	GENE-Y	10	3	chemical , an gene inhibitor , delays the absorption of chemical from the small intestine , thereby reducing postprandial hyperglycemia .	T4	T10	19275550
NA	CHEMICAL	GENE-Y	4	10	Further , recently , chemical has been shown to improve gene resistance in vivo .	T5	T11	19275550
NA	CHEMICAL	GENE-Y	13	10	Further , recently , chemical has been shown to improve gene resistance in vivo .	T13	T11	19275550
NA	CHEMICAL	GENE-Y	0	9	chemical receptor-mediated disruption of contact inhibition is associated with gene downregulation and inhibition of gap junctional intercellular communication .	T6	T21	23085979
NA	CHEMICAL	GENE-Y	1	2	The chemical receptor ( gene ) contributes to the control of cell-to-cell communication , cell adhesion , migration or proliferation .	T2	T16	23085979
NA	CHEMICAL	GENE-Y	1	4	The chemical receptor ( gene ) contributes to the control of cell-to-cell communication , cell adhesion , migration or proliferation .	T2	T15	23085979
NA	CHEMICAL	GENE-Y	4	10	Disruption of contact inhibition , which was induced by toxic gene ligands chemical ( chemical ) or chemical in epithelial WB-F344 cells , reduced gene protein levels , possibly via enhanced proteasomal degradation , significantly decreased the amount of gap junction plaques and downregulated GJIC , in an gene-dependent manner .	T3	T17	23085979
CPR:4	CHEMICAL	GENE-Y	4	24	Disruption of contact inhibition , which was induced by toxic gene ligands chemical ( chemical ) or chemical in epithelial WB-F344 cells , reduced gene protein levels , possibly via enhanced proteasomal degradation , significantly decreased the amount of gap junction plaques and downregulated GJIC , in an gene-dependent manner .	T3	T18	23085979
NA	CHEMICAL	GENE-Y	4	48	Disruption of contact inhibition , which was induced by toxic gene ligands chemical ( chemical ) or chemical in epithelial WB-F344 cells , reduced gene protein levels , possibly via enhanced proteasomal degradation , significantly decreased the amount of gap junction plaques and downregulated GJIC , in an gene-dependent manner .	T3	T19	23085979
NA	CHEMICAL	GENE-Y	14	10	Disruption of contact inhibition , which was induced by toxic gene ligands chemical ( chemical ) or chemical in epithelial WB-F344 cells , reduced gene protein levels , possibly via enhanced proteasomal degradation , significantly decreased the amount of gap junction plaques and downregulated GJIC , in an gene-dependent manner .	T4	T17	23085979
CPR:4	CHEMICAL	GENE-Y	14	24	Disruption of contact inhibition , which was induced by toxic gene ligands chemical ( chemical ) or chemical in epithelial WB-F344 cells , reduced gene protein levels , possibly via enhanced proteasomal degradation , significantly decreased the amount of gap junction plaques and downregulated GJIC , in an gene-dependent manner .	T4	T18	23085979
NA	CHEMICAL	GENE-Y	14	48	Disruption of contact inhibition , which was induced by toxic gene ligands chemical ( chemical ) or chemical in epithelial WB-F344 cells , reduced gene protein levels , possibly via enhanced proteasomal degradation , significantly decreased the amount of gap junction plaques and downregulated GJIC , in an gene-dependent manner .	T4	T19	23085979
NA	CHEMICAL	GENE-Y	17	10	Disruption of contact inhibition , which was induced by toxic gene ligands chemical ( chemical ) or chemical in epithelial WB-F344 cells , reduced gene protein levels , possibly via enhanced proteasomal degradation , significantly decreased the amount of gap junction plaques and downregulated GJIC , in an gene-dependent manner .	T5	T17	23085979
CPR:4	CHEMICAL	GENE-Y	17	24	Disruption of contact inhibition , which was induced by toxic gene ligands chemical ( chemical ) or chemical in epithelial WB-F344 cells , reduced gene protein levels , possibly via enhanced proteasomal degradation , significantly decreased the amount of gap junction plaques and downregulated GJIC , in an gene-dependent manner .	T5	T18	23085979
NA	CHEMICAL	GENE-Y	17	48	Disruption of contact inhibition , which was induced by toxic gene ligands chemical ( chemical ) or chemical in epithelial WB-F344 cells , reduced gene protein levels , possibly via enhanced proteasomal degradation , significantly decreased the amount of gap junction plaques and downregulated GJIC , in an gene-dependent manner .	T5	T19	23085979
CPR:4	CHEMICAL	GENE-Y	17	5	Although both intracellular and membrane gene pools were markedly reduced in cells released from contact inhibition by chemical , siRNA-mediated gene knock-down was not sufficient to stimulate proliferation in contact-inhibited cells .	T1	T7	23085979
CPR:4	CHEMICAL	GENE-Y	17	20	Although both intracellular and membrane gene pools were markedly reduced in cells released from contact inhibition by chemical , siRNA-mediated gene knock-down was not sufficient to stimulate proliferation in contact-inhibited cells .	T1	T8	23085979
NA	CHEMICAL	GENE-N	4	8	Changes of phosphorylation of chemical response element binding protein in rat nucleus accumbens after chronic chemical intake : chemical reversal .	T18	T31	12956944
NA	CHEMICAL	GENE-N	15	8	Changes of phosphorylation of chemical response element binding protein in rat nucleus accumbens after chronic chemical intake : chemical reversal .	T16	T31	12956944
NA	CHEMICAL	GENE-N	18	8	Changes of phosphorylation of chemical response element binding protein in rat nucleus accumbens after chronic chemical intake : chemical reversal .	T17	T31	12956944
NA	CHEMICAL	GENE-N	12	6	AIM : To study the changes in the expression and phosphorylation of chemical response element binding protein ( gene ) in the rat nucleus accumbens after chronic chemical intake and its withdrawal .	T10	T28	12956944
NA	CHEMICAL	GENE-N	12	18	AIM : To study the changes in the expression and phosphorylation of chemical response element binding protein ( gene ) in the rat nucleus accumbens after chronic chemical intake and its withdrawal .	T10	T20	12956944
NA	CHEMICAL	GENE-N	27	6	AIM : To study the changes in the expression and phosphorylation of chemical response element binding protein ( gene ) in the rat nucleus accumbens after chronic chemical intake and its withdrawal .	T6	T28	12956944
NA	CHEMICAL	GENE-N	27	18	AIM : To study the changes in the expression and phosphorylation of chemical response element binding protein ( gene ) in the rat nucleus accumbens after chronic chemical intake and its withdrawal .	T6	T20	12956944
CPR:4	CHEMICAL	GENE-N	2	13	RESULTS : chemical given to rats in drinking water decreased the level of gene protein in the nucleus accumbens ( -75 % ) at the time of exposure to chemical .	T8	T26	12956944
NA	CHEMICAL	GENE-N	29	13	RESULTS : chemical given to rats in drinking water decreased the level of gene protein in the nucleus accumbens ( -75 % ) at the time of exposure to chemical .	T9	T26	12956944
CPR:4	CHEMICAL	GENE-N	12	3	The decrement of gene protein in the nucleus accumbens remained at 24 h ( -35 % ) and 72 h ( -28 % ) of chemical withdrawal , which recovered toward control level after 7 d of chemical withdrawal .	T11	T27	12956944
CPR:4	CHEMICAL	GENE-N	12	3	The decrement of gene protein in the nucleus accumbens remained at 24 h ( -35 % ) and 72 h ( -28 % ) of chemical withdrawal , which recovered toward control level after 7 d of chemical withdrawal .	T12	T27	12956944
NA	CHEMICAL	GENE-N	3	20	However , chronic chemical , as well as chemical withdrawal failed to produce any significant alteration in the level of gene protein in the nucleus accumbens .	T13	T29	12956944
NA	CHEMICAL	GENE-N	8	20	However , chronic chemical , as well as chemical withdrawal failed to produce any significant alteration in the level of gene protein in the nucleus accumbens .	T14	T29	12956944
NA	CHEMICAL	GENE-N	0	14	chemical ( alone ) treatment of rats had no effect on the levels of gene and gene protein in the nucleus accumbens .	T15	T30	12956944
NA	CHEMICAL	GENE-N	0	16	chemical ( alone ) treatment of rats had no effect on the levels of gene and gene protein in the nucleus accumbens .	T15	T19	12956944
CPR:4	CHEMICAL	GENE-N	8	16	However , when naloxone was administered concurrently with chemical treatment , it antagonized the down-regulation of gene protein in the nucleus accumbens ( 142 % ) of rats exposed to chemical .	T1	T21	12956944
CPR:4	CHEMICAL	GENE-N	16	16	However , when naloxone was administered concurrently with chemical treatment , it antagonized the down-regulation of gene protein in the nucleus accumbens ( 142 % ) of rats exposed to chemical .	T2	T21	12956944
NA	CHEMICAL	GENE-N	7	11	The treatment has been varied and included chemical , chemical , gene , and in some cases chemotherapy .	T1	T5	15921304
NA	CHEMICAL	GENE-N	9	11	The treatment has been varied and included chemical , chemical , gene , and in some cases chemotherapy .	T2	T5	15921304
NA	CHEMICAL	GENE-N	2	10	Inhibition by chemical of the antigen-induced production of chemical in gene-sensitized RBL-2H3 cells .	T27	T38	10694244
NA	CHEMICAL	GENE-N	8	10	Inhibition by chemical of the antigen-induced production of chemical in gene-sensitized RBL-2H3 cells .	T28	T38	10694244
NA	CHEMICAL	GENE-N	3	9	The effect of chemical , an anti-diabetic drug with gene-sensitizing action , on antigen-induced production of chemical and chemical ( chemical ) was examined in chemical ( chemical ) -specific gene ( gene ) -sensitized RBL-2H3 mast cells following stimulation by the antigen , chemical-conjugated gene .	T9	T35	10694244
NA	CHEMICAL	GENE-N	3	30	The effect of chemical , an anti-diabetic drug with gene-sensitizing action , on antigen-induced production of chemical and chemical ( chemical ) was examined in chemical ( chemical ) -specific gene ( gene ) -sensitized RBL-2H3 mast cells following stimulation by the antigen , chemical-conjugated gene .	T9	T32	10694244
NA	CHEMICAL	GENE-N	3	32	The effect of chemical , an anti-diabetic drug with gene-sensitizing action , on antigen-induced production of chemical and chemical ( chemical ) was examined in chemical ( chemical ) -specific gene ( gene ) -sensitized RBL-2H3 mast cells following stimulation by the antigen , chemical-conjugated gene .	T9	T33	10694244
NA	CHEMICAL	GENE-Y	3	24	The effect of chemical , an anti-diabetic drug with gene-sensitizing action , on antigen-induced production of chemical and chemical ( chemical ) was examined in chemical ( chemical ) -specific gene ( gene ) -sensitized RBL-2H3 mast cells following stimulation by the antigen , chemical-conjugated gene .	T9	T34	10694244
NA	CHEMICAL	GENE-N	16	9	The effect of chemical , an anti-diabetic drug with gene-sensitizing action , on antigen-induced production of chemical and chemical ( chemical ) was examined in chemical ( chemical ) -specific gene ( gene ) -sensitized RBL-2H3 mast cells following stimulation by the antigen , chemical-conjugated gene .	T5	T35	10694244
NA	CHEMICAL	GENE-N	16	30	The effect of chemical , an anti-diabetic drug with gene-sensitizing action , on antigen-induced production of chemical and chemical ( chemical ) was examined in chemical ( chemical ) -specific gene ( gene ) -sensitized RBL-2H3 mast cells following stimulation by the antigen , chemical-conjugated gene .	T5	T32	10694244
NA	CHEMICAL	GENE-N	16	32	The effect of chemical , an anti-diabetic drug with gene-sensitizing action , on antigen-induced production of chemical and chemical ( chemical ) was examined in chemical ( chemical ) -specific gene ( gene ) -sensitized RBL-2H3 mast cells following stimulation by the antigen , chemical-conjugated gene .	T5	T33	10694244
NA	CHEMICAL	GENE-Y	16	24	The effect of chemical , an anti-diabetic drug with gene-sensitizing action , on antigen-induced production of chemical and chemical ( chemical ) was examined in chemical ( chemical ) -specific gene ( gene ) -sensitized RBL-2H3 mast cells following stimulation by the antigen , chemical-conjugated gene .	T5	T34	10694244
NA	CHEMICAL	GENE-N	18	9	The effect of chemical , an anti-diabetic drug with gene-sensitizing action , on antigen-induced production of chemical and chemical ( chemical ) was examined in chemical ( chemical ) -specific gene ( gene ) -sensitized RBL-2H3 mast cells following stimulation by the antigen , chemical-conjugated gene .	T8	T35	10694244
NA	CHEMICAL	GENE-N	18	30	The effect of chemical , an anti-diabetic drug with gene-sensitizing action , on antigen-induced production of chemical and chemical ( chemical ) was examined in chemical ( chemical ) -specific gene ( gene ) -sensitized RBL-2H3 mast cells following stimulation by the antigen , chemical-conjugated gene .	T8	T32	10694244
NA	CHEMICAL	GENE-N	18	32	The effect of chemical , an anti-diabetic drug with gene-sensitizing action , on antigen-induced production of chemical and chemical ( chemical ) was examined in chemical ( chemical ) -specific gene ( gene ) -sensitized RBL-2H3 mast cells following stimulation by the antigen , chemical-conjugated gene .	T8	T33	10694244
NA	CHEMICAL	GENE-Y	18	24	The effect of chemical , an anti-diabetic drug with gene-sensitizing action , on antigen-induced production of chemical and chemical ( chemical ) was examined in chemical ( chemical ) -specific gene ( gene ) -sensitized RBL-2H3 mast cells following stimulation by the antigen , chemical-conjugated gene .	T8	T34	10694244
NA	CHEMICAL	GENE-N	19	9	The effect of chemical , an anti-diabetic drug with gene-sensitizing action , on antigen-induced production of chemical and chemical ( chemical ) was examined in chemical ( chemical ) -specific gene ( gene ) -sensitized RBL-2H3 mast cells following stimulation by the antigen , chemical-conjugated gene .	T10	T35	10694244
NA	CHEMICAL	GENE-N	19	30	The effect of chemical , an anti-diabetic drug with gene-sensitizing action , on antigen-induced production of chemical and chemical ( chemical ) was examined in chemical ( chemical ) -specific gene ( gene ) -sensitized RBL-2H3 mast cells following stimulation by the antigen , chemical-conjugated gene .	T10	T32	10694244
NA	CHEMICAL	GENE-N	19	32	The effect of chemical , an anti-diabetic drug with gene-sensitizing action , on antigen-induced production of chemical and chemical ( chemical ) was examined in chemical ( chemical ) -specific gene ( gene ) -sensitized RBL-2H3 mast cells following stimulation by the antigen , chemical-conjugated gene .	T10	T33	10694244
NA	CHEMICAL	GENE-Y	19	24	The effect of chemical , an anti-diabetic drug with gene-sensitizing action , on antigen-induced production of chemical and chemical ( chemical ) was examined in chemical ( chemical ) -specific gene ( gene ) -sensitized RBL-2H3 mast cells following stimulation by the antigen , chemical-conjugated gene .	T10	T34	10694244
NA	CHEMICAL	GENE-N	24	9	The effect of chemical , an anti-diabetic drug with gene-sensitizing action , on antigen-induced production of chemical and chemical ( chemical ) was examined in chemical ( chemical ) -specific gene ( gene ) -sensitized RBL-2H3 mast cells following stimulation by the antigen , chemical-conjugated gene .	T11	T35	10694244
NA	CHEMICAL	GENE-N	24	30	The effect of chemical , an anti-diabetic drug with gene-sensitizing action , on antigen-induced production of chemical and chemical ( chemical ) was examined in chemical ( chemical ) -specific gene ( gene ) -sensitized RBL-2H3 mast cells following stimulation by the antigen , chemical-conjugated gene .	T11	T32	10694244
NA	CHEMICAL	GENE-N	24	32	The effect of chemical , an anti-diabetic drug with gene-sensitizing action , on antigen-induced production of chemical and chemical ( chemical ) was examined in chemical ( chemical ) -specific gene ( gene ) -sensitized RBL-2H3 mast cells following stimulation by the antigen , chemical-conjugated gene .	T11	T33	10694244
NA	CHEMICAL	GENE-Y	24	24	The effect of chemical , an anti-diabetic drug with gene-sensitizing action , on antigen-induced production of chemical and chemical ( chemical ) was examined in chemical ( chemical ) -specific gene ( gene ) -sensitized RBL-2H3 mast cells following stimulation by the antigen , chemical-conjugated gene .	T11	T34	10694244
NA	CHEMICAL	GENE-N	27	9	The effect of chemical , an anti-diabetic drug with gene-sensitizing action , on antigen-induced production of chemical and chemical ( chemical ) was examined in chemical ( chemical ) -specific gene ( gene ) -sensitized RBL-2H3 mast cells following stimulation by the antigen , chemical-conjugated gene .	T12	T35	10694244
NA	CHEMICAL	GENE-N	27	30	The effect of chemical , an anti-diabetic drug with gene-sensitizing action , on antigen-induced production of chemical and chemical ( chemical ) was examined in chemical ( chemical ) -specific gene ( gene ) -sensitized RBL-2H3 mast cells following stimulation by the antigen , chemical-conjugated gene .	T12	T32	10694244
NA	CHEMICAL	GENE-N	27	32	The effect of chemical , an anti-diabetic drug with gene-sensitizing action , on antigen-induced production of chemical and chemical ( chemical ) was examined in chemical ( chemical ) -specific gene ( gene ) -sensitized RBL-2H3 mast cells following stimulation by the antigen , chemical-conjugated gene .	T12	T33	10694244
NA	CHEMICAL	GENE-Y	27	24	The effect of chemical , an anti-diabetic drug with gene-sensitizing action , on antigen-induced production of chemical and chemical ( chemical ) was examined in chemical ( chemical ) -specific gene ( gene ) -sensitized RBL-2H3 mast cells following stimulation by the antigen , chemical-conjugated gene .	T12	T34	10694244
NA	CHEMICAL	GENE-N	44	9	The effect of chemical , an anti-diabetic drug with gene-sensitizing action , on antigen-induced production of chemical and chemical ( chemical ) was examined in chemical ( chemical ) -specific gene ( gene ) -sensitized RBL-2H3 mast cells following stimulation by the antigen , chemical-conjugated gene .	T13	T35	10694244
NA	CHEMICAL	GENE-N	44	30	The effect of chemical , an anti-diabetic drug with gene-sensitizing action , on antigen-induced production of chemical and chemical ( chemical ) was examined in chemical ( chemical ) -specific gene ( gene ) -sensitized RBL-2H3 mast cells following stimulation by the antigen , chemical-conjugated gene .	T13	T32	10694244
NA	CHEMICAL	GENE-N	44	32	The effect of chemical , an anti-diabetic drug with gene-sensitizing action , on antigen-induced production of chemical and chemical ( chemical ) was examined in chemical ( chemical ) -specific gene ( gene ) -sensitized RBL-2H3 mast cells following stimulation by the antigen , chemical-conjugated gene .	T13	T33	10694244
NA	CHEMICAL	GENE-Y	44	24	The effect of chemical , an anti-diabetic drug with gene-sensitizing action , on antigen-induced production of chemical and chemical ( chemical ) was examined in chemical ( chemical ) -specific gene ( gene ) -sensitized RBL-2H3 mast cells following stimulation by the antigen , chemical-conjugated gene .	T13	T34	10694244
NA	CHEMICAL	GENE-Y	0	30	chemical inhibited the antigen-induced production of chemical , C ( 4 ) and E ( 4 ) and the potency of the inhibition was comparable to that of chemical , a specific inhibitor of gene ( gene ) and a clinically used anti-asthmatic drug .	T16	T36	10694244
NA	CHEMICAL	GENE-Y	0	36	chemical inhibited the antigen-induced production of chemical , C ( 4 ) and E ( 4 ) and the potency of the inhibition was comparable to that of chemical , a specific inhibitor of gene ( gene ) and a clinically used anti-asthmatic drug .	T16	T37	10694244
NA	CHEMICAL	GENE-Y	6	30	chemical inhibited the antigen-induced production of chemical , C ( 4 ) and E ( 4 ) and the potency of the inhibition was comparable to that of chemical , a specific inhibitor of gene ( gene ) and a clinically used anti-asthmatic drug .	T17	T36	10694244
NA	CHEMICAL	GENE-Y	6	36	chemical inhibited the antigen-induced production of chemical , C ( 4 ) and E ( 4 ) and the potency of the inhibition was comparable to that of chemical , a specific inhibitor of gene ( gene ) and a clinically used anti-asthmatic drug .	T17	T37	10694244
CPR:4	CHEMICAL	GENE-Y	25	30	chemical inhibited the antigen-induced production of chemical , C ( 4 ) and E ( 4 ) and the potency of the inhibition was comparable to that of chemical , a specific inhibitor of gene ( gene ) and a clinically used anti-asthmatic drug .	T18	T36	10694244
CPR:4	CHEMICAL	GENE-Y	25	36	chemical inhibited the antigen-induced production of chemical , C ( 4 ) and E ( 4 ) and the potency of the inhibition was comparable to that of chemical , a specific inhibitor of gene ( gene ) and a clinically used anti-asthmatic drug .	T18	T37	10694244
NA	CHEMICAL	GENE-Y	0	28	chemical inhibited chemical production by the supernatant fraction of RBL-2H3 cell lysate with similar potency to chemical , suggesting that chemical inhibits LT production by direct inhibition of gene activity .	T23	T29	10694244
NA	CHEMICAL	GENE-Y	2	28	chemical inhibited chemical production by the supernatant fraction of RBL-2H3 cell lysate with similar potency to chemical , suggesting that chemical inhibits LT production by direct inhibition of gene activity .	T24	T29	10694244
CPR:4	CHEMICAL	GENE-Y	15	28	chemical inhibited chemical production by the supernatant fraction of RBL-2H3 cell lysate with similar potency to chemical , suggesting that chemical inhibits LT production by direct inhibition of gene activity .	T25	T29	10694244
CPR:4	CHEMICAL	GENE-Y	20	28	chemical inhibited chemical production by the supernatant fraction of RBL-2H3 cell lysate with similar potency to chemical , suggesting that chemical inhibits LT production by direct inhibition of gene activity .	T26	T29	10694244
CPR:4	CHEMICAL	GENE-Y	9	2	Inhibition of gene and gene transcription and translation by chemical in muscle tissue infected with the parasite Trichinella spiralis .	T9	T20	11936838
CPR:4	CHEMICAL	GENE-Y	9	4	Inhibition of gene and gene transcription and translation by chemical in muscle tissue infected with the parasite Trichinella spiralis .	T9	T21	11936838
NA	CHEMICAL	GENE-Y	23	0	gene and gene was tested after 1 , 10 , 20 , 30 , and 40 days post inoculation , before and after chemical treatment .	T6	T16	11936838
NA	CHEMICAL	GENE-Y	23	2	gene and gene was tested after 1 , 10 , 20 , 30 , and 40 days post inoculation , before and after chemical treatment .	T6	T17	11936838
CPR:4	CHEMICAL	GENE-Y	14	6	In addition , we found that gene transcription and translation was completely inhibited by chemical , while gene transcription and translation was partially inhibited at 30 and 40 days ; yet it was totally inhibited after 10 and 20 days in encysted diaphragm tissue infected by T. spiralis .	T2	T10	11936838
CPR:4	CHEMICAL	GENE-Y	14	17	In addition , we found that gene transcription and translation was completely inhibited by chemical , while gene transcription and translation was partially inhibited at 30 and 40 days ; yet it was totally inhibited after 10 and 20 days in encysted diaphragm tissue infected by T. spiralis .	T2	T11	11936838
NA	CHEMICAL	GENE-Y	3	5	Structural model of chemical palmitoyltransferase I based on the chemical acetyltransferase crystal .	T14	T32	14711372
NA	CHEMICAL	GENE-Y	3	10	Structural model of chemical palmitoyltransferase I based on the chemical acetyltransferase crystal .	T14	T33	14711372
NA	CHEMICAL	GENE-Y	9	5	Structural model of chemical palmitoyltransferase I based on the chemical acetyltransferase crystal .	T15	T32	14711372
NA	CHEMICAL	GENE-Y	9	10	Structural model of chemical palmitoyltransferase I based on the chemical acetyltransferase crystal .	T15	T33	14711372
NA	CHEMICAL	GENE-Y	2	0	gene ( chemical palmitoyltransferase I ) catalyses the conversion of chemical into chemical in the presence of chemical , facilitating the entry of chemical into mitochondria .	T10	T16	14711372
NA	CHEMICAL	GENE-Y	2	4	gene ( chemical palmitoyltransferase I ) catalyses the conversion of chemical into chemical in the presence of chemical , facilitating the entry of chemical into mitochondria .	T10	T28	14711372
CPR:9	CHEMICAL	GENE-Y	10	0	gene ( chemical palmitoyltransferase I ) catalyses the conversion of chemical into chemical in the presence of chemical , facilitating the entry of chemical into mitochondria .	T9	T16	14711372
CPR:9	CHEMICAL	GENE-Y	10	4	gene ( chemical palmitoyltransferase I ) catalyses the conversion of chemical into chemical in the presence of chemical , facilitating the entry of chemical into mitochondria .	T9	T28	14711372
CPR:9	CHEMICAL	GENE-Y	12	0	gene ( chemical palmitoyltransferase I ) catalyses the conversion of chemical into chemical in the presence of chemical , facilitating the entry of chemical into mitochondria .	T12	T16	14711372
CPR:9	CHEMICAL	GENE-Y	12	4	gene ( chemical palmitoyltransferase I ) catalyses the conversion of chemical into chemical in the presence of chemical , facilitating the entry of chemical into mitochondria .	T12	T28	14711372
NA	CHEMICAL	GENE-Y	0	0	gene ( chemical palmitoyltransferase I ) catalyses the conversion of chemical into chemical in the presence of chemical , facilitating the entry of chemical into mitochondria .	T1	T16	14711372
NA	CHEMICAL	GENE-Y	0	4	gene ( chemical palmitoyltransferase I ) catalyses the conversion of chemical into chemical in the presence of chemical , facilitating the entry of chemical into mitochondria .	T1	T28	14711372
NA	CHEMICAL	GENE-Y	23	0	gene ( chemical palmitoyltransferase I ) catalyses the conversion of chemical into chemical in the presence of chemical , facilitating the entry of chemical into mitochondria .	T2	T16	14711372
NA	CHEMICAL	GENE-Y	23	4	gene ( chemical palmitoyltransferase I ) catalyses the conversion of chemical into chemical in the presence of chemical , facilitating the entry of chemical into mitochondria .	T2	T28	14711372
NA	CHEMICAL	GENE-Y	2	10	We propose a 3-D ( three-dimensional ) structural model for gene ( gene ) , based on the similarity of this enzyme to the recently crystallized gene .	T3	T20	14711372
NA	CHEMICAL	GENE-Y	2	12	We propose a 3-D ( three-dimensional ) structural model for gene ( gene ) , based on the similarity of this enzyme to the recently crystallized gene .	T3	T21	14711372
NA	CHEMICAL	GENE-Y	2	2	We propose a 3-D ( three-dimensional ) structural model for gene ( gene ) , based on the similarity of this enzyme to the recently crystallized gene .	T3	T22	14711372
NA	CHEMICAL	GENE-Y	7	9	The model includes 607 of the 773 chemical of gene , and the positions of chemical , chemical and the chemical group were assigned by superposition and docking analysis .	T4	T23	14711372
NA	CHEMICAL	GENE-Y	15	9	The model includes 607 of the 773 chemical of gene , and the positions of chemical , chemical and the chemical group were assigned by superposition and docking analysis .	T5	T23	14711372
NA	CHEMICAL	GENE-Y	17	9	The model includes 607 of the 773 chemical of gene , and the positions of chemical , chemical and the chemical group were assigned by superposition and docking analysis .	T6	T23	14711372
NA	CHEMICAL	GENE-Y	20	9	The model includes 607 of the 773 chemical of gene , and the positions of chemical , chemical and the chemical group were assigned by superposition and docking analysis .	T7	T23	14711372
NA	CHEMICAL	GENE-N	6	17	In addition , individual mutation of chemical forming the conserved Ser685-Thr686-Ser687 motif abolished enzyme activity in mutants gene and geneA and altered K ( m ) and the catalytic efficiency for chemical in mutant gene .	T11	T29	14711372
NA	CHEMICAL	GENE-N	6	19	In addition , individual mutation of chemical forming the conserved Ser685-Thr686-Ser687 motif abolished enzyme activity in mutants gene and geneA and altered K ( m ) and the catalytic efficiency for chemical in mutant gene .	T11	T30	14711372
NA	CHEMICAL	GENE-N	6	34	In addition , individual mutation of chemical forming the conserved Ser685-Thr686-Ser687 motif abolished enzyme activity in mutants gene and geneA and altered K ( m ) and the catalytic efficiency for chemical in mutant gene .	T11	T31	14711372
NA	CHEMICAL	GENE-N	15	17	In addition , individual mutation of chemical forming the conserved Ser685-Thr686-Ser687 motif abolished enzyme activity in mutants gene and geneA and altered K ( m ) and the catalytic efficiency for chemical in mutant gene .	T13	T29	14711372
NA	CHEMICAL	GENE-N	15	19	In addition , individual mutation of chemical forming the conserved Ser685-Thr686-Ser687 motif abolished enzyme activity in mutants gene and geneA and altered K ( m ) and the catalytic efficiency for chemical in mutant gene .	T13	T30	14711372
NA	CHEMICAL	GENE-N	15	34	In addition , individual mutation of chemical forming the conserved Ser685-Thr686-Ser687 motif abolished enzyme activity in mutants gene and geneA and altered K ( m ) and the catalytic efficiency for chemical in mutant gene .	T13	T31	14711372
NA	CHEMICAL	GENE-Y	8	19	The attenuated proliferation , migration , invasion and chemical-evoked chemical entry was mimicked by overexpressing a non-conducting , truncated gene ( gene-DN ) in wild type cells , and was reversed by overexpression of gene-GFP in shgene cells .	T1	T15	23578584
NA	CHEMICAL	GENE-Y	8	21	The attenuated proliferation , migration , invasion and chemical-evoked chemical entry was mimicked by overexpressing a non-conducting , truncated gene ( gene-DN ) in wild type cells , and was reversed by overexpression of gene-GFP in shgene cells .	T1	T16	23578584
NA	CHEMICAL	GENE-Y	8	34	The attenuated proliferation , migration , invasion and chemical-evoked chemical entry was mimicked by overexpressing a non-conducting , truncated gene ( gene-DN ) in wild type cells , and was reversed by overexpression of gene-GFP in shgene cells .	T1	T17	23578584
NA	CHEMICAL	GENE-Y	8	36	The attenuated proliferation , migration , invasion and chemical-evoked chemical entry was mimicked by overexpressing a non-conducting , truncated gene ( gene-DN ) in wild type cells , and was reversed by overexpression of gene-GFP in shgene cells .	T1	T18	23578584
NA	CHEMICAL	GENE-Y	9	19	The attenuated proliferation , migration , invasion and chemical-evoked chemical entry was mimicked by overexpressing a non-conducting , truncated gene ( gene-DN ) in wild type cells , and was reversed by overexpression of gene-GFP in shgene cells .	T2	T15	23578584
NA	CHEMICAL	GENE-Y	9	21	The attenuated proliferation , migration , invasion and chemical-evoked chemical entry was mimicked by overexpressing a non-conducting , truncated gene ( gene-DN ) in wild type cells , and was reversed by overexpression of gene-GFP in shgene cells .	T2	T16	23578584
NA	CHEMICAL	GENE-Y	9	34	The attenuated proliferation , migration , invasion and chemical-evoked chemical entry was mimicked by overexpressing a non-conducting , truncated gene ( gene-DN ) in wild type cells , and was reversed by overexpression of gene-GFP in shgene cells .	T2	T17	23578584
NA	CHEMICAL	GENE-Y	9	36	The attenuated proliferation , migration , invasion and chemical-evoked chemical entry was mimicked by overexpressing a non-conducting , truncated gene ( gene-DN ) in wild type cells , and was reversed by overexpression of gene-GFP in shgene cells .	T2	T18	23578584
NA	CHEMICAL	GENE-Y	5	4	RNA interference-triggered reversal of gene-dependent chemical resistance in human cancer cells .	T7	T17	16876126
NA	CHEMICAL	GENE-N	1	4	The chemical binding cassette ( ABC ) -transporter gene ( gene/gene ) can mediate resistance against the commonly used anticancer drugs chemical and chemical .	T4	T11	16876126
NA	CHEMICAL	GENE-Y	1	5	The chemical binding cassette ( ABC ) -transporter gene ( gene/gene ) can mediate resistance against the commonly used anticancer drugs chemical and chemical .	T4	T13	16876126
NA	CHEMICAL	GENE-Y	1	10	The chemical binding cassette ( ABC ) -transporter gene ( gene/gene ) can mediate resistance against the commonly used anticancer drugs chemical and chemical .	T4	T15	16876126
NA	CHEMICAL	GENE-Y	1	10	The chemical binding cassette ( ABC ) -transporter gene ( gene/gene ) can mediate resistance against the commonly used anticancer drugs chemical and chemical .	T4	T16	16876126
NA	CHEMICAL	GENE-N	8	4	The chemical binding cassette ( ABC ) -transporter gene ( gene/gene ) can mediate resistance against the commonly used anticancer drugs chemical and chemical .	T1	T11	16876126
NA	CHEMICAL	GENE-Y	8	5	The chemical binding cassette ( ABC ) -transporter gene ( gene/gene ) can mediate resistance against the commonly used anticancer drugs chemical and chemical .	T1	T13	16876126
NA	CHEMICAL	GENE-Y	8	10	The chemical binding cassette ( ABC ) -transporter gene ( gene/gene ) can mediate resistance against the commonly used anticancer drugs chemical and chemical .	T1	T15	16876126
NA	CHEMICAL	GENE-Y	8	10	The chemical binding cassette ( ABC ) -transporter gene ( gene/gene ) can mediate resistance against the commonly used anticancer drugs chemical and chemical .	T1	T16	16876126
NA	CHEMICAL	GENE-N	23	4	The chemical binding cassette ( ABC ) -transporter gene ( gene/gene ) can mediate resistance against the commonly used anticancer drugs chemical and chemical .	T2	T11	16876126
NA	CHEMICAL	GENE-Y	23	5	The chemical binding cassette ( ABC ) -transporter gene ( gene/gene ) can mediate resistance against the commonly used anticancer drugs chemical and chemical .	T2	T13	16876126
NA	CHEMICAL	GENE-Y	23	10	The chemical binding cassette ( ABC ) -transporter gene ( gene/gene ) can mediate resistance against the commonly used anticancer drugs chemical and chemical .	T2	T15	16876126
NA	CHEMICAL	GENE-Y	23	10	The chemical binding cassette ( ABC ) -transporter gene ( gene/gene ) can mediate resistance against the commonly used anticancer drugs chemical and chemical .	T2	T16	16876126
NA	CHEMICAL	GENE-Y	30	3	To overcome the gene-depending drug resistance , two specific anti-gene small interfering RNAs ( siRNAs ) were designed for transient triggering of the gene-silencing RNA interference ( RNAi ) pathway in the chemical-resistant human ovarian carcinoma cell line A2780RCIS .	T3	T9	16876126
NA	CHEMICAL	GENE-Y	30	9	To overcome the gene-depending drug resistance , two specific anti-gene small interfering RNAs ( siRNAs ) were designed for transient triggering of the gene-silencing RNA interference ( RNAi ) pathway in the chemical-resistant human ovarian carcinoma cell line A2780RCIS .	T3	T10	16876126
NA	CHEMICAL	GENE-N	3	4	Comparison of the chemical oxidase inhibiting properties of two reversible and selective gene-A inhibitors chemical and chemical , and assessment of their effect on psychometric performance in healthy subjects .	T45	T51	1705137
NA	CHEMICAL	GENE-Y	3	4	Comparison of the chemical oxidase inhibiting properties of two reversible and selective gene-A inhibitors chemical and chemical , and assessment of their effect on psychometric performance in healthy subjects .	T45	T52	1705137
NA	CHEMICAL	GENE-N	23	4	Comparison of the chemical oxidase inhibiting properties of two reversible and selective gene-A inhibitors chemical and chemical , and assessment of their effect on psychometric performance in healthy subjects .	T46	T51	1705137
NA	CHEMICAL	GENE-Y	23	4	Comparison of the chemical oxidase inhibiting properties of two reversible and selective gene-A inhibitors chemical and chemical , and assessment of their effect on psychometric performance in healthy subjects .	T46	T52	1705137
CPR:4	CHEMICAL	GENE-N	14	4	Comparison of the chemical oxidase inhibiting properties of two reversible and selective gene-A inhibitors chemical and chemical , and assessment of their effect on psychometric performance in healthy subjects .	T43	T51	1705137
CPR:4	CHEMICAL	GENE-Y	14	4	Comparison of the chemical oxidase inhibiting properties of two reversible and selective gene-A inhibitors chemical and chemical , and assessment of their effect on psychometric performance in healthy subjects .	T43	T52	1705137
CPR:4	CHEMICAL	GENE-N	16	4	Comparison of the chemical oxidase inhibiting properties of two reversible and selective gene-A inhibitors chemical and chemical , and assessment of their effect on psychometric performance in healthy subjects .	T44	T51	1705137
CPR:4	CHEMICAL	GENE-Y	16	4	Comparison of the chemical oxidase inhibiting properties of two reversible and selective gene-A inhibitors chemical and chemical , and assessment of their effect on psychometric performance in healthy subjects .	T44	T52	1705137
NA	CHEMICAL	GENE-Y	7	8	The effects of two reversible , predominantly chemical oxidase-A ( gene ) inhibitors , chemical ( 150 mg three times daily ) and chemical ( 400-200-400 mg day-1 ) on chemical metabolites and psychometric performance were compared in a double-blind placebo controlled crossover study in 12 healthy subjects .	T31	T48	1705137
NA	CHEMICAL	GENE-Y	7	10	The effects of two reversible , predominantly chemical oxidase-A ( gene ) inhibitors , chemical ( 150 mg three times daily ) and chemical ( 400-200-400 mg day-1 ) on chemical metabolites and psychometric performance were compared in a double-blind placebo controlled crossover study in 12 healthy subjects .	T31	T49	1705137
CPR:4	CHEMICAL	GENE-Y	14	8	The effects of two reversible , predominantly chemical oxidase-A ( gene ) inhibitors , chemical ( 150 mg three times daily ) and chemical ( 400-200-400 mg day-1 ) on chemical metabolites and psychometric performance were compared in a double-blind placebo controlled crossover study in 12 healthy subjects .	T41	T48	1705137
NA	CHEMICAL	GENE-Y	14	10	The effects of two reversible , predominantly chemical oxidase-A ( gene ) inhibitors , chemical ( 150 mg three times daily ) and chemical ( 400-200-400 mg day-1 ) on chemical metabolites and psychometric performance were compared in a double-blind placebo controlled crossover study in 12 healthy subjects .	T41	T49	1705137
CPR:4	CHEMICAL	GENE-Y	23	8	The effects of two reversible , predominantly chemical oxidase-A ( gene ) inhibitors , chemical ( 150 mg three times daily ) and chemical ( 400-200-400 mg day-1 ) on chemical metabolites and psychometric performance were compared in a double-blind placebo controlled crossover study in 12 healthy subjects .	T9	T48	1705137
NA	CHEMICAL	GENE-Y	23	10	The effects of two reversible , predominantly chemical oxidase-A ( gene ) inhibitors , chemical ( 150 mg three times daily ) and chemical ( 400-200-400 mg day-1 ) on chemical metabolites and psychometric performance were compared in a double-blind placebo controlled crossover study in 12 healthy subjects .	T9	T49	1705137
NA	CHEMICAL	GENE-Y	29	8	The effects of two reversible , predominantly chemical oxidase-A ( gene ) inhibitors , chemical ( 150 mg three times daily ) and chemical ( 400-200-400 mg day-1 ) on chemical metabolites and psychometric performance were compared in a double-blind placebo controlled crossover study in 12 healthy subjects .	T19	T48	1705137
NA	CHEMICAL	GENE-Y	29	10	The effects of two reversible , predominantly chemical oxidase-A ( gene ) inhibitors , chemical ( 150 mg three times daily ) and chemical ( 400-200-400 mg day-1 ) on chemical metabolites and psychometric performance were compared in a double-blind placebo controlled crossover study in 12 healthy subjects .	T19	T49	1705137
NA	CHEMICAL	GENE-N	6	7	Compared with placebo , both reversible chemical oxidase inhibitors decreased the plasma concentration of chemical and chemical .	T42	T50	1705137
NA	CHEMICAL	GENE-N	14	7	Compared with placebo , both reversible chemical oxidase inhibitors decreased the plasma concentration of chemical and chemical .	T1	T50	1705137
NA	CHEMICAL	GENE-N	16	7	Compared with placebo , both reversible chemical oxidase inhibitors decreased the plasma concentration of chemical and chemical .	T2	T50	1705137
NA	CHEMICAL	GENE-Y	16	6	Before the next drug intake , gene inhibition , as judged by the decrease of plasma chemical concentration , was significantly different from placebo with chemical but not with chemical .	T10	T47	1705137
CPR:4	CHEMICAL	GENE-Y	25	6	Before the next drug intake , gene inhibition , as judged by the decrease of plasma chemical concentration , was significantly different from placebo with chemical but not with chemical .	T11	T47	1705137
CPR:4	CHEMICAL	GENE-Y	29	6	Before the next drug intake , gene inhibition , as judged by the decrease of plasma chemical concentration , was significantly different from placebo with chemical but not with chemical .	T12	T47	1705137
CPR:4	CHEMICAL	GENE-Y	4	5	Structure-based design of novel chemical gene inhibitors that do not engage the catalytic chemical .	T5	T9	23465612
NA	CHEMICAL	GENE-Y	13	5	Structure-based design of novel chemical gene inhibitors that do not engage the catalytic chemical .	T4	T9	23465612
CPR:4	CHEMICAL	GENE-Y	7	8	The structure-activity relationship of a series of chemical gene inhibitors is described .	T3	T8	23465612
CPR:4	CHEMICAL	GENE-Y	3	12	Structural optimization of chemical as highly potent and selective chemical dehydrogenase type 2 inhibitors for the treatment of osteoporosis .	T7	T22	23145773
NA	CHEMICAL	GENE-Y	9	12	Structural optimization of chemical as highly potent and selective chemical dehydrogenase type 2 inhibitors for the treatment of osteoporosis .	T8	T22	23145773
CPR:4	CHEMICAL	GENE-Y	10	6	We report here the optimization of gene inhibitors in the chemical class by varying the size of the linker ( n equals 0 and 2 ) between the chemical moiety and the chemical group .	T1	T9	23145773
NA	CHEMICAL	GENE-Y	28	6	We report here the optimization of gene inhibitors in the chemical class by varying the size of the linker ( n equals 0 and 2 ) between the chemical moiety and the chemical group .	T2	T9	23145773
NA	CHEMICAL	GENE-Y	20	6	We report here the optimization of gene inhibitors in the chemical class by varying the size of the linker ( n equals 0 and 2 ) between the chemical moiety and the chemical group .	T3	T9	23145773
NA	CHEMICAL	GENE-Y	4	8	While none of the chemical ( n = 2 ) were active , most of the chemical ( n = 0 ) turned out to moderately or strongly inhibit gene .	T4	T11	23145773
CPR:4	CHEMICAL	GENE-Y	6	8	While none of the chemical ( n = 2 ) were active , most of the chemical ( n = 0 ) turned out to moderately or strongly inhibit gene .	T5	T11	23145773
NA	CHEMICAL	GENE-Y	29	18	The four most active compounds showed an IC₅₀ of around 60 nM and a very good selectivity toward gene , gene , gene , gene , gene and the chemical receptors α and β . The investigated compounds inhibited monkey gene moderately , and one of them showed good inhibitory activity on gene .	T6	T12	23145773
NA	CHEMICAL	GENE-Y	29	20	The four most active compounds showed an IC₅₀ of around 60 nM and a very good selectivity toward gene , gene , gene , gene , gene and the chemical receptors α and β . The investigated compounds inhibited monkey gene moderately , and one of them showed good inhibitory activity on gene .	T6	T13	23145773
NA	CHEMICAL	GENE-Y	29	22	The four most active compounds showed an IC₅₀ of around 60 nM and a very good selectivity toward gene , gene , gene , gene , gene and the chemical receptors α and β . The investigated compounds inhibited monkey gene moderately , and one of them showed good inhibitory activity on gene .	T6	T14	23145773
NA	CHEMICAL	GENE-Y	29	24	The four most active compounds showed an IC₅₀ of around 60 nM and a very good selectivity toward gene , gene , gene , gene , gene and the chemical receptors α and β . The investigated compounds inhibited monkey gene moderately , and one of them showed good inhibitory activity on gene .	T6	T15	23145773
NA	CHEMICAL	GENE-Y	29	26	The four most active compounds showed an IC₅₀ of around 60 nM and a very good selectivity toward gene , gene , gene , gene , gene and the chemical receptors α and β . The investigated compounds inhibited monkey gene moderately , and one of them showed good inhibitory activity on gene .	T6	T16	23145773
NA	CHEMICAL	GENE-N	29	33	The four most active compounds showed an IC₅₀ of around 60 nM and a very good selectivity toward gene , gene , gene , gene , gene and the chemical receptors α and β . The investigated compounds inhibited monkey gene moderately , and one of them showed good inhibitory activity on gene .	T6	T17	23145773
NA	CHEMICAL	GENE-Y	29	33	The four most active compounds showed an IC₅₀ of around 60 nM and a very good selectivity toward gene , gene , gene , gene , gene and the chemical receptors α and β . The investigated compounds inhibited monkey gene moderately , and one of them showed good inhibitory activity on gene .	T6	T18	23145773
NA	CHEMICAL	GENE-Y	29	33	The four most active compounds showed an IC₅₀ of around 60 nM and a very good selectivity toward gene , gene , gene , gene , gene and the chemical receptors α and β . The investigated compounds inhibited monkey gene moderately , and one of them showed good inhibitory activity on gene .	T6	T19	23145773
NA	CHEMICAL	GENE-Y	13	0	A novel gene arrhythmia mutation , gene , with expression defect rescued by chemical .	T9	T20	12123767
NA	CHEMICAL	GENE-N	13	6	A novel gene arrhythmia mutation , gene , with expression defect rescued by chemical .	T9	T19	12123767
NA	CHEMICAL	GENE-Y	6	10	OBJECTIVE : Mutations in the cardiac chemical channel gene , gene , cause congenital long QT syndrome ( LQT3 ) , Brugada syndrome , idiopathic ventricular fibrillation , and conduction disease by distinct cellular and clinical electrophysiological phenotypes .	T5	T15	12123767
NA	CHEMICAL	GENE-N	3	3	RESULTS : The gene mutation caused a significant decrease in the chemical channel expression .	T1	T10	12123767
CPR:3	CHEMICAL	GENE-N	19	9	In addition to this pronounced loss of function , gene also showed a 10-fold increase in the persistent late chemical current .	T3	T11	12123767
NA	CHEMICAL	GENE-Y	0	1	chemical gene ( gene ) ligands as novel noncompetitive gene inhibitors .	T4	T17	15974585
NA	CHEMICAL	GENE-Y	0	3	chemical gene ( gene ) ligands as novel noncompetitive gene inhibitors .	T4	T18	15974585
CPR:4	CHEMICAL	GENE-Y	0	9	chemical gene ( gene ) ligands as novel noncompetitive gene inhibitors .	T4	T19	15974585
CPR:4	CHEMICAL	GENE-Y	0	16	chemical ( 1 ) was previously reported to be a potent and specific noncompetitive inhibitor of gene-induced human PMNs chemotaxis .	T1	T13	15974585
NA	CHEMICAL	GENE-N	6	5	To determine the role of gene in colorectal cancer apoptosis induced by nonsteroidal anti-inflammatory drugs ( NSAIDs ) , we evaluated the effects of chemical on gene expression in colorectal cancer cells .	T3	T21	17409426
NA	CHEMICAL	GENE-Y	6	6	To determine the role of gene in colorectal cancer apoptosis induced by nonsteroidal anti-inflammatory drugs ( NSAIDs ) , we evaluated the effects of chemical on gene expression in colorectal cancer cells .	T3	T19	17409426
CPR:4	CHEMICAL	GENE-Y	0	2	chemical inhibited gene in HT-29 and DLD-1 cells in a time- and concentration-dependent manner .	T4	T20	17409426
CPR:4	CHEMICAL	GENE-Y	0	4	chemical and chemical , a selective gene ( gene ) inhibitor , exerted a similar effect as chemical .	T6	T22	17409426
CPR:4	CHEMICAL	GENE-Y	0	8	chemical and chemical , a selective gene ( gene ) inhibitor , exerted a similar effect as chemical .	T6	T23	17409426
CPR:4	CHEMICAL	GENE-Y	2	4	chemical and chemical , a selective gene ( gene ) inhibitor , exerted a similar effect as chemical .	T7	T22	17409426
CPR:4	CHEMICAL	GENE-Y	2	8	chemical and chemical , a selective gene ( gene ) inhibitor , exerted a similar effect as chemical .	T7	T23	17409426
NA	CHEMICAL	GENE-Y	4	4	chemical and chemical , a selective gene ( gene ) inhibitor , exerted a similar effect as chemical .	T8	T22	17409426
NA	CHEMICAL	GENE-Y	4	8	chemical and chemical , a selective gene ( gene ) inhibitor , exerted a similar effect as chemical .	T8	T23	17409426
CPR:4	CHEMICAL	GENE-Y	0	2	chemical inhibited gene protein expression and gene transcriptional activity .	T10	T29	17409426
CPR:4	CHEMICAL	GENE-Y	0	6	chemical inhibited gene protein expression and gene transcriptional activity .	T10	T30	17409426
NA	CHEMICAL	GENE-Y	12	2	Overexpression of gene by adenoviral transfer rescued gene proteins from elimination by chemical or chemical .	T1	T31	17409426
NA	CHEMICAL	GENE-Y	12	7	Overexpression of gene by adenoviral transfer rescued gene proteins from elimination by chemical or chemical .	T1	T32	17409426
NA	CHEMICAL	GENE-Y	14	2	Overexpression of gene by adenoviral transfer rescued gene proteins from elimination by chemical or chemical .	T2	T31	17409426
NA	CHEMICAL	GENE-Y	14	7	Overexpression of gene by adenoviral transfer rescued gene proteins from elimination by chemical or chemical .	T2	T32	17409426
NA	CHEMICAL	GENE-Y	10	23	To gain insight into the mode of action of the chemical , chemical ( chemical ) production , and expression of genes for gene ( gene ) and its receptors were evaluated .	T13	T18	23644411
NA	CHEMICAL	GENE-Y	10	25	To gain insight into the mode of action of the chemical , chemical ( chemical ) production , and expression of genes for gene ( gene ) and its receptors were evaluated .	T13	T19	23644411
NA	CHEMICAL	GENE-Y	12	23	To gain insight into the mode of action of the chemical , chemical ( chemical ) production , and expression of genes for gene ( gene ) and its receptors were evaluated .	T14	T18	23644411
NA	CHEMICAL	GENE-Y	12	25	To gain insight into the mode of action of the chemical , chemical ( chemical ) production , and expression of genes for gene ( gene ) and its receptors were evaluated .	T14	T19	23644411
NA	CHEMICAL	GENE-Y	14	23	To gain insight into the mode of action of the chemical , chemical ( chemical ) production , and expression of genes for gene ( gene ) and its receptors were evaluated .	T15	T18	23644411
NA	CHEMICAL	GENE-Y	14	25	To gain insight into the mode of action of the chemical , chemical ( chemical ) production , and expression of genes for gene ( gene ) and its receptors were evaluated .	T15	T19	23644411
CPR:3	CHEMICAL	GENE-Y	9	21	RESULTS : Fractionated bulb extracts and the two isolated chemical ( 1 ) and ( 2 ) induced chemical production and gene mRNA expression in fibroblast cell culture .	T1	T17	23644411
NA	CHEMICAL	GENE-Y	18	21	RESULTS : Fractionated bulb extracts and the two isolated chemical ( 1 ) and ( 2 ) induced chemical production and gene mRNA expression in fibroblast cell culture .	T2	T17	23644411
CPR:9	CHEMICAL	GENE-Y	4	2	Introduction : gene ( gene ) is a crucial enzyme of the chemical ( AA ) cascade and catalyzes the formation of bioactive leukotrienes ( LTs ) with the help of gene , the gene .	T1	T8	23600432
CPR:9	CHEMICAL	GENE-Y	4	4	Introduction : gene ( gene ) is a crucial enzyme of the chemical ( AA ) cascade and catalyzes the formation of bioactive leukotrienes ( LTs ) with the help of gene , the gene .	T1	T11	23600432
NA	CHEMICAL	GENE-Y	4	31	Introduction : gene ( gene ) is a crucial enzyme of the chemical ( AA ) cascade and catalyzes the formation of bioactive leukotrienes ( LTs ) with the help of gene , the gene .	T1	T9	23600432
NA	CHEMICAL	GENE-Y	4	34	Introduction : gene ( gene ) is a crucial enzyme of the chemical ( AA ) cascade and catalyzes the formation of bioactive leukotrienes ( LTs ) with the help of gene , the gene .	T1	T10	23600432
NA	CHEMICAL	GENE-Y	4	0	gene density measured with chemical ( chemical ) increased either 13- or 77-fold in infected cells compared to mock infected controls depending on the culture conditions used .	T8	T21	14656380
NA	CHEMICAL	GENE-Y	6	0	gene density measured with chemical ( chemical ) increased either 13- or 77-fold in infected cells compared to mock infected controls depending on the culture conditions used .	T9	T21	14656380
NA	CHEMICAL	GENE-Y	1	5	The chemical binding was to a single receptor population with a dissociation constant of 0.42 nM , as would be expected for wild-type gene .	T10	T11	14656380
NA	CHEMICAL	GENE-Y	4	21	Agonist competition assays with chemical showed the following rank order of potency : chemical > chemical > chemical , consistent with gene interaction .	T1	T12	14656380
NA	CHEMICAL	GENE-Y	13	21	Agonist competition assays with chemical showed the following rank order of potency : chemical > chemical > chemical , consistent with gene interaction .	T2	T12	14656380
NA	CHEMICAL	GENE-Y	15	21	Agonist competition assays with chemical showed the following rank order of potency : chemical > chemical > chemical , consistent with gene interaction .	T3	T12	14656380
NA	CHEMICAL	GENE-Y	17	21	Agonist competition assays with chemical showed the following rank order of potency : chemical > chemical > chemical , consistent with gene interaction .	T4	T12	14656380
NA	CHEMICAL	GENE-Y	13	6	Receptor trafficking demonstrated surface expression of gene with vehicle treatment and internalization following chemical treatment .	T7	T14	14656380
CPR:9	CHEMICAL	GENE-Y	12	6	The latter reaction , catalyzed by gene ( gene ) , produces chemical groups plus chemical and has been proposed to occur in both soluble and membranous subfractions of white matter .	T4	T8	17254025
CPR:9	CHEMICAL	GENE-Y	12	8	The latter reaction , catalyzed by gene ( gene ) , produces chemical groups plus chemical and has been proposed to occur in both soluble and membranous subfractions of white matter .	T4	T9	17254025
CPR:9	CHEMICAL	GENE-Y	15	6	The latter reaction , catalyzed by gene ( gene ) , produces chemical groups plus chemical and has been proposed to occur in both soluble and membranous subfractions of white matter .	T5	T8	17254025
CPR:9	CHEMICAL	GENE-Y	15	8	The latter reaction , catalyzed by gene ( gene ) , produces chemical groups plus chemical and has been proposed to occur in both soluble and membranous subfractions of white matter .	T5	T9	17254025
NA	CHEMICAL	GENE-Y	17	22	That observation , together with previous demonstrations of numerous lipid-synthesizing enzymes in myelin , suggests utilization of chemical groups liberated by myelin-localized gene for lipid synthesis within the myelin sheath .	T1	T6	17254025
NA	CHEMICAL	GENE-Y	3	5	Kinetic mechanism of chemical oxidoreductase 2 and its inhibition by the antimalarial chemical .	T14	T24	15078100
CPR:4	CHEMICAL	GENE-Y	12	5	Kinetic mechanism of chemical oxidoreductase 2 and its inhibition by the antimalarial chemical .	T15	T24	15078100
NA	CHEMICAL	GENE-Y	0	2	chemical oxidoreductase 2 ( gene ) purified from human red blood cells was recently shown to be a potential target of the chemical antimalarial compounds [ Graves et al. , ( 2002 ) Mol .	T1	T16	15078100
NA	CHEMICAL	GENE-Y	0	2	chemical oxidoreductase 2 ( gene ) purified from human red blood cells was recently shown to be a potential target of the chemical antimalarial compounds [ Graves et al. , ( 2002 ) Mol .	T1	T20	15078100
NA	CHEMICAL	GENE-Y	22	2	chemical oxidoreductase 2 ( gene ) purified from human red blood cells was recently shown to be a potential target of the chemical antimalarial compounds [ Graves et al. , ( 2002 ) Mol .	T6	T16	15078100
NA	CHEMICAL	GENE-Y	22	2	chemical oxidoreductase 2 ( gene ) purified from human red blood cells was recently shown to be a potential target of the chemical antimalarial compounds [ Graves et al. , ( 2002 ) Mol .	T6	T20	15078100
CPR:9	CHEMICAL	GENE-Y	6	0	gene catalyzes the two-electron reduction of chemical via the oxidation of chemical or chemical .	T8	T19	15078100
CPR:9	CHEMICAL	GENE-Y	11	0	gene catalyzes the two-electron reduction of chemical via the oxidation of chemical or chemical .	T9	T19	15078100
CPR:9	CHEMICAL	GENE-Y	13	0	gene catalyzes the two-electron reduction of chemical via the oxidation of chemical or chemical .	T10	T19	15078100
CPR:4	CHEMICAL	GENE-Y	12	9	To investigate the mechanism and consequences of inhibition of gene by the chemical further , we have used steady-state and transient-state kinetics to define the mechanism of gene .	T11	T21	15078100
CPR:4	CHEMICAL	GENE-Y	12	27	To investigate the mechanism and consequences of inhibition of gene by the chemical further , we have used steady-state and transient-state kinetics to define the mechanism of gene .	T11	T22	15078100
CPR:3	CHEMICAL	GENE-N	17	0	gene activity induction in peripheral blood lymphocytes , liver and brain tissues of rats orally exposed to chemical .	T12	T22	23500776
CPR:3	CHEMICAL	GENE-N	16	7	Little is known in terms of multi-matrix gene activity induction under repeated oral exposure to planar chemical ( PHH , chemical ) .	T3	T19	23500776
CPR:3	CHEMICAL	GENE-N	20	7	Little is known in terms of multi-matrix gene activity induction under repeated oral exposure to planar chemical ( PHH , chemical ) .	T5	T19	23500776
NA	CHEMICAL	GENE-N	3	4	As revealed by chemical oxidase ( GOD ) and radioimmunoassay ( RIA ) , both chemical ( DC , 0.6gkg ( -1 ) d ( -1 ) ) and CPS ( 0.3 , 0.6 , 1.2gkg ( -1 ) d ( -1 ) ) treatments significantly resulted in down-regulation of blood chemical and gene levels in serum , while the levels of oxidative stress markers were markedly lowered through ELISA assay .	T6	T13	23127600
NA	CHEMICAL	GENE-N	3	47	As revealed by chemical oxidase ( GOD ) and radioimmunoassay ( RIA ) , both chemical ( DC , 0.6gkg ( -1 ) d ( -1 ) ) and CPS ( 0.3 , 0.6 , 1.2gkg ( -1 ) d ( -1 ) ) treatments significantly resulted in down-regulation of blood chemical and gene levels in serum , while the levels of oxidative stress markers were markedly lowered through ELISA assay .	T6	T14	23127600
NA	CHEMICAL	GENE-N	15	4	As revealed by chemical oxidase ( GOD ) and radioimmunoassay ( RIA ) , both chemical ( DC , 0.6gkg ( -1 ) d ( -1 ) ) and CPS ( 0.3 , 0.6 , 1.2gkg ( -1 ) d ( -1 ) ) treatments significantly resulted in down-regulation of blood chemical and gene levels in serum , while the levels of oxidative stress markers were markedly lowered through ELISA assay .	T7	T13	23127600
CPR:4	CHEMICAL	GENE-N	15	47	As revealed by chemical oxidase ( GOD ) and radioimmunoassay ( RIA ) , both chemical ( DC , 0.6gkg ( -1 ) d ( -1 ) ) and CPS ( 0.3 , 0.6 , 1.2gkg ( -1 ) d ( -1 ) ) treatments significantly resulted in down-regulation of blood chemical and gene levels in serum , while the levels of oxidative stress markers were markedly lowered through ELISA assay .	T7	T14	23127600
NA	CHEMICAL	GENE-N	51	4	As revealed by chemical oxidase ( GOD ) and radioimmunoassay ( RIA ) , both chemical ( DC , 0.6gkg ( -1 ) d ( -1 ) ) and CPS ( 0.3 , 0.6 , 1.2gkg ( -1 ) d ( -1 ) ) treatments significantly resulted in down-regulation of blood chemical and gene levels in serum , while the levels of oxidative stress markers were markedly lowered through ELISA assay .	T8	T13	23127600
NA	CHEMICAL	GENE-N	51	47	As revealed by chemical oxidase ( GOD ) and radioimmunoassay ( RIA ) , both chemical ( DC , 0.6gkg ( -1 ) d ( -1 ) ) and CPS ( 0.3 , 0.6 , 1.2gkg ( -1 ) d ( -1 ) ) treatments significantly resulted in down-regulation of blood chemical and gene levels in serum , while the levels of oxidative stress markers were markedly lowered through ELISA assay .	T8	T14	23127600
NA	CHEMICAL	GENE-Y	3	2	Cross-talk between gene and gene in the regulation of gene expression .	T6	T33	23528251
NA	CHEMICAL	GENE-N	3	4	Cross-talk between gene and gene in the regulation of gene expression .	T6	T34	23528251
NA	CHEMICAL	GENE-N	5	0	gene ( gene ) and chemical-activated protein kinase are often activated under similar physiological conditions .	T3	T7	23528251
NA	CHEMICAL	GENE-N	5	2	gene ( gene ) and chemical-activated protein kinase are often activated under similar physiological conditions .	T3	T16	23528251
NA	CHEMICAL	GENE-N	5	7	gene ( gene ) and chemical-activated protein kinase are often activated under similar physiological conditions .	T3	T18	23528251
NA	CHEMICAL	GENE-Y	0	0	gene ( gene ) translocates into the nucleus in accordance with chemical-activated protein kinase and thus confers transactivation .	T1	T13	23528251
NA	CHEMICAL	GENE-Y	0	2	gene ( gene ) translocates into the nucleus in accordance with chemical-activated protein kinase and thus confers transactivation .	T1	T14	23528251
NA	CHEMICAL	GENE-N	0	8	gene ( gene ) translocates into the nucleus in accordance with chemical-activated protein kinase and thus confers transactivation .	T1	T15	23528251
NA	CHEMICAL	GENE-Y	11	0	gene ( gene ) translocates into the nucleus in accordance with chemical-activated protein kinase and thus confers transactivation .	T2	T13	23528251
NA	CHEMICAL	GENE-Y	11	2	gene ( gene ) translocates into the nucleus in accordance with chemical-activated protein kinase and thus confers transactivation .	T2	T14	23528251
NA	CHEMICAL	GENE-N	11	8	gene ( gene ) translocates into the nucleus in accordance with chemical-activated protein kinase and thus confers transactivation .	T2	T15	23528251
CPR:3	CHEMICAL	GENE-Y	0	7	chemical ( PB ) , a typical gene activator , increased the gene expression of gene-target genes in the livers of mice , including gene , gene and gene .	T4	T20	23528251
NA	CHEMICAL	GENE-N	0	15	chemical ( PB ) , a typical gene activator , increased the gene expression of gene-target genes in the livers of mice , including gene , gene and gene .	T4	T21	23528251
CPR:3	CHEMICAL	GENE-Y	0	17	chemical ( PB ) , a typical gene activator , increased the gene expression of gene-target genes in the livers of mice , including gene , gene and gene .	T4	T22	23528251
CPR:3	CHEMICAL	GENE-Y	0	5	chemical ( PB ) , a typical gene activator , increased the gene expression of gene-target genes in the livers of mice , including gene , gene and gene .	T4	T23	23528251
CPR:3	CHEMICAL	GENE-Y	0	5	chemical ( PB ) , a typical gene activator , increased the gene expression of gene-target genes in the livers of mice , including gene , gene and gene .	T4	T24	23528251
CPR:3	CHEMICAL	GENE-N	0	4	chemical , a typical gene activator , induced the gene expression of gene-target genes , including gene and gene , an accumulation of nuclear gene and an increase in the gene-mediated transactivation in the mouse liver .	T5	T27	23528251
NA	CHEMICAL	GENE-Y	0	12	chemical , a typical gene activator , induced the gene expression of gene-target genes , including gene and gene , an accumulation of nuclear gene and an increase in the gene-mediated transactivation in the mouse liver .	T5	T28	23528251
CPR:3	CHEMICAL	GENE-Y	0	16	chemical , a typical gene activator , induced the gene expression of gene-target genes , including gene and gene , an accumulation of nuclear gene and an increase in the gene-mediated transactivation in the mouse liver .	T5	T29	23528251
CPR:3	CHEMICAL	GENE-Y	0	18	chemical , a typical gene activator , induced the gene expression of gene-target genes , including gene and gene , an accumulation of nuclear gene and an increase in the gene-mediated transactivation in the mouse liver .	T5	T30	23528251
NA	CHEMICAL	GENE-Y	0	24	chemical , a typical gene activator , induced the gene expression of gene-target genes , including gene and gene , an accumulation of nuclear gene and an increase in the gene-mediated transactivation in the mouse liver .	T5	T31	23528251
NA	CHEMICAL	GENE-N	0	30	chemical , a typical gene activator , induced the gene expression of gene-target genes , including gene and gene , an accumulation of nuclear gene and an increase in the gene-mediated transactivation in the mouse liver .	T5	T32	23528251
NA	CHEMICAL	GENE-N	0	11	chemical compounds regulate the level of ROS production by the chemical oxidase gene .	T15	T31	23583257
NA	CHEMICAL	GENE-Y	0	12	chemical compounds regulate the level of ROS production by the chemical oxidase gene .	T15	T32	23583257
NA	CHEMICAL	GENE-N	10	11	chemical compounds regulate the level of ROS production by the chemical oxidase gene .	T16	T31	23583257
NA	CHEMICAL	GENE-Y	10	12	chemical compounds regulate the level of ROS production by the chemical oxidase gene .	T16	T32	23583257
NA	CHEMICAL	GENE-N	0	1	chemical oxidase gene is expressed in a wide range of tissues and plays a role in cellular signaling by providing reactive chemical species ( ROS ) as intracellular messengers .	T1	T17	23583257
NA	CHEMICAL	GENE-Y	0	2	chemical oxidase gene is expressed in a wide range of tissues and plays a role in cellular signaling by providing reactive chemical species ( ROS ) as intracellular messengers .	T1	T19	23583257
NA	CHEMICAL	GENE-N	21	1	chemical oxidase gene is expressed in a wide range of tissues and plays a role in cellular signaling by providing reactive chemical species ( ROS ) as intracellular messengers .	T2	T17	23583257
NA	CHEMICAL	GENE-Y	21	2	chemical oxidase gene is expressed in a wide range of tissues and plays a role in cellular signaling by providing reactive chemical species ( ROS ) as intracellular messengers .	T2	T19	23583257
CPR:3	CHEMICAL	GENE-Y	27	0	gene gene activity is thought to be constitutive and regulated at the transcriptional level ; however , we challenge this point of view and suggest that specific chemical derivatives could modulate this activity .	T4	T20	23583257
CPR:3	CHEMICAL	GENE-N	27	1	gene gene activity is thought to be constitutive and regulated at the transcriptional level ; however , we challenge this point of view and suggest that specific chemical derivatives could modulate this activity .	T4	T21	23583257
CPR:3	CHEMICAL	GENE-Y	13	9	In fact , we demonstrated a significant stimulation of gene activity by 4 chemical derivatives ( chemical , chemical , chemical , and chemical ) observed in 3 different cellular models , HEK293E , T-REx™ , and chondrocyte cell lines .	T5	T22	23583257
CPR:3	CHEMICAL	GENE-Y	16	9	In fact , we demonstrated a significant stimulation of gene activity by 4 chemical derivatives ( chemical , chemical , chemical , and chemical ) observed in 3 different cellular models , HEK293E , T-REx™ , and chondrocyte cell lines .	T6	T22	23583257
CPR:3	CHEMICAL	GENE-Y	18	9	In fact , we demonstrated a significant stimulation of gene activity by 4 chemical derivatives ( chemical , chemical , chemical , and chemical ) observed in 3 different cellular models , HEK293E , T-REx™ , and chondrocyte cell lines .	T7	T22	23583257
CPR:3	CHEMICAL	GENE-Y	20	9	In fact , we demonstrated a significant stimulation of gene activity by 4 chemical derivatives ( chemical , chemical , chemical , and chemical ) observed in 3 different cellular models , HEK293E , T-REx™ , and chondrocyte cell lines .	T8	T22	23583257
CPR:3	CHEMICAL	GENE-Y	23	9	In fact , we demonstrated a significant stimulation of gene activity by 4 chemical derivatives ( chemical , chemical , chemical , and chemical ) observed in 3 different cellular models , HEK293E , T-REx™ , and chondrocyte cell lines .	T9	T22	23583257
NA	CHEMICAL	GENE-Y	5	8	Furthermore , we showed that chemical : chemical oxidoreductase ( gene ) may participate in this stimulation .	T10	T25	23583257
NA	CHEMICAL	GENE-Y	5	10	Furthermore , we showed that chemical : chemical oxidoreductase ( gene ) may participate in this stimulation .	T10	T26	23583257
NA	CHEMICAL	GENE-Y	7	8	Furthermore , we showed that chemical : chemical oxidoreductase ( gene ) may participate in this stimulation .	T11	T25	23583257
NA	CHEMICAL	GENE-Y	7	10	Furthermore , we showed that chemical : chemical oxidoreductase ( gene ) may participate in this stimulation .	T11	T26	23583257
NA	CHEMICAL	GENE-Y	4	2	Interestingly , gene activity is also stimulated by reducing agents that possibly act by reducing the chemical bridge ( chemical226 , chemical270 ) located in the gene of gene .	T12	T27	23583257
NA	CHEMICAL	GENE-N	4	26	Interestingly , gene activity is also stimulated by reducing agents that possibly act by reducing the chemical bridge ( chemical226 , chemical270 ) located in the gene of gene .	T12	T28	23583257
NA	CHEMICAL	GENE-Y	4	28	Interestingly , gene activity is also stimulated by reducing agents that possibly act by reducing the chemical bridge ( chemical226 , chemical270 ) located in the gene of gene .	T12	T29	23583257
NA	CHEMICAL	GENE-Y	19	2	Interestingly , gene activity is also stimulated by reducing agents that possibly act by reducing the chemical bridge ( chemical226 , chemical270 ) located in the gene of gene .	T13	T27	23583257
NA	CHEMICAL	GENE-N	19	26	Interestingly , gene activity is also stimulated by reducing agents that possibly act by reducing the chemical bridge ( chemical226 , chemical270 ) located in the gene of gene .	T13	T28	23583257
NA	CHEMICAL	GENE-Y	19	28	Interestingly , gene activity is also stimulated by reducing agents that possibly act by reducing the chemical bridge ( chemical226 , chemical270 ) located in the gene of gene .	T13	T29	23583257
NA	CHEMICAL	GENE-Y	21	2	Interestingly , gene activity is also stimulated by reducing agents that possibly act by reducing the chemical bridge ( chemical226 , chemical270 ) located in the gene of gene .	T14	T27	23583257
NA	CHEMICAL	GENE-N	21	26	Interestingly , gene activity is also stimulated by reducing agents that possibly act by reducing the chemical bridge ( chemical226 , chemical270 ) located in the gene of gene .	T14	T28	23583257
NA	CHEMICAL	GENE-Y	21	28	Interestingly , gene activity is also stimulated by reducing agents that possibly act by reducing the chemical bridge ( chemical226 , chemical270 ) located in the gene of gene .	T14	T29	23583257
CPR:3	CHEMICAL	GENE-Y	4	2	Activation of gene with chemical attenuates diabetes induced myocardial injury in rats .	T11	T25	23500772
NA	CHEMICAL	GENE-Y	6	6	This study assessed changes in myocardial gene expression in the diabetic rat , in particular the diabetic rat pretreated with gene activator chemical ( chemical ) .	T1	T18	23500772
CPR:3	CHEMICAL	GENE-Y	6	20	This study assessed changes in myocardial gene expression in the diabetic rat , in particular the diabetic rat pretreated with gene activator chemical ( chemical ) .	T1	T15	23500772
NA	CHEMICAL	GENE-Y	24	6	This study assessed changes in myocardial gene expression in the diabetic rat , in particular the diabetic rat pretreated with gene activator chemical ( chemical ) .	T2	T18	23500772
CPR:3	CHEMICAL	GENE-Y	24	20	This study assessed changes in myocardial gene expression in the diabetic rat , in particular the diabetic rat pretreated with gene activator chemical ( chemical ) .	T2	T15	23500772
NA	CHEMICAL	GENE-N	7	12	Compared with control group , fasting blood chemical ( FBG ) and gene ( gene ) levels were increased in DM groups .	T5	T16	23500772
NA	CHEMICAL	GENE-N	7	14	Compared with control group , fasting blood chemical ( FBG ) and gene ( gene ) levels were increased in DM groups .	T5	T17	23500772
NA	CHEMICAL	GENE-N	15	0	gene level in DM12W group was higher than in DM4W group , gene level in chemical+DM8W group was lower than in DM8W group .	T6	T19	23500772
CPR:4	CHEMICAL	GENE-N	15	12	gene level in DM12W group was higher than in DM4W group , gene level in chemical+DM8W group was lower than in DM8W group .	T6	T20	23500772
NA	CHEMICAL	GENE-N	15	4	In DM groups , gene activity , gene mRNA and protein levels were reduced , chemical content was increased compared with control group ; which decreased further as diabetes progressed .	T8	T21	23500772
NA	CHEMICAL	GENE-Y	15	7	In DM groups , gene activity , gene mRNA and protein levels were reduced , chemical content was increased compared with control group ; which decreased further as diabetes progressed .	T8	T22	23500772
CPR:3	CHEMICAL	GENE-N	9	5	Compared with DM8W group , gene and gene in chemical+DM8W group was increased , chemical was decreased .	T9	T23	23500772
CPR:3	CHEMICAL	GENE-Y	9	7	Compared with DM8W group , gene and gene in chemical+DM8W group was increased , chemical was decreased .	T9	T24	23500772
NA	CHEMICAL	GENE-N	14	5	Compared with DM8W group , gene and gene in chemical+DM8W group was increased , chemical was decreased .	T10	T23	23500772
NA	CHEMICAL	GENE-Y	14	7	Compared with DM8W group , gene and gene in chemical+DM8W group was increased , chemical was decreased .	T10	T24	23500772
NA	CHEMICAL	GENE-Y	8	2	Mice overexpressing gene exhibited at adult age impaired chemical tolerance associated with reduced insulin secretion , decreased β-cell mass , and β-cell hypotrophy .	T1	T21	23274887
NA	CHEMICAL	GENE-Y	5	13	In vitro inhibitory effects of non-chemical anti-inflammatory drugs on chemical glucuronidation in recombinant gene -- potent inhibition by chemical .	T27	T32	16278927
NA	CHEMICAL	GENE-Y	8	13	In vitro inhibitory effects of non-chemical anti-inflammatory drugs on chemical glucuronidation in recombinant gene -- potent inhibition by chemical .	T28	T32	16278927
CPR:4	CHEMICAL	GENE-Y	18	13	In vitro inhibitory effects of non-chemical anti-inflammatory drugs on chemical glucuronidation in recombinant gene -- potent inhibition by chemical .	T26	T32	16278927
NA	CHEMICAL	GENE-Y	4	15	The inhibitory potencies of non-chemical anti-inflammatory drugs ( NSAIDs ) on chemical-glucuronosyltransferase ( UGT ) 1A9 activity were investigated in recombinant gene using chemical ( chemical ) as a substrate for glucuronidation .	T5	T31	16278927
NA	CHEMICAL	GENE-Y	4	13	The inhibitory potencies of non-chemical anti-inflammatory drugs ( NSAIDs ) on chemical-glucuronosyltransferase ( UGT ) 1A9 activity were investigated in recombinant gene using chemical ( chemical ) as a substrate for glucuronidation .	T5	T30	16278927
NA	CHEMICAL	GENE-Y	11	15	The inhibitory potencies of non-chemical anti-inflammatory drugs ( NSAIDs ) on chemical-glucuronosyltransferase ( UGT ) 1A9 activity were investigated in recombinant gene using chemical ( chemical ) as a substrate for glucuronidation .	T21	T31	16278927
NA	CHEMICAL	GENE-Y	11	13	The inhibitory potencies of non-chemical anti-inflammatory drugs ( NSAIDs ) on chemical-glucuronosyltransferase ( UGT ) 1A9 activity were investigated in recombinant gene using chemical ( chemical ) as a substrate for glucuronidation .	T21	T30	16278927
NA	CHEMICAL	GENE-Y	10	15	The inhibitory potencies of non-chemical anti-inflammatory drugs ( NSAIDs ) on chemical-glucuronosyltransferase ( UGT ) 1A9 activity were investigated in recombinant gene using chemical ( chemical ) as a substrate for glucuronidation .	T2	T31	16278927
NA	CHEMICAL	GENE-Y	10	13	The inhibitory potencies of non-chemical anti-inflammatory drugs ( NSAIDs ) on chemical-glucuronosyltransferase ( UGT ) 1A9 activity were investigated in recombinant gene using chemical ( chemical ) as a substrate for glucuronidation .	T2	T30	16278927
NA	CHEMICAL	GENE-Y	21	15	The inhibitory potencies of non-chemical anti-inflammatory drugs ( NSAIDs ) on chemical-glucuronosyltransferase ( UGT ) 1A9 activity were investigated in recombinant gene using chemical ( chemical ) as a substrate for glucuronidation .	T3	T31	16278927
NA	CHEMICAL	GENE-Y	21	13	The inhibitory potencies of non-chemical anti-inflammatory drugs ( NSAIDs ) on chemical-glucuronosyltransferase ( UGT ) 1A9 activity were investigated in recombinant gene using chemical ( chemical ) as a substrate for glucuronidation .	T3	T30	16278927
NA	CHEMICAL	GENE-Y	14	6	Differential phosphoproteome of the striatum from gene knockout and gene knockout mice treated with chemical : Correlations with chemical-induced neurotoxicity .	T12	T38	23459167
NA	CHEMICAL	GENE-Y	14	9	Differential phosphoproteome of the striatum from gene knockout and gene knockout mice treated with chemical : Correlations with chemical-induced neurotoxicity .	T12	T39	23459167
NA	CHEMICAL	GENE-Y	18	6	Differential phosphoproteome of the striatum from gene knockout and gene knockout mice treated with chemical : Correlations with chemical-induced neurotoxicity .	T13	T38	23459167
NA	CHEMICAL	GENE-Y	18	9	Differential phosphoproteome of the striatum from gene knockout and gene knockout mice treated with chemical : Correlations with chemical-induced neurotoxicity .	T13	T39	23459167
NA	CHEMICAL	GENE-Y	17	3	The neurotrophic factors gene ( gene ) and gene ( gene ) have been shown to modulate chemical-induced neurotoxicity .	T10	T25	23459167
NA	CHEMICAL	GENE-Y	17	5	The neurotrophic factors gene ( gene ) and gene ( gene ) have been shown to modulate chemical-induced neurotoxicity .	T10	T26	23459167
NA	CHEMICAL	GENE-Y	17	8	The neurotrophic factors gene ( gene ) and gene ( gene ) have been shown to modulate chemical-induced neurotoxicity .	T10	T27	23459167
NA	CHEMICAL	GENE-Y	17	10	The neurotrophic factors gene ( gene ) and gene ( gene ) have been shown to modulate chemical-induced neurotoxicity .	T10	T28	23459167
NA	CHEMICAL	GENE-Y	11	2	Accordingly , gene-/- and gene-/- mice show an increased vulnerability to chemical-induced neurotoxic effects .	T6	T19	23459167
NA	CHEMICAL	GENE-Y	11	4	Accordingly , gene-/- and gene-/- mice show an increased vulnerability to chemical-induced neurotoxic effects .	T6	T20	23459167
NA	CHEMICAL	GENE-Y	10	61	In an effort to uncover new pharmacological targets to prevent chemical neurotoxic effects , we have now used a proteomic approach to study protein phosphorylation , in which we combined phosphoprotein enrichment , by immobilized metal affinity chromatography ( IMAC ) , with two-dimensional gel electrophoresis and mass spectrometry , in order to identify the phosphoproteins regulated in the striatum of gene-/- , gene-/- and wild type ( WT ) mice treated with chemical .	T7	T29	23459167
NA	CHEMICAL	GENE-Y	10	63	In an effort to uncover new pharmacological targets to prevent chemical neurotoxic effects , we have now used a proteomic approach to study protein phosphorylation , in which we combined phosphoprotein enrichment , by immobilized metal affinity chromatography ( IMAC ) , with two-dimensional gel electrophoresis and mass spectrometry , in order to identify the phosphoproteins regulated in the striatum of gene-/- , gene-/- and wild type ( WT ) mice treated with chemical .	T7	T30	23459167
NA	CHEMICAL	GENE-Y	18	61	In an effort to uncover new pharmacological targets to prevent chemical neurotoxic effects , we have now used a proteomic approach to study protein phosphorylation , in which we combined phosphoprotein enrichment , by immobilized metal affinity chromatography ( IMAC ) , with two-dimensional gel electrophoresis and mass spectrometry , in order to identify the phosphoproteins regulated in the striatum of gene-/- , gene-/- and wild type ( WT ) mice treated with chemical .	T8	T29	23459167
NA	CHEMICAL	GENE-Y	18	63	In an effort to uncover new pharmacological targets to prevent chemical neurotoxic effects , we have now used a proteomic approach to study protein phosphorylation , in which we combined phosphoprotein enrichment , by immobilized metal affinity chromatography ( IMAC ) , with two-dimensional gel electrophoresis and mass spectrometry , in order to identify the phosphoproteins regulated in the striatum of gene-/- , gene-/- and wild type ( WT ) mice treated with chemical .	T8	T30	23459167
NA	CHEMICAL	GENE-Y	12	17	We identified 13 differentially expressed phosphoproteins that are judged to be relevant in the neuroprotective roles of gene and gene against chemical-induced neurotoxicity .	T9	T31	23459167
NA	CHEMICAL	GENE-Y	12	19	We identified 13 differentially expressed phosphoproteins that are judged to be relevant in the neuroprotective roles of gene and gene against chemical-induced neurotoxicity .	T9	T32	23459167
NA	CHEMICAL	GENE-Y	22	12	It is very interesting to note that 4 of these phosphoproteins , gene ( gene ) , gene ( gene ) , chemical dehydrogenase family 1 member A1 ( gene ) and chemical kinase U-type ( gene ) , are known to be involved in Parkinson 's disease , a result of significant importance since gene and gene have been also demonstrated to limit Parkinson 's disease ( PD ) progress and have been suggested to be among the important genetic factors possibly preventing the development of PD in chemical abusers .	T11	T33	23459167
NA	CHEMICAL	GENE-Y	22	14	It is very interesting to note that 4 of these phosphoproteins , gene ( gene ) , gene ( gene ) , chemical dehydrogenase family 1 member A1 ( gene ) and chemical kinase U-type ( gene ) , are known to be involved in Parkinson 's disease , a result of significant importance since gene and gene have been also demonstrated to limit Parkinson 's disease ( PD ) progress and have been suggested to be among the important genetic factors possibly preventing the development of PD in chemical abusers .	T11	T34	23459167
NA	CHEMICAL	GENE-Y	22	17	It is very interesting to note that 4 of these phosphoproteins , gene ( gene ) , gene ( gene ) , chemical dehydrogenase family 1 member A1 ( gene ) and chemical kinase U-type ( gene ) , are known to be involved in Parkinson 's disease , a result of significant importance since gene and gene have been also demonstrated to limit Parkinson 's disease ( PD ) progress and have been suggested to be among the important genetic factors possibly preventing the development of PD in chemical abusers .	T11	T35	23459167
NA	CHEMICAL	GENE-Y	22	19	It is very interesting to note that 4 of these phosphoproteins , gene ( gene ) , gene ( gene ) , chemical dehydrogenase family 1 member A1 ( gene ) and chemical kinase U-type ( gene ) , are known to be involved in Parkinson 's disease , a result of significant importance since gene and gene have been also demonstrated to limit Parkinson 's disease ( PD ) progress and have been suggested to be among the important genetic factors possibly preventing the development of PD in chemical abusers .	T11	T36	23459167
NA	CHEMICAL	GENE-Y	22	25	It is very interesting to note that 4 of these phosphoproteins , gene ( gene ) , gene ( gene ) , chemical dehydrogenase family 1 member A1 ( gene ) and chemical kinase U-type ( gene ) , are known to be involved in Parkinson 's disease , a result of significant importance since gene and gene have been also demonstrated to limit Parkinson 's disease ( PD ) progress and have been suggested to be among the important genetic factors possibly preventing the development of PD in chemical abusers .	T11	T37	23459167
NA	CHEMICAL	GENE-Y	22	25	It is very interesting to note that 4 of these phosphoproteins , gene ( gene ) , gene ( gene ) , chemical dehydrogenase family 1 member A1 ( gene ) and chemical kinase U-type ( gene ) , are known to be involved in Parkinson 's disease , a result of significant importance since gene and gene have been also demonstrated to limit Parkinson 's disease ( PD ) progress and have been suggested to be among the important genetic factors possibly preventing the development of PD in chemical abusers .	T11	T14	23459167
NA	CHEMICAL	GENE-Y	22	34	It is very interesting to note that 4 of these phosphoproteins , gene ( gene ) , gene ( gene ) , chemical dehydrogenase family 1 member A1 ( gene ) and chemical kinase U-type ( gene ) , are known to be involved in Parkinson 's disease , a result of significant importance since gene and gene have been also demonstrated to limit Parkinson 's disease ( PD ) progress and have been suggested to be among the important genetic factors possibly preventing the development of PD in chemical abusers .	T11	T15	23459167
NA	CHEMICAL	GENE-Y	22	25	It is very interesting to note that 4 of these phosphoproteins , gene ( gene ) , gene ( gene ) , chemical dehydrogenase family 1 member A1 ( gene ) and chemical kinase U-type ( gene ) , are known to be involved in Parkinson 's disease , a result of significant importance since gene and gene have been also demonstrated to limit Parkinson 's disease ( PD ) progress and have been suggested to be among the important genetic factors possibly preventing the development of PD in chemical abusers .	T11	T16	23459167
NA	CHEMICAL	GENE-Y	22	55	It is very interesting to note that 4 of these phosphoproteins , gene ( gene ) , gene ( gene ) , chemical dehydrogenase family 1 member A1 ( gene ) and chemical kinase U-type ( gene ) , are known to be involved in Parkinson 's disease , a result of significant importance since gene and gene have been also demonstrated to limit Parkinson 's disease ( PD ) progress and have been suggested to be among the important genetic factors possibly preventing the development of PD in chemical abusers .	T11	T17	23459167
NA	CHEMICAL	GENE-Y	22	57	It is very interesting to note that 4 of these phosphoproteins , gene ( gene ) , gene ( gene ) , chemical dehydrogenase family 1 member A1 ( gene ) and chemical kinase U-type ( gene ) , are known to be involved in Parkinson 's disease , a result of significant importance since gene and gene have been also demonstrated to limit Parkinson 's disease ( PD ) progress and have been suggested to be among the important genetic factors possibly preventing the development of PD in chemical abusers .	T11	T18	23459167
NA	CHEMICAL	GENE-Y	22	12	It is very interesting to note that 4 of these phosphoproteins , gene ( gene ) , gene ( gene ) , chemical dehydrogenase family 1 member A1 ( gene ) and chemical kinase U-type ( gene ) , are known to be involved in Parkinson 's disease , a result of significant importance since gene and gene have been also demonstrated to limit Parkinson 's disease ( PD ) progress and have been suggested to be among the important genetic factors possibly preventing the development of PD in chemical abusers .	T1	T33	23459167
NA	CHEMICAL	GENE-Y	22	14	It is very interesting to note that 4 of these phosphoproteins , gene ( gene ) , gene ( gene ) , chemical dehydrogenase family 1 member A1 ( gene ) and chemical kinase U-type ( gene ) , are known to be involved in Parkinson 's disease , a result of significant importance since gene and gene have been also demonstrated to limit Parkinson 's disease ( PD ) progress and have been suggested to be among the important genetic factors possibly preventing the development of PD in chemical abusers .	T1	T34	23459167
NA	CHEMICAL	GENE-Y	22	17	It is very interesting to note that 4 of these phosphoproteins , gene ( gene ) , gene ( gene ) , chemical dehydrogenase family 1 member A1 ( gene ) and chemical kinase U-type ( gene ) , are known to be involved in Parkinson 's disease , a result of significant importance since gene and gene have been also demonstrated to limit Parkinson 's disease ( PD ) progress and have been suggested to be among the important genetic factors possibly preventing the development of PD in chemical abusers .	T1	T35	23459167
NA	CHEMICAL	GENE-Y	22	19	It is very interesting to note that 4 of these phosphoproteins , gene ( gene ) , gene ( gene ) , chemical dehydrogenase family 1 member A1 ( gene ) and chemical kinase U-type ( gene ) , are known to be involved in Parkinson 's disease , a result of significant importance since gene and gene have been also demonstrated to limit Parkinson 's disease ( PD ) progress and have been suggested to be among the important genetic factors possibly preventing the development of PD in chemical abusers .	T1	T36	23459167
NA	CHEMICAL	GENE-Y	22	25	It is very interesting to note that 4 of these phosphoproteins , gene ( gene ) , gene ( gene ) , chemical dehydrogenase family 1 member A1 ( gene ) and chemical kinase U-type ( gene ) , are known to be involved in Parkinson 's disease , a result of significant importance since gene and gene have been also demonstrated to limit Parkinson 's disease ( PD ) progress and have been suggested to be among the important genetic factors possibly preventing the development of PD in chemical abusers .	T1	T37	23459167
NA	CHEMICAL	GENE-Y	22	25	It is very interesting to note that 4 of these phosphoproteins , gene ( gene ) , gene ( gene ) , chemical dehydrogenase family 1 member A1 ( gene ) and chemical kinase U-type ( gene ) , are known to be involved in Parkinson 's disease , a result of significant importance since gene and gene have been also demonstrated to limit Parkinson 's disease ( PD ) progress and have been suggested to be among the important genetic factors possibly preventing the development of PD in chemical abusers .	T1	T14	23459167
NA	CHEMICAL	GENE-Y	22	34	It is very interesting to note that 4 of these phosphoproteins , gene ( gene ) , gene ( gene ) , chemical dehydrogenase family 1 member A1 ( gene ) and chemical kinase U-type ( gene ) , are known to be involved in Parkinson 's disease , a result of significant importance since gene and gene have been also demonstrated to limit Parkinson 's disease ( PD ) progress and have been suggested to be among the important genetic factors possibly preventing the development of PD in chemical abusers .	T1	T15	23459167
NA	CHEMICAL	GENE-Y	22	25	It is very interesting to note that 4 of these phosphoproteins , gene ( gene ) , gene ( gene ) , chemical dehydrogenase family 1 member A1 ( gene ) and chemical kinase U-type ( gene ) , are known to be involved in Parkinson 's disease , a result of significant importance since gene and gene have been also demonstrated to limit Parkinson 's disease ( PD ) progress and have been suggested to be among the important genetic factors possibly preventing the development of PD in chemical abusers .	T1	T16	23459167
NA	CHEMICAL	GENE-Y	22	55	It is very interesting to note that 4 of these phosphoproteins , gene ( gene ) , gene ( gene ) , chemical dehydrogenase family 1 member A1 ( gene ) and chemical kinase U-type ( gene ) , are known to be involved in Parkinson 's disease , a result of significant importance since gene and gene have been also demonstrated to limit Parkinson 's disease ( PD ) progress and have been suggested to be among the important genetic factors possibly preventing the development of PD in chemical abusers .	T1	T17	23459167
NA	CHEMICAL	GENE-Y	22	57	It is very interesting to note that 4 of these phosphoproteins , gene ( gene ) , gene ( gene ) , chemical dehydrogenase family 1 member A1 ( gene ) and chemical kinase U-type ( gene ) , are known to be involved in Parkinson 's disease , a result of significant importance since gene and gene have been also demonstrated to limit Parkinson 's disease ( PD ) progress and have been suggested to be among the important genetic factors possibly preventing the development of PD in chemical abusers .	T1	T18	23459167
NA	CHEMICAL	GENE-Y	44	12	It is very interesting to note that 4 of these phosphoproteins , gene ( gene ) , gene ( gene ) , chemical dehydrogenase family 1 member A1 ( gene ) and chemical kinase U-type ( gene ) , are known to be involved in Parkinson 's disease , a result of significant importance since gene and gene have been also demonstrated to limit Parkinson 's disease ( PD ) progress and have been suggested to be among the important genetic factors possibly preventing the development of PD in chemical abusers .	T2	T33	23459167
NA	CHEMICAL	GENE-Y	44	14	It is very interesting to note that 4 of these phosphoproteins , gene ( gene ) , gene ( gene ) , chemical dehydrogenase family 1 member A1 ( gene ) and chemical kinase U-type ( gene ) , are known to be involved in Parkinson 's disease , a result of significant importance since gene and gene have been also demonstrated to limit Parkinson 's disease ( PD ) progress and have been suggested to be among the important genetic factors possibly preventing the development of PD in chemical abusers .	T2	T34	23459167
NA	CHEMICAL	GENE-Y	44	17	It is very interesting to note that 4 of these phosphoproteins , gene ( gene ) , gene ( gene ) , chemical dehydrogenase family 1 member A1 ( gene ) and chemical kinase U-type ( gene ) , are known to be involved in Parkinson 's disease , a result of significant importance since gene and gene have been also demonstrated to limit Parkinson 's disease ( PD ) progress and have been suggested to be among the important genetic factors possibly preventing the development of PD in chemical abusers .	T2	T35	23459167
NA	CHEMICAL	GENE-Y	44	19	It is very interesting to note that 4 of these phosphoproteins , gene ( gene ) , gene ( gene ) , chemical dehydrogenase family 1 member A1 ( gene ) and chemical kinase U-type ( gene ) , are known to be involved in Parkinson 's disease , a result of significant importance since gene and gene have been also demonstrated to limit Parkinson 's disease ( PD ) progress and have been suggested to be among the important genetic factors possibly preventing the development of PD in chemical abusers .	T2	T36	23459167
NA	CHEMICAL	GENE-Y	44	25	It is very interesting to note that 4 of these phosphoproteins , gene ( gene ) , gene ( gene ) , chemical dehydrogenase family 1 member A1 ( gene ) and chemical kinase U-type ( gene ) , are known to be involved in Parkinson 's disease , a result of significant importance since gene and gene have been also demonstrated to limit Parkinson 's disease ( PD ) progress and have been suggested to be among the important genetic factors possibly preventing the development of PD in chemical abusers .	T2	T37	23459167
NA	CHEMICAL	GENE-Y	44	25	It is very interesting to note that 4 of these phosphoproteins , gene ( gene ) , gene ( gene ) , chemical dehydrogenase family 1 member A1 ( gene ) and chemical kinase U-type ( gene ) , are known to be involved in Parkinson 's disease , a result of significant importance since gene and gene have been also demonstrated to limit Parkinson 's disease ( PD ) progress and have been suggested to be among the important genetic factors possibly preventing the development of PD in chemical abusers .	T2	T14	23459167
NA	CHEMICAL	GENE-Y	44	34	It is very interesting to note that 4 of these phosphoproteins , gene ( gene ) , gene ( gene ) , chemical dehydrogenase family 1 member A1 ( gene ) and chemical kinase U-type ( gene ) , are known to be involved in Parkinson 's disease , a result of significant importance since gene and gene have been also demonstrated to limit Parkinson 's disease ( PD ) progress and have been suggested to be among the important genetic factors possibly preventing the development of PD in chemical abusers .	T2	T15	23459167
NA	CHEMICAL	GENE-Y	44	25	It is very interesting to note that 4 of these phosphoproteins , gene ( gene ) , gene ( gene ) , chemical dehydrogenase family 1 member A1 ( gene ) and chemical kinase U-type ( gene ) , are known to be involved in Parkinson 's disease , a result of significant importance since gene and gene have been also demonstrated to limit Parkinson 's disease ( PD ) progress and have been suggested to be among the important genetic factors possibly preventing the development of PD in chemical abusers .	T2	T16	23459167
NA	CHEMICAL	GENE-Y	44	55	It is very interesting to note that 4 of these phosphoproteins , gene ( gene ) , gene ( gene ) , chemical dehydrogenase family 1 member A1 ( gene ) and chemical kinase U-type ( gene ) , are known to be involved in Parkinson 's disease , a result of significant importance since gene and gene have been also demonstrated to limit Parkinson 's disease ( PD ) progress and have been suggested to be among the important genetic factors possibly preventing the development of PD in chemical abusers .	T2	T17	23459167
NA	CHEMICAL	GENE-Y	44	57	It is very interesting to note that 4 of these phosphoproteins , gene ( gene ) , gene ( gene ) , chemical dehydrogenase family 1 member A1 ( gene ) and chemical kinase U-type ( gene ) , are known to be involved in Parkinson 's disease , a result of significant importance since gene and gene have been also demonstrated to limit Parkinson 's disease ( PD ) progress and have been suggested to be among the important genetic factors possibly preventing the development of PD in chemical abusers .	T2	T18	23459167
NA	CHEMICAL	GENE-Y	7	14	The data identify phosphoproteins differentially regulated by chemical treatment and/or the presence of endogenous gene/gene which may be relevant mediators of gene/gene neuroprotective effects against chemical-induced neurotoxicity .	T3	T21	23459167
NA	CHEMICAL	GENE-Y	7	14	The data identify phosphoproteins differentially regulated by chemical treatment and/or the presence of endogenous gene/gene which may be relevant mediators of gene/gene neuroprotective effects against chemical-induced neurotoxicity .	T3	T22	23459167
NA	CHEMICAL	GENE-Y	7	21	The data identify phosphoproteins differentially regulated by chemical treatment and/or the presence of endogenous gene/gene which may be relevant mediators of gene/gene neuroprotective effects against chemical-induced neurotoxicity .	T3	T23	23459167
NA	CHEMICAL	GENE-Y	7	21	The data identify phosphoproteins differentially regulated by chemical treatment and/or the presence of endogenous gene/gene which may be relevant mediators of gene/gene neuroprotective effects against chemical-induced neurotoxicity .	T3	T24	23459167
NA	CHEMICAL	GENE-Y	25	14	The data identify phosphoproteins differentially regulated by chemical treatment and/or the presence of endogenous gene/gene which may be relevant mediators of gene/gene neuroprotective effects against chemical-induced neurotoxicity .	T4	T21	23459167
NA	CHEMICAL	GENE-Y	25	14	The data identify phosphoproteins differentially regulated by chemical treatment and/or the presence of endogenous gene/gene which may be relevant mediators of gene/gene neuroprotective effects against chemical-induced neurotoxicity .	T4	T22	23459167
NA	CHEMICAL	GENE-Y	25	21	The data identify phosphoproteins differentially regulated by chemical treatment and/or the presence of endogenous gene/gene which may be relevant mediators of gene/gene neuroprotective effects against chemical-induced neurotoxicity .	T4	T23	23459167
NA	CHEMICAL	GENE-Y	25	21	The data identify phosphoproteins differentially regulated by chemical treatment and/or the presence of endogenous gene/gene which may be relevant mediators of gene/gene neuroprotective effects against chemical-induced neurotoxicity .	T4	T24	23459167
NA	CHEMICAL	GENE-Y	4	11	Cooperative homotropic interaction of chemical with the catalytic site of chemical 4-monooxygenase .	T23	T31	2226440
NA	CHEMICAL	GENE-Y	10	11	Cooperative homotropic interaction of chemical with the catalytic site of chemical 4-monooxygenase .	T24	T31	2226440
CPR:4	CHEMICAL	GENE-Y	0	13	chemical ( chemical , chemical and chemical ) are potent inhibitors of chemical 4-monooxygenase ( chemical hydroxylase , gene ) .	T1	T30	2226440
CPR:4	CHEMICAL	GENE-Y	0	16	chemical ( chemical , chemical and chemical ) are potent inhibitors of chemical 4-monooxygenase ( chemical hydroxylase , gene ) .	T1	T25	2226440
CPR:4	CHEMICAL	GENE-Y	0	18	chemical ( chemical , chemical and chemical ) are potent inhibitors of chemical 4-monooxygenase ( chemical hydroxylase , gene ) .	T1	T26	2226440
CPR:4	CHEMICAL	GENE-Y	2	13	chemical ( chemical , chemical and chemical ) are potent inhibitors of chemical 4-monooxygenase ( chemical hydroxylase , gene ) .	T11	T30	2226440
CPR:4	CHEMICAL	GENE-Y	2	16	chemical ( chemical , chemical and chemical ) are potent inhibitors of chemical 4-monooxygenase ( chemical hydroxylase , gene ) .	T11	T25	2226440
CPR:4	CHEMICAL	GENE-Y	2	18	chemical ( chemical , chemical and chemical ) are potent inhibitors of chemical 4-monooxygenase ( chemical hydroxylase , gene ) .	T11	T26	2226440
CPR:4	CHEMICAL	GENE-Y	4	13	chemical ( chemical , chemical and chemical ) are potent inhibitors of chemical 4-monooxygenase ( chemical hydroxylase , gene ) .	T15	T30	2226440
CPR:4	CHEMICAL	GENE-Y	4	16	chemical ( chemical , chemical and chemical ) are potent inhibitors of chemical 4-monooxygenase ( chemical hydroxylase , gene ) .	T15	T25	2226440
CPR:4	CHEMICAL	GENE-Y	4	18	chemical ( chemical , chemical and chemical ) are potent inhibitors of chemical 4-monooxygenase ( chemical hydroxylase , gene ) .	T15	T26	2226440
CPR:4	CHEMICAL	GENE-Y	6	13	chemical ( chemical , chemical and chemical ) are potent inhibitors of chemical 4-monooxygenase ( chemical hydroxylase , gene ) .	T16	T30	2226440
CPR:4	CHEMICAL	GENE-Y	6	16	chemical ( chemical , chemical and chemical ) are potent inhibitors of chemical 4-monooxygenase ( chemical hydroxylase , gene ) .	T16	T25	2226440
CPR:4	CHEMICAL	GENE-Y	6	18	chemical ( chemical , chemical and chemical ) are potent inhibitors of chemical 4-monooxygenase ( chemical hydroxylase , gene ) .	T16	T26	2226440
NA	CHEMICAL	GENE-Y	12	13	chemical ( chemical , chemical and chemical ) are potent inhibitors of chemical 4-monooxygenase ( chemical hydroxylase , gene ) .	T21	T30	2226440
NA	CHEMICAL	GENE-Y	12	16	chemical ( chemical , chemical and chemical ) are potent inhibitors of chemical 4-monooxygenase ( chemical hydroxylase , gene ) .	T21	T25	2226440
NA	CHEMICAL	GENE-Y	12	18	chemical ( chemical , chemical and chemical ) are potent inhibitors of chemical 4-monooxygenase ( chemical hydroxylase , gene ) .	T21	T26	2226440
NA	CHEMICAL	GENE-Y	15	13	chemical ( chemical , chemical and chemical ) are potent inhibitors of chemical 4-monooxygenase ( chemical hydroxylase , gene ) .	T3	T30	2226440
NA	CHEMICAL	GENE-Y	15	16	chemical ( chemical , chemical and chemical ) are potent inhibitors of chemical 4-monooxygenase ( chemical hydroxylase , gene ) .	T3	T25	2226440
NA	CHEMICAL	GENE-Y	15	18	chemical ( chemical , chemical and chemical ) are potent inhibitors of chemical 4-monooxygenase ( chemical hydroxylase , gene ) .	T3	T26	2226440
NA	CHEMICAL	GENE-Y	4	7	The high-affinity binding of chemical to chemical hydroxylase , as studied by equilibrium microdialysis ( anaerobically ) and ultrafiltration ( aerobically ) , shows positive cooperativity ( h = 1.9 ) ; at pH 7.2 and 20 degrees C the rat enzyme binds about 0.5 mol chemical/mol subunit with a half-maximal binding ( S50 ) at 0.25 microM chemical .	T18	T29	2226440
NA	CHEMICAL	GENE-Y	6	7	The high-affinity binding of chemical to chemical hydroxylase , as studied by equilibrium microdialysis ( anaerobically ) and ultrafiltration ( aerobically ) , shows positive cooperativity ( h = 1.9 ) ; at pH 7.2 and 20 degrees C the rat enzyme binds about 0.5 mol chemical/mol subunit with a half-maximal binding ( S50 ) at 0.25 microM chemical .	T19	T29	2226440
NA	CHEMICAL	GENE-Y	46	7	The high-affinity binding of chemical to chemical hydroxylase , as studied by equilibrium microdialysis ( anaerobically ) and ultrafiltration ( aerobically ) , shows positive cooperativity ( h = 1.9 ) ; at pH 7.2 and 20 degrees C the rat enzyme binds about 0.5 mol chemical/mol subunit with a half-maximal binding ( S50 ) at 0.25 microM chemical .	T20	T29	2226440
NA	CHEMICAL	GENE-Y	49	7	The high-affinity binding of chemical to chemical hydroxylase , as studied by equilibrium microdialysis ( anaerobically ) and ultrafiltration ( aerobically ) , shows positive cooperativity ( h = 1.9 ) ; at pH 7.2 and 20 degrees C the rat enzyme binds about 0.5 mol chemical/mol subunit with a half-maximal binding ( S50 ) at 0.25 microM chemical .	T22	T29	2226440
NA	CHEMICAL	GENE-Y	0	8	chemical and chemical hypersensitivity of yeast cells overexpressing gene .	T4	T13	1322791
NA	CHEMICAL	GENE-Y	2	8	chemical and chemical hypersensitivity of yeast cells overexpressing gene .	T5	T13	1322791
NA	CHEMICAL	GENE-Y	5	5	Increasing the cellular concentration of gene in yeast by expressing constitutively a plasmid-borne gene gene encoding the enzyme greatly increases the sensitivity of the cells to chemical and chemical ( chemical ) .	T1	T10	1322791
NA	CHEMICAL	GENE-Y	5	13	Increasing the cellular concentration of gene in yeast by expressing constitutively a plasmid-borne gene gene encoding the enzyme greatly increases the sensitivity of the cells to chemical and chemical ( chemical ) .	T1	T6	1322791
NA	CHEMICAL	GENE-Y	25	5	Increasing the cellular concentration of gene in yeast by expressing constitutively a plasmid-borne gene gene encoding the enzyme greatly increases the sensitivity of the cells to chemical and chemical ( chemical ) .	T2	T10	1322791
NA	CHEMICAL	GENE-Y	25	13	Increasing the cellular concentration of gene in yeast by expressing constitutively a plasmid-borne gene gene encoding the enzyme greatly increases the sensitivity of the cells to chemical and chemical ( chemical ) .	T2	T6	1322791
NA	CHEMICAL	GENE-Y	30	5	Increasing the cellular concentration of gene in yeast by expressing constitutively a plasmid-borne gene gene encoding the enzyme greatly increases the sensitivity of the cells to chemical and chemical ( chemical ) .	T3	T10	1322791
NA	CHEMICAL	GENE-Y	30	13	Increasing the cellular concentration of gene in yeast by expressing constitutively a plasmid-borne gene gene encoding the enzyme greatly increases the sensitivity of the cells to chemical and chemical ( chemical ) .	T3	T6	1322791
NA	CHEMICAL	GENE-N	2	14	Degradation of chemical and studies of the interaction of resulting chemical compounds with the gene targeting gene gene .	T9	T22	23473681
NA	CHEMICAL	GENE-N	2	16	Degradation of chemical and studies of the interaction of resulting chemical compounds with the gene targeting gene gene .	T9	T20	23473681
NA	CHEMICAL	GENE-N	2	17	Degradation of chemical and studies of the interaction of resulting chemical compounds with the gene targeting gene gene .	T9	T21	23473681
NA	CHEMICAL	GENE-N	10	14	Degradation of chemical and studies of the interaction of resulting chemical compounds with the gene targeting gene gene .	T10	T22	23473681
NA	CHEMICAL	GENE-N	10	16	Degradation of chemical and studies of the interaction of resulting chemical compounds with the gene targeting gene gene .	T10	T20	23473681
NA	CHEMICAL	GENE-N	10	17	Degradation of chemical and studies of the interaction of resulting chemical compounds with the gene targeting gene gene .	T10	T21	23473681
CPR:4	CHEMICAL	GENE-N	14	22	We previously employed a chemical genomic strategy to identify a novel small molecule , chemical , as a likely inhibitor of the gene targeting gene , gene .	T2	T13	23473681
CPR:4	CHEMICAL	GENE-N	14	3	We previously employed a chemical genomic strategy to identify a novel small molecule , chemical , as a likely inhibitor of the gene targeting gene , gene .	T2	T14	23473681
CPR:4	CHEMICAL	GENE-N	14	26	We previously employed a chemical genomic strategy to identify a novel small molecule , chemical , as a likely inhibitor of the gene targeting gene , gene .	T2	T15	23473681
NA	CHEMICAL	GENE-N	9	30	Herein , we demonstrate that the antibacterial activity of chemical and the chemical compounds are similar ; these activities are suppressed or sensitized in response to increases or decreases of gene copy number , respectively .	T5	T18	23473681
NA	CHEMICAL	GENE-N	12	30	Herein , we demonstrate that the antibacterial activity of chemical and the chemical compounds are similar ; these activities are suppressed or sensitized in response to increases or decreases of gene copy number , respectively .	T6	T18	23473681
NA	CHEMICAL	GENE-N	7	11	We provide STD NMR data which confirms a physical interaction between gene and the chemical degradation product of chemical , with a Kd of ~150 μM .	T7	T19	23473681
NA	CHEMICAL	GENE-N	18	11	We provide STD NMR data which confirms a physical interaction between gene and the chemical degradation product of chemical , with a Kd of ~150 μM .	T8	T19	23473681
CPR:3	CHEMICAL	GENE-Y	1	21	Pretreatment of human breast carcinoma MCF-7 cells for 24 h with the groundnut extract and soybean chemical increased gene expression of gene ( gene ) , a major antioxidative stress enzyme .	T5	T12	23265491
CPR:3	CHEMICAL	GENE-Y	1	23	Pretreatment of human breast carcinoma MCF-7 cells for 24 h with the groundnut extract and soybean chemical increased gene expression of gene ( gene ) , a major antioxidative stress enzyme .	T5	T13	23265491
CPR:4	CHEMICAL	GENE-Y	2	10	Synthesis and in vitro evaluation of chemical derivatives as potent gene inhibitors .	T5	T12	23497227
CPR:4	CHEMICAL	GENE-Y	3	15	A series of chemical have been synthesised , characterised and tested for their in vitro gene chemical kinase inhibitory activity .	T2	T11	23497227
CPR:4	CHEMICAL	GENE-N	3	13	A series of chemical have been synthesised , characterised and tested for their in vitro gene chemical kinase inhibitory activity .	T2	T6	23497227
NA	CHEMICAL	GENE-Y	13	15	A series of chemical have been synthesised , characterised and tested for their in vitro gene chemical kinase inhibitory activity .	T1	T11	23497227
NA	CHEMICAL	GENE-N	13	13	A series of chemical have been synthesised , characterised and tested for their in vitro gene chemical kinase inhibitory activity .	T1	T6	23497227
NA	CHEMICAL	GENE-Y	10	2	Interactions between gene and gene : effects on affinity for chemical-cytochrome P450 reductase and substrate metabolism .	T6	T43	23043184
NA	CHEMICAL	GENE-Y	10	4	Interactions between gene and gene : effects on affinity for chemical-cytochrome P450 reductase and substrate metabolism .	T6	T44	23043184
NA	CHEMICAL	GENE-Y	10	12	Interactions between gene and gene : effects on affinity for chemical-cytochrome P450 reductase and substrate metabolism .	T6	T45	23043184
NA	CHEMICAL	GENE-Y	4	4	The results show that gene inhibits gene-mediated metabolism of chemical ( chemical ) with a K ( i ) of 0.04 µM .	T2	T28	23043184
CPR:9	CHEMICAL	GENE-Y	4	6	The results show that gene inhibits gene-mediated metabolism of chemical ( chemical ) with a K ( i ) of 0.04 µM .	T2	T29	23043184
NA	CHEMICAL	GENE-Y	11	4	The results show that gene inhibits gene-mediated metabolism of chemical ( chemical ) with a K ( i ) of 0.04 µM .	T3	T28	23043184
CPR:9	CHEMICAL	GENE-Y	11	6	The results show that gene inhibits gene-mediated metabolism of chemical ( chemical ) with a K ( i ) of 0.04 µM .	T3	T29	23043184
NA	CHEMICAL	GENE-Y	9	2	However , gene is not an inhibitor of gene-mediated chemical hydroxylation .	T4	T30	23043184
CPR:9	CHEMICAL	GENE-Y	9	8	However , gene is not an inhibitor of gene-mediated chemical hydroxylation .	T4	T31	23043184
NA	CHEMICAL	GENE-Y	10	12	When these inhibition studies were performed with the artificial oxidant chemical , gene did not significantly inhibit gene activity .	T5	T32	23043184
NA	CHEMICAL	GENE-Y	10	17	When these inhibition studies were performed with the artificial oxidant chemical , gene did not significantly inhibit gene activity .	T5	T33	23043184
NA	CHEMICAL	GENE-Y	2	2	Additionally , gene increased the apparent K ( M ) of gene for chemical by 8-fold and the apparent K ( M ) did not decrease to its original value when saturating concentrations of gene were used .	T1	T11	23043184
NA	CHEMICAL	GENE-Y	2	11	Additionally , gene increased the apparent K ( M ) of gene for chemical by 8-fold and the apparent K ( M ) did not decrease to its original value when saturating concentrations of gene were used .	T1	T12	23043184
NA	CHEMICAL	GENE-Y	2	34	Additionally , gene increased the apparent K ( M ) of gene for chemical by 8-fold and the apparent K ( M ) did not decrease to its original value when saturating concentrations of gene were used .	T1	T13	23043184
CPR:4	CHEMICAL	GENE-Y	32	42	Pharmacological treatment has been studied and it could be demonstrated , that some mutant currents may be insufficiently suppressed by drugs targeted to block the specific current such as , e.g. , chemical or chemical in patients with a mutation in the gene-coding gene gene ( gene ) .	T1	T4	17497253
CPR:4	CHEMICAL	GENE-Y	32	44	Pharmacological treatment has been studied and it could be demonstrated , that some mutant currents may be insufficiently suppressed by drugs targeted to block the specific current such as , e.g. , chemical or chemical in patients with a mutation in the gene-coding gene gene ( gene ) .	T1	T5	17497253
CPR:4	CHEMICAL	GENE-Y	32	46	Pharmacological treatment has been studied and it could be demonstrated , that some mutant currents may be insufficiently suppressed by drugs targeted to block the specific current such as , e.g. , chemical or chemical in patients with a mutation in the gene-coding gene gene ( gene ) .	T1	T6	17497253
CPR:4	CHEMICAL	GENE-Y	34	42	Pharmacological treatment has been studied and it could be demonstrated , that some mutant currents may be insufficiently suppressed by drugs targeted to block the specific current such as , e.g. , chemical or chemical in patients with a mutation in the gene-coding gene gene ( gene ) .	T2	T4	17497253
CPR:4	CHEMICAL	GENE-Y	34	44	Pharmacological treatment has been studied and it could be demonstrated , that some mutant currents may be insufficiently suppressed by drugs targeted to block the specific current such as , e.g. , chemical or chemical in patients with a mutation in the gene-coding gene gene ( gene ) .	T2	T5	17497253
CPR:4	CHEMICAL	GENE-Y	34	46	Pharmacological treatment has been studied and it could be demonstrated , that some mutant currents may be insufficiently suppressed by drugs targeted to block the specific current such as , e.g. , chemical or chemical in patients with a mutation in the gene-coding gene gene ( gene ) .	T2	T6	17497253
CPR:6	CHEMICAL	GENE-Y	0	3	chemical , an gene antagonist , inhibits the positive inotropic effect but not the accumulation of chemical in rabbit heart .	T26	T35	8894610
NA	CHEMICAL	GENE-Y	16	3	chemical , an gene antagonist , inhibits the positive inotropic effect but not the accumulation of chemical in rabbit heart .	T27	T35	8894610
CPR:6	CHEMICAL	GENE-Y	3	5	The influence of chemical , a selective gene antagonist , on the positive inotropic effect and the accumulation of chemical that are induced via gene was studied in comparison with that of another gene ligand chemical in the rabbit ventricular myocardium .	T13	T34	8894610
NA	CHEMICAL	GENE-N	3	5	The influence of chemical , a selective gene antagonist , on the positive inotropic effect and the accumulation of chemical that are induced via gene was studied in comparison with that of another gene ligand chemical in the rabbit ventricular myocardium .	T13	T30	8894610
NA	CHEMICAL	GENE-Y	3	5	The influence of chemical , a selective gene antagonist , on the positive inotropic effect and the accumulation of chemical that are induced via gene was studied in comparison with that of another gene ligand chemical in the rabbit ventricular myocardium .	T13	T32	8894610
NA	CHEMICAL	GENE-Y	5	5	The influence of chemical , a selective gene antagonist , on the positive inotropic effect and the accumulation of chemical that are induced via gene was studied in comparison with that of another gene ligand chemical in the rabbit ventricular myocardium .	T6	T34	8894610
NA	CHEMICAL	GENE-N	5	5	The influence of chemical , a selective gene antagonist , on the positive inotropic effect and the accumulation of chemical that are induced via gene was studied in comparison with that of another gene ligand chemical in the rabbit ventricular myocardium .	T6	T30	8894610
NA	CHEMICAL	GENE-Y	5	5	The influence of chemical , a selective gene antagonist , on the positive inotropic effect and the accumulation of chemical that are induced via gene was studied in comparison with that of another gene ligand chemical in the rabbit ventricular myocardium .	T6	T32	8894610
NA	CHEMICAL	GENE-Y	5	5	The influence of chemical , a selective gene antagonist , on the positive inotropic effect and the accumulation of chemical that are induced via gene was studied in comparison with that of another gene ligand chemical in the rabbit ventricular myocardium .	T17	T34	8894610
NA	CHEMICAL	GENE-N	5	5	The influence of chemical , a selective gene antagonist , on the positive inotropic effect and the accumulation of chemical that are induced via gene was studied in comparison with that of another gene ligand chemical in the rabbit ventricular myocardium .	T17	T30	8894610
NA	CHEMICAL	GENE-Y	5	5	The influence of chemical , a selective gene antagonist , on the positive inotropic effect and the accumulation of chemical that are induced via gene was studied in comparison with that of another gene ligand chemical in the rabbit ventricular myocardium .	T17	T32	8894610
CPR:5	CHEMICAL	GENE-N	0	2	chemical elicited a concentration-dependent positive inotropic effect via gene in the presence of either chemical or chemical .	T18	T33	8894610
NA	CHEMICAL	GENE-N	2	2	chemical elicited a concentration-dependent positive inotropic effect via gene in the presence of either chemical or chemical .	T19	T33	8894610
NA	CHEMICAL	GENE-N	16	2	chemical elicited a concentration-dependent positive inotropic effect via gene in the presence of either chemical or chemical .	T20	T33	8894610
CPR:6	CHEMICAL	GENE-Y	0	13	chemical effectively antagonized the positive inotropic effect of chemical even after inactivation of gene by treatment with chemical , which is an indication that the chemical-sensitive subtype belongs to a class resistant to chemical .	T25	T28	8894610
CPR:5	CHEMICAL	GENE-Y	8	13	chemical effectively antagonized the positive inotropic effect of chemical even after inactivation of gene by treatment with chemical , which is an indication that the chemical-sensitive subtype belongs to a class resistant to chemical .	T1	T28	8894610
CPR:4	CHEMICAL	GENE-Y	0	13	chemical effectively antagonized the positive inotropic effect of chemical even after inactivation of gene by treatment with chemical , which is an indication that the chemical-sensitive subtype belongs to a class resistant to chemical .	T2	T28	8894610
NA	CHEMICAL	GENE-Y	25	13	chemical effectively antagonized the positive inotropic effect of chemical even after inactivation of gene by treatment with chemical , which is an indication that the chemical-sensitive subtype belongs to a class resistant to chemical .	T3	T28	8894610
NA	CHEMICAL	GENE-Y	33	13	chemical effectively antagonized the positive inotropic effect of chemical even after inactivation of gene by treatment with chemical , which is an indication that the chemical-sensitive subtype belongs to a class resistant to chemical .	T4	T28	8894610
CPR:6	CHEMICAL	GENE-N	0	17	chemical , over the range of concentrations at which it antagonized the positive inotropic effect mediated by gene , did not affect the accumulation of chemical that was induced by 10 microM chemical .	T5	T29	8894610
NA	CHEMICAL	GENE-N	7	17	chemical , over the range of concentrations at which it antagonized the positive inotropic effect mediated by gene , did not affect the accumulation of chemical that was induced by 10 microM chemical .	T7	T29	8894610
NA	CHEMICAL	GENE-N	32	17	chemical , over the range of concentrations at which it antagonized the positive inotropic effect mediated by gene , did not affect the accumulation of chemical that was induced by 10 microM chemical .	T8	T29	8894610
CPR:9	CHEMICAL	GENE-N	10	4	Cloning and characterization of a novel gene that hydrolyzes both chemical and chemical ( gene ) .	T20	T37	10373451
CPR:9	CHEMICAL	GENE-Y	10	14	Cloning and characterization of a novel gene that hydrolyzes both chemical and chemical ( gene ) .	T20	T36	10373451
CPR:9	CHEMICAL	GENE-N	12	4	Cloning and characterization of a novel gene that hydrolyzes both chemical and chemical ( gene ) .	T21	T37	10373451
CPR:9	CHEMICAL	GENE-Y	12	14	Cloning and characterization of a novel gene that hydrolyzes both chemical and chemical ( gene ) .	T21	T36	10373451
NA	CHEMICAL	GENE-N	2	3	The deduced chemical sequence contains 779 chemical , including a putative chemical binding sequence in the chemical-terminal portion of the molecule and a catalytic domain that is 16-47 % identical in chemical sequence to those of other gene families .	T1	T26	10373451
NA	CHEMICAL	GENE-N	2	37	The deduced chemical sequence contains 779 chemical , including a putative chemical binding sequence in the chemical-terminal portion of the molecule and a catalytic domain that is 16-47 % identical in chemical sequence to those of other gene families .	T1	T28	10373451
NA	CHEMICAL	GENE-N	6	3	The deduced chemical sequence contains 779 chemical , including a putative chemical binding sequence in the chemical-terminal portion of the molecule and a catalytic domain that is 16-47 % identical in chemical sequence to those of other gene families .	T2	T26	10373451
NA	CHEMICAL	GENE-N	6	37	The deduced chemical sequence contains 779 chemical , including a putative chemical binding sequence in the chemical-terminal portion of the molecule and a catalytic domain that is 16-47 % identical in chemical sequence to those of other gene families .	T2	T28	10373451
NA	CHEMICAL	GENE-N	11	3	The deduced chemical sequence contains 779 chemical , including a putative chemical binding sequence in the chemical-terminal portion of the molecule and a catalytic domain that is 16-47 % identical in chemical sequence to those of other gene families .	T3	T26	10373451
NA	CHEMICAL	GENE-N	11	37	The deduced chemical sequence contains 779 chemical , including a putative chemical binding sequence in the chemical-terminal portion of the molecule and a catalytic domain that is 16-47 % identical in chemical sequence to those of other gene families .	T3	T28	10373451
NA	CHEMICAL	GENE-N	9	3	The deduced chemical sequence contains 779 chemical , including a putative chemical binding sequence in the chemical-terminal portion of the molecule and a catalytic domain that is 16-47 % identical in chemical sequence to those of other gene families .	T4	T26	10373451
NA	CHEMICAL	GENE-N	9	37	The deduced chemical sequence contains 779 chemical , including a putative chemical binding sequence in the chemical-terminal portion of the molecule and a catalytic domain that is 16-47 % identical in chemical sequence to those of other gene families .	T4	T28	10373451
NA	CHEMICAL	GENE-N	9	3	The deduced chemical sequence contains 779 chemical , including a putative chemical binding sequence in the chemical-terminal portion of the molecule and a catalytic domain that is 16-47 % identical in chemical sequence to those of other gene families .	T5	T26	10373451
NA	CHEMICAL	GENE-N	9	37	The deduced chemical sequence contains 779 chemical , including a putative chemical binding sequence in the chemical-terminal portion of the molecule and a catalytic domain that is 16-47 % identical in chemical sequence to those of other gene families .	T5	T28	10373451
CPR:9	CHEMICAL	GENE-Y	9	1	Recombinant gene transfected and expressed in COS-7 cells hydrolyzed chemical and chemical with Km values of 0.26 and 7.2 microM , respectively , and Vmax with chemical was almost twice that with chemical .	T6	T29	10373451
CPR:9	CHEMICAL	GENE-Y	11	1	Recombinant gene transfected and expressed in COS-7 cells hydrolyzed chemical and chemical with Km values of 0.26 and 7.2 microM , respectively , and Vmax with chemical was almost twice that with chemical .	T7	T29	10373451
CPR:9	CHEMICAL	GENE-Y	26	1	Recombinant gene transfected and expressed in COS-7 cells hydrolyzed chemical and chemical with Km values of 0.26 and 7.2 microM , respectively , and Vmax with chemical was almost twice that with chemical .	T8	T29	10373451
CPR:9	CHEMICAL	GENE-Y	32	1	Recombinant gene transfected and expressed in COS-7 cells hydrolyzed chemical and chemical with Km values of 0.26 and 7.2 microM , respectively , and Vmax with chemical was almost twice that with chemical .	T9	T29	10373451
CPR:4	CHEMICAL	GENE-N	6	2	Of the gene inhibitors tested , chemical was most effective , with IC50 values of 1.2 and 0.45 microM for inhibition of chemical and chemical hydrolysis , respectively .	T10	T31	10373451
CPR:9	CHEMICAL	GENE-N	22	2	Of the gene inhibitors tested , chemical was most effective , with IC50 values of 1.2 and 0.45 microM for inhibition of chemical and chemical hydrolysis , respectively .	T11	T31	10373451
CPR:9	CHEMICAL	GENE-N	24	2	Of the gene inhibitors tested , chemical was most effective , with IC50 values of 1.2 and 0.45 microM for inhibition of chemical and chemical hydrolysis , respectively .	T12	T31	10373451
NA	CHEMICAL	GENE-Y	7	2	Thus , gene exhibited properties of a chemical PDE and a chemical-inhibited chemical PDE .	T17	T32	10373451
NA	CHEMICAL	GENE-N	7	8	Thus , gene exhibited properties of a chemical PDE and a chemical-inhibited chemical PDE .	T17	T33	10373451
NA	CHEMICAL	GENE-N	7	8	Thus , gene exhibited properties of a chemical PDE and a chemical-inhibited chemical PDE .	T17	T34	10373451
NA	CHEMICAL	GENE-Y	11	2	Thus , gene exhibited properties of a chemical PDE and a chemical-inhibited chemical PDE .	T18	T32	10373451
NA	CHEMICAL	GENE-N	11	8	Thus , gene exhibited properties of a chemical PDE and a chemical-inhibited chemical PDE .	T18	T33	10373451
NA	CHEMICAL	GENE-N	11	8	Thus , gene exhibited properties of a chemical PDE and a chemical-inhibited chemical PDE .	T18	T34	10373451
NA	CHEMICAL	GENE-Y	12	2	Thus , gene exhibited properties of a chemical PDE and a chemical-inhibited chemical PDE .	T19	T32	10373451
NA	CHEMICAL	GENE-N	12	8	Thus , gene exhibited properties of a chemical PDE and a chemical-inhibited chemical PDE .	T19	T33	10373451
NA	CHEMICAL	GENE-N	12	8	Thus , gene exhibited properties of a chemical PDE and a chemical-inhibited chemical PDE .	T19	T34	10373451
NA	CHEMICAL	GENE-Y	5	0	gene ( gene ) is a nuclear enzyme that removes chemical groups from chemical residues in gene and other proteins to epigenetically regulate gene expression .	T1	T3	23085085
NA	CHEMICAL	GENE-Y	5	2	gene ( gene ) is a nuclear enzyme that removes chemical groups from chemical residues in gene and other proteins to epigenetically regulate gene expression .	T1	T7	23085085
NA	CHEMICAL	GENE-N	5	4	gene ( gene ) is a nuclear enzyme that removes chemical groups from chemical residues in gene and other proteins to epigenetically regulate gene expression .	T1	T4	23085085
NA	CHEMICAL	GENE-Y	13	0	gene ( gene ) is a nuclear enzyme that removes chemical groups from chemical residues in gene and other proteins to epigenetically regulate gene expression .	T2	T3	23085085
NA	CHEMICAL	GENE-Y	13	2	gene ( gene ) is a nuclear enzyme that removes chemical groups from chemical residues in gene and other proteins to epigenetically regulate gene expression .	T2	T7	23085085
NA	CHEMICAL	GENE-N	13	4	gene ( gene ) is a nuclear enzyme that removes chemical groups from chemical residues in gene and other proteins to epigenetically regulate gene expression .	T2	T4	23085085
NA	CHEMICAL	GENE-Y	24	18	In this study , we determined the effect of Rhodobacter sphaeroides lipopolysaccharide ( Rs-LPS ) , an established gene antagonist , on early-stage atherosclerosis in nondiabetic and chemical-induced diabetic gene-deficient ( gene ( -/- ) ) mice .	T5	T13	23060524
NA	CHEMICAL	GENE-Y	24	29	In this study , we determined the effect of Rhodobacter sphaeroides lipopolysaccharide ( Rs-LPS ) , an established gene antagonist , on early-stage atherosclerosis in nondiabetic and chemical-induced diabetic gene-deficient ( gene ( -/- ) ) mice .	T5	T15	23060524
NA	CHEMICAL	GENE-Y	24	31	In this study , we determined the effect of Rhodobacter sphaeroides lipopolysaccharide ( Rs-LPS ) , an established gene antagonist , on early-stage atherosclerosis in nondiabetic and chemical-induced diabetic gene-deficient ( gene ( -/- ) ) mice .	T5	T16	23060524
NA	CHEMICAL	GENE-Y	12	0	Nanobody-gene nanoparticles ( NANAPs ) for the delivery of a gene inhibitor chemical to gene overexpressing tumor cells .	T13	T27	23159529
CPR:4	CHEMICAL	GENE-N	12	9	Nanobody-gene nanoparticles ( NANAPs ) for the delivery of a gene inhibitor chemical to gene overexpressing tumor cells .	T13	T26	23159529
NA	CHEMICAL	GENE-Y	12	14	Nanobody-gene nanoparticles ( NANAPs ) for the delivery of a gene inhibitor chemical to gene overexpressing tumor cells .	T13	T28	23159529
NA	CHEMICAL	GENE-Y	0	2	chemical crosslinked gene nanoparticles with a size of approximately 100nm were loaded with the gene inhibitor chemical-L ( x ) -a chemical-bound chemical analogue-which couples the drug to chemical residues of gene and is released in a reductive environment .	T12	T14	23159529
NA	CHEMICAL	GENE-N	0	5	chemical crosslinked gene nanoparticles with a size of approximately 100nm were loaded with the gene inhibitor chemical-L ( x ) -a chemical-bound chemical analogue-which couples the drug to chemical residues of gene and is released in a reductive environment .	T12	T17	23159529
NA	CHEMICAL	GENE-Y	0	5	chemical crosslinked gene nanoparticles with a size of approximately 100nm were loaded with the gene inhibitor chemical-L ( x ) -a chemical-bound chemical analogue-which couples the drug to chemical residues of gene and is released in a reductive environment .	T12	T18	23159529
NA	CHEMICAL	GENE-Y	16	2	chemical crosslinked gene nanoparticles with a size of approximately 100nm were loaded with the gene inhibitor chemical-L ( x ) -a chemical-bound chemical analogue-which couples the drug to chemical residues of gene and is released in a reductive environment .	T2	T14	23159529
CPR:4	CHEMICAL	GENE-N	16	5	chemical crosslinked gene nanoparticles with a size of approximately 100nm were loaded with the gene inhibitor chemical-L ( x ) -a chemical-bound chemical analogue-which couples the drug to chemical residues of gene and is released in a reductive environment .	T2	T17	23159529
NA	CHEMICAL	GENE-Y	16	5	chemical crosslinked gene nanoparticles with a size of approximately 100nm were loaded with the gene inhibitor chemical-L ( x ) -a chemical-bound chemical analogue-which couples the drug to chemical residues of gene and is released in a reductive environment .	T2	T18	23159529
NA	CHEMICAL	GENE-Y	5	2	chemical crosslinked gene nanoparticles with a size of approximately 100nm were loaded with the gene inhibitor chemical-L ( x ) -a chemical-bound chemical analogue-which couples the drug to chemical residues of gene and is released in a reductive environment .	T3	T14	23159529
NA	CHEMICAL	GENE-N	5	5	chemical crosslinked gene nanoparticles with a size of approximately 100nm were loaded with the gene inhibitor chemical-L ( x ) -a chemical-bound chemical analogue-which couples the drug to chemical residues of gene and is released in a reductive environment .	T3	T17	23159529
NA	CHEMICAL	GENE-Y	5	5	chemical crosslinked gene nanoparticles with a size of approximately 100nm were loaded with the gene inhibitor chemical-L ( x ) -a chemical-bound chemical analogue-which couples the drug to chemical residues of gene and is released in a reductive environment .	T3	T18	23159529
NA	CHEMICAL	GENE-Y	22	2	chemical crosslinked gene nanoparticles with a size of approximately 100nm were loaded with the gene inhibitor chemical-L ( x ) -a chemical-bound chemical analogue-which couples the drug to chemical residues of gene and is released in a reductive environment .	T4	T14	23159529
NA	CHEMICAL	GENE-N	22	5	chemical crosslinked gene nanoparticles with a size of approximately 100nm were loaded with the gene inhibitor chemical-L ( x ) -a chemical-bound chemical analogue-which couples the drug to chemical residues of gene and is released in a reductive environment .	T4	T17	23159529
NA	CHEMICAL	GENE-Y	22	5	chemical crosslinked gene nanoparticles with a size of approximately 100nm were loaded with the gene inhibitor chemical-L ( x ) -a chemical-bound chemical analogue-which couples the drug to chemical residues of gene and is released in a reductive environment .	T4	T18	23159529
NA	CHEMICAL	GENE-Y	28	2	chemical crosslinked gene nanoparticles with a size of approximately 100nm were loaded with the gene inhibitor chemical-L ( x ) -a chemical-bound chemical analogue-which couples the drug to chemical residues of gene and is released in a reductive environment .	T5	T14	23159529
NA	CHEMICAL	GENE-N	28	5	chemical crosslinked gene nanoparticles with a size of approximately 100nm were loaded with the gene inhibitor chemical-L ( x ) -a chemical-bound chemical analogue-which couples the drug to chemical residues of gene and is released in a reductive environment .	T5	T17	23159529
NA	CHEMICAL	GENE-Y	28	5	chemical crosslinked gene nanoparticles with a size of approximately 100nm were loaded with the gene inhibitor chemical-L ( x ) -a chemical-bound chemical analogue-which couples the drug to chemical residues of gene and is released in a reductive environment .	T5	T18	23159529
NA	CHEMICAL	GENE-Y	6	0	gene nanoparticles were surface-coated with bifunctional chemical 3500 ( chemical ) and a nanobody-the single variable domain of an antibody- ( Ega1 ) against the gene ( gene ) .	T6	T19	23159529
NA	CHEMICAL	GENE-Y	6	25	gene nanoparticles were surface-coated with bifunctional chemical 3500 ( chemical ) and a nanobody-the single variable domain of an antibody- ( Ega1 ) against the gene ( gene ) .	T6	T20	23159529
NA	CHEMICAL	GENE-Y	6	27	gene nanoparticles were surface-coated with bifunctional chemical 3500 ( chemical ) and a nanobody-the single variable domain of an antibody- ( Ega1 ) against the gene ( gene ) .	T6	T21	23159529
NA	CHEMICAL	GENE-Y	9	0	gene nanoparticles were surface-coated with bifunctional chemical 3500 ( chemical ) and a nanobody-the single variable domain of an antibody- ( Ega1 ) against the gene ( gene ) .	T7	T19	23159529
NA	CHEMICAL	GENE-Y	9	25	gene nanoparticles were surface-coated with bifunctional chemical 3500 ( chemical ) and a nanobody-the single variable domain of an antibody- ( Ega1 ) against the gene ( gene ) .	T7	T20	23159529
NA	CHEMICAL	GENE-Y	9	27	gene nanoparticles were surface-coated with bifunctional chemical 3500 ( chemical ) and a nanobody-the single variable domain of an antibody- ( Ega1 ) against the gene ( gene ) .	T7	T21	23159529
NA	CHEMICAL	GENE-Y	0	9	EGa1-chemical functionalized nanoparticles showed a 40-fold higher binding to gene-positive chemical squamous head and neck cancer cells in comparison to PEGylated nanoparticles .	T8	T22	23159529
NA	CHEMICAL	GENE-Y	10	9	EGa1-chemical functionalized nanoparticles showed a 40-fold higher binding to gene-positive chemical squamous head and neck cancer cells in comparison to PEGylated nanoparticles .	T9	T22	23159529
NA	CHEMICAL	GENE-N	0	10	chemical-L ( x ) loaded EGa1-chemical nanoparticles were internalized by gene-mediated endocytosis and ultimately digested in lysosomes .	T10	T23	23159529
NA	CHEMICAL	GENE-N	5	10	chemical-L ( x ) loaded EGa1-chemical nanoparticles were internalized by gene-mediated endocytosis and ultimately digested in lysosomes .	T11	T23	23159529
NA	CHEMICAL	GENE-N	32	9	The intracellular routing of EGa1 targeted nanoparticles leads to a successful release of the gene inhibitor in the cell and inhibition of proliferation whereas the non-targeted formulations had no antiproliferative effects on chemical cells .	T1	T25	23159529
NA	CHEMICAL	GENE-Y	20	20	One of the therapeutic strategies aimed at ameliorating the clinical manifestations of Alzheimer 's disease is to enhance cholinergic neurotransmission in relevant parts of the brain by the use of gene inhibitors to delay the breakdown of chemical released into synaptic clefts .	T11	T18	19370562
CPR:4	CHEMICAL	GENE-Y	0	6	chemical , the first of the gene inhibitors to undergo extensive trials for this purpose , was associated with significant adverse effects including hepatotoxicity .	T13	T19	19370562
CPR:4	CHEMICAL	GENE-Y	5	1	Other gene inhibitors , including chemical , with superior properties in terms of specificity of action and low risk of adverse effects , have now been introduced .	T14	T20	19370562
CPR:3	CHEMICAL	GENE-Y	5	9	The treatment of mice with chemical alone enhances chemical decarboxylase activity to 4.6 folds , protein chemical formation increased up to 2.9 folds and DNA synthesis expressed in terms of chemical incorporation increased to 3.2 folds , and antioxidants and antioxidant enzymes decreased to 1.8-2.5 folds , compared with the corresponding saline-treated controls .	T4	T14	23444334
NA	CHEMICAL	GENE-Y	8	9	The treatment of mice with chemical alone enhances chemical decarboxylase activity to 4.6 folds , protein chemical formation increased up to 2.9 folds and DNA synthesis expressed in terms of chemical incorporation increased to 3.2 folds , and antioxidants and antioxidant enzymes decreased to 1.8-2.5 folds , compared with the corresponding saline-treated controls .	T5	T14	23444334
NA	CHEMICAL	GENE-Y	16	9	The treatment of mice with chemical alone enhances chemical decarboxylase activity to 4.6 folds , protein chemical formation increased up to 2.9 folds and DNA synthesis expressed in terms of chemical incorporation increased to 3.2 folds , and antioxidants and antioxidant enzymes decreased to 1.8-2.5 folds , compared with the corresponding saline-treated controls .	T6	T14	23444334
NA	CHEMICAL	GENE-Y	27	9	The treatment of mice with chemical alone enhances chemical decarboxylase activity to 4.6 folds , protein chemical formation increased up to 2.9 folds and DNA synthesis expressed in terms of chemical incorporation increased to 3.2 folds , and antioxidants and antioxidant enzymes decreased to 1.8-2.5 folds , compared with the corresponding saline-treated controls .	T7	T14	23444334
CPR:4	CHEMICAL	GENE-N	3	5	Multiple exposure to chemical , a gene ( gene ) inhibitor , induces acinar hypertrophy in the salivary gland .	T2	T8	16651698
CPR:4	CHEMICAL	GENE-N	3	8	Multiple exposure to chemical , a gene ( gene ) inhibitor , induces acinar hypertrophy in the salivary gland .	T2	T12	16651698
NA	CHEMICAL	GENE-N	3	15	This study examined the effect of chemical on the gene expression of secretory proteins and gene in the submaxillary gland .	T1	T7	16651698
NA	CHEMICAL	GENE-Y	10	8	The gene expressions for the secretory protein , gene ( Cyschemical ) , and gene in the submaxillary gland were quantified using RT-PCR .	T4	T9	16651698
NA	CHEMICAL	GENE-N	10	14	The gene expressions for the secretory protein , gene ( Cyschemical ) , and gene in the submaxillary gland were quantified using RT-PCR .	T4	T11	16651698
CPR:3	CHEMICAL	GENE-Y	0	11	chemical exposure resulted in a sustained increase in mRNA expression for gene and gene , but gene gene expression was unchanged .	T5	T13	16651698
CPR:3	CHEMICAL	GENE-Y	0	13	chemical exposure resulted in a sustained increase in mRNA expression for gene and gene , but gene gene expression was unchanged .	T5	T14	16651698
NA	CHEMICAL	GENE-Y	0	16	chemical exposure resulted in a sustained increase in mRNA expression for gene and gene , but gene gene expression was unchanged .	T5	T15	16651698
NA	CHEMICAL	GENE-Y	2	4	Reduced plasma chemical levels in female patients with borderline personality disorder .	T13	T24	23201337
NA	CHEMICAL	GENE-Y	5	2	The neuropeptide gene is involved in social cognition and interaction across species and plays a crucial role in the regulation of affiliative behaviors .	T6	T19	23201337
NA	CHEMICAL	GENE-Y	2	0	gene levels in cerebrospinal fluid ( CSF ) , but also in plasma or urine , have been shown to be negatively associated with childhood traumata , aggressive behavior , and suicide attempts .	T5	T18	23201337
NA	CHEMICAL	GENE-Y	7	12	Recently , an altered activity of the chemical system has been discussed to play a prominent role in borderline personality disorder ( BPD ) , which is thought to be closely related to traumatic experiences in childhood and is characterized by ( para ) suicidal behaviors as well as aggressive outbursts .	T7	T20	23201337
NA	CHEMICAL	GENE-Y	8	16	In the present study , we compared plasma chemical levels of women with and without BPD in the follicular phase and assessed the relationship between gene concentrations and childhood traumata .	T8	T21	23201337
NA	CHEMICAL	GENE-Y	8	16	In the present study , we compared plasma chemical levels of women with and without BPD in the follicular phase and assessed the relationship between gene concentrations and childhood traumata .	T8	T22	23201337
NA	CHEMICAL	GENE-Y	16	16	In the present study , we compared plasma chemical levels of women with and without BPD in the follicular phase and assessed the relationship between gene concentrations and childhood traumata .	T9	T21	23201337
NA	CHEMICAL	GENE-Y	16	16	In the present study , we compared plasma chemical levels of women with and without BPD in the follicular phase and assessed the relationship between gene concentrations and childhood traumata .	T9	T22	23201337
NA	CHEMICAL	GENE-Y	4	4	In addition , plasma gene correlated negatively with experiences of childhood traumata , in particular with emotional neglect and abuse .	T1	T14	23201337
NA	CHEMICAL	GENE-Y	16	11	The results of mediation analyses do not support a model of gene being a prominent mediator in the link between childhood trauma and BPD .	T2	T15	23201337
CPR:3	CHEMICAL	GENE-N	24	11	Recently , it has been shown that the activation of particular gene bitter taste receptors is partially involved with the bitter aftertaste sensation of chemical and chemical .	T10	T16	17567713
CPR:3	CHEMICAL	GENE-N	26	11	Recently , it has been shown that the activation of particular gene bitter taste receptors is partially involved with the bitter aftertaste sensation of chemical and chemical .	T11	T16	17567713
NA	CHEMICAL	GENE-Y	1	4	Using chemical imaging on gene receptors heterologously expressed in the human embryonic kidney ( HEK ) 293 cells and on dissociated primary sensory neurons , we find that in both systems , AS activate gene receptors , and , moreover , they sensitize these channels to acid and heat .	T1	T12	17567713
NA	CHEMICAL	GENE-Y	1	34	Using chemical imaging on gene receptors heterologously expressed in the human embryonic kidney ( HEK ) 293 cells and on dissociated primary sensory neurons , we find that in both systems , AS activate gene receptors , and , moreover , they sensitize these channels to acid and heat .	T1	T13	17567713
CPR:3	CHEMICAL	GENE-Y	9	4	We also found that gene receptors are activated by chemical , chemical , and chemical , three salts known to produce a metallic taste sensation .	T2	T14	17567713
CPR:3	CHEMICAL	GENE-Y	11	4	We also found that gene receptors are activated by chemical , chemical , and chemical , three salts known to produce a metallic taste sensation .	T3	T14	17567713
CPR:3	CHEMICAL	GENE-Y	14	4	We also found that gene receptors are activated by chemical , chemical , and chemical , three salts known to produce a metallic taste sensation .	T4	T14	17567713
NA	CHEMICAL	GENE-N	3	2	Although reducing gene chemical ( gene-c ) levels decreases morbidity and mortality , this therapeutic intervention only translates into a 25-40 % reduction in cardiovascular events .	T1	T8	23322769
NA	CHEMICAL	GENE-N	3	5	Although reducing gene chemical ( gene-c ) levels decreases morbidity and mortality , this therapeutic intervention only translates into a 25-40 % reduction in cardiovascular events .	T1	T11	23322769
NA	CHEMICAL	GENE-N	20	7	Epidemiological studies have shown that a high geneL-c level is not the only risk factor for CAD ; low gene chemical ( gene-c ) is an independent risk factor for CAD .	T5	T16	23322769
NA	CHEMICAL	GENE-N	20	19	Epidemiological studies have shown that a high geneL-c level is not the only risk factor for CAD ; low gene chemical ( gene-c ) is an independent risk factor for CAD .	T5	T17	23322769
NA	CHEMICAL	GENE-N	20	22	Epidemiological studies have shown that a high geneL-c level is not the only risk factor for CAD ; low gene chemical ( gene-c ) is an independent risk factor for CAD .	T5	T18	23322769
NA	CHEMICAL	GENE-Y	14	0	geneI ( gene ) is the major protein component of gene-c that mediates reverse chemical transport from tissues to the liver for excretion .	T6	T19	23322769
NA	CHEMICAL	GENE-Y	14	2	geneI ( gene ) is the major protein component of gene-c that mediates reverse chemical transport from tissues to the liver for excretion .	T6	T20	23322769
NA	CHEMICAL	GENE-N	14	10	geneI ( gene ) is the major protein component of gene-c that mediates reverse chemical transport from tissues to the liver for excretion .	T6	T21	23322769
NA	CHEMICAL	GENE-Y	0	2	chemical H4 receptor antagonism diminishes existing airway inflammation and dysfunction via modulation of gene .	T3	T26	20573261
NA	CHEMICAL	GENE-N	0	13	chemical H4 receptor antagonism diminishes existing airway inflammation and dysfunction via modulation of gene .	T3	T27	20573261
NA	CHEMICAL	GENE-Y	0	2	chemical H4 receptor ( gene ) perturbation has previously been shown to modify acute inflammation and gene production in a murine model of asthma .	T1	T13	20573261
NA	CHEMICAL	GENE-Y	0	1	chemical H4 receptor ( gene ) perturbation has previously been shown to modify acute inflammation and gene production in a murine model of asthma .	T1	T14	20573261
NA	CHEMICAL	GENE-N	0	11	chemical H4 receptor ( gene ) perturbation has previously been shown to modify acute inflammation and gene production in a murine model of asthma .	T1	T15	20573261
CPR:6	CHEMICAL	GENE-Y	9	9	After inflammation was established mice were dosed with the gene antagonist , chemical , or anti-gene antibody for comparison .	T2	T22	20573261
NA	CHEMICAL	GENE-Y	9	15	After inflammation was established mice were dosed with the gene antagonist , chemical , or anti-gene antibody for comparison .	T2	T23	20573261
NA	CHEMICAL	GENE-Y	0	9	chemical microdosing for protein and peptide drug development : gene as a case study .	T5	T11	23256472
NA	CHEMICAL	GENE-Y	7	8	RESULTS : In an animal study with chemical-labeled gene in Han-Wistar rats , an increase of chemical-gene is observed after dose administration .	T2	T8	23256472
NA	CHEMICAL	GENE-Y	7	16	RESULTS : In an animal study with chemical-labeled gene in Han-Wistar rats , an increase of chemical-gene is observed after dose administration .	T2	T9	23256472
NA	CHEMICAL	GENE-Y	16	8	RESULTS : In an animal study with chemical-labeled gene in Han-Wistar rats , an increase of chemical-gene is observed after dose administration .	T3	T8	23256472
NA	CHEMICAL	GENE-Y	16	16	RESULTS : In an animal study with chemical-labeled gene in Han-Wistar rats , an increase of chemical-gene is observed after dose administration .	T3	T9	23256472
NA	CHEMICAL	GENE-N	0	1	chemical receptors/gene genes in human cancer .	T4	T26	12668276
NA	CHEMICAL	GENE-Y	2	7	Estimation of chemical maintenance dose based on gene ( gene ) and gene genotypes .	T13	T33	17510308
NA	CHEMICAL	GENE-N	2	9	Estimation of chemical maintenance dose based on gene ( gene ) and gene genotypes .	T13	T34	17510308
NA	CHEMICAL	GENE-Y	2	12	Estimation of chemical maintenance dose based on gene ( gene ) and gene genotypes .	T13	T35	17510308
NA	CHEMICAL	GENE-Y	8	2	BACKGROUND : gene polymorphisms are associated with decreased chemical clearance and lower maintenance dosage .	T9	T17	17510308
NA	CHEMICAL	GENE-Y	13	3	Decreased expression of gene resulting from the gene substitution has also been implicated in lower chemical dose requirements .	T5	T20	17510308
NA	CHEMICAL	GENE-N	13	7	Decreased expression of gene resulting from the gene substitution has also been implicated in lower chemical dose requirements .	T5	T24	17510308
NA	CHEMICAL	GENE-Y	1	16	Plasma chemical concentrations and chemical maintenance dose were compared among patients on the basis of the gene gene genotype .	T7	T27	17510308
NA	CHEMICAL	GENE-N	1	17	Plasma chemical concentrations and chemical maintenance dose were compared among patients on the basis of the gene gene genotype .	T7	T28	17510308
NA	CHEMICAL	GENE-Y	4	16	Plasma chemical concentrations and chemical maintenance dose were compared among patients on the basis of the gene gene genotype .	T8	T27	17510308
NA	CHEMICAL	GENE-N	4	17	Plasma chemical concentrations and chemical maintenance dose were compared among patients on the basis of the gene gene genotype .	T8	T28	17510308
NA	CHEMICAL	GENE-Y	12	5	RESULTS : Eighty percent of gene*1/*1 patients stabilized on < 4.0 mg/day chemical had at least 1 gene -1639A allele .	T10	T29	17510308
NA	CHEMICAL	GENE-Y	12	16	RESULTS : Eighty percent of gene*1/*1 patients stabilized on < 4.0 mg/day chemical had at least 1 gene -1639A allele .	T10	T30	17510308
NA	CHEMICAL	GENE-Y	1	27	Mean chemical doses ( SD ) were 6.7 ( 3.3 ) , 4.3 ( 2.2 ) , and 2.7 ( 1.2 ) mg/day for patients with the gene -1639GG , GA , and AA genotypes , respectively .	T11	T31	17510308
NA	CHEMICAL	GENE-Y	4	11	Steady-state plasma concentrations of chemical were lowest in patients with the gene -1639AA genotype and demonstrated a positive association with the gene -1639G allele copy number ( trend P = 0.012 ) .	T12	T32	17510308
NA	CHEMICAL	GENE-Y	4	21	Steady-state plasma concentrations of chemical were lowest in patients with the gene -1639AA genotype and demonstrated a positive association with the gene -1639G allele copy number ( trend P = 0.012 ) .	T12	T14	17510308
NA	CHEMICAL	GENE-Y	3	3	A model including gene and gene genotypes , age , sex , and body weight accounted for 61 % of the variance in chemical daily maintenance dose .	T1	T15	17510308
NA	CHEMICAL	GENE-Y	3	5	A model including gene and gene genotypes , age , sex , and body weight accounted for 61 % of the variance in chemical daily maintenance dose .	T1	T16	17510308
NA	CHEMICAL	GENE-Y	2	18	Higher plasma chemical concentrations corresponding to increased chemical maintenance dosages support a hypothesis for increased expression of the gene -1639G allele .	T2	T21	17510308
NA	CHEMICAL	GENE-Y	7	18	Higher plasma chemical concentrations corresponding to increased chemical maintenance dosages support a hypothesis for increased expression of the gene -1639G allele .	T3	T21	17510308
CPR:9	CHEMICAL	GENE-Y	24	20	The scientific basis of this treatment of ED includes relaxation of the corpus cavernosum smooth muscle tissue by inhibition of gene that breaks down chemical , the key pathway for the production of erectile function in humans .	T2	T10	12614192
CPR:4	CHEMICAL	GENE-N	17	28	Many clinical studies , both pre- and post-marketing , have demonstrated the clinical efficacy and safety of chemical ( chemical , Pfizer ) - the first approved selective gene inhibitor for the treatment of ED .	T3	T11	12614192
CPR:4	CHEMICAL	GENE-N	19	28	Many clinical studies , both pre- and post-marketing , have demonstrated the clinical efficacy and safety of chemical ( chemical , Pfizer ) - the first approved selective gene inhibitor for the treatment of ED .	T4	T11	12614192
CPR:4	CHEMICAL	GENE-Y	0	4	chemical is inhibitory of gene at a rate tenfold higher than for the next gene ( gene ) , which produces visual changes through the retinal rods .	T5	T12	12614192
CPR:4	CHEMICAL	GENE-N	0	14	chemical is inhibitory of gene at a rate tenfold higher than for the next gene ( gene ) , which produces visual changes through the retinal rods .	T5	T13	12614192
CPR:4	CHEMICAL	GENE-N	0	16	chemical is inhibitory of gene at a rate tenfold higher than for the next gene ( gene ) , which produces visual changes through the retinal rods .	T5	T14	12614192
CPR:6	CHEMICAL	GENE-Y	2	10	Identification of a novel chemical derivative as a highly potent gene antagonist with an anti-obesity profile .	T2	T6	23206862
NA	CHEMICAL	GENE-Y	25	6	Optimization of HTS hit 1 for gene binding affinity , gene inhibition , solubility and metabolic stability led to the identification of some orally available chemical-linker derivatives for in vivo study .	T1	T4	23206862
NA	CHEMICAL	GENE-N	25	10	Optimization of HTS hit 1 for gene binding affinity , gene inhibition , solubility and metabolic stability led to the identification of some orally available chemical-linker derivatives for in vivo study .	T1	T5	23206862
CPR:3	CHEMICAL	GENE-Y	2	8	Treatment with chemical resulted in nuclear condensation ( a morphological change due to apoptosis of NSCs ) 24hr after the treatment and activated gene after 6 hr , indicating that chemical may cause apoptosis of neuronal cells via activation of the gene cascade .	T7	T11	12826271
NA	CHEMICAL	GENE-N	2	8	Treatment with chemical resulted in nuclear condensation ( a morphological change due to apoptosis of NSCs ) 24hr after the treatment and activated gene after 6 hr , indicating that chemical may cause apoptosis of neuronal cells via activation of the gene cascade .	T7	T12	12826271
NA	CHEMICAL	GENE-Y	8	8	Treatment with chemical resulted in nuclear condensation ( a morphological change due to apoptosis of NSCs ) 24hr after the treatment and activated gene after 6 hr , indicating that chemical may cause apoptosis of neuronal cells via activation of the gene cascade .	T8	T11	12826271
CPR:3	CHEMICAL	GENE-N	8	8	Treatment with chemical resulted in nuclear condensation ( a morphological change due to apoptosis of NSCs ) 24hr after the treatment and activated gene after 6 hr , indicating that chemical may cause apoptosis of neuronal cells via activation of the gene cascade .	T8	T12	12826271
NA	CHEMICAL	GENE-Y	4	5	A significant decrease of chemical aminotransferase , chemical aminotransferase , chemical dehydrogenase ( gene ) activities and chemical ( chemical ) levels and an increase of chemical ( chemical ) quantity was observed after chemical and PC administration alone .	T14	T31	22815248
NA	CHEMICAL	GENE-N	4	5	A significant decrease of chemical aminotransferase , chemical aminotransferase , chemical dehydrogenase ( gene ) activities and chemical ( chemical ) levels and an increase of chemical ( chemical ) quantity was observed after chemical and PC administration alone .	T14	T32	22815248
NA	CHEMICAL	GENE-N	4	11	A significant decrease of chemical aminotransferase , chemical aminotransferase , chemical dehydrogenase ( gene ) activities and chemical ( chemical ) levels and an increase of chemical ( chemical ) quantity was observed after chemical and PC administration alone .	T14	T33	22815248
NA	CHEMICAL	GENE-N	4	13	A significant decrease of chemical aminotransferase , chemical aminotransferase , chemical dehydrogenase ( gene ) activities and chemical ( chemical ) levels and an increase of chemical ( chemical ) quantity was observed after chemical and PC administration alone .	T14	T34	22815248
NA	CHEMICAL	GENE-Y	7	5	A significant decrease of chemical aminotransferase , chemical aminotransferase , chemical dehydrogenase ( gene ) activities and chemical ( chemical ) levels and an increase of chemical ( chemical ) quantity was observed after chemical and PC administration alone .	T16	T31	22815248
NA	CHEMICAL	GENE-N	7	5	A significant decrease of chemical aminotransferase , chemical aminotransferase , chemical dehydrogenase ( gene ) activities and chemical ( chemical ) levels and an increase of chemical ( chemical ) quantity was observed after chemical and PC administration alone .	T16	T32	22815248
NA	CHEMICAL	GENE-N	7	11	A significant decrease of chemical aminotransferase , chemical aminotransferase , chemical dehydrogenase ( gene ) activities and chemical ( chemical ) levels and an increase of chemical ( chemical ) quantity was observed after chemical and PC administration alone .	T16	T33	22815248
NA	CHEMICAL	GENE-N	7	13	A significant decrease of chemical aminotransferase , chemical aminotransferase , chemical dehydrogenase ( gene ) activities and chemical ( chemical ) levels and an increase of chemical ( chemical ) quantity was observed after chemical and PC administration alone .	T16	T34	22815248
NA	CHEMICAL	GENE-Y	10	5	A significant decrease of chemical aminotransferase , chemical aminotransferase , chemical dehydrogenase ( gene ) activities and chemical ( chemical ) levels and an increase of chemical ( chemical ) quantity was observed after chemical and PC administration alone .	T17	T31	22815248
NA	CHEMICAL	GENE-N	10	5	A significant decrease of chemical aminotransferase , chemical aminotransferase , chemical dehydrogenase ( gene ) activities and chemical ( chemical ) levels and an increase of chemical ( chemical ) quantity was observed after chemical and PC administration alone .	T17	T32	22815248
NA	CHEMICAL	GENE-N	10	11	A significant decrease of chemical aminotransferase , chemical aminotransferase , chemical dehydrogenase ( gene ) activities and chemical ( chemical ) levels and an increase of chemical ( chemical ) quantity was observed after chemical and PC administration alone .	T17	T33	22815248
NA	CHEMICAL	GENE-N	10	13	A significant decrease of chemical aminotransferase , chemical aminotransferase , chemical dehydrogenase ( gene ) activities and chemical ( chemical ) levels and an increase of chemical ( chemical ) quantity was observed after chemical and PC administration alone .	T17	T34	22815248
NA	CHEMICAL	GENE-Y	17	5	A significant decrease of chemical aminotransferase , chemical aminotransferase , chemical dehydrogenase ( gene ) activities and chemical ( chemical ) levels and an increase of chemical ( chemical ) quantity was observed after chemical and PC administration alone .	T18	T31	22815248
NA	CHEMICAL	GENE-N	17	5	A significant decrease of chemical aminotransferase , chemical aminotransferase , chemical dehydrogenase ( gene ) activities and chemical ( chemical ) levels and an increase of chemical ( chemical ) quantity was observed after chemical and PC administration alone .	T18	T32	22815248
NA	CHEMICAL	GENE-N	17	11	A significant decrease of chemical aminotransferase , chemical aminotransferase , chemical dehydrogenase ( gene ) activities and chemical ( chemical ) levels and an increase of chemical ( chemical ) quantity was observed after chemical and PC administration alone .	T18	T33	22815248
NA	CHEMICAL	GENE-N	17	13	A significant decrease of chemical aminotransferase , chemical aminotransferase , chemical dehydrogenase ( gene ) activities and chemical ( chemical ) levels and an increase of chemical ( chemical ) quantity was observed after chemical and PC administration alone .	T18	T34	22815248
NA	CHEMICAL	GENE-Y	19	5	A significant decrease of chemical aminotransferase , chemical aminotransferase , chemical dehydrogenase ( gene ) activities and chemical ( chemical ) levels and an increase of chemical ( chemical ) quantity was observed after chemical and PC administration alone .	T19	T31	22815248
NA	CHEMICAL	GENE-N	19	5	A significant decrease of chemical aminotransferase , chemical aminotransferase , chemical dehydrogenase ( gene ) activities and chemical ( chemical ) levels and an increase of chemical ( chemical ) quantity was observed after chemical and PC administration alone .	T19	T32	22815248
NA	CHEMICAL	GENE-N	19	11	A significant decrease of chemical aminotransferase , chemical aminotransferase , chemical dehydrogenase ( gene ) activities and chemical ( chemical ) levels and an increase of chemical ( chemical ) quantity was observed after chemical and PC administration alone .	T19	T33	22815248
NA	CHEMICAL	GENE-N	19	13	A significant decrease of chemical aminotransferase , chemical aminotransferase , chemical dehydrogenase ( gene ) activities and chemical ( chemical ) levels and an increase of chemical ( chemical ) quantity was observed after chemical and PC administration alone .	T19	T34	22815248
NA	CHEMICAL	GENE-Y	26	5	A significant decrease of chemical aminotransferase , chemical aminotransferase , chemical dehydrogenase ( gene ) activities and chemical ( chemical ) levels and an increase of chemical ( chemical ) quantity was observed after chemical and PC administration alone .	T20	T31	22815248
NA	CHEMICAL	GENE-N	26	5	A significant decrease of chemical aminotransferase , chemical aminotransferase , chemical dehydrogenase ( gene ) activities and chemical ( chemical ) levels and an increase of chemical ( chemical ) quantity was observed after chemical and PC administration alone .	T20	T32	22815248
NA	CHEMICAL	GENE-N	26	11	A significant decrease of chemical aminotransferase , chemical aminotransferase , chemical dehydrogenase ( gene ) activities and chemical ( chemical ) levels and an increase of chemical ( chemical ) quantity was observed after chemical and PC administration alone .	T20	T33	22815248
NA	CHEMICAL	GENE-N	26	13	A significant decrease of chemical aminotransferase , chemical aminotransferase , chemical dehydrogenase ( gene ) activities and chemical ( chemical ) levels and an increase of chemical ( chemical ) quantity was observed after chemical and PC administration alone .	T20	T34	22815248
NA	CHEMICAL	GENE-Y	0	5	A significant decrease of chemical aminotransferase , chemical aminotransferase , chemical dehydrogenase ( gene ) activities and chemical ( chemical ) levels and an increase of chemical ( chemical ) quantity was observed after chemical and PC administration alone .	T21	T31	22815248
NA	CHEMICAL	GENE-N	0	5	A significant decrease of chemical aminotransferase , chemical aminotransferase , chemical dehydrogenase ( gene ) activities and chemical ( chemical ) levels and an increase of chemical ( chemical ) quantity was observed after chemical and PC administration alone .	T21	T32	22815248
NA	CHEMICAL	GENE-N	0	11	A significant decrease of chemical aminotransferase , chemical aminotransferase , chemical dehydrogenase ( gene ) activities and chemical ( chemical ) levels and an increase of chemical ( chemical ) quantity was observed after chemical and PC administration alone .	T21	T33	22815248
NA	CHEMICAL	GENE-N	0	13	A significant decrease of chemical aminotransferase , chemical aminotransferase , chemical dehydrogenase ( gene ) activities and chemical ( chemical ) levels and an increase of chemical ( chemical ) quantity was observed after chemical and PC administration alone .	T21	T34	22815248
CPR:4	CHEMICAL	GENE-Y	34	5	A significant decrease of chemical aminotransferase , chemical aminotransferase , chemical dehydrogenase ( gene ) activities and chemical ( chemical ) levels and an increase of chemical ( chemical ) quantity was observed after chemical and PC administration alone .	T22	T31	22815248
CPR:4	CHEMICAL	GENE-N	34	5	A significant decrease of chemical aminotransferase , chemical aminotransferase , chemical dehydrogenase ( gene ) activities and chemical ( chemical ) levels and an increase of chemical ( chemical ) quantity was observed after chemical and PC administration alone .	T22	T32	22815248
CPR:4	CHEMICAL	GENE-N	34	11	A significant decrease of chemical aminotransferase , chemical aminotransferase , chemical dehydrogenase ( gene ) activities and chemical ( chemical ) levels and an increase of chemical ( chemical ) quantity was observed after chemical and PC administration alone .	T22	T33	22815248
CPR:4	CHEMICAL	GENE-N	34	13	A significant decrease of chemical aminotransferase , chemical aminotransferase , chemical dehydrogenase ( gene ) activities and chemical ( chemical ) levels and an increase of chemical ( chemical ) quantity was observed after chemical and PC administration alone .	T22	T34	22815248
NA	CHEMICAL	GENE-N	8	3	PSM pre-treatment decreased gene and gene activities and chemical levels and increased the levels of cell protector chemical .	T23	T35	22815248
NA	CHEMICAL	GENE-N	8	5	PSM pre-treatment decreased gene and gene activities and chemical levels and increased the levels of cell protector chemical .	T23	T36	22815248
NA	CHEMICAL	GENE-N	17	3	PSM pre-treatment decreased gene and gene activities and chemical levels and increased the levels of cell protector chemical .	T24	T35	22815248
NA	CHEMICAL	GENE-N	17	5	PSM pre-treatment decreased gene and gene activities and chemical levels and increased the levels of cell protector chemical .	T24	T36	22815248
CPR:3	CHEMICAL	GENE-N	10	9	In the chemical hepatotoxicity model , pre-treatment with PSM or chemical resulted in significantly increased activities of chemical-chemical-demethylase and chemical 4-hydroxylase activity and gene , compared to the chemical only group .	T26	T28	22815248
CPR:3	CHEMICAL	GENE-N	10	20	In the chemical hepatotoxicity model , pre-treatment with PSM or chemical resulted in significantly increased activities of chemical-chemical-demethylase and chemical 4-hydroxylase activity and gene , compared to the chemical only group .	T26	T29	22815248
CPR:3	CHEMICAL	GENE-N	10	23	In the chemical hepatotoxicity model , pre-treatment with PSM or chemical resulted in significantly increased activities of chemical-chemical-demethylase and chemical 4-hydroxylase activity and gene , compared to the chemical only group .	T26	T30	22815248
NA	CHEMICAL	GENE-N	9	9	In the chemical hepatotoxicity model , pre-treatment with PSM or chemical resulted in significantly increased activities of chemical-chemical-demethylase and chemical 4-hydroxylase activity and gene , compared to the chemical only group .	T1	T28	22815248
NA	CHEMICAL	GENE-N	9	20	In the chemical hepatotoxicity model , pre-treatment with PSM or chemical resulted in significantly increased activities of chemical-chemical-demethylase and chemical 4-hydroxylase activity and gene , compared to the chemical only group .	T1	T29	22815248
NA	CHEMICAL	GENE-N	9	23	In the chemical hepatotoxicity model , pre-treatment with PSM or chemical resulted in significantly increased activities of chemical-chemical-demethylase and chemical 4-hydroxylase activity and gene , compared to the chemical only group .	T1	T30	22815248
NA	CHEMICAL	GENE-N	2	9	In the chemical hepatotoxicity model , pre-treatment with PSM or chemical resulted in significantly increased activities of chemical-chemical-demethylase and chemical 4-hydroxylase activity and gene , compared to the chemical only group .	T2	T28	22815248
NA	CHEMICAL	GENE-N	2	20	In the chemical hepatotoxicity model , pre-treatment with PSM or chemical resulted in significantly increased activities of chemical-chemical-demethylase and chemical 4-hydroxylase activity and gene , compared to the chemical only group .	T2	T29	22815248
NA	CHEMICAL	GENE-N	2	23	In the chemical hepatotoxicity model , pre-treatment with PSM or chemical resulted in significantly increased activities of chemical-chemical-demethylase and chemical 4-hydroxylase activity and gene , compared to the chemical only group .	T2	T30	22815248
NA	CHEMICAL	GENE-N	12	9	In the chemical hepatotoxicity model , pre-treatment with PSM or chemical resulted in significantly increased activities of chemical-chemical-demethylase and chemical 4-hydroxylase activity and gene , compared to the chemical only group .	T3	T28	22815248
NA	CHEMICAL	GENE-N	12	20	In the chemical hepatotoxicity model , pre-treatment with PSM or chemical resulted in significantly increased activities of chemical-chemical-demethylase and chemical 4-hydroxylase activity and gene , compared to the chemical only group .	T3	T29	22815248
NA	CHEMICAL	GENE-N	12	23	In the chemical hepatotoxicity model , pre-treatment with PSM or chemical resulted in significantly increased activities of chemical-chemical-demethylase and chemical 4-hydroxylase activity and gene , compared to the chemical only group .	T3	T30	22815248
CPR:3	CHEMICAL	GENE-N	28	9	In the chemical hepatotoxicity model , pre-treatment with PSM or chemical resulted in significantly increased activities of chemical-chemical-demethylase and chemical 4-hydroxylase activity and gene , compared to the chemical only group .	T4	T28	22815248
CPR:3	CHEMICAL	GENE-N	28	20	In the chemical hepatotoxicity model , pre-treatment with PSM or chemical resulted in significantly increased activities of chemical-chemical-demethylase and chemical 4-hydroxylase activity and gene , compared to the chemical only group .	T4	T29	22815248
CPR:3	CHEMICAL	GENE-N	28	23	In the chemical hepatotoxicity model , pre-treatment with PSM or chemical resulted in significantly increased activities of chemical-chemical-demethylase and chemical 4-hydroxylase activity and gene , compared to the chemical only group .	T4	T30	22815248
NA	CHEMICAL	GENE-Y	3	13	RATIONALE : There is substantial evidence that chemical can produce effects linked to gene receptor occupancy .	T20	T38	12373423
NA	CHEMICAL	GENE-N	14	24	Nevertheless , this action has generally been ignored in the mechanism of action of chemical , in favor of an exclusive role for chemical receptors in considering its antiparkinsonian effects , or an exclusive role of gene receptor activation in hallucinogenesis .	T14	T33	12373423
NA	CHEMICAL	GENE-N	14	36	Nevertheless , this action has generally been ignored in the mechanism of action of chemical , in favor of an exclusive role for chemical receptors in considering its antiparkinsonian effects , or an exclusive role of gene receptor activation in hallucinogenesis .	T14	T34	12373423
NA	CHEMICAL	GENE-N	8	24	Nevertheless , this action has generally been ignored in the mechanism of action of chemical , in favor of an exclusive role for chemical receptors in considering its antiparkinsonian effects , or an exclusive role of gene receptor activation in hallucinogenesis .	T18	T33	12373423
NA	CHEMICAL	GENE-N	8	36	Nevertheless , this action has generally been ignored in the mechanism of action of chemical , in favor of an exclusive role for chemical receptors in considering its antiparkinsonian effects , or an exclusive role of gene receptor activation in hallucinogenesis .	T18	T34	12373423
NA	CHEMICAL	GENE-Y	12	14	These conclusions are surprising when one considers that the potent interaction of chemical with gene receptors has been demonstrated in several different laboratories and that activation of gene and gene receptors can modulate dopaminergically mediated responses .	T19	T35	12373423
NA	CHEMICAL	GENE-Y	12	27	These conclusions are surprising when one considers that the potent interaction of chemical with gene receptors has been demonstrated in several different laboratories and that activation of gene and gene receptors can modulate dopaminergically mediated responses .	T19	T36	12373423
NA	CHEMICAL	GENE-Y	12	29	These conclusions are surprising when one considers that the potent interaction of chemical with gene receptors has been demonstrated in several different laboratories and that activation of gene and gene receptors can modulate dopaminergically mediated responses .	T19	T37	12373423
CPR:5	CHEMICAL	GENE-Y	7	11	RESULTS : In drug discrimination studies , chemical fully mimicked the gene agonist chemical , only partially substituted for chemical and chemical , and failed to substitute for chemical .	T2	T28	12373423
CPR:5	CHEMICAL	GENE-Y	13	11	RESULTS : In drug discrimination studies , chemical fully mimicked the gene agonist chemical , only partially substituted for chemical and chemical , and failed to substitute for chemical .	T3	T28	12373423
NA	CHEMICAL	GENE-Y	19	11	RESULTS : In drug discrimination studies , chemical fully mimicked the gene agonist chemical , only partially substituted for chemical and chemical , and failed to substitute for chemical .	T4	T28	12373423
NA	CHEMICAL	GENE-Y	21	11	RESULTS : In drug discrimination studies , chemical fully mimicked the gene agonist chemical , only partially substituted for chemical and chemical , and failed to substitute for chemical .	T5	T28	12373423
NA	CHEMICAL	GENE-Y	28	11	RESULTS : In drug discrimination studies , chemical fully mimicked the gene agonist chemical , only partially substituted for chemical and chemical , and failed to substitute for chemical .	T6	T28	12373423
NA	CHEMICAL	GENE-Y	0	27	chemical produced a significant dose-related increase in flat body posture , forepaw treading , and lower-lip retraction which reflect a modulation of behavior by action at central gene receptors .	T7	T29	12373423
CPR:6	CHEMICAL	GENE-Y	3	8	Only pMPPI [ chemical ] , a selective gene antagonist , was effective in inhibiting all chemical syndrome behaviors produced by chemical , whereas pMPPI was without effect on any behavior induced by chemical .	T8	T30	12373423
NA	CHEMICAL	GENE-Y	16	8	Only pMPPI [ chemical ] , a selective gene antagonist , was effective in inhibiting all chemical syndrome behaviors produced by chemical , whereas pMPPI was without effect on any behavior induced by chemical .	T9	T30	12373423
NA	CHEMICAL	GENE-Y	21	8	Only pMPPI [ chemical ] , a selective gene antagonist , was effective in inhibiting all chemical syndrome behaviors produced by chemical , whereas pMPPI was without effect on any behavior induced by chemical .	T10	T30	12373423
NA	CHEMICAL	GENE-Y	33	8	Only pMPPI [ chemical ] , a selective gene antagonist , was effective in inhibiting all chemical syndrome behaviors produced by chemical , whereas pMPPI was without effect on any behavior induced by chemical .	T11	T30	12373423
CPR:5	CHEMICAL	GENE-Y	19	17	Lisuride dose dependently decreased body temperature in rats with a potency similar to that of the selective gene agonist chemical .	T12	T31	12373423
NA	CHEMICAL	GENE-N	10	8	Influence of developmental lead exposure on expression of gene and chemical-binding proteins in hippocampus .	T9	T16	23246732
NA	CHEMICAL	GENE-N	10	11	Influence of developmental lead exposure on expression of gene and chemical-binding proteins in hippocampus .	T9	T17	23246732
NA	CHEMICAL	GENE-N	8	6	Since DNA methylation is regulated by gene and chemical-binding proteins , this study assessed the extent to which developmental chemical exposure might affect expression of these proteins in the hippocampus .	T5	T14	23246732
NA	CHEMICAL	GENE-N	8	9	Since DNA methylation is regulated by gene and chemical-binding proteins , this study assessed the extent to which developmental chemical exposure might affect expression of these proteins in the hippocampus .	T5	T15	23246732
NA	CHEMICAL	GENE-N	19	6	Since DNA methylation is regulated by gene and chemical-binding proteins , this study assessed the extent to which developmental chemical exposure might affect expression of these proteins in the hippocampus .	T6	T14	23246732
NA	CHEMICAL	GENE-N	19	9	Since DNA methylation is regulated by gene and chemical-binding proteins , this study assessed the extent to which developmental chemical exposure might affect expression of these proteins in the hippocampus .	T6	T15	23246732
NA	CHEMICAL	GENE-Y	7	10	Western blot analyses showed significant effects of chemical exposure on gene , gene , and gene expression , with effects often seen at the lowest level of exposure and modified by sex and developmental window of chemical exposure .	T1	T10	23246732
NA	CHEMICAL	GENE-Y	7	12	Western blot analyses showed significant effects of chemical exposure on gene , gene , and gene expression , with effects often seen at the lowest level of exposure and modified by sex and developmental window of chemical exposure .	T1	T11	23246732
NA	CHEMICAL	GENE-Y	7	15	Western blot analyses showed significant effects of chemical exposure on gene , gene , and gene expression , with effects often seen at the lowest level of exposure and modified by sex and developmental window of chemical exposure .	T1	T12	23246732
NA	CHEMICAL	GENE-Y	36	10	Western blot analyses showed significant effects of chemical exposure on gene , gene , and gene expression , with effects often seen at the lowest level of exposure and modified by sex and developmental window of chemical exposure .	T2	T10	23246732
NA	CHEMICAL	GENE-Y	36	12	Western blot analyses showed significant effects of chemical exposure on gene , gene , and gene expression , with effects often seen at the lowest level of exposure and modified by sex and developmental window of chemical exposure .	T2	T11	23246732
NA	CHEMICAL	GENE-Y	36	15	Western blot analyses showed significant effects of chemical exposure on gene , gene , and gene expression , with effects often seen at the lowest level of exposure and modified by sex and developmental window of chemical exposure .	T2	T12	23246732
NA	CHEMICAL	GENE-Y	1	6	Despite a low chemical identity between gene and gene ( approximately 28 % ) , both channel proteins share the same overall structural arrangement consisting of two gene and four transmembrane segments ( TMS ) .	T3	T18	9003761
NA	CHEMICAL	GENE-Y	1	8	Despite a low chemical identity between gene and gene ( approximately 28 % ) , both channel proteins share the same overall structural arrangement consisting of two gene and four transmembrane segments ( TMS ) .	T3	T19	9003761
NA	CHEMICAL	GENE-N	1	1	Despite a low chemical identity between gene and gene ( approximately 28 % ) , both channel proteins share the same overall structural arrangement consisting of two gene and four transmembrane segments ( TMS ) .	T3	T20	9003761
NA	CHEMICAL	GENE-Y	0	4	chemical currents generated by gene are inwardly rectifying while chemical currents generated by gene are outwardly rectifying .	T4	T21	9003761
NA	CHEMICAL	GENE-Y	0	13	chemical currents generated by gene are inwardly rectifying while chemical currents generated by gene are outwardly rectifying .	T4	T22	9003761
NA	CHEMICAL	GENE-Y	9	4	chemical currents generated by gene are inwardly rectifying while chemical currents generated by gene are outwardly rectifying .	T5	T21	9003761
NA	CHEMICAL	GENE-Y	9	13	chemical currents generated by gene are inwardly rectifying while chemical currents generated by gene are outwardly rectifying .	T5	T22	9003761
NA	CHEMICAL	GENE-Y	13	0	gene currents are insensitive to pharmacological agents that block gene activity such as chemical and chemical .	T6	T23	9003761
CPR:4	CHEMICAL	GENE-Y	13	9	gene currents are insensitive to pharmacological agents that block gene activity such as chemical and chemical .	T6	T24	9003761
NA	CHEMICAL	GENE-Y	15	0	gene currents are insensitive to pharmacological agents that block gene activity such as chemical and chemical .	T7	T23	9003761
CPR:4	CHEMICAL	GENE-Y	15	9	gene currents are insensitive to pharmacological agents that block gene activity such as chemical and chemical .	T7	T24	9003761
NA	CHEMICAL	GENE-Y	18	3	Extensive inhibitions of gene activity are observed after activation of gene . gene currents are sensitive to extracellular chemical and chemical .	T8	T26	9003761
NA	CHEMICAL	GENE-N	18	10	Extensive inhibitions of gene activity are observed after activation of gene . gene currents are sensitive to extracellular chemical and chemical .	T8	T27	9003761
NA	CHEMICAL	GENE-Y	18	12	Extensive inhibitions of gene activity are observed after activation of gene . gene currents are sensitive to extracellular chemical and chemical .	T8	T28	9003761
NA	CHEMICAL	GENE-Y	20	3	Extensive inhibitions of gene activity are observed after activation of gene . gene currents are sensitive to extracellular chemical and chemical .	T9	T26	9003761
NA	CHEMICAL	GENE-N	20	10	Extensive inhibitions of gene activity are observed after activation of gene . gene currents are sensitive to extracellular chemical and chemical .	T9	T27	9003761
NA	CHEMICAL	GENE-Y	20	12	Extensive inhibitions of gene activity are observed after activation of gene . gene currents are sensitive to extracellular chemical and chemical .	T9	T28	9003761
NA	CHEMICAL	GENE-N	12	0	gene : modified chemical binding site associated with chemical -- > chemical or chemical mutants of gene subunit .	T48	T57	7885191
NA	CHEMICAL	GENE-Y	12	16	gene : modified chemical binding site associated with chemical -- > chemical or chemical mutants of gene subunit .	T48	T58	7885191
NA	CHEMICAL	GENE-N	3	0	gene : modified chemical binding site associated with chemical -- > chemical or chemical mutants of gene subunit .	T49	T57	7885191
NA	CHEMICAL	GENE-Y	3	16	gene : modified chemical binding site associated with chemical -- > chemical or chemical mutants of gene subunit .	T49	T58	7885191
NA	CHEMICAL	GENE-N	8	0	gene : modified chemical binding site associated with chemical -- > chemical or chemical mutants of gene subunit .	T50	T57	7885191
NA	CHEMICAL	GENE-Y	8	16	gene : modified chemical binding site associated with chemical -- > chemical or chemical mutants of gene subunit .	T50	T58	7885191
NA	CHEMICAL	GENE-N	11	0	gene : modified chemical binding site associated with chemical -- > chemical or chemical mutants of gene subunit .	T51	T57	7885191
NA	CHEMICAL	GENE-Y	11	16	gene : modified chemical binding site associated with chemical -- > chemical or chemical mutants of gene subunit .	T51	T58	7885191
NA	CHEMICAL	GENE-N	13	0	gene : modified chemical binding site associated with chemical -- > chemical or chemical mutants of gene subunit .	T46	T57	7885191
NA	CHEMICAL	GENE-Y	13	16	gene : modified chemical binding site associated with chemical -- > chemical or chemical mutants of gene subunit .	T46	T58	7885191
NA	CHEMICAL	GENE-N	6	9	The non-competitive blocker site of the chemical-gated chemical ion channel in normal susceptible strains of Drosophila melanogaster and simulans binds chemical ( chemical ) at specific sites with KdS of 1.6-1.9 nM and BmaxS of 171-181 fmol/mg protein .	T25	T54	7885191
NA	CHEMICAL	GENE-N	7	9	The non-competitive blocker site of the chemical-gated chemical ion channel in normal susceptible strains of Drosophila melanogaster and simulans binds chemical ( chemical ) at specific sites with KdS of 1.6-1.9 nM and BmaxS of 171-181 fmol/mg protein .	T32	T54	7885191
NA	CHEMICAL	GENE-N	20	9	The non-competitive blocker site of the chemical-gated chemical ion channel in normal susceptible strains of Drosophila melanogaster and simulans binds chemical ( chemical ) at specific sites with KdS of 1.6-1.9 nM and BmaxS of 171-181 fmol/mg protein .	T14	T54	7885191
NA	CHEMICAL	GENE-N	22	9	The non-competitive blocker site of the chemical-gated chemical ion channel in normal susceptible strains of Drosophila melanogaster and simulans binds chemical ( chemical ) at specific sites with KdS of 1.6-1.9 nM and BmaxS of 171-181 fmol/mg protein .	T21	T54	7885191
NA	CHEMICAL	GENE-N	0	9	chemical resistance in D. melanogaster has been attributed to a mutation resulting in an gene replacement in the gene subunit and in D. simulans to an homologous chemical -- > chemical or chemical replacement .	T39	T55	7885191
NA	CHEMICAL	GENE-Y	0	8	chemical resistance in D. melanogaster has been attributed to a mutation resulting in an gene replacement in the gene subunit and in D. simulans to an homologous chemical -- > chemical or chemical replacement .	T39	T56	7885191
NA	CHEMICAL	GENE-N	30	9	chemical resistance in D. melanogaster has been attributed to a mutation resulting in an gene replacement in the gene subunit and in D. simulans to an homologous chemical -- > chemical or chemical replacement .	T40	T55	7885191
NA	CHEMICAL	GENE-Y	30	8	chemical resistance in D. melanogaster has been attributed to a mutation resulting in an gene replacement in the gene subunit and in D. simulans to an homologous chemical -- > chemical or chemical replacement .	T40	T56	7885191
NA	CHEMICAL	GENE-N	9	9	chemical resistance in D. melanogaster has been attributed to a mutation resulting in an gene replacement in the gene subunit and in D. simulans to an homologous chemical -- > chemical or chemical replacement .	T42	T55	7885191
NA	CHEMICAL	GENE-Y	9	8	chemical resistance in D. melanogaster has been attributed to a mutation resulting in an gene replacement in the gene subunit and in D. simulans to an homologous chemical -- > chemical or chemical replacement .	T42	T56	7885191
NA	CHEMICAL	GENE-N	32	9	chemical resistance in D. melanogaster has been attributed to a mutation resulting in an gene replacement in the gene subunit and in D. simulans to an homologous chemical -- > chemical or chemical replacement .	T44	T55	7885191
NA	CHEMICAL	GENE-Y	32	8	chemical resistance in D. melanogaster has been attributed to a mutation resulting in an gene replacement in the gene subunit and in D. simulans to an homologous chemical -- > chemical or chemical replacement .	T44	T56	7885191
CPR:4	CHEMICAL	GENE-Y	3	13	The channel activators chemical and chemical usually retain their inhibitory potency in the gene subunit mutants .	T12	T52	7885191
CPR:4	CHEMICAL	GENE-Y	5	13	The channel activators chemical and chemical usually retain their inhibitory potency in the gene subunit mutants .	T13	T52	7885191
NA	CHEMICAL	GENE-N	4	16	In contrast , the chemical -- > chemical replacement has less impact in protecting the chemical channel from the action of insecticidal blockers .	T18	T53	7885191
NA	CHEMICAL	GENE-N	7	16	In contrast , the chemical -- > chemical replacement has less impact in protecting the chemical channel from the action of insecticidal blockers .	T19	T53	7885191
NA	CHEMICAL	GENE-N	15	16	In contrast , the chemical -- > chemical replacement has less impact in protecting the chemical channel from the action of insecticidal blockers .	T20	T53	7885191
NA	CHEMICAL	GENE-N	0	2	chemical phosphokinase MB ( gene ) , chemical ( chemical ) and chemical ( chemical ) levels were evaluated in heart tissue at the end of treatments .	T16	T36	23523949
NA	CHEMICAL	GENE-N	0	2	chemical phosphokinase MB ( gene ) , chemical ( chemical ) and chemical ( chemical ) levels were evaluated in heart tissue at the end of treatments .	T16	T37	23523949
NA	CHEMICAL	GENE-N	7	2	chemical phosphokinase MB ( gene ) , chemical ( chemical ) and chemical ( chemical ) levels were evaluated in heart tissue at the end of treatments .	T17	T36	23523949
NA	CHEMICAL	GENE-N	7	2	chemical phosphokinase MB ( gene ) , chemical ( chemical ) and chemical ( chemical ) levels were evaluated in heart tissue at the end of treatments .	T17	T37	23523949
NA	CHEMICAL	GENE-N	9	2	chemical phosphokinase MB ( gene ) , chemical ( chemical ) and chemical ( chemical ) levels were evaluated in heart tissue at the end of treatments .	T18	T36	23523949
NA	CHEMICAL	GENE-N	9	2	chemical phosphokinase MB ( gene ) , chemical ( chemical ) and chemical ( chemical ) levels were evaluated in heart tissue at the end of treatments .	T18	T37	23523949
NA	CHEMICAL	GENE-N	12	2	chemical phosphokinase MB ( gene ) , chemical ( chemical ) and chemical ( chemical ) levels were evaluated in heart tissue at the end of treatments .	T19	T36	23523949
NA	CHEMICAL	GENE-N	12	2	chemical phosphokinase MB ( gene ) , chemical ( chemical ) and chemical ( chemical ) levels were evaluated in heart tissue at the end of treatments .	T19	T37	23523949
NA	CHEMICAL	GENE-N	14	2	chemical phosphokinase MB ( gene ) , chemical ( chemical ) and chemical ( chemical ) levels were evaluated in heart tissue at the end of treatments .	T20	T36	23523949
NA	CHEMICAL	GENE-N	14	2	chemical phosphokinase MB ( gene ) , chemical ( chemical ) and chemical ( chemical ) levels were evaluated in heart tissue at the end of treatments .	T20	T37	23523949
CPR:3	CHEMICAL	GENE-N	2	13	RESULTS : chemical induced histophatological damages and elevated the level of cardiac marker gene .	T22	T44	23523949
NA	CHEMICAL	GENE-Y	6	21	These effects were associated with increased chemical level , lower level of reduced chemical and induction of apoptosis through elevation of gene/gene ratio ( both protein and mRNA levels ) , gene release to the cytosol and activation gene in cardiac tissue .	T23	T27	23523949
NA	CHEMICAL	GENE-Y	6	21	These effects were associated with increased chemical level , lower level of reduced chemical and induction of apoptosis through elevation of gene/gene ratio ( both protein and mRNA levels ) , gene release to the cytosol and activation gene in cardiac tissue .	T23	T28	23523949
NA	CHEMICAL	GENE-Y	6	31	These effects were associated with increased chemical level , lower level of reduced chemical and induction of apoptosis through elevation of gene/gene ratio ( both protein and mRNA levels ) , gene release to the cytosol and activation gene in cardiac tissue .	T23	T29	23523949
NA	CHEMICAL	GENE-Y	6	38	These effects were associated with increased chemical level , lower level of reduced chemical and induction of apoptosis through elevation of gene/gene ratio ( both protein and mRNA levels ) , gene release to the cytosol and activation gene in cardiac tissue .	T23	T30	23523949
NA	CHEMICAL	GENE-Y	13	21	These effects were associated with increased chemical level , lower level of reduced chemical and induction of apoptosis through elevation of gene/gene ratio ( both protein and mRNA levels ) , gene release to the cytosol and activation gene in cardiac tissue .	T24	T27	23523949
NA	CHEMICAL	GENE-Y	13	21	These effects were associated with increased chemical level , lower level of reduced chemical and induction of apoptosis through elevation of gene/gene ratio ( both protein and mRNA levels ) , gene release to the cytosol and activation gene in cardiac tissue .	T24	T28	23523949
NA	CHEMICAL	GENE-Y	13	31	These effects were associated with increased chemical level , lower level of reduced chemical and induction of apoptosis through elevation of gene/gene ratio ( both protein and mRNA levels ) , gene release to the cytosol and activation gene in cardiac tissue .	T24	T29	23523949
NA	CHEMICAL	GENE-Y	13	38	These effects were associated with increased chemical level , lower level of reduced chemical and induction of apoptosis through elevation of gene/gene ratio ( both protein and mRNA levels ) , gene release to the cytosol and activation gene in cardiac tissue .	T24	T30	23523949
CPR:4	CHEMICAL	GENE-N	0	15	chemical ( 25 and 50mg/kg ) or chemical improved histopathological damages , decreased chemical and gene , increased chemical content and attenuated the increase of gene/gene ratio , activation of gene and release of gene to the cytosol induced by chemical .	T1	T31	23523949
CPR:4	CHEMICAL	GENE-Y	0	25	chemical ( 25 and 50mg/kg ) or chemical improved histopathological damages , decreased chemical and gene , increased chemical content and attenuated the increase of gene/gene ratio , activation of gene and release of gene to the cytosol induced by chemical .	T1	T32	23523949
CPR:4	CHEMICAL	GENE-Y	0	25	chemical ( 25 and 50mg/kg ) or chemical improved histopathological damages , decreased chemical and gene , increased chemical content and attenuated the increase of gene/gene ratio , activation of gene and release of gene to the cytosol induced by chemical .	T1	T33	23523949
CPR:3	CHEMICAL	GENE-Y	0	30	chemical ( 25 and 50mg/kg ) or chemical improved histopathological damages , decreased chemical and gene , increased chemical content and attenuated the increase of gene/gene ratio , activation of gene and release of gene to the cytosol induced by chemical .	T1	T34	23523949
CPR:4	CHEMICAL	GENE-Y	0	34	chemical ( 25 and 50mg/kg ) or chemical improved histopathological damages , decreased chemical and gene , increased chemical content and attenuated the increase of gene/gene ratio , activation of gene and release of gene to the cytosol induced by chemical .	T1	T35	23523949
CPR:4	CHEMICAL	GENE-N	7	15	chemical ( 25 and 50mg/kg ) or chemical improved histopathological damages , decreased chemical and gene , increased chemical content and attenuated the increase of gene/gene ratio , activation of gene and release of gene to the cytosol induced by chemical .	T2	T31	23523949
CPR:4	CHEMICAL	GENE-Y	7	25	chemical ( 25 and 50mg/kg ) or chemical improved histopathological damages , decreased chemical and gene , increased chemical content and attenuated the increase of gene/gene ratio , activation of gene and release of gene to the cytosol induced by chemical .	T2	T32	23523949
CPR:4	CHEMICAL	GENE-Y	7	25	chemical ( 25 and 50mg/kg ) or chemical improved histopathological damages , decreased chemical and gene , increased chemical content and attenuated the increase of gene/gene ratio , activation of gene and release of gene to the cytosol induced by chemical .	T2	T33	23523949
CPR:3	CHEMICAL	GENE-Y	7	30	chemical ( 25 and 50mg/kg ) or chemical improved histopathological damages , decreased chemical and gene , increased chemical content and attenuated the increase of gene/gene ratio , activation of gene and release of gene to the cytosol induced by chemical .	T2	T34	23523949
NA	CHEMICAL	GENE-Y	7	34	chemical ( 25 and 50mg/kg ) or chemical improved histopathological damages , decreased chemical and gene , increased chemical content and attenuated the increase of gene/gene ratio , activation of gene and release of gene to the cytosol induced by chemical .	T2	T35	23523949
NA	CHEMICAL	GENE-N	13	15	chemical ( 25 and 50mg/kg ) or chemical improved histopathological damages , decreased chemical and gene , increased chemical content and attenuated the increase of gene/gene ratio , activation of gene and release of gene to the cytosol induced by chemical .	T3	T31	23523949
NA	CHEMICAL	GENE-Y	13	25	chemical ( 25 and 50mg/kg ) or chemical improved histopathological damages , decreased chemical and gene , increased chemical content and attenuated the increase of gene/gene ratio , activation of gene and release of gene to the cytosol induced by chemical .	T3	T32	23523949
NA	CHEMICAL	GENE-Y	13	25	chemical ( 25 and 50mg/kg ) or chemical improved histopathological damages , decreased chemical and gene , increased chemical content and attenuated the increase of gene/gene ratio , activation of gene and release of gene to the cytosol induced by chemical .	T3	T33	23523949
NA	CHEMICAL	GENE-Y	13	30	chemical ( 25 and 50mg/kg ) or chemical improved histopathological damages , decreased chemical and gene , increased chemical content and attenuated the increase of gene/gene ratio , activation of gene and release of gene to the cytosol induced by chemical .	T3	T34	23523949
NA	CHEMICAL	GENE-Y	13	34	chemical ( 25 and 50mg/kg ) or chemical improved histopathological damages , decreased chemical and gene , increased chemical content and attenuated the increase of gene/gene ratio , activation of gene and release of gene to the cytosol induced by chemical .	T3	T35	23523949
NA	CHEMICAL	GENE-N	18	15	chemical ( 25 and 50mg/kg ) or chemical improved histopathological damages , decreased chemical and gene , increased chemical content and attenuated the increase of gene/gene ratio , activation of gene and release of gene to the cytosol induced by chemical .	T4	T31	23523949
NA	CHEMICAL	GENE-Y	18	25	chemical ( 25 and 50mg/kg ) or chemical improved histopathological damages , decreased chemical and gene , increased chemical content and attenuated the increase of gene/gene ratio , activation of gene and release of gene to the cytosol induced by chemical .	T4	T32	23523949
NA	CHEMICAL	GENE-Y	18	25	chemical ( 25 and 50mg/kg ) or chemical improved histopathological damages , decreased chemical and gene , increased chemical content and attenuated the increase of gene/gene ratio , activation of gene and release of gene to the cytosol induced by chemical .	T4	T33	23523949
NA	CHEMICAL	GENE-Y	18	30	chemical ( 25 and 50mg/kg ) or chemical improved histopathological damages , decreased chemical and gene , increased chemical content and attenuated the increase of gene/gene ratio , activation of gene and release of gene to the cytosol induced by chemical .	T4	T34	23523949
NA	CHEMICAL	GENE-Y	18	34	chemical ( 25 and 50mg/kg ) or chemical improved histopathological damages , decreased chemical and gene , increased chemical content and attenuated the increase of gene/gene ratio , activation of gene and release of gene to the cytosol induced by chemical .	T4	T35	23523949
NA	CHEMICAL	GENE-N	40	15	chemical ( 25 and 50mg/kg ) or chemical improved histopathological damages , decreased chemical and gene , increased chemical content and attenuated the increase of gene/gene ratio , activation of gene and release of gene to the cytosol induced by chemical .	T6	T31	23523949
CPR:3	CHEMICAL	GENE-Y	40	25	chemical ( 25 and 50mg/kg ) or chemical improved histopathological damages , decreased chemical and gene , increased chemical content and attenuated the increase of gene/gene ratio , activation of gene and release of gene to the cytosol induced by chemical .	T6	T32	23523949
CPR:4	CHEMICAL	GENE-Y	40	25	chemical ( 25 and 50mg/kg ) or chemical improved histopathological damages , decreased chemical and gene , increased chemical content and attenuated the increase of gene/gene ratio , activation of gene and release of gene to the cytosol induced by chemical .	T6	T33	23523949
CPR:3	CHEMICAL	GENE-Y	40	30	chemical ( 25 and 50mg/kg ) or chemical improved histopathological damages , decreased chemical and gene , increased chemical content and attenuated the increase of gene/gene ratio , activation of gene and release of gene to the cytosol induced by chemical .	T6	T34	23523949
CPR:3	CHEMICAL	GENE-Y	40	34	chemical ( 25 and 50mg/kg ) or chemical improved histopathological damages , decreased chemical and gene , increased chemical content and attenuated the increase of gene/gene ratio , activation of gene and release of gene to the cytosol induced by chemical .	T6	T35	23523949
NA	CHEMICAL	GENE-Y	0	1	chemical D2-receptor imaging with chemical SPECT in migraine patients abusing chemical : does chemical cross the blood brain barrier ?	T10	T17	8242725
NA	CHEMICAL	GENE-Y	4	1	chemical D2-receptor imaging with chemical SPECT in migraine patients abusing chemical : does chemical cross the blood brain barrier ?	T12	T17	8242725
NA	CHEMICAL	GENE-Y	6	1	chemical D2-receptor imaging with chemical SPECT in migraine patients abusing chemical : does chemical cross the blood brain barrier ?	T13	T17	8242725
NA	CHEMICAL	GENE-Y	6	1	chemical D2-receptor imaging with chemical SPECT in migraine patients abusing chemical : does chemical cross the blood brain barrier ?	T11	T17	8242725
NA	CHEMICAL	GENE-Y	6	12	Two migraine patients were studied by in vivo SPECT using the chemical D2-receptor specific radioligand chemical ( chemical ) during chemical abuse and after withdrawal .	T9	T16	8242725
NA	CHEMICAL	GENE-Y	15	12	Two migraine patients were studied by in vivo SPECT using the chemical D2-receptor specific radioligand chemical ( chemical ) during chemical abuse and after withdrawal .	T1	T16	8242725
NA	CHEMICAL	GENE-Y	17	12	Two migraine patients were studied by in vivo SPECT using the chemical D2-receptor specific radioligand chemical ( chemical ) during chemical abuse and after withdrawal .	T2	T16	8242725
NA	CHEMICAL	GENE-Y	6	12	Two migraine patients were studied by in vivo SPECT using the chemical D2-receptor specific radioligand chemical ( chemical ) during chemical abuse and after withdrawal .	T3	T16	8242725
NA	CHEMICAL	GENE-Y	12	18	Striatum/cerebellum and striatum/occipital cortex ratios of count rate density were calculated as a semiquantitative measurement for striatal chemical D2-receptor binding potential .	T4	T14	8242725
NA	CHEMICAL	GENE-N	0	4	chemical modulates expression of gene and chemical-/chemical domain-binding proteins in murine embryonic fibroblasts .	T9	T23	23395981
NA	CHEMICAL	GENE-N	0	8	chemical modulates expression of gene and chemical-/chemical domain-binding proteins in murine embryonic fibroblasts .	T9	T24	23395981
NA	CHEMICAL	GENE-N	6	4	chemical modulates expression of gene and chemical-/chemical domain-binding proteins in murine embryonic fibroblasts .	T10	T23	23395981
NA	CHEMICAL	GENE-N	6	8	chemical modulates expression of gene and chemical-/chemical domain-binding proteins in murine embryonic fibroblasts .	T10	T24	23395981
NA	CHEMICAL	GENE-N	6	4	chemical modulates expression of gene and chemical-/chemical domain-binding proteins in murine embryonic fibroblasts .	T11	T23	23395981
NA	CHEMICAL	GENE-N	6	8	chemical modulates expression of gene and chemical-/chemical domain-binding proteins in murine embryonic fibroblasts .	T11	T24	23395981
NA	CHEMICAL	GENE-N	10	21	The present study was designed to test the hypothesis that chemical alters global DNA methylation , and modulates expression of the gene ( gene ) and various chemical-binding proteins .	T2	T12	23395981
NA	CHEMICAL	GENE-N	10	23	The present study was designed to test the hypothesis that chemical alters global DNA methylation , and modulates expression of the gene ( gene ) and various chemical-binding proteins .	T2	T13	23395981
NA	CHEMICAL	GENE-N	10	28	The present study was designed to test the hypothesis that chemical alters global DNA methylation , and modulates expression of the gene ( gene ) and various chemical-binding proteins .	T2	T14	23395981
NA	CHEMICAL	GENE-N	27	21	The present study was designed to test the hypothesis that chemical alters global DNA methylation , and modulates expression of the gene ( gene ) and various chemical-binding proteins .	T3	T12	23395981
NA	CHEMICAL	GENE-N	27	23	The present study was designed to test the hypothesis that chemical alters global DNA methylation , and modulates expression of the gene ( gene ) and various chemical-binding proteins .	T3	T13	23395981
NA	CHEMICAL	GENE-N	27	28	The present study was designed to test the hypothesis that chemical alters global DNA methylation , and modulates expression of the gene ( gene ) and various chemical-binding proteins .	T3	T14	23395981
CPR:4	CHEMICAL	GENE-N	3	7	In addition , chemical induced degradation of gene ( gene1 , gene , and gene ) , as well as the chemical-binding proteins ( gene , gene and gene ) , in MEF cells by the proteasomal pathway .	T6	T15	23395981
CPR:4	CHEMICAL	GENE-Y	3	9	In addition , chemical induced degradation of gene ( gene1 , gene , and gene ) , as well as the chemical-binding proteins ( gene , gene and gene ) , in MEF cells by the proteasomal pathway .	T6	T16	23395981
CPR:4	CHEMICAL	GENE-Y	3	11	In addition , chemical induced degradation of gene ( gene1 , gene , and gene ) , as well as the chemical-binding proteins ( gene , gene and gene ) , in MEF cells by the proteasomal pathway .	T6	T17	23395981
CPR:4	CHEMICAL	GENE-Y	3	14	In addition , chemical induced degradation of gene ( gene1 , gene , and gene ) , as well as the chemical-binding proteins ( gene , gene and gene ) , in MEF cells by the proteasomal pathway .	T6	T18	23395981
CPR:4	CHEMICAL	GENE-N	3	22	In addition , chemical induced degradation of gene ( gene1 , gene , and gene ) , as well as the chemical-binding proteins ( gene , gene and gene ) , in MEF cells by the proteasomal pathway .	T6	T19	23395981
CPR:4	CHEMICAL	GENE-Y	3	24	In addition , chemical induced degradation of gene ( gene1 , gene , and gene ) , as well as the chemical-binding proteins ( gene , gene and gene ) , in MEF cells by the proteasomal pathway .	T6	T20	23395981
CPR:4	CHEMICAL	GENE-Y	3	26	In addition , chemical induced degradation of gene ( gene1 , gene , and gene ) , as well as the chemical-binding proteins ( gene , gene and gene ) , in MEF cells by the proteasomal pathway .	T6	T21	23395981
CPR:4	CHEMICAL	GENE-Y	3	28	In addition , chemical induced degradation of gene ( gene1 , gene , and gene ) , as well as the chemical-binding proteins ( gene , gene and gene ) , in MEF cells by the proteasomal pathway .	T6	T22	23395981
NA	CHEMICAL	GENE-N	21	7	In addition , chemical induced degradation of gene ( gene1 , gene , and gene ) , as well as the chemical-binding proteins ( gene , gene and gene ) , in MEF cells by the proteasomal pathway .	T7	T15	23395981
NA	CHEMICAL	GENE-Y	21	9	In addition , chemical induced degradation of gene ( gene1 , gene , and gene ) , as well as the chemical-binding proteins ( gene , gene and gene ) , in MEF cells by the proteasomal pathway .	T7	T16	23395981
NA	CHEMICAL	GENE-Y	21	11	In addition , chemical induced degradation of gene ( gene1 , gene , and gene ) , as well as the chemical-binding proteins ( gene , gene and gene ) , in MEF cells by the proteasomal pathway .	T7	T17	23395981
NA	CHEMICAL	GENE-Y	21	14	In addition , chemical induced degradation of gene ( gene1 , gene , and gene ) , as well as the chemical-binding proteins ( gene , gene and gene ) , in MEF cells by the proteasomal pathway .	T7	T18	23395981
NA	CHEMICAL	GENE-N	21	22	In addition , chemical induced degradation of gene ( gene1 , gene , and gene ) , as well as the chemical-binding proteins ( gene , gene and gene ) , in MEF cells by the proteasomal pathway .	T7	T19	23395981
NA	CHEMICAL	GENE-Y	21	24	In addition , chemical induced degradation of gene ( gene1 , gene , and gene ) , as well as the chemical-binding proteins ( gene , gene and gene ) , in MEF cells by the proteasomal pathway .	T7	T20	23395981
NA	CHEMICAL	GENE-Y	21	26	In addition , chemical induced degradation of gene ( gene1 , gene , and gene ) , as well as the chemical-binding proteins ( gene , gene and gene ) , in MEF cells by the proteasomal pathway .	T7	T21	23395981
NA	CHEMICAL	GENE-Y	21	28	In addition , chemical induced degradation of gene ( gene1 , gene , and gene ) , as well as the chemical-binding proteins ( gene , gene and gene ) , in MEF cells by the proteasomal pathway .	T7	T22	23395981
NA	CHEMICAL	GENE-N	0	1	chemical reductases ( gene ) metabolize a wide range of substrates , including chemical ( chemical ) , generating metabolites ( chemical ) and reactive chemical species ( ROS ) , which are capable of initiating and promoting carcinogenesis .	T1	T12	22872607
NA	CHEMICAL	GENE-N	0	3	chemical reductases ( gene ) metabolize a wide range of substrates , including chemical ( chemical ) , generating metabolites ( chemical ) and reactive chemical species ( ROS ) , which are capable of initiating and promoting carcinogenesis .	T1	T19	22872607
CPR:9	CHEMICAL	GENE-N	6	1	chemical reductases ( gene ) metabolize a wide range of substrates , including chemical ( chemical ) , generating metabolites ( chemical ) and reactive chemical species ( ROS ) , which are capable of initiating and promoting carcinogenesis .	T11	T12	22872607
CPR:9	CHEMICAL	GENE-N	6	3	chemical reductases ( gene ) metabolize a wide range of substrates , including chemical ( chemical ) , generating metabolites ( chemical ) and reactive chemical species ( ROS ) , which are capable of initiating and promoting carcinogenesis .	T11	T19	22872607
CPR:9	CHEMICAL	GENE-N	15	1	chemical reductases ( gene ) metabolize a wide range of substrates , including chemical ( chemical ) , generating metabolites ( chemical ) and reactive chemical species ( ROS ) , which are capable of initiating and promoting carcinogenesis .	T3	T12	22872607
CPR:9	CHEMICAL	GENE-N	15	3	chemical reductases ( gene ) metabolize a wide range of substrates , including chemical ( chemical ) , generating metabolites ( chemical ) and reactive chemical species ( ROS ) , which are capable of initiating and promoting carcinogenesis .	T3	T19	22872607
CPR:9	CHEMICAL	GENE-N	21	1	chemical reductases ( gene ) metabolize a wide range of substrates , including chemical ( chemical ) , generating metabolites ( chemical ) and reactive chemical species ( ROS ) , which are capable of initiating and promoting carcinogenesis .	T6	T12	22872607
CPR:9	CHEMICAL	GENE-N	21	3	chemical reductases ( gene ) metabolize a wide range of substrates , including chemical ( chemical ) , generating metabolites ( chemical ) and reactive chemical species ( ROS ) , which are capable of initiating and promoting carcinogenesis .	T6	T19	22872607
CPR:9	CHEMICAL	GENE-N	25	1	chemical reductases ( gene ) metabolize a wide range of substrates , including chemical ( chemical ) , generating metabolites ( chemical ) and reactive chemical species ( ROS ) , which are capable of initiating and promoting carcinogenesis .	T7	T12	22872607
CPR:9	CHEMICAL	GENE-N	25	3	chemical reductases ( gene ) metabolize a wide range of substrates , including chemical ( chemical ) , generating metabolites ( chemical ) and reactive chemical species ( ROS ) , which are capable of initiating and promoting carcinogenesis .	T7	T19	22872607
CPR:3	CHEMICAL	GENE-N	2	11	Exposure to chemical , their metabolites , and ROS further increase gene isoform expression that may amplify oxidative damage .	T8	T20	22872607
CPR:9	CHEMICAL	GENE-N	6	4	Despite the importance of gene in chemical metabolism , there are no studies that evaluate , in general human populations , the effect of chemical on gene expression in peripheral blood lymphocytes ( PBLs ) .	T9	T23	22872607
NA	CHEMICAL	GENE-N	6	26	Despite the importance of gene in chemical metabolism , there are no studies that evaluate , in general human populations , the effect of chemical on gene expression in peripheral blood lymphocytes ( PBLs ) .	T9	T24	22872607
NA	CHEMICAL	GENE-N	24	4	Despite the importance of gene in chemical metabolism , there are no studies that evaluate , in general human populations , the effect of chemical on gene expression in peripheral blood lymphocytes ( PBLs ) .	T10	T23	22872607
NA	CHEMICAL	GENE-N	24	26	Despite the importance of gene in chemical metabolism , there are no studies that evaluate , in general human populations , the effect of chemical on gene expression in peripheral blood lymphocytes ( PBLs ) .	T10	T24	22872607
NA	CHEMICAL	GENE-Y	23	13	In the smoker group , there is a statistically significant positive association between gene , gene , and gene mRNA induction and urine chemical levels in individuals with a body mass index ( BMI ) less than 25 .	T2	T30	22872607
NA	CHEMICAL	GENE-Y	23	15	In the smoker group , there is a statistically significant positive association between gene , gene , and gene mRNA induction and urine chemical levels in individuals with a body mass index ( BMI ) less than 25 .	T2	T31	22872607
NA	CHEMICAL	GENE-Y	23	18	In the smoker group , there is a statistically significant positive association between gene , gene , and gene mRNA induction and urine chemical levels in individuals with a body mass index ( BMI ) less than 25 .	T2	T32	22872607
NA	CHEMICAL	GENE-N	11	12	All three mutations affect the structure and the function of the chemical channel gene .	T5	T8	10443304
NA	CHEMICAL	GENE-Y	11	13	All three mutations affect the structure and the function of the chemical channel gene .	T5	T9	10443304
NA	CHEMICAL	GENE-N	10	11	Two mutations result in total loss of function of the chemical channel .	T6	T10	10443304
NA	CHEMICAL	GENE-N	11	12	The other mutation results in acceleration of the recovery of the chemical channel from inactivation .	T7	T11	10443304
NA	CHEMICAL	GENE-N	0	1	chemical kinase and chemical phosphorylase level as the main predictive parameter for sensitivity to chemical in a mouse model .	T30	T50	14719072
NA	CHEMICAL	GENE-Y	0	4	chemical kinase and chemical phosphorylase level as the main predictive parameter for sensitivity to chemical in a mouse model .	T30	T51	14719072
NA	CHEMICAL	GENE-N	3	1	chemical kinase and chemical phosphorylase level as the main predictive parameter for sensitivity to chemical in a mouse model .	T32	T50	14719072
NA	CHEMICAL	GENE-Y	3	4	chemical kinase and chemical phosphorylase level as the main predictive parameter for sensitivity to chemical in a mouse model .	T32	T51	14719072
NA	CHEMICAL	GENE-N	14	1	chemical kinase and chemical phosphorylase level as the main predictive parameter for sensitivity to chemical in a mouse model .	T31	T50	14719072
NA	CHEMICAL	GENE-Y	14	4	chemical kinase and chemical phosphorylase level as the main predictive parameter for sensitivity to chemical in a mouse model .	T31	T51	14719072
CPR:4	CHEMICAL	GENE-Y	0	18	chemical currently undergoing clinical trials , has been demonstrated to have at least two mechanisms , inhibition of gene and incorporation into DNA .	T22	T39	14719072
NA	CHEMICAL	GENE-N	11	12	In the present study , we measured the enzyme activity of chemical kinase ( gene ) , chemical phosphorylase ( gene ) and chemical synthase ( gene ) in human cancer xenografts to investigate the contribution of these enzymes to the sensitivity of chemical .	T25	T40	14719072
NA	CHEMICAL	GENE-N	11	14	In the present study , we measured the enzyme activity of chemical kinase ( gene ) , chemical phosphorylase ( gene ) and chemical synthase ( gene ) in human cancer xenografts to investigate the contribution of these enzymes to the sensitivity of chemical .	T25	T41	14719072
NA	CHEMICAL	GENE-Y	11	18	In the present study , we measured the enzyme activity of chemical kinase ( gene ) , chemical phosphorylase ( gene ) and chemical synthase ( gene ) in human cancer xenografts to investigate the contribution of these enzymes to the sensitivity of chemical .	T25	T42	14719072
NA	CHEMICAL	GENE-Y	11	20	In the present study , we measured the enzyme activity of chemical kinase ( gene ) , chemical phosphorylase ( gene ) and chemical synthase ( gene ) in human cancer xenografts to investigate the contribution of these enzymes to the sensitivity of chemical .	T25	T43	14719072
NA	CHEMICAL	GENE-Y	11	24	In the present study , we measured the enzyme activity of chemical kinase ( gene ) , chemical phosphorylase ( gene ) and chemical synthase ( gene ) in human cancer xenografts to investigate the contribution of these enzymes to the sensitivity of chemical .	T25	T44	14719072
NA	CHEMICAL	GENE-Y	11	26	In the present study , we measured the enzyme activity of chemical kinase ( gene ) , chemical phosphorylase ( gene ) and chemical synthase ( gene ) in human cancer xenografts to investigate the contribution of these enzymes to the sensitivity of chemical .	T25	T45	14719072
NA	CHEMICAL	GENE-N	17	12	In the present study , we measured the enzyme activity of chemical kinase ( gene ) , chemical phosphorylase ( gene ) and chemical synthase ( gene ) in human cancer xenografts to investigate the contribution of these enzymes to the sensitivity of chemical .	T26	T40	14719072
NA	CHEMICAL	GENE-N	17	14	In the present study , we measured the enzyme activity of chemical kinase ( gene ) , chemical phosphorylase ( gene ) and chemical synthase ( gene ) in human cancer xenografts to investigate the contribution of these enzymes to the sensitivity of chemical .	T26	T41	14719072
NA	CHEMICAL	GENE-Y	17	18	In the present study , we measured the enzyme activity of chemical kinase ( gene ) , chemical phosphorylase ( gene ) and chemical synthase ( gene ) in human cancer xenografts to investigate the contribution of these enzymes to the sensitivity of chemical .	T26	T42	14719072
NA	CHEMICAL	GENE-Y	17	20	In the present study , we measured the enzyme activity of chemical kinase ( gene ) , chemical phosphorylase ( gene ) and chemical synthase ( gene ) in human cancer xenografts to investigate the contribution of these enzymes to the sensitivity of chemical .	T26	T43	14719072
NA	CHEMICAL	GENE-Y	17	24	In the present study , we measured the enzyme activity of chemical kinase ( gene ) , chemical phosphorylase ( gene ) and chemical synthase ( gene ) in human cancer xenografts to investigate the contribution of these enzymes to the sensitivity of chemical .	T26	T44	14719072
NA	CHEMICAL	GENE-Y	17	26	In the present study , we measured the enzyme activity of chemical kinase ( gene ) , chemical phosphorylase ( gene ) and chemical synthase ( gene ) in human cancer xenografts to investigate the contribution of these enzymes to the sensitivity of chemical .	T26	T45	14719072
NA	CHEMICAL	GENE-N	23	12	In the present study , we measured the enzyme activity of chemical kinase ( gene ) , chemical phosphorylase ( gene ) and chemical synthase ( gene ) in human cancer xenografts to investigate the contribution of these enzymes to the sensitivity of chemical .	T27	T40	14719072
NA	CHEMICAL	GENE-N	23	14	In the present study , we measured the enzyme activity of chemical kinase ( gene ) , chemical phosphorylase ( gene ) and chemical synthase ( gene ) in human cancer xenografts to investigate the contribution of these enzymes to the sensitivity of chemical .	T27	T41	14719072
NA	CHEMICAL	GENE-Y	23	18	In the present study , we measured the enzyme activity of chemical kinase ( gene ) , chemical phosphorylase ( gene ) and chemical synthase ( gene ) in human cancer xenografts to investigate the contribution of these enzymes to the sensitivity of chemical .	T27	T42	14719072
NA	CHEMICAL	GENE-Y	23	20	In the present study , we measured the enzyme activity of chemical kinase ( gene ) , chemical phosphorylase ( gene ) and chemical synthase ( gene ) in human cancer xenografts to investigate the contribution of these enzymes to the sensitivity of chemical .	T27	T43	14719072
NA	CHEMICAL	GENE-Y	23	24	In the present study , we measured the enzyme activity of chemical kinase ( gene ) , chemical phosphorylase ( gene ) and chemical synthase ( gene ) in human cancer xenografts to investigate the contribution of these enzymes to the sensitivity of chemical .	T27	T44	14719072
NA	CHEMICAL	GENE-Y	23	26	In the present study , we measured the enzyme activity of chemical kinase ( gene ) , chemical phosphorylase ( gene ) and chemical synthase ( gene ) in human cancer xenografts to investigate the contribution of these enzymes to the sensitivity of chemical .	T27	T45	14719072
NA	CHEMICAL	GENE-N	43	12	In the present study , we measured the enzyme activity of chemical kinase ( gene ) , chemical phosphorylase ( gene ) and chemical synthase ( gene ) in human cancer xenografts to investigate the contribution of these enzymes to the sensitivity of chemical .	T28	T40	14719072
NA	CHEMICAL	GENE-N	43	14	In the present study , we measured the enzyme activity of chemical kinase ( gene ) , chemical phosphorylase ( gene ) and chemical synthase ( gene ) in human cancer xenografts to investigate the contribution of these enzymes to the sensitivity of chemical .	T28	T41	14719072
NA	CHEMICAL	GENE-Y	43	18	In the present study , we measured the enzyme activity of chemical kinase ( gene ) , chemical phosphorylase ( gene ) and chemical synthase ( gene ) in human cancer xenografts to investigate the contribution of these enzymes to the sensitivity of chemical .	T28	T42	14719072
NA	CHEMICAL	GENE-Y	43	20	In the present study , we measured the enzyme activity of chemical kinase ( gene ) , chemical phosphorylase ( gene ) and chemical synthase ( gene ) in human cancer xenografts to investigate the contribution of these enzymes to the sensitivity of chemical .	T28	T43	14719072
CPR:4	CHEMICAL	GENE-Y	43	24	In the present study , we measured the enzyme activity of chemical kinase ( gene ) , chemical phosphorylase ( gene ) and chemical synthase ( gene ) in human cancer xenografts to investigate the contribution of these enzymes to the sensitivity of chemical .	T28	T44	14719072
CPR:4	CHEMICAL	GENE-Y	43	26	In the present study , we measured the enzyme activity of chemical kinase ( gene ) , chemical phosphorylase ( gene ) and chemical synthase ( gene ) in human cancer xenografts to investigate the contribution of these enzymes to the sensitivity of chemical .	T28	T45	14719072
NA	CHEMICAL	GENE-N	3	9	Antitumor activity of chemical appears to be associated with gene , tumor growth and gene .	T29	T46	14719072
NA	CHEMICAL	GENE-Y	3	14	Antitumor activity of chemical appears to be associated with gene , tumor growth and gene .	T29	T47	14719072
NA	CHEMICAL	GENE-N	10	28	These results suggested that the activation and degradation pattern of chemical plays an important role in the efficacy of chemical and that it is possible to use the gene/gene ratio to predict response to chemical therapy .	T3	T33	14719072
NA	CHEMICAL	GENE-Y	10	28	These results suggested that the activation and degradation pattern of chemical plays an important role in the efficacy of chemical and that it is possible to use the gene/gene ratio to predict response to chemical therapy .	T3	T34	14719072
NA	CHEMICAL	GENE-N	19	28	These results suggested that the activation and degradation pattern of chemical plays an important role in the efficacy of chemical and that it is possible to use the gene/gene ratio to predict response to chemical therapy .	T4	T33	14719072
NA	CHEMICAL	GENE-Y	19	28	These results suggested that the activation and degradation pattern of chemical plays an important role in the efficacy of chemical and that it is possible to use the gene/gene ratio to predict response to chemical therapy .	T4	T34	14719072
NA	CHEMICAL	GENE-N	34	28	These results suggested that the activation and degradation pattern of chemical plays an important role in the efficacy of chemical and that it is possible to use the gene/gene ratio to predict response to chemical therapy .	T5	T33	14719072
NA	CHEMICAL	GENE-Y	34	28	These results suggested that the activation and degradation pattern of chemical plays an important role in the efficacy of chemical and that it is possible to use the gene/gene ratio to predict response to chemical therapy .	T5	T34	14719072
NA	CHEMICAL	GENE-N	3	5	Neuroprotective role of chemical-sensitive chemical channels in cerebral ischemia .	T17	T27	23123646
NA	CHEMICAL	GENE-N	4	5	Neuroprotective role of chemical-sensitive chemical channels in cerebral ischemia .	T18	T27	23123646
NA	CHEMICAL	GENE-N	0	8	chemical-sensitive chemical ( chemical ( chemical ) ) channels are weak , inward rectifiers that couple metabolic status to cell membrane electrical activity , thus modulating many cellular functions .	T1	T19	23123646
NA	CHEMICAL	GENE-N	1	8	chemical-sensitive chemical ( chemical ( chemical ) ) channels are weak , inward rectifiers that couple metabolic status to cell membrane electrical activity , thus modulating many cellular functions .	T2	T19	23123646
NA	CHEMICAL	GENE-N	3	8	chemical-sensitive chemical ( chemical ( chemical ) ) channels are weak , inward rectifiers that couple metabolic status to cell membrane electrical activity , thus modulating many cellular functions .	T7	T19	23123646
NA	CHEMICAL	GENE-N	5	8	chemical-sensitive chemical ( chemical ( chemical ) ) channels are weak , inward rectifiers that couple metabolic status to cell membrane electrical activity , thus modulating many cellular functions .	T8	T19	23123646
CPR:3	CHEMICAL	GENE-N	4	11	An increase in the chemical/chemical ratio opens chemical ( chemical ) channels , leading to membrane hyperpolarization .	T3	T20	23123646
CPR:3	CHEMICAL	GENE-N	4	11	An increase in the chemical/chemical ratio opens chemical ( chemical ) channels , leading to membrane hyperpolarization .	T4	T20	23123646
NA	CHEMICAL	GENE-N	7	11	An increase in the chemical/chemical ratio opens chemical ( chemical ) channels , leading to membrane hyperpolarization .	T5	T20	23123646
NA	CHEMICAL	GENE-N	9	11	An increase in the chemical/chemical ratio opens chemical ( chemical ) channels , leading to membrane hyperpolarization .	T6	T20	23123646
NA	CHEMICAL	GENE-N	0	4	chemical ( chemical ) channels are ubiquitously expressed in neurons located in different regions of the brain , including the hippocampus and cortex .	T9	T21	23123646
NA	CHEMICAL	GENE-N	2	4	chemical ( chemical ) channels are ubiquitously expressed in neurons located in different regions of the brain , including the hippocampus and cortex .	T10	T21	23123646
NA	CHEMICAL	GENE-N	13	9	In vivo animal studies confirmed that knocking out the gene subunit of the chemical ( chemical ) channels increases ischemic infarction , and overexpression of the gene subunit reduces neuronal injury from ischemic insults .	T11	T22	23123646
NA	CHEMICAL	GENE-N	13	17	In vivo animal studies confirmed that knocking out the gene subunit of the chemical ( chemical ) channels increases ischemic infarction , and overexpression of the gene subunit reduces neuronal injury from ischemic insults .	T11	T23	23123646
NA	CHEMICAL	GENE-N	13	26	In vivo animal studies confirmed that knocking out the gene subunit of the chemical ( chemical ) channels increases ischemic infarction , and overexpression of the gene subunit reduces neuronal injury from ischemic insults .	T11	T24	23123646
NA	CHEMICAL	GENE-N	15	9	In vivo animal studies confirmed that knocking out the gene subunit of the chemical ( chemical ) channels increases ischemic infarction , and overexpression of the gene subunit reduces neuronal injury from ischemic insults .	T12	T22	23123646
NA	CHEMICAL	GENE-N	15	17	In vivo animal studies confirmed that knocking out the gene subunit of the chemical ( chemical ) channels increases ischemic infarction , and overexpression of the gene subunit reduces neuronal injury from ischemic insults .	T12	T23	23123646
NA	CHEMICAL	GENE-N	15	26	In vivo animal studies confirmed that knocking out the gene subunit of the chemical ( chemical ) channels increases ischemic infarction , and overexpression of the gene subunit reduces neuronal injury from ischemic insults .	T12	T24	23123646
NA	CHEMICAL	GENE-N	13	6	These findings provide the basis for a practical strategy whereby activation of endogenous chemical ( chemical ) channels reduces cellular damage resulting from cerebral ischemic stroke .	T13	T25	23123646
NA	CHEMICAL	GENE-N	15	6	These findings provide the basis for a practical strategy whereby activation of endogenous chemical ( chemical ) channels reduces cellular damage resulting from cerebral ischemic stroke .	T14	T25	23123646
NA	CHEMICAL	GENE-Y	9	2	Overexpression of gene in adult rat ventricular myocytes enhances chemical cardiostimulation : implications for 'putative ' gene pharmacology .	T23	T37	14757703
NA	CHEMICAL	GENE-N	9	16	Overexpression of gene in adult rat ventricular myocytes enhances chemical cardiostimulation : implications for 'putative ' gene pharmacology .	T23	T36	14757703
CPR:3	CHEMICAL	GENE-N	0	9	chemical mediates cardiostimulation by activation of the 'putative ' gene ; however , it has recently been reported that disruption of the gene gene abolishes this effect .	T14	T35	14757703
CPR:3	CHEMICAL	GENE-Y	0	22	chemical mediates cardiostimulation by activation of the 'putative ' gene ; however , it has recently been reported that disruption of the gene gene abolishes this effect .	T14	T27	14757703
NA	CHEMICAL	GENE-Y	5	4	We have adenovirally overexpressed gene in isolated , cultured adult rat ventricular cardiomyocytes and observed the inotropic potency of chemical and chemical ( in the presence of 1 microm chemical ) .	T15	T33	14757703
NA	CHEMICAL	GENE-Y	21	4	We have adenovirally overexpressed gene in isolated , cultured adult rat ventricular cardiomyocytes and observed the inotropic potency of chemical and chemical ( in the presence of 1 microm chemical ) .	T16	T33	14757703
NA	CHEMICAL	GENE-Y	29	4	We have adenovirally overexpressed gene in isolated , cultured adult rat ventricular cardiomyocytes and observed the inotropic potency of chemical and chemical ( in the presence of 1 microm chemical ) .	T17	T33	14757703
NA	CHEMICAL	GENE-Y	9	2	3. gene overexpression enhanced the inotropic potency of chemical by 11.7-fold ( pD ( 2 ) 8.76+/-0.14 ) and CGP 12177A by 5.9-fold ( 7.11+/-0.10 ) , respectively .	T21	T34	14757703
NA	CHEMICAL	GENE-N	4	10	The cardiostimulant effects of chemical were enhanced by IBMX ( gene inhibitor ) and decreased by chemical ( chemical antagonist ) .	T1	T24	14757703
NA	CHEMICAL	GENE-N	10	10	The cardiostimulant effects of chemical were enhanced by IBMX ( gene inhibitor ) and decreased by chemical ( chemical antagonist ) .	T2	T24	14757703
NA	CHEMICAL	GENE-N	18	10	The cardiostimulant effects of chemical were enhanced by IBMX ( gene inhibitor ) and decreased by chemical ( chemical antagonist ) .	T3	T24	14757703
CPR:3	CHEMICAL	GENE-Y	0	10	chemical but not chemical initiated arrhythmias at lower concentrations following gene overexpression .	T6	T25	14757703
NA	CHEMICAL	GENE-Y	3	10	chemical but not chemical initiated arrhythmias at lower concentrations following gene overexpression .	T7	T25	14757703
CPR:3	CHEMICAL	GENE-Y	0	5	chemical saturation binding in Adv.beta ( 1 ) myocytes demonstrated approximately 18-fold increase in gene .	T8	T26	14757703
CPR:3	CHEMICAL	GENE-Y	0	16	chemical saturation binding , in the presence of chemical , increased approximately 5-fold following overexpression of gene .	T9	T28	14757703
CPR:3	CHEMICAL	GENE-Y	8	16	chemical saturation binding , in the presence of chemical , increased approximately 5-fold following overexpression of gene .	T10	T28	14757703
NA	CHEMICAL	GENE-Y	6	7	This study demonstrates enhanced cardiostimulation by chemical ( in the presence of chemical ) in rat ventricular myocytes overexpressing gene , mediated by a gene/chemical signalling pathway .	T11	T29	14757703
NA	CHEMICAL	GENE-N	6	24	This study demonstrates enhanced cardiostimulation by chemical ( in the presence of chemical ) in rat ventricular myocytes overexpressing gene , mediated by a gene/chemical signalling pathway .	T11	T30	14757703
NA	CHEMICAL	GENE-Y	12	7	This study demonstrates enhanced cardiostimulation by chemical ( in the presence of chemical ) in rat ventricular myocytes overexpressing gene , mediated by a gene/chemical signalling pathway .	T12	T29	14757703
NA	CHEMICAL	GENE-N	12	24	This study demonstrates enhanced cardiostimulation by chemical ( in the presence of chemical ) in rat ventricular myocytes overexpressing gene , mediated by a gene/chemical signalling pathway .	T12	T30	14757703
NA	CHEMICAL	GENE-Y	24	7	This study demonstrates enhanced cardiostimulation by chemical ( in the presence of chemical ) in rat ventricular myocytes overexpressing gene , mediated by a gene/chemical signalling pathway .	T13	T29	14757703
NA	CHEMICAL	GENE-N	24	24	This study demonstrates enhanced cardiostimulation by chemical ( in the presence of chemical ) in rat ventricular myocytes overexpressing gene , mediated by a gene/chemical signalling pathway .	T13	T30	14757703
NA	CHEMICAL	GENE-Y	1	1	Cells in which gene was depleted had decreased gene ( gene ) abundance and increased gene at the later stages of the DNA damage response .	T2	T9	23612710
NA	CHEMICAL	GENE-Y	1	8	Cells in which gene was depleted had decreased gene ( gene ) abundance and increased gene at the later stages of the DNA damage response .	T2	T10	23612710
NA	CHEMICAL	GENE-Y	1	10	Cells in which gene was depleted had decreased gene ( gene ) abundance and increased gene at the later stages of the DNA damage response .	T2	T11	23612710
NA	CHEMICAL	GENE-Y	1	15	Cells in which gene was depleted had decreased gene ( gene ) abundance and increased gene at the later stages of the DNA damage response .	T2	T12	23612710
NA	CHEMICAL	GENE-Y	0	15	chemical was required for continued expression of genes encoding proteins that promote cell cycle progression in arrested cells .	T3	T13	23612710
NA	CHEMICAL	GENE-Y	0	3	chemical-terminal amidation , a required post-translational modification for the bioactivation of many neuropeptides , entails sequential enzymic action by gene ( gene , gene ) and gene ( gene , gene ) .	T1	T12	10947967
NA	CHEMICAL	GENE-Y	0	21	chemical-terminal amidation , a required post-translational modification for the bioactivation of many neuropeptides , entails sequential enzymic action by gene ( gene , gene ) and gene ( gene , gene ) .	T1	T15	10947967
NA	CHEMICAL	GENE-Y	0	23	chemical-terminal amidation , a required post-translational modification for the bioactivation of many neuropeptides , entails sequential enzymic action by gene ( gene , gene ) and gene ( gene , gene ) .	T1	T16	10947967
NA	CHEMICAL	GENE-Y	0	3	chemical-terminal amidation , a required post-translational modification for the bioactivation of many neuropeptides , entails sequential enzymic action by gene ( gene , gene ) and gene ( gene , gene ) .	T1	T17	10947967
NA	CHEMICAL	GENE-Y	0	28	chemical-terminal amidation , a required post-translational modification for the bioactivation of many neuropeptides , entails sequential enzymic action by gene ( gene , gene ) and gene ( gene , gene ) .	T1	T18	10947967
NA	CHEMICAL	GENE-Y	0	30	chemical-terminal amidation , a required post-translational modification for the bioactivation of many neuropeptides , entails sequential enzymic action by gene ( gene , gene ) and gene ( gene , gene ) .	T1	T19	10947967
CPR:4	CHEMICAL	GENE-Y	6	3	Kinetic parameters for gene inactivation by chemical were obtained by using both the conventional dilution assay method and the more complex progress curve method .	T8	T21	10947967
CPR:4	CHEMICAL	GENE-Y	7	4	Stereochemical studies established that gene inactivation by chemical is stereospecific with respect to the moiety at the P ( 2 ) position , which is consistent with previous results with substrates and reversible inhibitors .	T3	T11	10947967
NA	CHEMICAL	GENE-N	5	0	gene as a source of chemical for adrenal steroidogenesis : a study in individuals with low plasma gene-C .	T9	T32	23511897
NA	CHEMICAL	GENE-N	5	17	gene as a source of chemical for adrenal steroidogenesis : a study in individuals with low plasma gene-C .	T9	T33	23511897
NA	CHEMICAL	GENE-N	8	7	Few studies have addressed the delivery of gene-derived chemical to the adrenals for chemical production in humans .	T6	T17	23511897
NA	CHEMICAL	GENE-N	13	7	Few studies have addressed the delivery of gene-derived chemical to the adrenals for chemical production in humans .	T8	T17	23511897
NA	CHEMICAL	GENE-Y	4	22	To study this , chemical profiles in urine were assessed in male subjects suffering from functional mutations in chemical binding cassette transporter A1 ( gene ) ( n = 24 ) , gene ( gene ) ( n = 40 ) , as well as in 11 subjects with low gene chemical ( gene-C ) without gene/gene mutations .	T2	T16	23511897
NA	CHEMICAL	GENE-Y	4	22	To study this , chemical profiles in urine were assessed in male subjects suffering from functional mutations in chemical binding cassette transporter A1 ( gene ) ( n = 24 ) , gene ( gene ) ( n = 40 ) , as well as in 11 subjects with low gene chemical ( gene-C ) without gene/gene mutations .	T2	T18	23511897
NA	CHEMICAL	GENE-Y	4	27	To study this , chemical profiles in urine were assessed in male subjects suffering from functional mutations in chemical binding cassette transporter A1 ( gene ) ( n = 24 ) , gene ( gene ) ( n = 40 ) , as well as in 11 subjects with low gene chemical ( gene-C ) without gene/gene mutations .	T2	T19	23511897
NA	CHEMICAL	GENE-Y	4	34	To study this , chemical profiles in urine were assessed in male subjects suffering from functional mutations in chemical binding cassette transporter A1 ( gene ) ( n = 24 ) , gene ( gene ) ( n = 40 ) , as well as in 11 subjects with low gene chemical ( gene-C ) without gene/gene mutations .	T2	T20	23511897
NA	CHEMICAL	GENE-N	4	50	To study this , chemical profiles in urine were assessed in male subjects suffering from functional mutations in chemical binding cassette transporter A1 ( gene ) ( n = 24 ) , gene ( gene ) ( n = 40 ) , as well as in 11 subjects with low gene chemical ( gene-C ) without gene/gene mutations .	T2	T21	23511897
NA	CHEMICAL	GENE-N	4	53	To study this , chemical profiles in urine were assessed in male subjects suffering from functional mutations in chemical binding cassette transporter A1 ( gene ) ( n = 24 ) , gene ( gene ) ( n = 40 ) , as well as in 11 subjects with low gene chemical ( gene-C ) without gene/gene mutations .	T2	T22	23511897
NA	CHEMICAL	GENE-Y	4	22	To study this , chemical profiles in urine were assessed in male subjects suffering from functional mutations in chemical binding cassette transporter A1 ( gene ) ( n = 24 ) , gene ( gene ) ( n = 40 ) , as well as in 11 subjects with low gene chemical ( gene-C ) without gene/gene mutations .	T2	T23	23511897
NA	CHEMICAL	GENE-Y	4	56	To study this , chemical profiles in urine were assessed in male subjects suffering from functional mutations in chemical binding cassette transporter A1 ( gene ) ( n = 24 ) , gene ( gene ) ( n = 40 ) , as well as in 11 subjects with low gene chemical ( gene-C ) without gene/gene mutations .	T2	T24	23511897
NA	CHEMICAL	GENE-Y	18	22	To study this , chemical profiles in urine were assessed in male subjects suffering from functional mutations in chemical binding cassette transporter A1 ( gene ) ( n = 24 ) , gene ( gene ) ( n = 40 ) , as well as in 11 subjects with low gene chemical ( gene-C ) without gene/gene mutations .	T3	T16	23511897
NA	CHEMICAL	GENE-Y	18	22	To study this , chemical profiles in urine were assessed in male subjects suffering from functional mutations in chemical binding cassette transporter A1 ( gene ) ( n = 24 ) , gene ( gene ) ( n = 40 ) , as well as in 11 subjects with low gene chemical ( gene-C ) without gene/gene mutations .	T3	T18	23511897
NA	CHEMICAL	GENE-Y	18	27	To study this , chemical profiles in urine were assessed in male subjects suffering from functional mutations in chemical binding cassette transporter A1 ( gene ) ( n = 24 ) , gene ( gene ) ( n = 40 ) , as well as in 11 subjects with low gene chemical ( gene-C ) without gene/gene mutations .	T3	T19	23511897
NA	CHEMICAL	GENE-Y	18	34	To study this , chemical profiles in urine were assessed in male subjects suffering from functional mutations in chemical binding cassette transporter A1 ( gene ) ( n = 24 ) , gene ( gene ) ( n = 40 ) , as well as in 11 subjects with low gene chemical ( gene-C ) without gene/gene mutations .	T3	T20	23511897
NA	CHEMICAL	GENE-N	18	50	To study this , chemical profiles in urine were assessed in male subjects suffering from functional mutations in chemical binding cassette transporter A1 ( gene ) ( n = 24 ) , gene ( gene ) ( n = 40 ) , as well as in 11 subjects with low gene chemical ( gene-C ) without gene/gene mutations .	T3	T21	23511897
NA	CHEMICAL	GENE-N	18	53	To study this , chemical profiles in urine were assessed in male subjects suffering from functional mutations in chemical binding cassette transporter A1 ( gene ) ( n = 24 ) , gene ( gene ) ( n = 40 ) , as well as in 11 subjects with low gene chemical ( gene-C ) without gene/gene mutations .	T3	T22	23511897
NA	CHEMICAL	GENE-Y	18	22	To study this , chemical profiles in urine were assessed in male subjects suffering from functional mutations in chemical binding cassette transporter A1 ( gene ) ( n = 24 ) , gene ( gene ) ( n = 40 ) , as well as in 11 subjects with low gene chemical ( gene-C ) without gene/gene mutations .	T3	T23	23511897
NA	CHEMICAL	GENE-Y	18	56	To study this , chemical profiles in urine were assessed in male subjects suffering from functional mutations in chemical binding cassette transporter A1 ( gene ) ( n = 24 ) , gene ( gene ) ( n = 40 ) , as well as in 11 subjects with low gene chemical ( gene-C ) without gene/gene mutations .	T3	T24	23511897
NA	CHEMICAL	GENE-Y	51	22	To study this , chemical profiles in urine were assessed in male subjects suffering from functional mutations in chemical binding cassette transporter A1 ( gene ) ( n = 24 ) , gene ( gene ) ( n = 40 ) , as well as in 11 subjects with low gene chemical ( gene-C ) without gene/gene mutations .	T4	T16	23511897
NA	CHEMICAL	GENE-Y	51	22	To study this , chemical profiles in urine were assessed in male subjects suffering from functional mutations in chemical binding cassette transporter A1 ( gene ) ( n = 24 ) , gene ( gene ) ( n = 40 ) , as well as in 11 subjects with low gene chemical ( gene-C ) without gene/gene mutations .	T4	T18	23511897
NA	CHEMICAL	GENE-Y	51	27	To study this , chemical profiles in urine were assessed in male subjects suffering from functional mutations in chemical binding cassette transporter A1 ( gene ) ( n = 24 ) , gene ( gene ) ( n = 40 ) , as well as in 11 subjects with low gene chemical ( gene-C ) without gene/gene mutations .	T4	T19	23511897
NA	CHEMICAL	GENE-Y	51	34	To study this , chemical profiles in urine were assessed in male subjects suffering from functional mutations in chemical binding cassette transporter A1 ( gene ) ( n = 24 ) , gene ( gene ) ( n = 40 ) , as well as in 11 subjects with low gene chemical ( gene-C ) without gene/gene mutations .	T4	T20	23511897
NA	CHEMICAL	GENE-N	51	50	To study this , chemical profiles in urine were assessed in male subjects suffering from functional mutations in chemical binding cassette transporter A1 ( gene ) ( n = 24 ) , gene ( gene ) ( n = 40 ) , as well as in 11 subjects with low gene chemical ( gene-C ) without gene/gene mutations .	T4	T21	23511897
NA	CHEMICAL	GENE-N	51	53	To study this , chemical profiles in urine were assessed in male subjects suffering from functional mutations in chemical binding cassette transporter A1 ( gene ) ( n = 24 ) , gene ( gene ) ( n = 40 ) , as well as in 11 subjects with low gene chemical ( gene-C ) without gene/gene mutations .	T4	T22	23511897
NA	CHEMICAL	GENE-Y	51	22	To study this , chemical profiles in urine were assessed in male subjects suffering from functional mutations in chemical binding cassette transporter A1 ( gene ) ( n = 24 ) , gene ( gene ) ( n = 40 ) , as well as in 11 subjects with low gene chemical ( gene-C ) without gene/gene mutations .	T4	T23	23511897
NA	CHEMICAL	GENE-Y	51	56	To study this , chemical profiles in urine were assessed in male subjects suffering from functional mutations in chemical binding cassette transporter A1 ( gene ) ( n = 24 ) , gene ( gene ) ( n = 40 ) , as well as in 11 subjects with low gene chemical ( gene-C ) without gene/gene mutations .	T4	T24	23511897
NA	CHEMICAL	GENE-N	11	5	In all groups with low gene-C levels , urinary excretion of chemical was reduced by 33 % , 27 % , and 32 % compared with controls ( all P < 0.04 ) .	T7	T29	23511897
CPR:4	CHEMICAL	GENE-N	0	12	chemical ( chemical , chemical ) , a dual-action inhibitor that targets gene/gene/gene pathway in tumor cells and chemical kinases gene/gene in tumor vasculature .	T10	T41	16757355
CPR:4	CHEMICAL	GENE-N	0	12	chemical ( chemical , chemical ) , a dual-action inhibitor that targets gene/gene/gene pathway in tumor cells and chemical kinases gene/gene in tumor vasculature .	T10	T42	16757355
CPR:4	CHEMICAL	GENE-N	0	12	chemical ( chemical , chemical ) , a dual-action inhibitor that targets gene/gene/gene pathway in tumor cells and chemical kinases gene/gene in tumor vasculature .	T10	T43	16757355
CPR:4	CHEMICAL	GENE-N	0	7	chemical ( chemical , chemical ) , a dual-action inhibitor that targets gene/gene/gene pathway in tumor cells and chemical kinases gene/gene in tumor vasculature .	T10	T38	16757355
CPR:4	CHEMICAL	GENE-N	0	20	chemical ( chemical , chemical ) , a dual-action inhibitor that targets gene/gene/gene pathway in tumor cells and chemical kinases gene/gene in tumor vasculature .	T10	T39	16757355
CPR:4	CHEMICAL	GENE-N	0	20	chemical ( chemical , chemical ) , a dual-action inhibitor that targets gene/gene/gene pathway in tumor cells and chemical kinases gene/gene in tumor vasculature .	T10	T40	16757355
CPR:4	CHEMICAL	GENE-N	2	12	chemical ( chemical , chemical ) , a dual-action inhibitor that targets gene/gene/gene pathway in tumor cells and chemical kinases gene/gene in tumor vasculature .	T12	T41	16757355
CPR:4	CHEMICAL	GENE-N	2	12	chemical ( chemical , chemical ) , a dual-action inhibitor that targets gene/gene/gene pathway in tumor cells and chemical kinases gene/gene in tumor vasculature .	T12	T42	16757355
CPR:4	CHEMICAL	GENE-N	2	12	chemical ( chemical , chemical ) , a dual-action inhibitor that targets gene/gene/gene pathway in tumor cells and chemical kinases gene/gene in tumor vasculature .	T12	T43	16757355
CPR:4	CHEMICAL	GENE-N	2	7	chemical ( chemical , chemical ) , a dual-action inhibitor that targets gene/gene/gene pathway in tumor cells and chemical kinases gene/gene in tumor vasculature .	T12	T38	16757355
CPR:4	CHEMICAL	GENE-N	2	20	chemical ( chemical , chemical ) , a dual-action inhibitor that targets gene/gene/gene pathway in tumor cells and chemical kinases gene/gene in tumor vasculature .	T12	T39	16757355
CPR:4	CHEMICAL	GENE-N	2	20	chemical ( chemical , chemical ) , a dual-action inhibitor that targets gene/gene/gene pathway in tumor cells and chemical kinases gene/gene in tumor vasculature .	T12	T40	16757355
CPR:4	CHEMICAL	GENE-N	4	12	chemical ( chemical , chemical ) , a dual-action inhibitor that targets gene/gene/gene pathway in tumor cells and chemical kinases gene/gene in tumor vasculature .	T13	T41	16757355
CPR:4	CHEMICAL	GENE-N	4	12	chemical ( chemical , chemical ) , a dual-action inhibitor that targets gene/gene/gene pathway in tumor cells and chemical kinases gene/gene in tumor vasculature .	T13	T42	16757355
CPR:4	CHEMICAL	GENE-N	4	12	chemical ( chemical , chemical ) , a dual-action inhibitor that targets gene/gene/gene pathway in tumor cells and chemical kinases gene/gene in tumor vasculature .	T13	T43	16757355
CPR:4	CHEMICAL	GENE-N	4	7	chemical ( chemical , chemical ) , a dual-action inhibitor that targets gene/gene/gene pathway in tumor cells and chemical kinases gene/gene in tumor vasculature .	T13	T38	16757355
CPR:4	CHEMICAL	GENE-N	4	20	chemical ( chemical , chemical ) , a dual-action inhibitor that targets gene/gene/gene pathway in tumor cells and chemical kinases gene/gene in tumor vasculature .	T13	T39	16757355
CPR:4	CHEMICAL	GENE-N	4	20	chemical ( chemical , chemical ) , a dual-action inhibitor that targets gene/gene/gene pathway in tumor cells and chemical kinases gene/gene in tumor vasculature .	T13	T40	16757355
NA	CHEMICAL	GENE-N	14	12	chemical ( chemical , chemical ) , a dual-action inhibitor that targets gene/gene/gene pathway in tumor cells and chemical kinases gene/gene in tumor vasculature .	T11	T41	16757355
NA	CHEMICAL	GENE-N	14	12	chemical ( chemical , chemical ) , a dual-action inhibitor that targets gene/gene/gene pathway in tumor cells and chemical kinases gene/gene in tumor vasculature .	T11	T42	16757355
NA	CHEMICAL	GENE-N	14	12	chemical ( chemical , chemical ) , a dual-action inhibitor that targets gene/gene/gene pathway in tumor cells and chemical kinases gene/gene in tumor vasculature .	T11	T43	16757355
NA	CHEMICAL	GENE-N	14	7	chemical ( chemical , chemical ) , a dual-action inhibitor that targets gene/gene/gene pathway in tumor cells and chemical kinases gene/gene in tumor vasculature .	T11	T38	16757355
NA	CHEMICAL	GENE-N	14	20	chemical ( chemical , chemical ) , a dual-action inhibitor that targets gene/gene/gene pathway in tumor cells and chemical kinases gene/gene in tumor vasculature .	T11	T39	16757355
NA	CHEMICAL	GENE-N	14	20	chemical ( chemical , chemical ) , a dual-action inhibitor that targets gene/gene/gene pathway in tumor cells and chemical kinases gene/gene in tumor vasculature .	T11	T40	16757355
NA	CHEMICAL	GENE-N	4	4	In addition , several gene , acting upstream of gene , were found either mutated or overexpressed in human tumors .	T1	T14	16757355
NA	CHEMICAL	GENE-N	4	9	In addition , several gene , acting upstream of gene , were found either mutated or overexpressed in human tumors .	T1	T21	16757355
CPR:4	CHEMICAL	GENE-Y	4	0	A novel class of chemical that inhibits gene gene was discovered using a combination of medicinal and combinatorial chemistry approaches .	T5	T30	16757355
CPR:4	CHEMICAL	GENE-N	4	8	A novel class of chemical that inhibits gene gene was discovered using a combination of medicinal and combinatorial chemistry approaches .	T5	T31	16757355
CPR:4	CHEMICAL	GENE-N	0	3	chemical inhibited the gene activity of both gene and gene ( wild type and gene mutant ) .	T9	T32	16757355
CPR:4	CHEMICAL	GENE-Y	0	7	chemical inhibited the gene activity of both gene and gene ( wild type and gene mutant ) .	T9	T33	16757355
CPR:4	CHEMICAL	GENE-Y	0	9	chemical inhibited the gene activity of both gene and gene ( wild type and gene mutant ) .	T9	T34	16757355
CPR:4	CHEMICAL	GENE-N	0	14	chemical inhibited the gene activity of both gene and gene ( wild type and gene mutant ) .	T9	T35	16757355
CPR:4	CHEMICAL	GENE-N	3	15	Further characterization of chemical revealed that this molecule was a multikinase inhibitor that targeted the gene family ( gene and gene ) and gene family ( gene and gene ) , which play key roles in tumor progression and angiogenesis .	T2	T15	16757355
CPR:4	CHEMICAL	GENE-Y	3	18	Further characterization of chemical revealed that this molecule was a multikinase inhibitor that targeted the gene family ( gene and gene ) and gene family ( gene and gene ) , which play key roles in tumor progression and angiogenesis .	T2	T16	16757355
CPR:4	CHEMICAL	GENE-Y	3	20	Further characterization of chemical revealed that this molecule was a multikinase inhibitor that targeted the gene family ( gene and gene ) and gene family ( gene and gene ) , which play key roles in tumor progression and angiogenesis .	T2	T17	16757355
CPR:4	CHEMICAL	GENE-N	3	23	Further characterization of chemical revealed that this molecule was a multikinase inhibitor that targeted the gene family ( gene and gene ) and gene family ( gene and gene ) , which play key roles in tumor progression and angiogenesis .	T2	T18	16757355
CPR:4	CHEMICAL	GENE-Y	3	9	Further characterization of chemical revealed that this molecule was a multikinase inhibitor that targeted the gene family ( gene and gene ) and gene family ( gene and gene ) , which play key roles in tumor progression and angiogenesis .	T2	T19	16757355
CPR:4	CHEMICAL	GENE-Y	3	28	Further characterization of chemical revealed that this molecule was a multikinase inhibitor that targeted the gene family ( gene and gene ) and gene family ( gene and gene ) , which play key roles in tumor progression and angiogenesis .	T2	T20	16757355
CPR:4	CHEMICAL	GENE-N	2	8	Thus , chemical may inhibit tumor growth by a dual mechanism , acting either directly on the tumor ( through inhibition of gene and gene signaling ) and/or on tumor angiogenesis ( through inhibition of gene and gene signaling ) .	T3	T22	16757355
CPR:4	CHEMICAL	GENE-Y	2	24	Thus , chemical may inhibit tumor growth by a dual mechanism , acting either directly on the tumor ( through inhibition of gene and gene signaling ) and/or on tumor angiogenesis ( through inhibition of gene and gene signaling ) .	T3	T23	16757355
CPR:4	CHEMICAL	GENE-N	2	35	Thus , chemical may inhibit tumor growth by a dual mechanism , acting either directly on the tumor ( through inhibition of gene and gene signaling ) and/or on tumor angiogenesis ( through inhibition of gene and gene signaling ) .	T3	T24	16757355
CPR:4	CHEMICAL	GENE-N	2	37	Thus , chemical may inhibit tumor growth by a dual mechanism , acting either directly on the tumor ( through inhibition of gene and gene signaling ) and/or on tumor angiogenesis ( through inhibition of gene and gene signaling ) .	T3	T25	16757355
NA	CHEMICAL	GENE-Y	0	3	chemical-binding cassette transporter A1 is involved in hepatic chemical secretion .	T20	T33	19427182
CPR:9	CHEMICAL	GENE-Y	8	3	chemical-binding cassette transporter A1 is involved in hepatic chemical secretion .	T21	T33	19427182
NA	CHEMICAL	GENE-Y	0	2	chemical transfer protein ( gene ) , the product of the gene responsible for familial isolated chemical deficiency , plays an important role in maintaining the plasma chemical level by mediating the secretion of chemical by the liver .	T18	T32	19427182
NA	CHEMICAL	GENE-Y	0	4	chemical transfer protein ( gene ) , the product of the gene responsible for familial isolated chemical deficiency , plays an important role in maintaining the plasma chemical level by mediating the secretion of chemical by the liver .	T18	T24	19427182
NA	CHEMICAL	GENE-Y	16	2	chemical transfer protein ( gene ) , the product of the gene responsible for familial isolated chemical deficiency , plays an important role in maintaining the plasma chemical level by mediating the secretion of chemical by the liver .	T9	T32	19427182
NA	CHEMICAL	GENE-Y	16	4	chemical transfer protein ( gene ) , the product of the gene responsible for familial isolated chemical deficiency , plays an important role in maintaining the plasma chemical level by mediating the secretion of chemical by the liver .	T9	T24	19427182
CPR:9	CHEMICAL	GENE-Y	27	2	chemical transfer protein ( gene ) , the product of the gene responsible for familial isolated chemical deficiency , plays an important role in maintaining the plasma chemical level by mediating the secretion of chemical by the liver .	T10	T32	19427182
CPR:9	CHEMICAL	GENE-Y	27	4	chemical transfer protein ( gene ) , the product of the gene responsible for familial isolated chemical deficiency , plays an important role in maintaining the plasma chemical level by mediating the secretion of chemical by the liver .	T10	T24	19427182
CPR:9	CHEMICAL	GENE-Y	34	2	chemical transfer protein ( gene ) , the product of the gene responsible for familial isolated chemical deficiency , plays an important role in maintaining the plasma chemical level by mediating the secretion of chemical by the liver .	T11	T32	19427182
CPR:9	CHEMICAL	GENE-Y	34	4	chemical transfer protein ( gene ) , the product of the gene responsible for familial isolated chemical deficiency , plays an important role in maintaining the plasma chemical level by mediating the secretion of chemical by the liver .	T11	T24	19427182
NA	CHEMICAL	GENE-Y	5	1	From in vitro experiments using chemical and McARH7777 cells that stably express chemical transfer protein ( gene ) , the following results were obtained .	T15	T26	19427182
NA	CHEMICAL	GENE-Y	5	16	From in vitro experiments using chemical and McARH7777 cells that stably express chemical transfer protein ( gene ) , the following results were obtained .	T15	T27	19427182
NA	CHEMICAL	GENE-Y	12	1	From in vitro experiments using chemical and McARH7777 cells that stably express chemical transfer protein ( gene ) , the following results were obtained .	T16	T26	19427182
NA	CHEMICAL	GENE-Y	12	16	From in vitro experiments using chemical and McARH7777 cells that stably express chemical transfer protein ( gene ) , the following results were obtained .	T16	T27	19427182
NA	CHEMICAL	GENE-Y	14	4	First , addition of gene ( gene ) , a direct acceptor of the chemical-binding cassette transporter A1 ( gene ) -secreted lipids , increased chemical secretion in a dose-dependent manner .	T17	T28	19427182
NA	CHEMICAL	GENE-Y	14	6	First , addition of gene ( gene ) , a direct acceptor of the chemical-binding cassette transporter A1 ( gene ) -secreted lipids , increased chemical secretion in a dose-dependent manner .	T17	T29	19427182
NA	CHEMICAL	GENE-Y	14	17	First , addition of gene ( gene ) , a direct acceptor of the chemical-binding cassette transporter A1 ( gene ) -secreted lipids , increased chemical secretion in a dose-dependent manner .	T17	T30	19427182
NA	CHEMICAL	GENE-Y	14	17	First , addition of gene ( gene ) , a direct acceptor of the chemical-binding cassette transporter A1 ( gene ) -secreted lipids , increased chemical secretion in a dose-dependent manner .	T17	T31	19427182
CPR:9	CHEMICAL	GENE-Y	9	4	First , addition of gene ( gene ) , a direct acceptor of the chemical-binding cassette transporter A1 ( gene ) -secreted lipids , increased chemical secretion in a dose-dependent manner .	T19	T28	19427182
CPR:9	CHEMICAL	GENE-Y	9	6	First , addition of gene ( gene ) , a direct acceptor of the chemical-binding cassette transporter A1 ( gene ) -secreted lipids , increased chemical secretion in a dose-dependent manner .	T19	T29	19427182
CPR:9	CHEMICAL	GENE-Y	9	17	First , addition of gene ( gene ) , a direct acceptor of the chemical-binding cassette transporter A1 ( gene ) -secreted lipids , increased chemical secretion in a dose-dependent manner .	T19	T30	19427182
CPR:9	CHEMICAL	GENE-Y	9	17	First , addition of gene ( gene ) , a direct acceptor of the chemical-binding cassette transporter A1 ( gene ) -secreted lipids , increased chemical secretion in a dose-dependent manner .	T19	T31	19427182
CPR:4	CHEMICAL	GENE-Y	2	13	Second , chemical , an antiatherogenic compound reported to be an inactivator of gene reduced hepatic chemical secretion .	T2	T22	19427182
NA	CHEMICAL	GENE-Y	8	13	Second , chemical , an antiatherogenic compound reported to be an inactivator of gene reduced hepatic chemical secretion .	T4	T22	19427182
CPR:9	CHEMICAL	GENE-Y	5	2	Third , gene-RNAi suppressed hepatic chemical secretion .	T5	T23	19427182
NA	CHEMICAL	GENE-Y	14	14	Structural , kinetic , and thermodynamic analysis of the binding of the 40 kDa chemical-gene and its individual positional isomers to the extracellular domain of the receptor gene .	T4	T19	15898717
NA	CHEMICAL	GENE-Y	14	27	Structural , kinetic , and thermodynamic analysis of the binding of the 40 kDa chemical-gene and its individual positional isomers to the extracellular domain of the receptor gene .	T4	T18	15898717
NA	CHEMICAL	GENE-Y	3	4	This 40 kDa chemical-conjugated gene ( ( 40 ) PEG-gene ) is obtained by the covalent binding of one 40 kDa branched PEG-polymer to a chemical side-chain of gene .	T2	T12	15898717
NA	CHEMICAL	GENE-Y	3	5	This 40 kDa chemical-conjugated gene ( ( 40 ) PEG-gene ) is obtained by the covalent binding of one 40 kDa branched PEG-polymer to a chemical side-chain of gene .	T2	T13	15898717
NA	CHEMICAL	GENE-Y	3	5	This 40 kDa chemical-conjugated gene ( ( 40 ) PEG-gene ) is obtained by the covalent binding of one 40 kDa branched PEG-polymer to a chemical side-chain of gene .	T2	T14	15898717
NA	CHEMICAL	GENE-Y	25	4	This 40 kDa chemical-conjugated gene ( ( 40 ) PEG-gene ) is obtained by the covalent binding of one 40 kDa branched PEG-polymer to a chemical side-chain of gene .	T3	T12	15898717
NA	CHEMICAL	GENE-Y	25	5	This 40 kDa chemical-conjugated gene ( ( 40 ) PEG-gene ) is obtained by the covalent binding of one 40 kDa branched PEG-polymer to a chemical side-chain of gene .	T3	T13	15898717
NA	CHEMICAL	GENE-Y	25	5	This 40 kDa chemical-conjugated gene ( ( 40 ) PEG-gene ) is obtained by the covalent binding of one 40 kDa branched PEG-polymer to a chemical side-chain of gene .	T3	T14	15898717
NA	CHEMICAL	GENE-N	0	28	chemical NPs ( concentration range 25-200 µg/ml ) induced dose-dependent cytotoxicity in both types of cells , which was demonstrated by cell viability ( chemical ) and chemical dehydrogenase leakage assays .	T6	T19	23315277
NA	CHEMICAL	GENE-N	2	28	chemical NPs ( concentration range 25-200 µg/ml ) induced dose-dependent cytotoxicity in both types of cells , which was demonstrated by cell viability ( chemical ) and chemical dehydrogenase leakage assays .	T8	T19	23315277
NA	CHEMICAL	GENE-N	27	28	chemical NPs ( concentration range 25-200 µg/ml ) induced dose-dependent cytotoxicity in both types of cells , which was demonstrated by cell viability ( chemical ) and chemical dehydrogenase leakage assays .	T9	T19	23315277
CPR:3	CHEMICAL	GENE-Y	14	25	Quantitative real-time polymerase chain reaction analysis showed that following the exposure of cells to chemical NPs , the messenger RNA level of apoptotic genes ( gene and gene ) were upregulated in a dose-dependent manner .	T13	T15	23315277
CPR:3	CHEMICAL	GENE-Y	14	27	Quantitative real-time polymerase chain reaction analysis showed that following the exposure of cells to chemical NPs , the messenger RNA level of apoptotic genes ( gene and gene ) were upregulated in a dose-dependent manner .	T13	T16	23315277
CPR:3	CHEMICAL	GENE-Y	4	4	Moreover , activities of gene and gene enzymes were also significantly higher in both kinds of cells exposed to chemical NPs .	T1	T17	23315277
CPR:3	CHEMICAL	GENE-Y	4	6	Moreover , activities of gene and gene enzymes were also significantly higher in both kinds of cells exposed to chemical NPs .	T1	T18	23315277
NA	CHEMICAL	GENE-Y	6	0	gene density and function ( agonist-induced chemical production ) was measured in myometrial samples from both groups .	T5	T12	1332478
CPR:4	CHEMICAL	GENE-Y	5	5	The failure of the myometrium to respond to chemical ( desensitization ) was associated with significant reductions in agonist-induced chemical production and gene concentration in myometrial tissue collected from these animals compared with the saline solution-treated controls .	T7	T13	1332478
NA	CHEMICAL	GENE-Y	19	5	The failure of the myometrium to respond to chemical ( desensitization ) was associated with significant reductions in agonist-induced chemical production and gene concentration in myometrial tissue collected from these animals compared with the saline solution-treated controls .	T8	T13	1332478
CPR:4	CHEMICAL	GENE-Y	0	6	chemical inhibits growth of tumors through gene degradation independent of antiangiogenesis .	T12	T33	15982930
NA	CHEMICAL	GENE-Y	5	27	We evaluated the effects of chemical on the growth of human tumor cells expressing ( MCF-7 and HL-60 ) or not expressing ( HeLa and K562 ) gene in vitro .	T8	T22	15982930
NA	CHEMICAL	GENE-Y	6	8	We also studied the effects of chemical on gene , gene or gene expression , gene , gene , GSH and gene in these cells .	T9	T23	15982930
NA	CHEMICAL	GENE-Y	6	10	We also studied the effects of chemical on gene , gene or gene expression , gene , gene , GSH and gene in these cells .	T9	T24	15982930
NA	CHEMICAL	GENE-Y	6	12	We also studied the effects of chemical on gene , gene or gene expression , gene , gene , GSH and gene in these cells .	T9	T25	15982930
NA	CHEMICAL	GENE-Y	6	15	We also studied the effects of chemical on gene , gene or gene expression , gene , gene , GSH and gene in these cells .	T9	T26	15982930
NA	CHEMICAL	GENE-Y	6	17	We also studied the effects of chemical on gene , gene or gene expression , gene , gene , GSH and gene in these cells .	T9	T27	15982930
NA	CHEMICAL	GENE-Y	6	21	We also studied the effects of chemical on gene , gene or gene expression , gene , gene , GSH and gene in these cells .	T9	T28	15982930
CPR:4	CHEMICAL	GENE-Y	0	2	chemical reduced gene expression accompanied by a decrease of gene protein , gene , gene , GSH and an increased gene , but had no effect on that of gene , in MCF-7 and HL-60 .	T11	T29	15982930
CPR:4	CHEMICAL	GENE-Y	0	9	chemical reduced gene expression accompanied by a decrease of gene protein , gene , gene , GSH and an increased gene , but had no effect on that of gene , in MCF-7 and HL-60 .	T11	T30	15982930
CPR:4	CHEMICAL	GENE-Y	0	6	chemical reduced gene expression accompanied by a decrease of gene protein , gene , gene , GSH and an increased gene , but had no effect on that of gene , in MCF-7 and HL-60 .	T11	T31	15982930
CPR:4	CHEMICAL	GENE-Y	0	14	chemical reduced gene expression accompanied by a decrease of gene protein , gene , gene , GSH and an increased gene , but had no effect on that of gene , in MCF-7 and HL-60 .	T11	T32	15982930
CPR:3	CHEMICAL	GENE-Y	0	20	chemical reduced gene expression accompanied by a decrease of gene protein , gene , gene , GSH and an increased gene , but had no effect on that of gene , in MCF-7 and HL-60 .	T11	T13	15982930
NA	CHEMICAL	GENE-Y	0	29	chemical reduced gene expression accompanied by a decrease of gene protein , gene , gene , GSH and an increased gene , but had no effect on that of gene , in MCF-7 and HL-60 .	T11	T14	15982930
NA	CHEMICAL	GENE-Y	16	5	Moreover , cells not expressing gene were insensitive to the growth-inhibitory and effects on gene of chemical .	T2	T15	15982930
NA	CHEMICAL	GENE-N	16	8	Moreover , cells not expressing gene were insensitive to the growth-inhibitory and effects on gene of chemical .	T2	T16	15982930
NA	CHEMICAL	GENE-Y	13	31	In our mouse xenograft model of OVCAR-3 and HCT-8 , we found that chemical could decrease intratumoral microvessel density in both tumors ; it exerted antitumor effects only on OVCAR-3 expressing gene but did not on HCT-8 not expressing gene .	T3	T17	15982930
NA	CHEMICAL	GENE-Y	13	39	In our mouse xenograft model of OVCAR-3 and HCT-8 , we found that chemical could decrease intratumoral microvessel density in both tumors ; it exerted antitumor effects only on OVCAR-3 expressing gene but did not on HCT-8 not expressing gene .	T3	T18	15982930
NA	CHEMICAL	GENE-Y	2	4	Effect of chemical on gene and gene in vivo was consistent with that of in vitro .	T5	T19	15982930
NA	CHEMICAL	GENE-Y	2	6	Effect of chemical on gene and gene in vivo was consistent with that of in vitro .	T5	T20	15982930
CPR:4	CHEMICAL	GENE-Y	2	19	OBJECTIVE : chemical and chemical are two relatively new nonsteroidal anti-inflammatory drugs ( NSAIDs ) that selectively inhibit the gene ( gene ) isoenzyme at therapeutic concentrations .	T3	T19	12093311
CPR:4	CHEMICAL	GENE-Y	2	21	OBJECTIVE : chemical and chemical are two relatively new nonsteroidal anti-inflammatory drugs ( NSAIDs ) that selectively inhibit the gene ( gene ) isoenzyme at therapeutic concentrations .	T3	T20	12093311
CPR:4	CHEMICAL	GENE-Y	4	19	OBJECTIVE : chemical and chemical are two relatively new nonsteroidal anti-inflammatory drugs ( NSAIDs ) that selectively inhibit the gene ( gene ) isoenzyme at therapeutic concentrations .	T10	T19	12093311
CPR:4	CHEMICAL	GENE-Y	4	21	OBJECTIVE : chemical and chemical are two relatively new nonsteroidal anti-inflammatory drugs ( NSAIDs ) that selectively inhibit the gene ( gene ) isoenzyme at therapeutic concentrations .	T10	T20	12093311
CPR:4	CHEMICAL	GENE-Y	19	17	This study was conducted in order to understand the association between acute renal failure and the two gene inhibitors chemical and chemical .	T11	T23	12093311
CPR:4	CHEMICAL	GENE-Y	21	17	This study was conducted in order to understand the association between acute renal failure and the two gene inhibitors chemical and chemical .	T12	T23	12093311
NA	CHEMICAL	GENE-Y	7	0	gene polymorphisms influence steady-state plasma levels of chemical and chemical active moiety .	T21	T39	18708991
NA	CHEMICAL	GENE-Y	9	0	gene polymorphisms influence steady-state plasma levels of chemical and chemical active moiety .	T22	T39	18708991
CPR:9	CHEMICAL	GENE-N	0	13	chemical is metabolized to its active metabolite , chemical , mainly by the gene enzymes gene .	T1	T38	18708991
NA	CHEMICAL	GENE-N	0	15	chemical is metabolized to its active metabolite , chemical , mainly by the gene enzymes gene .	T1	T24	18708991
CPR:9	CHEMICAL	GENE-N	1	13	chemical is metabolized to its active metabolite , chemical , mainly by the gene enzymes gene .	T13	T38	18708991
NA	CHEMICAL	GENE-N	1	15	chemical is metabolized to its active metabolite , chemical , mainly by the gene enzymes gene .	T13	T24	18708991
CPR:9	CHEMICAL	GENE-N	1	7	Both chemical and chemical are substrates of gene ( gene ) , a transport protein involved in drug absorption , distribution , and elimination .	T11	T32	18708991
CPR:9	CHEMICAL	GENE-N	1	9	Both chemical and chemical are substrates of gene ( gene ) , a transport protein involved in drug absorption , distribution , and elimination .	T11	T33	18708991
CPR:9	CHEMICAL	GENE-N	3	7	Both chemical and chemical are substrates of gene ( gene ) , a transport protein involved in drug absorption , distribution , and elimination .	T12	T32	18708991
CPR:9	CHEMICAL	GENE-N	3	9	Both chemical and chemical are substrates of gene ( gene ) , a transport protein involved in drug absorption , distribution , and elimination .	T12	T33	18708991
NA	CHEMICAL	GENE-Y	22	16	The aim of the present study was to evaluate the influence of polymorphisms in genes encoding gene and gene ( gene ) on the steady-state plasma levels of chemical , chemical , and the active moiety , taking gene genotype status into account .	T14	T34	18708991
NA	CHEMICAL	GENE-N	22	18	The aim of the present study was to evaluate the influence of polymorphisms in genes encoding gene and gene ( gene ) on the steady-state plasma levels of chemical , chemical , and the active moiety , taking gene genotype status into account .	T14	T35	18708991
NA	CHEMICAL	GENE-Y	22	20	The aim of the present study was to evaluate the influence of polymorphisms in genes encoding gene and gene ( gene ) on the steady-state plasma levels of chemical , chemical , and the active moiety , taking gene genotype status into account .	T14	T36	18708991
NA	CHEMICAL	GENE-Y	22	38	The aim of the present study was to evaluate the influence of polymorphisms in genes encoding gene and gene ( gene ) on the steady-state plasma levels of chemical , chemical , and the active moiety , taking gene genotype status into account .	T14	T37	18708991
NA	CHEMICAL	GENE-Y	22	16	The aim of the present study was to evaluate the influence of polymorphisms in genes encoding gene and gene ( gene ) on the steady-state plasma levels of chemical , chemical , and the active moiety , taking gene genotype status into account .	T15	T34	18708991
NA	CHEMICAL	GENE-N	22	18	The aim of the present study was to evaluate the influence of polymorphisms in genes encoding gene and gene ( gene ) on the steady-state plasma levels of chemical , chemical , and the active moiety , taking gene genotype status into account .	T15	T35	18708991
NA	CHEMICAL	GENE-Y	22	20	The aim of the present study was to evaluate the influence of polymorphisms in genes encoding gene and gene ( gene ) on the steady-state plasma levels of chemical , chemical , and the active moiety , taking gene genotype status into account .	T15	T36	18708991
NA	CHEMICAL	GENE-Y	22	38	The aim of the present study was to evaluate the influence of polymorphisms in genes encoding gene and gene ( gene ) on the steady-state plasma levels of chemical , chemical , and the active moiety , taking gene genotype status into account .	T15	T37	18708991
NA	CHEMICAL	GENE-Y	1	1	The gene genotype did not influence chemical , chemical , or active moiety C/Ds .	T2	T26	18708991
NA	CHEMICAL	GENE-Y	8	1	The gene genotype did not influence chemical , chemical , or active moiety C/Ds .	T3	T26	18708991
NA	CHEMICAL	GENE-Y	11	1	The gene genotype in these 46 patients was again associated with chemical C/D ( P = 0.001 ) but not with chemical C/D or active moiety C/D , as previously shown by our group in 37 of these patients .	T4	T27	18708991
NA	CHEMICAL	GENE-Y	21	1	The gene genotype in these 46 patients was again associated with chemical C/D ( P = 0.001 ) but not with chemical C/D or active moiety C/D , as previously shown by our group in 37 of these patients .	T5	T27	18708991
NA	CHEMICAL	GENE-Y	12	4	Patients homozygous for the gene 3435T/2677T/1236T haplotype had significantly lower C/Ds of chemical ( P = 0.026 ) and active moiety ( P = 0.028 ) than patients carrying other gene genotypes .	T6	T28	18708991
NA	CHEMICAL	GENE-Y	12	30	Patients homozygous for the gene 3435T/2677T/1236T haplotype had significantly lower C/Ds of chemical ( P = 0.026 ) and active moiety ( P = 0.028 ) than patients carrying other gene genotypes .	T6	T29	18708991
NA	CHEMICAL	GENE-Y	0	1	chemical/chemical N1-acetyltransferase ( gene ) is a key enzyme in the control of chemical levels in human cells , as acetylation of chemical and chemical triggers export or degradation .	T1	T21	16455797
NA	CHEMICAL	GENE-Y	0	3	chemical/chemical N1-acetyltransferase ( gene ) is a key enzyme in the control of chemical levels in human cells , as acetylation of chemical and chemical triggers export or degradation .	T1	T27	16455797
NA	CHEMICAL	GENE-Y	0	1	chemical/chemical N1-acetyltransferase ( gene ) is a key enzyme in the control of chemical levels in human cells , as acetylation of chemical and chemical triggers export or degradation .	T2	T21	16455797
NA	CHEMICAL	GENE-Y	0	3	chemical/chemical N1-acetyltransferase ( gene ) is a key enzyme in the control of chemical levels in human cells , as acetylation of chemical and chemical triggers export or degradation .	T2	T27	16455797
CPR:9	CHEMICAL	GENE-Y	6	1	chemical/chemical N1-acetyltransferase ( gene ) is a key enzyme in the control of chemical levels in human cells , as acetylation of chemical and chemical triggers export or degradation .	T18	T21	16455797
NA	CHEMICAL	GENE-Y	6	3	chemical/chemical N1-acetyltransferase ( gene ) is a key enzyme in the control of chemical levels in human cells , as acetylation of chemical and chemical triggers export or degradation .	T18	T27	16455797
CPR:9	CHEMICAL	GENE-Y	9	1	chemical/chemical N1-acetyltransferase ( gene ) is a key enzyme in the control of chemical levels in human cells , as acetylation of chemical and chemical triggers export or degradation .	T8	T21	16455797
NA	CHEMICAL	GENE-Y	9	3	chemical/chemical N1-acetyltransferase ( gene ) is a key enzyme in the control of chemical levels in human cells , as acetylation of chemical and chemical triggers export or degradation .	T8	T27	16455797
CPR:9	CHEMICAL	GENE-Y	9	1	chemical/chemical N1-acetyltransferase ( gene ) is a key enzyme in the control of chemical levels in human cells , as acetylation of chemical and chemical triggers export or degradation .	T9	T21	16455797
NA	CHEMICAL	GENE-Y	9	3	chemical/chemical N1-acetyltransferase ( gene ) is a key enzyme in the control of chemical levels in human cells , as acetylation of chemical and chemical triggers export or degradation .	T9	T27	16455797
NA	CHEMICAL	GENE-Y	2	28	Increased intracellular chemical levels accompany several types of cancers as well as other human diseases , and compounds that affect the expression , activity , or stability of gene are being explored as potential therapeutic drugs .	T12	T26	16455797
NA	CHEMICAL	GENE-Y	33	3	We have expressed gene from the cloned cDNA in Escherichia coli and have determined high-resolution structures of wild-type and mutant gene , as the free dimer and in binary and ternary complexes with chemical , chemical ( chemical ) , chemical , and the inhibitor chemical ( BE-3-3-3 ) .	T13	T28	16455797
NA	CHEMICAL	GENE-Y	33	20	We have expressed gene from the cloned cDNA in Escherichia coli and have determined high-resolution structures of wild-type and mutant gene , as the free dimer and in binary and ternary complexes with chemical , chemical ( chemical ) , chemical , and the inhibitor chemical ( BE-3-3-3 ) .	T13	T29	16455797
NA	CHEMICAL	GENE-Y	35	3	We have expressed gene from the cloned cDNA in Escherichia coli and have determined high-resolution structures of wild-type and mutant gene , as the free dimer and in binary and ternary complexes with chemical , chemical ( chemical ) , chemical , and the inhibitor chemical ( BE-3-3-3 ) .	T14	T28	16455797
NA	CHEMICAL	GENE-Y	35	20	We have expressed gene from the cloned cDNA in Escherichia coli and have determined high-resolution structures of wild-type and mutant gene , as the free dimer and in binary and ternary complexes with chemical , chemical ( chemical ) , chemical , and the inhibitor chemical ( BE-3-3-3 ) .	T14	T29	16455797
NA	CHEMICAL	GENE-Y	37	3	We have expressed gene from the cloned cDNA in Escherichia coli and have determined high-resolution structures of wild-type and mutant gene , as the free dimer and in binary and ternary complexes with chemical , chemical ( chemical ) , chemical , and the inhibitor chemical ( BE-3-3-3 ) .	T15	T28	16455797
NA	CHEMICAL	GENE-Y	37	20	We have expressed gene from the cloned cDNA in Escherichia coli and have determined high-resolution structures of wild-type and mutant gene , as the free dimer and in binary and ternary complexes with chemical , chemical ( chemical ) , chemical , and the inhibitor chemical ( BE-3-3-3 ) .	T15	T29	16455797
NA	CHEMICAL	GENE-Y	8	3	We have expressed gene from the cloned cDNA in Escherichia coli and have determined high-resolution structures of wild-type and mutant gene , as the free dimer and in binary and ternary complexes with chemical , chemical ( chemical ) , chemical , and the inhibitor chemical ( BE-3-3-3 ) .	T16	T28	16455797
NA	CHEMICAL	GENE-Y	8	20	We have expressed gene from the cloned cDNA in Escherichia coli and have determined high-resolution structures of wild-type and mutant gene , as the free dimer and in binary and ternary complexes with chemical , chemical ( chemical ) , chemical , and the inhibitor chemical ( BE-3-3-3 ) .	T16	T29	16455797
NA	CHEMICAL	GENE-Y	8	3	We have expressed gene from the cloned cDNA in Escherichia coli and have determined high-resolution structures of wild-type and mutant gene , as the free dimer and in binary and ternary complexes with chemical , chemical ( chemical ) , chemical , and the inhibitor chemical ( BE-3-3-3 ) .	T17	T28	16455797
NA	CHEMICAL	GENE-Y	8	20	We have expressed gene from the cloned cDNA in Escherichia coli and have determined high-resolution structures of wild-type and mutant gene , as the free dimer and in binary and ternary complexes with chemical , chemical ( chemical ) , chemical , and the inhibitor chemical ( BE-3-3-3 ) .	T17	T29	16455797
NA	CHEMICAL	GENE-Y	4	0	gene was found to self-chemical chemical-26 in the presence of chemical and absence of substrate , a reaction apparently catalzyed by chemical bound in the second channel of the asymmetric dimer .	T4	T22	16455797
NA	CHEMICAL	GENE-Y	5	0	gene was found to self-chemical chemical-26 in the presence of chemical and absence of substrate , a reaction apparently catalzyed by chemical bound in the second channel of the asymmetric dimer .	T5	T22	16455797
NA	CHEMICAL	GENE-Y	10	0	gene was found to self-chemical chemical-26 in the presence of chemical and absence of substrate , a reaction apparently catalzyed by chemical bound in the second channel of the asymmetric dimer .	T6	T22	16455797
NA	CHEMICAL	GENE-Y	21	0	gene was found to self-chemical chemical-26 in the presence of chemical and absence of substrate , a reaction apparently catalzyed by chemical bound in the second channel of the asymmetric dimer .	T7	T22	16455797
CPR:9	CHEMICAL	GENE-Y	14	16	These unexpected and intriguing complexities seem likely to have some as yet undefined role in regulating gene activity or stability as a part of chemical homeostasis .	T10	T23	16455797
NA	CHEMICAL	GENE-N	7	0	gene ( gene ) are newly described chemical-rich proteins that share significant aminoterminal structural similarity with the conventional gene and are involved in a diversity of biological functions , including growth regulation .	T1	T7	11089538
NA	CHEMICAL	GENE-N	7	2	gene ( gene ) are newly described chemical-rich proteins that share significant aminoterminal structural similarity with the conventional gene and are involved in a diversity of biological functions , including growth regulation .	T1	T27	11089538
NA	CHEMICAL	GENE-N	7	18	gene ( gene ) are newly described chemical-rich proteins that share significant aminoterminal structural similarity with the conventional gene and are involved in a diversity of biological functions , including growth regulation .	T1	T21	11089538
NA	CHEMICAL	GENE-Y	2	0	gene ( gene/gene/chemical-stimulating factor ) is a potential tumor-suppressor gene that is differentially expressed in meningiomas , mammary and prostatic cancers , compared with their malignant counterparts .	T6	T22	11089538
NA	CHEMICAL	GENE-Y	2	2	gene ( gene/gene/chemical-stimulating factor ) is a potential tumor-suppressor gene that is differentially expressed in meningiomas , mammary and prostatic cancers , compared with their malignant counterparts .	T6	T23	11089538
NA	CHEMICAL	GENE-Y	2	2	gene ( gene/gene/chemical-stimulating factor ) is a potential tumor-suppressor gene that is differentially expressed in meningiomas , mammary and prostatic cancers , compared with their malignant counterparts .	T6	T24	11089538
NA	CHEMICAL	GENE-Y	2	3	gene ( gene/gene/chemical-stimulating factor ) is a potential tumor-suppressor gene that is differentially expressed in meningiomas , mammary and prostatic cancers , compared with their malignant counterparts .	T6	T25	11089538
CPR:3	CHEMICAL	GENE-Y	10	2	Moreover , gene noticeably increased in response to gene and chemical ( chemical ) in HPEC and PC-3 cells , and it decreased in response to gene in HPEC .	T2	T9	11089538
NA	CHEMICAL	GENE-Y	10	8	Moreover , gene noticeably increased in response to gene and chemical ( chemical ) in HPEC and PC-3 cells , and it decreased in response to gene in HPEC .	T2	T10	11089538
NA	CHEMICAL	GENE-Y	10	26	Moreover , gene noticeably increased in response to gene and chemical ( chemical ) in HPEC and PC-3 cells , and it decreased in response to gene in HPEC .	T2	T11	11089538
CPR:3	CHEMICAL	GENE-Y	12	2	Moreover , gene noticeably increased in response to gene and chemical ( chemical ) in HPEC and PC-3 cells , and it decreased in response to gene in HPEC .	T3	T9	11089538
NA	CHEMICAL	GENE-Y	12	8	Moreover , gene noticeably increased in response to gene and chemical ( chemical ) in HPEC and PC-3 cells , and it decreased in response to gene in HPEC .	T3	T10	11089538
NA	CHEMICAL	GENE-Y	12	26	Moreover , gene noticeably increased in response to gene and chemical ( chemical ) in HPEC and PC-3 cells , and it decreased in response to gene in HPEC .	T3	T11	11089538
NA	CHEMICAL	GENE-Y	8	0	gene ( gene ) mRNA and immunoreactive proteins in mouse brain .	T7	T22	21712771
NA	CHEMICAL	GENE-Y	8	2	gene ( gene ) mRNA and immunoreactive proteins in mouse brain .	T7	T23	21712771
NA	CHEMICAL	GENE-Y	41	2	OBJECTIVE : gene ( gene ) mRNA and protein were examined ( 1 ) to determine whether adult mouse brain expresses full-length gene mRNA that can be translated to functional transporter protein and ( 2 ) to compare immunoreactive gene proteins in brain and adrenal .	T4	T9	21712771
NA	CHEMICAL	GENE-Y	41	4	OBJECTIVE : gene ( gene ) mRNA and protein were examined ( 1 ) to determine whether adult mouse brain expresses full-length gene mRNA that can be translated to functional transporter protein and ( 2 ) to compare immunoreactive gene proteins in brain and adrenal .	T4	T16	21712771
NA	CHEMICAL	GENE-Y	41	12	OBJECTIVE : gene ( gene ) mRNA and protein were examined ( 1 ) to determine whether adult mouse brain expresses full-length gene mRNA that can be translated to functional transporter protein and ( 2 ) to compare immunoreactive gene proteins in brain and adrenal .	T4	T12	21712771
NA	CHEMICAL	GENE-Y	41	12	OBJECTIVE : gene ( gene ) mRNA and protein were examined ( 1 ) to determine whether adult mouse brain expresses full-length gene mRNA that can be translated to functional transporter protein and ( 2 ) to compare immunoreactive gene proteins in brain and adrenal .	T4	T14	21712771
CPR:4	CHEMICAL	GENE-N	9	17	Transfection of the brain cDNA into COS-1 cells resulted in transporter activity that was blocked by the gene inhibitor chemical and a proton ionophore , but not by chemical , which has a high affinity for gene .	T5	T20	21712771
NA	CHEMICAL	GENE-Y	9	36	Transfection of the brain cDNA into COS-1 cells resulted in transporter activity that was blocked by the gene inhibitor chemical and a proton ionophore , but not by chemical , which has a high affinity for gene .	T5	T21	21712771
NA	CHEMICAL	GENE-N	9	17	Transfection of the brain cDNA into COS-1 cells resulted in transporter activity that was blocked by the gene inhibitor chemical and a proton ionophore , but not by chemical , which has a high affinity for gene .	T6	T20	21712771
NA	CHEMICAL	GENE-Y	9	36	Transfection of the brain cDNA into COS-1 cells resulted in transporter activity that was blocked by the gene inhibitor chemical and a proton ionophore , but not by chemical , which has a high affinity for gene .	T6	T21	21712771
NA	CHEMICAL	GENE-Y	4	9	Antibodies to either the chemical- or chemical- terminus of gene detected two proteins ( 73 and 55 kD ) in transfected COS-1 cells .	T2	T8	21712771
NA	CHEMICAL	GENE-Y	1	43	The chemical-terminal antibodies detected both proteins in extracts of mouse medulla/pons , cortex , hypothalamus , and cerebellum but only the 73 kD protein and higher molecular weight immunoreactive proteins in mouse adrenal and rat PC12 cells , which are positive controls for gene .	T3	T10	21712771
NA	CHEMICAL	GENE-N	19	22	A multivariable model adjusted for age , sex , population group , immigrant status , BMI , season of chemical measurement , gene and gene chemical , chemical , estimated glomerular filtration rate , history of hypertension or cardiovascular disease , Charlson comorbidity index , smoking , and socioeconomic status revealed an inverse association between chemical and the risk of progression to IFG and diabetes .	T12	T15	23393216
NA	CHEMICAL	GENE-N	19	24	A multivariable model adjusted for age , sex , population group , immigrant status , BMI , season of chemical measurement , gene and gene chemical , chemical , estimated glomerular filtration rate , history of hypertension or cardiovascular disease , Charlson comorbidity index , smoking , and socioeconomic status revealed an inverse association between chemical and the risk of progression to IFG and diabetes .	T12	T16	23393216
NA	CHEMICAL	GENE-N	19	22	A multivariable model adjusted for age , sex , population group , immigrant status , BMI , season of chemical measurement , gene and gene chemical , chemical , estimated glomerular filtration rate , history of hypertension or cardiovascular disease , Charlson comorbidity index , smoking , and socioeconomic status revealed an inverse association between chemical and the risk of progression to IFG and diabetes .	T1	T15	23393216
NA	CHEMICAL	GENE-N	19	24	A multivariable model adjusted for age , sex , population group , immigrant status , BMI , season of chemical measurement , gene and gene chemical , chemical , estimated glomerular filtration rate , history of hypertension or cardiovascular disease , Charlson comorbidity index , smoking , and socioeconomic status revealed an inverse association between chemical and the risk of progression to IFG and diabetes .	T1	T16	23393216
NA	CHEMICAL	GENE-N	27	22	A multivariable model adjusted for age , sex , population group , immigrant status , BMI , season of chemical measurement , gene and gene chemical , chemical , estimated glomerular filtration rate , history of hypertension or cardiovascular disease , Charlson comorbidity index , smoking , and socioeconomic status revealed an inverse association between chemical and the risk of progression to IFG and diabetes .	T3	T15	23393216
NA	CHEMICAL	GENE-N	27	24	A multivariable model adjusted for age , sex , population group , immigrant status , BMI , season of chemical measurement , gene and gene chemical , chemical , estimated glomerular filtration rate , history of hypertension or cardiovascular disease , Charlson comorbidity index , smoking , and socioeconomic status revealed an inverse association between chemical and the risk of progression to IFG and diabetes .	T3	T16	23393216
NA	CHEMICAL	GENE-N	55	22	A multivariable model adjusted for age , sex , population group , immigrant status , BMI , season of chemical measurement , gene and gene chemical , chemical , estimated glomerular filtration rate , history of hypertension or cardiovascular disease , Charlson comorbidity index , smoking , and socioeconomic status revealed an inverse association between chemical and the risk of progression to IFG and diabetes .	T4	T15	23393216
NA	CHEMICAL	GENE-N	55	24	A multivariable model adjusted for age , sex , population group , immigrant status , BMI , season of chemical measurement , gene and gene chemical , chemical , estimated glomerular filtration rate , history of hypertension or cardiovascular disease , Charlson comorbidity index , smoking , and socioeconomic status revealed an inverse association between chemical and the risk of progression to IFG and diabetes .	T4	T16	23393216
NA	CHEMICAL	GENE-Y	4	5	The role of platelet/lymphocyte chemical transporter in depression and beyond .	T6	T11	23514378
NA	CHEMICAL	GENE-Y	0	4	chemical and nonsteroidal chemical receptor ( gene ) agonists have been synthesized as well , although the latter are still in a very early stage of development .	T30	T46	16291771
NA	CHEMICAL	GENE-Y	0	6	chemical and nonsteroidal chemical receptor ( gene ) agonists have been synthesized as well , although the latter are still in a very early stage of development .	T30	T47	16291771
NA	CHEMICAL	GENE-Y	3	4	chemical and nonsteroidal chemical receptor ( gene ) agonists have been synthesized as well , although the latter are still in a very early stage of development .	T31	T46	16291771
NA	CHEMICAL	GENE-Y	3	6	chemical and nonsteroidal chemical receptor ( gene ) agonists have been synthesized as well , although the latter are still in a very early stage of development .	T31	T47	16291771
NA	CHEMICAL	GENE-N	0	7	chemical , an antihypertensive drug , binds to gene .	T1	T19	7906055
NA	CHEMICAL	GENE-N	4	5	The endogenous ligand for chemical receptors may be a chemical-displacing substance , a small molecule isolated from bovine brain .	T2	T17	7906055
NA	CHEMICAL	GENE-N	9	5	The endogenous ligand for chemical receptors may be a chemical-displacing substance , a small molecule isolated from bovine brain .	T3	T17	7906055
NA	CHEMICAL	GENE-N	0	2	chemical binds to gene and stimulates release of chemical from adrenal chromaffin cells .	T7	T18	7906055
NA	CHEMICAL	GENE-N	8	2	chemical binds to gene and stimulates release of chemical from adrenal chromaffin cells .	T9	T18	7906055
NA	CHEMICAL	GENE-Y	4	5	Its biosynthetic enzyme , chemical decarboxylase , is present in brain .	T10	T20	7906055
CPR:4	CHEMICAL	GENE-N	0	2	chemical is a gene inhibitor that induces the hydrolysis of body chemical , including chemical at cholinergic synapses .	T6	T30	17390078
NA	CHEMICAL	GENE-N	11	2	chemical is a gene inhibitor that induces the hydrolysis of body chemical , including chemical at cholinergic synapses .	T7	T30	17390078
NA	CHEMICAL	GENE-N	2	2	chemical is a gene inhibitor that induces the hydrolysis of body chemical , including chemical at cholinergic synapses .	T8	T30	17390078
CPR:3	CHEMICAL	GENE-Y	6	6	There was also an increase in gene , gene , gene , gene , gene , gene , gene , gene , gene and mutant gene protein expression in the chemical-treated cells .	T1	T13	17390078
CPR:3	CHEMICAL	GENE-Y	6	8	There was also an increase in gene , gene , gene , gene , gene , gene , gene , gene , gene and mutant gene protein expression in the chemical-treated cells .	T1	T14	17390078
CPR:3	CHEMICAL	GENE-Y	6	10	There was also an increase in gene , gene , gene , gene , gene , gene , gene , gene , gene and mutant gene protein expression in the chemical-treated cells .	T1	T15	17390078
CPR:3	CHEMICAL	GENE-Y	6	12	There was also an increase in gene , gene , gene , gene , gene , gene , gene , gene , gene and mutant gene protein expression in the chemical-treated cells .	T1	T16	17390078
NA	CHEMICAL	GENE-Y	6	14	There was also an increase in gene , gene , gene , gene , gene , gene , gene , gene , gene and mutant gene protein expression in the chemical-treated cells .	T1	T17	17390078
CPR:3	CHEMICAL	GENE-Y	6	16	There was also an increase in gene , gene , gene , gene , gene , gene , gene , gene , gene and mutant gene protein expression in the chemical-treated cells .	T1	T18	17390078
CPR:3	CHEMICAL	GENE-Y	6	18	There was also an increase in gene , gene , gene , gene , gene , gene , gene , gene , gene and mutant gene protein expression in the chemical-treated cells .	T1	T19	17390078
CPR:3	CHEMICAL	GENE-Y	6	5	There was also an increase in gene , gene , gene , gene , gene , gene , gene , gene , gene and mutant gene protein expression in the chemical-treated cells .	T1	T20	17390078
CPR:3	CHEMICAL	GENE-Y	6	5	There was also an increase in gene , gene , gene , gene , gene , gene , gene , gene , gene and mutant gene protein expression in the chemical-treated cells .	T1	T21	17390078
CPR:3	CHEMICAL	GENE-Y	6	25	There was also an increase in gene , gene , gene , gene , gene , gene , gene , gene , gene and mutant gene protein expression in the chemical-treated cells .	T1	T22	17390078
CPR:6	CHEMICAL	GENE-Y	17	4	Brain but not spinal gene receptor is responsible for the anti-allodynic effect of an gene subunit-selective antagonist chemical in a rat chronic constriction injury model .	T12	T21	15452358
CPR:6	CHEMICAL	GENE-Y	17	14	Brain but not spinal gene receptor is responsible for the anti-allodynic effect of an gene subunit-selective antagonist chemical in a rat chronic constriction injury model .	T12	T22	15452358
CPR:6	CHEMICAL	GENE-Y	14	10	In order to examine the site of action of an gene subtype-selective gene antagonist chemical , we investigated its analgesic effect in a rat model of neuropathic pain at various routes of administration .	T10	T18	15452358
CPR:6	CHEMICAL	GENE-N	14	12	In order to examine the site of action of an gene subtype-selective gene antagonist chemical , we investigated its analgesic effect in a rat model of neuropathic pain at various routes of administration .	T10	T19	15452358
NA	CHEMICAL	GENE-Y	14	19	A receptor binding assay using rat forebrain and spinal cord membrane preparations demonstrated that chemical bound to the brain gene receptor with a greater extent compared to the spinal cord one .	T11	T20	15452358
CPR:4	CHEMICAL	GENE-Y	8	14	These findings suggest that the anti-allodynia effect of chemical is ascribable to blockade of gene receptors at the brain , but not at the spinal cord .	T1	T13	15452358
CPR:4	CHEMICAL	GENE-Y	1	1	The gene ( gene ) and gene ( gene ) inhibitory activities of a series of chemical ( 2 , 3 ) , chemical ( 5 , 6 ) , chemical ( 11-13 ) / chemical ( 14 ) , chemical ( 15 ) / chemical ( 16 ) are described .	T1	T19	12871155
CPR:4	CHEMICAL	GENE-Y	1	3	The gene ( gene ) and gene ( gene ) inhibitory activities of a series of chemical ( 2 , 3 ) , chemical ( 5 , 6 ) , chemical ( 11-13 ) / chemical ( 14 ) , chemical ( 15 ) / chemical ( 16 ) are described .	T1	T17	12871155
CPR:4	CHEMICAL	GENE-Y	1	6	The gene ( gene ) and gene ( gene ) inhibitory activities of a series of chemical ( 2 , 3 ) , chemical ( 5 , 6 ) , chemical ( 11-13 ) / chemical ( 14 ) , chemical ( 15 ) / chemical ( 16 ) are described .	T1	T18	12871155
CPR:4	CHEMICAL	GENE-Y	1	8	The gene ( gene ) and gene ( gene ) inhibitory activities of a series of chemical ( 2 , 3 ) , chemical ( 5 , 6 ) , chemical ( 11-13 ) / chemical ( 14 ) , chemical ( 15 ) / chemical ( 16 ) are described .	T1	T20	12871155
CPR:4	CHEMICAL	GENE-Y	13	1	The gene ( gene ) and gene ( gene ) inhibitory activities of a series of chemical ( 2 , 3 ) , chemical ( 5 , 6 ) , chemical ( 11-13 ) / chemical ( 14 ) , chemical ( 15 ) / chemical ( 16 ) are described .	T3	T19	12871155
CPR:4	CHEMICAL	GENE-Y	13	3	The gene ( gene ) and gene ( gene ) inhibitory activities of a series of chemical ( 2 , 3 ) , chemical ( 5 , 6 ) , chemical ( 11-13 ) / chemical ( 14 ) , chemical ( 15 ) / chemical ( 16 ) are described .	T3	T17	12871155
CPR:4	CHEMICAL	GENE-Y	13	6	The gene ( gene ) and gene ( gene ) inhibitory activities of a series of chemical ( 2 , 3 ) , chemical ( 5 , 6 ) , chemical ( 11-13 ) / chemical ( 14 ) , chemical ( 15 ) / chemical ( 16 ) are described .	T3	T18	12871155
CPR:4	CHEMICAL	GENE-Y	13	8	The gene ( gene ) and gene ( gene ) inhibitory activities of a series of chemical ( 2 , 3 ) , chemical ( 5 , 6 ) , chemical ( 11-13 ) / chemical ( 14 ) , chemical ( 15 ) / chemical ( 16 ) are described .	T3	T20	12871155
CPR:4	CHEMICAL	GENE-Y	12	1	The gene ( gene ) and gene ( gene ) inhibitory activities of a series of chemical ( 2 , 3 ) , chemical ( 5 , 6 ) , chemical ( 11-13 ) / chemical ( 14 ) , chemical ( 15 ) / chemical ( 16 ) are described .	T4	T19	12871155
CPR:4	CHEMICAL	GENE-Y	12	3	The gene ( gene ) and gene ( gene ) inhibitory activities of a series of chemical ( 2 , 3 ) , chemical ( 5 , 6 ) , chemical ( 11-13 ) / chemical ( 14 ) , chemical ( 15 ) / chemical ( 16 ) are described .	T4	T17	12871155
CPR:4	CHEMICAL	GENE-Y	12	6	The gene ( gene ) and gene ( gene ) inhibitory activities of a series of chemical ( 2 , 3 ) , chemical ( 5 , 6 ) , chemical ( 11-13 ) / chemical ( 14 ) , chemical ( 15 ) / chemical ( 16 ) are described .	T4	T18	12871155
CPR:4	CHEMICAL	GENE-Y	12	8	The gene ( gene ) and gene ( gene ) inhibitory activities of a series of chemical ( 2 , 3 ) , chemical ( 5 , 6 ) , chemical ( 11-13 ) / chemical ( 14 ) , chemical ( 15 ) / chemical ( 16 ) are described .	T4	T20	12871155
CPR:4	CHEMICAL	GENE-Y	13	1	The gene ( gene ) and gene ( gene ) inhibitory activities of a series of chemical ( 2 , 3 ) , chemical ( 5 , 6 ) , chemical ( 11-13 ) / chemical ( 14 ) , chemical ( 15 ) / chemical ( 16 ) are described .	T5	T19	12871155
CPR:4	CHEMICAL	GENE-Y	13	3	The gene ( gene ) and gene ( gene ) inhibitory activities of a series of chemical ( 2 , 3 ) , chemical ( 5 , 6 ) , chemical ( 11-13 ) / chemical ( 14 ) , chemical ( 15 ) / chemical ( 16 ) are described .	T5	T17	12871155
CPR:4	CHEMICAL	GENE-Y	13	6	The gene ( gene ) and gene ( gene ) inhibitory activities of a series of chemical ( 2 , 3 ) , chemical ( 5 , 6 ) , chemical ( 11-13 ) / chemical ( 14 ) , chemical ( 15 ) / chemical ( 16 ) are described .	T5	T18	12871155
CPR:4	CHEMICAL	GENE-Y	13	8	The gene ( gene ) and gene ( gene ) inhibitory activities of a series of chemical ( 2 , 3 ) , chemical ( 5 , 6 ) , chemical ( 11-13 ) / chemical ( 14 ) , chemical ( 15 ) / chemical ( 16 ) are described .	T5	T20	12871155
CPR:4	CHEMICAL	GENE-Y	13	1	The gene ( gene ) and gene ( gene ) inhibitory activities of a series of chemical ( 2 , 3 ) , chemical ( 5 , 6 ) , chemical ( 11-13 ) / chemical ( 14 ) , chemical ( 15 ) / chemical ( 16 ) are described .	T6	T19	12871155
CPR:4	CHEMICAL	GENE-Y	13	3	The gene ( gene ) and gene ( gene ) inhibitory activities of a series of chemical ( 2 , 3 ) , chemical ( 5 , 6 ) , chemical ( 11-13 ) / chemical ( 14 ) , chemical ( 15 ) / chemical ( 16 ) are described .	T6	T17	12871155
CPR:4	CHEMICAL	GENE-Y	13	6	The gene ( gene ) and gene ( gene ) inhibitory activities of a series of chemical ( 2 , 3 ) , chemical ( 5 , 6 ) , chemical ( 11-13 ) / chemical ( 14 ) , chemical ( 15 ) / chemical ( 16 ) are described .	T6	T18	12871155
CPR:4	CHEMICAL	GENE-Y	13	8	The gene ( gene ) and gene ( gene ) inhibitory activities of a series of chemical ( 2 , 3 ) , chemical ( 5 , 6 ) , chemical ( 11-13 ) / chemical ( 14 ) , chemical ( 15 ) / chemical ( 16 ) are described .	T6	T20	12871155
CPR:4	CHEMICAL	GENE-Y	13	1	The gene ( gene ) and gene ( gene ) inhibitory activities of a series of chemical ( 2 , 3 ) , chemical ( 5 , 6 ) , chemical ( 11-13 ) / chemical ( 14 ) , chemical ( 15 ) / chemical ( 16 ) are described .	T7	T19	12871155
CPR:4	CHEMICAL	GENE-Y	13	3	The gene ( gene ) and gene ( gene ) inhibitory activities of a series of chemical ( 2 , 3 ) , chemical ( 5 , 6 ) , chemical ( 11-13 ) / chemical ( 14 ) , chemical ( 15 ) / chemical ( 16 ) are described .	T7	T17	12871155
CPR:4	CHEMICAL	GENE-Y	13	6	The gene ( gene ) and gene ( gene ) inhibitory activities of a series of chemical ( 2 , 3 ) , chemical ( 5 , 6 ) , chemical ( 11-13 ) / chemical ( 14 ) , chemical ( 15 ) / chemical ( 16 ) are described .	T7	T18	12871155
CPR:4	CHEMICAL	GENE-Y	13	8	The gene ( gene ) and gene ( gene ) inhibitory activities of a series of chemical ( 2 , 3 ) , chemical ( 5 , 6 ) , chemical ( 11-13 ) / chemical ( 14 ) , chemical ( 15 ) / chemical ( 16 ) are described .	T7	T20	12871155
CPR:4	CHEMICAL	GENE-Y	6	14	These compounds are competitive and , in a few cases , non-competitive inhibitors for gene , the most potent being compound ( 14 ) , though three-fold less active than chemical .	T14	T21	12871155
CPR:4	CHEMICAL	GENE-Y	7	1	The gene inhibitory activity is only significant in compounds 11 and 14 , ten-fold less active than chemical .	T2	T15	12871155
CPR:4	CHEMICAL	GENE-N	6	6	3D-QSAR-assisted drug design : identification of a potent chemical-based gene inhibitor .	T5	T11	23172777
CPR:4	CHEMICAL	GENE-Y	10	33	Three different 3D-QSAR models were built and validated by using a set of 66 chemical ( Model I ) and chemical ( Model II ) compounds with IC ( 50 ) values toward gene ranging from 33 nM to 10.5 μM .	T3	T8	23172777
CPR:4	CHEMICAL	GENE-Y	10	33	Three different 3D-QSAR models were built and validated by using a set of 66 chemical ( Model I ) and chemical ( Model II ) compounds with IC ( 50 ) values toward gene ranging from 33 nM to 10.5 μM .	T4	T8	23172777
NA	CHEMICAL	GENE-Y	16	5	In many renal diseases , gene ( gene ) -stimulated canonical gene and noncanonical gene ( gene ) promote increased protein synthesis and mesangial cell hypertrophy .	T1	T29	23362262
NA	CHEMICAL	GENE-Y	16	7	In many renal diseases , gene ( gene ) -stimulated canonical gene and noncanonical gene ( gene ) promote increased protein synthesis and mesangial cell hypertrophy .	T1	T36	23362262
NA	CHEMICAL	GENE-Y	16	11	In many renal diseases , gene ( gene ) -stimulated canonical gene and noncanonical gene ( gene ) promote increased protein synthesis and mesangial cell hypertrophy .	T1	T45	23362262
NA	CHEMICAL	GENE-Y	16	14	In many renal diseases , gene ( gene ) -stimulated canonical gene and noncanonical gene ( gene ) promote increased protein synthesis and mesangial cell hypertrophy .	T1	T6	23362262
NA	CHEMICAL	GENE-Y	16	16	In many renal diseases , gene ( gene ) -stimulated canonical gene and noncanonical gene ( gene ) promote increased protein synthesis and mesangial cell hypertrophy .	T1	T18	23362262
CPR:4	CHEMICAL	GENE-Y	4	2	Using the gene inhibitor chemical we found that gene-induced both early and sustained activation of gene and gene was necessary for gene suppression .	T2	T43	23362262
NA	CHEMICAL	GENE-Y	4	8	Using the gene inhibitor chemical we found that gene-induced both early and sustained activation of gene and gene was necessary for gene suppression .	T2	T44	23362262
NA	CHEMICAL	GENE-Y	4	15	Using the gene inhibitor chemical we found that gene-induced both early and sustained activation of gene and gene was necessary for gene suppression .	T2	T46	23362262
NA	CHEMICAL	GENE-Y	4	17	Using the gene inhibitor chemical we found that gene-induced both early and sustained activation of gene and gene was necessary for gene suppression .	T2	T47	23362262
NA	CHEMICAL	GENE-Y	4	21	Using the gene inhibitor chemical we found that gene-induced both early and sustained activation of gene and gene was necessary for gene suppression .	T2	T48	23362262
CPR:3	CHEMICAL	GENE-Y	0	3	chemical-induced reversal of gene suppression by gene was associated with a significant inhibition of gene-stimulated protein synthesis and hypertrophy .	T3	T49	23362262
NA	CHEMICAL	GENE-Y	0	6	chemical-induced reversal of gene suppression by gene was associated with a significant inhibition of gene-stimulated protein synthesis and hypertrophy .	T3	T50	23362262
NA	CHEMICAL	GENE-Y	0	6	chemical-induced reversal of gene suppression by gene was associated with a significant inhibition of gene-stimulated protein synthesis and hypertrophy .	T3	T5	23362262
NA	CHEMICAL	GENE-N	23	15	Molecular , genetic , and electrophysiological evidence indicates that at least one of the plant gene-like molecules , gene , functions as an chemical-gated chemical channel at the plasma membrane .	T3	T22	23590882
NA	CHEMICAL	GENE-N	23	18	Molecular , genetic , and electrophysiological evidence indicates that at least one of the plant gene-like molecules , gene , functions as an chemical-gated chemical channel at the plasma membrane .	T3	T9	23590882
NA	CHEMICAL	GENE-N	23	22	Molecular , genetic , and electrophysiological evidence indicates that at least one of the plant gene-like molecules , gene , functions as an chemical-gated chemical channel at the plasma membrane .	T3	T10	23590882
NA	CHEMICAL	GENE-N	24	15	Molecular , genetic , and electrophysiological evidence indicates that at least one of the plant gene-like molecules , gene , functions as an chemical-gated chemical channel at the plasma membrane .	T4	T22	23590882
NA	CHEMICAL	GENE-N	24	18	Molecular , genetic , and electrophysiological evidence indicates that at least one of the plant gene-like molecules , gene , functions as an chemical-gated chemical channel at the plasma membrane .	T4	T9	23590882
NA	CHEMICAL	GENE-N	24	22	Molecular , genetic , and electrophysiological evidence indicates that at least one of the plant gene-like molecules , gene , functions as an chemical-gated chemical channel at the plasma membrane .	T4	T10	23590882
NA	CHEMICAL	GENE-N	0	4	chemical allosterically inhibits the gene .	T10	T25	23619386
NA	CHEMICAL	GENE-Y	0	8	chemical is a canonical allosteric inhibitor of the gene gene with immunosuppressive and pro-apoptotic activities .	T1	T22	23619386
NA	CHEMICAL	GENE-N	0	2	chemical is a canonical allosteric inhibitor of the gene gene with immunosuppressive and pro-apoptotic activities .	T1	T23	23619386
NA	CHEMICAL	GENE-N	3	9	We found that in vitro chemical also regulates the gene , an essential intracellular protease of the gene-gene pathway .	T6	T14	23619386
NA	CHEMICAL	GENE-N	3	3	We found that in vitro chemical also regulates the gene , an essential intracellular protease of the gene-gene pathway .	T6	T15	23619386
NA	CHEMICAL	GENE-N	3	17	We found that in vitro chemical also regulates the gene , an essential intracellular protease of the gene-gene pathway .	T6	T16	23619386
CPR:4	CHEMICAL	GENE-N	0	2	chemical inhibits gene and selected gene activities of the catalytic core gene at low micromolar concentrations .	T7	T17	23619386
CPR:4	CHEMICAL	GENE-N	0	5	chemical inhibits gene and selected gene activities of the catalytic core gene at low micromolar concentrations .	T7	T18	23619386
CPR:4	CHEMICAL	GENE-N	0	11	chemical inhibits gene and selected gene activities of the catalytic core gene at low micromolar concentrations .	T7	T19	23619386
NA	CHEMICAL	GENE-N	5	9	Interestingly , we showed that chemical shares all the gene targeting properties not only with other two-domain , closed-ring analogs ( rapalogs ) , but also with its single domain mimics , and with chemical .	T9	T24	23619386
NA	CHEMICAL	GENE-N	9	9	Interestingly , we showed that chemical shares all the gene targeting properties not only with other two-domain , closed-ring analogs ( rapalogs ) , but also with its single domain mimics , and with chemical .	T2	T24	23619386
NA	CHEMICAL	GENE-Y	5	15	The latter is the first in vivo open-ring metabolite of chemical that does not affect gene .	T3	T11	23619386
NA	CHEMICAL	GENE-N	4	17	We hypothesize that the chemical and related compounds bind to the α face and allosterically impact the gene function .	T4	T12	23619386
NA	CHEMICAL	GENE-N	18	0	gene ( gene ) is one of the key enzymes involved in the complex interaction between the cyclic chemical and chemical second-messenger systems .	T6	T17	9231746
NA	CHEMICAL	GENE-N	18	2	gene ( gene ) is one of the key enzymes involved in the complex interaction between the cyclic chemical and chemical second-messenger systems .	T6	T23	9231746
NA	CHEMICAL	GENE-N	20	0	gene ( gene ) is one of the key enzymes involved in the complex interaction between the cyclic chemical and chemical second-messenger systems .	T5	T17	9231746
NA	CHEMICAL	GENE-N	20	2	gene ( gene ) is one of the key enzymes involved in the complex interaction between the cyclic chemical and chemical second-messenger systems .	T5	T23	9231746
NA	CHEMICAL	GENE-N	18	10	A variety of pharmacological agents have been used to inhibit gene , and this inhibition occurs mostly via chemical-dependent association with the proteins .	T7	T21	9231746
NA	CHEMICAL	GENE-N	6	13	We have examined the effect of chemical chemical-channel blockers chemical and chemical on gene .	T8	T24	9231746
NA	CHEMICAL	GENE-N	7	13	We have examined the effect of chemical chemical-channel blockers chemical and chemical on gene .	T9	T24	9231746
NA	CHEMICAL	GENE-N	9	13	We have examined the effect of chemical chemical-channel blockers chemical and chemical on gene .	T10	T24	9231746
NA	CHEMICAL	GENE-N	11	13	We have examined the effect of chemical chemical-channel blockers chemical and chemical on gene .	T11	T24	9231746
CPR:4	CHEMICAL	GENE-Y	19	7	The results suggest that the 63-kDa ( gene ) and 60-kDa ( gene ) gene isozymes are inhibited by chemical and chemical by partial competitive inhibition and that these two chemical antagonists appear to counteract each other .	T12	T25	9231746
CPR:4	CHEMICAL	GENE-Y	19	12	The results suggest that the 63-kDa ( gene ) and 60-kDa ( gene ) gene isozymes are inhibited by chemical and chemical by partial competitive inhibition and that these two chemical antagonists appear to counteract each other .	T12	T26	9231746
CPR:4	CHEMICAL	GENE-N	19	14	The results suggest that the 63-kDa ( gene ) and 60-kDa ( gene ) gene isozymes are inhibited by chemical and chemical by partial competitive inhibition and that these two chemical antagonists appear to counteract each other .	T12	T27	9231746
CPR:4	CHEMICAL	GENE-Y	21	7	The results suggest that the 63-kDa ( gene ) and 60-kDa ( gene ) gene isozymes are inhibited by chemical and chemical by partial competitive inhibition and that these two chemical antagonists appear to counteract each other .	T13	T25	9231746
CPR:4	CHEMICAL	GENE-Y	21	12	The results suggest that the 63-kDa ( gene ) and 60-kDa ( gene ) gene isozymes are inhibited by chemical and chemical by partial competitive inhibition and that these two chemical antagonists appear to counteract each other .	T13	T26	9231746
CPR:4	CHEMICAL	GENE-N	21	14	The results suggest that the 63-kDa ( gene ) and 60-kDa ( gene ) gene isozymes are inhibited by chemical and chemical by partial competitive inhibition and that these two chemical antagonists appear to counteract each other .	T13	T27	9231746
NA	CHEMICAL	GENE-Y	30	7	The results suggest that the 63-kDa ( gene ) and 60-kDa ( gene ) gene isozymes are inhibited by chemical and chemical by partial competitive inhibition and that these two chemical antagonists appear to counteract each other .	T14	T25	9231746
NA	CHEMICAL	GENE-Y	30	12	The results suggest that the 63-kDa ( gene ) and 60-kDa ( gene ) gene isozymes are inhibited by chemical and chemical by partial competitive inhibition and that these two chemical antagonists appear to counteract each other .	T14	T26	9231746
NA	CHEMICAL	GENE-N	30	14	The results suggest that the 63-kDa ( gene ) and 60-kDa ( gene ) gene isozymes are inhibited by chemical and chemical by partial competitive inhibition and that these two chemical antagonists appear to counteract each other .	T14	T27	9231746
NA	CHEMICAL	GENE-N	5	5	Characterization of the regulation of gene gene by gene .	T5	T52	17018843
NA	CHEMICAL	GENE-Y	5	6	Characterization of the regulation of gene gene by gene .	T5	T53	17018843
NA	CHEMICAL	GENE-Y	5	8	Characterization of the regulation of gene gene by gene .	T5	T54	17018843
NA	CHEMICAL	GENE-Y	5	5	In the proximal tubule , gene regulates volume and acid-base regulation through stimulation of the chemical/chemical exchanger gene .	T1	T14	17018843
NA	CHEMICAL	GENE-N	5	16	In the proximal tubule , gene regulates volume and acid-base regulation through stimulation of the chemical/chemical exchanger gene .	T1	T32	17018843
NA	CHEMICAL	GENE-Y	5	17	In the proximal tubule , gene regulates volume and acid-base regulation through stimulation of the chemical/chemical exchanger gene .	T1	T33	17018843
NA	CHEMICAL	GENE-Y	15	5	In the proximal tubule , gene regulates volume and acid-base regulation through stimulation of the chemical/chemical exchanger gene .	T2	T14	17018843
NA	CHEMICAL	GENE-N	15	16	In the proximal tubule , gene regulates volume and acid-base regulation through stimulation of the chemical/chemical exchanger gene .	T2	T32	17018843
NA	CHEMICAL	GENE-Y	15	17	In the proximal tubule , gene regulates volume and acid-base regulation through stimulation of the chemical/chemical exchanger gene .	T2	T33	17018843
NA	CHEMICAL	GENE-Y	1	1	Chronic gene ( 24 h ) activates gene through the classic chemical 3-kinase-gene ( gene-gene ) pathway as gene stimulates gene phosphorylation and the gene effect can be blocked by the gene inhibitor chemical or a dominant-negative gene .	T3	T38	17018843
NA	CHEMICAL	GENE-Y	1	7	Chronic gene ( 24 h ) activates gene through the classic chemical 3-kinase-gene ( gene-gene ) pathway as gene stimulates gene phosphorylation and the gene effect can be blocked by the gene inhibitor chemical or a dominant-negative gene .	T3	T39	17018843
NA	CHEMICAL	GENE-N	1	17	Chronic gene ( 24 h ) activates gene through the classic chemical 3-kinase-gene ( gene-gene ) pathway as gene stimulates gene phosphorylation and the gene effect can be blocked by the gene inhibitor chemical or a dominant-negative gene .	T3	T40	17018843
NA	CHEMICAL	GENE-N	1	12	Chronic gene ( 24 h ) activates gene through the classic chemical 3-kinase-gene ( gene-gene ) pathway as gene stimulates gene phosphorylation and the gene effect can be blocked by the gene inhibitor chemical or a dominant-negative gene .	T3	T41	17018843
NA	CHEMICAL	GENE-N	1	14	Chronic gene ( 24 h ) activates gene through the classic chemical 3-kinase-gene ( gene-gene ) pathway as gene stimulates gene phosphorylation and the gene effect can be blocked by the gene inhibitor chemical or a dominant-negative gene .	T3	T42	17018843
NA	CHEMICAL	GENE-N	1	14	Chronic gene ( 24 h ) activates gene through the classic chemical 3-kinase-gene ( gene-gene ) pathway as gene stimulates gene phosphorylation and the gene effect can be blocked by the gene inhibitor chemical or a dominant-negative gene .	T3	T43	17018843
NA	CHEMICAL	GENE-Y	1	18	Chronic gene ( 24 h ) activates gene through the classic chemical 3-kinase-gene ( gene-gene ) pathway as gene stimulates gene phosphorylation and the gene effect can be blocked by the gene inhibitor chemical or a dominant-negative gene .	T3	T44	17018843
NA	CHEMICAL	GENE-N	1	20	Chronic gene ( 24 h ) activates gene through the classic chemical 3-kinase-gene ( gene-gene ) pathway as gene stimulates gene phosphorylation and the gene effect can be blocked by the gene inhibitor chemical or a dominant-negative gene .	T3	T45	17018843
NA	CHEMICAL	GENE-Y	1	24	Chronic gene ( 24 h ) activates gene through the classic chemical 3-kinase-gene ( gene-gene ) pathway as gene stimulates gene phosphorylation and the gene effect can be blocked by the gene inhibitor chemical or a dominant-negative gene .	T3	T46	17018843
NA	CHEMICAL	GENE-N	1	31	Chronic gene ( 24 h ) activates gene through the classic chemical 3-kinase-gene ( gene-gene ) pathway as gene stimulates gene phosphorylation and the gene effect can be blocked by the gene inhibitor chemical or a dominant-negative gene .	T3	T47	17018843
NA	CHEMICAL	GENE-N	1	37	Chronic gene ( 24 h ) activates gene through the classic chemical 3-kinase-gene ( gene-gene ) pathway as gene stimulates gene phosphorylation and the gene effect can be blocked by the gene inhibitor chemical or a dominant-negative gene .	T3	T48	17018843
NA	CHEMICAL	GENE-Y	12	1	Chronic gene ( 24 h ) activates gene through the classic chemical 3-kinase-gene ( gene-gene ) pathway as gene stimulates gene phosphorylation and the gene effect can be blocked by the gene inhibitor chemical or a dominant-negative gene .	T4	T38	17018843
NA	CHEMICAL	GENE-Y	12	7	Chronic gene ( 24 h ) activates gene through the classic chemical 3-kinase-gene ( gene-gene ) pathway as gene stimulates gene phosphorylation and the gene effect can be blocked by the gene inhibitor chemical or a dominant-negative gene .	T4	T39	17018843
CPR:4	CHEMICAL	GENE-N	12	17	Chronic gene ( 24 h ) activates gene through the classic chemical 3-kinase-gene ( gene-gene ) pathway as gene stimulates gene phosphorylation and the gene effect can be blocked by the gene inhibitor chemical or a dominant-negative gene .	T4	T40	17018843
NA	CHEMICAL	GENE-N	12	12	Chronic gene ( 24 h ) activates gene through the classic chemical 3-kinase-gene ( gene-gene ) pathway as gene stimulates gene phosphorylation and the gene effect can be blocked by the gene inhibitor chemical or a dominant-negative gene .	T4	T41	17018843
CPR:4	CHEMICAL	GENE-N	12	14	Chronic gene ( 24 h ) activates gene through the classic chemical 3-kinase-gene ( gene-gene ) pathway as gene stimulates gene phosphorylation and the gene effect can be blocked by the gene inhibitor chemical or a dominant-negative gene .	T4	T42	17018843
NA	CHEMICAL	GENE-N	12	14	Chronic gene ( 24 h ) activates gene through the classic chemical 3-kinase-gene ( gene-gene ) pathway as gene stimulates gene phosphorylation and the gene effect can be blocked by the gene inhibitor chemical or a dominant-negative gene .	T4	T43	17018843
NA	CHEMICAL	GENE-Y	12	18	Chronic gene ( 24 h ) activates gene through the classic chemical 3-kinase-gene ( gene-gene ) pathway as gene stimulates gene phosphorylation and the gene effect can be blocked by the gene inhibitor chemical or a dominant-negative gene .	T4	T44	17018843
NA	CHEMICAL	GENE-N	12	20	Chronic gene ( 24 h ) activates gene through the classic chemical 3-kinase-gene ( gene-gene ) pathway as gene stimulates gene phosphorylation and the gene effect can be blocked by the gene inhibitor chemical or a dominant-negative gene .	T4	T45	17018843
NA	CHEMICAL	GENE-Y	12	24	Chronic gene ( 24 h ) activates gene through the classic chemical 3-kinase-gene ( gene-gene ) pathway as gene stimulates gene phosphorylation and the gene effect can be blocked by the gene inhibitor chemical or a dominant-negative gene .	T4	T46	17018843
CPR:4	CHEMICAL	GENE-N	12	31	Chronic gene ( 24 h ) activates gene through the classic chemical 3-kinase-gene ( gene-gene ) pathway as gene stimulates gene phosphorylation and the gene effect can be blocked by the gene inhibitor chemical or a dominant-negative gene .	T4	T47	17018843
NA	CHEMICAL	GENE-N	12	37	Chronic gene ( 24 h ) activates gene through the classic chemical 3-kinase-gene ( gene-gene ) pathway as gene stimulates gene phosphorylation and the gene effect can be blocked by the gene inhibitor chemical or a dominant-negative gene .	T4	T48	17018843
NA	CHEMICAL	GENE-Y	16	3	Post-translational modifications of gene such as phosphorylation , ubiquitination , SUMOylation , methylation and poly ( chemical-ribosyl ) ation have been shown to play important roles in telomere function .	T1	T5	23307557
NA	CHEMICAL	GENE-Y	16	4	Here we show that gene specifically interacts with the gene , and that gene acetylates the chemical residue at position 293 of gene .	T2	T6	23307557
NA	CHEMICAL	GENE-Y	16	9	Here we show that gene specifically interacts with the gene , and that gene acetylates the chemical residue at position 293 of gene .	T2	T7	23307557
NA	CHEMICAL	GENE-Y	16	13	Here we show that gene specifically interacts with the gene , and that gene acetylates the chemical residue at position 293 of gene .	T2	T9	23307557
NA	CHEMICAL	GENE-Y	16	22	Here we show that gene specifically interacts with the gene , and that gene acetylates the chemical residue at position 293 of gene .	T2	T10	23307557
CPR:3	CHEMICAL	GENE-N	0	1	chemical-induced gene and basal chemical/chemical-ATPase trafficking via gene-chemical 4-kinaseIIIβ trans Golgi signalling in M1 cortical collecting duct cells .	T14	T38	23541637
NA	CHEMICAL	GENE-Y	0	7	chemical-induced gene and basal chemical/chemical-ATPase trafficking via gene-chemical 4-kinaseIIIβ trans Golgi signalling in M1 cortical collecting duct cells .	T14	T40	23541637
NA	CHEMICAL	GENE-Y	0	8	chemical-induced gene and basal chemical/chemical-ATPase trafficking via gene-chemical 4-kinaseIIIβ trans Golgi signalling in M1 cortical collecting duct cells .	T14	T41	23541637
NA	CHEMICAL	GENE-N	4	1	chemical-induced gene and basal chemical/chemical-ATPase trafficking via gene-chemical 4-kinaseIIIβ trans Golgi signalling in M1 cortical collecting duct cells .	T15	T38	23541637
NA	CHEMICAL	GENE-Y	4	7	chemical-induced gene and basal chemical/chemical-ATPase trafficking via gene-chemical 4-kinaseIIIβ trans Golgi signalling in M1 cortical collecting duct cells .	T15	T40	23541637
NA	CHEMICAL	GENE-Y	4	8	chemical-induced gene and basal chemical/chemical-ATPase trafficking via gene-chemical 4-kinaseIIIβ trans Golgi signalling in M1 cortical collecting duct cells .	T15	T41	23541637
NA	CHEMICAL	GENE-N	4	1	chemical-induced gene and basal chemical/chemical-ATPase trafficking via gene-chemical 4-kinaseIIIβ trans Golgi signalling in M1 cortical collecting duct cells .	T16	T38	23541637
NA	CHEMICAL	GENE-Y	4	7	chemical-induced gene and basal chemical/chemical-ATPase trafficking via gene-chemical 4-kinaseIIIβ trans Golgi signalling in M1 cortical collecting duct cells .	T16	T40	23541637
NA	CHEMICAL	GENE-Y	4	8	chemical-induced gene and basal chemical/chemical-ATPase trafficking via gene-chemical 4-kinaseIIIβ trans Golgi signalling in M1 cortical collecting duct cells .	T16	T41	23541637
NA	CHEMICAL	GENE-N	7	1	chemical-induced gene and basal chemical/chemical-ATPase trafficking via gene-chemical 4-kinaseIIIβ trans Golgi signalling in M1 cortical collecting duct cells .	T17	T38	23541637
NA	CHEMICAL	GENE-Y	7	7	chemical-induced gene and basal chemical/chemical-ATPase trafficking via gene-chemical 4-kinaseIIIβ trans Golgi signalling in M1 cortical collecting duct cells .	T17	T40	23541637
NA	CHEMICAL	GENE-Y	7	8	chemical-induced gene and basal chemical/chemical-ATPase trafficking via gene-chemical 4-kinaseIIIβ trans Golgi signalling in M1 cortical collecting duct cells .	T17	T41	23541637
NA	CHEMICAL	GENE-N	0	18	chemical regulates chemical transport in the distal nephron through multiple mechanisms that include the transcriptional control of epithelial gene ( gene ) and chemical/chemical-ATPase subunits .	T1	T22	23541637
NA	CHEMICAL	GENE-N	0	20	chemical regulates chemical transport in the distal nephron through multiple mechanisms that include the transcriptional control of epithelial gene ( gene ) and chemical/chemical-ATPase subunits .	T1	T23	23541637
NA	CHEMICAL	GENE-N	0	19	chemical regulates chemical transport in the distal nephron through multiple mechanisms that include the transcriptional control of epithelial gene ( gene ) and chemical/chemical-ATPase subunits .	T1	T24	23541637
NA	CHEMICAL	GENE-N	2	18	chemical regulates chemical transport in the distal nephron through multiple mechanisms that include the transcriptional control of epithelial gene ( gene ) and chemical/chemical-ATPase subunits .	T7	T22	23541637
NA	CHEMICAL	GENE-N	2	20	chemical regulates chemical transport in the distal nephron through multiple mechanisms that include the transcriptional control of epithelial gene ( gene ) and chemical/chemical-ATPase subunits .	T7	T23	23541637
NA	CHEMICAL	GENE-N	2	19	chemical regulates chemical transport in the distal nephron through multiple mechanisms that include the transcriptional control of epithelial gene ( gene ) and chemical/chemical-ATPase subunits .	T7	T24	23541637
NA	CHEMICAL	GENE-N	19	18	chemical regulates chemical transport in the distal nephron through multiple mechanisms that include the transcriptional control of epithelial gene ( gene ) and chemical/chemical-ATPase subunits .	T4	T22	23541637
NA	CHEMICAL	GENE-N	19	20	chemical regulates chemical transport in the distal nephron through multiple mechanisms that include the transcriptional control of epithelial gene ( gene ) and chemical/chemical-ATPase subunits .	T4	T23	23541637
NA	CHEMICAL	GENE-N	19	19	chemical regulates chemical transport in the distal nephron through multiple mechanisms that include the transcriptional control of epithelial gene ( gene ) and chemical/chemical-ATPase subunits .	T4	T24	23541637
NA	CHEMICAL	GENE-N	19	18	chemical regulates chemical transport in the distal nephron through multiple mechanisms that include the transcriptional control of epithelial gene ( gene ) and chemical/chemical-ATPase subunits .	T5	T22	23541637
NA	CHEMICAL	GENE-N	19	20	chemical regulates chemical transport in the distal nephron through multiple mechanisms that include the transcriptional control of epithelial gene ( gene ) and chemical/chemical-ATPase subunits .	T5	T23	23541637
NA	CHEMICAL	GENE-N	19	19	chemical regulates chemical transport in the distal nephron through multiple mechanisms that include the transcriptional control of epithelial gene ( gene ) and chemical/chemical-ATPase subunits .	T5	T24	23541637
CPR:3	CHEMICAL	GENE-Y	0	7	chemical also induces the rapid phosphorylation of gene ( gene ) .	T6	T25	23541637
CPR:3	CHEMICAL	GENE-Y	0	9	chemical also induces the rapid phosphorylation of gene ( gene ) .	T6	T26	23541637
NA	CHEMICAL	GENE-Y	23	0	gene isoforms regulate protein trafficking , by the control of vesicle fission from the trans Golgi network ( TGN ) through activation of chemical 4-kinaseIIIβ ( gene ) .	T8	T27	23541637
NA	CHEMICAL	GENE-Y	23	24	gene isoforms regulate protein trafficking , by the control of vesicle fission from the trans Golgi network ( TGN ) through activation of chemical 4-kinaseIIIβ ( gene ) .	T8	T28	23541637
NA	CHEMICAL	GENE-Y	23	26	gene isoforms regulate protein trafficking , by the control of vesicle fission from the trans Golgi network ( TGN ) through activation of chemical 4-kinaseIIIβ ( gene ) .	T8	T29	23541637
NA	CHEMICAL	GENE-Y	5	1	In gene-deficient cells , the chemical-sensitive current was significantly reduced and chemical/chemical-ATPase α and β subunits showed aberrant localization .	T9	T32	23541637
NA	CHEMICAL	GENE-N	5	14	In gene-deficient cells , the chemical-sensitive current was significantly reduced and chemical/chemical-ATPase α and β subunits showed aberrant localization .	T9	T33	23541637
NA	CHEMICAL	GENE-Y	11	1	In gene-deficient cells , the chemical-sensitive current was significantly reduced and chemical/chemical-ATPase α and β subunits showed aberrant localization .	T10	T32	23541637
NA	CHEMICAL	GENE-N	11	14	In gene-deficient cells , the chemical-sensitive current was significantly reduced and chemical/chemical-ATPase α and β subunits showed aberrant localization .	T10	T33	23541637
NA	CHEMICAL	GENE-Y	11	1	In gene-deficient cells , the chemical-sensitive current was significantly reduced and chemical/chemical-ATPase α and β subunits showed aberrant localization .	T11	T32	23541637
NA	CHEMICAL	GENE-N	11	14	In gene-deficient cells , the chemical-sensitive current was significantly reduced and chemical/chemical-ATPase α and β subunits showed aberrant localization .	T11	T33	23541637
NA	CHEMICAL	GENE-Y	9	0	gene and gene localize to the TGN , and chemical induced an interaction between gene and gene following chemical treatment .	T12	T34	23541637
NA	CHEMICAL	GENE-Y	9	2	gene and gene localize to the TGN , and chemical induced an interaction between gene and gene following chemical treatment .	T12	T35	23541637
NA	CHEMICAL	GENE-Y	9	14	gene and gene localize to the TGN , and chemical induced an interaction between gene and gene following chemical treatment .	T12	T36	23541637
NA	CHEMICAL	GENE-Y	9	16	gene and gene localize to the TGN , and chemical induced an interaction between gene and gene following chemical treatment .	T12	T37	23541637
NA	CHEMICAL	GENE-Y	18	0	gene and gene localize to the TGN , and chemical induced an interaction between gene and gene following chemical treatment .	T13	T34	23541637
NA	CHEMICAL	GENE-Y	18	2	gene and gene localize to the TGN , and chemical induced an interaction between gene and gene following chemical treatment .	T13	T35	23541637
NA	CHEMICAL	GENE-Y	18	14	gene and gene localize to the TGN , and chemical induced an interaction between gene and gene following chemical treatment .	T13	T36	23541637
NA	CHEMICAL	GENE-Y	18	16	gene and gene localize to the TGN , and chemical induced an interaction between gene and gene following chemical treatment .	T13	T37	23541637
NA	CHEMICAL	GENE-N	0	2	chemical as an allosteric modulator of chemical-sensitive chemical channels in colonic inflammation .	T27	T40	23115325
NA	CHEMICAL	GENE-N	6	2	chemical as an allosteric modulator of chemical-sensitive chemical channels in colonic inflammation .	T28	T40	23115325
NA	CHEMICAL	GENE-N	1	2	chemical as an allosteric modulator of chemical-sensitive chemical channels in colonic inflammation .	T29	T40	23115325
NA	CHEMICAL	GENE-N	1	3	The chemical-sensitive chemical channel ( chemical ( chemical ) ) in mouse colonic smooth muscle cell is a complex containing a pore-forming subunit ( gene ) and a chemical receptor subunit ( gene ) .	T17	T38	23115325
NA	CHEMICAL	GENE-N	1	4	The chemical-sensitive chemical channel ( chemical ( chemical ) ) in mouse colonic smooth muscle cell is a complex containing a pore-forming subunit ( gene ) and a chemical receptor subunit ( gene ) .	T17	T36	23115325
NA	CHEMICAL	GENE-Y	1	24	The chemical-sensitive chemical channel ( chemical ( chemical ) ) in mouse colonic smooth muscle cell is a complex containing a pore-forming subunit ( gene ) and a chemical receptor subunit ( gene ) .	T17	T30	23115325
NA	CHEMICAL	GENE-N	1	29	The chemical-sensitive chemical channel ( chemical ( chemical ) ) in mouse colonic smooth muscle cell is a complex containing a pore-forming subunit ( gene ) and a chemical receptor subunit ( gene ) .	T17	T31	23115325
NA	CHEMICAL	GENE-Y	1	32	The chemical-sensitive chemical channel ( chemical ( chemical ) ) in mouse colonic smooth muscle cell is a complex containing a pore-forming subunit ( gene ) and a chemical receptor subunit ( gene ) .	T17	T35	23115325
NA	CHEMICAL	GENE-N	2	3	The chemical-sensitive chemical channel ( chemical ( chemical ) ) in mouse colonic smooth muscle cell is a complex containing a pore-forming subunit ( gene ) and a chemical receptor subunit ( gene ) .	T12	T38	23115325
NA	CHEMICAL	GENE-N	2	4	The chemical-sensitive chemical channel ( chemical ( chemical ) ) in mouse colonic smooth muscle cell is a complex containing a pore-forming subunit ( gene ) and a chemical receptor subunit ( gene ) .	T12	T36	23115325
NA	CHEMICAL	GENE-Y	2	24	The chemical-sensitive chemical channel ( chemical ( chemical ) ) in mouse colonic smooth muscle cell is a complex containing a pore-forming subunit ( gene ) and a chemical receptor subunit ( gene ) .	T12	T30	23115325
NA	CHEMICAL	GENE-N	2	29	The chemical-sensitive chemical channel ( chemical ( chemical ) ) in mouse colonic smooth muscle cell is a complex containing a pore-forming subunit ( gene ) and a chemical receptor subunit ( gene ) .	T12	T31	23115325
NA	CHEMICAL	GENE-Y	2	32	The chemical-sensitive chemical channel ( chemical ( chemical ) ) in mouse colonic smooth muscle cell is a complex containing a pore-forming subunit ( gene ) and a chemical receptor subunit ( gene ) .	T12	T35	23115325
NA	CHEMICAL	GENE-N	5	3	The chemical-sensitive chemical channel ( chemical ( chemical ) ) in mouse colonic smooth muscle cell is a complex containing a pore-forming subunit ( gene ) and a chemical receptor subunit ( gene ) .	T13	T38	23115325
NA	CHEMICAL	GENE-N	5	4	The chemical-sensitive chemical channel ( chemical ( chemical ) ) in mouse colonic smooth muscle cell is a complex containing a pore-forming subunit ( gene ) and a chemical receptor subunit ( gene ) .	T13	T36	23115325
NA	CHEMICAL	GENE-Y	5	24	The chemical-sensitive chemical channel ( chemical ( chemical ) ) in mouse colonic smooth muscle cell is a complex containing a pore-forming subunit ( gene ) and a chemical receptor subunit ( gene ) .	T13	T30	23115325
NA	CHEMICAL	GENE-N	5	29	The chemical-sensitive chemical channel ( chemical ( chemical ) ) in mouse colonic smooth muscle cell is a complex containing a pore-forming subunit ( gene ) and a chemical receptor subunit ( gene ) .	T13	T31	23115325
NA	CHEMICAL	GENE-Y	5	32	The chemical-sensitive chemical channel ( chemical ( chemical ) ) in mouse colonic smooth muscle cell is a complex containing a pore-forming subunit ( gene ) and a chemical receptor subunit ( gene ) .	T13	T35	23115325
NA	CHEMICAL	GENE-N	7	3	The chemical-sensitive chemical channel ( chemical ( chemical ) ) in mouse colonic smooth muscle cell is a complex containing a pore-forming subunit ( gene ) and a chemical receptor subunit ( gene ) .	T16	T38	23115325
NA	CHEMICAL	GENE-N	7	4	The chemical-sensitive chemical channel ( chemical ( chemical ) ) in mouse colonic smooth muscle cell is a complex containing a pore-forming subunit ( gene ) and a chemical receptor subunit ( gene ) .	T16	T36	23115325
NA	CHEMICAL	GENE-Y	7	24	The chemical-sensitive chemical channel ( chemical ( chemical ) ) in mouse colonic smooth muscle cell is a complex containing a pore-forming subunit ( gene ) and a chemical receptor subunit ( gene ) .	T16	T30	23115325
NA	CHEMICAL	GENE-N	7	29	The chemical-sensitive chemical channel ( chemical ( chemical ) ) in mouse colonic smooth muscle cell is a complex containing a pore-forming subunit ( gene ) and a chemical receptor subunit ( gene ) .	T16	T31	23115325
NA	CHEMICAL	GENE-Y	7	32	The chemical-sensitive chemical channel ( chemical ( chemical ) ) in mouse colonic smooth muscle cell is a complex containing a pore-forming subunit ( gene ) and a chemical receptor subunit ( gene ) .	T16	T35	23115325
NA	CHEMICAL	GENE-N	17	3	The chemical-sensitive chemical channel ( chemical ( chemical ) ) in mouse colonic smooth muscle cell is a complex containing a pore-forming subunit ( gene ) and a chemical receptor subunit ( gene ) .	T7	T38	23115325
NA	CHEMICAL	GENE-N	17	4	The chemical-sensitive chemical channel ( chemical ( chemical ) ) in mouse colonic smooth muscle cell is a complex containing a pore-forming subunit ( gene ) and a chemical receptor subunit ( gene ) .	T7	T36	23115325
NA	CHEMICAL	GENE-Y	17	24	The chemical-sensitive chemical channel ( chemical ( chemical ) ) in mouse colonic smooth muscle cell is a complex containing a pore-forming subunit ( gene ) and a chemical receptor subunit ( gene ) .	T7	T30	23115325
NA	CHEMICAL	GENE-N	17	29	The chemical-sensitive chemical channel ( chemical ( chemical ) ) in mouse colonic smooth muscle cell is a complex containing a pore-forming subunit ( gene ) and a chemical receptor subunit ( gene ) .	T7	T31	23115325
NA	CHEMICAL	GENE-Y	17	32	The chemical-sensitive chemical channel ( chemical ( chemical ) ) in mouse colonic smooth muscle cell is a complex containing a pore-forming subunit ( gene ) and a chemical receptor subunit ( gene ) .	T7	T35	23115325
NA	CHEMICAL	GENE-N	10	14	Whole-cell voltage-clamp techniques were used to study the alterations in chemical ( chemical ) channels in smooth muscle cells in experimental colitis .	T14	T37	23115325
NA	CHEMICAL	GENE-N	12	14	Whole-cell voltage-clamp techniques were used to study the alterations in chemical ( chemical ) channels in smooth muscle cells in experimental colitis .	T15	T37	23115325
CPR:3	CHEMICAL	GENE-N	4	9	The concentration response to chemical ( chemical ) , a chemical ( chemical ) channel opener , was significantly shifted to the left in the inflamed smooth-muscle cells .	T22	T39	23115325
CPR:3	CHEMICAL	GENE-N	6	9	The concentration response to chemical ( chemical ) , a chemical ( chemical ) channel opener , was significantly shifted to the left in the inflamed smooth-muscle cells .	T23	T39	23115325
NA	CHEMICAL	GENE-N	10	9	The concentration response to chemical ( chemical ) , a chemical ( chemical ) channel opener , was significantly shifted to the left in the inflamed smooth-muscle cells .	T24	T39	23115325
NA	CHEMICAL	GENE-N	12	9	The concentration response to chemical ( chemical ) , a chemical ( chemical ) channel opener , was significantly shifted to the left in the inflamed smooth-muscle cells .	T25	T39	23115325
NA	CHEMICAL	GENE-Y	2	4	Sulfhydration of chemical receptor 2B ( gene ) was induced by chemical and colonic inflammation .	T8	T32	23115325
NA	CHEMICAL	GENE-Y	2	4	Sulfhydration of chemical receptor 2B ( gene ) was induced by chemical and colonic inflammation .	T8	T33	23115325
CPR:3	CHEMICAL	GENE-Y	11	4	Sulfhydration of chemical receptor 2B ( gene ) was induced by chemical and colonic inflammation .	T9	T32	23115325
CPR:3	CHEMICAL	GENE-Y	11	4	Sulfhydration of chemical receptor 2B ( gene ) was induced by chemical and colonic inflammation .	T9	T33	23115325
NA	CHEMICAL	GENE-Y	9	10	Patients were eligible regardless of site of disease , chemical receptor status , or age .	T1	T24	3058238
NA	CHEMICAL	GENE-Y	0	1	chemical transporter function in vivo : assessment by chronoamperometry .	T20	T26	9928259
CPR:9	CHEMICAL	GENE-Y	21	10	From these data , it is inferred that both the gene and gene contribute to the active clearance of exogenously applied chemical in the dentate gyrus .	T14	T22	9928259
CPR:9	CHEMICAL	GENE-Y	21	12	From these data , it is inferred that both the gene and gene contribute to the active clearance of exogenously applied chemical in the dentate gyrus .	T14	T23	9928259
CPR:6	CHEMICAL	GENE-N	4	12	In another experiment , chemical , an antagonist of the chemical terminal autoreceptor , also prolonged the clearance of chemical from the CA3 region .	T15	T24	9928259
NA	CHEMICAL	GENE-N	10	12	In another experiment , chemical , an antagonist of the chemical terminal autoreceptor , also prolonged the clearance of chemical from the CA3 region .	T16	T24	9928259
NA	CHEMICAL	GENE-N	19	12	In another experiment , chemical , an antagonist of the chemical terminal autoreceptor , also prolonged the clearance of chemical from the CA3 region .	T18	T24	9928259
CPR:6	CHEMICAL	GENE-Y	3	12	Pharmacological properties of chemical as a member of a new class of gene antagonists .	T12	T23	3440035
CPR:6	CHEMICAL	GENE-Y	2	9	Derivatives of chemical are a new class of non-peptide gene ( gene ) antagonists .	T2	T21	3440035
CPR:6	CHEMICAL	GENE-Y	2	11	Derivatives of chemical are a new class of non-peptide gene ( gene ) antagonists .	T2	T13	3440035
NA	CHEMICAL	GENE-N	5	19	The most potent compound , chemical ( chemical , chemical ) , has a great affinity for the pancreatic gene and is a competitive , specific and potent gene antagonist on the smooth muscles of the gall bladder and ileum of the guinea pig and on the gene-induced gene secretion of isolated pancreatic acini .	T1	T15	3440035
CPR:6	CHEMICAL	GENE-Y	5	28	The most potent compound , chemical ( chemical , chemical ) , has a great affinity for the pancreatic gene and is a competitive , specific and potent gene antagonist on the smooth muscles of the gall bladder and ileum of the guinea pig and on the gene-induced gene secretion of isolated pancreatic acini .	T1	T16	3440035
NA	CHEMICAL	GENE-Y	5	47	The most potent compound , chemical ( chemical , chemical ) , has a great affinity for the pancreatic gene and is a competitive , specific and potent gene antagonist on the smooth muscles of the gall bladder and ileum of the guinea pig and on the gene-induced gene secretion of isolated pancreatic acini .	T1	T17	3440035
NA	CHEMICAL	GENE-N	5	13	The most potent compound , chemical ( chemical , chemical ) , has a great affinity for the pancreatic gene and is a competitive , specific and potent gene antagonist on the smooth muscles of the gall bladder and ileum of the guinea pig and on the gene-induced gene secretion of isolated pancreatic acini .	T1	T18	3440035
NA	CHEMICAL	GENE-N	7	19	The most potent compound , chemical ( chemical , chemical ) , has a great affinity for the pancreatic gene and is a competitive , specific and potent gene antagonist on the smooth muscles of the gall bladder and ileum of the guinea pig and on the gene-induced gene secretion of isolated pancreatic acini .	T3	T15	3440035
CPR:6	CHEMICAL	GENE-Y	7	28	The most potent compound , chemical ( chemical , chemical ) , has a great affinity for the pancreatic gene and is a competitive , specific and potent gene antagonist on the smooth muscles of the gall bladder and ileum of the guinea pig and on the gene-induced gene secretion of isolated pancreatic acini .	T3	T16	3440035
NA	CHEMICAL	GENE-Y	7	47	The most potent compound , chemical ( chemical , chemical ) , has a great affinity for the pancreatic gene and is a competitive , specific and potent gene antagonist on the smooth muscles of the gall bladder and ileum of the guinea pig and on the gene-induced gene secretion of isolated pancreatic acini .	T3	T17	3440035
NA	CHEMICAL	GENE-N	7	13	The most potent compound , chemical ( chemical , chemical ) , has a great affinity for the pancreatic gene and is a competitive , specific and potent gene antagonist on the smooth muscles of the gall bladder and ileum of the guinea pig and on the gene-induced gene secretion of isolated pancreatic acini .	T3	T18	3440035
NA	CHEMICAL	GENE-N	9	19	The most potent compound , chemical ( chemical , chemical ) , has a great affinity for the pancreatic gene and is a competitive , specific and potent gene antagonist on the smooth muscles of the gall bladder and ileum of the guinea pig and on the gene-induced gene secretion of isolated pancreatic acini .	T4	T15	3440035
CPR:6	CHEMICAL	GENE-Y	9	28	The most potent compound , chemical ( chemical , chemical ) , has a great affinity for the pancreatic gene and is a competitive , specific and potent gene antagonist on the smooth muscles of the gall bladder and ileum of the guinea pig and on the gene-induced gene secretion of isolated pancreatic acini .	T4	T16	3440035
NA	CHEMICAL	GENE-Y	9	47	The most potent compound , chemical ( chemical , chemical ) , has a great affinity for the pancreatic gene and is a competitive , specific and potent gene antagonist on the smooth muscles of the gall bladder and ileum of the guinea pig and on the gene-induced gene secretion of isolated pancreatic acini .	T4	T17	3440035
NA	CHEMICAL	GENE-N	9	13	The most potent compound , chemical ( chemical , chemical ) , has a great affinity for the pancreatic gene and is a competitive , specific and potent gene antagonist on the smooth muscles of the gall bladder and ileum of the guinea pig and on the gene-induced gene secretion of isolated pancreatic acini .	T4	T18	3440035
NA	CHEMICAL	GENE-N	2	0	gene or chemical ( chemical ) .	T6	T19	3440035
NA	CHEMICAL	GENE-N	4	0	gene or chemical ( chemical ) .	T7	T19	3440035
NA	CHEMICAL	GENE-Y	14	6	It antagonizes the satiety effect of gene in the rat and is protective against chemical- , chemical- and diet-induced pancreatitis .	T8	T20	3440035
NA	CHEMICAL	GENE-Y	16	6	It antagonizes the satiety effect of gene in the rat and is protective against chemical- , chemical- and diet-induced pancreatitis .	T9	T20	3440035
NA	CHEMICAL	GENE-Y	0	12	chemical is therefore a useful pharmacological tool to study the functions of gene .	T10	T22	3440035
CPR:9	CHEMICAL	GENE-N	0	7	chemical are biosynthesised from chemical by the gene enzyme complex called gene .	T1	T22	17020418
CPR:9	CHEMICAL	GENE-Y	0	11	chemical are biosynthesised from chemical by the gene enzyme complex called gene .	T1	T24	17020418
NA	CHEMICAL	GENE-N	4	7	chemical are biosynthesised from chemical by the gene enzyme complex called gene .	T6	T22	17020418
CPR:9	CHEMICAL	GENE-Y	4	11	chemical are biosynthesised from chemical by the gene enzyme complex called gene .	T6	T24	17020418
CPR:9	CHEMICAL	GENE-Y	11	5	In breast cancer , intratumoural gene is the source for local chemical production in the tissue .	T5	T19	17020418
NA	CHEMICAL	GENE-Y	13	2	Inhibition of gene is an important approach for reducing growth stimulatory effects of chemical in chemical-dependent breast cancer .	T7	T20	17020418
NA	CHEMICAL	GENE-Y	15	2	Inhibition of gene is an important approach for reducing growth stimulatory effects of chemical in chemical-dependent breast cancer .	T8	T20	17020418
CPR:4	CHEMICAL	GENE-Y	7	5	The potent and selective third-generation gene inhibitors chemical , chemical and exemestane were introduced to the market as endocrine therapy in postmenopausal patients failing anti-chemical therapy alone , or multiple hormonal therapies .	T9	T21	17020418
CPR:4	CHEMICAL	GENE-Y	9	5	The potent and selective third-generation gene inhibitors chemical , chemical and exemestane were introduced to the market as endocrine therapy in postmenopausal patients failing anti-chemical therapy alone , or multiple hormonal therapies .	T10	T21	17020418
NA	CHEMICAL	GENE-Y	24	5	The potent and selective third-generation gene inhibitors chemical , chemical and exemestane were introduced to the market as endocrine therapy in postmenopausal patients failing anti-chemical therapy alone , or multiple hormonal therapies .	T11	T21	17020418
CPR:4	CHEMICAL	GENE-Y	0	6	chemical and chemical are both non-chemical gene inhibitors that compete with the substrate for binding to the enzyme active site .	T12	T23	17020418
CPR:4	CHEMICAL	GENE-Y	2	6	chemical and chemical are both non-chemical gene inhibitors that compete with the substrate for binding to the enzyme active site .	T13	T23	17020418
NA	CHEMICAL	GENE-Y	5	6	chemical and chemical are both non-chemical gene inhibitors that compete with the substrate for binding to the enzyme active site .	T14	T23	17020418
NA	CHEMICAL	GENE-Y	2	2	Exemestane is a mechanism-based chemical inhibitor that mimics the substrate , is converted by the enzyme to a reactive intermediate , and results in inactivation of gene .	T15	T26	17020418
NA	CHEMICAL	GENE-Y	18	2	These third-generation gene inhibitors are currently approved as first-line therapy for the treatment of postmenopausal women with metastatic chemical-dependent breast cancer .	T2	T16	17020418
NA	CHEMICAL	GENE-Y	14	4	The use of an gene inhibitor as initial therapy , or after treatment with chemical , is now recommended as adjuvant hormonal therapy for postmenopausal women with hormone-dependent breast cancer .	T3	T17	17020418
NA	CHEMICAL	GENE-N	3	7	CNTs with linear chemical amphiphiles trigger the gene pathway of the complement through both L-ficolin and mannan-binding gene recognition .	T4	T9	23301860
NA	CHEMICAL	GENE-N	3	17	CNTs with linear chemical amphiphiles trigger the gene pathway of the complement through both L-ficolin and mannan-binding gene recognition .	T4	T10	23301860
CPR:3	CHEMICAL	GENE-N	4	9	An amphiphile with branched chemical architecture also activated the gene pathway but only through L-ficolin recognition .	T2	T6	23301860
CPR:6	CHEMICAL	GENE-N	9	5	Synthesis and antagonistic activity at gene subtypes of some chemical derivatives of chemical .	T5	T11	10530931
CPR:6	CHEMICAL	GENE-N	12	5	Synthesis and antagonistic activity at gene subtypes of some chemical derivatives of chemical .	T4	T11	10530931
NA	CHEMICAL	GENE-N	3	28	A series of chemical analogues of the muscarinic antagonist chemical bearing 1-substituents of different lipophilic , electronic , and steric properties was synthesized and their affinity for the gene subtypes was evaluated by functional tests .	T1	T6	10530931
CPR:6	CHEMICAL	GENE-N	9	28	A series of chemical analogues of the muscarinic antagonist chemical bearing 1-substituents of different lipophilic , electronic , and steric properties was synthesized and their affinity for the gene subtypes was evaluated by functional tests .	T3	T6	10530931
NA	CHEMICAL	GENE-Y	3	13	The contractions to chemical were inhibited by chemical and chemical indicating involvement of gene and gene receptors , respectively .	T10	T13	20347047
NA	CHEMICAL	GENE-Y	3	15	The contractions to chemical were inhibited by chemical and chemical indicating involvement of gene and gene receptors , respectively .	T10	T14	20347047
CPR:4	CHEMICAL	GENE-Y	7	13	The contractions to chemical were inhibited by chemical and chemical indicating involvement of gene and gene receptors , respectively .	T11	T13	20347047
NA	CHEMICAL	GENE-Y	7	15	The contractions to chemical were inhibited by chemical and chemical indicating involvement of gene and gene receptors , respectively .	T11	T14	20347047
NA	CHEMICAL	GENE-Y	9	13	The contractions to chemical were inhibited by chemical and chemical indicating involvement of gene and gene receptors , respectively .	T12	T13	20347047
CPR:4	CHEMICAL	GENE-Y	9	15	The contractions to chemical were inhibited by chemical and chemical indicating involvement of gene and gene receptors , respectively .	T12	T14	20347047
NA	CHEMICAL	GENE-Y	7	28	In the asthmatic model , AHR to chemical was demonstrated in conscious , freely moving mice in vivo and in isolated trachea in vitro 24 and 72h after gene challenge .	T1	T21	20347047
CPR:4	CHEMICAL	GENE-N	4	15	Concentration-dependent inhibitory effects of chemical on the metabolism of chemical , a dual probe of gene and gene , in rats .	T17	T27	23458730
CPR:4	CHEMICAL	GENE-N	4	17	Concentration-dependent inhibitory effects of chemical on the metabolism of chemical , a dual probe of gene and gene , in rats .	T17	T28	23458730
CPR:9	CHEMICAL	GENE-N	9	15	Concentration-dependent inhibitory effects of chemical on the metabolism of chemical , a dual probe of gene and gene , in rats .	T18	T27	23458730
CPR:9	CHEMICAL	GENE-N	9	17	Concentration-dependent inhibitory effects of chemical on the metabolism of chemical , a dual probe of gene and gene , in rats .	T18	T28	23458730
CPR:4	CHEMICAL	GENE-N	11	26	In the current study , we reveal the inhibitory effects of chemical on the metabolism of chemical ( chemical ) , a dual probe substrate of gene and gene , in rats .	T6	T23	23458730
CPR:4	CHEMICAL	GENE-N	11	28	In the current study , we reveal the inhibitory effects of chemical on the metabolism of chemical ( chemical ) , a dual probe substrate of gene and gene , in rats .	T6	T24	23458730
CPR:9	CHEMICAL	GENE-N	16	26	In the current study , we reveal the inhibitory effects of chemical on the metabolism of chemical ( chemical ) , a dual probe substrate of gene and gene , in rats .	T7	T23	23458730
CPR:9	CHEMICAL	GENE-N	16	28	In the current study , we reveal the inhibitory effects of chemical on the metabolism of chemical ( chemical ) , a dual probe substrate of gene and gene , in rats .	T7	T24	23458730
CPR:9	CHEMICAL	GENE-N	18	26	In the current study , we reveal the inhibitory effects of chemical on the metabolism of chemical ( chemical ) , a dual probe substrate of gene and gene , in rats .	T8	T23	23458730
CPR:9	CHEMICAL	GENE-N	18	28	In the current study , we reveal the inhibitory effects of chemical on the metabolism of chemical ( chemical ) , a dual probe substrate of gene and gene , in rats .	T8	T24	23458730
CPR:4	CHEMICAL	GENE-N	4	9	Lineweaver-Burk plots demonstrated that chemical inhibited the activities of gene and gene in a non-competitive manner in rat liver microsomes ( RLMs ) .	T9	T25	23458730
CPR:4	CHEMICAL	GENE-N	4	11	Lineweaver-Burk plots demonstrated that chemical inhibited the activities of gene and gene in a non-competitive manner in rat liver microsomes ( RLMs ) .	T9	T26	23458730
CPR:4	CHEMICAL	GENE-N	4	3	The activity of gene in excised liver samples from rats following multiple chemical treatment was significantly decreased compared to that of the control group ( P < 0.05 ) , whereas multiple doses of chemical had no obvious effect on the activity of gene .	T2	T19	23458730
NA	CHEMICAL	GENE-N	4	25	The activity of gene in excised liver samples from rats following multiple chemical treatment was significantly decreased compared to that of the control group ( P < 0.05 ) , whereas multiple doses of chemical had no obvious effect on the activity of gene .	T2	T20	23458730
NA	CHEMICAL	GENE-N	4	3	The activity of gene in excised liver samples from rats following multiple chemical treatment was significantly decreased compared to that of the control group ( P < 0.05 ) , whereas multiple doses of chemical had no obvious effect on the activity of gene .	T3	T19	23458730
NA	CHEMICAL	GENE-N	4	25	The activity of gene in excised liver samples from rats following multiple chemical treatment was significantly decreased compared to that of the control group ( P < 0.05 ) , whereas multiple doses of chemical had no obvious effect on the activity of gene .	T3	T20	23458730
NA	CHEMICAL	GENE-Y	3	5	Pharmacokinetic Interactions between chemical Oxidase A Inhibitor chemical and chemical , and the Impact of gene Status .	T33	T50	23393220
NA	CHEMICAL	GENE-Y	3	15	Pharmacokinetic Interactions between chemical Oxidase A Inhibitor chemical and chemical , and the Impact of gene Status .	T33	T49	23393220
CPR:4	CHEMICAL	GENE-Y	7	5	Pharmacokinetic Interactions between chemical Oxidase A Inhibitor chemical and chemical , and the Impact of gene Status .	T34	T50	23393220
NA	CHEMICAL	GENE-Y	7	15	Pharmacokinetic Interactions between chemical Oxidase A Inhibitor chemical and chemical , and the Impact of gene Status .	T34	T49	23393220
NA	CHEMICAL	GENE-Y	9	5	Pharmacokinetic Interactions between chemical Oxidase A Inhibitor chemical and chemical , and the Impact of gene Status .	T35	T50	23393220
NA	CHEMICAL	GENE-Y	9	15	Pharmacokinetic Interactions between chemical Oxidase A Inhibitor chemical and chemical , and the Impact of gene Status .	T35	T49	23393220
NA	CHEMICAL	GENE-Y	8	10	Our recent study has demonstrated that coadministration of chemical oxidase A ( gene ) inhibitor chemical ( 5 mg/kg ) increases systemic exposure to chemical ( 2 mg/kg ) and active metabolite bufotenine .	T17	T43	23393220
NA	CHEMICAL	GENE-Y	8	10	Our recent study has demonstrated that coadministration of chemical oxidase A ( gene ) inhibitor chemical ( 5 mg/kg ) increases systemic exposure to chemical ( 2 mg/kg ) and active metabolite bufotenine .	T17	T44	23393220
CPR:4	CHEMICAL	GENE-Y	15	10	Our recent study has demonstrated that coadministration of chemical oxidase A ( gene ) inhibitor chemical ( 5 mg/kg ) increases systemic exposure to chemical ( 2 mg/kg ) and active metabolite bufotenine .	T18	T43	23393220
CPR:4	CHEMICAL	GENE-Y	15	10	Our recent study has demonstrated that coadministration of chemical oxidase A ( gene ) inhibitor chemical ( 5 mg/kg ) increases systemic exposure to chemical ( 2 mg/kg ) and active metabolite bufotenine .	T18	T44	23393220
NA	CHEMICAL	GENE-Y	17	10	Our recent study has demonstrated that coadministration of chemical oxidase A ( gene ) inhibitor chemical ( 5 mg/kg ) increases systemic exposure to chemical ( 2 mg/kg ) and active metabolite bufotenine .	T19	T43	23393220
NA	CHEMICAL	GENE-Y	17	10	Our recent study has demonstrated that coadministration of chemical oxidase A ( gene ) inhibitor chemical ( 5 mg/kg ) increases systemic exposure to chemical ( 2 mg/kg ) and active metabolite bufotenine .	T19	T44	23393220
NA	CHEMICAL	GENE-Y	6	25	This study is aimed at delineating chemical and chemical pharmacokinetic ( PK ) interactions at multiple dose levels , as well as the impact of gene that affects chemical PK and determines chemical chemical-demethylation to produce chemical .	T21	T45	23393220
NA	CHEMICAL	GENE-Y	8	25	This study is aimed at delineating chemical and chemical pharmacokinetic ( PK ) interactions at multiple dose levels , as well as the impact of gene that affects chemical PK and determines chemical chemical-demethylation to produce chemical .	T22	T45	23393220
NA	CHEMICAL	GENE-Y	28	25	This study is aimed at delineating chemical and chemical pharmacokinetic ( PK ) interactions at multiple dose levels , as well as the impact of gene that affects chemical PK and determines chemical chemical-demethylation to produce chemical .	T23	T45	23393220
NA	CHEMICAL	GENE-Y	32	25	This study is aimed at delineating chemical and chemical pharmacokinetic ( PK ) interactions at multiple dose levels , as well as the impact of gene that affects chemical PK and determines chemical chemical-demethylation to produce chemical .	T24	T45	23393220
NA	CHEMICAL	GENE-Y	33	25	This study is aimed at delineating chemical and chemical pharmacokinetic ( PK ) interactions at multiple dose levels , as well as the impact of gene that affects chemical PK and determines chemical chemical-demethylation to produce chemical .	T25	T45	23393220
NA	CHEMICAL	GENE-Y	36	25	This study is aimed at delineating chemical and chemical pharmacokinetic ( PK ) interactions at multiple dose levels , as well as the impact of gene that affects chemical PK and determines chemical chemical-demethylation to produce chemical .	T26	T45	23393220
CPR:4	CHEMICAL	GENE-Y	10	6	Our data revealed that inhibition of gene-mediated metabolic elimination by chemical ( 2 , 5 , and 15 mg/kg ) led to a sharp increase in systemic and cerebral exposure to chemical ( 2 and 10 mg/kg ) at all dose combinations .	T28	T46	23393220
NA	CHEMICAL	GENE-Y	14	6	Our data revealed that inhibition of gene-mediated metabolic elimination by chemical ( 2 , 5 , and 15 mg/kg ) led to a sharp increase in systemic and cerebral exposure to chemical ( 2 and 10 mg/kg ) at all dose combinations .	T29	T46	23393220
NA	CHEMICAL	GENE-Y	5	18	A more pronounced effect on chemical PK was associated with greater exposure to chemical in wild-type mice than gene-humanized ( Tg-gene ) mice .	T30	T47	23393220
NA	CHEMICAL	GENE-Y	5	20	A more pronounced effect on chemical PK was associated with greater exposure to chemical in wild-type mice than gene-humanized ( Tg-gene ) mice .	T30	T48	23393220
NA	CHEMICAL	GENE-Y	13	18	A more pronounced effect on chemical PK was associated with greater exposure to chemical in wild-type mice than gene-humanized ( Tg-gene ) mice .	T31	T47	23393220
NA	CHEMICAL	GENE-Y	13	20	A more pronounced effect on chemical PK was associated with greater exposure to chemical in wild-type mice than gene-humanized ( Tg-gene ) mice .	T31	T48	23393220
NA	CHEMICAL	GENE-Y	0	17	chemical ( 5 mg/kg ) also increased blood and brain chemical concentrations that were generally higher in Tg-gene mice .	T32	T36	23393220
NA	CHEMICAL	GENE-Y	10	17	chemical ( 5 mg/kg ) also increased blood and brain chemical concentrations that were generally higher in Tg-gene mice .	T2	T36	23393220
CPR:4	CHEMICAL	GENE-Y	1	8	The in vivo inhibitory effect of chemical on gene-catalyzed chemical formation was confirmed by in vitro study using purified gene .	T5	T37	23393220
CPR:4	CHEMICAL	GENE-Y	1	19	The in vivo inhibitory effect of chemical on gene-catalyzed chemical formation was confirmed by in vitro study using purified gene .	T5	T38	23393220
CPR:9	CHEMICAL	GENE-Y	1	8	The in vivo inhibitory effect of chemical on gene-catalyzed chemical formation was confirmed by in vitro study using purified gene .	T6	T37	23393220
CPR:9	CHEMICAL	GENE-Y	1	19	The in vivo inhibitory effect of chemical on gene-catalyzed chemical formation was confirmed by in vitro study using purified gene .	T6	T38	23393220
CPR:9	CHEMICAL	GENE-Y	15	12	Given these findings , a unified PK model including the inhibition of gene- and gene-catalyzed chemical metabolism by chemical was developed to describe blood chemical , chemical , and chemical PK profiles in both wild-type and Tg-gene mouse models .	T8	T39	23393220
CPR:9	CHEMICAL	GENE-Y	15	14	Given these findings , a unified PK model including the inhibition of gene- and gene-catalyzed chemical metabolism by chemical was developed to describe blood chemical , chemical , and chemical PK profiles in both wild-type and Tg-gene mouse models .	T8	T40	23393220
CPR:9	CHEMICAL	GENE-Y	15	36	Given these findings , a unified PK model including the inhibition of gene- and gene-catalyzed chemical metabolism by chemical was developed to describe blood chemical , chemical , and chemical PK profiles in both wild-type and Tg-gene mouse models .	T8	T41	23393220
CPR:4	CHEMICAL	GENE-Y	4	12	Given these findings , a unified PK model including the inhibition of gene- and gene-catalyzed chemical metabolism by chemical was developed to describe blood chemical , chemical , and chemical PK profiles in both wild-type and Tg-gene mouse models .	T9	T39	23393220
CPR:4	CHEMICAL	GENE-Y	4	14	Given these findings , a unified PK model including the inhibition of gene- and gene-catalyzed chemical metabolism by chemical was developed to describe blood chemical , chemical , and chemical PK profiles in both wild-type and Tg-gene mouse models .	T9	T40	23393220
CPR:4	CHEMICAL	GENE-Y	4	36	Given these findings , a unified PK model including the inhibition of gene- and gene-catalyzed chemical metabolism by chemical was developed to describe blood chemical , chemical , and chemical PK profiles in both wild-type and Tg-gene mouse models .	T9	T41	23393220
CPR:4	CHEMICAL	GENE-Y	4	12	Given these findings , a unified PK model including the inhibition of gene- and gene-catalyzed chemical metabolism by chemical was developed to describe blood chemical , chemical , and chemical PK profiles in both wild-type and Tg-gene mouse models .	T10	T39	23393220
CPR:4	CHEMICAL	GENE-Y	4	14	Given these findings , a unified PK model including the inhibition of gene- and gene-catalyzed chemical metabolism by chemical was developed to describe blood chemical , chemical , and chemical PK profiles in both wild-type and Tg-gene mouse models .	T10	T40	23393220
CPR:4	CHEMICAL	GENE-Y	4	36	Given these findings , a unified PK model including the inhibition of gene- and gene-catalyzed chemical metabolism by chemical was developed to describe blood chemical , chemical , and chemical PK profiles in both wild-type and Tg-gene mouse models .	T10	T41	23393220
CPR:9	CHEMICAL	GENE-Y	26	12	Given these findings , a unified PK model including the inhibition of gene- and gene-catalyzed chemical metabolism by chemical was developed to describe blood chemical , chemical , and chemical PK profiles in both wild-type and Tg-gene mouse models .	T11	T39	23393220
CPR:9	CHEMICAL	GENE-Y	26	14	Given these findings , a unified PK model including the inhibition of gene- and gene-catalyzed chemical metabolism by chemical was developed to describe blood chemical , chemical , and chemical PK profiles in both wild-type and Tg-gene mouse models .	T11	T40	23393220
CPR:9	CHEMICAL	GENE-Y	26	36	Given these findings , a unified PK model including the inhibition of gene- and gene-catalyzed chemical metabolism by chemical was developed to describe blood chemical , chemical , and chemical PK profiles in both wild-type and Tg-gene mouse models .	T11	T41	23393220
NA	CHEMICAL	GENE-Y	29	12	Given these findings , a unified PK model including the inhibition of gene- and gene-catalyzed chemical metabolism by chemical was developed to describe blood chemical , chemical , and chemical PK profiles in both wild-type and Tg-gene mouse models .	T12	T39	23393220
NA	CHEMICAL	GENE-Y	29	14	Given these findings , a unified PK model including the inhibition of gene- and gene-catalyzed chemical metabolism by chemical was developed to describe blood chemical , chemical , and chemical PK profiles in both wild-type and Tg-gene mouse models .	T12	T40	23393220
NA	CHEMICAL	GENE-Y	29	36	Given these findings , a unified PK model including the inhibition of gene- and gene-catalyzed chemical metabolism by chemical was developed to describe blood chemical , chemical , and chemical PK profiles in both wild-type and Tg-gene mouse models .	T12	T41	23393220
CPR:3	CHEMICAL	GENE-Y	5	1	Central gene receptor stimulation by chemical increases blood chemical in rats .	T8	T15	11972287
NA	CHEMICAL	GENE-Y	8	1	Central gene receptor stimulation by chemical increases blood chemical in rats .	T9	T15	11972287
NA	CHEMICAL	GENE-Y	13	13	The aim of the present study was to investigate the role of central gene receptors on the control of blood chemical in stressed and non-stressed rats in both fasted and fed states .	T1	T13	11972287
CPR:5	CHEMICAL	GENE-Y	2	6	Injections of chemical , a selective gene receptor agonist , induced a significant increase in blood chemical in non-stressed rats in both fasted and in fed states .	T2	T11	11972287
NA	CHEMICAL	GENE-Y	16	6	Injections of chemical , a selective gene receptor agonist , induced a significant increase in blood chemical in non-stressed rats in both fasted and in fed states .	T3	T11	11972287
CPR:5	CHEMICAL	GENE-Y	4	16	The hyperglycemic effect of chemical central administration was blocked by pretreatment with ondansetron , a specific gene receptor antagonist , indicating that the effects here obtained with chemical were a result of its interaction with gene receptors .	T4	T12	11972287
NA	CHEMICAL	GENE-Y	4	35	The hyperglycemic effect of chemical central administration was blocked by pretreatment with ondansetron , a specific gene receptor antagonist , indicating that the effects here obtained with chemical were a result of its interaction with gene receptors .	T4	T14	11972287
NA	CHEMICAL	GENE-Y	27	16	The hyperglycemic effect of chemical central administration was blocked by pretreatment with ondansetron , a specific gene receptor antagonist , indicating that the effects here obtained with chemical were a result of its interaction with gene receptors .	T5	T12	11972287
NA	CHEMICAL	GENE-Y	27	35	The hyperglycemic effect of chemical central administration was blocked by pretreatment with ondansetron , a specific gene receptor antagonist , indicating that the effects here obtained with chemical were a result of its interaction with gene receptors .	T5	T14	11972287
NA	CHEMICAL	GENE-Y	1	4	Plasma chemical-terminal pro-brain natriuretic peptide and gene : prognostic utility and prediction of benefit from chemical in chronic ischemic left ventricular dysfunction .	T15	T32	11401111
NA	CHEMICAL	GENE-Y	1	6	Plasma chemical-terminal pro-brain natriuretic peptide and gene : prognostic utility and prediction of benefit from chemical in chronic ischemic left ventricular dysfunction .	T15	T31	11401111
NA	CHEMICAL	GENE-Y	15	4	Plasma chemical-terminal pro-brain natriuretic peptide and gene : prognostic utility and prediction of benefit from chemical in chronic ischemic left ventricular dysfunction .	T14	T32	11401111
NA	CHEMICAL	GENE-Y	15	6	Plasma chemical-terminal pro-brain natriuretic peptide and gene : prognostic utility and prediction of benefit from chemical in chronic ischemic left ventricular dysfunction .	T14	T31	11401111
NA	CHEMICAL	GENE-Y	34	19	OBJECTIVES : We sought to assess plasma concentrations of the chemical ( chemical ) -terminal portion of pro-brain natriuretic peptide ( chemical-BNP ) and gene for prediction of adverse outcomes and responses to treatment in 297 patients with ischemic left ventricular ( LV ) dysfunction who were randomly assigned to receive chemical or placebo .	T10	T28	11401111
NA	CHEMICAL	GENE-Y	34	12	OBJECTIVES : We sought to assess plasma concentrations of the chemical ( chemical ) -terminal portion of pro-brain natriuretic peptide ( chemical-BNP ) and gene for prediction of adverse outcomes and responses to treatment in 297 patients with ischemic left ventricular ( LV ) dysfunction who were randomly assigned to receive chemical or placebo .	T10	T16	11401111
NA	CHEMICAL	GENE-Y	34	24	OBJECTIVES : We sought to assess plasma concentrations of the chemical ( chemical ) -terminal portion of pro-brain natriuretic peptide ( chemical-BNP ) and gene for prediction of adverse outcomes and responses to treatment in 297 patients with ischemic left ventricular ( LV ) dysfunction who were randomly assigned to receive chemical or placebo .	T10	T17	11401111
NA	CHEMICAL	GENE-Y	12	19	OBJECTIVES : We sought to assess plasma concentrations of the chemical ( chemical ) -terminal portion of pro-brain natriuretic peptide ( chemical-BNP ) and gene for prediction of adverse outcomes and responses to treatment in 297 patients with ischemic left ventricular ( LV ) dysfunction who were randomly assigned to receive chemical or placebo .	T11	T28	11401111
NA	CHEMICAL	GENE-Y	12	12	OBJECTIVES : We sought to assess plasma concentrations of the chemical ( chemical ) -terminal portion of pro-brain natriuretic peptide ( chemical-BNP ) and gene for prediction of adverse outcomes and responses to treatment in 297 patients with ischemic left ventricular ( LV ) dysfunction who were randomly assigned to receive chemical or placebo .	T11	T16	11401111
NA	CHEMICAL	GENE-Y	12	24	OBJECTIVES : We sought to assess plasma concentrations of the chemical ( chemical ) -terminal portion of pro-brain natriuretic peptide ( chemical-BNP ) and gene for prediction of adverse outcomes and responses to treatment in 297 patients with ischemic left ventricular ( LV ) dysfunction who were randomly assigned to receive chemical or placebo .	T11	T17	11401111
NA	CHEMICAL	GENE-Y	10	19	OBJECTIVES : We sought to assess plasma concentrations of the chemical ( chemical ) -terminal portion of pro-brain natriuretic peptide ( chemical-BNP ) and gene for prediction of adverse outcomes and responses to treatment in 297 patients with ischemic left ventricular ( LV ) dysfunction who were randomly assigned to receive chemical or placebo .	T1	T28	11401111
NA	CHEMICAL	GENE-Y	10	12	OBJECTIVES : We sought to assess plasma concentrations of the chemical ( chemical ) -terminal portion of pro-brain natriuretic peptide ( chemical-BNP ) and gene for prediction of adverse outcomes and responses to treatment in 297 patients with ischemic left ventricular ( LV ) dysfunction who were randomly assigned to receive chemical or placebo .	T1	T16	11401111
NA	CHEMICAL	GENE-Y	10	24	OBJECTIVES : We sought to assess plasma concentrations of the chemical ( chemical ) -terminal portion of pro-brain natriuretic peptide ( chemical-BNP ) and gene for prediction of adverse outcomes and responses to treatment in 297 patients with ischemic left ventricular ( LV ) dysfunction who were randomly assigned to receive chemical or placebo .	T1	T17	11401111
NA	CHEMICAL	GENE-Y	51	19	OBJECTIVES : We sought to assess plasma concentrations of the chemical ( chemical ) -terminal portion of pro-brain natriuretic peptide ( chemical-BNP ) and gene for prediction of adverse outcomes and responses to treatment in 297 patients with ischemic left ventricular ( LV ) dysfunction who were randomly assigned to receive chemical or placebo .	T7	T28	11401111
NA	CHEMICAL	GENE-Y	51	12	OBJECTIVES : We sought to assess plasma concentrations of the chemical ( chemical ) -terminal portion of pro-brain natriuretic peptide ( chemical-BNP ) and gene for prediction of adverse outcomes and responses to treatment in 297 patients with ischemic left ventricular ( LV ) dysfunction who were randomly assigned to receive chemical or placebo .	T7	T16	11401111
NA	CHEMICAL	GENE-Y	51	24	OBJECTIVES : We sought to assess plasma concentrations of the chemical ( chemical ) -terminal portion of pro-brain natriuretic peptide ( chemical-BNP ) and gene for prediction of adverse outcomes and responses to treatment in 297 patients with ischemic left ventricular ( LV ) dysfunction who were randomly assigned to receive chemical or placebo .	T7	T17	11401111
NA	CHEMICAL	GENE-Y	0	18	BACKGROUchemicalD : Although neurohormonal status has known prognostic significance in heart failure , the predictive power of either gene or gene in chronic ischemic LV dysfunction has not been previously reported .	T8	T24	11401111
NA	CHEMICAL	GENE-Y	0	9	BACKGROUchemicalD : Although neurohormonal status has known prognostic significance in heart failure , the predictive power of either gene or gene in chronic ischemic LV dysfunction has not been previously reported .	T8	T25	11401111
NA	CHEMICAL	GENE-Y	3	5	METHODS : Plasma chemical-BNP and gene were measured in 297 patients with chronic ischemic ( LV ) dysfunction before randomization to chemical or placebo , added to established treatment with a converting enzyme inhibitor and loop diuretic ( with or without digoxin ) .	T9	T27	11401111
NA	CHEMICAL	GENE-Y	21	5	METHODS : Plasma chemical-BNP and gene were measured in 297 patients with chronic ischemic ( LV ) dysfunction before randomization to chemical or placebo , added to established treatment with a converting enzyme inhibitor and loop diuretic ( with or without digoxin ) .	T12	T27	11401111
NA	CHEMICAL	GENE-Y	3	5	RESULTS : Above-median chemical-BNP and gene levels conferred increased risks ( all p < 0.001 ) of mortality ( risk ratios [ 95 % confidence intervals ] : 4.67 [ 2-10.9 ] and 3.92 [ 1.76-8.7 ] , respectively ) and hospital admission with heart failure ( 4.7 [ 2.2-10.3 ] and 2.4 [ 1.3-4.5 ] , respectively ) .	T13	T30	11401111
NA	CHEMICAL	GENE-Y	0	15	chemical reduced the risk of death or heart failure in patients with above-median levels of chemical-BNP or gene , or both , to rates not significantly different from those observed in patients with levels below the median value .	T3	T18	11401111
NA	CHEMICAL	GENE-Y	0	9	chemical reduced the risk of death or heart failure in patients with above-median levels of chemical-BNP or gene , or both , to rates not significantly different from those observed in patients with levels below the median value .	T3	T19	11401111
NA	CHEMICAL	GENE-Y	0	11	COchemicalCLUSIONS : In patients with established ischemic LV dysfunction , plasma gene and gene are independent predictors of mortality and heart failure .	T4	T20	11401111
NA	CHEMICAL	GENE-Y	0	13	COchemicalCLUSIONS : In patients with established ischemic LV dysfunction , plasma gene and gene are independent predictors of mortality and heart failure .	T4	T21	11401111
NA	CHEMICAL	GENE-N	2	8	Mutation of chemical 228 to chemical enhances the gene activity of gene . gene ( gene ) normally transfers chemical from chemical to chemical in the presence of chemical ion ( chemical-T activity ) and also transfers chemical from chemical to chemical ( chemical-T activity ) , albeit at only 0.3 % efficiency .	T36	T56	15736931
NA	CHEMICAL	GENE-Y	2	11	Mutation of chemical 228 to chemical enhances the gene activity of gene . gene ( gene ) normally transfers chemical from chemical to chemical in the presence of chemical ion ( chemical-T activity ) and also transfers chemical from chemical to chemical ( chemical-T activity ) , albeit at only 0.3 % efficiency .	T36	T57	15736931
NA	CHEMICAL	GENE-Y	2	13	Mutation of chemical 228 to chemical enhances the gene activity of gene . gene ( gene ) normally transfers chemical from chemical to chemical in the presence of chemical ion ( chemical-T activity ) and also transfers chemical from chemical to chemical ( chemical-T activity ) , albeit at only 0.3 % efficiency .	T36	T38	15736931
NA	CHEMICAL	GENE-Y	2	15	Mutation of chemical 228 to chemical enhances the gene activity of gene . gene ( gene ) normally transfers chemical from chemical to chemical in the presence of chemical ion ( chemical-T activity ) and also transfers chemical from chemical to chemical ( chemical-T activity ) , albeit at only 0.3 % efficiency .	T36	T49	15736931
CPR:3	CHEMICAL	GENE-N	5	8	Mutation of chemical 228 to chemical enhances the gene activity of gene . gene ( gene ) normally transfers chemical from chemical to chemical in the presence of chemical ion ( chemical-T activity ) and also transfers chemical from chemical to chemical ( chemical-T activity ) , albeit at only 0.3 % efficiency .	T37	T56	15736931
NA	CHEMICAL	GENE-Y	5	11	Mutation of chemical 228 to chemical enhances the gene activity of gene . gene ( gene ) normally transfers chemical from chemical to chemical in the presence of chemical ion ( chemical-T activity ) and also transfers chemical from chemical to chemical ( chemical-T activity ) , albeit at only 0.3 % efficiency .	T37	T57	15736931
NA	CHEMICAL	GENE-Y	5	13	Mutation of chemical 228 to chemical enhances the gene activity of gene . gene ( gene ) normally transfers chemical from chemical to chemical in the presence of chemical ion ( chemical-T activity ) and also transfers chemical from chemical to chemical ( chemical-T activity ) , albeit at only 0.3 % efficiency .	T37	T38	15736931
NA	CHEMICAL	GENE-Y	5	15	Mutation of chemical 228 to chemical enhances the gene activity of gene . gene ( gene ) normally transfers chemical from chemical to chemical in the presence of chemical ion ( chemical-T activity ) and also transfers chemical from chemical to chemical ( chemical-T activity ) , albeit at only 0.3 % efficiency .	T37	T49	15736931
NA	CHEMICAL	GENE-N	19	8	Mutation of chemical 228 to chemical enhances the gene activity of gene . gene ( gene ) normally transfers chemical from chemical to chemical in the presence of chemical ion ( chemical-T activity ) and also transfers chemical from chemical to chemical ( chemical-T activity ) , albeit at only 0.3 % efficiency .	T28	T56	15736931
NA	CHEMICAL	GENE-Y	19	11	Mutation of chemical 228 to chemical enhances the gene activity of gene . gene ( gene ) normally transfers chemical from chemical to chemical in the presence of chemical ion ( chemical-T activity ) and also transfers chemical from chemical to chemical ( chemical-T activity ) , albeit at only 0.3 % efficiency .	T28	T57	15736931
NA	CHEMICAL	GENE-Y	19	13	Mutation of chemical 228 to chemical enhances the gene activity of gene . gene ( gene ) normally transfers chemical from chemical to chemical in the presence of chemical ion ( chemical-T activity ) and also transfers chemical from chemical to chemical ( chemical-T activity ) , albeit at only 0.3 % efficiency .	T28	T38	15736931
NA	CHEMICAL	GENE-Y	19	15	Mutation of chemical 228 to chemical enhances the gene activity of gene . gene ( gene ) normally transfers chemical from chemical to chemical in the presence of chemical ion ( chemical-T activity ) and also transfers chemical from chemical to chemical ( chemical-T activity ) , albeit at only 0.3 % efficiency .	T28	T49	15736931
NA	CHEMICAL	GENE-N	21	8	Mutation of chemical 228 to chemical enhances the gene activity of gene . gene ( gene ) normally transfers chemical from chemical to chemical in the presence of chemical ion ( chemical-T activity ) and also transfers chemical from chemical to chemical ( chemical-T activity ) , albeit at only 0.3 % efficiency .	T30	T56	15736931
NA	CHEMICAL	GENE-Y	21	11	Mutation of chemical 228 to chemical enhances the gene activity of gene . gene ( gene ) normally transfers chemical from chemical to chemical in the presence of chemical ion ( chemical-T activity ) and also transfers chemical from chemical to chemical ( chemical-T activity ) , albeit at only 0.3 % efficiency .	T30	T57	15736931
CPR:9	CHEMICAL	GENE-Y	21	13	Mutation of chemical 228 to chemical enhances the gene activity of gene . gene ( gene ) normally transfers chemical from chemical to chemical in the presence of chemical ion ( chemical-T activity ) and also transfers chemical from chemical to chemical ( chemical-T activity ) , albeit at only 0.3 % efficiency .	T30	T38	15736931
CPR:9	CHEMICAL	GENE-Y	21	15	Mutation of chemical 228 to chemical enhances the gene activity of gene . gene ( gene ) normally transfers chemical from chemical to chemical in the presence of chemical ion ( chemical-T activity ) and also transfers chemical from chemical to chemical ( chemical-T activity ) , albeit at only 0.3 % efficiency .	T30	T49	15736931
NA	CHEMICAL	GENE-N	23	8	Mutation of chemical 228 to chemical enhances the gene activity of gene . gene ( gene ) normally transfers chemical from chemical to chemical in the presence of chemical ion ( chemical-T activity ) and also transfers chemical from chemical to chemical ( chemical-T activity ) , albeit at only 0.3 % efficiency .	T34	T56	15736931
NA	CHEMICAL	GENE-Y	23	11	Mutation of chemical 228 to chemical enhances the gene activity of gene . gene ( gene ) normally transfers chemical from chemical to chemical in the presence of chemical ion ( chemical-T activity ) and also transfers chemical from chemical to chemical ( chemical-T activity ) , albeit at only 0.3 % efficiency .	T34	T57	15736931
NA	CHEMICAL	GENE-Y	23	13	Mutation of chemical 228 to chemical enhances the gene activity of gene . gene ( gene ) normally transfers chemical from chemical to chemical in the presence of chemical ion ( chemical-T activity ) and also transfers chemical from chemical to chemical ( chemical-T activity ) , albeit at only 0.3 % efficiency .	T34	T38	15736931
NA	CHEMICAL	GENE-Y	23	15	Mutation of chemical 228 to chemical enhances the gene activity of gene . gene ( gene ) normally transfers chemical from chemical to chemical in the presence of chemical ion ( chemical-T activity ) and also transfers chemical from chemical to chemical ( chemical-T activity ) , albeit at only 0.3 % efficiency .	T34	T49	15736931
NA	CHEMICAL	GENE-N	2	8	Mutation of chemical 228 to chemical enhances the gene activity of gene . gene ( gene ) normally transfers chemical from chemical to chemical in the presence of chemical ion ( chemical-T activity ) and also transfers chemical from chemical to chemical ( chemical-T activity ) , albeit at only 0.3 % efficiency .	T3	T56	15736931
NA	CHEMICAL	GENE-Y	2	11	Mutation of chemical 228 to chemical enhances the gene activity of gene . gene ( gene ) normally transfers chemical from chemical to chemical in the presence of chemical ion ( chemical-T activity ) and also transfers chemical from chemical to chemical ( chemical-T activity ) , albeit at only 0.3 % efficiency .	T3	T57	15736931
NA	CHEMICAL	GENE-Y	2	13	Mutation of chemical 228 to chemical enhances the gene activity of gene . gene ( gene ) normally transfers chemical from chemical to chemical in the presence of chemical ion ( chemical-T activity ) and also transfers chemical from chemical to chemical ( chemical-T activity ) , albeit at only 0.3 % efficiency .	T3	T38	15736931
NA	CHEMICAL	GENE-Y	2	15	Mutation of chemical 228 to chemical enhances the gene activity of gene . gene ( gene ) normally transfers chemical from chemical to chemical in the presence of chemical ion ( chemical-T activity ) and also transfers chemical from chemical to chemical ( chemical-T activity ) , albeit at only 0.3 % efficiency .	T3	T49	15736931
NA	CHEMICAL	GENE-N	31	8	Mutation of chemical 228 to chemical enhances the gene activity of gene . gene ( gene ) normally transfers chemical from chemical to chemical in the presence of chemical ion ( chemical-T activity ) and also transfers chemical from chemical to chemical ( chemical-T activity ) , albeit at only 0.3 % efficiency .	T6	T56	15736931
NA	CHEMICAL	GENE-Y	31	11	Mutation of chemical 228 to chemical enhances the gene activity of gene . gene ( gene ) normally transfers chemical from chemical to chemical in the presence of chemical ion ( chemical-T activity ) and also transfers chemical from chemical to chemical ( chemical-T activity ) , albeit at only 0.3 % efficiency .	T6	T57	15736931
NA	CHEMICAL	GENE-Y	31	13	Mutation of chemical 228 to chemical enhances the gene activity of gene . gene ( gene ) normally transfers chemical from chemical to chemical in the presence of chemical ion ( chemical-T activity ) and also transfers chemical from chemical to chemical ( chemical-T activity ) , albeit at only 0.3 % efficiency .	T6	T38	15736931
NA	CHEMICAL	GENE-Y	31	15	Mutation of chemical 228 to chemical enhances the gene activity of gene . gene ( gene ) normally transfers chemical from chemical to chemical in the presence of chemical ion ( chemical-T activity ) and also transfers chemical from chemical to chemical ( chemical-T activity ) , albeit at only 0.3 % efficiency .	T6	T49	15736931
NA	CHEMICAL	GENE-N	37	8	Mutation of chemical 228 to chemical enhances the gene activity of gene . gene ( gene ) normally transfers chemical from chemical to chemical in the presence of chemical ion ( chemical-T activity ) and also transfers chemical from chemical to chemical ( chemical-T activity ) , albeit at only 0.3 % efficiency .	T13	T56	15736931
NA	CHEMICAL	GENE-Y	37	11	Mutation of chemical 228 to chemical enhances the gene activity of gene . gene ( gene ) normally transfers chemical from chemical to chemical in the presence of chemical ion ( chemical-T activity ) and also transfers chemical from chemical to chemical ( chemical-T activity ) , albeit at only 0.3 % efficiency .	T13	T57	15736931
NA	CHEMICAL	GENE-Y	37	13	Mutation of chemical 228 to chemical enhances the gene activity of gene . gene ( gene ) normally transfers chemical from chemical to chemical in the presence of chemical ion ( chemical-T activity ) and also transfers chemical from chemical to chemical ( chemical-T activity ) , albeit at only 0.3 % efficiency .	T13	T38	15736931
NA	CHEMICAL	GENE-Y	37	15	Mutation of chemical 228 to chemical enhances the gene activity of gene . gene ( gene ) normally transfers chemical from chemical to chemical in the presence of chemical ion ( chemical-T activity ) and also transfers chemical from chemical to chemical ( chemical-T activity ) , albeit at only 0.3 % efficiency .	T13	T49	15736931
NA	CHEMICAL	GENE-N	39	8	Mutation of chemical 228 to chemical enhances the gene activity of gene . gene ( gene ) normally transfers chemical from chemical to chemical in the presence of chemical ion ( chemical-T activity ) and also transfers chemical from chemical to chemical ( chemical-T activity ) , albeit at only 0.3 % efficiency .	T15	T56	15736931
NA	CHEMICAL	GENE-Y	39	11	Mutation of chemical 228 to chemical enhances the gene activity of gene . gene ( gene ) normally transfers chemical from chemical to chemical in the presence of chemical ion ( chemical-T activity ) and also transfers chemical from chemical to chemical ( chemical-T activity ) , albeit at only 0.3 % efficiency .	T15	T57	15736931
NA	CHEMICAL	GENE-Y	39	13	Mutation of chemical 228 to chemical enhances the gene activity of gene . gene ( gene ) normally transfers chemical from chemical to chemical in the presence of chemical ion ( chemical-T activity ) and also transfers chemical from chemical to chemical ( chemical-T activity ) , albeit at only 0.3 % efficiency .	T15	T38	15736931
NA	CHEMICAL	GENE-Y	39	15	Mutation of chemical 228 to chemical enhances the gene activity of gene . gene ( gene ) normally transfers chemical from chemical to chemical in the presence of chemical ion ( chemical-T activity ) and also transfers chemical from chemical to chemical ( chemical-T activity ) , albeit at only 0.3 % efficiency .	T15	T49	15736931
NA	CHEMICAL	GENE-N	41	8	Mutation of chemical 228 to chemical enhances the gene activity of gene . gene ( gene ) normally transfers chemical from chemical to chemical in the presence of chemical ion ( chemical-T activity ) and also transfers chemical from chemical to chemical ( chemical-T activity ) , albeit at only 0.3 % efficiency .	T16	T56	15736931
NA	CHEMICAL	GENE-Y	41	11	Mutation of chemical 228 to chemical enhances the gene activity of gene . gene ( gene ) normally transfers chemical from chemical to chemical in the presence of chemical ion ( chemical-T activity ) and also transfers chemical from chemical to chemical ( chemical-T activity ) , albeit at only 0.3 % efficiency .	T16	T57	15736931
NA	CHEMICAL	GENE-Y	41	13	Mutation of chemical 228 to chemical enhances the gene activity of gene . gene ( gene ) normally transfers chemical from chemical to chemical in the presence of chemical ion ( chemical-T activity ) and also transfers chemical from chemical to chemical ( chemical-T activity ) , albeit at only 0.3 % efficiency .	T16	T38	15736931
NA	CHEMICAL	GENE-Y	41	15	Mutation of chemical 228 to chemical enhances the gene activity of gene . gene ( gene ) normally transfers chemical from chemical to chemical in the presence of chemical ion ( chemical-T activity ) and also transfers chemical from chemical to chemical ( chemical-T activity ) , albeit at only 0.3 % efficiency .	T16	T49	15736931
NA	CHEMICAL	GENE-N	43	8	Mutation of chemical 228 to chemical enhances the gene activity of gene . gene ( gene ) normally transfers chemical from chemical to chemical in the presence of chemical ion ( chemical-T activity ) and also transfers chemical from chemical to chemical ( chemical-T activity ) , albeit at only 0.3 % efficiency .	T17	T56	15736931
NA	CHEMICAL	GENE-Y	43	11	Mutation of chemical 228 to chemical enhances the gene activity of gene . gene ( gene ) normally transfers chemical from chemical to chemical in the presence of chemical ion ( chemical-T activity ) and also transfers chemical from chemical to chemical ( chemical-T activity ) , albeit at only 0.3 % efficiency .	T17	T57	15736931
NA	CHEMICAL	GENE-Y	43	13	Mutation of chemical 228 to chemical enhances the gene activity of gene . gene ( gene ) normally transfers chemical from chemical to chemical in the presence of chemical ion ( chemical-T activity ) and also transfers chemical from chemical to chemical ( chemical-T activity ) , albeit at only 0.3 % efficiency .	T17	T38	15736931
NA	CHEMICAL	GENE-Y	43	15	Mutation of chemical 228 to chemical enhances the gene activity of gene . gene ( gene ) normally transfers chemical from chemical to chemical in the presence of chemical ion ( chemical-T activity ) and also transfers chemical from chemical to chemical ( chemical-T activity ) , albeit at only 0.3 % efficiency .	T17	T49	15736931
NA	CHEMICAL	GENE-Y	9	3	In addition , gene ( gene ) enhances this chemical-T activity more than 25 times .	T18	T46	15736931
NA	CHEMICAL	GENE-Y	9	5	In addition , gene ( gene ) enhances this chemical-T activity more than 25 times .	T18	T47	15736931
NA	CHEMICAL	GENE-Y	6	9	Comparison of the crystal structures of chemical- and chemical-bound gene reveals that the chemical group in both chemical and chemical moieties forms a chemical bond with the side chain chemical group of Glu317 .	T19	T50	15736931
NA	CHEMICAL	GENE-Y	8	9	Comparison of the crystal structures of chemical- and chemical-bound gene reveals that the chemical group in both chemical and chemical moieties forms a chemical bond with the side chain chemical group of Glu317 .	T20	T50	15736931
NA	CHEMICAL	GENE-Y	13	9	Comparison of the crystal structures of chemical- and chemical-bound gene reveals that the chemical group in both chemical and chemical moieties forms a chemical bond with the side chain chemical group of Glu317 .	T21	T50	15736931
NA	CHEMICAL	GENE-Y	17	9	Comparison of the crystal structures of chemical- and chemical-bound gene reveals that the chemical group in both chemical and chemical moieties forms a chemical bond with the side chain chemical group of Glu317 .	T22	T50	15736931
NA	CHEMICAL	GENE-Y	19	9	Comparison of the crystal structures of chemical- and chemical-bound gene reveals that the chemical group in both chemical and chemical moieties forms a chemical bond with the side chain chemical group of Glu317 .	T23	T50	15736931
NA	CHEMICAL	GENE-Y	23	9	Comparison of the crystal structures of chemical- and chemical-bound gene reveals that the chemical group in both chemical and chemical moieties forms a chemical bond with the side chain chemical group of Glu317 .	T24	T50	15736931
NA	CHEMICAL	GENE-Y	22	9	Comparison of the crystal structures of chemical- and chemical-bound gene reveals that the chemical group in both chemical and chemical moieties forms a chemical bond with the side chain chemical group of Glu317 .	T25	T50	15736931
NA	CHEMICAL	GENE-N	13	22	In this study , we show that mutation of Arg228 , a residue in the vicinity of Glu317 , to chemical ( gene-chemical-T1 ) results in a 15-fold higher chemical-T activity , which is further enhanced by LA to nearly 25 % of the chemical-T activity of the wild type .	T31	T52	15736931
NA	CHEMICAL	GENE-N	13	11	In this study , we show that mutation of Arg228 , a residue in the vicinity of Glu317 , to chemical ( gene-chemical-T1 ) results in a 15-fold higher chemical-T activity , which is further enhanced by LA to nearly 25 % of the chemical-T activity of the wild type .	T31	T53	15736931
NA	CHEMICAL	GENE-N	13	11	In this study , we show that mutation of Arg228 , a residue in the vicinity of Glu317 , to chemical ( gene-chemical-T1 ) results in a 15-fold higher chemical-T activity , which is further enhanced by LA to nearly 25 % of the chemical-T activity of the wild type .	T31	T55	15736931
NA	CHEMICAL	GENE-N	11	22	In this study , we show that mutation of Arg228 , a residue in the vicinity of Glu317 , to chemical ( gene-chemical-T1 ) results in a 15-fold higher chemical-T activity , which is further enhanced by LA to nearly 25 % of the chemical-T activity of the wild type .	T32	T52	15736931
NA	CHEMICAL	GENE-N	11	11	In this study , we show that mutation of Arg228 , a residue in the vicinity of Glu317 , to chemical ( gene-chemical-T1 ) results in a 15-fold higher chemical-T activity , which is further enhanced by LA to nearly 25 % of the chemical-T activity of the wild type .	T32	T53	15736931
NA	CHEMICAL	GENE-N	11	11	In this study , we show that mutation of Arg228 , a residue in the vicinity of Glu317 , to chemical ( gene-chemical-T1 ) results in a 15-fold higher chemical-T activity , which is further enhanced by LA to nearly 25 % of the chemical-T activity of the wild type .	T32	T55	15736931
NA	CHEMICAL	GENE-N	29	22	In this study , we show that mutation of Arg228 , a residue in the vicinity of Glu317 , to chemical ( gene-chemical-T1 ) results in a 15-fold higher chemical-T activity , which is further enhanced by LA to nearly 25 % of the chemical-T activity of the wild type .	T33	T52	15736931
NA	CHEMICAL	GENE-N	29	11	In this study , we show that mutation of Arg228 , a residue in the vicinity of Glu317 , to chemical ( gene-chemical-T1 ) results in a 15-fold higher chemical-T activity , which is further enhanced by LA to nearly 25 % of the chemical-T activity of the wild type .	T33	T53	15736931
NA	CHEMICAL	GENE-N	29	11	In this study , we show that mutation of Arg228 , a residue in the vicinity of Glu317 , to chemical ( gene-chemical-T1 ) results in a 15-fold higher chemical-T activity , which is further enhanced by LA to nearly 25 % of the chemical-T activity of the wild type .	T33	T55	15736931
NA	CHEMICAL	GENE-N	11	22	In this study , we show that mutation of Arg228 , a residue in the vicinity of Glu317 , to chemical ( gene-chemical-T1 ) results in a 15-fold higher chemical-T activity , which is further enhanced by LA to nearly 25 % of the chemical-T activity of the wild type .	T35	T52	15736931
NA	CHEMICAL	GENE-N	11	11	In this study , we show that mutation of Arg228 , a residue in the vicinity of Glu317 , to chemical ( gene-chemical-T1 ) results in a 15-fold higher chemical-T activity , which is further enhanced by LA to nearly 25 % of the chemical-T activity of the wild type .	T35	T53	15736931
NA	CHEMICAL	GENE-N	11	11	In this study , we show that mutation of Arg228 , a residue in the vicinity of Glu317 , to chemical ( gene-chemical-T1 ) results in a 15-fold higher chemical-T activity , which is further enhanced by LA to nearly 25 % of the chemical-T activity of the wild type .	T35	T55	15736931
NA	CHEMICAL	GENE-N	4	4	The crystal structure of gene-chemical-T1 complexed with LA , chemical , and chemical determined at 1.9 A resolution shows that the Asp318 side chain exhibits a minor alternate conformation , compared to that in the wild type .	T5	T41	15736931
NA	CHEMICAL	GENE-N	4	25	The crystal structure of gene-chemical-T1 complexed with LA , chemical , and chemical determined at 1.9 A resolution shows that the Asp318 side chain exhibits a minor alternate conformation , compared to that in the wild type .	T5	T42	15736931
NA	CHEMICAL	GENE-N	9	4	The crystal structure of gene-chemical-T1 complexed with LA , chemical , and chemical determined at 1.9 A resolution shows that the Asp318 side chain exhibits a minor alternate conformation , compared to that in the wild type .	T7	T41	15736931
NA	CHEMICAL	GENE-N	9	25	The crystal structure of gene-chemical-T1 complexed with LA , chemical , and chemical determined at 1.9 A resolution shows that the Asp318 side chain exhibits a minor alternate conformation , compared to that in the wild type .	T7	T42	15736931
NA	CHEMICAL	GENE-N	12	4	The crystal structure of gene-chemical-T1 complexed with LA , chemical , and chemical determined at 1.9 A resolution shows that the Asp318 side chain exhibits a minor alternate conformation , compared to that in the wild type .	T8	T41	15736931
NA	CHEMICAL	GENE-N	12	25	The crystal structure of gene-chemical-T1 complexed with LA , chemical , and chemical determined at 1.9 A resolution shows that the Asp318 side chain exhibits a minor alternate conformation , compared to that in the wild type .	T8	T42	15736931
CPR:4	CHEMICAL	GENE-N	1	5	State-dependent chemical block of chemical channels .	T17	T34	15562257
NA	CHEMICAL	GENE-N	4	5	State-dependent chemical block of chemical channels .	T18	T34	15562257
CPR:6	CHEMICAL	GENE-N	0	2	chemical is a gene antagonist with reported cross-reactivity with other classes of ion channels , including chemical , chemical , and chemical channels .	T1	T24	15562257
NA	CHEMICAL	GENE-N	0	2	chemical is a gene antagonist with reported cross-reactivity with other classes of ion channels , including chemical , chemical , and chemical channels .	T1	T20	15562257
NA	CHEMICAL	GENE-N	2	2	chemical is a gene antagonist with reported cross-reactivity with other classes of ion channels , including chemical , chemical , and chemical channels .	T12	T24	15562257
NA	CHEMICAL	GENE-N	2	2	chemical is a gene antagonist with reported cross-reactivity with other classes of ion channels , including chemical , chemical , and chemical channels .	T12	T20	15562257
NA	CHEMICAL	GENE-N	16	2	chemical is a gene antagonist with reported cross-reactivity with other classes of ion channels , including chemical , chemical , and chemical channels .	T4	T24	15562257
NA	CHEMICAL	GENE-N	16	2	chemical is a gene antagonist with reported cross-reactivity with other classes of ion channels , including chemical , chemical , and chemical channels .	T4	T20	15562257
NA	CHEMICAL	GENE-N	18	2	chemical is a gene antagonist with reported cross-reactivity with other classes of ion channels , including chemical , chemical , and chemical channels .	T5	T24	15562257
NA	CHEMICAL	GENE-N	18	2	chemical is a gene antagonist with reported cross-reactivity with other classes of ion channels , including chemical , chemical , and chemical channels .	T5	T20	15562257
NA	CHEMICAL	GENE-N	2	2	chemical is a gene antagonist with reported cross-reactivity with other classes of ion channels , including chemical , chemical , and chemical channels .	T6	T24	15562257
NA	CHEMICAL	GENE-N	2	2	chemical is a gene antagonist with reported cross-reactivity with other classes of ion channels , including chemical , chemical , and chemical channels .	T6	T20	15562257
CPR:4	CHEMICAL	GENE-N	7	12	Using whole-cell voltage clamp , we examined chemical block of four chemical channel isoforms expressed in human embryonic kidney cells : gene ( cardiac ) , gene ( skeletal muscle ) , gene ( brain ) , and gene ( peripheral nerve ) .	T10	T25	15562257
CPR:4	CHEMICAL	GENE-Y	7	21	Using whole-cell voltage clamp , we examined chemical block of four chemical channel isoforms expressed in human embryonic kidney cells : gene ( cardiac ) , gene ( skeletal muscle ) , gene ( brain ) , and gene ( peripheral nerve ) .	T10	T26	15562257
CPR:4	CHEMICAL	GENE-Y	7	26	Using whole-cell voltage clamp , we examined chemical block of four chemical channel isoforms expressed in human embryonic kidney cells : gene ( cardiac ) , gene ( skeletal muscle ) , gene ( brain ) , and gene ( peripheral nerve ) .	T10	T27	15562257
CPR:4	CHEMICAL	GENE-Y	7	32	Using whole-cell voltage clamp , we examined chemical block of four chemical channel isoforms expressed in human embryonic kidney cells : gene ( cardiac ) , gene ( skeletal muscle ) , gene ( brain ) , and gene ( peripheral nerve ) .	T10	T28	15562257
CPR:4	CHEMICAL	GENE-Y	7	38	Using whole-cell voltage clamp , we examined chemical block of four chemical channel isoforms expressed in human embryonic kidney cells : gene ( cardiac ) , gene ( skeletal muscle ) , gene ( brain ) , and gene ( peripheral nerve ) .	T10	T29	15562257
NA	CHEMICAL	GENE-N	11	12	Using whole-cell voltage clamp , we examined chemical block of four chemical channel isoforms expressed in human embryonic kidney cells : gene ( cardiac ) , gene ( skeletal muscle ) , gene ( brain ) , and gene ( peripheral nerve ) .	T11	T25	15562257
NA	CHEMICAL	GENE-Y	11	21	Using whole-cell voltage clamp , we examined chemical block of four chemical channel isoforms expressed in human embryonic kidney cells : gene ( cardiac ) , gene ( skeletal muscle ) , gene ( brain ) , and gene ( peripheral nerve ) .	T11	T26	15562257
NA	CHEMICAL	GENE-Y	11	26	Using whole-cell voltage clamp , we examined chemical block of four chemical channel isoforms expressed in human embryonic kidney cells : gene ( cardiac ) , gene ( skeletal muscle ) , gene ( brain ) , and gene ( peripheral nerve ) .	T11	T27	15562257
NA	CHEMICAL	GENE-Y	11	32	Using whole-cell voltage clamp , we examined chemical block of four chemical channel isoforms expressed in human embryonic kidney cells : gene ( cardiac ) , gene ( skeletal muscle ) , gene ( brain ) , and gene ( peripheral nerve ) .	T11	T28	15562257
NA	CHEMICAL	GENE-Y	11	38	Using whole-cell voltage clamp , we examined chemical block of four chemical channel isoforms expressed in human embryonic kidney cells : gene ( cardiac ) , gene ( skeletal muscle ) , gene ( brain ) , and gene ( peripheral nerve ) .	T11	T29	15562257
CPR:4	CHEMICAL	GENE-Y	0	2	chemical blocked gene in a use/frequency-dependent manner , indicating preferential binding to states visited during depolarization .	T13	T30	15562257
CPR:4	CHEMICAL	GENE-N	0	6	chemical blocked currents of all chemical channel isoforms with similar affinity and a dependence on holding potential , and drug off-rate was slowed at depolarized potentials ( k ( off ) was 0.024/s at -130 mV and 0.007/s at -100 mV for gene ) .	T14	T31	15562257
CPR:4	CHEMICAL	GENE-Y	0	12	chemical blocked currents of all chemical channel isoforms with similar affinity and a dependence on holding potential , and drug off-rate was slowed at depolarized potentials ( k ( off ) was 0.024/s at -130 mV and 0.007/s at -100 mV for gene ) .	T14	T32	15562257
NA	CHEMICAL	GENE-N	5	6	chemical blocked currents of all chemical channel isoforms with similar affinity and a dependence on holding potential , and drug off-rate was slowed at depolarized potentials ( k ( off ) was 0.024/s at -130 mV and 0.007/s at -100 mV for gene ) .	T15	T31	15562257
NA	CHEMICAL	GENE-Y	5	12	chemical blocked currents of all chemical channel isoforms with similar affinity and a dependence on holding potential , and drug off-rate was slowed at depolarized potentials ( k ( off ) was 0.024/s at -130 mV and 0.007/s at -100 mV for gene ) .	T15	T32	15562257
NA	CHEMICAL	GENE-Y	6	9	We further probed the interaction of chemical with inactivated gene channels .	T16	T33	15562257
CPR:4	CHEMICAL	GENE-Y	20	12	In addition , inhibiting the binding of the fast inactivation lid ( gene ICM + MTSET ) did not alter chemical block , confirming that the drug does not preferentially interact with the fast-inactivated state .	T2	T19	15562257
CPR:4	CHEMICAL	GENE-Y	10	10	When selectively applied to channels after inducing slow inactivation with a 60-s pulse to -10 mV , chemical ( 1 microM ) produced 45 % fractional block in gene and greater block ( 88 % ) in an isoform ( gene ) that slow-inactivates more completely .	T7	T21	15562257
CPR:4	CHEMICAL	GENE-Y	10	10	When selectively applied to channels after inducing slow inactivation with a 60-s pulse to -10 mV , chemical ( 1 microM ) produced 45 % fractional block in gene and greater block ( 88 % ) in an isoform ( gene ) that slow-inactivates more completely .	T7	T22	15562257
NA	CHEMICAL	GENE-Y	2	12	Roles of chemical in drug-drug interactions : underlying molecular mechanisms involving the gene .	T8	T15	16480505
CPR:9	CHEMICAL	GENE-N	5	21	The concomitantly administered effects of chemical on other drugs can result in their altered metabolism or transportation that are metabolised by gene or transported by gene in the gastrointestinal tract and liver .	T2	T9	16480505
CPR:9	CHEMICAL	GENE-N	5	11	The concomitantly administered effects of chemical on other drugs can result in their altered metabolism or transportation that are metabolised by gene or transported by gene in the gastrointestinal tract and liver .	T2	T10	16480505
CPR:5	CHEMICAL	GENE-Y	3	13	In general , chemical can act on a pattern : chemical activates the gene that in turn affects gene , gene and gene activities .	T3	T11	16480505
NA	CHEMICAL	GENE-N	3	18	In general , chemical can act on a pattern : chemical activates the gene that in turn affects gene , gene and gene activities .	T3	T12	16480505
NA	CHEMICAL	GENE-N	3	6	In general , chemical can act on a pattern : chemical activates the gene that in turn affects gene , gene and gene activities .	T3	T13	16480505
NA	CHEMICAL	GENE-N	3	15	In general , chemical can act on a pattern : chemical activates the gene that in turn affects gene , gene and gene activities .	T3	T14	16480505
CPR:3	CHEMICAL	GENE-Y	7	13	In general , chemical can act on a pattern : chemical activates the gene that in turn affects gene , gene and gene activities .	T4	T11	16480505
NA	CHEMICAL	GENE-N	7	18	In general , chemical can act on a pattern : chemical activates the gene that in turn affects gene , gene and gene activities .	T4	T12	16480505
NA	CHEMICAL	GENE-N	7	6	In general , chemical can act on a pattern : chemical activates the gene that in turn affects gene , gene and gene activities .	T4	T13	16480505
NA	CHEMICAL	GENE-N	7	15	In general , chemical can act on a pattern : chemical activates the gene that in turn affects gene , gene and gene activities .	T4	T14	16480505
NA	CHEMICAL	GENE-Y	7	13	In general , chemical can act on a pattern : chemical activates the gene that in turn affects gene , gene and gene activities .	T5	T11	16480505
NA	CHEMICAL	GENE-N	7	18	In general , chemical can act on a pattern : chemical activates the gene that in turn affects gene , gene and gene activities .	T5	T12	16480505
NA	CHEMICAL	GENE-N	7	6	In general , chemical can act on a pattern : chemical activates the gene that in turn affects gene , gene and gene activities .	T5	T13	16480505
NA	CHEMICAL	GENE-N	7	15	In general , chemical can act on a pattern : chemical activates the gene that in turn affects gene , gene and gene activities .	T5	T14	16480505
CPR:4	CHEMICAL	GENE-Y	0	11	chemical ( chemical ) , is a naturally occurring potent reversible gene inhibitor that penetrates the blood-brain barrier .	T15	T24	23123250
CPR:4	CHEMICAL	GENE-Y	2	11	chemical ( chemical ) , is a naturally occurring potent reversible gene inhibitor that penetrates the blood-brain barrier .	T16	T24	23123250
CPR:4	CHEMICAL	GENE-Y	4	12	The synthetic stereoisomer , chemical , is less toxic due to poor gene inhibition and is suitable for both pre-/post-exposure treatments of nerve agent toxicity .	T18	T27	23123250
NA	CHEMICAL	GENE-Y	10	8	Induction of the liver cancer-down-regulated long noncoding RNA gene mediates chemical-induced apoptosis of liver cancer cells .	T10	T19	23643933
CPR:4	CHEMICAL	GENE-N	12	9	Considerable attention has focused on the antitumor effect of gene inhibitor ( chemical , chemical ) as well as the coding gene expression-induced apoptosis of cancer cells .	T7	T17	23643933
CPR:4	CHEMICAL	GENE-N	14	9	Considerable attention has focused on the antitumor effect of gene inhibitor ( chemical , chemical ) as well as the coding gene expression-induced apoptosis of cancer cells .	T8	T17	23643933
CPR:3	CHEMICAL	GENE-Y	12	12	Among these differentially expressed lncRNAs , the greatest change was noted for gene , which had more than 300 folds induction upon chemical treatment .	T1	T18	23643933
CPR:3	CHEMICAL	GENE-Y	0	3	chemical selectively induced gene in four studied HCC cell lines .	T2	T11	23643933
CPR:3	CHEMICAL	GENE-Y	1	2	The chemical-induced gene expression was positively correlated with the apoptotic effect of chemical in HCC cells .	T3	T13	23643933
NA	CHEMICAL	GENE-Y	12	2	The chemical-induced gene expression was positively correlated with the apoptotic effect of chemical in HCC cells .	T4	T13	23643933
NA	CHEMICAL	GENE-Y	10	7	In addition , knockdown the expression of gene significantly reduced chemical-induced apoptosis of Huh7cells .	T5	T14	23643933
NA	CHEMICAL	GENE-N	2	8	Success of chemical , chemical , chemical and gene treatments in acute chemical intoxication .	T35	T54	10403635
NA	CHEMICAL	GENE-N	4	8	Success of chemical , chemical , chemical and gene treatments in acute chemical intoxication .	T36	T54	10403635
NA	CHEMICAL	GENE-N	6	8	Success of chemical , chemical , chemical and gene treatments in acute chemical intoxication .	T37	T54	10403635
NA	CHEMICAL	GENE-N	10	8	Success of chemical , chemical , chemical and gene treatments in acute chemical intoxication .	T38	T54	10403635
CPR:4	CHEMICAL	GENE-N	4	9	The acute toxicity of chemical ( OP ) compounds in mammals is due to their irreversible inhibition of gene ( gene ) in the nervous system , which leads to increased synaptic chemical levels .	T20	T40	10403635
CPR:4	CHEMICAL	GENE-N	4	20	The acute toxicity of chemical ( OP ) compounds in mammals is due to their irreversible inhibition of gene ( gene ) in the nervous system , which leads to increased synaptic chemical levels .	T20	T42	10403635
CPR:9	CHEMICAL	GENE-N	9	9	The acute toxicity of chemical ( OP ) compounds in mammals is due to their irreversible inhibition of gene ( gene ) in the nervous system , which leads to increased synaptic chemical levels .	T16	T40	10403635
CPR:9	CHEMICAL	GENE-N	9	20	The acute toxicity of chemical ( OP ) compounds in mammals is due to their irreversible inhibition of gene ( gene ) in the nervous system , which leads to increased synaptic chemical levels .	T16	T42	10403635
NA	CHEMICAL	GENE-N	1	10	administered chemical , chemical , chemical , and an chemical hydrolase , gene , in acute chemical intoxication were studied in mice .	T21	T49	10403635
NA	CHEMICAL	GENE-N	1	12	administered chemical , chemical , chemical , and an chemical hydrolase , gene , in acute chemical intoxication were studied in mice .	T21	T50	10403635
NA	CHEMICAL	GENE-N	3	10	administered chemical , chemical , chemical , and an chemical hydrolase , gene , in acute chemical intoxication were studied in mice .	T22	T49	10403635
NA	CHEMICAL	GENE-N	3	12	administered chemical , chemical , chemical , and an chemical hydrolase , gene , in acute chemical intoxication were studied in mice .	T22	T50	10403635
NA	CHEMICAL	GENE-N	5	10	administered chemical , chemical , chemical , and an chemical hydrolase , gene , in acute chemical intoxication were studied in mice .	T23	T49	10403635
NA	CHEMICAL	GENE-N	5	12	administered chemical , chemical , chemical , and an chemical hydrolase , gene , in acute chemical intoxication were studied in mice .	T23	T50	10403635
NA	CHEMICAL	GENE-N	8	10	administered chemical , chemical , chemical , and an chemical hydrolase , gene , in acute chemical intoxication were studied in mice .	T24	T49	10403635
NA	CHEMICAL	GENE-N	8	12	administered chemical , chemical , chemical , and an chemical hydrolase , gene , in acute chemical intoxication were studied in mice .	T24	T50	10403635
NA	CHEMICAL	GENE-N	14	10	administered chemical , chemical , chemical , and an chemical hydrolase , gene , in acute chemical intoxication were studied in mice .	T25	T49	10403635
NA	CHEMICAL	GENE-N	14	12	administered chemical , chemical , chemical , and an chemical hydrolase , gene , in acute chemical intoxication were studied in mice .	T25	T50	10403635
NA	CHEMICAL	GENE-N	3	30	The mice received chemical ( 0.06 mg/kg body weight ) , chemical ( 0.09 mg/kg body weight ) , the chemical derivative chemical ( 0.90 mg/kg body weight ) or gene ( 104 U/g , 10.7 microg/g body weight ) 10 min prior to the i.g .	T27	T51	10403635
NA	CHEMICAL	GENE-N	11	30	The mice received chemical ( 0.06 mg/kg body weight ) , chemical ( 0.09 mg/kg body weight ) , the chemical derivative chemical ( 0.90 mg/kg body weight ) or gene ( 104 U/g , 10.7 microg/g body weight ) 10 min prior to the i.g .	T28	T51	10403635
NA	CHEMICAL	GENE-N	20	30	The mice received chemical ( 0.06 mg/kg body weight ) , chemical ( 0.09 mg/kg body weight ) , the chemical derivative chemical ( 0.90 mg/kg body weight ) or gene ( 104 U/g , 10.7 microg/g body weight ) 10 min prior to the i.g .	T29	T51	10403635
NA	CHEMICAL	GENE-N	22	30	The mice received chemical ( 0.06 mg/kg body weight ) , chemical ( 0.09 mg/kg body weight ) , the chemical derivative chemical ( 0.90 mg/kg body weight ) or gene ( 104 U/g , 10.7 microg/g body weight ) 10 min prior to the i.g .	T30	T51	10403635
NA	CHEMICAL	GENE-N	0	5	chemical was also administered with gene .	T32	T52	10403635
NA	CHEMICAL	GENE-N	6	0	gene was the most effective antidote in chemical intoxication .	T33	T53	10403635
NA	CHEMICAL	GENE-N	4	10	The LD50 value for chemical increased 3.4-fold in mice receiving gene .	T34	T39	10403635
NA	CHEMICAL	GENE-N	4	2	Both the gene and chemical treatments protected the brain gene activities measured 24 h after chemical exposure .	T8	T41	10403635
NA	CHEMICAL	GENE-Y	4	9	Both the gene and chemical treatments protected the brain gene activities measured 24 h after chemical exposure .	T8	T43	10403635
NA	CHEMICAL	GENE-N	15	2	Both the gene and chemical treatments protected the brain gene activities measured 24 h after chemical exposure .	T9	T41	10403635
NA	CHEMICAL	GENE-Y	15	9	Both the gene and chemical treatments protected the brain gene activities measured 24 h after chemical exposure .	T9	T43	10403635
NA	CHEMICAL	GENE-N	3	1	In gene and chemical-treated mice , a 4- and 2-fold higher chemical dose , respectively , was needed to cause a 50 % inhibition of brain gene activity .	T10	T44	10403635
NA	CHEMICAL	GENE-Y	3	26	In gene and chemical-treated mice , a 4- and 2-fold higher chemical dose , respectively , was needed to cause a 50 % inhibition of brain gene activity .	T10	T45	10403635
NA	CHEMICAL	GENE-N	6	1	In gene and chemical-treated mice , a 4- and 2-fold higher chemical dose , respectively , was needed to cause a 50 % inhibition of brain gene activity .	T11	T44	10403635
CPR:4	CHEMICAL	GENE-Y	6	26	In gene and chemical-treated mice , a 4- and 2-fold higher chemical dose , respectively , was needed to cause a 50 % inhibition of brain gene activity .	T11	T45	10403635
NA	CHEMICAL	GENE-N	5	5	Moreover , the combination of gene-chemical increased the LD50 value for chemical 4.3-fold .	T12	T46	10403635
NA	CHEMICAL	GENE-N	11	5	Moreover , the combination of gene-chemical increased the LD50 value for chemical 4.3-fold .	T13	T46	10403635
NA	CHEMICAL	GENE-N	4	4	The animals pretreated with gene-chemical tolerated four times the lethal dose in control animals , furthermore their survival time was 2-3 h in comparison to 20 min in controls .	T14	T47	10403635
NA	CHEMICAL	GENE-N	5	3	In conclusion , gene and chemical were the most effective treatments against chemical intoxication .	T15	T48	10403635
NA	CHEMICAL	GENE-N	12	3	In conclusion , gene and chemical were the most effective treatments against chemical intoxication .	T17	T48	10403635
NA	CHEMICAL	GENE-Y	21	23	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T11	T30	16441928
NA	CHEMICAL	GENE-Y	21	25	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T11	T31	16441928
NA	CHEMICAL	GENE-N	21	31	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T11	T32	16441928
NA	CHEMICAL	GENE-N	21	33	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T11	T33	16441928
NA	CHEMICAL	GENE-N	21	39	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T11	T34	16441928
NA	CHEMICAL	GENE-Y	21	41	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T11	T35	16441928
NA	CHEMICAL	GENE-N	21	53	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T11	T36	16441928
NA	CHEMICAL	GENE-Y	21	16	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T11	T37	16441928
NA	CHEMICAL	GENE-N	21	68	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T11	T38	16441928
NA	CHEMICAL	GENE-Y	21	70	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T11	T39	16441928
NA	CHEMICAL	GENE-Y	21	72	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T11	T40	16441928
NA	CHEMICAL	GENE-Y	33	23	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T12	T30	16441928
NA	CHEMICAL	GENE-Y	33	25	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T12	T31	16441928
NA	CHEMICAL	GENE-N	33	31	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T12	T32	16441928
NA	CHEMICAL	GENE-N	33	33	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T12	T33	16441928
NA	CHEMICAL	GENE-N	33	39	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T12	T34	16441928
NA	CHEMICAL	GENE-Y	33	41	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T12	T35	16441928
NA	CHEMICAL	GENE-N	33	53	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T12	T36	16441928
NA	CHEMICAL	GENE-Y	33	16	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T12	T37	16441928
NA	CHEMICAL	GENE-N	33	68	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T12	T38	16441928
NA	CHEMICAL	GENE-Y	33	70	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T12	T39	16441928
NA	CHEMICAL	GENE-Y	33	72	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T12	T40	16441928
NA	CHEMICAL	GENE-Y	35	23	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T13	T30	16441928
NA	CHEMICAL	GENE-Y	35	25	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T13	T31	16441928
NA	CHEMICAL	GENE-N	35	31	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T13	T32	16441928
NA	CHEMICAL	GENE-N	35	33	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T13	T33	16441928
NA	CHEMICAL	GENE-N	35	39	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T13	T34	16441928
NA	CHEMICAL	GENE-Y	35	41	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T13	T35	16441928
NA	CHEMICAL	GENE-N	35	53	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T13	T36	16441928
NA	CHEMICAL	GENE-Y	35	16	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T13	T37	16441928
NA	CHEMICAL	GENE-N	35	68	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T13	T38	16441928
NA	CHEMICAL	GENE-Y	35	70	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T13	T39	16441928
NA	CHEMICAL	GENE-Y	35	72	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T13	T40	16441928
NA	CHEMICAL	GENE-Y	46	23	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T14	T30	16441928
NA	CHEMICAL	GENE-Y	46	25	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T14	T31	16441928
NA	CHEMICAL	GENE-N	46	31	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T14	T32	16441928
NA	CHEMICAL	GENE-N	46	33	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T14	T33	16441928
NA	CHEMICAL	GENE-N	46	39	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T14	T34	16441928
NA	CHEMICAL	GENE-Y	46	41	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T14	T35	16441928
NA	CHEMICAL	GENE-N	46	53	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T14	T36	16441928
NA	CHEMICAL	GENE-Y	46	16	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T14	T37	16441928
NA	CHEMICAL	GENE-N	46	68	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T14	T38	16441928
NA	CHEMICAL	GENE-Y	46	70	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T14	T39	16441928
NA	CHEMICAL	GENE-Y	46	72	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T14	T40	16441928
NA	CHEMICAL	GENE-Y	48	23	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T15	T30	16441928
NA	CHEMICAL	GENE-Y	48	25	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T15	T31	16441928
NA	CHEMICAL	GENE-N	48	31	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T15	T32	16441928
NA	CHEMICAL	GENE-N	48	33	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T15	T33	16441928
NA	CHEMICAL	GENE-N	48	39	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T15	T34	16441928
NA	CHEMICAL	GENE-Y	48	41	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T15	T35	16441928
NA	CHEMICAL	GENE-N	48	53	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T15	T36	16441928
NA	CHEMICAL	GENE-Y	48	16	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T15	T37	16441928
NA	CHEMICAL	GENE-N	48	68	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T15	T38	16441928
NA	CHEMICAL	GENE-Y	48	70	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T15	T39	16441928
NA	CHEMICAL	GENE-Y	48	72	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T15	T40	16441928
NA	CHEMICAL	GENE-Y	50	23	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T16	T30	16441928
NA	CHEMICAL	GENE-Y	50	25	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T16	T31	16441928
NA	CHEMICAL	GENE-N	50	31	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T16	T32	16441928
NA	CHEMICAL	GENE-N	50	33	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T16	T33	16441928
NA	CHEMICAL	GENE-N	50	39	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T16	T34	16441928
NA	CHEMICAL	GENE-Y	50	41	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T16	T35	16441928
NA	CHEMICAL	GENE-N	50	53	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T16	T36	16441928
NA	CHEMICAL	GENE-Y	50	16	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T16	T37	16441928
NA	CHEMICAL	GENE-N	50	68	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T16	T38	16441928
NA	CHEMICAL	GENE-Y	50	70	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T16	T39	16441928
NA	CHEMICAL	GENE-Y	50	72	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T16	T40	16441928
NA	CHEMICAL	GENE-Y	52	23	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T17	T30	16441928
NA	CHEMICAL	GENE-Y	52	25	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T17	T31	16441928
NA	CHEMICAL	GENE-N	52	31	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T17	T32	16441928
NA	CHEMICAL	GENE-N	52	33	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T17	T33	16441928
NA	CHEMICAL	GENE-N	52	39	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T17	T34	16441928
NA	CHEMICAL	GENE-Y	52	41	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T17	T35	16441928
NA	CHEMICAL	GENE-N	52	53	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T17	T36	16441928
NA	CHEMICAL	GENE-Y	52	16	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T17	T37	16441928
NA	CHEMICAL	GENE-N	52	68	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T17	T38	16441928
NA	CHEMICAL	GENE-Y	52	70	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T17	T39	16441928
NA	CHEMICAL	GENE-Y	52	72	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T17	T40	16441928
NA	CHEMICAL	GENE-Y	55	23	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T18	T30	16441928
NA	CHEMICAL	GENE-Y	55	25	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T18	T31	16441928
NA	CHEMICAL	GENE-N	55	31	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T18	T32	16441928
NA	CHEMICAL	GENE-N	55	33	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T18	T33	16441928
NA	CHEMICAL	GENE-N	55	39	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T18	T34	16441928
NA	CHEMICAL	GENE-Y	55	41	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T18	T35	16441928
NA	CHEMICAL	GENE-N	55	53	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T18	T36	16441928
NA	CHEMICAL	GENE-Y	55	16	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T18	T37	16441928
NA	CHEMICAL	GENE-N	55	68	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T18	T38	16441928
NA	CHEMICAL	GENE-Y	55	70	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T18	T39	16441928
NA	CHEMICAL	GENE-Y	55	72	On days 0 and 35 , patients ' nutritional status was assessed by BMI , normalized protein catabolic rate , predialytic chemical , gene and gene ; lipid metabolism by plasma gene- and gene-chemical , chemical , phospholipids , gene and gene ; oxidative status by chemical , chemical , chemical , chemical peroxidase , chemical and advanced oxidized protein products ; inflammatory status by serum gene , gene , gene and gene .	T18	T40	16441928
NA	CHEMICAL	GENE-Y	20	20	Significant changes were observed from day 0 to day 35 ( P < 0.05 ) : nutritional criteria improved ( gene in OO ; gene , gene and chemical in SO ) ; gene-chemical , gene and gene ratio increased in both groups .	T1	T19	16441928
NA	CHEMICAL	GENE-Y	20	21	Significant changes were observed from day 0 to day 35 ( P < 0.05 ) : nutritional criteria improved ( gene in OO ; gene , gene and chemical in SO ) ; gene-chemical , gene and gene ratio increased in both groups .	T1	T20	16441928
NA	CHEMICAL	GENE-Y	20	21	Significant changes were observed from day 0 to day 35 ( P < 0.05 ) : nutritional criteria improved ( gene in OO ; gene , gene and chemical in SO ) ; gene-chemical , gene and gene ratio increased in both groups .	T1	T21	16441928
NA	CHEMICAL	GENE-N	20	33	Significant changes were observed from day 0 to day 35 ( P < 0.05 ) : nutritional criteria improved ( gene in OO ; gene , gene and chemical in SO ) ; gene-chemical , gene and gene ratio increased in both groups .	T1	T22	16441928
NA	CHEMICAL	GENE-N	20	35	Significant changes were observed from day 0 to day 35 ( P < 0.05 ) : nutritional criteria improved ( gene in OO ; gene , gene and chemical in SO ) ; gene-chemical , gene and gene ratio increased in both groups .	T1	T23	16441928
NA	CHEMICAL	GENE-N	20	37	Significant changes were observed from day 0 to day 35 ( P < 0.05 ) : nutritional criteria improved ( gene in OO ; gene , gene and chemical in SO ) ; gene-chemical , gene and gene ratio increased in both groups .	T1	T24	16441928
NA	CHEMICAL	GENE-Y	24	20	Significant changes were observed from day 0 to day 35 ( P < 0.05 ) : nutritional criteria improved ( gene in OO ; gene , gene and chemical in SO ) ; gene-chemical , gene and gene ratio increased in both groups .	T2	T19	16441928
NA	CHEMICAL	GENE-Y	24	21	Significant changes were observed from day 0 to day 35 ( P < 0.05 ) : nutritional criteria improved ( gene in OO ; gene , gene and chemical in SO ) ; gene-chemical , gene and gene ratio increased in both groups .	T2	T20	16441928
NA	CHEMICAL	GENE-Y	24	21	Significant changes were observed from day 0 to day 35 ( P < 0.05 ) : nutritional criteria improved ( gene in OO ; gene , gene and chemical in SO ) ; gene-chemical , gene and gene ratio increased in both groups .	T2	T21	16441928
NA	CHEMICAL	GENE-N	24	33	Significant changes were observed from day 0 to day 35 ( P < 0.05 ) : nutritional criteria improved ( gene in OO ; gene , gene and chemical in SO ) ; gene-chemical , gene and gene ratio increased in both groups .	T2	T22	16441928
NA	CHEMICAL	GENE-N	24	35	Significant changes were observed from day 0 to day 35 ( P < 0.05 ) : nutritional criteria improved ( gene in OO ; gene , gene and chemical in SO ) ; gene-chemical , gene and gene ratio increased in both groups .	T2	T23	16441928
NA	CHEMICAL	GENE-N	24	37	Significant changes were observed from day 0 to day 35 ( P < 0.05 ) : nutritional criteria improved ( gene in OO ; gene , gene and chemical in SO ) ; gene-chemical , gene and gene ratio increased in both groups .	T2	T24	16441928
NA	CHEMICAL	GENE-N	0	0	gene-chemical decreased in OO ; gene increased and gene decreased in SO ; chemical/chemical ratio increased in OO ; chemical decreased in both groups ; gene increased in both groups .	T3	T25	16441928
NA	CHEMICAL	GENE-Y	0	5	gene-chemical decreased in OO ; gene increased and gene decreased in SO ; chemical/chemical ratio increased in OO ; chemical decreased in both groups ; gene increased in both groups .	T3	T26	16441928
NA	CHEMICAL	GENE-Y	0	8	gene-chemical decreased in OO ; gene increased and gene decreased in SO ; chemical/chemical ratio increased in OO ; chemical decreased in both groups ; gene increased in both groups .	T3	T27	16441928
NA	CHEMICAL	GENE-Y	0	25	gene-chemical decreased in OO ; gene increased and gene decreased in SO ; chemical/chemical ratio increased in OO ; chemical decreased in both groups ; gene increased in both groups .	T3	T28	16441928
NA	CHEMICAL	GENE-N	13	0	gene-chemical decreased in OO ; gene increased and gene decreased in SO ; chemical/chemical ratio increased in OO ; chemical decreased in both groups ; gene increased in both groups .	T4	T25	16441928
NA	CHEMICAL	GENE-Y	13	5	gene-chemical decreased in OO ; gene increased and gene decreased in SO ; chemical/chemical ratio increased in OO ; chemical decreased in both groups ; gene increased in both groups .	T4	T26	16441928
NA	CHEMICAL	GENE-Y	13	8	gene-chemical decreased in OO ; gene increased and gene decreased in SO ; chemical/chemical ratio increased in OO ; chemical decreased in both groups ; gene increased in both groups .	T4	T27	16441928
NA	CHEMICAL	GENE-Y	13	25	gene-chemical decreased in OO ; gene increased and gene decreased in SO ; chemical/chemical ratio increased in OO ; chemical decreased in both groups ; gene increased in both groups .	T4	T28	16441928
NA	CHEMICAL	GENE-N	13	0	gene-chemical decreased in OO ; gene increased and gene decreased in SO ; chemical/chemical ratio increased in OO ; chemical decreased in both groups ; gene increased in both groups .	T5	T25	16441928
NA	CHEMICAL	GENE-Y	13	5	gene-chemical decreased in OO ; gene increased and gene decreased in SO ; chemical/chemical ratio increased in OO ; chemical decreased in both groups ; gene increased in both groups .	T5	T26	16441928
NA	CHEMICAL	GENE-Y	13	8	gene-chemical decreased in OO ; gene increased and gene decreased in SO ; chemical/chemical ratio increased in OO ; chemical decreased in both groups ; gene increased in both groups .	T5	T27	16441928
NA	CHEMICAL	GENE-Y	13	25	gene-chemical decreased in OO ; gene increased and gene decreased in SO ; chemical/chemical ratio increased in OO ; chemical decreased in both groups ; gene increased in both groups .	T5	T28	16441928
NA	CHEMICAL	GENE-N	19	0	gene-chemical decreased in OO ; gene increased and gene decreased in SO ; chemical/chemical ratio increased in OO ; chemical decreased in both groups ; gene increased in both groups .	T6	T25	16441928
NA	CHEMICAL	GENE-Y	19	5	gene-chemical decreased in OO ; gene increased and gene decreased in SO ; chemical/chemical ratio increased in OO ; chemical decreased in both groups ; gene increased in both groups .	T6	T26	16441928
NA	CHEMICAL	GENE-Y	19	8	gene-chemical decreased in OO ; gene increased and gene decreased in SO ; chemical/chemical ratio increased in OO ; chemical decreased in both groups ; gene increased in both groups .	T6	T27	16441928
NA	CHEMICAL	GENE-Y	19	25	gene-chemical decreased in OO ; gene increased and gene decreased in SO ; chemical/chemical ratio increased in OO ; chemical decreased in both groups ; gene increased in both groups .	T6	T28	16441928
CPR:4	CHEMICAL	GENE-Y	6	4	Pharmacological doses of the gene inhibitor chemical reduce albuminura in diabetes .	T2	T14	23557706
CPR:4	CHEMICAL	GENE-N	1	11	High chemical ( HG ) induces apoptosis of podocytes , inhibits gene activation , inactivates gene and activates gene .	T3	T16	23557706
CPR:4	CHEMICAL	GENE-Y	1	15	High chemical ( HG ) induces apoptosis of podocytes , inhibits gene activation , inactivates gene and activates gene .	T3	T17	23557706
CPR:3	CHEMICAL	GENE-Y	1	18	High chemical ( HG ) induces apoptosis of podocytes , inhibits gene activation , inactivates gene and activates gene .	T3	T18	23557706
NA	CHEMICAL	GENE-Y	10	6	HG also increases the levels of gene and gene and chemical oxidase activity .	T4	T19	23557706
NA	CHEMICAL	GENE-Y	10	8	HG also increases the levels of gene and gene and chemical oxidase activity .	T4	T20	23557706
NA	CHEMICAL	GENE-N	10	11	HG also increases the levels of gene and gene and chemical oxidase activity .	T4	T21	23557706
CPR:4	CHEMICAL	GENE-Y	6	2	Inhibition of gene by low dose chemical decreases HG-induced gene and gene , chemical oxidase activity and podocyte apoptosis .	T5	T22	23557706
CPR:4	CHEMICAL	GENE-Y	6	9	Inhibition of gene by low dose chemical decreases HG-induced gene and gene , chemical oxidase activity and podocyte apoptosis .	T5	T23	23557706
CPR:4	CHEMICAL	GENE-Y	6	11	Inhibition of gene by low dose chemical decreases HG-induced gene and gene , chemical oxidase activity and podocyte apoptosis .	T5	T24	23557706
CPR:4	CHEMICAL	GENE-N	6	14	Inhibition of gene by low dose chemical decreases HG-induced gene and gene , chemical oxidase activity and podocyte apoptosis .	T5	T25	23557706
NA	CHEMICAL	GENE-Y	13	2	Inhibition of gene by low dose chemical decreases HG-induced gene and gene , chemical oxidase activity and podocyte apoptosis .	T6	T22	23557706
NA	CHEMICAL	GENE-Y	13	9	Inhibition of gene by low dose chemical decreases HG-induced gene and gene , chemical oxidase activity and podocyte apoptosis .	T6	T23	23557706
NA	CHEMICAL	GENE-Y	13	11	Inhibition of gene by low dose chemical decreases HG-induced gene and gene , chemical oxidase activity and podocyte apoptosis .	T6	T24	23557706
NA	CHEMICAL	GENE-N	13	14	Inhibition of gene by low dose chemical decreases HG-induced gene and gene , chemical oxidase activity and podocyte apoptosis .	T6	T25	23557706
NA	CHEMICAL	GENE-N	27	15	In isolated glomeruli of OVE26 mice , there is similar decrease in the activation of gene and gene and activation of gene with increase in gene and chemical oxidase activity .	T7	T31	23557706
NA	CHEMICAL	GENE-Y	27	11	In isolated glomeruli of OVE26 mice , there is similar decrease in the activation of gene and gene and activation of gene with increase in gene and chemical oxidase activity .	T7	T32	23557706
NA	CHEMICAL	GENE-Y	27	21	In isolated glomeruli of OVE26 mice , there is similar decrease in the activation of gene and gene and activation of gene with increase in gene and chemical oxidase activity .	T7	T33	23557706
NA	CHEMICAL	GENE-Y	27	25	In isolated glomeruli of OVE26 mice , there is similar decrease in the activation of gene and gene and activation of gene with increase in gene and chemical oxidase activity .	T7	T34	23557706
NA	CHEMICAL	GENE-N	27	28	In isolated glomeruli of OVE26 mice , there is similar decrease in the activation of gene and gene and activation of gene with increase in gene and chemical oxidase activity .	T7	T35	23557706
CPR:4	CHEMICAL	GENE-Y	7	2	Inhibition of gene by small dose of chemical reduces podocyte apoptosis , attenuates glomerular injury and albuminuria .	T8	T36	23557706
NA	CHEMICAL	GENE-N	2	5	Optimization of chemical binding to gene : binding affinity dissection and incremental construction of a high-affinity analog of chemical .	T7	T13	18559268
NA	CHEMICAL	GENE-N	14	5	Optimization of chemical binding to gene : binding affinity dissection and incremental construction of a high-affinity analog of chemical .	T6	T13	18559268
NA	CHEMICAL	GENE-N	5	1	The gene binding affinities of a series of synthetic chemical have been measured with the aims of dissecting individual group contributions and obtaining a rationale for the design of novel compounds with the ability to overcome drug resistance .	T3	T8	18559268
NA	CHEMICAL	GENE-N	19	18	Insight into the structural basis for this improvement was gained with molecular modeling and NMR data obtained for gene-bound chemical .	T4	T9	18559268
NA	CHEMICAL	GENE-N	0	4	chemical with affinities for gene well above their affinities for gene are shown not to be affected by multidrug resistance .	T5	T10	18559268
NA	CHEMICAL	GENE-N	0	10	chemical with affinities for gene well above their affinities for gene are shown not to be affected by multidrug resistance .	T5	T11	18559268
NA	CHEMICAL	GENE-Y	4	16	A series of novel chemical were synthesized and evaluated for their anticancer effects involving induction of gene .	T1	T5	23567950
CPR:9	CHEMICAL	GENE-N	11	5	The discovery of an inducible gene whose apparent substrate preference is chemical indicates that chemical catabolism is more complex than that originally proposed .	T9	T14	12727196
NA	CHEMICAL	GENE-N	5	5	The discovery of an inducible gene whose apparent substrate preference is chemical indicates that chemical catabolism is more complex than that originally proposed .	T1	T14	12727196
NA	CHEMICAL	GENE-Y	16	15	To facilitate the study of this enzyme , the purification and characterization of the recombinant gene/gene chemical oxidase are reported .	T2	T11	12727196
NA	CHEMICAL	GENE-Y	16	15	To facilitate the study of this enzyme , the purification and characterization of the recombinant gene/gene chemical oxidase are reported .	T2	T12	12727196
NA	CHEMICAL	GENE-N	16	17	To facilitate the study of this enzyme , the purification and characterization of the recombinant gene/gene chemical oxidase are reported .	T2	T13	12727196
CPR:9	CHEMICAL	GENE-Y	4	1	Purified gene/gene oxidizes both chemical ( K ( m ) =1.6 microM ) and chemical ( K ( m ) =51 microM ) , but does not oxidize chemical .	T3	T15	12727196
CPR:9	CHEMICAL	GENE-Y	4	1	Purified gene/gene oxidizes both chemical ( K ( m ) =1.6 microM ) and chemical ( K ( m ) =51 microM ) , but does not oxidize chemical .	T3	T16	12727196
CPR:9	CHEMICAL	GENE-Y	5	1	Purified gene/gene oxidizes both chemical ( K ( m ) =1.6 microM ) and chemical ( K ( m ) =51 microM ) , but does not oxidize chemical .	T4	T15	12727196
CPR:9	CHEMICAL	GENE-Y	5	1	Purified gene/gene oxidizes both chemical ( K ( m ) =1.6 microM ) and chemical ( K ( m ) =51 microM ) , but does not oxidize chemical .	T4	T16	12727196
NA	CHEMICAL	GENE-Y	8	1	Purified gene/gene oxidizes both chemical ( K ( m ) =1.6 microM ) and chemical ( K ( m ) =51 microM ) , but does not oxidize chemical .	T5	T15	12727196
NA	CHEMICAL	GENE-Y	8	1	Purified gene/gene oxidizes both chemical ( K ( m ) =1.6 microM ) and chemical ( K ( m ) =51 microM ) , but does not oxidize chemical .	T5	T16	12727196
NA	CHEMICAL	GENE-Y	11	31	The purified human enzyme also does not oxidize eight representative antitumor chemical analogues ; however , specific oligamine analogues were found to be potent inhibitors of the oxidation of chemical by gene/gene .	T6	T17	12727196
NA	CHEMICAL	GENE-Y	11	31	The purified human enzyme also does not oxidize eight representative antitumor chemical analogues ; however , specific oligamine analogues were found to be potent inhibitors of the oxidation of chemical by gene/gene .	T6	T18	12727196
CPR:9	CHEMICAL	GENE-Y	29	31	The purified human enzyme also does not oxidize eight representative antitumor chemical analogues ; however , specific oligamine analogues were found to be potent inhibitors of the oxidation of chemical by gene/gene .	T7	T17	12727196
CPR:9	CHEMICAL	GENE-Y	29	31	The purified human enzyme also does not oxidize eight representative antitumor chemical analogues ; however , specific oligamine analogues were found to be potent inhibitors of the oxidation of chemical by gene/gene .	T7	T18	12727196
NA	CHEMICAL	GENE-N	4	2	Involvement of gene-sensitive gene in the hormonal inhibition of chemical-sensitive chemical currents in an gene-secreting cell line ( RINm5F ) .	T25	T55	1680855
NA	CHEMICAL	GENE-N	4	3	Involvement of gene-sensitive gene in the hormonal inhibition of chemical-sensitive chemical currents in an gene-secreting cell line ( RINm5F ) .	T25	T56	1680855
NA	CHEMICAL	GENE-Y	4	4	Involvement of gene-sensitive gene in the hormonal inhibition of chemical-sensitive chemical currents in an gene-secreting cell line ( RINm5F ) .	T25	T54	1680855
NA	CHEMICAL	GENE-N	10	2	Involvement of gene-sensitive gene in the hormonal inhibition of chemical-sensitive chemical currents in an gene-secreting cell line ( RINm5F ) .	T24	T55	1680855
NA	CHEMICAL	GENE-N	10	3	Involvement of gene-sensitive gene in the hormonal inhibition of chemical-sensitive chemical currents in an gene-secreting cell line ( RINm5F ) .	T24	T56	1680855
NA	CHEMICAL	GENE-Y	10	4	Involvement of gene-sensitive gene in the hormonal inhibition of chemical-sensitive chemical currents in an gene-secreting cell line ( RINm5F ) .	T24	T54	1680855
CPR:4	CHEMICAL	GENE-Y	0	2	chemical inhibits gene secretion via pertussis toxin-sensitive mechanisms .	T1	T45	1680855
NA	CHEMICAL	GENE-Y	2	8	Since voltage-dependent chemical currents play a key role in gene secretion , we examined whether chemical modulates voltage-dependent chemical currents of the rat insulinoma cell line , RINm5F .	T2	T35	1680855
NA	CHEMICAL	GENE-Y	5	8	Since voltage-dependent chemical currents play a key role in gene secretion , we examined whether chemical modulates voltage-dependent chemical currents of the rat insulinoma cell line , RINm5F .	T7	T35	1680855
NA	CHEMICAL	GENE-Y	5	8	Since voltage-dependent chemical currents play a key role in gene secretion , we examined whether chemical modulates voltage-dependent chemical currents of the rat insulinoma cell line , RINm5F .	T11	T35	1680855
NA	CHEMICAL	GENE-N	0	2	chemical via gene inhibited the chemical currents by about 50 % .	T14	T46	1680855
NA	CHEMICAL	GENE-N	5	2	chemical via gene inhibited the chemical currents by about 50 % .	T15	T46	1680855
CPR:4	CHEMICAL	GENE-Y	0	4	chemical which also inhibits gene secretion was less efficient ( inhibition by 20 % ) .	T16	T48	1680855
NA	CHEMICAL	GENE-N	4	28	The hormonal inhibition of chemical currents was not affected by intracellularly applied chemical but blocked by the intracellularly applied chemical analog chemical and by pretreatment of cells with gene .	T17	T49	1680855
NA	CHEMICAL	GENE-N	12	28	The hormonal inhibition of chemical currents was not affected by intracellularly applied chemical but blocked by the intracellularly applied chemical analog chemical and by pretreatment of cells with gene .	T18	T49	1680855
NA	CHEMICAL	GENE-N	19	28	The hormonal inhibition of chemical currents was not affected by intracellularly applied chemical but blocked by the intracellularly applied chemical analog chemical and by pretreatment of cells with gene .	T19	T49	1680855
NA	CHEMICAL	GENE-N	21	28	The hormonal inhibition of chemical currents was not affected by intracellularly applied chemical but blocked by the intracellularly applied chemical analog chemical and by pretreatment of cells with gene .	T20	T49	1680855
NA	CHEMICAL	GENE-Y	3	2	In contrast to chemical and gene , gene , another inhibitor of gene secretion , reduced chemical currents by about 40 % in a gene-insensitive manner .	T21	T50	1680855
NA	CHEMICAL	GENE-Y	3	7	In contrast to chemical and gene , gene , another inhibitor of gene secretion , reduced chemical currents by about 40 % in a gene-insensitive manner .	T21	T51	1680855
CPR:4	CHEMICAL	GENE-Y	3	12	In contrast to chemical and gene , gene , another inhibitor of gene secretion , reduced chemical currents by about 40 % in a gene-insensitive manner .	T21	T52	1680855
NA	CHEMICAL	GENE-N	3	2	In contrast to chemical and gene , gene , another inhibitor of gene secretion , reduced chemical currents by about 40 % in a gene-insensitive manner .	T21	T53	1680855
NA	CHEMICAL	GENE-Y	2	2	In contrast to chemical and gene , gene , another inhibitor of gene secretion , reduced chemical currents by about 40 % in a gene-insensitive manner .	T22	T50	1680855
NA	CHEMICAL	GENE-Y	2	7	In contrast to chemical and gene , gene , another inhibitor of gene secretion , reduced chemical currents by about 40 % in a gene-insensitive manner .	T22	T51	1680855
CPR:4	CHEMICAL	GENE-Y	2	12	In contrast to chemical and gene , gene , another inhibitor of gene secretion , reduced chemical currents by about 40 % in a gene-insensitive manner .	T22	T52	1680855
NA	CHEMICAL	GENE-N	2	2	In contrast to chemical and gene , gene , another inhibitor of gene secretion , reduced chemical currents by about 40 % in a gene-insensitive manner .	T22	T53	1680855
NA	CHEMICAL	GENE-Y	16	2	In contrast to chemical and gene , gene , another inhibitor of gene secretion , reduced chemical currents by about 40 % in a gene-insensitive manner .	T23	T50	1680855
NA	CHEMICAL	GENE-Y	16	7	In contrast to chemical and gene , gene , another inhibitor of gene secretion , reduced chemical currents by about 40 % in a gene-insensitive manner .	T23	T51	1680855
NA	CHEMICAL	GENE-Y	16	12	In contrast to chemical and gene , gene , another inhibitor of gene secretion , reduced chemical currents by about 40 % in a gene-insensitive manner .	T23	T52	1680855
NA	CHEMICAL	GENE-N	16	2	In contrast to chemical and gene , gene , another inhibitor of gene secretion , reduced chemical currents by about 40 % in a gene-insensitive manner .	T23	T53	1680855
NA	CHEMICAL	GENE-N	7	7	In membranes of control but not of gene-treated cells , chemical via gene stimulated incorporation of the photo-reactive chemical analog chemical into pertussis toxin substrates comigrating with the alpha-subunits of gene , gene , and the not further identified gene subtype .	T3	T33	1680855
NA	CHEMICAL	GENE-N	7	12	In membranes of control but not of gene-treated cells , chemical via gene stimulated incorporation of the photo-reactive chemical analog chemical into pertussis toxin substrates comigrating with the alpha-subunits of gene , gene , and the not further identified gene subtype .	T3	T34	1680855
NA	CHEMICAL	GENE-Y	7	30	In membranes of control but not of gene-treated cells , chemical via gene stimulated incorporation of the photo-reactive chemical analog chemical into pertussis toxin substrates comigrating with the alpha-subunits of gene , gene , and the not further identified gene subtype .	T3	T36	1680855
NA	CHEMICAL	GENE-Y	7	32	In membranes of control but not of gene-treated cells , chemical via gene stimulated incorporation of the photo-reactive chemical analog chemical into pertussis toxin substrates comigrating with the alpha-subunits of gene , gene , and the not further identified gene subtype .	T3	T37	1680855
NA	CHEMICAL	GENE-N	7	39	In membranes of control but not of gene-treated cells , chemical via gene stimulated incorporation of the photo-reactive chemical analog chemical into pertussis toxin substrates comigrating with the alpha-subunits of gene , gene , and the not further identified gene subtype .	T3	T38	1680855
NA	CHEMICAL	GENE-N	18	7	In membranes of control but not of gene-treated cells , chemical via gene stimulated incorporation of the photo-reactive chemical analog chemical into pertussis toxin substrates comigrating with the alpha-subunits of gene , gene , and the not further identified gene subtype .	T4	T33	1680855
NA	CHEMICAL	GENE-N	18	12	In membranes of control but not of gene-treated cells , chemical via gene stimulated incorporation of the photo-reactive chemical analog chemical into pertussis toxin substrates comigrating with the alpha-subunits of gene , gene , and the not further identified gene subtype .	T4	T34	1680855
NA	CHEMICAL	GENE-Y	18	30	In membranes of control but not of gene-treated cells , chemical via gene stimulated incorporation of the photo-reactive chemical analog chemical into pertussis toxin substrates comigrating with the alpha-subunits of gene , gene , and the not further identified gene subtype .	T4	T36	1680855
NA	CHEMICAL	GENE-Y	18	32	In membranes of control but not of gene-treated cells , chemical via gene stimulated incorporation of the photo-reactive chemical analog chemical into pertussis toxin substrates comigrating with the alpha-subunits of gene , gene , and the not further identified gene subtype .	T4	T37	1680855
NA	CHEMICAL	GENE-N	18	39	In membranes of control but not of gene-treated cells , chemical via gene stimulated incorporation of the photo-reactive chemical analog chemical into pertussis toxin substrates comigrating with the alpha-subunits of gene , gene , and the not further identified gene subtype .	T4	T38	1680855
NA	CHEMICAL	GENE-N	20	7	In membranes of control but not of gene-treated cells , chemical via gene stimulated incorporation of the photo-reactive chemical analog chemical into pertussis toxin substrates comigrating with the alpha-subunits of gene , gene , and the not further identified gene subtype .	T5	T33	1680855
NA	CHEMICAL	GENE-N	20	12	In membranes of control but not of gene-treated cells , chemical via gene stimulated incorporation of the photo-reactive chemical analog chemical into pertussis toxin substrates comigrating with the alpha-subunits of gene , gene , and the not further identified gene subtype .	T5	T34	1680855
NA	CHEMICAL	GENE-Y	20	30	In membranes of control but not of gene-treated cells , chemical via gene stimulated incorporation of the photo-reactive chemical analog chemical into pertussis toxin substrates comigrating with the alpha-subunits of gene , gene , and the not further identified gene subtype .	T5	T36	1680855
NA	CHEMICAL	GENE-Y	20	32	In membranes of control but not of gene-treated cells , chemical via gene stimulated incorporation of the photo-reactive chemical analog chemical into pertussis toxin substrates comigrating with the alpha-subunits of gene , gene , and the not further identified gene subtype .	T5	T37	1680855
NA	CHEMICAL	GENE-N	20	39	In membranes of control but not of gene-treated cells , chemical via gene stimulated incorporation of the photo-reactive chemical analog chemical into pertussis toxin substrates comigrating with the alpha-subunits of gene , gene , and the not further identified gene subtype .	T5	T38	1680855
NA	CHEMICAL	GENE-Y	0	3	chemical protects against gene induced sensitivity to oxidative stress in dopaminergic cells .	T12	T20	20624440
CPR:4	CHEMICAL	GENE-Y	0	11	chemical is a chemical and irreversible chemical oxidase ( MAO ) B inhibitor used for the treatment of Parkinson 's disease ( PD ) .	T1	T16	20624440
CPR:4	CHEMICAL	GENE-Y	2	11	chemical is a chemical and irreversible chemical oxidase ( MAO ) B inhibitor used for the treatment of Parkinson 's disease ( PD ) .	T6	T16	20624440
NA	CHEMICAL	GENE-Y	2	11	chemical is a chemical and irreversible chemical oxidase ( MAO ) B inhibitor used for the treatment of Parkinson 's disease ( PD ) .	T7	T16	20624440
NA	CHEMICAL	GENE-Y	3	3	We have used a combination of gene and free radical mediated toxicity in a dopaminergic cell line to provide a model of nigral toxicity in order to investigate the potential molecular mechanisms that mediate chemical protection .	T8	T15	20624440
NA	CHEMICAL	GENE-N	3	22	We demonstrate that chemical protects against cell death induced by the combination of free radicals generated by chemical and either wild-type or gene mutant gene over-expression .	T9	T17	20624440
NA	CHEMICAL	GENE-Y	3	24	We demonstrate that chemical protects against cell death induced by the combination of free radicals generated by chemical and either wild-type or gene mutant gene over-expression .	T9	T18	20624440
NA	CHEMICAL	GENE-N	17	22	We demonstrate that chemical protects against cell death induced by the combination of free radicals generated by chemical and either wild-type or gene mutant gene over-expression .	T10	T17	20624440
NA	CHEMICAL	GENE-Y	17	24	We demonstrate that chemical protects against cell death induced by the combination of free radicals generated by chemical and either wild-type or gene mutant gene over-expression .	T10	T18	20624440
NA	CHEMICAL	GENE-Y	14	8	This protection was associated with a reduction in gene activation , a reduction in chemical generation and a trend to ameliorate the fall in mitochondrial membrane potential .	T11	T19	20624440
NA	CHEMICAL	GENE-Y	3	3	The results support a role for chemical in protecting dopaminergic cells against free radical mediated damage and apoptosis in the presence of gene over-expression .	T4	T13	20624440
NA	CHEMICAL	GENE-Y	1	4	Although chemical chemical-transferase omega 1 ( gene ) and chemical methyltransferase have been shown or thought to catalyze chemical reduction , their role in chemical reduction in vivo , or in cell extracts is uncertain .	T24	T52	23414340
NA	CHEMICAL	GENE-Y	1	4	Although chemical chemical-transferase omega 1 ( gene ) and chemical methyltransferase have been shown or thought to catalyze chemical reduction , their role in chemical reduction in vivo , or in cell extracts is uncertain .	T24	T53	23414340
NA	CHEMICAL	GENE-Y	1	10	Although chemical chemical-transferase omega 1 ( gene ) and chemical methyltransferase have been shown or thought to catalyze chemical reduction , their role in chemical reduction in vivo , or in cell extracts is uncertain .	T24	T54	23414340
NA	CHEMICAL	GENE-Y	2	4	Although chemical chemical-transferase omega 1 ( gene ) and chemical methyltransferase have been shown or thought to catalyze chemical reduction , their role in chemical reduction in vivo , or in cell extracts is uncertain .	T28	T52	23414340
NA	CHEMICAL	GENE-Y	2	4	Although chemical chemical-transferase omega 1 ( gene ) and chemical methyltransferase have been shown or thought to catalyze chemical reduction , their role in chemical reduction in vivo , or in cell extracts is uncertain .	T28	T53	23414340
NA	CHEMICAL	GENE-Y	2	10	Although chemical chemical-transferase omega 1 ( gene ) and chemical methyltransferase have been shown or thought to catalyze chemical reduction , their role in chemical reduction in vivo , or in cell extracts is uncertain .	T28	T54	23414340
NA	CHEMICAL	GENE-Y	9	4	Although chemical chemical-transferase omega 1 ( gene ) and chemical methyltransferase have been shown or thought to catalyze chemical reduction , their role in chemical reduction in vivo , or in cell extracts is uncertain .	T30	T52	23414340
NA	CHEMICAL	GENE-Y	9	4	Although chemical chemical-transferase omega 1 ( gene ) and chemical methyltransferase have been shown or thought to catalyze chemical reduction , their role in chemical reduction in vivo , or in cell extracts is uncertain .	T30	T53	23414340
NA	CHEMICAL	GENE-Y	9	10	Although chemical chemical-transferase omega 1 ( gene ) and chemical methyltransferase have been shown or thought to catalyze chemical reduction , their role in chemical reduction in vivo , or in cell extracts is uncertain .	T30	T54	23414340
CPR:9	CHEMICAL	GENE-Y	5	4	Although chemical chemical-transferase omega 1 ( gene ) and chemical methyltransferase have been shown or thought to catalyze chemical reduction , their role in chemical reduction in vivo , or in cell extracts is uncertain .	T31	T52	23414340
NA	CHEMICAL	GENE-Y	5	4	Although chemical chemical-transferase omega 1 ( gene ) and chemical methyltransferase have been shown or thought to catalyze chemical reduction , their role in chemical reduction in vivo , or in cell extracts is uncertain .	T31	T53	23414340
CPR:9	CHEMICAL	GENE-Y	5	10	Although chemical chemical-transferase omega 1 ( gene ) and chemical methyltransferase have been shown or thought to catalyze chemical reduction , their role in chemical reduction in vivo , or in cell extracts is uncertain .	T31	T54	23414340
NA	CHEMICAL	GENE-Y	5	4	Although chemical chemical-transferase omega 1 ( gene ) and chemical methyltransferase have been shown or thought to catalyze chemical reduction , their role in chemical reduction in vivo , or in cell extracts is uncertain .	T32	T52	23414340
NA	CHEMICAL	GENE-Y	5	4	Although chemical chemical-transferase omega 1 ( gene ) and chemical methyltransferase have been shown or thought to catalyze chemical reduction , their role in chemical reduction in vivo , or in cell extracts is uncertain .	T32	T53	23414340
NA	CHEMICAL	GENE-Y	5	10	Although chemical chemical-transferase omega 1 ( gene ) and chemical methyltransferase have been shown or thought to catalyze chemical reduction , their role in chemical reduction in vivo , or in cell extracts is uncertain .	T32	T54	23414340
NA	CHEMICAL	GENE-N	4	29	Pretreatment of rats with chemical ( chemical ) depletors ( chemical or chemical ) delayed the elimination of chemical and the accumulation of RBC-bound chemical , whereas the indirect gene inhibitor chemical-oxidized chemical was without effect .	T2	T47	23414340
NA	CHEMICAL	GENE-N	6	29	Pretreatment of rats with chemical ( chemical ) depletors ( chemical or chemical ) delayed the elimination of chemical and the accumulation of RBC-bound chemical , whereas the indirect gene inhibitor chemical-oxidized chemical was without effect .	T3	T47	23414340
NA	CHEMICAL	GENE-N	10	29	Pretreatment of rats with chemical ( chemical ) depletors ( chemical or chemical ) delayed the elimination of chemical and the accumulation of RBC-bound chemical , whereas the indirect gene inhibitor chemical-oxidized chemical was without effect .	T4	T47	23414340
NA	CHEMICAL	GENE-N	12	29	Pretreatment of rats with chemical ( chemical ) depletors ( chemical or chemical ) delayed the elimination of chemical and the accumulation of RBC-bound chemical , whereas the indirect gene inhibitor chemical-oxidized chemical was without effect .	T5	T47	23414340
NA	CHEMICAL	GENE-N	5	29	Pretreatment of rats with chemical ( chemical ) depletors ( chemical or chemical ) delayed the elimination of chemical and the accumulation of RBC-bound chemical , whereas the indirect gene inhibitor chemical-oxidized chemical was without effect .	T6	T47	23414340
NA	CHEMICAL	GENE-N	24	29	Pretreatment of rats with chemical ( chemical ) depletors ( chemical or chemical ) delayed the elimination of chemical and the accumulation of RBC-bound chemical , whereas the indirect gene inhibitor chemical-oxidized chemical was without effect .	T7	T47	23414340
NA	CHEMICAL	GENE-N	31	29	Pretreatment of rats with chemical ( chemical ) depletors ( chemical or chemical ) delayed the elimination of chemical and the accumulation of RBC-bound chemical , whereas the indirect gene inhibitor chemical-oxidized chemical was without effect .	T8	T47	23414340
CPR:4	CHEMICAL	GENE-N	32	29	Pretreatment of rats with chemical ( chemical ) depletors ( chemical or chemical ) delayed the elimination of chemical and the accumulation of RBC-bound chemical , whereas the indirect gene inhibitor chemical-oxidized chemical was without effect .	T9	T47	23414340
CPR:4	CHEMICAL	GENE-N	7	1	Although gene ( gene ) inhibitors ( chemical and chemical ) inhibited cytosolic chemical reduction , recombinant gene plus chemical , alone or when added to the cytosol , failed to support chemical reduction .	T17	T48	23414340
CPR:4	CHEMICAL	GENE-N	7	3	Although gene ( gene ) inhibitors ( chemical and chemical ) inhibited cytosolic chemical reduction , recombinant gene plus chemical , alone or when added to the cytosol , failed to support chemical reduction .	T17	T49	23414340
NA	CHEMICAL	GENE-N	7	17	Although gene ( gene ) inhibitors ( chemical and chemical ) inhibited cytosolic chemical reduction , recombinant gene plus chemical , alone or when added to the cytosol , failed to support chemical reduction .	T17	T50	23414340
CPR:4	CHEMICAL	GENE-N	2	1	Although gene ( gene ) inhibitors ( chemical and chemical ) inhibited cytosolic chemical reduction , recombinant gene plus chemical , alone or when added to the cytosol , failed to support chemical reduction .	T18	T48	23414340
CPR:4	CHEMICAL	GENE-N	2	3	Although gene ( gene ) inhibitors ( chemical and chemical ) inhibited cytosolic chemical reduction , recombinant gene plus chemical , alone or when added to the cytosol , failed to support chemical reduction .	T18	T49	23414340
NA	CHEMICAL	GENE-N	2	17	Although gene ( gene ) inhibitors ( chemical and chemical ) inhibited cytosolic chemical reduction , recombinant gene plus chemical , alone or when added to the cytosol , failed to support chemical reduction .	T18	T50	23414340
NA	CHEMICAL	GENE-N	2	1	Although gene ( gene ) inhibitors ( chemical and chemical ) inhibited cytosolic chemical reduction , recombinant gene plus chemical , alone or when added to the cytosol , failed to support chemical reduction .	T19	T48	23414340
NA	CHEMICAL	GENE-N	2	3	Although gene ( gene ) inhibitors ( chemical and chemical ) inhibited cytosolic chemical reduction , recombinant gene plus chemical , alone or when added to the cytosol , failed to support chemical reduction .	T19	T49	23414340
NA	CHEMICAL	GENE-N	2	17	Although gene ( gene ) inhibitors ( chemical and chemical ) inhibited cytosolic chemical reduction , recombinant gene plus chemical , alone or when added to the cytosol , failed to support chemical reduction .	T19	T50	23414340
NA	CHEMICAL	GENE-N	19	1	Although gene ( gene ) inhibitors ( chemical and chemical ) inhibited cytosolic chemical reduction , recombinant gene plus chemical , alone or when added to the cytosol , failed to support chemical reduction .	T21	T48	23414340
NA	CHEMICAL	GENE-N	19	3	Although gene ( gene ) inhibitors ( chemical and chemical ) inhibited cytosolic chemical reduction , recombinant gene plus chemical , alone or when added to the cytosol , failed to support chemical reduction .	T21	T49	23414340
NA	CHEMICAL	GENE-N	19	17	Although gene ( gene ) inhibitors ( chemical and chemical ) inhibited cytosolic chemical reduction , recombinant gene plus chemical , alone or when added to the cytosol , failed to support chemical reduction .	T21	T50	23414340
NA	CHEMICAL	GENE-N	2	1	Although gene ( gene ) inhibitors ( chemical and chemical ) inhibited cytosolic chemical reduction , recombinant gene plus chemical , alone or when added to the cytosol , failed to support chemical reduction .	T22	T48	23414340
NA	CHEMICAL	GENE-N	2	3	Although gene ( gene ) inhibitors ( chemical and chemical ) inhibited cytosolic chemical reduction , recombinant gene plus chemical , alone or when added to the cytosol , failed to support chemical reduction .	T22	T49	23414340
NA	CHEMICAL	GENE-N	2	17	Although gene ( gene ) inhibitors ( chemical and chemical ) inhibited cytosolic chemical reduction , recombinant gene plus chemical , alone or when added to the cytosol , failed to support chemical reduction .	T22	T50	23414340
NA	CHEMICAL	GENE-Y	2	13	PURPOSE : chemical-to-chemical ratio levels in infertile men improve during treatment with the gene inhibitor , chemical , and resulting changes in semen parameters .	T41	T44	11792932
NA	CHEMICAL	GENE-Y	2	13	PURPOSE : chemical-to-chemical ratio levels in infertile men improve during treatment with the gene inhibitor , chemical , and resulting changes in semen parameters .	T16	T44	11792932
CPR:4	CHEMICAL	GENE-Y	2	13	PURPOSE : chemical-to-chemical ratio levels in infertile men improve during treatment with the gene inhibitor , chemical , and resulting changes in semen parameters .	T1	T44	11792932
CPR:4	CHEMICAL	GENE-Y	5	7	We evaluated the effect of chemical , a more selective gene inhibitor , on the hormonal and semen profiles of infertile men with abnormal baseline chemical-to-chemical ratios .	T7	T42	11792932
NA	CHEMICAL	GENE-Y	13	7	We evaluated the effect of chemical , a more selective gene inhibitor , on the hormonal and semen profiles of infertile men with abnormal baseline chemical-to-chemical ratios .	T28	T42	11792932
NA	CHEMICAL	GENE-Y	7	7	We evaluated the effect of chemical , a more selective gene inhibitor , on the hormonal and semen profiles of infertile men with abnormal baseline chemical-to-chemical ratios .	T29	T42	11792932
NA	CHEMICAL	GENE-Y	10	7	CONCLUSIONS : Men who are infertile with a low serum chemical-to-chemical ratio can be treated with an gene inhibitor .	T17	T43	11792932
NA	CHEMICAL	GENE-Y	7	7	CONCLUSIONS : Men who are infertile with a low serum chemical-to-chemical ratio can be treated with an gene inhibitor .	T18	T43	11792932
CPR:6	CHEMICAL	GENE-N	0	4	chemical , a chemical receptor antagonist , inhibits gene production via a mechanism distinct from gene antagonism .	T12	T31	15650315
CPR:4	CHEMICAL	GENE-Y	0	8	chemical , a chemical receptor antagonist , inhibits gene production via a mechanism distinct from gene antagonism .	T12	T32	15650315
CPR:6	CHEMICAL	GENE-N	0	4	chemical , a chemical receptor antagonist , inhibits gene production via a mechanism distinct from gene antagonism .	T12	T30	15650315
NA	CHEMICAL	GENE-N	3	4	chemical , a chemical receptor antagonist , inhibits gene production via a mechanism distinct from gene antagonism .	T14	T31	15650315
NA	CHEMICAL	GENE-Y	3	8	chemical , a chemical receptor antagonist , inhibits gene production via a mechanism distinct from gene antagonism .	T14	T32	15650315
NA	CHEMICAL	GENE-N	3	4	chemical , a chemical receptor antagonist , inhibits gene production via a mechanism distinct from gene antagonism .	T14	T30	15650315
CPR:6	CHEMICAL	GENE-Y	2	7	BACKGROUND : chemical , a chemical receptor 1 ( gene ) antagonist , inhibits not only airway smooth muscle contraction , but also allergic inflammation .	T1	T23	15650315
CPR:6	CHEMICAL	GENE-Y	2	7	BACKGROUND : chemical , a chemical receptor 1 ( gene ) antagonist , inhibits not only airway smooth muscle contraction , but also allergic inflammation .	T1	T25	15650315
NA	CHEMICAL	GENE-Y	5	7	BACKGROUND : chemical , a chemical receptor 1 ( gene ) antagonist , inhibits not only airway smooth muscle contraction , but also allergic inflammation .	T6	T23	15650315
NA	CHEMICAL	GENE-Y	5	7	BACKGROUND : chemical , a chemical receptor 1 ( gene ) antagonist , inhibits not only airway smooth muscle contraction , but also allergic inflammation .	T6	T25	15650315
CPR:4	CHEMICAL	GENE-Y	11	12	The aim of this study was to determine the mechanism of chemical-induced gene ( gene ) inhibition in allergic inflammation .	T5	T21	15650315
CPR:4	CHEMICAL	GENE-Y	11	14	The aim of this study was to determine the mechanism of chemical-induced gene ( gene ) inhibition in allergic inflammation .	T5	T22	15650315
CPR:4	CHEMICAL	GENE-Y	7	14	RESULTS : Pretreatment of lung tissues with chemical alone significantly decreased the amount of gene protein in the culture medium by 40 % .	T9	T28	15650315
CPR:4	CHEMICAL	GENE-Y	0	3	chemical-induced inhibition of gene mRNA expression was noted in various cells , irrespective of their gene mRNA expression status .	T2	T16	15650315
NA	CHEMICAL	GENE-Y	0	15	chemical-induced inhibition of gene mRNA expression was noted in various cells , irrespective of their gene mRNA expression status .	T2	T17	15650315
NA	CHEMICAL	GENE-Y	3	10	In addition , chemical per se failed to upregulate the gene production .	T3	T18	15650315
NA	CHEMICAL	GENE-Y	3	15	Anti-diabetic Activity of chemical is due to an Active Metabolite , chemical , that Upregulates gene Gene Expression in 3T3-L1 cells .	T12	T20	22718571
CPR:3	CHEMICAL	GENE-Y	7	15	Anti-diabetic Activity of chemical is due to an Active Metabolite , chemical , that Upregulates gene Gene Expression in 3T3-L1 cells .	T13	T20	22718571
NA	CHEMICAL	GENE-Y	0	14	chemical treatment had no significant effect on adipogenesis , or the mRNA expression of gene and gene ; however , there was a significant increase in the mRNA expression of gene .	T6	T14	22718571
NA	CHEMICAL	GENE-Y	0	16	chemical treatment had no significant effect on adipogenesis , or the mRNA expression of gene and gene ; however , there was a significant increase in the mRNA expression of gene .	T6	T15	22718571
CPR:3	CHEMICAL	GENE-Y	0	6	chemical treatment had no significant effect on adipogenesis , or the mRNA expression of gene and gene ; however , there was a significant increase in the mRNA expression of gene .	T6	T16	22718571
CPR:3	CHEMICAL	GENE-Y	7	24	On the other hand , treatment with chemical significantly increased adipogenesis , which was associated with a significant increase in the mRNA expression of gene , gene and gene .	T8	T17	22718571
CPR:3	CHEMICAL	GENE-Y	7	26	On the other hand , treatment with chemical significantly increased adipogenesis , which was associated with a significant increase in the mRNA expression of gene , gene and gene .	T8	T18	22718571
CPR:3	CHEMICAL	GENE-Y	7	16	On the other hand , treatment with chemical significantly increased adipogenesis , which was associated with a significant increase in the mRNA expression of gene , gene and gene .	T8	T19	22718571
NA	CHEMICAL	GENE-Y	2	0	gene single chemical polymorphisms on gene-chemical and overweight : the D.E.S.I.R .	T4	T30	17135600
NA	CHEMICAL	GENE-N	2	5	gene single chemical polymorphisms on gene-chemical and overweight : the D.E.S.I.R .	T4	T31	17135600
NA	CHEMICAL	GENE-Y	5	0	gene single chemical polymorphisms on gene-chemical and overweight : the D.E.S.I.R .	T5	T30	17135600
NA	CHEMICAL	GENE-N	5	5	gene single chemical polymorphisms on gene-chemical and overweight : the D.E.S.I.R .	T5	T31	17135600
NA	CHEMICAL	GENE-Y	1	3	The chemical-binding cassette A1 ( gene ) gene plays a key role in reverse chemical transport .	T2	T20	17135600
NA	CHEMICAL	GENE-Y	1	3	The chemical-binding cassette A1 ( gene ) gene plays a key role in reverse chemical transport .	T2	T22	17135600
NA	CHEMICAL	GENE-Y	14	3	The chemical-binding cassette A1 ( gene ) gene plays a key role in reverse chemical transport .	T3	T20	17135600
NA	CHEMICAL	GENE-Y	14	3	The chemical-binding cassette A1 ( gene ) gene plays a key role in reverse chemical transport .	T3	T22	17135600
NA	CHEMICAL	GENE-Y	1	1	Some gene gene polymorphisms have been associated with gene-chemical ( gene-C ) concentrations .	T1	T10	17135600
NA	CHEMICAL	GENE-N	1	8	Some gene gene polymorphisms have been associated with gene-chemical ( gene-C ) concentrations .	T1	T13	17135600
NA	CHEMICAL	GENE-N	1	10	Some gene gene polymorphisms have been associated with gene-chemical ( gene-C ) concentrations .	T1	T14	17135600
CPR:3	CHEMICAL	GENE-Y	0	3	chemical activates the gene and induces gene in primary human hepatocytes and human cancer cell lines HepG2 and LS174T .	T22	T40	23419638
NA	CHEMICAL	GENE-Y	0	6	chemical activates the gene and induces gene in primary human hepatocytes and human cancer cell lines HepG2 and LS174T .	T22	T41	23419638
NA	CHEMICAL	GENE-Y	5	22	We examined the effects of chemical ( chemical , chemical , chemical , chemical , chemical , chemical ) on the chemical receptor ( gene ) -gene signaling pathway in human hepatocytes , hepatic HepG2 and intestinal LS174T cancer cells .	T8	T26	23419638
NA	CHEMICAL	GENE-Y	5	24	We examined the effects of chemical ( chemical , chemical , chemical , chemical , chemical , chemical ) on the chemical receptor ( gene ) -gene signaling pathway in human hepatocytes , hepatic HepG2 and intestinal LS174T cancer cells .	T8	T30	23419638
NA	CHEMICAL	GENE-Y	5	26	We examined the effects of chemical ( chemical , chemical , chemical , chemical , chemical , chemical ) on the chemical receptor ( gene ) -gene signaling pathway in human hepatocytes , hepatic HepG2 and intestinal LS174T cancer cells .	T8	T31	23419638
NA	CHEMICAL	GENE-Y	7	22	We examined the effects of chemical ( chemical , chemical , chemical , chemical , chemical , chemical ) on the chemical receptor ( gene ) -gene signaling pathway in human hepatocytes , hepatic HepG2 and intestinal LS174T cancer cells .	T11	T26	23419638
NA	CHEMICAL	GENE-Y	7	24	We examined the effects of chemical ( chemical , chemical , chemical , chemical , chemical , chemical ) on the chemical receptor ( gene ) -gene signaling pathway in human hepatocytes , hepatic HepG2 and intestinal LS174T cancer cells .	T11	T30	23419638
NA	CHEMICAL	GENE-Y	7	26	We examined the effects of chemical ( chemical , chemical , chemical , chemical , chemical , chemical ) on the chemical receptor ( gene ) -gene signaling pathway in human hepatocytes , hepatic HepG2 and intestinal LS174T cancer cells .	T11	T31	23419638
NA	CHEMICAL	GENE-Y	9	22	We examined the effects of chemical ( chemical , chemical , chemical , chemical , chemical , chemical ) on the chemical receptor ( gene ) -gene signaling pathway in human hepatocytes , hepatic HepG2 and intestinal LS174T cancer cells .	T13	T26	23419638
NA	CHEMICAL	GENE-Y	9	24	We examined the effects of chemical ( chemical , chemical , chemical , chemical , chemical , chemical ) on the chemical receptor ( gene ) -gene signaling pathway in human hepatocytes , hepatic HepG2 and intestinal LS174T cancer cells .	T13	T30	23419638
NA	CHEMICAL	GENE-Y	9	26	We examined the effects of chemical ( chemical , chemical , chemical , chemical , chemical , chemical ) on the chemical receptor ( gene ) -gene signaling pathway in human hepatocytes , hepatic HepG2 and intestinal LS174T cancer cells .	T13	T31	23419638
NA	CHEMICAL	GENE-Y	11	22	We examined the effects of chemical ( chemical , chemical , chemical , chemical , chemical , chemical ) on the chemical receptor ( gene ) -gene signaling pathway in human hepatocytes , hepatic HepG2 and intestinal LS174T cancer cells .	T16	T26	23419638
NA	CHEMICAL	GENE-Y	11	24	We examined the effects of chemical ( chemical , chemical , chemical , chemical , chemical , chemical ) on the chemical receptor ( gene ) -gene signaling pathway in human hepatocytes , hepatic HepG2 and intestinal LS174T cancer cells .	T16	T30	23419638
NA	CHEMICAL	GENE-Y	11	26	We examined the effects of chemical ( chemical , chemical , chemical , chemical , chemical , chemical ) on the chemical receptor ( gene ) -gene signaling pathway in human hepatocytes , hepatic HepG2 and intestinal LS174T cancer cells .	T16	T31	23419638
NA	CHEMICAL	GENE-Y	13	22	We examined the effects of chemical ( chemical , chemical , chemical , chemical , chemical , chemical ) on the chemical receptor ( gene ) -gene signaling pathway in human hepatocytes , hepatic HepG2 and intestinal LS174T cancer cells .	T18	T26	23419638
NA	CHEMICAL	GENE-Y	13	24	We examined the effects of chemical ( chemical , chemical , chemical , chemical , chemical , chemical ) on the chemical receptor ( gene ) -gene signaling pathway in human hepatocytes , hepatic HepG2 and intestinal LS174T cancer cells .	T18	T30	23419638
NA	CHEMICAL	GENE-Y	13	26	We examined the effects of chemical ( chemical , chemical , chemical , chemical , chemical , chemical ) on the chemical receptor ( gene ) -gene signaling pathway in human hepatocytes , hepatic HepG2 and intestinal LS174T cancer cells .	T18	T31	23419638
NA	CHEMICAL	GENE-Y	15	22	We examined the effects of chemical ( chemical , chemical , chemical , chemical , chemical , chemical ) on the chemical receptor ( gene ) -gene signaling pathway in human hepatocytes , hepatic HepG2 and intestinal LS174T cancer cells .	T19	T26	23419638
NA	CHEMICAL	GENE-Y	15	24	We examined the effects of chemical ( chemical , chemical , chemical , chemical , chemical , chemical ) on the chemical receptor ( gene ) -gene signaling pathway in human hepatocytes , hepatic HepG2 and intestinal LS174T cancer cells .	T19	T30	23419638
NA	CHEMICAL	GENE-Y	15	26	We examined the effects of chemical ( chemical , chemical , chemical , chemical , chemical , chemical ) on the chemical receptor ( gene ) -gene signaling pathway in human hepatocytes , hepatic HepG2 and intestinal LS174T cancer cells .	T19	T31	23419638
NA	CHEMICAL	GENE-Y	17	22	We examined the effects of chemical ( chemical , chemical , chemical , chemical , chemical , chemical ) on the chemical receptor ( gene ) -gene signaling pathway in human hepatocytes , hepatic HepG2 and intestinal LS174T cancer cells .	T21	T26	23419638
NA	CHEMICAL	GENE-Y	17	24	We examined the effects of chemical ( chemical , chemical , chemical , chemical , chemical , chemical ) on the chemical receptor ( gene ) -gene signaling pathway in human hepatocytes , hepatic HepG2 and intestinal LS174T cancer cells .	T21	T30	23419638
NA	CHEMICAL	GENE-Y	17	26	We examined the effects of chemical ( chemical , chemical , chemical , chemical , chemical , chemical ) on the chemical receptor ( gene ) -gene signaling pathway in human hepatocytes , hepatic HepG2 and intestinal LS174T cancer cells .	T21	T31	23419638
NA	CHEMICAL	GENE-Y	19	22	We examined the effects of chemical ( chemical , chemical , chemical , chemical , chemical , chemical ) on the chemical receptor ( gene ) -gene signaling pathway in human hepatocytes , hepatic HepG2 and intestinal LS174T cancer cells .	T5	T26	23419638
NA	CHEMICAL	GENE-Y	19	24	We examined the effects of chemical ( chemical , chemical , chemical , chemical , chemical , chemical ) on the chemical receptor ( gene ) -gene signaling pathway in human hepatocytes , hepatic HepG2 and intestinal LS174T cancer cells .	T5	T30	23419638
NA	CHEMICAL	GENE-Y	19	26	We examined the effects of chemical ( chemical , chemical , chemical , chemical , chemical , chemical ) on the chemical receptor ( gene ) -gene signaling pathway in human hepatocytes , hepatic HepG2 and intestinal LS174T cancer cells .	T5	T31	23419638
CPR:3	CHEMICAL	GENE-Y	4	0	gene-dependent reporter gene expression in transfected HepG2 cells was increased by chemical in a concentration-dependent manner at 24h .	T9	T32	23419638
CPR:3	CHEMICAL	GENE-Y	2	7	Similarly , chemical induced the expression of gene mRNA up to 5-fold in HepG2 and LS174T cells relative to the induction by 5 nM chemical ( chemical ) , the most potent activator of gene .	T10	T33	23419638
NA	CHEMICAL	GENE-Y	2	34	Similarly , chemical induced the expression of gene mRNA up to 5-fold in HepG2 and LS174T cells relative to the induction by 5 nM chemical ( chemical ) , the most potent activator of gene .	T10	T34	23419638
CPR:3	CHEMICAL	GENE-Y	1	7	Similarly , chemical induced the expression of gene mRNA up to 5-fold in HepG2 and LS174T cells relative to the induction by 5 nM chemical ( chemical ) , the most potent activator of gene .	T12	T33	23419638
CPR:3	CHEMICAL	GENE-Y	1	34	Similarly , chemical induced the expression of gene mRNA up to 5-fold in HepG2 and LS174T cells relative to the induction by 5 nM chemical ( chemical ) , the most potent activator of gene .	T12	T34	23419638
CPR:3	CHEMICAL	GENE-Y	26	7	Similarly , chemical induced the expression of gene mRNA up to 5-fold in HepG2 and LS174T cells relative to the induction by 5 nM chemical ( chemical ) , the most potent activator of gene .	T14	T33	23419638
CPR:3	CHEMICAL	GENE-Y	26	34	Similarly , chemical induced the expression of gene mRNA up to 5-fold in HepG2 and LS174T cells relative to the induction by 5 nM chemical ( chemical ) , the most potent activator of gene .	T14	T34	23419638
CPR:3	CHEMICAL	GENE-Y	8	0	gene and gene mRNAs were also increased by chemical in three primary human hepatocytes cultures ( approximately 5 % of chemical potency ) and the increase in gene protein in HepG2 and LS174T cells was comparable to the increase in catalytic activity of gene enzyme .	T15	T35	23419638
CPR:3	CHEMICAL	GENE-Y	8	2	gene and gene mRNAs were also increased by chemical in three primary human hepatocytes cultures ( approximately 5 % of chemical potency ) and the increase in gene protein in HepG2 and LS174T cells was comparable to the increase in catalytic activity of gene enzyme .	T15	T36	23419638
CPR:3	CHEMICAL	GENE-Y	8	27	gene and gene mRNAs were also increased by chemical in three primary human hepatocytes cultures ( approximately 5 % of chemical potency ) and the increase in gene protein in HepG2 and LS174T cells was comparable to the increase in catalytic activity of gene enzyme .	T15	T37	23419638
CPR:3	CHEMICAL	GENE-Y	8	43	gene and gene mRNAs were also increased by chemical in three primary human hepatocytes cultures ( approximately 5 % of chemical potency ) and the increase in gene protein in HepG2 and LS174T cells was comparable to the increase in catalytic activity of gene enzyme .	T15	T38	23419638
CPR:3	CHEMICAL	GENE-Y	20	0	gene and gene mRNAs were also increased by chemical in three primary human hepatocytes cultures ( approximately 5 % of chemical potency ) and the increase in gene protein in HepG2 and LS174T cells was comparable to the increase in catalytic activity of gene enzyme .	T17	T35	23419638
CPR:3	CHEMICAL	GENE-Y	20	2	gene and gene mRNAs were also increased by chemical in three primary human hepatocytes cultures ( approximately 5 % of chemical potency ) and the increase in gene protein in HepG2 and LS174T cells was comparable to the increase in catalytic activity of gene enzyme .	T17	T36	23419638
CPR:3	CHEMICAL	GENE-Y	20	27	gene and gene mRNAs were also increased by chemical in three primary human hepatocytes cultures ( approximately 5 % of chemical potency ) and the increase in gene protein in HepG2 and LS174T cells was comparable to the increase in catalytic activity of gene enzyme .	T17	T37	23419638
CPR:3	CHEMICAL	GENE-Y	20	43	gene and gene mRNAs were also increased by chemical in three primary human hepatocytes cultures ( approximately 5 % of chemical potency ) and the increase in gene protein in HepG2 and LS174T cells was comparable to the increase in catalytic activity of gene enzyme .	T17	T38	23419638
NA	CHEMICAL	GENE-Y	5	11	Ligand binding analysis demonstrated that chemical was a weak ligand of gene .	T20	T39	23419638
CPR:4	CHEMICAL	GENE-Y	13	10	Enzyme kinetic analyses using human liver microsomes revealed inhibition of gene activity by chemical ( IC50 78 μM ) and chemical ( IC50 33 μM ) .	T1	T23	23419638
CPR:4	CHEMICAL	GENE-Y	10	10	Enzyme kinetic analyses using human liver microsomes revealed inhibition of gene activity by chemical ( IC50 78 μM ) and chemical ( IC50 33 μM ) .	T2	T23	23419638
NA	CHEMICAL	GENE-N	4	6	Absence of correlation between chemical accumulation in gene , chemical increase , and apoptosis induction on 158N murine oligodendrocytes .	T26	T34	23473804
NA	CHEMICAL	GENE-N	9	6	Absence of correlation between chemical accumulation in gene , chemical increase , and apoptosis induction on 158N murine oligodendrocytes .	T27	T34	23473804
NA	CHEMICAL	GENE-Y	10	29	To this end , 158N murine oligodendrocytes were treated with chemical or chemical inducing an apoptotic mode of cell death characterized by condensation/fragmentation of the nuclei , dephosphorylation of gene and gene , mitochondrial depolarization involving gene , and gene activation .	T15	T30	23473804
NA	CHEMICAL	GENE-N	10	31	To this end , 158N murine oligodendrocytes were treated with chemical or chemical inducing an apoptotic mode of cell death characterized by condensation/fragmentation of the nuclei , dephosphorylation of gene and gene , mitochondrial depolarization involving gene , and gene activation .	T15	T31	23473804
CPR:3	CHEMICAL	GENE-Y	10	36	To this end , 158N murine oligodendrocytes were treated with chemical or chemical inducing an apoptotic mode of cell death characterized by condensation/fragmentation of the nuclei , dephosphorylation of gene and gene , mitochondrial depolarization involving gene , and gene activation .	T15	T32	23473804
CPR:3	CHEMICAL	GENE-Y	10	39	To this end , 158N murine oligodendrocytes were treated with chemical or chemical inducing an apoptotic mode of cell death characterized by condensation/fragmentation of the nuclei , dephosphorylation of gene and gene , mitochondrial depolarization involving gene , and gene activation .	T15	T33	23473804
NA	CHEMICAL	GENE-Y	12	29	To this end , 158N murine oligodendrocytes were treated with chemical or chemical inducing an apoptotic mode of cell death characterized by condensation/fragmentation of the nuclei , dephosphorylation of gene and gene , mitochondrial depolarization involving gene , and gene activation .	T16	T30	23473804
NA	CHEMICAL	GENE-N	12	31	To this end , 158N murine oligodendrocytes were treated with chemical or chemical inducing an apoptotic mode of cell death characterized by condensation/fragmentation of the nuclei , dephosphorylation of gene and gene , mitochondrial depolarization involving gene , and gene activation .	T16	T31	23473804
CPR:3	CHEMICAL	GENE-Y	12	36	To this end , 158N murine oligodendrocytes were treated with chemical or chemical inducing an apoptotic mode of cell death characterized by condensation/fragmentation of the nuclei , dephosphorylation of gene and gene , mitochondrial depolarization involving gene , and gene activation .	T16	T32	23473804
CPR:3	CHEMICAL	GENE-Y	12	39	To this end , 158N murine oligodendrocytes were treated with chemical or chemical inducing an apoptotic mode of cell death characterized by condensation/fragmentation of the nuclei , dephosphorylation of gene and gene , mitochondrial depolarization involving gene , and gene activation .	T16	T33	23473804
NA	CHEMICAL	GENE-Y	11	2	Down-regulation of gene in control and gene transfected HEK cells increases chemical-induced oxidative stress and cell toxicity .	T10	T25	23628791
NA	CHEMICAL	GENE-Y	11	6	Down-regulation of gene in control and gene transfected HEK cells increases chemical-induced oxidative stress and cell toxicity .	T10	T26	23628791
NA	CHEMICAL	GENE-Y	20	9	Genes linked to early onset of Parkinsonism which includes gene and gene have already been suggested to promote development of chemical toxicity .	T5	T17	23628791
NA	CHEMICAL	GENE-Y	20	11	Genes linked to early onset of Parkinsonism which includes gene and gene have already been suggested to promote development of chemical toxicity .	T5	T18	23628791
NA	CHEMICAL	GENE-Y	10	8	Of the other Parkinson-linked genes , mutations in gene , an autosomal dominant gene , represent another likely candidate involved in the development of chemical .	T6	T19	23628791
NA	CHEMICAL	GENE-Y	10	7	In this paper the effect of shRNA gene knock-down on chemical toxicity was examined in control and gene transfected HEK293 cells .	T7	T20	23628791
NA	CHEMICAL	GENE-Y	10	17	In this paper the effect of shRNA gene knock-down on chemical toxicity was examined in control and gene transfected HEK293 cells .	T7	T21	23628791
NA	CHEMICAL	GENE-Y	6	3	Results demonstrate that gene down-regulation potentiates chemical toxicity in both control and gene-transfected cell as well as potentiates DA toxicity .	T8	T22	23628791
NA	CHEMICAL	GENE-Y	6	12	Results demonstrate that gene down-regulation potentiates chemical toxicity in both control and gene-transfected cell as well as potentiates DA toxicity .	T8	T23	23628791
CPR:3	CHEMICAL	GENE-N	3	14	Combined treatment of chemical and DA further augments cell toxicity , ROS production and gene phosphorylation in gene deficient cells compared to controls .	T9	T24	23628791
NA	CHEMICAL	GENE-Y	3	17	Combined treatment of chemical and DA further augments cell toxicity , ROS production and gene phosphorylation in gene deficient cells compared to controls .	T9	T11	23628791
NA	CHEMICAL	GENE-Y	3	35	The effects of chemical ( chemical ) and chemical ( chemical ) , for example , depend on the ability to increase chemical in the synapse , by effects on either the plasma membrane transporter gene or the vesicular transporter for chemical storage , gene .	T1	T11	21272013
NA	CHEMICAL	GENE-Y	3	44	The effects of chemical ( chemical ) and chemical ( chemical ) , for example , depend on the ability to increase chemical in the synapse , by effects on either the plasma membrane transporter gene or the vesicular transporter for chemical storage , gene .	T1	T12	21272013
NA	CHEMICAL	GENE-Y	5	35	The effects of chemical ( chemical ) and chemical ( chemical ) , for example , depend on the ability to increase chemical in the synapse , by effects on either the plasma membrane transporter gene or the vesicular transporter for chemical storage , gene .	T2	T11	21272013
NA	CHEMICAL	GENE-Y	5	44	The effects of chemical ( chemical ) and chemical ( chemical ) , for example , depend on the ability to increase chemical in the synapse , by effects on either the plasma membrane transporter gene or the vesicular transporter for chemical storage , gene .	T2	T12	21272013
NA	CHEMICAL	GENE-Y	8	35	The effects of chemical ( chemical ) and chemical ( chemical ) , for example , depend on the ability to increase chemical in the synapse , by effects on either the plasma membrane transporter gene or the vesicular transporter for chemical storage , gene .	T3	T11	21272013
NA	CHEMICAL	GENE-Y	8	44	The effects of chemical ( chemical ) and chemical ( chemical ) , for example , depend on the ability to increase chemical in the synapse , by effects on either the plasma membrane transporter gene or the vesicular transporter for chemical storage , gene .	T3	T12	21272013
NA	CHEMICAL	GENE-Y	10	35	The effects of chemical ( chemical ) and chemical ( chemical ) , for example , depend on the ability to increase chemical in the synapse , by effects on either the plasma membrane transporter gene or the vesicular transporter for chemical storage , gene .	T4	T11	21272013
NA	CHEMICAL	GENE-Y	10	44	The effects of chemical ( chemical ) and chemical ( chemical ) , for example , depend on the ability to increase chemical in the synapse , by effects on either the plasma membrane transporter gene or the vesicular transporter for chemical storage , gene .	T4	T12	21272013
NA	CHEMICAL	GENE-Y	22	35	The effects of chemical ( chemical ) and chemical ( chemical ) , for example , depend on the ability to increase chemical in the synapse , by effects on either the plasma membrane transporter gene or the vesicular transporter for chemical storage , gene .	T5	T11	21272013
NA	CHEMICAL	GENE-Y	22	44	The effects of chemical ( chemical ) and chemical ( chemical ) , for example , depend on the ability to increase chemical in the synapse , by effects on either the plasma membrane transporter gene or the vesicular transporter for chemical storage , gene .	T5	T12	21272013
NA	CHEMICAL	GENE-Y	17	35	The effects of chemical ( chemical ) and chemical ( chemical ) , for example , depend on the ability to increase chemical in the synapse , by effects on either the plasma membrane transporter gene or the vesicular transporter for chemical storage , gene .	T6	T11	21272013
NA	CHEMICAL	GENE-Y	17	44	The effects of chemical ( chemical ) and chemical ( chemical ) , for example , depend on the ability to increase chemical in the synapse , by effects on either the plasma membrane transporter gene or the vesicular transporter for chemical storage , gene .	T6	T12	21272013
NA	CHEMICAL	GENE-Y	9	4	The potential role of gene as a target for chemical and chemical has been reviewed extensively .	T7	T13	21272013
NA	CHEMICAL	GENE-Y	11	4	The potential role of gene as a target for chemical and chemical has been reviewed extensively .	T8	T13	21272013
NA	CHEMICAL	GENE-Y	21	23	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T11	T30	17035141
NA	CHEMICAL	GENE-Y	21	27	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T11	T31	17035141
NA	CHEMICAL	GENE-Y	21	23	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T11	T32	17035141
NA	CHEMICAL	GENE-Y	21	31	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T11	T33	17035141
NA	CHEMICAL	GENE-Y	21	23	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T11	T34	17035141
NA	CHEMICAL	GENE-Y	21	23	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T11	T35	17035141
NA	CHEMICAL	GENE-Y	21	39	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T11	T36	17035141
NA	CHEMICAL	GENE-Y	21	41	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T11	T37	17035141
NA	CHEMICAL	GENE-Y	21	45	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T11	T38	17035141
NA	CHEMICAL	GENE-Y	21	39	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T11	T39	17035141
NA	CHEMICAL	GENE-Y	21	45	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T11	T40	17035141
NA	CHEMICAL	GENE-Y	21	54	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T11	T41	17035141
NA	CHEMICAL	GENE-Y	21	17	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T11	T22	17035141
NA	CHEMICAL	GENE-Y	25	23	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T12	T30	17035141
NA	CHEMICAL	GENE-Y	25	27	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T12	T31	17035141
NA	CHEMICAL	GENE-Y	25	23	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T12	T32	17035141
NA	CHEMICAL	GENE-Y	25	31	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T12	T33	17035141
NA	CHEMICAL	GENE-Y	25	23	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T12	T34	17035141
NA	CHEMICAL	GENE-Y	25	23	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T12	T35	17035141
NA	CHEMICAL	GENE-Y	25	39	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T12	T36	17035141
NA	CHEMICAL	GENE-Y	25	41	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T12	T37	17035141
NA	CHEMICAL	GENE-Y	25	45	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T12	T38	17035141
NA	CHEMICAL	GENE-Y	25	39	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T12	T39	17035141
NA	CHEMICAL	GENE-Y	25	45	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T12	T40	17035141
NA	CHEMICAL	GENE-Y	25	54	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T12	T41	17035141
NA	CHEMICAL	GENE-Y	25	17	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T12	T22	17035141
NA	CHEMICAL	GENE-Y	33	23	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T13	T30	17035141
NA	CHEMICAL	GENE-Y	33	27	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T13	T31	17035141
NA	CHEMICAL	GENE-Y	33	23	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T13	T32	17035141
NA	CHEMICAL	GENE-Y	33	31	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T13	T33	17035141
NA	CHEMICAL	GENE-Y	33	23	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T13	T34	17035141
NA	CHEMICAL	GENE-Y	33	23	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T13	T35	17035141
NA	CHEMICAL	GENE-Y	33	39	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T13	T36	17035141
NA	CHEMICAL	GENE-Y	33	41	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T13	T37	17035141
NA	CHEMICAL	GENE-Y	33	45	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T13	T38	17035141
NA	CHEMICAL	GENE-Y	33	39	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T13	T39	17035141
NA	CHEMICAL	GENE-Y	33	45	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T13	T40	17035141
NA	CHEMICAL	GENE-Y	33	54	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T13	T41	17035141
NA	CHEMICAL	GENE-Y	33	17	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T13	T22	17035141
NA	CHEMICAL	GENE-Y	37	23	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T14	T30	17035141
NA	CHEMICAL	GENE-Y	37	27	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T14	T31	17035141
NA	CHEMICAL	GENE-Y	37	23	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T14	T32	17035141
NA	CHEMICAL	GENE-Y	37	31	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T14	T33	17035141
NA	CHEMICAL	GENE-Y	37	23	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T14	T34	17035141
NA	CHEMICAL	GENE-Y	37	23	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T14	T35	17035141
NA	CHEMICAL	GENE-Y	37	39	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T14	T36	17035141
NA	CHEMICAL	GENE-Y	37	41	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T14	T37	17035141
NA	CHEMICAL	GENE-Y	37	45	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T14	T38	17035141
NA	CHEMICAL	GENE-Y	37	39	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T14	T39	17035141
NA	CHEMICAL	GENE-Y	37	45	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T14	T40	17035141
NA	CHEMICAL	GENE-Y	37	54	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T14	T41	17035141
NA	CHEMICAL	GENE-Y	37	17	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T14	T22	17035141
NA	CHEMICAL	GENE-Y	12	23	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T15	T30	17035141
NA	CHEMICAL	GENE-Y	12	27	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T15	T31	17035141
NA	CHEMICAL	GENE-Y	12	23	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T15	T32	17035141
NA	CHEMICAL	GENE-Y	12	31	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T15	T33	17035141
NA	CHEMICAL	GENE-Y	12	23	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T15	T34	17035141
NA	CHEMICAL	GENE-Y	12	23	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T15	T35	17035141
NA	CHEMICAL	GENE-Y	12	39	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T15	T36	17035141
NA	CHEMICAL	GENE-Y	12	41	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T15	T37	17035141
NA	CHEMICAL	GENE-Y	12	45	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T15	T38	17035141
NA	CHEMICAL	GENE-Y	12	39	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T15	T39	17035141
NA	CHEMICAL	GENE-Y	12	45	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T15	T40	17035141
NA	CHEMICAL	GENE-Y	12	54	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T15	T41	17035141
NA	CHEMICAL	GENE-Y	12	17	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T15	T22	17035141
NA	CHEMICAL	GENE-Y	17	23	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T16	T30	17035141
NA	CHEMICAL	GENE-Y	17	27	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T16	T31	17035141
NA	CHEMICAL	GENE-Y	17	23	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T16	T32	17035141
NA	CHEMICAL	GENE-Y	17	31	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T16	T33	17035141
NA	CHEMICAL	GENE-Y	17	23	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T16	T34	17035141
NA	CHEMICAL	GENE-Y	17	23	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T16	T35	17035141
NA	CHEMICAL	GENE-Y	17	39	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T16	T36	17035141
NA	CHEMICAL	GENE-Y	17	41	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T16	T37	17035141
NA	CHEMICAL	GENE-Y	17	45	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T16	T38	17035141
NA	CHEMICAL	GENE-Y	17	39	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T16	T39	17035141
NA	CHEMICAL	GENE-Y	17	45	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T16	T40	17035141
NA	CHEMICAL	GENE-Y	17	54	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T16	T41	17035141
NA	CHEMICAL	GENE-Y	17	17	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T16	T22	17035141
NA	CHEMICAL	GENE-Y	47	23	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T17	T30	17035141
NA	CHEMICAL	GENE-Y	47	27	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T17	T31	17035141
NA	CHEMICAL	GENE-Y	47	23	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T17	T32	17035141
NA	CHEMICAL	GENE-Y	47	31	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T17	T33	17035141
NA	CHEMICAL	GENE-Y	47	23	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T17	T34	17035141
NA	CHEMICAL	GENE-Y	47	23	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T17	T35	17035141
NA	CHEMICAL	GENE-Y	47	39	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T17	T36	17035141
NA	CHEMICAL	GENE-Y	47	41	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T17	T37	17035141
NA	CHEMICAL	GENE-Y	47	45	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T17	T38	17035141
NA	CHEMICAL	GENE-Y	47	39	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T17	T39	17035141
NA	CHEMICAL	GENE-Y	47	45	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T17	T40	17035141
NA	CHEMICAL	GENE-Y	47	54	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T17	T41	17035141
NA	CHEMICAL	GENE-Y	47	17	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T17	T22	17035141
NA	CHEMICAL	GENE-Y	17	23	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T18	T30	17035141
NA	CHEMICAL	GENE-Y	17	27	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T18	T31	17035141
NA	CHEMICAL	GENE-Y	17	23	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T18	T32	17035141
NA	CHEMICAL	GENE-Y	17	31	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T18	T33	17035141
NA	CHEMICAL	GENE-Y	17	23	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T18	T34	17035141
NA	CHEMICAL	GENE-Y	17	23	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T18	T35	17035141
NA	CHEMICAL	GENE-Y	17	39	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T18	T36	17035141
NA	CHEMICAL	GENE-Y	17	41	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T18	T37	17035141
NA	CHEMICAL	GENE-Y	17	45	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T18	T38	17035141
NA	CHEMICAL	GENE-Y	17	39	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T18	T39	17035141
NA	CHEMICAL	GENE-Y	17	45	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T18	T40	17035141
NA	CHEMICAL	GENE-Y	17	54	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T18	T41	17035141
NA	CHEMICAL	GENE-Y	17	17	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T18	T22	17035141
NA	CHEMICAL	GENE-Y	17	23	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T19	T30	17035141
NA	CHEMICAL	GENE-Y	17	27	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T19	T31	17035141
NA	CHEMICAL	GENE-Y	17	23	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T19	T32	17035141
NA	CHEMICAL	GENE-Y	17	31	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T19	T33	17035141
NA	CHEMICAL	GENE-Y	17	23	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T19	T34	17035141
NA	CHEMICAL	GENE-Y	17	23	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T19	T35	17035141
NA	CHEMICAL	GENE-Y	17	39	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T19	T36	17035141
NA	CHEMICAL	GENE-Y	17	41	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T19	T37	17035141
NA	CHEMICAL	GENE-Y	17	45	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T19	T38	17035141
NA	CHEMICAL	GENE-Y	17	39	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T19	T39	17035141
NA	CHEMICAL	GENE-Y	17	45	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T19	T40	17035141
NA	CHEMICAL	GENE-Y	17	54	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T19	T41	17035141
NA	CHEMICAL	GENE-Y	17	17	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T19	T22	17035141
NA	CHEMICAL	GENE-Y	17	23	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T20	T30	17035141
NA	CHEMICAL	GENE-Y	17	27	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T20	T31	17035141
NA	CHEMICAL	GENE-Y	17	23	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T20	T32	17035141
NA	CHEMICAL	GENE-Y	17	31	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T20	T33	17035141
NA	CHEMICAL	GENE-Y	17	23	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T20	T34	17035141
NA	CHEMICAL	GENE-Y	17	23	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T20	T35	17035141
NA	CHEMICAL	GENE-Y	17	39	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T20	T36	17035141
NA	CHEMICAL	GENE-Y	17	41	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T20	T37	17035141
NA	CHEMICAL	GENE-Y	17	45	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T20	T38	17035141
NA	CHEMICAL	GENE-Y	17	39	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T20	T39	17035141
NA	CHEMICAL	GENE-Y	17	45	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T20	T40	17035141
NA	CHEMICAL	GENE-Y	17	54	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T20	T41	17035141
NA	CHEMICAL	GENE-Y	17	17	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T20	T22	17035141
NA	CHEMICAL	GENE-Y	17	23	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T1	T30	17035141
NA	CHEMICAL	GENE-Y	17	27	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T1	T31	17035141
NA	CHEMICAL	GENE-Y	17	23	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T1	T32	17035141
NA	CHEMICAL	GENE-Y	17	31	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T1	T33	17035141
NA	CHEMICAL	GENE-Y	17	23	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T1	T34	17035141
NA	CHEMICAL	GENE-Y	17	23	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T1	T35	17035141
NA	CHEMICAL	GENE-Y	17	39	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T1	T36	17035141
NA	CHEMICAL	GENE-Y	17	41	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T1	T37	17035141
NA	CHEMICAL	GENE-Y	17	45	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T1	T38	17035141
NA	CHEMICAL	GENE-Y	17	39	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T1	T39	17035141
NA	CHEMICAL	GENE-Y	17	45	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T1	T40	17035141
NA	CHEMICAL	GENE-Y	17	54	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T1	T41	17035141
NA	CHEMICAL	GENE-Y	17	17	METHODS : In 304 Caucasian American NTD families with myelomeningocele or anencephaly , we examined 28 polymorphisms in 11 genes : chemical receptor 1 , chemical receptor 2 , gene , gene , chemical dehydrogenase 1 , chemical-transferase chemical reductase ( gene ) , chemical methyltransferase , chemical-chemical methyltransferase reductase , chemical-chemical methyltransferase ( gene ) , and chemical-beta-synthase .	T1	T22	17035141
NA	CHEMICAL	GENE-Y	4	10	RESULTS : Only single chemical polymorphisms ( SNPs ) in gene were significantly associated in the overall data set ; this significance was strongest when mothers took chemical-containing nutritional supplements before conception .	T2	T23	17035141
NA	CHEMICAL	GENE-Y	27	10	RESULTS : Only single chemical polymorphisms ( SNPs ) in gene were significantly associated in the overall data set ; this significance was strongest when mothers took chemical-containing nutritional supplements before conception .	T4	T23	17035141
NA	CHEMICAL	GENE-Y	3	18	Other SNPs in chemical pathway genes were marginally significant in some analyses when stratified by maternal supplementation , gene , or gene allele transmission .	T6	T26	17035141
NA	CHEMICAL	GENE-Y	3	21	Other SNPs in chemical pathway genes were marginally significant in some analyses when stratified by maternal supplementation , gene , or gene allele transmission .	T6	T27	17035141
NA	CHEMICAL	GENE-Y	1	4	The chemical sequence of gene contains 649 bp , and the mature protein is predicted to have 131 chemical residues-104 of which make up the large subunit , and 27 of which make up the small subunit .	T1	T19	23142507
NA	CHEMICAL	GENE-Y	18	4	The chemical sequence of gene contains 649 bp , and the mature protein is predicted to have 131 chemical residues-104 of which make up the large subunit , and 27 of which make up the small subunit .	T2	T19	23142507
NA	CHEMICAL	GENE-Y	12	3	The 3D-structure of gene consists of three conserved alpha-helices : h1 ( chemical24-chemical34 ) , h2 ( chemical59-chemical71 ) , and h3 ( chemical80-chemical89 ) .	T3	T23	23142507
NA	CHEMICAL	GENE-Y	12	3	The 3D-structure of gene consists of three conserved alpha-helices : h1 ( chemical24-chemical34 ) , h2 ( chemical59-chemical71 ) , and h3 ( chemical80-chemical89 ) .	T4	T23	23142507
NA	CHEMICAL	GENE-Y	17	3	The 3D-structure of gene consists of three conserved alpha-helices : h1 ( chemical24-chemical34 ) , h2 ( chemical59-chemical71 ) , and h3 ( chemical80-chemical89 ) .	T5	T23	23142507
NA	CHEMICAL	GENE-Y	17	3	The 3D-structure of gene consists of three conserved alpha-helices : h1 ( chemical24-chemical34 ) , h2 ( chemical59-chemical71 ) , and h3 ( chemical80-chemical89 ) .	T6	T23	23142507
NA	CHEMICAL	GENE-Y	23	3	The 3D-structure of gene consists of three conserved alpha-helices : h1 ( chemical24-chemical34 ) , h2 ( chemical59-chemical71 ) , and h3 ( chemical80-chemical89 ) .	T7	T23	23142507
NA	CHEMICAL	GENE-Y	23	3	The 3D-structure of gene consists of three conserved alpha-helices : h1 ( chemical24-chemical34 ) , h2 ( chemical59-chemical71 ) , and h3 ( chemical80-chemical89 ) .	T8	T23	23142507
NA	CHEMICAL	GENE-Y	3	3	In addition , gene toxin , like diphtheria toxin itself , must pass through an acidic compartment in order to deliver its chemical chemical transferase activity to the cytosol of target T cells .	T1	T16	3124610
NA	CHEMICAL	GENE-N	3	14	In addition , gene toxin , like diphtheria toxin itself , must pass through an acidic compartment in order to deliver its chemical chemical transferase activity to the cytosol of target T cells .	T1	T18	3124610
NA	CHEMICAL	GENE-Y	23	3	In addition , gene toxin , like diphtheria toxin itself , must pass through an acidic compartment in order to deliver its chemical chemical transferase activity to the cytosol of target T cells .	T2	T16	3124610
NA	CHEMICAL	GENE-N	23	14	In addition , gene toxin , like diphtheria toxin itself , must pass through an acidic compartment in order to deliver its chemical chemical transferase activity to the cytosol of target T cells .	T2	T18	3124610
NA	CHEMICAL	GENE-N	0	1	chemical Receptor Activation Down-Regulates Expression of gene in Cultured Hippocampal Neurons .	T13	T24	23585058
NA	CHEMICAL	GENE-Y	0	1	chemical Receptor Activation Down-Regulates Expression of gene in Cultured Hippocampal Neurons .	T13	T25	23585058
NA	CHEMICAL	GENE-N	6	9	Neurosteroids are endogenous allosteric modulators of chemical type A receptors ( gene ) , and enhance gene-mediated inhibition .	T10	T22	23585058
NA	CHEMICAL	GENE-N	6	8	Neurosteroids are endogenous allosteric modulators of chemical type A receptors ( gene ) , and enhance gene-mediated inhibition .	T10	T23	23585058
NA	CHEMICAL	GENE-N	6	8	Neurosteroids are endogenous allosteric modulators of chemical type A receptors ( gene ) , and enhance gene-mediated inhibition .	T10	T16	23585058
NA	CHEMICAL	GENE-N	2	9	Chelation of chemical ions by chemical or blockade of gene activation by chemical also prevented the chemical effects .	T3	T15	23585058
NA	CHEMICAL	GENE-N	5	9	Chelation of chemical ions by chemical or blockade of gene activation by chemical also prevented the chemical effects .	T4	T15	23585058
CPR:4	CHEMICAL	GENE-N	12	9	Chelation of chemical ions by chemical or blockade of gene activation by chemical also prevented the chemical effects .	T5	T15	23585058
NA	CHEMICAL	GENE-N	16	9	Chelation of chemical ions by chemical or blockade of gene activation by chemical also prevented the chemical effects .	T6	T15	23585058
NA	CHEMICAL	GENE-Y	16	43	We evaluated the relationships between the plasma and the cerebrospinal fluid ( CSF ) concentrations of chemical , the chemical precursors chemical , chemical and chemical , and the chemical elimination products chemical and chemical , and the CSF markers for AD pathology gene and gene in 86 subjects with normal cognition and in 107 AD patients .	T9	T27	23291240
NA	CHEMICAL	GENE-Y	16	45	We evaluated the relationships between the plasma and the cerebrospinal fluid ( CSF ) concentrations of chemical , the chemical precursors chemical , chemical and chemical , and the chemical elimination products chemical and chemical , and the CSF markers for AD pathology gene and gene in 86 subjects with normal cognition and in 107 AD patients .	T9	T28	23291240
NA	CHEMICAL	GENE-Y	19	43	We evaluated the relationships between the plasma and the cerebrospinal fluid ( CSF ) concentrations of chemical , the chemical precursors chemical , chemical and chemical , and the chemical elimination products chemical and chemical , and the CSF markers for AD pathology gene and gene in 86 subjects with normal cognition and in 107 AD patients .	T10	T27	23291240
NA	CHEMICAL	GENE-Y	19	45	We evaluated the relationships between the plasma and the cerebrospinal fluid ( CSF ) concentrations of chemical , the chemical precursors chemical , chemical and chemical , and the chemical elimination products chemical and chemical , and the CSF markers for AD pathology gene and gene in 86 subjects with normal cognition and in 107 AD patients .	T10	T28	23291240
NA	CHEMICAL	GENE-Y	21	43	We evaluated the relationships between the plasma and the cerebrospinal fluid ( CSF ) concentrations of chemical , the chemical precursors chemical , chemical and chemical , and the chemical elimination products chemical and chemical , and the CSF markers for AD pathology gene and gene in 86 subjects with normal cognition and in 107 AD patients .	T11	T27	23291240
NA	CHEMICAL	GENE-Y	21	45	We evaluated the relationships between the plasma and the cerebrospinal fluid ( CSF ) concentrations of chemical , the chemical precursors chemical , chemical and chemical , and the chemical elimination products chemical and chemical , and the CSF markers for AD pathology gene and gene in 86 subjects with normal cognition and in 107 AD patients .	T11	T28	23291240
NA	CHEMICAL	GENE-Y	23	43	We evaluated the relationships between the plasma and the cerebrospinal fluid ( CSF ) concentrations of chemical , the chemical precursors chemical , chemical and chemical , and the chemical elimination products chemical and chemical , and the CSF markers for AD pathology gene and gene in 86 subjects with normal cognition and in 107 AD patients .	T12	T27	23291240
NA	CHEMICAL	GENE-Y	23	45	We evaluated the relationships between the plasma and the cerebrospinal fluid ( CSF ) concentrations of chemical , the chemical precursors chemical , chemical and chemical , and the chemical elimination products chemical and chemical , and the CSF markers for AD pathology gene and gene in 86 subjects with normal cognition and in 107 AD patients .	T12	T28	23291240
NA	CHEMICAL	GENE-Y	25	43	We evaluated the relationships between the plasma and the cerebrospinal fluid ( CSF ) concentrations of chemical , the chemical precursors chemical , chemical and chemical , and the chemical elimination products chemical and chemical , and the CSF markers for AD pathology gene and gene in 86 subjects with normal cognition and in 107 AD patients .	T13	T27	23291240
NA	CHEMICAL	GENE-Y	25	45	We evaluated the relationships between the plasma and the cerebrospinal fluid ( CSF ) concentrations of chemical , the chemical precursors chemical , chemical and chemical , and the chemical elimination products chemical and chemical , and the CSF markers for AD pathology gene and gene in 86 subjects with normal cognition and in 107 AD patients .	T13	T28	23291240
NA	CHEMICAL	GENE-Y	29	43	We evaluated the relationships between the plasma and the cerebrospinal fluid ( CSF ) concentrations of chemical , the chemical precursors chemical , chemical and chemical , and the chemical elimination products chemical and chemical , and the CSF markers for AD pathology gene and gene in 86 subjects with normal cognition and in 107 AD patients .	T14	T27	23291240
NA	CHEMICAL	GENE-Y	29	45	We evaluated the relationships between the plasma and the cerebrospinal fluid ( CSF ) concentrations of chemical , the chemical precursors chemical , chemical and chemical , and the chemical elimination products chemical and chemical , and the CSF markers for AD pathology gene and gene in 86 subjects with normal cognition and in 107 AD patients .	T14	T28	23291240
NA	CHEMICAL	GENE-Y	32	43	We evaluated the relationships between the plasma and the cerebrospinal fluid ( CSF ) concentrations of chemical , the chemical precursors chemical , chemical and chemical , and the chemical elimination products chemical and chemical , and the CSF markers for AD pathology gene and gene in 86 subjects with normal cognition and in 107 AD patients .	T15	T27	23291240
NA	CHEMICAL	GENE-Y	32	45	We evaluated the relationships between the plasma and the cerebrospinal fluid ( CSF ) concentrations of chemical , the chemical precursors chemical , chemical and chemical , and the chemical elimination products chemical and chemical , and the CSF markers for AD pathology gene and gene in 86 subjects with normal cognition and in 107 AD patients .	T15	T28	23291240
NA	CHEMICAL	GENE-Y	34	43	We evaluated the relationships between the plasma and the cerebrospinal fluid ( CSF ) concentrations of chemical , the chemical precursors chemical , chemical and chemical , and the chemical elimination products chemical and chemical , and the CSF markers for AD pathology gene and gene in 86 subjects with normal cognition and in 107 AD patients .	T16	T27	23291240
NA	CHEMICAL	GENE-Y	34	45	We evaluated the relationships between the plasma and the cerebrospinal fluid ( CSF ) concentrations of chemical , the chemical precursors chemical , chemical and chemical , and the chemical elimination products chemical and chemical , and the CSF markers for AD pathology gene and gene in 86 subjects with normal cognition and in 107 AD patients .	T16	T28	23291240
NA	CHEMICAL	GENE-Y	1	21	CSF chemical , chemical and chemical in the AD group , and CSF chemical in the control group correlated with the gene levels .	T17	T22	23291240
NA	CHEMICAL	GENE-Y	3	21	CSF chemical , chemical and chemical in the AD group , and CSF chemical in the control group correlated with the gene levels .	T18	T22	23291240
NA	CHEMICAL	GENE-Y	5	21	CSF chemical , chemical and chemical in the AD group , and CSF chemical in the control group correlated with the gene levels .	T19	T22	23291240
NA	CHEMICAL	GENE-Y	13	21	CSF chemical , chemical and chemical in the AD group , and CSF chemical in the control group correlated with the gene levels .	T20	T22	23291240
NA	CHEMICAL	GENE-Y	27	15	In multivariate regression tests including age , gender , albumin ratio , number of the gene alleles , and diagnosis , gene levels independently predicted the CSF chemical , chemical and chemical concentrations .	T1	T24	23291240
NA	CHEMICAL	GENE-Y	27	21	In multivariate regression tests including age , gender , albumin ratio , number of the gene alleles , and diagnosis , gene levels independently predicted the CSF chemical , chemical and chemical concentrations .	T1	T25	23291240
NA	CHEMICAL	GENE-Y	15	15	In multivariate regression tests including age , gender , albumin ratio , number of the gene alleles , and diagnosis , gene levels independently predicted the CSF chemical , chemical and chemical concentrations .	T2	T24	23291240
NA	CHEMICAL	GENE-Y	15	21	In multivariate regression tests including age , gender , albumin ratio , number of the gene alleles , and diagnosis , gene levels independently predicted the CSF chemical , chemical and chemical concentrations .	T2	T25	23291240
NA	CHEMICAL	GENE-Y	31	15	In multivariate regression tests including age , gender , albumin ratio , number of the gene alleles , and diagnosis , gene levels independently predicted the CSF chemical , chemical and chemical concentrations .	T3	T24	23291240
NA	CHEMICAL	GENE-Y	31	21	In multivariate regression tests including age , gender , albumin ratio , number of the gene alleles , and diagnosis , gene levels independently predicted the CSF chemical , chemical and chemical concentrations .	T3	T25	23291240
CPR:6	CHEMICAL	GENE-Y	0	2	chemical , a gene antagonist , reduces chemical influx into cortical synaptosomes by direct interaction with chemical channels : comparison with other gene antagonists .	T35	T47	10864881
NA	CHEMICAL	GENE-N	0	2	chemical , a gene antagonist , reduces chemical influx into cortical synaptosomes by direct interaction with chemical channels : comparison with other gene antagonists .	T35	T46	10864881
CPR:6	CHEMICAL	GENE-N	0	2	chemical , a gene antagonist , reduces chemical influx into cortical synaptosomes by direct interaction with chemical channels : comparison with other gene antagonists .	T35	T48	10864881
NA	CHEMICAL	GENE-Y	2	2	chemical , a gene antagonist , reduces chemical influx into cortical synaptosomes by direct interaction with chemical channels : comparison with other gene antagonists .	T37	T47	10864881
NA	CHEMICAL	GENE-N	2	2	chemical , a gene antagonist , reduces chemical influx into cortical synaptosomes by direct interaction with chemical channels : comparison with other gene antagonists .	T37	T46	10864881
NA	CHEMICAL	GENE-N	2	2	chemical , a gene antagonist , reduces chemical influx into cortical synaptosomes by direct interaction with chemical channels : comparison with other gene antagonists .	T37	T48	10864881
NA	CHEMICAL	GENE-Y	2	2	chemical , a gene antagonist , reduces chemical influx into cortical synaptosomes by direct interaction with chemical channels : comparison with other gene antagonists .	T36	T47	10864881
NA	CHEMICAL	GENE-N	2	2	chemical , a gene antagonist , reduces chemical influx into cortical synaptosomes by direct interaction with chemical channels : comparison with other gene antagonists .	T36	T46	10864881
NA	CHEMICAL	GENE-N	2	2	chemical , a gene antagonist , reduces chemical influx into cortical synaptosomes by direct interaction with chemical channels : comparison with other gene antagonists .	T36	T48	10864881
CPR:6	CHEMICAL	GENE-Y	0	2	chemical , a gene antagonist used for the treatment of glaucoma , is known to be neuroprotective in paradigms of ischaemia/excitotoxicity .	T1	T38	10864881
CPR:6	CHEMICAL	GENE-N	7	10	In this study , we examined whether chemical and other gene antagonists interact directly with neurotoxin binding to sites 1 and 2 of the gene ( chemical channel ) in rat cerebrocortical synaptosomes .	T19	T40	10864881
NA	CHEMICAL	GENE-N	7	24	In this study , we examined whether chemical and other gene antagonists interact directly with neurotoxin binding to sites 1 and 2 of the gene ( chemical channel ) in rat cerebrocortical synaptosomes .	T19	T41	10864881
NA	CHEMICAL	GENE-N	7	27	In this study , we examined whether chemical and other gene antagonists interact directly with neurotoxin binding to sites 1 and 2 of the gene ( chemical channel ) in rat cerebrocortical synaptosomes .	T19	T42	10864881
NA	CHEMICAL	GENE-N	25	10	In this study , we examined whether chemical and other gene antagonists interact directly with neurotoxin binding to sites 1 and 2 of the gene ( chemical channel ) in rat cerebrocortical synaptosomes .	T21	T40	10864881
NA	CHEMICAL	GENE-N	25	24	In this study , we examined whether chemical and other gene antagonists interact directly with neurotoxin binding to sites 1 and 2 of the gene ( chemical channel ) in rat cerebrocortical synaptosomes .	T21	T41	10864881
NA	CHEMICAL	GENE-N	25	27	In this study , we examined whether chemical and other gene antagonists interact directly with neurotoxin binding to sites 1 and 2 of the gene ( chemical channel ) in rat cerebrocortical synaptosomes .	T21	T42	10864881
NA	CHEMICAL	GENE-N	0	9	chemical inhibited specific chemical ( chemical ) binding to gene in a concentration-dependent manner with an IC ( 50 ) value of 9.8 microM .	T22	T43	10864881
NA	CHEMICAL	GENE-N	3	9	chemical inhibited specific chemical ( chemical ) binding to gene in a concentration-dependent manner with an IC ( 50 ) value of 9.8 microM .	T23	T43	10864881
NA	CHEMICAL	GENE-N	4	9	chemical inhibited specific chemical ( chemical ) binding to gene in a concentration-dependent manner with an IC ( 50 ) value of 9.8 microM .	T24	T43	10864881
CPR:6	CHEMICAL	GENE-N	8	4	Comparison of all the gene antagonists tested revealed a potency order of chemical > chemical approximately chemical > chemical approximately chemical > /=chemical > chemical .	T25	T44	10864881
CPR:6	CHEMICAL	GENE-N	8	4	Comparison of all the gene antagonists tested revealed a potency order of chemical > chemical approximately chemical > chemical approximately chemical > /=chemical > chemical .	T26	T44	10864881
CPR:6	CHEMICAL	GENE-N	8	4	Comparison of all the gene antagonists tested revealed a potency order of chemical > chemical approximately chemical > chemical approximately chemical > /=chemical > chemical .	T27	T44	10864881
CPR:6	CHEMICAL	GENE-N	18	4	Comparison of all the gene antagonists tested revealed a potency order of chemical > chemical approximately chemical > chemical approximately chemical > /=chemical > chemical .	T28	T44	10864881
CPR:6	CHEMICAL	GENE-N	8	4	Comparison of all the gene antagonists tested revealed a potency order of chemical > chemical approximately chemical > chemical approximately chemical > /=chemical > chemical .	T29	T44	10864881
CPR:6	CHEMICAL	GENE-N	22	4	Comparison of all the gene antagonists tested revealed a potency order of chemical > chemical approximately chemical > chemical approximately chemical > /=chemical > chemical .	T30	T44	10864881
CPR:6	CHEMICAL	GENE-N	8	4	Comparison of all the gene antagonists tested revealed a potency order of chemical > chemical approximately chemical > chemical approximately chemical > /=chemical > chemical .	T31	T44	10864881
NA	CHEMICAL	GENE-N	5	12	None of the drugs caused a significant inhibition of chemical binding to gene , even at concentrations as high as 250 microM .	T32	T45	10864881
CPR:3	CHEMICAL	GENE-N	3	5	The treatment with chemical exhibited a significant increase in some serum hepatic and renal biochemical parameters ( chemical aminotransferase , chemical aminotransferase , gene , total protein , gene , chemical , chemical , chemical and chemical ) .	T4	T15	22301814
CPR:3	CHEMICAL	GENE-N	3	5	The treatment with chemical exhibited a significant increase in some serum hepatic and renal biochemical parameters ( chemical aminotransferase , chemical aminotransferase , gene , total protein , gene , chemical , chemical , chemical and chemical ) .	T4	T16	22301814
CPR:3	CHEMICAL	GENE-N	3	5	The treatment with chemical exhibited a significant increase in some serum hepatic and renal biochemical parameters ( chemical aminotransferase , chemical aminotransferase , gene , total protein , gene , chemical , chemical , chemical and chemical ) .	T4	T17	22301814
CPR:3	CHEMICAL	GENE-Y	3	5	The treatment with chemical exhibited a significant increase in some serum hepatic and renal biochemical parameters ( chemical aminotransferase , chemical aminotransferase , gene , total protein , gene , chemical , chemical , chemical and chemical ) .	T4	T18	22301814
NA	CHEMICAL	GENE-N	5	5	The treatment with chemical exhibited a significant increase in some serum hepatic and renal biochemical parameters ( chemical aminotransferase , chemical aminotransferase , gene , total protein , gene , chemical , chemical , chemical and chemical ) .	T5	T15	22301814
NA	CHEMICAL	GENE-N	5	5	The treatment with chemical exhibited a significant increase in some serum hepatic and renal biochemical parameters ( chemical aminotransferase , chemical aminotransferase , gene , total protein , gene , chemical , chemical , chemical and chemical ) .	T5	T16	22301814
NA	CHEMICAL	GENE-N	5	5	The treatment with chemical exhibited a significant increase in some serum hepatic and renal biochemical parameters ( chemical aminotransferase , chemical aminotransferase , gene , total protein , gene , chemical , chemical , chemical and chemical ) .	T5	T17	22301814
NA	CHEMICAL	GENE-Y	5	5	The treatment with chemical exhibited a significant increase in some serum hepatic and renal biochemical parameters ( chemical aminotransferase , chemical aminotransferase , gene , total protein , gene , chemical , chemical , chemical and chemical ) .	T5	T18	22301814
NA	CHEMICAL	GENE-N	5	5	The treatment with chemical exhibited a significant increase in some serum hepatic and renal biochemical parameters ( chemical aminotransferase , chemical aminotransferase , gene , total protein , gene , chemical , chemical , chemical and chemical ) .	T6	T15	22301814
NA	CHEMICAL	GENE-N	5	5	The treatment with chemical exhibited a significant increase in some serum hepatic and renal biochemical parameters ( chemical aminotransferase , chemical aminotransferase , gene , total protein , gene , chemical , chemical , chemical and chemical ) .	T6	T16	22301814
NA	CHEMICAL	GENE-N	5	5	The treatment with chemical exhibited a significant increase in some serum hepatic and renal biochemical parameters ( chemical aminotransferase , chemical aminotransferase , gene , total protein , gene , chemical , chemical , chemical and chemical ) .	T6	T17	22301814
NA	CHEMICAL	GENE-Y	5	5	The treatment with chemical exhibited a significant increase in some serum hepatic and renal biochemical parameters ( chemical aminotransferase , chemical aminotransferase , gene , total protein , gene , chemical , chemical , chemical and chemical ) .	T6	T18	22301814
NA	CHEMICAL	GENE-N	8	5	The treatment with chemical exhibited a significant increase in some serum hepatic and renal biochemical parameters ( chemical aminotransferase , chemical aminotransferase , gene , total protein , gene , chemical , chemical , chemical and chemical ) .	T7	T15	22301814
NA	CHEMICAL	GENE-N	8	5	The treatment with chemical exhibited a significant increase in some serum hepatic and renal biochemical parameters ( chemical aminotransferase , chemical aminotransferase , gene , total protein , gene , chemical , chemical , chemical and chemical ) .	T7	T16	22301814
NA	CHEMICAL	GENE-N	8	5	The treatment with chemical exhibited a significant increase in some serum hepatic and renal biochemical parameters ( chemical aminotransferase , chemical aminotransferase , gene , total protein , gene , chemical , chemical , chemical and chemical ) .	T7	T17	22301814
NA	CHEMICAL	GENE-Y	8	5	The treatment with chemical exhibited a significant increase in some serum hepatic and renal biochemical parameters ( chemical aminotransferase , chemical aminotransferase , gene , total protein , gene , chemical , chemical , chemical and chemical ) .	T7	T18	22301814
NA	CHEMICAL	GENE-N	32	5	The treatment with chemical exhibited a significant increase in some serum hepatic and renal biochemical parameters ( chemical aminotransferase , chemical aminotransferase , gene , total protein , gene , chemical , chemical , chemical and chemical ) .	T8	T15	22301814
NA	CHEMICAL	GENE-N	32	5	The treatment with chemical exhibited a significant increase in some serum hepatic and renal biochemical parameters ( chemical aminotransferase , chemical aminotransferase , gene , total protein , gene , chemical , chemical , chemical and chemical ) .	T8	T16	22301814
NA	CHEMICAL	GENE-N	32	5	The treatment with chemical exhibited a significant increase in some serum hepatic and renal biochemical parameters ( chemical aminotransferase , chemical aminotransferase , gene , total protein , gene , chemical , chemical , chemical and chemical ) .	T8	T17	22301814
NA	CHEMICAL	GENE-Y	32	5	The treatment with chemical exhibited a significant increase in some serum hepatic and renal biochemical parameters ( chemical aminotransferase , chemical aminotransferase , gene , total protein , gene , chemical , chemical , chemical and chemical ) .	T8	T18	22301814
NA	CHEMICAL	GENE-N	5	5	The treatment with chemical exhibited a significant increase in some serum hepatic and renal biochemical parameters ( chemical aminotransferase , chemical aminotransferase , gene , total protein , gene , chemical , chemical , chemical and chemical ) .	T9	T15	22301814
NA	CHEMICAL	GENE-N	5	5	The treatment with chemical exhibited a significant increase in some serum hepatic and renal biochemical parameters ( chemical aminotransferase , chemical aminotransferase , gene , total protein , gene , chemical , chemical , chemical and chemical ) .	T9	T16	22301814
NA	CHEMICAL	GENE-N	5	5	The treatment with chemical exhibited a significant increase in some serum hepatic and renal biochemical parameters ( chemical aminotransferase , chemical aminotransferase , gene , total protein , gene , chemical , chemical , chemical and chemical ) .	T9	T17	22301814
NA	CHEMICAL	GENE-Y	5	5	The treatment with chemical exhibited a significant increase in some serum hepatic and renal biochemical parameters ( chemical aminotransferase , chemical aminotransferase , gene , total protein , gene , chemical , chemical , chemical and chemical ) .	T9	T18	22301814
NA	CHEMICAL	GENE-N	5	5	The treatment with chemical exhibited a significant increase in some serum hepatic and renal biochemical parameters ( chemical aminotransferase , chemical aminotransferase , gene , total protein , gene , chemical , chemical , chemical and chemical ) .	T10	T15	22301814
NA	CHEMICAL	GENE-N	5	5	The treatment with chemical exhibited a significant increase in some serum hepatic and renal biochemical parameters ( chemical aminotransferase , chemical aminotransferase , gene , total protein , gene , chemical , chemical , chemical and chemical ) .	T10	T16	22301814
NA	CHEMICAL	GENE-N	5	5	The treatment with chemical exhibited a significant increase in some serum hepatic and renal biochemical parameters ( chemical aminotransferase , chemical aminotransferase , gene , total protein , gene , chemical , chemical , chemical and chemical ) .	T10	T17	22301814
NA	CHEMICAL	GENE-Y	5	5	The treatment with chemical exhibited a significant increase in some serum hepatic and renal biochemical parameters ( chemical aminotransferase , chemical aminotransferase , gene , total protein , gene , chemical , chemical , chemical and chemical ) .	T10	T18	22301814
NA	CHEMICAL	GENE-Y	16	4	Conformational variations of both gene and inhibitors provide the structural basis for the physiological effects of chemical and chemical .	T8	T18	17959709
CPR:4	CHEMICAL	GENE-Y	18	4	Conformational variations of both gene and inhibitors provide the structural basis for the physiological effects of chemical and chemical .	T9	T18	17959709
NA	CHEMICAL	GENE-Y	0	5	chemical has higher affinity to gene ( gene ) than chemical and lower administered dosage for the treatment of erectile dysfunction .	T1	T11	17959709
NA	CHEMICAL	GENE-Y	0	7	chemical has higher affinity to gene ( gene ) than chemical and lower administered dosage for the treatment of erectile dysfunction .	T1	T14	17959709
NA	CHEMICAL	GENE-Y	10	5	chemical has higher affinity to gene ( gene ) than chemical and lower administered dosage for the treatment of erectile dysfunction .	T6	T11	17959709
NA	CHEMICAL	GENE-Y	10	7	chemical has higher affinity to gene ( gene ) than chemical and lower administered dosage for the treatment of erectile dysfunction .	T6	T14	17959709
NA	CHEMICAL	GENE-N	3	3	Reported here is a crystal structure of the fully active and nonmutated gene in complex with chemical .	T2	T10	17959709
NA	CHEMICAL	GENE-Y	11	11	The structure shows that the conformation of the H-loop in the gene-chemical complex is different from those of any known structures of the unliganded gene and its complexes with the inhibitors .	T3	T12	17959709
NA	CHEMICAL	GENE-Y	11	24	The structure shows that the conformation of the H-loop in the gene-chemical complex is different from those of any known structures of the unliganded gene and its complexes with the inhibitors .	T3	T13	17959709
NA	CHEMICAL	GENE-Y	7	16	In addition , the molecular configuration of chemical differs from that of chemical when bound to gene .	T4	T15	17959709
NA	CHEMICAL	GENE-Y	12	16	In addition , the molecular configuration of chemical differs from that of chemical when bound to gene .	T5	T15	17959709
NA	CHEMICAL	GENE-N	7	24	It is noteworthy that the binding of chemical causes loss of the divalent metal ions that have been observed in all the previously published gene structures .	T7	T16	17959709
NA	CHEMICAL	GENE-N	0	5	chemical drives a tertiary fold in the gene with familial disease mutation sites at the interface .	T9	T15	23290724
NA	CHEMICAL	GENE-Y	5	12	Here , we identify a chemical-driven chemical-terminal to chemical-terminal tertiary interaction in gene .	T5	T12	23290724
NA	CHEMICAL	GENE-Y	8	12	Here , we identify a chemical-driven chemical-terminal to chemical-terminal tertiary interaction in gene .	T6	T12	23290724
CPR:4	CHEMICAL	GENE-Y	0	5	chemical suppressed the expression of gene , gene , gene , gene , gene and gene at the mRNA and protein level , and inhibited the adhesion of leukocytes to A549 cells .	T5	T9	23160090
CPR:4	CHEMICAL	GENE-Y	0	7	chemical suppressed the expression of gene , gene , gene , gene , gene and gene at the mRNA and protein level , and inhibited the adhesion of leukocytes to A549 cells .	T5	T10	23160090
CPR:4	CHEMICAL	GENE-Y	0	9	chemical suppressed the expression of gene , gene , gene , gene , gene and gene at the mRNA and protein level , and inhibited the adhesion of leukocytes to A549 cells .	T5	T11	23160090
CPR:4	CHEMICAL	GENE-Y	0	11	chemical suppressed the expression of gene , gene , gene , gene , gene and gene at the mRNA and protein level , and inhibited the adhesion of leukocytes to A549 cells .	T5	T12	23160090
CPR:4	CHEMICAL	GENE-Y	0	13	chemical suppressed the expression of gene , gene , gene , gene , gene and gene at the mRNA and protein level , and inhibited the adhesion of leukocytes to A549 cells .	T5	T13	23160090
CPR:4	CHEMICAL	GENE-Y	0	15	chemical suppressed the expression of gene , gene , gene , gene , gene and gene at the mRNA and protein level , and inhibited the adhesion of leukocytes to A549 cells .	T5	T14	23160090
CPR:4	CHEMICAL	GENE-N	0	4	chemical treatment also decreased gene gene nuclear translocation and inhibited the phosphorylation of gene gene ( gene gene ) .	T6	T15	23160090
CPR:4	CHEMICAL	GENE-Y	0	5	chemical treatment also decreased gene gene nuclear translocation and inhibited the phosphorylation of gene gene ( gene gene ) .	T6	T16	23160090
CPR:4	CHEMICAL	GENE-N	0	13	chemical treatment also decreased gene gene nuclear translocation and inhibited the phosphorylation of gene gene ( gene gene ) .	T6	T17	23160090
CPR:4	CHEMICAL	GENE-N	0	14	chemical treatment also decreased gene gene nuclear translocation and inhibited the phosphorylation of gene gene ( gene gene ) .	T6	T18	23160090
CPR:4	CHEMICAL	GENE-N	0	16	chemical treatment also decreased gene gene nuclear translocation and inhibited the phosphorylation of gene gene ( gene gene ) .	T6	T19	23160090
CPR:4	CHEMICAL	GENE-N	0	17	chemical treatment also decreased gene gene nuclear translocation and inhibited the phosphorylation of gene gene ( gene gene ) .	T6	T20	23160090
NA	CHEMICAL	GENE-Y	4	8	Key marker of diabetes in cells is the gene ( gene ) which also responds to exogenous chemicals , and is over expressed up to 5- and 4-fold , by Tinospora cordifolia and chemical , respectively .	T2	T6	23290487
NA	CHEMICAL	GENE-Y	4	10	Key marker of diabetes in cells is the gene ( gene ) which also responds to exogenous chemicals , and is over expressed up to 5- and 4-fold , by Tinospora cordifolia and chemical , respectively .	T2	T7	23290487
CPR:9	CHEMICAL	GENE-Y	8	2	Next to gene , the predominant protein influencing chemical metabolism is gene whose expressions were also positively modulated .	T3	T8	23290487
NA	CHEMICAL	GENE-N	8	11	Next to gene , the predominant protein influencing chemical metabolism is gene whose expressions were also positively modulated .	T3	T9	23290487
NA	CHEMICAL	GENE-Y	10	4	Species-specific differences in the gene transactivation function upon binding with chemical .	T12	T23	12188035
CPR:5	CHEMICAL	GENE-N	0	28	chemical ( chemical ) , chemical ( chemical ) , and their esterified-derivatives had full transrepression agonistic activity in a reporter assay using CV-1 cells transfected with either gene .	T5	T20	12188035
CPR:5	CHEMICAL	GENE-N	2	28	chemical ( chemical ) , chemical ( chemical ) , and their esterified-derivatives had full transrepression agonistic activity in a reporter assay using CV-1 cells transfected with either gene .	T6	T20	12188035
CPR:5	CHEMICAL	GENE-N	5	28	chemical ( chemical ) , chemical ( chemical ) , and their esterified-derivatives had full transrepression agonistic activity in a reporter assay using CV-1 cells transfected with either gene .	T7	T20	12188035
CPR:5	CHEMICAL	GENE-N	7	28	chemical ( chemical ) , chemical ( chemical ) , and their esterified-derivatives had full transrepression agonistic activity in a reporter assay using CV-1 cells transfected with either gene .	T8	T20	12188035
CPR:5	CHEMICAL	GENE-Y	1	15	The esterified-chemical , however , had only partial transactivation agonistic activity in cells transfected with gene , whereas chemical and esterified-chemical had full transactivation agonistic activity .	T9	T22	12188035
CPR:5	CHEMICAL	GENE-Y	18	15	The esterified-chemical , however , had only partial transactivation agonistic activity in cells transfected with gene , whereas chemical and esterified-chemical had full transactivation agonistic activity .	T10	T22	12188035
CPR:5	CHEMICAL	GENE-Y	20	15	The esterified-chemical , however , had only partial transactivation agonistic activity in cells transfected with gene , whereas chemical and esterified-chemical had full transactivation agonistic activity .	T11	T22	12188035
NA	CHEMICAL	GENE-Y	9	2	Moreover , in rat hepatoma H4-II-E cells , the esterified-chemical failed to induce chemical aminotransferase , which is regulated by gene-mediated transactivation activity .	T1	T13	12188035
CPR:5	CHEMICAL	GENE-Y	9	20	Moreover , in rat hepatoma H4-II-E cells , the esterified-chemical failed to induce chemical aminotransferase , which is regulated by gene-mediated transactivation activity .	T1	T14	12188035
NA	CHEMICAL	GENE-Y	2	2	Moreover , in rat hepatoma H4-II-E cells , the esterified-chemical failed to induce chemical aminotransferase , which is regulated by gene-mediated transactivation activity .	T2	T13	12188035
NA	CHEMICAL	GENE-Y	2	20	Moreover , in rat hepatoma H4-II-E cells , the esterified-chemical failed to induce chemical aminotransferase , which is regulated by gene-mediated transactivation activity .	T2	T14	12188035
CPR:5	CHEMICAL	GENE-Y	7	10	Consistent with the weak transactivation activity of esterified-chemical mediated by gene , there were few side effects , evaluated by thymus involution and body weight loss , in an antigen-induced asthmatic model in rats .	T3	T16	12188035
CPR:4	CHEMICAL	GENE-N	3	8	Anti-inflammatory effect of chemical via the suppression of gene pathway .	T13	T36	23597450
CPR:4	CHEMICAL	GENE-Y	4	15	Promoter assay revealed that chemical inhibits LPS-induced chemical and chemical production through the suppression of gene and gene at the transcriptional level .	T10	T34	23597450
CPR:4	CHEMICAL	GENE-Y	4	17	Promoter assay revealed that chemical inhibits LPS-induced chemical and chemical production through the suppression of gene and gene at the transcriptional level .	T10	T35	23597450
NA	CHEMICAL	GENE-Y	7	15	Promoter assay revealed that chemical inhibits LPS-induced chemical and chemical production through the suppression of gene and gene at the transcriptional level .	T11	T34	23597450
NA	CHEMICAL	GENE-Y	7	17	Promoter assay revealed that chemical inhibits LPS-induced chemical and chemical production through the suppression of gene and gene at the transcriptional level .	T11	T35	23597450
NA	CHEMICAL	GENE-Y	9	15	Promoter assay revealed that chemical inhibits LPS-induced chemical and chemical production through the suppression of gene and gene at the transcriptional level .	T12	T34	23597450
NA	CHEMICAL	GENE-Y	9	17	Promoter assay revealed that chemical inhibits LPS-induced chemical and chemical production through the suppression of gene and gene at the transcriptional level .	T12	T35	23597450
CPR:4	CHEMICAL	GENE-N	3	5	In addition , chemical inhibits gene-dependent inflammatory responses by modulating gene ( gene ) -gene ( gene ) -gene signaling .	T2	T14	23597450
NA	CHEMICAL	GENE-N	3	10	In addition , chemical inhibits gene-dependent inflammatory responses by modulating gene ( gene ) -gene ( gene ) -gene signaling .	T2	T15	23597450
NA	CHEMICAL	GENE-N	3	12	In addition , chemical inhibits gene-dependent inflammatory responses by modulating gene ( gene ) -gene ( gene ) -gene signaling .	T2	T16	23597450
NA	CHEMICAL	GENE-Y	3	14	In addition , chemical inhibits gene-dependent inflammatory responses by modulating gene ( gene ) -gene ( gene ) -gene signaling .	T2	T17	23597450
NA	CHEMICAL	GENE-Y	3	16	In addition , chemical inhibits gene-dependent inflammatory responses by modulating gene ( gene ) -gene ( gene ) -gene signaling .	T2	T18	23597450
NA	CHEMICAL	GENE-N	3	18	In addition , chemical inhibits gene-dependent inflammatory responses by modulating gene ( gene ) -gene ( gene ) -gene signaling .	T2	T19	23597450
CPR:4	CHEMICAL	GENE-N	5	12	Consistent with these results , chemical significantly reduced serum levels of inflammatory gene and mortality in mice challenged with lipopolysaccharide .	T3	T20	23597450
NA	CHEMICAL	GENE-Y	1	0	gene chemical receptors , seizures , and the amygdala .	T17	T42	12724156
NA	CHEMICAL	GENE-N	1	2	gene chemical receptors , seizures , and the amygdala .	T17	T43	12724156
NA	CHEMICAL	GENE-Y	9	5	Several lines of evidence implicate gene ( gene ) chemical receptors , a type of gene , in the amygdala 's vulnerability to seizures and epileptogenesis .	T8	T25	12724156
NA	CHEMICAL	GENE-Y	9	6	Several lines of evidence implicate gene ( gene ) chemical receptors , a type of gene , in the amygdala 's vulnerability to seizures and epileptogenesis .	T8	T26	12724156
NA	CHEMICAL	GENE-N	9	10	Several lines of evidence implicate gene ( gene ) chemical receptors , a type of gene , in the amygdala 's vulnerability to seizures and epileptogenesis .	T8	T29	12724156
NA	CHEMICAL	GENE-N	9	15	Several lines of evidence implicate gene ( gene ) chemical receptors , a type of gene , in the amygdala 's vulnerability to seizures and epileptogenesis .	T8	T30	12724156
NA	CHEMICAL	GENE-Y	12	5	Several lines of evidence implicate gene ( gene ) chemical receptors , a type of gene , in the amygdala 's vulnerability to seizures and epileptogenesis .	T9	T25	12724156
NA	CHEMICAL	GENE-Y	12	6	Several lines of evidence implicate gene ( gene ) chemical receptors , a type of gene , in the amygdala 's vulnerability to seizures and epileptogenesis .	T9	T26	12724156
NA	CHEMICAL	GENE-N	12	10	Several lines of evidence implicate gene ( gene ) chemical receptors , a type of gene , in the amygdala 's vulnerability to seizures and epileptogenesis .	T9	T29	12724156
NA	CHEMICAL	GENE-N	12	15	Several lines of evidence implicate gene ( gene ) chemical receptors , a type of gene , in the amygdala 's vulnerability to seizures and epileptogenesis .	T9	T30	12724156
NA	CHEMICAL	GENE-Y	6	5	Brain slice recordings indicate that gene chemical receptors mediate a portion of the synaptic excitation of neurons in the rat basolateral amygdala .	T10	T32	12724156
NA	CHEMICAL	GENE-N	6	7	Brain slice recordings indicate that gene chemical receptors mediate a portion of the synaptic excitation of neurons in the rat basolateral amygdala .	T10	T33	12724156
NA	CHEMICAL	GENE-Y	6	5	Whole-cell voltage-clamp studies demonstrate that gene chemical receptor-mediated synaptic currents are inwardly rectifying and are likely to be chemical permeable .	T11	T34	12724156
NA	CHEMICAL	GENE-N	6	16	Whole-cell voltage-clamp studies demonstrate that gene chemical receptor-mediated synaptic currents are inwardly rectifying and are likely to be chemical permeable .	T11	T35	12724156
NA	CHEMICAL	GENE-Y	18	5	Whole-cell voltage-clamp studies demonstrate that gene chemical receptor-mediated synaptic currents are inwardly rectifying and are likely to be chemical permeable .	T12	T34	12724156
NA	CHEMICAL	GENE-N	18	16	Whole-cell voltage-clamp studies demonstrate that gene chemical receptor-mediated synaptic currents are inwardly rectifying and are likely to be chemical permeable .	T12	T35	12724156
NA	CHEMICAL	GENE-Y	6	5	Prolonged activation of basolateral amygdala gene chemical receptors results in enduring synaptic facilitation through a chemical-dependent process .	T13	T36	12724156
NA	CHEMICAL	GENE-N	6	7	Prolonged activation of basolateral amygdala gene chemical receptors results in enduring synaptic facilitation through a chemical-dependent process .	T13	T37	12724156
NA	CHEMICAL	GENE-Y	14	5	Prolonged activation of basolateral amygdala gene chemical receptors results in enduring synaptic facilitation through a chemical-dependent process .	T14	T36	12724156
NA	CHEMICAL	GENE-N	14	7	Prolonged activation of basolateral amygdala gene chemical receptors results in enduring synaptic facilitation through a chemical-dependent process .	T14	T37	12724156
NA	CHEMICAL	GENE-Y	3	2	The selective gene chemical receptor agonist ATPA induces spontaneous epileptiform bursting that is sensitive to the gene gene antagonist chemical .	T15	T38	12724156
NA	CHEMICAL	GENE-N	3	4	The selective gene chemical receptor agonist ATPA induces spontaneous epileptiform bursting that is sensitive to the gene gene antagonist chemical .	T15	T39	12724156
NA	CHEMICAL	GENE-Y	3	16	The selective gene chemical receptor agonist ATPA induces spontaneous epileptiform bursting that is sensitive to the gene gene antagonist chemical .	T15	T40	12724156
NA	CHEMICAL	GENE-N	3	4	The selective gene chemical receptor agonist ATPA induces spontaneous epileptiform bursting that is sensitive to the gene gene antagonist chemical .	T15	T41	12724156
NA	CHEMICAL	GENE-Y	3	2	The selective gene chemical receptor agonist ATPA induces spontaneous epileptiform bursting that is sensitive to the gene gene antagonist chemical .	T1	T38	12724156
NA	CHEMICAL	GENE-N	3	4	The selective gene chemical receptor agonist ATPA induces spontaneous epileptiform bursting that is sensitive to the gene gene antagonist chemical .	T1	T39	12724156
CPR:6	CHEMICAL	GENE-Y	3	16	The selective gene chemical receptor agonist ATPA induces spontaneous epileptiform bursting that is sensitive to the gene gene antagonist chemical .	T1	T40	12724156
CPR:6	CHEMICAL	GENE-N	3	4	The selective gene chemical receptor agonist ATPA induces spontaneous epileptiform bursting that is sensitive to the gene gene antagonist chemical .	T1	T41	12724156
NA	CHEMICAL	GENE-Y	7	6	Together , these observations indicate that gene chemical receptors have a unique role in triggering epileptiform activity in the amygdala and could participate in long-term plasticity mechanisms that underlie some forms of epileptogenesis .	T2	T18	12724156
NA	CHEMICAL	GENE-N	7	8	Together , these observations indicate that gene chemical receptors have a unique role in triggering epileptiform activity in the amygdala and could participate in long-term plasticity mechanisms that underlie some forms of epileptogenesis .	T2	T19	12724156
NA	CHEMICAL	GENE-Y	3	2	Accordingly , gene chemical receptors represent a potential target for antiepileptic and antiepileptogenic drug treatments .	T3	T20	12724156
NA	CHEMICAL	GENE-N	3	4	Accordingly , gene chemical receptors represent a potential target for antiepileptic and antiepileptogenic drug treatments .	T3	T21	12724156
NA	CHEMICAL	GENE-N	9	10	Most antiepileptic drugs do not act through effects on chemical receptors .	T4	T22	12724156
NA	CHEMICAL	GENE-Y	0	6	chemical dose and the pharmacogenomics of gene and gene - rationale and perspectives .	T12	T23	17161452
NA	CHEMICAL	GENE-Y	0	8	chemical dose and the pharmacogenomics of gene and gene - rationale and perspectives .	T12	T24	17161452
CPR:9	CHEMICAL	GENE-Y	7	10	Pharmacogenetic analysis of two genes , the chemical metabolic enzyme gene and chemical target enzyme , chemical reductase complex 1 gene , confirmed their influence on chemical maintenance dose .	T4	T16	17161452
NA	CHEMICAL	GENE-Y	7	19	Pharmacogenetic analysis of two genes , the chemical metabolic enzyme gene and chemical target enzyme , chemical reductase complex 1 gene , confirmed their influence on chemical maintenance dose .	T4	T17	17161452
NA	CHEMICAL	GENE-Y	7	19	Pharmacogenetic analysis of two genes , the chemical metabolic enzyme gene and chemical target enzyme , chemical reductase complex 1 gene , confirmed their influence on chemical maintenance dose .	T4	T18	17161452
NA	CHEMICAL	GENE-Y	12	10	Pharmacogenetic analysis of two genes , the chemical metabolic enzyme gene and chemical target enzyme , chemical reductase complex 1 gene , confirmed their influence on chemical maintenance dose .	T5	T16	17161452
NA	CHEMICAL	GENE-Y	12	19	Pharmacogenetic analysis of two genes , the chemical metabolic enzyme gene and chemical target enzyme , chemical reductase complex 1 gene , confirmed their influence on chemical maintenance dose .	T5	T17	17161452
NA	CHEMICAL	GENE-Y	12	19	Pharmacogenetic analysis of two genes , the chemical metabolic enzyme gene and chemical target enzyme , chemical reductase complex 1 gene , confirmed their influence on chemical maintenance dose .	T5	T18	17161452
NA	CHEMICAL	GENE-Y	16	10	Pharmacogenetic analysis of two genes , the chemical metabolic enzyme gene and chemical target enzyme , chemical reductase complex 1 gene , confirmed their influence on chemical maintenance dose .	T6	T16	17161452
NA	CHEMICAL	GENE-Y	16	19	Pharmacogenetic analysis of two genes , the chemical metabolic enzyme gene and chemical target enzyme , chemical reductase complex 1 gene , confirmed their influence on chemical maintenance dose .	T6	T17	17161452
NA	CHEMICAL	GENE-Y	16	19	Pharmacogenetic analysis of two genes , the chemical metabolic enzyme gene and chemical target enzyme , chemical reductase complex 1 gene , confirmed their influence on chemical maintenance dose .	T6	T18	17161452
NA	CHEMICAL	GENE-Y	26	10	Pharmacogenetic analysis of two genes , the chemical metabolic enzyme gene and chemical target enzyme , chemical reductase complex 1 gene , confirmed their influence on chemical maintenance dose .	T7	T16	17161452
NA	CHEMICAL	GENE-Y	26	19	Pharmacogenetic analysis of two genes , the chemical metabolic enzyme gene and chemical target enzyme , chemical reductase complex 1 gene , confirmed their influence on chemical maintenance dose .	T7	T17	17161452
NA	CHEMICAL	GENE-Y	26	19	Pharmacogenetic analysis of two genes , the chemical metabolic enzyme gene and chemical target enzyme , chemical reductase complex 1 gene , confirmed their influence on chemical maintenance dose .	T7	T18	17161452
CPR:9	CHEMICAL	GENE-Y	10	2	Possession of gene*2 or gene*3 variant alleles , which result in decreased enzyme activity , is associated with a significant decrease in the mean chemical dose .	T8	T19	17161452
CPR:9	CHEMICAL	GENE-Y	10	4	Possession of gene*2 or gene*3 variant alleles , which result in decreased enzyme activity , is associated with a significant decrease in the mean chemical dose .	T8	T20	17161452
NA	CHEMICAL	GENE-Y	2	8	Several single chemical polymorphisms ( SNPs ) in gene are associated with chemical dose across the normal dose range .	T9	T21	17161452
NA	CHEMICAL	GENE-Y	7	8	Several single chemical polymorphisms ( SNPs ) in gene are associated with chemical dose across the normal dose range .	T10	T21	17161452
NA	CHEMICAL	GENE-Y	6	18	Haplotypes based on these SNPs explain a large fraction of the interindividual variation in chemical dose , and gene has an approximately three-fold greater effect than gene .	T11	T22	17161452
NA	CHEMICAL	GENE-Y	6	26	Haplotypes based on these SNPs explain a large fraction of the interindividual variation in chemical dose , and gene has an approximately three-fold greater effect than gene .	T11	T13	17161452
CPR:4	CHEMICAL	GENE-N	9	19	Previous studies by this research team proved that vasodilating chemical ( chemical ) E1 , E2 and I2 inhibit gene ( gene ) in vitro and in vivo , which suggested involvement of gene in gastric acid secretion inhibition and the increase of gastric mucosa blood flow produced by this group of chemical .	T6	T15	8667211
CPR:4	CHEMICAL	GENE-N	9	21	Previous studies by this research team proved that vasodilating chemical ( chemical ) E1 , E2 and I2 inhibit gene ( gene ) in vitro and in vivo , which suggested involvement of gene in gastric acid secretion inhibition and the increase of gastric mucosa blood flow produced by this group of chemical .	T6	T20	8667211
NA	CHEMICAL	GENE-N	9	33	Previous studies by this research team proved that vasodilating chemical ( chemical ) E1 , E2 and I2 inhibit gene ( gene ) in vitro and in vivo , which suggested involvement of gene in gastric acid secretion inhibition and the increase of gastric mucosa blood flow produced by this group of chemical .	T6	T24	8667211
CPR:4	CHEMICAL	GENE-N	11	19	Previous studies by this research team proved that vasodilating chemical ( chemical ) E1 , E2 and I2 inhibit gene ( gene ) in vitro and in vivo , which suggested involvement of gene in gastric acid secretion inhibition and the increase of gastric mucosa blood flow produced by this group of chemical .	T9	T15	8667211
CPR:4	CHEMICAL	GENE-N	11	21	Previous studies by this research team proved that vasodilating chemical ( chemical ) E1 , E2 and I2 inhibit gene ( gene ) in vitro and in vivo , which suggested involvement of gene in gastric acid secretion inhibition and the increase of gastric mucosa blood flow produced by this group of chemical .	T9	T20	8667211
NA	CHEMICAL	GENE-N	11	33	Previous studies by this research team proved that vasodilating chemical ( chemical ) E1 , E2 and I2 inhibit gene ( gene ) in vitro and in vivo , which suggested involvement of gene in gastric acid secretion inhibition and the increase of gastric mucosa blood flow produced by this group of chemical .	T9	T24	8667211
NA	CHEMICAL	GENE-N	21	19	Previous studies by this research team proved that vasodilating chemical ( chemical ) E1 , E2 and I2 inhibit gene ( gene ) in vitro and in vivo , which suggested involvement of gene in gastric acid secretion inhibition and the increase of gastric mucosa blood flow produced by this group of chemical .	T2	T15	8667211
NA	CHEMICAL	GENE-N	21	21	Previous studies by this research team proved that vasodilating chemical ( chemical ) E1 , E2 and I2 inhibit gene ( gene ) in vitro and in vivo , which suggested involvement of gene in gastric acid secretion inhibition and the increase of gastric mucosa blood flow produced by this group of chemical .	T2	T20	8667211
NA	CHEMICAL	GENE-N	21	33	Previous studies by this research team proved that vasodilating chemical ( chemical ) E1 , E2 and I2 inhibit gene ( gene ) in vitro and in vivo , which suggested involvement of gene in gastric acid secretion inhibition and the increase of gastric mucosa blood flow produced by this group of chemical .	T2	T24	8667211
NA	CHEMICAL	GENE-N	16	14	The results show that the NSAIDs used here , which reduce the activity of gene and chemical production , activated gene and gene in a dose-dependent manner by a mechanism of the noncompetitive type .	T7	T27	8667211
NA	CHEMICAL	GENE-Y	16	20	The results show that the NSAIDs used here , which reduce the activity of gene and chemical production , activated gene and gene in a dose-dependent manner by a mechanism of the noncompetitive type .	T7	T28	8667211
NA	CHEMICAL	GENE-Y	16	22	The results show that the NSAIDs used here , which reduce the activity of gene and chemical production , activated gene and gene in a dose-dependent manner by a mechanism of the noncompetitive type .	T7	T29	8667211
NA	CHEMICAL	GENE-Y	0	14	chemical and chemical added to NSAIDs amplified the activating effect of the latter on gene .	T8	T30	8667211
CPR:3	CHEMICAL	GENE-Y	2	14	chemical and chemical added to NSAIDs amplified the activating effect of the latter on gene .	T10	T30	8667211
CPR:4	CHEMICAL	GENE-Y	4	11	Association of PGE2 or chemical to NSAIDs reduced NSAID-induced activation of gene and gene .	T11	T31	8667211
CPR:4	CHEMICAL	GENE-Y	4	13	Association of PGE2 or chemical to NSAIDs reduced NSAID-induced activation of gene and gene .	T11	T32	8667211
CPR:3	CHEMICAL	GENE-Y	0	8	chemical abolished the inhibitory effect of chemical on gene and gene .	T12	T13	8667211
CPR:3	CHEMICAL	GENE-Y	0	10	chemical abolished the inhibitory effect of chemical on gene and gene .	T12	T14	8667211
CPR:4	CHEMICAL	GENE-Y	0	8	chemical abolished the inhibitory effect of chemical on gene and gene .	T1	T13	8667211
CPR:4	CHEMICAL	GENE-Y	0	10	chemical abolished the inhibitory effect of chemical on gene and gene .	T1	T14	8667211
NA	CHEMICAL	GENE-Y	0	3	chemical adenosyltransferase II beta subunit gene expression provides a proliferative advantage in human hepatoma .	T11	T23	12671891
NA	CHEMICAL	GENE-Y	14	9	BACKGROUND & AIMS : Of the 2 genes ( gene , gene ) encoding chemical adenosyltransferase , the enzyme that synthesizes chemical , gene , is expressed in liver , whereas gene is expressed in extrahepatic tissues .	T8	T17	12671891
NA	CHEMICAL	GENE-Y	14	6	BACKGROUND & AIMS : Of the 2 genes ( gene , gene ) encoding chemical adenosyltransferase , the enzyme that synthesizes chemical , gene , is expressed in liver , whereas gene is expressed in extrahepatic tissues .	T8	T18	12671891
NA	CHEMICAL	GENE-N	14	15	BACKGROUND & AIMS : Of the 2 genes ( gene , gene ) encoding chemical adenosyltransferase , the enzyme that synthesizes chemical , gene , is expressed in liver , whereas gene is expressed in extrahepatic tissues .	T8	T21	12671891
NA	CHEMICAL	GENE-Y	14	23	BACKGROUND & AIMS : Of the 2 genes ( gene , gene ) encoding chemical adenosyltransferase , the enzyme that synthesizes chemical , gene , is expressed in liver , whereas gene is expressed in extrahepatic tissues .	T8	T12	12671891
NA	CHEMICAL	GENE-Y	14	6	BACKGROUND & AIMS : Of the 2 genes ( gene , gene ) encoding chemical adenosyltransferase , the enzyme that synthesizes chemical , gene , is expressed in liver , whereas gene is expressed in extrahepatic tissues .	T8	T15	12671891
CPR:9	CHEMICAL	GENE-Y	9	9	BACKGROUND & AIMS : Of the 2 genes ( gene , gene ) encoding chemical adenosyltransferase , the enzyme that synthesizes chemical , gene , is expressed in liver , whereas gene is expressed in extrahepatic tissues .	T1	T17	12671891
CPR:9	CHEMICAL	GENE-Y	9	6	BACKGROUND & AIMS : Of the 2 genes ( gene , gene ) encoding chemical adenosyltransferase , the enzyme that synthesizes chemical , gene , is expressed in liver , whereas gene is expressed in extrahepatic tissues .	T1	T18	12671891
CPR:9	CHEMICAL	GENE-N	9	15	BACKGROUND & AIMS : Of the 2 genes ( gene , gene ) encoding chemical adenosyltransferase , the enzyme that synthesizes chemical , gene , is expressed in liver , whereas gene is expressed in extrahepatic tissues .	T1	T21	12671891
CPR:9	CHEMICAL	GENE-Y	9	23	BACKGROUND & AIMS : Of the 2 genes ( gene , gene ) encoding chemical adenosyltransferase , the enzyme that synthesizes chemical , gene , is expressed in liver , whereas gene is expressed in extrahepatic tissues .	T1	T12	12671891
NA	CHEMICAL	GENE-Y	9	6	BACKGROUND & AIMS : Of the 2 genes ( gene , gene ) encoding chemical adenosyltransferase , the enzyme that synthesizes chemical , gene , is expressed in liver , whereas gene is expressed in extrahepatic tissues .	T1	T15	12671891
NA	CHEMICAL	GENE-Y	13	19	The beta subunit has been cloned and shown to lower the K ( m ) of chemical adenosyltransferase II alpha2 ( the gene product ) for chemical and to render the enzyme more susceptible to chemical inhibition .	T6	T19	12671891
NA	CHEMICAL	GENE-Y	13	22	The beta subunit has been cloned and shown to lower the K ( m ) of chemical adenosyltransferase II alpha2 ( the gene product ) for chemical and to render the enzyme more susceptible to chemical inhibition .	T6	T20	12671891
CPR:9	CHEMICAL	GENE-Y	13	19	The beta subunit has been cloned and shown to lower the K ( m ) of chemical adenosyltransferase II alpha2 ( the gene product ) for chemical and to render the enzyme more susceptible to chemical inhibition .	T7	T19	12671891
CPR:9	CHEMICAL	GENE-Y	13	22	The beta subunit has been cloned and shown to lower the K ( m ) of chemical adenosyltransferase II alpha2 ( the gene product ) for chemical and to render the enzyme more susceptible to chemical inhibition .	T7	T20	12671891
CPR:4	CHEMICAL	GENE-Y	13	19	The beta subunit has been cloned and shown to lower the K ( m ) of chemical adenosyltransferase II alpha2 ( the gene product ) for chemical and to render the enzyme more susceptible to chemical inhibition .	T9	T19	12671891
CPR:4	CHEMICAL	GENE-Y	13	22	The beta subunit has been cloned and shown to lower the K ( m ) of chemical adenosyltransferase II alpha2 ( the gene product ) for chemical and to render the enzyme more susceptible to chemical inhibition .	T9	T20	12671891
NA	CHEMICAL	GENE-N	2	7	METHODS : chemical adenosyltransferase II alpha2 and beta subunit expression was analyzed in human and rat liver and hepatoma cell lines and their interaction studied in HuH7 cells .	T10	T22	12671891
NA	CHEMICAL	GENE-N	3	8	The interaction between chemical adenosyltransferase II alpha2 and beta subunit was demonstrated in HuH7 cells .	T3	T13	12671891
NA	CHEMICAL	GENE-Y	6	0	gene-mimetic peptides ( TXM ) reverse chemical induced apoptosis and restore gene secretion in insulinoma cells .	T10	T38	23327993
NA	CHEMICAL	GENE-N	6	11	gene-mimetic peptides ( TXM ) reverse chemical induced apoptosis and restore gene secretion in insulinoma cells .	T10	T39	23327993
NA	CHEMICAL	GENE-Y	21	1	The gene mimetics peptides ( TXM ) protected insulinoma INS 832/13 cells from oxidative stress induced by selectively inhibiting gene with chemical ( chemical ) .	T5	T28	23327993
CPR:4	CHEMICAL	GENE-N	21	19	The gene mimetics peptides ( TXM ) protected insulinoma INS 832/13 cells from oxidative stress induced by selectively inhibiting gene with chemical ( chemical ) .	T5	T31	23327993
NA	CHEMICAL	GENE-Y	23	1	The gene mimetics peptides ( TXM ) protected insulinoma INS 832/13 cells from oxidative stress induced by selectively inhibiting gene with chemical ( chemical ) .	T6	T28	23327993
CPR:4	CHEMICAL	GENE-N	23	19	The gene mimetics peptides ( TXM ) protected insulinoma INS 832/13 cells from oxidative stress induced by selectively inhibiting gene with chemical ( chemical ) .	T6	T31	23327993
CPR:3	CHEMICAL	GENE-N	7	8	The TXM peptides were effective in inhibiting chemical-induced gene , gene and gene ( gene ) phosphorylation , in correlation with preventing gene cleavage and thereby gene dissociation .	T8	T32	23327993
CPR:3	CHEMICAL	GENE-N	7	10	The TXM peptides were effective in inhibiting chemical-induced gene , gene and gene ( gene ) phosphorylation , in correlation with preventing gene cleavage and thereby gene dissociation .	T8	T33	23327993
CPR:3	CHEMICAL	GENE-N	7	12	The TXM peptides were effective in inhibiting chemical-induced gene , gene and gene ( gene ) phosphorylation , in correlation with preventing gene cleavage and thereby gene dissociation .	T8	T34	23327993
CPR:3	CHEMICAL	GENE-N	7	14	The TXM peptides were effective in inhibiting chemical-induced gene , gene and gene ( gene ) phosphorylation , in correlation with preventing gene cleavage and thereby gene dissociation .	T8	T35	23327993
NA	CHEMICAL	GENE-Y	7	22	The TXM peptides were effective in inhibiting chemical-induced gene , gene and gene ( gene ) phosphorylation , in correlation with preventing gene cleavage and thereby gene dissociation .	T8	T36	23327993
NA	CHEMICAL	GENE-Y	7	26	The TXM peptides were effective in inhibiting chemical-induced gene , gene and gene ( gene ) phosphorylation , in correlation with preventing gene cleavage and thereby gene dissociation .	T8	T37	23327993
NA	CHEMICAL	GENE-N	8	3	Unable to reverse gene phosphorylation , TXM-CB3 ( chemical ) appeared to function in part , through inhibiting gene-gene dissociation .	T4	T14	23327993
NA	CHEMICAL	GENE-Y	8	18	Unable to reverse gene phosphorylation , TXM-CB3 ( chemical ) appeared to function in part , through inhibiting gene-gene dissociation .	T4	T15	23327993
NA	CHEMICAL	GENE-Y	8	18	Unable to reverse gene phosphorylation , TXM-CB3 ( chemical ) appeared to function in part , through inhibiting gene-gene dissociation .	T4	T16	23327993
NA	CHEMICAL	GENE-Y	18	12	Biophysical properties , pharmacology , and modulation of human , neuronal L-type ( gene , gene ) voltage-dependent chemical currents .	T23	T46	11160515
NA	CHEMICAL	GENE-Y	18	12	Biophysical properties , pharmacology , and modulation of human , neuronal L-type ( gene , gene ) voltage-dependent chemical currents .	T23	T47	11160515
NA	CHEMICAL	GENE-N	9	0	gene ( VDCCs ) are multimeric complexes composed of a pore-forming alpha ( 1 ) subunit together with several accessory subunits , including alpha ( 2 ) delta , beta , and , in some cases , gamma subunits .	T14	T24	11160515
NA	CHEMICAL	GENE-N	17	7	Neuroendocrine L-type currents have a significant role in the control of neurosecretion and can be inhibited by chemical-binding ( G- ) proteins .	T20	T39	11160515
NA	CHEMICAL	GENE-N	18	10	To investigate the biophysical and pharmacological properties and role of gene modulation of gene , we have examined chemical channel currents formed by the gene subunit , co-expressed with alpha ( 2 ) delta-1 and beta ( 3a ) , stably expressed in a human embryonic kidney ( HEK ) 293 cell line , using whole cell and perforated patch-clamp techniques .	T21	T42	11160515
NA	CHEMICAL	GENE-Y	18	13	To investigate the biophysical and pharmacological properties and role of gene modulation of gene , we have examined chemical channel currents formed by the gene subunit , co-expressed with alpha ( 2 ) delta-1 and beta ( 3a ) , stably expressed in a human embryonic kidney ( HEK ) 293 cell line , using whole cell and perforated patch-clamp techniques .	T21	T43	11160515
NA	CHEMICAL	GENE-N	18	19	To investigate the biophysical and pharmacological properties and role of gene modulation of gene , we have examined chemical channel currents formed by the gene subunit , co-expressed with alpha ( 2 ) delta-1 and beta ( 3a ) , stably expressed in a human embryonic kidney ( HEK ) 293 cell line , using whole cell and perforated patch-clamp techniques .	T21	T44	11160515
NA	CHEMICAL	GENE-Y	18	24	To investigate the biophysical and pharmacological properties and role of gene modulation of gene , we have examined chemical channel currents formed by the gene subunit , co-expressed with alpha ( 2 ) delta-1 and beta ( 3a ) , stably expressed in a human embryonic kidney ( HEK ) 293 cell line , using whole cell and perforated patch-clamp techniques .	T21	T45	11160515
NA	CHEMICAL	GENE-N	43	10	To investigate the biophysical and pharmacological properties and role of gene modulation of gene , we have examined chemical channel currents formed by the gene subunit , co-expressed with alpha ( 2 ) delta-1 and beta ( 3a ) , stably expressed in a human embryonic kidney ( HEK ) 293 cell line , using whole cell and perforated patch-clamp techniques .	T22	T42	11160515
NA	CHEMICAL	GENE-Y	43	13	To investigate the biophysical and pharmacological properties and role of gene modulation of gene , we have examined chemical channel currents formed by the gene subunit , co-expressed with alpha ( 2 ) delta-1 and beta ( 3a ) , stably expressed in a human embryonic kidney ( HEK ) 293 cell line , using whole cell and perforated patch-clamp techniques .	T22	T43	11160515
NA	CHEMICAL	GENE-N	43	19	To investigate the biophysical and pharmacological properties and role of gene modulation of gene , we have examined chemical channel currents formed by the gene subunit , co-expressed with alpha ( 2 ) delta-1 and beta ( 3a ) , stably expressed in a human embryonic kidney ( HEK ) 293 cell line , using whole cell and perforated patch-clamp techniques .	T22	T44	11160515
NA	CHEMICAL	GENE-Y	43	24	To investigate the biophysical and pharmacological properties and role of gene modulation of gene , we have examined chemical channel currents formed by the gene subunit , co-expressed with alpha ( 2 ) delta-1 and beta ( 3a ) , stably expressed in a human embryonic kidney ( HEK ) 293 cell line , using whole cell and perforated patch-clamp techniques .	T22	T45	11160515
NA	CHEMICAL	GENE-Y	3	6	Activation of endogenous chemical receptor subtype 2 ( gene ) by chemical or activation of transiently transfected gene ( gene ( long ) ) by chemical had no effect .	T10	T27	11160515
NA	CHEMICAL	GENE-Y	3	6	Activation of endogenous chemical receptor subtype 2 ( gene ) by chemical or activation of transiently transfected gene ( gene ( long ) ) by chemical had no effect .	T10	T28	11160515
NA	CHEMICAL	GENE-N	3	4	Activation of endogenous chemical receptor subtype 2 ( gene ) by chemical or activation of transiently transfected gene ( gene ( long ) ) by chemical had no effect .	T10	T29	11160515
NA	CHEMICAL	GENE-N	3	6	Activation of endogenous chemical receptor subtype 2 ( gene ) by chemical or activation of transiently transfected gene ( gene ( long ) ) by chemical had no effect .	T10	T30	11160515
CPR:3	CHEMICAL	GENE-Y	11	6	Activation of endogenous chemical receptor subtype 2 ( gene ) by chemical or activation of transiently transfected gene ( gene ( long ) ) by chemical had no effect .	T11	T27	11160515
CPR:3	CHEMICAL	GENE-Y	11	6	Activation of endogenous chemical receptor subtype 2 ( gene ) by chemical or activation of transiently transfected gene ( gene ( long ) ) by chemical had no effect .	T11	T28	11160515
NA	CHEMICAL	GENE-N	11	4	Activation of endogenous chemical receptor subtype 2 ( gene ) by chemical or activation of transiently transfected gene ( gene ( long ) ) by chemical had no effect .	T11	T29	11160515
NA	CHEMICAL	GENE-N	11	6	Activation of endogenous chemical receptor subtype 2 ( gene ) by chemical or activation of transiently transfected gene ( gene ( long ) ) by chemical had no effect .	T11	T30	11160515
NA	CHEMICAL	GENE-Y	25	6	Activation of endogenous chemical receptor subtype 2 ( gene ) by chemical or activation of transiently transfected gene ( gene ( long ) ) by chemical had no effect .	T13	T27	11160515
NA	CHEMICAL	GENE-Y	25	6	Activation of endogenous chemical receptor subtype 2 ( gene ) by chemical or activation of transiently transfected gene ( gene ( long ) ) by chemical had no effect .	T13	T28	11160515
CPR:3	CHEMICAL	GENE-N	25	4	Activation of endogenous chemical receptor subtype 2 ( gene ) by chemical or activation of transiently transfected gene ( gene ( long ) ) by chemical had no effect .	T13	T29	11160515
CPR:3	CHEMICAL	GENE-N	25	6	Activation of endogenous chemical receptor subtype 2 ( gene ) by chemical or activation of transiently transfected gene ( gene ( long ) ) by chemical had no effect .	T13	T30	11160515
CPR:4	CHEMICAL	GENE-N	8	3	In contrast , in the same system , chemical-type currents , formed from transiently transfected alpha ( 1B ) /alpha ( 2 ) delta-1/beta ( 3 ) , showed strong gene-mediated inhibition .	T17	T31	11160515
NA	CHEMICAL	GENE-N	15	14	Furthermore , the I-II loop from the alpha ( 1D ) clone , expressed as a chemical-chemical-transferase ( gene ) fusion protein , did not bind Gbetagamma , unlike the gene fusion protein .	T18	T32	11160515
NA	CHEMICAL	GENE-N	15	18	Furthermore , the I-II loop from the alpha ( 1D ) clone , expressed as a chemical-chemical-transferase ( gene ) fusion protein , did not bind Gbetagamma , unlike the gene fusion protein .	T18	T33	11160515
NA	CHEMICAL	GENE-N	15	4	Furthermore , the I-II loop from the alpha ( 1D ) clone , expressed as a chemical-chemical-transferase ( gene ) fusion protein , did not bind Gbetagamma , unlike the gene fusion protein .	T18	T34	11160515
NA	CHEMICAL	GENE-N	16	14	Furthermore , the I-II loop from the alpha ( 1D ) clone , expressed as a chemical-chemical-transferase ( gene ) fusion protein , did not bind Gbetagamma , unlike the gene fusion protein .	T19	T32	11160515
NA	CHEMICAL	GENE-N	16	18	Furthermore , the I-II loop from the alpha ( 1D ) clone , expressed as a chemical-chemical-transferase ( gene ) fusion protein , did not bind Gbetagamma , unlike the gene fusion protein .	T19	T33	11160515
NA	CHEMICAL	GENE-N	16	4	Furthermore , the I-II loop from the alpha ( 1D ) clone , expressed as a chemical-chemical-transferase ( gene ) fusion protein , did not bind Gbetagamma , unlike the gene fusion protein .	T19	T34	11160515
CPR:4	CHEMICAL	GENE-Y	0	2	chemical , a small iminosugar molecule approved for the treatment of Gaucher disease , reversibly inhibits chemical synthase , which catalyses the first committed step in glycosphingolipid synthesis .	T3	T8	17603755
NA	CHEMICAL	GENE-Y	2	2	chemical , a small iminosugar molecule approved for the treatment of Gaucher disease , reversibly inhibits chemical synthase , which catalyses the first committed step in glycosphingolipid synthesis .	T4	T8	17603755
NA	CHEMICAL	GENE-Y	0	12	chemical enhances excitatory parasympathetic activity by competing with chemical for attachment to gene at sites of cholinergic transmission and enhancing cholinergic action .	T2	T8	10826417
NA	CHEMICAL	GENE-Y	8	12	chemical enhances excitatory parasympathetic activity by competing with chemical for attachment to gene at sites of cholinergic transmission and enhancing cholinergic action .	T3	T8	10826417
CPR:9	CHEMICAL	GENE-N	18	2	The mouse gene subfamily includes members that have wide tissue distribution and are active in the metabolism of chemical ( AA ) , chemical ( LA ) , and other lipids and xenobiotics .	T1	T7	23315644
CPR:9	CHEMICAL	GENE-N	23	2	The mouse gene subfamily includes members that have wide tissue distribution and are active in the metabolism of chemical ( AA ) , chemical ( LA ) , and other lipids and xenobiotics .	T2	T7	23315644
NA	CHEMICAL	GENE-Y	5	0	gene , a new platelet chemical receptor , target of chemical .	T20	T32	15199474
NA	CHEMICAL	GENE-N	5	6	gene , a new platelet chemical receptor , target of chemical .	T20	T33	15199474
NA	CHEMICAL	GENE-Y	10	0	gene , a new platelet chemical receptor , target of chemical .	T21	T32	15199474
NA	CHEMICAL	GENE-N	10	6	gene , a new platelet chemical receptor , target of chemical .	T21	T33	15199474
NA	CHEMICAL	GENE-N	4	7	The antiaggregating effect of chemical is attributed to an irreversible inhibition of chemical binding to a gene present at the platelet surface .	T14	T24	15199474
NA	CHEMICAL	GENE-N	12	7	The antiaggregating effect of chemical is attributed to an irreversible inhibition of chemical binding to a gene present at the platelet surface .	T15	T24	15199474
NA	CHEMICAL	GENE-N	10	1	Several gene have been described on platelets ; gene , a chemical channel , and gene a gene , have been found not to be antagonized by chemical .	T18	T25	15199474
NA	CHEMICAL	GENE-Y	10	8	Several gene have been described on platelets ; gene , a chemical channel , and gene a gene , have been found not to be antagonized by chemical .	T18	T26	15199474
NA	CHEMICAL	GENE-N	10	10	Several gene have been described on platelets ; gene , a chemical channel , and gene a gene , have been found not to be antagonized by chemical .	T18	T27	15199474
NA	CHEMICAL	GENE-Y	10	15	Several gene have been described on platelets ; gene , a chemical channel , and gene a gene , have been found not to be antagonized by chemical .	T18	T28	15199474
NA	CHEMICAL	GENE-N	10	17	Several gene have been described on platelets ; gene , a chemical channel , and gene a gene , have been found not to be antagonized by chemical .	T18	T29	15199474
NA	CHEMICAL	GENE-N	27	1	Several gene have been described on platelets ; gene , a chemical channel , and gene a gene , have been found not to be antagonized by chemical .	T19	T25	15199474
NA	CHEMICAL	GENE-Y	27	8	Several gene have been described on platelets ; gene , a chemical channel , and gene a gene , have been found not to be antagonized by chemical .	T19	T26	15199474
NA	CHEMICAL	GENE-N	27	10	Several gene have been described on platelets ; gene , a chemical channel , and gene a gene , have been found not to be antagonized by chemical .	T19	T27	15199474
NA	CHEMICAL	GENE-Y	27	15	Several gene have been described on platelets ; gene , a chemical channel , and gene a gene , have been found not to be antagonized by chemical .	T19	T28	15199474
NA	CHEMICAL	GENE-N	27	17	Several gene have been described on platelets ; gene , a chemical channel , and gene a gene , have been found not to be antagonized by chemical .	T19	T29	15199474
CPR:4	CHEMICAL	GENE-Y	4	8	Novel analgesic/anti-inflammatory agents : chemical and related compounds as gene inhibiting chemical donors .	T17	T23	23534442
CPR:4	CHEMICAL	GENE-Y	11	8	Novel analgesic/anti-inflammatory agents : chemical and related compounds as gene inhibiting chemical donors .	T16	T23	23534442
CPR:4	CHEMICAL	GENE-Y	3	16	New classes of chemical-derived chemical inverse chemical , chemical , and chemical ( 7-10 ) as gene selective inhibitors and chemical donors were synthesized and are herein reported .	T3	T19	23534442
CPR:4	CHEMICAL	GENE-Y	4	16	New classes of chemical-derived chemical inverse chemical , chemical , and chemical ( 7-10 ) as gene selective inhibitors and chemical donors were synthesized and are herein reported .	T4	T19	23534442
CPR:4	CHEMICAL	GENE-Y	6	16	New classes of chemical-derived chemical inverse chemical , chemical , and chemical ( 7-10 ) as gene selective inhibitors and chemical donors were synthesized and are herein reported .	T5	T19	23534442
CPR:4	CHEMICAL	GENE-Y	8	16	New classes of chemical-derived chemical inverse chemical , chemical , and chemical ( 7-10 ) as gene selective inhibitors and chemical donors were synthesized and are herein reported .	T6	T19	23534442
CPR:4	CHEMICAL	GENE-Y	11	16	New classes of chemical-derived chemical inverse chemical , chemical , and chemical ( 7-10 ) as gene selective inhibitors and chemical donors were synthesized and are herein reported .	T7	T19	23534442
NA	CHEMICAL	GENE-Y	20	16	New classes of chemical-derived chemical inverse chemical , chemical , and chemical ( 7-10 ) as gene selective inhibitors and chemical donors were synthesized and are herein reported .	T8	T19	23534442
CPR:4	CHEMICAL	GENE-Y	0	19	chemical derivatives showed chemical-dependent vasorelaxing properties , while most of the compounds proved to be very potent and selective gene inhibitors in in vitro experimental models .	T11	T20	23534442
NA	CHEMICAL	GENE-Y	3	19	chemical derivatives showed chemical-dependent vasorelaxing properties , while most of the compounds proved to be very potent and selective gene inhibitors in in vitro experimental models .	T12	T20	23534442
NA	CHEMICAL	GENE-Y	11	4	Binding of the agonist gene ( gene ) and inverse agonist chemical in wild-type gene changed the accessibility of reporter chemical , and the pattern was consistent with ligand-specific `` lid '' conformations of ECL2 .	T5	T23	23139413
NA	CHEMICAL	GENE-Y	11	6	Binding of the agonist gene ( gene ) and inverse agonist chemical in wild-type gene changed the accessibility of reporter chemical , and the pattern was consistent with ligand-specific `` lid '' conformations of ECL2 .	T5	T24	23139413
CPR:5	CHEMICAL	GENE-Y	11	14	Binding of the agonist gene ( gene ) and inverse agonist chemical in wild-type gene changed the accessibility of reporter chemical , and the pattern was consistent with ligand-specific `` lid '' conformations of ECL2 .	T5	T25	23139413
NA	CHEMICAL	GENE-Y	12	4	Binding of the agonist gene ( gene ) and inverse agonist chemical in wild-type gene changed the accessibility of reporter chemical , and the pattern was consistent with ligand-specific `` lid '' conformations of ECL2 .	T6	T23	23139413
NA	CHEMICAL	GENE-Y	12	6	Binding of the agonist gene ( gene ) and inverse agonist chemical in wild-type gene changed the accessibility of reporter chemical , and the pattern was consistent with ligand-specific `` lid '' conformations of ECL2 .	T6	T24	23139413
NA	CHEMICAL	GENE-Y	12	14	Binding of the agonist gene ( gene ) and inverse agonist chemical in wild-type gene changed the accessibility of reporter chemical , and the pattern was consistent with ligand-specific `` lid '' conformations of ECL2 .	T6	T25	23139413
NA	CHEMICAL	GENE-Y	4	9	Inhibitory effect of selective chemical reuptake inhibitors on the gene .	T24	T32	19429089
NA	CHEMICAL	GENE-Y	7	9	Inhibitory effect of selective chemical reuptake inhibitors on the gene .	T25	T32	19429089
NA	CHEMICAL	GENE-Y	1	1	The gene ( gene ) is the target molecule of action of some psychostimulants , such as chemical and chemical ( chemical ) .	T2	T28	19429089
NA	CHEMICAL	GENE-Y	1	3	The gene ( gene ) is the target molecule of action of some psychostimulants , such as chemical and chemical ( chemical ) .	T2	T29	19429089
NA	CHEMICAL	GENE-Y	14	1	The gene ( gene ) is the target molecule of action of some psychostimulants , such as chemical and chemical ( chemical ) .	T3	T28	19429089
NA	CHEMICAL	GENE-Y	14	3	The gene ( gene ) is the target molecule of action of some psychostimulants , such as chemical and chemical ( chemical ) .	T3	T29	19429089
NA	CHEMICAL	GENE-Y	21	1	The gene ( gene ) is the target molecule of action of some psychostimulants , such as chemical and chemical ( chemical ) .	T4	T28	19429089
NA	CHEMICAL	GENE-Y	21	3	The gene ( gene ) is the target molecule of action of some psychostimulants , such as chemical and chemical ( chemical ) .	T4	T29	19429089
NA	CHEMICAL	GENE-Y	12	20	The present study examined the effect of antidepressants , such as selective chemical reuptake inhibitors ( SSRIs ) , on gene activity by measuring chemical-dependent chemical uptake into synaptic vesicles prepared from rat striatum .	T6	T27	19429089
NA	CHEMICAL	GENE-Y	24	20	The present study examined the effect of antidepressants , such as selective chemical reuptake inhibitors ( SSRIs ) , on gene activity by measuring chemical-dependent chemical uptake into synaptic vesicles prepared from rat striatum .	T7	T27	19429089
CPR:9	CHEMICAL	GENE-Y	15	20	The present study examined the effect of antidepressants , such as selective chemical reuptake inhibitors ( SSRIs ) , on gene activity by measuring chemical-dependent chemical uptake into synaptic vesicles prepared from rat striatum .	T8	T27	19429089
CPR:4	CHEMICAL	GENE-Y	8	12	Moreover , kinetic analysis revealed that inhibition by chemical , a typical gene inhibitor , was uncompetitive , decreasing maximum velocity and affinity for chemical .	T19	T30	19429089
CPR:9	CHEMICAL	GENE-Y	10	12	Moreover , kinetic analysis revealed that inhibition by chemical , a typical gene inhibitor , was uncompetitive , decreasing maximum velocity and affinity for chemical .	T20	T30	19429089
NA	CHEMICAL	GENE-N	2	4	Activation of chemical-activated Protein Kinase and Phosphorylation of gene Mediate chemical Induced Apoptosis in HepG2 Liver Cancer Cells .	T17	T43	23325562
NA	CHEMICAL	GENE-Y	2	8	Activation of chemical-activated Protein Kinase and Phosphorylation of gene Mediate chemical Induced Apoptosis in HepG2 Liver Cancer Cells .	T17	T44	23325562
CPR:3	CHEMICAL	GENE-N	10	4	Activation of chemical-activated Protein Kinase and Phosphorylation of gene Mediate chemical Induced Apoptosis in HepG2 Liver Cancer Cells .	T16	T43	23325562
CPR:3	CHEMICAL	GENE-Y	10	8	Activation of chemical-activated Protein Kinase and Phosphorylation of gene Mediate chemical Induced Apoptosis in HepG2 Liver Cancer Cells .	T16	T44	23325562
NA	CHEMICAL	GENE-N	10	2	Thus , in the present study , the roles of chemical-activated protein kinase ( gene ) and gene ( gene ) were examined in ursolic acid induced apoptosis in HepG2 hepatocellular carcinoma cells .	T7	T27	23325562
NA	CHEMICAL	GENE-N	10	14	Thus , in the present study , the roles of chemical-activated protein kinase ( gene ) and gene ( gene ) were examined in ursolic acid induced apoptosis in HepG2 hepatocellular carcinoma cells .	T7	T28	23325562
NA	CHEMICAL	GENE-Y	10	17	Thus , in the present study , the roles of chemical-activated protein kinase ( gene ) and gene ( gene ) were examined in ursolic acid induced apoptosis in HepG2 hepatocellular carcinoma cells .	T7	T29	23325562
NA	CHEMICAL	GENE-Y	10	19	Thus , in the present study , the roles of chemical-activated protein kinase ( gene ) and gene ( gene ) were examined in ursolic acid induced apoptosis in HepG2 hepatocellular carcinoma cells .	T7	T30	23325562
NA	CHEMICAL	GENE-N	8	9	Also , ursolic acid enhanced the cleavages of chemical polymerase ( gene ) and gene , attenuated the expression of gene ( gene ) and gene in HepG2 cells .	T12	T31	23325562
NA	CHEMICAL	GENE-N	8	11	Also , ursolic acid enhanced the cleavages of chemical polymerase ( gene ) and gene , attenuated the expression of gene ( gene ) and gene in HepG2 cells .	T12	T32	23325562
NA	CHEMICAL	GENE-Y	8	14	Also , ursolic acid enhanced the cleavages of chemical polymerase ( gene ) and gene , attenuated the expression of gene ( gene ) and gene in HepG2 cells .	T12	T33	23325562
NA	CHEMICAL	GENE-Y	8	20	Also , ursolic acid enhanced the cleavages of chemical polymerase ( gene ) and gene , attenuated the expression of gene ( gene ) and gene in HepG2 cells .	T12	T34	23325562
NA	CHEMICAL	GENE-Y	8	22	Also , ursolic acid enhanced the cleavages of chemical polymerase ( gene ) and gene , attenuated the expression of gene ( gene ) and gene in HepG2 cells .	T12	T35	23325562
NA	CHEMICAL	GENE-Y	8	25	Also , ursolic acid enhanced the cleavages of chemical polymerase ( gene ) and gene , attenuated the expression of gene ( gene ) and gene in HepG2 cells .	T12	T36	23325562
CPR:3	CHEMICAL	GENE-N	2	7	Interestingly , chemical increased the phosphorylation of gene and gene and also enhanced phosphorylation of gene at inactive form chemical 9 , whereas chemical attenuated the phosphorylation of gene and gene in HepG2 cells .	T13	T37	23325562
CPR:3	CHEMICAL	GENE-N	2	9	Interestingly , chemical increased the phosphorylation of gene and gene and also enhanced phosphorylation of gene at inactive form chemical 9 , whereas chemical attenuated the phosphorylation of gene and gene in HepG2 cells .	T13	T38	23325562
CPR:3	CHEMICAL	GENE-Y	2	15	Interestingly , chemical increased the phosphorylation of gene and gene and also enhanced phosphorylation of gene at inactive form chemical 9 , whereas chemical attenuated the phosphorylation of gene and gene in HepG2 cells .	T13	T39	23325562
NA	CHEMICAL	GENE-N	2	28	Interestingly , chemical increased the phosphorylation of gene and gene and also enhanced phosphorylation of gene at inactive form chemical 9 , whereas chemical attenuated the phosphorylation of gene and gene in HepG2 cells .	T13	T40	23325562
NA	CHEMICAL	GENE-Y	2	30	Interestingly , chemical increased the phosphorylation of gene and gene and also enhanced phosphorylation of gene at inactive form chemical 9 , whereas chemical attenuated the phosphorylation of gene and gene in HepG2 cells .	T13	T41	23325562
NA	CHEMICAL	GENE-N	19	7	Interestingly , chemical increased the phosphorylation of gene and gene and also enhanced phosphorylation of gene at inactive form chemical 9 , whereas chemical attenuated the phosphorylation of gene and gene in HepG2 cells .	T14	T37	23325562
NA	CHEMICAL	GENE-N	19	9	Interestingly , chemical increased the phosphorylation of gene and gene and also enhanced phosphorylation of gene at inactive form chemical 9 , whereas chemical attenuated the phosphorylation of gene and gene in HepG2 cells .	T14	T38	23325562
NA	CHEMICAL	GENE-Y	19	15	Interestingly , chemical increased the phosphorylation of gene and gene and also enhanced phosphorylation of gene at inactive form chemical 9 , whereas chemical attenuated the phosphorylation of gene and gene in HepG2 cells .	T14	T39	23325562
NA	CHEMICAL	GENE-N	19	28	Interestingly , chemical increased the phosphorylation of gene and gene and also enhanced phosphorylation of gene at inactive form chemical 9 , whereas chemical attenuated the phosphorylation of gene and gene in HepG2 cells .	T14	T40	23325562
NA	CHEMICAL	GENE-Y	19	30	Interestingly , chemical increased the phosphorylation of gene and gene and also enhanced phosphorylation of gene at inactive form chemical 9 , whereas chemical attenuated the phosphorylation of gene and gene in HepG2 cells .	T14	T41	23325562
NA	CHEMICAL	GENE-N	23	7	Interestingly , chemical increased the phosphorylation of gene and gene and also enhanced phosphorylation of gene at inactive form chemical 9 , whereas chemical attenuated the phosphorylation of gene and gene in HepG2 cells .	T15	T37	23325562
NA	CHEMICAL	GENE-N	23	9	Interestingly , chemical increased the phosphorylation of gene and gene and also enhanced phosphorylation of gene at inactive form chemical 9 , whereas chemical attenuated the phosphorylation of gene and gene in HepG2 cells .	T15	T38	23325562
NA	CHEMICAL	GENE-Y	23	15	Interestingly , chemical increased the phosphorylation of gene and gene and also enhanced phosphorylation of gene at inactive form chemical 9 , whereas chemical attenuated the phosphorylation of gene and gene in HepG2 cells .	T15	T39	23325562
CPR:4	CHEMICAL	GENE-N	23	28	Interestingly , chemical increased the phosphorylation of gene and gene and also enhanced phosphorylation of gene at inactive form chemical 9 , whereas chemical attenuated the phosphorylation of gene and gene in HepG2 cells .	T15	T40	23325562
CPR:4	CHEMICAL	GENE-Y	23	30	Interestingly , chemical increased the phosphorylation of gene and gene and also enhanced phosphorylation of gene at inactive form chemical 9 , whereas chemical attenuated the phosphorylation of gene and gene in HepG2 cells .	T15	T41	23325562
CPR:4	CHEMICAL	GENE-N	4	2	Conversely , gene inhibitor chemical or gene inhibitor chemical blocked the cleavages of gene and gene induced by chemical in HepG2 cells .	T1	T42	23325562
NA	CHEMICAL	GENE-Y	4	6	Conversely , gene inhibitor chemical or gene inhibitor chemical blocked the cleavages of gene and gene induced by chemical in HepG2 cells .	T1	T18	23325562
NA	CHEMICAL	GENE-N	4	13	Conversely , gene inhibitor chemical or gene inhibitor chemical blocked the cleavages of gene and gene induced by chemical in HepG2 cells .	T1	T19	23325562
CPR:4	CHEMICAL	GENE-Y	4	15	Conversely , gene inhibitor chemical or gene inhibitor chemical blocked the cleavages of gene and gene induced by chemical in HepG2 cells .	T1	T20	23325562
NA	CHEMICAL	GENE-N	8	2	Conversely , gene inhibitor chemical or gene inhibitor chemical blocked the cleavages of gene and gene induced by chemical in HepG2 cells .	T2	T42	23325562
CPR:4	CHEMICAL	GENE-Y	8	6	Conversely , gene inhibitor chemical or gene inhibitor chemical blocked the cleavages of gene and gene induced by chemical in HepG2 cells .	T2	T18	23325562
NA	CHEMICAL	GENE-N	8	13	Conversely , gene inhibitor chemical or gene inhibitor chemical blocked the cleavages of gene and gene induced by chemical in HepG2 cells .	T2	T19	23325562
CPR:4	CHEMICAL	GENE-Y	8	15	Conversely , gene inhibitor chemical or gene inhibitor chemical blocked the cleavages of gene and gene induced by chemical in HepG2 cells .	T2	T20	23325562
NA	CHEMICAL	GENE-N	18	2	Conversely , gene inhibitor chemical or gene inhibitor chemical blocked the cleavages of gene and gene induced by chemical in HepG2 cells .	T3	T42	23325562
NA	CHEMICAL	GENE-Y	18	6	Conversely , gene inhibitor chemical or gene inhibitor chemical blocked the cleavages of gene and gene induced by chemical in HepG2 cells .	T3	T18	23325562
CPR:3	CHEMICAL	GENE-N	18	13	Conversely , gene inhibitor chemical or gene inhibitor chemical blocked the cleavages of gene and gene induced by chemical in HepG2 cells .	T3	T19	23325562
CPR:3	CHEMICAL	GENE-Y	18	15	Conversely , gene inhibitor chemical or gene inhibitor chemical blocked the cleavages of gene and gene induced by chemical in HepG2 cells .	T3	T20	23325562
CPR:4	CHEMICAL	GENE-N	4	6	Furthermore , proteosomal inhibitor chemical suppressed gene activation , gene phosphorylation , cleaved gene and deceased gene induced by chemical in HepG2 cells .	T4	T21	23325562
CPR:4	CHEMICAL	GENE-Y	4	9	Furthermore , proteosomal inhibitor chemical suppressed gene activation , gene phosphorylation , cleaved gene and deceased gene induced by chemical in HepG2 cells .	T4	T22	23325562
NA	CHEMICAL	GENE-N	4	13	Furthermore , proteosomal inhibitor chemical suppressed gene activation , gene phosphorylation , cleaved gene and deceased gene induced by chemical in HepG2 cells .	T4	T23	23325562
CPR:3	CHEMICAL	GENE-Y	4	16	Furthermore , proteosomal inhibitor chemical suppressed gene activation , gene phosphorylation , cleaved gene and deceased gene induced by chemical in HepG2 cells .	T4	T24	23325562
CPR:3	CHEMICAL	GENE-N	19	6	Furthermore , proteosomal inhibitor chemical suppressed gene activation , gene phosphorylation , cleaved gene and deceased gene induced by chemical in HepG2 cells .	T5	T21	23325562
CPR:3	CHEMICAL	GENE-Y	19	9	Furthermore , proteosomal inhibitor chemical suppressed gene activation , gene phosphorylation , cleaved gene and deceased gene induced by chemical in HepG2 cells .	T5	T22	23325562
NA	CHEMICAL	GENE-N	19	13	Furthermore , proteosomal inhibitor chemical suppressed gene activation , gene phosphorylation , cleaved gene and deceased gene induced by chemical in HepG2 cells .	T5	T23	23325562
CPR:4	CHEMICAL	GENE-Y	19	16	Furthermore , proteosomal inhibitor chemical suppressed gene activation , gene phosphorylation , cleaved gene and deceased gene induced by chemical in HepG2 cells .	T5	T24	23325562
NA	CHEMICAL	GENE-Y	3	5	Supra-normal stimulation of chemical D1 receptors in the prelimbic cortex blocks behavioral expression of both aversive and rewarding associative memories through a chemical-dependent signaling pathway .	T8	T20	23164618
NA	CHEMICAL	GENE-Y	22	5	Supra-normal stimulation of chemical D1 receptors in the prelimbic cortex blocks behavioral expression of both aversive and rewarding associative memories through a chemical-dependent signaling pathway .	T7	T20	23164618
NA	CHEMICAL	GENE-N	0	4	chemical ( DA ) receptor transmission through either gene or gene-like subtypes is involved critically in the processing of emotional information within the medial prefrontal cortex ( mPFC ) .	T1	T9	23164618
NA	CHEMICAL	GENE-Y	0	1	chemical ( DA ) receptor transmission through either gene or gene-like subtypes is involved critically in the processing of emotional information within the medial prefrontal cortex ( mPFC ) .	T1	T16	23164618
NA	CHEMICAL	GENE-Y	0	1	chemical ( DA ) receptor transmission through either gene or gene-like subtypes is involved critically in the processing of emotional information within the medial prefrontal cortex ( mPFC ) .	T1	T17	23164618
NA	CHEMICAL	GENE-Y	22	13	Furthermore , using an unbiased place conditioning procedure ( CPP ) , intra-PLC gene activation blocks the spontaneous expression of an associative chemical ( 5 mg/kg ; i.p . )	T6	T19	23164618
NA	CHEMICAL	GENE-Y	18	4	Interestingly , both intra-PLC gene mediated block of either fear-related or reward-related associative memories were dependent upon downstream chemical ( chemical ) signaling as both effects were rescued by co-administration of a chemical signaling inhibitor .	T3	T10	23164618
NA	CHEMICAL	GENE-Y	20	4	Interestingly , both intra-PLC gene mediated block of either fear-related or reward-related associative memories were dependent upon downstream chemical ( chemical ) signaling as both effects were rescued by co-administration of a chemical signaling inhibitor .	T4	T10	23164618
NA	CHEMICAL	GENE-Y	32	4	Interestingly , both intra-PLC gene mediated block of either fear-related or reward-related associative memories were dependent upon downstream chemical ( chemical ) signaling as both effects were rescued by co-administration of a chemical signaling inhibitor .	T5	T10	23164618
NA	CHEMICAL	GENE-Y	0	2	chemical synthase reductase polymorphisms are associated with serum gene levels in postmenopausal women .	T6	T21	17079868
NA	CHEMICAL	GENE-Y	0	8	chemical synthase reductase polymorphisms are associated with serum gene levels in postmenopausal women .	T6	T22	17079868
NA	CHEMICAL	GENE-Y	0	2	chemical synthase reductase ( gene ) is an enzyme involved in the conversion of chemical to chemical .	T2	T7	17079868
NA	CHEMICAL	GENE-Y	0	4	chemical synthase reductase ( gene ) is an enzyme involved in the conversion of chemical to chemical .	T2	T10	17079868
CPR:9	CHEMICAL	GENE-Y	14	2	chemical synthase reductase ( gene ) is an enzyme involved in the conversion of chemical to chemical .	T4	T7	17079868
CPR:9	CHEMICAL	GENE-Y	14	4	chemical synthase reductase ( gene ) is an enzyme involved in the conversion of chemical to chemical .	T4	T10	17079868
CPR:9	CHEMICAL	GENE-Y	10	2	chemical synthase reductase ( gene ) is an enzyme involved in the conversion of chemical to chemical .	T5	T7	17079868
CPR:9	CHEMICAL	GENE-Y	10	4	chemical synthase reductase ( gene ) is an enzyme involved in the conversion of chemical to chemical .	T5	T10	17079868
CPR:3	CHEMICAL	GENE-Y	0	11	chemical protects hepatocellular carcinoma cells against serum-starvation-induced cell death by upregulating gene .	T10	T27	23298258
NA	CHEMICAL	GENE-Y	10	5	The most upregulated genes are gene ( gene ) , chemical triad nucleotide binding protein 3 ( gene ) , gene and gene ( gene ) , which showed more than fivefold greater expression .	T7	T20	23298258
NA	CHEMICAL	GENE-Y	10	7	The most upregulated genes are gene ( gene ) , chemical triad nucleotide binding protein 3 ( gene ) , gene and gene ( gene ) , which showed more than fivefold greater expression .	T7	T21	23298258
NA	CHEMICAL	GENE-Y	10	15	The most upregulated genes are gene ( gene ) , chemical triad nucleotide binding protein 3 ( gene ) , gene and gene ( gene ) , which showed more than fivefold greater expression .	T7	T22	23298258
NA	CHEMICAL	GENE-Y	10	15	The most upregulated genes are gene ( gene ) , chemical triad nucleotide binding protein 3 ( gene ) , gene and gene ( gene ) , which showed more than fivefold greater expression .	T7	T23	23298258
NA	CHEMICAL	GENE-Y	10	20	The most upregulated genes are gene ( gene ) , chemical triad nucleotide binding protein 3 ( gene ) , gene and gene ( gene ) , which showed more than fivefold greater expression .	T7	T24	23298258
NA	CHEMICAL	GENE-Y	10	22	The most upregulated genes are gene ( gene ) , chemical triad nucleotide binding protein 3 ( gene ) , gene and gene ( gene ) , which showed more than fivefold greater expression .	T7	T25	23298258
NA	CHEMICAL	GENE-Y	10	24	The most upregulated genes are gene ( gene ) , chemical triad nucleotide binding protein 3 ( gene ) , gene and gene ( gene ) , which showed more than fivefold greater expression .	T7	T26	23298258
NA	CHEMICAL	GENE-Y	2	2	Knockdown of gene blocked enhancement in the early stage of cell adhesion by chemical treatment .	T1	T13	23298258
NA	CHEMICAL	GENE-Y	17	2	Thus , gene was identified as the key protein involved in the enhancement of cell adhesion of chemical under serum-free conditions .	T2	T18	23298258
CPR:3	CHEMICAL	GENE-Y	29	20	Firstly , in the normal human renal epithelial HK-2 cells , the measurement of the expression of 30 previously reported gene target genes in response to gene inducers ( chemical , chemical , chemical , and chemical ) showed that the gene is highly inducible by all treatments .	T1	T7	23305850
CPR:3	CHEMICAL	GENE-Y	29	26	Firstly , in the normal human renal epithelial HK-2 cells , the measurement of the expression of 30 previously reported gene target genes in response to gene inducers ( chemical , chemical , chemical , and chemical ) showed that the gene is highly inducible by all treatments .	T1	T8	23305850
CPR:3	CHEMICAL	GENE-Y	29	41	Firstly , in the normal human renal epithelial HK-2 cells , the measurement of the expression of 30 previously reported gene target genes in response to gene inducers ( chemical , chemical , chemical , and chemical ) showed that the gene is highly inducible by all treatments .	T1	T9	23305850
CPR:3	CHEMICAL	GENE-Y	2	20	Firstly , in the normal human renal epithelial HK-2 cells , the measurement of the expression of 30 previously reported gene target genes in response to gene inducers ( chemical , chemical , chemical , and chemical ) showed that the gene is highly inducible by all treatments .	T2	T7	23305850
CPR:3	CHEMICAL	GENE-Y	2	26	Firstly , in the normal human renal epithelial HK-2 cells , the measurement of the expression of 30 previously reported gene target genes in response to gene inducers ( chemical , chemical , chemical , and chemical ) showed that the gene is highly inducible by all treatments .	T2	T8	23305850
CPR:3	CHEMICAL	GENE-Y	2	41	Firstly , in the normal human renal epithelial HK-2 cells , the measurement of the expression of 30 previously reported gene target genes in response to gene inducers ( chemical , chemical , chemical , and chemical ) showed that the gene is highly inducible by all treatments .	T2	T9	23305850
CPR:3	CHEMICAL	GENE-Y	33	20	Firstly , in the normal human renal epithelial HK-2 cells , the measurement of the expression of 30 previously reported gene target genes in response to gene inducers ( chemical , chemical , chemical , and chemical ) showed that the gene is highly inducible by all treatments .	T3	T7	23305850
CPR:3	CHEMICAL	GENE-Y	33	26	Firstly , in the normal human renal epithelial HK-2 cells , the measurement of the expression of 30 previously reported gene target genes in response to gene inducers ( chemical , chemical , chemical , and chemical ) showed that the gene is highly inducible by all treatments .	T3	T8	23305850
CPR:3	CHEMICAL	GENE-Y	33	41	Firstly , in the normal human renal epithelial HK-2 cells , the measurement of the expression of 30 previously reported gene target genes in response to gene inducers ( chemical , chemical , chemical , and chemical ) showed that the gene is highly inducible by all treatments .	T3	T9	23305850
CPR:3	CHEMICAL	GENE-Y	36	20	Firstly , in the normal human renal epithelial HK-2 cells , the measurement of the expression of 30 previously reported gene target genes in response to gene inducers ( chemical , chemical , chemical , and chemical ) showed that the gene is highly inducible by all treatments .	T4	T7	23305850
CPR:3	CHEMICAL	GENE-Y	36	26	Firstly , in the normal human renal epithelial HK-2 cells , the measurement of the expression of 30 previously reported gene target genes in response to gene inducers ( chemical , chemical , chemical , and chemical ) showed that the gene is highly inducible by all treatments .	T4	T8	23305850
CPR:3	CHEMICAL	GENE-Y	36	41	Firstly , in the normal human renal epithelial HK-2 cells , the measurement of the expression of 30 previously reported gene target genes in response to gene inducers ( chemical , chemical , chemical , and chemical ) showed that the gene is highly inducible by all treatments .	T4	T9	23305850
CPR:3	CHEMICAL	GENE-Y	9	6	The treatment of U937 cells with gene inducers including chemical effectively elevated the expression of gene .	T5	T17	23305850
CPR:3	CHEMICAL	GENE-N	9	15	The treatment of U937 cells with gene inducers including chemical effectively elevated the expression of gene .	T5	T18	23305850
CPR:3	CHEMICAL	GENE-Y	9	12	Whereas , the levels of both the basal and chemical-inducible expression of gene were significantly reduced in gene-silenced stable U937 cells compared to the control cells .	T6	T19	23305850
NA	CHEMICAL	GENE-Y	9	17	Whereas , the levels of both the basal and chemical-inducible expression of gene were significantly reduced in gene-silenced stable U937 cells compared to the control cells .	T6	T20	23305850
NA	CHEMICAL	GENE-Y	6	11	Sepracor in the US is developing chemical [ chemical ] , a single isomer form of the gene agonist chemical [ chemical ] .	T8	T22	14725487
NA	CHEMICAL	GENE-Y	8	11	Sepracor in the US is developing chemical [ chemical ] , a single isomer form of the gene agonist chemical [ chemical ] .	T9	T22	14725487
CPR:5	CHEMICAL	GENE-Y	14	11	Sepracor in the US is developing chemical [ chemical ] , a single isomer form of the gene agonist chemical [ chemical ] .	T2	T22	14725487
CPR:5	CHEMICAL	GENE-Y	14	11	Sepracor in the US is developing chemical [ chemical ] , a single isomer form of the gene agonist chemical [ chemical ] .	T4	T22	14725487
NA	CHEMICAL	GENE-Y	4	6	Impaired function of prejunctional chemical A1 receptors expressed by perivascular sympathetic nerves in chemical-salt hypertensive rats .	T26	T44	23397055
NA	CHEMICAL	GENE-Y	13	6	Impaired function of prejunctional chemical A1 receptors expressed by perivascular sympathetic nerves in chemical-salt hypertensive rats .	T25	T44	23397055
NA	CHEMICAL	GENE-N	19	4	NE acts at prejunctional gene ( gene ) to inhibit NE release , and gene function is impaired in chemical-salt rats .	T15	T33	23397055
NA	CHEMICAL	GENE-N	19	6	NE acts at prejunctional gene ( gene ) to inhibit NE release , and gene function is impaired in chemical-salt rats .	T15	T34	23397055
NA	CHEMICAL	GENE-N	19	14	NE acts at prejunctional gene ( gene ) to inhibit NE release , and gene function is impaired in chemical-salt rats .	T15	T35	23397055
NA	CHEMICAL	GENE-Y	0	11	chemical , an enzymatic chemical degradation product , acts at prejunctional gene ( gene ) to inhibit NE release .	T16	T36	23397055
NA	CHEMICAL	GENE-Y	0	13	chemical , an enzymatic chemical degradation product , acts at prejunctional gene ( gene ) to inhibit NE release .	T16	T37	23397055
NA	CHEMICAL	GENE-Y	4	11	chemical , an enzymatic chemical degradation product , acts at prejunctional gene ( gene ) to inhibit NE release .	T17	T36	23397055
NA	CHEMICAL	GENE-Y	4	13	chemical , an enzymatic chemical degradation product , acts at prejunctional gene ( gene ) to inhibit NE release .	T17	T37	23397055
NA	CHEMICAL	GENE-Y	25	6	We tested the hypothesis that prejunctional gene function is impaired in sympathetic nerves supplying mesenteric arteries ( MAs ) and veins ( MVs ) of chemical-salt rats .	T19	T38	23397055
NA	CHEMICAL	GENE-Y	6	7	Immunohistochemical methods were used to localize chemical hydroxylase ( gene ) and gene in perivascular sympathetic nerves .	T21	T39	23397055
NA	CHEMICAL	GENE-Y	6	9	Immunohistochemical methods were used to localize chemical hydroxylase ( gene ) and gene in perivascular sympathetic nerves .	T21	T40	23397055
NA	CHEMICAL	GENE-Y	6	12	Immunohistochemical methods were used to localize chemical hydroxylase ( gene ) and gene in perivascular sympathetic nerves .	T21	T41	23397055
CPR:5	CHEMICAL	GENE-Y	0	6	chemical and chemical ( chemical , gene agonist ) constricted MVs but not MAs .	T23	T27	23397055
CPR:5	CHEMICAL	GENE-Y	2	6	chemical and chemical ( chemical , gene agonist ) constricted MVs but not MAs .	T24	T27	23397055
CPR:5	CHEMICAL	GENE-Y	4	6	chemical and chemical ( chemical , gene agonist ) constricted MVs but not MAs .	T1	T27	23397055
CPR:5	CHEMICAL	GENE-Y	3	1	The gene agonist chemical ( chemical ) ( 0.001-0.1 μM ) did not alter NE oxidation currents .	T9	T28	23397055
CPR:5	CHEMICAL	GENE-Y	5	1	The gene agonist chemical ( chemical ) ( 0.001-0.1 μM ) did not alter NE oxidation currents .	T11	T28	23397055
NA	CHEMICAL	GENE-Y	7	6	We conclude that there are prejunctional gene in arteries and both pre- and postjunctional gene in veins ; thus , chemical selectively constricts the veins .	T12	T29	23397055
NA	CHEMICAL	GENE-Y	7	14	We conclude that there are prejunctional gene in arteries and both pre- and postjunctional gene in veins ; thus , chemical selectively constricts the veins .	T12	T30	23397055
NA	CHEMICAL	GENE-Y	13	1	Prejunctional gene function is impaired in arteries , but not veins , from chemical-salt rats .	T13	T31	23397055
CPR:4	CHEMICAL	GENE-Y	0	2	chemical inhibits gene-induced inflammatory responses in vitro and in vivo .	T2	T15	23146691
NA	CHEMICAL	GENE-Y	5	1	Longer gene gene in impaired chemical tolerance and type 2 diabetes .	T10	T22	23357976
NA	CHEMICAL	GENE-N	5	2	Longer gene gene in impaired chemical tolerance and type 2 diabetes .	T10	T21	23357976
CPR:9	CHEMICAL	GENE-Y	7	0	gene encoded by the gene gene converts chemical to inactive chemical , and alteration in this enzymatic activity might affect chemical homeostasis by affecting circulating levels or tissue availability of glucocorticoids .	T7	T11	23357976
CPR:9	CHEMICAL	GENE-Y	7	4	gene encoded by the gene gene converts chemical to inactive chemical , and alteration in this enzymatic activity might affect chemical homeostasis by affecting circulating levels or tissue availability of glucocorticoids .	T7	T17	23357976
CPR:9	CHEMICAL	GENE-Y	10	0	gene encoded by the gene gene converts chemical to inactive chemical , and alteration in this enzymatic activity might affect chemical homeostasis by affecting circulating levels or tissue availability of glucocorticoids .	T9	T11	23357976
CPR:9	CHEMICAL	GENE-Y	10	4	gene encoded by the gene gene converts chemical to inactive chemical , and alteration in this enzymatic activity might affect chemical homeostasis by affecting circulating levels or tissue availability of glucocorticoids .	T9	T17	23357976
NA	CHEMICAL	GENE-Y	0	0	gene encoded by the gene gene converts chemical to inactive chemical , and alteration in this enzymatic activity might affect chemical homeostasis by affecting circulating levels or tissue availability of glucocorticoids .	T1	T11	23357976
NA	CHEMICAL	GENE-Y	0	4	gene encoded by the gene gene converts chemical to inactive chemical , and alteration in this enzymatic activity might affect chemical homeostasis by affecting circulating levels or tissue availability of glucocorticoids .	T1	T17	23357976
NA	CHEMICAL	GENE-Y	8	5	We investigated the association of gene variant with chemical homeostasis .	T2	T14	23357976
NA	CHEMICAL	GENE-N	3	25	Subjects with normal chemical tolerance ( n=585 ) , impaired chemical tolerance ( n=202 ) and type 2 diabetes ( n=355 ) were genotyped for a highly polymorphic gene polymorphism in the first intron of gene .	T3	T15	23357976
NA	CHEMICAL	GENE-Y	3	17	Subjects with normal chemical tolerance ( n=585 ) , impaired chemical tolerance ( n=202 ) and type 2 diabetes ( n=355 ) were genotyped for a highly polymorphic gene polymorphism in the first intron of gene .	T3	T16	23357976
NA	CHEMICAL	GENE-N	10	25	Subjects with normal chemical tolerance ( n=585 ) , impaired chemical tolerance ( n=202 ) and type 2 diabetes ( n=355 ) were genotyped for a highly polymorphic gene polymorphism in the first intron of gene .	T4	T15	23357976
NA	CHEMICAL	GENE-Y	10	17	Subjects with normal chemical tolerance ( n=585 ) , impaired chemical tolerance ( n=202 ) and type 2 diabetes ( n=355 ) were genotyped for a highly polymorphic gene polymorphism in the first intron of gene .	T4	T16	23357976
NA	CHEMICAL	GENE-Y	10	0	gene stimulates trypsinogen autoactivation by processing the activation peptide to a shorter form but also promotes degradation by cleaving the chemical binding loop in trypsinogen .	T3	T16	23601753
NA	CHEMICAL	GENE-N	10	22	gene stimulates trypsinogen autoactivation by processing the activation peptide to a shorter form but also promotes degradation by cleaving the chemical binding loop in trypsinogen .	T3	T17	23601753
NA	CHEMICAL	GENE-N	8	1	The gene in the trypsinogen activation peptide binds chemical ( KD ~1.6 mM ) , which stimulates autoactivation .	T5	T27	23601753
NA	CHEMICAL	GENE-N	14	7	Despite normal binding , autoactivation of mutants gene and gene was not stimulated by chemical .	T2	T6	23601753
NA	CHEMICAL	GENE-N	14	9	Despite normal binding , autoactivation of mutants gene and gene was not stimulated by chemical .	T2	T7	23601753
CPR:4	CHEMICAL	GENE-Y	9	7	Molecular determinants for the selective inhibition of gene by chemical .	T25	T43	17434872
CPR:4	CHEMICAL	GENE-Y	0	8	chemical is the first example of a marketed gene inhibitor of the chemical class , and it is reported to be the most selective COXIB in vivo .	T1	T40	17434872
CPR:4	CHEMICAL	GENE-Y	6	8	chemical is the first example of a marketed gene inhibitor of the chemical class , and it is reported to be the most selective COXIB in vivo .	T18	T40	17434872
CPR:4	CHEMICAL	GENE-Y	4	14	Using standard assays , chemical was found to be a poor inhibitor of purified gene and a relatively weak inhibitor of purified gene .	T16	T37	17434872
CPR:4	CHEMICAL	GENE-Y	4	22	Using standard assays , chemical was found to be a poor inhibitor of purified gene and a relatively weak inhibitor of purified gene .	T16	T38	17434872
CPR:4	CHEMICAL	GENE-Y	3	15	Kinetic studies with chemical demonstrated that it was a time-dependent and slowly reversible inhibitor of gene that exhibited at least two binding steps during inhibition .	T17	T41	17434872
CPR:4	CHEMICAL	GENE-Y	5	14	Inhibition studies demonstrated that the chemical group on the chemical ring is required for gene selectivity .	T23	T42	17434872
CPR:4	CHEMICAL	GENE-Y	9	14	Inhibition studies demonstrated that the chemical group on the chemical ring is required for gene selectivity .	T24	T42	17434872
CPR:4	CHEMICAL	GENE-N	11	22	The chemical identity and position of the substituents on the lower chemical ring were important in determining the potency and extent of gene inhibition as well as gene selectivity .	T2	T26	17434872
NA	CHEMICAL	GENE-Y	11	27	The chemical identity and position of the substituents on the lower chemical ring were important in determining the potency and extent of gene inhibition as well as gene selectivity .	T2	T27	17434872
NA	CHEMICAL	GENE-Y	2	18	Mutation of chemical-530 to chemical or chemical-349 to chemical or chemical abolished the potent inhibition observed with wild-type gene and key chemical analogs .	T3	T30	17434872
NA	CHEMICAL	GENE-Y	4	18	Mutation of chemical-530 to chemical or chemical-349 to chemical or chemical abolished the potent inhibition observed with wild-type gene and key chemical analogs .	T4	T30	17434872
NA	CHEMICAL	GENE-Y	6	18	Mutation of chemical-530 to chemical or chemical-349 to chemical or chemical abolished the potent inhibition observed with wild-type gene and key chemical analogs .	T5	T30	17434872
NA	CHEMICAL	GENE-Y	8	18	Mutation of chemical-530 to chemical or chemical-349 to chemical or chemical abolished the potent inhibition observed with wild-type gene and key chemical analogs .	T6	T30	17434872
NA	CHEMICAL	GENE-Y	10	18	Mutation of chemical-530 to chemical or chemical-349 to chemical or chemical abolished the potent inhibition observed with wild-type gene and key chemical analogs .	T7	T30	17434872
CPR:4	CHEMICAL	GENE-Y	21	18	Mutation of chemical-530 to chemical or chemical-349 to chemical or chemical abolished the potent inhibition observed with wild-type gene and key chemical analogs .	T8	T30	17434872
NA	CHEMICAL	GENE-N	2	5	Interestingly , a chemical-349 to Ile mutant was inhibited with equal potency to gene with chemical- , chemical- , or chemical-substituted inhibitors and , in the case of chemical , actually showed an increase in potency .	T9	T31	17434872
NA	CHEMICAL	GENE-Y	2	13	Interestingly , a chemical-349 to Ile mutant was inhibited with equal potency to gene with chemical- , chemical- , or chemical-substituted inhibitors and , in the case of chemical , actually showed an increase in potency .	T9	T32	17434872
CPR:4	CHEMICAL	GENE-N	1	5	Interestingly , a chemical-349 to Ile mutant was inhibited with equal potency to gene with chemical- , chemical- , or chemical-substituted inhibitors and , in the case of chemical , actually showed an increase in potency .	T10	T31	17434872
CPR:4	CHEMICAL	GENE-Y	1	13	Interestingly , a chemical-349 to Ile mutant was inhibited with equal potency to gene with chemical- , chemical- , or chemical-substituted inhibitors and , in the case of chemical , actually showed an increase in potency .	T10	T32	17434872
CPR:4	CHEMICAL	GENE-N	1	5	Interestingly , a chemical-349 to Ile mutant was inhibited with equal potency to gene with chemical- , chemical- , or chemical-substituted inhibitors and , in the case of chemical , actually showed an increase in potency .	T11	T31	17434872
CPR:4	CHEMICAL	GENE-Y	1	13	Interestingly , a chemical-349 to Ile mutant was inhibited with equal potency to gene with chemical- , chemical- , or chemical-substituted inhibitors and , in the case of chemical , actually showed an increase in potency .	T11	T32	17434872
CPR:4	CHEMICAL	GENE-N	19	5	Interestingly , a chemical-349 to Ile mutant was inhibited with equal potency to gene with chemical- , chemical- , or chemical-substituted inhibitors and , in the case of chemical , actually showed an increase in potency .	T12	T31	17434872
CPR:4	CHEMICAL	GENE-Y	19	13	Interestingly , a chemical-349 to Ile mutant was inhibited with equal potency to gene with chemical- , chemical- , or chemical-substituted inhibitors and , in the case of chemical , actually showed an increase in potency .	T12	T32	17434872
CPR:4	CHEMICAL	GENE-N	2	5	Interestingly , a chemical-349 to Ile mutant was inhibited with equal potency to gene with chemical- , chemical- , or chemical-substituted inhibitors and , in the case of chemical , actually showed an increase in potency .	T13	T31	17434872
CPR:4	CHEMICAL	GENE-Y	2	13	Interestingly , a chemical-349 to Ile mutant was inhibited with equal potency to gene with chemical- , chemical- , or chemical-substituted inhibitors and , in the case of chemical , actually showed an increase in potency .	T13	T32	17434872
NA	CHEMICAL	GENE-Y	6	7	Autoradiographs of PAGE-separated reactions containing either chemical-labeled gene or chemical-labeled gene showed that the increased gene activation was not due to gene-mediated feedback activation of gene and that there was increased cleavage of gene in the presence of gene in comparison with control reactions but only in the presence of both the enzyme and the surface .	T2	T23	10933803
NA	CHEMICAL	GENE-Y	6	10	Autoradiographs of PAGE-separated reactions containing either chemical-labeled gene or chemical-labeled gene showed that the increased gene activation was not due to gene-mediated feedback activation of gene and that there was increased cleavage of gene in the presence of gene in comparison with control reactions but only in the presence of both the enzyme and the surface .	T2	T24	10933803
NA	CHEMICAL	GENE-Y	6	15	Autoradiographs of PAGE-separated reactions containing either chemical-labeled gene or chemical-labeled gene showed that the increased gene activation was not due to gene-mediated feedback activation of gene and that there was increased cleavage of gene in the presence of gene in comparison with control reactions but only in the presence of both the enzyme and the surface .	T2	T25	10933803
NA	CHEMICAL	GENE-Y	6	21	Autoradiographs of PAGE-separated reactions containing either chemical-labeled gene or chemical-labeled gene showed that the increased gene activation was not due to gene-mediated feedback activation of gene and that there was increased cleavage of gene in the presence of gene in comparison with control reactions but only in the presence of both the enzyme and the surface .	T2	T26	10933803
NA	CHEMICAL	GENE-Y	6	25	Autoradiographs of PAGE-separated reactions containing either chemical-labeled gene or chemical-labeled gene showed that the increased gene activation was not due to gene-mediated feedback activation of gene and that there was increased cleavage of gene in the presence of gene in comparison with control reactions but only in the presence of both the enzyme and the surface .	T2	T27	10933803
NA	CHEMICAL	GENE-Y	6	33	Autoradiographs of PAGE-separated reactions containing either chemical-labeled gene or chemical-labeled gene showed that the increased gene activation was not due to gene-mediated feedback activation of gene and that there was increased cleavage of gene in the presence of gene in comparison with control reactions but only in the presence of both the enzyme and the surface .	T2	T28	10933803
NA	CHEMICAL	GENE-Y	6	38	Autoradiographs of PAGE-separated reactions containing either chemical-labeled gene or chemical-labeled gene showed that the increased gene activation was not due to gene-mediated feedback activation of gene and that there was increased cleavage of gene in the presence of gene in comparison with control reactions but only in the presence of both the enzyme and the surface .	T2	T29	10933803
NA	CHEMICAL	GENE-Y	9	7	Autoradiographs of PAGE-separated reactions containing either chemical-labeled gene or chemical-labeled gene showed that the increased gene activation was not due to gene-mediated feedback activation of gene and that there was increased cleavage of gene in the presence of gene in comparison with control reactions but only in the presence of both the enzyme and the surface .	T3	T23	10933803
NA	CHEMICAL	GENE-Y	9	10	Autoradiographs of PAGE-separated reactions containing either chemical-labeled gene or chemical-labeled gene showed that the increased gene activation was not due to gene-mediated feedback activation of gene and that there was increased cleavage of gene in the presence of gene in comparison with control reactions but only in the presence of both the enzyme and the surface .	T3	T24	10933803
NA	CHEMICAL	GENE-Y	9	15	Autoradiographs of PAGE-separated reactions containing either chemical-labeled gene or chemical-labeled gene showed that the increased gene activation was not due to gene-mediated feedback activation of gene and that there was increased cleavage of gene in the presence of gene in comparison with control reactions but only in the presence of both the enzyme and the surface .	T3	T25	10933803
NA	CHEMICAL	GENE-Y	9	21	Autoradiographs of PAGE-separated reactions containing either chemical-labeled gene or chemical-labeled gene showed that the increased gene activation was not due to gene-mediated feedback activation of gene and that there was increased cleavage of gene in the presence of gene in comparison with control reactions but only in the presence of both the enzyme and the surface .	T3	T26	10933803
NA	CHEMICAL	GENE-Y	9	25	Autoradiographs of PAGE-separated reactions containing either chemical-labeled gene or chemical-labeled gene showed that the increased gene activation was not due to gene-mediated feedback activation of gene and that there was increased cleavage of gene in the presence of gene in comparison with control reactions but only in the presence of both the enzyme and the surface .	T3	T27	10933803
NA	CHEMICAL	GENE-Y	9	33	Autoradiographs of PAGE-separated reactions containing either chemical-labeled gene or chemical-labeled gene showed that the increased gene activation was not due to gene-mediated feedback activation of gene and that there was increased cleavage of gene in the presence of gene in comparison with control reactions but only in the presence of both the enzyme and the surface .	T3	T28	10933803
NA	CHEMICAL	GENE-Y	9	38	Autoradiographs of PAGE-separated reactions containing either chemical-labeled gene or chemical-labeled gene showed that the increased gene activation was not due to gene-mediated feedback activation of gene and that there was increased cleavage of gene in the presence of gene in comparison with control reactions but only in the presence of both the enzyme and the surface .	T3	T29	10933803
NA	CHEMICAL	GENE-Y	30	4	Since plasma concentrations of gene , gene , gene , or gene did not by themselves potentiate gene generation and did not interfere with the potentiation of the reaction of gene , the effect is specific for gene and is not attributable to the gene of all chemical-dependent proteins .	T1	T5	10933803
NA	CHEMICAL	GENE-Y	30	6	Since plasma concentrations of gene , gene , gene , or gene did not by themselves potentiate gene generation and did not interfere with the potentiation of the reaction of gene , the effect is specific for gene and is not attributable to the gene of all chemical-dependent proteins .	T1	T6	10933803
NA	CHEMICAL	GENE-Y	30	8	Since plasma concentrations of gene , gene , gene , or gene did not by themselves potentiate gene generation and did not interfere with the potentiation of the reaction of gene , the effect is specific for gene and is not attributable to the gene of all chemical-dependent proteins .	T1	T7	10933803
NA	CHEMICAL	GENE-Y	30	11	Since plasma concentrations of gene , gene , gene , or gene did not by themselves potentiate gene generation and did not interfere with the potentiation of the reaction of gene , the effect is specific for gene and is not attributable to the gene of all chemical-dependent proteins .	T1	T8	10933803
NA	CHEMICAL	GENE-N	30	17	Since plasma concentrations of gene , gene , gene , or gene did not by themselves potentiate gene generation and did not interfere with the potentiation of the reaction of gene , the effect is specific for gene and is not attributable to the gene of all chemical-dependent proteins .	T1	T9	10933803
NA	CHEMICAL	GENE-Y	30	30	Since plasma concentrations of gene , gene , gene , or gene did not by themselves potentiate gene generation and did not interfere with the potentiation of the reaction of gene , the effect is specific for gene and is not attributable to the gene of all chemical-dependent proteins .	T1	T10	10933803
NA	CHEMICAL	GENE-Y	30	37	Since plasma concentrations of gene , gene , gene , or gene did not by themselves potentiate gene generation and did not interfere with the potentiation of the reaction of gene , the effect is specific for gene and is not attributable to the gene of all chemical-dependent proteins .	T1	T11	10933803
NA	CHEMICAL	GENE-N	30	44	Since plasma concentrations of gene , gene , gene , or gene did not by themselves potentiate gene generation and did not interfere with the potentiation of the reaction of gene , the effect is specific for gene and is not attributable to the gene of all chemical-dependent proteins .	T1	T12	10933803
NA	CHEMICAL	GENE-N	1	2	The chemical/chemical exchanger ( gene ) is a bidirectional transporter that normally extrudes chemical from the cell ( forward mode ) , but also brings chemical into the cell ( reverse mode ) under special conditions such as intracellular chemical ( chemical ( i ) ) accumulation or membrane depolarization .	T15	T34	17896959
NA	CHEMICAL	GENE-N	1	4	The chemical/chemical exchanger ( gene ) is a bidirectional transporter that normally extrudes chemical from the cell ( forward mode ) , but also brings chemical into the cell ( reverse mode ) under special conditions such as intracellular chemical ( chemical ( i ) ) accumulation or membrane depolarization .	T15	T31	17896959
NA	CHEMICAL	GENE-N	1	2	The chemical/chemical exchanger ( gene ) is a bidirectional transporter that normally extrudes chemical from the cell ( forward mode ) , but also brings chemical into the cell ( reverse mode ) under special conditions such as intracellular chemical ( chemical ( i ) ) accumulation or membrane depolarization .	T2	T34	17896959
NA	CHEMICAL	GENE-N	1	4	The chemical/chemical exchanger ( gene ) is a bidirectional transporter that normally extrudes chemical from the cell ( forward mode ) , but also brings chemical into the cell ( reverse mode ) under special conditions such as intracellular chemical ( chemical ( i ) ) accumulation or membrane depolarization .	T2	T31	17896959
CPR:9	CHEMICAL	GENE-N	3	2	The chemical/chemical exchanger ( gene ) is a bidirectional transporter that normally extrudes chemical from the cell ( forward mode ) , but also brings chemical into the cell ( reverse mode ) under special conditions such as intracellular chemical ( chemical ( i ) ) accumulation or membrane depolarization .	T23	T34	17896959
NA	CHEMICAL	GENE-N	3	4	The chemical/chemical exchanger ( gene ) is a bidirectional transporter that normally extrudes chemical from the cell ( forward mode ) , but also brings chemical into the cell ( reverse mode ) under special conditions such as intracellular chemical ( chemical ( i ) ) accumulation or membrane depolarization .	T23	T31	17896959
CPR:9	CHEMICAL	GENE-N	3	2	The chemical/chemical exchanger ( gene ) is a bidirectional transporter that normally extrudes chemical from the cell ( forward mode ) , but also brings chemical into the cell ( reverse mode ) under special conditions such as intracellular chemical ( chemical ( i ) ) accumulation or membrane depolarization .	T11	T34	17896959
NA	CHEMICAL	GENE-N	3	4	The chemical/chemical exchanger ( gene ) is a bidirectional transporter that normally extrudes chemical from the cell ( forward mode ) , but also brings chemical into the cell ( reverse mode ) under special conditions such as intracellular chemical ( chemical ( i ) ) accumulation or membrane depolarization .	T11	T31	17896959
NA	CHEMICAL	GENE-N	3	2	The chemical/chemical exchanger ( gene ) is a bidirectional transporter that normally extrudes chemical from the cell ( forward mode ) , but also brings chemical into the cell ( reverse mode ) under special conditions such as intracellular chemical ( chemical ( i ) ) accumulation or membrane depolarization .	T13	T34	17896959
NA	CHEMICAL	GENE-N	3	4	The chemical/chemical exchanger ( gene ) is a bidirectional transporter that normally extrudes chemical from the cell ( forward mode ) , but also brings chemical into the cell ( reverse mode ) under special conditions such as intracellular chemical ( chemical ( i ) ) accumulation or membrane depolarization .	T13	T31	17896959
NA	CHEMICAL	GENE-N	3	2	The chemical/chemical exchanger ( gene ) is a bidirectional transporter that normally extrudes chemical from the cell ( forward mode ) , but also brings chemical into the cell ( reverse mode ) under special conditions such as intracellular chemical ( chemical ( i ) ) accumulation or membrane depolarization .	T14	T34	17896959
NA	CHEMICAL	GENE-N	3	4	The chemical/chemical exchanger ( gene ) is a bidirectional transporter that normally extrudes chemical from the cell ( forward mode ) , but also brings chemical into the cell ( reverse mode ) under special conditions such as intracellular chemical ( chemical ( i ) ) accumulation or membrane depolarization .	T14	T31	17896959
NA	CHEMICAL	GENE-N	13	3	The pharmacology of gene inhibitors has been studied extensively since the development of chemical , a prototype chemical gene inhibitor , in 1996 .	T16	T37	17896959
CPR:4	CHEMICAL	GENE-N	13	18	The pharmacology of gene inhibitors has been studied extensively since the development of chemical , a prototype chemical gene inhibitor , in 1996 .	T16	T38	17896959
NA	CHEMICAL	GENE-N	17	3	The pharmacology of gene inhibitors has been studied extensively since the development of chemical , a prototype chemical gene inhibitor , in 1996 .	T17	T37	17896959
CPR:4	CHEMICAL	GENE-N	17	18	The pharmacology of gene inhibitors has been studied extensively since the development of chemical , a prototype chemical gene inhibitor , in 1996 .	T17	T38	17896959
CPR:4	CHEMICAL	GENE-N	6	7	Intriguingly , the inhibitory potency of chemical gene inhibitors is directly coupled to the rate of chemical ( i ) -dependent inactivation .	T21	T39	17896959
NA	CHEMICAL	GENE-N	16	7	Intriguingly , the inhibitory potency of chemical gene inhibitors is directly coupled to the rate of chemical ( i ) -dependent inactivation .	T22	T39	17896959
CPR:4	CHEMICAL	GENE-N	6	1	Existing gene blockers , such as chemical , chemical , chemical , chemical , and chemical , have been found to have an gene inhibitory action .	T6	T28	17896959
CPR:4	CHEMICAL	GENE-N	6	23	Existing gene blockers , such as chemical , chemical , chemical , chemical , and chemical , have been found to have an gene inhibitory action .	T6	T29	17896959
CPR:4	CHEMICAL	GENE-N	8	1	Existing gene blockers , such as chemical , chemical , chemical , chemical , and chemical , have been found to have an gene inhibitory action .	T7	T28	17896959
CPR:4	CHEMICAL	GENE-N	8	23	Existing gene blockers , such as chemical , chemical , chemical , chemical , and chemical , have been found to have an gene inhibitory action .	T7	T29	17896959
CPR:4	CHEMICAL	GENE-N	10	1	Existing gene blockers , such as chemical , chemical , chemical , chemical , and chemical , have been found to have an gene inhibitory action .	T8	T28	17896959
CPR:4	CHEMICAL	GENE-N	10	23	Existing gene blockers , such as chemical , chemical , chemical , chemical , and chemical , have been found to have an gene inhibitory action .	T8	T29	17896959
CPR:4	CHEMICAL	GENE-N	12	1	Existing gene blockers , such as chemical , chemical , chemical , chemical , and chemical , have been found to have an gene inhibitory action .	T9	T28	17896959
CPR:4	CHEMICAL	GENE-N	12	23	Existing gene blockers , such as chemical , chemical , chemical , chemical , and chemical , have been found to have an gene inhibitory action .	T9	T29	17896959
CPR:4	CHEMICAL	GENE-N	15	1	Existing gene blockers , such as chemical , chemical , chemical , chemical , and chemical , have been found to have an gene inhibitory action .	T10	T28	17896959
CPR:4	CHEMICAL	GENE-N	15	23	Existing gene blockers , such as chemical , chemical , chemical , chemical , and chemical , have been found to have an gene inhibitory action .	T10	T29	17896959
NA	CHEMICAL	GENE-N	9	5	In kidneys , stimulation of gene causes egress of chemical , conversion of chemical to chemical by ecto-gene , and metabolism of chemical to chemical by gene .	T16	T54	17308037
NA	CHEMICAL	GENE-N	9	17	In kidneys , stimulation of gene causes egress of chemical , conversion of chemical to chemical by ecto-gene , and metabolism of chemical to chemical by gene .	T16	T25	17308037
NA	CHEMICAL	GENE-Y	9	14	In kidneys , stimulation of gene causes egress of chemical , conversion of chemical to chemical by ecto-gene , and metabolism of chemical to chemical by gene .	T16	T39	17308037
NA	CHEMICAL	GENE-N	13	5	In kidneys , stimulation of gene causes egress of chemical , conversion of chemical to chemical by ecto-gene , and metabolism of chemical to chemical by gene .	T19	T54	17308037
CPR:9	CHEMICAL	GENE-N	13	17	In kidneys , stimulation of gene causes egress of chemical , conversion of chemical to chemical by ecto-gene , and metabolism of chemical to chemical by gene .	T19	T25	17308037
NA	CHEMICAL	GENE-Y	13	14	In kidneys , stimulation of gene causes egress of chemical , conversion of chemical to chemical by ecto-gene , and metabolism of chemical to chemical by gene .	T19	T39	17308037
NA	CHEMICAL	GENE-N	15	5	In kidneys , stimulation of gene causes egress of chemical , conversion of chemical to chemical by ecto-gene , and metabolism of chemical to chemical by gene .	T22	T54	17308037
CPR:9	CHEMICAL	GENE-N	15	17	In kidneys , stimulation of gene causes egress of chemical , conversion of chemical to chemical by ecto-gene , and metabolism of chemical to chemical by gene .	T22	T25	17308037
NA	CHEMICAL	GENE-Y	15	14	In kidneys , stimulation of gene causes egress of chemical , conversion of chemical to chemical by ecto-gene , and metabolism of chemical to chemical by gene .	T22	T39	17308037
NA	CHEMICAL	GENE-N	22	5	In kidneys , stimulation of gene causes egress of chemical , conversion of chemical to chemical by ecto-gene , and metabolism of chemical to chemical by gene .	T7	T54	17308037
NA	CHEMICAL	GENE-N	22	17	In kidneys , stimulation of gene causes egress of chemical , conversion of chemical to chemical by ecto-gene , and metabolism of chemical to chemical by gene .	T7	T25	17308037
CPR:9	CHEMICAL	GENE-Y	22	14	In kidneys , stimulation of gene causes egress of chemical , conversion of chemical to chemical by ecto-gene , and metabolism of chemical to chemical by gene .	T7	T39	17308037
NA	CHEMICAL	GENE-N	24	5	In kidneys , stimulation of gene causes egress of chemical , conversion of chemical to chemical by ecto-gene , and metabolism of chemical to chemical by gene .	T8	T54	17308037
NA	CHEMICAL	GENE-N	24	17	In kidneys , stimulation of gene causes egress of chemical , conversion of chemical to chemical by ecto-gene , and metabolism of chemical to chemical by gene .	T8	T25	17308037
CPR:9	CHEMICAL	GENE-Y	24	14	In kidneys , stimulation of gene causes egress of chemical , conversion of chemical to chemical by ecto-gene , and metabolism of chemical to chemical by gene .	T8	T39	17308037
CPR:4	CHEMICAL	GENE-N	8	2	A broad-spectrum gene ( gene ) inhibitor ( chemical , 300 microM , n=6 ) and an ecto-phosphodiesterase inhibitor ( chemical , 1 mM , n=6 ) significantly attenuated chemical-induced chemical secretion by 60 and 74 % , respectively .	T17	T55	17308037
CPR:4	CHEMICAL	GENE-N	8	4	A broad-spectrum gene ( gene ) inhibitor ( chemical , 300 microM , n=6 ) and an ecto-phosphodiesterase inhibitor ( chemical , 1 mM , n=6 ) significantly attenuated chemical-induced chemical secretion by 60 and 74 % , respectively .	T17	T56	17308037
NA	CHEMICAL	GENE-N	9	2	A broad-spectrum gene ( gene ) inhibitor ( chemical , 300 microM , n=6 ) and an ecto-phosphodiesterase inhibitor ( chemical , 1 mM , n=6 ) significantly attenuated chemical-induced chemical secretion by 60 and 74 % , respectively .	T18	T55	17308037
NA	CHEMICAL	GENE-N	9	4	A broad-spectrum gene ( gene ) inhibitor ( chemical , 300 microM , n=6 ) and an ecto-phosphodiesterase inhibitor ( chemical , 1 mM , n=6 ) significantly attenuated chemical-induced chemical secretion by 60 and 74 % , respectively .	T18	T56	17308037
NA	CHEMICAL	GENE-N	0	2	A broad-spectrum gene ( gene ) inhibitor ( chemical , 300 microM , n=6 ) and an ecto-phosphodiesterase inhibitor ( chemical , 1 mM , n=6 ) significantly attenuated chemical-induced chemical secretion by 60 and 74 % , respectively .	T20	T55	17308037
NA	CHEMICAL	GENE-N	0	4	A broad-spectrum gene ( gene ) inhibitor ( chemical , 300 microM , n=6 ) and an ecto-phosphodiesterase inhibitor ( chemical , 1 mM , n=6 ) significantly attenuated chemical-induced chemical secretion by 60 and 74 % , respectively .	T20	T56	17308037
NA	CHEMICAL	GENE-N	0	2	A broad-spectrum gene ( gene ) inhibitor ( chemical , 300 microM , n=6 ) and an ecto-phosphodiesterase inhibitor ( chemical , 1 mM , n=6 ) significantly attenuated chemical-induced chemical secretion by 60 and 74 % , respectively .	T21	T55	17308037
NA	CHEMICAL	GENE-N	0	4	A broad-spectrum gene ( gene ) inhibitor ( chemical , 300 microM , n=6 ) and an ecto-phosphodiesterase inhibitor ( chemical , 1 mM , n=6 ) significantly attenuated chemical-induced chemical secretion by 60 and 74 % , respectively .	T21	T56	17308037
CPR:4	CHEMICAL	GENE-N	4	2	Blockade of gene ( chemical , 100 microM ) , gene [ chemical , 30 microM ] , gene ( chemical , 10 microM ; cGMP , 10 microM ) , gene ( Ro 20-1724 [ chemical ] , 100 microM ) , gene and gene ( chemical , 30 microM ) , and gene [ chemical ( chemical ) , 10 microM ] did not alter renal ecto-gene activity .	T23	T57	17308037
NA	CHEMICAL	GENE-N	4	10	Blockade of gene ( chemical , 100 microM ) , gene [ chemical , 30 microM ] , gene ( chemical , 10 microM ; cGMP , 10 microM ) , gene ( Ro 20-1724 [ chemical ] , 100 microM ) , gene and gene ( chemical , 30 microM ) , and gene [ chemical ( chemical ) , 10 microM ] did not alter renal ecto-gene activity .	T23	T58	17308037
NA	CHEMICAL	GENE-N	4	18	Blockade of gene ( chemical , 100 microM ) , gene [ chemical , 30 microM ] , gene ( chemical , 10 microM ; cGMP , 10 microM ) , gene ( Ro 20-1724 [ chemical ] , 100 microM ) , gene and gene ( chemical , 30 microM ) , and gene [ chemical ( chemical ) , 10 microM ] did not alter renal ecto-gene activity .	T23	T26	17308037
NA	CHEMICAL	GENE-N	4	31	Blockade of gene ( chemical , 100 microM ) , gene [ chemical , 30 microM ] , gene ( chemical , 10 microM ; cGMP , 10 microM ) , gene ( Ro 20-1724 [ chemical ] , 100 microM ) , gene and gene ( chemical , 30 microM ) , and gene [ chemical ( chemical ) , 10 microM ] did not alter renal ecto-gene activity .	T23	T27	17308037
NA	CHEMICAL	GENE-Y	4	43	Blockade of gene ( chemical , 100 microM ) , gene [ chemical , 30 microM ] , gene ( chemical , 10 microM ; cGMP , 10 microM ) , gene ( Ro 20-1724 [ chemical ] , 100 microM ) , gene and gene ( chemical , 30 microM ) , and gene [ chemical ( chemical ) , 10 microM ] did not alter renal ecto-gene activity .	T23	T28	17308037
NA	CHEMICAL	GENE-N	4	45	Blockade of gene ( chemical , 100 microM ) , gene [ chemical , 30 microM ] , gene ( chemical , 10 microM ; cGMP , 10 microM ) , gene ( Ro 20-1724 [ chemical ] , 100 microM ) , gene and gene ( chemical , 30 microM ) , and gene [ chemical ( chemical ) , 10 microM ] did not alter renal ecto-gene activity .	T23	T29	17308037
NA	CHEMICAL	GENE-N	4	54	Blockade of gene ( chemical , 100 microM ) , gene [ chemical , 30 microM ] , gene ( chemical , 10 microM ; cGMP , 10 microM ) , gene ( Ro 20-1724 [ chemical ] , 100 microM ) , gene and gene ( chemical , 30 microM ) , and gene [ chemical ( chemical ) , 10 microM ] did not alter renal ecto-gene activity .	T23	T30	17308037
NA	CHEMICAL	GENE-N	4	68	Blockade of gene ( chemical , 100 microM ) , gene [ chemical , 30 microM ] , gene ( chemical , 10 microM ; cGMP , 10 microM ) , gene ( Ro 20-1724 [ chemical ] , 100 microM ) , gene and gene ( chemical , 30 microM ) , and gene [ chemical ( chemical ) , 10 microM ] did not alter renal ecto-gene activity .	T23	T31	17308037
NA	CHEMICAL	GENE-N	3	2	Blockade of gene ( chemical , 100 microM ) , gene [ chemical , 30 microM ] , gene ( chemical , 10 microM ; cGMP , 10 microM ) , gene ( Ro 20-1724 [ chemical ] , 100 microM ) , gene and gene ( chemical , 30 microM ) , and gene [ chemical ( chemical ) , 10 microM ] did not alter renal ecto-gene activity .	T24	T57	17308037
CPR:4	CHEMICAL	GENE-N	3	10	Blockade of gene ( chemical , 100 microM ) , gene [ chemical , 30 microM ] , gene ( chemical , 10 microM ; cGMP , 10 microM ) , gene ( Ro 20-1724 [ chemical ] , 100 microM ) , gene and gene ( chemical , 30 microM ) , and gene [ chemical ( chemical ) , 10 microM ] did not alter renal ecto-gene activity .	T24	T58	17308037
NA	CHEMICAL	GENE-N	3	18	Blockade of gene ( chemical , 100 microM ) , gene [ chemical , 30 microM ] , gene ( chemical , 10 microM ; cGMP , 10 microM ) , gene ( Ro 20-1724 [ chemical ] , 100 microM ) , gene and gene ( chemical , 30 microM ) , and gene [ chemical ( chemical ) , 10 microM ] did not alter renal ecto-gene activity .	T24	T26	17308037
NA	CHEMICAL	GENE-N	3	31	Blockade of gene ( chemical , 100 microM ) , gene [ chemical , 30 microM ] , gene ( chemical , 10 microM ; cGMP , 10 microM ) , gene ( Ro 20-1724 [ chemical ] , 100 microM ) , gene and gene ( chemical , 30 microM ) , and gene [ chemical ( chemical ) , 10 microM ] did not alter renal ecto-gene activity .	T24	T27	17308037
NA	CHEMICAL	GENE-Y	3	43	Blockade of gene ( chemical , 100 microM ) , gene [ chemical , 30 microM ] , gene ( chemical , 10 microM ; cGMP , 10 microM ) , gene ( Ro 20-1724 [ chemical ] , 100 microM ) , gene and gene ( chemical , 30 microM ) , and gene [ chemical ( chemical ) , 10 microM ] did not alter renal ecto-gene activity .	T24	T28	17308037
NA	CHEMICAL	GENE-N	3	45	Blockade of gene ( chemical , 100 microM ) , gene [ chemical , 30 microM ] , gene ( chemical , 10 microM ; cGMP , 10 microM ) , gene ( Ro 20-1724 [ chemical ] , 100 microM ) , gene and gene ( chemical , 30 microM ) , and gene [ chemical ( chemical ) , 10 microM ] did not alter renal ecto-gene activity .	T24	T29	17308037
NA	CHEMICAL	GENE-N	3	54	Blockade of gene ( chemical , 100 microM ) , gene [ chemical , 30 microM ] , gene ( chemical , 10 microM ; cGMP , 10 microM ) , gene ( Ro 20-1724 [ chemical ] , 100 microM ) , gene and gene ( chemical , 30 microM ) , and gene [ chemical ( chemical ) , 10 microM ] did not alter renal ecto-gene activity .	T24	T30	17308037
NA	CHEMICAL	GENE-N	3	68	Blockade of gene ( chemical , 100 microM ) , gene [ chemical , 30 microM ] , gene ( chemical , 10 microM ; cGMP , 10 microM ) , gene ( Ro 20-1724 [ chemical ] , 100 microM ) , gene and gene ( chemical , 30 microM ) , and gene [ chemical ( chemical ) , 10 microM ] did not alter renal ecto-gene activity .	T24	T31	17308037
NA	CHEMICAL	GENE-N	20	2	Blockade of gene ( chemical , 100 microM ) , gene [ chemical , 30 microM ] , gene ( chemical , 10 microM ; cGMP , 10 microM ) , gene ( Ro 20-1724 [ chemical ] , 100 microM ) , gene and gene ( chemical , 30 microM ) , and gene [ chemical ( chemical ) , 10 microM ] did not alter renal ecto-gene activity .	T1	T57	17308037
NA	CHEMICAL	GENE-N	20	10	Blockade of gene ( chemical , 100 microM ) , gene [ chemical , 30 microM ] , gene ( chemical , 10 microM ; cGMP , 10 microM ) , gene ( Ro 20-1724 [ chemical ] , 100 microM ) , gene and gene ( chemical , 30 microM ) , and gene [ chemical ( chemical ) , 10 microM ] did not alter renal ecto-gene activity .	T1	T58	17308037
CPR:4	CHEMICAL	GENE-N	20	18	Blockade of gene ( chemical , 100 microM ) , gene [ chemical , 30 microM ] , gene ( chemical , 10 microM ; cGMP , 10 microM ) , gene ( Ro 20-1724 [ chemical ] , 100 microM ) , gene and gene ( chemical , 30 microM ) , and gene [ chemical ( chemical ) , 10 microM ] did not alter renal ecto-gene activity .	T1	T26	17308037
NA	CHEMICAL	GENE-N	20	31	Blockade of gene ( chemical , 100 microM ) , gene [ chemical , 30 microM ] , gene ( chemical , 10 microM ; cGMP , 10 microM ) , gene ( Ro 20-1724 [ chemical ] , 100 microM ) , gene and gene ( chemical , 30 microM ) , and gene [ chemical ( chemical ) , 10 microM ] did not alter renal ecto-gene activity .	T1	T27	17308037
NA	CHEMICAL	GENE-Y	20	43	Blockade of gene ( chemical , 100 microM ) , gene [ chemical , 30 microM ] , gene ( chemical , 10 microM ; cGMP , 10 microM ) , gene ( Ro 20-1724 [ chemical ] , 100 microM ) , gene and gene ( chemical , 30 microM ) , and gene [ chemical ( chemical ) , 10 microM ] did not alter renal ecto-gene activity .	T1	T28	17308037
NA	CHEMICAL	GENE-N	20	45	Blockade of gene ( chemical , 100 microM ) , gene [ chemical , 30 microM ] , gene ( chemical , 10 microM ; cGMP , 10 microM ) , gene ( Ro 20-1724 [ chemical ] , 100 microM ) , gene and gene ( chemical , 30 microM ) , and gene [ chemical ( chemical ) , 10 microM ] did not alter renal ecto-gene activity .	T1	T29	17308037
NA	CHEMICAL	GENE-N	20	54	Blockade of gene ( chemical , 100 microM ) , gene [ chemical , 30 microM ] , gene ( chemical , 10 microM ; cGMP , 10 microM ) , gene ( Ro 20-1724 [ chemical ] , 100 microM ) , gene and gene ( chemical , 30 microM ) , and gene [ chemical ( chemical ) , 10 microM ] did not alter renal ecto-gene activity .	T1	T30	17308037
NA	CHEMICAL	GENE-N	20	68	Blockade of gene ( chemical , 100 microM ) , gene [ chemical , 30 microM ] , gene ( chemical , 10 microM ; cGMP , 10 microM ) , gene ( Ro 20-1724 [ chemical ] , 100 microM ) , gene and gene ( chemical , 30 microM ) , and gene [ chemical ( chemical ) , 10 microM ] did not alter renal ecto-gene activity .	T1	T31	17308037
NA	CHEMICAL	GENE-N	3	2	Blockade of gene ( chemical , 100 microM ) , gene [ chemical , 30 microM ] , gene ( chemical , 10 microM ; cGMP , 10 microM ) , gene ( Ro 20-1724 [ chemical ] , 100 microM ) , gene and gene ( chemical , 30 microM ) , and gene [ chemical ( chemical ) , 10 microM ] did not alter renal ecto-gene activity .	T2	T57	17308037
NA	CHEMICAL	GENE-N	3	10	Blockade of gene ( chemical , 100 microM ) , gene [ chemical , 30 microM ] , gene ( chemical , 10 microM ; cGMP , 10 microM ) , gene ( Ro 20-1724 [ chemical ] , 100 microM ) , gene and gene ( chemical , 30 microM ) , and gene [ chemical ( chemical ) , 10 microM ] did not alter renal ecto-gene activity .	T2	T58	17308037
NA	CHEMICAL	GENE-N	3	18	Blockade of gene ( chemical , 100 microM ) , gene [ chemical , 30 microM ] , gene ( chemical , 10 microM ; cGMP , 10 microM ) , gene ( Ro 20-1724 [ chemical ] , 100 microM ) , gene and gene ( chemical , 30 microM ) , and gene [ chemical ( chemical ) , 10 microM ] did not alter renal ecto-gene activity .	T2	T26	17308037
CPR:4	CHEMICAL	GENE-N	3	31	Blockade of gene ( chemical , 100 microM ) , gene [ chemical , 30 microM ] , gene ( chemical , 10 microM ; cGMP , 10 microM ) , gene ( Ro 20-1724 [ chemical ] , 100 microM ) , gene and gene ( chemical , 30 microM ) , and gene [ chemical ( chemical ) , 10 microM ] did not alter renal ecto-gene activity .	T2	T27	17308037
NA	CHEMICAL	GENE-Y	3	43	Blockade of gene ( chemical , 100 microM ) , gene [ chemical , 30 microM ] , gene ( chemical , 10 microM ; cGMP , 10 microM ) , gene ( Ro 20-1724 [ chemical ] , 100 microM ) , gene and gene ( chemical , 30 microM ) , and gene [ chemical ( chemical ) , 10 microM ] did not alter renal ecto-gene activity .	T2	T28	17308037
NA	CHEMICAL	GENE-N	3	45	Blockade of gene ( chemical , 100 microM ) , gene [ chemical , 30 microM ] , gene ( chemical , 10 microM ; cGMP , 10 microM ) , gene ( Ro 20-1724 [ chemical ] , 100 microM ) , gene and gene ( chemical , 30 microM ) , and gene [ chemical ( chemical ) , 10 microM ] did not alter renal ecto-gene activity .	T2	T29	17308037
NA	CHEMICAL	GENE-N	3	54	Blockade of gene ( chemical , 100 microM ) , gene [ chemical , 30 microM ] , gene ( chemical , 10 microM ; cGMP , 10 microM ) , gene ( Ro 20-1724 [ chemical ] , 100 microM ) , gene and gene ( chemical , 30 microM ) , and gene [ chemical ( chemical ) , 10 microM ] did not alter renal ecto-gene activity .	T2	T30	17308037
NA	CHEMICAL	GENE-N	3	68	Blockade of gene ( chemical , 100 microM ) , gene [ chemical , 30 microM ] , gene ( chemical , 10 microM ; cGMP , 10 microM ) , gene ( Ro 20-1724 [ chemical ] , 100 microM ) , gene and gene ( chemical , 30 microM ) , and gene [ chemical ( chemical ) , 10 microM ] did not alter renal ecto-gene activity .	T2	T31	17308037
NA	CHEMICAL	GENE-N	47	2	Blockade of gene ( chemical , 100 microM ) , gene [ chemical , 30 microM ] , gene ( chemical , 10 microM ; cGMP , 10 microM ) , gene ( Ro 20-1724 [ chemical ] , 100 microM ) , gene and gene ( chemical , 30 microM ) , and gene [ chemical ( chemical ) , 10 microM ] did not alter renal ecto-gene activity .	T3	T57	17308037
NA	CHEMICAL	GENE-N	47	10	Blockade of gene ( chemical , 100 microM ) , gene [ chemical , 30 microM ] , gene ( chemical , 10 microM ; cGMP , 10 microM ) , gene ( Ro 20-1724 [ chemical ] , 100 microM ) , gene and gene ( chemical , 30 microM ) , and gene [ chemical ( chemical ) , 10 microM ] did not alter renal ecto-gene activity .	T3	T58	17308037
NA	CHEMICAL	GENE-N	47	18	Blockade of gene ( chemical , 100 microM ) , gene [ chemical , 30 microM ] , gene ( chemical , 10 microM ; cGMP , 10 microM ) , gene ( Ro 20-1724 [ chemical ] , 100 microM ) , gene and gene ( chemical , 30 microM ) , and gene [ chemical ( chemical ) , 10 microM ] did not alter renal ecto-gene activity .	T3	T26	17308037
NA	CHEMICAL	GENE-N	47	31	Blockade of gene ( chemical , 100 microM ) , gene [ chemical , 30 microM ] , gene ( chemical , 10 microM ; cGMP , 10 microM ) , gene ( Ro 20-1724 [ chemical ] , 100 microM ) , gene and gene ( chemical , 30 microM ) , and gene [ chemical ( chemical ) , 10 microM ] did not alter renal ecto-gene activity .	T3	T27	17308037
CPR:4	CHEMICAL	GENE-Y	47	43	Blockade of gene ( chemical , 100 microM ) , gene [ chemical , 30 microM ] , gene ( chemical , 10 microM ; cGMP , 10 microM ) , gene ( Ro 20-1724 [ chemical ] , 100 microM ) , gene and gene ( chemical , 30 microM ) , and gene [ chemical ( chemical ) , 10 microM ] did not alter renal ecto-gene activity .	T3	T28	17308037
CPR:4	CHEMICAL	GENE-N	47	45	Blockade of gene ( chemical , 100 microM ) , gene [ chemical , 30 microM ] , gene ( chemical , 10 microM ; cGMP , 10 microM ) , gene ( Ro 20-1724 [ chemical ] , 100 microM ) , gene and gene ( chemical , 30 microM ) , and gene [ chemical ( chemical ) , 10 microM ] did not alter renal ecto-gene activity .	T3	T29	17308037
NA	CHEMICAL	GENE-N	47	54	Blockade of gene ( chemical , 100 microM ) , gene [ chemical , 30 microM ] , gene ( chemical , 10 microM ; cGMP , 10 microM ) , gene ( Ro 20-1724 [ chemical ] , 100 microM ) , gene and gene ( chemical , 30 microM ) , and gene [ chemical ( chemical ) , 10 microM ] did not alter renal ecto-gene activity .	T3	T30	17308037
NA	CHEMICAL	GENE-N	47	68	Blockade of gene ( chemical , 100 microM ) , gene [ chemical , 30 microM ] , gene ( chemical , 10 microM ; cGMP , 10 microM ) , gene ( Ro 20-1724 [ chemical ] , 100 microM ) , gene and gene ( chemical , 30 microM ) , and gene [ chemical ( chemical ) , 10 microM ] did not alter renal ecto-gene activity .	T3	T31	17308037
NA	CHEMICAL	GENE-N	56	2	Blockade of gene ( chemical , 100 microM ) , gene [ chemical , 30 microM ] , gene ( chemical , 10 microM ; cGMP , 10 microM ) , gene ( Ro 20-1724 [ chemical ] , 100 microM ) , gene and gene ( chemical , 30 microM ) , and gene [ chemical ( chemical ) , 10 microM ] did not alter renal ecto-gene activity .	T4	T57	17308037
NA	CHEMICAL	GENE-N	56	10	Blockade of gene ( chemical , 100 microM ) , gene [ chemical , 30 microM ] , gene ( chemical , 10 microM ; cGMP , 10 microM ) , gene ( Ro 20-1724 [ chemical ] , 100 microM ) , gene and gene ( chemical , 30 microM ) , and gene [ chemical ( chemical ) , 10 microM ] did not alter renal ecto-gene activity .	T4	T58	17308037
NA	CHEMICAL	GENE-N	56	18	Blockade of gene ( chemical , 100 microM ) , gene [ chemical , 30 microM ] , gene ( chemical , 10 microM ; cGMP , 10 microM ) , gene ( Ro 20-1724 [ chemical ] , 100 microM ) , gene and gene ( chemical , 30 microM ) , and gene [ chemical ( chemical ) , 10 microM ] did not alter renal ecto-gene activity .	T4	T26	17308037
NA	CHEMICAL	GENE-N	56	31	Blockade of gene ( chemical , 100 microM ) , gene [ chemical , 30 microM ] , gene ( chemical , 10 microM ; cGMP , 10 microM ) , gene ( Ro 20-1724 [ chemical ] , 100 microM ) , gene and gene ( chemical , 30 microM ) , and gene [ chemical ( chemical ) , 10 microM ] did not alter renal ecto-gene activity .	T4	T27	17308037
NA	CHEMICAL	GENE-Y	56	43	Blockade of gene ( chemical , 100 microM ) , gene [ chemical , 30 microM ] , gene ( chemical , 10 microM ; cGMP , 10 microM ) , gene ( Ro 20-1724 [ chemical ] , 100 microM ) , gene and gene ( chemical , 30 microM ) , and gene [ chemical ( chemical ) , 10 microM ] did not alter renal ecto-gene activity .	T4	T28	17308037
NA	CHEMICAL	GENE-N	56	45	Blockade of gene ( chemical , 100 microM ) , gene [ chemical , 30 microM ] , gene ( chemical , 10 microM ; cGMP , 10 microM ) , gene ( Ro 20-1724 [ chemical ] , 100 microM ) , gene and gene ( chemical , 30 microM ) , and gene [ chemical ( chemical ) , 10 microM ] did not alter renal ecto-gene activity .	T4	T29	17308037
CPR:4	CHEMICAL	GENE-N	56	54	Blockade of gene ( chemical , 100 microM ) , gene [ chemical , 30 microM ] , gene ( chemical , 10 microM ; cGMP , 10 microM ) , gene ( Ro 20-1724 [ chemical ] , 100 microM ) , gene and gene ( chemical , 30 microM ) , and gene [ chemical ( chemical ) , 10 microM ] did not alter renal ecto-gene activity .	T4	T30	17308037
NA	CHEMICAL	GENE-N	56	68	Blockade of gene ( chemical , 100 microM ) , gene [ chemical , 30 microM ] , gene ( chemical , 10 microM ; cGMP , 10 microM ) , gene ( Ro 20-1724 [ chemical ] , 100 microM ) , gene and gene ( chemical , 30 microM ) , and gene [ chemical ( chemical ) , 10 microM ] did not alter renal ecto-gene activity .	T4	T31	17308037
NA	CHEMICAL	GENE-N	2	2	Blockade of gene ( chemical , 100 microM ) , gene [ chemical , 30 microM ] , gene ( chemical , 10 microM ; cGMP , 10 microM ) , gene ( Ro 20-1724 [ chemical ] , 100 microM ) , gene and gene ( chemical , 30 microM ) , and gene [ chemical ( chemical ) , 10 microM ] did not alter renal ecto-gene activity .	T5	T57	17308037
NA	CHEMICAL	GENE-N	2	10	Blockade of gene ( chemical , 100 microM ) , gene [ chemical , 30 microM ] , gene ( chemical , 10 microM ; cGMP , 10 microM ) , gene ( Ro 20-1724 [ chemical ] , 100 microM ) , gene and gene ( chemical , 30 microM ) , and gene [ chemical ( chemical ) , 10 microM ] did not alter renal ecto-gene activity .	T5	T58	17308037
NA	CHEMICAL	GENE-N	2	18	Blockade of gene ( chemical , 100 microM ) , gene [ chemical , 30 microM ] , gene ( chemical , 10 microM ; cGMP , 10 microM ) , gene ( Ro 20-1724 [ chemical ] , 100 microM ) , gene and gene ( chemical , 30 microM ) , and gene [ chemical ( chemical ) , 10 microM ] did not alter renal ecto-gene activity .	T5	T26	17308037
NA	CHEMICAL	GENE-N	2	31	Blockade of gene ( chemical , 100 microM ) , gene [ chemical , 30 microM ] , gene ( chemical , 10 microM ; cGMP , 10 microM ) , gene ( Ro 20-1724 [ chemical ] , 100 microM ) , gene and gene ( chemical , 30 microM ) , and gene [ chemical ( chemical ) , 10 microM ] did not alter renal ecto-gene activity .	T5	T27	17308037
NA	CHEMICAL	GENE-Y	2	43	Blockade of gene ( chemical , 100 microM ) , gene [ chemical , 30 microM ] , gene ( chemical , 10 microM ; cGMP , 10 microM ) , gene ( Ro 20-1724 [ chemical ] , 100 microM ) , gene and gene ( chemical , 30 microM ) , and gene [ chemical ( chemical ) , 10 microM ] did not alter renal ecto-gene activity .	T5	T28	17308037
NA	CHEMICAL	GENE-N	2	45	Blockade of gene ( chemical , 100 microM ) , gene [ chemical , 30 microM ] , gene ( chemical , 10 microM ; cGMP , 10 microM ) , gene ( Ro 20-1724 [ chemical ] , 100 microM ) , gene and gene ( chemical , 30 microM ) , and gene [ chemical ( chemical ) , 10 microM ] did not alter renal ecto-gene activity .	T5	T29	17308037
CPR:4	CHEMICAL	GENE-N	2	54	Blockade of gene ( chemical , 100 microM ) , gene [ chemical , 30 microM ] , gene ( chemical , 10 microM ; cGMP , 10 microM ) , gene ( Ro 20-1724 [ chemical ] , 100 microM ) , gene and gene ( chemical , 30 microM ) , and gene [ chemical ( chemical ) , 10 microM ] did not alter renal ecto-gene activity .	T5	T30	17308037
NA	CHEMICAL	GENE-N	2	68	Blockade of gene ( chemical , 100 microM ) , gene [ chemical , 30 microM ] , gene ( chemical , 10 microM ; cGMP , 10 microM ) , gene ( Ro 20-1724 [ chemical ] , 100 microM ) , gene and gene ( chemical , 30 microM ) , and gene [ chemical ( chemical ) , 10 microM ] did not alter renal ecto-gene activity .	T5	T31	17308037
CPR:4	CHEMICAL	GENE-N	2	12	Administration of a concentration ( 100 microM ) of chemical that blocks gene inhibited ecto-gene activity ( by 44 % ) .	T6	T32	17308037
CPR:4	CHEMICAL	GENE-N	2	2	Administration of a concentration ( 100 microM ) of chemical that blocks gene inhibited ecto-gene activity ( by 44 % ) .	T6	T33	17308037
CPR:4	CHEMICAL	GENE-N	2	13	However , a lower concentration of chemical ( 3 microM ) that blocks gene , gene , and gene , but not gene , did not inhibit ecto-gene activity .	T9	T34	17308037
CPR:4	CHEMICAL	GENE-Y	2	15	However , a lower concentration of chemical ( 3 microM ) that blocks gene , gene , and gene , but not gene , did not inhibit ecto-gene activity .	T9	T35	17308037
CPR:4	CHEMICAL	GENE-Y	2	18	However , a lower concentration of chemical ( 3 microM ) that blocks gene , gene , and gene , but not gene , did not inhibit ecto-gene activity .	T9	T36	17308037
NA	CHEMICAL	GENE-N	2	22	However , a lower concentration of chemical ( 3 microM ) that blocks gene , gene , and gene , but not gene , did not inhibit ecto-gene activity .	T9	T37	17308037
NA	CHEMICAL	GENE-N	2	2	However , a lower concentration of chemical ( 3 microM ) that blocks gene , gene , and gene , but not gene , did not inhibit ecto-gene activity .	T9	T38	17308037
CPR:4	CHEMICAL	GENE-N	40	7	These data support the conclusion that renal ecto-gene activity is not mediated by gene , gene , gene , gene , gene , gene , gene , gene , gene , or gene and is inhibited by high concentrations of chemical .	T10	T40	17308037
NA	CHEMICAL	GENE-N	40	13	These data support the conclusion that renal ecto-gene activity is not mediated by gene , gene , gene , gene , gene , gene , gene , gene , gene , or gene and is inhibited by high concentrations of chemical .	T10	T41	17308037
NA	CHEMICAL	GENE-N	40	15	These data support the conclusion that renal ecto-gene activity is not mediated by gene , gene , gene , gene , gene , gene , gene , gene , gene , or gene and is inhibited by high concentrations of chemical .	T10	T42	17308037
NA	CHEMICAL	GENE-N	40	17	These data support the conclusion that renal ecto-gene activity is not mediated by gene , gene , gene , gene , gene , gene , gene , gene , gene , or gene and is inhibited by high concentrations of chemical .	T10	T43	17308037
NA	CHEMICAL	GENE-N	40	19	These data support the conclusion that renal ecto-gene activity is not mediated by gene , gene , gene , gene , gene , gene , gene , gene , gene , or gene and is inhibited by high concentrations of chemical .	T10	T44	17308037
NA	CHEMICAL	GENE-Y	40	21	These data support the conclusion that renal ecto-gene activity is not mediated by gene , gene , gene , gene , gene , gene , gene , gene , gene , or gene and is inhibited by high concentrations of chemical .	T10	T45	17308037
NA	CHEMICAL	GENE-N	40	23	These data support the conclusion that renal ecto-gene activity is not mediated by gene , gene , gene , gene , gene , gene , gene , gene , gene , or gene and is inhibited by high concentrations of chemical .	T10	T46	17308037
NA	CHEMICAL	GENE-N	40	25	These data support the conclusion that renal ecto-gene activity is not mediated by gene , gene , gene , gene , gene , gene , gene , gene , gene , or gene and is inhibited by high concentrations of chemical .	T10	T47	17308037
NA	CHEMICAL	GENE-N	40	27	These data support the conclusion that renal ecto-gene activity is not mediated by gene , gene , gene , gene , gene , gene , gene , gene , gene , or gene and is inhibited by high concentrations of chemical .	T10	T48	17308037
NA	CHEMICAL	GENE-Y	40	29	These data support the conclusion that renal ecto-gene activity is not mediated by gene , gene , gene , gene , gene , gene , gene , gene , gene , or gene and is inhibited by high concentrations of chemical .	T10	T49	17308037
NA	CHEMICAL	GENE-Y	40	32	These data support the conclusion that renal ecto-gene activity is not mediated by gene , gene , gene , gene , gene , gene , gene , gene , gene , or gene and is inhibited by high concentrations of chemical .	T10	T50	17308037
NA	CHEMICAL	GENE-N	0	1	chemical peroxidases and redox-regulated transcription factors .	T7	T39	17081103
NA	CHEMICAL	GENE-N	6	7	Analysis of the selenoproteome identified five chemical peroxidases ( gene ) in mammals : gene ( gene , gene ) , gene ( gene , gene ) , gene ( gene , gene ) , gene ( gene , gene ) and , in gene , which is restricted to the olfactory system .	T4	T28	17081103
NA	CHEMICAL	GENE-N	6	9	Analysis of the selenoproteome identified five chemical peroxidases ( gene ) in mammals : gene ( gene , gene ) , gene ( gene , gene ) , gene ( gene , gene ) , gene ( gene , gene ) and , in gene , which is restricted to the olfactory system .	T4	T35	17081103
NA	CHEMICAL	GENE-N	6	14	Analysis of the selenoproteome identified five chemical peroxidases ( gene ) in mammals : gene ( gene , gene ) , gene ( gene , gene ) , gene ( gene , gene ) , gene ( gene , gene ) and , in gene , which is restricted to the olfactory system .	T4	T38	17081103
NA	CHEMICAL	GENE-N	6	16	Analysis of the selenoproteome identified five chemical peroxidases ( gene ) in mammals : gene ( gene , gene ) , gene ( gene , gene ) , gene ( gene , gene ) , gene ( gene , gene ) and , in gene , which is restricted to the olfactory system .	T4	T10	17081103
NA	CHEMICAL	GENE-N	6	18	Analysis of the selenoproteome identified five chemical peroxidases ( gene ) in mammals : gene ( gene , gene ) , gene ( gene , gene ) , gene ( gene , gene ) , gene ( gene , gene ) and , in gene , which is restricted to the olfactory system .	T4	T12	17081103
NA	CHEMICAL	GENE-N	6	21	Analysis of the selenoproteome identified five chemical peroxidases ( gene ) in mammals : gene ( gene , gene ) , gene ( gene , gene ) , gene ( gene , gene ) , gene ( gene , gene ) and , in gene , which is restricted to the olfactory system .	T4	T13	17081103
NA	CHEMICAL	GENE-N	6	23	Analysis of the selenoproteome identified five chemical peroxidases ( gene ) in mammals : gene ( gene , gene ) , gene ( gene , gene ) , gene ( gene , gene ) , gene ( gene , gene ) and , in gene , which is restricted to the olfactory system .	T4	T18	17081103
NA	CHEMICAL	GENE-N	6	25	Analysis of the selenoproteome identified five chemical peroxidases ( gene ) in mammals : gene ( gene , gene ) , gene ( gene , gene ) , gene ( gene , gene ) , gene ( gene , gene ) and , in gene , which is restricted to the olfactory system .	T4	T19	17081103
NA	CHEMICAL	GENE-N	6	28	Analysis of the selenoproteome identified five chemical peroxidases ( gene ) in mammals : gene ( gene , gene ) , gene ( gene , gene ) , gene ( gene , gene ) , gene ( gene , gene ) and , in gene , which is restricted to the olfactory system .	T4	T20	17081103
NA	CHEMICAL	GENE-N	6	30	Analysis of the selenoproteome identified five chemical peroxidases ( gene ) in mammals : gene ( gene , gene ) , gene ( gene , gene ) , gene ( gene , gene ) , gene ( gene , gene ) and , in gene , which is restricted to the olfactory system .	T4	T21	17081103
NA	CHEMICAL	GENE-N	6	32	Analysis of the selenoproteome identified five chemical peroxidases ( gene ) in mammals : gene ( gene , gene ) , gene ( gene , gene ) , gene ( gene , gene ) , gene ( gene , gene ) and , in gene , which is restricted to the olfactory system .	T4	T22	17081103
NA	CHEMICAL	GENE-N	6	35	Analysis of the selenoproteome identified five chemical peroxidases ( gene ) in mammals : gene ( gene , gene ) , gene ( gene , gene ) , gene ( gene , gene ) , gene ( gene , gene ) and , in gene , which is restricted to the olfactory system .	T4	T23	17081103
NA	CHEMICAL	GENE-N	6	37	Analysis of the selenoproteome identified five chemical peroxidases ( gene ) in mammals : gene ( gene , gene ) , gene ( gene , gene ) , gene ( gene , gene ) , gene ( gene , gene ) and , in gene , which is restricted to the olfactory system .	T4	T24	17081103
NA	CHEMICAL	GENE-N	6	39	Analysis of the selenoproteome identified five chemical peroxidases ( gene ) in mammals : gene ( gene , gene ) , gene ( gene , gene ) , gene ( gene , gene ) , gene ( gene , gene ) and , in gene , which is restricted to the olfactory system .	T4	T25	17081103
NA	CHEMICAL	GENE-Y	6	44	Analysis of the selenoproteome identified five chemical peroxidases ( gene ) in mammals : gene ( gene , gene ) , gene ( gene , gene ) , gene ( gene , gene ) , gene ( gene , gene ) and , in gene , which is restricted to the olfactory system .	T4	T26	17081103
CPR:9	CHEMICAL	GENE-N	6	0	gene reduce hydroperoxides to the corresponding chemical by means of chemical ( chemical ) .	T1	T27	17081103
NA	CHEMICAL	GENE-N	0	0	gene reduce hydroperoxides to the corresponding chemical by means of chemical ( chemical ) .	T2	T27	17081103
NA	CHEMICAL	GENE-N	12	0	gene reduce hydroperoxides to the corresponding chemical by means of chemical ( chemical ) .	T3	T27	17081103
NA	CHEMICAL	GENE-N	10	0	gene specifically interferes with gene activation by gene , reduces chemical and chemical biosynthesis , prevents gene expression , and is indispensable for sperm maturation and embryogenesis .	T5	T32	17081103
NA	CHEMICAL	GENE-N	10	4	gene specifically interferes with gene activation by gene , reduces chemical and chemical biosynthesis , prevents gene expression , and is indispensable for sperm maturation and embryogenesis .	T5	T33	17081103
NA	CHEMICAL	GENE-N	10	7	gene specifically interferes with gene activation by gene , reduces chemical and chemical biosynthesis , prevents gene expression , and is indispensable for sperm maturation and embryogenesis .	T5	T34	17081103
NA	CHEMICAL	GENE-Y	10	16	gene specifically interferes with gene activation by gene , reduces chemical and chemical biosynthesis , prevents gene expression , and is indispensable for sperm maturation and embryogenesis .	T5	T36	17081103
NA	CHEMICAL	GENE-N	12	0	gene specifically interferes with gene activation by gene , reduces chemical and chemical biosynthesis , prevents gene expression , and is indispensable for sperm maturation and embryogenesis .	T6	T32	17081103
NA	CHEMICAL	GENE-N	12	4	gene specifically interferes with gene activation by gene , reduces chemical and chemical biosynthesis , prevents gene expression , and is indispensable for sperm maturation and embryogenesis .	T6	T33	17081103
NA	CHEMICAL	GENE-N	12	7	gene specifically interferes with gene activation by gene , reduces chemical and chemical biosynthesis , prevents gene expression , and is indispensable for sperm maturation and embryogenesis .	T6	T34	17081103
NA	CHEMICAL	GENE-Y	12	16	gene specifically interferes with gene activation by gene , reduces chemical and chemical biosynthesis , prevents gene expression , and is indispensable for sperm maturation and embryogenesis .	T6	T36	17081103
NA	CHEMICAL	GENE-N	0	4	chemical and chemical bioavailability in Caco-2 cells : influence of gene .	T8	T29	23411246
NA	CHEMICAL	GENE-N	2	4	chemical and chemical bioavailability in Caco-2 cells : influence of gene .	T9	T29	23411246
NA	CHEMICAL	GENE-N	20	12	A study has been made of the influence of two pools of gene ( gene ) obtained from gene ( gene ) fractions , and of three specific gene ( gene ( 1-25 ) 4P , gene ( 64-74 ) 4P and gene ( 1-19 ) 4P ) , on chemical bioavailability ( gene synthesis ) and chemical bioavailability ( retention , transport and uptake of chemical ) in Caco-2 cells .	T1	T22	23411246
NA	CHEMICAL	GENE-N	20	14	A study has been made of the influence of two pools of gene ( gene ) obtained from gene ( gene ) fractions , and of three specific gene ( gene ( 1-25 ) 4P , gene ( 64-74 ) 4P and gene ( 1-19 ) 4P ) , on chemical bioavailability ( gene synthesis ) and chemical bioavailability ( retention , transport and uptake of chemical ) in Caco-2 cells .	T1	T27	23411246
NA	CHEMICAL	GENE-N	20	18	A study has been made of the influence of two pools of gene ( gene ) obtained from gene ( gene ) fractions , and of three specific gene ( gene ( 1-25 ) 4P , gene ( 64-74 ) 4P and gene ( 1-19 ) 4P ) , on chemical bioavailability ( gene synthesis ) and chemical bioavailability ( retention , transport and uptake of chemical ) in Caco-2 cells .	T1	T28	23411246
NA	CHEMICAL	GENE-N	20	20	A study has been made of the influence of two pools of gene ( gene ) obtained from gene ( gene ) fractions , and of three specific gene ( gene ( 1-25 ) 4P , gene ( 64-74 ) 4P and gene ( 1-19 ) 4P ) , on chemical bioavailability ( gene synthesis ) and chemical bioavailability ( retention , transport and uptake of chemical ) in Caco-2 cells .	T1	T10	23411246
NA	CHEMICAL	GENE-N	20	28	A study has been made of the influence of two pools of gene ( gene ) obtained from gene ( gene ) fractions , and of three specific gene ( gene ( 1-25 ) 4P , gene ( 64-74 ) 4P and gene ( 1-19 ) 4P ) , on chemical bioavailability ( gene synthesis ) and chemical bioavailability ( retention , transport and uptake of chemical ) in Caco-2 cells .	T1	T11	23411246
NA	CHEMICAL	GENE-Y	20	30	A study has been made of the influence of two pools of gene ( gene ) obtained from gene ( gene ) fractions , and of three specific gene ( gene ( 1-25 ) 4P , gene ( 64-74 ) 4P and gene ( 1-19 ) 4P ) , on chemical bioavailability ( gene synthesis ) and chemical bioavailability ( retention , transport and uptake of chemical ) in Caco-2 cells .	T1	T12	23411246
NA	CHEMICAL	GENE-Y	20	13	A study has been made of the influence of two pools of gene ( gene ) obtained from gene ( gene ) fractions , and of three specific gene ( gene ( 1-25 ) 4P , gene ( 64-74 ) 4P and gene ( 1-19 ) 4P ) , on chemical bioavailability ( gene synthesis ) and chemical bioavailability ( retention , transport and uptake of chemical ) in Caco-2 cells .	T1	T13	23411246
NA	CHEMICAL	GENE-N	20	13	A study has been made of the influence of two pools of gene ( gene ) obtained from gene ( gene ) fractions , and of three specific gene ( gene ( 1-25 ) 4P , gene ( 64-74 ) 4P and gene ( 1-19 ) 4P ) , on chemical bioavailability ( gene synthesis ) and chemical bioavailability ( retention , transport and uptake of chemical ) in Caco-2 cells .	T1	T14	23411246
NA	CHEMICAL	GENE-Y	20	53	A study has been made of the influence of two pools of gene ( gene ) obtained from gene ( gene ) fractions , and of three specific gene ( gene ( 1-25 ) 4P , gene ( 64-74 ) 4P and gene ( 1-19 ) 4P ) , on chemical bioavailability ( gene synthesis ) and chemical bioavailability ( retention , transport and uptake of chemical ) in Caco-2 cells .	T1	T15	23411246
NA	CHEMICAL	GENE-N	12	12	A study has been made of the influence of two pools of gene ( gene ) obtained from gene ( gene ) fractions , and of three specific gene ( gene ( 1-25 ) 4P , gene ( 64-74 ) 4P and gene ( 1-19 ) 4P ) , on chemical bioavailability ( gene synthesis ) and chemical bioavailability ( retention , transport and uptake of chemical ) in Caco-2 cells .	T2	T22	23411246
NA	CHEMICAL	GENE-N	12	14	A study has been made of the influence of two pools of gene ( gene ) obtained from gene ( gene ) fractions , and of three specific gene ( gene ( 1-25 ) 4P , gene ( 64-74 ) 4P and gene ( 1-19 ) 4P ) , on chemical bioavailability ( gene synthesis ) and chemical bioavailability ( retention , transport and uptake of chemical ) in Caco-2 cells .	T2	T27	23411246
NA	CHEMICAL	GENE-N	12	18	A study has been made of the influence of two pools of gene ( gene ) obtained from gene ( gene ) fractions , and of three specific gene ( gene ( 1-25 ) 4P , gene ( 64-74 ) 4P and gene ( 1-19 ) 4P ) , on chemical bioavailability ( gene synthesis ) and chemical bioavailability ( retention , transport and uptake of chemical ) in Caco-2 cells .	T2	T28	23411246
NA	CHEMICAL	GENE-N	12	20	A study has been made of the influence of two pools of gene ( gene ) obtained from gene ( gene ) fractions , and of three specific gene ( gene ( 1-25 ) 4P , gene ( 64-74 ) 4P and gene ( 1-19 ) 4P ) , on chemical bioavailability ( gene synthesis ) and chemical bioavailability ( retention , transport and uptake of chemical ) in Caco-2 cells .	T2	T10	23411246
NA	CHEMICAL	GENE-N	12	28	A study has been made of the influence of two pools of gene ( gene ) obtained from gene ( gene ) fractions , and of three specific gene ( gene ( 1-25 ) 4P , gene ( 64-74 ) 4P and gene ( 1-19 ) 4P ) , on chemical bioavailability ( gene synthesis ) and chemical bioavailability ( retention , transport and uptake of chemical ) in Caco-2 cells .	T2	T11	23411246
NA	CHEMICAL	GENE-Y	12	30	A study has been made of the influence of two pools of gene ( gene ) obtained from gene ( gene ) fractions , and of three specific gene ( gene ( 1-25 ) 4P , gene ( 64-74 ) 4P and gene ( 1-19 ) 4P ) , on chemical bioavailability ( gene synthesis ) and chemical bioavailability ( retention , transport and uptake of chemical ) in Caco-2 cells .	T2	T12	23411246
NA	CHEMICAL	GENE-Y	12	13	A study has been made of the influence of two pools of gene ( gene ) obtained from gene ( gene ) fractions , and of three specific gene ( gene ( 1-25 ) 4P , gene ( 64-74 ) 4P and gene ( 1-19 ) 4P ) , on chemical bioavailability ( gene synthesis ) and chemical bioavailability ( retention , transport and uptake of chemical ) in Caco-2 cells .	T2	T13	23411246
NA	CHEMICAL	GENE-N	12	13	A study has been made of the influence of two pools of gene ( gene ) obtained from gene ( gene ) fractions , and of three specific gene ( gene ( 1-25 ) 4P , gene ( 64-74 ) 4P and gene ( 1-19 ) 4P ) , on chemical bioavailability ( gene synthesis ) and chemical bioavailability ( retention , transport and uptake of chemical ) in Caco-2 cells .	T2	T14	23411246
NA	CHEMICAL	GENE-Y	12	53	A study has been made of the influence of two pools of gene ( gene ) obtained from gene ( gene ) fractions , and of three specific gene ( gene ( 1-25 ) 4P , gene ( 64-74 ) 4P and gene ( 1-19 ) 4P ) , on chemical bioavailability ( gene synthesis ) and chemical bioavailability ( retention , transport and uptake of chemical ) in Caco-2 cells .	T2	T15	23411246
NA	CHEMICAL	GENE-N	66	12	A study has been made of the influence of two pools of gene ( gene ) obtained from gene ( gene ) fractions , and of three specific gene ( gene ( 1-25 ) 4P , gene ( 64-74 ) 4P and gene ( 1-19 ) 4P ) , on chemical bioavailability ( gene synthesis ) and chemical bioavailability ( retention , transport and uptake of chemical ) in Caco-2 cells .	T3	T22	23411246
NA	CHEMICAL	GENE-N	66	14	A study has been made of the influence of two pools of gene ( gene ) obtained from gene ( gene ) fractions , and of three specific gene ( gene ( 1-25 ) 4P , gene ( 64-74 ) 4P and gene ( 1-19 ) 4P ) , on chemical bioavailability ( gene synthesis ) and chemical bioavailability ( retention , transport and uptake of chemical ) in Caco-2 cells .	T3	T27	23411246
NA	CHEMICAL	GENE-N	66	18	A study has been made of the influence of two pools of gene ( gene ) obtained from gene ( gene ) fractions , and of three specific gene ( gene ( 1-25 ) 4P , gene ( 64-74 ) 4P and gene ( 1-19 ) 4P ) , on chemical bioavailability ( gene synthesis ) and chemical bioavailability ( retention , transport and uptake of chemical ) in Caco-2 cells .	T3	T28	23411246
NA	CHEMICAL	GENE-N	66	20	A study has been made of the influence of two pools of gene ( gene ) obtained from gene ( gene ) fractions , and of three specific gene ( gene ( 1-25 ) 4P , gene ( 64-74 ) 4P and gene ( 1-19 ) 4P ) , on chemical bioavailability ( gene synthesis ) and chemical bioavailability ( retention , transport and uptake of chemical ) in Caco-2 cells .	T3	T10	23411246
NA	CHEMICAL	GENE-N	66	28	A study has been made of the influence of two pools of gene ( gene ) obtained from gene ( gene ) fractions , and of three specific gene ( gene ( 1-25 ) 4P , gene ( 64-74 ) 4P and gene ( 1-19 ) 4P ) , on chemical bioavailability ( gene synthesis ) and chemical bioavailability ( retention , transport and uptake of chemical ) in Caco-2 cells .	T3	T11	23411246
NA	CHEMICAL	GENE-Y	66	30	A study has been made of the influence of two pools of gene ( gene ) obtained from gene ( gene ) fractions , and of three specific gene ( gene ( 1-25 ) 4P , gene ( 64-74 ) 4P and gene ( 1-19 ) 4P ) , on chemical bioavailability ( gene synthesis ) and chemical bioavailability ( retention , transport and uptake of chemical ) in Caco-2 cells .	T3	T12	23411246
NA	CHEMICAL	GENE-Y	66	13	A study has been made of the influence of two pools of gene ( gene ) obtained from gene ( gene ) fractions , and of three specific gene ( gene ( 1-25 ) 4P , gene ( 64-74 ) 4P and gene ( 1-19 ) 4P ) , on chemical bioavailability ( gene synthesis ) and chemical bioavailability ( retention , transport and uptake of chemical ) in Caco-2 cells .	T3	T13	23411246
NA	CHEMICAL	GENE-N	66	13	A study has been made of the influence of two pools of gene ( gene ) obtained from gene ( gene ) fractions , and of three specific gene ( gene ( 1-25 ) 4P , gene ( 64-74 ) 4P and gene ( 1-19 ) 4P ) , on chemical bioavailability ( gene synthesis ) and chemical bioavailability ( retention , transport and uptake of chemical ) in Caco-2 cells .	T3	T14	23411246
NA	CHEMICAL	GENE-Y	66	53	A study has been made of the influence of two pools of gene ( gene ) obtained from gene ( gene ) fractions , and of three specific gene ( gene ( 1-25 ) 4P , gene ( 64-74 ) 4P and gene ( 1-19 ) 4P ) , on chemical bioavailability ( gene synthesis ) and chemical bioavailability ( retention , transport and uptake of chemical ) in Caco-2 cells .	T3	T15	23411246
NA	CHEMICAL	GENE-N	25	0	gene and gene pools did not improve gene synthesis , but the three specific gene showed an increase in gene synthesis in Caco-2 cells versus chemical , gene ( 1-25 ) 4P being the most effective .	T4	T16	23411246
NA	CHEMICAL	GENE-N	25	2	gene and gene pools did not improve gene synthesis , but the three specific gene showed an increase in gene synthesis in Caco-2 cells versus chemical , gene ( 1-25 ) 4P being the most effective .	T4	T17	23411246
NA	CHEMICAL	GENE-Y	25	7	gene and gene pools did not improve gene synthesis , but the three specific gene showed an increase in gene synthesis in Caco-2 cells versus chemical , gene ( 1-25 ) 4P being the most effective .	T4	T18	23411246
NA	CHEMICAL	GENE-N	25	14	gene and gene pools did not improve gene synthesis , but the three specific gene showed an increase in gene synthesis in Caco-2 cells versus chemical , gene ( 1-25 ) 4P being the most effective .	T4	T19	23411246
NA	CHEMICAL	GENE-Y	25	18	gene and gene pools did not improve gene synthesis , but the three specific gene showed an increase in gene synthesis in Caco-2 cells versus chemical , gene ( 1-25 ) 4P being the most effective .	T4	T20	23411246
NA	CHEMICAL	GENE-Y	25	27	gene and gene pools did not improve gene synthesis , but the three specific gene showed an increase in gene synthesis in Caco-2 cells versus chemical , gene ( 1-25 ) 4P being the most effective .	T4	T21	23411246
NA	CHEMICAL	GENE-N	3	6	In relation to chemical bioavailability , gene , gene , gene ( 64-74 ) 4P and gene ( 1-25 ) 4P increased chemical uptake .	T5	T23	23411246
NA	CHEMICAL	GENE-N	3	8	In relation to chemical bioavailability , gene , gene , gene ( 64-74 ) 4P and gene ( 1-25 ) 4P increased chemical uptake .	T5	T24	23411246
NA	CHEMICAL	GENE-Y	3	10	In relation to chemical bioavailability , gene , gene , gene ( 64-74 ) 4P and gene ( 1-25 ) 4P increased chemical uptake .	T5	T25	23411246
NA	CHEMICAL	GENE-Y	3	16	In relation to chemical bioavailability , gene , gene , gene ( 64-74 ) 4P and gene ( 1-25 ) 4P increased chemical uptake .	T5	T26	23411246
CPR:9	CHEMICAL	GENE-N	22	6	In relation to chemical bioavailability , gene , gene , gene ( 64-74 ) 4P and gene ( 1-25 ) 4P increased chemical uptake .	T6	T23	23411246
CPR:9	CHEMICAL	GENE-N	22	8	In relation to chemical bioavailability , gene , gene , gene ( 64-74 ) 4P and gene ( 1-25 ) 4P increased chemical uptake .	T6	T24	23411246
CPR:9	CHEMICAL	GENE-Y	22	10	In relation to chemical bioavailability , gene , gene , gene ( 64-74 ) 4P and gene ( 1-25 ) 4P increased chemical uptake .	T6	T25	23411246
CPR:9	CHEMICAL	GENE-Y	22	16	In relation to chemical bioavailability , gene , gene , gene ( 64-74 ) 4P and gene ( 1-25 ) 4P increased chemical uptake .	T6	T26	23411246
NA	CHEMICAL	GENE-Y	0	0	gene stimulated chemical incorporation in these end buds in the absence and presence of gene .	T1	T13	7526860
NA	CHEMICAL	GENE-Y	0	14	gene stimulated chemical incorporation in these end buds in the absence and presence of gene .	T1	T14	7526860
NA	CHEMICAL	GENE-N	3	9	The effects of chemical on human cardiomyocyte function and gene activity .	T12	T19	23261645
NA	CHEMICAL	GENE-N	0	4	chemical was tested in a patch clamp assay to determine its effect on selected gene .	T7	T13	23261645
CPR:4	CHEMICAL	GENE-N	0	6	chemical also inhibited other channels including gene , gene , and gene ; however , the gene ( gene ) channel was minimally affected .	T10	T14	23261645
CPR:4	CHEMICAL	GENE-N	0	8	chemical also inhibited other channels including gene , gene , and gene ; however , the gene ( gene ) channel was minimally affected .	T10	T15	23261645
CPR:4	CHEMICAL	GENE-N	0	11	chemical also inhibited other channels including gene , gene , and gene ; however , the gene ( gene ) channel was minimally affected .	T10	T16	23261645
NA	CHEMICAL	GENE-Y	0	16	chemical also inhibited other channels including gene , gene , and gene ; however , the gene ( gene ) channel was minimally affected .	T10	T17	23261645
NA	CHEMICAL	GENE-Y	0	18	chemical also inhibited other channels including gene , gene , and gene ; however , the gene ( gene ) channel was minimally affected .	T10	T18	23261645
NA	CHEMICAL	GENE-N	15	3	Three types of gene represent the respective targets of the major gene ( gene , chemical and gene , respectively ) .	T18	T29	9040115
NA	CHEMICAL	GENE-N	15	11	Three types of gene represent the respective targets of the major gene ( gene , chemical and gene , respectively ) .	T18	T31	9040115
NA	CHEMICAL	GENE-Y	15	13	Three types of gene represent the respective targets of the major gene ( gene , chemical and gene , respectively ) .	T18	T32	9040115
NA	CHEMICAL	GENE-Y	15	17	Three types of gene represent the respective targets of the major gene ( gene , chemical and gene , respectively ) .	T18	T34	9040115
NA	CHEMICAL	GENE-N	17	23	There is , however , much information on the direct ( acute and chronic ) effects of chemical on the binding properties of gene , as well as modulation of gene synthesis and secretion ( e.g .	T7	T22	9040115
NA	CHEMICAL	GENE-N	17	30	There is , however , much information on the direct ( acute and chronic ) effects of chemical on the binding properties of gene , as well as modulation of gene synthesis and secretion ( e.g .	T7	T23	9040115
CPR:6	CHEMICAL	GENE-N	6	12	Conversely , opioid antagonists such as chemical and chemical ( which bind to non-selectively gene ) have been shown to decrease chemical consumption under various experimental conditions .	T11	T25	9040115
CPR:3	CHEMICAL	GENE-N	8	12	Conversely , opioid antagonists such as chemical and chemical ( which bind to non-selectively gene ) have been shown to decrease chemical consumption under various experimental conditions .	T12	T25	9040115
NA	CHEMICAL	GENE-N	21	12	Conversely , opioid antagonists such as chemical and chemical ( which bind to non-selectively gene ) have been shown to decrease chemical consumption under various experimental conditions .	T13	T25	9040115
CPR:4	CHEMICAL	GENE-N	0	5	chemical block of recombinant chemical receptors : selectivity for the gene subunit .	T18	T37	10690753
CPR:4	CHEMICAL	GENE-Y	0	10	chemical block of recombinant chemical receptors : selectivity for the gene subunit .	T18	T38	10690753
NA	CHEMICAL	GENE-N	4	5	chemical block of recombinant chemical receptors : selectivity for the gene subunit .	T19	T37	10690753
NA	CHEMICAL	GENE-Y	4	10	chemical block of recombinant chemical receptors : selectivity for the gene subunit .	T19	T38	10690753
CPR:4	CHEMICAL	GENE-N	2	8	The anticonvulsant chemical blocks chemical ( chemical ) receptors but fails to exhibit the neurobehavioral toxicity characteristic of other chemical receptor antagonists .	T8	T29	10690753
CPR:6	CHEMICAL	GENE-N	2	11	The anticonvulsant chemical blocks chemical ( chemical ) receptors but fails to exhibit the neurobehavioral toxicity characteristic of other chemical receptor antagonists .	T8	T26	10690753
NA	CHEMICAL	GENE-N	4	8	The anticonvulsant chemical blocks chemical ( chemical ) receptors but fails to exhibit the neurobehavioral toxicity characteristic of other chemical receptor antagonists .	T11	T29	10690753
NA	CHEMICAL	GENE-N	4	11	The anticonvulsant chemical blocks chemical ( chemical ) receptors but fails to exhibit the neurobehavioral toxicity characteristic of other chemical receptor antagonists .	T11	T26	10690753
NA	CHEMICAL	GENE-N	6	8	The anticonvulsant chemical blocks chemical ( chemical ) receptors but fails to exhibit the neurobehavioral toxicity characteristic of other chemical receptor antagonists .	T16	T29	10690753
NA	CHEMICAL	GENE-N	6	11	The anticonvulsant chemical blocks chemical ( chemical ) receptors but fails to exhibit the neurobehavioral toxicity characteristic of other chemical receptor antagonists .	T16	T26	10690753
NA	CHEMICAL	GENE-N	19	8	The anticonvulsant chemical blocks chemical ( chemical ) receptors but fails to exhibit the neurobehavioral toxicity characteristic of other chemical receptor antagonists .	T7	T29	10690753
NA	CHEMICAL	GENE-N	19	11	The anticonvulsant chemical blocks chemical ( chemical ) receptors but fails to exhibit the neurobehavioral toxicity characteristic of other chemical receptor antagonists .	T7	T26	10690753
NA	CHEMICAL	GENE-N	14	13	To investigate the possibility that chemical 's favorable toxicity profile could be related to chemical receptor subtype selectivity , we examined the specificity of felbamate block of recombinant genes composed of the gene subunit and various gene subunits .	T9	T27	10690753
NA	CHEMICAL	GENE-N	14	13	To investigate the possibility that chemical 's favorable toxicity profile could be related to chemical receptor subtype selectivity , we examined the specificity of felbamate block of recombinant genes composed of the gene subunit and various gene subunits .	T9	T28	10690753
NA	CHEMICAL	GENE-Y	14	32	To investigate the possibility that chemical 's favorable toxicity profile could be related to chemical receptor subtype selectivity , we examined the specificity of felbamate block of recombinant genes composed of the gene subunit and various gene subunits .	T9	T30	10690753
NA	CHEMICAL	GENE-N	14	36	To investigate the possibility that chemical 's favorable toxicity profile could be related to chemical receptor subtype selectivity , we examined the specificity of felbamate block of recombinant genes composed of the gene subunit and various gene subunits .	T9	T31	10690753
NA	CHEMICAL	GENE-N	5	13	To investigate the possibility that chemical 's favorable toxicity profile could be related to chemical receptor subtype selectivity , we examined the specificity of felbamate block of recombinant genes composed of the gene subunit and various gene subunits .	T10	T27	10690753
CPR:4	CHEMICAL	GENE-N	5	13	To investigate the possibility that chemical 's favorable toxicity profile could be related to chemical receptor subtype selectivity , we examined the specificity of felbamate block of recombinant genes composed of the gene subunit and various gene subunits .	T10	T28	10690753
CPR:4	CHEMICAL	GENE-Y	5	32	To investigate the possibility that chemical 's favorable toxicity profile could be related to chemical receptor subtype selectivity , we examined the specificity of felbamate block of recombinant genes composed of the gene subunit and various gene subunits .	T10	T30	10690753
CPR:4	CHEMICAL	GENE-N	5	36	To investigate the possibility that chemical 's favorable toxicity profile could be related to chemical receptor subtype selectivity , we examined the specificity of felbamate block of recombinant genes composed of the gene subunit and various gene subunits .	T10	T31	10690753
CPR:4	CHEMICAL	GENE-Y	0	2	chemical produced a rapid , concentration-dependent block of currents evoked by 50 microM chemical and 10 microM chemical in human embryonic kidney 293 cells expressing the gene subunit , and either the gene , gene or gene subunits ; the IC50 values for block were 2.6 , 0.52 and 2.4 mM , respectively ( holding potential , - 60 mV ) .	T13	T32	10690753
CPR:4	CHEMICAL	GENE-Y	0	32	chemical produced a rapid , concentration-dependent block of currents evoked by 50 microM chemical and 10 microM chemical in human embryonic kidney 293 cells expressing the gene subunit , and either the gene , gene or gene subunits ; the IC50 values for block were 2.6 , 0.52 and 2.4 mM , respectively ( holding potential , - 60 mV ) .	T13	T33	10690753
CPR:4	CHEMICAL	GENE-Y	0	34	chemical produced a rapid , concentration-dependent block of currents evoked by 50 microM chemical and 10 microM chemical in human embryonic kidney 293 cells expressing the gene subunit , and either the gene , gene or gene subunits ; the IC50 values for block were 2.6 , 0.52 and 2.4 mM , respectively ( holding potential , - 60 mV ) .	T13	T34	10690753
CPR:4	CHEMICAL	GENE-Y	0	36	chemical produced a rapid , concentration-dependent block of currents evoked by 50 microM chemical and 10 microM chemical in human embryonic kidney 293 cells expressing the gene subunit , and either the gene , gene or gene subunits ; the IC50 values for block were 2.6 , 0.52 and 2.4 mM , respectively ( holding potential , - 60 mV ) .	T13	T35	10690753
NA	CHEMICAL	GENE-Y	13	2	chemical produced a rapid , concentration-dependent block of currents evoked by 50 microM chemical and 10 microM chemical in human embryonic kidney 293 cells expressing the gene subunit , and either the gene , gene or gene subunits ; the IC50 values for block were 2.6 , 0.52 and 2.4 mM , respectively ( holding potential , - 60 mV ) .	T14	T32	10690753
NA	CHEMICAL	GENE-Y	13	32	chemical produced a rapid , concentration-dependent block of currents evoked by 50 microM chemical and 10 microM chemical in human embryonic kidney 293 cells expressing the gene subunit , and either the gene , gene or gene subunits ; the IC50 values for block were 2.6 , 0.52 and 2.4 mM , respectively ( holding potential , - 60 mV ) .	T14	T33	10690753
NA	CHEMICAL	GENE-Y	13	34	chemical produced a rapid , concentration-dependent block of currents evoked by 50 microM chemical and 10 microM chemical in human embryonic kidney 293 cells expressing the gene subunit , and either the gene , gene or gene subunits ; the IC50 values for block were 2.6 , 0.52 and 2.4 mM , respectively ( holding potential , - 60 mV ) .	T14	T34	10690753
NA	CHEMICAL	GENE-Y	13	36	chemical produced a rapid , concentration-dependent block of currents evoked by 50 microM chemical and 10 microM chemical in human embryonic kidney 293 cells expressing the gene subunit , and either the gene , gene or gene subunits ; the IC50 values for block were 2.6 , 0.52 and 2.4 mM , respectively ( holding potential , - 60 mV ) .	T14	T35	10690753
NA	CHEMICAL	GENE-Y	17	2	chemical produced a rapid , concentration-dependent block of currents evoked by 50 microM chemical and 10 microM chemical in human embryonic kidney 293 cells expressing the gene subunit , and either the gene , gene or gene subunits ; the IC50 values for block were 2.6 , 0.52 and 2.4 mM , respectively ( holding potential , - 60 mV ) .	T15	T32	10690753
NA	CHEMICAL	GENE-Y	17	32	chemical produced a rapid , concentration-dependent block of currents evoked by 50 microM chemical and 10 microM chemical in human embryonic kidney 293 cells expressing the gene subunit , and either the gene , gene or gene subunits ; the IC50 values for block were 2.6 , 0.52 and 2.4 mM , respectively ( holding potential , - 60 mV ) .	T15	T33	10690753
NA	CHEMICAL	GENE-Y	17	34	chemical produced a rapid , concentration-dependent block of currents evoked by 50 microM chemical and 10 microM chemical in human embryonic kidney 293 cells expressing the gene subunit , and either the gene , gene or gene subunits ; the IC50 values for block were 2.6 , 0.52 and 2.4 mM , respectively ( holding potential , - 60 mV ) .	T15	T34	10690753
NA	CHEMICAL	GENE-Y	17	36	chemical produced a rapid , concentration-dependent block of currents evoked by 50 microM chemical and 10 microM chemical in human embryonic kidney 293 cells expressing the gene subunit , and either the gene , gene or gene subunits ; the IC50 values for block were 2.6 , 0.52 and 2.4 mM , respectively ( holding potential , - 60 mV ) .	T15	T35	10690753
NA	CHEMICAL	GENE-N	36	28	The Hill coefficient values were < 1 and , in kinetic analyses , onset and recovery from block were well fit by double exponential functions , indicating binding to more than one blocking site on the chemical receptor channel complex .	T17	T36	10690753
CPR:4	CHEMICAL	GENE-N	4	8	The higher affinity of chemical block of chemical receptors containing the gene subunit could be accounted for by more rapid association and slower dissociation from these sites .	T1	T20	10690753
CPR:4	CHEMICAL	GENE-Y	4	11	The higher affinity of chemical block of chemical receptors containing the gene subunit could be accounted for by more rapid association and slower dissociation from these sites .	T1	T21	10690753
NA	CHEMICAL	GENE-N	7	8	The higher affinity of chemical block of chemical receptors containing the gene subunit could be accounted for by more rapid association and slower dissociation from these sites .	T2	T20	10690753
NA	CHEMICAL	GENE-Y	7	11	The higher affinity of chemical block of chemical receptors containing the gene subunit could be accounted for by more rapid association and slower dissociation from these sites .	T2	T21	10690753
CPR:4	CHEMICAL	GENE-N	3	9	We conclude that chemical exhibits modest selectivity for chemical receptors composed of gene/gene subunits .	T3	T22	10690753
CPR:4	CHEMICAL	GENE-Y	3	12	We conclude that chemical exhibits modest selectivity for chemical receptors composed of gene/gene subunits .	T3	T23	10690753
CPR:4	CHEMICAL	GENE-Y	3	12	We conclude that chemical exhibits modest selectivity for chemical receptors composed of gene/gene subunits .	T3	T24	10690753
NA	CHEMICAL	GENE-N	8	9	We conclude that chemical exhibits modest selectivity for chemical receptors composed of gene/gene subunits .	T4	T22	10690753
NA	CHEMICAL	GENE-Y	8	12	We conclude that chemical exhibits modest selectivity for chemical receptors composed of gene/gene subunits .	T4	T23	10690753
NA	CHEMICAL	GENE-Y	8	12	We conclude that chemical exhibits modest selectivity for chemical receptors composed of gene/gene subunits .	T4	T24	10690753
NA	CHEMICAL	GENE-N	12	13	The human genome codes for 13 members of a family of filament-forming chemical-binding proteins known as gene .	T2	T11	23163726
NA	CHEMICAL	GENE-N	12	16	The human genome codes for 13 members of a family of filament-forming chemical-binding proteins known as gene .	T2	T7	23163726
NA	CHEMICAL	GENE-Y	9	3	This construct ( gene-Gchemical ) , which includes the chemical-binding and C-terminal domains , purifies as a chemical-free monomer , allowing for its characterization in terms of chemical-binding and hydrolysis .	T3	T12	23163726
NA	CHEMICAL	GENE-N	9	12	This construct ( gene-Gchemical ) , which includes the chemical-binding and C-terminal domains , purifies as a chemical-free monomer , allowing for its characterization in terms of chemical-binding and hydrolysis .	T3	T13	23163726
NA	CHEMICAL	GENE-Y	3	3	This construct ( gene-Gchemical ) , which includes the chemical-binding and C-terminal domains , purifies as a chemical-free monomer , allowing for its characterization in terms of chemical-binding and hydrolysis .	T4	T12	23163726
NA	CHEMICAL	GENE-N	3	12	This construct ( gene-Gchemical ) , which includes the chemical-binding and C-terminal domains , purifies as a chemical-free monomer , allowing for its characterization in terms of chemical-binding and hydrolysis .	T4	T13	23163726
NA	CHEMICAL	GENE-Y	17	3	This construct ( gene-Gchemical ) , which includes the chemical-binding and C-terminal domains , purifies as a chemical-free monomer , allowing for its characterization in terms of chemical-binding and hydrolysis .	T5	T12	23163726
NA	CHEMICAL	GENE-N	17	12	This construct ( gene-Gchemical ) , which includes the chemical-binding and C-terminal domains , purifies as a chemical-free monomer , allowing for its characterization in terms of chemical-binding and hydrolysis .	T5	T13	23163726
NA	CHEMICAL	GENE-Y	27	3	This construct ( gene-Gchemical ) , which includes the chemical-binding and C-terminal domains , purifies as a chemical-free monomer , allowing for its characterization in terms of chemical-binding and hydrolysis .	T6	T12	23163726
NA	CHEMICAL	GENE-N	27	12	This construct ( gene-Gchemical ) , which includes the chemical-binding and C-terminal domains , purifies as a chemical-free monomer , allowing for its characterization in terms of chemical-binding and hydrolysis .	T6	T13	23163726
NA	CHEMICAL	GENE-Y	2	3	Interestingly , chemical-labeled gene ( chemical-gene ) could be readily loaded into nanogels with remarkable loading efficiencies ( up to 98.2 % ) and loading contents ( up to 48.2 wt. % ) .	T3	T18	23477570
NA	CHEMICAL	GENE-Y	2	5	Interestingly , chemical-labeled gene ( chemical-gene ) could be readily loaded into nanogels with remarkable loading efficiencies ( up to 98.2 % ) and loading contents ( up to 48.2 wt. % ) .	T3	T19	23477570
NA	CHEMICAL	GENE-Y	5	3	Interestingly , chemical-labeled gene ( chemical-gene ) could be readily loaded into nanogels with remarkable loading efficiencies ( up to 98.2 % ) and loading contents ( up to 48.2 wt. % ) .	T4	T18	23477570
NA	CHEMICAL	GENE-Y	5	5	Interestingly , chemical-labeled gene ( chemical-gene ) could be readily loaded into nanogels with remarkable loading efficiencies ( up to 98.2 % ) and loading contents ( up to 48.2 wt. % ) .	T4	T19	23477570
NA	CHEMICAL	GENE-Y	9	9	The in vitro release studies showed that release of chemical-gene was minimal under physiological conditions but significantly enhanced under reductive conditions in the presence of 10 mM chemical with about 96.8 % of chemical-gene released in 22 h from nanogel 1 .	T5	T20	23477570
NA	CHEMICAL	GENE-Y	9	33	The in vitro release studies showed that release of chemical-gene was minimal under physiological conditions but significantly enhanced under reductive conditions in the presence of 10 mM chemical with about 96.8 % of chemical-gene released in 22 h from nanogel 1 .	T5	T21	23477570
NA	CHEMICAL	GENE-Y	27	9	The in vitro release studies showed that release of chemical-gene was minimal under physiological conditions but significantly enhanced under reductive conditions in the presence of 10 mM chemical with about 96.8 % of chemical-gene released in 22 h from nanogel 1 .	T6	T20	23477570
NA	CHEMICAL	GENE-Y	27	33	The in vitro release studies showed that release of chemical-gene was minimal under physiological conditions but significantly enhanced under reductive conditions in the presence of 10 mM chemical with about 96.8 % of chemical-gene released in 22 h from nanogel 1 .	T6	T21	23477570
NA	CHEMICAL	GENE-Y	33	9	The in vitro release studies showed that release of chemical-gene was minimal under physiological conditions but significantly enhanced under reductive conditions in the presence of 10 mM chemical with about 96.8 % of chemical-gene released in 22 h from nanogel 1 .	T7	T20	23477570
NA	CHEMICAL	GENE-Y	33	33	The in vitro release studies showed that release of chemical-gene was minimal under physiological conditions but significantly enhanced under reductive conditions in the presence of 10 mM chemical with about 96.8 % of chemical-gene released in 22 h from nanogel 1 .	T7	T21	23477570
NA	CHEMICAL	GENE-Y	10	10	Confocal microscopy results showed that nanogel 1 delivered and released chemical-gene into the perinuclei region of HeLa cells following 8 h incubation .	T11	T22	23477570
NA	CHEMICAL	GENE-Y	2	26	There was a significant overlap ( 42 genes ) between the 3 and 30 ppb differentially expressed gene lists , with two of these genes ( gene and gene ) present in all three chemical treatments .	T3	T11	23358194
NA	CHEMICAL	GENE-Y	2	28	There was a significant overlap ( 42 genes ) between the 3 and 30 ppb differentially expressed gene lists , with two of these genes ( gene and gene ) present in all three chemical treatments .	T3	T12	23358194
CPR:4	CHEMICAL	GENE-Y	3	7	The antipsychotic drugs chemical and chemical block gene , a gene .	T12	T29	11511086
CPR:4	CHEMICAL	GENE-N	3	9	The antipsychotic drugs chemical and chemical block gene , a gene .	T12	T30	11511086
CPR:4	CHEMICAL	GENE-Y	5	7	The antipsychotic drugs chemical and chemical block gene , a gene .	T13	T29	11511086
CPR:4	CHEMICAL	GENE-N	5	9	The antipsychotic drugs chemical and chemical block gene , a gene .	T13	T30	11511086
CPR:4	CHEMICAL	GENE-N	3	17	The antipsychotic drugs chemical and chemical are known to prolong the QT interval on the electrocardiogram via a high affinity block of the gene known as gene ( gene ; gene ) .	T7	T19	11511086
CPR:4	CHEMICAL	GENE-Y	3	26	The antipsychotic drugs chemical and chemical are known to prolong the QT interval on the electrocardiogram via a high affinity block of the gene known as gene ( gene ; gene ) .	T7	T21	11511086
CPR:4	CHEMICAL	GENE-Y	3	28	The antipsychotic drugs chemical and chemical are known to prolong the QT interval on the electrocardiogram via a high affinity block of the gene known as gene ( gene ; gene ) .	T7	T22	11511086
CPR:4	CHEMICAL	GENE-Y	3	30	The antipsychotic drugs chemical and chemical are known to prolong the QT interval on the electrocardiogram via a high affinity block of the gene known as gene ( gene ; gene ) .	T7	T23	11511086
CPR:4	CHEMICAL	GENE-N	5	17	The antipsychotic drugs chemical and chemical are known to prolong the QT interval on the electrocardiogram via a high affinity block of the gene known as gene ( gene ; gene ) .	T9	T19	11511086
CPR:4	CHEMICAL	GENE-Y	5	26	The antipsychotic drugs chemical and chemical are known to prolong the QT interval on the electrocardiogram via a high affinity block of the gene known as gene ( gene ; gene ) .	T9	T21	11511086
CPR:4	CHEMICAL	GENE-Y	5	28	The antipsychotic drugs chemical and chemical are known to prolong the QT interval on the electrocardiogram via a high affinity block of the gene known as gene ( gene ; gene ) .	T9	T22	11511086
CPR:4	CHEMICAL	GENE-Y	5	30	The antipsychotic drugs chemical and chemical are known to prolong the QT interval on the electrocardiogram via a high affinity block of the gene known as gene ( gene ; gene ) .	T9	T23	11511086
NA	CHEMICAL	GENE-N	27	17	The antipsychotic drugs chemical and chemical are known to prolong the QT interval on the electrocardiogram via a high affinity block of the gene known as gene ( gene ; gene ) .	T6	T19	11511086
NA	CHEMICAL	GENE-Y	27	26	The antipsychotic drugs chemical and chemical are known to prolong the QT interval on the electrocardiogram via a high affinity block of the gene known as gene ( gene ; gene ) .	T6	T21	11511086
NA	CHEMICAL	GENE-Y	27	28	The antipsychotic drugs chemical and chemical are known to prolong the QT interval on the electrocardiogram via a high affinity block of the gene known as gene ( gene ; gene ) .	T6	T22	11511086
NA	CHEMICAL	GENE-Y	27	30	The antipsychotic drugs chemical and chemical are known to prolong the QT interval on the electrocardiogram via a high affinity block of the gene known as gene ( gene ; gene ) .	T6	T23	11511086
NA	CHEMICAL	GENE-Y	12	3	Transient expression of gene in Chinese hamster ovary cells produced outwardly directed chemical currents that activated at approximately -50 mV and produced a large transient component at positive membrane potentials .	T10	T28	11511086
CPR:4	CHEMICAL	GENE-Y	2	2	Block of gene by chemical also displayed a positive voltage-dependence .	T1	T15	11511086
CPR:4	CHEMICAL	GENE-Y	0	2	chemical blocked gene channel currents with an IC ( 50 ) of 103 nM and significant inhibition was noted at concentrations of 10 nM and higher .	T2	T16	11511086
CPR:4	CHEMICAL	GENE-Y	12	3	We conclude that gene can be blocked by certain antipsychotic drugs like chemical and chemical .	T3	T17	11511086
CPR:4	CHEMICAL	GENE-Y	14	3	We conclude that gene can be blocked by certain antipsychotic drugs like chemical and chemical .	T4	T17	11511086
CPR:4	CHEMICAL	GENE-Y	7	2	Inhibition of gene ( gene ) by chemical .	T3	T13	18068977
CPR:4	CHEMICAL	GENE-Y	7	4	Inhibition of gene ( gene ) by chemical .	T3	T14	18068977
CPR:4	CHEMICAL	GENE-Y	10	16	In this report , we show that the hypolipidemic agent chemical is a competitive inhibitor of gene in vitro , with K ( i ) =57.8+/-2.3 microM .	T1	T11	18068977
CPR:4	CHEMICAL	GENE-Y	0	2	chemical inhibits gene-induced phosphorylation of gene and gene in human colon cancer cells .	T9	T33	12566304
NA	CHEMICAL	GENE-N	0	5	chemical inhibits gene-induced phosphorylation of gene and gene in human colon cancer cells .	T9	T34	12566304
CPR:4	CHEMICAL	GENE-Y	0	7	chemical inhibits gene-induced phosphorylation of gene and gene in human colon cancer cells .	T9	T32	12566304
CPR:4	CHEMICAL	GENE-Y	0	3	chemical and selective gene inhibitors cause regression of colonic polyps in familial polyposis patients .	T5	T18	12566304
NA	CHEMICAL	GENE-N	2	4	Phosphorylation of chemical112 by gene inactivates gene and protects the tumor cell from apoptosis .	T7	T22	12566304
NA	CHEMICAL	GENE-Y	2	6	Phosphorylation of chemical112 by gene inactivates gene and protects the tumor cell from apoptosis .	T7	T23	12566304
CPR:4	CHEMICAL	GENE-N	0	9	chemical metabolites and other nonsteroidal anti-inflammatory drugs selectively inhibit gene phosphorylation in human colon cancer cells .	T8	T24	12566304
CPR:4	CHEMICAL	GENE-Y	11	0	gene-stimulated phosphorylation of gene and gene is blocked by pretreatment with chemical , a selective gene inhibitor .	T1	T29	12566304
CPR:4	CHEMICAL	GENE-N	11	3	gene-stimulated phosphorylation of gene and gene is blocked by pretreatment with chemical , a selective gene inhibitor .	T1	T30	12566304
CPR:4	CHEMICAL	GENE-Y	11	5	gene-stimulated phosphorylation of gene and gene is blocked by pretreatment with chemical , a selective gene inhibitor .	T1	T31	12566304
CPR:4	CHEMICAL	GENE-N	11	15	gene-stimulated phosphorylation of gene and gene is blocked by pretreatment with chemical , a selective gene inhibitor .	T1	T10	12566304
CPR:4	CHEMICAL	GENE-Y	4	9	Similarly , pretreatment with chemical blocks the ability of gene to induce gene and gene phosphorylation , but also down-regulates total gene but not gene protein levels .	T2	T11	12566304
NA	CHEMICAL	GENE-N	4	12	Similarly , pretreatment with chemical blocks the ability of gene to induce gene and gene phosphorylation , but also down-regulates total gene but not gene protein levels .	T2	T12	12566304
CPR:4	CHEMICAL	GENE-Y	4	14	Similarly , pretreatment with chemical blocks the ability of gene to induce gene and gene phosphorylation , but also down-regulates total gene but not gene protein levels .	T2	T13	12566304
CPR:4	CHEMICAL	GENE-Y	4	21	Similarly , pretreatment with chemical blocks the ability of gene to induce gene and gene phosphorylation , but also down-regulates total gene but not gene protein levels .	T2	T14	12566304
NA	CHEMICAL	GENE-N	4	24	Similarly , pretreatment with chemical blocks the ability of gene to induce gene and gene phosphorylation , but also down-regulates total gene but not gene protein levels .	T2	T15	12566304
CPR:4	CHEMICAL	GENE-Y	6	4	Add-on therapy with the gene inhibitor chemical improves glycemic control in gene-treated Japanese patients with type 2 diabetes mellitus .	T9	T25	23386390
NA	CHEMICAL	GENE-Y	6	10	Add-on therapy with the gene inhibitor chemical improves glycemic control in gene-treated Japanese patients with type 2 diabetes mellitus .	T9	T26	23386390
NA	CHEMICAL	GENE-Y	6	13	The effect of add-on therapy with chemical on glycemic control was prospectively investigated in patients with type 2 diabetes mellitus ( T2DM ) receiving gene alone or gene combined with oral antidiabetic drugs .	T5	T14	23386390
NA	CHEMICAL	GENE-N	6	13	The effect of add-on therapy with chemical on glycemic control was prospectively investigated in patients with type 2 diabetes mellitus ( T2DM ) receiving gene alone or gene combined with oral antidiabetic drugs .	T5	T15	23386390
NA	CHEMICAL	GENE-N	4	6	Concomitant oral drugs included chemical , gene inhibitors and chemical .	T6	T20	23386390
NA	CHEMICAL	GENE-N	9	6	Concomitant oral drugs included chemical , gene inhibitors and chemical .	T7	T20	23386390
CPR:3	CHEMICAL	GENE-Y	23	1	The gene ( gene ) of all patients improved significantly from 8.1±1.2 % to 7.6±1.1 % after 12 weeks of add-on therapy with chemical ( p < 0.01 ) , and the gene dosage was reduced from 27.3±15.8 U/day to 24.5±16.5 U/day ( p < 0.001 ) .	T8	T21	23386390
CPR:3	CHEMICAL	GENE-Y	23	3	The gene ( gene ) of all patients improved significantly from 8.1±1.2 % to 7.6±1.1 % after 12 weeks of add-on therapy with chemical ( p < 0.01 ) , and the gene dosage was reduced from 27.3±15.8 U/day to 24.5±16.5 U/day ( p < 0.001 ) .	T8	T22	23386390
NA	CHEMICAL	GENE-Y	23	32	The gene ( gene ) of all patients improved significantly from 8.1±1.2 % to 7.6±1.1 % after 12 weeks of add-on therapy with chemical ( p < 0.01 ) , and the gene dosage was reduced from 27.3±15.8 U/day to 24.5±16.5 U/day ( p < 0.001 ) .	T8	T23	23386390
NA	CHEMICAL	GENE-Y	4	2	The baseline gene and gene levels were identified as factors that predicted the response to add-on therapy with chemical .	T1	T24	23386390
NA	CHEMICAL	GENE-Y	4	4	The baseline gene and gene levels were identified as factors that predicted the response to add-on therapy with chemical .	T1	T10	23386390
NA	CHEMICAL	GENE-Y	8	5	Stratified analysis based on the gene regimen revealed a stronger antidiabetic effect and a high efficacy of chemical when it was added to basal gene therapy .	T3	T11	23386390
NA	CHEMICAL	GENE-Y	8	24	Stratified analysis based on the gene regimen revealed a stronger antidiabetic effect and a high efficacy of chemical when it was added to basal gene therapy .	T3	T12	23386390
NA	CHEMICAL	GENE-Y	22	28	We have investigated in normal human male subjects the importance , site of action , and receptor-mediated processes involved in rapid basal chemical feedback and its interaction with gene ( gene ) drive .	T4	T13	20427668
NA	CHEMICAL	GENE-Y	22	30	We have investigated in normal human male subjects the importance , site of action , and receptor-mediated processes involved in rapid basal chemical feedback and its interaction with gene ( gene ) drive .	T4	T14	20427668
CPR:4	CHEMICAL	GENE-Y	0	11	chemical also inhibited ACTH and chemical secretion in response to exogenous gene stimulation , inferring rapid feedback inhibition at the anterior pituitary .	T7	T17	20427668
CPR:9	CHEMICAL	GENE-Y	5	11	chemical also inhibited ACTH and chemical secretion in response to exogenous gene stimulation , inferring rapid feedback inhibition at the anterior pituitary .	T8	T17	20427668
NA	CHEMICAL	GENE-Y	11	1	Circulating gene peptide concentrations were unaffected , suggesting that the rapid chemical inhibitory effect specifically targeted ACTH secretion from pituitary corticotrophs .	T1	T9	20427668
NA	CHEMICAL	GENE-Y	0	7	chemical fast feedback was only reduced by gene antagonist pretreatment and not by gene antagonism , suggesting a gene-mediated pathway .	T2	T10	20427668
NA	CHEMICAL	GENE-Y	0	13	chemical fast feedback was only reduced by gene antagonist pretreatment and not by gene antagonism , suggesting a gene-mediated pathway .	T2	T11	20427668
NA	CHEMICAL	GENE-Y	0	18	chemical fast feedback was only reduced by gene antagonist pretreatment and not by gene antagonism , suggesting a gene-mediated pathway .	T2	T12	20427668
NA	CHEMICAL	GENE-N	4	5	Transcriptional control of the chemical/chemical transporter , gene , by physiological stress .	T8	T25	14523001
NA	CHEMICAL	GENE-Y	4	7	Transcriptional control of the chemical/chemical transporter , gene , by physiological stress .	T8	T26	14523001
NA	CHEMICAL	GENE-N	4	5	Transcriptional control of the chemical/chemical transporter , gene , by physiological stress .	T9	T25	14523001
NA	CHEMICAL	GENE-Y	4	7	Transcriptional control of the chemical/chemical transporter , gene , by physiological stress .	T9	T26	14523001
CPR:9	CHEMICAL	GENE-Y	7	0	gene , the transporter for the essential chemical , chemical and chemical , is one of the up-regulated genes .	T3	T18	14523001
CPR:9	CHEMICAL	GENE-Y	9	0	gene , the transporter for the essential chemical , chemical and chemical , is one of the up-regulated genes .	T4	T18	14523001
CPR:9	CHEMICAL	GENE-Y	11	0	gene , the transporter for the essential chemical , chemical and chemical , is one of the up-regulated genes .	T5	T18	14523001
NA	CHEMICAL	GENE-N	5	9	This induction is triggered by chemical depletion and the gene ( gene ) , which is caused by unfolded proteins in the endoplasmic reticulum .	T6	T20	14523001
NA	CHEMICAL	GENE-N	5	11	This induction is triggered by chemical depletion and the gene ( gene ) , which is caused by unfolded proteins in the endoplasmic reticulum .	T6	T21	14523001
NA	CHEMICAL	GENE-Y	5	10	The stimulation of transcription by chemical depletion requires activation of gene gene , which phosphorylates gene .	T2	T11	14523001
NA	CHEMICAL	GENE-N	5	11	The stimulation of transcription by chemical depletion requires activation of gene gene , which phosphorylates gene .	T2	T12	14523001
NA	CHEMICAL	GENE-Y	5	15	The stimulation of transcription by chemical depletion requires activation of gene gene , which phosphorylates gene .	T2	T13	14523001
NA	CHEMICAL	GENE-N	6	3	Crystal structures of gene bound to chemical and chemical : elucidation of the mechanism of enzyme inhibition by cyanobacterial toxins .	T12	T24	16343532
NA	CHEMICAL	GENE-N	8	3	Crystal structures of gene bound to chemical and chemical : elucidation of the mechanism of enzyme inhibition by cyanobacterial toxins .	T13	T24	16343532
NA	CHEMICAL	GENE-N	7	9	The toxins function by inhibiting broad specificity chemical/chemical protein phosphatases in the host cells , thereby disrupting signal transduction pathways .	T5	T15	16343532
NA	CHEMICAL	GENE-N	7	9	The toxins function by inhibiting broad specificity chemical/chemical protein phosphatases in the host cells , thereby disrupting signal transduction pathways .	T6	T15	16343532
NA	CHEMICAL	GENE-N	6	5	A previous crystal structure of a chemical bound to the catalytic subunit of gene ( gene ) showed distinct changes in the active site region when compared with gene structures bound to other toxins .	T7	T16	16343532
NA	CHEMICAL	GENE-N	6	15	A previous crystal structure of a chemical bound to the catalytic subunit of gene ( gene ) showed distinct changes in the active site region when compared with gene structures bound to other toxins .	T7	T17	16343532
NA	CHEMICAL	GENE-N	6	5	A previous crystal structure of a chemical bound to the catalytic subunit of gene ( gene ) showed distinct changes in the active site region when compared with gene structures bound to other toxins .	T7	T18	16343532
NA	CHEMICAL	GENE-N	10	8	We have elucidated the crystal structures of the gene , chemical ( chemical ) and chemical bound to gene .	T9	T19	16343532
NA	CHEMICAL	GENE-Y	10	6	We have elucidated the crystal structures of the gene , chemical ( chemical ) and chemical bound to gene .	T9	T20	16343532
NA	CHEMICAL	GENE-N	12	8	We have elucidated the crystal structures of the gene , chemical ( chemical ) and chemical bound to gene .	T10	T19	16343532
NA	CHEMICAL	GENE-Y	12	6	We have elucidated the crystal structures of the gene , chemical ( chemical ) and chemical bound to gene .	T10	T20	16343532
NA	CHEMICAL	GENE-N	15	8	We have elucidated the crystal structures of the gene , chemical ( chemical ) and chemical bound to gene .	T11	T19	16343532
NA	CHEMICAL	GENE-Y	15	6	We have elucidated the crystal structures of the gene , chemical ( chemical ) and chemical bound to gene .	T11	T20	16343532
NA	CHEMICAL	GENE-Y	0	11	chemical chemical metabolites were neurotoxic to SH-SY5Y neurons , leading to gene-independent cell death in a concentration- and time-dependent manner .	T36	T48	23194825
NA	CHEMICAL	GENE-Y	1	11	chemical chemical metabolites were neurotoxic to SH-SY5Y neurons , leading to gene-independent cell death in a concentration- and time-dependent manner .	T37	T48	23194825
NA	CHEMICAL	GENE-Y	2	17	Neither the chemical radical scavenger , tiron , nor the inhibitor of the chemical ( DA ) transporter , chemical , prevented the metabolites ' toxicity .	T1	T44	23194825
NA	CHEMICAL	GENE-Y	13	17	Neither the chemical radical scavenger , tiron , nor the inhibitor of the chemical ( DA ) transporter , chemical , prevented the metabolites ' toxicity .	T2	T44	23194825
CPR:4	CHEMICAL	GENE-Y	19	17	Neither the chemical radical scavenger , tiron , nor the inhibitor of the chemical ( DA ) transporter , chemical , prevented the metabolites ' toxicity .	T3	T44	23194825
NA	CHEMICAL	GENE-Y	3	18	Cells exposed to chemical showed an increase in intracellular chemical ( chemical ) levels , which , at the 48 h time-point , was not dependent in the activity increase of chemical synthetase ( gene ) , revealing a possible transient effect .	T5	T45	23194825
NA	CHEMICAL	GENE-Y	3	34	Cells exposed to chemical showed an increase in intracellular chemical ( chemical ) levels , which , at the 48 h time-point , was not dependent in the activity increase of chemical synthetase ( gene ) , revealing a possible transient effect .	T5	T46	23194825
NA	CHEMICAL	GENE-Y	9	18	Cells exposed to chemical showed an increase in intracellular chemical ( chemical ) levels , which , at the 48 h time-point , was not dependent in the activity increase of chemical synthetase ( gene ) , revealing a possible transient effect .	T6	T45	23194825
NA	CHEMICAL	GENE-Y	9	34	Cells exposed to chemical showed an increase in intracellular chemical ( chemical ) levels , which , at the 48 h time-point , was not dependent in the activity increase of chemical synthetase ( gene ) , revealing a possible transient effect .	T6	T46	23194825
NA	CHEMICAL	GENE-Y	11	18	Cells exposed to chemical showed an increase in intracellular chemical ( chemical ) levels , which , at the 48 h time-point , was not dependent in the activity increase of chemical synthetase ( gene ) , revealing a possible transient effect .	T7	T45	23194825
NA	CHEMICAL	GENE-Y	11	34	Cells exposed to chemical showed an increase in intracellular chemical ( chemical ) levels , which , at the 48 h time-point , was not dependent in the activity increase of chemical synthetase ( gene ) , revealing a possible transient effect .	T7	T46	23194825
NA	CHEMICAL	GENE-Y	7	18	Cells exposed to chemical showed an increase in intracellular chemical ( chemical ) levels , which , at the 48 h time-point , was not dependent in the activity increase of chemical synthetase ( gene ) , revealing a possible transient effect .	T8	T45	23194825
NA	CHEMICAL	GENE-Y	7	34	Cells exposed to chemical showed an increase in intracellular chemical ( chemical ) levels , which , at the 48 h time-point , was not dependent in the activity increase of chemical synthetase ( gene ) , revealing a possible transient effect .	T8	T46	23194825
CPR:4	CHEMICAL	GENE-Y	4	12	Importantly , pre-treatment with chemical ( chemical ) , an inhibitor of gene , prevented chemical induced increase in chemical levels , but did not augment this metabolite cytotoxicity .	T9	T47	23194825
CPR:4	CHEMICAL	GENE-Y	6	12	Importantly , pre-treatment with chemical ( chemical ) , an inhibitor of gene , prevented chemical induced increase in chemical levels , but did not augment this metabolite cytotoxicity .	T10	T47	23194825
NA	CHEMICAL	GENE-Y	15	12	Importantly , pre-treatment with chemical ( chemical ) , an inhibitor of gene , prevented chemical induced increase in chemical levels , but did not augment this metabolite cytotoxicity .	T11	T47	23194825
NA	CHEMICAL	GENE-Y	19	12	Importantly , pre-treatment with chemical ( chemical ) , an inhibitor of gene , prevented chemical induced increase in chemical levels , but did not augment this metabolite cytotoxicity .	T12	T47	23194825
CPR:4	CHEMICAL	GENE-Y	8	10	Synthesis , molecular modeling and evaluation of novel chemical derivatives as dual inhibitors for gene and gene aggregation .	T3	T12	23273219
CPR:4	CHEMICAL	GENE-Y	8	16	Synthesis , molecular modeling and evaluation of novel chemical derivatives as dual inhibitors for gene and gene aggregation .	T3	T13	23273219
CPR:4	CHEMICAL	GENE-Y	11	11	To develop new drugs for treatment of Alzheimer 's disease , a group of chemical was designed , synthesized and tested for their ability to inhibit gene , gene and aggregation of gene .	T2	T4	23273219
CPR:4	CHEMICAL	GENE-Y	11	11	To develop new drugs for treatment of Alzheimer 's disease , a group of chemical was designed , synthesized and tested for their ability to inhibit gene , gene and aggregation of gene .	T2	T5	23273219
NA	CHEMICAL	GENE-N	11	32	To develop new drugs for treatment of Alzheimer 's disease , a group of chemical was designed , synthesized and tested for their ability to inhibit gene , gene and aggregation of gene .	T2	T6	23273219
NA	CHEMICAL	GENE-Y	9	0	gene aggregation results showed that all compounds exhibited remarkable gene fibril aggregation inhibition activity with a nearly similar potential as the reference compound chemical , which makes them promising anti-Alzheimer drug candidates .	T1	T9	23273219
CPR:4	CHEMICAL	GENE-Y	9	9	gene aggregation results showed that all compounds exhibited remarkable gene fibril aggregation inhibition activity with a nearly similar potential as the reference compound chemical , which makes them promising anti-Alzheimer drug candidates .	T1	T10	23273219
NA	CHEMICAL	GENE-Y	8	17	To clarify the cause of age differences on chemical cataract formation in rats , mRNA expression of gene , gene and gene , as well as gene activity in Wistar rat lens at different ages were assayed , level of lipid peroxidation , extent of lens damage induced by chemical and barricade function of blood-retinal barrier ( BRB ) were investigated .	T3	T9	23194826
NA	CHEMICAL	GENE-Y	8	19	To clarify the cause of age differences on chemical cataract formation in rats , mRNA expression of gene , gene and gene , as well as gene activity in Wistar rat lens at different ages were assayed , level of lipid peroxidation , extent of lens damage induced by chemical and barricade function of blood-retinal barrier ( BRB ) were investigated .	T3	T10	23194826
NA	CHEMICAL	GENE-Y	8	21	To clarify the cause of age differences on chemical cataract formation in rats , mRNA expression of gene , gene and gene , as well as gene activity in Wistar rat lens at different ages were assayed , level of lipid peroxidation , extent of lens damage induced by chemical and barricade function of blood-retinal barrier ( BRB ) were investigated .	T3	T11	23194826
NA	CHEMICAL	GENE-N	8	26	To clarify the cause of age differences on chemical cataract formation in rats , mRNA expression of gene , gene and gene , as well as gene activity in Wistar rat lens at different ages were assayed , level of lipid peroxidation , extent of lens damage induced by chemical and barricade function of blood-retinal barrier ( BRB ) were investigated .	T3	T12	23194826
NA	CHEMICAL	GENE-Y	49	17	To clarify the cause of age differences on chemical cataract formation in rats , mRNA expression of gene , gene and gene , as well as gene activity in Wistar rat lens at different ages were assayed , level of lipid peroxidation , extent of lens damage induced by chemical and barricade function of blood-retinal barrier ( BRB ) were investigated .	T4	T9	23194826
NA	CHEMICAL	GENE-Y	49	19	To clarify the cause of age differences on chemical cataract formation in rats , mRNA expression of gene , gene and gene , as well as gene activity in Wistar rat lens at different ages were assayed , level of lipid peroxidation , extent of lens damage induced by chemical and barricade function of blood-retinal barrier ( BRB ) were investigated .	T4	T10	23194826
NA	CHEMICAL	GENE-Y	49	21	To clarify the cause of age differences on chemical cataract formation in rats , mRNA expression of gene , gene and gene , as well as gene activity in Wistar rat lens at different ages were assayed , level of lipid peroxidation , extent of lens damage induced by chemical and barricade function of blood-retinal barrier ( BRB ) were investigated .	T4	T11	23194826
NA	CHEMICAL	GENE-N	49	26	To clarify the cause of age differences on chemical cataract formation in rats , mRNA expression of gene , gene and gene , as well as gene activity in Wistar rat lens at different ages were assayed , level of lipid peroxidation , extent of lens damage induced by chemical and barricade function of blood-retinal barrier ( BRB ) were investigated .	T4	T12	23194826
NA	CHEMICAL	GENE-Y	6	8	Soy protein suppresses gene expression of chemical carboxylase alpha from gene in rat liver .	T5	T21	16636450
NA	CHEMICAL	GENE-N	6	10	Soy protein suppresses gene expression of chemical carboxylase alpha from gene in rat liver .	T5	T22	16636450
NA	CHEMICAL	GENE-N	19	20	Dietary soy protein isolate ( SPI ) reduces hepatic lipogenesis by suppressing gene expression of lipogenic enzymes , including chemical carboxylase ( gene ) .	T1	T6	16636450
NA	CHEMICAL	GENE-N	19	22	Dietary soy protein isolate ( SPI ) reduces hepatic lipogenesis by suppressing gene expression of lipogenic enzymes , including chemical carboxylase ( gene ) .	T1	T7	16636450
CPR:9	CHEMICAL	GENE-N	11	8	Rats were fed experimental diets containing SPI or gene as a chemical source .	T2	T10	16636450
NA	CHEMICAL	GENE-N	13	8	SPI feeding decreased the hepatic contents of total gene mRNA as well as chemical ( chemical ) content , but dietary SPI affected the amount of gene mRNA and protein very little .	T3	T11	16636450
NA	CHEMICAL	GENE-Y	13	14	SPI feeding decreased the hepatic contents of total gene mRNA as well as chemical ( chemical ) content , but dietary SPI affected the amount of gene mRNA and protein very little .	T3	T12	16636450
NA	CHEMICAL	GENE-N	15	8	SPI feeding decreased the hepatic contents of total gene mRNA as well as chemical ( chemical ) content , but dietary SPI affected the amount of gene mRNA and protein very little .	T4	T11	16636450
NA	CHEMICAL	GENE-Y	15	14	SPI feeding decreased the hepatic contents of total gene mRNA as well as chemical ( chemical ) content , but dietary SPI affected the amount of gene mRNA and protein very little .	T4	T12	16636450
NA	CHEMICAL	GENE-Y	12	5	Many lung cancers also express gene RNA and gene protein and biosynthesize chemical , which correlates with their metastatic potential .	T22	T33	10626810
NA	CHEMICAL	GENE-Y	12	8	Many lung cancers also express gene RNA and gene protein and biosynthesize chemical , which correlates with their metastatic potential .	T22	T34	10626810
CPR:4	CHEMICAL	GENE-Y	10	13	In this report , we evaluated the growth-inhibitory effects of chemical , a gene and gene inhibitor ; chemical ( chemical ) , a novel proapoptotic agent that does not inhibit gene enzymes ; and chemical ( chemical ) , a gene inhibitor on human lung cancer cell lines .	T23	T37	10626810
CPR:4	CHEMICAL	GENE-Y	10	15	In this report , we evaluated the growth-inhibitory effects of chemical , a gene and gene inhibitor ; chemical ( chemical ) , a novel proapoptotic agent that does not inhibit gene enzymes ; and chemical ( chemical ) , a gene inhibitor on human lung cancer cell lines .	T23	T38	10626810
NA	CHEMICAL	GENE-N	10	31	In this report , we evaluated the growth-inhibitory effects of chemical , a gene and gene inhibitor ; chemical ( chemical ) , a novel proapoptotic agent that does not inhibit gene enzymes ; and chemical ( chemical ) , a gene inhibitor on human lung cancer cell lines .	T23	T39	10626810
NA	CHEMICAL	GENE-N	10	12	In this report , we evaluated the growth-inhibitory effects of chemical , a gene and gene inhibitor ; chemical ( chemical ) , a novel proapoptotic agent that does not inhibit gene enzymes ; and chemical ( chemical ) , a gene inhibitor on human lung cancer cell lines .	T23	T40	10626810
NA	CHEMICAL	GENE-Y	18	13	In this report , we evaluated the growth-inhibitory effects of chemical , a gene and gene inhibitor ; chemical ( chemical ) , a novel proapoptotic agent that does not inhibit gene enzymes ; and chemical ( chemical ) , a gene inhibitor on human lung cancer cell lines .	T24	T37	10626810
NA	CHEMICAL	GENE-Y	18	15	In this report , we evaluated the growth-inhibitory effects of chemical , a gene and gene inhibitor ; chemical ( chemical ) , a novel proapoptotic agent that does not inhibit gene enzymes ; and chemical ( chemical ) , a gene inhibitor on human lung cancer cell lines .	T24	T38	10626810
NA	CHEMICAL	GENE-N	18	31	In this report , we evaluated the growth-inhibitory effects of chemical , a gene and gene inhibitor ; chemical ( chemical ) , a novel proapoptotic agent that does not inhibit gene enzymes ; and chemical ( chemical ) , a gene inhibitor on human lung cancer cell lines .	T24	T39	10626810
NA	CHEMICAL	GENE-N	18	12	In this report , we evaluated the growth-inhibitory effects of chemical , a gene and gene inhibitor ; chemical ( chemical ) , a novel proapoptotic agent that does not inhibit gene enzymes ; and chemical ( chemical ) , a gene inhibitor on human lung cancer cell lines .	T24	T40	10626810
NA	CHEMICAL	GENE-Y	20	13	In this report , we evaluated the growth-inhibitory effects of chemical , a gene and gene inhibitor ; chemical ( chemical ) , a novel proapoptotic agent that does not inhibit gene enzymes ; and chemical ( chemical ) , a gene inhibitor on human lung cancer cell lines .	T25	T37	10626810
NA	CHEMICAL	GENE-Y	20	15	In this report , we evaluated the growth-inhibitory effects of chemical , a gene and gene inhibitor ; chemical ( chemical ) , a novel proapoptotic agent that does not inhibit gene enzymes ; and chemical ( chemical ) , a gene inhibitor on human lung cancer cell lines .	T25	T38	10626810
NA	CHEMICAL	GENE-N	20	31	In this report , we evaluated the growth-inhibitory effects of chemical , a gene and gene inhibitor ; chemical ( chemical ) , a novel proapoptotic agent that does not inhibit gene enzymes ; and chemical ( chemical ) , a gene inhibitor on human lung cancer cell lines .	T25	T39	10626810
NA	CHEMICAL	GENE-N	20	12	In this report , we evaluated the growth-inhibitory effects of chemical , a gene and gene inhibitor ; chemical ( chemical ) , a novel proapoptotic agent that does not inhibit gene enzymes ; and chemical ( chemical ) , a gene inhibitor on human lung cancer cell lines .	T25	T40	10626810
NA	CHEMICAL	GENE-Y	12	13	In this report , we evaluated the growth-inhibitory effects of chemical , a gene and gene inhibitor ; chemical ( chemical ) , a novel proapoptotic agent that does not inhibit gene enzymes ; and chemical ( chemical ) , a gene inhibitor on human lung cancer cell lines .	T26	T37	10626810
NA	CHEMICAL	GENE-Y	12	15	In this report , we evaluated the growth-inhibitory effects of chemical , a gene and gene inhibitor ; chemical ( chemical ) , a novel proapoptotic agent that does not inhibit gene enzymes ; and chemical ( chemical ) , a gene inhibitor on human lung cancer cell lines .	T26	T38	10626810
NA	CHEMICAL	GENE-N	12	31	In this report , we evaluated the growth-inhibitory effects of chemical , a gene and gene inhibitor ; chemical ( chemical ) , a novel proapoptotic agent that does not inhibit gene enzymes ; and chemical ( chemical ) , a gene inhibitor on human lung cancer cell lines .	T26	T39	10626810
CPR:4	CHEMICAL	GENE-N	12	12	In this report , we evaluated the growth-inhibitory effects of chemical , a gene and gene inhibitor ; chemical ( chemical ) , a novel proapoptotic agent that does not inhibit gene enzymes ; and chemical ( chemical ) , a gene inhibitor on human lung cancer cell lines .	T26	T40	10626810
NA	CHEMICAL	GENE-Y	37	13	In this report , we evaluated the growth-inhibitory effects of chemical , a gene and gene inhibitor ; chemical ( chemical ) , a novel proapoptotic agent that does not inhibit gene enzymes ; and chemical ( chemical ) , a gene inhibitor on human lung cancer cell lines .	T27	T37	10626810
NA	CHEMICAL	GENE-Y	37	15	In this report , we evaluated the growth-inhibitory effects of chemical , a gene and gene inhibitor ; chemical ( chemical ) , a novel proapoptotic agent that does not inhibit gene enzymes ; and chemical ( chemical ) , a gene inhibitor on human lung cancer cell lines .	T27	T38	10626810
NA	CHEMICAL	GENE-N	37	31	In this report , we evaluated the growth-inhibitory effects of chemical , a gene and gene inhibitor ; chemical ( chemical ) , a novel proapoptotic agent that does not inhibit gene enzymes ; and chemical ( chemical ) , a gene inhibitor on human lung cancer cell lines .	T27	T39	10626810
CPR:4	CHEMICAL	GENE-N	37	12	In this report , we evaluated the growth-inhibitory effects of chemical , a gene and gene inhibitor ; chemical ( chemical ) , a novel proapoptotic agent that does not inhibit gene enzymes ; and chemical ( chemical ) , a gene inhibitor on human lung cancer cell lines .	T27	T40	10626810
NA	CHEMICAL	GENE-Y	3	0	gene , an chemical-dependent deacetylase , was identified as a molecule necessary for caloric restriction-related anti-aging strategies .	T1	T5	23361587
NA	CHEMICAL	GENE-N	3	4	gene , an chemical-dependent deacetylase , was identified as a molecule necessary for caloric restriction-related anti-aging strategies .	T1	T6	23361587
NA	CHEMICAL	GENE-Y	12	0	gene functions as an intracellular energy sensor to detect the concentration of chemical , and controls in vivo metabolic changes under caloric restriction and starvation through its gene activity to many targets including gene , nuclear transcriptional factors , and enzymes .	T2	T7	23361587
NA	CHEMICAL	GENE-N	12	2	gene functions as an intracellular energy sensor to detect the concentration of chemical , and controls in vivo metabolic changes under caloric restriction and starvation through its gene activity to many targets including gene , nuclear transcriptional factors , and enzymes .	T2	T8	23361587
NA	CHEMICAL	GENE-N	12	7	gene functions as an intracellular energy sensor to detect the concentration of chemical , and controls in vivo metabolic changes under caloric restriction and starvation through its gene activity to many targets including gene , nuclear transcriptional factors , and enzymes .	T2	T9	23361587
NA	CHEMICAL	GENE-N	0	7	chemical induces apoptosis in odontoblasts via a gene-dependent mechanism .	T10	T20	23578390
CPR:3	CHEMICAL	GENE-Y	5	9	Exposure of cells to 4mM chemical for 24h induced gene activation , ultrastructural alterations , and resulted in the translocation of gene to the mitochondria and the release of gene from the mitochondrial inter-membrane space into the cytosol , indicating that chemical-mediated apoptosis is mitochondria-dependent .	T6	T12	23578390
NA	CHEMICAL	GENE-Y	5	21	Exposure of cells to 4mM chemical for 24h induced gene activation , ultrastructural alterations , and resulted in the translocation of gene to the mitochondria and the release of gene from the mitochondrial inter-membrane space into the cytosol , indicating that chemical-mediated apoptosis is mitochondria-dependent .	T6	T13	23578390
NA	CHEMICAL	GENE-Y	5	29	Exposure of cells to 4mM chemical for 24h induced gene activation , ultrastructural alterations , and resulted in the translocation of gene to the mitochondria and the release of gene from the mitochondrial inter-membrane space into the cytosol , indicating that chemical-mediated apoptosis is mitochondria-dependent .	T6	T14	23578390
NA	CHEMICAL	GENE-Y	41	9	Exposure of cells to 4mM chemical for 24h induced gene activation , ultrastructural alterations , and resulted in the translocation of gene to the mitochondria and the release of gene from the mitochondrial inter-membrane space into the cytosol , indicating that chemical-mediated apoptosis is mitochondria-dependent .	T7	T12	23578390
NA	CHEMICAL	GENE-Y	41	21	Exposure of cells to 4mM chemical for 24h induced gene activation , ultrastructural alterations , and resulted in the translocation of gene to the mitochondria and the release of gene from the mitochondrial inter-membrane space into the cytosol , indicating that chemical-mediated apoptosis is mitochondria-dependent .	T7	T13	23578390
NA	CHEMICAL	GENE-Y	41	29	Exposure of cells to 4mM chemical for 24h induced gene activation , ultrastructural alterations , and resulted in the translocation of gene to the mitochondria and the release of gene from the mitochondrial inter-membrane space into the cytosol , indicating that chemical-mediated apoptosis is mitochondria-dependent .	T7	T14	23578390
CPR:3	CHEMICAL	GENE-N	0	6	chemical treatment also increased phosphorylation of gene and gene , but not gene , and apoptosis induced by chemical was notably or partly suppressed by treatment with gene or gene inhibitors , respectively .	T8	T15	23578390
CPR:3	CHEMICAL	GENE-N	0	8	chemical treatment also increased phosphorylation of gene and gene , but not gene , and apoptosis induced by chemical was notably or partly suppressed by treatment with gene or gene inhibitors , respectively .	T8	T16	23578390
NA	CHEMICAL	GENE-N	0	12	chemical treatment also increased phosphorylation of gene and gene , but not gene , and apoptosis induced by chemical was notably or partly suppressed by treatment with gene or gene inhibitors , respectively .	T8	T17	23578390
NA	CHEMICAL	GENE-N	0	27	chemical treatment also increased phosphorylation of gene and gene , but not gene , and apoptosis induced by chemical was notably or partly suppressed by treatment with gene or gene inhibitors , respectively .	T8	T18	23578390
NA	CHEMICAL	GENE-N	0	29	chemical treatment also increased phosphorylation of gene and gene , but not gene , and apoptosis induced by chemical was notably or partly suppressed by treatment with gene or gene inhibitors , respectively .	T8	T19	23578390
NA	CHEMICAL	GENE-N	18	6	chemical treatment also increased phosphorylation of gene and gene , but not gene , and apoptosis induced by chemical was notably or partly suppressed by treatment with gene or gene inhibitors , respectively .	T9	T15	23578390
NA	CHEMICAL	GENE-N	18	8	chemical treatment also increased phosphorylation of gene and gene , but not gene , and apoptosis induced by chemical was notably or partly suppressed by treatment with gene or gene inhibitors , respectively .	T9	T16	23578390
NA	CHEMICAL	GENE-N	18	12	chemical treatment also increased phosphorylation of gene and gene , but not gene , and apoptosis induced by chemical was notably or partly suppressed by treatment with gene or gene inhibitors , respectively .	T9	T17	23578390
NA	CHEMICAL	GENE-N	18	27	chemical treatment also increased phosphorylation of gene and gene , but not gene , and apoptosis induced by chemical was notably or partly suppressed by treatment with gene or gene inhibitors , respectively .	T9	T18	23578390
NA	CHEMICAL	GENE-N	18	29	chemical treatment also increased phosphorylation of gene and gene , but not gene , and apoptosis induced by chemical was notably or partly suppressed by treatment with gene or gene inhibitors , respectively .	T9	T19	23578390
NA	CHEMICAL	GENE-N	14	14	These two antibodies recognize closely spaced epitopes on the 55 kD chain of the gene . gene expression was examined on peripheral blood small lymphocytes in three groups of patients who received : chemical chemical and chemical for baseline immunosuppression ( n = 9 ) ; ( B ) anti-Tac with chemical and chemical as baseline immunosuppression ( n = 12 ) ; and ( C ) anti-Tac with chemical and chemical as baseline immunosuppression ( n = 5 ) .	T1	T13	2571203
NA	CHEMICAL	GENE-N	14	16	These two antibodies recognize closely spaced epitopes on the 55 kD chain of the gene . gene expression was examined on peripheral blood small lymphocytes in three groups of patients who received : chemical chemical and chemical for baseline immunosuppression ( n = 9 ) ; ( B ) anti-Tac with chemical and chemical as baseline immunosuppression ( n = 12 ) ; and ( C ) anti-Tac with chemical and chemical as baseline immunosuppression ( n = 5 ) .	T1	T14	2571203
NA	CHEMICAL	GENE-N	34	14	These two antibodies recognize closely spaced epitopes on the 55 kD chain of the gene . gene expression was examined on peripheral blood small lymphocytes in three groups of patients who received : chemical chemical and chemical for baseline immunosuppression ( n = 9 ) ; ( B ) anti-Tac with chemical and chemical as baseline immunosuppression ( n = 12 ) ; and ( C ) anti-Tac with chemical and chemical as baseline immunosuppression ( n = 5 ) .	T2	T13	2571203
NA	CHEMICAL	GENE-N	34	16	These two antibodies recognize closely spaced epitopes on the 55 kD chain of the gene . gene expression was examined on peripheral blood small lymphocytes in three groups of patients who received : chemical chemical and chemical for baseline immunosuppression ( n = 9 ) ; ( B ) anti-Tac with chemical and chemical as baseline immunosuppression ( n = 12 ) ; and ( C ) anti-Tac with chemical and chemical as baseline immunosuppression ( n = 5 ) .	T2	T14	2571203
NA	CHEMICAL	GENE-N	7	14	These two antibodies recognize closely spaced epitopes on the 55 kD chain of the gene . gene expression was examined on peripheral blood small lymphocytes in three groups of patients who received : chemical chemical and chemical for baseline immunosuppression ( n = 9 ) ; ( B ) anti-Tac with chemical and chemical as baseline immunosuppression ( n = 12 ) ; and ( C ) anti-Tac with chemical and chemical as baseline immunosuppression ( n = 5 ) .	T3	T13	2571203
NA	CHEMICAL	GENE-N	7	16	These two antibodies recognize closely spaced epitopes on the 55 kD chain of the gene . gene expression was examined on peripheral blood small lymphocytes in three groups of patients who received : chemical chemical and chemical for baseline immunosuppression ( n = 9 ) ; ( B ) anti-Tac with chemical and chemical as baseline immunosuppression ( n = 12 ) ; and ( C ) anti-Tac with chemical and chemical as baseline immunosuppression ( n = 5 ) .	T3	T14	2571203
NA	CHEMICAL	GENE-N	51	14	These two antibodies recognize closely spaced epitopes on the 55 kD chain of the gene . gene expression was examined on peripheral blood small lymphocytes in three groups of patients who received : chemical chemical and chemical for baseline immunosuppression ( n = 9 ) ; ( B ) anti-Tac with chemical and chemical as baseline immunosuppression ( n = 12 ) ; and ( C ) anti-Tac with chemical and chemical as baseline immunosuppression ( n = 5 ) .	T4	T13	2571203
NA	CHEMICAL	GENE-N	51	16	These two antibodies recognize closely spaced epitopes on the 55 kD chain of the gene . gene expression was examined on peripheral blood small lymphocytes in three groups of patients who received : chemical chemical and chemical for baseline immunosuppression ( n = 9 ) ; ( B ) anti-Tac with chemical and chemical as baseline immunosuppression ( n = 12 ) ; and ( C ) anti-Tac with chemical and chemical as baseline immunosuppression ( n = 5 ) .	T4	T14	2571203
NA	CHEMICAL	GENE-N	7	14	These two antibodies recognize closely spaced epitopes on the 55 kD chain of the gene . gene expression was examined on peripheral blood small lymphocytes in three groups of patients who received : chemical chemical and chemical for baseline immunosuppression ( n = 9 ) ; ( B ) anti-Tac with chemical and chemical as baseline immunosuppression ( n = 12 ) ; and ( C ) anti-Tac with chemical and chemical as baseline immunosuppression ( n = 5 ) .	T5	T13	2571203
NA	CHEMICAL	GENE-N	7	16	These two antibodies recognize closely spaced epitopes on the 55 kD chain of the gene . gene expression was examined on peripheral blood small lymphocytes in three groups of patients who received : chemical chemical and chemical for baseline immunosuppression ( n = 9 ) ; ( B ) anti-Tac with chemical and chemical as baseline immunosuppression ( n = 12 ) ; and ( C ) anti-Tac with chemical and chemical as baseline immunosuppression ( n = 5 ) .	T5	T14	2571203
NA	CHEMICAL	GENE-N	25	14	These two antibodies recognize closely spaced epitopes on the 55 kD chain of the gene . gene expression was examined on peripheral blood small lymphocytes in three groups of patients who received : chemical chemical and chemical for baseline immunosuppression ( n = 9 ) ; ( B ) anti-Tac with chemical and chemical as baseline immunosuppression ( n = 12 ) ; and ( C ) anti-Tac with chemical and chemical as baseline immunosuppression ( n = 5 ) .	T6	T13	2571203
NA	CHEMICAL	GENE-N	25	16	These two antibodies recognize closely spaced epitopes on the 55 kD chain of the gene . gene expression was examined on peripheral blood small lymphocytes in three groups of patients who received : chemical chemical and chemical for baseline immunosuppression ( n = 9 ) ; ( B ) anti-Tac with chemical and chemical as baseline immunosuppression ( n = 12 ) ; and ( C ) anti-Tac with chemical and chemical as baseline immunosuppression ( n = 5 ) .	T6	T14	2571203
NA	CHEMICAL	GENE-N	7	14	These two antibodies recognize closely spaced epitopes on the 55 kD chain of the gene . gene expression was examined on peripheral blood small lymphocytes in three groups of patients who received : chemical chemical and chemical for baseline immunosuppression ( n = 9 ) ; ( B ) anti-Tac with chemical and chemical as baseline immunosuppression ( n = 12 ) ; and ( C ) anti-Tac with chemical and chemical as baseline immunosuppression ( n = 5 ) .	T7	T13	2571203
NA	CHEMICAL	GENE-N	7	16	These two antibodies recognize closely spaced epitopes on the 55 kD chain of the gene . gene expression was examined on peripheral blood small lymphocytes in three groups of patients who received : chemical chemical and chemical for baseline immunosuppression ( n = 9 ) ; ( B ) anti-Tac with chemical and chemical as baseline immunosuppression ( n = 12 ) ; and ( C ) anti-Tac with chemical and chemical as baseline immunosuppression ( n = 5 ) .	T7	T14	2571203
NA	CHEMICAL	GENE-N	16	17	Hepatic function was assessed by evaluating the following parameters : liver histology ; plasma levels of chemical aminotransferase ( gene ) , chemical ( TG ) , chemical ( chemical ) , and chemical ( chemical ) ; expression levels of gene and gene ; and levels of gene and gene/gene protein .	T4	T17	23256442
NA	CHEMICAL	GENE-N	16	19	Hepatic function was assessed by evaluating the following parameters : liver histology ; plasma levels of chemical aminotransferase ( gene ) , chemical ( TG ) , chemical ( chemical ) , and chemical ( chemical ) ; expression levels of gene and gene ; and levels of gene and gene/gene protein .	T4	T18	23256442
NA	CHEMICAL	GENE-Y	16	41	Hepatic function was assessed by evaluating the following parameters : liver histology ; plasma levels of chemical aminotransferase ( gene ) , chemical ( TG ) , chemical ( chemical ) , and chemical ( chemical ) ; expression levels of gene and gene ; and levels of gene and gene/gene protein .	T4	T19	23256442
NA	CHEMICAL	GENE-Y	16	43	Hepatic function was assessed by evaluating the following parameters : liver histology ; plasma levels of chemical aminotransferase ( gene ) , chemical ( TG ) , chemical ( chemical ) , and chemical ( chemical ) ; expression levels of gene and gene ; and levels of gene and gene/gene protein .	T4	T20	23256442
NA	CHEMICAL	GENE-Y	16	48	Hepatic function was assessed by evaluating the following parameters : liver histology ; plasma levels of chemical aminotransferase ( gene ) , chemical ( TG ) , chemical ( chemical ) , and chemical ( chemical ) ; expression levels of gene and gene ; and levels of gene and gene/gene protein .	T4	T21	23256442
NA	CHEMICAL	GENE-N	16	50	Hepatic function was assessed by evaluating the following parameters : liver histology ; plasma levels of chemical aminotransferase ( gene ) , chemical ( TG ) , chemical ( chemical ) , and chemical ( chemical ) ; expression levels of gene and gene ; and levels of gene and gene/gene protein .	T4	T22	23256442
NA	CHEMICAL	GENE-N	16	50	Hepatic function was assessed by evaluating the following parameters : liver histology ; plasma levels of chemical aminotransferase ( gene ) , chemical ( TG ) , chemical ( chemical ) , and chemical ( chemical ) ; expression levels of gene and gene ; and levels of gene and gene/gene protein .	T4	T23	23256442
NA	CHEMICAL	GENE-N	22	17	Hepatic function was assessed by evaluating the following parameters : liver histology ; plasma levels of chemical aminotransferase ( gene ) , chemical ( TG ) , chemical ( chemical ) , and chemical ( chemical ) ; expression levels of gene and gene ; and levels of gene and gene/gene protein .	T5	T17	23256442
NA	CHEMICAL	GENE-N	22	19	Hepatic function was assessed by evaluating the following parameters : liver histology ; plasma levels of chemical aminotransferase ( gene ) , chemical ( TG ) , chemical ( chemical ) , and chemical ( chemical ) ; expression levels of gene and gene ; and levels of gene and gene/gene protein .	T5	T18	23256442
NA	CHEMICAL	GENE-Y	22	41	Hepatic function was assessed by evaluating the following parameters : liver histology ; plasma levels of chemical aminotransferase ( gene ) , chemical ( TG ) , chemical ( chemical ) , and chemical ( chemical ) ; expression levels of gene and gene ; and levels of gene and gene/gene protein .	T5	T19	23256442
NA	CHEMICAL	GENE-Y	22	43	Hepatic function was assessed by evaluating the following parameters : liver histology ; plasma levels of chemical aminotransferase ( gene ) , chemical ( TG ) , chemical ( chemical ) , and chemical ( chemical ) ; expression levels of gene and gene ; and levels of gene and gene/gene protein .	T5	T20	23256442
NA	CHEMICAL	GENE-Y	22	48	Hepatic function was assessed by evaluating the following parameters : liver histology ; plasma levels of chemical aminotransferase ( gene ) , chemical ( TG ) , chemical ( chemical ) , and chemical ( chemical ) ; expression levels of gene and gene ; and levels of gene and gene/gene protein .	T5	T21	23256442
NA	CHEMICAL	GENE-N	22	50	Hepatic function was assessed by evaluating the following parameters : liver histology ; plasma levels of chemical aminotransferase ( gene ) , chemical ( TG ) , chemical ( chemical ) , and chemical ( chemical ) ; expression levels of gene and gene ; and levels of gene and gene/gene protein .	T5	T22	23256442
NA	CHEMICAL	GENE-N	22	50	Hepatic function was assessed by evaluating the following parameters : liver histology ; plasma levels of chemical aminotransferase ( gene ) , chemical ( TG ) , chemical ( chemical ) , and chemical ( chemical ) ; expression levels of gene and gene ; and levels of gene and gene/gene protein .	T5	T23	23256442
NA	CHEMICAL	GENE-N	27	17	Hepatic function was assessed by evaluating the following parameters : liver histology ; plasma levels of chemical aminotransferase ( gene ) , chemical ( TG ) , chemical ( chemical ) , and chemical ( chemical ) ; expression levels of gene and gene ; and levels of gene and gene/gene protein .	T6	T17	23256442
NA	CHEMICAL	GENE-N	27	19	Hepatic function was assessed by evaluating the following parameters : liver histology ; plasma levels of chemical aminotransferase ( gene ) , chemical ( TG ) , chemical ( chemical ) , and chemical ( chemical ) ; expression levels of gene and gene ; and levels of gene and gene/gene protein .	T6	T18	23256442
NA	CHEMICAL	GENE-Y	27	41	Hepatic function was assessed by evaluating the following parameters : liver histology ; plasma levels of chemical aminotransferase ( gene ) , chemical ( TG ) , chemical ( chemical ) , and chemical ( chemical ) ; expression levels of gene and gene ; and levels of gene and gene/gene protein .	T6	T19	23256442
NA	CHEMICAL	GENE-Y	27	43	Hepatic function was assessed by evaluating the following parameters : liver histology ; plasma levels of chemical aminotransferase ( gene ) , chemical ( TG ) , chemical ( chemical ) , and chemical ( chemical ) ; expression levels of gene and gene ; and levels of gene and gene/gene protein .	T6	T20	23256442
NA	CHEMICAL	GENE-Y	27	48	Hepatic function was assessed by evaluating the following parameters : liver histology ; plasma levels of chemical aminotransferase ( gene ) , chemical ( TG ) , chemical ( chemical ) , and chemical ( chemical ) ; expression levels of gene and gene ; and levels of gene and gene/gene protein .	T6	T21	23256442
NA	CHEMICAL	GENE-N	27	50	Hepatic function was assessed by evaluating the following parameters : liver histology ; plasma levels of chemical aminotransferase ( gene ) , chemical ( TG ) , chemical ( chemical ) , and chemical ( chemical ) ; expression levels of gene and gene ; and levels of gene and gene/gene protein .	T6	T22	23256442
NA	CHEMICAL	GENE-N	27	50	Hepatic function was assessed by evaluating the following parameters : liver histology ; plasma levels of chemical aminotransferase ( gene ) , chemical ( TG ) , chemical ( chemical ) , and chemical ( chemical ) ; expression levels of gene and gene ; and levels of gene and gene/gene protein .	T6	T23	23256442
NA	CHEMICAL	GENE-N	29	17	Hepatic function was assessed by evaluating the following parameters : liver histology ; plasma levels of chemical aminotransferase ( gene ) , chemical ( TG ) , chemical ( chemical ) , and chemical ( chemical ) ; expression levels of gene and gene ; and levels of gene and gene/gene protein .	T7	T17	23256442
NA	CHEMICAL	GENE-N	29	19	Hepatic function was assessed by evaluating the following parameters : liver histology ; plasma levels of chemical aminotransferase ( gene ) , chemical ( TG ) , chemical ( chemical ) , and chemical ( chemical ) ; expression levels of gene and gene ; and levels of gene and gene/gene protein .	T7	T18	23256442
NA	CHEMICAL	GENE-Y	29	41	Hepatic function was assessed by evaluating the following parameters : liver histology ; plasma levels of chemical aminotransferase ( gene ) , chemical ( TG ) , chemical ( chemical ) , and chemical ( chemical ) ; expression levels of gene and gene ; and levels of gene and gene/gene protein .	T7	T19	23256442
NA	CHEMICAL	GENE-Y	29	43	Hepatic function was assessed by evaluating the following parameters : liver histology ; plasma levels of chemical aminotransferase ( gene ) , chemical ( TG ) , chemical ( chemical ) , and chemical ( chemical ) ; expression levels of gene and gene ; and levels of gene and gene/gene protein .	T7	T20	23256442
NA	CHEMICAL	GENE-Y	29	48	Hepatic function was assessed by evaluating the following parameters : liver histology ; plasma levels of chemical aminotransferase ( gene ) , chemical ( TG ) , chemical ( chemical ) , and chemical ( chemical ) ; expression levels of gene and gene ; and levels of gene and gene/gene protein .	T7	T21	23256442
NA	CHEMICAL	GENE-N	29	50	Hepatic function was assessed by evaluating the following parameters : liver histology ; plasma levels of chemical aminotransferase ( gene ) , chemical ( TG ) , chemical ( chemical ) , and chemical ( chemical ) ; expression levels of gene and gene ; and levels of gene and gene/gene protein .	T7	T22	23256442
NA	CHEMICAL	GENE-N	29	50	Hepatic function was assessed by evaluating the following parameters : liver histology ; plasma levels of chemical aminotransferase ( gene ) , chemical ( TG ) , chemical ( chemical ) , and chemical ( chemical ) ; expression levels of gene and gene ; and levels of gene and gene/gene protein .	T7	T23	23256442
NA	CHEMICAL	GENE-N	33	17	Hepatic function was assessed by evaluating the following parameters : liver histology ; plasma levels of chemical aminotransferase ( gene ) , chemical ( TG ) , chemical ( chemical ) , and chemical ( chemical ) ; expression levels of gene and gene ; and levels of gene and gene/gene protein .	T8	T17	23256442
NA	CHEMICAL	GENE-N	33	19	Hepatic function was assessed by evaluating the following parameters : liver histology ; plasma levels of chemical aminotransferase ( gene ) , chemical ( TG ) , chemical ( chemical ) , and chemical ( chemical ) ; expression levels of gene and gene ; and levels of gene and gene/gene protein .	T8	T18	23256442
NA	CHEMICAL	GENE-Y	33	41	Hepatic function was assessed by evaluating the following parameters : liver histology ; plasma levels of chemical aminotransferase ( gene ) , chemical ( TG ) , chemical ( chemical ) , and chemical ( chemical ) ; expression levels of gene and gene ; and levels of gene and gene/gene protein .	T8	T19	23256442
NA	CHEMICAL	GENE-Y	33	43	Hepatic function was assessed by evaluating the following parameters : liver histology ; plasma levels of chemical aminotransferase ( gene ) , chemical ( TG ) , chemical ( chemical ) , and chemical ( chemical ) ; expression levels of gene and gene ; and levels of gene and gene/gene protein .	T8	T20	23256442
NA	CHEMICAL	GENE-Y	33	48	Hepatic function was assessed by evaluating the following parameters : liver histology ; plasma levels of chemical aminotransferase ( gene ) , chemical ( TG ) , chemical ( chemical ) , and chemical ( chemical ) ; expression levels of gene and gene ; and levels of gene and gene/gene protein .	T8	T21	23256442
NA	CHEMICAL	GENE-N	33	50	Hepatic function was assessed by evaluating the following parameters : liver histology ; plasma levels of chemical aminotransferase ( gene ) , chemical ( TG ) , chemical ( chemical ) , and chemical ( chemical ) ; expression levels of gene and gene ; and levels of gene and gene/gene protein .	T8	T22	23256442
NA	CHEMICAL	GENE-N	33	50	Hepatic function was assessed by evaluating the following parameters : liver histology ; plasma levels of chemical aminotransferase ( gene ) , chemical ( TG ) , chemical ( chemical ) , and chemical ( chemical ) ; expression levels of gene and gene ; and levels of gene and gene/gene protein .	T8	T23	23256442
NA	CHEMICAL	GENE-N	35	17	Hepatic function was assessed by evaluating the following parameters : liver histology ; plasma levels of chemical aminotransferase ( gene ) , chemical ( TG ) , chemical ( chemical ) , and chemical ( chemical ) ; expression levels of gene and gene ; and levels of gene and gene/gene protein .	T9	T17	23256442
NA	CHEMICAL	GENE-N	35	19	Hepatic function was assessed by evaluating the following parameters : liver histology ; plasma levels of chemical aminotransferase ( gene ) , chemical ( TG ) , chemical ( chemical ) , and chemical ( chemical ) ; expression levels of gene and gene ; and levels of gene and gene/gene protein .	T9	T18	23256442
NA	CHEMICAL	GENE-Y	35	41	Hepatic function was assessed by evaluating the following parameters : liver histology ; plasma levels of chemical aminotransferase ( gene ) , chemical ( TG ) , chemical ( chemical ) , and chemical ( chemical ) ; expression levels of gene and gene ; and levels of gene and gene/gene protein .	T9	T19	23256442
NA	CHEMICAL	GENE-Y	35	43	Hepatic function was assessed by evaluating the following parameters : liver histology ; plasma levels of chemical aminotransferase ( gene ) , chemical ( TG ) , chemical ( chemical ) , and chemical ( chemical ) ; expression levels of gene and gene ; and levels of gene and gene/gene protein .	T9	T20	23256442
NA	CHEMICAL	GENE-Y	35	48	Hepatic function was assessed by evaluating the following parameters : liver histology ; plasma levels of chemical aminotransferase ( gene ) , chemical ( TG ) , chemical ( chemical ) , and chemical ( chemical ) ; expression levels of gene and gene ; and levels of gene and gene/gene protein .	T9	T21	23256442
NA	CHEMICAL	GENE-N	35	50	Hepatic function was assessed by evaluating the following parameters : liver histology ; plasma levels of chemical aminotransferase ( gene ) , chemical ( TG ) , chemical ( chemical ) , and chemical ( chemical ) ; expression levels of gene and gene ; and levels of gene and gene/gene protein .	T9	T22	23256442
NA	CHEMICAL	GENE-N	35	50	Hepatic function was assessed by evaluating the following parameters : liver histology ; plasma levels of chemical aminotransferase ( gene ) , chemical ( TG ) , chemical ( chemical ) , and chemical ( chemical ) ; expression levels of gene and gene ; and levels of gene and gene/gene protein .	T9	T23	23256442
NA	CHEMICAL	GENE-N	19	13	Moreover , EDL led to a significant decrease in the serum levels of gene , hepatic TG , and chemical , and in the expression levels of gene , and gene ; on the contrary , the levels of chemical increased .	T10	T24	23256442
NA	CHEMICAL	GENE-Y	19	27	Moreover , EDL led to a significant decrease in the serum levels of gene , hepatic TG , and chemical , and in the expression levels of gene , and gene ; on the contrary , the levels of chemical increased .	T10	T25	23256442
NA	CHEMICAL	GENE-Y	19	30	Moreover , EDL led to a significant decrease in the serum levels of gene , hepatic TG , and chemical , and in the expression levels of gene , and gene ; on the contrary , the levels of chemical increased .	T10	T13	23256442
NA	CHEMICAL	GENE-N	19	13	Moreover , EDL led to a significant decrease in the serum levels of gene , hepatic TG , and chemical , and in the expression levels of gene , and gene ; on the contrary , the levels of chemical increased .	T1	T24	23256442
NA	CHEMICAL	GENE-Y	19	27	Moreover , EDL led to a significant decrease in the serum levels of gene , hepatic TG , and chemical , and in the expression levels of gene , and gene ; on the contrary , the levels of chemical increased .	T1	T25	23256442
NA	CHEMICAL	GENE-Y	19	30	Moreover , EDL led to a significant decrease in the serum levels of gene , hepatic TG , and chemical , and in the expression levels of gene , and gene ; on the contrary , the levels of chemical increased .	T1	T13	23256442
CPR:5	CHEMICAL	GENE-Y	5	1	Direct-acting gene agonists , including chemical , chemical [ chemical ] , chemical [ chemical ] , and chemical [ chemical ] , produced dose-dependent increases in diuresis and decreases in colonic temperature , with slightly lower ED ( 50 ) values for diuresis than for hypothermia .	T17	T29	23019138
CPR:5	CHEMICAL	GENE-Y	3	1	Direct-acting gene agonists , including chemical , chemical [ chemical ] , chemical [ chemical ] , and chemical [ chemical ] , produced dose-dependent increases in diuresis and decreases in colonic temperature , with slightly lower ED ( 50 ) values for diuresis than for hypothermia .	T18	T29	23019138
CPR:5	CHEMICAL	GENE-Y	9	1	Direct-acting gene agonists , including chemical , chemical [ chemical ] , chemical [ chemical ] , and chemical [ chemical ] , produced dose-dependent increases in diuresis and decreases in colonic temperature , with slightly lower ED ( 50 ) values for diuresis than for hypothermia .	T19	T29	23019138
CPR:5	CHEMICAL	GENE-Y	12	1	Direct-acting gene agonists , including chemical , chemical [ chemical ] , chemical [ chemical ] , and chemical [ chemical ] , produced dose-dependent increases in diuresis and decreases in colonic temperature , with slightly lower ED ( 50 ) values for diuresis than for hypothermia .	T20	T29	23019138
CPR:5	CHEMICAL	GENE-Y	14	1	Direct-acting gene agonists , including chemical , chemical [ chemical ] , chemical [ chemical ] , and chemical [ chemical ] , produced dose-dependent increases in diuresis and decreases in colonic temperature , with slightly lower ED ( 50 ) values for diuresis than for hypothermia .	T21	T29	23019138
CPR:5	CHEMICAL	GENE-Y	18	1	Direct-acting gene agonists , including chemical , chemical [ chemical ] , chemical [ chemical ] , and chemical [ chemical ] , produced dose-dependent increases in diuresis and decreases in colonic temperature , with slightly lower ED ( 50 ) values for diuresis than for hypothermia .	T22	T29	23019138
CPR:5	CHEMICAL	GENE-Y	20	1	Direct-acting gene agonists , including chemical , chemical [ chemical ] , chemical [ chemical ] , and chemical [ chemical ] , produced dose-dependent increases in diuresis and decreases in colonic temperature , with slightly lower ED ( 50 ) values for diuresis than for hypothermia .	T23	T29	23019138
NA	CHEMICAL	GENE-Y	0	10	chemical ( 10.0 mg/kg ) had lesser effect than other CB agonists , and the gene agonist chemical [ chemical ] , the chemical transport inhibitor chemical , and the CB antagonist chemical did not have diuretic effects .	T4	T24	23019138
CPR:5	CHEMICAL	GENE-Y	17	10	chemical ( 10.0 mg/kg ) had lesser effect than other CB agonists , and the gene agonist chemical [ chemical ] , the chemical transport inhibitor chemical , and the CB antagonist chemical did not have diuretic effects .	T5	T24	23019138
CPR:5	CHEMICAL	GENE-Y	1	10	chemical ( 10.0 mg/kg ) had lesser effect than other CB agonists , and the gene agonist chemical [ chemical ] , the chemical transport inhibitor chemical , and the CB antagonist chemical did not have diuretic effects .	T6	T24	23019138
NA	CHEMICAL	GENE-Y	13	10	chemical ( 10.0 mg/kg ) had lesser effect than other CB agonists , and the gene agonist chemical [ chemical ] , the chemical transport inhibitor chemical , and the CB antagonist chemical did not have diuretic effects .	T7	T24	23019138
CPR:5	CHEMICAL	GENE-Y	26	10	chemical ( 10.0 mg/kg ) had lesser effect than other CB agonists , and the gene agonist chemical [ chemical ] , the chemical transport inhibitor chemical , and the CB antagonist chemical did not have diuretic effects .	T8	T24	23019138
NA	CHEMICAL	GENE-Y	32	10	chemical ( 10.0 mg/kg ) had lesser effect than other CB agonists , and the gene agonist chemical [ chemical ] , the chemical transport inhibitor chemical , and the CB antagonist chemical did not have diuretic effects .	T9	T24	23019138
CPR:5	CHEMICAL	GENE-Y	11	9	In further studies , the diuretic effects of the gene agonist chemical were similar in male and female rats , displayed a relatively rapid onset to action , and were dose-dependently antagonized by 30 minutes pretreatment with chemical , but not by the chemical receptor type I antagonist chemical , nor were the effects of chemical antagonized by the gene antagonist chemical [ chemical ] .	T10	T25	23019138
NA	CHEMICAL	GENE-Y	11	46	In further studies , the diuretic effects of the gene agonist chemical were similar in male and female rats , displayed a relatively rapid onset to action , and were dose-dependently antagonized by 30 minutes pretreatment with chemical , but not by the chemical receptor type I antagonist chemical , nor were the effects of chemical antagonized by the gene antagonist chemical [ chemical ] .	T10	T26	23019138
NA	CHEMICAL	GENE-Y	11	59	In further studies , the diuretic effects of the gene agonist chemical were similar in male and female rats , displayed a relatively rapid onset to action , and were dose-dependently antagonized by 30 minutes pretreatment with chemical , but not by the chemical receptor type I antagonist chemical , nor were the effects of chemical antagonized by the gene antagonist chemical [ chemical ] .	T10	T27	23019138
CPR:6	CHEMICAL	GENE-Y	21	9	In further studies , the diuretic effects of the gene agonist chemical were similar in male and female rats , displayed a relatively rapid onset to action , and were dose-dependently antagonized by 30 minutes pretreatment with chemical , but not by the chemical receptor type I antagonist chemical , nor were the effects of chemical antagonized by the gene antagonist chemical [ chemical ] .	T11	T25	23019138
NA	CHEMICAL	GENE-Y	21	46	In further studies , the diuretic effects of the gene agonist chemical were similar in male and female rats , displayed a relatively rapid onset to action , and were dose-dependently antagonized by 30 minutes pretreatment with chemical , but not by the chemical receptor type I antagonist chemical , nor were the effects of chemical antagonized by the gene antagonist chemical [ chemical ] .	T11	T26	23019138
NA	CHEMICAL	GENE-Y	21	59	In further studies , the diuretic effects of the gene agonist chemical were similar in male and female rats , displayed a relatively rapid onset to action , and were dose-dependently antagonized by 30 minutes pretreatment with chemical , but not by the chemical receptor type I antagonist chemical , nor were the effects of chemical antagonized by the gene antagonist chemical [ chemical ] .	T11	T27	23019138
NA	CHEMICAL	GENE-Y	21	9	In further studies , the diuretic effects of the gene agonist chemical were similar in male and female rats , displayed a relatively rapid onset to action , and were dose-dependently antagonized by 30 minutes pretreatment with chemical , but not by the chemical receptor type I antagonist chemical , nor were the effects of chemical antagonized by the gene antagonist chemical [ chemical ] .	T12	T25	23019138
NA	CHEMICAL	GENE-Y	21	46	In further studies , the diuretic effects of the gene agonist chemical were similar in male and female rats , displayed a relatively rapid onset to action , and were dose-dependently antagonized by 30 minutes pretreatment with chemical , but not by the chemical receptor type I antagonist chemical , nor were the effects of chemical antagonized by the gene antagonist chemical [ chemical ] .	T12	T26	23019138
NA	CHEMICAL	GENE-Y	21	59	In further studies , the diuretic effects of the gene agonist chemical were similar in male and female rats , displayed a relatively rapid onset to action , and were dose-dependently antagonized by 30 minutes pretreatment with chemical , but not by the chemical receptor type I antagonist chemical , nor were the effects of chemical antagonized by the gene antagonist chemical [ chemical ] .	T12	T27	23019138
NA	CHEMICAL	GENE-Y	14	9	In further studies , the diuretic effects of the gene agonist chemical were similar in male and female rats , displayed a relatively rapid onset to action , and were dose-dependently antagonized by 30 minutes pretreatment with chemical , but not by the chemical receptor type I antagonist chemical , nor were the effects of chemical antagonized by the gene antagonist chemical [ chemical ] .	T13	T25	23019138
CPR:6	CHEMICAL	GENE-Y	14	46	In further studies , the diuretic effects of the gene agonist chemical were similar in male and female rats , displayed a relatively rapid onset to action , and were dose-dependently antagonized by 30 minutes pretreatment with chemical , but not by the chemical receptor type I antagonist chemical , nor were the effects of chemical antagonized by the gene antagonist chemical [ chemical ] .	T13	T26	23019138
NA	CHEMICAL	GENE-Y	14	59	In further studies , the diuretic effects of the gene agonist chemical were similar in male and female rats , displayed a relatively rapid onset to action , and were dose-dependently antagonized by 30 minutes pretreatment with chemical , but not by the chemical receptor type I antagonist chemical , nor were the effects of chemical antagonized by the gene antagonist chemical [ chemical ] .	T13	T27	23019138
NA	CHEMICAL	GENE-Y	3	9	In further studies , the diuretic effects of the gene agonist chemical were similar in male and female rats , displayed a relatively rapid onset to action , and were dose-dependently antagonized by 30 minutes pretreatment with chemical , but not by the chemical receptor type I antagonist chemical , nor were the effects of chemical antagonized by the gene antagonist chemical [ chemical ] .	T14	T25	23019138
NA	CHEMICAL	GENE-Y	3	46	In further studies , the diuretic effects of the gene agonist chemical were similar in male and female rats , displayed a relatively rapid onset to action , and were dose-dependently antagonized by 30 minutes pretreatment with chemical , but not by the chemical receptor type I antagonist chemical , nor were the effects of chemical antagonized by the gene antagonist chemical [ chemical ] .	T14	T26	23019138
CPR:5	CHEMICAL	GENE-Y	3	59	In further studies , the diuretic effects of the gene agonist chemical were similar in male and female rats , displayed a relatively rapid onset to action , and were dose-dependently antagonized by 30 minutes pretreatment with chemical , but not by the chemical receptor type I antagonist chemical , nor were the effects of chemical antagonized by the gene antagonist chemical [ chemical ] .	T14	T27	23019138
NA	CHEMICAL	GENE-Y	33	9	In further studies , the diuretic effects of the gene agonist chemical were similar in male and female rats , displayed a relatively rapid onset to action , and were dose-dependently antagonized by 30 minutes pretreatment with chemical , but not by the chemical receptor type I antagonist chemical , nor were the effects of chemical antagonized by the gene antagonist chemical [ chemical ] .	T15	T25	23019138
NA	CHEMICAL	GENE-Y	33	46	In further studies , the diuretic effects of the gene agonist chemical were similar in male and female rats , displayed a relatively rapid onset to action , and were dose-dependently antagonized by 30 minutes pretreatment with chemical , but not by the chemical receptor type I antagonist chemical , nor were the effects of chemical antagonized by the gene antagonist chemical [ chemical ] .	T15	T26	23019138
CPR:6	CHEMICAL	GENE-Y	33	59	In further studies , the diuretic effects of the gene agonist chemical were similar in male and female rats , displayed a relatively rapid onset to action , and were dose-dependently antagonized by 30 minutes pretreatment with chemical , but not by the chemical receptor type I antagonist chemical , nor were the effects of chemical antagonized by the gene antagonist chemical [ chemical ] .	T15	T27	23019138
NA	CHEMICAL	GENE-Y	21	9	In further studies , the diuretic effects of the gene agonist chemical were similar in male and female rats , displayed a relatively rapid onset to action , and were dose-dependently antagonized by 30 minutes pretreatment with chemical , but not by the chemical receptor type I antagonist chemical , nor were the effects of chemical antagonized by the gene antagonist chemical [ chemical ] .	T16	T25	23019138
NA	CHEMICAL	GENE-Y	21	46	In further studies , the diuretic effects of the gene agonist chemical were similar in male and female rats , displayed a relatively rapid onset to action , and were dose-dependently antagonized by 30 minutes pretreatment with chemical , but not by the chemical receptor type I antagonist chemical , nor were the effects of chemical antagonized by the gene antagonist chemical [ chemical ] .	T16	T26	23019138
CPR:6	CHEMICAL	GENE-Y	21	59	In further studies , the diuretic effects of the gene agonist chemical were similar in male and female rats , displayed a relatively rapid onset to action , and were dose-dependently antagonized by 30 minutes pretreatment with chemical , but not by the chemical receptor type I antagonist chemical , nor were the effects of chemical antagonized by the gene antagonist chemical [ chemical ] .	T16	T27	23019138
CPR:4	CHEMICAL	GENE-Y	7	2	Suppression of gene/gene and gene/gene signaling by chemical inhibits the growth of human colorectal cancer cells .	T9	T44	23333577
CPR:4	CHEMICAL	GENE-N	7	2	Suppression of gene/gene and gene/gene signaling by chemical inhibits the growth of human colorectal cancer cells .	T9	T45	23333577
CPR:4	CHEMICAL	GENE-N	7	4	Suppression of gene/gene and gene/gene signaling by chemical inhibits the growth of human colorectal cancer cells .	T9	T46	23333577
CPR:4	CHEMICAL	GENE-Y	7	4	Suppression of gene/gene and gene/gene signaling by chemical inhibits the growth of human colorectal cancer cells .	T9	T47	23333577
CPR:4	CHEMICAL	GENE-Y	0	24	chemical inhibited the proliferation of HCT 116 cells by arresting transition of cell cycle from G1 to S phase along with the downregulation of gene , gene , gene , gene ( gene ) , gene , gene , and gene ( gene ) , and the upregulation of gene ( gene/gene ) and gene .	T5	T21	23333577
CPR:4	CHEMICAL	GENE-Y	0	26	chemical inhibited the proliferation of HCT 116 cells by arresting transition of cell cycle from G1 to S phase along with the downregulation of gene , gene , gene , gene ( gene ) , gene , gene , and gene ( gene ) , and the upregulation of gene ( gene/gene ) and gene .	T5	T22	23333577
CPR:4	CHEMICAL	GENE-Y	0	28	chemical inhibited the proliferation of HCT 116 cells by arresting transition of cell cycle from G1 to S phase along with the downregulation of gene , gene , gene , gene ( gene ) , gene , gene , and gene ( gene ) , and the upregulation of gene ( gene/gene ) and gene .	T5	T23	23333577
CPR:4	CHEMICAL	GENE-Y	0	30	chemical inhibited the proliferation of HCT 116 cells by arresting transition of cell cycle from G1 to S phase along with the downregulation of gene , gene , gene , gene ( gene ) , gene , gene , and gene ( gene ) , and the upregulation of gene ( gene/gene ) and gene .	T5	T24	23333577
CPR:4	CHEMICAL	GENE-Y	0	32	chemical inhibited the proliferation of HCT 116 cells by arresting transition of cell cycle from G1 to S phase along with the downregulation of gene , gene , gene , gene ( gene ) , gene , gene , and gene ( gene ) , and the upregulation of gene ( gene/gene ) and gene .	T5	T25	23333577
CPR:4	CHEMICAL	GENE-Y	0	35	chemical inhibited the proliferation of HCT 116 cells by arresting transition of cell cycle from G1 to S phase along with the downregulation of gene , gene , gene , gene ( gene ) , gene , gene , and gene ( gene ) , and the upregulation of gene ( gene/gene ) and gene .	T5	T26	23333577
CPR:4	CHEMICAL	GENE-Y	0	37	chemical inhibited the proliferation of HCT 116 cells by arresting transition of cell cycle from G1 to S phase along with the downregulation of gene , gene , gene , gene ( gene ) , gene , gene , and gene ( gene ) , and the upregulation of gene ( gene/gene ) and gene .	T5	T27	23333577
CPR:4	CHEMICAL	GENE-Y	0	40	chemical inhibited the proliferation of HCT 116 cells by arresting transition of cell cycle from G1 to S phase along with the downregulation of gene , gene , gene , gene ( gene ) , gene , gene , and gene ( gene ) , and the upregulation of gene ( gene/gene ) and gene .	T5	T28	23333577
CPR:4	CHEMICAL	GENE-Y	0	42	chemical inhibited the proliferation of HCT 116 cells by arresting transition of cell cycle from G1 to S phase along with the downregulation of gene , gene , gene , gene ( gene ) , gene , gene , and gene ( gene ) , and the upregulation of gene ( gene/gene ) and gene .	T5	T29	23333577
CPR:3	CHEMICAL	GENE-Y	0	49	chemical inhibited the proliferation of HCT 116 cells by arresting transition of cell cycle from G1 to S phase along with the downregulation of gene , gene , gene , gene ( gene ) , gene , gene , and gene ( gene ) , and the upregulation of gene ( gene/gene ) and gene .	T5	T30	23333577
CPR:3	CHEMICAL	GENE-Y	0	51	chemical inhibited the proliferation of HCT 116 cells by arresting transition of cell cycle from G1 to S phase along with the downregulation of gene , gene , gene , gene ( gene ) , gene , gene , and gene ( gene ) , and the upregulation of gene ( gene/gene ) and gene .	T5	T31	23333577
CPR:3	CHEMICAL	GENE-Y	0	51	chemical inhibited the proliferation of HCT 116 cells by arresting transition of cell cycle from G1 to S phase along with the downregulation of gene , gene , gene , gene ( gene ) , gene , gene , and gene ( gene ) , and the upregulation of gene ( gene/gene ) and gene .	T5	T32	23333577
CPR:3	CHEMICAL	GENE-Y	0	54	chemical inhibited the proliferation of HCT 116 cells by arresting transition of cell cycle from G1 to S phase along with the downregulation of gene , gene , gene , gene ( gene ) , gene , gene , and gene ( gene ) , and the upregulation of gene ( gene/gene ) and gene .	T5	T33	23333577
CPR:4	CHEMICAL	GENE-Y	0	11	chemical was also found to attenuate the activation of proteins involved in fgene ( gene ) /gene/gene ( gene ) signaling , and chemical 3-kinase ( gene ) /gene/ gene ( gene ) signaling pathway .	T6	T34	23333577
CPR:4	CHEMICAL	GENE-Y	0	14	chemical was also found to attenuate the activation of proteins involved in fgene ( gene ) /gene/gene ( gene ) signaling , and chemical 3-kinase ( gene ) /gene/ gene ( gene ) signaling pathway .	T6	T35	23333577
CPR:4	CHEMICAL	GENE-Y	0	16	chemical was also found to attenuate the activation of proteins involved in fgene ( gene ) /gene/gene ( gene ) signaling , and chemical 3-kinase ( gene ) /gene/ gene ( gene ) signaling pathway .	T6	T36	23333577
CPR:4	CHEMICAL	GENE-N	0	11	chemical was also found to attenuate the activation of proteins involved in fgene ( gene ) /gene/gene ( gene ) signaling , and chemical 3-kinase ( gene ) /gene/ gene ( gene ) signaling pathway .	T6	T37	23333577
CPR:4	CHEMICAL	GENE-N	0	18	chemical was also found to attenuate the activation of proteins involved in fgene ( gene ) /gene/gene ( gene ) signaling , and chemical 3-kinase ( gene ) /gene/ gene ( gene ) signaling pathway .	T6	T38	23333577
CPR:4	CHEMICAL	GENE-N	0	11	chemical was also found to attenuate the activation of proteins involved in fgene ( gene ) /gene/gene ( gene ) signaling , and chemical 3-kinase ( gene ) /gene/ gene ( gene ) signaling pathway .	T6	T39	23333577
CPR:4	CHEMICAL	GENE-N	0	26	chemical was also found to attenuate the activation of proteins involved in fgene ( gene ) /gene/gene ( gene ) signaling , and chemical 3-kinase ( gene ) /gene/ gene ( gene ) signaling pathway .	T6	T40	23333577
CPR:4	CHEMICAL	GENE-N	0	28	chemical was also found to attenuate the activation of proteins involved in fgene ( gene ) /gene/gene ( gene ) signaling , and chemical 3-kinase ( gene ) /gene/ gene ( gene ) signaling pathway .	T6	T41	23333577
CPR:4	CHEMICAL	GENE-Y	0	29	chemical was also found to attenuate the activation of proteins involved in fgene ( gene ) /gene/gene ( gene ) signaling , and chemical 3-kinase ( gene ) /gene/ gene ( gene ) signaling pathway .	T6	T42	23333577
CPR:4	CHEMICAL	GENE-Y	0	31	chemical was also found to attenuate the activation of proteins involved in fgene ( gene ) /gene/gene ( gene ) signaling , and chemical 3-kinase ( gene ) /gene/ gene ( gene ) signaling pathway .	T6	T43	23333577
NA	CHEMICAL	GENE-Y	11	11	chemical was also found to attenuate the activation of proteins involved in fgene ( gene ) /gene/gene ( gene ) signaling , and chemical 3-kinase ( gene ) /gene/ gene ( gene ) signaling pathway .	T7	T34	23333577
NA	CHEMICAL	GENE-Y	11	14	chemical was also found to attenuate the activation of proteins involved in fgene ( gene ) /gene/gene ( gene ) signaling , and chemical 3-kinase ( gene ) /gene/ gene ( gene ) signaling pathway .	T7	T35	23333577
NA	CHEMICAL	GENE-Y	11	16	chemical was also found to attenuate the activation of proteins involved in fgene ( gene ) /gene/gene ( gene ) signaling , and chemical 3-kinase ( gene ) /gene/ gene ( gene ) signaling pathway .	T7	T36	23333577
NA	CHEMICAL	GENE-N	11	11	chemical was also found to attenuate the activation of proteins involved in fgene ( gene ) /gene/gene ( gene ) signaling , and chemical 3-kinase ( gene ) /gene/ gene ( gene ) signaling pathway .	T7	T37	23333577
NA	CHEMICAL	GENE-N	11	18	chemical was also found to attenuate the activation of proteins involved in fgene ( gene ) /gene/gene ( gene ) signaling , and chemical 3-kinase ( gene ) /gene/ gene ( gene ) signaling pathway .	T7	T38	23333577
NA	CHEMICAL	GENE-N	11	11	chemical was also found to attenuate the activation of proteins involved in fgene ( gene ) /gene/gene ( gene ) signaling , and chemical 3-kinase ( gene ) /gene/ gene ( gene ) signaling pathway .	T7	T39	23333577
NA	CHEMICAL	GENE-N	11	26	chemical was also found to attenuate the activation of proteins involved in fgene ( gene ) /gene/gene ( gene ) signaling , and chemical 3-kinase ( gene ) /gene/ gene ( gene ) signaling pathway .	T7	T40	23333577
NA	CHEMICAL	GENE-N	11	28	chemical was also found to attenuate the activation of proteins involved in fgene ( gene ) /gene/gene ( gene ) signaling , and chemical 3-kinase ( gene ) /gene/ gene ( gene ) signaling pathway .	T7	T41	23333577
NA	CHEMICAL	GENE-Y	11	29	chemical was also found to attenuate the activation of proteins involved in fgene ( gene ) /gene/gene ( gene ) signaling , and chemical 3-kinase ( gene ) /gene/ gene ( gene ) signaling pathway .	T7	T42	23333577
NA	CHEMICAL	GENE-Y	11	31	chemical was also found to attenuate the activation of proteins involved in fgene ( gene ) /gene/gene ( gene ) signaling , and chemical 3-kinase ( gene ) /gene/ gene ( gene ) signaling pathway .	T7	T43	23333577
CPR:4	CHEMICAL	GENE-Y	2	8	Subsequently , chemical suppressed the nuclear translocation of gene , one of downstream molecules of gene/gene/gene signaling , and these events led to the sequential downregulation of gene-mediated transcription of target genes including gene , gene , gene , gene , gene , and gene .	T8	T10	23333577
CPR:4	CHEMICAL	GENE-N	2	15	Subsequently , chemical suppressed the nuclear translocation of gene , one of downstream molecules of gene/gene/gene signaling , and these events led to the sequential downregulation of gene-mediated transcription of target genes including gene , gene , gene , gene , gene , and gene .	T8	T11	23333577
CPR:4	CHEMICAL	GENE-N	2	15	Subsequently , chemical suppressed the nuclear translocation of gene , one of downstream molecules of gene/gene/gene signaling , and these events led to the sequential downregulation of gene-mediated transcription of target genes including gene , gene , gene , gene , gene , and gene .	T8	T12	23333577
CPR:4	CHEMICAL	GENE-Y	2	15	Subsequently , chemical suppressed the nuclear translocation of gene , one of downstream molecules of gene/gene/gene signaling , and these events led to the sequential downregulation of gene-mediated transcription of target genes including gene , gene , gene , gene , gene , and gene .	T8	T13	23333577
CPR:4	CHEMICAL	GENE-Y	2	27	Subsequently , chemical suppressed the nuclear translocation of gene , one of downstream molecules of gene/gene/gene signaling , and these events led to the sequential downregulation of gene-mediated transcription of target genes including gene , gene , gene , gene , gene , and gene .	T8	T14	23333577
CPR:4	CHEMICAL	GENE-Y	2	33	Subsequently , chemical suppressed the nuclear translocation of gene , one of downstream molecules of gene/gene/gene signaling , and these events led to the sequential downregulation of gene-mediated transcription of target genes including gene , gene , gene , gene , gene , and gene .	T8	T15	23333577
CPR:4	CHEMICAL	GENE-Y	2	35	Subsequently , chemical suppressed the nuclear translocation of gene , one of downstream molecules of gene/gene/gene signaling , and these events led to the sequential downregulation of gene-mediated transcription of target genes including gene , gene , gene , gene , gene , and gene .	T8	T16	23333577
CPR:4	CHEMICAL	GENE-Y	2	37	Subsequently , chemical suppressed the nuclear translocation of gene , one of downstream molecules of gene/gene/gene signaling , and these events led to the sequential downregulation of gene-mediated transcription of target genes including gene , gene , gene , gene , gene , and gene .	T8	T17	23333577
CPR:4	CHEMICAL	GENE-Y	2	39	Subsequently , chemical suppressed the nuclear translocation of gene , one of downstream molecules of gene/gene/gene signaling , and these events led to the sequential downregulation of gene-mediated transcription of target genes including gene , gene , gene , gene , gene , and gene .	T8	T18	23333577
CPR:4	CHEMICAL	GENE-Y	2	41	Subsequently , chemical suppressed the nuclear translocation of gene , one of downstream molecules of gene/gene/gene signaling , and these events led to the sequential downregulation of gene-mediated transcription of target genes including gene , gene , gene , gene , gene , and gene .	T8	T19	23333577
CPR:4	CHEMICAL	GENE-Y	2	44	Subsequently , chemical suppressed the nuclear translocation of gene , one of downstream molecules of gene/gene/gene signaling , and these events led to the sequential downregulation of gene-mediated transcription of target genes including gene , gene , gene , gene , gene , and gene .	T8	T20	23333577
NA	CHEMICAL	GENE-N	1	0	gene chemical kinases are potential participants in this process as they regulate development of other CNS regions and are expressed in basal ganglia nuclei , such as the substantia nigra ( SN ) and striatum .	T3	T18	17561836
NA	CHEMICAL	GENE-N	1	2	gene chemical kinases are potential participants in this process as they regulate development of other CNS regions and are expressed in basal ganglia nuclei , such as the substantia nigra ( SN ) and striatum .	T3	T19	17561836
NA	CHEMICAL	GENE-Y	12	5	In situ hybridization data and a direct comparison of SN neurons expressing chemical hydroxylase ( gene ) and/or the beta-gal marker for gene revealed that gene is not expressed in gene+ neurons of pars compacta ( SNc ) , but is restricted to neurons in pars reticulata ( SNr ) .	T2	T12	17561836
NA	CHEMICAL	GENE-Y	12	15	In situ hybridization data and a direct comparison of SN neurons expressing chemical hydroxylase ( gene ) and/or the beta-gal marker for gene revealed that gene is not expressed in gene+ neurons of pars compacta ( SNc ) , but is restricted to neurons in pars reticulata ( SNr ) .	T2	T13	17561836
NA	CHEMICAL	GENE-Y	12	22	In situ hybridization data and a direct comparison of SN neurons expressing chemical hydroxylase ( gene ) and/or the beta-gal marker for gene revealed that gene is not expressed in gene+ neurons of pars compacta ( SNc ) , but is restricted to neurons in pars reticulata ( SNr ) .	T2	T14	17561836
NA	CHEMICAL	GENE-Y	12	25	In situ hybridization data and a direct comparison of SN neurons expressing chemical hydroxylase ( gene ) and/or the beta-gal marker for gene revealed that gene is not expressed in gene+ neurons of pars compacta ( SNc ) , but is restricted to neurons in pars reticulata ( SNr ) .	T2	T15	17561836
NA	CHEMICAL	GENE-Y	12	30	In situ hybridization data and a direct comparison of SN neurons expressing chemical hydroxylase ( gene ) and/or the beta-gal marker for gene revealed that gene is not expressed in gene+ neurons of pars compacta ( SNc ) , but is restricted to neurons in pars reticulata ( SNr ) .	T2	T16	17561836
NA	CHEMICAL	GENE-Y	7	7	Consistent with this , we find that gene null mice exhibit a significant decrease in the volume and number of neurons ( 40 % decrease ) in SNr , whereas the volume and number of gene+ neurons in SNc is not significantly affected nor are there changes in the distribution of nigrostriatal chemical neurons .	T1	T17	17561836
NA	CHEMICAL	GENE-Y	7	35	Consistent with this , we find that gene null mice exhibit a significant decrease in the volume and number of neurons ( 40 % decrease ) in SNr , whereas the volume and number of gene+ neurons in SNc is not significantly affected nor are there changes in the distribution of nigrostriatal chemical neurons .	T1	T20	17561836
NA	CHEMICAL	GENE-N	4	4	This was accompanied by a significant increase in levels of serum chemical transaminase , chemical transaminase , and liver chemical content .	T11	T21	23435910
NA	CHEMICAL	GENE-Y	4	4	This was accompanied by a significant increase in levels of serum chemical transaminase , chemical transaminase , and liver chemical content .	T11	T22	23435910
NA	CHEMICAL	GENE-N	4	4	This was accompanied by a significant increase in levels of serum chemical transaminase , chemical transaminase , and liver chemical content .	T12	T21	23435910
NA	CHEMICAL	GENE-Y	4	4	This was accompanied by a significant increase in levels of serum chemical transaminase , chemical transaminase , and liver chemical content .	T12	T22	23435910
NA	CHEMICAL	GENE-N	4	4	This was accompanied by a significant increase in levels of serum chemical transaminase , chemical transaminase , and liver chemical content .	T13	T21	23435910
NA	CHEMICAL	GENE-Y	4	4	This was accompanied by a significant increase in levels of serum chemical transaminase , chemical transaminase , and liver chemical content .	T13	T22	23435910
CPR:4	CHEMICAL	GENE-N	2	11	Furthermore , chemical reduced hepatic chemical content , which correlated with a reduction in the expression of gene mRNA and histological analysis of gene in liver tissue .	T14	T23	23435910
NA	CHEMICAL	GENE-N	2	11	Furthermore , chemical reduced hepatic chemical content , which correlated with a reduction in the expression of gene mRNA and histological analysis of gene in liver tissue .	T14	T24	23435910
NA	CHEMICAL	GENE-N	5	11	Furthermore , chemical reduced hepatic chemical content , which correlated with a reduction in the expression of gene mRNA and histological analysis of gene in liver tissue .	T15	T23	23435910
NA	CHEMICAL	GENE-N	5	11	Furthermore , chemical reduced hepatic chemical content , which correlated with a reduction in the expression of gene mRNA and histological analysis of gene in liver tissue .	T15	T24	23435910
CPR:4	CHEMICAL	GENE-Y	23	10	Additionally , the expression of hepatic fibrosis-related factors such as gene and gene ( gene ) , were reduced in rats treated with chemical .	T16	T25	23435910
CPR:4	CHEMICAL	GENE-Y	23	12	Additionally , the expression of hepatic fibrosis-related factors such as gene and gene ( gene ) , were reduced in rats treated with chemical .	T16	T26	23435910
CPR:4	CHEMICAL	GENE-Y	23	14	Additionally , the expression of hepatic fibrosis-related factors such as gene and gene ( gene ) , were reduced in rats treated with chemical .	T16	T27	23435910
CPR:4	CHEMICAL	GENE-Y	6	32	In conclusion , we find that chemical exhibits hepatoprotective and antifibrotic effects against chemical-induced liver injury , most likely due to its antioxidant activities of scavenging radicals , its capacity to suppress gene and its ability to attenuate activation of hepatic stellate cells .	T2	T20	23435910
NA	CHEMICAL	GENE-Y	13	32	In conclusion , we find that chemical exhibits hepatoprotective and antifibrotic effects against chemical-induced liver injury , most likely due to its antioxidant activities of scavenging radicals , its capacity to suppress gene and its ability to attenuate activation of hepatic stellate cells .	T3	T20	23435910
NA	CHEMICAL	GENE-N	3	8	The effects of chemical ( chemical ) , a new anti-diabetic drug , on gene and gene secretion : comparison with the chemical and chemical .	T39	T70	11716850
NA	CHEMICAL	GENE-Y	3	16	The effects of chemical ( chemical ) , a new anti-diabetic drug , on gene and gene secretion : comparison with the chemical and chemical .	T39	T71	11716850
NA	CHEMICAL	GENE-N	5	8	The effects of chemical ( chemical ) , a new anti-diabetic drug , on gene and gene secretion : comparison with the chemical and chemical .	T41	T70	11716850
NA	CHEMICAL	GENE-Y	5	16	The effects of chemical ( chemical ) , a new anti-diabetic drug , on gene and gene secretion : comparison with the chemical and chemical .	T41	T71	11716850
NA	CHEMICAL	GENE-N	8	8	The effects of chemical ( chemical ) , a new anti-diabetic drug , on gene and gene secretion : comparison with the chemical and chemical .	T38	T70	11716850
NA	CHEMICAL	GENE-Y	8	16	The effects of chemical ( chemical ) , a new anti-diabetic drug , on gene and gene secretion : comparison with the chemical and chemical .	T38	T71	11716850
NA	CHEMICAL	GENE-N	8	8	The effects of chemical ( chemical ) , a new anti-diabetic drug , on gene and gene secretion : comparison with the chemical and chemical .	T40	T70	11716850
NA	CHEMICAL	GENE-Y	8	16	The effects of chemical ( chemical ) , a new anti-diabetic drug , on gene and gene secretion : comparison with the chemical and chemical .	T40	T71	11716850
CPR:3	CHEMICAL	GENE-Y	0	14	chemical ( chemical ) , a new anti-diabetic drug , is thought to stimulate gene secretion by closing the chemical-sensitive chemical ( chemical ( chemical ) ) channels in pancreatic beta-cells .	T1	T62	11716850
CPR:4	CHEMICAL	GENE-N	0	5	chemical ( chemical ) , a new anti-diabetic drug , is thought to stimulate gene secretion by closing the chemical-sensitive chemical ( chemical ( chemical ) ) channels in pancreatic beta-cells .	T1	T42	11716850
CPR:3	CHEMICAL	GENE-Y	2	14	chemical ( chemical ) , a new anti-diabetic drug , is thought to stimulate gene secretion by closing the chemical-sensitive chemical ( chemical ( chemical ) ) channels in pancreatic beta-cells .	T15	T62	11716850
CPR:4	CHEMICAL	GENE-N	2	5	chemical ( chemical ) , a new anti-diabetic drug , is thought to stimulate gene secretion by closing the chemical-sensitive chemical ( chemical ( chemical ) ) channels in pancreatic beta-cells .	T15	T42	11716850
NA	CHEMICAL	GENE-Y	19	14	chemical ( chemical ) , a new anti-diabetic drug , is thought to stimulate gene secretion by closing the chemical-sensitive chemical ( chemical ( chemical ) ) channels in pancreatic beta-cells .	T3	T62	11716850
NA	CHEMICAL	GENE-N	19	5	chemical ( chemical ) , a new anti-diabetic drug , is thought to stimulate gene secretion by closing the chemical-sensitive chemical ( chemical ( chemical ) ) channels in pancreatic beta-cells .	T3	T42	11716850
NA	CHEMICAL	GENE-Y	20	14	chemical ( chemical ) , a new anti-diabetic drug , is thought to stimulate gene secretion by closing the chemical-sensitive chemical ( chemical ( chemical ) ) channels in pancreatic beta-cells .	T8	T62	11716850
NA	CHEMICAL	GENE-N	20	5	chemical ( chemical ) , a new anti-diabetic drug , is thought to stimulate gene secretion by closing the chemical-sensitive chemical ( chemical ( chemical ) ) channels in pancreatic beta-cells .	T8	T42	11716850
NA	CHEMICAL	GENE-Y	22	14	chemical ( chemical ) , a new anti-diabetic drug , is thought to stimulate gene secretion by closing the chemical-sensitive chemical ( chemical ( chemical ) ) channels in pancreatic beta-cells .	T9	T62	11716850
NA	CHEMICAL	GENE-N	22	5	chemical ( chemical ) , a new anti-diabetic drug , is thought to stimulate gene secretion by closing the chemical-sensitive chemical ( chemical ( chemical ) ) channels in pancreatic beta-cells .	T9	T42	11716850
NA	CHEMICAL	GENE-Y	24	14	chemical ( chemical ) , a new anti-diabetic drug , is thought to stimulate gene secretion by closing the chemical-sensitive chemical ( chemical ( chemical ) ) channels in pancreatic beta-cells .	T12	T62	11716850
NA	CHEMICAL	GENE-N	24	5	chemical ( chemical ) , a new anti-diabetic drug , is thought to stimulate gene secretion by closing the chemical-sensitive chemical ( chemical ( chemical ) ) channels in pancreatic beta-cells .	T12	T42	11716850
NA	CHEMICAL	GENE-N	7	11	However , its selectivity for the various chemical ( chemical ) channels is not known .	T26	T48	11716850
NA	CHEMICAL	GENE-N	9	11	However , its selectivity for the various chemical ( chemical ) channels is not known .	T27	T48	11716850
NA	CHEMICAL	GENE-N	9	17	In this study , we examined the effects of chemical on various cloned chemical ( chemical ) channels ( gene/gene , gene/gene , and gene/gene ) reconstituted in COS-1 cells , and compared them to another chemical-related compound , chemical .	T28	T49	11716850
NA	CHEMICAL	GENE-Y	9	19	In this study , we examined the effects of chemical on various cloned chemical ( chemical ) channels ( gene/gene , gene/gene , and gene/gene ) reconstituted in COS-1 cells , and compared them to another chemical-related compound , chemical .	T28	T50	11716850
NA	CHEMICAL	GENE-Y	9	19	In this study , we examined the effects of chemical on various cloned chemical ( chemical ) channels ( gene/gene , gene/gene , and gene/gene ) reconstituted in COS-1 cells , and compared them to another chemical-related compound , chemical .	T28	T51	11716850
NA	CHEMICAL	GENE-Y	9	21	In this study , we examined the effects of chemical on various cloned chemical ( chemical ) channels ( gene/gene , gene/gene , and gene/gene ) reconstituted in COS-1 cells , and compared them to another chemical-related compound , chemical .	T28	T52	11716850
NA	CHEMICAL	GENE-Y	9	21	In this study , we examined the effects of chemical on various cloned chemical ( chemical ) channels ( gene/gene , gene/gene , and gene/gene ) reconstituted in COS-1 cells , and compared them to another chemical-related compound , chemical .	T28	T53	11716850
NA	CHEMICAL	GENE-Y	9	24	In this study , we examined the effects of chemical on various cloned chemical ( chemical ) channels ( gene/gene , gene/gene , and gene/gene ) reconstituted in COS-1 cells , and compared them to another chemical-related compound , chemical .	T28	T54	11716850
NA	CHEMICAL	GENE-Y	9	24	In this study , we examined the effects of chemical on various cloned chemical ( chemical ) channels ( gene/gene , gene/gene , and gene/gene ) reconstituted in COS-1 cells , and compared them to another chemical-related compound , chemical .	T28	T55	11716850
NA	CHEMICAL	GENE-N	13	17	In this study , we examined the effects of chemical on various cloned chemical ( chemical ) channels ( gene/gene , gene/gene , and gene/gene ) reconstituted in COS-1 cells , and compared them to another chemical-related compound , chemical .	T29	T49	11716850
NA	CHEMICAL	GENE-Y	13	19	In this study , we examined the effects of chemical on various cloned chemical ( chemical ) channels ( gene/gene , gene/gene , and gene/gene ) reconstituted in COS-1 cells , and compared them to another chemical-related compound , chemical .	T29	T50	11716850
NA	CHEMICAL	GENE-Y	13	19	In this study , we examined the effects of chemical on various cloned chemical ( chemical ) channels ( gene/gene , gene/gene , and gene/gene ) reconstituted in COS-1 cells , and compared them to another chemical-related compound , chemical .	T29	T51	11716850
NA	CHEMICAL	GENE-Y	13	21	In this study , we examined the effects of chemical on various cloned chemical ( chemical ) channels ( gene/gene , gene/gene , and gene/gene ) reconstituted in COS-1 cells , and compared them to another chemical-related compound , chemical .	T29	T52	11716850
NA	CHEMICAL	GENE-Y	13	21	In this study , we examined the effects of chemical on various cloned chemical ( chemical ) channels ( gene/gene , gene/gene , and gene/gene ) reconstituted in COS-1 cells , and compared them to another chemical-related compound , chemical .	T29	T53	11716850
NA	CHEMICAL	GENE-Y	13	24	In this study , we examined the effects of chemical on various cloned chemical ( chemical ) channels ( gene/gene , gene/gene , and gene/gene ) reconstituted in COS-1 cells , and compared them to another chemical-related compound , chemical .	T29	T54	11716850
NA	CHEMICAL	GENE-Y	13	24	In this study , we examined the effects of chemical on various cloned chemical ( chemical ) channels ( gene/gene , gene/gene , and gene/gene ) reconstituted in COS-1 cells , and compared them to another chemical-related compound , chemical .	T29	T55	11716850
NA	CHEMICAL	GENE-N	15	17	In this study , we examined the effects of chemical on various cloned chemical ( chemical ) channels ( gene/gene , gene/gene , and gene/gene ) reconstituted in COS-1 cells , and compared them to another chemical-related compound , chemical .	T30	T49	11716850
NA	CHEMICAL	GENE-Y	15	19	In this study , we examined the effects of chemical on various cloned chemical ( chemical ) channels ( gene/gene , gene/gene , and gene/gene ) reconstituted in COS-1 cells , and compared them to another chemical-related compound , chemical .	T30	T50	11716850
NA	CHEMICAL	GENE-Y	15	19	In this study , we examined the effects of chemical on various cloned chemical ( chemical ) channels ( gene/gene , gene/gene , and gene/gene ) reconstituted in COS-1 cells , and compared them to another chemical-related compound , chemical .	T30	T51	11716850
NA	CHEMICAL	GENE-Y	15	21	In this study , we examined the effects of chemical on various cloned chemical ( chemical ) channels ( gene/gene , gene/gene , and gene/gene ) reconstituted in COS-1 cells , and compared them to another chemical-related compound , chemical .	T30	T52	11716850
NA	CHEMICAL	GENE-Y	15	21	In this study , we examined the effects of chemical on various cloned chemical ( chemical ) channels ( gene/gene , gene/gene , and gene/gene ) reconstituted in COS-1 cells , and compared them to another chemical-related compound , chemical .	T30	T53	11716850
NA	CHEMICAL	GENE-Y	15	24	In this study , we examined the effects of chemical on various cloned chemical ( chemical ) channels ( gene/gene , gene/gene , and gene/gene ) reconstituted in COS-1 cells , and compared them to another chemical-related compound , chemical .	T30	T54	11716850
NA	CHEMICAL	GENE-Y	15	24	In this study , we examined the effects of chemical on various cloned chemical ( chemical ) channels ( gene/gene , gene/gene , and gene/gene ) reconstituted in COS-1 cells , and compared them to another chemical-related compound , chemical .	T30	T55	11716850
NA	CHEMICAL	GENE-N	27	17	In this study , we examined the effects of chemical on various cloned chemical ( chemical ) channels ( gene/gene , gene/gene , and gene/gene ) reconstituted in COS-1 cells , and compared them to another chemical-related compound , chemical .	T31	T49	11716850
NA	CHEMICAL	GENE-Y	27	19	In this study , we examined the effects of chemical on various cloned chemical ( chemical ) channels ( gene/gene , gene/gene , and gene/gene ) reconstituted in COS-1 cells , and compared them to another chemical-related compound , chemical .	T31	T50	11716850
NA	CHEMICAL	GENE-Y	27	19	In this study , we examined the effects of chemical on various cloned chemical ( chemical ) channels ( gene/gene , gene/gene , and gene/gene ) reconstituted in COS-1 cells , and compared them to another chemical-related compound , chemical .	T31	T51	11716850
NA	CHEMICAL	GENE-Y	27	21	In this study , we examined the effects of chemical on various cloned chemical ( chemical ) channels ( gene/gene , gene/gene , and gene/gene ) reconstituted in COS-1 cells , and compared them to another chemical-related compound , chemical .	T31	T52	11716850
NA	CHEMICAL	GENE-Y	27	21	In this study , we examined the effects of chemical on various cloned chemical ( chemical ) channels ( gene/gene , gene/gene , and gene/gene ) reconstituted in COS-1 cells , and compared them to another chemical-related compound , chemical .	T31	T53	11716850
NA	CHEMICAL	GENE-Y	27	24	In this study , we examined the effects of chemical on various cloned chemical ( chemical ) channels ( gene/gene , gene/gene , and gene/gene ) reconstituted in COS-1 cells , and compared them to another chemical-related compound , chemical .	T31	T54	11716850
NA	CHEMICAL	GENE-Y	27	24	In this study , we examined the effects of chemical on various cloned chemical ( chemical ) channels ( gene/gene , gene/gene , and gene/gene ) reconstituted in COS-1 cells , and compared them to another chemical-related compound , chemical .	T31	T55	11716850
NA	CHEMICAL	GENE-N	27	17	In this study , we examined the effects of chemical on various cloned chemical ( chemical ) channels ( gene/gene , gene/gene , and gene/gene ) reconstituted in COS-1 cells , and compared them to another chemical-related compound , chemical .	T32	T49	11716850
NA	CHEMICAL	GENE-Y	27	19	In this study , we examined the effects of chemical on various cloned chemical ( chemical ) channels ( gene/gene , gene/gene , and gene/gene ) reconstituted in COS-1 cells , and compared them to another chemical-related compound , chemical .	T32	T50	11716850
NA	CHEMICAL	GENE-Y	27	19	In this study , we examined the effects of chemical on various cloned chemical ( chemical ) channels ( gene/gene , gene/gene , and gene/gene ) reconstituted in COS-1 cells , and compared them to another chemical-related compound , chemical .	T32	T51	11716850
NA	CHEMICAL	GENE-Y	27	21	In this study , we examined the effects of chemical on various cloned chemical ( chemical ) channels ( gene/gene , gene/gene , and gene/gene ) reconstituted in COS-1 cells , and compared them to another chemical-related compound , chemical .	T32	T52	11716850
NA	CHEMICAL	GENE-Y	27	21	In this study , we examined the effects of chemical on various cloned chemical ( chemical ) channels ( gene/gene , gene/gene , and gene/gene ) reconstituted in COS-1 cells , and compared them to another chemical-related compound , chemical .	T32	T53	11716850
NA	CHEMICAL	GENE-Y	27	24	In this study , we examined the effects of chemical on various cloned chemical ( chemical ) channels ( gene/gene , gene/gene , and gene/gene ) reconstituted in COS-1 cells , and compared them to another chemical-related compound , chemical .	T32	T54	11716850
NA	CHEMICAL	GENE-Y	27	24	In this study , we examined the effects of chemical on various cloned chemical ( chemical ) channels ( gene/gene , gene/gene , and gene/gene ) reconstituted in COS-1 cells , and compared them to another chemical-related compound , chemical .	T32	T55	11716850
CPR:4	CHEMICAL	GENE-Y	8	11	Patch-clamp analysis using inside-out recording configuration showed that chemical inhibits the gene/gene channel currents in a dose-dependent manner ( IC50 value , 100 nM ) but does not significantly inhibit either gene/gene or gene/gene channel currents even at high doses ( more than 10 microM ) .	T33	T56	11716850
CPR:4	CHEMICAL	GENE-Y	8	11	Patch-clamp analysis using inside-out recording configuration showed that chemical inhibits the gene/gene channel currents in a dose-dependent manner ( IC50 value , 100 nM ) but does not significantly inhibit either gene/gene or gene/gene channel currents even at high doses ( more than 10 microM ) .	T33	T57	11716850
NA	CHEMICAL	GENE-Y	8	31	Patch-clamp analysis using inside-out recording configuration showed that chemical inhibits the gene/gene channel currents in a dose-dependent manner ( IC50 value , 100 nM ) but does not significantly inhibit either gene/gene or gene/gene channel currents even at high doses ( more than 10 microM ) .	T33	T58	11716850
NA	CHEMICAL	GENE-Y	8	31	Patch-clamp analysis using inside-out recording configuration showed that chemical inhibits the gene/gene channel currents in a dose-dependent manner ( IC50 value , 100 nM ) but does not significantly inhibit either gene/gene or gene/gene channel currents even at high doses ( more than 10 microM ) .	T33	T59	11716850
NA	CHEMICAL	GENE-Y	8	33	Patch-clamp analysis using inside-out recording configuration showed that chemical inhibits the gene/gene channel currents in a dose-dependent manner ( IC50 value , 100 nM ) but does not significantly inhibit either gene/gene or gene/gene channel currents even at high doses ( more than 10 microM ) .	T33	T60	11716850
NA	CHEMICAL	GENE-Y	8	33	Patch-clamp analysis using inside-out recording configuration showed that chemical inhibits the gene/gene channel currents in a dose-dependent manner ( IC50 value , 100 nM ) but does not significantly inhibit either gene/gene or gene/gene channel currents even at high doses ( more than 10 microM ) .	T33	T61	11716850
CPR:4	CHEMICAL	GENE-Y	0	2	chemical inhibits gene/gene and gene/gene channels at 100 nM , and inhibits gene/gene channels at high concentrations ( 1 microM ) .	T34	T63	11716850
CPR:4	CHEMICAL	GENE-Y	0	2	chemical inhibits gene/gene and gene/gene channels at 100 nM , and inhibits gene/gene channels at high concentrations ( 1 microM ) .	T34	T64	11716850
CPR:4	CHEMICAL	GENE-Y	0	4	chemical inhibits gene/gene and gene/gene channels at 100 nM , and inhibits gene/gene channels at high concentrations ( 1 microM ) .	T34	T65	11716850
CPR:4	CHEMICAL	GENE-Y	0	4	chemical inhibits gene/gene and gene/gene channels at 100 nM , and inhibits gene/gene channels at high concentrations ( 1 microM ) .	T34	T66	11716850
CPR:4	CHEMICAL	GENE-Y	0	12	chemical inhibits gene/gene and gene/gene channels at 100 nM , and inhibits gene/gene channels at high concentrations ( 1 microM ) .	T34	T67	11716850
CPR:4	CHEMICAL	GENE-Y	0	12	chemical inhibits gene/gene and gene/gene channels at 100 nM , and inhibits gene/gene channels at high concentrations ( 1 microM ) .	T34	T68	11716850
NA	CHEMICAL	GENE-Y	3	10	Binding experiments on chemical , chemical , and chemical to gene expressed in COS-1 cells revealed that they inhibit the binding of chemical to gene ( IC50 values : chemical , 280 nM ; chemical , 8 microM ; chemical , 1.6 microM ) , suggesting that they all share a chemical binding site .	T35	T69	11716850
NA	CHEMICAL	GENE-Y	3	24	Binding experiments on chemical , chemical , and chemical to gene expressed in COS-1 cells revealed that they inhibit the binding of chemical to gene ( IC50 values : chemical , 280 nM ; chemical , 8 microM ; chemical , 1.6 microM ) , suggesting that they all share a chemical binding site .	T35	T43	11716850
NA	CHEMICAL	GENE-Y	5	10	Binding experiments on chemical , chemical , and chemical to gene expressed in COS-1 cells revealed that they inhibit the binding of chemical to gene ( IC50 values : chemical , 280 nM ; chemical , 8 microM ; chemical , 1.6 microM ) , suggesting that they all share a chemical binding site .	T36	T69	11716850
NA	CHEMICAL	GENE-Y	5	24	Binding experiments on chemical , chemical , and chemical to gene expressed in COS-1 cells revealed that they inhibit the binding of chemical to gene ( IC50 values : chemical , 280 nM ; chemical , 8 microM ; chemical , 1.6 microM ) , suggesting that they all share a chemical binding site .	T36	T43	11716850
NA	CHEMICAL	GENE-Y	8	10	Binding experiments on chemical , chemical , and chemical to gene expressed in COS-1 cells revealed that they inhibit the binding of chemical to gene ( IC50 values : chemical , 280 nM ; chemical , 8 microM ; chemical , 1.6 microM ) , suggesting that they all share a chemical binding site .	T37	T69	11716850
NA	CHEMICAL	GENE-Y	8	24	Binding experiments on chemical , chemical , and chemical to gene expressed in COS-1 cells revealed that they inhibit the binding of chemical to gene ( IC50 values : chemical , 280 nM ; chemical , 8 microM ; chemical , 1.6 microM ) , suggesting that they all share a chemical binding site .	T37	T43	11716850
NA	CHEMICAL	GENE-Y	22	10	Binding experiments on chemical , chemical , and chemical to gene expressed in COS-1 cells revealed that they inhibit the binding of chemical to gene ( IC50 values : chemical , 280 nM ; chemical , 8 microM ; chemical , 1.6 microM ) , suggesting that they all share a chemical binding site .	T2	T69	11716850
NA	CHEMICAL	GENE-Y	22	24	Binding experiments on chemical , chemical , and chemical to gene expressed in COS-1 cells revealed that they inhibit the binding of chemical to gene ( IC50 values : chemical , 280 nM ; chemical , 8 microM ; chemical , 1.6 microM ) , suggesting that they all share a chemical binding site .	T2	T43	11716850
NA	CHEMICAL	GENE-Y	12	10	Binding experiments on chemical , chemical , and chemical to gene expressed in COS-1 cells revealed that they inhibit the binding of chemical to gene ( IC50 values : chemical , 280 nM ; chemical , 8 microM ; chemical , 1.6 microM ) , suggesting that they all share a chemical binding site .	T4	T69	11716850
NA	CHEMICAL	GENE-Y	12	24	Binding experiments on chemical , chemical , and chemical to gene expressed in COS-1 cells revealed that they inhibit the binding of chemical to gene ( IC50 values : chemical , 280 nM ; chemical , 8 microM ; chemical , 1.6 microM ) , suggesting that they all share a chemical binding site .	T4	T43	11716850
NA	CHEMICAL	GENE-Y	12	10	Binding experiments on chemical , chemical , and chemical to gene expressed in COS-1 cells revealed that they inhibit the binding of chemical to gene ( IC50 values : chemical , 280 nM ; chemical , 8 microM ; chemical , 1.6 microM ) , suggesting that they all share a chemical binding site .	T5	T69	11716850
NA	CHEMICAL	GENE-Y	12	24	Binding experiments on chemical , chemical , and chemical to gene expressed in COS-1 cells revealed that they inhibit the binding of chemical to gene ( IC50 values : chemical , 280 nM ; chemical , 8 microM ; chemical , 1.6 microM ) , suggesting that they all share a chemical binding site .	T5	T43	11716850
NA	CHEMICAL	GENE-Y	10	10	Binding experiments on chemical , chemical , and chemical to gene expressed in COS-1 cells revealed that they inhibit the binding of chemical to gene ( IC50 values : chemical , 280 nM ; chemical , 8 microM ; chemical , 1.6 microM ) , suggesting that they all share a chemical binding site .	T6	T69	11716850
NA	CHEMICAL	GENE-Y	10	24	Binding experiments on chemical , chemical , and chemical to gene expressed in COS-1 cells revealed that they inhibit the binding of chemical to gene ( IC50 values : chemical , 280 nM ; chemical , 8 microM ; chemical , 1.6 microM ) , suggesting that they all share a chemical binding site .	T6	T43	11716850
NA	CHEMICAL	GENE-Y	50	10	Binding experiments on chemical , chemical , and chemical to gene expressed in COS-1 cells revealed that they inhibit the binding of chemical to gene ( IC50 values : chemical , 280 nM ; chemical , 8 microM ; chemical , 1.6 microM ) , suggesting that they all share a chemical binding site .	T7	T69	11716850
NA	CHEMICAL	GENE-Y	50	24	Binding experiments on chemical , chemical , and chemical to gene expressed in COS-1 cells revealed that they inhibit the binding of chemical to gene ( IC50 values : chemical , 280 nM ; chemical , 8 microM ; chemical , 1.6 microM ) , suggesting that they all share a chemical binding site .	T7	T43	11716850
NA	CHEMICAL	GENE-N	4	1	The gene responses to chemical , chemical , chemical , and chemical in MIN6 cells after chronic chemical , chemical , or chemical treatment were comparable to those after chronic chemical and chemical treatment .	T10	T44	11716850
NA	CHEMICAL	GENE-N	6	1	The gene responses to chemical , chemical , chemical , and chemical in MIN6 cells after chronic chemical , chemical , or chemical treatment were comparable to those after chronic chemical and chemical treatment .	T11	T44	11716850
NA	CHEMICAL	GENE-N	3	1	The gene responses to chemical , chemical , chemical , and chemical in MIN6 cells after chronic chemical , chemical , or chemical treatment were comparable to those after chronic chemical and chemical treatment .	T13	T44	11716850
NA	CHEMICAL	GENE-N	11	1	The gene responses to chemical , chemical , chemical , and chemical in MIN6 cells after chronic chemical , chemical , or chemical treatment were comparable to those after chronic chemical and chemical treatment .	T14	T44	11716850
NA	CHEMICAL	GENE-N	12	1	The gene responses to chemical , chemical , chemical , and chemical in MIN6 cells after chronic chemical , chemical , or chemical treatment were comparable to those after chronic chemical and chemical treatment .	T16	T44	11716850
NA	CHEMICAL	GENE-N	12	1	The gene responses to chemical , chemical , chemical , and chemical in MIN6 cells after chronic chemical , chemical , or chemical treatment were comparable to those after chronic chemical and chemical treatment .	T17	T44	11716850
NA	CHEMICAL	GENE-N	12	1	The gene responses to chemical , chemical , chemical , and chemical in MIN6 cells after chronic chemical , chemical , or chemical treatment were comparable to those after chronic chemical and chemical treatment .	T18	T44	11716850
NA	CHEMICAL	GENE-N	3	1	The gene responses to chemical , chemical , chemical , and chemical in MIN6 cells after chronic chemical , chemical , or chemical treatment were comparable to those after chronic chemical and chemical treatment .	T19	T44	11716850
NA	CHEMICAL	GENE-N	32	1	The gene responses to chemical , chemical , chemical , and chemical in MIN6 cells after chronic chemical , chemical , or chemical treatment were comparable to those after chronic chemical and chemical treatment .	T20	T44	11716850
NA	CHEMICAL	GENE-N	3	9	Gliotransmission and brain chemical sensing : critical role of gene .	T13	T28	23160530
NA	CHEMICAL	GENE-Y	0	1	chemical-binding inhibitor ( gene ) and its processing product the gene ( gene ) , collectively named gene , are secreted by astroglia , and gene is a potent anorexigenic factor .	T6	T19	23160530
NA	CHEMICAL	GENE-Y	0	3	chemical-binding inhibitor ( gene ) and its processing product the gene ( gene ) , collectively named gene , are secreted by astroglia , and gene is a potent anorexigenic factor .	T6	T20	23160530
NA	CHEMICAL	GENE-N	0	10	chemical-binding inhibitor ( gene ) and its processing product the gene ( gene ) , collectively named gene , are secreted by astroglia , and gene is a potent anorexigenic factor .	T6	T21	23160530
NA	CHEMICAL	GENE-N	0	12	chemical-binding inhibitor ( gene ) and its processing product the gene ( gene ) , collectively named gene , are secreted by astroglia , and gene is a potent anorexigenic factor .	T6	T22	23160530
NA	CHEMICAL	GENE-N	0	17	chemical-binding inhibitor ( gene ) and its processing product the gene ( gene ) , collectively named gene , are secreted by astroglia , and gene is a potent anorexigenic factor .	T6	T23	23160530
NA	CHEMICAL	GENE-N	0	25	chemical-binding inhibitor ( gene ) and its processing product the gene ( gene ) , collectively named gene , are secreted by astroglia , and gene is a potent anorexigenic factor .	T6	T24	23160530
CPR:3	CHEMICAL	GENE-Y	8	12	First , we showed that intracerebroventricular administration of chemical in rats increases gene expression in hypothalamic glial-like tanycytes .	T8	T25	23160530
NA	CHEMICAL	GENE-N	11	18	Feeding experiments indicate that the anorexigenic effect of central administration of chemical was blunted by coinjection of an gene antagonist .	T10	T26	23160530
NA	CHEMICAL	GENE-N	6	8	The anorexigenic effects of centrally injected chemical or gene agonist were suppressed by blockade of the gene , suggesting that chemical sensing involves endozepinergic control of the gene pathway .	T12	T14	23160530
NA	CHEMICAL	GENE-N	6	7	The anorexigenic effects of centrally injected chemical or gene agonist were suppressed by blockade of the gene , suggesting that chemical sensing involves endozepinergic control of the gene pathway .	T12	T15	23160530
NA	CHEMICAL	GENE-N	6	7	The anorexigenic effects of centrally injected chemical or gene agonist were suppressed by blockade of the gene , suggesting that chemical sensing involves endozepinergic control of the gene pathway .	T12	T16	23160530
NA	CHEMICAL	GENE-N	6	8	The anorexigenic effects of centrally injected chemical or gene agonist were suppressed by blockade of the gene , suggesting that chemical sensing involves endozepinergic control of the gene pathway .	T1	T14	23160530
NA	CHEMICAL	GENE-N	6	7	The anorexigenic effects of centrally injected chemical or gene agonist were suppressed by blockade of the gene , suggesting that chemical sensing involves endozepinergic control of the gene pathway .	T1	T15	23160530
NA	CHEMICAL	GENE-N	6	7	The anorexigenic effects of centrally injected chemical or gene agonist were suppressed by blockade of the gene , suggesting that chemical sensing involves endozepinergic control of the gene pathway .	T1	T16	23160530
NA	CHEMICAL	GENE-N	9	6	Finally , we found that brain gene modulate blood chemical levels , suggesting their involvement in a feedback loop controlling whole-body chemical homeostasis .	T2	T17	23160530
NA	CHEMICAL	GENE-N	21	6	Finally , we found that brain gene modulate blood chemical levels , suggesting their involvement in a feedback loop controlling whole-body chemical homeostasis .	T3	T17	23160530
NA	CHEMICAL	GENE-N	5	6	The clinical profile of the chemical receptor blocker chemical .	T12	T27	12184062
CPR:4	CHEMICAL	GENE-N	8	6	The clinical profile of the chemical receptor blocker chemical .	T13	T27	12184062
NA	CHEMICAL	GENE-N	0	1	chemical receptor antagonists block chemical type 1 ( AT1 ) receptors and reduce the pressor effects of gene in the vasculature .	T1	T14	12184062
NA	CHEMICAL	GENE-Y	0	1	chemical receptor antagonists block chemical type 1 ( AT1 ) receptors and reduce the pressor effects of gene in the vasculature .	T1	T21	12184062
NA	CHEMICAL	GENE-Y	0	17	chemical receptor antagonists block chemical type 1 ( AT1 ) receptors and reduce the pressor effects of gene in the vasculature .	T1	T16	12184062
NA	CHEMICAL	GENE-N	4	1	chemical receptor antagonists block chemical type 1 ( AT1 ) receptors and reduce the pressor effects of gene in the vasculature .	T7	T14	12184062
NA	CHEMICAL	GENE-Y	4	1	chemical receptor antagonists block chemical type 1 ( AT1 ) receptors and reduce the pressor effects of gene in the vasculature .	T7	T21	12184062
NA	CHEMICAL	GENE-Y	4	17	chemical receptor antagonists block chemical type 1 ( AT1 ) receptors and reduce the pressor effects of gene in the vasculature .	T7	T16	12184062
NA	CHEMICAL	GENE-N	18	1	chemical receptor antagonists block chemical type 1 ( AT1 ) receptors and reduce the pressor effects of gene in the vasculature .	T3	T14	12184062
NA	CHEMICAL	GENE-Y	18	1	chemical receptor antagonists block chemical type 1 ( AT1 ) receptors and reduce the pressor effects of gene in the vasculature .	T3	T21	12184062
NA	CHEMICAL	GENE-Y	18	17	chemical receptor antagonists block chemical type 1 ( AT1 ) receptors and reduce the pressor effects of gene in the vasculature .	T3	T16	12184062
NA	CHEMICAL	GENE-Y	10	11	By this mechanism , they induce similar pharmacological effects to chemical-converting enzyme ( gene ) inhibitors , resulting in a lowering of blood pressure ( BP ) .	T6	T17	12184062
NA	CHEMICAL	GENE-Y	10	13	By this mechanism , they induce similar pharmacological effects to chemical-converting enzyme ( gene ) inhibitors , resulting in a lowering of blood pressure ( BP ) .	T6	T18	12184062
NA	CHEMICAL	GENE-Y	0	6	chemical acts not only at vascular gene receptors but also at presynaptic gene receptors , causing inhibition of sympathetically stimulated chemical release .	T9	T24	12184062
NA	CHEMICAL	GENE-Y	0	12	chemical acts not only at vascular gene receptors but also at presynaptic gene receptors , causing inhibition of sympathetically stimulated chemical release .	T9	T25	12184062
NA	CHEMICAL	GENE-Y	20	6	chemical acts not only at vascular gene receptors but also at presynaptic gene receptors , causing inhibition of sympathetically stimulated chemical release .	T10	T24	12184062
NA	CHEMICAL	GENE-Y	20	12	chemical acts not only at vascular gene receptors but also at presynaptic gene receptors , causing inhibition of sympathetically stimulated chemical release .	T10	T25	12184062
NA	CHEMICAL	GENE-N	0	5	chemical is not metabolized by gene enzymes and therefore has a low potential for metabolic drug interactions , which may be of importance when treating the elderly and patients on multiple drugs .	T11	T26	12184062
CPR:4	CHEMICAL	GENE-Y	3	14	In clinical trials chemical has proven to be at least as effective as the gene inhibitor enalapril in reducing BP , but with a significantly lower incidence of side effects .	T2	T15	12184062
NA	CHEMICAL	GENE-N	9	0	gene-associated mechanisms underlying the response of embryonic cells to chemical .	T7	T21	23274771
NA	CHEMICAL	GENE-Y	14	10	Therefore , we tried to assess the involvement of the gene subunit of gene in the embryonic response to the anti-cancer drug chemical ( chemical ) .	T2	T10	23274771
NA	CHEMICAL	GENE-N	14	13	Therefore , we tried to assess the involvement of the gene subunit of gene in the embryonic response to the anti-cancer drug chemical ( chemical ) .	T2	T11	23274771
NA	CHEMICAL	GENE-Y	24	10	Therefore , we tried to assess the involvement of the gene subunit of gene in the embryonic response to the anti-cancer drug chemical ( chemical ) .	T3	T10	23274771
NA	CHEMICAL	GENE-N	24	13	Therefore , we tried to assess the involvement of the gene subunit of gene in the embryonic response to the anti-cancer drug chemical ( chemical ) .	T3	T11	23274771
NA	CHEMICAL	GENE-Y	25	4	Thus , exposure of gene knockout ( gene ( -/- ) ) or wild type ( WT ) mouse embryonic fibroblasts ( MEFs ) to chemical resulted in a decrease in cell survival , culture density and cell proliferation , which was found to be more prominent in gene ( -/- ) MEFs .	T4	T13	23274771
NA	CHEMICAL	GENE-Y	25	7	Thus , exposure of gene knockout ( gene ( -/- ) ) or wild type ( WT ) mouse embryonic fibroblasts ( MEFs ) to chemical resulted in a decrease in cell survival , culture density and cell proliferation , which was found to be more prominent in gene ( -/- ) MEFs .	T4	T14	23274771
NA	CHEMICAL	GENE-Y	25	48	Thus , exposure of gene knockout ( gene ( -/- ) ) or wild type ( WT ) mouse embryonic fibroblasts ( MEFs ) to chemical resulted in a decrease in cell survival , culture density and cell proliferation , which was found to be more prominent in gene ( -/- ) MEFs .	T4	T15	23274771
NA	CHEMICAL	GENE-Y	6	20	Those phenomena were accompanied by a chemical-induced increase in the proportion of apoptotic cells , which was demonstrated only in gene ( -/- ) cells and a G2/M arrest , which was found to be more prominent in WT cells .	T5	T16	23274771
NA	CHEMICAL	GENE-Y	2	5	Furthermore , chemical-treated WT and gene ( -/- ) MEFs differed in their expression of various apoptosis-associated molecules , when the former demonstrated a decrease in the percentage of gene-positive and a more prominent decrease in the percentage of gene-positive cells , while a decreased percentage of gene-positive and a more prominent decrease in the percentage of gene-positive cells was detected among the latter .	T6	T17	23274771
CPR:4	CHEMICAL	GENE-Y	2	29	Furthermore , chemical-treated WT and gene ( -/- ) MEFs differed in their expression of various apoptosis-associated molecules , when the former demonstrated a decrease in the percentage of gene-positive and a more prominent decrease in the percentage of gene-positive cells , while a decreased percentage of gene-positive and a more prominent decrease in the percentage of gene-positive cells was detected among the latter .	T6	T18	23274771
NA	CHEMICAL	GENE-Y	2	39	Furthermore , chemical-treated WT and gene ( -/- ) MEFs differed in their expression of various apoptosis-associated molecules , when the former demonstrated a decrease in the percentage of gene-positive and a more prominent decrease in the percentage of gene-positive cells , while a decreased percentage of gene-positive and a more prominent decrease in the percentage of gene-positive cells was detected among the latter .	T6	T19	23274771
NA	CHEMICAL	GENE-Y	2	47	Furthermore , chemical-treated WT and gene ( -/- ) MEFs differed in their expression of various apoptosis-associated molecules , when the former demonstrated a decrease in the percentage of gene-positive and a more prominent decrease in the percentage of gene-positive cells , while a decreased percentage of gene-positive and a more prominent decrease in the percentage of gene-positive cells was detected among the latter .	T6	T20	23274771
NA	CHEMICAL	GENE-Y	2	57	Furthermore , chemical-treated WT and gene ( -/- ) MEFs differed in their expression of various apoptosis-associated molecules , when the former demonstrated a decrease in the percentage of gene-positive and a more prominent decrease in the percentage of gene-positive cells , while a decreased percentage of gene-positive and a more prominent decrease in the percentage of gene-positive cells was detected among the latter .	T6	T8	23274771
NA	CHEMICAL	GENE-Y	8	22	Preclinical studies demonstrate that the therapeutic activity of chemical resides in the S-isomer and that chemical binds with high affinity to the gene .	T11	T22	12387707
NA	CHEMICAL	GENE-Y	15	22	Preclinical studies demonstrate that the therapeutic activity of chemical resides in the S-isomer and that chemical binds with high affinity to the gene .	T12	T22	12387707
NA	CHEMICAL	GENE-Y	10	22	Preclinical studies demonstrate that the therapeutic activity of chemical resides in the S-isomer and that chemical binds with high affinity to the gene .	T14	T22	12387707
NA	CHEMICAL	GENE-N	3	8	In addition , chemical has negligible effects on gene drug-metabolising enzymes in vitro , suggesting a low potential for drug-drug interactions .	T19	T23	12387707
CPR:4	CHEMICAL	GENE-Y	7	13	In contrast , in the presence of chemical UFH accelerated the inhibition of gene by gene 10-fold more efficiently than comparable concentrations of the high affinity fractions of enoxaparin and fragmin .	T1	T3	11287128
CPR:4	CHEMICAL	GENE-Y	7	3	In contrast , in the presence of chemical UFH accelerated the inhibition of gene by gene 10-fold more efficiently than comparable concentrations of the high affinity fractions of enoxaparin and fragmin .	T1	T4	11287128
NA	CHEMICAL	GENE-Y	0	6	chemical-induced apoptotic changes were evaluated by gene chemical nick end labeling ( TUNEL ) assay and its related mechanism was confirmed by Western blot analysis and colorimetric assay .	T4	T13	23386780
NA	CHEMICAL	GENE-Y	7	6	chemical-induced apoptotic changes were evaluated by gene chemical nick end labeling ( TUNEL ) assay and its related mechanism was confirmed by Western blot analysis and colorimetric assay .	T5	T13	23386780
NA	CHEMICAL	GENE-N	33	2	However , gene gene ( gene gene ) and gene ( gene ) expression increased at 8-24 h. gene and gene activities also increased at 8-48 h and 12-48 h , respectively , in the same manner as gene gene and gene expression .	T6	T17	23386780
NA	CHEMICAL	GENE-N	33	3	However , gene gene ( gene gene ) and gene ( gene ) expression increased at 8-24 h. gene and gene activities also increased at 8-48 h and 12-48 h , respectively , in the same manner as gene gene and gene expression .	T6	T18	23386780
NA	CHEMICAL	GENE-N	33	5	However , gene gene ( gene gene ) and gene ( gene ) expression increased at 8-24 h. gene and gene activities also increased at 8-48 h and 12-48 h , respectively , in the same manner as gene gene and gene expression .	T6	T19	23386780
NA	CHEMICAL	GENE-N	33	6	However , gene gene ( gene gene ) and gene ( gene ) expression increased at 8-24 h. gene and gene activities also increased at 8-48 h and 12-48 h , respectively , in the same manner as gene gene and gene expression .	T6	T20	23386780
NA	CHEMICAL	GENE-N	33	9	However , gene gene ( gene gene ) and gene ( gene ) expression increased at 8-24 h. gene and gene activities also increased at 8-48 h and 12-48 h , respectively , in the same manner as gene gene and gene expression .	T6	T21	23386780
NA	CHEMICAL	GENE-N	33	11	However , gene gene ( gene gene ) and gene ( gene ) expression increased at 8-24 h. gene and gene activities also increased at 8-48 h and 12-48 h , respectively , in the same manner as gene gene and gene expression .	T6	T22	23386780
NA	CHEMICAL	GENE-Y	33	18	However , gene gene ( gene gene ) and gene ( gene ) expression increased at 8-24 h. gene and gene activities also increased at 8-48 h and 12-48 h , respectively , in the same manner as gene gene and gene expression .	T6	T23	23386780
NA	CHEMICAL	GENE-Y	33	20	However , gene gene ( gene gene ) and gene ( gene ) expression increased at 8-24 h. gene and gene activities also increased at 8-48 h and 12-48 h , respectively , in the same manner as gene gene and gene expression .	T6	T8	23386780
NA	CHEMICAL	GENE-N	33	38	However , gene gene ( gene gene ) and gene ( gene ) expression increased at 8-24 h. gene and gene activities also increased at 8-48 h and 12-48 h , respectively , in the same manner as gene gene and gene expression .	T6	T9	23386780
NA	CHEMICAL	GENE-N	33	39	However , gene gene ( gene gene ) and gene ( gene ) expression increased at 8-24 h. gene and gene activities also increased at 8-48 h and 12-48 h , respectively , in the same manner as gene gene and gene expression .	T6	T10	23386780
NA	CHEMICAL	GENE-N	33	41	However , gene gene ( gene gene ) and gene ( gene ) expression increased at 8-24 h. gene and gene activities also increased at 8-48 h and 12-48 h , respectively , in the same manner as gene gene and gene expression .	T6	T11	23386780
CPR:6	CHEMICAL	GENE-Y	3	13	Compared pharmacological characteristics in humans of racemic chemical and chemical , two chemical H1-receptor antagonists .	T17	T21	14505791
CPR:6	CHEMICAL	GENE-Y	3	13	Compared pharmacological characteristics in humans of racemic chemical and chemical , two chemical H1-receptor antagonists .	T18	T21	14505791
NA	CHEMICAL	GENE-Y	3	13	Compared pharmacological characteristics in humans of racemic chemical and chemical , two chemical H1-receptor antagonists .	T19	T21	14505791
NA	CHEMICAL	GENE-Y	2	3	The potent chemical H ( 1 ) -receptor antagonist chemical ( chemical ) is a racemic mixture of chemical ( now available under the trademark chemical and chemical .	T3	T20	14505791
CPR:6	CHEMICAL	GENE-Y	9	3	The potent chemical H ( 1 ) -receptor antagonist chemical ( chemical ) is a racemic mixture of chemical ( now available under the trademark chemical and chemical .	T10	T20	14505791
CPR:6	CHEMICAL	GENE-Y	11	3	The potent chemical H ( 1 ) -receptor antagonist chemical ( chemical ) is a racemic mixture of chemical ( now available under the trademark chemical and chemical .	T11	T20	14505791
CPR:6	CHEMICAL	GENE-Y	18	3	The potent chemical H ( 1 ) -receptor antagonist chemical ( chemical ) is a racemic mixture of chemical ( now available under the trademark chemical and chemical .	T15	T20	14505791
CPR:6	CHEMICAL	GENE-Y	14	3	The potent chemical H ( 1 ) -receptor antagonist chemical ( chemical ) is a racemic mixture of chemical ( now available under the trademark chemical and chemical .	T6	T20	14505791
CPR:6	CHEMICAL	GENE-Y	27	3	The potent chemical H ( 1 ) -receptor antagonist chemical ( chemical ) is a racemic mixture of chemical ( now available under the trademark chemical and chemical .	T7	T20	14505791
CPR:4	CHEMICAL	GENE-N	6	12	Inhibition of angiogenesis and invasion by chemical is mediated by downregulation of gene and gene through gene pathway in MDA-MB-231 breast cancer cells .	T13	T23	23454149
CPR:4	CHEMICAL	GENE-Y	6	14	Inhibition of angiogenesis and invasion by chemical is mediated by downregulation of gene and gene through gene pathway in MDA-MB-231 breast cancer cells .	T13	T24	23454149
CPR:4	CHEMICAL	GENE-N	6	16	Inhibition of angiogenesis and invasion by chemical is mediated by downregulation of gene and gene through gene pathway in MDA-MB-231 breast cancer cells .	T13	T22	23454149
CPR:4	CHEMICAL	GENE-Y	4	10	Gelatin zymography showed that chemical inhibited secretion and activity of gene .	T11	T17	23454149
CPR:4	CHEMICAL	GENE-N	4	10	Western blotting demonstrated that chemical effectively suppressed the expression of gene , gene , gene , and gene .	T12	T18	23454149
CPR:4	CHEMICAL	GENE-Y	4	12	Western blotting demonstrated that chemical effectively suppressed the expression of gene , gene , gene , and gene .	T12	T19	23454149
CPR:4	CHEMICAL	GENE-Y	4	14	Western blotting demonstrated that chemical effectively suppressed the expression of gene , gene , gene , and gene .	T12	T20	23454149
CPR:4	CHEMICAL	GENE-N	4	17	Western blotting demonstrated that chemical effectively suppressed the expression of gene , gene , gene , and gene .	T12	T21	23454149
CPR:4	CHEMICAL	GENE-N	4	13	These results suggested that chemical could inhibit invasion and angiogenesis by downregulation of geneand gene , resulting from the inhibition of gene pathway .	T1	T14	23454149
CPR:4	CHEMICAL	GENE-Y	4	14	These results suggested that chemical could inhibit invasion and angiogenesis by downregulation of geneand gene , resulting from the inhibition of gene pathway .	T1	T15	23454149
CPR:4	CHEMICAL	GENE-N	4	21	These results suggested that chemical could inhibit invasion and angiogenesis by downregulation of geneand gene , resulting from the inhibition of gene pathway .	T1	T16	23454149
CPR:9	CHEMICAL	GENE-N	22	0	gene ( gene ) , a dimeric glycoprotein synthesized in the anterior pituitary gland , is important for the production of sex chemical and gametes .	T1	T3	11299519
CPR:9	CHEMICAL	GENE-N	22	2	gene ( gene ) , a dimeric glycoprotein synthesized in the anterior pituitary gland , is important for the production of sex chemical and gametes .	T1	T8	11299519
CPR:9	CHEMICAL	GENE-Y	27	2	Humans with gene gene mutations tend to have a more severe phenotype than those with gene gene mutations , although infertility and varying degrees of impaired sex chemical production occur in both types of mutations .	T2	T9	11299519
NA	CHEMICAL	GENE-Y	27	15	Humans with gene gene mutations tend to have a more severe phenotype than those with gene gene mutations , although infertility and varying degrees of impaired sex chemical production occur in both types of mutations .	T2	T10	11299519
NA	CHEMICAL	GENE-Y	11	13	These variants are expected to encode either a full length ( gene ) or shortened protein lacking 22 chemical-terminus chemical ( gene ) .	T3	T18	23531488
NA	CHEMICAL	GENE-Y	7	13	These variants are expected to encode either a full length ( gene ) or shortened protein lacking 22 chemical-terminus chemical ( gene ) .	T4	T18	23531488
CPR:9	CHEMICAL	GENE-Y	1	16	Using a transient heterologous cell expression system , we find that the transport activities of the gene variant towards substrates chemical and chemical are similar to the well-characterized full length variant .	T1	T7	23531488
CPR:9	CHEMICAL	GENE-Y	1	16	Using a transient heterologous cell expression system , we find that the transport activities of the gene variant towards substrates chemical and chemical are similar to the well-characterized full length variant .	T2	T7	23531488
NA	CHEMICAL	GENE-Y	6	17	Anxiolytic- but not antidepressant-like activity of chemical , a novel , selective positive allosteric modulator of the gene receptor .	T15	T22	22634361
CPR:5	CHEMICAL	GENE-N	9	5	Previous studies demonstrated that the gene-selective orthosteric agonist , chemical produced anxiolytic- but not antidepressant-like effects upon peripheral administration .	T14	T18	22634361
NA	CHEMICAL	GENE-Y	8	20	Herein , we report the pharmacological actions of chemical , a novel , selective , and brain-penetrant positive allosteric modulator ( PAM ) of the gene receptor in the stress-induced hyperthermia ( SIH ) , four-plate , marble-burying and Vogel 's conflict tests .	T4	T17	22634361
NA	CHEMICAL	GENE-Y	4	18	The anti-hyperthermic effect of chemical ( 5 mg/kg ) in the SIH test was inhibited by the chemical receptor antagonist chemical ( 10 mg/kg ) and was not chemical-dependent , as it persisted in chemical-deficient mice and upon blockade of either chemical ( 1A ) receptors by chemical , or chemical ( 2A/2C ) receptors by chemical .	T5	T19	22634361
NA	CHEMICAL	GENE-Y	4	5	The anti-hyperthermic effect of chemical ( 5 mg/kg ) in the SIH test was inhibited by the chemical receptor antagonist chemical ( 10 mg/kg ) and was not chemical-dependent , as it persisted in chemical-deficient mice and upon blockade of either chemical ( 1A ) receptors by chemical , or chemical ( 2A/2C ) receptors by chemical .	T5	T20	22634361
NA	CHEMICAL	GENE-N	4	5	The anti-hyperthermic effect of chemical ( 5 mg/kg ) in the SIH test was inhibited by the chemical receptor antagonist chemical ( 10 mg/kg ) and was not chemical-dependent , as it persisted in chemical-deficient mice and upon blockade of either chemical ( 1A ) receptors by chemical , or chemical ( 2A/2C ) receptors by chemical .	T5	T21	22634361
NA	CHEMICAL	GENE-Y	9	18	The anti-hyperthermic effect of chemical ( 5 mg/kg ) in the SIH test was inhibited by the chemical receptor antagonist chemical ( 10 mg/kg ) and was not chemical-dependent , as it persisted in chemical-deficient mice and upon blockade of either chemical ( 1A ) receptors by chemical , or chemical ( 2A/2C ) receptors by chemical .	T6	T19	22634361
NA	CHEMICAL	GENE-Y	9	5	The anti-hyperthermic effect of chemical ( 5 mg/kg ) in the SIH test was inhibited by the chemical receptor antagonist chemical ( 10 mg/kg ) and was not chemical-dependent , as it persisted in chemical-deficient mice and upon blockade of either chemical ( 1A ) receptors by chemical , or chemical ( 2A/2C ) receptors by chemical .	T6	T20	22634361
NA	CHEMICAL	GENE-N	9	5	The anti-hyperthermic effect of chemical ( 5 mg/kg ) in the SIH test was inhibited by the chemical receptor antagonist chemical ( 10 mg/kg ) and was not chemical-dependent , as it persisted in chemical-deficient mice and upon blockade of either chemical ( 1A ) receptors by chemical , or chemical ( 2A/2C ) receptors by chemical .	T6	T21	22634361
CPR:6	CHEMICAL	GENE-Y	20	18	The anti-hyperthermic effect of chemical ( 5 mg/kg ) in the SIH test was inhibited by the chemical receptor antagonist chemical ( 10 mg/kg ) and was not chemical-dependent , as it persisted in chemical-deficient mice and upon blockade of either chemical ( 1A ) receptors by chemical , or chemical ( 2A/2C ) receptors by chemical .	T7	T19	22634361
NA	CHEMICAL	GENE-Y	20	5	The anti-hyperthermic effect of chemical ( 5 mg/kg ) in the SIH test was inhibited by the chemical receptor antagonist chemical ( 10 mg/kg ) and was not chemical-dependent , as it persisted in chemical-deficient mice and upon blockade of either chemical ( 1A ) receptors by chemical , or chemical ( 2A/2C ) receptors by chemical .	T7	T20	22634361
NA	CHEMICAL	GENE-N	20	5	The anti-hyperthermic effect of chemical ( 5 mg/kg ) in the SIH test was inhibited by the chemical receptor antagonist chemical ( 10 mg/kg ) and was not chemical-dependent , as it persisted in chemical-deficient mice and upon blockade of either chemical ( 1A ) receptors by chemical , or chemical ( 2A/2C ) receptors by chemical .	T7	T21	22634361
NA	CHEMICAL	GENE-Y	9	18	The anti-hyperthermic effect of chemical ( 5 mg/kg ) in the SIH test was inhibited by the chemical receptor antagonist chemical ( 10 mg/kg ) and was not chemical-dependent , as it persisted in chemical-deficient mice and upon blockade of either chemical ( 1A ) receptors by chemical , or chemical ( 2A/2C ) receptors by chemical .	T8	T19	22634361
NA	CHEMICAL	GENE-Y	9	5	The anti-hyperthermic effect of chemical ( 5 mg/kg ) in the SIH test was inhibited by the chemical receptor antagonist chemical ( 10 mg/kg ) and was not chemical-dependent , as it persisted in chemical-deficient mice and upon blockade of either chemical ( 1A ) receptors by chemical , or chemical ( 2A/2C ) receptors by chemical .	T8	T20	22634361
NA	CHEMICAL	GENE-N	9	5	The anti-hyperthermic effect of chemical ( 5 mg/kg ) in the SIH test was inhibited by the chemical receptor antagonist chemical ( 10 mg/kg ) and was not chemical-dependent , as it persisted in chemical-deficient mice and upon blockade of either chemical ( 1A ) receptors by chemical , or chemical ( 2A/2C ) receptors by chemical .	T8	T21	22634361
NA	CHEMICAL	GENE-Y	9	18	The anti-hyperthermic effect of chemical ( 5 mg/kg ) in the SIH test was inhibited by the chemical receptor antagonist chemical ( 10 mg/kg ) and was not chemical-dependent , as it persisted in chemical-deficient mice and upon blockade of either chemical ( 1A ) receptors by chemical , or chemical ( 2A/2C ) receptors by chemical .	T9	T19	22634361
NA	CHEMICAL	GENE-Y	9	5	The anti-hyperthermic effect of chemical ( 5 mg/kg ) in the SIH test was inhibited by the chemical receptor antagonist chemical ( 10 mg/kg ) and was not chemical-dependent , as it persisted in chemical-deficient mice and upon blockade of either chemical ( 1A ) receptors by chemical , or chemical ( 2A/2C ) receptors by chemical .	T9	T20	22634361
NA	CHEMICAL	GENE-N	9	5	The anti-hyperthermic effect of chemical ( 5 mg/kg ) in the SIH test was inhibited by the chemical receptor antagonist chemical ( 10 mg/kg ) and was not chemical-dependent , as it persisted in chemical-deficient mice and upon blockade of either chemical ( 1A ) receptors by chemical , or chemical ( 2A/2C ) receptors by chemical .	T9	T21	22634361
NA	CHEMICAL	GENE-Y	6	18	The anti-hyperthermic effect of chemical ( 5 mg/kg ) in the SIH test was inhibited by the chemical receptor antagonist chemical ( 10 mg/kg ) and was not chemical-dependent , as it persisted in chemical-deficient mice and upon blockade of either chemical ( 1A ) receptors by chemical , or chemical ( 2A/2C ) receptors by chemical .	T10	T19	22634361
NA	CHEMICAL	GENE-Y	6	5	The anti-hyperthermic effect of chemical ( 5 mg/kg ) in the SIH test was inhibited by the chemical receptor antagonist chemical ( 10 mg/kg ) and was not chemical-dependent , as it persisted in chemical-deficient mice and upon blockade of either chemical ( 1A ) receptors by chemical , or chemical ( 2A/2C ) receptors by chemical .	T10	T20	22634361
NA	CHEMICAL	GENE-N	6	5	The anti-hyperthermic effect of chemical ( 5 mg/kg ) in the SIH test was inhibited by the chemical receptor antagonist chemical ( 10 mg/kg ) and was not chemical-dependent , as it persisted in chemical-deficient mice and upon blockade of either chemical ( 1A ) receptors by chemical , or chemical ( 2A/2C ) receptors by chemical .	T10	T21	22634361
NA	CHEMICAL	GENE-Y	6	18	The anti-hyperthermic effect of chemical ( 5 mg/kg ) in the SIH test was inhibited by the chemical receptor antagonist chemical ( 10 mg/kg ) and was not chemical-dependent , as it persisted in chemical-deficient mice and upon blockade of either chemical ( 1A ) receptors by chemical , or chemical ( 2A/2C ) receptors by chemical .	T11	T19	22634361
CPR:4	CHEMICAL	GENE-Y	6	5	The anti-hyperthermic effect of chemical ( 5 mg/kg ) in the SIH test was inhibited by the chemical receptor antagonist chemical ( 10 mg/kg ) and was not chemical-dependent , as it persisted in chemical-deficient mice and upon blockade of either chemical ( 1A ) receptors by chemical , or chemical ( 2A/2C ) receptors by chemical .	T11	T20	22634361
NA	CHEMICAL	GENE-N	6	5	The anti-hyperthermic effect of chemical ( 5 mg/kg ) in the SIH test was inhibited by the chemical receptor antagonist chemical ( 10 mg/kg ) and was not chemical-dependent , as it persisted in chemical-deficient mice and upon blockade of either chemical ( 1A ) receptors by chemical , or chemical ( 2A/2C ) receptors by chemical .	T11	T21	22634361
NA	CHEMICAL	GENE-Y	6	18	The anti-hyperthermic effect of chemical ( 5 mg/kg ) in the SIH test was inhibited by the chemical receptor antagonist chemical ( 10 mg/kg ) and was not chemical-dependent , as it persisted in chemical-deficient mice and upon blockade of either chemical ( 1A ) receptors by chemical , or chemical ( 2A/2C ) receptors by chemical .	T12	T19	22634361
NA	CHEMICAL	GENE-Y	6	5	The anti-hyperthermic effect of chemical ( 5 mg/kg ) in the SIH test was inhibited by the chemical receptor antagonist chemical ( 10 mg/kg ) and was not chemical-dependent , as it persisted in chemical-deficient mice and upon blockade of either chemical ( 1A ) receptors by chemical , or chemical ( 2A/2C ) receptors by chemical .	T12	T20	22634361
NA	CHEMICAL	GENE-N	6	5	The anti-hyperthermic effect of chemical ( 5 mg/kg ) in the SIH test was inhibited by the chemical receptor antagonist chemical ( 10 mg/kg ) and was not chemical-dependent , as it persisted in chemical-deficient mice and upon blockade of either chemical ( 1A ) receptors by chemical , or chemical ( 2A/2C ) receptors by chemical .	T12	T21	22634361
NA	CHEMICAL	GENE-Y	9	18	The anti-hyperthermic effect of chemical ( 5 mg/kg ) in the SIH test was inhibited by the chemical receptor antagonist chemical ( 10 mg/kg ) and was not chemical-dependent , as it persisted in chemical-deficient mice and upon blockade of either chemical ( 1A ) receptors by chemical , or chemical ( 2A/2C ) receptors by chemical .	T13	T19	22634361
NA	CHEMICAL	GENE-Y	9	5	The anti-hyperthermic effect of chemical ( 5 mg/kg ) in the SIH test was inhibited by the chemical receptor antagonist chemical ( 10 mg/kg ) and was not chemical-dependent , as it persisted in chemical-deficient mice and upon blockade of either chemical ( 1A ) receptors by chemical , or chemical ( 2A/2C ) receptors by chemical .	T13	T20	22634361
CPR:4	CHEMICAL	GENE-N	9	5	The anti-hyperthermic effect of chemical ( 5 mg/kg ) in the SIH test was inhibited by the chemical receptor antagonist chemical ( 10 mg/kg ) and was not chemical-dependent , as it persisted in chemical-deficient mice and upon blockade of either chemical ( 1A ) receptors by chemical , or chemical ( 2A/2C ) receptors by chemical .	T13	T21	22634361
NA	CHEMICAL	GENE-Y	0	1	chemical hydroxylase binds chemical cofactor with negative cooperativity , as shown by kinetic analyses and surface plasmon resonance detection .	T21	T29	10411647
NA	CHEMICAL	GENE-Y	3	1	chemical hydroxylase binds chemical cofactor with negative cooperativity , as shown by kinetic analyses and surface plasmon resonance detection .	T22	T29	10411647
CPR:9	CHEMICAL	GENE-N	3	5	On phosphorylation of chemical by gene , the affinity for chemical increased ( [ S ] 0.5 = 11 +/- 2 microM ) and the negative cooperativity was amplified ( h = 0.27 +/- 0.03 ) .	T15	T26	10411647
NA	CHEMICAL	GENE-N	10	5	On phosphorylation of chemical by gene , the affinity for chemical increased ( [ S ] 0.5 = 11 +/- 2 microM ) and the negative cooperativity was amplified ( h = 0.27 +/- 0.03 ) .	T16	T26	10411647
NA	CHEMICAL	GENE-Y	2	9	The dimeric chemical-terminal deletion mutant ( Delta473-528 ) of gene also showed negative cooperativity of chemical binding ( h = 0.4 ) .	T17	T27	10411647
NA	CHEMICAL	GENE-Y	15	9	The dimeric chemical-terminal deletion mutant ( Delta473-528 ) of gene also showed negative cooperativity of chemical binding ( h = 0.4 ) .	T18	T27	10411647
NA	CHEMICAL	GENE-Y	17	13	Infrared spectroscopic studies revealed a reduced thermal stability both of the apo-and the holo-gene on binding of chemical and chemical ( chemical ) .	T5	T23	10411647
NA	CHEMICAL	GENE-Y	19	13	Infrared spectroscopic studies revealed a reduced thermal stability both of the apo-and the holo-gene on binding of chemical and chemical ( chemical ) .	T6	T23	10411647
NA	CHEMICAL	GENE-Y	21	13	Infrared spectroscopic studies revealed a reduced thermal stability both of the apo-and the holo-gene on binding of chemical and chemical ( chemical ) .	T7	T23	10411647
NA	CHEMICAL	GENE-N	8	10	Previous reports have identified a role for the chemical kinase receptor gene and its ligand , gene , as potential mediators of both bone formation by osteoblasts and bone resorption by osteoclasts .	T1	T14	23165754
NA	CHEMICAL	GENE-Y	8	11	Previous reports have identified a role for the chemical kinase receptor gene and its ligand , gene , as potential mediators of both bone formation by osteoblasts and bone resorption by osteoclasts .	T1	T19	23165754
NA	CHEMICAL	GENE-Y	8	16	Previous reports have identified a role for the chemical kinase receptor gene and its ligand , gene , as potential mediators of both bone formation by osteoblasts and bone resorption by osteoclasts .	T1	T20	23165754
NA	CHEMICAL	GENE-Y	15	0	gene produced by a vector containing the full coding sequence , which includes a possible chemical-terminal mitochondrial targeting signal , was proteolytically processed by E. coli and contained several chemical-terminal ends .	T8	T23	7929150
NA	CHEMICAL	GENE-Y	3	0	gene produced by a vector containing the full coding sequence , which includes a possible chemical-terminal mitochondrial targeting signal , was proteolytically processed by E. coli and contained several chemical-terminal ends .	T9	T23	7929150
NA	CHEMICAL	GENE-Y	2	28	The two chemical-terminal truncated vectors deleted , respectively , 1 ) the 29-chemical putative targeting sequence and 2 ) 51 chemical , yielding a protein equivalent to a gene isolated from mouse liver mitochondria ; and both vectors produced homogeneous protein fractions .	T10	T24	7929150
NA	CHEMICAL	GENE-Y	12	28	The two chemical-terminal truncated vectors deleted , respectively , 1 ) the 29-chemical putative targeting sequence and 2 ) 51 chemical , yielding a protein equivalent to a gene isolated from mouse liver mitochondria ; and both vectors produced homogeneous protein fractions .	T11	T24	7929150
NA	CHEMICAL	GENE-Y	20	28	The two chemical-terminal truncated vectors deleted , respectively , 1 ) the 29-chemical putative targeting sequence and 2 ) 51 chemical , yielding a protein equivalent to a gene isolated from mouse liver mitochondria ; and both vectors produced homogeneous protein fractions .	T12	T24	7929150
NA	CHEMICAL	GENE-Y	14	5	These latter two forms of gene had identical steady-state constants for the hydration of chemical , with maximal values of kcat/Km at 3 x 10 ( 7 ) M-1 s-1 and kcat at 3 x 10 ( 5 ) s-1 with an apparent pKa for catalysis of 7.4 determined from kcat/Km .	T13	T25	7929150
NA	CHEMICAL	GENE-Y	4	4	In catalytic properties , gene is closest to gene ; however , in inhibition by chemical , chemical , and chemical , gene is very similar to gene .	T1	T14	7929150
NA	CHEMICAL	GENE-Y	4	8	In catalytic properties , gene is closest to gene ; however , in inhibition by chemical , chemical , and chemical , gene is very similar to gene .	T1	T15	7929150
CPR:4	CHEMICAL	GENE-Y	4	22	In catalytic properties , gene is closest to gene ; however , in inhibition by chemical , chemical , and chemical , gene is very similar to gene .	T1	T16	7929150
CPR:4	CHEMICAL	GENE-Y	4	27	In catalytic properties , gene is closest to gene ; however , in inhibition by chemical , chemical , and chemical , gene is very similar to gene .	T1	T17	7929150
NA	CHEMICAL	GENE-Y	17	4	In catalytic properties , gene is closest to gene ; however , in inhibition by chemical , chemical , and chemical , gene is very similar to gene .	T2	T14	7929150
NA	CHEMICAL	GENE-Y	17	8	In catalytic properties , gene is closest to gene ; however , in inhibition by chemical , chemical , and chemical , gene is very similar to gene .	T2	T15	7929150
CPR:4	CHEMICAL	GENE-Y	17	22	In catalytic properties , gene is closest to gene ; however , in inhibition by chemical , chemical , and chemical , gene is very similar to gene .	T2	T16	7929150
CPR:4	CHEMICAL	GENE-Y	17	27	In catalytic properties , gene is closest to gene ; however , in inhibition by chemical , chemical , and chemical , gene is very similar to gene .	T2	T17	7929150
NA	CHEMICAL	GENE-Y	20	4	In catalytic properties , gene is closest to gene ; however , in inhibition by chemical , chemical , and chemical , gene is very similar to gene .	T3	T14	7929150
NA	CHEMICAL	GENE-Y	20	8	In catalytic properties , gene is closest to gene ; however , in inhibition by chemical , chemical , and chemical , gene is very similar to gene .	T3	T15	7929150
CPR:4	CHEMICAL	GENE-Y	20	22	In catalytic properties , gene is closest to gene ; however , in inhibition by chemical , chemical , and chemical , gene is very similar to gene .	T3	T16	7929150
CPR:4	CHEMICAL	GENE-Y	20	27	In catalytic properties , gene is closest to gene ; however , in inhibition by chemical , chemical , and chemical , gene is very similar to gene .	T3	T17	7929150
NA	CHEMICAL	GENE-Y	15	0	gene has a tyrosine at position 64 , where the highly active isozyme II has chemical serving as a proton shuttle in the catalytic pathway .	T4	T18	7929150
CPR:4	CHEMICAL	GENE-N	0	2	chemical , a gene inhibitor , arrests cell division and causes apoptosis in non-small lung cancer cells [ 283660 ] .	T2	T11	18465538
CPR:4	CHEMICAL	GENE-Y	29	14	In ex vivo experiments with tumor cells from refractory chronic lymphoblastic leukemia , dose-dependent gene inhibition associated with apoptotic changes was seen at concentrations greater than 100 nM of chemical .	T5	T12	18465538
CPR:4	CHEMICAL	GENE-N	0	2	chemical inhibits gene with an IC50 value of 0.4 mM [ 285707 ] .	T9	T13	18465538
CPR:3	CHEMICAL	GENE-Y	8	6	It was found that expression of gene protein in cortical neurons was increased in chemical-induced diabetes mellitus rat model .	T3	T16	23333261
NA	CHEMICAL	GENE-Y	10	4	The expression pattern of gene and gene correspond to 50mmol/L chemical ( hyperglycaemia ) was also found in primary cultured neurons .	T4	T19	23333261
NA	CHEMICAL	GENE-Y	10	6	The expression pattern of gene and gene correspond to 50mmol/L chemical ( hyperglycaemia ) was also found in primary cultured neurons .	T4	T20	23333261
CPR:3	CHEMICAL	GENE-Y	2	4	Moreover , chemical alleviated gene expression , and reversely raised gene expression in neurons treated with hyperglycaemia .	T1	T6	23333261
CPR:3	CHEMICAL	GENE-Y	2	10	Moreover , chemical alleviated gene expression , and reversely raised gene expression in neurons treated with hyperglycaemia .	T1	T7	23333261
CPR:4	CHEMICAL	GENE-Y	1	6	Previously , we showed that the gene ( gene ) stably expressed in Chinese hamster ovary ( CHO ) cells underwent down-regulation after prolonged chemical treatment .	T9	T34	10999950
CPR:4	CHEMICAL	GENE-Y	1	8	Previously , we showed that the gene ( gene ) stably expressed in Chinese hamster ovary ( CHO ) cells underwent down-regulation after prolonged chemical treatment .	T9	T38	10999950
CPR:4	CHEMICAL	GENE-Y	0	7	chemical caused a significant down-regulation of the gene , although chemical did not .	T10	T33	10999950
NA	CHEMICAL	GENE-Y	10	7	chemical caused a significant down-regulation of the gene , although chemical did not .	T11	T33	10999950
NA	CHEMICAL	GENE-Y	1	8	Neither chemical nor chemical caused down-regulation of the gene .	T12	T35	10999950
NA	CHEMICAL	GENE-Y	3	8	Neither chemical nor chemical caused down-regulation of the gene .	T13	T35	10999950
NA	CHEMICAL	GENE-Y	14	6	Expression of the dominant negative mutants gene ( 319-418 ) or gene-gene significantly reduced chemical-induced down-regulation of the gene .	T14	T37	10999950
NA	CHEMICAL	GENE-Y	14	11	Expression of the dominant negative mutants gene ( 319-418 ) or gene-gene significantly reduced chemical-induced down-regulation of the gene .	T14	T39	10999950
NA	CHEMICAL	GENE-N	14	11	Expression of the dominant negative mutants gene ( 319-418 ) or gene-gene significantly reduced chemical-induced down-regulation of the gene .	T14	T40	10999950
CPR:4	CHEMICAL	GENE-Y	14	10	Expression of the dominant negative mutants gene ( 319-418 ) or gene-gene significantly reduced chemical-induced down-regulation of the gene .	T14	T41	10999950
NA	CHEMICAL	GENE-Y	3	2	Coexpression of gene or gene and gene permitted chemical to induce down-regulation of the gene , although expression of gene or gene alone did not .	T15	T42	10999950
NA	CHEMICAL	GENE-Y	3	4	Coexpression of gene or gene and gene permitted chemical to induce down-regulation of the gene , although expression of gene or gene alone did not .	T15	T43	10999950
NA	CHEMICAL	GENE-Y	3	6	Coexpression of gene or gene and gene permitted chemical to induce down-regulation of the gene , although expression of gene or gene alone did not .	T15	T44	10999950
CPR:4	CHEMICAL	GENE-Y	3	3	Coexpression of gene or gene and gene permitted chemical to induce down-regulation of the gene , although expression of gene or gene alone did not .	T15	T45	10999950
NA	CHEMICAL	GENE-Y	3	19	Coexpression of gene or gene and gene permitted chemical to induce down-regulation of the gene , although expression of gene or gene alone did not .	T15	T46	10999950
NA	CHEMICAL	GENE-Y	3	21	Coexpression of gene or gene and gene permitted chemical to induce down-regulation of the gene , although expression of gene or gene alone did not .	T15	T47	10999950
CPR:4	CHEMICAL	GENE-Y	10	6	Expression of the dominant negative mutants gene-gene or gene-gene blunted chemical-induced down-regulation .	T16	T48	10999950
CPR:4	CHEMICAL	GENE-N	10	6	Expression of the dominant negative mutants gene-gene or gene-gene blunted chemical-induced down-regulation .	T16	T49	10999950
CPR:4	CHEMICAL	GENE-N	10	8	Expression of the dominant negative mutants gene-gene or gene-gene blunted chemical-induced down-regulation .	T16	T50	10999950
CPR:4	CHEMICAL	GENE-N	10	8	Expression of the dominant negative mutants gene-gene or gene-gene blunted chemical-induced down-regulation .	T16	T51	10999950
NA	CHEMICAL	GENE-N	5	7	Pretreatment with lysosomal enzyme inhibitors chemical or gene inhibitors ( gene inhibitor I , chemical , or chemical ) decreased the extent of chemical-induced down-regulation .	T1	T17	10999950
NA	CHEMICAL	GENE-N	5	10	Pretreatment with lysosomal enzyme inhibitors chemical or gene inhibitors ( gene inhibitor I , chemical , or chemical ) decreased the extent of chemical-induced down-regulation .	T1	T18	10999950
NA	CHEMICAL	GENE-N	14	7	Pretreatment with lysosomal enzyme inhibitors chemical or gene inhibitors ( gene inhibitor I , chemical , or chemical ) decreased the extent of chemical-induced down-regulation .	T2	T17	10999950
CPR:4	CHEMICAL	GENE-N	14	10	Pretreatment with lysosomal enzyme inhibitors chemical or gene inhibitors ( gene inhibitor I , chemical , or chemical ) decreased the extent of chemical-induced down-regulation .	T2	T18	10999950
NA	CHEMICAL	GENE-N	17	7	Pretreatment with lysosomal enzyme inhibitors chemical or gene inhibitors ( gene inhibitor I , chemical , or chemical ) decreased the extent of chemical-induced down-regulation .	T3	T17	10999950
CPR:4	CHEMICAL	GENE-N	17	10	Pretreatment with lysosomal enzyme inhibitors chemical or gene inhibitors ( gene inhibitor I , chemical , or chemical ) decreased the extent of chemical-induced down-regulation .	T3	T18	10999950
NA	CHEMICAL	GENE-N	13	7	Pretreatment with lysosomal enzyme inhibitors chemical or gene inhibitors ( gene inhibitor I , chemical , or chemical ) decreased the extent of chemical-induced down-regulation .	T4	T17	10999950
NA	CHEMICAL	GENE-N	13	10	Pretreatment with lysosomal enzyme inhibitors chemical or gene inhibitors ( gene inhibitor I , chemical , or chemical ) decreased the extent of chemical-induced down-regulation .	T4	T18	10999950
NA	CHEMICAL	GENE-N	3	5	A combination of chemical and gene inhibitor I abolished chemical-induced down-regulation .	T5	T19	10999950
NA	CHEMICAL	GENE-N	9	5	A combination of chemical and gene inhibitor I abolished chemical-induced down-regulation .	T6	T19	10999950
CPR:4	CHEMICAL	GENE-Y	4	8	These results indicate that chemical-induced down-regulation of the gene involves gene- , gene- , gene- , gene- , and gene-dependent mechanisms and receptors seem to be trafficked to lysosomes and gene for degradation .	T7	T20	10999950
NA	CHEMICAL	GENE-N	4	10	These results indicate that chemical-induced down-regulation of the gene involves gene- , gene- , gene- , gene- , and gene-dependent mechanisms and receptors seem to be trafficked to lysosomes and gene for degradation .	T7	T21	10999950
NA	CHEMICAL	GENE-Y	4	12	These results indicate that chemical-induced down-regulation of the gene involves gene- , gene- , gene- , gene- , and gene-dependent mechanisms and receptors seem to be trafficked to lysosomes and gene for degradation .	T7	T22	10999950
NA	CHEMICAL	GENE-N	4	14	These results indicate that chemical-induced down-regulation of the gene involves gene- , gene- , gene- , gene- , and gene-dependent mechanisms and receptors seem to be trafficked to lysosomes and gene for degradation .	T7	T23	10999950
NA	CHEMICAL	GENE-N	4	16	These results indicate that chemical-induced down-regulation of the gene involves gene- , gene- , gene- , gene- , and gene-dependent mechanisms and receptors seem to be trafficked to lysosomes and gene for degradation .	T7	T24	10999950
NA	CHEMICAL	GENE-N	4	19	These results indicate that chemical-induced down-regulation of the gene involves gene- , gene- , gene- , gene- , and gene-dependent mechanisms and receptors seem to be trafficked to lysosomes and gene for degradation .	T7	T25	10999950
NA	CHEMICAL	GENE-N	4	30	These results indicate that chemical-induced down-regulation of the gene involves gene- , gene- , gene- , gene- , and gene-dependent mechanisms and receptors seem to be trafficked to lysosomes and gene for degradation .	T7	T26	10999950
CPR:4	CHEMICAL	GENE-Y	1	8	Thus , chemical-induced internalization and down-regulation of the gene share initial common mechanisms .	T8	T27	10999950
CPR:5	CHEMICAL	GENE-Y	6	4	Cardiac effects of the gene agonist chemical in man .	T17	T27	7912539
CPR:5	CHEMICAL	GENE-Y	16	7	The aim of the present study was to evaluate the cardiac effects of the gene agonist chemical , and determine whether gene are involved in mediating chronotropic or inotropic responses in man .	T1	T25	7912539
NA	CHEMICAL	GENE-Y	16	7	The aim of the present study was to evaluate the cardiac effects of the gene agonist chemical , and determine whether gene are involved in mediating chronotropic or inotropic responses in man .	T1	T20	7912539
NA	CHEMICAL	GENE-Y	8	14	Eight normal males received single oral doses of chemical 8 mg ( chemical ) or the selective gene agonist chemical 8 mg ( chemical ) , after pretreatment with either placebo ( PL ) , chemical 5 mg ( B5 ) as a selective gene antagonist , or chemical 20 mg ( N20 ) to block gene .	T5	T21	7912539
NA	CHEMICAL	GENE-Y	8	14	Eight normal males received single oral doses of chemical 8 mg ( chemical ) or the selective gene agonist chemical 8 mg ( chemical ) , after pretreatment with either placebo ( PL ) , chemical 5 mg ( B5 ) as a selective gene antagonist , or chemical 20 mg ( N20 ) to block gene .	T5	T22	7912539
NA	CHEMICAL	GENE-N	8	14	Eight normal males received single oral doses of chemical 8 mg ( chemical ) or the selective gene agonist chemical 8 mg ( chemical ) , after pretreatment with either placebo ( PL ) , chemical 5 mg ( B5 ) as a selective gene antagonist , or chemical 20 mg ( N20 ) to block gene .	T5	T23	7912539
NA	CHEMICAL	GENE-Y	12	14	Eight normal males received single oral doses of chemical 8 mg ( chemical ) or the selective gene agonist chemical 8 mg ( chemical ) , after pretreatment with either placebo ( PL ) , chemical 5 mg ( B5 ) as a selective gene antagonist , or chemical 20 mg ( N20 ) to block gene .	T6	T21	7912539
NA	CHEMICAL	GENE-Y	12	14	Eight normal males received single oral doses of chemical 8 mg ( chemical ) or the selective gene agonist chemical 8 mg ( chemical ) , after pretreatment with either placebo ( PL ) , chemical 5 mg ( B5 ) as a selective gene antagonist , or chemical 20 mg ( N20 ) to block gene .	T6	T22	7912539
NA	CHEMICAL	GENE-N	12	14	Eight normal males received single oral doses of chemical 8 mg ( chemical ) or the selective gene agonist chemical 8 mg ( chemical ) , after pretreatment with either placebo ( PL ) , chemical 5 mg ( B5 ) as a selective gene antagonist , or chemical 20 mg ( N20 ) to block gene .	T6	T23	7912539
CPR:5	CHEMICAL	GENE-Y	19	14	Eight normal males received single oral doses of chemical 8 mg ( chemical ) or the selective gene agonist chemical 8 mg ( chemical ) , after pretreatment with either placebo ( PL ) , chemical 5 mg ( B5 ) as a selective gene antagonist , or chemical 20 mg ( N20 ) to block gene .	T7	T21	7912539
NA	CHEMICAL	GENE-Y	19	14	Eight normal males received single oral doses of chemical 8 mg ( chemical ) or the selective gene agonist chemical 8 mg ( chemical ) , after pretreatment with either placebo ( PL ) , chemical 5 mg ( B5 ) as a selective gene antagonist , or chemical 20 mg ( N20 ) to block gene .	T7	T22	7912539
NA	CHEMICAL	GENE-N	19	14	Eight normal males received single oral doses of chemical 8 mg ( chemical ) or the selective gene agonist chemical 8 mg ( chemical ) , after pretreatment with either placebo ( PL ) , chemical 5 mg ( B5 ) as a selective gene antagonist , or chemical 20 mg ( N20 ) to block gene .	T7	T23	7912539
CPR:5	CHEMICAL	GENE-Y	23	14	Eight normal males received single oral doses of chemical 8 mg ( chemical ) or the selective gene agonist chemical 8 mg ( chemical ) , after pretreatment with either placebo ( PL ) , chemical 5 mg ( B5 ) as a selective gene antagonist , or chemical 20 mg ( N20 ) to block gene .	T8	T21	7912539
NA	CHEMICAL	GENE-Y	23	14	Eight normal males received single oral doses of chemical 8 mg ( chemical ) or the selective gene agonist chemical 8 mg ( chemical ) , after pretreatment with either placebo ( PL ) , chemical 5 mg ( B5 ) as a selective gene antagonist , or chemical 20 mg ( N20 ) to block gene .	T8	T22	7912539
NA	CHEMICAL	GENE-N	23	14	Eight normal males received single oral doses of chemical 8 mg ( chemical ) or the selective gene agonist chemical 8 mg ( chemical ) , after pretreatment with either placebo ( PL ) , chemical 5 mg ( B5 ) as a selective gene antagonist , or chemical 20 mg ( N20 ) to block gene .	T8	T23	7912539
NA	CHEMICAL	GENE-Y	35	14	Eight normal males received single oral doses of chemical 8 mg ( chemical ) or the selective gene agonist chemical 8 mg ( chemical ) , after pretreatment with either placebo ( PL ) , chemical 5 mg ( B5 ) as a selective gene antagonist , or chemical 20 mg ( N20 ) to block gene .	T9	T21	7912539
CPR:6	CHEMICAL	GENE-Y	35	14	Eight normal males received single oral doses of chemical 8 mg ( chemical ) or the selective gene agonist chemical 8 mg ( chemical ) , after pretreatment with either placebo ( PL ) , chemical 5 mg ( B5 ) as a selective gene antagonist , or chemical 20 mg ( N20 ) to block gene .	T9	T22	7912539
NA	CHEMICAL	GENE-N	35	14	Eight normal males received single oral doses of chemical 8 mg ( chemical ) or the selective gene agonist chemical 8 mg ( chemical ) , after pretreatment with either placebo ( PL ) , chemical 5 mg ( B5 ) as a selective gene antagonist , or chemical 20 mg ( N20 ) to block gene .	T9	T23	7912539
NA	CHEMICAL	GENE-Y	42	14	Eight normal males received single oral doses of chemical 8 mg ( chemical ) or the selective gene agonist chemical 8 mg ( chemical ) , after pretreatment with either placebo ( PL ) , chemical 5 mg ( B5 ) as a selective gene antagonist , or chemical 20 mg ( N20 ) to block gene .	T10	T21	7912539
NA	CHEMICAL	GENE-Y	42	14	Eight normal males received single oral doses of chemical 8 mg ( chemical ) or the selective gene agonist chemical 8 mg ( chemical ) , after pretreatment with either placebo ( PL ) , chemical 5 mg ( B5 ) as a selective gene antagonist , or chemical 20 mg ( N20 ) to block gene .	T10	T22	7912539
NA	CHEMICAL	GENE-N	42	14	Eight normal males received single oral doses of chemical 8 mg ( chemical ) or the selective gene agonist chemical 8 mg ( chemical ) , after pretreatment with either placebo ( PL ) , chemical 5 mg ( B5 ) as a selective gene antagonist , or chemical 20 mg ( N20 ) to block gene .	T10	T23	7912539
CPR:3	CHEMICAL	GENE-Y	1	5	Both chemical and chemical produced a significant increase in postural finger tremor in keeping with gene stimulation , and this response was totally abolished by pretreatment with N20 .	T11	T24	7912539
CPR:3	CHEMICAL	GENE-Y	3	5	Both chemical and chemical produced a significant increase in postural finger tremor in keeping with gene stimulation , and this response was totally abolished by pretreatment with N20 .	T12	T24	7912539
NA	CHEMICAL	GENE-Y	12	31	Significant increases in systolic blood pressure and Doppler stroke distance occurred with chemical and chemical which were unaffected by pretreatment with B5 and completely blocked by N20 , in keeping with gene-mediated effects .	T13	T26	7912539
NA	CHEMICAL	GENE-Y	14	31	Significant increases in systolic blood pressure and Doppler stroke distance occurred with chemical and chemical which were unaffected by pretreatment with B5 and completely blocked by N20 , in keeping with gene-mediated effects .	T14	T26	7912539
NA	CHEMICAL	GENE-Y	0	14	chemical and chemical produced significant chronotropic and minute distance responses which were unaffected by gene blockade .	T15	T18	7912539
NA	CHEMICAL	GENE-Y	2	14	chemical and chemical produced significant chronotropic and minute distance responses which were unaffected by gene blockade .	T16	T18	7912539
NA	CHEMICAL	GENE-Y	8	27	However , whereas N20 blocked these responses to chemical , a small but significant response occurred with chemical in comparison with placebo despite complete blockade of co-existing gene-mediated effects .	T2	T19	7912539
NA	CHEMICAL	GENE-Y	17	27	However , whereas N20 blocked these responses to chemical , a small but significant response occurred with chemical in comparison with placebo despite complete blockade of co-existing gene-mediated effects .	T3	T19	7912539
NA	CHEMICAL	GENE-Y	3	6	Dose-response effect of chemical on cerebral gene after gene hyperstimulation .	T14	T31	16395286
NA	CHEMICAL	GENE-Y	3	8	Dose-response effect of chemical on cerebral gene after gene hyperstimulation .	T14	T32	16395286
CPR:4	CHEMICAL	GENE-Y	0	6	chemical was shown to decrease cerebral gene activities and angiogenesis induced by gene ( gene ) .	T6	T22	16395286
CPR:4	CHEMICAL	GENE-Y	0	3	chemical was shown to decrease cerebral gene activities and angiogenesis induced by gene ( gene ) .	T6	T23	16395286
CPR:4	CHEMICAL	GENE-Y	0	14	chemical was shown to decrease cerebral gene activities and angiogenesis induced by gene ( gene ) .	T6	T24	16395286
NA	CHEMICAL	GENE-Y	11	16	In the present study , we determined the dose-response effects of chemical and chemical on cerebral gene using our mouse model with gene focal hyperstimulation delivered with adenoviral vector ( Adgene ) in the brain .	T7	T25	16395286
NA	CHEMICAL	GENE-Y	11	22	In the present study , we determined the dose-response effects of chemical and chemical on cerebral gene using our mouse model with gene focal hyperstimulation delivered with adenoviral vector ( Adgene ) in the brain .	T7	T26	16395286
NA	CHEMICAL	GENE-Y	11	30	In the present study , we determined the dose-response effects of chemical and chemical on cerebral gene using our mouse model with gene focal hyperstimulation delivered with adenoviral vector ( Adgene ) in the brain .	T7	T27	16395286
NA	CHEMICAL	GENE-Y	13	16	In the present study , we determined the dose-response effects of chemical and chemical on cerebral gene using our mouse model with gene focal hyperstimulation delivered with adenoviral vector ( Adgene ) in the brain .	T8	T25	16395286
NA	CHEMICAL	GENE-Y	13	22	In the present study , we determined the dose-response effects of chemical and chemical on cerebral gene using our mouse model with gene focal hyperstimulation delivered with adenoviral vector ( Adgene ) in the brain .	T8	T26	16395286
NA	CHEMICAL	GENE-Y	13	30	In the present study , we determined the dose-response effects of chemical and chemical on cerebral gene using our mouse model with gene focal hyperstimulation delivered with adenoviral vector ( Adgene ) in the brain .	T8	T27	16395286
CPR:4	CHEMICAL	GENE-Y	16	5	Our results have shown that gene messenger ribonucleic acid ( mRNA ) expression was inhibited by chemical starting at 10 mg/kg/day ( P < 0.02 ) .	T11	T28	16395286
CPR:4	CHEMICAL	GENE-Y	0	6	chemical showed more potent inhibition on gene mRNA expression , starting at 1 ( P < 0.005 ) and further at more than 30 ( P < 0.001 ) mg/kg/day .	T12	T29	16395286
CPR:4	CHEMICAL	GENE-Y	6	10	At the enzymatic activity level , chemical started to suppress gene activity at 5 mg/kg/day ( P < 0.001 ) , while chemical had an effect at a lower dose , 1 mg/kg/day ( P < 0.02 ) .	T13	T15	16395286
NA	CHEMICAL	GENE-Y	6	10	At the enzymatic activity level , chemical started to suppress gene activity at 5 mg/kg/day ( P < 0.001 ) , while chemical had an effect at a lower dose , 1 mg/kg/day ( P < 0.02 ) .	T1	T15	16395286
CPR:4	CHEMICAL	GENE-Y	8	16	We also assessed the potential relevant signaling pathway in vitro to elucidate the mechanisms underlying the gene inhibition by chemical .	T2	T17	16395286
CPR:4	CHEMICAL	GENE-Y	3	10	In vitro , chemical , but not chemical , inhibits gene , at least in part , via the gene ( gene ) -mediated pathway .	T3	T18	16395286
NA	CHEMICAL	GENE-N	3	19	In vitro , chemical , but not chemical , inhibits gene , at least in part , via the gene ( gene ) -mediated pathway .	T3	T19	16395286
NA	CHEMICAL	GENE-N	3	21	In vitro , chemical , but not chemical , inhibits gene , at least in part , via the gene ( gene ) -mediated pathway .	T3	T20	16395286
CPR:4	CHEMICAL	GENE-Y	7	10	In vitro , chemical , but not chemical , inhibits gene , at least in part , via the gene ( gene ) -mediated pathway .	T4	T18	16395286
NA	CHEMICAL	GENE-N	7	19	In vitro , chemical , but not chemical , inhibits gene , at least in part , via the gene ( gene ) -mediated pathway .	T4	T19	16395286
NA	CHEMICAL	GENE-N	7	21	In vitro , chemical , but not chemical , inhibits gene , at least in part , via the gene ( gene ) -mediated pathway .	T4	T20	16395286
CPR:3	CHEMICAL	GENE-Y	8	2	Activation of gene mediates the cardiovascular effects of chemical .	T18	T35	14508322
NA	CHEMICAL	GENE-N	5	9	BACKGROUND : The intravenous anesthetic chemical exhibits structural similarities to specific gene agonists of the type such as chemical .	T11	T34	14508322
CPR:5	CHEMICAL	GENE-N	9	9	BACKGROUND : The intravenous anesthetic chemical exhibits structural similarities to specific gene agonists of the type such as chemical .	T4	T34	14508322
NA	CHEMICAL	GENE-N	5	5	The current study was performed to elucidate the possible interaction of chemical with gene in mice lacking individual gene subtypes ( alpha2-KO ) .	T9	T27	14508322
NA	CHEMICAL	GENE-N	5	5	The current study was performed to elucidate the possible interaction of chemical with gene in mice lacking individual gene subtypes ( alpha2-KO ) .	T9	T28	14508322
NA	CHEMICAL	GENE-N	6	6	METHODS : Sedative and cardiovascular responses to chemical and the alpha2-agonist , chemical , were determined in mice deficient in gene subtypes .	T10	T29	14508322
CPR:5	CHEMICAL	GENE-N	6	6	METHODS : Sedative and cardiovascular responses to chemical and the alpha2-agonist , chemical , were determined in mice deficient in gene subtypes .	T12	T29	14508322
CPR:6	CHEMICAL	GENE-N	7	5	Inhibition of binding of the gene antagonist chemical to recombinant gene by chemical was tested in human embryonic kidney ( HEK293 ) cells in vitro .	T13	T30	14508322
CPR:6	CHEMICAL	GENE-N	7	8	Inhibition of binding of the gene antagonist chemical to recombinant gene by chemical was tested in human embryonic kidney ( HEK293 ) cells in vitro .	T13	T31	14508322
NA	CHEMICAL	GENE-N	8	5	Inhibition of binding of the gene antagonist chemical to recombinant gene by chemical was tested in human embryonic kidney ( HEK293 ) cells in vitro .	T14	T30	14508322
NA	CHEMICAL	GENE-N	8	8	Inhibition of binding of the gene antagonist chemical to recombinant gene by chemical was tested in human embryonic kidney ( HEK293 ) cells in vitro .	T14	T31	14508322
NA	CHEMICAL	GENE-Y	19	24	RESULTS : In vivo , loss and recovery of the righting reflex required similar times after intraperitoneal injection of chemical in wild-type and in gene-deficient mice , indicating that the hypnotic effect of chemical in mice does not require the gene subtype .	T15	T32	14508322
NA	CHEMICAL	GENE-Y	19	40	RESULTS : In vivo , loss and recovery of the righting reflex required similar times after intraperitoneal injection of chemical in wild-type and in gene-deficient mice , indicating that the hypnotic effect of chemical in mice does not require the gene subtype .	T15	T33	14508322
NA	CHEMICAL	GENE-Y	33	24	RESULTS : In vivo , loss and recovery of the righting reflex required similar times after intraperitoneal injection of chemical in wild-type and in gene-deficient mice , indicating that the hypnotic effect of chemical in mice does not require the gene subtype .	T16	T32	14508322
NA	CHEMICAL	GENE-Y	33	40	RESULTS : In vivo , loss and recovery of the righting reflex required similar times after intraperitoneal injection of chemical in wild-type and in gene-deficient mice , indicating that the hypnotic effect of chemical in mice does not require the gene subtype .	T16	T33	14508322
NA	CHEMICAL	GENE-N	9	7	In membranes from HEK293 cells transfected with gene , chemical inhibited binding of the alpha2-antagonist , chemical , with higher potency from gene than from gene ( Ki alpha2A 208 microm , alpha2B 26 microm , alpha2C 56 microm ) .	T2	T19	14508322
NA	CHEMICAL	GENE-N	9	22	In membranes from HEK293 cells transfected with gene , chemical inhibited binding of the alpha2-antagonist , chemical , with higher potency from gene than from gene ( Ki alpha2A 208 microm , alpha2B 26 microm , alpha2C 56 microm ) .	T2	T20	14508322
NA	CHEMICAL	GENE-Y	9	25	In membranes from HEK293 cells transfected with gene , chemical inhibited binding of the alpha2-antagonist , chemical , with higher potency from gene than from gene ( Ki alpha2A 208 microm , alpha2B 26 microm , alpha2C 56 microm ) .	T2	T21	14508322
CPR:6	CHEMICAL	GENE-N	16	7	In membranes from HEK293 cells transfected with gene , chemical inhibited binding of the alpha2-antagonist , chemical , with higher potency from gene than from gene ( Ki alpha2A 208 microm , alpha2B 26 microm , alpha2C 56 microm ) .	T3	T19	14508322
NA	CHEMICAL	GENE-N	16	22	In membranes from HEK293 cells transfected with gene , chemical inhibited binding of the alpha2-antagonist , chemical , with higher potency from gene than from gene ( Ki alpha2A 208 microm , alpha2B 26 microm , alpha2C 56 microm ) .	T3	T20	14508322
CPR:6	CHEMICAL	GENE-Y	16	25	In membranes from HEK293 cells transfected with gene , chemical inhibited binding of the alpha2-antagonist , chemical , with higher potency from gene than from gene ( Ki alpha2A 208 microm , alpha2B 26 microm , alpha2C 56 microm ) .	T3	T21	14508322
NA	CHEMICAL	GENE-Y	5	1	In gene-expressing HEK293 cells , chemical rapidly increased phosphorylation of the gene gene .	T5	T22	14508322
CPR:3	CHEMICAL	GENE-N	5	11	In gene-expressing HEK293 cells , chemical rapidly increased phosphorylation of the gene gene .	T5	T23	14508322
CPR:3	CHEMICAL	GENE-N	5	12	In gene-expressing HEK293 cells , chemical rapidly increased phosphorylation of the gene gene .	T5	T24	14508322
CPR:5	CHEMICAL	GENE-N	6	12	CONCLUSIONS : These results indicate that chemical acts as an agonist at gene , which appears in vivo primarily as an gene-mediated increase in blood pressure .	T6	T25	14508322
NA	CHEMICAL	GENE-Y	6	21	CONCLUSIONS : These results indicate that chemical acts as an agonist at gene , which appears in vivo primarily as an gene-mediated increase in blood pressure .	T6	T26	14508322
NA	CHEMICAL	GENE-Y	19	9	While DNA damage does not affect phosphorylation at the gene site gene of gene , it increased phosphorylation at chemical517/chemical473 .	T3	T46	22935616
NA	CHEMICAL	GENE-N	19	11	While DNA damage does not affect phosphorylation at the gene site gene of gene , it increased phosphorylation at chemical517/chemical473 .	T3	T47	22935616
NA	CHEMICAL	GENE-Y	19	13	While DNA damage does not affect phosphorylation at the gene site gene of gene , it increased phosphorylation at chemical517/chemical473 .	T3	T48	22935616
NA	CHEMICAL	GENE-Y	9	9	While DNA damage does not affect phosphorylation at the gene site gene of gene , it increased phosphorylation at chemical517/chemical473 .	T4	T46	22935616
NA	CHEMICAL	GENE-N	9	11	While DNA damage does not affect phosphorylation at the gene site gene of gene , it increased phosphorylation at chemical517/chemical473 .	T4	T47	22935616
NA	CHEMICAL	GENE-Y	9	13	While DNA damage does not affect phosphorylation at the gene site gene of gene , it increased phosphorylation at chemical517/chemical473 .	T4	T48	22935616
NA	CHEMICAL	GENE-Y	3	3	In addition , gene and gene mutants have reduced levels of chemical-MPK-1/gene in their germ cells , indicating that the gene/gene pathway promotes gene signaling in the germline .	T1	T11	22935616
NA	CHEMICAL	GENE-Y	3	5	In addition , gene and gene mutants have reduced levels of chemical-MPK-1/gene in their germ cells , indicating that the gene/gene pathway promotes gene signaling in the germline .	T1	T12	22935616
NA	CHEMICAL	GENE-N	3	11	In addition , gene and gene mutants have reduced levels of chemical-MPK-1/gene in their germ cells , indicating that the gene/gene pathway promotes gene signaling in the germline .	T1	T14	22935616
NA	CHEMICAL	GENE-N	3	12	In addition , gene and gene mutants have reduced levels of chemical-MPK-1/gene in their germ cells , indicating that the gene/gene pathway promotes gene signaling in the germline .	T1	T16	22935616
NA	CHEMICAL	GENE-N	3	20	In addition , gene and gene mutants have reduced levels of chemical-MPK-1/gene in their germ cells , indicating that the gene/gene pathway promotes gene signaling in the germline .	T1	T17	22935616
NA	CHEMICAL	GENE-N	3	23	In addition , gene and gene mutants have reduced levels of chemical-MPK-1/gene in their germ cells , indicating that the gene/gene pathway promotes gene signaling in the germline .	T1	T18	22935616
NA	CHEMICAL	GENE-Y	6	14	This study examines the involvement of chemical in the induction of apoptosis by the gene inhibitor , camptothecin .	T17	T37	10712236
CPR:9	CHEMICAL	GENE-Y	2	14	Depletion of chemical , chemical , and chemical by chemical ( chemical ) , a specific inhibitor of chemical decarboxylase ( gene ) that is the first rate-limiting enzyme for chemical biosynthesis , decreased the apoptotic index .	T21	T39	10712236
CPR:9	CHEMICAL	GENE-Y	2	21	Depletion of chemical , chemical , and chemical by chemical ( chemical ) , a specific inhibitor of chemical decarboxylase ( gene ) that is the first rate-limiting enzyme for chemical biosynthesis , decreased the apoptotic index .	T21	T40	10712236
CPR:9	CHEMICAL	GENE-Y	4	14	Depletion of chemical , chemical , and chemical by chemical ( chemical ) , a specific inhibitor of chemical decarboxylase ( gene ) that is the first rate-limiting enzyme for chemical biosynthesis , decreased the apoptotic index .	T22	T39	10712236
CPR:9	CHEMICAL	GENE-Y	4	21	Depletion of chemical , chemical , and chemical by chemical ( chemical ) , a specific inhibitor of chemical decarboxylase ( gene ) that is the first rate-limiting enzyme for chemical biosynthesis , decreased the apoptotic index .	T22	T40	10712236
CPR:9	CHEMICAL	GENE-Y	7	14	Depletion of chemical , chemical , and chemical by chemical ( chemical ) , a specific inhibitor of chemical decarboxylase ( gene ) that is the first rate-limiting enzyme for chemical biosynthesis , decreased the apoptotic index .	T23	T39	10712236
CPR:9	CHEMICAL	GENE-Y	7	21	Depletion of chemical , chemical , and chemical by chemical ( chemical ) , a specific inhibitor of chemical decarboxylase ( gene ) that is the first rate-limiting enzyme for chemical biosynthesis , decreased the apoptotic index .	T23	T40	10712236
CPR:4	CHEMICAL	GENE-Y	9	14	Depletion of chemical , chemical , and chemical by chemical ( chemical ) , a specific inhibitor of chemical decarboxylase ( gene ) that is the first rate-limiting enzyme for chemical biosynthesis , decreased the apoptotic index .	T24	T39	10712236
CPR:4	CHEMICAL	GENE-Y	9	21	Depletion of chemical , chemical , and chemical by chemical ( chemical ) , a specific inhibitor of chemical decarboxylase ( gene ) that is the first rate-limiting enzyme for chemical biosynthesis , decreased the apoptotic index .	T24	T40	10712236
CPR:4	CHEMICAL	GENE-Y	11	14	Depletion of chemical , chemical , and chemical by chemical ( chemical ) , a specific inhibitor of chemical decarboxylase ( gene ) that is the first rate-limiting enzyme for chemical biosynthesis , decreased the apoptotic index .	T25	T39	10712236
CPR:4	CHEMICAL	GENE-Y	11	21	Depletion of chemical , chemical , and chemical by chemical ( chemical ) , a specific inhibitor of chemical decarboxylase ( gene ) that is the first rate-limiting enzyme for chemical biosynthesis , decreased the apoptotic index .	T25	T40	10712236
NA	CHEMICAL	GENE-Y	18	14	Depletion of chemical , chemical , and chemical by chemical ( chemical ) , a specific inhibitor of chemical decarboxylase ( gene ) that is the first rate-limiting enzyme for chemical biosynthesis , decreased the apoptotic index .	T26	T39	10712236
NA	CHEMICAL	GENE-Y	18	21	Depletion of chemical , chemical , and chemical by chemical ( chemical ) , a specific inhibitor of chemical decarboxylase ( gene ) that is the first rate-limiting enzyme for chemical biosynthesis , decreased the apoptotic index .	T26	T40	10712236
NA	CHEMICAL	GENE-Y	14	14	Depletion of chemical , chemical , and chemical by chemical ( chemical ) , a specific inhibitor of chemical decarboxylase ( gene ) that is the first rate-limiting enzyme for chemical biosynthesis , decreased the apoptotic index .	T27	T39	10712236
NA	CHEMICAL	GENE-Y	14	21	Depletion of chemical , chemical , and chemical by chemical ( chemical ) , a specific inhibitor of chemical decarboxylase ( gene ) that is the first rate-limiting enzyme for chemical biosynthesis , decreased the apoptotic index .	T27	T40	10712236
NA	CHEMICAL	GENE-Y	5	8	Delayed apoptosis was accompanied by a decrease in gene activity in chemical-depleted cells .	T28	T41	10712236
CPR:3	CHEMICAL	GENE-Y	2	20	Addition of chemical restored the induction of apoptosis as indicated by an increase in the number of detached cells and gene activity .	T29	T31	10712236
NA	CHEMICAL	GENE-Y	0	8	chemical depletion did not change the level of gene protein .	T1	T32	10712236
NA	CHEMICAL	GENE-Y	2	3	Inhibition of chemical decarboxylase by a specific inhibitor [ chemical ; chemical ] led to depletion of chemical and chemical with a significant accumulation of chemical and induction of gene .	T2	T33	10712236
NA	CHEMICAL	GENE-Y	2	29	Inhibition of chemical decarboxylase by a specific inhibitor [ chemical ; chemical ] led to depletion of chemical and chemical with a significant accumulation of chemical and induction of gene .	T2	T34	10712236
CPR:4	CHEMICAL	GENE-Y	5	3	Inhibition of chemical decarboxylase by a specific inhibitor [ chemical ; chemical ] led to depletion of chemical and chemical with a significant accumulation of chemical and induction of gene .	T3	T33	10712236
NA	CHEMICAL	GENE-Y	5	29	Inhibition of chemical decarboxylase by a specific inhibitor [ chemical ; chemical ] led to depletion of chemical and chemical with a significant accumulation of chemical and induction of gene .	T3	T34	10712236
CPR:4	CHEMICAL	GENE-Y	11	3	Inhibition of chemical decarboxylase by a specific inhibitor [ chemical ; chemical ] led to depletion of chemical and chemical with a significant accumulation of chemical and induction of gene .	T4	T33	10712236
NA	CHEMICAL	GENE-Y	11	29	Inhibition of chemical decarboxylase by a specific inhibitor [ chemical ; chemical ] led to depletion of chemical and chemical with a significant accumulation of chemical and induction of gene .	T4	T34	10712236
CPR:9	CHEMICAL	GENE-Y	17	3	Inhibition of chemical decarboxylase by a specific inhibitor [ chemical ; chemical ] led to depletion of chemical and chemical with a significant accumulation of chemical and induction of gene .	T5	T33	10712236
NA	CHEMICAL	GENE-Y	17	29	Inhibition of chemical decarboxylase by a specific inhibitor [ chemical ; chemical ] led to depletion of chemical and chemical with a significant accumulation of chemical and induction of gene .	T5	T34	10712236
CPR:9	CHEMICAL	GENE-Y	19	3	Inhibition of chemical decarboxylase by a specific inhibitor [ chemical ; chemical ] led to depletion of chemical and chemical with a significant accumulation of chemical and induction of gene .	T6	T33	10712236
NA	CHEMICAL	GENE-Y	19	29	Inhibition of chemical decarboxylase by a specific inhibitor [ chemical ; chemical ] led to depletion of chemical and chemical with a significant accumulation of chemical and induction of gene .	T6	T34	10712236
NA	CHEMICAL	GENE-Y	25	3	Inhibition of chemical decarboxylase by a specific inhibitor [ chemical ; chemical ] led to depletion of chemical and chemical with a significant accumulation of chemical and induction of gene .	T7	T33	10712236
NA	CHEMICAL	GENE-Y	25	29	Inhibition of chemical decarboxylase by a specific inhibitor [ chemical ; chemical ] led to depletion of chemical and chemical with a significant accumulation of chemical and induction of gene .	T7	T34	10712236
NA	CHEMICAL	GENE-Y	2	10	Addition of chemical to chemical-treated cell extracts did not increase gene activity .	T11	T35	10712236
NA	CHEMICAL	GENE-Y	4	10	Addition of chemical to chemical-treated cell extracts did not increase gene activity .	T12	T35	10712236
NA	CHEMICAL	GENE-Y	0	9	chemical , chemical , chemical , IP injected ( gene ( gene ) antagonist ) , or their combination were administered to rats one hour before chemical injection .	T15	T27	22989705
NA	CHEMICAL	GENE-Y	0	11	chemical , chemical , chemical , IP injected ( gene ( gene ) antagonist ) , or their combination were administered to rats one hour before chemical injection .	T15	T28	22989705
NA	CHEMICAL	GENE-Y	2	9	chemical , chemical , chemical , IP injected ( gene ( gene ) antagonist ) , or their combination were administered to rats one hour before chemical injection .	T16	T27	22989705
NA	CHEMICAL	GENE-Y	2	11	chemical , chemical , chemical , IP injected ( gene ( gene ) antagonist ) , or their combination were administered to rats one hour before chemical injection .	T16	T28	22989705
NA	CHEMICAL	GENE-Y	4	9	chemical , chemical , chemical , IP injected ( gene ( gene ) antagonist ) , or their combination were administered to rats one hour before chemical injection .	T17	T27	22989705
NA	CHEMICAL	GENE-Y	4	11	chemical , chemical , chemical , IP injected ( gene ( gene ) antagonist ) , or their combination were administered to rats one hour before chemical injection .	T17	T28	22989705
NA	CHEMICAL	GENE-Y	26	9	chemical , chemical , chemical , IP injected ( gene ( gene ) antagonist ) , or their combination were administered to rats one hour before chemical injection .	T18	T27	22989705
NA	CHEMICAL	GENE-Y	26	11	chemical , chemical , chemical , IP injected ( gene ( gene ) antagonist ) , or their combination were administered to rats one hour before chemical injection .	T18	T28	22989705
CPR:3	CHEMICAL	GENE-Y	5	20	The obtained results showed that chemical improved the renal function , structural changes , renal chemical ( chemical ) , gene ( gene ) , gene ( gene ) genes expression in chemical injected rats .	T19	T29	22989705
CPR:3	CHEMICAL	GENE-Y	5	22	The obtained results showed that chemical improved the renal function , structural changes , renal chemical ( chemical ) , gene ( gene ) , gene ( gene ) genes expression in chemical injected rats .	T19	T30	22989705
CPR:3	CHEMICAL	GENE-N	5	25	The obtained results showed that chemical improved the renal function , structural changes , renal chemical ( chemical ) , gene ( gene ) , gene ( gene ) genes expression in chemical injected rats .	T19	T31	22989705
CPR:3	CHEMICAL	GENE-N	5	27	The obtained results showed that chemical improved the renal function , structural changes , renal chemical ( chemical ) , gene ( gene ) , gene ( gene ) genes expression in chemical injected rats .	T19	T32	22989705
NA	CHEMICAL	GENE-Y	15	20	The obtained results showed that chemical improved the renal function , structural changes , renal chemical ( chemical ) , gene ( gene ) , gene ( gene ) genes expression in chemical injected rats .	T20	T29	22989705
NA	CHEMICAL	GENE-Y	15	22	The obtained results showed that chemical improved the renal function , structural changes , renal chemical ( chemical ) , gene ( gene ) , gene ( gene ) genes expression in chemical injected rats .	T20	T30	22989705
NA	CHEMICAL	GENE-N	15	25	The obtained results showed that chemical improved the renal function , structural changes , renal chemical ( chemical ) , gene ( gene ) , gene ( gene ) genes expression in chemical injected rats .	T20	T31	22989705
NA	CHEMICAL	GENE-N	15	27	The obtained results showed that chemical improved the renal function , structural changes , renal chemical ( chemical ) , gene ( gene ) , gene ( gene ) genes expression in chemical injected rats .	T20	T32	22989705
NA	CHEMICAL	GENE-Y	17	20	The obtained results showed that chemical improved the renal function , structural changes , renal chemical ( chemical ) , gene ( gene ) , gene ( gene ) genes expression in chemical injected rats .	T21	T29	22989705
NA	CHEMICAL	GENE-Y	17	22	The obtained results showed that chemical improved the renal function , structural changes , renal chemical ( chemical ) , gene ( gene ) , gene ( gene ) genes expression in chemical injected rats .	T21	T30	22989705
NA	CHEMICAL	GENE-N	17	25	The obtained results showed that chemical improved the renal function , structural changes , renal chemical ( chemical ) , gene ( gene ) , gene ( gene ) genes expression in chemical injected rats .	T21	T31	22989705
NA	CHEMICAL	GENE-N	17	27	The obtained results showed that chemical improved the renal function , structural changes , renal chemical ( chemical ) , gene ( gene ) , gene ( gene ) genes expression in chemical injected rats .	T21	T32	22989705
CPR:4	CHEMICAL	GENE-Y	31	20	The obtained results showed that chemical improved the renal function , structural changes , renal chemical ( chemical ) , gene ( gene ) , gene ( gene ) genes expression in chemical injected rats .	T22	T29	22989705
CPR:4	CHEMICAL	GENE-Y	31	22	The obtained results showed that chemical improved the renal function , structural changes , renal chemical ( chemical ) , gene ( gene ) , gene ( gene ) genes expression in chemical injected rats .	T22	T30	22989705
CPR:4	CHEMICAL	GENE-N	31	25	The obtained results showed that chemical improved the renal function , structural changes , renal chemical ( chemical ) , gene ( gene ) , gene ( gene ) genes expression in chemical injected rats .	T22	T31	22989705
CPR:4	CHEMICAL	GENE-N	31	27	The obtained results showed that chemical improved the renal function , structural changes , renal chemical ( chemical ) , gene ( gene ) , gene ( gene ) genes expression in chemical injected rats .	T22	T32	22989705
NA	CHEMICAL	GENE-Y	5	11	It increased both renal reduced chemical ( chemical ) content and gene gene expression .	T2	T25	22989705
NA	CHEMICAL	GENE-Y	7	11	It increased both renal reduced chemical ( chemical ) content and gene gene expression .	T3	T25	22989705
NA	CHEMICAL	GENE-Y	7	17	In conclusion , these results suggested that chemical protected against chemical- induced nephrotoxicity through its interaction with gene receptors and antioxidant effects .	T8	T26	22989705
NA	CHEMICAL	GENE-Y	10	17	In conclusion , these results suggested that chemical protected against chemical- induced nephrotoxicity through its interaction with gene receptors and antioxidant effects .	T9	T26	22989705
NA	CHEMICAL	GENE-Y	12	7	Thus far , PHA1 has been attributed to mutations affecting the gene or any of the three subunits assembling the chemical-sensitive epithelial chemical channel ( gene ) .	T1	T6	15547682
NA	CHEMICAL	GENE-N	12	23	Thus far , PHA1 has been attributed to mutations affecting the gene or any of the three subunits assembling the chemical-sensitive epithelial chemical channel ( gene ) .	T1	T7	15547682
NA	CHEMICAL	GENE-N	12	25	Thus far , PHA1 has been attributed to mutations affecting the gene or any of the three subunits assembling the chemical-sensitive epithelial chemical channel ( gene ) .	T1	T8	15547682
NA	CHEMICAL	GENE-Y	22	7	Thus far , PHA1 has been attributed to mutations affecting the gene or any of the three subunits assembling the chemical-sensitive epithelial chemical channel ( gene ) .	T2	T6	15547682
NA	CHEMICAL	GENE-N	22	23	Thus far , PHA1 has been attributed to mutations affecting the gene or any of the three subunits assembling the chemical-sensitive epithelial chemical channel ( gene ) .	T2	T7	15547682
NA	CHEMICAL	GENE-N	22	25	Thus far , PHA1 has been attributed to mutations affecting the gene or any of the three subunits assembling the chemical-sensitive epithelial chemical channel ( gene ) .	T2	T8	15547682
NA	CHEMICAL	GENE-Y	26	7	Recent studies have elucidated additional participants ( gene and members of the families of gene , gene , and gene , respectively ) regulating and/or interacting in the complex pathway of chemical retention in the chemical-sensitive distal nephron .	T3	T9	15547682
NA	CHEMICAL	GENE-N	26	14	Recent studies have elucidated additional participants ( gene and members of the families of gene , gene , and gene , respectively ) regulating and/or interacting in the complex pathway of chemical retention in the chemical-sensitive distal nephron .	T3	T10	15547682
NA	CHEMICAL	GENE-N	26	16	Recent studies have elucidated additional participants ( gene and members of the families of gene , gene , and gene , respectively ) regulating and/or interacting in the complex pathway of chemical retention in the chemical-sensitive distal nephron .	T3	T11	15547682
NA	CHEMICAL	GENE-N	26	19	Recent studies have elucidated additional participants ( gene and members of the families of gene , gene , and gene , respectively ) regulating and/or interacting in the complex pathway of chemical retention in the chemical-sensitive distal nephron .	T3	T12	15547682
NA	CHEMICAL	GENE-Y	31	7	Recent studies have elucidated additional participants ( gene and members of the families of gene , gene , and gene , respectively ) regulating and/or interacting in the complex pathway of chemical retention in the chemical-sensitive distal nephron .	T4	T9	15547682
NA	CHEMICAL	GENE-N	31	14	Recent studies have elucidated additional participants ( gene and members of the families of gene , gene , and gene , respectively ) regulating and/or interacting in the complex pathway of chemical retention in the chemical-sensitive distal nephron .	T4	T10	15547682
NA	CHEMICAL	GENE-N	31	16	Recent studies have elucidated additional participants ( gene and members of the families of gene , gene , and gene , respectively ) regulating and/or interacting in the complex pathway of chemical retention in the chemical-sensitive distal nephron .	T4	T11	15547682
NA	CHEMICAL	GENE-N	31	19	Recent studies have elucidated additional participants ( gene and members of the families of gene , gene , and gene , respectively ) regulating and/or interacting in the complex pathway of chemical retention in the chemical-sensitive distal nephron .	T4	T12	15547682
NA	CHEMICAL	GENE-Y	35	7	Recent studies have elucidated additional participants ( gene and members of the families of gene , gene , and gene , respectively ) regulating and/or interacting in the complex pathway of chemical retention in the chemical-sensitive distal nephron .	T5	T9	15547682
NA	CHEMICAL	GENE-N	35	14	Recent studies have elucidated additional participants ( gene and members of the families of gene , gene , and gene , respectively ) regulating and/or interacting in the complex pathway of chemical retention in the chemical-sensitive distal nephron .	T5	T10	15547682
NA	CHEMICAL	GENE-N	35	16	Recent studies have elucidated additional participants ( gene and members of the families of gene , gene , and gene , respectively ) regulating and/or interacting in the complex pathway of chemical retention in the chemical-sensitive distal nephron .	T5	T11	15547682
NA	CHEMICAL	GENE-N	35	19	Recent studies have elucidated additional participants ( gene and members of the families of gene , gene , and gene , respectively ) regulating and/or interacting in the complex pathway of chemical retention in the chemical-sensitive distal nephron .	T5	T12	15547682
CPR:4	CHEMICAL	GENE-N	0	2	chemical , a new gene inhibitor for the management of obesity .	T10	T14	10730683
CPR:3	CHEMICAL	GENE-N	0	4	chemical treatment also results in modest improvements in total chemical , gene , blood pressure , and fasting chemical and gene concentrations .	T3	T12	10730683
CPR:3	CHEMICAL	GENE-Y	0	4	chemical treatment also results in modest improvements in total chemical , gene , blood pressure , and fasting chemical and gene concentrations .	T3	T13	10730683
NA	CHEMICAL	GENE-N	9	4	chemical treatment also results in modest improvements in total chemical , gene , blood pressure , and fasting chemical and gene concentrations .	T4	T12	10730683
NA	CHEMICAL	GENE-Y	9	4	chemical treatment also results in modest improvements in total chemical , gene , blood pressure , and fasting chemical and gene concentrations .	T4	T13	10730683
NA	CHEMICAL	GENE-N	18	4	chemical treatment also results in modest improvements in total chemical , gene , blood pressure , and fasting chemical and gene concentrations .	T5	T12	10730683
NA	CHEMICAL	GENE-Y	18	4	chemical treatment also results in modest improvements in total chemical , gene , blood pressure , and fasting chemical and gene concentrations .	T5	T13	10730683
NA	CHEMICAL	GENE-Y	20	3	Inhibitors of the gene show some selectivity for cells of the lymphoid lineage and have been shown to be effective in late preclinical transplant models .	T5	T22	16978033
CPR:4	CHEMICAL	GENE-Y	0	3	chemical , a gene inhibitor is currently in phase II clinical trials.chemical , is a synthetic chemical that targets the critical enzyme of the de novo chemical synthesis , chemical dehydrogenase , and gene has completed phase II trials .	T6	T25	16978033
NA	CHEMICAL	GENE-Y	0	2	chemical , a gene inhibitor is currently in phase II clinical trials.chemical , is a synthetic chemical that targets the critical enzyme of the de novo chemical synthesis , chemical dehydrogenase , and gene has completed phase II trials .	T6	T26	16978033
NA	CHEMICAL	GENE-N	0	2	chemical , a gene inhibitor is currently in phase II clinical trials.chemical , is a synthetic chemical that targets the critical enzyme of the de novo chemical synthesis , chemical dehydrogenase , and gene has completed phase II trials .	T6	T27	16978033
NA	CHEMICAL	GENE-Y	11	3	chemical , a gene inhibitor is currently in phase II clinical trials.chemical , is a synthetic chemical that targets the critical enzyme of the de novo chemical synthesis , chemical dehydrogenase , and gene has completed phase II trials .	T7	T25	16978033
NA	CHEMICAL	GENE-Y	11	2	chemical , a gene inhibitor is currently in phase II clinical trials.chemical , is a synthetic chemical that targets the critical enzyme of the de novo chemical synthesis , chemical dehydrogenase , and gene has completed phase II trials .	T7	T26	16978033
NA	CHEMICAL	GENE-N	11	2	chemical , a gene inhibitor is currently in phase II clinical trials.chemical , is a synthetic chemical that targets the critical enzyme of the de novo chemical synthesis , chemical dehydrogenase , and gene has completed phase II trials .	T7	T27	16978033
NA	CHEMICAL	GENE-Y	2	3	chemical , a gene inhibitor is currently in phase II clinical trials.chemical , is a synthetic chemical that targets the critical enzyme of the de novo chemical synthesis , chemical dehydrogenase , and gene has completed phase II trials .	T8	T25	16978033
NA	CHEMICAL	GENE-Y	2	2	chemical , a gene inhibitor is currently in phase II clinical trials.chemical , is a synthetic chemical that targets the critical enzyme of the de novo chemical synthesis , chemical dehydrogenase , and gene has completed phase II trials .	T8	T26	16978033
NA	CHEMICAL	GENE-N	2	2	chemical , a gene inhibitor is currently in phase II clinical trials.chemical , is a synthetic chemical that targets the critical enzyme of the de novo chemical synthesis , chemical dehydrogenase , and gene has completed phase II trials .	T8	T27	16978033
NA	CHEMICAL	GENE-Y	7	3	chemical , a gene inhibitor is currently in phase II clinical trials.chemical , is a synthetic chemical that targets the critical enzyme of the de novo chemical synthesis , chemical dehydrogenase , and gene has completed phase II trials .	T9	T25	16978033
NA	CHEMICAL	GENE-Y	7	2	chemical , a gene inhibitor is currently in phase II clinical trials.chemical , is a synthetic chemical that targets the critical enzyme of the de novo chemical synthesis , chemical dehydrogenase , and gene has completed phase II trials .	T9	T26	16978033
NA	CHEMICAL	GENE-N	7	2	chemical , a gene inhibitor is currently in phase II clinical trials.chemical , is a synthetic chemical that targets the critical enzyme of the de novo chemical synthesis , chemical dehydrogenase , and gene has completed phase II trials .	T9	T27	16978033
NA	CHEMICAL	GENE-Y	2	3	chemical , a gene inhibitor is currently in phase II clinical trials.chemical , is a synthetic chemical that targets the critical enzyme of the de novo chemical synthesis , chemical dehydrogenase , and gene has completed phase II trials .	T10	T25	16978033
NA	CHEMICAL	GENE-Y	2	2	chemical , a gene inhibitor is currently in phase II clinical trials.chemical , is a synthetic chemical that targets the critical enzyme of the de novo chemical synthesis , chemical dehydrogenase , and gene has completed phase II trials .	T10	T26	16978033
NA	CHEMICAL	GENE-N	2	2	chemical , a gene inhibitor is currently in phase II clinical trials.chemical , is a synthetic chemical that targets the critical enzyme of the de novo chemical synthesis , chemical dehydrogenase , and gene has completed phase II trials .	T10	T27	16978033
NA	CHEMICAL	GENE-Y	7	3	chemical , a gene inhibitor is currently in phase II clinical trials.chemical , is a synthetic chemical that targets the critical enzyme of the de novo chemical synthesis , chemical dehydrogenase , and gene has completed phase II trials .	T11	T25	16978033
NA	CHEMICAL	GENE-Y	7	2	chemical , a gene inhibitor is currently in phase II clinical trials.chemical , is a synthetic chemical that targets the critical enzyme of the de novo chemical synthesis , chemical dehydrogenase , and gene has completed phase II trials .	T11	T26	16978033
NA	CHEMICAL	GENE-N	7	2	chemical , a gene inhibitor is currently in phase II clinical trials.chemical , is a synthetic chemical that targets the critical enzyme of the de novo chemical synthesis , chemical dehydrogenase , and gene has completed phase II trials .	T11	T27	16978033
NA	CHEMICAL	GENE-N	0	8	chemical ( chemical ) , a synthetic chemical receptor modulator that reduces the recirculation of lymphocytes to blood and peripheral tissues including inflammatory lesions and graft sites is undergoing phase III trials .	T13	T28	16978033
NA	CHEMICAL	GENE-N	2	8	chemical ( chemical ) , a synthetic chemical receptor modulator that reduces the recirculation of lymphocytes to blood and peripheral tissues including inflammatory lesions and graft sites is undergoing phase III trials .	T14	T28	16978033
NA	CHEMICAL	GENE-N	5	8	chemical ( chemical ) , a synthetic chemical receptor modulator that reduces the recirculation of lymphocytes to blood and peripheral tissues including inflammatory lesions and graft sites is undergoing phase III trials .	T15	T28	16978033
CPR:9	CHEMICAL	GENE-Y	3	8	Immunohistochemical characterization of chemical synthetic enzymes , chemical kinase-1 and gene , in various types of cancer .	T17	T37	20372850
CPR:9	CHEMICAL	GENE-Y	3	10	Immunohistochemical characterization of chemical synthetic enzymes , chemical kinase-1 and gene , in various types of cancer .	T17	T38	20372850
NA	CHEMICAL	GENE-Y	7	8	Immunohistochemical characterization of chemical synthetic enzymes , chemical kinase-1 and gene , in various types of cancer .	T18	T37	20372850
NA	CHEMICAL	GENE-Y	7	10	Immunohistochemical characterization of chemical synthetic enzymes , chemical kinase-1 and gene , in various types of cancer .	T18	T38	20372850
NA	CHEMICAL	GENE-Y	0	1	chemical kinase-1 ( gene and chemical synthase ( gene ) are key enzymes for salvage and de novo chemical synthesis , respectively .	T1	T19	20372850
NA	CHEMICAL	GENE-Y	0	3	chemical kinase-1 ( gene and chemical synthase ( gene ) are key enzymes for salvage and de novo chemical synthesis , respectively .	T1	T27	20372850
NA	CHEMICAL	GENE-Y	0	6	chemical kinase-1 ( gene and chemical synthase ( gene ) are key enzymes for salvage and de novo chemical synthesis , respectively .	T1	T28	20372850
NA	CHEMICAL	GENE-Y	0	8	chemical kinase-1 ( gene and chemical synthase ( gene ) are key enzymes for salvage and de novo chemical synthesis , respectively .	T1	T31	20372850
NA	CHEMICAL	GENE-Y	5	1	chemical kinase-1 ( gene and chemical synthase ( gene ) are key enzymes for salvage and de novo chemical synthesis , respectively .	T12	T19	20372850
NA	CHEMICAL	GENE-Y	5	3	chemical kinase-1 ( gene and chemical synthase ( gene ) are key enzymes for salvage and de novo chemical synthesis , respectively .	T12	T27	20372850
NA	CHEMICAL	GENE-Y	5	6	chemical kinase-1 ( gene and chemical synthase ( gene ) are key enzymes for salvage and de novo chemical synthesis , respectively .	T12	T28	20372850
NA	CHEMICAL	GENE-Y	5	8	chemical kinase-1 ( gene and chemical synthase ( gene ) are key enzymes for salvage and de novo chemical synthesis , respectively .	T12	T31	20372850
CPR:9	CHEMICAL	GENE-Y	18	1	chemical kinase-1 ( gene and chemical synthase ( gene ) are key enzymes for salvage and de novo chemical synthesis , respectively .	T16	T19	20372850
CPR:9	CHEMICAL	GENE-Y	18	3	chemical kinase-1 ( gene and chemical synthase ( gene ) are key enzymes for salvage and de novo chemical synthesis , respectively .	T16	T27	20372850
CPR:9	CHEMICAL	GENE-Y	18	6	chemical kinase-1 ( gene and chemical synthase ( gene ) are key enzymes for salvage and de novo chemical synthesis , respectively .	T16	T28	20372850
CPR:9	CHEMICAL	GENE-Y	18	8	chemical kinase-1 ( gene and chemical synthase ( gene ) are key enzymes for salvage and de novo chemical synthesis , respectively .	T16	T31	20372850
NA	CHEMICAL	GENE-Y	14	6	Numerous studies have suggested that increased gene levels are associated closely with resistance to chemical-based chemotherapy .	T9	T24	20372850
CPR:9	CHEMICAL	GENE-Y	0	12	chemical is a novel drug containing chemical , which is phosphorylated by gene to its active monophosphated form , that in turn can inhibit gene .	T10	T29	20372850
CPR:4	CHEMICAL	GENE-Y	0	24	chemical is a novel drug containing chemical , which is phosphorylated by gene to its active monophosphated form , that in turn can inhibit gene .	T10	T30	20372850
CPR:9	CHEMICAL	GENE-Y	6	12	chemical is a novel drug containing chemical , which is phosphorylated by gene to its active monophosphated form , that in turn can inhibit gene .	T11	T29	20372850
NA	CHEMICAL	GENE-Y	6	24	chemical is a novel drug containing chemical , which is phosphorylated by gene to its active monophosphated form , that in turn can inhibit gene .	T11	T30	20372850
CPR:9	CHEMICAL	GENE-Y	12	12	Gastrointestinal adenocarcinomas and squamous cell uterine carcinomas were often accompanied by high gene expression , indicating activation of chemical synthesis through both the salvage and de novo pathways .	T2	T20	20372850
NA	CHEMICAL	GENE-Y	7	33	These results led us to consider that chemical may also be effective for esophageal and uterine squamous cell carcinomas , as well as for gastrointestinal adenocarcinomas , even in chemical-resistant cases with high gene expression .	T3	T21	20372850
NA	CHEMICAL	GENE-Y	28	33	These results led us to consider that chemical may also be effective for esophageal and uterine squamous cell carcinomas , as well as for gastrointestinal adenocarcinomas , even in chemical-resistant cases with high gene expression .	T4	T21	20372850
NA	CHEMICAL	GENE-Y	32	25	In contrast , thyroid papillary carcinomas , lung adenocarcinomas , hepatocellular carcinomas , pancreatic ductal carcinomas , and renal cell carcinomas , which exhibit low gene expression , may be resistant to chemical .	T5	T22	20372850
NA	CHEMICAL	GENE-Y	20	13	Here we utilize transgenic and allograft breast cancer models to demonstrate that increased gene ( gene ) signalling can be a significant contributor to breast cancer progression in vivo .	T1	T3	22484424
NA	CHEMICAL	GENE-Y	20	15	Here we utilize transgenic and allograft breast cancer models to demonstrate that increased gene ( gene ) signalling can be a significant contributor to breast cancer progression in vivo .	T1	T4	22484424
NA	CHEMICAL	GENE-N	5	28	Point-mutation studies indicate that four chemical , chemical/chemical ( 7.38 ) , chemical/chemical ( 7.43 ) , chemical/chemical ( 7.46 ) , and chemical/chemical ( 7.47 ) in gene are critical for ligand selectivity as well as receptor conformation .	T2	T46	15635044
NA	CHEMICAL	GENE-N	7	28	Point-mutation studies indicate that four chemical , chemical/chemical ( 7.38 ) , chemical/chemical ( 7.43 ) , chemical/chemical ( 7.46 ) , and chemical/chemical ( 7.47 ) in gene are critical for ligand selectivity as well as receptor conformation .	T3	T46	15635044
NA	CHEMICAL	GENE-N	7	28	Point-mutation studies indicate that four chemical , chemical/chemical ( 7.38 ) , chemical/chemical ( 7.43 ) , chemical/chemical ( 7.46 ) , and chemical/chemical ( 7.47 ) in gene are critical for ligand selectivity as well as receptor conformation .	T4	T46	15635044
NA	CHEMICAL	GENE-N	12	28	Point-mutation studies indicate that four chemical , chemical/chemical ( 7.38 ) , chemical/chemical ( 7.43 ) , chemical/chemical ( 7.46 ) , and chemical/chemical ( 7.47 ) in gene are critical for ligand selectivity as well as receptor conformation .	T5	T46	15635044
NA	CHEMICAL	GENE-N	12	28	Point-mutation studies indicate that four chemical , chemical/chemical ( 7.38 ) , chemical/chemical ( 7.43 ) , chemical/chemical ( 7.46 ) , and chemical/chemical ( 7.47 ) in gene are critical for ligand selectivity as well as receptor conformation .	T6	T46	15635044
NA	CHEMICAL	GENE-N	17	28	Point-mutation studies indicate that four chemical , chemical/chemical ( 7.38 ) , chemical/chemical ( 7.43 ) , chemical/chemical ( 7.46 ) , and chemical/chemical ( 7.47 ) in gene are critical for ligand selectivity as well as receptor conformation .	T7	T46	15635044
NA	CHEMICAL	GENE-N	17	28	Point-mutation studies indicate that four chemical , chemical/chemical ( 7.38 ) , chemical/chemical ( 7.43 ) , chemical/chemical ( 7.46 ) , and chemical/chemical ( 7.47 ) in gene are critical for ligand selectivity as well as receptor conformation .	T8	T46	15635044
NA	CHEMICAL	GENE-N	23	28	Point-mutation studies indicate that four chemical , chemical/chemical ( 7.38 ) , chemical/chemical ( 7.43 ) , chemical/chemical ( 7.46 ) , and chemical/chemical ( 7.47 ) in gene are critical for ligand selectivity as well as receptor conformation .	T9	T46	15635044
NA	CHEMICAL	GENE-N	23	28	Point-mutation studies indicate that four chemical , chemical/chemical ( 7.38 ) , chemical/chemical ( 7.43 ) , chemical/chemical ( 7.46 ) , and chemical/chemical ( 7.47 ) in gene are critical for ligand selectivity as well as receptor conformation .	T10	T46	15635044
NA	CHEMICAL	GENE-N	6	22	Furthermore , a combinatory mutation ( chemical ( 7.31 ) -chemical ( 7.32 ) -chemical ( 7.33 ) motif to chemical in gene and chemical ( 7.38 ) , chemical ( 7.43 ) , chemical ( 7.46 ) , and chemical ( 7.47 ) to those of gene ) in gene exhibited an approximately 500-fold increased sensitivity to gene , indicating that these residues are critical for discriminating gene from gene .	T11	T48	15635044
NA	CHEMICAL	GENE-Y	6	47	Furthermore , a combinatory mutation ( chemical ( 7.31 ) -chemical ( 7.32 ) -chemical ( 7.33 ) motif to chemical in gene and chemical ( 7.38 ) , chemical ( 7.43 ) , chemical ( 7.46 ) , and chemical ( 7.47 ) to those of gene ) in gene exhibited an approximately 500-fold increased sensitivity to gene , indicating that these residues are critical for discriminating gene from gene .	T11	T49	15635044
NA	CHEMICAL	GENE-Y	6	50	Furthermore , a combinatory mutation ( chemical ( 7.31 ) -chemical ( 7.32 ) -chemical ( 7.33 ) motif to chemical in gene and chemical ( 7.38 ) , chemical ( 7.43 ) , chemical ( 7.46 ) , and chemical ( 7.47 ) to those of gene ) in gene exhibited an approximately 500-fold increased sensitivity to gene , indicating that these residues are critical for discriminating gene from gene .	T11	T50	15635044
NA	CHEMICAL	GENE-Y	6	58	Furthermore , a combinatory mutation ( chemical ( 7.31 ) -chemical ( 7.32 ) -chemical ( 7.33 ) motif to chemical in gene and chemical ( 7.38 ) , chemical ( 7.43 ) , chemical ( 7.46 ) , and chemical ( 7.47 ) to those of gene ) in gene exhibited an approximately 500-fold increased sensitivity to gene , indicating that these residues are critical for discriminating gene from gene .	T11	T20	15635044
NA	CHEMICAL	GENE-Y	6	68	Furthermore , a combinatory mutation ( chemical ( 7.31 ) -chemical ( 7.32 ) -chemical ( 7.33 ) motif to chemical in gene and chemical ( 7.38 ) , chemical ( 7.43 ) , chemical ( 7.46 ) , and chemical ( 7.47 ) to those of gene ) in gene exhibited an approximately 500-fold increased sensitivity to gene , indicating that these residues are critical for discriminating gene from gene .	T11	T21	15635044
NA	CHEMICAL	GENE-Y	6	70	Furthermore , a combinatory mutation ( chemical ( 7.31 ) -chemical ( 7.32 ) -chemical ( 7.33 ) motif to chemical in gene and chemical ( 7.38 ) , chemical ( 7.43 ) , chemical ( 7.46 ) , and chemical ( 7.47 ) to those of gene ) in gene exhibited an approximately 500-fold increased sensitivity to gene , indicating that these residues are critical for discriminating gene from gene .	T11	T22	15635044
NA	CHEMICAL	GENE-N	10	22	Furthermore , a combinatory mutation ( chemical ( 7.31 ) -chemical ( 7.32 ) -chemical ( 7.33 ) motif to chemical in gene and chemical ( 7.38 ) , chemical ( 7.43 ) , chemical ( 7.46 ) , and chemical ( 7.47 ) to those of gene ) in gene exhibited an approximately 500-fold increased sensitivity to gene , indicating that these residues are critical for discriminating gene from gene .	T12	T48	15635044
NA	CHEMICAL	GENE-Y	10	47	Furthermore , a combinatory mutation ( chemical ( 7.31 ) -chemical ( 7.32 ) -chemical ( 7.33 ) motif to chemical in gene and chemical ( 7.38 ) , chemical ( 7.43 ) , chemical ( 7.46 ) , and chemical ( 7.47 ) to those of gene ) in gene exhibited an approximately 500-fold increased sensitivity to gene , indicating that these residues are critical for discriminating gene from gene .	T12	T49	15635044
NA	CHEMICAL	GENE-Y	10	50	Furthermore , a combinatory mutation ( chemical ( 7.31 ) -chemical ( 7.32 ) -chemical ( 7.33 ) motif to chemical in gene and chemical ( 7.38 ) , chemical ( 7.43 ) , chemical ( 7.46 ) , and chemical ( 7.47 ) to those of gene ) in gene exhibited an approximately 500-fold increased sensitivity to gene , indicating that these residues are critical for discriminating gene from gene .	T12	T50	15635044
NA	CHEMICAL	GENE-Y	10	58	Furthermore , a combinatory mutation ( chemical ( 7.31 ) -chemical ( 7.32 ) -chemical ( 7.33 ) motif to chemical in gene and chemical ( 7.38 ) , chemical ( 7.43 ) , chemical ( 7.46 ) , and chemical ( 7.47 ) to those of gene ) in gene exhibited an approximately 500-fold increased sensitivity to gene , indicating that these residues are critical for discriminating gene from gene .	T12	T20	15635044
NA	CHEMICAL	GENE-Y	10	68	Furthermore , a combinatory mutation ( chemical ( 7.31 ) -chemical ( 7.32 ) -chemical ( 7.33 ) motif to chemical in gene and chemical ( 7.38 ) , chemical ( 7.43 ) , chemical ( 7.46 ) , and chemical ( 7.47 ) to those of gene ) in gene exhibited an approximately 500-fold increased sensitivity to gene , indicating that these residues are critical for discriminating gene from gene .	T12	T21	15635044
NA	CHEMICAL	GENE-Y	10	70	Furthermore , a combinatory mutation ( chemical ( 7.31 ) -chemical ( 7.32 ) -chemical ( 7.33 ) motif to chemical in gene and chemical ( 7.38 ) , chemical ( 7.43 ) , chemical ( 7.46 ) , and chemical ( 7.47 ) to those of gene ) in gene exhibited an approximately 500-fold increased sensitivity to gene , indicating that these residues are critical for discriminating gene from gene .	T12	T22	15635044
NA	CHEMICAL	GENE-N	14	22	Furthermore , a combinatory mutation ( chemical ( 7.31 ) -chemical ( 7.32 ) -chemical ( 7.33 ) motif to chemical in gene and chemical ( 7.38 ) , chemical ( 7.43 ) , chemical ( 7.46 ) , and chemical ( 7.47 ) to those of gene ) in gene exhibited an approximately 500-fold increased sensitivity to gene , indicating that these residues are critical for discriminating gene from gene .	T13	T48	15635044
NA	CHEMICAL	GENE-Y	14	47	Furthermore , a combinatory mutation ( chemical ( 7.31 ) -chemical ( 7.32 ) -chemical ( 7.33 ) motif to chemical in gene and chemical ( 7.38 ) , chemical ( 7.43 ) , chemical ( 7.46 ) , and chemical ( 7.47 ) to those of gene ) in gene exhibited an approximately 500-fold increased sensitivity to gene , indicating that these residues are critical for discriminating gene from gene .	T13	T49	15635044
NA	CHEMICAL	GENE-Y	14	50	Furthermore , a combinatory mutation ( chemical ( 7.31 ) -chemical ( 7.32 ) -chemical ( 7.33 ) motif to chemical in gene and chemical ( 7.38 ) , chemical ( 7.43 ) , chemical ( 7.46 ) , and chemical ( 7.47 ) to those of gene ) in gene exhibited an approximately 500-fold increased sensitivity to gene , indicating that these residues are critical for discriminating gene from gene .	T13	T50	15635044
NA	CHEMICAL	GENE-Y	14	58	Furthermore , a combinatory mutation ( chemical ( 7.31 ) -chemical ( 7.32 ) -chemical ( 7.33 ) motif to chemical in gene and chemical ( 7.38 ) , chemical ( 7.43 ) , chemical ( 7.46 ) , and chemical ( 7.47 ) to those of gene ) in gene exhibited an approximately 500-fold increased sensitivity to gene , indicating that these residues are critical for discriminating gene from gene .	T13	T20	15635044
NA	CHEMICAL	GENE-Y	14	68	Furthermore , a combinatory mutation ( chemical ( 7.31 ) -chemical ( 7.32 ) -chemical ( 7.33 ) motif to chemical in gene and chemical ( 7.38 ) , chemical ( 7.43 ) , chemical ( 7.46 ) , and chemical ( 7.47 ) to those of gene ) in gene exhibited an approximately 500-fold increased sensitivity to gene , indicating that these residues are critical for discriminating gene from gene .	T13	T21	15635044
NA	CHEMICAL	GENE-Y	14	70	Furthermore , a combinatory mutation ( chemical ( 7.31 ) -chemical ( 7.32 ) -chemical ( 7.33 ) motif to chemical in gene and chemical ( 7.38 ) , chemical ( 7.43 ) , chemical ( 7.46 ) , and chemical ( 7.47 ) to those of gene ) in gene exhibited an approximately 500-fold increased sensitivity to gene , indicating that these residues are critical for discriminating gene from gene .	T13	T22	15635044
NA	CHEMICAL	GENE-N	20	22	Furthermore , a combinatory mutation ( chemical ( 7.31 ) -chemical ( 7.32 ) -chemical ( 7.33 ) motif to chemical in gene and chemical ( 7.38 ) , chemical ( 7.43 ) , chemical ( 7.46 ) , and chemical ( 7.47 ) to those of gene ) in gene exhibited an approximately 500-fold increased sensitivity to gene , indicating that these residues are critical for discriminating gene from gene .	T14	T48	15635044
NA	CHEMICAL	GENE-Y	20	47	Furthermore , a combinatory mutation ( chemical ( 7.31 ) -chemical ( 7.32 ) -chemical ( 7.33 ) motif to chemical in gene and chemical ( 7.38 ) , chemical ( 7.43 ) , chemical ( 7.46 ) , and chemical ( 7.47 ) to those of gene ) in gene exhibited an approximately 500-fold increased sensitivity to gene , indicating that these residues are critical for discriminating gene from gene .	T14	T49	15635044
NA	CHEMICAL	GENE-Y	20	50	Furthermore , a combinatory mutation ( chemical ( 7.31 ) -chemical ( 7.32 ) -chemical ( 7.33 ) motif to chemical in gene and chemical ( 7.38 ) , chemical ( 7.43 ) , chemical ( 7.46 ) , and chemical ( 7.47 ) to those of gene ) in gene exhibited an approximately 500-fold increased sensitivity to gene , indicating that these residues are critical for discriminating gene from gene .	T14	T50	15635044
NA	CHEMICAL	GENE-Y	20	58	Furthermore , a combinatory mutation ( chemical ( 7.31 ) -chemical ( 7.32 ) -chemical ( 7.33 ) motif to chemical in gene and chemical ( 7.38 ) , chemical ( 7.43 ) , chemical ( 7.46 ) , and chemical ( 7.47 ) to those of gene ) in gene exhibited an approximately 500-fold increased sensitivity to gene , indicating that these residues are critical for discriminating gene from gene .	T14	T20	15635044
NA	CHEMICAL	GENE-Y	20	68	Furthermore , a combinatory mutation ( chemical ( 7.31 ) -chemical ( 7.32 ) -chemical ( 7.33 ) motif to chemical in gene and chemical ( 7.38 ) , chemical ( 7.43 ) , chemical ( 7.46 ) , and chemical ( 7.47 ) to those of gene ) in gene exhibited an approximately 500-fold increased sensitivity to gene , indicating that these residues are critical for discriminating gene from gene .	T14	T21	15635044
NA	CHEMICAL	GENE-Y	20	70	Furthermore , a combinatory mutation ( chemical ( 7.31 ) -chemical ( 7.32 ) -chemical ( 7.33 ) motif to chemical in gene and chemical ( 7.38 ) , chemical ( 7.43 ) , chemical ( 7.46 ) , and chemical ( 7.47 ) to those of gene ) in gene exhibited an approximately 500-fold increased sensitivity to gene , indicating that these residues are critical for discriminating gene from gene .	T14	T22	15635044
NA	CHEMICAL	GENE-N	24	22	Furthermore , a combinatory mutation ( chemical ( 7.31 ) -chemical ( 7.32 ) -chemical ( 7.33 ) motif to chemical in gene and chemical ( 7.38 ) , chemical ( 7.43 ) , chemical ( 7.46 ) , and chemical ( 7.47 ) to those of gene ) in gene exhibited an approximately 500-fold increased sensitivity to gene , indicating that these residues are critical for discriminating gene from gene .	T15	T48	15635044
NA	CHEMICAL	GENE-Y	24	47	Furthermore , a combinatory mutation ( chemical ( 7.31 ) -chemical ( 7.32 ) -chemical ( 7.33 ) motif to chemical in gene and chemical ( 7.38 ) , chemical ( 7.43 ) , chemical ( 7.46 ) , and chemical ( 7.47 ) to those of gene ) in gene exhibited an approximately 500-fold increased sensitivity to gene , indicating that these residues are critical for discriminating gene from gene .	T15	T49	15635044
NA	CHEMICAL	GENE-Y	24	50	Furthermore , a combinatory mutation ( chemical ( 7.31 ) -chemical ( 7.32 ) -chemical ( 7.33 ) motif to chemical in gene and chemical ( 7.38 ) , chemical ( 7.43 ) , chemical ( 7.46 ) , and chemical ( 7.47 ) to those of gene ) in gene exhibited an approximately 500-fold increased sensitivity to gene , indicating that these residues are critical for discriminating gene from gene .	T15	T50	15635044
NA	CHEMICAL	GENE-Y	24	58	Furthermore , a combinatory mutation ( chemical ( 7.31 ) -chemical ( 7.32 ) -chemical ( 7.33 ) motif to chemical in gene and chemical ( 7.38 ) , chemical ( 7.43 ) , chemical ( 7.46 ) , and chemical ( 7.47 ) to those of gene ) in gene exhibited an approximately 500-fold increased sensitivity to gene , indicating that these residues are critical for discriminating gene from gene .	T15	T20	15635044
NA	CHEMICAL	GENE-Y	24	68	Furthermore , a combinatory mutation ( chemical ( 7.31 ) -chemical ( 7.32 ) -chemical ( 7.33 ) motif to chemical in gene and chemical ( 7.38 ) , chemical ( 7.43 ) , chemical ( 7.46 ) , and chemical ( 7.47 ) to those of gene ) in gene exhibited an approximately 500-fold increased sensitivity to gene , indicating that these residues are critical for discriminating gene from gene .	T15	T21	15635044
NA	CHEMICAL	GENE-Y	24	70	Furthermore , a combinatory mutation ( chemical ( 7.31 ) -chemical ( 7.32 ) -chemical ( 7.33 ) motif to chemical in gene and chemical ( 7.38 ) , chemical ( 7.43 ) , chemical ( 7.46 ) , and chemical ( 7.47 ) to those of gene ) in gene exhibited an approximately 500-fold increased sensitivity to gene , indicating that these residues are critical for discriminating gene from gene .	T15	T22	15635044
NA	CHEMICAL	GENE-N	29	22	Furthermore , a combinatory mutation ( chemical ( 7.31 ) -chemical ( 7.32 ) -chemical ( 7.33 ) motif to chemical in gene and chemical ( 7.38 ) , chemical ( 7.43 ) , chemical ( 7.46 ) , and chemical ( 7.47 ) to those of gene ) in gene exhibited an approximately 500-fold increased sensitivity to gene , indicating that these residues are critical for discriminating gene from gene .	T16	T48	15635044
NA	CHEMICAL	GENE-Y	29	47	Furthermore , a combinatory mutation ( chemical ( 7.31 ) -chemical ( 7.32 ) -chemical ( 7.33 ) motif to chemical in gene and chemical ( 7.38 ) , chemical ( 7.43 ) , chemical ( 7.46 ) , and chemical ( 7.47 ) to those of gene ) in gene exhibited an approximately 500-fold increased sensitivity to gene , indicating that these residues are critical for discriminating gene from gene .	T16	T49	15635044
NA	CHEMICAL	GENE-Y	29	50	Furthermore , a combinatory mutation ( chemical ( 7.31 ) -chemical ( 7.32 ) -chemical ( 7.33 ) motif to chemical in gene and chemical ( 7.38 ) , chemical ( 7.43 ) , chemical ( 7.46 ) , and chemical ( 7.47 ) to those of gene ) in gene exhibited an approximately 500-fold increased sensitivity to gene , indicating that these residues are critical for discriminating gene from gene .	T16	T50	15635044
NA	CHEMICAL	GENE-Y	29	58	Furthermore , a combinatory mutation ( chemical ( 7.31 ) -chemical ( 7.32 ) -chemical ( 7.33 ) motif to chemical in gene and chemical ( 7.38 ) , chemical ( 7.43 ) , chemical ( 7.46 ) , and chemical ( 7.47 ) to those of gene ) in gene exhibited an approximately 500-fold increased sensitivity to gene , indicating that these residues are critical for discriminating gene from gene .	T16	T20	15635044
NA	CHEMICAL	GENE-Y	29	68	Furthermore , a combinatory mutation ( chemical ( 7.31 ) -chemical ( 7.32 ) -chemical ( 7.33 ) motif to chemical in gene and chemical ( 7.38 ) , chemical ( 7.43 ) , chemical ( 7.46 ) , and chemical ( 7.47 ) to those of gene ) in gene exhibited an approximately 500-fold increased sensitivity to gene , indicating that these residues are critical for discriminating gene from gene .	T16	T21	15635044
NA	CHEMICAL	GENE-Y	29	70	Furthermore , a combinatory mutation ( chemical ( 7.31 ) -chemical ( 7.32 ) -chemical ( 7.33 ) motif to chemical in gene and chemical ( 7.38 ) , chemical ( 7.43 ) , chemical ( 7.46 ) , and chemical ( 7.47 ) to those of gene ) in gene exhibited an approximately 500-fold increased sensitivity to gene , indicating that these residues are critical for discriminating gene from gene .	T16	T22	15635044
NA	CHEMICAL	GENE-N	2	22	Furthermore , a combinatory mutation ( chemical ( 7.31 ) -chemical ( 7.32 ) -chemical ( 7.33 ) motif to chemical in gene and chemical ( 7.38 ) , chemical ( 7.43 ) , chemical ( 7.46 ) , and chemical ( 7.47 ) to those of gene ) in gene exhibited an approximately 500-fold increased sensitivity to gene , indicating that these residues are critical for discriminating gene from gene .	T17	T48	15635044
NA	CHEMICAL	GENE-Y	2	47	Furthermore , a combinatory mutation ( chemical ( 7.31 ) -chemical ( 7.32 ) -chemical ( 7.33 ) motif to chemical in gene and chemical ( 7.38 ) , chemical ( 7.43 ) , chemical ( 7.46 ) , and chemical ( 7.47 ) to those of gene ) in gene exhibited an approximately 500-fold increased sensitivity to gene , indicating that these residues are critical for discriminating gene from gene .	T17	T49	15635044
NA	CHEMICAL	GENE-Y	2	50	Furthermore , a combinatory mutation ( chemical ( 7.31 ) -chemical ( 7.32 ) -chemical ( 7.33 ) motif to chemical in gene and chemical ( 7.38 ) , chemical ( 7.43 ) , chemical ( 7.46 ) , and chemical ( 7.47 ) to those of gene ) in gene exhibited an approximately 500-fold increased sensitivity to gene , indicating that these residues are critical for discriminating gene from gene .	T17	T50	15635044
NA	CHEMICAL	GENE-Y	2	58	Furthermore , a combinatory mutation ( chemical ( 7.31 ) -chemical ( 7.32 ) -chemical ( 7.33 ) motif to chemical in gene and chemical ( 7.38 ) , chemical ( 7.43 ) , chemical ( 7.46 ) , and chemical ( 7.47 ) to those of gene ) in gene exhibited an approximately 500-fold increased sensitivity to gene , indicating that these residues are critical for discriminating gene from gene .	T17	T20	15635044
NA	CHEMICAL	GENE-Y	2	68	Furthermore , a combinatory mutation ( chemical ( 7.31 ) -chemical ( 7.32 ) -chemical ( 7.33 ) motif to chemical in gene and chemical ( 7.38 ) , chemical ( 7.43 ) , chemical ( 7.46 ) , and chemical ( 7.47 ) to those of gene ) in gene exhibited an approximately 500-fold increased sensitivity to gene , indicating that these residues are critical for discriminating gene from gene .	T17	T21	15635044
NA	CHEMICAL	GENE-Y	2	70	Furthermore , a combinatory mutation ( chemical ( 7.31 ) -chemical ( 7.32 ) -chemical ( 7.33 ) motif to chemical in gene and chemical ( 7.38 ) , chemical ( 7.43 ) , chemical ( 7.46 ) , and chemical ( 7.47 ) to those of gene ) in gene exhibited an approximately 500-fold increased sensitivity to gene , indicating that these residues are critical for discriminating gene from gene .	T17	T22	15635044
NA	CHEMICAL	GENE-N	40	22	Furthermore , a combinatory mutation ( chemical ( 7.31 ) -chemical ( 7.32 ) -chemical ( 7.33 ) motif to chemical in gene and chemical ( 7.38 ) , chemical ( 7.43 ) , chemical ( 7.46 ) , and chemical ( 7.47 ) to those of gene ) in gene exhibited an approximately 500-fold increased sensitivity to gene , indicating that these residues are critical for discriminating gene from gene .	T18	T48	15635044
NA	CHEMICAL	GENE-Y	40	47	Furthermore , a combinatory mutation ( chemical ( 7.31 ) -chemical ( 7.32 ) -chemical ( 7.33 ) motif to chemical in gene and chemical ( 7.38 ) , chemical ( 7.43 ) , chemical ( 7.46 ) , and chemical ( 7.47 ) to those of gene ) in gene exhibited an approximately 500-fold increased sensitivity to gene , indicating that these residues are critical for discriminating gene from gene .	T18	T49	15635044
NA	CHEMICAL	GENE-Y	40	50	Furthermore , a combinatory mutation ( chemical ( 7.31 ) -chemical ( 7.32 ) -chemical ( 7.33 ) motif to chemical in gene and chemical ( 7.38 ) , chemical ( 7.43 ) , chemical ( 7.46 ) , and chemical ( 7.47 ) to those of gene ) in gene exhibited an approximately 500-fold increased sensitivity to gene , indicating that these residues are critical for discriminating gene from gene .	T18	T50	15635044
NA	CHEMICAL	GENE-Y	40	58	Furthermore , a combinatory mutation ( chemical ( 7.31 ) -chemical ( 7.32 ) -chemical ( 7.33 ) motif to chemical in gene and chemical ( 7.38 ) , chemical ( 7.43 ) , chemical ( 7.46 ) , and chemical ( 7.47 ) to those of gene ) in gene exhibited an approximately 500-fold increased sensitivity to gene , indicating that these residues are critical for discriminating gene from gene .	T18	T20	15635044
NA	CHEMICAL	GENE-Y	40	68	Furthermore , a combinatory mutation ( chemical ( 7.31 ) -chemical ( 7.32 ) -chemical ( 7.33 ) motif to chemical in gene and chemical ( 7.38 ) , chemical ( 7.43 ) , chemical ( 7.46 ) , and chemical ( 7.47 ) to those of gene ) in gene exhibited an approximately 500-fold increased sensitivity to gene , indicating that these residues are critical for discriminating gene from gene .	T18	T21	15635044
NA	CHEMICAL	GENE-Y	40	70	Furthermore , a combinatory mutation ( chemical ( 7.31 ) -chemical ( 7.32 ) -chemical ( 7.33 ) motif to chemical in gene and chemical ( 7.38 ) , chemical ( 7.43 ) , chemical ( 7.46 ) , and chemical ( 7.47 ) to those of gene ) in gene exhibited an approximately 500-fold increased sensitivity to gene , indicating that these residues are critical for discriminating gene from gene .	T18	T22	15635044
NA	CHEMICAL	GENE-Y	25	6	[ Trp ( 7 ) ] gene and [ Trp ( 8 ) ] gene but not [ His ( 5 ) ] gene exhibit a higher potency in activating wild-type gene than native gene , indicating that chemical at positions 7 and 8 of gene are more important than position 5 for differential recognition by gene .	T1	T23	15635044
NA	CHEMICAL	GENE-Y	25	14	[ Trp ( 7 ) ] gene and [ Trp ( 8 ) ] gene but not [ His ( 5 ) ] gene exhibit a higher potency in activating wild-type gene than native gene , indicating that chemical at positions 7 and 8 of gene are more important than position 5 for differential recognition by gene .	T1	T24	15635044
NA	CHEMICAL	GENE-Y	25	23	[ Trp ( 7 ) ] gene and [ Trp ( 8 ) ] gene but not [ His ( 5 ) ] gene exhibit a higher potency in activating wild-type gene than native gene , indicating that chemical at positions 7 and 8 of gene are more important than position 5 for differential recognition by gene .	T1	T25	15635044
NA	CHEMICAL	GENE-Y	25	31	[ Trp ( 7 ) ] gene and [ Trp ( 8 ) ] gene but not [ His ( 5 ) ] gene exhibit a higher potency in activating wild-type gene than native gene , indicating that chemical at positions 7 and 8 of gene are more important than position 5 for differential recognition by gene .	T1	T27	15635044
NA	CHEMICAL	GENE-Y	25	34	[ Trp ( 7 ) ] gene and [ Trp ( 8 ) ] gene but not [ His ( 5 ) ] gene exhibit a higher potency in activating wild-type gene than native gene , indicating that chemical at positions 7 and 8 of gene are more important than position 5 for differential recognition by gene .	T1	T28	15635044
NA	CHEMICAL	GENE-N	25	45	[ Trp ( 7 ) ] gene and [ Trp ( 8 ) ] gene but not [ His ( 5 ) ] gene exhibit a higher potency in activating wild-type gene than native gene , indicating that chemical at positions 7 and 8 of gene are more important than position 5 for differential recognition by gene .	T1	T29	15635044
NA	CHEMICAL	GENE-N	25	56	[ Trp ( 7 ) ] gene and [ Trp ( 8 ) ] gene but not [ His ( 5 ) ] gene exhibit a higher potency in activating wild-type gene than native gene , indicating that chemical at positions 7 and 8 of gene are more important than position 5 for differential recognition by gene .	T1	T31	15635044
CPR:4	CHEMICAL	GENE-N	4	4	Development and validation of a non-radioactive gene assay for studying cytomegalovirus resistance to chemical .	T8	T25	17197042
NA	CHEMICAL	GENE-Y	7	4	Phenotypic characterisation of the gene gene is a useful tool for testing for mutations in the gene gene thought to render HCMV resistant to chemical .	T3	T11	17197042
NA	CHEMICAL	GENE-N	7	5	Phenotypic characterisation of the gene gene is a useful tool for testing for mutations in the gene gene thought to render HCMV resistant to chemical .	T3	T17	17197042
NA	CHEMICAL	GENE-Y	7	16	Phenotypic characterisation of the gene gene is a useful tool for testing for mutations in the gene gene thought to render HCMV resistant to chemical .	T3	T10	17197042
NA	CHEMICAL	GENE-N	19	10	In this study , an in-house non-isotopic method for assessing polymerase enzymatic activity in the presence and absence of chemical was developed and its utility for gene phenotyping evaluated .	T4	T12	17197042
NA	CHEMICAL	GENE-N	9	0	gene activity was assessed by monitoring the incorporation of chemical-labelled nucleotides into the growing DNA chain and chemical concentrations inhibiting enzymatic activity by 50 % were determined .	T5	T13	17197042
NA	CHEMICAL	GENE-N	17	0	gene activity was assessed by monitoring the incorporation of chemical-labelled nucleotides into the growing DNA chain and chemical concentrations inhibiting enzymatic activity by 50 % were determined .	T6	T13	17197042
NA	CHEMICAL	GENE-N	11	3	The activity of gene containing mutations known to confer resistance to chemical ( gene , gene and gene ) was inhibited by concentrations of chemical eight to 14 times higher than those required to inhibit wild-type gene .	T7	T21	17197042
NA	CHEMICAL	GENE-N	11	13	The activity of gene containing mutations known to confer resistance to chemical ( gene , gene and gene ) was inhibited by concentrations of chemical eight to 14 times higher than those required to inhibit wild-type gene .	T7	T22	17197042
NA	CHEMICAL	GENE-N	11	15	The activity of gene containing mutations known to confer resistance to chemical ( gene , gene and gene ) was inhibited by concentrations of chemical eight to 14 times higher than those required to inhibit wild-type gene .	T7	T23	17197042
NA	CHEMICAL	GENE-N	11	17	The activity of gene containing mutations known to confer resistance to chemical ( gene , gene and gene ) was inhibited by concentrations of chemical eight to 14 times higher than those required to inhibit wild-type gene .	T7	T24	17197042
NA	CHEMICAL	GENE-N	11	36	The activity of gene containing mutations known to confer resistance to chemical ( gene , gene and gene ) was inhibited by concentrations of chemical eight to 14 times higher than those required to inhibit wild-type gene .	T7	T9	17197042
CPR:4	CHEMICAL	GENE-N	24	3	The activity of gene containing mutations known to confer resistance to chemical ( gene , gene and gene ) was inhibited by concentrations of chemical eight to 14 times higher than those required to inhibit wild-type gene .	T1	T21	17197042
CPR:4	CHEMICAL	GENE-N	24	13	The activity of gene containing mutations known to confer resistance to chemical ( gene , gene and gene ) was inhibited by concentrations of chemical eight to 14 times higher than those required to inhibit wild-type gene .	T1	T22	17197042
CPR:4	CHEMICAL	GENE-N	24	15	The activity of gene containing mutations known to confer resistance to chemical ( gene , gene and gene ) was inhibited by concentrations of chemical eight to 14 times higher than those required to inhibit wild-type gene .	T1	T23	17197042
CPR:4	CHEMICAL	GENE-N	24	17	The activity of gene containing mutations known to confer resistance to chemical ( gene , gene and gene ) was inhibited by concentrations of chemical eight to 14 times higher than those required to inhibit wild-type gene .	T1	T24	17197042
CPR:4	CHEMICAL	GENE-N	24	36	The activity of gene containing mutations known to confer resistance to chemical ( gene , gene and gene ) was inhibited by concentrations of chemical eight to 14 times higher than those required to inhibit wild-type gene .	T1	T9	17197042
NA	CHEMICAL	GENE-Y	4	5	A single residue in chemical-tRNA synthetase affecting chemical specificity and tRNA aminoacylation .	T7	T19	17378584
NA	CHEMICAL	GENE-Y	7	5	A single residue in chemical-tRNA synthetase affecting chemical specificity and tRNA aminoacylation .	T8	T19	17378584
NA	CHEMICAL	GENE-Y	6	0	gene ( gene ) achieves high chemicalation fidelity without a functional editing active site , representing a rare example of a gene ( gene ) that does not proofread its products .	T4	T9	17378584
NA	CHEMICAL	GENE-Y	6	2	gene ( gene ) achieves high chemicalation fidelity without a functional editing active site , representing a rare example of a gene ( gene ) that does not proofread its products .	T4	T12	17378584
NA	CHEMICAL	GENE-N	6	9	gene ( gene ) achieves high chemicalation fidelity without a functional editing active site , representing a rare example of a gene ( gene ) that does not proofread its products .	T4	T10	17378584
NA	CHEMICAL	GENE-N	6	9	gene ( gene ) achieves high chemicalation fidelity without a functional editing active site , representing a rare example of a gene ( gene ) that does not proofread its products .	T4	T11	17378584
NA	CHEMICAL	GENE-Y	28	12	Here we describe studies indicating that this particular residue ( K600 in gene and L570 in gene ) strongly impacts aminoacylation in two ways : it affects both chemical discrimination and transfer RNA ( tRNA ) binding .	T6	T17	17378584
NA	CHEMICAL	GENE-Y	28	16	Here we describe studies indicating that this particular residue ( K600 in gene and L570 in gene ) strongly impacts aminoacylation in two ways : it affects both chemical discrimination and transfer RNA ( tRNA ) binding .	T6	T18	17378584
NA	CHEMICAL	GENE-Y	9	19	While the neurobiological basis for the therapeutic activity of chemical is not fully understood , the drug is not a gene inhibitor and , therefore , acts differently from current AD therapies .	T11	T30	14530799
NA	CHEMICAL	GENE-N	0	4	chemical can interact with a variety of gene .	T14	T31	14530799
NA	CHEMICAL	GENE-N	2	3	However , chemical receptors appear to be a key target of chemical at therapeutic concentrations .	T15	T32	14530799
NA	CHEMICAL	GENE-N	7	3	However , chemical receptors appear to be a key target of chemical at therapeutic concentrations .	T16	T32	14530799
CPR:6	CHEMICAL	GENE-N	0	9	chemical is an uncompetitive ( channel blocking ) chemical receptor antagonist .	T17	T33	14530799
NA	CHEMICAL	GENE-N	8	9	chemical is an uncompetitive ( channel blocking ) chemical receptor antagonist .	T18	T33	14530799
NA	CHEMICAL	GENE-N	2	3	Like other chemical receptor antagonists , chemical at high concentrations can inhibit mechanisms of synaptic plasticity that are believed to underlie learning and memory .	T19	T34	14530799
CPR:6	CHEMICAL	GENE-N	6	3	Like other chemical receptor antagonists , chemical at high concentrations can inhibit mechanisms of synaptic plasticity that are believed to underlie learning and memory .	T20	T34	14530799
NA	CHEMICAL	GENE-N	2	3	Blockade of chemical receptors by chemical could theoretically confer disease-modifying activity in AD by inhibiting the `` weak '' chemical receptor-dependent excitotoxicity that has been hypothesized to play a role in the progressive neuronal loss that underlies the evolving dementia .	T2	T24	14530799
NA	CHEMICAL	GENE-N	2	26	Blockade of chemical receptors by chemical could theoretically confer disease-modifying activity in AD by inhibiting the `` weak '' chemical receptor-dependent excitotoxicity that has been hypothesized to play a role in the progressive neuronal loss that underlies the evolving dementia .	T2	T25	14530799
CPR:4	CHEMICAL	GENE-N	5	3	Blockade of chemical receptors by chemical could theoretically confer disease-modifying activity in AD by inhibiting the `` weak '' chemical receptor-dependent excitotoxicity that has been hypothesized to play a role in the progressive neuronal loss that underlies the evolving dementia .	T3	T24	14530799
CPR:4	CHEMICAL	GENE-N	5	26	Blockade of chemical receptors by chemical could theoretically confer disease-modifying activity in AD by inhibiting the `` weak '' chemical receptor-dependent excitotoxicity that has been hypothesized to play a role in the progressive neuronal loss that underlies the evolving dementia .	T3	T25	14530799
NA	CHEMICAL	GENE-N	19	3	Blockade of chemical receptors by chemical could theoretically confer disease-modifying activity in AD by inhibiting the `` weak '' chemical receptor-dependent excitotoxicity that has been hypothesized to play a role in the progressive neuronal loss that underlies the evolving dementia .	T4	T24	14530799
NA	CHEMICAL	GENE-N	19	26	Blockade of chemical receptors by chemical could theoretically confer disease-modifying activity in AD by inhibiting the `` weak '' chemical receptor-dependent excitotoxicity that has been hypothesized to play a role in the progressive neuronal loss that underlies the evolving dementia .	T4	T25	14530799
CPR:4	CHEMICAL	GENE-Y	3	10	Moreover , recent in vitro studies suggest that chemical abrogates gene ( gene ) toxicity and possibly inhibits gene production .	T5	T26	14530799
CPR:4	CHEMICAL	GENE-Y	3	12	Moreover , recent in vitro studies suggest that chemical abrogates gene ( gene ) toxicity and possibly inhibits gene production .	T5	T27	14530799
CPR:4	CHEMICAL	GENE-Y	3	18	Moreover , recent in vitro studies suggest that chemical abrogates gene ( gene ) toxicity and possibly inhibits gene production .	T5	T28	14530799
CPR:6	CHEMICAL	GENE-N	15	9	Considerable attention has focused on the investigation of theories to explain the better tolerability of chemical over other chemical receptor antagonists , particularly those that act by a similar channel blocking mechanism such as dissociative anesthetic-like agents ( chemical , chemical , chemical ) .	T6	T29	14530799
NA	CHEMICAL	GENE-N	18	9	Considerable attention has focused on the investigation of theories to explain the better tolerability of chemical over other chemical receptor antagonists , particularly those that act by a similar channel blocking mechanism such as dissociative anesthetic-like agents ( chemical , chemical , chemical ) .	T7	T29	14530799
NA	CHEMICAL	GENE-N	38	9	Considerable attention has focused on the investigation of theories to explain the better tolerability of chemical over other chemical receptor antagonists , particularly those that act by a similar channel blocking mechanism such as dissociative anesthetic-like agents ( chemical , chemical , chemical ) .	T8	T29	14530799
NA	CHEMICAL	GENE-N	27	9	Considerable attention has focused on the investigation of theories to explain the better tolerability of chemical over other chemical receptor antagonists , particularly those that act by a similar channel blocking mechanism such as dissociative anesthetic-like agents ( chemical , chemical , chemical ) .	T9	T29	14530799
NA	CHEMICAL	GENE-N	42	9	Considerable attention has focused on the investigation of theories to explain the better tolerability of chemical over other chemical receptor antagonists , particularly those that act by a similar channel blocking mechanism such as dissociative anesthetic-like agents ( chemical , chemical , chemical ) .	T10	T29	14530799
NA	CHEMICAL	GENE-Y	7	12	AIMS : To compare the effects of chemical and chemical , two gene ( gene ) preferential nonsteroidal anti-inflammatory drugs ( NSAIDs ) , on platelet gene activity and platelet function .	T10	T25	12047490
NA	CHEMICAL	GENE-Y	7	14	AIMS : To compare the effects of chemical and chemical , two gene ( gene ) preferential nonsteroidal anti-inflammatory drugs ( NSAIDs ) , on platelet gene activity and platelet function .	T10	T26	12047490
NA	CHEMICAL	GENE-Y	7	26	AIMS : To compare the effects of chemical and chemical , two gene ( gene ) preferential nonsteroidal anti-inflammatory drugs ( NSAIDs ) , on platelet gene activity and platelet function .	T10	T23	12047490
NA	CHEMICAL	GENE-Y	9	12	AIMS : To compare the effects of chemical and chemical , two gene ( gene ) preferential nonsteroidal anti-inflammatory drugs ( NSAIDs ) , on platelet gene activity and platelet function .	T13	T25	12047490
NA	CHEMICAL	GENE-Y	9	14	AIMS : To compare the effects of chemical and chemical , two gene ( gene ) preferential nonsteroidal anti-inflammatory drugs ( NSAIDs ) , on platelet gene activity and platelet function .	T13	T26	12047490
NA	CHEMICAL	GENE-Y	9	26	AIMS : To compare the effects of chemical and chemical , two gene ( gene ) preferential nonsteroidal anti-inflammatory drugs ( NSAIDs ) , on platelet gene activity and platelet function .	T13	T23	12047490
CPR:9	CHEMICAL	GENE-Y	9	0	gene inhibition was measured as percentage inhibition of serum chemical generation in clotting whole blood , and as closure time with use of the platelet function analyser PFA-100 .	T15	T24	12047490
CPR:4	CHEMICAL	GENE-Y	8	19	CONCLUSIONS : In the maximum registered dosage , chemical inhibits chemical production much more than meloxicam , signifying less gene selectivity of the former .	T5	T22	12047490
NA	CHEMICAL	GENE-Y	10	19	CONCLUSIONS : In the maximum registered dosage , chemical inhibits chemical production much more than meloxicam , signifying less gene selectivity of the former .	T6	T22	12047490
NA	CHEMICAL	GENE-Y	38	3	Thereafter , the gene hydrolysates were sequentially fractionated by ultra filtration membranes in cut-off molecular weight ( MW ) of 30 , 10 , and 1kDa , and tested their antioxidant activities in terms of RP ability , chemical radical scavenging ability , chemical radical scavenging ability , and FRAP assay .	T1	T4	23561109
NA	CHEMICAL	GENE-Y	43	3	Thereafter , the gene hydrolysates were sequentially fractionated by ultra filtration membranes in cut-off molecular weight ( MW ) of 30 , 10 , and 1kDa , and tested their antioxidant activities in terms of RP ability , chemical radical scavenging ability , chemical radical scavenging ability , and FRAP assay .	T2	T4	23561109
NA	CHEMICAL	GENE-Y	3	9	Hepatic activities of chemical-chemical-deethylase , chemical-chemical-depentylase , and chemical 6-hydroxylase , but not chemical hydroxylase were also elevated .	T4	T28	23104244
NA	CHEMICAL	GENE-N	3	14	Hepatic activities of chemical-chemical-deethylase , chemical-chemical-depentylase , and chemical 6-hydroxylase , but not chemical hydroxylase were also elevated .	T4	T29	23104244
NA	CHEMICAL	GENE-Y	3	9	Hepatic activities of chemical-chemical-deethylase , chemical-chemical-depentylase , and chemical 6-hydroxylase , but not chemical hydroxylase were also elevated .	T5	T28	23104244
NA	CHEMICAL	GENE-N	3	14	Hepatic activities of chemical-chemical-deethylase , chemical-chemical-depentylase , and chemical 6-hydroxylase , but not chemical hydroxylase were also elevated .	T5	T29	23104244
NA	CHEMICAL	GENE-Y	5	9	Hepatic activities of chemical-chemical-deethylase , chemical-chemical-depentylase , and chemical 6-hydroxylase , but not chemical hydroxylase were also elevated .	T6	T28	23104244
NA	CHEMICAL	GENE-N	5	14	Hepatic activities of chemical-chemical-deethylase , chemical-chemical-depentylase , and chemical 6-hydroxylase , but not chemical hydroxylase were also elevated .	T6	T29	23104244
NA	CHEMICAL	GENE-Y	5	9	Hepatic activities of chemical-chemical-deethylase , chemical-chemical-depentylase , and chemical 6-hydroxylase , but not chemical hydroxylase were also elevated .	T7	T28	23104244
NA	CHEMICAL	GENE-N	5	14	Hepatic activities of chemical-chemical-deethylase , chemical-chemical-depentylase , and chemical 6-hydroxylase , but not chemical hydroxylase were also elevated .	T7	T29	23104244
NA	CHEMICAL	GENE-Y	8	9	Hepatic activities of chemical-chemical-deethylase , chemical-chemical-depentylase , and chemical 6-hydroxylase , but not chemical hydroxylase were also elevated .	T8	T28	23104244
NA	CHEMICAL	GENE-N	8	14	Hepatic activities of chemical-chemical-deethylase , chemical-chemical-depentylase , and chemical 6-hydroxylase , but not chemical hydroxylase were also elevated .	T8	T29	23104244
NA	CHEMICAL	GENE-Y	13	9	Hepatic activities of chemical-chemical-deethylase , chemical-chemical-depentylase , and chemical 6-hydroxylase , but not chemical hydroxylase were also elevated .	T9	T28	23104244
NA	CHEMICAL	GENE-N	13	14	Hepatic activities of chemical-chemical-deethylase , chemical-chemical-depentylase , and chemical 6-hydroxylase , but not chemical hydroxylase were also elevated .	T9	T29	23104244
NA	CHEMICAL	GENE-Y	4	5	Interestingly , the increases in gene and gene levels , and chemical-O-deethylase , chemical-O-depentylase , and chemical 6-hydroxylase activities were attenuated by fermentation of GGT extract using Lactobacillus plantarum KFRI 402 , but not 144 .	T1	T12	23104244
NA	CHEMICAL	GENE-Y	4	7	Interestingly , the increases in gene and gene levels , and chemical-O-deethylase , chemical-O-depentylase , and chemical 6-hydroxylase activities were attenuated by fermentation of GGT extract using Lactobacillus plantarum KFRI 402 , but not 144 .	T1	T13	23104244
NA	CHEMICAL	GENE-Y	4	4	Interestingly , the increases in gene and gene levels , and chemical-O-deethylase , chemical-O-depentylase , and chemical 6-hydroxylase activities were attenuated by fermentation of GGT extract using Lactobacillus plantarum KFRI 402 , but not 144 .	T1	T14	23104244
NA	CHEMICAL	GENE-Y	4	4	Interestingly , the increases in gene and gene levels , and chemical-O-deethylase , chemical-O-depentylase , and chemical 6-hydroxylase activities were attenuated by fermentation of GGT extract using Lactobacillus plantarum KFRI 402 , but not 144 .	T1	T15	23104244
NA	CHEMICAL	GENE-Y	4	17	Interestingly , the increases in gene and gene levels , and chemical-O-deethylase , chemical-O-depentylase , and chemical 6-hydroxylase activities were attenuated by fermentation of GGT extract using Lactobacillus plantarum KFRI 402 , but not 144 .	T1	T16	23104244
NA	CHEMICAL	GENE-Y	4	5	Interestingly , the increases in gene and gene levels , and chemical-O-deethylase , chemical-O-depentylase , and chemical 6-hydroxylase activities were attenuated by fermentation of GGT extract using Lactobacillus plantarum KFRI 402 , but not 144 .	T2	T12	23104244
NA	CHEMICAL	GENE-Y	4	7	Interestingly , the increases in gene and gene levels , and chemical-O-deethylase , chemical-O-depentylase , and chemical 6-hydroxylase activities were attenuated by fermentation of GGT extract using Lactobacillus plantarum KFRI 402 , but not 144 .	T2	T13	23104244
NA	CHEMICAL	GENE-Y	4	4	Interestingly , the increases in gene and gene levels , and chemical-O-deethylase , chemical-O-depentylase , and chemical 6-hydroxylase activities were attenuated by fermentation of GGT extract using Lactobacillus plantarum KFRI 402 , but not 144 .	T2	T14	23104244
NA	CHEMICAL	GENE-Y	4	4	Interestingly , the increases in gene and gene levels , and chemical-O-deethylase , chemical-O-depentylase , and chemical 6-hydroxylase activities were attenuated by fermentation of GGT extract using Lactobacillus plantarum KFRI 402 , but not 144 .	T2	T15	23104244
NA	CHEMICAL	GENE-Y	4	17	Interestingly , the increases in gene and gene levels , and chemical-O-deethylase , chemical-O-depentylase , and chemical 6-hydroxylase activities were attenuated by fermentation of GGT extract using Lactobacillus plantarum KFRI 402 , but not 144 .	T2	T16	23104244
NA	CHEMICAL	GENE-Y	16	5	Interestingly , the increases in gene and gene levels , and chemical-O-deethylase , chemical-O-depentylase , and chemical 6-hydroxylase activities were attenuated by fermentation of GGT extract using Lactobacillus plantarum KFRI 402 , but not 144 .	T3	T12	23104244
NA	CHEMICAL	GENE-Y	16	7	Interestingly , the increases in gene and gene levels , and chemical-O-deethylase , chemical-O-depentylase , and chemical 6-hydroxylase activities were attenuated by fermentation of GGT extract using Lactobacillus plantarum KFRI 402 , but not 144 .	T3	T13	23104244
NA	CHEMICAL	GENE-Y	16	4	Interestingly , the increases in gene and gene levels , and chemical-O-deethylase , chemical-O-depentylase , and chemical 6-hydroxylase activities were attenuated by fermentation of GGT extract using Lactobacillus plantarum KFRI 402 , but not 144 .	T3	T14	23104244
NA	CHEMICAL	GENE-Y	16	4	Interestingly , the increases in gene and gene levels , and chemical-O-deethylase , chemical-O-depentylase , and chemical 6-hydroxylase activities were attenuated by fermentation of GGT extract using Lactobacillus plantarum KFRI 402 , but not 144 .	T3	T15	23104244
NA	CHEMICAL	GENE-Y	16	17	Interestingly , the increases in gene and gene levels , and chemical-O-deethylase , chemical-O-depentylase , and chemical 6-hydroxylase activities were attenuated by fermentation of GGT extract using Lactobacillus plantarum KFRI 402 , but not 144 .	T3	T16	23104244
NA	CHEMICAL	GENE-Y	0	1	chemical-dependent gene production leading to eosinophilia during late asthmatic response in guinea-pigs .	T16	T31	11972613
NA	CHEMICAL	GENE-Y	8	12	BACKGROUND : Allergic airway eosinophilia is suppressed by chemical ( chemical ) receptor ( gene receptor ) antagonists in several species including humans and guinea-pigs , suggesting that chemical are directly or indirectly involved in induction of the response .	T12	T25	11972613
NA	CHEMICAL	GENE-Y	8	14	BACKGROUND : Allergic airway eosinophilia is suppressed by chemical ( chemical ) receptor ( gene receptor ) antagonists in several species including humans and guinea-pigs , suggesting that chemical are directly or indirectly involved in induction of the response .	T12	T30	11972613
NA	CHEMICAL	GENE-Y	10	12	BACKGROUND : Allergic airway eosinophilia is suppressed by chemical ( chemical ) receptor ( gene receptor ) antagonists in several species including humans and guinea-pigs , suggesting that chemical are directly or indirectly involved in induction of the response .	T15	T25	11972613
NA	CHEMICAL	GENE-Y	10	14	BACKGROUND : Allergic airway eosinophilia is suppressed by chemical ( chemical ) receptor ( gene receptor ) antagonists in several species including humans and guinea-pigs , suggesting that chemical are directly or indirectly involved in induction of the response .	T15	T30	11972613
NA	CHEMICAL	GENE-Y	28	12	BACKGROUND : Allergic airway eosinophilia is suppressed by chemical ( chemical ) receptor ( gene receptor ) antagonists in several species including humans and guinea-pigs , suggesting that chemical are directly or indirectly involved in induction of the response .	T8	T25	11972613
NA	CHEMICAL	GENE-Y	28	14	BACKGROUND : Allergic airway eosinophilia is suppressed by chemical ( chemical ) receptor ( gene receptor ) antagonists in several species including humans and guinea-pigs , suggesting that chemical are directly or indirectly involved in induction of the response .	T8	T30	11972613
NA	CHEMICAL	GENE-Y	7	26	OBJECTIVE : We examined the effect of chemical antagonists ( chemical and chemical ) on antigen inhalation-induced eosinophilia in peripheral blood and lung , and on gene activity in serum during late increase of airway resistance ( late asthmatic response , LAR ) in sensitized guinea-pigs .	T9	T23	11972613
NA	CHEMICAL	GENE-Y	10	26	OBJECTIVE : We examined the effect of chemical antagonists ( chemical and chemical ) on antigen inhalation-induced eosinophilia in peripheral blood and lung , and on gene activity in serum during late increase of airway resistance ( late asthmatic response , LAR ) in sensitized guinea-pigs .	T10	T23	11972613
NA	CHEMICAL	GENE-Y	12	26	OBJECTIVE : We examined the effect of chemical antagonists ( chemical and chemical ) on antigen inhalation-induced eosinophilia in peripheral blood and lung , and on gene activity in serum during late increase of airway resistance ( late asthmatic response , LAR ) in sensitized guinea-pigs .	T11	T23	11972613
NA	CHEMICAL	GENE-Y	5	4	METHODS : Guinea-pigs inhaled gene ( gene ) + chemical and gene mists alternately for sensitization and challenge , respectively , once every 2 weeks .	T13	T24	11972613
NA	CHEMICAL	GENE-Y	5	6	METHODS : Guinea-pigs inhaled gene ( gene ) + chemical and gene mists alternately for sensitization and challenge , respectively , once every 2 weeks .	T13	T26	11972613
NA	CHEMICAL	GENE-Y	5	11	METHODS : Guinea-pigs inhaled gene ( gene ) + chemical and gene mists alternately for sensitization and challenge , respectively , once every 2 weeks .	T13	T27	11972613
NA	CHEMICAL	GENE-Y	8	12	At the fifth challenge , the effects of chemical antagonists and an anti-gene antibody ( TRFK-5 ) on the occurrence of LAR , and blood and lung eosinophilia , which appeared at 5 h after challenge , were examined .	T14	T28	11972613
NA	CHEMICAL	GENE-Y	3	6	The influence of chemical antagonists on gene activity was assessed .	T1	T17	11972613
CPR:4	CHEMICAL	GENE-Y	10	1	Increased gene activity in the serum was inhibited by both chemical and chemical by over 90 % .	T4	T19	11972613
CPR:4	CHEMICAL	GENE-Y	12	1	Increased gene activity in the serum was inhibited by both chemical and chemical by over 90 % .	T5	T19	11972613
NA	CHEMICAL	GENE-Y	2	9	CONCLUSIONS : chemical produced after antigen provocation sequentially induced gene production from some immune component cells via gene receptor activation .	T6	T20	11972613
CPR:3	CHEMICAL	GENE-Y	2	17	CONCLUSIONS : chemical produced after antigen provocation sequentially induced gene production from some immune component cells via gene receptor activation .	T6	T21	11972613
NA	CHEMICAL	GENE-N	13	10	The objective of the current study was to determine whether a low-dose subchronic chemical treatment ( 100 μg/kg for 8 consecutive days ) exerts long-term effects on apoptosis in the adult rat prefrontal cortex ( PFC ) by examining the expression of cell death-promoting molecules ( chemical polymerase ( gene ) , gene , gene , cleaved gene , gene ) and cell-survival molecules ( gene , gene ) .	T6	T18	23551329
NA	CHEMICAL	GENE-N	13	49	The objective of the current study was to determine whether a low-dose subchronic chemical treatment ( 100 μg/kg for 8 consecutive days ) exerts long-term effects on apoptosis in the adult rat prefrontal cortex ( PFC ) by examining the expression of cell death-promoting molecules ( chemical polymerase ( gene ) , gene , gene , cleaved gene , gene ) and cell-survival molecules ( gene , gene ) .	T6	T19	23551329
NA	CHEMICAL	GENE-Y	13	52	The objective of the current study was to determine whether a low-dose subchronic chemical treatment ( 100 μg/kg for 8 consecutive days ) exerts long-term effects on apoptosis in the adult rat prefrontal cortex ( PFC ) by examining the expression of cell death-promoting molecules ( chemical polymerase ( gene ) , gene , gene , cleaved gene , gene ) and cell-survival molecules ( gene , gene ) .	T6	T20	23551329
NA	CHEMICAL	GENE-Y	13	54	The objective of the current study was to determine whether a low-dose subchronic chemical treatment ( 100 μg/kg for 8 consecutive days ) exerts long-term effects on apoptosis in the adult rat prefrontal cortex ( PFC ) by examining the expression of cell death-promoting molecules ( chemical polymerase ( gene ) , gene , gene , cleaved gene , gene ) and cell-survival molecules ( gene , gene ) .	T6	T21	23551329
NA	CHEMICAL	GENE-Y	13	57	The objective of the current study was to determine whether a low-dose subchronic chemical treatment ( 100 μg/kg for 8 consecutive days ) exerts long-term effects on apoptosis in the adult rat prefrontal cortex ( PFC ) by examining the expression of cell death-promoting molecules ( chemical polymerase ( gene ) , gene , gene , cleaved gene , gene ) and cell-survival molecules ( gene , gene ) .	T6	T22	23551329
NA	CHEMICAL	GENE-Y	13	10	The objective of the current study was to determine whether a low-dose subchronic chemical treatment ( 100 μg/kg for 8 consecutive days ) exerts long-term effects on apoptosis in the adult rat prefrontal cortex ( PFC ) by examining the expression of cell death-promoting molecules ( chemical polymerase ( gene ) , gene , gene , cleaved gene , gene ) and cell-survival molecules ( gene , gene ) .	T6	T23	23551329
NA	CHEMICAL	GENE-N	13	65	The objective of the current study was to determine whether a low-dose subchronic chemical treatment ( 100 μg/kg for 8 consecutive days ) exerts long-term effects on apoptosis in the adult rat prefrontal cortex ( PFC ) by examining the expression of cell death-promoting molecules ( chemical polymerase ( gene ) , gene , gene , cleaved gene , gene ) and cell-survival molecules ( gene , gene ) .	T6	T24	23551329
NA	CHEMICAL	GENE-Y	13	67	The objective of the current study was to determine whether a low-dose subchronic chemical treatment ( 100 μg/kg for 8 consecutive days ) exerts long-term effects on apoptosis in the adult rat prefrontal cortex ( PFC ) by examining the expression of cell death-promoting molecules ( chemical polymerase ( gene ) , gene , gene , cleaved gene , gene ) and cell-survival molecules ( gene , gene ) .	T6	T25	23551329
NA	CHEMICAL	GENE-N	15	10	The objective of the current study was to determine whether a low-dose subchronic chemical treatment ( 100 μg/kg for 8 consecutive days ) exerts long-term effects on apoptosis in the adult rat prefrontal cortex ( PFC ) by examining the expression of cell death-promoting molecules ( chemical polymerase ( gene ) , gene , gene , cleaved gene , gene ) and cell-survival molecules ( gene , gene ) .	T8	T18	23551329
NA	CHEMICAL	GENE-N	15	49	The objective of the current study was to determine whether a low-dose subchronic chemical treatment ( 100 μg/kg for 8 consecutive days ) exerts long-term effects on apoptosis in the adult rat prefrontal cortex ( PFC ) by examining the expression of cell death-promoting molecules ( chemical polymerase ( gene ) , gene , gene , cleaved gene , gene ) and cell-survival molecules ( gene , gene ) .	T8	T19	23551329
NA	CHEMICAL	GENE-Y	15	52	The objective of the current study was to determine whether a low-dose subchronic chemical treatment ( 100 μg/kg for 8 consecutive days ) exerts long-term effects on apoptosis in the adult rat prefrontal cortex ( PFC ) by examining the expression of cell death-promoting molecules ( chemical polymerase ( gene ) , gene , gene , cleaved gene , gene ) and cell-survival molecules ( gene , gene ) .	T8	T20	23551329
NA	CHEMICAL	GENE-Y	15	54	The objective of the current study was to determine whether a low-dose subchronic chemical treatment ( 100 μg/kg for 8 consecutive days ) exerts long-term effects on apoptosis in the adult rat prefrontal cortex ( PFC ) by examining the expression of cell death-promoting molecules ( chemical polymerase ( gene ) , gene , gene , cleaved gene , gene ) and cell-survival molecules ( gene , gene ) .	T8	T21	23551329
NA	CHEMICAL	GENE-Y	15	57	The objective of the current study was to determine whether a low-dose subchronic chemical treatment ( 100 μg/kg for 8 consecutive days ) exerts long-term effects on apoptosis in the adult rat prefrontal cortex ( PFC ) by examining the expression of cell death-promoting molecules ( chemical polymerase ( gene ) , gene , gene , cleaved gene , gene ) and cell-survival molecules ( gene , gene ) .	T8	T22	23551329
NA	CHEMICAL	GENE-Y	15	10	The objective of the current study was to determine whether a low-dose subchronic chemical treatment ( 100 μg/kg for 8 consecutive days ) exerts long-term effects on apoptosis in the adult rat prefrontal cortex ( PFC ) by examining the expression of cell death-promoting molecules ( chemical polymerase ( gene ) , gene , gene , cleaved gene , gene ) and cell-survival molecules ( gene , gene ) .	T8	T23	23551329
NA	CHEMICAL	GENE-N	15	65	The objective of the current study was to determine whether a low-dose subchronic chemical treatment ( 100 μg/kg for 8 consecutive days ) exerts long-term effects on apoptosis in the adult rat prefrontal cortex ( PFC ) by examining the expression of cell death-promoting molecules ( chemical polymerase ( gene ) , gene , gene , cleaved gene , gene ) and cell-survival molecules ( gene , gene ) .	T8	T24	23551329
NA	CHEMICAL	GENE-Y	15	67	The objective of the current study was to determine whether a low-dose subchronic chemical treatment ( 100 μg/kg for 8 consecutive days ) exerts long-term effects on apoptosis in the adult rat prefrontal cortex ( PFC ) by examining the expression of cell death-promoting molecules ( chemical polymerase ( gene ) , gene , gene , cleaved gene , gene ) and cell-survival molecules ( gene , gene ) .	T8	T25	23551329
CPR:3	CHEMICAL	GENE-N	3	7	In PFC , chemical caused activation of gene , augmentation of pro-survival gene protein and enhanced gene/gene protein ratio , as well gene translocation to mitochondria .	T11	T26	23551329
CPR:3	CHEMICAL	GENE-Y	3	12	In PFC , chemical caused activation of gene , augmentation of pro-survival gene protein and enhanced gene/gene protein ratio , as well gene translocation to mitochondria .	T11	T27	23551329
CPR:3	CHEMICAL	GENE-Y	3	16	In PFC , chemical caused activation of gene , augmentation of pro-survival gene protein and enhanced gene/gene protein ratio , as well gene translocation to mitochondria .	T11	T28	23551329
CPR:3	CHEMICAL	GENE-Y	3	16	In PFC , chemical caused activation of gene , augmentation of pro-survival gene protein and enhanced gene/gene protein ratio , as well gene translocation to mitochondria .	T11	T29	23551329
NA	CHEMICAL	GENE-Y	3	22	In PFC , chemical caused activation of gene , augmentation of pro-survival gene protein and enhanced gene/gene protein ratio , as well gene translocation to mitochondria .	T11	T30	23551329
CPR:4	CHEMICAL	GENE-Y	7	7	Results of RT-PCR analysis showed decrease of gene mRNA level and no significant difference in gene and gene mRNA expressions in chemical-treated rats .	T1	T15	23551329
NA	CHEMICAL	GENE-Y	7	15	Results of RT-PCR analysis showed decrease of gene mRNA level and no significant difference in gene and gene mRNA expressions in chemical-treated rats .	T1	T16	23551329
NA	CHEMICAL	GENE-Y	7	17	Results of RT-PCR analysis showed decrease of gene mRNA level and no significant difference in gene and gene mRNA expressions in chemical-treated rats .	T1	T17	23551329
CPR:4	CHEMICAL	GENE-Y	0	2	chemical inhibits gene release and delays progression of amyotrophic lateral sclerosis in mice .	T11	T21	11986668
CPR:4	CHEMICAL	GENE-Y	3	7	We find that chemical inhibits mitochondrial permeability-transition-mediated gene release .	T8	T19	11986668
CPR:4	CHEMICAL	GENE-Y	0	3	chemical-mediated inhibition of gene release is demonstrated in vivo , in cells , and in isolated mitochondria .	T9	T20	11986668
NA	CHEMICAL	GENE-Y	2	12	Alkaptonuria , a rare autosomal recessive disorder caused by mutations in the gene gene and deficiency of chemical 1,2 dioxygenase , is characterized by ochronosis , arthritis , and daily excretion of gram quantities of chemical ( chemical ) .	T1	T21	15931605
NA	CHEMICAL	GENE-Y	2	2	Alkaptonuria , a rare autosomal recessive disorder caused by mutations in the gene gene and deficiency of chemical 1,2 dioxygenase , is characterized by ochronosis , arthritis , and daily excretion of gram quantities of chemical ( chemical ) .	T1	T18	15931605
NA	CHEMICAL	GENE-Y	2	12	Alkaptonuria , a rare autosomal recessive disorder caused by mutations in the gene gene and deficiency of chemical 1,2 dioxygenase , is characterized by ochronosis , arthritis , and daily excretion of gram quantities of chemical ( chemical ) .	T7	T21	15931605
NA	CHEMICAL	GENE-Y	2	2	Alkaptonuria , a rare autosomal recessive disorder caused by mutations in the gene gene and deficiency of chemical 1,2 dioxygenase , is characterized by ochronosis , arthritis , and daily excretion of gram quantities of chemical ( chemical ) .	T7	T18	15931605
NA	CHEMICAL	GENE-Y	37	12	Alkaptonuria , a rare autosomal recessive disorder caused by mutations in the gene gene and deficiency of chemical 1,2 dioxygenase , is characterized by ochronosis , arthritis , and daily excretion of gram quantities of chemical ( chemical ) .	T8	T21	15931605
NA	CHEMICAL	GENE-Y	37	2	Alkaptonuria , a rare autosomal recessive disorder caused by mutations in the gene gene and deficiency of chemical 1,2 dioxygenase , is characterized by ochronosis , arthritis , and daily excretion of gram quantities of chemical ( chemical ) .	T8	T18	15931605
NA	CHEMICAL	GENE-Y	7	8	Nitisinone , an inhibitor of the enzyme chemical dioxygenase , can drastically reduce urinary excretion of chemical in individuals with alkaptonuria .	T9	T20	15931605
NA	CHEMICAL	GENE-Y	16	8	Nitisinone , an inhibitor of the enzyme chemical dioxygenase , can drastically reduce urinary excretion of chemical in individuals with alkaptonuria .	T10	T20	15931605
NA	CHEMICAL	GENE-Y	5	0	gene interacts with gene ( gene ) , gene and other gene at the cell membrane and contributes to activation of the genegene and gene ( gene ) gene ( gene ) pathways .	T1	T8	22580612
NA	CHEMICAL	GENE-Y	5	3	gene interacts with gene ( gene ) , gene and other gene at the cell membrane and contributes to activation of the genegene and gene ( gene ) gene ( gene ) pathways .	T1	T9	22580612
NA	CHEMICAL	GENE-Y	5	5	gene interacts with gene ( gene ) , gene and other gene at the cell membrane and contributes to activation of the genegene and gene ( gene ) gene ( gene ) pathways .	T1	T10	22580612
NA	CHEMICAL	GENE-Y	5	8	gene interacts with gene ( gene ) , gene and other gene at the cell membrane and contributes to activation of the genegene and gene ( gene ) gene ( gene ) pathways .	T1	T11	22580612
NA	CHEMICAL	GENE-N	5	11	gene interacts with gene ( gene ) , gene and other gene at the cell membrane and contributes to activation of the genegene and gene ( gene ) gene ( gene ) pathways .	T1	T12	22580612
NA	CHEMICAL	GENE-N	5	22	gene interacts with gene ( gene ) , gene and other gene at the cell membrane and contributes to activation of the genegene and gene ( gene ) gene ( gene ) pathways .	T1	T13	22580612
NA	CHEMICAL	GENE-N	5	22	gene interacts with gene ( gene ) , gene and other gene at the cell membrane and contributes to activation of the genegene and gene ( gene ) gene ( gene ) pathways .	T1	T14	22580612
NA	CHEMICAL	GENE-N	5	24	gene interacts with gene ( gene ) , gene and other gene at the cell membrane and contributes to activation of the genegene and gene ( gene ) gene ( gene ) pathways .	T1	T15	22580612
NA	CHEMICAL	GENE-N	5	26	gene interacts with gene ( gene ) , gene and other gene at the cell membrane and contributes to activation of the genegene and gene ( gene ) gene ( gene ) pathways .	T1	T16	22580612
NA	CHEMICAL	GENE-N	5	28	gene interacts with gene ( gene ) , gene and other gene at the cell membrane and contributes to activation of the genegene and gene ( gene ) gene ( gene ) pathways .	T1	T17	22580612
NA	CHEMICAL	GENE-N	5	30	gene interacts with gene ( gene ) , gene and other gene at the cell membrane and contributes to activation of the genegene and gene ( gene ) gene ( gene ) pathways .	T1	T18	22580612
CPR:5	CHEMICAL	GENE-Y	5	7	OBJECTIVE : Preclinical evaluation of chemical , a gene ( gene ) and gene agonist , as a body-weight lowering , hypolipidemic and euglycemic agent .	T11	T31	12582227
CPR:5	CHEMICAL	GENE-Y	5	7	OBJECTIVE : Preclinical evaluation of chemical , a gene ( gene ) and gene agonist , as a body-weight lowering , hypolipidemic and euglycemic agent .	T11	T34	12582227
CPR:5	CHEMICAL	GENE-Y	5	7	OBJECTIVE : Preclinical evaluation of chemical , a gene ( gene ) and gene agonist , as a body-weight lowering , hypolipidemic and euglycemic agent .	T11	T23	12582227
CPR:5	CHEMICAL	GENE-Y	2	7	RESULTS : chemical showed concentration-dependent transactivation of gene and gene .	T19	T32	12582227
CPR:5	CHEMICAL	GENE-Y	2	9	RESULTS : chemical showed concentration-dependent transactivation of gene and gene .	T19	T33	12582227
CPR:4	CHEMICAL	GENE-Y	4	10	db/db mice treated with chemical showed 5- and 3.6-fold inhibition in chemical carboxykinase and chemical 6-phosphatase activity and 651 % and 77 % increases in the beta-oxidation enzymes chemical palmitoyltransferase and chemical acetyltransferase , respectively .	T3	T24	12582227
CPR:4	CHEMICAL	GENE-Y	4	15	db/db mice treated with chemical showed 5- and 3.6-fold inhibition in chemical carboxykinase and chemical 6-phosphatase activity and 651 % and 77 % increases in the beta-oxidation enzymes chemical palmitoyltransferase and chemical acetyltransferase , respectively .	T3	T25	12582227
CPR:3	CHEMICAL	GENE-N	4	29	db/db mice treated with chemical showed 5- and 3.6-fold inhibition in chemical carboxykinase and chemical 6-phosphatase activity and 651 % and 77 % increases in the beta-oxidation enzymes chemical palmitoyltransferase and chemical acetyltransferase , respectively .	T3	T26	12582227
CPR:3	CHEMICAL	GENE-Y	4	32	db/db mice treated with chemical showed 5- and 3.6-fold inhibition in chemical carboxykinase and chemical 6-phosphatase activity and 651 % and 77 % increases in the beta-oxidation enzymes chemical palmitoyltransferase and chemical acetyltransferase , respectively .	T3	T27	12582227
NA	CHEMICAL	GENE-Y	11	10	db/db mice treated with chemical showed 5- and 3.6-fold inhibition in chemical carboxykinase and chemical 6-phosphatase activity and 651 % and 77 % increases in the beta-oxidation enzymes chemical palmitoyltransferase and chemical acetyltransferase , respectively .	T4	T24	12582227
NA	CHEMICAL	GENE-Y	11	15	db/db mice treated with chemical showed 5- and 3.6-fold inhibition in chemical carboxykinase and chemical 6-phosphatase activity and 651 % and 77 % increases in the beta-oxidation enzymes chemical palmitoyltransferase and chemical acetyltransferase , respectively .	T4	T25	12582227
NA	CHEMICAL	GENE-N	11	29	db/db mice treated with chemical showed 5- and 3.6-fold inhibition in chemical carboxykinase and chemical 6-phosphatase activity and 651 % and 77 % increases in the beta-oxidation enzymes chemical palmitoyltransferase and chemical acetyltransferase , respectively .	T4	T26	12582227
NA	CHEMICAL	GENE-Y	11	32	db/db mice treated with chemical showed 5- and 3.6-fold inhibition in chemical carboxykinase and chemical 6-phosphatase activity and 651 % and 77 % increases in the beta-oxidation enzymes chemical palmitoyltransferase and chemical acetyltransferase , respectively .	T4	T27	12582227
NA	CHEMICAL	GENE-Y	14	10	db/db mice treated with chemical showed 5- and 3.6-fold inhibition in chemical carboxykinase and chemical 6-phosphatase activity and 651 % and 77 % increases in the beta-oxidation enzymes chemical palmitoyltransferase and chemical acetyltransferase , respectively .	T5	T24	12582227
NA	CHEMICAL	GENE-Y	14	15	db/db mice treated with chemical showed 5- and 3.6-fold inhibition in chemical carboxykinase and chemical 6-phosphatase activity and 651 % and 77 % increases in the beta-oxidation enzymes chemical palmitoyltransferase and chemical acetyltransferase , respectively .	T5	T25	12582227
NA	CHEMICAL	GENE-N	14	29	db/db mice treated with chemical showed 5- and 3.6-fold inhibition in chemical carboxykinase and chemical 6-phosphatase activity and 651 % and 77 % increases in the beta-oxidation enzymes chemical palmitoyltransferase and chemical acetyltransferase , respectively .	T5	T26	12582227
NA	CHEMICAL	GENE-Y	14	32	db/db mice treated with chemical showed 5- and 3.6-fold inhibition in chemical carboxykinase and chemical 6-phosphatase activity and 651 % and 77 % increases in the beta-oxidation enzymes chemical palmitoyltransferase and chemical acetyltransferase , respectively .	T5	T27	12582227
NA	CHEMICAL	GENE-Y	10	10	db/db mice treated with chemical showed 5- and 3.6-fold inhibition in chemical carboxykinase and chemical 6-phosphatase activity and 651 % and 77 % increases in the beta-oxidation enzymes chemical palmitoyltransferase and chemical acetyltransferase , respectively .	T6	T24	12582227
NA	CHEMICAL	GENE-Y	10	15	db/db mice treated with chemical showed 5- and 3.6-fold inhibition in chemical carboxykinase and chemical 6-phosphatase activity and 651 % and 77 % increases in the beta-oxidation enzymes chemical palmitoyltransferase and chemical acetyltransferase , respectively .	T6	T25	12582227
NA	CHEMICAL	GENE-N	10	29	db/db mice treated with chemical showed 5- and 3.6-fold inhibition in chemical carboxykinase and chemical 6-phosphatase activity and 651 % and 77 % increases in the beta-oxidation enzymes chemical palmitoyltransferase and chemical acetyltransferase , respectively .	T6	T26	12582227
NA	CHEMICAL	GENE-Y	10	32	db/db mice treated with chemical showed 5- and 3.6-fold inhibition in chemical carboxykinase and chemical 6-phosphatase activity and 651 % and 77 % increases in the beta-oxidation enzymes chemical palmitoyltransferase and chemical acetyltransferase , respectively .	T6	T27	12582227
NA	CHEMICAL	GENE-Y	10	10	db/db mice treated with chemical showed 5- and 3.6-fold inhibition in chemical carboxykinase and chemical 6-phosphatase activity and 651 % and 77 % increases in the beta-oxidation enzymes chemical palmitoyltransferase and chemical acetyltransferase , respectively .	T7	T24	12582227
NA	CHEMICAL	GENE-Y	10	15	db/db mice treated with chemical showed 5- and 3.6-fold inhibition in chemical carboxykinase and chemical 6-phosphatase activity and 651 % and 77 % increases in the beta-oxidation enzymes chemical palmitoyltransferase and chemical acetyltransferase , respectively .	T7	T25	12582227
NA	CHEMICAL	GENE-N	10	29	db/db mice treated with chemical showed 5- and 3.6-fold inhibition in chemical carboxykinase and chemical 6-phosphatase activity and 651 % and 77 % increases in the beta-oxidation enzymes chemical palmitoyltransferase and chemical acetyltransferase , respectively .	T7	T26	12582227
NA	CHEMICAL	GENE-Y	10	32	db/db mice treated with chemical showed 5- and 3.6-fold inhibition in chemical carboxykinase and chemical 6-phosphatase activity and 651 % and 77 % increases in the beta-oxidation enzymes chemical palmitoyltransferase and chemical acetyltransferase , respectively .	T7	T27	12582227
NA	CHEMICAL	GENE-Y	5	7	In vitro antiprogestational/antiglucocorticoid activity and chemical and gene binding of the putative metabolites and synthetic derivatives of chemical , chemical , and chemical .	T38	T54	15120421
NA	CHEMICAL	GENE-Y	17	7	In vitro antiprogestational/antiglucocorticoid activity and chemical and gene binding of the putative metabolites and synthetic derivatives of chemical , chemical , and chemical .	T35	T54	15120421
NA	CHEMICAL	GENE-Y	19	7	In vitro antiprogestational/antiglucocorticoid activity and chemical and gene binding of the putative metabolites and synthetic derivatives of chemical , chemical , and chemical .	T36	T54	15120421
NA	CHEMICAL	GENE-Y	22	7	In vitro antiprogestational/antiglucocorticoid activity and chemical and gene binding of the putative metabolites and synthetic derivatives of chemical , chemical , and chemical .	T37	T54	15120421
NA	CHEMICAL	GENE-N	22	23	We have examined the functional activities and potencies , in various cell-based assays , and relative binding affinities ( RBAs ) for chemical receptors ( gene ) and gene ( gene ) of the putative mono- and didemethylated metabolites of chemical , chemical , and chemical and of the chemical and aromatic A-ring derivatives of chemical and chemical .	T28	T46	15120421
NA	CHEMICAL	GENE-N	22	25	We have examined the functional activities and potencies , in various cell-based assays , and relative binding affinities ( RBAs ) for chemical receptors ( gene ) and gene ( gene ) of the putative mono- and didemethylated metabolites of chemical , chemical , and chemical and of the chemical and aromatic A-ring derivatives of chemical and chemical .	T28	T47	15120421
NA	CHEMICAL	GENE-Y	22	23	We have examined the functional activities and potencies , in various cell-based assays , and relative binding affinities ( RBAs ) for chemical receptors ( gene ) and gene ( gene ) of the putative mono- and didemethylated metabolites of chemical , chemical , and chemical and of the chemical and aromatic A-ring derivatives of chemical and chemical .	T28	T48	15120421
NA	CHEMICAL	GENE-Y	22	30	We have examined the functional activities and potencies , in various cell-based assays , and relative binding affinities ( RBAs ) for chemical receptors ( gene ) and gene ( gene ) of the putative mono- and didemethylated metabolites of chemical , chemical , and chemical and of the chemical and aromatic A-ring derivatives of chemical and chemical .	T28	T49	15120421
NA	CHEMICAL	GENE-N	40	23	We have examined the functional activities and potencies , in various cell-based assays , and relative binding affinities ( RBAs ) for chemical receptors ( gene ) and gene ( gene ) of the putative mono- and didemethylated metabolites of chemical , chemical , and chemical and of the chemical and aromatic A-ring derivatives of chemical and chemical .	T29	T46	15120421
NA	CHEMICAL	GENE-N	40	25	We have examined the functional activities and potencies , in various cell-based assays , and relative binding affinities ( RBAs ) for chemical receptors ( gene ) and gene ( gene ) of the putative mono- and didemethylated metabolites of chemical , chemical , and chemical and of the chemical and aromatic A-ring derivatives of chemical and chemical .	T29	T47	15120421
NA	CHEMICAL	GENE-Y	40	23	We have examined the functional activities and potencies , in various cell-based assays , and relative binding affinities ( RBAs ) for chemical receptors ( gene ) and gene ( gene ) of the putative mono- and didemethylated metabolites of chemical , chemical , and chemical and of the chemical and aromatic A-ring derivatives of chemical and chemical .	T29	T48	15120421
NA	CHEMICAL	GENE-Y	40	30	We have examined the functional activities and potencies , in various cell-based assays , and relative binding affinities ( RBAs ) for chemical receptors ( gene ) and gene ( gene ) of the putative mono- and didemethylated metabolites of chemical , chemical , and chemical and of the chemical and aromatic A-ring derivatives of chemical and chemical .	T29	T49	15120421
NA	CHEMICAL	GENE-N	42	23	We have examined the functional activities and potencies , in various cell-based assays , and relative binding affinities ( RBAs ) for chemical receptors ( gene ) and gene ( gene ) of the putative mono- and didemethylated metabolites of chemical , chemical , and chemical and of the chemical and aromatic A-ring derivatives of chemical and chemical .	T30	T46	15120421
NA	CHEMICAL	GENE-N	42	25	We have examined the functional activities and potencies , in various cell-based assays , and relative binding affinities ( RBAs ) for chemical receptors ( gene ) and gene ( gene ) of the putative mono- and didemethylated metabolites of chemical , chemical , and chemical and of the chemical and aromatic A-ring derivatives of chemical and chemical .	T30	T47	15120421
NA	CHEMICAL	GENE-Y	42	23	We have examined the functional activities and potencies , in various cell-based assays , and relative binding affinities ( RBAs ) for chemical receptors ( gene ) and gene ( gene ) of the putative mono- and didemethylated metabolites of chemical , chemical , and chemical and of the chemical and aromatic A-ring derivatives of chemical and chemical .	T30	T48	15120421
NA	CHEMICAL	GENE-Y	42	30	We have examined the functional activities and potencies , in various cell-based assays , and relative binding affinities ( RBAs ) for chemical receptors ( gene ) and gene ( gene ) of the putative mono- and didemethylated metabolites of chemical , chemical , and chemical and of the chemical and aromatic A-ring derivatives of chemical and chemical .	T30	T49	15120421
NA	CHEMICAL	GENE-N	45	23	We have examined the functional activities and potencies , in various cell-based assays , and relative binding affinities ( RBAs ) for chemical receptors ( gene ) and gene ( gene ) of the putative mono- and didemethylated metabolites of chemical , chemical , and chemical and of the chemical and aromatic A-ring derivatives of chemical and chemical .	T31	T46	15120421
NA	CHEMICAL	GENE-N	45	25	We have examined the functional activities and potencies , in various cell-based assays , and relative binding affinities ( RBAs ) for chemical receptors ( gene ) and gene ( gene ) of the putative mono- and didemethylated metabolites of chemical , chemical , and chemical and of the chemical and aromatic A-ring derivatives of chemical and chemical .	T31	T47	15120421
NA	CHEMICAL	GENE-Y	45	23	We have examined the functional activities and potencies , in various cell-based assays , and relative binding affinities ( RBAs ) for chemical receptors ( gene ) and gene ( gene ) of the putative mono- and didemethylated metabolites of chemical , chemical , and chemical and of the chemical and aromatic A-ring derivatives of chemical and chemical .	T31	T48	15120421
NA	CHEMICAL	GENE-Y	45	30	We have examined the functional activities and potencies , in various cell-based assays , and relative binding affinities ( RBAs ) for chemical receptors ( gene ) and gene ( gene ) of the putative mono- and didemethylated metabolites of chemical , chemical , and chemical and of the chemical and aromatic A-ring derivatives of chemical and chemical .	T31	T49	15120421
NA	CHEMICAL	GENE-N	49	23	We have examined the functional activities and potencies , in various cell-based assays , and relative binding affinities ( RBAs ) for chemical receptors ( gene ) and gene ( gene ) of the putative mono- and didemethylated metabolites of chemical , chemical , and chemical and of the chemical and aromatic A-ring derivatives of chemical and chemical .	T32	T46	15120421
NA	CHEMICAL	GENE-N	49	25	We have examined the functional activities and potencies , in various cell-based assays , and relative binding affinities ( RBAs ) for chemical receptors ( gene ) and gene ( gene ) of the putative mono- and didemethylated metabolites of chemical , chemical , and chemical and of the chemical and aromatic A-ring derivatives of chemical and chemical .	T32	T47	15120421
NA	CHEMICAL	GENE-Y	49	23	We have examined the functional activities and potencies , in various cell-based assays , and relative binding affinities ( RBAs ) for chemical receptors ( gene ) and gene ( gene ) of the putative mono- and didemethylated metabolites of chemical , chemical , and chemical and of the chemical and aromatic A-ring derivatives of chemical and chemical .	T32	T48	15120421
NA	CHEMICAL	GENE-Y	49	30	We have examined the functional activities and potencies , in various cell-based assays , and relative binding affinities ( RBAs ) for chemical receptors ( gene ) and gene ( gene ) of the putative mono- and didemethylated metabolites of chemical , chemical , and chemical and of the chemical and aromatic A-ring derivatives of chemical and chemical .	T32	T49	15120421
NA	CHEMICAL	GENE-N	55	23	We have examined the functional activities and potencies , in various cell-based assays , and relative binding affinities ( RBAs ) for chemical receptors ( gene ) and gene ( gene ) of the putative mono- and didemethylated metabolites of chemical , chemical , and chemical and of the chemical and aromatic A-ring derivatives of chemical and chemical .	T33	T46	15120421
NA	CHEMICAL	GENE-N	55	25	We have examined the functional activities and potencies , in various cell-based assays , and relative binding affinities ( RBAs ) for chemical receptors ( gene ) and gene ( gene ) of the putative mono- and didemethylated metabolites of chemical , chemical , and chemical and of the chemical and aromatic A-ring derivatives of chemical and chemical .	T33	T47	15120421
NA	CHEMICAL	GENE-Y	55	23	We have examined the functional activities and potencies , in various cell-based assays , and relative binding affinities ( RBAs ) for chemical receptors ( gene ) and gene ( gene ) of the putative mono- and didemethylated metabolites of chemical , chemical , and chemical and of the chemical and aromatic A-ring derivatives of chemical and chemical .	T33	T48	15120421
NA	CHEMICAL	GENE-Y	55	30	We have examined the functional activities and potencies , in various cell-based assays , and relative binding affinities ( RBAs ) for chemical receptors ( gene ) and gene ( gene ) of the putative mono- and didemethylated metabolites of chemical , chemical , and chemical and of the chemical and aromatic A-ring derivatives of chemical and chemical .	T33	T49	15120421
NA	CHEMICAL	GENE-N	57	23	We have examined the functional activities and potencies , in various cell-based assays , and relative binding affinities ( RBAs ) for chemical receptors ( gene ) and gene ( gene ) of the putative mono- and didemethylated metabolites of chemical , chemical , and chemical and of the chemical and aromatic A-ring derivatives of chemical and chemical .	T34	T46	15120421
NA	CHEMICAL	GENE-N	57	25	We have examined the functional activities and potencies , in various cell-based assays , and relative binding affinities ( RBAs ) for chemical receptors ( gene ) and gene ( gene ) of the putative mono- and didemethylated metabolites of chemical , chemical , and chemical and of the chemical and aromatic A-ring derivatives of chemical and chemical .	T34	T47	15120421
NA	CHEMICAL	GENE-Y	57	23	We have examined the functional activities and potencies , in various cell-based assays , and relative binding affinities ( RBAs ) for chemical receptors ( gene ) and gene ( gene ) of the putative mono- and didemethylated metabolites of chemical , chemical , and chemical and of the chemical and aromatic A-ring derivatives of chemical and chemical .	T34	T48	15120421
NA	CHEMICAL	GENE-Y	57	30	We have examined the functional activities and potencies , in various cell-based assays , and relative binding affinities ( RBAs ) for chemical receptors ( gene ) and gene ( gene ) of the putative mono- and didemethylated metabolites of chemical , chemical , and chemical and of the chemical and aromatic A-ring derivatives of chemical and chemical .	T34	T49	15120421
NA	CHEMICAL	GENE-Y	1	4	Monodemethylated chemical bound to gene with higher affinity than monodemethylated chemical or chemical .	T1	T39	15120421
NA	CHEMICAL	GENE-Y	10	4	Monodemethylated chemical bound to gene with higher affinity than monodemethylated chemical or chemical .	T2	T39	15120421
NA	CHEMICAL	GENE-Y	4	4	Monodemethylated chemical bound to gene with higher affinity than monodemethylated chemical or chemical .	T3	T39	15120421
NA	CHEMICAL	GENE-N	10	10	T47D-CO cells were used to assess inhibition of R5020-stimulated endogenous gene activity and transactivation of the gene-chemical kinase ( gene ) -luciferase ( LUC ) reporter plasmid in transient transfections .	T4	T40	15120421
NA	CHEMICAL	GENE-N	10	16	T47D-CO cells were used to assess inhibition of R5020-stimulated endogenous gene activity and transactivation of the gene-chemical kinase ( gene ) -luciferase ( LUC ) reporter plasmid in transient transfections .	T4	T41	15120421
NA	CHEMICAL	GENE-N	10	17	T47D-CO cells were used to assess inhibition of R5020-stimulated endogenous gene activity and transactivation of the gene-chemical kinase ( gene ) -luciferase ( LUC ) reporter plasmid in transient transfections .	T4	T42	15120421
NA	CHEMICAL	GENE-N	10	19	T47D-CO cells were used to assess inhibition of R5020-stimulated endogenous gene activity and transactivation of the gene-chemical kinase ( gene ) -luciferase ( LUC ) reporter plasmid in transient transfections .	T4	T43	15120421
NA	CHEMICAL	GENE-Y	6	6	At 10 ( -6 ) M in transcription assays , none of these compounds showed chemical agonist activity , whereas chemical and its monodemethylated metabolite manifested slight gene agonist activity .	T13	T44	15120421
NA	CHEMICAL	GENE-Y	6	27	At 10 ( -6 ) M in transcription assays , none of these compounds showed chemical agonist activity , whereas chemical and its monodemethylated metabolite manifested slight gene agonist activity .	T13	T45	15120421
NA	CHEMICAL	GENE-Y	20	6	At 10 ( -6 ) M in transcription assays , none of these compounds showed chemical agonist activity , whereas chemical and its monodemethylated metabolite manifested slight gene agonist activity .	T14	T44	15120421
CPR:5	CHEMICAL	GENE-Y	20	27	At 10 ( -6 ) M in transcription assays , none of these compounds showed chemical agonist activity , whereas chemical and its monodemethylated metabolite manifested slight gene agonist activity .	T14	T45	15120421
NA	CHEMICAL	GENE-Y	1	25	The chemical sequence data reported will appear in DDBJ , EMBL , GenBank ( R ) and GSDB chemical Sequence Databases ; the sequences of gene and gene cDNAs have the accession numbers gene and gene respectively and the partial adipose tissue and liver gene clones have the accession numbers gene and gene respectively .	T9	T20	12662154
NA	CHEMICAL	GENE-Y	1	27	The chemical sequence data reported will appear in DDBJ , EMBL , GenBank ( R ) and GSDB chemical Sequence Databases ; the sequences of gene and gene cDNAs have the accession numbers gene and gene respectively and the partial adipose tissue and liver gene clones have the accession numbers gene and gene respectively .	T9	T24	12662154
NA	CHEMICAL	GENE-Y	1	33	The chemical sequence data reported will appear in DDBJ , EMBL , GenBank ( R ) and GSDB chemical Sequence Databases ; the sequences of gene and gene cDNAs have the accession numbers gene and gene respectively and the partial adipose tissue and liver gene clones have the accession numbers gene and gene respectively .	T9	T28	12662154
NA	CHEMICAL	GENE-Y	1	35	The chemical sequence data reported will appear in DDBJ , EMBL , GenBank ( R ) and GSDB chemical Sequence Databases ; the sequences of gene and gene cDNAs have the accession numbers gene and gene respectively and the partial adipose tissue and liver gene clones have the accession numbers gene and gene respectively .	T9	T29	12662154
NA	CHEMICAL	GENE-Y	1	44	The chemical sequence data reported will appear in DDBJ , EMBL , GenBank ( R ) and GSDB chemical Sequence Databases ; the sequences of gene and gene cDNAs have the accession numbers gene and gene respectively and the partial adipose tissue and liver gene clones have the accession numbers gene and gene respectively .	T9	T31	12662154
NA	CHEMICAL	GENE-Y	1	50	The chemical sequence data reported will appear in DDBJ , EMBL , GenBank ( R ) and GSDB chemical Sequence Databases ; the sequences of gene and gene cDNAs have the accession numbers gene and gene respectively and the partial adipose tissue and liver gene clones have the accession numbers gene and gene respectively .	T9	T32	12662154
NA	CHEMICAL	GENE-Y	1	52	The chemical sequence data reported will appear in DDBJ , EMBL , GenBank ( R ) and GSDB chemical Sequence Databases ; the sequences of gene and gene cDNAs have the accession numbers gene and gene respectively and the partial adipose tissue and liver gene clones have the accession numbers gene and gene respectively .	T9	T33	12662154
NA	CHEMICAL	GENE-Y	18	25	The chemical sequence data reported will appear in DDBJ , EMBL , GenBank ( R ) and GSDB chemical Sequence Databases ; the sequences of gene and gene cDNAs have the accession numbers gene and gene respectively and the partial adipose tissue and liver gene clones have the accession numbers gene and gene respectively .	T12	T20	12662154
NA	CHEMICAL	GENE-Y	18	27	The chemical sequence data reported will appear in DDBJ , EMBL , GenBank ( R ) and GSDB chemical Sequence Databases ; the sequences of gene and gene cDNAs have the accession numbers gene and gene respectively and the partial adipose tissue and liver gene clones have the accession numbers gene and gene respectively .	T12	T24	12662154
NA	CHEMICAL	GENE-Y	18	33	The chemical sequence data reported will appear in DDBJ , EMBL , GenBank ( R ) and GSDB chemical Sequence Databases ; the sequences of gene and gene cDNAs have the accession numbers gene and gene respectively and the partial adipose tissue and liver gene clones have the accession numbers gene and gene respectively .	T12	T28	12662154
NA	CHEMICAL	GENE-Y	18	35	The chemical sequence data reported will appear in DDBJ , EMBL , GenBank ( R ) and GSDB chemical Sequence Databases ; the sequences of gene and gene cDNAs have the accession numbers gene and gene respectively and the partial adipose tissue and liver gene clones have the accession numbers gene and gene respectively .	T12	T29	12662154
NA	CHEMICAL	GENE-Y	18	44	The chemical sequence data reported will appear in DDBJ , EMBL , GenBank ( R ) and GSDB chemical Sequence Databases ; the sequences of gene and gene cDNAs have the accession numbers gene and gene respectively and the partial adipose tissue and liver gene clones have the accession numbers gene and gene respectively .	T12	T31	12662154
NA	CHEMICAL	GENE-Y	18	50	The chemical sequence data reported will appear in DDBJ , EMBL , GenBank ( R ) and GSDB chemical Sequence Databases ; the sequences of gene and gene cDNAs have the accession numbers gene and gene respectively and the partial adipose tissue and liver gene clones have the accession numbers gene and gene respectively .	T12	T32	12662154
NA	CHEMICAL	GENE-Y	18	52	The chemical sequence data reported will appear in DDBJ , EMBL , GenBank ( R ) and GSDB chemical Sequence Databases ; the sequences of gene and gene cDNAs have the accession numbers gene and gene respectively and the partial adipose tissue and liver gene clones have the accession numbers gene and gene respectively .	T12	T33	12662154
NA	CHEMICAL	GENE-Y	0	2	chemical palmitoyltransferase 1 ( gene ) is the key locus for the control of long-chain chemical beta-oxidation and liver ketogenesis .	T10	T34	12662154
NA	CHEMICAL	GENE-Y	0	2	chemical palmitoyltransferase 1 ( gene ) is the key locus for the control of long-chain chemical beta-oxidation and liver ketogenesis .	T10	T35	12662154
NA	CHEMICAL	GENE-Y	15	2	chemical palmitoyltransferase 1 ( gene ) is the key locus for the control of long-chain chemical beta-oxidation and liver ketogenesis .	T11	T34	12662154
NA	CHEMICAL	GENE-Y	15	2	chemical palmitoyltransferase 1 ( gene ) is the key locus for the control of long-chain chemical beta-oxidation and liver ketogenesis .	T11	T35	12662154
NA	CHEMICAL	GENE-Y	5	26	Their deduced chemical sequences show a high degree of conservation compared with orthologues from other mammalian species , with the notable exception of the chemical-terminus of gene .	T13	T16	12662154
NA	CHEMICAL	GENE-Y	2	26	Their deduced chemical sequences show a high degree of conservation compared with orthologues from other mammalian species , with the notable exception of the chemical-terminus of gene .	T1	T16	12662154
NA	CHEMICAL	GENE-Y	20	23	Expression in yeast allowed kinetic characterization of the two native enzymes , and of a chimaera in which the distinctive chemical-terminal segment of gene was replaced with that from gene .	T3	T26	12662154
NA	CHEMICAL	GENE-Y	20	29	Expression in yeast allowed kinetic characterization of the two native enzymes , and of a chimaera in which the distinctive chemical-terminal segment of gene was replaced with that from gene .	T3	T27	12662154
CPR:4	CHEMICAL	GENE-N	0	10	chemical ( chemical ( ® ) , AstraZeneca ) is a once-daily oral chemical kinase inhibitor that selectively inhibits signalling mediated by growth-factor receptor gene gene ( constitutively activated in roughly 60 % of all MTCs ) , gene , and gene .	T2	T7	23584948
CPR:4	CHEMICAL	GENE-N	0	10	chemical ( chemical ( ® ) , AstraZeneca ) is a once-daily oral chemical kinase inhibitor that selectively inhibits signalling mediated by growth-factor receptor gene gene ( constitutively activated in roughly 60 % of all MTCs ) , gene , and gene .	T2	T8	23584948
CPR:4	CHEMICAL	GENE-Y	0	25	chemical ( chemical ( ® ) , AstraZeneca ) is a once-daily oral chemical kinase inhibitor that selectively inhibits signalling mediated by growth-factor receptor gene gene ( constitutively activated in roughly 60 % of all MTCs ) , gene , and gene .	T2	T9	23584948
NA	CHEMICAL	GENE-N	0	38	chemical ( chemical ( ® ) , AstraZeneca ) is a once-daily oral chemical kinase inhibitor that selectively inhibits signalling mediated by growth-factor receptor gene gene ( constitutively activated in roughly 60 % of all MTCs ) , gene , and gene .	T2	T10	23584948
CPR:4	CHEMICAL	GENE-Y	0	23	chemical ( chemical ( ® ) , AstraZeneca ) is a once-daily oral chemical kinase inhibitor that selectively inhibits signalling mediated by growth-factor receptor gene gene ( constitutively activated in roughly 60 % of all MTCs ) , gene , and gene .	T2	T11	23584948
CPR:4	CHEMICAL	GENE-N	2	10	chemical ( chemical ( ® ) , AstraZeneca ) is a once-daily oral chemical kinase inhibitor that selectively inhibits signalling mediated by growth-factor receptor gene gene ( constitutively activated in roughly 60 % of all MTCs ) , gene , and gene .	T3	T7	23584948
NA	CHEMICAL	GENE-N	2	10	chemical ( chemical ( ® ) , AstraZeneca ) is a once-daily oral chemical kinase inhibitor that selectively inhibits signalling mediated by growth-factor receptor gene gene ( constitutively activated in roughly 60 % of all MTCs ) , gene , and gene .	T3	T8	23584948
NA	CHEMICAL	GENE-Y	2	25	chemical ( chemical ( ® ) , AstraZeneca ) is a once-daily oral chemical kinase inhibitor that selectively inhibits signalling mediated by growth-factor receptor gene gene ( constitutively activated in roughly 60 % of all MTCs ) , gene , and gene .	T3	T9	23584948
NA	CHEMICAL	GENE-N	2	38	chemical ( chemical ( ® ) , AstraZeneca ) is a once-daily oral chemical kinase inhibitor that selectively inhibits signalling mediated by growth-factor receptor gene gene ( constitutively activated in roughly 60 % of all MTCs ) , gene , and gene .	T3	T10	23584948
CPR:4	CHEMICAL	GENE-Y	2	23	chemical ( chemical ( ® ) , AstraZeneca ) is a once-daily oral chemical kinase inhibitor that selectively inhibits signalling mediated by growth-factor receptor gene gene ( constitutively activated in roughly 60 % of all MTCs ) , gene , and gene .	T3	T11	23584948
NA	CHEMICAL	GENE-N	13	10	chemical ( chemical ( ® ) , AstraZeneca ) is a once-daily oral chemical kinase inhibitor that selectively inhibits signalling mediated by growth-factor receptor gene gene ( constitutively activated in roughly 60 % of all MTCs ) , gene , and gene .	T4	T7	23584948
NA	CHEMICAL	GENE-N	13	10	chemical ( chemical ( ® ) , AstraZeneca ) is a once-daily oral chemical kinase inhibitor that selectively inhibits signalling mediated by growth-factor receptor gene gene ( constitutively activated in roughly 60 % of all MTCs ) , gene , and gene .	T4	T8	23584948
NA	CHEMICAL	GENE-Y	13	25	chemical ( chemical ( ® ) , AstraZeneca ) is a once-daily oral chemical kinase inhibitor that selectively inhibits signalling mediated by growth-factor receptor gene gene ( constitutively activated in roughly 60 % of all MTCs ) , gene , and gene .	T4	T9	23584948
NA	CHEMICAL	GENE-N	13	38	chemical ( chemical ( ® ) , AstraZeneca ) is a once-daily oral chemical kinase inhibitor that selectively inhibits signalling mediated by growth-factor receptor gene gene ( constitutively activated in roughly 60 % of all MTCs ) , gene , and gene .	T4	T10	23584948
NA	CHEMICAL	GENE-Y	13	23	chemical ( chemical ( ® ) , AstraZeneca ) is a once-daily oral chemical kinase inhibitor that selectively inhibits signalling mediated by growth-factor receptor gene gene ( constitutively activated in roughly 60 % of all MTCs ) , gene , and gene .	T4	T11	23584948
NA	CHEMICAL	GENE-N	29	10	chemical ( chemical ( ® ) , AstraZeneca ) is a once-daily oral chemical kinase inhibitor that selectively inhibits signalling mediated by growth-factor receptor gene gene ( constitutively activated in roughly 60 % of all MTCs ) , gene , and gene .	T5	T7	23584948
NA	CHEMICAL	GENE-N	29	10	chemical ( chemical ( ® ) , AstraZeneca ) is a once-daily oral chemical kinase inhibitor that selectively inhibits signalling mediated by growth-factor receptor gene gene ( constitutively activated in roughly 60 % of all MTCs ) , gene , and gene .	T5	T8	23584948
NA	CHEMICAL	GENE-Y	29	25	chemical ( chemical ( ® ) , AstraZeneca ) is a once-daily oral chemical kinase inhibitor that selectively inhibits signalling mediated by growth-factor receptor gene gene ( constitutively activated in roughly 60 % of all MTCs ) , gene , and gene .	T5	T9	23584948
NA	CHEMICAL	GENE-N	29	38	chemical ( chemical ( ® ) , AstraZeneca ) is a once-daily oral chemical kinase inhibitor that selectively inhibits signalling mediated by growth-factor receptor gene gene ( constitutively activated in roughly 60 % of all MTCs ) , gene , and gene .	T5	T10	23584948
NA	CHEMICAL	GENE-Y	29	23	chemical ( chemical ( ® ) , AstraZeneca ) is a once-daily oral chemical kinase inhibitor that selectively inhibits signalling mediated by growth-factor receptor gene gene ( constitutively activated in roughly 60 % of all MTCs ) , gene , and gene .	T5	T11	23584948
CPR:4	CHEMICAL	GENE-Y	8	13	Two mechanisms of action have been identified for chemical : inhibition of chemical dehydrogenase ( gene ) and inhibition of chemical kinases .	T6	T14	9666414
CPR:4	CHEMICAL	GENE-Y	8	15	Two mechanisms of action have been identified for chemical : inhibition of chemical dehydrogenase ( gene ) and inhibition of chemical kinases .	T6	T15	9666414
CPR:4	CHEMICAL	GENE-N	8	21	Two mechanisms of action have been identified for chemical : inhibition of chemical dehydrogenase ( gene ) and inhibition of chemical kinases .	T6	T16	9666414
NA	CHEMICAL	GENE-Y	12	13	Two mechanisms of action have been identified for chemical : inhibition of chemical dehydrogenase ( gene ) and inhibition of chemical kinases .	T7	T14	9666414
NA	CHEMICAL	GENE-Y	12	15	Two mechanisms of action have been identified for chemical : inhibition of chemical dehydrogenase ( gene ) and inhibition of chemical kinases .	T7	T15	9666414
NA	CHEMICAL	GENE-N	12	21	Two mechanisms of action have been identified for chemical : inhibition of chemical dehydrogenase ( gene ) and inhibition of chemical kinases .	T7	T16	9666414
NA	CHEMICAL	GENE-Y	20	13	Two mechanisms of action have been identified for chemical : inhibition of chemical dehydrogenase ( gene ) and inhibition of chemical kinases .	T8	T14	9666414
NA	CHEMICAL	GENE-Y	20	15	Two mechanisms of action have been identified for chemical : inhibition of chemical dehydrogenase ( gene ) and inhibition of chemical kinases .	T8	T15	9666414
NA	CHEMICAL	GENE-N	20	21	Two mechanisms of action have been identified for chemical : inhibition of chemical dehydrogenase ( gene ) and inhibition of chemical kinases .	T8	T16	9666414
CPR:4	CHEMICAL	GENE-Y	7	0	gene inhibition occurs at lower concentrations of chemical than that of chemical kinases and is currently considered the major mode of action .	T9	T17	9666414
CPR:4	CHEMICAL	GENE-N	7	12	gene inhibition occurs at lower concentrations of chemical than that of chemical kinases and is currently considered the major mode of action .	T9	T18	9666414
NA	CHEMICAL	GENE-Y	11	0	gene inhibition occurs at lower concentrations of chemical than that of chemical kinases and is currently considered the major mode of action .	T10	T17	9666414
NA	CHEMICAL	GENE-N	11	12	gene inhibition occurs at lower concentrations of chemical than that of chemical kinases and is currently considered the major mode of action .	T10	T18	9666414
NA	CHEMICAL	GENE-Y	4	5	In vitro inhibition of chemical acyltransferase by chemical from Sophora flavescens .	T22	T28	15114505
CPR:4	CHEMICAL	GENE-Y	7	5	In vitro inhibition of chemical acyltransferase by chemical from Sophora flavescens .	T23	T28	15114505
CPR:4	CHEMICAL	GENE-Y	1	8	Four chemical , chemical ( 1 ) , a chemical of 1 , chemical ( 2 ) , chemical ( 3 ) , chemical ( 4 ) and chemical ( 5 ) isolated from the roots of Sophora flavescens were investigated for their inhibitory effects on chemical acyltransferase ( gene ) .	T8	T24	15114505
CPR:4	CHEMICAL	GENE-Y	1	49	Four chemical , chemical ( 1 ) , a chemical of 1 , chemical ( 2 ) , chemical ( 3 ) , chemical ( 4 ) and chemical ( 5 ) isolated from the roots of Sophora flavescens were investigated for their inhibitory effects on chemical acyltransferase ( gene ) .	T8	T25	15114505
CPR:4	CHEMICAL	GENE-Y	3	8	Four chemical , chemical ( 1 ) , a chemical of 1 , chemical ( 2 ) , chemical ( 3 ) , chemical ( 4 ) and chemical ( 5 ) isolated from the roots of Sophora flavescens were investigated for their inhibitory effects on chemical acyltransferase ( gene ) .	T3	T24	15114505
CPR:4	CHEMICAL	GENE-Y	3	49	Four chemical , chemical ( 1 ) , a chemical of 1 , chemical ( 2 ) , chemical ( 3 ) , chemical ( 4 ) and chemical ( 5 ) isolated from the roots of Sophora flavescens were investigated for their inhibitory effects on chemical acyltransferase ( gene ) .	T3	T25	15114505
CPR:4	CHEMICAL	GENE-Y	8	8	Four chemical , chemical ( 1 ) , a chemical of 1 , chemical ( 2 ) , chemical ( 3 ) , chemical ( 4 ) and chemical ( 5 ) isolated from the roots of Sophora flavescens were investigated for their inhibitory effects on chemical acyltransferase ( gene ) .	T5	T24	15114505
CPR:4	CHEMICAL	GENE-Y	8	49	Four chemical , chemical ( 1 ) , a chemical of 1 , chemical ( 2 ) , chemical ( 3 ) , chemical ( 4 ) and chemical ( 5 ) isolated from the roots of Sophora flavescens were investigated for their inhibitory effects on chemical acyltransferase ( gene ) .	T5	T25	15114505
CPR:4	CHEMICAL	GENE-Y	8	8	Four chemical , chemical ( 1 ) , a chemical of 1 , chemical ( 2 ) , chemical ( 3 ) , chemical ( 4 ) and chemical ( 5 ) isolated from the roots of Sophora flavescens were investigated for their inhibitory effects on chemical acyltransferase ( gene ) .	T11	T24	15114505
CPR:4	CHEMICAL	GENE-Y	8	49	Four chemical , chemical ( 1 ) , a chemical of 1 , chemical ( 2 ) , chemical ( 3 ) , chemical ( 4 ) and chemical ( 5 ) isolated from the roots of Sophora flavescens were investigated for their inhibitory effects on chemical acyltransferase ( gene ) .	T11	T25	15114505
CPR:4	CHEMICAL	GENE-Y	8	8	Four chemical , chemical ( 1 ) , a chemical of 1 , chemical ( 2 ) , chemical ( 3 ) , chemical ( 4 ) and chemical ( 5 ) isolated from the roots of Sophora flavescens were investigated for their inhibitory effects on chemical acyltransferase ( gene ) .	T16	T24	15114505
CPR:4	CHEMICAL	GENE-Y	8	49	Four chemical , chemical ( 1 ) , a chemical of 1 , chemical ( 2 ) , chemical ( 3 ) , chemical ( 4 ) and chemical ( 5 ) isolated from the roots of Sophora flavescens were investigated for their inhibitory effects on chemical acyltransferase ( gene ) .	T16	T25	15114505
CPR:4	CHEMICAL	GENE-Y	23	8	Four chemical , chemical ( 1 ) , a chemical of 1 , chemical ( 2 ) , chemical ( 3 ) , chemical ( 4 ) and chemical ( 5 ) isolated from the roots of Sophora flavescens were investigated for their inhibitory effects on chemical acyltransferase ( gene ) .	T19	T24	15114505
CPR:4	CHEMICAL	GENE-Y	23	49	Four chemical , chemical ( 1 ) , a chemical of 1 , chemical ( 2 ) , chemical ( 3 ) , chemical ( 4 ) and chemical ( 5 ) isolated from the roots of Sophora flavescens were investigated for their inhibitory effects on chemical acyltransferase ( gene ) .	T19	T25	15114505
CPR:4	CHEMICAL	GENE-Y	13	8	Four chemical , chemical ( 1 ) , a chemical of 1 , chemical ( 2 ) , chemical ( 3 ) , chemical ( 4 ) and chemical ( 5 ) isolated from the roots of Sophora flavescens were investigated for their inhibitory effects on chemical acyltransferase ( gene ) .	T1	T24	15114505
CPR:4	CHEMICAL	GENE-Y	13	49	Four chemical , chemical ( 1 ) , a chemical of 1 , chemical ( 2 ) , chemical ( 3 ) , chemical ( 4 ) and chemical ( 5 ) isolated from the roots of Sophora flavescens were investigated for their inhibitory effects on chemical acyltransferase ( gene ) .	T1	T25	15114505
NA	CHEMICAL	GENE-Y	8	8	Four chemical , chemical ( 1 ) , a chemical of 1 , chemical ( 2 ) , chemical ( 3 ) , chemical ( 4 ) and chemical ( 5 ) isolated from the roots of Sophora flavescens were investigated for their inhibitory effects on chemical acyltransferase ( gene ) .	T2	T24	15114505
NA	CHEMICAL	GENE-Y	8	49	Four chemical , chemical ( 1 ) , a chemical of 1 , chemical ( 2 ) , chemical ( 3 ) , chemical ( 4 ) and chemical ( 5 ) isolated from the roots of Sophora flavescens were investigated for their inhibitory effects on chemical acyltransferase ( gene ) .	T2	T25	15114505
CPR:4	CHEMICAL	GENE-Y	1	3	The chemical inhibited gene activity in a dose-dependent manner with IC50 values of 10.9 microM ( 1 ) , 9.8 microM ( 2 ) , 8.6 microM ( 3 ) , 142.0 microM ( 4 ) and 250 microM ( 5 ) .	T4	T26	15114505
CPR:4	CHEMICAL	GENE-Y	5	19	These data suggest that the chemical side chain and the position of the chemical group are important for high gene inhibitory activity .	T17	T27	15114505
CPR:4	CHEMICAL	GENE-Y	13	19	These data suggest that the chemical side chain and the position of the chemical group are important for high gene inhibitory activity .	T18	T27	15114505
NA	CHEMICAL	GENE-Y	9	10	Effects of chronic social defeat stress on behavior and chemical acetyltransferase , gene , and gene in adult mice .	T1	T13	23468099
NA	CHEMICAL	GENE-Y	9	12	Effects of chronic social defeat stress on behavior and chemical acetyltransferase , gene , and gene in adult mice .	T1	T14	23468099
NA	CHEMICAL	GENE-Y	9	15	Effects of chronic social defeat stress on behavior and chemical acetyltransferase , gene , and gene in adult mice .	T1	T12	23468099
NA	CHEMICAL	GENE-N	3	17	Overall , higher chemical production was reduced by chemical supplementation , and this can be correlated with a general downregulation of genes encoding gene and gene of the gene .	T6	T21	23265543
NA	CHEMICAL	GENE-N	3	17	Overall , higher chemical production was reduced by chemical supplementation , and this can be correlated with a general downregulation of genes encoding gene and gene of the gene .	T6	T22	23265543
NA	CHEMICAL	GENE-N	3	17	Overall , higher chemical production was reduced by chemical supplementation , and this can be correlated with a general downregulation of genes encoding gene and gene of the gene .	T6	T23	23265543
CPR:4	CHEMICAL	GENE-N	8	17	Overall , higher chemical production was reduced by chemical supplementation , and this can be correlated with a general downregulation of genes encoding gene and gene of the gene .	T7	T21	23265543
CPR:4	CHEMICAL	GENE-N	8	17	Overall , higher chemical production was reduced by chemical supplementation , and this can be correlated with a general downregulation of genes encoding gene and gene of the gene .	T7	T22	23265543
NA	CHEMICAL	GENE-N	8	17	Overall , higher chemical production was reduced by chemical supplementation , and this can be correlated with a general downregulation of genes encoding gene and gene of the gene .	T7	T23	23265543
CPR:9	CHEMICAL	GENE-N	8	11	A high throughput assay for the glucuronidation of chemical by recombinant gene and liver microsomes .	T14	T31	23551063
NA	CHEMICAL	GENE-N	0	2	chemical-glucuronosyltransferases ( gene ) are versatile and important conjugation enzymes in the metabolism of drugs and other xenobiotics .	T6	T20	23551063
CPR:9	CHEMICAL	GENE-N	3	21	We have developed a convenient quantitative multi-well plate assay to measure the glucuronidation rate of chemical ( chemical ) for several gene .	T7	T18	23551063
CPR:9	CHEMICAL	GENE-N	17	21	We have developed a convenient quantitative multi-well plate assay to measure the glucuronidation rate of chemical ( chemical ) for several gene .	T8	T18	23551063
CPR:9	CHEMICAL	GENE-N	11	9	We have used this method to screen 11 recombinant gene for chemical glucuronidation activity and studied the reaction kinetics with the most active enzymes .	T9	T19	23551063
CPR:9	CHEMICAL	GENE-Y	11	15	At a substrate concentration of 20 µM , the most active chemical glucuronidation catalysts were gene followed by gene > gene > gene , whereas at 300 µM gene was about 10 times better catalyst than the other recombinant gene .	T11	T21	23551063
CPR:9	CHEMICAL	GENE-Y	11	18	At a substrate concentration of 20 µM , the most active chemical glucuronidation catalysts were gene followed by gene > gene > gene , whereas at 300 µM gene was about 10 times better catalyst than the other recombinant gene .	T11	T22	23551063
CPR:9	CHEMICAL	GENE-Y	11	20	At a substrate concentration of 20 µM , the most active chemical glucuronidation catalysts were gene followed by gene > gene > gene , whereas at 300 µM gene was about 10 times better catalyst than the other recombinant gene .	T11	T23	23551063
CPR:9	CHEMICAL	GENE-Y	11	22	At a substrate concentration of 20 µM , the most active chemical glucuronidation catalysts were gene followed by gene > gene > gene , whereas at 300 µM gene was about 10 times better catalyst than the other recombinant gene .	T11	T24	23551063
CPR:9	CHEMICAL	GENE-Y	11	28	At a substrate concentration of 20 µM , the most active chemical glucuronidation catalysts were gene followed by gene > gene > gene , whereas at 300 µM gene was about 10 times better catalyst than the other recombinant gene .	T11	T25	23551063
CPR:9	CHEMICAL	GENE-N	11	39	At a substrate concentration of 20 µM , the most active chemical glucuronidation catalysts were gene followed by gene > gene > gene , whereas at 300 µM gene was about 10 times better catalyst than the other recombinant gene .	T11	T26	23551063
NA	CHEMICAL	GENE-N	13	3	The activities of gene were low , whereas gene and gene exhibited no chemical glucuronidation activity .	T12	T27	23551063
NA	CHEMICAL	GENE-Y	13	8	The activities of gene were low , whereas gene and gene exhibited no chemical glucuronidation activity .	T12	T28	23551063
NA	CHEMICAL	GENE-Y	13	10	The activities of gene were low , whereas gene and gene exhibited no chemical glucuronidation activity .	T12	T29	23551063
CPR:9	CHEMICAL	GENE-Y	11	0	gene exhibited a significantly higher Vmax and Km values toward both chemical and chemical-chemical than the other gene .	T1	T30	23551063
CPR:9	CHEMICAL	GENE-N	11	17	gene exhibited a significantly higher Vmax and Km values toward both chemical and chemical-chemical than the other gene .	T1	T15	23551063
CPR:9	CHEMICAL	GENE-Y	13	0	gene exhibited a significantly higher Vmax and Km values toward both chemical and chemical-chemical than the other gene .	T2	T30	23551063
CPR:9	CHEMICAL	GENE-N	13	17	gene exhibited a significantly higher Vmax and Km values toward both chemical and chemical-chemical than the other gene .	T2	T15	23551063
CPR:9	CHEMICAL	GENE-Y	0	0	gene exhibited a significantly higher Vmax and Km values toward both chemical and chemical-chemical than the other gene .	T3	T30	23551063
CPR:9	CHEMICAL	GENE-N	0	17	gene exhibited a significantly higher Vmax and Km values toward both chemical and chemical-chemical than the other gene .	T3	T15	23551063
NA	CHEMICAL	GENE-N	14	0	gene inhibitors delay human eosinophil and neutrophil apoptosis in the absence and presence of chemical .	T12	T33	18282775
NA	CHEMICAL	GENE-N	13	5	We also evaluated whether a gene inhibitor could modulate the effect of a chemical on eosinophil and neutrophil apoptosis .	T9	T30	18282775
CPR:4	CHEMICAL	GENE-N	4	2	Inhibitors of gene ( chemical ; 0.1-10 microM ) and gene ( chemical ; 0.1-10 microM ) delayed spontaneous eosinophil apoptosis maximally by 25 % and 15 % , respectively .	T10	T31	18282775
NA	CHEMICAL	GENE-N	4	10	Inhibitors of gene ( chemical ; 0.1-10 microM ) and gene ( chemical ; 0.1-10 microM ) delayed spontaneous eosinophil apoptosis maximally by 25 % and 15 % , respectively .	T10	T32	18282775
NA	CHEMICAL	GENE-N	12	2	Inhibitors of gene ( chemical ; 0.1-10 microM ) and gene ( chemical ; 0.1-10 microM ) delayed spontaneous eosinophil apoptosis maximally by 25 % and 15 % , respectively .	T11	T31	18282775
CPR:4	CHEMICAL	GENE-N	12	10	Inhibitors of gene ( chemical ; 0.1-10 microM ) and gene ( chemical ; 0.1-10 microM ) delayed spontaneous eosinophil apoptosis maximally by 25 % and 15 % , respectively .	T11	T32	18282775
NA	CHEMICAL	GENE-N	3	4	A combination of a gene or gene inhibitor ( 10 microM ) with chemical ( 100 nM ) further delayed eosinophil apoptosis maximally by 42-49 % .	T1	T13	18282775
NA	CHEMICAL	GENE-N	3	6	A combination of a gene or gene inhibitor ( 10 microM ) with chemical ( 100 nM ) further delayed eosinophil apoptosis maximally by 42-49 % .	T1	T14	18282775
NA	CHEMICAL	GENE-Y	2	3	Inhibitor of chemical-specific PDE5 ( chemical ; 0.1-10 microM ) did not affect eosinophil apoptosis and only slightly increased spontaneous neutrophil apoptosis .	T5	T15	18282775
CPR:4	CHEMICAL	GENE-Y	5	3	Inhibitor of chemical-specific PDE5 ( chemical ; 0.1-10 microM ) did not affect eosinophil apoptosis and only slightly increased spontaneous neutrophil apoptosis .	T6	T15	18282775
NA	CHEMICAL	GENE-N	3	12	The effect of chemical on apoptosis was not significantly modulated by a gene inhibitor in eosinophils or neutrophils .	T7	T16	18282775
NA	CHEMICAL	GENE-N	8	9	The present results show that selective inhibitors of chemical-hydrolyzing PDEs ( gene and gene ) delay eosinophil apoptosis and , thus , increase their survival in vitro .	T8	T17	18282775
NA	CHEMICAL	GENE-N	8	11	The present results show that selective inhibitors of chemical-hydrolyzing PDEs ( gene and gene ) delay eosinophil apoptosis and , thus , increase their survival in vitro .	T8	T18	18282775
NA	CHEMICAL	GENE-N	8	13	The present results show that selective inhibitors of chemical-hydrolyzing PDEs ( gene and gene ) delay eosinophil apoptosis and , thus , increase their survival in vitro .	T8	T19	18282775
CPR:4	CHEMICAL	GENE-Y	13	7	OBJECTIVE : To evaluate the extent of gene ( gene ) inhibition by chemical , which has been reported to preferentially inhibit gene ( gene ) .	T24	T37	10340919
CPR:4	CHEMICAL	GENE-Y	13	9	OBJECTIVE : To evaluate the extent of gene ( gene ) inhibition by chemical , which has been reported to preferentially inhibit gene ( gene ) .	T24	T38	10340919
CPR:4	CHEMICAL	GENE-Y	13	22	OBJECTIVE : To evaluate the extent of gene ( gene ) inhibition by chemical , which has been reported to preferentially inhibit gene ( gene ) .	T24	T31	10340919
CPR:4	CHEMICAL	GENE-Y	13	24	OBJECTIVE : To evaluate the extent of gene ( gene ) inhibition by chemical , which has been reported to preferentially inhibit gene ( gene ) .	T24	T32	10340919
CPR:4	CHEMICAL	GENE-N	3	13	The effects of chemical were compared with those of chemical , a nonselective gene inhibitor .	T12	T35	10340919
CPR:4	CHEMICAL	GENE-N	2	13	The effects of chemical were compared with those of chemical , a nonselective gene inhibitor .	T13	T35	10340919
NA	CHEMICAL	GENE-Y	8	2	METHODS : gene inhibition was determined by measuring chemical ( chemical ) -generation from clotting whole blood ex vivo after single oral doses of 7.5 and 15 mg chemical and 75 mg chemical and at steady state ( 15 mg chemical daily and 150 mg chemical daily ) .	T14	T36	10340919
NA	CHEMICAL	GENE-Y	10	2	METHODS : gene inhibition was determined by measuring chemical ( chemical ) -generation from clotting whole blood ex vivo after single oral doses of 7.5 and 15 mg chemical and 75 mg chemical and at steady state ( 15 mg chemical daily and 150 mg chemical daily ) .	T15	T36	10340919
CPR:4	CHEMICAL	GENE-Y	28	2	METHODS : gene inhibition was determined by measuring chemical ( chemical ) -generation from clotting whole blood ex vivo after single oral doses of 7.5 and 15 mg chemical and 75 mg chemical and at steady state ( 15 mg chemical daily and 150 mg chemical daily ) .	T16	T36	10340919
CPR:4	CHEMICAL	GENE-Y	23	2	METHODS : gene inhibition was determined by measuring chemical ( chemical ) -generation from clotting whole blood ex vivo after single oral doses of 7.5 and 15 mg chemical and 75 mg chemical and at steady state ( 15 mg chemical daily and 150 mg chemical daily ) .	T17	T36	10340919
CPR:4	CHEMICAL	GENE-Y	40	2	METHODS : gene inhibition was determined by measuring chemical ( chemical ) -generation from clotting whole blood ex vivo after single oral doses of 7.5 and 15 mg chemical and 75 mg chemical and at steady state ( 15 mg chemical daily and 150 mg chemical daily ) .	T18	T36	10340919
CPR:4	CHEMICAL	GENE-Y	23	2	METHODS : gene inhibition was determined by measuring chemical ( chemical ) -generation from clotting whole blood ex vivo after single oral doses of 7.5 and 15 mg chemical and 75 mg chemical and at steady state ( 15 mg chemical daily and 150 mg chemical daily ) .	T19	T36	10340919
CPR:4	CHEMICAL	GENE-Y	9	6	Thus our data suggest that the gene preference of chemical observed in vitro may not result in clinical advantages when the higher dose of 15 mg is needed .	T11	T33	10340919
NA	CHEMICAL	GENE-Y	0	1	chemical esterase ( gene ) induced surface erosion of chemical ( chemical ) and drug release from chemical under mild physiological environment was investigated .	T1	T17	23639738
NA	CHEMICAL	GENE-Y	0	3	chemical esterase ( gene ) induced surface erosion of chemical ( chemical ) and drug release from chemical under mild physiological environment was investigated .	T1	T18	23639738
CPR:9	CHEMICAL	GENE-Y	4	1	chemical esterase ( gene ) induced surface erosion of chemical ( chemical ) and drug release from chemical under mild physiological environment was investigated .	T9	T17	23639738
CPR:9	CHEMICAL	GENE-Y	4	3	chemical esterase ( gene ) induced surface erosion of chemical ( chemical ) and drug release from chemical under mild physiological environment was investigated .	T9	T18	23639738
CPR:9	CHEMICAL	GENE-Y	11	1	chemical esterase ( gene ) induced surface erosion of chemical ( chemical ) and drug release from chemical under mild physiological environment was investigated .	T13	T17	23639738
CPR:9	CHEMICAL	GENE-Y	11	3	chemical esterase ( gene ) induced surface erosion of chemical ( chemical ) and drug release from chemical under mild physiological environment was investigated .	T13	T18	23639738
NA	CHEMICAL	GENE-Y	17	1	chemical esterase ( gene ) induced surface erosion of chemical ( chemical ) and drug release from chemical under mild physiological environment was investigated .	T2	T17	23639738
NA	CHEMICAL	GENE-Y	17	3	chemical esterase ( gene ) induced surface erosion of chemical ( chemical ) and drug release from chemical under mild physiological environment was investigated .	T2	T18	23639738
NA	CHEMICAL	GENE-Y	10	4	By this mechanism , gene-responsive drug in vitro release from chemical in situ forming depots ( ISFD ) was conducted successfully .	T11	T19	23639738
NA	CHEMICAL	GENE-Y	11	4	As expected , less gene ( gene ) was released from chemical41 compared with that of chemical200 in the same time period .	T12	T20	23639738
NA	CHEMICAL	GENE-Y	11	6	As expected , less gene ( gene ) was released from chemical41 compared with that of chemical200 in the same time period .	T12	T21	23639738
NA	CHEMICAL	GENE-Y	16	4	As expected , less gene ( gene ) was released from chemical41 compared with that of chemical200 in the same time period .	T14	T20	23639738
NA	CHEMICAL	GENE-Y	16	6	As expected , less gene ( gene ) was released from chemical41 compared with that of chemical200 in the same time period .	T14	T21	23639738
NA	CHEMICAL	GENE-N	2	24	We characterized in this study the pharmacokinetics and antitumor efficacy of chemical-chemical ( HK ) : siRNA nanoplexes modified with chemical and a cyclic gene ( gene ) ligand targeting gene and gene .	T3	T5	23360232
NA	CHEMICAL	GENE-N	2	26	We characterized in this study the pharmacokinetics and antitumor efficacy of chemical-chemical ( HK ) : siRNA nanoplexes modified with chemical and a cyclic gene ( gene ) ligand targeting gene and gene .	T3	T6	23360232
NA	CHEMICAL	GENE-Y	2	30	We characterized in this study the pharmacokinetics and antitumor efficacy of chemical-chemical ( HK ) : siRNA nanoplexes modified with chemical and a cyclic gene ( gene ) ligand targeting gene and gene .	T3	T7	23360232
NA	CHEMICAL	GENE-Y	2	2	We characterized in this study the pharmacokinetics and antitumor efficacy of chemical-chemical ( HK ) : siRNA nanoplexes modified with chemical and a cyclic gene ( gene ) ligand targeting gene and gene .	T3	T8	23360232
NA	CHEMICAL	GENE-N	2	24	We characterized in this study the pharmacokinetics and antitumor efficacy of chemical-chemical ( HK ) : siRNA nanoplexes modified with chemical and a cyclic gene ( gene ) ligand targeting gene and gene .	T4	T5	23360232
NA	CHEMICAL	GENE-N	2	26	We characterized in this study the pharmacokinetics and antitumor efficacy of chemical-chemical ( HK ) : siRNA nanoplexes modified with chemical and a cyclic gene ( gene ) ligand targeting gene and gene .	T4	T6	23360232
NA	CHEMICAL	GENE-Y	2	30	We characterized in this study the pharmacokinetics and antitumor efficacy of chemical-chemical ( HK ) : siRNA nanoplexes modified with chemical and a cyclic gene ( gene ) ligand targeting gene and gene .	T4	T7	23360232
NA	CHEMICAL	GENE-Y	2	2	We characterized in this study the pharmacokinetics and antitumor efficacy of chemical-chemical ( HK ) : siRNA nanoplexes modified with chemical and a cyclic gene ( gene ) ligand targeting gene and gene .	T4	T8	23360232
NA	CHEMICAL	GENE-N	20	24	We characterized in this study the pharmacokinetics and antitumor efficacy of chemical-chemical ( HK ) : siRNA nanoplexes modified with chemical and a cyclic gene ( gene ) ligand targeting gene and gene .	T2	T5	23360232
NA	CHEMICAL	GENE-N	20	26	We characterized in this study the pharmacokinetics and antitumor efficacy of chemical-chemical ( HK ) : siRNA nanoplexes modified with chemical and a cyclic gene ( gene ) ligand targeting gene and gene .	T2	T6	23360232
NA	CHEMICAL	GENE-Y	20	30	We characterized in this study the pharmacokinetics and antitumor efficacy of chemical-chemical ( HK ) : siRNA nanoplexes modified with chemical and a cyclic gene ( gene ) ligand targeting gene and gene .	T2	T7	23360232
NA	CHEMICAL	GENE-Y	20	2	We characterized in this study the pharmacokinetics and antitumor efficacy of chemical-chemical ( HK ) : siRNA nanoplexes modified with chemical and a cyclic gene ( gene ) ligand targeting gene and gene .	T2	T8	23360232
CPR:5	CHEMICAL	GENE-N	2	9	Effect of chemical ( chemical ) , a selective gene agonist , on motor performance in mice .	T14	T18	16730121
CPR:5	CHEMICAL	GENE-N	4	9	Effect of chemical ( chemical ) , a selective gene agonist , on motor performance in mice .	T15	T18	16730121
CPR:5	CHEMICAL	GENE-N	2	11	Effect of chemical ( chemical , chemical ) , a selective gene agonist , on motor coordination was studied using rota-rod performance in mice .	T1	T16	16730121
CPR:5	CHEMICAL	GENE-N	4	11	Effect of chemical ( chemical , chemical ) , a selective gene agonist , on motor coordination was studied using rota-rod performance in mice .	T12	T16	16730121
CPR:5	CHEMICAL	GENE-N	6	11	Effect of chemical ( chemical , chemical ) , a selective gene agonist , on motor coordination was studied using rota-rod performance in mice .	T13	T16	16730121
NA	CHEMICAL	GENE-N	0	10	chemical and chemical ( chemical ) , a ligand of gene biding site , also had no impairment on the performance , per se .	T3	T17	16730121
NA	CHEMICAL	GENE-N	2	10	chemical and chemical ( chemical ) , a ligand of gene biding site , also had no impairment on the performance , per se .	T4	T17	16730121
NA	CHEMICAL	GENE-N	4	10	chemical and chemical ( chemical ) , a ligand of gene biding site , also had no impairment on the performance , per se .	T5	T17	16730121
CPR:4	CHEMICAL	GENE-Y	28	8	BACKGROUND : Since the introduction of the first gene inhibitor ( ChEI ) in 1997 , most clinicians and probably most patients would consider the cholinergic drugs , chemical , chemical and chemical , to be the first line pharmacotherapy for mild to moderate Alzheimer 's disease.The drugs have slightly different pharmacological properties , but they all work by inhibiting the breakdown of chemical , an important neurotransmitter associated with memory , by blocking the enzyme gene .	T11	T39	16437532
CPR:4	CHEMICAL	GENE-Y	28	13	BACKGROUND : Since the introduction of the first gene inhibitor ( ChEI ) in 1997 , most clinicians and probably most patients would consider the cholinergic drugs , chemical , chemical and chemical , to be the first line pharmacotherapy for mild to moderate Alzheimer 's disease.The drugs have slightly different pharmacological properties , but they all work by inhibiting the breakdown of chemical , an important neurotransmitter associated with memory , by blocking the enzyme gene .	T11	T40	16437532
CPR:4	CHEMICAL	GENE-Y	13	8	BACKGROUND : Since the introduction of the first gene inhibitor ( ChEI ) in 1997 , most clinicians and probably most patients would consider the cholinergic drugs , chemical , chemical and chemical , to be the first line pharmacotherapy for mild to moderate Alzheimer 's disease.The drugs have slightly different pharmacological properties , but they all work by inhibiting the breakdown of chemical , an important neurotransmitter associated with memory , by blocking the enzyme gene .	T12	T39	16437532
CPR:4	CHEMICAL	GENE-Y	13	13	BACKGROUND : Since the introduction of the first gene inhibitor ( ChEI ) in 1997 , most clinicians and probably most patients would consider the cholinergic drugs , chemical , chemical and chemical , to be the first line pharmacotherapy for mild to moderate Alzheimer 's disease.The drugs have slightly different pharmacological properties , but they all work by inhibiting the breakdown of chemical , an important neurotransmitter associated with memory , by blocking the enzyme gene .	T12	T40	16437532
CPR:4	CHEMICAL	GENE-Y	13	8	BACKGROUND : Since the introduction of the first gene inhibitor ( ChEI ) in 1997 , most clinicians and probably most patients would consider the cholinergic drugs , chemical , chemical and chemical , to be the first line pharmacotherapy for mild to moderate Alzheimer 's disease.The drugs have slightly different pharmacological properties , but they all work by inhibiting the breakdown of chemical , an important neurotransmitter associated with memory , by blocking the enzyme gene .	T15	T39	16437532
CPR:4	CHEMICAL	GENE-Y	13	13	BACKGROUND : Since the introduction of the first gene inhibitor ( ChEI ) in 1997 , most clinicians and probably most patients would consider the cholinergic drugs , chemical , chemical and chemical , to be the first line pharmacotherapy for mild to moderate Alzheimer 's disease.The drugs have slightly different pharmacological properties , but they all work by inhibiting the breakdown of chemical , an important neurotransmitter associated with memory , by blocking the enzyme gene .	T15	T40	16437532
NA	CHEMICAL	GENE-Y	13	8	BACKGROUND : Since the introduction of the first gene inhibitor ( ChEI ) in 1997 , most clinicians and probably most patients would consider the cholinergic drugs , chemical , chemical and chemical , to be the first line pharmacotherapy for mild to moderate Alzheimer 's disease.The drugs have slightly different pharmacological properties , but they all work by inhibiting the breakdown of chemical , an important neurotransmitter associated with memory , by blocking the enzyme gene .	T25	T39	16437532
CPR:9	CHEMICAL	GENE-Y	13	13	BACKGROUND : Since the introduction of the first gene inhibitor ( ChEI ) in 1997 , most clinicians and probably most patients would consider the cholinergic drugs , chemical , chemical and chemical , to be the first line pharmacotherapy for mild to moderate Alzheimer 's disease.The drugs have slightly different pharmacological properties , but they all work by inhibiting the breakdown of chemical , an important neurotransmitter associated with memory , by blocking the enzyme gene .	T25	T40	16437532
CPR:4	CHEMICAL	GENE-N	5	7	Recent studies have reported that chemical , a gene inhibitor that targets the intracellular chemical kinase gene-gene and the gene , is an effective inhibitor of the gene , gene .	T4	T26	17049513
CPR:4	CHEMICAL	GENE-N	5	7	Recent studies have reported that chemical , a gene inhibitor that targets the intracellular chemical kinase gene-gene and the gene , is an effective inhibitor of the gene , gene .	T4	T12	17049513
CPR:4	CHEMICAL	GENE-Y	5	16	Recent studies have reported that chemical , a gene inhibitor that targets the intracellular chemical kinase gene-gene and the gene , is an effective inhibitor of the gene , gene .	T4	T17	17049513
CPR:4	CHEMICAL	GENE-Y	5	16	Recent studies have reported that chemical , a gene inhibitor that targets the intracellular chemical kinase gene-gene and the gene , is an effective inhibitor of the gene , gene .	T4	T18	17049513
CPR:4	CHEMICAL	GENE-N	5	19	Recent studies have reported that chemical , a gene inhibitor that targets the intracellular chemical kinase gene-gene and the gene , is an effective inhibitor of the gene , gene .	T4	T20	17049513
CPR:4	CHEMICAL	GENE-Y	5	27	Recent studies have reported that chemical , a gene inhibitor that targets the intracellular chemical kinase gene-gene and the gene , is an effective inhibitor of the gene , gene .	T4	T22	17049513
CPR:4	CHEMICAL	GENE-Y	5	29	Recent studies have reported that chemical , a gene inhibitor that targets the intracellular chemical kinase gene-gene and the gene , is an effective inhibitor of the gene , gene .	T4	T23	17049513
NA	CHEMICAL	GENE-N	14	7	Recent studies have reported that chemical , a gene inhibitor that targets the intracellular chemical kinase gene-gene and the gene , is an effective inhibitor of the gene , gene .	T1	T26	17049513
NA	CHEMICAL	GENE-N	14	7	Recent studies have reported that chemical , a gene inhibitor that targets the intracellular chemical kinase gene-gene and the gene , is an effective inhibitor of the gene , gene .	T1	T12	17049513
NA	CHEMICAL	GENE-Y	14	16	Recent studies have reported that chemical , a gene inhibitor that targets the intracellular chemical kinase gene-gene and the gene , is an effective inhibitor of the gene , gene .	T1	T17	17049513
NA	CHEMICAL	GENE-Y	14	16	Recent studies have reported that chemical , a gene inhibitor that targets the intracellular chemical kinase gene-gene and the gene , is an effective inhibitor of the gene , gene .	T1	T18	17049513
NA	CHEMICAL	GENE-N	14	19	Recent studies have reported that chemical , a gene inhibitor that targets the intracellular chemical kinase gene-gene and the gene , is an effective inhibitor of the gene , gene .	T1	T20	17049513
NA	CHEMICAL	GENE-Y	14	27	Recent studies have reported that chemical , a gene inhibitor that targets the intracellular chemical kinase gene-gene and the gene , is an effective inhibitor of the gene , gene .	T1	T22	17049513
NA	CHEMICAL	GENE-Y	14	29	Recent studies have reported that chemical , a gene inhibitor that targets the intracellular chemical kinase gene-gene and the gene , is an effective inhibitor of the gene , gene .	T1	T23	17049513
CPR:4	CHEMICAL	GENE-Y	10	2	Given that gene signalling through gene plays an important role in osteoclast biology , we speculated that blocking such a pathway with chemical may modulate osteoclast activity .	T5	T24	17049513
CPR:4	CHEMICAL	GENE-Y	10	5	Given that gene signalling through gene plays an important role in osteoclast biology , we speculated that blocking such a pathway with chemical may modulate osteoclast activity .	T5	T25	17049513
NA	CHEMICAL	GENE-Y	4	17	Our findings demonstrate that chemical dose-dependently stimulates osteoclast apoptosis , a phenomenon which is blocked by the gene inhibitor Z-VAD-fmk .	T7	T27	17049513
CPR:4	CHEMICAL	GENE-Y	0	6	chemical was also found to inhibit gene-induced osteoclast survival as well as gene-induced osteoclast bone resorbing activity , but was without effect on gene ( gene ) and gene ( gene ) -induced inhibition of osteoclasts apoptosis , further supporting the hypothesis that chemical may affect mature osteoclasts through the inhibition of gene .	T9	T28	17049513
CPR:4	CHEMICAL	GENE-Y	0	12	chemical was also found to inhibit gene-induced osteoclast survival as well as gene-induced osteoclast bone resorbing activity , but was without effect on gene ( gene ) and gene ( gene ) -induced inhibition of osteoclasts apoptosis , further supporting the hypothesis that chemical may affect mature osteoclasts through the inhibition of gene .	T9	T29	17049513
NA	CHEMICAL	GENE-Y	0	23	chemical was also found to inhibit gene-induced osteoclast survival as well as gene-induced osteoclast bone resorbing activity , but was without effect on gene ( gene ) and gene ( gene ) -induced inhibition of osteoclasts apoptosis , further supporting the hypothesis that chemical may affect mature osteoclasts through the inhibition of gene .	T9	T13	17049513
NA	CHEMICAL	GENE-Y	0	25	chemical was also found to inhibit gene-induced osteoclast survival as well as gene-induced osteoclast bone resorbing activity , but was without effect on gene ( gene ) and gene ( gene ) -induced inhibition of osteoclasts apoptosis , further supporting the hypothesis that chemical may affect mature osteoclasts through the inhibition of gene .	T9	T14	17049513
NA	CHEMICAL	GENE-Y	0	27	chemical was also found to inhibit gene-induced osteoclast survival as well as gene-induced osteoclast bone resorbing activity , but was without effect on gene ( gene ) and gene ( gene ) -induced inhibition of osteoclasts apoptosis , further supporting the hypothesis that chemical may affect mature osteoclasts through the inhibition of gene .	T9	T15	17049513
NA	CHEMICAL	GENE-Y	0	30	chemical was also found to inhibit gene-induced osteoclast survival as well as gene-induced osteoclast bone resorbing activity , but was without effect on gene ( gene ) and gene ( gene ) -induced inhibition of osteoclasts apoptosis , further supporting the hypothesis that chemical may affect mature osteoclasts through the inhibition of gene .	T9	T16	17049513
NA	CHEMICAL	GENE-Y	0	52	chemical was also found to inhibit gene-induced osteoclast survival as well as gene-induced osteoclast bone resorbing activity , but was without effect on gene ( gene ) and gene ( gene ) -induced inhibition of osteoclasts apoptosis , further supporting the hypothesis that chemical may affect mature osteoclasts through the inhibition of gene .	T9	T19	17049513
NA	CHEMICAL	GENE-Y	6	6	chemical was also found to inhibit gene-induced osteoclast survival as well as gene-induced osteoclast bone resorbing activity , but was without effect on gene ( gene ) and gene ( gene ) -induced inhibition of osteoclasts apoptosis , further supporting the hypothesis that chemical may affect mature osteoclasts through the inhibition of gene .	T2	T28	17049513
NA	CHEMICAL	GENE-Y	6	12	chemical was also found to inhibit gene-induced osteoclast survival as well as gene-induced osteoclast bone resorbing activity , but was without effect on gene ( gene ) and gene ( gene ) -induced inhibition of osteoclasts apoptosis , further supporting the hypothesis that chemical may affect mature osteoclasts through the inhibition of gene .	T2	T29	17049513
NA	CHEMICAL	GENE-Y	6	23	chemical was also found to inhibit gene-induced osteoclast survival as well as gene-induced osteoclast bone resorbing activity , but was without effect on gene ( gene ) and gene ( gene ) -induced inhibition of osteoclasts apoptosis , further supporting the hypothesis that chemical may affect mature osteoclasts through the inhibition of gene .	T2	T13	17049513
NA	CHEMICAL	GENE-Y	6	25	chemical was also found to inhibit gene-induced osteoclast survival as well as gene-induced osteoclast bone resorbing activity , but was without effect on gene ( gene ) and gene ( gene ) -induced inhibition of osteoclasts apoptosis , further supporting the hypothesis that chemical may affect mature osteoclasts through the inhibition of gene .	T2	T14	17049513
NA	CHEMICAL	GENE-Y	6	27	chemical was also found to inhibit gene-induced osteoclast survival as well as gene-induced osteoclast bone resorbing activity , but was without effect on gene ( gene ) and gene ( gene ) -induced inhibition of osteoclasts apoptosis , further supporting the hypothesis that chemical may affect mature osteoclasts through the inhibition of gene .	T2	T15	17049513
NA	CHEMICAL	GENE-Y	6	30	chemical was also found to inhibit gene-induced osteoclast survival as well as gene-induced osteoclast bone resorbing activity , but was without effect on gene ( gene ) and gene ( gene ) -induced inhibition of osteoclasts apoptosis , further supporting the hypothesis that chemical may affect mature osteoclasts through the inhibition of gene .	T2	T16	17049513
CPR:4	CHEMICAL	GENE-Y	6	52	chemical was also found to inhibit gene-induced osteoclast survival as well as gene-induced osteoclast bone resorbing activity , but was without effect on gene ( gene ) and gene ( gene ) -induced inhibition of osteoclasts apoptosis , further supporting the hypothesis that chemical may affect mature osteoclasts through the inhibition of gene .	T2	T19	17049513
NA	CHEMICAL	GENE-Y	1	8	Normal chemical regulation is achieved by having adequate gene secretion and effective chemical uptake/disposal .	T16	T45	23481236
NA	CHEMICAL	GENE-Y	12	8	Normal chemical regulation is achieved by having adequate gene secretion and effective chemical uptake/disposal .	T21	T45	23481236
NA	CHEMICAL	GENE-Y	2	2	Excess lipids in peripheral tissues - skeletal muscle , liver and adipose tissue - may attenuate gene signaling through the gene ( gene ) pathway and up-regulate gene ( gene ) , a negative regulator of gene signaling .	T9	T37	23481236
NA	CHEMICAL	GENE-N	2	20	Excess lipids in peripheral tissues - skeletal muscle , liver and adipose tissue - may attenuate gene signaling through the gene ( gene ) pathway and up-regulate gene ( gene ) , a negative regulator of gene signaling .	T9	T38	23481236
NA	CHEMICAL	GENE-N	2	22	Excess lipids in peripheral tissues - skeletal muscle , liver and adipose tissue - may attenuate gene signaling through the gene ( gene ) pathway and up-regulate gene ( gene ) , a negative regulator of gene signaling .	T9	T39	23481236
NA	CHEMICAL	GENE-Y	2	27	Excess lipids in peripheral tissues - skeletal muscle , liver and adipose tissue - may attenuate gene signaling through the gene ( gene ) pathway and up-regulate gene ( gene ) , a negative regulator of gene signaling .	T9	T40	23481236
NA	CHEMICAL	GENE-Y	2	29	Excess lipids in peripheral tissues - skeletal muscle , liver and adipose tissue - may attenuate gene signaling through the gene ( gene ) pathway and up-regulate gene ( gene ) , a negative regulator of gene signaling .	T9	T41	23481236
NA	CHEMICAL	GENE-Y	2	2	Excess lipids in peripheral tissues - skeletal muscle , liver and adipose tissue - may attenuate gene signaling through the gene ( gene ) pathway and up-regulate gene ( gene ) , a negative regulator of gene signaling .	T9	T42	23481236
NA	CHEMICAL	GENE-N	7	19	We studied accumulation of lipid metabolites [ chemical ( chemical ) , chemical ( chemical ) ] and chemical in relation to gene signaling and expression and phosphorylation of gene by preincubating rat skeletal muscle cells ( L6 myotubes ) with three saturated and three unsaturated free chemical ( FFAs ) ( 200 μM ) .	T10	T43	23481236
NA	CHEMICAL	GENE-Y	7	29	We studied accumulation of lipid metabolites [ chemical ( chemical ) , chemical ( chemical ) ] and chemical in relation to gene signaling and expression and phosphorylation of gene by preincubating rat skeletal muscle cells ( L6 myotubes ) with three saturated and three unsaturated free chemical ( FFAs ) ( 200 μM ) .	T10	T44	23481236
NA	CHEMICAL	GENE-N	9	19	We studied accumulation of lipid metabolites [ chemical ( chemical ) , chemical ( chemical ) ] and chemical in relation to gene signaling and expression and phosphorylation of gene by preincubating rat skeletal muscle cells ( L6 myotubes ) with three saturated and three unsaturated free chemical ( FFAs ) ( 200 μM ) .	T11	T43	23481236
NA	CHEMICAL	GENE-Y	9	29	We studied accumulation of lipid metabolites [ chemical ( chemical ) , chemical ( chemical ) ] and chemical in relation to gene signaling and expression and phosphorylation of gene by preincubating rat skeletal muscle cells ( L6 myotubes ) with three saturated and three unsaturated free chemical ( FFAs ) ( 200 μM ) .	T11	T44	23481236
NA	CHEMICAL	GENE-N	12	19	We studied accumulation of lipid metabolites [ chemical ( chemical ) , chemical ( chemical ) ] and chemical in relation to gene signaling and expression and phosphorylation of gene by preincubating rat skeletal muscle cells ( L6 myotubes ) with three saturated and three unsaturated free chemical ( FFAs ) ( 200 μM ) .	T12	T43	23481236
NA	CHEMICAL	GENE-Y	12	29	We studied accumulation of lipid metabolites [ chemical ( chemical ) , chemical ( chemical ) ] and chemical in relation to gene signaling and expression and phosphorylation of gene by preincubating rat skeletal muscle cells ( L6 myotubes ) with three saturated and three unsaturated free chemical ( FFAs ) ( 200 μM ) .	T12	T44	23481236
NA	CHEMICAL	GENE-N	14	19	We studied accumulation of lipid metabolites [ chemical ( chemical ) , chemical ( chemical ) ] and chemical in relation to gene signaling and expression and phosphorylation of gene by preincubating rat skeletal muscle cells ( L6 myotubes ) with three saturated and three unsaturated free chemical ( FFAs ) ( 200 μM ) .	T13	T43	23481236
NA	CHEMICAL	GENE-Y	14	29	We studied accumulation of lipid metabolites [ chemical ( chemical ) , chemical ( chemical ) ] and chemical in relation to gene signaling and expression and phosphorylation of gene by preincubating rat skeletal muscle cells ( L6 myotubes ) with three saturated and three unsaturated free chemical ( FFAs ) ( 200 μM ) .	T13	T44	23481236
NA	CHEMICAL	GENE-N	18	19	We studied accumulation of lipid metabolites [ chemical ( chemical ) , chemical ( chemical ) ] and chemical in relation to gene signaling and expression and phosphorylation of gene by preincubating rat skeletal muscle cells ( L6 myotubes ) with three saturated and three unsaturated free chemical ( FFAs ) ( 200 μM ) .	T14	T43	23481236
NA	CHEMICAL	GENE-Y	18	29	We studied accumulation of lipid metabolites [ chemical ( chemical ) , chemical ( chemical ) ] and chemical in relation to gene signaling and expression and phosphorylation of gene by preincubating rat skeletal muscle cells ( L6 myotubes ) with three saturated and three unsaturated free chemical ( FFAs ) ( 200 μM ) .	T14	T44	23481236
NA	CHEMICAL	GENE-N	47	19	We studied accumulation of lipid metabolites [ chemical ( chemical ) , chemical ( chemical ) ] and chemical in relation to gene signaling and expression and phosphorylation of gene by preincubating rat skeletal muscle cells ( L6 myotubes ) with three saturated and three unsaturated free chemical ( FFAs ) ( 200 μM ) .	T15	T43	23481236
NA	CHEMICAL	GENE-Y	47	29	We studied accumulation of lipid metabolites [ chemical ( chemical ) , chemical ( chemical ) ] and chemical in relation to gene signaling and expression and phosphorylation of gene by preincubating rat skeletal muscle cells ( L6 myotubes ) with three saturated and three unsaturated free chemical ( FFAs ) ( 200 μM ) .	T15	T44	23481236
CPR:4	CHEMICAL	GENE-N	4	4	Cells were also evaluated in the presence of chemical , an inhibitor of chemical 3-kinases and thus gene ( 0-100 nM ) .	T17	T46	23481236
CPR:4	CHEMICAL	GENE-N	4	17	Cells were also evaluated in the presence of chemical , an inhibitor of chemical 3-kinases and thus gene ( 0-100 nM ) .	T17	T47	23481236
NA	CHEMICAL	GENE-N	4	4	Cells were also evaluated in the presence of chemical , an inhibitor of chemical 3-kinases and thus gene ( 0-100 nM ) .	T18	T46	23481236
NA	CHEMICAL	GENE-N	4	17	Cells were also evaluated in the presence of chemical , an inhibitor of chemical 3-kinases and thus gene ( 0-100 nM ) .	T18	T47	23481236
NA	CHEMICAL	GENE-Y	3	7	Unsaturated FFAs increased chemical , chemical and gene expression significantly , but cells remained gene sensitive as assessed by robust gene and gene phosphorylation at chemical ( chemical ) 50 , chemical 398 and chemical 152 .	T19	T48	23481236
NA	CHEMICAL	GENE-N	3	14	Unsaturated FFAs increased chemical , chemical and gene expression significantly , but cells remained gene sensitive as assessed by robust gene and gene phosphorylation at chemical ( chemical ) 50 , chemical 398 and chemical 152 .	T19	T49	23481236
NA	CHEMICAL	GENE-N	3	20	Unsaturated FFAs increased chemical , chemical and gene expression significantly , but cells remained gene sensitive as assessed by robust gene and gene phosphorylation at chemical ( chemical ) 50 , chemical 398 and chemical 152 .	T19	T50	23481236
NA	CHEMICAL	GENE-Y	3	22	Unsaturated FFAs increased chemical , chemical and gene expression significantly , but cells remained gene sensitive as assessed by robust gene and gene phosphorylation at chemical ( chemical ) 50 , chemical 398 and chemical 152 .	T19	T51	23481236
NA	CHEMICAL	GENE-Y	5	7	Unsaturated FFAs increased chemical , chemical and gene expression significantly , but cells remained gene sensitive as assessed by robust gene and gene phosphorylation at chemical ( chemical ) 50 , chemical 398 and chemical 152 .	T20	T48	23481236
NA	CHEMICAL	GENE-N	5	14	Unsaturated FFAs increased chemical , chemical and gene expression significantly , but cells remained gene sensitive as assessed by robust gene and gene phosphorylation at chemical ( chemical ) 50 , chemical 398 and chemical 152 .	T20	T49	23481236
NA	CHEMICAL	GENE-N	5	20	Unsaturated FFAs increased chemical , chemical and gene expression significantly , but cells remained gene sensitive as assessed by robust gene and gene phosphorylation at chemical ( chemical ) 50 , chemical 398 and chemical 152 .	T20	T50	23481236
NA	CHEMICAL	GENE-Y	5	22	Unsaturated FFAs increased chemical , chemical and gene expression significantly , but cells remained gene sensitive as assessed by robust gene and gene phosphorylation at chemical ( chemical ) 50 , chemical 398 and chemical 152 .	T20	T51	23481236
NA	CHEMICAL	GENE-Y	25	7	Unsaturated FFAs increased chemical , chemical and gene expression significantly , but cells remained gene sensitive as assessed by robust gene and gene phosphorylation at chemical ( chemical ) 50 , chemical 398 and chemical 152 .	T22	T48	23481236
NA	CHEMICAL	GENE-N	25	14	Unsaturated FFAs increased chemical , chemical and gene expression significantly , but cells remained gene sensitive as assessed by robust gene and gene phosphorylation at chemical ( chemical ) 50 , chemical 398 and chemical 152 .	T22	T49	23481236
NA	CHEMICAL	GENE-N	25	20	Unsaturated FFAs increased chemical , chemical and gene expression significantly , but cells remained gene sensitive as assessed by robust gene and gene phosphorylation at chemical ( chemical ) 50 , chemical 398 and chemical 152 .	T22	T50	23481236
NA	CHEMICAL	GENE-Y	25	22	Unsaturated FFAs increased chemical , chemical and gene expression significantly , but cells remained gene sensitive as assessed by robust gene and gene phosphorylation at chemical ( chemical ) 50 , chemical 398 and chemical 152 .	T22	T51	23481236
NA	CHEMICAL	GENE-Y	27	7	Unsaturated FFAs increased chemical , chemical and gene expression significantly , but cells remained gene sensitive as assessed by robust gene and gene phosphorylation at chemical ( chemical ) 50 , chemical 398 and chemical 152 .	T23	T48	23481236
NA	CHEMICAL	GENE-N	27	14	Unsaturated FFAs increased chemical , chemical and gene expression significantly , but cells remained gene sensitive as assessed by robust gene and gene phosphorylation at chemical ( chemical ) 50 , chemical 398 and chemical 152 .	T23	T49	23481236
NA	CHEMICAL	GENE-N	27	20	Unsaturated FFAs increased chemical , chemical and gene expression significantly , but cells remained gene sensitive as assessed by robust gene and gene phosphorylation at chemical ( chemical ) 50 , chemical 398 and chemical 152 .	T23	T50	23481236
NA	CHEMICAL	GENE-Y	27	22	Unsaturated FFAs increased chemical , chemical and gene expression significantly , but cells remained gene sensitive as assessed by robust gene and gene phosphorylation at chemical ( chemical ) 50 , chemical 398 and chemical 152 .	T23	T51	23481236
NA	CHEMICAL	GENE-Y	31	7	Unsaturated FFAs increased chemical , chemical and gene expression significantly , but cells remained gene sensitive as assessed by robust gene and gene phosphorylation at chemical ( chemical ) 50 , chemical 398 and chemical 152 .	T24	T48	23481236
NA	CHEMICAL	GENE-N	31	14	Unsaturated FFAs increased chemical , chemical and gene expression significantly , but cells remained gene sensitive as assessed by robust gene and gene phosphorylation at chemical ( chemical ) 50 , chemical 398 and chemical 152 .	T24	T49	23481236
NA	CHEMICAL	GENE-N	31	20	Unsaturated FFAs increased chemical , chemical and gene expression significantly , but cells remained gene sensitive as assessed by robust gene and gene phosphorylation at chemical ( chemical ) 50 , chemical 398 and chemical 152 .	T24	T50	23481236
NA	CHEMICAL	GENE-Y	31	22	Unsaturated FFAs increased chemical , chemical and gene expression significantly , but cells remained gene sensitive as assessed by robust gene and gene phosphorylation at chemical ( chemical ) 50 , chemical 398 and chemical 152 .	T24	T51	23481236
NA	CHEMICAL	GENE-Y	3	7	Unsaturated FFAs increased chemical , chemical and gene expression significantly , but cells remained gene sensitive as assessed by robust gene and gene phosphorylation at chemical ( chemical ) 50 , chemical 398 and chemical 152 .	T1	T48	23481236
NA	CHEMICAL	GENE-N	3	14	Unsaturated FFAs increased chemical , chemical and gene expression significantly , but cells remained gene sensitive as assessed by robust gene and gene phosphorylation at chemical ( chemical ) 50 , chemical 398 and chemical 152 .	T1	T49	23481236
NA	CHEMICAL	GENE-N	3	20	Unsaturated FFAs increased chemical , chemical and gene expression significantly , but cells remained gene sensitive as assessed by robust gene and gene phosphorylation at chemical ( chemical ) 50 , chemical 398 and chemical 152 .	T1	T50	23481236
NA	CHEMICAL	GENE-Y	3	22	Unsaturated FFAs increased chemical , chemical and gene expression significantly , but cells remained gene sensitive as assessed by robust gene and gene phosphorylation at chemical ( chemical ) 50 , chemical 398 and chemical 152 .	T1	T51	23481236
CPR:3	CHEMICAL	GENE-Y	1	6	Saturated chemical increased chemical , up-regulated gene , and had gene and gene phosphorylation at chemical 50 impaired .	T2	T25	23481236
CPR:3	CHEMICAL	GENE-N	1	10	Saturated chemical increased chemical , up-regulated gene , and had gene and gene phosphorylation at chemical 50 impaired .	T2	T26	23481236
CPR:3	CHEMICAL	GENE-Y	1	12	Saturated chemical increased chemical , up-regulated gene , and had gene and gene phosphorylation at chemical 50 impaired .	T2	T27	23481236
NA	CHEMICAL	GENE-Y	3	6	Saturated chemical increased chemical , up-regulated gene , and had gene and gene phosphorylation at chemical 50 impaired .	T3	T25	23481236
NA	CHEMICAL	GENE-N	3	10	Saturated chemical increased chemical , up-regulated gene , and had gene and gene phosphorylation at chemical 50 impaired .	T3	T26	23481236
NA	CHEMICAL	GENE-Y	3	12	Saturated chemical increased chemical , up-regulated gene , and had gene and gene phosphorylation at chemical 50 impaired .	T3	T27	23481236
NA	CHEMICAL	GENE-Y	15	6	Saturated chemical increased chemical , up-regulated gene , and had gene and gene phosphorylation at chemical 50 impaired .	T4	T25	23481236
NA	CHEMICAL	GENE-N	15	10	Saturated chemical increased chemical , up-regulated gene , and had gene and gene phosphorylation at chemical 50 impaired .	T4	T26	23481236
NA	CHEMICAL	GENE-Y	15	12	Saturated chemical increased chemical , up-regulated gene , and had gene and gene phosphorylation at chemical 50 impaired .	T4	T27	23481236
CPR:4	CHEMICAL	GENE-N	4	8	Only FFAs that increased chemical caused impairment of gene and gene phosphorylation at chemical 50 .	T6	T30	23481236
CPR:4	CHEMICAL	GENE-Y	4	10	Only FFAs that increased chemical caused impairment of gene and gene phosphorylation at chemical 50 .	T6	T31	23481236
NA	CHEMICAL	GENE-N	13	8	Only FFAs that increased chemical caused impairment of gene and gene phosphorylation at chemical 50 .	T7	T30	23481236
NA	CHEMICAL	GENE-Y	13	10	Only FFAs that increased chemical caused impairment of gene and gene phosphorylation at chemical 50 .	T7	T31	23481236
NA	CHEMICAL	GENE-Y	26	38	Changes in coagulation and fibrinolysis were investigated in 20 patients with oesophageal varices , who underwent endoscopic injection sclerotherapy ( EIS ) with 5 per cent chemical ( chemical ) , by means of serial determination of plasma gene ( gene ) and chemical beta 15-42 ( gene ) .	T6	T17	3828735
NA	CHEMICAL	GENE-Y	26	40	Changes in coagulation and fibrinolysis were investigated in 20 patients with oesophageal varices , who underwent endoscopic injection sclerotherapy ( EIS ) with 5 per cent chemical ( chemical ) , by means of serial determination of plasma gene ( gene ) and chemical beta 15-42 ( gene ) .	T6	T18	3828735
NA	CHEMICAL	GENE-Y	26	23	Changes in coagulation and fibrinolysis were investigated in 20 patients with oesophageal varices , who underwent endoscopic injection sclerotherapy ( EIS ) with 5 per cent chemical ( chemical ) , by means of serial determination of plasma gene ( gene ) and chemical beta 15-42 ( gene ) .	T6	T19	3828735
NA	CHEMICAL	GENE-Y	26	23	Changes in coagulation and fibrinolysis were investigated in 20 patients with oesophageal varices , who underwent endoscopic injection sclerotherapy ( EIS ) with 5 per cent chemical ( chemical ) , by means of serial determination of plasma gene ( gene ) and chemical beta 15-42 ( gene ) .	T6	T20	3828735
NA	CHEMICAL	GENE-Y	28	38	Changes in coagulation and fibrinolysis were investigated in 20 patients with oesophageal varices , who underwent endoscopic injection sclerotherapy ( EIS ) with 5 per cent chemical ( chemical ) , by means of serial determination of plasma gene ( gene ) and chemical beta 15-42 ( gene ) .	T7	T17	3828735
NA	CHEMICAL	GENE-Y	28	40	Changes in coagulation and fibrinolysis were investigated in 20 patients with oesophageal varices , who underwent endoscopic injection sclerotherapy ( EIS ) with 5 per cent chemical ( chemical ) , by means of serial determination of plasma gene ( gene ) and chemical beta 15-42 ( gene ) .	T7	T18	3828735
NA	CHEMICAL	GENE-Y	28	23	Changes in coagulation and fibrinolysis were investigated in 20 patients with oesophageal varices , who underwent endoscopic injection sclerotherapy ( EIS ) with 5 per cent chemical ( chemical ) , by means of serial determination of plasma gene ( gene ) and chemical beta 15-42 ( gene ) .	T7	T19	3828735
NA	CHEMICAL	GENE-Y	28	23	Changes in coagulation and fibrinolysis were investigated in 20 patients with oesophageal varices , who underwent endoscopic injection sclerotherapy ( EIS ) with 5 per cent chemical ( chemical ) , by means of serial determination of plasma gene ( gene ) and chemical beta 15-42 ( gene ) .	T7	T20	3828735
NA	CHEMICAL	GENE-Y	43	38	Changes in coagulation and fibrinolysis were investigated in 20 patients with oesophageal varices , who underwent endoscopic injection sclerotherapy ( EIS ) with 5 per cent chemical ( chemical ) , by means of serial determination of plasma gene ( gene ) and chemical beta 15-42 ( gene ) .	T8	T17	3828735
NA	CHEMICAL	GENE-Y	43	40	Changes in coagulation and fibrinolysis were investigated in 20 patients with oesophageal varices , who underwent endoscopic injection sclerotherapy ( EIS ) with 5 per cent chemical ( chemical ) , by means of serial determination of plasma gene ( gene ) and chemical beta 15-42 ( gene ) .	T8	T18	3828735
NA	CHEMICAL	GENE-Y	43	23	Changes in coagulation and fibrinolysis were investigated in 20 patients with oesophageal varices , who underwent endoscopic injection sclerotherapy ( EIS ) with 5 per cent chemical ( chemical ) , by means of serial determination of plasma gene ( gene ) and chemical beta 15-42 ( gene ) .	T8	T19	3828735
NA	CHEMICAL	GENE-Y	43	23	Changes in coagulation and fibrinolysis were investigated in 20 patients with oesophageal varices , who underwent endoscopic injection sclerotherapy ( EIS ) with 5 per cent chemical ( chemical ) , by means of serial determination of plasma gene ( gene ) and chemical beta 15-42 ( gene ) .	T8	T20	3828735
CPR:4	CHEMICAL	GENE-N	8	10	In vitro studies , however , revealed that chemical inhibits gene clot formation because of the chemical-chelating ability of its constituent chemical , although chemical or chemical exhibited procoagulant activity in gene formation in vitro .	T9	T23	3828735
NA	CHEMICAL	GENE-Y	8	31	In vitro studies , however , revealed that chemical inhibits gene clot formation because of the chemical-chelating ability of its constituent chemical , although chemical or chemical exhibited procoagulant activity in gene formation in vitro .	T9	T24	3828735
NA	CHEMICAL	GENE-N	16	10	In vitro studies , however , revealed that chemical inhibits gene clot formation because of the chemical-chelating ability of its constituent chemical , although chemical or chemical exhibited procoagulant activity in gene formation in vitro .	T10	T23	3828735
NA	CHEMICAL	GENE-Y	16	31	In vitro studies , however , revealed that chemical inhibits gene clot formation because of the chemical-chelating ability of its constituent chemical , although chemical or chemical exhibited procoagulant activity in gene formation in vitro .	T10	T24	3828735
NA	CHEMICAL	GENE-N	21	10	In vitro studies , however , revealed that chemical inhibits gene clot formation because of the chemical-chelating ability of its constituent chemical , although chemical or chemical exhibited procoagulant activity in gene formation in vitro .	T11	T23	3828735
NA	CHEMICAL	GENE-Y	21	31	In vitro studies , however , revealed that chemical inhibits gene clot formation because of the chemical-chelating ability of its constituent chemical , although chemical or chemical exhibited procoagulant activity in gene formation in vitro .	T11	T24	3828735
NA	CHEMICAL	GENE-N	24	10	In vitro studies , however , revealed that chemical inhibits gene clot formation because of the chemical-chelating ability of its constituent chemical , although chemical or chemical exhibited procoagulant activity in gene formation in vitro .	T12	T23	3828735
NA	CHEMICAL	GENE-Y	24	31	In vitro studies , however , revealed that chemical inhibits gene clot formation because of the chemical-chelating ability of its constituent chemical , although chemical or chemical exhibited procoagulant activity in gene formation in vitro .	T12	T24	3828735
NA	CHEMICAL	GENE-N	26	10	In vitro studies , however , revealed that chemical inhibits gene clot formation because of the chemical-chelating ability of its constituent chemical , although chemical or chemical exhibited procoagulant activity in gene formation in vitro .	T13	T23	3828735
NA	CHEMICAL	GENE-Y	26	31	In vitro studies , however , revealed that chemical inhibits gene clot formation because of the chemical-chelating ability of its constituent chemical , although chemical or chemical exhibited procoagulant activity in gene formation in vitro .	T13	T24	3828735
NA	CHEMICAL	GENE-N	6	15	Nevertheless , an external application of chemical or chemical over decapsulized kidney of rat resulted in a significant accumulation of chemical-labelled gene .	T1	T15	3828735
NA	CHEMICAL	GENE-N	8	15	Nevertheless , an external application of chemical or chemical over decapsulized kidney of rat resulted in a significant accumulation of chemical-labelled gene .	T2	T15	3828735
NA	CHEMICAL	GENE-N	20	15	Nevertheless , an external application of chemical or chemical over decapsulized kidney of rat resulted in a significant accumulation of chemical-labelled gene .	T3	T15	3828735
NA	CHEMICAL	GENE-N	10	21	However , pretreatment with agents that block late I ( chemical ) , like chemical , chemical , and chemical , a novel mixed gene blocker for the rapid pharmacologic conversion of atrial fibrillation , significantly attenuates the prolonging effects of Class III agents or those induced by ATX-II , a specific toxin that delays chemical channel inactivation and amplifies late I ( chemical ) greatly , mimicking LQT3 .	T18	T25	16686685
NA	CHEMICAL	GENE-N	10	21	However , pretreatment with agents that block late I ( chemical ) , like chemical , chemical , and chemical , a novel mixed gene blocker for the rapid pharmacologic conversion of atrial fibrillation , significantly attenuates the prolonging effects of Class III agents or those induced by ATX-II , a specific toxin that delays chemical channel inactivation and amplifies late I ( chemical ) greatly , mimicking LQT3 .	T18	T22	16686685
NA	CHEMICAL	GENE-N	14	21	However , pretreatment with agents that block late I ( chemical ) , like chemical , chemical , and chemical , a novel mixed gene blocker for the rapid pharmacologic conversion of atrial fibrillation , significantly attenuates the prolonging effects of Class III agents or those induced by ATX-II , a specific toxin that delays chemical channel inactivation and amplifies late I ( chemical ) greatly , mimicking LQT3 .	T19	T25	16686685
NA	CHEMICAL	GENE-N	14	21	However , pretreatment with agents that block late I ( chemical ) , like chemical , chemical , and chemical , a novel mixed gene blocker for the rapid pharmacologic conversion of atrial fibrillation , significantly attenuates the prolonging effects of Class III agents or those induced by ATX-II , a specific toxin that delays chemical channel inactivation and amplifies late I ( chemical ) greatly , mimicking LQT3 .	T19	T22	16686685
NA	CHEMICAL	GENE-N	16	21	However , pretreatment with agents that block late I ( chemical ) , like chemical , chemical , and chemical , a novel mixed gene blocker for the rapid pharmacologic conversion of atrial fibrillation , significantly attenuates the prolonging effects of Class III agents or those induced by ATX-II , a specific toxin that delays chemical channel inactivation and amplifies late I ( chemical ) greatly , mimicking LQT3 .	T20	T25	16686685
NA	CHEMICAL	GENE-N	16	21	However , pretreatment with agents that block late I ( chemical ) , like chemical , chemical , and chemical , a novel mixed gene blocker for the rapid pharmacologic conversion of atrial fibrillation , significantly attenuates the prolonging effects of Class III agents or those induced by ATX-II , a specific toxin that delays chemical channel inactivation and amplifies late I ( chemical ) greatly , mimicking LQT3 .	T20	T22	16686685
CPR:4	CHEMICAL	GENE-N	19	21	However , pretreatment with agents that block late I ( chemical ) , like chemical , chemical , and chemical , a novel mixed gene blocker for the rapid pharmacologic conversion of atrial fibrillation , significantly attenuates the prolonging effects of Class III agents or those induced by ATX-II , a specific toxin that delays chemical channel inactivation and amplifies late I ( chemical ) greatly , mimicking LQT3 .	T21	T25	16686685
NA	CHEMICAL	GENE-N	19	21	However , pretreatment with agents that block late I ( chemical ) , like chemical , chemical , and chemical , a novel mixed gene blocker for the rapid pharmacologic conversion of atrial fibrillation , significantly attenuates the prolonging effects of Class III agents or those induced by ATX-II , a specific toxin that delays chemical channel inactivation and amplifies late I ( chemical ) greatly , mimicking LQT3 .	T21	T22	16686685
NA	CHEMICAL	GENE-N	10	21	However , pretreatment with agents that block late I ( chemical ) , like chemical , chemical , and chemical , a novel mixed gene blocker for the rapid pharmacologic conversion of atrial fibrillation , significantly attenuates the prolonging effects of Class III agents or those induced by ATX-II , a specific toxin that delays chemical channel inactivation and amplifies late I ( chemical ) greatly , mimicking LQT3 .	T1	T25	16686685
NA	CHEMICAL	GENE-N	10	21	However , pretreatment with agents that block late I ( chemical ) , like chemical , chemical , and chemical , a novel mixed gene blocker for the rapid pharmacologic conversion of atrial fibrillation , significantly attenuates the prolonging effects of Class III agents or those induced by ATX-II , a specific toxin that delays chemical channel inactivation and amplifies late I ( chemical ) greatly , mimicking LQT3 .	T1	T22	16686685
NA	CHEMICAL	GENE-N	16	21	However , pretreatment with agents that block late I ( chemical ) , like chemical , chemical , and chemical , a novel mixed gene blocker for the rapid pharmacologic conversion of atrial fibrillation , significantly attenuates the prolonging effects of Class III agents or those induced by ATX-II , a specific toxin that delays chemical channel inactivation and amplifies late I ( chemical ) greatly , mimicking LQT3 .	T2	T25	16686685
NA	CHEMICAL	GENE-N	16	21	However , pretreatment with agents that block late I ( chemical ) , like chemical , chemical , and chemical , a novel mixed gene blocker for the rapid pharmacologic conversion of atrial fibrillation , significantly attenuates the prolonging effects of Class III agents or those induced by ATX-II , a specific toxin that delays chemical channel inactivation and amplifies late I ( chemical ) greatly , mimicking LQT3 .	T2	T22	16686685
NA	CHEMICAL	GENE-N	1	2	The chemical channel block caused by chemical and chemical can be through the open or inactivated states of the channel , but both equivalently inhibit a late component of chemical current ( I ( chemical ) ) , recorded at 22 degrees C using whole-cell patch clamp of gene expressed in HEK cells .	T3	T23	16686685
NA	CHEMICAL	GENE-Y	1	48	The chemical channel block caused by chemical and chemical can be through the open or inactivated states of the channel , but both equivalently inhibit a late component of chemical current ( I ( chemical ) ) , recorded at 22 degrees C using whole-cell patch clamp of gene expressed in HEK cells .	T3	T24	16686685
CPR:4	CHEMICAL	GENE-N	6	2	The chemical channel block caused by chemical and chemical can be through the open or inactivated states of the channel , but both equivalently inhibit a late component of chemical current ( I ( chemical ) ) , recorded at 22 degrees C using whole-cell patch clamp of gene expressed in HEK cells .	T4	T23	16686685
NA	CHEMICAL	GENE-Y	6	48	The chemical channel block caused by chemical and chemical can be through the open or inactivated states of the channel , but both equivalently inhibit a late component of chemical current ( I ( chemical ) ) , recorded at 22 degrees C using whole-cell patch clamp of gene expressed in HEK cells .	T4	T24	16686685
CPR:4	CHEMICAL	GENE-N	8	2	The chemical channel block caused by chemical and chemical can be through the open or inactivated states of the channel , but both equivalently inhibit a late component of chemical current ( I ( chemical ) ) , recorded at 22 degrees C using whole-cell patch clamp of gene expressed in HEK cells .	T5	T23	16686685
NA	CHEMICAL	GENE-Y	8	48	The chemical channel block caused by chemical and chemical can be through the open or inactivated states of the channel , but both equivalently inhibit a late component of chemical current ( I ( chemical ) ) , recorded at 22 degrees C using whole-cell patch clamp of gene expressed in HEK cells .	T5	T24	16686685
NA	CHEMICAL	GENE-N	25	2	The chemical channel block caused by chemical and chemical can be through the open or inactivated states of the channel , but both equivalently inhibit a late component of chemical current ( I ( chemical ) ) , recorded at 22 degrees C using whole-cell patch clamp of gene expressed in HEK cells .	T6	T23	16686685
NA	CHEMICAL	GENE-Y	25	48	The chemical channel block caused by chemical and chemical can be through the open or inactivated states of the channel , but both equivalently inhibit a late component of chemical current ( I ( chemical ) ) , recorded at 22 degrees C using whole-cell patch clamp of gene expressed in HEK cells .	T6	T24	16686685
NA	CHEMICAL	GENE-N	25	2	The chemical channel block caused by chemical and chemical can be through the open or inactivated states of the channel , but both equivalently inhibit a late component of chemical current ( I ( chemical ) ) , recorded at 22 degrees C using whole-cell patch clamp of gene expressed in HEK cells .	T7	T23	16686685
NA	CHEMICAL	GENE-Y	25	48	The chemical channel block caused by chemical and chemical can be through the open or inactivated states of the channel , but both equivalently inhibit a late component of chemical current ( I ( chemical ) ) , recorded at 22 degrees C using whole-cell patch clamp of gene expressed in HEK cells .	T7	T24	16686685
NA	CHEMICAL	GENE-N	10	2	Identification of a new interaction mode between the gene of chemical-terminal Src kinase ( gene ) and gene ( gene ) /gene ( gene ) .	T6	T26	23548896
NA	CHEMICAL	GENE-Y	10	2	Identification of a new interaction mode between the gene of chemical-terminal Src kinase ( gene ) and gene ( gene ) /gene ( gene ) .	T6	T27	23548896
NA	CHEMICAL	GENE-Y	10	14	Identification of a new interaction mode between the gene of chemical-terminal Src kinase ( gene ) and gene ( gene ) /gene ( gene ) .	T6	T21	23548896
NA	CHEMICAL	GENE-Y	10	17	Identification of a new interaction mode between the gene of chemical-terminal Src kinase ( gene ) and gene ( gene ) /gene ( gene ) .	T6	T22	23548896
NA	CHEMICAL	GENE-Y	10	19	Identification of a new interaction mode between the gene of chemical-terminal Src kinase ( gene ) and gene ( gene ) /gene ( gene ) .	T6	T23	23548896
NA	CHEMICAL	GENE-Y	10	2	Identification of a new interaction mode between the gene of chemical-terminal Src kinase ( gene ) and gene ( gene ) /gene ( gene ) .	T6	T24	23548896
NA	CHEMICAL	GENE-Y	10	23	Identification of a new interaction mode between the gene of chemical-terminal Src kinase ( gene ) and gene ( gene ) /gene ( gene ) .	T6	T25	23548896
NA	CHEMICAL	GENE-N	6	2	Proteins with gene play major roles in chemical kinase signaling .	T4	T9	23548896
NA	CHEMICAL	GENE-N	6	6	Proteins with gene play major roles in chemical kinase signaling .	T4	T15	23548896
NA	CHEMICAL	GENE-N	10	8	Here we report the solution structure of the gene of chemical-terminal Src kinase ( gene ) in complex with a longer phosphopeptide from gene ( gene ) .	T3	T10	23548896
NA	CHEMICAL	GENE-Y	10	12	Here we report the solution structure of the gene of chemical-terminal Src kinase ( gene ) in complex with a longer phosphopeptide from gene ( gene ) .	T3	T11	23548896
NA	CHEMICAL	GENE-Y	10	14	Here we report the solution structure of the gene of chemical-terminal Src kinase ( gene ) in complex with a longer phosphopeptide from gene ( gene ) .	T3	T12	23548896
NA	CHEMICAL	GENE-Y	10	16	Here we report the solution structure of the gene of chemical-terminal Src kinase ( gene ) in complex with a longer phosphopeptide from gene ( gene ) .	T3	T13	23548896
NA	CHEMICAL	GENE-Y	10	25	Here we report the solution structure of the gene of chemical-terminal Src kinase ( gene ) in complex with a longer phosphopeptide from gene ( gene ) .	T3	T14	23548896
NA	CHEMICAL	GENE-Y	16	25	This structure , together with biochemical experiments , revealed the existence of a novel binding region in addition to the canonical chemical-314 binding site of gene .	T5	T16	23548896
CPR:9	CHEMICAL	GENE-Y	1	0	gene-derived chemical can influence several processes that are linked to carcinogenesis .	T3	T7	23580446
CPR:9	CHEMICAL	GENE-Y	2	1	Platelet-induced gene-dependent chemical synthesis in HT29 cells was involved in downregulation of gene ( gene/gene ) and upregulation of gene , since these effects were prevented by chemical ( a selective gene inhibitor ) and rescued by exogenous chemical .	T4	T27	23580446
NA	CHEMICAL	GENE-Y	2	12	Platelet-induced gene-dependent chemical synthesis in HT29 cells was involved in downregulation of gene ( gene/gene ) and upregulation of gene , since these effects were prevented by chemical ( a selective gene inhibitor ) and rescued by exogenous chemical .	T4	T28	23580446
NA	CHEMICAL	GENE-Y	2	14	Platelet-induced gene-dependent chemical synthesis in HT29 cells was involved in downregulation of gene ( gene/gene ) and upregulation of gene , since these effects were prevented by chemical ( a selective gene inhibitor ) and rescued by exogenous chemical .	T4	T29	23580446
NA	CHEMICAL	GENE-Y	2	14	Platelet-induced gene-dependent chemical synthesis in HT29 cells was involved in downregulation of gene ( gene/gene ) and upregulation of gene , since these effects were prevented by chemical ( a selective gene inhibitor ) and rescued by exogenous chemical .	T4	T30	23580446
NA	CHEMICAL	GENE-Y	2	4	Platelet-induced gene-dependent chemical synthesis in HT29 cells was involved in downregulation of gene ( gene/gene ) and upregulation of gene , since these effects were prevented by chemical ( a selective gene inhibitor ) and rescued by exogenous chemical .	T4	T31	23580446
NA	CHEMICAL	GENE-Y	2	31	Platelet-induced gene-dependent chemical synthesis in HT29 cells was involved in downregulation of gene ( gene/gene ) and upregulation of gene , since these effects were prevented by chemical ( a selective gene inhibitor ) and rescued by exogenous chemical .	T4	T32	23580446
NA	CHEMICAL	GENE-Y	11	1	Platelet-induced gene-dependent chemical synthesis in HT29 cells was involved in downregulation of gene ( gene/gene ) and upregulation of gene , since these effects were prevented by chemical ( a selective gene inhibitor ) and rescued by exogenous chemical .	T5	T27	23580446
CPR:3	CHEMICAL	GENE-Y	11	12	Platelet-induced gene-dependent chemical synthesis in HT29 cells was involved in downregulation of gene ( gene/gene ) and upregulation of gene , since these effects were prevented by chemical ( a selective gene inhibitor ) and rescued by exogenous chemical .	T5	T28	23580446
CPR:3	CHEMICAL	GENE-Y	11	14	Platelet-induced gene-dependent chemical synthesis in HT29 cells was involved in downregulation of gene ( gene/gene ) and upregulation of gene , since these effects were prevented by chemical ( a selective gene inhibitor ) and rescued by exogenous chemical .	T5	T29	23580446
CPR:3	CHEMICAL	GENE-Y	11	14	Platelet-induced gene-dependent chemical synthesis in HT29 cells was involved in downregulation of gene ( gene/gene ) and upregulation of gene , since these effects were prevented by chemical ( a selective gene inhibitor ) and rescued by exogenous chemical .	T5	T30	23580446
CPR:4	CHEMICAL	GENE-Y	11	4	Platelet-induced gene-dependent chemical synthesis in HT29 cells was involved in downregulation of gene ( gene/gene ) and upregulation of gene , since these effects were prevented by chemical ( a selective gene inhibitor ) and rescued by exogenous chemical .	T5	T31	23580446
CPR:4	CHEMICAL	GENE-Y	11	31	Platelet-induced gene-dependent chemical synthesis in HT29 cells was involved in downregulation of gene ( gene/gene ) and upregulation of gene , since these effects were prevented by chemical ( a selective gene inhibitor ) and rescued by exogenous chemical .	T5	T32	23580446
NA	CHEMICAL	GENE-Y	38	1	Platelet-induced gene-dependent chemical synthesis in HT29 cells was involved in downregulation of gene ( gene/gene ) and upregulation of gene , since these effects were prevented by chemical ( a selective gene inhibitor ) and rescued by exogenous chemical .	T6	T27	23580446
NA	CHEMICAL	GENE-Y	38	12	Platelet-induced gene-dependent chemical synthesis in HT29 cells was involved in downregulation of gene ( gene/gene ) and upregulation of gene , since these effects were prevented by chemical ( a selective gene inhibitor ) and rescued by exogenous chemical .	T6	T28	23580446
NA	CHEMICAL	GENE-Y	38	14	Platelet-induced gene-dependent chemical synthesis in HT29 cells was involved in downregulation of gene ( gene/gene ) and upregulation of gene , since these effects were prevented by chemical ( a selective gene inhibitor ) and rescued by exogenous chemical .	T6	T29	23580446
NA	CHEMICAL	GENE-Y	38	14	Platelet-induced gene-dependent chemical synthesis in HT29 cells was involved in downregulation of gene ( gene/gene ) and upregulation of gene , since these effects were prevented by chemical ( a selective gene inhibitor ) and rescued by exogenous chemical .	T6	T30	23580446
NA	CHEMICAL	GENE-Y	38	4	Platelet-induced gene-dependent chemical synthesis in HT29 cells was involved in downregulation of gene ( gene/gene ) and upregulation of gene , since these effects were prevented by chemical ( a selective gene inhibitor ) and rescued by exogenous chemical .	T6	T31	23580446
NA	CHEMICAL	GENE-Y	38	31	Platelet-induced gene-dependent chemical synthesis in HT29 cells was involved in downregulation of gene ( gene/gene ) and upregulation of gene , since these effects were prevented by chemical ( a selective gene inhibitor ) and rescued by exogenous chemical .	T6	T32	23580446
NA	CHEMICAL	GENE-Y	2	2	Inhibitors of gene function ( chemical , a dominant-negative form of gene , gene , and anti-gene antibody M3/38 ) or gene-mediated platelet adhesion ( revacept , a dimeric gene gene-gene ) prevented aberrant gene expression .	T1	T10	23580446
NA	CHEMICAL	GENE-Y	2	7	Inhibitors of gene function ( chemical , a dominant-negative form of gene , gene , and anti-gene antibody M3/38 ) or gene-mediated platelet adhesion ( revacept , a dimeric gene gene-gene ) prevented aberrant gene expression .	T1	T11	23580446
NA	CHEMICAL	GENE-Y	2	7	Inhibitors of gene function ( chemical , a dominant-negative form of gene , gene , and anti-gene antibody M3/38 ) or gene-mediated platelet adhesion ( revacept , a dimeric gene gene-gene ) prevented aberrant gene expression .	T1	T12	23580446
NA	CHEMICAL	GENE-Y	2	7	Inhibitors of gene function ( chemical , a dominant-negative form of gene , gene , and anti-gene antibody M3/38 ) or gene-mediated platelet adhesion ( revacept , a dimeric gene gene-gene ) prevented aberrant gene expression .	T1	T13	23580446
NA	CHEMICAL	GENE-Y	2	20	Inhibitors of gene function ( chemical , a dominant-negative form of gene , gene , and anti-gene antibody M3/38 ) or gene-mediated platelet adhesion ( revacept , a dimeric gene gene-gene ) prevented aberrant gene expression .	T1	T14	23580446
NA	CHEMICAL	GENE-Y	2	20	Inhibitors of gene function ( chemical , a dominant-negative form of gene , gene , and anti-gene antibody M3/38 ) or gene-mediated platelet adhesion ( revacept , a dimeric gene gene-gene ) prevented aberrant gene expression .	T1	T15	23580446
NA	CHEMICAL	GENE-Y	2	30	Inhibitors of gene function ( chemical , a dominant-negative form of gene , gene , and anti-gene antibody M3/38 ) or gene-mediated platelet adhesion ( revacept , a dimeric gene gene-gene ) prevented aberrant gene expression .	T1	T16	23580446
NA	CHEMICAL	GENE-N	2	30	Inhibitors of gene function ( chemical , a dominant-negative form of gene , gene , and anti-gene antibody M3/38 ) or gene-mediated platelet adhesion ( revacept , a dimeric gene gene-gene ) prevented aberrant gene expression .	T1	T17	23580446
NA	CHEMICAL	GENE-Y	2	34	Inhibitors of gene function ( chemical , a dominant-negative form of gene , gene , and anti-gene antibody M3/38 ) or gene-mediated platelet adhesion ( revacept , a dimeric gene gene-gene ) prevented aberrant gene expression .	T1	T18	23580446
NA	CHEMICAL	GENE-Y	1	27	Inhibition of platelet-cancer cell interaction by revacept was more effective than chemical in preventing platelet-induced mRNA changes of EMT markers suggesting that direct cell-cell contact and aberrant gene expression synergistically induced gene expression modifications associated with EMT .	T2	T19	23580446
NA	CHEMICAL	GENE-Y	0	9	chemical activity against Brugia malayi microfilariae is dependent on gene and the gene pathway .	T23	T38	15932636
NA	CHEMICAL	GENE-N	0	12	chemical activity against Brugia malayi microfilariae is dependent on gene and the gene pathway .	T23	T37	15932636
NA	CHEMICAL	GENE-N	8	10	Here we have investigated the contribution of the chemical and gene ( gene ) pathways to the activity of chemical against B. malayi microfilariae in mice .	T12	T31	15932636
NA	CHEMICAL	GENE-N	8	12	Here we have investigated the contribution of the chemical and gene ( gene ) pathways to the activity of chemical against B. malayi microfilariae in mice .	T12	T32	15932636
NA	CHEMICAL	GENE-N	19	10	Here we have investigated the contribution of the chemical and gene ( gene ) pathways to the activity of chemical against B. malayi microfilariae in mice .	T14	T31	15932636
NA	CHEMICAL	GENE-N	19	12	Here we have investigated the contribution of the chemical and gene ( gene ) pathways to the activity of chemical against B. malayi microfilariae in mice .	T14	T32	15932636
NA	CHEMICAL	GENE-Y	6	19	To investigate a role for inducible chemical in chemical 's activity , DEC and chemical were administered to microfilaraemic gene-/- mice and their background strain ( 129/SV ) .	T18	T33	15932636
NA	CHEMICAL	GENE-Y	8	19	To investigate a role for inducible chemical in chemical 's activity , DEC and chemical were administered to microfilaraemic gene-/- mice and their background strain ( 129/SV ) .	T19	T33	15932636
NA	CHEMICAL	GENE-Y	7	19	To investigate a role for inducible chemical in chemical 's activity , DEC and chemical were administered to microfilaraemic gene-/- mice and their background strain ( 129/SV ) .	T20	T33	15932636
NA	CHEMICAL	GENE-N	10	15	Western blot analysis was used to determine any effect of chemical on the production of gene and inducible chemical synthase ( gene ) proteins .	T21	T34	15932636
NA	CHEMICAL	GENE-Y	10	19	Western blot analysis was used to determine any effect of chemical on the production of gene and inducible chemical synthase ( gene ) proteins .	T21	T35	15932636
NA	CHEMICAL	GENE-Y	10	21	Western blot analysis was used to determine any effect of chemical on the production of gene and inducible chemical synthase ( gene ) proteins .	T21	T36	15932636
NA	CHEMICAL	GENE-N	18	15	Western blot analysis was used to determine any effect of chemical on the production of gene and inducible chemical synthase ( gene ) proteins .	T22	T34	15932636
NA	CHEMICAL	GENE-Y	18	19	Western blot analysis was used to determine any effect of chemical on the production of gene and inducible chemical synthase ( gene ) proteins .	T22	T35	15932636
NA	CHEMICAL	GENE-Y	18	21	Western blot analysis was used to determine any effect of chemical on the production of gene and inducible chemical synthase ( gene ) proteins .	T22	T36	15932636
NA	CHEMICAL	GENE-N	4	22	Pre-treatment of animals with chemical or chemical reduced DEC 's efficacy by almost 90 % or 56 % , respectively , supporting a role for the chemical and gene pathways in vivo .	T2	T25	15932636
NA	CHEMICAL	GENE-N	6	22	Pre-treatment of animals with chemical or chemical reduced DEC 's efficacy by almost 90 % or 56 % , respectively , supporting a role for the chemical and gene pathways in vivo .	T3	T25	15932636
NA	CHEMICAL	GENE-N	22	22	Pre-treatment of animals with chemical or chemical reduced DEC 's efficacy by almost 90 % or 56 % , respectively , supporting a role for the chemical and gene pathways in vivo .	T4	T25	15932636
CPR:4	CHEMICAL	GENE-Y	7	16	Furthermore , experiments showed that treatment with chemical results in a reduction in the amount of gene protein in peritoneal exudate cells .	T5	T26	15932636
NA	CHEMICAL	GENE-Y	11	3	Additionally , in gene-/- mice infected with B. malayi microfilariae , chemical showed no activity , whereas the efficacy of another antifilarial drug , chemical , was unaffected .	T6	T27	15932636
NA	CHEMICAL	GENE-Y	2	3	Additionally , in gene-/- mice infected with B. malayi microfilariae , chemical showed no activity , whereas the efficacy of another antifilarial drug , chemical , was unaffected .	T7	T27	15932636
NA	CHEMICAL	GENE-Y	10	31	CONCLUSION : These results confirm the important role of the chemical metabolic pathway in DEC 's mechanism of action in vivo and show that in addition to its effects on the gene pathway , it targets the gene pathway and gene .	T8	T28	15932636
NA	CHEMICAL	GENE-N	10	37	CONCLUSION : These results confirm the important role of the chemical metabolic pathway in DEC 's mechanism of action in vivo and show that in addition to its effects on the gene pathway , it targets the gene pathway and gene .	T8	T29	15932636
NA	CHEMICAL	GENE-Y	10	40	CONCLUSION : These results confirm the important role of the chemical metabolic pathway in DEC 's mechanism of action in vivo and show that in addition to its effects on the gene pathway , it targets the gene pathway and gene .	T8	T30	15932636
CPR:4	CHEMICAL	GENE-N	0	11	chemical-containing chemical induce apoptosis of hematopoietic tumor cells via inhibition of gene signaling pathways and gene-mediated activation of the intrinsic apoptotic pathway .	T16	T33	23085435
CPR:3	CHEMICAL	GENE-Y	0	15	chemical-containing chemical induce apoptosis of hematopoietic tumor cells via inhibition of gene signaling pathways and gene-mediated activation of the intrinsic apoptotic pathway .	T16	T34	23085435
CPR:4	CHEMICAL	GENE-N	1	11	chemical-containing chemical induce apoptosis of hematopoietic tumor cells via inhibition of gene signaling pathways and gene-mediated activation of the intrinsic apoptotic pathway .	T17	T33	23085435
CPR:3	CHEMICAL	GENE-Y	1	15	chemical-containing chemical induce apoptosis of hematopoietic tumor cells via inhibition of gene signaling pathways and gene-mediated activation of the intrinsic apoptotic pathway .	T17	T34	23085435
CPR:4	CHEMICAL	GENE-N	16	7	chemical-containing chemical ( chemical-chemical ) induce apoptosis in tumor cells by inhibiting the prenylation of small gene .	T1	T19	23085435
CPR:4	CHEMICAL	GENE-N	1	7	chemical-containing chemical ( chemical-chemical ) induce apoptosis in tumor cells by inhibiting the prenylation of small gene .	T3	T19	23085435
CPR:4	CHEMICAL	GENE-N	0	7	chemical-containing chemical ( chemical-chemical ) induce apoptosis in tumor cells by inhibiting the prenylation of small gene .	T6	T19	23085435
CPR:4	CHEMICAL	GENE-N	3	7	chemical-containing chemical ( chemical-chemical ) induce apoptosis in tumor cells by inhibiting the prenylation of small gene .	T7	T19	23085435
CPR:4	CHEMICAL	GENE-N	2	7	Furthermore , chemical-chemical decreased the levels of gene ( gene ) and gene via suppression of gene prenylation and enhanced gene expression .	T10	T20	23085435
CPR:4	CHEMICAL	GENE-N	2	9	Furthermore , chemical-chemical decreased the levels of gene ( gene ) and gene via suppression of gene prenylation and enhanced gene expression .	T10	T21	23085435
CPR:4	CHEMICAL	GENE-Y	2	12	Furthermore , chemical-chemical decreased the levels of gene ( gene ) and gene via suppression of gene prenylation and enhanced gene expression .	T10	T22	23085435
CPR:4	CHEMICAL	GENE-N	2	16	Furthermore , chemical-chemical decreased the levels of gene ( gene ) and gene via suppression of gene prenylation and enhanced gene expression .	T10	T23	23085435
CPR:3	CHEMICAL	GENE-Y	2	20	Furthermore , chemical-chemical decreased the levels of gene ( gene ) and gene via suppression of gene prenylation and enhanced gene expression .	T10	T24	23085435
CPR:4	CHEMICAL	GENE-N	2	7	Furthermore , chemical-chemical decreased the levels of gene ( gene ) and gene via suppression of gene prenylation and enhanced gene expression .	T11	T20	23085435
CPR:4	CHEMICAL	GENE-N	2	9	Furthermore , chemical-chemical decreased the levels of gene ( gene ) and gene via suppression of gene prenylation and enhanced gene expression .	T11	T21	23085435
CPR:4	CHEMICAL	GENE-Y	2	12	Furthermore , chemical-chemical decreased the levels of gene ( gene ) and gene via suppression of gene prenylation and enhanced gene expression .	T11	T22	23085435
CPR:4	CHEMICAL	GENE-N	2	16	Furthermore , chemical-chemical decreased the levels of gene ( gene ) and gene via suppression of gene prenylation and enhanced gene expression .	T11	T23	23085435
CPR:3	CHEMICAL	GENE-Y	2	20	Furthermore , chemical-chemical decreased the levels of gene ( gene ) and gene via suppression of gene prenylation and enhanced gene expression .	T11	T24	23085435
CPR:3	CHEMICAL	GENE-Y	5	19	The present results indicated that chemical-chemical induce apoptosis by decreasing the mitochondrial transmembrane potential , increasing the activation of gene and gene , and enhancing gene expression through inhibition of the gene/gene/gene and gene/gene pathways .	T12	T25	23085435
CPR:3	CHEMICAL	GENE-Y	5	21	The present results indicated that chemical-chemical induce apoptosis by decreasing the mitochondrial transmembrane potential , increasing the activation of gene and gene , and enhancing gene expression through inhibition of the gene/gene/gene and gene/gene pathways .	T12	T26	23085435
CPR:3	CHEMICAL	GENE-Y	5	25	The present results indicated that chemical-chemical induce apoptosis by decreasing the mitochondrial transmembrane potential , increasing the activation of gene and gene , and enhancing gene expression through inhibition of the gene/gene/gene and gene/gene pathways .	T12	T27	23085435
CPR:4	CHEMICAL	GENE-N	5	31	The present results indicated that chemical-chemical induce apoptosis by decreasing the mitochondrial transmembrane potential , increasing the activation of gene and gene , and enhancing gene expression through inhibition of the gene/gene/gene and gene/gene pathways .	T12	T28	23085435
CPR:4	CHEMICAL	GENE-N	5	31	The present results indicated that chemical-chemical induce apoptosis by decreasing the mitochondrial transmembrane potential , increasing the activation of gene and gene , and enhancing gene expression through inhibition of the gene/gene/gene and gene/gene pathways .	T12	T29	23085435
CPR:4	CHEMICAL	GENE-N	5	31	The present results indicated that chemical-chemical induce apoptosis by decreasing the mitochondrial transmembrane potential , increasing the activation of gene and gene , and enhancing gene expression through inhibition of the gene/gene/gene and gene/gene pathways .	T12	T30	23085435
CPR:4	CHEMICAL	GENE-N	5	33	The present results indicated that chemical-chemical induce apoptosis by decreasing the mitochondrial transmembrane potential , increasing the activation of gene and gene , and enhancing gene expression through inhibition of the gene/gene/gene and gene/gene pathways .	T12	T31	23085435
CPR:4	CHEMICAL	GENE-Y	5	33	The present results indicated that chemical-chemical induce apoptosis by decreasing the mitochondrial transmembrane potential , increasing the activation of gene and gene , and enhancing gene expression through inhibition of the gene/gene/gene and gene/gene pathways .	T12	T32	23085435
CPR:3	CHEMICAL	GENE-Y	5	19	The present results indicated that chemical-chemical induce apoptosis by decreasing the mitochondrial transmembrane potential , increasing the activation of gene and gene , and enhancing gene expression through inhibition of the gene/gene/gene and gene/gene pathways .	T13	T25	23085435
CPR:3	CHEMICAL	GENE-Y	5	21	The present results indicated that chemical-chemical induce apoptosis by decreasing the mitochondrial transmembrane potential , increasing the activation of gene and gene , and enhancing gene expression through inhibition of the gene/gene/gene and gene/gene pathways .	T13	T26	23085435
CPR:3	CHEMICAL	GENE-Y	5	25	The present results indicated that chemical-chemical induce apoptosis by decreasing the mitochondrial transmembrane potential , increasing the activation of gene and gene , and enhancing gene expression through inhibition of the gene/gene/gene and gene/gene pathways .	T13	T27	23085435
CPR:4	CHEMICAL	GENE-N	5	31	The present results indicated that chemical-chemical induce apoptosis by decreasing the mitochondrial transmembrane potential , increasing the activation of gene and gene , and enhancing gene expression through inhibition of the gene/gene/gene and gene/gene pathways .	T13	T28	23085435
CPR:4	CHEMICAL	GENE-N	5	31	The present results indicated that chemical-chemical induce apoptosis by decreasing the mitochondrial transmembrane potential , increasing the activation of gene and gene , and enhancing gene expression through inhibition of the gene/gene/gene and gene/gene pathways .	T13	T29	23085435
CPR:4	CHEMICAL	GENE-N	5	31	The present results indicated that chemical-chemical induce apoptosis by decreasing the mitochondrial transmembrane potential , increasing the activation of gene and gene , and enhancing gene expression through inhibition of the gene/gene/gene and gene/gene pathways .	T13	T30	23085435
CPR:4	CHEMICAL	GENE-N	5	33	The present results indicated that chemical-chemical induce apoptosis by decreasing the mitochondrial transmembrane potential , increasing the activation of gene and gene , and enhancing gene expression through inhibition of the gene/gene/gene and gene/gene pathways .	T13	T31	23085435
CPR:4	CHEMICAL	GENE-Y	5	33	The present results indicated that chemical-chemical induce apoptosis by decreasing the mitochondrial transmembrane potential , increasing the activation of gene and gene , and enhancing gene expression through inhibition of the gene/gene/gene and gene/gene pathways .	T13	T32	23085435
NA	CHEMICAL	GENE-N	3	22	The accumulation of chemical-chemical in bones suggests that they may act more effectively on tumors that have spread to bones or on gene-variable tumors .	T14	T18	23085435
NA	CHEMICAL	GENE-N	3	22	The accumulation of chemical-chemical in bones suggests that they may act more effectively on tumors that have spread to bones or on gene-variable tumors .	T15	T18	23085435
NA	CHEMICAL	GENE-Y	0	1	chemical receptor gene expression during pubertal development of male rats .	T21	T56	12606421
NA	CHEMICAL	GENE-Y	4	5	Appropriate expression of the chemical receptor ( chemical-R ) in gonadotropes is critical for chemical signaling and hence for gene secretion and sexual development .	T14	T45	12606421
NA	CHEMICAL	GENE-N	4	9	Appropriate expression of the chemical receptor ( chemical-R ) in gonadotropes is critical for chemical signaling and hence for gene secretion and sexual development .	T14	T23	12606421
NA	CHEMICAL	GENE-Y	7	5	Appropriate expression of the chemical receptor ( chemical-R ) in gonadotropes is critical for chemical signaling and hence for gene secretion and sexual development .	T15	T45	12606421
NA	CHEMICAL	GENE-N	7	9	Appropriate expression of the chemical receptor ( chemical-R ) in gonadotropes is critical for chemical signaling and hence for gene secretion and sexual development .	T15	T23	12606421
NA	CHEMICAL	GENE-Y	14	5	Appropriate expression of the chemical receptor ( chemical-R ) in gonadotropes is critical for chemical signaling and hence for gene secretion and sexual development .	T19	T45	12606421
NA	CHEMICAL	GENE-N	14	9	Appropriate expression of the chemical receptor ( chemical-R ) in gonadotropes is critical for chemical signaling and hence for gene secretion and sexual development .	T19	T23	12606421
NA	CHEMICAL	GENE-Y	8	14	In addition , the role of the endogenous chemical on the maturational changes of gene-R and gene subunit gene expression was investigated .	T16	T50	12606421
NA	CHEMICAL	GENE-N	8	9	In addition , the role of the endogenous chemical on the maturational changes of gene-R and gene subunit gene expression was investigated .	T16	T52	12606421
NA	CHEMICAL	GENE-N	7	9	To ascertain whether developmental activation of the chemical-R and gene subunit gene expression is gene dependent , we have studied the effect of blocking the endogenous chemical action by treating developing male rats with the specific gene antagonist cetrorelix ( 1.5 mg/kg body weight/week , s.c . )	T2	T31	12606421
NA	CHEMICAL	GENE-Y	7	14	To ascertain whether developmental activation of the chemical-R and gene subunit gene expression is gene dependent , we have studied the effect of blocking the endogenous chemical action by treating developing male rats with the specific gene antagonist cetrorelix ( 1.5 mg/kg body weight/week , s.c . )	T2	T32	12606421
NA	CHEMICAL	GENE-Y	7	36	To ascertain whether developmental activation of the chemical-R and gene subunit gene expression is gene dependent , we have studied the effect of blocking the endogenous chemical action by treating developing male rats with the specific gene antagonist cetrorelix ( 1.5 mg/kg body weight/week , s.c . )	T2	T33	12606421
NA	CHEMICAL	GENE-N	9	9	To ascertain whether developmental activation of the chemical-R and gene subunit gene expression is gene dependent , we have studied the effect of blocking the endogenous chemical action by treating developing male rats with the specific gene antagonist cetrorelix ( 1.5 mg/kg body weight/week , s.c . )	T3	T31	12606421
NA	CHEMICAL	GENE-Y	9	14	To ascertain whether developmental activation of the chemical-R and gene subunit gene expression is gene dependent , we have studied the effect of blocking the endogenous chemical action by treating developing male rats with the specific gene antagonist cetrorelix ( 1.5 mg/kg body weight/week , s.c . )	T3	T32	12606421
NA	CHEMICAL	GENE-Y	9	36	To ascertain whether developmental activation of the chemical-R and gene subunit gene expression is gene dependent , we have studied the effect of blocking the endogenous chemical action by treating developing male rats with the specific gene antagonist cetrorelix ( 1.5 mg/kg body weight/week , s.c . )	T3	T33	12606421
CPR:4	CHEMICAL	GENE-N	0	8	chemical also abolished the developmental rise of the gene subunit mRNAs during the two periods of the study .	T8	T36	12606421
NA	CHEMICAL	GENE-N	18	12	These data demonstrate that sexual maturation of male rats is accompanied by a progressive and concerted induction of chemical-R and gene subunit gene expression .	T10	T39	12606421
NA	CHEMICAL	GENE-N	3	5	Developmental activation of chemical-R and gene subunit genes is chemical dependent .	T11	T41	12606421
NA	CHEMICAL	GENE-N	9	5	Developmental activation of chemical-R and gene subunit genes is chemical dependent .	T12	T41	12606421
NA	CHEMICAL	GENE-Y	7	15	Evidence indicates that nerve gas toxins operate in ways in addition to inhibition of chemical esterase .	T9	T11	14529460
NA	CHEMICAL	GENE-Y	3	8	Effects of a chemical 5-HT ( 4 ) receptor antagonist chemical on gastrointestinal motor and sensory function in humans .	T11	T22	11034583
CPR:6	CHEMICAL	GENE-Y	10	8	Effects of a chemical 5-HT ( 4 ) receptor antagonist chemical on gastrointestinal motor and sensory function in humans .	T12	T22	11034583
NA	CHEMICAL	GENE-Y	2	7	BACKGROUND : chemical 5-HT ( 4 ) receptors are located on enteric cholinergic neurones and may regulate peristalsis .	T2	T14	11034583
CPR:6	CHEMICAL	GENE-Y	18	14	METHODS : Part A compared the effects of placebo to four doses of a gene receptor antagonist ( chemical ) on the chemical mediated increase in plasma chemical ( a gene mediated response ) and orocaecal transit in 18 subjects .	T7	T20	11034583
CPR:6	CHEMICAL	GENE-Y	18	17	METHODS : Part A compared the effects of placebo to four doses of a gene receptor antagonist ( chemical ) on the chemical mediated increase in plasma chemical ( a gene mediated response ) and orocaecal transit in 18 subjects .	T7	T21	11034583
CPR:5	CHEMICAL	GENE-Y	13	14	METHODS : Part A compared the effects of placebo to four doses of a gene receptor antagonist ( chemical ) on the chemical mediated increase in plasma chemical ( a gene mediated response ) and orocaecal transit in 18 subjects .	T8	T20	11034583
NA	CHEMICAL	GENE-Y	13	17	METHODS : Part A compared the effects of placebo to four doses of a gene receptor antagonist ( chemical ) on the chemical mediated increase in plasma chemical ( a gene mediated response ) and orocaecal transit in 18 subjects .	T8	T21	11034583
NA	CHEMICAL	GENE-Y	13	14	METHODS : Part A compared the effects of placebo to four doses of a gene receptor antagonist ( chemical ) on the chemical mediated increase in plasma chemical ( a gene mediated response ) and orocaecal transit in 18 subjects .	T9	T20	11034583
NA	CHEMICAL	GENE-Y	13	17	METHODS : Part A compared the effects of placebo to four doses of a gene receptor antagonist ( chemical ) on the chemical mediated increase in plasma chemical ( a gene mediated response ) and orocaecal transit in 18 subjects .	T9	T21	11034583
NA	CHEMICAL	GENE-Y	9	4	Differentiating the roles of gene and gene receptors using chemical , an gene agonist/gene antagonist .	T12	T27	22445601
NA	CHEMICAL	GENE-Y	9	6	Differentiating the roles of gene and gene receptors using chemical , an gene agonist/gene antagonist .	T12	T28	22445601
CPR:5	CHEMICAL	GENE-Y	9	12	Differentiating the roles of gene and gene receptors using chemical , an gene agonist/gene antagonist .	T12	T29	22445601
CPR:6	CHEMICAL	GENE-Y	9	13	Differentiating the roles of gene and gene receptors using chemical , an gene agonist/gene antagonist .	T12	T30	22445601
NA	CHEMICAL	GENE-N	11	6	Despite the potential therapeutic relevance of gene , there has been a lack of pharmacological tools for separating the roles of gene and gene receptor subtypes .	T9	T22	22445601
NA	CHEMICAL	GENE-Y	11	21	Despite the potential therapeutic relevance of gene , there has been a lack of pharmacological tools for separating the roles of gene and gene receptor subtypes .	T9	T17	22445601
NA	CHEMICAL	GENE-Y	11	23	Despite the potential therapeutic relevance of gene , there has been a lack of pharmacological tools for separating the roles of gene and gene receptor subtypes .	T9	T18	22445601
NA	CHEMICAL	GENE-N	0	4	chemical was claimed from gene expressed in non-neuronal cells to be a selective orthosteric gene agonist and gene antagonist .	T6	T19	22445601
CPR:5	CHEMICAL	GENE-Y	0	14	chemical was claimed from gene expressed in non-neuronal cells to be a selective orthosteric gene agonist and gene antagonist .	T6	T20	22445601
CPR:6	CHEMICAL	GENE-Y	0	17	chemical was claimed from gene expressed in non-neuronal cells to be a selective orthosteric gene agonist and gene antagonist .	T6	T21	22445601
NA	CHEMICAL	GENE-Y	29	31	Field excitatory post-synaptic potentials ( fEPSPs ) evoked by stimulation of the temporo-ammonic path ( TAP ) input to CA1 stratum lacunosum moleculare ( SLM ) were inhibited by chemical in gene-/- mice ( EC ( 50 ) 38 nM ) and wild-type littermates ( EC ( 50 ) 42 nM ) to a similar extent but were not significantly affected in gene-/- mice .	T8	T23	22445601
NA	CHEMICAL	GENE-Y	29	62	Field excitatory post-synaptic potentials ( fEPSPs ) evoked by stimulation of the temporo-ammonic path ( TAP ) input to CA1 stratum lacunosum moleculare ( SLM ) were inhibited by chemical in gene-/- mice ( EC ( 50 ) 38 nM ) and wild-type littermates ( EC ( 50 ) 42 nM ) to a similar extent but were not significantly affected in gene-/- mice .	T8	T24	22445601
NA	CHEMICAL	GENE-Y	4	6	Co-application of DCG-IV and chemical in gene-/- and wild-type littermates resulted in an additive effect , whereas in gene-/- mice , chemical reversed the inhibitory action of DCG-IV .	T10	T25	22445601
NA	CHEMICAL	GENE-Y	4	18	Co-application of DCG-IV and chemical in gene-/- and wild-type littermates resulted in an additive effect , whereas in gene-/- mice , chemical reversed the inhibitory action of DCG-IV .	T10	T26	22445601
NA	CHEMICAL	GENE-Y	21	6	Co-application of DCG-IV and chemical in gene-/- and wild-type littermates resulted in an additive effect , whereas in gene-/- mice , chemical reversed the inhibitory action of DCG-IV .	T11	T25	22445601
NA	CHEMICAL	GENE-Y	21	18	Co-application of DCG-IV and chemical in gene-/- and wild-type littermates resulted in an additive effect , whereas in gene-/- mice , chemical reversed the inhibitory action of DCG-IV .	T11	T26	22445601
CPR:5	CHEMICAL	GENE-Y	5	5	These results confirm the selective gene agonist and gene antagonist actions of chemical .	T1	T13	22445601
CPR:6	CHEMICAL	GENE-Y	5	8	These results confirm the selective gene agonist and gene antagonist actions of chemical .	T1	T14	22445601
NA	CHEMICAL	GENE-N	7	2	Modulation of gene ( gene ) by chemical in hepatic tissue and isolated hepatocyte of C57BL/6 mice .	T23	T40	23423713
NA	CHEMICAL	GENE-N	7	4	Modulation of gene ( gene ) by chemical in hepatic tissue and isolated hepatocyte of C57BL/6 mice .	T23	T41	23423713
NA	CHEMICAL	GENE-N	12	17	The objective of the current study was to investigate the effect of chemical ( chemical ) on gene expression and activity in C57BL/6 mice liver and isolated hepatocytes .	T16	T38	23423713
NA	CHEMICAL	GENE-N	13	17	The objective of the current study was to investigate the effect of chemical ( chemical ) on gene expression and activity in C57BL/6 mice liver and isolated hepatocytes .	T18	T38	23423713
NA	CHEMICAL	GENE-Y	10	62	For this purpose , C57BL6 mice were injected intraperitoneally with chemical ( 5 mg/kg ) in the absence and presence of chemical ( chemical ) ( 15 μg/kg ) for 6 and 24 h. Furthermore , isolated hepatocytes from C57BL6 mice were treated with chemical ( 5 , 10 , and 20 μM ) in the absence and presence of chemical ( 1 nM ) for 3 , 6 , 12 , and 24 h. In vivo , chemical alone did not significantly alter gene , gene , or gene mRNA , protein , or catalytic activity levels .	T7	T31	23423713
NA	CHEMICAL	GENE-Y	10	62	For this purpose , C57BL6 mice were injected intraperitoneally with chemical ( 5 mg/kg ) in the absence and presence of chemical ( chemical ) ( 15 μg/kg ) for 6 and 24 h. Furthermore , isolated hepatocytes from C57BL6 mice were treated with chemical ( 5 , 10 , and 20 μM ) in the absence and presence of chemical ( 1 nM ) for 3 , 6 , 12 , and 24 h. In vivo , chemical alone did not significantly alter gene , gene , or gene mRNA , protein , or catalytic activity levels .	T7	T32	23423713
NA	CHEMICAL	GENE-Y	10	62	For this purpose , C57BL6 mice were injected intraperitoneally with chemical ( 5 mg/kg ) in the absence and presence of chemical ( chemical ) ( 15 μg/kg ) for 6 and 24 h. Furthermore , isolated hepatocytes from C57BL6 mice were treated with chemical ( 5 , 10 , and 20 μM ) in the absence and presence of chemical ( 1 nM ) for 3 , 6 , 12 , and 24 h. In vivo , chemical alone did not significantly alter gene , gene , or gene mRNA , protein , or catalytic activity levels .	T7	T33	23423713
NA	CHEMICAL	GENE-Y	3	62	For this purpose , C57BL6 mice were injected intraperitoneally with chemical ( 5 mg/kg ) in the absence and presence of chemical ( chemical ) ( 15 μg/kg ) for 6 and 24 h. Furthermore , isolated hepatocytes from C57BL6 mice were treated with chemical ( 5 , 10 , and 20 μM ) in the absence and presence of chemical ( 1 nM ) for 3 , 6 , 12 , and 24 h. In vivo , chemical alone did not significantly alter gene , gene , or gene mRNA , protein , or catalytic activity levels .	T8	T31	23423713
NA	CHEMICAL	GENE-Y	3	62	For this purpose , C57BL6 mice were injected intraperitoneally with chemical ( 5 mg/kg ) in the absence and presence of chemical ( chemical ) ( 15 μg/kg ) for 6 and 24 h. Furthermore , isolated hepatocytes from C57BL6 mice were treated with chemical ( 5 , 10 , and 20 μM ) in the absence and presence of chemical ( 1 nM ) for 3 , 6 , 12 , and 24 h. In vivo , chemical alone did not significantly alter gene , gene , or gene mRNA , protein , or catalytic activity levels .	T8	T32	23423713
NA	CHEMICAL	GENE-Y	3	62	For this purpose , C57BL6 mice were injected intraperitoneally with chemical ( 5 mg/kg ) in the absence and presence of chemical ( chemical ) ( 15 μg/kg ) for 6 and 24 h. Furthermore , isolated hepatocytes from C57BL6 mice were treated with chemical ( 5 , 10 , and 20 μM ) in the absence and presence of chemical ( 1 nM ) for 3 , 6 , 12 , and 24 h. In vivo , chemical alone did not significantly alter gene , gene , or gene mRNA , protein , or catalytic activity levels .	T8	T33	23423713
NA	CHEMICAL	GENE-Y	23	62	For this purpose , C57BL6 mice were injected intraperitoneally with chemical ( 5 mg/kg ) in the absence and presence of chemical ( chemical ) ( 15 μg/kg ) for 6 and 24 h. Furthermore , isolated hepatocytes from C57BL6 mice were treated with chemical ( 5 , 10 , and 20 μM ) in the absence and presence of chemical ( 1 nM ) for 3 , 6 , 12 , and 24 h. In vivo , chemical alone did not significantly alter gene , gene , or gene mRNA , protein , or catalytic activity levels .	T9	T31	23423713
NA	CHEMICAL	GENE-Y	23	62	For this purpose , C57BL6 mice were injected intraperitoneally with chemical ( 5 mg/kg ) in the absence and presence of chemical ( chemical ) ( 15 μg/kg ) for 6 and 24 h. Furthermore , isolated hepatocytes from C57BL6 mice were treated with chemical ( 5 , 10 , and 20 μM ) in the absence and presence of chemical ( 1 nM ) for 3 , 6 , 12 , and 24 h. In vivo , chemical alone did not significantly alter gene , gene , or gene mRNA , protein , or catalytic activity levels .	T9	T32	23423713
NA	CHEMICAL	GENE-Y	23	62	For this purpose , C57BL6 mice were injected intraperitoneally with chemical ( 5 mg/kg ) in the absence and presence of chemical ( chemical ) ( 15 μg/kg ) for 6 and 24 h. Furthermore , isolated hepatocytes from C57BL6 mice were treated with chemical ( 5 , 10 , and 20 μM ) in the absence and presence of chemical ( 1 nM ) for 3 , 6 , 12 , and 24 h. In vivo , chemical alone did not significantly alter gene , gene , or gene mRNA , protein , or catalytic activity levels .	T9	T33	23423713
NA	CHEMICAL	GENE-Y	11	62	For this purpose , C57BL6 mice were injected intraperitoneally with chemical ( 5 mg/kg ) in the absence and presence of chemical ( chemical ) ( 15 μg/kg ) for 6 and 24 h. Furthermore , isolated hepatocytes from C57BL6 mice were treated with chemical ( 5 , 10 , and 20 μM ) in the absence and presence of chemical ( 1 nM ) for 3 , 6 , 12 , and 24 h. In vivo , chemical alone did not significantly alter gene , gene , or gene mRNA , protein , or catalytic activity levels .	T10	T31	23423713
NA	CHEMICAL	GENE-Y	11	62	For this purpose , C57BL6 mice were injected intraperitoneally with chemical ( 5 mg/kg ) in the absence and presence of chemical ( chemical ) ( 15 μg/kg ) for 6 and 24 h. Furthermore , isolated hepatocytes from C57BL6 mice were treated with chemical ( 5 , 10 , and 20 μM ) in the absence and presence of chemical ( 1 nM ) for 3 , 6 , 12 , and 24 h. In vivo , chemical alone did not significantly alter gene , gene , or gene mRNA , protein , or catalytic activity levels .	T10	T32	23423713
NA	CHEMICAL	GENE-Y	11	62	For this purpose , C57BL6 mice were injected intraperitoneally with chemical ( 5 mg/kg ) in the absence and presence of chemical ( chemical ) ( 15 μg/kg ) for 6 and 24 h. Furthermore , isolated hepatocytes from C57BL6 mice were treated with chemical ( 5 , 10 , and 20 μM ) in the absence and presence of chemical ( 1 nM ) for 3 , 6 , 12 , and 24 h. In vivo , chemical alone did not significantly alter gene , gene , or gene mRNA , protein , or catalytic activity levels .	T10	T33	23423713
NA	CHEMICAL	GENE-Y	60	62	For this purpose , C57BL6 mice were injected intraperitoneally with chemical ( 5 mg/kg ) in the absence and presence of chemical ( chemical ) ( 15 μg/kg ) for 6 and 24 h. Furthermore , isolated hepatocytes from C57BL6 mice were treated with chemical ( 5 , 10 , and 20 μM ) in the absence and presence of chemical ( 1 nM ) for 3 , 6 , 12 , and 24 h. In vivo , chemical alone did not significantly alter gene , gene , or gene mRNA , protein , or catalytic activity levels .	T11	T31	23423713
NA	CHEMICAL	GENE-Y	60	62	For this purpose , C57BL6 mice were injected intraperitoneally with chemical ( 5 mg/kg ) in the absence and presence of chemical ( chemical ) ( 15 μg/kg ) for 6 and 24 h. Furthermore , isolated hepatocytes from C57BL6 mice were treated with chemical ( 5 , 10 , and 20 μM ) in the absence and presence of chemical ( 1 nM ) for 3 , 6 , 12 , and 24 h. In vivo , chemical alone did not significantly alter gene , gene , or gene mRNA , protein , or catalytic activity levels .	T11	T32	23423713
NA	CHEMICAL	GENE-Y	60	62	For this purpose , C57BL6 mice were injected intraperitoneally with chemical ( 5 mg/kg ) in the absence and presence of chemical ( chemical ) ( 15 μg/kg ) for 6 and 24 h. Furthermore , isolated hepatocytes from C57BL6 mice were treated with chemical ( 5 , 10 , and 20 μM ) in the absence and presence of chemical ( 1 nM ) for 3 , 6 , 12 , and 24 h. In vivo , chemical alone did not significantly alter gene , gene , or gene mRNA , protein , or catalytic activity levels .	T11	T33	23423713
NA	CHEMICAL	GENE-Y	11	62	For this purpose , C57BL6 mice were injected intraperitoneally with chemical ( 5 mg/kg ) in the absence and presence of chemical ( chemical ) ( 15 μg/kg ) for 6 and 24 h. Furthermore , isolated hepatocytes from C57BL6 mice were treated with chemical ( 5 , 10 , and 20 μM ) in the absence and presence of chemical ( 1 nM ) for 3 , 6 , 12 , and 24 h. In vivo , chemical alone did not significantly alter gene , gene , or gene mRNA , protein , or catalytic activity levels .	T12	T31	23423713
NA	CHEMICAL	GENE-Y	11	62	For this purpose , C57BL6 mice were injected intraperitoneally with chemical ( 5 mg/kg ) in the absence and presence of chemical ( chemical ) ( 15 μg/kg ) for 6 and 24 h. Furthermore , isolated hepatocytes from C57BL6 mice were treated with chemical ( 5 , 10 , and 20 μM ) in the absence and presence of chemical ( 1 nM ) for 3 , 6 , 12 , and 24 h. In vivo , chemical alone did not significantly alter gene , gene , or gene mRNA , protein , or catalytic activity levels .	T12	T32	23423713
NA	CHEMICAL	GENE-Y	11	62	For this purpose , C57BL6 mice were injected intraperitoneally with chemical ( 5 mg/kg ) in the absence and presence of chemical ( chemical ) ( 15 μg/kg ) for 6 and 24 h. Furthermore , isolated hepatocytes from C57BL6 mice were treated with chemical ( 5 , 10 , and 20 μM ) in the absence and presence of chemical ( 1 nM ) for 3 , 6 , 12 , and 24 h. In vivo , chemical alone did not significantly alter gene , gene , or gene mRNA , protein , or catalytic activity levels .	T12	T33	23423713
CPR:3	CHEMICAL	GENE-Y	3	15	Upon co-exposure to chemical and chemical , chemical significantly potentiated the chemical-mediated induction of the gene , gene , and gene mRNA , protein , and catalytic activity levels at 24 h. In vitro , chemical decreased the chemical-mediated induction of gene mRNA , protein , and catalytic activity levels .	T13	T34	23423713
CPR:3	CHEMICAL	GENE-Y	3	17	Upon co-exposure to chemical and chemical , chemical significantly potentiated the chemical-mediated induction of the gene , gene , and gene mRNA , protein , and catalytic activity levels at 24 h. In vitro , chemical decreased the chemical-mediated induction of gene mRNA , protein , and catalytic activity levels .	T13	T35	23423713
CPR:3	CHEMICAL	GENE-Y	3	20	Upon co-exposure to chemical and chemical , chemical significantly potentiated the chemical-mediated induction of the gene , gene , and gene mRNA , protein , and catalytic activity levels at 24 h. In vitro , chemical decreased the chemical-mediated induction of gene mRNA , protein , and catalytic activity levels .	T13	T36	23423713
NA	CHEMICAL	GENE-Y	3	41	Upon co-exposure to chemical and chemical , chemical significantly potentiated the chemical-mediated induction of the gene , gene , and gene mRNA , protein , and catalytic activity levels at 24 h. In vitro , chemical decreased the chemical-mediated induction of gene mRNA , protein , and catalytic activity levels .	T13	T37	23423713
CPR:3	CHEMICAL	GENE-Y	5	15	Upon co-exposure to chemical and chemical , chemical significantly potentiated the chemical-mediated induction of the gene , gene , and gene mRNA , protein , and catalytic activity levels at 24 h. In vitro , chemical decreased the chemical-mediated induction of gene mRNA , protein , and catalytic activity levels .	T14	T34	23423713
CPR:3	CHEMICAL	GENE-Y	5	17	Upon co-exposure to chemical and chemical , chemical significantly potentiated the chemical-mediated induction of the gene , gene , and gene mRNA , protein , and catalytic activity levels at 24 h. In vitro , chemical decreased the chemical-mediated induction of gene mRNA , protein , and catalytic activity levels .	T14	T35	23423713
CPR:3	CHEMICAL	GENE-Y	5	20	Upon co-exposure to chemical and chemical , chemical significantly potentiated the chemical-mediated induction of the gene , gene , and gene mRNA , protein , and catalytic activity levels at 24 h. In vitro , chemical decreased the chemical-mediated induction of gene mRNA , protein , and catalytic activity levels .	T14	T36	23423713
NA	CHEMICAL	GENE-Y	5	41	Upon co-exposure to chemical and chemical , chemical significantly potentiated the chemical-mediated induction of the gene , gene , and gene mRNA , protein , and catalytic activity levels at 24 h. In vitro , chemical decreased the chemical-mediated induction of gene mRNA , protein , and catalytic activity levels .	T14	T37	23423713
CPR:3	CHEMICAL	GENE-Y	7	15	Upon co-exposure to chemical and chemical , chemical significantly potentiated the chemical-mediated induction of the gene , gene , and gene mRNA , protein , and catalytic activity levels at 24 h. In vitro , chemical decreased the chemical-mediated induction of gene mRNA , protein , and catalytic activity levels .	T15	T34	23423713
CPR:3	CHEMICAL	GENE-Y	7	17	Upon co-exposure to chemical and chemical , chemical significantly potentiated the chemical-mediated induction of the gene , gene , and gene mRNA , protein , and catalytic activity levels at 24 h. In vitro , chemical decreased the chemical-mediated induction of gene mRNA , protein , and catalytic activity levels .	T15	T35	23423713
CPR:3	CHEMICAL	GENE-Y	7	20	Upon co-exposure to chemical and chemical , chemical significantly potentiated the chemical-mediated induction of the gene , gene , and gene mRNA , protein , and catalytic activity levels at 24 h. In vitro , chemical decreased the chemical-mediated induction of gene mRNA , protein , and catalytic activity levels .	T15	T36	23423713
NA	CHEMICAL	GENE-Y	7	41	Upon co-exposure to chemical and chemical , chemical significantly potentiated the chemical-mediated induction of the gene , gene , and gene mRNA , protein , and catalytic activity levels at 24 h. In vitro , chemical decreased the chemical-mediated induction of gene mRNA , protein , and catalytic activity levels .	T15	T37	23423713
CPR:3	CHEMICAL	GENE-Y	11	15	Upon co-exposure to chemical and chemical , chemical significantly potentiated the chemical-mediated induction of the gene , gene , and gene mRNA , protein , and catalytic activity levels at 24 h. In vitro , chemical decreased the chemical-mediated induction of gene mRNA , protein , and catalytic activity levels .	T17	T34	23423713
CPR:3	CHEMICAL	GENE-Y	11	17	Upon co-exposure to chemical and chemical , chemical significantly potentiated the chemical-mediated induction of the gene , gene , and gene mRNA , protein , and catalytic activity levels at 24 h. In vitro , chemical decreased the chemical-mediated induction of gene mRNA , protein , and catalytic activity levels .	T17	T35	23423713
CPR:3	CHEMICAL	GENE-Y	11	20	Upon co-exposure to chemical and chemical , chemical significantly potentiated the chemical-mediated induction of the gene , gene , and gene mRNA , protein , and catalytic activity levels at 24 h. In vitro , chemical decreased the chemical-mediated induction of gene mRNA , protein , and catalytic activity levels .	T17	T36	23423713
NA	CHEMICAL	GENE-Y	11	41	Upon co-exposure to chemical and chemical , chemical significantly potentiated the chemical-mediated induction of the gene , gene , and gene mRNA , protein , and catalytic activity levels at 24 h. In vitro , chemical decreased the chemical-mediated induction of gene mRNA , protein , and catalytic activity levels .	T17	T37	23423713
NA	CHEMICAL	GENE-Y	35	15	Upon co-exposure to chemical and chemical , chemical significantly potentiated the chemical-mediated induction of the gene , gene , and gene mRNA , protein , and catalytic activity levels at 24 h. In vitro , chemical decreased the chemical-mediated induction of gene mRNA , protein , and catalytic activity levels .	T19	T34	23423713
NA	CHEMICAL	GENE-Y	35	17	Upon co-exposure to chemical and chemical , chemical significantly potentiated the chemical-mediated induction of the gene , gene , and gene mRNA , protein , and catalytic activity levels at 24 h. In vitro , chemical decreased the chemical-mediated induction of gene mRNA , protein , and catalytic activity levels .	T19	T35	23423713
NA	CHEMICAL	GENE-Y	35	20	Upon co-exposure to chemical and chemical , chemical significantly potentiated the chemical-mediated induction of the gene , gene , and gene mRNA , protein , and catalytic activity levels at 24 h. In vitro , chemical decreased the chemical-mediated induction of gene mRNA , protein , and catalytic activity levels .	T19	T36	23423713
CPR:4	CHEMICAL	GENE-Y	35	41	Upon co-exposure to chemical and chemical , chemical significantly potentiated the chemical-mediated induction of the gene , gene , and gene mRNA , protein , and catalytic activity levels at 24 h. In vitro , chemical decreased the chemical-mediated induction of gene mRNA , protein , and catalytic activity levels .	T19	T37	23423713
NA	CHEMICAL	GENE-Y	38	15	Upon co-exposure to chemical and chemical , chemical significantly potentiated the chemical-mediated induction of the gene , gene , and gene mRNA , protein , and catalytic activity levels at 24 h. In vitro , chemical decreased the chemical-mediated induction of gene mRNA , protein , and catalytic activity levels .	T20	T34	23423713
NA	CHEMICAL	GENE-Y	38	17	Upon co-exposure to chemical and chemical , chemical significantly potentiated the chemical-mediated induction of the gene , gene , and gene mRNA , protein , and catalytic activity levels at 24 h. In vitro , chemical decreased the chemical-mediated induction of gene mRNA , protein , and catalytic activity levels .	T20	T35	23423713
NA	CHEMICAL	GENE-Y	38	20	Upon co-exposure to chemical and chemical , chemical significantly potentiated the chemical-mediated induction of the gene , gene , and gene mRNA , protein , and catalytic activity levels at 24 h. In vitro , chemical decreased the chemical-mediated induction of gene mRNA , protein , and catalytic activity levels .	T20	T36	23423713
CPR:3	CHEMICAL	GENE-Y	38	41	Upon co-exposure to chemical and chemical , chemical significantly potentiated the chemical-mediated induction of the gene , gene , and gene mRNA , protein , and catalytic activity levels at 24 h. In vitro , chemical decreased the chemical-mediated induction of gene mRNA , protein , and catalytic activity levels .	T20	T37	23423713
CPR:4	CHEMICAL	GENE-Y	2	7	Furthermore , chemical significantly inhibited the chemical-induced gene-dependent luciferase activity .	T21	T39	23423713
CPR:3	CHEMICAL	GENE-Y	6	7	Furthermore , chemical significantly inhibited the chemical-induced gene-dependent luciferase activity .	T22	T39	23423713
CPR:3	CHEMICAL	GENE-N	0	3	chemical also increased gene ( gene ) levels in animals treated for 24 h. Upon treatment of isolated hepatocytes with gene alone or in the presence of chemical , there was an increase in the gene-dependent luciferase activity .	T1	T24	23423713
CPR:3	CHEMICAL	GENE-N	0	5	chemical also increased gene ( gene ) levels in animals treated for 24 h. Upon treatment of isolated hepatocytes with gene alone or in the presence of chemical , there was an increase in the gene-dependent luciferase activity .	T1	T25	23423713
NA	CHEMICAL	GENE-N	0	20	chemical also increased gene ( gene ) levels in animals treated for 24 h. Upon treatment of isolated hepatocytes with gene alone or in the presence of chemical , there was an increase in the gene-dependent luciferase activity .	T1	T26	23423713
NA	CHEMICAL	GENE-Y	0	35	chemical also increased gene ( gene ) levels in animals treated for 24 h. Upon treatment of isolated hepatocytes with gene alone or in the presence of chemical , there was an increase in the gene-dependent luciferase activity .	T1	T27	23423713
NA	CHEMICAL	GENE-N	3	3	chemical also increased gene ( gene ) levels in animals treated for 24 h. Upon treatment of isolated hepatocytes with gene alone or in the presence of chemical , there was an increase in the gene-dependent luciferase activity .	T2	T24	23423713
NA	CHEMICAL	GENE-N	3	5	chemical also increased gene ( gene ) levels in animals treated for 24 h. Upon treatment of isolated hepatocytes with gene alone or in the presence of chemical , there was an increase in the gene-dependent luciferase activity .	T2	T25	23423713
NA	CHEMICAL	GENE-N	3	20	chemical also increased gene ( gene ) levels in animals treated for 24 h. Upon treatment of isolated hepatocytes with gene alone or in the presence of chemical , there was an increase in the gene-dependent luciferase activity .	T2	T26	23423713
CPR:3	CHEMICAL	GENE-Y	3	35	chemical also increased gene ( gene ) levels in animals treated for 24 h. Upon treatment of isolated hepatocytes with gene alone or in the presence of chemical , there was an increase in the gene-dependent luciferase activity .	T2	T27	23423713
NA	CHEMICAL	GENE-N	9	26	When isolated hepatocytes were treated for 2 h with chemical in the presence of chemical , followed by replacement of the medium with new medium containing gene , there was further potentiation to the chemical-mediated effect .	T3	T28	23423713
NA	CHEMICAL	GENE-N	14	26	When isolated hepatocytes were treated for 2 h with chemical in the presence of chemical , followed by replacement of the medium with new medium containing gene , there was further potentiation to the chemical-mediated effect .	T4	T28	23423713
NA	CHEMICAL	GENE-N	34	26	When isolated hepatocytes were treated for 2 h with chemical in the presence of chemical , followed by replacement of the medium with new medium containing gene , there was further potentiation to the chemical-mediated effect .	T5	T28	23423713
CPR:4	CHEMICAL	GENE-N	0	5	chemical , an Inhibitor of gene Isolated from the Culture Broth of Streptomyces sp .	T3	T16	23414235
CPR:4	CHEMICAL	GENE-N	6	4	A new inhibitor of gene , chemical ( 1 ) , was isolated from the culture broth of Streptomyces sp .	T2	T5	23414235
CPR:3	CHEMICAL	GENE-Y	17	24	In this study , using reverse transcriptase PCR ( RT-PCR ) and ELISA , we showed that chemical up-regulated the expression and secretion of gene ( gene ) in a time-dependent manner in cultured HAPI microglial cells .	T11	T27	23583884
CPR:3	CHEMICAL	GENE-Y	17	26	In this study , using reverse transcriptase PCR ( RT-PCR ) and ELISA , we showed that chemical up-regulated the expression and secretion of gene ( gene ) in a time-dependent manner in cultured HAPI microglial cells .	T11	T28	23583884
CPR:3	CHEMICAL	GENE-Y	0	20	chemical also caused a fast ( within 30min as judged by the increase in its mRNA level ) activation of gene ( gene ) .	T13	T29	23583884
CPR:3	CHEMICAL	GENE-Y	0	22	chemical also caused a fast ( within 30min as judged by the increase in its mRNA level ) activation of gene ( gene ) .	T13	T30	23583884
CPR:3	CHEMICAL	GENE-Y	20	8	This initial action was accompanied by up-regulation of gene ( gene ) , an important inflammation marker within 1h after chemical treatment .	T14	T31	23583884
CPR:3	CHEMICAL	GENE-Y	20	10	This initial action was accompanied by up-regulation of gene ( gene ) , an important inflammation marker within 1h after chemical treatment .	T14	T32	23583884
CPR:3	CHEMICAL	GENE-Y	2	11	Further , chemical exposure could induce phosphorylation- and ubiquitination-dependent degradation of gene , and the translocation of gene from the cytosol to the nucleus in this microglial cell line .	T4	T21	23583884
NA	CHEMICAL	GENE-Y	2	17	Further , chemical exposure could induce phosphorylation- and ubiquitination-dependent degradation of gene , and the translocation of gene from the cytosol to the nucleus in this microglial cell line .	T4	T22	23583884
CPR:3	CHEMICAL	GENE-N	10	3	Thus , the gene signaling pathway can be activated after chemical treatment .	T5	T23	23583884
NA	CHEMICAL	GENE-N	2	7	However , chemical blockers also obviously attenuated gene activation and transnuclear transport induced by chemical .	T6	T24	23583884
CPR:3	CHEMICAL	GENE-N	14	7	However , chemical blockers also obviously attenuated gene activation and transnuclear transport induced by chemical .	T7	T24	23583884
CPR:4	CHEMICAL	GENE-N	3	0	gene inhibitors : chemical incorporating chemical moieties with strong anticonvulsant activity .	T12	T19	15110853
CPR:4	CHEMICAL	GENE-N	5	0	gene inhibitors : chemical incorporating chemical moieties with strong anticonvulsant activity .	T13	T19	15110853
CPR:4	CHEMICAL	GENE-N	34	10	Some of these derivatives showed good inhibitory potency against two gene isozymes involved in important physiological processes , gene , and gene , of the same order of magnitude as the clinically used drugs chemical and chemical .	T9	T14	15110853
CPR:4	CHEMICAL	GENE-Y	34	18	Some of these derivatives showed good inhibitory potency against two gene isozymes involved in important physiological processes , gene , and gene , of the same order of magnitude as the clinically used drugs chemical and chemical .	T9	T15	15110853
CPR:4	CHEMICAL	GENE-Y	34	21	Some of these derivatives showed good inhibitory potency against two gene isozymes involved in important physiological processes , gene , and gene , of the same order of magnitude as the clinically used drugs chemical and chemical .	T9	T16	15110853
CPR:4	CHEMICAL	GENE-N	36	10	Some of these derivatives showed good inhibitory potency against two gene isozymes involved in important physiological processes , gene , and gene , of the same order of magnitude as the clinically used drugs chemical and chemical .	T11	T14	15110853
CPR:4	CHEMICAL	GENE-Y	36	18	Some of these derivatives showed good inhibitory potency against two gene isozymes involved in important physiological processes , gene , and gene , of the same order of magnitude as the clinically used drugs chemical and chemical .	T11	T15	15110853
CPR:4	CHEMICAL	GENE-Y	36	21	Some of these derivatives showed good inhibitory potency against two gene isozymes involved in important physiological processes , gene , and gene , of the same order of magnitude as the clinically used drugs chemical and chemical .	T11	T16	15110853
NA	CHEMICAL	GENE-Y	2	0	gene modulates chemical signaling during gene-mediated osteoclast differentiation .	T9	T23	23395171
NA	CHEMICAL	GENE-Y	2	5	gene modulates chemical signaling during gene-mediated osteoclast differentiation .	T9	T24	23395171
NA	CHEMICAL	GENE-Y	9	2	Osteoclast maturation and function primarily depend on gene ( gene ) -mediated induction of gene ( gene ) , which is further activated via increased intracellular chemical ( [ chemical ] ( i ) ) oscillation .	T2	T18	23395171
NA	CHEMICAL	GENE-Y	9	9	Osteoclast maturation and function primarily depend on gene ( gene ) -mediated induction of gene ( gene ) , which is further activated via increased intracellular chemical ( [ chemical ] ( i ) ) oscillation .	T2	T22	23395171
NA	CHEMICAL	GENE-Y	9	14	Osteoclast maturation and function primarily depend on gene ( gene ) -mediated induction of gene ( gene ) , which is further activated via increased intracellular chemical ( [ chemical ] ( i ) ) oscillation .	T2	T13	23395171
NA	CHEMICAL	GENE-Y	9	16	Osteoclast maturation and function primarily depend on gene ( gene ) -mediated induction of gene ( gene ) , which is further activated via increased intracellular chemical ( [ chemical ] ( i ) ) oscillation .	T2	T14	23395171
NA	CHEMICAL	GENE-Y	8	2	Osteoclast maturation and function primarily depend on gene ( gene ) -mediated induction of gene ( gene ) , which is further activated via increased intracellular chemical ( [ chemical ] ( i ) ) oscillation .	T3	T18	23395171
NA	CHEMICAL	GENE-Y	8	9	Osteoclast maturation and function primarily depend on gene ( gene ) -mediated induction of gene ( gene ) , which is further activated via increased intracellular chemical ( [ chemical ] ( i ) ) oscillation .	T3	T22	23395171
NA	CHEMICAL	GENE-Y	8	14	Osteoclast maturation and function primarily depend on gene ( gene ) -mediated induction of gene ( gene ) , which is further activated via increased intracellular chemical ( [ chemical ] ( i ) ) oscillation .	T3	T13	23395171
NA	CHEMICAL	GENE-Y	8	16	Osteoclast maturation and function primarily depend on gene ( gene ) -mediated induction of gene ( gene ) , which is further activated via increased intracellular chemical ( [ chemical ] ( i ) ) oscillation .	T3	T14	23395171
NA	CHEMICAL	GENE-Y	5	4	Here , we identified gene ( gene ) as a regulator of chemical oscillation during osteoclastogenesis .	T5	T15	23395171
NA	CHEMICAL	GENE-Y	5	6	Here , we identified gene ( gene ) as a regulator of chemical oscillation during osteoclastogenesis .	T5	T16	23395171
NA	CHEMICAL	GENE-Y	8	2	Consequently , gene deficiency significantly diminishes gene-induced [ chemical ] ( i ) oscillation , which results in reduced chemical/calmodulin-dependent protein kinases ( CaMK ) IV and mitochondrial ROS , both of which contribute to achieving the gene activity necessary for osteoclast formation .	T7	T19	23395171
NA	CHEMICAL	GENE-Y	8	6	Consequently , gene deficiency significantly diminishes gene-induced [ chemical ] ( i ) oscillation , which results in reduced chemical/calmodulin-dependent protein kinases ( CaMK ) IV and mitochondrial ROS , both of which contribute to achieving the gene activity necessary for osteoclast formation .	T7	T20	23395171
NA	CHEMICAL	GENE-Y	8	25	Consequently , gene deficiency significantly diminishes gene-induced [ chemical ] ( i ) oscillation , which results in reduced chemical/calmodulin-dependent protein kinases ( CaMK ) IV and mitochondrial ROS , both of which contribute to achieving the gene activity necessary for osteoclast formation .	T7	T21	23395171
NA	CHEMICAL	GENE-N	8	37	Consequently , gene deficiency significantly diminishes gene-induced [ chemical ] ( i ) oscillation , which results in reduced chemical/calmodulin-dependent protein kinases ( CaMK ) IV and mitochondrial ROS , both of which contribute to achieving the gene activity necessary for osteoclast formation .	T7	T10	23395171
NA	CHEMICAL	GENE-Y	10	2	Consequently , gene deficiency significantly diminishes gene-induced [ chemical ] ( i ) oscillation , which results in reduced chemical/calmodulin-dependent protein kinases ( CaMK ) IV and mitochondrial ROS , both of which contribute to achieving the gene activity necessary for osteoclast formation .	T8	T19	23395171
NA	CHEMICAL	GENE-Y	10	6	Consequently , gene deficiency significantly diminishes gene-induced [ chemical ] ( i ) oscillation , which results in reduced chemical/calmodulin-dependent protein kinases ( CaMK ) IV and mitochondrial ROS , both of which contribute to achieving the gene activity necessary for osteoclast formation .	T8	T20	23395171
NA	CHEMICAL	GENE-Y	10	25	Consequently , gene deficiency significantly diminishes gene-induced [ chemical ] ( i ) oscillation , which results in reduced chemical/calmodulin-dependent protein kinases ( CaMK ) IV and mitochondrial ROS , both of which contribute to achieving the gene activity necessary for osteoclast formation .	T8	T21	23395171
NA	CHEMICAL	GENE-N	10	37	Consequently , gene deficiency significantly diminishes gene-induced [ chemical ] ( i ) oscillation , which results in reduced chemical/calmodulin-dependent protein kinases ( CaMK ) IV and mitochondrial ROS , both of which contribute to achieving the gene activity necessary for osteoclast formation .	T8	T10	23395171
NA	CHEMICAL	GENE-N	11	20	Results showed that 96 children ( 36.6 % ) presented a chemical deficiency ( chemical < 200 microg/L with a gene/gene molar ratio = 0.29 +/- 0.06 ) while 166 ( 63.3 % ) children presented normal blood concentrations of chemical ( chemical > or = 200 microg/L with a chemical Binding Protein/gene molar ratio = 0.40 +/- 0.08 ) .	T8	T24	15951260
NA	CHEMICAL	GENE-Y	11	10	Results showed that 96 children ( 36.6 % ) presented a chemical deficiency ( chemical < 200 microg/L with a gene/gene molar ratio = 0.29 +/- 0.06 ) while 166 ( 63.3 % ) children presented normal blood concentrations of chemical ( chemical > or = 200 microg/L with a chemical Binding Protein/gene molar ratio = 0.40 +/- 0.08 ) .	T8	T25	15951260
NA	CHEMICAL	GENE-Y	11	10	Results showed that 96 children ( 36.6 % ) presented a chemical deficiency ( chemical < 200 microg/L with a gene/gene molar ratio = 0.29 +/- 0.06 ) while 166 ( 63.3 % ) children presented normal blood concentrations of chemical ( chemical > or = 200 microg/L with a chemical Binding Protein/gene molar ratio = 0.40 +/- 0.08 ) .	T8	T27	15951260
NA	CHEMICAL	GENE-N	14	20	Results showed that 96 children ( 36.6 % ) presented a chemical deficiency ( chemical < 200 microg/L with a gene/gene molar ratio = 0.29 +/- 0.06 ) while 166 ( 63.3 % ) children presented normal blood concentrations of chemical ( chemical > or = 200 microg/L with a chemical Binding Protein/gene molar ratio = 0.40 +/- 0.08 ) .	T9	T24	15951260
NA	CHEMICAL	GENE-Y	14	10	Results showed that 96 children ( 36.6 % ) presented a chemical deficiency ( chemical < 200 microg/L with a gene/gene molar ratio = 0.29 +/- 0.06 ) while 166 ( 63.3 % ) children presented normal blood concentrations of chemical ( chemical > or = 200 microg/L with a chemical Binding Protein/gene molar ratio = 0.40 +/- 0.08 ) .	T9	T25	15951260
NA	CHEMICAL	GENE-Y	14	10	Results showed that 96 children ( 36.6 % ) presented a chemical deficiency ( chemical < 200 microg/L with a gene/gene molar ratio = 0.29 +/- 0.06 ) while 166 ( 63.3 % ) children presented normal blood concentrations of chemical ( chemical > or = 200 microg/L with a chemical Binding Protein/gene molar ratio = 0.40 +/- 0.08 ) .	T9	T27	15951260
NA	CHEMICAL	GENE-N	40	20	Results showed that 96 children ( 36.6 % ) presented a chemical deficiency ( chemical < 200 microg/L with a gene/gene molar ratio = 0.29 +/- 0.06 ) while 166 ( 63.3 % ) children presented normal blood concentrations of chemical ( chemical > or = 200 microg/L with a chemical Binding Protein/gene molar ratio = 0.40 +/- 0.08 ) .	T10	T24	15951260
NA	CHEMICAL	GENE-Y	40	10	Results showed that 96 children ( 36.6 % ) presented a chemical deficiency ( chemical < 200 microg/L with a gene/gene molar ratio = 0.29 +/- 0.06 ) while 166 ( 63.3 % ) children presented normal blood concentrations of chemical ( chemical > or = 200 microg/L with a chemical Binding Protein/gene molar ratio = 0.40 +/- 0.08 ) .	T10	T25	15951260
NA	CHEMICAL	GENE-Y	40	10	Results showed that 96 children ( 36.6 % ) presented a chemical deficiency ( chemical < 200 microg/L with a gene/gene molar ratio = 0.29 +/- 0.06 ) while 166 ( 63.3 % ) children presented normal blood concentrations of chemical ( chemical > or = 200 microg/L with a chemical Binding Protein/gene molar ratio = 0.40 +/- 0.08 ) .	T10	T27	15951260
NA	CHEMICAL	GENE-N	42	20	Results showed that 96 children ( 36.6 % ) presented a chemical deficiency ( chemical < 200 microg/L with a gene/gene molar ratio = 0.29 +/- 0.06 ) while 166 ( 63.3 % ) children presented normal blood concentrations of chemical ( chemical > or = 200 microg/L with a chemical Binding Protein/gene molar ratio = 0.40 +/- 0.08 ) .	T11	T24	15951260
NA	CHEMICAL	GENE-Y	42	10	Results showed that 96 children ( 36.6 % ) presented a chemical deficiency ( chemical < 200 microg/L with a gene/gene molar ratio = 0.29 +/- 0.06 ) while 166 ( 63.3 % ) children presented normal blood concentrations of chemical ( chemical > or = 200 microg/L with a chemical Binding Protein/gene molar ratio = 0.40 +/- 0.08 ) .	T11	T25	15951260
NA	CHEMICAL	GENE-Y	42	10	Results showed that 96 children ( 36.6 % ) presented a chemical deficiency ( chemical < 200 microg/L with a gene/gene molar ratio = 0.29 +/- 0.06 ) while 166 ( 63.3 % ) children presented normal blood concentrations of chemical ( chemical > or = 200 microg/L with a chemical Binding Protein/gene molar ratio = 0.40 +/- 0.08 ) .	T11	T27	15951260
NA	CHEMICAL	GENE-N	50	20	Results showed that 96 children ( 36.6 % ) presented a chemical deficiency ( chemical < 200 microg/L with a gene/gene molar ratio = 0.29 +/- 0.06 ) while 166 ( 63.3 % ) children presented normal blood concentrations of chemical ( chemical > or = 200 microg/L with a chemical Binding Protein/gene molar ratio = 0.40 +/- 0.08 ) .	T12	T24	15951260
NA	CHEMICAL	GENE-Y	50	10	Results showed that 96 children ( 36.6 % ) presented a chemical deficiency ( chemical < 200 microg/L with a gene/gene molar ratio = 0.29 +/- 0.06 ) while 166 ( 63.3 % ) children presented normal blood concentrations of chemical ( chemical > or = 200 microg/L with a chemical Binding Protein/gene molar ratio = 0.40 +/- 0.08 ) .	T12	T25	15951260
NA	CHEMICAL	GENE-Y	50	10	Results showed that 96 children ( 36.6 % ) presented a chemical deficiency ( chemical < 200 microg/L with a gene/gene molar ratio = 0.29 +/- 0.06 ) while 166 ( 63.3 % ) children presented normal blood concentrations of chemical ( chemical > or = 200 microg/L with a chemical Binding Protein/gene molar ratio = 0.40 +/- 0.08 ) .	T12	T27	15951260
NA	CHEMICAL	GENE-N	5	7	This study showed that the chemical binding protein and the gene are lower in children with chemical deficiency .	T13	T28	15951260
NA	CHEMICAL	GENE-N	5	10	This study showed that the chemical binding protein and the gene are lower in children with chemical deficiency .	T13	T29	15951260
NA	CHEMICAL	GENE-N	16	7	This study showed that the chemical binding protein and the gene are lower in children with chemical deficiency .	T14	T28	15951260
NA	CHEMICAL	GENE-N	16	10	This study showed that the chemical binding protein and the gene are lower in children with chemical deficiency .	T14	T29	15951260
NA	CHEMICAL	GENE-Y	16	9	On the other hand , an isolated increase of gene has been observed in boys with chemical deficiency .	T15	T30	15951260
CPR:3	CHEMICAL	GENE-N	4	6	The positive correlation between chemical and gene concentrations might be the result of the chemical inductive effect during gene synthesis .	T1	T18	15951260
CPR:3	CHEMICAL	GENE-N	4	18	The positive correlation between chemical and gene concentrations might be the result of the chemical inductive effect during gene synthesis .	T1	T19	15951260
CPR:3	CHEMICAL	GENE-N	14	6	The positive correlation between chemical and gene concentrations might be the result of the chemical inductive effect during gene synthesis .	T2	T18	15951260
CPR:3	CHEMICAL	GENE-N	14	18	The positive correlation between chemical and gene concentrations might be the result of the chemical inductive effect during gene synthesis .	T2	T19	15951260
NA	CHEMICAL	GENE-Y	8	4	The isolated increasing of gene in boys with chemical deficiency has been assigned to the ecosensitiveness of the unfavourable environment .	T4	T20	15951260
NA	CHEMICAL	GENE-Y	5	0	gene catalyzes specific elimination of L-chemical to chemical .	T20	T28	12560076
CPR:9	CHEMICAL	GENE-Y	7	0	gene catalyzes specific elimination of L-chemical to chemical .	T22	T28	12560076
CPR:5	CHEMICAL	GENE-N	0	10	chemical was previously identified in mammalian brain and was shown to be a co-agonist at the 'chemical ' site of the chemical ( chemical ) -type receptors .	T1	T23	12560076
NA	CHEMICAL	GENE-N	4	10	chemical was previously identified in mammalian brain and was shown to be a co-agonist at the 'chemical ' site of the chemical ( chemical ) -type receptors .	T18	T23	12560076
NA	CHEMICAL	GENE-N	12	10	chemical was previously identified in mammalian brain and was shown to be a co-agonist at the 'chemical ' site of the chemical ( chemical ) -type receptors .	T2	T23	12560076
NA	CHEMICAL	GENE-N	23	10	chemical was previously identified in mammalian brain and was shown to be a co-agonist at the 'chemical ' site of the chemical ( chemical ) -type receptors .	T3	T23	12560076
CPR:9	CHEMICAL	GENE-Y	2	7	Racemization of chemical is catalyzed by chemical racemase , a chemical-dependent enzyme expressed mainly in brain and liver .	T4	T24	12560076
NA	CHEMICAL	GENE-Y	6	7	Racemization of chemical is catalyzed by chemical racemase , a chemical-dependent enzyme expressed mainly in brain and liver .	T5	T24	12560076
NA	CHEMICAL	GENE-Y	9	7	Racemization of chemical is catalyzed by chemical racemase , a chemical-dependent enzyme expressed mainly in brain and liver .	T6	T24	12560076
NA	CHEMICAL	GENE-N	0	1	chemical receptor overactivation has been implicated in a number of pathological conditions and inhibitors of chemical racemase are thus potentially interesting targets for therapy .	T7	T25	12560076
NA	CHEMICAL	GENE-Y	0	7	chemical receptor overactivation has been implicated in a number of pathological conditions and inhibitors of chemical racemase are thus potentially interesting targets for therapy .	T7	T26	12560076
NA	CHEMICAL	GENE-N	6	1	chemical receptor overactivation has been implicated in a number of pathological conditions and inhibitors of chemical racemase are thus potentially interesting targets for therapy .	T8	T25	12560076
NA	CHEMICAL	GENE-Y	6	7	chemical receptor overactivation has been implicated in a number of pathological conditions and inhibitors of chemical racemase are thus potentially interesting targets for therapy .	T8	T26	12560076
NA	CHEMICAL	GENE-Y	4	3	We expressed recombinant gene in insect cells and purified it to near homogeneity .	T9	T27	12560076
CPR:4	CHEMICAL	GENE-Y	3	3	Several inhibitors of gene have been described , including chemical , which is currently in phase 3 clinical development for the treatment of atherosclerosis .	T1	T10	23260346
NA	CHEMICAL	GENE-Y	3	6	The selectivity that chemical and other gene inhibitors display across the larger chemical hydrolase family has not , however , been reported .	T2	T12	23260346
NA	CHEMICAL	GENE-N	3	13	The selectivity that chemical and other gene inhibitors display across the larger chemical hydrolase family has not , however , been reported .	T2	T13	23260346
NA	CHEMICAL	GENE-Y	12	6	The selectivity that chemical and other gene inhibitors display across the larger chemical hydrolase family has not , however , been reported .	T3	T12	23260346
NA	CHEMICAL	GENE-N	12	13	The selectivity that chemical and other gene inhibitors display across the larger chemical hydrolase family has not , however , been reported .	T3	T13	23260346
CPR:4	CHEMICAL	GENE-Y	4	15	We show that both chemical and a novel class of structurally distinct chemical inhibitors inactivate gene in mouse tissues and human cell lines with high selectivity .	T4	T17	23260346
CPR:4	CHEMICAL	GENE-Y	6	15	We show that both chemical and a novel class of structurally distinct chemical inhibitors inactivate gene in mouse tissues and human cell lines with high selectivity .	T5	T17	23260346
NA	CHEMICAL	GENE-Y	2	24	Although these chemicalic hormones are diverse in character , it is believed that their effects are mediated via the protein products of a single gene gene encoded on the X-chromosome .	T7	T11	11511858
NA	CHEMICAL	GENE-N	19	9	A great deal of information has now accumulated pertaining to the mechanisms by which gene , such as the chemical receptor , modulate the activity of responsive genes .	T8	T12	11511858
NA	CHEMICAL	GENE-Y	19	9	A great deal of information has now accumulated pertaining to the mechanisms by which gene , such as the chemical receptor , modulate the activity of responsive genes .	T8	T13	11511858
NA	CHEMICAL	GENE-N	20	2	In addition to studies focused on the mechanisms of gene function , additional work has illuminated the mechanism by which chemical are metabolized in selected tissues .	T9	T15	11511858
CPR:3	CHEMICAL	GENE-N	12	27	Cotreatments of 5 , 10 and 20 µg/mL concentrations of MEP with chemical decreased the frequencies of SCE and the chemical level and increased amount of chemical dismutase , chemical and chemical peroxidase which were decreased by chemical .	T6	T12	23293129
NA	CHEMICAL	GENE-N	12	32	Cotreatments of 5 , 10 and 20 µg/mL concentrations of MEP with chemical decreased the frequencies of SCE and the chemical level and increased amount of chemical dismutase , chemical and chemical peroxidase which were decreased by chemical .	T6	T13	23293129
NA	CHEMICAL	GENE-N	20	27	Cotreatments of 5 , 10 and 20 µg/mL concentrations of MEP with chemical decreased the frequencies of SCE and the chemical level and increased amount of chemical dismutase , chemical and chemical peroxidase which were decreased by chemical .	T7	T12	23293129
NA	CHEMICAL	GENE-N	20	32	Cotreatments of 5 , 10 and 20 µg/mL concentrations of MEP with chemical decreased the frequencies of SCE and the chemical level and increased amount of chemical dismutase , chemical and chemical peroxidase which were decreased by chemical .	T7	T13	23293129
NA	CHEMICAL	GENE-N	26	27	Cotreatments of 5 , 10 and 20 µg/mL concentrations of MEP with chemical decreased the frequencies of SCE and the chemical level and increased amount of chemical dismutase , chemical and chemical peroxidase which were decreased by chemical .	T8	T12	23293129
NA	CHEMICAL	GENE-N	26	32	Cotreatments of 5 , 10 and 20 µg/mL concentrations of MEP with chemical decreased the frequencies of SCE and the chemical level and increased amount of chemical dismutase , chemical and chemical peroxidase which were decreased by chemical .	T8	T13	23293129
NA	CHEMICAL	GENE-N	29	27	Cotreatments of 5 , 10 and 20 µg/mL concentrations of MEP with chemical decreased the frequencies of SCE and the chemical level and increased amount of chemical dismutase , chemical and chemical peroxidase which were decreased by chemical .	T9	T12	23293129
NA	CHEMICAL	GENE-N	29	32	Cotreatments of 5 , 10 and 20 µg/mL concentrations of MEP with chemical decreased the frequencies of SCE and the chemical level and increased amount of chemical dismutase , chemical and chemical peroxidase which were decreased by chemical .	T9	T13	23293129
NA	CHEMICAL	GENE-N	31	27	Cotreatments of 5 , 10 and 20 µg/mL concentrations of MEP with chemical decreased the frequencies of SCE and the chemical level and increased amount of chemical dismutase , chemical and chemical peroxidase which were decreased by chemical .	T10	T12	23293129
NA	CHEMICAL	GENE-N	31	32	Cotreatments of 5 , 10 and 20 µg/mL concentrations of MEP with chemical decreased the frequencies of SCE and the chemical level and increased amount of chemical dismutase , chemical and chemical peroxidase which were decreased by chemical .	T10	T13	23293129
NA	CHEMICAL	GENE-N	37	27	Cotreatments of 5 , 10 and 20 µg/mL concentrations of MEP with chemical decreased the frequencies of SCE and the chemical level and increased amount of chemical dismutase , chemical and chemical peroxidase which were decreased by chemical .	T11	T12	23293129
CPR:4	CHEMICAL	GENE-N	37	32	Cotreatments of 5 , 10 and 20 µg/mL concentrations of MEP with chemical decreased the frequencies of SCE and the chemical level and increased amount of chemical dismutase , chemical and chemical peroxidase which were decreased by chemical .	T11	T13	23293129
NA	CHEMICAL	GENE-Y	4	10	The four stereoisomers of chemical were synthesized and evaluated in gene , gene , gene , gene , gene , and gene binding and functional assays .	T1	T11	15357957
NA	CHEMICAL	GENE-Y	4	12	The four stereoisomers of chemical were synthesized and evaluated in gene , gene , gene , gene , gene , and gene binding and functional assays .	T1	T12	15357957
NA	CHEMICAL	GENE-Y	4	14	The four stereoisomers of chemical were synthesized and evaluated in gene , gene , gene , gene , gene , and gene binding and functional assays .	T1	T13	15357957
NA	CHEMICAL	GENE-Y	4	16	The four stereoisomers of chemical were synthesized and evaluated in gene , gene , gene , gene , gene , and gene binding and functional assays .	T1	T14	15357957
NA	CHEMICAL	GENE-Y	4	18	The four stereoisomers of chemical were synthesized and evaluated in gene , gene , gene , gene , gene , and gene binding and functional assays .	T1	T4	15357957
NA	CHEMICAL	GENE-Y	4	21	The four stereoisomers of chemical were synthesized and evaluated in gene , gene , gene , gene , gene , and gene binding and functional assays .	T1	T5	15357957
NA	CHEMICAL	GENE-N	4	37	The results showed that chemical increased [ chemical ] ( i ) and decreased [ chemical ] ( ER ) linearly in a time- and concentration-dependant manner , and chemical addition after the applying of a chemical receptor ( gene ) antagonist and an chemical receptor ( gene ) antagonist did not increase [ chemical ] ( i ) .	T16	T25	22921426
NA	CHEMICAL	GENE-N	4	39	The results showed that chemical increased [ chemical ] ( i ) and decreased [ chemical ] ( ER ) linearly in a time- and concentration-dependant manner , and chemical addition after the applying of a chemical receptor ( gene ) antagonist and an chemical receptor ( gene ) antagonist did not increase [ chemical ] ( i ) .	T16	T26	22921426
NA	CHEMICAL	GENE-N	4	37	The results showed that chemical increased [ chemical ] ( i ) and decreased [ chemical ] ( ER ) linearly in a time- and concentration-dependant manner , and chemical addition after the applying of a chemical receptor ( gene ) antagonist and an chemical receptor ( gene ) antagonist did not increase [ chemical ] ( i ) .	T16	T27	22921426
NA	CHEMICAL	GENE-N	4	9	The results showed that chemical increased [ chemical ] ( i ) and decreased [ chemical ] ( ER ) linearly in a time- and concentration-dependant manner , and chemical addition after the applying of a chemical receptor ( gene ) antagonist and an chemical receptor ( gene ) antagonist did not increase [ chemical ] ( i ) .	T16	T28	22921426
NA	CHEMICAL	GENE-N	7	37	The results showed that chemical increased [ chemical ] ( i ) and decreased [ chemical ] ( ER ) linearly in a time- and concentration-dependant manner , and chemical addition after the applying of a chemical receptor ( gene ) antagonist and an chemical receptor ( gene ) antagonist did not increase [ chemical ] ( i ) .	T17	T25	22921426
NA	CHEMICAL	GENE-N	7	39	The results showed that chemical increased [ chemical ] ( i ) and decreased [ chemical ] ( ER ) linearly in a time- and concentration-dependant manner , and chemical addition after the applying of a chemical receptor ( gene ) antagonist and an chemical receptor ( gene ) antagonist did not increase [ chemical ] ( i ) .	T17	T26	22921426
NA	CHEMICAL	GENE-N	7	37	The results showed that chemical increased [ chemical ] ( i ) and decreased [ chemical ] ( ER ) linearly in a time- and concentration-dependant manner , and chemical addition after the applying of a chemical receptor ( gene ) antagonist and an chemical receptor ( gene ) antagonist did not increase [ chemical ] ( i ) .	T17	T27	22921426
NA	CHEMICAL	GENE-N	7	9	The results showed that chemical increased [ chemical ] ( i ) and decreased [ chemical ] ( ER ) linearly in a time- and concentration-dependant manner , and chemical addition after the applying of a chemical receptor ( gene ) antagonist and an chemical receptor ( gene ) antagonist did not increase [ chemical ] ( i ) .	T17	T28	22921426
NA	CHEMICAL	GENE-N	9	37	The results showed that chemical increased [ chemical ] ( i ) and decreased [ chemical ] ( ER ) linearly in a time- and concentration-dependant manner , and chemical addition after the applying of a chemical receptor ( gene ) antagonist and an chemical receptor ( gene ) antagonist did not increase [ chemical ] ( i ) .	T18	T25	22921426
NA	CHEMICAL	GENE-N	9	39	The results showed that chemical increased [ chemical ] ( i ) and decreased [ chemical ] ( ER ) linearly in a time- and concentration-dependant manner , and chemical addition after the applying of a chemical receptor ( gene ) antagonist and an chemical receptor ( gene ) antagonist did not increase [ chemical ] ( i ) .	T18	T26	22921426
NA	CHEMICAL	GENE-N	9	37	The results showed that chemical increased [ chemical ] ( i ) and decreased [ chemical ] ( ER ) linearly in a time- and concentration-dependant manner , and chemical addition after the applying of a chemical receptor ( gene ) antagonist and an chemical receptor ( gene ) antagonist did not increase [ chemical ] ( i ) .	T18	T27	22921426
NA	CHEMICAL	GENE-N	9	9	The results showed that chemical increased [ chemical ] ( i ) and decreased [ chemical ] ( ER ) linearly in a time- and concentration-dependant manner , and chemical addition after the applying of a chemical receptor ( gene ) antagonist and an chemical receptor ( gene ) antagonist did not increase [ chemical ] ( i ) .	T18	T28	22921426
NA	CHEMICAL	GENE-N	9	37	The results showed that chemical increased [ chemical ] ( i ) and decreased [ chemical ] ( ER ) linearly in a time- and concentration-dependant manner , and chemical addition after the applying of a chemical receptor ( gene ) antagonist and an chemical receptor ( gene ) antagonist did not increase [ chemical ] ( i ) .	T19	T25	22921426
NA	CHEMICAL	GENE-N	9	39	The results showed that chemical increased [ chemical ] ( i ) and decreased [ chemical ] ( ER ) linearly in a time- and concentration-dependant manner , and chemical addition after the applying of a chemical receptor ( gene ) antagonist and an chemical receptor ( gene ) antagonist did not increase [ chemical ] ( i ) .	T19	T26	22921426
NA	CHEMICAL	GENE-N	9	37	The results showed that chemical increased [ chemical ] ( i ) and decreased [ chemical ] ( ER ) linearly in a time- and concentration-dependant manner , and chemical addition after the applying of a chemical receptor ( gene ) antagonist and an chemical receptor ( gene ) antagonist did not increase [ chemical ] ( i ) .	T19	T27	22921426
NA	CHEMICAL	GENE-N	9	9	The results showed that chemical increased [ chemical ] ( i ) and decreased [ chemical ] ( ER ) linearly in a time- and concentration-dependant manner , and chemical addition after the applying of a chemical receptor ( gene ) antagonist and an chemical receptor ( gene ) antagonist did not increase [ chemical ] ( i ) .	T19	T28	22921426
NA	CHEMICAL	GENE-N	10	37	The results showed that chemical increased [ chemical ] ( i ) and decreased [ chemical ] ( ER ) linearly in a time- and concentration-dependant manner , and chemical addition after the applying of a chemical receptor ( gene ) antagonist and an chemical receptor ( gene ) antagonist did not increase [ chemical ] ( i ) .	T20	T25	22921426
NA	CHEMICAL	GENE-N	10	39	The results showed that chemical increased [ chemical ] ( i ) and decreased [ chemical ] ( ER ) linearly in a time- and concentration-dependant manner , and chemical addition after the applying of a chemical receptor ( gene ) antagonist and an chemical receptor ( gene ) antagonist did not increase [ chemical ] ( i ) .	T20	T26	22921426
NA	CHEMICAL	GENE-N	10	37	The results showed that chemical increased [ chemical ] ( i ) and decreased [ chemical ] ( ER ) linearly in a time- and concentration-dependant manner , and chemical addition after the applying of a chemical receptor ( gene ) antagonist and an chemical receptor ( gene ) antagonist did not increase [ chemical ] ( i ) .	T20	T27	22921426
NA	CHEMICAL	GENE-N	10	9	The results showed that chemical increased [ chemical ] ( i ) and decreased [ chemical ] ( ER ) linearly in a time- and concentration-dependant manner , and chemical addition after the applying of a chemical receptor ( gene ) antagonist and an chemical receptor ( gene ) antagonist did not increase [ chemical ] ( i ) .	T20	T28	22921426
NA	CHEMICAL	GENE-N	10	37	The results showed that chemical increased [ chemical ] ( i ) and decreased [ chemical ] ( ER ) linearly in a time- and concentration-dependant manner , and chemical addition after the applying of a chemical receptor ( gene ) antagonist and an chemical receptor ( gene ) antagonist did not increase [ chemical ] ( i ) .	T21	T25	22921426
NA	CHEMICAL	GENE-N	10	39	The results showed that chemical increased [ chemical ] ( i ) and decreased [ chemical ] ( ER ) linearly in a time- and concentration-dependant manner , and chemical addition after the applying of a chemical receptor ( gene ) antagonist and an chemical receptor ( gene ) antagonist did not increase [ chemical ] ( i ) .	T21	T26	22921426
NA	CHEMICAL	GENE-N	10	37	The results showed that chemical increased [ chemical ] ( i ) and decreased [ chemical ] ( ER ) linearly in a time- and concentration-dependant manner , and chemical addition after the applying of a chemical receptor ( gene ) antagonist and an chemical receptor ( gene ) antagonist did not increase [ chemical ] ( i ) .	T21	T27	22921426
NA	CHEMICAL	GENE-N	10	9	The results showed that chemical increased [ chemical ] ( i ) and decreased [ chemical ] ( ER ) linearly in a time- and concentration-dependant manner , and chemical addition after the applying of a chemical receptor ( gene ) antagonist and an chemical receptor ( gene ) antagonist did not increase [ chemical ] ( i ) .	T21	T28	22921426
NA	CHEMICAL	GENE-N	9	37	The results showed that chemical increased [ chemical ] ( i ) and decreased [ chemical ] ( ER ) linearly in a time- and concentration-dependant manner , and chemical addition after the applying of a chemical receptor ( gene ) antagonist and an chemical receptor ( gene ) antagonist did not increase [ chemical ] ( i ) .	T22	T25	22921426
NA	CHEMICAL	GENE-N	9	39	The results showed that chemical increased [ chemical ] ( i ) and decreased [ chemical ] ( ER ) linearly in a time- and concentration-dependant manner , and chemical addition after the applying of a chemical receptor ( gene ) antagonist and an chemical receptor ( gene ) antagonist did not increase [ chemical ] ( i ) .	T22	T26	22921426
NA	CHEMICAL	GENE-N	9	37	The results showed that chemical increased [ chemical ] ( i ) and decreased [ chemical ] ( ER ) linearly in a time- and concentration-dependant manner , and chemical addition after the applying of a chemical receptor ( gene ) antagonist and an chemical receptor ( gene ) antagonist did not increase [ chemical ] ( i ) .	T22	T27	22921426
NA	CHEMICAL	GENE-N	9	9	The results showed that chemical increased [ chemical ] ( i ) and decreased [ chemical ] ( ER ) linearly in a time- and concentration-dependant manner , and chemical addition after the applying of a chemical receptor ( gene ) antagonist and an chemical receptor ( gene ) antagonist did not increase [ chemical ] ( i ) .	T22	T28	22921426
NA	CHEMICAL	GENE-Y	9	23	To determine whether these responses were common to other chemical of abuse , effects of chemical ( chemical ) on the plasmalemmal chemical transporter ( gene ) and gene ( gene ) were assessed .	T10	T32	11861820
NA	CHEMICAL	GENE-Y	9	25	To determine whether these responses were common to other chemical of abuse , effects of chemical ( chemical ) on the plasmalemmal chemical transporter ( gene ) and gene ( gene ) were assessed .	T10	T33	11861820
NA	CHEMICAL	GENE-Y	9	23	To determine whether these responses were common to other chemical of abuse , effects of chemical ( chemical ) on the plasmalemmal chemical transporter ( gene ) and gene ( gene ) were assessed .	T10	T34	11861820
NA	CHEMICAL	GENE-Y	9	30	To determine whether these responses were common to other chemical of abuse , effects of chemical ( chemical ) on the plasmalemmal chemical transporter ( gene ) and gene ( gene ) were assessed .	T10	T35	11861820
NA	CHEMICAL	GENE-Y	15	23	To determine whether these responses were common to other chemical of abuse , effects of chemical ( chemical ) on the plasmalemmal chemical transporter ( gene ) and gene ( gene ) were assessed .	T11	T32	11861820
NA	CHEMICAL	GENE-Y	15	25	To determine whether these responses were common to other chemical of abuse , effects of chemical ( chemical ) on the plasmalemmal chemical transporter ( gene ) and gene ( gene ) were assessed .	T11	T33	11861820
NA	CHEMICAL	GENE-Y	15	23	To determine whether these responses were common to other chemical of abuse , effects of chemical ( chemical ) on the plasmalemmal chemical transporter ( gene ) and gene ( gene ) were assessed .	T11	T34	11861820
NA	CHEMICAL	GENE-Y	15	30	To determine whether these responses were common to other chemical of abuse , effects of chemical ( chemical ) on the plasmalemmal chemical transporter ( gene ) and gene ( gene ) were assessed .	T11	T35	11861820
NA	CHEMICAL	GENE-Y	17	23	To determine whether these responses were common to other chemical of abuse , effects of chemical ( chemical ) on the plasmalemmal chemical transporter ( gene ) and gene ( gene ) were assessed .	T12	T32	11861820
NA	CHEMICAL	GENE-Y	17	25	To determine whether these responses were common to other chemical of abuse , effects of chemical ( chemical ) on the plasmalemmal chemical transporter ( gene ) and gene ( gene ) were assessed .	T12	T33	11861820
NA	CHEMICAL	GENE-Y	17	23	To determine whether these responses were common to other chemical of abuse , effects of chemical ( chemical ) on the plasmalemmal chemical transporter ( gene ) and gene ( gene ) were assessed .	T12	T34	11861820
NA	CHEMICAL	GENE-Y	17	30	To determine whether these responses were common to other chemical of abuse , effects of chemical ( chemical ) on the plasmalemmal chemical transporter ( gene ) and gene ( gene ) were assessed .	T12	T35	11861820
NA	CHEMICAL	GENE-Y	22	23	To determine whether these responses were common to other chemical of abuse , effects of chemical ( chemical ) on the plasmalemmal chemical transporter ( gene ) and gene ( gene ) were assessed .	T13	T32	11861820
NA	CHEMICAL	GENE-Y	22	25	To determine whether these responses were common to other chemical of abuse , effects of chemical ( chemical ) on the plasmalemmal chemical transporter ( gene ) and gene ( gene ) were assessed .	T13	T33	11861820
NA	CHEMICAL	GENE-Y	22	23	To determine whether these responses were common to other chemical of abuse , effects of chemical ( chemical ) on the plasmalemmal chemical transporter ( gene ) and gene ( gene ) were assessed .	T13	T34	11861820
NA	CHEMICAL	GENE-Y	22	30	To determine whether these responses were common to other chemical of abuse , effects of chemical ( chemical ) on the plasmalemmal chemical transporter ( gene ) and gene ( gene ) were assessed .	T13	T35	11861820
NA	CHEMICAL	GENE-Y	19	23	To determine whether these responses were common to other chemical of abuse , effects of chemical ( chemical ) on the plasmalemmal chemical transporter ( gene ) and gene ( gene ) were assessed .	T14	T32	11861820
NA	CHEMICAL	GENE-Y	19	25	To determine whether these responses were common to other chemical of abuse , effects of chemical ( chemical ) on the plasmalemmal chemical transporter ( gene ) and gene ( gene ) were assessed .	T14	T33	11861820
NA	CHEMICAL	GENE-Y	19	23	To determine whether these responses were common to other chemical of abuse , effects of chemical ( chemical ) on the plasmalemmal chemical transporter ( gene ) and gene ( gene ) were assessed .	T14	T34	11861820
NA	CHEMICAL	GENE-Y	19	30	To determine whether these responses were common to other chemical of abuse , effects of chemical ( chemical ) on the plasmalemmal chemical transporter ( gene ) and gene ( gene ) were assessed .	T14	T35	11861820
CPR:4	CHEMICAL	GENE-Y	7	22	Also in contrast to effects of multiple chemical injections , 1 ) chemical caused little or no decrease in binding of the gene ligand chemical , and 2 ) neither prevention of hyperthermia nor prior depletion of chemical prevented the chemical-induced reduction in plasmalemmal chemical transport .	T21	T36	11861820
NA	CHEMICAL	GENE-Y	12	22	Also in contrast to effects of multiple chemical injections , 1 ) chemical caused little or no decrease in binding of the gene ligand chemical , and 2 ) neither prevention of hyperthermia nor prior depletion of chemical prevented the chemical-induced reduction in plasmalemmal chemical transport .	T22	T36	11861820
NA	CHEMICAL	GENE-Y	24	22	Also in contrast to effects of multiple chemical injections , 1 ) chemical caused little or no decrease in binding of the gene ligand chemical , and 2 ) neither prevention of hyperthermia nor prior depletion of chemical prevented the chemical-induced reduction in plasmalemmal chemical transport .	T23	T36	11861820
CPR:9	CHEMICAL	GENE-Y	37	22	Also in contrast to effects of multiple chemical injections , 1 ) chemical caused little or no decrease in binding of the gene ligand chemical , and 2 ) neither prevention of hyperthermia nor prior depletion of chemical prevented the chemical-induced reduction in plasmalemmal chemical transport .	T24	T36	11861820
CPR:4	CHEMICAL	GENE-Y	40	22	Also in contrast to effects of multiple chemical injections , 1 ) chemical caused little or no decrease in binding of the gene ligand chemical , and 2 ) neither prevention of hyperthermia nor prior depletion of chemical prevented the chemical-induced reduction in plasmalemmal chemical transport .	T25	T36	11861820
CPR:9	CHEMICAL	GENE-Y	44	22	Also in contrast to effects of multiple chemical injections , 1 ) chemical caused little or no decrease in binding of the gene ligand chemical , and 2 ) neither prevention of hyperthermia nor prior depletion of chemical prevented the chemical-induced reduction in plasmalemmal chemical transport .	T1	T36	11861820
NA	CHEMICAL	GENE-Y	11	11	However , a role for phosphorylation was suggested because pretreatment with gene inhibitors attenuated the deficit caused by chemical in an in vitro model system .	T2	T28	11861820
NA	CHEMICAL	GENE-Y	7	4	In addition to affecting gene function , chemical rapidly decreased vesicular chemical transport as assessed in striatal vesicles prepared from treated rats .	T4	T29	11861820
CPR:9	CHEMICAL	GENE-Y	11	4	In addition to affecting gene function , chemical rapidly decreased vesicular chemical transport as assessed in striatal vesicles prepared from treated rats .	T5	T29	11861820
NA	CHEMICAL	GENE-Y	9	5	Transfection of HepG2 cells with gene provides protection against chemical-mediated oxidative injury .	T33	T51	17553661
CPR:9	CHEMICAL	GENE-N	0	5	chemical ( chemical ) is a mutagenic chemical produced during oxidative injury that is conjugated by several chemical chemical-transferase ( gene ) isoforms .	T1	T35	17553661
CPR:9	CHEMICAL	GENE-N	0	20	chemical ( chemical ) is a mutagenic chemical produced during oxidative injury that is conjugated by several chemical chemical-transferase ( gene ) isoforms .	T1	T38	17553661
CPR:9	CHEMICAL	GENE-N	2	5	chemical ( chemical ) is a mutagenic chemical produced during oxidative injury that is conjugated by several chemical chemical-transferase ( gene ) isoforms .	T17	T35	17553661
CPR:9	CHEMICAL	GENE-N	2	20	chemical ( chemical ) is a mutagenic chemical produced during oxidative injury that is conjugated by several chemical chemical-transferase ( gene ) isoforms .	T17	T38	17553661
CPR:9	CHEMICAL	GENE-N	5	5	chemical ( chemical ) is a mutagenic chemical produced during oxidative injury that is conjugated by several chemical chemical-transferase ( gene ) isoforms .	T24	T35	17553661
CPR:9	CHEMICAL	GENE-N	5	20	chemical ( chemical ) is a mutagenic chemical produced during oxidative injury that is conjugated by several chemical chemical-transferase ( gene ) isoforms .	T24	T38	17553661
NA	CHEMICAL	GENE-N	5	5	chemical ( chemical ) is a mutagenic chemical produced during oxidative injury that is conjugated by several chemical chemical-transferase ( gene ) isoforms .	T9	T35	17553661
NA	CHEMICAL	GENE-N	5	20	chemical ( chemical ) is a mutagenic chemical produced during oxidative injury that is conjugated by several chemical chemical-transferase ( gene ) isoforms .	T9	T38	17553661
NA	CHEMICAL	GENE-N	18	5	chemical ( chemical ) is a mutagenic chemical produced during oxidative injury that is conjugated by several chemical chemical-transferase ( gene ) isoforms .	T11	T35	17553661
NA	CHEMICAL	GENE-N	18	20	chemical ( chemical ) is a mutagenic chemical produced during oxidative injury that is conjugated by several chemical chemical-transferase ( gene ) isoforms .	T11	T38	17553661
CPR:9	CHEMICAL	GENE-Y	15	3	The alpha class gene enzyme ( gene ) has a particularly high catalytic efficiency toward chemical conjugation .	T22	T42	17553661
CPR:9	CHEMICAL	GENE-Y	15	6	The alpha class gene enzyme ( gene ) has a particularly high catalytic efficiency toward chemical conjugation .	T22	T43	17553661
NA	CHEMICAL	GENE-Y	14	2	However , gene expression is low in most human cells and there are other chemical metabolizing enzymes that detoxify chemical .	T23	T44	17553661
NA	CHEMICAL	GENE-Y	19	2	However , gene expression is low in most human cells and there are other chemical metabolizing enzymes that detoxify chemical .	T25	T44	17553661
NA	CHEMICAL	GENE-Y	21	12	In the current study , we determined the effect of over-expression of gene mRNA on the sensitivity of HepG2 cells to chemical injury .	T26	T45	17553661
NA	CHEMICAL	GENE-Y	22	5	HepG2 cells transfected with an gene vector construct exhibited high steady-state gene mRNA , high gene-HNE catalytic activities , but lower basal chemical ( chemical ) concentrations relative to insert-free vector ( control ) cells .	T28	T46	17553661
NA	CHEMICAL	GENE-Y	22	11	HepG2 cells transfected with an gene vector construct exhibited high steady-state gene mRNA , high gene-HNE catalytic activities , but lower basal chemical ( chemical ) concentrations relative to insert-free vector ( control ) cells .	T28	T47	17553661
NA	CHEMICAL	GENE-Y	22	15	HepG2 cells transfected with an gene vector construct exhibited high steady-state gene mRNA , high gene-HNE catalytic activities , but lower basal chemical ( chemical ) concentrations relative to insert-free vector ( control ) cells .	T28	T48	17553661
NA	CHEMICAL	GENE-Y	24	5	HepG2 cells transfected with an gene vector construct exhibited high steady-state gene mRNA , high gene-HNE catalytic activities , but lower basal chemical ( chemical ) concentrations relative to insert-free vector ( control ) cells .	T29	T46	17553661
NA	CHEMICAL	GENE-Y	24	11	HepG2 cells transfected with an gene vector construct exhibited high steady-state gene mRNA , high gene-HNE catalytic activities , but lower basal chemical ( chemical ) concentrations relative to insert-free vector ( control ) cells .	T29	T47	17553661
NA	CHEMICAL	GENE-Y	24	15	HepG2 cells transfected with an gene vector construct exhibited high steady-state gene mRNA , high gene-HNE catalytic activities , but lower basal chemical ( chemical ) concentrations relative to insert-free vector ( control ) cells .	T29	T48	17553661
NA	CHEMICAL	GENE-Y	2	13	Exposure to chemical elicited an increase in chemical concentrations in the control and gene cells , although the dose-response of chemical induction differed among the two cell types .	T30	T49	17553661
NA	CHEMICAL	GENE-Y	7	13	Exposure to chemical elicited an increase in chemical concentrations in the control and gene cells , although the dose-response of chemical induction differed among the two cell types .	T31	T49	17553661
NA	CHEMICAL	GENE-Y	20	13	Exposure to chemical elicited an increase in chemical concentrations in the control and gene cells , although the dose-response of chemical induction differed among the two cell types .	T32	T49	17553661
NA	CHEMICAL	GENE-Y	7	2	Specifically , gene cells had significantly higher chemical concentrations when exposed to 5-15 microM chemical , but not at 20 microM chemical , suggesting extensive chemical utilization at high concentrations of chemical .	T2	T50	17553661
CPR:9	CHEMICAL	GENE-Y	14	2	Specifically , gene cells had significantly higher chemical concentrations when exposed to 5-15 microM chemical , but not at 20 microM chemical , suggesting extensive chemical utilization at high concentrations of chemical .	T3	T50	17553661
CPR:9	CHEMICAL	GENE-Y	21	2	Specifically , gene cells had significantly higher chemical concentrations when exposed to 5-15 microM chemical , but not at 20 microM chemical , suggesting extensive chemical utilization at high concentrations of chemical .	T4	T50	17553661
NA	CHEMICAL	GENE-Y	2	2	Specifically , gene cells had significantly higher chemical concentrations when exposed to 5-15 microM chemical , but not at 20 microM chemical , suggesting extensive chemical utilization at high concentrations of chemical .	T5	T50	17553661
NA	CHEMICAL	GENE-Y	31	2	Specifically , gene cells had significantly higher chemical concentrations when exposed to 5-15 microM chemical , but not at 20 microM chemical , suggesting extensive chemical utilization at high concentrations of chemical .	T6	T50	17553661
NA	CHEMICAL	GENE-Y	16	1	The gene cells exhibited a significant growth advantage relative to control cells in the absence of chemical , and a trend towards increased growth at low dose exposures to chemical .	T7	T34	17553661
NA	CHEMICAL	GENE-Y	29	1	The gene cells exhibited a significant growth advantage relative to control cells in the absence of chemical , and a trend towards increased growth at low dose exposures to chemical .	T8	T34	17553661
NA	CHEMICAL	GENE-Y	17	3	However , the gene cells did not exhibit a growth advantage relative to control cells at higher chemical exposures associated with increased chemical utilization .	T10	T36	17553661
NA	CHEMICAL	GENE-Y	22	3	However , the gene cells did not exhibit a growth advantage relative to control cells at higher chemical exposures associated with increased chemical utilization .	T12	T36	17553661
NA	CHEMICAL	GENE-Y	9	4	As expected , the gene cells showed resistance to chemical stimulated lipid peroxidation at all chemical doses .	T13	T37	17553661
NA	CHEMICAL	GENE-Y	15	4	As expected , the gene cells showed resistance to chemical stimulated lipid peroxidation at all chemical doses .	T14	T37	17553661
NA	CHEMICAL	GENE-Y	14	9	In summary , our data indicates that over-expression of gene at levels conferring high gene-chemical conjugating activity confers a partial growth advantage to HepG2 cells and protects against chemical oxidative injury .	T15	T39	17553661
CPR:9	CHEMICAL	GENE-N	14	14	In summary , our data indicates that over-expression of gene at levels conferring high gene-chemical conjugating activity confers a partial growth advantage to HepG2 cells and protects against chemical oxidative injury .	T15	T40	17553661
NA	CHEMICAL	GENE-Y	28	9	In summary , our data indicates that over-expression of gene at levels conferring high gene-chemical conjugating activity confers a partial growth advantage to HepG2 cells and protects against chemical oxidative injury .	T16	T39	17553661
NA	CHEMICAL	GENE-N	28	14	In summary , our data indicates that over-expression of gene at levels conferring high gene-chemical conjugating activity confers a partial growth advantage to HepG2 cells and protects against chemical oxidative injury .	T16	T40	17553661
NA	CHEMICAL	GENE-Y	2	3	Involvement of chemical gene receptors in the modulation of noradrenergic transmission by chemical reuptake inhibitors : a microdialysis study in rat brain .	T17	T26	23636303
NA	CHEMICAL	GENE-Y	5	3	Involvement of chemical gene receptors in the modulation of noradrenergic transmission by chemical reuptake inhibitors : a microdialysis study in rat brain .	T18	T26	23636303
NA	CHEMICAL	GENE-N	12	19	OBJECTIVES : This study evaluates the neurochemical effect of the SSRI citalopram on brain noradrenergic activity and the chemical receptor involved in this effect .	T10	T24	23636303
CPR:6	CHEMICAL	GENE-N	11	9	In the local presence into the LC of the gene antagonist chemical ( 1 μM ) , systemic chemical increased NA in the LC ( Emax = 157 ± 25 % ) and PFC ( Emax = 175 ± 24 % ) .	T13	T25	23636303
NA	CHEMICAL	GENE-N	18	9	In the local presence into the LC of the gene antagonist chemical ( 1 μM ) , systemic chemical increased NA in the LC ( Emax = 157 ± 25 % ) and PFC ( Emax = 175 ± 24 % ) .	T14	T25	23636303
NA	CHEMICAL	GENE-Y	2	11	Local LC chemical effect was abolished by LC presence of the gene receptor antagonist chemical ( 1 μM ) but not the gene receptor antagonist chemical ( 1 μM ) .	T16	T19	23636303
NA	CHEMICAL	GENE-N	2	16	Local LC chemical effect was abolished by LC presence of the gene receptor antagonist chemical ( 1 μM ) but not the gene receptor antagonist chemical ( 1 μM ) .	T16	T20	23636303
CPR:6	CHEMICAL	GENE-Y	2	11	Local LC chemical effect was abolished by LC presence of the gene receptor antagonist chemical ( 1 μM ) but not the gene receptor antagonist chemical ( 1 μM ) .	T1	T19	23636303
NA	CHEMICAL	GENE-N	2	16	Local LC chemical effect was abolished by LC presence of the gene receptor antagonist chemical ( 1 μM ) but not the gene receptor antagonist chemical ( 1 μM ) .	T1	T20	23636303
NA	CHEMICAL	GENE-Y	10	11	Local LC chemical effect was abolished by LC presence of the gene receptor antagonist chemical ( 1 μM ) but not the gene receptor antagonist chemical ( 1 μM ) .	T2	T19	23636303
CPR:6	CHEMICAL	GENE-N	10	16	Local LC chemical effect was abolished by LC presence of the gene receptor antagonist chemical ( 1 μM ) but not the gene receptor antagonist chemical ( 1 μM ) .	T2	T20	23636303
NA	CHEMICAL	GENE-Y	4	17	CONCLUSIONS : The SSRI chemical modulates central noradrenergic neurotransmission by activation , through endogenous chemical , of gene receptors expressed in the somatodendritic ( LC ) and terminal ( PFC ) areas , which subsequently promote an enhancement of local NA .	T7	T21	23636303
NA	CHEMICAL	GENE-Y	14	17	CONCLUSIONS : The SSRI chemical modulates central noradrenergic neurotransmission by activation , through endogenous chemical , of gene receptors expressed in the somatodendritic ( LC ) and terminal ( PFC ) areas , which subsequently promote an enhancement of local NA .	T8	T21	23636303
CPR:6	CHEMICAL	GENE-Y	0	4	chemical : a novel gene antagonist for the treatment of cardiovascular disease .	T3	T9	23479389
CPR:6	CHEMICAL	GENE-Y	0	14	chemical derived from Zingiber officinale Roscoe ( ginger ) was identified as a novel gene antagonist , with an IC50 value of 8.173 µM .	T1	T5	23479389
CPR:4	CHEMICAL	GENE-Y	5	20	In muscle and liver , chemical ( 10 ng/kg/day ) induced increases in methylation and decreases in mRNA expression of gene .	T5	T15	23142538
CPR:4	CHEMICAL	GENE-Y	9	4	Effects of inhibition of gene ( gene ) by chemical in the cornea and tear fluid of eyes irradiated with UVB .	T7	T17	15866288
CPR:4	CHEMICAL	GENE-Y	9	6	Effects of inhibition of gene ( gene ) by chemical in the cornea and tear fluid of eyes irradiated with UVB .	T7	T18	15866288
CPR:4	CHEMICAL	GENE-Y	12	16	The purpose of the present study was to test our hypothesis that chemical , a specific gene inhibitor , effectively decreases gene activity in cornea as well as in tear fluid and favourably affects corneal healing .	T6	T15	15866288
CPR:4	CHEMICAL	GENE-Y	12	21	The purpose of the present study was to test our hypothesis that chemical , a specific gene inhibitor , effectively decreases gene activity in cornea as well as in tear fluid and favourably affects corneal healing .	T6	T9	15866288
NA	CHEMICAL	GENE-Y	13	8	Therefore , comparative histochemical and biochemical studies of gene and the effects of chemical were performed on rabbit corneas and tear fluid using the sensitive fluorogenic substrate chemical .	T3	T12	15866288
CPR:9	CHEMICAL	GENE-Y	27	8	Therefore , comparative histochemical and biochemical studies of gene and the effects of chemical were performed on rabbit corneas and tear fluid using the sensitive fluorogenic substrate chemical .	T4	T12	15866288
CPR:4	CHEMICAL	GENE-Y	1	24	When chemical was dropped on the eye surface on the first day of irradiation and subsequently daily until the end of the experiment , gene activity in both cornea and tear fluid was strongly inhibited .	T1	T10	15866288
NA	CHEMICAL	GENE-Y	0	1	chemical-converting enzyme inhibition and gene receptor blockade modify the pressure-natriuresis relationship by additive mechanisms in rats with gene and gene genes .	T28	T48	10446934
NA	CHEMICAL	GENE-N	0	4	chemical-converting enzyme inhibition and gene receptor blockade modify the pressure-natriuresis relationship by additive mechanisms in rats with gene and gene genes .	T28	T51	10446934
NA	CHEMICAL	GENE-Y	0	14	chemical-converting enzyme inhibition and gene receptor blockade modify the pressure-natriuresis relationship by additive mechanisms in rats with gene and gene genes .	T28	T49	10446934
NA	CHEMICAL	GENE-Y	0	14	chemical-converting enzyme inhibition and gene receptor blockade modify the pressure-natriuresis relationship by additive mechanisms in rats with gene and gene genes .	T28	T50	10446934
NA	CHEMICAL	GENE-Y	5	10	The pressure-natriuresis and -diuresis relationships in response to chronic chemical-converting enzyme ( gene ) inhibition and gene receptor blockade were evaluated .	T17	T40	10446934
NA	CHEMICAL	GENE-Y	5	12	The pressure-natriuresis and -diuresis relationships in response to chronic chemical-converting enzyme ( gene ) inhibition and gene receptor blockade were evaluated .	T17	T43	10446934
NA	CHEMICAL	GENE-N	5	16	The pressure-natriuresis and -diuresis relationships in response to chronic chemical-converting enzyme ( gene ) inhibition and gene receptor blockade were evaluated .	T17	T44	10446934
NA	CHEMICAL	GENE-Y	0	0	gene-chemical and chemical ( chemical ) system gene expression was also investigated .	T20	T45	10446934
NA	CHEMICAL	GENE-Y	2	0	gene-chemical and chemical ( chemical ) system gene expression was also investigated .	T21	T45	10446934
NA	CHEMICAL	GENE-Y	4	0	gene-chemical and chemical ( chemical ) system gene expression was also investigated .	T22	T45	10446934
CPR:3	CHEMICAL	GENE-N	12	0	gene and gene genes were downregulated in dTGR and were increased by chemical and chemical treatments , whereas no changes in the expression of gene and gene receptor genes were observed .	T8	T30	10446934
CPR:3	CHEMICAL	GENE-N	12	2	gene and gene genes were downregulated in dTGR and were increased by chemical and chemical treatments , whereas no changes in the expression of gene and gene receptor genes were observed .	T8	T31	10446934
NA	CHEMICAL	GENE-Y	12	24	gene and gene genes were downregulated in dTGR and were increased by chemical and chemical treatments , whereas no changes in the expression of gene and gene receptor genes were observed .	T8	T32	10446934
NA	CHEMICAL	GENE-Y	12	26	gene and gene genes were downregulated in dTGR and were increased by chemical and chemical treatments , whereas no changes in the expression of gene and gene receptor genes were observed .	T8	T33	10446934
CPR:3	CHEMICAL	GENE-N	14	0	gene and gene genes were downregulated in dTGR and were increased by chemical and chemical treatments , whereas no changes in the expression of gene and gene receptor genes were observed .	T9	T30	10446934
CPR:3	CHEMICAL	GENE-N	14	2	gene and gene genes were downregulated in dTGR and were increased by chemical and chemical treatments , whereas no changes in the expression of gene and gene receptor genes were observed .	T9	T31	10446934
NA	CHEMICAL	GENE-Y	14	24	gene and gene genes were downregulated in dTGR and were increased by chemical and chemical treatments , whereas no changes in the expression of gene and gene receptor genes were observed .	T9	T32	10446934
NA	CHEMICAL	GENE-Y	14	26	gene and gene genes were downregulated in dTGR and were increased by chemical and chemical treatments , whereas no changes in the expression of gene and gene receptor genes were observed .	T9	T33	10446934
CPR:3	CHEMICAL	GENE-Y	5	0	gene expression was increased by chemical but not by chemical .	T11	T34	10446934
NA	CHEMICAL	GENE-Y	9	0	gene expression was increased by chemical but not by chemical .	T12	T34	10446934
NA	CHEMICAL	GENE-Y	4	1	Neither gene nor neural chemical synthase gene expression was affected by drug treatments .	T13	T35	10446934
NA	CHEMICAL	GENE-Y	4	5	Neither gene nor neural chemical synthase gene expression was affected by drug treatments .	T13	T36	10446934
NA	CHEMICAL	GENE-Y	6	3	Therefore , submaximal gene inhibition enhanced chemical excretion mainly by increasing RBF and GFR , whereas submaximal gene receptor blockade decreased tubular chemical and water reabsorption .	T15	T37	10446934
NA	CHEMICAL	GENE-N	6	17	Therefore , submaximal gene inhibition enhanced chemical excretion mainly by increasing RBF and GFR , whereas submaximal gene receptor blockade decreased tubular chemical and water reabsorption .	T15	T38	10446934
NA	CHEMICAL	GENE-Y	22	3	Therefore , submaximal gene inhibition enhanced chemical excretion mainly by increasing RBF and GFR , whereas submaximal gene receptor blockade decreased tubular chemical and water reabsorption .	T16	T37	10446934
NA	CHEMICAL	GENE-N	22	17	Therefore , submaximal gene inhibition enhanced chemical excretion mainly by increasing RBF and GFR , whereas submaximal gene receptor blockade decreased tubular chemical and water reabsorption .	T16	T38	10446934
NA	CHEMICAL	GENE-Y	7	0	gene : A Negative Regulator of Basal chemical-Stimulated gene Secretion .	T10	T26	23274894
CPR:3	CHEMICAL	GENE-Y	7	8	gene : A Negative Regulator of Basal chemical-Stimulated gene Secretion .	T10	T27	23274894
NA	CHEMICAL	GENE-Y	24	10	Genome-wide association studies ( GWAS ) have linked polymorphisms in gene with variations in FBG and body fat , although not gene sensitivity or chemical tolerance .	T6	T15	23274894
NA	CHEMICAL	GENE-Y	24	9	Genome-wide association studies ( GWAS ) have linked polymorphisms in gene with variations in FBG and body fat , although not gene sensitivity or chemical tolerance .	T6	T16	23274894
NA	CHEMICAL	GENE-Y	7	0	gene encodes an islet-specific , endoplasmic reticulum-resident chemical-6-phosphatase catalytic subunit .	T7	T17	23274894
NA	CHEMICAL	GENE-Y	7	9	gene encodes an islet-specific , endoplasmic reticulum-resident chemical-6-phosphatase catalytic subunit .	T7	T18	23274894
NA	CHEMICAL	GENE-Y	9	0	gene deletion had little effect on gene sensitivity and chemical tolerance , whereas body fat was reduced in female gene knockout ( KO ) mice on both a chow and high-fat diet , observations that are all consistent with human GWAS data .	T8	T20	23274894
NA	CHEMICAL	GENE-N	9	6	gene deletion had little effect on gene sensitivity and chemical tolerance , whereas body fat was reduced in female gene knockout ( KO ) mice on both a chow and high-fat diet , observations that are all consistent with human GWAS data .	T8	T21	23274894
NA	CHEMICAL	GENE-Y	9	19	gene deletion had little effect on gene sensitivity and chemical tolerance , whereas body fat was reduced in female gene knockout ( KO ) mice on both a chow and high-fat diet , observations that are all consistent with human GWAS data .	T8	T22	23274894
NA	CHEMICAL	GENE-Y	12	0	gene deletion resulted in a leftward shift in the dose-response curve for chemical-stimulated gene secretion ( GSIS ) .	T9	T23	23274894
CPR:3	CHEMICAL	GENE-N	12	3	gene deletion resulted in a leftward shift in the dose-response curve for chemical-stimulated gene secretion ( GSIS ) .	T9	T24	23274894
NA	CHEMICAL	GENE-N	16	7	As a consequence , under fasting conditions in which plasma gene levels were identical , blood chemical levels were reduced in gene KO mice , again consistent with human GWAS data .	T1	T25	23274894
NA	CHEMICAL	GENE-Y	16	21	As a consequence , under fasting conditions in which plasma gene levels were identical , blood chemical levels were reduced in gene KO mice , again consistent with human GWAS data .	T1	T11	23274894
NA	CHEMICAL	GENE-Y	0	16	chemical-6-phosphatase activity was reduced , whereas basal cytoplasmic chemical levels were elevated in islets isolated from gene KO mice .	T2	T13	23274894
NA	CHEMICAL	GENE-Y	8	16	chemical-6-phosphatase activity was reduced , whereas basal cytoplasmic chemical levels were elevated in islets isolated from gene KO mice .	T3	T13	23274894
NA	CHEMICAL	GENE-Y	5	8	Synthesis and biological evaluation of chemical derivatives on gene .	T6	T12	23358258
CPR:4	CHEMICAL	GENE-Y	3	24	A series of chemical derivatives in which a chemical was inserted at position 8 of chemical scaffold was synthesized and evaluated as inhibitors of gene ( gene ) for the treatment of type 2 diabetes .	T1	T7	23358258
CPR:4	CHEMICAL	GENE-Y	3	26	A series of chemical derivatives in which a chemical was inserted at position 8 of chemical scaffold was synthesized and evaluated as inhibitors of gene ( gene ) for the treatment of type 2 diabetes .	T1	T8	23358258
NA	CHEMICAL	GENE-Y	8	24	A series of chemical derivatives in which a chemical was inserted at position 8 of chemical scaffold was synthesized and evaluated as inhibitors of gene ( gene ) for the treatment of type 2 diabetes .	T4	T7	23358258
NA	CHEMICAL	GENE-Y	8	26	A series of chemical derivatives in which a chemical was inserted at position 8 of chemical scaffold was synthesized and evaluated as inhibitors of gene ( gene ) for the treatment of type 2 diabetes .	T4	T8	23358258
CPR:4	CHEMICAL	GENE-Y	5	24	A series of chemical derivatives in which a chemical was inserted at position 8 of chemical scaffold was synthesized and evaluated as inhibitors of gene ( gene ) for the treatment of type 2 diabetes .	T5	T7	23358258
CPR:4	CHEMICAL	GENE-Y	5	26	A series of chemical derivatives in which a chemical was inserted at position 8 of chemical scaffold was synthesized and evaluated as inhibitors of gene ( gene ) for the treatment of type 2 diabetes .	T5	T8	23358258
NA	CHEMICAL	GENE-N	9	44	In this work , we report that the recombinant chemical chemical-transferase ( gene ) -gene ( gene ) isoforms , 65-kDa chemical decarboxylase ( gene ) ( gene-gene ) fusion protein or free truncated gene , were activated by gene ( gene ) to an extent of 60 % .	T3	T38	15686475
NA	CHEMICAL	GENE-N	9	12	In this work , we report that the recombinant chemical chemical-transferase ( gene ) -gene ( gene ) isoforms , 65-kDa chemical decarboxylase ( gene ) ( gene-gene ) fusion protein or free truncated gene , were activated by gene ( gene ) to an extent of 60 % .	T3	T43	15686475
NA	CHEMICAL	GENE-Y	9	14	In this work , we report that the recombinant chemical chemical-transferase ( gene ) -gene ( gene ) isoforms , 65-kDa chemical decarboxylase ( gene ) ( gene-gene ) fusion protein or free truncated gene , were activated by gene ( gene ) to an extent of 60 % .	T3	T44	15686475
NA	CHEMICAL	GENE-Y	9	16	In this work , we report that the recombinant chemical chemical-transferase ( gene ) -gene ( gene ) isoforms , 65-kDa chemical decarboxylase ( gene ) ( gene-gene ) fusion protein or free truncated gene , were activated by gene ( gene ) to an extent of 60 % .	T3	T17	15686475
NA	CHEMICAL	GENE-Y	9	22	In this work , we report that the recombinant chemical chemical-transferase ( gene ) -gene ( gene ) isoforms , 65-kDa chemical decarboxylase ( gene ) ( gene-gene ) fusion protein or free truncated gene , were activated by gene ( gene ) to an extent of 60 % .	T3	T22	15686475
NA	CHEMICAL	GENE-Y	9	24	In this work , we report that the recombinant chemical chemical-transferase ( gene ) -gene ( gene ) isoforms , 65-kDa chemical decarboxylase ( gene ) ( gene-gene ) fusion protein or free truncated gene , were activated by gene ( gene ) to an extent of 60 % .	T3	T26	15686475
NA	CHEMICAL	GENE-N	9	27	In this work , we report that the recombinant chemical chemical-transferase ( gene ) -gene ( gene ) isoforms , 65-kDa chemical decarboxylase ( gene ) ( gene-gene ) fusion protein or free truncated gene , were activated by gene ( gene ) to an extent of 60 % .	T3	T27	15686475
NA	CHEMICAL	GENE-Y	9	27	In this work , we report that the recombinant chemical chemical-transferase ( gene ) -gene ( gene ) isoforms , 65-kDa chemical decarboxylase ( gene ) ( gene-gene ) fusion protein or free truncated gene , were activated by gene ( gene ) to an extent of 60 % .	T3	T28	15686475
NA	CHEMICAL	GENE-Y	9	34	In this work , we report that the recombinant chemical chemical-transferase ( gene ) -gene ( gene ) isoforms , 65-kDa chemical decarboxylase ( gene ) ( gene-gene ) fusion protein or free truncated gene , were activated by gene ( gene ) to an extent of 60 % .	T3	T29	15686475
NA	CHEMICAL	GENE-Y	9	39	In this work , we report that the recombinant chemical chemical-transferase ( gene ) -gene ( gene ) isoforms , 65-kDa chemical decarboxylase ( gene ) ( gene-gene ) fusion protein or free truncated gene , were activated by gene ( gene ) to an extent of 60 % .	T3	T30	15686475
NA	CHEMICAL	GENE-Y	9	41	In this work , we report that the recombinant chemical chemical-transferase ( gene ) -gene ( gene ) isoforms , 65-kDa chemical decarboxylase ( gene ) ( gene-gene ) fusion protein or free truncated gene , were activated by gene ( gene ) to an extent of 60 % .	T3	T31	15686475
NA	CHEMICAL	GENE-N	10	44	In this work , we report that the recombinant chemical chemical-transferase ( gene ) -gene ( gene ) isoforms , 65-kDa chemical decarboxylase ( gene ) ( gene-gene ) fusion protein or free truncated gene , were activated by gene ( gene ) to an extent of 60 % .	T4	T38	15686475
NA	CHEMICAL	GENE-N	10	12	In this work , we report that the recombinant chemical chemical-transferase ( gene ) -gene ( gene ) isoforms , 65-kDa chemical decarboxylase ( gene ) ( gene-gene ) fusion protein or free truncated gene , were activated by gene ( gene ) to an extent of 60 % .	T4	T43	15686475
NA	CHEMICAL	GENE-Y	10	14	In this work , we report that the recombinant chemical chemical-transferase ( gene ) -gene ( gene ) isoforms , 65-kDa chemical decarboxylase ( gene ) ( gene-gene ) fusion protein or free truncated gene , were activated by gene ( gene ) to an extent of 60 % .	T4	T44	15686475
NA	CHEMICAL	GENE-Y	10	16	In this work , we report that the recombinant chemical chemical-transferase ( gene ) -gene ( gene ) isoforms , 65-kDa chemical decarboxylase ( gene ) ( gene-gene ) fusion protein or free truncated gene , were activated by gene ( gene ) to an extent of 60 % .	T4	T17	15686475
NA	CHEMICAL	GENE-Y	10	22	In this work , we report that the recombinant chemical chemical-transferase ( gene ) -gene ( gene ) isoforms , 65-kDa chemical decarboxylase ( gene ) ( gene-gene ) fusion protein or free truncated gene , were activated by gene ( gene ) to an extent of 60 % .	T4	T22	15686475
NA	CHEMICAL	GENE-Y	10	24	In this work , we report that the recombinant chemical chemical-transferase ( gene ) -gene ( gene ) isoforms , 65-kDa chemical decarboxylase ( gene ) ( gene-gene ) fusion protein or free truncated gene , were activated by gene ( gene ) to an extent of 60 % .	T4	T26	15686475
NA	CHEMICAL	GENE-N	10	27	In this work , we report that the recombinant chemical chemical-transferase ( gene ) -gene ( gene ) isoforms , 65-kDa chemical decarboxylase ( gene ) ( gene-gene ) fusion protein or free truncated gene , were activated by gene ( gene ) to an extent of 60 % .	T4	T27	15686475
NA	CHEMICAL	GENE-Y	10	27	In this work , we report that the recombinant chemical chemical-transferase ( gene ) -gene ( gene ) isoforms , 65-kDa chemical decarboxylase ( gene ) ( gene-gene ) fusion protein or free truncated gene , were activated by gene ( gene ) to an extent of 60 % .	T4	T28	15686475
NA	CHEMICAL	GENE-Y	10	34	In this work , we report that the recombinant chemical chemical-transferase ( gene ) -gene ( gene ) isoforms , 65-kDa chemical decarboxylase ( gene ) ( gene-gene ) fusion protein or free truncated gene , were activated by gene ( gene ) to an extent of 60 % .	T4	T29	15686475
NA	CHEMICAL	GENE-Y	10	39	In this work , we report that the recombinant chemical chemical-transferase ( gene ) -gene ( gene ) isoforms , 65-kDa chemical decarboxylase ( gene ) ( gene-gene ) fusion protein or free truncated gene , were activated by gene ( gene ) to an extent of 60 % .	T4	T30	15686475
NA	CHEMICAL	GENE-Y	10	41	In this work , we report that the recombinant chemical chemical-transferase ( gene ) -gene ( gene ) isoforms , 65-kDa chemical decarboxylase ( gene ) ( gene-gene ) fusion protein or free truncated gene , were activated by gene ( gene ) to an extent of 60 % .	T4	T31	15686475
NA	CHEMICAL	GENE-N	21	44	In this work , we report that the recombinant chemical chemical-transferase ( gene ) -gene ( gene ) isoforms , 65-kDa chemical decarboxylase ( gene ) ( gene-gene ) fusion protein or free truncated gene , were activated by gene ( gene ) to an extent of 60 % .	T9	T38	15686475
NA	CHEMICAL	GENE-N	21	12	In this work , we report that the recombinant chemical chemical-transferase ( gene ) -gene ( gene ) isoforms , 65-kDa chemical decarboxylase ( gene ) ( gene-gene ) fusion protein or free truncated gene , were activated by gene ( gene ) to an extent of 60 % .	T9	T43	15686475
NA	CHEMICAL	GENE-Y	21	14	In this work , we report that the recombinant chemical chemical-transferase ( gene ) -gene ( gene ) isoforms , 65-kDa chemical decarboxylase ( gene ) ( gene-gene ) fusion protein or free truncated gene , were activated by gene ( gene ) to an extent of 60 % .	T9	T44	15686475
NA	CHEMICAL	GENE-Y	21	16	In this work , we report that the recombinant chemical chemical-transferase ( gene ) -gene ( gene ) isoforms , 65-kDa chemical decarboxylase ( gene ) ( gene-gene ) fusion protein or free truncated gene , were activated by gene ( gene ) to an extent of 60 % .	T9	T17	15686475
NA	CHEMICAL	GENE-Y	21	22	In this work , we report that the recombinant chemical chemical-transferase ( gene ) -gene ( gene ) isoforms , 65-kDa chemical decarboxylase ( gene ) ( gene-gene ) fusion protein or free truncated gene , were activated by gene ( gene ) to an extent of 60 % .	T9	T22	15686475
NA	CHEMICAL	GENE-Y	21	24	In this work , we report that the recombinant chemical chemical-transferase ( gene ) -gene ( gene ) isoforms , 65-kDa chemical decarboxylase ( gene ) ( gene-gene ) fusion protein or free truncated gene , were activated by gene ( gene ) to an extent of 60 % .	T9	T26	15686475
NA	CHEMICAL	GENE-N	21	27	In this work , we report that the recombinant chemical chemical-transferase ( gene ) -gene ( gene ) isoforms , 65-kDa chemical decarboxylase ( gene ) ( gene-gene ) fusion protein or free truncated gene , were activated by gene ( gene ) to an extent of 60 % .	T9	T27	15686475
NA	CHEMICAL	GENE-Y	21	27	In this work , we report that the recombinant chemical chemical-transferase ( gene ) -gene ( gene ) isoforms , 65-kDa chemical decarboxylase ( gene ) ( gene-gene ) fusion protein or free truncated gene , were activated by gene ( gene ) to an extent of 60 % .	T9	T28	15686475
NA	CHEMICAL	GENE-Y	21	34	In this work , we report that the recombinant chemical chemical-transferase ( gene ) -gene ( gene ) isoforms , 65-kDa chemical decarboxylase ( gene ) ( gene-gene ) fusion protein or free truncated gene , were activated by gene ( gene ) to an extent of 60 % .	T9	T29	15686475
NA	CHEMICAL	GENE-Y	21	39	In this work , we report that the recombinant chemical chemical-transferase ( gene ) -gene ( gene ) isoforms , 65-kDa chemical decarboxylase ( gene ) ( gene-gene ) fusion protein or free truncated gene , were activated by gene ( gene ) to an extent of 60 % .	T9	T30	15686475
NA	CHEMICAL	GENE-Y	21	41	In this work , we report that the recombinant chemical chemical-transferase ( gene ) -gene ( gene ) isoforms , 65-kDa chemical decarboxylase ( gene ) ( gene-gene ) fusion protein or free truncated gene , were activated by gene ( gene ) to an extent of 60 % .	T9	T31	15686475
NA	CHEMICAL	GENE-N	24	44	In this work , we report that the recombinant chemical chemical-transferase ( gene ) -gene ( gene ) isoforms , 65-kDa chemical decarboxylase ( gene ) ( gene-gene ) fusion protein or free truncated gene , were activated by gene ( gene ) to an extent of 60 % .	T2	T38	15686475
NA	CHEMICAL	GENE-N	24	12	In this work , we report that the recombinant chemical chemical-transferase ( gene ) -gene ( gene ) isoforms , 65-kDa chemical decarboxylase ( gene ) ( gene-gene ) fusion protein or free truncated gene , were activated by gene ( gene ) to an extent of 60 % .	T2	T43	15686475
NA	CHEMICAL	GENE-Y	24	14	In this work , we report that the recombinant chemical chemical-transferase ( gene ) -gene ( gene ) isoforms , 65-kDa chemical decarboxylase ( gene ) ( gene-gene ) fusion protein or free truncated gene , were activated by gene ( gene ) to an extent of 60 % .	T2	T44	15686475
NA	CHEMICAL	GENE-Y	24	16	In this work , we report that the recombinant chemical chemical-transferase ( gene ) -gene ( gene ) isoforms , 65-kDa chemical decarboxylase ( gene ) ( gene-gene ) fusion protein or free truncated gene , were activated by gene ( gene ) to an extent of 60 % .	T2	T17	15686475
NA	CHEMICAL	GENE-Y	24	22	In this work , we report that the recombinant chemical chemical-transferase ( gene ) -gene ( gene ) isoforms , 65-kDa chemical decarboxylase ( gene ) ( gene-gene ) fusion protein or free truncated gene , were activated by gene ( gene ) to an extent of 60 % .	T2	T22	15686475
NA	CHEMICAL	GENE-Y	24	24	In this work , we report that the recombinant chemical chemical-transferase ( gene ) -gene ( gene ) isoforms , 65-kDa chemical decarboxylase ( gene ) ( gene-gene ) fusion protein or free truncated gene , were activated by gene ( gene ) to an extent of 60 % .	T2	T26	15686475
NA	CHEMICAL	GENE-N	24	27	In this work , we report that the recombinant chemical chemical-transferase ( gene ) -gene ( gene ) isoforms , 65-kDa chemical decarboxylase ( gene ) ( gene-gene ) fusion protein or free truncated gene , were activated by gene ( gene ) to an extent of 60 % .	T2	T27	15686475
NA	CHEMICAL	GENE-Y	24	27	In this work , we report that the recombinant chemical chemical-transferase ( gene ) -gene ( gene ) isoforms , 65-kDa chemical decarboxylase ( gene ) ( gene-gene ) fusion protein or free truncated gene , were activated by gene ( gene ) to an extent of 60 % .	T2	T28	15686475
NA	CHEMICAL	GENE-Y	24	34	In this work , we report that the recombinant chemical chemical-transferase ( gene ) -gene ( gene ) isoforms , 65-kDa chemical decarboxylase ( gene ) ( gene-gene ) fusion protein or free truncated gene , were activated by gene ( gene ) to an extent of 60 % .	T2	T29	15686475
NA	CHEMICAL	GENE-Y	24	39	In this work , we report that the recombinant chemical chemical-transferase ( gene ) -gene ( gene ) isoforms , 65-kDa chemical decarboxylase ( gene ) ( gene-gene ) fusion protein or free truncated gene , were activated by gene ( gene ) to an extent of 60 % .	T2	T30	15686475
NA	CHEMICAL	GENE-Y	24	41	In this work , we report that the recombinant chemical chemical-transferase ( gene ) -gene ( gene ) isoforms , 65-kDa chemical decarboxylase ( gene ) ( gene-gene ) fusion protein or free truncated gene , were activated by gene ( gene ) to an extent of 60 % .	T2	T31	15686475
NA	CHEMICAL	GENE-Y	16	10	The activation appears to be due to an increase of gene affinity for its cofactor , chemical ( chemical ) .	T5	T40	15686475
NA	CHEMICAL	GENE-Y	18	10	The activation appears to be due to an increase of gene affinity for its cofactor , chemical ( chemical ) .	T6	T40	15686475
CPR:9	CHEMICAL	GENE-Y	22	8	Firstly , the V ( max ) of gene was increased when gene was present whereas the affinity for the substrate , chemical , was not affected .	T7	T41	15686475
NA	CHEMICAL	GENE-Y	22	12	Firstly , the V ( max ) of gene was increased when gene was present whereas the affinity for the substrate , chemical , was not affected .	T7	T42	15686475
NA	CHEMICAL	GENE-Y	7	5	Secondly , the affinity of gene for chemical was increased in the presence of gene .	T8	T45	15686475
NA	CHEMICAL	GENE-Y	7	14	Secondly , the affinity of gene for chemical was increased in the presence of gene .	T8	T46	15686475
NA	CHEMICAL	GENE-Y	12	6	Hence , it is proposed that a conformational change is induced when gene interacts with gene or gene , resulting in an increase of gene affinity for chemical and the activation of gene .	T1	T18	15686475
NA	CHEMICAL	GENE-Y	12	15	Hence , it is proposed that a conformational change is induced when gene interacts with gene or gene , resulting in an increase of gene affinity for chemical and the activation of gene .	T1	T19	15686475
NA	CHEMICAL	GENE-Y	12	17	Hence , it is proposed that a conformational change is induced when gene interacts with gene or gene , resulting in an increase of gene affinity for chemical and the activation of gene .	T1	T20	15686475
NA	CHEMICAL	GENE-Y	12	24	Hence , it is proposed that a conformational change is induced when gene interacts with gene or gene , resulting in an increase of gene affinity for chemical and the activation of gene .	T1	T21	15686475
NA	CHEMICAL	GENE-Y	12	32	Hence , it is proposed that a conformational change is induced when gene interacts with gene or gene , resulting in an increase of gene affinity for chemical and the activation of gene .	T1	T23	15686475
CPR:3	CHEMICAL	GENE-Y	0	7	High-chemical environment enhanced oxidative stress and increased gene secretion from keratinocytes : New insights on impaired diabetic wound healing .	T5	T18	23423570
CPR:3	CHEMICAL	GENE-Y	14	17	Using cultured human keratinocytes and diabetic rat model , the current study showed that high-chemical environment enhanced gene production via gene ( gene ) -gene ( gene ) pathway in a reactive chemical species ( ROS ) -dependent manner in keratinocytes .	T3	T7	23423570
NA	CHEMICAL	GENE-Y	14	20	Using cultured human keratinocytes and diabetic rat model , the current study showed that high-chemical environment enhanced gene production via gene ( gene ) -gene ( gene ) pathway in a reactive chemical species ( ROS ) -dependent manner in keratinocytes .	T3	T8	23423570
NA	CHEMICAL	GENE-Y	14	22	Using cultured human keratinocytes and diabetic rat model , the current study showed that high-chemical environment enhanced gene production via gene ( gene ) -gene ( gene ) pathway in a reactive chemical species ( ROS ) -dependent manner in keratinocytes .	T3	T9	23423570
NA	CHEMICAL	GENE-N	14	24	Using cultured human keratinocytes and diabetic rat model , the current study showed that high-chemical environment enhanced gene production via gene ( gene ) -gene ( gene ) pathway in a reactive chemical species ( ROS ) -dependent manner in keratinocytes .	T3	T10	23423570
NA	CHEMICAL	GENE-N	14	26	Using cultured human keratinocytes and diabetic rat model , the current study showed that high-chemical environment enhanced gene production via gene ( gene ) -gene ( gene ) pathway in a reactive chemical species ( ROS ) -dependent manner in keratinocytes .	T3	T11	23423570
NA	CHEMICAL	GENE-Y	32	17	Using cultured human keratinocytes and diabetic rat model , the current study showed that high-chemical environment enhanced gene production via gene ( gene ) -gene ( gene ) pathway in a reactive chemical species ( ROS ) -dependent manner in keratinocytes .	T4	T7	23423570
NA	CHEMICAL	GENE-Y	32	20	Using cultured human keratinocytes and diabetic rat model , the current study showed that high-chemical environment enhanced gene production via gene ( gene ) -gene ( gene ) pathway in a reactive chemical species ( ROS ) -dependent manner in keratinocytes .	T4	T8	23423570
NA	CHEMICAL	GENE-Y	32	22	Using cultured human keratinocytes and diabetic rat model , the current study showed that high-chemical environment enhanced gene production via gene ( gene ) -gene ( gene ) pathway in a reactive chemical species ( ROS ) -dependent manner in keratinocytes .	T4	T9	23423570
NA	CHEMICAL	GENE-N	32	24	Using cultured human keratinocytes and diabetic rat model , the current study showed that high-chemical environment enhanced gene production via gene ( gene ) -gene ( gene ) pathway in a reactive chemical species ( ROS ) -dependent manner in keratinocytes .	T4	T10	23423570
NA	CHEMICAL	GENE-N	32	26	Using cultured human keratinocytes and diabetic rat model , the current study showed that high-chemical environment enhanced gene production via gene ( gene ) -gene ( gene ) pathway in a reactive chemical species ( ROS ) -dependent manner in keratinocytes .	T4	T11	23423570
NA	CHEMICAL	GENE-Y	2	6	No mutations in the chemical related gene and gene genes in patients with monogenic sclerosing bone disorders .	T4	T23	23563356
NA	CHEMICAL	GENE-Y	2	8	No mutations in the chemical related gene and gene genes in patients with monogenic sclerosing bone disorders .	T4	T24	23563356
NA	CHEMICAL	GENE-Y	22	7	Gene expression studies showed that mice lacking gene have increased expression of gene , the rate limiting enzyme for the production of chemical in the gut .	T2	T17	23563356
NA	CHEMICAL	GENE-Y	22	12	Gene expression studies showed that mice lacking gene have increased expression of gene , the rate limiting enzyme for the production of chemical in the gut .	T2	T18	23563356
NA	CHEMICAL	GENE-Y	11	4	Furthermore mice lacking either gene or gene , the receptor for chemical on the osteoblasts , were reported to have an increased bone mass due to increased bone formation .	T3	T19	23563356
NA	CHEMICAL	GENE-Y	11	6	Furthermore mice lacking either gene or gene , the receptor for chemical on the osteoblasts , were reported to have an increased bone mass due to increased bone formation .	T3	T20	23563356
NA	CHEMICAL	GENE-Y	2	8	This led to the still controversial hypothesis that gene influences bone formation indirectly by regulating the expression of gene and as a consequence influencing the production of chemical in the gut .	T1	T21	23563356
NA	CHEMICAL	GENE-Y	2	18	This led to the still controversial hypothesis that gene influences bone formation indirectly by regulating the expression of gene and as a consequence influencing the production of chemical in the gut .	T1	T22	23563356
NA	CHEMICAL	GENE-N	6	0	gene ( gene-peg5,000mw ) inhibits the in vitro and in vivo proliferation of human hepatocellular carcinoma through chemical depletion .	T16	T57	17210712
NA	CHEMICAL	GENE-N	6	2	gene ( gene-peg5,000mw ) inhibits the in vitro and in vivo proliferation of human hepatocellular carcinoma through chemical depletion .	T16	T58	17210712
NA	CHEMICAL	GENE-Y	11	13	Hepatocellular carcinoma ( HCC ) is believed to be auxotrophic for chemical through the lack of expression of chemical synthetase ( gene ) .	T10	T20	17210712
NA	CHEMICAL	GENE-Y	11	21	Hepatocellular carcinoma ( HCC ) is believed to be auxotrophic for chemical through the lack of expression of chemical synthetase ( gene ) .	T10	T27	17210712
NA	CHEMICAL	GENE-Y	11	13	Hepatocellular carcinoma ( HCC ) is believed to be auxotrophic for chemical through the lack of expression of chemical synthetase ( gene ) .	T1	T20	17210712
NA	CHEMICAL	GENE-Y	11	21	Hepatocellular carcinoma ( HCC ) is believed to be auxotrophic for chemical through the lack of expression of chemical synthetase ( gene ) .	T1	T27	17210712
NA	CHEMICAL	GENE-N	5	6	The successful use of the chemical-depleting enzyme chemical deiminase ( gene ) to treat gene-deficient tumors has opened up new possibilities for effective cancer therapy .	T5	T36	17210712
NA	CHEMICAL	GENE-N	5	8	The successful use of the chemical-depleting enzyme chemical deiminase ( gene ) to treat gene-deficient tumors has opened up new possibilities for effective cancer therapy .	T5	T40	17210712
NA	CHEMICAL	GENE-N	5	10	The successful use of the chemical-depleting enzyme chemical deiminase ( gene ) to treat gene-deficient tumors has opened up new possibilities for effective cancer therapy .	T5	T41	17210712
NA	CHEMICAL	GENE-Y	5	14	The successful use of the chemical-depleting enzyme chemical deiminase ( gene ) to treat gene-deficient tumors has opened up new possibilities for effective cancer therapy .	T5	T42	17210712
NA	CHEMICAL	GENE-N	7	6	The successful use of the chemical-depleting enzyme chemical deiminase ( gene ) to treat gene-deficient tumors has opened up new possibilities for effective cancer therapy .	T7	T36	17210712
NA	CHEMICAL	GENE-N	7	8	The successful use of the chemical-depleting enzyme chemical deiminase ( gene ) to treat gene-deficient tumors has opened up new possibilities for effective cancer therapy .	T7	T40	17210712
NA	CHEMICAL	GENE-N	7	10	The successful use of the chemical-depleting enzyme chemical deiminase ( gene ) to treat gene-deficient tumors has opened up new possibilities for effective cancer therapy .	T7	T41	17210712
NA	CHEMICAL	GENE-Y	7	14	The successful use of the chemical-depleting enzyme chemical deiminase ( gene ) to treat gene-deficient tumors has opened up new possibilities for effective cancer therapy .	T7	T42	17210712
NA	CHEMICAL	GENE-Y	19	3	Nevertheless , many gene-positive HCC cell lines are found to be resistant to gene treatment , although most require chemical for proliferation .	T8	T43	17210712
NA	CHEMICAL	GENE-N	19	13	Nevertheless , many gene-positive HCC cell lines are found to be resistant to gene treatment , although most require chemical for proliferation .	T8	T44	17210712
NA	CHEMICAL	GENE-N	4	5	Thus far , an chemical-depleting enzyme for killing gene-positive tumors has not been reported .	T9	T45	17210712
NA	CHEMICAL	GENE-Y	4	8	Thus far , an chemical-depleting enzyme for killing gene-positive tumors has not been reported .	T9	T46	17210712
NA	CHEMICAL	GENE-Y	7	3	They all expressed gene , but not chemical transcarbamylase ( gene ) , the enzyme that converts chemical , the product of degradation of chemical with gene , to chemical , which is converted back to chemical via gene .	T11	T52	17210712
NA	CHEMICAL	GENE-Y	7	8	They all expressed gene , but not chemical transcarbamylase ( gene ) , the enzyme that converts chemical , the product of degradation of chemical with gene , to chemical , which is converted back to chemical via gene .	T11	T53	17210712
NA	CHEMICAL	GENE-Y	7	10	They all expressed gene , but not chemical transcarbamylase ( gene ) , the enzyme that converts chemical , the product of degradation of chemical with gene , to chemical , which is converted back to chemical via gene .	T11	T54	17210712
NA	CHEMICAL	GENE-N	7	26	They all expressed gene , but not chemical transcarbamylase ( gene ) , the enzyme that converts chemical , the product of degradation of chemical with gene , to chemical , which is converted back to chemical via gene .	T11	T55	17210712
NA	CHEMICAL	GENE-Y	7	38	They all expressed gene , but not chemical transcarbamylase ( gene ) , the enzyme that converts chemical , the product of degradation of chemical with gene , to chemical , which is converted back to chemical via gene .	T11	T56	17210712
NA	CHEMICAL	GENE-Y	17	3	They all expressed gene , but not chemical transcarbamylase ( gene ) , the enzyme that converts chemical , the product of degradation of chemical with gene , to chemical , which is converted back to chemical via gene .	T12	T52	17210712
CPR:9	CHEMICAL	GENE-Y	17	8	They all expressed gene , but not chemical transcarbamylase ( gene ) , the enzyme that converts chemical , the product of degradation of chemical with gene , to chemical , which is converted back to chemical via gene .	T12	T53	17210712
CPR:9	CHEMICAL	GENE-Y	17	10	They all expressed gene , but not chemical transcarbamylase ( gene ) , the enzyme that converts chemical , the product of degradation of chemical with gene , to chemical , which is converted back to chemical via gene .	T12	T54	17210712
NA	CHEMICAL	GENE-N	17	26	They all expressed gene , but not chemical transcarbamylase ( gene ) , the enzyme that converts chemical , the product of degradation of chemical with gene , to chemical , which is converted back to chemical via gene .	T12	T55	17210712
NA	CHEMICAL	GENE-Y	17	38	They all expressed gene , but not chemical transcarbamylase ( gene ) , the enzyme that converts chemical , the product of degradation of chemical with gene , to chemical , which is converted back to chemical via gene .	T12	T56	17210712
NA	CHEMICAL	GENE-Y	24	3	They all expressed gene , but not chemical transcarbamylase ( gene ) , the enzyme that converts chemical , the product of degradation of chemical with gene , to chemical , which is converted back to chemical via gene .	T13	T52	17210712
NA	CHEMICAL	GENE-Y	24	8	They all expressed gene , but not chemical transcarbamylase ( gene ) , the enzyme that converts chemical , the product of degradation of chemical with gene , to chemical , which is converted back to chemical via gene .	T13	T53	17210712
NA	CHEMICAL	GENE-Y	24	10	They all expressed gene , but not chemical transcarbamylase ( gene ) , the enzyme that converts chemical , the product of degradation of chemical with gene , to chemical , which is converted back to chemical via gene .	T13	T54	17210712
CPR:9	CHEMICAL	GENE-N	24	26	They all expressed gene , but not chemical transcarbamylase ( gene ) , the enzyme that converts chemical , the product of degradation of chemical with gene , to chemical , which is converted back to chemical via gene .	T13	T55	17210712
NA	CHEMICAL	GENE-Y	24	38	They all expressed gene , but not chemical transcarbamylase ( gene ) , the enzyme that converts chemical , the product of degradation of chemical with gene , to chemical , which is converted back to chemical via gene .	T13	T56	17210712
NA	CHEMICAL	GENE-Y	29	3	They all expressed gene , but not chemical transcarbamylase ( gene ) , the enzyme that converts chemical , the product of degradation of chemical with gene , to chemical , which is converted back to chemical via gene .	T14	T52	17210712
NA	CHEMICAL	GENE-Y	29	8	They all expressed gene , but not chemical transcarbamylase ( gene ) , the enzyme that converts chemical , the product of degradation of chemical with gene , to chemical , which is converted back to chemical via gene .	T14	T53	17210712
NA	CHEMICAL	GENE-Y	29	10	They all expressed gene , but not chemical transcarbamylase ( gene ) , the enzyme that converts chemical , the product of degradation of chemical with gene , to chemical , which is converted back to chemical via gene .	T14	T54	17210712
CPR:9	CHEMICAL	GENE-N	29	26	They all expressed gene , but not chemical transcarbamylase ( gene ) , the enzyme that converts chemical , the product of degradation of chemical with gene , to chemical , which is converted back to chemical via gene .	T14	T55	17210712
NA	CHEMICAL	GENE-Y	29	38	They all expressed gene , but not chemical transcarbamylase ( gene ) , the enzyme that converts chemical , the product of degradation of chemical with gene , to chemical , which is converted back to chemical via gene .	T14	T56	17210712
NA	CHEMICAL	GENE-Y	36	3	They all expressed gene , but not chemical transcarbamylase ( gene ) , the enzyme that converts chemical , the product of degradation of chemical with gene , to chemical , which is converted back to chemical via gene .	T15	T52	17210712
NA	CHEMICAL	GENE-Y	36	8	They all expressed gene , but not chemical transcarbamylase ( gene ) , the enzyme that converts chemical , the product of degradation of chemical with gene , to chemical , which is converted back to chemical via gene .	T15	T53	17210712
NA	CHEMICAL	GENE-Y	36	10	They all expressed gene , but not chemical transcarbamylase ( gene ) , the enzyme that converts chemical , the product of degradation of chemical with gene , to chemical , which is converted back to chemical via gene .	T15	T54	17210712
NA	CHEMICAL	GENE-N	36	26	They all expressed gene , but not chemical transcarbamylase ( gene ) , the enzyme that converts chemical , the product of degradation of chemical with gene , to chemical , which is converted back to chemical via gene .	T15	T55	17210712
CPR:9	CHEMICAL	GENE-Y	36	38	They all expressed gene , but not chemical transcarbamylase ( gene ) , the enzyme that converts chemical , the product of degradation of chemical with gene , to chemical , which is converted back to chemical via gene .	T15	T56	17210712
NA	CHEMICAL	GENE-Y	7	7	This surprising correlation between the lack of gene expression and sensitivity of gene-positive HCC cells shows that gene-deficient HCCs are sensitive to gene-mediated chemical depletion .	T2	T23	17210712
NA	CHEMICAL	GENE-Y	7	12	This surprising correlation between the lack of gene expression and sensitivity of gene-positive HCC cells shows that gene-deficient HCCs are sensitive to gene-mediated chemical depletion .	T2	T24	17210712
NA	CHEMICAL	GENE-Y	7	17	This surprising correlation between the lack of gene expression and sensitivity of gene-positive HCC cells shows that gene-deficient HCCs are sensitive to gene-mediated chemical depletion .	T2	T25	17210712
CPR:9	CHEMICAL	GENE-N	7	22	This surprising correlation between the lack of gene expression and sensitivity of gene-positive HCC cells shows that gene-deficient HCCs are sensitive to gene-mediated chemical depletion .	T2	T26	17210712
NA	CHEMICAL	GENE-Y	13	8	Therefore , pretreatment tumor gene expression profiling of gene and gene could aid in predicting tumor response to chemical depletion with chemical-depleting enzymes .	T3	T28	17210712
NA	CHEMICAL	GENE-Y	13	10	Therefore , pretreatment tumor gene expression profiling of gene and gene could aid in predicting tumor response to chemical depletion with chemical-depleting enzymes .	T3	T29	17210712
CPR:9	CHEMICAL	GENE-N	13	22	Therefore , pretreatment tumor gene expression profiling of gene and gene could aid in predicting tumor response to chemical depletion with chemical-depleting enzymes .	T3	T30	17210712
NA	CHEMICAL	GENE-Y	13	8	Therefore , pretreatment tumor gene expression profiling of gene and gene could aid in predicting tumor response to chemical depletion with chemical-depleting enzymes .	T4	T28	17210712
NA	CHEMICAL	GENE-Y	13	10	Therefore , pretreatment tumor gene expression profiling of gene and gene could aid in predicting tumor response to chemical depletion with chemical-depleting enzymes .	T4	T29	17210712
NA	CHEMICAL	GENE-N	13	22	Therefore , pretreatment tumor gene expression profiling of gene and gene could aid in predicting tumor response to chemical depletion with chemical-depleting enzymes .	T4	T30	17210712
NA	CHEMICAL	GENE-Y	37	6	Furthermore , the growth of the gene-deficient Hep3B tumor cells ( gene-positive and gene-resistant ) in mice was inhibited by treatment with gene-peg ( 5,000mw ) , which is active alone and is synergistic in combination with chemical .	T6	T34	17210712
NA	CHEMICAL	GENE-Y	37	11	Furthermore , the growth of the gene-deficient Hep3B tumor cells ( gene-positive and gene-resistant ) in mice was inhibited by treatment with gene-peg ( 5,000mw ) , which is active alone and is synergistic in combination with chemical .	T6	T35	17210712
NA	CHEMICAL	GENE-N	37	13	Furthermore , the growth of the gene-deficient Hep3B tumor cells ( gene-positive and gene-resistant ) in mice was inhibited by treatment with gene-peg ( 5,000mw ) , which is active alone and is synergistic in combination with chemical .	T6	T37	17210712
NA	CHEMICAL	GENE-N	37	22	Furthermore , the growth of the gene-deficient Hep3B tumor cells ( gene-positive and gene-resistant ) in mice was inhibited by treatment with gene-peg ( 5,000mw ) , which is active alone and is synergistic in combination with chemical .	T6	T38	17210712
NA	CHEMICAL	GENE-Y	6	0	gene activity was strongly increased and chemical kinase activity was moderately reduced in all of the resistant variants , resulting in reduced accumulation of chemical analogues .	T7	T15	10444166
NA	CHEMICAL	GENE-Y	6	7	gene activity was strongly increased and chemical kinase activity was moderately reduced in all of the resistant variants , resulting in reduced accumulation of chemical analogues .	T7	T16	10444166
NA	CHEMICAL	GENE-Y	24	0	gene activity was strongly increased and chemical kinase activity was moderately reduced in all of the resistant variants , resulting in reduced accumulation of chemical analogues .	T8	T15	10444166
NA	CHEMICAL	GENE-Y	24	7	gene activity was strongly increased and chemical kinase activity was moderately reduced in all of the resistant variants , resulting in reduced accumulation of chemical analogues .	T8	T16	10444166
NA	CHEMICAL	GENE-Y	4	2	In addition a deletion in one of the alleles of the chemical kinase was detected in the chemical-resistant line .	T9	T17	10444166
NA	CHEMICAL	GENE-Y	2	2	In addition a deletion in one of the alleles of the chemical kinase was detected in the chemical-resistant line .	T10	T17	10444166
CPR:3	CHEMICAL	GENE-N	8	0	gene activity was found to be strongly increased in the chemical-selected line and gene was increased in the chemical-selected line .	T11	T18	10444166
NA	CHEMICAL	GENE-Y	8	13	gene activity was found to be strongly increased in the chemical-selected line and gene was increased in the chemical-selected line .	T11	T19	10444166
NA	CHEMICAL	GENE-N	8	0	gene activity was found to be strongly increased in the chemical-selected line and gene was increased in the chemical-selected line .	T12	T18	10444166
CPR:3	CHEMICAL	GENE-Y	8	13	gene activity was found to be strongly increased in the chemical-selected line and gene was increased in the chemical-selected line .	T12	T19	10444166
NA	CHEMICAL	GENE-N	5	15	The exposure of highly toxic chemical does not significantly impact the activity and expression of gene in rats determined by a novel ultra performance liquid chromatography-tandem mass spectrometric method of a specific probe chemical .	T12	T21	23085095
NA	CHEMICAL	GENE-N	33	15	The exposure of highly toxic chemical does not significantly impact the activity and expression of gene in rats determined by a novel ultra performance liquid chromatography-tandem mass spectrometric method of a specific probe chemical .	T11	T21	23085095
NA	CHEMICAL	GENE-N	18	19	Our study aims to explore the potent effects of AC , as a marker component of Aconitum , on gene using the probe chemical in rats .	T5	T18	23085095
NA	CHEMICAL	GENE-N	19	0	gene activity and protein levels in rat liver microsomes pretreated with oral AC were also measured using in vitro chemical metabolism and Western blot .	T7	T19	23085095
NA	CHEMICAL	GENE-N	17	12	Single dose and 7-day AC administration at 0.125mg/kg had no effect on gene activity since no change in the formation of chemical and chemical .	T1	T20	23085095
NA	CHEMICAL	GENE-N	11	12	Single dose and 7-day AC administration at 0.125mg/kg had no effect on gene activity since no change in the formation of chemical and chemical .	T2	T20	23085095
CPR:4	CHEMICAL	GENE-Y	0	8	chemical ( chemical ) decreased the expression of gene , gene , and gene induced by gene , while chemical ( chemical ) , a selective inhibitor of gene , decreased the expression of gene , gene , and gene .	T7	T10	17494951
CPR:4	CHEMICAL	GENE-Y	0	10	chemical ( chemical ) decreased the expression of gene , gene , and gene induced by gene , while chemical ( chemical ) , a selective inhibitor of gene , decreased the expression of gene , gene , and gene .	T7	T11	17494951
CPR:4	CHEMICAL	GENE-Y	0	13	chemical ( chemical ) decreased the expression of gene , gene , and gene induced by gene , while chemical ( chemical ) , a selective inhibitor of gene , decreased the expression of gene , gene , and gene .	T7	T12	17494951
NA	CHEMICAL	GENE-Y	0	16	chemical ( chemical ) decreased the expression of gene , gene , and gene induced by gene , while chemical ( chemical ) , a selective inhibitor of gene , decreased the expression of gene , gene , and gene .	T7	T13	17494951
NA	CHEMICAL	GENE-Y	0	28	chemical ( chemical ) decreased the expression of gene , gene , and gene induced by gene , while chemical ( chemical ) , a selective inhibitor of gene , decreased the expression of gene , gene , and gene .	T7	T14	17494951
NA	CHEMICAL	GENE-Y	0	34	chemical ( chemical ) decreased the expression of gene , gene , and gene induced by gene , while chemical ( chemical ) , a selective inhibitor of gene , decreased the expression of gene , gene , and gene .	T7	T15	17494951
NA	CHEMICAL	GENE-Y	0	36	chemical ( chemical ) decreased the expression of gene , gene , and gene induced by gene , while chemical ( chemical ) , a selective inhibitor of gene , decreased the expression of gene , gene , and gene .	T7	T16	17494951
NA	CHEMICAL	GENE-Y	0	39	chemical ( chemical ) decreased the expression of gene , gene , and gene induced by gene , while chemical ( chemical ) , a selective inhibitor of gene , decreased the expression of gene , gene , and gene .	T7	T17	17494951
CPR:4	CHEMICAL	GENE-Y	2	8	chemical ( chemical ) decreased the expression of gene , gene , and gene induced by gene , while chemical ( chemical ) , a selective inhibitor of gene , decreased the expression of gene , gene , and gene .	T8	T10	17494951
CPR:4	CHEMICAL	GENE-Y	2	10	chemical ( chemical ) decreased the expression of gene , gene , and gene induced by gene , while chemical ( chemical ) , a selective inhibitor of gene , decreased the expression of gene , gene , and gene .	T8	T11	17494951
CPR:4	CHEMICAL	GENE-Y	2	13	chemical ( chemical ) decreased the expression of gene , gene , and gene induced by gene , while chemical ( chemical ) , a selective inhibitor of gene , decreased the expression of gene , gene , and gene .	T8	T12	17494951
NA	CHEMICAL	GENE-Y	2	16	chemical ( chemical ) decreased the expression of gene , gene , and gene induced by gene , while chemical ( chemical ) , a selective inhibitor of gene , decreased the expression of gene , gene , and gene .	T8	T13	17494951
NA	CHEMICAL	GENE-Y	2	28	chemical ( chemical ) decreased the expression of gene , gene , and gene induced by gene , while chemical ( chemical ) , a selective inhibitor of gene , decreased the expression of gene , gene , and gene .	T8	T14	17494951
NA	CHEMICAL	GENE-Y	2	34	chemical ( chemical ) decreased the expression of gene , gene , and gene induced by gene , while chemical ( chemical ) , a selective inhibitor of gene , decreased the expression of gene , gene , and gene .	T8	T15	17494951
NA	CHEMICAL	GENE-Y	2	36	chemical ( chemical ) decreased the expression of gene , gene , and gene induced by gene , while chemical ( chemical ) , a selective inhibitor of gene , decreased the expression of gene , gene , and gene .	T8	T16	17494951
NA	CHEMICAL	GENE-Y	2	39	chemical ( chemical ) decreased the expression of gene , gene , and gene induced by gene , while chemical ( chemical ) , a selective inhibitor of gene , decreased the expression of gene , gene , and gene .	T8	T17	17494951
NA	CHEMICAL	GENE-Y	8	8	chemical ( chemical ) decreased the expression of gene , gene , and gene induced by gene , while chemical ( chemical ) , a selective inhibitor of gene , decreased the expression of gene , gene , and gene .	T1	T10	17494951
NA	CHEMICAL	GENE-Y	8	10	chemical ( chemical ) decreased the expression of gene , gene , and gene induced by gene , while chemical ( chemical ) , a selective inhibitor of gene , decreased the expression of gene , gene , and gene .	T1	T11	17494951
NA	CHEMICAL	GENE-Y	8	13	chemical ( chemical ) decreased the expression of gene , gene , and gene induced by gene , while chemical ( chemical ) , a selective inhibitor of gene , decreased the expression of gene , gene , and gene .	T1	T12	17494951
NA	CHEMICAL	GENE-Y	8	16	chemical ( chemical ) decreased the expression of gene , gene , and gene induced by gene , while chemical ( chemical ) , a selective inhibitor of gene , decreased the expression of gene , gene , and gene .	T1	T13	17494951
CPR:4	CHEMICAL	GENE-Y	8	28	chemical ( chemical ) decreased the expression of gene , gene , and gene induced by gene , while chemical ( chemical ) , a selective inhibitor of gene , decreased the expression of gene , gene , and gene .	T1	T14	17494951
CPR:4	CHEMICAL	GENE-Y	8	34	chemical ( chemical ) decreased the expression of gene , gene , and gene induced by gene , while chemical ( chemical ) , a selective inhibitor of gene , decreased the expression of gene , gene , and gene .	T1	T15	17494951
CPR:4	CHEMICAL	GENE-Y	8	36	chemical ( chemical ) decreased the expression of gene , gene , and gene induced by gene , while chemical ( chemical ) , a selective inhibitor of gene , decreased the expression of gene , gene , and gene .	T1	T16	17494951
CPR:4	CHEMICAL	GENE-Y	8	39	chemical ( chemical ) decreased the expression of gene , gene , and gene induced by gene , while chemical ( chemical ) , a selective inhibitor of gene , decreased the expression of gene , gene , and gene .	T1	T17	17494951
NA	CHEMICAL	GENE-Y	21	8	chemical ( chemical ) decreased the expression of gene , gene , and gene induced by gene , while chemical ( chemical ) , a selective inhibitor of gene , decreased the expression of gene , gene , and gene .	T2	T10	17494951
NA	CHEMICAL	GENE-Y	21	10	chemical ( chemical ) decreased the expression of gene , gene , and gene induced by gene , while chemical ( chemical ) , a selective inhibitor of gene , decreased the expression of gene , gene , and gene .	T2	T11	17494951
NA	CHEMICAL	GENE-Y	21	13	chemical ( chemical ) decreased the expression of gene , gene , and gene induced by gene , while chemical ( chemical ) , a selective inhibitor of gene , decreased the expression of gene , gene , and gene .	T2	T12	17494951
NA	CHEMICAL	GENE-Y	21	16	chemical ( chemical ) decreased the expression of gene , gene , and gene induced by gene , while chemical ( chemical ) , a selective inhibitor of gene , decreased the expression of gene , gene , and gene .	T2	T13	17494951
CPR:4	CHEMICAL	GENE-Y	21	28	chemical ( chemical ) decreased the expression of gene , gene , and gene induced by gene , while chemical ( chemical ) , a selective inhibitor of gene , decreased the expression of gene , gene , and gene .	T2	T14	17494951
CPR:4	CHEMICAL	GENE-Y	21	34	chemical ( chemical ) decreased the expression of gene , gene , and gene induced by gene , while chemical ( chemical ) , a selective inhibitor of gene , decreased the expression of gene , gene , and gene .	T2	T15	17494951
CPR:4	CHEMICAL	GENE-Y	21	36	chemical ( chemical ) decreased the expression of gene , gene , and gene induced by gene , while chemical ( chemical ) , a selective inhibitor of gene , decreased the expression of gene , gene , and gene .	T2	T16	17494951
CPR:4	CHEMICAL	GENE-Y	21	39	chemical ( chemical ) decreased the expression of gene , gene , and gene induced by gene , while chemical ( chemical ) , a selective inhibitor of gene , decreased the expression of gene , gene , and gene .	T2	T17	17494951
CPR:4	CHEMICAL	GENE-Y	0	8	chemical and chemical attenuated the mRNA expression of gene and gene induced by the costimulation of gene , gene , and LPS .	T3	T18	17494951
CPR:4	CHEMICAL	GENE-Y	0	10	chemical and chemical attenuated the mRNA expression of gene and gene induced by the costimulation of gene , gene , and LPS .	T3	T19	17494951
NA	CHEMICAL	GENE-Y	0	16	chemical and chemical attenuated the mRNA expression of gene and gene induced by the costimulation of gene , gene , and LPS .	T3	T20	17494951
NA	CHEMICAL	GENE-Y	0	18	chemical and chemical attenuated the mRNA expression of gene and gene induced by the costimulation of gene , gene , and LPS .	T3	T21	17494951
CPR:4	CHEMICAL	GENE-Y	2	8	chemical and chemical attenuated the mRNA expression of gene and gene induced by the costimulation of gene , gene , and LPS .	T4	T18	17494951
CPR:4	CHEMICAL	GENE-Y	2	10	chemical and chemical attenuated the mRNA expression of gene and gene induced by the costimulation of gene , gene , and LPS .	T4	T19	17494951
NA	CHEMICAL	GENE-Y	2	16	chemical and chemical attenuated the mRNA expression of gene and gene induced by the costimulation of gene , gene , and LPS .	T4	T20	17494951
NA	CHEMICAL	GENE-Y	2	18	chemical and chemical attenuated the mRNA expression of gene and gene induced by the costimulation of gene , gene , and LPS .	T4	T21	17494951
NA	CHEMICAL	GENE-N	10	11	In obese db/db mice , SBE treatment also reduced plasma chemical aminotransferase levels .	T1	T4	22532505
NA	CHEMICAL	GENE-Y	0	18	chemical nonresponsive methylmalonic acidemia ( MMA , mut complementation class ) results from mutations in the nuclear gene gene , which codes for the mitochondrial enzyme chemical mutase ( gene ) .	T1	T9	16281286
NA	CHEMICAL	GENE-Y	0	7	chemical nonresponsive methylmalonic acidemia ( MMA , mut complementation class ) results from mutations in the nuclear gene gene , which codes for the mitochondrial enzyme chemical mutase ( gene ) .	T1	T10	16281286
NA	CHEMICAL	GENE-Y	0	29	chemical nonresponsive methylmalonic acidemia ( MMA , mut complementation class ) results from mutations in the nuclear gene gene , which codes for the mitochondrial enzyme chemical mutase ( gene ) .	T1	T11	16281286
NA	CHEMICAL	GENE-Y	26	18	chemical nonresponsive methylmalonic acidemia ( MMA , mut complementation class ) results from mutations in the nuclear gene gene , which codes for the mitochondrial enzyme chemical mutase ( gene ) .	T2	T9	16281286
NA	CHEMICAL	GENE-Y	26	7	chemical nonresponsive methylmalonic acidemia ( MMA , mut complementation class ) results from mutations in the nuclear gene gene , which codes for the mitochondrial enzyme chemical mutase ( gene ) .	T2	T10	16281286
NA	CHEMICAL	GENE-Y	26	29	chemical nonresponsive methylmalonic acidemia ( MMA , mut complementation class ) results from mutations in the nuclear gene gene , which codes for the mitochondrial enzyme chemical mutase ( gene ) .	T2	T11	16281286
NA	CHEMICAL	GENE-Y	8	17	BACKGROUND : Systemic lupus erythematosus ( SLE ) is a complex genetic disease ; the chemical H4 receptor ( gene ) has been shown to be related to different kinds of autoimmune disorders ; and copy number variations ( CNVs ) have been found to be associated with various types of diseases .	T1	T12	20618322
NA	CHEMICAL	GENE-Y	8	16	BACKGROUND : Systemic lupus erythematosus ( SLE ) is a complex genetic disease ; the chemical H4 receptor ( gene ) has been shown to be related to different kinds of autoimmune disorders ; and copy number variations ( CNVs ) have been found to be associated with various types of diseases .	T1	T3	20618322
NA	CHEMICAL	GENE-Y	20	0	gene ( gene ) mediates the cross talk between gene and gene on gene gene expression and its ablation affects chemical homeostasis in male C57BL/6 mice .	T12	T47	23183186
NA	CHEMICAL	GENE-Y	20	2	gene ( gene ) mediates the cross talk between gene and gene on gene gene expression and its ablation affects chemical homeostasis in male C57BL/6 mice .	T12	T48	23183186
NA	CHEMICAL	GENE-N	20	9	gene ( gene ) mediates the cross talk between gene and gene on gene gene expression and its ablation affects chemical homeostasis in male C57BL/6 mice .	T12	T49	23183186
NA	CHEMICAL	GENE-Y	20	11	gene ( gene ) mediates the cross talk between gene and gene on gene gene expression and its ablation affects chemical homeostasis in male C57BL/6 mice .	T12	T50	23183186
NA	CHEMICAL	GENE-N	20	12	gene ( gene ) mediates the cross talk between gene and gene on gene gene expression and its ablation affects chemical homeostasis in male C57BL/6 mice .	T12	T51	23183186
NA	CHEMICAL	GENE-Y	17	6	Here we determined the role of gene in gene expression and the effect of gene deletion on chemical homeostasis .	T4	T31	23183186
NA	CHEMICAL	GENE-Y	17	8	Here we determined the role of gene in gene expression and the effect of gene deletion on chemical homeostasis .	T4	T32	23183186
NA	CHEMICAL	GENE-Y	17	14	Here we determined the role of gene in gene expression and the effect of gene deletion on chemical homeostasis .	T4	T33	23183186
NA	CHEMICAL	GENE-N	7	0	gene stimulated gene activation through increasing its chemical423 phosphorylation in gut gene-expressing cell lines , associated with increased gene mRNA levels .	T5	T34	23183186
NA	CHEMICAL	GENE-Y	7	2	gene stimulated gene activation through increasing its chemical423 phosphorylation in gut gene-expressing cell lines , associated with increased gene mRNA levels .	T5	T35	23183186
NA	CHEMICAL	GENE-Y	7	11	gene stimulated gene activation through increasing its chemical423 phosphorylation in gut gene-expressing cell lines , associated with increased gene mRNA levels .	T5	T36	23183186
NA	CHEMICAL	GENE-Y	7	18	gene stimulated gene activation through increasing its chemical423 phosphorylation in gut gene-expressing cell lines , associated with increased gene mRNA levels .	T5	T37	23183186
CPR:4	CHEMICAL	GENE-N	8	6	This stimulation was attenuated by the gene inhibitor chemical ( chemical ) or dominant-negative gene .	T6	T39	23183186
NA	CHEMICAL	GENE-Y	8	14	This stimulation was attenuated by the gene inhibitor chemical ( chemical ) or dominant-negative gene .	T6	T40	23183186
CPR:4	CHEMICAL	GENE-N	10	6	This stimulation was attenuated by the gene inhibitor chemical ( chemical ) or dominant-negative gene .	T7	T39	23183186
NA	CHEMICAL	GENE-Y	10	14	This stimulation was attenuated by the gene inhibitor chemical ( chemical ) or dominant-negative gene .	T7	T40	23183186
NA	CHEMICAL	GENE-N	3	1	Both gene and chemical-promoting agents activated β-cat chemical675 phosphorylation , which was attenuated by IPA3 or gene inhibition , respectively .	T8	T42	23183186
NA	CHEMICAL	GENE-N	3	16	Both gene and chemical-promoting agents activated β-cat chemical675 phosphorylation , which was attenuated by IPA3 or gene inhibition , respectively .	T8	T44	23183186
NA	CHEMICAL	GENE-N	7	1	Both gene and chemical-promoting agents activated β-cat chemical675 phosphorylation , which was attenuated by IPA3 or gene inhibition , respectively .	T9	T42	23183186
NA	CHEMICAL	GENE-N	7	16	Both gene and chemical-promoting agents activated β-cat chemical675 phosphorylation , which was attenuated by IPA3 or gene inhibition , respectively .	T9	T44	23183186
NA	CHEMICAL	GENE-Y	16	1	Gut gene levels were reduced in male gene ( -/- ) mice , associated with impaired chemical tolerance after an ip or oral chemical challenge .	T10	T45	23183186
NA	CHEMICAL	GENE-Y	16	7	Gut gene levels were reduced in male gene ( -/- ) mice , associated with impaired chemical tolerance after an ip or oral chemical challenge .	T10	T46	23183186
NA	CHEMICAL	GENE-Y	23	1	Gut gene levels were reduced in male gene ( -/- ) mice , associated with impaired chemical tolerance after an ip or oral chemical challenge .	T11	T45	23183186
NA	CHEMICAL	GENE-Y	23	7	Gut gene levels were reduced in male gene ( -/- ) mice , associated with impaired chemical tolerance after an ip or oral chemical challenge .	T11	T46	23183186
NA	CHEMICAL	GENE-Y	6	6	These mice had lower circulating active gene levels after a chemical challenge as well as reduced distal ileum gene content after insulin treatment .	T1	T13	23183186
NA	CHEMICAL	GENE-Y	6	18	These mice had lower circulating active gene levels after a chemical challenge as well as reduced distal ileum gene content after insulin treatment .	T1	T14	23183186
NA	CHEMICAL	GENE-Y	16	3	Finally , the gene ( -/- ) mice exhibited reduced brainstem gcg level and abolished gene chemical675 phosphorylation in brain neurons after gene treatment .	T2	T15	23183186
NA	CHEMICAL	GENE-Y	16	15	Finally , the gene ( -/- ) mice exhibited reduced brainstem gcg level and abolished gene chemical675 phosphorylation in brain neurons after gene treatment .	T2	T16	23183186
NA	CHEMICAL	GENE-N	16	18	Finally , the gene ( -/- ) mice exhibited reduced brainstem gcg level and abolished gene chemical675 phosphorylation in brain neurons after gene treatment .	T2	T17	23183186
NA	CHEMICAL	GENE-N	6	11	Synthesis and in vitro pharmacology at chemical and chemical preferring chemical receptors of chemical analogues .	T15	T33	13129570
NA	CHEMICAL	GENE-N	2	11	Synthesis and in vitro pharmacology at chemical and chemical preferring chemical receptors of chemical analogues .	T16	T33	13129570
NA	CHEMICAL	GENE-N	5	11	Synthesis and in vitro pharmacology at chemical and chemical preferring chemical receptors of chemical analogues .	T17	T33	13129570
NA	CHEMICAL	GENE-N	5	11	Synthesis and in vitro pharmacology at chemical and chemical preferring chemical receptors of chemical analogues .	T18	T33	13129570
CPR:5	CHEMICAL	GENE-N	0	8	chemical ( 1 ) is a potent chemical receptor agonist with moderate affinity for native chemical ( chemical ) receptors , whereas chemical ( 3 ) show high affinity for the gene subtype of chemical receptors and much lower affinity for the gene subtype of genes .	T1	T31	13129570
NA	CHEMICAL	GENE-N	0	8	chemical ( 1 ) is a potent chemical receptor agonist with moderate affinity for native chemical ( chemical ) receptors , whereas chemical ( 3 ) show high affinity for the gene subtype of chemical receptors and much lower affinity for the gene subtype of genes .	T1	T22	13129570
NA	CHEMICAL	GENE-Y	0	31	chemical ( 1 ) is a potent chemical receptor agonist with moderate affinity for native chemical ( chemical ) receptors , whereas chemical ( 3 ) show high affinity for the gene subtype of chemical receptors and much lower affinity for the gene subtype of genes .	T1	T23	13129570
NA	CHEMICAL	GENE-N	0	8	chemical ( 1 ) is a potent chemical receptor agonist with moderate affinity for native chemical ( chemical ) receptors , whereas chemical ( 3 ) show high affinity for the gene subtype of chemical receptors and much lower affinity for the gene subtype of genes .	T1	T24	13129570
NA	CHEMICAL	GENE-Y	0	42	chemical ( 1 ) is a potent chemical receptor agonist with moderate affinity for native chemical ( chemical ) receptors , whereas chemical ( 3 ) show high affinity for the gene subtype of chemical receptors and much lower affinity for the gene subtype of genes .	T1	T25	13129570
NA	CHEMICAL	GENE-N	0	8	chemical ( 1 ) is a potent chemical receptor agonist with moderate affinity for native chemical ( chemical ) receptors , whereas chemical ( 3 ) show high affinity for the gene subtype of chemical receptors and much lower affinity for the gene subtype of genes .	T1	T26	13129570
NA	CHEMICAL	GENE-N	7	8	chemical ( 1 ) is a potent chemical receptor agonist with moderate affinity for native chemical ( chemical ) receptors , whereas chemical ( 3 ) show high affinity for the gene subtype of chemical receptors and much lower affinity for the gene subtype of genes .	T13	T31	13129570
NA	CHEMICAL	GENE-N	7	8	chemical ( 1 ) is a potent chemical receptor agonist with moderate affinity for native chemical ( chemical ) receptors , whereas chemical ( 3 ) show high affinity for the gene subtype of chemical receptors and much lower affinity for the gene subtype of genes .	T13	T22	13129570
NA	CHEMICAL	GENE-Y	7	31	chemical ( 1 ) is a potent chemical receptor agonist with moderate affinity for native chemical ( chemical ) receptors , whereas chemical ( 3 ) show high affinity for the gene subtype of chemical receptors and much lower affinity for the gene subtype of genes .	T13	T23	13129570
NA	CHEMICAL	GENE-N	7	8	chemical ( 1 ) is a potent chemical receptor agonist with moderate affinity for native chemical ( chemical ) receptors , whereas chemical ( 3 ) show high affinity for the gene subtype of chemical receptors and much lower affinity for the gene subtype of genes .	T13	T24	13129570
NA	CHEMICAL	GENE-Y	7	42	chemical ( 1 ) is a potent chemical receptor agonist with moderate affinity for native chemical ( chemical ) receptors , whereas chemical ( 3 ) show high affinity for the gene subtype of chemical receptors and much lower affinity for the gene subtype of genes .	T13	T25	13129570
NA	CHEMICAL	GENE-N	7	8	chemical ( 1 ) is a potent chemical receptor agonist with moderate affinity for native chemical ( chemical ) receptors , whereas chemical ( 3 ) show high affinity for the gene subtype of chemical receptors and much lower affinity for the gene subtype of genes .	T13	T26	13129570
NA	CHEMICAL	GENE-N	5	8	chemical ( 1 ) is a potent chemical receptor agonist with moderate affinity for native chemical ( chemical ) receptors , whereas chemical ( 3 ) show high affinity for the gene subtype of chemical receptors and much lower affinity for the gene subtype of genes .	T4	T31	13129570
NA	CHEMICAL	GENE-N	5	8	chemical ( 1 ) is a potent chemical receptor agonist with moderate affinity for native chemical ( chemical ) receptors , whereas chemical ( 3 ) show high affinity for the gene subtype of chemical receptors and much lower affinity for the gene subtype of genes .	T4	T22	13129570
NA	CHEMICAL	GENE-Y	5	31	chemical ( 1 ) is a potent chemical receptor agonist with moderate affinity for native chemical ( chemical ) receptors , whereas chemical ( 3 ) show high affinity for the gene subtype of chemical receptors and much lower affinity for the gene subtype of genes .	T4	T23	13129570
NA	CHEMICAL	GENE-N	5	8	chemical ( 1 ) is a potent chemical receptor agonist with moderate affinity for native chemical ( chemical ) receptors , whereas chemical ( 3 ) show high affinity for the gene subtype of chemical receptors and much lower affinity for the gene subtype of genes .	T4	T24	13129570
NA	CHEMICAL	GENE-Y	5	42	chemical ( 1 ) is a potent chemical receptor agonist with moderate affinity for native chemical ( chemical ) receptors , whereas chemical ( 3 ) show high affinity for the gene subtype of chemical receptors and much lower affinity for the gene subtype of genes .	T4	T25	13129570
NA	CHEMICAL	GENE-N	5	8	chemical ( 1 ) is a potent chemical receptor agonist with moderate affinity for native chemical ( chemical ) receptors , whereas chemical ( 3 ) show high affinity for the gene subtype of chemical receptors and much lower affinity for the gene subtype of genes .	T4	T26	13129570
NA	CHEMICAL	GENE-N	17	8	chemical ( 1 ) is a potent chemical receptor agonist with moderate affinity for native chemical ( chemical ) receptors , whereas chemical ( 3 ) show high affinity for the gene subtype of chemical receptors and much lower affinity for the gene subtype of genes .	T5	T31	13129570
NA	CHEMICAL	GENE-N	17	8	chemical ( 1 ) is a potent chemical receptor agonist with moderate affinity for native chemical ( chemical ) receptors , whereas chemical ( 3 ) show high affinity for the gene subtype of chemical receptors and much lower affinity for the gene subtype of genes .	T5	T22	13129570
NA	CHEMICAL	GENE-Y	17	31	chemical ( 1 ) is a potent chemical receptor agonist with moderate affinity for native chemical ( chemical ) receptors , whereas chemical ( 3 ) show high affinity for the gene subtype of chemical receptors and much lower affinity for the gene subtype of genes .	T5	T23	13129570
NA	CHEMICAL	GENE-N	17	8	chemical ( 1 ) is a potent chemical receptor agonist with moderate affinity for native chemical ( chemical ) receptors , whereas chemical ( 3 ) show high affinity for the gene subtype of chemical receptors and much lower affinity for the gene subtype of genes .	T5	T24	13129570
NA	CHEMICAL	GENE-Y	17	42	chemical ( 1 ) is a potent chemical receptor agonist with moderate affinity for native chemical ( chemical ) receptors , whereas chemical ( 3 ) show high affinity for the gene subtype of chemical receptors and much lower affinity for the gene subtype of genes .	T5	T25	13129570
NA	CHEMICAL	GENE-N	17	8	chemical ( 1 ) is a potent chemical receptor agonist with moderate affinity for native chemical ( chemical ) receptors , whereas chemical ( 3 ) show high affinity for the gene subtype of chemical receptors and much lower affinity for the gene subtype of genes .	T5	T26	13129570
NA	CHEMICAL	GENE-N	5	8	chemical ( 1 ) is a potent chemical receptor agonist with moderate affinity for native chemical ( chemical ) receptors , whereas chemical ( 3 ) show high affinity for the gene subtype of chemical receptors and much lower affinity for the gene subtype of genes .	T6	T31	13129570
NA	CHEMICAL	GENE-N	5	8	chemical ( 1 ) is a potent chemical receptor agonist with moderate affinity for native chemical ( chemical ) receptors , whereas chemical ( 3 ) show high affinity for the gene subtype of chemical receptors and much lower affinity for the gene subtype of genes .	T6	T22	13129570
NA	CHEMICAL	GENE-Y	5	31	chemical ( 1 ) is a potent chemical receptor agonist with moderate affinity for native chemical ( chemical ) receptors , whereas chemical ( 3 ) show high affinity for the gene subtype of chemical receptors and much lower affinity for the gene subtype of genes .	T6	T23	13129570
NA	CHEMICAL	GENE-N	5	8	chemical ( 1 ) is a potent chemical receptor agonist with moderate affinity for native chemical ( chemical ) receptors , whereas chemical ( 3 ) show high affinity for the gene subtype of chemical receptors and much lower affinity for the gene subtype of genes .	T6	T24	13129570
NA	CHEMICAL	GENE-Y	5	42	chemical ( 1 ) is a potent chemical receptor agonist with moderate affinity for native chemical ( chemical ) receptors , whereas chemical ( 3 ) show high affinity for the gene subtype of chemical receptors and much lower affinity for the gene subtype of genes .	T6	T25	13129570
NA	CHEMICAL	GENE-N	5	8	chemical ( 1 ) is a potent chemical receptor agonist with moderate affinity for native chemical ( chemical ) receptors , whereas chemical ( 3 ) show high affinity for the gene subtype of chemical receptors and much lower affinity for the gene subtype of genes .	T6	T26	13129570
NA	CHEMICAL	GENE-N	34	8	chemical ( 1 ) is a potent chemical receptor agonist with moderate affinity for native chemical ( chemical ) receptors , whereas chemical ( 3 ) show high affinity for the gene subtype of chemical receptors and much lower affinity for the gene subtype of genes .	T7	T31	13129570
NA	CHEMICAL	GENE-N	34	8	chemical ( 1 ) is a potent chemical receptor agonist with moderate affinity for native chemical ( chemical ) receptors , whereas chemical ( 3 ) show high affinity for the gene subtype of chemical receptors and much lower affinity for the gene subtype of genes .	T7	T22	13129570
NA	CHEMICAL	GENE-Y	34	31	chemical ( 1 ) is a potent chemical receptor agonist with moderate affinity for native chemical ( chemical ) receptors , whereas chemical ( 3 ) show high affinity for the gene subtype of chemical receptors and much lower affinity for the gene subtype of genes .	T7	T23	13129570
NA	CHEMICAL	GENE-N	34	8	chemical ( 1 ) is a potent chemical receptor agonist with moderate affinity for native chemical ( chemical ) receptors , whereas chemical ( 3 ) show high affinity for the gene subtype of chemical receptors and much lower affinity for the gene subtype of genes .	T7	T24	13129570
NA	CHEMICAL	GENE-Y	34	42	chemical ( 1 ) is a potent chemical receptor agonist with moderate affinity for native chemical ( chemical ) receptors , whereas chemical ( 3 ) show high affinity for the gene subtype of chemical receptors and much lower affinity for the gene subtype of genes .	T7	T25	13129570
NA	CHEMICAL	GENE-N	34	8	chemical ( 1 ) is a potent chemical receptor agonist with moderate affinity for native chemical ( chemical ) receptors , whereas chemical ( 3 ) show high affinity for the gene subtype of chemical receptors and much lower affinity for the gene subtype of genes .	T7	T26	13129570
NA	CHEMICAL	GENE-Y	14	11	As an attempt to develop new pharmacological tools for studies of gene receptors , chemical ( 4a ) was designed as a structural hybrid between 1 and 3 .	T9	T27	13129570
NA	CHEMICAL	GENE-Y	20	7	4a was shown to be a potent gene agonist and a high affinity ligand and to indiscriminately bind to the chemical receptor subtypes gene with lower affinities .	T10	T28	13129570
NA	CHEMICAL	GENE-N	20	3	4a was shown to be a potent gene agonist and a high affinity ligand and to indiscriminately bind to the chemical receptor subtypes gene with lower affinities .	T10	T29	13129570
NA	CHEMICAL	GENE-N	20	23	4a was shown to be a potent gene agonist and a high affinity ligand and to indiscriminately bind to the chemical receptor subtypes gene with lower affinities .	T10	T30	13129570
NA	CHEMICAL	GENE-N	30	18	Compounds 4b-h were either inactive ( 4e , f ) or weaker than 4a as affinity ligands for gene and gene with relative potencies comparable with those of the corresponding chemical analogues as chemical receptor agonists .	T2	T32	13129570
NA	CHEMICAL	GENE-Y	30	20	Compounds 4b-h were either inactive ( 4e , f ) or weaker than 4a as affinity ligands for gene and gene with relative potencies comparable with those of the corresponding chemical analogues as chemical receptor agonists .	T2	T19	13129570
NA	CHEMICAL	GENE-N	30	10	Compounds 4b-h were either inactive ( 4e , f ) or weaker than 4a as affinity ligands for gene and gene with relative potencies comparable with those of the corresponding chemical analogues as chemical receptor agonists .	T2	T20	13129570
NA	CHEMICAL	GENE-N	18	18	Compounds 4b-h were either inactive ( 4e , f ) or weaker than 4a as affinity ligands for gene and gene with relative potencies comparable with those of the corresponding chemical analogues as chemical receptor agonists .	T3	T32	13129570
NA	CHEMICAL	GENE-Y	18	20	Compounds 4b-h were either inactive ( 4e , f ) or weaker than 4a as affinity ligands for gene and gene with relative potencies comparable with those of the corresponding chemical analogues as chemical receptor agonists .	T3	T19	13129570
NA	CHEMICAL	GENE-N	18	10	Compounds 4b-h were either inactive ( 4e , f ) or weaker than 4a as affinity ligands for gene and gene with relative potencies comparable with those of the corresponding chemical analogues as chemical receptor agonists .	T3	T20	13129570
NA	CHEMICAL	GENE-Y	2	0	gene and gene chemical kinases are important targets for therapy of different types of leukemia .	T1	T3	23567961
NA	CHEMICAL	GENE-N	2	2	gene and gene chemical kinases are important targets for therapy of different types of leukemia .	T1	T13	23567961
NA	CHEMICAL	GENE-N	2	4	gene and gene chemical kinases are important targets for therapy of different types of leukemia .	T1	T6	23567961
NA	CHEMICAL	GENE-N	0	8	chemical synthetase isoforms 1 , 4 , and 5 are present in different subcellular membranes in rat liver and can be inhibited independently .	T10	T38	11319232
NA	CHEMICAL	GENE-N	5	6	Inhibition studies have suggested that chemical synthetase ( gene , EC ) isoforms might regulate the use of chemical by different metabolic pathways .	T6	T27	11319232
NA	CHEMICAL	GENE-N	5	8	Inhibition studies have suggested that chemical synthetase ( gene , EC ) isoforms might regulate the use of chemical by different metabolic pathways .	T6	T30	11319232
NA	CHEMICAL	GENE-N	18	6	Inhibition studies have suggested that chemical synthetase ( gene , EC ) isoforms might regulate the use of chemical by different metabolic pathways .	T1	T27	11319232
NA	CHEMICAL	GENE-N	18	8	Inhibition studies have suggested that chemical synthetase ( gene , EC ) isoforms might regulate the use of chemical by different metabolic pathways .	T1	T30	11319232
CPR:4	CHEMICAL	GENE-Y	5	10	Consistent with these locations , chemical , an inhibitor of gene , inhibited gene activity 47 % in MAM and 28 % in endoplasmic reticulum .	T7	T31	11319232
CPR:4	CHEMICAL	GENE-N	5	13	Consistent with these locations , chemical , an inhibitor of gene , inhibited gene activity 47 % in MAM and 28 % in endoplasmic reticulum .	T7	T32	11319232
CPR:4	CHEMICAL	GENE-Y	0	4	chemical , a second gene inhibitor , inhibited gene activity < 10 % in microsomes and mitochondria and 45 % in MAM .	T8	T33	11319232
CPR:4	CHEMICAL	GENE-N	0	8	chemical , a second gene inhibitor , inhibited gene activity < 10 % in microsomes and mitochondria and 45 % in MAM .	T8	T34	11319232
CPR:4	CHEMICAL	GENE-Y	0	7	chemical , a competitive inhibitor of both gene and gene , inhibited gene activity similarly in endoplasmic reticulum , MAM , and mitochondria , suggesting that a hitherto unidentified chemical-sensitive gene is present in mitochondria .	T9	T35	11319232
CPR:4	CHEMICAL	GENE-Y	0	9	chemical , a competitive inhibitor of both gene and gene , inhibited gene activity similarly in endoplasmic reticulum , MAM , and mitochondria , suggesting that a hitherto unidentified chemical-sensitive gene is present in mitochondria .	T9	T36	11319232
CPR:4	CHEMICAL	GENE-N	0	12	chemical , a competitive inhibitor of both gene and gene , inhibited gene activity similarly in endoplasmic reticulum , MAM , and mitochondria , suggesting that a hitherto unidentified chemical-sensitive gene is present in mitochondria .	T9	T37	11319232
NA	CHEMICAL	GENE-N	0	30	chemical , a competitive inhibitor of both gene and gene , inhibited gene activity similarly in endoplasmic reticulum , MAM , and mitochondria , suggesting that a hitherto unidentified chemical-sensitive gene is present in mitochondria .	T9	T11	11319232
NA	CHEMICAL	GENE-Y	2	7	chemical , a competitive inhibitor of both gene and gene , inhibited gene activity similarly in endoplasmic reticulum , MAM , and mitochondria , suggesting that a hitherto unidentified chemical-sensitive gene is present in mitochondria .	T2	T35	11319232
NA	CHEMICAL	GENE-Y	2	9	chemical , a competitive inhibitor of both gene and gene , inhibited gene activity similarly in endoplasmic reticulum , MAM , and mitochondria , suggesting that a hitherto unidentified chemical-sensitive gene is present in mitochondria .	T2	T36	11319232
NA	CHEMICAL	GENE-N	2	12	chemical , a competitive inhibitor of both gene and gene , inhibited gene activity similarly in endoplasmic reticulum , MAM , and mitochondria , suggesting that a hitherto unidentified chemical-sensitive gene is present in mitochondria .	T2	T37	11319232
NA	CHEMICAL	GENE-N	2	30	chemical , a competitive inhibitor of both gene and gene , inhibited gene activity similarly in endoplasmic reticulum , MAM , and mitochondria , suggesting that a hitherto unidentified chemical-sensitive gene is present in mitochondria .	T2	T11	11319232
CPR:3	CHEMICAL	GENE-Y	6	17	Re-feeding normal chow or a high chemical diet for 24 h after a 48-h fast increased both gene and gene protein expression 1.5-2.0-fold , consistent with inhibition studies .	T3	T17	11319232
CPR:3	CHEMICAL	GENE-Y	6	19	Re-feeding normal chow or a high chemical diet for 24 h after a 48-h fast increased both gene and gene protein expression 1.5-2.0-fold , consistent with inhibition studies .	T3	T18	11319232
CPR:9	CHEMICAL	GENE-Y	11	4	These results suggest that gene and gene may be linked to chemical synthesis .	T4	T19	11319232
CPR:9	CHEMICAL	GENE-Y	11	6	These results suggest that gene and gene may be linked to chemical synthesis .	T4	T20	11319232
CPR:4	CHEMICAL	GENE-Y	4	12	Synthesis and evaluation of chemical linked prodrugs of chemical , a clinical gene inhibitor .	T8	T11	23578688
CPR:4	CHEMICAL	GENE-Y	8	12	Synthesis and evaluation of chemical linked prodrugs of chemical , a clinical gene inhibitor .	T9	T11	23578688
CPR:4	CHEMICAL	GENE-Y	3	14	A series of chemical linked prodrugs of 1 ( chemical ) , a clinical gene inhibitor , were synthesized and evaluated .	T1	T10	23578688
CPR:4	CHEMICAL	GENE-Y	9	14	A series of chemical linked prodrugs of 1 ( chemical ) , a clinical gene inhibitor , were synthesized and evaluated .	T6	T10	23578688
NA	CHEMICAL	GENE-N	15	7	The cDNAs of the full-length version of gene revealed that the gene gene consists of a 1005-bp ORF , which encodes 334 chemical residues , and 67- and 227-bp 5 ' and 3 ' UTRs , respectively .	T8	T24	23159790
NA	CHEMICAL	GENE-N	15	11	The cDNAs of the full-length version of gene revealed that the gene gene consists of a 1005-bp ORF , which encodes 334 chemical residues , and 67- and 227-bp 5 ' and 3 ' UTRs , respectively .	T8	T25	23159790
NA	CHEMICAL	GENE-N	23	1	The gene structure , which is composed of seven α-helixes and eleven β-strands , contains the β-strand/ɛchemical/α-helix structural motif , which contains the chemical-X-Ser-X-chemical consensus sequence .	T3	T15	23159790
NA	CHEMICAL	GENE-N	16	1	The gene structure , which is composed of seven α-helixes and eleven β-strands , contains the β-strand/ɛchemical/α-helix structural motif , which contains the chemical-X-Ser-X-chemical consensus sequence .	T4	T15	23159790
NA	CHEMICAL	GENE-N	23	1	The gene structure , which is composed of seven α-helixes and eleven β-strands , contains the β-strand/ɛchemical/α-helix structural motif , which contains the chemical-X-Ser-X-chemical consensus sequence .	T5	T15	23159790
NA	CHEMICAL	GENE-N	6	13	Moreover , the observed insertion of chemical into the lid domain of the gene structure is rare .	T6	T19	23159790
NA	CHEMICAL	GENE-N	3	0	gene subtype causing chemical-mediated vascular relaxation in rats .	T24	T33	8819507
NA	CHEMICAL	GENE-Y	2	45	Ka values in nM for chemical ( 19 ) , chemical ( 265 ) , chemical ( 197 ) , chemical ( 128 ) , and chemical ( 1531 ) for blocking relaxation in rat arteries were consistent with their affinities for binding at the gene subtype .	T19	T25	8819507
NA	CHEMICAL	GENE-Y	10	45	Ka values in nM for chemical ( 19 ) , chemical ( 265 ) , chemical ( 197 ) , chemical ( 128 ) , and chemical ( 1531 ) for blocking relaxation in rat arteries were consistent with their affinities for binding at the gene subtype .	T20	T25	8819507
NA	CHEMICAL	GENE-Y	15	45	Ka values in nM for chemical ( 19 ) , chemical ( 265 ) , chemical ( 197 ) , chemical ( 128 ) , and chemical ( 1531 ) for blocking relaxation in rat arteries were consistent with their affinities for binding at the gene subtype .	T21	T25	8819507
NA	CHEMICAL	GENE-Y	2	45	Ka values in nM for chemical ( 19 ) , chemical ( 265 ) , chemical ( 197 ) , chemical ( 128 ) , and chemical ( 1531 ) for blocking relaxation in rat arteries were consistent with their affinities for binding at the gene subtype .	T22	T25	8819507
NA	CHEMICAL	GENE-Y	2	45	Ka values in nM for chemical ( 19 ) , chemical ( 265 ) , chemical ( 197 ) , chemical ( 128 ) , and chemical ( 1531 ) for blocking relaxation in rat arteries were consistent with their affinities for binding at the gene subtype .	T23	T25	8819507
NA	CHEMICAL	GENE-Y	3	13	Ka values for chemical and chemical , drugs distinguishing the alpha-2D from the gene subtype , were significantly higher in blocking relaxation of rat arteries compared with pig arteries , suggesting the gene subtype mediates chemical-induced relaxation in rat arteries .	T1	T26	8819507
NA	CHEMICAL	GENE-Y	3	32	Ka values for chemical and chemical , drugs distinguishing the alpha-2D from the gene subtype , were significantly higher in blocking relaxation of rat arteries compared with pig arteries , suggesting the gene subtype mediates chemical-induced relaxation in rat arteries .	T1	T27	8819507
NA	CHEMICAL	GENE-Y	5	13	Ka values for chemical and chemical , drugs distinguishing the alpha-2D from the gene subtype , were significantly higher in blocking relaxation of rat arteries compared with pig arteries , suggesting the gene subtype mediates chemical-induced relaxation in rat arteries .	T2	T26	8819507
NA	CHEMICAL	GENE-Y	5	32	Ka values for chemical and chemical , drugs distinguishing the alpha-2D from the gene subtype , were significantly higher in blocking relaxation of rat arteries compared with pig arteries , suggesting the gene subtype mediates chemical-induced relaxation in rat arteries .	T2	T27	8819507
NA	CHEMICAL	GENE-Y	35	13	Ka values for chemical and chemical , drugs distinguishing the alpha-2D from the gene subtype , were significantly higher in blocking relaxation of rat arteries compared with pig arteries , suggesting the gene subtype mediates chemical-induced relaxation in rat arteries .	T3	T26	8819507
NA	CHEMICAL	GENE-Y	35	32	Ka values for chemical and chemical , drugs distinguishing the alpha-2D from the gene subtype , were significantly higher in blocking relaxation of rat arteries compared with pig arteries , suggesting the gene subtype mediates chemical-induced relaxation in rat arteries .	T3	T27	8819507
NA	CHEMICAL	GENE-N	2	3	We used chemical to oppose gene-mediated inhibition of chemical formation by directly stimulating chemical formation in endothelium .	T4	T28	8819507
NA	CHEMICAL	GENE-N	8	3	We used chemical to oppose gene-mediated inhibition of chemical formation by directly stimulating chemical formation in endothelium .	T5	T28	8819507
NA	CHEMICAL	GENE-N	13	3	We used chemical to oppose gene-mediated inhibition of chemical formation by directly stimulating chemical formation in endothelium .	T6	T28	8819507
CPR:6	CHEMICAL	GENE-N	4	1	The gene antagonist , chemical , is selective for gene .	T2	T6	14680444
CPR:6	CHEMICAL	GENE-N	4	9	The gene antagonist , chemical , is selective for gene .	T2	T7	14680444
NA	CHEMICAL	GENE-Y	3	4	Prosocial effects of chemical in two mouse models of autism spectrum disorders .	T10	T20	23643748
NA	CHEMICAL	GENE-Y	4	12	Clinical evidence suggests that chemical treatment improves social deficits and repetitive behavior in autism spectrum disorders ( ASDs ) .	T4	T15	23643748
NA	CHEMICAL	GENE-Y	1	6	Acute chemical did not increase sociability in BALB/cByJ ; however , sub-chronic gene had significant prosocial effects in both BALB/cByJ and C58/J .	T6	T17	23643748
NA	CHEMICAL	GENE-Y	1	6	Acute chemical did not increase sociability in BALB/cByJ ; however , sub-chronic gene had significant prosocial effects in both BALB/cByJ and C58/J .	T6	T18	23643748
NA	CHEMICAL	GENE-Y	6	6	Acute chemical did not increase sociability in BALB/cByJ ; however , sub-chronic gene had significant prosocial effects in both BALB/cByJ and C58/J .	T7	T17	23643748
NA	CHEMICAL	GENE-Y	6	6	Acute chemical did not increase sociability in BALB/cByJ ; however , sub-chronic gene had significant prosocial effects in both BALB/cByJ and C58/J .	T7	T18	23643748
NA	CHEMICAL	GENE-Y	9	11	Increased sociability was observed 24 hours following the final chemical dose in BALB/cByJ , while prosocial effects of gene emerged 1-2 weeks post-treatment in C58/J .	T8	T19	23643748
NA	CHEMICAL	GENE-Y	11	11	Increased sociability was observed 24 hours following the final chemical dose in BALB/cByJ , while prosocial effects of gene emerged 1-2 weeks post-treatment in C58/J .	T9	T19	23643748
NA	CHEMICAL	GENE-Y	3	7	Furthermore , acute chemical decreased motor stereotypy in C58/J and did not induce hypoactivity or anxiolytic-like effects in an open field test .	T1	T11	23643748
NA	CHEMICAL	GENE-Y	4	13	This study demonstrates that chemical administration can attenuate social deficits and repetitive behavior in mouse models of ASD , dependent on dose regimen and genotype .	T2	T12	23643748
NA	CHEMICAL	GENE-Y	27	3	Few targets like gene ( gene ) mutations and gene ( gene ) gene rearrangements have successfully been targeted with gene gene inhibitors ( TKIs ) and chemical , respectively .	T1	T2	23608109
NA	CHEMICAL	GENE-Y	27	5	Few targets like gene ( gene ) mutations and gene ( gene ) gene rearrangements have successfully been targeted with gene gene inhibitors ( TKIs ) and chemical , respectively .	T1	T3	23608109
NA	CHEMICAL	GENE-Y	27	9	Few targets like gene ( gene ) mutations and gene ( gene ) gene rearrangements have successfully been targeted with gene gene inhibitors ( TKIs ) and chemical , respectively .	T1	T4	23608109
NA	CHEMICAL	GENE-Y	27	11	Few targets like gene ( gene ) mutations and gene ( gene ) gene rearrangements have successfully been targeted with gene gene inhibitors ( TKIs ) and chemical , respectively .	T1	T5	23608109
NA	CHEMICAL	GENE-Y	27	20	Few targets like gene ( gene ) mutations and gene ( gene ) gene rearrangements have successfully been targeted with gene gene inhibitors ( TKIs ) and chemical , respectively .	T1	T6	23608109
NA	CHEMICAL	GENE-N	27	21	Few targets like gene ( gene ) mutations and gene ( gene ) gene rearrangements have successfully been targeted with gene gene inhibitors ( TKIs ) and chemical , respectively .	T1	T7	23608109
CPR:3	CHEMICAL	GENE-Y	6	1	Activating gene-gene signaling pathway contributes to chemical protection against gene-induced human endothelial cells apoptosis .	T12	T30	23538162
CPR:3	CHEMICAL	GENE-N	6	1	Activating gene-gene signaling pathway contributes to chemical protection against gene-induced human endothelial cells apoptosis .	T12	T31	23538162
CPR:4	CHEMICAL	GENE-Y	6	9	Activating gene-gene signaling pathway contributes to chemical protection against gene-induced human endothelial cells apoptosis .	T12	T29	23538162
NA	CHEMICAL	GENE-Y	16	9	Present study attempted to evaluate the potential mechanisms of gene-mediated insult and the protective effects of chemical on human endothelial cells .	T4	T18	23538162
CPR:4	CHEMICAL	GENE-Y	0	3	chemical attenuated the gene-associated mitochondrial apoptotic events , accompanied by inhibiting gene expression followed by intracellular reactive chemical species generation , and protein nitrotyrosination .	T5	T19	23538162
CPR:4	CHEMICAL	GENE-Y	0	11	chemical attenuated the gene-associated mitochondrial apoptotic events , accompanied by inhibiting gene expression followed by intracellular reactive chemical species generation , and protein nitrotyrosination .	T5	T20	23538162
NA	CHEMICAL	GENE-Y	17	3	chemical attenuated the gene-associated mitochondrial apoptotic events , accompanied by inhibiting gene expression followed by intracellular reactive chemical species generation , and protein nitrotyrosination .	T6	T19	23538162
NA	CHEMICAL	GENE-Y	17	11	chemical attenuated the gene-associated mitochondrial apoptotic events , accompanied by inhibiting gene expression followed by intracellular reactive chemical species generation , and protein nitrotyrosination .	T6	T20	23538162
CPR:6	CHEMICAL	GENE-Y	11	6	These protective effects were abolished by gene ( gene ) antagonist chemical or gene inhibitor chemical rather than chemical receptor α antagonist chemical .	T7	T21	23538162
CPR:6	CHEMICAL	GENE-Y	11	8	These protective effects were abolished by gene ( gene ) antagonist chemical or gene inhibitor chemical rather than chemical receptor α antagonist chemical .	T7	T22	23538162
NA	CHEMICAL	GENE-N	11	13	These protective effects were abolished by gene ( gene ) antagonist chemical or gene inhibitor chemical rather than chemical receptor α antagonist chemical .	T7	T23	23538162
NA	CHEMICAL	GENE-Y	11	20	These protective effects were abolished by gene ( gene ) antagonist chemical or gene inhibitor chemical rather than chemical receptor α antagonist chemical .	T7	T24	23538162
NA	CHEMICAL	GENE-Y	15	6	These protective effects were abolished by gene ( gene ) antagonist chemical or gene inhibitor chemical rather than chemical receptor α antagonist chemical .	T8	T21	23538162
NA	CHEMICAL	GENE-Y	15	8	These protective effects were abolished by gene ( gene ) antagonist chemical or gene inhibitor chemical rather than chemical receptor α antagonist chemical .	T8	T22	23538162
CPR:4	CHEMICAL	GENE-N	15	13	These protective effects were abolished by gene ( gene ) antagonist chemical or gene inhibitor chemical rather than chemical receptor α antagonist chemical .	T8	T23	23538162
NA	CHEMICAL	GENE-Y	15	20	These protective effects were abolished by gene ( gene ) antagonist chemical or gene inhibitor chemical rather than chemical receptor α antagonist chemical .	T8	T24	23538162
NA	CHEMICAL	GENE-Y	18	6	These protective effects were abolished by gene ( gene ) antagonist chemical or gene inhibitor chemical rather than chemical receptor α antagonist chemical .	T9	T21	23538162
NA	CHEMICAL	GENE-Y	18	8	These protective effects were abolished by gene ( gene ) antagonist chemical or gene inhibitor chemical rather than chemical receptor α antagonist chemical .	T9	T22	23538162
NA	CHEMICAL	GENE-N	18	13	These protective effects were abolished by gene ( gene ) antagonist chemical or gene inhibitor chemical rather than chemical receptor α antagonist chemical .	T9	T23	23538162
NA	CHEMICAL	GENE-Y	18	20	These protective effects were abolished by gene ( gene ) antagonist chemical or gene inhibitor chemical rather than chemical receptor α antagonist chemical .	T9	T24	23538162
NA	CHEMICAL	GENE-Y	22	6	These protective effects were abolished by gene ( gene ) antagonist chemical or gene inhibitor chemical rather than chemical receptor α antagonist chemical .	T10	T21	23538162
NA	CHEMICAL	GENE-Y	22	8	These protective effects were abolished by gene ( gene ) antagonist chemical or gene inhibitor chemical rather than chemical receptor α antagonist chemical .	T10	T22	23538162
NA	CHEMICAL	GENE-N	22	13	These protective effects were abolished by gene ( gene ) antagonist chemical or gene inhibitor chemical rather than chemical receptor α antagonist chemical .	T10	T23	23538162
CPR:6	CHEMICAL	GENE-Y	22	20	These protective effects were abolished by gene ( gene ) antagonist chemical or gene inhibitor chemical rather than chemical receptor α antagonist chemical .	T10	T24	23538162
CPR:4	CHEMICAL	GENE-Y	7	10	Taken together , our results suggested that chemical protected against gene-induced apoptosis at least in part by two complementary gene-dependent gene phosphorylation pathways : ( 1 ) down-regulating gene initiated protein nitrotyrosination , and ( 2 ) inhibiting mitochondrial apoptotic cascades .	T11	T25	23538162
NA	CHEMICAL	GENE-Y	7	19	Taken together , our results suggested that chemical protected against gene-induced apoptosis at least in part by two complementary gene-dependent gene phosphorylation pathways : ( 1 ) down-regulating gene initiated protein nitrotyrosination , and ( 2 ) inhibiting mitochondrial apoptotic cascades .	T11	T26	23538162
CPR:3	CHEMICAL	GENE-N	7	20	Taken together , our results suggested that chemical protected against gene-induced apoptosis at least in part by two complementary gene-dependent gene phosphorylation pathways : ( 1 ) down-regulating gene initiated protein nitrotyrosination , and ( 2 ) inhibiting mitochondrial apoptotic cascades .	T11	T27	23538162
CPR:4	CHEMICAL	GENE-Y	7	25	Taken together , our results suggested that chemical protected against gene-induced apoptosis at least in part by two complementary gene-dependent gene phosphorylation pathways : ( 1 ) down-regulating gene initiated protein nitrotyrosination , and ( 2 ) inhibiting mitochondrial apoptotic cascades .	T11	T28	23538162
NA	CHEMICAL	GENE-Y	0	6	chemical induces atherosclerotic plaque vulnerability in gene-knockout mice .	T14	T25	23270965
NA	CHEMICAL	GENE-Y	6	16	In this study , we investigated chemical-induced atherosclerotic plaque vulnerability ( possibility of rupture ) in gene-knockout ( gene ( -/- ) ) mice .	T7	T23	23270965
NA	CHEMICAL	GENE-Y	6	18	In this study , we investigated chemical-induced atherosclerotic plaque vulnerability ( possibility of rupture ) in gene-knockout ( gene ( -/- ) ) mice .	T7	T24	23270965
CPR:3	CHEMICAL	GENE-Y	26	12	Furthermore , compared with control groups , the plaque endothelium level of gene was 3-fold increased and the liver level of gene was 17.4-fold increased by chemical-HD .	T2	T15	23270965
CPR:3	CHEMICAL	GENE-Y	26	21	Furthermore , compared with control groups , the plaque endothelium level of gene was 3-fold increased and the liver level of gene was 17.4-fold increased by chemical-HD .	T2	T16	23270965
CPR:3	CHEMICAL	GENE-N	32	12	Meanwhile , the serum level of KC ( a functional homolog of gene and the main proinflammatory gene in mice ) in gene ( -/- ) mice was up to 357pg/ml in chemical-HD treated group .	T3	T17	23270965
CPR:3	CHEMICAL	GENE-N	32	17	Meanwhile , the serum level of KC ( a functional homolog of gene and the main proinflammatory gene in mice ) in gene ( -/- ) mice was up to 357pg/ml in chemical-HD treated group .	T3	T18	23270965
NA	CHEMICAL	GENE-Y	32	8	Meanwhile , the serum level of KC ( a functional homolog of gene and the main proinflammatory gene in mice ) in gene ( -/- ) mice was up to 357pg/ml in chemical-HD treated group .	T3	T19	23270965
NA	CHEMICAL	GENE-N	3	1	Cerebral gene occupancy in Schizophrenic patients treated with chemical or chemical .	T14	T18	15358979
NA	CHEMICAL	GENE-N	3	1	Cerebral gene occupancy in Schizophrenic patients treated with chemical or chemical .	T15	T18	15358979
NA	CHEMICAL	GENE-N	5	12	We report the results of a double-blind , randomized prospective trial on gene occupancy and the clinical effects of chemical versus chemical in a sample of neuroleptic-refractory schizophrenic patients .	T3	T17	15358979
NA	CHEMICAL	GENE-N	5	12	We report the results of a double-blind , randomized prospective trial on gene occupancy and the clinical effects of chemical versus chemical in a sample of neuroleptic-refractory schizophrenic patients .	T4	T17	15358979
CPR:4	CHEMICAL	GENE-Y	4	10	In mechanistic studies , chemical decreased the protein level of gene , which might be the possible molecular mechanism of chemical efficacy on the growth inhibition in SGC-7901 cells .	T5	T11	22619007
NA	CHEMICAL	GENE-Y	20	10	In mechanistic studies , chemical decreased the protein level of gene , which might be the possible molecular mechanism of chemical efficacy on the growth inhibition in SGC-7901 cells .	T6	T11	22619007
CPR:3	CHEMICAL	GENE-Y	3	8	In addition , chemical caused an increase in gene and gene protein level as well as mRNA levels .	T7	T12	22619007
CPR:3	CHEMICAL	GENE-Y	3	10	In addition , chemical caused an increase in gene and gene protein level as well as mRNA levels .	T7	T13	22619007
CPR:3	CHEMICAL	GENE-Y	6	15	It has been reported that oligomeric chemical of lotus seedpod ( LSOPC ) is effective in the alleviation of Alzheimer 's disease and diabetes through its antioxidant and gene-potentiating activities .	T2	T10	23411272
NA	CHEMICAL	GENE-Y	10	8	This study investigated the anti-glycative activity of LSOPC in a gene ( gene ) -chemical model .	T1	T11	23411272
NA	CHEMICAL	GENE-Y	10	12	This study investigated the anti-glycative activity of LSOPC in a gene ( gene ) -chemical model .	T1	T12	23411272
NA	CHEMICAL	GENE-N	9	14	A structural and functional perspective into the mechanism of chemical-sensitizers that target the cardiac gene .	T24	T42	20801130
NA	CHEMICAL	GENE-N	1	5	The chemical dependent interaction between gene ( gene ) and gene ( gene ) triggers contraction in heart muscle .	T10	T35	20801130
NA	CHEMICAL	GENE-N	1	7	The chemical dependent interaction between gene ( gene ) and gene ( gene ) triggers contraction in heart muscle .	T10	T36	20801130
NA	CHEMICAL	GENE-N	1	10	The chemical dependent interaction between gene ( gene ) and gene ( gene ) triggers contraction in heart muscle .	T10	T37	20801130
NA	CHEMICAL	GENE-N	1	12	The chemical dependent interaction between gene ( gene ) and gene ( gene ) triggers contraction in heart muscle .	T10	T38	20801130
NA	CHEMICAL	GENE-N	3	11	The affinities of chemical and chemical for the regulatory domain of gene were measured in the absence and presence of cTnI by NMR spectroscopy , and chemical was found to bind more strongly than chemical .	T17	T39	20801130
NA	CHEMICAL	GENE-N	5	11	The affinities of chemical and chemical for the regulatory domain of gene were measured in the absence and presence of cTnI by NMR spectroscopy , and chemical was found to bind more strongly than chemical .	T18	T39	20801130
NA	CHEMICAL	GENE-N	26	11	The affinities of chemical and chemical for the regulatory domain of gene were measured in the absence and presence of cTnI by NMR spectroscopy , and chemical was found to bind more strongly than chemical .	T19	T39	20801130
NA	CHEMICAL	GENE-N	34	11	The affinities of chemical and chemical for the regulatory domain of gene were measured in the absence and presence of cTnI by NMR spectroscopy , and chemical was found to bind more strongly than chemical .	T20	T39	20801130
NA	CHEMICAL	GENE-N	0	6	chemical also increased the affinity of gene for gene .	T21	T40	20801130
NA	CHEMICAL	GENE-N	0	8	chemical also increased the affinity of gene for gene .	T21	T41	20801130
NA	CHEMICAL	GENE-N	8	8	The high resolution NMR solution structure of the gene-gene-chemical ternary complex showed that chemical bound at the hydrophobic interface formed by gene and gene making critical interactions with residues such as Arg147 of gene .	T2	T25	20801130
NA	CHEMICAL	GENE-N	8	8	The high resolution NMR solution structure of the gene-gene-chemical ternary complex showed that chemical bound at the hydrophobic interface formed by gene and gene making critical interactions with residues such as Arg147 of gene .	T2	T26	20801130
NA	CHEMICAL	GENE-N	8	21	The high resolution NMR solution structure of the gene-gene-chemical ternary complex showed that chemical bound at the hydrophobic interface formed by gene and gene making critical interactions with residues such as Arg147 of gene .	T2	T27	20801130
NA	CHEMICAL	GENE-N	8	23	The high resolution NMR solution structure of the gene-gene-chemical ternary complex showed that chemical bound at the hydrophobic interface formed by gene and gene making critical interactions with residues such as Arg147 of gene .	T2	T28	20801130
NA	CHEMICAL	GENE-N	8	33	The high resolution NMR solution structure of the gene-gene-chemical ternary complex showed that chemical bound at the hydrophobic interface formed by gene and gene making critical interactions with residues such as Arg147 of gene .	T2	T29	20801130
NA	CHEMICAL	GENE-N	13	8	The high resolution NMR solution structure of the gene-gene-chemical ternary complex showed that chemical bound at the hydrophobic interface formed by gene and gene making critical interactions with residues such as Arg147 of gene .	T3	T25	20801130
NA	CHEMICAL	GENE-N	13	8	The high resolution NMR solution structure of the gene-gene-chemical ternary complex showed that chemical bound at the hydrophobic interface formed by gene and gene making critical interactions with residues such as Arg147 of gene .	T3	T26	20801130
NA	CHEMICAL	GENE-N	13	21	The high resolution NMR solution structure of the gene-gene-chemical ternary complex showed that chemical bound at the hydrophobic interface formed by gene and gene making critical interactions with residues such as Arg147 of gene .	T3	T27	20801130
NA	CHEMICAL	GENE-N	13	23	The high resolution NMR solution structure of the gene-gene-chemical ternary complex showed that chemical bound at the hydrophobic interface formed by gene and gene making critical interactions with residues such as Arg147 of gene .	T3	T28	20801130
NA	CHEMICAL	GENE-N	13	33	The high resolution NMR solution structure of the gene-gene-chemical ternary complex showed that chemical bound at the hydrophobic interface formed by gene and gene making critical interactions with residues such as Arg147 of gene .	T3	T29	20801130
NA	CHEMICAL	GENE-N	8	4	In the absence of gene , docking localized chemical to the same position in the hydrophobic groove of gene .	T4	T30	20801130
NA	CHEMICAL	GENE-N	8	18	In the absence of gene , docking localized chemical to the same position in the hydrophobic groove of gene .	T4	T31	20801130
CPR:3	CHEMICAL	GENE-Y	2	0	gene inhibitors chemical and chemical suppressed gene ( gene ) expression in murine primary splenocytes .	T14	T29	10207608
CPR:4	CHEMICAL	GENE-Y	2	6	gene inhibitors chemical and chemical suppressed gene ( gene ) expression in murine primary splenocytes .	T14	T30	10207608
CPR:4	CHEMICAL	GENE-Y	2	8	gene inhibitors chemical and chemical suppressed gene ( gene ) expression in murine primary splenocytes .	T14	T31	10207608
CPR:4	CHEMICAL	GENE-Y	4	0	gene inhibitors chemical and chemical suppressed gene ( gene ) expression in murine primary splenocytes .	T15	T29	10207608
CPR:4	CHEMICAL	GENE-Y	4	6	gene inhibitors chemical and chemical suppressed gene ( gene ) expression in murine primary splenocytes .	T15	T30	10207608
CPR:4	CHEMICAL	GENE-Y	4	8	gene inhibitors chemical and chemical suppressed gene ( gene ) expression in murine primary splenocytes .	T15	T31	10207608
CPR:4	CHEMICAL	GENE-Y	14	14	Therefore , the objective of the present study was to investigate the effects of gene inhibitors chemical ( chemical ) and chemical ( chemical ) on gene ( gene ) expression in murine primary splenocytes .	T1	T18	10207608
NA	CHEMICAL	GENE-Y	14	26	Therefore , the objective of the present study was to investigate the effects of gene inhibitors chemical ( chemical ) and chemical ( chemical ) on gene ( gene ) expression in murine primary splenocytes .	T1	T20	10207608
NA	CHEMICAL	GENE-Y	14	28	Therefore , the objective of the present study was to investigate the effects of gene inhibitors chemical ( chemical ) and chemical ( chemical ) on gene ( gene ) expression in murine primary splenocytes .	T1	T21	10207608
CPR:4	CHEMICAL	GENE-Y	18	14	Therefore , the objective of the present study was to investigate the effects of gene inhibitors chemical ( chemical ) and chemical ( chemical ) on gene ( gene ) expression in murine primary splenocytes .	T2	T18	10207608
NA	CHEMICAL	GENE-Y	18	26	Therefore , the objective of the present study was to investigate the effects of gene inhibitors chemical ( chemical ) and chemical ( chemical ) on gene ( gene ) expression in murine primary splenocytes .	T2	T20	10207608
NA	CHEMICAL	GENE-Y	18	28	Therefore , the objective of the present study was to investigate the effects of gene inhibitors chemical ( chemical ) and chemical ( chemical ) on gene ( gene ) expression in murine primary splenocytes .	T2	T21	10207608
CPR:4	CHEMICAL	GENE-Y	9	14	Therefore , the objective of the present study was to investigate the effects of gene inhibitors chemical ( chemical ) and chemical ( chemical ) on gene ( gene ) expression in murine primary splenocytes .	T3	T18	10207608
NA	CHEMICAL	GENE-Y	9	26	Therefore , the objective of the present study was to investigate the effects of gene inhibitors chemical ( chemical ) and chemical ( chemical ) on gene ( gene ) expression in murine primary splenocytes .	T3	T20	10207608
NA	CHEMICAL	GENE-Y	9	28	Therefore , the objective of the present study was to investigate the effects of gene inhibitors chemical ( chemical ) and chemical ( chemical ) on gene ( gene ) expression in murine primary splenocytes .	T3	T21	10207608
CPR:4	CHEMICAL	GENE-Y	23	14	Therefore , the objective of the present study was to investigate the effects of gene inhibitors chemical ( chemical ) and chemical ( chemical ) on gene ( gene ) expression in murine primary splenocytes .	T4	T18	10207608
NA	CHEMICAL	GENE-Y	23	26	Therefore , the objective of the present study was to investigate the effects of gene inhibitors chemical ( chemical ) and chemical ( chemical ) on gene ( gene ) expression in murine primary splenocytes .	T4	T20	10207608
NA	CHEMICAL	GENE-Y	23	28	Therefore , the objective of the present study was to investigate the effects of gene inhibitors chemical ( chemical ) and chemical ( chemical ) on gene ( gene ) expression in murine primary splenocytes .	T4	T21	10207608
CPR:4	CHEMICAL	GENE-Y	6	13	Pretreatment of the splenocytes with both chemical and chemical suppressed chemical plus ionomycin-induced gene secretion in a concentration-dependent manner .	T5	T22	10207608
CPR:4	CHEMICAL	GENE-Y	8	13	Pretreatment of the splenocytes with both chemical and chemical suppressed chemical plus ionomycin-induced gene secretion in a concentration-dependent manner .	T6	T22	10207608
CPR:3	CHEMICAL	GENE-Y	10	13	Pretreatment of the splenocytes with both chemical and chemical suppressed chemical plus ionomycin-induced gene secretion in a concentration-dependent manner .	T7	T22	10207608
CPR:4	CHEMICAL	GENE-Y	12	5	Inhibition > 90 % of gene secretion was observed at 1 microM chemical and 10 microM chemical compared to the respective vehicle control .	T8	T23	10207608
CPR:4	CHEMICAL	GENE-Y	16	5	Inhibition > 90 % of gene secretion was observed at 1 microM chemical and 10 microM chemical compared to the respective vehicle control .	T9	T23	10207608
CPR:4	CHEMICAL	GENE-Y	24	2	Likewise , gene steady-state mRNA expression was inhibited by both gene inhibitors in a concentration-dependent fashion with > 90 % inhibition at 1 microM chemical and 20 microM chemical .	T10	T24	10207608
CPR:4	CHEMICAL	GENE-Y	24	10	Likewise , gene steady-state mRNA expression was inhibited by both gene inhibitors in a concentration-dependent fashion with > 90 % inhibition at 1 microM chemical and 20 microM chemical .	T10	T25	10207608
CPR:4	CHEMICAL	GENE-Y	28	2	Likewise , gene steady-state mRNA expression was inhibited by both gene inhibitors in a concentration-dependent fashion with > 90 % inhibition at 1 microM chemical and 20 microM chemical .	T11	T24	10207608
CPR:4	CHEMICAL	GENE-Y	28	10	Likewise , gene steady-state mRNA expression was inhibited by both gene inhibitors in a concentration-dependent fashion with > 90 % inhibition at 1 microM chemical and 20 microM chemical .	T11	T25	10207608
CPR:4	CHEMICAL	GENE-Y	9	7	Taken together , these data demonstrated that gene inhibitors chemical and chemical are robust inhibitors of gene expression at both the mRNA and protein levels in murine splenocytes .	T12	T27	10207608
CPR:4	CHEMICAL	GENE-Y	9	16	Taken together , these data demonstrated that gene inhibitors chemical and chemical are robust inhibitors of gene expression at both the mRNA and protein levels in murine splenocytes .	T12	T28	10207608
CPR:4	CHEMICAL	GENE-Y	11	7	Taken together , these data demonstrated that gene inhibitors chemical and chemical are robust inhibitors of gene expression at both the mRNA and protein levels in murine splenocytes .	T13	T27	10207608
CPR:4	CHEMICAL	GENE-Y	11	16	Taken together , these data demonstrated that gene inhibitors chemical and chemical are robust inhibitors of gene expression at both the mRNA and protein levels in murine splenocytes .	T13	T28	10207608
CPR:4	CHEMICAL	GENE-N	1	6	Apple chemical suppress antigen presentation of gene by THP-1-derived dendritic cells .	T6	T24	23411172
CPR:4	CHEMICAL	GENE-N	3	0	A significant decrease in gene expression was observed in the AP and fractionated chemical-treated cells in the presence of gene ( gene ) , but no effect on gene expression was observed .	T2	T10	23411172
NA	CHEMICAL	GENE-N	3	3	A significant decrease in gene expression was observed in the AP and fractionated chemical-treated cells in the presence of gene ( gene ) , but no effect on gene expression was observed .	T2	T11	23411172
NA	CHEMICAL	GENE-N	3	0	A significant decrease in gene expression was observed in the AP and fractionated chemical-treated cells in the presence of gene ( gene ) , but no effect on gene expression was observed .	T2	T12	23411172
NA	CHEMICAL	GENE-N	3	28	A significant decrease in gene expression was observed in the AP and fractionated chemical-treated cells in the presence of gene ( gene ) , but no effect on gene expression was observed .	T2	T13	23411172
CPR:3	CHEMICAL	GENE-N	10	5	Furthermore , the up-regulation of gene and gene was found in the chemical trimers-treated cells in the presence of gene .	T4	T21	23411172
CPR:3	CHEMICAL	GENE-N	10	7	Furthermore , the up-regulation of gene and gene was found in the chemical trimers-treated cells in the presence of gene .	T4	T22	23411172
NA	CHEMICAL	GENE-N	10	19	Furthermore , the up-regulation of gene and gene was found in the chemical trimers-treated cells in the presence of gene .	T4	T23	23411172
NA	CHEMICAL	GENE-Y	13	8	The anti-inflammatory effects of WOE were closely attributed to decreased levels of tissue chemical and gene ( gene ) .	T1	T6	23411171
NA	CHEMICAL	GENE-Y	13	17	The anti-inflammatory effects of WOE were closely attributed to decreased levels of tissue chemical and gene ( gene ) .	T1	T7	23411171
NA	CHEMICAL	GENE-Y	28	23	Further evidence for WOE 's protection is shown in the reduction of lipid oxidation and the increase of antioxidant enzyme activities , including gene ( gene ) , chemical dismutase ( gene ) , and chemical peroxidase ( gene ) in vivo .	T2	T8	23411171
NA	CHEMICAL	GENE-Y	28	25	Further evidence for WOE 's protection is shown in the reduction of lipid oxidation and the increase of antioxidant enzyme activities , including gene ( gene ) , chemical dismutase ( gene ) , and chemical peroxidase ( gene ) in vivo .	T2	T9	23411171
NA	CHEMICAL	GENE-N	28	6	Further evidence for WOE 's protection is shown in the reduction of lipid oxidation and the increase of antioxidant enzyme activities , including gene ( gene ) , chemical dismutase ( gene ) , and chemical peroxidase ( gene ) in vivo .	T2	T10	23411171
NA	CHEMICAL	GENE-N	28	31	Further evidence for WOE 's protection is shown in the reduction of lipid oxidation and the increase of antioxidant enzyme activities , including gene ( gene ) , chemical dismutase ( gene ) , and chemical peroxidase ( gene ) in vivo .	T2	T11	23411171
NA	CHEMICAL	GENE-N	28	36	Further evidence for WOE 's protection is shown in the reduction of lipid oxidation and the increase of antioxidant enzyme activities , including gene ( gene ) , chemical dismutase ( gene ) , and chemical peroxidase ( gene ) in vivo .	T2	T12	23411171
NA	CHEMICAL	GENE-N	28	38	Further evidence for WOE 's protection is shown in the reduction of lipid oxidation and the increase of antioxidant enzyme activities , including gene ( gene ) , chemical dismutase ( gene ) , and chemical peroxidase ( gene ) in vivo .	T2	T13	23411171
NA	CHEMICAL	GENE-Y	35	23	Further evidence for WOE 's protection is shown in the reduction of lipid oxidation and the increase of antioxidant enzyme activities , including gene ( gene ) , chemical dismutase ( gene ) , and chemical peroxidase ( gene ) in vivo .	T3	T8	23411171
NA	CHEMICAL	GENE-Y	35	25	Further evidence for WOE 's protection is shown in the reduction of lipid oxidation and the increase of antioxidant enzyme activities , including gene ( gene ) , chemical dismutase ( gene ) , and chemical peroxidase ( gene ) in vivo .	T3	T9	23411171
NA	CHEMICAL	GENE-N	35	6	Further evidence for WOE 's protection is shown in the reduction of lipid oxidation and the increase of antioxidant enzyme activities , including gene ( gene ) , chemical dismutase ( gene ) , and chemical peroxidase ( gene ) in vivo .	T3	T10	23411171
NA	CHEMICAL	GENE-N	35	31	Further evidence for WOE 's protection is shown in the reduction of lipid oxidation and the increase of antioxidant enzyme activities , including gene ( gene ) , chemical dismutase ( gene ) , and chemical peroxidase ( gene ) in vivo .	T3	T11	23411171
NA	CHEMICAL	GENE-N	35	36	Further evidence for WOE 's protection is shown in the reduction of lipid oxidation and the increase of antioxidant enzyme activities , including gene ( gene ) , chemical dismutase ( gene ) , and chemical peroxidase ( gene ) in vivo .	T3	T12	23411171
NA	CHEMICAL	GENE-N	35	38	Further evidence for WOE 's protection is shown in the reduction of lipid oxidation and the increase of antioxidant enzyme activities , including gene ( gene ) , chemical dismutase ( gene ) , and chemical peroxidase ( gene ) in vivo .	T3	T13	23411171
CPR:4	CHEMICAL	GENE-Y	6	18	Epididymal tissue from wild-type mice responded in vitro to chemical and chemical with increased chemical release , reduced gene release , and increased chemical accumulation .	T4	T24	16835395
CPR:4	CHEMICAL	GENE-Y	6	18	Epididymal tissue from wild-type mice responded in vitro to chemical and chemical with increased chemical release , reduced gene release , and increased chemical accumulation .	T5	T24	16835395
NA	CHEMICAL	GENE-Y	14	18	Epididymal tissue from wild-type mice responded in vitro to chemical and chemical with increased chemical release , reduced gene release , and increased chemical accumulation .	T6	T24	16835395
NA	CHEMICAL	GENE-Y	23	18	Epididymal tissue from wild-type mice responded in vitro to chemical and chemical with increased chemical release , reduced gene release , and increased chemical accumulation .	T7	T24	16835395
NA	CHEMICAL	GENE-Y	8	14	Qualitatively similar but significantly attenuated responses to the chemical were observed in tissue from gene-null mice , an effect that was not associated with changes in gene mRNA expression .	T8	T25	16835395
NA	CHEMICAL	GENE-N	8	6	Qualitatively similar but significantly attenuated responses to the chemical were observed in tissue from gene-null mice , an effect that was not associated with changes in gene mRNA expression .	T8	T26	16835395
NA	CHEMICAL	GENE-Y	0	0	gene gene deletion did not affect gene expression or the ability of chemical to suppress chemical-induced lipolysis .	T1	T12	16835395
NA	CHEMICAL	GENE-Y	0	6	gene gene deletion did not affect gene expression or the ability of chemical to suppress chemical-induced lipolysis .	T1	T13	16835395
NA	CHEMICAL	GENE-Y	15	0	gene gene deletion did not affect gene expression or the ability of chemical to suppress chemical-induced lipolysis .	T2	T12	16835395
NA	CHEMICAL	GENE-Y	15	6	gene gene deletion did not affect gene expression or the ability of chemical to suppress chemical-induced lipolysis .	T2	T13	16835395
CPR:4	CHEMICAL	GENE-Y	0	32	chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) are antimetabolites which are metabolized to their corresponding active forms which inhibit DNA synthesis via inhibition of chemical synthase ( gene ) .	T1	T51	10891536
CPR:4	CHEMICAL	GENE-Y	0	34	chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) are antimetabolites which are metabolized to their corresponding active forms which inhibit DNA synthesis via inhibition of chemical synthase ( gene ) .	T1	T52	10891536
CPR:4	CHEMICAL	GENE-Y	2	32	chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) are antimetabolites which are metabolized to their corresponding active forms which inhibit DNA synthesis via inhibition of chemical synthase ( gene ) .	T16	T51	10891536
CPR:4	CHEMICAL	GENE-Y	2	34	chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) are antimetabolites which are metabolized to their corresponding active forms which inhibit DNA synthesis via inhibition of chemical synthase ( gene ) .	T16	T52	10891536
CPR:4	CHEMICAL	GENE-Y	5	32	chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) are antimetabolites which are metabolized to their corresponding active forms which inhibit DNA synthesis via inhibition of chemical synthase ( gene ) .	T27	T51	10891536
CPR:4	CHEMICAL	GENE-Y	5	34	chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) are antimetabolites which are metabolized to their corresponding active forms which inhibit DNA synthesis via inhibition of chemical synthase ( gene ) .	T27	T52	10891536
CPR:4	CHEMICAL	GENE-Y	7	32	chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) are antimetabolites which are metabolized to their corresponding active forms which inhibit DNA synthesis via inhibition of chemical synthase ( gene ) .	T29	T51	10891536
CPR:4	CHEMICAL	GENE-Y	7	34	chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) are antimetabolites which are metabolized to their corresponding active forms which inhibit DNA synthesis via inhibition of chemical synthase ( gene ) .	T29	T52	10891536
CPR:4	CHEMICAL	GENE-Y	10	32	chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) are antimetabolites which are metabolized to their corresponding active forms which inhibit DNA synthesis via inhibition of chemical synthase ( gene ) .	T30	T51	10891536
CPR:4	CHEMICAL	GENE-Y	10	34	chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) are antimetabolites which are metabolized to their corresponding active forms which inhibit DNA synthesis via inhibition of chemical synthase ( gene ) .	T30	T52	10891536
CPR:4	CHEMICAL	GENE-Y	1	32	chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) are antimetabolites which are metabolized to their corresponding active forms which inhibit DNA synthesis via inhibition of chemical synthase ( gene ) .	T37	T51	10891536
CPR:4	CHEMICAL	GENE-Y	1	34	chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) are antimetabolites which are metabolized to their corresponding active forms which inhibit DNA synthesis via inhibition of chemical synthase ( gene ) .	T37	T52	10891536
NA	CHEMICAL	GENE-Y	31	32	chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) are antimetabolites which are metabolized to their corresponding active forms which inhibit DNA synthesis via inhibition of chemical synthase ( gene ) .	T26	T51	10891536
NA	CHEMICAL	GENE-Y	31	34	chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) are antimetabolites which are metabolized to their corresponding active forms which inhibit DNA synthesis via inhibition of chemical synthase ( gene ) .	T26	T52	10891536
NA	CHEMICAL	GENE-Y	9	13	Analysis of enzyme activities and gene expression associated with chemical metabolism indicated that a significant decrease in chemical phosphoribosyltransferase activity in DLD-1/chemical cells , a 7-fold increase of gene mRNA in DLD-1/chemical cells , and a 37-fold decrease in gene activity of DLD-1/chemical cells were the major mechanisms of drug resistance .	T2	T43	10891536
NA	CHEMICAL	GENE-Y	9	28	Analysis of enzyme activities and gene expression associated with chemical metabolism indicated that a significant decrease in chemical phosphoribosyltransferase activity in DLD-1/chemical cells , a 7-fold increase of gene mRNA in DLD-1/chemical cells , and a 37-fold decrease in gene activity of DLD-1/chemical cells were the major mechanisms of drug resistance .	T2	T44	10891536
NA	CHEMICAL	GENE-Y	9	13	Analysis of enzyme activities and gene expression associated with chemical metabolism indicated that a significant decrease in chemical phosphoribosyltransferase activity in DLD-1/chemical cells , a 7-fold increase of gene mRNA in DLD-1/chemical cells , and a 37-fold decrease in gene activity of DLD-1/chemical cells were the major mechanisms of drug resistance .	T2	T45	10891536
NA	CHEMICAL	GENE-Y	13	13	Analysis of enzyme activities and gene expression associated with chemical metabolism indicated that a significant decrease in chemical phosphoribosyltransferase activity in DLD-1/chemical cells , a 7-fold increase of gene mRNA in DLD-1/chemical cells , and a 37-fold decrease in gene activity of DLD-1/chemical cells were the major mechanisms of drug resistance .	T3	T43	10891536
NA	CHEMICAL	GENE-Y	13	28	Analysis of enzyme activities and gene expression associated with chemical metabolism indicated that a significant decrease in chemical phosphoribosyltransferase activity in DLD-1/chemical cells , a 7-fold increase of gene mRNA in DLD-1/chemical cells , and a 37-fold decrease in gene activity of DLD-1/chemical cells were the major mechanisms of drug resistance .	T3	T44	10891536
NA	CHEMICAL	GENE-Y	13	13	Analysis of enzyme activities and gene expression associated with chemical metabolism indicated that a significant decrease in chemical phosphoribosyltransferase activity in DLD-1/chemical cells , a 7-fold increase of gene mRNA in DLD-1/chemical cells , and a 37-fold decrease in gene activity of DLD-1/chemical cells were the major mechanisms of drug resistance .	T3	T45	10891536
NA	CHEMICAL	GENE-Y	21	13	Analysis of enzyme activities and gene expression associated with chemical metabolism indicated that a significant decrease in chemical phosphoribosyltransferase activity in DLD-1/chemical cells , a 7-fold increase of gene mRNA in DLD-1/chemical cells , and a 37-fold decrease in gene activity of DLD-1/chemical cells were the major mechanisms of drug resistance .	T4	T43	10891536
NA	CHEMICAL	GENE-Y	21	28	Analysis of enzyme activities and gene expression associated with chemical metabolism indicated that a significant decrease in chemical phosphoribosyltransferase activity in DLD-1/chemical cells , a 7-fold increase of gene mRNA in DLD-1/chemical cells , and a 37-fold decrease in gene activity of DLD-1/chemical cells were the major mechanisms of drug resistance .	T4	T44	10891536
NA	CHEMICAL	GENE-Y	21	13	Analysis of enzyme activities and gene expression associated with chemical metabolism indicated that a significant decrease in chemical phosphoribosyltransferase activity in DLD-1/chemical cells , a 7-fold increase of gene mRNA in DLD-1/chemical cells , and a 37-fold decrease in gene activity of DLD-1/chemical cells were the major mechanisms of drug resistance .	T4	T45	10891536
NA	CHEMICAL	GENE-Y	31	13	Analysis of enzyme activities and gene expression associated with chemical metabolism indicated that a significant decrease in chemical phosphoribosyltransferase activity in DLD-1/chemical cells , a 7-fold increase of gene mRNA in DLD-1/chemical cells , and a 37-fold decrease in gene activity of DLD-1/chemical cells were the major mechanisms of drug resistance .	T5	T43	10891536
NA	CHEMICAL	GENE-Y	31	28	Analysis of enzyme activities and gene expression associated with chemical metabolism indicated that a significant decrease in chemical phosphoribosyltransferase activity in DLD-1/chemical cells , a 7-fold increase of gene mRNA in DLD-1/chemical cells , and a 37-fold decrease in gene activity of DLD-1/chemical cells were the major mechanisms of drug resistance .	T5	T44	10891536
NA	CHEMICAL	GENE-Y	31	13	Analysis of enzyme activities and gene expression associated with chemical metabolism indicated that a significant decrease in chemical phosphoribosyltransferase activity in DLD-1/chemical cells , a 7-fold increase of gene mRNA in DLD-1/chemical cells , and a 37-fold decrease in gene activity of DLD-1/chemical cells were the major mechanisms of drug resistance .	T5	T45	10891536
NA	CHEMICAL	GENE-Y	42	13	Analysis of enzyme activities and gene expression associated with chemical metabolism indicated that a significant decrease in chemical phosphoribosyltransferase activity in DLD-1/chemical cells , a 7-fold increase of gene mRNA in DLD-1/chemical cells , and a 37-fold decrease in gene activity of DLD-1/chemical cells were the major mechanisms of drug resistance .	T6	T43	10891536
NA	CHEMICAL	GENE-Y	42	28	Analysis of enzyme activities and gene expression associated with chemical metabolism indicated that a significant decrease in chemical phosphoribosyltransferase activity in DLD-1/chemical cells , a 7-fold increase of gene mRNA in DLD-1/chemical cells , and a 37-fold decrease in gene activity of DLD-1/chemical cells were the major mechanisms of drug resistance .	T6	T44	10891536
NA	CHEMICAL	GENE-Y	42	13	Analysis of enzyme activities and gene expression associated with chemical metabolism indicated that a significant decrease in chemical phosphoribosyltransferase activity in DLD-1/chemical cells , a 7-fold increase of gene mRNA in DLD-1/chemical cells , and a 37-fold decrease in gene activity of DLD-1/chemical cells were the major mechanisms of drug resistance .	T6	T45	10891536
NA	CHEMICAL	GENE-Y	1	5	When DLD-1/chemical cells expressing increased gene mRNA were treated with chemical and chemical for only 4 h , the resistance ratios of DLD-1/chemical cells to parental DLD-1 cells were markedly different for chemical and chemical , suggesting that the cytotoxicity with short-time exposure to chemical is due to a mechanism other than gene inhibition , although the cytotoxicity of chemical in the short-time is low compared to that of long-time exposure .	T13	T46	10891536
NA	CHEMICAL	GENE-Y	1	52	When DLD-1/chemical cells expressing increased gene mRNA were treated with chemical and chemical for only 4 h , the resistance ratios of DLD-1/chemical cells to parental DLD-1 cells were markedly different for chemical and chemical , suggesting that the cytotoxicity with short-time exposure to chemical is due to a mechanism other than gene inhibition , although the cytotoxicity of chemical in the short-time is low compared to that of long-time exposure .	T13	T47	10891536
NA	CHEMICAL	GENE-Y	10	5	When DLD-1/chemical cells expressing increased gene mRNA were treated with chemical and chemical for only 4 h , the resistance ratios of DLD-1/chemical cells to parental DLD-1 cells were markedly different for chemical and chemical , suggesting that the cytotoxicity with short-time exposure to chemical is due to a mechanism other than gene inhibition , although the cytotoxicity of chemical in the short-time is low compared to that of long-time exposure .	T14	T46	10891536
NA	CHEMICAL	GENE-Y	10	52	When DLD-1/chemical cells expressing increased gene mRNA were treated with chemical and chemical for only 4 h , the resistance ratios of DLD-1/chemical cells to parental DLD-1 cells were markedly different for chemical and chemical , suggesting that the cytotoxicity with short-time exposure to chemical is due to a mechanism other than gene inhibition , although the cytotoxicity of chemical in the short-time is low compared to that of long-time exposure .	T14	T47	10891536
NA	CHEMICAL	GENE-Y	12	5	When DLD-1/chemical cells expressing increased gene mRNA were treated with chemical and chemical for only 4 h , the resistance ratios of DLD-1/chemical cells to parental DLD-1 cells were markedly different for chemical and chemical , suggesting that the cytotoxicity with short-time exposure to chemical is due to a mechanism other than gene inhibition , although the cytotoxicity of chemical in the short-time is low compared to that of long-time exposure .	T15	T46	10891536
NA	CHEMICAL	GENE-Y	12	52	When DLD-1/chemical cells expressing increased gene mRNA were treated with chemical and chemical for only 4 h , the resistance ratios of DLD-1/chemical cells to parental DLD-1 cells were markedly different for chemical and chemical , suggesting that the cytotoxicity with short-time exposure to chemical is due to a mechanism other than gene inhibition , although the cytotoxicity of chemical in the short-time is low compared to that of long-time exposure .	T15	T47	10891536
NA	CHEMICAL	GENE-Y	22	5	When DLD-1/chemical cells expressing increased gene mRNA were treated with chemical and chemical for only 4 h , the resistance ratios of DLD-1/chemical cells to parental DLD-1 cells were markedly different for chemical and chemical , suggesting that the cytotoxicity with short-time exposure to chemical is due to a mechanism other than gene inhibition , although the cytotoxicity of chemical in the short-time is low compared to that of long-time exposure .	T17	T46	10891536
NA	CHEMICAL	GENE-Y	22	52	When DLD-1/chemical cells expressing increased gene mRNA were treated with chemical and chemical for only 4 h , the resistance ratios of DLD-1/chemical cells to parental DLD-1 cells were markedly different for chemical and chemical , suggesting that the cytotoxicity with short-time exposure to chemical is due to a mechanism other than gene inhibition , although the cytotoxicity of chemical in the short-time is low compared to that of long-time exposure .	T17	T47	10891536
NA	CHEMICAL	GENE-Y	32	5	When DLD-1/chemical cells expressing increased gene mRNA were treated with chemical and chemical for only 4 h , the resistance ratios of DLD-1/chemical cells to parental DLD-1 cells were markedly different for chemical and chemical , suggesting that the cytotoxicity with short-time exposure to chemical is due to a mechanism other than gene inhibition , although the cytotoxicity of chemical in the short-time is low compared to that of long-time exposure .	T18	T46	10891536
NA	CHEMICAL	GENE-Y	32	52	When DLD-1/chemical cells expressing increased gene mRNA were treated with chemical and chemical for only 4 h , the resistance ratios of DLD-1/chemical cells to parental DLD-1 cells were markedly different for chemical and chemical , suggesting that the cytotoxicity with short-time exposure to chemical is due to a mechanism other than gene inhibition , although the cytotoxicity of chemical in the short-time is low compared to that of long-time exposure .	T18	T47	10891536
NA	CHEMICAL	GENE-Y	16	5	When DLD-1/chemical cells expressing increased gene mRNA were treated with chemical and chemical for only 4 h , the resistance ratios of DLD-1/chemical cells to parental DLD-1 cells were markedly different for chemical and chemical , suggesting that the cytotoxicity with short-time exposure to chemical is due to a mechanism other than gene inhibition , although the cytotoxicity of chemical in the short-time is low compared to that of long-time exposure .	T19	T46	10891536
NA	CHEMICAL	GENE-Y	16	52	When DLD-1/chemical cells expressing increased gene mRNA were treated with chemical and chemical for only 4 h , the resistance ratios of DLD-1/chemical cells to parental DLD-1 cells were markedly different for chemical and chemical , suggesting that the cytotoxicity with short-time exposure to chemical is due to a mechanism other than gene inhibition , although the cytotoxicity of chemical in the short-time is low compared to that of long-time exposure .	T19	T47	10891536
NA	CHEMICAL	GENE-Y	16	5	When DLD-1/chemical cells expressing increased gene mRNA were treated with chemical and chemical for only 4 h , the resistance ratios of DLD-1/chemical cells to parental DLD-1 cells were markedly different for chemical and chemical , suggesting that the cytotoxicity with short-time exposure to chemical is due to a mechanism other than gene inhibition , although the cytotoxicity of chemical in the short-time is low compared to that of long-time exposure .	T20	T46	10891536
CPR:4	CHEMICAL	GENE-Y	16	52	When DLD-1/chemical cells expressing increased gene mRNA were treated with chemical and chemical for only 4 h , the resistance ratios of DLD-1/chemical cells to parental DLD-1 cells were markedly different for chemical and chemical , suggesting that the cytotoxicity with short-time exposure to chemical is due to a mechanism other than gene inhibition , although the cytotoxicity of chemical in the short-time is low compared to that of long-time exposure .	T20	T47	10891536
NA	CHEMICAL	GENE-Y	16	5	When DLD-1/chemical cells expressing increased gene mRNA were treated with chemical and chemical for only 4 h , the resistance ratios of DLD-1/chemical cells to parental DLD-1 cells were markedly different for chemical and chemical , suggesting that the cytotoxicity with short-time exposure to chemical is due to a mechanism other than gene inhibition , although the cytotoxicity of chemical in the short-time is low compared to that of long-time exposure .	T21	T46	10891536
NA	CHEMICAL	GENE-Y	16	52	When DLD-1/chemical cells expressing increased gene mRNA were treated with chemical and chemical for only 4 h , the resistance ratios of DLD-1/chemical cells to parental DLD-1 cells were markedly different for chemical and chemical , suggesting that the cytotoxicity with short-time exposure to chemical is due to a mechanism other than gene inhibition , although the cytotoxicity of chemical in the short-time is low compared to that of long-time exposure .	T21	T47	10891536
CPR:3	CHEMICAL	GENE-Y	13	2	Expression of gene ( gene ) is upregulated in the liver by dietary chemical .	T4	T9	16365052
CPR:3	CHEMICAL	GENE-Y	13	4	Expression of gene ( gene ) is upregulated in the liver by dietary chemical .	T4	T12	16365052
NA	CHEMICAL	GENE-N	3	5	Previously , 3 chemical/insulin response elements were identified in the 5'-flanking region of the gene gene up to bp -170 .	T1	T6	16365052
NA	CHEMICAL	GENE-Y	3	14	Previously , 3 chemical/insulin response elements were identified in the 5'-flanking region of the gene gene up to bp -170 .	T1	T11	16365052
NA	CHEMICAL	GENE-N	0	3	A Role for gene in the Activation of chemical-Ribosylation Factors ( gene ) and gene Recruitment .	T4	T39	23572528
NA	CHEMICAL	GENE-N	0	9	A Role for gene in the Activation of chemical-Ribosylation Factors ( gene ) and gene Recruitment .	T4	T40	23572528
NA	CHEMICAL	GENE-N	0	0	A Role for gene in the Activation of chemical-Ribosylation Factors ( gene ) and gene Recruitment .	T4	T41	23572528
NA	CHEMICAL	GENE-N	0	0	A Role for gene in the Activation of chemical-Ribosylation Factors ( gene ) and gene Recruitment .	T4	T42	23572528
NA	CHEMICAL	GENE-N	10	10	We examined the specificity and initial sites of recruitment of gene-dependent gene ( gene and gene ) in response to the Golgi or endosomal localization of specific gene ( gene , chemical receptor ( gene ) and gene lacking a chemical-terminal domain gene ) .	T2	T25	23572528
NA	CHEMICAL	GENE-N	10	11	We examined the specificity and initial sites of recruitment of gene-dependent gene ( gene and gene ) in response to the Golgi or endosomal localization of specific gene ( gene , chemical receptor ( gene ) and gene lacking a chemical-terminal domain gene ) .	T2	T26	23572528
NA	CHEMICAL	GENE-N	10	13	We examined the specificity and initial sites of recruitment of gene-dependent gene ( gene and gene ) in response to the Golgi or endosomal localization of specific gene ( gene , chemical receptor ( gene ) and gene lacking a chemical-terminal domain gene ) .	T2	T27	23572528
NA	CHEMICAL	GENE-N	10	15	We examined the specificity and initial sites of recruitment of gene-dependent gene ( gene and gene ) in response to the Golgi or endosomal localization of specific gene ( gene , chemical receptor ( gene ) and gene lacking a chemical-terminal domain gene ) .	T2	T28	23572528
NA	CHEMICAL	GENE-N	10	17	We examined the specificity and initial sites of recruitment of gene-dependent gene ( gene and gene ) in response to the Golgi or endosomal localization of specific gene ( gene , chemical receptor ( gene ) and gene lacking a chemical-terminal domain gene ) .	T2	T29	23572528
NA	CHEMICAL	GENE-Y	10	17	We examined the specificity and initial sites of recruitment of gene-dependent gene ( gene and gene ) in response to the Golgi or endosomal localization of specific gene ( gene , chemical receptor ( gene ) and gene lacking a chemical-terminal domain gene ) .	T2	T30	23572528
NA	CHEMICAL	GENE-Y	10	19	We examined the specificity and initial sites of recruitment of gene-dependent gene ( gene and gene ) in response to the Golgi or endosomal localization of specific gene ( gene , chemical receptor ( gene ) and gene lacking a chemical-terminal domain gene ) .	T2	T31	23572528
NA	CHEMICAL	GENE-Y	10	34	We examined the specificity and initial sites of recruitment of gene-dependent gene ( gene and gene ) in response to the Golgi or endosomal localization of specific gene ( gene , chemical receptor ( gene ) and gene lacking a chemical-terminal domain gene ) .	T2	T32	23572528
NA	CHEMICAL	GENE-Y	10	37	We examined the specificity and initial sites of recruitment of gene-dependent gene ( gene and gene ) in response to the Golgi or endosomal localization of specific gene ( gene , chemical receptor ( gene ) and gene lacking a chemical-terminal domain gene ) .	T2	T33	23572528
NA	CHEMICAL	GENE-Y	10	42	We examined the specificity and initial sites of recruitment of gene-dependent gene ( gene and gene ) in response to the Golgi or endosomal localization of specific gene ( gene , chemical receptor ( gene ) and gene lacking a chemical-terminal domain gene ) .	T2	T34	23572528
NA	CHEMICAL	GENE-N	29	10	We examined the specificity and initial sites of recruitment of gene-dependent gene ( gene and gene ) in response to the Golgi or endosomal localization of specific gene ( gene , chemical receptor ( gene ) and gene lacking a chemical-terminal domain gene ) .	T3	T25	23572528
NA	CHEMICAL	GENE-N	29	11	We examined the specificity and initial sites of recruitment of gene-dependent gene ( gene and gene ) in response to the Golgi or endosomal localization of specific gene ( gene , chemical receptor ( gene ) and gene lacking a chemical-terminal domain gene ) .	T3	T26	23572528
NA	CHEMICAL	GENE-N	29	13	We examined the specificity and initial sites of recruitment of gene-dependent gene ( gene and gene ) in response to the Golgi or endosomal localization of specific gene ( gene , chemical receptor ( gene ) and gene lacking a chemical-terminal domain gene ) .	T3	T27	23572528
NA	CHEMICAL	GENE-N	29	15	We examined the specificity and initial sites of recruitment of gene-dependent gene ( gene and gene ) in response to the Golgi or endosomal localization of specific gene ( gene , chemical receptor ( gene ) and gene lacking a chemical-terminal domain gene ) .	T3	T28	23572528
NA	CHEMICAL	GENE-N	29	17	We examined the specificity and initial sites of recruitment of gene-dependent gene ( gene and gene ) in response to the Golgi or endosomal localization of specific gene ( gene , chemical receptor ( gene ) and gene lacking a chemical-terminal domain gene ) .	T3	T29	23572528
NA	CHEMICAL	GENE-Y	29	17	We examined the specificity and initial sites of recruitment of gene-dependent gene ( gene and gene ) in response to the Golgi or endosomal localization of specific gene ( gene , chemical receptor ( gene ) and gene lacking a chemical-terminal domain gene ) .	T3	T30	23572528
NA	CHEMICAL	GENE-Y	29	19	We examined the specificity and initial sites of recruitment of gene-dependent gene ( gene and gene ) in response to the Golgi or endosomal localization of specific gene ( gene , chemical receptor ( gene ) and gene lacking a chemical-terminal domain gene ) .	T3	T31	23572528
NA	CHEMICAL	GENE-Y	29	34	We examined the specificity and initial sites of recruitment of gene-dependent gene ( gene and gene ) in response to the Golgi or endosomal localization of specific gene ( gene , chemical receptor ( gene ) and gene lacking a chemical-terminal domain gene ) .	T3	T32	23572528
NA	CHEMICAL	GENE-Y	29	37	We examined the specificity and initial sites of recruitment of gene-dependent gene ( gene and gene ) in response to the Golgi or endosomal localization of specific gene ( gene , chemical receptor ( gene ) and gene lacking a chemical-terminal domain gene ) .	T3	T33	23572528
NA	CHEMICAL	GENE-Y	29	42	We examined the specificity and initial sites of recruitment of gene-dependent gene ( gene and gene ) in response to the Golgi or endosomal localization of specific gene ( gene , chemical receptor ( gene ) and gene lacking a chemical-terminal domain gene ) .	T3	T34	23572528
NA	CHEMICAL	GENE-Y	4	18	Using temperature block , chemical , and recovery from each , we found that the cytoplasmic tail of gene causes the recruitment of gene and gene to recycling endosomes and not at the Golgi , as predicted by steady state staining profiles .	T1	T14	23572528
NA	CHEMICAL	GENE-N	4	23	Using temperature block , chemical , and recovery from each , we found that the cytoplasmic tail of gene causes the recruitment of gene and gene to recycling endosomes and not at the Golgi , as predicted by steady state staining profiles .	T1	T15	23572528
NA	CHEMICAL	GENE-N	4	25	Using temperature block , chemical , and recovery from each , we found that the cytoplasmic tail of gene causes the recruitment of gene and gene to recycling endosomes and not at the Golgi , as predicted by steady state staining profiles .	T1	T16	23572528
NA	CHEMICAL	GENE-N	0	13	chemical ( chemical ) depress neuronal excitability via positive allosteric modulation of inhibitory gene ( gene ) .	T1	T36	21262851
NA	CHEMICAL	GENE-N	0	1	chemical ( chemical ) depress neuronal excitability via positive allosteric modulation of inhibitory gene ( gene ) .	T1	T40	21262851
NA	CHEMICAL	GENE-N	2	13	chemical ( chemical ) depress neuronal excitability via positive allosteric modulation of inhibitory gene ( gene ) .	T16	T36	21262851
NA	CHEMICAL	GENE-N	2	1	chemical ( chemical ) depress neuronal excitability via positive allosteric modulation of inhibitory gene ( gene ) .	T16	T40	21262851
NA	CHEMICAL	GENE-N	0	4	chemical and other positive gene modulators , including chemical , chemical , and chemical , can also inhibit gene ( gene ) , which could contribute to reduced neuronal excitability .	T7	T47	21262851
CPR:4	CHEMICAL	GENE-N	0	18	chemical and other positive gene modulators , including chemical , chemical , and chemical , can also inhibit gene ( gene ) , which could contribute to reduced neuronal excitability .	T7	T52	21262851
CPR:4	CHEMICAL	GENE-N	0	20	chemical and other positive gene modulators , including chemical , chemical , and chemical , can also inhibit gene ( gene ) , which could contribute to reduced neuronal excitability .	T7	T53	21262851
NA	CHEMICAL	GENE-N	8	4	chemical and other positive gene modulators , including chemical , chemical , and chemical , can also inhibit gene ( gene ) , which could contribute to reduced neuronal excitability .	T18	T47	21262851
CPR:4	CHEMICAL	GENE-N	8	18	chemical and other positive gene modulators , including chemical , chemical , and chemical , can also inhibit gene ( gene ) , which could contribute to reduced neuronal excitability .	T18	T52	21262851
CPR:4	CHEMICAL	GENE-N	8	20	chemical and other positive gene modulators , including chemical , chemical , and chemical , can also inhibit gene ( gene ) , which could contribute to reduced neuronal excitability .	T18	T53	21262851
NA	CHEMICAL	GENE-N	10	4	chemical and other positive gene modulators , including chemical , chemical , and chemical , can also inhibit gene ( gene ) , which could contribute to reduced neuronal excitability .	T19	T47	21262851
CPR:4	CHEMICAL	GENE-N	10	18	chemical and other positive gene modulators , including chemical , chemical , and chemical , can also inhibit gene ( gene ) , which could contribute to reduced neuronal excitability .	T19	T52	21262851
CPR:4	CHEMICAL	GENE-N	10	20	chemical and other positive gene modulators , including chemical , chemical , and chemical , can also inhibit gene ( gene ) , which could contribute to reduced neuronal excitability .	T19	T53	21262851
NA	CHEMICAL	GENE-N	13	4	chemical and other positive gene modulators , including chemical , chemical , and chemical , can also inhibit gene ( gene ) , which could contribute to reduced neuronal excitability .	T20	T47	21262851
CPR:4	CHEMICAL	GENE-N	13	18	chemical and other positive gene modulators , including chemical , chemical , and chemical , can also inhibit gene ( gene ) , which could contribute to reduced neuronal excitability .	T20	T52	21262851
CPR:4	CHEMICAL	GENE-N	13	20	chemical and other positive gene modulators , including chemical , chemical , and chemical , can also inhibit gene ( gene ) , which could contribute to reduced neuronal excitability .	T20	T53	21262851
NA	CHEMICAL	GENE-Y	7	8	The current studies assessed the effects of chemical ( chemical , chemical , and chemical ) , chemical , chemical , and chemical on whole-cell chemical currents through recombinant neuronal gene and gene gene expressed with beta ( 3 ) and alpha ( 2 ) delta-1 in HEK293T cells .	T22	T57	21262851
NA	CHEMICAL	GENE-Y	7	8	The current studies assessed the effects of chemical ( chemical , chemical , and chemical ) , chemical , chemical , and chemical on whole-cell chemical currents through recombinant neuronal gene and gene gene expressed with beta ( 3 ) and alpha ( 2 ) delta-1 in HEK293T cells .	T22	T58	21262851
NA	CHEMICAL	GENE-N	7	33	The current studies assessed the effects of chemical ( chemical , chemical , and chemical ) , chemical , chemical , and chemical on whole-cell chemical currents through recombinant neuronal gene and gene gene expressed with beta ( 3 ) and alpha ( 2 ) delta-1 in HEK293T cells .	T22	T59	21262851
NA	CHEMICAL	GENE-Y	9	8	The current studies assessed the effects of chemical ( chemical , chemical , and chemical ) , chemical , chemical , and chemical on whole-cell chemical currents through recombinant neuronal gene and gene gene expressed with beta ( 3 ) and alpha ( 2 ) delta-1 in HEK293T cells .	T23	T57	21262851
NA	CHEMICAL	GENE-Y	9	8	The current studies assessed the effects of chemical ( chemical , chemical , and chemical ) , chemical , chemical , and chemical on whole-cell chemical currents through recombinant neuronal gene and gene gene expressed with beta ( 3 ) and alpha ( 2 ) delta-1 in HEK293T cells .	T23	T58	21262851
NA	CHEMICAL	GENE-N	9	33	The current studies assessed the effects of chemical ( chemical , chemical , and chemical ) , chemical , chemical , and chemical on whole-cell chemical currents through recombinant neuronal gene and gene gene expressed with beta ( 3 ) and alpha ( 2 ) delta-1 in HEK293T cells .	T23	T59	21262851
NA	CHEMICAL	GENE-Y	11	8	The current studies assessed the effects of chemical ( chemical , chemical , and chemical ) , chemical , chemical , and chemical on whole-cell chemical currents through recombinant neuronal gene and gene gene expressed with beta ( 3 ) and alpha ( 2 ) delta-1 in HEK293T cells .	T24	T57	21262851
NA	CHEMICAL	GENE-Y	11	8	The current studies assessed the effects of chemical ( chemical , chemical , and chemical ) , chemical , chemical , and chemical on whole-cell chemical currents through recombinant neuronal gene and gene gene expressed with beta ( 3 ) and alpha ( 2 ) delta-1 in HEK293T cells .	T24	T58	21262851
NA	CHEMICAL	GENE-N	11	33	The current studies assessed the effects of chemical ( chemical , chemical , and chemical ) , chemical , chemical , and chemical on whole-cell chemical currents through recombinant neuronal gene and gene gene expressed with beta ( 3 ) and alpha ( 2 ) delta-1 in HEK293T cells .	T24	T59	21262851
NA	CHEMICAL	GENE-Y	14	8	The current studies assessed the effects of chemical ( chemical , chemical , and chemical ) , chemical , chemical , and chemical on whole-cell chemical currents through recombinant neuronal gene and gene gene expressed with beta ( 3 ) and alpha ( 2 ) delta-1 in HEK293T cells .	T25	T57	21262851
NA	CHEMICAL	GENE-Y	14	8	The current studies assessed the effects of chemical ( chemical , chemical , and chemical ) , chemical , chemical , and chemical on whole-cell chemical currents through recombinant neuronal gene and gene gene expressed with beta ( 3 ) and alpha ( 2 ) delta-1 in HEK293T cells .	T25	T58	21262851
NA	CHEMICAL	GENE-N	14	33	The current studies assessed the effects of chemical ( chemical , chemical , and chemical ) , chemical , chemical , and chemical on whole-cell chemical currents through recombinant neuronal gene and gene gene expressed with beta ( 3 ) and alpha ( 2 ) delta-1 in HEK293T cells .	T25	T59	21262851
NA	CHEMICAL	GENE-Y	17	8	The current studies assessed the effects of chemical ( chemical , chemical , and chemical ) , chemical , chemical , and chemical on whole-cell chemical currents through recombinant neuronal gene and gene gene expressed with beta ( 3 ) and alpha ( 2 ) delta-1 in HEK293T cells .	T26	T57	21262851
NA	CHEMICAL	GENE-Y	17	8	The current studies assessed the effects of chemical ( chemical , chemical , and chemical ) , chemical , chemical , and chemical on whole-cell chemical currents through recombinant neuronal gene and gene gene expressed with beta ( 3 ) and alpha ( 2 ) delta-1 in HEK293T cells .	T26	T58	21262851
NA	CHEMICAL	GENE-N	17	33	The current studies assessed the effects of chemical ( chemical , chemical , and chemical ) , chemical , chemical , and chemical on whole-cell chemical currents through recombinant neuronal gene and gene gene expressed with beta ( 3 ) and alpha ( 2 ) delta-1 in HEK293T cells .	T26	T59	21262851
NA	CHEMICAL	GENE-Y	19	8	The current studies assessed the effects of chemical ( chemical , chemical , and chemical ) , chemical , chemical , and chemical on whole-cell chemical currents through recombinant neuronal gene and gene gene expressed with beta ( 3 ) and alpha ( 2 ) delta-1 in HEK293T cells .	T27	T57	21262851
NA	CHEMICAL	GENE-Y	19	8	The current studies assessed the effects of chemical ( chemical , chemical , and chemical ) , chemical , chemical , and chemical on whole-cell chemical currents through recombinant neuronal gene and gene gene expressed with beta ( 3 ) and alpha ( 2 ) delta-1 in HEK293T cells .	T27	T58	21262851
NA	CHEMICAL	GENE-N	19	33	The current studies assessed the effects of chemical ( chemical , chemical , and chemical ) , chemical , chemical , and chemical on whole-cell chemical currents through recombinant neuronal gene and gene gene expressed with beta ( 3 ) and alpha ( 2 ) delta-1 in HEK293T cells .	T27	T59	21262851
NA	CHEMICAL	GENE-Y	22	8	The current studies assessed the effects of chemical ( chemical , chemical , and chemical ) , chemical , chemical , and chemical on whole-cell chemical currents through recombinant neuronal gene and gene gene expressed with beta ( 3 ) and alpha ( 2 ) delta-1 in HEK293T cells .	T28	T57	21262851
NA	CHEMICAL	GENE-Y	22	8	The current studies assessed the effects of chemical ( chemical , chemical , and chemical ) , chemical , chemical , and chemical on whole-cell chemical currents through recombinant neuronal gene and gene gene expressed with beta ( 3 ) and alpha ( 2 ) delta-1 in HEK293T cells .	T28	T58	21262851
NA	CHEMICAL	GENE-N	22	33	The current studies assessed the effects of chemical ( chemical , chemical , and chemical ) , chemical , chemical , and chemical on whole-cell chemical currents through recombinant neuronal gene and gene gene expressed with beta ( 3 ) and alpha ( 2 ) delta-1 in HEK293T cells .	T28	T59	21262851
NA	CHEMICAL	GENE-Y	8	8	The current studies assessed the effects of chemical ( chemical , chemical , and chemical ) , chemical , chemical , and chemical on whole-cell chemical currents through recombinant neuronal gene and gene gene expressed with beta ( 3 ) and alpha ( 2 ) delta-1 in HEK293T cells .	T29	T57	21262851
NA	CHEMICAL	GENE-Y	8	8	The current studies assessed the effects of chemical ( chemical , chemical , and chemical ) , chemical , chemical , and chemical on whole-cell chemical currents through recombinant neuronal gene and gene gene expressed with beta ( 3 ) and alpha ( 2 ) delta-1 in HEK293T cells .	T29	T58	21262851
NA	CHEMICAL	GENE-N	8	33	The current studies assessed the effects of chemical ( chemical , chemical , and chemical ) , chemical , chemical , and chemical on whole-cell chemical currents through recombinant neuronal gene and gene gene expressed with beta ( 3 ) and alpha ( 2 ) delta-1 in HEK293T cells .	T29	T59	21262851
CPR:4	CHEMICAL	GENE-Y	5	0	gene channels were less sensitive to chemical inhibition than gene channels , similar to chemical ( chemical ) gene antagonists .	T2	T35	21262851
CPR:4	CHEMICAL	GENE-Y	5	9	gene channels were less sensitive to chemical inhibition than gene channels , similar to chemical ( chemical ) gene antagonists .	T2	T37	21262851
NA	CHEMICAL	GENE-N	5	18	gene channels were less sensitive to chemical inhibition than gene channels , similar to chemical ( chemical ) gene antagonists .	T2	T38	21262851
CPR:4	CHEMICAL	GENE-Y	0	0	gene channels were less sensitive to chemical inhibition than gene channels , similar to chemical ( chemical ) gene antagonists .	T3	T35	21262851
CPR:4	CHEMICAL	GENE-Y	0	9	gene channels were less sensitive to chemical inhibition than gene channels , similar to chemical ( chemical ) gene antagonists .	T3	T37	21262851
CPR:6	CHEMICAL	GENE-N	0	18	gene channels were less sensitive to chemical inhibition than gene channels , similar to chemical ( chemical ) gene antagonists .	T3	T38	21262851
CPR:4	CHEMICAL	GENE-Y	16	0	gene channels were less sensitive to chemical inhibition than gene channels , similar to chemical ( chemical ) gene antagonists .	T4	T35	21262851
CPR:4	CHEMICAL	GENE-Y	16	9	gene channels were less sensitive to chemical inhibition than gene channels , similar to chemical ( chemical ) gene antagonists .	T4	T37	21262851
CPR:6	CHEMICAL	GENE-N	16	18	gene channels were less sensitive to chemical inhibition than gene channels , similar to chemical ( chemical ) gene antagonists .	T4	T38	21262851
NA	CHEMICAL	GENE-N	18	1	All gene modulators induced a negative shift in the steady-state inactivation curve of gene channels , but only chemical and chemical induced a negative shift in gene channel inactivation .	T5	T39	21262851
NA	CHEMICAL	GENE-Y	18	4	All gene modulators induced a negative shift in the steady-state inactivation curve of gene channels , but only chemical and chemical induced a negative shift in gene channel inactivation .	T5	T41	21262851
CPR:4	CHEMICAL	GENE-Y	18	4	All gene modulators induced a negative shift in the steady-state inactivation curve of gene channels , but only chemical and chemical induced a negative shift in gene channel inactivation .	T5	T42	21262851
NA	CHEMICAL	GENE-N	4	1	All gene modulators induced a negative shift in the steady-state inactivation curve of gene channels , but only chemical and chemical induced a negative shift in gene channel inactivation .	T6	T39	21262851
NA	CHEMICAL	GENE-Y	4	4	All gene modulators induced a negative shift in the steady-state inactivation curve of gene channels , but only chemical and chemical induced a negative shift in gene channel inactivation .	T6	T41	21262851
CPR:4	CHEMICAL	GENE-Y	4	4	All gene modulators induced a negative shift in the steady-state inactivation curve of gene channels , but only chemical and chemical induced a negative shift in gene channel inactivation .	T6	T42	21262851
NA	CHEMICAL	GENE-N	13	3	Mutation of the gene ( gene and gene ) in gene channels reduced chemical potency .	T9	T43	21262851
NA	CHEMICAL	GENE-N	13	5	Mutation of the gene ( gene and gene ) in gene channels reduced chemical potency .	T9	T44	21262851
NA	CHEMICAL	GENE-N	13	7	Mutation of the gene ( gene and gene ) in gene channels reduced chemical potency .	T9	T45	21262851
NA	CHEMICAL	GENE-Y	13	4	Mutation of the gene ( gene and gene ) in gene channels reduced chemical potency .	T9	T46	21262851
NA	CHEMICAL	GENE-N	5	18	Despite the structural similarity between chemical and chemical , mutation of an chemical important for chemical potency ( gene ) did not affect chemical potency .	T10	T48	21262851
NA	CHEMICAL	GENE-N	7	18	Despite the structural similarity between chemical and chemical , mutation of an chemical important for chemical potency ( gene ) did not affect chemical potency .	T11	T48	21262851
NA	CHEMICAL	GENE-N	12	18	Despite the structural similarity between chemical and chemical , mutation of an chemical important for chemical potency ( gene ) did not affect chemical potency .	T12	T48	21262851
NA	CHEMICAL	GENE-N	15	18	Despite the structural similarity between chemical and chemical , mutation of an chemical important for chemical potency ( gene ) did not affect chemical potency .	T13	T48	21262851
CPR:4	CHEMICAL	GENE-N	23	18	Despite the structural similarity between chemical and chemical , mutation of an chemical important for chemical potency ( gene ) did not affect chemical potency .	T14	T48	21262851
CPR:4	CHEMICAL	GENE-Y	1	8	Comparison of the effect of chemical ( a gene inhibitor ) , chemical , and placebo on the gastroduodenal mucosa of patients with osteoarthritis : a randomized , double-blind , placebo-controlled trial .	T10	T13	10693877
NA	CHEMICAL	GENE-Y	1	8	Comparison of the effect of chemical ( a gene inhibitor ) , chemical , and placebo on the gastroduodenal mucosa of patients with osteoarthritis : a randomized , double-blind , placebo-controlled trial .	T11	T13	10693877
CPR:4	CHEMICAL	GENE-Y	11	18	OBJECTIVE : This randomized , double-blind study tested the hypothesis that chemical , a drug that specifically inhibits gene , would cause fewer gastroduodenal ulcers than chemical ( in a multicenter trial ) , and its side effects would be equivalent to those of placebo ( in a prespecified analysis combining the results with another trial of identical design ) .	T6	T12	10693877
NA	CHEMICAL	GENE-Y	26	18	OBJECTIVE : This randomized , double-blind study tested the hypothesis that chemical , a drug that specifically inhibits gene , would cause fewer gastroduodenal ulcers than chemical ( in a multicenter trial ) , and its side effects would be equivalent to those of placebo ( in a prespecified analysis combining the results with another trial of identical design ) .	T4	T12	10693877
CPR:4	CHEMICAL	GENE-Y	0	16	chemical as a template for structure-based drug design : identification of new chemical series of irreversible gene inhibitors with improved lipophilic efficiency .	T5	T10	23466229
CPR:4	CHEMICAL	GENE-Y	2	16	chemical as a template for structure-based drug design : identification of new chemical series of irreversible gene inhibitors with improved lipophilic efficiency .	T6	T10	23466229
CPR:4	CHEMICAL	GENE-Y	10	16	The structure-based design , synthesis , and biological evaluation of a new chemical series of irreversible gene inhibitors are described herein .	T4	T7	23466229
CPR:4	CHEMICAL	GENE-Y	12	27	The modification of the inhibitor scaffold of 1 and 2 from a chemical core to a chemical core led to discovery of a new series of potent gene inhibitors with excellent physicochemical properties .	T1	T8	23466229
CPR:4	CHEMICAL	GENE-Y	11	27	The modification of the inhibitor scaffold of 1 and 2 from a chemical core to a chemical core led to discovery of a new series of potent gene inhibitors with excellent physicochemical properties .	T2	T8	23466229
NA	CHEMICAL	GENE-Y	1	3	Critical chemical in gene catalytic site that provide for high-affinity interaction with chemical and inhibitors .	T42	T60	17979301
NA	CHEMICAL	GENE-Y	12	3	Critical chemical in gene catalytic site that provide for high-affinity interaction with chemical and inhibitors .	T41	T60	17979301
NA	CHEMICAL	GENE-Y	11	4	The molecular bases for gene ( gene ) catalytic-site affinity for chemical ( chemical ) and potency of inhibitors are poorly understood .	T39	T52	17979301
NA	CHEMICAL	GENE-Y	11	6	The molecular bases for gene ( gene ) catalytic-site affinity for chemical ( chemical ) and potency of inhibitors are poorly understood .	T39	T53	17979301
NA	CHEMICAL	GENE-Y	11	4	The molecular bases for gene ( gene ) catalytic-site affinity for chemical ( chemical ) and potency of inhibitors are poorly understood .	T3	T52	17979301
NA	CHEMICAL	GENE-Y	11	6	The molecular bases for gene ( gene ) catalytic-site affinity for chemical ( chemical ) and potency of inhibitors are poorly understood .	T3	T53	17979301
NA	CHEMICAL	GENE-N	8	3	Cocrystal structures of gene with inhibitors reveal a chemical bond and hydrophobic interactions with chemical-612 , chemical bonds with chemical-817 , a hydrophobic clamp formed by chemical-820 and chemical-782 , and contacts with chemical-613 , chemical-765 , and chemical-786 [ Sung et al .	T24	T51	17979301
NA	CHEMICAL	GENE-N	14	3	Cocrystal structures of gene with inhibitors reveal a chemical bond and hydrophobic interactions with chemical-612 , chemical bonds with chemical-817 , a hydrophobic clamp formed by chemical-820 and chemical-782 , and contacts with chemical-613 , chemical-765 , and chemical-786 [ Sung et al .	T25	T51	17979301
NA	CHEMICAL	GENE-N	16	3	Cocrystal structures of gene with inhibitors reveal a chemical bond and hydrophobic interactions with chemical-612 , chemical bonds with chemical-817 , a hydrophobic clamp formed by chemical-820 and chemical-782 , and contacts with chemical-613 , chemical-765 , and chemical-786 [ Sung et al .	T26	T51	17979301
NA	CHEMICAL	GENE-N	19	3	Cocrystal structures of gene with inhibitors reveal a chemical bond and hydrophobic interactions with chemical-612 , chemical bonds with chemical-817 , a hydrophobic clamp formed by chemical-820 and chemical-782 , and contacts with chemical-613 , chemical-765 , and chemical-786 [ Sung et al .	T27	T51	17979301
NA	CHEMICAL	GENE-N	26	3	Cocrystal structures of gene with inhibitors reveal a chemical bond and hydrophobic interactions with chemical-612 , chemical bonds with chemical-817 , a hydrophobic clamp formed by chemical-820 and chemical-782 , and contacts with chemical-613 , chemical-765 , and chemical-786 [ Sung et al .	T28	T51	17979301
NA	CHEMICAL	GENE-N	7	3	Cocrystal structures of gene with inhibitors reveal a chemical bond and hydrophobic interactions with chemical-612 , chemical bonds with chemical-817 , a hydrophobic clamp formed by chemical-820 and chemical-782 , and contacts with chemical-613 , chemical-765 , and chemical-786 [ Sung et al .	T29	T51	17979301
NA	CHEMICAL	GENE-N	33	3	Cocrystal structures of gene with inhibitors reveal a chemical bond and hydrophobic interactions with chemical-612 , chemical bonds with chemical-817 , a hydrophobic clamp formed by chemical-820 and chemical-782 , and contacts with chemical-613 , chemical-765 , and chemical-786 [ Sung et al .	T30	T51	17979301
NA	CHEMICAL	GENE-N	35	3	Cocrystal structures of gene with inhibitors reveal a chemical bond and hydrophobic interactions with chemical-612 , chemical bonds with chemical-817 , a hydrophobic clamp formed by chemical-820 and chemical-782 , and contacts with chemical-613 , chemical-765 , and chemical-786 [ Sung et al .	T31	T51	17979301
NA	CHEMICAL	GENE-N	38	3	Cocrystal structures of gene with inhibitors reveal a chemical bond and hydrophobic interactions with chemical-612 , chemical bonds with chemical-817 , a hydrophobic clamp formed by chemical-820 and chemical-782 , and contacts with chemical-613 , chemical-765 , and chemical-786 [ Sung et al .	T32	T51	17979301
NA	CHEMICAL	GENE-N	3	30	Catalytic-site affinities for chemical , chemical , chemical , chemical , or chemical ( chemical ) were respectively weakened 14- , 123- , 30- , 51- , and 43-fold for gene ; 63- , 511- , 43- , 95- and 61-fold for gene ; and 59- , 448- , 71- , 137- , and 93-fold for gene .	T33	T57	17979301
NA	CHEMICAL	GENE-N	3	42	Catalytic-site affinities for chemical , chemical , chemical , chemical , or chemical ( chemical ) were respectively weakened 14- , 123- , 30- , 51- , and 43-fold for gene ; 63- , 511- , 43- , 95- and 61-fold for gene ; and 59- , 448- , 71- , 137- , and 93-fold for gene .	T33	T58	17979301
NA	CHEMICAL	GENE-N	3	56	Catalytic-site affinities for chemical , chemical , chemical , chemical , or chemical ( chemical ) were respectively weakened 14- , 123- , 30- , 51- , and 43-fold for gene ; 63- , 511- , 43- , 95- and 61-fold for gene ; and 59- , 448- , 71- , 137- , and 93-fold for gene .	T33	T59	17979301
NA	CHEMICAL	GENE-N	5	30	Catalytic-site affinities for chemical , chemical , chemical , chemical , or chemical ( chemical ) were respectively weakened 14- , 123- , 30- , 51- , and 43-fold for gene ; 63- , 511- , 43- , 95- and 61-fold for gene ; and 59- , 448- , 71- , 137- , and 93-fold for gene .	T34	T57	17979301
NA	CHEMICAL	GENE-N	5	42	Catalytic-site affinities for chemical , chemical , chemical , chemical , or chemical ( chemical ) were respectively weakened 14- , 123- , 30- , 51- , and 43-fold for gene ; 63- , 511- , 43- , 95- and 61-fold for gene ; and 59- , 448- , 71- , 137- , and 93-fold for gene .	T34	T58	17979301
NA	CHEMICAL	GENE-N	5	56	Catalytic-site affinities for chemical , chemical , chemical , chemical , or chemical ( chemical ) were respectively weakened 14- , 123- , 30- , 51- , and 43-fold for gene ; 63- , 511- , 43- , 95- and 61-fold for gene ; and 59- , 448- , 71- , 137- , and 93-fold for gene .	T34	T59	17979301
NA	CHEMICAL	GENE-N	7	30	Catalytic-site affinities for chemical , chemical , chemical , chemical , or chemical ( chemical ) were respectively weakened 14- , 123- , 30- , 51- , and 43-fold for gene ; 63- , 511- , 43- , 95- and 61-fold for gene ; and 59- , 448- , 71- , 137- , and 93-fold for gene .	T35	T57	17979301
NA	CHEMICAL	GENE-N	7	42	Catalytic-site affinities for chemical , chemical , chemical , chemical , or chemical ( chemical ) were respectively weakened 14- , 123- , 30- , 51- , and 43-fold for gene ; 63- , 511- , 43- , 95- and 61-fold for gene ; and 59- , 448- , 71- , 137- , and 93-fold for gene .	T35	T58	17979301
NA	CHEMICAL	GENE-N	7	56	Catalytic-site affinities for chemical , chemical , chemical , chemical , or chemical ( chemical ) were respectively weakened 14- , 123- , 30- , 51- , and 43-fold for gene ; 63- , 511- , 43- , 95- and 61-fold for gene ; and 59- , 448- , 71- , 137- , and 93-fold for gene .	T35	T59	17979301
NA	CHEMICAL	GENE-N	9	30	Catalytic-site affinities for chemical , chemical , chemical , chemical , or chemical ( chemical ) were respectively weakened 14- , 123- , 30- , 51- , and 43-fold for gene ; 63- , 511- , 43- , 95- and 61-fold for gene ; and 59- , 448- , 71- , 137- , and 93-fold for gene .	T36	T57	17979301
CPR:9	CHEMICAL	GENE-N	9	42	Catalytic-site affinities for chemical , chemical , chemical , chemical , or chemical ( chemical ) were respectively weakened 14- , 123- , 30- , 51- , and 43-fold for gene ; 63- , 511- , 43- , 95- and 61-fold for gene ; and 59- , 448- , 71- , 137- , and 93-fold for gene .	T36	T58	17979301
NA	CHEMICAL	GENE-N	9	56	Catalytic-site affinities for chemical , chemical , chemical , chemical , or chemical ( chemical ) were respectively weakened 14- , 123- , 30- , 51- , and 43-fold for gene ; 63- , 511- , 43- , 95- and 61-fold for gene ; and 59- , 448- , 71- , 137- , and 93-fold for gene .	T36	T59	17979301
NA	CHEMICAL	GENE-N	12	30	Catalytic-site affinities for chemical , chemical , chemical , chemical , or chemical ( chemical ) were respectively weakened 14- , 123- , 30- , 51- , and 43-fold for gene ; 63- , 511- , 43- , 95- and 61-fold for gene ; and 59- , 448- , 71- , 137- , and 93-fold for gene .	T37	T57	17979301
NA	CHEMICAL	GENE-N	12	42	Catalytic-site affinities for chemical , chemical , chemical , chemical , or chemical ( chemical ) were respectively weakened 14- , 123- , 30- , 51- , and 43-fold for gene ; 63- , 511- , 43- , 95- and 61-fold for gene ; and 59- , 448- , 71- , 137- , and 93-fold for gene .	T37	T58	17979301
NA	CHEMICAL	GENE-N	12	56	Catalytic-site affinities for chemical , chemical , chemical , chemical , or chemical ( chemical ) were respectively weakened 14- , 123- , 30- , 51- , and 43-fold for gene ; 63- , 511- , 43- , 95- and 61-fold for gene ; and 59- , 448- , 71- , 137- , and 93-fold for gene .	T37	T59	17979301
NA	CHEMICAL	GENE-N	14	30	Catalytic-site affinities for chemical , chemical , chemical , chemical , or chemical ( chemical ) were respectively weakened 14- , 123- , 30- , 51- , and 43-fold for gene ; 63- , 511- , 43- , 95- and 61-fold for gene ; and 59- , 448- , 71- , 137- , and 93-fold for gene .	T38	T57	17979301
NA	CHEMICAL	GENE-N	14	42	Catalytic-site affinities for chemical , chemical , chemical , chemical , or chemical ( chemical ) were respectively weakened 14- , 123- , 30- , 51- , and 43-fold for gene ; 63- , 511- , 43- , 95- and 61-fold for gene ; and 59- , 448- , 71- , 137- , and 93-fold for gene .	T38	T58	17979301
NA	CHEMICAL	GENE-N	14	56	Catalytic-site affinities for chemical , chemical , chemical , chemical , or chemical ( chemical ) were respectively weakened 14- , 123- , 30- , 51- , and 43-fold for gene ; 63- , 511- , 43- , 95- and 61-fold for gene ; and 59- , 448- , 71- , 137- , and 93-fold for gene .	T38	T59	17979301
NA	CHEMICAL	GENE-N	4	2	Affinity of gene for chemical , chemical , chemical , chemical , or chemical was reduced 5.5- , 23- , 10- , 3- , and 12-fold , respectively .	T9	T43	17979301
NA	CHEMICAL	GENE-N	6	2	Affinity of gene for chemical , chemical , chemical , chemical , or chemical was reduced 5.5- , 23- , 10- , 3- , and 12-fold , respectively .	T10	T43	17979301
NA	CHEMICAL	GENE-N	8	2	Affinity of gene for chemical , chemical , chemical , chemical , or chemical was reduced 5.5- , 23- , 10- , 3- , and 12-fold , respectively .	T11	T43	17979301
NA	CHEMICAL	GENE-N	10	2	Affinity of gene for chemical , chemical , chemical , chemical , or chemical was reduced 5.5- , 23- , 10- , 3- , and 12-fold , respectively .	T12	T43	17979301
NA	CHEMICAL	GENE-N	13	2	Affinity of gene for chemical , chemical , chemical , chemical , or chemical was reduced 5.5- , 23- , 10- , 3- , and 12-fold , respectively .	T13	T43	17979301
NA	CHEMICAL	GENE-N	4	13	Change in affinity for chemical , chemical , chemical , or chemical in gene , gene , gene , or gene was less , but affinity of gene or gene for chemical was weakened 37- and 17-fold , respectively .	T14	T44	17979301
NA	CHEMICAL	GENE-N	4	15	Change in affinity for chemical , chemical , chemical , or chemical in gene , gene , gene , or gene was less , but affinity of gene or gene for chemical was weakened 37- and 17-fold , respectively .	T14	T45	17979301
NA	CHEMICAL	GENE-N	4	17	Change in affinity for chemical , chemical , chemical , or chemical in gene , gene , gene , or gene was less , but affinity of gene or gene for chemical was weakened 37- and 17-fold , respectively .	T14	T46	17979301
NA	CHEMICAL	GENE-N	4	20	Change in affinity for chemical , chemical , chemical , or chemical in gene , gene , gene , or gene was less , but affinity of gene or gene for chemical was weakened 37- and 17-fold , respectively .	T14	T47	17979301
NA	CHEMICAL	GENE-N	4	27	Change in affinity for chemical , chemical , chemical , or chemical in gene , gene , gene , or gene was less , but affinity of gene or gene for chemical was weakened 37- and 17-fold , respectively .	T14	T48	17979301
NA	CHEMICAL	GENE-N	4	29	Change in affinity for chemical , chemical , chemical , or chemical in gene , gene , gene , or gene was less , but affinity of gene or gene for chemical was weakened 37- and 17-fold , respectively .	T14	T49	17979301
NA	CHEMICAL	GENE-N	6	13	Change in affinity for chemical , chemical , chemical , or chemical in gene , gene , gene , or gene was less , but affinity of gene or gene for chemical was weakened 37- and 17-fold , respectively .	T15	T44	17979301
NA	CHEMICAL	GENE-N	6	15	Change in affinity for chemical , chemical , chemical , or chemical in gene , gene , gene , or gene was less , but affinity of gene or gene for chemical was weakened 37- and 17-fold , respectively .	T15	T45	17979301
NA	CHEMICAL	GENE-N	6	17	Change in affinity for chemical , chemical , chemical , or chemical in gene , gene , gene , or gene was less , but affinity of gene or gene for chemical was weakened 37- and 17-fold , respectively .	T15	T46	17979301
NA	CHEMICAL	GENE-N	6	20	Change in affinity for chemical , chemical , chemical , or chemical in gene , gene , gene , or gene was less , but affinity of gene or gene for chemical was weakened 37- and 17-fold , respectively .	T15	T47	17979301
NA	CHEMICAL	GENE-N	6	27	Change in affinity for chemical , chemical , chemical , or chemical in gene , gene , gene , or gene was less , but affinity of gene or gene for chemical was weakened 37- and 17-fold , respectively .	T15	T48	17979301
NA	CHEMICAL	GENE-N	6	29	Change in affinity for chemical , chemical , chemical , or chemical in gene , gene , gene , or gene was less , but affinity of gene or gene for chemical was weakened 37- and 17-fold , respectively .	T15	T49	17979301
NA	CHEMICAL	GENE-N	8	13	Change in affinity for chemical , chemical , chemical , or chemical in gene , gene , gene , or gene was less , but affinity of gene or gene for chemical was weakened 37- and 17-fold , respectively .	T16	T44	17979301
NA	CHEMICAL	GENE-N	8	15	Change in affinity for chemical , chemical , chemical , or chemical in gene , gene , gene , or gene was less , but affinity of gene or gene for chemical was weakened 37- and 17-fold , respectively .	T16	T45	17979301
NA	CHEMICAL	GENE-N	8	17	Change in affinity for chemical , chemical , chemical , or chemical in gene , gene , gene , or gene was less , but affinity of gene or gene for chemical was weakened 37- and 17-fold , respectively .	T16	T46	17979301
NA	CHEMICAL	GENE-N	8	20	Change in affinity for chemical , chemical , chemical , or chemical in gene , gene , gene , or gene was less , but affinity of gene or gene for chemical was weakened 37- and 17-fold , respectively .	T16	T47	17979301
NA	CHEMICAL	GENE-N	8	27	Change in affinity for chemical , chemical , chemical , or chemical in gene , gene , gene , or gene was less , but affinity of gene or gene for chemical was weakened 37- and 17-fold , respectively .	T16	T48	17979301
NA	CHEMICAL	GENE-N	8	29	Change in affinity for chemical , chemical , chemical , or chemical in gene , gene , gene , or gene was less , but affinity of gene or gene for chemical was weakened 37- and 17-fold , respectively .	T16	T49	17979301
NA	CHEMICAL	GENE-N	11	13	Change in affinity for chemical , chemical , chemical , or chemical in gene , gene , gene , or gene was less , but affinity of gene or gene for chemical was weakened 37- and 17-fold , respectively .	T17	T44	17979301
NA	CHEMICAL	GENE-N	11	15	Change in affinity for chemical , chemical , chemical , or chemical in gene , gene , gene , or gene was less , but affinity of gene or gene for chemical was weakened 37- and 17-fold , respectively .	T17	T45	17979301
NA	CHEMICAL	GENE-N	11	17	Change in affinity for chemical , chemical , chemical , or chemical in gene , gene , gene , or gene was less , but affinity of gene or gene for chemical was weakened 37- and 17-fold , respectively .	T17	T46	17979301
NA	CHEMICAL	GENE-N	11	20	Change in affinity for chemical , chemical , chemical , or chemical in gene , gene , gene , or gene was less , but affinity of gene or gene for chemical was weakened 37- and 17-fold , respectively .	T17	T47	17979301
NA	CHEMICAL	GENE-N	11	27	Change in affinity for chemical , chemical , chemical , or chemical in gene , gene , gene , or gene was less , but affinity of gene or gene for chemical was weakened 37- and 17-fold , respectively .	T17	T48	17979301
NA	CHEMICAL	GENE-N	11	29	Change in affinity for chemical , chemical , chemical , or chemical in gene , gene , gene , or gene was less , but affinity of gene or gene for chemical was weakened 37- and 17-fold , respectively .	T17	T49	17979301
NA	CHEMICAL	GENE-N	31	13	Change in affinity for chemical , chemical , chemical , or chemical in gene , gene , gene , or gene was less , but affinity of gene or gene for chemical was weakened 37- and 17-fold , respectively .	T18	T44	17979301
NA	CHEMICAL	GENE-N	31	15	Change in affinity for chemical , chemical , chemical , or chemical in gene , gene , gene , or gene was less , but affinity of gene or gene for chemical was weakened 37- and 17-fold , respectively .	T18	T45	17979301
NA	CHEMICAL	GENE-N	31	17	Change in affinity for chemical , chemical , chemical , or chemical in gene , gene , gene , or gene was less , but affinity of gene or gene for chemical was weakened 37- and 17-fold , respectively .	T18	T46	17979301
NA	CHEMICAL	GENE-N	31	20	Change in affinity for chemical , chemical , chemical , or chemical in gene , gene , gene , or gene was less , but affinity of gene or gene for chemical was weakened 37- and 17-fold , respectively .	T18	T47	17979301
NA	CHEMICAL	GENE-N	31	27	Change in affinity for chemical , chemical , chemical , or chemical in gene , gene , gene , or gene was less , but affinity of gene or gene for chemical was weakened 37- and 17-fold , respectively .	T18	T48	17979301
NA	CHEMICAL	GENE-N	31	29	Change in affinity for chemical , chemical , chemical , or chemical in gene , gene , gene , or gene was less , but affinity of gene or gene for chemical was weakened 37- and 17-fold , respectively .	T18	T49	17979301
NA	CHEMICAL	GENE-Y	0	11	chemical- and chemical-induced reduction in chemical concentrations : effects on chemical transporter densities .	T13	T23	12398910
NA	CHEMICAL	GENE-Y	2	11	chemical- and chemical-induced reduction in chemical concentrations : effects on chemical transporter densities .	T14	T23	12398910
NA	CHEMICAL	GENE-Y	5	11	chemical- and chemical-induced reduction in chemical concentrations : effects on chemical transporter densities .	T15	T23	12398910
NA	CHEMICAL	GENE-Y	4	11	chemical- and chemical-induced reduction in chemical concentrations : effects on chemical transporter densities .	T16	T23	12398910
CPR:4	CHEMICAL	GENE-Y	3	11	Low levels of chemical may reduce the density of the chemical transporter ( gene ) by either increasing trafficking or reducing synthesis ; a `` neuroadaptive response '' .	T1	T20	12398910
CPR:4	CHEMICAL	GENE-Y	3	13	Low levels of chemical may reduce the density of the chemical transporter ( gene ) by either increasing trafficking or reducing synthesis ; a `` neuroadaptive response '' .	T1	T22	12398910
NA	CHEMICAL	GENE-Y	10	11	Low levels of chemical may reduce the density of the chemical transporter ( gene ) by either increasing trafficking or reducing synthesis ; a `` neuroadaptive response '' .	T9	T20	12398910
NA	CHEMICAL	GENE-Y	10	13	Low levels of chemical may reduce the density of the chemical transporter ( gene ) by either increasing trafficking or reducing synthesis ; a `` neuroadaptive response '' .	T9	T22	12398910
CPR:4	CHEMICAL	GENE-Y	3	10	To determine whether chemical ( chemical ) -induced reductions in gene density could be related to such a mechanism , chemical or chemical was administered to rats , and brain chemical and gene density were measured .	T2	T17	12398910
NA	CHEMICAL	GENE-Y	3	32	To determine whether chemical ( chemical ) -induced reductions in gene density could be related to such a mechanism , chemical or chemical was administered to rats , and brain chemical and gene density were measured .	T2	T18	12398910
CPR:4	CHEMICAL	GENE-Y	5	10	To determine whether chemical ( chemical ) -induced reductions in gene density could be related to such a mechanism , chemical or chemical was administered to rats , and brain chemical and gene density were measured .	T3	T17	12398910
NA	CHEMICAL	GENE-Y	5	32	To determine whether chemical ( chemical ) -induced reductions in gene density could be related to such a mechanism , chemical or chemical was administered to rats , and brain chemical and gene density were measured .	T3	T18	12398910
NA	CHEMICAL	GENE-Y	9	10	To determine whether chemical ( chemical ) -induced reductions in gene density could be related to such a mechanism , chemical or chemical was administered to rats , and brain chemical and gene density were measured .	T4	T17	12398910
NA	CHEMICAL	GENE-Y	9	32	To determine whether chemical ( chemical ) -induced reductions in gene density could be related to such a mechanism , chemical or chemical was administered to rats , and brain chemical and gene density were measured .	T4	T18	12398910
NA	CHEMICAL	GENE-Y	22	10	To determine whether chemical ( chemical ) -induced reductions in gene density could be related to such a mechanism , chemical or chemical was administered to rats , and brain chemical and gene density were measured .	T5	T17	12398910
NA	CHEMICAL	GENE-Y	22	32	To determine whether chemical ( chemical ) -induced reductions in gene density could be related to such a mechanism , chemical or chemical was administered to rats , and brain chemical and gene density were measured .	T5	T18	12398910
NA	CHEMICAL	GENE-Y	9	10	To determine whether chemical ( chemical ) -induced reductions in gene density could be related to such a mechanism , chemical or chemical was administered to rats , and brain chemical and gene density were measured .	T6	T17	12398910
NA	CHEMICAL	GENE-Y	9	32	To determine whether chemical ( chemical ) -induced reductions in gene density could be related to such a mechanism , chemical or chemical was administered to rats , and brain chemical and gene density were measured .	T6	T18	12398910
CPR:4	CHEMICAL	GENE-Y	3	5	However , only chemical reduced gene density .	T8	T19	12398910
CPR:4	CHEMICAL	GENE-Y	0	11	chemical suppresses chemical synthesis by repressing both transcription and activity of gene in allergic rats .	T20	T37	17075268
NA	CHEMICAL	GENE-Y	2	11	chemical suppresses chemical synthesis by repressing both transcription and activity of gene in allergic rats .	T21	T37	17075268
CPR:9	CHEMICAL	GENE-Y	2	6	BACKGROUND : chemical synthesized by chemical decarboxylase ( gene ) from chemical is a major chemical mediator in the development of nasal allergy which is characterized by nasal hypersensitivity .	T3	T32	17075268
CPR:9	CHEMICAL	GENE-Y	2	8	BACKGROUND : chemical synthesized by chemical decarboxylase ( gene ) from chemical is a major chemical mediator in the development of nasal allergy which is characterized by nasal hypersensitivity .	T3	T34	17075268
NA	CHEMICAL	GENE-Y	5	6	BACKGROUND : chemical synthesized by chemical decarboxylase ( gene ) from chemical is a major chemical mediator in the development of nasal allergy which is characterized by nasal hypersensitivity .	T13	T32	17075268
NA	CHEMICAL	GENE-Y	5	8	BACKGROUND : chemical synthesized by chemical decarboxylase ( gene ) from chemical is a major chemical mediator in the development of nasal allergy which is characterized by nasal hypersensitivity .	T13	T34	17075268
CPR:9	CHEMICAL	GENE-Y	11	6	BACKGROUND : chemical synthesized by chemical decarboxylase ( gene ) from chemical is a major chemical mediator in the development of nasal allergy which is characterized by nasal hypersensitivity .	T18	T32	17075268
CPR:9	CHEMICAL	GENE-Y	11	8	BACKGROUND : chemical synthesized by chemical decarboxylase ( gene ) from chemical is a major chemical mediator in the development of nasal allergy which is characterized by nasal hypersensitivity .	T18	T34	17075268
CPR:9	CHEMICAL	GENE-Y	5	8	However the regulatory mechanism of chemical synthesis by gene remains to be elucidated .	T11	T30	17075268
NA	CHEMICAL	GENE-Y	12	15	The objectives of the present study were to examine the changes of chemical content , gene activity and gene mRNA expression in the nasal mucosa of allergy model rats sensitized by the exposure to chemical ( chemical ) and to investigate the effect of chemical on the above mentioned allergic parameters .	T12	T31	17075268
NA	CHEMICAL	GENE-Y	12	18	The objectives of the present study were to examine the changes of chemical content , gene activity and gene mRNA expression in the nasal mucosa of allergy model rats sensitized by the exposure to chemical ( chemical ) and to investigate the effect of chemical on the above mentioned allergic parameters .	T12	T33	17075268
NA	CHEMICAL	GENE-Y	34	15	The objectives of the present study were to examine the changes of chemical content , gene activity and gene mRNA expression in the nasal mucosa of allergy model rats sensitized by the exposure to chemical ( chemical ) and to investigate the effect of chemical on the above mentioned allergic parameters .	T14	T31	17075268
NA	CHEMICAL	GENE-Y	34	18	The objectives of the present study were to examine the changes of chemical content , gene activity and gene mRNA expression in the nasal mucosa of allergy model rats sensitized by the exposure to chemical ( chemical ) and to investigate the effect of chemical on the above mentioned allergic parameters .	T14	T33	17075268
NA	CHEMICAL	GENE-Y	36	15	The objectives of the present study were to examine the changes of chemical content , gene activity and gene mRNA expression in the nasal mucosa of allergy model rats sensitized by the exposure to chemical ( chemical ) and to investigate the effect of chemical on the above mentioned allergic parameters .	T15	T31	17075268
NA	CHEMICAL	GENE-Y	36	18	The objectives of the present study were to examine the changes of chemical content , gene activity and gene mRNA expression in the nasal mucosa of allergy model rats sensitized by the exposure to chemical ( chemical ) and to investigate the effect of chemical on the above mentioned allergic parameters .	T15	T33	17075268
NA	CHEMICAL	GENE-Y	44	15	The objectives of the present study were to examine the changes of chemical content , gene activity and gene mRNA expression in the nasal mucosa of allergy model rats sensitized by the exposure to chemical ( chemical ) and to investigate the effect of chemical on the above mentioned allergic parameters .	T16	T31	17075268
NA	CHEMICAL	GENE-Y	44	18	The objectives of the present study were to examine the changes of chemical content , gene activity and gene mRNA expression in the nasal mucosa of allergy model rats sensitized by the exposure to chemical ( chemical ) and to investigate the effect of chemical on the above mentioned allergic parameters .	T16	T33	17075268
NA	CHEMICAL	GENE-Y	0	3	chemical content and gene activity in the nasal mucosa were determined using fluorometric high performance liquid chromatography .	T19	T35	17075268
NA	CHEMICAL	GENE-Y	0	3	chemical content , gene activity and gene mRNA expression in nasal mucosa were also significantly increased after chemical provocation .	T2	T22	17075268
NA	CHEMICAL	GENE-Y	0	6	chemical content , gene activity and gene mRNA expression in nasal mucosa were also significantly increased after chemical provocation .	T2	T23	17075268
CPR:3	CHEMICAL	GENE-Y	17	3	chemical content , gene activity and gene mRNA expression in nasal mucosa were also significantly increased after chemical provocation .	T4	T22	17075268
CPR:3	CHEMICAL	GENE-Y	17	6	chemical content , gene activity and gene mRNA expression in nasal mucosa were also significantly increased after chemical provocation .	T4	T23	17075268
CPR:4	CHEMICAL	GENE-Y	2	14	Pretreatment with chemical significantly suppressed nasal allergy-like behaviors , up-regulation of chemical content , gene activity and gene mRNA induced by chemical in chemical-sensitized rats .	T5	T24	17075268
CPR:4	CHEMICAL	GENE-Y	2	17	Pretreatment with chemical significantly suppressed nasal allergy-like behaviors , up-regulation of chemical content , gene activity and gene mRNA induced by chemical in chemical-sensitized rats .	T5	T25	17075268
NA	CHEMICAL	GENE-Y	11	14	Pretreatment with chemical significantly suppressed nasal allergy-like behaviors , up-regulation of chemical content , gene activity and gene mRNA induced by chemical in chemical-sensitized rats .	T6	T24	17075268
NA	CHEMICAL	GENE-Y	11	17	Pretreatment with chemical significantly suppressed nasal allergy-like behaviors , up-regulation of chemical content , gene activity and gene mRNA induced by chemical in chemical-sensitized rats .	T6	T25	17075268
CPR:3	CHEMICAL	GENE-Y	21	14	Pretreatment with chemical significantly suppressed nasal allergy-like behaviors , up-regulation of chemical content , gene activity and gene mRNA induced by chemical in chemical-sensitized rats .	T7	T24	17075268
CPR:3	CHEMICAL	GENE-Y	21	17	Pretreatment with chemical significantly suppressed nasal allergy-like behaviors , up-regulation of chemical content , gene activity and gene mRNA induced by chemical in chemical-sensitized rats .	T7	T25	17075268
NA	CHEMICAL	GENE-Y	23	14	Pretreatment with chemical significantly suppressed nasal allergy-like behaviors , up-regulation of chemical content , gene activity and gene mRNA induced by chemical in chemical-sensitized rats .	T8	T24	17075268
CPR:3	CHEMICAL	GENE-Y	23	17	Pretreatment with chemical significantly suppressed nasal allergy-like behaviors , up-regulation of chemical content , gene activity and gene mRNA induced by chemical in chemical-sensitized rats .	T8	T25	17075268
CPR:9	CHEMICAL	GENE-Y	9	13	CONCLUSIONS : These findings indicate that increased synthesis of chemical through up-regulation of gene gene expression and gene activity in nasal mucosa plays an important role in the development of nasal hypersensitivity .	T9	T26	17075268
CPR:9	CHEMICAL	GENE-Y	9	17	CONCLUSIONS : These findings indicate that increased synthesis of chemical through up-regulation of gene gene expression and gene activity in nasal mucosa plays an important role in the development of nasal hypersensitivity .	T9	T27	17075268
NA	CHEMICAL	GENE-Y	3	11	Levels of brain chemical ( Ach ) , serum and brain gene ( gene ) activity , gene ( gene ) , total gene ( gene ) , and gene ( gene ) were estimated .	T1	T4	23631499
NA	CHEMICAL	GENE-Y	3	5	Levels of brain chemical ( Ach ) , serum and brain gene ( gene ) activity , gene ( gene ) , total gene ( gene ) , and gene ( gene ) were estimated .	T1	T5	23631499
NA	CHEMICAL	GENE-Y	3	17	Levels of brain chemical ( Ach ) , serum and brain gene ( gene ) activity , gene ( gene ) , total gene ( gene ) , and gene ( gene ) were estimated .	T1	T6	23631499
NA	CHEMICAL	GENE-Y	3	19	Levels of brain chemical ( Ach ) , serum and brain gene ( gene ) activity , gene ( gene ) , total gene ( gene ) , and gene ( gene ) were estimated .	T1	T7	23631499
NA	CHEMICAL	GENE-N	3	23	Levels of brain chemical ( Ach ) , serum and brain gene ( gene ) activity , gene ( gene ) , total gene ( gene ) , and gene ( gene ) were estimated .	T1	T8	23631499
NA	CHEMICAL	GENE-N	3	25	Levels of brain chemical ( Ach ) , serum and brain gene ( gene ) activity , gene ( gene ) , total gene ( gene ) , and gene ( gene ) were estimated .	T1	T9	23631499
NA	CHEMICAL	GENE-Y	3	29	Levels of brain chemical ( Ach ) , serum and brain gene ( gene ) activity , gene ( gene ) , total gene ( gene ) , and gene ( gene ) were estimated .	T1	T10	23631499
NA	CHEMICAL	GENE-Y	3	31	Levels of brain chemical ( Ach ) , serum and brain gene ( gene ) activity , gene ( gene ) , total gene ( gene ) , and gene ( gene ) were estimated .	T1	T11	23631499
NA	CHEMICAL	GENE-Y	3	10	Neuroprotective effects of chemical against excitotoxicity partially through down-regulation of gene-containing chemical receptors .	T17	T24	23219339
NA	CHEMICAL	GENE-N	3	12	Neuroprotective effects of chemical against excitotoxicity partially through down-regulation of gene-containing chemical receptors .	T17	T23	23219339
NA	CHEMICAL	GENE-Y	11	10	Neuroprotective effects of chemical against excitotoxicity partially through down-regulation of gene-containing chemical receptors .	T16	T24	23219339
NA	CHEMICAL	GENE-N	11	12	Neuroprotective effects of chemical against excitotoxicity partially through down-regulation of gene-containing chemical receptors .	T16	T23	23219339
CPR:4	CHEMICAL	GENE-Y	5	10	Western blot analysis revealed that chemical decreased the expression of gene and repaired the balance of pro- and anti-apoptotic proteins .	T14	T21	23219339
CPR:4	CHEMICAL	GENE-Y	2	8	Furthermore , chemical significantly reversed the up-regulation of gene and inhibited the chemical overload in the cultured neurons after challenging the chemical .	T15	T22	23219339
NA	CHEMICAL	GENE-Y	8	8	Furthermore , chemical significantly reversed the up-regulation of gene and inhibited the chemical overload in the cultured neurons after challenging the chemical .	T2	T22	23219339
NA	CHEMICAL	GENE-Y	21	8	Furthermore , chemical significantly reversed the up-regulation of gene and inhibited the chemical overload in the cultured neurons after challenging the chemical .	T3	T22	23219339
NA	CHEMICAL	GENE-Y	7	8	Drug binding interactions in the inner cavity of gene channels : molecular insights from structure-activity relationships of chemical and chemical analogs .	T15	T22	16291873
NA	CHEMICAL	GENE-Y	19	8	Drug binding interactions in the inner cavity of gene channels : molecular insights from structure-activity relationships of chemical and chemical analogs .	T16	T22	16291873
NA	CHEMICAL	GENE-Y	24	3	Binding sites for gene blockers have been mapped within the inner cavity of the channel and include aromatic residues in the S6 helix ( chemical-652 , chemical-656 ) and residues in the pore helix ( chemical-623 , chemical-624 , chemical-625 ) .	T7	T19	16291873
NA	CHEMICAL	GENE-Y	26	3	Binding sites for gene blockers have been mapped within the inner cavity of the channel and include aromatic residues in the S6 helix ( chemical-652 , chemical-656 ) and residues in the pore helix ( chemical-623 , chemical-624 , chemical-625 ) .	T8	T19	16291873
NA	CHEMICAL	GENE-Y	35	3	Binding sites for gene blockers have been mapped within the inner cavity of the channel and include aromatic residues in the S6 helix ( chemical-652 , chemical-656 ) and residues in the pore helix ( chemical-623 , chemical-624 , chemical-625 ) .	T9	T19	16291873
NA	CHEMICAL	GENE-Y	37	3	Binding sites for gene blockers have been mapped within the inner cavity of the channel and include aromatic residues in the S6 helix ( chemical-652 , chemical-656 ) and residues in the pore helix ( chemical-623 , chemical-624 , chemical-625 ) .	T10	T19	16291873
NA	CHEMICAL	GENE-Y	39	3	Binding sites for gene blockers have been mapped within the inner cavity of the channel and include aromatic residues in the S6 helix ( chemical-652 , chemical-656 ) and residues in the pore helix ( chemical-623 , chemical-624 , chemical-625 ) .	T11	T19	16291873
CPR:4	CHEMICAL	GENE-Y	3	12	We used mutagenesis of these residues , combined with an investigation of gene block by close analogs of chemical and chemical , to assess how specific alterations in drug structure affected potency and binding interactions .	T12	T20	16291873
CPR:4	CHEMICAL	GENE-Y	20	12	We used mutagenesis of these residues , combined with an investigation of gene block by close analogs of chemical and chemical , to assess how specific alterations in drug structure affected potency and binding interactions .	T13	T20	16291873
NA	CHEMICAL	GENE-Y	9	17	In contrast , analogs with different para-substituents on the chemical ring had significantly different potencies for wild-type gene block .	T1	T17	16291873
NA	CHEMICAL	GENE-N	7	16	This mini-review evaluates the theoretical potential of a pharmacological enhancement strategy of cognitive remediation training with gene ( gene ) agonists .	T1	T3	22705396
NA	CHEMICAL	GENE-N	7	18	This mini-review evaluates the theoretical potential of a pharmacological enhancement strategy of cognitive remediation training with gene ( gene ) agonists .	T1	T4	22705396
CPR:4	CHEMICAL	GENE-Y	0	11	chemical exerts antitumor activity against human osteosarcoma cells by inhibiting the gene/gene signaling pathway .	T18	T43	23313376
CPR:4	CHEMICAL	GENE-Y	0	11	chemical exerts antitumor activity against human osteosarcoma cells by inhibiting the gene/gene signaling pathway .	T18	T44	23313376
NA	CHEMICAL	GENE-Y	10	20	In this study , we assessed the antitumor activity of chemical against human osteosarcoma cells and explored the role of gene/gene and apoptosis-related signaling pathways on the activity of chemical .	T12	T41	23313376
NA	CHEMICAL	GENE-Y	10	20	In this study , we assessed the antitumor activity of chemical against human osteosarcoma cells and explored the role of gene/gene and apoptosis-related signaling pathways on the activity of chemical .	T12	T42	23313376
NA	CHEMICAL	GENE-Y	29	20	In this study , we assessed the antitumor activity of chemical against human osteosarcoma cells and explored the role of gene/gene and apoptosis-related signaling pathways on the activity of chemical .	T14	T41	23313376
NA	CHEMICAL	GENE-Y	29	20	In this study , we assessed the antitumor activity of chemical against human osteosarcoma cells and explored the role of gene/gene and apoptosis-related signaling pathways on the activity of chemical .	T14	T42	23313376
CPR:4	CHEMICAL	GENE-Y	2	9	Furthermore , chemical treatment directly inhibited the phosphorylation of gene at chemical 1007 and the downstream activation of gene .	T1	T19	23313376
CPR:4	CHEMICAL	GENE-Y	2	18	Furthermore , chemical treatment directly inhibited the phosphorylation of gene at chemical 1007 and the downstream activation of gene .	T1	T20	23313376
NA	CHEMICAL	GENE-Y	11	9	Furthermore , chemical treatment directly inhibited the phosphorylation of gene at chemical 1007 and the downstream activation of gene .	T3	T19	23313376
NA	CHEMICAL	GENE-Y	11	18	Furthermore , chemical treatment directly inhibited the phosphorylation of gene at chemical 1007 and the downstream activation of gene .	T3	T20	23313376
CPR:4	CHEMICAL	GENE-Y	0	6	chemical also down-regulated the expression of gene target genes , including the anti-apoptotic proteins gene and gene , leading to the up-regulation of mitochondrial apoptosis pathway-related proteins ( gene , gene , cytosolic gene , and cleaved gene ) and gene inhibitors such as gene and gene .	T4	T21	23313376
CPR:4	CHEMICAL	GENE-Y	0	14	chemical also down-regulated the expression of gene target genes , including the anti-apoptotic proteins gene and gene , leading to the up-regulation of mitochondrial apoptosis pathway-related proteins ( gene , gene , cytosolic gene , and cleaved gene ) and gene inhibitors such as gene and gene .	T4	T22	23313376
CPR:4	CHEMICAL	GENE-Y	0	16	chemical also down-regulated the expression of gene target genes , including the anti-apoptotic proteins gene and gene , leading to the up-regulation of mitochondrial apoptosis pathway-related proteins ( gene , gene , cytosolic gene , and cleaved gene ) and gene inhibitors such as gene and gene .	T4	T23	23313376
CPR:3	CHEMICAL	GENE-Y	0	28	chemical also down-regulated the expression of gene target genes , including the anti-apoptotic proteins gene and gene , leading to the up-regulation of mitochondrial apoptosis pathway-related proteins ( gene , gene , cytosolic gene , and cleaved gene ) and gene inhibitors such as gene and gene .	T4	T24	23313376
CPR:3	CHEMICAL	GENE-Y	0	30	chemical also down-regulated the expression of gene target genes , including the anti-apoptotic proteins gene and gene , leading to the up-regulation of mitochondrial apoptosis pathway-related proteins ( gene , gene , cytosolic gene , and cleaved gene ) and gene inhibitors such as gene and gene .	T4	T25	23313376
CPR:3	CHEMICAL	GENE-Y	0	33	chemical also down-regulated the expression of gene target genes , including the anti-apoptotic proteins gene and gene , leading to the up-regulation of mitochondrial apoptosis pathway-related proteins ( gene , gene , cytosolic gene , and cleaved gene ) and gene inhibitors such as gene and gene .	T4	T26	23313376
CPR:3	CHEMICAL	GENE-Y	0	37	chemical also down-regulated the expression of gene target genes , including the anti-apoptotic proteins gene and gene , leading to the up-regulation of mitochondrial apoptosis pathway-related proteins ( gene , gene , cytosolic gene , and cleaved gene ) and gene inhibitors such as gene and gene .	T4	T27	23313376
NA	CHEMICAL	GENE-N	0	40	chemical also down-regulated the expression of gene target genes , including the anti-apoptotic proteins gene and gene , leading to the up-regulation of mitochondrial apoptosis pathway-related proteins ( gene , gene , cytosolic gene , and cleaved gene ) and gene inhibitors such as gene and gene .	T4	T28	23313376
CPR:3	CHEMICAL	GENE-Y	0	44	chemical also down-regulated the expression of gene target genes , including the anti-apoptotic proteins gene and gene , leading to the up-regulation of mitochondrial apoptosis pathway-related proteins ( gene , gene , cytosolic gene , and cleaved gene ) and gene inhibitors such as gene and gene .	T4	T29	23313376
CPR:3	CHEMICAL	GENE-Y	0	46	chemical also down-regulated the expression of gene target genes , including the anti-apoptotic proteins gene and gene , leading to the up-regulation of mitochondrial apoptosis pathway-related proteins ( gene , gene , cytosolic gene , and cleaved gene ) and gene inhibitors such as gene and gene .	T4	T30	23313376
NA	CHEMICAL	GENE-Y	0	8	chemical , used in combination with a known gene/gene inhibitor , chemical , further decreased the viability of osteosarcoma cells .	T5	T31	23313376
NA	CHEMICAL	GENE-Y	0	8	chemical , used in combination with a known gene/gene inhibitor , chemical , further decreased the viability of osteosarcoma cells .	T5	T32	23313376
CPR:4	CHEMICAL	GENE-Y	11	8	chemical , used in combination with a known gene/gene inhibitor , chemical , further decreased the viability of osteosarcoma cells .	T7	T31	23313376
CPR:4	CHEMICAL	GENE-Y	11	8	chemical , used in combination with a known gene/gene inhibitor , chemical , further decreased the viability of osteosarcoma cells .	T7	T32	23313376
CPR:4	CHEMICAL	GENE-Y	3	15	Taken together , chemical is a potent inhibitor of osteosarcoma cell growth that targets the gene/gene signaling pathway .	T8	T33	23313376
CPR:4	CHEMICAL	GENE-Y	3	15	Taken together , chemical is a potent inhibitor of osteosarcoma cell growth that targets the gene/gene signaling pathway .	T8	T34	23313376
NA	CHEMICAL	GENE-Y	8	2	In vitro gene release studies were performed in chemical buffer pH 7.4 and also in chemical pH 2 with and without gene .	T4	T11	23313633
NA	CHEMICAL	GENE-N	8	7	In vitro gene release studies were performed in chemical buffer pH 7.4 and also in chemical pH 2 with and without gene .	T4	T12	23313633
NA	CHEMICAL	GENE-Y	15	2	In vitro gene release studies were performed in chemical buffer pH 7.4 and also in chemical pH 2 with and without gene .	T5	T11	23313633
NA	CHEMICAL	GENE-N	15	7	In vitro gene release studies were performed in chemical buffer pH 7.4 and also in chemical pH 2 with and without gene .	T5	T12	23313633
NA	CHEMICAL	GENE-Y	6	16	Further insights into the effect of chemical in short QT syndrome caused by a mutation in gene .	T7	T12	15673388
CPR:4	CHEMICAL	GENE-N	14	17	INTRODUCTION : The principal aim of this study was to assess the efficacy of chemical in suppressing gene in vitro and in modulating the rate dependence of the QT interval in the `` SQT1 '' form of the short QT syndrome .	T5	T8	15673388
NA	CHEMICAL	GENE-Y	8	8	Data from heterologous expression of wild-type and mutant gene genes indicate the mutation causes a 20-fold increase in IC50 of d-sotalol but only a 5.8-fold increase in IC50 of chemical .	T1	T11	15673388
CPR:4	CHEMICAL	GENE-N	4	15	Endogenously produced asymmetrically methylated chemical residues are competitive inhibitors of all three isoforms of chemical synthase ( gene ) .	T5	T10	10950934
CPR:4	CHEMICAL	GENE-N	4	17	Endogenously produced asymmetrically methylated chemical residues are competitive inhibitors of all three isoforms of chemical synthase ( gene ) .	T5	T12	10950934
NA	CHEMICAL	GENE-N	14	15	Endogenously produced asymmetrically methylated chemical residues are competitive inhibitors of all three isoforms of chemical synthase ( gene ) .	T1	T10	10950934
NA	CHEMICAL	GENE-N	14	17	Endogenously produced asymmetrically methylated chemical residues are competitive inhibitors of all three isoforms of chemical synthase ( gene ) .	T1	T12	10950934
NA	CHEMICAL	GENE-N	2	3	The enzyme chemical dimethylaminohydrolase ( gene ) specifically hydrolyzes these asymmetrically methylated chemical residues to citrulline and methylamines .	T2	T15	10950934
NA	CHEMICAL	GENE-N	2	5	The enzyme chemical dimethylaminohydrolase ( gene ) specifically hydrolyzes these asymmetrically methylated chemical residues to citrulline and methylamines .	T2	T17	10950934
CPR:9	CHEMICAL	GENE-N	12	3	The enzyme chemical dimethylaminohydrolase ( gene ) specifically hydrolyzes these asymmetrically methylated chemical residues to citrulline and methylamines .	T3	T15	10950934
CPR:9	CHEMICAL	GENE-N	12	5	The enzyme chemical dimethylaminohydrolase ( gene ) specifically hydrolyzes these asymmetrically methylated chemical residues to citrulline and methylamines .	T3	T17	10950934
CPR:9	CHEMICAL	GENE-N	8	11	Previously we have proposed that regulation of asymmetric chemical concentration by gene may provide a novel mechanism for the regulation of gene activity in vivo .	T4	T18	10950934
NA	CHEMICAL	GENE-N	8	21	Previously we have proposed that regulation of asymmetric chemical concentration by gene may provide a novel mechanism for the regulation of gene activity in vivo .	T4	T19	10950934
NA	CHEMICAL	GENE-Y	4	5	Discovery and optimization of chemical as inhibitors of chemical aminopeptidase-2 : a structural basis for the reduction of gene binding .	T4	T14	16789740
CPR:4	CHEMICAL	GENE-Y	4	11	Discovery and optimization of chemical as inhibitors of chemical aminopeptidase-2 : a structural basis for the reduction of gene binding .	T4	T13	16789740
NA	CHEMICAL	GENE-Y	8	5	Discovery and optimization of chemical as inhibitors of chemical aminopeptidase-2 : a structural basis for the reduction of gene binding .	T5	T14	16789740
NA	CHEMICAL	GENE-Y	8	11	Discovery and optimization of chemical as inhibitors of chemical aminopeptidase-2 : a structural basis for the reduction of gene binding .	T5	T13	16789740
NA	CHEMICAL	GENE-Y	0	1	chemical aminopeptidase-2 ( gene ) is a novel target for cancer therapy .	T1	T6	16789740
NA	CHEMICAL	GENE-Y	0	3	chemical aminopeptidase-2 ( gene ) is a novel target for cancer therapy .	T1	T9	16789740
NA	CHEMICAL	GENE-Y	14	12	As part of an effort to discover orally active reversible inhibitors of gene , a series of chemical with micromolar affinities for gene were identified using affinity selection by mass spectrometry ( ASMS ) screening .	T2	T7	16789740
NA	CHEMICAL	GENE-Y	14	22	As part of an effort to discover orally active reversible inhibitors of gene , a series of chemical with micromolar affinities for gene were identified using affinity selection by mass spectrometry ( ASMS ) screening .	T2	T8	16789740
CPR:6	CHEMICAL	GENE-N	2	7	Actions of chemical , a selective chemical H2-receptor antagonist , on gastric acid secretion in dogs , rats and frogs .	T17	T21	2877081
NA	CHEMICAL	GENE-N	4	7	Actions of chemical , a selective chemical H2-receptor antagonist , on gastric acid secretion in dogs , rats and frogs .	T18	T21	2877081
CPR:6	CHEMICAL	GENE-N	0	8	chemical ( chemical ) , a selective chemical H2-receptor antagonist , is a potent inhibitor of gastric acid secretion .	T1	T19	2877081
CPR:6	CHEMICAL	GENE-N	2	8	chemical ( chemical ) , a selective chemical H2-receptor antagonist , is a potent inhibitor of gastric acid secretion .	T2	T19	2877081
NA	CHEMICAL	GENE-N	5	8	chemical ( chemical ) , a selective chemical H2-receptor antagonist , is a potent inhibitor of gastric acid secretion .	T7	T19	2877081
NA	CHEMICAL	GENE-Y	19	23	Against acid secretion from the vagally innervated gastric fistula and Heidenhain pouch of dogs stimulated with submaximal doses of chemical , chemical and gene , chemical was , respectively , 6.5 , 5 and 4.7 times as active as chemical by i.v .	T8	T20	2877081
NA	CHEMICAL	GENE-Y	21	23	Against acid secretion from the vagally innervated gastric fistula and Heidenhain pouch of dogs stimulated with submaximal doses of chemical , chemical and gene , chemical was , respectively , 6.5 , 5 and 4.7 times as active as chemical by i.v .	T9	T20	2877081
NA	CHEMICAL	GENE-Y	25	23	Against acid secretion from the vagally innervated gastric fistula and Heidenhain pouch of dogs stimulated with submaximal doses of chemical , chemical and gene , chemical was , respectively , 6.5 , 5 and 4.7 times as active as chemical by i.v .	T10	T20	2877081
NA	CHEMICAL	GENE-Y	39	23	Against acid secretion from the vagally innervated gastric fistula and Heidenhain pouch of dogs stimulated with submaximal doses of chemical , chemical and gene , chemical was , respectively , 6.5 , 5 and 4.7 times as active as chemical by i.v .	T11	T20	2877081
NA	CHEMICAL	GENE-Y	3	9	Glioma cell sensitivity to chemical : the role of gene and chemical-induced DNA damage .	T6	T17	11166732
NA	CHEMICAL	GENE-Y	3	9	Glioma cell sensitivity to chemical : the role of gene and chemical-induced DNA damage .	T7	T17	11166732
CPR:4	CHEMICAL	GENE-Y	0	3	chemical is a gene inhibitor which is currently evaluated as an adjuvant agent for malignant glioma .	T1	T8	11166732
CPR:3	CHEMICAL	GENE-Y	17	1	High gene protein levels , but not genetic or functional gene status , were associated with increased chemical-induced DNA/gene complex formation .	T3	T10	11166732
NA	CHEMICAL	GENE-Y	17	10	High gene protein levels , but not genetic or functional gene status , were associated with increased chemical-induced DNA/gene complex formation .	T3	T11	11166732
NA	CHEMICAL	GENE-Y	17	18	High gene protein levels , but not genetic or functional gene status , were associated with increased chemical-induced DNA/gene complex formation .	T3	T12	11166732
NA	CHEMICAL	GENE-Y	14	2	Neither functional gene status , nor gene protein levels , nor complex formation predicted chemical-induced growth inhibition .	T4	T13	11166732
NA	CHEMICAL	GENE-Y	14	6	Neither functional gene status , nor gene protein levels , nor complex formation predicted chemical-induced growth inhibition .	T4	T14	11166732
CPR:4	CHEMICAL	GENE-Y	12	10	Synthesis and Structure-Activity Relationship Studies of Derivatives of the Dual gene-gene Inhibitor chemical .	T16	T22	23495205
CPR:4	CHEMICAL	GENE-Y	12	10	Synthesis and Structure-Activity Relationship Studies of Derivatives of the Dual gene-gene Inhibitor chemical .	T16	T23	23495205
CPR:4	CHEMICAL	GENE-Y	0	15	chemical and its ortho-halogenated ( chemical , chemical , chemical ) derivatives are first-generation dual gene and gene inhibitors ( DASIs ) .	T1	T17	23495205
CPR:4	CHEMICAL	GENE-Y	0	17	chemical and its ortho-halogenated ( chemical , chemical , chemical ) derivatives are first-generation dual gene and gene inhibitors ( DASIs ) .	T1	T18	23495205
CPR:4	CHEMICAL	GENE-Y	5	15	chemical and its ortho-halogenated ( chemical , chemical , chemical ) derivatives are first-generation dual gene and gene inhibitors ( DASIs ) .	T15	T17	23495205
CPR:4	CHEMICAL	GENE-Y	5	17	chemical and its ortho-halogenated ( chemical , chemical , chemical ) derivatives are first-generation dual gene and gene inhibitors ( DASIs ) .	T15	T18	23495205
CPR:4	CHEMICAL	GENE-Y	7	15	chemical and its ortho-halogenated ( chemical , chemical , chemical ) derivatives are first-generation dual gene and gene inhibitors ( DASIs ) .	T2	T17	23495205
CPR:4	CHEMICAL	GENE-Y	7	17	chemical and its ortho-halogenated ( chemical , chemical , chemical ) derivatives are first-generation dual gene and gene inhibitors ( DASIs ) .	T2	T18	23495205
CPR:4	CHEMICAL	GENE-Y	9	15	chemical and its ortho-halogenated ( chemical , chemical , chemical ) derivatives are first-generation dual gene and gene inhibitors ( DASIs ) .	T3	T17	23495205
CPR:4	CHEMICAL	GENE-Y	9	17	chemical and its ortho-halogenated ( chemical , chemical , chemical ) derivatives are first-generation dual gene and gene inhibitors ( DASIs ) .	T3	T18	23495205
CPR:4	CHEMICAL	GENE-Y	9	15	The most potent in vitro DASI discovered is an chemical derivative with IC50 values against gene and chemical sulfatase in a JEG-3 cell preparation of 0.2 and 2.5 nM , respectively .	T12	T19	23495205
CPR:4	CHEMICAL	GENE-Y	9	18	The most potent in vitro DASI discovered is an chemical derivative with IC50 values against gene and chemical sulfatase in a JEG-3 cell preparation of 0.2 and 2.5 nM , respectively .	T12	T20	23495205
NA	CHEMICAL	GENE-Y	17	15	The most potent in vitro DASI discovered is an chemical derivative with IC50 values against gene and chemical sulfatase in a JEG-3 cell preparation of 0.2 and 2.5 nM , respectively .	T13	T19	23495205
NA	CHEMICAL	GENE-Y	17	18	The most potent in vitro DASI discovered is an chemical derivative with IC50 values against gene and chemical sulfatase in a JEG-3 cell preparation of 0.2 and 2.5 nM , respectively .	T13	T20	23495205
NA	CHEMICAL	GENE-N	18	20	Proximal tubule cells extract dicarboxylates from filtrate and blood , using cotransporters located in the brush border [ chemical dicarboxylate cotransporter ( gene ) ] and basolateral cell membrane ( gene ) .	T6	T33	15561973
NA	CHEMICAL	GENE-Y	18	22	Proximal tubule cells extract dicarboxylates from filtrate and blood , using cotransporters located in the brush border [ chemical dicarboxylate cotransporter ( gene ) ] and basolateral cell membrane ( gene ) .	T6	T35	15561973
NA	CHEMICAL	GENE-Y	18	30	Proximal tubule cells extract dicarboxylates from filtrate and blood , using cotransporters located in the brush border [ chemical dicarboxylate cotransporter ( gene ) ] and basolateral cell membrane ( gene ) .	T6	T38	15561973
CPR:4	CHEMICAL	GENE-Y	14	9	As opposed to the rat and flounder orthologs , gene was hardly inhibited by chemical concentrations up to 5 mM .	T7	T34	15561973
NA	CHEMICAL	GENE-Y	6	6	Tissue expression and translational control of genee/chemical transaminase K mRNAs .	T12	T34	12850267
NA	CHEMICAL	GENE-Y	6	8	Tissue expression and translational control of genee/chemical transaminase K mRNAs .	T12	T35	12850267
CPR:6	CHEMICAL	GENE-N	0	8	chemical ( chemical ) is an endogenous chemical receptor antagonist at the level of the different ionotropic genes .	T1	T24	12850267
CPR:6	CHEMICAL	GENE-N	0	8	chemical ( chemical ) is an endogenous chemical receptor antagonist at the level of the different ionotropic genes .	T1	T33	12850267
CPR:6	CHEMICAL	GENE-N	2	8	chemical ( chemical ) is an endogenous chemical receptor antagonist at the level of the different ionotropic genes .	T3	T24	12850267
CPR:6	CHEMICAL	GENE-N	2	8	chemical ( chemical ) is an endogenous chemical receptor antagonist at the level of the different ionotropic genes .	T3	T33	12850267
NA	CHEMICAL	GENE-N	7	8	chemical ( chemical ) is an endogenous chemical receptor antagonist at the level of the different ionotropic genes .	T10	T24	12850267
NA	CHEMICAL	GENE-N	7	8	chemical ( chemical ) is an endogenous chemical receptor antagonist at the level of the different ionotropic genes .	T10	T33	12850267
NA	CHEMICAL	GENE-N	10	8	chemical ( chemical ) is an endogenous chemical receptor antagonist at the level of the different ionotropic genes .	T2	T24	12850267
NA	CHEMICAL	GENE-N	10	8	chemical ( chemical ) is an endogenous chemical receptor antagonist at the level of the different ionotropic genes .	T2	T33	12850267
CPR:9	CHEMICAL	GENE-Y	9	13	One of the enzymes responsible for the production of chemical , chemical aminotransferase I ( gene ) , also catalyses the reversible transamination of chemical to chemical ( gene , gene ) .	T6	T20	12850267
CPR:9	CHEMICAL	GENE-Y	9	13	One of the enzymes responsible for the production of chemical , chemical aminotransferase I ( gene ) , also catalyses the reversible transamination of chemical to chemical ( gene , gene ) .	T6	T21	12850267
NA	CHEMICAL	GENE-Y	9	28	One of the enzymes responsible for the production of chemical , chemical aminotransferase I ( gene ) , also catalyses the reversible transamination of chemical to chemical ( gene , gene ) .	T6	T22	12850267
NA	CHEMICAL	GENE-Y	9	30	One of the enzymes responsible for the production of chemical , chemical aminotransferase I ( gene ) , also catalyses the reversible transamination of chemical to chemical ( gene , gene ) .	T6	T23	12850267
NA	CHEMICAL	GENE-Y	11	13	One of the enzymes responsible for the production of chemical , chemical aminotransferase I ( gene ) , also catalyses the reversible transamination of chemical to chemical ( gene , gene ) .	T7	T20	12850267
NA	CHEMICAL	GENE-Y	11	13	One of the enzymes responsible for the production of chemical , chemical aminotransferase I ( gene ) , also catalyses the reversible transamination of chemical to chemical ( gene , gene ) .	T7	T21	12850267
NA	CHEMICAL	GENE-Y	11	28	One of the enzymes responsible for the production of chemical , chemical aminotransferase I ( gene ) , also catalyses the reversible transamination of chemical to chemical ( gene , gene ) .	T7	T22	12850267
NA	CHEMICAL	GENE-Y	11	30	One of the enzymes responsible for the production of chemical , chemical aminotransferase I ( gene ) , also catalyses the reversible transamination of chemical to chemical ( gene , gene ) .	T7	T23	12850267
CPR:9	CHEMICAL	GENE-Y	24	13	One of the enzymes responsible for the production of chemical , chemical aminotransferase I ( gene ) , also catalyses the reversible transamination of chemical to chemical ( gene , gene ) .	T8	T20	12850267
CPR:9	CHEMICAL	GENE-Y	24	13	One of the enzymes responsible for the production of chemical , chemical aminotransferase I ( gene ) , also catalyses the reversible transamination of chemical to chemical ( gene , gene ) .	T8	T21	12850267
CPR:9	CHEMICAL	GENE-Y	24	28	One of the enzymes responsible for the production of chemical , chemical aminotransferase I ( gene ) , also catalyses the reversible transamination of chemical to chemical ( gene , gene ) .	T8	T22	12850267
NA	CHEMICAL	GENE-Y	24	30	One of the enzymes responsible for the production of chemical , chemical aminotransferase I ( gene ) , also catalyses the reversible transamination of chemical to chemical ( gene , gene ) .	T8	T23	12850267
CPR:9	CHEMICAL	GENE-Y	26	13	One of the enzymes responsible for the production of chemical , chemical aminotransferase I ( gene ) , also catalyses the reversible transamination of chemical to chemical ( gene , gene ) .	T9	T20	12850267
CPR:9	CHEMICAL	GENE-Y	26	13	One of the enzymes responsible for the production of chemical , chemical aminotransferase I ( gene ) , also catalyses the reversible transamination of chemical to chemical ( gene , gene ) .	T9	T21	12850267
CPR:9	CHEMICAL	GENE-Y	26	28	One of the enzymes responsible for the production of chemical , chemical aminotransferase I ( gene ) , also catalyses the reversible transamination of chemical to chemical ( gene , gene ) .	T9	T22	12850267
CPR:9	CHEMICAL	GENE-Y	26	30	One of the enzymes responsible for the production of chemical , chemical aminotransferase I ( gene ) , also catalyses the reversible transamination of chemical to chemical ( gene , gene ) .	T9	T23	12850267
NA	CHEMICAL	GENE-N	19	11	In this review , the various elements that participate in non-canonical gene signaling , including gene , gene , gene/gene , and chemical , are discussed , focusing on their effect on ASM phenotype and function .	T1	T7	22874922
NA	CHEMICAL	GENE-N	19	15	In this review , the various elements that participate in non-canonical gene signaling , including gene , gene , gene/gene , and chemical , are discussed , focusing on their effect on ASM phenotype and function .	T1	T8	22874922
NA	CHEMICAL	GENE-N	19	17	In this review , the various elements that participate in non-canonical gene signaling , including gene , gene , gene/gene , and chemical , are discussed , focusing on their effect on ASM phenotype and function .	T1	T9	22874922
NA	CHEMICAL	GENE-N	19	19	In this review , the various elements that participate in non-canonical gene signaling , including gene , gene , gene/gene , and chemical , are discussed , focusing on their effect on ASM phenotype and function .	T1	T10	22874922
NA	CHEMICAL	GENE-Y	19	9	In this review , the various elements that participate in non-canonical gene signaling , including gene , gene , gene/gene , and chemical , are discussed , focusing on their effect on ASM phenotype and function .	T1	T11	22874922
NA	CHEMICAL	GENE-N	18	10	Spermine was rapidly taken up and metabolized to spermidine and an unknown , possibly acetamidopropanal , by gene ( gene ) and chemical oxidase ( gene ) .	T12	T28	15133083
NA	CHEMICAL	GENE-N	18	19	Spermine was rapidly taken up and metabolized to spermidine and an unknown , possibly acetamidopropanal , by gene ( gene ) and chemical oxidase ( gene ) .	T12	T29	15133083
NA	CHEMICAL	GENE-N	18	23	Spermine was rapidly taken up and metabolized to spermidine and an unknown , possibly acetamidopropanal , by gene ( gene ) and chemical oxidase ( gene ) .	T12	T30	15133083
NA	CHEMICAL	GENE-N	18	25	Spermine was rapidly taken up and metabolized to spermidine and an unknown , possibly acetamidopropanal , by gene ( gene ) and chemical oxidase ( gene ) .	T12	T31	15133083
NA	CHEMICAL	GENE-N	22	10	Spermine was rapidly taken up and metabolized to spermidine and an unknown , possibly acetamidopropanal , by gene ( gene ) and chemical oxidase ( gene ) .	T13	T28	15133083
NA	CHEMICAL	GENE-N	22	19	Spermine was rapidly taken up and metabolized to spermidine and an unknown , possibly acetamidopropanal , by gene ( gene ) and chemical oxidase ( gene ) .	T13	T29	15133083
NA	CHEMICAL	GENE-N	22	23	Spermine was rapidly taken up and metabolized to spermidine and an unknown , possibly acetamidopropanal , by gene ( gene ) and chemical oxidase ( gene ) .	T13	T30	15133083
NA	CHEMICAL	GENE-N	22	25	Spermine was rapidly taken up and metabolized to spermidine and an unknown , possibly acetamidopropanal , by gene ( gene ) and chemical oxidase ( gene ) .	T13	T31	15133083
NA	CHEMICAL	GENE-N	0	45	chemical analogues of chemical , such as chemical and chemical , as well as chemical analogues [ chemical , a chemical 3-7-3 analogue ] blocked uptake and interconversion of chemical at micromolar levels and , in the case of chemical , acted as substrate for gene .	T15	T24	15133083
NA	CHEMICAL	GENE-N	3	45	chemical analogues of chemical , such as chemical and chemical , as well as chemical analogues [ chemical , a chemical 3-7-3 analogue ] blocked uptake and interconversion of chemical at micromolar levels and , in the case of chemical , acted as substrate for gene .	T16	T24	15133083
NA	CHEMICAL	GENE-N	7	45	chemical analogues of chemical , such as chemical and chemical , as well as chemical analogues [ chemical , a chemical 3-7-3 analogue ] blocked uptake and interconversion of chemical at micromolar levels and , in the case of chemical , acted as substrate for gene .	T17	T24	15133083
NA	CHEMICAL	GENE-N	9	45	chemical analogues of chemical , such as chemical and chemical , as well as chemical analogues [ chemical , a chemical 3-7-3 analogue ] blocked uptake and interconversion of chemical at micromolar levels and , in the case of chemical , acted as substrate for gene .	T18	T24	15133083
NA	CHEMICAL	GENE-N	14	45	chemical analogues of chemical , such as chemical and chemical , as well as chemical analogues [ chemical , a chemical 3-7-3 analogue ] blocked uptake and interconversion of chemical at micromolar levels and , in the case of chemical , acted as substrate for gene .	T19	T24	15133083
NA	CHEMICAL	GENE-N	17	45	chemical analogues of chemical , such as chemical and chemical , as well as chemical analogues [ chemical , a chemical 3-7-3 analogue ] blocked uptake and interconversion of chemical at micromolar levels and , in the case of chemical , acted as substrate for gene .	T20	T24	15133083
NA	CHEMICAL	GENE-N	20	45	chemical analogues of chemical , such as chemical and chemical , as well as chemical analogues [ chemical , a chemical 3-7-3 analogue ] blocked uptake and interconversion of chemical at micromolar levels and , in the case of chemical , acted as substrate for gene .	T21	T24	15133083
NA	CHEMICAL	GENE-N	0	45	chemical analogues of chemical , such as chemical and chemical , as well as chemical analogues [ chemical , a chemical 3-7-3 analogue ] blocked uptake and interconversion of chemical at micromolar levels and , in the case of chemical , acted as substrate for gene .	T1	T24	15133083
CPR:9	CHEMICAL	GENE-N	17	45	chemical analogues of chemical , such as chemical and chemical , as well as chemical analogues [ chemical , a chemical 3-7-3 analogue ] blocked uptake and interconversion of chemical at micromolar levels and , in the case of chemical , acted as substrate for gene .	T2	T24	15133083
CPR:4	CHEMICAL	GENE-N	0	2	chemical inhibited gene activity with a mixed type of inhibition in which the analogue had a 70-fold higher affinity for the enzyme than the natural substrate , chemical .	T3	T27	15133083
NA	CHEMICAL	GENE-N	10	2	chemical inhibited gene activity with a mixed type of inhibition in which the analogue had a 70-fold higher affinity for the enzyme than the natural substrate , chemical .	T4	T27	15133083
CPR:6	CHEMICAL	GENE-Y	1	9	A chemical with selective and long-acting opioid antagonism at gene in vitro .	T16	T18	2855368
NA	CHEMICAL	GENE-N	3	9	The interaction of chemical ( chemical ) with various gene types was studied in vitro .	T3	T17	2855368
NA	CHEMICAL	GENE-N	5	9	The interaction of chemical ( chemical ) with various gene types was studied in vitro .	T7	T17	2855368
NA	CHEMICAL	GENE-Y	12	6	The aim of the study was to determine whether the dihydroxylated antiestrogen chemical , with a high affinity for the gene and low intrinsic estrogenic activity , could inhibit the uterotropic actions of steroidal [ chemical ( chemical ) ] and nonsteroidal [ ICI 3188 and chemical ( chemical ) ] estrogens in immature rats and also the uterotropic actions of chemical and chemical in the ovariectomized mouse and immature rat .	T34	T39	6872937
NA	CHEMICAL	GENE-Y	15	6	The aim of the study was to determine whether the dihydroxylated antiestrogen chemical , with a high affinity for the gene and low intrinsic estrogenic activity , could inhibit the uterotropic actions of steroidal [ chemical ( chemical ) ] and nonsteroidal [ ICI 3188 and chemical ( chemical ) ] estrogens in immature rats and also the uterotropic actions of chemical and chemical in the ovariectomized mouse and immature rat .	T21	T39	6872937
NA	CHEMICAL	GENE-Y	37	6	The aim of the study was to determine whether the dihydroxylated antiestrogen chemical , with a high affinity for the gene and low intrinsic estrogenic activity , could inhibit the uterotropic actions of steroidal [ chemical ( chemical ) ] and nonsteroidal [ ICI 3188 and chemical ( chemical ) ] estrogens in immature rats and also the uterotropic actions of chemical and chemical in the ovariectomized mouse and immature rat .	T26	T39	6872937
NA	CHEMICAL	GENE-Y	15	6	The aim of the study was to determine whether the dihydroxylated antiestrogen chemical , with a high affinity for the gene and low intrinsic estrogenic activity , could inhibit the uterotropic actions of steroidal [ chemical ( chemical ) ] and nonsteroidal [ ICI 3188 and chemical ( chemical ) ] estrogens in immature rats and also the uterotropic actions of chemical and chemical in the ovariectomized mouse and immature rat .	T27	T39	6872937
NA	CHEMICAL	GENE-Y	48	6	The aim of the study was to determine whether the dihydroxylated antiestrogen chemical , with a high affinity for the gene and low intrinsic estrogenic activity , could inhibit the uterotropic actions of steroidal [ chemical ( chemical ) ] and nonsteroidal [ ICI 3188 and chemical ( chemical ) ] estrogens in immature rats and also the uterotropic actions of chemical and chemical in the ovariectomized mouse and immature rat .	T28	T39	6872937
NA	CHEMICAL	GENE-Y	15	6	The aim of the study was to determine whether the dihydroxylated antiestrogen chemical , with a high affinity for the gene and low intrinsic estrogenic activity , could inhibit the uterotropic actions of steroidal [ chemical ( chemical ) ] and nonsteroidal [ ICI 3188 and chemical ( chemical ) ] estrogens in immature rats and also the uterotropic actions of chemical and chemical in the ovariectomized mouse and immature rat .	T29	T39	6872937
NA	CHEMICAL	GENE-Y	15	6	The aim of the study was to determine whether the dihydroxylated antiestrogen chemical , with a high affinity for the gene and low intrinsic estrogenic activity , could inhibit the uterotropic actions of steroidal [ chemical ( chemical ) ] and nonsteroidal [ ICI 3188 and chemical ( chemical ) ] estrogens in immature rats and also the uterotropic actions of chemical and chemical in the ovariectomized mouse and immature rat .	T30	T39	6872937
CPR:9	CHEMICAL	GENE-N	8	0	gene are involved in the transport of the chemical conjugates of the ultimate carcinogen of chemical in human Caco-2 cells .	T19	T32	22899102
NA	CHEMICAL	GENE-N	15	0	gene are involved in the transport of the chemical conjugates of the ultimate carcinogen of chemical in human Caco-2 cells .	T18	T32	22899102
NA	CHEMICAL	GENE-N	25	41	In the present study , differentiated human intestinal Caco-2 cells were used as a model for the human small intestine to investigate the detoxification of chemical and excretion of stereoisomeric chemical conjugates in the presence of an inhibitor of the chemical-cleaving enzyme gene at the cell surface .	T14	T30	22899102
NA	CHEMICAL	GENE-N	25	12	In the present study , differentiated human intestinal Caco-2 cells were used as a model for the human small intestine to investigate the detoxification of chemical and excretion of stereoisomeric chemical conjugates in the presence of an inhibitor of the chemical-cleaving enzyme gene at the cell surface .	T14	T31	22899102
NA	CHEMICAL	GENE-N	13	41	In the present study , differentiated human intestinal Caco-2 cells were used as a model for the human small intestine to investigate the detoxification of chemical and excretion of stereoisomeric chemical conjugates in the presence of an inhibitor of the chemical-cleaving enzyme gene at the cell surface .	T15	T30	22899102
NA	CHEMICAL	GENE-N	13	12	In the present study , differentiated human intestinal Caco-2 cells were used as a model for the human small intestine to investigate the detoxification of chemical and excretion of stereoisomeric chemical conjugates in the presence of an inhibitor of the chemical-cleaving enzyme gene at the cell surface .	T15	T31	22899102
NA	CHEMICAL	GENE-N	13	41	In the present study , differentiated human intestinal Caco-2 cells were used as a model for the human small intestine to investigate the detoxification of chemical and excretion of stereoisomeric chemical conjugates in the presence of an inhibitor of the chemical-cleaving enzyme gene at the cell surface .	T16	T30	22899102
NA	CHEMICAL	GENE-N	13	12	In the present study , differentiated human intestinal Caco-2 cells were used as a model for the human small intestine to investigate the detoxification of chemical and excretion of stereoisomeric chemical conjugates in the presence of an inhibitor of the chemical-cleaving enzyme gene at the cell surface .	T16	T31	22899102
CPR:9	CHEMICAL	GENE-N	15	5	Inhibition studies revealed that the gene ( gene ) are involved in the transport of chemical conjugates .	T3	T20	22899102
CPR:9	CHEMICAL	GENE-N	15	7	Inhibition studies revealed that the gene ( gene ) are involved in the transport of chemical conjugates .	T3	T21	22899102
CPR:9	CHEMICAL	GENE-Y	29	1	Stable gene , gene and gene knockdown cell lines were generated , thus making it possible to demonstrate that gene mediates the basolateral and gene the apical excretion of chemical conjugates .	T4	T22	22899102
CPR:9	CHEMICAL	GENE-Y	29	3	Stable gene , gene and gene knockdown cell lines were generated , thus making it possible to demonstrate that gene mediates the basolateral and gene the apical excretion of chemical conjugates .	T4	T23	22899102
NA	CHEMICAL	GENE-Y	29	5	Stable gene , gene and gene knockdown cell lines were generated , thus making it possible to demonstrate that gene mediates the basolateral and gene the apical excretion of chemical conjugates .	T4	T24	22899102
CPR:9	CHEMICAL	GENE-Y	29	19	Stable gene , gene and gene knockdown cell lines were generated , thus making it possible to demonstrate that gene mediates the basolateral and gene the apical excretion of chemical conjugates .	T4	T25	22899102
CPR:9	CHEMICAL	GENE-Y	29	24	Stable gene , gene and gene knockdown cell lines were generated , thus making it possible to demonstrate that gene mediates the basolateral and gene the apical excretion of chemical conjugates .	T4	T26	22899102
NA	CHEMICAL	GENE-N	4	0	gene was cloned from a human chemical cDNA library and the gene localized to chromosome 3q11.2 .	T6	T18	10702256
NA	CHEMICAL	GENE-N	5	7	The functional protein contains 1160 chemical with a large central gene , three consensus sites for glycosaminoglycan attachment , two epidermal growth factor-like repeats , a putative gene , and a potential transmembrane domain near the chemical-terminal .	T7	T22	10702256
NA	CHEMICAL	GENE-N	5	27	The functional protein contains 1160 chemical with a large central gene , three consensus sites for glycosaminoglycan attachment , two epidermal growth factor-like repeats , a putative gene , and a potential transmembrane domain near the chemical-terminal .	T7	T8	10702256
NA	CHEMICAL	GENE-N	36	7	The functional protein contains 1160 chemical with a large central gene , three consensus sites for glycosaminoglycan attachment , two epidermal growth factor-like repeats , a putative gene , and a potential transmembrane domain near the chemical-terminal .	T1	T22	10702256
NA	CHEMICAL	GENE-N	36	27	The functional protein contains 1160 chemical with a large central gene , three consensus sites for glycosaminoglycan attachment , two epidermal growth factor-like repeats , a putative gene , and a potential transmembrane domain near the chemical-terminal .	T1	T8	10702256
NA	CHEMICAL	GENE-N	2	25	Removal of chemical- and chemical-linked oligosaccharides reduces the M ( r ) to approximately 160,000 , suggesting that approximately 60 % of the mass of gene is chemical .	T2	T11	10702256
NA	CHEMICAL	GENE-N	4	25	Removal of chemical- and chemical-linked oligosaccharides reduces the M ( r ) to approximately 160,000 , suggesting that approximately 60 % of the mass of gene is chemical .	T3	T11	10702256
NA	CHEMICAL	GENE-N	10	25	Removal of chemical- and chemical-linked oligosaccharides reduces the M ( r ) to approximately 160,000 , suggesting that approximately 60 % of the mass of gene is chemical .	T4	T11	10702256
CPR:4	CHEMICAL	GENE-Y	0	8	chemical improves TNBS-induced colitis in rats by inhibiting gene expression via the gene/gene signaling pathway .	T15	T38	23250811
CPR:4	CHEMICAL	GENE-Y	0	12	chemical improves TNBS-induced colitis in rats by inhibiting gene expression via the gene/gene signaling pathway .	T15	T39	23250811
CPR:4	CHEMICAL	GENE-N	0	12	chemical improves TNBS-induced colitis in rats by inhibiting gene expression via the gene/gene signaling pathway .	T15	T40	23250811
CPR:4	CHEMICAL	GENE-Y	4	17	This study explored whether chemical improves colonic inflammation in a rat colitis model through inhibition of the gene/gene signaling pathway and gene expression .	T10	T30	23250811
CPR:4	CHEMICAL	GENE-N	4	17	This study explored whether chemical improves colonic inflammation in a rat colitis model through inhibition of the gene/gene signaling pathway and gene expression .	T10	T31	23250811
CPR:4	CHEMICAL	GENE-Y	4	21	This study explored whether chemical improves colonic inflammation in a rat colitis model through inhibition of the gene/gene signaling pathway and gene expression .	T10	T32	23250811
CPR:4	CHEMICAL	GENE-Y	8	27	Compared with the untreated colitis group , the chemical-treated group showed significant decreases in the disease activity index , colonic mucosa damage index , histological score , gene activity , and expressions of gene mRNA , gene mRNA , gene protein , gene gene protein , and gene gene protein ( p < 0.05 ) .	T14	T37	23250811
CPR:4	CHEMICAL	GENE-N	8	33	Compared with the untreated colitis group , the chemical-treated group showed significant decreases in the disease activity index , colonic mucosa damage index , histological score , gene activity , and expressions of gene mRNA , gene mRNA , gene protein , gene gene protein , and gene gene protein ( p < 0.05 ) .	T14	T16	23250811
CPR:4	CHEMICAL	GENE-Y	8	36	Compared with the untreated colitis group , the chemical-treated group showed significant decreases in the disease activity index , colonic mucosa damage index , histological score , gene activity , and expressions of gene mRNA , gene mRNA , gene protein , gene gene protein , and gene gene protein ( p < 0.05 ) .	T14	T17	23250811
CPR:4	CHEMICAL	GENE-Y	8	39	Compared with the untreated colitis group , the chemical-treated group showed significant decreases in the disease activity index , colonic mucosa damage index , histological score , gene activity , and expressions of gene mRNA , gene mRNA , gene protein , gene gene protein , and gene gene protein ( p < 0.05 ) .	T14	T18	23250811
CPR:4	CHEMICAL	GENE-N	8	42	Compared with the untreated colitis group , the chemical-treated group showed significant decreases in the disease activity index , colonic mucosa damage index , histological score , gene activity , and expressions of gene mRNA , gene mRNA , gene protein , gene gene protein , and gene gene protein ( p < 0.05 ) .	T14	T19	23250811
CPR:4	CHEMICAL	GENE-Y	8	43	Compared with the untreated colitis group , the chemical-treated group showed significant decreases in the disease activity index , colonic mucosa damage index , histological score , gene activity , and expressions of gene mRNA , gene mRNA , gene protein , gene gene protein , and gene gene protein ( p < 0.05 ) .	T14	T20	23250811
CPR:4	CHEMICAL	GENE-Y	8	47	Compared with the untreated colitis group , the chemical-treated group showed significant decreases in the disease activity index , colonic mucosa damage index , histological score , gene activity , and expressions of gene mRNA , gene mRNA , gene protein , gene gene protein , and gene gene protein ( p < 0.05 ) .	T14	T21	23250811
CPR:4	CHEMICAL	GENE-Y	8	48	Compared with the untreated colitis group , the chemical-treated group showed significant decreases in the disease activity index , colonic mucosa damage index , histological score , gene activity , and expressions of gene mRNA , gene mRNA , gene protein , gene gene protein , and gene gene protein ( p < 0.05 ) .	T14	T22	23250811
CPR:4	CHEMICAL	GENE-Y	5	6	There was no significant difference in gene , gene , and gene mRNA and proteins between chemical-treated and chemical-treated groups .	T4	T24	23250811
CPR:4	CHEMICAL	GENE-N	5	8	There was no significant difference in gene , gene , and gene mRNA and proteins between chemical-treated and chemical-treated groups .	T4	T25	23250811
CPR:4	CHEMICAL	GENE-Y	5	11	There was no significant difference in gene , gene , and gene mRNA and proteins between chemical-treated and chemical-treated groups .	T4	T26	23250811
CPR:4	CHEMICAL	GENE-Y	5	6	There was no significant difference in gene , gene , and gene mRNA and proteins between chemical-treated and chemical-treated groups .	T5	T24	23250811
CPR:4	CHEMICAL	GENE-N	5	8	There was no significant difference in gene , gene , and gene mRNA and proteins between chemical-treated and chemical-treated groups .	T5	T25	23250811
CPR:4	CHEMICAL	GENE-Y	5	11	There was no significant difference in gene , gene , and gene mRNA and proteins between chemical-treated and chemical-treated groups .	T5	T26	23250811
NA	CHEMICAL	GENE-N	0	6	gene , a subunit of the gene-specific general transcription factor gene , comprises an chemical-terminal chemical phosphatase domain ( gene-gene ) whose catalytic activity and cellular function is poorly understood .	T1	T14	23569204
NA	CHEMICAL	GENE-Y	0	10	gene , a subunit of the gene-specific general transcription factor gene , comprises an chemical-terminal chemical phosphatase domain ( gene-gene ) whose catalytic activity and cellular function is poorly understood .	T1	T7	23569204
NA	CHEMICAL	GENE-N	0	2	gene , a subunit of the gene-specific general transcription factor gene , comprises an chemical-terminal chemical phosphatase domain ( gene-gene ) whose catalytic activity and cellular function is poorly understood .	T1	T8	23569204
NA	CHEMICAL	GENE-Y	0	16	gene , a subunit of the gene-specific general transcription factor gene , comprises an chemical-terminal chemical phosphatase domain ( gene-gene ) whose catalytic activity and cellular function is poorly understood .	T1	T9	23569204
NA	CHEMICAL	GENE-N	0	16	gene , a subunit of the gene-specific general transcription factor gene , comprises an chemical-terminal chemical phosphatase domain ( gene-gene ) whose catalytic activity and cellular function is poorly understood .	T1	T10	23569204
NA	CHEMICAL	GENE-N	24	6	gene , a subunit of the gene-specific general transcription factor gene , comprises an chemical-terminal chemical phosphatase domain ( gene-gene ) whose catalytic activity and cellular function is poorly understood .	T2	T14	23569204
NA	CHEMICAL	GENE-Y	24	10	gene , a subunit of the gene-specific general transcription factor gene , comprises an chemical-terminal chemical phosphatase domain ( gene-gene ) whose catalytic activity and cellular function is poorly understood .	T2	T7	23569204
NA	CHEMICAL	GENE-N	24	2	gene , a subunit of the gene-specific general transcription factor gene , comprises an chemical-terminal chemical phosphatase domain ( gene-gene ) whose catalytic activity and cellular function is poorly understood .	T2	T8	23569204
NA	CHEMICAL	GENE-Y	24	16	gene , a subunit of the gene-specific general transcription factor gene , comprises an chemical-terminal chemical phosphatase domain ( gene-gene ) whose catalytic activity and cellular function is poorly understood .	T2	T9	23569204
NA	CHEMICAL	GENE-N	24	16	gene , a subunit of the gene-specific general transcription factor gene , comprises an chemical-terminal chemical phosphatase domain ( gene-gene ) whose catalytic activity and cellular function is poorly understood .	T2	T10	23569204
NA	CHEMICAL	GENE-Y	15	6	We solved the crystal structures of gene-gene and its closely related paralogue gene and used in silico docking methods to identify chemical and chemical containing peptides as possible substrates that were subsequently validated using in vitro gene assays .	T3	T11	23569204
NA	CHEMICAL	GENE-N	15	6	We solved the crystal structures of gene-gene and its closely related paralogue gene and used in silico docking methods to identify chemical and chemical containing peptides as possible substrates that were subsequently validated using in vitro gene assays .	T3	T12	23569204
NA	CHEMICAL	GENE-N	15	12	We solved the crystal structures of gene-gene and its closely related paralogue gene and used in silico docking methods to identify chemical and chemical containing peptides as possible substrates that were subsequently validated using in vitro gene assays .	T3	T13	23569204
NA	CHEMICAL	GENE-N	15	26	We solved the crystal structures of gene-gene and its closely related paralogue gene and used in silico docking methods to identify chemical and chemical containing peptides as possible substrates that were subsequently validated using in vitro gene assays .	T3	T15	23569204
NA	CHEMICAL	GENE-Y	15	6	We solved the crystal structures of gene-gene and its closely related paralogue gene and used in silico docking methods to identify chemical and chemical containing peptides as possible substrates that were subsequently validated using in vitro gene assays .	T4	T11	23569204
NA	CHEMICAL	GENE-N	15	6	We solved the crystal structures of gene-gene and its closely related paralogue gene and used in silico docking methods to identify chemical and chemical containing peptides as possible substrates that were subsequently validated using in vitro gene assays .	T4	T12	23569204
NA	CHEMICAL	GENE-N	15	12	We solved the crystal structures of gene-gene and its closely related paralogue gene and used in silico docking methods to identify chemical and chemical containing peptides as possible substrates that were subsequently validated using in vitro gene assays .	T4	T13	23569204
NA	CHEMICAL	GENE-N	15	26	We solved the crystal structures of gene-gene and its closely related paralogue gene and used in silico docking methods to identify chemical and chemical containing peptides as possible substrates that were subsequently validated using in vitro gene assays .	T4	T15	23569204
NA	CHEMICAL	GENE-N	2	7	A comparative chemical-proteomic study identified additional phosphopeptides as possible targets , which show the involvement of these two gene in the regulation of a variety of cellular functions .	T5	T16	23569204
NA	CHEMICAL	GENE-N	44	44	OBJECTIVETo describe and make available an interactive , 24-variable homeostasis model assessment ( iHOMA2 ) that extends the HOMA2 model , enabling the modeling of physiology and treatment effects , to present equations of the HOMA2 and iHOMA2 models , and to exemplify iHOMA2 in two widely differing scenarios : changes in gene sensitivity with chemical and changes in renal threshold with chemical chemical transporter ( gene ) inhibition.RESEARCH DESIGN AND METHODSiHOMA2 enables a user of the available software to examine and modify the mathematical functions describing the organs and tissues involved in the chemical and hormonal compartments .	T5	T14	23564921
NA	CHEMICAL	GENE-N	44	5	OBJECTIVETo describe and make available an interactive , 24-variable homeostasis model assessment ( iHOMA2 ) that extends the HOMA2 model , enabling the modeling of physiology and treatment effects , to present equations of the HOMA2 and iHOMA2 models , and to exemplify iHOMA2 in two widely differing scenarios : changes in gene sensitivity with chemical and changes in renal threshold with chemical chemical transporter ( gene ) inhibition.RESEARCH DESIGN AND METHODSiHOMA2 enables a user of the available software to examine and modify the mathematical functions describing the organs and tissues involved in the chemical and hormonal compartments .	T5	T15	23564921
NA	CHEMICAL	GENE-Y	44	66	OBJECTIVETo describe and make available an interactive , 24-variable homeostasis model assessment ( iHOMA2 ) that extends the HOMA2 model , enabling the modeling of physiology and treatment effects , to present equations of the HOMA2 and iHOMA2 models , and to exemplify iHOMA2 in two widely differing scenarios : changes in gene sensitivity with chemical and changes in renal threshold with chemical chemical transporter ( gene ) inhibition.RESEARCH DESIGN AND METHODSiHOMA2 enables a user of the available software to examine and modify the mathematical functions describing the organs and tissues involved in the chemical and hormonal compartments .	T5	T16	23564921
NA	CHEMICAL	GENE-N	62	44	OBJECTIVETo describe and make available an interactive , 24-variable homeostasis model assessment ( iHOMA2 ) that extends the HOMA2 model , enabling the modeling of physiology and treatment effects , to present equations of the HOMA2 and iHOMA2 models , and to exemplify iHOMA2 in two widely differing scenarios : changes in gene sensitivity with chemical and changes in renal threshold with chemical chemical transporter ( gene ) inhibition.RESEARCH DESIGN AND METHODSiHOMA2 enables a user of the available software to examine and modify the mathematical functions describing the organs and tissues involved in the chemical and hormonal compartments .	T6	T14	23564921
NA	CHEMICAL	GENE-N	62	5	OBJECTIVETo describe and make available an interactive , 24-variable homeostasis model assessment ( iHOMA2 ) that extends the HOMA2 model , enabling the modeling of physiology and treatment effects , to present equations of the HOMA2 and iHOMA2 models , and to exemplify iHOMA2 in two widely differing scenarios : changes in gene sensitivity with chemical and changes in renal threshold with chemical chemical transporter ( gene ) inhibition.RESEARCH DESIGN AND METHODSiHOMA2 enables a user of the available software to examine and modify the mathematical functions describing the organs and tissues involved in the chemical and hormonal compartments .	T6	T15	23564921
NA	CHEMICAL	GENE-Y	62	66	OBJECTIVETo describe and make available an interactive , 24-variable homeostasis model assessment ( iHOMA2 ) that extends the HOMA2 model , enabling the modeling of physiology and treatment effects , to present equations of the HOMA2 and iHOMA2 models , and to exemplify iHOMA2 in two widely differing scenarios : changes in gene sensitivity with chemical and changes in renal threshold with chemical chemical transporter ( gene ) inhibition.RESEARCH DESIGN AND METHODSiHOMA2 enables a user of the available software to examine and modify the mathematical functions describing the organs and tissues involved in the chemical and hormonal compartments .	T6	T16	23564921
NA	CHEMICAL	GENE-N	63	44	OBJECTIVETo describe and make available an interactive , 24-variable homeostasis model assessment ( iHOMA2 ) that extends the HOMA2 model , enabling the modeling of physiology and treatment effects , to present equations of the HOMA2 and iHOMA2 models , and to exemplify iHOMA2 in two widely differing scenarios : changes in gene sensitivity with chemical and changes in renal threshold with chemical chemical transporter ( gene ) inhibition.RESEARCH DESIGN AND METHODSiHOMA2 enables a user of the available software to examine and modify the mathematical functions describing the organs and tissues involved in the chemical and hormonal compartments .	T7	T14	23564921
NA	CHEMICAL	GENE-N	63	5	OBJECTIVETo describe and make available an interactive , 24-variable homeostasis model assessment ( iHOMA2 ) that extends the HOMA2 model , enabling the modeling of physiology and treatment effects , to present equations of the HOMA2 and iHOMA2 models , and to exemplify iHOMA2 in two widely differing scenarios : changes in gene sensitivity with chemical and changes in renal threshold with chemical chemical transporter ( gene ) inhibition.RESEARCH DESIGN AND METHODSiHOMA2 enables a user of the available software to examine and modify the mathematical functions describing the organs and tissues involved in the chemical and hormonal compartments .	T7	T15	23564921
NA	CHEMICAL	GENE-Y	63	66	OBJECTIVETo describe and make available an interactive , 24-variable homeostasis model assessment ( iHOMA2 ) that extends the HOMA2 model , enabling the modeling of physiology and treatment effects , to present equations of the HOMA2 and iHOMA2 models , and to exemplify iHOMA2 in two widely differing scenarios : changes in gene sensitivity with chemical and changes in renal threshold with chemical chemical transporter ( gene ) inhibition.RESEARCH DESIGN AND METHODSiHOMA2 enables a user of the available software to examine and modify the mathematical functions describing the organs and tissues involved in the chemical and hormonal compartments .	T7	T16	23564921
NA	CHEMICAL	GENE-N	94	44	OBJECTIVETo describe and make available an interactive , 24-variable homeostasis model assessment ( iHOMA2 ) that extends the HOMA2 model , enabling the modeling of physiology and treatment effects , to present equations of the HOMA2 and iHOMA2 models , and to exemplify iHOMA2 in two widely differing scenarios : changes in gene sensitivity with chemical and changes in renal threshold with chemical chemical transporter ( gene ) inhibition.RESEARCH DESIGN AND METHODSiHOMA2 enables a user of the available software to examine and modify the mathematical functions describing the organs and tissues involved in the chemical and hormonal compartments .	T8	T14	23564921
NA	CHEMICAL	GENE-N	94	5	OBJECTIVETo describe and make available an interactive , 24-variable homeostasis model assessment ( iHOMA2 ) that extends the HOMA2 model , enabling the modeling of physiology and treatment effects , to present equations of the HOMA2 and iHOMA2 models , and to exemplify iHOMA2 in two widely differing scenarios : changes in gene sensitivity with chemical and changes in renal threshold with chemical chemical transporter ( gene ) inhibition.RESEARCH DESIGN AND METHODSiHOMA2 enables a user of the available software to examine and modify the mathematical functions describing the organs and tissues involved in the chemical and hormonal compartments .	T8	T15	23564921
NA	CHEMICAL	GENE-Y	94	66	OBJECTIVETo describe and make available an interactive , 24-variable homeostasis model assessment ( iHOMA2 ) that extends the HOMA2 model , enabling the modeling of physiology and treatment effects , to present equations of the HOMA2 and iHOMA2 models , and to exemplify iHOMA2 in two widely differing scenarios : changes in gene sensitivity with chemical and changes in renal threshold with chemical chemical transporter ( gene ) inhibition.RESEARCH DESIGN AND METHODSiHOMA2 enables a user of the available software to examine and modify the mathematical functions describing the organs and tissues involved in the chemical and hormonal compartments .	T8	T16	23564921
NA	CHEMICAL	GENE-Y	34	4	We exemplify this with gene inhibition modeling ( by changing the renal threshold parameters ) using published data of renal effect , showing that the modeled effect is concordant with the effects on fasting chemical from independent data.RESULTSiHOMA2 modeling of chemical effect suggested that changes in insulin sensitivity in the fasting state are predominantly hepatic .	T9	T17	23564921
NA	CHEMICAL	GENE-Y	32	4	We exemplify this with gene inhibition modeling ( by changing the renal threshold parameters ) using published data of renal effect , showing that the modeled effect is concordant with the effects on fasting chemical from independent data.RESULTSiHOMA2 modeling of chemical effect suggested that changes in insulin sensitivity in the fasting state are predominantly hepatic .	T10	T17	23564921
NA	CHEMICAL	GENE-Y	0	0	gene inhibition modeled by iHOMA2 resulted in a decrease in mean chemical of 1.1 mmol/L .	T1	T11	23564921
NA	CHEMICAL	GENE-Y	24	22	Manipulation of iHOMA2s renal excretion threshold variable suggested that a decrease of 17 % was required to obtain a 0.9 mmol/L decrease in mean chemical.CONCLUSIONSiHOMA2 is an extended mathematical model for the assessment of gene resistance and β-cell function .	T3	T12	23564921
NA	CHEMICAL	GENE-Y	10	7	Recent studies have demonstrated the association between gene*58:01 allele and chemical-induced SCARs , which might explain ethnic differences in their incidences .	T2	T7	23381951
NA	CHEMICAL	GENE-N	0	14	chemical extract of Adiantum capillus-veneris L. suppresses the production of inflammatory mediators by inhibiting gene activation .	T5	T35	23542147
NA	CHEMICAL	GENE-Y	17	28	MATERIALS AND METHODS : The plant ethanolic extracts were initially tested against lipopolysaccharide ( LPS ) -induced chemical ( chemical ) production in RAW264.7 mouse macrophages , and gene ( gene ) and gene ( gene ) production in human U937 monocytes .	T3	T27	23542147
NA	CHEMICAL	GENE-Y	17	30	MATERIALS AND METHODS : The plant ethanolic extracts were initially tested against lipopolysaccharide ( LPS ) -induced chemical ( chemical ) production in RAW264.7 mouse macrophages , and gene ( gene ) and gene ( gene ) production in human U937 monocytes .	T3	T28	23542147
NA	CHEMICAL	GENE-Y	17	33	MATERIALS AND METHODS : The plant ethanolic extracts were initially tested against lipopolysaccharide ( LPS ) -induced chemical ( chemical ) production in RAW264.7 mouse macrophages , and gene ( gene ) and gene ( gene ) production in human U937 monocytes .	T3	T29	23542147
NA	CHEMICAL	GENE-Y	17	35	MATERIALS AND METHODS : The plant ethanolic extracts were initially tested against lipopolysaccharide ( LPS ) -induced chemical ( chemical ) production in RAW264.7 mouse macrophages , and gene ( gene ) and gene ( gene ) production in human U937 monocytes .	T3	T30	23542147
NA	CHEMICAL	GENE-Y	19	28	MATERIALS AND METHODS : The plant ethanolic extracts were initially tested against lipopolysaccharide ( LPS ) -induced chemical ( chemical ) production in RAW264.7 mouse macrophages , and gene ( gene ) and gene ( gene ) production in human U937 monocytes .	T4	T27	23542147
NA	CHEMICAL	GENE-Y	19	30	MATERIALS AND METHODS : The plant ethanolic extracts were initially tested against lipopolysaccharide ( LPS ) -induced chemical ( chemical ) production in RAW264.7 mouse macrophages , and gene ( gene ) and gene ( gene ) production in human U937 monocytes .	T4	T28	23542147
NA	CHEMICAL	GENE-Y	19	33	MATERIALS AND METHODS : The plant ethanolic extracts were initially tested against lipopolysaccharide ( LPS ) -induced chemical ( chemical ) production in RAW264.7 mouse macrophages , and gene ( gene ) and gene ( gene ) production in human U937 monocytes .	T4	T29	23542147
NA	CHEMICAL	GENE-Y	19	35	MATERIALS AND METHODS : The plant ethanolic extracts were initially tested against lipopolysaccharide ( LPS ) -induced chemical ( chemical ) production in RAW264.7 mouse macrophages , and gene ( gene ) and gene ( gene ) production in human U937 monocytes .	T4	T30	23542147
NA	CHEMICAL	GENE-Y	8	10	RESULTS : The plant ethanolic extracts effectively suppressed chemical , gene and gene release with an IC50 less than 50μg/ml .	T1	T9	23542147
NA	CHEMICAL	GENE-Y	8	12	RESULTS : The plant ethanolic extracts effectively suppressed chemical , gene and gene release with an IC50 less than 50μg/ml .	T1	T10	23542147
NA	CHEMICAL	GENE-Y	12	12	This was confirmed by their ability to selectively abrogate the induction of gene transcription , whereas the gene gene , which is not transcribed selectively by an gene complex containing a form of gene phosphorylated on chemical536 , did not change .	T2	T20	23542147
NA	CHEMICAL	GENE-Y	12	17	This was confirmed by their ability to selectively abrogate the induction of gene transcription , whereas the gene gene , which is not transcribed selectively by an gene complex containing a form of gene phosphorylated on chemical536 , did not change .	T2	T21	23542147
NA	CHEMICAL	GENE-N	12	27	This was confirmed by their ability to selectively abrogate the induction of gene transcription , whereas the gene gene , which is not transcribed selectively by an gene complex containing a form of gene phosphorylated on chemical536 , did not change .	T2	T22	23542147
NA	CHEMICAL	GENE-Y	12	33	This was confirmed by their ability to selectively abrogate the induction of gene transcription , whereas the gene gene , which is not transcribed selectively by an gene complex containing a form of gene phosphorylated on chemical536 , did not change .	T2	T23	23542147
NA	CHEMICAL	GENE-Y	11	6	A Re-evaluation of the Role of gene , the gene in chemical-Drug Entry into Human Cells .	T14	T26	23543413
NA	CHEMICAL	GENE-N	11	9	A Re-evaluation of the Role of gene , the gene in chemical-Drug Entry into Human Cells .	T14	T27	23543413
NA	CHEMICAL	GENE-Y	25	5	It has been claimed that gene , the gene , is the major entry pathway for chemical and related drugs via a mechanism that mimics chemical .	T7	T18	23543413
NA	CHEMICAL	GENE-N	25	8	It has been claimed that gene , the gene , is the major entry pathway for chemical and related drugs via a mechanism that mimics chemical .	T7	T19	23543413
CPR:9	CHEMICAL	GENE-Y	16	5	It has been claimed that gene , the gene , is the major entry pathway for chemical and related drugs via a mechanism that mimics chemical .	T8	T18	23543413
CPR:9	CHEMICAL	GENE-N	16	8	It has been claimed that gene , the gene , is the major entry pathway for chemical and related drugs via a mechanism that mimics chemical .	T8	T19	23543413
NA	CHEMICAL	GENE-Y	8	21	We compared the uptake rates of copper with chemical ( and several analogs ) into HEK293 cells over-expressing wild-type or mutant gene , mouse embryonic fibroblasts ( mefs ) that do or do not express gene , and human ovarian tumor cells , sensitive or resistant to cDDP .	T9	T22	23543413
NA	CHEMICAL	GENE-Y	8	35	We compared the uptake rates of copper with chemical ( and several analogs ) into HEK293 cells over-expressing wild-type or mutant gene , mouse embryonic fibroblasts ( mefs ) that do or do not express gene , and human ovarian tumor cells , sensitive or resistant to cDDP .	T9	T23	23543413
NA	CHEMICAL	GENE-Y	8	15	We have also compared the effects of extracellular chemical , which causes regulatory endocytosis of gene , to those of chemical .	T10	T24	23543413
NA	CHEMICAL	GENE-Y	20	15	We have also compared the effects of extracellular chemical , which causes regulatory endocytosis of gene , to those of chemical .	T11	T24	23543413
CPR:9	CHEMICAL	GENE-Y	10	6	We confirm the correlation between higher gene levels and higher chemical-drug uptake in tumor cells sensitive to the drug .	T12	T25	23543413
NA	CHEMICAL	GENE-Y	13	5	However , we show that gene is not the major entry route of chemical-drugs and that the chemical transporter is not internalized in response to extracellular drug .	T2	T15	23543413
NA	CHEMICAL	GENE-Y	17	5	However , we show that gene is not the major entry route of chemical-drugs and that the chemical transporter is not internalized in response to extracellular drug .	T3	T15	23543413
NA	CHEMICAL	GENE-Y	1	31	Cytotoxic chemical ( chemical ) and chemical ( chemical ) lesions induced in DNA and RNA in vitro and in pre-damaged DNA and RNA bacteriophages in vivo are repaired by the gene and a gene .	T1	T10	23276627
NA	CHEMICAL	GENE-Y	1	34	Cytotoxic chemical ( chemical ) and chemical ( chemical ) lesions induced in DNA and RNA in vitro and in pre-damaged DNA and RNA bacteriophages in vivo are repaired by the gene and a gene .	T1	T11	23276627
NA	CHEMICAL	GENE-Y	3	31	Cytotoxic chemical ( chemical ) and chemical ( chemical ) lesions induced in DNA and RNA in vitro and in pre-damaged DNA and RNA bacteriophages in vivo are repaired by the gene and a gene .	T3	T10	23276627
NA	CHEMICAL	GENE-Y	3	34	Cytotoxic chemical ( chemical ) and chemical ( chemical ) lesions induced in DNA and RNA in vitro and in pre-damaged DNA and RNA bacteriophages in vivo are repaired by the gene and a gene .	T3	T11	23276627
NA	CHEMICAL	GENE-Y	6	31	Cytotoxic chemical ( chemical ) and chemical ( chemical ) lesions induced in DNA and RNA in vitro and in pre-damaged DNA and RNA bacteriophages in vivo are repaired by the gene and a gene .	T4	T10	23276627
NA	CHEMICAL	GENE-Y	6	34	Cytotoxic chemical ( chemical ) and chemical ( chemical ) lesions induced in DNA and RNA in vitro and in pre-damaged DNA and RNA bacteriophages in vivo are repaired by the gene and a gene .	T4	T11	23276627
NA	CHEMICAL	GENE-Y	8	31	Cytotoxic chemical ( chemical ) and chemical ( chemical ) lesions induced in DNA and RNA in vitro and in pre-damaged DNA and RNA bacteriophages in vivo are repaired by the gene and a gene .	T5	T10	23276627
NA	CHEMICAL	GENE-Y	8	34	Cytotoxic chemical ( chemical ) and chemical ( chemical ) lesions induced in DNA and RNA in vitro and in pre-damaged DNA and RNA bacteriophages in vivo are repaired by the gene and a gene .	T5	T11	23276627
NA	CHEMICAL	GENE-Y	28	4	Here , we demonstrate gene-mediated repair of endogenous RNA in vivo by measuring differences in lesion-accumulation in two independent gene-proficient and deficient E. coli strains during exposure to chemical ( chemical ) .	T6	T12	23276627
NA	CHEMICAL	GENE-Y	28	19	Here , we demonstrate gene-mediated repair of endogenous RNA in vivo by measuring differences in lesion-accumulation in two independent gene-proficient and deficient E. coli strains during exposure to chemical ( chemical ) .	T6	T13	23276627
NA	CHEMICAL	GENE-Y	30	4	Here , we demonstrate gene-mediated repair of endogenous RNA in vivo by measuring differences in lesion-accumulation in two independent gene-proficient and deficient E. coli strains during exposure to chemical ( chemical ) .	T7	T12	23276627
NA	CHEMICAL	GENE-Y	30	19	Here , we demonstrate gene-mediated repair of endogenous RNA in vivo by measuring differences in lesion-accumulation in two independent gene-proficient and deficient E. coli strains during exposure to chemical ( chemical ) .	T7	T13	23276627
NA	CHEMICAL	GENE-Y	0	8	chemical-induced apoptosis of melanoma cells is mediated by gene ( gene ) via mitochondrial and non-mitochondrial-dependent mechanisms .	T12	T33	23564313
NA	CHEMICAL	GENE-Y	0	10	chemical-induced apoptosis of melanoma cells is mediated by gene ( gene ) via mitochondrial and non-mitochondrial-dependent mechanisms .	T12	T34	23564313
NA	CHEMICAL	GENE-Y	11	31	In the present study , the exposure of melanoma cells to chemical was found to trigger apoptosis as evidenced by the loss of mitochondrial membrane potential , the release of both gene and gene , activation of gene , and cleavage of chemical-Polymerase .	T5	T21	23564313
NA	CHEMICAL	GENE-Y	11	10	In the present study , the exposure of melanoma cells to chemical was found to trigger apoptosis as evidenced by the loss of mitochondrial membrane potential , the release of both gene and gene , activation of gene , and cleavage of chemical-Polymerase .	T5	T22	23564313
NA	CHEMICAL	GENE-N	11	37	In the present study , the exposure of melanoma cells to chemical was found to trigger apoptosis as evidenced by the loss of mitochondrial membrane potential , the release of both gene and gene , activation of gene , and cleavage of chemical-Polymerase .	T5	T23	23564313
NA	CHEMICAL	GENE-N	11	17	In the present study , the exposure of melanoma cells to chemical was found to trigger apoptosis as evidenced by the loss of mitochondrial membrane potential , the release of both gene and gene , activation of gene , and cleavage of chemical-Polymerase .	T5	T24	23564313
NA	CHEMICAL	GENE-Y	42	31	In the present study , the exposure of melanoma cells to chemical was found to trigger apoptosis as evidenced by the loss of mitochondrial membrane potential , the release of both gene and gene , activation of gene , and cleavage of chemical-Polymerase .	T6	T21	23564313
NA	CHEMICAL	GENE-Y	42	10	In the present study , the exposure of melanoma cells to chemical was found to trigger apoptosis as evidenced by the loss of mitochondrial membrane potential , the release of both gene and gene , activation of gene , and cleavage of chemical-Polymerase .	T6	T22	23564313
NA	CHEMICAL	GENE-N	42	37	In the present study , the exposure of melanoma cells to chemical was found to trigger apoptosis as evidenced by the loss of mitochondrial membrane potential , the release of both gene and gene , activation of gene , and cleavage of chemical-Polymerase .	T6	T23	23564313
NA	CHEMICAL	GENE-N	42	17	In the present study , the exposure of melanoma cells to chemical was found to trigger apoptosis as evidenced by the loss of mitochondrial membrane potential , the release of both gene and gene , activation of gene , and cleavage of chemical-Polymerase .	T6	T24	23564313
CPR:3	CHEMICAL	GENE-Y	22	7	Also , chemical enhances the phosphorylation of gene , the accumulation of reactive chemical species , the release of intracellular chemical , as well as the activation of gene , gene , gene , gene ( gene ) gene , and chemical requiring enzyme 1α .	T7	T25	23564313
CPR:3	CHEMICAL	GENE-Y	22	28	Also , chemical enhances the phosphorylation of gene , the accumulation of reactive chemical species , the release of intracellular chemical , as well as the activation of gene , gene , gene , gene ( gene ) gene , and chemical requiring enzyme 1α .	T7	T26	23564313
CPR:3	CHEMICAL	GENE-N	22	22	Also , chemical enhances the phosphorylation of gene , the accumulation of reactive chemical species , the release of intracellular chemical , as well as the activation of gene , gene , gene , gene ( gene ) gene , and chemical requiring enzyme 1α .	T7	T27	23564313
CPR:3	CHEMICAL	GENE-N	22	32	Also , chemical enhances the phosphorylation of gene , the accumulation of reactive chemical species , the release of intracellular chemical , as well as the activation of gene , gene , gene , gene ( gene ) gene , and chemical requiring enzyme 1α .	T7	T28	23564313
CPR:3	CHEMICAL	GENE-Y	22	34	Also , chemical enhances the phosphorylation of gene , the accumulation of reactive chemical species , the release of intracellular chemical , as well as the activation of gene , gene , gene , gene ( gene ) gene , and chemical requiring enzyme 1α .	T7	T29	23564313
CPR:3	CHEMICAL	GENE-Y	22	36	Also , chemical enhances the phosphorylation of gene , the accumulation of reactive chemical species , the release of intracellular chemical , as well as the activation of gene , gene , gene , gene ( gene ) gene , and chemical requiring enzyme 1α .	T7	T30	23564313
CPR:3	CHEMICAL	GENE-N	22	22	Also , chemical enhances the phosphorylation of gene , the accumulation of reactive chemical species , the release of intracellular chemical , as well as the activation of gene , gene , gene , gene ( gene ) gene , and chemical requiring enzyme 1α .	T7	T31	23564313
CPR:3	CHEMICAL	GENE-Y	22	44	Also , chemical enhances the phosphorylation of gene , the accumulation of reactive chemical species , the release of intracellular chemical , as well as the activation of gene , gene , gene , gene ( gene ) gene , and chemical requiring enzyme 1α .	T7	T32	23564313
NA	CHEMICAL	GENE-Y	13	7	Also , chemical enhances the phosphorylation of gene , the accumulation of reactive chemical species , the release of intracellular chemical , as well as the activation of gene , gene , gene , gene ( gene ) gene , and chemical requiring enzyme 1α .	T8	T25	23564313
NA	CHEMICAL	GENE-Y	13	28	Also , chemical enhances the phosphorylation of gene , the accumulation of reactive chemical species , the release of intracellular chemical , as well as the activation of gene , gene , gene , gene ( gene ) gene , and chemical requiring enzyme 1α .	T8	T26	23564313
NA	CHEMICAL	GENE-N	13	22	Also , chemical enhances the phosphorylation of gene , the accumulation of reactive chemical species , the release of intracellular chemical , as well as the activation of gene , gene , gene , gene ( gene ) gene , and chemical requiring enzyme 1α .	T8	T27	23564313
NA	CHEMICAL	GENE-N	13	32	Also , chemical enhances the phosphorylation of gene , the accumulation of reactive chemical species , the release of intracellular chemical , as well as the activation of gene , gene , gene , gene ( gene ) gene , and chemical requiring enzyme 1α .	T8	T28	23564313
NA	CHEMICAL	GENE-Y	13	34	Also , chemical enhances the phosphorylation of gene , the accumulation of reactive chemical species , the release of intracellular chemical , as well as the activation of gene , gene , gene , gene ( gene ) gene , and chemical requiring enzyme 1α .	T8	T29	23564313
NA	CHEMICAL	GENE-Y	13	36	Also , chemical enhances the phosphorylation of gene , the accumulation of reactive chemical species , the release of intracellular chemical , as well as the activation of gene , gene , gene , gene ( gene ) gene , and chemical requiring enzyme 1α .	T8	T30	23564313
NA	CHEMICAL	GENE-N	13	22	Also , chemical enhances the phosphorylation of gene , the accumulation of reactive chemical species , the release of intracellular chemical , as well as the activation of gene , gene , gene , gene ( gene ) gene , and chemical requiring enzyme 1α .	T8	T31	23564313
NA	CHEMICAL	GENE-Y	13	44	Also , chemical enhances the phosphorylation of gene , the accumulation of reactive chemical species , the release of intracellular chemical , as well as the activation of gene , gene , gene , gene ( gene ) gene , and chemical requiring enzyme 1α .	T8	T32	23564313
NA	CHEMICAL	GENE-Y	20	7	Also , chemical enhances the phosphorylation of gene , the accumulation of reactive chemical species , the release of intracellular chemical , as well as the activation of gene , gene , gene , gene ( gene ) gene , and chemical requiring enzyme 1α .	T9	T25	23564313
NA	CHEMICAL	GENE-Y	20	28	Also , chemical enhances the phosphorylation of gene , the accumulation of reactive chemical species , the release of intracellular chemical , as well as the activation of gene , gene , gene , gene ( gene ) gene , and chemical requiring enzyme 1α .	T9	T26	23564313
NA	CHEMICAL	GENE-N	20	22	Also , chemical enhances the phosphorylation of gene , the accumulation of reactive chemical species , the release of intracellular chemical , as well as the activation of gene , gene , gene , gene ( gene ) gene , and chemical requiring enzyme 1α .	T9	T27	23564313
NA	CHEMICAL	GENE-N	20	32	Also , chemical enhances the phosphorylation of gene , the accumulation of reactive chemical species , the release of intracellular chemical , as well as the activation of gene , gene , gene , gene ( gene ) gene , and chemical requiring enzyme 1α .	T9	T28	23564313
NA	CHEMICAL	GENE-Y	20	34	Also , chemical enhances the phosphorylation of gene , the accumulation of reactive chemical species , the release of intracellular chemical , as well as the activation of gene , gene , gene , gene ( gene ) gene , and chemical requiring enzyme 1α .	T9	T29	23564313
NA	CHEMICAL	GENE-Y	20	36	Also , chemical enhances the phosphorylation of gene , the accumulation of reactive chemical species , the release of intracellular chemical , as well as the activation of gene , gene , gene , gene ( gene ) gene , and chemical requiring enzyme 1α .	T9	T30	23564313
NA	CHEMICAL	GENE-N	20	22	Also , chemical enhances the phosphorylation of gene , the accumulation of reactive chemical species , the release of intracellular chemical , as well as the activation of gene , gene , gene , gene ( gene ) gene , and chemical requiring enzyme 1α .	T9	T31	23564313
NA	CHEMICAL	GENE-Y	20	44	Also , chemical enhances the phosphorylation of gene , the accumulation of reactive chemical species , the release of intracellular chemical , as well as the activation of gene , gene , gene , gene ( gene ) gene , and chemical requiring enzyme 1α .	T9	T32	23564313
NA	CHEMICAL	GENE-Y	2	7	Also , chemical enhances the phosphorylation of gene , the accumulation of reactive chemical species , the release of intracellular chemical , as well as the activation of gene , gene , gene , gene ( gene ) gene , and chemical requiring enzyme 1α .	T10	T25	23564313
NA	CHEMICAL	GENE-Y	2	28	Also , chemical enhances the phosphorylation of gene , the accumulation of reactive chemical species , the release of intracellular chemical , as well as the activation of gene , gene , gene , gene ( gene ) gene , and chemical requiring enzyme 1α .	T10	T26	23564313
NA	CHEMICAL	GENE-N	2	22	Also , chemical enhances the phosphorylation of gene , the accumulation of reactive chemical species , the release of intracellular chemical , as well as the activation of gene , gene , gene , gene ( gene ) gene , and chemical requiring enzyme 1α .	T10	T27	23564313
NA	CHEMICAL	GENE-N	2	32	Also , chemical enhances the phosphorylation of gene , the accumulation of reactive chemical species , the release of intracellular chemical , as well as the activation of gene , gene , gene , gene ( gene ) gene , and chemical requiring enzyme 1α .	T10	T28	23564313
NA	CHEMICAL	GENE-Y	2	34	Also , chemical enhances the phosphorylation of gene , the accumulation of reactive chemical species , the release of intracellular chemical , as well as the activation of gene , gene , gene , gene ( gene ) gene , and chemical requiring enzyme 1α .	T10	T29	23564313
NA	CHEMICAL	GENE-Y	2	36	Also , chemical enhances the phosphorylation of gene , the accumulation of reactive chemical species , the release of intracellular chemical , as well as the activation of gene , gene , gene , gene ( gene ) gene , and chemical requiring enzyme 1α .	T10	T30	23564313
NA	CHEMICAL	GENE-N	2	22	Also , chemical enhances the phosphorylation of gene , the accumulation of reactive chemical species , the release of intracellular chemical , as well as the activation of gene , gene , gene , gene ( gene ) gene , and chemical requiring enzyme 1α .	T10	T31	23564313
NA	CHEMICAL	GENE-Y	2	44	Also , chemical enhances the phosphorylation of gene , the accumulation of reactive chemical species , the release of intracellular chemical , as well as the activation of gene , gene , gene , gene ( gene ) gene , and chemical requiring enzyme 1α .	T10	T32	23564313
NA	CHEMICAL	GENE-Y	41	7	Also , chemical enhances the phosphorylation of gene , the accumulation of reactive chemical species , the release of intracellular chemical , as well as the activation of gene , gene , gene , gene ( gene ) gene , and chemical requiring enzyme 1α .	T11	T25	23564313
NA	CHEMICAL	GENE-Y	41	28	Also , chemical enhances the phosphorylation of gene , the accumulation of reactive chemical species , the release of intracellular chemical , as well as the activation of gene , gene , gene , gene ( gene ) gene , and chemical requiring enzyme 1α .	T11	T26	23564313
NA	CHEMICAL	GENE-N	41	22	Also , chemical enhances the phosphorylation of gene , the accumulation of reactive chemical species , the release of intracellular chemical , as well as the activation of gene , gene , gene , gene ( gene ) gene , and chemical requiring enzyme 1α .	T11	T27	23564313
NA	CHEMICAL	GENE-N	41	32	Also , chemical enhances the phosphorylation of gene , the accumulation of reactive chemical species , the release of intracellular chemical , as well as the activation of gene , gene , gene , gene ( gene ) gene , and chemical requiring enzyme 1α .	T11	T28	23564313
NA	CHEMICAL	GENE-Y	41	34	Also , chemical enhances the phosphorylation of gene , the accumulation of reactive chemical species , the release of intracellular chemical , as well as the activation of gene , gene , gene , gene ( gene ) gene , and chemical requiring enzyme 1α .	T11	T29	23564313
NA	CHEMICAL	GENE-Y	41	36	Also , chemical enhances the phosphorylation of gene , the accumulation of reactive chemical species , the release of intracellular chemical , as well as the activation of gene , gene , gene , gene ( gene ) gene , and chemical requiring enzyme 1α .	T11	T30	23564313
NA	CHEMICAL	GENE-N	41	22	Also , chemical enhances the phosphorylation of gene , the accumulation of reactive chemical species , the release of intracellular chemical , as well as the activation of gene , gene , gene , gene ( gene ) gene , and chemical requiring enzyme 1α .	T11	T31	23564313
NA	CHEMICAL	GENE-Y	41	44	Also , chemical enhances the phosphorylation of gene , the accumulation of reactive chemical species , the release of intracellular chemical , as well as the activation of gene , gene , gene , gene ( gene ) gene , and chemical requiring enzyme 1α .	T11	T32	23564313
CPR:3	CHEMICAL	GENE-N	3	12	In addition , chemical induces the DNA-binding activities of the transcription factor gene , gene , gene , and gene , together with the expression of gene and gene proteins .	T1	T13	23564313
CPR:3	CHEMICAL	GENE-Y	3	14	In addition , chemical induces the DNA-binding activities of the transcription factor gene , gene , gene , and gene , together with the expression of gene and gene proteins .	T1	T14	23564313
CPR:3	CHEMICAL	GENE-Y	3	16	In addition , chemical induces the DNA-binding activities of the transcription factor gene , gene , gene , and gene , together with the expression of gene and gene proteins .	T1	T15	23564313
CPR:3	CHEMICAL	GENE-Y	3	19	In addition , chemical induces the DNA-binding activities of the transcription factor gene , gene , gene , and gene , together with the expression of gene and gene proteins .	T1	T16	23564313
CPR:3	CHEMICAL	GENE-N	3	26	In addition , chemical induces the DNA-binding activities of the transcription factor gene , gene , gene , and gene , together with the expression of gene and gene proteins .	T1	T17	23564313
CPR:3	CHEMICAL	GENE-Y	3	28	In addition , chemical induces the DNA-binding activities of the transcription factor gene , gene , gene , and gene , together with the expression of gene and gene proteins .	T1	T18	23564313
NA	CHEMICAL	GENE-Y	5	9	Moreover , inhibitory experiments addressed a central role for gene in the regulation of chemical-induced apoptosis of melanoma cells via mitochondrial and non-mitochondrial-dependent mechanisms .	T2	T19	23564313
CPR:4	CHEMICAL	GENE-N	0	7	chemical ( chemical ) exhibits moderate dual gene-inhibitory activity and promises as a combined bronchodilatory/anti-inflammatory agent .	T1	T11	23200255
CPR:4	CHEMICAL	GENE-N	2	7	chemical ( chemical ) exhibits moderate dual gene-inhibitory activity and promises as a combined bronchodilatory/anti-inflammatory agent .	T2	T11	23200255
CPR:4	CHEMICAL	GENE-N	0	9	chemical-alkylation of the chemical ring markedly enhances potency against gene but suppresses gene inhibition .	T3	T12	23200255
CPR:4	CHEMICAL	GENE-N	0	12	chemical-alkylation of the chemical ring markedly enhances potency against gene but suppresses gene inhibition .	T3	T13	23200255
CPR:4	CHEMICAL	GENE-N	3	9	chemical-alkylation of the chemical ring markedly enhances potency against gene but suppresses gene inhibition .	T4	T12	23200255
CPR:4	CHEMICAL	GENE-N	3	12	chemical-alkylation of the chemical ring markedly enhances potency against gene but suppresses gene inhibition .	T4	T13	23200255
CPR:4	CHEMICAL	GENE-N	2	13	Addition of a chemical extension to the chemical-alkyl group facilitates both enhancement of gene-inhibitory activity and restoration of potent gene inhibition .	T5	T14	23200255
CPR:4	CHEMICAL	GENE-N	2	19	Addition of a chemical extension to the chemical-alkyl group facilitates both enhancement of gene-inhibitory activity and restoration of potent gene inhibition .	T5	T15	23200255
CPR:4	CHEMICAL	GENE-N	3	13	Addition of a chemical extension to the chemical-alkyl group facilitates both enhancement of gene-inhibitory activity and restoration of potent gene inhibition .	T6	T14	23200255
CPR:4	CHEMICAL	GENE-N	3	19	Addition of a chemical extension to the chemical-alkyl group facilitates both enhancement of gene-inhibitory activity and restoration of potent gene inhibition .	T6	T15	23200255
CPR:4	CHEMICAL	GENE-Y	0	2	chemical inhibits gene activation in breast cancer cells by a reactive chemical species-mediated mechanism and independently of gene and gene .	T13	T58	23478800
NA	CHEMICAL	GENE-Y	0	17	chemical inhibits gene activation in breast cancer cells by a reactive chemical species-mediated mechanism and independently of gene and gene .	T13	T56	23478800
NA	CHEMICAL	GENE-Y	0	19	chemical inhibits gene activation in breast cancer cells by a reactive chemical species-mediated mechanism and independently of gene and gene .	T13	T57	23478800
NA	CHEMICAL	GENE-Y	11	2	chemical inhibits gene activation in breast cancer cells by a reactive chemical species-mediated mechanism and independently of gene and gene .	T15	T58	23478800
NA	CHEMICAL	GENE-Y	11	17	chemical inhibits gene activation in breast cancer cells by a reactive chemical species-mediated mechanism and independently of gene and gene .	T15	T56	23478800
NA	CHEMICAL	GENE-Y	11	19	chemical inhibits gene activation in breast cancer cells by a reactive chemical species-mediated mechanism and independently of gene and gene .	T15	T57	23478800
NA	CHEMICAL	GENE-Y	4	2	chemical inhibits gene activation in breast cancer cells by a reactive chemical species-mediated mechanism and independently of gene and gene .	T14	T58	23478800
NA	CHEMICAL	GENE-Y	4	17	chemical inhibits gene activation in breast cancer cells by a reactive chemical species-mediated mechanism and independently of gene and gene .	T14	T56	23478800
NA	CHEMICAL	GENE-Y	4	19	chemical inhibits gene activation in breast cancer cells by a reactive chemical species-mediated mechanism and independently of gene and gene .	T14	T57	23478800
NA	CHEMICAL	GENE-Y	31	2	As the gene ( gene ) /gene ( gene ) pathway has been shown to be functionally associated with gene receptors , we asked if this pathway could mediate gene/gene activation in response to gene ligands .	T8	T38	23478800
NA	CHEMICAL	GENE-Y	31	4	As the gene ( gene ) /gene ( gene ) pathway has been shown to be functionally associated with gene receptors , we asked if this pathway could mediate gene/gene activation in response to gene ligands .	T8	T39	23478800
NA	CHEMICAL	GENE-Y	31	6	As the gene ( gene ) /gene ( gene ) pathway has been shown to be functionally associated with gene receptors , we asked if this pathway could mediate gene/gene activation in response to gene ligands .	T8	T40	23478800
NA	CHEMICAL	GENE-Y	31	8	As the gene ( gene ) /gene ( gene ) pathway has been shown to be functionally associated with gene receptors , we asked if this pathway could mediate gene/gene activation in response to gene ligands .	T8	T41	23478800
NA	CHEMICAL	GENE-Y	31	19	As the gene ( gene ) /gene ( gene ) pathway has been shown to be functionally associated with gene receptors , we asked if this pathway could mediate gene/gene activation in response to gene ligands .	T8	T42	23478800
NA	CHEMICAL	GENE-Y	31	29	As the gene ( gene ) /gene ( gene ) pathway has been shown to be functionally associated with gene receptors , we asked if this pathway could mediate gene/gene activation in response to gene ligands .	T8	T43	23478800
NA	CHEMICAL	GENE-Y	31	29	As the gene ( gene ) /gene ( gene ) pathway has been shown to be functionally associated with gene receptors , we asked if this pathway could mediate gene/gene activation in response to gene ligands .	T8	T44	23478800
NA	CHEMICAL	GENE-Y	31	34	As the gene ( gene ) /gene ( gene ) pathway has been shown to be functionally associated with gene receptors , we asked if this pathway could mediate gene/gene activation in response to gene ligands .	T8	T45	23478800
CPR:4	CHEMICAL	GENE-N	7	9	Here we found that the anticancer agent chemical , a gene inhibitor , reduced the activation of gene and motility in response to the gene ligand gene in breast cancer cells .	T9	T46	23478800
CPR:4	CHEMICAL	GENE-Y	7	9	Here we found that the anticancer agent chemical , a gene inhibitor , reduced the activation of gene and motility in response to the gene ligand gene in breast cancer cells .	T9	T47	23478800
NA	CHEMICAL	GENE-Y	7	24	Here we found that the anticancer agent chemical , a gene inhibitor , reduced the activation of gene and motility in response to the gene ligand gene in breast cancer cells .	T9	T48	23478800
NA	CHEMICAL	GENE-Y	7	20	Here we found that the anticancer agent chemical , a gene inhibitor , reduced the activation of gene and motility in response to the gene ligand gene in breast cancer cells .	T9	T49	23478800
NA	CHEMICAL	GENE-Y	19	2	However , gene activation was not affected by gene or gene RNA interference , suggesting that the effect of chemical occurs through a gene-independent mechanism .	T10	T50	23478800
NA	CHEMICAL	GENE-Y	19	8	However , gene activation was not affected by gene or gene RNA interference , suggesting that the effect of chemical occurs through a gene-independent mechanism .	T10	T51	23478800
NA	CHEMICAL	GENE-Y	19	10	However , gene activation was not affected by gene or gene RNA interference , suggesting that the effect of chemical occurs through a gene-independent mechanism .	T10	T52	23478800
NA	CHEMICAL	GENE-N	19	22	However , gene activation was not affected by gene or gene RNA interference , suggesting that the effect of chemical occurs through a gene-independent mechanism .	T10	T53	23478800
NA	CHEMICAL	GENE-Y	0	8	chemical also failed to affect the activation of gene by gene .	T11	T54	23478800
NA	CHEMICAL	GENE-Y	0	10	chemical also failed to affect the activation of gene by gene .	T11	T55	23478800
CPR:3	CHEMICAL	GENE-N	4	7	Subsequent analysis revealed that chemical strongly activates gene and the gene effector gene ( gene ) in breast cancer cells and induces the formation of stress fibers .	T12	T17	23478800
CPR:3	CHEMICAL	GENE-N	4	10	Subsequent analysis revealed that chemical strongly activates gene and the gene effector gene ( gene ) in breast cancer cells and induces the formation of stress fibers .	T12	T18	23478800
CPR:3	CHEMICAL	GENE-N	4	12	Subsequent analysis revealed that chemical strongly activates gene and the gene effector gene ( gene ) in breast cancer cells and induces the formation of stress fibers .	T12	T19	23478800
CPR:3	CHEMICAL	GENE-N	4	14	Subsequent analysis revealed that chemical strongly activates gene and the gene effector gene ( gene ) in breast cancer cells and induces the formation of stress fibers .	T12	T20	23478800
NA	CHEMICAL	GENE-N	12	5	Interestingly , disruption of the gene-gene pathway prevented the inhibitory effect of chemical on gene activation by gene .	T1	T21	23478800
NA	CHEMICAL	GENE-N	12	5	Interestingly , disruption of the gene-gene pathway prevented the inhibitory effect of chemical on gene activation by gene .	T1	T22	23478800
CPR:4	CHEMICAL	GENE-Y	12	14	Interestingly , disruption of the gene-gene pathway prevented the inhibitory effect of chemical on gene activation by gene .	T1	T23	23478800
NA	CHEMICAL	GENE-Y	12	17	Interestingly , disruption of the gene-gene pathway prevented the inhibitory effect of chemical on gene activation by gene .	T1	T24	23478800
CPR:3	CHEMICAL	GENE-N	5	5	Lastly , we found that gene activation by chemical is mediated by reactive chemical species ( ROS ) .	T2	T25	23478800
NA	CHEMICAL	GENE-N	13	5	Lastly , we found that gene activation by chemical is mediated by reactive chemical species ( ROS ) .	T3	T25	23478800
CPR:3	CHEMICAL	GENE-Y	3	16	The ROS scavenger chemical and the mitochondrial antioxidant Mito-TEMPO rescued the inhibitory effect of chemical on gene activation .	T4	T27	23478800
CPR:4	CHEMICAL	GENE-Y	14	16	The ROS scavenger chemical and the mitochondrial antioxidant Mito-TEMPO rescued the inhibitory effect of chemical on gene activation .	T5	T27	23478800
NA	CHEMICAL	GENE-Y	6	2	Specificity of gene : formation of all-trans-13,14-dihydrochemical and chemical .	T26	T48	17253779
CPR:9	CHEMICAL	GENE-Y	8	2	Specificity of gene : formation of all-trans-13,14-dihydrochemical and chemical .	T28	T48	17253779
NA	CHEMICAL	GENE-N	2	7	Metabolism of chemical , chemical , leads to the formation of chemical , the visual chromophore , and chemical , which is involved in the regulation of gene expression through the chemical receptor .	T8	T36	17253779
NA	CHEMICAL	GENE-N	4	7	Metabolism of chemical , chemical , leads to the formation of chemical , the visual chromophore , and chemical , which is involved in the regulation of gene expression through the chemical receptor .	T17	T36	17253779
NA	CHEMICAL	GENE-N	11	7	Metabolism of chemical , chemical , leads to the formation of chemical , the visual chromophore , and chemical , which is involved in the regulation of gene expression through the chemical receptor .	T24	T36	17253779
NA	CHEMICAL	GENE-N	18	7	Metabolism of chemical , chemical , leads to the formation of chemical , the visual chromophore , and chemical , which is involved in the regulation of gene expression through the chemical receptor .	T4	T36	17253779
NA	CHEMICAL	GENE-N	31	7	Metabolism of chemical , chemical , leads to the formation of chemical , the visual chromophore , and chemical , which is involved in the regulation of gene expression through the chemical receptor .	T15	T36	17253779
CPR:9	CHEMICAL	GENE-Y	1	13	Specifically , chemical is transiently oxidized to chemical before being oxidized further by gene enzymes .	T22	T38	17253779
NA	CHEMICAL	GENE-Y	7	13	Specifically , chemical is transiently oxidized to chemical before being oxidized further by gene enzymes .	T23	T38	17253779
NA	CHEMICAL	GENE-Y	11	9	Here , we report the identification of two putative gene homologues in zebrafish , one of which , gene ( gene ) , also had chemical saturase activity , whereas gene ( gene ) was inactive under similar conditions .	T25	T39	17253779
NA	CHEMICAL	GENE-Y	11	18	Here , we report the identification of two putative gene homologues in zebrafish , one of which , gene ( gene ) , also had chemical saturase activity , whereas gene ( gene ) was inactive under similar conditions .	T25	T40	17253779
NA	CHEMICAL	GENE-Y	11	20	Here , we report the identification of two putative gene homologues in zebrafish , one of which , gene ( gene ) , also had chemical saturase activity , whereas gene ( gene ) was inactive under similar conditions .	T25	T41	17253779
NA	CHEMICAL	GENE-Y	11	26	Here , we report the identification of two putative gene homologues in zebrafish , one of which , gene ( gene ) , also had chemical saturase activity , whereas gene ( gene ) was inactive under similar conditions .	T25	T42	17253779
NA	CHEMICAL	GENE-Y	11	30	Here , we report the identification of two putative gene homologues in zebrafish , one of which , gene ( gene ) , also had chemical saturase activity , whereas gene ( gene ) was inactive under similar conditions .	T25	T43	17253779
NA	CHEMICAL	GENE-Y	11	32	Here , we report the identification of two putative gene homologues in zebrafish , one of which , gene ( gene ) , also had chemical saturase activity , whereas gene ( gene ) was inactive under similar conditions .	T25	T44	17253779
NA	CHEMICAL	GENE-Y	8	1	Unlike gene ( gene ) , gene had an altered bond specificity saturating either the 13-14 or 7-8 double bonds of chemical to produce either chemical or chemical , respectively .	T1	T45	17253779
NA	CHEMICAL	GENE-Y	8	3	Unlike gene ( gene ) , gene had an altered bond specificity saturating either the 13-14 or 7-8 double bonds of chemical to produce either chemical or chemical , respectively .	T1	T46	17253779
CPR:9	CHEMICAL	GENE-Y	8	6	Unlike gene ( gene ) , gene had an altered bond specificity saturating either the 13-14 or 7-8 double bonds of chemical to produce either chemical or chemical , respectively .	T1	T47	17253779
NA	CHEMICAL	GENE-Y	5	1	Unlike gene ( gene ) , gene had an altered bond specificity saturating either the 13-14 or 7-8 double bonds of chemical to produce either chemical or chemical , respectively .	T2	T45	17253779
NA	CHEMICAL	GENE-Y	5	3	Unlike gene ( gene ) , gene had an altered bond specificity saturating either the 13-14 or 7-8 double bonds of chemical to produce either chemical or chemical , respectively .	T2	T46	17253779
CPR:9	CHEMICAL	GENE-Y	5	6	Unlike gene ( gene ) , gene had an altered bond specificity saturating either the 13-14 or 7-8 double bonds of chemical to produce either chemical or chemical , respectively .	T2	T47	17253779
NA	CHEMICAL	GENE-Y	5	1	Unlike gene ( gene ) , gene had an altered bond specificity saturating either the 13-14 or 7-8 double bonds of chemical to produce either chemical or chemical , respectively .	T3	T45	17253779
NA	CHEMICAL	GENE-Y	5	3	Unlike gene ( gene ) , gene had an altered bond specificity saturating either the 13-14 or 7-8 double bonds of chemical to produce either chemical or chemical , respectively .	T3	T46	17253779
CPR:9	CHEMICAL	GENE-Y	5	6	Unlike gene ( gene ) , gene had an altered bond specificity saturating either the 13-14 or 7-8 double bonds of chemical to produce either chemical or chemical , respectively .	T3	T47	17253779
CPR:9	CHEMICAL	GENE-Y	5	0	gene also saturated the 13-14 or 7-8 double bonds of chemical ( chemical ) , a second endogenous form of chemical in zebrafish .	T5	T29	17253779
CPR:9	CHEMICAL	GENE-Y	12	0	gene also saturated the 13-14 or 7-8 double bonds of chemical ( chemical ) , a second endogenous form of chemical in zebrafish .	T6	T29	17253779
NA	CHEMICAL	GENE-Y	20	0	gene also saturated the 13-14 or 7-8 double bonds of chemical ( chemical ) , a second endogenous form of chemical in zebrafish .	T7	T29	17253779
NA	CHEMICAL	GENE-Y	1	20	Exogenous chemical , chemical , or chemical led to the strong induction of the expression of the chemical-metabolizing enzyme , gene , arguing for an active signaling function of chemical metabolites in zebrafish .	T10	T35	17253779
NA	CHEMICAL	GENE-Y	2	20	Exogenous chemical , chemical , or chemical led to the strong induction of the expression of the chemical-metabolizing enzyme , gene , arguing for an active signaling function of chemical metabolites in zebrafish .	T11	T35	17253779
NA	CHEMICAL	GENE-Y	2	20	Exogenous chemical , chemical , or chemical led to the strong induction of the expression of the chemical-metabolizing enzyme , gene , arguing for an active signaling function of chemical metabolites in zebrafish .	T12	T35	17253779
NA	CHEMICAL	GENE-Y	17	20	Exogenous chemical , chemical , or chemical led to the strong induction of the expression of the chemical-metabolizing enzyme , gene , arguing for an active signaling function of chemical metabolites in zebrafish .	T13	T35	17253779
NA	CHEMICAL	GENE-Y	5	20	Exogenous chemical , chemical , or chemical led to the strong induction of the expression of the chemical-metabolizing enzyme , gene , arguing for an active signaling function of chemical metabolites in zebrafish .	T14	T35	17253779
NA	CHEMICAL	GENE-Y	3	17	Despite more than a decade of research in the field of endocrine active compounds targeting the chemical receptor ( gene ) , and although suitable cell lines can be obtained , no validated human stably transfected chemical sensitive transactivation assay is available .	T33	T42	19836445
NA	CHEMICAL	GENE-Y	3	19	Despite more than a decade of research in the field of endocrine active compounds targeting the chemical receptor ( gene ) , and although suitable cell lines can be obtained , no validated human stably transfected chemical sensitive transactivation assay is available .	T33	T39	19836445
NA	CHEMICAL	GENE-Y	3	17	Despite more than a decade of research in the field of endocrine active compounds targeting the chemical receptor ( gene ) , and although suitable cell lines can be obtained , no validated human stably transfected chemical sensitive transactivation assay is available .	T22	T42	19836445
NA	CHEMICAL	GENE-Y	3	19	Despite more than a decade of research in the field of endocrine active compounds targeting the chemical receptor ( gene ) , and although suitable cell lines can be obtained , no validated human stably transfected chemical sensitive transactivation assay is available .	T22	T39	19836445
NA	CHEMICAL	GENE-Y	4	0	A few compounds , chemical ( chemical ) , chemical and chemical , were studied using a real world scenario , i.e. , assuming that their interaction with the gene was not known : A prescreening for agonism and true , competitive antagonism was used to select conditions such as the appropriate mode of action , and the working range excluding cytotoxicity for the final screening .	T32	T38	19836445
NA	CHEMICAL	GENE-Y	6	0	A few compounds , chemical ( chemical ) , chemical and chemical , were studied using a real world scenario , i.e. , assuming that their interaction with the gene was not known : A prescreening for agonism and true , competitive antagonism was used to select conditions such as the appropriate mode of action , and the working range excluding cytotoxicity for the final screening .	T34	T38	19836445
NA	CHEMICAL	GENE-Y	9	0	A few compounds , chemical ( chemical ) , chemical and chemical , were studied using a real world scenario , i.e. , assuming that their interaction with the gene was not known : A prescreening for agonism and true , competitive antagonism was used to select conditions such as the appropriate mode of action , and the working range excluding cytotoxicity for the final screening .	T35	T38	19836445
NA	CHEMICAL	GENE-Y	11	0	A few compounds , chemical ( chemical ) , chemical and chemical , were studied using a real world scenario , i.e. , assuming that their interaction with the gene was not known : A prescreening for agonism and true , competitive antagonism was used to select conditions such as the appropriate mode of action , and the working range excluding cytotoxicity for the final screening .	T36	T38	19836445
NA	CHEMICAL	GENE-N	6	5	Cytotoxicity was assessed in parallel as chemical dehydrogenase release .	T17	T40	19836445
NA	CHEMICAL	GENE-N	19	2	Ten IU/mL gene was also incubated with pooled plasma of stroke patients , that was previously oxidized with the chemical ( chemical ) donor chemical ( chemical ) , to destroy gene and alpha2-antigene .	T8	T50	14507109
CPR:4	CHEMICAL	GENE-Y	19	31	Ten IU/mL gene was also incubated with pooled plasma of stroke patients , that was previously oxidized with the chemical ( chemical ) donor chemical ( chemical ) , to destroy gene and alpha2-antigene .	T8	T52	14507109
NA	CHEMICAL	GENE-Y	19	33	Ten IU/mL gene was also incubated with pooled plasma of stroke patients , that was previously oxidized with the chemical ( chemical ) donor chemical ( chemical ) , to destroy gene and alpha2-antigene .	T8	T53	14507109
NA	CHEMICAL	GENE-N	21	2	Ten IU/mL gene was also incubated with pooled plasma of stroke patients , that was previously oxidized with the chemical ( chemical ) donor chemical ( chemical ) , to destroy gene and alpha2-antigene .	T9	T50	14507109
CPR:4	CHEMICAL	GENE-Y	21	31	Ten IU/mL gene was also incubated with pooled plasma of stroke patients , that was previously oxidized with the chemical ( chemical ) donor chemical ( chemical ) , to destroy gene and alpha2-antigene .	T9	T52	14507109
NA	CHEMICAL	GENE-Y	21	33	Ten IU/mL gene was also incubated with pooled plasma of stroke patients , that was previously oxidized with the chemical ( chemical ) donor chemical ( chemical ) , to destroy gene and alpha2-antigene .	T9	T53	14507109
NA	CHEMICAL	GENE-N	24	2	Ten IU/mL gene was also incubated with pooled plasma of stroke patients , that was previously oxidized with the chemical ( chemical ) donor chemical ( chemical ) , to destroy gene and alpha2-antigene .	T10	T50	14507109
CPR:4	CHEMICAL	GENE-Y	24	31	Ten IU/mL gene was also incubated with pooled plasma of stroke patients , that was previously oxidized with the chemical ( chemical ) donor chemical ( chemical ) , to destroy gene and alpha2-antigene .	T10	T52	14507109
CPR:4	CHEMICAL	GENE-Y	24	33	Ten IU/mL gene was also incubated with pooled plasma of stroke patients , that was previously oxidized with the chemical ( chemical ) donor chemical ( chemical ) , to destroy gene and alpha2-antigene .	T10	T53	14507109
NA	CHEMICAL	GENE-N	26	2	Ten IU/mL gene was also incubated with pooled plasma of stroke patients , that was previously oxidized with the chemical ( chemical ) donor chemical ( chemical ) , to destroy gene and alpha2-antigene .	T11	T50	14507109
CPR:4	CHEMICAL	GENE-Y	26	31	Ten IU/mL gene was also incubated with pooled plasma of stroke patients , that was previously oxidized with the chemical ( chemical ) donor chemical ( chemical ) , to destroy gene and alpha2-antigene .	T11	T52	14507109
CPR:4	CHEMICAL	GENE-Y	26	33	Ten IU/mL gene was also incubated with pooled plasma of stroke patients , that was previously oxidized with the chemical ( chemical ) donor chemical ( chemical ) , to destroy gene and alpha2-antigene .	T11	T53	14507109
CPR:9	CHEMICAL	GENE-Y	16	3	For determination of gene activity , 10 microL thereof was incubated with 150 microL 1.5 M chemical , pH 8.7 , and 100 microL 20 mM chemical preoxidized ( 15 minutes 37 degrees C ) pooled normal chemical buffered chemical-plasma for 30 minutes ( 37 degrees C ) .	T2	T13	14507109
NA	CHEMICAL	GENE-Y	26	3	For determination of gene activity , 10 microL thereof was incubated with 150 microL 1.5 M chemical , pH 8.7 , and 100 microL 20 mM chemical preoxidized ( 15 minutes 37 degrees C ) pooled normal chemical buffered chemical-plasma for 30 minutes ( 37 degrees C ) .	T3	T13	14507109
NA	CHEMICAL	GENE-Y	37	3	For determination of gene activity , 10 microL thereof was incubated with 150 microL 1.5 M chemical , pH 8.7 , and 100 microL 20 mM chemical preoxidized ( 15 minutes 37 degrees C ) pooled normal chemical buffered chemical-plasma for 30 minutes ( 37 degrees C ) .	T4	T13	14507109
NA	CHEMICAL	GENE-Y	39	3	For determination of gene activity , 10 microL thereof was incubated with 150 microL 1.5 M chemical , pH 8.7 , and 100 microL 20 mM chemical preoxidized ( 15 minutes 37 degrees C ) pooled normal chemical buffered chemical-plasma for 30 minutes ( 37 degrees C ) .	T5	T13	14507109
CPR:9	CHEMICAL	GENE-N	8	4	For determination of [ gene+gene ] -activity , chemical was added after this incubation .	T6	T14	14507109
CPR:9	CHEMICAL	GENE-Y	8	4	For determination of [ gene+gene ] -activity , chemical was added after this incubation .	T6	T15	14507109
CPR:3	CHEMICAL	GENE-Y	0	14	chemical attenuates high chemical-induced lipid accumulation in human HepG2 hepatocytes through the activation of gene/chemical-activated protein kinase-dependent signalling .	T16	T35	23122079
CPR:3	CHEMICAL	GENE-N	0	6	chemical attenuates high chemical-induced lipid accumulation in human HepG2 hepatocytes through the activation of gene/chemical-activated protein kinase-dependent signalling .	T16	T36	23122079
NA	CHEMICAL	GENE-Y	3	14	chemical attenuates high chemical-induced lipid accumulation in human HepG2 hepatocytes through the activation of gene/chemical-activated protein kinase-dependent signalling .	T18	T35	23122079
NA	CHEMICAL	GENE-N	3	6	chemical attenuates high chemical-induced lipid accumulation in human HepG2 hepatocytes through the activation of gene/chemical-activated protein kinase-dependent signalling .	T18	T36	23122079
NA	CHEMICAL	GENE-Y	14	14	chemical attenuates high chemical-induced lipid accumulation in human HepG2 hepatocytes through the activation of gene/chemical-activated protein kinase-dependent signalling .	T17	T35	23122079
NA	CHEMICAL	GENE-N	14	6	chemical attenuates high chemical-induced lipid accumulation in human HepG2 hepatocytes through the activation of gene/chemical-activated protein kinase-dependent signalling .	T17	T36	23122079
CPR:4	CHEMICAL	GENE-Y	0	6	chemical strongly inhibited high chemical-induced chemical synthase ( gene ) expression by modulating chemical regulatory element-binding protein-1c ( gene ) activation .	T7	T24	23122079
CPR:4	CHEMICAL	GENE-Y	0	8	chemical strongly inhibited high chemical-induced chemical synthase ( gene ) expression by modulating chemical regulatory element-binding protein-1c ( gene ) activation .	T7	T25	23122079
NA	CHEMICAL	GENE-Y	0	16	chemical strongly inhibited high chemical-induced chemical synthase ( gene ) expression by modulating chemical regulatory element-binding protein-1c ( gene ) activation .	T7	T26	23122079
NA	CHEMICAL	GENE-Y	0	18	chemical strongly inhibited high chemical-induced chemical synthase ( gene ) expression by modulating chemical regulatory element-binding protein-1c ( gene ) activation .	T7	T27	23122079
CPR:3	CHEMICAL	GENE-Y	4	6	chemical strongly inhibited high chemical-induced chemical synthase ( gene ) expression by modulating chemical regulatory element-binding protein-1c ( gene ) activation .	T8	T24	23122079
CPR:3	CHEMICAL	GENE-Y	4	8	chemical strongly inhibited high chemical-induced chemical synthase ( gene ) expression by modulating chemical regulatory element-binding protein-1c ( gene ) activation .	T8	T25	23122079
NA	CHEMICAL	GENE-Y	4	16	chemical strongly inhibited high chemical-induced chemical synthase ( gene ) expression by modulating chemical regulatory element-binding protein-1c ( gene ) activation .	T8	T26	23122079
NA	CHEMICAL	GENE-Y	4	18	chemical strongly inhibited high chemical-induced chemical synthase ( gene ) expression by modulating chemical regulatory element-binding protein-1c ( gene ) activation .	T8	T27	23122079
NA	CHEMICAL	GENE-Y	5	6	chemical strongly inhibited high chemical-induced chemical synthase ( gene ) expression by modulating chemical regulatory element-binding protein-1c ( gene ) activation .	T9	T24	23122079
NA	CHEMICAL	GENE-Y	5	8	chemical strongly inhibited high chemical-induced chemical synthase ( gene ) expression by modulating chemical regulatory element-binding protein-1c ( gene ) activation .	T9	T25	23122079
NA	CHEMICAL	GENE-Y	5	16	chemical strongly inhibited high chemical-induced chemical synthase ( gene ) expression by modulating chemical regulatory element-binding protein-1c ( gene ) activation .	T9	T26	23122079
NA	CHEMICAL	GENE-Y	5	18	chemical strongly inhibited high chemical-induced chemical synthase ( gene ) expression by modulating chemical regulatory element-binding protein-1c ( gene ) activation .	T9	T27	23122079
NA	CHEMICAL	GENE-Y	13	6	chemical strongly inhibited high chemical-induced chemical synthase ( gene ) expression by modulating chemical regulatory element-binding protein-1c ( gene ) activation .	T10	T24	23122079
NA	CHEMICAL	GENE-Y	13	8	chemical strongly inhibited high chemical-induced chemical synthase ( gene ) expression by modulating chemical regulatory element-binding protein-1c ( gene ) activation .	T10	T25	23122079
NA	CHEMICAL	GENE-Y	13	16	chemical strongly inhibited high chemical-induced chemical synthase ( gene ) expression by modulating chemical regulatory element-binding protein-1c ( gene ) activation .	T10	T26	23122079
NA	CHEMICAL	GENE-Y	13	18	chemical strongly inhibited high chemical-induced chemical synthase ( gene ) expression by modulating chemical regulatory element-binding protein-1c ( gene ) activation .	T10	T27	23122079
NA	CHEMICAL	GENE-N	6	8	Moreover , use of the pharmacological chemical-activated protein kinase ( gene ) inhibitor chemical revealed that gene is essential for suppressing gene expression in chemical-treated cells .	T11	T28	23122079
NA	CHEMICAL	GENE-N	6	10	Moreover , use of the pharmacological chemical-activated protein kinase ( gene ) inhibitor chemical revealed that gene is essential for suppressing gene expression in chemical-treated cells .	T11	T29	23122079
NA	CHEMICAL	GENE-N	6	16	Moreover , use of the pharmacological chemical-activated protein kinase ( gene ) inhibitor chemical revealed that gene is essential for suppressing gene expression in chemical-treated cells .	T11	T30	23122079
NA	CHEMICAL	GENE-Y	6	21	Moreover , use of the pharmacological chemical-activated protein kinase ( gene ) inhibitor chemical revealed that gene is essential for suppressing gene expression in chemical-treated cells .	T11	T31	23122079
CPR:4	CHEMICAL	GENE-N	13	8	Moreover , use of the pharmacological chemical-activated protein kinase ( gene ) inhibitor chemical revealed that gene is essential for suppressing gene expression in chemical-treated cells .	T12	T28	23122079
CPR:4	CHEMICAL	GENE-N	13	10	Moreover , use of the pharmacological chemical-activated protein kinase ( gene ) inhibitor chemical revealed that gene is essential for suppressing gene expression in chemical-treated cells .	T12	T29	23122079
CPR:4	CHEMICAL	GENE-N	13	16	Moreover , use of the pharmacological chemical-activated protein kinase ( gene ) inhibitor chemical revealed that gene is essential for suppressing gene expression in chemical-treated cells .	T12	T30	23122079
NA	CHEMICAL	GENE-Y	13	21	Moreover , use of the pharmacological chemical-activated protein kinase ( gene ) inhibitor chemical revealed that gene is essential for suppressing gene expression in chemical-treated cells .	T12	T31	23122079
NA	CHEMICAL	GENE-N	23	8	Moreover , use of the pharmacological chemical-activated protein kinase ( gene ) inhibitor chemical revealed that gene is essential for suppressing gene expression in chemical-treated cells .	T13	T28	23122079
NA	CHEMICAL	GENE-N	23	10	Moreover , use of the pharmacological chemical-activated protein kinase ( gene ) inhibitor chemical revealed that gene is essential for suppressing gene expression in chemical-treated cells .	T13	T29	23122079
NA	CHEMICAL	GENE-N	23	16	Moreover , use of the pharmacological chemical-activated protein kinase ( gene ) inhibitor chemical revealed that gene is essential for suppressing gene expression in chemical-treated cells .	T13	T30	23122079
NA	CHEMICAL	GENE-Y	23	21	Moreover , use of the pharmacological chemical-activated protein kinase ( gene ) inhibitor chemical revealed that gene is essential for suppressing gene expression in chemical-treated cells .	T13	T31	23122079
NA	CHEMICAL	GENE-Y	14	5	Finally , we found that gene ( gene ) phosphorylation is required for the chemical-enhanced activation of gene in HepG2 hepatocytes .	T14	T32	23122079
NA	CHEMICAL	GENE-Y	14	7	Finally , we found that gene ( gene ) phosphorylation is required for the chemical-enhanced activation of gene in HepG2 hepatocytes .	T14	T33	23122079
CPR:3	CHEMICAL	GENE-N	14	17	Finally , we found that gene ( gene ) phosphorylation is required for the chemical-enhanced activation of gene in HepG2 hepatocytes .	T14	T34	23122079
NA	CHEMICAL	GENE-Y	11	12	A critical role in organismal homeostatic functions is played by the chemical receptor ( gene ) complex , which senses environmental and endogenous compounds , influences metabolic responses controlling phase I/II gene expression , and modulates vital phenomena such as development , inflammation and adaptive immunity .	T1	T6	23438471
NA	CHEMICAL	GENE-Y	11	0	A critical role in organismal homeostatic functions is played by the chemical receptor ( gene ) complex , which senses environmental and endogenous compounds , influences metabolic responses controlling phase I/II gene expression , and modulates vital phenomena such as development , inflammation and adaptive immunity .	T1	T7	23438471
CPR:4	CHEMICAL	GENE-Y	6	10	We evaluated the clinical effectiveness of chemical , an ultra-short-acting gene blocking drug , to control the sinus tachycardia and increase in arterial blood pressures induced by electroconvulsive therapy ( ECT ) .	T4	T9	1975995
CPR:3	CHEMICAL	GENE-Y	6	22	Our results showed that low dose chemical and E2 could influence the mammosphere area of iDMECs and upregulate the expression level of gene and gene proteins , while only chemical could downregulate the expression of gene protein .	T10	T12	23391485
CPR:3	CHEMICAL	GENE-Y	6	24	Our results showed that low dose chemical and E2 could influence the mammosphere area of iDMECs and upregulate the expression level of gene and gene proteins , while only chemical could downregulate the expression of gene protein .	T10	T13	23391485
NA	CHEMICAL	GENE-Y	6	35	Our results showed that low dose chemical and E2 could influence the mammosphere area of iDMECs and upregulate the expression level of gene and gene proteins , while only chemical could downregulate the expression of gene protein .	T10	T14	23391485
NA	CHEMICAL	GENE-Y	6	22	Our results showed that low dose chemical and E2 could influence the mammosphere area of iDMECs and upregulate the expression level of gene and gene proteins , while only chemical could downregulate the expression of gene protein .	T1	T12	23391485
NA	CHEMICAL	GENE-Y	6	24	Our results showed that low dose chemical and E2 could influence the mammosphere area of iDMECs and upregulate the expression level of gene and gene proteins , while only chemical could downregulate the expression of gene protein .	T1	T13	23391485
CPR:4	CHEMICAL	GENE-Y	6	35	Our results showed that low dose chemical and E2 could influence the mammosphere area of iDMECs and upregulate the expression level of gene and gene proteins , while only chemical could downregulate the expression of gene protein .	T1	T14	23391485
CPR:6	CHEMICAL	GENE-Y	0	3	chemical , a gene antagonist for the mobilization of hematopoietic stem cells .	T6	T16	18847313
CPR:4	CHEMICAL	GENE-N	0	17	chemical ( chemical , Genzyme Corporation ) is a chemical molecule that antagonizes the binding of the gene gene ( gene ) to its cognate receptor gene .	T1	T9	18847313
CPR:4	CHEMICAL	GENE-Y	0	8	chemical ( chemical , Genzyme Corporation ) is a chemical molecule that antagonizes the binding of the gene gene ( gene ) to its cognate receptor gene .	T1	T10	18847313
CPR:4	CHEMICAL	GENE-Y	0	20	chemical ( chemical , Genzyme Corporation ) is a chemical molecule that antagonizes the binding of the gene gene ( gene ) to its cognate receptor gene .	T1	T11	18847313
CPR:4	CHEMICAL	GENE-Y	0	26	chemical ( chemical , Genzyme Corporation ) is a chemical molecule that antagonizes the binding of the gene gene ( gene ) to its cognate receptor gene .	T1	T12	18847313
CPR:4	CHEMICAL	GENE-N	2	17	chemical ( chemical , Genzyme Corporation ) is a chemical molecule that antagonizes the binding of the gene gene ( gene ) to its cognate receptor gene .	T2	T9	18847313
CPR:4	CHEMICAL	GENE-Y	2	8	chemical ( chemical , Genzyme Corporation ) is a chemical molecule that antagonizes the binding of the gene gene ( gene ) to its cognate receptor gene .	T2	T10	18847313
CPR:4	CHEMICAL	GENE-Y	2	20	chemical ( chemical , Genzyme Corporation ) is a chemical molecule that antagonizes the binding of the gene gene ( gene ) to its cognate receptor gene .	T2	T11	18847313
CPR:4	CHEMICAL	GENE-Y	2	26	chemical ( chemical , Genzyme Corporation ) is a chemical molecule that antagonizes the binding of the gene gene ( gene ) to its cognate receptor gene .	T2	T12	18847313
CPR:4	CHEMICAL	GENE-N	8	17	chemical ( chemical , Genzyme Corporation ) is a chemical molecule that antagonizes the binding of the gene gene ( gene ) to its cognate receptor gene .	T3	T9	18847313
CPR:4	CHEMICAL	GENE-Y	8	8	chemical ( chemical , Genzyme Corporation ) is a chemical molecule that antagonizes the binding of the gene gene ( gene ) to its cognate receptor gene .	T3	T10	18847313
CPR:4	CHEMICAL	GENE-Y	8	20	chemical ( chemical , Genzyme Corporation ) is a chemical molecule that antagonizes the binding of the gene gene ( gene ) to its cognate receptor gene .	T3	T11	18847313
CPR:4	CHEMICAL	GENE-Y	8	26	chemical ( chemical , Genzyme Corporation ) is a chemical molecule that antagonizes the binding of the gene gene ( gene ) to its cognate receptor gene .	T3	T12	18847313
NA	CHEMICAL	GENE-Y	0	22	chemical results in the rapid and reversible mobilization of hematopoietic stem cells into the peripheral circulation and is synergistic when combined with gene .	T4	T13	18847313
NA	CHEMICAL	GENE-Y	8	12	Recent studies identified novel allosteric modulators of the chemical ( chemical ) transporter ( gene ) .	T30	T51	19244097
NA	CHEMICAL	GENE-Y	8	14	Recent studies identified novel allosteric modulators of the chemical ( chemical ) transporter ( gene ) .	T30	T55	19244097
NA	CHEMICAL	GENE-Y	10	12	Recent studies identified novel allosteric modulators of the chemical ( chemical ) transporter ( gene ) .	T35	T51	19244097
NA	CHEMICAL	GENE-Y	10	14	Recent studies identified novel allosteric modulators of the chemical ( chemical ) transporter ( gene ) .	T35	T55	19244097
NA	CHEMICAL	GENE-Y	0	31	chemical ( chemical ) , chemical ( chemical ) , and chemical ( chemical ) partially inhibited chemical ( chemical ) binding , slowed the dissociation rate of chemical from the gene , and partially inhibited chemical uptake .	T43	T50	19244097
NA	CHEMICAL	GENE-Y	2	31	chemical ( chemical ) , chemical ( chemical ) , and chemical ( chemical ) partially inhibited chemical ( chemical ) binding , slowed the dissociation rate of chemical from the gene , and partially inhibited chemical uptake .	T11	T50	19244097
NA	CHEMICAL	GENE-Y	1	31	chemical ( chemical ) , chemical ( chemical ) , and chemical ( chemical ) partially inhibited chemical ( chemical ) binding , slowed the dissociation rate of chemical from the gene , and partially inhibited chemical uptake .	T13	T50	19244097
NA	CHEMICAL	GENE-Y	7	31	chemical ( chemical ) , chemical ( chemical ) , and chemical ( chemical ) partially inhibited chemical ( chemical ) binding , slowed the dissociation rate of chemical from the gene , and partially inhibited chemical uptake .	T21	T50	19244097
NA	CHEMICAL	GENE-Y	1	31	chemical ( chemical ) , chemical ( chemical ) , and chemical ( chemical ) partially inhibited chemical ( chemical ) binding , slowed the dissociation rate of chemical from the gene , and partially inhibited chemical uptake .	T22	T50	19244097
NA	CHEMICAL	GENE-Y	13	31	chemical ( chemical ) , chemical ( chemical ) , and chemical ( chemical ) partially inhibited chemical ( chemical ) binding , slowed the dissociation rate of chemical from the gene , and partially inhibited chemical uptake .	T23	T50	19244097
NA	CHEMICAL	GENE-Y	17	31	chemical ( chemical ) , chemical ( chemical ) , and chemical ( chemical ) partially inhibited chemical ( chemical ) binding , slowed the dissociation rate of chemical from the gene , and partially inhibited chemical uptake .	T24	T50	19244097
NA	CHEMICAL	GENE-Y	19	31	chemical ( chemical ) , chemical ( chemical ) , and chemical ( chemical ) partially inhibited chemical ( chemical ) binding , slowed the dissociation rate of chemical from the gene , and partially inhibited chemical uptake .	T25	T50	19244097
NA	CHEMICAL	GENE-Y	1	31	chemical ( chemical ) , chemical ( chemical ) , and chemical ( chemical ) partially inhibited chemical ( chemical ) binding , slowed the dissociation rate of chemical from the gene , and partially inhibited chemical uptake .	T26	T50	19244097
NA	CHEMICAL	GENE-Y	1	31	chemical ( chemical ) , chemical ( chemical ) , and chemical ( chemical ) partially inhibited chemical ( chemical ) binding , slowed the dissociation rate of chemical from the gene , and partially inhibited chemical uptake .	T27	T50	19244097
NA	CHEMICAL	GENE-Y	8	23	In the present study , we report that chemical and chemical , at doses that do not alter release , partially inhibited chemical-induced gene-mediated release of chemical ( chemical ) orchemical from striatal synaptosomes ( `` gene-mediated chemical release '' ) in a dose-dependent manner .	T28	T52	19244097
NA	CHEMICAL	GENE-Y	8	36	In the present study , we report that chemical and chemical , at doses that do not alter release , partially inhibited chemical-induced gene-mediated release of chemical ( chemical ) orchemical from striatal synaptosomes ( `` gene-mediated chemical release '' ) in a dose-dependent manner .	T28	T53	19244097
NA	CHEMICAL	GENE-Y	10	23	In the present study , we report that chemical and chemical , at doses that do not alter release , partially inhibited chemical-induced gene-mediated release of chemical ( chemical ) orchemical from striatal synaptosomes ( `` gene-mediated chemical release '' ) in a dose-dependent manner .	T29	T52	19244097
NA	CHEMICAL	GENE-Y	10	36	In the present study , we report that chemical and chemical , at doses that do not alter release , partially inhibited chemical-induced gene-mediated release of chemical ( chemical ) orchemical from striatal synaptosomes ( `` gene-mediated chemical release '' ) in a dose-dependent manner .	T29	T53	19244097
NA	CHEMICAL	GENE-Y	22	23	In the present study , we report that chemical and chemical , at doses that do not alter release , partially inhibited chemical-induced gene-mediated release of chemical ( chemical ) orchemical from striatal synaptosomes ( `` gene-mediated chemical release '' ) in a dose-dependent manner .	T31	T52	19244097
NA	CHEMICAL	GENE-Y	22	36	In the present study , we report that chemical and chemical , at doses that do not alter release , partially inhibited chemical-induced gene-mediated release of chemical ( chemical ) orchemical from striatal synaptosomes ( `` gene-mediated chemical release '' ) in a dose-dependent manner .	T31	T53	19244097
NA	CHEMICAL	GENE-Y	26	23	In the present study , we report that chemical and chemical , at doses that do not alter release , partially inhibited chemical-induced gene-mediated release of chemical ( chemical ) orchemical from striatal synaptosomes ( `` gene-mediated chemical release '' ) in a dose-dependent manner .	T32	T52	19244097
NA	CHEMICAL	GENE-Y	26	36	In the present study , we report that chemical and chemical , at doses that do not alter release , partially inhibited chemical-induced gene-mediated release of chemical ( chemical ) orchemical from striatal synaptosomes ( `` gene-mediated chemical release '' ) in a dose-dependent manner .	T32	T53	19244097
NA	CHEMICAL	GENE-Y	27	23	In the present study , we report that chemical and chemical , at doses that do not alter release , partially inhibited chemical-induced gene-mediated release of chemical ( chemical ) orchemical from striatal synaptosomes ( `` gene-mediated chemical release '' ) in a dose-dependent manner .	T33	T52	19244097
NA	CHEMICAL	GENE-Y	27	36	In the present study , we report that chemical and chemical , at doses that do not alter release , partially inhibited chemical-induced gene-mediated release of chemical ( chemical ) orchemical from striatal synaptosomes ( `` gene-mediated chemical release '' ) in a dose-dependent manner .	T33	T53	19244097
NA	CHEMICAL	GENE-Y	15	23	In the present study , we report that chemical and chemical , at doses that do not alter release , partially inhibited chemical-induced gene-mediated release of chemical ( chemical ) orchemical from striatal synaptosomes ( `` gene-mediated chemical release '' ) in a dose-dependent manner .	T34	T52	19244097
NA	CHEMICAL	GENE-Y	15	36	In the present study , we report that chemical and chemical , at doses that do not alter release , partially inhibited chemical-induced gene-mediated release of chemical ( chemical ) orchemical from striatal synaptosomes ( `` gene-mediated chemical release '' ) in a dose-dependent manner .	T34	T53	19244097
NA	CHEMICAL	GENE-Y	37	23	In the present study , we report that chemical and chemical , at doses that do not alter release , partially inhibited chemical-induced gene-mediated release of chemical ( chemical ) orchemical from striatal synaptosomes ( `` gene-mediated chemical release '' ) in a dose-dependent manner .	T36	T52	19244097
NA	CHEMICAL	GENE-Y	37	36	In the present study , we report that chemical and chemical , at doses that do not alter release , partially inhibited chemical-induced gene-mediated release of chemical ( chemical ) orchemical from striatal synaptosomes ( `` gene-mediated chemical release '' ) in a dose-dependent manner .	T36	T53	19244097
NA	CHEMICAL	GENE-Y	0	6	chemical , which does not alter gene-mediated chemical release measured with chemical , reversed the effect of chemical .	T37	T54	19244097
NA	CHEMICAL	GENE-Y	7	6	chemical , which does not alter gene-mediated chemical release measured with chemical , reversed the effect of chemical .	T38	T54	19244097
NA	CHEMICAL	GENE-Y	11	6	chemical , which does not alter gene-mediated chemical release measured with chemical , reversed the effect of chemical .	T39	T54	19244097
NA	CHEMICAL	GENE-Y	17	6	chemical , which does not alter gene-mediated chemical release measured with chemical , reversed the effect of chemical .	T40	T54	19244097
NA	CHEMICAL	GENE-Y	0	6	chemical and chemical also partially inhibited gene-mediated chemical release induced by chemical or chemical , demonstrating that the observed partial inhibition is not specific for a particular gene substrate .	T41	T56	19244097
NA	CHEMICAL	GENE-Y	0	27	chemical and chemical also partially inhibited gene-mediated chemical release induced by chemical or chemical , demonstrating that the observed partial inhibition is not specific for a particular gene substrate .	T41	T47	19244097
NA	CHEMICAL	GENE-Y	2	6	chemical and chemical also partially inhibited gene-mediated chemical release induced by chemical or chemical , demonstrating that the observed partial inhibition is not specific for a particular gene substrate .	T42	T56	19244097
NA	CHEMICAL	GENE-Y	2	27	chemical and chemical also partially inhibited gene-mediated chemical release induced by chemical or chemical , demonstrating that the observed partial inhibition is not specific for a particular gene substrate .	T42	T47	19244097
NA	CHEMICAL	GENE-Y	7	6	chemical and chemical also partially inhibited gene-mediated chemical release induced by chemical or chemical , demonstrating that the observed partial inhibition is not specific for a particular gene substrate .	T44	T56	19244097
NA	CHEMICAL	GENE-Y	7	27	chemical and chemical also partially inhibited gene-mediated chemical release induced by chemical or chemical , demonstrating that the observed partial inhibition is not specific for a particular gene substrate .	T44	T47	19244097
NA	CHEMICAL	GENE-Y	11	6	chemical and chemical also partially inhibited gene-mediated chemical release induced by chemical or chemical , demonstrating that the observed partial inhibition is not specific for a particular gene substrate .	T1	T56	19244097
NA	CHEMICAL	GENE-Y	11	27	chemical and chemical also partially inhibited gene-mediated chemical release induced by chemical or chemical , demonstrating that the observed partial inhibition is not specific for a particular gene substrate .	T1	T47	19244097
NA	CHEMICAL	GENE-Y	13	6	chemical and chemical also partially inhibited gene-mediated chemical release induced by chemical or chemical , demonstrating that the observed partial inhibition is not specific for a particular gene substrate .	T2	T56	19244097
NA	CHEMICAL	GENE-Y	13	27	chemical and chemical also partially inhibited gene-mediated chemical release induced by chemical or chemical , demonstrating that the observed partial inhibition is not specific for a particular gene substrate .	T2	T47	19244097
NA	CHEMICAL	GENE-Y	4	6	Crystal structure of the chemical-dependent chemical dehydratase from human liver .	T9	T20	15689518
NA	CHEMICAL	GENE-Y	5	6	Crystal structure of the chemical-dependent chemical dehydratase from human liver .	T10	T20	15689518
NA	CHEMICAL	GENE-Y	0	1	chemical dehydratase ( gene ) , a member of the beta-family of chemical-dependent ( PLP ) enzymes , catalyzes the deamination of chemical and chemical to yield chemical or chemical .	T1	T11	15689518
NA	CHEMICAL	GENE-Y	0	3	chemical dehydratase ( gene ) , a member of the beta-family of chemical-dependent ( PLP ) enzymes , catalyzes the deamination of chemical and chemical to yield chemical or chemical .	T1	T13	15689518
NA	CHEMICAL	GENE-Y	6	1	chemical dehydratase ( gene ) , a member of the beta-family of chemical-dependent ( PLP ) enzymes , catalyzes the deamination of chemical and chemical to yield chemical or chemical .	T7	T11	15689518
NA	CHEMICAL	GENE-Y	6	3	chemical dehydratase ( gene ) , a member of the beta-family of chemical-dependent ( PLP ) enzymes , catalyzes the deamination of chemical and chemical to yield chemical or chemical .	T7	T13	15689518
CPR:9	CHEMICAL	GENE-Y	22	1	chemical dehydratase ( gene ) , a member of the beta-family of chemical-dependent ( PLP ) enzymes , catalyzes the deamination of chemical and chemical to yield chemical or chemical .	T2	T11	15689518
CPR:9	CHEMICAL	GENE-Y	22	3	chemical dehydratase ( gene ) , a member of the beta-family of chemical-dependent ( PLP ) enzymes , catalyzes the deamination of chemical and chemical to yield chemical or chemical .	T2	T13	15689518
CPR:9	CHEMICAL	GENE-Y	24	1	chemical dehydratase ( gene ) , a member of the beta-family of chemical-dependent ( PLP ) enzymes , catalyzes the deamination of chemical and chemical to yield chemical or chemical .	T3	T11	15689518
CPR:9	CHEMICAL	GENE-Y	24	3	chemical dehydratase ( gene ) , a member of the beta-family of chemical-dependent ( PLP ) enzymes , catalyzes the deamination of chemical and chemical to yield chemical or chemical .	T3	T13	15689518
CPR:9	CHEMICAL	GENE-Y	6	1	chemical dehydratase ( gene ) , a member of the beta-family of chemical-dependent ( PLP ) enzymes , catalyzes the deamination of chemical and chemical to yield chemical or chemical .	T4	T11	15689518
CPR:9	CHEMICAL	GENE-Y	6	3	chemical dehydratase ( gene ) , a member of the beta-family of chemical-dependent ( PLP ) enzymes , catalyzes the deamination of chemical and chemical to yield chemical or chemical .	T4	T13	15689518
CPR:9	CHEMICAL	GENE-Y	6	1	chemical dehydratase ( gene ) , a member of the beta-family of chemical-dependent ( PLP ) enzymes , catalyzes the deamination of chemical and chemical to yield chemical or chemical .	T5	T11	15689518
CPR:9	CHEMICAL	GENE-Y	6	3	chemical dehydratase ( gene ) , a member of the beta-family of chemical-dependent ( PLP ) enzymes , catalyzes the deamination of chemical and chemical to yield chemical or chemical .	T5	T13	15689518
NA	CHEMICAL	GENE-Y	4	5	The crystal structure of chemical dehydratase from human liver ( gene ) has been solved at 2.5 A-resolution by molecular replacement .	T6	T12	15689518
NA	CHEMICAL	GENE-Y	4	10	The crystal structure of chemical dehydratase from human liver ( gene ) has been solved at 2.5 A-resolution by molecular replacement .	T6	T14	15689518
NA	CHEMICAL	GENE-Y	13	3	Comparison with the gene- ( PLP-OMS ) holo-enzyme reveals a large structural difference in active sites caused by the artifical chemical .	T8	T16	15689518
NA	CHEMICAL	GENE-Y	4	27	The mechanisms by which chemical may influence proliferation are manifold : they control the transcription and the turnover of the key enzyme in chemical synthesis , chemical reductase , by binding to gene , gene and gene .	T4	T15	23500545
NA	CHEMICAL	GENE-Y	4	32	The mechanisms by which chemical may influence proliferation are manifold : they control the transcription and the turnover of the key enzyme in chemical synthesis , chemical reductase , by binding to gene , gene and gene .	T4	T16	23500545
NA	CHEMICAL	GENE-Y	4	34	The mechanisms by which chemical may influence proliferation are manifold : they control the transcription and the turnover of the key enzyme in chemical synthesis , chemical reductase , by binding to gene , gene and gene .	T4	T17	23500545
NA	CHEMICAL	GENE-N	4	31	The mechanisms by which chemical may influence proliferation are manifold : they control the transcription and the turnover of the key enzyme in chemical synthesis , chemical reductase , by binding to gene , gene and gene .	T4	T18	23500545
NA	CHEMICAL	GENE-Y	23	27	The mechanisms by which chemical may influence proliferation are manifold : they control the transcription and the turnover of the key enzyme in chemical synthesis , chemical reductase , by binding to gene , gene and gene .	T5	T15	23500545
NA	CHEMICAL	GENE-Y	23	32	The mechanisms by which chemical may influence proliferation are manifold : they control the transcription and the turnover of the key enzyme in chemical synthesis , chemical reductase , by binding to gene , gene and gene .	T5	T16	23500545
NA	CHEMICAL	GENE-Y	23	34	The mechanisms by which chemical may influence proliferation are manifold : they control the transcription and the turnover of the key enzyme in chemical synthesis , chemical reductase , by binding to gene , gene and gene .	T5	T17	23500545
NA	CHEMICAL	GENE-N	23	31	The mechanisms by which chemical may influence proliferation are manifold : they control the transcription and the turnover of the key enzyme in chemical synthesis , chemical reductase , by binding to gene , gene and gene .	T5	T18	23500545
NA	CHEMICAL	GENE-Y	26	27	The mechanisms by which chemical may influence proliferation are manifold : they control the transcription and the turnover of the key enzyme in chemical synthesis , chemical reductase , by binding to gene , gene and gene .	T6	T15	23500545
NA	CHEMICAL	GENE-Y	26	32	The mechanisms by which chemical may influence proliferation are manifold : they control the transcription and the turnover of the key enzyme in chemical synthesis , chemical reductase , by binding to gene , gene and gene .	T6	T16	23500545
NA	CHEMICAL	GENE-Y	26	34	The mechanisms by which chemical may influence proliferation are manifold : they control the transcription and the turnover of the key enzyme in chemical synthesis , chemical reductase , by binding to gene , gene and gene .	T6	T17	23500545
NA	CHEMICAL	GENE-N	26	31	The mechanisms by which chemical may influence proliferation are manifold : they control the transcription and the turnover of the key enzyme in chemical synthesis , chemical reductase , by binding to gene , gene and gene .	T6	T18	23500545
CPR:9	CHEMICAL	GENE-N	0	3	chemical uptake from gene , intracellular vesicle transport and lipid transfer are also modified by chemical .	T11	T20	23500545
NA	CHEMICAL	GENE-N	15	3	chemical uptake from gene , intracellular vesicle transport and lipid transfer are also modified by chemical .	T12	T20	23500545
NA	CHEMICAL	GENE-N	0	3	chemical interfere with gene , gene and gene pathways of proliferation and differentiation .	T13	T21	23500545
NA	CHEMICAL	GENE-N	0	5	chemical interfere with gene , gene and gene pathways of proliferation and differentiation .	T13	T22	23500545
NA	CHEMICAL	GENE-N	0	7	chemical interfere with gene , gene and gene pathways of proliferation and differentiation .	T13	T23	23500545
CPR:9	CHEMICAL	GENE-N	1	2	The chemical kinase inhibitor chemical ( `` chemical '' ) inhibits gene-driven signaling and suppresses the growth of gene-overexpressing tumor cells .	T10	T25	11585753
NA	CHEMICAL	GENE-Y	1	11	The chemical kinase inhibitor chemical ( `` chemical '' ) inhibits gene-driven signaling and suppresses the growth of gene-overexpressing tumor cells .	T10	T26	11585753
NA	CHEMICAL	GENE-Y	1	18	The chemical kinase inhibitor chemical ( `` chemical '' ) inhibits gene-driven signaling and suppresses the growth of gene-overexpressing tumor cells .	T10	T24	11585753
CPR:4	CHEMICAL	GENE-N	4	2	The chemical kinase inhibitor chemical ( `` chemical '' ) inhibits gene-driven signaling and suppresses the growth of gene-overexpressing tumor cells .	T8	T25	11585753
CPR:4	CHEMICAL	GENE-Y	4	11	The chemical kinase inhibitor chemical ( `` chemical '' ) inhibits gene-driven signaling and suppresses the growth of gene-overexpressing tumor cells .	T8	T26	11585753
NA	CHEMICAL	GENE-Y	4	18	The chemical kinase inhibitor chemical ( `` chemical '' ) inhibits gene-driven signaling and suppresses the growth of gene-overexpressing tumor cells .	T8	T24	11585753
CPR:4	CHEMICAL	GENE-N	7	2	The chemical kinase inhibitor chemical ( `` chemical '' ) inhibits gene-driven signaling and suppresses the growth of gene-overexpressing tumor cells .	T9	T25	11585753
CPR:4	CHEMICAL	GENE-Y	7	11	The chemical kinase inhibitor chemical ( `` chemical '' ) inhibits gene-driven signaling and suppresses the growth of gene-overexpressing tumor cells .	T9	T26	11585753
CPR:4	CHEMICAL	GENE-Y	7	18	The chemical kinase inhibitor chemical ( `` chemical '' ) inhibits gene-driven signaling and suppresses the growth of gene-overexpressing tumor cells .	T9	T24	11585753
CPR:4	CHEMICAL	GENE-N	0	7	chemical ( `` chemical '' ) , a chemical kinase inhibitor selective for the gene , has shown good activity in preclinical studies and in the early phase of clinical trials .	T2	T13	11585753
CPR:4	CHEMICAL	GENE-Y	0	14	chemical ( `` chemical '' ) , a chemical kinase inhibitor selective for the gene , has shown good activity in preclinical studies and in the early phase of clinical trials .	T2	T14	11585753
CPR:4	CHEMICAL	GENE-N	3	7	chemical ( `` chemical '' ) , a chemical kinase inhibitor selective for the gene , has shown good activity in preclinical studies and in the early phase of clinical trials .	T3	T13	11585753
CPR:4	CHEMICAL	GENE-Y	3	14	chemical ( `` chemical '' ) , a chemical kinase inhibitor selective for the gene , has shown good activity in preclinical studies and in the early phase of clinical trials .	T3	T14	11585753
CPR:9	CHEMICAL	GENE-N	8	7	chemical ( `` chemical '' ) , a chemical kinase inhibitor selective for the gene , has shown good activity in preclinical studies and in the early phase of clinical trials .	T4	T13	11585753
NA	CHEMICAL	GENE-Y	8	14	chemical ( `` chemical '' ) , a chemical kinase inhibitor selective for the gene , has shown good activity in preclinical studies and in the early phase of clinical trials .	T4	T14	11585753
NA	CHEMICAL	GENE-Y	20	14	In a panel of human breast cancer and other epithelial tumor cell lines , gene-overexpressing tumors were particularly sensitive to chemical .	T6	T17	11585753
NA	CHEMICAL	GENE-Y	29	13	Growth inhibition of these tumor cell lines was associated with the dephosphorylation of gene , gene , and gene , accompanied by the loss of association of HER3 with chemical 3-kinase , and down-regulation of gene activity .	T7	T18	11585753
NA	CHEMICAL	GENE-Y	29	15	Growth inhibition of these tumor cell lines was associated with the dephosphorylation of gene , gene , and gene , accompanied by the loss of association of HER3 with chemical 3-kinase , and down-regulation of gene activity .	T7	T19	11585753
NA	CHEMICAL	GENE-Y	29	18	Growth inhibition of these tumor cell lines was associated with the dephosphorylation of gene , gene , and gene , accompanied by the loss of association of HER3 with chemical 3-kinase , and down-regulation of gene activity .	T7	T20	11585753
CPR:9	CHEMICAL	GENE-N	29	30	Growth inhibition of these tumor cell lines was associated with the dephosphorylation of gene , gene , and gene , accompanied by the loss of association of HER3 with chemical 3-kinase , and down-regulation of gene activity .	T7	T21	11585753
NA	CHEMICAL	GENE-N	29	35	Growth inhibition of these tumor cell lines was associated with the dephosphorylation of gene , gene , and gene , accompanied by the loss of association of HER3 with chemical 3-kinase , and down-regulation of gene activity .	T7	T22	11585753
NA	CHEMICAL	GENE-N	0	12	chemical Presents Synergistic Anti-proliferative Activity With chemical Via Altering Cell Cycle and gene Signaling in 95-D Lung Cancer Cells .	T11	T22	23554049
NA	CHEMICAL	GENE-N	6	12	chemical Presents Synergistic Anti-proliferative Activity With chemical Via Altering Cell Cycle and gene Signaling in 95-D Lung Cancer Cells .	T12	T22	23554049
NA	CHEMICAL	GENE-Y	0	1	chemical synthetase deficiency is the most frequently recognized disorder and , in its severe form , it is associated with hemolytic anemia , metabolic acidosis , 5-oxoprolinuria , central nervous system ( CNS ) damage and recurrent bacterial infections .	T16	T29	17397529
NA	CHEMICAL	GENE-Y	0	1	chemical synthetase deficiency is also associated with hemolytic anemia , and some patients with this disorder show defects of neuromuscular function and generalized aminoaciduria .	T19	T30	17397529
NA	CHEMICAL	GENE-Y	0	1	chemical transpeptidase deficiency has been found in patients with CNS involvement and glutathionuria .	T2	T21	17397529
NA	CHEMICAL	GENE-Y	12	5	Diagnosis is made by measuring the concentration of different metabolites in the chemical cycle , enzyme activity and in chemical synthetase and chemical synthetase deficiency , also by mutation analysis .	T3	T24	17397529
NA	CHEMICAL	GENE-Y	12	5	Diagnosis is made by measuring the concentration of different metabolites in the chemical cycle , enzyme activity and in chemical synthetase and chemical synthetase deficiency , also by mutation analysis .	T3	T25	17397529
NA	CHEMICAL	GENE-Y	19	5	Diagnosis is made by measuring the concentration of different metabolites in the chemical cycle , enzyme activity and in chemical synthetase and chemical synthetase deficiency , also by mutation analysis .	T4	T24	17397529
NA	CHEMICAL	GENE-Y	19	5	Diagnosis is made by measuring the concentration of different metabolites in the chemical cycle , enzyme activity and in chemical synthetase and chemical synthetase deficiency , also by mutation analysis .	T4	T25	17397529
NA	CHEMICAL	GENE-Y	10	5	Diagnosis is made by measuring the concentration of different metabolites in the chemical cycle , enzyme activity and in chemical synthetase and chemical synthetase deficiency , also by mutation analysis .	T5	T24	17397529
NA	CHEMICAL	GENE-Y	10	5	Diagnosis is made by measuring the concentration of different metabolites in the chemical cycle , enzyme activity and in chemical synthetase and chemical synthetase deficiency , also by mutation analysis .	T5	T25	17397529
NA	CHEMICAL	GENE-Y	4	6	The effects of the chemical A3 receptor agonist chemical on chemical-induced experimental acute pancreatitis .	T14	T27	23625750
CPR:5	CHEMICAL	GENE-Y	8	6	The effects of the chemical A3 receptor agonist chemical on chemical-induced experimental acute pancreatitis .	T15	T27	23625750
NA	CHEMICAL	GENE-Y	10	6	The effects of the chemical A3 receptor agonist chemical on chemical-induced experimental acute pancreatitis .	T16	T27	23625750
NA	CHEMICAL	GENE-Y	3	5	The role of chemical A3 receptors and their distribution in the gastrointestinal tract have been widely investigated .	T2	T18	23625750
NA	CHEMICAL	GENE-Y	5	7	However , the role of chemical A3 receptor agonist in pancreatitis has not been well established .	T7	T22	23625750
NA	CHEMICAL	GENE-Y	14	18	The aim of this study is ( Ed note : Purpose statements should be in present tense ) to evaluate the effects of the chemical A3 receptor agonist on the course of chemical-induced experimental acute pancreatitis ( EAP ) .	T8	T23	23625750
NA	CHEMICAL	GENE-Y	32	18	The aim of this study is ( Ed note : Purpose statements should be in present tense ) to evaluate the effects of the chemical A3 receptor agonist on the course of chemical-induced experimental acute pancreatitis ( EAP ) .	T9	T23	23625750
NA	CHEMICAL	GENE-Y	32	34	The experiments were performed on 80 male Wistar rats , 58 of which survived , subdivided into 3 groups : C-control rats , I-EAP group , and II-EAP group treated with the chemical A3 receptor agonist chemical chemical at a dose of 0.75 mg/kg b.w .	T10	T24	23625750
CPR:5	CHEMICAL	GENE-Y	36	34	The experiments were performed on 80 male Wistar rats , 58 of which survived , subdivided into 3 groups : C-control rats , I-EAP group , and II-EAP group treated with the chemical A3 receptor agonist chemical chemical at a dose of 0.75 mg/kg b.w .	T11	T24	23625750
CPR:5	CHEMICAL	GENE-Y	4	34	The experiments were performed on 80 male Wistar rats , 58 of which survived , subdivided into 3 groups : C-control rats , I-EAP group , and II-EAP group treated with the chemical A3 receptor agonist chemical chemical at a dose of 0.75 mg/kg b.w .	T12	T24	23625750
CPR:4	CHEMICAL	GENE-N	2	5	In the chemical group , gene activity was decreased with statistically high significance compared to group I . The activity of gene was not significantly different among the experimental groups but higher than in the control group .	T1	T17	23625750
NA	CHEMICAL	GENE-N	2	21	In the chemical group , gene activity was decreased with statistically high significance compared to group I . The activity of gene was not significantly different among the experimental groups but higher than in the control group .	T1	T19	23625750
CPR:5	CHEMICAL	GENE-Y	5	3	The use of gene agonist chemical attenuates EAP .	T4	T20	23625750
CPR:9	CHEMICAL	GENE-N	7	2	The enzyme gene catalyses the oxygenation of chemical , leading to the formation of chemical .	T5	T18	7832763
CPR:9	CHEMICAL	GENE-N	2	2	The enzyme gene catalyses the oxygenation of chemical , leading to the formation of chemical .	T1	T18	7832763
NA	CHEMICAL	GENE-Y	9	0	gene had a specific activity of 18.8 mumol of chemical/mg with a Km of 13.8 microM for chemical and Vmax .	T4	T26	7832763
CPR:9	CHEMICAL	GENE-Y	2	0	gene had a specific activity of 18.8 mumol of chemical/mg with a Km of 13.8 microM for chemical and Vmax .	T6	T26	7832763
NA	CHEMICAL	GENE-Y	4	9	of 1500 nmol of chemical/nmol of enzyme , whereas gene had a specific activity of 12.2 mumol of O2/mg with a Km of 8.7 microM for chemical and a Vmax .	T7	T27	7832763
CPR:9	CHEMICAL	GENE-Y	11	9	of 1500 nmol of chemical/nmol of enzyme , whereas gene had a specific activity of 12.2 mumol of O2/mg with a Km of 8.7 microM for chemical and a Vmax .	T8	T27	7832763
CPR:4	CHEMICAL	GENE-Y	0	3	chemical inhibited both gene and gene , whereas chemical and chemical selectively inhibited gene .	T10	T28	7832763
CPR:4	CHEMICAL	GENE-Y	0	5	chemical inhibited both gene and gene , whereas chemical and chemical selectively inhibited gene .	T10	T29	7832763
NA	CHEMICAL	GENE-Y	0	13	chemical inhibited both gene and gene , whereas chemical and chemical selectively inhibited gene .	T10	T30	7832763
NA	CHEMICAL	GENE-Y	8	3	chemical inhibited both gene and gene , whereas chemical and chemical selectively inhibited gene .	T11	T28	7832763
NA	CHEMICAL	GENE-Y	8	5	chemical inhibited both gene and gene , whereas chemical and chemical selectively inhibited gene .	T11	T29	7832763
CPR:4	CHEMICAL	GENE-Y	8	13	chemical inhibited both gene and gene , whereas chemical and chemical selectively inhibited gene .	T11	T30	7832763
NA	CHEMICAL	GENE-Y	10	3	chemical inhibited both gene and gene , whereas chemical and chemical selectively inhibited gene .	T12	T28	7832763
NA	CHEMICAL	GENE-Y	10	5	chemical inhibited both gene and gene , whereas chemical and chemical selectively inhibited gene .	T12	T29	7832763
CPR:4	CHEMICAL	GENE-Y	10	13	chemical inhibited both gene and gene , whereas chemical and chemical selectively inhibited gene .	T12	T30	7832763
CPR:4	CHEMICAL	GENE-Y	1	8	Both chemical and chemical exhibited time-dependent inactivation of gene , as did chemical on both enzymes .	T13	T31	7832763
CPR:4	CHEMICAL	GENE-Y	3	8	Both chemical and chemical exhibited time-dependent inactivation of gene , as did chemical on both enzymes .	T14	T31	7832763
CPR:4	CHEMICAL	GENE-Y	12	8	Both chemical and chemical exhibited time-dependent inactivation of gene , as did chemical on both enzymes .	T15	T31	7832763
CPR:4	CHEMICAL	GENE-Y	6	4	The competitive inhibitor of gene , chemical , also displayed competitive inhibition of gene .	T2	T16	7832763
CPR:4	CHEMICAL	GENE-Y	6	13	The competitive inhibitor of gene , chemical , also displayed competitive inhibition of gene .	T2	T17	7832763
NA	CHEMICAL	GENE-N	3	3	The profile of a range of gene antagonists was determined in vitro against cloned gene and against chemical-mediated contractions of rat aorta and human prostate .	T18	T48	8799556
NA	CHEMICAL	GENE-N	3	3	The profile of a range of gene antagonists was determined in vitro against cloned gene and against chemical-mediated contractions of rat aorta and human prostate .	T18	T41	8799556
NA	CHEMICAL	GENE-N	1	20	The chemical antagonists , chemical , chemical and chemical displayed high affinity but were non selective for the three cloned gene .	T29	T52	8799556
NA	CHEMICAL	GENE-N	4	20	The chemical antagonists , chemical , chemical and chemical displayed high affinity but were non selective for the three cloned gene .	T30	T52	8799556
NA	CHEMICAL	GENE-N	6	20	The chemical antagonists , chemical , chemical and chemical displayed high affinity but were non selective for the three cloned gene .	T31	T52	8799556
NA	CHEMICAL	GENE-N	8	20	The chemical antagonists , chemical , chemical and chemical displayed high affinity but were non selective for the three cloned gene .	T32	T52	8799556
NA	CHEMICAL	GENE-N	0	6	chemical and chemical showed selectivity for gene relative to the gene .	T33	T53	8799556
NA	CHEMICAL	GENE-Y	0	10	chemical and chemical showed selectivity for gene relative to the gene .	T33	T54	8799556
NA	CHEMICAL	GENE-N	2	6	chemical and chemical showed selectivity for gene relative to the gene .	T34	T53	8799556
NA	CHEMICAL	GENE-Y	2	10	chemical and chemical showed selectivity for gene relative to the gene .	T34	T54	8799556
NA	CHEMICAL	GENE-N	0	10	chemical , chemical , chemical , chemical showed selectivity for gene relative to the gene .	T35	T55	8799556
NA	CHEMICAL	GENE-Y	0	14	chemical , chemical , chemical , chemical showed selectivity for gene relative to the gene .	T35	T56	8799556
NA	CHEMICAL	GENE-N	2	10	chemical , chemical , chemical , chemical showed selectivity for gene relative to the gene .	T36	T55	8799556
NA	CHEMICAL	GENE-Y	2	14	chemical , chemical , chemical , chemical showed selectivity for gene relative to the gene .	T36	T56	8799556
NA	CHEMICAL	GENE-N	1	10	chemical , chemical , chemical , chemical showed selectivity for gene relative to the gene .	T37	T55	8799556
NA	CHEMICAL	GENE-Y	1	14	chemical , chemical , chemical , chemical showed selectivity for gene relative to the gene .	T37	T56	8799556
NA	CHEMICAL	GENE-N	6	10	chemical , chemical , chemical , chemical showed selectivity for gene relative to the gene .	T38	T55	8799556
NA	CHEMICAL	GENE-Y	6	14	chemical , chemical , chemical , chemical showed selectivity for gene relative to the gene .	T38	T56	8799556
NA	CHEMICAL	GENE-Y	0	7	chemical showed high affinity and selectivity for gene ( pKi 8.6 ) relative to gene ( pKi = 7.3 ) and gene ( pKi = 7.1 ) subtypes .	T39	T57	8799556
NA	CHEMICAL	GENE-Y	0	14	chemical showed high affinity and selectivity for gene ( pKi 8.6 ) relative to gene ( pKi = 7.3 ) and gene ( pKi = 7.1 ) subtypes .	T39	T58	8799556
NA	CHEMICAL	GENE-Y	0	21	chemical showed high affinity and selectivity for gene ( pKi 8.6 ) relative to gene ( pKi = 7.3 ) and gene ( pKi = 7.1 ) subtypes .	T39	T40	8799556
CPR:6	CHEMICAL	GENE-Y	0	12	chemical , chemical , chemical , chemical , chemical and chemical appeared to act as competitive antagonists of chemical-mediated contractions of rat aorta yielding pA2 affinity estimates which were similar to binding affinities at cloned gene .	T1	T42	8799556
CPR:6	CHEMICAL	GENE-Y	2	12	chemical , chemical , chemical , chemical , chemical and chemical appeared to act as competitive antagonists of chemical-mediated contractions of rat aorta yielding pA2 affinity estimates which were similar to binding affinities at cloned gene .	T2	T42	8799556
CPR:6	CHEMICAL	GENE-Y	1	12	chemical , chemical , chemical , chemical , chemical and chemical appeared to act as competitive antagonists of chemical-mediated contractions of rat aorta yielding pA2 affinity estimates which were similar to binding affinities at cloned gene .	T3	T42	8799556
CPR:6	CHEMICAL	GENE-Y	6	12	chemical , chemical , chemical , chemical , chemical and chemical appeared to act as competitive antagonists of chemical-mediated contractions of rat aorta yielding pA2 affinity estimates which were similar to binding affinities at cloned gene .	T4	T42	8799556
CPR:6	CHEMICAL	GENE-Y	8	12	chemical , chemical , chemical , chemical , chemical and chemical appeared to act as competitive antagonists of chemical-mediated contractions of rat aorta yielding pA2 affinity estimates which were similar to binding affinities at cloned gene .	T5	T42	8799556
CPR:6	CHEMICAL	GENE-Y	10	12	chemical , chemical , chemical , chemical , chemical and chemical appeared to act as competitive antagonists of chemical-mediated contractions of rat aorta yielding pA2 affinity estimates which were similar to binding affinities at cloned gene .	T6	T42	8799556
NA	CHEMICAL	GENE-Y	18	12	chemical , chemical , chemical , chemical , chemical and chemical appeared to act as competitive antagonists of chemical-mediated contractions of rat aorta yielding pA2 affinity estimates which were similar to binding affinities at cloned gene .	T7	T42	8799556
NA	CHEMICAL	GENE-Y	4	17	The affinity estimate for chemical on human prostate was lower than the corresponding binding affinity determined at gene and chemical was a very weak antagonist on human prostate ( pA2 = 6.0 ) relative to the high affinity ( pKi = 8.6 ) determined at cloned gene .	T19	T44	8799556
NA	CHEMICAL	GENE-Y	4	21	The affinity estimate for chemical on human prostate was lower than the corresponding binding affinity determined at gene and chemical was a very weak antagonist on human prostate ( pA2 = 6.0 ) relative to the high affinity ( pKi = 8.6 ) determined at cloned gene .	T19	T45	8799556
NA	CHEMICAL	GENE-Y	19	17	The affinity estimate for chemical on human prostate was lower than the corresponding binding affinity determined at gene and chemical was a very weak antagonist on human prostate ( pA2 = 6.0 ) relative to the high affinity ( pKi = 8.6 ) determined at cloned gene .	T20	T44	8799556
NA	CHEMICAL	GENE-Y	19	21	The affinity estimate for chemical on human prostate was lower than the corresponding binding affinity determined at gene and chemical was a very weak antagonist on human prostate ( pA2 = 6.0 ) relative to the high affinity ( pKi = 8.6 ) determined at cloned gene .	T20	T45	8799556
NA	CHEMICAL	GENE-N	1	7	Data in this study suggest that the gene mediating chemical-induced contractions of human prostate , whilst having some of the characteristics of an gene , can not be satisfactorily aligned with cloned gene .	T26	T46	8799556
NA	CHEMICAL	GENE-Y	1	23	Data in this study suggest that the gene mediating chemical-induced contractions of human prostate , whilst having some of the characteristics of an gene , can not be satisfactorily aligned with cloned gene .	T26	T47	8799556
NA	CHEMICAL	GENE-N	1	32	Data in this study suggest that the gene mediating chemical-induced contractions of human prostate , whilst having some of the characteristics of an gene , can not be satisfactorily aligned with cloned gene .	T26	T49	8799556
CPR:3	CHEMICAL	GENE-N	12	8	Time-dependent changes in hepatic and intestinal induction of gene after administration of chemical to rats .	T12	T23	23339625
CPR:3	CHEMICAL	GENE-N	26	26	We investigated the effects of the dose of and the number of times an inducer was administered and the duration of induction of hepatic and intestinal gene ( gene ) in rats using chemical ( chemical ) and chemical ( chemical ) as an inducer and a substrate to gene , respectively .	T1	T15	23339625
CPR:3	CHEMICAL	GENE-N	26	28	We investigated the effects of the dose of and the number of times an inducer was administered and the duration of induction of hepatic and intestinal gene ( gene ) in rats using chemical ( chemical ) and chemical ( chemical ) as an inducer and a substrate to gene , respectively .	T1	T16	23339625
CPR:9	CHEMICAL	GENE-N	26	49	We investigated the effects of the dose of and the number of times an inducer was administered and the duration of induction of hepatic and intestinal gene ( gene ) in rats using chemical ( chemical ) and chemical ( chemical ) as an inducer and a substrate to gene , respectively .	T1	T17	23339625
CPR:3	CHEMICAL	GENE-N	35	26	We investigated the effects of the dose of and the number of times an inducer was administered and the duration of induction of hepatic and intestinal gene ( gene ) in rats using chemical ( chemical ) and chemical ( chemical ) as an inducer and a substrate to gene , respectively .	T2	T15	23339625
CPR:3	CHEMICAL	GENE-N	35	28	We investigated the effects of the dose of and the number of times an inducer was administered and the duration of induction of hepatic and intestinal gene ( gene ) in rats using chemical ( chemical ) and chemical ( chemical ) as an inducer and a substrate to gene , respectively .	T2	T16	23339625
CPR:9	CHEMICAL	GENE-N	35	49	We investigated the effects of the dose of and the number of times an inducer was administered and the duration of induction of hepatic and intestinal gene ( gene ) in rats using chemical ( chemical ) and chemical ( chemical ) as an inducer and a substrate to gene , respectively .	T2	T17	23339625
CPR:9	CHEMICAL	GENE-N	38	26	We investigated the effects of the dose of and the number of times an inducer was administered and the duration of induction of hepatic and intestinal gene ( gene ) in rats using chemical ( chemical ) and chemical ( chemical ) as an inducer and a substrate to gene , respectively .	T3	T15	23339625
CPR:9	CHEMICAL	GENE-N	38	28	We investigated the effects of the dose of and the number of times an inducer was administered and the duration of induction of hepatic and intestinal gene ( gene ) in rats using chemical ( chemical ) and chemical ( chemical ) as an inducer and a substrate to gene , respectively .	T3	T16	23339625
CPR:9	CHEMICAL	GENE-N	38	49	We investigated the effects of the dose of and the number of times an inducer was administered and the duration of induction of hepatic and intestinal gene ( gene ) in rats using chemical ( chemical ) and chemical ( chemical ) as an inducer and a substrate to gene , respectively .	T3	T17	23339625
NA	CHEMICAL	GENE-N	40	26	We investigated the effects of the dose of and the number of times an inducer was administered and the duration of induction of hepatic and intestinal gene ( gene ) in rats using chemical ( chemical ) and chemical ( chemical ) as an inducer and a substrate to gene , respectively .	T4	T15	23339625
CPR:9	CHEMICAL	GENE-N	40	28	We investigated the effects of the dose of and the number of times an inducer was administered and the duration of induction of hepatic and intestinal gene ( gene ) in rats using chemical ( chemical ) and chemical ( chemical ) as an inducer and a substrate to gene , respectively .	T4	T16	23339625
CPR:9	CHEMICAL	GENE-N	40	49	We investigated the effects of the dose of and the number of times an inducer was administered and the duration of induction of hepatic and intestinal gene ( gene ) in rats using chemical ( chemical ) and chemical ( chemical ) as an inducer and a substrate to gene , respectively .	T4	T17	23339625
NA	CHEMICAL	GENE-N	4	20	The number of times chemical was administered was not a significant factor in the induction of either hepatic or intestinal gene ; however , administration of chemical multiple times markedly decreased the bioavailability of chemical by self-induction of gene .	T5	T18	23339625
NA	CHEMICAL	GENE-N	4	38	The number of times chemical was administered was not a significant factor in the induction of either hepatic or intestinal gene ; however , administration of chemical multiple times markedly decreased the bioavailability of chemical by self-induction of gene .	T5	T19	23339625
NA	CHEMICAL	GENE-N	26	20	The number of times chemical was administered was not a significant factor in the induction of either hepatic or intestinal gene ; however , administration of chemical multiple times markedly decreased the bioavailability of chemical by self-induction of gene .	T6	T18	23339625
NA	CHEMICAL	GENE-N	26	38	The number of times chemical was administered was not a significant factor in the induction of either hepatic or intestinal gene ; however , administration of chemical multiple times markedly decreased the bioavailability of chemical by self-induction of gene .	T6	T19	23339625
NA	CHEMICAL	GENE-N	34	20	The number of times chemical was administered was not a significant factor in the induction of either hepatic or intestinal gene ; however , administration of chemical multiple times markedly decreased the bioavailability of chemical by self-induction of gene .	T7	T18	23339625
NA	CHEMICAL	GENE-N	34	38	The number of times chemical was administered was not a significant factor in the induction of either hepatic or intestinal gene ; however , administration of chemical multiple times markedly decreased the bioavailability of chemical by self-induction of gene .	T7	T19	23339625
CPR:3	CHEMICAL	GENE-N	11	0	gene induction in the liver increased depending on the dose of chemical , whereas that in intestine showed a mild increase , but the induction level was almost constant regardless of the dose of chemical .	T8	T20	23339625
CPR:3	CHEMICAL	GENE-N	34	0	gene induction in the liver increased depending on the dose of chemical , whereas that in intestine showed a mild increase , but the induction level was almost constant regardless of the dose of chemical .	T9	T20	23339625
CPR:3	CHEMICAL	GENE-N	6	12	Administration of a single dose of chemical showed a temporal increase in gene activity in both tissues and the induction ratios reached maximum values at 12 h after chemical administration .	T10	T21	23339625
CPR:3	CHEMICAL	GENE-N	28	12	Administration of a single dose of chemical showed a temporal increase in gene activity in both tissues and the induction ratios reached maximum values at 12 h after chemical administration .	T11	T21	23339625
NA	CHEMICAL	GENE-Y	1	4	The chemical-binding sites of chemical/gene determine its capacity to suppress matrix invasion by squamous cell carcinoma cells .	T13	T22	23347038
NA	CHEMICAL	GENE-Y	4	4	The chemical-binding sites of chemical/gene determine its capacity to suppress matrix invasion by squamous cell carcinoma cells .	T12	T22	23347038
NA	CHEMICAL	GENE-Y	1	5	The chemical ( chemical ) /gene ( gene ) interacts with a variety of factors that impinge on tumour invasion and metastasis .	T6	T16	23347038
NA	CHEMICAL	GENE-Y	1	7	The chemical ( chemical ) /gene ( gene ) interacts with a variety of factors that impinge on tumour invasion and metastasis .	T6	T18	23347038
NA	CHEMICAL	GENE-Y	3	5	The chemical ( chemical ) /gene ( gene ) interacts with a variety of factors that impinge on tumour invasion and metastasis .	T10	T16	23347038
NA	CHEMICAL	GENE-Y	3	7	The chemical ( chemical ) /gene ( gene ) interacts with a variety of factors that impinge on tumour invasion and metastasis .	T10	T18	23347038
NA	CHEMICAL	GENE-Y	8	8	It has been shown that expression of wild-type chemical/gene reduces the tumorigenic and invasive properties of receptor-deficient SCC-VII squamous cell carcinoma cells .	T4	T15	23347038
NA	CHEMICAL	GENE-Y	7	7	We have now used mutant forms of chemical/gene to assess the relevance of the different ligand-binding sites of the receptor for its biological activities in this cellular system .	T5	T17	23347038
NA	CHEMICAL	GENE-Y	8	8	The results of the present study demonstrate that chemical/gene does not require a functional binding site for gene for inhibition of anchorage-independent growth and matrix invasion by SCC-VII cells .	T7	T19	23347038
NA	CHEMICAL	GENE-Y	8	17	The results of the present study demonstrate that chemical/gene does not require a functional binding site for gene for inhibition of anchorage-independent growth and matrix invasion by SCC-VII cells .	T7	T20	23347038
NA	CHEMICAL	GENE-Y	7	7	These findings highlight that the interaction between chemical/gene and chemical-modified ligands is not only important for intracellular accumulation of lysosomal enzymes and formation of dense lysosomes , but is also crucial for the ability of the receptor to suppress SCC-VII growth and invasion .	T9	T21	23347038
NA	CHEMICAL	GENE-Y	9	7	These findings highlight that the interaction between chemical/gene and chemical-modified ligands is not only important for intracellular accumulation of lysosomal enzymes and formation of dense lysosomes , but is also crucial for the ability of the receptor to suppress SCC-VII growth and invasion .	T11	T21	23347038
CPR:3	CHEMICAL	GENE-Y	4	4	Correlation between activation of gene and gene downregulation in a mouse adipocyte cell line by a series of chemical .	T1	T10	23563205
CPR:4	CHEMICAL	GENE-Y	4	6	Correlation between activation of gene and gene downregulation in a mouse adipocyte cell line by a series of chemical .	T1	T11	23563205
CPR:9	CHEMICAL	GENE-Y	21	5	Here , we demonstrate that gene ( gene ) , an enzyme that catalyzes the conversion of the peptide bond of chemical/chemical-chemical moieties in signaling proteins from cis to trans , is highly susceptible to chemical modification .	T13	T28	23231502
CPR:9	CHEMICAL	GENE-Y	21	7	Here , we demonstrate that gene ( gene ) , an enzyme that catalyzes the conversion of the peptide bond of chemical/chemical-chemical moieties in signaling proteins from cis to trans , is highly susceptible to chemical modification .	T13	T29	23231502
CPR:9	CHEMICAL	GENE-Y	21	5	Here , we demonstrate that gene ( gene ) , an enzyme that catalyzes the conversion of the peptide bond of chemical/chemical-chemical moieties in signaling proteins from cis to trans , is highly susceptible to chemical modification .	T14	T28	23231502
CPR:9	CHEMICAL	GENE-Y	21	7	Here , we demonstrate that gene ( gene ) , an enzyme that catalyzes the conversion of the peptide bond of chemical/chemical-chemical moieties in signaling proteins from cis to trans , is highly susceptible to chemical modification .	T14	T29	23231502
CPR:9	CHEMICAL	GENE-Y	21	5	Here , we demonstrate that gene ( gene ) , an enzyme that catalyzes the conversion of the peptide bond of chemical/chemical-chemical moieties in signaling proteins from cis to trans , is highly susceptible to chemical modification .	T15	T28	23231502
CPR:9	CHEMICAL	GENE-Y	21	7	Here , we demonstrate that gene ( gene ) , an enzyme that catalyzes the conversion of the peptide bond of chemical/chemical-chemical moieties in signaling proteins from cis to trans , is highly susceptible to chemical modification .	T15	T29	23231502
NA	CHEMICAL	GENE-Y	35	5	Here , we demonstrate that gene ( gene ) , an enzyme that catalyzes the conversion of the peptide bond of chemical/chemical-chemical moieties in signaling proteins from cis to trans , is highly susceptible to chemical modification .	T16	T28	23231502
NA	CHEMICAL	GENE-Y	35	7	Here , we demonstrate that gene ( gene ) , an enzyme that catalyzes the conversion of the peptide bond of chemical/chemical-chemical moieties in signaling proteins from cis to trans , is highly susceptible to chemical modification .	T16	T29	23231502
NA	CHEMICAL	GENE-Y	5	3	Incubation of purified gene with chemical followed by MALDI-TOF/TOF mass spectrometry resulted in detection of Michael adducts at the active site residues chemical-157 and chemical-113 .	T17	T30	23231502
NA	CHEMICAL	GENE-Y	22	3	Incubation of purified gene with chemical followed by MALDI-TOF/TOF mass spectrometry resulted in detection of Michael adducts at the active site residues chemical-157 and chemical-113 .	T18	T30	23231502
NA	CHEMICAL	GENE-Y	24	3	Incubation of purified gene with chemical followed by MALDI-TOF/TOF mass spectrometry resulted in detection of Michael adducts at the active site residues chemical-157 and chemical-113 .	T19	T30	23231502
NA	CHEMICAL	GENE-Y	10	0	gene was adducted in MDA-MB-231 breast cancer cells treated with chemical as judged by click chemistry conjugation with chemical followed by streptavidin-based pulldown and Western blotting with anti-gene antibody .	T22	T31	23231502
NA	CHEMICAL	GENE-Y	10	3	gene was adducted in MDA-MB-231 breast cancer cells treated with chemical as judged by click chemistry conjugation with chemical followed by streptavidin-based pulldown and Western blotting with anti-gene antibody .	T22	T24	23231502
NA	CHEMICAL	GENE-Y	3	0	gene was adducted in MDA-MB-231 breast cancer cells treated with chemical as judged by click chemistry conjugation with chemical followed by streptavidin-based pulldown and Western blotting with anti-gene antibody .	T1	T31	23231502
NA	CHEMICAL	GENE-Y	3	3	gene was adducted in MDA-MB-231 breast cancer cells treated with chemical as judged by click chemistry conjugation with chemical followed by streptavidin-based pulldown and Western blotting with anti-gene antibody .	T1	T24	23231502
NA	CHEMICAL	GENE-Y	9	10	Furthermore , orbitrap MS data support the adduction of chemical-113 in the gene active site upon chemical treatment of MDA-MB-231 cells .	T2	T25	23231502
NA	CHEMICAL	GENE-Y	16	10	Furthermore , orbitrap MS data support the adduction of chemical-113 in the gene active site upon chemical treatment of MDA-MB-231 cells .	T3	T25	23231502
NA	CHEMICAL	GENE-Y	12	3	siRNA knockdown of gene in MDA-MB-231 cells partially protected the cells from chemical-induced toxicity .	T4	T26	23231502
NA	CHEMICAL	GENE-Y	2	0	gene inhibits chemical oxidase activation and protects endothelial function in the rat aorta : Implications for vascular aging .	T23	T52	23422569
NA	CHEMICAL	GENE-N	2	3	gene inhibits chemical oxidase activation and protects endothelial function in the rat aorta : Implications for vascular aging .	T23	T53	23422569
NA	CHEMICAL	GENE-N	7	8	Vascular aging is characterized by up-regulation of chemical oxidase , oxidative stress and endothelial dysfunction .	T13	T46	23422569
NA	CHEMICAL	GENE-Y	10	21	Previous studies demonstrate that the activity of the evolutionarily conserved chemical-dependent deacetylase gene declines with age and that pharmacological activators of SIRT1 confer significant anti-aging cardiovascular effects .	T9	T42	23422569
NA	CHEMICAL	GENE-Y	10	12	Previous studies demonstrate that the activity of the evolutionarily conserved chemical-dependent deacetylase gene declines with age and that pharmacological activators of SIRT1 confer significant anti-aging cardiovascular effects .	T9	T43	23422569
NA	CHEMICAL	GENE-Y	7	5	To determine whether dysregulation of gene promotes chemical oxidase-dependent production of reactive chemical species ( ROS ) and impairs endothelial function we assessed the effects of three structurally different inhibitors of gene ( chemical , chemical , chemical ) in aorta segments isolated from young Wistar rats .	T11	T44	23422569
NA	CHEMICAL	GENE-Y	7	31	To determine whether dysregulation of gene promotes chemical oxidase-dependent production of reactive chemical species ( ROS ) and impairs endothelial function we assessed the effects of three structurally different inhibitors of gene ( chemical , chemical , chemical ) in aorta segments isolated from young Wistar rats .	T11	T47	23422569
NA	CHEMICAL	GENE-Y	12	5	To determine whether dysregulation of gene promotes chemical oxidase-dependent production of reactive chemical species ( ROS ) and impairs endothelial function we assessed the effects of three structurally different inhibitors of gene ( chemical , chemical , chemical ) in aorta segments isolated from young Wistar rats .	T12	T44	23422569
NA	CHEMICAL	GENE-Y	12	31	To determine whether dysregulation of gene promotes chemical oxidase-dependent production of reactive chemical species ( ROS ) and impairs endothelial function we assessed the effects of three structurally different inhibitors of gene ( chemical , chemical , chemical ) in aorta segments isolated from young Wistar rats .	T12	T47	23422569
NA	CHEMICAL	GENE-Y	33	5	To determine whether dysregulation of gene promotes chemical oxidase-dependent production of reactive chemical species ( ROS ) and impairs endothelial function we assessed the effects of three structurally different inhibitors of gene ( chemical , chemical , chemical ) in aorta segments isolated from young Wistar rats .	T14	T44	23422569
CPR:4	CHEMICAL	GENE-Y	33	31	To determine whether dysregulation of gene promotes chemical oxidase-dependent production of reactive chemical species ( ROS ) and impairs endothelial function we assessed the effects of three structurally different inhibitors of gene ( chemical , chemical , chemical ) in aorta segments isolated from young Wistar rats .	T14	T47	23422569
NA	CHEMICAL	GENE-Y	35	5	To determine whether dysregulation of gene promotes chemical oxidase-dependent production of reactive chemical species ( ROS ) and impairs endothelial function we assessed the effects of three structurally different inhibitors of gene ( chemical , chemical , chemical ) in aorta segments isolated from young Wistar rats .	T15	T44	23422569
CPR:4	CHEMICAL	GENE-Y	35	31	To determine whether dysregulation of gene promotes chemical oxidase-dependent production of reactive chemical species ( ROS ) and impairs endothelial function we assessed the effects of three structurally different inhibitors of gene ( chemical , chemical , chemical ) in aorta segments isolated from young Wistar rats .	T15	T47	23422569
NA	CHEMICAL	GENE-Y	37	5	To determine whether dysregulation of gene promotes chemical oxidase-dependent production of reactive chemical species ( ROS ) and impairs endothelial function we assessed the effects of three structurally different inhibitors of gene ( chemical , chemical , chemical ) in aorta segments isolated from young Wistar rats .	T16	T44	23422569
CPR:4	CHEMICAL	GENE-Y	37	31	To determine whether dysregulation of gene promotes chemical oxidase-dependent production of reactive chemical species ( ROS ) and impairs endothelial function we assessed the effects of three structurally different inhibitors of gene ( chemical , chemical , chemical ) in aorta segments isolated from young Wistar rats .	T16	T47	23422569
NA	CHEMICAL	GENE-Y	18	2	Inhibition of gene induced endothelial dysfunction , as shown by the significantly reduced relaxation to the endothelium-dependent vasodilators chemical and the chemical ionophore chemical .	T17	T48	23422569
NA	CHEMICAL	GENE-Y	21	2	Inhibition of gene induced endothelial dysfunction , as shown by the significantly reduced relaxation to the endothelium-dependent vasodilators chemical and the chemical ionophore chemical .	T18	T48	23422569
NA	CHEMICAL	GENE-Y	23	2	Inhibition of gene induced endothelial dysfunction , as shown by the significantly reduced relaxation to the endothelium-dependent vasodilators chemical and the chemical ionophore chemical .	T19	T48	23422569
NA	CHEMICAL	GENE-Y	15	4	Endothelial dysfunction induced by gene inhibition was prevented by treatment of the vessels with the chemical oxidase inhibitor chemical or chemical dismutase .	T20	T49	23422569
NA	CHEMICAL	GENE-N	15	16	Endothelial dysfunction induced by gene inhibition was prevented by treatment of the vessels with the chemical oxidase inhibitor chemical or chemical dismutase .	T20	T50	23422569
NA	CHEMICAL	GENE-N	15	21	Endothelial dysfunction induced by gene inhibition was prevented by treatment of the vessels with the chemical oxidase inhibitor chemical or chemical dismutase .	T20	T51	23422569
NA	CHEMICAL	GENE-Y	18	4	Endothelial dysfunction induced by gene inhibition was prevented by treatment of the vessels with the chemical oxidase inhibitor chemical or chemical dismutase .	T21	T49	23422569
CPR:4	CHEMICAL	GENE-N	18	16	Endothelial dysfunction induced by gene inhibition was prevented by treatment of the vessels with the chemical oxidase inhibitor chemical or chemical dismutase .	T21	T50	23422569
NA	CHEMICAL	GENE-N	18	21	Endothelial dysfunction induced by gene inhibition was prevented by treatment of the vessels with the chemical oxidase inhibitor chemical or chemical dismutase .	T21	T51	23422569
NA	CHEMICAL	GENE-Y	20	4	Endothelial dysfunction induced by gene inhibition was prevented by treatment of the vessels with the chemical oxidase inhibitor chemical or chemical dismutase .	T22	T49	23422569
NA	CHEMICAL	GENE-N	20	16	Endothelial dysfunction induced by gene inhibition was prevented by treatment of the vessels with the chemical oxidase inhibitor chemical or chemical dismutase .	T22	T50	23422569
NA	CHEMICAL	GENE-N	20	21	Endothelial dysfunction induced by gene inhibition was prevented by treatment of the vessels with the chemical oxidase inhibitor chemical or chemical dismutase .	T22	T51	23422569
CPR:9	CHEMICAL	GENE-Y	6	2	Inhibition of gene significantly increased vascular chemical production , enhanced chemical oxidase activity , and mRNA expression of its subunits gene and gene , which were prevented by chemical .	T1	T24	23422569
NA	CHEMICAL	GENE-N	6	11	Inhibition of gene significantly increased vascular chemical production , enhanced chemical oxidase activity , and mRNA expression of its subunits gene and gene , which were prevented by chemical .	T1	T25	23422569
NA	CHEMICAL	GENE-Y	6	20	Inhibition of gene significantly increased vascular chemical production , enhanced chemical oxidase activity , and mRNA expression of its subunits gene and gene , which were prevented by chemical .	T1	T26	23422569
NA	CHEMICAL	GENE-Y	6	22	Inhibition of gene significantly increased vascular chemical production , enhanced chemical oxidase activity , and mRNA expression of its subunits gene and gene , which were prevented by chemical .	T1	T27	23422569
NA	CHEMICAL	GENE-Y	2	2	Inhibition of gene significantly increased vascular chemical production , enhanced chemical oxidase activity , and mRNA expression of its subunits gene and gene , which were prevented by chemical .	T2	T24	23422569
NA	CHEMICAL	GENE-N	2	11	Inhibition of gene significantly increased vascular chemical production , enhanced chemical oxidase activity , and mRNA expression of its subunits gene and gene , which were prevented by chemical .	T2	T25	23422569
NA	CHEMICAL	GENE-Y	2	20	Inhibition of gene significantly increased vascular chemical production , enhanced chemical oxidase activity , and mRNA expression of its subunits gene and gene , which were prevented by chemical .	T2	T26	23422569
NA	CHEMICAL	GENE-Y	2	22	Inhibition of gene significantly increased vascular chemical production , enhanced chemical oxidase activity , and mRNA expression of its subunits gene and gene , which were prevented by chemical .	T2	T27	23422569
NA	CHEMICAL	GENE-Y	28	2	Inhibition of gene significantly increased vascular chemical production , enhanced chemical oxidase activity , and mRNA expression of its subunits gene and gene , which were prevented by chemical .	T3	T24	23422569
CPR:4	CHEMICAL	GENE-N	28	11	Inhibition of gene significantly increased vascular chemical production , enhanced chemical oxidase activity , and mRNA expression of its subunits gene and gene , which were prevented by chemical .	T3	T25	23422569
CPR:4	CHEMICAL	GENE-Y	28	20	Inhibition of gene significantly increased vascular chemical production , enhanced chemical oxidase activity , and mRNA expression of its subunits gene and gene , which were prevented by chemical .	T3	T26	23422569
CPR:4	CHEMICAL	GENE-Y	28	22	Inhibition of gene significantly increased vascular chemical production , enhanced chemical oxidase activity , and mRNA expression of its subunits gene and gene , which were prevented by chemical .	T3	T27	23422569
NA	CHEMICAL	GENE-Y	9	0	gene ( gene ) activation mimicked the effects of chemical while gene inhibition prevented the effects of this gene activator .	T4	T28	23422569
NA	CHEMICAL	GENE-Y	9	2	gene ( gene ) activation mimicked the effects of chemical while gene inhibition prevented the effects of this gene activator .	T4	T29	23422569
NA	CHEMICAL	GENE-Y	9	11	gene ( gene ) activation mimicked the effects of chemical while gene inhibition prevented the effects of this gene activator .	T4	T30	23422569
CPR:3	CHEMICAL	GENE-Y	9	18	gene ( gene ) activation mimicked the effects of chemical while gene inhibition prevented the effects of this gene activator .	T4	T31	23422569
NA	CHEMICAL	GENE-Y	5	0	gene co-precipitated with gene and chemical increased the acetylation of the gene coactivator gene , which was suppressed by chemical .	T5	T32	23422569
NA	CHEMICAL	GENE-Y	5	3	gene co-precipitated with gene and chemical increased the acetylation of the gene coactivator gene , which was suppressed by chemical .	T5	T33	23422569
NA	CHEMICAL	GENE-Y	5	11	gene co-precipitated with gene and chemical increased the acetylation of the gene coactivator gene , which was suppressed by chemical .	T5	T34	23422569
CPR:3	CHEMICAL	GENE-Y	5	13	gene co-precipitated with gene and chemical increased the acetylation of the gene coactivator gene , which was suppressed by chemical .	T5	T35	23422569
NA	CHEMICAL	GENE-Y	19	0	gene co-precipitated with gene and chemical increased the acetylation of the gene coactivator gene , which was suppressed by chemical .	T6	T32	23422569
NA	CHEMICAL	GENE-Y	19	3	gene co-precipitated with gene and chemical increased the acetylation of the gene coactivator gene , which was suppressed by chemical .	T6	T33	23422569
NA	CHEMICAL	GENE-Y	19	11	gene co-precipitated with gene and chemical increased the acetylation of the gene coactivator gene , which was suppressed by chemical .	T6	T34	23422569
CPR:4	CHEMICAL	GENE-Y	19	13	gene co-precipitated with gene and chemical increased the acetylation of the gene coactivator gene , which was suppressed by chemical .	T6	T35	23422569
NA	CHEMICAL	GENE-Y	12	6	In conclusion , impaired activity of gene induces endothelial dysfunction and up-regulates chemical oxidase-derived ROS production in the vascular wall , mimicking the vascular aging phenotype .	T7	T36	23422569
NA	CHEMICAL	GENE-N	10	10	The increased activities of the most important intestinal efflux ( gene - gene , gene - gene , gene - gene ) and uptake ( chemical Transporter 1 - gene , gene - gene , gene - gene ) transporters were caused by changes in electrophysiological membrane properties and by allosteric modifications .	T1	T19	21838705
NA	CHEMICAL	GENE-N	10	12	The increased activities of the most important intestinal efflux ( gene - gene , gene - gene , gene - gene ) and uptake ( chemical Transporter 1 - gene , gene - gene , gene - gene ) transporters were caused by changes in electrophysiological membrane properties and by allosteric modifications .	T1	T20	21838705
NA	CHEMICAL	GENE-Y	10	14	The increased activities of the most important intestinal efflux ( gene - gene , gene - gene , gene - gene ) and uptake ( chemical Transporter 1 - gene , gene - gene , gene - gene ) transporters were caused by changes in electrophysiological membrane properties and by allosteric modifications .	T1	T21	21838705
NA	CHEMICAL	GENE-Y	10	11	The increased activities of the most important intestinal efflux ( gene - gene , gene - gene , gene - gene ) and uptake ( chemical Transporter 1 - gene , gene - gene , gene - gene ) transporters were caused by changes in electrophysiological membrane properties and by allosteric modifications .	T1	T5	21838705
NA	CHEMICAL	GENE-Y	10	18	The increased activities of the most important intestinal efflux ( gene - gene , gene - gene , gene - gene ) and uptake ( chemical Transporter 1 - gene , gene - gene , gene - gene ) transporters were caused by changes in electrophysiological membrane properties and by allosteric modifications .	T1	T6	21838705
NA	CHEMICAL	GENE-Y	10	20	The increased activities of the most important intestinal efflux ( gene - gene , gene - gene , gene - gene ) and uptake ( chemical Transporter 1 - gene , gene - gene , gene - gene ) transporters were caused by changes in electrophysiological membrane properties and by allosteric modifications .	T1	T7	21838705
NA	CHEMICAL	GENE-Y	10	27	The increased activities of the most important intestinal efflux ( gene - gene , gene - gene , gene - gene ) and uptake ( chemical Transporter 1 - gene , gene - gene , gene - gene ) transporters were caused by changes in electrophysiological membrane properties and by allosteric modifications .	T1	T8	21838705
NA	CHEMICAL	GENE-Y	10	27	The increased activities of the most important intestinal efflux ( gene - gene , gene - gene , gene - gene ) and uptake ( chemical Transporter 1 - gene , gene - gene , gene - gene ) transporters were caused by changes in electrophysiological membrane properties and by allosteric modifications .	T1	T9	21838705
NA	CHEMICAL	GENE-N	10	31	The increased activities of the most important intestinal efflux ( gene - gene , gene - gene , gene - gene ) and uptake ( chemical Transporter 1 - gene , gene - gene , gene - gene ) transporters were caused by changes in electrophysiological membrane properties and by allosteric modifications .	T1	T10	21838705
NA	CHEMICAL	GENE-N	10	33	The increased activities of the most important intestinal efflux ( gene - gene , gene - gene , gene - gene ) and uptake ( chemical Transporter 1 - gene , gene - gene , gene - gene ) transporters were caused by changes in electrophysiological membrane properties and by allosteric modifications .	T1	T11	21838705
NA	CHEMICAL	GENE-Y	10	27	The increased activities of the most important intestinal efflux ( gene - gene , gene - gene , gene - gene ) and uptake ( chemical Transporter 1 - gene , gene - gene , gene - gene ) transporters were caused by changes in electrophysiological membrane properties and by allosteric modifications .	T1	T12	21838705
NA	CHEMICAL	GENE-Y	10	27	The increased activities of the most important intestinal efflux ( gene - gene , gene - gene , gene - gene ) and uptake ( chemical Transporter 1 - gene , gene - gene , gene - gene ) transporters were caused by changes in electrophysiological membrane properties and by allosteric modifications .	T1	T13	21838705
CPR:4	CHEMICAL	GENE-N	10	8	Because clinical studies investigating interactions between garlic and gene inhibitors chemical and chemical have already been performed , we used these in vivo data to evaluate the in vitro results and the reliability of the models employed as screening tools for forecasting the potential of first-pass intestinal metabolism changes .	T2	T14	21838705
CPR:4	CHEMICAL	GENE-N	12	8	Because clinical studies investigating interactions between garlic and gene inhibitors chemical and chemical have already been performed , we used these in vivo data to evaluate the in vitro results and the reliability of the models employed as screening tools for forecasting the potential of first-pass intestinal metabolism changes .	T3	T14	21838705
CPR:4	CHEMICAL	GENE-Y	9	0	gene inhibitors currently under investigation include the small molecules chemical ( chemical , chemical ) and chemical ( chemical , chemical ) , as well as monoclonal antibodies such as chemical ( chemical , chemical ) .	T1	T22	14967461
CPR:4	CHEMICAL	GENE-Y	0	0	gene inhibitors currently under investigation include the small molecules chemical ( chemical , chemical ) and chemical ( chemical , chemical ) , as well as monoclonal antibodies such as chemical ( chemical , chemical ) .	T2	T22	14967461
CPR:4	CHEMICAL	GENE-Y	13	0	gene inhibitors currently under investigation include the small molecules chemical ( chemical , chemical ) and chemical ( chemical , chemical ) , as well as monoclonal antibodies such as chemical ( chemical , chemical ) .	T3	T22	14967461
CPR:4	CHEMICAL	GENE-Y	16	0	gene inhibitors currently under investigation include the small molecules chemical ( chemical , chemical ) and chemical ( chemical , chemical ) , as well as monoclonal antibodies such as chemical ( chemical , chemical ) .	T4	T22	14967461
CPR:4	CHEMICAL	GENE-Y	18	0	gene inhibitors currently under investigation include the small molecules chemical ( chemical , chemical ) and chemical ( chemical , chemical ) , as well as monoclonal antibodies such as chemical ( chemical , chemical ) .	T5	T22	14967461
CPR:4	CHEMICAL	GENE-Y	20	0	gene inhibitors currently under investigation include the small molecules chemical ( chemical , chemical ) and chemical ( chemical , chemical ) , as well as monoclonal antibodies such as chemical ( chemical , chemical ) .	T6	T22	14967461
CPR:4	CHEMICAL	GENE-Y	30	0	gene inhibitors currently under investigation include the small molecules chemical ( chemical , chemical ) and chemical ( chemical , chemical ) , as well as monoclonal antibodies such as chemical ( chemical , chemical ) .	T7	T22	14967461
CPR:4	CHEMICAL	GENE-Y	32	0	gene inhibitors currently under investigation include the small molecules chemical ( chemical , chemical ) and chemical ( chemical , chemical ) , as well as monoclonal antibodies such as chemical ( chemical , chemical ) .	T8	T22	14967461
CPR:4	CHEMICAL	GENE-Y	34	0	gene inhibitors currently under investigation include the small molecules chemical ( chemical , chemical ) and chemical ( chemical , chemical ) , as well as monoclonal antibodies such as chemical ( chemical , chemical ) .	T9	T22	14967461
CPR:4	CHEMICAL	GENE-Y	10	14	Agents that have only begun to undergo clinical evaluation include chemical , an irreversible pan-gene chemical gene inhibitor , and chemical and chemical , both examples of dual kinase inhibitors ( inhibiting gene and gene ) .	T10	T23	14967461
CPR:4	CHEMICAL	GENE-N	10	28	Agents that have only begun to undergo clinical evaluation include chemical , an irreversible pan-gene chemical gene inhibitor , and chemical and chemical , both examples of dual kinase inhibitors ( inhibiting gene and gene ) .	T10	T24	14967461
NA	CHEMICAL	GENE-N	10	16	Agents that have only begun to undergo clinical evaluation include chemical , an irreversible pan-gene chemical gene inhibitor , and chemical and chemical , both examples of dual kinase inhibitors ( inhibiting gene and gene ) .	T10	T25	14967461
NA	CHEMICAL	GENE-Y	10	5	Agents that have only begun to undergo clinical evaluation include chemical , an irreversible pan-gene chemical gene inhibitor , and chemical and chemical , both examples of dual kinase inhibitors ( inhibiting gene and gene ) .	T10	T26	14967461
NA	CHEMICAL	GENE-Y	10	34	Agents that have only begun to undergo clinical evaluation include chemical , an irreversible pan-gene chemical gene inhibitor , and chemical and chemical , both examples of dual kinase inhibitors ( inhibiting gene and gene ) .	T10	T27	14967461
NA	CHEMICAL	GENE-Y	15	14	Agents that have only begun to undergo clinical evaluation include chemical , an irreversible pan-gene chemical gene inhibitor , and chemical and chemical , both examples of dual kinase inhibitors ( inhibiting gene and gene ) .	T11	T23	14967461
NA	CHEMICAL	GENE-N	15	28	Agents that have only begun to undergo clinical evaluation include chemical , an irreversible pan-gene chemical gene inhibitor , and chemical and chemical , both examples of dual kinase inhibitors ( inhibiting gene and gene ) .	T11	T24	14967461
NA	CHEMICAL	GENE-N	15	16	Agents that have only begun to undergo clinical evaluation include chemical , an irreversible pan-gene chemical gene inhibitor , and chemical and chemical , both examples of dual kinase inhibitors ( inhibiting gene and gene ) .	T11	T25	14967461
NA	CHEMICAL	GENE-Y	15	5	Agents that have only begun to undergo clinical evaluation include chemical , an irreversible pan-gene chemical gene inhibitor , and chemical and chemical , both examples of dual kinase inhibitors ( inhibiting gene and gene ) .	T11	T26	14967461
NA	CHEMICAL	GENE-Y	15	34	Agents that have only begun to undergo clinical evaluation include chemical , an irreversible pan-gene chemical gene inhibitor , and chemical and chemical , both examples of dual kinase inhibitors ( inhibiting gene and gene ) .	T11	T27	14967461
NA	CHEMICAL	GENE-Y	20	14	Agents that have only begun to undergo clinical evaluation include chemical , an irreversible pan-gene chemical gene inhibitor , and chemical and chemical , both examples of dual kinase inhibitors ( inhibiting gene and gene ) .	T12	T23	14967461
NA	CHEMICAL	GENE-N	20	28	Agents that have only begun to undergo clinical evaluation include chemical , an irreversible pan-gene chemical gene inhibitor , and chemical and chemical , both examples of dual kinase inhibitors ( inhibiting gene and gene ) .	T12	T24	14967461
CPR:4	CHEMICAL	GENE-N	20	16	Agents that have only begun to undergo clinical evaluation include chemical , an irreversible pan-gene chemical gene inhibitor , and chemical and chemical , both examples of dual kinase inhibitors ( inhibiting gene and gene ) .	T12	T25	14967461
CPR:4	CHEMICAL	GENE-Y	20	5	Agents that have only begun to undergo clinical evaluation include chemical , an irreversible pan-gene chemical gene inhibitor , and chemical and chemical , both examples of dual kinase inhibitors ( inhibiting gene and gene ) .	T12	T26	14967461
CPR:4	CHEMICAL	GENE-Y	20	34	Agents that have only begun to undergo clinical evaluation include chemical , an irreversible pan-gene chemical gene inhibitor , and chemical and chemical , both examples of dual kinase inhibitors ( inhibiting gene and gene ) .	T12	T27	14967461
NA	CHEMICAL	GENE-Y	22	14	Agents that have only begun to undergo clinical evaluation include chemical , an irreversible pan-gene chemical gene inhibitor , and chemical and chemical , both examples of dual kinase inhibitors ( inhibiting gene and gene ) .	T13	T23	14967461
NA	CHEMICAL	GENE-N	22	28	Agents that have only begun to undergo clinical evaluation include chemical , an irreversible pan-gene chemical gene inhibitor , and chemical and chemical , both examples of dual kinase inhibitors ( inhibiting gene and gene ) .	T13	T24	14967461
CPR:4	CHEMICAL	GENE-N	22	16	Agents that have only begun to undergo clinical evaluation include chemical , an irreversible pan-gene chemical gene inhibitor , and chemical and chemical , both examples of dual kinase inhibitors ( inhibiting gene and gene ) .	T13	T25	14967461
CPR:4	CHEMICAL	GENE-Y	22	5	Agents that have only begun to undergo clinical evaluation include chemical , an irreversible pan-gene chemical gene inhibitor , and chemical and chemical , both examples of dual kinase inhibitors ( inhibiting gene and gene ) .	T13	T26	14967461
CPR:4	CHEMICAL	GENE-Y	22	34	Agents that have only begun to undergo clinical evaluation include chemical , an irreversible pan-gene chemical gene inhibitor , and chemical and chemical , both examples of dual kinase inhibitors ( inhibiting gene and gene ) .	T13	T27	14967461
NA	CHEMICAL	GENE-Y	1	5	Deduced chemical sequence from the gene cDNA .	T15	T32	6687626
NA	CHEMICAL	GENE-Y	3	10	The nonapeptide hormone chemical-like chemical-chemical ( chemical ) is synthesized as part of a larger precursor polypeptide .	T6	T24	6687626
NA	CHEMICAL	GENE-Y	4	10	The nonapeptide hormone chemical-like chemical-chemical ( chemical ) is synthesized as part of a larger precursor polypeptide .	T7	T24	6687626
NA	CHEMICAL	GENE-Y	4	10	The nonapeptide hormone chemical-like chemical-chemical ( chemical ) is synthesized as part of a larger precursor polypeptide .	T8	T24	6687626
NA	CHEMICAL	GENE-Y	6	10	The nonapeptide hormone chemical-like chemical-chemical ( chemical ) is synthesized as part of a larger precursor polypeptide .	T10	T24	6687626
NA	CHEMICAL	GENE-N	37	27	A protein of molecular weight ( Mr ) approximately 20,000 has been isolated from supraoptic nuclei of rat hypothalami which , after tryptic cleavage , released a gene-like molecule of Mr approximately 10,000 and an oligopeptide related to chemical .	T9	T25	6687626
NA	CHEMICAL	GENE-Y	37	37	A protein of molecular weight ( Mr ) approximately 20,000 has been isolated from supraoptic nuclei of rat hypothalami which , after tryptic cleavage , released a gene-like molecule of Mr approximately 10,000 and an oligopeptide related to chemical .	T9	T26	6687626
NA	CHEMICAL	GENE-Y	14	23	Among the primary translation products a single polypeptide of Mr approximately 16,500 was shown to contain antigenic determinants recognized by specific antisera against gene and chemical .	T11	T28	6687626
NA	CHEMICAL	GENE-Y	14	14	Among the primary translation products a single polypeptide of Mr approximately 16,500 was shown to contain antigenic determinants recognized by specific antisera against gene and chemical .	T11	T29	6687626
NA	CHEMICAL	GENE-Y	4	8	Here we report the chemical sequence of the gene which was derived from sequence analysis of the cloned cDNA .	T12	T30	6687626
NA	CHEMICAL	GENE-Y	13	6	As is the case for the gene , the signal sequence of the gene precursor is immediately followed by the nonapeptide hormone which is connected to gene by a gene sequence .	T1	T31	6687626
NA	CHEMICAL	GENE-Y	13	13	As is the case for the gene , the signal sequence of the gene precursor is immediately followed by the nonapeptide hormone which is connected to gene by a gene sequence .	T1	T17	6687626
NA	CHEMICAL	GENE-Y	13	26	As is the case for the gene , the signal sequence of the gene precursor is immediately followed by the nonapeptide hormone which is connected to gene by a gene sequence .	T1	T18	6687626
NA	CHEMICAL	GENE-N	13	29	As is the case for the gene , the signal sequence of the gene precursor is immediately followed by the nonapeptide hormone which is connected to gene by a gene sequence .	T1	T19	6687626
NA	CHEMICAL	GENE-Y	28	6	As is the case for the gene , the signal sequence of the gene precursor is immediately followed by the nonapeptide hormone which is connected to gene by a gene sequence .	T2	T31	6687626
NA	CHEMICAL	GENE-Y	28	13	As is the case for the gene , the signal sequence of the gene precursor is immediately followed by the nonapeptide hormone which is connected to gene by a gene sequence .	T2	T17	6687626
NA	CHEMICAL	GENE-Y	28	26	As is the case for the gene , the signal sequence of the gene precursor is immediately followed by the nonapeptide hormone which is connected to gene by a gene sequence .	T2	T18	6687626
NA	CHEMICAL	GENE-N	28	29	As is the case for the gene , the signal sequence of the gene precursor is immediately followed by the nonapeptide hormone which is connected to gene by a gene sequence .	T2	T19	6687626
NA	CHEMICAL	GENE-Y	6	6	As is the case for the gene , the signal sequence of the gene precursor is immediately followed by the nonapeptide hormone which is connected to gene by a gene sequence .	T3	T31	6687626
NA	CHEMICAL	GENE-Y	6	13	As is the case for the gene , the signal sequence of the gene precursor is immediately followed by the nonapeptide hormone which is connected to gene by a gene sequence .	T3	T17	6687626
NA	CHEMICAL	GENE-Y	6	26	As is the case for the gene , the signal sequence of the gene precursor is immediately followed by the nonapeptide hormone which is connected to gene by a gene sequence .	T3	T18	6687626
NA	CHEMICAL	GENE-N	6	29	As is the case for the gene , the signal sequence of the gene precursor is immediately followed by the nonapeptide hormone which is connected to gene by a gene sequence .	T3	T19	6687626
NA	CHEMICAL	GENE-Y	13	13	In 16 healthy volunteers we studied the effects of 100 microg intravenously administered gene in absence or presence of 12 mg chemical on heat or pressure pain sensitivity , using a double-blind , cross-over and placebo-controlled design .	T2	T28	16534240
NA	CHEMICAL	GENE-Y	9	5	To evaluate analgesic effects of gene via release of gene derivatives , we determined plasma concentrations of gene-immunoreactive material ( IRM ) , authentic gene ( gene ) and gene IRM , in parallel with heat and pressure pain tolerance thresholds before and 15 and 30 min after treatment with gene ( or placebo ) , and 5 min after chemical ( or placebo ) administration which was administered 40 min after gene ( or placebo ) injection .	T3	T29	16534240
NA	CHEMICAL	GENE-Y	9	9	To evaluate analgesic effects of gene via release of gene derivatives , we determined plasma concentrations of gene-immunoreactive material ( IRM ) , authentic gene ( gene ) and gene IRM , in parallel with heat and pressure pain tolerance thresholds before and 15 and 30 min after treatment with gene ( or placebo ) , and 5 min after chemical ( or placebo ) administration which was administered 40 min after gene ( or placebo ) injection .	T3	T30	16534240
NA	CHEMICAL	GENE-Y	9	17	To evaluate analgesic effects of gene via release of gene derivatives , we determined plasma concentrations of gene-immunoreactive material ( IRM ) , authentic gene ( gene ) and gene IRM , in parallel with heat and pressure pain tolerance thresholds before and 15 and 30 min after treatment with gene ( or placebo ) , and 5 min after chemical ( or placebo ) administration which was administered 40 min after gene ( or placebo ) injection .	T3	T32	16534240
NA	CHEMICAL	GENE-Y	9	24	To evaluate analgesic effects of gene via release of gene derivatives , we determined plasma concentrations of gene-immunoreactive material ( IRM ) , authentic gene ( gene ) and gene IRM , in parallel with heat and pressure pain tolerance thresholds before and 15 and 30 min after treatment with gene ( or placebo ) , and 5 min after chemical ( or placebo ) administration which was administered 40 min after gene ( or placebo ) injection .	T3	T33	16534240
NA	CHEMICAL	GENE-Y	9	19	To evaluate analgesic effects of gene via release of gene derivatives , we determined plasma concentrations of gene-immunoreactive material ( IRM ) , authentic gene ( gene ) and gene IRM , in parallel with heat and pressure pain tolerance thresholds before and 15 and 30 min after treatment with gene ( or placebo ) , and 5 min after chemical ( or placebo ) administration which was administered 40 min after gene ( or placebo ) injection .	T3	T34	16534240
NA	CHEMICAL	GENE-Y	9	29	To evaluate analgesic effects of gene via release of gene derivatives , we determined plasma concentrations of gene-immunoreactive material ( IRM ) , authentic gene ( gene ) and gene IRM , in parallel with heat and pressure pain tolerance thresholds before and 15 and 30 min after treatment with gene ( or placebo ) , and 5 min after chemical ( or placebo ) administration which was administered 40 min after gene ( or placebo ) injection .	T3	T35	16534240
NA	CHEMICAL	GENE-Y	9	50	To evaluate analgesic effects of gene via release of gene derivatives , we determined plasma concentrations of gene-immunoreactive material ( IRM ) , authentic gene ( gene ) and gene IRM , in parallel with heat and pressure pain tolerance thresholds before and 15 and 30 min after treatment with gene ( or placebo ) , and 5 min after chemical ( or placebo ) administration which was administered 40 min after gene ( or placebo ) injection .	T3	T36	16534240
NA	CHEMICAL	GENE-Y	9	72	To evaluate analgesic effects of gene via release of gene derivatives , we determined plasma concentrations of gene-immunoreactive material ( IRM ) , authentic gene ( gene ) and gene IRM , in parallel with heat and pressure pain tolerance thresholds before and 15 and 30 min after treatment with gene ( or placebo ) , and 5 min after chemical ( or placebo ) administration which was administered 40 min after gene ( or placebo ) injection .	T3	T38	16534240
NA	CHEMICAL	GENE-Y	2	2	Furthermore , gene did not induce increases of heat pain tolerance thresholds , but of pressure pain tolerance thresholds , which , however , were not reversible by chemical .	T1	T11	16534240
NA	CHEMICAL	GENE-N	19	24	The specific activity of gene ( gene ) was significantly elevated ( 205 % , p < 0.0001 ) in the dwarf mice , as were chemical synthase ( 50 % , p < 0.01 ) , gene ( 83 % , p < 0.001 ) , and chemical chemical-methyltransferase ( gene , 91 % , p < 0.001 ) activities .	T10	T17	12742526
NA	CHEMICAL	GENE-N	19	6	The specific activity of gene ( gene ) was significantly elevated ( 205 % , p < 0.0001 ) in the dwarf mice , as were chemical synthase ( 50 % , p < 0.01 ) , gene ( 83 % , p < 0.001 ) , and chemical chemical-methyltransferase ( gene , 91 % , p < 0.001 ) activities .	T10	T18	12742526
NA	CHEMICAL	GENE-N	19	24	The specific activity of gene ( gene ) was significantly elevated ( 205 % , p < 0.0001 ) in the dwarf mice , as were chemical synthase ( 50 % , p < 0.01 ) , gene ( 83 % , p < 0.001 ) , and chemical chemical-methyltransferase ( gene , 91 % , p < 0.001 ) activities .	T10	T20	12742526
NA	CHEMICAL	GENE-Y	19	24	The specific activity of gene ( gene ) was significantly elevated ( 205 % , p < 0.0001 ) in the dwarf mice , as were chemical synthase ( 50 % , p < 0.01 ) , gene ( 83 % , p < 0.001 ) , and chemical chemical-methyltransferase ( gene , 91 % , p < 0.001 ) activities .	T10	T21	12742526
NA	CHEMICAL	GENE-Y	19	24	The specific activity of gene ( gene ) was significantly elevated ( 205 % , p < 0.0001 ) in the dwarf mice , as were chemical synthase ( 50 % , p < 0.01 ) , gene ( 83 % , p < 0.001 ) , and chemical chemical-methyltransferase ( gene , 91 % , p < 0.001 ) activities .	T10	T22	12742526
NA	CHEMICAL	GENE-Y	19	51	The specific activity of gene ( gene ) was significantly elevated ( 205 % , p < 0.0001 ) in the dwarf mice , as were chemical synthase ( 50 % , p < 0.01 ) , gene ( 83 % , p < 0.001 ) , and chemical chemical-methyltransferase ( gene , 91 % , p < 0.001 ) activities .	T10	T23	12742526
NA	CHEMICAL	GENE-N	19	24	The specific activity of gene ( gene ) was significantly elevated ( 205 % , p < 0.0001 ) in the dwarf mice , as were chemical synthase ( 50 % , p < 0.01 ) , gene ( 83 % , p < 0.001 ) , and chemical chemical-methyltransferase ( gene , 91 % , p < 0.001 ) activities .	T11	T17	12742526
NA	CHEMICAL	GENE-N	19	6	The specific activity of gene ( gene ) was significantly elevated ( 205 % , p < 0.0001 ) in the dwarf mice , as were chemical synthase ( 50 % , p < 0.01 ) , gene ( 83 % , p < 0.001 ) , and chemical chemical-methyltransferase ( gene , 91 % , p < 0.001 ) activities .	T11	T18	12742526
NA	CHEMICAL	GENE-N	19	24	The specific activity of gene ( gene ) was significantly elevated ( 205 % , p < 0.0001 ) in the dwarf mice , as were chemical synthase ( 50 % , p < 0.01 ) , gene ( 83 % , p < 0.001 ) , and chemical chemical-methyltransferase ( gene , 91 % , p < 0.001 ) activities .	T11	T20	12742526
NA	CHEMICAL	GENE-Y	19	24	The specific activity of gene ( gene ) was significantly elevated ( 205 % , p < 0.0001 ) in the dwarf mice , as were chemical synthase ( 50 % , p < 0.01 ) , gene ( 83 % , p < 0.001 ) , and chemical chemical-methyltransferase ( gene , 91 % , p < 0.001 ) activities .	T11	T21	12742526
NA	CHEMICAL	GENE-Y	19	24	The specific activity of gene ( gene ) was significantly elevated ( 205 % , p < 0.0001 ) in the dwarf mice , as were chemical synthase ( 50 % , p < 0.01 ) , gene ( 83 % , p < 0.001 ) , and chemical chemical-methyltransferase ( gene , 91 % , p < 0.001 ) activities .	T11	T22	12742526
NA	CHEMICAL	GENE-Y	19	51	The specific activity of gene ( gene ) was significantly elevated ( 205 % , p < 0.0001 ) in the dwarf mice , as were chemical synthase ( 50 % , p < 0.01 ) , gene ( 83 % , p < 0.001 ) , and chemical chemical-methyltransferase ( gene , 91 % , p < 0.001 ) activities .	T11	T23	12742526
NA	CHEMICAL	GENE-N	19	24	The specific activity of gene ( gene ) was significantly elevated ( 205 % , p < 0.0001 ) in the dwarf mice , as were chemical synthase ( 50 % , p < 0.01 ) , gene ( 83 % , p < 0.001 ) , and chemical chemical-methyltransferase ( gene , 91 % , p < 0.001 ) activities .	T12	T17	12742526
NA	CHEMICAL	GENE-N	19	6	The specific activity of gene ( gene ) was significantly elevated ( 205 % , p < 0.0001 ) in the dwarf mice , as were chemical synthase ( 50 % , p < 0.01 ) , gene ( 83 % , p < 0.001 ) , and chemical chemical-methyltransferase ( gene , 91 % , p < 0.001 ) activities .	T12	T18	12742526
NA	CHEMICAL	GENE-N	19	24	The specific activity of gene ( gene ) was significantly elevated ( 205 % , p < 0.0001 ) in the dwarf mice , as were chemical synthase ( 50 % , p < 0.01 ) , gene ( 83 % , p < 0.001 ) , and chemical chemical-methyltransferase ( gene , 91 % , p < 0.001 ) activities .	T12	T20	12742526
NA	CHEMICAL	GENE-Y	19	24	The specific activity of gene ( gene ) was significantly elevated ( 205 % , p < 0.0001 ) in the dwarf mice , as were chemical synthase ( 50 % , p < 0.01 ) , gene ( 83 % , p < 0.001 ) , and chemical chemical-methyltransferase ( gene , 91 % , p < 0.001 ) activities .	T12	T21	12742526
NA	CHEMICAL	GENE-Y	19	24	The specific activity of gene ( gene ) was significantly elevated ( 205 % , p < 0.0001 ) in the dwarf mice , as were chemical synthase ( 50 % , p < 0.01 ) , gene ( 83 % , p < 0.001 ) , and chemical chemical-methyltransferase ( gene , 91 % , p < 0.001 ) activities .	T12	T22	12742526
NA	CHEMICAL	GENE-Y	19	51	The specific activity of gene ( gene ) was significantly elevated ( 205 % , p < 0.0001 ) in the dwarf mice , as were chemical synthase ( 50 % , p < 0.01 ) , gene ( 83 % , p < 0.001 ) , and chemical chemical-methyltransferase ( gene , 91 % , p < 0.001 ) activities .	T12	T23	12742526
NA	CHEMICAL	GENE-N	4	24	The specific activity of gene ( gene ) was significantly elevated ( 205 % , p < 0.0001 ) in the dwarf mice , as were chemical synthase ( 50 % , p < 0.01 ) , gene ( 83 % , p < 0.001 ) , and chemical chemical-methyltransferase ( gene , 91 % , p < 0.001 ) activities .	T13	T17	12742526
NA	CHEMICAL	GENE-N	4	6	The specific activity of gene ( gene ) was significantly elevated ( 205 % , p < 0.0001 ) in the dwarf mice , as were chemical synthase ( 50 % , p < 0.01 ) , gene ( 83 % , p < 0.001 ) , and chemical chemical-methyltransferase ( gene , 91 % , p < 0.001 ) activities .	T13	T18	12742526
NA	CHEMICAL	GENE-N	4	24	The specific activity of gene ( gene ) was significantly elevated ( 205 % , p < 0.0001 ) in the dwarf mice , as were chemical synthase ( 50 % , p < 0.01 ) , gene ( 83 % , p < 0.001 ) , and chemical chemical-methyltransferase ( gene , 91 % , p < 0.001 ) activities .	T13	T20	12742526
NA	CHEMICAL	GENE-Y	4	24	The specific activity of gene ( gene ) was significantly elevated ( 205 % , p < 0.0001 ) in the dwarf mice , as were chemical synthase ( 50 % , p < 0.01 ) , gene ( 83 % , p < 0.001 ) , and chemical chemical-methyltransferase ( gene , 91 % , p < 0.001 ) activities .	T13	T21	12742526
NA	CHEMICAL	GENE-Y	4	24	The specific activity of gene ( gene ) was significantly elevated ( 205 % , p < 0.0001 ) in the dwarf mice , as were chemical synthase ( 50 % , p < 0.01 ) , gene ( 83 % , p < 0.001 ) , and chemical chemical-methyltransferase ( gene , 91 % , p < 0.001 ) activities .	T13	T22	12742526
NA	CHEMICAL	GENE-Y	4	51	The specific activity of gene ( gene ) was significantly elevated ( 205 % , p < 0.0001 ) in the dwarf mice , as were chemical synthase ( 50 % , p < 0.01 ) , gene ( 83 % , p < 0.001 ) , and chemical chemical-methyltransferase ( gene , 91 % , p < 0.001 ) activities .	T13	T23	12742526
CPR:9	CHEMICAL	GENE-N	15	5	Even though the activities of gene and gene were elevated , the concentration of liver chemical was decreased ( 24 % , p < 0.001 ) and chemical increased ( 113 % , p < 0.001 ) in the dwarf mice .	T1	T24	12742526
CPR:9	CHEMICAL	GENE-Y	15	7	Even though the activities of gene and gene were elevated , the concentration of liver chemical was decreased ( 24 % , p < 0.001 ) and chemical increased ( 113 % , p < 0.001 ) in the dwarf mice .	T1	T25	12742526
CPR:9	CHEMICAL	GENE-N	5	5	Even though the activities of gene and gene were elevated , the concentration of liver chemical was decreased ( 24 % , p < 0.001 ) and chemical increased ( 113 % , p < 0.001 ) in the dwarf mice .	T2	T24	12742526
CPR:9	CHEMICAL	GENE-Y	5	7	Even though the activities of gene and gene were elevated , the concentration of liver chemical was decreased ( 24 % , p < 0.001 ) and chemical increased ( 113 % , p < 0.001 ) in the dwarf mice .	T2	T25	12742526
NA	CHEMICAL	GENE-Y	11	3	Threshold concentrations of gene : the effects on contractions induced by chemical in isolated rat cerebral and mesenteric arteries .	T23	T39	10522750
NA	CHEMICAL	GENE-Y	10	4	In basilar arteries , gene reduces the contractions induced by chemical ( chemical ) , by the chemical agonist chemical , and by gene .	T5	T30	10522750
NA	CHEMICAL	GENE-Y	10	23	In basilar arteries , gene reduces the contractions induced by chemical ( chemical ) , by the chemical agonist chemical , and by gene .	T5	T31	10522750
NA	CHEMICAL	GENE-Y	12	4	In basilar arteries , gene reduces the contractions induced by chemical ( chemical ) , by the chemical agonist chemical , and by gene .	T6	T30	10522750
NA	CHEMICAL	GENE-Y	12	23	In basilar arteries , gene reduces the contractions induced by chemical ( chemical ) , by the chemical agonist chemical , and by gene .	T6	T31	10522750
NA	CHEMICAL	GENE-Y	17	4	In basilar arteries , gene reduces the contractions induced by chemical ( chemical ) , by the chemical agonist chemical , and by gene .	T7	T30	10522750
NA	CHEMICAL	GENE-Y	17	23	In basilar arteries , gene reduces the contractions induced by chemical ( chemical ) , by the chemical agonist chemical , and by gene .	T7	T31	10522750
NA	CHEMICAL	GENE-Y	19	4	In basilar arteries , gene reduces the contractions induced by chemical ( chemical ) , by the chemical agonist chemical , and by gene .	T8	T30	10522750
NA	CHEMICAL	GENE-Y	19	23	In basilar arteries , gene reduces the contractions induced by chemical ( chemical ) , by the chemical agonist chemical , and by gene .	T8	T31	10522750
NA	CHEMICAL	GENE-Y	10	4	The inhibitory effect of gene on the contraction induced by chemical is abolished by deendothelialization , by the gene antagonist chemical , by chemical , or by chemical .	T10	T32	10522750
NA	CHEMICAL	GENE-Y	10	18	The inhibitory effect of gene on the contraction induced by chemical is abolished by deendothelialization , by the gene antagonist chemical , by chemical , or by chemical .	T10	T33	10522750
NA	CHEMICAL	GENE-Y	20	4	The inhibitory effect of gene on the contraction induced by chemical is abolished by deendothelialization , by the gene antagonist chemical , by chemical , or by chemical .	T11	T32	10522750
CPR:6	CHEMICAL	GENE-Y	20	18	The inhibitory effect of gene on the contraction induced by chemical is abolished by deendothelialization , by the gene antagonist chemical , by chemical , or by chemical .	T11	T33	10522750
NA	CHEMICAL	GENE-Y	23	4	The inhibitory effect of gene on the contraction induced by chemical is abolished by deendothelialization , by the gene antagonist chemical , by chemical , or by chemical .	T12	T32	10522750
NA	CHEMICAL	GENE-Y	23	18	The inhibitory effect of gene on the contraction induced by chemical is abolished by deendothelialization , by the gene antagonist chemical , by chemical , or by chemical .	T12	T33	10522750
NA	CHEMICAL	GENE-Y	27	4	The inhibitory effect of gene on the contraction induced by chemical is abolished by deendothelialization , by the gene antagonist chemical , by chemical , or by chemical .	T13	T32	10522750
NA	CHEMICAL	GENE-Y	27	18	The inhibitory effect of gene on the contraction induced by chemical is abolished by deendothelialization , by the gene antagonist chemical , by chemical , or by chemical .	T13	T33	10522750
NA	CHEMICAL	GENE-Y	10	4	In mesenteric arteries , gene potentiates the contractile effects of chemical , chemical , and chemical .	T14	T34	10522750
NA	CHEMICAL	GENE-Y	12	4	In mesenteric arteries , gene potentiates the contractile effects of chemical , chemical , and chemical .	T15	T34	10522750
NA	CHEMICAL	GENE-Y	15	4	In mesenteric arteries , gene potentiates the contractile effects of chemical , chemical , and chemical .	T16	T34	10522750
NA	CHEMICAL	GENE-Y	8	21	The potentiation of the contractile effect induced by chemical is only somewhat modified by deendothelialization , but abolished by the chemical receptor antagonists chemical and chemical .	T17	T37	10522750
NA	CHEMICAL	GENE-Y	20	21	The potentiation of the contractile effect induced by chemical is only somewhat modified by deendothelialization , but abolished by the chemical receptor antagonists chemical and chemical .	T18	T37	10522750
CPR:6	CHEMICAL	GENE-Y	23	21	The potentiation of the contractile effect induced by chemical is only somewhat modified by deendothelialization , but abolished by the chemical receptor antagonists chemical and chemical .	T19	T37	10522750
CPR:6	CHEMICAL	GENE-Y	25	21	The potentiation of the contractile effect induced by chemical is only somewhat modified by deendothelialization , but abolished by the chemical receptor antagonists chemical and chemical .	T20	T37	10522750
NA	CHEMICAL	GENE-N	0	4	chemical and chemical-sensitive chemical channels are involved in this inhibitory action .	T1	T26	10522750
NA	CHEMICAL	GENE-N	2	4	chemical and chemical-sensitive chemical channels are involved in this inhibitory action .	T2	T26	10522750
NA	CHEMICAL	GENE-N	3	4	chemical and chemical-sensitive chemical channels are involved in this inhibitory action .	T3	T26	10522750
NA	CHEMICAL	GENE-N	15	3	In contrast , gene potentiates contractile actions in mesenteric arteries via the release of endogeneous chemical from non-endothelial cells .	T4	T27	10522750
CPR:9	CHEMICAL	GENE-Y	9	2	Transport by gene and gene enhances the cytotoxicity of chemical and several chemical derivatives .	T17	T31	23327877
CPR:9	CHEMICAL	GENE-Y	9	4	Transport by gene and gene enhances the cytotoxicity of chemical and several chemical derivatives .	T17	T32	23327877
CPR:9	CHEMICAL	GENE-Y	12	2	Transport by gene and gene enhances the cytotoxicity of chemical and several chemical derivatives .	T16	T31	23327877
CPR:9	CHEMICAL	GENE-Y	12	4	Transport by gene and gene enhances the cytotoxicity of chemical and several chemical derivatives .	T16	T32	23327877
NA	CHEMICAL	GENE-N	0	17	chemical such as green tea chemical and chemical have been shown to modulate the function of some gene .	T7	T24	23327877
NA	CHEMICAL	GENE-N	5	17	chemical such as green tea chemical and chemical have been shown to modulate the function of some gene .	T8	T24	23327877
NA	CHEMICAL	GENE-N	7	17	chemical such as green tea chemical and chemical have been shown to modulate the function of some gene .	T9	T24	23327877
NA	CHEMICAL	GENE-Y	11	20	In the present study , the extent to which six substituted chemical derivatives ( 1-6 ) affected the function of gene and gene was investigated .	T10	T25	23327877
NA	CHEMICAL	GENE-Y	11	22	In the present study , the extent to which six substituted chemical derivatives ( 1-6 ) affected the function of gene and gene was investigated .	T10	T26	23327877
CPR:9	CHEMICAL	GENE-Y	6	36	Uptake of the radiolabeled model substrates chemical , chemical , and chemical ( chemical ) was determined in the absence and presence of compounds 1-6 using Chinese hamster ovary ( CHO ) cells stably expressing either gene or gene .	T11	T27	23327877
CPR:9	CHEMICAL	GENE-Y	6	38	Uptake of the radiolabeled model substrates chemical , chemical , and chemical ( chemical ) was determined in the absence and presence of compounds 1-6 using Chinese hamster ovary ( CHO ) cells stably expressing either gene or gene .	T11	T28	23327877
CPR:9	CHEMICAL	GENE-Y	8	36	Uptake of the radiolabeled model substrates chemical , chemical , and chemical ( chemical ) was determined in the absence and presence of compounds 1-6 using Chinese hamster ovary ( CHO ) cells stably expressing either gene or gene .	T12	T27	23327877
CPR:9	CHEMICAL	GENE-Y	8	38	Uptake of the radiolabeled model substrates chemical , chemical , and chemical ( chemical ) was determined in the absence and presence of compounds 1-6 using Chinese hamster ovary ( CHO ) cells stably expressing either gene or gene .	T12	T28	23327877
CPR:9	CHEMICAL	GENE-Y	11	36	Uptake of the radiolabeled model substrates chemical , chemical , and chemical ( chemical ) was determined in the absence and presence of compounds 1-6 using Chinese hamster ovary ( CHO ) cells stably expressing either gene or gene .	T13	T27	23327877
CPR:9	CHEMICAL	GENE-Y	11	38	Uptake of the radiolabeled model substrates chemical , chemical , and chemical ( chemical ) was determined in the absence and presence of compounds 1-6 using Chinese hamster ovary ( CHO ) cells stably expressing either gene or gene .	T13	T28	23327877
CPR:9	CHEMICAL	GENE-Y	13	36	Uptake of the radiolabeled model substrates chemical , chemical , and chemical ( chemical ) was determined in the absence and presence of compounds 1-6 using Chinese hamster ovary ( CHO ) cells stably expressing either gene or gene .	T14	T27	23327877
CPR:9	CHEMICAL	GENE-Y	13	38	Uptake of the radiolabeled model substrates chemical , chemical , and chemical ( chemical ) was determined in the absence and presence of compounds 1-6 using Chinese hamster ovary ( CHO ) cells stably expressing either gene or gene .	T14	T28	23327877
CPR:9	CHEMICAL	GENE-Y	4	3	Compound 6 stimulated gene-mediated chemical uptake by increasing the apparent affinity of gene for its substrate .	T15	T30	23327877
CPR:9	CHEMICAL	GENE-Y	4	12	Compound 6 stimulated gene-mediated chemical uptake by increasing the apparent affinity of gene for its substrate .	T15	T19	23327877
CPR:9	CHEMICAL	GENE-N	4	15	Cytotoxicity assays demonstrated that chemical ( chemical ) and most of compounds 1-6 killed preferentially gene-expressing CHO cells .	T1	T20	23327877
CPR:9	CHEMICAL	GENE-N	6	15	Cytotoxicity assays demonstrated that chemical ( chemical ) and most of compounds 1-6 killed preferentially gene-expressing CHO cells .	T2	T20	23327877
NA	CHEMICAL	GENE-Y	0	2	chemical , 1 , and 3 were the most potent cytotoxic compounds , with chemical and 3 selectively killing gene-expressing cells .	T3	T21	23327877
CPR:9	CHEMICAL	GENE-Y	14	2	chemical , 1 , and 3 were the most potent cytotoxic compounds , with chemical and 3 selectively killing gene-expressing cells .	T4	T21	23327877
NA	CHEMICAL	GENE-N	6	7	We previously reported that the enzyme chemical dehydrogenase ( gene ) has increased activity and gene expression in placentas from preeclamptic pregnancies [ Tsoi SCM , Zheng J , Xu F , Kay HH .	T4	T22	17275903
NA	CHEMICAL	GENE-N	6	9	We previously reported that the enzyme chemical dehydrogenase ( gene ) has increased activity and gene expression in placentas from preeclamptic pregnancies [ Tsoi SCM , Zheng J , Xu F , Kay HH .	T4	T26	17275903
NA	CHEMICAL	GENE-N	3	4	Differential expression of chemical dehydrogenase isozymes ( gene ) in human placenta with high expression of gene isozyme in the endothelial cells of pre-eclampsia villi .	T10	T31	17275903
NA	CHEMICAL	GENE-N	3	7	Differential expression of chemical dehydrogenase isozymes ( gene ) in human placenta with high expression of gene isozyme in the endothelial cells of pre-eclampsia villi .	T10	T32	17275903
NA	CHEMICAL	GENE-Y	3	6	Differential expression of chemical dehydrogenase isozymes ( gene ) in human placenta with high expression of gene isozyme in the endothelial cells of pre-eclampsia villi .	T10	T33	17275903
CPR:9	CHEMICAL	GENE-N	4	0	gene is responsible for chemical conversion to chemical through glycolysis .	T11	T34	17275903
CPR:9	CHEMICAL	GENE-N	7	0	gene is responsible for chemical conversion to chemical through glycolysis .	T12	T34	17275903
NA	CHEMICAL	GENE-N	16	16	In this study , we further investigated the role of hypoxia in primary trophoblast cells and a cultured cell line , JEG3 cells , to obtain a better understanding of how it affects the activities of chemical dehydrogenase , chemical production and regulatory genes , as a possible model for preeclampsia .	T13	T35	17275903
NA	CHEMICAL	GENE-N	16	16	In this study , we further investigated the role of hypoxia in primary trophoblast cells and a cultured cell line , JEG3 cells , to obtain a better understanding of how it affects the activities of chemical dehydrogenase , chemical production and regulatory genes , as a possible model for preeclampsia .	T14	T35	17275903
NA	CHEMICAL	GENE-N	1	2	Two chemical transporters ( gene and gene ) mRNA and protein expression were also studied under hypoxia .	T2	T19	17275903
NA	CHEMICAL	GENE-Y	1	4	Two chemical transporters ( gene and gene ) mRNA and protein expression were also studied under hypoxia .	T2	T20	17275903
NA	CHEMICAL	GENE-Y	1	6	Two chemical transporters ( gene and gene ) mRNA and protein expression were also studied under hypoxia .	T2	T21	17275903
NA	CHEMICAL	GENE-Y	3	7	Of the two chemical transporters studied , gene mRNA and protein level are increased under hypoxia .	T7	T28	17275903
CPR:4	CHEMICAL	GENE-N	0	9	chemical inhibits chemical production in lipopolysaccharide-stimulated BV2 microglia via gene suppression and gene-dependent gene induction .	T22	T50	23542513
CPR:3	CHEMICAL	GENE-Y	0	12	chemical inhibits chemical production in lipopolysaccharide-stimulated BV2 microglia via gene suppression and gene-dependent gene induction .	T22	T51	23542513
CPR:3	CHEMICAL	GENE-Y	0	13	chemical inhibits chemical production in lipopolysaccharide-stimulated BV2 microglia via gene suppression and gene-dependent gene induction .	T22	T52	23542513
NA	CHEMICAL	GENE-N	2	9	chemical inhibits chemical production in lipopolysaccharide-stimulated BV2 microglia via gene suppression and gene-dependent gene induction .	T23	T50	23542513
NA	CHEMICAL	GENE-Y	2	12	chemical inhibits chemical production in lipopolysaccharide-stimulated BV2 microglia via gene suppression and gene-dependent gene induction .	T23	T51	23542513
NA	CHEMICAL	GENE-Y	2	13	chemical inhibits chemical production in lipopolysaccharide-stimulated BV2 microglia via gene suppression and gene-dependent gene induction .	T23	T52	23542513
CPR:4	CHEMICAL	GENE-Y	3	28	In this study , we found that chemical ( chemical ) from Hizikia fusiforme considerably inhibits lipopolysaccharide ( LPS ) -stimulated chemical production by suppressing the expression of gene ( ichemicalS ) in BV2 microglia .	T14	T32	23542513
CPR:4	CHEMICAL	GENE-Y	9	28	In this study , we found that chemical ( chemical ) from Hizikia fusiforme considerably inhibits lipopolysaccharide ( LPS ) -stimulated chemical production by suppressing the expression of gene ( ichemicalS ) in BV2 microglia .	T18	T32	23542513
NA	CHEMICAL	GENE-Y	21	28	In this study , we found that chemical ( chemical ) from Hizikia fusiforme considerably inhibits lipopolysaccharide ( LPS ) -stimulated chemical production by suppressing the expression of gene ( ichemicalS ) in BV2 microglia .	T11	T32	23542513
NA	CHEMICAL	GENE-Y	30	28	In this study , we found that chemical ( chemical ) from Hizikia fusiforme considerably inhibits lipopolysaccharide ( LPS ) -stimulated chemical production by suppressing the expression of gene ( ichemicalS ) in BV2 microglia .	T12	T32	23542513
CPR:4	CHEMICAL	GENE-N	3	8	In addition , chemical blocked LPS-induced phosphorylation of gene , resulting in suppression of the nuclear translocation of gene ( gene ) subunits , namely gene and gene , which are important molecules involved in the regulation of gene expression .	T13	T34	23542513
CPR:4	CHEMICAL	GENE-N	3	18	In addition , chemical blocked LPS-induced phosphorylation of gene , resulting in suppression of the nuclear translocation of gene ( gene ) subunits , namely gene and gene , which are important molecules involved in the regulation of gene expression .	T13	T35	23542513
CPR:4	CHEMICAL	GENE-N	3	20	In addition , chemical blocked LPS-induced phosphorylation of gene , resulting in suppression of the nuclear translocation of gene ( gene ) subunits , namely gene and gene , which are important molecules involved in the regulation of gene expression .	T13	T36	23542513
CPR:4	CHEMICAL	GENE-Y	3	25	In addition , chemical blocked LPS-induced phosphorylation of gene , resulting in suppression of the nuclear translocation of gene ( gene ) subunits , namely gene and gene , which are important molecules involved in the regulation of gene expression .	T13	T37	23542513
CPR:4	CHEMICAL	GENE-Y	3	27	In addition , chemical blocked LPS-induced phosphorylation of gene , resulting in suppression of the nuclear translocation of gene ( gene ) subunits , namely gene and gene , which are important molecules involved in the regulation of gene expression .	T13	T38	23542513
NA	CHEMICAL	GENE-Y	3	38	In addition , chemical blocked LPS-induced phosphorylation of gene , resulting in suppression of the nuclear translocation of gene ( gene ) subunits , namely gene and gene , which are important molecules involved in the regulation of gene expression .	T13	T39	23542513
CPR:4	CHEMICAL	GENE-N	0	7	chemical ( chemical ) , a specific gene inhibitor , along with gene inhibitor ( PSI ) significantly inhibited LPS-induced gene expression , which indirectly suggested that chemical downregulated gene expression by suppressing gene activity .	T15	T40	23542513
NA	CHEMICAL	GENE-N	0	5	chemical ( chemical ) , a specific gene inhibitor , along with gene inhibitor ( PSI ) significantly inhibited LPS-induced gene expression , which indirectly suggested that chemical downregulated gene expression by suppressing gene activity .	T15	T41	23542513
CPR:4	CHEMICAL	GENE-Y	0	20	chemical ( chemical ) , a specific gene inhibitor , along with gene inhibitor ( PSI ) significantly inhibited LPS-induced gene expression , which indirectly suggested that chemical downregulated gene expression by suppressing gene activity .	T15	T42	23542513
NA	CHEMICAL	GENE-Y	0	29	chemical ( chemical ) , a specific gene inhibitor , along with gene inhibitor ( PSI ) significantly inhibited LPS-induced gene expression , which indirectly suggested that chemical downregulated gene expression by suppressing gene activity .	T15	T43	23542513
NA	CHEMICAL	GENE-N	0	33	chemical ( chemical ) , a specific gene inhibitor , along with gene inhibitor ( PSI ) significantly inhibited LPS-induced gene expression , which indirectly suggested that chemical downregulated gene expression by suppressing gene activity .	T15	T44	23542513
CPR:4	CHEMICAL	GENE-N	2	7	chemical ( chemical ) , a specific gene inhibitor , along with gene inhibitor ( PSI ) significantly inhibited LPS-induced gene expression , which indirectly suggested that chemical downregulated gene expression by suppressing gene activity .	T16	T40	23542513
NA	CHEMICAL	GENE-N	2	5	chemical ( chemical ) , a specific gene inhibitor , along with gene inhibitor ( PSI ) significantly inhibited LPS-induced gene expression , which indirectly suggested that chemical downregulated gene expression by suppressing gene activity .	T16	T41	23542513
CPR:4	CHEMICAL	GENE-Y	2	20	chemical ( chemical ) , a specific gene inhibitor , along with gene inhibitor ( PSI ) significantly inhibited LPS-induced gene expression , which indirectly suggested that chemical downregulated gene expression by suppressing gene activity .	T16	T42	23542513
NA	CHEMICAL	GENE-Y	2	29	chemical ( chemical ) , a specific gene inhibitor , along with gene inhibitor ( PSI ) significantly inhibited LPS-induced gene expression , which indirectly suggested that chemical downregulated gene expression by suppressing gene activity .	T16	T43	23542513
NA	CHEMICAL	GENE-N	2	33	chemical ( chemical ) , a specific gene inhibitor , along with gene inhibitor ( PSI ) significantly inhibited LPS-induced gene expression , which indirectly suggested that chemical downregulated gene expression by suppressing gene activity .	T16	T44	23542513
NA	CHEMICAL	GENE-N	27	7	chemical ( chemical ) , a specific gene inhibitor , along with gene inhibitor ( PSI ) significantly inhibited LPS-induced gene expression , which indirectly suggested that chemical downregulated gene expression by suppressing gene activity .	T17	T40	23542513
NA	CHEMICAL	GENE-N	27	5	chemical ( chemical ) , a specific gene inhibitor , along with gene inhibitor ( PSI ) significantly inhibited LPS-induced gene expression , which indirectly suggested that chemical downregulated gene expression by suppressing gene activity .	T17	T41	23542513
NA	CHEMICAL	GENE-Y	27	20	chemical ( chemical ) , a specific gene inhibitor , along with gene inhibitor ( PSI ) significantly inhibited LPS-induced gene expression , which indirectly suggested that chemical downregulated gene expression by suppressing gene activity .	T17	T42	23542513
CPR:4	CHEMICAL	GENE-Y	27	29	chemical ( chemical ) , a specific gene inhibitor , along with gene inhibitor ( PSI ) significantly inhibited LPS-induced gene expression , which indirectly suggested that chemical downregulated gene expression by suppressing gene activity .	T17	T43	23542513
CPR:4	CHEMICAL	GENE-N	27	33	chemical ( chemical ) , a specific gene inhibitor , along with gene inhibitor ( PSI ) significantly inhibited LPS-induced gene expression , which indirectly suggested that chemical downregulated gene expression by suppressing gene activity .	T17	T44	23542513
CPR:3	CHEMICAL	GENE-Y	5	7	Thus , we found that chemical enhances gene ( gene ) expression via gene ( gene ) activation .	T19	T45	23542513
CPR:3	CHEMICAL	GENE-Y	5	9	Thus , we found that chemical enhances gene ( gene ) expression via gene ( gene ) activation .	T19	T46	23542513
CPR:3	CHEMICAL	GENE-Y	5	13	Thus , we found that chemical enhances gene ( gene ) expression via gene ( gene ) activation .	T19	T47	23542513
CPR:3	CHEMICAL	GENE-Y	5	15	Thus , we found that chemical enhances gene ( gene ) expression via gene ( gene ) activation .	T19	T48	23542513
CPR:3	CHEMICAL	GENE-Y	3	10	In addition , chemical ( chemical ) , a specific gene inducer , predominantly suppressed LPS-induced chemical production .	T20	T49	23542513
CPR:3	CHEMICAL	GENE-Y	5	10	In addition , chemical ( chemical ) , a specific gene inducer , predominantly suppressed LPS-induced chemical production .	T21	T49	23542513
NA	CHEMICAL	GENE-Y	16	10	In addition , chemical ( chemical ) , a specific gene inducer , predominantly suppressed LPS-induced chemical production .	T1	T49	23542513
CPR:4	CHEMICAL	GENE-Y	3	10	In contrast , chemical ( chemical ) , a specific gene inhibitor , showed a partial suppressive effect of chemical on LPS-induced chemical production .	T2	T24	23542513
CPR:4	CHEMICAL	GENE-Y	5	10	In contrast , chemical ( chemical ) , a specific gene inhibitor , showed a partial suppressive effect of chemical on LPS-induced chemical production .	T3	T24	23542513
NA	CHEMICAL	GENE-Y	19	10	In contrast , chemical ( chemical ) , a specific gene inhibitor , showed a partial suppressive effect of chemical on LPS-induced chemical production .	T4	T24	23542513
NA	CHEMICAL	GENE-Y	22	10	In contrast , chemical ( chemical ) , a specific gene inhibitor , showed a partial suppressive effect of chemical on LPS-induced chemical production .	T5	T24	23542513
CPR:3	CHEMICAL	GENE-Y	2	8	Further , chemical increased specific DNA-binding activity of gene , and transient knockdown with gene siRNA subsequently reversed chemical-induced chemical inhibition , which was followed by suppression of gene activity .	T6	T25	23542513
CPR:3	CHEMICAL	GENE-Y	2	14	Further , chemical increased specific DNA-binding activity of gene , and transient knockdown with gene siRNA subsequently reversed chemical-induced chemical inhibition , which was followed by suppression of gene activity .	T6	T26	23542513
CPR:3	CHEMICAL	GENE-Y	2	28	Further , chemical increased specific DNA-binding activity of gene , and transient knockdown with gene siRNA subsequently reversed chemical-induced chemical inhibition , which was followed by suppression of gene activity .	T6	T27	23542513
CPR:3	CHEMICAL	GENE-Y	18	8	Further , chemical increased specific DNA-binding activity of gene , and transient knockdown with gene siRNA subsequently reversed chemical-induced chemical inhibition , which was followed by suppression of gene activity .	T7	T25	23542513
CPR:3	CHEMICAL	GENE-Y	18	14	Further , chemical increased specific DNA-binding activity of gene , and transient knockdown with gene siRNA subsequently reversed chemical-induced chemical inhibition , which was followed by suppression of gene activity .	T7	T26	23542513
CPR:4	CHEMICAL	GENE-Y	18	28	Further , chemical increased specific DNA-binding activity of gene , and transient knockdown with gene siRNA subsequently reversed chemical-induced chemical inhibition , which was followed by suppression of gene activity .	T7	T27	23542513
NA	CHEMICAL	GENE-Y	19	8	Further , chemical increased specific DNA-binding activity of gene , and transient knockdown with gene siRNA subsequently reversed chemical-induced chemical inhibition , which was followed by suppression of gene activity .	T8	T25	23542513
NA	CHEMICAL	GENE-Y	19	14	Further , chemical increased specific DNA-binding activity of gene , and transient knockdown with gene siRNA subsequently reversed chemical-induced chemical inhibition , which was followed by suppression of gene activity .	T8	T26	23542513
CPR:4	CHEMICAL	GENE-Y	19	28	Further , chemical increased specific DNA-binding activity of gene , and transient knockdown with gene siRNA subsequently reversed chemical-induced chemical inhibition , which was followed by suppression of gene activity .	T8	T27	23542513
CPR:4	CHEMICAL	GENE-Y	5	6	Synthesis and biological evaluation of chemical as potent and selective inhibitors of chemical esterase .	T9	T23	23601990
NA	CHEMICAL	GENE-Y	12	6	Synthesis and biological evaluation of chemical as potent and selective inhibitors of chemical esterase .	T8	T23	23601990
CPR:4	CHEMICAL	GENE-Y	3	10	A series of chemical were synthesized and investigated in vitro as inhibitors of pancreatic chemical esterase ( gene ) and gene ( gene ) .	T2	T10	23601990
CPR:4	CHEMICAL	GENE-Y	3	10	A series of chemical were synthesized and investigated in vitro as inhibitors of pancreatic chemical esterase ( gene ) and gene ( gene ) .	T2	T11	23601990
CPR:4	CHEMICAL	GENE-Y	3	8	A series of chemical were synthesized and investigated in vitro as inhibitors of pancreatic chemical esterase ( gene ) and gene ( gene ) .	T2	T12	23601990
CPR:4	CHEMICAL	GENE-Y	3	0	A series of chemical were synthesized and investigated in vitro as inhibitors of pancreatic chemical esterase ( gene ) and gene ( gene ) .	T2	T13	23601990
NA	CHEMICAL	GENE-Y	14	10	A series of chemical were synthesized and investigated in vitro as inhibitors of pancreatic chemical esterase ( gene ) and gene ( gene ) .	T1	T10	23601990
NA	CHEMICAL	GENE-Y	14	10	A series of chemical were synthesized and investigated in vitro as inhibitors of pancreatic chemical esterase ( gene ) and gene ( gene ) .	T1	T11	23601990
NA	CHEMICAL	GENE-Y	14	8	A series of chemical were synthesized and investigated in vitro as inhibitors of pancreatic chemical esterase ( gene ) and gene ( gene ) .	T1	T12	23601990
NA	CHEMICAL	GENE-Y	14	0	A series of chemical were synthesized and investigated in vitro as inhibitors of pancreatic chemical esterase ( gene ) and gene ( gene ) .	T1	T13	23601990
CPR:4	CHEMICAL	GENE-Y	20	13	The results showed that most of the synthesized compounds exhibited nanomolar potency against gene , much better than the parent chemical .	T3	T14	23601990
CPR:4	CHEMICAL	GENE-Y	3	10	Furthermore , these chemical demonstrated good to high selectivity for gene over gene , which only showed micromolar potency inhibition of gene .	T4	T15	23601990
CPR:4	CHEMICAL	GENE-Y	3	12	Furthermore , these chemical demonstrated good to high selectivity for gene over gene , which only showed micromolar potency inhibition of gene .	T4	T16	23601990
CPR:4	CHEMICAL	GENE-Y	3	21	Furthermore , these chemical demonstrated good to high selectivity for gene over gene , which only showed micromolar potency inhibition of gene .	T4	T17	23601990
CPR:4	CHEMICAL	GENE-Y	7	27	The structure-activity relationships revealed that the free chemical group at position 5 and chemical group at position 7 of the chemical are favorable to the inhibition of gene .	T5	T21	23601990
CPR:4	CHEMICAL	GENE-Y	9	27	The structure-activity relationships revealed that the free chemical group at position 5 and chemical group at position 7 of the chemical are favorable to the inhibition of gene .	T6	T21	23601990
CPR:4	CHEMICAL	GENE-Y	20	27	The structure-activity relationships revealed that the free chemical group at position 5 and chemical group at position 7 of the chemical are favorable to the inhibition of gene .	T7	T21	23601990
NA	CHEMICAL	GENE-Y	4	2	Induction of gene is a nonspecific biomarker of chemical receptor activation : results of large scale screening of pharmaceuticals and toxicants in vivo and in vitro .	T8	T28	17327465
NA	CHEMICAL	GENE-Y	4	9	Induction of gene is a nonspecific biomarker of chemical receptor activation : results of large scale screening of pharmaceuticals and toxicants in vivo and in vitro .	T8	T29	17327465
NA	CHEMICAL	GENE-Y	13	2	Expression of gene and its related enzyme activity have long been used as a biomarker for chemical receptor ( gene ) activation and a warning of chemical-like toxicity .	T7	T13	17327465
NA	CHEMICAL	GENE-Y	13	17	Expression of gene and its related enzyme activity have long been used as a biomarker for chemical receptor ( gene ) activation and a warning of chemical-like toxicity .	T7	T27	17327465
NA	CHEMICAL	GENE-Y	13	19	Expression of gene and its related enzyme activity have long been used as a biomarker for chemical receptor ( gene ) activation and a warning of chemical-like toxicity .	T7	T12	17327465
NA	CHEMICAL	GENE-Y	26	2	Expression of gene and its related enzyme activity have long been used as a biomarker for chemical receptor ( gene ) activation and a warning of chemical-like toxicity .	T5	T13	17327465
NA	CHEMICAL	GENE-Y	26	17	Expression of gene and its related enzyme activity have long been used as a biomarker for chemical receptor ( gene ) activation and a warning of chemical-like toxicity .	T5	T27	17327465
NA	CHEMICAL	GENE-Y	26	19	Expression of gene and its related enzyme activity have long been used as a biomarker for chemical receptor ( gene ) activation and a warning of chemical-like toxicity .	T5	T12	17327465
NA	CHEMICAL	GENE-Y	0	2	chemical : a chemical analog for the treatment of acute variceal bleeding .	T8	T11	19708854
NA	CHEMICAL	GENE-Y	2	2	chemical : a chemical analog for the treatment of acute variceal bleeding .	T9	T11	19708854
NA	CHEMICAL	GENE-Y	7	18	Although no comparisons have been made between chemical and other chemical analogues , this drug has been shown to have efficacy in the control of acute variceal bleeding as well as reducing the risk of recurrent bleeding and death , especially when started prior to endoscopy .	T4	T10	19708854
NA	CHEMICAL	GENE-Y	10	18	Although no comparisons have been made between chemical and other chemical analogues , this drug has been shown to have efficacy in the control of acute variceal bleeding as well as reducing the risk of recurrent bleeding and death , especially when started prior to endoscopy .	T5	T10	19708854
CPR:9	CHEMICAL	GENE-Y	0	12	chemical is absorbed in the small bowel and is rapidly catabolized by gene ( gene ) and chemical-chemical-methyltransferase ( gene ) .	T4	T17	9633680
CPR:9	CHEMICAL	GENE-Y	0	14	chemical is absorbed in the small bowel and is rapidly catabolized by gene ( gene ) and chemical-chemical-methyltransferase ( gene ) .	T4	T18	9633680
CPR:9	CHEMICAL	GENE-Y	0	19	chemical is absorbed in the small bowel and is rapidly catabolized by gene ( gene ) and chemical-chemical-methyltransferase ( gene ) .	T4	T20	9633680
NA	CHEMICAL	GENE-Y	3	12	chemical is absorbed in the small bowel and is rapidly catabolized by gene ( gene ) and chemical-chemical-methyltransferase ( gene ) .	T5	T17	9633680
NA	CHEMICAL	GENE-Y	3	14	chemical is absorbed in the small bowel and is rapidly catabolized by gene ( gene ) and chemical-chemical-methyltransferase ( gene ) .	T5	T18	9633680
NA	CHEMICAL	GENE-Y	3	19	chemical is absorbed in the small bowel and is rapidly catabolized by gene ( gene ) and chemical-chemical-methyltransferase ( gene ) .	T5	T20	9633680
NA	CHEMICAL	GENE-Y	17	12	chemical is absorbed in the small bowel and is rapidly catabolized by gene ( gene ) and chemical-chemical-methyltransferase ( gene ) .	T6	T17	9633680
NA	CHEMICAL	GENE-Y	17	14	chemical is absorbed in the small bowel and is rapidly catabolized by gene ( gene ) and chemical-chemical-methyltransferase ( gene ) .	T6	T18	9633680
NA	CHEMICAL	GENE-Y	17	19	chemical is absorbed in the small bowel and is rapidly catabolized by gene ( gene ) and chemical-chemical-methyltransferase ( gene ) .	T6	T20	9633680
NA	CHEMICAL	GENE-Y	17	12	chemical is absorbed in the small bowel and is rapidly catabolized by gene ( gene ) and chemical-chemical-methyltransferase ( gene ) .	T7	T17	9633680
NA	CHEMICAL	GENE-Y	17	14	chemical is absorbed in the small bowel and is rapidly catabolized by gene ( gene ) and chemical-chemical-methyltransferase ( gene ) .	T7	T18	9633680
NA	CHEMICAL	GENE-Y	17	19	chemical is absorbed in the small bowel and is rapidly catabolized by gene ( gene ) and chemical-chemical-methyltransferase ( gene ) .	T7	T20	9633680
CPR:9	CHEMICAL	GENE-Y	6	2	Because gastric gene and gene degrade chemical , the drug is given with inhibitors of gene ( chemical or chemical ) , and inhibitors of gene will also enter clinical use .	T8	T21	9633680
CPR:9	CHEMICAL	GENE-Y	6	4	Because gastric gene and gene degrade chemical , the drug is given with inhibitors of gene ( chemical or chemical ) , and inhibitors of gene will also enter clinical use .	T8	T22	9633680
NA	CHEMICAL	GENE-Y	6	15	Because gastric gene and gene degrade chemical , the drug is given with inhibitors of gene ( chemical or chemical ) , and inhibitors of gene will also enter clinical use .	T8	T23	9633680
NA	CHEMICAL	GENE-Y	6	25	Because gastric gene and gene degrade chemical , the drug is given with inhibitors of gene ( chemical or chemical ) , and inhibitors of gene will also enter clinical use .	T8	T24	9633680
NA	CHEMICAL	GENE-Y	17	2	Because gastric gene and gene degrade chemical , the drug is given with inhibitors of gene ( chemical or chemical ) , and inhibitors of gene will also enter clinical use .	T9	T21	9633680
NA	CHEMICAL	GENE-Y	17	4	Because gastric gene and gene degrade chemical , the drug is given with inhibitors of gene ( chemical or chemical ) , and inhibitors of gene will also enter clinical use .	T9	T22	9633680
CPR:4	CHEMICAL	GENE-Y	17	15	Because gastric gene and gene degrade chemical , the drug is given with inhibitors of gene ( chemical or chemical ) , and inhibitors of gene will also enter clinical use .	T9	T23	9633680
NA	CHEMICAL	GENE-Y	17	25	Because gastric gene and gene degrade chemical , the drug is given with inhibitors of gene ( chemical or chemical ) , and inhibitors of gene will also enter clinical use .	T9	T24	9633680
NA	CHEMICAL	GENE-Y	19	2	Because gastric gene and gene degrade chemical , the drug is given with inhibitors of gene ( chemical or chemical ) , and inhibitors of gene will also enter clinical use .	T10	T21	9633680
NA	CHEMICAL	GENE-Y	19	4	Because gastric gene and gene degrade chemical , the drug is given with inhibitors of gene ( chemical or chemical ) , and inhibitors of gene will also enter clinical use .	T10	T22	9633680
CPR:4	CHEMICAL	GENE-Y	19	15	Because gastric gene and gene degrade chemical , the drug is given with inhibitors of gene ( chemical or chemical ) , and inhibitors of gene will also enter clinical use .	T10	T23	9633680
NA	CHEMICAL	GENE-Y	19	25	Because gastric gene and gene degrade chemical , the drug is given with inhibitors of gene ( chemical or chemical ) , and inhibitors of gene will also enter clinical use .	T10	T24	9633680
NA	CHEMICAL	GENE-Y	8	19	Although the exact site of decarboxylation of exogenous chemical to chemical in the brain is unknown , most striatal gene is located in nigrostriatal dopaminergic nerve terminals .	T11	T25	9633680
NA	CHEMICAL	GENE-Y	10	19	Although the exact site of decarboxylation of exogenous chemical to chemical in the brain is unknown , most striatal gene is located in nigrostriatal dopaminergic nerve terminals .	T12	T25	9633680
NA	CHEMICAL	GENE-N	2	14	Newly synthesized chemical is stored in the terminals and then released , stimulating postsynaptic gene and mediating the antiparkinsonian action of chemical .	T13	T26	9633680
NA	CHEMICAL	GENE-N	21	14	Newly synthesized chemical is stored in the terminals and then released , stimulating postsynaptic gene and mediating the antiparkinsonian action of chemical .	T14	T26	9633680
NA	CHEMICAL	GENE-N	1	0	gene ( gene ) , a multisubunit enzyme located at the ruffled border and in lysosomes of osteoclasts , is necessary for bone resorption .	T2	T3	22865292
NA	CHEMICAL	GENE-N	1	2	gene ( gene ) , a multisubunit enzyme located at the ruffled border and in lysosomes of osteoclasts , is necessary for bone resorption .	T2	T19	22865292
CPR:3	CHEMICAL	GENE-N	3	6	The lysosomal inhibitor chemical significantly increased gene accumulation in +/+ cells , consistent with the hypothesis that higher lysosomal pH impairs gene degradation , leading to a higher gene/gene ratio and consequently gene inhibition .	T1	T12	22865292
NA	CHEMICAL	GENE-N	3	21	The lysosomal inhibitor chemical significantly increased gene accumulation in +/+ cells , consistent with the hypothesis that higher lysosomal pH impairs gene degradation , leading to a higher gene/gene ratio and consequently gene inhibition .	T1	T13	22865292
NA	CHEMICAL	GENE-N	3	28	The lysosomal inhibitor chemical significantly increased gene accumulation in +/+ cells , consistent with the hypothesis that higher lysosomal pH impairs gene degradation , leading to a higher gene/gene ratio and consequently gene inhibition .	T1	T14	22865292
NA	CHEMICAL	GENE-N	3	28	The lysosomal inhibitor chemical significantly increased gene accumulation in +/+ cells , consistent with the hypothesis that higher lysosomal pH impairs gene degradation , leading to a higher gene/gene ratio and consequently gene inhibition .	T1	T15	22865292
NA	CHEMICAL	GENE-N	3	32	The lysosomal inhibitor chemical significantly increased gene accumulation in +/+ cells , consistent with the hypothesis that higher lysosomal pH impairs gene degradation , leading to a higher gene/gene ratio and consequently gene inhibition .	T1	T16	22865292
CPR:6	CHEMICAL	GENE-N	0	3	chemical ( > or = 3 x 10 ( -8 ) M ) and chemical ( > or = 10 ( -8 ) M ) caused surmountable antagonism of the chemical responses of the atria and the pA2 values were 8.60 and 8.98 at the gene of the rat left atria and 7.90 and 8.31 , respectively , on the guinea-pig left atria which has functional gene .	T15	T26	1361547
NA	CHEMICAL	GENE-N	0	3	chemical ( > or = 3 x 10 ( -8 ) M ) and chemical ( > or = 10 ( -8 ) M ) caused surmountable antagonism of the chemical responses of the atria and the pA2 values were 8.60 and 8.98 at the gene of the rat left atria and 7.90 and 8.31 , respectively , on the guinea-pig left atria which has functional gene .	T15	T27	1361547
CPR:6	CHEMICAL	GENE-N	14	3	chemical ( > or = 3 x 10 ( -8 ) M ) and chemical ( > or = 10 ( -8 ) M ) caused surmountable antagonism of the chemical responses of the atria and the pA2 values were 8.60 and 8.98 at the gene of the rat left atria and 7.90 and 8.31 , respectively , on the guinea-pig left atria which has functional gene .	T16	T26	1361547
NA	CHEMICAL	GENE-N	14	3	chemical ( > or = 3 x 10 ( -8 ) M ) and chemical ( > or = 10 ( -8 ) M ) caused surmountable antagonism of the chemical responses of the atria and the pA2 values were 8.60 and 8.98 at the gene of the rat left atria and 7.90 and 8.31 , respectively , on the guinea-pig left atria which has functional gene .	T16	T27	1361547
CPR:5	CHEMICAL	GENE-N	30	3	chemical ( > or = 3 x 10 ( -8 ) M ) and chemical ( > or = 10 ( -8 ) M ) caused surmountable antagonism of the chemical responses of the atria and the pA2 values were 8.60 and 8.98 at the gene of the rat left atria and 7.90 and 8.31 , respectively , on the guinea-pig left atria which has functional gene .	T17	T26	1361547
NA	CHEMICAL	GENE-N	30	3	chemical ( > or = 3 x 10 ( -8 ) M ) and chemical ( > or = 10 ( -8 ) M ) caused surmountable antagonism of the chemical responses of the atria and the pA2 values were 8.60 and 8.98 at the gene of the rat left atria and 7.90 and 8.31 , respectively , on the guinea-pig left atria which has functional gene .	T17	T27	1361547
NA	CHEMICAL	GENE-Y	0	7	chemical and chemical ( both at > or = 10 ( -7 ) M ) attenuated the spontaneous contractile activity of the rat portal vein and the attenuation to chemical at 10 ( -6 ) M was abolished by chemical which illustrates that the chemical-induced attenuation is gene mediated .	T18	T23	1361547
NA	CHEMICAL	GENE-Y	2	7	chemical and chemical ( both at > or = 10 ( -7 ) M ) attenuated the spontaneous contractile activity of the rat portal vein and the attenuation to chemical at 10 ( -6 ) M was abolished by chemical which illustrates that the chemical-induced attenuation is gene mediated .	T19	T23	1361547
NA	CHEMICAL	GENE-Y	29	7	chemical and chemical ( both at > or = 10 ( -7 ) M ) attenuated the spontaneous contractile activity of the rat portal vein and the attenuation to chemical at 10 ( -6 ) M was abolished by chemical which illustrates that the chemical-induced attenuation is gene mediated .	T20	T23	1361547
NA	CHEMICAL	GENE-Y	0	7	chemical and chemical ( both at > or = 10 ( -7 ) M ) attenuated the spontaneous contractile activity of the rat portal vein and the attenuation to chemical at 10 ( -6 ) M was abolished by chemical which illustrates that the chemical-induced attenuation is gene mediated .	T1	T23	1361547
NA	CHEMICAL	GENE-Y	29	7	chemical and chemical ( both at > or = 10 ( -7 ) M ) attenuated the spontaneous contractile activity of the rat portal vein and the attenuation to chemical at 10 ( -6 ) M was abolished by chemical which illustrates that the chemical-induced attenuation is gene mediated .	T2	T23	1361547
NA	CHEMICAL	GENE-N	1	18	The chemical attenuation responses of the portal vein were inhibited by chemical and chemical ( both at > or = 10 ( -7 ) M ) and the pA2 value for the chemical at gene was 7.59 .	T3	T24	1361547
NA	CHEMICAL	GENE-N	11	18	The chemical attenuation responses of the portal vein were inhibited by chemical and chemical ( both at > or = 10 ( -7 ) M ) and the pA2 value for the chemical at gene was 7.59 .	T4	T24	1361547
NA	CHEMICAL	GENE-N	13	18	The chemical attenuation responses of the portal vein were inhibited by chemical and chemical ( both at > or = 10 ( -7 ) M ) and the pA2 value for the chemical at gene was 7.59 .	T5	T24	1361547
CPR:6	CHEMICAL	GENE-N	32	18	The chemical attenuation responses of the portal vein were inhibited by chemical and chemical ( both at > or = 10 ( -7 ) M ) and the pA2 value for the chemical at gene was 7.59 .	T7	T24	1361547
NA	CHEMICAL	GENE-Y	4	5	Antiaggressive activity of central chemical in male rats .	T10	T20	23624810
NA	CHEMICAL	GENE-Y	11	16	RATIONALE : A substantial body of research suggests that the neuropeptide chemical promotes social affiliative behaviors in a wide range of animals including humans .	T7	T17	23624810
NA	CHEMICAL	GENE-Y	6	6	OBJECTIVE : Our primary goal was to examine the putative serenic effect of chemical in a feral strain ( wild type Groningen , WTG ) of rats that generally show a much broader variation and higher levels of intermale aggression than commonly used laboratory strains of rats .	T4	T14	23624810
NA	CHEMICAL	GENE-Y	15	17	METHODS : Resident animals were intracerebroventricularly ( icv ) administered with different doses of synthetic chemical and gene receptor antagonist , alone and in combination , in order to manipulate brain chemical functioning and to assess their behavioral response to an intruder .	T5	T15	23624810
NA	CHEMICAL	GENE-Y	15	18	METHODS : Resident animals were intracerebroventricularly ( icv ) administered with different doses of synthetic chemical and gene receptor antagonist , alone and in combination , in order to manipulate brain chemical functioning and to assess their behavioral response to an intruder .	T5	T16	23624810
NA	CHEMICAL	GENE-Y	15	23	METHODS : Resident animals were intracerebroventricularly ( icv ) administered with different doses of synthetic chemical and gene receptor antagonist , alone and in combination , in order to manipulate brain chemical functioning and to assess their behavioral response to an intruder .	T5	T18	23624810
NA	CHEMICAL	GENE-Y	23	17	METHODS : Resident animals were intracerebroventricularly ( icv ) administered with different doses of synthetic chemical and gene receptor antagonist , alone and in combination , in order to manipulate brain chemical functioning and to assess their behavioral response to an intruder .	T6	T15	23624810
NA	CHEMICAL	GENE-Y	23	18	METHODS : Resident animals were intracerebroventricularly ( icv ) administered with different doses of synthetic chemical and gene receptor antagonist , alone and in combination , in order to manipulate brain chemical functioning and to assess their behavioral response to an intruder .	T6	T16	23624810
NA	CHEMICAL	GENE-Y	23	23	METHODS : Resident animals were intracerebroventricularly ( icv ) administered with different doses of synthetic chemical and gene receptor antagonist , alone and in combination , in order to manipulate brain chemical functioning and to assess their behavioral response to an intruder .	T6	T18	23624810
NA	CHEMICAL	GENE-Y	23	17	METHODS : Resident animals were intracerebroventricularly ( icv ) administered with different doses of synthetic chemical and gene receptor antagonist , alone and in combination , in order to manipulate brain chemical functioning and to assess their behavioral response to an intruder .	T8	T15	23624810
NA	CHEMICAL	GENE-Y	23	18	METHODS : Resident animals were intracerebroventricularly ( icv ) administered with different doses of synthetic chemical and gene receptor antagonist , alone and in combination , in order to manipulate brain chemical functioning and to assess their behavioral response to an intruder .	T8	T16	23624810
NA	CHEMICAL	GENE-Y	23	23	METHODS : Resident animals were intracerebroventricularly ( icv ) administered with different doses of synthetic chemical and gene receptor antagonist , alone and in combination , in order to manipulate brain chemical functioning and to assess their behavioral response to an intruder .	T8	T18	23624810
NA	CHEMICAL	GENE-Y	10	16	RESULTS : Our data clearly demonstrate that acute icv administered chemical produces dose-dependent and receptor-selective changes in social behavior , reducing aggression and potentiating social exploration .	T9	T19	23624810
NA	CHEMICAL	GENE-Y	8	9	On the other hand , administration of an chemical receptor antagonist tends to increase ( nonsignificantly ) aggression only in low-medium aggressive animals .	T1	T11	23624810
NA	CHEMICAL	GENE-Y	9	20	CONCLUSIONS : These results suggest that transiently enhancing brain chemical function has potent antiaggressive effects , whereas its attenuation tends to enhance aggressiveness .	T2	T12	23624810
NA	CHEMICAL	GENE-Y	0	5	chemical bond activation in chemical mutase by stabilization of the post-homolysis product chemical chemical .	T13	T19	16305240
NA	CHEMICAL	GENE-Y	4	5	chemical bond activation in chemical mutase by stabilization of the post-homolysis product chemical chemical .	T15	T19	16305240
NA	CHEMICAL	GENE-Y	12	5	chemical bond activation in chemical mutase by stabilization of the post-homolysis product chemical chemical .	T16	T19	16305240
NA	CHEMICAL	GENE-Y	3	5	chemical bond activation in chemical mutase by stabilization of the post-homolysis product chemical chemical .	T14	T19	16305240
NA	CHEMICAL	GENE-Y	27	35	In this work , we utilized magnetic circular dichroism spectroscopy to explore how the electronic structure of the reduced B12 cofactor ( i.e. , the post-homolysis product chemical ) is modulated by the enzyme chemical mutase .	T5	T17	16305240
NA	CHEMICAL	GENE-Y	34	35	In this work , we utilized magnetic circular dichroism spectroscopy to explore how the electronic structure of the reduced B12 cofactor ( i.e. , the post-homolysis product chemical ) is modulated by the enzyme chemical mutase .	T6	T17	16305240
NA	CHEMICAL	GENE-Y	3	8	showed that when chemical is bound to the gene active site , no enzymatic perturbation of the chemical electronic structure occurs , even in the presence of substrate ( analogues ) .	T10	T18	16305240
NA	CHEMICAL	GENE-Y	17	8	showed that when chemical is bound to the gene active site , no enzymatic perturbation of the chemical electronic structure occurs , even in the presence of substrate ( analogues ) .	T12	T18	16305240
NA	CHEMICAL	GENE-Y	29	2	With respect to the type of neurotransmitter control underlying the changes produced by various neuroleptics , it is quite obvious from the comparisons with the respective drug effects that chemical-D1-receptor controlled transmission is not responsible for this action .	T1	T8	1352051
NA	CHEMICAL	GENE-Y	52	16	Obesity-induced chronic low-grade inflammation originates from adipose tissue and is crucial for obesity-driven metabolic deterioration including gene resistance and type 2 diabetes.Chronic inflammation may be a consequence of a failure to actively resolve inflammation , and could result from a lack of local specialized pro-resolving lipid mediators ( SPM ) such as chemical and protectins , which derive from the n-3 chemical chemical ( chemical ) and chemical ( chemical ) .	T6	T26	23349501
NA	CHEMICAL	GENE-Y	25	16	Obesity-induced chronic low-grade inflammation originates from adipose tissue and is crucial for obesity-driven metabolic deterioration including gene resistance and type 2 diabetes.Chronic inflammation may be a consequence of a failure to actively resolve inflammation , and could result from a lack of local specialized pro-resolving lipid mediators ( SPM ) such as chemical and protectins , which derive from the n-3 chemical chemical ( chemical ) and chemical ( chemical ) .	T7	T26	23349501
NA	CHEMICAL	GENE-Y	25	16	Obesity-induced chronic low-grade inflammation originates from adipose tissue and is crucial for obesity-driven metabolic deterioration including gene resistance and type 2 diabetes.Chronic inflammation may be a consequence of a failure to actively resolve inflammation , and could result from a lack of local specialized pro-resolving lipid mediators ( SPM ) such as chemical and protectins , which derive from the n-3 chemical chemical ( chemical ) and chemical ( chemical ) .	T8	T26	23349501
NA	CHEMICAL	GENE-Y	64	16	Obesity-induced chronic low-grade inflammation originates from adipose tissue and is crucial for obesity-driven metabolic deterioration including gene resistance and type 2 diabetes.Chronic inflammation may be a consequence of a failure to actively resolve inflammation , and could result from a lack of local specialized pro-resolving lipid mediators ( SPM ) such as chemical and protectins , which derive from the n-3 chemical chemical ( chemical ) and chemical ( chemical ) .	T9	T26	23349501
NA	CHEMICAL	GENE-Y	25	16	Obesity-induced chronic low-grade inflammation originates from adipose tissue and is crucial for obesity-driven metabolic deterioration including gene resistance and type 2 diabetes.Chronic inflammation may be a consequence of a failure to actively resolve inflammation , and could result from a lack of local specialized pro-resolving lipid mediators ( SPM ) such as chemical and protectins , which derive from the n-3 chemical chemical ( chemical ) and chemical ( chemical ) .	T10	T26	23349501
NA	CHEMICAL	GENE-Y	69	16	Obesity-induced chronic low-grade inflammation originates from adipose tissue and is crucial for obesity-driven metabolic deterioration including gene resistance and type 2 diabetes.Chronic inflammation may be a consequence of a failure to actively resolve inflammation , and could result from a lack of local specialized pro-resolving lipid mediators ( SPM ) such as chemical and protectins , which derive from the n-3 chemical chemical ( chemical ) and chemical ( chemical ) .	T11	T26	23349501
CPR:3	CHEMICAL	GENE-N	1	11	Dietary chemical/chemical treatment restored endogenous biosynthesis of n-3 derived lipid mediators in obesity while attenuating adipose tissue inflammation and improving gene sensitivity .	T19	T22	23349501
CPR:3	CHEMICAL	GENE-N	1	11	Dietary chemical/chemical treatment restored endogenous biosynthesis of n-3 derived lipid mediators in obesity while attenuating adipose tissue inflammation and improving gene sensitivity .	T20	T22	23349501
CPR:4	CHEMICAL	GENE-N	2	10	Notably , chemical treatment reduced adipose tissue expression of inflammatory gene , increased gene expression and improved chemical tolerance parallel to gene sensitivity in obese mice .	T1	T23	23349501
CPR:3	CHEMICAL	GENE-Y	2	13	Notably , chemical treatment reduced adipose tissue expression of inflammatory gene , increased gene expression and improved chemical tolerance parallel to gene sensitivity in obese mice .	T1	T24	23349501
CPR:3	CHEMICAL	GENE-N	2	21	Notably , chemical treatment reduced adipose tissue expression of inflammatory gene , increased gene expression and improved chemical tolerance parallel to gene sensitivity in obese mice .	T1	T25	23349501
NA	CHEMICAL	GENE-N	10	10	Notably , chemical treatment reduced adipose tissue expression of inflammatory gene , increased gene expression and improved chemical tolerance parallel to gene sensitivity in obese mice .	T2	T23	23349501
NA	CHEMICAL	GENE-Y	10	13	Notably , chemical treatment reduced adipose tissue expression of inflammatory gene , increased gene expression and improved chemical tolerance parallel to gene sensitivity in obese mice .	T2	T24	23349501
NA	CHEMICAL	GENE-N	10	21	Notably , chemical treatment reduced adipose tissue expression of inflammatory gene , increased gene expression and improved chemical tolerance parallel to gene sensitivity in obese mice .	T2	T25	23349501
NA	CHEMICAL	GENE-N	6	3	Discovery of novel gene ligands by a virtual screening approach : further development of chemical as gene agonists .	T4	T11	23131798
CPR:5	CHEMICAL	GENE-Y	6	16	Discovery of novel gene ligands by a virtual screening approach : further development of chemical as gene agonists .	T4	T10	23131798
CPR:5	CHEMICAL	GENE-Y	5	3	One of the gene agonists , chemical ( 19 , -logEC ( 50 ) =7.5 , E ( max ) =255 % ) was selected for further development .	T1	T7	23131798
CPR:5	CHEMICAL	GENE-Y	6	18	As far as we are aware , the compound 's chemical scaffold represents a new core structure for gene agonists .	T2	T8	23131798
CPR:4	CHEMICAL	GENE-Y	0	12	chemical is a selective chemical ( chemical ) V ( 2 ) receptor blocker used to induce free water diuresis in the treatment of euvolemic or hypervolemic hyponatremia .	T1	T15	19337422
NA	CHEMICAL	GENE-Y	2	12	chemical is a selective chemical ( chemical ) V ( 2 ) receptor blocker used to induce free water diuresis in the treatment of euvolemic or hypervolemic hyponatremia .	T4	T15	19337422
NA	CHEMICAL	GENE-Y	6	12	chemical is a selective chemical ( chemical ) V ( 2 ) receptor blocker used to induce free water diuresis in the treatment of euvolemic or hypervolemic hyponatremia .	T7	T15	19337422
CPR:3	CHEMICAL	GENE-Y	3	5	Prolonged use of chemical leads to increased endogenous levels of chemical and perhaps over-stimulation of gene .	T8	T17	19337422
NA	CHEMICAL	GENE-Y	10	5	Prolonged use of chemical leads to increased endogenous levels of chemical and perhaps over-stimulation of gene .	T9	T17	19337422
CPR:9	CHEMICAL	GENE-Y	3	8	In addition , chemical is metabolized by the gene system ; thus physicians should be aware of the potential for increased interactions with other medications .	T11	T18	19337422
NA	CHEMICAL	GENE-N	1	1	The gene physically associates with these complexes to recruit them during transcription and mediates phosphorylation at chemical-2 of the chemical-terminal domain ( CTD ) of gene .	T1	T18	23230273
NA	CHEMICAL	GENE-N	1	25	The gene physically associates with these complexes to recruit them during transcription and mediates phosphorylation at chemical-2 of the chemical-terminal domain ( CTD ) of gene .	T1	T19	23230273
NA	CHEMICAL	GENE-N	19	1	The gene physically associates with these complexes to recruit them during transcription and mediates phosphorylation at chemical-2 of the chemical-terminal domain ( CTD ) of gene .	T2	T18	23230273
NA	CHEMICAL	GENE-N	19	25	The gene physically associates with these complexes to recruit them during transcription and mediates phosphorylation at chemical-2 of the chemical-terminal domain ( CTD ) of gene .	T2	T19	23230273
NA	CHEMICAL	GENE-Y	12	14	Additionally , on day 11 of both study periods , 150 mg chemical ( gene ) , 125 mg chemical ( gene ) , 20 mg chemical ( gene ) , 30 mg chemical ( gene ) , and 2 mg chemical ( gene ) were administered orally .	T7	T17	23401474
NA	CHEMICAL	GENE-Y	12	21	Additionally , on day 11 of both study periods , 150 mg chemical ( gene ) , 125 mg chemical ( gene ) , 20 mg chemical ( gene ) , 30 mg chemical ( gene ) , and 2 mg chemical ( gene ) were administered orally .	T7	T18	23401474
NA	CHEMICAL	GENE-Y	12	28	Additionally , on day 11 of both study periods , 150 mg chemical ( gene ) , 125 mg chemical ( gene ) , 20 mg chemical ( gene ) , 30 mg chemical ( gene ) , and 2 mg chemical ( gene ) were administered orally .	T7	T19	23401474
NA	CHEMICAL	GENE-Y	12	35	Additionally , on day 11 of both study periods , 150 mg chemical ( gene ) , 125 mg chemical ( gene ) , 20 mg chemical ( gene ) , 30 mg chemical ( gene ) , and 2 mg chemical ( gene ) were administered orally .	T7	T20	23401474
NA	CHEMICAL	GENE-Y	12	43	Additionally , on day 11 of both study periods , 150 mg chemical ( gene ) , 125 mg chemical ( gene ) , 20 mg chemical ( gene ) , 30 mg chemical ( gene ) , and 2 mg chemical ( gene ) were administered orally .	T7	T21	23401474
NA	CHEMICAL	GENE-Y	19	14	Additionally , on day 11 of both study periods , 150 mg chemical ( gene ) , 125 mg chemical ( gene ) , 20 mg chemical ( gene ) , 30 mg chemical ( gene ) , and 2 mg chemical ( gene ) were administered orally .	T8	T17	23401474
NA	CHEMICAL	GENE-Y	19	21	Additionally , on day 11 of both study periods , 150 mg chemical ( gene ) , 125 mg chemical ( gene ) , 20 mg chemical ( gene ) , 30 mg chemical ( gene ) , and 2 mg chemical ( gene ) were administered orally .	T8	T18	23401474
NA	CHEMICAL	GENE-Y	19	28	Additionally , on day 11 of both study periods , 150 mg chemical ( gene ) , 125 mg chemical ( gene ) , 20 mg chemical ( gene ) , 30 mg chemical ( gene ) , and 2 mg chemical ( gene ) were administered orally .	T8	T19	23401474
NA	CHEMICAL	GENE-Y	19	35	Additionally , on day 11 of both study periods , 150 mg chemical ( gene ) , 125 mg chemical ( gene ) , 20 mg chemical ( gene ) , 30 mg chemical ( gene ) , and 2 mg chemical ( gene ) were administered orally .	T8	T20	23401474
NA	CHEMICAL	GENE-Y	19	43	Additionally , on day 11 of both study periods , 150 mg chemical ( gene ) , 125 mg chemical ( gene ) , 20 mg chemical ( gene ) , 30 mg chemical ( gene ) , and 2 mg chemical ( gene ) were administered orally .	T8	T21	23401474
NA	CHEMICAL	GENE-Y	26	14	Additionally , on day 11 of both study periods , 150 mg chemical ( gene ) , 125 mg chemical ( gene ) , 20 mg chemical ( gene ) , 30 mg chemical ( gene ) , and 2 mg chemical ( gene ) were administered orally .	T9	T17	23401474
NA	CHEMICAL	GENE-Y	26	21	Additionally , on day 11 of both study periods , 150 mg chemical ( gene ) , 125 mg chemical ( gene ) , 20 mg chemical ( gene ) , 30 mg chemical ( gene ) , and 2 mg chemical ( gene ) were administered orally .	T9	T18	23401474
NA	CHEMICAL	GENE-Y	26	28	Additionally , on day 11 of both study periods , 150 mg chemical ( gene ) , 125 mg chemical ( gene ) , 20 mg chemical ( gene ) , 30 mg chemical ( gene ) , and 2 mg chemical ( gene ) were administered orally .	T9	T19	23401474
NA	CHEMICAL	GENE-Y	26	35	Additionally , on day 11 of both study periods , 150 mg chemical ( gene ) , 125 mg chemical ( gene ) , 20 mg chemical ( gene ) , 30 mg chemical ( gene ) , and 2 mg chemical ( gene ) were administered orally .	T9	T20	23401474
NA	CHEMICAL	GENE-Y	26	43	Additionally , on day 11 of both study periods , 150 mg chemical ( gene ) , 125 mg chemical ( gene ) , 20 mg chemical ( gene ) , 30 mg chemical ( gene ) , and 2 mg chemical ( gene ) were administered orally .	T9	T21	23401474
NA	CHEMICAL	GENE-Y	33	14	Additionally , on day 11 of both study periods , 150 mg chemical ( gene ) , 125 mg chemical ( gene ) , 20 mg chemical ( gene ) , 30 mg chemical ( gene ) , and 2 mg chemical ( gene ) were administered orally .	T10	T17	23401474
NA	CHEMICAL	GENE-Y	33	21	Additionally , on day 11 of both study periods , 150 mg chemical ( gene ) , 125 mg chemical ( gene ) , 20 mg chemical ( gene ) , 30 mg chemical ( gene ) , and 2 mg chemical ( gene ) were administered orally .	T10	T18	23401474
NA	CHEMICAL	GENE-Y	33	28	Additionally , on day 11 of both study periods , 150 mg chemical ( gene ) , 125 mg chemical ( gene ) , 20 mg chemical ( gene ) , 30 mg chemical ( gene ) , and 2 mg chemical ( gene ) were administered orally .	T10	T19	23401474
NA	CHEMICAL	GENE-Y	33	35	Additionally , on day 11 of both study periods , 150 mg chemical ( gene ) , 125 mg chemical ( gene ) , 20 mg chemical ( gene ) , 30 mg chemical ( gene ) , and 2 mg chemical ( gene ) were administered orally .	T10	T20	23401474
NA	CHEMICAL	GENE-Y	33	43	Additionally , on day 11 of both study periods , 150 mg chemical ( gene ) , 125 mg chemical ( gene ) , 20 mg chemical ( gene ) , 30 mg chemical ( gene ) , and 2 mg chemical ( gene ) were administered orally .	T10	T21	23401474
NA	CHEMICAL	GENE-Y	41	14	Additionally , on day 11 of both study periods , 150 mg chemical ( gene ) , 125 mg chemical ( gene ) , 20 mg chemical ( gene ) , 30 mg chemical ( gene ) , and 2 mg chemical ( gene ) were administered orally .	T11	T17	23401474
NA	CHEMICAL	GENE-Y	41	21	Additionally , on day 11 of both study periods , 150 mg chemical ( gene ) , 125 mg chemical ( gene ) , 20 mg chemical ( gene ) , 30 mg chemical ( gene ) , and 2 mg chemical ( gene ) were administered orally .	T11	T18	23401474
NA	CHEMICAL	GENE-Y	41	28	Additionally , on day 11 of both study periods , 150 mg chemical ( gene ) , 125 mg chemical ( gene ) , 20 mg chemical ( gene ) , 30 mg chemical ( gene ) , and 2 mg chemical ( gene ) were administered orally .	T11	T19	23401474
NA	CHEMICAL	GENE-Y	41	35	Additionally , on day 11 of both study periods , 150 mg chemical ( gene ) , 125 mg chemical ( gene ) , 20 mg chemical ( gene ) , 30 mg chemical ( gene ) , and 2 mg chemical ( gene ) were administered orally .	T11	T20	23401474
NA	CHEMICAL	GENE-Y	41	43	Additionally , on day 11 of both study periods , 150 mg chemical ( gene ) , 125 mg chemical ( gene ) , 20 mg chemical ( gene ) , 30 mg chemical ( gene ) , and 2 mg chemical ( gene ) were administered orally .	T11	T21	23401474
NA	CHEMICAL	GENE-Y	9	25	The 90 % CI for the AUC0-t ratio of chemical but not for chemical/chemical plasma ratio 3 hours post-dose or chemical/chemical AUC0-t ratio ( secondary gene metrics ) was above the predefined threshold of 1.43 , probably caused by the inherent high variability of chemical pharmacokinetics .	T1	T14	23401474
NA	CHEMICAL	GENE-Y	13	25	The 90 % CI for the AUC0-t ratio of chemical but not for chemical/chemical plasma ratio 3 hours post-dose or chemical/chemical AUC0-t ratio ( secondary gene metrics ) was above the predefined threshold of 1.43 , probably caused by the inherent high variability of chemical pharmacokinetics .	T2	T14	23401474
NA	CHEMICAL	GENE-Y	13	25	The 90 % CI for the AUC0-t ratio of chemical but not for chemical/chemical plasma ratio 3 hours post-dose or chemical/chemical AUC0-t ratio ( secondary gene metrics ) was above the predefined threshold of 1.43 , probably caused by the inherent high variability of chemical pharmacokinetics .	T3	T14	23401474
NA	CHEMICAL	GENE-Y	20	25	The 90 % CI for the AUC0-t ratio of chemical but not for chemical/chemical plasma ratio 3 hours post-dose or chemical/chemical AUC0-t ratio ( secondary gene metrics ) was above the predefined threshold of 1.43 , probably caused by the inherent high variability of chemical pharmacokinetics .	T4	T14	23401474
NA	CHEMICAL	GENE-Y	20	25	The 90 % CI for the AUC0-t ratio of chemical but not for chemical/chemical plasma ratio 3 hours post-dose or chemical/chemical AUC0-t ratio ( secondary gene metrics ) was above the predefined threshold of 1.43 , probably caused by the inherent high variability of chemical pharmacokinetics .	T5	T14	23401474
NA	CHEMICAL	GENE-Y	44	25	The 90 % CI for the AUC0-t ratio of chemical but not for chemical/chemical plasma ratio 3 hours post-dose or chemical/chemical AUC0-t ratio ( secondary gene metrics ) was above the predefined threshold of 1.43 , probably caused by the inherent high variability of chemical pharmacokinetics .	T6	T14	23401474
NA	CHEMICAL	GENE-N	0	2	chemical , an efficacious antidepressant and smoking cessation agent , inhibits chemical and chemical transporters ( gene and gene , respectively ) .	T1	T48	12183670
CPR:4	CHEMICAL	GENE-Y	0	16	chemical , an efficacious antidepressant and smoking cessation agent , inhibits chemical and chemical transporters ( gene and gene , respectively ) .	T1	T40	12183670
CPR:4	CHEMICAL	GENE-Y	0	18	chemical , an efficacious antidepressant and smoking cessation agent , inhibits chemical and chemical transporters ( gene and gene , respectively ) .	T1	T41	12183670
NA	CHEMICAL	GENE-N	11	2	chemical , an efficacious antidepressant and smoking cessation agent , inhibits chemical and chemical transporters ( gene and gene , respectively ) .	T29	T48	12183670
NA	CHEMICAL	GENE-Y	11	16	chemical , an efficacious antidepressant and smoking cessation agent , inhibits chemical and chemical transporters ( gene and gene , respectively ) .	T29	T40	12183670
NA	CHEMICAL	GENE-Y	11	18	chemical , an efficacious antidepressant and smoking cessation agent , inhibits chemical and chemical transporters ( gene and gene , respectively ) .	T29	T41	12183670
NA	CHEMICAL	GENE-N	13	2	chemical , an efficacious antidepressant and smoking cessation agent , inhibits chemical and chemical transporters ( gene and gene , respectively ) .	T33	T48	12183670
NA	CHEMICAL	GENE-Y	13	16	chemical , an efficacious antidepressant and smoking cessation agent , inhibits chemical and chemical transporters ( gene and gene , respectively ) .	T33	T40	12183670
NA	CHEMICAL	GENE-Y	13	18	chemical , an efficacious antidepressant and smoking cessation agent , inhibits chemical and chemical transporters ( gene and gene , respectively ) .	T33	T41	12183670
NA	CHEMICAL	GENE-N	2	9	Recently , chemical has been reported to noncompetitively inhibit gene expressed in Xenopus oocytes or established cell lines .	T14	T46	12183670
NA	CHEMICAL	GENE-N	11	9	Recently , chemical has been reported to noncompetitively inhibit gene expressed in Xenopus oocytes or established cell lines .	T19	T46	12183670
NA	CHEMICAL	GENE-N	4	8	The present study evaluated chemical-induced inhibition of native gene using functional neurotransmitter release assays , chemical-evoked [ chemical ] overflow from superfused rat striatal slices preloaded with chemical ( chemical ) , and chemical-evoked [ chemical ] overflow from hippocampal slices preloaded with chemical ( chemical ) .	T20	T47	12183670
NA	CHEMICAL	GENE-N	15	8	The present study evaluated chemical-induced inhibition of native gene using functional neurotransmitter release assays , chemical-evoked [ chemical ] overflow from superfused rat striatal slices preloaded with chemical ( chemical ) , and chemical-evoked [ chemical ] overflow from hippocampal slices preloaded with chemical ( chemical ) .	T21	T47	12183670
NA	CHEMICAL	GENE-N	17	8	The present study evaluated chemical-induced inhibition of native gene using functional neurotransmitter release assays , chemical-evoked [ chemical ] overflow from superfused rat striatal slices preloaded with chemical ( chemical ) , and chemical-evoked [ chemical ] overflow from hippocampal slices preloaded with chemical ( chemical ) .	T22	T47	12183670
NA	CHEMICAL	GENE-N	16	8	The present study evaluated chemical-induced inhibition of native gene using functional neurotransmitter release assays , chemical-evoked [ chemical ] overflow from superfused rat striatal slices preloaded with chemical ( chemical ) , and chemical-evoked [ chemical ] overflow from hippocampal slices preloaded with chemical ( chemical ) .	T23	T47	12183670
NA	CHEMICAL	GENE-N	16	8	The present study evaluated chemical-induced inhibition of native gene using functional neurotransmitter release assays , chemical-evoked [ chemical ] overflow from superfused rat striatal slices preloaded with chemical ( chemical ) , and chemical-evoked [ chemical ] overflow from hippocampal slices preloaded with chemical ( chemical ) .	T24	T47	12183670
NA	CHEMICAL	GENE-N	33	8	The present study evaluated chemical-induced inhibition of native gene using functional neurotransmitter release assays , chemical-evoked [ chemical ] overflow from superfused rat striatal slices preloaded with chemical ( chemical ) , and chemical-evoked [ chemical ] overflow from hippocampal slices preloaded with chemical ( chemical ) .	T25	T47	12183670
NA	CHEMICAL	GENE-N	28	8	The present study evaluated chemical-induced inhibition of native gene using functional neurotransmitter release assays , chemical-evoked [ chemical ] overflow from superfused rat striatal slices preloaded with chemical ( chemical ) , and chemical-evoked [ chemical ] overflow from hippocampal slices preloaded with chemical ( chemical ) .	T26	T47	12183670
NA	CHEMICAL	GENE-N	16	8	The present study evaluated chemical-induced inhibition of native gene using functional neurotransmitter release assays , chemical-evoked [ chemical ] overflow from superfused rat striatal slices preloaded with chemical ( chemical ) , and chemical-evoked [ chemical ] overflow from hippocampal slices preloaded with chemical ( chemical ) .	T27	T47	12183670
NA	CHEMICAL	GENE-N	16	8	The present study evaluated chemical-induced inhibition of native gene using functional neurotransmitter release assays , chemical-evoked [ chemical ] overflow from superfused rat striatal slices preloaded with chemical ( chemical ) , and chemical-evoked [ chemical ] overflow from hippocampal slices preloaded with chemical ( chemical ) .	T28	T47	12183670
CPR:4	CHEMICAL	GENE-Y	5	7	To eliminate the interaction of chemical with gene or gene , chemical or chemical , respectively , was included in the superfusion buffer .	T30	T49	12183670
CPR:4	CHEMICAL	GENE-Y	5	9	To eliminate the interaction of chemical with gene or gene , chemical or chemical , respectively , was included in the superfusion buffer .	T30	T50	12183670
NA	CHEMICAL	GENE-Y	11	7	To eliminate the interaction of chemical with gene or gene , chemical or chemical , respectively , was included in the superfusion buffer .	T31	T49	12183670
NA	CHEMICAL	GENE-Y	11	9	To eliminate the interaction of chemical with gene or gene , chemical or chemical , respectively , was included in the superfusion buffer .	T31	T50	12183670
NA	CHEMICAL	GENE-Y	13	7	To eliminate the interaction of chemical with gene or gene , chemical or chemical , respectively , was included in the superfusion buffer .	T32	T49	12183670
NA	CHEMICAL	GENE-Y	13	9	To eliminate the interaction of chemical with gene or gene , chemical or chemical , respectively , was included in the superfusion buffer .	T32	T50	12183670
NA	CHEMICAL	GENE-N	2	8	Thus , chemical acts as an antagonist at gene in rat striatum and hippocampus , respectively , across the same concentration range that inhibits gene and gene function .	T17	T42	12183670
CPR:4	CHEMICAL	GENE-Y	2	24	Thus , chemical acts as an antagonist at gene in rat striatum and hippocampus , respectively , across the same concentration range that inhibits gene and gene function .	T17	T43	12183670
CPR:4	CHEMICAL	GENE-Y	2	26	Thus , chemical acts as an antagonist at gene in rat striatum and hippocampus , respectively , across the same concentration range that inhibits gene and gene function .	T17	T44	12183670
NA	CHEMICAL	GENE-N	6	1	Adopted gene ( gene ) , chemical X receptor ( gene ) , plays a central role in the regulation of xeno- and endobiotic metabolism .	T3	T18	23330542
NA	CHEMICAL	GENE-N	6	3	Adopted gene ( gene ) , chemical X receptor ( gene ) , plays a central role in the regulation of xeno- and endobiotic metabolism .	T3	T12	23330542
NA	CHEMICAL	GENE-Y	6	8	Adopted gene ( gene ) , chemical X receptor ( gene ) , plays a central role in the regulation of xeno- and endobiotic metabolism .	T3	T13	23330542
NA	CHEMICAL	GENE-Y	6	7	Adopted gene ( gene ) , chemical X receptor ( gene ) , plays a central role in the regulation of xeno- and endobiotic metabolism .	T3	T16	23330542
NA	CHEMICAL	GENE-Y	22	9	However , more recently , it is clear that gene is also an important mediator of adverse xeno- ( e.g. , enhances chemical toxicity ) and endobiotic ( e.g. , hepatic steatosis ) metabolic phenotypes .	T4	T14	23330542
CPR:6	CHEMICAL	GENE-Y	5	8	Since the original discovery of chemical analogs as gene antagonists , we have preliminarily defined an important gene antagonist pharmacophore and developed less-toxic gene antagonists .	T1	T6	23330542
CPR:6	CHEMICAL	GENE-Y	5	17	Since the original discovery of chemical analogs as gene antagonists , we have preliminarily defined an important gene antagonist pharmacophore and developed less-toxic gene antagonists .	T1	T7	23330542
CPR:6	CHEMICAL	GENE-Y	5	23	Since the original discovery of chemical analogs as gene antagonists , we have preliminarily defined an important gene antagonist pharmacophore and developed less-toxic gene antagonists .	T1	T8	23330542
CPR:4	CHEMICAL	GENE-Y	0	6	chemical , a potent and selective gene inhibitor , achieves antitumor activity while sparing platelets .	T5	T17	23291630
CPR:4	CHEMICAL	GENE-Y	14	21	The therapeutic potential of directly inhibiting prosurvival proteins was unveiled with the development of chemical , a selective inhibitor of both gene and gene ( gene ) , which has shown clinical efficacy in some gene-dependent hematological cancers .	T1	T10	23291630
CPR:4	CHEMICAL	GENE-Y	14	23	The therapeutic potential of directly inhibiting prosurvival proteins was unveiled with the development of chemical , a selective inhibitor of both gene and gene ( gene ) , which has shown clinical efficacy in some gene-dependent hematological cancers .	T1	T11	23291630
CPR:4	CHEMICAL	GENE-Y	14	24	The therapeutic potential of directly inhibiting prosurvival proteins was unveiled with the development of chemical , a selective inhibitor of both gene and gene ( gene ) , which has shown clinical efficacy in some gene-dependent hematological cancers .	T1	T12	23291630
NA	CHEMICAL	GENE-Y	14	35	The therapeutic potential of directly inhibiting prosurvival proteins was unveiled with the development of chemical , a selective inhibitor of both gene and gene ( gene ) , which has shown clinical efficacy in some gene-dependent hematological cancers .	T1	T13	23291630
CPR:4	CHEMICAL	GENE-Y	6	16	Here we report the re-engineering of chemical to create a highly potent , orally bioavailable and gene-selective inhibitor , chemical .	T2	T15	23291630
CPR:4	CHEMICAL	GENE-Y	19	16	Here we report the re-engineering of chemical to create a highly potent , orally bioavailable and gene-selective inhibitor , chemical .	T3	T15	23291630
NA	CHEMICAL	GENE-N	2	9	Mutation of a single chemical residue in the potential gene increased the secretion efficiency of gene by threefold .	T1	T16	9607108
NA	CHEMICAL	GENE-Y	2	15	Mutation of a single chemical residue in the potential gene increased the secretion efficiency of gene by threefold .	T1	T17	9607108
NA	CHEMICAL	GENE-N	3	6	We propose that chemical binds the gene in the gene and provides the essential requirement for a stable interaction between the heavy and light chains .	T2	T24	9607108
NA	CHEMICAL	GENE-N	3	7	We propose that chemical binds the gene in the gene and provides the essential requirement for a stable interaction between the heavy and light chains .	T2	T25	9607108
NA	CHEMICAL	GENE-Y	10	1	The gene and gene interaction with gene occurs primarily through chemical-terminal linked oligosaccharides within the heavily glycosylated gene and this interaction appears to be required for gene secretion .	T4	T28	9607108
NA	CHEMICAL	GENE-Y	10	3	The gene and gene interaction with gene occurs primarily through chemical-terminal linked oligosaccharides within the heavily glycosylated gene and this interaction appears to be required for gene secretion .	T4	T29	9607108
NA	CHEMICAL	GENE-Y	10	6	The gene and gene interaction with gene occurs primarily through chemical-terminal linked oligosaccharides within the heavily glycosylated gene and this interaction appears to be required for gene secretion .	T4	T30	9607108
NA	CHEMICAL	GENE-N	10	17	The gene and gene interaction with gene occurs primarily through chemical-terminal linked oligosaccharides within the heavily glycosylated gene and this interaction appears to be required for gene secretion .	T4	T31	9607108
NA	CHEMICAL	GENE-Y	10	26	The gene and gene interaction with gene occurs primarily through chemical-terminal linked oligosaccharides within the heavily glycosylated gene and this interaction appears to be required for gene secretion .	T4	T32	9607108
NA	CHEMICAL	GENE-Y	15	15	In this study , we performed live imaging analyses of Neuro-2a cells expressing SCAT3 , a gene cleavage peptide sequence linking two fluorescent proteins ; enhanced cyan fluorescence protein ( ECFP ) and Venus , to determine whether chemical ( chemical ; 0 , 1 , 5 , or 10 μM ) affects both neurite outgrowth and/or induces apoptosis with the same doses and in the same cell cultures .	T7	T19	23022324
NA	CHEMICAL	GENE-Y	15	15	In this study , we performed live imaging analyses of Neuro-2a cells expressing SCAT3 , a gene cleavage peptide sequence linking two fluorescent proteins ; enhanced cyan fluorescence protein ( ECFP ) and Venus , to determine whether chemical ( chemical ; 0 , 1 , 5 , or 10 μM ) affects both neurite outgrowth and/or induces apoptosis with the same doses and in the same cell cultures .	T8	T19	23022324
NA	CHEMICAL	GENE-Y	22	42	We observed that the area ratio of neurite to cell body in SCAT3-expressing cells was significantly reduced by 5 and 10 μM chemical , but not by 1 μM , although the emission ratio of ECFP to Venus , an endpoint of gene activity , was not changed .	T9	T20	23022324
CPR:3	CHEMICAL	GENE-N	0	5	chemical increased the mRNA levels of the gene and decreased the mRNA levels of gene and gene in a dose-dependent manner ; no significant effect was found in the mRNA levels of the gene , gene , or gene .	T5	T13	23022324
CPR:4	CHEMICAL	GENE-Y	0	14	chemical increased the mRNA levels of the gene and decreased the mRNA levels of gene and gene in a dose-dependent manner ; no significant effect was found in the mRNA levels of the gene , gene , or gene .	T5	T14	23022324
CPR:4	CHEMICAL	GENE-N	0	16	chemical increased the mRNA levels of the gene and decreased the mRNA levels of gene and gene in a dose-dependent manner ; no significant effect was found in the mRNA levels of the gene , gene , or gene .	T5	T15	23022324
NA	CHEMICAL	GENE-Y	0	5	chemical increased the mRNA levels of the gene and decreased the mRNA levels of gene and gene in a dose-dependent manner ; no significant effect was found in the mRNA levels of the gene , gene , or gene .	T5	T16	23022324
NA	CHEMICAL	GENE-Y	0	35	chemical increased the mRNA levels of the gene and decreased the mRNA levels of gene and gene in a dose-dependent manner ; no significant effect was found in the mRNA levels of the gene , gene , or gene .	T5	T17	23022324
NA	CHEMICAL	GENE-N	0	17	chemical increased the mRNA levels of the gene and decreased the mRNA levels of gene and gene in a dose-dependent manner ; no significant effect was found in the mRNA levels of the gene , gene , or gene .	T5	T18	23022324
NA	CHEMICAL	GENE-Y	3	10	Effects of some chemical compounds on the reactivatability of chemical-inhibited gene in vitro .	T24	T35	3345199
CPR:4	CHEMICAL	GENE-Y	9	10	Effects of some chemical compounds on the reactivatability of chemical-inhibited gene in vitro .	T25	T35	3345199
CPR:4	CHEMICAL	GENE-Y	7	0	gene ( gene ) inhibited by the chemical chemical ( chemical ) rapidly becomes resistant to reactivation by chemical due to dealkylation of the chemical-enzyme complex .	T16	T26	3345199
CPR:4	CHEMICAL	GENE-Y	7	2	gene ( gene ) inhibited by the chemical chemical ( chemical ) rapidly becomes resistant to reactivation by chemical due to dealkylation of the chemical-enzyme complex .	T16	T32	3345199
CPR:4	CHEMICAL	GENE-Y	8	0	gene ( gene ) inhibited by the chemical chemical ( chemical ) rapidly becomes resistant to reactivation by chemical due to dealkylation of the chemical-enzyme complex .	T17	T26	3345199
CPR:4	CHEMICAL	GENE-Y	8	2	gene ( gene ) inhibited by the chemical chemical ( chemical ) rapidly becomes resistant to reactivation by chemical due to dealkylation of the chemical-enzyme complex .	T17	T32	3345199
CPR:4	CHEMICAL	GENE-Y	10	0	gene ( gene ) inhibited by the chemical chemical ( chemical ) rapidly becomes resistant to reactivation by chemical due to dealkylation of the chemical-enzyme complex .	T18	T26	3345199
CPR:4	CHEMICAL	GENE-Y	10	2	gene ( gene ) inhibited by the chemical chemical ( chemical ) rapidly becomes resistant to reactivation by chemical due to dealkylation of the chemical-enzyme complex .	T18	T32	3345199
CPR:3	CHEMICAL	GENE-Y	18	0	gene ( gene ) inhibited by the chemical chemical ( chemical ) rapidly becomes resistant to reactivation by chemical due to dealkylation of the chemical-enzyme complex .	T6	T26	3345199
CPR:3	CHEMICAL	GENE-Y	18	2	gene ( gene ) inhibited by the chemical chemical ( chemical ) rapidly becomes resistant to reactivation by chemical due to dealkylation of the chemical-enzyme complex .	T6	T32	3345199
NA	CHEMICAL	GENE-Y	24	0	gene ( gene ) inhibited by the chemical chemical ( chemical ) rapidly becomes resistant to reactivation by chemical due to dealkylation of the chemical-enzyme complex .	T8	T26	3345199
NA	CHEMICAL	GENE-Y	24	2	gene ( gene ) inhibited by the chemical chemical ( chemical ) rapidly becomes resistant to reactivation by chemical due to dealkylation of the chemical-enzyme complex .	T8	T32	3345199
NA	CHEMICAL	GENE-Y	5	24	The effect of the four chemical compounds chemical ( chemical ) , chemical , chemical and chemical on the reactivatability of chemical-inhibited , solubilized gene from human erythrocytes was investigated in vitro .	T9	T33	3345199
NA	CHEMICAL	GENE-Y	7	24	The effect of the four chemical compounds chemical ( chemical ) , chemical , chemical and chemical on the reactivatability of chemical-inhibited , solubilized gene from human erythrocytes was investigated in vitro .	T10	T33	3345199
NA	CHEMICAL	GENE-Y	9	24	The effect of the four chemical compounds chemical ( chemical ) , chemical , chemical and chemical on the reactivatability of chemical-inhibited , solubilized gene from human erythrocytes was investigated in vitro .	T11	T33	3345199
NA	CHEMICAL	GENE-Y	12	24	The effect of the four chemical compounds chemical ( chemical ) , chemical , chemical and chemical on the reactivatability of chemical-inhibited , solubilized gene from human erythrocytes was investigated in vitro .	T12	T33	3345199
NA	CHEMICAL	GENE-Y	14	24	The effect of the four chemical compounds chemical ( chemical ) , chemical , chemical and chemical on the reactivatability of chemical-inhibited , solubilized gene from human erythrocytes was investigated in vitro .	T13	T33	3345199
NA	CHEMICAL	GENE-Y	16	24	The effect of the four chemical compounds chemical ( chemical ) , chemical , chemical and chemical on the reactivatability of chemical-inhibited , solubilized gene from human erythrocytes was investigated in vitro .	T14	T33	3345199
CPR:4	CHEMICAL	GENE-Y	21	24	The effect of the four chemical compounds chemical ( chemical ) , chemical , chemical and chemical on the reactivatability of chemical-inhibited , solubilized gene from human erythrocytes was investigated in vitro .	T15	T33	3345199
NA	CHEMICAL	GENE-Y	6	40	The reactivation experiments were performed in a four-step procedure ( chemical-inhibition at 0 degree and pH 10 , aging at 37 degrees and pH 7.3 , reactivation by the chemical HI 6 at 37 degrees and pH 7.3 followed by gene assay ) .	T23	T27	3345199
NA	CHEMICAL	GENE-Y	29	40	The reactivation experiments were performed in a four-step procedure ( chemical-inhibition at 0 degree and pH 10 , aging at 37 degrees and pH 7.3 , reactivation by the chemical HI 6 at 37 degrees and pH 7.3 followed by gene assay ) .	T1	T27	3345199
CPR:4	CHEMICAL	GENE-Y	15	16	If the effectors were added after 5 min of aging they increased the activity of chemical-inhibited gene , but to a considerably smaller extent than HI 6 .	T7	T30	3345199
CPR:6	CHEMICAL	GENE-N	8	17	However , recent clinical studies have shown that a single low-dose injection of chemical , an chemical receptor ( gene ) antagonist , has rapid antidepressant effects that are observed within hours and are long lasting .	T8	T20	23337256
CPR:6	CHEMICAL	GENE-N	8	19	However , recent clinical studies have shown that a single low-dose injection of chemical , an chemical receptor ( gene ) antagonist , has rapid antidepressant effects that are observed within hours and are long lasting .	T8	T21	23337256
NA	CHEMICAL	GENE-N	8	17	However , recent clinical studies have shown that a single low-dose injection of chemical , an chemical receptor ( gene ) antagonist , has rapid antidepressant effects that are observed within hours and are long lasting .	T9	T20	23337256
NA	CHEMICAL	GENE-N	8	19	However , recent clinical studies have shown that a single low-dose injection of chemical , an chemical receptor ( gene ) antagonist , has rapid antidepressant effects that are observed within hours and are long lasting .	T9	T21	23337256
NA	CHEMICAL	GENE-Y	9	5	In preclinical studies , the gene ( gene ) in the medial prefrontal cortex and the gene ( gene ) in the hippocampus have been proposed as critical mediators of chemical 's rapid antidepressant actions .	T5	T14	23337256
NA	CHEMICAL	GENE-Y	9	7	In preclinical studies , the gene ( gene ) in the medial prefrontal cortex and the gene ( gene ) in the hippocampus have been proposed as critical mediators of chemical 's rapid antidepressant actions .	T5	T15	23337256
NA	CHEMICAL	GENE-N	9	16	In preclinical studies , the gene ( gene ) in the medial prefrontal cortex and the gene ( gene ) in the hippocampus have been proposed as critical mediators of chemical 's rapid antidepressant actions .	T5	T16	23337256
NA	CHEMICAL	GENE-Y	9	18	In preclinical studies , the gene ( gene ) in the medial prefrontal cortex and the gene ( gene ) in the hippocampus have been proposed as critical mediators of chemical 's rapid antidepressant actions .	T5	T17	23337256
NA	CHEMICAL	GENE-Y	9	5	In preclinical studies , the gene ( gene ) in the medial prefrontal cortex and the gene ( gene ) in the hippocampus have been proposed as critical mediators of chemical 's rapid antidepressant actions .	T6	T14	23337256
NA	CHEMICAL	GENE-Y	9	7	In preclinical studies , the gene ( gene ) in the medial prefrontal cortex and the gene ( gene ) in the hippocampus have been proposed as critical mediators of chemical 's rapid antidepressant actions .	T6	T15	23337256
NA	CHEMICAL	GENE-N	9	16	In preclinical studies , the gene ( gene ) in the medial prefrontal cortex and the gene ( gene ) in the hippocampus have been proposed as critical mediators of chemical 's rapid antidepressant actions .	T6	T16	23337256
NA	CHEMICAL	GENE-Y	9	18	In preclinical studies , the gene ( gene ) in the medial prefrontal cortex and the gene ( gene ) in the hippocampus have been proposed as critical mediators of chemical 's rapid antidepressant actions .	T6	T17	23337256
NA	CHEMICAL	GENE-Y	7	18	This study also investigated the effect of chemical on cortical and hippocampal monoaminergic neurotransmitters ' levels together with gene enzyme ( gene ) activity , both of which are known to be important in control of cognitive function .	T1	T19	12957216
NA	CHEMICAL	GENE-Y	7	21	This study also investigated the effect of chemical on cortical and hippocampal monoaminergic neurotransmitters ' levels together with gene enzyme ( gene ) activity , both of which are known to be important in control of cognitive function .	T1	T20	12957216
NA	CHEMICAL	GENE-Y	2	8	neither affected chemical ( chemical ) level nor gene activity in rat cortex and hippocampus .	T3	T21	12957216
NA	CHEMICAL	GENE-Y	4	8	neither affected chemical ( chemical ) level nor gene activity in rat cortex and hippocampus .	T4	T21	12957216
NA	CHEMICAL	GENE-N	13	19	Using electrophysiologic techniques , the present study assessed the in vivo action of chemical on chemical ( chemical ) receptor subtypes gene , gene , and gene ; chemical ( chemical ) D2 autoreceptors , and gene .	T13	T38	25225185
NA	CHEMICAL	GENE-Y	13	21	Using electrophysiologic techniques , the present study assessed the in vivo action of chemical on chemical ( chemical ) receptor subtypes gene , gene , and gene ; chemical ( chemical ) D2 autoreceptors , and gene .	T13	T39	25225185
NA	CHEMICAL	GENE-Y	13	23	Using electrophysiologic techniques , the present study assessed the in vivo action of chemical on chemical ( chemical ) receptor subtypes gene , gene , and gene ; chemical ( chemical ) D2 autoreceptors , and gene .	T13	T40	25225185
NA	CHEMICAL	GENE-Y	13	26	Using electrophysiologic techniques , the present study assessed the in vivo action of chemical on chemical ( chemical ) receptor subtypes gene , gene , and gene ; chemical ( chemical ) D2 autoreceptors , and gene .	T13	T41	25225185
NA	CHEMICAL	GENE-Y	13	19	Using electrophysiologic techniques , the present study assessed the in vivo action of chemical on chemical ( chemical ) receptor subtypes gene , gene , and gene ; chemical ( chemical ) D2 autoreceptors , and gene .	T13	T42	25225185
NA	CHEMICAL	GENE-N	13	19	Using electrophysiologic techniques , the present study assessed the in vivo action of chemical on chemical ( chemical ) receptor subtypes gene , gene , and gene ; chemical ( chemical ) D2 autoreceptors , and gene .	T13	T43	25225185
NA	CHEMICAL	GENE-N	9	19	Using electrophysiologic techniques , the present study assessed the in vivo action of chemical on chemical ( chemical ) receptor subtypes gene , gene , and gene ; chemical ( chemical ) D2 autoreceptors , and gene .	T14	T38	25225185
NA	CHEMICAL	GENE-Y	9	21	Using electrophysiologic techniques , the present study assessed the in vivo action of chemical on chemical ( chemical ) receptor subtypes gene , gene , and gene ; chemical ( chemical ) D2 autoreceptors , and gene .	T14	T39	25225185
NA	CHEMICAL	GENE-Y	9	23	Using electrophysiologic techniques , the present study assessed the in vivo action of chemical on chemical ( chemical ) receptor subtypes gene , gene , and gene ; chemical ( chemical ) D2 autoreceptors , and gene .	T14	T40	25225185
NA	CHEMICAL	GENE-Y	9	26	Using electrophysiologic techniques , the present study assessed the in vivo action of chemical on chemical ( chemical ) receptor subtypes gene , gene , and gene ; chemical ( chemical ) D2 autoreceptors , and gene .	T14	T41	25225185
NA	CHEMICAL	GENE-Y	9	19	Using electrophysiologic techniques , the present study assessed the in vivo action of chemical on chemical ( chemical ) receptor subtypes gene , gene , and gene ; chemical ( chemical ) D2 autoreceptors , and gene .	T14	T42	25225185
NA	CHEMICAL	GENE-N	9	19	Using electrophysiologic techniques , the present study assessed the in vivo action of chemical on chemical ( chemical ) receptor subtypes gene , gene , and gene ; chemical ( chemical ) D2 autoreceptors , and gene .	T14	T43	25225185
NA	CHEMICAL	GENE-N	17	19	Using electrophysiologic techniques , the present study assessed the in vivo action of chemical on chemical ( chemical ) receptor subtypes gene , gene , and gene ; chemical ( chemical ) D2 autoreceptors , and gene .	T15	T38	25225185
NA	CHEMICAL	GENE-Y	17	21	Using electrophysiologic techniques , the present study assessed the in vivo action of chemical on chemical ( chemical ) receptor subtypes gene , gene , and gene ; chemical ( chemical ) D2 autoreceptors , and gene .	T15	T39	25225185
NA	CHEMICAL	GENE-Y	17	23	Using electrophysiologic techniques , the present study assessed the in vivo action of chemical on chemical ( chemical ) receptor subtypes gene , gene , and gene ; chemical ( chemical ) D2 autoreceptors , and gene .	T15	T40	25225185
NA	CHEMICAL	GENE-Y	17	26	Using electrophysiologic techniques , the present study assessed the in vivo action of chemical on chemical ( chemical ) receptor subtypes gene , gene , and gene ; chemical ( chemical ) D2 autoreceptors , and gene .	T15	T41	25225185
NA	CHEMICAL	GENE-Y	17	19	Using electrophysiologic techniques , the present study assessed the in vivo action of chemical on chemical ( chemical ) receptor subtypes gene , gene , and gene ; chemical ( chemical ) D2 autoreceptors , and gene .	T15	T42	25225185
NA	CHEMICAL	GENE-N	17	19	Using electrophysiologic techniques , the present study assessed the in vivo action of chemical on chemical ( chemical ) receptor subtypes gene , gene , and gene ; chemical ( chemical ) D2 autoreceptors , and gene .	T15	T43	25225185
NA	CHEMICAL	GENE-N	9	19	Using electrophysiologic techniques , the present study assessed the in vivo action of chemical on chemical ( chemical ) receptor subtypes gene , gene , and gene ; chemical ( chemical ) D2 autoreceptors , and gene .	T16	T38	25225185
NA	CHEMICAL	GENE-Y	9	21	Using electrophysiologic techniques , the present study assessed the in vivo action of chemical on chemical ( chemical ) receptor subtypes gene , gene , and gene ; chemical ( chemical ) D2 autoreceptors , and gene .	T16	T39	25225185
NA	CHEMICAL	GENE-Y	9	23	Using electrophysiologic techniques , the present study assessed the in vivo action of chemical on chemical ( chemical ) receptor subtypes gene , gene , and gene ; chemical ( chemical ) D2 autoreceptors , and gene .	T16	T40	25225185
NA	CHEMICAL	GENE-Y	9	26	Using electrophysiologic techniques , the present study assessed the in vivo action of chemical on chemical ( chemical ) receptor subtypes gene , gene , and gene ; chemical ( chemical ) D2 autoreceptors , and gene .	T16	T41	25225185
NA	CHEMICAL	GENE-Y	9	19	Using electrophysiologic techniques , the present study assessed the in vivo action of chemical on chemical ( chemical ) receptor subtypes gene , gene , and gene ; chemical ( chemical ) D2 autoreceptors , and gene .	T16	T42	25225185
NA	CHEMICAL	GENE-N	9	19	Using electrophysiologic techniques , the present study assessed the in vivo action of chemical on chemical ( chemical ) receptor subtypes gene , gene , and gene ; chemical ( chemical ) D2 autoreceptors , and gene .	T16	T43	25225185
NA	CHEMICAL	GENE-N	30	19	Using electrophysiologic techniques , the present study assessed the in vivo action of chemical on chemical ( chemical ) receptor subtypes gene , gene , and gene ; chemical ( chemical ) D2 autoreceptors , and gene .	T17	T38	25225185
NA	CHEMICAL	GENE-Y	30	21	Using electrophysiologic techniques , the present study assessed the in vivo action of chemical on chemical ( chemical ) receptor subtypes gene , gene , and gene ; chemical ( chemical ) D2 autoreceptors , and gene .	T17	T39	25225185
NA	CHEMICAL	GENE-Y	30	23	Using electrophysiologic techniques , the present study assessed the in vivo action of chemical on chemical ( chemical ) receptor subtypes gene , gene , and gene ; chemical ( chemical ) D2 autoreceptors , and gene .	T17	T40	25225185
NA	CHEMICAL	GENE-Y	30	26	Using electrophysiologic techniques , the present study assessed the in vivo action of chemical on chemical ( chemical ) receptor subtypes gene , gene , and gene ; chemical ( chemical ) D2 autoreceptors , and gene .	T17	T41	25225185
NA	CHEMICAL	GENE-Y	30	19	Using electrophysiologic techniques , the present study assessed the in vivo action of chemical on chemical ( chemical ) receptor subtypes gene , gene , and gene ; chemical ( chemical ) D2 autoreceptors , and gene .	T17	T42	25225185
NA	CHEMICAL	GENE-N	30	19	Using electrophysiologic techniques , the present study assessed the in vivo action of chemical on chemical ( chemical ) receptor subtypes gene , gene , and gene ; chemical ( chemical ) D2 autoreceptors , and gene .	T17	T43	25225185
NA	CHEMICAL	GENE-Y	31	6	In addition , the effects on gene autoreceptors in the dorsal raphe nucleus ( DRN ) and gene in the ventral tegmental area ( VTA ) were compared with those of chemical , an agent in wide clinical use .	T18	T44	25225185
NA	CHEMICAL	GENE-Y	31	7	In addition , the effects on gene autoreceptors in the dorsal raphe nucleus ( DRN ) and gene in the ventral tegmental area ( VTA ) were compared with those of chemical , an agent in wide clinical use .	T18	T45	25225185
CPR:5	CHEMICAL	GENE-Y	4	13	In the DRN , chemical completely inhibited the firing of chemical neurons via gene agonism and was more potent than chemical ( ED50 = 230 and 700 mug/kg , respectively ) .	T19	T46	25225185
NA	CHEMICAL	GENE-Y	10	13	In the DRN , chemical completely inhibited the firing of chemical neurons via gene agonism and was more potent than chemical ( ED50 = 230 and 700 mug/kg , respectively ) .	T20	T46	25225185
CPR:5	CHEMICAL	GENE-Y	20	13	In the DRN , chemical completely inhibited the firing of chemical neurons via gene agonism and was more potent than chemical ( ED50 = 230 and 700 mug/kg , respectively ) .	T21	T46	25225185
NA	CHEMICAL	GENE-Y	5	13	In the locus coeruleus , chemical reversed the inhibitory effect of the preferential gene receptor agonist chemical ( chemical ) on chemical neuronal firing ( ED50 = 110 mug/kg ) , demonstrating gene antagonistic action .	T23	T47	25225185
NA	CHEMICAL	GENE-Y	5	32	In the locus coeruleus , chemical reversed the inhibitory effect of the preferential gene receptor agonist chemical ( chemical ) on chemical neuronal firing ( ED50 = 110 mug/kg ) , demonstrating gene antagonistic action .	T23	T31	25225185
CPR:5	CHEMICAL	GENE-Y	16	13	In the locus coeruleus , chemical reversed the inhibitory effect of the preferential gene receptor agonist chemical ( chemical ) on chemical neuronal firing ( ED50 = 110 mug/kg ) , demonstrating gene antagonistic action .	T24	T47	25225185
NA	CHEMICAL	GENE-Y	16	32	In the locus coeruleus , chemical reversed the inhibitory effect of the preferential gene receptor agonist chemical ( chemical ) on chemical neuronal firing ( ED50 = 110 mug/kg ) , demonstrating gene antagonistic action .	T24	T31	25225185
CPR:5	CHEMICAL	GENE-Y	4	13	In the locus coeruleus , chemical reversed the inhibitory effect of the preferential gene receptor agonist chemical ( chemical ) on chemical neuronal firing ( ED50 = 110 mug/kg ) , demonstrating gene antagonistic action .	T25	T47	25225185
NA	CHEMICAL	GENE-Y	4	32	In the locus coeruleus , chemical reversed the inhibitory effect of the preferential gene receptor agonist chemical ( chemical ) on chemical neuronal firing ( ED50 = 110 mug/kg ) , demonstrating gene antagonistic action .	T25	T31	25225185
NA	CHEMICAL	GENE-Y	21	13	In the locus coeruleus , chemical reversed the inhibitory effect of the preferential gene receptor agonist chemical ( chemical ) on chemical neuronal firing ( ED50 = 110 mug/kg ) , demonstrating gene antagonistic action .	T26	T47	25225185
NA	CHEMICAL	GENE-Y	21	32	In the locus coeruleus , chemical reversed the inhibitory effect of the preferential gene receptor agonist chemical ( chemical ) on chemical neuronal firing ( ED50 = 110 mug/kg ) , demonstrating gene antagonistic action .	T26	T31	25225185
NA	CHEMICAL	GENE-Y	0	34	chemical reversed the inhibitory effect of the chemical agonist chemical on VTA DA neurons ( ED50 = 61 mug/kg ) , whereas it was ineffective when administered alone , indicating partial agonistic action on gene .	T2	T32	25225185
NA	CHEMICAL	GENE-Y	7	34	chemical reversed the inhibitory effect of the chemical agonist chemical on VTA DA neurons ( ED50 = 61 mug/kg ) , whereas it was ineffective when administered alone , indicating partial agonistic action on gene .	T3	T32	25225185
CPR:5	CHEMICAL	GENE-Y	9	34	chemical reversed the inhibitory effect of the chemical agonist chemical on VTA DA neurons ( ED50 = 61 mug/kg ) , whereas it was ineffective when administered alone , indicating partial agonistic action on gene .	T4	T32	25225185
NA	CHEMICAL	GENE-Y	2	20	Compared with chemical , which significantly inhibited the firing activity of VTA chemical neurons , chemical displayed less efficacy at gene .	T5	T33	25225185
NA	CHEMICAL	GENE-Y	12	20	Compared with chemical , which significantly inhibited the firing activity of VTA chemical neurons , chemical displayed less efficacy at gene .	T6	T33	25225185
CPR:4	CHEMICAL	GENE-Y	15	20	Compared with chemical , which significantly inhibited the firing activity of VTA chemical neurons , chemical displayed less efficacy at gene .	T7	T33	25225185
CPR:5	CHEMICAL	GENE-Y	4	11	In the hippocampus , chemical acted as a full agonist at gene receptors on pyramidal neurons .	T8	T34	25225185
NA	CHEMICAL	GENE-N	4	8	Furthermore , it increased chemical release by terminal gene but not gene autoreceptor antagonism .	T9	T35	25225185
NA	CHEMICAL	GENE-Y	4	11	Furthermore , it increased chemical release by terminal gene but not gene autoreceptor antagonism .	T9	T36	25225185
CPR:6	CHEMICAL	GENE-Y	6	8	In the lateral geniculate nucleus , chemical displayed gene antagonistic action .	T10	T37	25225185
NA	CHEMICAL	GENE-Y	5	9	We evaluated the effects of chemical and an chemical-converting enzyme inhibitor ( chemical ) on nerve blood flow ( NBF ) and electrophysiology in control and diabetic rats .	T6	T23	10398211
NA	CHEMICAL	GENE-Y	7	9	We evaluated the effects of chemical and an chemical-converting enzyme inhibitor ( chemical ) on nerve blood flow ( NBF ) and electrophysiology in control and diabetic rats .	T9	T23	10398211
CPR:4	CHEMICAL	GENE-Y	12	9	We evaluated the effects of chemical and an chemical-converting enzyme inhibitor ( chemical ) on nerve blood flow ( NBF ) and electrophysiology in control and diabetic rats .	T12	T23	10398211
NA	CHEMICAL	GENE-N	4	5	We topically applied the chemical synthase ( gene ) inhibitor , chemical , on sciatic nerve and observed reduced inhibition of NBF in EDN , which was correctable with a chemical diet .	T13	T24	10398211
NA	CHEMICAL	GENE-N	4	7	We topically applied the chemical synthase ( gene ) inhibitor , chemical , on sciatic nerve and observed reduced inhibition of NBF in EDN , which was correctable with a chemical diet .	T13	T16	10398211
CPR:4	CHEMICAL	GENE-N	4	5	We topically applied the chemical synthase ( gene ) inhibitor , chemical , on sciatic nerve and observed reduced inhibition of NBF in EDN , which was correctable with a chemical diet .	T1	T24	10398211
CPR:4	CHEMICAL	GENE-N	4	7	We topically applied the chemical synthase ( gene ) inhibitor , chemical , on sciatic nerve and observed reduced inhibition of NBF in EDN , which was correctable with a chemical diet .	T1	T16	10398211
NA	CHEMICAL	GENE-N	29	5	We topically applied the chemical synthase ( gene ) inhibitor , chemical , on sciatic nerve and observed reduced inhibition of NBF in EDN , which was correctable with a chemical diet .	T2	T24	10398211
NA	CHEMICAL	GENE-N	29	7	We topically applied the chemical synthase ( gene ) inhibitor , chemical , on sciatic nerve and observed reduced inhibition of NBF in EDN , which was correctable with a chemical diet .	T2	T16	10398211
NA	CHEMICAL	GENE-Y	0	1	chemical receptor induces gene expression through gene favoring gene elongation .	T4	T28	23640331
NA	CHEMICAL	GENE-Y	0	3	chemical receptor induces gene expression through gene favoring gene elongation .	T4	T29	23640331
NA	CHEMICAL	GENE-N	0	6	chemical receptor induces gene expression through gene favoring gene elongation .	T4	T30	23640331
NA	CHEMICAL	GENE-N	0	8	chemical receptor induces gene expression through gene favoring gene elongation .	T4	T31	23640331
NA	CHEMICAL	GENE-N	0	1	chemical receptors were classically described for regulating transcription by binding to target gene promoters .	T1	T5	23640331
NA	CHEMICAL	GENE-N	6	8	However , genome-wide studies reveal that chemical receptors-binding sites are mainly located at intragenic regions .	T2	T9	23640331
NA	CHEMICAL	GENE-Y	14	19	To determine the role of these sites , we examined the effect of progestins on the transcription of the gene gene , where only gene ( gene ) were identified .	T3	T10	23640331
NA	CHEMICAL	GENE-N	14	6	To determine the role of these sites , we examined the effect of progestins on the transcription of the gene gene , where only gene ( gene ) were identified .	T3	T11	23640331
NA	CHEMICAL	GENE-N	14	26	To determine the role of these sites , we examined the effect of progestins on the transcription of the gene gene , where only gene ( gene ) were identified .	T3	T12	23640331
CPR:4	CHEMICAL	GENE-Y	4	7	Identification and synthesis of chemical derivatives as gene ( gene ) inhibitors .	T2	T11	23489628
CPR:4	CHEMICAL	GENE-N	4	9	Identification and synthesis of chemical derivatives as gene ( gene ) inhibitors .	T2	T12	23489628
CPR:4	CHEMICAL	GENE-Y	13	20	In this study , we employed virtual screening and chemical synthesis to identify a series of chemical derivatives as potent gene ( gene ) inhibitors .	T1	T5	23489628
CPR:4	CHEMICAL	GENE-N	13	22	In this study , we employed virtual screening and chemical synthesis to identify a series of chemical derivatives as potent gene ( gene ) inhibitors .	T1	T6	23489628
NA	CHEMICAL	GENE-Y	9	21	A similar signature is associated with the persistence of chemical ( chemical ) in DNA , and it also depends on gene activity .	T1	T11	23305949
NA	CHEMICAL	GENE-Y	11	21	A similar signature is associated with the persistence of chemical ( chemical ) in DNA , and it also depends on gene activity .	T2	T11	23305949
NA	CHEMICAL	GENE-Y	21	9	There is only partial overlap , however , between gene-dependent deletion hotspots identified in highly transcribed DNA and those associated with chemical , suggesting the existence of both chemical-dependent and chemical-independent events .	T3	T12	23305949
NA	CHEMICAL	GENE-Y	28	9	There is only partial overlap , however , between gene-dependent deletion hotspots identified in highly transcribed DNA and those associated with chemical , suggesting the existence of both chemical-dependent and chemical-independent events .	T4	T12	23305949
NA	CHEMICAL	GENE-Y	30	9	There is only partial overlap , however , between gene-dependent deletion hotspots identified in highly transcribed DNA and those associated with chemical , suggesting the existence of both chemical-dependent and chemical-independent events .	T5	T12	23305949
CPR:4	CHEMICAL	GENE-N	2	4	Effects of chemical ( a chemical chemical channel blocker ) and analogues on gene .	T40	T77	2833901
NA	CHEMICAL	GENE-N	2	13	Effects of chemical ( a chemical chemical channel blocker ) and analogues on gene .	T40	T78	2833901
CPR:4	CHEMICAL	GENE-N	5	4	Effects of chemical ( a chemical chemical channel blocker ) and analogues on gene .	T41	T77	2833901
NA	CHEMICAL	GENE-N	5	13	Effects of chemical ( a chemical chemical channel blocker ) and analogues on gene .	T41	T78	2833901
NA	CHEMICAL	GENE-N	4	4	Effects of chemical ( a chemical chemical channel blocker ) and analogues on gene .	T42	T77	2833901
NA	CHEMICAL	GENE-N	4	13	Effects of chemical ( a chemical chemical channel blocker ) and analogues on gene .	T42	T78	2833901
NA	CHEMICAL	GENE-N	12	10	We have examined the effects on the activities of three gene ( chemical phosphodiesterase , gene and gene ) of the chemical chemical channel blocker chemical and three analogues ( chemical , oxidized and chemical ) exhibiting different pharmacological potencies .	T36	T69	2833901
NA	CHEMICAL	GENE-N	12	13	We have examined the effects on the activities of three gene ( chemical phosphodiesterase , gene and gene ) of the chemical chemical channel blocker chemical and three analogues ( chemical , oxidized and chemical ) exhibiting different pharmacological potencies .	T36	T74	2833901
NA	CHEMICAL	GENE-N	12	15	We have examined the effects on the activities of three gene ( chemical phosphodiesterase , gene and gene ) of the chemical chemical channel blocker chemical and three analogues ( chemical , oxidized and chemical ) exhibiting different pharmacological potencies .	T36	T45	2833901
NA	CHEMICAL	GENE-Y	12	17	We have examined the effects on the activities of three gene ( chemical phosphodiesterase , gene and gene ) of the chemical chemical channel blocker chemical and three analogues ( chemical , oxidized and chemical ) exhibiting different pharmacological potencies .	T36	T47	2833901
NA	CHEMICAL	GENE-N	12	23	We have examined the effects on the activities of three gene ( chemical phosphodiesterase , gene and gene ) of the chemical chemical channel blocker chemical and three analogues ( chemical , oxidized and chemical ) exhibiting different pharmacological potencies .	T36	T56	2833901
NA	CHEMICAL	GENE-N	21	10	We have examined the effects on the activities of three gene ( chemical phosphodiesterase , gene and gene ) of the chemical chemical channel blocker chemical and three analogues ( chemical , oxidized and chemical ) exhibiting different pharmacological potencies .	T7	T69	2833901
NA	CHEMICAL	GENE-N	21	13	We have examined the effects on the activities of three gene ( chemical phosphodiesterase , gene and gene ) of the chemical chemical channel blocker chemical and three analogues ( chemical , oxidized and chemical ) exhibiting different pharmacological potencies .	T7	T74	2833901
NA	CHEMICAL	GENE-N	21	15	We have examined the effects on the activities of three gene ( chemical phosphodiesterase , gene and gene ) of the chemical chemical channel blocker chemical and three analogues ( chemical , oxidized and chemical ) exhibiting different pharmacological potencies .	T7	T45	2833901
NA	CHEMICAL	GENE-Y	21	17	We have examined the effects on the activities of three gene ( chemical phosphodiesterase , gene and gene ) of the chemical chemical channel blocker chemical and three analogues ( chemical , oxidized and chemical ) exhibiting different pharmacological potencies .	T7	T47	2833901
NA	CHEMICAL	GENE-N	21	23	We have examined the effects on the activities of three gene ( chemical phosphodiesterase , gene and gene ) of the chemical chemical channel blocker chemical and three analogues ( chemical , oxidized and chemical ) exhibiting different pharmacological potencies .	T7	T56	2833901
NA	CHEMICAL	GENE-N	22	10	We have examined the effects on the activities of three gene ( chemical phosphodiesterase , gene and gene ) of the chemical chemical channel blocker chemical and three analogues ( chemical , oxidized and chemical ) exhibiting different pharmacological potencies .	T11	T69	2833901
NA	CHEMICAL	GENE-N	22	13	We have examined the effects on the activities of three gene ( chemical phosphodiesterase , gene and gene ) of the chemical chemical channel blocker chemical and three analogues ( chemical , oxidized and chemical ) exhibiting different pharmacological potencies .	T11	T74	2833901
NA	CHEMICAL	GENE-N	22	15	We have examined the effects on the activities of three gene ( chemical phosphodiesterase , gene and gene ) of the chemical chemical channel blocker chemical and three analogues ( chemical , oxidized and chemical ) exhibiting different pharmacological potencies .	T11	T45	2833901
NA	CHEMICAL	GENE-Y	22	17	We have examined the effects on the activities of three gene ( chemical phosphodiesterase , gene and gene ) of the chemical chemical channel blocker chemical and three analogues ( chemical , oxidized and chemical ) exhibiting different pharmacological potencies .	T11	T47	2833901
NA	CHEMICAL	GENE-N	22	23	We have examined the effects on the activities of three gene ( chemical phosphodiesterase , gene and gene ) of the chemical chemical channel blocker chemical and three analogues ( chemical , oxidized and chemical ) exhibiting different pharmacological potencies .	T11	T56	2833901
NA	CHEMICAL	GENE-N	25	10	We have examined the effects on the activities of three gene ( chemical phosphodiesterase , gene and gene ) of the chemical chemical channel blocker chemical and three analogues ( chemical , oxidized and chemical ) exhibiting different pharmacological potencies .	T16	T69	2833901
NA	CHEMICAL	GENE-N	25	13	We have examined the effects on the activities of three gene ( chemical phosphodiesterase , gene and gene ) of the chemical chemical channel blocker chemical and three analogues ( chemical , oxidized and chemical ) exhibiting different pharmacological potencies .	T16	T74	2833901
NA	CHEMICAL	GENE-N	25	15	We have examined the effects on the activities of three gene ( chemical phosphodiesterase , gene and gene ) of the chemical chemical channel blocker chemical and three analogues ( chemical , oxidized and chemical ) exhibiting different pharmacological potencies .	T16	T45	2833901
NA	CHEMICAL	GENE-Y	25	17	We have examined the effects on the activities of three gene ( chemical phosphodiesterase , gene and gene ) of the chemical chemical channel blocker chemical and three analogues ( chemical , oxidized and chemical ) exhibiting different pharmacological potencies .	T16	T47	2833901
CPR:4	CHEMICAL	GENE-N	25	23	We have examined the effects on the activities of three gene ( chemical phosphodiesterase , gene and gene ) of the chemical chemical channel blocker chemical and three analogues ( chemical , oxidized and chemical ) exhibiting different pharmacological potencies .	T16	T56	2833901
NA	CHEMICAL	GENE-N	30	10	We have examined the effects on the activities of three gene ( chemical phosphodiesterase , gene and gene ) of the chemical chemical channel blocker chemical and three analogues ( chemical , oxidized and chemical ) exhibiting different pharmacological potencies .	T21	T69	2833901
NA	CHEMICAL	GENE-N	30	13	We have examined the effects on the activities of three gene ( chemical phosphodiesterase , gene and gene ) of the chemical chemical channel blocker chemical and three analogues ( chemical , oxidized and chemical ) exhibiting different pharmacological potencies .	T21	T74	2833901
NA	CHEMICAL	GENE-N	30	15	We have examined the effects on the activities of three gene ( chemical phosphodiesterase , gene and gene ) of the chemical chemical channel blocker chemical and three analogues ( chemical , oxidized and chemical ) exhibiting different pharmacological potencies .	T21	T45	2833901
NA	CHEMICAL	GENE-Y	30	17	We have examined the effects on the activities of three gene ( chemical phosphodiesterase , gene and gene ) of the chemical chemical channel blocker chemical and three analogues ( chemical , oxidized and chemical ) exhibiting different pharmacological potencies .	T21	T47	2833901
NA	CHEMICAL	GENE-N	30	23	We have examined the effects on the activities of three gene ( chemical phosphodiesterase , gene and gene ) of the chemical chemical channel blocker chemical and three analogues ( chemical , oxidized and chemical ) exhibiting different pharmacological potencies .	T21	T56	2833901
NA	CHEMICAL	GENE-N	34	10	We have examined the effects on the activities of three gene ( chemical phosphodiesterase , gene and gene ) of the chemical chemical channel blocker chemical and three analogues ( chemical , oxidized and chemical ) exhibiting different pharmacological potencies .	T23	T69	2833901
NA	CHEMICAL	GENE-N	34	13	We have examined the effects on the activities of three gene ( chemical phosphodiesterase , gene and gene ) of the chemical chemical channel blocker chemical and three analogues ( chemical , oxidized and chemical ) exhibiting different pharmacological potencies .	T23	T74	2833901
NA	CHEMICAL	GENE-N	34	15	We have examined the effects on the activities of three gene ( chemical phosphodiesterase , gene and gene ) of the chemical chemical channel blocker chemical and three analogues ( chemical , oxidized and chemical ) exhibiting different pharmacological potencies .	T23	T45	2833901
NA	CHEMICAL	GENE-Y	34	17	We have examined the effects on the activities of three gene ( chemical phosphodiesterase , gene and gene ) of the chemical chemical channel blocker chemical and three analogues ( chemical , oxidized and chemical ) exhibiting different pharmacological potencies .	T23	T47	2833901
NA	CHEMICAL	GENE-N	34	23	We have examined the effects on the activities of three gene ( chemical phosphodiesterase , gene and gene ) of the chemical chemical channel blocker chemical and three analogues ( chemical , oxidized and chemical ) exhibiting different pharmacological potencies .	T23	T56	2833901
NA	CHEMICAL	GENE-N	1	2	The chemical phosphodiesterase was inhibited completely by chemical and the chemical analogue with IC50 values of 3.7 and 1.5 microM respectively .	T24	T67	2833901
CPR:4	CHEMICAL	GENE-N	7	2	The chemical phosphodiesterase was inhibited completely by chemical and the chemical analogue with IC50 values of 3.7 and 1.5 microM respectively .	T25	T67	2833901
CPR:4	CHEMICAL	GENE-N	10	2	The chemical phosphodiesterase was inhibited completely by chemical and the chemical analogue with IC50 values of 3.7 and 1.5 microM respectively .	T26	T67	2833901
NA	CHEMICAL	GENE-N	3	11	The oxidized and chemical analogues were relatively ineffective in inhibiting chemical phosphodiesterase .	T27	T68	2833901
NA	CHEMICAL	GENE-N	10	11	The oxidized and chemical analogues were relatively ineffective in inhibiting chemical phosphodiesterase .	T28	T68	2833901
CPR:4	CHEMICAL	GENE-N	0	14	chemical and the chemical analogue inhibited the basal ( chemical/gene-independent ) activity of chemical phosphodiesterase as well as the calmodulin-stimulated activity .	T29	T70	2833901
CPR:4	CHEMICAL	GENE-Y	0	9	chemical and the chemical analogue inhibited the basal ( chemical/gene-independent ) activity of chemical phosphodiesterase as well as the calmodulin-stimulated activity .	T29	T71	2833901
CPR:4	CHEMICAL	GENE-N	3	14	chemical and the chemical analogue inhibited the basal ( chemical/gene-independent ) activity of chemical phosphodiesterase as well as the calmodulin-stimulated activity .	T30	T70	2833901
CPR:4	CHEMICAL	GENE-Y	3	9	chemical and the chemical analogue inhibited the basal ( chemical/gene-independent ) activity of chemical phosphodiesterase as well as the calmodulin-stimulated activity .	T30	T71	2833901
NA	CHEMICAL	GENE-N	9	14	chemical and the chemical analogue inhibited the basal ( chemical/gene-independent ) activity of chemical phosphodiesterase as well as the calmodulin-stimulated activity .	T31	T70	2833901
NA	CHEMICAL	GENE-Y	9	9	chemical and the chemical analogue inhibited the basal ( chemical/gene-independent ) activity of chemical phosphodiesterase as well as the calmodulin-stimulated activity .	T31	T71	2833901
NA	CHEMICAL	GENE-N	13	14	chemical and the chemical analogue inhibited the basal ( chemical/gene-independent ) activity of chemical phosphodiesterase as well as the calmodulin-stimulated activity .	T32	T70	2833901
NA	CHEMICAL	GENE-Y	13	9	chemical and the chemical analogue inhibited the basal ( chemical/gene-independent ) activity of chemical phosphodiesterase as well as the calmodulin-stimulated activity .	T32	T71	2833901
NA	CHEMICAL	GENE-Y	8	0	gene was relatively ineffective in preventing inhibition of chemical phosphodiesterase by chemical and the chemical analogue .	T33	T72	2833901
NA	CHEMICAL	GENE-N	8	9	gene was relatively ineffective in preventing inhibition of chemical phosphodiesterase by chemical and the chemical analogue .	T33	T73	2833901
NA	CHEMICAL	GENE-Y	4	0	gene was relatively ineffective in preventing inhibition of chemical phosphodiesterase by chemical and the chemical analogue .	T34	T72	2833901
CPR:4	CHEMICAL	GENE-N	4	9	gene was relatively ineffective in preventing inhibition of chemical phosphodiesterase by chemical and the chemical analogue .	T34	T73	2833901
NA	CHEMICAL	GENE-Y	14	0	gene was relatively ineffective in preventing inhibition of chemical phosphodiesterase by chemical and the chemical analogue .	T35	T72	2833901
CPR:4	CHEMICAL	GENE-N	14	9	gene was relatively ineffective in preventing inhibition of chemical phosphodiesterase by chemical and the chemical analogue .	T35	T73	2833901
NA	CHEMICAL	GENE-N	4	10	These observations suggest that chemical may act directly on the gene as well as through gene .	T37	T75	2833901
NA	CHEMICAL	GENE-Y	4	15	These observations suggest that chemical may act directly on the gene as well as through gene .	T37	T76	2833901
NA	CHEMICAL	GENE-Y	0	6	chemical and the chemical analogue inhibited chemical/gene-dependent gene with similar potencies ( IC50 = 17.4 microM ) , whereas the oxidized and chemical analogues caused no inhibition .	T38	T43	2833901
CPR:4	CHEMICAL	GENE-N	0	7	chemical and the chemical analogue inhibited chemical/gene-dependent gene with similar potencies ( IC50 = 17.4 microM ) , whereas the oxidized and chemical analogues caused no inhibition .	T38	T44	2833901
NA	CHEMICAL	GENE-Y	3	6	chemical and the chemical analogue inhibited chemical/gene-dependent gene with similar potencies ( IC50 = 17.4 microM ) , whereas the oxidized and chemical analogues caused no inhibition .	T39	T43	2833901
CPR:4	CHEMICAL	GENE-N	3	7	chemical and the chemical analogue inhibited chemical/gene-dependent gene with similar potencies ( IC50 = 17.4 microM ) , whereas the oxidized and chemical analogues caused no inhibition .	T39	T44	2833901
NA	CHEMICAL	GENE-Y	6	6	chemical and the chemical analogue inhibited chemical/gene-dependent gene with similar potencies ( IC50 = 17.4 microM ) , whereas the oxidized and chemical analogues caused no inhibition .	T1	T43	2833901
NA	CHEMICAL	GENE-N	6	7	chemical and the chemical analogue inhibited chemical/gene-dependent gene with similar potencies ( IC50 = 17.4 microM ) , whereas the oxidized and chemical analogues caused no inhibition .	T1	T44	2833901
NA	CHEMICAL	GENE-Y	22	6	chemical and the chemical analogue inhibited chemical/gene-dependent gene with similar potencies ( IC50 = 17.4 microM ) , whereas the oxidized and chemical analogues caused no inhibition .	T2	T43	2833901
NA	CHEMICAL	GENE-N	22	7	chemical and the chemical analogue inhibited chemical/gene-dependent gene with similar potencies ( IC50 = 17.4 microM ) , whereas the oxidized and chemical analogues caused no inhibition .	T2	T44	2833901
CPR:4	CHEMICAL	GENE-Y	2	8	Similarly , chemical and the chemical analogue inhibited gene activity whether the isolated 20 kD light chain ( IC50 = 12.6 microM ) or intact gene ( IC50 = 11.0 microM ) was used as substrate .	T3	T46	2833901
NA	CHEMICAL	GENE-N	2	25	Similarly , chemical and the chemical analogue inhibited gene activity whether the isolated 20 kD light chain ( IC50 = 12.6 microM ) or intact gene ( IC50 = 11.0 microM ) was used as substrate .	T3	T48	2833901
CPR:4	CHEMICAL	GENE-Y	5	8	Similarly , chemical and the chemical analogue inhibited gene activity whether the isolated 20 kD light chain ( IC50 = 12.6 microM ) or intact gene ( IC50 = 11.0 microM ) was used as substrate .	T4	T46	2833901
NA	CHEMICAL	GENE-N	5	25	Similarly , chemical and the chemical analogue inhibited gene activity whether the isolated 20 kD light chain ( IC50 = 12.6 microM ) or intact gene ( IC50 = 11.0 microM ) was used as substrate .	T4	T48	2833901
NA	CHEMICAL	GENE-N	5	17	Finally , the effects of chemical and the three analogues on two processes which are dependent on gene phosphorylation were examined , namely the gene-activated chemical-ATPase activity of gene and the assembly of gene filaments .	T6	T50	2833901
NA	CHEMICAL	GENE-N	5	24	Finally , the effects of chemical and the three analogues on two processes which are dependent on gene phosphorylation were examined , namely the gene-activated chemical-ATPase activity of gene and the assembly of gene filaments .	T6	T51	2833901
NA	CHEMICAL	GENE-N	5	28	Finally , the effects of chemical and the three analogues on two processes which are dependent on gene phosphorylation were examined , namely the gene-activated chemical-ATPase activity of gene and the assembly of gene filaments .	T6	T53	2833901
NA	CHEMICAL	GENE-N	5	33	Finally , the effects of chemical and the three analogues on two processes which are dependent on gene phosphorylation were examined , namely the gene-activated chemical-ATPase activity of gene and the assembly of gene filaments .	T6	T54	2833901
NA	CHEMICAL	GENE-N	25	17	Finally , the effects of chemical and the three analogues on two processes which are dependent on gene phosphorylation were examined , namely the gene-activated chemical-ATPase activity of gene and the assembly of gene filaments .	T8	T50	2833901
NA	CHEMICAL	GENE-N	25	24	Finally , the effects of chemical and the three analogues on two processes which are dependent on gene phosphorylation were examined , namely the gene-activated chemical-ATPase activity of gene and the assembly of gene filaments .	T8	T51	2833901
NA	CHEMICAL	GENE-N	25	28	Finally , the effects of chemical and the three analogues on two processes which are dependent on gene phosphorylation were examined , namely the gene-activated chemical-ATPase activity of gene and the assembly of gene filaments .	T8	T53	2833901
NA	CHEMICAL	GENE-N	25	33	Finally , the effects of chemical and the three analogues on two processes which are dependent on gene phosphorylation were examined , namely the gene-activated chemical-ATPase activity of gene and the assembly of gene filaments .	T8	T54	2833901
NA	CHEMICAL	GENE-N	0	7	chemical and the chemical analogue inhibited the gene-activated chemical-ATPase activity of smooth muscle gene ( IC50 = 25.1 microM ) .	T9	T55	2833901
CPR:4	CHEMICAL	GENE-N	0	13	chemical and the chemical analogue inhibited the gene-activated chemical-ATPase activity of smooth muscle gene ( IC50 = 25.1 microM ) .	T9	T58	2833901
NA	CHEMICAL	GENE-N	3	7	chemical and the chemical analogue inhibited the gene-activated chemical-ATPase activity of smooth muscle gene ( IC50 = 25.1 microM ) .	T10	T55	2833901
CPR:4	CHEMICAL	GENE-N	3	13	chemical and the chemical analogue inhibited the gene-activated chemical-ATPase activity of smooth muscle gene ( IC50 = 25.1 microM ) .	T10	T58	2833901
NA	CHEMICAL	GENE-N	8	7	chemical and the chemical analogue inhibited the gene-activated chemical-ATPase activity of smooth muscle gene ( IC50 = 25.1 microM ) .	T12	T55	2833901
NA	CHEMICAL	GENE-N	8	13	chemical and the chemical analogue inhibited the gene-activated chemical-ATPase activity of smooth muscle gene ( IC50 = 25.1 microM ) .	T12	T58	2833901
CPR:4	CHEMICAL	GENE-N	2	8	Similarly , chemical and the chemical analogue blocked gene filament assembly induced by low concentrations of gene , whereas the oxidized and chemical analogues did not .	T14	T59	2833901
NA	CHEMICAL	GENE-Y	2	16	Similarly , chemical and the chemical analogue blocked gene filament assembly induced by low concentrations of gene , whereas the oxidized and chemical analogues did not .	T14	T60	2833901
CPR:4	CHEMICAL	GENE-N	5	8	Similarly , chemical and the chemical analogue blocked gene filament assembly induced by low concentrations of gene , whereas the oxidized and chemical analogues did not .	T15	T59	2833901
NA	CHEMICAL	GENE-Y	5	16	Similarly , chemical and the chemical analogue blocked gene filament assembly induced by low concentrations of gene , whereas the oxidized and chemical analogues did not .	T15	T60	2833901
NA	CHEMICAL	GENE-N	22	8	Similarly , chemical and the chemical analogue blocked gene filament assembly induced by low concentrations of gene , whereas the oxidized and chemical analogues did not .	T17	T59	2833901
NA	CHEMICAL	GENE-Y	22	16	Similarly , chemical and the chemical analogue blocked gene filament assembly induced by low concentrations of gene , whereas the oxidized and chemical analogues did not .	T17	T60	2833901
NA	CHEMICAL	GENE-N	7	5	Again , inhibition of the gene-activated gene chemical-ATPase and gene filament assembly by chemical and the chemical analogue could be reversed by raising the gene concentration .	T18	T61	2833901
NA	CHEMICAL	GENE-N	7	6	Again , inhibition of the gene-activated gene chemical-ATPase and gene filament assembly by chemical and the chemical analogue could be reversed by raising the gene concentration .	T18	T62	2833901
NA	CHEMICAL	GENE-N	7	9	Again , inhibition of the gene-activated gene chemical-ATPase and gene filament assembly by chemical and the chemical analogue could be reversed by raising the gene concentration .	T18	T64	2833901
NA	CHEMICAL	GENE-Y	7	24	Again , inhibition of the gene-activated gene chemical-ATPase and gene filament assembly by chemical and the chemical analogue could be reversed by raising the gene concentration .	T18	T65	2833901
NA	CHEMICAL	GENE-N	13	5	Again , inhibition of the gene-activated gene chemical-ATPase and gene filament assembly by chemical and the chemical analogue could be reversed by raising the gene concentration .	T19	T61	2833901
CPR:4	CHEMICAL	GENE-N	13	6	Again , inhibition of the gene-activated gene chemical-ATPase and gene filament assembly by chemical and the chemical analogue could be reversed by raising the gene concentration .	T19	T62	2833901
CPR:4	CHEMICAL	GENE-N	13	9	Again , inhibition of the gene-activated gene chemical-ATPase and gene filament assembly by chemical and the chemical analogue could be reversed by raising the gene concentration .	T19	T64	2833901
NA	CHEMICAL	GENE-Y	13	24	Again , inhibition of the gene-activated gene chemical-ATPase and gene filament assembly by chemical and the chemical analogue could be reversed by raising the gene concentration .	T19	T65	2833901
NA	CHEMICAL	GENE-N	16	5	Again , inhibition of the gene-activated gene chemical-ATPase and gene filament assembly by chemical and the chemical analogue could be reversed by raising the gene concentration .	T20	T61	2833901
CPR:4	CHEMICAL	GENE-N	16	6	Again , inhibition of the gene-activated gene chemical-ATPase and gene filament assembly by chemical and the chemical analogue could be reversed by raising the gene concentration .	T20	T62	2833901
CPR:4	CHEMICAL	GENE-N	16	9	Again , inhibition of the gene-activated gene chemical-ATPase and gene filament assembly by chemical and the chemical analogue could be reversed by raising the gene concentration .	T20	T64	2833901
NA	CHEMICAL	GENE-Y	16	24	Again , inhibition of the gene-activated gene chemical-ATPase and gene filament assembly by chemical and the chemical analogue could be reversed by raising the gene concentration .	T20	T65	2833901
NA	CHEMICAL	GENE-Y	2	2	Both the gene-chemical system and the sympathetic nervous system are involved in hypertension , hence targeting these systems is likely to be of benefit in the treatment of hypertension .	T6	T14	18093407
NA	CHEMICAL	GENE-Y	2	11	Both the gene-chemical system and the sympathetic nervous system are involved in hypertension , hence targeting these systems is likely to be of benefit in the treatment of hypertension .	T6	T15	18093407
NA	CHEMICAL	GENE-Y	0	3	chemical type 1 receptor blockers ( ARBs ) are used for controlling blood pressure and treating heart failure in a broad range of patients , including those with diabetes and the elderly .	T7	T16	18093407
CPR:6	CHEMICAL	GENE-Y	2	10	The ARB chemical is a nonbiphenyl nontetrazole chemical type 1 receptor ( gene ) antagonist , which acts to decrease total peripheral resistance .	T8	T17	18093407
CPR:6	CHEMICAL	GENE-Y	2	9	The ARB chemical is a nonbiphenyl nontetrazole chemical type 1 receptor ( gene ) antagonist , which acts to decrease total peripheral resistance .	T8	T18	18093407
NA	CHEMICAL	GENE-Y	7	10	The ARB chemical is a nonbiphenyl nontetrazole chemical type 1 receptor ( gene ) antagonist , which acts to decrease total peripheral resistance .	T9	T17	18093407
NA	CHEMICAL	GENE-Y	7	9	The ARB chemical is a nonbiphenyl nontetrazole chemical type 1 receptor ( gene ) antagonist , which acts to decrease total peripheral resistance .	T9	T18	18093407
NA	CHEMICAL	GENE-Y	0	4	chemical acts at vascular gene ( postsynaptically ) and at presynaptic gene , where it inhibits chemical release .	T10	T19	18093407
NA	CHEMICAL	GENE-Y	0	11	chemical acts at vascular gene ( postsynaptically ) and at presynaptic gene , where it inhibits chemical release .	T10	T12	18093407
NA	CHEMICAL	GENE-Y	0	4	chemical acts at vascular gene ( postsynaptically ) and at presynaptic gene , where it inhibits chemical release .	T1	T19	18093407
NA	CHEMICAL	GENE-Y	0	11	chemical acts at vascular gene ( postsynaptically ) and at presynaptic gene , where it inhibits chemical release .	T1	T12	18093407
NA	CHEMICAL	GENE-Y	4	29	In clinical studies , chemical has been shown to significantly reduce cardiovascular and cerebrovascular events , whilst avoiding the persistent cough that commonly occurs with the use of chemical-converting enzyme inhibitors .	T2	T13	18093407
NA	CHEMICAL	GENE-Y	28	29	In clinical studies , chemical has been shown to significantly reduce cardiovascular and cerebrovascular events , whilst avoiding the persistent cough that commonly occurs with the use of chemical-converting enzyme inhibitors .	T3	T13	18093407
NA	CHEMICAL	GENE-N	3	7	Differential inhibition of chemical and chemical binding to gene in rat brain membranes with gene inhibitors .	T41	T56	11330337
NA	CHEMICAL	GENE-Y	3	9	Differential inhibition of chemical and chemical binding to gene in rat brain membranes with gene inhibitors .	T41	T55	11330337
NA	CHEMICAL	GENE-N	5	7	Differential inhibition of chemical and chemical binding to gene in rat brain membranes with gene inhibitors .	T42	T56	11330337
NA	CHEMICAL	GENE-Y	5	9	Differential inhibition of chemical and chemical binding to gene in rat brain membranes with gene inhibitors .	T42	T55	11330337
NA	CHEMICAL	GENE-Y	22	8	In the present study , the capacity of gene inhibitors to interact with gene was assessed by their ability to displace both chemical and chemical binding in rat brain membranes .	T24	T49	11330337
NA	CHEMICAL	GENE-N	22	10	In the present study , the capacity of gene inhibitors to interact with gene was assessed by their ability to displace both chemical and chemical binding in rat brain membranes .	T24	T51	11330337
NA	CHEMICAL	GENE-Y	24	8	In the present study , the capacity of gene inhibitors to interact with gene was assessed by their ability to displace both chemical and chemical binding in rat brain membranes .	T25	T49	11330337
NA	CHEMICAL	GENE-N	24	10	In the present study , the capacity of gene inhibitors to interact with gene was assessed by their ability to displace both chemical and chemical binding in rat brain membranes .	T25	T51	11330337
NA	CHEMICAL	GENE-Y	15	11	A series of compounds , representative of the principal classes of gene inhibitors , displaced chemical binding with high-to-moderate potency ( chemical > chemical=chemical=chemical > chemical > chemical=chemical > chemical ) whereas only chemical and chemical displaced chemical binding .	T28	T54	11330337
NA	CHEMICAL	GENE-Y	21	11	A series of compounds , representative of the principal classes of gene inhibitors , displaced chemical binding with high-to-moderate potency ( chemical > chemical=chemical=chemical > chemical > chemical=chemical > chemical ) whereas only chemical and chemical displaced chemical binding .	T29	T54	11330337
NA	CHEMICAL	GENE-Y	23	11	A series of compounds , representative of the principal classes of gene inhibitors , displaced chemical binding with high-to-moderate potency ( chemical > chemical=chemical=chemical > chemical > chemical=chemical > chemical ) whereas only chemical and chemical displaced chemical binding .	T30	T54	11330337
NA	CHEMICAL	GENE-Y	23	11	A series of compounds , representative of the principal classes of gene inhibitors , displaced chemical binding with high-to-moderate potency ( chemical > chemical=chemical=chemical > chemical > chemical=chemical > chemical ) whereas only chemical and chemical displaced chemical binding .	T31	T54	11330337
NA	CHEMICAL	GENE-Y	23	11	A series of compounds , representative of the principal classes of gene inhibitors , displaced chemical binding with high-to-moderate potency ( chemical > chemical=chemical=chemical > chemical > chemical=chemical > chemical ) whereas only chemical and chemical displaced chemical binding .	T32	T54	11330337
NA	CHEMICAL	GENE-Y	25	11	A series of compounds , representative of the principal classes of gene inhibitors , displaced chemical binding with high-to-moderate potency ( chemical > chemical=chemical=chemical > chemical > chemical=chemical > chemical ) whereas only chemical and chemical displaced chemical binding .	T33	T54	11330337
NA	CHEMICAL	GENE-Y	27	11	A series of compounds , representative of the principal classes of gene inhibitors , displaced chemical binding with high-to-moderate potency ( chemical > chemical=chemical=chemical > chemical > chemical=chemical > chemical ) whereas only chemical and chemical displaced chemical binding .	T34	T54	11330337
NA	CHEMICAL	GENE-Y	27	11	A series of compounds , representative of the principal classes of gene inhibitors , displaced chemical binding with high-to-moderate potency ( chemical > chemical=chemical=chemical > chemical > chemical=chemical > chemical ) whereas only chemical and chemical displaced chemical binding .	T35	T54	11330337
NA	CHEMICAL	GENE-Y	29	11	A series of compounds , representative of the principal classes of gene inhibitors , displaced chemical binding with high-to-moderate potency ( chemical > chemical=chemical=chemical > chemical > chemical=chemical > chemical ) whereas only chemical and chemical displaced chemical binding .	T36	T54	11330337
NA	CHEMICAL	GENE-Y	33	11	A series of compounds , representative of the principal classes of gene inhibitors , displaced chemical binding with high-to-moderate potency ( chemical > chemical=chemical=chemical > chemical > chemical=chemical > chemical ) whereas only chemical and chemical displaced chemical binding .	T37	T54	11330337
NA	CHEMICAL	GENE-Y	35	11	A series of compounds , representative of the principal classes of gene inhibitors , displaced chemical binding with high-to-moderate potency ( chemical > chemical=chemical=chemical > chemical > chemical=chemical > chemical ) whereas only chemical and chemical displaced chemical binding .	T38	T54	11330337
NA	CHEMICAL	GENE-Y	37	11	A series of compounds , representative of the principal classes of gene inhibitors , displaced chemical binding with high-to-moderate potency ( chemical > chemical=chemical=chemical > chemical > chemical=chemical > chemical ) whereas only chemical and chemical displaced chemical binding .	T39	T54	11330337
CPR:4	CHEMICAL	GENE-Y	10	3	The capacity of gene inhibitors , with the exception of chemical and chemical , to displace bound chemical in preference to chemical predicts that the former compounds could act as potential agonists at gene .	T2	T43	11330337
NA	CHEMICAL	GENE-N	10	14	The capacity of gene inhibitors , with the exception of chemical and chemical , to displace bound chemical in preference to chemical predicts that the former compounds could act as potential agonists at gene .	T2	T44	11330337
CPR:4	CHEMICAL	GENE-Y	12	3	The capacity of gene inhibitors , with the exception of chemical and chemical , to displace bound chemical in preference to chemical predicts that the former compounds could act as potential agonists at gene .	T3	T43	11330337
NA	CHEMICAL	GENE-N	12	14	The capacity of gene inhibitors , with the exception of chemical and chemical , to displace bound chemical in preference to chemical predicts that the former compounds could act as potential agonists at gene .	T3	T44	11330337
NA	CHEMICAL	GENE-Y	3	3	The capacity of gene inhibitors , with the exception of chemical and chemical , to displace bound chemical in preference to chemical predicts that the former compounds could act as potential agonists at gene .	T4	T43	11330337
NA	CHEMICAL	GENE-N	3	14	The capacity of gene inhibitors , with the exception of chemical and chemical , to displace bound chemical in preference to chemical predicts that the former compounds could act as potential agonists at gene .	T4	T44	11330337
NA	CHEMICAL	GENE-Y	21	3	The capacity of gene inhibitors , with the exception of chemical and chemical , to displace bound chemical in preference to chemical predicts that the former compounds could act as potential agonists at gene .	T5	T43	11330337
NA	CHEMICAL	GENE-N	21	14	The capacity of gene inhibitors , with the exception of chemical and chemical , to displace bound chemical in preference to chemical predicts that the former compounds could act as potential agonists at gene .	T5	T44	11330337
CPR:4	CHEMICAL	GENE-Y	11	7	Moreover , the rank order for potency in inhibiting gene ( chemical > chemical=chemical =chemical > chemical=chemical=chemical > chemical > chemical > chemical ) indicated that the most effective inhibitors of gene also displaced chemical to the greatest extent .	T6	T45	11330337
CPR:4	CHEMICAL	GENE-Y	11	7	Moreover , the rank order for potency in inhibiting gene ( chemical > chemical=chemical =chemical > chemical=chemical=chemical > chemical > chemical > chemical ) indicated that the most effective inhibitors of gene also displaced chemical to the greatest extent .	T6	T46	11330337
CPR:4	CHEMICAL	GENE-Y	7	7	Moreover , the rank order for potency in inhibiting gene ( chemical > chemical=chemical =chemical > chemical=chemical=chemical > chemical > chemical > chemical ) indicated that the most effective inhibitors of gene also displaced chemical to the greatest extent .	T7	T45	11330337
CPR:4	CHEMICAL	GENE-Y	7	7	Moreover , the rank order for potency in inhibiting gene ( chemical > chemical=chemical =chemical > chemical=chemical=chemical > chemical > chemical > chemical ) indicated that the most effective inhibitors of gene also displaced chemical to the greatest extent .	T7	T46	11330337
CPR:4	CHEMICAL	GENE-Y	7	7	Moreover , the rank order for potency in inhibiting gene ( chemical > chemical=chemical =chemical > chemical=chemical=chemical > chemical > chemical > chemical ) indicated that the most effective inhibitors of gene also displaced chemical to the greatest extent .	T8	T45	11330337
CPR:4	CHEMICAL	GENE-Y	7	7	Moreover , the rank order for potency in inhibiting gene ( chemical > chemical=chemical =chemical > chemical=chemical=chemical > chemical > chemical > chemical ) indicated that the most effective inhibitors of gene also displaced chemical to the greatest extent .	T8	T46	11330337
CPR:4	CHEMICAL	GENE-Y	7	7	Moreover , the rank order for potency in inhibiting gene ( chemical > chemical=chemical =chemical > chemical=chemical=chemical > chemical > chemical > chemical ) indicated that the most effective inhibitors of gene also displaced chemical to the greatest extent .	T9	T45	11330337
CPR:4	CHEMICAL	GENE-Y	7	7	Moreover , the rank order for potency in inhibiting gene ( chemical > chemical=chemical =chemical > chemical=chemical=chemical > chemical > chemical > chemical ) indicated that the most effective inhibitors of gene also displaced chemical to the greatest extent .	T9	T46	11330337
CPR:4	CHEMICAL	GENE-Y	7	7	Moreover , the rank order for potency in inhibiting gene ( chemical > chemical=chemical =chemical > chemical=chemical=chemical > chemical > chemical > chemical ) indicated that the most effective inhibitors of gene also displaced chemical to the greatest extent .	T10	T45	11330337
CPR:4	CHEMICAL	GENE-Y	7	7	Moreover , the rank order for potency in inhibiting gene ( chemical > chemical=chemical =chemical > chemical=chemical=chemical > chemical > chemical > chemical ) indicated that the most effective inhibitors of gene also displaced chemical to the greatest extent .	T10	T46	11330337
CPR:4	CHEMICAL	GENE-Y	16	7	Moreover , the rank order for potency in inhibiting gene ( chemical > chemical=chemical =chemical > chemical=chemical=chemical > chemical > chemical > chemical ) indicated that the most effective inhibitors of gene also displaced chemical to the greatest extent .	T11	T45	11330337
CPR:4	CHEMICAL	GENE-Y	16	7	Moreover , the rank order for potency in inhibiting gene ( chemical > chemical=chemical =chemical > chemical=chemical=chemical > chemical > chemical > chemical ) indicated that the most effective inhibitors of gene also displaced chemical to the greatest extent .	T11	T46	11330337
CPR:4	CHEMICAL	GENE-Y	7	7	Moreover , the rank order for potency in inhibiting gene ( chemical > chemical=chemical =chemical > chemical=chemical=chemical > chemical > chemical > chemical ) indicated that the most effective inhibitors of gene also displaced chemical to the greatest extent .	T12	T45	11330337
CPR:4	CHEMICAL	GENE-Y	7	7	Moreover , the rank order for potency in inhibiting gene ( chemical > chemical=chemical =chemical > chemical=chemical=chemical > chemical > chemical > chemical ) indicated that the most effective inhibitors of gene also displaced chemical to the greatest extent .	T12	T46	11330337
CPR:4	CHEMICAL	GENE-Y	7	7	Moreover , the rank order for potency in inhibiting gene ( chemical > chemical=chemical =chemical > chemical=chemical=chemical > chemical > chemical > chemical ) indicated that the most effective inhibitors of gene also displaced chemical to the greatest extent .	T13	T45	11330337
CPR:4	CHEMICAL	GENE-Y	7	7	Moreover , the rank order for potency in inhibiting gene ( chemical > chemical=chemical =chemical > chemical=chemical=chemical > chemical > chemical > chemical ) indicated that the most effective inhibitors of gene also displaced chemical to the greatest extent .	T13	T46	11330337
CPR:4	CHEMICAL	GENE-Y	20	7	Moreover , the rank order for potency in inhibiting gene ( chemical > chemical=chemical =chemical > chemical=chemical=chemical > chemical > chemical > chemical ) indicated that the most effective inhibitors of gene also displaced chemical to the greatest extent .	T14	T45	11330337
CPR:4	CHEMICAL	GENE-Y	20	7	Moreover , the rank order for potency in inhibiting gene ( chemical > chemical=chemical =chemical > chemical=chemical=chemical > chemical > chemical > chemical ) indicated that the most effective inhibitors of gene also displaced chemical to the greatest extent .	T14	T46	11330337
CPR:4	CHEMICAL	GENE-Y	7	7	Moreover , the rank order for potency in inhibiting gene ( chemical > chemical=chemical =chemical > chemical=chemical=chemical > chemical > chemical > chemical ) indicated that the most effective inhibitors of gene also displaced chemical to the greatest extent .	T15	T45	11330337
CPR:4	CHEMICAL	GENE-Y	7	7	Moreover , the rank order for potency in inhibiting gene ( chemical > chemical=chemical =chemical > chemical=chemical=chemical > chemical > chemical > chemical ) indicated that the most effective inhibitors of gene also displaced chemical to the greatest extent .	T15	T46	11330337
NA	CHEMICAL	GENE-Y	7	7	Moreover , the rank order for potency in inhibiting gene ( chemical > chemical=chemical =chemical > chemical=chemical=chemical > chemical > chemical > chemical ) indicated that the most effective inhibitors of gene also displaced chemical to the greatest extent .	T16	T45	11330337
NA	CHEMICAL	GENE-Y	7	7	Moreover , the rank order for potency in inhibiting gene ( chemical > chemical=chemical =chemical > chemical=chemical=chemical > chemical > chemical > chemical ) indicated that the most effective inhibitors of gene also displaced chemical to the greatest extent .	T16	T46	11330337
NA	CHEMICAL	GENE-N	7	5	The capacity of these inhibitors to displace chemical-M binding preclude their utilisation for the prevention of chemical catabolism in rat brain membranes , the latter being required to estimate the binding of acetylcholine to chemical-labelled gene .	T17	T47	11330337
NA	CHEMICAL	GENE-N	16	5	The capacity of these inhibitors to displace chemical-M binding preclude their utilisation for the prevention of chemical catabolism in rat brain membranes , the latter being required to estimate the binding of acetylcholine to chemical-labelled gene .	T18	T47	11330337
NA	CHEMICAL	GENE-N	18	5	The capacity of these inhibitors to displace chemical-M binding preclude their utilisation for the prevention of chemical catabolism in rat brain membranes , the latter being required to estimate the binding of acetylcholine to chemical-labelled gene .	T19	T47	11330337
NA	CHEMICAL	GENE-Y	17	2	Treatment with gene resulted in hypodiploid DNA contents , increased gene/ gene ratio and induction of reactive chemical species ( ROS ) production .	T1	T21	23643883
NA	CHEMICAL	GENE-Y	17	10	Treatment with gene resulted in hypodiploid DNA contents , increased gene/ gene ratio and induction of reactive chemical species ( ROS ) production .	T1	T22	23643883
NA	CHEMICAL	GENE-Y	17	11	Treatment with gene resulted in hypodiploid DNA contents , increased gene/ gene ratio and induction of reactive chemical species ( ROS ) production .	T1	T23	23643883
CPR:4	CHEMICAL	GENE-N	5	10	In addition , pretreatment with chemical ( chemical ) , a broad spectrum of gene inhibitor , could not rescue apoptotic cells from gene toxicity .	T2	T27	23643883
NA	CHEMICAL	GENE-Y	5	23	In addition , pretreatment with chemical ( chemical ) , a broad spectrum of gene inhibitor , could not rescue apoptotic cells from gene toxicity .	T2	T4	23643883
CPR:4	CHEMICAL	GENE-N	7	10	In addition , pretreatment with chemical ( chemical ) , a broad spectrum of gene inhibitor , could not rescue apoptotic cells from gene toxicity .	T3	T27	23643883
NA	CHEMICAL	GENE-Y	7	23	In addition , pretreatment with chemical ( chemical ) , a broad spectrum of gene inhibitor , could not rescue apoptotic cells from gene toxicity .	T3	T4	23643883
CPR:9	CHEMICAL	GENE-N	1	1	The gene ( gene ) is a multi-subunit enzyme that transfers electrons from gene to molecular chemical , yielding water .	T1	T17	23125284
CPR:9	CHEMICAL	GENE-N	1	3	The gene ( gene ) is a multi-subunit enzyme that transfers electrons from gene to molecular chemical , yielding water .	T1	T19	23125284
NA	CHEMICAL	GENE-Y	1	13	The gene ( gene ) is a multi-subunit enzyme that transfers electrons from gene to molecular chemical , yielding water .	T1	T8	23125284
NA	CHEMICAL	GENE-Y	1	5	Effects of chemical , a gene ligand , on the haemodynamics of chemical-induced renal failure in rats .	T26	T41	22859660
NA	CHEMICAL	GENE-Y	12	5	Effects of chemical , a gene ligand , on the haemodynamics of chemical-induced renal failure in rats .	T27	T41	22859660
NA	CHEMICAL	GENE-Y	10	4	The modulating effect of gene ligand on haemodynamic effects of chemical ( PE ) , gene ( gene ) , gene ( gene ) , chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) were evaluated in chemical-induced acute kidney injury in rats .	T2	T34	22859660
NA	CHEMICAL	GENE-Y	10	15	The modulating effect of gene ligand on haemodynamic effects of chemical ( PE ) , gene ( gene ) , gene ( gene ) , chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) were evaluated in chemical-induced acute kidney injury in rats .	T2	T28	22859660
NA	CHEMICAL	GENE-Y	10	17	The modulating effect of gene ligand on haemodynamic effects of chemical ( PE ) , gene ( gene ) , gene ( gene ) , chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) were evaluated in chemical-induced acute kidney injury in rats .	T2	T31	22859660
NA	CHEMICAL	GENE-Y	10	20	The modulating effect of gene ligand on haemodynamic effects of chemical ( PE ) , gene ( gene ) , gene ( gene ) , chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) were evaluated in chemical-induced acute kidney injury in rats .	T2	T32	22859660
NA	CHEMICAL	GENE-Y	10	22	The modulating effect of gene ligand on haemodynamic effects of chemical ( PE ) , gene ( gene ) , gene ( gene ) , chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) were evaluated in chemical-induced acute kidney injury in rats .	T2	T33	22859660
NA	CHEMICAL	GENE-Y	25	4	The modulating effect of gene ligand on haemodynamic effects of chemical ( PE ) , gene ( gene ) , gene ( gene ) , chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) were evaluated in chemical-induced acute kidney injury in rats .	T12	T34	22859660
NA	CHEMICAL	GENE-Y	25	15	The modulating effect of gene ligand on haemodynamic effects of chemical ( PE ) , gene ( gene ) , gene ( gene ) , chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) were evaluated in chemical-induced acute kidney injury in rats .	T12	T28	22859660
NA	CHEMICAL	GENE-Y	25	17	The modulating effect of gene ligand on haemodynamic effects of chemical ( PE ) , gene ( gene ) , gene ( gene ) , chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) were evaluated in chemical-induced acute kidney injury in rats .	T12	T31	22859660
NA	CHEMICAL	GENE-Y	25	20	The modulating effect of gene ligand on haemodynamic effects of chemical ( PE ) , gene ( gene ) , gene ( gene ) , chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) were evaluated in chemical-induced acute kidney injury in rats .	T12	T32	22859660
NA	CHEMICAL	GENE-Y	25	22	The modulating effect of gene ligand on haemodynamic effects of chemical ( PE ) , gene ( gene ) , gene ( gene ) , chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) were evaluated in chemical-induced acute kidney injury in rats .	T12	T33	22859660
NA	CHEMICAL	GENE-Y	27	4	The modulating effect of gene ligand on haemodynamic effects of chemical ( PE ) , gene ( gene ) , gene ( gene ) , chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) were evaluated in chemical-induced acute kidney injury in rats .	T13	T34	22859660
NA	CHEMICAL	GENE-Y	27	15	The modulating effect of gene ligand on haemodynamic effects of chemical ( PE ) , gene ( gene ) , gene ( gene ) , chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) were evaluated in chemical-induced acute kidney injury in rats .	T13	T28	22859660
NA	CHEMICAL	GENE-Y	27	17	The modulating effect of gene ligand on haemodynamic effects of chemical ( PE ) , gene ( gene ) , gene ( gene ) , chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) were evaluated in chemical-induced acute kidney injury in rats .	T13	T31	22859660
NA	CHEMICAL	GENE-Y	27	20	The modulating effect of gene ligand on haemodynamic effects of chemical ( PE ) , gene ( gene ) , gene ( gene ) , chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) were evaluated in chemical-induced acute kidney injury in rats .	T13	T32	22859660
NA	CHEMICAL	GENE-Y	27	22	The modulating effect of gene ligand on haemodynamic effects of chemical ( PE ) , gene ( gene ) , gene ( gene ) , chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) were evaluated in chemical-induced acute kidney injury in rats .	T13	T33	22859660
NA	CHEMICAL	GENE-Y	30	4	The modulating effect of gene ligand on haemodynamic effects of chemical ( PE ) , gene ( gene ) , gene ( gene ) , chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) were evaluated in chemical-induced acute kidney injury in rats .	T14	T34	22859660
NA	CHEMICAL	GENE-Y	30	15	The modulating effect of gene ligand on haemodynamic effects of chemical ( PE ) , gene ( gene ) , gene ( gene ) , chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) were evaluated in chemical-induced acute kidney injury in rats .	T14	T28	22859660
NA	CHEMICAL	GENE-Y	30	17	The modulating effect of gene ligand on haemodynamic effects of chemical ( PE ) , gene ( gene ) , gene ( gene ) , chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) were evaluated in chemical-induced acute kidney injury in rats .	T14	T31	22859660
NA	CHEMICAL	GENE-Y	30	20	The modulating effect of gene ligand on haemodynamic effects of chemical ( PE ) , gene ( gene ) , gene ( gene ) , chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) were evaluated in chemical-induced acute kidney injury in rats .	T14	T32	22859660
NA	CHEMICAL	GENE-Y	30	22	The modulating effect of gene ligand on haemodynamic effects of chemical ( PE ) , gene ( gene ) , gene ( gene ) , chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) were evaluated in chemical-induced acute kidney injury in rats .	T14	T33	22859660
NA	CHEMICAL	GENE-Y	32	4	The modulating effect of gene ligand on haemodynamic effects of chemical ( PE ) , gene ( gene ) , gene ( gene ) , chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) were evaluated in chemical-induced acute kidney injury in rats .	T15	T34	22859660
NA	CHEMICAL	GENE-Y	32	15	The modulating effect of gene ligand on haemodynamic effects of chemical ( PE ) , gene ( gene ) , gene ( gene ) , chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) were evaluated in chemical-induced acute kidney injury in rats .	T15	T28	22859660
NA	CHEMICAL	GENE-Y	32	17	The modulating effect of gene ligand on haemodynamic effects of chemical ( PE ) , gene ( gene ) , gene ( gene ) , chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) were evaluated in chemical-induced acute kidney injury in rats .	T15	T31	22859660
NA	CHEMICAL	GENE-Y	32	20	The modulating effect of gene ligand on haemodynamic effects of chemical ( PE ) , gene ( gene ) , gene ( gene ) , chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) were evaluated in chemical-induced acute kidney injury in rats .	T15	T32	22859660
NA	CHEMICAL	GENE-Y	32	22	The modulating effect of gene ligand on haemodynamic effects of chemical ( PE ) , gene ( gene ) , gene ( gene ) , chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) were evaluated in chemical-induced acute kidney injury in rats .	T15	T33	22859660
NA	CHEMICAL	GENE-Y	35	4	The modulating effect of gene ligand on haemodynamic effects of chemical ( PE ) , gene ( gene ) , gene ( gene ) , chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) were evaluated in chemical-induced acute kidney injury in rats .	T16	T34	22859660
NA	CHEMICAL	GENE-Y	35	15	The modulating effect of gene ligand on haemodynamic effects of chemical ( PE ) , gene ( gene ) , gene ( gene ) , chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) were evaluated in chemical-induced acute kidney injury in rats .	T16	T28	22859660
NA	CHEMICAL	GENE-Y	35	17	The modulating effect of gene ligand on haemodynamic effects of chemical ( PE ) , gene ( gene ) , gene ( gene ) , chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) were evaluated in chemical-induced acute kidney injury in rats .	T16	T31	22859660
NA	CHEMICAL	GENE-Y	35	20	The modulating effect of gene ligand on haemodynamic effects of chemical ( PE ) , gene ( gene ) , gene ( gene ) , chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) were evaluated in chemical-induced acute kidney injury in rats .	T16	T32	22859660
NA	CHEMICAL	GENE-Y	35	22	The modulating effect of gene ligand on haemodynamic effects of chemical ( PE ) , gene ( gene ) , gene ( gene ) , chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) were evaluated in chemical-induced acute kidney injury in rats .	T16	T33	22859660
NA	CHEMICAL	GENE-Y	37	4	The modulating effect of gene ligand on haemodynamic effects of chemical ( PE ) , gene ( gene ) , gene ( gene ) , chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) were evaluated in chemical-induced acute kidney injury in rats .	T17	T34	22859660
NA	CHEMICAL	GENE-Y	37	15	The modulating effect of gene ligand on haemodynamic effects of chemical ( PE ) , gene ( gene ) , gene ( gene ) , chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) were evaluated in chemical-induced acute kidney injury in rats .	T17	T28	22859660
NA	CHEMICAL	GENE-Y	37	17	The modulating effect of gene ligand on haemodynamic effects of chemical ( PE ) , gene ( gene ) , gene ( gene ) , chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) were evaluated in chemical-induced acute kidney injury in rats .	T17	T31	22859660
NA	CHEMICAL	GENE-Y	37	20	The modulating effect of gene ligand on haemodynamic effects of chemical ( PE ) , gene ( gene ) , gene ( gene ) , chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) were evaluated in chemical-induced acute kidney injury in rats .	T17	T32	22859660
NA	CHEMICAL	GENE-Y	37	22	The modulating effect of gene ligand on haemodynamic effects of chemical ( PE ) , gene ( gene ) , gene ( gene ) , chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) were evaluated in chemical-induced acute kidney injury in rats .	T17	T33	22859660
NA	CHEMICAL	GENE-Y	42	4	The modulating effect of gene ligand on haemodynamic effects of chemical ( PE ) , gene ( gene ) , gene ( gene ) , chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) were evaluated in chemical-induced acute kidney injury in rats .	T18	T34	22859660
NA	CHEMICAL	GENE-Y	42	15	The modulating effect of gene ligand on haemodynamic effects of chemical ( PE ) , gene ( gene ) , gene ( gene ) , chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) were evaluated in chemical-induced acute kidney injury in rats .	T18	T28	22859660
NA	CHEMICAL	GENE-Y	42	17	The modulating effect of gene ligand on haemodynamic effects of chemical ( PE ) , gene ( gene ) , gene ( gene ) , chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) were evaluated in chemical-induced acute kidney injury in rats .	T18	T31	22859660
NA	CHEMICAL	GENE-Y	42	20	The modulating effect of gene ligand on haemodynamic effects of chemical ( PE ) , gene ( gene ) , gene ( gene ) , chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) were evaluated in chemical-induced acute kidney injury in rats .	T18	T32	22859660
NA	CHEMICAL	GENE-Y	42	22	The modulating effect of gene ligand on haemodynamic effects of chemical ( PE ) , gene ( gene ) , gene ( gene ) , chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) were evaluated in chemical-induced acute kidney injury in rats .	T18	T33	22859660
CPR:3	CHEMICAL	GENE-Y	11	1	For gene and gene , MAP was also increased for the chemical group but not in a dose-dependent fashion .	T20	T35	22859660
CPR:3	CHEMICAL	GENE-Y	11	3	For gene and gene , MAP was also increased for the chemical group but not in a dose-dependent fashion .	T20	T36	22859660
NA	CHEMICAL	GENE-Y	13	16	On the medullary blood flow ( MBF ) , while the lower doses of PE and gene increased the perfusion unit on the chemical-treated group , the higher doses decreased the perfusion unit .	T21	T37	22859660
NA	CHEMICAL	GENE-Y	2	5	The effects of PE and gene on the cortical blood flow ( CBF ) of chemical-treated group is similar to that of MBF for the same group but not for gene .	T22	T39	22859660
NA	CHEMICAL	GENE-Y	2	30	The effects of PE and gene on the cortical blood flow ( CBF ) of chemical-treated group is similar to that of MBF for the same group but not for gene .	T22	T40	22859660
NA	CHEMICAL	GENE-Y	7	2	Suppression of gene via gene contributes to chemical-induced oxidative stress and fibrogenesis .	T10	T22	23570914
NA	CHEMICAL	GENE-N	7	4	Suppression of gene via gene contributes to chemical-induced oxidative stress and fibrogenesis .	T10	T23	23570914
NA	CHEMICAL	GENE-N	6	11	Treatment of C57 BL/6 mice with chemical increased fibroblast viability and gene production and significantly downregulated gene .	T3	T16	23570914
CPR:4	CHEMICAL	GENE-N	6	16	Treatment of C57 BL/6 mice with chemical increased fibroblast viability and gene production and significantly downregulated gene .	T3	T17	23570914
NA	CHEMICAL	GENE-N	11	12	In addition , prominent oxidative stress was indicated by changes in chemical dismutase , gene activity , and chemical and chemical-reactive substance levels .	T4	T18	23570914
NA	CHEMICAL	GENE-N	11	14	In addition , prominent oxidative stress was indicated by changes in chemical dismutase , gene activity , and chemical and chemical-reactive substance levels .	T4	T19	23570914
NA	CHEMICAL	GENE-N	18	12	In addition , prominent oxidative stress was indicated by changes in chemical dismutase , gene activity , and chemical and chemical-reactive substance levels .	T5	T18	23570914
NA	CHEMICAL	GENE-N	18	14	In addition , prominent oxidative stress was indicated by changes in chemical dismutase , gene activity , and chemical and chemical-reactive substance levels .	T5	T19	23570914
NA	CHEMICAL	GENE-N	20	12	In addition , prominent oxidative stress was indicated by changes in chemical dismutase , gene activity , and chemical and chemical-reactive substance levels .	T6	T18	23570914
NA	CHEMICAL	GENE-N	20	14	In addition , prominent oxidative stress was indicated by changes in chemical dismutase , gene activity , and chemical and chemical-reactive substance levels .	T6	T19	23570914
CPR:4	CHEMICAL	GENE-Y	5	7	In a cell-based model , chemical suppressed gene activation via gene phosphorylation , enhancing intracellular reactive chemical species in lung fibroblasts and stimulating abnormal cell proliferation and collagen secretion .	T7	T20	23570914
CPR:3	CHEMICAL	GENE-N	5	1	In a cell-based model , chemical suppressed gene activation via gene phosphorylation , enhancing intracellular reactive chemical species in lung fibroblasts and stimulating abnormal cell proliferation and collagen secretion .	T7	T21	23570914
NA	CHEMICAL	GENE-Y	16	7	In a cell-based model , chemical suppressed gene activation via gene phosphorylation , enhancing intracellular reactive chemical species in lung fibroblasts and stimulating abnormal cell proliferation and collagen secretion .	T8	T20	23570914
NA	CHEMICAL	GENE-N	16	1	In a cell-based model , chemical suppressed gene activation via gene phosphorylation , enhancing intracellular reactive chemical species in lung fibroblasts and stimulating abnormal cell proliferation and collagen secretion .	T8	T21	23570914
CPR:9	CHEMICAL	GENE-Y	3	2	Block of gene chemical channels by novel chemical analogues of chemical .	T26	T36	15066664
CPR:9	CHEMICAL	GENE-N	3	4	Block of gene chemical channels by novel chemical analogues of chemical .	T26	T35	15066664
CPR:4	CHEMICAL	GENE-Y	7	2	Block of gene chemical channels by novel chemical analogues of chemical .	T27	T36	15066664
CPR:4	CHEMICAL	GENE-N	7	4	Block of gene chemical channels by novel chemical analogues of chemical .	T27	T35	15066664
CPR:4	CHEMICAL	GENE-Y	10	2	Block of gene chemical channels by novel chemical analogues of chemical .	T28	T36	15066664
CPR:4	CHEMICAL	GENE-N	10	4	Block of gene chemical channels by novel chemical analogues of chemical .	T28	T35	15066664
CPR:9	CHEMICAL	GENE-N	2	0	gene are a critical component of electrically excitable cells .	T11	T29	15066664
CPR:4	CHEMICAL	GENE-N	0	7	chemical ( chemical , chemical ) is an established chemical channel blocker and is a useful anticonvulsant and class 1b antiarrhythmic , and has been effectively used in the treatment of neuropathic pain .	T25	T30	15066664
CPR:4	CHEMICAL	GENE-N	0	7	chemical ( chemical , chemical ) is an established chemical channel blocker and is a useful anticonvulsant and class 1b antiarrhythmic , and has been effectively used in the treatment of neuropathic pain .	T2	T30	15066664
CPR:4	CHEMICAL	GENE-N	4	7	chemical ( chemical , chemical ) is an established chemical channel blocker and is a useful anticonvulsant and class 1b antiarrhythmic , and has been effectively used in the treatment of neuropathic pain .	T4	T30	15066664
CPR:9	CHEMICAL	GENE-N	9	7	chemical ( chemical , chemical ) is an established chemical channel blocker and is a useful anticonvulsant and class 1b antiarrhythmic , and has been effectively used in the treatment of neuropathic pain .	T8	T30	15066664
CPR:4	CHEMICAL	GENE-Y	8	18	In this study , we have synthesized novel chemical analogues of chemical and examined their ability to inhibit gene chemical channels expressed in Chinese Hamster Ovary ( CHO-K1 ) cells .	T12	T32	15066664
CPR:4	CHEMICAL	GENE-N	8	20	In this study , we have synthesized novel chemical analogues of chemical and examined their ability to inhibit gene chemical channels expressed in Chinese Hamster Ovary ( CHO-K1 ) cells .	T12	T33	15066664
CPR:4	CHEMICAL	GENE-Y	11	18	In this study , we have synthesized novel chemical analogues of chemical and examined their ability to inhibit gene chemical channels expressed in Chinese Hamster Ovary ( CHO-K1 ) cells .	T13	T32	15066664
CPR:4	CHEMICAL	GENE-N	11	20	In this study , we have synthesized novel chemical analogues of chemical and examined their ability to inhibit gene chemical channels expressed in Chinese Hamster Ovary ( CHO-K1 ) cells .	T13	T33	15066664
CPR:9	CHEMICAL	GENE-Y	19	18	In this study , we have synthesized novel chemical analogues of chemical and examined their ability to inhibit gene chemical channels expressed in Chinese Hamster Ovary ( CHO-K1 ) cells .	T14	T32	15066664
CPR:9	CHEMICAL	GENE-N	19	20	In this study , we have synthesized novel chemical analogues of chemical and examined their ability to inhibit gene chemical channels expressed in Chinese Hamster Ovary ( CHO-K1 ) cells .	T14	T33	15066664
CPR:4	CHEMICAL	GENE-Y	2	14	In comparison to chemical , the novel chemical-substituted chemical compounds produced as much as a 20-fold greater tonic and frequency-dependent blockade of gene channels with an IC ( 50 ) value of 14.5 microM .	T22	T34	15066664
CPR:4	CHEMICAL	GENE-Y	7	14	In comparison to chemical , the novel chemical-substituted chemical compounds produced as much as a 20-fold greater tonic and frequency-dependent blockade of gene channels with an IC ( 50 ) value of 14.5 microM .	T23	T34	15066664
CPR:4	CHEMICAL	GENE-Y	8	14	In comparison to chemical , the novel chemical-substituted chemical compounds produced as much as a 20-fold greater tonic and frequency-dependent blockade of gene channels with an IC ( 50 ) value of 14.5 microM .	T24	T34	15066664
CPR:4	CHEMICAL	GENE-Y	1	2	Using chemical as a reference gene ( gene ) inhibitor , the objective of this study was to develop an adverse outcome pathway ( AOP ) that provided quantitative linkages across levels of biological organization during zebrafish embryogenesis .	T4	T11	23046524
CPR:4	CHEMICAL	GENE-Y	1	7	Using chemical as a reference gene ( gene ) inhibitor , the objective of this study was to develop an adverse outcome pathway ( AOP ) that provided quantitative linkages across levels of biological organization during zebrafish embryogenesis .	T4	T14	23046524
CPR:4	CHEMICAL	GENE-Y	9	25	We then showed that static exposure of embryos to chemical ( 31.2-500 nM ) from 5 to 96 hpf resulted in significant stage- and concentration-dependent gene inhibition , albeit these effects were fully reversible within 48 h following transfer to clean water .	T3	T15	23046524
NA	CHEMICAL	GENE-Y	14	8	However , even in the presence of significant gene inhibition , exposure to non-teratogenic chemical concentrations ( ≤250 nM ) did not adversely impact secondary motoneuron development at 96 hpf .	T5	T16	23046524
CPR:3	CHEMICAL	GENE-Y	1	20	Based on these studies , the frequency of spontaneous tail contractions at 26 hpf - a developmental stage with minimal gene expression and activity - was significantly higher following exposure to chemical concentrations as low as 31.2 nM .	T1	T8	23046524
NA	CHEMICAL	GENE-Y	7	2	Characterization of gene reveals high affinity for chemical .	T24	T33	6227474
NA	CHEMICAL	GENE-Y	11	9	However , due to the very high affinity of gene for chemical at 4 C , this slight contamination resulted in significant alterations in the apparent affinity of chemical competing for chemical-binding sites .	T14	T31	6227474
NA	CHEMICAL	GENE-Y	28	9	However , due to the very high affinity of gene for chemical at 4 C , this slight contamination resulted in significant alterations in the apparent affinity of chemical competing for chemical-binding sites .	T15	T31	6227474
NA	CHEMICAL	GENE-Y	31	9	However , due to the very high affinity of gene for chemical at 4 C , this slight contamination resulted in significant alterations in the apparent affinity of chemical competing for chemical-binding sites .	T16	T31	6227474
CPR:4	CHEMICAL	GENE-Y	8	10	Selective precipitation of cytosol receptors with 36 % chemical reduced gene concentrations to negligible levels .	T17	T32	6227474
NA	CHEMICAL	GENE-Y	15	8	Readdition of a small quantity of dialyzed serum to cytosol preparations yielded a profile of chemical binding similar to that of the kidney gene ( chemical greater than chemical greater than chemical ) .	T5	T25	6227474
NA	CHEMICAL	GENE-Y	2	8	Readdition of a small quantity of dialyzed serum to cytosol preparations yielded a profile of chemical binding similar to that of the kidney gene ( chemical greater than chemical greater than chemical ) .	T7	T25	6227474
NA	CHEMICAL	GENE-Y	28	8	Readdition of a small quantity of dialyzed serum to cytosol preparations yielded a profile of chemical binding similar to that of the kidney gene ( chemical greater than chemical greater than chemical ) .	T8	T25	6227474
NA	CHEMICAL	GENE-Y	31	8	Readdition of a small quantity of dialyzed serum to cytosol preparations yielded a profile of chemical binding similar to that of the kidney gene ( chemical greater than chemical greater than chemical ) .	T9	T25	6227474
NA	CHEMICAL	GENE-Y	23	0	gene ( gene ) is a potential therapeutic target for Parkinson 's disease and this Letter describes the SAR of a series of chemical based gene inhibitors .	T1	T2	23522834
NA	CHEMICAL	GENE-Y	23	2	gene ( gene ) is a potential therapeutic target for Parkinson 's disease and this Letter describes the SAR of a series of chemical based gene inhibitors .	T1	T4	23522834
CPR:4	CHEMICAL	GENE-Y	23	25	gene ( gene ) is a potential therapeutic target for Parkinson 's disease and this Letter describes the SAR of a series of chemical based gene inhibitors .	T1	T3	23522834
CPR:4	CHEMICAL	GENE-Y	3	14	In combination with chemical , the ability of chemical to reduce the contents of gene and its target gene products was also evident in a time- and dose-dependent experiment .	T6	T22	23146690
CPR:4	CHEMICAL	GENE-Y	8	14	In combination with chemical , the ability of chemical to reduce the contents of gene and its target gene products was also evident in a time- and dose-dependent experiment .	T7	T22	23146690
NA	CHEMICAL	GENE-N	3	4	The inhibition of chemical 3-kinase using chemical augmented a decrease in the gene level induced by their combination , but it showed no significant effects on expression of gene and gene .	T8	T23	23146690
NA	CHEMICAL	GENE-Y	3	12	The inhibition of chemical 3-kinase using chemical augmented a decrease in the gene level induced by their combination , but it showed no significant effects on expression of gene and gene .	T8	T24	23146690
NA	CHEMICAL	GENE-Y	3	28	The inhibition of chemical 3-kinase using chemical augmented a decrease in the gene level induced by their combination , but it showed no significant effects on expression of gene and gene .	T8	T12	23146690
NA	CHEMICAL	GENE-Y	3	30	The inhibition of chemical 3-kinase using chemical augmented a decrease in the gene level induced by their combination , but it showed no significant effects on expression of gene and gene .	T8	T13	23146690
CPR:4	CHEMICAL	GENE-N	6	4	The inhibition of chemical 3-kinase using chemical augmented a decrease in the gene level induced by their combination , but it showed no significant effects on expression of gene and gene .	T9	T23	23146690
CPR:4	CHEMICAL	GENE-Y	6	12	The inhibition of chemical 3-kinase using chemical augmented a decrease in the gene level induced by their combination , but it showed no significant effects on expression of gene and gene .	T9	T24	23146690
NA	CHEMICAL	GENE-Y	6	28	The inhibition of chemical 3-kinase using chemical augmented a decrease in the gene level induced by their combination , but it showed no significant effects on expression of gene and gene .	T9	T12	23146690
NA	CHEMICAL	GENE-Y	6	30	The inhibition of chemical 3-kinase using chemical augmented a decrease in the gene level induced by their combination , but it showed no significant effects on expression of gene and gene .	T9	T13	23146690
NA	CHEMICAL	GENE-N	4	10	The effects of adulthood chemical treatment on cognitive performance and gene content in male and female rats neonatally treated with chemical .	T17	T30	17067304
NA	CHEMICAL	GENE-N	12	10	The effects of adulthood chemical treatment on cognitive performance and gene content in male and female rats neonatally treated with chemical .	T16	T30	17067304
NA	CHEMICAL	GENE-Y	0	1	chemical gene priming was verified through a yawning behavioural test , a D2 receptor-mediated event , before chemical was administered as well as after chemical treatment and behavioural testing were complete .	T8	T27	17067304
NA	CHEMICAL	GENE-Y	6	1	chemical gene priming was verified through a yawning behavioural test , a D2 receptor-mediated event , before chemical was administered as well as after chemical treatment and behavioural testing were complete .	T10	T27	17067304
NA	CHEMICAL	GENE-Y	6	1	chemical gene priming was verified through a yawning behavioural test , a D2 receptor-mediated event , before chemical was administered as well as after chemical treatment and behavioural testing were complete .	T11	T27	17067304
CPR:3	CHEMICAL	GENE-Y	4	7	Results showed that neonatal chemical treatment induced gene priming that was eliminated by chemical treatment .	T12	T28	17067304
CPR:4	CHEMICAL	GENE-Y	13	7	Results showed that neonatal chemical treatment induced gene priming that was eliminated by chemical treatment .	T13	T28	17067304
NA	CHEMICAL	GENE-Y	9	6	On the MWM place version , gene-primed rats demonstrated a significant impairment that was eliminated by chemical treatment , but chemical treatment to animals neonatally treated with saline produced a significant deficit on the place version of the MWM .	T14	T29	17067304
NA	CHEMICAL	GENE-Y	9	6	On the MWM place version , gene-primed rats demonstrated a significant impairment that was eliminated by chemical treatment , but chemical treatment to animals neonatally treated with saline produced a significant deficit on the place version of the MWM .	T15	T29	17067304
CPR:4	CHEMICAL	GENE-Y	6	14	Brain tissue analyses revealed that neonatal chemical treatment produced a significant decrease in hippocampal gene , gene and gene that was eliminated by chemical treatment .	T1	T18	17067304
CPR:4	CHEMICAL	GENE-Y	6	16	Brain tissue analyses revealed that neonatal chemical treatment produced a significant decrease in hippocampal gene , gene and gene that was eliminated by chemical treatment .	T1	T19	17067304
CPR:4	CHEMICAL	GENE-Y	6	18	Brain tissue analyses revealed that neonatal chemical treatment produced a significant decrease in hippocampal gene , gene and gene that was eliminated by chemical treatment .	T1	T20	17067304
CPR:3	CHEMICAL	GENE-Y	9	14	Brain tissue analyses revealed that neonatal chemical treatment produced a significant decrease in hippocampal gene , gene and gene that was eliminated by chemical treatment .	T2	T18	17067304
CPR:3	CHEMICAL	GENE-Y	9	16	Brain tissue analyses revealed that neonatal chemical treatment produced a significant decrease in hippocampal gene , gene and gene that was eliminated by chemical treatment .	T2	T19	17067304
CPR:3	CHEMICAL	GENE-Y	9	18	Brain tissue analyses revealed that neonatal chemical treatment produced a significant decrease in hippocampal gene , gene and gene that was eliminated by chemical treatment .	T2	T20	17067304
CPR:4	CHEMICAL	GENE-Y	1	8	Neonatal chemical treatment produced a significant decrease in gene and gene in the frontal cortex that was unaffected by chemical treatment .	T3	T21	17067304
CPR:4	CHEMICAL	GENE-Y	1	10	Neonatal chemical treatment produced a significant decrease in gene and gene in the frontal cortex that was unaffected by chemical treatment .	T3	T22	17067304
NA	CHEMICAL	GENE-Y	4	8	Neonatal chemical treatment produced a significant decrease in gene and gene in the frontal cortex that was unaffected by chemical treatment .	T4	T21	17067304
NA	CHEMICAL	GENE-Y	4	10	Neonatal chemical treatment produced a significant decrease in gene and gene in the frontal cortex that was unaffected by chemical treatment .	T4	T22	17067304
NA	CHEMICAL	GENE-N	2	1	The gene-like chemical protease gene is a target for the development of antifibrinolytic drugs for use in cardiac surgery with cardiopulmonary bypass or organ transplantations to reduce excessive blood loss .	T1	T7	23294255
NA	CHEMICAL	GENE-N	2	3	The gene-like chemical protease gene is a target for the development of antifibrinolytic drugs for use in cardiac surgery with cardiopulmonary bypass or organ transplantations to reduce excessive blood loss .	T1	T4	23294255
NA	CHEMICAL	GENE-Y	2	4	The gene-like chemical protease gene is a target for the development of antifibrinolytic drugs for use in cardiac surgery with cardiopulmonary bypass or organ transplantations to reduce excessive blood loss .	T1	T6	23294255
NA	CHEMICAL	GENE-Y	19	7	The most potent inhibitor 8 binds to gene with an inhibition constant of 0.2 nM , whereas K ( i ) values > 1 μM were determined for nearly all other tested gene , with the exception of gene , which is also inhibited in the nanomolar range .	T2	T8	23294255
NA	CHEMICAL	GENE-N	19	32	The most potent inhibitor 8 binds to gene with an inhibition constant of 0.2 nM , whereas K ( i ) values > 1 μM were determined for nearly all other tested gene , with the exception of gene , which is also inhibited in the nanomolar range .	T2	T9	23294255
NA	CHEMICAL	GENE-N	19	19	The most potent inhibitor 8 binds to gene with an inhibition constant of 0.2 nM , whereas K ( i ) values > 1 μM were determined for nearly all other tested gene , with the exception of gene , which is also inhibited in the nanomolar range .	T2	T10	23294255
NA	CHEMICAL	GENE-Y	4	3	Selective antagonism of gene chemical-receptor-mediated synaptic currents by chemical in rat basolateral amygdala neurons .	T12	T23	12904467
NA	CHEMICAL	GENE-N	4	9	Selective antagonism of gene chemical-receptor-mediated synaptic currents by chemical in rat basolateral amygdala neurons .	T12	T24	12904467
CPR:6	CHEMICAL	GENE-Y	8	3	Selective antagonism of gene chemical-receptor-mediated synaptic currents by chemical in rat basolateral amygdala neurons .	T13	T23	12904467
CPR:6	CHEMICAL	GENE-N	8	9	Selective antagonism of gene chemical-receptor-mediated synaptic currents by chemical in rat basolateral amygdala neurons .	T13	T24	12904467
NA	CHEMICAL	GENE-N	13	9	The drug has been reported to interact with various gene types , including chemical/chemical receptors .	T3	T16	12904467
NA	CHEMICAL	GENE-N	13	5	The drug has been reported to interact with various gene types , including chemical/chemical receptors .	T3	T17	12904467
NA	CHEMICAL	GENE-N	13	9	The drug has been reported to interact with various gene types , including chemical/chemical receptors .	T4	T16	12904467
NA	CHEMICAL	GENE-N	13	5	The drug has been reported to interact with various gene types , including chemical/chemical receptors .	T4	T17	12904467
CPR:4	CHEMICAL	GENE-N	13	34	In whole-cell voltage-clamp recordings from principal neurons of the rat basolateral amygdala , chemical at low concentrations ( IC50 , approximately 0.5 microm ) selectively inhibited pharmacologically isolated excitatory synaptic currents mediated by chemical receptors containing the gene subunit .	T5	T18	12904467
CPR:4	CHEMICAL	GENE-Y	13	37	In whole-cell voltage-clamp recordings from principal neurons of the rat basolateral amygdala , chemical at low concentrations ( IC50 , approximately 0.5 microm ) selectively inhibited pharmacologically isolated excitatory synaptic currents mediated by chemical receptors containing the gene subunit .	T5	T19	12904467
NA	CHEMICAL	GENE-N	14	34	In whole-cell voltage-clamp recordings from principal neurons of the rat basolateral amygdala , chemical at low concentrations ( IC50 , approximately 0.5 microm ) selectively inhibited pharmacologically isolated excitatory synaptic currents mediated by chemical receptors containing the gene subunit .	T6	T18	12904467
NA	CHEMICAL	GENE-Y	14	37	In whole-cell voltage-clamp recordings from principal neurons of the rat basolateral amygdala , chemical at low concentrations ( IC50 , approximately 0.5 microm ) selectively inhibited pharmacologically isolated excitatory synaptic currents mediated by chemical receptors containing the gene subunit .	T6	T19	12904467
NA	CHEMICAL	GENE-Y	3	2	Inhibition of gene chemical receptors could represent a key mechanism underlying the anticonvulsant activity of chemical .	T10	T21	12904467
NA	CHEMICAL	GENE-N	3	4	Inhibition of gene chemical receptors could represent a key mechanism underlying the anticonvulsant activity of chemical .	T10	T22	12904467
CPR:4	CHEMICAL	GENE-Y	7	2	Inhibition of gene chemical receptors could represent a key mechanism underlying the anticonvulsant activity of chemical .	T11	T21	12904467
CPR:4	CHEMICAL	GENE-N	7	4	Inhibition of gene chemical receptors could represent a key mechanism underlying the anticonvulsant activity of chemical .	T11	T22	12904467
NA	CHEMICAL	GENE-Y	6	2	Identification of an Allosteric Modulator of chemical Transporter with Novel Mechanism of Action .	T11	T23	23632081
NA	CHEMICAL	GENE-Y	0	1	chemical transporters ( gene ) play an essential role in the termination and regulation of chemical signaling in the brain .	T1	T12	23632081
NA	CHEMICAL	GENE-Y	0	3	chemical transporters ( gene ) play an essential role in the termination and regulation of chemical signaling in the brain .	T1	T19	23632081
NA	CHEMICAL	GENE-Y	9	1	chemical transporters ( gene ) play an essential role in the termination and regulation of chemical signaling in the brain .	T10	T12	23632081
NA	CHEMICAL	GENE-Y	9	3	chemical transporters ( gene ) play an essential role in the termination and regulation of chemical signaling in the brain .	T10	T19	23632081
NA	CHEMICAL	GENE-N	8	6	Using the structure of the bacterial transporter homologue chemical transporter as a template , we developed a structural model of gene .	T9	T21	23632081
NA	CHEMICAL	GENE-Y	8	20	Using the structure of the bacterial transporter homologue chemical transporter as a template , we developed a structural model of gene .	T9	T22	23632081
CPR:9	CHEMICAL	GENE-Y	20	33	In functional transport assays , we found that one of the identified molecules , ATM7 , increased the reuptake of chemical , possibly by facilitating the interaction of chemical with transport-ready conformations of gene when concentrations of chemical were low and rate limiting .	T2	T15	23632081
CPR:9	CHEMICAL	GENE-Y	28	33	In functional transport assays , we found that one of the identified molecules , ATM7 , increased the reuptake of chemical , possibly by facilitating the interaction of chemical with transport-ready conformations of gene when concentrations of chemical were low and rate limiting .	T3	T15	23632081
CPR:9	CHEMICAL	GENE-Y	37	33	In functional transport assays , we found that one of the identified molecules , ATM7 , increased the reuptake of chemical , possibly by facilitating the interaction of chemical with transport-ready conformations of gene when concentrations of chemical were low and rate limiting .	T4	T15	23632081
NA	CHEMICAL	GENE-Y	2	17	In addition , ATM7 potentiates chemical ( chemical , `` Ecstasy '' ) -induced reversed transport by gene .	T5	T16	23632081
NA	CHEMICAL	GENE-Y	7	17	In addition , ATM7 potentiates chemical ( chemical , `` Ecstasy '' ) -induced reversed transport by gene .	T6	T16	23632081
NA	CHEMICAL	GENE-Y	5	0	gene ( gene ) and chemical chemical ( 2A ) receptors have been reported to form heterodimers that modulate gene-mediated intracellular signaling differentially compared to gene and gene homomers .	T13	T31	23179966
NA	CHEMICAL	GENE-N	5	2	gene ( gene ) and chemical chemical ( 2A ) receptors have been reported to form heterodimers that modulate gene-mediated intracellular signaling differentially compared to gene and gene homomers .	T13	T32	23179966
NA	CHEMICAL	GENE-Y	5	1	gene ( gene ) and chemical chemical ( 2A ) receptors have been reported to form heterodimers that modulate gene-mediated intracellular signaling differentially compared to gene and gene homomers .	T13	T33	23179966
NA	CHEMICAL	GENE-N	5	19	gene ( gene ) and chemical chemical ( 2A ) receptors have been reported to form heterodimers that modulate gene-mediated intracellular signaling differentially compared to gene and gene homomers .	T13	T34	23179966
NA	CHEMICAL	GENE-Y	5	25	gene ( gene ) and chemical chemical ( 2A ) receptors have been reported to form heterodimers that modulate gene-mediated intracellular signaling differentially compared to gene and gene homomers .	T13	T35	23179966
NA	CHEMICAL	GENE-Y	5	1	gene ( gene ) and chemical chemical ( 2A ) receptors have been reported to form heterodimers that modulate gene-mediated intracellular signaling differentially compared to gene and gene homomers .	T13	T36	23179966
NA	CHEMICAL	GENE-Y	6	0	gene ( gene ) and chemical chemical ( 2A ) receptors have been reported to form heterodimers that modulate gene-mediated intracellular signaling differentially compared to gene and gene homomers .	T14	T31	23179966
NA	CHEMICAL	GENE-N	6	2	gene ( gene ) and chemical chemical ( 2A ) receptors have been reported to form heterodimers that modulate gene-mediated intracellular signaling differentially compared to gene and gene homomers .	T14	T32	23179966
NA	CHEMICAL	GENE-Y	6	1	gene ( gene ) and chemical chemical ( 2A ) receptors have been reported to form heterodimers that modulate gene-mediated intracellular signaling differentially compared to gene and gene homomers .	T14	T33	23179966
NA	CHEMICAL	GENE-N	6	19	gene ( gene ) and chemical chemical ( 2A ) receptors have been reported to form heterodimers that modulate gene-mediated intracellular signaling differentially compared to gene and gene homomers .	T14	T34	23179966
NA	CHEMICAL	GENE-Y	6	25	gene ( gene ) and chemical chemical ( 2A ) receptors have been reported to form heterodimers that modulate gene-mediated intracellular signaling differentially compared to gene and gene homomers .	T14	T35	23179966
NA	CHEMICAL	GENE-Y	6	1	gene ( gene ) and chemical chemical ( 2A ) receptors have been reported to form heterodimers that modulate gene-mediated intracellular signaling differentially compared to gene and gene homomers .	T14	T36	23179966
NA	CHEMICAL	GENE-N	20	2	Moving from receptors to postsynaptic density ( PSD ) scenario , the scaffolding protein PSD-95 is known to interact with chemical ( chemical ) , D ( 2 ) and chemical ( 2 ) receptors , regulating their activation state .	T20	T38	23179966
NA	CHEMICAL	GENE-N	22	2	Moving from receptors to postsynaptic density ( PSD ) scenario , the scaffolding protein PSD-95 is known to interact with chemical ( chemical ) , D ( 2 ) and chemical ( 2 ) receptors , regulating their activation state .	T21	T38	23179966
NA	CHEMICAL	GENE-N	30	2	Moving from receptors to postsynaptic density ( PSD ) scenario , the scaffolding protein PSD-95 is known to interact with chemical ( chemical ) , D ( 2 ) and chemical ( 2 ) receptors , regulating their activation state .	T22	T38	23179966
NA	CHEMICAL	GENE-N	15	0	gene1a , the inducible member of the Homer family of PSD proteins that is implicated in glutamatergic signal transduction , is induced in striatum by antipsychotics with high chemical receptor affinity and in the cortex by antipsychotics with mixed serotonergic/dopaminergic profile .	T1	T39	23179966
NA	CHEMICAL	GENE-N	5	5	Signaling molecules , such as gene and gene ( gene ) , could be involved in the mechanism of action of antipsychotics , targeting chemical , chemical , and chemical neurotransmission .	T2	T28	23179966
NA	CHEMICAL	GENE-N	5	4	Signaling molecules , such as gene and gene ( gene ) , could be involved in the mechanism of action of antipsychotics , targeting chemical , chemical , and chemical neurotransmission .	T2	T29	23179966
NA	CHEMICAL	GENE-N	5	9	Signaling molecules , such as gene and gene ( gene ) , could be involved in the mechanism of action of antipsychotics , targeting chemical , chemical , and chemical neurotransmission .	T2	T30	23179966
NA	CHEMICAL	GENE-N	9	5	Signaling molecules , such as gene and gene ( gene ) , could be involved in the mechanism of action of antipsychotics , targeting chemical , chemical , and chemical neurotransmission .	T3	T28	23179966
NA	CHEMICAL	GENE-N	9	4	Signaling molecules , such as gene and gene ( gene ) , could be involved in the mechanism of action of antipsychotics , targeting chemical , chemical , and chemical neurotransmission .	T3	T29	23179966
NA	CHEMICAL	GENE-N	9	9	Signaling molecules , such as gene and gene ( gene ) , could be involved in the mechanism of action of antipsychotics , targeting chemical , chemical , and chemical neurotransmission .	T3	T30	23179966
NA	CHEMICAL	GENE-N	29	5	Signaling molecules , such as gene and gene ( gene ) , could be involved in the mechanism of action of antipsychotics , targeting chemical , chemical , and chemical neurotransmission .	T4	T28	23179966
NA	CHEMICAL	GENE-N	29	4	Signaling molecules , such as gene and gene ( gene ) , could be involved in the mechanism of action of antipsychotics , targeting chemical , chemical , and chemical neurotransmission .	T4	T29	23179966
NA	CHEMICAL	GENE-N	29	9	Signaling molecules , such as gene and gene ( gene ) , could be involved in the mechanism of action of antipsychotics , targeting chemical , chemical , and chemical neurotransmission .	T4	T30	23179966
CPR:4	CHEMICAL	GENE-N	0	4	chemical inhibition of canonical gene signaling disrupts prostatic bud formation in mouse urogenital sinus .	T12	T40	23429912
CPR:4	CHEMICAL	GENE-N	6	9	In support of the hypothesis that chemical decreases canonical gene signaling , we identify inhibitory effects of chemical on multiple components of the canonical gene signaling pathway in the UGS that temporally coincide with the inhibitory effect of chemical on prostatic bud formation : ( 1 ) expression of gene ( gene and gene ) that promote canonical gene signaling is reduced ; ( 2 ) expression of gene , gene , and gene , established canonical gene target genes , is decreased ; ( 3 ) expression of gene , a gene that activates canonical gene signaling , is reduced ; and ( 4 ) expression of gene ( gene ) , inhibitors of canonical gene signaling , is not increased by chemical .	T8	T30	23429912
NA	CHEMICAL	GENE-N	6	24	In support of the hypothesis that chemical decreases canonical gene signaling , we identify inhibitory effects of chemical on multiple components of the canonical gene signaling pathway in the UGS that temporally coincide with the inhibitory effect of chemical on prostatic bud formation : ( 1 ) expression of gene ( gene and gene ) that promote canonical gene signaling is reduced ; ( 2 ) expression of gene , gene , and gene , established canonical gene target genes , is decreased ; ( 3 ) expression of gene , a gene that activates canonical gene signaling , is reduced ; and ( 4 ) expression of gene ( gene ) , inhibitors of canonical gene signaling , is not increased by chemical .	T8	T31	23429912
NA	CHEMICAL	GENE-N	6	18	In support of the hypothesis that chemical decreases canonical gene signaling , we identify inhibitory effects of chemical on multiple components of the canonical gene signaling pathway in the UGS that temporally coincide with the inhibitory effect of chemical on prostatic bud formation : ( 1 ) expression of gene ( gene and gene ) that promote canonical gene signaling is reduced ; ( 2 ) expression of gene , gene , and gene , established canonical gene target genes , is decreased ; ( 3 ) expression of gene , a gene that activates canonical gene signaling , is reduced ; and ( 4 ) expression of gene ( gene ) , inhibitors of canonical gene signaling , is not increased by chemical .	T8	T32	23429912
NA	CHEMICAL	GENE-Y	6	51	In support of the hypothesis that chemical decreases canonical gene signaling , we identify inhibitory effects of chemical on multiple components of the canonical gene signaling pathway in the UGS that temporally coincide with the inhibitory effect of chemical on prostatic bud formation : ( 1 ) expression of gene ( gene and gene ) that promote canonical gene signaling is reduced ; ( 2 ) expression of gene , gene , and gene , established canonical gene target genes , is decreased ; ( 3 ) expression of gene , a gene that activates canonical gene signaling , is reduced ; and ( 4 ) expression of gene ( gene ) , inhibitors of canonical gene signaling , is not increased by chemical .	T8	T33	23429912
NA	CHEMICAL	GENE-Y	6	53	In support of the hypothesis that chemical decreases canonical gene signaling , we identify inhibitory effects of chemical on multiple components of the canonical gene signaling pathway in the UGS that temporally coincide with the inhibitory effect of chemical on prostatic bud formation : ( 1 ) expression of gene ( gene and gene ) that promote canonical gene signaling is reduced ; ( 2 ) expression of gene , gene , and gene , established canonical gene target genes , is decreased ; ( 3 ) expression of gene , a gene that activates canonical gene signaling , is reduced ; and ( 4 ) expression of gene ( gene ) , inhibitors of canonical gene signaling , is not increased by chemical .	T8	T34	23429912
NA	CHEMICAL	GENE-N	6	58	In support of the hypothesis that chemical decreases canonical gene signaling , we identify inhibitory effects of chemical on multiple components of the canonical gene signaling pathway in the UGS that temporally coincide with the inhibitory effect of chemical on prostatic bud formation : ( 1 ) expression of gene ( gene and gene ) that promote canonical gene signaling is reduced ; ( 2 ) expression of gene , gene , and gene , established canonical gene target genes , is decreased ; ( 3 ) expression of gene , a gene that activates canonical gene signaling , is reduced ; and ( 4 ) expression of gene ( gene ) , inhibitors of canonical gene signaling , is not increased by chemical .	T8	T35	23429912
NA	CHEMICAL	GENE-Y	6	45	In support of the hypothesis that chemical decreases canonical gene signaling , we identify inhibitory effects of chemical on multiple components of the canonical gene signaling pathway in the UGS that temporally coincide with the inhibitory effect of chemical on prostatic bud formation : ( 1 ) expression of gene ( gene and gene ) that promote canonical gene signaling is reduced ; ( 2 ) expression of gene , gene , and gene , established canonical gene target genes , is decreased ; ( 3 ) expression of gene , a gene that activates canonical gene signaling , is reduced ; and ( 4 ) expression of gene ( gene ) , inhibitors of canonical gene signaling , is not increased by chemical .	T8	T36	23429912
NA	CHEMICAL	GENE-Y	6	45	In support of the hypothesis that chemical decreases canonical gene signaling , we identify inhibitory effects of chemical on multiple components of the canonical gene signaling pathway in the UGS that temporally coincide with the inhibitory effect of chemical on prostatic bud formation : ( 1 ) expression of gene ( gene and gene ) that promote canonical gene signaling is reduced ; ( 2 ) expression of gene , gene , and gene , established canonical gene target genes , is decreased ; ( 3 ) expression of gene , a gene that activates canonical gene signaling , is reduced ; and ( 4 ) expression of gene ( gene ) , inhibitors of canonical gene signaling , is not increased by chemical .	T8	T37	23429912
NA	CHEMICAL	GENE-Y	6	45	In support of the hypothesis that chemical decreases canonical gene signaling , we identify inhibitory effects of chemical on multiple components of the canonical gene signaling pathway in the UGS that temporally coincide with the inhibitory effect of chemical on prostatic bud formation : ( 1 ) expression of gene ( gene and gene ) that promote canonical gene signaling is reduced ; ( 2 ) expression of gene , gene , and gene , established canonical gene target genes , is decreased ; ( 3 ) expression of gene , a gene that activates canonical gene signaling , is reduced ; and ( 4 ) expression of gene ( gene ) , inhibitors of canonical gene signaling , is not increased by chemical .	T8	T38	23429912
NA	CHEMICAL	GENE-N	6	77	In support of the hypothesis that chemical decreases canonical gene signaling , we identify inhibitory effects of chemical on multiple components of the canonical gene signaling pathway in the UGS that temporally coincide with the inhibitory effect of chemical on prostatic bud formation : ( 1 ) expression of gene ( gene and gene ) that promote canonical gene signaling is reduced ; ( 2 ) expression of gene , gene , and gene , established canonical gene target genes , is decreased ; ( 3 ) expression of gene , a gene that activates canonical gene signaling , is reduced ; and ( 4 ) expression of gene ( gene ) , inhibitors of canonical gene signaling , is not increased by chemical .	T8	T39	23429912
NA	CHEMICAL	GENE-Y	6	89	In support of the hypothesis that chemical decreases canonical gene signaling , we identify inhibitory effects of chemical on multiple components of the canonical gene signaling pathway in the UGS that temporally coincide with the inhibitory effect of chemical on prostatic bud formation : ( 1 ) expression of gene ( gene and gene ) that promote canonical gene signaling is reduced ; ( 2 ) expression of gene , gene , and gene , established canonical gene target genes , is decreased ; ( 3 ) expression of gene , a gene that activates canonical gene signaling , is reduced ; and ( 4 ) expression of gene ( gene ) , inhibitors of canonical gene signaling , is not increased by chemical .	T8	T13	23429912
NA	CHEMICAL	GENE-Y	6	92	In support of the hypothesis that chemical decreases canonical gene signaling , we identify inhibitory effects of chemical on multiple components of the canonical gene signaling pathway in the UGS that temporally coincide with the inhibitory effect of chemical on prostatic bud formation : ( 1 ) expression of gene ( gene and gene ) that promote canonical gene signaling is reduced ; ( 2 ) expression of gene , gene , and gene , established canonical gene target genes , is decreased ; ( 3 ) expression of gene , a gene that activates canonical gene signaling , is reduced ; and ( 4 ) expression of gene ( gene ) , inhibitors of canonical gene signaling , is not increased by chemical .	T8	T14	23429912
NA	CHEMICAL	GENE-N	6	96	In support of the hypothesis that chemical decreases canonical gene signaling , we identify inhibitory effects of chemical on multiple components of the canonical gene signaling pathway in the UGS that temporally coincide with the inhibitory effect of chemical on prostatic bud formation : ( 1 ) expression of gene ( gene and gene ) that promote canonical gene signaling is reduced ; ( 2 ) expression of gene , gene , and gene , established canonical gene target genes , is decreased ; ( 3 ) expression of gene , a gene that activates canonical gene signaling , is reduced ; and ( 4 ) expression of gene ( gene ) , inhibitors of canonical gene signaling , is not increased by chemical .	T8	T15	23429912
NA	CHEMICAL	GENE-N	6	108	In support of the hypothesis that chemical decreases canonical gene signaling , we identify inhibitory effects of chemical on multiple components of the canonical gene signaling pathway in the UGS that temporally coincide with the inhibitory effect of chemical on prostatic bud formation : ( 1 ) expression of gene ( gene and gene ) that promote canonical gene signaling is reduced ; ( 2 ) expression of gene , gene , and gene , established canonical gene target genes , is decreased ; ( 3 ) expression of gene , a gene that activates canonical gene signaling , is reduced ; and ( 4 ) expression of gene ( gene ) , inhibitors of canonical gene signaling , is not increased by chemical .	T8	T16	23429912
NA	CHEMICAL	GENE-N	6	110	In support of the hypothesis that chemical decreases canonical gene signaling , we identify inhibitory effects of chemical on multiple components of the canonical gene signaling pathway in the UGS that temporally coincide with the inhibitory effect of chemical on prostatic bud formation : ( 1 ) expression of gene ( gene and gene ) that promote canonical gene signaling is reduced ; ( 2 ) expression of gene , gene , and gene , established canonical gene target genes , is decreased ; ( 3 ) expression of gene , a gene that activates canonical gene signaling , is reduced ; and ( 4 ) expression of gene ( gene ) , inhibitors of canonical gene signaling , is not increased by chemical .	T8	T17	23429912
NA	CHEMICAL	GENE-N	6	116	In support of the hypothesis that chemical decreases canonical gene signaling , we identify inhibitory effects of chemical on multiple components of the canonical gene signaling pathway in the UGS that temporally coincide with the inhibitory effect of chemical on prostatic bud formation : ( 1 ) expression of gene ( gene and gene ) that promote canonical gene signaling is reduced ; ( 2 ) expression of gene , gene , and gene , established canonical gene target genes , is decreased ; ( 3 ) expression of gene , a gene that activates canonical gene signaling , is reduced ; and ( 4 ) expression of gene ( gene ) , inhibitors of canonical gene signaling , is not increased by chemical .	T8	T18	23429912
NA	CHEMICAL	GENE-N	17	9	In support of the hypothesis that chemical decreases canonical gene signaling , we identify inhibitory effects of chemical on multiple components of the canonical gene signaling pathway in the UGS that temporally coincide with the inhibitory effect of chemical on prostatic bud formation : ( 1 ) expression of gene ( gene and gene ) that promote canonical gene signaling is reduced ; ( 2 ) expression of gene , gene , and gene , established canonical gene target genes , is decreased ; ( 3 ) expression of gene , a gene that activates canonical gene signaling , is reduced ; and ( 4 ) expression of gene ( gene ) , inhibitors of canonical gene signaling , is not increased by chemical .	T9	T30	23429912
NA	CHEMICAL	GENE-N	17	24	In support of the hypothesis that chemical decreases canonical gene signaling , we identify inhibitory effects of chemical on multiple components of the canonical gene signaling pathway in the UGS that temporally coincide with the inhibitory effect of chemical on prostatic bud formation : ( 1 ) expression of gene ( gene and gene ) that promote canonical gene signaling is reduced ; ( 2 ) expression of gene , gene , and gene , established canonical gene target genes , is decreased ; ( 3 ) expression of gene , a gene that activates canonical gene signaling , is reduced ; and ( 4 ) expression of gene ( gene ) , inhibitors of canonical gene signaling , is not increased by chemical .	T9	T31	23429912
NA	CHEMICAL	GENE-N	17	18	In support of the hypothesis that chemical decreases canonical gene signaling , we identify inhibitory effects of chemical on multiple components of the canonical gene signaling pathway in the UGS that temporally coincide with the inhibitory effect of chemical on prostatic bud formation : ( 1 ) expression of gene ( gene and gene ) that promote canonical gene signaling is reduced ; ( 2 ) expression of gene , gene , and gene , established canonical gene target genes , is decreased ; ( 3 ) expression of gene , a gene that activates canonical gene signaling , is reduced ; and ( 4 ) expression of gene ( gene ) , inhibitors of canonical gene signaling , is not increased by chemical .	T9	T32	23429912
NA	CHEMICAL	GENE-Y	17	51	In support of the hypothesis that chemical decreases canonical gene signaling , we identify inhibitory effects of chemical on multiple components of the canonical gene signaling pathway in the UGS that temporally coincide with the inhibitory effect of chemical on prostatic bud formation : ( 1 ) expression of gene ( gene and gene ) that promote canonical gene signaling is reduced ; ( 2 ) expression of gene , gene , and gene , established canonical gene target genes , is decreased ; ( 3 ) expression of gene , a gene that activates canonical gene signaling , is reduced ; and ( 4 ) expression of gene ( gene ) , inhibitors of canonical gene signaling , is not increased by chemical .	T9	T33	23429912
NA	CHEMICAL	GENE-Y	17	53	In support of the hypothesis that chemical decreases canonical gene signaling , we identify inhibitory effects of chemical on multiple components of the canonical gene signaling pathway in the UGS that temporally coincide with the inhibitory effect of chemical on prostatic bud formation : ( 1 ) expression of gene ( gene and gene ) that promote canonical gene signaling is reduced ; ( 2 ) expression of gene , gene , and gene , established canonical gene target genes , is decreased ; ( 3 ) expression of gene , a gene that activates canonical gene signaling , is reduced ; and ( 4 ) expression of gene ( gene ) , inhibitors of canonical gene signaling , is not increased by chemical .	T9	T34	23429912
NA	CHEMICAL	GENE-N	17	58	In support of the hypothesis that chemical decreases canonical gene signaling , we identify inhibitory effects of chemical on multiple components of the canonical gene signaling pathway in the UGS that temporally coincide with the inhibitory effect of chemical on prostatic bud formation : ( 1 ) expression of gene ( gene and gene ) that promote canonical gene signaling is reduced ; ( 2 ) expression of gene , gene , and gene , established canonical gene target genes , is decreased ; ( 3 ) expression of gene , a gene that activates canonical gene signaling , is reduced ; and ( 4 ) expression of gene ( gene ) , inhibitors of canonical gene signaling , is not increased by chemical .	T9	T35	23429912
NA	CHEMICAL	GENE-Y	17	45	In support of the hypothesis that chemical decreases canonical gene signaling , we identify inhibitory effects of chemical on multiple components of the canonical gene signaling pathway in the UGS that temporally coincide with the inhibitory effect of chemical on prostatic bud formation : ( 1 ) expression of gene ( gene and gene ) that promote canonical gene signaling is reduced ; ( 2 ) expression of gene , gene , and gene , established canonical gene target genes , is decreased ; ( 3 ) expression of gene , a gene that activates canonical gene signaling , is reduced ; and ( 4 ) expression of gene ( gene ) , inhibitors of canonical gene signaling , is not increased by chemical .	T9	T36	23429912
NA	CHEMICAL	GENE-Y	17	45	In support of the hypothesis that chemical decreases canonical gene signaling , we identify inhibitory effects of chemical on multiple components of the canonical gene signaling pathway in the UGS that temporally coincide with the inhibitory effect of chemical on prostatic bud formation : ( 1 ) expression of gene ( gene and gene ) that promote canonical gene signaling is reduced ; ( 2 ) expression of gene , gene , and gene , established canonical gene target genes , is decreased ; ( 3 ) expression of gene , a gene that activates canonical gene signaling , is reduced ; and ( 4 ) expression of gene ( gene ) , inhibitors of canonical gene signaling , is not increased by chemical .	T9	T37	23429912
NA	CHEMICAL	GENE-Y	17	45	In support of the hypothesis that chemical decreases canonical gene signaling , we identify inhibitory effects of chemical on multiple components of the canonical gene signaling pathway in the UGS that temporally coincide with the inhibitory effect of chemical on prostatic bud formation : ( 1 ) expression of gene ( gene and gene ) that promote canonical gene signaling is reduced ; ( 2 ) expression of gene , gene , and gene , established canonical gene target genes , is decreased ; ( 3 ) expression of gene , a gene that activates canonical gene signaling , is reduced ; and ( 4 ) expression of gene ( gene ) , inhibitors of canonical gene signaling , is not increased by chemical .	T9	T38	23429912
NA	CHEMICAL	GENE-N	17	77	In support of the hypothesis that chemical decreases canonical gene signaling , we identify inhibitory effects of chemical on multiple components of the canonical gene signaling pathway in the UGS that temporally coincide with the inhibitory effect of chemical on prostatic bud formation : ( 1 ) expression of gene ( gene and gene ) that promote canonical gene signaling is reduced ; ( 2 ) expression of gene , gene , and gene , established canonical gene target genes , is decreased ; ( 3 ) expression of gene , a gene that activates canonical gene signaling , is reduced ; and ( 4 ) expression of gene ( gene ) , inhibitors of canonical gene signaling , is not increased by chemical .	T9	T39	23429912
NA	CHEMICAL	GENE-Y	17	89	In support of the hypothesis that chemical decreases canonical gene signaling , we identify inhibitory effects of chemical on multiple components of the canonical gene signaling pathway in the UGS that temporally coincide with the inhibitory effect of chemical on prostatic bud formation : ( 1 ) expression of gene ( gene and gene ) that promote canonical gene signaling is reduced ; ( 2 ) expression of gene , gene , and gene , established canonical gene target genes , is decreased ; ( 3 ) expression of gene , a gene that activates canonical gene signaling , is reduced ; and ( 4 ) expression of gene ( gene ) , inhibitors of canonical gene signaling , is not increased by chemical .	T9	T13	23429912
NA	CHEMICAL	GENE-Y	17	92	In support of the hypothesis that chemical decreases canonical gene signaling , we identify inhibitory effects of chemical on multiple components of the canonical gene signaling pathway in the UGS that temporally coincide with the inhibitory effect of chemical on prostatic bud formation : ( 1 ) expression of gene ( gene and gene ) that promote canonical gene signaling is reduced ; ( 2 ) expression of gene , gene , and gene , established canonical gene target genes , is decreased ; ( 3 ) expression of gene , a gene that activates canonical gene signaling , is reduced ; and ( 4 ) expression of gene ( gene ) , inhibitors of canonical gene signaling , is not increased by chemical .	T9	T14	23429912
NA	CHEMICAL	GENE-N	17	96	In support of the hypothesis that chemical decreases canonical gene signaling , we identify inhibitory effects of chemical on multiple components of the canonical gene signaling pathway in the UGS that temporally coincide with the inhibitory effect of chemical on prostatic bud formation : ( 1 ) expression of gene ( gene and gene ) that promote canonical gene signaling is reduced ; ( 2 ) expression of gene , gene , and gene , established canonical gene target genes , is decreased ; ( 3 ) expression of gene , a gene that activates canonical gene signaling , is reduced ; and ( 4 ) expression of gene ( gene ) , inhibitors of canonical gene signaling , is not increased by chemical .	T9	T15	23429912
NA	CHEMICAL	GENE-N	17	108	In support of the hypothesis that chemical decreases canonical gene signaling , we identify inhibitory effects of chemical on multiple components of the canonical gene signaling pathway in the UGS that temporally coincide with the inhibitory effect of chemical on prostatic bud formation : ( 1 ) expression of gene ( gene and gene ) that promote canonical gene signaling is reduced ; ( 2 ) expression of gene , gene , and gene , established canonical gene target genes , is decreased ; ( 3 ) expression of gene , a gene that activates canonical gene signaling , is reduced ; and ( 4 ) expression of gene ( gene ) , inhibitors of canonical gene signaling , is not increased by chemical .	T9	T16	23429912
NA	CHEMICAL	GENE-N	17	110	In support of the hypothesis that chemical decreases canonical gene signaling , we identify inhibitory effects of chemical on multiple components of the canonical gene signaling pathway in the UGS that temporally coincide with the inhibitory effect of chemical on prostatic bud formation : ( 1 ) expression of gene ( gene and gene ) that promote canonical gene signaling is reduced ; ( 2 ) expression of gene , gene , and gene , established canonical gene target genes , is decreased ; ( 3 ) expression of gene , a gene that activates canonical gene signaling , is reduced ; and ( 4 ) expression of gene ( gene ) , inhibitors of canonical gene signaling , is not increased by chemical .	T9	T17	23429912
NA	CHEMICAL	GENE-N	17	116	In support of the hypothesis that chemical decreases canonical gene signaling , we identify inhibitory effects of chemical on multiple components of the canonical gene signaling pathway in the UGS that temporally coincide with the inhibitory effect of chemical on prostatic bud formation : ( 1 ) expression of gene ( gene and gene ) that promote canonical gene signaling is reduced ; ( 2 ) expression of gene , gene , and gene , established canonical gene target genes , is decreased ; ( 3 ) expression of gene , a gene that activates canonical gene signaling , is reduced ; and ( 4 ) expression of gene ( gene ) , inhibitors of canonical gene signaling , is not increased by chemical .	T9	T18	23429912
NA	CHEMICAL	GENE-N	38	9	In support of the hypothesis that chemical decreases canonical gene signaling , we identify inhibitory effects of chemical on multiple components of the canonical gene signaling pathway in the UGS that temporally coincide with the inhibitory effect of chemical on prostatic bud formation : ( 1 ) expression of gene ( gene and gene ) that promote canonical gene signaling is reduced ; ( 2 ) expression of gene , gene , and gene , established canonical gene target genes , is decreased ; ( 3 ) expression of gene , a gene that activates canonical gene signaling , is reduced ; and ( 4 ) expression of gene ( gene ) , inhibitors of canonical gene signaling , is not increased by chemical .	T11	T30	23429912
NA	CHEMICAL	GENE-N	38	24	In support of the hypothesis that chemical decreases canonical gene signaling , we identify inhibitory effects of chemical on multiple components of the canonical gene signaling pathway in the UGS that temporally coincide with the inhibitory effect of chemical on prostatic bud formation : ( 1 ) expression of gene ( gene and gene ) that promote canonical gene signaling is reduced ; ( 2 ) expression of gene , gene , and gene , established canonical gene target genes , is decreased ; ( 3 ) expression of gene , a gene that activates canonical gene signaling , is reduced ; and ( 4 ) expression of gene ( gene ) , inhibitors of canonical gene signaling , is not increased by chemical .	T11	T31	23429912
CPR:4	CHEMICAL	GENE-N	38	18	In support of the hypothesis that chemical decreases canonical gene signaling , we identify inhibitory effects of chemical on multiple components of the canonical gene signaling pathway in the UGS that temporally coincide with the inhibitory effect of chemical on prostatic bud formation : ( 1 ) expression of gene ( gene and gene ) that promote canonical gene signaling is reduced ; ( 2 ) expression of gene , gene , and gene , established canonical gene target genes , is decreased ; ( 3 ) expression of gene , a gene that activates canonical gene signaling , is reduced ; and ( 4 ) expression of gene ( gene ) , inhibitors of canonical gene signaling , is not increased by chemical .	T11	T32	23429912
CPR:4	CHEMICAL	GENE-Y	38	51	In support of the hypothesis that chemical decreases canonical gene signaling , we identify inhibitory effects of chemical on multiple components of the canonical gene signaling pathway in the UGS that temporally coincide with the inhibitory effect of chemical on prostatic bud formation : ( 1 ) expression of gene ( gene and gene ) that promote canonical gene signaling is reduced ; ( 2 ) expression of gene , gene , and gene , established canonical gene target genes , is decreased ; ( 3 ) expression of gene , a gene that activates canonical gene signaling , is reduced ; and ( 4 ) expression of gene ( gene ) , inhibitors of canonical gene signaling , is not increased by chemical .	T11	T33	23429912
CPR:4	CHEMICAL	GENE-Y	38	53	In support of the hypothesis that chemical decreases canonical gene signaling , we identify inhibitory effects of chemical on multiple components of the canonical gene signaling pathway in the UGS that temporally coincide with the inhibitory effect of chemical on prostatic bud formation : ( 1 ) expression of gene ( gene and gene ) that promote canonical gene signaling is reduced ; ( 2 ) expression of gene , gene , and gene , established canonical gene target genes , is decreased ; ( 3 ) expression of gene , a gene that activates canonical gene signaling , is reduced ; and ( 4 ) expression of gene ( gene ) , inhibitors of canonical gene signaling , is not increased by chemical .	T11	T34	23429912
NA	CHEMICAL	GENE-N	38	58	In support of the hypothesis that chemical decreases canonical gene signaling , we identify inhibitory effects of chemical on multiple components of the canonical gene signaling pathway in the UGS that temporally coincide with the inhibitory effect of chemical on prostatic bud formation : ( 1 ) expression of gene ( gene and gene ) that promote canonical gene signaling is reduced ; ( 2 ) expression of gene , gene , and gene , established canonical gene target genes , is decreased ; ( 3 ) expression of gene , a gene that activates canonical gene signaling , is reduced ; and ( 4 ) expression of gene ( gene ) , inhibitors of canonical gene signaling , is not increased by chemical .	T11	T35	23429912
CPR:4	CHEMICAL	GENE-Y	38	45	In support of the hypothesis that chemical decreases canonical gene signaling , we identify inhibitory effects of chemical on multiple components of the canonical gene signaling pathway in the UGS that temporally coincide with the inhibitory effect of chemical on prostatic bud formation : ( 1 ) expression of gene ( gene and gene ) that promote canonical gene signaling is reduced ; ( 2 ) expression of gene , gene , and gene , established canonical gene target genes , is decreased ; ( 3 ) expression of gene , a gene that activates canonical gene signaling , is reduced ; and ( 4 ) expression of gene ( gene ) , inhibitors of canonical gene signaling , is not increased by chemical .	T11	T36	23429912
CPR:4	CHEMICAL	GENE-Y	38	45	In support of the hypothesis that chemical decreases canonical gene signaling , we identify inhibitory effects of chemical on multiple components of the canonical gene signaling pathway in the UGS that temporally coincide with the inhibitory effect of chemical on prostatic bud formation : ( 1 ) expression of gene ( gene and gene ) that promote canonical gene signaling is reduced ; ( 2 ) expression of gene , gene , and gene , established canonical gene target genes , is decreased ; ( 3 ) expression of gene , a gene that activates canonical gene signaling , is reduced ; and ( 4 ) expression of gene ( gene ) , inhibitors of canonical gene signaling , is not increased by chemical .	T11	T37	23429912
CPR:4	CHEMICAL	GENE-Y	38	45	In support of the hypothesis that chemical decreases canonical gene signaling , we identify inhibitory effects of chemical on multiple components of the canonical gene signaling pathway in the UGS that temporally coincide with the inhibitory effect of chemical on prostatic bud formation : ( 1 ) expression of gene ( gene and gene ) that promote canonical gene signaling is reduced ; ( 2 ) expression of gene , gene , and gene , established canonical gene target genes , is decreased ; ( 3 ) expression of gene , a gene that activates canonical gene signaling , is reduced ; and ( 4 ) expression of gene ( gene ) , inhibitors of canonical gene signaling , is not increased by chemical .	T11	T38	23429912
NA	CHEMICAL	GENE-N	38	77	In support of the hypothesis that chemical decreases canonical gene signaling , we identify inhibitory effects of chemical on multiple components of the canonical gene signaling pathway in the UGS that temporally coincide with the inhibitory effect of chemical on prostatic bud formation : ( 1 ) expression of gene ( gene and gene ) that promote canonical gene signaling is reduced ; ( 2 ) expression of gene , gene , and gene , established canonical gene target genes , is decreased ; ( 3 ) expression of gene , a gene that activates canonical gene signaling , is reduced ; and ( 4 ) expression of gene ( gene ) , inhibitors of canonical gene signaling , is not increased by chemical .	T11	T39	23429912
CPR:4	CHEMICAL	GENE-Y	38	89	In support of the hypothesis that chemical decreases canonical gene signaling , we identify inhibitory effects of chemical on multiple components of the canonical gene signaling pathway in the UGS that temporally coincide with the inhibitory effect of chemical on prostatic bud formation : ( 1 ) expression of gene ( gene and gene ) that promote canonical gene signaling is reduced ; ( 2 ) expression of gene , gene , and gene , established canonical gene target genes , is decreased ; ( 3 ) expression of gene , a gene that activates canonical gene signaling , is reduced ; and ( 4 ) expression of gene ( gene ) , inhibitors of canonical gene signaling , is not increased by chemical .	T11	T13	23429912
CPR:4	CHEMICAL	GENE-Y	38	92	In support of the hypothesis that chemical decreases canonical gene signaling , we identify inhibitory effects of chemical on multiple components of the canonical gene signaling pathway in the UGS that temporally coincide with the inhibitory effect of chemical on prostatic bud formation : ( 1 ) expression of gene ( gene and gene ) that promote canonical gene signaling is reduced ; ( 2 ) expression of gene , gene , and gene , established canonical gene target genes , is decreased ; ( 3 ) expression of gene , a gene that activates canonical gene signaling , is reduced ; and ( 4 ) expression of gene ( gene ) , inhibitors of canonical gene signaling , is not increased by chemical .	T11	T14	23429912
NA	CHEMICAL	GENE-N	38	96	In support of the hypothesis that chemical decreases canonical gene signaling , we identify inhibitory effects of chemical on multiple components of the canonical gene signaling pathway in the UGS that temporally coincide with the inhibitory effect of chemical on prostatic bud formation : ( 1 ) expression of gene ( gene and gene ) that promote canonical gene signaling is reduced ; ( 2 ) expression of gene , gene , and gene , established canonical gene target genes , is decreased ; ( 3 ) expression of gene , a gene that activates canonical gene signaling , is reduced ; and ( 4 ) expression of gene ( gene ) , inhibitors of canonical gene signaling , is not increased by chemical .	T11	T15	23429912
NA	CHEMICAL	GENE-N	38	108	In support of the hypothesis that chemical decreases canonical gene signaling , we identify inhibitory effects of chemical on multiple components of the canonical gene signaling pathway in the UGS that temporally coincide with the inhibitory effect of chemical on prostatic bud formation : ( 1 ) expression of gene ( gene and gene ) that promote canonical gene signaling is reduced ; ( 2 ) expression of gene , gene , and gene , established canonical gene target genes , is decreased ; ( 3 ) expression of gene , a gene that activates canonical gene signaling , is reduced ; and ( 4 ) expression of gene ( gene ) , inhibitors of canonical gene signaling , is not increased by chemical .	T11	T16	23429912
NA	CHEMICAL	GENE-N	38	110	In support of the hypothesis that chemical decreases canonical gene signaling , we identify inhibitory effects of chemical on multiple components of the canonical gene signaling pathway in the UGS that temporally coincide with the inhibitory effect of chemical on prostatic bud formation : ( 1 ) expression of gene ( gene and gene ) that promote canonical gene signaling is reduced ; ( 2 ) expression of gene , gene , and gene , established canonical gene target genes , is decreased ; ( 3 ) expression of gene , a gene that activates canonical gene signaling , is reduced ; and ( 4 ) expression of gene ( gene ) , inhibitors of canonical gene signaling , is not increased by chemical .	T11	T17	23429912
NA	CHEMICAL	GENE-N	38	116	In support of the hypothesis that chemical decreases canonical gene signaling , we identify inhibitory effects of chemical on multiple components of the canonical gene signaling pathway in the UGS that temporally coincide with the inhibitory effect of chemical on prostatic bud formation : ( 1 ) expression of gene ( gene and gene ) that promote canonical gene signaling is reduced ; ( 2 ) expression of gene , gene , and gene , established canonical gene target genes , is decreased ; ( 3 ) expression of gene , a gene that activates canonical gene signaling , is reduced ; and ( 4 ) expression of gene ( gene ) , inhibitors of canonical gene signaling , is not increased by chemical .	T11	T18	23429912
NA	CHEMICAL	GENE-N	38	9	In support of the hypothesis that chemical decreases canonical gene signaling , we identify inhibitory effects of chemical on multiple components of the canonical gene signaling pathway in the UGS that temporally coincide with the inhibitory effect of chemical on prostatic bud formation : ( 1 ) expression of gene ( gene and gene ) that promote canonical gene signaling is reduced ; ( 2 ) expression of gene , gene , and gene , established canonical gene target genes , is decreased ; ( 3 ) expression of gene , a gene that activates canonical gene signaling , is reduced ; and ( 4 ) expression of gene ( gene ) , inhibitors of canonical gene signaling , is not increased by chemical .	T1	T30	23429912
NA	CHEMICAL	GENE-N	38	24	In support of the hypothesis that chemical decreases canonical gene signaling , we identify inhibitory effects of chemical on multiple components of the canonical gene signaling pathway in the UGS that temporally coincide with the inhibitory effect of chemical on prostatic bud formation : ( 1 ) expression of gene ( gene and gene ) that promote canonical gene signaling is reduced ; ( 2 ) expression of gene , gene , and gene , established canonical gene target genes , is decreased ; ( 3 ) expression of gene , a gene that activates canonical gene signaling , is reduced ; and ( 4 ) expression of gene ( gene ) , inhibitors of canonical gene signaling , is not increased by chemical .	T1	T31	23429912
NA	CHEMICAL	GENE-N	38	18	In support of the hypothesis that chemical decreases canonical gene signaling , we identify inhibitory effects of chemical on multiple components of the canonical gene signaling pathway in the UGS that temporally coincide with the inhibitory effect of chemical on prostatic bud formation : ( 1 ) expression of gene ( gene and gene ) that promote canonical gene signaling is reduced ; ( 2 ) expression of gene , gene , and gene , established canonical gene target genes , is decreased ; ( 3 ) expression of gene , a gene that activates canonical gene signaling , is reduced ; and ( 4 ) expression of gene ( gene ) , inhibitors of canonical gene signaling , is not increased by chemical .	T1	T32	23429912
NA	CHEMICAL	GENE-Y	38	51	In support of the hypothesis that chemical decreases canonical gene signaling , we identify inhibitory effects of chemical on multiple components of the canonical gene signaling pathway in the UGS that temporally coincide with the inhibitory effect of chemical on prostatic bud formation : ( 1 ) expression of gene ( gene and gene ) that promote canonical gene signaling is reduced ; ( 2 ) expression of gene , gene , and gene , established canonical gene target genes , is decreased ; ( 3 ) expression of gene , a gene that activates canonical gene signaling , is reduced ; and ( 4 ) expression of gene ( gene ) , inhibitors of canonical gene signaling , is not increased by chemical .	T1	T33	23429912
NA	CHEMICAL	GENE-Y	38	53	In support of the hypothesis that chemical decreases canonical gene signaling , we identify inhibitory effects of chemical on multiple components of the canonical gene signaling pathway in the UGS that temporally coincide with the inhibitory effect of chemical on prostatic bud formation : ( 1 ) expression of gene ( gene and gene ) that promote canonical gene signaling is reduced ; ( 2 ) expression of gene , gene , and gene , established canonical gene target genes , is decreased ; ( 3 ) expression of gene , a gene that activates canonical gene signaling , is reduced ; and ( 4 ) expression of gene ( gene ) , inhibitors of canonical gene signaling , is not increased by chemical .	T1	T34	23429912
NA	CHEMICAL	GENE-N	38	58	In support of the hypothesis that chemical decreases canonical gene signaling , we identify inhibitory effects of chemical on multiple components of the canonical gene signaling pathway in the UGS that temporally coincide with the inhibitory effect of chemical on prostatic bud formation : ( 1 ) expression of gene ( gene and gene ) that promote canonical gene signaling is reduced ; ( 2 ) expression of gene , gene , and gene , established canonical gene target genes , is decreased ; ( 3 ) expression of gene , a gene that activates canonical gene signaling , is reduced ; and ( 4 ) expression of gene ( gene ) , inhibitors of canonical gene signaling , is not increased by chemical .	T1	T35	23429912
NA	CHEMICAL	GENE-Y	38	45	In support of the hypothesis that chemical decreases canonical gene signaling , we identify inhibitory effects of chemical on multiple components of the canonical gene signaling pathway in the UGS that temporally coincide with the inhibitory effect of chemical on prostatic bud formation : ( 1 ) expression of gene ( gene and gene ) that promote canonical gene signaling is reduced ; ( 2 ) expression of gene , gene , and gene , established canonical gene target genes , is decreased ; ( 3 ) expression of gene , a gene that activates canonical gene signaling , is reduced ; and ( 4 ) expression of gene ( gene ) , inhibitors of canonical gene signaling , is not increased by chemical .	T1	T36	23429912
NA	CHEMICAL	GENE-Y	38	45	In support of the hypothesis that chemical decreases canonical gene signaling , we identify inhibitory effects of chemical on multiple components of the canonical gene signaling pathway in the UGS that temporally coincide with the inhibitory effect of chemical on prostatic bud formation : ( 1 ) expression of gene ( gene and gene ) that promote canonical gene signaling is reduced ; ( 2 ) expression of gene , gene , and gene , established canonical gene target genes , is decreased ; ( 3 ) expression of gene , a gene that activates canonical gene signaling , is reduced ; and ( 4 ) expression of gene ( gene ) , inhibitors of canonical gene signaling , is not increased by chemical .	T1	T37	23429912
NA	CHEMICAL	GENE-Y	38	45	In support of the hypothesis that chemical decreases canonical gene signaling , we identify inhibitory effects of chemical on multiple components of the canonical gene signaling pathway in the UGS that temporally coincide with the inhibitory effect of chemical on prostatic bud formation : ( 1 ) expression of gene ( gene and gene ) that promote canonical gene signaling is reduced ; ( 2 ) expression of gene , gene , and gene , established canonical gene target genes , is decreased ; ( 3 ) expression of gene , a gene that activates canonical gene signaling , is reduced ; and ( 4 ) expression of gene ( gene ) , inhibitors of canonical gene signaling , is not increased by chemical .	T1	T38	23429912
NA	CHEMICAL	GENE-N	38	77	In support of the hypothesis that chemical decreases canonical gene signaling , we identify inhibitory effects of chemical on multiple components of the canonical gene signaling pathway in the UGS that temporally coincide with the inhibitory effect of chemical on prostatic bud formation : ( 1 ) expression of gene ( gene and gene ) that promote canonical gene signaling is reduced ; ( 2 ) expression of gene , gene , and gene , established canonical gene target genes , is decreased ; ( 3 ) expression of gene , a gene that activates canonical gene signaling , is reduced ; and ( 4 ) expression of gene ( gene ) , inhibitors of canonical gene signaling , is not increased by chemical .	T1	T39	23429912
NA	CHEMICAL	GENE-Y	38	89	In support of the hypothesis that chemical decreases canonical gene signaling , we identify inhibitory effects of chemical on multiple components of the canonical gene signaling pathway in the UGS that temporally coincide with the inhibitory effect of chemical on prostatic bud formation : ( 1 ) expression of gene ( gene and gene ) that promote canonical gene signaling is reduced ; ( 2 ) expression of gene , gene , and gene , established canonical gene target genes , is decreased ; ( 3 ) expression of gene , a gene that activates canonical gene signaling , is reduced ; and ( 4 ) expression of gene ( gene ) , inhibitors of canonical gene signaling , is not increased by chemical .	T1	T13	23429912
NA	CHEMICAL	GENE-Y	38	92	In support of the hypothesis that chemical decreases canonical gene signaling , we identify inhibitory effects of chemical on multiple components of the canonical gene signaling pathway in the UGS that temporally coincide with the inhibitory effect of chemical on prostatic bud formation : ( 1 ) expression of gene ( gene and gene ) that promote canonical gene signaling is reduced ; ( 2 ) expression of gene , gene , and gene , established canonical gene target genes , is decreased ; ( 3 ) expression of gene , a gene that activates canonical gene signaling , is reduced ; and ( 4 ) expression of gene ( gene ) , inhibitors of canonical gene signaling , is not increased by chemical .	T1	T14	23429912
NA	CHEMICAL	GENE-N	38	96	In support of the hypothesis that chemical decreases canonical gene signaling , we identify inhibitory effects of chemical on multiple components of the canonical gene signaling pathway in the UGS that temporally coincide with the inhibitory effect of chemical on prostatic bud formation : ( 1 ) expression of gene ( gene and gene ) that promote canonical gene signaling is reduced ; ( 2 ) expression of gene , gene , and gene , established canonical gene target genes , is decreased ; ( 3 ) expression of gene , a gene that activates canonical gene signaling , is reduced ; and ( 4 ) expression of gene ( gene ) , inhibitors of canonical gene signaling , is not increased by chemical .	T1	T15	23429912
NA	CHEMICAL	GENE-N	38	108	In support of the hypothesis that chemical decreases canonical gene signaling , we identify inhibitory effects of chemical on multiple components of the canonical gene signaling pathway in the UGS that temporally coincide with the inhibitory effect of chemical on prostatic bud formation : ( 1 ) expression of gene ( gene and gene ) that promote canonical gene signaling is reduced ; ( 2 ) expression of gene , gene , and gene , established canonical gene target genes , is decreased ; ( 3 ) expression of gene , a gene that activates canonical gene signaling , is reduced ; and ( 4 ) expression of gene ( gene ) , inhibitors of canonical gene signaling , is not increased by chemical .	T1	T16	23429912
NA	CHEMICAL	GENE-N	38	110	In support of the hypothesis that chemical decreases canonical gene signaling , we identify inhibitory effects of chemical on multiple components of the canonical gene signaling pathway in the UGS that temporally coincide with the inhibitory effect of chemical on prostatic bud formation : ( 1 ) expression of gene ( gene and gene ) that promote canonical gene signaling is reduced ; ( 2 ) expression of gene , gene , and gene , established canonical gene target genes , is decreased ; ( 3 ) expression of gene , a gene that activates canonical gene signaling , is reduced ; and ( 4 ) expression of gene ( gene ) , inhibitors of canonical gene signaling , is not increased by chemical .	T1	T17	23429912
NA	CHEMICAL	GENE-N	38	116	In support of the hypothesis that chemical decreases canonical gene signaling , we identify inhibitory effects of chemical on multiple components of the canonical gene signaling pathway in the UGS that temporally coincide with the inhibitory effect of chemical on prostatic bud formation : ( 1 ) expression of gene ( gene and gene ) that promote canonical gene signaling is reduced ; ( 2 ) expression of gene , gene , and gene , established canonical gene target genes , is decreased ; ( 3 ) expression of gene , a gene that activates canonical gene signaling , is reduced ; and ( 4 ) expression of gene ( gene ) , inhibitors of canonical gene signaling , is not increased by chemical .	T1	T18	23429912
CPR:4	CHEMICAL	GENE-N	3	7	Thus , the chemical-induced reduction in canonical gene signaling is associated with a decrease in activators ( gene and gene ) rather than an increase in inhibitors ( gene and gene ) of the pathway .	T2	T19	23429912
CPR:4	CHEMICAL	GENE-Y	3	17	Thus , the chemical-induced reduction in canonical gene signaling is associated with a decrease in activators ( gene and gene ) rather than an increase in inhibitors ( gene and gene ) of the pathway .	T2	T20	23429912
CPR:4	CHEMICAL	GENE-Y	3	19	Thus , the chemical-induced reduction in canonical gene signaling is associated with a decrease in activators ( gene and gene ) rather than an increase in inhibitors ( gene and gene ) of the pathway .	T2	T21	23429912
CPR:4	CHEMICAL	GENE-Y	3	28	Thus , the chemical-induced reduction in canonical gene signaling is associated with a decrease in activators ( gene and gene ) rather than an increase in inhibitors ( gene and gene ) of the pathway .	T2	T22	23429912
CPR:4	CHEMICAL	GENE-Y	3	30	Thus , the chemical-induced reduction in canonical gene signaling is associated with a decrease in activators ( gene and gene ) rather than an increase in inhibitors ( gene and gene ) of the pathway .	T2	T23	23429912
NA	CHEMICAL	GENE-Y	8	13	This study focuses on determining whether treatment of chemical-exposed UGS organ cultures with gene and/or gene is capable of rescuing the inhibitory effects of chemical on canonical gene signaling and prostatic bud formation .	T3	T24	23429912
NA	CHEMICAL	GENE-Y	8	15	This study focuses on determining whether treatment of chemical-exposed UGS organ cultures with gene and/or gene is capable of rescuing the inhibitory effects of chemical on canonical gene signaling and prostatic bud formation .	T3	T25	23429912
NA	CHEMICAL	GENE-N	8	27	This study focuses on determining whether treatment of chemical-exposed UGS organ cultures with gene and/or gene is capable of rescuing the inhibitory effects of chemical on canonical gene signaling and prostatic bud formation .	T3	T26	23429912
NA	CHEMICAL	GENE-Y	24	13	This study focuses on determining whether treatment of chemical-exposed UGS organ cultures with gene and/or gene is capable of rescuing the inhibitory effects of chemical on canonical gene signaling and prostatic bud formation .	T4	T24	23429912
NA	CHEMICAL	GENE-Y	24	15	This study focuses on determining whether treatment of chemical-exposed UGS organ cultures with gene and/or gene is capable of rescuing the inhibitory effects of chemical on canonical gene signaling and prostatic bud formation .	T4	T25	23429912
CPR:4	CHEMICAL	GENE-N	24	27	This study focuses on determining whether treatment of chemical-exposed UGS organ cultures with gene and/or gene is capable of rescuing the inhibitory effects of chemical on canonical gene signaling and prostatic bud formation .	T4	T26	23429912
NA	CHEMICAL	GENE-Y	0	4	chemical covalently binds to gene and induces gene-mediated apoptosis .	T12	T26	23229512
NA	CHEMICAL	GENE-Y	0	7	chemical covalently binds to gene and induces gene-mediated apoptosis .	T12	T27	23229512
NA	CHEMICAL	GENE-Y	16	4	Here , we identified gene antagonist killer 1 ( gene ) as a molecular target of chemical-induced apoptosis .	T5	T14	23229512
NA	CHEMICAL	GENE-Y	16	9	Here , we identified gene antagonist killer 1 ( gene ) as a molecular target of chemical-induced apoptosis .	T5	T15	23229512
NA	CHEMICAL	GENE-Y	0	4	chemical directly interacts with gene and induces mitochondrial-mediated apoptosis .	T6	T16	23229512
NA	CHEMICAL	GENE-Y	30	1	Although gene and gene ( gene ) , another member of the gene family , are generally thought to be functionally redundant , only gene is necessary and sufficient for chemical-induced gene ( gene ) release and cell death .	T7	T17	23229512
NA	CHEMICAL	GENE-Y	30	3	Although gene and gene ( gene ) , another member of the gene family , are generally thought to be functionally redundant , only gene is necessary and sufficient for chemical-induced gene ( gene ) release and cell death .	T7	T18	23229512
NA	CHEMICAL	GENE-Y	30	5	Although gene and gene ( gene ) , another member of the gene family , are generally thought to be functionally redundant , only gene is necessary and sufficient for chemical-induced gene ( gene ) release and cell death .	T7	T19	23229512
NA	CHEMICAL	GENE-Y	30	12	Although gene and gene ( gene ) , another member of the gene family , are generally thought to be functionally redundant , only gene is necessary and sufficient for chemical-induced gene ( gene ) release and cell death .	T7	T20	23229512
NA	CHEMICAL	GENE-Y	30	24	Although gene and gene ( gene ) , another member of the gene family , are generally thought to be functionally redundant , only gene is necessary and sufficient for chemical-induced gene ( gene ) release and cell death .	T7	T21	23229512
CPR:3	CHEMICAL	GENE-Y	30	31	Although gene and gene ( gene ) , another member of the gene family , are generally thought to be functionally redundant , only gene is necessary and sufficient for chemical-induced gene ( gene ) release and cell death .	T7	T22	23229512
CPR:3	CHEMICAL	GENE-Y	30	33	Although gene and gene ( gene ) , another member of the gene family , are generally thought to be functionally redundant , only gene is necessary and sufficient for chemical-induced gene ( gene ) release and cell death .	T7	T23	23229512
NA	CHEMICAL	GENE-Y	2	20	Moreover , chemical , an intracellular metabolite of chemical , was shown to covalently bind to the chemical-166 residue of gene .	T8	T24	23229512
NA	CHEMICAL	GENE-Y	8	20	Moreover , chemical , an intracellular metabolite of chemical , was shown to covalently bind to the chemical-166 residue of gene .	T9	T24	23229512
NA	CHEMICAL	GENE-Y	17	20	Moreover , chemical , an intracellular metabolite of chemical , was shown to covalently bind to the chemical-166 residue of gene .	T10	T24	23229512
NA	CHEMICAL	GENE-N	2	8	In the chemical+chemical group , activities of chemical dismutase , gene in serum and chemical/chemical were significantly increased , histopathological effects were reduced , and chemical accumulation markedly decreased in the liver , compared with the chemical-treated group .	T24	T31	23023136
NA	CHEMICAL	GENE-Y	2	10	In the chemical+chemical group , activities of chemical dismutase , gene in serum and chemical/chemical were significantly increased , histopathological effects were reduced , and chemical accumulation markedly decreased in the liver , compared with the chemical-treated group .	T24	T32	23023136
NA	CHEMICAL	GENE-N	2	8	In the chemical+chemical group , activities of chemical dismutase , gene in serum and chemical/chemical were significantly increased , histopathological effects were reduced , and chemical accumulation markedly decreased in the liver , compared with the chemical-treated group .	T25	T31	23023136
NA	CHEMICAL	GENE-Y	2	10	In the chemical+chemical group , activities of chemical dismutase , gene in serum and chemical/chemical were significantly increased , histopathological effects were reduced , and chemical accumulation markedly decreased in the liver , compared with the chemical-treated group .	T25	T32	23023136
NA	CHEMICAL	GENE-N	7	8	In the chemical+chemical group , activities of chemical dismutase , gene in serum and chemical/chemical were significantly increased , histopathological effects were reduced , and chemical accumulation markedly decreased in the liver , compared with the chemical-treated group .	T26	T31	23023136
NA	CHEMICAL	GENE-Y	7	10	In the chemical+chemical group , activities of chemical dismutase , gene in serum and chemical/chemical were significantly increased , histopathological effects were reduced , and chemical accumulation markedly decreased in the liver , compared with the chemical-treated group .	T26	T32	23023136
NA	CHEMICAL	GENE-N	14	8	In the chemical+chemical group , activities of chemical dismutase , gene in serum and chemical/chemical were significantly increased , histopathological effects were reduced , and chemical accumulation markedly decreased in the liver , compared with the chemical-treated group .	T27	T31	23023136
NA	CHEMICAL	GENE-Y	14	10	In the chemical+chemical group , activities of chemical dismutase , gene in serum and chemical/chemical were significantly increased , histopathological effects were reduced , and chemical accumulation markedly decreased in the liver , compared with the chemical-treated group .	T27	T32	23023136
NA	CHEMICAL	GENE-N	14	8	In the chemical+chemical group , activities of chemical dismutase , gene in serum and chemical/chemical were significantly increased , histopathological effects were reduced , and chemical accumulation markedly decreased in the liver , compared with the chemical-treated group .	T28	T31	23023136
NA	CHEMICAL	GENE-Y	14	10	In the chemical+chemical group , activities of chemical dismutase , gene in serum and chemical/chemical were significantly increased , histopathological effects were reduced , and chemical accumulation markedly decreased in the liver , compared with the chemical-treated group .	T28	T32	23023136
NA	CHEMICAL	GENE-N	2	8	In the chemical+chemical group , activities of chemical dismutase , gene in serum and chemical/chemical were significantly increased , histopathological effects were reduced , and chemical accumulation markedly decreased in the liver , compared with the chemical-treated group .	T2	T31	23023136
NA	CHEMICAL	GENE-Y	2	10	In the chemical+chemical group , activities of chemical dismutase , gene in serum and chemical/chemical were significantly increased , histopathological effects were reduced , and chemical accumulation markedly decreased in the liver , compared with the chemical-treated group .	T2	T32	23023136
NA	CHEMICAL	GENE-N	10	8	In the chemical+chemical group , activities of chemical dismutase , gene in serum and chemical/chemical were significantly increased , histopathological effects were reduced , and chemical accumulation markedly decreased in the liver , compared with the chemical-treated group .	T3	T31	23023136
NA	CHEMICAL	GENE-Y	10	10	In the chemical+chemical group , activities of chemical dismutase , gene in serum and chemical/chemical were significantly increased , histopathological effects were reduced , and chemical accumulation markedly decreased in the liver , compared with the chemical-treated group .	T3	T32	23023136
CPR:4	CHEMICAL	GENE-N	0	6	chemical treatment showed a significant decline in the levels of blood chemical , gene ( gene ) , gene gene unit ( in pancreas ) and gene ( plasma ) , serum chemical ( chemical ) with an elevation in plasma gene .	T1	T19	23277230
CPR:4	CHEMICAL	GENE-N	0	15	chemical treatment showed a significant decline in the levels of blood chemical , gene ( gene ) , gene gene unit ( in pancreas ) and gene ( plasma ) , serum chemical ( chemical ) with an elevation in plasma gene .	T1	T20	23277230
CPR:4	CHEMICAL	GENE-N	0	18	chemical treatment showed a significant decline in the levels of blood chemical , gene ( gene ) , gene gene unit ( in pancreas ) and gene ( plasma ) , serum chemical ( chemical ) with an elevation in plasma gene .	T1	T21	23277230
CPR:4	CHEMICAL	GENE-Y	0	19	chemical treatment showed a significant decline in the levels of blood chemical , gene ( gene ) , gene gene unit ( in pancreas ) and gene ( plasma ) , serum chemical ( chemical ) with an elevation in plasma gene .	T1	T22	23277230
CPR:4	CHEMICAL	GENE-Y	0	26	chemical treatment showed a significant decline in the levels of blood chemical , gene ( gene ) , gene gene unit ( in pancreas ) and gene ( plasma ) , serum chemical ( chemical ) with an elevation in plasma gene .	T1	T23	23277230
CPR:3	CHEMICAL	GENE-N	0	6	chemical treatment showed a significant decline in the levels of blood chemical , gene ( gene ) , gene gene unit ( in pancreas ) and gene ( plasma ) , serum chemical ( chemical ) with an elevation in plasma gene .	T1	T24	23277230
NA	CHEMICAL	GENE-N	11	6	chemical treatment showed a significant decline in the levels of blood chemical , gene ( gene ) , gene gene unit ( in pancreas ) and gene ( plasma ) , serum chemical ( chemical ) with an elevation in plasma gene .	T2	T19	23277230
NA	CHEMICAL	GENE-N	11	15	chemical treatment showed a significant decline in the levels of blood chemical , gene ( gene ) , gene gene unit ( in pancreas ) and gene ( plasma ) , serum chemical ( chemical ) with an elevation in plasma gene .	T2	T20	23277230
NA	CHEMICAL	GENE-N	11	18	chemical treatment showed a significant decline in the levels of blood chemical , gene ( gene ) , gene gene unit ( in pancreas ) and gene ( plasma ) , serum chemical ( chemical ) with an elevation in plasma gene .	T2	T21	23277230
NA	CHEMICAL	GENE-Y	11	19	chemical treatment showed a significant decline in the levels of blood chemical , gene ( gene ) , gene gene unit ( in pancreas ) and gene ( plasma ) , serum chemical ( chemical ) with an elevation in plasma gene .	T2	T22	23277230
NA	CHEMICAL	GENE-Y	11	26	chemical treatment showed a significant decline in the levels of blood chemical , gene ( gene ) , gene gene unit ( in pancreas ) and gene ( plasma ) , serum chemical ( chemical ) with an elevation in plasma gene .	T2	T23	23277230
NA	CHEMICAL	GENE-N	11	6	chemical treatment showed a significant decline in the levels of blood chemical , gene ( gene ) , gene gene unit ( in pancreas ) and gene ( plasma ) , serum chemical ( chemical ) with an elevation in plasma gene .	T2	T24	23277230
NA	CHEMICAL	GENE-N	32	6	chemical treatment showed a significant decline in the levels of blood chemical , gene ( gene ) , gene gene unit ( in pancreas ) and gene ( plasma ) , serum chemical ( chemical ) with an elevation in plasma gene .	T3	T19	23277230
NA	CHEMICAL	GENE-N	32	15	chemical treatment showed a significant decline in the levels of blood chemical , gene ( gene ) , gene gene unit ( in pancreas ) and gene ( plasma ) , serum chemical ( chemical ) with an elevation in plasma gene .	T3	T20	23277230
NA	CHEMICAL	GENE-N	32	18	chemical treatment showed a significant decline in the levels of blood chemical , gene ( gene ) , gene gene unit ( in pancreas ) and gene ( plasma ) , serum chemical ( chemical ) with an elevation in plasma gene .	T3	T21	23277230
NA	CHEMICAL	GENE-Y	32	19	chemical treatment showed a significant decline in the levels of blood chemical , gene ( gene ) , gene gene unit ( in pancreas ) and gene ( plasma ) , serum chemical ( chemical ) with an elevation in plasma gene .	T3	T22	23277230
NA	CHEMICAL	GENE-Y	32	26	chemical treatment showed a significant decline in the levels of blood chemical , gene ( gene ) , gene gene unit ( in pancreas ) and gene ( plasma ) , serum chemical ( chemical ) with an elevation in plasma gene .	T3	T23	23277230
NA	CHEMICAL	GENE-N	32	6	chemical treatment showed a significant decline in the levels of blood chemical , gene ( gene ) , gene gene unit ( in pancreas ) and gene ( plasma ) , serum chemical ( chemical ) with an elevation in plasma gene .	T3	T24	23277230
NA	CHEMICAL	GENE-N	34	6	chemical treatment showed a significant decline in the levels of blood chemical , gene ( gene ) , gene gene unit ( in pancreas ) and gene ( plasma ) , serum chemical ( chemical ) with an elevation in plasma gene .	T4	T19	23277230
NA	CHEMICAL	GENE-N	34	15	chemical treatment showed a significant decline in the levels of blood chemical , gene ( gene ) , gene gene unit ( in pancreas ) and gene ( plasma ) , serum chemical ( chemical ) with an elevation in plasma gene .	T4	T20	23277230
NA	CHEMICAL	GENE-N	34	18	chemical treatment showed a significant decline in the levels of blood chemical , gene ( gene ) , gene gene unit ( in pancreas ) and gene ( plasma ) , serum chemical ( chemical ) with an elevation in plasma gene .	T4	T21	23277230
NA	CHEMICAL	GENE-Y	34	19	chemical treatment showed a significant decline in the levels of blood chemical , gene ( gene ) , gene gene unit ( in pancreas ) and gene ( plasma ) , serum chemical ( chemical ) with an elevation in plasma gene .	T4	T22	23277230
NA	CHEMICAL	GENE-Y	34	26	chemical treatment showed a significant decline in the levels of blood chemical , gene ( gene ) , gene gene unit ( in pancreas ) and gene ( plasma ) , serum chemical ( chemical ) with an elevation in plasma gene .	T4	T23	23277230
NA	CHEMICAL	GENE-N	34	6	chemical treatment showed a significant decline in the levels of blood chemical , gene ( gene ) , gene gene unit ( in pancreas ) and gene ( plasma ) , serum chemical ( chemical ) with an elevation in plasma gene .	T4	T24	23277230
NA	CHEMICAL	GENE-Y	2	0	gene , a new partner in adipocyte glyceroneogenesis and an atypical target of chemical .	T19	T41	17545671
NA	CHEMICAL	GENE-Y	2	0	gene , a new partner in adipocyte glyceroneogenesis and an atypical target of chemical .	T20	T41	17545671
NA	CHEMICAL	GENE-Y	13	3	We show that gene ( gene ) is involved in adipocyte glyceroneogenesis , a regulated pathway that controls chemical homeostasis by promoting chemical formation for chemical re-esterification during fasting .	T10	T25	17545671
NA	CHEMICAL	GENE-Y	13	5	We show that gene ( gene ) is involved in adipocyte glyceroneogenesis , a regulated pathway that controls chemical homeostasis by promoting chemical formation for chemical re-esterification during fasting .	T10	T32	17545671
NA	CHEMICAL	GENE-Y	13	3	We show that gene ( gene ) is involved in adipocyte glyceroneogenesis , a regulated pathway that controls chemical homeostasis by promoting chemical formation for chemical re-esterification during fasting .	T5	T25	17545671
NA	CHEMICAL	GENE-Y	13	5	We show that gene ( gene ) is involved in adipocyte glyceroneogenesis , a regulated pathway that controls chemical homeostasis by promoting chemical formation for chemical re-esterification during fasting .	T5	T32	17545671
NA	CHEMICAL	GENE-Y	13	3	We show that gene ( gene ) is involved in adipocyte glyceroneogenesis , a regulated pathway that controls chemical homeostasis by promoting chemical formation for chemical re-esterification during fasting .	T8	T25	17545671
NA	CHEMICAL	GENE-Y	13	5	We show that gene ( gene ) is involved in adipocyte glyceroneogenesis , a regulated pathway that controls chemical homeostasis by promoting chemical formation for chemical re-esterification during fasting .	T8	T32	17545671
NA	CHEMICAL	GENE-Y	13	3	We show that gene ( gene ) is involved in adipocyte glyceroneogenesis , a regulated pathway that controls chemical homeostasis by promoting chemical formation for chemical re-esterification during fasting .	T9	T25	17545671
NA	CHEMICAL	GENE-Y	13	5	We show that gene ( gene ) is involved in adipocyte glyceroneogenesis , a regulated pathway that controls chemical homeostasis by promoting chemical formation for chemical re-esterification during fasting .	T9	T32	17545671
NA	CHEMICAL	GENE-Y	3	0	gene activity , as well as the incorporation of chemical into the neutral lipid fraction of 3T3-gene adipocytes was stimulated by the chemical ( chemical ) chemical .	T11	T30	17545671
NA	CHEMICAL	GENE-N	3	16	gene activity , as well as the incorporation of chemical into the neutral lipid fraction of 3T3-gene adipocytes was stimulated by the chemical ( chemical ) chemical .	T11	T31	17545671
CPR:3	CHEMICAL	GENE-Y	22	0	gene activity , as well as the incorporation of chemical into the neutral lipid fraction of 3T3-gene adipocytes was stimulated by the chemical ( chemical ) chemical .	T12	T30	17545671
NA	CHEMICAL	GENE-N	22	16	gene activity , as well as the incorporation of chemical into the neutral lipid fraction of 3T3-gene adipocytes was stimulated by the chemical ( chemical ) chemical .	T12	T31	17545671
CPR:3	CHEMICAL	GENE-Y	24	0	gene activity , as well as the incorporation of chemical into the neutral lipid fraction of 3T3-gene adipocytes was stimulated by the chemical ( chemical ) chemical .	T13	T30	17545671
NA	CHEMICAL	GENE-N	24	16	gene activity , as well as the incorporation of chemical into the neutral lipid fraction of 3T3-gene adipocytes was stimulated by the chemical ( chemical ) chemical .	T13	T31	17545671
CPR:3	CHEMICAL	GENE-Y	26	0	gene activity , as well as the incorporation of chemical into the neutral lipid fraction of 3T3-gene adipocytes was stimulated by the chemical ( chemical ) chemical .	T14	T30	17545671
NA	CHEMICAL	GENE-N	26	16	gene activity , as well as the incorporation of chemical into the neutral lipid fraction of 3T3-gene adipocytes was stimulated by the chemical ( chemical ) chemical .	T14	T31	17545671
NA	CHEMICAL	GENE-Y	12	2	Nevertheless , gene is indirectly necessary for both gene basal expression and chemical responsiveness because they are , respectively , diminished and abolished by ectopic overexpression of a dominant negative gene .	T17	T37	17545671
NA	CHEMICAL	GENE-Y	12	8	Nevertheless , gene is indirectly necessary for both gene basal expression and chemical responsiveness because they are , respectively , diminished and abolished by ectopic overexpression of a dominant negative gene .	T17	T38	17545671
NA	CHEMICAL	GENE-Y	12	27	Nevertheless , gene is indirectly necessary for both gene basal expression and chemical responsiveness because they are , respectively , diminished and abolished by ectopic overexpression of a dominant negative gene .	T17	T39	17545671
NA	CHEMICAL	GENE-Y	2	1	The gene chemical-responsive site was restricted to a single chemical chemical located at -381 to -376 bp whose mutation impaired the specific gene binding .	T18	T40	17545671
NA	CHEMICAL	GENE-Y	2	7	The gene chemical-responsive site was restricted to a single chemical chemical located at -381 to -376 bp whose mutation impaired the specific gene binding .	T18	T21	17545671
NA	CHEMICAL	GENE-Y	2	1	The gene chemical-responsive site was restricted to a single chemical chemical located at -381 to -376 bp whose mutation impaired the specific gene binding .	T1	T40	17545671
NA	CHEMICAL	GENE-Y	2	7	The gene chemical-responsive site was restricted to a single chemical chemical located at -381 to -376 bp whose mutation impaired the specific gene binding .	T1	T21	17545671
NA	CHEMICAL	GENE-Y	7	1	The gene chemical-responsive site was restricted to a single chemical chemical located at -381 to -376 bp whose mutation impaired the specific gene binding .	T2	T40	17545671
NA	CHEMICAL	GENE-Y	7	7	The gene chemical-responsive site was restricted to a single chemical chemical located at -381 to -376 bp whose mutation impaired the specific gene binding .	T2	T21	17545671
NA	CHEMICAL	GENE-Y	11	0	gene ectopic expression activated the gene gene transcription in absence of chemical , and its protein amount in nuclear extracts is 1.8-fold increased by chemical treatment of adipocytes .	T3	T22	17545671
NA	CHEMICAL	GENE-Y	11	5	gene ectopic expression activated the gene gene transcription in absence of chemical , and its protein amount in nuclear extracts is 1.8-fold increased by chemical treatment of adipocytes .	T3	T23	17545671
CPR:3	CHEMICAL	GENE-Y	24	0	gene ectopic expression activated the gene gene transcription in absence of chemical , and its protein amount in nuclear extracts is 1.8-fold increased by chemical treatment of adipocytes .	T4	T22	17545671
CPR:3	CHEMICAL	GENE-Y	24	5	gene ectopic expression activated the gene gene transcription in absence of chemical , and its protein amount in nuclear extracts is 1.8-fold increased by chemical treatment of adipocytes .	T4	T23	17545671
CPR:3	CHEMICAL	GENE-Y	13	5	Finally , the amounts of gene and gene mRNAs were similarly increased by chemical treatment of human adipose tissue explants , confirming coordinated regulation .	T6	T24	17545671
CPR:3	CHEMICAL	GENE-Y	13	7	Finally , the amounts of gene and gene mRNAs were similarly increased by chemical treatment of human adipose tissue explants , confirming coordinated regulation .	T6	T26	17545671
NA	CHEMICAL	GENE-Y	1	1	The gene ( gene ) regulates hepatic drug metabolism by activating genes such as gene ( gene ) and certain gene .	T1	T18	23539296
NA	CHEMICAL	GENE-Y	1	3	The gene ( gene ) regulates hepatic drug metabolism by activating genes such as gene ( gene ) and certain gene .	T1	T19	23539296
NA	CHEMICAL	GENE-N	1	14	The gene ( gene ) regulates hepatic drug metabolism by activating genes such as gene ( gene ) and certain gene .	T1	T7	23539296
NA	CHEMICAL	GENE-N	1	16	The gene ( gene ) regulates hepatic drug metabolism by activating genes such as gene ( gene ) and certain gene .	T1	T10	23539296
NA	CHEMICAL	GENE-N	1	13	The gene ( gene ) regulates hepatic drug metabolism by activating genes such as gene ( gene ) and certain gene .	T1	T11	23539296
CPR:3	CHEMICAL	GENE-N	9	9	Here , we have now found that activation of gene gene by chemical potentiated induction of gene mRNA by gene ligand in HepG2 cells to levels observed in ligand-treated human primary hepatocytes .	T2	T20	23539296
CPR:3	CHEMICAL	GENE-N	9	10	Here , we have now found that activation of gene gene by chemical potentiated induction of gene mRNA by gene ligand in HepG2 cells to levels observed in ligand-treated human primary hepatocytes .	T2	T21	23539296
CPR:3	CHEMICAL	GENE-Y	9	16	Here , we have now found that activation of gene gene by chemical potentiated induction of gene mRNA by gene ligand in HepG2 cells to levels observed in ligand-treated human primary hepatocytes .	T2	T22	23539296
NA	CHEMICAL	GENE-Y	9	19	Here , we have now found that activation of gene gene by chemical potentiated induction of gene mRNA by gene ligand in HepG2 cells to levels observed in ligand-treated human primary hepatocytes .	T2	T23	23539296
NA	CHEMICAL	GENE-N	9	3	siRNA knockdown of gene gene abrogated the ability of chemical to synergistically induce gene mRNA .	T3	T24	23539296
NA	CHEMICAL	GENE-N	9	4	siRNA knockdown of gene gene abrogated the ability of chemical to synergistically induce gene mRNA .	T3	T25	23539296
CPR:3	CHEMICAL	GENE-Y	9	13	siRNA knockdown of gene gene abrogated the ability of chemical to synergistically induce gene mRNA .	T3	T26	23539296
CPR:3	CHEMICAL	GENE-Y	5	3	In addition to gene , chemical co-treatment potentiated an increase in gene and gene mRNAs but not gene or chemical-glucuronosyltransferase 1A1 mRNAs .	T4	T27	23539296
CPR:3	CHEMICAL	GENE-Y	5	11	In addition to gene , chemical co-treatment potentiated an increase in gene and gene mRNAs but not gene or chemical-glucuronosyltransferase 1A1 mRNAs .	T4	T28	23539296
CPR:3	CHEMICAL	GENE-Y	5	13	In addition to gene , chemical co-treatment potentiated an increase in gene and gene mRNAs but not gene or chemical-glucuronosyltransferase 1A1 mRNAs .	T4	T29	23539296
NA	CHEMICAL	GENE-Y	5	17	In addition to gene , chemical co-treatment potentiated an increase in gene and gene mRNAs but not gene or chemical-glucuronosyltransferase 1A1 mRNAs .	T4	T30	23539296
NA	CHEMICAL	GENE-Y	5	20	In addition to gene , chemical co-treatment potentiated an increase in gene and gene mRNAs but not gene or chemical-glucuronosyltransferase 1A1 mRNAs .	T4	T31	23539296
NA	CHEMICAL	GENE-Y	19	3	In addition to gene , chemical co-treatment potentiated an increase in gene and gene mRNAs but not gene or chemical-glucuronosyltransferase 1A1 mRNAs .	T5	T27	23539296
NA	CHEMICAL	GENE-Y	19	11	In addition to gene , chemical co-treatment potentiated an increase in gene and gene mRNAs but not gene or chemical-glucuronosyltransferase 1A1 mRNAs .	T5	T28	23539296
NA	CHEMICAL	GENE-Y	19	13	In addition to gene , chemical co-treatment potentiated an increase in gene and gene mRNAs but not gene or chemical-glucuronosyltransferase 1A1 mRNAs .	T5	T29	23539296
NA	CHEMICAL	GENE-Y	19	17	In addition to gene , chemical co-treatment potentiated an increase in gene and gene mRNAs but not gene or chemical-glucuronosyltransferase 1A1 mRNAs .	T5	T30	23539296
NA	CHEMICAL	GENE-Y	19	20	In addition to gene , chemical co-treatment potentiated an increase in gene and gene mRNAs but not gene or chemical-glucuronosyltransferase 1A1 mRNAs .	T5	T31	23539296
CPR:4	CHEMICAL	GENE-Y	3	9	Clinical pharmacology of chemical , a novel , chemical gene inhibitor .	T11	T19	1705633
CPR:4	CHEMICAL	GENE-Y	8	9	Clinical pharmacology of chemical , a novel , chemical gene inhibitor .	T12	T19	1705633
CPR:4	CHEMICAL	GENE-Y	0	9	chemical ( chemical ) , a potent , chemical gene inhibitor , mimics the transition state of the gene substrate , gene .	T1	T17	1705633
CPR:4	CHEMICAL	GENE-Y	0	18	chemical ( chemical ) , a potent , chemical gene inhibitor , mimics the transition state of the gene substrate , gene .	T1	T18	1705633
NA	CHEMICAL	GENE-Y	0	5	chemical ( chemical ) , a potent , chemical gene inhibitor , mimics the transition state of the gene substrate , gene .	T1	T13	1705633
CPR:4	CHEMICAL	GENE-Y	2	9	chemical ( chemical ) , a potent , chemical gene inhibitor , mimics the transition state of the gene substrate , gene .	T2	T17	1705633
CPR:4	CHEMICAL	GENE-Y	2	18	chemical ( chemical ) , a potent , chemical gene inhibitor , mimics the transition state of the gene substrate , gene .	T2	T18	1705633
NA	CHEMICAL	GENE-Y	2	5	chemical ( chemical ) , a potent , chemical gene inhibitor , mimics the transition state of the gene substrate , gene .	T2	T13	1705633
CPR:4	CHEMICAL	GENE-Y	8	9	chemical ( chemical ) , a potent , chemical gene inhibitor , mimics the transition state of the gene substrate , gene .	T7	T17	1705633
CPR:4	CHEMICAL	GENE-Y	8	18	chemical ( chemical ) , a potent , chemical gene inhibitor , mimics the transition state of the gene substrate , gene .	T7	T18	1705633
NA	CHEMICAL	GENE-Y	8	5	chemical ( chemical ) , a potent , chemical gene inhibitor , mimics the transition state of the gene substrate , gene .	T7	T13	1705633
CPR:4	CHEMICAL	GENE-Y	0	10	chemical has been shown to produce dose-related suppression of plasma gene activity ( PRA ) and chemical when administered intravenously .	T4	T15	1705633
NA	CHEMICAL	GENE-Y	16	10	chemical has been shown to produce dose-related suppression of plasma gene activity ( PRA ) and chemical when administered intravenously .	T5	T15	1705633
NA	CHEMICAL	GENE-Y	3	0	gene deficiency enhances chemical-induced apoptosis .	T11	T31	23344961
NA	CHEMICAL	GENE-Y	0	6	chemical ( chemical ) , a gene-targeting drug that stabilizes gene-DNA covalent adducts , can induce S-phase-specific cytotoxicity due to the arrest of progressing replication forks .	T1	T20	23344961
NA	CHEMICAL	GENE-Y	0	10	chemical ( chemical ) , a gene-targeting drug that stabilizes gene-DNA covalent adducts , can induce S-phase-specific cytotoxicity due to the arrest of progressing replication forks .	T1	T27	23344961
NA	CHEMICAL	GENE-Y	2	6	chemical ( chemical ) , a gene-targeting drug that stabilizes gene-DNA covalent adducts , can induce S-phase-specific cytotoxicity due to the arrest of progressing replication forks .	T3	T20	23344961
NA	CHEMICAL	GENE-Y	2	10	chemical ( chemical ) , a gene-targeting drug that stabilizes gene-DNA covalent adducts , can induce S-phase-specific cytotoxicity due to the arrest of progressing replication forks .	T3	T27	23344961
NA	CHEMICAL	GENE-Y	16	7	In this study , we have identified gene ( gene ) as a specific determinant for chemical sensitivity , but not for many other cytotoxic agents , in non-S-phase cells .	T5	T21	23344961
NA	CHEMICAL	GENE-Y	16	9	In this study , we have identified gene ( gene ) as a specific determinant for chemical sensitivity , but not for many other cytotoxic agents , in non-S-phase cells .	T5	T22	23344961
NA	CHEMICAL	GENE-Y	17	10	First , quiescent mouse embryonic fibroblasts ( MEFs ) lacking gene were shown to be hypersensitive to chemical with prominent induction of apoptosis .	T6	T23	23344961
CPR:4	CHEMICAL	GENE-Y	2	5	Second , chemical , a gene catalytic inhibitor known to deplete gene , specifically sensitized MEFs to chemical .	T7	T24	23344961
CPR:4	CHEMICAL	GENE-Y	2	11	Second , chemical , a gene catalytic inhibitor known to deplete gene , specifically sensitized MEFs to chemical .	T7	T25	23344961
NA	CHEMICAL	GENE-Y	17	5	Second , chemical , a gene catalytic inhibitor known to deplete gene , specifically sensitized MEFs to chemical .	T8	T24	23344961
NA	CHEMICAL	GENE-Y	17	11	Second , chemical , a gene catalytic inhibitor known to deplete gene , specifically sensitized MEFs to chemical .	T8	T25	23344961
NA	CHEMICAL	GENE-Y	6	0	To explore the molecular basis for chemical hypersensitivity in gene-deficient cells , we found that upon chemical exposure , the gene ( gene ) became progressively depleted , followed by recovery to nearly the original level in wild-type MEFs , whereas gene remained depleted without recovery in gene-deficient cells .	T9	T26	23344961
NA	CHEMICAL	GENE-N	6	20	To explore the molecular basis for chemical hypersensitivity in gene-deficient cells , we found that upon chemical exposure , the gene ( gene ) became progressively depleted , followed by recovery to nearly the original level in wild-type MEFs , whereas gene remained depleted without recovery in gene-deficient cells .	T9	T28	23344961
NA	CHEMICAL	GENE-N	6	22	To explore the molecular basis for chemical hypersensitivity in gene-deficient cells , we found that upon chemical exposure , the gene ( gene ) became progressively depleted , followed by recovery to nearly the original level in wild-type MEFs , whereas gene remained depleted without recovery in gene-deficient cells .	T9	T29	23344961
NA	CHEMICAL	GENE-N	6	41	To explore the molecular basis for chemical hypersensitivity in gene-deficient cells , we found that upon chemical exposure , the gene ( gene ) became progressively depleted , followed by recovery to nearly the original level in wild-type MEFs , whereas gene remained depleted without recovery in gene-deficient cells .	T9	T30	23344961
NA	CHEMICAL	GENE-Y	6	0	To explore the molecular basis for chemical hypersensitivity in gene-deficient cells , we found that upon chemical exposure , the gene ( gene ) became progressively depleted , followed by recovery to nearly the original level in wild-type MEFs , whereas gene remained depleted without recovery in gene-deficient cells .	T9	T12	23344961
NA	CHEMICAL	GENE-Y	16	0	To explore the molecular basis for chemical hypersensitivity in gene-deficient cells , we found that upon chemical exposure , the gene ( gene ) became progressively depleted , followed by recovery to nearly the original level in wild-type MEFs , whereas gene remained depleted without recovery in gene-deficient cells .	T10	T26	23344961
CPR:4	CHEMICAL	GENE-N	16	20	To explore the molecular basis for chemical hypersensitivity in gene-deficient cells , we found that upon chemical exposure , the gene ( gene ) became progressively depleted , followed by recovery to nearly the original level in wild-type MEFs , whereas gene remained depleted without recovery in gene-deficient cells .	T10	T28	23344961
CPR:4	CHEMICAL	GENE-N	16	22	To explore the molecular basis for chemical hypersensitivity in gene-deficient cells , we found that upon chemical exposure , the gene ( gene ) became progressively depleted , followed by recovery to nearly the original level in wild-type MEFs , whereas gene remained depleted without recovery in gene-deficient cells .	T10	T29	23344961
CPR:4	CHEMICAL	GENE-N	16	41	To explore the molecular basis for chemical hypersensitivity in gene-deficient cells , we found that upon chemical exposure , the gene ( gene ) became progressively depleted , followed by recovery to nearly the original level in wild-type MEFs , whereas gene remained depleted without recovery in gene-deficient cells .	T10	T30	23344961
NA	CHEMICAL	GENE-Y	16	0	To explore the molecular basis for chemical hypersensitivity in gene-deficient cells , we found that upon chemical exposure , the gene ( gene ) became progressively depleted , followed by recovery to nearly the original level in wild-type MEFs , whereas gene remained depleted without recovery in gene-deficient cells .	T10	T12	23344961
NA	CHEMICAL	GENE-Y	0	2	chemical Oxidase NOX5-S and gene Mediate Acid-Induced gene Expression in Barrett 's Esophageal Adenocarcinoma Cells .	T15	T55	23439561
NA	CHEMICAL	GENE-Y	0	4	chemical Oxidase NOX5-S and gene Mediate Acid-Induced gene Expression in Barrett 's Esophageal Adenocarcinoma Cells .	T15	T56	23439561
NA	CHEMICAL	GENE-Y	0	7	chemical Oxidase NOX5-S and gene Mediate Acid-Induced gene Expression in Barrett 's Esophageal Adenocarcinoma Cells .	T15	T57	23439561
CPR:9	CHEMICAL	GENE-Y	5	0	gene ( gene ) -derived chemical ( chemical ) has been shown to be important in esophageal tumorigenesis .	T3	T18	23439561
CPR:9	CHEMICAL	GENE-Y	5	2	gene ( gene ) -derived chemical ( chemical ) has been shown to be important in esophageal tumorigenesis .	T3	T25	23439561
CPR:9	CHEMICAL	GENE-Y	7	0	gene ( gene ) -derived chemical ( chemical ) has been shown to be important in esophageal tumorigenesis .	T5	T18	23439561
CPR:9	CHEMICAL	GENE-Y	7	2	gene ( gene ) -derived chemical ( chemical ) has been shown to be important in esophageal tumorigenesis .	T5	T25	23439561
CPR:9	CHEMICAL	GENE-Y	7	4	We have shown that gene mediates acid-induced chemical production .	T6	T36	23439561
NA	CHEMICAL	GENE-Y	1	2	The chemical synthase ( gene ) responsible for acid-induced chemical production in BE , however , is not known .	T7	T37	23439561
NA	CHEMICAL	GENE-Y	1	4	The chemical synthase ( gene ) responsible for acid-induced chemical production in BE , however , is not known .	T7	T38	23439561
NA	CHEMICAL	GENE-Y	9	2	The chemical synthase ( gene ) responsible for acid-induced chemical production in BE , however , is not known .	T8	T37	23439561
NA	CHEMICAL	GENE-Y	9	4	The chemical synthase ( gene ) responsible for acid-induced chemical production in BE , however , is not known .	T8	T38	23439561
NA	CHEMICAL	GENE-Y	15	2	Knockdown of gene by gene small interfering RNA ( siRNA ) blocked acid-induced increase in chemical production and chemical incorporation .	T9	T47	23439561
NA	CHEMICAL	GENE-Y	15	4	Knockdown of gene by gene small interfering RNA ( siRNA ) blocked acid-induced increase in chemical production and chemical incorporation .	T9	T48	23439561
NA	CHEMICAL	GENE-Y	14	2	Knockdown of gene by gene small interfering RNA ( siRNA ) blocked acid-induced increase in chemical production and chemical incorporation .	T10	T47	23439561
NA	CHEMICAL	GENE-Y	14	4	Knockdown of gene by gene small interfering RNA ( siRNA ) blocked acid-induced increase in chemical production and chemical incorporation .	T10	T48	23439561
NA	CHEMICAL	GENE-N	2	3	Knockdown of chemical oxidase , gene , a variant lacking chemical-binding domains , by gene siRNA significantly inhibited acid-induced increase in gene expression , chemical incorporation , and chemical production .	T11	T49	23439561
NA	CHEMICAL	GENE-Y	2	5	Knockdown of chemical oxidase , gene , a variant lacking chemical-binding domains , by gene siRNA significantly inhibited acid-induced increase in gene expression , chemical incorporation , and chemical production .	T11	T50	23439561
NA	CHEMICAL	GENE-N	2	7	Knockdown of chemical oxidase , gene , a variant lacking chemical-binding domains , by gene siRNA significantly inhibited acid-induced increase in gene expression , chemical incorporation , and chemical production .	T11	T51	23439561
NA	CHEMICAL	GENE-Y	2	14	Knockdown of chemical oxidase , gene , a variant lacking chemical-binding domains , by gene siRNA significantly inhibited acid-induced increase in gene expression , chemical incorporation , and chemical production .	T11	T52	23439561
NA	CHEMICAL	GENE-Y	2	21	Knockdown of chemical oxidase , gene , a variant lacking chemical-binding domains , by gene siRNA significantly inhibited acid-induced increase in gene expression , chemical incorporation , and chemical production .	T11	T53	23439561
NA	CHEMICAL	GENE-N	7	3	Knockdown of chemical oxidase , gene , a variant lacking chemical-binding domains , by gene siRNA significantly inhibited acid-induced increase in gene expression , chemical incorporation , and chemical production .	T12	T49	23439561
NA	CHEMICAL	GENE-Y	7	5	Knockdown of chemical oxidase , gene , a variant lacking chemical-binding domains , by gene siRNA significantly inhibited acid-induced increase in gene expression , chemical incorporation , and chemical production .	T12	T50	23439561
NA	CHEMICAL	GENE-N	7	7	Knockdown of chemical oxidase , gene , a variant lacking chemical-binding domains , by gene siRNA significantly inhibited acid-induced increase in gene expression , chemical incorporation , and chemical production .	T12	T51	23439561
NA	CHEMICAL	GENE-Y	7	14	Knockdown of chemical oxidase , gene , a variant lacking chemical-binding domains , by gene siRNA significantly inhibited acid-induced increase in gene expression , chemical incorporation , and chemical production .	T12	T52	23439561
NA	CHEMICAL	GENE-Y	7	21	Knockdown of chemical oxidase , gene , a variant lacking chemical-binding domains , by gene siRNA significantly inhibited acid-induced increase in gene expression , chemical incorporation , and chemical production .	T12	T53	23439561
NA	CHEMICAL	GENE-N	20	3	Knockdown of chemical oxidase , gene , a variant lacking chemical-binding domains , by gene siRNA significantly inhibited acid-induced increase in gene expression , chemical incorporation , and chemical production .	T13	T49	23439561
NA	CHEMICAL	GENE-Y	20	5	Knockdown of chemical oxidase , gene , a variant lacking chemical-binding domains , by gene siRNA significantly inhibited acid-induced increase in gene expression , chemical incorporation , and chemical production .	T13	T50	23439561
NA	CHEMICAL	GENE-N	20	7	Knockdown of chemical oxidase , gene , a variant lacking chemical-binding domains , by gene siRNA significantly inhibited acid-induced increase in gene expression , chemical incorporation , and chemical production .	T13	T51	23439561
NA	CHEMICAL	GENE-Y	20	14	Knockdown of chemical oxidase , gene , a variant lacking chemical-binding domains , by gene siRNA significantly inhibited acid-induced increase in gene expression , chemical incorporation , and chemical production .	T13	T52	23439561
NA	CHEMICAL	GENE-Y	20	21	Knockdown of chemical oxidase , gene , a variant lacking chemical-binding domains , by gene siRNA significantly inhibited acid-induced increase in gene expression , chemical incorporation , and chemical production .	T13	T53	23439561
NA	CHEMICAL	GENE-N	28	3	Knockdown of chemical oxidase , gene , a variant lacking chemical-binding domains , by gene siRNA significantly inhibited acid-induced increase in gene expression , chemical incorporation , and chemical production .	T14	T49	23439561
NA	CHEMICAL	GENE-Y	28	5	Knockdown of chemical oxidase , gene , a variant lacking chemical-binding domains , by gene siRNA significantly inhibited acid-induced increase in gene expression , chemical incorporation , and chemical production .	T14	T50	23439561
NA	CHEMICAL	GENE-N	28	7	Knockdown of chemical oxidase , gene , a variant lacking chemical-binding domains , by gene siRNA significantly inhibited acid-induced increase in gene expression , chemical incorporation , and chemical production .	T14	T51	23439561
NA	CHEMICAL	GENE-Y	28	14	Knockdown of chemical oxidase , gene , a variant lacking chemical-binding domains , by gene siRNA significantly inhibited acid-induced increase in gene expression , chemical incorporation , and chemical production .	T14	T52	23439561
NA	CHEMICAL	GENE-Y	28	21	Knockdown of chemical oxidase , gene , a variant lacking chemical-binding domains , by gene siRNA significantly inhibited acid-induced increase in gene expression , chemical incorporation , and chemical production .	T14	T53	23439561
NA	CHEMICAL	GENE-Y	11	2	Knockdown of gene gene by gene siRNA significantly decreased acid-induced increase in gene expression , chemical incorporation , and chemical production .	T1	T21	23439561
NA	CHEMICAL	GENE-Y	11	3	Knockdown of gene gene by gene siRNA significantly decreased acid-induced increase in gene expression , chemical incorporation , and chemical production .	T1	T22	23439561
NA	CHEMICAL	GENE-Y	11	5	Knockdown of gene gene by gene siRNA significantly decreased acid-induced increase in gene expression , chemical incorporation , and chemical production .	T1	T23	23439561
NA	CHEMICAL	GENE-Y	11	12	Knockdown of gene gene by gene siRNA significantly decreased acid-induced increase in gene expression , chemical incorporation , and chemical production .	T1	T24	23439561
NA	CHEMICAL	GENE-Y	2	2	Knockdown of gene gene by gene siRNA significantly decreased acid-induced increase in gene expression , chemical incorporation , and chemical production .	T2	T21	23439561
NA	CHEMICAL	GENE-Y	2	3	Knockdown of gene gene by gene siRNA significantly decreased acid-induced increase in gene expression , chemical incorporation , and chemical production .	T2	T22	23439561
NA	CHEMICAL	GENE-Y	2	5	Knockdown of gene gene by gene siRNA significantly decreased acid-induced increase in gene expression , chemical incorporation , and chemical production .	T2	T23	23439561
NA	CHEMICAL	GENE-Y	2	12	Knockdown of gene gene by gene siRNA significantly decreased acid-induced increase in gene expression , chemical incorporation , and chemical production .	T2	T24	23439561
CPR:9	CHEMICAL	GENE-Y	8	3	We conclude that gene mediates acid-induced increase in chemical production and cell proliferation .	T4	T30	23439561
NA	CHEMICAL	GENE-Y	0	9	chemical and asthma : an appraisal based on specific gene antagonism .	T19	T31	1977506
CPR:5	CHEMICAL	GENE-Y	0	0	gene antagonists have been utilized , following their initial chemical synthesis in 1933 , both in the treatment of conditions in which chemical is considered to be of pathogenic importance and conversely to help elucidate the role of chemical in disease , through an evaluation of their influence on disease expression .	T2	T20	1977506
CPR:5	CHEMICAL	GENE-Y	11	0	gene antagonists have been utilized , following their initial chemical synthesis in 1933 , both in the treatment of conditions in which chemical is considered to be of pathogenic importance and conversely to help elucidate the role of chemical in disease , through an evaluation of their influence on disease expression .	T16	T20	1977506
CPR:5	CHEMICAL	GENE-Y	2	6	While there is considerable indirect evidence to implicate chemical in the pathogenesis of asthma , a critical evaluation of gene antagonism in this condition has , until recently , proved difficult , as many of the early gene antagonists possessed additional actions , such as anti-cholinergic , local anaesthetic , gene antagonistic and anti-serotonin activity .	T18	T27	1977506
CPR:5	CHEMICAL	GENE-Y	2	6	While there is considerable indirect evidence to implicate chemical in the pathogenesis of asthma , a critical evaluation of gene antagonism in this condition has , until recently , proved difficult , as many of the early gene antagonists possessed additional actions , such as anti-cholinergic , local anaesthetic , gene antagonistic and anti-serotonin activity .	T18	T28	1977506
NA	CHEMICAL	GENE-N	2	6	While there is considerable indirect evidence to implicate chemical in the pathogenesis of asthma , a critical evaluation of gene antagonism in this condition has , until recently , proved difficult , as many of the early gene antagonists possessed additional actions , such as anti-cholinergic , local anaesthetic , gene antagonistic and anti-serotonin activity .	T18	T29	1977506
CPR:5	CHEMICAL	GENE-Y	18	4	The recent development of gene antagonists devoid of clinical sedative effects has enabled the administration of doses of gene-antichemicals which achieve a greater degree of gene blockade within the airways , thus permitting a better appraisal of the role of histamine in this condition .	T3	T23	1977506
NA	CHEMICAL	GENE-Y	18	18	The recent development of gene antagonists devoid of clinical sedative effects has enabled the administration of doses of gene-antichemicals which achieve a greater degree of gene blockade within the airways , thus permitting a better appraisal of the role of histamine in this condition .	T3	T24	1977506
CPR:5	CHEMICAL	GENE-Y	18	25	The recent development of gene antagonists devoid of clinical sedative effects has enabled the administration of doses of gene-antichemicals which achieve a greater degree of gene blockade within the airways , thus permitting a better appraisal of the role of histamine in this condition .	T3	T25	1977506
NA	CHEMICAL	GENE-N	1	5	The chemical moiety of the gene fragment , markedly increases the half-life of CZP and confers to the drug a unique structure that differs from the other anti-gene agents tested for the treatment of Crohn 's disease , rheumatoid arthritis , ankylosing spondylitis , axial spondyloarthritis , nonradiographic spondyloarthritis , PsO , and PsA .	T1	T9	23620660
NA	CHEMICAL	GENE-Y	1	19	The chemical moiety of the gene fragment , markedly increases the half-life of CZP and confers to the drug a unique structure that differs from the other anti-gene agents tested for the treatment of Crohn 's disease , rheumatoid arthritis , ankylosing spondylitis , axial spondyloarthritis , nonradiographic spondyloarthritis , PsO , and PsA .	T1	T10	23620660
CPR:4	CHEMICAL	GENE-N	0	5	chemical and chemical , selective gene inhibitors , suppressed gene secretion to a lesser extent .	T11	T39	11969359
CPR:4	CHEMICAL	GENE-Y	0	9	chemical and chemical , selective gene inhibitors , suppressed gene secretion to a lesser extent .	T11	T40	11969359
CPR:4	CHEMICAL	GENE-N	2	5	chemical and chemical , selective gene inhibitors , suppressed gene secretion to a lesser extent .	T12	T39	11969359
CPR:4	CHEMICAL	GENE-Y	2	9	chemical and chemical , selective gene inhibitors , suppressed gene secretion to a lesser extent .	T12	T40	11969359
CPR:4	CHEMICAL	GENE-N	3	6	The effects of chemical ( unspecific gene inhibitor ) , chemical ( gene inhibitor ) , EHNA ( gene inhibitor ) and the gene inhibitors chemical and chemical were weak .	T1	T13	11969359
NA	CHEMICAL	GENE-N	3	12	The effects of chemical ( unspecific gene inhibitor ) , chemical ( gene inhibitor ) , EHNA ( gene inhibitor ) and the gene inhibitors chemical and chemical were weak .	T1	T14	11969359
NA	CHEMICAL	GENE-Y	3	18	The effects of chemical ( unspecific gene inhibitor ) , chemical ( gene inhibitor ) , EHNA ( gene inhibitor ) and the gene inhibitors chemical and chemical were weak .	T1	T15	11969359
NA	CHEMICAL	GENE-Y	3	23	The effects of chemical ( unspecific gene inhibitor ) , chemical ( gene inhibitor ) , EHNA ( gene inhibitor ) and the gene inhibitors chemical and chemical were weak .	T1	T16	11969359
NA	CHEMICAL	GENE-N	10	6	The effects of chemical ( unspecific gene inhibitor ) , chemical ( gene inhibitor ) , EHNA ( gene inhibitor ) and the gene inhibitors chemical and chemical were weak .	T2	T13	11969359
CPR:4	CHEMICAL	GENE-N	10	12	The effects of chemical ( unspecific gene inhibitor ) , chemical ( gene inhibitor ) , EHNA ( gene inhibitor ) and the gene inhibitors chemical and chemical were weak .	T2	T14	11969359
NA	CHEMICAL	GENE-Y	10	18	The effects of chemical ( unspecific gene inhibitor ) , chemical ( gene inhibitor ) , EHNA ( gene inhibitor ) and the gene inhibitors chemical and chemical were weak .	T2	T15	11969359
NA	CHEMICAL	GENE-Y	10	23	The effects of chemical ( unspecific gene inhibitor ) , chemical ( gene inhibitor ) , EHNA ( gene inhibitor ) and the gene inhibitors chemical and chemical were weak .	T2	T16	11969359
NA	CHEMICAL	GENE-N	25	6	The effects of chemical ( unspecific gene inhibitor ) , chemical ( gene inhibitor ) , EHNA ( gene inhibitor ) and the gene inhibitors chemical and chemical were weak .	T3	T13	11969359
NA	CHEMICAL	GENE-N	25	12	The effects of chemical ( unspecific gene inhibitor ) , chemical ( gene inhibitor ) , EHNA ( gene inhibitor ) and the gene inhibitors chemical and chemical were weak .	T3	T14	11969359
NA	CHEMICAL	GENE-Y	25	18	The effects of chemical ( unspecific gene inhibitor ) , chemical ( gene inhibitor ) , EHNA ( gene inhibitor ) and the gene inhibitors chemical and chemical were weak .	T3	T15	11969359
CPR:4	CHEMICAL	GENE-Y	25	23	The effects of chemical ( unspecific gene inhibitor ) , chemical ( gene inhibitor ) , EHNA ( gene inhibitor ) and the gene inhibitors chemical and chemical were weak .	T3	T16	11969359
NA	CHEMICAL	GENE-N	27	6	The effects of chemical ( unspecific gene inhibitor ) , chemical ( gene inhibitor ) , EHNA ( gene inhibitor ) and the gene inhibitors chemical and chemical were weak .	T4	T13	11969359
NA	CHEMICAL	GENE-N	27	12	The effects of chemical ( unspecific gene inhibitor ) , chemical ( gene inhibitor ) , EHNA ( gene inhibitor ) and the gene inhibitors chemical and chemical were weak .	T4	T14	11969359
NA	CHEMICAL	GENE-Y	27	18	The effects of chemical ( unspecific gene inhibitor ) , chemical ( gene inhibitor ) , EHNA ( gene inhibitor ) and the gene inhibitors chemical and chemical were weak .	T4	T15	11969359
CPR:4	CHEMICAL	GENE-Y	27	23	The effects of chemical ( unspecific gene inhibitor ) , chemical ( gene inhibitor ) , EHNA ( gene inhibitor ) and the gene inhibitors chemical and chemical were weak .	T4	T16	11969359
CPR:4	CHEMICAL	GENE-Y	7	16	In human blood , the tested glucocorticoids chemical , chemical and chemical inhibited the LPS induced gene release potently in a concentration dependent manner , whereas in dispersed human nasal polyp cells , the effect of the glucocorticoids on allergically induced gene release , with the exception of chemical , was much less pronounced .	T5	T17	11969359
CPR:4	CHEMICAL	GENE-Y	7	41	In human blood , the tested glucocorticoids chemical , chemical and chemical inhibited the LPS induced gene release potently in a concentration dependent manner , whereas in dispersed human nasal polyp cells , the effect of the glucocorticoids on allergically induced gene release , with the exception of chemical , was much less pronounced .	T5	T18	11969359
CPR:4	CHEMICAL	GENE-Y	9	16	In human blood , the tested glucocorticoids chemical , chemical and chemical inhibited the LPS induced gene release potently in a concentration dependent manner , whereas in dispersed human nasal polyp cells , the effect of the glucocorticoids on allergically induced gene release , with the exception of chemical , was much less pronounced .	T6	T17	11969359
CPR:4	CHEMICAL	GENE-Y	9	41	In human blood , the tested glucocorticoids chemical , chemical and chemical inhibited the LPS induced gene release potently in a concentration dependent manner , whereas in dispersed human nasal polyp cells , the effect of the glucocorticoids on allergically induced gene release , with the exception of chemical , was much less pronounced .	T6	T18	11969359
CPR:4	CHEMICAL	GENE-Y	11	16	In human blood , the tested glucocorticoids chemical , chemical and chemical inhibited the LPS induced gene release potently in a concentration dependent manner , whereas in dispersed human nasal polyp cells , the effect of the glucocorticoids on allergically induced gene release , with the exception of chemical , was much less pronounced .	T7	T17	11969359
CPR:4	CHEMICAL	GENE-Y	11	41	In human blood , the tested glucocorticoids chemical , chemical and chemical inhibited the LPS induced gene release potently in a concentration dependent manner , whereas in dispersed human nasal polyp cells , the effect of the glucocorticoids on allergically induced gene release , with the exception of chemical , was much less pronounced .	T7	T18	11969359
NA	CHEMICAL	GENE-Y	20	16	In human blood , the tested glucocorticoids chemical , chemical and chemical inhibited the LPS induced gene release potently in a concentration dependent manner , whereas in dispersed human nasal polyp cells , the effect of the glucocorticoids on allergically induced gene release , with the exception of chemical , was much less pronounced .	T8	T17	11969359
NA	CHEMICAL	GENE-Y	20	41	In human blood , the tested glucocorticoids chemical , chemical and chemical inhibited the LPS induced gene release potently in a concentration dependent manner , whereas in dispersed human nasal polyp cells , the effect of the glucocorticoids on allergically induced gene release , with the exception of chemical , was much less pronounced .	T8	T18	11969359
CPR:4	CHEMICAL	GENE-N	7	2	The selective gene inhibitors , and to a certain extent the gene inhibitors chemical and chemical , reduced the gene release in a concentration dependent manner .	T9	T23	11969359
CPR:4	CHEMICAL	GENE-N	7	11	The selective gene inhibitors , and to a certain extent the gene inhibitors chemical and chemical , reduced the gene release in a concentration dependent manner .	T9	T24	11969359
CPR:4	CHEMICAL	GENE-Y	7	19	The selective gene inhibitors , and to a certain extent the gene inhibitors chemical and chemical , reduced the gene release in a concentration dependent manner .	T9	T25	11969359
CPR:4	CHEMICAL	GENE-N	15	2	The selective gene inhibitors , and to a certain extent the gene inhibitors chemical and chemical , reduced the gene release in a concentration dependent manner .	T10	T23	11969359
CPR:4	CHEMICAL	GENE-N	15	11	The selective gene inhibitors , and to a certain extent the gene inhibitors chemical and chemical , reduced the gene release in a concentration dependent manner .	T10	T24	11969359
CPR:4	CHEMICAL	GENE-Y	15	19	The selective gene inhibitors , and to a certain extent the gene inhibitors chemical and chemical , reduced the gene release in a concentration dependent manner .	T10	T25	11969359
NA	CHEMICAL	GENE-N	7	5	Specifically , light microscopy revealed a decrease in chemical hydroxylase-expressing ( chemical ) neurons in the midbrain of chemical-exposed fetuses and electron microscopy identified a reduction in spine synapses in the CA1 region of hippocampus .	T1	T20	23337607
NA	CHEMICAL	GENE-N	5	5	Specifically , light microscopy revealed a decrease in chemical hydroxylase-expressing ( chemical ) neurons in the midbrain of chemical-exposed fetuses and electron microscopy identified a reduction in spine synapses in the CA1 region of hippocampus .	T2	T20	23337607
NA	CHEMICAL	GENE-N	18	5	Specifically , light microscopy revealed a decrease in chemical hydroxylase-expressing ( chemical ) neurons in the midbrain of chemical-exposed fetuses and electron microscopy identified a reduction in spine synapses in the CA1 region of hippocampus .	T3	T20	23337607
CPR:3	CHEMICAL	GENE-Y	2	4	Effect of chemical-induced constitutive gene activity on contractile receptor function in airway smooth muscle .	T20	T29	11730729
CPR:3	CHEMICAL	GENE-Y	10	12	In the present study , we investigated the effect of chemical-induced constitutive gene activity on gene agonist- and chemical-induced bovine tracheal smooth muscle contractions .	T10	T28	11730729
NA	CHEMICAL	GENE-N	10	15	In the present study , we investigated the effect of chemical-induced constitutive gene activity on gene agonist- and chemical-induced bovine tracheal smooth muscle contractions .	T10	T21	11730729
NA	CHEMICAL	GENE-Y	18	12	In the present study , we investigated the effect of chemical-induced constitutive gene activity on gene agonist- and chemical-induced bovine tracheal smooth muscle contractions .	T6	T28	11730729
NA	CHEMICAL	GENE-N	18	15	In the present study , we investigated the effect of chemical-induced constitutive gene activity on gene agonist- and chemical-induced bovine tracheal smooth muscle contractions .	T6	T21	11730729
NA	CHEMICAL	GENE-N	10	11	Bovine tracheal smooth muscle strips were incubated with 10 microM chemical or vehicle for various periods of time ( 5 , 30 min , 18 h ) at 37 degrees C. After extensive washout ( 3 h , 37 degrees C ) , isometric contractions were measured to the full gene agonist chemical , the partial gene agonist chemical ( chemical ) and chemical .	T8	T26	11730729
NA	CHEMICAL	GENE-N	10	11	Bovine tracheal smooth muscle strips were incubated with 10 microM chemical or vehicle for various periods of time ( 5 , 30 min , 18 h ) at 37 degrees C. After extensive washout ( 3 h , 37 degrees C ) , isometric contractions were measured to the full gene agonist chemical , the partial gene agonist chemical ( chemical ) and chemical .	T8	T27	11730729
CPR:5	CHEMICAL	GENE-N	25	11	Bovine tracheal smooth muscle strips were incubated with 10 microM chemical or vehicle for various periods of time ( 5 , 30 min , 18 h ) at 37 degrees C. After extensive washout ( 3 h , 37 degrees C ) , isometric contractions were measured to the full gene agonist chemical , the partial gene agonist chemical ( chemical ) and chemical .	T9	T26	11730729
NA	CHEMICAL	GENE-N	25	11	Bovine tracheal smooth muscle strips were incubated with 10 microM chemical or vehicle for various periods of time ( 5 , 30 min , 18 h ) at 37 degrees C. After extensive washout ( 3 h , 37 degrees C ) , isometric contractions were measured to the full gene agonist chemical , the partial gene agonist chemical ( chemical ) and chemical .	T9	T27	11730729
NA	CHEMICAL	GENE-N	11	11	Bovine tracheal smooth muscle strips were incubated with 10 microM chemical or vehicle for various periods of time ( 5 , 30 min , 18 h ) at 37 degrees C. After extensive washout ( 3 h , 37 degrees C ) , isometric contractions were measured to the full gene agonist chemical , the partial gene agonist chemical ( chemical ) and chemical .	T11	T26	11730729
CPR:5	CHEMICAL	GENE-N	11	11	Bovine tracheal smooth muscle strips were incubated with 10 microM chemical or vehicle for various periods of time ( 5 , 30 min , 18 h ) at 37 degrees C. After extensive washout ( 3 h , 37 degrees C ) , isometric contractions were measured to the full gene agonist chemical , the partial gene agonist chemical ( chemical ) and chemical .	T11	T27	11730729
NA	CHEMICAL	GENE-N	35	11	Bovine tracheal smooth muscle strips were incubated with 10 microM chemical or vehicle for various periods of time ( 5 , 30 min , 18 h ) at 37 degrees C. After extensive washout ( 3 h , 37 degrees C ) , isometric contractions were measured to the full gene agonist chemical , the partial gene agonist chemical ( chemical ) and chemical .	T12	T26	11730729
NA	CHEMICAL	GENE-N	35	11	Bovine tracheal smooth muscle strips were incubated with 10 microM chemical or vehicle for various periods of time ( 5 , 30 min , 18 h ) at 37 degrees C. After extensive washout ( 3 h , 37 degrees C ) , isometric contractions were measured to the full gene agonist chemical , the partial gene agonist chemical ( chemical ) and chemical .	T12	T27	11730729
NA	CHEMICAL	GENE-N	22	11	Bovine tracheal smooth muscle strips were incubated with 10 microM chemical or vehicle for various periods of time ( 5 , 30 min , 18 h ) at 37 degrees C. After extensive washout ( 3 h , 37 degrees C ) , isometric contractions were measured to the full gene agonist chemical , the partial gene agonist chemical ( chemical ) and chemical .	T13	T26	11730729
CPR:5	CHEMICAL	GENE-N	22	11	Bovine tracheal smooth muscle strips were incubated with 10 microM chemical or vehicle for various periods of time ( 5 , 30 min , 18 h ) at 37 degrees C. After extensive washout ( 3 h , 37 degrees C ) , isometric contractions were measured to the full gene agonist chemical , the partial gene agonist chemical ( chemical ) and chemical .	T13	T27	11730729
CPR:3	CHEMICAL	GENE-Y	3	5	In conclusion , chemical-induced constitutive gene activity reduces gene agonist- and chemical-induced contractions of bovine tracheal smooth muscle , which can be reversed by the inverse agonist chemical .	T4	T22	11730729
NA	CHEMICAL	GENE-N	3	8	In conclusion , chemical-induced constitutive gene activity reduces gene agonist- and chemical-induced contractions of bovine tracheal smooth muscle , which can be reversed by the inverse agonist chemical .	T4	T23	11730729
NA	CHEMICAL	GENE-Y	11	5	In conclusion , chemical-induced constitutive gene activity reduces gene agonist- and chemical-induced contractions of bovine tracheal smooth muscle , which can be reversed by the inverse agonist chemical .	T5	T22	11730729
NA	CHEMICAL	GENE-N	11	8	In conclusion , chemical-induced constitutive gene activity reduces gene agonist- and chemical-induced contractions of bovine tracheal smooth muscle , which can be reversed by the inverse agonist chemical .	T5	T23	11730729
CPR:5	CHEMICAL	GENE-Y	27	5	In conclusion , chemical-induced constitutive gene activity reduces gene agonist- and chemical-induced contractions of bovine tracheal smooth muscle , which can be reversed by the inverse agonist chemical .	T7	T22	11730729
NA	CHEMICAL	GENE-N	27	8	In conclusion , chemical-induced constitutive gene activity reduces gene agonist- and chemical-induced contractions of bovine tracheal smooth muscle , which can be reversed by the inverse agonist chemical .	T7	T23	11730729
NA	CHEMICAL	GENE-Y	26	10	The twigs of Cudrania tricuspidata were found to show strong gene inhibitory activity , and further detailed component analysis resulted in the isolation of a new chemical , chemical ( 1 ) , plus twenty-seven known compounds ( 2-28 ) .	T1	T7	23262271
NA	CHEMICAL	GENE-Y	13	10	The twigs of Cudrania tricuspidata were found to show strong gene inhibitory activity , and further detailed component analysis resulted in the isolation of a new chemical , chemical ( 1 ) , plus twenty-seven known compounds ( 2-28 ) .	T2	T7	23262271
NA	CHEMICAL	GENE-N	15	23	Controversial results obtained from human and animal studies on the prevention of heart disease by chemical and chemical warrant a better understanding of gene function and interaction .	T25	T32	17000933
NA	CHEMICAL	GENE-N	17	23	Controversial results obtained from human and animal studies on the prevention of heart disease by chemical and chemical warrant a better understanding of gene function and interaction .	T3	T32	17000933
NA	CHEMICAL	GENE-Y	12	17	To address this issue and taking into account that effects of synthetic chemical are not only referable to action through the chemical receptor but may also be mediated by other chemical receptors , we characterized cardiovascular function and inflammatory gene expression in chemical salt-treated rats on long-term administration of chemical , chemical , and chemical , a new chemical exhibiting antimineralocorticoid activity .	T15	T33	17000933
NA	CHEMICAL	GENE-N	12	17	To address this issue and taking into account that effects of synthetic chemical are not only referable to action through the chemical receptor but may also be mediated by other chemical receptors , we characterized cardiovascular function and inflammatory gene expression in chemical salt-treated rats on long-term administration of chemical , chemical , and chemical , a new chemical exhibiting antimineralocorticoid activity .	T15	T34	17000933
NA	CHEMICAL	GENE-Y	21	17	To address this issue and taking into account that effects of synthetic chemical are not only referable to action through the chemical receptor but may also be mediated by other chemical receptors , we characterized cardiovascular function and inflammatory gene expression in chemical salt-treated rats on long-term administration of chemical , chemical , and chemical , a new chemical exhibiting antimineralocorticoid activity .	T16	T33	17000933
NA	CHEMICAL	GENE-N	21	17	To address this issue and taking into account that effects of synthetic chemical are not only referable to action through the chemical receptor but may also be mediated by other chemical receptors , we characterized cardiovascular function and inflammatory gene expression in chemical salt-treated rats on long-term administration of chemical , chemical , and chemical , a new chemical exhibiting antimineralocorticoid activity .	T16	T34	17000933
NA	CHEMICAL	GENE-Y	30	17	To address this issue and taking into account that effects of synthetic chemical are not only referable to action through the chemical receptor but may also be mediated by other chemical receptors , we characterized cardiovascular function and inflammatory gene expression in chemical salt-treated rats on long-term administration of chemical , chemical , and chemical , a new chemical exhibiting antimineralocorticoid activity .	T17	T33	17000933
NA	CHEMICAL	GENE-N	30	17	To address this issue and taking into account that effects of synthetic chemical are not only referable to action through the chemical receptor but may also be mediated by other chemical receptors , we characterized cardiovascular function and inflammatory gene expression in chemical salt-treated rats on long-term administration of chemical , chemical , and chemical , a new chemical exhibiting antimineralocorticoid activity .	T17	T34	17000933
NA	CHEMICAL	GENE-Y	42	17	To address this issue and taking into account that effects of synthetic chemical are not only referable to action through the chemical receptor but may also be mediated by other chemical receptors , we characterized cardiovascular function and inflammatory gene expression in chemical salt-treated rats on long-term administration of chemical , chemical , and chemical , a new chemical exhibiting antimineralocorticoid activity .	T18	T33	17000933
NA	CHEMICAL	GENE-N	42	17	To address this issue and taking into account that effects of synthetic chemical are not only referable to action through the chemical receptor but may also be mediated by other chemical receptors , we characterized cardiovascular function and inflammatory gene expression in chemical salt-treated rats on long-term administration of chemical , chemical , and chemical , a new chemical exhibiting antimineralocorticoid activity .	T18	T34	17000933
NA	CHEMICAL	GENE-Y	26	17	To address this issue and taking into account that effects of synthetic chemical are not only referable to action through the chemical receptor but may also be mediated by other chemical receptors , we characterized cardiovascular function and inflammatory gene expression in chemical salt-treated rats on long-term administration of chemical , chemical , and chemical , a new chemical exhibiting antimineralocorticoid activity .	T19	T33	17000933
NA	CHEMICAL	GENE-N	26	17	To address this issue and taking into account that effects of synthetic chemical are not only referable to action through the chemical receptor but may also be mediated by other chemical receptors , we characterized cardiovascular function and inflammatory gene expression in chemical salt-treated rats on long-term administration of chemical , chemical , and chemical , a new chemical exhibiting antimineralocorticoid activity .	T19	T34	17000933
NA	CHEMICAL	GENE-Y	51	17	To address this issue and taking into account that effects of synthetic chemical are not only referable to action through the chemical receptor but may also be mediated by other chemical receptors , we characterized cardiovascular function and inflammatory gene expression in chemical salt-treated rats on long-term administration of chemical , chemical , and chemical , a new chemical exhibiting antimineralocorticoid activity .	T20	T33	17000933
NA	CHEMICAL	GENE-N	51	17	To address this issue and taking into account that effects of synthetic chemical are not only referable to action through the chemical receptor but may also be mediated by other chemical receptors , we characterized cardiovascular function and inflammatory gene expression in chemical salt-treated rats on long-term administration of chemical , chemical , and chemical , a new chemical exhibiting antimineralocorticoid activity .	T20	T34	17000933
NA	CHEMICAL	GENE-Y	45	17	To address this issue and taking into account that effects of synthetic chemical are not only referable to action through the chemical receptor but may also be mediated by other chemical receptors , we characterized cardiovascular function and inflammatory gene expression in chemical salt-treated rats on long-term administration of chemical , chemical , and chemical , a new chemical exhibiting antimineralocorticoid activity .	T21	T33	17000933
NA	CHEMICAL	GENE-N	45	17	To address this issue and taking into account that effects of synthetic chemical are not only referable to action through the chemical receptor but may also be mediated by other chemical receptors , we characterized cardiovascular function and inflammatory gene expression in chemical salt-treated rats on long-term administration of chemical , chemical , and chemical , a new chemical exhibiting antimineralocorticoid activity .	T21	T34	17000933
NA	CHEMICAL	GENE-Y	17	17	To address this issue and taking into account that effects of synthetic chemical are not only referable to action through the chemical receptor but may also be mediated by other chemical receptors , we characterized cardiovascular function and inflammatory gene expression in chemical salt-treated rats on long-term administration of chemical , chemical , and chemical , a new chemical exhibiting antimineralocorticoid activity .	T22	T33	17000933
NA	CHEMICAL	GENE-N	17	17	To address this issue and taking into account that effects of synthetic chemical are not only referable to action through the chemical receptor but may also be mediated by other chemical receptors , we characterized cardiovascular function and inflammatory gene expression in chemical salt-treated rats on long-term administration of chemical , chemical , and chemical , a new chemical exhibiting antimineralocorticoid activity .	T22	T34	17000933
CPR:3	CHEMICAL	GENE-Y	4	5	The beneficial role of chemical on blood pressure , cardiac hypertrophy , vascular gene expression , perivascular fibrosis , and impaired chemical-dependent relaxation of isolated aortic rings was completely abrogated by coadministration of chemical .	T1	T30	17000933
NA	CHEMICAL	GENE-Y	21	5	The beneficial role of chemical on blood pressure , cardiac hypertrophy , vascular gene expression , perivascular fibrosis , and impaired chemical-dependent relaxation of isolated aortic rings was completely abrogated by coadministration of chemical .	T2	T30	17000933
CPR:4	CHEMICAL	GENE-Y	33	5	The beneficial role of chemical on blood pressure , cardiac hypertrophy , vascular gene expression , perivascular fibrosis , and impaired chemical-dependent relaxation of isolated aortic rings was completely abrogated by coadministration of chemical .	T4	T30	17000933
NA	CHEMICAL	GENE-N	10	20	The current results support the hypothesis of complex interactions among chemical , chemical , glucocorticoid , chemical , and mineralocorticoid receptor signaling in cardiovascular injury and inflammation .	T8	T31	17000933
NA	CHEMICAL	GENE-N	12	20	The current results support the hypothesis of complex interactions among chemical , chemical , glucocorticoid , chemical , and mineralocorticoid receptor signaling in cardiovascular injury and inflammation .	T9	T31	17000933
NA	CHEMICAL	GENE-N	16	20	The current results support the hypothesis of complex interactions among chemical , chemical , glucocorticoid , chemical , and mineralocorticoid receptor signaling in cardiovascular injury and inflammation .	T10	T31	17000933
NA	CHEMICAL	GENE-N	7	4	OBJECTIVE : Inhibition of gene activity improves chemical-oxidative stress , endothelial and coronary function .	T7	T12	19482847
NA	CHEMICAL	GENE-Y	9	27	The authors investigated ( a ) the association of chemical-oxidative stress and endothelial function with myocardial deformation , ( b ) the effects of anakinra , an gene antagonist on myocardial deformation in patients with rheumatoid arthritis ( RA ) .	T3	T13	19482847
CPR:4	CHEMICAL	GENE-Y	3	5	Antitumor activity of chemical in gene-driven leukemic cells .	T12	T26	17205056
NA	CHEMICAL	GENE-N	8	8	Activating internal tandem duplication ( ITD ) insertions in the gene of the gene chemical kinase are found in about one fourth of patients with acute myeloid leukemia and have been shown to be an independent negative prognostic factor for survival .	T10	T21	17205056
NA	CHEMICAL	GENE-Y	8	13	Activating internal tandem duplication ( ITD ) insertions in the gene of the gene chemical kinase are found in about one fourth of patients with acute myeloid leukemia and have been shown to be an independent negative prognostic factor for survival .	T10	T24	17205056
NA	CHEMICAL	GENE-N	8	8	Activating internal tandem duplication ( ITD ) insertions in the gene of the gene chemical kinase are found in about one fourth of patients with acute myeloid leukemia and have been shown to be an independent negative prognostic factor for survival .	T10	T25	17205056
CPR:4	CHEMICAL	GENE-Y	3	11	We show that chemical ( chemical , chemical ) potently inhibits gene enzymatic and signaling activities .	T2	T15	17205056
CPR:4	CHEMICAL	GENE-Y	5	11	We show that chemical ( chemical , chemical ) potently inhibits gene enzymatic and signaling activities .	T3	T15	17205056
CPR:4	CHEMICAL	GENE-Y	7	11	We show that chemical ( chemical , chemical ) potently inhibits gene enzymatic and signaling activities .	T4	T15	17205056
NA	CHEMICAL	GENE-Y	7	6	In HEK293 cells stably transfected with gene-WT or gene-ITD , chemical blocked basal and ligand dependent gene-mediated chemical autophosphorylation as well as gene and gene phosphorylation .	T5	T16	17205056
NA	CHEMICAL	GENE-Y	7	8	In HEK293 cells stably transfected with gene-WT or gene-ITD , chemical blocked basal and ligand dependent gene-mediated chemical autophosphorylation as well as gene and gene phosphorylation .	T5	T17	17205056
CPR:4	CHEMICAL	GENE-Y	7	16	In HEK293 cells stably transfected with gene-WT or gene-ITD , chemical blocked basal and ligand dependent gene-mediated chemical autophosphorylation as well as gene and gene phosphorylation .	T5	T18	17205056
CPR:4	CHEMICAL	GENE-N	7	19	In HEK293 cells stably transfected with gene-WT or gene-ITD , chemical blocked basal and ligand dependent gene-mediated chemical autophosphorylation as well as gene and gene phosphorylation .	T5	T19	17205056
CPR:4	CHEMICAL	GENE-Y	7	24	In HEK293 cells stably transfected with gene-WT or gene-ITD , chemical blocked basal and ligand dependent gene-mediated chemical autophosphorylation as well as gene and gene phosphorylation .	T5	T20	17205056
NA	CHEMICAL	GENE-Y	17	6	In HEK293 cells stably transfected with gene-WT or gene-ITD , chemical blocked basal and ligand dependent gene-mediated chemical autophosphorylation as well as gene and gene phosphorylation .	T6	T16	17205056
NA	CHEMICAL	GENE-Y	17	8	In HEK293 cells stably transfected with gene-WT or gene-ITD , chemical blocked basal and ligand dependent gene-mediated chemical autophosphorylation as well as gene and gene phosphorylation .	T6	T17	17205056
NA	CHEMICAL	GENE-Y	17	16	In HEK293 cells stably transfected with gene-WT or gene-ITD , chemical blocked basal and ligand dependent gene-mediated chemical autophosphorylation as well as gene and gene phosphorylation .	T6	T18	17205056
NA	CHEMICAL	GENE-N	17	19	In HEK293 cells stably transfected with gene-WT or gene-ITD , chemical blocked basal and ligand dependent gene-mediated chemical autophosphorylation as well as gene and gene phosphorylation .	T6	T19	17205056
NA	CHEMICAL	GENE-Y	17	24	In HEK293 cells stably transfected with gene-WT or gene-ITD , chemical blocked basal and ligand dependent gene-mediated chemical autophosphorylation as well as gene and gene phosphorylation .	T6	T20	17205056
CPR:4	CHEMICAL	GENE-Y	8	18	In leukemia cell lines MV4-11 and EOL-1 , chemical treatment resulted in decreased cell proliferation and inhibition of gene signaling .	T7	T22	17205056
CPR:4	CHEMICAL	GENE-Y	13	4	The growth of the gene-independent RS4-11 cell line was only weakly inhibited by chemical .	T8	T23	17205056
NA	CHEMICAL	GENE-N	2	12	Affinities of chemical and various reuptake inhibitors for the chemical and chemical transporters .	T33	T42	9669506
NA	CHEMICAL	GENE-N	9	12	Affinities of chemical and various reuptake inhibitors for the chemical and chemical transporters .	T34	T42	9669506
NA	CHEMICAL	GENE-N	11	12	Affinities of chemical and various reuptake inhibitors for the chemical and chemical transporters .	T35	T42	9669506
NA	CHEMICAL	GENE-N	8	31	In vitro radioligand binding studies were carried out in rat brain membranes to assess the affinity of various reuptake inhibitors for the chemical ( chemical , chemical ) and the chemical transporters using the selective ligands chemical and chemical , respectively .	T7	T36	9669506
NA	CHEMICAL	GENE-N	8	31	In vitro radioligand binding studies were carried out in rat brain membranes to assess the affinity of various reuptake inhibitors for the chemical ( chemical , chemical ) and the chemical transporters using the selective ligands chemical and chemical , respectively .	T8	T36	9669506
NA	CHEMICAL	GENE-N	26	31	In vitro radioligand binding studies were carried out in rat brain membranes to assess the affinity of various reuptake inhibitors for the chemical ( chemical , chemical ) and the chemical transporters using the selective ligands chemical and chemical , respectively .	T9	T36	9669506
NA	CHEMICAL	GENE-N	8	31	In vitro radioligand binding studies were carried out in rat brain membranes to assess the affinity of various reuptake inhibitors for the chemical ( chemical , chemical ) and the chemical transporters using the selective ligands chemical and chemical , respectively .	T10	T36	9669506
NA	CHEMICAL	GENE-N	8	31	In vitro radioligand binding studies were carried out in rat brain membranes to assess the affinity of various reuptake inhibitors for the chemical ( chemical , chemical ) and the chemical transporters using the selective ligands chemical and chemical , respectively .	T11	T36	9669506
NA	CHEMICAL	GENE-N	8	31	In vitro radioligand binding studies were carried out in rat brain membranes to assess the affinity of various reuptake inhibitors for the chemical ( chemical , chemical ) and the chemical transporters using the selective ligands chemical and chemical , respectively .	T12	T36	9669506
NA	CHEMICAL	GENE-Y	2	11	The selective chemical reuptake inhibitors chemical , chemical and chemical displayed a high affinity for the chemical transporter , whereas the chemical reuptake inhibitor chemical had a high affinity for the chemical transporter .	T13	T37	9669506
NA	CHEMICAL	GENE-Y	2	11	The selective chemical reuptake inhibitors chemical , chemical and chemical displayed a high affinity for the chemical transporter , whereas the chemical reuptake inhibitor chemical had a high affinity for the chemical transporter .	T13	T38	9669506
NA	CHEMICAL	GENE-Y	5	11	The selective chemical reuptake inhibitors chemical , chemical and chemical displayed a high affinity for the chemical transporter , whereas the chemical reuptake inhibitor chemical had a high affinity for the chemical transporter .	T14	T37	9669506
NA	CHEMICAL	GENE-Y	5	11	The selective chemical reuptake inhibitors chemical , chemical and chemical displayed a high affinity for the chemical transporter , whereas the chemical reuptake inhibitor chemical had a high affinity for the chemical transporter .	T14	T38	9669506
NA	CHEMICAL	GENE-Y	7	11	The selective chemical reuptake inhibitors chemical , chemical and chemical displayed a high affinity for the chemical transporter , whereas the chemical reuptake inhibitor chemical had a high affinity for the chemical transporter .	T15	T37	9669506
NA	CHEMICAL	GENE-Y	7	11	The selective chemical reuptake inhibitors chemical , chemical and chemical displayed a high affinity for the chemical transporter , whereas the chemical reuptake inhibitor chemical had a high affinity for the chemical transporter .	T15	T38	9669506
NA	CHEMICAL	GENE-Y	9	11	The selective chemical reuptake inhibitors chemical , chemical and chemical displayed a high affinity for the chemical transporter , whereas the chemical reuptake inhibitor chemical had a high affinity for the chemical transporter .	T16	T37	9669506
NA	CHEMICAL	GENE-Y	9	11	The selective chemical reuptake inhibitors chemical , chemical and chemical displayed a high affinity for the chemical transporter , whereas the chemical reuptake inhibitor chemical had a high affinity for the chemical transporter .	T16	T38	9669506
NA	CHEMICAL	GENE-Y	16	11	The selective chemical reuptake inhibitors chemical , chemical and chemical displayed a high affinity for the chemical transporter , whereas the chemical reuptake inhibitor chemical had a high affinity for the chemical transporter .	T17	T37	9669506
NA	CHEMICAL	GENE-Y	16	11	The selective chemical reuptake inhibitors chemical , chemical and chemical displayed a high affinity for the chemical transporter , whereas the chemical reuptake inhibitor chemical had a high affinity for the chemical transporter .	T17	T38	9669506
NA	CHEMICAL	GENE-Y	21	11	The selective chemical reuptake inhibitors chemical , chemical and chemical displayed a high affinity for the chemical transporter , whereas the chemical reuptake inhibitor chemical had a high affinity for the chemical transporter .	T18	T37	9669506
NA	CHEMICAL	GENE-Y	21	11	The selective chemical reuptake inhibitors chemical , chemical and chemical displayed a high affinity for the chemical transporter , whereas the chemical reuptake inhibitor chemical had a high affinity for the chemical transporter .	T18	T38	9669506
NA	CHEMICAL	GENE-Y	11	11	The selective chemical reuptake inhibitors chemical , chemical and chemical displayed a high affinity for the chemical transporter , whereas the chemical reuptake inhibitor chemical had a high affinity for the chemical transporter .	T19	T37	9669506
NA	CHEMICAL	GENE-Y	11	11	The selective chemical reuptake inhibitors chemical , chemical and chemical displayed a high affinity for the chemical transporter , whereas the chemical reuptake inhibitor chemical had a high affinity for the chemical transporter .	T19	T38	9669506
NA	CHEMICAL	GENE-Y	31	11	The selective chemical reuptake inhibitors chemical , chemical and chemical displayed a high affinity for the chemical transporter , whereas the chemical reuptake inhibitor chemical had a high affinity for the chemical transporter .	T20	T37	9669506
NA	CHEMICAL	GENE-Y	31	11	The selective chemical reuptake inhibitors chemical , chemical and chemical displayed a high affinity for the chemical transporter , whereas the chemical reuptake inhibitor chemical had a high affinity for the chemical transporter .	T20	T38	9669506
NA	CHEMICAL	GENE-N	0	2	chemical , a dual chemical and chemical reuptake inhibitor , displayed a high affinity for both the chemical and the chemical transporters .	T21	T39	9669506
NA	CHEMICAL	GENE-N	4	2	chemical , a dual chemical and chemical reuptake inhibitor , displayed a high affinity for both the chemical and the chemical transporters .	T22	T39	9669506
NA	CHEMICAL	GENE-N	6	2	chemical , a dual chemical and chemical reuptake inhibitor , displayed a high affinity for both the chemical and the chemical transporters .	T23	T39	9669506
NA	CHEMICAL	GENE-N	17	2	chemical , a dual chemical and chemical reuptake inhibitor , displayed a high affinity for both the chemical and the chemical transporters .	T24	T39	9669506
NA	CHEMICAL	GENE-N	20	2	chemical , a dual chemical and chemical reuptake inhibitor , displayed a high affinity for both the chemical and the chemical transporters .	T25	T39	9669506
NA	CHEMICAL	GENE-Y	2	4	Interestingly , chemical , a dual chemical and chemical reuptake inhibitor , displayed only a moderate affinity for the chemical transporter ( Ki = 74 nM ) and a very low affinity for the chemical transporter ( Ki = 1.26 microM ) .	T26	T40	9669506
NA	CHEMICAL	GENE-Y	2	4	Interestingly , chemical , a dual chemical and chemical reuptake inhibitor , displayed only a moderate affinity for the chemical transporter ( Ki = 74 nM ) and a very low affinity for the chemical transporter ( Ki = 1.26 microM ) .	T26	T41	9669506
NA	CHEMICAL	GENE-Y	6	4	Interestingly , chemical , a dual chemical and chemical reuptake inhibitor , displayed only a moderate affinity for the chemical transporter ( Ki = 74 nM ) and a very low affinity for the chemical transporter ( Ki = 1.26 microM ) .	T27	T40	9669506
NA	CHEMICAL	GENE-Y	6	4	Interestingly , chemical , a dual chemical and chemical reuptake inhibitor , displayed only a moderate affinity for the chemical transporter ( Ki = 74 nM ) and a very low affinity for the chemical transporter ( Ki = 1.26 microM ) .	T27	T41	9669506
NA	CHEMICAL	GENE-Y	8	4	Interestingly , chemical , a dual chemical and chemical reuptake inhibitor , displayed only a moderate affinity for the chemical transporter ( Ki = 74 nM ) and a very low affinity for the chemical transporter ( Ki = 1.26 microM ) .	T28	T40	9669506
NA	CHEMICAL	GENE-Y	8	4	Interestingly , chemical , a dual chemical and chemical reuptake inhibitor , displayed only a moderate affinity for the chemical transporter ( Ki = 74 nM ) and a very low affinity for the chemical transporter ( Ki = 1.26 microM ) .	T28	T41	9669506
NA	CHEMICAL	GENE-Y	19	4	Interestingly , chemical , a dual chemical and chemical reuptake inhibitor , displayed only a moderate affinity for the chemical transporter ( Ki = 74 nM ) and a very low affinity for the chemical transporter ( Ki = 1.26 microM ) .	T29	T40	9669506
NA	CHEMICAL	GENE-Y	19	4	Interestingly , chemical , a dual chemical and chemical reuptake inhibitor , displayed only a moderate affinity for the chemical transporter ( Ki = 74 nM ) and a very low affinity for the chemical transporter ( Ki = 1.26 microM ) .	T29	T41	9669506
NA	CHEMICAL	GENE-Y	34	4	Interestingly , chemical , a dual chemical and chemical reuptake inhibitor , displayed only a moderate affinity for the chemical transporter ( Ki = 74 nM ) and a very low affinity for the chemical transporter ( Ki = 1.26 microM ) .	T30	T40	9669506
NA	CHEMICAL	GENE-Y	34	4	Interestingly , chemical , a dual chemical and chemical reuptake inhibitor , displayed only a moderate affinity for the chemical transporter ( Ki = 74 nM ) and a very low affinity for the chemical transporter ( Ki = 1.26 microM ) .	T30	T41	9669506
CPR:6	CHEMICAL	GENE-N	2	6	Effects of chemical , other chemical H2-receptor antagonists and chemical on gastric acid secretory states in rats and dogs .	T24	T29	2886642
NA	CHEMICAL	GENE-N	5	6	Effects of chemical , other chemical H2-receptor antagonists and chemical on gastric acid secretory states in rats and dogs .	T25	T29	2886642
NA	CHEMICAL	GENE-N	9	6	Effects of chemical , other chemical H2-receptor antagonists and chemical on gastric acid secretory states in rats and dogs .	T26	T29	2886642
CPR:6	CHEMICAL	GENE-N	0	4	chemical , a chemical H2-receptor antagonist , inhibited gastric acid secretion in pylorus-ligated rats ( ED50 = 4.9 mg/kg intraduodenal ; 3.4 mg/kg p.o .	T1	T27	2886642
NA	CHEMICAL	GENE-N	2	4	chemical , a chemical H2-receptor antagonist , inhibited gastric acid secretion in pylorus-ligated rats ( ED50 = 4.9 mg/kg intraduodenal ; 3.4 mg/kg p.o .	T7	T27	2886642
NA	CHEMICAL	GENE-N	7	20	The nonspecific inhibition of gastric acid by chemical supports the existence of interdependence between chemical and the gastrin and cholinergic receptors on the parietal cell surface .	T13	T28	2886642
NA	CHEMICAL	GENE-N	14	20	The nonspecific inhibition of gastric acid by chemical supports the existence of interdependence between chemical and the gastrin and cholinergic receptors on the parietal cell surface .	T14	T28	2886642
NA	CHEMICAL	GENE-Y	2	4	Effect of chemical on gene/gene chemical receptor gating .	T13	T30	23007555
NA	CHEMICAL	GENE-Y	2	4	Effect of chemical on gene/gene chemical receptor gating .	T13	T31	23007555
NA	CHEMICAL	GENE-N	2	6	Effect of chemical on gene/gene chemical receptor gating .	T13	T32	23007555
NA	CHEMICAL	GENE-Y	5	4	Effect of chemical on gene/gene chemical receptor gating .	T14	T30	23007555
NA	CHEMICAL	GENE-Y	5	4	Effect of chemical on gene/gene chemical receptor gating .	T14	T31	23007555
NA	CHEMICAL	GENE-N	5	6	Effect of chemical on gene/gene chemical receptor gating .	T14	T32	23007555
NA	CHEMICAL	GENE-Y	0	6	chemical is an allosteric inhibitor of gene/gene chemical receptors .	T1	T25	23007555
NA	CHEMICAL	GENE-Y	0	6	chemical is an allosteric inhibitor of gene/gene chemical receptors .	T1	T26	23007555
NA	CHEMICAL	GENE-N	0	8	chemical is an allosteric inhibitor of gene/gene chemical receptors .	T1	T29	23007555
NA	CHEMICAL	GENE-Y	7	6	chemical is an allosteric inhibitor of gene/gene chemical receptors .	T9	T25	23007555
NA	CHEMICAL	GENE-Y	7	6	chemical is an allosteric inhibitor of gene/gene chemical receptors .	T9	T26	23007555
NA	CHEMICAL	GENE-N	7	8	chemical is an allosteric inhibitor of gene/gene chemical receptors .	T9	T29	23007555
NA	CHEMICAL	GENE-Y	1	17	Interestingly , recent crystallographic evidence identified that chemical unlike chemical , binds at the interface of the gene/gene chemical terminal domain dimer by an induced-fit mechanism .	T6	T23	23007555
NA	CHEMICAL	GENE-Y	1	17	Interestingly , recent crystallographic evidence identified that chemical unlike chemical , binds at the interface of the gene/gene chemical terminal domain dimer by an induced-fit mechanism .	T6	T24	23007555
NA	CHEMICAL	GENE-Y	9	17	Interestingly , recent crystallographic evidence identified that chemical unlike chemical , binds at the interface of the gene/gene chemical terminal domain dimer by an induced-fit mechanism .	T7	T23	23007555
NA	CHEMICAL	GENE-Y	9	17	Interestingly , recent crystallographic evidence identified that chemical unlike chemical , binds at the interface of the gene/gene chemical terminal domain dimer by an induced-fit mechanism .	T7	T24	23007555
NA	CHEMICAL	GENE-Y	18	17	Interestingly , recent crystallographic evidence identified that chemical unlike chemical , binds at the interface of the gene/gene chemical terminal domain dimer by an induced-fit mechanism .	T8	T23	23007555
NA	CHEMICAL	GENE-Y	18	17	Interestingly , recent crystallographic evidence identified that chemical unlike chemical , binds at the interface of the gene/gene chemical terminal domain dimer by an induced-fit mechanism .	T8	T24	23007555
NA	CHEMICAL	GENE-Y	8	10	We found distinct differences in the action of chemical at gene/gene in comparison with previous studies on the effect of chemical on gene/gene gating , which may arise due to their unique binding sites .	T2	T15	23007555
NA	CHEMICAL	GENE-Y	8	10	We found distinct differences in the action of chemical at gene/gene in comparison with previous studies on the effect of chemical on gene/gene gating , which may arise due to their unique binding sites .	T2	T16	23007555
NA	CHEMICAL	GENE-Y	8	22	We found distinct differences in the action of chemical at gene/gene in comparison with previous studies on the effect of chemical on gene/gene gating , which may arise due to their unique binding sites .	T2	T17	23007555
NA	CHEMICAL	GENE-Y	8	22	We found distinct differences in the action of chemical at gene/gene in comparison with previous studies on the effect of chemical on gene/gene gating , which may arise due to their unique binding sites .	T2	T18	23007555
NA	CHEMICAL	GENE-Y	4	10	We found distinct differences in the action of chemical at gene/gene in comparison with previous studies on the effect of chemical on gene/gene gating , which may arise due to their unique binding sites .	T3	T15	23007555
NA	CHEMICAL	GENE-Y	4	10	We found distinct differences in the action of chemical at gene/gene in comparison with previous studies on the effect of chemical on gene/gene gating , which may arise due to their unique binding sites .	T3	T16	23007555
NA	CHEMICAL	GENE-Y	4	22	We found distinct differences in the action of chemical at gene/gene in comparison with previous studies on the effect of chemical on gene/gene gating , which may arise due to their unique binding sites .	T3	T17	23007555
NA	CHEMICAL	GENE-Y	4	22	We found distinct differences in the action of chemical at gene/gene in comparison with previous studies on the effect of chemical on gene/gene gating , which may arise due to their unique binding sites .	T3	T18	23007555
CPR:6	CHEMICAL	GENE-Y	4	5	[ Pharmacological effects of a gene antagonist chemical on chemical dependence ] .	T17	T21	19068776
NA	CHEMICAL	GENE-Y	4	5	[ Pharmacological effects of a gene antagonist chemical on chemical dependence ] .	T18	T21	19068776
CPR:6	CHEMICAL	GENE-Y	4	5	In many countries , a gene antagonist chemical has been used in the treatment of chemical dependence .	T6	T19	19068776
NA	CHEMICAL	GENE-Y	4	5	In many countries , a gene antagonist chemical has been used in the treatment of chemical dependence .	T7	T19	19068776
NA	CHEMICAL	GENE-Y	22	7	The endogenous opioid agonists , such as gene , increase the activity of the mesolimbic dopaminergic system through the inhibition of the chemical ( chemical ) -containing inhibitory interneurons in the ventral tegmental area , resulting in the expression of chemical reinforcement and/or rewarding effect .	T12	T20	19068776
NA	CHEMICAL	GENE-Y	24	7	The endogenous opioid agonists , such as gene , increase the activity of the mesolimbic dopaminergic system through the inhibition of the chemical ( chemical ) -containing inhibitory interneurons in the ventral tegmental area , resulting in the expression of chemical reinforcement and/or rewarding effect .	T13	T20	19068776
NA	CHEMICAL	GENE-Y	40	7	The endogenous opioid agonists , such as gene , increase the activity of the mesolimbic dopaminergic system through the inhibition of the chemical ( chemical ) -containing inhibitory interneurons in the ventral tegmental area , resulting in the expression of chemical reinforcement and/or rewarding effect .	T14	T20	19068776
NA	CHEMICAL	GENE-N	3	3	Enzymatic characterization of a recombinant isoform hybrid of chemical decarboxylase ( gene ) expressed in yeast .	T12	T29	12067524
NA	CHEMICAL	GENE-N	3	11	Enzymatic characterization of a recombinant isoform hybrid of chemical decarboxylase ( gene ) expressed in yeast .	T12	T30	12067524
NA	CHEMICAL	GENE-N	4	5	BACKGROUND AND AIMS : chemical decarboxylase ( gene , gene ) catalyses the conversion of chemical to chemical ( chemical ) .	T4	T17	12067524
NA	CHEMICAL	GENE-N	4	7	BACKGROUND AND AIMS : chemical decarboxylase ( gene , gene ) catalyses the conversion of chemical to chemical ( chemical ) .	T4	T22	12067524
NA	CHEMICAL	GENE-Y	4	9	BACKGROUND AND AIMS : chemical decarboxylase ( gene , gene ) catalyses the conversion of chemical to chemical ( chemical ) .	T4	T23	12067524
CPR:9	CHEMICAL	GENE-N	15	5	BACKGROUND AND AIMS : chemical decarboxylase ( gene , gene ) catalyses the conversion of chemical to chemical ( chemical ) .	T11	T17	12067524
CPR:9	CHEMICAL	GENE-N	15	7	BACKGROUND AND AIMS : chemical decarboxylase ( gene , gene ) catalyses the conversion of chemical to chemical ( chemical ) .	T11	T22	12067524
CPR:9	CHEMICAL	GENE-Y	15	9	BACKGROUND AND AIMS : chemical decarboxylase ( gene , gene ) catalyses the conversion of chemical to chemical ( chemical ) .	T11	T23	12067524
CPR:9	CHEMICAL	GENE-N	15	5	BACKGROUND AND AIMS : chemical decarboxylase ( gene , gene ) catalyses the conversion of chemical to chemical ( chemical ) .	T1	T17	12067524
CPR:9	CHEMICAL	GENE-N	15	7	BACKGROUND AND AIMS : chemical decarboxylase ( gene , gene ) catalyses the conversion of chemical to chemical ( chemical ) .	T1	T22	12067524
CPR:9	CHEMICAL	GENE-Y	15	9	BACKGROUND AND AIMS : chemical decarboxylase ( gene , gene ) catalyses the conversion of chemical to chemical ( chemical ) .	T1	T23	12067524
CPR:9	CHEMICAL	GENE-N	19	5	BACKGROUND AND AIMS : chemical decarboxylase ( gene , gene ) catalyses the conversion of chemical to chemical ( chemical ) .	T3	T17	12067524
CPR:9	CHEMICAL	GENE-N	19	7	BACKGROUND AND AIMS : chemical decarboxylase ( gene , gene ) catalyses the conversion of chemical to chemical ( chemical ) .	T3	T22	12067524
CPR:9	CHEMICAL	GENE-Y	19	9	BACKGROUND AND AIMS : chemical decarboxylase ( gene , gene ) catalyses the conversion of chemical to chemical ( chemical ) .	T3	T23	12067524
NA	CHEMICAL	GENE-Y	7	0	A hybrid cDNA was created by fusing a human cDNA for chemical 1-101 of gene to a human cDNA for chemical 96-585 of gene ; the recombinant ( r ) protein was expressed in yeast and was shown to have equivalent immunoreactivity to gene with diabetes sera .	T5	T19	12067524
NA	CHEMICAL	GENE-Y	7	0	A hybrid cDNA was created by fusing a human cDNA for chemical 1-101 of gene to a human cDNA for chemical 96-585 of gene ; the recombinant ( r ) protein was expressed in yeast and was shown to have equivalent immunoreactivity to gene with diabetes sera .	T5	T20	12067524
NA	CHEMICAL	GENE-N	7	0	A hybrid cDNA was created by fusing a human cDNA for chemical 1-101 of gene to a human cDNA for chemical 96-585 of gene ; the recombinant ( r ) protein was expressed in yeast and was shown to have equivalent immunoreactivity to gene with diabetes sera .	T5	T21	12067524
NA	CHEMICAL	GENE-Y	7	0	A hybrid cDNA was created by fusing a human cDNA for chemical 1-101 of gene to a human cDNA for chemical 96-585 of gene ; the recombinant ( r ) protein was expressed in yeast and was shown to have equivalent immunoreactivity to gene with diabetes sera .	T6	T19	12067524
NA	CHEMICAL	GENE-Y	7	0	A hybrid cDNA was created by fusing a human cDNA for chemical 1-101 of gene to a human cDNA for chemical 96-585 of gene ; the recombinant ( r ) protein was expressed in yeast and was shown to have equivalent immunoreactivity to gene with diabetes sera .	T6	T20	12067524
NA	CHEMICAL	GENE-N	7	0	A hybrid cDNA was created by fusing a human cDNA for chemical 1-101 of gene to a human cDNA for chemical 96-585 of gene ; the recombinant ( r ) protein was expressed in yeast and was shown to have equivalent immunoreactivity to gene with diabetes sera .	T6	T21	12067524
NA	CHEMICAL	GENE-N	13	9	METHODS : Studies were performed on enzymatic activity of gene by production of chemical from chemical , enzyme kinetics , binding to the enzyme cofactor chemical ( chemical ) , stability according to differences in pH , temperature and duration of storage , and antigenic reactivity with various gene-specific antisera .	T7	T25	12067524
NA	CHEMICAL	GENE-N	13	48	METHODS : Studies were performed on enzymatic activity of gene by production of chemical from chemical , enzyme kinetics , binding to the enzyme cofactor chemical ( chemical ) , stability according to differences in pH , temperature and duration of storage , and antigenic reactivity with various gene-specific antisera .	T7	T26	12067524
NA	CHEMICAL	GENE-N	15	9	METHODS : Studies were performed on enzymatic activity of gene by production of chemical from chemical , enzyme kinetics , binding to the enzyme cofactor chemical ( chemical ) , stability according to differences in pH , temperature and duration of storage , and antigenic reactivity with various gene-specific antisera .	T8	T25	12067524
NA	CHEMICAL	GENE-N	15	48	METHODS : Studies were performed on enzymatic activity of gene by production of chemical from chemical , enzyme kinetics , binding to the enzyme cofactor chemical ( chemical ) , stability according to differences in pH , temperature and duration of storage , and antigenic reactivity with various gene-specific antisera .	T8	T26	12067524
NA	CHEMICAL	GENE-N	25	9	METHODS : Studies were performed on enzymatic activity of gene by production of chemical from chemical , enzyme kinetics , binding to the enzyme cofactor chemical ( chemical ) , stability according to differences in pH , temperature and duration of storage , and antigenic reactivity with various gene-specific antisera .	T9	T25	12067524
NA	CHEMICAL	GENE-N	25	48	METHODS : Studies were performed on enzymatic activity of gene by production of chemical from chemical , enzyme kinetics , binding to the enzyme cofactor chemical ( chemical ) , stability according to differences in pH , temperature and duration of storage , and antigenic reactivity with various gene-specific antisera .	T9	T26	12067524
NA	CHEMICAL	GENE-N	27	9	METHODS : Studies were performed on enzymatic activity of gene by production of chemical from chemical , enzyme kinetics , binding to the enzyme cofactor chemical ( chemical ) , stability according to differences in pH , temperature and duration of storage , and antigenic reactivity with various gene-specific antisera .	T10	T25	12067524
NA	CHEMICAL	GENE-N	27	48	METHODS : Studies were performed on enzymatic activity of gene by production of chemical from chemical , enzyme kinetics , binding to the enzyme cofactor chemical ( chemical ) , stability according to differences in pH , temperature and duration of storage , and antigenic reactivity with various gene-specific antisera .	T10	T26	12067524
NA	CHEMICAL	GENE-Y	15	4	CLA treatment increased serum gene ( gene ) significantly ( p=0.0172 ) , while serum chemical concentration was not changed by CLA .	T7	T10	23578644
NA	CHEMICAL	GENE-Y	15	6	CLA treatment increased serum gene ( gene ) significantly ( p=0.0172 ) , while serum chemical concentration was not changed by CLA .	T7	T11	23578644
NA	CHEMICAL	GENE-N	34	23	Citrated blood from healthy subjects was stimulated : i ) from passage through the `` Platelet Function Analyzer '' ( PFA-100 ) , a device that exposes blood to standardized high shear flow through gene/chemical cartridges ; ii ) by collagen and chemical ( 2 and 50 mug/ml , respectively ) added in combination under stirring in an aggregometer cuvette ; iii ) with recombinant gene , to generate gene concentrations able to activate platelets without inducing blood clotting , or iv ) the Thrombin Receptor Activating Peptide-6 ( TRAP-6 ) .	T1	T9	17549299
NA	CHEMICAL	GENE-Y	34	23	Citrated blood from healthy subjects was stimulated : i ) from passage through the `` Platelet Function Analyzer '' ( PFA-100 ) , a device that exposes blood to standardized high shear flow through gene/chemical cartridges ; ii ) by collagen and chemical ( 2 and 50 mug/ml , respectively ) added in combination under stirring in an aggregometer cuvette ; iii ) with recombinant gene , to generate gene concentrations able to activate platelets without inducing blood clotting , or iv ) the Thrombin Receptor Activating Peptide-6 ( TRAP-6 ) .	T1	T10	17549299
NA	CHEMICAL	GENE-Y	34	8	Citrated blood from healthy subjects was stimulated : i ) from passage through the `` Platelet Function Analyzer '' ( PFA-100 ) , a device that exposes blood to standardized high shear flow through gene/chemical cartridges ; ii ) by collagen and chemical ( 2 and 50 mug/ml , respectively ) added in combination under stirring in an aggregometer cuvette ; iii ) with recombinant gene , to generate gene concentrations able to activate platelets without inducing blood clotting , or iv ) the Thrombin Receptor Activating Peptide-6 ( TRAP-6 ) .	T1	T11	17549299
NA	CHEMICAL	GENE-N	42	23	Citrated blood from healthy subjects was stimulated : i ) from passage through the `` Platelet Function Analyzer '' ( PFA-100 ) , a device that exposes blood to standardized high shear flow through gene/chemical cartridges ; ii ) by collagen and chemical ( 2 and 50 mug/ml , respectively ) added in combination under stirring in an aggregometer cuvette ; iii ) with recombinant gene , to generate gene concentrations able to activate platelets without inducing blood clotting , or iv ) the Thrombin Receptor Activating Peptide-6 ( TRAP-6 ) .	T2	T9	17549299
NA	CHEMICAL	GENE-Y	42	23	Citrated blood from healthy subjects was stimulated : i ) from passage through the `` Platelet Function Analyzer '' ( PFA-100 ) , a device that exposes blood to standardized high shear flow through gene/chemical cartridges ; ii ) by collagen and chemical ( 2 and 50 mug/ml , respectively ) added in combination under stirring in an aggregometer cuvette ; iii ) with recombinant gene , to generate gene concentrations able to activate platelets without inducing blood clotting , or iv ) the Thrombin Receptor Activating Peptide-6 ( TRAP-6 ) .	T2	T10	17549299
NA	CHEMICAL	GENE-Y	42	8	Citrated blood from healthy subjects was stimulated : i ) from passage through the `` Platelet Function Analyzer '' ( PFA-100 ) , a device that exposes blood to standardized high shear flow through gene/chemical cartridges ; ii ) by collagen and chemical ( 2 and 50 mug/ml , respectively ) added in combination under stirring in an aggregometer cuvette ; iii ) with recombinant gene , to generate gene concentrations able to activate platelets without inducing blood clotting , or iv ) the Thrombin Receptor Activating Peptide-6 ( TRAP-6 ) .	T2	T11	17549299
CPR:5	CHEMICAL	GENE-Y	6	1	The gene ( gene ) agonists chemical and chemical have similar beneficial effects in animal models of heart failure .	T16	T26	16973691
CPR:5	CHEMICAL	GENE-Y	6	2	The gene ( gene ) agonists chemical and chemical have similar beneficial effects in animal models of heart failure .	T16	T25	16973691
CPR:5	CHEMICAL	GENE-Y	8	1	The gene ( gene ) agonists chemical and chemical have similar beneficial effects in animal models of heart failure .	T17	T26	16973691
CPR:5	CHEMICAL	GENE-Y	8	2	The gene ( gene ) agonists chemical and chemical have similar beneficial effects in animal models of heart failure .	T17	T25	16973691
CPR:6	CHEMICAL	GENE-Y	9	0	gene antagonism ( 10 mg kg ( -1 ) chemical ) prevented 92 % ( P < 0.05 ) of apoptosis induced by all three agonists , but chemical-induced apoptosis could also be prevented by 96 % ( P < 0.05 ) by gene antagonism ( 10 mg kg ( -1 ) ICI 118 551 ) .	T4	T23	16973691
NA	CHEMICAL	GENE-Y	9	2	gene antagonism ( 10 mg kg ( -1 ) chemical ) prevented 92 % ( P < 0.05 ) of apoptosis induced by all three agonists , but chemical-induced apoptosis could also be prevented by 96 % ( P < 0.05 ) by gene antagonism ( 10 mg kg ( -1 ) ICI 118 551 ) .	T4	T24	16973691
NA	CHEMICAL	GENE-Y	27	0	gene antagonism ( 10 mg kg ( -1 ) chemical ) prevented 92 % ( P < 0.05 ) of apoptosis induced by all three agonists , but chemical-induced apoptosis could also be prevented by 96 % ( P < 0.05 ) by gene antagonism ( 10 mg kg ( -1 ) ICI 118 551 ) .	T5	T23	16973691
NA	CHEMICAL	GENE-Y	27	2	gene antagonism ( 10 mg kg ( -1 ) chemical ) prevented 92 % ( P < 0.05 ) of apoptosis induced by all three agonists , but chemical-induced apoptosis could also be prevented by 96 % ( P < 0.05 ) by gene antagonism ( 10 mg kg ( -1 ) ICI 118 551 ) .	T5	T24	16973691
NA	CHEMICAL	GENE-Y	2	0	gene attenuates chemical regulatory element-binding protein ( gene ) phosphorylation induced by chronic chemical and chemical challenge in Cath.a cells and primary striatal cultures .	T8	T18	16417577
NA	CHEMICAL	GENE-N	2	5	gene attenuates chemical regulatory element-binding protein ( gene ) phosphorylation induced by chronic chemical and chemical challenge in Cath.a cells and primary striatal cultures .	T8	T19	16417577
NA	CHEMICAL	GENE-N	2	7	gene attenuates chemical regulatory element-binding protein ( gene ) phosphorylation induced by chronic chemical and chemical challenge in Cath.a cells and primary striatal cultures .	T8	T20	16417577
NA	CHEMICAL	GENE-Y	13	0	gene attenuates chemical regulatory element-binding protein ( gene ) phosphorylation induced by chronic chemical and chemical challenge in Cath.a cells and primary striatal cultures .	T6	T18	16417577
CPR:3	CHEMICAL	GENE-N	13	5	gene attenuates chemical regulatory element-binding protein ( gene ) phosphorylation induced by chronic chemical and chemical challenge in Cath.a cells and primary striatal cultures .	T6	T19	16417577
CPR:3	CHEMICAL	GENE-N	13	7	gene attenuates chemical regulatory element-binding protein ( gene ) phosphorylation induced by chronic chemical and chemical challenge in Cath.a cells and primary striatal cultures .	T6	T20	16417577
NA	CHEMICAL	GENE-Y	15	0	gene attenuates chemical regulatory element-binding protein ( gene ) phosphorylation induced by chronic chemical and chemical challenge in Cath.a cells and primary striatal cultures .	T7	T18	16417577
CPR:3	CHEMICAL	GENE-N	15	5	gene attenuates chemical regulatory element-binding protein ( gene ) phosphorylation induced by chronic chemical and chemical challenge in Cath.a cells and primary striatal cultures .	T7	T19	16417577
CPR:3	CHEMICAL	GENE-N	15	7	gene attenuates chemical regulatory element-binding protein ( gene ) phosphorylation induced by chronic chemical and chemical challenge in Cath.a cells and primary striatal cultures .	T7	T20	16417577
NA	CHEMICAL	GENE-Y	8	2	The neuropeptide gene has been shown to attenuate chemical signaling in multiple cell types .	T2	T9	16417577
NA	CHEMICAL	GENE-Y	13	6	The current study demonstrates that acute gene treatment blocks the consequences of increased chemical signaling following chronic opiate administration and withdrawal in Cath.a cells and primary cultures of striatal neurons as measured by phosphorylation of the transcription factor chemical regulatory element-binding protein ( gene ) .	T3	T10	16417577
NA	CHEMICAL	GENE-N	13	21	The current study demonstrates that acute gene treatment blocks the consequences of increased chemical signaling following chronic opiate administration and withdrawal in Cath.a cells and primary cultures of striatal neurons as measured by phosphorylation of the transcription factor chemical regulatory element-binding protein ( gene ) .	T3	T11	16417577
NA	CHEMICAL	GENE-N	13	43	The current study demonstrates that acute gene treatment blocks the consequences of increased chemical signaling following chronic opiate administration and withdrawal in Cath.a cells and primary cultures of striatal neurons as measured by phosphorylation of the transcription factor chemical regulatory element-binding protein ( gene ) .	T3	T12	16417577
NA	CHEMICAL	GENE-Y	38	6	The current study demonstrates that acute gene treatment blocks the consequences of increased chemical signaling following chronic opiate administration and withdrawal in Cath.a cells and primary cultures of striatal neurons as measured by phosphorylation of the transcription factor chemical regulatory element-binding protein ( gene ) .	T4	T10	16417577
NA	CHEMICAL	GENE-N	38	21	The current study demonstrates that acute gene treatment blocks the consequences of increased chemical signaling following chronic opiate administration and withdrawal in Cath.a cells and primary cultures of striatal neurons as measured by phosphorylation of the transcription factor chemical regulatory element-binding protein ( gene ) .	T4	T11	16417577
NA	CHEMICAL	GENE-N	38	43	The current study demonstrates that acute gene treatment blocks the consequences of increased chemical signaling following chronic opiate administration and withdrawal in Cath.a cells and primary cultures of striatal neurons as measured by phosphorylation of the transcription factor chemical regulatory element-binding protein ( gene ) .	T4	T12	16417577
NA	CHEMICAL	GENE-N	2	3	Inhibition of chemical oxidase by chemical analogues .	T23	T32	23374869
CPR:4	CHEMICAL	GENE-N	5	3	Inhibition of chemical oxidase by chemical analogues .	T24	T32	23374869
CPR:4	CHEMICAL	GENE-N	9	23	Based on recent reports that the small molecules , chemical and chemical , are suitable scaffolds for the design of high potency chemical oxidase ( gene ) inhibitors , the present study examines the gene inhibitory properties of a series of chemical [ chemical ] analogues .	T10	T26	23374869
CPR:4	CHEMICAL	GENE-N	9	25	Based on recent reports that the small molecules , chemical and chemical , are suitable scaffolds for the design of high potency chemical oxidase ( gene ) inhibitors , the present study examines the gene inhibitory properties of a series of chemical [ chemical ] analogues .	T10	T27	23374869
NA	CHEMICAL	GENE-N	9	34	Based on recent reports that the small molecules , chemical and chemical , are suitable scaffolds for the design of high potency chemical oxidase ( gene ) inhibitors , the present study examines the gene inhibitory properties of a series of chemical [ chemical ] analogues .	T10	T28	23374869
CPR:4	CHEMICAL	GENE-N	11	23	Based on recent reports that the small molecules , chemical and chemical , are suitable scaffolds for the design of high potency chemical oxidase ( gene ) inhibitors , the present study examines the gene inhibitory properties of a series of chemical [ chemical ] analogues .	T11	T26	23374869
CPR:4	CHEMICAL	GENE-N	11	25	Based on recent reports that the small molecules , chemical and chemical , are suitable scaffolds for the design of high potency chemical oxidase ( gene ) inhibitors , the present study examines the gene inhibitory properties of a series of chemical [ chemical ] analogues .	T11	T27	23374869
NA	CHEMICAL	GENE-N	11	34	Based on recent reports that the small molecules , chemical and chemical , are suitable scaffolds for the design of high potency chemical oxidase ( gene ) inhibitors , the present study examines the gene inhibitory properties of a series of chemical [ chemical ] analogues .	T11	T28	23374869
NA	CHEMICAL	GENE-N	1	23	Based on recent reports that the small molecules , chemical and chemical , are suitable scaffolds for the design of high potency chemical oxidase ( gene ) inhibitors , the present study examines the gene inhibitory properties of a series of chemical [ chemical ] analogues .	T3	T26	23374869
NA	CHEMICAL	GENE-N	1	25	Based on recent reports that the small molecules , chemical and chemical , are suitable scaffolds for the design of high potency chemical oxidase ( gene ) inhibitors , the present study examines the gene inhibitory properties of a series of chemical [ chemical ] analogues .	T3	T27	23374869
NA	CHEMICAL	GENE-N	1	34	Based on recent reports that the small molecules , chemical and chemical , are suitable scaffolds for the design of high potency chemical oxidase ( gene ) inhibitors , the present study examines the gene inhibitory properties of a series of chemical [ chemical ] analogues .	T3	T28	23374869
NA	CHEMICAL	GENE-N	38	23	Based on recent reports that the small molecules , chemical and chemical , are suitable scaffolds for the design of high potency chemical oxidase ( gene ) inhibitors , the present study examines the gene inhibitory properties of a series of chemical [ chemical ] analogues .	T4	T26	23374869
NA	CHEMICAL	GENE-N	38	25	Based on recent reports that the small molecules , chemical and chemical , are suitable scaffolds for the design of high potency chemical oxidase ( gene ) inhibitors , the present study examines the gene inhibitory properties of a series of chemical [ chemical ] analogues .	T4	T27	23374869
CPR:4	CHEMICAL	GENE-N	38	34	Based on recent reports that the small molecules , chemical and chemical , are suitable scaffolds for the design of high potency chemical oxidase ( gene ) inhibitors , the present study examines the gene inhibitory properties of a series of chemical [ chemical ] analogues .	T4	T28	23374869
NA	CHEMICAL	GENE-N	1	23	Based on recent reports that the small molecules , chemical and chemical , are suitable scaffolds for the design of high potency chemical oxidase ( gene ) inhibitors , the present study examines the gene inhibitory properties of a series of chemical [ chemical ] analogues .	T5	T26	23374869
NA	CHEMICAL	GENE-N	1	25	Based on recent reports that the small molecules , chemical and chemical , are suitable scaffolds for the design of high potency chemical oxidase ( gene ) inhibitors , the present study examines the gene inhibitory properties of a series of chemical [ chemical ] analogues .	T5	T27	23374869
CPR:4	CHEMICAL	GENE-N	1	34	Based on recent reports that the small molecules , chemical and chemical , are suitable scaffolds for the design of high potency chemical oxidase ( gene ) inhibitors , the present study examines the gene inhibitory properties of a series of chemical [ chemical ] analogues .	T5	T28	23374869
NA	CHEMICAL	GENE-N	0	30	chemical is structurally related to chemical and chemical and it is demonstrated here that substitution at C6 of the chemical moiety yields compounds endowed with high binding affinities to both gene isoforms .	T6	T29	23374869
NA	CHEMICAL	GENE-N	1	30	chemical is structurally related to chemical and chemical and it is demonstrated here that substitution at C6 of the chemical moiety yields compounds endowed with high binding affinities to both gene isoforms .	T7	T29	23374869
NA	CHEMICAL	GENE-N	7	30	chemical is structurally related to chemical and chemical and it is demonstrated here that substitution at C6 of the chemical moiety yields compounds endowed with high binding affinities to both gene isoforms .	T8	T29	23374869
NA	CHEMICAL	GENE-N	19	30	chemical is structurally related to chemical and chemical and it is demonstrated here that substitution at C6 of the chemical moiety yields compounds endowed with high binding affinities to both gene isoforms .	T9	T29	23374869
CPR:4	CHEMICAL	GENE-Y	5	7	In most instances , C6-substituted chemical exhibit gene specific inhibition .	T12	T31	23374869
NA	CHEMICAL	GENE-N	1	52	Among a series of chemical bearing substituents on the para position of the chemical ring the general order of potency was chemical > chemical > chemical > chemical > chemical > chemical > chemical . The results also show that the binding modes of representative chemical are reversible and competitive at both gene isoforms .	T13	T25	23374869
NA	CHEMICAL	GENE-N	13	52	Among a series of chemical bearing substituents on the para position of the chemical ring the general order of potency was chemical > chemical > chemical > chemical > chemical > chemical > chemical . The results also show that the binding modes of representative chemical are reversible and competitive at both gene isoforms .	T14	T25	23374869
NA	CHEMICAL	GENE-N	21	52	Among a series of chemical bearing substituents on the para position of the chemical ring the general order of potency was chemical > chemical > chemical > chemical > chemical > chemical > chemical . The results also show that the binding modes of representative chemical are reversible and competitive at both gene isoforms .	T15	T25	23374869
NA	CHEMICAL	GENE-N	4	52	Among a series of chemical bearing substituents on the para position of the chemical ring the general order of potency was chemical > chemical > chemical > chemical > chemical > chemical > chemical . The results also show that the binding modes of representative chemical are reversible and competitive at both gene isoforms .	T16	T25	23374869
NA	CHEMICAL	GENE-N	25	52	Among a series of chemical bearing substituents on the para position of the chemical ring the general order of potency was chemical > chemical > chemical > chemical > chemical > chemical > chemical . The results also show that the binding modes of representative chemical are reversible and competitive at both gene isoforms .	T17	T25	23374869
NA	CHEMICAL	GENE-N	27	52	Among a series of chemical bearing substituents on the para position of the chemical ring the general order of potency was chemical > chemical > chemical > chemical > chemical > chemical > chemical . The results also show that the binding modes of representative chemical are reversible and competitive at both gene isoforms .	T18	T25	23374869
NA	CHEMICAL	GENE-N	29	52	Among a series of chemical bearing substituents on the para position of the chemical ring the general order of potency was chemical > chemical > chemical > chemical > chemical > chemical > chemical . The results also show that the binding modes of representative chemical are reversible and competitive at both gene isoforms .	T19	T25	23374869
NA	CHEMICAL	GENE-N	31	52	Among a series of chemical bearing substituents on the para position of the chemical ring the general order of potency was chemical > chemical > chemical > chemical > chemical > chemical > chemical . The results also show that the binding modes of representative chemical are reversible and competitive at both gene isoforms .	T20	T25	23374869
NA	CHEMICAL	GENE-N	33	52	Among a series of chemical bearing substituents on the para position of the chemical ring the general order of potency was chemical > chemical > chemical > chemical > chemical > chemical > chemical . The results also show that the binding modes of representative chemical are reversible and competitive at both gene isoforms .	T21	T25	23374869
CPR:4	CHEMICAL	GENE-N	1	52	Among a series of chemical bearing substituents on the para position of the chemical ring the general order of potency was chemical > chemical > chemical > chemical > chemical > chemical > chemical . The results also show that the binding modes of representative chemical are reversible and competitive at both gene isoforms .	T22	T25	23374869
CPR:4	CHEMICAL	GENE-Y	2	17	A novel chemical derivate prevents the development of dextran sulfate chemical-induced murine experimental colitis via inhibition of gene inflammasome .	T11	T27	23506741
NA	CHEMICAL	GENE-Y	10	17	A novel chemical derivate prevents the development of dextran sulfate chemical-induced murine experimental colitis via inhibition of gene inflammasome .	T10	T27	23506741
NA	CHEMICAL	GENE-Y	12	40	In the present study , we aimed at examining the effect of chemical , a synthetic small molecular compound also named chemical , for the treatment of dextran chemical chemical ( DSS ) -induced experimental colitis in mice via targeting gene inflammasome .	T4	T19	23506741
NA	CHEMICAL	GENE-Y	14	40	In the present study , we aimed at examining the effect of chemical , a synthetic small molecular compound also named chemical , for the treatment of dextran chemical chemical ( DSS ) -induced experimental colitis in mice via targeting gene inflammasome .	T5	T19	23506741
NA	CHEMICAL	GENE-Y	7	40	In the present study , we aimed at examining the effect of chemical , a synthetic small molecular compound also named chemical , for the treatment of dextran chemical chemical ( DSS ) -induced experimental colitis in mice via targeting gene inflammasome .	T6	T19	23506741
NA	CHEMICAL	GENE-Y	29	40	In the present study , we aimed at examining the effect of chemical , a synthetic small molecular compound also named chemical , for the treatment of dextran chemical chemical ( DSS ) -induced experimental colitis in mice via targeting gene inflammasome .	T7	T19	23506741
CPR:4	CHEMICAL	GENE-N	18	11	In addition , the disease activity index , histopathologic scores and gene activity were also significantly reduced by chemical treatment .	T8	T20	23506741
CPR:4	CHEMICAL	GENE-N	28	9	Moreover , protein and mRNA levels of DSS-induced proinflammatory gene in colon , including gene , gene , gene , gene and gene , were markedly suppressed by chemical .	T9	T21	23506741
CPR:4	CHEMICAL	GENE-Y	28	14	Moreover , protein and mRNA levels of DSS-induced proinflammatory gene in colon , including gene , gene , gene , gene and gene , were markedly suppressed by chemical .	T9	T22	23506741
CPR:4	CHEMICAL	GENE-Y	28	16	Moreover , protein and mRNA levels of DSS-induced proinflammatory gene in colon , including gene , gene , gene , gene and gene , were markedly suppressed by chemical .	T9	T23	23506741
CPR:4	CHEMICAL	GENE-Y	28	18	Moreover , protein and mRNA levels of DSS-induced proinflammatory gene in colon , including gene , gene , gene , gene and gene , were markedly suppressed by chemical .	T9	T24	23506741
CPR:4	CHEMICAL	GENE-Y	28	20	Moreover , protein and mRNA levels of DSS-induced proinflammatory gene in colon , including gene , gene , gene , gene and gene , were markedly suppressed by chemical .	T9	T25	23506741
CPR:4	CHEMICAL	GENE-Y	28	22	Moreover , protein and mRNA levels of DSS-induced proinflammatory gene in colon , including gene , gene , gene , gene and gene , were markedly suppressed by chemical .	T9	T26	23506741
CPR:4	CHEMICAL	GENE-Y	2	2	Furthermore , a decreased CD11c ( + ) macrophage infiltration in colons and inactivation of gene in peritoneal macrophages were detected in chemical-2-treated mice .	T1	T13	23506741
CPR:4	CHEMICAL	GENE-Y	5	15	The mechanism of action of chemical was related to the inhibition of the cleavage of gene , gene and gene which in turn suppressed the activation of gene inflammasome .	T2	T14	23506741
CPR:4	CHEMICAL	GENE-Y	5	17	The mechanism of action of chemical was related to the inhibition of the cleavage of gene , gene and gene which in turn suppressed the activation of gene inflammasome .	T2	T15	23506741
CPR:4	CHEMICAL	GENE-Y	5	19	The mechanism of action of chemical was related to the inhibition of the cleavage of gene , gene and gene which in turn suppressed the activation of gene inflammasome .	T2	T16	23506741
CPR:4	CHEMICAL	GENE-Y	5	27	The mechanism of action of chemical was related to the inhibition of the cleavage of gene , gene and gene which in turn suppressed the activation of gene inflammasome .	T2	T17	23506741
CPR:4	CHEMICAL	GENE-Y	0	6	chemical inhibits melanogenesis through downregulation of gene-dependent expression of chemical reductase gene .	T16	T34	23063590
CPR:4	CHEMICAL	GENE-Y	0	10	chemical inhibits melanogenesis through downregulation of gene-dependent expression of chemical reductase gene .	T16	T35	23063590
NA	CHEMICAL	GENE-Y	9	6	chemical inhibits melanogenesis through downregulation of gene-dependent expression of chemical reductase gene .	T17	T34	23063590
NA	CHEMICAL	GENE-Y	9	10	chemical inhibits melanogenesis through downregulation of gene-dependent expression of chemical reductase gene .	T17	T35	23063590
CPR:4	CHEMICAL	GENE-Y	21	4	The mRNA levels of gene ( gene ) and its downstream genes gene , gene , and gene were reduced by chemical treatment .	T10	T22	23063590
CPR:4	CHEMICAL	GENE-Y	21	6	The mRNA levels of gene ( gene ) and its downstream genes gene , gene , and gene were reduced by chemical treatment .	T10	T23	23063590
CPR:4	CHEMICAL	GENE-Y	21	12	The mRNA levels of gene ( gene ) and its downstream genes gene , gene , and gene were reduced by chemical treatment .	T10	T24	23063590
CPR:4	CHEMICAL	GENE-Y	21	5	The mRNA levels of gene ( gene ) and its downstream genes gene , gene , and gene were reduced by chemical treatment .	T10	T25	23063590
CPR:4	CHEMICAL	GENE-Y	21	17	The mRNA levels of gene ( gene ) and its downstream genes gene , gene , and gene were reduced by chemical treatment .	T10	T26	23063590
CPR:4	CHEMICAL	GENE-Y	25	9	Additionally , the mRNA levels of melanogenesis-related genes ( gene , gene ( gene ) , and gene ( gene ) ) were down-regulated by chemical .	T11	T27	23063590
CPR:4	CHEMICAL	GENE-Y	25	11	Additionally , the mRNA levels of melanogenesis-related genes ( gene , gene ( gene ) , and gene ( gene ) ) were down-regulated by chemical .	T11	T28	23063590
CPR:4	CHEMICAL	GENE-Y	25	13	Additionally , the mRNA levels of melanogenesis-related genes ( gene , gene ( gene ) , and gene ( gene ) ) were down-regulated by chemical .	T11	T29	23063590
CPR:4	CHEMICAL	GENE-Y	25	17	Additionally , the mRNA levels of melanogenesis-related genes ( gene , gene ( gene ) , and gene ( gene ) ) were down-regulated by chemical .	T11	T30	23063590
CPR:4	CHEMICAL	GENE-Y	25	19	Additionally , the mRNA levels of melanogenesis-related genes ( gene , gene ( gene ) , and gene ( gene ) ) were down-regulated by chemical .	T11	T31	23063590
NA	CHEMICAL	GENE-N	2	5	Furthermore , chemical production and gene ( gene ) activity were suppressed by chemical .	T12	T32	23063590
NA	CHEMICAL	GENE-N	2	7	Furthermore , chemical production and gene ( gene ) activity were suppressed by chemical .	T12	T33	23063590
CPR:4	CHEMICAL	GENE-N	13	5	Furthermore , chemical production and gene ( gene ) activity were suppressed by chemical .	T13	T32	23063590
CPR:4	CHEMICAL	GENE-N	13	7	Furthermore , chemical production and gene ( gene ) activity were suppressed by chemical .	T13	T33	23063590
NA	CHEMICAL	GENE-Y	5	5	Moreover , attempts to elucidate a possible mechanism underlying the chemical-mediated effects revealed that chemical regulated melanogenesis by inhibiting chemical synthesis through downregulation of the chemical ( chemical ) reductase gene , which was mediated through reduced expression of the gene gene .	T14	T18	23063590
NA	CHEMICAL	GENE-Y	5	40	Moreover , attempts to elucidate a possible mechanism underlying the chemical-mediated effects revealed that chemical regulated melanogenesis by inhibiting chemical synthesis through downregulation of the chemical ( chemical ) reductase gene , which was mediated through reduced expression of the gene gene .	T14	T19	23063590
CPR:4	CHEMICAL	GENE-Y	5	5	Moreover , attempts to elucidate a possible mechanism underlying the chemical-mediated effects revealed that chemical regulated melanogenesis by inhibiting chemical synthesis through downregulation of the chemical ( chemical ) reductase gene , which was mediated through reduced expression of the gene gene .	T15	T18	23063590
CPR:4	CHEMICAL	GENE-Y	5	40	Moreover , attempts to elucidate a possible mechanism underlying the chemical-mediated effects revealed that chemical regulated melanogenesis by inhibiting chemical synthesis through downregulation of the chemical ( chemical ) reductase gene , which was mediated through reduced expression of the gene gene .	T15	T19	23063590
NA	CHEMICAL	GENE-Y	19	5	Moreover , attempts to elucidate a possible mechanism underlying the chemical-mediated effects revealed that chemical regulated melanogenesis by inhibiting chemical synthesis through downregulation of the chemical ( chemical ) reductase gene , which was mediated through reduced expression of the gene gene .	T2	T18	23063590
NA	CHEMICAL	GENE-Y	19	40	Moreover , attempts to elucidate a possible mechanism underlying the chemical-mediated effects revealed that chemical regulated melanogenesis by inhibiting chemical synthesis through downregulation of the chemical ( chemical ) reductase gene , which was mediated through reduced expression of the gene gene .	T2	T19	23063590
NA	CHEMICAL	GENE-Y	25	5	Moreover , attempts to elucidate a possible mechanism underlying the chemical-mediated effects revealed that chemical regulated melanogenesis by inhibiting chemical synthesis through downregulation of the chemical ( chemical ) reductase gene , which was mediated through reduced expression of the gene gene .	T3	T18	23063590
NA	CHEMICAL	GENE-Y	25	40	Moreover , attempts to elucidate a possible mechanism underlying the chemical-mediated effects revealed that chemical regulated melanogenesis by inhibiting chemical synthesis through downregulation of the chemical ( chemical ) reductase gene , which was mediated through reduced expression of the gene gene .	T3	T19	23063590
NA	CHEMICAL	GENE-Y	27	5	Moreover , attempts to elucidate a possible mechanism underlying the chemical-mediated effects revealed that chemical regulated melanogenesis by inhibiting chemical synthesis through downregulation of the chemical ( chemical ) reductase gene , which was mediated through reduced expression of the gene gene .	T4	T18	23063590
NA	CHEMICAL	GENE-Y	27	40	Moreover , attempts to elucidate a possible mechanism underlying the chemical-mediated effects revealed that chemical regulated melanogenesis by inhibiting chemical synthesis through downregulation of the chemical ( chemical ) reductase gene , which was mediated through reduced expression of the gene gene .	T4	T19	23063590
NA	CHEMICAL	GENE-N	6	7	Cloning and expression of a novel chemical receptor with high affinity for chemical psychotropic drugs .	T20	T34	7680751
NA	CHEMICAL	GENE-N	12	7	Cloning and expression of a novel chemical receptor with high affinity for chemical psychotropic drugs .	T21	T34	7680751
NA	CHEMICAL	GENE-N	12	8	We have used the polymerase chain reaction technique to selectively amplify a chemical-binding protein-coupled receptor cDNA sequence from rat striatal mRNA that exhibits high homology to previously cloned chemical receptors .	T17	T33	7680751
NA	CHEMICAL	GENE-N	12	8	We have used the polymerase chain reaction technique to selectively amplify a chemical-binding protein-coupled receptor cDNA sequence from rat striatal mRNA that exhibits high homology to previously cloned chemical receptors .	T17	T25	7680751
NA	CHEMICAL	GENE-N	8	8	We have used the polymerase chain reaction technique to selectively amplify a chemical-binding protein-coupled receptor cDNA sequence from rat striatal mRNA that exhibits high homology to previously cloned chemical receptors .	T13	T33	7680751
NA	CHEMICAL	GENE-N	8	8	We have used the polymerase chain reaction technique to selectively amplify a chemical-binding protein-coupled receptor cDNA sequence from rat striatal mRNA that exhibits high homology to previously cloned chemical receptors .	T13	T25	7680751
NA	CHEMICAL	GENE-N	9	6	Within these hydrophobic regions , this receptor was found to be 41-36 % identical to the following chemical [ chemical ( chemical ) ] receptors : gene > gene > gene > gene > gene > gene .	T14	T26	7680751
NA	CHEMICAL	GENE-Y	9	26	Within these hydrophobic regions , this receptor was found to be 41-36 % identical to the following chemical [ chemical ( chemical ) ] receptors : gene > gene > gene > gene > gene > gene .	T14	T27	7680751
NA	CHEMICAL	GENE-Y	9	28	Within these hydrophobic regions , this receptor was found to be 41-36 % identical to the following chemical [ chemical ( chemical ) ] receptors : gene > gene > gene > gene > gene > gene .	T14	T28	7680751
NA	CHEMICAL	GENE-Y	9	30	Within these hydrophobic regions , this receptor was found to be 41-36 % identical to the following chemical [ chemical ( chemical ) ] receptors : gene > gene > gene > gene > gene > gene .	T14	T29	7680751
NA	CHEMICAL	GENE-Y	9	32	Within these hydrophobic regions , this receptor was found to be 41-36 % identical to the following chemical [ chemical ( chemical ) ] receptors : gene > gene > gene > gene > gene > gene .	T14	T30	7680751
NA	CHEMICAL	GENE-Y	9	34	Within these hydrophobic regions , this receptor was found to be 41-36 % identical to the following chemical [ chemical ( chemical ) ] receptors : gene > gene > gene > gene > gene > gene .	T14	T31	7680751
NA	CHEMICAL	GENE-Y	9	36	Within these hydrophobic regions , this receptor was found to be 41-36 % identical to the following chemical [ chemical ( chemical ) ] receptors : gene > gene > gene > gene > gene > gene .	T14	T32	7680751
NA	CHEMICAL	GENE-N	19	6	Within these hydrophobic regions , this receptor was found to be 41-36 % identical to the following chemical [ chemical ( chemical ) ] receptors : gene > gene > gene > gene > gene > gene .	T15	T26	7680751
NA	CHEMICAL	GENE-Y	19	26	Within these hydrophobic regions , this receptor was found to be 41-36 % identical to the following chemical [ chemical ( chemical ) ] receptors : gene > gene > gene > gene > gene > gene .	T15	T27	7680751
NA	CHEMICAL	GENE-Y	19	28	Within these hydrophobic regions , this receptor was found to be 41-36 % identical to the following chemical [ chemical ( chemical ) ] receptors : gene > gene > gene > gene > gene > gene .	T15	T28	7680751
NA	CHEMICAL	GENE-Y	19	30	Within these hydrophobic regions , this receptor was found to be 41-36 % identical to the following chemical [ chemical ( chemical ) ] receptors : gene > gene > gene > gene > gene > gene .	T15	T29	7680751
NA	CHEMICAL	GENE-Y	19	32	Within these hydrophobic regions , this receptor was found to be 41-36 % identical to the following chemical [ chemical ( chemical ) ] receptors : gene > gene > gene > gene > gene > gene .	T15	T30	7680751
NA	CHEMICAL	GENE-Y	19	34	Within these hydrophobic regions , this receptor was found to be 41-36 % identical to the following chemical [ chemical ( chemical ) ] receptors : gene > gene > gene > gene > gene > gene .	T15	T31	7680751
NA	CHEMICAL	GENE-Y	19	36	Within these hydrophobic regions , this receptor was found to be 41-36 % identical to the following chemical [ chemical ( chemical ) ] receptors : gene > gene > gene > gene > gene > gene .	T15	T32	7680751
NA	CHEMICAL	GENE-N	21	6	Within these hydrophobic regions , this receptor was found to be 41-36 % identical to the following chemical [ chemical ( chemical ) ] receptors : gene > gene > gene > gene > gene > gene .	T16	T26	7680751
NA	CHEMICAL	GENE-Y	21	26	Within these hydrophobic regions , this receptor was found to be 41-36 % identical to the following chemical [ chemical ( chemical ) ] receptors : gene > gene > gene > gene > gene > gene .	T16	T27	7680751
NA	CHEMICAL	GENE-Y	21	28	Within these hydrophobic regions , this receptor was found to be 41-36 % identical to the following chemical [ chemical ( chemical ) ] receptors : gene > gene > gene > gene > gene > gene .	T16	T28	7680751
NA	CHEMICAL	GENE-Y	21	30	Within these hydrophobic regions , this receptor was found to be 41-36 % identical to the following chemical [ chemical ( chemical ) ] receptors : gene > gene > gene > gene > gene > gene .	T16	T29	7680751
NA	CHEMICAL	GENE-Y	21	32	Within these hydrophobic regions , this receptor was found to be 41-36 % identical to the following chemical [ chemical ( chemical ) ] receptors : gene > gene > gene > gene > gene > gene .	T16	T30	7680751
NA	CHEMICAL	GENE-Y	21	34	Within these hydrophobic regions , this receptor was found to be 41-36 % identical to the following chemical [ chemical ( chemical ) ] receptors : gene > gene > gene > gene > gene > gene .	T16	T31	7680751
NA	CHEMICAL	GENE-Y	21	36	Within these hydrophobic regions , this receptor was found to be 41-36 % identical to the following chemical [ chemical ( chemical ) ] receptors : gene > gene > gene > gene > gene > gene .	T16	T32	7680751
NA	CHEMICAL	GENE-N	3	26	The inhibition of chemical binding by other serotonergic agonists and antagonists revealed a pharmacological profile that does not correlate with that of any previously described chemical receptor subtype .	T3	T22	7680751
NA	CHEMICAL	GENE-N	25	26	The inhibition of chemical binding by other serotonergic agonists and antagonists revealed a pharmacological profile that does not correlate with that of any previously described chemical receptor subtype .	T4	T22	7680751
CPR:3	CHEMICAL	GENE-N	9	11	In HEK-293 cells stably transfected with this receptor , chemical elicits a potent stimulation of chemical cyclase activity , which is blocked by antipsychotic and antidepressant drugs .	T9	T23	7680751
NA	CHEMICAL	GENE-N	11	11	In HEK-293 cells stably transfected with this receptor , chemical elicits a potent stimulation of chemical cyclase activity , which is blocked by antipsychotic and antidepressant drugs .	T10	T23	7680751
NA	CHEMICAL	GENE-N	19	8	The distinct structural and pharmacological properties of this receptor site indicate that it represents a completely novel subtype of chemical receptor .	T11	T24	7680751
NA	CHEMICAL	GENE-Y	2	12	Effect of chemical , chemical , on melanin synthesis in humans with gene variant alleles .	T8	T15	16293341
NA	CHEMICAL	GENE-Y	4	12	Effect of chemical , chemical , on melanin synthesis in humans with gene variant alleles .	T9	T15	16293341
NA	CHEMICAL	GENE-Y	0	6	chemical ( chemical ) binds the gene to significantly increase the eumelanin content of human skin cells .	T1	T12	16293341
NA	CHEMICAL	GENE-Y	2	6	chemical ( chemical ) binds the gene to significantly increase the eumelanin content of human skin cells .	T2	T12	16293341
NA	CHEMICAL	GENE-Y	13	18	In this study of 77 Caucasian individuals , we investigated the effects of chemical in individuals with variant gene genotypes , as it has been suggested through in vitro studies that variant alleles decrease chemical binding efficacy , which would subsequently affect the synthesis of melanin .	T3	T11	16293341
NA	CHEMICAL	GENE-Y	34	18	In this study of 77 Caucasian individuals , we investigated the effects of chemical in individuals with variant gene genotypes , as it has been suggested through in vitro studies that variant alleles decrease chemical binding efficacy , which would subsequently affect the synthesis of melanin .	T4	T11	16293341
CPR:4	CHEMICAL	GENE-Y	0	12	chemical ( chemical , chemical ) is the first oral inhibitor of gene ( gene ) to reach the oncology clinic .	T1	T18	20531964
CPR:4	CHEMICAL	GENE-Y	0	14	chemical ( chemical , chemical ) is the first oral inhibitor of gene ( gene ) to reach the oncology clinic .	T1	T19	20531964
CPR:4	CHEMICAL	GENE-Y	2	12	chemical ( chemical , chemical ) is the first oral inhibitor of gene ( gene ) to reach the oncology clinic .	T3	T18	20531964
CPR:4	CHEMICAL	GENE-Y	2	14	chemical ( chemical , chemical ) is the first oral inhibitor of gene ( gene ) to reach the oncology clinic .	T3	T19	20531964
CPR:4	CHEMICAL	GENE-Y	4	12	chemical ( chemical , chemical ) is the first oral inhibitor of gene ( gene ) to reach the oncology clinic .	T6	T18	20531964
CPR:4	CHEMICAL	GENE-Y	4	14	chemical ( chemical , chemical ) is the first oral inhibitor of gene ( gene ) to reach the oncology clinic .	T6	T19	20531964
NA	CHEMICAL	GENE-N	11	29	A phase III randomized placebo-controlled trial has examined the impact of chemical in patients with clear cell renal cancers and progressive disease on or within 6 months of the gene chemical kinase inhibitors chemical and/or chemical .	T7	T16	20531964
NA	CHEMICAL	GENE-N	11	12	A phase III randomized placebo-controlled trial has examined the impact of chemical in patients with clear cell renal cancers and progressive disease on or within 6 months of the gene chemical kinase inhibitors chemical and/or chemical .	T7	T17	20531964
NA	CHEMICAL	GENE-N	12	29	A phase III randomized placebo-controlled trial has examined the impact of chemical in patients with clear cell renal cancers and progressive disease on or within 6 months of the gene chemical kinase inhibitors chemical and/or chemical .	T8	T16	20531964
NA	CHEMICAL	GENE-N	12	12	A phase III randomized placebo-controlled trial has examined the impact of chemical in patients with clear cell renal cancers and progressive disease on or within 6 months of the gene chemical kinase inhibitors chemical and/or chemical .	T8	T17	20531964
CPR:4	CHEMICAL	GENE-N	12	29	A phase III randomized placebo-controlled trial has examined the impact of chemical in patients with clear cell renal cancers and progressive disease on or within 6 months of the gene chemical kinase inhibitors chemical and/or chemical .	T9	T16	20531964
CPR:4	CHEMICAL	GENE-N	12	12	A phase III randomized placebo-controlled trial has examined the impact of chemical in patients with clear cell renal cancers and progressive disease on or within 6 months of the gene chemical kinase inhibitors chemical and/or chemical .	T9	T17	20531964
CPR:4	CHEMICAL	GENE-N	23	29	A phase III randomized placebo-controlled trial has examined the impact of chemical in patients with clear cell renal cancers and progressive disease on or within 6 months of the gene chemical kinase inhibitors chemical and/or chemical .	T10	T16	20531964
CPR:4	CHEMICAL	GENE-N	23	12	A phase III randomized placebo-controlled trial has examined the impact of chemical in patients with clear cell renal cancers and progressive disease on or within 6 months of the gene chemical kinase inhibitors chemical and/or chemical .	T10	T17	20531964
NA	CHEMICAL	GENE-N	5	15	One major route involves the chemical ( chemical ) -dependent activities of the chemical decarboxylase complex ( gene , gene ) and chemical hydroxymethyltransferase ( gene , gene ) with chemical ( chemical ) as one-chemical ( chemical ) source .	T2	T59	12668769
NA	CHEMICAL	GENE-N	5	17	One major route involves the chemical ( chemical ) -dependent activities of the chemical decarboxylase complex ( gene , gene ) and chemical hydroxymethyltransferase ( gene , gene ) with chemical ( chemical ) as one-chemical ( chemical ) source .	T2	T62	12668769
NA	CHEMICAL	GENE-Y	5	19	One major route involves the chemical ( chemical ) -dependent activities of the chemical decarboxylase complex ( gene , gene ) and chemical hydroxymethyltransferase ( gene , gene ) with chemical ( chemical ) as one-chemical ( chemical ) source .	T2	T64	12668769
NA	CHEMICAL	GENE-N	5	23	One major route involves the chemical ( chemical ) -dependent activities of the chemical decarboxylase complex ( gene , gene ) and chemical hydroxymethyltransferase ( gene , gene ) with chemical ( chemical ) as one-chemical ( chemical ) source .	T2	T67	12668769
NA	CHEMICAL	GENE-N	5	25	One major route involves the chemical ( chemical ) -dependent activities of the chemical decarboxylase complex ( gene , gene ) and chemical hydroxymethyltransferase ( gene , gene ) with chemical ( chemical ) as one-chemical ( chemical ) source .	T2	T74	12668769
NA	CHEMICAL	GENE-Y	5	27	One major route involves the chemical ( chemical ) -dependent activities of the chemical decarboxylase complex ( gene , gene ) and chemical hydroxymethyltransferase ( gene , gene ) with chemical ( chemical ) as one-chemical ( chemical ) source .	T2	T77	12668769
NA	CHEMICAL	GENE-N	7	15	One major route involves the chemical ( chemical ) -dependent activities of the chemical decarboxylase complex ( gene , gene ) and chemical hydroxymethyltransferase ( gene , gene ) with chemical ( chemical ) as one-chemical ( chemical ) source .	T6	T59	12668769
NA	CHEMICAL	GENE-N	7	17	One major route involves the chemical ( chemical ) -dependent activities of the chemical decarboxylase complex ( gene , gene ) and chemical hydroxymethyltransferase ( gene , gene ) with chemical ( chemical ) as one-chemical ( chemical ) source .	T6	T62	12668769
NA	CHEMICAL	GENE-Y	7	19	One major route involves the chemical ( chemical ) -dependent activities of the chemical decarboxylase complex ( gene , gene ) and chemical hydroxymethyltransferase ( gene , gene ) with chemical ( chemical ) as one-chemical ( chemical ) source .	T6	T64	12668769
NA	CHEMICAL	GENE-N	7	23	One major route involves the chemical ( chemical ) -dependent activities of the chemical decarboxylase complex ( gene , gene ) and chemical hydroxymethyltransferase ( gene , gene ) with chemical ( chemical ) as one-chemical ( chemical ) source .	T6	T67	12668769
NA	CHEMICAL	GENE-N	7	25	One major route involves the chemical ( chemical ) -dependent activities of the chemical decarboxylase complex ( gene , gene ) and chemical hydroxymethyltransferase ( gene , gene ) with chemical ( chemical ) as one-chemical ( chemical ) source .	T6	T74	12668769
NA	CHEMICAL	GENE-Y	7	27	One major route involves the chemical ( chemical ) -dependent activities of the chemical decarboxylase complex ( gene , gene ) and chemical hydroxymethyltransferase ( gene , gene ) with chemical ( chemical ) as one-chemical ( chemical ) source .	T6	T77	12668769
NA	CHEMICAL	GENE-N	13	15	One major route involves the chemical ( chemical ) -dependent activities of the chemical decarboxylase complex ( gene , gene ) and chemical hydroxymethyltransferase ( gene , gene ) with chemical ( chemical ) as one-chemical ( chemical ) source .	T13	T59	12668769
NA	CHEMICAL	GENE-N	13	17	One major route involves the chemical ( chemical ) -dependent activities of the chemical decarboxylase complex ( gene , gene ) and chemical hydroxymethyltransferase ( gene , gene ) with chemical ( chemical ) as one-chemical ( chemical ) source .	T13	T62	12668769
NA	CHEMICAL	GENE-Y	13	19	One major route involves the chemical ( chemical ) -dependent activities of the chemical decarboxylase complex ( gene , gene ) and chemical hydroxymethyltransferase ( gene , gene ) with chemical ( chemical ) as one-chemical ( chemical ) source .	T13	T64	12668769
NA	CHEMICAL	GENE-N	13	23	One major route involves the chemical ( chemical ) -dependent activities of the chemical decarboxylase complex ( gene , gene ) and chemical hydroxymethyltransferase ( gene , gene ) with chemical ( chemical ) as one-chemical ( chemical ) source .	T13	T67	12668769
NA	CHEMICAL	GENE-N	13	25	One major route involves the chemical ( chemical ) -dependent activities of the chemical decarboxylase complex ( gene , gene ) and chemical hydroxymethyltransferase ( gene , gene ) with chemical ( chemical ) as one-chemical ( chemical ) source .	T13	T74	12668769
NA	CHEMICAL	GENE-Y	13	27	One major route involves the chemical ( chemical ) -dependent activities of the chemical decarboxylase complex ( gene , gene ) and chemical hydroxymethyltransferase ( gene , gene ) with chemical ( chemical ) as one-chemical ( chemical ) source .	T13	T77	12668769
NA	CHEMICAL	GENE-N	22	15	One major route involves the chemical ( chemical ) -dependent activities of the chemical decarboxylase complex ( gene , gene ) and chemical hydroxymethyltransferase ( gene , gene ) with chemical ( chemical ) as one-chemical ( chemical ) source .	T24	T59	12668769
NA	CHEMICAL	GENE-N	22	17	One major route involves the chemical ( chemical ) -dependent activities of the chemical decarboxylase complex ( gene , gene ) and chemical hydroxymethyltransferase ( gene , gene ) with chemical ( chemical ) as one-chemical ( chemical ) source .	T24	T62	12668769
NA	CHEMICAL	GENE-Y	22	19	One major route involves the chemical ( chemical ) -dependent activities of the chemical decarboxylase complex ( gene , gene ) and chemical hydroxymethyltransferase ( gene , gene ) with chemical ( chemical ) as one-chemical ( chemical ) source .	T24	T64	12668769
NA	CHEMICAL	GENE-N	22	23	One major route involves the chemical ( chemical ) -dependent activities of the chemical decarboxylase complex ( gene , gene ) and chemical hydroxymethyltransferase ( gene , gene ) with chemical ( chemical ) as one-chemical ( chemical ) source .	T24	T67	12668769
NA	CHEMICAL	GENE-N	22	25	One major route involves the chemical ( chemical ) -dependent activities of the chemical decarboxylase complex ( gene , gene ) and chemical hydroxymethyltransferase ( gene , gene ) with chemical ( chemical ) as one-chemical ( chemical ) source .	T24	T74	12668769
NA	CHEMICAL	GENE-Y	22	27	One major route involves the chemical ( chemical ) -dependent activities of the chemical decarboxylase complex ( gene , gene ) and chemical hydroxymethyltransferase ( gene , gene ) with chemical ( chemical ) as one-chemical ( chemical ) source .	T24	T77	12668769
CPR:9	CHEMICAL	GENE-N	30	15	One major route involves the chemical ( chemical ) -dependent activities of the chemical decarboxylase complex ( gene , gene ) and chemical hydroxymethyltransferase ( gene , gene ) with chemical ( chemical ) as one-chemical ( chemical ) source .	T36	T59	12668769
CPR:9	CHEMICAL	GENE-N	30	17	One major route involves the chemical ( chemical ) -dependent activities of the chemical decarboxylase complex ( gene , gene ) and chemical hydroxymethyltransferase ( gene , gene ) with chemical ( chemical ) as one-chemical ( chemical ) source .	T36	T62	12668769
CPR:9	CHEMICAL	GENE-Y	30	19	One major route involves the chemical ( chemical ) -dependent activities of the chemical decarboxylase complex ( gene , gene ) and chemical hydroxymethyltransferase ( gene , gene ) with chemical ( chemical ) as one-chemical ( chemical ) source .	T36	T64	12668769
CPR:9	CHEMICAL	GENE-N	30	23	One major route involves the chemical ( chemical ) -dependent activities of the chemical decarboxylase complex ( gene , gene ) and chemical hydroxymethyltransferase ( gene , gene ) with chemical ( chemical ) as one-chemical ( chemical ) source .	T36	T67	12668769
CPR:9	CHEMICAL	GENE-N	30	25	One major route involves the chemical ( chemical ) -dependent activities of the chemical decarboxylase complex ( gene , gene ) and chemical hydroxymethyltransferase ( gene , gene ) with chemical ( chemical ) as one-chemical ( chemical ) source .	T36	T74	12668769
CPR:9	CHEMICAL	GENE-Y	30	27	One major route involves the chemical ( chemical ) -dependent activities of the chemical decarboxylase complex ( gene , gene ) and chemical hydroxymethyltransferase ( gene , gene ) with chemical ( chemical ) as one-chemical ( chemical ) source .	T36	T77	12668769
CPR:9	CHEMICAL	GENE-N	32	15	One major route involves the chemical ( chemical ) -dependent activities of the chemical decarboxylase complex ( gene , gene ) and chemical hydroxymethyltransferase ( gene , gene ) with chemical ( chemical ) as one-chemical ( chemical ) source .	T37	T59	12668769
CPR:9	CHEMICAL	GENE-N	32	17	One major route involves the chemical ( chemical ) -dependent activities of the chemical decarboxylase complex ( gene , gene ) and chemical hydroxymethyltransferase ( gene , gene ) with chemical ( chemical ) as one-chemical ( chemical ) source .	T37	T62	12668769
CPR:9	CHEMICAL	GENE-Y	32	19	One major route involves the chemical ( chemical ) -dependent activities of the chemical decarboxylase complex ( gene , gene ) and chemical hydroxymethyltransferase ( gene , gene ) with chemical ( chemical ) as one-chemical ( chemical ) source .	T37	T64	12668769
CPR:9	CHEMICAL	GENE-N	32	23	One major route involves the chemical ( chemical ) -dependent activities of the chemical decarboxylase complex ( gene , gene ) and chemical hydroxymethyltransferase ( gene , gene ) with chemical ( chemical ) as one-chemical ( chemical ) source .	T37	T67	12668769
CPR:9	CHEMICAL	GENE-N	32	25	One major route involves the chemical ( chemical ) -dependent activities of the chemical decarboxylase complex ( gene , gene ) and chemical hydroxymethyltransferase ( gene , gene ) with chemical ( chemical ) as one-chemical ( chemical ) source .	T37	T74	12668769
CPR:9	CHEMICAL	GENE-Y	32	27	One major route involves the chemical ( chemical ) -dependent activities of the chemical decarboxylase complex ( gene , gene ) and chemical hydroxymethyltransferase ( gene , gene ) with chemical ( chemical ) as one-chemical ( chemical ) source .	T37	T77	12668769
NA	CHEMICAL	GENE-N	35	15	One major route involves the chemical ( chemical ) -dependent activities of the chemical decarboxylase complex ( gene , gene ) and chemical hydroxymethyltransferase ( gene , gene ) with chemical ( chemical ) as one-chemical ( chemical ) source .	T38	T59	12668769
NA	CHEMICAL	GENE-N	35	17	One major route involves the chemical ( chemical ) -dependent activities of the chemical decarboxylase complex ( gene , gene ) and chemical hydroxymethyltransferase ( gene , gene ) with chemical ( chemical ) as one-chemical ( chemical ) source .	T38	T62	12668769
NA	CHEMICAL	GENE-Y	35	19	One major route involves the chemical ( chemical ) -dependent activities of the chemical decarboxylase complex ( gene , gene ) and chemical hydroxymethyltransferase ( gene , gene ) with chemical ( chemical ) as one-chemical ( chemical ) source .	T38	T64	12668769
NA	CHEMICAL	GENE-N	35	23	One major route involves the chemical ( chemical ) -dependent activities of the chemical decarboxylase complex ( gene , gene ) and chemical hydroxymethyltransferase ( gene , gene ) with chemical ( chemical ) as one-chemical ( chemical ) source .	T38	T67	12668769
NA	CHEMICAL	GENE-N	35	25	One major route involves the chemical ( chemical ) -dependent activities of the chemical decarboxylase complex ( gene , gene ) and chemical hydroxymethyltransferase ( gene , gene ) with chemical ( chemical ) as one-chemical ( chemical ) source .	T38	T74	12668769
NA	CHEMICAL	GENE-Y	35	27	One major route involves the chemical ( chemical ) -dependent activities of the chemical decarboxylase complex ( gene , gene ) and chemical hydroxymethyltransferase ( gene , gene ) with chemical ( chemical ) as one-chemical ( chemical ) source .	T38	T77	12668769
NA	CHEMICAL	GENE-N	37	15	One major route involves the chemical ( chemical ) -dependent activities of the chemical decarboxylase complex ( gene , gene ) and chemical hydroxymethyltransferase ( gene , gene ) with chemical ( chemical ) as one-chemical ( chemical ) source .	T39	T59	12668769
NA	CHEMICAL	GENE-N	37	17	One major route involves the chemical ( chemical ) -dependent activities of the chemical decarboxylase complex ( gene , gene ) and chemical hydroxymethyltransferase ( gene , gene ) with chemical ( chemical ) as one-chemical ( chemical ) source .	T39	T62	12668769
NA	CHEMICAL	GENE-Y	37	19	One major route involves the chemical ( chemical ) -dependent activities of the chemical decarboxylase complex ( gene , gene ) and chemical hydroxymethyltransferase ( gene , gene ) with chemical ( chemical ) as one-chemical ( chemical ) source .	T39	T64	12668769
NA	CHEMICAL	GENE-N	37	23	One major route involves the chemical ( chemical ) -dependent activities of the chemical decarboxylase complex ( gene , gene ) and chemical hydroxymethyltransferase ( gene , gene ) with chemical ( chemical ) as one-chemical ( chemical ) source .	T39	T67	12668769
NA	CHEMICAL	GENE-N	37	25	One major route involves the chemical ( chemical ) -dependent activities of the chemical decarboxylase complex ( gene , gene ) and chemical hydroxymethyltransferase ( gene , gene ) with chemical ( chemical ) as one-chemical ( chemical ) source .	T39	T74	12668769
NA	CHEMICAL	GENE-Y	37	27	One major route involves the chemical ( chemical ) -dependent activities of the chemical decarboxylase complex ( gene , gene ) and chemical hydroxymethyltransferase ( gene , gene ) with chemical ( chemical ) as one-chemical ( chemical ) source .	T39	T77	12668769
NA	CHEMICAL	GENE-Y	2	11	An alternative chemical-dependent pathway involves the chemical-chemical synthase/gene activities with chemical as chemical source .	T40	T80	12668769
NA	CHEMICAL	GENE-N	2	7	An alternative chemical-dependent pathway involves the chemical-chemical synthase/gene activities with chemical as chemical source .	T40	T81	12668769
NA	CHEMICAL	GENE-Y	6	11	An alternative chemical-dependent pathway involves the chemical-chemical synthase/gene activities with chemical as chemical source .	T41	T80	12668769
NA	CHEMICAL	GENE-N	6	7	An alternative chemical-dependent pathway involves the chemical-chemical synthase/gene activities with chemical as chemical source .	T41	T81	12668769
NA	CHEMICAL	GENE-Y	6	11	An alternative chemical-dependent pathway involves the chemical-chemical synthase/gene activities with chemical as chemical source .	T42	T80	12668769
NA	CHEMICAL	GENE-N	6	7	An alternative chemical-dependent pathway involves the chemical-chemical synthase/gene activities with chemical as chemical source .	T42	T81	12668769
CPR:9	CHEMICAL	GENE-Y	10	11	An alternative chemical-dependent pathway involves the chemical-chemical synthase/gene activities with chemical as chemical source .	T43	T80	12668769
CPR:9	CHEMICAL	GENE-N	10	7	An alternative chemical-dependent pathway involves the chemical-chemical synthase/gene activities with chemical as chemical source .	T43	T81	12668769
NA	CHEMICAL	GENE-Y	12	11	An alternative chemical-dependent pathway involves the chemical-chemical synthase/gene activities with chemical as chemical source .	T44	T80	12668769
NA	CHEMICAL	GENE-N	12	7	An alternative chemical-dependent pathway involves the chemical-chemical synthase/gene activities with chemical as chemical source .	T44	T81	12668769
NA	CHEMICAL	GENE-Y	5	6	Firstly , transgenic plants overexpressing chemical dehydrogenase ( gene , gene ) were used to continue our previous studies on the function of gene in chemical metabolism .	T45	T82	12668769
NA	CHEMICAL	GENE-Y	5	8	Firstly , transgenic plants overexpressing chemical dehydrogenase ( gene , gene ) were used to continue our previous studies on the function of gene in chemical metabolism .	T45	T83	12668769
NA	CHEMICAL	GENE-Y	5	10	Firstly , transgenic plants overexpressing chemical dehydrogenase ( gene , gene ) were used to continue our previous studies on the function of gene in chemical metabolism .	T45	T84	12668769
NA	CHEMICAL	GENE-Y	5	23	Firstly , transgenic plants overexpressing chemical dehydrogenase ( gene , gene ) were used to continue our previous studies on the function of gene in chemical metabolism .	T45	T85	12668769
CPR:9	CHEMICAL	GENE-Y	25	6	Firstly , transgenic plants overexpressing chemical dehydrogenase ( gene , gene ) were used to continue our previous studies on the function of gene in chemical metabolism .	T46	T82	12668769
CPR:9	CHEMICAL	GENE-Y	25	8	Firstly , transgenic plants overexpressing chemical dehydrogenase ( gene , gene ) were used to continue our previous studies on the function of gene in chemical metabolism .	T46	T83	12668769
CPR:9	CHEMICAL	GENE-Y	25	10	Firstly , transgenic plants overexpressing chemical dehydrogenase ( gene , gene ) were used to continue our previous studies on the function of gene in chemical metabolism .	T46	T84	12668769
CPR:9	CHEMICAL	GENE-Y	25	23	Firstly , transgenic plants overexpressing chemical dehydrogenase ( gene , gene ) were used to continue our previous studies on the function of gene in chemical metabolism .	T46	T85	12668769
NA	CHEMICAL	GENE-Y	17	3	We concluded that gene has no direct role in the regulation of the above two pathways of chemical synthesis ; the breakdown of chemical to chemical by the gene reaction is the primary and preferred fate of the organic acid in Arabidopsis .	T4	T53	12668769
NA	CHEMICAL	GENE-Y	17	28	We concluded that gene has no direct role in the regulation of the above two pathways of chemical synthesis ; the breakdown of chemical to chemical by the gene reaction is the primary and preferred fate of the organic acid in Arabidopsis .	T4	T54	12668769
NA	CHEMICAL	GENE-Y	3	3	We concluded that gene has no direct role in the regulation of the above two pathways of chemical synthesis ; the breakdown of chemical to chemical by the gene reaction is the primary and preferred fate of the organic acid in Arabidopsis .	T5	T53	12668769
CPR:9	CHEMICAL	GENE-Y	3	28	We concluded that gene has no direct role in the regulation of the above two pathways of chemical synthesis ; the breakdown of chemical to chemical by the gene reaction is the primary and preferred fate of the organic acid in Arabidopsis .	T5	T54	12668769
NA	CHEMICAL	GENE-Y	25	3	We concluded that gene has no direct role in the regulation of the above two pathways of chemical synthesis ; the breakdown of chemical to chemical by the gene reaction is the primary and preferred fate of the organic acid in Arabidopsis .	T7	T53	12668769
CPR:9	CHEMICAL	GENE-Y	25	28	We concluded that gene has no direct role in the regulation of the above two pathways of chemical synthesis ; the breakdown of chemical to chemical by the gene reaction is the primary and preferred fate of the organic acid in Arabidopsis .	T7	T54	12668769
NA	CHEMICAL	GENE-N	6	4	The ratio between the gene/gene and chemical-chemical synthase/gene pathways of chemical synthesis from chemical and chemical , respectively , in Arabidopsis shoots was 21 : 1 ; in roots , 9 : 1 .	T8	T55	12668769
NA	CHEMICAL	GENE-N	6	4	The ratio between the gene/gene and chemical-chemical synthase/gene pathways of chemical synthesis from chemical and chemical , respectively , in Arabidopsis shoots was 21 : 1 ; in roots , 9 : 1 .	T8	T56	12668769
NA	CHEMICAL	GENE-N	6	7	The ratio between the gene/gene and chemical-chemical synthase/gene pathways of chemical synthesis from chemical and chemical , respectively , in Arabidopsis shoots was 21 : 1 ; in roots , 9 : 1 .	T8	T58	12668769
NA	CHEMICAL	GENE-N	6	4	The ratio between the gene/gene and chemical-chemical synthase/gene pathways of chemical synthesis from chemical and chemical , respectively , in Arabidopsis shoots was 21 : 1 ; in roots , 9 : 1 .	T9	T55	12668769
NA	CHEMICAL	GENE-N	6	4	The ratio between the gene/gene and chemical-chemical synthase/gene pathways of chemical synthesis from chemical and chemical , respectively , in Arabidopsis shoots was 21 : 1 ; in roots , 9 : 1 .	T9	T56	12668769
NA	CHEMICAL	GENE-N	6	7	The ratio between the gene/gene and chemical-chemical synthase/gene pathways of chemical synthesis from chemical and chemical , respectively , in Arabidopsis shoots was 21 : 1 ; in roots , 9 : 1 .	T9	T58	12668769
NA	CHEMICAL	GENE-N	10	4	The ratio between the gene/gene and chemical-chemical synthase/gene pathways of chemical synthesis from chemical and chemical , respectively , in Arabidopsis shoots was 21 : 1 ; in roots , 9 : 1 .	T10	T55	12668769
CPR:9	CHEMICAL	GENE-N	10	4	The ratio between the gene/gene and chemical-chemical synthase/gene pathways of chemical synthesis from chemical and chemical , respectively , in Arabidopsis shoots was 21 : 1 ; in roots , 9 : 1 .	T10	T56	12668769
CPR:9	CHEMICAL	GENE-N	10	7	The ratio between the gene/gene and chemical-chemical synthase/gene pathways of chemical synthesis from chemical and chemical , respectively , in Arabidopsis shoots was 21 : 1 ; in roots , 9 : 1 .	T10	T58	12668769
CPR:9	CHEMICAL	GENE-N	13	4	The ratio between the gene/gene and chemical-chemical synthase/gene pathways of chemical synthesis from chemical and chemical , respectively , in Arabidopsis shoots was 21 : 1 ; in roots , 9 : 1 .	T11	T55	12668769
NA	CHEMICAL	GENE-N	13	4	The ratio between the gene/gene and chemical-chemical synthase/gene pathways of chemical synthesis from chemical and chemical , respectively , in Arabidopsis shoots was 21 : 1 ; in roots , 9 : 1 .	T11	T56	12668769
NA	CHEMICAL	GENE-N	13	7	The ratio between the gene/gene and chemical-chemical synthase/gene pathways of chemical synthesis from chemical and chemical , respectively , in Arabidopsis shoots was 21 : 1 ; in roots , 9 : 1 .	T11	T58	12668769
NA	CHEMICAL	GENE-N	15	4	The ratio between the gene/gene and chemical-chemical synthase/gene pathways of chemical synthesis from chemical and chemical , respectively , in Arabidopsis shoots was 21 : 1 ; in roots , 9 : 1 .	T12	T55	12668769
NA	CHEMICAL	GENE-N	15	4	The ratio between the gene/gene and chemical-chemical synthase/gene pathways of chemical synthesis from chemical and chemical , respectively , in Arabidopsis shoots was 21 : 1 ; in roots , 9 : 1 .	T12	T56	12668769
NA	CHEMICAL	GENE-N	15	7	The ratio between the gene/gene and chemical-chemical synthase/gene pathways of chemical synthesis from chemical and chemical , respectively , in Arabidopsis shoots was 21 : 1 ; in roots , 9 : 1 .	T12	T58	12668769
NA	CHEMICAL	GENE-Y	8	11	In shoots , therefore , the pathway from chemical plays only a small role in chemical synthesis ; in the case of roots , results indicated that the 9 : 1 ratio was as a result of greater fluxes of chemical through both pathways together with a relatively higher contribution from the chemical-chemical synthase/gene route than in shoots .	T14	T60	12668769
NA	CHEMICAL	GENE-N	8	53	In shoots , therefore , the pathway from chemical plays only a small role in chemical synthesis ; in the case of roots , results indicated that the 9 : 1 ratio was as a result of greater fluxes of chemical through both pathways together with a relatively higher contribution from the chemical-chemical synthase/gene route than in shoots .	T14	T61	12668769
NA	CHEMICAL	GENE-Y	15	11	In shoots , therefore , the pathway from chemical plays only a small role in chemical synthesis ; in the case of roots , results indicated that the 9 : 1 ratio was as a result of greater fluxes of chemical through both pathways together with a relatively higher contribution from the chemical-chemical synthase/gene route than in shoots .	T15	T60	12668769
NA	CHEMICAL	GENE-N	15	53	In shoots , therefore , the pathway from chemical plays only a small role in chemical synthesis ; in the case of roots , results indicated that the 9 : 1 ratio was as a result of greater fluxes of chemical through both pathways together with a relatively higher contribution from the chemical-chemical synthase/gene route than in shoots .	T15	T61	12668769
NA	CHEMICAL	GENE-Y	30	11	In shoots , therefore , the pathway from chemical plays only a small role in chemical synthesis ; in the case of roots , results indicated that the 9 : 1 ratio was as a result of greater fluxes of chemical through both pathways together with a relatively higher contribution from the chemical-chemical synthase/gene route than in shoots .	T16	T60	12668769
NA	CHEMICAL	GENE-N	30	53	In shoots , therefore , the pathway from chemical plays only a small role in chemical synthesis ; in the case of roots , results indicated that the 9 : 1 ratio was as a result of greater fluxes of chemical through both pathways together with a relatively higher contribution from the chemical-chemical synthase/gene route than in shoots .	T16	T61	12668769
NA	CHEMICAL	GENE-Y	30	11	In shoots , therefore , the pathway from chemical plays only a small role in chemical synthesis ; in the case of roots , results indicated that the 9 : 1 ratio was as a result of greater fluxes of chemical through both pathways together with a relatively higher contribution from the chemical-chemical synthase/gene route than in shoots .	T17	T60	12668769
NA	CHEMICAL	GENE-N	30	53	In shoots , therefore , the pathway from chemical plays only a small role in chemical synthesis ; in the case of roots , results indicated that the 9 : 1 ratio was as a result of greater fluxes of chemical through both pathways together with a relatively higher contribution from the chemical-chemical synthase/gene route than in shoots .	T17	T61	12668769
NA	CHEMICAL	GENE-Y	52	11	In shoots , therefore , the pathway from chemical plays only a small role in chemical synthesis ; in the case of roots , results indicated that the 9 : 1 ratio was as a result of greater fluxes of chemical through both pathways together with a relatively higher contribution from the chemical-chemical synthase/gene route than in shoots .	T18	T60	12668769
NA	CHEMICAL	GENE-N	52	53	In shoots , therefore , the pathway from chemical plays only a small role in chemical synthesis ; in the case of roots , results indicated that the 9 : 1 ratio was as a result of greater fluxes of chemical through both pathways together with a relatively higher contribution from the chemical-chemical synthase/gene route than in shoots .	T18	T61	12668769
NA	CHEMICAL	GENE-N	6	9	We also examined the synthesis of chemical in a gene-deficient mutant of Arabidopsis ( chemical ) where the gene/gene pathway was impaired .	T19	T63	12668769
NA	CHEMICAL	GENE-N	6	18	We also examined the synthesis of chemical in a gene-deficient mutant of Arabidopsis ( chemical ) where the gene/gene pathway was impaired .	T19	T65	12668769
NA	CHEMICAL	GENE-N	6	18	We also examined the synthesis of chemical in a gene-deficient mutant of Arabidopsis ( chemical ) where the gene/gene pathway was impaired .	T19	T66	12668769
NA	CHEMICAL	GENE-N	14	9	We also examined the synthesis of chemical in a gene-deficient mutant of Arabidopsis ( chemical ) where the gene/gene pathway was impaired .	T20	T63	12668769
NA	CHEMICAL	GENE-N	14	18	We also examined the synthesis of chemical in a gene-deficient mutant of Arabidopsis ( chemical ) where the gene/gene pathway was impaired .	T20	T65	12668769
NA	CHEMICAL	GENE-N	14	18	We also examined the synthesis of chemical in a gene-deficient mutant of Arabidopsis ( chemical ) where the gene/gene pathway was impaired .	T20	T66	12668769
CPR:9	CHEMICAL	GENE-N	8	12	On the other hand , the accumulation of chemical through the chemical-chemical synthase/gene pathway in chemical plants was 2.5-fold greater than that in WT plants .	T27	T69	12668769
NA	CHEMICAL	GENE-N	11	12	On the other hand , the accumulation of chemical through the chemical-chemical synthase/gene pathway in chemical plants was 2.5-fold greater than that in WT plants .	T28	T69	12668769
NA	CHEMICAL	GENE-N	11	12	On the other hand , the accumulation of chemical through the chemical-chemical synthase/gene pathway in chemical plants was 2.5-fold greater than that in WT plants .	T29	T69	12668769
NA	CHEMICAL	GENE-N	15	12	On the other hand , the accumulation of chemical through the chemical-chemical synthase/gene pathway in chemical plants was 2.5-fold greater than that in WT plants .	T30	T69	12668769
NA	CHEMICAL	GENE-Y	20	7	Biomarkers of systemic inflammation and injuries ( gene , gene , gene , gene ) , heart oxidative stress ( chemical , gene ) and endothelial function ( gene , gene ) were analyzed after the 6th exposure .	T10	T20	23182954
NA	CHEMICAL	GENE-Y	20	9	Biomarkers of systemic inflammation and injuries ( gene , gene , gene , gene ) , heart oxidative stress ( chemical , gene ) and endothelial function ( gene , gene ) were analyzed after the 6th exposure .	T10	T21	23182954
NA	CHEMICAL	GENE-N	20	11	Biomarkers of systemic inflammation and injuries ( gene , gene , gene , gene ) , heart oxidative stress ( chemical , gene ) and endothelial function ( gene , gene ) were analyzed after the 6th exposure .	T10	T22	23182954
NA	CHEMICAL	GENE-N	20	13	Biomarkers of systemic inflammation and injuries ( gene , gene , gene , gene ) , heart oxidative stress ( chemical , gene ) and endothelial function ( gene , gene ) were analyzed after the 6th exposure .	T10	T23	23182954
NA	CHEMICAL	GENE-N	20	22	Biomarkers of systemic inflammation and injuries ( gene , gene , gene , gene ) , heart oxidative stress ( chemical , gene ) and endothelial function ( gene , gene ) were analyzed after the 6th exposure .	T10	T24	23182954
NA	CHEMICAL	GENE-Y	20	28	Biomarkers of systemic inflammation and injuries ( gene , gene , gene , gene ) , heart oxidative stress ( chemical , gene ) and endothelial function ( gene , gene ) were analyzed after the 6th exposure .	T10	T25	23182954
NA	CHEMICAL	GENE-Y	20	30	Biomarkers of systemic inflammation and injuries ( gene , gene , gene , gene ) , heart oxidative stress ( chemical , gene ) and endothelial function ( gene , gene ) were analyzed after the 6th exposure .	T10	T26	23182954
NA	CHEMICAL	GENE-Y	17	15	Results showed that PM ( 2.5 ) alone exposure could trigger the significant increase of gene , chemical , gene , gene and SBP and decrease of heart rate variability ( HRV ) , a marker of cardiac autonomic nervous system ( ANS ) function .	T2	T12	23182954
NA	CHEMICAL	GENE-N	17	19	Results showed that PM ( 2.5 ) alone exposure could trigger the significant increase of gene , chemical , gene , gene and SBP and decrease of heart rate variability ( HRV ) , a marker of cardiac autonomic nervous system ( ANS ) function .	T2	T13	23182954
NA	CHEMICAL	GENE-Y	17	21	Results showed that PM ( 2.5 ) alone exposure could trigger the significant increase of gene , chemical , gene , gene and SBP and decrease of heart rate variability ( HRV ) , a marker of cardiac autonomic nervous system ( ANS ) function .	T2	T14	23182954
CPR:3	CHEMICAL	GENE-Y	0	11	chemical plus PM ( 2.5 ) exposure , however , induced gene , gene , gene , gene and chemical increase , gene and HRV decrease significantly in a dose-response way .	T4	T15	23182954
CPR:3	CHEMICAL	GENE-Y	0	13	chemical plus PM ( 2.5 ) exposure , however , induced gene , gene , gene , gene and chemical increase , gene and HRV decrease significantly in a dose-response way .	T4	T16	23182954
CPR:3	CHEMICAL	GENE-N	0	15	chemical plus PM ( 2.5 ) exposure , however , induced gene , gene , gene , gene and chemical increase , gene and HRV decrease significantly in a dose-response way .	T4	T17	23182954
CPR:3	CHEMICAL	GENE-N	0	17	chemical plus PM ( 2.5 ) exposure , however , induced gene , gene , gene , gene and chemical increase , gene and HRV decrease significantly in a dose-response way .	T4	T18	23182954
CPR:4	CHEMICAL	GENE-N	0	22	chemical plus PM ( 2.5 ) exposure , however , induced gene , gene , gene , gene and chemical increase , gene and HRV decrease significantly in a dose-response way .	T4	T19	23182954
NA	CHEMICAL	GENE-Y	19	11	chemical plus PM ( 2.5 ) exposure , however , induced gene , gene , gene , gene and chemical increase , gene and HRV decrease significantly in a dose-response way .	T5	T15	23182954
NA	CHEMICAL	GENE-Y	19	13	chemical plus PM ( 2.5 ) exposure , however , induced gene , gene , gene , gene and chemical increase , gene and HRV decrease significantly in a dose-response way .	T5	T16	23182954
NA	CHEMICAL	GENE-N	19	15	chemical plus PM ( 2.5 ) exposure , however , induced gene , gene , gene , gene and chemical increase , gene and HRV decrease significantly in a dose-response way .	T5	T17	23182954
NA	CHEMICAL	GENE-N	19	17	chemical plus PM ( 2.5 ) exposure , however , induced gene , gene , gene , gene and chemical increase , gene and HRV decrease significantly in a dose-response way .	T5	T18	23182954
NA	CHEMICAL	GENE-N	19	22	chemical plus PM ( 2.5 ) exposure , however , induced gene , gene , gene , gene and chemical increase , gene and HRV decrease significantly in a dose-response way .	T5	T19	23182954
NA	CHEMICAL	GENE-Y	17	0	gene ( gene ) safeguards pig proximal tubular LLC-PK1 cells against reduction in gene activity induced by chemical . Megalin , a family of gene related to the gene , is a major pathway for proximal tubular chemical accumulation .	T18	T42	15777622
NA	CHEMICAL	GENE-Y	17	2	gene ( gene ) safeguards pig proximal tubular LLC-PK1 cells against reduction in gene activity induced by chemical . Megalin , a family of gene related to the gene , is a major pathway for proximal tubular chemical accumulation .	T18	T43	15777622
CPR:4	CHEMICAL	GENE-Y	17	13	gene ( gene ) safeguards pig proximal tubular LLC-PK1 cells against reduction in gene activity induced by chemical . Megalin , a family of gene related to the gene , is a major pathway for proximal tubular chemical accumulation .	T18	T44	15777622
NA	CHEMICAL	GENE-N	17	24	gene ( gene ) safeguards pig proximal tubular LLC-PK1 cells against reduction in gene activity induced by chemical . Megalin , a family of gene related to the gene , is a major pathway for proximal tubular chemical accumulation .	T18	T28	15777622
NA	CHEMICAL	GENE-N	17	26	gene ( gene ) safeguards pig proximal tubular LLC-PK1 cells against reduction in gene activity induced by chemical . Megalin , a family of gene related to the gene , is a major pathway for proximal tubular chemical accumulation .	T18	T32	15777622
NA	CHEMICAL	GENE-Y	12	0	gene ( gene ) safeguards pig proximal tubular LLC-PK1 cells against reduction in gene activity induced by chemical . Megalin , a family of gene related to the gene , is a major pathway for proximal tubular chemical accumulation .	T6	T42	15777622
NA	CHEMICAL	GENE-Y	12	2	gene ( gene ) safeguards pig proximal tubular LLC-PK1 cells against reduction in gene activity induced by chemical . Megalin , a family of gene related to the gene , is a major pathway for proximal tubular chemical accumulation .	T6	T43	15777622
NA	CHEMICAL	GENE-Y	12	13	gene ( gene ) safeguards pig proximal tubular LLC-PK1 cells against reduction in gene activity induced by chemical . Megalin , a family of gene related to the gene , is a major pathway for proximal tubular chemical accumulation .	T6	T44	15777622
CPR:9	CHEMICAL	GENE-N	12	24	gene ( gene ) safeguards pig proximal tubular LLC-PK1 cells against reduction in gene activity induced by chemical . Megalin , a family of gene related to the gene , is a major pathway for proximal tubular chemical accumulation .	T6	T28	15777622
CPR:9	CHEMICAL	GENE-N	12	26	gene ( gene ) safeguards pig proximal tubular LLC-PK1 cells against reduction in gene activity induced by chemical . Megalin , a family of gene related to the gene , is a major pathway for proximal tubular chemical accumulation .	T6	T32	15777622
CPR:4	CHEMICAL	GENE-Y	4	7	We previously reported that chemical antibiotics reduce gene-dependent chemical transport in pig proximal tubular epithelial LLC-PK1 cells in parallel with the order of their nephrotoxicity .	T9	T29	15777622
NA	CHEMICAL	GENE-Y	8	7	We previously reported that chemical antibiotics reduce gene-dependent chemical transport in pig proximal tubular epithelial LLC-PK1 cells in parallel with the order of their nephrotoxicity .	T10	T29	15777622
CPR:4	CHEMICAL	GENE-Y	8	15	In this study , using a model of chemical ( chemical ) -induced reduction in gene activity , we examined whether ligands for megalin protect LLC-PK1 cells from the chemical-induced reduction in gene activity .	T11	T30	15777622
NA	CHEMICAL	GENE-Y	8	32	In this study , using a model of chemical ( chemical ) -induced reduction in gene activity , we examined whether ligands for megalin protect LLC-PK1 cells from the chemical-induced reduction in gene activity .	T11	T31	15777622
CPR:4	CHEMICAL	GENE-Y	10	15	In this study , using a model of chemical ( chemical ) -induced reduction in gene activity , we examined whether ligands for megalin protect LLC-PK1 cells from the chemical-induced reduction in gene activity .	T12	T30	15777622
NA	CHEMICAL	GENE-Y	10	32	In this study , using a model of chemical ( chemical ) -induced reduction in gene activity , we examined whether ligands for megalin protect LLC-PK1 cells from the chemical-induced reduction in gene activity .	T12	T31	15777622
NA	CHEMICAL	GENE-Y	29	15	In this study , using a model of chemical ( chemical ) -induced reduction in gene activity , we examined whether ligands for megalin protect LLC-PK1 cells from the chemical-induced reduction in gene activity .	T13	T30	15777622
CPR:4	CHEMICAL	GENE-Y	29	32	In this study , using a model of chemical ( chemical ) -induced reduction in gene activity , we examined whether ligands for megalin protect LLC-PK1 cells from the chemical-induced reduction in gene activity .	T13	T31	15777622
NA	CHEMICAL	GENE-Y	20	9	Then the cells were treated with various concentrations of gene , gene and gene with or without 100 microg/ml of chemical , and the gene-dependent chemical ( chemical ) uptake and levels of gene expression were determined .	T14	T36	15777622
NA	CHEMICAL	GENE-Y	20	8	Then the cells were treated with various concentrations of gene , gene and gene with or without 100 microg/ml of chemical , and the gene-dependent chemical ( chemical ) uptake and levels of gene expression were determined .	T14	T37	15777622
NA	CHEMICAL	GENE-Y	20	13	Then the cells were treated with various concentrations of gene , gene and gene with or without 100 microg/ml of chemical , and the gene-dependent chemical ( chemical ) uptake and levels of gene expression were determined .	T14	T38	15777622
NA	CHEMICAL	GENE-Y	20	24	Then the cells were treated with various concentrations of gene , gene and gene with or without 100 microg/ml of chemical , and the gene-dependent chemical ( chemical ) uptake and levels of gene expression were determined .	T14	T39	15777622
NA	CHEMICAL	GENE-Y	20	33	Then the cells were treated with various concentrations of gene , gene and gene with or without 100 microg/ml of chemical , and the gene-dependent chemical ( chemical ) uptake and levels of gene expression were determined .	T14	T40	15777622
NA	CHEMICAL	GENE-Y	25	9	Then the cells were treated with various concentrations of gene , gene and gene with or without 100 microg/ml of chemical , and the gene-dependent chemical ( chemical ) uptake and levels of gene expression were determined .	T15	T36	15777622
NA	CHEMICAL	GENE-Y	25	8	Then the cells were treated with various concentrations of gene , gene and gene with or without 100 microg/ml of chemical , and the gene-dependent chemical ( chemical ) uptake and levels of gene expression were determined .	T15	T37	15777622
NA	CHEMICAL	GENE-Y	25	13	Then the cells were treated with various concentrations of gene , gene and gene with or without 100 microg/ml of chemical , and the gene-dependent chemical ( chemical ) uptake and levels of gene expression were determined .	T15	T38	15777622
CPR:9	CHEMICAL	GENE-Y	25	24	Then the cells were treated with various concentrations of gene , gene and gene with or without 100 microg/ml of chemical , and the gene-dependent chemical ( chemical ) uptake and levels of gene expression were determined .	T15	T39	15777622
NA	CHEMICAL	GENE-Y	25	33	Then the cells were treated with various concentrations of gene , gene and gene with or without 100 microg/ml of chemical , and the gene-dependent chemical ( chemical ) uptake and levels of gene expression were determined .	T15	T40	15777622
NA	CHEMICAL	GENE-Y	27	9	Then the cells were treated with various concentrations of gene , gene and gene with or without 100 microg/ml of chemical , and the gene-dependent chemical ( chemical ) uptake and levels of gene expression were determined .	T16	T36	15777622
NA	CHEMICAL	GENE-Y	27	8	Then the cells were treated with various concentrations of gene , gene and gene with or without 100 microg/ml of chemical , and the gene-dependent chemical ( chemical ) uptake and levels of gene expression were determined .	T16	T37	15777622
NA	CHEMICAL	GENE-Y	27	13	Then the cells were treated with various concentrations of gene , gene and gene with or without 100 microg/ml of chemical , and the gene-dependent chemical ( chemical ) uptake and levels of gene expression were determined .	T16	T38	15777622
CPR:9	CHEMICAL	GENE-Y	27	24	Then the cells were treated with various concentrations of gene , gene and gene with or without 100 microg/ml of chemical , and the gene-dependent chemical ( chemical ) uptake and levels of gene expression were determined .	T16	T39	15777622
NA	CHEMICAL	GENE-Y	27	33	Then the cells were treated with various concentrations of gene , gene and gene with or without 100 microg/ml of chemical , and the gene-dependent chemical ( chemical ) uptake and levels of gene expression were determined .	T16	T40	15777622
NA	CHEMICAL	GENE-Y	14	1	As a result , we demonstrated that the gene significantly protects these cells from chemical-induced reduction in chemical uptake , but neither gene nor gene does .	T17	T41	15777622
NA	CHEMICAL	GENE-Y	14	1	As a result , we demonstrated that the gene significantly protects these cells from chemical-induced reduction in chemical uptake , but neither gene nor gene does .	T17	T19	15777622
NA	CHEMICAL	GENE-Y	14	1	As a result , we demonstrated that the gene significantly protects these cells from chemical-induced reduction in chemical uptake , but neither gene nor gene does .	T17	T20	15777622
NA	CHEMICAL	GENE-Y	14	1	As a result , we demonstrated that the gene significantly protects these cells from chemical-induced reduction in chemical uptake , but neither gene nor gene does .	T1	T41	15777622
NA	CHEMICAL	GENE-Y	14	1	As a result , we demonstrated that the gene significantly protects these cells from chemical-induced reduction in chemical uptake , but neither gene nor gene does .	T1	T19	15777622
NA	CHEMICAL	GENE-Y	14	1	As a result , we demonstrated that the gene significantly protects these cells from chemical-induced reduction in chemical uptake , but neither gene nor gene does .	T1	T20	15777622
NA	CHEMICAL	GENE-Y	6	16	In accord with a rise in chemical uptake activity , the mRNA and protein levels of gene were apparently up-regulated in the presence of gene .	T2	T21	15777622
NA	CHEMICAL	GENE-Y	6	3	In accord with a rise in chemical uptake activity , the mRNA and protein levels of gene were apparently up-regulated in the presence of gene .	T2	T22	15777622
NA	CHEMICAL	GENE-Y	8	12	Furthermore , we found that the uptake of chemical is decreased by gene , and that gene showed obvious protection against the chemical-dependent chemical ( chemical ) release from LLC-PK1 cells .	T3	T23	15777622
NA	CHEMICAL	GENE-Y	8	16	Furthermore , we found that the uptake of chemical is decreased by gene , and that gene showed obvious protection against the chemical-dependent chemical ( chemical ) release from LLC-PK1 cells .	T3	T24	15777622
NA	CHEMICAL	GENE-Y	22	12	Furthermore , we found that the uptake of chemical is decreased by gene , and that gene showed obvious protection against the chemical-dependent chemical ( chemical ) release from LLC-PK1 cells .	T4	T23	15777622
NA	CHEMICAL	GENE-Y	22	16	Furthermore , we found that the uptake of chemical is decreased by gene , and that gene showed obvious protection against the chemical-dependent chemical ( chemical ) release from LLC-PK1 cells .	T4	T24	15777622
NA	CHEMICAL	GENE-Y	23	12	Furthermore , we found that the uptake of chemical is decreased by gene , and that gene showed obvious protection against the chemical-dependent chemical ( chemical ) release from LLC-PK1 cells .	T5	T23	15777622
NA	CHEMICAL	GENE-Y	23	16	Furthermore , we found that the uptake of chemical is decreased by gene , and that gene showed obvious protection against the chemical-dependent chemical ( chemical ) release from LLC-PK1 cells .	T5	T24	15777622
NA	CHEMICAL	GENE-Y	25	12	Furthermore , we found that the uptake of chemical is decreased by gene , and that gene showed obvious protection against the chemical-dependent chemical ( chemical ) release from LLC-PK1 cells .	T7	T23	15777622
NA	CHEMICAL	GENE-Y	25	16	Furthermore , we found that the uptake of chemical is decreased by gene , and that gene showed obvious protection against the chemical-dependent chemical ( chemical ) release from LLC-PK1 cells .	T7	T24	15777622
CPR:5	CHEMICAL	GENE-N	8	8	OBJECTIVES : The aim of this study was to determine whether cocaine 's sympathomimetic actions can be reversed by a potent centrally acting gene ( gene ) agonist ( chemical ) .	T6	T15	17692748
CPR:5	CHEMICAL	GENE-N	8	25	OBJECTIVES : The aim of this study was to determine whether cocaine 's sympathomimetic actions can be reversed by a potent centrally acting gene ( gene ) agonist ( chemical ) .	T6	T17	17692748
NA	CHEMICAL	GENE-Y	0	24	chemical was effective in blocking these sympathomimetic actions of chemical even in all 7 subjects who were homozygous for the Del322-325 polymorphism in the gene , a loss-of-function mutation that is highly enriched in blacks .	T2	T14	17692748
NA	CHEMICAL	GENE-Y	3	24	chemical was effective in blocking these sympathomimetic actions of chemical even in all 7 subjects who were homozygous for the Del322-325 polymorphism in the gene , a loss-of-function mutation that is highly enriched in blacks .	T3	T14	17692748
NA	CHEMICAL	GENE-Y	12	14	CONCLUSIONS : The data advance the novel hypothesis that central sympatholysis with chemical constitutes a highly effective countermeasure for cocaine 's sympathomimetic actions on the human cardiovascular system , even in individuals carrying the geneDel322-325 polymorphism .	T4	T16	17692748
NA	CHEMICAL	GENE-Y	2	2	Probing for a hydrophobic a binding register in gene with chemical .	T9	T13	15336276
NA	CHEMICAL	GENE-Y	17	17	To explore for the existence of an auxiliary hydrophobic binding register remote from the active site of gene a series of chemical derivatives of chemical were synthesized and evaluated for their inhibitory potencies against gene .	T1	T10	15336276
CPR:4	CHEMICAL	GENE-Y	17	34	To explore for the existence of an auxiliary hydrophobic binding register remote from the active site of gene a series of chemical derivatives of chemical were synthesized and evaluated for their inhibitory potencies against gene .	T1	T12	15336276
NA	CHEMICAL	GENE-Y	18	17	To explore for the existence of an auxiliary hydrophobic binding register remote from the active site of gene a series of chemical derivatives of chemical were synthesized and evaluated for their inhibitory potencies against gene .	T2	T10	15336276
CPR:4	CHEMICAL	GENE-Y	18	34	To explore for the existence of an auxiliary hydrophobic binding register remote from the active site of gene a series of chemical derivatives of chemical were synthesized and evaluated for their inhibitory potencies against gene .	T2	T12	15336276
NA	CHEMICAL	GENE-N	3	12	Apoptosis initiation of chemical in SGC-7901 gastric carcinoma cancer cells via a gene-gene pathway .	T10	T20	23100158
NA	CHEMICAL	GENE-N	3	12	Apoptosis initiation of chemical in SGC-7901 gastric carcinoma cancer cells via a gene-gene pathway .	T10	T21	23100158
NA	CHEMICAL	GENE-N	5	26	To investigate the effects of chemical on apoptosis initiation and its possible mechanisms of action , we qualified cell apoptosis , proteins related to apoptosis and a chemical 3-kinase ( gene ) -gene pathway in human gastric adenocarcinoma cancer SGC-7901 cells .	T3	T11	23100158
NA	CHEMICAL	GENE-N	5	30	To investigate the effects of chemical on apoptosis initiation and its possible mechanisms of action , we qualified cell apoptosis , proteins related to apoptosis and a chemical 3-kinase ( gene ) -gene pathway in human gastric adenocarcinoma cancer SGC-7901 cells .	T3	T12	23100158
NA	CHEMICAL	GENE-N	5	32	To investigate the effects of chemical on apoptosis initiation and its possible mechanisms of action , we qualified cell apoptosis , proteins related to apoptosis and a chemical 3-kinase ( gene ) -gene pathway in human gastric adenocarcinoma cancer SGC-7901 cells .	T3	T13	23100158
NA	CHEMICAL	GENE-N	23	26	To investigate the effects of chemical on apoptosis initiation and its possible mechanisms of action , we qualified cell apoptosis , proteins related to apoptosis and a chemical 3-kinase ( gene ) -gene pathway in human gastric adenocarcinoma cancer SGC-7901 cells .	T4	T11	23100158
NA	CHEMICAL	GENE-N	23	30	To investigate the effects of chemical on apoptosis initiation and its possible mechanisms of action , we qualified cell apoptosis , proteins related to apoptosis and a chemical 3-kinase ( gene ) -gene pathway in human gastric adenocarcinoma cancer SGC-7901 cells .	T4	T12	23100158
NA	CHEMICAL	GENE-N	23	32	To investigate the effects of chemical on apoptosis initiation and its possible mechanisms of action , we qualified cell apoptosis , proteins related to apoptosis and a chemical 3-kinase ( gene ) -gene pathway in human gastric adenocarcinoma cancer SGC-7901 cells .	T4	T13	23100158
NA	CHEMICAL	GENE-Y	4	7	The results demonstrated that chemical-induced apoptosis in a dose-dependent manner in SGC-7901 cells treated with chemical ( 25 , 50 , 100 and 200 μmol/L ) for 24 h. chemical was also shown to induce the expression of cleaved-gene and inhibit gene expression in SGC-7901 cells in a dose-dependent manner .	T5	T14	23100158
NA	CHEMICAL	GENE-Y	4	41	The results demonstrated that chemical-induced apoptosis in a dose-dependent manner in SGC-7901 cells treated with chemical ( 25 , 50 , 100 and 200 μmol/L ) for 24 h. chemical was also shown to induce the expression of cleaved-gene and inhibit gene expression in SGC-7901 cells in a dose-dependent manner .	T5	T15	23100158
NA	CHEMICAL	GENE-Y	15	7	The results demonstrated that chemical-induced apoptosis in a dose-dependent manner in SGC-7901 cells treated with chemical ( 25 , 50 , 100 and 200 μmol/L ) for 24 h. chemical was also shown to induce the expression of cleaved-gene and inhibit gene expression in SGC-7901 cells in a dose-dependent manner .	T6	T14	23100158
NA	CHEMICAL	GENE-Y	15	41	The results demonstrated that chemical-induced apoptosis in a dose-dependent manner in SGC-7901 cells treated with chemical ( 25 , 50 , 100 and 200 μmol/L ) for 24 h. chemical was also shown to induce the expression of cleaved-gene and inhibit gene expression in SGC-7901 cells in a dose-dependent manner .	T6	T15	23100158
CPR:3	CHEMICAL	GENE-Y	29	7	The results demonstrated that chemical-induced apoptosis in a dose-dependent manner in SGC-7901 cells treated with chemical ( 25 , 50 , 100 and 200 μmol/L ) for 24 h. chemical was also shown to induce the expression of cleaved-gene and inhibit gene expression in SGC-7901 cells in a dose-dependent manner .	T7	T14	23100158
CPR:4	CHEMICAL	GENE-Y	29	41	The results demonstrated that chemical-induced apoptosis in a dose-dependent manner in SGC-7901 cells treated with chemical ( 25 , 50 , 100 and 200 μmol/L ) for 24 h. chemical was also shown to induce the expression of cleaved-gene and inhibit gene expression in SGC-7901 cells in a dose-dependent manner .	T7	T15	23100158
CPR:4	CHEMICAL	GENE-N	15	5	The significantly decreased levels of gene and gene expression were observed in SGC-7901 cells after chemical treatments in a time- and dose-dependent manner ( P < 0.01 ) .	T8	T16	23100158
CPR:4	CHEMICAL	GENE-N	15	7	The significantly decreased levels of gene and gene expression were observed in SGC-7901 cells after chemical treatments in a time- and dose-dependent manner ( P < 0.01 ) .	T8	T17	23100158
NA	CHEMICAL	GENE-N	9	15	Thus , the apoptosis induction in SGC-7901 cells by chemical may be regulated through a gene-gene pathway .	T9	T18	23100158
NA	CHEMICAL	GENE-N	9	15	Thus , the apoptosis induction in SGC-7901 cells by chemical may be regulated through a gene-gene pathway .	T9	T19	23100158
NA	CHEMICAL	GENE-N	7	8	We examined the effect of inhibition of chemical/chemical exchange ( gene ) on duodenal bicarbonate secretion ( DBS ) in rats to further understand DBS regulation .	T10	T35	12881227
NA	CHEMICAL	GENE-N	7	10	We examined the effect of inhibition of chemical/chemical exchange ( gene ) on duodenal bicarbonate secretion ( DBS ) in rats to further understand DBS regulation .	T10	T40	12881227
NA	CHEMICAL	GENE-N	7	8	We examined the effect of inhibition of chemical/chemical exchange ( gene ) on duodenal bicarbonate secretion ( DBS ) in rats to further understand DBS regulation .	T12	T35	12881227
NA	CHEMICAL	GENE-N	7	10	We examined the effect of inhibition of chemical/chemical exchange ( gene ) on duodenal bicarbonate secretion ( DBS ) in rats to further understand DBS regulation .	T12	T40	12881227
CPR:4	CHEMICAL	GENE-N	0	14	chemical ( 50 microM ; chemical ) , a concentration that selectively inhibits the gene isoforms gene and gene , but not gene , did not affect DBS .	T8	T31	12881227
CPR:4	CHEMICAL	GENE-Y	0	16	chemical ( 50 microM ; chemical ) , a concentration that selectively inhibits the gene isoforms gene and gene , but not gene , did not affect DBS .	T8	T32	12881227
CPR:4	CHEMICAL	GENE-Y	0	18	chemical ( 50 microM ; chemical ) , a concentration that selectively inhibits the gene isoforms gene and gene , but not gene , did not affect DBS .	T8	T33	12881227
CPR:4	CHEMICAL	GENE-Y	0	22	chemical ( 50 microM ; chemical ) , a concentration that selectively inhibits the gene isoforms gene and gene , but not gene , did not affect DBS .	T8	T34	12881227
CPR:4	CHEMICAL	GENE-N	5	14	chemical ( 50 microM ; chemical ) , a concentration that selectively inhibits the gene isoforms gene and gene , but not gene , did not affect DBS .	T9	T31	12881227
CPR:4	CHEMICAL	GENE-Y	5	16	chemical ( 50 microM ; chemical ) , a concentration that selectively inhibits the gene isoforms gene and gene , but not gene , did not affect DBS .	T9	T32	12881227
CPR:4	CHEMICAL	GENE-Y	5	18	chemical ( 50 microM ; chemical ) , a concentration that selectively inhibits the gene isoforms gene and gene , but not gene , did not affect DBS .	T9	T33	12881227
CPR:4	CHEMICAL	GENE-Y	5	22	chemical ( 50 microM ; chemical ) , a concentration that selectively inhibits the gene isoforms gene and gene , but not gene , did not affect DBS .	T9	T34	12881227
CPR:4	CHEMICAL	GENE-Y	4	11	Nevertheless , 3 mM chemical , a higher concentration that inhibits gene , gene , and gene , significantly increased DBS .	T11	T36	12881227
CPR:4	CHEMICAL	GENE-Y	4	13	Nevertheless , 3 mM chemical , a higher concentration that inhibits gene , gene , and gene , significantly increased DBS .	T11	T37	12881227
CPR:4	CHEMICAL	GENE-Y	4	2	Nevertheless , 3 mM chemical , a higher concentration that inhibits gene , gene , and gene , significantly increased DBS .	T11	T38	12881227
CPR:4	CHEMICAL	GENE-Y	2	10	Moreover , chemical and chemical , both specific inhibitors of gene only , or perfusion with chemical-free solutions , dose dependently increased DBS , as measured by pH-stat and chemical-sensitive electrode , without affecting intracellular pH .	T13	T39	12881227
CPR:4	CHEMICAL	GENE-Y	4	10	Moreover , chemical and chemical , both specific inhibitors of gene only , or perfusion with chemical-free solutions , dose dependently increased DBS , as measured by pH-stat and chemical-sensitive electrode , without affecting intracellular pH .	T14	T39	12881227
NA	CHEMICAL	GENE-Y	16	10	Moreover , chemical and chemical , both specific inhibitors of gene only , or perfusion with chemical-free solutions , dose dependently increased DBS , as measured by pH-stat and chemical-sensitive electrode , without affecting intracellular pH .	T15	T39	12881227
NA	CHEMICAL	GENE-Y	29	10	Moreover , chemical and chemical , both specific inhibitors of gene only , or perfusion with chemical-free solutions , dose dependently increased DBS , as measured by pH-stat and chemical-sensitive electrode , without affecting intracellular pH .	T16	T39	12881227
CPR:4	CHEMICAL	GENE-Y	8	13	Nevertheless , coperfusion with 0.1 and 0.3 mM chemical , which inhibits the gene ( gene ) , dose dependently inhibited chemical-induced DBS .	T20	T41	12881227
CPR:4	CHEMICAL	GENE-Y	8	15	Nevertheless , coperfusion with 0.1 and 0.3 mM chemical , which inhibits the gene ( gene ) , dose dependently inhibited chemical-induced DBS .	T20	T42	12881227
NA	CHEMICAL	GENE-Y	21	13	Nevertheless , coperfusion with 0.1 and 0.3 mM chemical , which inhibits the gene ( gene ) , dose dependently inhibited chemical-induced DBS .	T1	T41	12881227
NA	CHEMICAL	GENE-Y	21	15	Nevertheless , coperfusion with 0.1 and 0.3 mM chemical , which inhibits the gene ( gene ) , dose dependently inhibited chemical-induced DBS .	T1	T42	12881227
NA	CHEMICAL	GENE-Y	6	6	In conclusion , only specific apical gene inhibition increased DBS , whereas chemical synthesis , chemical-chemical- cotransporter activation , or intracellular chemical- formation by chemical anhydrase was not involved .	T2	T21	12881227
NA	CHEMICAL	GENE-Y	6	16	In conclusion , only specific apical gene inhibition increased DBS , whereas chemical synthesis , chemical-chemical- cotransporter activation , or intracellular chemical- formation by chemical anhydrase was not involved .	T2	T22	12881227
NA	CHEMICAL	GENE-N	6	25	In conclusion , only specific apical gene inhibition increased DBS , whereas chemical synthesis , chemical-chemical- cotransporter activation , or intracellular chemical- formation by chemical anhydrase was not involved .	T2	T23	12881227
NA	CHEMICAL	GENE-Y	15	6	In conclusion , only specific apical gene inhibition increased DBS , whereas chemical synthesis , chemical-chemical- cotransporter activation , or intracellular chemical- formation by chemical anhydrase was not involved .	T3	T21	12881227
NA	CHEMICAL	GENE-Y	15	16	In conclusion , only specific apical gene inhibition increased DBS , whereas chemical synthesis , chemical-chemical- cotransporter activation , or intracellular chemical- formation by chemical anhydrase was not involved .	T3	T22	12881227
NA	CHEMICAL	GENE-N	15	25	In conclusion , only specific apical gene inhibition increased DBS , whereas chemical synthesis , chemical-chemical- cotransporter activation , or intracellular chemical- formation by chemical anhydrase was not involved .	T3	T23	12881227
NA	CHEMICAL	GENE-Y	15	6	In conclusion , only specific apical gene inhibition increased DBS , whereas chemical synthesis , chemical-chemical- cotransporter activation , or intracellular chemical- formation by chemical anhydrase was not involved .	T4	T21	12881227
NA	CHEMICAL	GENE-Y	15	16	In conclusion , only specific apical gene inhibition increased DBS , whereas chemical synthesis , chemical-chemical- cotransporter activation , or intracellular chemical- formation by chemical anhydrase was not involved .	T4	T22	12881227
NA	CHEMICAL	GENE-N	15	25	In conclusion , only specific apical gene inhibition increased DBS , whereas chemical synthesis , chemical-chemical- cotransporter activation , or intracellular chemical- formation by chemical anhydrase was not involved .	T4	T23	12881227
NA	CHEMICAL	GENE-Y	21	6	In conclusion , only specific apical gene inhibition increased DBS , whereas chemical synthesis , chemical-chemical- cotransporter activation , or intracellular chemical- formation by chemical anhydrase was not involved .	T5	T21	12881227
NA	CHEMICAL	GENE-Y	21	16	In conclusion , only specific apical gene inhibition increased DBS , whereas chemical synthesis , chemical-chemical- cotransporter activation , or intracellular chemical- formation by chemical anhydrase was not involved .	T5	T22	12881227
CPR:9	CHEMICAL	GENE-N	21	25	In conclusion , only specific apical gene inhibition increased DBS , whereas chemical synthesis , chemical-chemical- cotransporter activation , or intracellular chemical- formation by chemical anhydrase was not involved .	T5	T23	12881227
NA	CHEMICAL	GENE-Y	24	6	In conclusion , only specific apical gene inhibition increased DBS , whereas chemical synthesis , chemical-chemical- cotransporter activation , or intracellular chemical- formation by chemical anhydrase was not involved .	T6	T21	12881227
NA	CHEMICAL	GENE-Y	24	16	In conclusion , only specific apical gene inhibition increased DBS , whereas chemical synthesis , chemical-chemical- cotransporter activation , or intracellular chemical- formation by chemical anhydrase was not involved .	T6	T22	12881227
NA	CHEMICAL	GENE-N	24	25	In conclusion , only specific apical gene inhibition increased DBS , whereas chemical synthesis , chemical-chemical- cotransporter activation , or intracellular chemical- formation by chemical anhydrase was not involved .	T6	T23	12881227
NA	CHEMICAL	GENE-Y	0	2	chemical , gene gene polymorphism , and the risk of nonfatal myocardial infarction .	T17	T23	17284757
NA	CHEMICAL	GENE-Y	12	2	BACKGROUND : gene ( gene ) is the rate-limiting step in the chemical ( chemical ) biosynthetic pathway .	T13	T19	17284757
NA	CHEMICAL	GENE-Y	12	4	BACKGROUND : gene ( gene ) is the rate-limiting step in the chemical ( chemical ) biosynthetic pathway .	T13	T22	17284757
NA	CHEMICAL	GENE-Y	2	2	BACKGROUND : gene ( gene ) is the rate-limiting step in the chemical ( chemical ) biosynthetic pathway .	T1	T19	17284757
NA	CHEMICAL	GENE-Y	2	4	BACKGROUND : gene ( gene ) is the rate-limiting step in the chemical ( chemical ) biosynthetic pathway .	T1	T22	17284757
CPR:9	CHEMICAL	GENE-Y	21	18	OBJECTIVE : The aim was to test whether the common deletion [ T/- ] in the promoter of gene affects the chemical biosynthetic pathway and consequently modifies the effect of chemical ( chemical ) on myocardial infarction ( MI ) .	T9	T21	17284757
CPR:9	CHEMICAL	GENE-Y	30	18	OBJECTIVE : The aim was to test whether the common deletion [ T/- ] in the promoter of gene affects the chemical biosynthetic pathway and consequently modifies the effect of chemical ( chemical ) on myocardial infarction ( MI ) .	T10	T21	17284757
CPR:9	CHEMICAL	GENE-Y	32	18	OBJECTIVE : The aim was to test whether the common deletion [ T/- ] in the promoter of gene affects the chemical biosynthetic pathway and consequently modifies the effect of chemical ( chemical ) on myocardial infarction ( MI ) .	T11	T21	17284757
NA	CHEMICAL	GENE-Y	18	1	The gene deletion was not associated with MI and did not significantly modify the association between adipose tissue chemical and the risk of MI .	T3	T18	17284757
NA	CHEMICAL	GENE-Y	10	3	CONCLUSIONS : The gene deletion may prevent the conversion of chemical into chemical .	T4	T20	17284757
NA	CHEMICAL	GENE-Y	12	3	CONCLUSIONS : The gene deletion may prevent the conversion of chemical into chemical .	T5	T20	17284757
NA	CHEMICAL	GENE-Y	9	12	It remains to be fully elucidated whether use of chemical , an gene sensitizer , and/or chemical , gene secretagogues , affect cancer incidence in subjects with T2DM .	T5	T14	23419783
NA	CHEMICAL	GENE-Y	9	18	It remains to be fully elucidated whether use of chemical , an gene sensitizer , and/or chemical , gene secretagogues , affect cancer incidence in subjects with T2DM .	T5	T15	23419783
NA	CHEMICAL	GENE-Y	16	12	It remains to be fully elucidated whether use of chemical , an gene sensitizer , and/or chemical , gene secretagogues , affect cancer incidence in subjects with T2DM .	T6	T14	23419783
NA	CHEMICAL	GENE-Y	16	18	It remains to be fully elucidated whether use of chemical , an gene sensitizer , and/or chemical , gene secretagogues , affect cancer incidence in subjects with T2DM .	T6	T15	23419783
NA	CHEMICAL	GENE-Y	1	4	Adolescence chemical treatment in a rodent model of attention deficit/hyperactivity disorder : chemical transporter function and cellular distribution in adulthood .	T16	T28	23623751
NA	CHEMICAL	GENE-Y	3	4	Adolescence chemical treatment in a rodent model of attention deficit/hyperactivity disorder : chemical transporter function and cellular distribution in adulthood .	T15	T28	23623751
CPR:4	CHEMICAL	GENE-N	0	2	chemical , an inhibitor of chemical and chemical transporters ( gene and gene , respectively ) , is a standard treatment for ADHD .	T1	T21	23623751
CPR:4	CHEMICAL	GENE-Y	0	10	chemical , an inhibitor of chemical and chemical transporters ( gene and gene , respectively ) , is a standard treatment for ADHD .	T1	T24	23623751
CPR:4	CHEMICAL	GENE-Y	0	12	chemical , an inhibitor of chemical and chemical transporters ( gene and gene , respectively ) , is a standard treatment for ADHD .	T1	T25	23623751
NA	CHEMICAL	GENE-N	5	2	chemical , an inhibitor of chemical and chemical transporters ( gene and gene , respectively ) , is a standard treatment for ADHD .	T7	T21	23623751
NA	CHEMICAL	GENE-Y	5	10	chemical , an inhibitor of chemical and chemical transporters ( gene and gene , respectively ) , is a standard treatment for ADHD .	T7	T24	23623751
NA	CHEMICAL	GENE-Y	5	12	chemical , an inhibitor of chemical and chemical transporters ( gene and gene , respectively ) , is a standard treatment for ADHD .	T7	T25	23623751
NA	CHEMICAL	GENE-N	7	2	chemical , an inhibitor of chemical and chemical transporters ( gene and gene , respectively ) , is a standard treatment for ADHD .	T8	T21	23623751
NA	CHEMICAL	GENE-Y	7	10	chemical , an inhibitor of chemical and chemical transporters ( gene and gene , respectively ) , is a standard treatment for ADHD .	T8	T24	23623751
NA	CHEMICAL	GENE-Y	7	12	chemical , an inhibitor of chemical and chemical transporters ( gene and gene , respectively ) , is a standard treatment for ADHD .	T8	T25	23623751
NA	CHEMICAL	GENE-Y	5	19	Our previous results showed that chemical treatment in adolescent SHR enhanced chemical self-administration during adulthood , and alterations in gene function in prefrontal cortex play a role in this response .	T11	T26	23623751
NA	CHEMICAL	GENE-Y	7	19	Our previous results showed that chemical treatment in adolescent SHR enhanced chemical self-administration during adulthood , and alterations in gene function in prefrontal cortex play a role in this response .	T12	T26	23623751
CPR:3	CHEMICAL	GENE-Y	0	2	chemical increased gene Vmax in SHR mPFC and decreased gene Vmax in WKY OFC .	T3	T17	23623751
CPR:4	CHEMICAL	GENE-Y	0	9	chemical increased gene Vmax in SHR mPFC and decreased gene Vmax in WKY OFC .	T3	T18	23623751
CPR:4	CHEMICAL	GENE-Y	2	4	Also , chemical decreased gene Km in WIS OFC .	T4	T19	23623751
NA	CHEMICAL	GENE-Y	2	6	Further , chemical did not alter gene cellular localization , indicating that chemical treatment during adolescence regulated gene function in SHR mPFC in a trafficking-independent manner .	T5	T20	23623751
NA	CHEMICAL	GENE-Y	2	17	Further , chemical did not alter gene cellular localization , indicating that chemical treatment during adolescence regulated gene function in SHR mPFC in a trafficking-independent manner .	T5	T22	23623751
NA	CHEMICAL	GENE-Y	12	6	Further , chemical did not alter gene cellular localization , indicating that chemical treatment during adolescence regulated gene function in SHR mPFC in a trafficking-independent manner .	T6	T20	23623751
NA	CHEMICAL	GENE-Y	12	17	Further , chemical did not alter gene cellular localization , indicating that chemical treatment during adolescence regulated gene function in SHR mPFC in a trafficking-independent manner .	T6	T22	23623751
NA	CHEMICAL	GENE-Y	2	4	Effect of chemical on gene in human aortic smooth muscle cells .	T27	T47	15963471
CPR:3	CHEMICAL	GENE-Y	0	10	chemical are a new class of anti-diabetic agents which increase gene sensitivity by binding to the gene ( gene ) and stimulating the expression of gene-responsive genes involved in chemical and lipid metabolism .	T1	T44	15963471
NA	CHEMICAL	GENE-Y	0	2	chemical are a new class of anti-diabetic agents which increase gene sensitivity by binding to the gene ( gene ) and stimulating the expression of gene-responsive genes involved in chemical and lipid metabolism .	T1	T30	15963471
NA	CHEMICAL	GENE-Y	0	2	chemical are a new class of anti-diabetic agents which increase gene sensitivity by binding to the gene ( gene ) and stimulating the expression of gene-responsive genes involved in chemical and lipid metabolism .	T1	T36	15963471
CPR:3	CHEMICAL	GENE-Y	0	25	chemical are a new class of anti-diabetic agents which increase gene sensitivity by binding to the gene ( gene ) and stimulating the expression of gene-responsive genes involved in chemical and lipid metabolism .	T1	T40	15963471
NA	CHEMICAL	GENE-Y	29	10	chemical are a new class of anti-diabetic agents which increase gene sensitivity by binding to the gene ( gene ) and stimulating the expression of gene-responsive genes involved in chemical and lipid metabolism .	T17	T44	15963471
NA	CHEMICAL	GENE-Y	29	2	chemical are a new class of anti-diabetic agents which increase gene sensitivity by binding to the gene ( gene ) and stimulating the expression of gene-responsive genes involved in chemical and lipid metabolism .	T17	T30	15963471
NA	CHEMICAL	GENE-Y	29	2	chemical are a new class of anti-diabetic agents which increase gene sensitivity by binding to the gene ( gene ) and stimulating the expression of gene-responsive genes involved in chemical and lipid metabolism .	T17	T36	15963471
NA	CHEMICAL	GENE-Y	29	25	chemical are a new class of anti-diabetic agents which increase gene sensitivity by binding to the gene ( gene ) and stimulating the expression of gene-responsive genes involved in chemical and lipid metabolism .	T17	T40	15963471
NA	CHEMICAL	GENE-Y	8	17	The present study studied the effects of three chemical , chemical , chemical and chemical , on gene in the human aortic smooth muscle cells ( HASMCs ) .	T18	T43	15963471
NA	CHEMICAL	GENE-Y	10	17	The present study studied the effects of three chemical , chemical , chemical and chemical , on gene in the human aortic smooth muscle cells ( HASMCs ) .	T19	T43	15963471
NA	CHEMICAL	GENE-Y	12	17	The present study studied the effects of three chemical , chemical , chemical and chemical , on gene in the human aortic smooth muscle cells ( HASMCs ) .	T20	T43	15963471
NA	CHEMICAL	GENE-Y	14	17	The present study studied the effects of three chemical , chemical , chemical and chemical , on gene in the human aortic smooth muscle cells ( HASMCs ) .	T21	T43	15963471
NA	CHEMICAL	GENE-Y	6	11	Although incubating HASMCs for 48h with chemical had no effect on gene mRNA and protein levels , chemical acutely inhibited chemical uptake and chemical binding of HASMCs with IC50 values of 2.35+/-0.35 and 3.99+/-0.57microM , respectively .	T22	T45	15963471
NA	CHEMICAL	GENE-Y	10	11	Although incubating HASMCs for 48h with chemical had no effect on gene mRNA and protein levels , chemical acutely inhibited chemical uptake and chemical binding of HASMCs with IC50 values of 2.35+/-0.35 and 3.99+/-0.57microM , respectively .	T23	T45	15963471
NA	CHEMICAL	GENE-Y	8	11	Although incubating HASMCs for 48h with chemical had no effect on gene mRNA and protein levels , chemical acutely inhibited chemical uptake and chemical binding of HASMCs with IC50 values of 2.35+/-0.35 and 3.99+/-0.57microM , respectively .	T24	T45	15963471
NA	CHEMICAL	GENE-Y	23	11	Although incubating HASMCs for 48h with chemical had no effect on gene mRNA and protein levels , chemical acutely inhibited chemical uptake and chemical binding of HASMCs with IC50 values of 2.35+/-0.35 and 3.99+/-0.57microM , respectively .	T25	T45	15963471
NA	CHEMICAL	GENE-Y	3	5	The effect of chemical on gene was gene-independent and kinetic studies revealed that chemical was a competitive inhibitor of gene .	T26	T46	15963471
NA	CHEMICAL	GENE-Y	3	7	The effect of chemical on gene was gene-independent and kinetic studies revealed that chemical was a competitive inhibitor of gene .	T26	T28	15963471
NA	CHEMICAL	GENE-Y	3	19	The effect of chemical on gene was gene-independent and kinetic studies revealed that chemical was a competitive inhibitor of gene .	T26	T29	15963471
NA	CHEMICAL	GENE-Y	3	5	The effect of chemical on gene was gene-independent and kinetic studies revealed that chemical was a competitive inhibitor of gene .	T2	T46	15963471
NA	CHEMICAL	GENE-Y	3	7	The effect of chemical on gene was gene-independent and kinetic studies revealed that chemical was a competitive inhibitor of gene .	T2	T28	15963471
CPR:4	CHEMICAL	GENE-Y	3	19	The effect of chemical on gene was gene-independent and kinetic studies revealed that chemical was a competitive inhibitor of gene .	T2	T29	15963471
CPR:4	CHEMICAL	GENE-Y	5	14	The difference in structure of chemical did not account for its inhibitory effect on gene because chemical did not inhibit chemical uptake by HASMCs .	T10	T31	15963471
NA	CHEMICAL	GENE-Y	16	14	The difference in structure of chemical did not account for its inhibitory effect on gene because chemical did not inhibit chemical uptake by HASMCs .	T11	T31	15963471
NA	CHEMICAL	GENE-Y	2	14	The difference in structure of chemical did not account for its inhibitory effect on gene because chemical did not inhibit chemical uptake by HASMCs .	T12	T31	15963471
NA	CHEMICAL	GENE-N	12	2	Using the gene deficient PK15NTD cells stably expressing gene and gene , it was found that chemical inhibited gene but had no effect on gene .	T13	T32	15963471
NA	CHEMICAL	GENE-Y	12	8	Using the gene deficient PK15NTD cells stably expressing gene and gene , it was found that chemical inhibited gene but had no effect on gene .	T13	T33	15963471
NA	CHEMICAL	GENE-Y	12	10	Using the gene deficient PK15NTD cells stably expressing gene and gene , it was found that chemical inhibited gene but had no effect on gene .	T13	T34	15963471
CPR:4	CHEMICAL	GENE-Y	12	18	Using the gene deficient PK15NTD cells stably expressing gene and gene , it was found that chemical inhibited gene but had no effect on gene .	T13	T35	15963471
NA	CHEMICAL	GENE-Y	12	24	Using the gene deficient PK15NTD cells stably expressing gene and gene , it was found that chemical inhibited gene but had no effect on gene .	T13	T37	15963471
CPR:4	CHEMICAL	GENE-Y	4	18	From these results , it is suggested that chemical may enhance the vasodilatory effect of chemical by inhibiting gene .	T14	T38	15963471
NA	CHEMICAL	GENE-Y	15	18	From these results , it is suggested that chemical may enhance the vasodilatory effect of chemical by inhibiting gene .	T15	T38	15963471
NA	CHEMICAL	GENE-N	2	6	Dynamics of chemical rebinding to the gene from bacterial pathogens .	T25	T48	16690332
NA	CHEMICAL	GENE-N	25	12	Some Gram-positive bacterial pathogens harbor a gene that encodes a protein ( gene , gene ) with striking sequence identity to the gene of mammalian chemical synthases ( chemicalS ) .	T23	T46	16690332
NA	CHEMICAL	GENE-N	25	10	Some Gram-positive bacterial pathogens harbor a gene that encodes a protein ( gene , gene ) with striking sequence identity to the gene of mammalian chemical synthases ( chemicalS ) .	T23	T47	16690332
NA	CHEMICAL	GENE-N	25	5	Some Gram-positive bacterial pathogens harbor a gene that encodes a protein ( gene , gene ) with striking sequence identity to the gene of mammalian chemical synthases ( chemicalS ) .	T23	T34	16690332
NA	CHEMICAL	GENE-N	25	5	Some Gram-positive bacterial pathogens harbor a gene that encodes a protein ( gene , gene ) with striking sequence identity to the gene of mammalian chemical synthases ( chemicalS ) .	T23	T36	16690332
NA	CHEMICAL	GENE-N	28	12	Some Gram-positive bacterial pathogens harbor a gene that encodes a protein ( gene , gene ) with striking sequence identity to the gene of mammalian chemical synthases ( chemicalS ) .	T15	T46	16690332
NA	CHEMICAL	GENE-N	28	10	Some Gram-positive bacterial pathogens harbor a gene that encodes a protein ( gene , gene ) with striking sequence identity to the gene of mammalian chemical synthases ( chemicalS ) .	T15	T47	16690332
NA	CHEMICAL	GENE-N	28	5	Some Gram-positive bacterial pathogens harbor a gene that encodes a protein ( gene , gene ) with striking sequence identity to the gene of mammalian chemical synthases ( chemicalS ) .	T15	T34	16690332
NA	CHEMICAL	GENE-N	28	5	Some Gram-positive bacterial pathogens harbor a gene that encodes a protein ( gene , gene ) with striking sequence identity to the gene of mammalian chemical synthases ( chemicalS ) .	T15	T36	16690332
NA	CHEMICAL	GENE-N	5	9	However , they lack the chemical-terminal and the chemical motif participating to the stability of an active dimer in the mammalian isoforms .	T16	T38	16690332
NA	CHEMICAL	GENE-N	8	9	However , they lack the chemical-terminal and the chemical motif participating to the stability of an active dimer in the mammalian isoforms .	T17	T38	16690332
NA	CHEMICAL	GENE-N	18	4	The unique properties of gene make it an excellent model system for probing how the heme environment tunes chemical dynamics and for comparing it to the gene ( echemicalS ( HD ) ) using ultrafast transient spectroscopy .	T18	T39	16690332
NA	CHEMICAL	GENE-N	18	26	The unique properties of gene make it an excellent model system for probing how the heme environment tunes chemical dynamics and for comparing it to the gene ( echemicalS ( HD ) ) using ultrafast transient spectroscopy .	T18	T40	16690332
NA	CHEMICAL	GENE-N	18	27	The unique properties of gene make it an excellent model system for probing how the heme environment tunes chemical dynamics and for comparing it to the gene ( echemicalS ( HD ) ) using ultrafast transient spectroscopy .	T18	T41	16690332
NA	CHEMICAL	GENE-N	28	4	The unique properties of gene make it an excellent model system for probing how the heme environment tunes chemical dynamics and for comparing it to the gene ( echemicalS ( HD ) ) using ultrafast transient spectroscopy .	T19	T39	16690332
NA	CHEMICAL	GENE-N	28	26	The unique properties of gene make it an excellent model system for probing how the heme environment tunes chemical dynamics and for comparing it to the gene ( echemicalS ( HD ) ) using ultrafast transient spectroscopy .	T19	T40	16690332
NA	CHEMICAL	GENE-N	28	27	The unique properties of gene make it an excellent model system for probing how the heme environment tunes chemical dynamics and for comparing it to the gene ( echemicalS ( HD ) ) using ultrafast transient spectroscopy .	T19	T41	16690332
NA	CHEMICAL	GENE-N	0	3	chemical rebinding in gene from Staphylococcus aureus ( gene ) is faster than that measured for either Bacillus anthracis ( gene ) or for gene in both oxidized and reduced forms in the presence of chemical .	T20	T42	16690332
NA	CHEMICAL	GENE-N	0	8	chemical rebinding in gene from Staphylococcus aureus ( gene ) is faster than that measured for either Bacillus anthracis ( gene ) or for gene in both oxidized and reduced forms in the presence of chemical .	T20	T43	16690332
NA	CHEMICAL	GENE-N	0	20	chemical rebinding in gene from Staphylococcus aureus ( gene ) is faster than that measured for either Bacillus anthracis ( gene ) or for gene in both oxidized and reduced forms in the presence of chemical .	T20	T44	16690332
NA	CHEMICAL	GENE-N	0	7	chemical rebinding in gene from Staphylococcus aureus ( gene ) is faster than that measured for either Bacillus anthracis ( gene ) or for gene in both oxidized and reduced forms in the presence of chemical .	T20	T45	16690332
NA	CHEMICAL	GENE-N	2	3	chemical rebinding in gene from Staphylococcus aureus ( gene ) is faster than that measured for either Bacillus anthracis ( gene ) or for gene in both oxidized and reduced forms in the presence of chemical .	T21	T42	16690332
NA	CHEMICAL	GENE-N	2	8	chemical rebinding in gene from Staphylococcus aureus ( gene ) is faster than that measured for either Bacillus anthracis ( gene ) or for gene in both oxidized and reduced forms in the presence of chemical .	T21	T43	16690332
NA	CHEMICAL	GENE-N	2	20	chemical rebinding in gene from Staphylococcus aureus ( gene ) is faster than that measured for either Bacillus anthracis ( gene ) or for gene in both oxidized and reduced forms in the presence of chemical .	T21	T44	16690332
NA	CHEMICAL	GENE-N	2	7	chemical rebinding in gene from Staphylococcus aureus ( gene ) is faster than that measured for either Bacillus anthracis ( gene ) or for gene in both oxidized and reduced forms in the presence of chemical .	T21	T45	16690332
NA	CHEMICAL	GENE-N	8	11	Our data are consistent with different barriers for chemical recombination in gene and gene and the presence of a second chemical-binding site .	T24	T27	16690332
NA	CHEMICAL	GENE-N	8	13	Our data are consistent with different barriers for chemical recombination in gene and gene and the presence of a second chemical-binding site .	T24	T28	16690332
NA	CHEMICAL	GENE-N	20	11	Our data are consistent with different barriers for chemical recombination in gene and gene and the presence of a second chemical-binding site .	T1	T27	16690332
NA	CHEMICAL	GENE-N	20	13	Our data are consistent with different barriers for chemical recombination in gene and gene and the presence of a second chemical-binding site .	T1	T28	16690332
NA	CHEMICAL	GENE-N	5	10	The hypothesis that an additional chemical-binding cavity is present in gene is also consistent with the effect of the chemical concentration on its rebinding .	T2	T29	16690332
NA	CHEMICAL	GENE-N	19	10	The hypothesis that an additional chemical-binding cavity is present in gene is also consistent with the effect of the chemical concentration on its rebinding .	T3	T29	16690332
NA	CHEMICAL	GENE-N	6	13	The lack of the effect of chemical concentration on the geminate rebinding in gene could be due to an isolated second site .	T4	T30	16690332
NA	CHEMICAL	GENE-N	7	5	We confirm the existence of a second chemical site in the gene of the gene as previously hypothesized [ A. Slama-Schwok , M. Negrerie , V. Berka , J.C .	T5	T31	16690332
NA	CHEMICAL	GENE-Y	7	14	We confirm the existence of a second chemical site in the gene of the gene as previously hypothesized [ A. Slama-Schwok , M. Negrerie , V. Berka , J.C .	T5	T32	16690332
NA	CHEMICAL	GENE-Y	2	8	Martin , chemical ( chemical ) traffic in gene .	T6	T33	16690332
NA	CHEMICAL	GENE-Y	4	8	Martin , chemical ( chemical ) traffic in gene .	T7	T33	16690332
CPR:5	CHEMICAL	GENE-Y	2	0	gene agonist chemical enhances functional recovery after detachment caused by subretinal injection in normal and rds mice .	T15	T16	14507899
CPR:4	CHEMICAL	GENE-N	0	2	chemical , a balanced inhibitor of gene and gene , reduces inflammation in a rabbit model of atherosclerosis .	T17	T33	17015640
CPR:4	CHEMICAL	GENE-Y	0	2	chemical , a balanced inhibitor of gene and gene , reduces inflammation in a rabbit model of atherosclerosis .	T17	T34	17015640
CPR:4	CHEMICAL	GENE-Y	0	2	chemical , a dual anti-inflammatory drug that inhibits gene ( gene ) and gene ( gene ) enzymes , may have a better cardiovascular profile that gene inhibitors due to gene blockade-mediated antithrombotic effect and a better gastrointestinal tolerability .	T1	T29	17015640
CPR:4	CHEMICAL	GENE-N	0	10	chemical , a dual anti-inflammatory drug that inhibits gene ( gene ) and gene ( gene ) enzymes , may have a better cardiovascular profile that gene inhibitors due to gene blockade-mediated antithrombotic effect and a better gastrointestinal tolerability .	T1	T30	17015640
CPR:4	CHEMICAL	GENE-N	0	2	chemical , a dual anti-inflammatory drug that inhibits gene ( gene ) and gene ( gene ) enzymes , may have a better cardiovascular profile that gene inhibitors due to gene blockade-mediated antithrombotic effect and a better gastrointestinal tolerability .	T1	T31	17015640
CPR:4	CHEMICAL	GENE-N	0	15	chemical , a dual anti-inflammatory drug that inhibits gene ( gene ) and gene ( gene ) enzymes , may have a better cardiovascular profile that gene inhibitors due to gene blockade-mediated antithrombotic effect and a better gastrointestinal tolerability .	T1	T32	17015640
NA	CHEMICAL	GENE-Y	0	2	chemical , a dual anti-inflammatory drug that inhibits gene ( gene ) and gene ( gene ) enzymes , may have a better cardiovascular profile that gene inhibitors due to gene blockade-mediated antithrombotic effect and a better gastrointestinal tolerability .	T1	T26	17015640
CPR:4	CHEMICAL	GENE-Y	0	2	chemical , a dual anti-inflammatory drug that inhibits gene ( gene ) and gene ( gene ) enzymes , may have a better cardiovascular profile that gene inhibitors due to gene blockade-mediated antithrombotic effect and a better gastrointestinal tolerability .	T1	T27	17015640
NA	CHEMICAL	GENE-Y	5	27	We examined the anti-inflammatory effect of chemical on atherosclerotic lesions as well as in isolated neutrophils from whole blood of rabbits compared with a selective inhibitor of gene , chemical .	T11	T28	17015640
CPR:4	CHEMICAL	GENE-Y	5	27	We examined the anti-inflammatory effect of chemical on atherosclerotic lesions as well as in isolated neutrophils from whole blood of rabbits compared with a selective inhibitor of gene , chemical .	T12	T28	17015640
CPR:4	CHEMICAL	GENE-Y	0	4	chemical reduced intima/media ratio in injured arteries , the macrophages infiltration in the neointimal area , gene ( gene ) gene expression , and the activation of gene in rabbit atheroma .	T16	T18	17015640
CPR:4	CHEMICAL	GENE-Y	0	18	chemical reduced intima/media ratio in injured arteries , the macrophages infiltration in the neointimal area , gene ( gene ) gene expression , and the activation of gene in rabbit atheroma .	T16	T19	17015640
CPR:4	CHEMICAL	GENE-N	0	27	chemical reduced intima/media ratio in injured arteries , the macrophages infiltration in the neointimal area , gene ( gene ) gene expression , and the activation of gene in rabbit atheroma .	T16	T20	17015640
CPR:4	CHEMICAL	GENE-Y	2	4	Moreover , chemical inhibited gene and gene protein expression in vascular lesions .	T2	T21	17015640
CPR:4	CHEMICAL	GENE-Y	2	6	Moreover , chemical inhibited gene and gene protein expression in vascular lesions .	T2	T22	17015640
CPR:4	CHEMICAL	GENE-Y	0	3	chemical only diminished gene protein expression and gene gene expression in vascular atheroma .	T3	T23	17015640
CPR:4	CHEMICAL	GENE-Y	0	7	chemical only diminished gene protein expression and gene gene expression in vascular atheroma .	T3	T24	17015640
CPR:4	CHEMICAL	GENE-Y	0	3	chemical almost abolished gene activity by inhibiting chemical generation in rabbit neutrophils and prevented platelet chemical production from whole blood .	T5	T25	17015640
CPR:9	CHEMICAL	GENE-Y	7	3	chemical almost abolished gene activity by inhibiting chemical generation in rabbit neutrophils and prevented platelet chemical production from whole blood .	T6	T25	17015640
CPR:9	CHEMICAL	GENE-Y	15	3	chemical almost abolished gene activity by inhibiting chemical generation in rabbit neutrophils and prevented platelet chemical production from whole blood .	T7	T25	17015640
NA	CHEMICAL	GENE-Y	21	31	We analyzed clinical and genetic factors contributing to infections in 457 subjects with early rheumatoid arthritis ( RA ) enrolled in a prospective , 1-year clinical trial of chemical and the gene inhibitor etanercept .	T1	T3	15526004
NA	CHEMICAL	GENE-Y	7	14	Subjects were genotyped for the following single chemical polymorphisms ( SNPs ) : ( gene -308 , -238 , and + 488 ) ; gene ( gene ) ( gene + 249 , + 365 , and + 720 ) ; and gene gene 131 H/R ; gene 176 F/V ; and gene NA 1/2 and genotypes were correlated with infections .	T2	T4	15526004
NA	CHEMICAL	GENE-Y	7	24	Subjects were genotyped for the following single chemical polymorphisms ( SNPs ) : ( gene -308 , -238 , and + 488 ) ; gene ( gene ) ( gene + 249 , + 365 , and + 720 ) ; and gene gene 131 H/R ; gene 176 F/V ; and gene NA 1/2 and genotypes were correlated with infections .	T2	T5	15526004
NA	CHEMICAL	GENE-Y	7	26	Subjects were genotyped for the following single chemical polymorphisms ( SNPs ) : ( gene -308 , -238 , and + 488 ) ; gene ( gene ) ( gene + 249 , + 365 , and + 720 ) ; and gene gene 131 H/R ; gene 176 F/V ; and gene NA 1/2 and genotypes were correlated with infections .	T2	T6	15526004
NA	CHEMICAL	GENE-Y	7	29	Subjects were genotyped for the following single chemical polymorphisms ( SNPs ) : ( gene -308 , -238 , and + 488 ) ; gene ( gene ) ( gene + 249 , + 365 , and + 720 ) ; and gene gene 131 H/R ; gene 176 F/V ; and gene NA 1/2 and genotypes were correlated with infections .	T2	T7	15526004
NA	CHEMICAL	GENE-N	7	42	Subjects were genotyped for the following single chemical polymorphisms ( SNPs ) : ( gene -308 , -238 , and + 488 ) ; gene ( gene ) ( gene + 249 , + 365 , and + 720 ) ; and gene gene 131 H/R ; gene 176 F/V ; and gene NA 1/2 and genotypes were correlated with infections .	T2	T8	15526004
NA	CHEMICAL	GENE-Y	7	43	Subjects were genotyped for the following single chemical polymorphisms ( SNPs ) : ( gene -308 , -238 , and + 488 ) ; gene ( gene ) ( gene + 249 , + 365 , and + 720 ) ; and gene gene 131 H/R ; gene 176 F/V ; and gene NA 1/2 and genotypes were correlated with infections .	T2	T9	15526004
NA	CHEMICAL	GENE-Y	7	47	Subjects were genotyped for the following single chemical polymorphisms ( SNPs ) : ( gene -308 , -238 , and + 488 ) ; gene ( gene ) ( gene + 249 , + 365 , and + 720 ) ; and gene gene 131 H/R ; gene 176 F/V ; and gene NA 1/2 and genotypes were correlated with infections .	T2	T10	15526004
NA	CHEMICAL	GENE-Y	7	52	Subjects were genotyped for the following single chemical polymorphisms ( SNPs ) : ( gene -308 , -238 , and + 488 ) ; gene ( gene ) ( gene + 249 , + 365 , and + 720 ) ; and gene gene 131 H/R ; gene 176 F/V ; and gene NA 1/2 and genotypes were correlated with infections .	T2	T11	15526004
NA	CHEMICAL	GENE-N	2	4	Effects of chemical/chemical protein phosphatase inhibitors on chemical-induced antinociception in the tail flick test in mice .	T21	T34	12650833
NA	CHEMICAL	GENE-N	2	4	Effects of chemical/chemical protein phosphatase inhibitors on chemical-induced antinociception in the tail flick test in mice .	T22	T34	12650833
NA	CHEMICAL	GENE-N	7	4	Effects of chemical/chemical protein phosphatase inhibitors on chemical-induced antinociception in the tail flick test in mice .	T23	T34	12650833
NA	CHEMICAL	GENE-N	11	13	The aim of this study was to evaluate the effects of chemical/chemical protein phosphatase ( gene ) inhibitors on chemical-induced antinociception in the tail flick test in mice , and on chemical binding to the forebrain crude synaptosome fraction .	T12	T29	12650833
NA	CHEMICAL	GENE-N	11	15	The aim of this study was to evaluate the effects of chemical/chemical protein phosphatase ( gene ) inhibitors on chemical-induced antinociception in the tail flick test in mice , and on chemical binding to the forebrain crude synaptosome fraction .	T12	T32	12650833
NA	CHEMICAL	GENE-N	11	13	The aim of this study was to evaluate the effects of chemical/chemical protein phosphatase ( gene ) inhibitors on chemical-induced antinociception in the tail flick test in mice , and on chemical binding to the forebrain crude synaptosome fraction .	T13	T29	12650833
NA	CHEMICAL	GENE-N	11	15	The aim of this study was to evaluate the effects of chemical/chemical protein phosphatase ( gene ) inhibitors on chemical-induced antinociception in the tail flick test in mice , and on chemical binding to the forebrain crude synaptosome fraction .	T13	T32	12650833
NA	CHEMICAL	GENE-N	19	13	The aim of this study was to evaluate the effects of chemical/chemical protein phosphatase ( gene ) inhibitors on chemical-induced antinociception in the tail flick test in mice , and on chemical binding to the forebrain crude synaptosome fraction .	T2	T29	12650833
NA	CHEMICAL	GENE-N	19	15	The aim of this study was to evaluate the effects of chemical/chemical protein phosphatase ( gene ) inhibitors on chemical-induced antinociception in the tail flick test in mice , and on chemical binding to the forebrain crude synaptosome fraction .	T2	T32	12650833
NA	CHEMICAL	GENE-N	18	13	The aim of this study was to evaluate the effects of chemical/chemical protein phosphatase ( gene ) inhibitors on chemical-induced antinociception in the tail flick test in mice , and on chemical binding to the forebrain crude synaptosome fraction .	T6	T29	12650833
NA	CHEMICAL	GENE-N	18	15	The aim of this study was to evaluate the effects of chemical/chemical protein phosphatase ( gene ) inhibitors on chemical-induced antinociception in the tail flick test in mice , and on chemical binding to the forebrain crude synaptosome fraction .	T6	T32	12650833
NA	CHEMICAL	GENE-N	1	25	Neither chemical nor chemical ( 1-10000 nM ) displaced chemical from its specific binding sites , which indicates that they do not interact at the gene level .	T7	T28	12650833
NA	CHEMICAL	GENE-N	3	25	Neither chemical nor chemical ( 1-10000 nM ) displaced chemical from its specific binding sites , which indicates that they do not interact at the gene level .	T8	T28	12650833
NA	CHEMICAL	GENE-N	9	25	Neither chemical nor chemical ( 1-10000 nM ) displaced chemical from its specific binding sites , which indicates that they do not interact at the gene level .	T9	T28	12650833
CPR:4	CHEMICAL	GENE-N	6	20	administration of very low doses of chemical ( 0.001-1 pg/mouse ) and chemical ( 0.001-1 ng/mouse ) , which inhibit gene , produced a dose-dependent antagonism of the antinociception induced by chemical ( s.c. ) .	T10	T30	12650833
CPR:4	CHEMICAL	GENE-N	12	20	administration of very low doses of chemical ( 0.001-1 pg/mouse ) and chemical ( 0.001-1 ng/mouse ) , which inhibit gene , produced a dose-dependent antagonism of the antinociception induced by chemical ( s.c. ) .	T11	T30	12650833
NA	CHEMICAL	GENE-N	31	20	administration of very low doses of chemical ( 0.001-1 pg/mouse ) and chemical ( 0.001-1 ng/mouse ) , which inhibit gene , produced a dose-dependent antagonism of the antinociception induced by chemical ( s.c. ) .	T14	T30	12650833
NA	CHEMICAL	GENE-N	5	9	) , an analogue of chemical lacking activity against gene , did not affect the antinociceptive effect of chemical .	T16	T31	12650833
NA	CHEMICAL	GENE-N	18	9	) , an analogue of chemical lacking activity against gene , did not affect the antinociceptive effect of chemical .	T17	T31	12650833
NA	CHEMICAL	GENE-N	8	5	) , which also block gene , and chemical ( 0.1 fg/mouse-1 ng/mouse , i.c.v .	T20	T33	12650833
NA	CHEMICAL	GENE-N	14	6	) , which inhibits equally both gene and gene , did not modify the chemical-induced antinociception .	T1	T24	12650833
NA	CHEMICAL	GENE-N	14	8	) , which inhibits equally both gene and gene , did not modify the chemical-induced antinociception .	T1	T25	12650833
NA	CHEMICAL	GENE-Y	5	2	Structure of gene complexed with chemical at 2.3 A resolution .	T18	T25	10606746
NA	CHEMICAL	GENE-Y	18	12	The inhibitor binds at the base of the active site gorge of gene , interacting with both the chemical-binding site ( chemical-84 ) and the chemical-binding pocket ( chemical-288 , chemical-290 ) .	T3	T21	10606746
NA	CHEMICAL	GENE-N	18	9	The inhibitor binds at the base of the active site gorge of gene , interacting with both the chemical-binding site ( chemical-84 ) and the chemical-binding pocket ( chemical-288 , chemical-290 ) .	T3	T22	10606746
NA	CHEMICAL	GENE-N	18	26	The inhibitor binds at the base of the active site gorge of gene , interacting with both the chemical-binding site ( chemical-84 ) and the chemical-binding pocket ( chemical-288 , chemical-290 ) .	T3	T23	10606746
NA	CHEMICAL	GENE-Y	21	12	The inhibitor binds at the base of the active site gorge of gene , interacting with both the chemical-binding site ( chemical-84 ) and the chemical-binding pocket ( chemical-288 , chemical-290 ) .	T4	T21	10606746
NA	CHEMICAL	GENE-N	21	9	The inhibitor binds at the base of the active site gorge of gene , interacting with both the chemical-binding site ( chemical-84 ) and the chemical-binding pocket ( chemical-288 , chemical-290 ) .	T4	T22	10606746
NA	CHEMICAL	GENE-N	21	26	The inhibitor binds at the base of the active site gorge of gene , interacting with both the chemical-binding site ( chemical-84 ) and the chemical-binding pocket ( chemical-288 , chemical-290 ) .	T4	T23	10606746
NA	CHEMICAL	GENE-Y	25	12	The inhibitor binds at the base of the active site gorge of gene , interacting with both the chemical-binding site ( chemical-84 ) and the chemical-binding pocket ( chemical-288 , chemical-290 ) .	T5	T21	10606746
NA	CHEMICAL	GENE-N	25	9	The inhibitor binds at the base of the active site gorge of gene , interacting with both the chemical-binding site ( chemical-84 ) and the chemical-binding pocket ( chemical-288 , chemical-290 ) .	T5	T22	10606746
NA	CHEMICAL	GENE-N	25	26	The inhibitor binds at the base of the active site gorge of gene , interacting with both the chemical-binding site ( chemical-84 ) and the chemical-binding pocket ( chemical-288 , chemical-290 ) .	T5	T23	10606746
NA	CHEMICAL	GENE-Y	28	12	The inhibitor binds at the base of the active site gorge of gene , interacting with both the chemical-binding site ( chemical-84 ) and the chemical-binding pocket ( chemical-288 , chemical-290 ) .	T6	T21	10606746
NA	CHEMICAL	GENE-N	28	9	The inhibitor binds at the base of the active site gorge of gene , interacting with both the chemical-binding site ( chemical-84 ) and the chemical-binding pocket ( chemical-288 , chemical-290 ) .	T6	T22	10606746
NA	CHEMICAL	GENE-N	28	26	The inhibitor binds at the base of the active site gorge of gene , interacting with both the chemical-binding site ( chemical-84 ) and the chemical-binding pocket ( chemical-288 , chemical-290 ) .	T6	T23	10606746
NA	CHEMICAL	GENE-Y	30	12	The inhibitor binds at the base of the active site gorge of gene , interacting with both the chemical-binding site ( chemical-84 ) and the chemical-binding pocket ( chemical-288 , chemical-290 ) .	T7	T21	10606746
NA	CHEMICAL	GENE-N	30	9	The inhibitor binds at the base of the active site gorge of gene , interacting with both the chemical-binding site ( chemical-84 ) and the chemical-binding pocket ( chemical-288 , chemical-290 ) .	T7	T22	10606746
NA	CHEMICAL	GENE-N	30	26	The inhibitor binds at the base of the active site gorge of gene , interacting with both the chemical-binding site ( chemical-84 ) and the chemical-binding pocket ( chemical-288 , chemical-290 ) .	T7	T23	10606746
CPR:3	CHEMICAL	GENE-N	16	8	Activation of an apoptotic signal transduction pathway involved in the upregulation of gene and gene in chemical-induced primary cultured cardiomyocytes .	T19	T37	23266505
CPR:3	CHEMICAL	GENE-Y	16	14	Activation of an apoptotic signal transduction pathway involved in the upregulation of gene and gene in chemical-induced primary cultured cardiomyocytes .	T19	T38	23266505
CPR:3	CHEMICAL	GENE-N	4	24	In this study , chemical ( chemical ) -induced apoptosis of cardiomyocyte was evaluated based on the previous studies , and the roles of gene signaling were clarified .	T7	T21	23266505
CPR:3	CHEMICAL	GENE-N	6	24	In this study , chemical ( chemical ) -induced apoptosis of cardiomyocyte was evaluated based on the previous studies , and the roles of gene signaling were clarified .	T10	T21	23266505
NA	CHEMICAL	GENE-N	5	12	Cardiomyocytes that were injured by chemical were assayed by the chemical and gene leakage ratio .	T15	T24	23266505
NA	CHEMICAL	GENE-N	10	12	Cardiomyocytes that were injured by chemical were assayed by the chemical and gene leakage ratio .	T16	T24	23266505
CPR:3	CHEMICAL	GENE-N	0	2	chemical increased gene expression and gene activity and promoted Bid cleavage .	T17	T31	23266505
CPR:3	CHEMICAL	GENE-Y	0	5	chemical increased gene expression and gene activity and promoted Bid cleavage .	T17	T32	23266505
CPR:4	CHEMICAL	GENE-N	15	3	The upregulation of gene , gene and gene activity were further inhibited by treatment with chemical in the presence of chemical .	T18	T34	23266505
CPR:4	CHEMICAL	GENE-Y	15	5	The upregulation of gene , gene and gene activity were further inhibited by treatment with chemical in the presence of chemical .	T18	T35	23266505
CPR:4	CHEMICAL	GENE-Y	15	7	The upregulation of gene , gene and gene activity were further inhibited by treatment with chemical in the presence of chemical .	T18	T36	23266505
CPR:3	CHEMICAL	GENE-N	15	3	The upregulation of gene , gene and gene activity were further inhibited by treatment with chemical in the presence of chemical .	T1	T34	23266505
CPR:3	CHEMICAL	GENE-Y	15	5	The upregulation of gene , gene and gene activity were further inhibited by treatment with chemical in the presence of chemical .	T1	T35	23266505
CPR:3	CHEMICAL	GENE-Y	15	7	The upregulation of gene , gene and gene activity were further inhibited by treatment with chemical in the presence of chemical .	T1	T36	23266505
CPR:4	CHEMICAL	GENE-Y	2	2	Additionally , gene levels in the cytosol decreased due to chemical but not due to chemical .	T2	T20	23266505
NA	CHEMICAL	GENE-Y	4	2	Additionally , gene levels in the cytosol decreased due to chemical but not due to chemical .	T3	T20	23266505
NA	CHEMICAL	GENE-N	6	11	On the basis of data obtained in rabbits , the chemical receptor ligand chemical has been suggested to decrease blood pressure in humans by activating central gene .	T11	T27	10988273
NA	CHEMICAL	GENE-Y	6	17	On the basis of data obtained in rabbits , the chemical receptor ligand chemical has been suggested to decrease blood pressure in humans by activating central gene .	T11	T21	10988273
NA	CHEMICAL	GENE-N	6	11	On the basis of data obtained in rabbits , the chemical receptor ligand chemical has been suggested to decrease blood pressure in humans by activating central gene .	T13	T27	10988273
CPR:3	CHEMICAL	GENE-Y	6	17	On the basis of data obtained in rabbits , the chemical receptor ligand chemical has been suggested to decrease blood pressure in humans by activating central gene .	T13	T21	10988273
CPR:3	CHEMICAL	GENE-N	18	0	A prerequisite for this hypothesis was the unproved assumption that rabbit and human gene are equally activated by chemical .	T10	T25	10988273
NA	CHEMICAL	GENE-N	16	9	Human atrial appendages and rabbit pulmonary arteries were used to determine the potencies of gene agonists in inhibiting the electrically ( 2 Hz ) evoked chemical release and of antagonists in counteracting the gene-mediated inhibition induced by chemical .	T12	T28	10988273
NA	CHEMICAL	GENE-N	16	9	Human atrial appendages and rabbit pulmonary arteries were used to determine the potencies of gene agonists in inhibiting the electrically ( 2 Hz ) evoked chemical release and of antagonists in counteracting the gene-mediated inhibition induced by chemical .	T12	T29	10988273
NA	CHEMICAL	GENE-N	16	9	Human atrial appendages and rabbit pulmonary arteries were used to determine the potencies of gene agonists in inhibiting the electrically ( 2 Hz ) evoked chemical release and of antagonists in counteracting the gene-mediated inhibition induced by chemical .	T14	T28	10988273
CPR:4	CHEMICAL	GENE-N	16	9	Human atrial appendages and rabbit pulmonary arteries were used to determine the potencies of gene agonists in inhibiting the electrically ( 2 Hz ) evoked chemical release and of antagonists in counteracting the gene-mediated inhibition induced by chemical .	T14	T29	10988273
CPR:6	CHEMICAL	GENE-N	6	25	In the rabbit pulmonary artery , chemical and chemical are potent full agonists , whereas in the human atrial appendages they are antagonists at the gene , sharing this property with chemical , chemical , and chemical .	T15	T30	10988273
CPR:6	CHEMICAL	GENE-N	8	25	In the rabbit pulmonary artery , chemical and chemical are potent full agonists , whereas in the human atrial appendages they are antagonists at the gene , sharing this property with chemical , chemical , and chemical .	T16	T30	10988273
CPR:6	CHEMICAL	GENE-N	6	25	In the rabbit pulmonary artery , chemical and chemical are potent full agonists , whereas in the human atrial appendages they are antagonists at the gene , sharing this property with chemical , chemical , and chemical .	T1	T30	10988273
CPR:6	CHEMICAL	GENE-N	15	25	In the rabbit pulmonary artery , chemical and chemical are potent full agonists , whereas in the human atrial appendages they are antagonists at the gene , sharing this property with chemical , chemical , and chemical .	T2	T30	10988273
CPR:6	CHEMICAL	GENE-N	25	25	In the rabbit pulmonary artery , chemical and chemical are potent full agonists , whereas in the human atrial appendages they are antagonists at the gene , sharing this property with chemical , chemical , and chemical .	T3	T30	10988273
NA	CHEMICAL	GENE-Y	3	3	In addition , a partial nucleotide and chemical sequence of the gene ( a region known to substantially influence the pharmacological characteristics of the gene ) revealed marked differences between the rabbit and the human gene .	T5	T17	10988273
NA	CHEMICAL	GENE-N	3	3	In addition , a partial nucleotide and chemical sequence of the gene ( a region known to substantially influence the pharmacological characteristics of the gene ) revealed marked differences between the rabbit and the human gene .	T5	T18	10988273
NA	CHEMICAL	GENE-N	3	3	In addition , a partial nucleotide and chemical sequence of the gene ( a region known to substantially influence the pharmacological characteristics of the gene ) revealed marked differences between the rabbit and the human gene .	T5	T19	10988273
CPR:6	CHEMICAL	GENE-N	24	16	The sympathetic nerves of both the human atrial appendages and rabbit pulmonary artery are endowed with gene , at which , however , both chemical and chemical exhibit different properties ( antagonism and agonism , respectively ) .	T6	T20	10988273
CPR:5	CHEMICAL	GENE-N	26	16	The sympathetic nerves of both the human atrial appendages and rabbit pulmonary artery are endowed with gene , at which , however , both chemical and chemical exhibit different properties ( antagonism and agonism , respectively ) .	T7	T20	10988273
NA	CHEMICAL	GENE-Y	14	0	gene , a recently identified cell surface gene , is the key enzyme of chemical homoeostasis modulating the expression of the liver peptide hormone gene .	T3	T4	23293962
NA	CHEMICAL	GENE-N	14	2	gene , a recently identified cell surface gene , is the key enzyme of chemical homoeostasis modulating the expression of the liver peptide hormone gene .	T3	T18	23293962
NA	CHEMICAL	GENE-Y	14	24	gene , a recently identified cell surface gene , is the key enzyme of chemical homoeostasis modulating the expression of the liver peptide hormone gene .	T3	T8	23293962
CPR:4	CHEMICAL	GENE-Y	0	10	chemical reduced the expression of pro-inflammatory mediates , such as gene ( gene ) , gene ( gene ) , gene ( ichemicalS ) , and gene ( gene ) .	T7	T16	23376161
CPR:4	CHEMICAL	GENE-Y	0	12	chemical reduced the expression of pro-inflammatory mediates , such as gene ( gene ) , gene ( gene ) , gene ( ichemicalS ) , and gene ( gene ) .	T7	T17	23376161
CPR:4	CHEMICAL	GENE-Y	0	15	chemical reduced the expression of pro-inflammatory mediates , such as gene ( gene ) , gene ( gene ) , gene ( ichemicalS ) , and gene ( gene ) .	T7	T18	23376161
CPR:4	CHEMICAL	GENE-Y	0	17	chemical reduced the expression of pro-inflammatory mediates , such as gene ( gene ) , gene ( gene ) , gene ( ichemicalS ) , and gene ( gene ) .	T7	T19	23376161
CPR:4	CHEMICAL	GENE-Y	0	9	chemical reduced the expression of pro-inflammatory mediates , such as gene ( gene ) , gene ( gene ) , gene ( ichemicalS ) , and gene ( gene ) .	T7	T20	23376161
CPR:4	CHEMICAL	GENE-Y	0	26	chemical reduced the expression of pro-inflammatory mediates , such as gene ( gene ) , gene ( gene ) , gene ( ichemicalS ) , and gene ( gene ) .	T7	T22	23376161
CPR:4	CHEMICAL	GENE-Y	0	28	chemical reduced the expression of pro-inflammatory mediates , such as gene ( gene ) , gene ( gene ) , gene ( ichemicalS ) , and gene ( gene ) .	T7	T23	23376161
NA	CHEMICAL	GENE-Y	22	10	chemical reduced the expression of pro-inflammatory mediates , such as gene ( gene ) , gene ( gene ) , gene ( ichemicalS ) , and gene ( gene ) .	T8	T16	23376161
NA	CHEMICAL	GENE-Y	22	12	chemical reduced the expression of pro-inflammatory mediates , such as gene ( gene ) , gene ( gene ) , gene ( ichemicalS ) , and gene ( gene ) .	T8	T17	23376161
NA	CHEMICAL	GENE-Y	22	15	chemical reduced the expression of pro-inflammatory mediates , such as gene ( gene ) , gene ( gene ) , gene ( ichemicalS ) , and gene ( gene ) .	T8	T18	23376161
NA	CHEMICAL	GENE-Y	22	17	chemical reduced the expression of pro-inflammatory mediates , such as gene ( gene ) , gene ( gene ) , gene ( ichemicalS ) , and gene ( gene ) .	T8	T19	23376161
NA	CHEMICAL	GENE-Y	22	9	chemical reduced the expression of pro-inflammatory mediates , such as gene ( gene ) , gene ( gene ) , gene ( ichemicalS ) , and gene ( gene ) .	T8	T20	23376161
NA	CHEMICAL	GENE-Y	22	26	chemical reduced the expression of pro-inflammatory mediates , such as gene ( gene ) , gene ( gene ) , gene ( ichemicalS ) , and gene ( gene ) .	T8	T22	23376161
NA	CHEMICAL	GENE-Y	22	28	chemical reduced the expression of pro-inflammatory mediates , such as gene ( gene ) , gene ( gene ) , gene ( ichemicalS ) , and gene ( gene ) .	T8	T23	23376161
CPR:4	CHEMICAL	GENE-N	15	10	Promoter and electromobility shift assays showed that transcriptional activation of gene was significantly reduced by chemical treatment , while gene was not .	T9	T24	23376161
NA	CHEMICAL	GENE-Y	15	19	Promoter and electromobility shift assays showed that transcriptional activation of gene was significantly reduced by chemical treatment , while gene was not .	T9	T25	23376161
CPR:4	CHEMICAL	GENE-N	0	6	chemical also suppressed AGE-induced phosphorylation of gene , degradation of gene and the nuclear localization of gene .	T10	T26	23376161
CPR:4	CHEMICAL	GENE-Y	0	10	chemical also suppressed AGE-induced phosphorylation of gene , degradation of gene and the nuclear localization of gene .	T10	T27	23376161
CPR:4	CHEMICAL	GENE-N	0	16	chemical also suppressed AGE-induced phosphorylation of gene , degradation of gene and the nuclear localization of gene .	T10	T13	23376161
NA	CHEMICAL	GENE-N	7	32	Moreover , the production of intracellular reactive chemical species ( ROS ) elicited by AGE was also suppressed by chemical treatment , through dual action of reducing ROS itself and inhibiting chemical oxidase activity .	T1	T14	23376161
CPR:4	CHEMICAL	GENE-N	19	32	Moreover , the production of intracellular reactive chemical species ( ROS ) elicited by AGE was also suppressed by chemical treatment , through dual action of reducing ROS itself and inhibiting chemical oxidase activity .	T2	T14	23376161
NA	CHEMICAL	GENE-N	31	32	Moreover , the production of intracellular reactive chemical species ( ROS ) elicited by AGE was also suppressed by chemical treatment , through dual action of reducing ROS itself and inhibiting chemical oxidase activity .	T3	T14	23376161
CPR:4	CHEMICAL	GENE-N	4	13	Our findings indicate that chemical suppresses AGE-mediated inflammation by inhibiting ROS production and gene activity .	T4	T15	23376161
NA	CHEMICAL	GENE-Y	2	0	gene ( gene ) is a gene-containing protein and one of the binding partners for several trans-membrane chemical-kinase receptors , including gene ( gene ) and gene ( gene ) .	T1	T2	23614367
NA	CHEMICAL	GENE-Y	2	2	gene ( gene ) is a gene-containing protein and one of the binding partners for several trans-membrane chemical-kinase receptors , including gene ( gene ) and gene ( gene ) .	T1	T13	23614367
NA	CHEMICAL	GENE-N	2	5	gene ( gene ) is a gene-containing protein and one of the binding partners for several trans-membrane chemical-kinase receptors , including gene ( gene ) and gene ( gene ) .	T1	T15	23614367
NA	CHEMICAL	GENE-N	2	18	gene ( gene ) is a gene-containing protein and one of the binding partners for several trans-membrane chemical-kinase receptors , including gene ( gene ) and gene ( gene ) .	T1	T7	23614367
NA	CHEMICAL	GENE-Y	2	21	gene ( gene ) is a gene-containing protein and one of the binding partners for several trans-membrane chemical-kinase receptors , including gene ( gene ) and gene ( gene ) .	T1	T8	23614367
NA	CHEMICAL	GENE-Y	2	23	gene ( gene ) is a gene-containing protein and one of the binding partners for several trans-membrane chemical-kinase receptors , including gene ( gene ) and gene ( gene ) .	T1	T9	23614367
NA	CHEMICAL	GENE-Y	2	26	gene ( gene ) is a gene-containing protein and one of the binding partners for several trans-membrane chemical-kinase receptors , including gene ( gene ) and gene ( gene ) .	T1	T10	23614367
NA	CHEMICAL	GENE-Y	2	28	gene ( gene ) is a gene-containing protein and one of the binding partners for several trans-membrane chemical-kinase receptors , including gene ( gene ) and gene ( gene ) .	T1	T11	23614367
NA	CHEMICAL	GENE-Y	7	0	gene was chemically bound via linkers to chemical-loaded gene-NP .	T3	T10	16554356
NA	CHEMICAL	GENE-Y	7	8	gene was chemically bound via linkers to chemical-loaded gene-NP .	T3	T11	16554356
NA	CHEMICAL	GENE-N	7	5	Competitive displacement binding assays using gene/BVD15-DO3A against chemical-chemical ( 4 ) -BBN yielded an IC ( 50 ) value of 18 ± 0.7 nM for gene in T-47D cells , a human breast cancer cell line .	T1	T6	23265893
NA	CHEMICAL	GENE-N	7	8	Competitive displacement binding assays using gene/BVD15-DO3A against chemical-chemical ( 4 ) -BBN yielded an IC ( 50 ) value of 18 ± 0.7 nM for gene in T-47D cells , a human breast cancer cell line .	T1	T7	23265893
NA	CHEMICAL	GENE-Y	7	25	Competitive displacement binding assays using gene/BVD15-DO3A against chemical-chemical ( 4 ) -BBN yielded an IC ( 50 ) value of 18 ± 0.7 nM for gene in T-47D cells , a human breast cancer cell line .	T1	T8	23265893
NA	CHEMICAL	GENE-N	7	5	Competitive displacement binding assays using gene/BVD15-DO3A against chemical-chemical ( 4 ) -BBN yielded an IC ( 50 ) value of 18 ± 0.7 nM for gene in T-47D cells , a human breast cancer cell line .	T2	T6	23265893
NA	CHEMICAL	GENE-N	7	8	Competitive displacement binding assays using gene/BVD15-DO3A against chemical-chemical ( 4 ) -BBN yielded an IC ( 50 ) value of 18 ± 0.7 nM for gene in T-47D cells , a human breast cancer cell line .	T2	T7	23265893
NA	CHEMICAL	GENE-Y	7	25	Competitive displacement binding assays using gene/BVD15-DO3A against chemical-chemical ( 4 ) -BBN yielded an IC ( 50 ) value of 18 ± 0.7 nM for gene in T-47D cells , a human breast cancer cell line .	T2	T8	23265893
NA	CHEMICAL	GENE-N	9	4	A similar assay using gene/BVD15-DO3A against gene showed IC ( 50 ) values of 80 ± 11 nM for gene in MCF7 cells , another human breast cancer cell line .	T3	T9	23265893
NA	CHEMICAL	GENE-Y	9	6	A similar assay using gene/BVD15-DO3A against gene showed IC ( 50 ) values of 80 ± 11 nM for gene in MCF7 cells , another human breast cancer cell line .	T3	T10	23265893
NA	CHEMICAL	GENE-Y	9	19	A similar assay using gene/BVD15-DO3A against gene showed IC ( 50 ) values of 80 ± 11 nM for gene in MCF7 cells , another human breast cancer cell line .	T3	T11	23265893
CPR:4	CHEMICAL	GENE-N	5	6	Structure activity relationship studies of chemical gene inhibitors .	T7	T10	23265892
NA	CHEMICAL	GENE-Y	14	30	An investigation is detailed of the structure activity relationships ( SAR ) of two chemical side chains of compound ( - ) -1a ( chemical ) , a potent , gene-selective gene inhibitor and clinical candidate for the treatment of Alzheimer 's disease .	T6	T8	23265892
NA	CHEMICAL	GENE-N	14	20	An investigation is detailed of the structure activity relationships ( SAR ) of two chemical side chains of compound ( - ) -1a ( chemical ) , a potent , gene-selective gene inhibitor and clinical candidate for the treatment of Alzheimer 's disease .	T6	T9	23265892
CPR:4	CHEMICAL	GENE-Y	24	30	An investigation is detailed of the structure activity relationships ( SAR ) of two chemical side chains of compound ( - ) -1a ( chemical ) , a potent , gene-selective gene inhibitor and clinical candidate for the treatment of Alzheimer 's disease .	T1	T8	23265892
CPR:4	CHEMICAL	GENE-N	24	20	An investigation is detailed of the structure activity relationships ( SAR ) of two chemical side chains of compound ( - ) -1a ( chemical ) , a potent , gene-selective gene inhibitor and clinical candidate for the treatment of Alzheimer 's disease .	T1	T9	23265892
NA	CHEMICAL	GENE-Y	0	31	chemical play a central role in homeostasis of the normal male skeleton , and chemical deficiency rather than chemical deficiency seems to be primarily responsible for the adverse skeletal effects of gene agonists .	T2	T15	17062721
NA	CHEMICAL	GENE-Y	14	31	chemical play a central role in homeostasis of the normal male skeleton , and chemical deficiency rather than chemical deficiency seems to be primarily responsible for the adverse skeletal effects of gene agonists .	T3	T15	17062721
NA	CHEMICAL	GENE-Y	18	31	chemical play a central role in homeostasis of the normal male skeleton , and chemical deficiency rather than chemical deficiency seems to be primarily responsible for the adverse skeletal effects of gene agonists .	T4	T15	17062721
NA	CHEMICAL	GENE-Y	5	14	In randomized controlled trials , chemical ( chemical and chemical ) and selective chemical receptor modulators ( chemical and chemical ) increased bone mineral density in gene agonist-treated men .	T5	T17	17062721
NA	CHEMICAL	GENE-Y	5	26	In randomized controlled trials , chemical ( chemical and chemical ) and selective chemical receptor modulators ( chemical and chemical ) increased bone mineral density in gene agonist-treated men .	T5	T18	17062721
NA	CHEMICAL	GENE-Y	7	14	In randomized controlled trials , chemical ( chemical and chemical ) and selective chemical receptor modulators ( chemical and chemical ) increased bone mineral density in gene agonist-treated men .	T6	T17	17062721
NA	CHEMICAL	GENE-Y	7	26	In randomized controlled trials , chemical ( chemical and chemical ) and selective chemical receptor modulators ( chemical and chemical ) increased bone mineral density in gene agonist-treated men .	T6	T18	17062721
NA	CHEMICAL	GENE-Y	9	14	In randomized controlled trials , chemical ( chemical and chemical ) and selective chemical receptor modulators ( chemical and chemical ) increased bone mineral density in gene agonist-treated men .	T7	T17	17062721
NA	CHEMICAL	GENE-Y	9	26	In randomized controlled trials , chemical ( chemical and chemical ) and selective chemical receptor modulators ( chemical and chemical ) increased bone mineral density in gene agonist-treated men .	T7	T18	17062721
NA	CHEMICAL	GENE-Y	13	14	In randomized controlled trials , chemical ( chemical and chemical ) and selective chemical receptor modulators ( chemical and chemical ) increased bone mineral density in gene agonist-treated men .	T8	T17	17062721
NA	CHEMICAL	GENE-Y	13	26	In randomized controlled trials , chemical ( chemical and chemical ) and selective chemical receptor modulators ( chemical and chemical ) increased bone mineral density in gene agonist-treated men .	T8	T18	17062721
NA	CHEMICAL	GENE-Y	17	14	In randomized controlled trials , chemical ( chemical and chemical ) and selective chemical receptor modulators ( chemical and chemical ) increased bone mineral density in gene agonist-treated men .	T9	T17	17062721
NA	CHEMICAL	GENE-Y	17	26	In randomized controlled trials , chemical ( chemical and chemical ) and selective chemical receptor modulators ( chemical and chemical ) increased bone mineral density in gene agonist-treated men .	T9	T18	17062721
NA	CHEMICAL	GENE-Y	19	14	In randomized controlled trials , chemical ( chemical and chemical ) and selective chemical receptor modulators ( chemical and chemical ) increased bone mineral density in gene agonist-treated men .	T10	T17	17062721
NA	CHEMICAL	GENE-Y	19	26	In randomized controlled trials , chemical ( chemical and chemical ) and selective chemical receptor modulators ( chemical and chemical ) increased bone mineral density in gene agonist-treated men .	T10	T18	17062721
NA	CHEMICAL	GENE-Y	9	3	The centerpiece of the AND gate is a bisected chemical-tRNA synthetase ( gene ) that charges the chemical surrogate chemical ( chemical ) to tRNA ( chemical ) .	T3	T14	23406315
NA	CHEMICAL	GENE-Y	9	12	The centerpiece of the AND gate is a bisected chemical-tRNA synthetase ( gene ) that charges the chemical surrogate chemical ( chemical ) to tRNA ( chemical ) .	T3	T15	23406315
NA	CHEMICAL	GENE-Y	17	3	The centerpiece of the AND gate is a bisected chemical-tRNA synthetase ( gene ) that charges the chemical surrogate chemical ( chemical ) to tRNA ( chemical ) .	T4	T14	23406315
NA	CHEMICAL	GENE-Y	17	12	The centerpiece of the AND gate is a bisected chemical-tRNA synthetase ( gene ) that charges the chemical surrogate chemical ( chemical ) to tRNA ( chemical ) .	T4	T15	23406315
NA	CHEMICAL	GENE-Y	7	3	The centerpiece of the AND gate is a bisected chemical-tRNA synthetase ( gene ) that charges the chemical surrogate chemical ( chemical ) to tRNA ( chemical ) .	T5	T14	23406315
NA	CHEMICAL	GENE-Y	7	12	The centerpiece of the AND gate is a bisected chemical-tRNA synthetase ( gene ) that charges the chemical surrogate chemical ( chemical ) to tRNA ( chemical ) .	T5	T15	23406315
NA	CHEMICAL	GENE-Y	21	3	The centerpiece of the AND gate is a bisected chemical-tRNA synthetase ( gene ) that charges the chemical surrogate chemical ( chemical ) to tRNA ( chemical ) .	T6	T14	23406315
NA	CHEMICAL	GENE-Y	21	12	The centerpiece of the AND gate is a bisected chemical-tRNA synthetase ( gene ) that charges the chemical surrogate chemical ( chemical ) to tRNA ( chemical ) .	T6	T15	23406315
NA	CHEMICAL	GENE-Y	26	3	The centerpiece of the AND gate is a bisected chemical-tRNA synthetase ( gene ) that charges the chemical surrogate chemical ( chemical ) to tRNA ( chemical ) .	T7	T14	23406315
NA	CHEMICAL	GENE-Y	26	12	The centerpiece of the AND gate is a bisected chemical-tRNA synthetase ( gene ) that charges the chemical surrogate chemical ( chemical ) to tRNA ( chemical ) .	T7	T15	23406315
NA	CHEMICAL	GENE-Y	16	23	chemicalellular protein labeling occurs only upon activation of two different promoters that drive expression of the chemical- and C-terminal fragments of the bisected gene .	T8	T16	23406315
NA	CHEMICAL	GENE-Y	0	23	chemicalellular protein labeling occurs only upon activation of two different promoters that drive expression of the chemical- and C-terminal fragments of the bisected gene .	T9	T16	23406315
NA	CHEMICAL	GENE-N	25	13	The anti-UC activity of these compounds may be explained by reducing the pro-inflammatory gene gene ( gene ) , in addition to reduction of colonic chemical ( chemical ) contents .	T13	T16	23580316
NA	CHEMICAL	GENE-Y	25	14	The anti-UC activity of these compounds may be explained by reducing the pro-inflammatory gene gene ( gene ) , in addition to reduction of colonic chemical ( chemical ) contents .	T13	T17	23580316
NA	CHEMICAL	GENE-Y	25	16	The anti-UC activity of these compounds may be explained by reducing the pro-inflammatory gene gene ( gene ) , in addition to reduction of colonic chemical ( chemical ) contents .	T13	T18	23580316
NA	CHEMICAL	GENE-N	27	13	The anti-UC activity of these compounds may be explained by reducing the pro-inflammatory gene gene ( gene ) , in addition to reduction of colonic chemical ( chemical ) contents .	T14	T16	23580316
NA	CHEMICAL	GENE-Y	27	14	The anti-UC activity of these compounds may be explained by reducing the pro-inflammatory gene gene ( gene ) , in addition to reduction of colonic chemical ( chemical ) contents .	T14	T17	23580316
NA	CHEMICAL	GENE-Y	27	16	The anti-UC activity of these compounds may be explained by reducing the pro-inflammatory gene gene ( gene ) , in addition to reduction of colonic chemical ( chemical ) contents .	T14	T18	23580316
CPR:4	CHEMICAL	GENE-Y	0	6	chemical incorporating chemical moieties strongly inhibit gene .	T6	T17	23642478
CPR:4	CHEMICAL	GENE-Y	2	6	chemical incorporating chemical moieties strongly inhibit gene .	T7	T17	23642478
CPR:4	CHEMICAL	GENE-Y	3	13	A series of chemical incorporating chemical moieties ( chemical analogs ) were assayed as inhibitors of the gene ( gene , gene ) from Saccharomyces cerevisiae , gene .	T1	T8	23642478
CPR:4	CHEMICAL	GENE-N	3	0	A series of chemical incorporating chemical moieties ( chemical analogs ) were assayed as inhibitors of the gene ( gene , gene ) from Saccharomyces cerevisiae , gene .	T1	T9	23642478
CPR:4	CHEMICAL	GENE-Y	3	21	A series of chemical incorporating chemical moieties ( chemical analogs ) were assayed as inhibitors of the gene ( gene , gene ) from Saccharomyces cerevisiae , gene .	T1	T10	23642478
CPR:4	CHEMICAL	GENE-Y	3	0	A series of chemical incorporating chemical moieties ( chemical analogs ) were assayed as inhibitors of the gene ( gene , gene ) from Saccharomyces cerevisiae , gene .	T1	T11	23642478
CPR:4	CHEMICAL	GENE-Y	5	13	A series of chemical incorporating chemical moieties ( chemical analogs ) were assayed as inhibitors of the gene ( gene , gene ) from Saccharomyces cerevisiae , gene .	T2	T8	23642478
CPR:4	CHEMICAL	GENE-N	5	0	A series of chemical incorporating chemical moieties ( chemical analogs ) were assayed as inhibitors of the gene ( gene , gene ) from Saccharomyces cerevisiae , gene .	T2	T9	23642478
CPR:4	CHEMICAL	GENE-Y	5	21	A series of chemical incorporating chemical moieties ( chemical analogs ) were assayed as inhibitors of the gene ( gene , gene ) from Saccharomyces cerevisiae , gene .	T2	T10	23642478
CPR:4	CHEMICAL	GENE-Y	5	0	A series of chemical incorporating chemical moieties ( chemical analogs ) were assayed as inhibitors of the gene ( gene , gene ) from Saccharomyces cerevisiae , gene .	T2	T11	23642478
CPR:4	CHEMICAL	GENE-Y	8	13	A series of chemical incorporating chemical moieties ( chemical analogs ) were assayed as inhibitors of the gene ( gene , gene ) from Saccharomyces cerevisiae , gene .	T5	T8	23642478
CPR:4	CHEMICAL	GENE-N	8	0	A series of chemical incorporating chemical moieties ( chemical analogs ) were assayed as inhibitors of the gene ( gene , gene ) from Saccharomyces cerevisiae , gene .	T5	T9	23642478
CPR:4	CHEMICAL	GENE-Y	8	21	A series of chemical incorporating chemical moieties ( chemical analogs ) were assayed as inhibitors of the gene ( gene , gene ) from Saccharomyces cerevisiae , gene .	T5	T10	23642478
CPR:4	CHEMICAL	GENE-Y	8	0	A series of chemical incorporating chemical moieties ( chemical analogs ) were assayed as inhibitors of the gene ( gene , gene ) from Saccharomyces cerevisiae , gene .	T5	T11	23642478
NA	CHEMICAL	GENE-Y	3	13	The nonsteroidal antichemical chemical ( chemical ) weakly interacts with the prostatic cytosolic gene and shows a fast dissociation rate .	T7	T24	6374639
NA	CHEMICAL	GENE-Y	5	13	The nonsteroidal antichemical chemical ( chemical ) weakly interacts with the prostatic cytosolic gene and shows a fast dissociation rate .	T9	T24	6374639
NA	CHEMICAL	GENE-Y	2	13	The nonsteroidal antichemical chemical ( chemical ) weakly interacts with the prostatic cytosolic gene and shows a fast dissociation rate .	T12	T24	6374639
NA	CHEMICAL	GENE-N	17	24	This is due to the property of the pure antiandrogen to neutralize the inhibitory feedback effect of chemical at the pituitary level on the gene responsiveness to gene , as illustrated in vitro in rat anterior pituitary cells in culture as well as in vivo in intact and castrated animals .	T10	T22	6374639
NA	CHEMICAL	GENE-Y	17	27	This is due to the property of the pure antiandrogen to neutralize the inhibitory feedback effect of chemical at the pituitary level on the gene responsiveness to gene , as illustrated in vitro in rat anterior pituitary cells in culture as well as in vivo in intact and castrated animals .	T10	T23	6374639
NA	CHEMICAL	GENE-N	12	17	In intact animals , neutralization of the inhibitory feedback action of endogenous chemical leads to an increased gene and chemical secretion , which partly overcomes the direct action of the antiandrogen at the level of the prostate and seminal vesicles .	T11	T25	6374639
NA	CHEMICAL	GENE-N	14	17	In intact animals , neutralization of the inhibitory feedback action of endogenous chemical leads to an increased gene and chemical secretion , which partly overcomes the direct action of the antiandrogen at the level of the prostate and seminal vesicles .	T13	T25	6374639
NA	CHEMICAL	GENE-N	5	23	In fact , the plasma chemical concentration is more than doubled 6 hr after the administration of 10 mg of chemical while plasma gene and chemical levels are increased by 7- and 17-fold , respectively , after 14 days of similar daily treatment .	T1	T16	6374639
NA	CHEMICAL	GENE-N	20	23	In fact , the plasma chemical concentration is more than doubled 6 hr after the administration of 10 mg of chemical while plasma gene and chemical levels are increased by 7- and 17-fold , respectively , after 14 days of similar daily treatment .	T2	T16	6374639
NA	CHEMICAL	GENE-N	25	23	In fact , the plasma chemical concentration is more than doubled 6 hr after the administration of 10 mg of chemical while plasma gene and chemical levels are increased by 7- and 17-fold , respectively , after 14 days of similar daily treatment .	T3	T16	6374639
CPR:4	CHEMICAL	GENE-Y	0	2	chemical , a selective chemical reuptake inhibitor , exhibits high affinity and selectivity for the gene .	T10	T19	16633143
NA	CHEMICAL	GENE-Y	4	2	chemical , a selective chemical reuptake inhibitor , exhibits high affinity and selectivity for the gene .	T11	T19	16633143
NA	CHEMICAL	GENE-N	4	5	Neurochemical effects of the chemical oxidase inhibitor chemical on brain chemical and chemical : A comparison with chemical .	T56	T81	19203467
CPR:4	CHEMICAL	GENE-N	7	5	Neurochemical effects of the chemical oxidase inhibitor chemical on brain chemical and chemical : A comparison with chemical .	T57	T81	19203467
NA	CHEMICAL	GENE-N	10	5	Neurochemical effects of the chemical oxidase inhibitor chemical on brain chemical and chemical : A comparison with chemical .	T58	T81	19203467
NA	CHEMICAL	GENE-N	12	5	Neurochemical effects of the chemical oxidase inhibitor chemical on brain chemical and chemical : A comparison with chemical .	T59	T81	19203467
NA	CHEMICAL	GENE-N	17	5	Neurochemical effects of the chemical oxidase inhibitor chemical on brain chemical and chemical : A comparison with chemical .	T55	T81	19203467
CPR:4	CHEMICAL	GENE-N	4	18	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T26	T61	19203467
CPR:4	CHEMICAL	GENE-N	4	20	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T26	T63	19203467
NA	CHEMICAL	GENE-Y	4	9	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T26	T68	19203467
NA	CHEMICAL	GENE-Y	4	81	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T26	T69	19203467
NA	CHEMICAL	GENE-N	4	79	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T26	T70	19203467
NA	CHEMICAL	GENE-N	4	9	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T26	T72	19203467
CPR:4	CHEMICAL	GENE-N	6	18	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T33	T61	19203467
CPR:4	CHEMICAL	GENE-N	6	20	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T33	T63	19203467
NA	CHEMICAL	GENE-Y	6	9	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T33	T68	19203467
NA	CHEMICAL	GENE-Y	6	81	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T33	T69	19203467
NA	CHEMICAL	GENE-N	6	79	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T33	T70	19203467
NA	CHEMICAL	GENE-N	6	9	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T33	T72	19203467
NA	CHEMICAL	GENE-N	4	18	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T2	T61	19203467
NA	CHEMICAL	GENE-N	4	20	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T2	T63	19203467
NA	CHEMICAL	GENE-Y	4	9	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T2	T68	19203467
NA	CHEMICAL	GENE-Y	4	81	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T2	T69	19203467
NA	CHEMICAL	GENE-N	4	79	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T2	T70	19203467
NA	CHEMICAL	GENE-N	4	9	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T2	T72	19203467
NA	CHEMICAL	GENE-N	30	18	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T23	T61	19203467
NA	CHEMICAL	GENE-N	30	20	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T23	T63	19203467
NA	CHEMICAL	GENE-Y	30	9	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T23	T68	19203467
NA	CHEMICAL	GENE-Y	30	81	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T23	T69	19203467
NA	CHEMICAL	GENE-N	30	79	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T23	T70	19203467
NA	CHEMICAL	GENE-N	30	9	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T23	T72	19203467
NA	CHEMICAL	GENE-N	32	18	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T24	T61	19203467
NA	CHEMICAL	GENE-N	32	20	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T24	T63	19203467
NA	CHEMICAL	GENE-Y	32	9	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T24	T68	19203467
NA	CHEMICAL	GENE-Y	32	81	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T24	T69	19203467
NA	CHEMICAL	GENE-N	32	79	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T24	T70	19203467
NA	CHEMICAL	GENE-N	32	9	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T24	T72	19203467
NA	CHEMICAL	GENE-N	34	18	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T25	T61	19203467
NA	CHEMICAL	GENE-N	34	20	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T25	T63	19203467
NA	CHEMICAL	GENE-Y	34	9	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T25	T68	19203467
NA	CHEMICAL	GENE-Y	34	81	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T25	T69	19203467
NA	CHEMICAL	GENE-N	34	79	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T25	T70	19203467
NA	CHEMICAL	GENE-N	34	9	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T25	T72	19203467
NA	CHEMICAL	GENE-N	9	18	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T27	T61	19203467
NA	CHEMICAL	GENE-N	9	20	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T27	T63	19203467
NA	CHEMICAL	GENE-Y	9	9	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T27	T68	19203467
NA	CHEMICAL	GENE-Y	9	81	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T27	T69	19203467
NA	CHEMICAL	GENE-N	9	79	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T27	T70	19203467
NA	CHEMICAL	GENE-N	9	9	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T27	T72	19203467
NA	CHEMICAL	GENE-N	39	18	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T28	T61	19203467
NA	CHEMICAL	GENE-N	39	20	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T28	T63	19203467
NA	CHEMICAL	GENE-Y	39	9	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T28	T68	19203467
NA	CHEMICAL	GENE-Y	39	81	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T28	T69	19203467
NA	CHEMICAL	GENE-N	39	79	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T28	T70	19203467
NA	CHEMICAL	GENE-N	39	9	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T28	T72	19203467
NA	CHEMICAL	GENE-N	43	18	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T29	T61	19203467
NA	CHEMICAL	GENE-N	43	20	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T29	T63	19203467
CPR:4	CHEMICAL	GENE-Y	43	9	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T29	T68	19203467
CPR:4	CHEMICAL	GENE-Y	43	81	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T29	T69	19203467
NA	CHEMICAL	GENE-N	43	79	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T29	T70	19203467
NA	CHEMICAL	GENE-N	43	9	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T29	T72	19203467
NA	CHEMICAL	GENE-N	45	18	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T30	T61	19203467
NA	CHEMICAL	GENE-N	45	20	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T30	T63	19203467
CPR:4	CHEMICAL	GENE-Y	45	9	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T30	T68	19203467
CPR:4	CHEMICAL	GENE-Y	45	81	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T30	T69	19203467
NA	CHEMICAL	GENE-N	45	79	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T30	T70	19203467
NA	CHEMICAL	GENE-N	45	9	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T30	T72	19203467
NA	CHEMICAL	GENE-N	53	18	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T31	T61	19203467
NA	CHEMICAL	GENE-N	53	20	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T31	T63	19203467
NA	CHEMICAL	GENE-Y	53	9	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T31	T68	19203467
NA	CHEMICAL	GENE-Y	53	81	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T31	T69	19203467
NA	CHEMICAL	GENE-N	53	79	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T31	T70	19203467
NA	CHEMICAL	GENE-N	53	9	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T31	T72	19203467
NA	CHEMICAL	GENE-N	57	18	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T32	T61	19203467
NA	CHEMICAL	GENE-N	57	20	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T32	T63	19203467
NA	CHEMICAL	GENE-Y	57	9	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T32	T68	19203467
NA	CHEMICAL	GENE-Y	57	81	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T32	T69	19203467
NA	CHEMICAL	GENE-N	57	79	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T32	T70	19203467
NA	CHEMICAL	GENE-N	57	9	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T32	T72	19203467
NA	CHEMICAL	GENE-N	60	18	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T34	T61	19203467
NA	CHEMICAL	GENE-N	60	20	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T34	T63	19203467
NA	CHEMICAL	GENE-Y	60	9	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T34	T68	19203467
NA	CHEMICAL	GENE-Y	60	81	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T34	T69	19203467
NA	CHEMICAL	GENE-N	60	79	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T34	T70	19203467
NA	CHEMICAL	GENE-N	60	9	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T34	T72	19203467
NA	CHEMICAL	GENE-N	72	18	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T35	T61	19203467
NA	CHEMICAL	GENE-N	72	20	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T35	T63	19203467
NA	CHEMICAL	GENE-Y	72	9	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T35	T68	19203467
NA	CHEMICAL	GENE-Y	72	81	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T35	T69	19203467
NA	CHEMICAL	GENE-N	72	79	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T35	T70	19203467
NA	CHEMICAL	GENE-N	72	9	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T35	T72	19203467
NA	CHEMICAL	GENE-N	74	18	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T36	T61	19203467
NA	CHEMICAL	GENE-N	74	20	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T36	T63	19203467
NA	CHEMICAL	GENE-Y	74	9	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T36	T68	19203467
NA	CHEMICAL	GENE-Y	74	81	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T36	T69	19203467
NA	CHEMICAL	GENE-N	74	79	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T36	T70	19203467
NA	CHEMICAL	GENE-N	74	9	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T36	T72	19203467
NA	CHEMICAL	GENE-N	83	18	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T38	T61	19203467
NA	CHEMICAL	GENE-N	83	20	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T38	T63	19203467
NA	CHEMICAL	GENE-Y	83	9	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T38	T68	19203467
NA	CHEMICAL	GENE-Y	83	81	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T38	T69	19203467
NA	CHEMICAL	GENE-N	83	79	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T38	T70	19203467
NA	CHEMICAL	GENE-N	83	9	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T38	T72	19203467
NA	CHEMICAL	GENE-N	86	18	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T39	T61	19203467
NA	CHEMICAL	GENE-N	86	20	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T39	T63	19203467
NA	CHEMICAL	GENE-Y	86	9	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T39	T68	19203467
NA	CHEMICAL	GENE-Y	86	81	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T39	T69	19203467
NA	CHEMICAL	GENE-N	86	79	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T39	T70	19203467
NA	CHEMICAL	GENE-N	86	9	PURPOSE : To compare chemical ( chemical ) , an antidepressant drug with anxiolytic properties which inhibits chemical oxidase ( gene ) but also elevates rat brain levels of the chemical ? -chemical ( chemical ) and chemical ( chemical ) , with chemical ( chemical ) , an anticonvulsant which elevates brain chemical by inhibition of chemical transaminase ( chemical-T ) , with regard to their actions on brain levels of chemical and chemical and on activities of gene , gene and chemical transaminase ( chemical-T ) .	T39	T72	19203467
NA	CHEMICAL	GENE-N	6	51	METHODS : Male rats were administered chemical ( 10 mg/kg ) or chemical ( 1,000 mg/kg ) i.p. , and the rats were euthanized 4 hours later and the brains removed for analysis of levels of chemical and chemical ( by electron capture gas chromatography after derivatization ) and activities of gene , chemical-T and chemical-T ( radiochemical assays ) .	T40	T74	19203467
NA	CHEMICAL	GENE-N	12	51	METHODS : Male rats were administered chemical ( 10 mg/kg ) or chemical ( 1,000 mg/kg ) i.p. , and the rats were euthanized 4 hours later and the brains removed for analysis of levels of chemical and chemical ( by electron capture gas chromatography after derivatization ) and activities of gene , chemical-T and chemical-T ( radiochemical assays ) .	T41	T74	19203467
NA	CHEMICAL	GENE-N	36	51	METHODS : Male rats were administered chemical ( 10 mg/kg ) or chemical ( 1,000 mg/kg ) i.p. , and the rats were euthanized 4 hours later and the brains removed for analysis of levels of chemical and chemical ( by electron capture gas chromatography after derivatization ) and activities of gene , chemical-T and chemical-T ( radiochemical assays ) .	T42	T74	19203467
NA	CHEMICAL	GENE-N	38	51	METHODS : Male rats were administered chemical ( 10 mg/kg ) or chemical ( 1,000 mg/kg ) i.p. , and the rats were euthanized 4 hours later and the brains removed for analysis of levels of chemical and chemical ( by electron capture gas chromatography after derivatization ) and activities of gene , chemical-T and chemical-T ( radiochemical assays ) .	T43	T74	19203467
NA	CHEMICAL	GENE-N	53	51	METHODS : Male rats were administered chemical ( 10 mg/kg ) or chemical ( 1,000 mg/kg ) i.p. , and the rats were euthanized 4 hours later and the brains removed for analysis of levels of chemical and chemical ( by electron capture gas chromatography after derivatization ) and activities of gene , chemical-T and chemical-T ( radiochemical assays ) .	T44	T74	19203467
NA	CHEMICAL	GENE-N	55	51	METHODS : Male rats were administered chemical ( 10 mg/kg ) or chemical ( 1,000 mg/kg ) i.p. , and the rats were euthanized 4 hours later and the brains removed for analysis of levels of chemical and chemical ( by electron capture gas chromatography after derivatization ) and activities of gene , chemical-T and chemical-T ( radiochemical assays ) .	T45	T74	19203467
CPR:4	CHEMICAL	GENE-N	1	3	Only chemical inhibited gene and chemical-T and elevated chemical levels .	T50	T78	19203467
NA	CHEMICAL	GENE-N	5	3	Only chemical inhibited gene and chemical-T and elevated chemical levels .	T51	T78	19203467
NA	CHEMICAL	GENE-N	8	3	Only chemical inhibited gene and chemical-T and elevated chemical levels .	T52	T78	19203467
NA	CHEMICAL	GENE-N	3	9	The effects of chemical on both chemical and their gene were blocked by pre-treatment with the gene inhibitor chemical .	T53	T80	19203467
NA	CHEMICAL	GENE-N	3	16	The effects of chemical on both chemical and their gene were blocked by pre-treatment with the gene inhibitor chemical .	T53	T60	19203467
NA	CHEMICAL	GENE-N	6	9	The effects of chemical on both chemical and their gene were blocked by pre-treatment with the gene inhibitor chemical .	T54	T80	19203467
NA	CHEMICAL	GENE-N	6	16	The effects of chemical on both chemical and their gene were blocked by pre-treatment with the gene inhibitor chemical .	T54	T60	19203467
CPR:4	CHEMICAL	GENE-N	18	9	The effects of chemical on both chemical and their gene were blocked by pre-treatment with the gene inhibitor chemical .	T1	T80	19203467
CPR:4	CHEMICAL	GENE-N	18	16	The effects of chemical on both chemical and their gene were blocked by pre-treatment with the gene inhibitor chemical .	T1	T60	19203467
NA	CHEMICAL	GENE-N	7	26	CONCLUSIONS : At the doses studied , chemical was as effective as chemical at elevating brain chemical levels , but , unlike chemical , also inhibited gene and chemical-T ( and increased brain chemical levels ) .	T6	T64	19203467
NA	CHEMICAL	GENE-N	12	26	CONCLUSIONS : At the doses studied , chemical was as effective as chemical at elevating brain chemical levels , but , unlike chemical , also inhibited gene and chemical-T ( and increased brain chemical levels ) .	T7	T64	19203467
NA	CHEMICAL	GENE-N	16	26	CONCLUSIONS : At the doses studied , chemical was as effective as chemical at elevating brain chemical levels , but , unlike chemical , also inhibited gene and chemical-T ( and increased brain chemical levels ) .	T8	T64	19203467
CPR:4	CHEMICAL	GENE-N	22	26	CONCLUSIONS : At the doses studied , chemical was as effective as chemical at elevating brain chemical levels , but , unlike chemical , also inhibited gene and chemical-T ( and increased brain chemical levels ) .	T9	T64	19203467
NA	CHEMICAL	GENE-N	28	26	CONCLUSIONS : At the doses studied , chemical was as effective as chemical at elevating brain chemical levels , but , unlike chemical , also inhibited gene and chemical-T ( and increased brain chemical levels ) .	T10	T64	19203467
NA	CHEMICAL	GENE-N	33	26	CONCLUSIONS : At the doses studied , chemical was as effective as chemical at elevating brain chemical levels , but , unlike chemical , also inhibited gene and chemical-T ( and increased brain chemical levels ) .	T11	T64	19203467
CPR:4	CHEMICAL	GENE-N	7	5	Pretreatment of rats with the gene inhibitor chemical prevented the increase in brain chemical and chemical levels with chemical , but did not block the effect of chemical on chemical .	T12	T66	19203467
NA	CHEMICAL	GENE-N	13	5	Pretreatment of rats with the gene inhibitor chemical prevented the increase in brain chemical and chemical levels with chemical , but did not block the effect of chemical on chemical .	T13	T66	19203467
NA	CHEMICAL	GENE-N	15	5	Pretreatment of rats with the gene inhibitor chemical prevented the increase in brain chemical and chemical levels with chemical , but did not block the effect of chemical on chemical .	T14	T66	19203467
NA	CHEMICAL	GENE-N	18	5	Pretreatment of rats with the gene inhibitor chemical prevented the increase in brain chemical and chemical levels with chemical , but did not block the effect of chemical on chemical .	T15	T66	19203467
NA	CHEMICAL	GENE-N	27	5	Pretreatment of rats with the gene inhibitor chemical prevented the increase in brain chemical and chemical levels with chemical , but did not block the effect of chemical on chemical .	T16	T66	19203467
NA	CHEMICAL	GENE-N	29	5	Pretreatment of rats with the gene inhibitor chemical prevented the increase in brain chemical and chemical levels with chemical , but did not block the effect of chemical on chemical .	T17	T66	19203467
NA	CHEMICAL	GENE-Y	0	0	gene crystallized as a symmetric dimer formed by the interaction of hgene . Two molecules of chemical are bound in the dimer interface .	T1	T14	14676196
NA	CHEMICAL	GENE-N	0	11	gene crystallized as a symmetric dimer formed by the interaction of hgene . Two molecules of chemical are bound in the dimer interface .	T1	T15	14676196
CPR:4	CHEMICAL	GENE-N	7	5	Pharmacokinetic and pharmacodynamic modeling of gene inhibitor chemical for the inhibition of gene messenger RNA expression and antitumor efficacy in xenografted tumor model mice .	T6	T19	23298863
CPR:4	CHEMICAL	GENE-Y	7	12	Pharmacokinetic and pharmacodynamic modeling of gene inhibitor chemical for the inhibition of gene messenger RNA expression and antitumor efficacy in xenografted tumor model mice .	T6	T20	23298863
NA	CHEMICAL	GENE-N	0	9	chemical ( chemical ) is a potent , selective gene signaling pathway inhibitor that binds to gene and is being developed for the treatment of cancer .	T1	T13	23298863
NA	CHEMICAL	GENE-Y	0	16	chemical ( chemical ) is a potent , selective gene signaling pathway inhibitor that binds to gene and is being developed for the treatment of cancer .	T1	T14	23298863
CPR:4	CHEMICAL	GENE-N	2	9	chemical ( chemical ) is a potent , selective gene signaling pathway inhibitor that binds to gene and is being developed for the treatment of cancer .	T3	T13	23298863
NA	CHEMICAL	GENE-Y	2	16	chemical ( chemical ) is a potent , selective gene signaling pathway inhibitor that binds to gene and is being developed for the treatment of cancer .	T3	T14	23298863
NA	CHEMICAL	GENE-Y	19	24	The objectives of these studies were to explore the possibility of establishing of a link between the pharmacokinetics of chemical and the responses of gene mRNA in tumor-associated stromal or skin cells and the antitumor effect of gene inhibition .	T4	T15	23298863
NA	CHEMICAL	GENE-N	19	37	The objectives of these studies were to explore the possibility of establishing of a link between the pharmacokinetics of chemical and the responses of gene mRNA in tumor-associated stromal or skin cells and the antitumor effect of gene inhibition .	T4	T16	23298863
NA	CHEMICAL	GENE-Y	18	24	To this end , we built pharmacokinetic and pharmacodynamic models that describe the relationship of the concentrations of chemical plasma to the responses of gene mRNA in the tumor ( target ) and skin ( surrogate ) and to tumor growth inhibition in mice bearing xenografts of human pancreatic tumors ( PAN-04 ) .	T5	T17	23298863
CPR:4	CHEMICAL	GENE-Y	13	4	The IC50 values for gene mRNA inhibition in the tumor and skin by chemical were estimated to be 0.0457 and 0.113 μg/ml , respectively .	T2	T7	23298863
NA	CHEMICAL	GENE-Y	2	1	chemical transfer in chemical chemical-methyltransferase .	T15	T20	16851960
NA	CHEMICAL	GENE-Y	0	1	chemical transfer in chemical chemical-methyltransferase .	T16	T20	16851960
CPR:9	CHEMICAL	GENE-Y	22	16	Density functional theory calculations using the hybrid functional B3LYP have been performed to study the chemical transfer step in chemical chemical-methyltransferase ( gene ) .	T1	T17	16851960
CPR:9	CHEMICAL	GENE-Y	22	22	Density functional theory calculations using the hybrid functional B3LYP have been performed to study the chemical transfer step in chemical chemical-methyltransferase ( gene ) .	T1	T18	16851960
NA	CHEMICAL	GENE-Y	18	16	Density functional theory calculations using the hybrid functional B3LYP have been performed to study the chemical transfer step in chemical chemical-methyltransferase ( gene ) .	T2	T17	16851960
NA	CHEMICAL	GENE-Y	18	22	Density functional theory calculations using the hybrid functional B3LYP have been performed to study the chemical transfer step in chemical chemical-methyltransferase ( gene ) .	T2	T18	16851960
NA	CHEMICAL	GENE-Y	15	16	Density functional theory calculations using the hybrid functional B3LYP have been performed to study the chemical transfer step in chemical chemical-methyltransferase ( gene ) .	T3	T17	16851960
NA	CHEMICAL	GENE-Y	15	22	Density functional theory calculations using the hybrid functional B3LYP have been performed to study the chemical transfer step in chemical chemical-methyltransferase ( gene ) .	T3	T18	16851960
CPR:9	CHEMICAL	GENE-Y	16	13	The starting point for the calculations is the recent X-ray crystal structure of gene complexed with chemical and acetate .	T8	T19	16851960
NA	CHEMICAL	GENE-Y	0	11	chemical protects human dental pulp cells from chemical-induced oxidative toxicity via gene pathway-dependent gene expressions .	T19	T34	23318726
NA	CHEMICAL	GENE-Y	0	13	chemical protects human dental pulp cells from chemical-induced oxidative toxicity via gene pathway-dependent gene expressions .	T19	T33	23318726
NA	CHEMICAL	GENE-Y	7	11	chemical protects human dental pulp cells from chemical-induced oxidative toxicity via gene pathway-dependent gene expressions .	T20	T34	23318726
NA	CHEMICAL	GENE-Y	7	13	chemical protects human dental pulp cells from chemical-induced oxidative toxicity via gene pathway-dependent gene expressions .	T20	T33	23318726
CPR:3	CHEMICAL	GENE-Y	0	4	chemical also increased chemical oxygenase-1 ( gene ) protein expression and gene activity .	T14	T27	23318726
CPR:3	CHEMICAL	GENE-Y	0	6	chemical also increased chemical oxygenase-1 ( gene ) protein expression and gene activity .	T14	T28	23318726
CPR:3	CHEMICAL	GENE-Y	0	11	chemical also increased chemical oxygenase-1 ( gene ) protein expression and gene activity .	T14	T29	23318726
NA	CHEMICAL	GENE-Y	3	4	chemical also increased chemical oxygenase-1 ( gene ) protein expression and gene activity .	T15	T27	23318726
NA	CHEMICAL	GENE-Y	3	6	chemical also increased chemical oxygenase-1 ( gene ) protein expression and gene activity .	T15	T28	23318726
NA	CHEMICAL	GENE-Y	3	11	chemical also increased chemical oxygenase-1 ( gene ) protein expression and gene activity .	T15	T29	23318726
NA	CHEMICAL	GENE-Y	3	4	In addition , chemical-dependent gene expression was required for the inhibition of chemical-induced cell death and ROS generation .	T16	T30	23318726
NA	CHEMICAL	GENE-Y	12	4	In addition , chemical-dependent gene expression was required for the inhibition of chemical-induced cell death and ROS generation .	T17	T30	23318726
CPR:3	CHEMICAL	GENE-Y	2	8	Furthermore , chemical treatment caused nuclear accumulation of gene ( gene ) and increased the promoter activity of gene ( gene ) .	T18	T31	23318726
CPR:3	CHEMICAL	GENE-Y	2	10	Furthermore , chemical treatment caused nuclear accumulation of gene ( gene ) and increased the promoter activity of gene ( gene ) .	T18	T32	23318726
CPR:3	CHEMICAL	GENE-N	2	18	Furthermore , chemical treatment caused nuclear accumulation of gene ( gene ) and increased the promoter activity of gene ( gene ) .	T18	T21	23318726
CPR:3	CHEMICAL	GENE-N	2	20	Furthermore , chemical treatment caused nuclear accumulation of gene ( gene ) and increased the promoter activity of gene ( gene ) .	T18	T22	23318726
NA	CHEMICAL	GENE-N	6	5	Treatment of HDP cells with a gene ( gene ) inhibitor also reduced chemical-induced gene expression , and chemical treatment led to increased gene phosphorylation .	T2	T23	23318726
NA	CHEMICAL	GENE-N	6	8	Treatment of HDP cells with a gene ( gene ) inhibitor also reduced chemical-induced gene expression , and chemical treatment led to increased gene phosphorylation .	T2	T24	23318726
NA	CHEMICAL	GENE-Y	6	14	Treatment of HDP cells with a gene ( gene ) inhibitor also reduced chemical-induced gene expression , and chemical treatment led to increased gene phosphorylation .	T2	T25	23318726
NA	CHEMICAL	GENE-N	6	23	Treatment of HDP cells with a gene ( gene ) inhibitor also reduced chemical-induced gene expression , and chemical treatment led to increased gene phosphorylation .	T2	T26	23318726
NA	CHEMICAL	GENE-N	13	5	Treatment of HDP cells with a gene ( gene ) inhibitor also reduced chemical-induced gene expression , and chemical treatment led to increased gene phosphorylation .	T3	T23	23318726
NA	CHEMICAL	GENE-N	13	8	Treatment of HDP cells with a gene ( gene ) inhibitor also reduced chemical-induced gene expression , and chemical treatment led to increased gene phosphorylation .	T3	T24	23318726
CPR:3	CHEMICAL	GENE-Y	13	14	Treatment of HDP cells with a gene ( gene ) inhibitor also reduced chemical-induced gene expression , and chemical treatment led to increased gene phosphorylation .	T3	T25	23318726
NA	CHEMICAL	GENE-N	13	23	Treatment of HDP cells with a gene ( gene ) inhibitor also reduced chemical-induced gene expression , and chemical treatment led to increased gene phosphorylation .	T3	T26	23318726
NA	CHEMICAL	GENE-N	18	5	Treatment of HDP cells with a gene ( gene ) inhibitor also reduced chemical-induced gene expression , and chemical treatment led to increased gene phosphorylation .	T4	T23	23318726
NA	CHEMICAL	GENE-N	18	8	Treatment of HDP cells with a gene ( gene ) inhibitor also reduced chemical-induced gene expression , and chemical treatment led to increased gene phosphorylation .	T4	T24	23318726
NA	CHEMICAL	GENE-Y	18	14	Treatment of HDP cells with a gene ( gene ) inhibitor also reduced chemical-induced gene expression , and chemical treatment led to increased gene phosphorylation .	T4	T25	23318726
CPR:3	CHEMICAL	GENE-N	18	23	Treatment of HDP cells with a gene ( gene ) inhibitor also reduced chemical-induced gene expression , and chemical treatment led to increased gene phosphorylation .	T4	T26	23318726
CPR:4	CHEMICAL	GENE-Y	0	3	chemical therapy results in reduced mRNA expression of gene ( gene ) and gene in cells from bronchoalveolar lavage ( BAL ) but not of gene .	T11	T18	8600944
CPR:4	CHEMICAL	GENE-Y	0	10	chemical therapy results in reduced mRNA expression of gene ( gene ) and gene in cells from bronchoalveolar lavage ( BAL ) but not of gene .	T11	T22	8600944
CPR:4	CHEMICAL	GENE-Y	0	13	chemical therapy results in reduced mRNA expression of gene ( gene ) and gene in cells from bronchoalveolar lavage ( BAL ) but not of gene .	T11	T25	8600944
NA	CHEMICAL	GENE-Y	0	25	chemical therapy results in reduced mRNA expression of gene ( gene ) and gene in cells from bronchoalveolar lavage ( BAL ) but not of gene .	T11	T28	8600944
CPR:4	CHEMICAL	GENE-N	17	15	In vitro studies with blood-derived T cells , however , show inhibition of all three gene by chemical .	T7	T29	8600944
CPR:4	CHEMICAL	GENE-N	0	6	chemical ( chemical ) inhibited the anti-gene-induced production of gene , gene and gene in all 20 clones tested .	T9	T30	8600944
CPR:4	CHEMICAL	GENE-Y	0	9	chemical ( chemical ) inhibited the anti-gene-induced production of gene , gene and gene in all 20 clones tested .	T9	T31	8600944
CPR:4	CHEMICAL	GENE-Y	0	11	chemical ( chemical ) inhibited the anti-gene-induced production of gene , gene and gene in all 20 clones tested .	T9	T32	8600944
CPR:4	CHEMICAL	GENE-Y	0	13	chemical ( chemical ) inhibited the anti-gene-induced production of gene , gene and gene in all 20 clones tested .	T9	T33	8600944
CPR:4	CHEMICAL	GENE-N	2	6	chemical ( chemical ) inhibited the anti-gene-induced production of gene , gene and gene in all 20 clones tested .	T10	T30	8600944
CPR:4	CHEMICAL	GENE-Y	2	9	chemical ( chemical ) inhibited the anti-gene-induced production of gene , gene and gene in all 20 clones tested .	T10	T31	8600944
CPR:4	CHEMICAL	GENE-Y	2	11	chemical ( chemical ) inhibited the anti-gene-induced production of gene , gene and gene in all 20 clones tested .	T10	T32	8600944
CPR:4	CHEMICAL	GENE-Y	2	13	chemical ( chemical ) inhibited the anti-gene-induced production of gene , gene and gene in all 20 clones tested .	T10	T33	8600944
CPR:3	CHEMICAL	GENE-Y	0	4	chemical enhanced the ratio gene/gene ( mean +/- SEM : control , 28.7 +/- 17.6 ; with 10-7 M DEX , 55.0 +/- 27.5 , P < 0.005 ) .	T12	T37	8600944
CPR:3	CHEMICAL	GENE-Y	0	4	chemical enhanced the ratio gene/gene ( mean +/- SEM : control , 28.7 +/- 17.6 ; with 10-7 M DEX , 55.0 +/- 27.5 , P < 0.005 ) .	T12	T38	8600944
NA	CHEMICAL	GENE-Y	13	15	Interestingly , two categories of clones were distinguished based on the effects of chemical on gene production and gene expression and proliferation ; 1 ) In low gene producers chemical blocked gene production and decreased gene expression and proliferation ; 2 ) In high gene producers chemical inhibited gene production partially and enhanced gene expression and proliferation .	T13	T39	8600944
NA	CHEMICAL	GENE-Y	13	18	Interestingly , two categories of clones were distinguished based on the effects of chemical on gene production and gene expression and proliferation ; 1 ) In low gene producers chemical blocked gene production and decreased gene expression and proliferation ; 2 ) In high gene producers chemical inhibited gene production partially and enhanced gene expression and proliferation .	T13	T40	8600944
NA	CHEMICAL	GENE-Y	13	27	Interestingly , two categories of clones were distinguished based on the effects of chemical on gene production and gene expression and proliferation ; 1 ) In low gene producers chemical blocked gene production and decreased gene expression and proliferation ; 2 ) In high gene producers chemical inhibited gene production partially and enhanced gene expression and proliferation .	T13	T41	8600944
NA	CHEMICAL	GENE-Y	13	31	Interestingly , two categories of clones were distinguished based on the effects of chemical on gene production and gene expression and proliferation ; 1 ) In low gene producers chemical blocked gene production and decreased gene expression and proliferation ; 2 ) In high gene producers chemical inhibited gene production partially and enhanced gene expression and proliferation .	T13	T42	8600944
NA	CHEMICAL	GENE-Y	13	35	Interestingly , two categories of clones were distinguished based on the effects of chemical on gene production and gene expression and proliferation ; 1 ) In low gene producers chemical blocked gene production and decreased gene expression and proliferation ; 2 ) In high gene producers chemical inhibited gene production partially and enhanced gene expression and proliferation .	T13	T43	8600944
NA	CHEMICAL	GENE-Y	13	40	Interestingly , two categories of clones were distinguished based on the effects of chemical on gene production and gene expression and proliferation ; 1 ) In low gene producers chemical blocked gene production and decreased gene expression and proliferation ; 2 ) In high gene producers chemical inhibited gene production partially and enhanced gene expression and proliferation .	T13	T15	8600944
NA	CHEMICAL	GENE-Y	13	40	Interestingly , two categories of clones were distinguished based on the effects of chemical on gene production and gene expression and proliferation ; 1 ) In low gene producers chemical blocked gene production and decreased gene expression and proliferation ; 2 ) In high gene producers chemical inhibited gene production partially and enhanced gene expression and proliferation .	T13	T16	8600944
NA	CHEMICAL	GENE-Y	13	53	Interestingly , two categories of clones were distinguished based on the effects of chemical on gene production and gene expression and proliferation ; 1 ) In low gene producers chemical blocked gene production and decreased gene expression and proliferation ; 2 ) In high gene producers chemical inhibited gene production partially and enhanced gene expression and proliferation .	T13	T17	8600944
NA	CHEMICAL	GENE-Y	29	15	Interestingly , two categories of clones were distinguished based on the effects of chemical on gene production and gene expression and proliferation ; 1 ) In low gene producers chemical blocked gene production and decreased gene expression and proliferation ; 2 ) In high gene producers chemical inhibited gene production partially and enhanced gene expression and proliferation .	T14	T39	8600944
NA	CHEMICAL	GENE-Y	29	18	Interestingly , two categories of clones were distinguished based on the effects of chemical on gene production and gene expression and proliferation ; 1 ) In low gene producers chemical blocked gene production and decreased gene expression and proliferation ; 2 ) In high gene producers chemical inhibited gene production partially and enhanced gene expression and proliferation .	T14	T40	8600944
NA	CHEMICAL	GENE-Y	29	27	Interestingly , two categories of clones were distinguished based on the effects of chemical on gene production and gene expression and proliferation ; 1 ) In low gene producers chemical blocked gene production and decreased gene expression and proliferation ; 2 ) In high gene producers chemical inhibited gene production partially and enhanced gene expression and proliferation .	T14	T41	8600944
CPR:4	CHEMICAL	GENE-Y	29	31	Interestingly , two categories of clones were distinguished based on the effects of chemical on gene production and gene expression and proliferation ; 1 ) In low gene producers chemical blocked gene production and decreased gene expression and proliferation ; 2 ) In high gene producers chemical inhibited gene production partially and enhanced gene expression and proliferation .	T14	T42	8600944
CPR:4	CHEMICAL	GENE-Y	29	35	Interestingly , two categories of clones were distinguished based on the effects of chemical on gene production and gene expression and proliferation ; 1 ) In low gene producers chemical blocked gene production and decreased gene expression and proliferation ; 2 ) In high gene producers chemical inhibited gene production partially and enhanced gene expression and proliferation .	T14	T43	8600944
NA	CHEMICAL	GENE-Y	29	40	Interestingly , two categories of clones were distinguished based on the effects of chemical on gene production and gene expression and proliferation ; 1 ) In low gene producers chemical blocked gene production and decreased gene expression and proliferation ; 2 ) In high gene producers chemical inhibited gene production partially and enhanced gene expression and proliferation .	T14	T15	8600944
NA	CHEMICAL	GENE-Y	29	40	Interestingly , two categories of clones were distinguished based on the effects of chemical on gene production and gene expression and proliferation ; 1 ) In low gene producers chemical blocked gene production and decreased gene expression and proliferation ; 2 ) In high gene producers chemical inhibited gene production partially and enhanced gene expression and proliferation .	T14	T16	8600944
NA	CHEMICAL	GENE-Y	29	53	Interestingly , two categories of clones were distinguished based on the effects of chemical on gene production and gene expression and proliferation ; 1 ) In low gene producers chemical blocked gene production and decreased gene expression and proliferation ; 2 ) In high gene producers chemical inhibited gene production partially and enhanced gene expression and proliferation .	T14	T17	8600944
NA	CHEMICAL	GENE-Y	13	15	Interestingly , two categories of clones were distinguished based on the effects of chemical on gene production and gene expression and proliferation ; 1 ) In low gene producers chemical blocked gene production and decreased gene expression and proliferation ; 2 ) In high gene producers chemical inhibited gene production partially and enhanced gene expression and proliferation .	T1	T39	8600944
NA	CHEMICAL	GENE-Y	13	18	Interestingly , two categories of clones were distinguished based on the effects of chemical on gene production and gene expression and proliferation ; 1 ) In low gene producers chemical blocked gene production and decreased gene expression and proliferation ; 2 ) In high gene producers chemical inhibited gene production partially and enhanced gene expression and proliferation .	T1	T40	8600944
NA	CHEMICAL	GENE-Y	13	27	Interestingly , two categories of clones were distinguished based on the effects of chemical on gene production and gene expression and proliferation ; 1 ) In low gene producers chemical blocked gene production and decreased gene expression and proliferation ; 2 ) In high gene producers chemical inhibited gene production partially and enhanced gene expression and proliferation .	T1	T41	8600944
NA	CHEMICAL	GENE-Y	13	31	Interestingly , two categories of clones were distinguished based on the effects of chemical on gene production and gene expression and proliferation ; 1 ) In low gene producers chemical blocked gene production and decreased gene expression and proliferation ; 2 ) In high gene producers chemical inhibited gene production partially and enhanced gene expression and proliferation .	T1	T42	8600944
NA	CHEMICAL	GENE-Y	13	35	Interestingly , two categories of clones were distinguished based on the effects of chemical on gene production and gene expression and proliferation ; 1 ) In low gene producers chemical blocked gene production and decreased gene expression and proliferation ; 2 ) In high gene producers chemical inhibited gene production partially and enhanced gene expression and proliferation .	T1	T43	8600944
NA	CHEMICAL	GENE-Y	13	40	Interestingly , two categories of clones were distinguished based on the effects of chemical on gene production and gene expression and proliferation ; 1 ) In low gene producers chemical blocked gene production and decreased gene expression and proliferation ; 2 ) In high gene producers chemical inhibited gene production partially and enhanced gene expression and proliferation .	T1	T15	8600944
CPR:4	CHEMICAL	GENE-Y	13	40	Interestingly , two categories of clones were distinguished based on the effects of chemical on gene production and gene expression and proliferation ; 1 ) In low gene producers chemical blocked gene production and decreased gene expression and proliferation ; 2 ) In high gene producers chemical inhibited gene production partially and enhanced gene expression and proliferation .	T1	T16	8600944
CPR:3	CHEMICAL	GENE-Y	13	53	Interestingly , two categories of clones were distinguished based on the effects of chemical on gene production and gene expression and proliferation ; 1 ) In low gene producers chemical blocked gene production and decreased gene expression and proliferation ; 2 ) In high gene producers chemical inhibited gene production partially and enhanced gene expression and proliferation .	T1	T17	8600944
NA	CHEMICAL	GENE-Y	2	0	Anti-gene and anti-gene blocked the chemical-induced increase in proliferation .	T2	T19	8600944
NA	CHEMICAL	GENE-Y	2	2	Anti-gene and anti-gene blocked the chemical-induced increase in proliferation .	T2	T20	8600944
CPR:4	CHEMICAL	GENE-Y	26	6	In conclusion , the production of gene and gene by T-cell clones ( derived either from BAL or blood ) was more sensitive to inhibition by chemical than that of gene , which may account for the therapeutic effects of glucocorticosteroids in patients with asthma .	T3	T23	8600944
CPR:4	CHEMICAL	GENE-Y	26	8	In conclusion , the production of gene and gene by T-cell clones ( derived either from BAL or blood ) was more sensitive to inhibition by chemical than that of gene , which may account for the therapeutic effects of glucocorticosteroids in patients with asthma .	T3	T24	8600944
CPR:4	CHEMICAL	GENE-Y	26	30	In conclusion , the production of gene and gene by T-cell clones ( derived either from BAL or blood ) was more sensitive to inhibition by chemical than that of gene , which may account for the therapeutic effects of glucocorticosteroids in patients with asthma .	T3	T26	8600944
NA	CHEMICAL	GENE-Y	1	2	Polymorphisms in gene and gene transporters genes are associated with prolonged time to progression in unresectable gastrointestinal stromal tumours treated with chemical therapy .	T8	T24	23127916
NA	CHEMICAL	GENE-Y	1	4	Polymorphisms in gene and gene transporters genes are associated with prolonged time to progression in unresectable gastrointestinal stromal tumours treated with chemical therapy .	T8	T25	23127916
CPR:4	CHEMICAL	GENE-N	15	17	The two basic mainstays of gastrointestinal stromal tumours ( GIST ) treatment are surgery and chemical , a selective chemical kinase inhibitor that allows achieving a stable or responding disease in about 80 % of patients with unresectable/metastatic GIST .	T6	T13	23127916
NA	CHEMICAL	GENE-N	19	17	The two basic mainstays of gastrointestinal stromal tumours ( GIST ) treatment are surgery and chemical , a selective chemical kinase inhibitor that allows achieving a stable or responding disease in about 80 % of patients with unresectable/metastatic GIST .	T1	T13	23127916
NA	CHEMICAL	GENE-Y	2	6	Response to chemical mainly depends from gene and gene mutational status .	T3	T22	23127916
NA	CHEMICAL	GENE-Y	2	8	Response to chemical mainly depends from gene and gene mutational status .	T3	T23	23127916
NA	CHEMICAL	GENE-Y	2	6	The selective chemical ( chemical ) transporter inhibitor chemical ( formerly called chemical or chemical ) has been shown to alleviate symptoms in Attention Deficit/Hyperactivity Disorder ( ADHD ) .	T3	T32	12431845
NA	CHEMICAL	GENE-Y	4	6	The selective chemical ( chemical ) transporter inhibitor chemical ( formerly called chemical or chemical ) has been shown to alleviate symptoms in Attention Deficit/Hyperactivity Disorder ( ADHD ) .	T12	T32	12431845
CPR:4	CHEMICAL	GENE-Y	8	6	The selective chemical ( chemical ) transporter inhibitor chemical ( formerly called chemical or chemical ) has been shown to alleviate symptoms in Attention Deficit/Hyperactivity Disorder ( ADHD ) .	T19	T32	12431845
CPR:4	CHEMICAL	GENE-Y	12	6	The selective chemical ( chemical ) transporter inhibitor chemical ( formerly called chemical or chemical ) has been shown to alleviate symptoms in Attention Deficit/Hyperactivity Disorder ( ADHD ) .	T25	T32	12431845
CPR:4	CHEMICAL	GENE-Y	14	6	The selective chemical ( chemical ) transporter inhibitor chemical ( formerly called chemical or chemical ) has been shown to alleviate symptoms in Attention Deficit/Hyperactivity Disorder ( ADHD ) .	T27	T32	12431845
NA	CHEMICAL	GENE-N	7	18	We investigated the mechanism of action of chemical in ADHD by evaluating the interaction of chemical with chemical transporters , the effects on extracellular levels of chemical , and the expression of the neuronal activity marker gene in brain regions .	T10	T33	12431845
NA	CHEMICAL	GENE-Y	7	36	We investigated the mechanism of action of chemical in ADHD by evaluating the interaction of chemical with chemical transporters , the effects on extracellular levels of chemical , and the expression of the neuronal activity marker gene in brain regions .	T10	T34	12431845
NA	CHEMICAL	GENE-N	8	18	We investigated the mechanism of action of chemical in ADHD by evaluating the interaction of chemical with chemical transporters , the effects on extracellular levels of chemical , and the expression of the neuronal activity marker gene in brain regions .	T11	T33	12431845
NA	CHEMICAL	GENE-Y	8	36	We investigated the mechanism of action of chemical in ADHD by evaluating the interaction of chemical with chemical transporters , the effects on extracellular levels of chemical , and the expression of the neuronal activity marker gene in brain regions .	T11	T34	12431845
NA	CHEMICAL	GENE-N	8	18	We investigated the mechanism of action of chemical in ADHD by evaluating the interaction of chemical with chemical transporters , the effects on extracellular levels of chemical , and the expression of the neuronal activity marker gene in brain regions .	T13	T33	12431845
NA	CHEMICAL	GENE-Y	8	36	We investigated the mechanism of action of chemical in ADHD by evaluating the interaction of chemical with chemical transporters , the effects on extracellular levels of chemical , and the expression of the neuronal activity marker gene in brain regions .	T13	T34	12431845
NA	CHEMICAL	GENE-N	8	18	We investigated the mechanism of action of chemical in ADHD by evaluating the interaction of chemical with chemical transporters , the effects on extracellular levels of chemical , and the expression of the neuronal activity marker gene in brain regions .	T14	T33	12431845
NA	CHEMICAL	GENE-Y	8	36	We investigated the mechanism of action of chemical in ADHD by evaluating the interaction of chemical with chemical transporters , the effects on extracellular levels of chemical , and the expression of the neuronal activity marker gene in brain regions .	T14	T34	12431845
NA	CHEMICAL	GENE-N	0	11	chemical inhibited binding of radioligands to clonal cell lines transfected with gene with dissociation constants ( K ( i ) ) values of 5 , 77 and 1451 nM , respectively , demonstrating selectivity for chemical transporters .	T15	T35	12431845
NA	CHEMICAL	GENE-Y	0	36	chemical inhibited binding of radioligands to clonal cell lines transfected with gene with dissociation constants ( K ( i ) ) values of 5 , 77 and 1451 nM , respectively , demonstrating selectivity for chemical transporters .	T15	T36	12431845
NA	CHEMICAL	GENE-N	35	11	chemical inhibited binding of radioligands to clonal cell lines transfected with gene with dissociation constants ( K ( i ) ) values of 5 , 77 and 1451 nM , respectively , demonstrating selectivity for chemical transporters .	T16	T35	12431845
NA	CHEMICAL	GENE-Y	35	36	chemical inhibited binding of radioligands to clonal cell lines transfected with gene with dissociation constants ( K ( i ) ) values of 5 , 77 and 1451 nM , respectively , demonstrating selectivity for chemical transporters .	T16	T36	12431845
NA	CHEMICAL	GENE-N	5	11	chemical inhibited binding of radioligands to clonal cell lines transfected with gene with dissociation constants ( K ( i ) ) values of 5 , 77 and 1451 nM , respectively , demonstrating selectivity for chemical transporters .	T17	T35	12431845
NA	CHEMICAL	GENE-Y	5	36	chemical inhibited binding of radioligands to clonal cell lines transfected with gene with dissociation constants ( K ( i ) ) values of 5 , 77 and 1451 nM , respectively , demonstrating selectivity for chemical transporters .	T17	T36	12431845
NA	CHEMICAL	GENE-N	23	11	chemical inhibited binding of radioligands to clonal cell lines transfected with gene with dissociation constants ( K ( i ) ) values of 5 , 77 and 1451 nM , respectively , demonstrating selectivity for chemical transporters .	T18	T35	12431845
NA	CHEMICAL	GENE-Y	23	36	chemical inhibited binding of radioligands to clonal cell lines transfected with gene with dissociation constants ( K ( i ) ) values of 5 , 77 and 1451 nM , respectively , demonstrating selectivity for chemical transporters .	T18	T36	12431845
NA	CHEMICAL	GENE-N	18	11	chemical inhibited binding of radioligands to clonal cell lines transfected with gene with dissociation constants ( K ( i ) ) values of 5 , 77 and 1451 nM , respectively , demonstrating selectivity for chemical transporters .	T20	T35	12431845
NA	CHEMICAL	GENE-Y	18	36	chemical inhibited binding of radioligands to clonal cell lines transfected with gene with dissociation constants ( K ( i ) ) values of 5 , 77 and 1451 nM , respectively , demonstrating selectivity for chemical transporters .	T20	T36	12431845
NA	CHEMICAL	GENE-Y	11	7	The expression of the neuronal activity marker gene was increased 3.7-fold in PFC by chemical administration , but was not increased in the striatum or nucleus accumbens , consistent with the regional distribution of increased DA ( EX ) .	T2	T31	12431845
NA	CHEMICAL	GENE-N	8	4	We begin by capturing gene using a complementary chemical oligonucleotide tethered to beads .	T1	T4	23249751
CPR:4	CHEMICAL	GENE-Y	10	14	No influence of moderate hepatic impairment on the pharmacokinetics of chemical , an oral gene selective inhibitor .	T11	T14	15177307
CPR:4	CHEMICAL	GENE-Y	28	22	The aim of this study was to evaluate the influence of hepatic impairment on the pharmacokinetics ( PK ) of the novel gene ( gene ) selective inhibitor chemical ( chemical ) , so that dose recommendations for clinical use can be provided .	T6	T12	15177307
CPR:4	CHEMICAL	GENE-Y	28	24	The aim of this study was to evaluate the influence of hepatic impairment on the pharmacokinetics ( PK ) of the novel gene ( gene ) selective inhibitor chemical ( chemical ) , so that dose recommendations for clinical use can be provided .	T6	T13	15177307
CPR:4	CHEMICAL	GENE-Y	30	22	The aim of this study was to evaluate the influence of hepatic impairment on the pharmacokinetics ( PK ) of the novel gene ( gene ) selective inhibitor chemical ( chemical ) , so that dose recommendations for clinical use can be provided .	T7	T12	15177307
CPR:4	CHEMICAL	GENE-Y	30	24	The aim of this study was to evaluate the influence of hepatic impairment on the pharmacokinetics ( PK ) of the novel gene ( gene ) selective inhibitor chemical ( chemical ) , so that dose recommendations for clinical use can be provided .	T7	T13	15177307
NA	CHEMICAL	GENE-N	3	1	The gene are chemical-dependent gene that bind certain sialylated , fucosylated , sulfated glycoprotein ligands .	T3	T24	9466983
NA	CHEMICAL	GENE-N	3	4	The gene are chemical-dependent gene that bind certain sialylated , fucosylated , sulfated glycoprotein ligands .	T3	T21	9466983
NA	CHEMICAL	GENE-Y	6	0	gene also recognizes endothelial proteoglycans in a chemical-dependent manner , via heparan sulfate ( HS ) glycosaminoglycan chains enriched in unsubstituted chemical units .	T4	T13	9466983
NA	CHEMICAL	GENE-Y	5	0	gene also recognizes endothelial proteoglycans in a chemical-dependent manner , via heparan sulfate ( HS ) glycosaminoglycan chains enriched in unsubstituted chemical units .	T5	T13	9466983
NA	CHEMICAL	GENE-Y	11	7	Despite this , HS chains bound to gene are eluted by chemical ( chemical ) , but only at high concentrations .	T6	T26	9466983
NA	CHEMICAL	GENE-Y	13	7	Despite this , HS chains bound to gene are eluted by chemical ( chemical ) , but only at high concentrations .	T7	T26	9466983
NA	CHEMICAL	GENE-Y	21	19	Porcine intestinal mucosal ( mast cell-derived ) heparin ( PIM-heparin ) shows similar properties , with no binding to gene , chemical-dependent binding of a subfraction to gene and to gene , and chemical-independent binding of a larger fraction to gene , the latter being disrupted by high chemical concentrations .	T8	T27	9466983
NA	CHEMICAL	GENE-Y	21	27	Porcine intestinal mucosal ( mast cell-derived ) heparin ( PIM-heparin ) shows similar properties , with no binding to gene , chemical-dependent binding of a subfraction to gene and to gene , and chemical-independent binding of a larger fraction to gene , the latter being disrupted by high chemical concentrations .	T8	T28	9466983
NA	CHEMICAL	GENE-Y	21	30	Porcine intestinal mucosal ( mast cell-derived ) heparin ( PIM-heparin ) shows similar properties , with no binding to gene , chemical-dependent binding of a subfraction to gene and to gene , and chemical-independent binding of a larger fraction to gene , the latter being disrupted by high chemical concentrations .	T8	T29	9466983
NA	CHEMICAL	GENE-Y	21	40	Porcine intestinal mucosal ( mast cell-derived ) heparin ( PIM-heparin ) shows similar properties , with no binding to gene , chemical-dependent binding of a subfraction to gene and to gene , and chemical-independent binding of a larger fraction to gene , the latter being disrupted by high chemical concentrations .	T8	T30	9466983
NA	CHEMICAL	GENE-Y	24	19	Porcine intestinal mucosal ( mast cell-derived ) heparin ( PIM-heparin ) shows similar properties , with no binding to gene , chemical-dependent binding of a subfraction to gene and to gene , and chemical-independent binding of a larger fraction to gene , the latter being disrupted by high chemical concentrations .	T9	T27	9466983
NA	CHEMICAL	GENE-Y	24	27	Porcine intestinal mucosal ( mast cell-derived ) heparin ( PIM-heparin ) shows similar properties , with no binding to gene , chemical-dependent binding of a subfraction to gene and to gene , and chemical-independent binding of a larger fraction to gene , the latter being disrupted by high chemical concentrations .	T9	T28	9466983
NA	CHEMICAL	GENE-Y	24	30	Porcine intestinal mucosal ( mast cell-derived ) heparin ( PIM-heparin ) shows similar properties , with no binding to gene , chemical-dependent binding of a subfraction to gene and to gene , and chemical-independent binding of a larger fraction to gene , the latter being disrupted by high chemical concentrations .	T9	T29	9466983
NA	CHEMICAL	GENE-Y	24	40	Porcine intestinal mucosal ( mast cell-derived ) heparin ( PIM-heparin ) shows similar properties , with no binding to gene , chemical-dependent binding of a subfraction to gene and to gene , and chemical-independent binding of a larger fraction to gene , the latter being disrupted by high chemical concentrations .	T9	T30	9466983
NA	CHEMICAL	GENE-Y	48	19	Porcine intestinal mucosal ( mast cell-derived ) heparin ( PIM-heparin ) shows similar properties , with no binding to gene , chemical-dependent binding of a subfraction to gene and to gene , and chemical-independent binding of a larger fraction to gene , the latter being disrupted by high chemical concentrations .	T10	T27	9466983
NA	CHEMICAL	GENE-Y	48	27	Porcine intestinal mucosal ( mast cell-derived ) heparin ( PIM-heparin ) shows similar properties , with no binding to gene , chemical-dependent binding of a subfraction to gene and to gene , and chemical-independent binding of a larger fraction to gene , the latter being disrupted by high chemical concentrations .	T10	T28	9466983
NA	CHEMICAL	GENE-Y	48	30	Porcine intestinal mucosal ( mast cell-derived ) heparin ( PIM-heparin ) shows similar properties , with no binding to gene , chemical-dependent binding of a subfraction to gene and to gene , and chemical-independent binding of a larger fraction to gene , the latter being disrupted by high chemical concentrations .	T10	T29	9466983
NA	CHEMICAL	GENE-Y	48	40	Porcine intestinal mucosal ( mast cell-derived ) heparin ( PIM-heparin ) shows similar properties , with no binding to gene , chemical-dependent binding of a subfraction to gene and to gene , and chemical-independent binding of a larger fraction to gene , the latter being disrupted by high chemical concentrations .	T10	T30	9466983
NA	CHEMICAL	GENE-N	7	20	Analysis of defined heparin fragment pools shows a size dependence for interaction , with chemical showing easily detectable binding to gene affinity columns .	T1	T11	9466983
NA	CHEMICAL	GENE-Y	22	0	gene binding fragments include more heavily sulfated and epimerized regions and , as with the endothelial HS chains , they are enriched in chemical groups .	T2	T12	9466983
NA	CHEMICAL	GENE-Y	14	34	A major part of this processing requires endoproteolytic cleavage at specific pairs of basic chemical residues , an event necessary for the maturation of a variety of important biologically active proteins , such as gene and gene .	T2	T10	1435788
NA	CHEMICAL	GENE-Y	14	24	A major part of this processing requires endoproteolytic cleavage at specific pairs of basic chemical residues , an event necessary for the maturation of a variety of important biologically active proteins , such as gene and gene .	T2	T11	1435788
NA	CHEMICAL	GENE-N	7	8	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T10	T28	23614730
NA	CHEMICAL	GENE-N	7	10	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T10	T29	23614730
NA	CHEMICAL	GENE-Y	7	13	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T10	T30	23614730
NA	CHEMICAL	GENE-Y	7	15	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T10	T31	23614730
NA	CHEMICAL	GENE-N	7	19	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T10	T32	23614730
NA	CHEMICAL	GENE-N	7	21	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T10	T33	23614730
NA	CHEMICAL	GENE-Y	7	9	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T10	T34	23614730
NA	CHEMICAL	GENE-Y	7	9	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T10	T35	23614730
NA	CHEMICAL	GENE-Y	7	38	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T10	T36	23614730
NA	CHEMICAL	GENE-Y	7	40	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T10	T37	23614730
NA	CHEMICAL	GENE-N	7	48	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T10	T38	23614730
NA	CHEMICAL	GENE-N	7	44	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T10	T39	23614730
NA	CHEMICAL	GENE-N	7	52	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T10	T40	23614730
NA	CHEMICAL	GENE-N	18	8	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T11	T28	23614730
NA	CHEMICAL	GENE-N	18	10	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T11	T29	23614730
NA	CHEMICAL	GENE-Y	18	13	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T11	T30	23614730
NA	CHEMICAL	GENE-Y	18	15	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T11	T31	23614730
NA	CHEMICAL	GENE-N	18	19	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T11	T32	23614730
NA	CHEMICAL	GENE-N	18	21	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T11	T33	23614730
NA	CHEMICAL	GENE-Y	18	9	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T11	T34	23614730
NA	CHEMICAL	GENE-Y	18	9	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T11	T35	23614730
NA	CHEMICAL	GENE-Y	18	38	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T11	T36	23614730
NA	CHEMICAL	GENE-Y	18	40	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T11	T37	23614730
NA	CHEMICAL	GENE-N	18	48	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T11	T38	23614730
NA	CHEMICAL	GENE-N	18	44	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T11	T39	23614730
NA	CHEMICAL	GENE-N	18	52	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T11	T40	23614730
NA	CHEMICAL	GENE-N	24	8	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T12	T28	23614730
NA	CHEMICAL	GENE-N	24	10	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T12	T29	23614730
NA	CHEMICAL	GENE-Y	24	13	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T12	T30	23614730
NA	CHEMICAL	GENE-Y	24	15	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T12	T31	23614730
NA	CHEMICAL	GENE-N	24	19	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T12	T32	23614730
NA	CHEMICAL	GENE-N	24	21	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T12	T33	23614730
NA	CHEMICAL	GENE-Y	24	9	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T12	T34	23614730
NA	CHEMICAL	GENE-Y	24	9	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T12	T35	23614730
NA	CHEMICAL	GENE-Y	24	38	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T12	T36	23614730
NA	CHEMICAL	GENE-Y	24	40	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T12	T37	23614730
NA	CHEMICAL	GENE-N	24	48	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T12	T38	23614730
NA	CHEMICAL	GENE-N	24	44	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T12	T39	23614730
NA	CHEMICAL	GENE-N	24	52	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T12	T40	23614730
NA	CHEMICAL	GENE-N	26	8	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T13	T28	23614730
NA	CHEMICAL	GENE-N	26	10	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T13	T29	23614730
NA	CHEMICAL	GENE-Y	26	13	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T13	T30	23614730
NA	CHEMICAL	GENE-Y	26	15	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T13	T31	23614730
NA	CHEMICAL	GENE-N	26	19	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T13	T32	23614730
NA	CHEMICAL	GENE-N	26	21	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T13	T33	23614730
NA	CHEMICAL	GENE-Y	26	9	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T13	T34	23614730
NA	CHEMICAL	GENE-Y	26	9	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T13	T35	23614730
NA	CHEMICAL	GENE-Y	26	38	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T13	T36	23614730
NA	CHEMICAL	GENE-Y	26	40	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T13	T37	23614730
NA	CHEMICAL	GENE-N	26	48	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T13	T38	23614730
NA	CHEMICAL	GENE-N	26	44	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T13	T39	23614730
NA	CHEMICAL	GENE-N	26	52	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T13	T40	23614730
NA	CHEMICAL	GENE-N	29	8	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T14	T28	23614730
NA	CHEMICAL	GENE-N	29	10	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T14	T29	23614730
NA	CHEMICAL	GENE-Y	29	13	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T14	T30	23614730
NA	CHEMICAL	GENE-Y	29	15	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T14	T31	23614730
NA	CHEMICAL	GENE-N	29	19	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T14	T32	23614730
NA	CHEMICAL	GENE-N	29	21	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T14	T33	23614730
NA	CHEMICAL	GENE-Y	29	9	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T14	T34	23614730
NA	CHEMICAL	GENE-Y	29	9	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T14	T35	23614730
NA	CHEMICAL	GENE-Y	29	38	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T14	T36	23614730
NA	CHEMICAL	GENE-Y	29	40	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T14	T37	23614730
NA	CHEMICAL	GENE-N	29	48	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T14	T38	23614730
NA	CHEMICAL	GENE-N	29	44	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T14	T39	23614730
NA	CHEMICAL	GENE-N	29	52	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T14	T40	23614730
NA	CHEMICAL	GENE-N	31	8	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T15	T28	23614730
NA	CHEMICAL	GENE-N	31	10	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T15	T29	23614730
NA	CHEMICAL	GENE-Y	31	13	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T15	T30	23614730
NA	CHEMICAL	GENE-Y	31	15	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T15	T31	23614730
NA	CHEMICAL	GENE-N	31	19	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T15	T32	23614730
NA	CHEMICAL	GENE-N	31	21	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T15	T33	23614730
NA	CHEMICAL	GENE-Y	31	9	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T15	T34	23614730
NA	CHEMICAL	GENE-Y	31	9	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T15	T35	23614730
NA	CHEMICAL	GENE-Y	31	38	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T15	T36	23614730
NA	CHEMICAL	GENE-Y	31	40	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T15	T37	23614730
NA	CHEMICAL	GENE-N	31	48	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T15	T38	23614730
NA	CHEMICAL	GENE-N	31	44	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T15	T39	23614730
NA	CHEMICAL	GENE-N	31	52	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T15	T40	23614730
NA	CHEMICAL	GENE-N	43	8	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T16	T28	23614730
NA	CHEMICAL	GENE-N	43	10	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T16	T29	23614730
NA	CHEMICAL	GENE-Y	43	13	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T16	T30	23614730
NA	CHEMICAL	GENE-Y	43	15	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T16	T31	23614730
NA	CHEMICAL	GENE-N	43	19	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T16	T32	23614730
NA	CHEMICAL	GENE-N	43	21	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T16	T33	23614730
NA	CHEMICAL	GENE-Y	43	9	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T16	T34	23614730
NA	CHEMICAL	GENE-Y	43	9	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T16	T35	23614730
NA	CHEMICAL	GENE-Y	43	38	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T16	T36	23614730
NA	CHEMICAL	GENE-Y	43	40	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T16	T37	23614730
NA	CHEMICAL	GENE-N	43	48	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T16	T38	23614730
NA	CHEMICAL	GENE-N	43	44	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T16	T39	23614730
NA	CHEMICAL	GENE-N	43	52	Total blood count , blood indices of chemical kinase ( gene ) , gene ( gene ) , chemical dismutase ( gene ) , chemical ( chemical ) , chemical ( chemical ) , gene , gene , gene ( gene ) , chemical antigen ( CA ) 19.9 and gene ( gene ) were assayed .	T16	T40	23614730
CPR:3	CHEMICAL	GENE-N	5	13	Results : The administration of chemical 1.6 % w/w created significant increased changes in the levels of total WBC , lymphocytes , RBC , gene , packed cell volume , platelets , mean corpuscular volume , and mean corpuscular gene in rats after 24 , 48 , and 72 h of continuous inhalation ; however , there was a significant reduction in neutrophils at transient reduction in the monocytes after 24 and 48 h to return to normal after 72 h. Significant increases in the levels of gene , gene , gene , chemical , chemical , gene , gene , and gene were recorded .	T1	T17	23614730
CPR:3	CHEMICAL	GENE-N	5	13	Results : The administration of chemical 1.6 % w/w created significant increased changes in the levels of total WBC , lymphocytes , RBC , gene , packed cell volume , platelets , mean corpuscular volume , and mean corpuscular gene in rats after 24 , 48 , and 72 h of continuous inhalation ; however , there was a significant reduction in neutrophils at transient reduction in the monocytes after 24 and 48 h to return to normal after 72 h. Significant increases in the levels of gene , gene , gene , chemical , chemical , gene , gene , and gene were recorded .	T1	T18	23614730
NA	CHEMICAL	GENE-N	5	87	Results : The administration of chemical 1.6 % w/w created significant increased changes in the levels of total WBC , lymphocytes , RBC , gene , packed cell volume , platelets , mean corpuscular volume , and mean corpuscular gene in rats after 24 , 48 , and 72 h of continuous inhalation ; however , there was a significant reduction in neutrophils at transient reduction in the monocytes after 24 and 48 h to return to normal after 72 h. Significant increases in the levels of gene , gene , gene , chemical , chemical , gene , gene , and gene were recorded .	T1	T19	23614730
NA	CHEMICAL	GENE-Y	5	89	Results : The administration of chemical 1.6 % w/w created significant increased changes in the levels of total WBC , lymphocytes , RBC , gene , packed cell volume , platelets , mean corpuscular volume , and mean corpuscular gene in rats after 24 , 48 , and 72 h of continuous inhalation ; however , there was a significant reduction in neutrophils at transient reduction in the monocytes after 24 and 48 h to return to normal after 72 h. Significant increases in the levels of gene , gene , gene , chemical , chemical , gene , gene , and gene were recorded .	T1	T20	23614730
NA	CHEMICAL	GENE-N	5	91	Results : The administration of chemical 1.6 % w/w created significant increased changes in the levels of total WBC , lymphocytes , RBC , gene , packed cell volume , platelets , mean corpuscular volume , and mean corpuscular gene in rats after 24 , 48 , and 72 h of continuous inhalation ; however , there was a significant reduction in neutrophils at transient reduction in the monocytes after 24 and 48 h to return to normal after 72 h. Significant increases in the levels of gene , gene , gene , chemical , chemical , gene , gene , and gene were recorded .	T1	T21	23614730
NA	CHEMICAL	GENE-Y	5	97	Results : The administration of chemical 1.6 % w/w created significant increased changes in the levels of total WBC , lymphocytes , RBC , gene , packed cell volume , platelets , mean corpuscular volume , and mean corpuscular gene in rats after 24 , 48 , and 72 h of continuous inhalation ; however , there was a significant reduction in neutrophils at transient reduction in the monocytes after 24 and 48 h to return to normal after 72 h. Significant increases in the levels of gene , gene , gene , chemical , chemical , gene , gene , and gene were recorded .	T1	T22	23614730
NA	CHEMICAL	GENE-Y	5	99	Results : The administration of chemical 1.6 % w/w created significant increased changes in the levels of total WBC , lymphocytes , RBC , gene , packed cell volume , platelets , mean corpuscular volume , and mean corpuscular gene in rats after 24 , 48 , and 72 h of continuous inhalation ; however , there was a significant reduction in neutrophils at transient reduction in the monocytes after 24 and 48 h to return to normal after 72 h. Significant increases in the levels of gene , gene , gene , chemical , chemical , gene , gene , and gene were recorded .	T1	T23	23614730
NA	CHEMICAL	GENE-Y	5	102	Results : The administration of chemical 1.6 % w/w created significant increased changes in the levels of total WBC , lymphocytes , RBC , gene , packed cell volume , platelets , mean corpuscular volume , and mean corpuscular gene in rats after 24 , 48 , and 72 h of continuous inhalation ; however , there was a significant reduction in neutrophils at transient reduction in the monocytes after 24 and 48 h to return to normal after 72 h. Significant increases in the levels of gene , gene , gene , chemical , chemical , gene , gene , and gene were recorded .	T1	T24	23614730
NA	CHEMICAL	GENE-N	89	13	Results : The administration of chemical 1.6 % w/w created significant increased changes in the levels of total WBC , lymphocytes , RBC , gene , packed cell volume , platelets , mean corpuscular volume , and mean corpuscular gene in rats after 24 , 48 , and 72 h of continuous inhalation ; however , there was a significant reduction in neutrophils at transient reduction in the monocytes after 24 and 48 h to return to normal after 72 h. Significant increases in the levels of gene , gene , gene , chemical , chemical , gene , gene , and gene were recorded .	T2	T17	23614730
NA	CHEMICAL	GENE-N	89	13	Results : The administration of chemical 1.6 % w/w created significant increased changes in the levels of total WBC , lymphocytes , RBC , gene , packed cell volume , platelets , mean corpuscular volume , and mean corpuscular gene in rats after 24 , 48 , and 72 h of continuous inhalation ; however , there was a significant reduction in neutrophils at transient reduction in the monocytes after 24 and 48 h to return to normal after 72 h. Significant increases in the levels of gene , gene , gene , chemical , chemical , gene , gene , and gene were recorded .	T2	T18	23614730
NA	CHEMICAL	GENE-N	89	87	Results : The administration of chemical 1.6 % w/w created significant increased changes in the levels of total WBC , lymphocytes , RBC , gene , packed cell volume , platelets , mean corpuscular volume , and mean corpuscular gene in rats after 24 , 48 , and 72 h of continuous inhalation ; however , there was a significant reduction in neutrophils at transient reduction in the monocytes after 24 and 48 h to return to normal after 72 h. Significant increases in the levels of gene , gene , gene , chemical , chemical , gene , gene , and gene were recorded .	T2	T19	23614730
NA	CHEMICAL	GENE-Y	89	89	Results : The administration of chemical 1.6 % w/w created significant increased changes in the levels of total WBC , lymphocytes , RBC , gene , packed cell volume , platelets , mean corpuscular volume , and mean corpuscular gene in rats after 24 , 48 , and 72 h of continuous inhalation ; however , there was a significant reduction in neutrophils at transient reduction in the monocytes after 24 and 48 h to return to normal after 72 h. Significant increases in the levels of gene , gene , gene , chemical , chemical , gene , gene , and gene were recorded .	T2	T20	23614730
NA	CHEMICAL	GENE-N	89	91	Results : The administration of chemical 1.6 % w/w created significant increased changes in the levels of total WBC , lymphocytes , RBC , gene , packed cell volume , platelets , mean corpuscular volume , and mean corpuscular gene in rats after 24 , 48 , and 72 h of continuous inhalation ; however , there was a significant reduction in neutrophils at transient reduction in the monocytes after 24 and 48 h to return to normal after 72 h. Significant increases in the levels of gene , gene , gene , chemical , chemical , gene , gene , and gene were recorded .	T2	T21	23614730
NA	CHEMICAL	GENE-Y	89	97	Results : The administration of chemical 1.6 % w/w created significant increased changes in the levels of total WBC , lymphocytes , RBC , gene , packed cell volume , platelets , mean corpuscular volume , and mean corpuscular gene in rats after 24 , 48 , and 72 h of continuous inhalation ; however , there was a significant reduction in neutrophils at transient reduction in the monocytes after 24 and 48 h to return to normal after 72 h. Significant increases in the levels of gene , gene , gene , chemical , chemical , gene , gene , and gene were recorded .	T2	T22	23614730
NA	CHEMICAL	GENE-Y	89	99	Results : The administration of chemical 1.6 % w/w created significant increased changes in the levels of total WBC , lymphocytes , RBC , gene , packed cell volume , platelets , mean corpuscular volume , and mean corpuscular gene in rats after 24 , 48 , and 72 h of continuous inhalation ; however , there was a significant reduction in neutrophils at transient reduction in the monocytes after 24 and 48 h to return to normal after 72 h. Significant increases in the levels of gene , gene , gene , chemical , chemical , gene , gene , and gene were recorded .	T2	T23	23614730
NA	CHEMICAL	GENE-Y	89	102	Results : The administration of chemical 1.6 % w/w created significant increased changes in the levels of total WBC , lymphocytes , RBC , gene , packed cell volume , platelets , mean corpuscular volume , and mean corpuscular gene in rats after 24 , 48 , and 72 h of continuous inhalation ; however , there was a significant reduction in neutrophils at transient reduction in the monocytes after 24 and 48 h to return to normal after 72 h. Significant increases in the levels of gene , gene , gene , chemical , chemical , gene , gene , and gene were recorded .	T2	T24	23614730
NA	CHEMICAL	GENE-N	95	13	Results : The administration of chemical 1.6 % w/w created significant increased changes in the levels of total WBC , lymphocytes , RBC , gene , packed cell volume , platelets , mean corpuscular volume , and mean corpuscular gene in rats after 24 , 48 , and 72 h of continuous inhalation ; however , there was a significant reduction in neutrophils at transient reduction in the monocytes after 24 and 48 h to return to normal after 72 h. Significant increases in the levels of gene , gene , gene , chemical , chemical , gene , gene , and gene were recorded .	T3	T17	23614730
NA	CHEMICAL	GENE-N	95	13	Results : The administration of chemical 1.6 % w/w created significant increased changes in the levels of total WBC , lymphocytes , RBC , gene , packed cell volume , platelets , mean corpuscular volume , and mean corpuscular gene in rats after 24 , 48 , and 72 h of continuous inhalation ; however , there was a significant reduction in neutrophils at transient reduction in the monocytes after 24 and 48 h to return to normal after 72 h. Significant increases in the levels of gene , gene , gene , chemical , chemical , gene , gene , and gene were recorded .	T3	T18	23614730
NA	CHEMICAL	GENE-N	95	87	Results : The administration of chemical 1.6 % w/w created significant increased changes in the levels of total WBC , lymphocytes , RBC , gene , packed cell volume , platelets , mean corpuscular volume , and mean corpuscular gene in rats after 24 , 48 , and 72 h of continuous inhalation ; however , there was a significant reduction in neutrophils at transient reduction in the monocytes after 24 and 48 h to return to normal after 72 h. Significant increases in the levels of gene , gene , gene , chemical , chemical , gene , gene , and gene were recorded .	T3	T19	23614730
NA	CHEMICAL	GENE-Y	95	89	Results : The administration of chemical 1.6 % w/w created significant increased changes in the levels of total WBC , lymphocytes , RBC , gene , packed cell volume , platelets , mean corpuscular volume , and mean corpuscular gene in rats after 24 , 48 , and 72 h of continuous inhalation ; however , there was a significant reduction in neutrophils at transient reduction in the monocytes after 24 and 48 h to return to normal after 72 h. Significant increases in the levels of gene , gene , gene , chemical , chemical , gene , gene , and gene were recorded .	T3	T20	23614730
NA	CHEMICAL	GENE-N	95	91	Results : The administration of chemical 1.6 % w/w created significant increased changes in the levels of total WBC , lymphocytes , RBC , gene , packed cell volume , platelets , mean corpuscular volume , and mean corpuscular gene in rats after 24 , 48 , and 72 h of continuous inhalation ; however , there was a significant reduction in neutrophils at transient reduction in the monocytes after 24 and 48 h to return to normal after 72 h. Significant increases in the levels of gene , gene , gene , chemical , chemical , gene , gene , and gene were recorded .	T3	T21	23614730
NA	CHEMICAL	GENE-Y	95	97	Results : The administration of chemical 1.6 % w/w created significant increased changes in the levels of total WBC , lymphocytes , RBC , gene , packed cell volume , platelets , mean corpuscular volume , and mean corpuscular gene in rats after 24 , 48 , and 72 h of continuous inhalation ; however , there was a significant reduction in neutrophils at transient reduction in the monocytes after 24 and 48 h to return to normal after 72 h. Significant increases in the levels of gene , gene , gene , chemical , chemical , gene , gene , and gene were recorded .	T3	T22	23614730
NA	CHEMICAL	GENE-Y	95	99	Results : The administration of chemical 1.6 % w/w created significant increased changes in the levels of total WBC , lymphocytes , RBC , gene , packed cell volume , platelets , mean corpuscular volume , and mean corpuscular gene in rats after 24 , 48 , and 72 h of continuous inhalation ; however , there was a significant reduction in neutrophils at transient reduction in the monocytes after 24 and 48 h to return to normal after 72 h. Significant increases in the levels of gene , gene , gene , chemical , chemical , gene , gene , and gene were recorded .	T3	T23	23614730
NA	CHEMICAL	GENE-Y	95	102	Results : The administration of chemical 1.6 % w/w created significant increased changes in the levels of total WBC , lymphocytes , RBC , gene , packed cell volume , platelets , mean corpuscular volume , and mean corpuscular gene in rats after 24 , 48 , and 72 h of continuous inhalation ; however , there was a significant reduction in neutrophils at transient reduction in the monocytes after 24 and 48 h to return to normal after 72 h. Significant increases in the levels of gene , gene , gene , chemical , chemical , gene , gene , and gene were recorded .	T3	T24	23614730
NA	CHEMICAL	GENE-Y	4	8	Preferential block of late chemical current in the gene by the class I ( C ) antiarrhythmic chemical .	T21	T31	10617684
CPR:4	CHEMICAL	GENE-Y	6	8	Preferential block of late chemical current in the gene by the class I ( C ) antiarrhythmic chemical .	T20	T31	10617684
CPR:4	CHEMICAL	GENE-Y	0	20	chemical block of chemical current ( I ( chemical ) ) was investigated in wild-type ( WT ) or the gene subunit mutation with three chemical deleted ( gene ) stably transfected into human embryonic kidney 293 cells using whole-cell , patch-clamp recordings .	T1	T27	10617684
CPR:4	CHEMICAL	GENE-Y	0	28	chemical block of chemical current ( I ( chemical ) ) was investigated in wild-type ( WT ) or the gene subunit mutation with three chemical deleted ( gene ) stably transfected into human embryonic kidney 293 cells using whole-cell , patch-clamp recordings .	T1	T24	10617684
NA	CHEMICAL	GENE-Y	3	20	chemical block of chemical current ( I ( chemical ) ) was investigated in wild-type ( WT ) or the gene subunit mutation with three chemical deleted ( gene ) stably transfected into human embryonic kidney 293 cells using whole-cell , patch-clamp recordings .	T9	T27	10617684
NA	CHEMICAL	GENE-Y	3	28	chemical block of chemical current ( I ( chemical ) ) was investigated in wild-type ( WT ) or the gene subunit mutation with three chemical deleted ( gene ) stably transfected into human embryonic kidney 293 cells using whole-cell , patch-clamp recordings .	T9	T24	10617684
NA	CHEMICAL	GENE-Y	8	20	chemical block of chemical current ( I ( chemical ) ) was investigated in wild-type ( WT ) or the gene subunit mutation with three chemical deleted ( gene ) stably transfected into human embryonic kidney 293 cells using whole-cell , patch-clamp recordings .	T12	T27	10617684
NA	CHEMICAL	GENE-Y	8	28	chemical block of chemical current ( I ( chemical ) ) was investigated in wild-type ( WT ) or the gene subunit mutation with three chemical deleted ( gene ) stably transfected into human embryonic kidney 293 cells using whole-cell , patch-clamp recordings .	T12	T24	10617684
NA	CHEMICAL	GENE-Y	25	20	chemical block of chemical current ( I ( chemical ) ) was investigated in wild-type ( WT ) or the gene subunit mutation with three chemical deleted ( gene ) stably transfected into human embryonic kidney 293 cells using whole-cell , patch-clamp recordings .	T8	T27	10617684
NA	CHEMICAL	GENE-Y	25	28	chemical block of chemical current ( I ( chemical ) ) was investigated in wild-type ( WT ) or the gene subunit mutation with three chemical deleted ( gene ) stably transfected into human embryonic kidney 293 cells using whole-cell , patch-clamp recordings .	T8	T24	10617684
NA	CHEMICAL	GENE-Y	7	4	Compared with WT , gene I ( chemical ) was more sensitive to chemical , and chemical preferentially inhibited late I ( chemical ) ( mean current between 20 and 23.5 ms after depolarization ) compared with peak I ( chemical ) .	T13	T25	10617684
CPR:4	CHEMICAL	GENE-Y	13	4	Compared with WT , gene I ( chemical ) was more sensitive to chemical , and chemical preferentially inhibited late I ( chemical ) ( mean current between 20 and 23.5 ms after depolarization ) compared with peak I ( chemical ) .	T14	T25	10617684
CPR:4	CHEMICAL	GENE-Y	16	4	Compared with WT , gene I ( chemical ) was more sensitive to chemical , and chemical preferentially inhibited late I ( chemical ) ( mean current between 20 and 23.5 ms after depolarization ) compared with peak I ( chemical ) .	T15	T25	10617684
NA	CHEMICAL	GENE-Y	22	4	Compared with WT , gene I ( chemical ) was more sensitive to chemical , and chemical preferentially inhibited late I ( chemical ) ( mean current between 20 and 23.5 ms after depolarization ) compared with peak I ( chemical ) .	T16	T25	10617684
NA	CHEMICAL	GENE-Y	40	4	Compared with WT , gene I ( chemical ) was more sensitive to chemical , and chemical preferentially inhibited late I ( chemical ) ( mean current between 20 and 23.5 ms after depolarization ) compared with peak I ( chemical ) .	T17	T25	10617684
NA	CHEMICAL	GENE-Y	12	32	The IC ( 50 ) value of peak and late I ( chemical ) for WT was 127 +/- 6 and 44 +/- 2 microM ( n = 20 ) and for gene was 80 +/- 9 and 19 +/- 2 microM ( n = 31 ) respectively .	T18	T26	10617684
NA	CHEMICAL	GENE-Y	5	17	UDB of peak I ( chemical ) was greater and developed more slowly during pulse trains for gene than for WT .	T19	T28	10617684
NA	CHEMICAL	GENE-Y	8	1	For gene , UDB of late I ( chemical ) was greater than for peak I ( chemical ) .	T2	T30	10617684
NA	CHEMICAL	GENE-Y	1	1	For gene , UDB of late I ( chemical ) was greater than for peak I ( chemical ) .	T3	T30	10617684
CPR:4	CHEMICAL	GENE-Y	7	3	We conclude that gene interacts differently with chemical than with WT , leading to increased block and slowed recovery , especially for late I ( chemical ) .	T5	T23	10617684
NA	CHEMICAL	GENE-Y	25	3	We conclude that gene interacts differently with chemical than with WT , leading to increased block and slowed recovery , especially for late I ( chemical ) .	T6	T23	10617684
NA	CHEMICAL	GENE-N	0	1	chemical channels in renal disease .	T11	T24	10561751
NA	CHEMICAL	GENE-N	14	17	Recent studies of hereditary renal tubular disorders have facilitated the identification and roles of chemical channels and cotransporters in the regulation of the most abundant anion , chemical , in the ECF .	T1	T12	10561751
NA	CHEMICAL	GENE-N	27	17	Recent studies of hereditary renal tubular disorders have facilitated the identification and roles of chemical channels and cotransporters in the regulation of the most abundant anion , chemical , in the ECF .	T2	T12	10561751
NA	CHEMICAL	GENE-N	31	3	Mutations of another gene , gene , are associated with a form of Bartter 's syndrome , whereas other forms of Bartter 's syndrome are caused by mutations in the chemical-sensitive sodium-chemical-chemical cotransporter ( gene ) and the gene , gene .	T4	T15	10561751
NA	CHEMICAL	GENE-Y	31	5	Mutations of another gene , gene , are associated with a form of Bartter 's syndrome , whereas other forms of Bartter 's syndrome are caused by mutations in the chemical-sensitive sodium-chemical-chemical cotransporter ( gene ) and the gene , gene .	T4	T16	10561751
NA	CHEMICAL	GENE-N	31	10	Mutations of another gene , gene , are associated with a form of Bartter 's syndrome , whereas other forms of Bartter 's syndrome are caused by mutations in the chemical-sensitive sodium-chemical-chemical cotransporter ( gene ) and the gene , gene .	T4	T17	10561751
NA	CHEMICAL	GENE-Y	31	34	Mutations of another gene , gene , are associated with a form of Bartter 's syndrome , whereas other forms of Bartter 's syndrome are caused by mutations in the chemical-sensitive sodium-chemical-chemical cotransporter ( gene ) and the gene , gene .	T4	T18	10561751
NA	CHEMICAL	GENE-N	31	10	Mutations of another gene , gene , are associated with a form of Bartter 's syndrome , whereas other forms of Bartter 's syndrome are caused by mutations in the chemical-sensitive sodium-chemical-chemical cotransporter ( gene ) and the gene , gene .	T4	T19	10561751
NA	CHEMICAL	GENE-Y	31	40	Mutations of another gene , gene , are associated with a form of Bartter 's syndrome , whereas other forms of Bartter 's syndrome are caused by mutations in the chemical-sensitive sodium-chemical-chemical cotransporter ( gene ) and the gene , gene .	T4	T20	10561751
NA	CHEMICAL	GENE-N	10	3	Mutations of another gene , gene , are associated with a form of Bartter 's syndrome , whereas other forms of Bartter 's syndrome are caused by mutations in the chemical-sensitive sodium-chemical-chemical cotransporter ( gene ) and the gene , gene .	T5	T15	10561751
NA	CHEMICAL	GENE-Y	10	5	Mutations of another gene , gene , are associated with a form of Bartter 's syndrome , whereas other forms of Bartter 's syndrome are caused by mutations in the chemical-sensitive sodium-chemical-chemical cotransporter ( gene ) and the gene , gene .	T5	T16	10561751
NA	CHEMICAL	GENE-N	10	10	Mutations of another gene , gene , are associated with a form of Bartter 's syndrome , whereas other forms of Bartter 's syndrome are caused by mutations in the chemical-sensitive sodium-chemical-chemical cotransporter ( gene ) and the gene , gene .	T5	T17	10561751
NA	CHEMICAL	GENE-Y	10	34	Mutations of another gene , gene , are associated with a form of Bartter 's syndrome , whereas other forms of Bartter 's syndrome are caused by mutations in the chemical-sensitive sodium-chemical-chemical cotransporter ( gene ) and the gene , gene .	T5	T18	10561751
NA	CHEMICAL	GENE-N	10	10	Mutations of another gene , gene , are associated with a form of Bartter 's syndrome , whereas other forms of Bartter 's syndrome are caused by mutations in the chemical-sensitive sodium-chemical-chemical cotransporter ( gene ) and the gene , gene .	T5	T19	10561751
NA	CHEMICAL	GENE-Y	10	40	Mutations of another gene , gene , are associated with a form of Bartter 's syndrome , whereas other forms of Bartter 's syndrome are caused by mutations in the chemical-sensitive sodium-chemical-chemical cotransporter ( gene ) and the gene , gene .	T5	T20	10561751
NA	CHEMICAL	GENE-N	10	3	Mutations of another gene , gene , are associated with a form of Bartter 's syndrome , whereas other forms of Bartter 's syndrome are caused by mutations in the chemical-sensitive sodium-chemical-chemical cotransporter ( gene ) and the gene , gene .	T6	T15	10561751
NA	CHEMICAL	GENE-Y	10	5	Mutations of another gene , gene , are associated with a form of Bartter 's syndrome , whereas other forms of Bartter 's syndrome are caused by mutations in the chemical-sensitive sodium-chemical-chemical cotransporter ( gene ) and the gene , gene .	T6	T16	10561751
NA	CHEMICAL	GENE-N	10	10	Mutations of another gene , gene , are associated with a form of Bartter 's syndrome , whereas other forms of Bartter 's syndrome are caused by mutations in the chemical-sensitive sodium-chemical-chemical cotransporter ( gene ) and the gene , gene .	T6	T17	10561751
NA	CHEMICAL	GENE-Y	10	34	Mutations of another gene , gene , are associated with a form of Bartter 's syndrome , whereas other forms of Bartter 's syndrome are caused by mutations in the chemical-sensitive sodium-chemical-chemical cotransporter ( gene ) and the gene , gene .	T6	T18	10561751
NA	CHEMICAL	GENE-N	10	10	Mutations of another gene , gene , are associated with a form of Bartter 's syndrome , whereas other forms of Bartter 's syndrome are caused by mutations in the chemical-sensitive sodium-chemical-chemical cotransporter ( gene ) and the gene , gene .	T6	T19	10561751
NA	CHEMICAL	GENE-Y	10	40	Mutations of another gene , gene , are associated with a form of Bartter 's syndrome , whereas other forms of Bartter 's syndrome are caused by mutations in the chemical-sensitive sodium-chemical-chemical cotransporter ( gene ) and the gene , gene .	T6	T20	10561751
NA	CHEMICAL	GENE-N	10	3	Mutations of another gene , gene , are associated with a form of Bartter 's syndrome , whereas other forms of Bartter 's syndrome are caused by mutations in the chemical-sensitive sodium-chemical-chemical cotransporter ( gene ) and the gene , gene .	T7	T15	10561751
NA	CHEMICAL	GENE-Y	10	5	Mutations of another gene , gene , are associated with a form of Bartter 's syndrome , whereas other forms of Bartter 's syndrome are caused by mutations in the chemical-sensitive sodium-chemical-chemical cotransporter ( gene ) and the gene , gene .	T7	T16	10561751
NA	CHEMICAL	GENE-N	10	10	Mutations of another gene , gene , are associated with a form of Bartter 's syndrome , whereas other forms of Bartter 's syndrome are caused by mutations in the chemical-sensitive sodium-chemical-chemical cotransporter ( gene ) and the gene , gene .	T7	T17	10561751
NA	CHEMICAL	GENE-Y	10	34	Mutations of another gene , gene , are associated with a form of Bartter 's syndrome , whereas other forms of Bartter 's syndrome are caused by mutations in the chemical-sensitive sodium-chemical-chemical cotransporter ( gene ) and the gene , gene .	T7	T18	10561751
NA	CHEMICAL	GENE-N	10	10	Mutations of another gene , gene , are associated with a form of Bartter 's syndrome , whereas other forms of Bartter 's syndrome are caused by mutations in the chemical-sensitive sodium-chemical-chemical cotransporter ( gene ) and the gene , gene .	T7	T19	10561751
NA	CHEMICAL	GENE-Y	10	40	Mutations of another gene , gene , are associated with a form of Bartter 's syndrome , whereas other forms of Bartter 's syndrome are caused by mutations in the chemical-sensitive sodium-chemical-chemical cotransporter ( gene ) and the gene , gene .	T7	T20	10561751
NA	CHEMICAL	GENE-Y	5	7	Finally , mutations of the chemical-sensitive chemical cotransporter ( gene ) are associated with Gitelman 's syndrome .	T8	T21	10561751
NA	CHEMICAL	GENE-Y	5	9	Finally , mutations of the chemical-sensitive chemical cotransporter ( gene ) are associated with Gitelman 's syndrome .	T8	T22	10561751
NA	CHEMICAL	GENE-Y	6	7	Finally , mutations of the chemical-sensitive chemical cotransporter ( gene ) are associated with Gitelman 's syndrome .	T9	T21	10561751
NA	CHEMICAL	GENE-Y	6	9	Finally , mutations of the chemical-sensitive chemical cotransporter ( gene ) are associated with Gitelman 's syndrome .	T9	T22	10561751
NA	CHEMICAL	GENE-N	0	8	chemical induces autophagy in MDA-MB-231 cells by regulating gene-gene pathway .	T12	T28	23000445
NA	CHEMICAL	GENE-Y	0	8	chemical induces autophagy in MDA-MB-231 cells by regulating gene-gene pathway .	T12	T29	23000445
NA	CHEMICAL	GENE-N	3	8	We report that chemical triggered the formation of gene ( gene ) positive autophagosomes and the accumulation of acidic vesicular and autolysosomes in MDA-MB-231 cells .	T3	T22	23000445
NA	CHEMICAL	GENE-N	3	10	We report that chemical triggered the formation of gene ( gene ) positive autophagosomes and the accumulation of acidic vesicular and autolysosomes in MDA-MB-231 cells .	T3	T23	23000445
CPR:3	CHEMICAL	GENE-Y	4	9	The results showed that chemical promotes the expression of gene and gene .	T7	T24	23000445
CPR:3	CHEMICAL	GENE-Y	4	11	The results showed that chemical promotes the expression of gene and gene .	T7	T25	23000445
CPR:4	CHEMICAL	GENE-Y	0	6	chemical also suppressed the activation of gene ( gene ) and gene ( gene by regulating the expression of the gene ( gene ) and gene involved gene ( gene ) signaling pathway .	T10	T26	23000445
CPR:4	CHEMICAL	GENE-Y	0	8	chemical also suppressed the activation of gene ( gene ) and gene ( gene by regulating the expression of the gene ( gene ) and gene involved gene ( gene ) signaling pathway .	T10	T27	23000445
CPR:4	CHEMICAL	GENE-N	0	11	chemical also suppressed the activation of gene ( gene ) and gene ( gene by regulating the expression of the gene ( gene ) and gene involved gene ( gene ) signaling pathway .	T10	T13	23000445
CPR:4	CHEMICAL	GENE-N	0	9	chemical also suppressed the activation of gene ( gene ) and gene ( gene by regulating the expression of the gene ( gene ) and gene involved gene ( gene ) signaling pathway .	T10	T14	23000445
NA	CHEMICAL	GENE-N	0	20	chemical also suppressed the activation of gene ( gene ) and gene ( gene by regulating the expression of the gene ( gene ) and gene involved gene ( gene ) signaling pathway .	T10	T15	23000445
NA	CHEMICAL	GENE-N	0	22	chemical also suppressed the activation of gene ( gene ) and gene ( gene by regulating the expression of the gene ( gene ) and gene involved gene ( gene ) signaling pathway .	T10	T16	23000445
NA	CHEMICAL	GENE-N	0	25	chemical also suppressed the activation of gene ( gene ) and gene ( gene by regulating the expression of the gene ( gene ) and gene involved gene ( gene ) signaling pathway .	T10	T17	23000445
NA	CHEMICAL	GENE-N	0	27	chemical also suppressed the activation of gene ( gene ) and gene ( gene by regulating the expression of the gene ( gene ) and gene involved gene ( gene ) signaling pathway .	T10	T18	23000445
NA	CHEMICAL	GENE-N	0	29	chemical also suppressed the activation of gene ( gene ) and gene ( gene by regulating the expression of the gene ( gene ) and gene involved gene ( gene ) signaling pathway .	T10	T19	23000445
NA	CHEMICAL	GENE-Y	0	1	chemical 2,3-dioxygenase ( gene ) , a chemical catabolizing enzyme , has been implicated in the pathogenesis of various neurological disorders .	T1	T9	17661345
NA	CHEMICAL	GENE-Y	0	3	chemical 2,3-dioxygenase ( gene ) , a chemical catabolizing enzyme , has been implicated in the pathogenesis of various neurological disorders .	T1	T16	17661345
CPR:9	CHEMICAL	GENE-Y	6	1	chemical 2,3-dioxygenase ( gene ) , a chemical catabolizing enzyme , has been implicated in the pathogenesis of various neurological disorders .	T6	T9	17661345
CPR:9	CHEMICAL	GENE-Y	6	3	chemical 2,3-dioxygenase ( gene ) , a chemical catabolizing enzyme , has been implicated in the pathogenesis of various neurological disorders .	T6	T16	17661345
NA	CHEMICAL	GENE-Y	12	0	gene expression is induced by gene and leads to neurotoxicity by generating chemical .	T3	T14	17661345
NA	CHEMICAL	GENE-Y	12	5	gene expression is induced by gene and leads to neurotoxicity by generating chemical .	T3	T15	17661345
NA	CHEMICAL	GENE-Y	2	3	However , chemical-tRNA synthetase ( gene ) , which is coinduced with gene by gene , is downregulated by gene and gene .	T7	T27	17661345
NA	CHEMICAL	GENE-Y	2	5	However , chemical-tRNA synthetase ( gene ) , which is coinduced with gene by gene , is downregulated by gene and gene .	T7	T28	17661345
NA	CHEMICAL	GENE-Y	2	12	However , chemical-tRNA synthetase ( gene ) , which is coinduced with gene by gene , is downregulated by gene and gene .	T7	T29	17661345
NA	CHEMICAL	GENE-Y	2	14	However , chemical-tRNA synthetase ( gene ) , which is coinduced with gene by gene , is downregulated by gene and gene .	T7	T30	17661345
NA	CHEMICAL	GENE-Y	2	19	However , chemical-tRNA synthetase ( gene ) , which is coinduced with gene by gene , is downregulated by gene and gene .	T7	T31	17661345
NA	CHEMICAL	GENE-Y	2	21	However , chemical-tRNA synthetase ( gene ) , which is coinduced with gene by gene , is downregulated by gene and gene .	T7	T32	17661345
NA	CHEMICAL	GENE-N	1	2	The chemical 3-kinase ( gene ) pathway further differentiated the regulation of these two enzymes , as inhibiting the gene pathway eliminated gene induction of gene , whereas such inhibition greatly enhanced gene expression .	T8	T40	17661345
NA	CHEMICAL	GENE-N	1	4	The chemical 3-kinase ( gene ) pathway further differentiated the regulation of these two enzymes , as inhibiting the gene pathway eliminated gene induction of gene , whereas such inhibition greatly enhanced gene expression .	T8	T41	17661345
NA	CHEMICAL	GENE-N	1	19	The chemical 3-kinase ( gene ) pathway further differentiated the regulation of these two enzymes , as inhibiting the gene pathway eliminated gene induction of gene , whereas such inhibition greatly enhanced gene expression .	T8	T10	17661345
NA	CHEMICAL	GENE-Y	1	22	The chemical 3-kinase ( gene ) pathway further differentiated the regulation of these two enzymes , as inhibiting the gene pathway eliminated gene induction of gene , whereas such inhibition greatly enhanced gene expression .	T8	T11	17661345
NA	CHEMICAL	GENE-Y	1	25	The chemical 3-kinase ( gene ) pathway further differentiated the regulation of these two enzymes , as inhibiting the gene pathway eliminated gene induction of gene , whereas such inhibition greatly enhanced gene expression .	T8	T12	17661345
NA	CHEMICAL	GENE-Y	1	32	The chemical 3-kinase ( gene ) pathway further differentiated the regulation of these two enzymes , as inhibiting the gene pathway eliminated gene induction of gene , whereas such inhibition greatly enhanced gene expression .	T8	T13	17661345
NA	CHEMICAL	GENE-Y	0	10	chemical Dyes as Differential Modulators of Organic Anion Transport by gene , gene and gene .	T24	T36	23530018
NA	CHEMICAL	GENE-Y	0	12	chemical Dyes as Differential Modulators of Organic Anion Transport by gene , gene and gene .	T24	T37	23530018
NA	CHEMICAL	GENE-Y	0	14	chemical Dyes as Differential Modulators of Organic Anion Transport by gene , gene and gene .	T24	T38	23530018
NA	CHEMICAL	GENE-N	6	0	gene ( gene ) mediate the chemical-dependent efflux of structurally diverse compounds , including anticancer drugs and physiological organic anions .	T16	T25	23530018
NA	CHEMICAL	GENE-N	6	2	gene ( gene ) mediate the chemical-dependent efflux of structurally diverse compounds , including anticancer drugs and physiological organic anions .	T16	T29	23530018
NA	CHEMICAL	GENE-N	3	24	Five classes of chemical dyes ( chemical ) were examined for their ability to modulate transport of chemical ( chemical ) ( a prototypical gene substrate ) into gene-enriched inside-out membrane vesicles .	T9	T30	23530018
NA	CHEMICAL	GENE-N	3	28	Five classes of chemical dyes ( chemical ) were examined for their ability to modulate transport of chemical ( chemical ) ( a prototypical gene substrate ) into gene-enriched inside-out membrane vesicles .	T9	T31	23530018
NA	CHEMICAL	GENE-N	6	24	Five classes of chemical dyes ( chemical ) were examined for their ability to modulate transport of chemical ( chemical ) ( a prototypical gene substrate ) into gene-enriched inside-out membrane vesicles .	T10	T30	23530018
NA	CHEMICAL	GENE-N	6	28	Five classes of chemical dyes ( chemical ) were examined for their ability to modulate transport of chemical ( chemical ) ( a prototypical gene substrate ) into gene-enriched inside-out membrane vesicles .	T10	T31	23530018
CPR:9	CHEMICAL	GENE-N	17	24	Five classes of chemical dyes ( chemical ) were examined for their ability to modulate transport of chemical ( chemical ) ( a prototypical gene substrate ) into gene-enriched inside-out membrane vesicles .	T11	T30	23530018
NA	CHEMICAL	GENE-N	17	28	Five classes of chemical dyes ( chemical ) were examined for their ability to modulate transport of chemical ( chemical ) ( a prototypical gene substrate ) into gene-enriched inside-out membrane vesicles .	T11	T31	23530018
CPR:9	CHEMICAL	GENE-N	19	24	Five classes of chemical dyes ( chemical ) were examined for their ability to modulate transport of chemical ( chemical ) ( a prototypical gene substrate ) into gene-enriched inside-out membrane vesicles .	T12	T30	23530018
NA	CHEMICAL	GENE-N	19	28	Five classes of chemical dyes ( chemical ) were examined for their ability to modulate transport of chemical ( chemical ) ( a prototypical gene substrate ) into gene-enriched inside-out membrane vesicles .	T12	T31	23530018
CPR:4	CHEMICAL	GENE-Y	3	5	Sixteen of 34 chemical inhibited gene-mediated chemical uptake by > 50 % ( IC50 's 0.7-7.6 μM ) .	T15	T32	23530018
CPR:9	CHEMICAL	GENE-Y	6	5	Sixteen of 34 chemical inhibited gene-mediated chemical uptake by > 50 % ( IC50 's 0.7-7.6 μM ) .	T17	T32	23530018
NA	CHEMICAL	GENE-Y	2	42	Of 9 chemical with IC50 's ≤2 μM , two belonged to Class I , two to Class III and five to Class V. When tested in the intact cells , only 4 of 16 chemical ( at 10 μM ) inhibited gene-mediated chemical efflux by > 50 % ( III-1 , V-3 , -4 , -6 ) while a fifth ( I-5 ) inhibited efflux by just 23 % .	T18	T33	23530018
CPR:4	CHEMICAL	GENE-Y	35	42	Of 9 chemical with IC50 's ≤2 μM , two belonged to Class I , two to Class III and five to Class V. When tested in the intact cells , only 4 of 16 chemical ( at 10 μM ) inhibited gene-mediated chemical efflux by > 50 % ( III-1 , V-3 , -4 , -6 ) while a fifth ( I-5 ) inhibited efflux by just 23 % .	T19	T33	23530018
CPR:9	CHEMICAL	GENE-Y	26	42	Of 9 chemical with IC50 's ≤2 μM , two belonged to Class I , two to Class III and five to Class V. When tested in the intact cells , only 4 of 16 chemical ( at 10 μM ) inhibited gene-mediated chemical efflux by > 50 % ( III-1 , V-3 , -4 , -6 ) while a fifth ( I-5 ) inhibited efflux by just 23 % .	T20	T33	23530018
CPR:4	CHEMICAL	GENE-Y	2	8	These five chemical also inhibited chemical uptake by gene .	T21	T34	23530018
CPR:9	CHEMICAL	GENE-Y	5	8	These five chemical also inhibited chemical uptake by gene .	T22	T34	23530018
NA	CHEMICAL	GENE-Y	16	6	In contrast , their effects on gene varied with two ( V-4 , V-6 ) inhibiting chemical transport ( IC50 's 2.0 , 9.2 μM ) , two ( V-3 , III-1 ) stimulating transport ( > 2-fold ) , while chemical I-5 had no effect .	T23	T35	23530018
NA	CHEMICAL	GENE-Y	41	6	In contrast , their effects on gene varied with two ( V-4 , V-6 ) inhibiting chemical transport ( IC50 's 2.0 , 9.2 μM ) , two ( V-3 , III-1 ) stimulating transport ( > 2-fold ) , while chemical I-5 had no effect .	T1	T35	23530018
NA	CHEMICAL	GENE-Y	10	10	Strikingly , although V-3 and V-4 had opposite effects on gene activity , they are structurally identical except for their chemical atom ( chemical versus chemical ) .	T2	T26	23530018
NA	CHEMICAL	GENE-Y	23	10	Strikingly , although V-3 and V-4 had opposite effects on gene activity , they are structurally identical except for their chemical atom ( chemical versus chemical ) .	T3	T26	23530018
NA	CHEMICAL	GENE-Y	25	10	Strikingly , although V-3 and V-4 had opposite effects on gene activity , they are structurally identical except for their chemical atom ( chemical versus chemical ) .	T4	T26	23530018
CPR:4	CHEMICAL	GENE-Y	7	2	Inhibition of gene ( gene ) by chemical and chemical reduces tumor growth and lung metastases in mice bearing Lewis lung carcinoma .	T15	T24	10328230
CPR:4	CHEMICAL	GENE-Y	7	4	Inhibition of gene ( gene ) by chemical and chemical reduces tumor growth and lung metastases in mice bearing Lewis lung carcinoma .	T15	T25	10328230
CPR:4	CHEMICAL	GENE-Y	9	2	Inhibition of gene ( gene ) by chemical and chemical reduces tumor growth and lung metastases in mice bearing Lewis lung carcinoma .	T16	T24	10328230
CPR:4	CHEMICAL	GENE-Y	9	4	Inhibition of gene ( gene ) by chemical and chemical reduces tumor growth and lung metastases in mice bearing Lewis lung carcinoma .	T16	T25	10328230
CPR:4	CHEMICAL	GENE-N	11	8	We have examined the effects of the synthetic gene inhibitor , chemical ( chemical ) and the chemical-converting enzyme inhibitor , chemical , on gene activity of murine Lewis-lung-carcinoma cells ( 3LL ) in vitro , and on local growth and lung metastasis of the same tumor implanted intramuscularly in syngeneic C57BL/6 mice .	T13	T21	10328230
NA	CHEMICAL	GENE-Y	11	18	We have examined the effects of the synthetic gene inhibitor , chemical ( chemical ) and the chemical-converting enzyme inhibitor , chemical , on gene activity of murine Lewis-lung-carcinoma cells ( 3LL ) in vitro , and on local growth and lung metastasis of the same tumor implanted intramuscularly in syngeneic C57BL/6 mice .	T13	T17	10328230
NA	CHEMICAL	GENE-N	11	24	We have examined the effects of the synthetic gene inhibitor , chemical ( chemical ) and the chemical-converting enzyme inhibitor , chemical , on gene activity of murine Lewis-lung-carcinoma cells ( 3LL ) in vitro , and on local growth and lung metastasis of the same tumor implanted intramuscularly in syngeneic C57BL/6 mice .	T13	T20	10328230
CPR:4	CHEMICAL	GENE-N	13	8	We have examined the effects of the synthetic gene inhibitor , chemical ( chemical ) and the chemical-converting enzyme inhibitor , chemical , on gene activity of murine Lewis-lung-carcinoma cells ( 3LL ) in vitro , and on local growth and lung metastasis of the same tumor implanted intramuscularly in syngeneic C57BL/6 mice .	T14	T21	10328230
NA	CHEMICAL	GENE-Y	13	18	We have examined the effects of the synthetic gene inhibitor , chemical ( chemical ) and the chemical-converting enzyme inhibitor , chemical , on gene activity of murine Lewis-lung-carcinoma cells ( 3LL ) in vitro , and on local growth and lung metastasis of the same tumor implanted intramuscularly in syngeneic C57BL/6 mice .	T14	T17	10328230
NA	CHEMICAL	GENE-N	13	24	We have examined the effects of the synthetic gene inhibitor , chemical ( chemical ) and the chemical-converting enzyme inhibitor , chemical , on gene activity of murine Lewis-lung-carcinoma cells ( 3LL ) in vitro , and on local growth and lung metastasis of the same tumor implanted intramuscularly in syngeneic C57BL/6 mice .	T14	T20	10328230
NA	CHEMICAL	GENE-N	11	8	We have examined the effects of the synthetic gene inhibitor , chemical ( chemical ) and the chemical-converting enzyme inhibitor , chemical , on gene activity of murine Lewis-lung-carcinoma cells ( 3LL ) in vitro , and on local growth and lung metastasis of the same tumor implanted intramuscularly in syngeneic C57BL/6 mice .	T1	T21	10328230
NA	CHEMICAL	GENE-Y	11	18	We have examined the effects of the synthetic gene inhibitor , chemical ( chemical ) and the chemical-converting enzyme inhibitor , chemical , on gene activity of murine Lewis-lung-carcinoma cells ( 3LL ) in vitro , and on local growth and lung metastasis of the same tumor implanted intramuscularly in syngeneic C57BL/6 mice .	T1	T17	10328230
NA	CHEMICAL	GENE-N	11	24	We have examined the effects of the synthetic gene inhibitor , chemical ( chemical ) and the chemical-converting enzyme inhibitor , chemical , on gene activity of murine Lewis-lung-carcinoma cells ( 3LL ) in vitro , and on local growth and lung metastasis of the same tumor implanted intramuscularly in syngeneic C57BL/6 mice .	T1	T20	10328230
NA	CHEMICAL	GENE-N	21	8	We have examined the effects of the synthetic gene inhibitor , chemical ( chemical ) and the chemical-converting enzyme inhibitor , chemical , on gene activity of murine Lewis-lung-carcinoma cells ( 3LL ) in vitro , and on local growth and lung metastasis of the same tumor implanted intramuscularly in syngeneic C57BL/6 mice .	T4	T21	10328230
CPR:4	CHEMICAL	GENE-Y	21	18	We have examined the effects of the synthetic gene inhibitor , chemical ( chemical ) and the chemical-converting enzyme inhibitor , chemical , on gene activity of murine Lewis-lung-carcinoma cells ( 3LL ) in vitro , and on local growth and lung metastasis of the same tumor implanted intramuscularly in syngeneic C57BL/6 mice .	T4	T17	10328230
NA	CHEMICAL	GENE-N	21	24	We have examined the effects of the synthetic gene inhibitor , chemical ( chemical ) and the chemical-converting enzyme inhibitor , chemical , on gene activity of murine Lewis-lung-carcinoma cells ( 3LL ) in vitro , and on local growth and lung metastasis of the same tumor implanted intramuscularly in syngeneic C57BL/6 mice .	T4	T20	10328230
CPR:4	CHEMICAL	GENE-Y	4	14	Here we report that chemical treatment resulted in decreased transcription and protein levels of gene by 3LL cells .	T9	T22	10328230
CPR:4	CHEMICAL	GENE-N	1	9	Both chemical and captopril also prevented substrate degradation by gene released in conditioned medium by cultured cells .	T10	T23	10328230
NA	CHEMICAL	GENE-Y	2	18	Effects of chemical on extracellular concentrations of chemical and chemical in the rat frontal cortex : augmentation via gene receptor antagonism .	T28	T37	10462128
NA	CHEMICAL	GENE-Y	7	18	Effects of chemical on extracellular concentrations of chemical and chemical in the rat frontal cortex : augmentation via gene receptor antagonism .	T29	T37	10462128
NA	CHEMICAL	GENE-Y	9	18	Effects of chemical on extracellular concentrations of chemical and chemical in the rat frontal cortex : augmentation via gene receptor antagonism .	T30	T37	10462128
NA	CHEMICAL	GENE-Y	2	18	Preclinically , chemical has been shown to potently inhibit dorsal raphe neuronal ( DRN ) firing through a gene mediated mechanism , in a similar manner to SSRIs .	T14	T35	10462128
CPR:6	CHEMICAL	GENE-Y	7	5	Combination treatment with the selective gene antagonist chemical produced a dose-dependent augmentation of chemical-induced ( 3-30 mg/kg s.c ) extracellular chemical concentrations , but had no further effect on chemical above that produced by chemical alone .	T23	T36	10462128
NA	CHEMICAL	GENE-Y	9	5	Combination treatment with the selective gene antagonist chemical produced a dose-dependent augmentation of chemical-induced ( 3-30 mg/kg s.c ) extracellular chemical concentrations , but had no further effect on chemical above that produced by chemical alone .	T24	T36	10462128
NA	CHEMICAL	GENE-Y	20	5	Combination treatment with the selective gene antagonist chemical produced a dose-dependent augmentation of chemical-induced ( 3-30 mg/kg s.c ) extracellular chemical concentrations , but had no further effect on chemical above that produced by chemical alone .	T25	T36	10462128
NA	CHEMICAL	GENE-Y	29	5	Combination treatment with the selective gene antagonist chemical produced a dose-dependent augmentation of chemical-induced ( 3-30 mg/kg s.c ) extracellular chemical concentrations , but had no further effect on chemical above that produced by chemical alone .	T26	T36	10462128
NA	CHEMICAL	GENE-Y	9	5	Combination treatment with the selective gene antagonist chemical produced a dose-dependent augmentation of chemical-induced ( 3-30 mg/kg s.c ) extracellular chemical concentrations , but had no further effect on chemical above that produced by chemical alone .	T27	T36	10462128
CPR:6	CHEMICAL	GENE-Y	1	1	The beta-adrenergic/gene receptor antagonist chemical and the selective gene antagonist chemical produced no significant augmentation of chemical-induced changes in either chemical or chemical .	T3	T31	10462128
NA	CHEMICAL	GENE-N	1	8	The beta-adrenergic/gene receptor antagonist chemical and the selective gene antagonist chemical produced no significant augmentation of chemical-induced changes in either chemical or chemical .	T3	T32	10462128
NA	CHEMICAL	GENE-Y	10	1	The beta-adrenergic/gene receptor antagonist chemical and the selective gene antagonist chemical produced no significant augmentation of chemical-induced changes in either chemical or chemical .	T4	T31	10462128
NA	CHEMICAL	GENE-N	10	8	The beta-adrenergic/gene receptor antagonist chemical and the selective gene antagonist chemical produced no significant augmentation of chemical-induced changes in either chemical or chemical .	T4	T32	10462128
NA	CHEMICAL	GENE-Y	16	1	The beta-adrenergic/gene receptor antagonist chemical and the selective gene antagonist chemical produced no significant augmentation of chemical-induced changes in either chemical or chemical .	T5	T31	10462128
NA	CHEMICAL	GENE-N	16	8	The beta-adrenergic/gene receptor antagonist chemical and the selective gene antagonist chemical produced no significant augmentation of chemical-induced changes in either chemical or chemical .	T5	T32	10462128
NA	CHEMICAL	GENE-Y	20	1	The beta-adrenergic/gene receptor antagonist chemical and the selective gene antagonist chemical produced no significant augmentation of chemical-induced changes in either chemical or chemical .	T6	T31	10462128
NA	CHEMICAL	GENE-N	20	8	The beta-adrenergic/gene receptor antagonist chemical and the selective gene antagonist chemical produced no significant augmentation of chemical-induced changes in either chemical or chemical .	T6	T32	10462128
NA	CHEMICAL	GENE-Y	22	1	The beta-adrenergic/gene receptor antagonist chemical and the selective gene antagonist chemical produced no significant augmentation of chemical-induced changes in either chemical or chemical .	T7	T31	10462128
NA	CHEMICAL	GENE-N	22	8	The beta-adrenergic/gene receptor antagonist chemical and the selective gene antagonist chemical produced no significant augmentation of chemical-induced changes in either chemical or chemical .	T7	T32	10462128
NA	CHEMICAL	GENE-N	5	2	Using the gene antagonists , chemical and chemical , we also demonstrate the role of the gene in the augmentation of chemical-induced changes .	T8	T33	10462128
NA	CHEMICAL	GENE-N	5	16	Using the gene antagonists , chemical and chemical , we also demonstrate the role of the gene in the augmentation of chemical-induced changes .	T8	T34	10462128
NA	CHEMICAL	GENE-N	7	2	Using the gene antagonists , chemical and chemical , we also demonstrate the role of the gene in the augmentation of chemical-induced changes .	T9	T33	10462128
NA	CHEMICAL	GENE-N	7	16	Using the gene antagonists , chemical and chemical , we also demonstrate the role of the gene in the augmentation of chemical-induced changes .	T9	T34	10462128
NA	CHEMICAL	GENE-N	17	2	Using the gene antagonists , chemical and chemical , we also demonstrate the role of the gene in the augmentation of chemical-induced changes .	T10	T33	10462128
NA	CHEMICAL	GENE-N	17	16	Using the gene antagonists , chemical and chemical , we also demonstrate the role of the gene in the augmentation of chemical-induced changes .	T10	T34	10462128
CPR:4	CHEMICAL	GENE-Y	1	10	Identification of chemical central cores for the inhibition of chemical hydrolase .	T10	T16	23260350
NA	CHEMICAL	GENE-Y	9	10	Identification of chemical central cores for the inhibition of chemical hydrolase .	T11	T16	23260350
NA	CHEMICAL	GENE-Y	0	1	chemical hydrolase ( gene ) is a cystolic enzyme that stereospecifically catalyzes the transformation of chemical to chemical .	T9	T15	23260350
NA	CHEMICAL	GENE-Y	0	2	chemical hydrolase ( gene ) is a cystolic enzyme that stereospecifically catalyzes the transformation of chemical to chemical .	T9	T12	23260350
CPR:9	CHEMICAL	GENE-Y	2	1	chemical hydrolase ( gene ) is a cystolic enzyme that stereospecifically catalyzes the transformation of chemical to chemical .	T2	T15	23260350
CPR:9	CHEMICAL	GENE-Y	2	2	chemical hydrolase ( gene ) is a cystolic enzyme that stereospecifically catalyzes the transformation of chemical to chemical .	T2	T12	23260350
CPR:9	CHEMICAL	GENE-Y	2	1	chemical hydrolase ( gene ) is a cystolic enzyme that stereospecifically catalyzes the transformation of chemical to chemical .	T3	T15	23260350
CPR:9	CHEMICAL	GENE-Y	2	2	chemical hydrolase ( gene ) is a cystolic enzyme that stereospecifically catalyzes the transformation of chemical to chemical .	T3	T12	23260350
CPR:4	CHEMICAL	GENE-Y	7	11	This paper describes the identification and synthesis of substituted chemical as gene inhibitors .	T5	T13	23260350
CPR:5	CHEMICAL	GENE-Y	0	3	chemical is a gene and gene receptor agonist that promotes gene/gene heterodimerization and has potent neurotrophic activity .	T11	T27	19549602
CPR:5	CHEMICAL	GENE-Y	0	5	chemical is a gene and gene receptor agonist that promotes gene/gene heterodimerization and has potent neurotrophic activity .	T11	T28	19549602
NA	CHEMICAL	GENE-Y	0	10	chemical is a gene and gene receptor agonist that promotes gene/gene heterodimerization and has potent neurotrophic activity .	T11	T29	19549602
NA	CHEMICAL	GENE-Y	0	10	chemical is a gene and gene receptor agonist that promotes gene/gene heterodimerization and has potent neurotrophic activity .	T11	T30	19549602
NA	CHEMICAL	GENE-Y	4	12	We report here that chemical , an antidepressant drug , directly binds gene and gene and triggers their dimerization and activation .	T1	T14	19549602
NA	CHEMICAL	GENE-Y	4	14	We report here that chemical , an antidepressant drug , directly binds gene and gene and triggers their dimerization and activation .	T1	T15	19549602
CPR:3	CHEMICAL	GENE-Y	0	15	chemical , but not any other chemical or selective chemical reuptake inhibitor antidepressants , promotes gene autophosphorylation in primary neurons and induces neurite outgrowth in PC12 cells .	T2	T16	19549602
NA	CHEMICAL	GENE-Y	6	15	chemical , but not any other chemical or selective chemical reuptake inhibitor antidepressants , promotes gene autophosphorylation in primary neurons and induces neurite outgrowth in PC12 cells .	T3	T16	19549602
NA	CHEMICAL	GENE-Y	9	15	chemical , but not any other chemical or selective chemical reuptake inhibitor antidepressants , promotes gene autophosphorylation in primary neurons and induces neurite outgrowth in PC12 cells .	T4	T16	19549602
NA	CHEMICAL	GENE-Y	0	7	chemical binds the extracellular domain of both gene and gene and promotes gene-gene receptor heterodimerization .	T5	T18	19549602
NA	CHEMICAL	GENE-Y	0	9	chemical binds the extracellular domain of both gene and gene and promotes gene-gene receptor heterodimerization .	T5	T19	19549602
NA	CHEMICAL	GENE-Y	0	12	chemical binds the extracellular domain of both gene and gene and promotes gene-gene receptor heterodimerization .	T5	T20	19549602
NA	CHEMICAL	GENE-Y	0	12	chemical binds the extracellular domain of both gene and gene and promotes gene-gene receptor heterodimerization .	T5	T21	19549602
NA	CHEMICAL	GENE-Y	2	6	Truncation of chemical binding motif on gene abrogates the receptor dimerization by chemical .	T6	T22	19549602
NA	CHEMICAL	GENE-Y	12	6	Truncation of chemical binding motif on gene abrogates the receptor dimerization by chemical .	T7	T22	19549602
NA	CHEMICAL	GENE-N	9	28	Sixty-four female mice ( ICR ) were injected with chemical ( 0 , 7.5 , 15 and 30 µg/d ) for 3 d starting from the day of gene treatment .	T4	T8	23339678
NA	CHEMICAL	GENE-Y	4	4	A head-to-head comparison between gene detemir and NPH gene in women with type 1 diabetes showed that while foetal outcomes did not differ , fasting plasma chemical improved with gene detemir without an increased incidence of hypoglycaemia .	T1	T13	23489521
NA	CHEMICAL	GENE-Y	4	8	A head-to-head comparison between gene detemir and NPH gene in women with type 1 diabetes showed that while foetal outcomes did not differ , fasting plasma chemical improved with gene detemir without an increased incidence of hypoglycaemia .	T1	T14	23489521
CPR:3	CHEMICAL	GENE-Y	4	9	A head-to-head comparison between gene detemir and NPH gene in women with type 1 diabetes showed that while foetal outcomes did not differ , fasting plasma chemical improved with gene detemir without an increased incidence of hypoglycaemia .	T1	T2	23489521
CPR:4	CHEMICAL	GENE-N	4	6	The inhibitory effect of chemical on gene activation is not dependent on chemical-gene pathway .	T18	T29	15465035
NA	CHEMICAL	GENE-N	4	12	The inhibitory effect of chemical on gene activation is not dependent on chemical-gene pathway .	T18	T30	15465035
NA	CHEMICAL	GENE-N	12	6	The inhibitory effect of chemical on gene activation is not dependent on chemical-gene pathway .	T19	T29	15465035
NA	CHEMICAL	GENE-N	12	12	The inhibitory effect of chemical on gene activation is not dependent on chemical-gene pathway .	T19	T30	15465035
NA	CHEMICAL	GENE-N	12	15	One of the most important transcription factors that activate the expression of chemical-regulated genes is gene ( gene ) .	T1	T20	15465035
NA	CHEMICAL	GENE-N	12	17	One of the most important transcription factors that activate the expression of chemical-regulated genes is gene ( gene ) .	T1	T21	15465035
NA	CHEMICAL	GENE-N	9	25	We investigated the effect of the clinically used nitrates chemical ( chemical ) , chemical ( chemical ) , and chemical ( chemical ) on gene-mediated transcriptional responses to hypoxia .	T5	T22	15465035
NA	CHEMICAL	GENE-N	11	25	We investigated the effect of the clinically used nitrates chemical ( chemical ) , chemical ( chemical ) , and chemical ( chemical ) on gene-mediated transcriptional responses to hypoxia .	T6	T22	15465035
NA	CHEMICAL	GENE-N	14	25	We investigated the effect of the clinically used nitrates chemical ( chemical ) , chemical ( chemical ) , and chemical ( chemical ) on gene-mediated transcriptional responses to hypoxia .	T7	T22	15465035
NA	CHEMICAL	GENE-N	16	25	We investigated the effect of the clinically used nitrates chemical ( chemical ) , chemical ( chemical ) , and chemical ( chemical ) on gene-mediated transcriptional responses to hypoxia .	T8	T22	15465035
NA	CHEMICAL	GENE-N	20	25	We investigated the effect of the clinically used nitrates chemical ( chemical ) , chemical ( chemical ) , and chemical ( chemical ) on gene-mediated transcriptional responses to hypoxia .	T9	T22	15465035
NA	CHEMICAL	GENE-N	22	25	We investigated the effect of the clinically used nitrates chemical ( chemical ) , chemical ( chemical ) , and chemical ( chemical ) on gene-mediated transcriptional responses to hypoxia .	T10	T22	15465035
CPR:4	CHEMICAL	GENE-N	9	11	We demonstrate that among the three nitrates , only chemical inhibits gene activation in response to hypoxia .	T11	T23	15465035
NA	CHEMICAL	GENE-N	3	9	In contrast , chemical or chemical does not affect gene activity .	T12	T24	15465035
NA	CHEMICAL	GENE-N	5	9	In contrast , chemical or chemical does not affect gene activity .	T13	T24	15465035
CPR:4	CHEMICAL	GENE-Y	0	8	chemical suppress activation of microglia : down-regulation of gene by chemical .	T17	T36	10200320
CPR:4	CHEMICAL	GENE-Y	10	8	chemical suppress activation of microglia : down-regulation of gene by chemical .	T18	T36	10200320
CPR:4	CHEMICAL	GENE-Y	0	5	chemical were potent inhibitors of gene induction and were more effective than their precursors , chemical .	T10	T33	10200320
CPR:4	CHEMICAL	GENE-Y	15	5	chemical were potent inhibitors of gene induction and were more effective than their precursors , chemical .	T11	T33	10200320
CPR:4	CHEMICAL	GENE-N	4	6	In activated microglia , chemical suppressed gene activity , gene mRNA , and protein levels .	T15	T34	10200320
CPR:4	CHEMICAL	GENE-Y	4	9	In activated microglia , chemical suppressed gene activity , gene mRNA , and protein levels .	T15	T35	10200320
NA	CHEMICAL	GENE-Y	3	12	The action of chemical does not appear to involve its nuclear receptor gene ( gene ) because chemical , a specific ligand of gene , was unable to inhibit gene induction , and neither chemical nor chemical could stimulate the activity of a gene-dependent promoter in the absence of cotransfected gene .	T16	T20	10200320
NA	CHEMICAL	GENE-Y	3	14	The action of chemical does not appear to involve its nuclear receptor gene ( gene ) because chemical , a specific ligand of gene , was unable to inhibit gene induction , and neither chemical nor chemical could stimulate the activity of a gene-dependent promoter in the absence of cotransfected gene .	T16	T21	10200320
NA	CHEMICAL	GENE-Y	3	19	The action of chemical does not appear to involve its nuclear receptor gene ( gene ) because chemical , a specific ligand of gene , was unable to inhibit gene induction , and neither chemical nor chemical could stimulate the activity of a gene-dependent promoter in the absence of cotransfected gene .	T16	T22	10200320
NA	CHEMICAL	GENE-Y	3	29	The action of chemical does not appear to involve its nuclear receptor gene ( gene ) because chemical , a specific ligand of gene , was unable to inhibit gene induction , and neither chemical nor chemical could stimulate the activity of a gene-dependent promoter in the absence of cotransfected gene .	T16	T23	10200320
NA	CHEMICAL	GENE-N	3	43	The action of chemical does not appear to involve its nuclear receptor gene ( gene ) because chemical , a specific ligand of gene , was unable to inhibit gene induction , and neither chemical nor chemical could stimulate the activity of a gene-dependent promoter in the absence of cotransfected gene .	T16	T24	10200320
NA	CHEMICAL	GENE-Y	3	19	The action of chemical does not appear to involve its nuclear receptor gene ( gene ) because chemical , a specific ligand of gene , was unable to inhibit gene induction , and neither chemical nor chemical could stimulate the activity of a gene-dependent promoter in the absence of cotransfected gene .	T16	T25	10200320
NA	CHEMICAL	GENE-Y	3	12	The action of chemical does not appear to involve its nuclear receptor gene ( gene ) because chemical , a specific ligand of gene , was unable to inhibit gene induction , and neither chemical nor chemical could stimulate the activity of a gene-dependent promoter in the absence of cotransfected gene .	T1	T20	10200320
NA	CHEMICAL	GENE-Y	3	14	The action of chemical does not appear to involve its nuclear receptor gene ( gene ) because chemical , a specific ligand of gene , was unable to inhibit gene induction , and neither chemical nor chemical could stimulate the activity of a gene-dependent promoter in the absence of cotransfected gene .	T1	T21	10200320
NA	CHEMICAL	GENE-Y	3	19	The action of chemical does not appear to involve its nuclear receptor gene ( gene ) because chemical , a specific ligand of gene , was unable to inhibit gene induction , and neither chemical nor chemical could stimulate the activity of a gene-dependent promoter in the absence of cotransfected gene .	T1	T22	10200320
NA	CHEMICAL	GENE-Y	3	29	The action of chemical does not appear to involve its nuclear receptor gene ( gene ) because chemical , a specific ligand of gene , was unable to inhibit gene induction , and neither chemical nor chemical could stimulate the activity of a gene-dependent promoter in the absence of cotransfected gene .	T1	T23	10200320
NA	CHEMICAL	GENE-N	3	43	The action of chemical does not appear to involve its nuclear receptor gene ( gene ) because chemical , a specific ligand of gene , was unable to inhibit gene induction , and neither chemical nor chemical could stimulate the activity of a gene-dependent promoter in the absence of cotransfected gene .	T1	T24	10200320
NA	CHEMICAL	GENE-Y	3	19	The action of chemical does not appear to involve its nuclear receptor gene ( gene ) because chemical , a specific ligand of gene , was unable to inhibit gene induction , and neither chemical nor chemical could stimulate the activity of a gene-dependent promoter in the absence of cotransfected gene .	T1	T25	10200320
NA	CHEMICAL	GENE-Y	12	12	The action of chemical does not appear to involve its nuclear receptor gene ( gene ) because chemical , a specific ligand of gene , was unable to inhibit gene induction , and neither chemical nor chemical could stimulate the activity of a gene-dependent promoter in the absence of cotransfected gene .	T2	T20	10200320
NA	CHEMICAL	GENE-Y	12	14	The action of chemical does not appear to involve its nuclear receptor gene ( gene ) because chemical , a specific ligand of gene , was unable to inhibit gene induction , and neither chemical nor chemical could stimulate the activity of a gene-dependent promoter in the absence of cotransfected gene .	T2	T21	10200320
NA	CHEMICAL	GENE-Y	12	19	The action of chemical does not appear to involve its nuclear receptor gene ( gene ) because chemical , a specific ligand of gene , was unable to inhibit gene induction , and neither chemical nor chemical could stimulate the activity of a gene-dependent promoter in the absence of cotransfected gene .	T2	T22	10200320
NA	CHEMICAL	GENE-Y	12	29	The action of chemical does not appear to involve its nuclear receptor gene ( gene ) because chemical , a specific ligand of gene , was unable to inhibit gene induction , and neither chemical nor chemical could stimulate the activity of a gene-dependent promoter in the absence of cotransfected gene .	T2	T23	10200320
NA	CHEMICAL	GENE-N	12	43	The action of chemical does not appear to involve its nuclear receptor gene ( gene ) because chemical , a specific ligand of gene , was unable to inhibit gene induction , and neither chemical nor chemical could stimulate the activity of a gene-dependent promoter in the absence of cotransfected gene .	T2	T24	10200320
NA	CHEMICAL	GENE-Y	12	19	The action of chemical does not appear to involve its nuclear receptor gene ( gene ) because chemical , a specific ligand of gene , was unable to inhibit gene induction , and neither chemical nor chemical could stimulate the activity of a gene-dependent promoter in the absence of cotransfected gene .	T2	T25	10200320
NA	CHEMICAL	GENE-Y	36	12	The action of chemical does not appear to involve its nuclear receptor gene ( gene ) because chemical , a specific ligand of gene , was unable to inhibit gene induction , and neither chemical nor chemical could stimulate the activity of a gene-dependent promoter in the absence of cotransfected gene .	T3	T20	10200320
NA	CHEMICAL	GENE-Y	36	14	The action of chemical does not appear to involve its nuclear receptor gene ( gene ) because chemical , a specific ligand of gene , was unable to inhibit gene induction , and neither chemical nor chemical could stimulate the activity of a gene-dependent promoter in the absence of cotransfected gene .	T3	T21	10200320
NA	CHEMICAL	GENE-Y	36	19	The action of chemical does not appear to involve its nuclear receptor gene ( gene ) because chemical , a specific ligand of gene , was unable to inhibit gene induction , and neither chemical nor chemical could stimulate the activity of a gene-dependent promoter in the absence of cotransfected gene .	T3	T22	10200320
NA	CHEMICAL	GENE-Y	36	29	The action of chemical does not appear to involve its nuclear receptor gene ( gene ) because chemical , a specific ligand of gene , was unable to inhibit gene induction , and neither chemical nor chemical could stimulate the activity of a gene-dependent promoter in the absence of cotransfected gene .	T3	T23	10200320
NA	CHEMICAL	GENE-N	36	43	The action of chemical does not appear to involve its nuclear receptor gene ( gene ) because chemical , a specific ligand of gene , was unable to inhibit gene induction , and neither chemical nor chemical could stimulate the activity of a gene-dependent promoter in the absence of cotransfected gene .	T3	T24	10200320
NA	CHEMICAL	GENE-Y	36	19	The action of chemical does not appear to involve its nuclear receptor gene ( gene ) because chemical , a specific ligand of gene , was unable to inhibit gene induction , and neither chemical nor chemical could stimulate the activity of a gene-dependent promoter in the absence of cotransfected gene .	T3	T25	10200320
NA	CHEMICAL	GENE-N	0	13	chemical did not block nuclear translocation or DNA-binding activity of the transcription factor gene , but it did inhibit the activity of an gene reporter construct , suggesting that the mechanism of suppression of microglial gene by chemical may involve interference with gene transcriptional activity in the nucleus .	T4	T26	10200320
CPR:4	CHEMICAL	GENE-N	0	23	chemical did not block nuclear translocation or DNA-binding activity of the transcription factor gene , but it did inhibit the activity of an gene reporter construct , suggesting that the mechanism of suppression of microglial gene by chemical may involve interference with gene transcriptional activity in the nucleus .	T4	T27	10200320
NA	CHEMICAL	GENE-Y	0	35	chemical did not block nuclear translocation or DNA-binding activity of the transcription factor gene , but it did inhibit the activity of an gene reporter construct , suggesting that the mechanism of suppression of microglial gene by chemical may involve interference with gene transcriptional activity in the nucleus .	T4	T28	10200320
NA	CHEMICAL	GENE-N	0	42	chemical did not block nuclear translocation or DNA-binding activity of the transcription factor gene , but it did inhibit the activity of an gene reporter construct , suggesting that the mechanism of suppression of microglial gene by chemical may involve interference with gene transcriptional activity in the nucleus .	T4	T29	10200320
NA	CHEMICAL	GENE-N	37	13	chemical did not block nuclear translocation or DNA-binding activity of the transcription factor gene , but it did inhibit the activity of an gene reporter construct , suggesting that the mechanism of suppression of microglial gene by chemical may involve interference with gene transcriptional activity in the nucleus .	T5	T26	10200320
NA	CHEMICAL	GENE-N	37	23	chemical did not block nuclear translocation or DNA-binding activity of the transcription factor gene , but it did inhibit the activity of an gene reporter construct , suggesting that the mechanism of suppression of microglial gene by chemical may involve interference with gene transcriptional activity in the nucleus .	T5	T27	10200320
CPR:4	CHEMICAL	GENE-Y	37	35	chemical did not block nuclear translocation or DNA-binding activity of the transcription factor gene , but it did inhibit the activity of an gene reporter construct , suggesting that the mechanism of suppression of microglial gene by chemical may involve interference with gene transcriptional activity in the nucleus .	T5	T28	10200320
NA	CHEMICAL	GENE-N	37	42	chemical did not block nuclear translocation or DNA-binding activity of the transcription factor gene , but it did inhibit the activity of an gene reporter construct , suggesting that the mechanism of suppression of microglial gene by chemical may involve interference with gene transcriptional activity in the nucleus .	T5	T29	10200320
NA	CHEMICAL	GENE-Y	16	17	DISCUSSION : These results are consistent with previous studies that found that : ( 1 ) chemical kinase had a very low activity in children with autism and ( 2 ) chemical ( chemical ) levels are unusually low in children with autism .	T1	T20	16494569
NA	CHEMICAL	GENE-Y	19	17	DISCUSSION : These results are consistent with previous studies that found that : ( 1 ) chemical kinase had a very low activity in children with autism and ( 2 ) chemical ( chemical ) levels are unusually low in children with autism .	T2	T20	16494569
NA	CHEMICAL	GENE-Y	33	17	DISCUSSION : These results are consistent with previous studies that found that : ( 1 ) chemical kinase had a very low activity in children with autism and ( 2 ) chemical ( chemical ) levels are unusually low in children with autism .	T3	T20	16494569
NA	CHEMICAL	GENE-Y	3	7	CONCLUSIONS : Total chemical is abnormally high in autism , consistent with previous reports of an impaired chemical kinase for the conversion of chemical and chemical to chemical .	T8	T21	16494569
NA	CHEMICAL	GENE-Y	17	7	CONCLUSIONS : Total chemical is abnormally high in autism , consistent with previous reports of an impaired chemical kinase for the conversion of chemical and chemical to chemical .	T9	T21	16494569
CPR:9	CHEMICAL	GENE-Y	7	7	CONCLUSIONS : Total chemical is abnormally high in autism , consistent with previous reports of an impaired chemical kinase for the conversion of chemical and chemical to chemical .	T10	T21	16494569
CPR:9	CHEMICAL	GENE-Y	25	7	CONCLUSIONS : Total chemical is abnormally high in autism , consistent with previous reports of an impaired chemical kinase for the conversion of chemical and chemical to chemical .	T11	T21	16494569
CPR:9	CHEMICAL	GENE-Y	27	7	CONCLUSIONS : Total chemical is abnormally high in autism , consistent with previous reports of an impaired chemical kinase for the conversion of chemical and chemical to chemical .	T12	T21	16494569
NA	CHEMICAL	GENE-Y	4	33	The anti-amnesic effect of chemical on the chemical-induced memory impairment was also antagonized by a chemical ( chemical ) releaser , chemical , and by a chemical precursor , chemical , whereas a gene-selective agonist , chemical , was inactive .	T7	T22	2530096
NA	CHEMICAL	GENE-Y	7	33	The anti-amnesic effect of chemical on the chemical-induced memory impairment was also antagonized by a chemical ( chemical ) releaser , chemical , and by a chemical precursor , chemical , whereas a gene-selective agonist , chemical , was inactive .	T8	T22	2530096
NA	CHEMICAL	GENE-Y	5	33	The anti-amnesic effect of chemical on the chemical-induced memory impairment was also antagonized by a chemical ( chemical ) releaser , chemical , and by a chemical precursor , chemical , whereas a gene-selective agonist , chemical , was inactive .	T9	T22	2530096
NA	CHEMICAL	GENE-Y	17	33	The anti-amnesic effect of chemical on the chemical-induced memory impairment was also antagonized by a chemical ( chemical ) releaser , chemical , and by a chemical precursor , chemical , whereas a gene-selective agonist , chemical , was inactive .	T10	T22	2530096
NA	CHEMICAL	GENE-Y	14	33	The anti-amnesic effect of chemical on the chemical-induced memory impairment was also antagonized by a chemical ( chemical ) releaser , chemical , and by a chemical precursor , chemical , whereas a gene-selective agonist , chemical , was inactive .	T11	T22	2530096
NA	CHEMICAL	GENE-Y	26	33	The anti-amnesic effect of chemical on the chemical-induced memory impairment was also antagonized by a chemical ( chemical ) releaser , chemical , and by a chemical precursor , chemical , whereas a gene-selective agonist , chemical , was inactive .	T12	T22	2530096
NA	CHEMICAL	GENE-Y	14	33	The anti-amnesic effect of chemical on the chemical-induced memory impairment was also antagonized by a chemical ( chemical ) releaser , chemical , and by a chemical precursor , chemical , whereas a gene-selective agonist , chemical , was inactive .	T13	T22	2530096
CPR:5	CHEMICAL	GENE-Y	14	33	The anti-amnesic effect of chemical on the chemical-induced memory impairment was also antagonized by a chemical ( chemical ) releaser , chemical , and by a chemical precursor , chemical , whereas a gene-selective agonist , chemical , was inactive .	T14	T22	2530096
NA	CHEMICAL	GENE-N	4	13	The memory-improving effect of chemical on chemical-induced amnesia was potentiated by a selective gene antagonist , chemical .	T15	T23	2530096
NA	CHEMICAL	GENE-N	6	13	The memory-improving effect of chemical on chemical-induced amnesia was potentiated by a selective gene antagonist , chemical .	T16	T23	2530096
CPR:6	CHEMICAL	GENE-N	11	13	The memory-improving effect of chemical on chemical-induced amnesia was potentiated by a selective gene antagonist , chemical .	T17	T23	2530096
NA	CHEMICAL	GENE-N	0	3	chemical independently modulates gene and chemical-dependent protein kinase signaling pathways .	T15	T40	16546990
NA	CHEMICAL	GENE-N	0	7	chemical independently modulates gene and chemical-dependent protein kinase signaling pathways .	T15	T41	16546990
NA	CHEMICAL	GENE-N	5	3	chemical independently modulates gene and chemical-dependent protein kinase signaling pathways .	T16	T40	16546990
NA	CHEMICAL	GENE-N	5	7	chemical independently modulates gene and chemical-dependent protein kinase signaling pathways .	T16	T41	16546990
CPR:3	CHEMICAL	GENE-N	0	4	chemical metabolites simultaneously ( a ) increase cellular chemical and subsequently activate chemical-dependent protein kinase ( gene ) ; ( b ) activate gene ( gene ) ; ( c ) inhibit gene ( gene ) ; and ( d ) decrease gene protein expression at times and doses consistent with apoptosis .	T9	T27	16546990
CPR:3	CHEMICAL	GENE-N	0	16	chemical metabolites simultaneously ( a ) increase cellular chemical and subsequently activate chemical-dependent protein kinase ( gene ) ; ( b ) activate gene ( gene ) ; ( c ) inhibit gene ( gene ) ; and ( d ) decrease gene protein expression at times and doses consistent with apoptosis .	T9	T28	16546990
CPR:4	CHEMICAL	GENE-N	0	4	chemical metabolites simultaneously ( a ) increase cellular chemical and subsequently activate chemical-dependent protein kinase ( gene ) ; ( b ) activate gene ( gene ) ; ( c ) inhibit gene ( gene ) ; and ( d ) decrease gene protein expression at times and doses consistent with apoptosis .	T9	T29	16546990
CPR:4	CHEMICAL	GENE-N	0	25	chemical metabolites simultaneously ( a ) increase cellular chemical and subsequently activate chemical-dependent protein kinase ( gene ) ; ( b ) activate gene ( gene ) ; ( c ) inhibit gene ( gene ) ; and ( d ) decrease gene protein expression at times and doses consistent with apoptosis .	T9	T30	16546990
NA	CHEMICAL	GENE-N	0	32	chemical metabolites simultaneously ( a ) increase cellular chemical and subsequently activate chemical-dependent protein kinase ( gene ) ; ( b ) activate gene ( gene ) ; ( c ) inhibit gene ( gene ) ; and ( d ) decrease gene protein expression at times and doses consistent with apoptosis .	T9	T31	16546990
NA	CHEMICAL	GENE-N	0	34	chemical metabolites simultaneously ( a ) increase cellular chemical and subsequently activate chemical-dependent protein kinase ( gene ) ; ( b ) activate gene ( gene ) ; ( c ) inhibit gene ( gene ) ; and ( d ) decrease gene protein expression at times and doses consistent with apoptosis .	T9	T32	16546990
CPR:4	CHEMICAL	GENE-Y	0	4	chemical metabolites simultaneously ( a ) increase cellular chemical and subsequently activate chemical-dependent protein kinase ( gene ) ; ( b ) activate gene ( gene ) ; ( c ) inhibit gene ( gene ) ; and ( d ) decrease gene protein expression at times and doses consistent with apoptosis .	T9	T33	16546990
NA	CHEMICAL	GENE-N	8	4	chemical metabolites simultaneously ( a ) increase cellular chemical and subsequently activate chemical-dependent protein kinase ( gene ) ; ( b ) activate gene ( gene ) ; ( c ) inhibit gene ( gene ) ; and ( d ) decrease gene protein expression at times and doses consistent with apoptosis .	T10	T27	16546990
NA	CHEMICAL	GENE-N	8	16	chemical metabolites simultaneously ( a ) increase cellular chemical and subsequently activate chemical-dependent protein kinase ( gene ) ; ( b ) activate gene ( gene ) ; ( c ) inhibit gene ( gene ) ; and ( d ) decrease gene protein expression at times and doses consistent with apoptosis .	T10	T28	16546990
NA	CHEMICAL	GENE-N	8	4	chemical metabolites simultaneously ( a ) increase cellular chemical and subsequently activate chemical-dependent protein kinase ( gene ) ; ( b ) activate gene ( gene ) ; ( c ) inhibit gene ( gene ) ; and ( d ) decrease gene protein expression at times and doses consistent with apoptosis .	T10	T29	16546990
NA	CHEMICAL	GENE-N	8	25	chemical metabolites simultaneously ( a ) increase cellular chemical and subsequently activate chemical-dependent protein kinase ( gene ) ; ( b ) activate gene ( gene ) ; ( c ) inhibit gene ( gene ) ; and ( d ) decrease gene protein expression at times and doses consistent with apoptosis .	T10	T30	16546990
NA	CHEMICAL	GENE-N	8	32	chemical metabolites simultaneously ( a ) increase cellular chemical and subsequently activate chemical-dependent protein kinase ( gene ) ; ( b ) activate gene ( gene ) ; ( c ) inhibit gene ( gene ) ; and ( d ) decrease gene protein expression at times and doses consistent with apoptosis .	T10	T31	16546990
NA	CHEMICAL	GENE-N	8	34	chemical metabolites simultaneously ( a ) increase cellular chemical and subsequently activate chemical-dependent protein kinase ( gene ) ; ( b ) activate gene ( gene ) ; ( c ) inhibit gene ( gene ) ; and ( d ) decrease gene protein expression at times and doses consistent with apoptosis .	T10	T32	16546990
NA	CHEMICAL	GENE-Y	8	4	chemical metabolites simultaneously ( a ) increase cellular chemical and subsequently activate chemical-dependent protein kinase ( gene ) ; ( b ) activate gene ( gene ) ; ( c ) inhibit gene ( gene ) ; and ( d ) decrease gene protein expression at times and doses consistent with apoptosis .	T10	T33	16546990
NA	CHEMICAL	GENE-N	12	4	chemical metabolites simultaneously ( a ) increase cellular chemical and subsequently activate chemical-dependent protein kinase ( gene ) ; ( b ) activate gene ( gene ) ; ( c ) inhibit gene ( gene ) ; and ( d ) decrease gene protein expression at times and doses consistent with apoptosis .	T11	T27	16546990
NA	CHEMICAL	GENE-N	12	16	chemical metabolites simultaneously ( a ) increase cellular chemical and subsequently activate chemical-dependent protein kinase ( gene ) ; ( b ) activate gene ( gene ) ; ( c ) inhibit gene ( gene ) ; and ( d ) decrease gene protein expression at times and doses consistent with apoptosis .	T11	T28	16546990
NA	CHEMICAL	GENE-N	12	4	chemical metabolites simultaneously ( a ) increase cellular chemical and subsequently activate chemical-dependent protein kinase ( gene ) ; ( b ) activate gene ( gene ) ; ( c ) inhibit gene ( gene ) ; and ( d ) decrease gene protein expression at times and doses consistent with apoptosis .	T11	T29	16546990
NA	CHEMICAL	GENE-N	12	25	chemical metabolites simultaneously ( a ) increase cellular chemical and subsequently activate chemical-dependent protein kinase ( gene ) ; ( b ) activate gene ( gene ) ; ( c ) inhibit gene ( gene ) ; and ( d ) decrease gene protein expression at times and doses consistent with apoptosis .	T11	T30	16546990
NA	CHEMICAL	GENE-N	12	32	chemical metabolites simultaneously ( a ) increase cellular chemical and subsequently activate chemical-dependent protein kinase ( gene ) ; ( b ) activate gene ( gene ) ; ( c ) inhibit gene ( gene ) ; and ( d ) decrease gene protein expression at times and doses consistent with apoptosis .	T11	T31	16546990
NA	CHEMICAL	GENE-N	12	34	chemical metabolites simultaneously ( a ) increase cellular chemical and subsequently activate chemical-dependent protein kinase ( gene ) ; ( b ) activate gene ( gene ) ; ( c ) inhibit gene ( gene ) ; and ( d ) decrease gene protein expression at times and doses consistent with apoptosis .	T11	T32	16546990
NA	CHEMICAL	GENE-Y	12	4	chemical metabolites simultaneously ( a ) increase cellular chemical and subsequently activate chemical-dependent protein kinase ( gene ) ; ( b ) activate gene ( gene ) ; ( c ) inhibit gene ( gene ) ; and ( d ) decrease gene protein expression at times and doses consistent with apoptosis .	T11	T33	16546990
NA	CHEMICAL	GENE-N	21	9	The purpose of this study was to determine if gene , gene , gene , and gene are independent targets for chemical in vitro .	T13	T34	16546990
NA	CHEMICAL	GENE-N	21	11	The purpose of this study was to determine if gene , gene , gene , and gene are independent targets for chemical in vitro .	T13	T35	16546990
NA	CHEMICAL	GENE-N	21	13	The purpose of this study was to determine if gene , gene , gene , and gene are independent targets for chemical in vitro .	T13	T36	16546990
NA	CHEMICAL	GENE-Y	21	16	The purpose of this study was to determine if gene , gene , gene , and gene are independent targets for chemical in vitro .	T13	T37	16546990
NA	CHEMICAL	GENE-N	5	3	Pharmacologic activation of gene with chemical increases gene phosphorylation and induces apoptosis in colon cancer cells without modulating gene phosphorylation or gene protein expression .	T14	T38	16546990
NA	CHEMICAL	GENE-N	5	7	Pharmacologic activation of gene with chemical increases gene phosphorylation and induces apoptosis in colon cancer cells without modulating gene phosphorylation or gene protein expression .	T14	T39	16546990
NA	CHEMICAL	GENE-N	5	18	Pharmacologic activation of gene with chemical increases gene phosphorylation and induces apoptosis in colon cancer cells without modulating gene phosphorylation or gene protein expression .	T14	T17	16546990
NA	CHEMICAL	GENE-Y	5	12	Pharmacologic activation of gene with chemical increases gene phosphorylation and induces apoptosis in colon cancer cells without modulating gene phosphorylation or gene protein expression .	T14	T18	16546990
NA	CHEMICAL	GENE-N	2	2	Inhibition of gene with chemical induces apoptosis but fails to activate gene phosphorylation or down-regulate gene protein expression .	T1	T19	16546990
NA	CHEMICAL	GENE-N	2	11	Inhibition of gene with chemical induces apoptosis but fails to activate gene phosphorylation or down-regulate gene protein expression .	T1	T20	16546990
NA	CHEMICAL	GENE-Y	2	15	Inhibition of gene with chemical induces apoptosis but fails to activate gene phosphorylation or down-regulate gene protein expression .	T1	T21	16546990
NA	CHEMICAL	GENE-N	2	20	Cotreatment with chemical and chemical synergistically increases apoptosis in colorectal cancer cells and recapitulates the effects of chemical treatment on gene , gene , and gene .	T2	T22	16546990
CPR:3	CHEMICAL	GENE-N	2	22	Cotreatment with chemical and chemical synergistically increases apoptosis in colorectal cancer cells and recapitulates the effects of chemical treatment on gene , gene , and gene .	T2	T23	16546990
CPR:4	CHEMICAL	GENE-Y	2	8	Cotreatment with chemical and chemical synergistically increases apoptosis in colorectal cancer cells and recapitulates the effects of chemical treatment on gene , gene , and gene .	T2	T24	16546990
NA	CHEMICAL	GENE-N	4	20	Cotreatment with chemical and chemical synergistically increases apoptosis in colorectal cancer cells and recapitulates the effects of chemical treatment on gene , gene , and gene .	T3	T22	16546990
CPR:3	CHEMICAL	GENE-N	4	22	Cotreatment with chemical and chemical synergistically increases apoptosis in colorectal cancer cells and recapitulates the effects of chemical treatment on gene , gene , and gene .	T3	T23	16546990
CPR:4	CHEMICAL	GENE-Y	4	8	Cotreatment with chemical and chemical synergistically increases apoptosis in colorectal cancer cells and recapitulates the effects of chemical treatment on gene , gene , and gene .	T3	T24	16546990
NA	CHEMICAL	GENE-N	8	20	Cotreatment with chemical and chemical synergistically increases apoptosis in colorectal cancer cells and recapitulates the effects of chemical treatment on gene , gene , and gene .	T4	T22	16546990
CPR:3	CHEMICAL	GENE-N	8	22	Cotreatment with chemical and chemical synergistically increases apoptosis in colorectal cancer cells and recapitulates the effects of chemical treatment on gene , gene , and gene .	T4	T23	16546990
CPR:4	CHEMICAL	GENE-Y	8	8	Cotreatment with chemical and chemical synergistically increases apoptosis in colorectal cancer cells and recapitulates the effects of chemical treatment on gene , gene , and gene .	T4	T24	16546990
NA	CHEMICAL	GENE-Y	14	3	Cellular mechanisms of gene resistance : role of gene and gene ( gene ) chemical phosphorylation .	T4	T28	19683471
NA	CHEMICAL	GENE-N	14	8	Cellular mechanisms of gene resistance : role of gene and gene ( gene ) chemical phosphorylation .	T4	T29	19683471
NA	CHEMICAL	GENE-N	14	10	Cellular mechanisms of gene resistance : role of gene and gene ( gene ) chemical phosphorylation .	T4	T30	19683471
NA	CHEMICAL	GENE-N	14	12	Cellular mechanisms of gene resistance : role of gene and gene ( gene ) chemical phosphorylation .	T4	T27	19683471
NA	CHEMICAL	GENE-Y	10	3	Cellular mechanisms of gene resistance : role of gene and gene ( gene ) chemical phosphorylation .	T3	T28	19683471
NA	CHEMICAL	GENE-N	10	8	Cellular mechanisms of gene resistance : role of gene and gene ( gene ) chemical phosphorylation .	T3	T29	19683471
NA	CHEMICAL	GENE-N	10	10	Cellular mechanisms of gene resistance : role of gene and gene ( gene ) chemical phosphorylation .	T3	T30	19683471
NA	CHEMICAL	GENE-N	10	12	Cellular mechanisms of gene resistance : role of gene and gene ( gene ) chemical phosphorylation .	T3	T27	19683471
NA	CHEMICAL	GENE-N	2	0	gene ( gene ) chemical phosphorylation is a time-controlled physiological feedback mechanism in gene signaling that is hijacked by metabolic and inflammatory stresses to promote gene resistance .	T1	T5	19683471
NA	CHEMICAL	GENE-N	2	2	gene ( gene ) chemical phosphorylation is a time-controlled physiological feedback mechanism in gene signaling that is hijacked by metabolic and inflammatory stresses to promote gene resistance .	T1	T14	19683471
NA	CHEMICAL	GENE-Y	2	12	gene ( gene ) chemical phosphorylation is a time-controlled physiological feedback mechanism in gene signaling that is hijacked by metabolic and inflammatory stresses to promote gene resistance .	T1	T6	19683471
NA	CHEMICAL	GENE-Y	2	12	gene ( gene ) chemical phosphorylation is a time-controlled physiological feedback mechanism in gene signaling that is hijacked by metabolic and inflammatory stresses to promote gene resistance .	T1	T7	19683471
NA	CHEMICAL	GENE-N	24	0	gene , including gene , gene , gene , gene , and gene , activated by the inducers of gene resistance induce uncontrolled gene chemical phosphorylation .	T2	T8	19683471
NA	CHEMICAL	GENE-Y	24	3	gene , including gene , gene , gene , gene , and gene , activated by the inducers of gene resistance induce uncontrolled gene chemical phosphorylation .	T2	T9	19683471
NA	CHEMICAL	GENE-N	24	5	gene , including gene , gene , gene , gene , and gene , activated by the inducers of gene resistance induce uncontrolled gene chemical phosphorylation .	T2	T10	19683471
NA	CHEMICAL	GENE-N	24	7	gene , including gene , gene , gene , gene , and gene , activated by the inducers of gene resistance induce uncontrolled gene chemical phosphorylation .	T2	T11	19683471
NA	CHEMICAL	GENE-Y	24	9	gene , including gene , gene , gene , gene , and gene , activated by the inducers of gene resistance induce uncontrolled gene chemical phosphorylation .	T2	T12	19683471
NA	CHEMICAL	GENE-N	24	12	gene , including gene , gene , gene , gene , and gene , activated by the inducers of gene resistance induce uncontrolled gene chemical phosphorylation .	T2	T13	19683471
NA	CHEMICAL	GENE-Y	24	19	gene , including gene , gene , gene , gene , and gene , activated by the inducers of gene resistance induce uncontrolled gene chemical phosphorylation .	T2	T15	19683471
NA	CHEMICAL	GENE-N	24	23	gene , including gene , gene , gene , gene , and gene , activated by the inducers of gene resistance induce uncontrolled gene chemical phosphorylation .	T2	T16	19683471
CPR:3	CHEMICAL	GENE-N	0	3	chemical activates chemical anhydrase and antagonizes the effect of the specific gene inhibitor chemical , by a direct mechanism of action .	T14	T39	11430635
CPR:3	CHEMICAL	GENE-N	0	3	chemical activates chemical anhydrase and antagonizes the effect of the specific gene inhibitor chemical , by a direct mechanism of action .	T14	T40	11430635
NA	CHEMICAL	GENE-N	2	3	chemical activates chemical anhydrase and antagonizes the effect of the specific gene inhibitor chemical , by a direct mechanism of action .	T16	T39	11430635
NA	CHEMICAL	GENE-N	2	3	chemical activates chemical anhydrase and antagonizes the effect of the specific gene inhibitor chemical , by a direct mechanism of action .	T16	T40	11430635
NA	CHEMICAL	GENE-N	16	3	chemical activates chemical anhydrase and antagonizes the effect of the specific gene inhibitor chemical , by a direct mechanism of action .	T17	T39	11430635
NA	CHEMICAL	GENE-N	16	3	chemical activates chemical anhydrase and antagonizes the effect of the specific gene inhibitor chemical , by a direct mechanism of action .	T17	T40	11430635
CPR:4	CHEMICAL	GENE-N	13	3	chemical activates chemical anhydrase and antagonizes the effect of the specific gene inhibitor chemical , by a direct mechanism of action .	T15	T39	11430635
CPR:4	CHEMICAL	GENE-N	13	3	chemical activates chemical anhydrase and antagonizes the effect of the specific gene inhibitor chemical , by a direct mechanism of action .	T15	T40	11430635
NA	CHEMICAL	GENE-N	10	23	OBJECTIVES : In this paper we investigated the effect of chemical , chemical and their combination in vitro and in vivo on chemical anhydrase ( gene ) isozymes .	T8	T22	11430635
NA	CHEMICAL	GENE-N	10	25	OBJECTIVES : In this paper we investigated the effect of chemical , chemical and their combination in vitro and in vivo on chemical anhydrase ( gene ) isozymes .	T8	T24	11430635
NA	CHEMICAL	GENE-N	12	23	OBJECTIVES : In this paper we investigated the effect of chemical , chemical and their combination in vitro and in vivo on chemical anhydrase ( gene ) isozymes .	T11	T22	11430635
NA	CHEMICAL	GENE-N	12	25	OBJECTIVES : In this paper we investigated the effect of chemical , chemical and their combination in vitro and in vivo on chemical anhydrase ( gene ) isozymes .	T11	T24	11430635
NA	CHEMICAL	GENE-N	21	23	OBJECTIVES : In this paper we investigated the effect of chemical , chemical and their combination in vitro and in vivo on chemical anhydrase ( gene ) isozymes .	T4	T22	11430635
NA	CHEMICAL	GENE-N	21	25	OBJECTIVES : In this paper we investigated the effect of chemical , chemical and their combination in vitro and in vivo on chemical anhydrase ( gene ) isozymes .	T4	T24	11430635
NA	CHEMICAL	GENE-N	8	14	The effects of single and combined administration of chemical and chemical on red cell gene and on gastric acid secretion were studied in vivo .	T6	T30	11430635
NA	CHEMICAL	GENE-N	10	14	The effects of single and combined administration of chemical and chemical on red cell gene and on gastric acid secretion were studied in vivo .	T7	T30	11430635
CPR:4	CHEMICAL	GENE-N	0	6	chemical , a specific inhibitor of gene , reduces the activity of gene and gene from red cells .	T10	T33	11430635
CPR:4	CHEMICAL	GENE-Y	0	12	chemical , a specific inhibitor of gene , reduces the activity of gene and gene from red cells .	T10	T34	11430635
CPR:4	CHEMICAL	GENE-Y	0	14	chemical , a specific inhibitor of gene , reduces the activity of gene and gene from red cells .	T10	T35	11430635
CPR:3	CHEMICAL	GENE-N	0	3	chemical completely antagonizes gene activity , i.e .	T12	T36	11430635
CPR:4	CHEMICAL	GENE-N	5	7	abolishes the inhibitory effect of chemical on gene .	T13	T37	11430635
CPR:4	CHEMICAL	GENE-N	6	8	CONCLUSIONS : Our results show that chemical , a known gene ( gene ) inhibitor , is also an activator of gene .	T1	T18	11430635
CPR:4	CHEMICAL	GENE-N	6	12	CONCLUSIONS : Our results show that chemical , a known gene ( gene ) inhibitor , is also an activator of gene .	T1	T19	11430635
CPR:3	CHEMICAL	GENE-N	6	21	CONCLUSIONS : Our results show that chemical , a known gene ( gene ) inhibitor , is also an activator of gene .	T1	T20	11430635
CPR:3	CHEMICAL	GENE-N	5	12	Our data also prove that chemical is not only an activator of gene but also antagonizes the effect of chemical , a specific inhibitor of this enzyme .	T2	T21	11430635
CPR:4	CHEMICAL	GENE-N	19	12	Our data also prove that chemical is not only an activator of gene but also antagonizes the effect of chemical , a specific inhibitor of this enzyme .	T3	T21	11430635
CPR:6	CHEMICAL	GENE-N	0	2	chemical : a dual chemical receptor v1a/v2 antagonist [ corrected ] .	T8	T22	17919259
NA	CHEMICAL	GENE-N	2	2	chemical : a dual chemical receptor v1a/v2 antagonist [ corrected ] .	T9	T22	17919259
NA	CHEMICAL	GENE-Y	5	5	Several fluid retentive states such as heart failure , cirrhosis of the liver , and syndrome of inappropriate antidiuretic hormone secretion are associated with inappropriate elevation in plasma levels of gene ( gene ) , a neuropeptide that is secreted by the hypothalamus and plays a critical role in the regulation of serum osmolality and in circulatory homeostasis .	T3	T12	17919259
NA	CHEMICAL	GENE-Y	5	32	Several fluid retentive states such as heart failure , cirrhosis of the liver , and syndrome of inappropriate antidiuretic hormone secretion are associated with inappropriate elevation in plasma levels of gene ( gene ) , a neuropeptide that is secreted by the hypothalamus and plays a critical role in the regulation of serum osmolality and in circulatory homeostasis .	T3	T13	17919259
CPR:6	CHEMICAL	GENE-N	0	5	chemical is a nonpeptide dual gene antagonist .	T6	T19	17919259
NA	CHEMICAL	GENE-Y	11	6	Pulmonary delivery of an aerosolized recombinant gene pretreatment protects against aerosolized chemical in macaques .	T4	T18	23178380
NA	CHEMICAL	GENE-Y	12	0	gene ( gene ) is the leading pretreatment candidate against exposure to chemical ( OPs ) , which pose an ever increasing public and military health .	T3	T5	23178380
NA	CHEMICAL	GENE-Y	12	2	gene ( gene ) is the leading pretreatment candidate against exposure to chemical ( OPs ) , which pose an ever increasing public and military health .	T3	T10	23178380
NA	CHEMICAL	GENE-Y	6	6	In contrast to parenteral delivery of gene , which currently requires posttranslational modification for good plasma stability , an unmodified aer-gene pretreatment given 1-40h prior to > 1 LD50 of aer-chemical ( Px ) was able to prevent inhibition of circulating gene in a dose-dependent manner .	T1	T17	23178380
NA	CHEMICAL	GENE-Y	6	20	In contrast to parenteral delivery of gene , which currently requires posttranslational modification for good plasma stability , an unmodified aer-gene pretreatment given 1-40h prior to > 1 LD50 of aer-chemical ( Px ) was able to prevent inhibition of circulating gene in a dose-dependent manner .	T1	T6	23178380
CPR:3	CHEMICAL	GENE-Y	6	41	In contrast to parenteral delivery of gene , which currently requires posttranslational modification for good plasma stability , an unmodified aer-gene pretreatment given 1-40h prior to > 1 LD50 of aer-chemical ( Px ) was able to prevent inhibition of circulating gene in a dose-dependent manner .	T1	T7	23178380
NA	CHEMICAL	GENE-N	3	1	The gene , chemical decarboxylase ( gene ) , contains a region of sequence similarity , including six identical residues gene , to the gene of coxsackie B virus , suggesting that cross-reactivity between coxsackie B virus and gene can initiate autoimmune diabetes .	T8	T25	11034389
NA	CHEMICAL	GENE-N	3	4	The gene , chemical decarboxylase ( gene ) , contains a region of sequence similarity , including six identical residues gene , to the gene of coxsackie B virus , suggesting that cross-reactivity between coxsackie B virus and gene can initiate autoimmune diabetes .	T8	T23	11034389
NA	CHEMICAL	GENE-Y	3	6	The gene , chemical decarboxylase ( gene ) , contains a region of sequence similarity , including six identical residues gene , to the gene of coxsackie B virus , suggesting that cross-reactivity between coxsackie B virus and gene can initiate autoimmune diabetes .	T8	T29	11034389
NA	CHEMICAL	GENE-N	3	20	The gene , chemical decarboxylase ( gene ) , contains a region of sequence similarity , including six identical residues gene , to the gene of coxsackie B virus , suggesting that cross-reactivity between coxsackie B virus and gene can initiate autoimmune diabetes .	T8	T19	11034389
NA	CHEMICAL	GENE-Y	3	24	The gene , chemical decarboxylase ( gene ) , contains a region of sequence similarity , including six identical residues gene , to the gene of coxsackie B virus , suggesting that cross-reactivity between coxsackie B virus and gene can initiate autoimmune diabetes .	T8	T21	11034389
NA	CHEMICAL	GENE-Y	3	38	The gene , chemical decarboxylase ( gene ) , contains a region of sequence similarity , including six identical residues gene , to the gene of coxsackie B virus , suggesting that cross-reactivity between coxsackie B virus and gene can initiate autoimmune diabetes .	T8	T22	11034389
NA	CHEMICAL	GENE-N	8	8	The identified peptide sequences could be mapped to a homology model of the chemical ( chemical ) binding domain of gene .	T9	T26	11034389
NA	CHEMICAL	GENE-Y	8	20	The identified peptide sequences could be mapped to a homology model of the chemical ( chemical ) binding domain of gene .	T9	T27	11034389
NA	CHEMICAL	GENE-N	15	8	The identified peptide sequences could be mapped to a homology model of the chemical ( chemical ) binding domain of gene .	T10	T26	11034389
NA	CHEMICAL	GENE-Y	15	20	The identified peptide sequences could be mapped to a homology model of the chemical ( chemical ) binding domain of gene .	T10	T27	11034389
NA	CHEMICAL	GENE-N	9	3	For MIchemicalA3 , a surface loop containing the sequence chemical and two adjacent exposed helixes were identified in the chemical binding domain as well as a region of the C terminus of gene that has previously been identified as critical for MICA3 binding .	T11	T30	11034389
NA	CHEMICAL	GENE-Y	9	32	For MIchemicalA3 , a surface loop containing the sequence chemical and two adjacent exposed helixes were identified in the chemical binding domain as well as a region of the C terminus of gene that has previously been identified as critical for MICA3 binding .	T11	T31	11034389
NA	CHEMICAL	GENE-N	19	3	For MIchemicalA3 , a surface loop containing the sequence chemical and two adjacent exposed helixes were identified in the chemical binding domain as well as a region of the C terminus of gene that has previously been identified as critical for MICA3 binding .	T12	T30	11034389
NA	CHEMICAL	GENE-Y	19	32	For MIchemicalA3 , a surface loop containing the sequence chemical and two adjacent exposed helixes were identified in the chemical binding domain as well as a region of the C terminus of gene that has previously been identified as critical for MICA3 binding .	T12	T31	11034389
NA	CHEMICAL	GENE-N	1	3	For MIchemicalA3 , a surface loop containing the sequence chemical and two adjacent exposed helixes were identified in the chemical binding domain as well as a region of the C terminus of gene that has previously been identified as critical for MICA3 binding .	T13	T30	11034389
NA	CHEMICAL	GENE-Y	1	32	For MIchemicalA3 , a surface loop containing the sequence chemical and two adjacent exposed helixes were identified in the chemical binding domain as well as a region of the C terminus of gene that has previously been identified as critical for MICA3 binding .	T13	T31	11034389
NA	CHEMICAL	GENE-N	10	7	Peptide sequences selected using MICA4 were rich in basic or chemical-containing chemical , and the surface of the gene surrounding Lys358 , which is known to be critical for MICA4 binding , was likewise rich in these chemical .	T1	T15	11034389
NA	CHEMICAL	GENE-N	11	7	Peptide sequences selected using MICA4 were rich in basic or chemical-containing chemical , and the surface of the gene surrounding Lys358 , which is known to be critical for MICA4 binding , was likewise rich in these chemical .	T2	T15	11034389
NA	CHEMICAL	GENE-N	37	7	Peptide sequences selected using MICA4 were rich in basic or chemical-containing chemical , and the surface of the gene surrounding Lys358 , which is known to be critical for MICA4 binding , was likewise rich in these chemical .	T4	T15	11034389
CPR:9	CHEMICAL	GENE-Y	2	0	gene modulates chemical synthesis through nonfreely exchangeable chemical pools in human endothelial cells .	T27	T50	16801455
CPR:9	CHEMICAL	GENE-Y	7	0	gene modulates chemical synthesis through nonfreely exchangeable chemical pools in human endothelial cells .	T28	T50	16801455
CPR:9	CHEMICAL	GENE-Y	3	26	Reduced synthesis of chemical ( chemical ) contributes to the endothelial dysfunction and may be related to limited availability of chemical , the common substrate of gene ( gene ) and cytosolic gene and gene .	T14	T36	16801455
CPR:9	CHEMICAL	GENE-N	3	28	Reduced synthesis of chemical ( chemical ) contributes to the endothelial dysfunction and may be related to limited availability of chemical , the common substrate of gene ( gene ) and cytosolic gene and gene .	T14	T38	16801455
CPR:9	CHEMICAL	GENE-Y	3	32	Reduced synthesis of chemical ( chemical ) contributes to the endothelial dysfunction and may be related to limited availability of chemical , the common substrate of gene ( gene ) and cytosolic gene and gene .	T14	T39	16801455
CPR:9	CHEMICAL	GENE-Y	3	34	Reduced synthesis of chemical ( chemical ) contributes to the endothelial dysfunction and may be related to limited availability of chemical , the common substrate of gene ( gene ) and cytosolic gene and gene .	T14	T40	16801455
CPR:9	CHEMICAL	GENE-Y	5	26	Reduced synthesis of chemical ( chemical ) contributes to the endothelial dysfunction and may be related to limited availability of chemical , the common substrate of gene ( gene ) and cytosolic gene and gene .	T16	T36	16801455
CPR:9	CHEMICAL	GENE-N	5	28	Reduced synthesis of chemical ( chemical ) contributes to the endothelial dysfunction and may be related to limited availability of chemical , the common substrate of gene ( gene ) and cytosolic gene and gene .	T16	T38	16801455
CPR:9	CHEMICAL	GENE-Y	5	32	Reduced synthesis of chemical ( chemical ) contributes to the endothelial dysfunction and may be related to limited availability of chemical , the common substrate of gene ( gene ) and cytosolic gene and gene .	T16	T39	16801455
CPR:9	CHEMICAL	GENE-Y	5	34	Reduced synthesis of chemical ( chemical ) contributes to the endothelial dysfunction and may be related to limited availability of chemical , the common substrate of gene ( gene ) and cytosolic gene and gene .	T16	T40	16801455
CPR:9	CHEMICAL	GENE-Y	20	26	Reduced synthesis of chemical ( chemical ) contributes to the endothelial dysfunction and may be related to limited availability of chemical , the common substrate of gene ( gene ) and cytosolic gene and gene .	T6	T36	16801455
CPR:9	CHEMICAL	GENE-N	20	28	Reduced synthesis of chemical ( chemical ) contributes to the endothelial dysfunction and may be related to limited availability of chemical , the common substrate of gene ( gene ) and cytosolic gene and gene .	T6	T38	16801455
CPR:9	CHEMICAL	GENE-Y	20	32	Reduced synthesis of chemical ( chemical ) contributes to the endothelial dysfunction and may be related to limited availability of chemical , the common substrate of gene ( gene ) and cytosolic gene and gene .	T6	T39	16801455
CPR:9	CHEMICAL	GENE-Y	20	34	Reduced synthesis of chemical ( chemical ) contributes to the endothelial dysfunction and may be related to limited availability of chemical , the common substrate of gene ( gene ) and cytosolic gene and gene .	T6	T40	16801455
CPR:9	CHEMICAL	GENE-N	7	3	To determine whether gene modulate the endothelial chemical synthesis , we investigated the effects of the competitive gene inhibitor chemical ( chemical ) on the activity of gene , gene , and chemical transporter and on chemical release at surface of human umbilical vein endothelial cells ( HUVECs ) .	T15	T41	16801455
NA	CHEMICAL	GENE-N	7	17	To determine whether gene modulate the endothelial chemical synthesis , we investigated the effects of the competitive gene inhibitor chemical ( chemical ) on the activity of gene , gene , and chemical transporter and on chemical release at surface of human umbilical vein endothelial cells ( HUVECs ) .	T15	T42	16801455
NA	CHEMICAL	GENE-N	7	27	To determine whether gene modulate the endothelial chemical synthesis , we investigated the effects of the competitive gene inhibitor chemical ( chemical ) on the activity of gene , gene , and chemical transporter and on chemical release at surface of human umbilical vein endothelial cells ( HUVECs ) .	T15	T43	16801455
NA	CHEMICAL	GENE-N	7	29	To determine whether gene modulate the endothelial chemical synthesis , we investigated the effects of the competitive gene inhibitor chemical ( chemical ) on the activity of gene , gene , and chemical transporter and on chemical release at surface of human umbilical vein endothelial cells ( HUVECs ) .	T15	T44	16801455
NA	CHEMICAL	GENE-N	7	33	To determine whether gene modulate the endothelial chemical synthesis , we investigated the effects of the competitive gene inhibitor chemical ( chemical ) on the activity of gene , gene , and chemical transporter and on chemical release at surface of human umbilical vein endothelial cells ( HUVECs ) .	T15	T45	16801455
NA	CHEMICAL	GENE-N	19	3	To determine whether gene modulate the endothelial chemical synthesis , we investigated the effects of the competitive gene inhibitor chemical ( chemical ) on the activity of gene , gene , and chemical transporter and on chemical release at surface of human umbilical vein endothelial cells ( HUVECs ) .	T17	T41	16801455
CPR:4	CHEMICAL	GENE-N	19	17	To determine whether gene modulate the endothelial chemical synthesis , we investigated the effects of the competitive gene inhibitor chemical ( chemical ) on the activity of gene , gene , and chemical transporter and on chemical release at surface of human umbilical vein endothelial cells ( HUVECs ) .	T17	T42	16801455
NA	CHEMICAL	GENE-N	19	27	To determine whether gene modulate the endothelial chemical synthesis , we investigated the effects of the competitive gene inhibitor chemical ( chemical ) on the activity of gene , gene , and chemical transporter and on chemical release at surface of human umbilical vein endothelial cells ( HUVECs ) .	T17	T43	16801455
NA	CHEMICAL	GENE-N	19	29	To determine whether gene modulate the endothelial chemical synthesis , we investigated the effects of the competitive gene inhibitor chemical ( chemical ) on the activity of gene , gene , and chemical transporter and on chemical release at surface of human umbilical vein endothelial cells ( HUVECs ) .	T17	T44	16801455
NA	CHEMICAL	GENE-N	19	33	To determine whether gene modulate the endothelial chemical synthesis , we investigated the effects of the competitive gene inhibitor chemical ( chemical ) on the activity of gene , gene , and chemical transporter and on chemical release at surface of human umbilical vein endothelial cells ( HUVECs ) .	T17	T45	16801455
NA	CHEMICAL	GENE-N	21	3	To determine whether gene modulate the endothelial chemical synthesis , we investigated the effects of the competitive gene inhibitor chemical ( chemical ) on the activity of gene , gene , and chemical transporter and on chemical release at surface of human umbilical vein endothelial cells ( HUVECs ) .	T18	T41	16801455
CPR:4	CHEMICAL	GENE-N	21	17	To determine whether gene modulate the endothelial chemical synthesis , we investigated the effects of the competitive gene inhibitor chemical ( chemical ) on the activity of gene , gene , and chemical transporter and on chemical release at surface of human umbilical vein endothelial cells ( HUVECs ) .	T18	T42	16801455
NA	CHEMICAL	GENE-N	21	27	To determine whether gene modulate the endothelial chemical synthesis , we investigated the effects of the competitive gene inhibitor chemical ( chemical ) on the activity of gene , gene , and chemical transporter and on chemical release at surface of human umbilical vein endothelial cells ( HUVECs ) .	T18	T43	16801455
NA	CHEMICAL	GENE-N	21	29	To determine whether gene modulate the endothelial chemical synthesis , we investigated the effects of the competitive gene inhibitor chemical ( chemical ) on the activity of gene , gene , and chemical transporter and on chemical release at surface of human umbilical vein endothelial cells ( HUVECs ) .	T18	T44	16801455
NA	CHEMICAL	GENE-N	21	33	To determine whether gene modulate the endothelial chemical synthesis , we investigated the effects of the competitive gene inhibitor chemical ( chemical ) on the activity of gene , gene , and chemical transporter and on chemical release at surface of human umbilical vein endothelial cells ( HUVECs ) .	T18	T45	16801455
NA	CHEMICAL	GENE-N	32	3	To determine whether gene modulate the endothelial chemical synthesis , we investigated the effects of the competitive gene inhibitor chemical ( chemical ) on the activity of gene , gene , and chemical transporter and on chemical release at surface of human umbilical vein endothelial cells ( HUVECs ) .	T19	T41	16801455
NA	CHEMICAL	GENE-N	32	17	To determine whether gene modulate the endothelial chemical synthesis , we investigated the effects of the competitive gene inhibitor chemical ( chemical ) on the activity of gene , gene , and chemical transporter and on chemical release at surface of human umbilical vein endothelial cells ( HUVECs ) .	T19	T42	16801455
NA	CHEMICAL	GENE-N	32	27	To determine whether gene modulate the endothelial chemical synthesis , we investigated the effects of the competitive gene inhibitor chemical ( chemical ) on the activity of gene , gene , and chemical transporter and on chemical release at surface of human umbilical vein endothelial cells ( HUVECs ) .	T19	T43	16801455
NA	CHEMICAL	GENE-N	32	29	To determine whether gene modulate the endothelial chemical synthesis , we investigated the effects of the competitive gene inhibitor chemical ( chemical ) on the activity of gene , gene , and chemical transporter and on chemical release at surface of human umbilical vein endothelial cells ( HUVECs ) .	T19	T44	16801455
NA	CHEMICAL	GENE-N	32	33	To determine whether gene modulate the endothelial chemical synthesis , we investigated the effects of the competitive gene inhibitor chemical ( chemical ) on the activity of gene , gene , and chemical transporter and on chemical release at surface of human umbilical vein endothelial cells ( HUVECs ) .	T19	T45	16801455
NA	CHEMICAL	GENE-N	36	3	To determine whether gene modulate the endothelial chemical synthesis , we investigated the effects of the competitive gene inhibitor chemical ( chemical ) on the activity of gene , gene , and chemical transporter and on chemical release at surface of human umbilical vein endothelial cells ( HUVECs ) .	T20	T41	16801455
NA	CHEMICAL	GENE-N	36	17	To determine whether gene modulate the endothelial chemical synthesis , we investigated the effects of the competitive gene inhibitor chemical ( chemical ) on the activity of gene , gene , and chemical transporter and on chemical release at surface of human umbilical vein endothelial cells ( HUVECs ) .	T20	T42	16801455
NA	CHEMICAL	GENE-N	36	27	To determine whether gene modulate the endothelial chemical synthesis , we investigated the effects of the competitive gene inhibitor chemical ( chemical ) on the activity of gene , gene , and chemical transporter and on chemical release at surface of human umbilical vein endothelial cells ( HUVECs ) .	T20	T43	16801455
NA	CHEMICAL	GENE-N	36	29	To determine whether gene modulate the endothelial chemical synthesis , we investigated the effects of the competitive gene inhibitor chemical ( chemical ) on the activity of gene , gene , and chemical transporter and on chemical release at surface of human umbilical vein endothelial cells ( HUVECs ) .	T20	T44	16801455
NA	CHEMICAL	GENE-N	36	33	To determine whether gene modulate the endothelial chemical synthesis , we investigated the effects of the competitive gene inhibitor chemical ( chemical ) on the activity of gene , gene , and chemical transporter and on chemical release at surface of human umbilical vein endothelial cells ( HUVECs ) .	T20	T45	16801455
CPR:4	CHEMICAL	GENE-N	4	8	In unstimulated cells , chemical dose-dependently reduced the gene activity with maximal inhibition at 20 microM .	T21	T46	16801455
NA	CHEMICAL	GENE-Y	8	5	When HUVECs were stimulated by gene without extracellular chemical , chemical dose-dependently increased the gene activity and the chemical release with maximal effects at 20 microM .	T22	T47	16801455
NA	CHEMICAL	GENE-N	8	14	When HUVECs were stimulated by gene without extracellular chemical , chemical dose-dependently increased the gene activity and the chemical release with maximal effects at 20 microM .	T22	T48	16801455
NA	CHEMICAL	GENE-Y	10	5	When HUVECs were stimulated by gene without extracellular chemical , chemical dose-dependently increased the gene activity and the chemical release with maximal effects at 20 microM .	T23	T47	16801455
CPR:3	CHEMICAL	GENE-N	10	14	When HUVECs were stimulated by gene without extracellular chemical , chemical dose-dependently increased the gene activity and the chemical release with maximal effects at 20 microM .	T23	T48	16801455
NA	CHEMICAL	GENE-Y	18	5	When HUVECs were stimulated by gene without extracellular chemical , chemical dose-dependently increased the gene activity and the chemical release with maximal effects at 20 microM .	T24	T47	16801455
NA	CHEMICAL	GENE-N	18	14	When HUVECs were stimulated by gene without extracellular chemical , chemical dose-dependently increased the gene activity and the chemical release with maximal effects at 20 microM .	T24	T48	16801455
CPR:3	CHEMICAL	GENE-N	1	8	Extracellular chemical also dose-dependently increased chemical release and gene activity .	T25	T49	16801455
NA	CHEMICAL	GENE-N	5	8	Extracellular chemical also dose-dependently increased chemical release and gene activity .	T26	T49	16801455
NA	CHEMICAL	GENE-Y	6	5	When HUVECs were stimulated by gene in the presence of 100 microM chemical , gene activity and chemical release were similar in untreated and chemical-treated cells .	T1	T29	16801455
NA	CHEMICAL	GENE-N	6	14	When HUVECs were stimulated by gene in the presence of 100 microM chemical , gene activity and chemical release were similar in untreated and chemical-treated cells .	T1	T30	16801455
NA	CHEMICAL	GENE-Y	5	5	When HUVECs were stimulated by gene in the presence of 100 microM chemical , gene activity and chemical release were similar in untreated and chemical-treated cells .	T2	T29	16801455
NA	CHEMICAL	GENE-N	5	14	When HUVECs were stimulated by gene in the presence of 100 microM chemical , gene activity and chemical release were similar in untreated and chemical-treated cells .	T2	T30	16801455
NA	CHEMICAL	GENE-Y	14	5	When HUVECs were stimulated by gene in the presence of 100 microM chemical , gene activity and chemical release were similar in untreated and chemical-treated cells .	T3	T29	16801455
NA	CHEMICAL	GENE-N	14	14	When HUVECs were stimulated by gene in the presence of 100 microM chemical , gene activity and chemical release were similar in untreated and chemical-treated cells .	T3	T30	16801455
NA	CHEMICAL	GENE-N	5	11	However , despite activation of chemical uptake , the inhibition of gene activity by chemical was still significant .	T4	T31	16801455
CPR:4	CHEMICAL	GENE-N	14	11	However , despite activation of chemical uptake , the inhibition of gene activity by chemical was still significant .	T5	T31	16801455
NA	CHEMICAL	GENE-Y	3	9	[ Effect of chemical on the expression of chemical receptor messenger RNA and protein in uterine leiomyomata ] .	T9	T25	10682471
NA	CHEMICAL	GENE-Y	4	9	[ Effect of chemical on the expression of chemical receptor messenger RNA and protein in uterine leiomyomata ] .	T10	T25	10682471
NA	CHEMICAL	GENE-Y	7	8	OBJECTIVE : To determine the expression of chemical receptor ( gene ) mRNA and gene levels in the myometrium and leiomyomata from untreated and chemical pretreated women with leiomyoma and to examine the mechanism of chemical treatment on uterine leiomyomata .	T6	T19	10682471
NA	CHEMICAL	GENE-Y	7	10	OBJECTIVE : To determine the expression of chemical receptor ( gene ) mRNA and gene levels in the myometrium and leiomyomata from untreated and chemical pretreated women with leiomyoma and to examine the mechanism of chemical treatment on uterine leiomyomata .	T6	T22	10682471
NA	CHEMICAL	GENE-Y	7	14	OBJECTIVE : To determine the expression of chemical receptor ( gene ) mRNA and gene levels in the myometrium and leiomyomata from untreated and chemical pretreated women with leiomyoma and to examine the mechanism of chemical treatment on uterine leiomyomata .	T6	T23	10682471
NA	CHEMICAL	GENE-Y	24	8	OBJECTIVE : To determine the expression of chemical receptor ( gene ) mRNA and gene levels in the myometrium and leiomyomata from untreated and chemical pretreated women with leiomyoma and to examine the mechanism of chemical treatment on uterine leiomyomata .	T4	T19	10682471
NA	CHEMICAL	GENE-Y	24	10	OBJECTIVE : To determine the expression of chemical receptor ( gene ) mRNA and gene levels in the myometrium and leiomyomata from untreated and chemical pretreated women with leiomyoma and to examine the mechanism of chemical treatment on uterine leiomyomata .	T4	T22	10682471
NA	CHEMICAL	GENE-Y	24	14	OBJECTIVE : To determine the expression of chemical receptor ( gene ) mRNA and gene levels in the myometrium and leiomyomata from untreated and chemical pretreated women with leiomyoma and to examine the mechanism of chemical treatment on uterine leiomyomata .	T4	T23	10682471
NA	CHEMICAL	GENE-Y	30	8	OBJECTIVE : To determine the expression of chemical receptor ( gene ) mRNA and gene levels in the myometrium and leiomyomata from untreated and chemical pretreated women with leiomyoma and to examine the mechanism of chemical treatment on uterine leiomyomata .	T5	T19	10682471
NA	CHEMICAL	GENE-Y	30	10	OBJECTIVE : To determine the expression of chemical receptor ( gene ) mRNA and gene levels in the myometrium and leiomyomata from untreated and chemical pretreated women with leiomyoma and to examine the mechanism of chemical treatment on uterine leiomyomata .	T5	T22	10682471
NA	CHEMICAL	GENE-Y	30	14	OBJECTIVE : To determine the expression of chemical receptor ( gene ) mRNA and gene levels in the myometrium and leiomyomata from untreated and chemical pretreated women with leiomyoma and to examine the mechanism of chemical treatment on uterine leiomyomata .	T5	T23	10682471
NA	CHEMICAL	GENE-N	33	4	METHODS : Expression of gene and gene were determined by Northern blot and HAP of single-dose saturated analysis in myometrium and leiomyomata ( center and marginal area ) from 27 untreated and 6 chemical pretreated women with leiomyomata .	T7	T17	10682471
NA	CHEMICAL	GENE-Y	33	6	METHODS : Expression of gene and gene were determined by Northern blot and HAP of single-dose saturated analysis in myometrium and leiomyomata ( center and marginal area ) from 27 untreated and 6 chemical pretreated women with leiomyomata .	T7	T18	10682471
CPR:4	CHEMICAL	GENE-N	20	0	gene abundance in both myometruim and leiomyomata ( center and marginal area ) was significantly decreased in 4 patients continuing chemical treatment before the operation but not in the other 2 patients stopping chemical 1 month before operation .	T1	T24	10682471
NA	CHEMICAL	GENE-N	0	0	gene abundance in both myometruim and leiomyomata ( center and marginal area ) was significantly decreased in 4 patients continuing chemical treatment before the operation but not in the other 2 patients stopping chemical 1 month before operation .	T2	T24	10682471
CPR:4	CHEMICAL	GENE-Y	5	19	One of the mechanism of chemical action on decreasing leiomyomata volume may be related to suppression on expression of gene .	T3	T14	10682471
NA	CHEMICAL	GENE-N	1	5	Linking chemical ( A ) receptor subunits to chemical-induced conditioned taste aversion and recovery from acute chemical intoxication .	T22	T28	23147414
NA	CHEMICAL	GENE-N	8	5	Linking chemical ( A ) receptor subunits to chemical-induced conditioned taste aversion and recovery from acute chemical intoxication .	T21	T28	23147414
NA	CHEMICAL	GENE-N	16	5	Linking chemical ( A ) receptor subunits to chemical-induced conditioned taste aversion and recovery from acute chemical intoxication .	T20	T28	23147414
NA	CHEMICAL	GENE-N	0	3	chemical type A receptors ( chemical ( A ) -R ) are important for chemical actions and it is of interest to link individual subunits with specific chemical behaviors .	T1	T23	23147414
NA	CHEMICAL	GENE-N	0	2	chemical type A receptors ( chemical ( A ) -R ) are important for chemical actions and it is of interest to link individual subunits with specific chemical behaviors .	T1	T26	23147414
NA	CHEMICAL	GENE-N	2	3	chemical type A receptors ( chemical ( A ) -R ) are important for chemical actions and it is of interest to link individual subunits with specific chemical behaviors .	T11	T23	23147414
NA	CHEMICAL	GENE-N	2	2	chemical type A receptors ( chemical ( A ) -R ) are important for chemical actions and it is of interest to link individual subunits with specific chemical behaviors .	T11	T26	23147414
NA	CHEMICAL	GENE-N	14	3	chemical type A receptors ( chemical ( A ) -R ) are important for chemical actions and it is of interest to link individual subunits with specific chemical behaviors .	T14	T23	23147414
NA	CHEMICAL	GENE-N	14	2	chemical type A receptors ( chemical ( A ) -R ) are important for chemical actions and it is of interest to link individual subunits with specific chemical behaviors .	T14	T26	23147414
NA	CHEMICAL	GENE-N	27	3	chemical type A receptors ( chemical ( A ) -R ) are important for chemical actions and it is of interest to link individual subunits with specific chemical behaviors .	T6	T23	23147414
NA	CHEMICAL	GENE-N	27	2	chemical type A receptors ( chemical ( A ) -R ) are important for chemical actions and it is of interest to link individual subunits with specific chemical behaviors .	T6	T26	23147414
NA	CHEMICAL	GENE-N	8	25	We studied null mutant mice for six different chemical ( A ) -R subunits ( α1 , α2 , α3 , α4 , α5 and δ ) .	T10	T25	23147414
NA	CHEMICAL	GENE-Y	9	16	All together , they indicate that aversive property of chemical is dependent on chemical action on gene . Deletion of the α2-subunit led to faster recovery whereas absence of the α3-subunit slowed recovery from chemical-induced incoordination ( rotarod ) .	T15	T27	23147414
NA	CHEMICAL	GENE-Y	13	16	All together , they indicate that aversive property of chemical is dependent on chemical action on gene . Deletion of the α2-subunit led to faster recovery whereas absence of the α3-subunit slowed recovery from chemical-induced incoordination ( rotarod ) .	T16	T27	23147414
NA	CHEMICAL	GENE-Y	34	16	All together , they indicate that aversive property of chemical is dependent on chemical action on gene . Deletion of the α2-subunit led to faster recovery whereas absence of the α3-subunit slowed recovery from chemical-induced incoordination ( rotarod ) .	T18	T27	23147414
NA	CHEMICAL	GENE-N	11	20	Therefore , recovery of rotarod incoordination is under control of two chemical ( A ) -R subunits : α2 and α3 .	T4	T24	23147414
NA	CHEMICAL	GENE-Y	0	3	chemical gene receptor-induced gene-mediated production of chemical in D ( 2 ) -transfected Chinese hamster ovary cells without simultaneous administration of a chemical-mobilizing agent .	T19	T40	12110374
NA	CHEMICAL	GENE-Y	0	1	chemical gene receptor-induced gene-mediated production of chemical in D ( 2 ) -transfected Chinese hamster ovary cells without simultaneous administration of a chemical-mobilizing agent .	T19	T41	12110374
CPR:9	CHEMICAL	GENE-Y	6	3	chemical gene receptor-induced gene-mediated production of chemical in D ( 2 ) -transfected Chinese hamster ovary cells without simultaneous administration of a chemical-mobilizing agent .	T21	T40	12110374
NA	CHEMICAL	GENE-Y	6	1	chemical gene receptor-induced gene-mediated production of chemical in D ( 2 ) -transfected Chinese hamster ovary cells without simultaneous administration of a chemical-mobilizing agent .	T21	T41	12110374
NA	CHEMICAL	GENE-Y	9	3	chemical gene receptor-induced gene-mediated production of chemical in D ( 2 ) -transfected Chinese hamster ovary cells without simultaneous administration of a chemical-mobilizing agent .	T20	T40	12110374
NA	CHEMICAL	GENE-Y	9	1	chemical gene receptor-induced gene-mediated production of chemical in D ( 2 ) -transfected Chinese hamster ovary cells without simultaneous administration of a chemical-mobilizing agent .	T20	T41	12110374
NA	CHEMICAL	GENE-Y	11	9	We have earlier demonstrated that chemical stimulates the liberation of the chemical ( chemical ) precursor , chemical , in Chinese hamster ovary cells transfected with the gene , also without concomitant administration of a chemical-releasing agent [ Nilsson et al. , Br J Pharmacol 1998 ; 124:1651-8 ] .	T15	T32	12110374
NA	CHEMICAL	GENE-Y	12	9	We have earlier demonstrated that chemical stimulates the liberation of the chemical ( chemical ) precursor , chemical , in Chinese hamster ovary cells transfected with the gene , also without concomitant administration of a chemical-releasing agent [ Nilsson et al. , Br J Pharmacol 1998 ; 124:1651-8 ] .	T17	T32	12110374
NA	CHEMICAL	GENE-Y	17	9	We have earlier demonstrated that chemical stimulates the liberation of the chemical ( chemical ) precursor , chemical , in Chinese hamster ovary cells transfected with the gene , also without concomitant administration of a chemical-releasing agent [ Nilsson et al. , Br J Pharmacol 1998 ; 124:1651-8 ] .	T3	T32	12110374
NA	CHEMICAL	GENE-Y	5	9	We have earlier demonstrated that chemical stimulates the liberation of the chemical ( chemical ) precursor , chemical , in Chinese hamster ovary cells transfected with the gene , also without concomitant administration of a chemical-releasing agent [ Nilsson et al. , Br J Pharmacol 1998 ; 124:1651-8 ] .	T8	T32	12110374
NA	CHEMICAL	GENE-Y	12	9	We have earlier demonstrated that chemical stimulates the liberation of the chemical ( chemical ) precursor , chemical , in Chinese hamster ovary cells transfected with the gene , also without concomitant administration of a chemical-releasing agent [ Nilsson et al. , Br J Pharmacol 1998 ; 124:1651-8 ] .	T9	T32	12110374
CPR:6	CHEMICAL	GENE-Y	8	6	The effect was counteracted by the gene antagonist chemical , gene , the inhibitor of intracellular chemical release TMB-8 , incubation in chemical-free experimental medium , and gene desensitization obtained by chronic pretreatment with the phorbol ester TPA .	T12	T33	12110374
NA	CHEMICAL	GENE-N	8	10	The effect was counteracted by the gene antagonist chemical , gene , the inhibitor of intracellular chemical release TMB-8 , incubation in chemical-free experimental medium , and gene desensitization obtained by chronic pretreatment with the phorbol ester TPA .	T12	T34	12110374
NA	CHEMICAL	GENE-N	8	27	The effect was counteracted by the gene antagonist chemical , gene , the inhibitor of intracellular chemical release TMB-8 , incubation in chemical-free experimental medium , and gene desensitization obtained by chronic pretreatment with the phorbol ester TPA .	T12	T35	12110374
NA	CHEMICAL	GENE-Y	16	6	The effect was counteracted by the gene antagonist chemical , gene , the inhibitor of intracellular chemical release TMB-8 , incubation in chemical-free experimental medium , and gene desensitization obtained by chronic pretreatment with the phorbol ester TPA .	T13	T33	12110374
NA	CHEMICAL	GENE-N	16	10	The effect was counteracted by the gene antagonist chemical , gene , the inhibitor of intracellular chemical release TMB-8 , incubation in chemical-free experimental medium , and gene desensitization obtained by chronic pretreatment with the phorbol ester TPA .	T13	T34	12110374
NA	CHEMICAL	GENE-N	16	27	The effect was counteracted by the gene antagonist chemical , gene , the inhibitor of intracellular chemical release TMB-8 , incubation in chemical-free experimental medium , and gene desensitization obtained by chronic pretreatment with the phorbol ester TPA .	T13	T35	12110374
NA	CHEMICAL	GENE-Y	22	6	The effect was counteracted by the gene antagonist chemical , gene , the inhibitor of intracellular chemical release TMB-8 , incubation in chemical-free experimental medium , and gene desensitization obtained by chronic pretreatment with the phorbol ester TPA .	T14	T33	12110374
NA	CHEMICAL	GENE-N	22	10	The effect was counteracted by the gene antagonist chemical , gene , the inhibitor of intracellular chemical release TMB-8 , incubation in chemical-free experimental medium , and gene desensitization obtained by chronic pretreatment with the phorbol ester TPA .	T14	T34	12110374
NA	CHEMICAL	GENE-N	22	27	The effect was counteracted by the gene antagonist chemical , gene , the inhibitor of intracellular chemical release TMB-8 , incubation in chemical-free experimental medium , and gene desensitization obtained by chronic pretreatment with the phorbol ester TPA .	T14	T35	12110374
CPR:4	CHEMICAL	GENE-N	13	7	It was also antagonized by the non-specific gene ( gene ) inhibitor , chemical , and by the selective gene inhibitor , chemical , but not by the specific gene inhibitor , chemical .	T16	T36	12110374
CPR:4	CHEMICAL	GENE-N	13	9	It was also antagonized by the non-specific gene ( gene ) inhibitor , chemical , and by the selective gene inhibitor , chemical , but not by the specific gene inhibitor , chemical .	T16	T37	12110374
NA	CHEMICAL	GENE-Y	13	19	It was also antagonized by the non-specific gene ( gene ) inhibitor , chemical , and by the selective gene inhibitor , chemical , but not by the specific gene inhibitor , chemical .	T16	T38	12110374
NA	CHEMICAL	GENE-Y	13	29	It was also antagonized by the non-specific gene ( gene ) inhibitor , chemical , and by the selective gene inhibitor , chemical , but not by the specific gene inhibitor , chemical .	T16	T22	12110374
NA	CHEMICAL	GENE-N	22	7	It was also antagonized by the non-specific gene ( gene ) inhibitor , chemical , and by the selective gene inhibitor , chemical , but not by the specific gene inhibitor , chemical .	T18	T36	12110374
NA	CHEMICAL	GENE-N	22	9	It was also antagonized by the non-specific gene ( gene ) inhibitor , chemical , and by the selective gene inhibitor , chemical , but not by the specific gene inhibitor , chemical .	T18	T37	12110374
CPR:4	CHEMICAL	GENE-Y	22	19	It was also antagonized by the non-specific gene ( gene ) inhibitor , chemical , and by the selective gene inhibitor , chemical , but not by the specific gene inhibitor , chemical .	T18	T38	12110374
NA	CHEMICAL	GENE-Y	22	29	It was also antagonized by the non-specific gene ( gene ) inhibitor , chemical , and by the selective gene inhibitor , chemical , but not by the specific gene inhibitor , chemical .	T18	T22	12110374
NA	CHEMICAL	GENE-N	13	7	It was also antagonized by the non-specific gene ( gene ) inhibitor , chemical , and by the selective gene inhibitor , chemical , but not by the specific gene inhibitor , chemical .	T1	T36	12110374
NA	CHEMICAL	GENE-N	13	9	It was also antagonized by the non-specific gene ( gene ) inhibitor , chemical , and by the selective gene inhibitor , chemical , but not by the specific gene inhibitor , chemical .	T1	T37	12110374
NA	CHEMICAL	GENE-Y	13	19	It was also antagonized by the non-specific gene ( gene ) inhibitor , chemical , and by the selective gene inhibitor , chemical , but not by the specific gene inhibitor , chemical .	T1	T38	12110374
CPR:4	CHEMICAL	GENE-Y	13	29	It was also antagonized by the non-specific gene ( gene ) inhibitor , chemical , and by the selective gene inhibitor , chemical , but not by the specific gene inhibitor , chemical .	T1	T22	12110374
CPR:4	CHEMICAL	GENE-Y	3	3	Both the non-specific gene inhibitor , chemical , and an inhibitor of gene and gene , AACOF3 , counteracted the effect ; in contrast , a selective gene inhibitor , BEL , and a selective gene inhibitor , TAPC , were ineffective .	T2	T23	12110374
NA	CHEMICAL	GENE-Y	3	12	Both the non-specific gene inhibitor , chemical , and an inhibitor of gene and gene , AACOF3 , counteracted the effect ; in contrast , a selective gene inhibitor , BEL , and a selective gene inhibitor , TAPC , were ineffective .	T2	T24	12110374
NA	CHEMICAL	GENE-Y	3	14	Both the non-specific gene inhibitor , chemical , and an inhibitor of gene and gene , AACOF3 , counteracted the effect ; in contrast , a selective gene inhibitor , BEL , and a selective gene inhibitor , TAPC , were ineffective .	T2	T25	12110374
NA	CHEMICAL	GENE-Y	3	27	Both the non-specific gene inhibitor , chemical , and an inhibitor of gene and gene , AACOF3 , counteracted the effect ; in contrast , a selective gene inhibitor , BEL , and a selective gene inhibitor , TAPC , were ineffective .	T2	T26	12110374
NA	CHEMICAL	GENE-N	3	35	Both the non-specific gene inhibitor , chemical , and an inhibitor of gene and gene , AACOF3 , counteracted the effect ; in contrast , a selective gene inhibitor , BEL , and a selective gene inhibitor , TAPC , were ineffective .	T2	T27	12110374
CPR:3	CHEMICAL	GENE-Y	6	15	The results reinforce previous assumptions that chemical may interact with chemical metabolism by means of gene activation , and implicate an involvement of gene and gene in this effect .	T5	T28	12110374
NA	CHEMICAL	GENE-Y	6	23	The results reinforce previous assumptions that chemical may interact with chemical metabolism by means of gene activation , and implicate an involvement of gene and gene in this effect .	T5	T29	12110374
NA	CHEMICAL	GENE-Y	6	25	The results reinforce previous assumptions that chemical may interact with chemical metabolism by means of gene activation , and implicate an involvement of gene and gene in this effect .	T5	T30	12110374
NA	CHEMICAL	GENE-Y	10	15	The results reinforce previous assumptions that chemical may interact with chemical metabolism by means of gene activation , and implicate an involvement of gene and gene in this effect .	T6	T28	12110374
NA	CHEMICAL	GENE-Y	10	23	The results reinforce previous assumptions that chemical may interact with chemical metabolism by means of gene activation , and implicate an involvement of gene and gene in this effect .	T6	T29	12110374
NA	CHEMICAL	GENE-Y	10	25	The results reinforce previous assumptions that chemical may interact with chemical metabolism by means of gene activation , and implicate an involvement of gene and gene in this effect .	T6	T30	12110374
NA	CHEMICAL	GENE-N	7	31	MATERIALS AND METHODS : To determine the chemical-like effect of Cyperi Rhizoma extract ( CRE ) , we measured luciferase expression after transfection of a promoter construct containing an chemical response element ( gene ) and treatment of CRE .	T10	T23	23639362
NA	CHEMICAL	GENE-N	7	33	MATERIALS AND METHODS : To determine the chemical-like effect of Cyperi Rhizoma extract ( CRE ) , we measured luciferase expression after transfection of a promoter construct containing an chemical response element ( gene ) and treatment of CRE .	T10	T24	23639362
NA	CHEMICAL	GENE-N	29	31	MATERIALS AND METHODS : To determine the chemical-like effect of Cyperi Rhizoma extract ( CRE ) , we measured luciferase expression after transfection of a promoter construct containing an chemical response element ( gene ) and treatment of CRE .	T11	T23	23639362
NA	CHEMICAL	GENE-N	29	33	MATERIALS AND METHODS : To determine the chemical-like effect of Cyperi Rhizoma extract ( CRE ) , we measured luciferase expression after transfection of a promoter construct containing an chemical response element ( gene ) and treatment of CRE .	T11	T24	23639362
NA	CHEMICAL	GENE-Y	11	17	To evaluate the neuroprotective effect of CRE , we measured striatal chemical , movement ability , chemical hydroxylase ( gene ) immunoreactivity , and apoptosis-related protein expression levels after treatment of CRE either with or without chemical ( chemical ) in ovariectomized female mice .	T12	T25	23639362
NA	CHEMICAL	GENE-Y	11	19	To evaluate the neuroprotective effect of CRE , we measured striatal chemical , movement ability , chemical hydroxylase ( gene ) immunoreactivity , and apoptosis-related protein expression levels after treatment of CRE either with or without chemical ( chemical ) in ovariectomized female mice .	T12	T26	23639362
NA	CHEMICAL	GENE-Y	16	17	To evaluate the neuroprotective effect of CRE , we measured striatal chemical , movement ability , chemical hydroxylase ( gene ) immunoreactivity , and apoptosis-related protein expression levels after treatment of CRE either with or without chemical ( chemical ) in ovariectomized female mice .	T13	T25	23639362
NA	CHEMICAL	GENE-Y	16	19	To evaluate the neuroprotective effect of CRE , we measured striatal chemical , movement ability , chemical hydroxylase ( gene ) immunoreactivity , and apoptosis-related protein expression levels after treatment of CRE either with or without chemical ( chemical ) in ovariectomized female mice .	T13	T26	23639362
NA	CHEMICAL	GENE-Y	7	17	To evaluate the neuroprotective effect of CRE , we measured striatal chemical , movement ability , chemical hydroxylase ( gene ) immunoreactivity , and apoptosis-related protein expression levels after treatment of CRE either with or without chemical ( chemical ) in ovariectomized female mice .	T14	T25	23639362
NA	CHEMICAL	GENE-Y	7	19	To evaluate the neuroprotective effect of CRE , we measured striatal chemical , movement ability , chemical hydroxylase ( gene ) immunoreactivity , and apoptosis-related protein expression levels after treatment of CRE either with or without chemical ( chemical ) in ovariectomized female mice .	T14	T26	23639362
NA	CHEMICAL	GENE-Y	38	17	To evaluate the neuroprotective effect of CRE , we measured striatal chemical , movement ability , chemical hydroxylase ( gene ) immunoreactivity , and apoptosis-related protein expression levels after treatment of CRE either with or without chemical ( chemical ) in ovariectomized female mice .	T15	T25	23639362
NA	CHEMICAL	GENE-Y	38	19	To evaluate the neuroprotective effect of CRE , we measured striatal chemical , movement ability , chemical hydroxylase ( gene ) immunoreactivity , and apoptosis-related protein expression levels after treatment of CRE either with or without chemical ( chemical ) in ovariectomized female mice .	T15	T26	23639362
NA	CHEMICAL	GENE-Y	15	6	CRE and EB treatment also recovered gene immunopositive fibers and cells , respectively , from chemical toxicity .	T4	T18	23639362
CPR:4	CHEMICAL	GENE-Y	2	5	Additionally , chemical significantly down-regulated gene expression in the mitochondria of dopaminergic cells in the SN , followed by an increase in gene expression , gene translocation to the cytosol , andcleaved-gene expression , whereas these were inhibited by CRE or EB treatment .	T5	T19	23639362
CPR:3	CHEMICAL	GENE-Y	2	22	Additionally , chemical significantly down-regulated gene expression in the mitochondria of dopaminergic cells in the SN , followed by an increase in gene expression , gene translocation to the cytosol , andcleaved-gene expression , whereas these were inhibited by CRE or EB treatment .	T5	T20	23639362
NA	CHEMICAL	GENE-Y	2	25	Additionally , chemical significantly down-regulated gene expression in the mitochondria of dopaminergic cells in the SN , followed by an increase in gene expression , gene translocation to the cytosol , andcleaved-gene expression , whereas these were inhibited by CRE or EB treatment .	T5	T21	23639362
CPR:3	CHEMICAL	GENE-Y	2	31	Additionally , chemical significantly down-regulated gene expression in the mitochondria of dopaminergic cells in the SN , followed by an increase in gene expression , gene translocation to the cytosol , andcleaved-gene expression , whereas these were inhibited by CRE or EB treatment .	T5	T22	23639362
NA	CHEMICAL	GENE-N	13	29	We report herein the location of the binding site for the inhaled anesthetic chemical at the chemical residue level of resolution in the ligand binding cavity in a prototypical gene , gene .	T2	T12	11961111
NA	CHEMICAL	GENE-Y	13	21	We report herein the location of the binding site for the inhaled anesthetic chemical at the chemical residue level of resolution in the ligand binding cavity in a prototypical gene , gene .	T2	T13	11961111
NA	CHEMICAL	GENE-N	16	29	We report herein the location of the binding site for the inhaled anesthetic chemical at the chemical residue level of resolution in the ligand binding cavity in a prototypical gene , gene .	T3	T12	11961111
NA	CHEMICAL	GENE-Y	16	21	We report herein the location of the binding site for the inhaled anesthetic chemical at the chemical residue level of resolution in the ligand binding cavity in a prototypical gene , gene .	T3	T13	11961111
NA	CHEMICAL	GENE-Y	3	4	Radiosequence analysis of chemical-labeled gene revealed that chemical contacts an chemical residue ( Trp265 ) lining the ligand binding cavity in the transmembrane core of the receptor .	T8	T14	11961111
NA	CHEMICAL	GENE-Y	7	4	Radiosequence analysis of chemical-labeled gene revealed that chemical contacts an chemical residue ( Trp265 ) lining the ligand binding cavity in the transmembrane core of the receptor .	T9	T14	11961111
NA	CHEMICAL	GENE-Y	10	4	Radiosequence analysis of chemical-labeled gene revealed that chemical contacts an chemical residue ( Trp265 ) lining the ligand binding cavity in the transmembrane core of the receptor .	T10	T14	11961111
NA	CHEMICAL	GENE-Y	0	2	chemical metabolism in male and female rat kidney : mitochondrial expression of chemical aminotransferase and gene .	T24	T48	14871882
NA	CHEMICAL	GENE-Y	0	15	chemical metabolism in male and female rat kidney : mitochondrial expression of chemical aminotransferase and gene .	T24	T47	14871882
NA	CHEMICAL	GENE-Y	2	2	chemical metabolism in male and female rat kidney : mitochondrial expression of chemical aminotransferase and gene .	T25	T48	14871882
NA	CHEMICAL	GENE-Y	2	15	chemical metabolism in male and female rat kidney : mitochondrial expression of chemical aminotransferase and gene .	T25	T47	14871882
NA	CHEMICAL	GENE-Y	4	24	In the kidney , chemical is reabsorbed along the proximal convoluted tubule ( PCT ) , transported by basolateral carriers , and produced by gene ( gene ) .	T6	T31	14871882
NA	CHEMICAL	GENE-Y	4	26	In the kidney , chemical is reabsorbed along the proximal convoluted tubule ( PCT ) , transported by basolateral carriers , and produced by gene ( gene ) .	T6	T32	14871882
NA	CHEMICAL	GENE-Y	0	1	chemical aminotransferase ( gene ) and gene were localized using specific antibodies .	T19	T39	14871882
NA	CHEMICAL	GENE-Y	0	3	chemical aminotransferase ( gene ) and gene were localized using specific antibodies .	T19	T40	14871882
NA	CHEMICAL	GENE-Y	0	6	chemical aminotransferase ( gene ) and gene were localized using specific antibodies .	T19	T41	14871882
NA	CHEMICAL	GENE-Y	0	1	chemical decarboxylase ( gene ) mRNAs were localized by in situ hybridization .	T23	T42	14871882
NA	CHEMICAL	GENE-Y	0	3	chemical decarboxylase ( gene ) mRNAs were localized by in situ hybridization .	T23	T43	14871882
NA	CHEMICAL	GENE-Y	6	1	Because gene and gene proteins overlapped in PST mitochondria , chemical-derived chemical may be preferentially converted to chemical , as proven by chemical oxidation .	T7	T34	14871882
NA	CHEMICAL	GENE-Y	6	3	Because gene and gene proteins overlapped in PST mitochondria , chemical-derived chemical may be preferentially converted to chemical , as proven by chemical oxidation .	T7	T35	14871882
NA	CHEMICAL	GENE-Y	6	1	Because gene and gene proteins overlapped in PST mitochondria , chemical-derived chemical may be preferentially converted to chemical , as proven by chemical oxidation .	T8	T34	14871882
NA	CHEMICAL	GENE-Y	6	3	Because gene and gene proteins overlapped in PST mitochondria , chemical-derived chemical may be preferentially converted to chemical , as proven by chemical oxidation .	T8	T35	14871882
NA	CHEMICAL	GENE-Y	17	1	Because gene and gene proteins overlapped in PST mitochondria , chemical-derived chemical may be preferentially converted to chemical , as proven by chemical oxidation .	T9	T34	14871882
NA	CHEMICAL	GENE-Y	17	3	Because gene and gene proteins overlapped in PST mitochondria , chemical-derived chemical may be preferentially converted to chemical , as proven by chemical oxidation .	T9	T35	14871882
NA	CHEMICAL	GENE-Y	6	1	Because gene and gene proteins overlapped in PST mitochondria , chemical-derived chemical may be preferentially converted to chemical , as proven by chemical oxidation .	T10	T34	14871882
NA	CHEMICAL	GENE-Y	6	3	Because gene and gene proteins overlapped in PST mitochondria , chemical-derived chemical may be preferentially converted to chemical , as proven by chemical oxidation .	T10	T35	14871882
NA	CHEMICAL	GENE-Y	7	5	However , the coexpression of gene , chemical decarboxylase , and chemical synthetase in PST suggests that chemical can also be metabolized to chemical , chemical , and chemical .	T11	T36	14871882
NA	CHEMICAL	GENE-N	7	8	However , the coexpression of gene , chemical decarboxylase , and chemical synthetase in PST suggests that chemical can also be metabolized to chemical , chemical , and chemical .	T11	T37	14871882
NA	CHEMICAL	GENE-Y	7	2	However , the coexpression of gene , chemical decarboxylase , and chemical synthetase in PST suggests that chemical can also be metabolized to chemical , chemical , and chemical .	T11	T38	14871882
NA	CHEMICAL	GENE-Y	11	5	However , the coexpression of gene , chemical decarboxylase , and chemical synthetase in PST suggests that chemical can also be metabolized to chemical , chemical , and chemical .	T12	T36	14871882
NA	CHEMICAL	GENE-N	11	8	However , the coexpression of gene , chemical decarboxylase , and chemical synthetase in PST suggests that chemical can also be metabolized to chemical , chemical , and chemical .	T12	T37	14871882
NA	CHEMICAL	GENE-Y	11	2	However , the coexpression of gene , chemical decarboxylase , and chemical synthetase in PST suggests that chemical can also be metabolized to chemical , chemical , and chemical .	T12	T38	14871882
NA	CHEMICAL	GENE-Y	13	5	However , the coexpression of gene , chemical decarboxylase , and chemical synthetase in PST suggests that chemical can also be metabolized to chemical , chemical , and chemical .	T13	T36	14871882
NA	CHEMICAL	GENE-N	13	8	However , the coexpression of gene , chemical decarboxylase , and chemical synthetase in PST suggests that chemical can also be metabolized to chemical , chemical , and chemical .	T13	T37	14871882
NA	CHEMICAL	GENE-Y	13	2	However , the coexpression of gene , chemical decarboxylase , and chemical synthetase in PST suggests that chemical can also be metabolized to chemical , chemical , and chemical .	T13	T38	14871882
NA	CHEMICAL	GENE-Y	13	5	However , the coexpression of gene , chemical decarboxylase , and chemical synthetase in PST suggests that chemical can also be metabolized to chemical , chemical , and chemical .	T15	T36	14871882
NA	CHEMICAL	GENE-N	13	8	However , the coexpression of gene , chemical decarboxylase , and chemical synthetase in PST suggests that chemical can also be metabolized to chemical , chemical , and chemical .	T15	T37	14871882
NA	CHEMICAL	GENE-Y	13	2	However , the coexpression of gene , chemical decarboxylase , and chemical synthetase in PST suggests that chemical can also be metabolized to chemical , chemical , and chemical .	T15	T38	14871882
NA	CHEMICAL	GENE-Y	25	5	However , the coexpression of gene , chemical decarboxylase , and chemical synthetase in PST suggests that chemical can also be metabolized to chemical , chemical , and chemical .	T16	T36	14871882
NA	CHEMICAL	GENE-N	25	8	However , the coexpression of gene , chemical decarboxylase , and chemical synthetase in PST suggests that chemical can also be metabolized to chemical , chemical , and chemical .	T16	T37	14871882
NA	CHEMICAL	GENE-Y	25	2	However , the coexpression of gene , chemical decarboxylase , and chemical synthetase in PST suggests that chemical can also be metabolized to chemical , chemical , and chemical .	T16	T38	14871882
NA	CHEMICAL	GENE-Y	13	5	However , the coexpression of gene , chemical decarboxylase , and chemical synthetase in PST suggests that chemical can also be metabolized to chemical , chemical , and chemical .	T17	T36	14871882
NA	CHEMICAL	GENE-N	13	8	However , the coexpression of gene , chemical decarboxylase , and chemical synthetase in PST suggests that chemical can also be metabolized to chemical , chemical , and chemical .	T17	T37	14871882
NA	CHEMICAL	GENE-Y	13	2	However , the coexpression of gene , chemical decarboxylase , and chemical synthetase in PST suggests that chemical can also be metabolized to chemical , chemical , and chemical .	T17	T38	14871882
NA	CHEMICAL	GENE-N	54	28	The noticeable characteristic that distinguished the different classes was their size ( molecular weight ) differences and domain structure : Class I ( P-I ) , the small gene , have molecular masses of 20-30 kDa , contain only a gene and the gene ; Class II ( P-II ) , the medium size gene , molecular masses of 30-60 kDa , contain the gene , gene and gene ; Class III ( P-III ) , the large gene , have molecular masses of 60-100 kDa , contain gene , gene , gene and chemical-rich domain structure .	T1	T7	23000249
NA	CHEMICAL	GENE-N	54	17	The noticeable characteristic that distinguished the different classes was their size ( molecular weight ) differences and domain structure : Class I ( P-I ) , the small gene , have molecular masses of 20-30 kDa , contain only a gene and the gene ; Class II ( P-II ) , the medium size gene , molecular masses of 30-60 kDa , contain the gene , gene and gene ; Class III ( P-III ) , the large gene , have molecular masses of 60-100 kDa , contain gene , gene , gene and chemical-rich domain structure .	T1	T8	23000249
NA	CHEMICAL	GENE-N	54	17	The noticeable characteristic that distinguished the different classes was their size ( molecular weight ) differences and domain structure : Class I ( P-I ) , the small gene , have molecular masses of 20-30 kDa , contain only a gene and the gene ; Class II ( P-II ) , the medium size gene , molecular masses of 30-60 kDa , contain the gene , gene and gene ; Class III ( P-III ) , the large gene , have molecular masses of 60-100 kDa , contain gene , gene , gene and chemical-rich domain structure .	T1	T9	23000249
NA	CHEMICAL	GENE-N	54	54	The noticeable characteristic that distinguished the different classes was their size ( molecular weight ) differences and domain structure : Class I ( P-I ) , the small gene , have molecular masses of 20-30 kDa , contain only a gene and the gene ; Class II ( P-II ) , the medium size gene , molecular masses of 30-60 kDa , contain the gene , gene and gene ; Class III ( P-III ) , the large gene , have molecular masses of 60-100 kDa , contain gene , gene , gene and chemical-rich domain structure .	T1	T10	23000249
NA	CHEMICAL	GENE-N	54	17	The noticeable characteristic that distinguished the different classes was their size ( molecular weight ) differences and domain structure : Class I ( P-I ) , the small gene , have molecular masses of 20-30 kDa , contain only a gene and the gene ; Class II ( P-II ) , the medium size gene , molecular masses of 30-60 kDa , contain the gene , gene and gene ; Class III ( P-III ) , the large gene , have molecular masses of 60-100 kDa , contain gene , gene , gene and chemical-rich domain structure .	T1	T11	23000249
NA	CHEMICAL	GENE-N	54	17	The noticeable characteristic that distinguished the different classes was their size ( molecular weight ) differences and domain structure : Class I ( P-I ) , the small gene , have molecular masses of 20-30 kDa , contain only a gene and the gene ; Class II ( P-II ) , the medium size gene , molecular masses of 30-60 kDa , contain the gene , gene and gene ; Class III ( P-III ) , the large gene , have molecular masses of 60-100 kDa , contain gene , gene , gene and chemical-rich domain structure .	T1	T12	23000249
NA	CHEMICAL	GENE-N	54	17	The noticeable characteristic that distinguished the different classes was their size ( molecular weight ) differences and domain structure : Class I ( P-I ) , the small gene , have molecular masses of 20-30 kDa , contain only a gene and the gene ; Class II ( P-II ) , the medium size gene , molecular masses of 30-60 kDa , contain the gene , gene and gene ; Class III ( P-III ) , the large gene , have molecular masses of 60-100 kDa , contain gene , gene , gene and chemical-rich domain structure .	T1	T13	23000249
NA	CHEMICAL	GENE-N	54	78	The noticeable characteristic that distinguished the different classes was their size ( molecular weight ) differences and domain structure : Class I ( P-I ) , the small gene , have molecular masses of 20-30 kDa , contain only a gene and the gene ; Class II ( P-II ) , the medium size gene , molecular masses of 30-60 kDa , contain the gene , gene and gene ; Class III ( P-III ) , the large gene , have molecular masses of 60-100 kDa , contain gene , gene , gene and chemical-rich domain structure .	T1	T14	23000249
NA	CHEMICAL	GENE-N	54	88	The noticeable characteristic that distinguished the different classes was their size ( molecular weight ) differences and domain structure : Class I ( P-I ) , the small gene , have molecular masses of 20-30 kDa , contain only a gene and the gene ; Class II ( P-II ) , the medium size gene , molecular masses of 30-60 kDa , contain the gene , gene and gene ; Class III ( P-III ) , the large gene , have molecular masses of 60-100 kDa , contain gene , gene , gene and chemical-rich domain structure .	T1	T15	23000249
NA	CHEMICAL	GENE-N	54	39	The noticeable characteristic that distinguished the different classes was their size ( molecular weight ) differences and domain structure : Class I ( P-I ) , the small gene , have molecular masses of 20-30 kDa , contain only a gene and the gene ; Class II ( P-II ) , the medium size gene , molecular masses of 30-60 kDa , contain the gene , gene and gene ; Class III ( P-III ) , the large gene , have molecular masses of 60-100 kDa , contain gene , gene , gene and chemical-rich domain structure .	T1	T16	23000249
NA	CHEMICAL	GENE-N	54	92	The noticeable characteristic that distinguished the different classes was their size ( molecular weight ) differences and domain structure : Class I ( P-I ) , the small gene , have molecular masses of 20-30 kDa , contain only a gene and the gene ; Class II ( P-II ) , the medium size gene , molecular masses of 30-60 kDa , contain the gene , gene and gene ; Class III ( P-III ) , the large gene , have molecular masses of 60-100 kDa , contain gene , gene , gene and chemical-rich domain structure .	T1	T17	23000249
NA	CHEMICAL	GENE-N	54	17	The noticeable characteristic that distinguished the different classes was their size ( molecular weight ) differences and domain structure : Class I ( P-I ) , the small gene , have molecular masses of 20-30 kDa , contain only a gene and the gene ; Class II ( P-II ) , the medium size gene , molecular masses of 30-60 kDa , contain the gene , gene and gene ; Class III ( P-III ) , the large gene , have molecular masses of 60-100 kDa , contain gene , gene , gene and chemical-rich domain structure .	T1	T18	23000249
NA	CHEMICAL	GENE-N	5	5	The active site of the gene has a consensus gene sequence and a chemical-turn .	T2	T23	23000249
NA	CHEMICAL	GENE-N	5	9	The active site of the gene has a consensus gene sequence and a chemical-turn .	T2	T24	23000249
NA	CHEMICAL	GENE-Y	6	5	To illuminate the controversy on gene- or gene involvement in chemical-mediated contractions of rat small mesenteric artery ( SMA ) , we have studied the effects of subtype-selective gene agonists and antagonists under different experimental conditions .	T22	T36	10401556
NA	CHEMICAL	GENE-N	6	6	To illuminate the controversy on gene- or gene involvement in chemical-mediated contractions of rat small mesenteric artery ( SMA ) , we have studied the effects of subtype-selective gene agonists and antagonists under different experimental conditions .	T22	T37	10401556
NA	CHEMICAL	GENE-N	6	6	To illuminate the controversy on gene- or gene involvement in chemical-mediated contractions of rat small mesenteric artery ( SMA ) , we have studied the effects of subtype-selective gene agonists and antagonists under different experimental conditions .	T22	T34	10401556
NA	CHEMICAL	GENE-N	0	17	chemical antagonized all agonists with a low potency ( pA2 : 8.29-8.80 ) indicating the involvement of gene-rather than gene .	T16	T38	10401556
NA	CHEMICAL	GENE-Y	0	5	chemical antagonized all agonists with a low potency ( pA2 : 8.29-8.80 ) indicating the involvement of gene-rather than gene .	T16	T39	10401556
CPR:6	CHEMICAL	GENE-N	4	2	The putative gene antagonist chemical , but not the gene antagonist chemical ( 10 microM ) antagonized chemical-induced contractions of SMA .	T17	T40	10401556
NA	CHEMICAL	GENE-Y	4	9	The putative gene antagonist chemical , but not the gene antagonist chemical ( 10 microM ) antagonized chemical-induced contractions of SMA .	T17	T41	10401556
NA	CHEMICAL	GENE-N	11	2	The putative gene antagonist chemical , but not the gene antagonist chemical ( 10 microM ) antagonized chemical-induced contractions of SMA .	T18	T40	10401556
CPR:6	CHEMICAL	GENE-Y	11	9	The putative gene antagonist chemical , but not the gene antagonist chemical ( 10 microM ) antagonized chemical-induced contractions of SMA .	T18	T41	10401556
NA	CHEMICAL	GENE-N	17	2	The putative gene antagonist chemical , but not the gene antagonist chemical ( 10 microM ) antagonized chemical-induced contractions of SMA .	T19	T40	10401556
NA	CHEMICAL	GENE-Y	17	9	The putative gene antagonist chemical , but not the gene antagonist chemical ( 10 microM ) antagonized chemical-induced contractions of SMA .	T19	T41	10401556
CPR:6	CHEMICAL	GENE-Y	7	5	The potency of the selective gene antagonist chemical against chemical ( pA2 = 6.16 +/- 0.13 ) and of the selective gene antagonist chemical against chemical ( pKB = 8.35 +/- 0.10 ) and against the selective gene agonist chemical ( pKB = 8.40 +/- 0.09 ) were too low to account for gene- and gene involvement .	T20	T42	10401556
NA	CHEMICAL	GENE-Y	7	21	The potency of the selective gene antagonist chemical against chemical ( pA2 = 6.16 +/- 0.13 ) and of the selective gene antagonist chemical against chemical ( pKB = 8.35 +/- 0.10 ) and against the selective gene agonist chemical ( pKB = 8.40 +/- 0.09 ) were too low to account for gene- and gene involvement .	T20	T43	10401556
NA	CHEMICAL	GENE-Y	7	37	The potency of the selective gene antagonist chemical against chemical ( pA2 = 6.16 +/- 0.13 ) and of the selective gene antagonist chemical against chemical ( pKB = 8.35 +/- 0.10 ) and against the selective gene agonist chemical ( pKB = 8.40 +/- 0.09 ) were too low to account for gene- and gene involvement .	T20	T44	10401556
NA	CHEMICAL	GENE-Y	7	53	The potency of the selective gene antagonist chemical against chemical ( pA2 = 6.16 +/- 0.13 ) and of the selective gene antagonist chemical against chemical ( pKB = 8.35 +/- 0.10 ) and against the selective gene agonist chemical ( pKB = 8.40 +/- 0.09 ) were too low to account for gene- and gene involvement .	T20	T25	10401556
NA	CHEMICAL	GENE-Y	7	50	The potency of the selective gene antagonist chemical against chemical ( pA2 = 6.16 +/- 0.13 ) and of the selective gene antagonist chemical against chemical ( pKB = 8.35 +/- 0.10 ) and against the selective gene agonist chemical ( pKB = 8.40 +/- 0.09 ) were too low to account for gene- and gene involvement .	T20	T26	10401556
NA	CHEMICAL	GENE-Y	9	5	The potency of the selective gene antagonist chemical against chemical ( pA2 = 6.16 +/- 0.13 ) and of the selective gene antagonist chemical against chemical ( pKB = 8.35 +/- 0.10 ) and against the selective gene agonist chemical ( pKB = 8.40 +/- 0.09 ) were too low to account for gene- and gene involvement .	T21	T42	10401556
NA	CHEMICAL	GENE-Y	9	21	The potency of the selective gene antagonist chemical against chemical ( pA2 = 6.16 +/- 0.13 ) and of the selective gene antagonist chemical against chemical ( pKB = 8.35 +/- 0.10 ) and against the selective gene agonist chemical ( pKB = 8.40 +/- 0.09 ) were too low to account for gene- and gene involvement .	T21	T43	10401556
NA	CHEMICAL	GENE-Y	9	37	The potency of the selective gene antagonist chemical against chemical ( pA2 = 6.16 +/- 0.13 ) and of the selective gene antagonist chemical against chemical ( pKB = 8.35 +/- 0.10 ) and against the selective gene agonist chemical ( pKB = 8.40 +/- 0.09 ) were too low to account for gene- and gene involvement .	T21	T44	10401556
NA	CHEMICAL	GENE-Y	9	53	The potency of the selective gene antagonist chemical against chemical ( pA2 = 6.16 +/- 0.13 ) and of the selective gene antagonist chemical against chemical ( pKB = 8.35 +/- 0.10 ) and against the selective gene agonist chemical ( pKB = 8.40 +/- 0.09 ) were too low to account for gene- and gene involvement .	T21	T25	10401556
NA	CHEMICAL	GENE-Y	9	50	The potency of the selective gene antagonist chemical against chemical ( pA2 = 6.16 +/- 0.13 ) and of the selective gene antagonist chemical against chemical ( pKB = 8.35 +/- 0.10 ) and against the selective gene agonist chemical ( pKB = 8.40 +/- 0.09 ) were too low to account for gene- and gene involvement .	T21	T26	10401556
NA	CHEMICAL	GENE-Y	23	5	The potency of the selective gene antagonist chemical against chemical ( pA2 = 6.16 +/- 0.13 ) and of the selective gene antagonist chemical against chemical ( pKB = 8.35 +/- 0.10 ) and against the selective gene agonist chemical ( pKB = 8.40 +/- 0.09 ) were too low to account for gene- and gene involvement .	T23	T42	10401556
CPR:6	CHEMICAL	GENE-Y	23	21	The potency of the selective gene antagonist chemical against chemical ( pA2 = 6.16 +/- 0.13 ) and of the selective gene antagonist chemical against chemical ( pKB = 8.35 +/- 0.10 ) and against the selective gene agonist chemical ( pKB = 8.40 +/- 0.09 ) were too low to account for gene- and gene involvement .	T23	T43	10401556
NA	CHEMICAL	GENE-Y	23	37	The potency of the selective gene antagonist chemical against chemical ( pA2 = 6.16 +/- 0.13 ) and of the selective gene antagonist chemical against chemical ( pKB = 8.35 +/- 0.10 ) and against the selective gene agonist chemical ( pKB = 8.40 +/- 0.09 ) were too low to account for gene- and gene involvement .	T23	T44	10401556
NA	CHEMICAL	GENE-Y	23	53	The potency of the selective gene antagonist chemical against chemical ( pA2 = 6.16 +/- 0.13 ) and of the selective gene antagonist chemical against chemical ( pKB = 8.35 +/- 0.10 ) and against the selective gene agonist chemical ( pKB = 8.40 +/- 0.09 ) were too low to account for gene- and gene involvement .	T23	T25	10401556
NA	CHEMICAL	GENE-Y	23	50	The potency of the selective gene antagonist chemical against chemical ( pA2 = 6.16 +/- 0.13 ) and of the selective gene antagonist chemical against chemical ( pKB = 8.35 +/- 0.10 ) and against the selective gene agonist chemical ( pKB = 8.40 +/- 0.09 ) were too low to account for gene- and gene involvement .	T23	T26	10401556
NA	CHEMICAL	GENE-Y	25	5	The potency of the selective gene antagonist chemical against chemical ( pA2 = 6.16 +/- 0.13 ) and of the selective gene antagonist chemical against chemical ( pKB = 8.35 +/- 0.10 ) and against the selective gene agonist chemical ( pKB = 8.40 +/- 0.09 ) were too low to account for gene- and gene involvement .	T24	T42	10401556
NA	CHEMICAL	GENE-Y	25	21	The potency of the selective gene antagonist chemical against chemical ( pA2 = 6.16 +/- 0.13 ) and of the selective gene antagonist chemical against chemical ( pKB = 8.35 +/- 0.10 ) and against the selective gene agonist chemical ( pKB = 8.40 +/- 0.09 ) were too low to account for gene- and gene involvement .	T24	T43	10401556
NA	CHEMICAL	GENE-Y	25	37	The potency of the selective gene antagonist chemical against chemical ( pA2 = 6.16 +/- 0.13 ) and of the selective gene antagonist chemical against chemical ( pKB = 8.35 +/- 0.10 ) and against the selective gene agonist chemical ( pKB = 8.40 +/- 0.09 ) were too low to account for gene- and gene involvement .	T24	T44	10401556
NA	CHEMICAL	GENE-Y	25	53	The potency of the selective gene antagonist chemical against chemical ( pA2 = 6.16 +/- 0.13 ) and of the selective gene antagonist chemical against chemical ( pKB = 8.35 +/- 0.10 ) and against the selective gene agonist chemical ( pKB = 8.40 +/- 0.09 ) were too low to account for gene- and gene involvement .	T24	T25	10401556
NA	CHEMICAL	GENE-Y	25	50	The potency of the selective gene antagonist chemical against chemical ( pA2 = 6.16 +/- 0.13 ) and of the selective gene antagonist chemical against chemical ( pKB = 8.35 +/- 0.10 ) and against the selective gene agonist chemical ( pKB = 8.40 +/- 0.09 ) were too low to account for gene- and gene involvement .	T24	T26	10401556
NA	CHEMICAL	GENE-Y	39	5	The potency of the selective gene antagonist chemical against chemical ( pA2 = 6.16 +/- 0.13 ) and of the selective gene antagonist chemical against chemical ( pKB = 8.35 +/- 0.10 ) and against the selective gene agonist chemical ( pKB = 8.40 +/- 0.09 ) were too low to account for gene- and gene involvement .	T1	T42	10401556
NA	CHEMICAL	GENE-Y	39	21	The potency of the selective gene antagonist chemical against chemical ( pA2 = 6.16 +/- 0.13 ) and of the selective gene antagonist chemical against chemical ( pKB = 8.35 +/- 0.10 ) and against the selective gene agonist chemical ( pKB = 8.40 +/- 0.09 ) were too low to account for gene- and gene involvement .	T1	T43	10401556
CPR:5	CHEMICAL	GENE-Y	39	37	The potency of the selective gene antagonist chemical against chemical ( pA2 = 6.16 +/- 0.13 ) and of the selective gene antagonist chemical against chemical ( pKB = 8.35 +/- 0.10 ) and against the selective gene agonist chemical ( pKB = 8.40 +/- 0.09 ) were too low to account for gene- and gene involvement .	T1	T44	10401556
NA	CHEMICAL	GENE-Y	39	53	The potency of the selective gene antagonist chemical against chemical ( pA2 = 6.16 +/- 0.13 ) and of the selective gene antagonist chemical against chemical ( pKB = 8.35 +/- 0.10 ) and against the selective gene agonist chemical ( pKB = 8.40 +/- 0.09 ) were too low to account for gene- and gene involvement .	T1	T25	10401556
NA	CHEMICAL	GENE-Y	39	50	The potency of the selective gene antagonist chemical against chemical ( pA2 = 6.16 +/- 0.13 ) and of the selective gene antagonist chemical against chemical ( pKB = 8.35 +/- 0.10 ) and against the selective gene agonist chemical ( pKB = 8.40 +/- 0.09 ) were too low to account for gene- and gene involvement .	T1	T26	10401556
NA	CHEMICAL	GENE-Y	3	3	Selective protection of a putative gene population against the irreversible action of chemical also failed to increase the potency of chemical ( pA2 = 8.25 +/- 0.06 against A61603 ) .	T5	T27	10401556
NA	CHEMICAL	GENE-Y	20	3	Selective protection of a putative gene population against the irreversible action of chemical also failed to increase the potency of chemical ( pA2 = 8.25 +/- 0.06 against A61603 ) .	T6	T27	10401556
NA	CHEMICAL	GENE-Y	5	12	Combined concentration-ratio analysis demonstrated that chemical , which does not discriminate between gene- and gene , and chemical competed for binding at the same site in the SMA .	T7	T28	10401556
NA	CHEMICAL	GENE-N	5	14	Combined concentration-ratio analysis demonstrated that chemical , which does not discriminate between gene- and gene , and chemical competed for binding at the same site in the SMA .	T7	T29	10401556
NA	CHEMICAL	GENE-Y	17	12	Combined concentration-ratio analysis demonstrated that chemical , which does not discriminate between gene- and gene , and chemical competed for binding at the same site in the SMA .	T8	T28	10401556
NA	CHEMICAL	GENE-N	17	14	Combined concentration-ratio analysis demonstrated that chemical , which does not discriminate between gene- and gene , and chemical competed for binding at the same site in the SMA .	T8	T29	10401556
NA	CHEMICAL	GENE-N	5	14	In summary , data obtained in our experiments in rat SMA indicate that the gene mediating chemical-induced contraction displays a distinct gene pharmacology .	T9	T30	10401556
NA	CHEMICAL	GENE-N	5	19	In summary , data obtained in our experiments in rat SMA indicate that the gene mediating chemical-induced contraction displays a distinct gene pharmacology .	T9	T31	10401556
NA	CHEMICAL	GENE-N	8	9	1527 ) provides an intriguing example of how chemical kinase inhibitors can be put to many uses .	T1	T7	16497876
CPR:4	CHEMICAL	GENE-N	7	18	In this article , the action of chemical ( chemical ) is contrasted with that of chemical , a gene inhibitor that is currently being used to treat chronic myelogenous leukemia and other disorders .	T2	T8	16497876
CPR:4	CHEMICAL	GENE-N	9	18	In this article , the action of chemical ( chemical ) is contrasted with that of chemical , a gene inhibitor that is currently being used to treat chronic myelogenous leukemia and other disorders .	T3	T8	16497876
CPR:4	CHEMICAL	GENE-N	16	18	In this article , the action of chemical ( chemical ) is contrasted with that of chemical , a gene inhibitor that is currently being used to treat chronic myelogenous leukemia and other disorders .	T4	T8	16497876
NA	CHEMICAL	GENE-N	5	6	Both pharmacologic inhibitors target several chemical kinases , including gene-gene and the gene ( gene ) .	T5	T9	16497876
NA	CHEMICAL	GENE-Y	5	9	Both pharmacologic inhibitors target several chemical kinases , including gene-gene and the gene ( gene ) .	T5	T10	16497876
NA	CHEMICAL	GENE-Y	5	9	Both pharmacologic inhibitors target several chemical kinases , including gene-gene and the gene ( gene ) .	T5	T11	16497876
NA	CHEMICAL	GENE-N	5	12	Both pharmacologic inhibitors target several chemical kinases , including gene-gene and the gene ( gene ) .	T5	T12	16497876
NA	CHEMICAL	GENE-N	5	14	Both pharmacologic inhibitors target several chemical kinases , including gene-gene and the gene ( gene ) .	T5	T13	16497876
NA	CHEMICAL	GENE-N	7	18	Due to the ubiquitous nature of the chemical pathway , general inhibitors of chemical signaling proteins such as gene , gene and gene would act non-specifically and universally , increasing the likelihood of serious 'off target ' effects .	T2	T7	23495691
NA	CHEMICAL	GENE-Y	7	20	Due to the ubiquitous nature of the chemical pathway , general inhibitors of chemical signaling proteins such as gene , gene and gene would act non-specifically and universally , increasing the likelihood of serious 'off target ' effects .	T2	T8	23495691
NA	CHEMICAL	GENE-N	7	22	Due to the ubiquitous nature of the chemical pathway , general inhibitors of chemical signaling proteins such as gene , gene and gene would act non-specifically and universally , increasing the likelihood of serious 'off target ' effects .	T2	T9	23495691
NA	CHEMICAL	GENE-N	13	18	Due to the ubiquitous nature of the chemical pathway , general inhibitors of chemical signaling proteins such as gene , gene and gene would act non-specifically and universally , increasing the likelihood of serious 'off target ' effects .	T3	T7	23495691
NA	CHEMICAL	GENE-Y	13	20	Due to the ubiquitous nature of the chemical pathway , general inhibitors of chemical signaling proteins such as gene , gene and gene would act non-specifically and universally , increasing the likelihood of serious 'off target ' effects .	T3	T8	23495691
NA	CHEMICAL	GENE-N	13	22	Due to the ubiquitous nature of the chemical pathway , general inhibitors of chemical signaling proteins such as gene , gene and gene would act non-specifically and universally , increasing the likelihood of serious 'off target ' effects .	T3	T9	23495691
CPR:4	CHEMICAL	GENE-Y	0	2	chemical suppresses gene oligomer-induced microglia activation and thereby protects PC-12 cells from inflammation-mediated toxicity .	T14	T41	23261590
CPR:4	CHEMICAL	GENE-Y	12	29	In this study , focus was given to evaluate the ability of chemical , an chemical alkaloid isolated from marine-derived Microsporum sp. , to attenuate microglial activation by oligomeric gene ( gene ) .	T5	T30	23261590
CPR:4	CHEMICAL	GENE-Y	12	31	In this study , focus was given to evaluate the ability of chemical , an chemical alkaloid isolated from marine-derived Microsporum sp. , to attenuate microglial activation by oligomeric gene ( gene ) .	T5	T31	23261590
CPR:4	CHEMICAL	GENE-Y	15	29	In this study , focus was given to evaluate the ability of chemical , an chemical alkaloid isolated from marine-derived Microsporum sp. , to attenuate microglial activation by oligomeric gene ( gene ) .	T6	T30	23261590
CPR:4	CHEMICAL	GENE-Y	15	31	In this study , focus was given to evaluate the ability of chemical , an chemical alkaloid isolated from marine-derived Microsporum sp. , to attenuate microglial activation by oligomeric gene ( gene ) .	T6	T31	23261590
CPR:4	CHEMICAL	GENE-Y	0	13	chemical treatment significantly inhibited the generation of reactive chemical and chemical species in gene-activated BV-2 microglia cells .	T7	T32	23261590
NA	CHEMICAL	GENE-Y	8	13	chemical treatment significantly inhibited the generation of reactive chemical and chemical species in gene-activated BV-2 microglia cells .	T8	T32	23261590
NA	CHEMICAL	GENE-Y	10	13	chemical treatment significantly inhibited the generation of reactive chemical and chemical species in gene-activated BV-2 microglia cells .	T9	T32	23261590
CPR:4	CHEMICAL	GENE-Y	6	15	In addition , we found that chemical significantly suppressed the production of neurotoxic inflammatory mediator gene ( gene ) , gene ( gene ) , gene ( gene ) , and chemical ( chemical ) in activated BV-2 cells .	T10	T33	23261590
CPR:4	CHEMICAL	GENE-Y	6	17	In addition , we found that chemical significantly suppressed the production of neurotoxic inflammatory mediator gene ( gene ) , gene ( gene ) , gene ( gene ) , and chemical ( chemical ) in activated BV-2 cells .	T10	T34	23261590
CPR:4	CHEMICAL	GENE-Y	6	20	In addition , we found that chemical significantly suppressed the production of neurotoxic inflammatory mediator gene ( gene ) , gene ( gene ) , gene ( gene ) , and chemical ( chemical ) in activated BV-2 cells .	T10	T35	23261590
CPR:4	CHEMICAL	GENE-Y	6	22	In addition , we found that chemical significantly suppressed the production of neurotoxic inflammatory mediator gene ( gene ) , gene ( gene ) , gene ( gene ) , and chemical ( chemical ) in activated BV-2 cells .	T10	T36	23261590
CPR:4	CHEMICAL	GENE-Y	6	25	In addition , we found that chemical significantly suppressed the production of neurotoxic inflammatory mediator gene ( gene ) , gene ( gene ) , gene ( gene ) , and chemical ( chemical ) in activated BV-2 cells .	T10	T38	23261590
CPR:4	CHEMICAL	GENE-Y	6	27	In addition , we found that chemical significantly suppressed the production of neurotoxic inflammatory mediator gene ( gene ) , gene ( gene ) , gene ( gene ) , and chemical ( chemical ) in activated BV-2 cells .	T10	T39	23261590
NA	CHEMICAL	GENE-Y	31	15	In addition , we found that chemical significantly suppressed the production of neurotoxic inflammatory mediator gene ( gene ) , gene ( gene ) , gene ( gene ) , and chemical ( chemical ) in activated BV-2 cells .	T11	T33	23261590
NA	CHEMICAL	GENE-Y	31	17	In addition , we found that chemical significantly suppressed the production of neurotoxic inflammatory mediator gene ( gene ) , gene ( gene ) , gene ( gene ) , and chemical ( chemical ) in activated BV-2 cells .	T11	T34	23261590
NA	CHEMICAL	GENE-Y	31	20	In addition , we found that chemical significantly suppressed the production of neurotoxic inflammatory mediator gene ( gene ) , gene ( gene ) , gene ( gene ) , and chemical ( chemical ) in activated BV-2 cells .	T11	T35	23261590
NA	CHEMICAL	GENE-Y	31	22	In addition , we found that chemical significantly suppressed the production of neurotoxic inflammatory mediator gene ( gene ) , gene ( gene ) , gene ( gene ) , and chemical ( chemical ) in activated BV-2 cells .	T11	T36	23261590
NA	CHEMICAL	GENE-Y	31	25	In addition , we found that chemical significantly suppressed the production of neurotoxic inflammatory mediator gene ( gene ) , gene ( gene ) , gene ( gene ) , and chemical ( chemical ) in activated BV-2 cells .	T11	T38	23261590
NA	CHEMICAL	GENE-Y	31	27	In addition , we found that chemical significantly suppressed the production of neurotoxic inflammatory mediator gene ( gene ) , gene ( gene ) , gene ( gene ) , and chemical ( chemical ) in activated BV-2 cells .	T11	T39	23261590
NA	CHEMICAL	GENE-Y	33	15	In addition , we found that chemical significantly suppressed the production of neurotoxic inflammatory mediator gene ( gene ) , gene ( gene ) , gene ( gene ) , and chemical ( chemical ) in activated BV-2 cells .	T12	T33	23261590
NA	CHEMICAL	GENE-Y	33	17	In addition , we found that chemical significantly suppressed the production of neurotoxic inflammatory mediator gene ( gene ) , gene ( gene ) , gene ( gene ) , and chemical ( chemical ) in activated BV-2 cells .	T12	T34	23261590
NA	CHEMICAL	GENE-Y	33	20	In addition , we found that chemical significantly suppressed the production of neurotoxic inflammatory mediator gene ( gene ) , gene ( gene ) , gene ( gene ) , and chemical ( chemical ) in activated BV-2 cells .	T12	T35	23261590
NA	CHEMICAL	GENE-Y	33	22	In addition , we found that chemical significantly suppressed the production of neurotoxic inflammatory mediator gene ( gene ) , gene ( gene ) , gene ( gene ) , and chemical ( chemical ) in activated BV-2 cells .	T12	T36	23261590
NA	CHEMICAL	GENE-Y	33	25	In addition , we found that chemical significantly suppressed the production of neurotoxic inflammatory mediator gene ( gene ) , gene ( gene ) , gene ( gene ) , and chemical ( chemical ) in activated BV-2 cells .	T12	T38	23261590
NA	CHEMICAL	GENE-Y	33	27	In addition , we found that chemical significantly suppressed the production of neurotoxic inflammatory mediator gene ( gene ) , gene ( gene ) , gene ( gene ) , and chemical ( chemical ) in activated BV-2 cells .	T12	T39	23261590
NA	CHEMICAL	GENE-N	13	27	Further , activated microglia-mediated apoptosis of PC-12 pheochromocytoma cells was significantly repressed by chemical . The molecular mechanism studies suggested that chemical may block the phosphorylation of gene ( gene ) molecule gene , gene ( gene ) and nuclear translocation of gene ( gene ) gene and gene subunits .	T1	T21	23261590
NA	CHEMICAL	GENE-N	13	29	Further , activated microglia-mediated apoptosis of PC-12 pheochromocytoma cells was significantly repressed by chemical . The molecular mechanism studies suggested that chemical may block the phosphorylation of gene ( gene ) molecule gene , gene ( gene ) and nuclear translocation of gene ( gene ) gene and gene subunits .	T1	T22	23261590
NA	CHEMICAL	GENE-N	13	32	Further , activated microglia-mediated apoptosis of PC-12 pheochromocytoma cells was significantly repressed by chemical . The molecular mechanism studies suggested that chemical may block the phosphorylation of gene ( gene ) molecule gene , gene ( gene ) and nuclear translocation of gene ( gene ) gene and gene subunits .	T1	T23	23261590
NA	CHEMICAL	GENE-Y	13	34	Further , activated microglia-mediated apoptosis of PC-12 pheochromocytoma cells was significantly repressed by chemical . The molecular mechanism studies suggested that chemical may block the phosphorylation of gene ( gene ) molecule gene , gene ( gene ) and nuclear translocation of gene ( gene ) gene and gene subunits .	T1	T24	23261590
NA	CHEMICAL	GENE-Y	13	36	Further , activated microglia-mediated apoptosis of PC-12 pheochromocytoma cells was significantly repressed by chemical . The molecular mechanism studies suggested that chemical may block the phosphorylation of gene ( gene ) molecule gene , gene ( gene ) and nuclear translocation of gene ( gene ) gene and gene subunits .	T1	T25	23261590
NA	CHEMICAL	GENE-N	13	42	Further , activated microglia-mediated apoptosis of PC-12 pheochromocytoma cells was significantly repressed by chemical . The molecular mechanism studies suggested that chemical may block the phosphorylation of gene ( gene ) molecule gene , gene ( gene ) and nuclear translocation of gene ( gene ) gene and gene subunits .	T1	T26	23261590
NA	CHEMICAL	GENE-N	13	44	Further , activated microglia-mediated apoptosis of PC-12 pheochromocytoma cells was significantly repressed by chemical . The molecular mechanism studies suggested that chemical may block the phosphorylation of gene ( gene ) molecule gene , gene ( gene ) and nuclear translocation of gene ( gene ) gene and gene subunits .	T1	T27	23261590
NA	CHEMICAL	GENE-Y	13	46	Further , activated microglia-mediated apoptosis of PC-12 pheochromocytoma cells was significantly repressed by chemical . The molecular mechanism studies suggested that chemical may block the phosphorylation of gene ( gene ) molecule gene , gene ( gene ) and nuclear translocation of gene ( gene ) gene and gene subunits .	T1	T28	23261590
NA	CHEMICAL	GENE-Y	13	48	Further , activated microglia-mediated apoptosis of PC-12 pheochromocytoma cells was significantly repressed by chemical . The molecular mechanism studies suggested that chemical may block the phosphorylation of gene ( gene ) molecule gene , gene ( gene ) and nuclear translocation of gene ( gene ) gene and gene subunits .	T1	T29	23261590
CPR:4	CHEMICAL	GENE-N	21	27	Further , activated microglia-mediated apoptosis of PC-12 pheochromocytoma cells was significantly repressed by chemical . The molecular mechanism studies suggested that chemical may block the phosphorylation of gene ( gene ) molecule gene , gene ( gene ) and nuclear translocation of gene ( gene ) gene and gene subunits .	T2	T21	23261590
CPR:4	CHEMICAL	GENE-N	21	29	Further , activated microglia-mediated apoptosis of PC-12 pheochromocytoma cells was significantly repressed by chemical . The molecular mechanism studies suggested that chemical may block the phosphorylation of gene ( gene ) molecule gene , gene ( gene ) and nuclear translocation of gene ( gene ) gene and gene subunits .	T2	T22	23261590
CPR:4	CHEMICAL	GENE-N	21	32	Further , activated microglia-mediated apoptosis of PC-12 pheochromocytoma cells was significantly repressed by chemical . The molecular mechanism studies suggested that chemical may block the phosphorylation of gene ( gene ) molecule gene , gene ( gene ) and nuclear translocation of gene ( gene ) gene and gene subunits .	T2	T23	23261590
CPR:4	CHEMICAL	GENE-Y	21	34	Further , activated microglia-mediated apoptosis of PC-12 pheochromocytoma cells was significantly repressed by chemical . The molecular mechanism studies suggested that chemical may block the phosphorylation of gene ( gene ) molecule gene , gene ( gene ) and nuclear translocation of gene ( gene ) gene and gene subunits .	T2	T24	23261590
CPR:4	CHEMICAL	GENE-Y	21	36	Further , activated microglia-mediated apoptosis of PC-12 pheochromocytoma cells was significantly repressed by chemical . The molecular mechanism studies suggested that chemical may block the phosphorylation of gene ( gene ) molecule gene , gene ( gene ) and nuclear translocation of gene ( gene ) gene and gene subunits .	T2	T25	23261590
CPR:4	CHEMICAL	GENE-N	21	42	Further , activated microglia-mediated apoptosis of PC-12 pheochromocytoma cells was significantly repressed by chemical . The molecular mechanism studies suggested that chemical may block the phosphorylation of gene ( gene ) molecule gene , gene ( gene ) and nuclear translocation of gene ( gene ) gene and gene subunits .	T2	T26	23261590
CPR:4	CHEMICAL	GENE-N	21	44	Further , activated microglia-mediated apoptosis of PC-12 pheochromocytoma cells was significantly repressed by chemical . The molecular mechanism studies suggested that chemical may block the phosphorylation of gene ( gene ) molecule gene , gene ( gene ) and nuclear translocation of gene ( gene ) gene and gene subunits .	T2	T27	23261590
CPR:4	CHEMICAL	GENE-Y	21	46	Further , activated microglia-mediated apoptosis of PC-12 pheochromocytoma cells was significantly repressed by chemical . The molecular mechanism studies suggested that chemical may block the phosphorylation of gene ( gene ) molecule gene , gene ( gene ) and nuclear translocation of gene ( gene ) gene and gene subunits .	T2	T28	23261590
CPR:4	CHEMICAL	GENE-Y	21	48	Further , activated microglia-mediated apoptosis of PC-12 pheochromocytoma cells was significantly repressed by chemical . The molecular mechanism studies suggested that chemical may block the phosphorylation of gene ( gene ) molecule gene , gene ( gene ) and nuclear translocation of gene ( gene ) gene and gene subunits .	T2	T29	23261590
CPR:4	CHEMICAL	GENE-Y	9	14	In this study , we assessed the effects of chemical and chemical , known gene and gene inhibitors , respectively , on the enantioselective disposition of chemical in conjunction with gene polymorphisms in humans .	T7	T18	23381968
CPR:4	CHEMICAL	GENE-N	9	16	In this study , we assessed the effects of chemical and chemical , known gene and gene inhibitors , respectively , on the enantioselective disposition of chemical in conjunction with gene polymorphisms in humans .	T7	T20	23381968
CPR:4	CHEMICAL	GENE-Y	9	30	In this study , we assessed the effects of chemical and chemical , known gene and gene inhibitors , respectively , on the enantioselective disposition of chemical in conjunction with gene polymorphisms in humans .	T7	T17	23381968
CPR:4	CHEMICAL	GENE-Y	11	14	In this study , we assessed the effects of chemical and chemical , known gene and gene inhibitors , respectively , on the enantioselective disposition of chemical in conjunction with gene polymorphisms in humans .	T8	T18	23381968
CPR:4	CHEMICAL	GENE-N	11	16	In this study , we assessed the effects of chemical and chemical , known gene and gene inhibitors , respectively , on the enantioselective disposition of chemical in conjunction with gene polymorphisms in humans .	T8	T20	23381968
NA	CHEMICAL	GENE-Y	11	30	In this study , we assessed the effects of chemical and chemical , known gene and gene inhibitors , respectively , on the enantioselective disposition of chemical in conjunction with gene polymorphisms in humans .	T8	T17	23381968
NA	CHEMICAL	GENE-Y	16	14	In this study , we assessed the effects of chemical and chemical , known gene and gene inhibitors , respectively , on the enantioselective disposition of chemical in conjunction with gene polymorphisms in humans .	T2	T18	23381968
NA	CHEMICAL	GENE-N	16	16	In this study , we assessed the effects of chemical and chemical , known gene and gene inhibitors , respectively , on the enantioselective disposition of chemical in conjunction with gene polymorphisms in humans .	T2	T20	23381968
NA	CHEMICAL	GENE-Y	16	30	In this study , we assessed the effects of chemical and chemical , known gene and gene inhibitors , respectively , on the enantioselective disposition of chemical in conjunction with gene polymorphisms in humans .	T2	T17	23381968
NA	CHEMICAL	GENE-Y	2	9	Exposure to chemical was higher in subjects with the gene*6/*6 genotype , but no statistical difference was observed among the gene genotypes .	T11	T19	23381968
NA	CHEMICAL	GENE-Y	2	20	Exposure to chemical was higher in subjects with the gene*6/*6 genotype , but no statistical difference was observed among the gene genotypes .	T11	T21	23381968
NA	CHEMICAL	GENE-Y	4	11	Experimental cystathioninuria was induced in rats by administration of the chemical gamma-lyase inhibitor , chemical .	T14	T19	10954021
CPR:4	CHEMICAL	GENE-Y	4	11	Experimental cystathioninuria was induced in rats by administration of the chemical gamma-lyase inhibitor , chemical .	T1	T19	10954021
NA	CHEMICAL	GENE-N	1	0	gene chemical Goals in High-Risk Patients : How Low Do We Go and How Do We Get There ?	T6	T15	23494186
NA	CHEMICAL	GENE-N	6	5	It is widely recognised that gene chemical ( gene-C ) is one of the most important and modifiable risk factors for cardiovascular disease ( CVD ) .	T2	T9	23494186
NA	CHEMICAL	GENE-N	6	8	It is widely recognised that gene chemical ( gene-C ) is one of the most important and modifiable risk factors for cardiovascular disease ( CVD ) .	T2	T12	23494186
NA	CHEMICAL	GENE-Y	2	3	Statins ( chemical reductase inhibitors ) have consistently been shown to decrease both gene-C and CVD risk in almost all patient categories , with the exception of heart and kidney failure as well as advanced aortic stenosis .	T1	T7	23494186
NA	CHEMICAL	GENE-N	2	13	Statins ( chemical reductase inhibitors ) have consistently been shown to decrease both gene-C and CVD risk in almost all patient categories , with the exception of heart and kidney failure as well as advanced aortic stenosis .	T1	T8	23494186
NA	CHEMICAL	GENE-N	0	6	chemical is specific for the chemical receptor-alpha/beta , and has therapeutic effects in chemical resistant acute promyelocytic leukemia .	T6	T18	15843826
NA	CHEMICAL	GENE-N	5	6	chemical is specific for the chemical receptor-alpha/beta , and has therapeutic effects in chemical resistant acute promyelocytic leukemia .	T7	T18	15843826
NA	CHEMICAL	GENE-N	13	6	chemical is specific for the chemical receptor-alpha/beta , and has therapeutic effects in chemical resistant acute promyelocytic leukemia .	T8	T18	15843826
CPR:4	CHEMICAL	GENE-Y	0	21	chemical slightly inhibited the growth of both myeloma cells and HUVECs , and remarkably inhibited the growth of HUVECs stimulated by gene .	T9	T19	15843826
CPR:4	CHEMICAL	GENE-Y	0	2	chemical inhibited gene-induced phosphorylation of gene .	T11	T20	15843826
CPR:4	CHEMICAL	GENE-N	0	5	chemical inhibited gene-induced phosphorylation of gene .	T11	T15	15843826
CPR:4	CHEMICAL	GENE-Y	3	3	In addition , gene-induced formation of tube-like structures in vitro and neovascularization in mouse corneas were significantly inhibited by chemical .	T1	T16	15843826
NA	CHEMICAL	GENE-Y	3	13	Effect of the chemical and chemical on chemical turnover in cultured cells expressing gene or gene receptors .	T20	T34	7824160
NA	CHEMICAL	GENE-Y	3	15	Effect of the chemical and chemical on chemical turnover in cultured cells expressing gene or gene receptors .	T20	T35	7824160
NA	CHEMICAL	GENE-Y	5	13	Effect of the chemical and chemical on chemical turnover in cultured cells expressing gene or gene receptors .	T21	T34	7824160
NA	CHEMICAL	GENE-Y	5	15	Effect of the chemical and chemical on chemical turnover in cultured cells expressing gene or gene receptors .	T21	T35	7824160
NA	CHEMICAL	GENE-Y	7	13	Effect of the chemical and chemical on chemical turnover in cultured cells expressing gene or gene receptors .	T22	T34	7824160
NA	CHEMICAL	GENE-Y	7	15	Effect of the chemical and chemical on chemical turnover in cultured cells expressing gene or gene receptors .	T22	T35	7824160
NA	CHEMICAL	GENE-Y	4	23	The effect of the chemical ( chemical ) and its chemical ( chemical ) on chemical accumulation was studied in cells expressing either gene or gene receptors .	T4	T25	7824160
NA	CHEMICAL	GENE-Y	4	25	The effect of the chemical ( chemical ) and its chemical ( chemical ) on chemical accumulation was studied in cells expressing either gene or gene receptors .	T4	T26	7824160
NA	CHEMICAL	GENE-Y	6	23	The effect of the chemical ( chemical ) and its chemical ( chemical ) on chemical accumulation was studied in cells expressing either gene or gene receptors .	T15	T25	7824160
NA	CHEMICAL	GENE-Y	6	25	The effect of the chemical ( chemical ) and its chemical ( chemical ) on chemical accumulation was studied in cells expressing either gene or gene receptors .	T15	T26	7824160
NA	CHEMICAL	GENE-Y	10	23	The effect of the chemical ( chemical ) and its chemical ( chemical ) on chemical accumulation was studied in cells expressing either gene or gene receptors .	T16	T25	7824160
NA	CHEMICAL	GENE-Y	10	25	The effect of the chemical ( chemical ) and its chemical ( chemical ) on chemical accumulation was studied in cells expressing either gene or gene receptors .	T16	T26	7824160
NA	CHEMICAL	GENE-Y	12	23	The effect of the chemical ( chemical ) and its chemical ( chemical ) on chemical accumulation was studied in cells expressing either gene or gene receptors .	T2	T25	7824160
NA	CHEMICAL	GENE-Y	12	25	The effect of the chemical ( chemical ) and its chemical ( chemical ) on chemical accumulation was studied in cells expressing either gene or gene receptors .	T2	T26	7824160
NA	CHEMICAL	GENE-Y	14	23	The effect of the chemical ( chemical ) and its chemical ( chemical ) on chemical accumulation was studied in cells expressing either gene or gene receptors .	T3	T25	7824160
NA	CHEMICAL	GENE-Y	14	25	The effect of the chemical ( chemical ) and its chemical ( chemical ) on chemical accumulation was studied in cells expressing either gene or gene receptors .	T3	T26	7824160
NA	CHEMICAL	GENE-Y	3	17	The isomers of chemical produced a concentration dependent increase in chemical ( chemical ) hydrolysis at the gene receptors , with the chemical being more potent than the S ( + ) at the gene receptor .	T5	T27	7824160
NA	CHEMICAL	GENE-Y	3	34	The isomers of chemical produced a concentration dependent increase in chemical ( chemical ) hydrolysis at the gene receptors , with the chemical being more potent than the S ( + ) at the gene receptor .	T5	T28	7824160
NA	CHEMICAL	GENE-Y	9	17	The isomers of chemical produced a concentration dependent increase in chemical ( chemical ) hydrolysis at the gene receptors , with the chemical being more potent than the S ( + ) at the gene receptor .	T6	T27	7824160
NA	CHEMICAL	GENE-Y	9	34	The isomers of chemical produced a concentration dependent increase in chemical ( chemical ) hydrolysis at the gene receptors , with the chemical being more potent than the S ( + ) at the gene receptor .	T6	T28	7824160
NA	CHEMICAL	GENE-Y	12	17	The isomers of chemical produced a concentration dependent increase in chemical ( chemical ) hydrolysis at the gene receptors , with the chemical being more potent than the S ( + ) at the gene receptor .	T7	T27	7824160
NA	CHEMICAL	GENE-Y	12	34	The isomers of chemical produced a concentration dependent increase in chemical ( chemical ) hydrolysis at the gene receptors , with the chemical being more potent than the S ( + ) at the gene receptor .	T7	T28	7824160
NA	CHEMICAL	GENE-Y	22	17	The isomers of chemical produced a concentration dependent increase in chemical ( chemical ) hydrolysis at the gene receptors , with the chemical being more potent than the S ( + ) at the gene receptor .	T8	T27	7824160
NA	CHEMICAL	GENE-Y	22	34	The isomers of chemical produced a concentration dependent increase in chemical ( chemical ) hydrolysis at the gene receptors , with the chemical being more potent than the S ( + ) at the gene receptor .	T8	T28	7824160
NA	CHEMICAL	GENE-Y	1	8	The chemical were significantly less efficacious at the gene receptor as compared to chemical ; chemical had no effect .	T9	T29	7824160
NA	CHEMICAL	GENE-Y	13	8	The chemical were significantly less efficacious at the gene receptor as compared to chemical ; chemical had no effect .	T10	T29	7824160
NA	CHEMICAL	GENE-Y	15	8	The chemical were significantly less efficacious at the gene receptor as compared to chemical ; chemical had no effect .	T11	T29	7824160
NA	CHEMICAL	GENE-Y	6	2	At the gene receptor , both chemical were equipotent at stimulating chemical hydrolysis , with the chemical being more efficacious at the gene receptor compared with the R ( - ) isomer .	T12	T30	7824160
NA	CHEMICAL	GENE-Y	6	22	At the gene receptor , both chemical were equipotent at stimulating chemical hydrolysis , with the chemical being more efficacious at the gene receptor compared with the R ( - ) isomer .	T12	T31	7824160
NA	CHEMICAL	GENE-Y	11	2	At the gene receptor , both chemical were equipotent at stimulating chemical hydrolysis , with the chemical being more efficacious at the gene receptor compared with the R ( - ) isomer .	T13	T30	7824160
NA	CHEMICAL	GENE-Y	11	22	At the gene receptor , both chemical were equipotent at stimulating chemical hydrolysis , with the chemical being more efficacious at the gene receptor compared with the R ( - ) isomer .	T13	T31	7824160
NA	CHEMICAL	GENE-Y	16	2	At the gene receptor , both chemical were equipotent at stimulating chemical hydrolysis , with the chemical being more efficacious at the gene receptor compared with the R ( - ) isomer .	T14	T30	7824160
NA	CHEMICAL	GENE-Y	16	22	At the gene receptor , both chemical were equipotent at stimulating chemical hydrolysis , with the chemical being more efficacious at the gene receptor compared with the R ( - ) isomer .	T14	T31	7824160
NA	CHEMICAL	GENE-Y	17	6	In all cases at both the gene and gene receptors , the affinities of the isomers of chemical and chemical were at least 2-3 orders of magnitude less than chemical .	T17	T32	7824160
NA	CHEMICAL	GENE-Y	17	8	In all cases at both the gene and gene receptors , the affinities of the isomers of chemical and chemical were at least 2-3 orders of magnitude less than chemical .	T17	T33	7824160
NA	CHEMICAL	GENE-Y	19	6	In all cases at both the gene and gene receptors , the affinities of the isomers of chemical and chemical were at least 2-3 orders of magnitude less than chemical .	T18	T32	7824160
NA	CHEMICAL	GENE-Y	19	8	In all cases at both the gene and gene receptors , the affinities of the isomers of chemical and chemical were at least 2-3 orders of magnitude less than chemical .	T18	T33	7824160
NA	CHEMICAL	GENE-Y	29	6	In all cases at both the gene and gene receptors , the affinities of the isomers of chemical and chemical were at least 2-3 orders of magnitude less than chemical .	T19	T32	7824160
NA	CHEMICAL	GENE-Y	29	8	In all cases at both the gene and gene receptors , the affinities of the isomers of chemical and chemical were at least 2-3 orders of magnitude less than chemical .	T19	T33	7824160
NA	CHEMICAL	GENE-N	3	10	Influence of the chemical D2 receptor ( DRD2 ) exon 8 genotype on efficacy of chemical and clinical outcome of chemical withdrawal .	T8	T17	11692072
NA	CHEMICAL	GENE-N	15	10	Influence of the chemical D2 receptor ( DRD2 ) exon 8 genotype on efficacy of chemical and clinical outcome of chemical withdrawal .	T9	T17	11692072
NA	CHEMICAL	GENE-N	20	10	Influence of the chemical D2 receptor ( DRD2 ) exon 8 genotype on efficacy of chemical and clinical outcome of chemical withdrawal .	T7	T17	11692072
NA	CHEMICAL	GENE-N	15	9	We tested the hypothesis that allelic variants of the gene genotype are associated with ( i ) chemical D2 antagonist tiapride dose in treatment of chemical withdrawal ( n = 50 ) and ( ii ) with anxiety and depression in patients during alcoholism detoxification therapy ( admission n = 87 ; discharge n = 50 ) .	T4	T12	11692072
NA	CHEMICAL	GENE-Y	15	18	We tested the hypothesis that allelic variants of the gene genotype are associated with ( i ) chemical D2 antagonist tiapride dose in treatment of chemical withdrawal ( n = 50 ) and ( ii ) with anxiety and depression in patients during alcoholism detoxification therapy ( admission n = 87 ; discharge n = 50 ) .	T4	T10	11692072
NA	CHEMICAL	GENE-N	9	9	We tested the hypothesis that allelic variants of the gene genotype are associated with ( i ) chemical D2 antagonist tiapride dose in treatment of chemical withdrawal ( n = 50 ) and ( ii ) with anxiety and depression in patients during alcoholism detoxification therapy ( admission n = 87 ; discharge n = 50 ) .	T1	T12	11692072
NA	CHEMICAL	GENE-Y	9	18	We tested the hypothesis that allelic variants of the gene genotype are associated with ( i ) chemical D2 antagonist tiapride dose in treatment of chemical withdrawal ( n = 50 ) and ( ii ) with anxiety and depression in patients during alcoholism detoxification therapy ( admission n = 87 ; discharge n = 50 ) .	T1	T10	11692072
NA	CHEMICAL	GENE-N	25	9	We tested the hypothesis that allelic variants of the gene genotype are associated with ( i ) chemical D2 antagonist tiapride dose in treatment of chemical withdrawal ( n = 50 ) and ( ii ) with anxiety and depression in patients during alcoholism detoxification therapy ( admission n = 87 ; discharge n = 50 ) .	T2	T12	11692072
NA	CHEMICAL	GENE-Y	25	18	We tested the hypothesis that allelic variants of the gene genotype are associated with ( i ) chemical D2 antagonist tiapride dose in treatment of chemical withdrawal ( n = 50 ) and ( ii ) with anxiety and depression in patients during alcoholism detoxification therapy ( admission n = 87 ; discharge n = 50 ) .	T2	T10	11692072
NA	CHEMICAL	GENE-N	9	0	gene A/A genotype was associated with increased dose of chemical during a 9-day detoxification therapy and with increased anxiety and depression scores on admission and 2 weeks later .	T3	T11	11692072
NA	CHEMICAL	GENE-Y	16	5	In an earlier report , gene E8 A/A genotype was associated with reduced responsiveness to the chemical D2 agonist chemical ; however , it is not clear whether both findings share the same biological basis .	T5	T14	11692072
NA	CHEMICAL	GENE-Y	16	17	In an earlier report , gene E8 A/A genotype was associated with reduced responsiveness to the chemical D2 agonist chemical ; however , it is not clear whether both findings share the same biological basis .	T5	T15	11692072
NA	CHEMICAL	GENE-Y	19	5	In an earlier report , gene E8 A/A genotype was associated with reduced responsiveness to the chemical D2 agonist chemical ; however , it is not clear whether both findings share the same biological basis .	T6	T14	11692072
CPR:5	CHEMICAL	GENE-Y	19	17	In an earlier report , gene E8 A/A genotype was associated with reduced responsiveness to the chemical D2 agonist chemical ; however , it is not clear whether both findings share the same biological basis .	T6	T15	11692072
NA	CHEMICAL	GENE-Y	6	7	Recent studies highlight the capacity of chemical to bind gene ( gene ) and deliver it in high concentration to the ulcer .	T2	T7	7948825
NA	CHEMICAL	GENE-Y	6	11	Recent studies highlight the capacity of chemical to bind gene ( gene ) and deliver it in high concentration to the ulcer .	T2	T8	7948825
NA	CHEMICAL	GENE-N	4	9	A PET study of chemical D2 and chemical 5-HT2 receptor occupancy in patients with schizophrenia treated with therapeutic doses of chemical .	T21	T34	15121646
NA	CHEMICAL	GENE-N	7	9	A PET study of chemical D2 and chemical 5-HT2 receptor occupancy in patients with schizophrenia treated with therapeutic doses of chemical .	T22	T34	15121646
NA	CHEMICAL	GENE-N	20	9	A PET study of chemical D2 and chemical 5-HT2 receptor occupancy in patients with schizophrenia treated with therapeutic doses of chemical .	T20	T34	15121646
NA	CHEMICAL	GENE-Y	2	19	OBJECTIVE : chemical is an atypical antipsychotic drug that shows a higher affinity for chemical chemical ( 2 ) receptors compared with chemical D ( 2 ) receptors in vitro .	T2	T23	15121646
NA	CHEMICAL	GENE-Y	2	19	OBJECTIVE : chemical is an atypical antipsychotic drug that shows a higher affinity for chemical chemical ( 2 ) receptors compared with chemical D ( 2 ) receptors in vitro .	T2	T28	15121646
NA	CHEMICAL	GENE-Y	14	19	OBJECTIVE : chemical is an atypical antipsychotic drug that shows a higher affinity for chemical chemical ( 2 ) receptors compared with chemical D ( 2 ) receptors in vitro .	T18	T23	15121646
NA	CHEMICAL	GENE-Y	14	19	OBJECTIVE : chemical is an atypical antipsychotic drug that shows a higher affinity for chemical chemical ( 2 ) receptors compared with chemical D ( 2 ) receptors in vitro .	T18	T28	15121646
NA	CHEMICAL	GENE-Y	14	19	OBJECTIVE : chemical is an atypical antipsychotic drug that shows a higher affinity for chemical chemical ( 2 ) receptors compared with chemical D ( 2 ) receptors in vitro .	T1	T23	15121646
NA	CHEMICAL	GENE-Y	14	19	OBJECTIVE : chemical is an atypical antipsychotic drug that shows a higher affinity for chemical chemical ( 2 ) receptors compared with chemical D ( 2 ) receptors in vitro .	T1	T28	15121646
NA	CHEMICAL	GENE-Y	10	19	OBJECTIVE : chemical is an atypical antipsychotic drug that shows a higher affinity for chemical chemical ( 2 ) receptors compared with chemical D ( 2 ) receptors in vitro .	T5	T23	15121646
NA	CHEMICAL	GENE-Y	10	19	OBJECTIVE : chemical is an atypical antipsychotic drug that shows a higher affinity for chemical chemical ( 2 ) receptors compared with chemical D ( 2 ) receptors in vitro .	T5	T28	15121646
NA	CHEMICAL	GENE-Y	5	10	METHOD : The authors conducted a PET study to evaluate gene occupancy ( using chemical ) and chemical ( 2 ) occupancy ( using chemical ) in brain regions of interest in 16 patients with schizophrenia or schizoaffective disorder randomly assigned to receive 40 , 80 , 120 , or 160 mg/day of chemical , which reflected the recommended dose range .	T13	T30	15121646
NA	CHEMICAL	GENE-Y	5	12	METHOD : The authors conducted a PET study to evaluate gene occupancy ( using chemical ) and chemical ( 2 ) occupancy ( using chemical ) in brain regions of interest in 16 patients with schizophrenia or schizoaffective disorder randomly assigned to receive 40 , 80 , 120 , or 160 mg/day of chemical , which reflected the recommended dose range .	T13	T31	15121646
NA	CHEMICAL	GENE-Y	17	10	METHOD : The authors conducted a PET study to evaluate gene occupancy ( using chemical ) and chemical ( 2 ) occupancy ( using chemical ) in brain regions of interest in 16 patients with schizophrenia or schizoaffective disorder randomly assigned to receive 40 , 80 , 120 , or 160 mg/day of chemical , which reflected the recommended dose range .	T14	T30	15121646
NA	CHEMICAL	GENE-Y	17	12	METHOD : The authors conducted a PET study to evaluate gene occupancy ( using chemical ) and chemical ( 2 ) occupancy ( using chemical ) in brain regions of interest in 16 patients with schizophrenia or schizoaffective disorder randomly assigned to receive 40 , 80 , 120 , or 160 mg/day of chemical , which reflected the recommended dose range .	T14	T31	15121646
NA	CHEMICAL	GENE-Y	8	10	METHOD : The authors conducted a PET study to evaluate gene occupancy ( using chemical ) and chemical ( 2 ) occupancy ( using chemical ) in brain regions of interest in 16 patients with schizophrenia or schizoaffective disorder randomly assigned to receive 40 , 80 , 120 , or 160 mg/day of chemical , which reflected the recommended dose range .	T15	T30	15121646
NA	CHEMICAL	GENE-Y	8	12	METHOD : The authors conducted a PET study to evaluate gene occupancy ( using chemical ) and chemical ( 2 ) occupancy ( using chemical ) in brain regions of interest in 16 patients with schizophrenia or schizoaffective disorder randomly assigned to receive 40 , 80 , 120 , or 160 mg/day of chemical , which reflected the recommended dose range .	T15	T31	15121646
NA	CHEMICAL	GENE-Y	5	10	METHOD : The authors conducted a PET study to evaluate gene occupancy ( using chemical ) and chemical ( 2 ) occupancy ( using chemical ) in brain regions of interest in 16 patients with schizophrenia or schizoaffective disorder randomly assigned to receive 40 , 80 , 120 , or 160 mg/day of chemical , which reflected the recommended dose range .	T16	T30	15121646
NA	CHEMICAL	GENE-Y	5	12	METHOD : The authors conducted a PET study to evaluate gene occupancy ( using chemical ) and chemical ( 2 ) occupancy ( using chemical ) in brain regions of interest in 16 patients with schizophrenia or schizoaffective disorder randomly assigned to receive 40 , 80 , 120 , or 160 mg/day of chemical , which reflected the recommended dose range .	T16	T31	15121646
NA	CHEMICAL	GENE-Y	4	5	RESULTS : The mean chemical ( 2 ) receptor occupancy was significantly higher than the mean gene occupancy ( mean=76 % , SD=15 % , and mean=56 % , SD=18 % , respectively ) .	T17	T32	15121646
NA	CHEMICAL	GENE-Y	4	8	RESULTS : The mean chemical ( 2 ) receptor occupancy was significantly higher than the mean gene occupancy ( mean=76 % , SD=15 % , and mean=56 % , SD=18 % , respectively ) .	T17	T33	15121646
NA	CHEMICAL	GENE-Y	3	10	The estimated plasma chemical concentration associated with 50 % maximal gene receptor occupancy was almost four times lower than that for gene occupancy .	T19	T24	15121646
NA	CHEMICAL	GENE-Y	3	11	The estimated plasma chemical concentration associated with 50 % maximal gene receptor occupancy was almost four times lower than that for gene occupancy .	T19	T25	15121646
NA	CHEMICAL	GENE-Y	6	16	CONCLUSIONS : These data affirm that chemical is similar to other novel antipsychotics in having greater gene than gene occupancy at therapeutic doses and suggest that the optimal effective dose of chemical is closer to 120 mg/day than to the lower doses suggested by previous PET studies .	T3	T26	15121646
NA	CHEMICAL	GENE-N	6	9	CONCLUSIONS : These data affirm that chemical is similar to other novel antipsychotics in having greater gene than gene occupancy at therapeutic doses and suggest that the optimal effective dose of chemical is closer to 120 mg/day than to the lower doses suggested by previous PET studies .	T3	T27	15121646
NA	CHEMICAL	GENE-Y	31	16	CONCLUSIONS : These data affirm that chemical is similar to other novel antipsychotics in having greater gene than gene occupancy at therapeutic doses and suggest that the optimal effective dose of chemical is closer to 120 mg/day than to the lower doses suggested by previous PET studies .	T4	T26	15121646
NA	CHEMICAL	GENE-N	31	9	CONCLUSIONS : These data affirm that chemical is similar to other novel antipsychotics in having greater gene than gene occupancy at therapeutic doses and suggest that the optimal effective dose of chemical is closer to 120 mg/day than to the lower doses suggested by previous PET studies .	T4	T27	15121646
NA	CHEMICAL	GENE-Y	14	3	The relatively high gene occupancy , even at trough plasma levels , suggests that chemical is more similar to chemical and olanzapine in receptor occupancy profile than to chemical and chemical .	T6	T29	15121646
NA	CHEMICAL	GENE-Y	15	3	The relatively high gene occupancy , even at trough plasma levels , suggests that chemical is more similar to chemical and olanzapine in receptor occupancy profile than to chemical and chemical .	T7	T29	15121646
NA	CHEMICAL	GENE-Y	22	3	The relatively high gene occupancy , even at trough plasma levels , suggests that chemical is more similar to chemical and olanzapine in receptor occupancy profile than to chemical and chemical .	T8	T29	15121646
NA	CHEMICAL	GENE-Y	22	3	The relatively high gene occupancy , even at trough plasma levels , suggests that chemical is more similar to chemical and olanzapine in receptor occupancy profile than to chemical and chemical .	T9	T29	15121646
NA	CHEMICAL	GENE-Y	2	6	Lutein and chemical interact to modify gene mRNA levels through the gene/gene pathway in chickens and HD11 cell lines .	T9	T32	16702329
NA	CHEMICAL	GENE-Y	2	11	Lutein and chemical interact to modify gene mRNA levels through the gene/gene pathway in chickens and HD11 cell lines .	T9	T33	16702329
NA	CHEMICAL	GENE-N	2	11	Lutein and chemical interact to modify gene mRNA levels through the gene/gene pathway in chickens and HD11 cell lines .	T9	T34	16702329
NA	CHEMICAL	GENE-Y	13	19	Two experiments were conducted to investigate the effect of lutein and fat or chemical ( chemical ) interaction on gene ( gene ) , gene , and chemical X receptor ( RXR ) alpha and gamma mRNA levels .	T8	T14	16702329
NA	CHEMICAL	GENE-Y	13	21	Two experiments were conducted to investigate the effect of lutein and fat or chemical ( chemical ) interaction on gene ( gene ) , gene , and chemical X receptor ( RXR ) alpha and gamma mRNA levels .	T8	T21	16702329
NA	CHEMICAL	GENE-N	13	24	Two experiments were conducted to investigate the effect of lutein and fat or chemical ( chemical ) interaction on gene ( gene ) , gene , and chemical X receptor ( RXR ) alpha and gamma mRNA levels .	T8	T23	16702329
NA	CHEMICAL	GENE-N	13	35	Two experiments were conducted to investigate the effect of lutein and fat or chemical ( chemical ) interaction on gene ( gene ) , gene , and chemical X receptor ( RXR ) alpha and gamma mRNA levels .	T8	T27	16702329
NA	CHEMICAL	GENE-Y	15	19	Two experiments were conducted to investigate the effect of lutein and fat or chemical ( chemical ) interaction on gene ( gene ) , gene , and chemical X receptor ( RXR ) alpha and gamma mRNA levels .	T1	T14	16702329
NA	CHEMICAL	GENE-Y	15	21	Two experiments were conducted to investigate the effect of lutein and fat or chemical ( chemical ) interaction on gene ( gene ) , gene , and chemical X receptor ( RXR ) alpha and gamma mRNA levels .	T1	T21	16702329
NA	CHEMICAL	GENE-N	15	24	Two experiments were conducted to investigate the effect of lutein and fat or chemical ( chemical ) interaction on gene ( gene ) , gene , and chemical X receptor ( RXR ) alpha and gamma mRNA levels .	T1	T23	16702329
NA	CHEMICAL	GENE-N	15	35	Two experiments were conducted to investigate the effect of lutein and fat or chemical ( chemical ) interaction on gene ( gene ) , gene , and chemical X receptor ( RXR ) alpha and gamma mRNA levels .	T1	T27	16702329
NA	CHEMICAL	GENE-Y	21	19	Two experiments were conducted to investigate the effect of lutein and fat or chemical ( chemical ) interaction on gene ( gene ) , gene , and chemical X receptor ( RXR ) alpha and gamma mRNA levels .	T2	T14	16702329
NA	CHEMICAL	GENE-Y	21	21	Two experiments were conducted to investigate the effect of lutein and fat or chemical ( chemical ) interaction on gene ( gene ) , gene , and chemical X receptor ( RXR ) alpha and gamma mRNA levels .	T2	T21	16702329
NA	CHEMICAL	GENE-N	21	24	Two experiments were conducted to investigate the effect of lutein and fat or chemical ( chemical ) interaction on gene ( gene ) , gene , and chemical X receptor ( RXR ) alpha and gamma mRNA levels .	T2	T23	16702329
NA	CHEMICAL	GENE-N	21	35	Two experiments were conducted to investigate the effect of lutein and fat or chemical ( chemical ) interaction on gene ( gene ) , gene , and chemical X receptor ( RXR ) alpha and gamma mRNA levels .	T2	T27	16702329
NA	CHEMICAL	GENE-Y	27	19	Two experiments were conducted to investigate the effect of lutein and fat or chemical ( chemical ) interaction on gene ( gene ) , gene , and chemical X receptor ( RXR ) alpha and gamma mRNA levels .	T5	T14	16702329
NA	CHEMICAL	GENE-Y	27	21	Two experiments were conducted to investigate the effect of lutein and fat or chemical ( chemical ) interaction on gene ( gene ) , gene , and chemical X receptor ( RXR ) alpha and gamma mRNA levels .	T5	T21	16702329
NA	CHEMICAL	GENE-N	27	24	Two experiments were conducted to investigate the effect of lutein and fat or chemical ( chemical ) interaction on gene ( gene ) , gene , and chemical X receptor ( RXR ) alpha and gamma mRNA levels .	T5	T23	16702329
NA	CHEMICAL	GENE-N	27	35	Two experiments were conducted to investigate the effect of lutein and fat or chemical ( chemical ) interaction on gene ( gene ) , gene , and chemical X receptor ( RXR ) alpha and gamma mRNA levels .	T5	T27	16702329
CPR:6	CHEMICAL	GENE-Y	0	2	chemical , a gene antagonist , prevented ( P < 0.01 ) the lutein-induced gene mRNA downregulation in HD11 cells .	T3	T17	16702329
CPR:3	CHEMICAL	GENE-Y	0	14	chemical , a gene antagonist , prevented ( P < 0.01 ) the lutein-induced gene mRNA downregulation in HD11 cells .	T3	T18	16702329
NA	CHEMICAL	GENE-N	2	3	A novel chemical kinase switch is a mechanism of chemical resistance in gastrointestinal stromal tumors .	T18	T40	17325667
NA	CHEMICAL	GENE-N	6	3	A novel chemical kinase switch is a mechanism of chemical resistance in gastrointestinal stromal tumors .	T17	T40	17325667
CPR:4	CHEMICAL	GENE-Y	13	19	Gene expression profiling ( GEP ) of GIST-S , GIST-R cells and two chemical resistant GIST patients demonstrated that gene is downregulated implying a major role in chemical resistance .	T11	T29	17325667
CPR:4	CHEMICAL	GENE-Y	27	19	Gene expression profiling ( GEP ) of GIST-S , GIST-R cells and two chemical resistant GIST patients demonstrated that gene is downregulated implying a major role in chemical resistance .	T12	T29	17325667
NA	CHEMICAL	GENE-N	6	11	Instead , GIST-R cells have acquired chemical resistance by overexpressing the gene - gene - in a 'gene switch ' .	T13	T31	17325667
NA	CHEMICAL	GENE-Y	6	13	Instead , GIST-R cells have acquired chemical resistance by overexpressing the gene - gene - in a 'gene switch ' .	T13	T32	17325667
NA	CHEMICAL	GENE-N	6	15	Instead , GIST-R cells have acquired chemical resistance by overexpressing the gene - gene - in a 'gene switch ' .	T13	T33	17325667
NA	CHEMICAL	GENE-N	15	11	Instead , GIST-R cells have acquired chemical resistance by overexpressing the gene - gene - in a 'gene switch ' .	T14	T31	17325667
NA	CHEMICAL	GENE-Y	15	13	Instead , GIST-R cells have acquired chemical resistance by overexpressing the gene - gene - in a 'gene switch ' .	T14	T32	17325667
NA	CHEMICAL	GENE-N	15	15	Instead , GIST-R cells have acquired chemical resistance by overexpressing the gene - gene - in a 'gene switch ' .	T14	T33	17325667
NA	CHEMICAL	GENE-Y	4	9	Further , the two chemical resistant GIST patients express gene and not gene , seen by immunohistochemistry ( IHC ) .	T15	T34	17325667
NA	CHEMICAL	GENE-Y	4	12	Further , the two chemical resistant GIST patients express gene and not gene , seen by immunohistochemistry ( IHC ) .	T15	T36	17325667
NA	CHEMICAL	GENE-Y	5	3	In GIST-R , gene is chemical phosphorylated and its ligand gene is overexpressed implying autocrine activation .	T16	T39	17325667
NA	CHEMICAL	GENE-Y	5	10	In GIST-R , gene is chemical phosphorylated and its ligand gene is overexpressed implying autocrine activation .	T16	T20	17325667
NA	CHEMICAL	GENE-N	17	4	Molecular modeling of the gene of mutant gene ( gene ) and gene showed no binding to chemical but efficient binding to chemical , a novel gene/gene gene inhibitor .	T1	T22	17325667
NA	CHEMICAL	GENE-Y	17	7	Molecular modeling of the gene of mutant gene ( gene ) and gene showed no binding to chemical but efficient binding to chemical , a novel gene/gene gene inhibitor .	T1	T23	17325667
NA	CHEMICAL	GENE-N	17	9	Molecular modeling of the gene of mutant gene ( gene ) and gene showed no binding to chemical but efficient binding to chemical , a novel gene/gene gene inhibitor .	T1	T24	17325667
NA	CHEMICAL	GENE-Y	17	12	Molecular modeling of the gene of mutant gene ( gene ) and gene showed no binding to chemical but efficient binding to chemical , a novel gene/gene gene inhibitor .	T1	T25	17325667
NA	CHEMICAL	GENE-Y	17	26	Molecular modeling of the gene of mutant gene ( gene ) and gene showed no binding to chemical but efficient binding to chemical , a novel gene/gene gene inhibitor .	T1	T26	17325667
NA	CHEMICAL	GENE-Y	17	26	Molecular modeling of the gene of mutant gene ( gene ) and gene showed no binding to chemical but efficient binding to chemical , a novel gene/gene gene inhibitor .	T1	T27	17325667
NA	CHEMICAL	GENE-N	17	24	Molecular modeling of the gene of mutant gene ( gene ) and gene showed no binding to chemical but efficient binding to chemical , a novel gene/gene gene inhibitor .	T1	T28	17325667
NA	CHEMICAL	GENE-N	4	4	Molecular modeling of the gene of mutant gene ( gene ) and gene showed no binding to chemical but efficient binding to chemical , a novel gene/gene gene inhibitor .	T2	T22	17325667
NA	CHEMICAL	GENE-Y	4	7	Molecular modeling of the gene of mutant gene ( gene ) and gene showed no binding to chemical but efficient binding to chemical , a novel gene/gene gene inhibitor .	T2	T23	17325667
NA	CHEMICAL	GENE-N	4	9	Molecular modeling of the gene of mutant gene ( gene ) and gene showed no binding to chemical but efficient binding to chemical , a novel gene/gene gene inhibitor .	T2	T24	17325667
NA	CHEMICAL	GENE-Y	4	12	Molecular modeling of the gene of mutant gene ( gene ) and gene showed no binding to chemical but efficient binding to chemical , a novel gene/gene gene inhibitor .	T2	T25	17325667
CPR:4	CHEMICAL	GENE-Y	4	26	Molecular modeling of the gene of mutant gene ( gene ) and gene showed no binding to chemical but efficient binding to chemical , a novel gene/gene gene inhibitor .	T2	T26	17325667
CPR:4	CHEMICAL	GENE-Y	4	26	Molecular modeling of the gene of mutant gene ( gene ) and gene showed no binding to chemical but efficient binding to chemical , a novel gene/gene gene inhibitor .	T2	T27	17325667
CPR:4	CHEMICAL	GENE-N	4	24	Molecular modeling of the gene of mutant gene ( gene ) and gene showed no binding to chemical but efficient binding to chemical , a novel gene/gene gene inhibitor .	T2	T28	17325667
NA	CHEMICAL	GENE-Y	14	8	The IC50-values obtained for the inhibition of lipopolysaccharide ( LPS ) -induced release of chemical ( chemical ) reflecting gene-mediated chemical release were 47 microg/ml and 0.6 microg/ml , for the Salix extract 1520L and chemical-like research compound chemical , respectively .	T4	T13	15070163
NA	CHEMICAL	GENE-Y	16	8	The IC50-values obtained for the inhibition of lipopolysaccharide ( LPS ) -induced release of chemical ( chemical ) reflecting gene-mediated chemical release were 47 microg/ml and 0.6 microg/ml , for the Salix extract 1520L and chemical-like research compound chemical , respectively .	T5	T13	15070163
CPR:9	CHEMICAL	GENE-Y	20	8	The IC50-values obtained for the inhibition of lipopolysaccharide ( LPS ) -induced release of chemical ( chemical ) reflecting gene-mediated chemical release were 47 microg/ml and 0.6 microg/ml , for the Salix extract 1520L and chemical-like research compound chemical , respectively .	T6	T13	15070163
NA	CHEMICAL	GENE-Y	6	8	The IC50-values obtained for the inhibition of lipopolysaccharide ( LPS ) -induced release of chemical ( chemical ) reflecting gene-mediated chemical release were 47 microg/ml and 0.6 microg/ml , for the Salix extract 1520L and chemical-like research compound chemical , respectively .	T7	T13	15070163
NA	CHEMICAL	GENE-Y	38	8	The IC50-values obtained for the inhibition of lipopolysaccharide ( LPS ) -induced release of chemical ( chemical ) reflecting gene-mediated chemical release were 47 microg/ml and 0.6 microg/ml , for the Salix extract 1520L and chemical-like research compound chemical , respectively .	T8	T13	15070163
CPR:9	CHEMICAL	GENE-Y	8	8	Our results indicate that Salix extract 1520L inhibits gene-mediated chemical release through compounds other than chemical or chemical .	T1	T11	15070163
NA	CHEMICAL	GENE-Y	15	8	Our results indicate that Salix extract 1520L inhibits gene-mediated chemical release through compounds other than chemical or chemical .	T2	T11	15070163
NA	CHEMICAL	GENE-Y	17	8	Our results indicate that Salix extract 1520L inhibits gene-mediated chemical release through compounds other than chemical or chemical .	T3	T11	15070163
CPR:5	CHEMICAL	GENE-Y	0	1	chemical ( chemical ) and its prodrug chemical ( chemical ) are highly potent gene agonists often used in asthma patients .	T1	T22	20012638
CPR:5	CHEMICAL	GENE-Y	2	1	chemical ( chemical ) and its prodrug chemical ( chemical ) are highly potent gene agonists often used in asthma patients .	T6	T22	20012638
CPR:5	CHEMICAL	GENE-Y	7	1	chemical ( chemical ) and its prodrug chemical ( chemical ) are highly potent gene agonists often used in asthma patients .	T11	T22	20012638
CPR:5	CHEMICAL	GENE-Y	9	1	chemical ( chemical ) and its prodrug chemical ( chemical ) are highly potent gene agonists often used in asthma patients .	T13	T22	20012638
CPR:4	CHEMICAL	GENE-N	3	10	The anti-inflammatory drugs chemical and chemical inhibited the activation of gene , which further explains the mechanism of action of these drugs .	T1	T9	8052854
CPR:4	CHEMICAL	GENE-N	5	10	The anti-inflammatory drugs chemical and chemical inhibited the activation of gene , which further explains the mechanism of action of these drugs .	T2	T9	8052854
NA	CHEMICAL	GENE-N	16	18	At the end of the 2-h reperfusion , western blot analysis of the cardioprotective transcription factors gene , gene , gene and gene , the inflammatory mediator gene ( gene ) , the pro-apoptotic factors gene and gene ( pJchemicalK ) , the anti-apoptotic protein gene , as well as of the cardioprotective enzyme gene ( gene ) , was performed in the left ventricle and spleen .	T5	T48	23535516
NA	CHEMICAL	GENE-Y	16	20	At the end of the 2-h reperfusion , western blot analysis of the cardioprotective transcription factors gene , gene , gene and gene , the inflammatory mediator gene ( gene ) , the pro-apoptotic factors gene and gene ( pJchemicalK ) , the anti-apoptotic protein gene , as well as of the cardioprotective enzyme gene ( gene ) , was performed in the left ventricle and spleen .	T5	T49	23535516
NA	CHEMICAL	GENE-Y	16	22	At the end of the 2-h reperfusion , western blot analysis of the cardioprotective transcription factors gene , gene , gene and gene , the inflammatory mediator gene ( gene ) , the pro-apoptotic factors gene and gene ( pJchemicalK ) , the anti-apoptotic protein gene , as well as of the cardioprotective enzyme gene ( gene ) , was performed in the left ventricle and spleen .	T5	T50	23535516
NA	CHEMICAL	GENE-Y	16	27	At the end of the 2-h reperfusion , western blot analysis of the cardioprotective transcription factors gene , gene , gene and gene , the inflammatory mediator gene ( gene ) , the pro-apoptotic factors gene and gene ( pJchemicalK ) , the anti-apoptotic protein gene , as well as of the cardioprotective enzyme gene ( gene ) , was performed in the left ventricle and spleen .	T5	T52	23535516
NA	CHEMICAL	GENE-Y	16	29	At the end of the 2-h reperfusion , western blot analysis of the cardioprotective transcription factors gene , gene , gene and gene , the inflammatory mediator gene ( gene ) , the pro-apoptotic factors gene and gene ( pJchemicalK ) , the anti-apoptotic protein gene , as well as of the cardioprotective enzyme gene ( gene ) , was performed in the left ventricle and spleen .	T5	T53	23535516
NA	CHEMICAL	GENE-Y	16	35	At the end of the 2-h reperfusion , western blot analysis of the cardioprotective transcription factors gene , gene , gene and gene , the inflammatory mediator gene ( gene ) , the pro-apoptotic factors gene and gene ( pJchemicalK ) , the anti-apoptotic protein gene , as well as of the cardioprotective enzyme gene ( gene ) , was performed in the left ventricle and spleen .	T5	T54	23535516
NA	CHEMICAL	GENE-N	16	37	At the end of the 2-h reperfusion , western blot analysis of the cardioprotective transcription factors gene , gene , gene and gene , the inflammatory mediator gene ( gene ) , the pro-apoptotic factors gene and gene ( pJchemicalK ) , the anti-apoptotic protein gene , as well as of the cardioprotective enzyme gene ( gene ) , was performed in the left ventricle and spleen .	T5	T55	23535516
NA	CHEMICAL	GENE-N	16	39	At the end of the 2-h reperfusion , western blot analysis of the cardioprotective transcription factors gene , gene , gene and gene , the inflammatory mediator gene ( gene ) , the pro-apoptotic factors gene and gene ( pJchemicalK ) , the anti-apoptotic protein gene , as well as of the cardioprotective enzyme gene ( gene ) , was performed in the left ventricle and spleen .	T5	T56	23535516
NA	CHEMICAL	GENE-Y	16	45	At the end of the 2-h reperfusion , western blot analysis of the cardioprotective transcription factors gene , gene , gene and gene , the inflammatory mediator gene ( gene ) , the pro-apoptotic factors gene and gene ( pJchemicalK ) , the anti-apoptotic protein gene , as well as of the cardioprotective enzyme gene ( gene ) , was performed in the left ventricle and spleen .	T5	T57	23535516
NA	CHEMICAL	GENE-Y	16	47	At the end of the 2-h reperfusion , western blot analysis of the cardioprotective transcription factors gene , gene , gene and gene , the inflammatory mediator gene ( gene ) , the pro-apoptotic factors gene and gene ( pJchemicalK ) , the anti-apoptotic protein gene , as well as of the cardioprotective enzyme gene ( gene ) , was performed in the left ventricle and spleen .	T5	T58	23535516
NA	CHEMICAL	GENE-Y	16	56	At the end of the 2-h reperfusion , western blot analysis of the cardioprotective transcription factors gene , gene , gene and gene , the inflammatory mediator gene ( gene ) , the pro-apoptotic factors gene and gene ( pJchemicalK ) , the anti-apoptotic protein gene , as well as of the cardioprotective enzyme gene ( gene ) , was performed in the left ventricle and spleen .	T5	T59	23535516
NA	CHEMICAL	GENE-Y	13	10	Intravenous treatment , during coronary artery occlusion , with the gene analogs [ chemical ( 4 ) , chemical ( 7 ) ] gene ( NDP-gene ) and gene [ gene ] , induced a left ventricle up-regulation of gene , gene and gene ( gene-dependent ) , and a reduction in gene and gene levels ; these effects of NDP-gene and gene were associated with over-expression of the pro-survival proteins gene and gene , and marked decrease of the myocardial infarct size .	T1	T6	23535516
NA	CHEMICAL	GENE-Y	13	23	Intravenous treatment , during coronary artery occlusion , with the gene analogs [ chemical ( 4 ) , chemical ( 7 ) ] gene ( NDP-gene ) and gene [ gene ] , induced a left ventricle up-regulation of gene , gene and gene ( gene-dependent ) , and a reduction in gene and gene levels ; these effects of NDP-gene and gene were associated with over-expression of the pro-survival proteins gene and gene , and marked decrease of the myocardial infarct size .	T1	T7	23535516
NA	CHEMICAL	GENE-Y	13	25	Intravenous treatment , during coronary artery occlusion , with the gene analogs [ chemical ( 4 ) , chemical ( 7 ) ] gene ( NDP-gene ) and gene [ gene ] , induced a left ventricle up-regulation of gene , gene and gene ( gene-dependent ) , and a reduction in gene and gene levels ; these effects of NDP-gene and gene were associated with over-expression of the pro-survival proteins gene and gene , and marked decrease of the myocardial infarct size .	T1	T8	23535516
NA	CHEMICAL	GENE-Y	13	15	Intravenous treatment , during coronary artery occlusion , with the gene analogs [ chemical ( 4 ) , chemical ( 7 ) ] gene ( NDP-gene ) and gene [ gene ] , induced a left ventricle up-regulation of gene , gene and gene ( gene-dependent ) , and a reduction in gene and gene levels ; these effects of NDP-gene and gene were associated with over-expression of the pro-survival proteins gene and gene , and marked decrease of the myocardial infarct size .	T1	T9	23535516
NA	CHEMICAL	GENE-Y	13	14	Intravenous treatment , during coronary artery occlusion , with the gene analogs [ chemical ( 4 ) , chemical ( 7 ) ] gene ( NDP-gene ) and gene [ gene ] , induced a left ventricle up-regulation of gene , gene and gene ( gene-dependent ) , and a reduction in gene and gene levels ; these effects of NDP-gene and gene were associated with over-expression of the pro-survival proteins gene and gene , and marked decrease of the myocardial infarct size .	T1	T10	23535516
NA	CHEMICAL	GENE-Y	13	39	Intravenous treatment , during coronary artery occlusion , with the gene analogs [ chemical ( 4 ) , chemical ( 7 ) ] gene ( NDP-gene ) and gene [ gene ] , induced a left ventricle up-regulation of gene , gene and gene ( gene-dependent ) , and a reduction in gene and gene levels ; these effects of NDP-gene and gene were associated with over-expression of the pro-survival proteins gene and gene , and marked decrease of the myocardial infarct size .	T1	T11	23535516
NA	CHEMICAL	GENE-N	13	41	Intravenous treatment , during coronary artery occlusion , with the gene analogs [ chemical ( 4 ) , chemical ( 7 ) ] gene ( NDP-gene ) and gene [ gene ] , induced a left ventricle up-regulation of gene , gene and gene ( gene-dependent ) , and a reduction in gene and gene levels ; these effects of NDP-gene and gene were associated with over-expression of the pro-survival proteins gene and gene , and marked decrease of the myocardial infarct size .	T1	T12	23535516
NA	CHEMICAL	GENE-Y	13	43	Intravenous treatment , during coronary artery occlusion , with the gene analogs [ chemical ( 4 ) , chemical ( 7 ) ] gene ( NDP-gene ) and gene [ gene ] , induced a left ventricle up-regulation of gene , gene and gene ( gene-dependent ) , and a reduction in gene and gene levels ; these effects of NDP-gene and gene were associated with over-expression of the pro-survival proteins gene and gene , and marked decrease of the myocardial infarct size .	T1	T14	23535516
NA	CHEMICAL	GENE-N	13	45	Intravenous treatment , during coronary artery occlusion , with the gene analogs [ chemical ( 4 ) , chemical ( 7 ) ] gene ( NDP-gene ) and gene [ gene ] , induced a left ventricle up-regulation of gene , gene and gene ( gene-dependent ) , and a reduction in gene and gene levels ; these effects of NDP-gene and gene were associated with over-expression of the pro-survival proteins gene and gene , and marked decrease of the myocardial infarct size .	T1	T15	23535516
NA	CHEMICAL	GENE-N	13	52	Intravenous treatment , during coronary artery occlusion , with the gene analogs [ chemical ( 4 ) , chemical ( 7 ) ] gene ( NDP-gene ) and gene [ gene ] , induced a left ventricle up-regulation of gene , gene and gene ( gene-dependent ) , and a reduction in gene and gene levels ; these effects of NDP-gene and gene were associated with over-expression of the pro-survival proteins gene and gene , and marked decrease of the myocardial infarct size .	T1	T16	23535516
NA	CHEMICAL	GENE-Y	13	54	Intravenous treatment , during coronary artery occlusion , with the gene analogs [ chemical ( 4 ) , chemical ( 7 ) ] gene ( NDP-gene ) and gene [ gene ] , induced a left ventricle up-regulation of gene , gene and gene ( gene-dependent ) , and a reduction in gene and gene levels ; these effects of NDP-gene and gene were associated with over-expression of the pro-survival proteins gene and gene , and marked decrease of the myocardial infarct size .	T1	T17	23535516
NA	CHEMICAL	GENE-Y	13	60	Intravenous treatment , during coronary artery occlusion , with the gene analogs [ chemical ( 4 ) , chemical ( 7 ) ] gene ( NDP-gene ) and gene [ gene ] , induced a left ventricle up-regulation of gene , gene and gene ( gene-dependent ) , and a reduction in gene and gene levels ; these effects of NDP-gene and gene were associated with over-expression of the pro-survival proteins gene and gene , and marked decrease of the myocardial infarct size .	T1	T18	23535516
NA	CHEMICAL	GENE-Y	13	14	Intravenous treatment , during coronary artery occlusion , with the gene analogs [ chemical ( 4 ) , chemical ( 7 ) ] gene ( NDP-gene ) and gene [ gene ] , induced a left ventricle up-regulation of gene , gene and gene ( gene-dependent ) , and a reduction in gene and gene levels ; these effects of NDP-gene and gene were associated with over-expression of the pro-survival proteins gene and gene , and marked decrease of the myocardial infarct size .	T1	T19	23535516
NA	CHEMICAL	GENE-Y	13	71	Intravenous treatment , during coronary artery occlusion , with the gene analogs [ chemical ( 4 ) , chemical ( 7 ) ] gene ( NDP-gene ) and gene [ gene ] , induced a left ventricle up-regulation of gene , gene and gene ( gene-dependent ) , and a reduction in gene and gene levels ; these effects of NDP-gene and gene were associated with over-expression of the pro-survival proteins gene and gene , and marked decrease of the myocardial infarct size .	T1	T20	23535516
NA	CHEMICAL	GENE-Y	13	73	Intravenous treatment , during coronary artery occlusion , with the gene analogs [ chemical ( 4 ) , chemical ( 7 ) ] gene ( NDP-gene ) and gene [ gene ] , induced a left ventricle up-regulation of gene , gene and gene ( gene-dependent ) , and a reduction in gene and gene levels ; these effects of NDP-gene and gene were associated with over-expression of the pro-survival proteins gene and gene , and marked decrease of the myocardial infarct size .	T1	T21	23535516
NA	CHEMICAL	GENE-Y	18	10	Intravenous treatment , during coronary artery occlusion , with the gene analogs [ chemical ( 4 ) , chemical ( 7 ) ] gene ( NDP-gene ) and gene [ gene ] , induced a left ventricle up-regulation of gene , gene and gene ( gene-dependent ) , and a reduction in gene and gene levels ; these effects of NDP-gene and gene were associated with over-expression of the pro-survival proteins gene and gene , and marked decrease of the myocardial infarct size .	T2	T6	23535516
NA	CHEMICAL	GENE-Y	18	23	Intravenous treatment , during coronary artery occlusion , with the gene analogs [ chemical ( 4 ) , chemical ( 7 ) ] gene ( NDP-gene ) and gene [ gene ] , induced a left ventricle up-regulation of gene , gene and gene ( gene-dependent ) , and a reduction in gene and gene levels ; these effects of NDP-gene and gene were associated with over-expression of the pro-survival proteins gene and gene , and marked decrease of the myocardial infarct size .	T2	T7	23535516
NA	CHEMICAL	GENE-Y	18	25	Intravenous treatment , during coronary artery occlusion , with the gene analogs [ chemical ( 4 ) , chemical ( 7 ) ] gene ( NDP-gene ) and gene [ gene ] , induced a left ventricle up-regulation of gene , gene and gene ( gene-dependent ) , and a reduction in gene and gene levels ; these effects of NDP-gene and gene were associated with over-expression of the pro-survival proteins gene and gene , and marked decrease of the myocardial infarct size .	T2	T8	23535516
NA	CHEMICAL	GENE-Y	18	15	Intravenous treatment , during coronary artery occlusion , with the gene analogs [ chemical ( 4 ) , chemical ( 7 ) ] gene ( NDP-gene ) and gene [ gene ] , induced a left ventricle up-regulation of gene , gene and gene ( gene-dependent ) , and a reduction in gene and gene levels ; these effects of NDP-gene and gene were associated with over-expression of the pro-survival proteins gene and gene , and marked decrease of the myocardial infarct size .	T2	T9	23535516
NA	CHEMICAL	GENE-Y	18	14	Intravenous treatment , during coronary artery occlusion , with the gene analogs [ chemical ( 4 ) , chemical ( 7 ) ] gene ( NDP-gene ) and gene [ gene ] , induced a left ventricle up-regulation of gene , gene and gene ( gene-dependent ) , and a reduction in gene and gene levels ; these effects of NDP-gene and gene were associated with over-expression of the pro-survival proteins gene and gene , and marked decrease of the myocardial infarct size .	T2	T10	23535516
NA	CHEMICAL	GENE-Y	18	39	Intravenous treatment , during coronary artery occlusion , with the gene analogs [ chemical ( 4 ) , chemical ( 7 ) ] gene ( NDP-gene ) and gene [ gene ] , induced a left ventricle up-regulation of gene , gene and gene ( gene-dependent ) , and a reduction in gene and gene levels ; these effects of NDP-gene and gene were associated with over-expression of the pro-survival proteins gene and gene , and marked decrease of the myocardial infarct size .	T2	T11	23535516
NA	CHEMICAL	GENE-N	18	41	Intravenous treatment , during coronary artery occlusion , with the gene analogs [ chemical ( 4 ) , chemical ( 7 ) ] gene ( NDP-gene ) and gene [ gene ] , induced a left ventricle up-regulation of gene , gene and gene ( gene-dependent ) , and a reduction in gene and gene levels ; these effects of NDP-gene and gene were associated with over-expression of the pro-survival proteins gene and gene , and marked decrease of the myocardial infarct size .	T2	T12	23535516
NA	CHEMICAL	GENE-Y	18	43	Intravenous treatment , during coronary artery occlusion , with the gene analogs [ chemical ( 4 ) , chemical ( 7 ) ] gene ( NDP-gene ) and gene [ gene ] , induced a left ventricle up-regulation of gene , gene and gene ( gene-dependent ) , and a reduction in gene and gene levels ; these effects of NDP-gene and gene were associated with over-expression of the pro-survival proteins gene and gene , and marked decrease of the myocardial infarct size .	T2	T14	23535516
NA	CHEMICAL	GENE-N	18	45	Intravenous treatment , during coronary artery occlusion , with the gene analogs [ chemical ( 4 ) , chemical ( 7 ) ] gene ( NDP-gene ) and gene [ gene ] , induced a left ventricle up-regulation of gene , gene and gene ( gene-dependent ) , and a reduction in gene and gene levels ; these effects of NDP-gene and gene were associated with over-expression of the pro-survival proteins gene and gene , and marked decrease of the myocardial infarct size .	T2	T15	23535516
NA	CHEMICAL	GENE-N	18	52	Intravenous treatment , during coronary artery occlusion , with the gene analogs [ chemical ( 4 ) , chemical ( 7 ) ] gene ( NDP-gene ) and gene [ gene ] , induced a left ventricle up-regulation of gene , gene and gene ( gene-dependent ) , and a reduction in gene and gene levels ; these effects of NDP-gene and gene were associated with over-expression of the pro-survival proteins gene and gene , and marked decrease of the myocardial infarct size .	T2	T16	23535516
NA	CHEMICAL	GENE-Y	18	54	Intravenous treatment , during coronary artery occlusion , with the gene analogs [ chemical ( 4 ) , chemical ( 7 ) ] gene ( NDP-gene ) and gene [ gene ] , induced a left ventricle up-regulation of gene , gene and gene ( gene-dependent ) , and a reduction in gene and gene levels ; these effects of NDP-gene and gene were associated with over-expression of the pro-survival proteins gene and gene , and marked decrease of the myocardial infarct size .	T2	T17	23535516
NA	CHEMICAL	GENE-Y	18	60	Intravenous treatment , during coronary artery occlusion , with the gene analogs [ chemical ( 4 ) , chemical ( 7 ) ] gene ( NDP-gene ) and gene [ gene ] , induced a left ventricle up-regulation of gene , gene and gene ( gene-dependent ) , and a reduction in gene and gene levels ; these effects of NDP-gene and gene were associated with over-expression of the pro-survival proteins gene and gene , and marked decrease of the myocardial infarct size .	T2	T18	23535516
NA	CHEMICAL	GENE-Y	18	14	Intravenous treatment , during coronary artery occlusion , with the gene analogs [ chemical ( 4 ) , chemical ( 7 ) ] gene ( NDP-gene ) and gene [ gene ] , induced a left ventricle up-regulation of gene , gene and gene ( gene-dependent ) , and a reduction in gene and gene levels ; these effects of NDP-gene and gene were associated with over-expression of the pro-survival proteins gene and gene , and marked decrease of the myocardial infarct size .	T2	T19	23535516
NA	CHEMICAL	GENE-Y	18	71	Intravenous treatment , during coronary artery occlusion , with the gene analogs [ chemical ( 4 ) , chemical ( 7 ) ] gene ( NDP-gene ) and gene [ gene ] , induced a left ventricle up-regulation of gene , gene and gene ( gene-dependent ) , and a reduction in gene and gene levels ; these effects of NDP-gene and gene were associated with over-expression of the pro-survival proteins gene and gene , and marked decrease of the myocardial infarct size .	T2	T20	23535516
NA	CHEMICAL	GENE-Y	18	73	Intravenous treatment , during coronary artery occlusion , with the gene analogs [ chemical ( 4 ) , chemical ( 7 ) ] gene ( NDP-gene ) and gene [ gene ] , induced a left ventricle up-regulation of gene , gene and gene ( gene-dependent ) , and a reduction in gene and gene levels ; these effects of NDP-gene and gene were associated with over-expression of the pro-survival proteins gene and gene , and marked decrease of the myocardial infarct size .	T2	T21	23535516
CPR:4	CHEMICAL	GENE-N	2	2	Blockade of gene and gene pathways with chemical and chemical , respectively , abrogated the myocardial infarct size reduction by NDP-gene .	T3	T30	23535516
NA	CHEMICAL	GENE-N	2	4	Blockade of gene and gene pathways with chemical and chemical , respectively , abrogated the myocardial infarct size reduction by NDP-gene .	T3	T31	23535516
NA	CHEMICAL	GENE-Y	2	20	Blockade of gene and gene pathways with chemical and chemical , respectively , abrogated the myocardial infarct size reduction by NDP-gene .	T3	T33	23535516
NA	CHEMICAL	GENE-N	9	2	Blockade of gene and gene pathways with chemical and chemical , respectively , abrogated the myocardial infarct size reduction by NDP-gene .	T4	T30	23535516
CPR:4	CHEMICAL	GENE-N	9	4	Blockade of gene and gene pathways with chemical and chemical , respectively , abrogated the myocardial infarct size reduction by NDP-gene .	T4	T31	23535516
NA	CHEMICAL	GENE-Y	9	20	Blockade of gene and gene pathways with chemical and chemical , respectively , abrogated the myocardial infarct size reduction by NDP-gene .	T4	T33	23535516
NA	CHEMICAL	GENE-N	16	5	Thus , both species possess gene genes encoding inactive peptides , as previously described for chimpanzee chemical .	T16	T36	16916952
NA	CHEMICAL	GENE-Y	16	2	The updated gene gene sequence revealed inactivation by frame shifts , premature stop codons , and chemical changes specifying nonconservative replacement of chemical residues , similar to inactivation of gene .	T1	T38	16916952
NA	CHEMICAL	GENE-Y	16	26	The updated gene gene sequence revealed inactivation by frame shifts , premature stop codons , and chemical changes specifying nonconservative replacement of chemical residues , similar to inactivation of gene .	T1	T20	16916952
NA	CHEMICAL	GENE-Y	22	2	The updated gene gene sequence revealed inactivation by frame shifts , premature stop codons , and chemical changes specifying nonconservative replacement of chemical residues , similar to inactivation of gene .	T2	T38	16916952
NA	CHEMICAL	GENE-Y	22	26	The updated gene gene sequence revealed inactivation by frame shifts , premature stop codons , and chemical changes specifying nonconservative replacement of chemical residues , similar to inactivation of gene .	T2	T20	16916952
CPR:4	CHEMICAL	GENE-Y	0	5	chemical ( chemical ) inhibits genegene , an chemical-resistant activating mutation that triggers neoplastic growth in most patients with systemic mastocytosis .	T13	T37	16434489
CPR:4	CHEMICAL	GENE-N	0	5	chemical ( chemical ) inhibits genegene , an chemical-resistant activating mutation that triggers neoplastic growth in most patients with systemic mastocytosis .	T13	T38	16434489
NA	CHEMICAL	GENE-Y	2	5	chemical ( chemical ) inhibits genegene , an chemical-resistant activating mutation that triggers neoplastic growth in most patients with systemic mastocytosis .	T14	T37	16434489
CPR:4	CHEMICAL	GENE-N	2	5	chemical ( chemical ) inhibits genegene , an chemical-resistant activating mutation that triggers neoplastic growth in most patients with systemic mastocytosis .	T14	T38	16434489
NA	CHEMICAL	GENE-Y	8	5	chemical ( chemical ) inhibits genegene , an chemical-resistant activating mutation that triggers neoplastic growth in most patients with systemic mastocytosis .	T15	T37	16434489
NA	CHEMICAL	GENE-N	8	5	chemical ( chemical ) inhibits genegene , an chemical-resistant activating mutation that triggers neoplastic growth in most patients with systemic mastocytosis .	T15	T38	16434489
NA	CHEMICAL	GENE-Y	6	23	This mutation is inherently resistant to chemical and , to date , there remains no effective curative therapy for systemic mastocytosis associated with genegene .	T6	T22	16434489
NA	CHEMICAL	GENE-N	6	23	This mutation is inherently resistant to chemical and , to date , there remains no effective curative therapy for systemic mastocytosis associated with genegene .	T6	T23	16434489
CPR:4	CHEMICAL	GENE-Y	0	9	chemical ( chemical ) is a novel orally bioavailable gene/gene inhibitor that has activity against multiple chemical-resistant gene-gene isoforms in vitro that is presently showing considerable promise in early-phase clinical trials of chronic myeloid leukemia ( CML ) .	T7	T24	16434489
CPR:4	CHEMICAL	GENE-Y	0	9	chemical ( chemical ) is a novel orally bioavailable gene/gene inhibitor that has activity against multiple chemical-resistant gene-gene isoforms in vitro that is presently showing considerable promise in early-phase clinical trials of chronic myeloid leukemia ( CML ) .	T7	T25	16434489
NA	CHEMICAL	GENE-Y	0	17	chemical ( chemical ) is a novel orally bioavailable gene/gene inhibitor that has activity against multiple chemical-resistant gene-gene isoforms in vitro that is presently showing considerable promise in early-phase clinical trials of chronic myeloid leukemia ( CML ) .	T7	T26	16434489
NA	CHEMICAL	GENE-Y	0	17	chemical ( chemical ) is a novel orally bioavailable gene/gene inhibitor that has activity against multiple chemical-resistant gene-gene isoforms in vitro that is presently showing considerable promise in early-phase clinical trials of chronic myeloid leukemia ( CML ) .	T7	T27	16434489
CPR:4	CHEMICAL	GENE-Y	2	9	chemical ( chemical ) is a novel orally bioavailable gene/gene inhibitor that has activity against multiple chemical-resistant gene-gene isoforms in vitro that is presently showing considerable promise in early-phase clinical trials of chronic myeloid leukemia ( CML ) .	T8	T24	16434489
CPR:4	CHEMICAL	GENE-Y	2	9	chemical ( chemical ) is a novel orally bioavailable gene/gene inhibitor that has activity against multiple chemical-resistant gene-gene isoforms in vitro that is presently showing considerable promise in early-phase clinical trials of chronic myeloid leukemia ( CML ) .	T8	T25	16434489
NA	CHEMICAL	GENE-Y	2	17	chemical ( chemical ) is a novel orally bioavailable gene/gene inhibitor that has activity against multiple chemical-resistant gene-gene isoforms in vitro that is presently showing considerable promise in early-phase clinical trials of chronic myeloid leukemia ( CML ) .	T8	T26	16434489
NA	CHEMICAL	GENE-Y	2	17	chemical ( chemical ) is a novel orally bioavailable gene/gene inhibitor that has activity against multiple chemical-resistant gene-gene isoforms in vitro that is presently showing considerable promise in early-phase clinical trials of chronic myeloid leukemia ( CML ) .	T8	T27	16434489
NA	CHEMICAL	GENE-Y	5	9	chemical ( chemical ) is a novel orally bioavailable gene/gene inhibitor that has activity against multiple chemical-resistant gene-gene isoforms in vitro that is presently showing considerable promise in early-phase clinical trials of chronic myeloid leukemia ( CML ) .	T9	T24	16434489
NA	CHEMICAL	GENE-Y	5	9	chemical ( chemical ) is a novel orally bioavailable gene/gene inhibitor that has activity against multiple chemical-resistant gene-gene isoforms in vitro that is presently showing considerable promise in early-phase clinical trials of chronic myeloid leukemia ( CML ) .	T9	T25	16434489
NA	CHEMICAL	GENE-Y	5	17	chemical ( chemical ) is a novel orally bioavailable gene/gene inhibitor that has activity against multiple chemical-resistant gene-gene isoforms in vitro that is presently showing considerable promise in early-phase clinical trials of chronic myeloid leukemia ( CML ) .	T9	T26	16434489
NA	CHEMICAL	GENE-Y	5	17	chemical ( chemical ) is a novel orally bioavailable gene/gene inhibitor that has activity against multiple chemical-resistant gene-gene isoforms in vitro that is presently showing considerable promise in early-phase clinical trials of chronic myeloid leukemia ( CML ) .	T9	T27	16434489
CPR:4	CHEMICAL	GENE-Y	10	14	In this study , we demonstrate significant inhibitory activity of chemical against both wild-type gene and the genegene mutation in the nanomolar range in in vitro and cell-based gene assays .	T11	T30	16434489
CPR:4	CHEMICAL	GENE-Y	10	17	In this study , we demonstrate significant inhibitory activity of chemical against both wild-type gene and the genegene mutation in the nanomolar range in in vitro and cell-based gene assays .	T11	T32	16434489
CPR:4	CHEMICAL	GENE-N	10	17	In this study , we demonstrate significant inhibitory activity of chemical against both wild-type gene and the genegene mutation in the nanomolar range in in vitro and cell-based gene assays .	T11	T33	16434489
NA	CHEMICAL	GENE-N	10	19	In this study , we demonstrate significant inhibitory activity of chemical against both wild-type gene and the genegene mutation in the nanomolar range in in vitro and cell-based gene assays .	T11	T34	16434489
CPR:4	CHEMICAL	GENE-Y	2	9	Additionally , chemical leads to growth inhibition of a genegene-harboring human masto-cytosis cell line .	T12	T35	16434489
CPR:4	CHEMICAL	GENE-N	2	9	Additionally , chemical leads to growth inhibition of a genegene-harboring human masto-cytosis cell line .	T12	T36	16434489
NA	CHEMICAL	GENE-Y	16	5	Computer modeling suggests that the genegene mutation destabilizes the inactive conformation of the gene to which chemical binds , but it is not predicted to impair binding of gene by chemical .	T2	T16	16434489
NA	CHEMICAL	GENE-N	16	5	Computer modeling suggests that the genegene mutation destabilizes the inactive conformation of the gene to which chemical binds , but it is not predicted to impair binding of gene by chemical .	T2	T17	16434489
NA	CHEMICAL	GENE-N	16	13	Computer modeling suggests that the genegene mutation destabilizes the inactive conformation of the gene to which chemical binds , but it is not predicted to impair binding of gene by chemical .	T2	T18	16434489
NA	CHEMICAL	GENE-Y	16	28	Computer modeling suggests that the genegene mutation destabilizes the inactive conformation of the gene to which chemical binds , but it is not predicted to impair binding of gene by chemical .	T2	T20	16434489
NA	CHEMICAL	GENE-Y	30	5	Computer modeling suggests that the genegene mutation destabilizes the inactive conformation of the gene to which chemical binds , but it is not predicted to impair binding of gene by chemical .	T3	T16	16434489
NA	CHEMICAL	GENE-N	30	5	Computer modeling suggests that the genegene mutation destabilizes the inactive conformation of the gene to which chemical binds , but it is not predicted to impair binding of gene by chemical .	T3	T17	16434489
NA	CHEMICAL	GENE-N	30	13	Computer modeling suggests that the genegene mutation destabilizes the inactive conformation of the gene to which chemical binds , but it is not predicted to impair binding of gene by chemical .	T3	T18	16434489
NA	CHEMICAL	GENE-Y	30	28	Computer modeling suggests that the genegene mutation destabilizes the inactive conformation of the gene to which chemical binds , but it is not predicted to impair binding of gene by chemical .	T3	T20	16434489
CPR:4	CHEMICAL	GENE-Y	2	2	Disposition of a specific gene inhibitor , chemical , in human .	T20	T22	12167567
CPR:4	CHEMICAL	GENE-Y	0	2	chemical is a potent and specific inhibitor of gene , which is used for the treatment of rheumatoid arthritis , osteoarthritis , and the dysmenorrhea pain .	T1	T21	12167567
NA	CHEMICAL	GENE-Y	0	9	chemical , an opiate analog , differently modifies the gene responses to gene and chemical in patients with Addison 's disease .	T18	T43	2855105
NA	CHEMICAL	GENE-Y	0	12	chemical , an opiate analog , differently modifies the gene responses to gene and chemical in patients with Addison 's disease .	T18	T44	2855105
NA	CHEMICAL	GENE-Y	0	15	chemical , an opiate analog , differently modifies the gene responses to gene and chemical in patients with Addison 's disease .	T18	T42	2855105
NA	CHEMICAL	GENE-Y	14	9	chemical , an opiate analog , differently modifies the gene responses to gene and chemical in patients with Addison 's disease .	T19	T43	2855105
NA	CHEMICAL	GENE-Y	14	12	chemical , an opiate analog , differently modifies the gene responses to gene and chemical in patients with Addison 's disease .	T19	T44	2855105
NA	CHEMICAL	GENE-Y	14	15	chemical , an opiate analog , differently modifies the gene responses to gene and chemical in patients with Addison 's disease .	T19	T42	2855105
CPR:4	CHEMICAL	GENE-Y	0	9	chemical is a peripheral opiate agonist able to inhibit gene secretion .	T1	T37	2855105
NA	CHEMICAL	GENE-Y	7	10	In this work , the interactions between chemical and two gene secretagogues , chemical ( chemical ) and gene ( gene ) , were investigated in patients with Addison 's disease .	T4	T25	2855105
NA	CHEMICAL	GENE-Y	7	25	In this work , the interactions between chemical and two gene secretagogues , chemical ( chemical ) and gene ( gene ) , were investigated in patients with Addison 's disease .	T4	T28	2855105
NA	CHEMICAL	GENE-Y	7	18	In this work , the interactions between chemical and two gene secretagogues , chemical ( chemical ) and gene ( gene ) , were investigated in patients with Addison 's disease .	T4	T30	2855105
NA	CHEMICAL	GENE-Y	7	20	In this work , the interactions between chemical and two gene secretagogues , chemical ( chemical ) and gene ( gene ) , were investigated in patients with Addison 's disease .	T4	T31	2855105
NA	CHEMICAL	GENE-Y	13	10	In this work , the interactions between chemical and two gene secretagogues , chemical ( chemical ) and gene ( gene ) , were investigated in patients with Addison 's disease .	T10	T25	2855105
NA	CHEMICAL	GENE-Y	13	25	In this work , the interactions between chemical and two gene secretagogues , chemical ( chemical ) and gene ( gene ) , were investigated in patients with Addison 's disease .	T10	T28	2855105
NA	CHEMICAL	GENE-Y	13	18	In this work , the interactions between chemical and two gene secretagogues , chemical ( chemical ) and gene ( gene ) , were investigated in patients with Addison 's disease .	T10	T30	2855105
NA	CHEMICAL	GENE-Y	13	20	In this work , the interactions between chemical and two gene secretagogues , chemical ( chemical ) and gene ( gene ) , were investigated in patients with Addison 's disease .	T10	T31	2855105
NA	CHEMICAL	GENE-Y	15	10	In this work , the interactions between chemical and two gene secretagogues , chemical ( chemical ) and gene ( gene ) , were investigated in patients with Addison 's disease .	T11	T25	2855105
NA	CHEMICAL	GENE-Y	15	25	In this work , the interactions between chemical and two gene secretagogues , chemical ( chemical ) and gene ( gene ) , were investigated in patients with Addison 's disease .	T11	T28	2855105
NA	CHEMICAL	GENE-Y	15	18	In this work , the interactions between chemical and two gene secretagogues , chemical ( chemical ) and gene ( gene ) , were investigated in patients with Addison 's disease .	T11	T30	2855105
NA	CHEMICAL	GENE-Y	15	20	In this work , the interactions between chemical and two gene secretagogues , chemical ( chemical ) and gene ( gene ) , were investigated in patients with Addison 's disease .	T11	T31	2855105
CPR:4	CHEMICAL	GENE-Y	3	10	In all patients chemical induced a significant fall in plasma gene levels .	T14	T34	2855105
NA	CHEMICAL	GENE-Y	0	2	chemical increased gene levels after both chemical ( from 48 +/- 17.3 to a peak of 95 +/- 21 pmol/l ) and placebo ( from 231 +/- 59.5 to 365 +/- 86.6 pmol/l ) : the interaction between treatments and time was not significant .	T15	T36	2855105
NA	CHEMICAL	GENE-Y	6	2	chemical increased gene levels after both chemical ( from 48 +/- 17.3 to a peak of 95 +/- 21 pmol/l ) and placebo ( from 231 +/- 59.5 to 365 +/- 86.6 pmol/l ) : the interaction between treatments and time was not significant .	T16	T36	2855105
NA	CHEMICAL	GENE-Y	2	0	gene caused a rise in plasma gene after both chemical ( from 30 +/- 16.6 to a peak of 108 +/- 31 pmol/l ) and placebo ( from 98.5 +/- 47 to 211 +/- 61.7 pmol/l ) : the interaction between treatments and time was significant , and the first phase of gene-induced gene secretion was significantly lower after chemical .	T17	T38	2855105
NA	CHEMICAL	GENE-Y	2	6	gene caused a rise in plasma gene after both chemical ( from 30 +/- 16.6 to a peak of 108 +/- 31 pmol/l ) and placebo ( from 98.5 +/- 47 to 211 +/- 61.7 pmol/l ) : the interaction between treatments and time was significant , and the first phase of gene-induced gene secretion was significantly lower after chemical .	T17	T39	2855105
NA	CHEMICAL	GENE-Y	2	52	gene caused a rise in plasma gene after both chemical ( from 30 +/- 16.6 to a peak of 108 +/- 31 pmol/l ) and placebo ( from 98.5 +/- 47 to 211 +/- 61.7 pmol/l ) : the interaction between treatments and time was significant , and the first phase of gene-induced gene secretion was significantly lower after chemical .	T17	T40	2855105
NA	CHEMICAL	GENE-Y	2	53	gene caused a rise in plasma gene after both chemical ( from 30 +/- 16.6 to a peak of 108 +/- 31 pmol/l ) and placebo ( from 98.5 +/- 47 to 211 +/- 61.7 pmol/l ) : the interaction between treatments and time was significant , and the first phase of gene-induced gene secretion was significantly lower after chemical .	T17	T41	2855105
NA	CHEMICAL	GENE-Y	2	0	gene caused a rise in plasma gene after both chemical ( from 30 +/- 16.6 to a peak of 108 +/- 31 pmol/l ) and placebo ( from 98.5 +/- 47 to 211 +/- 61.7 pmol/l ) : the interaction between treatments and time was significant , and the first phase of gene-induced gene secretion was significantly lower after chemical .	T2	T38	2855105
NA	CHEMICAL	GENE-Y	2	6	gene caused a rise in plasma gene after both chemical ( from 30 +/- 16.6 to a peak of 108 +/- 31 pmol/l ) and placebo ( from 98.5 +/- 47 to 211 +/- 61.7 pmol/l ) : the interaction between treatments and time was significant , and the first phase of gene-induced gene secretion was significantly lower after chemical .	T2	T39	2855105
CPR:4	CHEMICAL	GENE-Y	2	52	gene caused a rise in plasma gene after both chemical ( from 30 +/- 16.6 to a peak of 108 +/- 31 pmol/l ) and placebo ( from 98.5 +/- 47 to 211 +/- 61.7 pmol/l ) : the interaction between treatments and time was significant , and the first phase of gene-induced gene secretion was significantly lower after chemical .	T2	T40	2855105
CPR:4	CHEMICAL	GENE-Y	2	53	gene caused a rise in plasma gene after both chemical ( from 30 +/- 16.6 to a peak of 108 +/- 31 pmol/l ) and placebo ( from 98.5 +/- 47 to 211 +/- 61.7 pmol/l ) : the interaction between treatments and time was significant , and the first phase of gene-induced gene secretion was significantly lower after chemical .	T2	T41	2855105
NA	CHEMICAL	GENE-Y	4	20	These data demonstrate that chemical differently modifies the stimulatory action of chemical and gene on gene secretion : namely , gene and chemical act in an additive manner , while gene and chemical interact in a non additive way .	T3	T20	2855105
NA	CHEMICAL	GENE-Y	4	13	These data demonstrate that chemical differently modifies the stimulatory action of chemical and gene on gene secretion : namely , gene and chemical act in an additive manner , while gene and chemical interact in a non additive way .	T3	T21	2855105
NA	CHEMICAL	GENE-Y	4	15	These data demonstrate that chemical differently modifies the stimulatory action of chemical and gene on gene secretion : namely , gene and chemical act in an additive manner , while gene and chemical interact in a non additive way .	T3	T22	2855105
NA	CHEMICAL	GENE-Y	4	30	These data demonstrate that chemical differently modifies the stimulatory action of chemical and gene on gene secretion : namely , gene and chemical act in an additive manner , while gene and chemical interact in a non additive way .	T3	T24	2855105
NA	CHEMICAL	GENE-Y	11	20	These data demonstrate that chemical differently modifies the stimulatory action of chemical and gene on gene secretion : namely , gene and chemical act in an additive manner , while gene and chemical interact in a non additive way .	T5	T20	2855105
NA	CHEMICAL	GENE-Y	11	13	These data demonstrate that chemical differently modifies the stimulatory action of chemical and gene on gene secretion : namely , gene and chemical act in an additive manner , while gene and chemical interact in a non additive way .	T5	T21	2855105
NA	CHEMICAL	GENE-Y	11	15	These data demonstrate that chemical differently modifies the stimulatory action of chemical and gene on gene secretion : namely , gene and chemical act in an additive manner , while gene and chemical interact in a non additive way .	T5	T22	2855105
NA	CHEMICAL	GENE-Y	11	30	These data demonstrate that chemical differently modifies the stimulatory action of chemical and gene on gene secretion : namely , gene and chemical act in an additive manner , while gene and chemical interact in a non additive way .	T5	T24	2855105
NA	CHEMICAL	GENE-Y	22	20	These data demonstrate that chemical differently modifies the stimulatory action of chemical and gene on gene secretion : namely , gene and chemical act in an additive manner , while gene and chemical interact in a non additive way .	T7	T20	2855105
NA	CHEMICAL	GENE-Y	22	13	These data demonstrate that chemical differently modifies the stimulatory action of chemical and gene on gene secretion : namely , gene and chemical act in an additive manner , while gene and chemical interact in a non additive way .	T7	T21	2855105
NA	CHEMICAL	GENE-Y	22	15	These data demonstrate that chemical differently modifies the stimulatory action of chemical and gene on gene secretion : namely , gene and chemical act in an additive manner , while gene and chemical interact in a non additive way .	T7	T22	2855105
NA	CHEMICAL	GENE-Y	22	30	These data demonstrate that chemical differently modifies the stimulatory action of chemical and gene on gene secretion : namely , gene and chemical act in an additive manner , while gene and chemical interact in a non additive way .	T7	T24	2855105
NA	CHEMICAL	GENE-Y	32	20	These data demonstrate that chemical differently modifies the stimulatory action of chemical and gene on gene secretion : namely , gene and chemical act in an additive manner , while gene and chemical interact in a non additive way .	T8	T20	2855105
NA	CHEMICAL	GENE-Y	32	13	These data demonstrate that chemical differently modifies the stimulatory action of chemical and gene on gene secretion : namely , gene and chemical act in an additive manner , while gene and chemical interact in a non additive way .	T8	T21	2855105
NA	CHEMICAL	GENE-Y	32	15	These data demonstrate that chemical differently modifies the stimulatory action of chemical and gene on gene secretion : namely , gene and chemical act in an additive manner , while gene and chemical interact in a non additive way .	T8	T22	2855105
NA	CHEMICAL	GENE-Y	32	30	These data demonstrate that chemical differently modifies the stimulatory action of chemical and gene on gene secretion : namely , gene and chemical act in an additive manner , while gene and chemical interact in a non additive way .	T8	T24	2855105
CPR:4	CHEMICAL	GENE-Y	0	13	chemical , isolated from Juglans mandshurica Maxim , induces apoptosis via down-regulation of gene expression in human prostate cancer LNCaP cells .	T19	T28	23643730
CPR:4	CHEMICAL	GENE-Y	5	13	Moreover , we found that chemical significantly inhibited the expression levels of chemical receptor ( gene ) and gene ( gene ) in a dose-dependent manner , as well as abrogated up-regulation of gene and gene genes with and/or without chemical ( chemical ) .	T2	T20	23643730
CPR:4	CHEMICAL	GENE-Y	5	15	Moreover , we found that chemical significantly inhibited the expression levels of chemical receptor ( gene ) and gene ( gene ) in a dose-dependent manner , as well as abrogated up-regulation of gene and gene genes with and/or without chemical ( chemical ) .	T2	T21	23643730
CPR:4	CHEMICAL	GENE-Y	5	18	Moreover , we found that chemical significantly inhibited the expression levels of chemical receptor ( gene ) and gene ( gene ) in a dose-dependent manner , as well as abrogated up-regulation of gene and gene genes with and/or without chemical ( chemical ) .	T2	T22	23643730
CPR:4	CHEMICAL	GENE-Y	5	20	Moreover , we found that chemical significantly inhibited the expression levels of chemical receptor ( gene ) and gene ( gene ) in a dose-dependent manner , as well as abrogated up-regulation of gene and gene genes with and/or without chemical ( chemical ) .	T2	T23	23643730
CPR:4	CHEMICAL	GENE-Y	5	33	Moreover , we found that chemical significantly inhibited the expression levels of chemical receptor ( gene ) and gene ( gene ) in a dose-dependent manner , as well as abrogated up-regulation of gene and gene genes with and/or without chemical ( chemical ) .	T2	T24	23643730
CPR:4	CHEMICAL	GENE-Y	5	35	Moreover , we found that chemical significantly inhibited the expression levels of chemical receptor ( gene ) and gene ( gene ) in a dose-dependent manner , as well as abrogated up-regulation of gene and gene genes with and/or without chemical ( chemical ) .	T2	T25	23643730
NA	CHEMICAL	GENE-Y	12	13	Moreover , we found that chemical significantly inhibited the expression levels of chemical receptor ( gene ) and gene ( gene ) in a dose-dependent manner , as well as abrogated up-regulation of gene and gene genes with and/or without chemical ( chemical ) .	T3	T20	23643730
NA	CHEMICAL	GENE-Y	12	15	Moreover , we found that chemical significantly inhibited the expression levels of chemical receptor ( gene ) and gene ( gene ) in a dose-dependent manner , as well as abrogated up-regulation of gene and gene genes with and/or without chemical ( chemical ) .	T3	T21	23643730
NA	CHEMICAL	GENE-Y	12	18	Moreover , we found that chemical significantly inhibited the expression levels of chemical receptor ( gene ) and gene ( gene ) in a dose-dependent manner , as well as abrogated up-regulation of gene and gene genes with and/or without chemical ( chemical ) .	T3	T22	23643730
NA	CHEMICAL	GENE-Y	12	20	Moreover , we found that chemical significantly inhibited the expression levels of chemical receptor ( gene ) and gene ( gene ) in a dose-dependent manner , as well as abrogated up-regulation of gene and gene genes with and/or without chemical ( chemical ) .	T3	T23	23643730
NA	CHEMICAL	GENE-Y	12	33	Moreover , we found that chemical significantly inhibited the expression levels of chemical receptor ( gene ) and gene ( gene ) in a dose-dependent manner , as well as abrogated up-regulation of gene and gene genes with and/or without chemical ( chemical ) .	T3	T24	23643730
NA	CHEMICAL	GENE-Y	12	35	Moreover , we found that chemical significantly inhibited the expression levels of chemical receptor ( gene ) and gene ( gene ) in a dose-dependent manner , as well as abrogated up-regulation of gene and gene genes with and/or without chemical ( chemical ) .	T3	T25	23643730
NA	CHEMICAL	GENE-Y	40	13	Moreover , we found that chemical significantly inhibited the expression levels of chemical receptor ( gene ) and gene ( gene ) in a dose-dependent manner , as well as abrogated up-regulation of gene and gene genes with and/or without chemical ( chemical ) .	T5	T20	23643730
NA	CHEMICAL	GENE-Y	40	15	Moreover , we found that chemical significantly inhibited the expression levels of chemical receptor ( gene ) and gene ( gene ) in a dose-dependent manner , as well as abrogated up-regulation of gene and gene genes with and/or without chemical ( chemical ) .	T5	T21	23643730
NA	CHEMICAL	GENE-Y	40	18	Moreover , we found that chemical significantly inhibited the expression levels of chemical receptor ( gene ) and gene ( gene ) in a dose-dependent manner , as well as abrogated up-regulation of gene and gene genes with and/or without chemical ( chemical ) .	T5	T22	23643730
NA	CHEMICAL	GENE-Y	40	20	Moreover , we found that chemical significantly inhibited the expression levels of chemical receptor ( gene ) and gene ( gene ) in a dose-dependent manner , as well as abrogated up-regulation of gene and gene genes with and/or without chemical ( chemical ) .	T5	T23	23643730
NA	CHEMICAL	GENE-Y	40	33	Moreover , we found that chemical significantly inhibited the expression levels of chemical receptor ( gene ) and gene ( gene ) in a dose-dependent manner , as well as abrogated up-regulation of gene and gene genes with and/or without chemical ( chemical ) .	T5	T24	23643730
NA	CHEMICAL	GENE-Y	40	35	Moreover , we found that chemical significantly inhibited the expression levels of chemical receptor ( gene ) and gene ( gene ) in a dose-dependent manner , as well as abrogated up-regulation of gene and gene genes with and/or without chemical ( chemical ) .	T5	T25	23643730
NA	CHEMICAL	GENE-Y	42	13	Moreover , we found that chemical significantly inhibited the expression levels of chemical receptor ( gene ) and gene ( gene ) in a dose-dependent manner , as well as abrogated up-regulation of gene and gene genes with and/or without chemical ( chemical ) .	T6	T20	23643730
NA	CHEMICAL	GENE-Y	42	15	Moreover , we found that chemical significantly inhibited the expression levels of chemical receptor ( gene ) and gene ( gene ) in a dose-dependent manner , as well as abrogated up-regulation of gene and gene genes with and/or without chemical ( chemical ) .	T6	T21	23643730
NA	CHEMICAL	GENE-Y	42	18	Moreover , we found that chemical significantly inhibited the expression levels of chemical receptor ( gene ) and gene ( gene ) in a dose-dependent manner , as well as abrogated up-regulation of gene and gene genes with and/or without chemical ( chemical ) .	T6	T22	23643730
NA	CHEMICAL	GENE-Y	42	20	Moreover , we found that chemical significantly inhibited the expression levels of chemical receptor ( gene ) and gene ( gene ) in a dose-dependent manner , as well as abrogated up-regulation of gene and gene genes with and/or without chemical ( chemical ) .	T6	T23	23643730
NA	CHEMICAL	GENE-Y	42	33	Moreover , we found that chemical significantly inhibited the expression levels of chemical receptor ( gene ) and gene ( gene ) in a dose-dependent manner , as well as abrogated up-regulation of gene and gene genes with and/or without chemical ( chemical ) .	T6	T24	23643730
NA	CHEMICAL	GENE-Y	42	35	Moreover , we found that chemical significantly inhibited the expression levels of chemical receptor ( gene ) and gene ( gene ) in a dose-dependent manner , as well as abrogated up-regulation of gene and gene genes with and/or without chemical ( chemical ) .	T6	T25	23643730
CPR:4	CHEMICAL	GENE-Y	7	18	Take together , our results demonstrated that chemical might induce the apoptosis in LNCaP cell via down-regulation of gene expression .	T7	T26	23643730
CPR:4	CHEMICAL	GENE-Y	0	12	chemical , as an anti-rheumatic gold compound , suppresses LPS-induced homodimerization of gene .	T11	T32	17034761
CPR:4	CHEMICAL	GENE-Y	4	6	Our results demonstrated that chemical suppressed gene-mediated activation of transcription factors , gene and gene , and expression of gene , a pro-inflammatory enzyme .	T8	T17	17034761
CPR:4	CHEMICAL	GENE-N	4	12	Our results demonstrated that chemical suppressed gene-mediated activation of transcription factors , gene and gene , and expression of gene , a pro-inflammatory enzyme .	T8	T18	17034761
CPR:4	CHEMICAL	GENE-Y	4	14	Our results demonstrated that chemical suppressed gene-mediated activation of transcription factors , gene and gene , and expression of gene , a pro-inflammatory enzyme .	T8	T19	17034761
CPR:4	CHEMICAL	GENE-Y	4	19	Our results demonstrated that chemical suppressed gene-mediated activation of transcription factors , gene and gene , and expression of gene , a pro-inflammatory enzyme .	T8	T20	17034761
CPR:4	CHEMICAL	GENE-Y	9	15	This suppression was well correlated with the inhibitory effect of chemical on the homodimerization of gene induced by an agonist .	T9	T21	17034761
CPR:4	CHEMICAL	GENE-N	2	4	Furthermore , chemical inhibited gene activation induced by gene-dependent downstream signaling components of gene , gene , gene , and gene .	T10	T22	17034761
NA	CHEMICAL	GENE-Y	2	8	Furthermore , chemical inhibited gene activation induced by gene-dependent downstream signaling components of gene , gene , gene , and gene .	T10	T23	17034761
NA	CHEMICAL	GENE-Y	2	13	Furthermore , chemical inhibited gene activation induced by gene-dependent downstream signaling components of gene , gene , gene , and gene .	T10	T24	17034761
NA	CHEMICAL	GENE-Y	2	15	Furthermore , chemical inhibited gene activation induced by gene-dependent downstream signaling components of gene , gene , gene , and gene .	T10	T25	17034761
NA	CHEMICAL	GENE-Y	2	17	Furthermore , chemical inhibited gene activation induced by gene-dependent downstream signaling components of gene , gene , gene , and gene .	T10	T26	17034761
NA	CHEMICAL	GENE-Y	2	20	Furthermore , chemical inhibited gene activation induced by gene-dependent downstream signaling components of gene , gene , gene , and gene .	T10	T27	17034761
CPR:4	CHEMICAL	GENE-Y	16	0	gene activation induced by gene-independent signaling components , gene and gene , was also downregulated by chemical .	T1	T28	17034761
NA	CHEMICAL	GENE-Y	16	4	gene activation induced by gene-independent signaling components , gene and gene , was also downregulated by chemical .	T1	T29	17034761
CPR:4	CHEMICAL	GENE-Y	16	8	gene activation induced by gene-independent signaling components , gene and gene , was also downregulated by chemical .	T1	T30	17034761
CPR:4	CHEMICAL	GENE-Y	16	10	gene activation induced by gene-independent signaling components , gene and gene , was also downregulated by chemical .	T1	T31	17034761
CPR:4	CHEMICAL	GENE-Y	5	11	Our results first demonstrate that chemical suppresses the multiple steps in gene signaling , especially the homodimerization of gene .	T2	T13	17034761
CPR:4	CHEMICAL	GENE-Y	5	18	Our results first demonstrate that chemical suppresses the multiple steps in gene signaling , especially the homodimerization of gene .	T2	T14	17034761
NA	CHEMICAL	GENE-N	16	9	Contribution of the m1 transmembrane helix and pre-m1 region to positive allosteric modulation and gating of chemical receptors .	T14	T24	23455314
NA	CHEMICAL	GENE-N	0	4	chemical ( chemical ) receptors are gene whose function is critical for normal excitatory synaptic transmission in the brain and whose dysfunction has been implicated in several neurologic conditions .	T1	T15	23455314
NA	CHEMICAL	GENE-N	0	6	chemical ( chemical ) receptors are gene whose function is critical for normal excitatory synaptic transmission in the brain and whose dysfunction has been implicated in several neurologic conditions .	T1	T20	23455314
NA	CHEMICAL	GENE-N	2	4	chemical ( chemical ) receptors are gene whose function is critical for normal excitatory synaptic transmission in the brain and whose dysfunction has been implicated in several neurologic conditions .	T6	T15	23455314
NA	CHEMICAL	GENE-N	2	6	chemical ( chemical ) receptors are gene whose function is critical for normal excitatory synaptic transmission in the brain and whose dysfunction has been implicated in several neurologic conditions .	T6	T20	23455314
NA	CHEMICAL	GENE-N	0	1	chemical receptor function is subject to extensive allosteric regulation both by endogenous compounds and by exogenous small molecules .	T7	T19	23455314
NA	CHEMICAL	GENE-N	19	20	Elucidating the structural determinants and mechanism of action by which allosteric regulators control gating will enhance our understanding of chemical receptor activation and facilitate the development of novel therapeutics .	T8	T21	23455314
NA	CHEMICAL	GENE-N	3	7	We show that chemical does not bind to the chemical-terminal domain of the chemical receptor and does not share structural determinants with modulators acting at the agonist-binding domain dimer interface or gene pore .	T11	T22	23455314
NA	CHEMICAL	GENE-N	3	31	We show that chemical does not bind to the chemical-terminal domain of the chemical receptor and does not share structural determinants with modulators acting at the agonist-binding domain dimer interface or gene pore .	T11	T23	23455314
NA	CHEMICAL	GENE-N	9	7	We show that chemical does not bind to the chemical-terminal domain of the chemical receptor and does not share structural determinants with modulators acting at the agonist-binding domain dimer interface or gene pore .	T12	T22	23455314
NA	CHEMICAL	GENE-N	9	31	We show that chemical does not bind to the chemical-terminal domain of the chemical receptor and does not share structural determinants with modulators acting at the agonist-binding domain dimer interface or gene pore .	T12	T23	23455314
NA	CHEMICAL	GENE-N	13	7	We show that chemical does not bind to the chemical-terminal domain of the chemical receptor and does not share structural determinants with modulators acting at the agonist-binding domain dimer interface or gene pore .	T13	T22	23455314
NA	CHEMICAL	GENE-N	13	31	We show that chemical does not bind to the chemical-terminal domain of the chemical receptor and does not share structural determinants with modulators acting at the agonist-binding domain dimer interface or gene pore .	T13	T23	23455314
NA	CHEMICAL	GENE-N	15	16	We also show that mutations within the GluN2D pre-M1 region alter open probability of the chemical receptor .	T3	T16	23455314
NA	CHEMICAL	GENE-Y	3	17	military and civilian chemical countermeasure , chemical ( chemical ) , is under consideration for replacement with a more effective gene reactivator , chemical ( chemical ) .	T1	T15	23314320
NA	CHEMICAL	GENE-Y	6	17	military and civilian chemical countermeasure , chemical ( chemical ) , is under consideration for replacement with a more effective gene reactivator , chemical ( chemical ) .	T2	T15	23314320
NA	CHEMICAL	GENE-Y	8	17	military and civilian chemical countermeasure , chemical ( chemical ) , is under consideration for replacement with a more effective gene reactivator , chemical ( chemical ) .	T4	T15	23314320
CPR:3	CHEMICAL	GENE-Y	17	17	military and civilian chemical countermeasure , chemical ( chemical ) , is under consideration for replacement with a more effective gene reactivator , chemical ( chemical ) .	T5	T15	23314320
CPR:3	CHEMICAL	GENE-Y	25	17	military and civilian chemical countermeasure , chemical ( chemical ) , is under consideration for replacement with a more effective gene reactivator , chemical ( chemical ) .	T6	T15	23314320
NA	CHEMICAL	GENE-Y	2	2	Based on a previous model structure for the chemical chemical , the model includes key sites of gene inhibition ( brain and diaphragm ) , as well as fat , kidney , liver , rapidly perfused tissues and slowly perfused tissues .	T10	T16	23314320
NA	CHEMICAL	GENE-Y	2	2	Based on a previous model structure for the chemical chemical , the model includes key sites of gene inhibition ( brain and diaphragm ) , as well as fat , kidney , liver , rapidly perfused tissues and slowly perfused tissues .	T11	T16	23314320
CPR:4	CHEMICAL	GENE-Y	0	1	chemical as Selective gene Inhibitors .	T2	T5	23350847
NA	CHEMICAL	GENE-N	0	1	chemical racemases from barley , Hordeum vulgare L. , and other plant species represent a distinct eukaryotic group : gene cloning and recombinant protein characterization .	T27	T36	17499824
NA	CHEMICAL	GENE-Y	12	8	In this study , we cloned and sequenced a cDNA encoding a chemical racemase from barley which contained an open reading frame encoding 337 chemical residues .	T3	T30	17499824
NA	CHEMICAL	GENE-Y	8	8	In this study , we cloned and sequenced a cDNA encoding a chemical racemase from barley which contained an open reading frame encoding 337 chemical residues .	T4	T30	17499824
NA	CHEMICAL	GENE-N	2	12	The deduced chemical sequence showed significant identity to plant and mammalian chemical racemases and contained conserved chemical ( chemical ) -binding chemical and chemical-interacting chemical residues .	T5	T31	17499824
NA	CHEMICAL	GENE-N	11	12	The deduced chemical sequence showed significant identity to plant and mammalian chemical racemases and contained conserved chemical ( chemical ) -binding chemical and chemical-interacting chemical residues .	T6	T31	17499824
NA	CHEMICAL	GENE-N	16	12	The deduced chemical sequence showed significant identity to plant and mammalian chemical racemases and contained conserved chemical ( chemical ) -binding chemical and chemical-interacting chemical residues .	T7	T31	17499824
NA	CHEMICAL	GENE-N	18	12	The deduced chemical sequence showed significant identity to plant and mammalian chemical racemases and contained conserved chemical ( chemical ) -binding chemical and chemical-interacting chemical residues .	T8	T31	17499824
NA	CHEMICAL	GENE-N	21	12	The deduced chemical sequence showed significant identity to plant and mammalian chemical racemases and contained conserved chemical ( chemical ) -binding chemical and chemical-interacting chemical residues .	T9	T31	17499824
NA	CHEMICAL	GENE-N	23	12	The deduced chemical sequence showed significant identity to plant and mammalian chemical racemases and contained conserved chemical ( chemical ) -binding chemical and chemical-interacting chemical residues .	T10	T31	17499824
NA	CHEMICAL	GENE-N	24	12	The deduced chemical sequence showed significant identity to plant and mammalian chemical racemases and contained conserved chemical ( chemical ) -binding chemical and chemical-interacting chemical residues .	T11	T31	17499824
NA	CHEMICAL	GENE-N	3	8	The enzyme requires chemical and divalent cations such as chemical , chemical , or chemical , but not chemical , whereas mammalian chemical racemase activity is increased by chemical .	T15	T32	17499824
NA	CHEMICAL	GENE-N	9	8	The enzyme requires chemical and divalent cations such as chemical , chemical , or chemical , but not chemical , whereas mammalian chemical racemase activity is increased by chemical .	T16	T32	17499824
NA	CHEMICAL	GENE-N	11	8	The enzyme requires chemical and divalent cations such as chemical , chemical , or chemical , but not chemical , whereas mammalian chemical racemase activity is increased by chemical .	T17	T32	17499824
NA	CHEMICAL	GENE-N	14	8	The enzyme requires chemical and divalent cations such as chemical , chemical , or chemical , but not chemical , whereas mammalian chemical racemase activity is increased by chemical .	T18	T32	17499824
NA	CHEMICAL	GENE-N	18	8	The enzyme requires chemical and divalent cations such as chemical , chemical , or chemical , but not chemical , whereas mammalian chemical racemase activity is increased by chemical .	T19	T32	17499824
NA	CHEMICAL	GENE-N	22	8	The enzyme requires chemical and divalent cations such as chemical , chemical , or chemical , but not chemical , whereas mammalian chemical racemase activity is increased by chemical .	T20	T32	17499824
CPR:3	CHEMICAL	GENE-N	28	8	The enzyme requires chemical and divalent cations such as chemical , chemical , or chemical , but not chemical , whereas mammalian chemical racemase activity is increased by chemical .	T21	T32	17499824
NA	CHEMICAL	GENE-N	9	20	In addition to the results regarding the effect of chemical on enzyme activity and the phylogenetic analysis of eukaryotic chemical racemases , the antiserum against gene did not form a precipitate with barley and rice gene .	T22	T33	17499824
NA	CHEMICAL	GENE-Y	9	25	In addition to the results regarding the effect of chemical on enzyme activity and the phylogenetic analysis of eukaryotic chemical racemases , the antiserum against gene did not form a precipitate with barley and rice gene .	T22	T34	17499824
NA	CHEMICAL	GENE-N	9	20	In addition to the results regarding the effect of chemical on enzyme activity and the phylogenetic analysis of eukaryotic chemical racemases , the antiserum against gene did not form a precipitate with barley and rice gene .	T22	T35	17499824
NA	CHEMICAL	GENE-N	19	20	In addition to the results regarding the effect of chemical on enzyme activity and the phylogenetic analysis of eukaryotic chemical racemases , the antiserum against gene did not form a precipitate with barley and rice gene .	T24	T33	17499824
NA	CHEMICAL	GENE-Y	19	25	In addition to the results regarding the effect of chemical on enzyme activity and the phylogenetic analysis of eukaryotic chemical racemases , the antiserum against gene did not form a precipitate with barley and rice gene .	T24	T34	17499824
NA	CHEMICAL	GENE-N	19	20	In addition to the results regarding the effect of chemical on enzyme activity and the phylogenetic analysis of eukaryotic chemical racemases , the antiserum against gene did not form a precipitate with barley and rice gene .	T24	T35	17499824
NA	CHEMICAL	GENE-N	9	12	In higher cortical structures such as the hippocampus , chemical , via gene ( gene ) activation , has been shown to reinforce the cognitive processes of attention and memory .	T8	T22	15908512
NA	CHEMICAL	GENE-N	9	14	In higher cortical structures such as the hippocampus , chemical , via gene ( gene ) activation , has been shown to reinforce the cognitive processes of attention and memory .	T8	T25	15908512
CPR:5	CHEMICAL	GENE-N	4	2	The selective gene agonist chemical caused an enhancement of hippocampal CA3 network activity , as measured by an increase in frequency of spontaneous burst discharges recorded in the CA3 region .	T13	T29	15908512
NA	CHEMICAL	GENE-N	10	4	In the presence of gene blockade , concentration-response curves for chemical , chemical , and chemical suggested that a gene was involved in this response , and the rank order of potency was chemical > chemical = chemical .	T14	T30	15908512
NA	CHEMICAL	GENE-Y	10	18	In the presence of gene blockade , concentration-response curves for chemical , chemical , and chemical suggested that a gene was involved in this response , and the rank order of potency was chemical > chemical = chemical .	T14	T17	15908512
NA	CHEMICAL	GENE-N	12	4	In the presence of gene blockade , concentration-response curves for chemical , chemical , and chemical suggested that a gene was involved in this response , and the rank order of potency was chemical > chemical = chemical .	T15	T30	15908512
NA	CHEMICAL	GENE-Y	12	18	In the presence of gene blockade , concentration-response curves for chemical , chemical , and chemical suggested that a gene was involved in this response , and the rank order of potency was chemical > chemical = chemical .	T15	T17	15908512
NA	CHEMICAL	GENE-N	15	4	In the presence of gene blockade , concentration-response curves for chemical , chemical , and chemical suggested that a gene was involved in this response , and the rank order of potency was chemical > chemical = chemical .	T16	T30	15908512
NA	CHEMICAL	GENE-Y	15	18	In the presence of gene blockade , concentration-response curves for chemical , chemical , and chemical suggested that a gene was involved in this response , and the rank order of potency was chemical > chemical = chemical .	T16	T17	15908512
NA	CHEMICAL	GENE-N	33	4	In the presence of gene blockade , concentration-response curves for chemical , chemical , and chemical suggested that a gene was involved in this response , and the rank order of potency was chemical > chemical = chemical .	T2	T30	15908512
NA	CHEMICAL	GENE-Y	33	18	In the presence of gene blockade , concentration-response curves for chemical , chemical , and chemical suggested that a gene was involved in this response , and the rank order of potency was chemical > chemical = chemical .	T2	T17	15908512
NA	CHEMICAL	GENE-N	4	4	In the presence of gene blockade , concentration-response curves for chemical , chemical , and chemical suggested that a gene was involved in this response , and the rank order of potency was chemical > chemical = chemical .	T3	T30	15908512
NA	CHEMICAL	GENE-Y	4	18	In the presence of gene blockade , concentration-response curves for chemical , chemical , and chemical suggested that a gene was involved in this response , and the rank order of potency was chemical > chemical = chemical .	T3	T17	15908512
NA	CHEMICAL	GENE-N	22	4	In the presence of gene blockade , concentration-response curves for chemical , chemical , and chemical suggested that a gene was involved in this response , and the rank order of potency was chemical > chemical = chemical .	T4	T30	15908512
NA	CHEMICAL	GENE-Y	22	18	In the presence of gene blockade , concentration-response curves for chemical , chemical , and chemical suggested that a gene was involved in this response , and the rank order of potency was chemical > chemical = chemical .	T4	T17	15908512
CPR:6	CHEMICAL	GENE-Y	4	2	The selective gene antagonists chemical and chemical blocked chemical-induced enhancement , with apparent K ( b ) values of 85 +/- 36 and 3.9 +/- 1.7 nM , respectively .	T5	T20	15908512
CPR:6	CHEMICAL	GENE-Y	6	2	The selective gene antagonists chemical and chemical blocked chemical-induced enhancement , with apparent K ( b ) values of 85 +/- 36 and 3.9 +/- 1.7 nM , respectively .	T6	T20	15908512
CPR:5	CHEMICAL	GENE-Y	8	2	The selective gene antagonists chemical and chemical blocked chemical-induced enhancement , with apparent K ( b ) values of 85 +/- 36 and 3.9 +/- 1.7 nM , respectively .	T7	T20	15908512
CPR:6	CHEMICAL	GENE-Y	2	5	In contrast , the selective gene antagonists chemical and chemical inhibited chemical-mediated enhancement with apparent low affinities ( K ( b ) of 222 +/- 61 and 9268 +/- 512 nM , respectively ) .	T9	T21	15908512
CPR:6	CHEMICAL	GENE-Y	9	5	In contrast , the selective gene antagonists chemical and chemical inhibited chemical-mediated enhancement with apparent low affinities ( K ( b ) of 222 +/- 61 and 9268 +/- 512 nM , respectively ) .	T10	T21	15908512
CPR:5	CHEMICAL	GENE-Y	11	5	In contrast , the selective gene antagonists chemical and chemical inhibited chemical-mediated enhancement with apparent low affinities ( K ( b ) of 222 +/- 61 and 9268 +/- 512 nM , respectively ) .	T11	T21	15908512
NA	CHEMICAL	GENE-N	7	7	In the AG+GG group , males with gene chemical levels < 40 mg/dL are less frequent ( P = 0.05 ) and obesity tends to be less prevalent ( P = 0.07 ) .	T1	T10	23637347
NA	CHEMICAL	GENE-Y	3	0	gene overexpression increases chemical and protects against gene-induced abdominal aortic aneurysm in mice .	T9	T28	23446230
NA	CHEMICAL	GENE-Y	3	7	gene overexpression increases chemical and protects against gene-induced abdominal aortic aneurysm in mice .	T9	T29	23446230
CPR:9	CHEMICAL	GENE-Y	5	0	gene ( gene ) metabolizes chemical to form chemical ( chemical ) , which possess various beneficial effects on the cardiovascular system .	T5	T10	23446230
CPR:9	CHEMICAL	GENE-Y	5	2	gene ( gene ) metabolizes chemical to form chemical ( chemical ) , which possess various beneficial effects on the cardiovascular system .	T5	T17	23446230
CPR:9	CHEMICAL	GENE-Y	8	0	gene ( gene ) metabolizes chemical to form chemical ( chemical ) , which possess various beneficial effects on the cardiovascular system .	T7	T10	23446230
CPR:9	CHEMICAL	GENE-Y	8	2	gene ( gene ) metabolizes chemical to form chemical ( chemical ) , which possess various beneficial effects on the cardiovascular system .	T7	T17	23446230
CPR:9	CHEMICAL	GENE-Y	10	0	gene ( gene ) metabolizes chemical to form chemical ( chemical ) , which possess various beneficial effects on the cardiovascular system .	T2	T10	23446230
CPR:9	CHEMICAL	GENE-Y	10	2	gene ( gene ) metabolizes chemical to form chemical ( chemical ) , which possess various beneficial effects on the cardiovascular system .	T2	T17	23446230
CPR:9	CHEMICAL	GENE-Y	4	7	However , whether increasing chemical production by gene overexpression in vivo could prevent abdominal aortic aneurysm ( AAA ) remains unknown .	T4	T16	23446230
NA	CHEMICAL	GENE-Y	11	0	rAAV-gene delivery led to an abundant aortic gene expression and increased chemical generation .	T6	T20	23446230
NA	CHEMICAL	GENE-Y	11	7	rAAV-gene delivery led to an abundant aortic gene expression and increased chemical generation .	T6	T21	23446230
NA	CHEMICAL	GENE-Y	14	11	In cultured vascular smooth muscle cells ( VSMCs ) , rAAV-mediated gene overexpression and chemical markedly suppressed gene-induced inflammatory gene expression .	T8	T25	23446230
CPR:4	CHEMICAL	GENE-Y	14	17	In cultured vascular smooth muscle cells ( VSMCs ) , rAAV-mediated gene overexpression and chemical markedly suppressed gene-induced inflammatory gene expression .	T8	T26	23446230
CPR:4	CHEMICAL	GENE-N	14	19	In cultured vascular smooth muscle cells ( VSMCs ) , rAAV-mediated gene overexpression and chemical markedly suppressed gene-induced inflammatory gene expression .	T8	T27	23446230
NA	CHEMICAL	GENE-Y	3	3	Moreover , overexpressed gene and chemical inhibited gene-induced macrophage migration in a VSMC-macrophage coculture system .	T1	T11	23446230
CPR:4	CHEMICAL	GENE-Y	3	7	Moreover , overexpressed gene and chemical inhibited gene-induced macrophage migration in a VSMC-macrophage coculture system .	T1	T12	23446230
NA	CHEMICAL	GENE-N	16	0	gene are the membrane proteins that mediate the pain-relieving effect of opioid drugs , such as chemical and chemical as well as gene gene and gene .	T1	T4	7959748
NA	CHEMICAL	GENE-N	16	22	gene are the membrane proteins that mediate the pain-relieving effect of opioid drugs , such as chemical and chemical as well as gene gene and gene .	T1	T5	7959748
NA	CHEMICAL	GENE-Y	16	23	gene are the membrane proteins that mediate the pain-relieving effect of opioid drugs , such as chemical and chemical as well as gene gene and gene .	T1	T6	7959748
NA	CHEMICAL	GENE-N	16	25	gene are the membrane proteins that mediate the pain-relieving effect of opioid drugs , such as chemical and chemical as well as gene gene and gene .	T1	T7	7959748
NA	CHEMICAL	GENE-N	18	0	gene are the membrane proteins that mediate the pain-relieving effect of opioid drugs , such as chemical and chemical as well as gene gene and gene .	T2	T4	7959748
NA	CHEMICAL	GENE-N	18	22	gene are the membrane proteins that mediate the pain-relieving effect of opioid drugs , such as chemical and chemical as well as gene gene and gene .	T2	T5	7959748
NA	CHEMICAL	GENE-Y	18	23	gene are the membrane proteins that mediate the pain-relieving effect of opioid drugs , such as chemical and chemical as well as gene gene and gene .	T2	T6	7959748
NA	CHEMICAL	GENE-N	18	25	gene are the membrane proteins that mediate the pain-relieving effect of opioid drugs , such as chemical and chemical as well as gene gene and gene .	T2	T7	7959748
NA	CHEMICAL	GENE-Y	2	4	Effect of chemical on gene and gene activities in the presence of chemical in rat selected brain and peripheral tissues .	T13	T23	17159811
NA	CHEMICAL	GENE-Y	2	6	Effect of chemical on gene and gene activities in the presence of chemical in rat selected brain and peripheral tissues .	T13	T24	17159811
NA	CHEMICAL	GENE-Y	8	4	Effect of chemical on gene and gene activities in the presence of chemical in rat selected brain and peripheral tissues .	T12	T23	17159811
NA	CHEMICAL	GENE-Y	8	6	Effect of chemical on gene and gene activities in the presence of chemical in rat selected brain and peripheral tissues .	T12	T24	17159811
CPR:4	CHEMICAL	GENE-Y	4	11	OBJECTIVES : The alkaloid chemical ( chemical ) , which exhibits a combined gene and direct parasympathomimetic mechanism of action , is employed in conjunction with therapeutic interventions in the stimulation of central cholinergic transfer in cognitive diseases .	T4	T19	17159811
CPR:4	CHEMICAL	GENE-Y	6	11	OBJECTIVES : The alkaloid chemical ( chemical ) , which exhibits a combined gene and direct parasympathomimetic mechanism of action , is employed in conjunction with therapeutic interventions in the stimulation of central cholinergic transfer in cognitive diseases .	T6	T19	17159811
CPR:4	CHEMICAL	GENE-Y	4	8	In the interaction of chemical and chemical , gene inhibition was stronger but without any statistical significance .	T10	T22	17159811
NA	CHEMICAL	GENE-Y	6	8	In the interaction of chemical and chemical , gene inhibition was stronger but without any statistical significance .	T11	T22	17159811
CPR:4	CHEMICAL	GENE-N	0	6	chemical inhibits T-cell activation by targeting gene , gene and gene signaling pathways .	T13	T35	21631396
CPR:4	CHEMICAL	GENE-N	0	8	chemical inhibits T-cell activation by targeting gene , gene and gene signaling pathways .	T13	T36	21631396
CPR:4	CHEMICAL	GENE-Y	0	10	chemical inhibits T-cell activation by targeting gene , gene and gene signaling pathways .	T13	T37	21631396
CPR:4	CHEMICAL	GENE-Y	3	5	We found that chemical inhibits gene ( gene ) and gene-gene transcription in stimulated Jurkat cells , a human T-cell leukemia cell line .	T9	T23	21631396
CPR:4	CHEMICAL	GENE-Y	3	7	We found that chemical inhibits gene ( gene ) and gene-gene transcription in stimulated Jurkat cells , a human T-cell leukemia cell line .	T9	T24	21631396
CPR:3	CHEMICAL	GENE-Y	3	10	We found that chemical inhibits gene ( gene ) and gene-gene transcription in stimulated Jurkat cells , a human T-cell leukemia cell line .	T9	T25	21631396
NA	CHEMICAL	GENE-N	7	19	To further characterize the inhibitory mechanisms of chemical at the transcriptional level , we examined the transcriptional activities of gene ( gene ) , gene ( gene ) , and gene ( gene ) transcription factors and found that chemical inhibited gene-dependent transcriptional activity without affecting either the phosphorylation , the degradation of the cytoplasmic gene , gene or the DNA-binding activity .	T11	T26	21631396
NA	CHEMICAL	GENE-N	7	21	To further characterize the inhibitory mechanisms of chemical at the transcriptional level , we examined the transcriptional activities of gene ( gene ) , gene ( gene ) , and gene ( gene ) transcription factors and found that chemical inhibited gene-dependent transcriptional activity without affecting either the phosphorylation , the degradation of the cytoplasmic gene , gene or the DNA-binding activity .	T11	T27	21631396
NA	CHEMICAL	GENE-N	7	24	To further characterize the inhibitory mechanisms of chemical at the transcriptional level , we examined the transcriptional activities of gene ( gene ) , gene ( gene ) , and gene ( gene ) transcription factors and found that chemical inhibited gene-dependent transcriptional activity without affecting either the phosphorylation , the degradation of the cytoplasmic gene , gene or the DNA-binding activity .	T11	T28	21631396
NA	CHEMICAL	GENE-N	7	26	To further characterize the inhibitory mechanisms of chemical at the transcriptional level , we examined the transcriptional activities of gene ( gene ) , gene ( gene ) , and gene ( gene ) transcription factors and found that chemical inhibited gene-dependent transcriptional activity without affecting either the phosphorylation , the degradation of the cytoplasmic gene , gene or the DNA-binding activity .	T11	T29	21631396
NA	CHEMICAL	GENE-Y	7	30	To further characterize the inhibitory mechanisms of chemical at the transcriptional level , we examined the transcriptional activities of gene ( gene ) , gene ( gene ) , and gene ( gene ) transcription factors and found that chemical inhibited gene-dependent transcriptional activity without affecting either the phosphorylation , the degradation of the cytoplasmic gene , gene or the DNA-binding activity .	T11	T30	21631396
NA	CHEMICAL	GENE-Y	7	32	To further characterize the inhibitory mechanisms of chemical at the transcriptional level , we examined the transcriptional activities of gene ( gene ) , gene ( gene ) , and gene ( gene ) transcription factors and found that chemical inhibited gene-dependent transcriptional activity without affecting either the phosphorylation , the degradation of the cytoplasmic gene , gene or the DNA-binding activity .	T11	T31	21631396
NA	CHEMICAL	GENE-N	7	41	To further characterize the inhibitory mechanisms of chemical at the transcriptional level , we examined the transcriptional activities of gene ( gene ) , gene ( gene ) , and gene ( gene ) transcription factors and found that chemical inhibited gene-dependent transcriptional activity without affecting either the phosphorylation , the degradation of the cytoplasmic gene , gene or the DNA-binding activity .	T11	T32	21631396
NA	CHEMICAL	GENE-Y	7	55	To further characterize the inhibitory mechanisms of chemical at the transcriptional level , we examined the transcriptional activities of gene ( gene ) , gene ( gene ) , and gene ( gene ) transcription factors and found that chemical inhibited gene-dependent transcriptional activity without affecting either the phosphorylation , the degradation of the cytoplasmic gene , gene or the DNA-binding activity .	T11	T33	21631396
NA	CHEMICAL	GENE-Y	7	57	To further characterize the inhibitory mechanisms of chemical at the transcriptional level , we examined the transcriptional activities of gene ( gene ) , gene ( gene ) , and gene ( gene ) transcription factors and found that chemical inhibited gene-dependent transcriptional activity without affecting either the phosphorylation , the degradation of the cytoplasmic gene , gene or the DNA-binding activity .	T11	T34	21631396
NA	CHEMICAL	GENE-N	39	19	To further characterize the inhibitory mechanisms of chemical at the transcriptional level , we examined the transcriptional activities of gene ( gene ) , gene ( gene ) , and gene ( gene ) transcription factors and found that chemical inhibited gene-dependent transcriptional activity without affecting either the phosphorylation , the degradation of the cytoplasmic gene , gene or the DNA-binding activity .	T12	T26	21631396
NA	CHEMICAL	GENE-N	39	21	To further characterize the inhibitory mechanisms of chemical at the transcriptional level , we examined the transcriptional activities of gene ( gene ) , gene ( gene ) , and gene ( gene ) transcription factors and found that chemical inhibited gene-dependent transcriptional activity without affecting either the phosphorylation , the degradation of the cytoplasmic gene , gene or the DNA-binding activity .	T12	T27	21631396
NA	CHEMICAL	GENE-N	39	24	To further characterize the inhibitory mechanisms of chemical at the transcriptional level , we examined the transcriptional activities of gene ( gene ) , gene ( gene ) , and gene ( gene ) transcription factors and found that chemical inhibited gene-dependent transcriptional activity without affecting either the phosphorylation , the degradation of the cytoplasmic gene , gene or the DNA-binding activity .	T12	T28	21631396
NA	CHEMICAL	GENE-N	39	26	To further characterize the inhibitory mechanisms of chemical at the transcriptional level , we examined the transcriptional activities of gene ( gene ) , gene ( gene ) , and gene ( gene ) transcription factors and found that chemical inhibited gene-dependent transcriptional activity without affecting either the phosphorylation , the degradation of the cytoplasmic gene , gene or the DNA-binding activity .	T12	T29	21631396
NA	CHEMICAL	GENE-Y	39	30	To further characterize the inhibitory mechanisms of chemical at the transcriptional level , we examined the transcriptional activities of gene ( gene ) , gene ( gene ) , and gene ( gene ) transcription factors and found that chemical inhibited gene-dependent transcriptional activity without affecting either the phosphorylation , the degradation of the cytoplasmic gene , gene or the DNA-binding activity .	T12	T30	21631396
NA	CHEMICAL	GENE-Y	39	32	To further characterize the inhibitory mechanisms of chemical at the transcriptional level , we examined the transcriptional activities of gene ( gene ) , gene ( gene ) , and gene ( gene ) transcription factors and found that chemical inhibited gene-dependent transcriptional activity without affecting either the phosphorylation , the degradation of the cytoplasmic gene , gene or the DNA-binding activity .	T12	T31	21631396
CPR:4	CHEMICAL	GENE-N	39	41	To further characterize the inhibitory mechanisms of chemical at the transcriptional level , we examined the transcriptional activities of gene ( gene ) , gene ( gene ) , and gene ( gene ) transcription factors and found that chemical inhibited gene-dependent transcriptional activity without affecting either the phosphorylation , the degradation of the cytoplasmic gene , gene or the DNA-binding activity .	T12	T32	21631396
NA	CHEMICAL	GENE-Y	39	55	To further characterize the inhibitory mechanisms of chemical at the transcriptional level , we examined the transcriptional activities of gene ( gene ) , gene ( gene ) , and gene ( gene ) transcription factors and found that chemical inhibited gene-dependent transcriptional activity without affecting either the phosphorylation , the degradation of the cytoplasmic gene , gene or the DNA-binding activity .	T12	T33	21631396
NA	CHEMICAL	GENE-Y	39	57	To further characterize the inhibitory mechanisms of chemical at the transcriptional level , we examined the transcriptional activities of gene ( gene ) , gene ( gene ) , and gene ( gene ) transcription factors and found that chemical inhibited gene-dependent transcriptional activity without affecting either the phosphorylation , the degradation of the cytoplasmic gene , gene or the DNA-binding activity .	T12	T34	21631396
CPR:4	CHEMICAL	GENE-Y	11	5	However , phosphorylation of the gene/gene subunit was clearly inhibited by chemical in stimulated cells .	T2	T14	21631396
CPR:4	CHEMICAL	GENE-Y	11	5	However , phosphorylation of the gene/gene subunit was clearly inhibited by chemical in stimulated cells .	T2	T15	21631396
CPR:4	CHEMICAL	GENE-N	3	9	In addition , chemical inhibited the transcriptional activity of gene without interfering with the chemical-induced gene dephosphorylation event , which represents the major signaling pathway for its activation .	T3	T16	21631396
NA	CHEMICAL	GENE-N	3	15	In addition , chemical inhibited the transcriptional activity of gene without interfering with the chemical-induced gene dephosphorylation event , which represents the major signaling pathway for its activation .	T3	T17	21631396
NA	CHEMICAL	GENE-N	14	9	In addition , chemical inhibited the transcriptional activity of gene without interfering with the chemical-induced gene dephosphorylation event , which represents the major signaling pathway for its activation .	T4	T16	21631396
CPR:3	CHEMICAL	GENE-N	14	15	In addition , chemical inhibited the transcriptional activity of gene without interfering with the chemical-induced gene dephosphorylation event , which represents the major signaling pathway for its activation .	T4	T17	21631396
NA	CHEMICAL	GENE-N	22	0	gene cooperates with gene , a compound of the gene complex , to activate target genes , and we also found that chemical inhibited both gene activation and gene transcriptional activity .	T5	T18	21631396
NA	CHEMICAL	GENE-Y	22	3	gene cooperates with gene , a compound of the gene complex , to activate target genes , and we also found that chemical inhibited both gene activation and gene transcriptional activity .	T5	T19	21631396
NA	CHEMICAL	GENE-Y	22	9	gene cooperates with gene , a compound of the gene complex , to activate target genes , and we also found that chemical inhibited both gene activation and gene transcriptional activity .	T5	T20	21631396
CPR:4	CHEMICAL	GENE-N	22	25	gene cooperates with gene , a compound of the gene complex , to activate target genes , and we also found that chemical inhibited both gene activation and gene transcriptional activity .	T5	T21	21631396
CPR:4	CHEMICAL	GENE-Y	22	28	gene cooperates with gene , a compound of the gene complex , to activate target genes , and we also found that chemical inhibited both gene activation and gene transcriptional activity .	T5	T22	21631396
CPR:9	CHEMICAL	GENE-N	0	7	chemical was metabolised by chemical to form a chemical conjugate ( chemical ) in RAW 264.7 cells , via a potential mechanism involving the catalytic activity of chemical-chemical-transferase ( gene ) .	T20	T31	23578607
CPR:9	CHEMICAL	GENE-N	0	29	chemical was metabolised by chemical to form a chemical conjugate ( chemical ) in RAW 264.7 cells , via a potential mechanism involving the catalytic activity of chemical-chemical-transferase ( gene ) .	T20	T32	23578607
NA	CHEMICAL	GENE-N	4	7	chemical was metabolised by chemical to form a chemical conjugate ( chemical ) in RAW 264.7 cells , via a potential mechanism involving the catalytic activity of chemical-chemical-transferase ( gene ) .	T21	T31	23578607
NA	CHEMICAL	GENE-N	4	29	chemical was metabolised by chemical to form a chemical conjugate ( chemical ) in RAW 264.7 cells , via a potential mechanism involving the catalytic activity of chemical-chemical-transferase ( gene ) .	T21	T32	23578607
NA	CHEMICAL	GENE-N	8	7	chemical was metabolised by chemical to form a chemical conjugate ( chemical ) in RAW 264.7 cells , via a potential mechanism involving the catalytic activity of chemical-chemical-transferase ( gene ) .	T22	T31	23578607
NA	CHEMICAL	GENE-N	8	29	chemical was metabolised by chemical to form a chemical conjugate ( chemical ) in RAW 264.7 cells , via a potential mechanism involving the catalytic activity of chemical-chemical-transferase ( gene ) .	T22	T32	23578607
CPR:9	CHEMICAL	GENE-N	11	7	chemical was metabolised by chemical to form a chemical conjugate ( chemical ) in RAW 264.7 cells , via a potential mechanism involving the catalytic activity of chemical-chemical-transferase ( gene ) .	T23	T31	23578607
CPR:9	CHEMICAL	GENE-N	11	29	chemical was metabolised by chemical to form a chemical conjugate ( chemical ) in RAW 264.7 cells , via a potential mechanism involving the catalytic activity of chemical-chemical-transferase ( gene ) .	T23	T32	23578607
NA	CHEMICAL	GENE-N	7	7	chemical was metabolised by chemical to form a chemical conjugate ( chemical ) in RAW 264.7 cells , via a potential mechanism involving the catalytic activity of chemical-chemical-transferase ( gene ) .	T24	T31	23578607
NA	CHEMICAL	GENE-N	7	29	chemical was metabolised by chemical to form a chemical conjugate ( chemical ) in RAW 264.7 cells , via a potential mechanism involving the catalytic activity of chemical-chemical-transferase ( gene ) .	T24	T32	23578607
NA	CHEMICAL	GENE-N	27	7	chemical was metabolised by chemical to form a chemical conjugate ( chemical ) in RAW 264.7 cells , via a potential mechanism involving the catalytic activity of chemical-chemical-transferase ( gene ) .	T25	T31	23578607
NA	CHEMICAL	GENE-N	27	29	chemical was metabolised by chemical to form a chemical conjugate ( chemical ) in RAW 264.7 cells , via a potential mechanism involving the catalytic activity of chemical-chemical-transferase ( gene ) .	T25	T32	23578607
CPR:4	CHEMICAL	GENE-Y	6	8	Previously , we have found that chemical , a chemical derivative , inhibits gene ( gene ) -mediated angiogenesis signaling in human endothelial cells .	T2	T13	23453071
CPR:4	CHEMICAL	GENE-Y	6	15	Previously , we have found that chemical , a chemical derivative , inhibits gene ( gene ) -mediated angiogenesis signaling in human endothelial cells .	T2	T10	23453071
CPR:4	CHEMICAL	GENE-Y	8	8	Previously , we have found that chemical , a chemical derivative , inhibits gene ( gene ) -mediated angiogenesis signaling in human endothelial cells .	T4	T13	23453071
CPR:4	CHEMICAL	GENE-Y	8	15	Previously , we have found that chemical , a chemical derivative , inhibits gene ( gene ) -mediated angiogenesis signaling in human endothelial cells .	T4	T10	23453071
CPR:4	CHEMICAL	GENE-Y	2	5	Furthermore , chemical inhibited the gene-induced phosphorylation and intracellular chemical kinase activity of gene ( gene ) and the activation of its downstream gene pathway .	T6	T11	23453071
CPR:4	CHEMICAL	GENE-N	2	10	Furthermore , chemical inhibited the gene-induced phosphorylation and intracellular chemical kinase activity of gene ( gene ) and the activation of its downstream gene pathway .	T6	T12	23453071
CPR:4	CHEMICAL	GENE-Y	2	13	Furthermore , chemical inhibited the gene-induced phosphorylation and intracellular chemical kinase activity of gene ( gene ) and the activation of its downstream gene pathway .	T6	T14	23453071
CPR:4	CHEMICAL	GENE-Y	2	15	Furthermore , chemical inhibited the gene-induced phosphorylation and intracellular chemical kinase activity of gene ( gene ) and the activation of its downstream gene pathway .	T6	T15	23453071
CPR:4	CHEMICAL	GENE-N	2	23	Furthermore , chemical inhibited the gene-induced phosphorylation and intracellular chemical kinase activity of gene ( gene ) and the activation of its downstream gene pathway .	T6	T16	23453071
NA	CHEMICAL	GENE-Y	9	5	Furthermore , chemical inhibited the gene-induced phosphorylation and intracellular chemical kinase activity of gene ( gene ) and the activation of its downstream gene pathway .	T7	T11	23453071
NA	CHEMICAL	GENE-N	9	10	Furthermore , chemical inhibited the gene-induced phosphorylation and intracellular chemical kinase activity of gene ( gene ) and the activation of its downstream gene pathway .	T7	T12	23453071
NA	CHEMICAL	GENE-Y	9	13	Furthermore , chemical inhibited the gene-induced phosphorylation and intracellular chemical kinase activity of gene ( gene ) and the activation of its downstream gene pathway .	T7	T14	23453071
NA	CHEMICAL	GENE-Y	9	15	Furthermore , chemical inhibited the gene-induced phosphorylation and intracellular chemical kinase activity of gene ( gene ) and the activation of its downstream gene pathway .	T7	T15	23453071
NA	CHEMICAL	GENE-N	9	23	Furthermore , chemical inhibited the gene-induced phosphorylation and intracellular chemical kinase activity of gene ( gene ) and the activation of its downstream gene pathway .	T7	T16	23453071
NA	CHEMICAL	GENE-Y	3	4	Six children with chemical oxidase ( gene ) deficiency presented with neonatal epileptic encephalopathy .	T1	T6	17216302
NA	CHEMICAL	GENE-Y	3	6	Six children with chemical oxidase ( gene ) deficiency presented with neonatal epileptic encephalopathy .	T1	T7	17216302
CPR:4	CHEMICAL	GENE-Y	0	3	chemical analogues inhibit gene expression in the human monocytic cell line THP-1 via a chemical-dependent mechanism .	T20	T34	1375507
NA	CHEMICAL	GENE-Y	14	3	chemical analogues inhibit gene expression in the human monocytic cell line THP-1 via a chemical-dependent mechanism .	T21	T34	1375507
CPR:4	CHEMICAL	GENE-Y	11	5	The present studies were undertaken to determine whether stable analogues of chemical , a potent endothelium-derived platelet inhibitor and vasodilator , could inhibit gene expression by human monocytic cells .	T12	T28	1375507
CPR:4	CHEMICAL	GENE-Y	5	12	Preincubation for 30 minutes with chemical , chemical , and chemical led to a dose-dependent inhibition of gene expression induced by all three challenging agents .	T13	T32	1375507
CPR:4	CHEMICAL	GENE-Y	7	12	Preincubation for 30 minutes with chemical , chemical , and chemical led to a dose-dependent inhibition of gene expression induced by all three challenging agents .	T14	T32	1375507
CPR:4	CHEMICAL	GENE-Y	10	12	Preincubation for 30 minutes with chemical , chemical , and chemical led to a dose-dependent inhibition of gene expression induced by all three challenging agents .	T15	T32	1375507
NA	CHEMICAL	GENE-Y	0	17	chemical was the most potent : 50 % inhibition occurred at 5 nM , a concentration close to the reported dissociation constant for chemical binding to the platelet chemical receptor .	T16	T33	1375507
NA	CHEMICAL	GENE-Y	23	17	chemical was the most potent : 50 % inhibition occurred at 5 nM , a concentration close to the reported dissociation constant for chemical binding to the platelet chemical receptor .	T17	T33	1375507
NA	CHEMICAL	GENE-Y	14	17	chemical was the most potent : 50 % inhibition occurred at 5 nM , a concentration close to the reported dissociation constant for chemical binding to the platelet chemical receptor .	T18	T33	1375507
NA	CHEMICAL	GENE-Y	5	12	An orally active analogue , chemical , was equally effective against endotoxin-induced gene expression .	T19	T22	1375507
CPR:4	CHEMICAL	GENE-N	5	10	This effect was potentiated by chemical , an inhibitor of gene .	T5	T24	1375507
CPR:4	CHEMICAL	GENE-Y	12	6	The inhibitory effects of iloprost on gene expression were also potentiated by chemical and mimicked by chemical and dchemical but not chemical .	T6	T25	1375507
CPR:4	CHEMICAL	GENE-Y	16	6	The inhibitory effects of iloprost on gene expression were also potentiated by chemical and mimicked by chemical and dchemical but not chemical .	T7	T25	1375507
CPR:4	CHEMICAL	GENE-Y	18	6	The inhibitory effects of iloprost on gene expression were also potentiated by chemical and mimicked by chemical and dchemical but not chemical .	T8	T25	1375507
NA	CHEMICAL	GENE-Y	21	6	The inhibitory effects of iloprost on gene expression were also potentiated by chemical and mimicked by chemical and dchemical but not chemical .	T9	T25	1375507
NA	CHEMICAL	GENE-Y	6	6	To characterise further the relationship between gene and torpor , we profiled gene expression in mice during prolonged fasting , cold exposure , and chemical-induced hypometabolism , as well as in naturally occurring torpor bouts in the Siberian hamster .	T1	T11	23584857
NA	CHEMICAL	GENE-Y	6	12	To characterise further the relationship between gene and torpor , we profiled gene expression in mice during prolonged fasting , cold exposure , and chemical-induced hypometabolism , as well as in naturally occurring torpor bouts in the Siberian hamster .	T1	T12	23584857
NA	CHEMICAL	GENE-Y	6	3	The interaction between gene and the chemical channel gene preserves coupling in the presence of gene .	T10	T39	22659088
NA	CHEMICAL	GENE-N	6	7	The interaction between gene and the chemical channel gene preserves coupling in the presence of gene .	T10	T40	22659088
NA	CHEMICAL	GENE-Y	6	8	The interaction between gene and the chemical channel gene preserves coupling in the presence of gene .	T10	T41	22659088
NA	CHEMICAL	GENE-N	6	11	The interaction between gene and the chemical channel gene preserves coupling in the presence of gene .	T10	T38	22659088
NA	CHEMICAL	GENE-N	11	0	gene ( gene ) are gene that regulate neuronal activity in a number of ways .	T4	T11	22659088
NA	CHEMICAL	GENE-N	11	2	gene ( gene ) are gene that regulate neuronal activity in a number of ways .	T4	T24	22659088
NA	CHEMICAL	GENE-N	11	5	gene ( gene ) are gene that regulate neuronal activity in a number of ways .	T4	T26	22659088
NA	CHEMICAL	GENE-N	22	8	This localization is in turn dependent on the gene family of scaffolding proteins which bind to a small motif on the distal chemical-termini of gene , localize the receptors near the PSD , strengthen coupling to post-synaptic effectors and simultaneously uncouple the gene from extra-synaptic effectors such as gene .	T5	T23	22659088
NA	CHEMICAL	GENE-N	22	24	This localization is in turn dependent on the gene family of scaffolding proteins which bind to a small motif on the distal chemical-termini of gene , localize the receptors near the PSD , strengthen coupling to post-synaptic effectors and simultaneously uncouple the gene from extra-synaptic effectors such as gene .	T5	T25	22659088
NA	CHEMICAL	GENE-N	22	42	This localization is in turn dependent on the gene family of scaffolding proteins which bind to a small motif on the distal chemical-termini of gene , localize the receptors near the PSD , strengthen coupling to post-synaptic effectors and simultaneously uncouple the gene from extra-synaptic effectors such as gene .	T5	T27	22659088
NA	CHEMICAL	GENE-N	22	16	This localization is in turn dependent on the gene family of scaffolding proteins which bind to a small motif on the distal chemical-termini of gene , localize the receptors near the PSD , strengthen coupling to post-synaptic effectors and simultaneously uncouple the gene from extra-synaptic effectors such as gene .	T5	T28	22659088
NA	CHEMICAL	GENE-Y	22	14	Here the selectivity of this uncoupling process was examined by testing the ability of gene to uncouple gene from multiple gene including chemical ( V2.2 ) ( gene ) , chemical ( V3.2 ) ( gene , and chemical ( V2.1 ) ( gene ) expressed in rat sympathetic neurons from the superior cervical ganglion ( SCG ) .	T7	T29	22659088
NA	CHEMICAL	GENE-Y	22	17	Here the selectivity of this uncoupling process was examined by testing the ability of gene to uncouple gene from multiple gene including chemical ( V2.2 ) ( gene ) , chemical ( V3.2 ) ( gene , and chemical ( V2.1 ) ( gene ) expressed in rat sympathetic neurons from the superior cervical ganglion ( SCG ) .	T7	T30	22659088
NA	CHEMICAL	GENE-N	22	20	Here the selectivity of this uncoupling process was examined by testing the ability of gene to uncouple gene from multiple gene including chemical ( V2.2 ) ( gene ) , chemical ( V3.2 ) ( gene , and chemical ( V2.1 ) ( gene ) expressed in rat sympathetic neurons from the superior cervical ganglion ( SCG ) .	T7	T31	22659088
NA	CHEMICAL	GENE-Y	22	23	Here the selectivity of this uncoupling process was examined by testing the ability of gene to uncouple gene from multiple gene including chemical ( V2.2 ) ( gene ) , chemical ( V3.2 ) ( gene , and chemical ( V2.1 ) ( gene ) expressed in rat sympathetic neurons from the superior cervical ganglion ( SCG ) .	T7	T32	22659088
NA	CHEMICAL	GENE-N	22	27	Here the selectivity of this uncoupling process was examined by testing the ability of gene to uncouple gene from multiple gene including chemical ( V2.2 ) ( gene ) , chemical ( V3.2 ) ( gene , and chemical ( V2.1 ) ( gene ) expressed in rat sympathetic neurons from the superior cervical ganglion ( SCG ) .	T7	T33	22659088
NA	CHEMICAL	GENE-Y	22	23	Here the selectivity of this uncoupling process was examined by testing the ability of gene to uncouple gene from multiple gene including chemical ( V2.2 ) ( gene ) , chemical ( V3.2 ) ( gene , and chemical ( V2.1 ) ( gene ) expressed in rat sympathetic neurons from the superior cervical ganglion ( SCG ) .	T7	T34	22659088
NA	CHEMICAL	GENE-N	22	25	Here the selectivity of this uncoupling process was examined by testing the ability of gene to uncouple gene from multiple gene including chemical ( V2.2 ) ( gene ) , chemical ( V3.2 ) ( gene , and chemical ( V2.1 ) ( gene ) expressed in rat sympathetic neurons from the superior cervical ganglion ( SCG ) .	T7	T35	22659088
NA	CHEMICAL	GENE-Y	22	23	Here the selectivity of this uncoupling process was examined by testing the ability of gene to uncouple gene from multiple gene including chemical ( V2.2 ) ( gene ) , chemical ( V3.2 ) ( gene , and chemical ( V2.1 ) ( gene ) expressed in rat sympathetic neurons from the superior cervical ganglion ( SCG ) .	T7	T36	22659088
NA	CHEMICAL	GENE-N	22	43	Here the selectivity of this uncoupling process was examined by testing the ability of gene to uncouple gene from multiple gene including chemical ( V2.2 ) ( gene ) , chemical ( V3.2 ) ( gene , and chemical ( V2.1 ) ( gene ) expressed in rat sympathetic neurons from the superior cervical ganglion ( SCG ) .	T7	T37	22659088
NA	CHEMICAL	GENE-Y	30	14	Here the selectivity of this uncoupling process was examined by testing the ability of gene to uncouple gene from multiple gene including chemical ( V2.2 ) ( gene ) , chemical ( V3.2 ) ( gene , and chemical ( V2.1 ) ( gene ) expressed in rat sympathetic neurons from the superior cervical ganglion ( SCG ) .	T8	T29	22659088
NA	CHEMICAL	GENE-Y	30	17	Here the selectivity of this uncoupling process was examined by testing the ability of gene to uncouple gene from multiple gene including chemical ( V2.2 ) ( gene ) , chemical ( V3.2 ) ( gene , and chemical ( V2.1 ) ( gene ) expressed in rat sympathetic neurons from the superior cervical ganglion ( SCG ) .	T8	T30	22659088
NA	CHEMICAL	GENE-N	30	20	Here the selectivity of this uncoupling process was examined by testing the ability of gene to uncouple gene from multiple gene including chemical ( V2.2 ) ( gene ) , chemical ( V3.2 ) ( gene , and chemical ( V2.1 ) ( gene ) expressed in rat sympathetic neurons from the superior cervical ganglion ( SCG ) .	T8	T31	22659088
NA	CHEMICAL	GENE-Y	30	23	Here the selectivity of this uncoupling process was examined by testing the ability of gene to uncouple gene from multiple gene including chemical ( V2.2 ) ( gene ) , chemical ( V3.2 ) ( gene , and chemical ( V2.1 ) ( gene ) expressed in rat sympathetic neurons from the superior cervical ganglion ( SCG ) .	T8	T32	22659088
NA	CHEMICAL	GENE-N	30	27	Here the selectivity of this uncoupling process was examined by testing the ability of gene to uncouple gene from multiple gene including chemical ( V2.2 ) ( gene ) , chemical ( V3.2 ) ( gene , and chemical ( V2.1 ) ( gene ) expressed in rat sympathetic neurons from the superior cervical ganglion ( SCG ) .	T8	T33	22659088
NA	CHEMICAL	GENE-Y	30	23	Here the selectivity of this uncoupling process was examined by testing the ability of gene to uncouple gene from multiple gene including chemical ( V2.2 ) ( gene ) , chemical ( V3.2 ) ( gene , and chemical ( V2.1 ) ( gene ) expressed in rat sympathetic neurons from the superior cervical ganglion ( SCG ) .	T8	T34	22659088
NA	CHEMICAL	GENE-N	30	25	Here the selectivity of this uncoupling process was examined by testing the ability of gene to uncouple gene from multiple gene including chemical ( V2.2 ) ( gene ) , chemical ( V3.2 ) ( gene , and chemical ( V2.1 ) ( gene ) expressed in rat sympathetic neurons from the superior cervical ganglion ( SCG ) .	T8	T35	22659088
NA	CHEMICAL	GENE-Y	30	23	Here the selectivity of this uncoupling process was examined by testing the ability of gene to uncouple gene from multiple gene including chemical ( V2.2 ) ( gene ) , chemical ( V3.2 ) ( gene , and chemical ( V2.1 ) ( gene ) expressed in rat sympathetic neurons from the superior cervical ganglion ( SCG ) .	T8	T36	22659088
NA	CHEMICAL	GENE-N	30	43	Here the selectivity of this uncoupling process was examined by testing the ability of gene to uncouple gene from multiple gene including chemical ( V2.2 ) ( gene ) , chemical ( V3.2 ) ( gene , and chemical ( V2.1 ) ( gene ) expressed in rat sympathetic neurons from the superior cervical ganglion ( SCG ) .	T8	T37	22659088
NA	CHEMICAL	GENE-Y	38	14	Here the selectivity of this uncoupling process was examined by testing the ability of gene to uncouple gene from multiple gene including chemical ( V2.2 ) ( gene ) , chemical ( V3.2 ) ( gene , and chemical ( V2.1 ) ( gene ) expressed in rat sympathetic neurons from the superior cervical ganglion ( SCG ) .	T9	T29	22659088
NA	CHEMICAL	GENE-Y	38	17	Here the selectivity of this uncoupling process was examined by testing the ability of gene to uncouple gene from multiple gene including chemical ( V2.2 ) ( gene ) , chemical ( V3.2 ) ( gene , and chemical ( V2.1 ) ( gene ) expressed in rat sympathetic neurons from the superior cervical ganglion ( SCG ) .	T9	T30	22659088
NA	CHEMICAL	GENE-N	38	20	Here the selectivity of this uncoupling process was examined by testing the ability of gene to uncouple gene from multiple gene including chemical ( V2.2 ) ( gene ) , chemical ( V3.2 ) ( gene , and chemical ( V2.1 ) ( gene ) expressed in rat sympathetic neurons from the superior cervical ganglion ( SCG ) .	T9	T31	22659088
NA	CHEMICAL	GENE-Y	38	23	Here the selectivity of this uncoupling process was examined by testing the ability of gene to uncouple gene from multiple gene including chemical ( V2.2 ) ( gene ) , chemical ( V3.2 ) ( gene , and chemical ( V2.1 ) ( gene ) expressed in rat sympathetic neurons from the superior cervical ganglion ( SCG ) .	T9	T32	22659088
NA	CHEMICAL	GENE-N	38	27	Here the selectivity of this uncoupling process was examined by testing the ability of gene to uncouple gene from multiple gene including chemical ( V2.2 ) ( gene ) , chemical ( V3.2 ) ( gene , and chemical ( V2.1 ) ( gene ) expressed in rat sympathetic neurons from the superior cervical ganglion ( SCG ) .	T9	T33	22659088
NA	CHEMICAL	GENE-Y	38	23	Here the selectivity of this uncoupling process was examined by testing the ability of gene to uncouple gene from multiple gene including chemical ( V2.2 ) ( gene ) , chemical ( V3.2 ) ( gene , and chemical ( V2.1 ) ( gene ) expressed in rat sympathetic neurons from the superior cervical ganglion ( SCG ) .	T9	T34	22659088
NA	CHEMICAL	GENE-N	38	25	Here the selectivity of this uncoupling process was examined by testing the ability of gene to uncouple gene from multiple gene including chemical ( V2.2 ) ( gene ) , chemical ( V3.2 ) ( gene , and chemical ( V2.1 ) ( gene ) expressed in rat sympathetic neurons from the superior cervical ganglion ( SCG ) .	T9	T35	22659088
NA	CHEMICAL	GENE-Y	38	23	Here the selectivity of this uncoupling process was examined by testing the ability of gene to uncouple gene from multiple gene including chemical ( V2.2 ) ( gene ) , chemical ( V3.2 ) ( gene , and chemical ( V2.1 ) ( gene ) expressed in rat sympathetic neurons from the superior cervical ganglion ( SCG ) .	T9	T36	22659088
NA	CHEMICAL	GENE-N	38	43	Here the selectivity of this uncoupling process was examined by testing the ability of gene to uncouple gene from multiple gene including chemical ( V2.2 ) ( gene ) , chemical ( V3.2 ) ( gene , and chemical ( V2.1 ) ( gene ) expressed in rat sympathetic neurons from the superior cervical ganglion ( SCG ) .	T9	T37	22659088
NA	CHEMICAL	GENE-Y	10	10	Uncoupling from this channel was achieved by co-expression of an gene chemical-terminal protein designed to disrupt a previously described direct interaction between these two proteins , suggesting that this interaction allows incorporation of chemical ( V2.1 ) into the gene/gene signaling complex , thereby preserving modulation in the presence of scaffolding gene .	T1	T15	22659088
NA	CHEMICAL	GENE-Y	10	16	Uncoupling from this channel was achieved by co-expression of an gene chemical-terminal protein designed to disrupt a previously described direct interaction between these two proteins , suggesting that this interaction allows incorporation of chemical ( V2.1 ) into the gene/gene signaling complex , thereby preserving modulation in the presence of scaffolding gene .	T1	T16	22659088
NA	CHEMICAL	GENE-Y	10	39	Uncoupling from this channel was achieved by co-expression of an gene chemical-terminal protein designed to disrupt a previously described direct interaction between these two proteins , suggesting that this interaction allows incorporation of chemical ( V2.1 ) into the gene/gene signaling complex , thereby preserving modulation in the presence of scaffolding gene .	T1	T17	22659088
NA	CHEMICAL	GENE-N	10	39	Uncoupling from this channel was achieved by co-expression of an gene chemical-terminal protein designed to disrupt a previously described direct interaction between these two proteins , suggesting that this interaction allows incorporation of chemical ( V2.1 ) into the gene/gene signaling complex , thereby preserving modulation in the presence of scaffolding gene .	T1	T18	22659088
NA	CHEMICAL	GENE-N	10	12	Uncoupling from this channel was achieved by co-expression of an gene chemical-terminal protein designed to disrupt a previously described direct interaction between these two proteins , suggesting that this interaction allows incorporation of chemical ( V2.1 ) into the gene/gene signaling complex , thereby preserving modulation in the presence of scaffolding gene .	T1	T19	22659088
NA	CHEMICAL	GENE-Y	16	10	Uncoupling from this channel was achieved by co-expression of an gene chemical-terminal protein designed to disrupt a previously described direct interaction between these two proteins , suggesting that this interaction allows incorporation of chemical ( V2.1 ) into the gene/gene signaling complex , thereby preserving modulation in the presence of scaffolding gene .	T2	T15	22659088
NA	CHEMICAL	GENE-Y	16	16	Uncoupling from this channel was achieved by co-expression of an gene chemical-terminal protein designed to disrupt a previously described direct interaction between these two proteins , suggesting that this interaction allows incorporation of chemical ( V2.1 ) into the gene/gene signaling complex , thereby preserving modulation in the presence of scaffolding gene .	T2	T16	22659088
NA	CHEMICAL	GENE-Y	16	39	Uncoupling from this channel was achieved by co-expression of an gene chemical-terminal protein designed to disrupt a previously described direct interaction between these two proteins , suggesting that this interaction allows incorporation of chemical ( V2.1 ) into the gene/gene signaling complex , thereby preserving modulation in the presence of scaffolding gene .	T2	T17	22659088
NA	CHEMICAL	GENE-N	16	39	Uncoupling from this channel was achieved by co-expression of an gene chemical-terminal protein designed to disrupt a previously described direct interaction between these two proteins , suggesting that this interaction allows incorporation of chemical ( V2.1 ) into the gene/gene signaling complex , thereby preserving modulation in the presence of scaffolding gene .	T2	T18	22659088
NA	CHEMICAL	GENE-N	16	12	Uncoupling from this channel was achieved by co-expression of an gene chemical-terminal protein designed to disrupt a previously described direct interaction between these two proteins , suggesting that this interaction allows incorporation of chemical ( V2.1 ) into the gene/gene signaling complex , thereby preserving modulation in the presence of scaffolding gene .	T2	T19	22659088
NA	CHEMICAL	GENE-N	5	7	Characterization of the interaction of chemical with gene . chemical ( chemical ) is one of the active ingredients in Euphorbia peplus , which has been used in traditional medicine .	T23	T37	15126366
NA	CHEMICAL	GENE-N	9	7	Characterization of the interaction of chemical with gene . chemical ( chemical ) is one of the active ingredients in Euphorbia peplus , which has been used in traditional medicine .	T1	T37	15126366
NA	CHEMICAL	GENE-N	11	7	Characterization of the interaction of chemical with gene . chemical ( chemical ) is one of the active ingredients in Euphorbia peplus , which has been used in traditional medicine .	T10	T37	15126366
NA	CHEMICAL	GENE-N	8	11	Here , we report the initial characterization of chemical as a gene ( gene ) ligand .	T9	T28	15126366
NA	CHEMICAL	GENE-N	8	13	Here , we report the initial characterization of chemical as a gene ( gene ) ligand .	T9	T29	15126366
NA	CHEMICAL	GENE-Y	0	3	chemical bound to gene in the presence of chemical with high affinity ; however , under these assay conditions , little gene isoform selectivity was observed .	T11	T30	15126366
NA	CHEMICAL	GENE-N	0	21	chemical bound to gene in the presence of chemical with high affinity ; however , under these assay conditions , little gene isoform selectivity was observed .	T11	T31	15126366
NA	CHEMICAL	GENE-Y	4	3	chemical bound to gene in the presence of chemical with high affinity ; however , under these assay conditions , little gene isoform selectivity was observed .	T12	T30	15126366
NA	CHEMICAL	GENE-N	4	21	chemical bound to gene in the presence of chemical with high affinity ; however , under these assay conditions , little gene isoform selectivity was observed .	T12	T31	15126366
CPR:4	CHEMICAL	GENE-N	11	0	gene isoforms did show different sensitivity and selectivity for down-regulation by chemical and chemical ( chemical ) in WEHI-231 , HOP-92 , and Colo-205 cells .	T13	T32	15126366
CPR:4	CHEMICAL	GENE-N	13	0	gene isoforms did show different sensitivity and selectivity for down-regulation by chemical and chemical ( chemical ) in WEHI-231 , HOP-92 , and Colo-205 cells .	T14	T32	15126366
CPR:4	CHEMICAL	GENE-N	15	0	gene isoforms did show different sensitivity and selectivity for down-regulation by chemical and chemical ( chemical ) in WEHI-231 , HOP-92 , and Colo-205 cells .	T15	T32	15126366
NA	CHEMICAL	GENE-Y	5	11	In intact CHO-K1 cells , chemical was able to translocate different gene-tagged gene isoforms , visualized by confocal microscopy , with equal or higher potency than chemical .	T18	T33	15126366
NA	CHEMICAL	GENE-N	5	12	In intact CHO-K1 cells , chemical was able to translocate different gene-tagged gene isoforms , visualized by confocal microscopy , with equal or higher potency than chemical .	T18	T34	15126366
NA	CHEMICAL	GENE-Y	26	11	In intact CHO-K1 cells , chemical was able to translocate different gene-tagged gene isoforms , visualized by confocal microscopy , with equal or higher potency than chemical .	T19	T33	15126366
NA	CHEMICAL	GENE-N	26	12	In intact CHO-K1 cells , chemical was able to translocate different gene-tagged gene isoforms , visualized by confocal microscopy , with equal or higher potency than chemical .	T19	T34	15126366
NA	CHEMICAL	GENE-Y	12	0	gene in particular showed a different pattern of translocation in response to chemical and chemical .	T20	T35	15126366
NA	CHEMICAL	GENE-Y	14	0	gene in particular showed a different pattern of translocation in response to chemical and chemical .	T21	T35	15126366
CPR:3	CHEMICAL	GENE-N	0	10	chemical induced a higher level of secretion of the inflammatory gene gene compared with chemical in the WEHI-231 cells and displayed a marked biphasic dose-response curve for the induction .	T22	T36	15126366
CPR:3	CHEMICAL	GENE-Y	0	11	chemical induced a higher level of secretion of the inflammatory gene gene compared with chemical in the WEHI-231 cells and displayed a marked biphasic dose-response curve for the induction .	T22	T24	15126366
CPR:3	CHEMICAL	GENE-N	0	10	chemical induced a higher level of secretion of the inflammatory gene gene compared with chemical in the WEHI-231 cells and displayed a marked biphasic dose-response curve for the induction .	T2	T36	15126366
CPR:3	CHEMICAL	GENE-Y	0	11	chemical induced a higher level of secretion of the inflammatory gene gene compared with chemical in the WEHI-231 cells and displayed a marked biphasic dose-response curve for the induction .	T2	T24	15126366
NA	CHEMICAL	GENE-N	0	12	chemical was unable to cause the same extent of association of the gene of gene with lipids , compared with chemical or the physiological regulator chemical , and was able to partially block the association induced by these agents , measured by surface plasmon resonance .	T3	T25	15126366
NA	CHEMICAL	GENE-Y	0	14	chemical was unable to cause the same extent of association of the gene of gene with lipids , compared with chemical or the physiological regulator chemical , and was able to partially block the association induced by these agents , measured by surface plasmon resonance .	T3	T26	15126366
NA	CHEMICAL	GENE-N	20	12	chemical was unable to cause the same extent of association of the gene of gene with lipids , compared with chemical or the physiological regulator chemical , and was able to partially block the association induced by these agents , measured by surface plasmon resonance .	T4	T25	15126366
NA	CHEMICAL	GENE-Y	20	14	chemical was unable to cause the same extent of association of the gene of gene with lipids , compared with chemical or the physiological regulator chemical , and was able to partially block the association induced by these agents , measured by surface plasmon resonance .	T4	T26	15126366
NA	CHEMICAL	GENE-N	25	12	chemical was unable to cause the same extent of association of the gene of gene with lipids , compared with chemical or the physiological regulator chemical , and was able to partially block the association induced by these agents , measured by surface plasmon resonance .	T5	T25	15126366
NA	CHEMICAL	GENE-Y	25	14	chemical was unable to cause the same extent of association of the gene of gene with lipids , compared with chemical or the physiological regulator chemical , and was able to partially block the association induced by these agents , measured by surface plasmon resonance .	T5	T26	15126366
CPR:3	CHEMICAL	GENE-Y	9	6	The in vitro kinase activity of gene induced by chemical was lower than that induced by chemical .	T6	T27	15126366
CPR:3	CHEMICAL	GENE-Y	16	6	The in vitro kinase activity of gene induced by chemical was lower than that induced by chemical .	T7	T27	15126366
NA	CHEMICAL	GENE-N	7	5	Functional consequences of the arrhythmogenic gene gene chemical channel mutant probed by viral gene transfer in cardiomyocytes .	T7	T27	11351021
NA	CHEMICAL	GENE-Y	7	6	Functional consequences of the arrhythmogenic gene gene chemical channel mutant probed by viral gene transfer in cardiomyocytes .	T7	T28	11351021
NA	CHEMICAL	GENE-N	7	8	Functional consequences of the arrhythmogenic gene gene chemical channel mutant probed by viral gene transfer in cardiomyocytes .	T7	T29	11351021
NA	CHEMICAL	GENE-N	1	2	The chemical channel gene gene is mutated in the heritable long QT ( LQT ) syndrome .	T1	T10	11351021
NA	CHEMICAL	GENE-Y	1	4	The chemical channel gene gene is mutated in the heritable long QT ( LQT ) syndrome .	T1	T13	11351021
NA	CHEMICAL	GENE-Y	8	6	Spiro heterocycles as potential inhibitors of gene : chemical/chemical-mediated synthesis of novel chemical .	T12	T19	23410798
NA	CHEMICAL	GENE-Y	8	6	Spiro heterocycles as potential inhibitors of gene : chemical/chemical-mediated synthesis of novel chemical .	T13	T19	23410798
CPR:4	CHEMICAL	GENE-Y	12	6	Spiro heterocycles as potential inhibitors of gene : chemical/chemical-mediated synthesis of novel chemical .	T14	T19	23410798
CPR:4	CHEMICAL	GENE-Y	1	8	Novel chemical were designed as potential inhibitiors of gene .	T7	T15	23410798
NA	CHEMICAL	GENE-N	9	14	Potent and selective : The unique nature of the chemical binding pocket structure of gene family gene ( gene ) was used for the development of bisubstrate inhibitors and a fluorescent probe with sub-nanomolar affinity .	T3	T10	23616352
NA	CHEMICAL	GENE-N	9	16	Potent and selective : The unique nature of the chemical binding pocket structure of gene family gene ( gene ) was used for the development of bisubstrate inhibitors and a fluorescent probe with sub-nanomolar affinity .	T3	T11	23616352
NA	CHEMICAL	GENE-N	9	18	Potent and selective : The unique nature of the chemical binding pocket structure of gene family gene ( gene ) was used for the development of bisubstrate inhibitors and a fluorescent probe with sub-nanomolar affinity .	T3	T4	23616352
NA	CHEMICAL	GENE-Y	2	16	Conjugates of chemical-rich peptides with two chemical mimetic scaffolds were synthesized and tested as inhibitors of gene .	T1	T5	23616352
NA	CHEMICAL	GENE-Y	6	16	Conjugates of chemical-rich peptides with two chemical mimetic scaffolds were synthesized and tested as inhibitors of gene .	T2	T5	23616352
CPR:4	CHEMICAL	GENE-Y	4	9	The inhibitory effect of chemical on the stress-induced plasma gene level in mice .	T12	T20	14642426
NA	CHEMICAL	GENE-Y	3	6	The effect of chemical on plasma gene ( gene ) in non-stressed and immobilization-stressed mice were investigated .	T1	T15	14642426
NA	CHEMICAL	GENE-Y	3	8	The effect of chemical on plasma gene ( gene ) in non-stressed and immobilization-stressed mice were investigated .	T1	T17	14642426
CPR:4	CHEMICAL	GENE-Y	2	14	Ginseng total chemical , chemical administered intraperitoneally attenuated the immobilization stress-induced increase in plasma gene level .	T2	T13	14642426
CPR:4	CHEMICAL	GENE-Y	4	14	Ginseng total chemical , chemical administered intraperitoneally attenuated the immobilization stress-induced increase in plasma gene level .	T3	T13	14642426
NA	CHEMICAL	GENE-Y	6	11	But , intracerebroventricular injection of each chemical did not affect plasma gene level induced by immobilization stress .	T4	T14	14642426
CPR:4	CHEMICAL	GENE-Y	0	8	chemical significantly decreased chemical and/or chemical-induced increase of gene level in macrophage cell line ( RAW 264.7 ) .	T5	T16	14642426
CPR:3	CHEMICAL	GENE-Y	3	8	chemical significantly decreased chemical and/or chemical-induced increase of gene level in macrophage cell line ( RAW 264.7 ) .	T6	T16	14642426
CPR:3	CHEMICAL	GENE-Y	5	8	chemical significantly decreased chemical and/or chemical-induced increase of gene level in macrophage cell line ( RAW 264.7 ) .	T7	T16	14642426
CPR:4	CHEMICAL	GENE-Y	11	19	Thus , it can be suggested that the inhibitory action of chemical against the immobilization stress-induced increase of plasma gene level would be in periphery ; at least in part , mediated by blocking chemical- and/or chemical-induced increase of gene level in macrophage rather than in the brain .	T8	T18	14642426
CPR:4	CHEMICAL	GENE-Y	11	39	Thus , it can be suggested that the inhibitory action of chemical against the immobilization stress-induced increase of plasma gene level would be in periphery ; at least in part , mediated by blocking chemical- and/or chemical-induced increase of gene level in macrophage rather than in the brain .	T8	T19	14642426
NA	CHEMICAL	GENE-Y	23	19	Thus , it can be suggested that the inhibitory action of chemical against the immobilization stress-induced increase of plasma gene level would be in periphery ; at least in part , mediated by blocking chemical- and/or chemical-induced increase of gene level in macrophage rather than in the brain .	T9	T18	14642426
CPR:3	CHEMICAL	GENE-Y	23	39	Thus , it can be suggested that the inhibitory action of chemical against the immobilization stress-induced increase of plasma gene level would be in periphery ; at least in part , mediated by blocking chemical- and/or chemical-induced increase of gene level in macrophage rather than in the brain .	T9	T19	14642426
NA	CHEMICAL	GENE-Y	23	19	Thus , it can be suggested that the inhibitory action of chemical against the immobilization stress-induced increase of plasma gene level would be in periphery ; at least in part , mediated by blocking chemical- and/or chemical-induced increase of gene level in macrophage rather than in the brain .	T10	T18	14642426
CPR:3	CHEMICAL	GENE-Y	23	39	Thus , it can be suggested that the inhibitory action of chemical against the immobilization stress-induced increase of plasma gene level would be in periphery ; at least in part , mediated by blocking chemical- and/or chemical-induced increase of gene level in macrophage rather than in the brain .	T10	T19	14642426
NA	CHEMICAL	GENE-N	6	14	The in vivo effects of the non-chemical anti-inflammatory drug ( NSAID ) chemical , a pro-drug of the NSAID chemical , on lipid peroxidation , chemical levels and activity of antioxidant enzymes ( chemical dismutase , gene , chemical peroxidase and chemical reductase ) in rat gastric mucosa , colon mucosa and liver , were compared with the effects of non-selective ( chemical , chemical ) and gene selective ( chemical ) NSAIDs .	T7	T20	17391279
NA	CHEMICAL	GENE-Y	6	14	The in vivo effects of the non-chemical anti-inflammatory drug ( NSAID ) chemical , a pro-drug of the NSAID chemical , on lipid peroxidation , chemical levels and activity of antioxidant enzymes ( chemical dismutase , gene , chemical peroxidase and chemical reductase ) in rat gastric mucosa , colon mucosa and liver , were compared with the effects of non-selective ( chemical , chemical ) and gene selective ( chemical ) NSAIDs .	T7	T21	17391279
NA	CHEMICAL	GENE-N	6	14	The in vivo effects of the non-chemical anti-inflammatory drug ( NSAID ) chemical , a pro-drug of the NSAID chemical , on lipid peroxidation , chemical levels and activity of antioxidant enzymes ( chemical dismutase , gene , chemical peroxidase and chemical reductase ) in rat gastric mucosa , colon mucosa and liver , were compared with the effects of non-selective ( chemical , chemical ) and gene selective ( chemical ) NSAIDs .	T7	T22	17391279
NA	CHEMICAL	GENE-N	6	14	The in vivo effects of the non-chemical anti-inflammatory drug ( NSAID ) chemical , a pro-drug of the NSAID chemical , on lipid peroxidation , chemical levels and activity of antioxidant enzymes ( chemical dismutase , gene , chemical peroxidase and chemical reductase ) in rat gastric mucosa , colon mucosa and liver , were compared with the effects of non-selective ( chemical , chemical ) and gene selective ( chemical ) NSAIDs .	T7	T23	17391279
NA	CHEMICAL	GENE-Y	6	67	The in vivo effects of the non-chemical anti-inflammatory drug ( NSAID ) chemical , a pro-drug of the NSAID chemical , on lipid peroxidation , chemical levels and activity of antioxidant enzymes ( chemical dismutase , gene , chemical peroxidase and chemical reductase ) in rat gastric mucosa , colon mucosa and liver , were compared with the effects of non-selective ( chemical , chemical ) and gene selective ( chemical ) NSAIDs .	T7	T24	17391279
NA	CHEMICAL	GENE-N	12	14	The in vivo effects of the non-chemical anti-inflammatory drug ( NSAID ) chemical , a pro-drug of the NSAID chemical , on lipid peroxidation , chemical levels and activity of antioxidant enzymes ( chemical dismutase , gene , chemical peroxidase and chemical reductase ) in rat gastric mucosa , colon mucosa and liver , were compared with the effects of non-selective ( chemical , chemical ) and gene selective ( chemical ) NSAIDs .	T16	T20	17391279
NA	CHEMICAL	GENE-Y	12	14	The in vivo effects of the non-chemical anti-inflammatory drug ( NSAID ) chemical , a pro-drug of the NSAID chemical , on lipid peroxidation , chemical levels and activity of antioxidant enzymes ( chemical dismutase , gene , chemical peroxidase and chemical reductase ) in rat gastric mucosa , colon mucosa and liver , were compared with the effects of non-selective ( chemical , chemical ) and gene selective ( chemical ) NSAIDs .	T16	T21	17391279
NA	CHEMICAL	GENE-N	12	14	The in vivo effects of the non-chemical anti-inflammatory drug ( NSAID ) chemical , a pro-drug of the NSAID chemical , on lipid peroxidation , chemical levels and activity of antioxidant enzymes ( chemical dismutase , gene , chemical peroxidase and chemical reductase ) in rat gastric mucosa , colon mucosa and liver , were compared with the effects of non-selective ( chemical , chemical ) and gene selective ( chemical ) NSAIDs .	T16	T22	17391279
NA	CHEMICAL	GENE-N	12	14	The in vivo effects of the non-chemical anti-inflammatory drug ( NSAID ) chemical , a pro-drug of the NSAID chemical , on lipid peroxidation , chemical levels and activity of antioxidant enzymes ( chemical dismutase , gene , chemical peroxidase and chemical reductase ) in rat gastric mucosa , colon mucosa and liver , were compared with the effects of non-selective ( chemical , chemical ) and gene selective ( chemical ) NSAIDs .	T16	T23	17391279
NA	CHEMICAL	GENE-Y	12	67	The in vivo effects of the non-chemical anti-inflammatory drug ( NSAID ) chemical , a pro-drug of the NSAID chemical , on lipid peroxidation , chemical levels and activity of antioxidant enzymes ( chemical dismutase , gene , chemical peroxidase and chemical reductase ) in rat gastric mucosa , colon mucosa and liver , were compared with the effects of non-selective ( chemical , chemical ) and gene selective ( chemical ) NSAIDs .	T16	T24	17391279
NA	CHEMICAL	GENE-N	1	14	The in vivo effects of the non-chemical anti-inflammatory drug ( NSAID ) chemical , a pro-drug of the NSAID chemical , on lipid peroxidation , chemical levels and activity of antioxidant enzymes ( chemical dismutase , gene , chemical peroxidase and chemical reductase ) in rat gastric mucosa , colon mucosa and liver , were compared with the effects of non-selective ( chemical , chemical ) and gene selective ( chemical ) NSAIDs .	T2	T20	17391279
NA	CHEMICAL	GENE-Y	1	14	The in vivo effects of the non-chemical anti-inflammatory drug ( NSAID ) chemical , a pro-drug of the NSAID chemical , on lipid peroxidation , chemical levels and activity of antioxidant enzymes ( chemical dismutase , gene , chemical peroxidase and chemical reductase ) in rat gastric mucosa , colon mucosa and liver , were compared with the effects of non-selective ( chemical , chemical ) and gene selective ( chemical ) NSAIDs .	T2	T21	17391279
NA	CHEMICAL	GENE-N	1	14	The in vivo effects of the non-chemical anti-inflammatory drug ( NSAID ) chemical , a pro-drug of the NSAID chemical , on lipid peroxidation , chemical levels and activity of antioxidant enzymes ( chemical dismutase , gene , chemical peroxidase and chemical reductase ) in rat gastric mucosa , colon mucosa and liver , were compared with the effects of non-selective ( chemical , chemical ) and gene selective ( chemical ) NSAIDs .	T2	T22	17391279
NA	CHEMICAL	GENE-N	1	14	The in vivo effects of the non-chemical anti-inflammatory drug ( NSAID ) chemical , a pro-drug of the NSAID chemical , on lipid peroxidation , chemical levels and activity of antioxidant enzymes ( chemical dismutase , gene , chemical peroxidase and chemical reductase ) in rat gastric mucosa , colon mucosa and liver , were compared with the effects of non-selective ( chemical , chemical ) and gene selective ( chemical ) NSAIDs .	T2	T23	17391279
NA	CHEMICAL	GENE-Y	1	67	The in vivo effects of the non-chemical anti-inflammatory drug ( NSAID ) chemical , a pro-drug of the NSAID chemical , on lipid peroxidation , chemical levels and activity of antioxidant enzymes ( chemical dismutase , gene , chemical peroxidase and chemical reductase ) in rat gastric mucosa , colon mucosa and liver , were compared with the effects of non-selective ( chemical , chemical ) and gene selective ( chemical ) NSAIDs .	T2	T24	17391279
NA	CHEMICAL	GENE-N	14	14	The in vivo effects of the non-chemical anti-inflammatory drug ( NSAID ) chemical , a pro-drug of the NSAID chemical , on lipid peroxidation , chemical levels and activity of antioxidant enzymes ( chemical dismutase , gene , chemical peroxidase and chemical reductase ) in rat gastric mucosa , colon mucosa and liver , were compared with the effects of non-selective ( chemical , chemical ) and gene selective ( chemical ) NSAIDs .	T3	T20	17391279
NA	CHEMICAL	GENE-Y	14	14	The in vivo effects of the non-chemical anti-inflammatory drug ( NSAID ) chemical , a pro-drug of the NSAID chemical , on lipid peroxidation , chemical levels and activity of antioxidant enzymes ( chemical dismutase , gene , chemical peroxidase and chemical reductase ) in rat gastric mucosa , colon mucosa and liver , were compared with the effects of non-selective ( chemical , chemical ) and gene selective ( chemical ) NSAIDs .	T3	T21	17391279
NA	CHEMICAL	GENE-N	14	14	The in vivo effects of the non-chemical anti-inflammatory drug ( NSAID ) chemical , a pro-drug of the NSAID chemical , on lipid peroxidation , chemical levels and activity of antioxidant enzymes ( chemical dismutase , gene , chemical peroxidase and chemical reductase ) in rat gastric mucosa , colon mucosa and liver , were compared with the effects of non-selective ( chemical , chemical ) and gene selective ( chemical ) NSAIDs .	T3	T22	17391279
NA	CHEMICAL	GENE-N	14	14	The in vivo effects of the non-chemical anti-inflammatory drug ( NSAID ) chemical , a pro-drug of the NSAID chemical , on lipid peroxidation , chemical levels and activity of antioxidant enzymes ( chemical dismutase , gene , chemical peroxidase and chemical reductase ) in rat gastric mucosa , colon mucosa and liver , were compared with the effects of non-selective ( chemical , chemical ) and gene selective ( chemical ) NSAIDs .	T3	T23	17391279
NA	CHEMICAL	GENE-Y	14	67	The in vivo effects of the non-chemical anti-inflammatory drug ( NSAID ) chemical , a pro-drug of the NSAID chemical , on lipid peroxidation , chemical levels and activity of antioxidant enzymes ( chemical dismutase , gene , chemical peroxidase and chemical reductase ) in rat gastric mucosa , colon mucosa and liver , were compared with the effects of non-selective ( chemical , chemical ) and gene selective ( chemical ) NSAIDs .	T3	T24	17391279
NA	CHEMICAL	GENE-N	33	14	The in vivo effects of the non-chemical anti-inflammatory drug ( NSAID ) chemical , a pro-drug of the NSAID chemical , on lipid peroxidation , chemical levels and activity of antioxidant enzymes ( chemical dismutase , gene , chemical peroxidase and chemical reductase ) in rat gastric mucosa , colon mucosa and liver , were compared with the effects of non-selective ( chemical , chemical ) and gene selective ( chemical ) NSAIDs .	T4	T20	17391279
NA	CHEMICAL	GENE-Y	33	14	The in vivo effects of the non-chemical anti-inflammatory drug ( NSAID ) chemical , a pro-drug of the NSAID chemical , on lipid peroxidation , chemical levels and activity of antioxidant enzymes ( chemical dismutase , gene , chemical peroxidase and chemical reductase ) in rat gastric mucosa , colon mucosa and liver , were compared with the effects of non-selective ( chemical , chemical ) and gene selective ( chemical ) NSAIDs .	T4	T21	17391279
NA	CHEMICAL	GENE-N	33	14	The in vivo effects of the non-chemical anti-inflammatory drug ( NSAID ) chemical , a pro-drug of the NSAID chemical , on lipid peroxidation , chemical levels and activity of antioxidant enzymes ( chemical dismutase , gene , chemical peroxidase and chemical reductase ) in rat gastric mucosa , colon mucosa and liver , were compared with the effects of non-selective ( chemical , chemical ) and gene selective ( chemical ) NSAIDs .	T4	T22	17391279
NA	CHEMICAL	GENE-N	33	14	The in vivo effects of the non-chemical anti-inflammatory drug ( NSAID ) chemical , a pro-drug of the NSAID chemical , on lipid peroxidation , chemical levels and activity of antioxidant enzymes ( chemical dismutase , gene , chemical peroxidase and chemical reductase ) in rat gastric mucosa , colon mucosa and liver , were compared with the effects of non-selective ( chemical , chemical ) and gene selective ( chemical ) NSAIDs .	T4	T23	17391279
NA	CHEMICAL	GENE-Y	33	67	The in vivo effects of the non-chemical anti-inflammatory drug ( NSAID ) chemical , a pro-drug of the NSAID chemical , on lipid peroxidation , chemical levels and activity of antioxidant enzymes ( chemical dismutase , gene , chemical peroxidase and chemical reductase ) in rat gastric mucosa , colon mucosa and liver , were compared with the effects of non-selective ( chemical , chemical ) and gene selective ( chemical ) NSAIDs .	T4	T24	17391279
NA	CHEMICAL	GENE-N	14	14	The in vivo effects of the non-chemical anti-inflammatory drug ( NSAID ) chemical , a pro-drug of the NSAID chemical , on lipid peroxidation , chemical levels and activity of antioxidant enzymes ( chemical dismutase , gene , chemical peroxidase and chemical reductase ) in rat gastric mucosa , colon mucosa and liver , were compared with the effects of non-selective ( chemical , chemical ) and gene selective ( chemical ) NSAIDs .	T5	T20	17391279
NA	CHEMICAL	GENE-Y	14	14	The in vivo effects of the non-chemical anti-inflammatory drug ( NSAID ) chemical , a pro-drug of the NSAID chemical , on lipid peroxidation , chemical levels and activity of antioxidant enzymes ( chemical dismutase , gene , chemical peroxidase and chemical reductase ) in rat gastric mucosa , colon mucosa and liver , were compared with the effects of non-selective ( chemical , chemical ) and gene selective ( chemical ) NSAIDs .	T5	T21	17391279
NA	CHEMICAL	GENE-N	14	14	The in vivo effects of the non-chemical anti-inflammatory drug ( NSAID ) chemical , a pro-drug of the NSAID chemical , on lipid peroxidation , chemical levels and activity of antioxidant enzymes ( chemical dismutase , gene , chemical peroxidase and chemical reductase ) in rat gastric mucosa , colon mucosa and liver , were compared with the effects of non-selective ( chemical , chemical ) and gene selective ( chemical ) NSAIDs .	T5	T22	17391279
NA	CHEMICAL	GENE-N	14	14	The in vivo effects of the non-chemical anti-inflammatory drug ( NSAID ) chemical , a pro-drug of the NSAID chemical , on lipid peroxidation , chemical levels and activity of antioxidant enzymes ( chemical dismutase , gene , chemical peroxidase and chemical reductase ) in rat gastric mucosa , colon mucosa and liver , were compared with the effects of non-selective ( chemical , chemical ) and gene selective ( chemical ) NSAIDs .	T5	T23	17391279
NA	CHEMICAL	GENE-Y	14	67	The in vivo effects of the non-chemical anti-inflammatory drug ( NSAID ) chemical , a pro-drug of the NSAID chemical , on lipid peroxidation , chemical levels and activity of antioxidant enzymes ( chemical dismutase , gene , chemical peroxidase and chemical reductase ) in rat gastric mucosa , colon mucosa and liver , were compared with the effects of non-selective ( chemical , chemical ) and gene selective ( chemical ) NSAIDs .	T5	T24	17391279
NA	CHEMICAL	GENE-N	14	14	The in vivo effects of the non-chemical anti-inflammatory drug ( NSAID ) chemical , a pro-drug of the NSAID chemical , on lipid peroxidation , chemical levels and activity of antioxidant enzymes ( chemical dismutase , gene , chemical peroxidase and chemical reductase ) in rat gastric mucosa , colon mucosa and liver , were compared with the effects of non-selective ( chemical , chemical ) and gene selective ( chemical ) NSAIDs .	T6	T20	17391279
NA	CHEMICAL	GENE-Y	14	14	The in vivo effects of the non-chemical anti-inflammatory drug ( NSAID ) chemical , a pro-drug of the NSAID chemical , on lipid peroxidation , chemical levels and activity of antioxidant enzymes ( chemical dismutase , gene , chemical peroxidase and chemical reductase ) in rat gastric mucosa , colon mucosa and liver , were compared with the effects of non-selective ( chemical , chemical ) and gene selective ( chemical ) NSAIDs .	T6	T21	17391279
NA	CHEMICAL	GENE-N	14	14	The in vivo effects of the non-chemical anti-inflammatory drug ( NSAID ) chemical , a pro-drug of the NSAID chemical , on lipid peroxidation , chemical levels and activity of antioxidant enzymes ( chemical dismutase , gene , chemical peroxidase and chemical reductase ) in rat gastric mucosa , colon mucosa and liver , were compared with the effects of non-selective ( chemical , chemical ) and gene selective ( chemical ) NSAIDs .	T6	T22	17391279
NA	CHEMICAL	GENE-N	14	14	The in vivo effects of the non-chemical anti-inflammatory drug ( NSAID ) chemical , a pro-drug of the NSAID chemical , on lipid peroxidation , chemical levels and activity of antioxidant enzymes ( chemical dismutase , gene , chemical peroxidase and chemical reductase ) in rat gastric mucosa , colon mucosa and liver , were compared with the effects of non-selective ( chemical , chemical ) and gene selective ( chemical ) NSAIDs .	T6	T23	17391279
NA	CHEMICAL	GENE-Y	14	67	The in vivo effects of the non-chemical anti-inflammatory drug ( NSAID ) chemical , a pro-drug of the NSAID chemical , on lipid peroxidation , chemical levels and activity of antioxidant enzymes ( chemical dismutase , gene , chemical peroxidase and chemical reductase ) in rat gastric mucosa , colon mucosa and liver , were compared with the effects of non-selective ( chemical , chemical ) and gene selective ( chemical ) NSAIDs .	T6	T24	17391279
NA	CHEMICAL	GENE-N	1	14	The in vivo effects of the non-chemical anti-inflammatory drug ( NSAID ) chemical , a pro-drug of the NSAID chemical , on lipid peroxidation , chemical levels and activity of antioxidant enzymes ( chemical dismutase , gene , chemical peroxidase and chemical reductase ) in rat gastric mucosa , colon mucosa and liver , were compared with the effects of non-selective ( chemical , chemical ) and gene selective ( chemical ) NSAIDs .	T8	T20	17391279
NA	CHEMICAL	GENE-Y	1	14	The in vivo effects of the non-chemical anti-inflammatory drug ( NSAID ) chemical , a pro-drug of the NSAID chemical , on lipid peroxidation , chemical levels and activity of antioxidant enzymes ( chemical dismutase , gene , chemical peroxidase and chemical reductase ) in rat gastric mucosa , colon mucosa and liver , were compared with the effects of non-selective ( chemical , chemical ) and gene selective ( chemical ) NSAIDs .	T8	T21	17391279
NA	CHEMICAL	GENE-N	1	14	The in vivo effects of the non-chemical anti-inflammatory drug ( NSAID ) chemical , a pro-drug of the NSAID chemical , on lipid peroxidation , chemical levels and activity of antioxidant enzymes ( chemical dismutase , gene , chemical peroxidase and chemical reductase ) in rat gastric mucosa , colon mucosa and liver , were compared with the effects of non-selective ( chemical , chemical ) and gene selective ( chemical ) NSAIDs .	T8	T22	17391279
NA	CHEMICAL	GENE-N	1	14	The in vivo effects of the non-chemical anti-inflammatory drug ( NSAID ) chemical , a pro-drug of the NSAID chemical , on lipid peroxidation , chemical levels and activity of antioxidant enzymes ( chemical dismutase , gene , chemical peroxidase and chemical reductase ) in rat gastric mucosa , colon mucosa and liver , were compared with the effects of non-selective ( chemical , chemical ) and gene selective ( chemical ) NSAIDs .	T8	T23	17391279
NA	CHEMICAL	GENE-Y	1	67	The in vivo effects of the non-chemical anti-inflammatory drug ( NSAID ) chemical , a pro-drug of the NSAID chemical , on lipid peroxidation , chemical levels and activity of antioxidant enzymes ( chemical dismutase , gene , chemical peroxidase and chemical reductase ) in rat gastric mucosa , colon mucosa and liver , were compared with the effects of non-selective ( chemical , chemical ) and gene selective ( chemical ) NSAIDs .	T8	T24	17391279
NA	CHEMICAL	GENE-N	4	14	The in vivo effects of the non-chemical anti-inflammatory drug ( NSAID ) chemical , a pro-drug of the NSAID chemical , on lipid peroxidation , chemical levels and activity of antioxidant enzymes ( chemical dismutase , gene , chemical peroxidase and chemical reductase ) in rat gastric mucosa , colon mucosa and liver , were compared with the effects of non-selective ( chemical , chemical ) and gene selective ( chemical ) NSAIDs .	T9	T20	17391279
NA	CHEMICAL	GENE-Y	4	14	The in vivo effects of the non-chemical anti-inflammatory drug ( NSAID ) chemical , a pro-drug of the NSAID chemical , on lipid peroxidation , chemical levels and activity of antioxidant enzymes ( chemical dismutase , gene , chemical peroxidase and chemical reductase ) in rat gastric mucosa , colon mucosa and liver , were compared with the effects of non-selective ( chemical , chemical ) and gene selective ( chemical ) NSAIDs .	T9	T21	17391279
NA	CHEMICAL	GENE-N	4	14	The in vivo effects of the non-chemical anti-inflammatory drug ( NSAID ) chemical , a pro-drug of the NSAID chemical , on lipid peroxidation , chemical levels and activity of antioxidant enzymes ( chemical dismutase , gene , chemical peroxidase and chemical reductase ) in rat gastric mucosa , colon mucosa and liver , were compared with the effects of non-selective ( chemical , chemical ) and gene selective ( chemical ) NSAIDs .	T9	T22	17391279
NA	CHEMICAL	GENE-N	4	14	The in vivo effects of the non-chemical anti-inflammatory drug ( NSAID ) chemical , a pro-drug of the NSAID chemical , on lipid peroxidation , chemical levels and activity of antioxidant enzymes ( chemical dismutase , gene , chemical peroxidase and chemical reductase ) in rat gastric mucosa , colon mucosa and liver , were compared with the effects of non-selective ( chemical , chemical ) and gene selective ( chemical ) NSAIDs .	T9	T23	17391279
NA	CHEMICAL	GENE-Y	4	67	The in vivo effects of the non-chemical anti-inflammatory drug ( NSAID ) chemical , a pro-drug of the NSAID chemical , on lipid peroxidation , chemical levels and activity of antioxidant enzymes ( chemical dismutase , gene , chemical peroxidase and chemical reductase ) in rat gastric mucosa , colon mucosa and liver , were compared with the effects of non-selective ( chemical , chemical ) and gene selective ( chemical ) NSAIDs .	T9	T24	17391279
NA	CHEMICAL	GENE-N	70	14	The in vivo effects of the non-chemical anti-inflammatory drug ( NSAID ) chemical , a pro-drug of the NSAID chemical , on lipid peroxidation , chemical levels and activity of antioxidant enzymes ( chemical dismutase , gene , chemical peroxidase and chemical reductase ) in rat gastric mucosa , colon mucosa and liver , were compared with the effects of non-selective ( chemical , chemical ) and gene selective ( chemical ) NSAIDs .	T10	T20	17391279
NA	CHEMICAL	GENE-Y	70	14	The in vivo effects of the non-chemical anti-inflammatory drug ( NSAID ) chemical , a pro-drug of the NSAID chemical , on lipid peroxidation , chemical levels and activity of antioxidant enzymes ( chemical dismutase , gene , chemical peroxidase and chemical reductase ) in rat gastric mucosa , colon mucosa and liver , were compared with the effects of non-selective ( chemical , chemical ) and gene selective ( chemical ) NSAIDs .	T10	T21	17391279
NA	CHEMICAL	GENE-N	70	14	The in vivo effects of the non-chemical anti-inflammatory drug ( NSAID ) chemical , a pro-drug of the NSAID chemical , on lipid peroxidation , chemical levels and activity of antioxidant enzymes ( chemical dismutase , gene , chemical peroxidase and chemical reductase ) in rat gastric mucosa , colon mucosa and liver , were compared with the effects of non-selective ( chemical , chemical ) and gene selective ( chemical ) NSAIDs .	T10	T22	17391279
NA	CHEMICAL	GENE-N	70	14	The in vivo effects of the non-chemical anti-inflammatory drug ( NSAID ) chemical , a pro-drug of the NSAID chemical , on lipid peroxidation , chemical levels and activity of antioxidant enzymes ( chemical dismutase , gene , chemical peroxidase and chemical reductase ) in rat gastric mucosa , colon mucosa and liver , were compared with the effects of non-selective ( chemical , chemical ) and gene selective ( chemical ) NSAIDs .	T10	T23	17391279
NA	CHEMICAL	GENE-Y	70	67	The in vivo effects of the non-chemical anti-inflammatory drug ( NSAID ) chemical , a pro-drug of the NSAID chemical , on lipid peroxidation , chemical levels and activity of antioxidant enzymes ( chemical dismutase , gene , chemical peroxidase and chemical reductase ) in rat gastric mucosa , colon mucosa and liver , were compared with the effects of non-selective ( chemical , chemical ) and gene selective ( chemical ) NSAIDs .	T10	T24	17391279
CPR:3	CHEMICAL	GENE-N	0	11	chemical treatment led to an increase in lipid peroxidation , chemical peroxidase and chemical dehydrogenase activities and to a decrease in gene activity and chemical levels in gastric mucosa .	T11	T25	17391279
CPR:3	CHEMICAL	GENE-Y	0	14	chemical treatment led to an increase in lipid peroxidation , chemical peroxidase and chemical dehydrogenase activities and to a decrease in gene activity and chemical levels in gastric mucosa .	T11	T26	17391279
CPR:4	CHEMICAL	GENE-Y	0	18	chemical treatment led to an increase in lipid peroxidation , chemical peroxidase and chemical dehydrogenase activities and to a decrease in gene activity and chemical levels in gastric mucosa .	T11	T27	17391279
NA	CHEMICAL	GENE-N	10	11	chemical treatment led to an increase in lipid peroxidation , chemical peroxidase and chemical dehydrogenase activities and to a decrease in gene activity and chemical levels in gastric mucosa .	T12	T25	17391279
NA	CHEMICAL	GENE-Y	10	14	chemical treatment led to an increase in lipid peroxidation , chemical peroxidase and chemical dehydrogenase activities and to a decrease in gene activity and chemical levels in gastric mucosa .	T12	T26	17391279
NA	CHEMICAL	GENE-Y	10	18	chemical treatment led to an increase in lipid peroxidation , chemical peroxidase and chemical dehydrogenase activities and to a decrease in gene activity and chemical levels in gastric mucosa .	T12	T27	17391279
NA	CHEMICAL	GENE-N	13	11	chemical treatment led to an increase in lipid peroxidation , chemical peroxidase and chemical dehydrogenase activities and to a decrease in gene activity and chemical levels in gastric mucosa .	T13	T25	17391279
NA	CHEMICAL	GENE-Y	13	14	chemical treatment led to an increase in lipid peroxidation , chemical peroxidase and chemical dehydrogenase activities and to a decrease in gene activity and chemical levels in gastric mucosa .	T13	T26	17391279
NA	CHEMICAL	GENE-Y	13	18	chemical treatment led to an increase in lipid peroxidation , chemical peroxidase and chemical dehydrogenase activities and to a decrease in gene activity and chemical levels in gastric mucosa .	T13	T27	17391279
NA	CHEMICAL	GENE-N	18	11	chemical treatment led to an increase in lipid peroxidation , chemical peroxidase and chemical dehydrogenase activities and to a decrease in gene activity and chemical levels in gastric mucosa .	T14	T25	17391279
NA	CHEMICAL	GENE-Y	18	14	chemical treatment led to an increase in lipid peroxidation , chemical peroxidase and chemical dehydrogenase activities and to a decrease in gene activity and chemical levels in gastric mucosa .	T14	T26	17391279
NA	CHEMICAL	GENE-Y	18	18	chemical treatment led to an increase in lipid peroxidation , chemical peroxidase and chemical dehydrogenase activities and to a decrease in gene activity and chemical levels in gastric mucosa .	T14	T27	17391279
CPR:4	CHEMICAL	GENE-Y	0	8	chemical , an effective competitive inhibitor of the gene used orally for palliative treatment of prostatic carcinoma and regulation of prostatic hyperplasia was evaluated for its genotoxic effects in the intact rat and in primary cultures of human hepatocytes .	T1	T8	10752671
CPR:3	CHEMICAL	GENE-N	6	7	In the liver of rats given chemical as initiating agent at the dose of 500 mg/kg/week for 6 successive weeks , gene-positive foci were detected only in 3 of 10 rats .	T5	T9	10752671
CPR:3	CHEMICAL	GENE-Y	30	13	Evidence has accumulated in the last few years that the expression of the gene ( gene ) in thyroid cells is induced by gene , through pathways which involve intracellular chemical accumulation and protein synthesis .	T4	T24	1663395
CPR:3	CHEMICAL	GENE-Y	30	15	Evidence has accumulated in the last few years that the expression of the gene ( gene ) in thyroid cells is induced by gene , through pathways which involve intracellular chemical accumulation and protein synthesis .	T4	T6	1663395
NA	CHEMICAL	GENE-N	30	23	Evidence has accumulated in the last few years that the expression of the gene ( gene ) in thyroid cells is induced by gene , through pathways which involve intracellular chemical accumulation and protein synthesis .	T4	T14	1663395
NA	CHEMICAL	GENE-N	2	0	gene and chemical also increase the levels of the specific mRNA for gene in thyroid cells from different species .	T5	T20	1663395
CPR:3	CHEMICAL	GENE-Y	2	12	gene and chemical also increase the levels of the specific mRNA for gene in thyroid cells from different species .	T5	T21	1663395
NA	CHEMICAL	GENE-Y	17	3	The modulation of gene surface expression by gene can explain the decrease of circulating anti-MAb observed during chemical therapy in hypothyroid patients with Hashimoto 's thyroiditis .	T1	T7	1663395
NA	CHEMICAL	GENE-N	17	7	The modulation of gene surface expression by gene can explain the decrease of circulating anti-MAb observed during chemical therapy in hypothyroid patients with Hashimoto 's thyroiditis .	T1	T8	1663395
NA	CHEMICAL	GENE-Y	5	23	Other agents , such as chemical and chemical , which influence thyroid cell function , do not directly interfere with the expression of gene .	T2	T9	1663395
NA	CHEMICAL	GENE-Y	7	23	Other agents , such as chemical and chemical , which influence thyroid cell function , do not directly interfere with the expression of gene .	T3	T9	1663395
NA	CHEMICAL	GENE-N	13	1	As gene agonism has been found to elicit behaviors associated with visceral illness in rodents , we also examined the effect of peripheral exenatide on chemical consumption and locomotor activity .	T5	T10	16534527
NA	CHEMICAL	GENE-N	1	5	Plasma chemical , chemical and gene were also significantly reduced ( P < 0.05 ) .	T2	T6	16534527
NA	CHEMICAL	GENE-N	3	5	Plasma chemical , chemical and gene were also significantly reduced ( P < 0.05 ) .	T3	T6	16534527
NA	CHEMICAL	GENE-Y	0	5	chemical modulates the expression of gene and gene in a rat model of volume-overload heart failure .	T6	T33	15732037
NA	CHEMICAL	GENE-Y	0	7	chemical modulates the expression of gene and gene in a rat model of volume-overload heart failure .	T6	T34	15732037
CPR:4	CHEMICAL	GENE-Y	2	9	Treatment with chemical reversed both protein and mRNA of gene , gene , gene , and gene to the baseline values .	T1	T20	15732037
CPR:4	CHEMICAL	GENE-Y	2	11	Treatment with chemical reversed both protein and mRNA of gene , gene , gene , and gene to the baseline values .	T1	T21	15732037
CPR:4	CHEMICAL	GENE-Y	2	13	Treatment with chemical reversed both protein and mRNA of gene , gene , gene , and gene to the baseline values .	T1	T22	15732037
CPR:3	CHEMICAL	GENE-Y	2	16	Treatment with chemical reversed both protein and mRNA of gene , gene , gene , and gene to the baseline values .	T1	T23	15732037
CPR:4	CHEMICAL	GENE-Y	4	4	Increased immunohistochemical labeling of gene , gene , and gene in the ventricular myocardium was observed in the shunt group and chemical again normalized the labeling .	T2	T24	15732037
CPR:4	CHEMICAL	GENE-Y	4	6	Increased immunohistochemical labeling of gene , gene , and gene in the ventricular myocardium was observed in the shunt group and chemical again normalized the labeling .	T2	T25	15732037
CPR:4	CHEMICAL	GENE-Y	4	9	Increased immunohistochemical labeling of gene , gene , and gene in the ventricular myocardium was observed in the shunt group and chemical again normalized the labeling .	T2	T26	15732037
NA	CHEMICAL	GENE-N	11	17	Leukocyte adhesion during inflammation is initiated by the binding of sialofucosylated chemical expressed on leukocytes to endothelial gene .	T1	T13	23192350
NA	CHEMICAL	GENE-Y	4	11	Results demonstrate that predominantly gene , and to a lesser extent gene , forms the gene-ligand at the chemical terminus of leukocyte gene ( gene ) in humans and mice .	T2	T35	23192350
NA	CHEMICAL	GENE-N	4	15	Results demonstrate that predominantly gene , and to a lesser extent gene , forms the gene-ligand at the chemical terminus of leukocyte gene ( gene ) in humans and mice .	T2	T36	23192350
NA	CHEMICAL	GENE-N	4	6	Results demonstrate that predominantly gene , and to a lesser extent gene , forms the gene-ligand at the chemical terminus of leukocyte gene ( gene ) in humans and mice .	T2	T37	23192350
NA	CHEMICAL	GENE-N	4	11	Results demonstrate that predominantly gene , and to a lesser extent gene , forms the gene-ligand at the chemical terminus of leukocyte gene ( gene ) in humans and mice .	T2	T3	23192350
NA	CHEMICAL	GENE-N	0	7	chemical sequencing also demonstrated the presence of gene around the gene in other gene genes : CpG dinucleotides at +149 relative to the gene for gene ; -48 , +101 , and +356 for gene ; -572 and -550 for gene ; and -122 and +216 for gene were differentially methylated among the liver , kidney , and cerebrum .	T1	T29	23033256
NA	CHEMICAL	GENE-N	0	10	chemical sequencing also demonstrated the presence of gene around the gene in other gene genes : CpG dinucleotides at +149 relative to the gene for gene ; -48 , +101 , and +356 for gene ; -572 and -550 for gene ; and -122 and +216 for gene were differentially methylated among the liver , kidney , and cerebrum .	T1	T30	23033256
NA	CHEMICAL	GENE-Y	0	13	chemical sequencing also demonstrated the presence of gene around the gene in other gene genes : CpG dinucleotides at +149 relative to the gene for gene ; -48 , +101 , and +356 for gene ; -572 and -550 for gene ; and -122 and +216 for gene were differentially methylated among the liver , kidney , and cerebrum .	T1	T31	23033256
NA	CHEMICAL	GENE-N	0	23	chemical sequencing also demonstrated the presence of gene around the gene in other gene genes : CpG dinucleotides at +149 relative to the gene for gene ; -48 , +101 , and +356 for gene ; -572 and -550 for gene ; and -122 and +216 for gene were differentially methylated among the liver , kidney , and cerebrum .	T1	T32	23033256
NA	CHEMICAL	GENE-Y	0	18	chemical sequencing also demonstrated the presence of gene around the gene in other gene genes : CpG dinucleotides at +149 relative to the gene for gene ; -48 , +101 , and +356 for gene ; -572 and -550 for gene ; and -122 and +216 for gene were differentially methylated among the liver , kidney , and cerebrum .	T1	T33	23033256
NA	CHEMICAL	GENE-Y	0	18	chemical sequencing also demonstrated the presence of gene around the gene in other gene genes : CpG dinucleotides at +149 relative to the gene for gene ; -48 , +101 , and +356 for gene ; -572 and -550 for gene ; and -122 and +216 for gene were differentially methylated among the liver , kidney , and cerebrum .	T1	T34	23033256
NA	CHEMICAL	GENE-Y	0	18	chemical sequencing also demonstrated the presence of gene around the gene in other gene genes : CpG dinucleotides at +149 relative to the gene for gene ; -48 , +101 , and +356 for gene ; -572 and -550 for gene ; and -122 and +216 for gene were differentially methylated among the liver , kidney , and cerebrum .	T1	T35	23033256
NA	CHEMICAL	GENE-N	0	18	chemical sequencing also demonstrated the presence of gene around the gene in other gene genes : CpG dinucleotides at +149 relative to the gene for gene ; -48 , +101 , and +356 for gene ; -572 and -550 for gene ; and -122 and +216 for gene were differentially methylated among the liver , kidney , and cerebrum .	T1	T36	23033256
NA	CHEMICAL	GENE-Y	5	8	Predicting cardiomyopathic phenotypes by altering chemical affinity of gene . Cardiac diseases associated with mutations in gene subunits include hypertrophic cardiomyopathy ( HCM ) , dilated cardiomyopathy ( DCM ) , and restrictive cardiomyopathy ( RCM ) .	T13	T34	20566645
NA	CHEMICAL	GENE-N	5	15	Predicting cardiomyopathic phenotypes by altering chemical affinity of gene . Cardiac diseases associated with mutations in gene subunits include hypertrophic cardiomyopathy ( HCM ) , dilated cardiomyopathy ( DCM ) , and restrictive cardiomyopathy ( RCM ) .	T13	T24	20566645
NA	CHEMICAL	GENE-Y	3	6	Mutations in the chemical sensor , gene ( gene ) , were generated to increase/decrease the chemical sensitivity of cardiac skinned fibers to create the characteristic effects of DCM , HCM , and RCM .	T8	T22	20566645
NA	CHEMICAL	GENE-Y	3	8	Mutations in the chemical sensor , gene ( gene ) , were generated to increase/decrease the chemical sensitivity of cardiac skinned fibers to create the characteristic effects of DCM , HCM , and RCM .	T8	T23	20566645
NA	CHEMICAL	GENE-Y	7	6	Mutations in the chemical sensor , gene ( gene ) , were generated to increase/decrease the chemical sensitivity of cardiac skinned fibers to create the characteristic effects of DCM , HCM , and RCM .	T9	T22	20566645
NA	CHEMICAL	GENE-Y	7	8	Mutations in the chemical sensor , gene ( gene ) , were generated to increase/decrease the chemical sensitivity of cardiac skinned fibers to create the characteristic effects of DCM , HCM , and RCM .	T9	T23	20566645
NA	CHEMICAL	GENE-N	2	3	One mutant ( gene ) was found with HCM-like properties ( increased chemical sensitivity of force and normal levels of gene inhibition ) .	T10	T26	20566645
NA	CHEMICAL	GENE-N	2	20	One mutant ( gene ) was found with HCM-like properties ( increased chemical sensitivity of force and normal levels of gene inhibition ) .	T10	T27	20566645
NA	CHEMICAL	GENE-N	2	3	Three mutants ( gene , gene , and gene ) were identified with RCM-like properties ( a large increase in chemical sensitivity , partial loss of gene inhibition , and increased basal force ) .	T11	T28	20566645
NA	CHEMICAL	GENE-N	2	5	Three mutants ( gene , gene , and gene ) were identified with RCM-like properties ( a large increase in chemical sensitivity , partial loss of gene inhibition , and increased basal force ) .	T11	T29	20566645
NA	CHEMICAL	GENE-N	2	8	Three mutants ( gene , gene , and gene ) were identified with RCM-like properties ( a large increase in chemical sensitivity , partial loss of gene inhibition , and increased basal force ) .	T11	T30	20566645
NA	CHEMICAL	GENE-N	2	16	Three mutants ( gene , gene , and gene ) were identified with RCM-like properties ( a large increase in chemical sensitivity , partial loss of gene inhibition , and increased basal force ) .	T11	T31	20566645
NA	CHEMICAL	GENE-N	4	5	Two mutations were identified ( gene and gene ) with DCM properties ( decreased chemical sensitivity , maximal force recovery , and activation of the gene at high [ chemical ] ) .	T12	T32	20566645
NA	CHEMICAL	GENE-N	4	7	Two mutations were identified ( gene and gene ) with DCM properties ( decreased chemical sensitivity , maximal force recovery , and activation of the gene at high [ chemical ] ) .	T12	T33	20566645
NA	CHEMICAL	GENE-N	4	25	Two mutations were identified ( gene and gene ) with DCM properties ( decreased chemical sensitivity , maximal force recovery , and activation of the gene at high [ chemical ] ) .	T12	T14	20566645
NA	CHEMICAL	GENE-N	4	5	Two mutations were identified ( gene and gene ) with DCM properties ( decreased chemical sensitivity , maximal force recovery , and activation of the gene at high [ chemical ] ) .	T1	T32	20566645
NA	CHEMICAL	GENE-N	4	7	Two mutations were identified ( gene and gene ) with DCM properties ( decreased chemical sensitivity , maximal force recovery , and activation of the gene at high [ chemical ] ) .	T1	T33	20566645
NA	CHEMICAL	GENE-N	4	25	Two mutations were identified ( gene and gene ) with DCM properties ( decreased chemical sensitivity , maximal force recovery , and activation of the gene at high [ chemical ] ) .	T1	T14	20566645
NA	CHEMICAL	GENE-Y	6	10	Steady-state fluorescence was utilized to assess chemical affinity in isolated gene containing gene and did not necessarily mirror the fiber chemical sensitivity .	T2	T15	20566645
NA	CHEMICAL	GENE-N	6	12	Steady-state fluorescence was utilized to assess chemical affinity in isolated gene containing gene and did not necessarily mirror the fiber chemical sensitivity .	T2	T16	20566645
NA	CHEMICAL	GENE-Y	20	10	Steady-state fluorescence was utilized to assess chemical affinity in isolated gene containing gene and did not necessarily mirror the fiber chemical sensitivity .	T3	T15	20566645
NA	CHEMICAL	GENE-N	20	12	Steady-state fluorescence was utilized to assess chemical affinity in isolated gene containing gene and did not necessarily mirror the fiber chemical sensitivity .	T3	T16	20566645
NA	CHEMICAL	GENE-Y	6	4	Circular dichroism of mutant gene revealed a trend where increased alpha-helical content correlated with increased chemical sensitivity in skinned fibers and vice versa .	T4	T17	20566645
NA	CHEMICAL	GENE-N	0	6	chemical modulates desensitization of the chemical receptor subtype gene in Xenopus oocytes .	T15	T31	10626836
NA	CHEMICAL	GENE-Y	0	8	chemical modulates desensitization of the chemical receptor subtype gene in Xenopus oocytes .	T15	T32	10626836
NA	CHEMICAL	GENE-N	5	6	chemical modulates desensitization of the chemical receptor subtype gene in Xenopus oocytes .	T16	T31	10626836
NA	CHEMICAL	GENE-Y	5	8	chemical modulates desensitization of the chemical receptor subtype gene in Xenopus oocytes .	T16	T32	10626836
NA	CHEMICAL	GENE-N	9	10	Analysis of splice variants and site-directed mutants of the chemical receptor gene expressed in Xenopus oocytes has shown that chemical produces a large potentiation of the gene splice variant and suggested that chemical might inhibit rapid desensitization , which is characteristic of this receptor ( Karkanias , N. and Papke , R. , Subtype-specific effects of chemical on chemical receptor function .	T11	T25	10626836
NA	CHEMICAL	GENE-Y	9	11	Analysis of splice variants and site-directed mutants of the chemical receptor gene expressed in Xenopus oocytes has shown that chemical produces a large potentiation of the gene splice variant and suggested that chemical might inhibit rapid desensitization , which is characteristic of this receptor ( Karkanias , N. and Papke , R. , Subtype-specific effects of chemical on chemical receptor function .	T11	T27	10626836
NA	CHEMICAL	GENE-Y	9	26	Analysis of splice variants and site-directed mutants of the chemical receptor gene expressed in Xenopus oocytes has shown that chemical produces a large potentiation of the gene splice variant and suggested that chemical might inhibit rapid desensitization , which is characteristic of this receptor ( Karkanias , N. and Papke , R. , Subtype-specific effects of chemical on chemical receptor function .	T11	T23	10626836
NA	CHEMICAL	GENE-N	9	10	Analysis of splice variants and site-directed mutants of the chemical receptor gene expressed in Xenopus oocytes has shown that chemical produces a large potentiation of the gene splice variant and suggested that chemical might inhibit rapid desensitization , which is characteristic of this receptor ( Karkanias , N. and Papke , R. , Subtype-specific effects of chemical on chemical receptor function .	T11	T24	10626836
NA	CHEMICAL	GENE-N	19	10	Analysis of splice variants and site-directed mutants of the chemical receptor gene expressed in Xenopus oocytes has shown that chemical produces a large potentiation of the gene splice variant and suggested that chemical might inhibit rapid desensitization , which is characteristic of this receptor ( Karkanias , N. and Papke , R. , Subtype-specific effects of chemical on chemical receptor function .	T3	T25	10626836
NA	CHEMICAL	GENE-Y	19	11	Analysis of splice variants and site-directed mutants of the chemical receptor gene expressed in Xenopus oocytes has shown that chemical produces a large potentiation of the gene splice variant and suggested that chemical might inhibit rapid desensitization , which is characteristic of this receptor ( Karkanias , N. and Papke , R. , Subtype-specific effects of chemical on chemical receptor function .	T3	T27	10626836
CPR:3	CHEMICAL	GENE-Y	19	26	Analysis of splice variants and site-directed mutants of the chemical receptor gene expressed in Xenopus oocytes has shown that chemical produces a large potentiation of the gene splice variant and suggested that chemical might inhibit rapid desensitization , which is characteristic of this receptor ( Karkanias , N. and Papke , R. , Subtype-specific effects of chemical on chemical receptor function .	T3	T23	10626836
NA	CHEMICAL	GENE-N	19	10	Analysis of splice variants and site-directed mutants of the chemical receptor gene expressed in Xenopus oocytes has shown that chemical produces a large potentiation of the gene splice variant and suggested that chemical might inhibit rapid desensitization , which is characteristic of this receptor ( Karkanias , N. and Papke , R. , Subtype-specific effects of chemical on chemical receptor function .	T3	T24	10626836
NA	CHEMICAL	GENE-N	32	10	Analysis of splice variants and site-directed mutants of the chemical receptor gene expressed in Xenopus oocytes has shown that chemical produces a large potentiation of the gene splice variant and suggested that chemical might inhibit rapid desensitization , which is characteristic of this receptor ( Karkanias , N. and Papke , R. , Subtype-specific effects of chemical on chemical receptor function .	T8	T25	10626836
NA	CHEMICAL	GENE-Y	32	11	Analysis of splice variants and site-directed mutants of the chemical receptor gene expressed in Xenopus oocytes has shown that chemical produces a large potentiation of the gene splice variant and suggested that chemical might inhibit rapid desensitization , which is characteristic of this receptor ( Karkanias , N. and Papke , R. , Subtype-specific effects of chemical on chemical receptor function .	T8	T27	10626836
CPR:3	CHEMICAL	GENE-Y	32	26	Analysis of splice variants and site-directed mutants of the chemical receptor gene expressed in Xenopus oocytes has shown that chemical produces a large potentiation of the gene splice variant and suggested that chemical might inhibit rapid desensitization , which is characteristic of this receptor ( Karkanias , N. and Papke , R. , Subtype-specific effects of chemical on chemical receptor function .	T8	T23	10626836
NA	CHEMICAL	GENE-N	32	10	Analysis of splice variants and site-directed mutants of the chemical receptor gene expressed in Xenopus oocytes has shown that chemical produces a large potentiation of the gene splice variant and suggested that chemical might inhibit rapid desensitization , which is characteristic of this receptor ( Karkanias , N. and Papke , R. , Subtype-specific effects of chemical on chemical receptor function .	T8	T24	10626836
NA	CHEMICAL	GENE-N	56	10	Analysis of splice variants and site-directed mutants of the chemical receptor gene expressed in Xenopus oocytes has shown that chemical produces a large potentiation of the gene splice variant and suggested that chemical might inhibit rapid desensitization , which is characteristic of this receptor ( Karkanias , N. and Papke , R. , Subtype-specific effects of chemical on chemical receptor function .	T9	T25	10626836
NA	CHEMICAL	GENE-Y	56	11	Analysis of splice variants and site-directed mutants of the chemical receptor gene expressed in Xenopus oocytes has shown that chemical produces a large potentiation of the gene splice variant and suggested that chemical might inhibit rapid desensitization , which is characteristic of this receptor ( Karkanias , N. and Papke , R. , Subtype-specific effects of chemical on chemical receptor function .	T9	T27	10626836
NA	CHEMICAL	GENE-Y	56	26	Analysis of splice variants and site-directed mutants of the chemical receptor gene expressed in Xenopus oocytes has shown that chemical produces a large potentiation of the gene splice variant and suggested that chemical might inhibit rapid desensitization , which is characteristic of this receptor ( Karkanias , N. and Papke , R. , Subtype-specific effects of chemical on chemical receptor function .	T9	T23	10626836
NA	CHEMICAL	GENE-N	56	10	Analysis of splice variants and site-directed mutants of the chemical receptor gene expressed in Xenopus oocytes has shown that chemical produces a large potentiation of the gene splice variant and suggested that chemical might inhibit rapid desensitization , which is characteristic of this receptor ( Karkanias , N. and Papke , R. , Subtype-specific effects of chemical on chemical receptor function .	T9	T24	10626836
NA	CHEMICAL	GENE-N	21	10	Analysis of splice variants and site-directed mutants of the chemical receptor gene expressed in Xenopus oocytes has shown that chemical produces a large potentiation of the gene splice variant and suggested that chemical might inhibit rapid desensitization , which is characteristic of this receptor ( Karkanias , N. and Papke , R. , Subtype-specific effects of chemical on chemical receptor function .	T10	T25	10626836
NA	CHEMICAL	GENE-Y	21	11	Analysis of splice variants and site-directed mutants of the chemical receptor gene expressed in Xenopus oocytes has shown that chemical produces a large potentiation of the gene splice variant and suggested that chemical might inhibit rapid desensitization , which is characteristic of this receptor ( Karkanias , N. and Papke , R. , Subtype-specific effects of chemical on chemical receptor function .	T10	T27	10626836
NA	CHEMICAL	GENE-Y	21	26	Analysis of splice variants and site-directed mutants of the chemical receptor gene expressed in Xenopus oocytes has shown that chemical produces a large potentiation of the gene splice variant and suggested that chemical might inhibit rapid desensitization , which is characteristic of this receptor ( Karkanias , N. and Papke , R. , Subtype-specific effects of chemical on chemical receptor function .	T10	T23	10626836
NA	CHEMICAL	GENE-N	21	10	Analysis of splice variants and site-directed mutants of the chemical receptor gene expressed in Xenopus oocytes has shown that chemical produces a large potentiation of the gene splice variant and suggested that chemical might inhibit rapid desensitization , which is characteristic of this receptor ( Karkanias , N. and Papke , R. , Subtype-specific effects of chemical on chemical receptor function .	T10	T24	10626836
NA	CHEMICAL	GENE-N	10	11	and Seeburg , P.H , Control of kinetic properties of chemical receptor channels by nuclear RNA editing .	T12	T26	10626836
CPR:3	CHEMICAL	GENE-Y	14	17	Science , 9 ( 266 ) ( 1994 ) 1709-1713 ) greatly attenuates the chemical-induced potentiation of gene .	T13	T28	10626836
NA	CHEMICAL	GENE-Y	34	8	Additionally , experiments with the non-desensitizing site-directed mutant gene ( gene ) ( Stern-Bach , Y. , Russo , S. , Neuman , M. and Rosenmund , C. , A point mutation in the chemical binding site blocks desensitization of chemical receptors .	T14	T29	10626836
NA	CHEMICAL	GENE-N	34	10	Additionally , experiments with the non-desensitizing site-directed mutant gene ( gene ) ( Stern-Bach , Y. , Russo , S. , Neuman , M. and Rosenmund , C. , A point mutation in the chemical binding site blocks desensitization of chemical receptors .	T14	T30	10626836
NA	CHEMICAL	GENE-N	34	41	Additionally , experiments with the non-desensitizing site-directed mutant gene ( gene ) ( Stern-Bach , Y. , Russo , S. , Neuman , M. and Rosenmund , C. , A point mutation in the chemical binding site blocks desensitization of chemical receptors .	T14	T17	10626836
NA	CHEMICAL	GENE-Y	29	8	Additionally , experiments with the non-desensitizing site-directed mutant gene ( gene ) ( Stern-Bach , Y. , Russo , S. , Neuman , M. and Rosenmund , C. , A point mutation in the chemical binding site blocks desensitization of chemical receptors .	T1	T29	10626836
NA	CHEMICAL	GENE-N	29	10	Additionally , experiments with the non-desensitizing site-directed mutant gene ( gene ) ( Stern-Bach , Y. , Russo , S. , Neuman , M. and Rosenmund , C. , A point mutation in the chemical binding site blocks desensitization of chemical receptors .	T1	T30	10626836
NA	CHEMICAL	GENE-N	29	41	Additionally , experiments with the non-desensitizing site-directed mutant gene ( gene ) ( Stern-Bach , Y. , Russo , S. , Neuman , M. and Rosenmund , C. , A point mutation in the chemical binding site blocks desensitization of chemical receptors .	T1	T17	10626836
CPR:3	CHEMICAL	GENE-Y	11	13	Neuron , 21 ( 1998 ) 907-918 ) further confirms that chemical enhances gene responses by reducing desensitization , since lithium 's effects are reversed in this mutant .	T2	T18	10626836
NA	CHEMICAL	GENE-Y	12	4	Lithium 's effects on gene desensitization are distinct from the effects of chemical on desensitization .	T4	T19	10626836
NA	CHEMICAL	GENE-Y	1	4	The chemical channel subunit Kvbeta3 interacts with gene and attenuates its sensitivity to changes in redox potentials .	T5	T27	19780818
NA	CHEMICAL	GENE-Y	1	7	The chemical channel subunit Kvbeta3 interacts with gene and attenuates its sensitivity to changes in redox potentials .	T5	T28	19780818
NA	CHEMICAL	GENE-Y	8	5	A candidate regulatory protein of gene is the chemical channel subunit Kvbeta3 , previously identified by bacterial two-hybrid strategies .	T3	T13	19780818
NA	CHEMICAL	GENE-Y	8	11	A candidate regulatory protein of gene is the chemical channel subunit Kvbeta3 , previously identified by bacterial two-hybrid strategies .	T3	T14	19780818
NA	CHEMICAL	GENE-Y	10	0	gene is known to accelerate inactivation of otherwise slowly inactivating chemical channels under reducing conditions .	T4	T20	19780818
NA	CHEMICAL	GENE-N	10	11	gene is known to accelerate inactivation of otherwise slowly inactivating chemical channels under reducing conditions .	T4	T21	19780818
CPR:4	CHEMICAL	GENE-Y	6	3	Furthermore , the gene channel blockers chemical and chemical were less effective in inhibiting gene currents when gene was co-expressed .	T1	T26	19780818
NA	CHEMICAL	GENE-Y	6	14	Furthermore , the gene channel blockers chemical and chemical were less effective in inhibiting gene currents when gene was co-expressed .	T1	T7	19780818
NA	CHEMICAL	GENE-Y	6	17	Furthermore , the gene channel blockers chemical and chemical were less effective in inhibiting gene currents when gene was co-expressed .	T1	T8	19780818
CPR:4	CHEMICAL	GENE-Y	3	3	Furthermore , the gene channel blockers chemical and chemical were less effective in inhibiting gene currents when gene was co-expressed .	T2	T26	19780818
NA	CHEMICAL	GENE-Y	3	14	Furthermore , the gene channel blockers chemical and chemical were less effective in inhibiting gene currents when gene was co-expressed .	T2	T7	19780818
NA	CHEMICAL	GENE-Y	3	17	Furthermore , the gene channel blockers chemical and chemical were less effective in inhibiting gene currents when gene was co-expressed .	T2	T8	19780818
NA	CHEMICAL	GENE-Y	9	1	The gene ( gene ) has an essential role in multiple signaling pathways , including cell proliferation and migration , through extracellular ligand binding and subsequent activation of its intracellular chemical kinase ( TK ) domain .	T6	T29	22349823
NA	CHEMICAL	GENE-Y	9	3	The gene ( gene ) has an essential role in multiple signaling pathways , including cell proliferation and migration , through extracellular ligand binding and subsequent activation of its intracellular chemical kinase ( TK ) domain .	T6	T27	22349823
NA	CHEMICAL	GENE-N	9	9	The gene ( gene ) has an essential role in multiple signaling pathways , including cell proliferation and migration , through extracellular ligand binding and subsequent activation of its intracellular chemical kinase ( TK ) domain .	T6	T23	22349823
CPR:4	CHEMICAL	GENE-N	8	4	They display sensitivity to gene inhibitors , including chemical and chemical .	T7	T28	22349823
CPR:4	CHEMICAL	GENE-N	10	4	They display sensitivity to gene inhibitors , including chemical and chemical .	T8	T28	22349823
NA	CHEMICAL	GENE-N	16	13	In this study , our biochemical analyses revealed that the introduction of the gene mutation confers chemical resistance on the gene mutant .	T9	T32	22349823
NA	CHEMICAL	GENE-N	16	20	In this study , our biochemical analyses revealed that the introduction of the gene mutation confers chemical resistance on the gene mutant .	T9	T33	22349823
NA	CHEMICAL	GENE-N	10	1	The gene/gene double mutant has enhanced activity and retains high chemical-binding affinity .	T10	T34	22349823
NA	CHEMICAL	GENE-N	10	1	The gene/gene double mutant has enhanced activity and retains high chemical-binding affinity .	T10	T35	22349823
NA	CHEMICAL	GENE-N	5	1	The gene mutation increases the chemical affinity of the gene mutant , explaining the acquired drug resistance of the double mutant .	T11	T36	22349823
NA	CHEMICAL	GENE-N	5	9	The gene mutation increases the chemical affinity of the gene mutant , explaining the acquired drug resistance of the double mutant .	T11	T37	22349823
NA	CHEMICAL	GENE-N	1	1	The chemical790 side chain of the gene/gene double mutant , in the apo form and chemical- and AMPPNP-bound forms , adopts different conformations that explain the accommodation of these ligands .	T1	T17	22349823
NA	CHEMICAL	GENE-N	1	6	The chemical790 side chain of the gene/gene double mutant , in the apo form and chemical- and AMPPNP-bound forms , adopts different conformations that explain the accommodation of these ligands .	T1	T18	22349823
NA	CHEMICAL	GENE-N	10	1	The chemical790 side chain of the gene/gene double mutant , in the apo form and chemical- and AMPPNP-bound forms , adopts different conformations that explain the accommodation of these ligands .	T2	T17	22349823
NA	CHEMICAL	GENE-N	10	6	The chemical790 side chain of the gene/gene double mutant , in the apo form and chemical- and AMPPNP-bound forms , adopts different conformations that explain the accommodation of these ligands .	T2	T18	22349823
NA	CHEMICAL	GENE-N	15	2	In the gene mutant structure , the active-site cleft is expanded by the repositioning of chemical723 within the P-loop .	T3	T19	22349823
NA	CHEMICAL	GENE-N	11	6	Notably , the introduction of the gene mutation greatly enhanced the chemical sensitivity of the wild-type gene in vivo , supporting our hypothesis that the expansion of the active-site cleft results in enhanced chemical sensitivity .	T4	T20	22349823
NA	CHEMICAL	GENE-Y	11	16	Notably , the introduction of the gene mutation greatly enhanced the chemical sensitivity of the wild-type gene in vivo , supporting our hypothesis that the expansion of the active-site cleft results in enhanced chemical sensitivity .	T4	T21	22349823
NA	CHEMICAL	GENE-N	17	6	Notably , the introduction of the gene mutation greatly enhanced the chemical sensitivity of the wild-type gene in vivo , supporting our hypothesis that the expansion of the active-site cleft results in enhanced chemical sensitivity .	T5	T20	22349823
NA	CHEMICAL	GENE-Y	17	16	Notably , the introduction of the gene mutation greatly enhanced the chemical sensitivity of the wild-type gene in vivo , supporting our hypothesis that the expansion of the active-site cleft results in enhanced chemical sensitivity .	T5	T21	22349823
NA	CHEMICAL	GENE-Y	2	3	Redesign of chemical acetyltransferase specificity by protein engineering .	T18	T36	15155769
NA	CHEMICAL	GENE-Y	0	1	chemical acetyltransferases ( gene ) catalyze the reversible conversion of chemical and chemical to chemical and free CoA .	T2	T19	15155769
NA	CHEMICAL	GENE-Y	0	3	chemical acetyltransferases ( gene ) catalyze the reversible conversion of chemical and chemical to chemical and free CoA .	T2	T25	15155769
CPR:9	CHEMICAL	GENE-Y	10	1	chemical acetyltransferases ( gene ) catalyze the reversible conversion of chemical and chemical to chemical and free CoA .	T5	T19	15155769
CPR:9	CHEMICAL	GENE-Y	10	3	chemical acetyltransferases ( gene ) catalyze the reversible conversion of chemical and chemical to chemical and free CoA .	T5	T25	15155769
CPR:9	CHEMICAL	GENE-Y	12	1	chemical acetyltransferases ( gene ) catalyze the reversible conversion of chemical and chemical to chemical and free CoA .	T6	T19	15155769
CPR:9	CHEMICAL	GENE-Y	12	3	chemical acetyltransferases ( gene ) catalyze the reversible conversion of chemical and chemical to chemical and free CoA .	T6	T25	15155769
CPR:9	CHEMICAL	GENE-Y	14	1	chemical acetyltransferases ( gene ) catalyze the reversible conversion of chemical and chemical to chemical and free CoA .	T7	T19	15155769
CPR:9	CHEMICAL	GENE-Y	14	3	chemical acetyltransferases ( gene ) catalyze the reversible conversion of chemical and chemical to chemical and free CoA .	T7	T25	15155769
CPR:9	CHEMICAL	GENE-N	10	1	The gene mutated gene showed higher activity toward longer chain chemical : activity toward chemical was 1250-fold higher than that of the wild-type gene , and lower activity toward its natural substrate , chemical .	T8	T27	15155769
CPR:9	CHEMICAL	GENE-Y	10	3	The gene mutated gene showed higher activity toward longer chain chemical : activity toward chemical was 1250-fold higher than that of the wild-type gene , and lower activity toward its natural substrate , chemical .	T8	T28	15155769
CPR:9	CHEMICAL	GENE-Y	10	23	The gene mutated gene showed higher activity toward longer chain chemical : activity toward chemical was 1250-fold higher than that of the wild-type gene , and lower activity toward its natural substrate , chemical .	T8	T29	15155769
CPR:9	CHEMICAL	GENE-N	14	1	The gene mutated gene showed higher activity toward longer chain chemical : activity toward chemical was 1250-fold higher than that of the wild-type gene , and lower activity toward its natural substrate , chemical .	T9	T27	15155769
CPR:9	CHEMICAL	GENE-Y	14	3	The gene mutated gene showed higher activity toward longer chain chemical : activity toward chemical was 1250-fold higher than that of the wild-type gene , and lower activity toward its natural substrate , chemical .	T9	T28	15155769
CPR:9	CHEMICAL	GENE-Y	14	23	The gene mutated gene showed higher activity toward longer chain chemical : activity toward chemical was 1250-fold higher than that of the wild-type gene , and lower activity toward its natural substrate , chemical .	T9	T29	15155769
CPR:9	CHEMICAL	GENE-N	33	1	The gene mutated gene showed higher activity toward longer chain chemical : activity toward chemical was 1250-fold higher than that of the wild-type gene , and lower activity toward its natural substrate , chemical .	T10	T27	15155769
CPR:9	CHEMICAL	GENE-Y	33	3	The gene mutated gene showed higher activity toward longer chain chemical : activity toward chemical was 1250-fold higher than that of the wild-type gene , and lower activity toward its natural substrate , chemical .	T10	T28	15155769
CPR:9	CHEMICAL	GENE-Y	33	23	The gene mutated gene showed higher activity toward longer chain chemical : activity toward chemical was 1250-fold higher than that of the wild-type gene , and lower activity toward its natural substrate , chemical .	T10	T29	15155769
CPR:9	CHEMICAL	GENE-Y	12	5	Kinetic constants of the mutant gene showed modification in favor of longer chemical as substrates .	T11	T30	15155769
NA	CHEMICAL	GENE-N	9	15	In the reverse case , mutation of the orthologous chemical ( Gly553 ) to chemical in chemical octanoyltransferase ( gene ) decreased activity toward its natural substrates , medium- and long-chain chemical , and increased activity toward short-chain chemical .	T12	T31	15155769
NA	CHEMICAL	GENE-Y	9	17	In the reverse case , mutation of the orthologous chemical ( Gly553 ) to chemical in chemical octanoyltransferase ( gene ) decreased activity toward its natural substrates , medium- and long-chain chemical , and increased activity toward short-chain chemical .	T12	T32	15155769
NA	CHEMICAL	GENE-Y	9	19	In the reverse case , mutation of the orthologous chemical ( Gly553 ) to chemical in chemical octanoyltransferase ( gene ) decreased activity toward its natural substrates , medium- and long-chain chemical , and increased activity toward short-chain chemical .	T12	T33	15155769
NA	CHEMICAL	GENE-N	14	15	In the reverse case , mutation of the orthologous chemical ( Gly553 ) to chemical in chemical octanoyltransferase ( gene ) decreased activity toward its natural substrates , medium- and long-chain chemical , and increased activity toward short-chain chemical .	T13	T31	15155769
NA	CHEMICAL	GENE-Y	14	17	In the reverse case , mutation of the orthologous chemical ( Gly553 ) to chemical in chemical octanoyltransferase ( gene ) decreased activity toward its natural substrates , medium- and long-chain chemical , and increased activity toward short-chain chemical .	T13	T32	15155769
NA	CHEMICAL	GENE-Y	14	19	In the reverse case , mutation of the orthologous chemical ( Gly553 ) to chemical in chemical octanoyltransferase ( gene ) decreased activity toward its natural substrates , medium- and long-chain chemical , and increased activity toward short-chain chemical .	T13	T33	15155769
NA	CHEMICAL	GENE-N	15	15	In the reverse case , mutation of the orthologous chemical ( Gly553 ) to chemical in chemical octanoyltransferase ( gene ) decreased activity toward its natural substrates , medium- and long-chain chemical , and increased activity toward short-chain chemical .	T14	T31	15155769
NA	CHEMICAL	GENE-Y	15	17	In the reverse case , mutation of the orthologous chemical ( Gly553 ) to chemical in chemical octanoyltransferase ( gene ) decreased activity toward its natural substrates , medium- and long-chain chemical , and increased activity toward short-chain chemical .	T14	T32	15155769
NA	CHEMICAL	GENE-Y	15	19	In the reverse case , mutation of the orthologous chemical ( Gly553 ) to chemical in chemical octanoyltransferase ( gene ) decreased activity toward its natural substrates , medium- and long-chain chemical , and increased activity toward short-chain chemical .	T14	T33	15155769
NA	CHEMICAL	GENE-N	31	15	In the reverse case , mutation of the orthologous chemical ( Gly553 ) to chemical in chemical octanoyltransferase ( gene ) decreased activity toward its natural substrates , medium- and long-chain chemical , and increased activity toward short-chain chemical .	T15	T31	15155769
CPR:9	CHEMICAL	GENE-Y	31	17	In the reverse case , mutation of the orthologous chemical ( Gly553 ) to chemical in chemical octanoyltransferase ( gene ) decreased activity toward its natural substrates , medium- and long-chain chemical , and increased activity toward short-chain chemical .	T15	T32	15155769
CPR:9	CHEMICAL	GENE-Y	31	19	In the reverse case , mutation of the orthologous chemical ( Gly553 ) to chemical in chemical octanoyltransferase ( gene ) decreased activity toward its natural substrates , medium- and long-chain chemical , and increased activity toward short-chain chemical .	T15	T33	15155769
NA	CHEMICAL	GENE-N	38	15	In the reverse case , mutation of the orthologous chemical ( Gly553 ) to chemical in chemical octanoyltransferase ( gene ) decreased activity toward its natural substrates , medium- and long-chain chemical , and increased activity toward short-chain chemical .	T16	T31	15155769
CPR:9	CHEMICAL	GENE-Y	38	17	In the reverse case , mutation of the orthologous chemical ( Gly553 ) to chemical in chemical octanoyltransferase ( gene ) decreased activity toward its natural substrates , medium- and long-chain chemical , and increased activity toward short-chain chemical .	T16	T32	15155769
CPR:9	CHEMICAL	GENE-Y	38	19	In the reverse case , mutation of the orthologous chemical ( Gly553 ) to chemical in chemical octanoyltransferase ( gene ) decreased activity toward its natural substrates , medium- and long-chain chemical , and increased activity toward short-chain chemical .	T16	T33	15155769
CPR:9	CHEMICAL	GENE-Y	11	17	We conclude that Met564 blocks the entry of medium- and long-chain chemical to the catalytic site of gene .	T1	T20	15155769
NA	CHEMICAL	GENE-Y	15	10	Mallory bodies ( MBs ) are cytoplasmic inclusions that contain gene ( gene ) and gene and are present in hepatocytes of individuals with chemical liver disease , chemical steatohepatitis , or benign or malignant hepatocellular neoplasia .	T2	T16	12388748
NA	CHEMICAL	GENE-Y	15	12	Mallory bodies ( MBs ) are cytoplasmic inclusions that contain gene ( gene ) and gene and are present in hepatocytes of individuals with chemical liver disease , chemical steatohepatitis , or benign or malignant hepatocellular neoplasia .	T2	T18	12388748
NA	CHEMICAL	GENE-Y	15	15	Mallory bodies ( MBs ) are cytoplasmic inclusions that contain gene ( gene ) and gene and are present in hepatocytes of individuals with chemical liver disease , chemical steatohepatitis , or benign or malignant hepatocellular neoplasia .	T2	T20	12388748
NA	CHEMICAL	GENE-Y	28	10	Mallory bodies ( MBs ) are cytoplasmic inclusions that contain gene ( gene ) and gene and are present in hepatocytes of individuals with chemical liver disease , chemical steatohepatitis , or benign or malignant hepatocellular neoplasia .	T3	T16	12388748
NA	CHEMICAL	GENE-Y	28	12	Mallory bodies ( MBs ) are cytoplasmic inclusions that contain gene ( gene ) and gene and are present in hepatocytes of individuals with chemical liver disease , chemical steatohepatitis , or benign or malignant hepatocellular neoplasia .	T3	T18	12388748
NA	CHEMICAL	GENE-Y	28	15	Mallory bodies ( MBs ) are cytoplasmic inclusions that contain gene ( gene ) and gene and are present in hepatocytes of individuals with chemical liver disease , chemical steatohepatitis , or benign or malignant hepatocellular neoplasia .	T3	T20	12388748
CPR:3	CHEMICAL	GENE-Y	1	19	Culture of HepG2 cells with chemical has now been shown to induce both the formation of intracellular aggregates containing gene as well as an increase in the abundance of gene mRNA .	T5	T14	12388748
CPR:3	CHEMICAL	GENE-Y	1	29	Culture of HepG2 cells with chemical has now been shown to induce both the formation of intracellular aggregates containing gene as well as an increase in the abundance of gene mRNA .	T5	T15	12388748
NA	CHEMICAL	GENE-Y	26	2	Overexpression of gene in HepG2 , HeLa , or COS-7 cells also induced the formation of intracellular aggregates that stained with antibodies to gene and with chemical ( characteristics of MBs formed in vivo ) , eventually leading to cell death .	T6	T17	12388748
NA	CHEMICAL	GENE-N	26	3	Overexpression of gene in HepG2 , HeLa , or COS-7 cells also induced the formation of intracellular aggregates that stained with antibodies to gene and with chemical ( characteristics of MBs formed in vivo ) , eventually leading to cell death .	T6	T19	12388748
NA	CHEMICAL	GENE-Y	4	8	In contrast , an chemical-terminal deletion mutant of gene promoted the formation of intracellular aggregates even in the absence of gene overexpression .	T1	T9	12388748
NA	CHEMICAL	GENE-Y	4	20	In contrast , an chemical-terminal deletion mutant of gene promoted the formation of intracellular aggregates even in the absence of gene overexpression .	T1	T10	12388748
CPR:9	CHEMICAL	GENE-N	4	25	Absorption and secretion of chemical increase at acid pH levels , possibly because of its non-ionized state at these pHs and/or because of participation of a chemical/chemical cotransporter or a chemical/chemical antiporter .	T10	T15	23291323
CPR:9	CHEMICAL	GENE-N	4	25	Absorption and secretion of chemical increase at acid pH levels , possibly because of its non-ionized state at these pHs and/or because of participation of a chemical/chemical cotransporter or a chemical/chemical antiporter .	T10	T14	23291323
NA	CHEMICAL	GENE-N	26	25	Absorption and secretion of chemical increase at acid pH levels , possibly because of its non-ionized state at these pHs and/or because of participation of a chemical/chemical cotransporter or a chemical/chemical antiporter .	T11	T15	23291323
NA	CHEMICAL	GENE-N	26	25	Absorption and secretion of chemical increase at acid pH levels , possibly because of its non-ionized state at these pHs and/or because of participation of a chemical/chemical cotransporter or a chemical/chemical antiporter .	T11	T14	23291323
NA	CHEMICAL	GENE-N	26	25	Absorption and secretion of chemical increase at acid pH levels , possibly because of its non-ionized state at these pHs and/or because of participation of a chemical/chemical cotransporter or a chemical/chemical antiporter .	T12	T15	23291323
NA	CHEMICAL	GENE-N	26	25	Absorption and secretion of chemical increase at acid pH levels , possibly because of its non-ionized state at these pHs and/or because of participation of a chemical/chemical cotransporter or a chemical/chemical antiporter .	T12	T14	23291323
NA	CHEMICAL	GENE-N	4	25	Absorption and secretion of chemical increase at acid pH levels , possibly because of its non-ionized state at these pHs and/or because of participation of a chemical/chemical cotransporter or a chemical/chemical antiporter .	T1	T15	23291323
NA	CHEMICAL	GENE-N	4	25	Absorption and secretion of chemical increase at acid pH levels , possibly because of its non-ionized state at these pHs and/or because of participation of a chemical/chemical cotransporter or a chemical/chemical antiporter .	T1	T14	23291323
NA	CHEMICAL	GENE-N	30	25	Absorption and secretion of chemical increase at acid pH levels , possibly because of its non-ionized state at these pHs and/or because of participation of a chemical/chemical cotransporter or a chemical/chemical antiporter .	T2	T15	23291323
NA	CHEMICAL	GENE-N	30	25	Absorption and secretion of chemical increase at acid pH levels , possibly because of its non-ionized state at these pHs and/or because of participation of a chemical/chemical cotransporter or a chemical/chemical antiporter .	T2	T14	23291323
NA	CHEMICAL	GENE-Y	2	2	MORAb-003 , a fully humanized monoclonal antibody against the chemical receptor alpha , for the potential treatment of epithelial ovarian cancer .	T4	T6	18058577
NA	CHEMICAL	GENE-Y	6	6	Morphotek Inc is developing MORAb-003 , a humanized monoclonal antibody directed against chemical receptor alpha , for the potential treatment of ovarian cancer .	T3	T5	18058577
NA	CHEMICAL	GENE-Y	0	7	chemical products of chemical displayed significantly diminished gene-dependent cleavage of DNA and cytotoxicity to human HL-60 leukemia cells .	T1	T37	23402364
CPR:4	CHEMICAL	GENE-Y	3	7	chemical products of chemical displayed significantly diminished gene-dependent cleavage of DNA and cytotoxicity to human HL-60 leukemia cells .	T2	T37	23402364
NA	CHEMICAL	GENE-N	3	4	LPS-mediated induction of chemical synthase in murine macrophages resulted in chemical resistance compared to Raw cells .	T3	T38	23402364
NA	CHEMICAL	GENE-N	10	4	LPS-mediated induction of chemical synthase in murine macrophages resulted in chemical resistance compared to Raw cells .	T4	T38	23402364
NA	CHEMICAL	GENE-Y	2	6	Furthermore , chemical products derived from gene rapidly reacted with chemical leading to decreased DNA damage and cytotoxicity .	T5	T39	23402364
NA	CHEMICAL	GENE-Y	10	6	Furthermore , chemical products derived from gene rapidly reacted with chemical leading to decreased DNA damage and cytotoxicity .	T6	T39	23402364
NA	CHEMICAL	GENE-Y	7	28	In fact , while elimination of testicular chemical by castration alone has never been shown to prolong life in metastatic prostate cancer , combination of castration ( surgical or medical with a chemical ( gene ) agonist ) with a pure anti-chemical has been the first treatment shown to prolong life .	T28	T29	20541672
NA	CHEMICAL	GENE-Y	7	34	In fact , while elimination of testicular chemical by castration alone has never been shown to prolong life in metastatic prostate cancer , combination of castration ( surgical or medical with a chemical ( gene ) agonist ) with a pure anti-chemical has been the first treatment shown to prolong life .	T28	T30	20541672
NA	CHEMICAL	GENE-Y	28	28	In fact , while elimination of testicular chemical by castration alone has never been shown to prolong life in metastatic prostate cancer , combination of castration ( surgical or medical with a chemical ( gene ) agonist ) with a pure anti-chemical has been the first treatment shown to prolong life .	T1	T29	20541672
NA	CHEMICAL	GENE-Y	28	34	In fact , while elimination of testicular chemical by castration alone has never been shown to prolong life in metastatic prostate cancer , combination of castration ( surgical or medical with a chemical ( gene ) agonist ) with a pure anti-chemical has been the first treatment shown to prolong life .	T1	T30	20541672
NA	CHEMICAL	GENE-Y	7	28	In fact , while elimination of testicular chemical by castration alone has never been shown to prolong life in metastatic prostate cancer , combination of castration ( surgical or medical with a chemical ( gene ) agonist ) with a pure anti-chemical has been the first treatment shown to prolong life .	T2	T29	20541672
NA	CHEMICAL	GENE-Y	7	34	In fact , while elimination of testicular chemical by castration alone has never been shown to prolong life in metastatic prostate cancer , combination of castration ( surgical or medical with a chemical ( gene ) agonist ) with a pure anti-chemical has been the first treatment shown to prolong life .	T2	T30	20541672
NA	CHEMICAL	GENE-Y	31	28	In fact , while elimination of testicular chemical by castration alone has never been shown to prolong life in metastatic prostate cancer , combination of castration ( surgical or medical with a chemical ( gene ) agonist ) with a pure anti-chemical has been the first treatment shown to prolong life .	T3	T29	20541672
NA	CHEMICAL	GENE-Y	31	34	In fact , while elimination of testicular chemical by castration alone has never been shown to prolong life in metastatic prostate cancer , combination of castration ( surgical or medical with a chemical ( gene ) agonist ) with a pure anti-chemical has been the first treatment shown to prolong life .	T3	T30	20541672
NA	CHEMICAL	GENE-Y	4	7	While the role of chemical was believed to have become non-significant in cancer progressing under any form of chemical blockade , recent data have shown increased expression of the chemical receptor ( gene ) in treatment-resistant disease with a benefit of further chemical blockade .	T6	T33	20541672
NA	CHEMICAL	GENE-Y	4	32	While the role of chemical was believed to have become non-significant in cancer progressing under any form of chemical blockade , recent data have shown increased expression of the chemical receptor ( gene ) in treatment-resistant disease with a benefit of further chemical blockade .	T6	T34	20541672
NA	CHEMICAL	GENE-Y	18	7	While the role of chemical was believed to have become non-significant in cancer progressing under any form of chemical blockade , recent data have shown increased expression of the chemical receptor ( gene ) in treatment-resistant disease with a benefit of further chemical blockade .	T7	T33	20541672
NA	CHEMICAL	GENE-Y	18	32	While the role of chemical was believed to have become non-significant in cancer progressing under any form of chemical blockade , recent data have shown increased expression of the chemical receptor ( gene ) in treatment-resistant disease with a benefit of further chemical blockade .	T7	T34	20541672
NA	CHEMICAL	GENE-Y	29	7	While the role of chemical was believed to have become non-significant in cancer progressing under any form of chemical blockade , recent data have shown increased expression of the chemical receptor ( gene ) in treatment-resistant disease with a benefit of further chemical blockade .	T8	T33	20541672
NA	CHEMICAL	GENE-Y	29	32	While the role of chemical was believed to have become non-significant in cancer progressing under any form of chemical blockade , recent data have shown increased expression of the chemical receptor ( gene ) in treatment-resistant disease with a benefit of further chemical blockade .	T8	T34	20541672
NA	CHEMICAL	GENE-Y	38	7	While the role of chemical was believed to have become non-significant in cancer progressing under any form of chemical blockade , recent data have shown increased expression of the chemical receptor ( gene ) in treatment-resistant disease with a benefit of further chemical blockade .	T9	T33	20541672
NA	CHEMICAL	GENE-Y	38	32	While the role of chemical was believed to have become non-significant in cancer progressing under any form of chemical blockade , recent data have shown increased expression of the chemical receptor ( gene ) in treatment-resistant disease with a benefit of further chemical blockade .	T9	T34	20541672
NA	CHEMICAL	GENE-Y	3	8	Since the available anti-chemical have low affinity for gene and can not block chemical action completely , especially in the presence of increased gene levels , it becomes important to discover more potent and purely antagonistic blockers of gene .	T10	T35	20541672
NA	CHEMICAL	GENE-Y	3	23	Since the available anti-chemical have low affinity for gene and can not block chemical action completely , especially in the presence of increased gene levels , it becomes important to discover more potent and purely antagonistic blockers of gene .	T10	T36	20541672
NA	CHEMICAL	GENE-Y	3	38	Since the available anti-chemical have low affinity for gene and can not block chemical action completely , especially in the presence of increased gene levels , it becomes important to discover more potent and purely antagonistic blockers of gene .	T10	T37	20541672
NA	CHEMICAL	GENE-Y	9	8	Since the available anti-chemical have low affinity for gene and can not block chemical action completely , especially in the presence of increased gene levels , it becomes important to discover more potent and purely antagonistic blockers of gene .	T11	T35	20541672
NA	CHEMICAL	GENE-Y	9	23	Since the available anti-chemical have low affinity for gene and can not block chemical action completely , especially in the presence of increased gene levels , it becomes important to discover more potent and purely antagonistic blockers of gene .	T11	T36	20541672
NA	CHEMICAL	GENE-Y	9	38	Since the available anti-chemical have low affinity for gene and can not block chemical action completely , especially in the presence of increased gene levels , it becomes important to discover more potent and purely antagonistic blockers of gene .	T11	T37	20541672
NA	CHEMICAL	GENE-Y	1	0	gene or catalytically inactive chemical-gene bound indistinguishably to HUVEC and gene transfectants , and inhibited equally well the binding of 125I-gene to these cells .	T3	T27	9079657
NA	CHEMICAL	GENE-Y	1	4	gene or catalytically inactive chemical-gene bound indistinguishably to HUVEC and gene transfectants , and inhibited equally well the binding of 125I-gene to these cells .	T3	T28	9079657
NA	CHEMICAL	GENE-Y	1	10	gene or catalytically inactive chemical-gene bound indistinguishably to HUVEC and gene transfectants , and inhibited equally well the binding of 125I-gene to these cells .	T3	T29	9079657
NA	CHEMICAL	GENE-Y	1	20	gene or catalytically inactive chemical-gene bound indistinguishably to HUVEC and gene transfectants , and inhibited equally well the binding of 125I-gene to these cells .	T3	T30	9079657
NA	CHEMICAL	GENE-Y	17	1	A gene peptide duplicating the gene gene inhibited gene-independent gene activation by HUVEC and blocked binding of chemical-gene to these cells in a dose-dependent manner ( IC50 approximately 20-40 microM ) .	T5	T33	9079657
NA	CHEMICAL	GENE-N	17	5	A gene peptide duplicating the gene gene inhibited gene-independent gene activation by HUVEC and blocked binding of chemical-gene to these cells in a dose-dependent manner ( IC50 approximately 20-40 microM ) .	T5	T34	9079657
NA	CHEMICAL	GENE-N	17	6	A gene peptide duplicating the gene gene inhibited gene-independent gene activation by HUVEC and blocked binding of chemical-gene to these cells in a dose-dependent manner ( IC50 approximately 20-40 microM ) .	T5	T35	9079657
NA	CHEMICAL	GENE-Y	17	8	A gene peptide duplicating the gene gene inhibited gene-independent gene activation by HUVEC and blocked binding of chemical-gene to these cells in a dose-dependent manner ( IC50 approximately 20-40 microM ) .	T5	T36	9079657
NA	CHEMICAL	GENE-Y	17	9	A gene peptide duplicating the gene gene inhibited gene-independent gene activation by HUVEC and blocked binding of chemical-gene to these cells in a dose-dependent manner ( IC50 approximately 20-40 microM ) .	T5	T37	9079657
NA	CHEMICAL	GENE-Y	17	17	A gene peptide duplicating the gene gene inhibited gene-independent gene activation by HUVEC and blocked binding of chemical-gene to these cells in a dose-dependent manner ( IC50 approximately 20-40 microM ) .	T5	T38	9079657
NA	CHEMICAL	GENE-Y	16	6	A recombinant chimeric molecule expressing the gene sequence gene within a gene backbone inhibited binding of chemical-gene to HUVEC and gene transfectants in a dose-dependent fashion , while recombinant gene or plasma gene had no effect .	T1	T6	9079657
NA	CHEMICAL	GENE-N	16	8	A recombinant chimeric molecule expressing the gene sequence gene within a gene backbone inhibited binding of chemical-gene to HUVEC and gene transfectants in a dose-dependent fashion , while recombinant gene or plasma gene had no effect .	T1	T7	9079657
NA	CHEMICAL	GENE-Y	16	11	A recombinant chimeric molecule expressing the gene sequence gene within a gene backbone inhibited binding of chemical-gene to HUVEC and gene transfectants in a dose-dependent fashion , while recombinant gene or plasma gene had no effect .	T1	T8	9079657
NA	CHEMICAL	GENE-Y	16	10	A recombinant chimeric molecule expressing the gene sequence gene within a gene backbone inhibited binding of chemical-gene to HUVEC and gene transfectants in a dose-dependent fashion , while recombinant gene or plasma gene had no effect .	T1	T9	9079657
NA	CHEMICAL	GENE-Y	16	20	A recombinant chimeric molecule expressing the gene sequence gene within a gene backbone inhibited binding of chemical-gene to HUVEC and gene transfectants in a dose-dependent fashion , while recombinant gene or plasma gene had no effect .	T1	T11	9079657
NA	CHEMICAL	GENE-Y	16	29	A recombinant chimeric molecule expressing the gene sequence gene within a gene backbone inhibited binding of chemical-gene to HUVEC and gene transfectants in a dose-dependent fashion , while recombinant gene or plasma gene had no effect .	T1	T12	9079657
NA	CHEMICAL	GENE-Y	16	10	A recombinant chimeric molecule expressing the gene sequence gene within a gene backbone inhibited binding of chemical-gene to HUVEC and gene transfectants in a dose-dependent fashion , while recombinant gene or plasma gene had no effect .	T1	T13	9079657
NA	CHEMICAL	GENE-Y	4	4	Furthermore , binding of chemical-gene to immobilized JC15 was inhibited by molar excess of unlabeled gene , but not by comparable concentrations of gene .	T2	T19	9079657
NA	CHEMICAL	GENE-Y	4	15	Furthermore , binding of chemical-gene to immobilized JC15 was inhibited by molar excess of unlabeled gene , but not by comparable concentrations of gene .	T2	T20	9079657
NA	CHEMICAL	GENE-N	4	23	Furthermore , binding of chemical-gene to immobilized JC15 was inhibited by molar excess of unlabeled gene , but not by comparable concentrations of gene .	T2	T21	9079657
NA	CHEMICAL	GENE-N	4	12	The effect of inorganic chemical on endothelium-dependent relaxation : Role of chemical oxidase and chemical .	T32	T43	23384446
NA	CHEMICAL	GENE-N	11	12	The effect of inorganic chemical on endothelium-dependent relaxation : Role of chemical oxidase and chemical .	T33	T43	23384446
NA	CHEMICAL	GENE-N	14	12	The effect of inorganic chemical on endothelium-dependent relaxation : Role of chemical oxidase and chemical .	T34	T43	23384446
NA	CHEMICAL	GENE-N	3	28	Endothelium-dependent relaxations , chemical ( chemical ) and endothelium derived hyperpolarizing factor ( EDHF ) -type , were studied in rabbit iliac artery and aortic rings using the gene agonist chemical ( chemical ) and by chemical ( chemical ) , which promotes store-operated chemical entry by inhibiting the endothelial gene pump .	T17	T38	23384446
NA	CHEMICAL	GENE-N	3	50	Endothelium-dependent relaxations , chemical ( chemical ) and endothelium derived hyperpolarizing factor ( EDHF ) -type , were studied in rabbit iliac artery and aortic rings using the gene agonist chemical ( chemical ) and by chemical ( chemical ) , which promotes store-operated chemical entry by inhibiting the endothelial gene pump .	T17	T39	23384446
NA	CHEMICAL	GENE-N	5	28	Endothelium-dependent relaxations , chemical ( chemical ) and endothelium derived hyperpolarizing factor ( EDHF ) -type , were studied in rabbit iliac artery and aortic rings using the gene agonist chemical ( chemical ) and by chemical ( chemical ) , which promotes store-operated chemical entry by inhibiting the endothelial gene pump .	T18	T38	23384446
NA	CHEMICAL	GENE-N	5	50	Endothelium-dependent relaxations , chemical ( chemical ) and endothelium derived hyperpolarizing factor ( EDHF ) -type , were studied in rabbit iliac artery and aortic rings using the gene agonist chemical ( chemical ) and by chemical ( chemical ) , which promotes store-operated chemical entry by inhibiting the endothelial gene pump .	T18	T39	23384446
CPR:5	CHEMICAL	GENE-N	19	28	Endothelium-dependent relaxations , chemical ( chemical ) and endothelium derived hyperpolarizing factor ( EDHF ) -type , were studied in rabbit iliac artery and aortic rings using the gene agonist chemical ( chemical ) and by chemical ( chemical ) , which promotes store-operated chemical entry by inhibiting the endothelial gene pump .	T19	T38	23384446
NA	CHEMICAL	GENE-N	19	50	Endothelium-dependent relaxations , chemical ( chemical ) and endothelium derived hyperpolarizing factor ( EDHF ) -type , were studied in rabbit iliac artery and aortic rings using the gene agonist chemical ( chemical ) and by chemical ( chemical ) , which promotes store-operated chemical entry by inhibiting the endothelial gene pump .	T19	T39	23384446
CPR:5	CHEMICAL	GENE-N	32	28	Endothelium-dependent relaxations , chemical ( chemical ) and endothelium derived hyperpolarizing factor ( EDHF ) -type , were studied in rabbit iliac artery and aortic rings using the gene agonist chemical ( chemical ) and by chemical ( chemical ) , which promotes store-operated chemical entry by inhibiting the endothelial gene pump .	T20	T38	23384446
NA	CHEMICAL	GENE-N	32	50	Endothelium-dependent relaxations , chemical ( chemical ) and endothelium derived hyperpolarizing factor ( EDHF ) -type , were studied in rabbit iliac artery and aortic rings using the gene agonist chemical ( chemical ) and by chemical ( chemical ) , which promotes store-operated chemical entry by inhibiting the endothelial gene pump .	T20	T39	23384446
NA	CHEMICAL	GENE-N	36	28	Endothelium-dependent relaxations , chemical ( chemical ) and endothelium derived hyperpolarizing factor ( EDHF ) -type , were studied in rabbit iliac artery and aortic rings using the gene agonist chemical ( chemical ) and by chemical ( chemical ) , which promotes store-operated chemical entry by inhibiting the endothelial gene pump .	T21	T38	23384446
CPR:4	CHEMICAL	GENE-N	36	50	Endothelium-dependent relaxations , chemical ( chemical ) and endothelium derived hyperpolarizing factor ( EDHF ) -type , were studied in rabbit iliac artery and aortic rings using the gene agonist chemical ( chemical ) and by chemical ( chemical ) , which promotes store-operated chemical entry by inhibiting the endothelial gene pump .	T21	T39	23384446
NA	CHEMICAL	GENE-N	38	28	Endothelium-dependent relaxations , chemical ( chemical ) and endothelium derived hyperpolarizing factor ( EDHF ) -type , were studied in rabbit iliac artery and aortic rings using the gene agonist chemical ( chemical ) and by chemical ( chemical ) , which promotes store-operated chemical entry by inhibiting the endothelial gene pump .	T22	T38	23384446
CPR:4	CHEMICAL	GENE-N	38	50	Endothelium-dependent relaxations , chemical ( chemical ) and endothelium derived hyperpolarizing factor ( EDHF ) -type , were studied in rabbit iliac artery and aortic rings using the gene agonist chemical ( chemical ) and by chemical ( chemical ) , which promotes store-operated chemical entry by inhibiting the endothelial gene pump .	T22	T39	23384446
NA	CHEMICAL	GENE-N	4	28	Endothelium-dependent relaxations , chemical ( chemical ) and endothelium derived hyperpolarizing factor ( EDHF ) -type , were studied in rabbit iliac artery and aortic rings using the gene agonist chemical ( chemical ) and by chemical ( chemical ) , which promotes store-operated chemical entry by inhibiting the endothelial gene pump .	T23	T38	23384446
NA	CHEMICAL	GENE-N	4	50	Endothelium-dependent relaxations , chemical ( chemical ) and endothelium derived hyperpolarizing factor ( EDHF ) -type , were studied in rabbit iliac artery and aortic rings using the gene agonist chemical ( chemical ) and by chemical ( chemical ) , which promotes store-operated chemical entry by inhibiting the endothelial gene pump .	T23	T39	23384446
NA	CHEMICAL	GENE-Y	7	4	Potentiation was prevented by gene , the gene/chemical dismutase mimetic chemical and the chemical oxidase inhibitor chemical .	T30	T40	23384446
NA	CHEMICAL	GENE-Y	7	7	Potentiation was prevented by gene , the gene/chemical dismutase mimetic chemical and the chemical oxidase inhibitor chemical .	T30	T41	23384446
NA	CHEMICAL	GENE-N	7	8	Potentiation was prevented by gene , the gene/chemical dismutase mimetic chemical and the chemical oxidase inhibitor chemical .	T30	T42	23384446
NA	CHEMICAL	GENE-N	7	14	Potentiation was prevented by gene , the gene/chemical dismutase mimetic chemical and the chemical oxidase inhibitor chemical .	T30	T35	23384446
NA	CHEMICAL	GENE-Y	10	4	Potentiation was prevented by gene , the gene/chemical dismutase mimetic chemical and the chemical oxidase inhibitor chemical .	T31	T40	23384446
NA	CHEMICAL	GENE-Y	10	7	Potentiation was prevented by gene , the gene/chemical dismutase mimetic chemical and the chemical oxidase inhibitor chemical .	T31	T41	23384446
NA	CHEMICAL	GENE-N	10	8	Potentiation was prevented by gene , the gene/chemical dismutase mimetic chemical and the chemical oxidase inhibitor chemical .	T31	T42	23384446
NA	CHEMICAL	GENE-N	10	14	Potentiation was prevented by gene , the gene/chemical dismutase mimetic chemical and the chemical oxidase inhibitor chemical .	T31	T35	23384446
NA	CHEMICAL	GENE-Y	13	4	Potentiation was prevented by gene , the gene/chemical dismutase mimetic chemical and the chemical oxidase inhibitor chemical .	T1	T40	23384446
NA	CHEMICAL	GENE-Y	13	7	Potentiation was prevented by gene , the gene/chemical dismutase mimetic chemical and the chemical oxidase inhibitor chemical .	T1	T41	23384446
NA	CHEMICAL	GENE-N	13	8	Potentiation was prevented by gene , the gene/chemical dismutase mimetic chemical and the chemical oxidase inhibitor chemical .	T1	T42	23384446
NA	CHEMICAL	GENE-N	13	14	Potentiation was prevented by gene , the gene/chemical dismutase mimetic chemical and the chemical oxidase inhibitor chemical .	T1	T35	23384446
NA	CHEMICAL	GENE-Y	16	4	Potentiation was prevented by gene , the gene/chemical dismutase mimetic chemical and the chemical oxidase inhibitor chemical .	T2	T40	23384446
NA	CHEMICAL	GENE-Y	16	7	Potentiation was prevented by gene , the gene/chemical dismutase mimetic chemical and the chemical oxidase inhibitor chemical .	T2	T41	23384446
NA	CHEMICAL	GENE-N	16	8	Potentiation was prevented by gene , the gene/chemical dismutase mimetic chemical and the chemical oxidase inhibitor chemical .	T2	T42	23384446
CPR:4	CHEMICAL	GENE-N	16	14	Potentiation was prevented by gene , the gene/chemical dismutase mimetic chemical and the chemical oxidase inhibitor chemical .	T2	T35	23384446
NA	CHEMICAL	GENE-N	4	10	Our results suggest that chemical can potentiate EDHF-type relaxations via a mechanism that is dependent on chemical , thus demonstrating that dismutation of the chemical anion generated by chemical oxidase can potentially offset loss of chemical bioavailability under conditions of reduced gene activity .	T9	T36	23384446
NA	CHEMICAL	GENE-Y	4	41	Our results suggest that chemical can potentiate EDHF-type relaxations via a mechanism that is dependent on chemical , thus demonstrating that dismutation of the chemical anion generated by chemical oxidase can potentially offset loss of chemical bioavailability under conditions of reduced gene activity .	T9	T37	23384446
NA	CHEMICAL	GENE-N	16	10	Our results suggest that chemical can potentiate EDHF-type relaxations via a mechanism that is dependent on chemical , thus demonstrating that dismutation of the chemical anion generated by chemical oxidase can potentially offset loss of chemical bioavailability under conditions of reduced gene activity .	T10	T36	23384446
NA	CHEMICAL	GENE-Y	16	41	Our results suggest that chemical can potentiate EDHF-type relaxations via a mechanism that is dependent on chemical , thus demonstrating that dismutation of the chemical anion generated by chemical oxidase can potentially offset loss of chemical bioavailability under conditions of reduced gene activity .	T10	T37	23384446
CPR:9	CHEMICAL	GENE-N	24	10	Our results suggest that chemical can potentiate EDHF-type relaxations via a mechanism that is dependent on chemical , thus demonstrating that dismutation of the chemical anion generated by chemical oxidase can potentially offset loss of chemical bioavailability under conditions of reduced gene activity .	T11	T36	23384446
NA	CHEMICAL	GENE-Y	24	41	Our results suggest that chemical can potentiate EDHF-type relaxations via a mechanism that is dependent on chemical , thus demonstrating that dismutation of the chemical anion generated by chemical oxidase can potentially offset loss of chemical bioavailability under conditions of reduced gene activity .	T11	T37	23384446
NA	CHEMICAL	GENE-N	28	10	Our results suggest that chemical can potentiate EDHF-type relaxations via a mechanism that is dependent on chemical , thus demonstrating that dismutation of the chemical anion generated by chemical oxidase can potentially offset loss of chemical bioavailability under conditions of reduced gene activity .	T12	T36	23384446
NA	CHEMICAL	GENE-Y	28	41	Our results suggest that chemical can potentiate EDHF-type relaxations via a mechanism that is dependent on chemical , thus demonstrating that dismutation of the chemical anion generated by chemical oxidase can potentially offset loss of chemical bioavailability under conditions of reduced gene activity .	T12	T37	23384446
NA	CHEMICAL	GENE-N	35	10	Our results suggest that chemical can potentiate EDHF-type relaxations via a mechanism that is dependent on chemical , thus demonstrating that dismutation of the chemical anion generated by chemical oxidase can potentially offset loss of chemical bioavailability under conditions of reduced gene activity .	T13	T36	23384446
NA	CHEMICAL	GENE-Y	35	41	Our results suggest that chemical can potentiate EDHF-type relaxations via a mechanism that is dependent on chemical , thus demonstrating that dismutation of the chemical anion generated by chemical oxidase can potentially offset loss of chemical bioavailability under conditions of reduced gene activity .	T13	T37	23384446
NA	CHEMICAL	GENE-Y	2	0	gene ( gene ) , a chemical protease well known for generating gene , has been demonstrated to induce gene ( gene ) gene expression and protein secretion in renal interstitial fibroblasts .	T2	T4	16303771
NA	CHEMICAL	GENE-Y	2	2	gene ( gene ) , a chemical protease well known for generating gene , has been demonstrated to induce gene ( gene ) gene expression and protein secretion in renal interstitial fibroblasts .	T2	T24	16303771
NA	CHEMICAL	GENE-N	2	5	gene ( gene ) , a chemical protease well known for generating gene , has been demonstrated to induce gene ( gene ) gene expression and protein secretion in renal interstitial fibroblasts .	T2	T27	16303771
CPR:3	CHEMICAL	GENE-Y	2	5	gene ( gene ) , a chemical protease well known for generating gene , has been demonstrated to induce gene ( gene ) gene expression and protein secretion in renal interstitial fibroblasts .	T2	T35	16303771
CPR:3	CHEMICAL	GENE-Y	2	5	gene ( gene ) , a chemical protease well known for generating gene , has been demonstrated to induce gene ( gene ) gene expression and protein secretion in renal interstitial fibroblasts .	T2	T14	16303771
NA	CHEMICAL	GENE-Y	2	21	gene ( gene ) , a chemical protease well known for generating gene , has been demonstrated to induce gene ( gene ) gene expression and protein secretion in renal interstitial fibroblasts .	T2	T21	16303771
NA	CHEMICAL	GENE-Y	2	2	Furthermore , gene induced rapid chemical phosphorylation on the beta subunit of gene , which was followed by the activation of gene and its downstream gene .	T3	T39	16303771
NA	CHEMICAL	GENE-Y	2	12	Furthermore , gene induced rapid chemical phosphorylation on the beta subunit of gene , which was followed by the activation of gene and its downstream gene .	T3	T5	16303771
CPR:3	CHEMICAL	GENE-Y	2	21	Furthermore , gene induced rapid chemical phosphorylation on the beta subunit of gene , which was followed by the activation of gene and its downstream gene .	T3	T6	16303771
CPR:3	CHEMICAL	GENE-N	2	25	Furthermore , gene induced rapid chemical phosphorylation on the beta subunit of gene , which was followed by the activation of gene and its downstream gene .	T3	T7	16303771
NA	CHEMICAL	GENE-Y	15	21	In lymphoblastoid cells induced to undergo endoplasmic reticulum ( ER ) stress by treatment of chemical , higher fold change of gene and gene mRNA levels were observed in rs7903146-TT cells than that in rs7903146-CC cells ( P = 0.02 for gene ; P = 0.004 for gene ) , suggesting ER stress plays a role in PDR pathogenesis .	T1	T11	23434931
NA	CHEMICAL	GENE-Y	15	23	In lymphoblastoid cells induced to undergo endoplasmic reticulum ( ER ) stress by treatment of chemical , higher fold change of gene and gene mRNA levels were observed in rs7903146-TT cells than that in rs7903146-CC cells ( P = 0.02 for gene ; P = 0.004 for gene ) , suggesting ER stress plays a role in PDR pathogenesis .	T1	T12	23434931
NA	CHEMICAL	GENE-Y	15	41	In lymphoblastoid cells induced to undergo endoplasmic reticulum ( ER ) stress by treatment of chemical , higher fold change of gene and gene mRNA levels were observed in rs7903146-TT cells than that in rs7903146-CC cells ( P = 0.02 for gene ; P = 0.004 for gene ) , suggesting ER stress plays a role in PDR pathogenesis .	T1	T13	23434931
NA	CHEMICAL	GENE-Y	15	47	In lymphoblastoid cells induced to undergo endoplasmic reticulum ( ER ) stress by treatment of chemical , higher fold change of gene and gene mRNA levels were observed in rs7903146-TT cells than that in rs7903146-CC cells ( P = 0.02 for gene ; P = 0.004 for gene ) , suggesting ER stress plays a role in PDR pathogenesis .	T1	T14	23434931
NA	CHEMICAL	GENE-Y	2	16	Retinas of chemical-induced retinopathy ( OIR ) mice ( a model for PDR ) had higher gene and gene mRNA levels than controls ( P = 2.9E-04 for gene ; P = 1.9E-07 for gene ) .	T2	T18	23434931
NA	CHEMICAL	GENE-Y	2	18	Retinas of chemical-induced retinopathy ( OIR ) mice ( a model for PDR ) had higher gene and gene mRNA levels than controls ( P = 2.9E-04 for gene ; P = 1.9E-07 for gene ) .	T2	T3	23434931
NA	CHEMICAL	GENE-Y	2	28	Retinas of chemical-induced retinopathy ( OIR ) mice ( a model for PDR ) had higher gene and gene mRNA levels than controls ( P = 2.9E-04 for gene ; P = 1.9E-07 for gene ) .	T2	T4	23434931
NA	CHEMICAL	GENE-Y	2	34	Retinas of chemical-induced retinopathy ( OIR ) mice ( a model for PDR ) had higher gene and gene mRNA levels than controls ( P = 2.9E-04 for gene ; P = 1.9E-07 for gene ) .	T2	T5	23434931
CPR:4	CHEMICAL	GENE-N	9	2	Inhibition of gene with a series of natural product chemical and chemical .	T21	T35	20185318
CPR:4	CHEMICAL	GENE-N	4	2	Inhibition of gene with a series of natural product chemical and chemical .	T22	T35	20185318
CPR:4	CHEMICAL	GENE-N	3	36	A series of chemical and chemical natural products , such as chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical , were investigated for their inhibitory effects against the gene gene ( gene , gene ) .	T4	T25	20185318
CPR:4	CHEMICAL	GENE-N	3	10	A series of chemical and chemical natural products , such as chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical , were investigated for their inhibitory effects against the gene gene ( gene , gene ) .	T4	T26	20185318
CPR:4	CHEMICAL	GENE-N	3	0	A series of chemical and chemical natural products , such as chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical , were investigated for their inhibitory effects against the gene gene ( gene , gene ) .	T4	T27	20185318
CPR:4	CHEMICAL	GENE-Y	3	41	A series of chemical and chemical natural products , such as chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical , were investigated for their inhibitory effects against the gene gene ( gene , gene ) .	T4	T28	20185318
CPR:4	CHEMICAL	GENE-N	5	36	A series of chemical and chemical natural products , such as chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical , were investigated for their inhibitory effects against the gene gene ( gene , gene ) .	T9	T25	20185318
CPR:4	CHEMICAL	GENE-N	5	10	A series of chemical and chemical natural products , such as chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical , were investigated for their inhibitory effects against the gene gene ( gene , gene ) .	T9	T26	20185318
CPR:4	CHEMICAL	GENE-N	5	0	A series of chemical and chemical natural products , such as chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical , were investigated for their inhibitory effects against the gene gene ( gene , gene ) .	T9	T27	20185318
CPR:4	CHEMICAL	GENE-Y	5	41	A series of chemical and chemical natural products , such as chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical , were investigated for their inhibitory effects against the gene gene ( gene , gene ) .	T9	T28	20185318
CPR:4	CHEMICAL	GENE-N	11	36	A series of chemical and chemical natural products , such as chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical , were investigated for their inhibitory effects against the gene gene ( gene , gene ) .	T11	T25	20185318
CPR:4	CHEMICAL	GENE-N	11	10	A series of chemical and chemical natural products , such as chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical , were investigated for their inhibitory effects against the gene gene ( gene , gene ) .	T11	T26	20185318
CPR:4	CHEMICAL	GENE-N	11	0	A series of chemical and chemical natural products , such as chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical , were investigated for their inhibitory effects against the gene gene ( gene , gene ) .	T11	T27	20185318
CPR:4	CHEMICAL	GENE-Y	11	41	A series of chemical and chemical natural products , such as chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical , were investigated for their inhibitory effects against the gene gene ( gene , gene ) .	T11	T28	20185318
CPR:4	CHEMICAL	GENE-N	13	36	A series of chemical and chemical natural products , such as chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical , were investigated for their inhibitory effects against the gene gene ( gene , gene ) .	T17	T25	20185318
CPR:4	CHEMICAL	GENE-N	13	10	A series of chemical and chemical natural products , such as chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical , were investigated for their inhibitory effects against the gene gene ( gene , gene ) .	T17	T26	20185318
CPR:4	CHEMICAL	GENE-N	13	0	A series of chemical and chemical natural products , such as chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical , were investigated for their inhibitory effects against the gene gene ( gene , gene ) .	T17	T27	20185318
CPR:4	CHEMICAL	GENE-Y	13	41	A series of chemical and chemical natural products , such as chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical , were investigated for their inhibitory effects against the gene gene ( gene , gene ) .	T17	T28	20185318
CPR:4	CHEMICAL	GENE-N	11	36	A series of chemical and chemical natural products , such as chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical , were investigated for their inhibitory effects against the gene gene ( gene , gene ) .	T1	T25	20185318
CPR:4	CHEMICAL	GENE-N	11	10	A series of chemical and chemical natural products , such as chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical , were investigated for their inhibitory effects against the gene gene ( gene , gene ) .	T1	T26	20185318
CPR:4	CHEMICAL	GENE-N	11	0	A series of chemical and chemical natural products , such as chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical , were investigated for their inhibitory effects against the gene gene ( gene , gene ) .	T1	T27	20185318
CPR:4	CHEMICAL	GENE-Y	11	41	A series of chemical and chemical natural products , such as chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical , were investigated for their inhibitory effects against the gene gene ( gene , gene ) .	T1	T28	20185318
CPR:4	CHEMICAL	GENE-N	17	36	A series of chemical and chemical natural products , such as chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical , were investigated for their inhibitory effects against the gene gene ( gene , gene ) .	T3	T25	20185318
CPR:4	CHEMICAL	GENE-N	17	10	A series of chemical and chemical natural products , such as chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical , were investigated for their inhibitory effects against the gene gene ( gene , gene ) .	T3	T26	20185318
CPR:4	CHEMICAL	GENE-N	17	0	A series of chemical and chemical natural products , such as chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical , were investigated for their inhibitory effects against the gene gene ( gene , gene ) .	T3	T27	20185318
CPR:4	CHEMICAL	GENE-Y	17	41	A series of chemical and chemical natural products , such as chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical , were investigated for their inhibitory effects against the gene gene ( gene , gene ) .	T3	T28	20185318
CPR:4	CHEMICAL	GENE-N	19	36	A series of chemical and chemical natural products , such as chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical , were investigated for their inhibitory effects against the gene gene ( gene , gene ) .	T5	T25	20185318
CPR:4	CHEMICAL	GENE-N	19	10	A series of chemical and chemical natural products , such as chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical , were investigated for their inhibitory effects against the gene gene ( gene , gene ) .	T5	T26	20185318
CPR:4	CHEMICAL	GENE-N	19	0	A series of chemical and chemical natural products , such as chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical , were investigated for their inhibitory effects against the gene gene ( gene , gene ) .	T5	T27	20185318
CPR:4	CHEMICAL	GENE-Y	19	41	A series of chemical and chemical natural products , such as chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical , were investigated for their inhibitory effects against the gene gene ( gene , gene ) .	T5	T28	20185318
CPR:4	CHEMICAL	GENE-N	21	36	A series of chemical and chemical natural products , such as chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical , were investigated for their inhibitory effects against the gene gene ( gene , gene ) .	T6	T25	20185318
CPR:4	CHEMICAL	GENE-N	21	10	A series of chemical and chemical natural products , such as chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical , were investigated for their inhibitory effects against the gene gene ( gene , gene ) .	T6	T26	20185318
CPR:4	CHEMICAL	GENE-N	21	0	A series of chemical and chemical natural products , such as chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical , were investigated for their inhibitory effects against the gene gene ( gene , gene ) .	T6	T27	20185318
CPR:4	CHEMICAL	GENE-Y	21	41	A series of chemical and chemical natural products , such as chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical , were investigated for their inhibitory effects against the gene gene ( gene , gene ) .	T6	T28	20185318
CPR:4	CHEMICAL	GENE-N	23	36	A series of chemical and chemical natural products , such as chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical , were investigated for their inhibitory effects against the gene gene ( gene , gene ) .	T7	T25	20185318
CPR:4	CHEMICAL	GENE-N	23	10	A series of chemical and chemical natural products , such as chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical , were investigated for their inhibitory effects against the gene gene ( gene , gene ) .	T7	T26	20185318
CPR:4	CHEMICAL	GENE-N	23	0	A series of chemical and chemical natural products , such as chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical , were investigated for their inhibitory effects against the gene gene ( gene , gene ) .	T7	T27	20185318
CPR:4	CHEMICAL	GENE-Y	23	41	A series of chemical and chemical natural products , such as chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical , were investigated for their inhibitory effects against the gene gene ( gene , gene ) .	T7	T28	20185318
CPR:4	CHEMICAL	GENE-N	26	36	A series of chemical and chemical natural products , such as chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical , were investigated for their inhibitory effects against the gene gene ( gene , gene ) .	T8	T25	20185318
CPR:4	CHEMICAL	GENE-N	26	10	A series of chemical and chemical natural products , such as chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical , were investigated for their inhibitory effects against the gene gene ( gene , gene ) .	T8	T26	20185318
CPR:4	CHEMICAL	GENE-N	26	0	A series of chemical and chemical natural products , such as chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical , were investigated for their inhibitory effects against the gene gene ( gene , gene ) .	T8	T27	20185318
CPR:4	CHEMICAL	GENE-Y	26	41	A series of chemical and chemical natural products , such as chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical , were investigated for their inhibitory effects against the gene gene ( gene , gene ) .	T8	T28	20185318
CPR:4	CHEMICAL	GENE-N	0	8	chemical like the ones investigated here possess a gene inhibition mechanism distinct of that of the chemical/chemical used clinically or the chemical .	T12	T33	20185318
CPR:4	CHEMICAL	GENE-N	7	8	chemical like the ones investigated here possess a gene inhibition mechanism distinct of that of the chemical/chemical used clinically or the chemical .	T13	T33	20185318
CPR:4	CHEMICAL	GENE-N	7	8	chemical like the ones investigated here possess a gene inhibition mechanism distinct of that of the chemical/chemical used clinically or the chemical .	T14	T33	20185318
CPR:4	CHEMICAL	GENE-N	7	8	chemical like the ones investigated here possess a gene inhibition mechanism distinct of that of the chemical/chemical used clinically or the chemical .	T15	T33	20185318
CPR:9	CHEMICAL	GENE-N	22	11	In the present study , we have evaluated possible participation of gene ( gene ) responsible for the bidirectional membrane transport of chemical in the cytoprotective property in osteoblasts .	T5	T14	16766717
CPR:9	CHEMICAL	GENE-N	22	13	In the present study , we have evaluated possible participation of gene ( gene ) responsible for the bidirectional membrane transport of chemical in the cytoprotective property in osteoblasts .	T5	T15	16766717
NA	CHEMICAL	GENE-N	3	23	The accumulation of chemical occurred in a temperature- and pH-dependent manner in osteoblasts cultured for 7 days with high sensitivity to a specific gene inhibitor , whereas chemical was released into extracellular spaces from cultured osteoblasts in a fashion sensitive to the gene inhibitor .	T7	T17	16766717
NA	CHEMICAL	GENE-N	3	42	The accumulation of chemical occurred in a temperature- and pH-dependent manner in osteoblasts cultured for 7 days with high sensitivity to a specific gene inhibitor , whereas chemical was released into extracellular spaces from cultured osteoblasts in a fashion sensitive to the gene inhibitor .	T7	T18	16766717
NA	CHEMICAL	GENE-N	6	23	The accumulation of chemical occurred in a temperature- and pH-dependent manner in osteoblasts cultured for 7 days with high sensitivity to a specific gene inhibitor , whereas chemical was released into extracellular spaces from cultured osteoblasts in a fashion sensitive to the gene inhibitor .	T8	T17	16766717
NA	CHEMICAL	GENE-N	6	42	The accumulation of chemical occurred in a temperature- and pH-dependent manner in osteoblasts cultured for 7 days with high sensitivity to a specific gene inhibitor , whereas chemical was released into extracellular spaces from cultured osteoblasts in a fashion sensitive to the gene inhibitor .	T8	T18	16766717
NA	CHEMICAL	GENE-Y	14	4	Transient overexpression of the gene isoform led to reduced vulnerability to the cytotoxicity of chemical with an increased activity of chemical accumulation in murine osteoblastic MC3T3-E1 cells .	T9	T19	16766717
NA	CHEMICAL	GENE-Y	4	4	Transient overexpression of the gene isoform led to reduced vulnerability to the cytotoxicity of chemical with an increased activity of chemical accumulation in murine osteoblastic MC3T3-E1 cells .	T1	T19	16766717
NA	CHEMICAL	GENE-N	3	11	Oral administration of chemical prevents endothelial dysfunction and vascular oxidative stress in the aortas of gene-resistant rats .	T25	T37	11009561
NA	CHEMICAL	GENE-Y	4	4	We have reported that a deficiency of chemical ( chemical ) , an active cofactor of gene ( echemicalS ) , contributes to the endothelial dysfunction through reduced gene activity and increased chemical ( chemical ) generation in the gene-resistant state .	T13	T36	11009561
NA	CHEMICAL	GENE-Y	4	28	We have reported that a deficiency of chemical ( chemical ) , an active cofactor of gene ( echemicalS ) , contributes to the endothelial dysfunction through reduced gene activity and increased chemical ( chemical ) generation in the gene-resistant state .	T13	T27	11009561
NA	CHEMICAL	GENE-N	4	37	We have reported that a deficiency of chemical ( chemical ) , an active cofactor of gene ( echemicalS ) , contributes to the endothelial dysfunction through reduced gene activity and increased chemical ( chemical ) generation in the gene-resistant state .	T13	T33	11009561
NA	CHEMICAL	GENE-Y	8	4	We have reported that a deficiency of chemical ( chemical ) , an active cofactor of gene ( echemicalS ) , contributes to the endothelial dysfunction through reduced gene activity and increased chemical ( chemical ) generation in the gene-resistant state .	T16	T36	11009561
NA	CHEMICAL	GENE-Y	8	28	We have reported that a deficiency of chemical ( chemical ) , an active cofactor of gene ( echemicalS ) , contributes to the endothelial dysfunction through reduced gene activity and increased chemical ( chemical ) generation in the gene-resistant state .	T16	T27	11009561
NA	CHEMICAL	GENE-N	8	37	We have reported that a deficiency of chemical ( chemical ) , an active cofactor of gene ( echemicalS ) , contributes to the endothelial dysfunction through reduced gene activity and increased chemical ( chemical ) generation in the gene-resistant state .	T16	T33	11009561
NA	CHEMICAL	GENE-Y	7	4	We have reported that a deficiency of chemical ( chemical ) , an active cofactor of gene ( echemicalS ) , contributes to the endothelial dysfunction through reduced gene activity and increased chemical ( chemical ) generation in the gene-resistant state .	T1	T36	11009561
NA	CHEMICAL	GENE-Y	7	28	We have reported that a deficiency of chemical ( chemical ) , an active cofactor of gene ( echemicalS ) , contributes to the endothelial dysfunction through reduced gene activity and increased chemical ( chemical ) generation in the gene-resistant state .	T1	T27	11009561
NA	CHEMICAL	GENE-N	7	37	We have reported that a deficiency of chemical ( chemical ) , an active cofactor of gene ( echemicalS ) , contributes to the endothelial dysfunction through reduced gene activity and increased chemical ( chemical ) generation in the gene-resistant state .	T1	T33	11009561
NA	CHEMICAL	GENE-Y	4	4	We have reported that a deficiency of chemical ( chemical ) , an active cofactor of gene ( echemicalS ) , contributes to the endothelial dysfunction through reduced gene activity and increased chemical ( chemical ) generation in the gene-resistant state .	T10	T36	11009561
NA	CHEMICAL	GENE-Y	4	28	We have reported that a deficiency of chemical ( chemical ) , an active cofactor of gene ( echemicalS ) , contributes to the endothelial dysfunction through reduced gene activity and increased chemical ( chemical ) generation in the gene-resistant state .	T10	T27	11009561
NA	CHEMICAL	GENE-N	4	37	We have reported that a deficiency of chemical ( chemical ) , an active cofactor of gene ( echemicalS ) , contributes to the endothelial dysfunction through reduced gene activity and increased chemical ( chemical ) generation in the gene-resistant state .	T10	T33	11009561
NA	CHEMICAL	GENE-Y	8	4	We have reported that a deficiency of chemical ( chemical ) , an active cofactor of gene ( echemicalS ) , contributes to the endothelial dysfunction through reduced gene activity and increased chemical ( chemical ) generation in the gene-resistant state .	T11	T36	11009561
NA	CHEMICAL	GENE-Y	8	28	We have reported that a deficiency of chemical ( chemical ) , an active cofactor of gene ( echemicalS ) , contributes to the endothelial dysfunction through reduced gene activity and increased chemical ( chemical ) generation in the gene-resistant state .	T11	T27	11009561
NA	CHEMICAL	GENE-N	8	37	We have reported that a deficiency of chemical ( chemical ) , an active cofactor of gene ( echemicalS ) , contributes to the endothelial dysfunction through reduced gene activity and increased chemical ( chemical ) generation in the gene-resistant state .	T11	T33	11009561
NA	CHEMICAL	GENE-N	14	23	To further confirm this hypothesis , we investigated the effects of dietary treatment with chemical on endothelium-dependent arterial relaxation and vascular oxidative stress in the aortas of gene-resistant rats .	T12	T34	11009561
CPR:3	CHEMICAL	GENE-Y	1	10	The chemical treatment was associated with a 2-fold increase in gene activity as well as a 70 % reduction in endothelial chemical production compared with those in chemical-fed rats .	T21	T35	11009561
NA	CHEMICAL	GENE-Y	21	10	The chemical treatment was associated with a 2-fold increase in gene activity as well as a 70 % reduction in endothelial chemical production compared with those in chemical-fed rats .	T22	T35	11009561
NA	CHEMICAL	GENE-Y	27	10	The chemical treatment was associated with a 2-fold increase in gene activity as well as a 70 % reduction in endothelial chemical production compared with those in chemical-fed rats .	T23	T35	11009561
CPR:3	CHEMICAL	GENE-N	1	7	The chemical treatment also partially improved the gene sensitivity and blood pressure , as well as the serum chemical concentration , in the chemical-fed rats .	T24	T26	11009561
NA	CHEMICAL	GENE-N	1	7	The chemical treatment also partially improved the gene sensitivity and blood pressure , as well as the serum chemical concentration , in the chemical-fed rats .	T2	T26	11009561
NA	CHEMICAL	GENE-N	23	7	The chemical treatment also partially improved the gene sensitivity and blood pressure , as well as the serum chemical concentration , in the chemical-fed rats .	T3	T26	11009561
CPR:4	CHEMICAL	GENE-N	2	30	Moreover , chemical treatment of the chemical-fed rats markedly reduced the lipid chemical content of both aortic and cardiac tissues and inhibited the activation of 2 redox-sensitive transcription factors , gene and gene , which were increased in chemical-fed rats .	T4	T28	11009561
CPR:4	CHEMICAL	GENE-Y	2	32	Moreover , chemical treatment of the chemical-fed rats markedly reduced the lipid chemical content of both aortic and cardiac tissues and inhibited the activation of 2 redox-sensitive transcription factors , gene and gene , which were increased in chemical-fed rats .	T4	T29	11009561
CPR:3	CHEMICAL	GENE-N	6	30	Moreover , chemical treatment of the chemical-fed rats markedly reduced the lipid chemical content of both aortic and cardiac tissues and inhibited the activation of 2 redox-sensitive transcription factors , gene and gene , which were increased in chemical-fed rats .	T5	T28	11009561
CPR:3	CHEMICAL	GENE-Y	6	32	Moreover , chemical treatment of the chemical-fed rats markedly reduced the lipid chemical content of both aortic and cardiac tissues and inhibited the activation of 2 redox-sensitive transcription factors , gene and gene , which were increased in chemical-fed rats .	T5	T29	11009561
NA	CHEMICAL	GENE-N	12	30	Moreover , chemical treatment of the chemical-fed rats markedly reduced the lipid chemical content of both aortic and cardiac tissues and inhibited the activation of 2 redox-sensitive transcription factors , gene and gene , which were increased in chemical-fed rats .	T6	T28	11009561
NA	CHEMICAL	GENE-Y	12	32	Moreover , chemical treatment of the chemical-fed rats markedly reduced the lipid chemical content of both aortic and cardiac tissues and inhibited the activation of 2 redox-sensitive transcription factors , gene and gene , which were increased in chemical-fed rats .	T6	T29	11009561
CPR:3	CHEMICAL	GENE-N	38	30	Moreover , chemical treatment of the chemical-fed rats markedly reduced the lipid chemical content of both aortic and cardiac tissues and inhibited the activation of 2 redox-sensitive transcription factors , gene and gene , which were increased in chemical-fed rats .	T7	T28	11009561
CPR:3	CHEMICAL	GENE-Y	38	32	Moreover , chemical treatment of the chemical-fed rats markedly reduced the lipid chemical content of both aortic and cardiac tissues and inhibited the activation of 2 redox-sensitive transcription factors , gene and gene , which were increased in chemical-fed rats .	T7	T29	11009561
NA	CHEMICAL	GENE-Y	15	4	Here we report that gene null mice are lean and protected from diet-induced obesity and chemical intolerance .	T1	T6	23633521
NA	CHEMICAL	GENE-N	10	11	Experimental as well as clinical reports support the hypothesis that chemical channel blockers such as chemical may be an appropriate therapeutic approach in LQTS .	T7	T12	15944809
CPR:4	CHEMICAL	GENE-N	15	11	Experimental as well as clinical reports support the hypothesis that chemical channel blockers such as chemical may be an appropriate therapeutic approach in LQTS .	T8	T12	15944809
CPR:4	CHEMICAL	GENE-N	10	16	METHODS AND RESULTS : In 8 Langendorff-perfused rabbit hearts , chemical ( 0.1 microM ) , an inhibitor of chemical channel inactivation , led to a marked increase in QT-interval and simultaneously recorded monophasic ventricular action potentials ( MAPs ) ( p < 0.05 ) thereby mimicking LQT3 .	T9	T13	15944809
NA	CHEMICAL	GENE-N	19	16	METHODS AND RESULTS : In 8 Langendorff-perfused rabbit hearts , chemical ( 0.1 microM ) , an inhibitor of chemical channel inactivation , led to a marked increase in QT-interval and simultaneously recorded monophasic ventricular action potentials ( MAPs ) ( p < 0.05 ) thereby mimicking LQT3 .	T10	T13	15944809
NA	CHEMICAL	GENE-Y	10	2	Involvement of gene and gene in the regulation of the chemical , chemical-ATPase by chemical in MDCK cells .	T19	T44	16516814
NA	CHEMICAL	GENE-Y	10	4	Involvement of gene and gene in the regulation of the chemical , chemical-ATPase by chemical in MDCK cells .	T19	T45	16516814
NA	CHEMICAL	GENE-N	10	11	Involvement of gene and gene in the regulation of the chemical , chemical-ATPase by chemical in MDCK cells .	T19	T46	16516814
NA	CHEMICAL	GENE-Y	12	2	Involvement of gene and gene in the regulation of the chemical , chemical-ATPase by chemical in MDCK cells .	T20	T44	16516814
NA	CHEMICAL	GENE-Y	12	4	Involvement of gene and gene in the regulation of the chemical , chemical-ATPase by chemical in MDCK cells .	T20	T45	16516814
NA	CHEMICAL	GENE-N	12	11	Involvement of gene and gene in the regulation of the chemical , chemical-ATPase by chemical in MDCK cells .	T20	T46	16516814
NA	CHEMICAL	GENE-Y	3	2	Involvement of gene and gene in the regulation of the chemical , chemical-ATPase by chemical in MDCK cells .	T21	T44	16516814
NA	CHEMICAL	GENE-Y	3	4	Involvement of gene and gene in the regulation of the chemical , chemical-ATPase by chemical in MDCK cells .	T21	T45	16516814
NA	CHEMICAL	GENE-N	3	11	Involvement of gene and gene in the regulation of the chemical , chemical-ATPase by chemical in MDCK cells .	T21	T46	16516814
NA	CHEMICAL	GENE-N	14	17	In MDCchemical cells , which model distal tubule cells , the transcription of the chemical , K-ATPase beta1 subunit is regulated by PGE1 and PGE2 .	T9	T29	16516814
NA	CHEMICAL	GENE-N	1	17	In MDCchemical cells , which model distal tubule cells , the transcription of the chemical , K-ATPase beta1 subunit is regulated by PGE1 and PGE2 .	T11	T29	16516814
CPR:5	CHEMICAL	GENE-Y	15	3	The involvement of gene and gene is indicated by studies with the gene selective agonist chemical , and the gene selective agonist chemical ( which stimulate ) , as well as by studies with the antagonists chemical ( gene specific ) and chemical ( EP1 and gene specific ) .	T14	T32	16516814
NA	CHEMICAL	GENE-Y	15	5	The involvement of gene and gene is indicated by studies with the gene selective agonist chemical , and the gene selective agonist chemical ( which stimulate ) , as well as by studies with the antagonists chemical ( gene specific ) and chemical ( EP1 and gene specific ) .	T14	T33	16516814
CPR:5	CHEMICAL	GENE-Y	15	12	The involvement of gene and gene is indicated by studies with the gene selective agonist chemical , and the gene selective agonist chemical ( which stimulate ) , as well as by studies with the antagonists chemical ( gene specific ) and chemical ( EP1 and gene specific ) .	T14	T34	16516814
NA	CHEMICAL	GENE-Y	15	19	The involvement of gene and gene is indicated by studies with the gene selective agonist chemical , and the gene selective agonist chemical ( which stimulate ) , as well as by studies with the antagonists chemical ( gene specific ) and chemical ( EP1 and gene specific ) .	T14	T35	16516814
NA	CHEMICAL	GENE-Y	15	38	The involvement of gene and gene is indicated by studies with the gene selective agonist chemical , and the gene selective agonist chemical ( which stimulate ) , as well as by studies with the antagonists chemical ( gene specific ) and chemical ( EP1 and gene specific ) .	T14	T36	16516814
NA	CHEMICAL	GENE-Y	15	46	The involvement of gene and gene is indicated by studies with the gene selective agonist chemical , and the gene selective agonist chemical ( which stimulate ) , as well as by studies with the antagonists chemical ( gene specific ) and chemical ( EP1 and gene specific ) .	T14	T37	16516814
NA	CHEMICAL	GENE-Y	22	3	The involvement of gene and gene is indicated by studies with the gene selective agonist chemical , and the gene selective agonist chemical ( which stimulate ) , as well as by studies with the antagonists chemical ( gene specific ) and chemical ( EP1 and gene specific ) .	T15	T32	16516814
CPR:5	CHEMICAL	GENE-Y	22	5	The involvement of gene and gene is indicated by studies with the gene selective agonist chemical , and the gene selective agonist chemical ( which stimulate ) , as well as by studies with the antagonists chemical ( gene specific ) and chemical ( EP1 and gene specific ) .	T15	T33	16516814
NA	CHEMICAL	GENE-Y	22	12	The involvement of gene and gene is indicated by studies with the gene selective agonist chemical , and the gene selective agonist chemical ( which stimulate ) , as well as by studies with the antagonists chemical ( gene specific ) and chemical ( EP1 and gene specific ) .	T15	T34	16516814
CPR:5	CHEMICAL	GENE-Y	22	19	The involvement of gene and gene is indicated by studies with the gene selective agonist chemical , and the gene selective agonist chemical ( which stimulate ) , as well as by studies with the antagonists chemical ( gene specific ) and chemical ( EP1 and gene specific ) .	T15	T35	16516814
NA	CHEMICAL	GENE-Y	22	38	The involvement of gene and gene is indicated by studies with the gene selective agonist chemical , and the gene selective agonist chemical ( which stimulate ) , as well as by studies with the antagonists chemical ( gene specific ) and chemical ( EP1 and gene specific ) .	T15	T36	16516814
NA	CHEMICAL	GENE-Y	22	46	The involvement of gene and gene is indicated by studies with the gene selective agonist chemical , and the gene selective agonist chemical ( which stimulate ) , as well as by studies with the antagonists chemical ( gene specific ) and chemical ( EP1 and gene specific ) .	T15	T37	16516814
CPR:5	CHEMICAL	GENE-Y	36	3	The involvement of gene and gene is indicated by studies with the gene selective agonist chemical , and the gene selective agonist chemical ( which stimulate ) , as well as by studies with the antagonists chemical ( gene specific ) and chemical ( EP1 and gene specific ) .	T16	T32	16516814
NA	CHEMICAL	GENE-Y	36	5	The involvement of gene and gene is indicated by studies with the gene selective agonist chemical , and the gene selective agonist chemical ( which stimulate ) , as well as by studies with the antagonists chemical ( gene specific ) and chemical ( EP1 and gene specific ) .	T16	T33	16516814
CPR:5	CHEMICAL	GENE-Y	36	12	The involvement of gene and gene is indicated by studies with the gene selective agonist chemical , and the gene selective agonist chemical ( which stimulate ) , as well as by studies with the antagonists chemical ( gene specific ) and chemical ( EP1 and gene specific ) .	T16	T34	16516814
NA	CHEMICAL	GENE-Y	36	19	The involvement of gene and gene is indicated by studies with the gene selective agonist chemical , and the gene selective agonist chemical ( which stimulate ) , as well as by studies with the antagonists chemical ( gene specific ) and chemical ( EP1 and gene specific ) .	T16	T35	16516814
CPR:5	CHEMICAL	GENE-Y	36	38	The involvement of gene and gene is indicated by studies with the gene selective agonist chemical , and the gene selective agonist chemical ( which stimulate ) , as well as by studies with the antagonists chemical ( gene specific ) and chemical ( EP1 and gene specific ) .	T16	T36	16516814
NA	CHEMICAL	GENE-Y	36	46	The involvement of gene and gene is indicated by studies with the gene selective agonist chemical , and the gene selective agonist chemical ( which stimulate ) , as well as by studies with the antagonists chemical ( gene specific ) and chemical ( EP1 and gene specific ) .	T16	T37	16516814
CPR:5	CHEMICAL	GENE-Y	42	3	The involvement of gene and gene is indicated by studies with the gene selective agonist chemical , and the gene selective agonist chemical ( which stimulate ) , as well as by studies with the antagonists chemical ( gene specific ) and chemical ( EP1 and gene specific ) .	T17	T32	16516814
CPR:5	CHEMICAL	GENE-Y	42	5	The involvement of gene and gene is indicated by studies with the gene selective agonist chemical , and the gene selective agonist chemical ( which stimulate ) , as well as by studies with the antagonists chemical ( gene specific ) and chemical ( EP1 and gene specific ) .	T17	T33	16516814
CPR:5	CHEMICAL	GENE-Y	42	12	The involvement of gene and gene is indicated by studies with the gene selective agonist chemical , and the gene selective agonist chemical ( which stimulate ) , as well as by studies with the antagonists chemical ( gene specific ) and chemical ( EP1 and gene specific ) .	T17	T34	16516814
CPR:5	CHEMICAL	GENE-Y	42	19	The involvement of gene and gene is indicated by studies with the gene selective agonist chemical , and the gene selective agonist chemical ( which stimulate ) , as well as by studies with the antagonists chemical ( gene specific ) and chemical ( EP1 and gene specific ) .	T17	T35	16516814
CPR:6	CHEMICAL	GENE-Y	42	38	The involvement of gene and gene is indicated by studies with the gene selective agonist chemical , and the gene selective agonist chemical ( which stimulate ) , as well as by studies with the antagonists chemical ( gene specific ) and chemical ( EP1 and gene specific ) .	T17	T36	16516814
CPR:6	CHEMICAL	GENE-Y	42	46	The involvement of gene and gene is indicated by studies with the gene selective agonist chemical , and the gene selective agonist chemical ( which stimulate ) , as well as by studies with the antagonists chemical ( gene specific ) and chemical ( EP1 and gene specific ) .	T17	T37	16516814
NA	CHEMICAL	GENE-N	12	5	Consistent with the involvement of gene coupled gene , is that the chemical stimulation is inhibited by the gene expression vector ( encoding the gene ) , as well as by the gene PKI .	T18	T38	16516814
NA	CHEMICAL	GENE-Y	12	7	Consistent with the involvement of gene coupled gene , is that the chemical stimulation is inhibited by the gene expression vector ( encoding the gene ) , as well as by the gene PKI .	T18	T39	16516814
NA	CHEMICAL	GENE-N	12	18	Consistent with the involvement of gene coupled gene , is that the chemical stimulation is inhibited by the gene expression vector ( encoding the gene ) , as well as by the gene PKI .	T18	T40	16516814
NA	CHEMICAL	GENE-N	12	24	Consistent with the involvement of gene coupled gene , is that the chemical stimulation is inhibited by the gene expression vector ( encoding the gene ) , as well as by the gene PKI .	T18	T41	16516814
NA	CHEMICAL	GENE-N	12	32	Consistent with the involvement of gene coupled gene , is that the chemical stimulation is inhibited by the gene expression vector ( encoding the gene ) , as well as by the gene PKI .	T18	T42	16516814
NA	CHEMICAL	GENE-Y	18	2	In addition to this evidence ( for the involvement of gene ) , evidence for the involvement of gene in the chemical mediated stimulation of chemical , chemical-ATPase beta subunit gene transcription includes the stimulatory effect of chemical , as well as the inhibitory effects of chemical .	T2	T43	16516814
NA	CHEMICAL	GENE-Y	18	2	In addition to this evidence ( for the involvement of gene ) , evidence for the involvement of gene in the chemical mediated stimulation of chemical , chemical-ATPase beta subunit gene transcription includes the stimulatory effect of chemical , as well as the inhibitory effects of chemical .	T2	T22	16516814
CPR:3	CHEMICAL	GENE-N	18	28	In addition to this evidence ( for the involvement of gene ) , evidence for the involvement of gene in the chemical mediated stimulation of chemical , chemical-ATPase beta subunit gene transcription includes the stimulatory effect of chemical , as well as the inhibitory effects of chemical .	T2	T23	16516814
NA	CHEMICAL	GENE-Y	25	2	In addition to this evidence ( for the involvement of gene ) , evidence for the involvement of gene in the chemical mediated stimulation of chemical , chemical-ATPase beta subunit gene transcription includes the stimulatory effect of chemical , as well as the inhibitory effects of chemical .	T3	T43	16516814
NA	CHEMICAL	GENE-Y	25	2	In addition to this evidence ( for the involvement of gene ) , evidence for the involvement of gene in the chemical mediated stimulation of chemical , chemical-ATPase beta subunit gene transcription includes the stimulatory effect of chemical , as well as the inhibitory effects of chemical .	T3	T22	16516814
NA	CHEMICAL	GENE-N	25	28	In addition to this evidence ( for the involvement of gene ) , evidence for the involvement of gene in the chemical mediated stimulation of chemical , chemical-ATPase beta subunit gene transcription includes the stimulatory effect of chemical , as well as the inhibitory effects of chemical .	T3	T23	16516814
NA	CHEMICAL	GENE-Y	10	2	In addition to this evidence ( for the involvement of gene ) , evidence for the involvement of gene in the chemical mediated stimulation of chemical , chemical-ATPase beta subunit gene transcription includes the stimulatory effect of chemical , as well as the inhibitory effects of chemical .	T4	T43	16516814
NA	CHEMICAL	GENE-Y	10	2	In addition to this evidence ( for the involvement of gene ) , evidence for the involvement of gene in the chemical mediated stimulation of chemical , chemical-ATPase beta subunit gene transcription includes the stimulatory effect of chemical , as well as the inhibitory effects of chemical .	T4	T22	16516814
NA	CHEMICAL	GENE-N	10	28	In addition to this evidence ( for the involvement of gene ) , evidence for the involvement of gene in the chemical mediated stimulation of chemical , chemical-ATPase beta subunit gene transcription includes the stimulatory effect of chemical , as well as the inhibitory effects of chemical .	T4	T23	16516814
NA	CHEMICAL	GENE-Y	37	2	In addition to this evidence ( for the involvement of gene ) , evidence for the involvement of gene in the chemical mediated stimulation of chemical , chemical-ATPase beta subunit gene transcription includes the stimulatory effect of chemical , as well as the inhibitory effects of chemical .	T5	T43	16516814
NA	CHEMICAL	GENE-Y	37	2	In addition to this evidence ( for the involvement of gene ) , evidence for the involvement of gene in the chemical mediated stimulation of chemical , chemical-ATPase beta subunit gene transcription includes the stimulatory effect of chemical , as well as the inhibitory effects of chemical .	T5	T22	16516814
CPR:3	CHEMICAL	GENE-N	37	28	In addition to this evidence ( for the involvement of gene ) , evidence for the involvement of gene in the chemical mediated stimulation of chemical , chemical-ATPase beta subunit gene transcription includes the stimulatory effect of chemical , as well as the inhibitory effects of chemical .	T5	T23	16516814
NA	CHEMICAL	GENE-Y	46	2	In addition to this evidence ( for the involvement of gene ) , evidence for the involvement of gene in the chemical mediated stimulation of chemical , chemical-ATPase beta subunit gene transcription includes the stimulatory effect of chemical , as well as the inhibitory effects of chemical .	T6	T43	16516814
NA	CHEMICAL	GENE-Y	46	2	In addition to this evidence ( for the involvement of gene ) , evidence for the involvement of gene in the chemical mediated stimulation of chemical , chemical-ATPase beta subunit gene transcription includes the stimulatory effect of chemical , as well as the inhibitory effects of chemical .	T6	T22	16516814
CPR:4	CHEMICAL	GENE-N	46	28	In addition to this evidence ( for the involvement of gene ) , evidence for the involvement of gene in the chemical mediated stimulation of chemical , chemical-ATPase beta subunit gene transcription includes the stimulatory effect of chemical , as well as the inhibitory effects of chemical .	T6	T23	16516814
NA	CHEMICAL	GENE-N	23	10	The newly synthesized compounds were tested for their in vitro gene inhibition and in vivo carrageenan induced hind paw edema in rats and chemical induced vascular permeability in mice .	T9	T16	23357629
NA	CHEMICAL	GENE-Y	3	9	The effect of chemical on chemical toxicity and chemical transporter ( gene ) in control and gene transfected HEK cells .	T15	T26	23313730
NA	CHEMICAL	GENE-Y	3	11	The effect of chemical on chemical toxicity and chemical transporter ( gene ) in control and gene transfected HEK cells .	T15	T27	23313730
NA	CHEMICAL	GENE-Y	3	16	The effect of chemical on chemical toxicity and chemical transporter ( gene ) in control and gene transfected HEK cells .	T15	T28	23313730
NA	CHEMICAL	GENE-Y	5	9	The effect of chemical on chemical toxicity and chemical transporter ( gene ) in control and gene transfected HEK cells .	T16	T26	23313730
NA	CHEMICAL	GENE-Y	5	11	The effect of chemical on chemical toxicity and chemical transporter ( gene ) in control and gene transfected HEK cells .	T16	T27	23313730
NA	CHEMICAL	GENE-Y	5	16	The effect of chemical on chemical toxicity and chemical transporter ( gene ) in control and gene transfected HEK cells .	T16	T28	23313730
NA	CHEMICAL	GENE-Y	8	9	The effect of chemical on chemical toxicity and chemical transporter ( gene ) in control and gene transfected HEK cells .	T17	T26	23313730
NA	CHEMICAL	GENE-Y	8	11	The effect of chemical on chemical toxicity and chemical transporter ( gene ) in control and gene transfected HEK cells .	T17	T27	23313730
NA	CHEMICAL	GENE-Y	8	16	The effect of chemical on chemical toxicity and chemical transporter ( gene ) in control and gene transfected HEK cells .	T17	T28	23313730
NA	CHEMICAL	GENE-Y	10	27	Although chemicalrgic neurons within the nigrostriatal pathway appear intact , chemical-induced irregularities in DA transmission have been observed including decreased chemical-induced DA release and loss of the gene ( gene ) .	T6	T21	23313730
NA	CHEMICAL	GENE-Y	10	13	Although chemicalrgic neurons within the nigrostriatal pathway appear intact , chemical-induced irregularities in DA transmission have been observed including decreased chemical-induced DA release and loss of the gene ( gene ) .	T6	T22	23313730
NA	CHEMICAL	GENE-Y	12	27	Although chemicalrgic neurons within the nigrostriatal pathway appear intact , chemical-induced irregularities in DA transmission have been observed including decreased chemical-induced DA release and loss of the gene ( gene ) .	T7	T21	23313730
NA	CHEMICAL	GENE-Y	12	13	Although chemicalrgic neurons within the nigrostriatal pathway appear intact , chemical-induced irregularities in DA transmission have been observed including decreased chemical-induced DA release and loss of the gene ( gene ) .	T7	T22	23313730
NA	CHEMICAL	GENE-Y	1	27	Although chemicalrgic neurons within the nigrostriatal pathway appear intact , chemical-induced irregularities in DA transmission have been observed including decreased chemical-induced DA release and loss of the gene ( gene ) .	T8	T21	23313730
NA	CHEMICAL	GENE-Y	1	13	Although chemicalrgic neurons within the nigrostriatal pathway appear intact , chemical-induced irregularities in DA transmission have been observed including decreased chemical-induced DA release and loss of the gene ( gene ) .	T8	T22	23313730
NA	CHEMICAL	GENE-Y	8	10	Results of studies to evaluate the effect of chemical and DA on cell viability in control and gene-transfected HEK cells reveal that chemical is equally toxic to both cell lines whereas DA was only toxic to cells containing gene .	T9	T23	23313730
NA	CHEMICAL	GENE-Y	8	10	Results of studies to evaluate the effect of chemical and DA on cell viability in control and gene-transfected HEK cells reveal that chemical is equally toxic to both cell lines whereas DA was only toxic to cells containing gene .	T9	T24	23313730
NA	CHEMICAL	GENE-Y	22	10	Results of studies to evaluate the effect of chemical and DA on cell viability in control and gene-transfected HEK cells reveal that chemical is equally toxic to both cell lines whereas DA was only toxic to cells containing gene .	T10	T23	23313730
NA	CHEMICAL	GENE-Y	22	10	Results of studies to evaluate the effect of chemical and DA on cell viability in control and gene-transfected HEK cells reveal that chemical is equally toxic to both cell lines whereas DA was only toxic to cells containing gene .	T10	T24	23313730
NA	CHEMICAL	GENE-Y	1	3	When chemical and DA were added simultaneously to the media , cell toxicity was similar to that produced by chemical alone suggesting that chemical may suppress DA uptake in the gene containing cells .	T11	T25	23313730
NA	CHEMICAL	GENE-Y	19	3	When chemical and DA were added simultaneously to the media , cell toxicity was similar to that produced by chemical alone suggesting that chemical may suppress DA uptake in the gene containing cells .	T12	T25	23313730
NA	CHEMICAL	GENE-Y	23	3	When chemical and DA were added simultaneously to the media , cell toxicity was similar to that produced by chemical alone suggesting that chemical may suppress DA uptake in the gene containing cells .	T13	T25	23313730
NA	CHEMICAL	GENE-Y	0	6	chemical was also shown to decrease DA uptake and chemical-induced DA efflux in gene containing cells .	T1	T18	23313730
NA	CHEMICAL	GENE-Y	9	6	chemical was also shown to decrease DA uptake and chemical-induced DA efflux in gene containing cells .	T2	T18	23313730
NA	CHEMICAL	GENE-Y	5	12	Time-lapsed confocal microscopy indicates that chemical can promote trafficking of cell surface gene into intracellular compartments which may account for the decrease in DA uptake and DA efflux in these cells .	T3	T19	23313730
NA	CHEMICAL	GENE-Y	2	32	METHODS : chemical and its R- ( - ) - and S- ( + ) -enantiomers were synthesized and tested for inhibition of chemical ( chemical ) uptake and chemical binding in gene ( gene ) wild-type and mutants with altered conformational equilibria .	T14	T39	22537794
NA	CHEMICAL	GENE-Y	2	34	METHODS : chemical and its R- ( - ) - and S- ( + ) -enantiomers were synthesized and tested for inhibition of chemical ( chemical ) uptake and chemical binding in gene ( gene ) wild-type and mutants with altered conformational equilibria .	T14	T40	22537794
CPR:9	CHEMICAL	GENE-Y	23	32	METHODS : chemical and its R- ( - ) - and S- ( + ) -enantiomers were synthesized and tested for inhibition of chemical ( chemical ) uptake and chemical binding in gene ( gene ) wild-type and mutants with altered conformational equilibria .	T15	T39	22537794
CPR:9	CHEMICAL	GENE-Y	23	34	METHODS : chemical and its R- ( - ) - and S- ( + ) -enantiomers were synthesized and tested for inhibition of chemical ( chemical ) uptake and chemical binding in gene ( gene ) wild-type and mutants with altered conformational equilibria .	T15	T40	22537794
CPR:9	CHEMICAL	GENE-Y	25	32	METHODS : chemical and its R- ( - ) - and S- ( + ) -enantiomers were synthesized and tested for inhibition of chemical ( chemical ) uptake and chemical binding in gene ( gene ) wild-type and mutants with altered conformational equilibria .	T16	T39	22537794
CPR:9	CHEMICAL	GENE-Y	25	34	METHODS : chemical and its R- ( - ) - and S- ( + ) -enantiomers were synthesized and tested for inhibition of chemical ( chemical ) uptake and chemical binding in gene ( gene ) wild-type and mutants with altered conformational equilibria .	T16	T40	22537794
NA	CHEMICAL	GENE-Y	29	32	METHODS : chemical and its R- ( - ) - and S- ( + ) -enantiomers were synthesized and tested for inhibition of chemical ( chemical ) uptake and chemical binding in gene ( gene ) wild-type and mutants with altered conformational equilibria .	T17	T39	22537794
NA	CHEMICAL	GENE-Y	29	34	METHODS : chemical and its R- ( - ) - and S- ( + ) -enantiomers were synthesized and tested for inhibition of chemical ( chemical ) uptake and chemical binding in gene ( gene ) wild-type and mutants with altered conformational equilibria .	T17	T40	22537794
NA	CHEMICAL	GENE-Y	31	32	METHODS : chemical and its R- ( - ) - and S- ( + ) -enantiomers were synthesized and tested for inhibition of chemical ( chemical ) uptake and chemical binding in gene ( gene ) wild-type and mutants with altered conformational equilibria .	T18	T39	22537794
NA	CHEMICAL	GENE-Y	31	34	METHODS : chemical and its R- ( - ) - and S- ( + ) -enantiomers were synthesized and tested for inhibition of chemical ( chemical ) uptake and chemical binding in gene ( gene ) wild-type and mutants with altered conformational equilibria .	T18	T40	22537794
NA	CHEMICAL	GENE-Y	2	6	RESULTS : chemical bind to the gene and inhibit chemical uptake less potently than chemical , with chemical having approximately threefold higher affinity than its S-enantiomer .	T24	T41	22537794
CPR:9	CHEMICAL	GENE-Y	9	6	RESULTS : chemical bind to the gene and inhibit chemical uptake less potently than chemical , with chemical having approximately threefold higher affinity than its S-enantiomer .	T25	T41	22537794
NA	CHEMICAL	GENE-Y	14	6	RESULTS : chemical bind to the gene and inhibit chemical uptake less potently than chemical , with chemical having approximately threefold higher affinity than its S-enantiomer .	T26	T41	22537794
NA	CHEMICAL	GENE-Y	17	6	RESULTS : chemical bind to the gene and inhibit chemical uptake less potently than chemical , with chemical having approximately threefold higher affinity than its S-enantiomer .	T27	T41	22537794
NA	CHEMICAL	GENE-Y	0	7	chemical was significantly less potent in the gene gene mutant compared with wild-type gene , whereas chemical was affected less .	T1	T31	22537794
NA	CHEMICAL	GENE-N	0	8	chemical was significantly less potent in the gene gene mutant compared with wild-type gene , whereas chemical was affected less .	T1	T32	22537794
NA	CHEMICAL	GENE-Y	0	13	chemical was significantly less potent in the gene gene mutant compared with wild-type gene , whereas chemical was affected less .	T1	T33	22537794
NA	CHEMICAL	GENE-Y	5	7	chemical was significantly less potent in the gene gene mutant compared with wild-type gene , whereas chemical was affected less .	T2	T31	22537794
NA	CHEMICAL	GENE-N	5	8	chemical was significantly less potent in the gene gene mutant compared with wild-type gene , whereas chemical was affected less .	T2	T32	22537794
NA	CHEMICAL	GENE-Y	5	13	chemical was significantly less potent in the gene gene mutant compared with wild-type gene , whereas chemical was affected less .	T2	T33	22537794
NA	CHEMICAL	GENE-N	18	3	Studies with the gene gene mutant showed that the R- and S-enantiomers tolerated the inward-facing conformation better than chemical , which was further supported by chemical reactivity on the gene gene gene .	T4	T34	22537794
NA	CHEMICAL	GENE-Y	18	4	Studies with the gene gene mutant showed that the R- and S-enantiomers tolerated the inward-facing conformation better than chemical , which was further supported by chemical reactivity on the gene gene gene .	T4	T35	22537794
NA	CHEMICAL	GENE-Y	18	29	Studies with the gene gene mutant showed that the R- and S-enantiomers tolerated the inward-facing conformation better than chemical , which was further supported by chemical reactivity on the gene gene gene .	T4	T36	22537794
NA	CHEMICAL	GENE-N	18	30	Studies with the gene gene mutant showed that the R- and S-enantiomers tolerated the inward-facing conformation better than chemical , which was further supported by chemical reactivity on the gene gene gene .	T4	T37	22537794
NA	CHEMICAL	GENE-N	18	31	Studies with the gene gene mutant showed that the R- and S-enantiomers tolerated the inward-facing conformation better than chemical , which was further supported by chemical reactivity on the gene gene gene .	T4	T38	22537794
NA	CHEMICAL	GENE-N	17	3	Studies with the gene gene mutant showed that the R- and S-enantiomers tolerated the inward-facing conformation better than chemical , which was further supported by chemical reactivity on the gene gene gene .	T5	T34	22537794
NA	CHEMICAL	GENE-Y	17	4	Studies with the gene gene mutant showed that the R- and S-enantiomers tolerated the inward-facing conformation better than chemical , which was further supported by chemical reactivity on the gene gene gene .	T5	T35	22537794
NA	CHEMICAL	GENE-Y	17	29	Studies with the gene gene mutant showed that the R- and S-enantiomers tolerated the inward-facing conformation better than chemical , which was further supported by chemical reactivity on the gene gene gene .	T5	T36	22537794
NA	CHEMICAL	GENE-N	17	30	Studies with the gene gene mutant showed that the R- and S-enantiomers tolerated the inward-facing conformation better than chemical , which was further supported by chemical reactivity on the gene gene gene .	T5	T37	22537794
NA	CHEMICAL	GENE-N	17	31	Studies with the gene gene mutant showed that the R- and S-enantiomers tolerated the inward-facing conformation better than chemical , which was further supported by chemical reactivity on the gene gene gene .	T5	T38	22537794
NA	CHEMICAL	GENE-Y	0	7	chemical enhances chemical-induced cytotoxic , apoptotic and anti-gene effects in a human colon carcinoma cell line .	T26	T40	20596674
NA	CHEMICAL	GENE-Y	2	7	chemical enhances chemical-induced cytotoxic , apoptotic and anti-gene effects in a human colon carcinoma cell line .	T27	T40	20596674
CPR:4	CHEMICAL	GENE-Y	0	4	chemical ( chemical ) is a gene ( gene ) inhibitor chemotherapeutic agent .	T1	T32	20596674
CPR:4	CHEMICAL	GENE-Y	0	8	chemical ( chemical ) is a gene ( gene ) inhibitor chemotherapeutic agent .	T1	T34	20596674
CPR:4	CHEMICAL	GENE-Y	2	4	chemical ( chemical ) is a gene ( gene ) inhibitor chemotherapeutic agent .	T4	T32	20596674
CPR:4	CHEMICAL	GENE-Y	2	8	chemical ( chemical ) is a gene ( gene ) inhibitor chemotherapeutic agent .	T4	T34	20596674
NA	CHEMICAL	GENE-Y	11	19	The aim of this study was to investigate the effects of chemical ( chemical ) and chemical on cellular gene activity in drug-treated cells and evaluate the influence of chemical on the mode of action of chemical , on proliferation and apoptosis of HT-29 cells .	T15	T33	20596674
NA	CHEMICAL	GENE-Y	13	19	The aim of this study was to investigate the effects of chemical ( chemical ) and chemical on cellular gene activity in drug-treated cells and evaluate the influence of chemical on the mode of action of chemical , on proliferation and apoptosis of HT-29 cells .	T16	T33	20596674
NA	CHEMICAL	GENE-Y	16	19	The aim of this study was to investigate the effects of chemical ( chemical ) and chemical on cellular gene activity in drug-treated cells and evaluate the influence of chemical on the mode of action of chemical , on proliferation and apoptosis of HT-29 cells .	T17	T33	20596674
NA	CHEMICAL	GENE-Y	29	19	The aim of this study was to investigate the effects of chemical ( chemical ) and chemical on cellular gene activity in drug-treated cells and evaluate the influence of chemical on the mode of action of chemical , on proliferation and apoptosis of HT-29 cells .	T18	T33	20596674
NA	CHEMICAL	GENE-Y	36	19	The aim of this study was to investigate the effects of chemical ( chemical ) and chemical on cellular gene activity in drug-treated cells and evaluate the influence of chemical on the mode of action of chemical , on proliferation and apoptosis of HT-29 cells .	T19	T33	20596674
NA	CHEMICAL	GENE-Y	13	32	Decatenation assay , band depletion and Western blot analysis , cytotoxic assay ( chemical ) , flow cytometric studies ( cell cycle and survivin expression ) , apoptosis ( chemical-chemical staining and gene activity ) and gene and gene secretion were determined .	T20	T35	20596674
NA	CHEMICAL	GENE-Y	13	36	Decatenation assay , band depletion and Western blot analysis , cytotoxic assay ( chemical ) , flow cytometric studies ( cell cycle and survivin expression ) , apoptosis ( chemical-chemical staining and gene activity ) and gene and gene secretion were determined .	T20	T36	20596674
NA	CHEMICAL	GENE-Y	13	38	Decatenation assay , band depletion and Western blot analysis , cytotoxic assay ( chemical ) , flow cytometric studies ( cell cycle and survivin expression ) , apoptosis ( chemical-chemical staining and gene activity ) and gene and gene secretion were determined .	T20	T37	20596674
NA	CHEMICAL	GENE-Y	29	32	Decatenation assay , band depletion and Western blot analysis , cytotoxic assay ( chemical ) , flow cytometric studies ( cell cycle and survivin expression ) , apoptosis ( chemical-chemical staining and gene activity ) and gene and gene secretion were determined .	T21	T35	20596674
NA	CHEMICAL	GENE-Y	29	36	Decatenation assay , band depletion and Western blot analysis , cytotoxic assay ( chemical ) , flow cytometric studies ( cell cycle and survivin expression ) , apoptosis ( chemical-chemical staining and gene activity ) and gene and gene secretion were determined .	T21	T36	20596674
NA	CHEMICAL	GENE-Y	29	38	Decatenation assay , band depletion and Western blot analysis , cytotoxic assay ( chemical ) , flow cytometric studies ( cell cycle and survivin expression ) , apoptosis ( chemical-chemical staining and gene activity ) and gene and gene secretion were determined .	T21	T37	20596674
NA	CHEMICAL	GENE-Y	29	32	Decatenation assay , band depletion and Western blot analysis , cytotoxic assay ( chemical ) , flow cytometric studies ( cell cycle and survivin expression ) , apoptosis ( chemical-chemical staining and gene activity ) and gene and gene secretion were determined .	T22	T35	20596674
NA	CHEMICAL	GENE-Y	29	36	Decatenation assay , band depletion and Western blot analysis , cytotoxic assay ( chemical ) , flow cytometric studies ( cell cycle and survivin expression ) , apoptosis ( chemical-chemical staining and gene activity ) and gene and gene secretion were determined .	T22	T36	20596674
NA	CHEMICAL	GENE-Y	29	38	Decatenation assay , band depletion and Western blot analysis , cytotoxic assay ( chemical ) , flow cytometric studies ( cell cycle and survivin expression ) , apoptosis ( chemical-chemical staining and gene activity ) and gene and gene secretion were determined .	T22	T37	20596674
NA	CHEMICAL	GENE-Y	0	6	chemical or chemical slightly affected cellular gene activity in nuclear extracts derived from drug-treated cells while the combination enhanced inhibitory activity and the reduction in band depletion of gene .	T23	T38	20596674
CPR:4	CHEMICAL	GENE-Y	0	28	chemical or chemical slightly affected cellular gene activity in nuclear extracts derived from drug-treated cells while the combination enhanced inhibitory activity and the reduction in band depletion of gene .	T23	T39	20596674
NA	CHEMICAL	GENE-Y	2	6	chemical or chemical slightly affected cellular gene activity in nuclear extracts derived from drug-treated cells while the combination enhanced inhibitory activity and the reduction in band depletion of gene .	T24	T38	20596674
CPR:4	CHEMICAL	GENE-Y	2	28	chemical or chemical slightly affected cellular gene activity in nuclear extracts derived from drug-treated cells while the combination enhanced inhibitory activity and the reduction in band depletion of gene .	T24	T39	20596674
NA	CHEMICAL	GENE-Y	3	6	Apoptosis studies ( chemical staining and gene activity ) showed a marked increase in the presence of chemical and chemical compared to chemical alone .	T3	T28	20596674
CPR:3	CHEMICAL	GENE-Y	17	6	Apoptosis studies ( chemical staining and gene activity ) showed a marked increase in the presence of chemical and chemical compared to chemical alone .	T5	T28	20596674
CPR:3	CHEMICAL	GENE-Y	19	6	Apoptosis studies ( chemical staining and gene activity ) showed a marked increase in the presence of chemical and chemical compared to chemical alone .	T6	T28	20596674
CPR:3	CHEMICAL	GENE-Y	22	6	Apoptosis studies ( chemical staining and gene activity ) showed a marked increase in the presence of chemical and chemical compared to chemical alone .	T7	T28	20596674
NA	CHEMICAL	GENE-Y	0	5	chemical induced the release of gene , and addition of chemical reduced enhanced release and the spontaneous release of gene from the cells .	T8	T29	20596674
NA	CHEMICAL	GENE-Y	0	19	chemical induced the release of gene , and addition of chemical reduced enhanced release and the spontaneous release of gene from the cells .	T8	T30	20596674
NA	CHEMICAL	GENE-Y	10	5	chemical induced the release of gene , and addition of chemical reduced enhanced release and the spontaneous release of gene from the cells .	T9	T29	20596674
NA	CHEMICAL	GENE-Y	10	19	chemical induced the release of gene , and addition of chemical reduced enhanced release and the spontaneous release of gene from the cells .	T9	T30	20596674
CPR:4	CHEMICAL	GENE-Y	18	13	In conclusion , the results suggest that the enhancement in the reduction of gene activity by the combined chemical/chemical treatments was probably due to the increase in the level of the DNA-enzyme cleavable complexes formed by both drugs .	T11	T31	20596674
CPR:4	CHEMICAL	GENE-Y	18	13	In conclusion , the results suggest that the enhancement in the reduction of gene activity by the combined chemical/chemical treatments was probably due to the increase in the level of the DNA-enzyme cleavable complexes formed by both drugs .	T12	T31	20596674
NA	CHEMICAL	GENE-Y	0	5	chemical ( chemical ) is a chemical that selectively induces cell death in human cancer cells through chemical : chemical oxidoreductase-1 ( gene ) .	T1	T14	23333901
NA	CHEMICAL	GENE-Y	0	22	chemical ( chemical ) is a chemical that selectively induces cell death in human cancer cells through chemical : chemical oxidoreductase-1 ( gene ) .	T1	T15	23333901
NA	CHEMICAL	GENE-Y	2	5	chemical ( chemical ) is a chemical that selectively induces cell death in human cancer cells through chemical : chemical oxidoreductase-1 ( gene ) .	T4	T14	23333901
NA	CHEMICAL	GENE-Y	2	22	chemical ( chemical ) is a chemical that selectively induces cell death in human cancer cells through chemical : chemical oxidoreductase-1 ( gene ) .	T4	T15	23333901
NA	CHEMICAL	GENE-Y	5	5	chemical ( chemical ) is a chemical that selectively induces cell death in human cancer cells through chemical : chemical oxidoreductase-1 ( gene ) .	T5	T14	23333901
NA	CHEMICAL	GENE-Y	5	22	chemical ( chemical ) is a chemical that selectively induces cell death in human cancer cells through chemical : chemical oxidoreductase-1 ( gene ) .	T5	T15	23333901
NA	CHEMICAL	GENE-Y	1	5	chemical ( chemical ) is a chemical that selectively induces cell death in human cancer cells through chemical : chemical oxidoreductase-1 ( gene ) .	T2	T14	23333901
NA	CHEMICAL	GENE-Y	1	22	chemical ( chemical ) is a chemical that selectively induces cell death in human cancer cells through chemical : chemical oxidoreductase-1 ( gene ) .	T2	T15	23333901
NA	CHEMICAL	GENE-Y	12	5	chemical ( chemical ) is a chemical that selectively induces cell death in human cancer cells through chemical : chemical oxidoreductase-1 ( gene ) .	T3	T14	23333901
NA	CHEMICAL	GENE-Y	12	22	chemical ( chemical ) is a chemical that selectively induces cell death in human cancer cells through chemical : chemical oxidoreductase-1 ( gene ) .	T3	T15	23333901
CPR:4	CHEMICAL	GENE-N	0	5	chemical forestalls cigarette smoke induced gene activation in alveolar epithelial cells .	T8	T24	23615073
CPR:4	CHEMICAL	GENE-N	4	17	It is possible that chemical , an antioxidant , may prevent cigarette smoke ( CS ) -induced gene activation that involves degradation of gene and nuclear translocation of gene/gene in alveolar epithelial cells .	T4	T13	23615073
CPR:4	CHEMICAL	GENE-Y	4	23	It is possible that chemical , an antioxidant , may prevent cigarette smoke ( CS ) -induced gene activation that involves degradation of gene and nuclear translocation of gene/gene in alveolar epithelial cells .	T4	T14	23615073
NA	CHEMICAL	GENE-Y	4	28	It is possible that chemical , an antioxidant , may prevent cigarette smoke ( CS ) -induced gene activation that involves degradation of gene and nuclear translocation of gene/gene in alveolar epithelial cells .	T4	T15	23615073
NA	CHEMICAL	GENE-Y	4	28	It is possible that chemical , an antioxidant , may prevent cigarette smoke ( CS ) -induced gene activation that involves degradation of gene and nuclear translocation of gene/gene in alveolar epithelial cells .	T4	T16	23615073
NA	CHEMICAL	GENE-N	12	17	Therefore , to examine the hypothesis , we verified the effect of chemical on CS-induced expression of gene driven luciferase reporter and gene binding at its target DNA by EMSA in alveolar epithelial A549 cells .	T5	T17	23615073
NA	CHEMICAL	GENE-N	12	22	Therefore , to examine the hypothesis , we verified the effect of chemical on CS-induced expression of gene driven luciferase reporter and gene binding at its target DNA by EMSA in alveolar epithelial A549 cells .	T5	T18	23615073
NA	CHEMICAL	GENE-Y	25	6	We also examined the level of gene and sub-cellular distribution of gene by western blotting and immunofluorescence respectively in CSE-treated A549 cells with or without chemical pretreatment .	T6	T19	23615073
NA	CHEMICAL	GENE-Y	25	11	We also examined the level of gene and sub-cellular distribution of gene by western blotting and immunofluorescence respectively in CSE-treated A549 cells with or without chemical pretreatment .	T6	T20	23615073
NA	CHEMICAL	GENE-N	25	11	We observed a significant reduction in CSE induced luciferase expression , gene DNA binding , gene degradation and gene nuclear translocation in cells pretreated with chemical . To further validate the result , we examined sub-cellular distribution of gene in lungs of CS-exposed guinea pigs treated or untreated with chemical . Result showed that chemical treatment resulted in markedly reduced gene nuclear translocation .	T7	T21	23615073
CPR:4	CHEMICAL	GENE-Y	25	15	We observed a significant reduction in CSE induced luciferase expression , gene DNA binding , gene degradation and gene nuclear translocation in cells pretreated with chemical . To further validate the result , we examined sub-cellular distribution of gene in lungs of CS-exposed guinea pigs treated or untreated with chemical . Result showed that chemical treatment resulted in markedly reduced gene nuclear translocation .	T7	T22	23615073
NA	CHEMICAL	GENE-Y	25	18	We observed a significant reduction in CSE induced luciferase expression , gene DNA binding , gene degradation and gene nuclear translocation in cells pretreated with chemical . To further validate the result , we examined sub-cellular distribution of gene in lungs of CS-exposed guinea pigs treated or untreated with chemical . Result showed that chemical treatment resulted in markedly reduced gene nuclear translocation .	T7	T23	23615073
NA	CHEMICAL	GENE-Y	25	38	We observed a significant reduction in CSE induced luciferase expression , gene DNA binding , gene degradation and gene nuclear translocation in cells pretreated with chemical . To further validate the result , we examined sub-cellular distribution of gene in lungs of CS-exposed guinea pigs treated or untreated with chemical . Result showed that chemical treatment resulted in markedly reduced gene nuclear translocation .	T7	T9	23615073
NA	CHEMICAL	GENE-Y	25	60	We observed a significant reduction in CSE induced luciferase expression , gene DNA binding , gene degradation and gene nuclear translocation in cells pretreated with chemical . To further validate the result , we examined sub-cellular distribution of gene in lungs of CS-exposed guinea pigs treated or untreated with chemical . Result showed that chemical treatment resulted in markedly reduced gene nuclear translocation .	T7	T10	23615073
NA	CHEMICAL	GENE-N	49	11	We observed a significant reduction in CSE induced luciferase expression , gene DNA binding , gene degradation and gene nuclear translocation in cells pretreated with chemical . To further validate the result , we examined sub-cellular distribution of gene in lungs of CS-exposed guinea pigs treated or untreated with chemical . Result showed that chemical treatment resulted in markedly reduced gene nuclear translocation .	T1	T21	23615073
NA	CHEMICAL	GENE-Y	49	15	We observed a significant reduction in CSE induced luciferase expression , gene DNA binding , gene degradation and gene nuclear translocation in cells pretreated with chemical . To further validate the result , we examined sub-cellular distribution of gene in lungs of CS-exposed guinea pigs treated or untreated with chemical . Result showed that chemical treatment resulted in markedly reduced gene nuclear translocation .	T1	T22	23615073
NA	CHEMICAL	GENE-Y	49	18	We observed a significant reduction in CSE induced luciferase expression , gene DNA binding , gene degradation and gene nuclear translocation in cells pretreated with chemical . To further validate the result , we examined sub-cellular distribution of gene in lungs of CS-exposed guinea pigs treated or untreated with chemical . Result showed that chemical treatment resulted in markedly reduced gene nuclear translocation .	T1	T23	23615073
NA	CHEMICAL	GENE-Y	49	38	We observed a significant reduction in CSE induced luciferase expression , gene DNA binding , gene degradation and gene nuclear translocation in cells pretreated with chemical . To further validate the result , we examined sub-cellular distribution of gene in lungs of CS-exposed guinea pigs treated or untreated with chemical . Result showed that chemical treatment resulted in markedly reduced gene nuclear translocation .	T1	T9	23615073
NA	CHEMICAL	GENE-Y	49	60	We observed a significant reduction in CSE induced luciferase expression , gene DNA binding , gene degradation and gene nuclear translocation in cells pretreated with chemical . To further validate the result , we examined sub-cellular distribution of gene in lungs of CS-exposed guinea pigs treated or untreated with chemical . Result showed that chemical treatment resulted in markedly reduced gene nuclear translocation .	T1	T10	23615073
NA	CHEMICAL	GENE-N	11	11	We observed a significant reduction in CSE induced luciferase expression , gene DNA binding , gene degradation and gene nuclear translocation in cells pretreated with chemical . To further validate the result , we examined sub-cellular distribution of gene in lungs of CS-exposed guinea pigs treated or untreated with chemical . Result showed that chemical treatment resulted in markedly reduced gene nuclear translocation .	T2	T21	23615073
NA	CHEMICAL	GENE-Y	11	15	We observed a significant reduction in CSE induced luciferase expression , gene DNA binding , gene degradation and gene nuclear translocation in cells pretreated with chemical . To further validate the result , we examined sub-cellular distribution of gene in lungs of CS-exposed guinea pigs treated or untreated with chemical . Result showed that chemical treatment resulted in markedly reduced gene nuclear translocation .	T2	T22	23615073
NA	CHEMICAL	GENE-Y	11	18	We observed a significant reduction in CSE induced luciferase expression , gene DNA binding , gene degradation and gene nuclear translocation in cells pretreated with chemical . To further validate the result , we examined sub-cellular distribution of gene in lungs of CS-exposed guinea pigs treated or untreated with chemical . Result showed that chemical treatment resulted in markedly reduced gene nuclear translocation .	T2	T23	23615073
NA	CHEMICAL	GENE-Y	11	38	We observed a significant reduction in CSE induced luciferase expression , gene DNA binding , gene degradation and gene nuclear translocation in cells pretreated with chemical . To further validate the result , we examined sub-cellular distribution of gene in lungs of CS-exposed guinea pigs treated or untreated with chemical . Result showed that chemical treatment resulted in markedly reduced gene nuclear translocation .	T2	T9	23615073
CPR:4	CHEMICAL	GENE-Y	11	60	We observed a significant reduction in CSE induced luciferase expression , gene DNA binding , gene degradation and gene nuclear translocation in cells pretreated with chemical . To further validate the result , we examined sub-cellular distribution of gene in lungs of CS-exposed guinea pigs treated or untreated with chemical . Result showed that chemical treatment resulted in markedly reduced gene nuclear translocation .	T2	T10	23615073
NA	CHEMICAL	GENE-Y	1	2	A chemical-sensitive gene : cloning , expression , and electrophysiological characterization .	T15	T27	8302852
NA	CHEMICAL	GENE-Y	1	4	A chemical-sensitive , high-affinity gene cDNA , denoted gene , was isolated and characterized in oocytes .	T4	T20	8302852
NA	CHEMICAL	GENE-Y	1	8	A chemical-sensitive , high-affinity gene cDNA , denoted gene , was isolated and characterized in oocytes .	T4	T17	8302852
NA	CHEMICAL	GENE-Y	14	4	A chemical-sensitive , high-affinity gene cDNA , denoted gene , was isolated and characterized in oocytes .	T8	T20	8302852
NA	CHEMICAL	GENE-Y	14	8	A chemical-sensitive , high-affinity gene cDNA , denoted gene , was isolated and characterized in oocytes .	T8	T17	8302852
NA	CHEMICAL	GENE-Y	14	4	A chemical-sensitive , high-affinity gene cDNA , denoted gene , was isolated and characterized in oocytes .	T10	T20	8302852
NA	CHEMICAL	GENE-Y	14	8	A chemical-sensitive , high-affinity gene cDNA , denoted gene , was isolated and characterized in oocytes .	T10	T17	8302852
NA	CHEMICAL	GENE-Y	0	0	gene shows little transport of other chemical and is chemical and chemical dependent .	T1	T18	8302852
NA	CHEMICAL	GENE-Y	9	0	gene shows little transport of other chemical and is chemical and chemical dependent .	T2	T18	8302852
NA	CHEMICAL	GENE-Y	11	0	gene shows little transport of other chemical and is chemical and chemical dependent .	T3	T18	8302852
NA	CHEMICAL	GENE-N	8	10	After adjusting for age , sex , total chemical , gene-cholesterol and chemical , max-IMT was significantly increased in the highest tertile of gene ( 0.969±0.033 vs 0.959±0.033 vs 1.077±0.033mm , respectively ; P=0.026 ) .	T1	T10	23380568
NA	CHEMICAL	GENE-Y	8	23	After adjusting for age , sex , total chemical , gene-cholesterol and chemical , max-IMT was significantly increased in the highest tertile of gene ( 0.969±0.033 vs 0.959±0.033 vs 1.077±0.033mm , respectively ; P=0.026 ) .	T1	T12	23380568
NA	CHEMICAL	GENE-N	12	10	After adjusting for age , sex , total chemical , gene-cholesterol and chemical , max-IMT was significantly increased in the highest tertile of gene ( 0.969±0.033 vs 0.959±0.033 vs 1.077±0.033mm , respectively ; P=0.026 ) .	T2	T10	23380568
NA	CHEMICAL	GENE-Y	12	23	After adjusting for age , sex , total chemical , gene-cholesterol and chemical , max-IMT was significantly increased in the highest tertile of gene ( 0.969±0.033 vs 0.959±0.033 vs 1.077±0.033mm , respectively ; P=0.026 ) .	T2	T12	23380568
NA	CHEMICAL	GENE-Y	1	2	Liver chemical dehydrogenase and kidney chemical-chemical methyltransferase expression are not affected by chemical or chemical intake in growing rats .	T23	T39	16920841
NA	CHEMICAL	GENE-N	1	6	Liver chemical dehydrogenase and kidney chemical-chemical methyltransferase expression are not affected by chemical or chemical intake in growing rats .	T23	T38	16920841
NA	CHEMICAL	GENE-Y	5	2	Liver chemical dehydrogenase and kidney chemical-chemical methyltransferase expression are not affected by chemical or chemical intake in growing rats .	T21	T39	16920841
NA	CHEMICAL	GENE-N	5	6	Liver chemical dehydrogenase and kidney chemical-chemical methyltransferase expression are not affected by chemical or chemical intake in growing rats .	T21	T38	16920841
NA	CHEMICAL	GENE-Y	5	2	Liver chemical dehydrogenase and kidney chemical-chemical methyltransferase expression are not affected by chemical or chemical intake in growing rats .	T22	T39	16920841
NA	CHEMICAL	GENE-N	5	6	Liver chemical dehydrogenase and kidney chemical-chemical methyltransferase expression are not affected by chemical or chemical intake in growing rats .	T22	T38	16920841
NA	CHEMICAL	GENE-Y	12	2	Liver chemical dehydrogenase and kidney chemical-chemical methyltransferase expression are not affected by chemical or chemical intake in growing rats .	T19	T39	16920841
NA	CHEMICAL	GENE-N	12	6	Liver chemical dehydrogenase and kidney chemical-chemical methyltransferase expression are not affected by chemical or chemical intake in growing rats .	T19	T38	16920841
NA	CHEMICAL	GENE-Y	14	2	Liver chemical dehydrogenase and kidney chemical-chemical methyltransferase expression are not affected by chemical or chemical intake in growing rats .	T20	T39	16920841
NA	CHEMICAL	GENE-N	14	6	Liver chemical dehydrogenase and kidney chemical-chemical methyltransferase expression are not affected by chemical or chemical intake in growing rats .	T20	T38	16920841
NA	CHEMICAL	GENE-Y	0	1	chemical dehydrogenase ( gene ) and chemical-chemical methyltransferase ( gene ) are 2 enzymes involved in chemical oxidation .	T1	T24	16920841
NA	CHEMICAL	GENE-Y	0	3	chemical dehydrogenase ( gene ) and chemical-chemical methyltransferase ( gene ) are 2 enzymes involved in chemical oxidation .	T1	T30	16920841
NA	CHEMICAL	GENE-N	0	7	chemical dehydrogenase ( gene ) and chemical-chemical methyltransferase ( gene ) are 2 enzymes involved in chemical oxidation .	T1	T31	16920841
NA	CHEMICAL	GENE-N	0	9	chemical dehydrogenase ( gene ) and chemical-chemical methyltransferase ( gene ) are 2 enzymes involved in chemical oxidation .	T1	T34	16920841
NA	CHEMICAL	GENE-Y	6	1	chemical dehydrogenase ( gene ) and chemical-chemical methyltransferase ( gene ) are 2 enzymes involved in chemical oxidation .	T10	T24	16920841
NA	CHEMICAL	GENE-Y	6	3	chemical dehydrogenase ( gene ) and chemical-chemical methyltransferase ( gene ) are 2 enzymes involved in chemical oxidation .	T10	T30	16920841
NA	CHEMICAL	GENE-N	6	7	chemical dehydrogenase ( gene ) and chemical-chemical methyltransferase ( gene ) are 2 enzymes involved in chemical oxidation .	T10	T31	16920841
NA	CHEMICAL	GENE-N	6	9	chemical dehydrogenase ( gene ) and chemical-chemical methyltransferase ( gene ) are 2 enzymes involved in chemical oxidation .	T10	T34	16920841
NA	CHEMICAL	GENE-Y	6	1	chemical dehydrogenase ( gene ) and chemical-chemical methyltransferase ( gene ) are 2 enzymes involved in chemical oxidation .	T13	T24	16920841
NA	CHEMICAL	GENE-Y	6	3	chemical dehydrogenase ( gene ) and chemical-chemical methyltransferase ( gene ) are 2 enzymes involved in chemical oxidation .	T13	T30	16920841
NA	CHEMICAL	GENE-N	6	7	chemical dehydrogenase ( gene ) and chemical-chemical methyltransferase ( gene ) are 2 enzymes involved in chemical oxidation .	T13	T31	16920841
NA	CHEMICAL	GENE-N	6	9	chemical dehydrogenase ( gene ) and chemical-chemical methyltransferase ( gene ) are 2 enzymes involved in chemical oxidation .	T13	T34	16920841
CPR:9	CHEMICAL	GENE-Y	15	1	chemical dehydrogenase ( gene ) and chemical-chemical methyltransferase ( gene ) are 2 enzymes involved in chemical oxidation .	T2	T24	16920841
CPR:9	CHEMICAL	GENE-Y	15	3	chemical dehydrogenase ( gene ) and chemical-chemical methyltransferase ( gene ) are 2 enzymes involved in chemical oxidation .	T2	T30	16920841
CPR:9	CHEMICAL	GENE-N	15	7	chemical dehydrogenase ( gene ) and chemical-chemical methyltransferase ( gene ) are 2 enzymes involved in chemical oxidation .	T2	T31	16920841
CPR:9	CHEMICAL	GENE-N	15	9	chemical dehydrogenase ( gene ) and chemical-chemical methyltransferase ( gene ) are 2 enzymes involved in chemical oxidation .	T2	T34	16920841
NA	CHEMICAL	GENE-N	16	0	gene is expressed at high levels in rat liver and its expression is regulated by dietary chemical and chemical .	T8	T28	16920841
NA	CHEMICAL	GENE-N	6	0	gene is expressed at high levels in rat liver and its expression is regulated by dietary chemical and chemical .	T9	T28	16920841
NA	CHEMICAL	GENE-N	27	0	gene is also found in rat kidney , albeit in substantially lower amounts , but it is not known whether kidney gene expression is regulated by dietary chemical or chemical .	T11	T29	16920841
NA	CHEMICAL	GENE-N	27	21	gene is also found in rat kidney , albeit in substantially lower amounts , but it is not known whether kidney gene expression is regulated by dietary chemical or chemical .	T11	T32	16920841
NA	CHEMICAL	GENE-N	4	0	gene is also found in rat kidney , albeit in substantially lower amounts , but it is not known whether kidney gene expression is regulated by dietary chemical or chemical .	T12	T29	16920841
NA	CHEMICAL	GENE-N	4	21	gene is also found in rat kidney , albeit in substantially lower amounts , but it is not known whether kidney gene expression is regulated by dietary chemical or chemical .	T12	T32	16920841
NA	CHEMICAL	GENE-N	10	1	Liver gene activity was 1.3-fold higher in rats fed the chemical deficient diet containing chemical , which was reflected in corresponding increases in mRNA content and immunodetectable protein .	T17	T37	16920841
CPR:3	CHEMICAL	GENE-N	6	1	Liver gene activity was 1.3-fold higher in rats fed the chemical deficient diet containing chemical , which was reflected in corresponding increases in mRNA content and immunodetectable protein .	T18	T37	16920841
CPR:3	CHEMICAL	GENE-N	3	9	Independent of dietary chemical , supplemental chemical increased hepatic gene activity approximately 30 % .	T3	T25	16920841
CPR:3	CHEMICAL	GENE-N	6	9	Independent of dietary chemical , supplemental chemical increased hepatic gene activity approximately 30 % .	T4	T25	16920841
CPR:5	CHEMICAL	GENE-Y	2	6	Pharmacology of chemical , a selective gene/gene receptor agonist : a novel therapeutic drug for sleep disorders .	T9	T16	19228178
CPR:5	CHEMICAL	GENE-Y	2	6	Pharmacology of chemical , a selective gene/gene receptor agonist : a novel therapeutic drug for sleep disorders .	T9	T17	19228178
NA	CHEMICAL	GENE-N	9	17	However , current treatment of insomnia with hypnotics , chemical A ( GABA ( A ) ) receptor modulators , induces various side effects , including cognitive impairment , motor disturbance , dependence , tolerance , hangover , and rebound insomnia .	T1	T10	19228178
CPR:5	CHEMICAL	GENE-Y	0	1	chemical ( chemical ; Takeda Pharmaceutical Company Limited , Osaka , Japan ) is an orally active , highly selective chemical gene/gene receptor agonist .	T2	T11	19228178
CPR:5	CHEMICAL	GENE-Y	0	1	chemical ( chemical ; Takeda Pharmaceutical Company Limited , Osaka , Japan ) is an orally active , highly selective chemical gene/gene receptor agonist .	T2	T12	19228178
NA	CHEMICAL	GENE-Y	2	1	chemical ( chemical ; Takeda Pharmaceutical Company Limited , Osaka , Japan ) is an orally active , highly selective chemical gene/gene receptor agonist .	T3	T11	19228178
NA	CHEMICAL	GENE-Y	2	1	chemical ( chemical ; Takeda Pharmaceutical Company Limited , Osaka , Japan ) is an orally active , highly selective chemical gene/gene receptor agonist .	T3	T12	19228178
NA	CHEMICAL	GENE-Y	20	1	chemical ( chemical ; Takeda Pharmaceutical Company Limited , Osaka , Japan ) is an orally active , highly selective chemical gene/gene receptor agonist .	T4	T11	19228178
NA	CHEMICAL	GENE-Y	20	1	chemical ( chemical ; Takeda Pharmaceutical Company Limited , Osaka , Japan ) is an orally active , highly selective chemical gene/gene receptor agonist .	T4	T12	19228178
NA	CHEMICAL	GENE-N	9	6	Unlike the sedative hypnotics that target gene complexes , chemical is a chronohypnotic that acts on the chemical gene and gene receptors , which are primarily located in the suprachiasmatic nucleus , the body 's `` master clock . ''	T5	T13	19228178
CPR:5	CHEMICAL	GENE-Y	9	18	Unlike the sedative hypnotics that target gene complexes , chemical is a chronohypnotic that acts on the chemical gene and gene receptors , which are primarily located in the suprachiasmatic nucleus , the body 's `` master clock . ''	T5	T14	19228178
CPR:5	CHEMICAL	GENE-Y	9	20	Unlike the sedative hypnotics that target gene complexes , chemical is a chronohypnotic that acts on the chemical gene and gene receptors , which are primarily located in the suprachiasmatic nucleus , the body 's `` master clock . ''	T5	T15	19228178
NA	CHEMICAL	GENE-N	11	6	Unlike the sedative hypnotics that target gene complexes , chemical is a chronohypnotic that acts on the chemical gene and gene receptors , which are primarily located in the suprachiasmatic nucleus , the body 's `` master clock . ''	T6	T13	19228178
NA	CHEMICAL	GENE-Y	11	18	Unlike the sedative hypnotics that target gene complexes , chemical is a chronohypnotic that acts on the chemical gene and gene receptors , which are primarily located in the suprachiasmatic nucleus , the body 's `` master clock . ''	T6	T14	19228178
NA	CHEMICAL	GENE-Y	11	20	Unlike the sedative hypnotics that target gene complexes , chemical is a chronohypnotic that acts on the chemical gene and gene receptors , which are primarily located in the suprachiasmatic nucleus , the body 's `` master clock . ''	T6	T15	19228178
NA	CHEMICAL	GENE-Y	7	2	A novel gene positive allosteric modulator acts at a unique site and confers stimulus bias to gene signaling .	T15	T32	23348500
NA	CHEMICAL	GENE-Y	7	16	A novel gene positive allosteric modulator acts at a unique site and confers stimulus bias to gene signaling .	T15	T31	23348500
NA	CHEMICAL	GENE-Y	5	0	gene ( gene ) is a target for the treatment of central nervous system ( CNS ) disorders , such as schizophrenia and Alzheimer 's disease .	T5	T16	23348500
NA	CHEMICAL	GENE-Y	5	2	gene ( gene ) is a target for the treatment of central nervous system ( CNS ) disorders , such as schizophrenia and Alzheimer 's disease .	T5	T25	23348500
NA	CHEMICAL	GENE-Y	14	10	Previous work has extensively characterized a common allosteric site on gene , termed the chemical ( chemical ) binding site .	T8	T27	23348500
NA	CHEMICAL	GENE-Y	15	10	Previous work has extensively characterized a common allosteric site on gene , termed the chemical ( chemical ) binding site .	T9	T27	23348500
NA	CHEMICAL	GENE-Y	6	3	However , one gene PAM , chemical ( chemical ) , interacts with a separate allosteric site on gene .	T10	T28	23348500
NA	CHEMICAL	GENE-Y	6	18	However , one gene PAM , chemical ( chemical ) , interacts with a separate allosteric site on gene .	T10	T29	23348500
NA	CHEMICAL	GENE-Y	1	3	However , one gene PAM , chemical ( chemical ) , interacts with a separate allosteric site on gene .	T11	T28	23348500
NA	CHEMICAL	GENE-Y	1	18	However , one gene PAM , chemical ( chemical ) , interacts with a separate allosteric site on gene .	T11	T29	23348500
NA	CHEMICAL	GENE-Y	21	17	Using cell-based assays and brain slice preparations , we characterized the interaction of a potent and efficacious gene PAM from the chemical series termed chemical ( chemical ) .	T12	T30	23348500
NA	CHEMICAL	GENE-Y	24	17	Using cell-based assays and brain slice preparations , we characterized the interaction of a potent and efficacious gene PAM from the chemical series termed chemical ( chemical ) .	T13	T30	23348500
NA	CHEMICAL	GENE-Y	7	17	Using cell-based assays and brain slice preparations , we characterized the interaction of a potent and efficacious gene PAM from the chemical series termed chemical ( chemical ) .	T14	T30	23348500
NA	CHEMICAL	GENE-Y	0	7	chemical binds to the chemical site on gene and potentiates gene-mediated responses in both recombinant and native systems .	T1	T17	23348500
CPR:3	CHEMICAL	GENE-Y	0	10	chemical binds to the chemical site on gene and potentiates gene-mediated responses in both recombinant and native systems .	T1	T18	23348500
NA	CHEMICAL	GENE-Y	4	7	chemical binds to the chemical site on gene and potentiates gene-mediated responses in both recombinant and native systems .	T2	T17	23348500
NA	CHEMICAL	GENE-Y	4	10	chemical binds to the chemical site on gene and potentiates gene-mediated responses in both recombinant and native systems .	T2	T18	23348500
NA	CHEMICAL	GENE-Y	2	5	However , chemical provides greater gene subtype selectivity than does chemical , making it more suitable for studies of effects on gene in CNS preparations .	T3	T19	23348500
NA	CHEMICAL	GENE-Y	2	21	However , chemical provides greater gene subtype selectivity than does chemical , making it more suitable for studies of effects on gene in CNS preparations .	T3	T20	23348500
NA	CHEMICAL	GENE-Y	10	5	However , chemical provides greater gene subtype selectivity than does chemical , making it more suitable for studies of effects on gene in CNS preparations .	T4	T19	23348500
NA	CHEMICAL	GENE-Y	10	21	However , chemical provides greater gene subtype selectivity than does chemical , making it more suitable for studies of effects on gene in CNS preparations .	T4	T20	23348500
NA	CHEMICAL	GENE-Y	2	6	Potentiation of chemical action by an gene-selective chemical analog in INS-1 cells : comparison of chemical and chemical and a potential role for gene activation of a 2-APB-sensitive Ca2+ influx .	T37	T56	23071106
NA	CHEMICAL	GENE-Y	2	23	Potentiation of chemical action by an gene-selective chemical analog in INS-1 cells : comparison of chemical and chemical and a potential role for gene activation of a 2-APB-sensitive Ca2+ influx .	T37	T55	23071106
NA	CHEMICAL	GENE-Y	7	6	Potentiation of chemical action by an gene-selective chemical analog in INS-1 cells : comparison of chemical and chemical and a potential role for gene activation of a 2-APB-sensitive Ca2+ influx .	T38	T56	23071106
NA	CHEMICAL	GENE-Y	7	23	Potentiation of chemical action by an gene-selective chemical analog in INS-1 cells : comparison of chemical and chemical and a potential role for gene activation of a 2-APB-sensitive Ca2+ influx .	T38	T55	23071106
NA	CHEMICAL	GENE-Y	15	6	Potentiation of chemical action by an gene-selective chemical analog in INS-1 cells : comparison of chemical and chemical and a potential role for gene activation of a 2-APB-sensitive Ca2+ influx .	T39	T56	23071106
NA	CHEMICAL	GENE-Y	15	23	Potentiation of chemical action by an gene-selective chemical analog in INS-1 cells : comparison of chemical and chemical and a potential role for gene activation of a 2-APB-sensitive Ca2+ influx .	T39	T55	23071106
NA	CHEMICAL	GENE-Y	17	6	Potentiation of chemical action by an gene-selective chemical analog in INS-1 cells : comparison of chemical and chemical and a potential role for gene activation of a 2-APB-sensitive Ca2+ influx .	T36	T56	23071106
NA	CHEMICAL	GENE-Y	17	23	Potentiation of chemical action by an gene-selective chemical analog in INS-1 cells : comparison of chemical and chemical and a potential role for gene activation of a 2-APB-sensitive Ca2+ influx .	T36	T55	23071106
CPR:4	CHEMICAL	GENE-N	0	5	chemical and gliclazide block the gene gene/gene , causing membrane depolarization and stimulating gene secretion in pancreatic beta cells .	T1	T49	23071106
CPR:4	CHEMICAL	GENE-Y	0	6	chemical and gliclazide block the gene gene/gene , causing membrane depolarization and stimulating gene secretion in pancreatic beta cells .	T1	T51	23071106
CPR:4	CHEMICAL	GENE-Y	0	6	chemical and gliclazide block the gene gene/gene , causing membrane depolarization and stimulating gene secretion in pancreatic beta cells .	T1	T52	23071106
CPR:3	CHEMICAL	GENE-Y	0	13	chemical and gliclazide block the gene gene/gene , causing membrane depolarization and stimulating gene secretion in pancreatic beta cells .	T1	T42	23071106
NA	CHEMICAL	GENE-Y	7	6	We examined the ability of the gene-selective chemical analog chemical to potentiate the action of these drugs and the mechanism that might account for it .	T18	T47	23071106
NA	CHEMICAL	GENE-Y	9	6	We examined the ability of the gene-selective chemical analog chemical to potentiate the action of these drugs and the mechanism that might account for it .	T19	T47	23071106
CPR:3	CHEMICAL	GENE-N	7	0	gene secretion stimulated by both 200 μM chemical and 20 μM chemical , concentrations that had equivalent effects on membrane potential , was inhibited by chemical ( 1 μM ) or the gene blocker chemical ( 2 μM ) and was potentiated by chemical at concentrations ≥2 μM in INS-1 cells .	T20	T48	23071106
NA	CHEMICAL	GENE-N	7	32	gene secretion stimulated by both 200 μM chemical and 20 μM chemical , concentrations that had equivalent effects on membrane potential , was inhibited by chemical ( 1 μM ) or the gene blocker chemical ( 2 μM ) and was potentiated by chemical at concentrations ≥2 μM in INS-1 cells .	T20	T50	23071106
CPR:3	CHEMICAL	GENE-N	11	0	gene secretion stimulated by both 200 μM chemical and 20 μM chemical , concentrations that had equivalent effects on membrane potential , was inhibited by chemical ( 1 μM ) or the gene blocker chemical ( 2 μM ) and was potentiated by chemical at concentrations ≥2 μM in INS-1 cells .	T21	T48	23071106
NA	CHEMICAL	GENE-N	11	32	gene secretion stimulated by both 200 μM chemical and 20 μM chemical , concentrations that had equivalent effects on membrane potential , was inhibited by chemical ( 1 μM ) or the gene blocker chemical ( 2 μM ) and was potentiated by chemical at concentrations ≥2 μM in INS-1 cells .	T21	T50	23071106
CPR:4	CHEMICAL	GENE-N	25	0	gene secretion stimulated by both 200 μM chemical and 20 μM chemical , concentrations that had equivalent effects on membrane potential , was inhibited by chemical ( 1 μM ) or the gene blocker chemical ( 2 μM ) and was potentiated by chemical at concentrations ≥2 μM in INS-1 cells .	T22	T48	23071106
NA	CHEMICAL	GENE-N	25	32	gene secretion stimulated by both 200 μM chemical and 20 μM chemical , concentrations that had equivalent effects on membrane potential , was inhibited by chemical ( 1 μM ) or the gene blocker chemical ( 2 μM ) and was potentiated by chemical at concentrations ≥2 μM in INS-1 cells .	T22	T50	23071106
NA	CHEMICAL	GENE-N	26	0	gene secretion stimulated by both 200 μM chemical and 20 μM chemical , concentrations that had equivalent effects on membrane potential , was inhibited by chemical ( 1 μM ) or the gene blocker chemical ( 2 μM ) and was potentiated by chemical at concentrations ≥2 μM in INS-1 cells .	T23	T48	23071106
NA	CHEMICAL	GENE-N	26	32	gene secretion stimulated by both 200 μM chemical and 20 μM chemical , concentrations that had equivalent effects on membrane potential , was inhibited by chemical ( 1 μM ) or the gene blocker chemical ( 2 μM ) and was potentiated by chemical at concentrations ≥2 μM in INS-1 cells .	T23	T50	23071106
CPR:4	CHEMICAL	GENE-N	34	0	gene secretion stimulated by both 200 μM chemical and 20 μM chemical , concentrations that had equivalent effects on membrane potential , was inhibited by chemical ( 1 μM ) or the gene blocker chemical ( 2 μM ) and was potentiated by chemical at concentrations ≥2 μM in INS-1 cells .	T24	T48	23071106
CPR:4	CHEMICAL	GENE-N	34	32	gene secretion stimulated by both 200 μM chemical and 20 μM chemical , concentrations that had equivalent effects on membrane potential , was inhibited by chemical ( 1 μM ) or the gene blocker chemical ( 2 μM ) and was potentiated by chemical at concentrations ≥2 μM in INS-1 cells .	T24	T50	23071106
CPR:3	CHEMICAL	GENE-N	36	0	gene secretion stimulated by both 200 μM chemical and 20 μM chemical , concentrations that had equivalent effects on membrane potential , was inhibited by chemical ( 1 μM ) or the gene blocker chemical ( 2 μM ) and was potentiated by chemical at concentrations ≥2 μM in INS-1 cells .	T25	T48	23071106
NA	CHEMICAL	GENE-N	36	32	gene secretion stimulated by both 200 μM chemical and 20 μM chemical , concentrations that had equivalent effects on membrane potential , was inhibited by chemical ( 1 μM ) or the gene blocker chemical ( 2 μM ) and was potentiated by chemical at concentrations ≥2 μM in INS-1 cells .	T25	T50	23071106
CPR:3	CHEMICAL	GENE-N	1	5	Both chemical and chemical stimulated gene activity ; however , only chemical did so independently of its activity at chemical ( chemical ) channels , and this activity was partially inhibited by gene .	T31	T53	23071106
NA	CHEMICAL	GENE-N	1	23	Both chemical and chemical stimulated gene activity ; however , only chemical did so independently of its activity at chemical ( chemical ) channels , and this activity was partially inhibited by gene .	T31	T54	23071106
NA	CHEMICAL	GENE-N	1	32	Both chemical and chemical stimulated gene activity ; however , only chemical did so independently of its activity at chemical ( chemical ) channels , and this activity was partially inhibited by gene .	T31	T40	23071106
CPR:3	CHEMICAL	GENE-N	3	5	Both chemical and chemical stimulated gene activity ; however , only chemical did so independently of its activity at chemical ( chemical ) channels , and this activity was partially inhibited by gene .	T32	T53	23071106
NA	CHEMICAL	GENE-N	3	23	Both chemical and chemical stimulated gene activity ; however , only chemical did so independently of its activity at chemical ( chemical ) channels , and this activity was partially inhibited by gene .	T32	T54	23071106
NA	CHEMICAL	GENE-N	3	32	Both chemical and chemical stimulated gene activity ; however , only chemical did so independently of its activity at chemical ( chemical ) channels , and this activity was partially inhibited by gene .	T32	T40	23071106
NA	CHEMICAL	GENE-N	11	5	Both chemical and chemical stimulated gene activity ; however , only chemical did so independently of its activity at chemical ( chemical ) channels , and this activity was partially inhibited by gene .	T33	T53	23071106
CPR:3	CHEMICAL	GENE-N	11	23	Both chemical and chemical stimulated gene activity ; however , only chemical did so independently of its activity at chemical ( chemical ) channels , and this activity was partially inhibited by gene .	T33	T54	23071106
NA	CHEMICAL	GENE-N	11	32	Both chemical and chemical stimulated gene activity ; however , only chemical did so independently of its activity at chemical ( chemical ) channels , and this activity was partially inhibited by gene .	T33	T40	23071106
NA	CHEMICAL	GENE-N	19	5	Both chemical and chemical stimulated gene activity ; however , only chemical did so independently of its activity at chemical ( chemical ) channels , and this activity was partially inhibited by gene .	T34	T53	23071106
NA	CHEMICAL	GENE-N	19	23	Both chemical and chemical stimulated gene activity ; however , only chemical did so independently of its activity at chemical ( chemical ) channels , and this activity was partially inhibited by gene .	T34	T54	23071106
NA	CHEMICAL	GENE-N	19	32	Both chemical and chemical stimulated gene activity ; however , only chemical did so independently of its activity at chemical ( chemical ) channels , and this activity was partially inhibited by gene .	T34	T40	23071106
NA	CHEMICAL	GENE-N	21	5	Both chemical and chemical stimulated gene activity ; however , only chemical did so independently of its activity at chemical ( chemical ) channels , and this activity was partially inhibited by gene .	T35	T53	23071106
NA	CHEMICAL	GENE-N	21	23	Both chemical and chemical stimulated gene activity ; however , only chemical did so independently of its activity at chemical ( chemical ) channels , and this activity was partially inhibited by gene .	T35	T54	23071106
NA	CHEMICAL	GENE-N	21	32	Both chemical and chemical stimulated gene activity ; however , only chemical did so independently of its activity at chemical ( chemical ) channels , and this activity was partially inhibited by gene .	T35	T40	23071106
NA	CHEMICAL	GENE-N	0	9	chemical alone ( 5 μM ) did not stimulate gene secretion , but did increase intracellular chemical concentration significantly , and this activity was inhibited by 25 μM chemical ( chemical ) or the removal of extracellular chemical .	T2	T41	23071106
NA	CHEMICAL	GENE-N	2	9	chemical alone ( 5 μM ) did not stimulate gene secretion , but did increase intracellular chemical concentration significantly , and this activity was inhibited by 25 μM chemical ( chemical ) or the removal of extracellular chemical .	T3	T41	23071106
NA	CHEMICAL	GENE-N	9	9	chemical alone ( 5 μM ) did not stimulate gene secretion , but did increase intracellular chemical concentration significantly , and this activity was inhibited by 25 μM chemical ( chemical ) or the removal of extracellular chemical .	T4	T41	23071106
NA	CHEMICAL	GENE-N	30	9	chemical alone ( 5 μM ) did not stimulate gene secretion , but did increase intracellular chemical concentration significantly , and this activity was inhibited by 25 μM chemical ( chemical ) or the removal of extracellular chemical .	T5	T41	23071106
NA	CHEMICAL	GENE-N	2	9	chemical alone ( 5 μM ) did not stimulate gene secretion , but did increase intracellular chemical concentration significantly , and this activity was inhibited by 25 μM chemical ( chemical ) or the removal of extracellular chemical .	T6	T41	23071106
CPR:3	CHEMICAL	GENE-N	0	3	chemical potentiation of gene secretion stimulated by chemical was markedly inhibited by chemical ( 25 μM ) and enhanced by the gene inhibitor chemical ( 1 μM ) .	T7	T43	23071106
NA	CHEMICAL	GENE-N	0	21	chemical potentiation of gene secretion stimulated by chemical was markedly inhibited by chemical ( 25 μM ) and enhanced by the gene inhibitor chemical ( 1 μM ) .	T7	T44	23071106
CPR:3	CHEMICAL	GENE-N	7	3	chemical potentiation of gene secretion stimulated by chemical was markedly inhibited by chemical ( 25 μM ) and enhanced by the gene inhibitor chemical ( 1 μM ) .	T8	T43	23071106
NA	CHEMICAL	GENE-N	7	21	chemical potentiation of gene secretion stimulated by chemical was markedly inhibited by chemical ( 25 μM ) and enhanced by the gene inhibitor chemical ( 1 μM ) .	T8	T44	23071106
CPR:4	CHEMICAL	GENE-N	12	3	chemical potentiation of gene secretion stimulated by chemical was markedly inhibited by chemical ( 25 μM ) and enhanced by the gene inhibitor chemical ( 1 μM ) .	T9	T43	23071106
NA	CHEMICAL	GENE-N	12	21	chemical potentiation of gene secretion stimulated by chemical was markedly inhibited by chemical ( 25 μM ) and enhanced by the gene inhibitor chemical ( 1 μM ) .	T9	T44	23071106
CPR:3	CHEMICAL	GENE-N	23	3	chemical potentiation of gene secretion stimulated by chemical was markedly inhibited by chemical ( 25 μM ) and enhanced by the gene inhibitor chemical ( 1 μM ) .	T10	T43	23071106
CPR:4	CHEMICAL	GENE-N	23	21	chemical potentiation of gene secretion stimulated by chemical was markedly inhibited by chemical ( 25 μM ) and enhanced by the gene inhibitor chemical ( 1 μM ) .	T10	T44	23071106
CPR:4	CHEMICAL	GENE-N	0	9	chemical analogues as potential inhibitors of the chemical binding site at the chemical transporter .	T19	T35	12213053
CPR:4	CHEMICAL	GENE-Y	0	13	chemical analogues as potential inhibitors of the chemical binding site at the chemical transporter .	T19	T36	12213053
NA	CHEMICAL	GENE-N	7	9	chemical analogues as potential inhibitors of the chemical binding site at the chemical transporter .	T20	T35	12213053
NA	CHEMICAL	GENE-Y	7	13	chemical analogues as potential inhibitors of the chemical binding site at the chemical transporter .	T20	T36	12213053
NA	CHEMICAL	GENE-N	12	9	chemical analogues as potential inhibitors of the chemical binding site at the chemical transporter .	T21	T35	12213053
CPR:9	CHEMICAL	GENE-Y	12	13	chemical analogues as potential inhibitors of the chemical binding site at the chemical transporter .	T21	T36	12213053
NA	CHEMICAL	GENE-N	3	14	A series of chemical ( 2 ) and chemical ( 3 ) analogues with a variety of electron-donating and electron-withdrawing groups in the pendant chemical group and the chemical ring C , as well as H , chemical , and chemical groups replacing the chemical group were synthesized , and their binding affinities at the chemical transporter ( gene ) on rat or guinea pig striatal membranes were determined .	T1	T22	12213053
NA	CHEMICAL	GENE-N	3	0	A series of chemical ( 2 ) and chemical ( 3 ) analogues with a variety of electron-donating and electron-withdrawing groups in the pendant chemical group and the chemical ring C , as well as H , chemical , and chemical groups replacing the chemical group were synthesized , and their binding affinities at the chemical transporter ( gene ) on rat or guinea pig striatal membranes were determined .	T1	T23	12213053
NA	CHEMICAL	GENE-N	8	14	A series of chemical ( 2 ) and chemical ( 3 ) analogues with a variety of electron-donating and electron-withdrawing groups in the pendant chemical group and the chemical ring C , as well as H , chemical , and chemical groups replacing the chemical group were synthesized , and their binding affinities at the chemical transporter ( gene ) on rat or guinea pig striatal membranes were determined .	T7	T22	12213053
NA	CHEMICAL	GENE-N	8	0	A series of chemical ( 2 ) and chemical ( 3 ) analogues with a variety of electron-donating and electron-withdrawing groups in the pendant chemical group and the chemical ring C , as well as H , chemical , and chemical groups replacing the chemical group were synthesized , and their binding affinities at the chemical transporter ( gene ) on rat or guinea pig striatal membranes were determined .	T7	T23	12213053
NA	CHEMICAL	GENE-N	14	14	A series of chemical ( 2 ) and chemical ( 3 ) analogues with a variety of electron-donating and electron-withdrawing groups in the pendant chemical group and the chemical ring C , as well as H , chemical , and chemical groups replacing the chemical group were synthesized , and their binding affinities at the chemical transporter ( gene ) on rat or guinea pig striatal membranes were determined .	T2	T22	12213053
NA	CHEMICAL	GENE-N	14	0	A series of chemical ( 2 ) and chemical ( 3 ) analogues with a variety of electron-donating and electron-withdrawing groups in the pendant chemical group and the chemical ring C , as well as H , chemical , and chemical groups replacing the chemical group were synthesized , and their binding affinities at the chemical transporter ( gene ) on rat or guinea pig striatal membranes were determined .	T2	T23	12213053
NA	CHEMICAL	GENE-N	28	14	A series of chemical ( 2 ) and chemical ( 3 ) analogues with a variety of electron-donating and electron-withdrawing groups in the pendant chemical group and the chemical ring C , as well as H , chemical , and chemical groups replacing the chemical group were synthesized , and their binding affinities at the chemical transporter ( gene ) on rat or guinea pig striatal membranes were determined .	T3	T22	12213053
NA	CHEMICAL	GENE-N	28	0	A series of chemical ( 2 ) and chemical ( 3 ) analogues with a variety of electron-donating and electron-withdrawing groups in the pendant chemical group and the chemical ring C , as well as H , chemical , and chemical groups replacing the chemical group were synthesized , and their binding affinities at the chemical transporter ( gene ) on rat or guinea pig striatal membranes were determined .	T3	T23	12213053
NA	CHEMICAL	GENE-N	37	14	A series of chemical ( 2 ) and chemical ( 3 ) analogues with a variety of electron-donating and electron-withdrawing groups in the pendant chemical group and the chemical ring C , as well as H , chemical , and chemical groups replacing the chemical group were synthesized , and their binding affinities at the chemical transporter ( gene ) on rat or guinea pig striatal membranes were determined .	T4	T22	12213053
NA	CHEMICAL	GENE-N	37	0	A series of chemical ( 2 ) and chemical ( 3 ) analogues with a variety of electron-donating and electron-withdrawing groups in the pendant chemical group and the chemical ring C , as well as H , chemical , and chemical groups replacing the chemical group were synthesized , and their binding affinities at the chemical transporter ( gene ) on rat or guinea pig striatal membranes were determined .	T4	T23	12213053
NA	CHEMICAL	GENE-N	14	14	A series of chemical ( 2 ) and chemical ( 3 ) analogues with a variety of electron-donating and electron-withdrawing groups in the pendant chemical group and the chemical ring C , as well as H , chemical , and chemical groups replacing the chemical group were synthesized , and their binding affinities at the chemical transporter ( gene ) on rat or guinea pig striatal membranes were determined .	T5	T22	12213053
NA	CHEMICAL	GENE-N	14	0	A series of chemical ( 2 ) and chemical ( 3 ) analogues with a variety of electron-donating and electron-withdrawing groups in the pendant chemical group and the chemical ring C , as well as H , chemical , and chemical groups replacing the chemical group were synthesized , and their binding affinities at the chemical transporter ( gene ) on rat or guinea pig striatal membranes were determined .	T5	T23	12213053
NA	CHEMICAL	GENE-N	44	14	A series of chemical ( 2 ) and chemical ( 3 ) analogues with a variety of electron-donating and electron-withdrawing groups in the pendant chemical group and the chemical ring C , as well as H , chemical , and chemical groups replacing the chemical group were synthesized , and their binding affinities at the chemical transporter ( gene ) on rat or guinea pig striatal membranes were determined .	T6	T22	12213053
NA	CHEMICAL	GENE-N	44	0	A series of chemical ( 2 ) and chemical ( 3 ) analogues with a variety of electron-donating and electron-withdrawing groups in the pendant chemical group and the chemical ring C , as well as H , chemical , and chemical groups replacing the chemical group were synthesized , and their binding affinities at the chemical transporter ( gene ) on rat or guinea pig striatal membranes were determined .	T6	T23	12213053
NA	CHEMICAL	GENE-N	14	14	A series of chemical ( 2 ) and chemical ( 3 ) analogues with a variety of electron-donating and electron-withdrawing groups in the pendant chemical group and the chemical ring C , as well as H , chemical , and chemical groups replacing the chemical group were synthesized , and their binding affinities at the chemical transporter ( gene ) on rat or guinea pig striatal membranes were determined .	T8	T22	12213053
NA	CHEMICAL	GENE-N	14	0	A series of chemical ( 2 ) and chemical ( 3 ) analogues with a variety of electron-donating and electron-withdrawing groups in the pendant chemical group and the chemical ring C , as well as H , chemical , and chemical groups replacing the chemical group were synthesized , and their binding affinities at the chemical transporter ( gene ) on rat or guinea pig striatal membranes were determined .	T8	T23	12213053
CPR:9	CHEMICAL	GENE-Y	13	25	Several active analogues were also evaluated for their ability to block uptake of chemical , chemical , and chemical and inhibit binding of chemical at HEK-gene , HEK-gene , and HEK-gene cells .	T9	T24	12213053
NA	CHEMICAL	GENE-Y	13	27	Several active analogues were also evaluated for their ability to block uptake of chemical , chemical , and chemical and inhibit binding of chemical at HEK-gene , HEK-gene , and HEK-gene cells .	T9	T25	12213053
NA	CHEMICAL	GENE-Y	13	30	Several active analogues were also evaluated for their ability to block uptake of chemical , chemical , and chemical and inhibit binding of chemical at HEK-gene , HEK-gene , and HEK-gene cells .	T9	T26	12213053
NA	CHEMICAL	GENE-Y	15	25	Several active analogues were also evaluated for their ability to block uptake of chemical , chemical , and chemical and inhibit binding of chemical at HEK-gene , HEK-gene , and HEK-gene cells .	T10	T24	12213053
CPR:9	CHEMICAL	GENE-Y	15	27	Several active analogues were also evaluated for their ability to block uptake of chemical , chemical , and chemical and inhibit binding of chemical at HEK-gene , HEK-gene , and HEK-gene cells .	T10	T25	12213053
NA	CHEMICAL	GENE-Y	15	30	Several active analogues were also evaluated for their ability to block uptake of chemical , chemical , and chemical and inhibit binding of chemical at HEK-gene , HEK-gene , and HEK-gene cells .	T10	T26	12213053
NA	CHEMICAL	GENE-Y	18	25	Several active analogues were also evaluated for their ability to block uptake of chemical , chemical , and chemical and inhibit binding of chemical at HEK-gene , HEK-gene , and HEK-gene cells .	T11	T24	12213053
NA	CHEMICAL	GENE-Y	18	27	Several active analogues were also evaluated for their ability to block uptake of chemical , chemical , and chemical and inhibit binding of chemical at HEK-gene , HEK-gene , and HEK-gene cells .	T11	T25	12213053
CPR:9	CHEMICAL	GENE-Y	18	30	Several active analogues were also evaluated for their ability to block uptake of chemical , chemical , and chemical and inhibit binding of chemical at HEK-gene , HEK-gene , and HEK-gene cells .	T11	T26	12213053
NA	CHEMICAL	GENE-Y	23	25	Several active analogues were also evaluated for their ability to block uptake of chemical , chemical , and chemical and inhibit binding of chemical at HEK-gene , HEK-gene , and HEK-gene cells .	T12	T24	12213053
NA	CHEMICAL	GENE-Y	23	27	Several active analogues were also evaluated for their ability to block uptake of chemical , chemical , and chemical and inhibit binding of chemical at HEK-gene , HEK-gene , and HEK-gene cells .	T12	T25	12213053
NA	CHEMICAL	GENE-Y	23	30	Several active analogues were also evaluated for their ability to block uptake of chemical , chemical , and chemical and inhibit binding of chemical at HEK-gene , HEK-gene , and HEK-gene cells .	T12	T26	12213053
NA	CHEMICAL	GENE-Y	0	25	chemical ( 26 ) was found to be a pro-drug , oxidizing ( chemical -- > chemical ) to chemical on rat striatal membranes and HEK-gene cells .	T13	T27	12213053
NA	CHEMICAL	GENE-Y	13	25	chemical ( 26 ) was found to be a pro-drug , oxidizing ( chemical -- > chemical ) to chemical on rat striatal membranes and HEK-gene cells .	T14	T27	12213053
NA	CHEMICAL	GENE-Y	16	25	chemical ( 26 ) was found to be a pro-drug , oxidizing ( chemical -- > chemical ) to chemical on rat striatal membranes and HEK-gene cells .	T15	T27	12213053
NA	CHEMICAL	GENE-Y	8	25	chemical ( 26 ) was found to be a pro-drug , oxidizing ( chemical -- > chemical ) to chemical on rat striatal membranes and HEK-gene cells .	T16	T27	12213053
NA	CHEMICAL	GENE-Y	1	16	The chemical analogue ( 38 ) of chemical was the most potent and selective ligand for HEK-gene cells ( gene K ( i ) = 1.1 nM ; gene/gene = 1283 and gene/gene = 38 ) .	T17	T28	12213053
NA	CHEMICAL	GENE-Y	1	19	The chemical analogue ( 38 ) of chemical was the most potent and selective ligand for HEK-gene cells ( gene K ( i ) = 1.1 nM ; gene/gene = 1283 and gene/gene = 38 ) .	T17	T29	12213053
NA	CHEMICAL	GENE-Y	1	28	The chemical analogue ( 38 ) of chemical was the most potent and selective ligand for HEK-gene cells ( gene K ( i ) = 1.1 nM ; gene/gene = 1283 and gene/gene = 38 ) .	T17	T30	12213053
NA	CHEMICAL	GENE-Y	1	28	The chemical analogue ( 38 ) of chemical was the most potent and selective ligand for HEK-gene cells ( gene K ( i ) = 1.1 nM ; gene/gene = 1283 and gene/gene = 38 ) .	T17	T31	12213053
NA	CHEMICAL	GENE-Y	1	32	The chemical analogue ( 38 ) of chemical was the most potent and selective ligand for HEK-gene cells ( gene K ( i ) = 1.1 nM ; gene/gene = 1283 and gene/gene = 38 ) .	T17	T32	12213053
NA	CHEMICAL	GENE-Y	1	32	The chemical analogue ( 38 ) of chemical was the most potent and selective ligand for HEK-gene cells ( gene K ( i ) = 1.1 nM ; gene/gene = 1283 and gene/gene = 38 ) .	T17	T33	12213053
NA	CHEMICAL	GENE-Y	7	16	The chemical analogue ( 38 ) of chemical was the most potent and selective ligand for HEK-gene cells ( gene K ( i ) = 1.1 nM ; gene/gene = 1283 and gene/gene = 38 ) .	T18	T28	12213053
NA	CHEMICAL	GENE-Y	7	19	The chemical analogue ( 38 ) of chemical was the most potent and selective ligand for HEK-gene cells ( gene K ( i ) = 1.1 nM ; gene/gene = 1283 and gene/gene = 38 ) .	T18	T29	12213053
NA	CHEMICAL	GENE-Y	7	28	The chemical analogue ( 38 ) of chemical was the most potent and selective ligand for HEK-gene cells ( gene K ( i ) = 1.1 nM ; gene/gene = 1283 and gene/gene = 38 ) .	T18	T30	12213053
NA	CHEMICAL	GENE-Y	7	28	The chemical analogue ( 38 ) of chemical was the most potent and selective ligand for HEK-gene cells ( gene K ( i ) = 1.1 nM ; gene/gene = 1283 and gene/gene = 38 ) .	T18	T31	12213053
NA	CHEMICAL	GENE-Y	7	32	The chemical analogue ( 38 ) of chemical was the most potent and selective ligand for HEK-gene cells ( gene K ( i ) = 1.1 nM ; gene/gene = 1283 and gene/gene = 38 ) .	T18	T32	12213053
NA	CHEMICAL	GENE-Y	7	32	The chemical analogue ( 38 ) of chemical was the most potent and selective ligand for HEK-gene cells ( gene K ( i ) = 1.1 nM ; gene/gene = 1283 and gene/gene = 38 ) .	T18	T33	12213053
CPR:3	CHEMICAL	GENE-Y	3	15	Withdrawal from free-choice chemical consumption results in increased packing density of chemical synthetase-immunoreactive astrocytes in the prelimbic cortex of chemical-preferring rats .	T18	T32	16484281
NA	CHEMICAL	GENE-Y	6	15	Withdrawal from free-choice chemical consumption results in increased packing density of chemical synthetase-immunoreactive astrocytes in the prelimbic cortex of chemical-preferring rats .	T19	T32	16484281
NA	CHEMICAL	GENE-Y	19	15	Withdrawal from free-choice chemical consumption results in increased packing density of chemical synthetase-immunoreactive astrocytes in the prelimbic cortex of chemical-preferring rats .	T17	T32	16484281
CPR:9	CHEMICAL	GENE-Y	3	3	Astrocytes may play a role in these manifestations because astrocytes are essential in the regulation of released chemical and its conversion to chemical through the enzyme chemical synthetase ( gene ) .	T7	T26	16484281
CPR:9	CHEMICAL	GENE-Y	3	29	Astrocytes may play a role in these manifestations because astrocytes are essential in the regulation of released chemical and its conversion to chemical through the enzyme chemical synthetase ( gene ) .	T7	T27	16484281
CPR:9	CHEMICAL	GENE-Y	3	3	Astrocytes may play a role in these manifestations because astrocytes are essential in the regulation of released chemical and its conversion to chemical through the enzyme chemical synthetase ( gene ) .	T8	T26	16484281
CPR:9	CHEMICAL	GENE-Y	3	29	Astrocytes may play a role in these manifestations because astrocytes are essential in the regulation of released chemical and its conversion to chemical through the enzyme chemical synthetase ( gene ) .	T8	T27	16484281
NA	CHEMICAL	GENE-Y	3	3	Astrocytes may play a role in these manifestations because astrocytes are essential in the regulation of released chemical and its conversion to chemical through the enzyme chemical synthetase ( gene ) .	T9	T26	16484281
NA	CHEMICAL	GENE-Y	3	29	Astrocytes may play a role in these manifestations because astrocytes are essential in the regulation of released chemical and its conversion to chemical through the enzyme chemical synthetase ( gene ) .	T9	T27	16484281
NA	CHEMICAL	GENE-Y	9	19	However , it is unclear if withdrawal from free-choice chemical drinking causes changes in the numbers of astrocytes expressing gene or the cytoskeletal protein of astrocytes gene ( gene ) .	T10	T28	16484281
NA	CHEMICAL	GENE-Y	9	13	However , it is unclear if withdrawal from free-choice chemical drinking causes changes in the numbers of astrocytes expressing gene or the cytoskeletal protein of astrocytes gene ( gene ) .	T10	T29	16484281
NA	CHEMICAL	GENE-Y	9	28	However , it is unclear if withdrawal from free-choice chemical drinking causes changes in the numbers of astrocytes expressing gene or the cytoskeletal protein of astrocytes gene ( gene ) .	T10	T30	16484281
NA	CHEMICAL	GENE-Y	0	8	chemical withdrawal significantly increased the packing density of gene- and gene-IR astrocytes in the PLC of P rats as compared with P rats with continuous access to ethanol .	T2	T21	16484281
NA	CHEMICAL	GENE-Y	0	10	chemical withdrawal significantly increased the packing density of gene- and gene-IR astrocytes in the PLC of P rats as compared with P rats with continuous access to ethanol .	T2	T22	16484281
NA	CHEMICAL	GENE-Y	5	18	In addition , there was a positive correlation between the pre-withdrawal chemical consumption and the packing density of gene-IR astrocytes .	T3	T23	16484281
NA	CHEMICAL	GENE-Y	20	16	Isolated neutrophils and platelets resuspended in heparin-anticoagulated plasma were recirculated with and without blocking antibodies to gene , gene , or gene ( gene ) in chemical tubing using a roller pump .	T1	T5	17651117
NA	CHEMICAL	GENE-Y	20	18	Isolated neutrophils and platelets resuspended in heparin-anticoagulated plasma were recirculated with and without blocking antibodies to gene , gene , or gene ( gene ) in chemical tubing using a roller pump .	T1	T6	17651117
NA	CHEMICAL	GENE-Y	20	21	Isolated neutrophils and platelets resuspended in heparin-anticoagulated plasma were recirculated with and without blocking antibodies to gene , gene , or gene ( gene ) in chemical tubing using a roller pump .	T1	T7	17651117
NA	CHEMICAL	GENE-Y	20	23	Isolated neutrophils and platelets resuspended in heparin-anticoagulated plasma were recirculated with and without blocking antibodies to gene , gene , or gene ( gene ) in chemical tubing using a roller pump .	T1	T8	17651117
NA	CHEMICAL	GENE-Y	11	0	gene is a novel target gene of gene promoting chemoresistance to chemical in human gastric cancer cells .	T12	T33	22370641
NA	CHEMICAL	GENE-Y	11	2	gene is a novel target gene of gene promoting chemoresistance to chemical in human gastric cancer cells .	T12	T34	22370641
NA	CHEMICAL	GENE-Y	18	0	gene knock-down and overexpression experiments demonstrated that gene increased the resistance to apoptotic cell death induced by the chemical chemotherapeutics chemical ( chemical ) and chemical ( chemical ) .	T5	T24	22370641
NA	CHEMICAL	GENE-Y	18	7	gene knock-down and overexpression experiments demonstrated that gene increased the resistance to apoptotic cell death induced by the chemical chemotherapeutics chemical ( chemical ) and chemical ( chemical ) .	T5	T25	22370641
NA	CHEMICAL	GENE-Y	20	0	gene knock-down and overexpression experiments demonstrated that gene increased the resistance to apoptotic cell death induced by the chemical chemotherapeutics chemical ( chemical ) and chemical ( chemical ) .	T6	T24	22370641
NA	CHEMICAL	GENE-Y	20	7	gene knock-down and overexpression experiments demonstrated that gene increased the resistance to apoptotic cell death induced by the chemical chemotherapeutics chemical ( chemical ) and chemical ( chemical ) .	T6	T25	22370641
NA	CHEMICAL	GENE-Y	22	0	gene knock-down and overexpression experiments demonstrated that gene increased the resistance to apoptotic cell death induced by the chemical chemotherapeutics chemical ( chemical ) and chemical ( chemical ) .	T7	T24	22370641
NA	CHEMICAL	GENE-Y	22	7	gene knock-down and overexpression experiments demonstrated that gene increased the resistance to apoptotic cell death induced by the chemical chemotherapeutics chemical ( chemical ) and chemical ( chemical ) .	T7	T25	22370641
NA	CHEMICAL	GENE-Y	25	0	gene knock-down and overexpression experiments demonstrated that gene increased the resistance to apoptotic cell death induced by the chemical chemotherapeutics chemical ( chemical ) and chemical ( chemical ) .	T8	T24	22370641
NA	CHEMICAL	GENE-Y	25	7	gene knock-down and overexpression experiments demonstrated that gene increased the resistance to apoptotic cell death induced by the chemical chemotherapeutics chemical ( chemical ) and chemical ( chemical ) .	T8	T25	22370641
NA	CHEMICAL	GENE-Y	27	0	gene knock-down and overexpression experiments demonstrated that gene increased the resistance to apoptotic cell death induced by the chemical chemotherapeutics chemical ( chemical ) and chemical ( chemical ) .	T9	T24	22370641
NA	CHEMICAL	GENE-Y	27	7	gene knock-down and overexpression experiments demonstrated that gene increased the resistance to apoptotic cell death induced by the chemical chemotherapeutics chemical ( chemical ) and chemical ( chemical ) .	T9	T25	22370641
CPR:3	CHEMICAL	GENE-N	0	6	chemical increased the activity of the gene through gene-dependent binding of gene to the proximal gene .	T10	T26	22370641
NA	CHEMICAL	GENE-Y	0	8	chemical increased the activity of the gene through gene-dependent binding of gene to the proximal gene .	T10	T27	22370641
NA	CHEMICAL	GENE-Y	0	11	chemical increased the activity of the gene through gene-dependent binding of gene to the proximal gene .	T10	T28	22370641
CPR:3	CHEMICAL	GENE-N	0	15	chemical increased the activity of the gene through gene-dependent binding of gene to the proximal gene .	T10	T29	22370641
CPR:3	CHEMICAL	GENE-Y	0	3	chemical increased both gene/gene and gene expression in human GC cells and within the tumor area of a murine model of GC ( CEA424-SV40 TAg ) .	T11	T30	22370641
CPR:3	CHEMICAL	GENE-Y	0	3	chemical increased both gene/gene and gene expression in human GC cells and within the tumor area of a murine model of GC ( CEA424-SV40 TAg ) .	T11	T31	22370641
CPR:3	CHEMICAL	GENE-Y	0	5	chemical increased both gene/gene and gene expression in human GC cells and within the tumor area of a murine model of GC ( CEA424-SV40 TAg ) .	T11	T32	22370641
NA	CHEMICAL	GENE-Y	4	4	In GC patients , gene expression was positively associated with the tumor stage and the nodal status , and inversely correlated with the response to ECF ( chemical , chemical , chemical ) chemotherapy .	T1	T13	22370641
NA	CHEMICAL	GENE-Y	29	4	In GC patients , gene expression was positively associated with the tumor stage and the nodal status , and inversely correlated with the response to ECF ( chemical , chemical , chemical ) chemotherapy .	T2	T13	22370641
NA	CHEMICAL	GENE-Y	31	4	In GC patients , gene expression was positively associated with the tumor stage and the nodal status , and inversely correlated with the response to ECF ( chemical , chemical , chemical ) chemotherapy .	T3	T13	22370641
CPR:3	CHEMICAL	GENE-Y	19	4	These results showed that gene and gene are upregulated by chemotherapeutics and enhance the resistance of GC cells to chemical drugs .	T4	T14	22370641
CPR:3	CHEMICAL	GENE-Y	19	6	These results showed that gene and gene are upregulated by chemotherapeutics and enhance the resistance of GC cells to chemical drugs .	T4	T15	22370641
CPR:5	CHEMICAL	GENE-N	0	10	chemical ( chemical ) : a novel agonist at chemical1-like receptors in the canine basilar artery .	T29	T47	7944828
CPR:5	CHEMICAL	GENE-N	2	10	chemical ( chemical ) : a novel agonist at chemical1-like receptors in the canine basilar artery .	T30	T47	7944828
NA	CHEMICAL	GENE-N	5	10	chemical ( chemical ) : a novel agonist at chemical1-like receptors in the canine basilar artery .	T31	T47	7944828
NA	CHEMICAL	GENE-N	4	22	The contractile effects of chemical in the basilar artery were compared with those produced by chemical ( chemical ) and the chemical receptor agonist chemical .	T13	T46	7944828
NA	CHEMICAL	GENE-N	5	22	The contractile effects of chemical in the basilar artery were compared with those produced by chemical ( chemical ) and the chemical receptor agonist chemical .	T14	T46	7944828
NA	CHEMICAL	GENE-N	17	22	The contractile effects of chemical in the basilar artery were compared with those produced by chemical ( chemical ) and the chemical receptor agonist chemical .	T15	T46	7944828
NA	CHEMICAL	GENE-N	21	22	The contractile effects of chemical in the basilar artery were compared with those produced by chemical ( chemical ) and the chemical receptor agonist chemical .	T16	T46	7944828
NA	CHEMICAL	GENE-N	5	22	The contractile effects of chemical in the basilar artery were compared with those produced by chemical ( chemical ) and the chemical receptor agonist chemical .	T17	T46	7944828
NA	CHEMICAL	GENE-N	3	16	The effects of chemical in the basilar artery were not modified by incubation with either the gene antagonist chemical ( 0.01-1 microM ) , the gene and gene receptor antagonist ICS205930 ( chemical ; 0.1-10 microM ) , the gene receptor antagonist chemical ( 0.01-1 microM ) , the gene blocker with high affinity for gene and gene binding sites chemical ( 0.01-1 microM ) , or the gene antagonist chemical ( 0.01-1 microM ) .	T28	T32	7944828
NA	CHEMICAL	GENE-N	3	25	The effects of chemical in the basilar artery were not modified by incubation with either the gene antagonist chemical ( 0.01-1 microM ) , the gene and gene receptor antagonist ICS205930 ( chemical ; 0.1-10 microM ) , the gene receptor antagonist chemical ( 0.01-1 microM ) , the gene blocker with high affinity for gene and gene binding sites chemical ( 0.01-1 microM ) , or the gene antagonist chemical ( 0.01-1 microM ) .	T28	T33	7944828
NA	CHEMICAL	GENE-Y	3	27	The effects of chemical in the basilar artery were not modified by incubation with either the gene antagonist chemical ( 0.01-1 microM ) , the gene and gene receptor antagonist ICS205930 ( chemical ; 0.1-10 microM ) , the gene receptor antagonist chemical ( 0.01-1 microM ) , the gene blocker with high affinity for gene and gene binding sites chemical ( 0.01-1 microM ) , or the gene antagonist chemical ( 0.01-1 microM ) .	T28	T34	7944828
NA	CHEMICAL	GENE-Y	3	39	The effects of chemical in the basilar artery were not modified by incubation with either the gene antagonist chemical ( 0.01-1 microM ) , the gene and gene receptor antagonist ICS205930 ( chemical ; 0.1-10 microM ) , the gene receptor antagonist chemical ( 0.01-1 microM ) , the gene blocker with high affinity for gene and gene binding sites chemical ( 0.01-1 microM ) , or the gene antagonist chemical ( 0.01-1 microM ) .	T28	T35	7944828
NA	CHEMICAL	GENE-N	3	49	The effects of chemical in the basilar artery were not modified by incubation with either the gene antagonist chemical ( 0.01-1 microM ) , the gene and gene receptor antagonist ICS205930 ( chemical ; 0.1-10 microM ) , the gene receptor antagonist chemical ( 0.01-1 microM ) , the gene blocker with high affinity for gene and gene binding sites chemical ( 0.01-1 microM ) , or the gene antagonist chemical ( 0.01-1 microM ) .	T28	T36	7944828
NA	CHEMICAL	GENE-Y	3	55	The effects of chemical in the basilar artery were not modified by incubation with either the gene antagonist chemical ( 0.01-1 microM ) , the gene and gene receptor antagonist ICS205930 ( chemical ; 0.1-10 microM ) , the gene receptor antagonist chemical ( 0.01-1 microM ) , the gene blocker with high affinity for gene and gene binding sites chemical ( 0.01-1 microM ) , or the gene antagonist chemical ( 0.01-1 microM ) .	T28	T37	7944828
NA	CHEMICAL	GENE-Y	3	57	The effects of chemical in the basilar artery were not modified by incubation with either the gene antagonist chemical ( 0.01-1 microM ) , the gene and gene receptor antagonist ICS205930 ( chemical ; 0.1-10 microM ) , the gene receptor antagonist chemical ( 0.01-1 microM ) , the gene blocker with high affinity for gene and gene binding sites chemical ( 0.01-1 microM ) , or the gene antagonist chemical ( 0.01-1 microM ) .	T28	T38	7944828
NA	CHEMICAL	GENE-N	3	66	The effects of chemical in the basilar artery were not modified by incubation with either the gene antagonist chemical ( 0.01-1 microM ) , the gene and gene receptor antagonist ICS205930 ( chemical ; 0.1-10 microM ) , the gene receptor antagonist chemical ( 0.01-1 microM ) , the gene blocker with high affinity for gene and gene binding sites chemical ( 0.01-1 microM ) , or the gene antagonist chemical ( 0.01-1 microM ) .	T28	T39	7944828
CPR:6	CHEMICAL	GENE-N	3	16	The effects of chemical in the basilar artery were not modified by incubation with either the gene antagonist chemical ( 0.01-1 microM ) , the gene and gene receptor antagonist ICS205930 ( chemical ; 0.1-10 microM ) , the gene receptor antagonist chemical ( 0.01-1 microM ) , the gene blocker with high affinity for gene and gene binding sites chemical ( 0.01-1 microM ) , or the gene antagonist chemical ( 0.01-1 microM ) .	T2	T32	7944828
NA	CHEMICAL	GENE-N	3	25	The effects of chemical in the basilar artery were not modified by incubation with either the gene antagonist chemical ( 0.01-1 microM ) , the gene and gene receptor antagonist ICS205930 ( chemical ; 0.1-10 microM ) , the gene receptor antagonist chemical ( 0.01-1 microM ) , the gene blocker with high affinity for gene and gene binding sites chemical ( 0.01-1 microM ) , or the gene antagonist chemical ( 0.01-1 microM ) .	T2	T33	7944828
NA	CHEMICAL	GENE-Y	3	27	The effects of chemical in the basilar artery were not modified by incubation with either the gene antagonist chemical ( 0.01-1 microM ) , the gene and gene receptor antagonist ICS205930 ( chemical ; 0.1-10 microM ) , the gene receptor antagonist chemical ( 0.01-1 microM ) , the gene blocker with high affinity for gene and gene binding sites chemical ( 0.01-1 microM ) , or the gene antagonist chemical ( 0.01-1 microM ) .	T2	T34	7944828
NA	CHEMICAL	GENE-Y	3	39	The effects of chemical in the basilar artery were not modified by incubation with either the gene antagonist chemical ( 0.01-1 microM ) , the gene and gene receptor antagonist ICS205930 ( chemical ; 0.1-10 microM ) , the gene receptor antagonist chemical ( 0.01-1 microM ) , the gene blocker with high affinity for gene and gene binding sites chemical ( 0.01-1 microM ) , or the gene antagonist chemical ( 0.01-1 microM ) .	T2	T35	7944828
NA	CHEMICAL	GENE-N	3	49	The effects of chemical in the basilar artery were not modified by incubation with either the gene antagonist chemical ( 0.01-1 microM ) , the gene and gene receptor antagonist ICS205930 ( chemical ; 0.1-10 microM ) , the gene receptor antagonist chemical ( 0.01-1 microM ) , the gene blocker with high affinity for gene and gene binding sites chemical ( 0.01-1 microM ) , or the gene antagonist chemical ( 0.01-1 microM ) .	T2	T36	7944828
NA	CHEMICAL	GENE-Y	3	55	The effects of chemical in the basilar artery were not modified by incubation with either the gene antagonist chemical ( 0.01-1 microM ) , the gene and gene receptor antagonist ICS205930 ( chemical ; 0.1-10 microM ) , the gene receptor antagonist chemical ( 0.01-1 microM ) , the gene blocker with high affinity for gene and gene binding sites chemical ( 0.01-1 microM ) , or the gene antagonist chemical ( 0.01-1 microM ) .	T2	T37	7944828
NA	CHEMICAL	GENE-Y	3	57	The effects of chemical in the basilar artery were not modified by incubation with either the gene antagonist chemical ( 0.01-1 microM ) , the gene and gene receptor antagonist ICS205930 ( chemical ; 0.1-10 microM ) , the gene receptor antagonist chemical ( 0.01-1 microM ) , the gene blocker with high affinity for gene and gene binding sites chemical ( 0.01-1 microM ) , or the gene antagonist chemical ( 0.01-1 microM ) .	T2	T38	7944828
NA	CHEMICAL	GENE-N	3	66	The effects of chemical in the basilar artery were not modified by incubation with either the gene antagonist chemical ( 0.01-1 microM ) , the gene and gene receptor antagonist ICS205930 ( chemical ; 0.1-10 microM ) , the gene receptor antagonist chemical ( 0.01-1 microM ) , the gene blocker with high affinity for gene and gene binding sites chemical ( 0.01-1 microM ) , or the gene antagonist chemical ( 0.01-1 microM ) .	T2	T39	7944828
NA	CHEMICAL	GENE-N	16	16	The effects of chemical in the basilar artery were not modified by incubation with either the gene antagonist chemical ( 0.01-1 microM ) , the gene and gene receptor antagonist ICS205930 ( chemical ; 0.1-10 microM ) , the gene receptor antagonist chemical ( 0.01-1 microM ) , the gene blocker with high affinity for gene and gene binding sites chemical ( 0.01-1 microM ) , or the gene antagonist chemical ( 0.01-1 microM ) .	T3	T32	7944828
CPR:6	CHEMICAL	GENE-N	16	25	The effects of chemical in the basilar artery were not modified by incubation with either the gene antagonist chemical ( 0.01-1 microM ) , the gene and gene receptor antagonist ICS205930 ( chemical ; 0.1-10 microM ) , the gene receptor antagonist chemical ( 0.01-1 microM ) , the gene blocker with high affinity for gene and gene binding sites chemical ( 0.01-1 microM ) , or the gene antagonist chemical ( 0.01-1 microM ) .	T3	T33	7944828
CPR:6	CHEMICAL	GENE-Y	16	27	The effects of chemical in the basilar artery were not modified by incubation with either the gene antagonist chemical ( 0.01-1 microM ) , the gene and gene receptor antagonist ICS205930 ( chemical ; 0.1-10 microM ) , the gene receptor antagonist chemical ( 0.01-1 microM ) , the gene blocker with high affinity for gene and gene binding sites chemical ( 0.01-1 microM ) , or the gene antagonist chemical ( 0.01-1 microM ) .	T3	T34	7944828
NA	CHEMICAL	GENE-Y	16	39	The effects of chemical in the basilar artery were not modified by incubation with either the gene antagonist chemical ( 0.01-1 microM ) , the gene and gene receptor antagonist ICS205930 ( chemical ; 0.1-10 microM ) , the gene receptor antagonist chemical ( 0.01-1 microM ) , the gene blocker with high affinity for gene and gene binding sites chemical ( 0.01-1 microM ) , or the gene antagonist chemical ( 0.01-1 microM ) .	T3	T35	7944828
NA	CHEMICAL	GENE-N	16	49	The effects of chemical in the basilar artery were not modified by incubation with either the gene antagonist chemical ( 0.01-1 microM ) , the gene and gene receptor antagonist ICS205930 ( chemical ; 0.1-10 microM ) , the gene receptor antagonist chemical ( 0.01-1 microM ) , the gene blocker with high affinity for gene and gene binding sites chemical ( 0.01-1 microM ) , or the gene antagonist chemical ( 0.01-1 microM ) .	T3	T36	7944828
NA	CHEMICAL	GENE-Y	16	55	The effects of chemical in the basilar artery were not modified by incubation with either the gene antagonist chemical ( 0.01-1 microM ) , the gene and gene receptor antagonist ICS205930 ( chemical ; 0.1-10 microM ) , the gene receptor antagonist chemical ( 0.01-1 microM ) , the gene blocker with high affinity for gene and gene binding sites chemical ( 0.01-1 microM ) , or the gene antagonist chemical ( 0.01-1 microM ) .	T3	T37	7944828
NA	CHEMICAL	GENE-Y	16	57	The effects of chemical in the basilar artery were not modified by incubation with either the gene antagonist chemical ( 0.01-1 microM ) , the gene and gene receptor antagonist ICS205930 ( chemical ; 0.1-10 microM ) , the gene receptor antagonist chemical ( 0.01-1 microM ) , the gene blocker with high affinity for gene and gene binding sites chemical ( 0.01-1 microM ) , or the gene antagonist chemical ( 0.01-1 microM ) .	T3	T38	7944828
NA	CHEMICAL	GENE-N	16	66	The effects of chemical in the basilar artery were not modified by incubation with either the gene antagonist chemical ( 0.01-1 microM ) , the gene and gene receptor antagonist ICS205930 ( chemical ; 0.1-10 microM ) , the gene receptor antagonist chemical ( 0.01-1 microM ) , the gene blocker with high affinity for gene and gene binding sites chemical ( 0.01-1 microM ) , or the gene antagonist chemical ( 0.01-1 microM ) .	T3	T39	7944828
NA	CHEMICAL	GENE-N	4	16	The effects of chemical in the basilar artery were not modified by incubation with either the gene antagonist chemical ( 0.01-1 microM ) , the gene and gene receptor antagonist ICS205930 ( chemical ; 0.1-10 microM ) , the gene receptor antagonist chemical ( 0.01-1 microM ) , the gene blocker with high affinity for gene and gene binding sites chemical ( 0.01-1 microM ) , or the gene antagonist chemical ( 0.01-1 microM ) .	T4	T32	7944828
NA	CHEMICAL	GENE-N	4	25	The effects of chemical in the basilar artery were not modified by incubation with either the gene antagonist chemical ( 0.01-1 microM ) , the gene and gene receptor antagonist ICS205930 ( chemical ; 0.1-10 microM ) , the gene receptor antagonist chemical ( 0.01-1 microM ) , the gene blocker with high affinity for gene and gene binding sites chemical ( 0.01-1 microM ) , or the gene antagonist chemical ( 0.01-1 microM ) .	T4	T33	7944828
NA	CHEMICAL	GENE-Y	4	27	The effects of chemical in the basilar artery were not modified by incubation with either the gene antagonist chemical ( 0.01-1 microM ) , the gene and gene receptor antagonist ICS205930 ( chemical ; 0.1-10 microM ) , the gene receptor antagonist chemical ( 0.01-1 microM ) , the gene blocker with high affinity for gene and gene binding sites chemical ( 0.01-1 microM ) , or the gene antagonist chemical ( 0.01-1 microM ) .	T4	T34	7944828
CPR:6	CHEMICAL	GENE-Y	4	39	The effects of chemical in the basilar artery were not modified by incubation with either the gene antagonist chemical ( 0.01-1 microM ) , the gene and gene receptor antagonist ICS205930 ( chemical ; 0.1-10 microM ) , the gene receptor antagonist chemical ( 0.01-1 microM ) , the gene blocker with high affinity for gene and gene binding sites chemical ( 0.01-1 microM ) , or the gene antagonist chemical ( 0.01-1 microM ) .	T4	T35	7944828
NA	CHEMICAL	GENE-N	4	49	The effects of chemical in the basilar artery were not modified by incubation with either the gene antagonist chemical ( 0.01-1 microM ) , the gene and gene receptor antagonist ICS205930 ( chemical ; 0.1-10 microM ) , the gene receptor antagonist chemical ( 0.01-1 microM ) , the gene blocker with high affinity for gene and gene binding sites chemical ( 0.01-1 microM ) , or the gene antagonist chemical ( 0.01-1 microM ) .	T4	T36	7944828
NA	CHEMICAL	GENE-Y	4	55	The effects of chemical in the basilar artery were not modified by incubation with either the gene antagonist chemical ( 0.01-1 microM ) , the gene and gene receptor antagonist ICS205930 ( chemical ; 0.1-10 microM ) , the gene receptor antagonist chemical ( 0.01-1 microM ) , the gene blocker with high affinity for gene and gene binding sites chemical ( 0.01-1 microM ) , or the gene antagonist chemical ( 0.01-1 microM ) .	T4	T37	7944828
NA	CHEMICAL	GENE-Y	4	57	The effects of chemical in the basilar artery were not modified by incubation with either the gene antagonist chemical ( 0.01-1 microM ) , the gene and gene receptor antagonist ICS205930 ( chemical ; 0.1-10 microM ) , the gene receptor antagonist chemical ( 0.01-1 microM ) , the gene blocker with high affinity for gene and gene binding sites chemical ( 0.01-1 microM ) , or the gene antagonist chemical ( 0.01-1 microM ) .	T4	T38	7944828
NA	CHEMICAL	GENE-N	4	66	The effects of chemical in the basilar artery were not modified by incubation with either the gene antagonist chemical ( 0.01-1 microM ) , the gene and gene receptor antagonist ICS205930 ( chemical ; 0.1-10 microM ) , the gene receptor antagonist chemical ( 0.01-1 microM ) , the gene blocker with high affinity for gene and gene binding sites chemical ( 0.01-1 microM ) , or the gene antagonist chemical ( 0.01-1 microM ) .	T4	T39	7944828
NA	CHEMICAL	GENE-N	4	16	The effects of chemical in the basilar artery were not modified by incubation with either the gene antagonist chemical ( 0.01-1 microM ) , the gene and gene receptor antagonist ICS205930 ( chemical ; 0.1-10 microM ) , the gene receptor antagonist chemical ( 0.01-1 microM ) , the gene blocker with high affinity for gene and gene binding sites chemical ( 0.01-1 microM ) , or the gene antagonist chemical ( 0.01-1 microM ) .	T6	T32	7944828
NA	CHEMICAL	GENE-N	4	25	The effects of chemical in the basilar artery were not modified by incubation with either the gene antagonist chemical ( 0.01-1 microM ) , the gene and gene receptor antagonist ICS205930 ( chemical ; 0.1-10 microM ) , the gene receptor antagonist chemical ( 0.01-1 microM ) , the gene blocker with high affinity for gene and gene binding sites chemical ( 0.01-1 microM ) , or the gene antagonist chemical ( 0.01-1 microM ) .	T6	T33	7944828
NA	CHEMICAL	GENE-Y	4	27	The effects of chemical in the basilar artery were not modified by incubation with either the gene antagonist chemical ( 0.01-1 microM ) , the gene and gene receptor antagonist ICS205930 ( chemical ; 0.1-10 microM ) , the gene receptor antagonist chemical ( 0.01-1 microM ) , the gene blocker with high affinity for gene and gene binding sites chemical ( 0.01-1 microM ) , or the gene antagonist chemical ( 0.01-1 microM ) .	T6	T34	7944828
NA	CHEMICAL	GENE-Y	4	39	The effects of chemical in the basilar artery were not modified by incubation with either the gene antagonist chemical ( 0.01-1 microM ) , the gene and gene receptor antagonist ICS205930 ( chemical ; 0.1-10 microM ) , the gene receptor antagonist chemical ( 0.01-1 microM ) , the gene blocker with high affinity for gene and gene binding sites chemical ( 0.01-1 microM ) , or the gene antagonist chemical ( 0.01-1 microM ) .	T6	T35	7944828
CPR:4	CHEMICAL	GENE-N	4	49	The effects of chemical in the basilar artery were not modified by incubation with either the gene antagonist chemical ( 0.01-1 microM ) , the gene and gene receptor antagonist ICS205930 ( chemical ; 0.1-10 microM ) , the gene receptor antagonist chemical ( 0.01-1 microM ) , the gene blocker with high affinity for gene and gene binding sites chemical ( 0.01-1 microM ) , or the gene antagonist chemical ( 0.01-1 microM ) .	T6	T36	7944828
NA	CHEMICAL	GENE-Y	4	55	The effects of chemical in the basilar artery were not modified by incubation with either the gene antagonist chemical ( 0.01-1 microM ) , the gene and gene receptor antagonist ICS205930 ( chemical ; 0.1-10 microM ) , the gene receptor antagonist chemical ( 0.01-1 microM ) , the gene blocker with high affinity for gene and gene binding sites chemical ( 0.01-1 microM ) , or the gene antagonist chemical ( 0.01-1 microM ) .	T6	T37	7944828
NA	CHEMICAL	GENE-Y	4	57	The effects of chemical in the basilar artery were not modified by incubation with either the gene antagonist chemical ( 0.01-1 microM ) , the gene and gene receptor antagonist ICS205930 ( chemical ; 0.1-10 microM ) , the gene receptor antagonist chemical ( 0.01-1 microM ) , the gene blocker with high affinity for gene and gene binding sites chemical ( 0.01-1 microM ) , or the gene antagonist chemical ( 0.01-1 microM ) .	T6	T38	7944828
NA	CHEMICAL	GENE-N	4	66	The effects of chemical in the basilar artery were not modified by incubation with either the gene antagonist chemical ( 0.01-1 microM ) , the gene and gene receptor antagonist ICS205930 ( chemical ; 0.1-10 microM ) , the gene receptor antagonist chemical ( 0.01-1 microM ) , the gene blocker with high affinity for gene and gene binding sites chemical ( 0.01-1 microM ) , or the gene antagonist chemical ( 0.01-1 microM ) .	T6	T39	7944828
NA	CHEMICAL	GENE-N	4	16	The effects of chemical in the basilar artery were not modified by incubation with either the gene antagonist chemical ( 0.01-1 microM ) , the gene and gene receptor antagonist ICS205930 ( chemical ; 0.1-10 microM ) , the gene receptor antagonist chemical ( 0.01-1 microM ) , the gene blocker with high affinity for gene and gene binding sites chemical ( 0.01-1 microM ) , or the gene antagonist chemical ( 0.01-1 microM ) .	T7	T32	7944828
NA	CHEMICAL	GENE-N	4	25	The effects of chemical in the basilar artery were not modified by incubation with either the gene antagonist chemical ( 0.01-1 microM ) , the gene and gene receptor antagonist ICS205930 ( chemical ; 0.1-10 microM ) , the gene receptor antagonist chemical ( 0.01-1 microM ) , the gene blocker with high affinity for gene and gene binding sites chemical ( 0.01-1 microM ) , or the gene antagonist chemical ( 0.01-1 microM ) .	T7	T33	7944828
NA	CHEMICAL	GENE-Y	4	27	The effects of chemical in the basilar artery were not modified by incubation with either the gene antagonist chemical ( 0.01-1 microM ) , the gene and gene receptor antagonist ICS205930 ( chemical ; 0.1-10 microM ) , the gene receptor antagonist chemical ( 0.01-1 microM ) , the gene blocker with high affinity for gene and gene binding sites chemical ( 0.01-1 microM ) , or the gene antagonist chemical ( 0.01-1 microM ) .	T7	T34	7944828
NA	CHEMICAL	GENE-Y	4	39	The effects of chemical in the basilar artery were not modified by incubation with either the gene antagonist chemical ( 0.01-1 microM ) , the gene and gene receptor antagonist ICS205930 ( chemical ; 0.1-10 microM ) , the gene receptor antagonist chemical ( 0.01-1 microM ) , the gene blocker with high affinity for gene and gene binding sites chemical ( 0.01-1 microM ) , or the gene antagonist chemical ( 0.01-1 microM ) .	T7	T35	7944828
NA	CHEMICAL	GENE-N	4	49	The effects of chemical in the basilar artery were not modified by incubation with either the gene antagonist chemical ( 0.01-1 microM ) , the gene and gene receptor antagonist ICS205930 ( chemical ; 0.1-10 microM ) , the gene receptor antagonist chemical ( 0.01-1 microM ) , the gene blocker with high affinity for gene and gene binding sites chemical ( 0.01-1 microM ) , or the gene antagonist chemical ( 0.01-1 microM ) .	T7	T36	7944828
NA	CHEMICAL	GENE-Y	4	55	The effects of chemical in the basilar artery were not modified by incubation with either the gene antagonist chemical ( 0.01-1 microM ) , the gene and gene receptor antagonist ICS205930 ( chemical ; 0.1-10 microM ) , the gene receptor antagonist chemical ( 0.01-1 microM ) , the gene blocker with high affinity for gene and gene binding sites chemical ( 0.01-1 microM ) , or the gene antagonist chemical ( 0.01-1 microM ) .	T7	T37	7944828
NA	CHEMICAL	GENE-Y	4	57	The effects of chemical in the basilar artery were not modified by incubation with either the gene antagonist chemical ( 0.01-1 microM ) , the gene and gene receptor antagonist ICS205930 ( chemical ; 0.1-10 microM ) , the gene receptor antagonist chemical ( 0.01-1 microM ) , the gene blocker with high affinity for gene and gene binding sites chemical ( 0.01-1 microM ) , or the gene antagonist chemical ( 0.01-1 microM ) .	T7	T38	7944828
CPR:6	CHEMICAL	GENE-N	4	66	The effects of chemical in the basilar artery were not modified by incubation with either the gene antagonist chemical ( 0.01-1 microM ) , the gene and gene receptor antagonist ICS205930 ( chemical ; 0.1-10 microM ) , the gene receptor antagonist chemical ( 0.01-1 microM ) , the gene blocker with high affinity for gene and gene binding sites chemical ( 0.01-1 microM ) , or the gene antagonist chemical ( 0.01-1 microM ) .	T7	T39	7944828
CPR:5	CHEMICAL	GENE-N	4	14	In contrast , the chemical-induced responses were potently and concentration-dependently antagonized by the mixed gene and gene antagonist chemical ( 0.01-1 microM ) .	T8	T40	7944828
CPR:5	CHEMICAL	GENE-N	4	16	In contrast , the chemical-induced responses were potently and concentration-dependently antagonized by the mixed gene and gene antagonist chemical ( 0.01-1 microM ) .	T8	T41	7944828
CPR:6	CHEMICAL	GENE-N	3	14	In contrast , the chemical-induced responses were potently and concentration-dependently antagonized by the mixed gene and gene antagonist chemical ( 0.01-1 microM ) .	T10	T40	7944828
CPR:6	CHEMICAL	GENE-N	3	16	In contrast , the chemical-induced responses were potently and concentration-dependently antagonized by the mixed gene and gene antagonist chemical ( 0.01-1 microM ) .	T10	T41	7944828
CPR:3	CHEMICAL	GENE-N	4	12	It is concluded that chemical contracts the canine basilar artery by stimulating gene unrelated to either the gene or gene receptor subtypes .	T11	T42	7944828
CPR:3	CHEMICAL	GENE-Y	4	17	It is concluded that chemical contracts the canine basilar artery by stimulating gene unrelated to either the gene or gene receptor subtypes .	T11	T43	7944828
CPR:3	CHEMICAL	GENE-Y	4	19	It is concluded that chemical contracts the canine basilar artery by stimulating gene unrelated to either the gene or gene receptor subtypes .	T11	T44	7944828
CPR:9	CHEMICAL	GENE-Y	3	16	PURPOSE : The chemical ( chemical ) is converted to chemical ( chemical ) by chemical phosphorylase ( gene ) inside target tissues .	T2	T43	15132128
CPR:9	CHEMICAL	GENE-Y	3	18	PURPOSE : The chemical ( chemical ) is converted to chemical ( chemical ) by chemical phosphorylase ( gene ) inside target tissues .	T2	T20	15132128
CPR:9	CHEMICAL	GENE-Y	5	16	PURPOSE : The chemical ( chemical ) is converted to chemical ( chemical ) by chemical phosphorylase ( gene ) inside target tissues .	T8	T43	15132128
CPR:9	CHEMICAL	GENE-Y	5	18	PURPOSE : The chemical ( chemical ) is converted to chemical ( chemical ) by chemical phosphorylase ( gene ) inside target tissues .	T8	T20	15132128
CPR:9	CHEMICAL	GENE-Y	10	16	PURPOSE : The chemical ( chemical ) is converted to chemical ( chemical ) by chemical phosphorylase ( gene ) inside target tissues .	T10	T43	15132128
CPR:9	CHEMICAL	GENE-Y	10	18	PURPOSE : The chemical ( chemical ) is converted to chemical ( chemical ) by chemical phosphorylase ( gene ) inside target tissues .	T10	T20	15132128
CPR:9	CHEMICAL	GENE-Y	12	16	PURPOSE : The chemical ( chemical ) is converted to chemical ( chemical ) by chemical phosphorylase ( gene ) inside target tissues .	T11	T43	15132128
CPR:9	CHEMICAL	GENE-Y	12	18	PURPOSE : The chemical ( chemical ) is converted to chemical ( chemical ) by chemical phosphorylase ( gene ) inside target tissues .	T11	T20	15132128
NA	CHEMICAL	GENE-Y	15	16	PURPOSE : The chemical ( chemical ) is converted to chemical ( chemical ) by chemical phosphorylase ( gene ) inside target tissues .	T12	T43	15132128
NA	CHEMICAL	GENE-Y	15	18	PURPOSE : The chemical ( chemical ) is converted to chemical ( chemical ) by chemical phosphorylase ( gene ) inside target tissues .	T12	T20	15132128
CPR:4	CHEMICAL	GENE-Y	0	8	chemical interferes with DNA synthesis by blocking chemical synthase ( gene ) but is inactivated by chemical dehydrogenase ( gene ) .	T3	T26	15132128
CPR:4	CHEMICAL	GENE-Y	0	10	chemical interferes with DNA synthesis by blocking chemical synthase ( gene ) but is inactivated by chemical dehydrogenase ( gene ) .	T3	T27	15132128
NA	CHEMICAL	GENE-Y	0	17	chemical interferes with DNA synthesis by blocking chemical synthase ( gene ) but is inactivated by chemical dehydrogenase ( gene ) .	T3	T28	15132128
NA	CHEMICAL	GENE-Y	0	19	chemical interferes with DNA synthesis by blocking chemical synthase ( gene ) but is inactivated by chemical dehydrogenase ( gene ) .	T3	T29	15132128
NA	CHEMICAL	GENE-Y	7	8	chemical interferes with DNA synthesis by blocking chemical synthase ( gene ) but is inactivated by chemical dehydrogenase ( gene ) .	T5	T26	15132128
NA	CHEMICAL	GENE-Y	7	10	chemical interferes with DNA synthesis by blocking chemical synthase ( gene ) but is inactivated by chemical dehydrogenase ( gene ) .	T5	T27	15132128
NA	CHEMICAL	GENE-Y	7	17	chemical interferes with DNA synthesis by blocking chemical synthase ( gene ) but is inactivated by chemical dehydrogenase ( gene ) .	T5	T28	15132128
NA	CHEMICAL	GENE-Y	7	19	chemical interferes with DNA synthesis by blocking chemical synthase ( gene ) but is inactivated by chemical dehydrogenase ( gene ) .	T5	T29	15132128
NA	CHEMICAL	GENE-Y	16	8	chemical interferes with DNA synthesis by blocking chemical synthase ( gene ) but is inactivated by chemical dehydrogenase ( gene ) .	T6	T26	15132128
NA	CHEMICAL	GENE-Y	16	10	chemical interferes with DNA synthesis by blocking chemical synthase ( gene ) but is inactivated by chemical dehydrogenase ( gene ) .	T6	T27	15132128
NA	CHEMICAL	GENE-Y	16	17	chemical interferes with DNA synthesis by blocking chemical synthase ( gene ) but is inactivated by chemical dehydrogenase ( gene ) .	T6	T28	15132128
NA	CHEMICAL	GENE-Y	16	19	chemical interferes with DNA synthesis by blocking chemical synthase ( gene ) but is inactivated by chemical dehydrogenase ( gene ) .	T6	T29	15132128
CPR:9	CHEMICAL	GENE-Y	15	5	Favorable enzyme profiles ( high gene and low gene ) generate high intratumor levels of chemical that are effective against many tumors , especially those with low gene .	T7	T30	15132128
CPR:9	CHEMICAL	GENE-Y	15	8	Favorable enzyme profiles ( high gene and low gene ) generate high intratumor levels of chemical that are effective against many tumors , especially those with low gene .	T7	T31	15132128
NA	CHEMICAL	GENE-Y	15	27	Favorable enzyme profiles ( high gene and low gene ) generate high intratumor levels of chemical that are effective against many tumors , especially those with low gene .	T7	T32	15132128
NA	CHEMICAL	GENE-Y	0	20	chemical has not been tested against thyroid cancers , and it is not known to what extent thyroid cancers express gene , gene or gene .	T9	T33	15132128
NA	CHEMICAL	GENE-Y	0	22	chemical has not been tested against thyroid cancers , and it is not known to what extent thyroid cancers express gene , gene or gene .	T9	T34	15132128
NA	CHEMICAL	GENE-Y	0	24	chemical has not been tested against thyroid cancers , and it is not known to what extent thyroid cancers express gene , gene or gene .	T9	T35	15132128
NA	CHEMICAL	GENE-Y	6	6	Only five tumors failed to express gene but four of these expressed gene , suggesting chemical resistance .	T1	T18	15132128
NA	CHEMICAL	GENE-Y	6	12	Only five tumors failed to express gene but four of these expressed gene , suggesting chemical resistance .	T1	T19	15132128
NA	CHEMICAL	GENE-Y	11	14	Importantly , the oral dose of these stimulants , which produce chemical-type subjective effects in humans , correlated with the their potency in releasing chemical , not chemical , and did not decrease plasma gene , an effect mediated by chemical release .	T2	T34	11071707
NA	CHEMICAL	GENE-Y	24	14	Importantly , the oral dose of these stimulants , which produce chemical-type subjective effects in humans , correlated with the their potency in releasing chemical , not chemical , and did not decrease plasma gene , an effect mediated by chemical release .	T3	T34	11071707
NA	CHEMICAL	GENE-Y	27	14	Importantly , the oral dose of these stimulants , which produce chemical-type subjective effects in humans , correlated with the their potency in releasing chemical , not chemical , and did not decrease plasma gene , an effect mediated by chemical release .	T4	T34	11071707
NA	CHEMICAL	GENE-Y	40	14	Importantly , the oral dose of these stimulants , which produce chemical-type subjective effects in humans , correlated with the their potency in releasing chemical , not chemical , and did not decrease plasma gene , an effect mediated by chemical release .	T5	T34	11071707
NA	CHEMICAL	GENE-N	6	11	By examining the relative effects of chemical ( chemical ) , gene ( gene , the avian homologue to gene ) and gene ( gene ) , the present study aimed to define the hormone profile regulating stress-induced increases in AA in the POM .	T4	T16	23253172
NA	CHEMICAL	GENE-N	6	13	By examining the relative effects of chemical ( chemical ) , gene ( gene , the avian homologue to gene ) and gene ( gene ) , the present study aimed to define the hormone profile regulating stress-induced increases in AA in the POM .	T4	T17	23253172
NA	CHEMICAL	GENE-Y	6	19	By examining the relative effects of chemical ( chemical ) , gene ( gene , the avian homologue to gene ) and gene ( gene ) , the present study aimed to define the hormone profile regulating stress-induced increases in AA in the POM .	T4	T18	23253172
NA	CHEMICAL	GENE-Y	6	18	By examining the relative effects of chemical ( chemical ) , gene ( gene , the avian homologue to gene ) and gene ( gene ) , the present study aimed to define the hormone profile regulating stress-induced increases in AA in the POM .	T4	T19	23253172
NA	CHEMICAL	GENE-Y	6	24	By examining the relative effects of chemical ( chemical ) , gene ( gene , the avian homologue to gene ) and gene ( gene ) , the present study aimed to define the hormone profile regulating stress-induced increases in AA in the POM .	T4	T20	23253172
NA	CHEMICAL	GENE-N	8	11	By examining the relative effects of chemical ( chemical ) , gene ( gene , the avian homologue to gene ) and gene ( gene ) , the present study aimed to define the hormone profile regulating stress-induced increases in AA in the POM .	T5	T16	23253172
NA	CHEMICAL	GENE-N	8	13	By examining the relative effects of chemical ( chemical ) , gene ( gene , the avian homologue to gene ) and gene ( gene ) , the present study aimed to define the hormone profile regulating stress-induced increases in AA in the POM .	T5	T17	23253172
NA	CHEMICAL	GENE-Y	8	19	By examining the relative effects of chemical ( chemical ) , gene ( gene , the avian homologue to gene ) and gene ( gene ) , the present study aimed to define the hormone profile regulating stress-induced increases in AA in the POM .	T5	T18	23253172
NA	CHEMICAL	GENE-Y	8	18	By examining the relative effects of chemical ( chemical ) , gene ( gene , the avian homologue to gene ) and gene ( gene ) , the present study aimed to define the hormone profile regulating stress-induced increases in AA in the POM .	T5	T19	23253172
NA	CHEMICAL	GENE-Y	8	24	By examining the relative effects of chemical ( chemical ) , gene ( gene , the avian homologue to gene ) and gene ( gene ) , the present study aimed to define the hormone profile regulating stress-induced increases in AA in the POM .	T5	T20	23253172
NA	CHEMICAL	GENE-N	18	11	By examining the relative effects of chemical ( chemical ) , gene ( gene , the avian homologue to gene ) and gene ( gene ) , the present study aimed to define the hormone profile regulating stress-induced increases in AA in the POM .	T6	T16	23253172
NA	CHEMICAL	GENE-N	18	13	By examining the relative effects of chemical ( chemical ) , gene ( gene , the avian homologue to gene ) and gene ( gene ) , the present study aimed to define the hormone profile regulating stress-induced increases in AA in the POM .	T6	T17	23253172
NA	CHEMICAL	GENE-Y	18	19	By examining the relative effects of chemical ( chemical ) , gene ( gene , the avian homologue to gene ) and gene ( gene ) , the present study aimed to define the hormone profile regulating stress-induced increases in AA in the POM .	T6	T18	23253172
NA	CHEMICAL	GENE-Y	18	18	By examining the relative effects of chemical ( chemical ) , gene ( gene , the avian homologue to gene ) and gene ( gene ) , the present study aimed to define the hormone profile regulating stress-induced increases in AA in the POM .	T6	T19	23253172
NA	CHEMICAL	GENE-Y	18	24	By examining the relative effects of chemical ( chemical ) , gene ( gene , the avian homologue to gene ) and gene ( gene ) , the present study aimed to define the hormone profile regulating stress-induced increases in AA in the POM .	T6	T20	23253172
NA	CHEMICAL	GENE-N	39	11	By examining the relative effects of chemical ( chemical ) , gene ( gene , the avian homologue to gene ) and gene ( gene ) , the present study aimed to define the hormone profile regulating stress-induced increases in AA in the POM .	T8	T16	23253172
NA	CHEMICAL	GENE-N	39	13	By examining the relative effects of chemical ( chemical ) , gene ( gene , the avian homologue to gene ) and gene ( gene ) , the present study aimed to define the hormone profile regulating stress-induced increases in AA in the POM .	T8	T17	23253172
NA	CHEMICAL	GENE-Y	39	19	By examining the relative effects of chemical ( chemical ) , gene ( gene , the avian homologue to gene ) and gene ( gene ) , the present study aimed to define the hormone profile regulating stress-induced increases in AA in the POM .	T8	T18	23253172
NA	CHEMICAL	GENE-Y	39	18	By examining the relative effects of chemical ( chemical ) , gene ( gene , the avian homologue to gene ) and gene ( gene ) , the present study aimed to define the hormone profile regulating stress-induced increases in AA in the POM .	T8	T19	23253172
NA	CHEMICAL	GENE-Y	39	24	By examining the relative effects of chemical ( chemical ) , gene ( gene , the avian homologue to gene ) and gene ( gene ) , the present study aimed to define the hormone profile regulating stress-induced increases in AA in the POM .	T8	T20	23253172
NA	CHEMICAL	GENE-Y	3	7	We found that chemical , chemical and gene all appear to play some role in these changes in the male brain .	T9	T22	23253172
NA	CHEMICAL	GENE-Y	5	7	We found that chemical , chemical and gene all appear to play some role in these changes in the male brain .	T10	T22	23253172
CPR:9	CHEMICAL	GENE-Y	10	8	The influence of sex , ethnicity , and gene genotype on chemical metabolism as an index of hepatic gene activity in humans .	T9	T25	23238783
NA	CHEMICAL	GENE-Y	10	18	The influence of sex , ethnicity , and gene genotype on chemical metabolism as an index of hepatic gene activity in humans .	T9	T24	23238783
NA	CHEMICAL	GENE-Y	22	9	To identify important covariates associated with interindividual variation in gene activity in vivo , we evaluated these effects in healthy volunteers using chemical ( chemical GlaxoSmithKline , Research Triangle Park , NC ) as a gene probe substrate .	T4	T18	23238783
CPR:9	CHEMICAL	GENE-Y	22	35	To identify important covariates associated with interindividual variation in gene activity in vivo , we evaluated these effects in healthy volunteers using chemical ( chemical GlaxoSmithKline , Research Triangle Park , NC ) as a gene probe substrate .	T4	T19	23238783
NA	CHEMICAL	GENE-Y	24	9	To identify important covariates associated with interindividual variation in gene activity in vivo , we evaluated these effects in healthy volunteers using chemical ( chemical GlaxoSmithKline , Research Triangle Park , NC ) as a gene probe substrate .	T5	T18	23238783
CPR:9	CHEMICAL	GENE-Y	24	35	To identify important covariates associated with interindividual variation in gene activity in vivo , we evaluated these effects in healthy volunteers using chemical ( chemical GlaxoSmithKline , Research Triangle Park , NC ) as a gene probe substrate .	T5	T19	23238783
CPR:9	CHEMICAL	GENE-Y	4	4	These results suggest that gene genotype is the most important patient variable for predicting the level of gene activity in women , when measured by the metabolism of chemical .	T1	T14	23238783
CPR:9	CHEMICAL	GENE-Y	4	17	These results suggest that gene genotype is the most important patient variable for predicting the level of gene activity in women , when measured by the metabolism of chemical .	T1	T15	23238783
CPR:9	CHEMICAL	GENE-Y	1	10	The chemical metabolic ratio appears to detect known differences in gene activity associated with genetic polymorphism , across different ethnic groups .	T2	T16	23238783
NA	CHEMICAL	GENE-Y	2	0	gene encodes chemical 5-kinase β type I ( gene ) , an enzyme functionally linked to gene cytoskeleton dynamics that phosphorylates chemical [ chemical ] to generate chemical [ chemical ] .	T5	T20	23552101
NA	CHEMICAL	GENE-Y	2	6	gene encodes chemical 5-kinase β type I ( gene ) , an enzyme functionally linked to gene cytoskeleton dynamics that phosphorylates chemical [ chemical ] to generate chemical [ chemical ] .	T5	T21	23552101
NA	CHEMICAL	GENE-Y	2	4	gene encodes chemical 5-kinase β type I ( gene ) , an enzyme functionally linked to gene cytoskeleton dynamics that phosphorylates chemical [ chemical ] to generate chemical [ chemical ] .	T5	T22	23552101
NA	CHEMICAL	GENE-N	2	16	gene encodes chemical 5-kinase β type I ( gene ) , an enzyme functionally linked to gene cytoskeleton dynamics that phosphorylates chemical [ chemical ] to generate chemical [ chemical ] .	T5	T23	23552101
CPR:9	CHEMICAL	GENE-Y	21	0	gene encodes chemical 5-kinase β type I ( gene ) , an enzyme functionally linked to gene cytoskeleton dynamics that phosphorylates chemical [ chemical ] to generate chemical [ chemical ] .	T6	T20	23552101
CPR:9	CHEMICAL	GENE-Y	21	6	gene encodes chemical 5-kinase β type I ( gene ) , an enzyme functionally linked to gene cytoskeleton dynamics that phosphorylates chemical [ chemical ] to generate chemical [ chemical ] .	T6	T21	23552101
CPR:9	CHEMICAL	GENE-Y	21	4	gene encodes chemical 5-kinase β type I ( gene ) , an enzyme functionally linked to gene cytoskeleton dynamics that phosphorylates chemical [ chemical ] to generate chemical [ chemical ] .	T6	T22	23552101
NA	CHEMICAL	GENE-N	21	16	gene encodes chemical 5-kinase β type I ( gene ) , an enzyme functionally linked to gene cytoskeleton dynamics that phosphorylates chemical [ chemical ] to generate chemical [ chemical ] .	T6	T23	23552101
CPR:9	CHEMICAL	GENE-Y	6	0	gene encodes chemical 5-kinase β type I ( gene ) , an enzyme functionally linked to gene cytoskeleton dynamics that phosphorylates chemical [ chemical ] to generate chemical [ chemical ] .	T7	T20	23552101
CPR:9	CHEMICAL	GENE-Y	6	6	gene encodes chemical 5-kinase β type I ( gene ) , an enzyme functionally linked to gene cytoskeleton dynamics that phosphorylates chemical [ chemical ] to generate chemical [ chemical ] .	T7	T21	23552101
CPR:9	CHEMICAL	GENE-Y	6	4	gene encodes chemical 5-kinase β type I ( gene ) , an enzyme functionally linked to gene cytoskeleton dynamics that phosphorylates chemical [ chemical ] to generate chemical [ chemical ] .	T7	T22	23552101
NA	CHEMICAL	GENE-N	6	16	gene encodes chemical 5-kinase β type I ( gene ) , an enzyme functionally linked to gene cytoskeleton dynamics that phosphorylates chemical [ chemical ] to generate chemical [ chemical ] .	T7	T23	23552101
CPR:9	CHEMICAL	GENE-Y	10	0	gene encodes chemical 5-kinase β type I ( gene ) , an enzyme functionally linked to gene cytoskeleton dynamics that phosphorylates chemical [ chemical ] to generate chemical [ chemical ] .	T1	T20	23552101
CPR:9	CHEMICAL	GENE-Y	10	6	gene encodes chemical 5-kinase β type I ( gene ) , an enzyme functionally linked to gene cytoskeleton dynamics that phosphorylates chemical [ chemical ] to generate chemical [ chemical ] .	T1	T21	23552101
CPR:9	CHEMICAL	GENE-Y	10	4	gene encodes chemical 5-kinase β type I ( gene ) , an enzyme functionally linked to gene cytoskeleton dynamics that phosphorylates chemical [ chemical ] to generate chemical [ chemical ] .	T1	T22	23552101
NA	CHEMICAL	GENE-N	10	16	gene encodes chemical 5-kinase β type I ( gene ) , an enzyme functionally linked to gene cytoskeleton dynamics that phosphorylates chemical [ chemical ] to generate chemical [ chemical ] .	T1	T23	23552101
CPR:9	CHEMICAL	GENE-Y	0	0	gene encodes chemical 5-kinase β type I ( gene ) , an enzyme functionally linked to gene cytoskeleton dynamics that phosphorylates chemical [ chemical ] to generate chemical [ chemical ] .	T2	T20	23552101
CPR:9	CHEMICAL	GENE-Y	0	6	gene encodes chemical 5-kinase β type I ( gene ) , an enzyme functionally linked to gene cytoskeleton dynamics that phosphorylates chemical [ chemical ] to generate chemical [ chemical ] .	T2	T21	23552101
CPR:9	CHEMICAL	GENE-Y	0	4	gene encodes chemical 5-kinase β type I ( gene ) , an enzyme functionally linked to gene cytoskeleton dynamics that phosphorylates chemical [ chemical ] to generate chemical [ chemical ] .	T2	T22	23552101
NA	CHEMICAL	GENE-N	0	16	gene encodes chemical 5-kinase β type I ( gene ) , an enzyme functionally linked to gene cytoskeleton dynamics that phosphorylates chemical [ chemical ] to generate chemical [ chemical ] .	T2	T23	23552101
CPR:9	CHEMICAL	GENE-Y	1	4	Accordingly , loss of gene function in FRDA cells was accompanied by decreased chemical levels and was shown instrumental for destabilization of the actin network and delayed cell spreading .	T3	T8	23552101
NA	CHEMICAL	GENE-N	4	23	In mammalian cells , chemical ( chemical ) is synthesized through the action of the endoplasmic reticulum enzymes , chemical synthase 1 and 2 , and the decarboxylation of PtdSer accounts for the majority of chemical ( chemical ) synthesis .	T2	T16	12761285
NA	CHEMICAL	GENE-N	6	23	In mammalian cells , chemical ( chemical ) is synthesized through the action of the endoplasmic reticulum enzymes , chemical synthase 1 and 2 , and the decarboxylation of PtdSer accounts for the majority of chemical ( chemical ) synthesis .	T8	T16	12761285
NA	CHEMICAL	GENE-N	19	23	In mammalian cells , chemical ( chemical ) is synthesized through the action of the endoplasmic reticulum enzymes , chemical synthase 1 and 2 , and the decarboxylation of PtdSer accounts for the majority of chemical ( chemical ) synthesis .	T1	T16	12761285
NA	CHEMICAL	GENE-N	35	23	In mammalian cells , chemical ( chemical ) is synthesized through the action of the endoplasmic reticulum enzymes , chemical synthase 1 and 2 , and the decarboxylation of PtdSer accounts for the majority of chemical ( chemical ) synthesis .	T3	T16	12761285
NA	CHEMICAL	GENE-N	37	23	In mammalian cells , chemical ( chemical ) is synthesized through the action of the endoplasmic reticulum enzymes , chemical synthase 1 and 2 , and the decarboxylation of PtdSer accounts for the majority of chemical ( chemical ) synthesis .	T4	T16	12761285
NA	CHEMICAL	GENE-N	6	18	We have identified > 50 potential gene substrates of both cytosolic and mitochondrial origin that bear hallmark chemical-terminal gene binding motifs .	T1	T15	23201124
NA	CHEMICAL	GENE-Y	11	13	Effect of water extracts from edible myrtaceae plants on uptake of chemical in gene-treated FL83B mouse hepatocytes .	T8	T13	22532499
NA	CHEMICAL	GENE-N	0	26	chemical uptake test showed that pink wax apple fruit extract ( PWFE ) exhibits the highest chemical uptake activity , at an increment of 21 % in the gene-resistant FL83B mouse hepatocytes as compared with the gene-treated control group .	T3	T10	22532499
NA	CHEMICAL	GENE-Y	0	36	chemical uptake test showed that pink wax apple fruit extract ( PWFE ) exhibits the highest chemical uptake activity , at an increment of 21 % in the gene-resistant FL83B mouse hepatocytes as compared with the gene-treated control group .	T3	T11	22532499
NA	CHEMICAL	GENE-N	16	26	chemical uptake test showed that pink wax apple fruit extract ( PWFE ) exhibits the highest chemical uptake activity , at an increment of 21 % in the gene-resistant FL83B mouse hepatocytes as compared with the gene-treated control group .	T4	T10	22532499
NA	CHEMICAL	GENE-Y	16	36	chemical uptake test showed that pink wax apple fruit extract ( PWFE ) exhibits the highest chemical uptake activity , at an increment of 21 % in the gene-resistant FL83B mouse hepatocytes as compared with the gene-treated control group .	T4	T11	22532499
NA	CHEMICAL	GENE-N	13	16	This compound , at the concentration of 6.25 µg/mL , exhibits the same chemical uptake improvement in gene-resistant cells as PWFE at a 100-µg/mL dose .	T6	T12	22532499
NA	CHEMICAL	GENE-N	0	5	chemical regulates obesity by targeting gene signaling .	T19	T44	23517912
NA	CHEMICAL	GENE-N	8	18	In this study , we have demonstrated that chemical prevents diet-induced obesity through regulation of the signaling of gene ( gene ) , a central mediator of cellular growth , cellular proliferation and lipid biosynthesis .	T9	T28	23517912
NA	CHEMICAL	GENE-N	8	20	In this study , we have demonstrated that chemical prevents diet-induced obesity through regulation of the signaling of gene ( gene ) , a central mediator of cellular growth , cellular proliferation and lipid biosynthesis .	T9	T29	23517912
NA	CHEMICAL	GENE-N	23	18	In this study , we have demonstrated that chemical prevents diet-induced obesity through regulation of the signaling of gene ( gene ) , a central mediator of cellular growth , cellular proliferation and lipid biosynthesis .	T13	T28	23517912
NA	CHEMICAL	GENE-N	23	20	In this study , we have demonstrated that chemical prevents diet-induced obesity through regulation of the signaling of gene ( gene ) , a central mediator of cellular growth , cellular proliferation and lipid biosynthesis .	T13	T29	23517912
NA	CHEMICAL	GENE-N	3	5	To evaluate whether chemical regulates gene signaling , we investigated the phosphorylation and gene activity of the gene ( gene ) and gene in 3T3-L1 preadipocytes .	T14	T30	23517912
NA	CHEMICAL	GENE-N	3	13	To evaluate whether chemical regulates gene signaling , we investigated the phosphorylation and gene activity of the gene ( gene ) and gene in 3T3-L1 preadipocytes .	T14	T31	23517912
NA	CHEMICAL	GENE-Y	3	17	To evaluate whether chemical regulates gene signaling , we investigated the phosphorylation and gene activity of the gene ( gene ) and gene in 3T3-L1 preadipocytes .	T14	T32	23517912
NA	CHEMICAL	GENE-Y	3	19	To evaluate whether chemical regulates gene signaling , we investigated the phosphorylation and gene activity of the gene ( gene ) and gene in 3T3-L1 preadipocytes .	T14	T33	23517912
NA	CHEMICAL	GENE-N	3	22	To evaluate whether chemical regulates gene signaling , we investigated the phosphorylation and gene activity of the gene ( gene ) and gene in 3T3-L1 preadipocytes .	T14	T34	23517912
CPR:4	CHEMICAL	GENE-Y	0	8	chemical treatment of preadipocytes reduced the phosphorylation of gene and gene in a time- and concentration-dependent manner .	T15	T35	23517912
CPR:4	CHEMICAL	GENE-N	0	10	chemical treatment of preadipocytes reduced the phosphorylation of gene and gene in a time- and concentration-dependent manner .	T15	T36	23517912
CPR:4	CHEMICAL	GENE-N	6	9	To further our understanding of how chemical negatively regulates gene signaling , we analyzed the phosphorylation of gene , gene and gene in chemical-treated gene-knockdown cells .	T16	T37	23517912
NA	CHEMICAL	GENE-Y	6	17	To further our understanding of how chemical negatively regulates gene signaling , we analyzed the phosphorylation of gene , gene and gene in chemical-treated gene-knockdown cells .	T16	T38	23517912
NA	CHEMICAL	GENE-Y	6	19	To further our understanding of how chemical negatively regulates gene signaling , we analyzed the phosphorylation of gene , gene and gene in chemical-treated gene-knockdown cells .	T16	T39	23517912
NA	CHEMICAL	GENE-N	6	21	To further our understanding of how chemical negatively regulates gene signaling , we analyzed the phosphorylation of gene , gene and gene in chemical-treated gene-knockdown cells .	T16	T40	23517912
NA	CHEMICAL	GENE-Y	6	24	To further our understanding of how chemical negatively regulates gene signaling , we analyzed the phosphorylation of gene , gene and gene in chemical-treated gene-knockdown cells .	T16	T41	23517912
NA	CHEMICAL	GENE-N	22	9	To further our understanding of how chemical negatively regulates gene signaling , we analyzed the phosphorylation of gene , gene and gene in chemical-treated gene-knockdown cells .	T17	T37	23517912
NA	CHEMICAL	GENE-Y	22	17	To further our understanding of how chemical negatively regulates gene signaling , we analyzed the phosphorylation of gene , gene and gene in chemical-treated gene-knockdown cells .	T17	T38	23517912
NA	CHEMICAL	GENE-Y	22	19	To further our understanding of how chemical negatively regulates gene signaling , we analyzed the phosphorylation of gene , gene and gene in chemical-treated gene-knockdown cells .	T17	T39	23517912
NA	CHEMICAL	GENE-N	22	21	To further our understanding of how chemical negatively regulates gene signaling , we analyzed the phosphorylation of gene , gene and gene in chemical-treated gene-knockdown cells .	T17	T40	23517912
NA	CHEMICAL	GENE-Y	22	24	To further our understanding of how chemical negatively regulates gene signaling , we analyzed the phosphorylation of gene , gene and gene in chemical-treated gene-knockdown cells .	T17	T41	23517912
CPR:4	CHEMICAL	GENE-N	4	7	The results suggested that chemical treatment inhibits gene activity in an gene-dependent manner .	T18	T42	23517912
CPR:4	CHEMICAL	GENE-N	4	11	The results suggested that chemical treatment inhibits gene activity in an gene-dependent manner .	T18	T43	23517912
NA	CHEMICAL	GENE-Y	0	14	chemical treatment inhibited adipocyte differentiation , consistent with the negative effect of chemical on gene .	T2	T21	23517912
CPR:4	CHEMICAL	GENE-Y	12	14	chemical treatment inhibited adipocyte differentiation , consistent with the negative effect of chemical on gene .	T4	T21	23517912
NA	CHEMICAL	GENE-Y	4	10	The inhibitory effect of chemical on adipogenesis is dependent of gene activity , suggesting that chemical inhibits adipogenesis and the accumulation of intracellular chemical during adipocyte differentiation by targeting gene signaling .	T5	T22	23517912
NA	CHEMICAL	GENE-N	4	29	The inhibitory effect of chemical on adipogenesis is dependent of gene activity , suggesting that chemical inhibits adipogenesis and the accumulation of intracellular chemical during adipocyte differentiation by targeting gene signaling .	T5	T23	23517912
NA	CHEMICAL	GENE-Y	7	10	The inhibitory effect of chemical on adipogenesis is dependent of gene activity , suggesting that chemical inhibits adipogenesis and the accumulation of intracellular chemical during adipocyte differentiation by targeting gene signaling .	T6	T22	23517912
NA	CHEMICAL	GENE-N	7	29	The inhibitory effect of chemical on adipogenesis is dependent of gene activity , suggesting that chemical inhibits adipogenesis and the accumulation of intracellular chemical during adipocyte differentiation by targeting gene signaling .	T6	T23	23517912
NA	CHEMICAL	GENE-Y	23	10	The inhibitory effect of chemical on adipogenesis is dependent of gene activity , suggesting that chemical inhibits adipogenesis and the accumulation of intracellular chemical during adipocyte differentiation by targeting gene signaling .	T7	T22	23517912
NA	CHEMICAL	GENE-N	23	29	The inhibitory effect of chemical on adipogenesis is dependent of gene activity , suggesting that chemical inhibits adipogenesis and the accumulation of intracellular chemical during adipocyte differentiation by targeting gene signaling .	T7	T23	23517912
CPR:4	CHEMICAL	GENE-N	4	10	We also observed that chemical efficiently suppressed the phosphorylation of gene , gene and gene in adipose tissue .	T10	T24	23517912
CPR:4	CHEMICAL	GENE-Y	4	12	We also observed that chemical efficiently suppressed the phosphorylation of gene , gene and gene in adipose tissue .	T10	T25	23517912
CPR:4	CHEMICAL	GENE-N	4	14	We also observed that chemical efficiently suppressed the phosphorylation of gene , gene and gene in adipose tissue .	T10	T26	23517912
CPR:4	CHEMICAL	GENE-N	11	8	Collectively , these results suggest that inhibition of gene signaling by chemical prevents adipocyte differentiation of 3T3-L1 preadipocytes and obesity in HFD-fed mice .	T11	T27	23517912
NA	CHEMICAL	GENE-Y	15	16	We found a substantial metabolism of the tested substrates , ranging from 26 % ( chemical-glucuronosyltransferase 1A1 ) , 47 % ( gene ) , to 240 % ( gene ) of primary human hepatocytes .	T7	T12	23238784
NA	CHEMICAL	GENE-Y	15	22	We found a substantial metabolism of the tested substrates , ranging from 26 % ( chemical-glucuronosyltransferase 1A1 ) , 47 % ( gene ) , to 240 % ( gene ) of primary human hepatocytes .	T7	T13	23238784
NA	CHEMICAL	GENE-Y	15	29	We found a substantial metabolism of the tested substrates , ranging from 26 % ( chemical-glucuronosyltransferase 1A1 ) , 47 % ( gene ) , to 240 % ( gene ) of primary human hepatocytes .	T7	T14	23238784
CPR:3	CHEMICAL	GENE-Y	8	1	The gene activity could be induced 2-fold by chemical , whereas gene activity remained equally high .	T8	T15	23238784
CPR:3	CHEMICAL	GENE-Y	8	11	The gene activity could be induced 2-fold by chemical , whereas gene activity remained equally high .	T8	T16	23238784
NA	CHEMICAL	GENE-N	0	2	chemical binds to gene on these cells and is displaceable by unlabelled chemical in concentrations up to 10 ( -7 ) M. However , at greater concentrations of chemical , there is a paradoxical accumulation of chemical which we have attributed to Transport-P .	T19	T24	11156594
NA	CHEMICAL	GENE-N	12	2	chemical binds to gene on these cells and is displaceable by unlabelled chemical in concentrations up to 10 ( -7 ) M. However , at greater concentrations of chemical , there is a paradoxical accumulation of chemical which we have attributed to Transport-P .	T9	T24	11156594
NA	CHEMICAL	GENE-N	13	2	chemical binds to gene on these cells and is displaceable by unlabelled chemical in concentrations up to 10 ( -7 ) M. However , at greater concentrations of chemical , there is a paradoxical accumulation of chemical which we have attributed to Transport-P .	T10	T24	11156594
NA	CHEMICAL	GENE-N	13	2	chemical binds to gene on these cells and is displaceable by unlabelled chemical in concentrations up to 10 ( -7 ) M. However , at greater concentrations of chemical , there is a paradoxical accumulation of chemical which we have attributed to Transport-P .	T11	T24	11156594
NA	CHEMICAL	GENE-N	5	1	Using a mouse peptidergic ( chemical , chemical ) neuronal cell line which possesses Transport-P , we have studied the interaction of gene with Transport-P .	T17	T33	11156594
NA	CHEMICAL	GENE-N	7	1	Using a mouse peptidergic ( chemical , chemical ) neuronal cell line which possesses Transport-P , we have studied the interaction of gene with Transport-P .	T18	T33	11156594
NA	CHEMICAL	GENE-Y	17	13	Polymerase chain reactions and DNA sequencing of the products demonstrated that only the gene is present in chemical cells .	T1	T21	11156594
NA	CHEMICAL	GENE-Y	5	5	In COS cells transfected with gene cDNA and in DDT ( 1 ) MF-2 cells which express native gene , chemical was displaced by unlabelled chemical in a normal equilibrium process , with no chemical paradox in concentrations up to 10 ( -6 ) M. In DDT ( 1 ) MF-2 cells , chemical was displaced likewise by a series of gene adrenergic agonists , none of which increased the binding of chemical .	T2	T23	11156594
NA	CHEMICAL	GENE-Y	5	18	In COS cells transfected with gene cDNA and in DDT ( 1 ) MF-2 cells which express native gene , chemical was displaced by unlabelled chemical in a normal equilibrium process , with no chemical paradox in concentrations up to 10 ( -6 ) M. In DDT ( 1 ) MF-2 cells , chemical was displaced likewise by a series of gene adrenergic agonists , none of which increased the binding of chemical .	T2	T25	11156594
NA	CHEMICAL	GENE-N	5	10	In COS cells transfected with gene cDNA and in DDT ( 1 ) MF-2 cells which express native gene , chemical was displaced by unlabelled chemical in a normal equilibrium process , with no chemical paradox in concentrations up to 10 ( -6 ) M. In DDT ( 1 ) MF-2 cells , chemical was displaced likewise by a series of gene adrenergic agonists , none of which increased the binding of chemical .	T2	T26	11156594
NA	CHEMICAL	GENE-Y	8	5	In COS cells transfected with gene cDNA and in DDT ( 1 ) MF-2 cells which express native gene , chemical was displaced by unlabelled chemical in a normal equilibrium process , with no chemical paradox in concentrations up to 10 ( -6 ) M. In DDT ( 1 ) MF-2 cells , chemical was displaced likewise by a series of gene adrenergic agonists , none of which increased the binding of chemical .	T3	T23	11156594
NA	CHEMICAL	GENE-Y	8	18	In COS cells transfected with gene cDNA and in DDT ( 1 ) MF-2 cells which express native gene , chemical was displaced by unlabelled chemical in a normal equilibrium process , with no chemical paradox in concentrations up to 10 ( -6 ) M. In DDT ( 1 ) MF-2 cells , chemical was displaced likewise by a series of gene adrenergic agonists , none of which increased the binding of chemical .	T3	T25	11156594
NA	CHEMICAL	GENE-N	8	10	In COS cells transfected with gene cDNA and in DDT ( 1 ) MF-2 cells which express native gene , chemical was displaced by unlabelled chemical in a normal equilibrium process , with no chemical paradox in concentrations up to 10 ( -6 ) M. In DDT ( 1 ) MF-2 cells , chemical was displaced likewise by a series of gene adrenergic agonists , none of which increased the binding of chemical .	T3	T26	11156594
NA	CHEMICAL	GENE-Y	8	5	In COS cells transfected with gene cDNA and in DDT ( 1 ) MF-2 cells which express native gene , chemical was displaced by unlabelled chemical in a normal equilibrium process , with no chemical paradox in concentrations up to 10 ( -6 ) M. In DDT ( 1 ) MF-2 cells , chemical was displaced likewise by a series of gene adrenergic agonists , none of which increased the binding of chemical .	T4	T23	11156594
NA	CHEMICAL	GENE-Y	8	18	In COS cells transfected with gene cDNA and in DDT ( 1 ) MF-2 cells which express native gene , chemical was displaced by unlabelled chemical in a normal equilibrium process , with no chemical paradox in concentrations up to 10 ( -6 ) M. In DDT ( 1 ) MF-2 cells , chemical was displaced likewise by a series of gene adrenergic agonists , none of which increased the binding of chemical .	T4	T25	11156594
NA	CHEMICAL	GENE-N	8	10	In COS cells transfected with gene cDNA and in DDT ( 1 ) MF-2 cells which express native gene , chemical was displaced by unlabelled chemical in a normal equilibrium process , with no chemical paradox in concentrations up to 10 ( -6 ) M. In DDT ( 1 ) MF-2 cells , chemical was displaced likewise by a series of gene adrenergic agonists , none of which increased the binding of chemical .	T4	T26	11156594
NA	CHEMICAL	GENE-Y	8	5	In COS cells transfected with gene cDNA and in DDT ( 1 ) MF-2 cells which express native gene , chemical was displaced by unlabelled chemical in a normal equilibrium process , with no chemical paradox in concentrations up to 10 ( -6 ) M. In DDT ( 1 ) MF-2 cells , chemical was displaced likewise by a series of gene adrenergic agonists , none of which increased the binding of chemical .	T5	T23	11156594
NA	CHEMICAL	GENE-Y	8	18	In COS cells transfected with gene cDNA and in DDT ( 1 ) MF-2 cells which express native gene , chemical was displaced by unlabelled chemical in a normal equilibrium process , with no chemical paradox in concentrations up to 10 ( -6 ) M. In DDT ( 1 ) MF-2 cells , chemical was displaced likewise by a series of gene adrenergic agonists , none of which increased the binding of chemical .	T5	T25	11156594
NA	CHEMICAL	GENE-N	8	10	In COS cells transfected with gene cDNA and in DDT ( 1 ) MF-2 cells which express native gene , chemical was displaced by unlabelled chemical in a normal equilibrium process , with no chemical paradox in concentrations up to 10 ( -6 ) M. In DDT ( 1 ) MF-2 cells , chemical was displaced likewise by a series of gene adrenergic agonists , none of which increased the binding of chemical .	T5	T26	11156594
NA	CHEMICAL	GENE-Y	8	5	In COS cells transfected with gene cDNA and in DDT ( 1 ) MF-2 cells which express native gene , chemical was displaced by unlabelled chemical in a normal equilibrium process , with no chemical paradox in concentrations up to 10 ( -6 ) M. In DDT ( 1 ) MF-2 cells , chemical was displaced likewise by a series of gene adrenergic agonists , none of which increased the binding of chemical .	T6	T23	11156594
NA	CHEMICAL	GENE-Y	8	18	In COS cells transfected with gene cDNA and in DDT ( 1 ) MF-2 cells which express native gene , chemical was displaced by unlabelled chemical in a normal equilibrium process , with no chemical paradox in concentrations up to 10 ( -6 ) M. In DDT ( 1 ) MF-2 cells , chemical was displaced likewise by a series of gene adrenergic agonists , none of which increased the binding of chemical .	T6	T25	11156594
NA	CHEMICAL	GENE-N	8	10	In COS cells transfected with gene cDNA and in DDT ( 1 ) MF-2 cells which express native gene , chemical was displaced by unlabelled chemical in a normal equilibrium process , with no chemical paradox in concentrations up to 10 ( -6 ) M. In DDT ( 1 ) MF-2 cells , chemical was displaced likewise by a series of gene adrenergic agonists , none of which increased the binding of chemical .	T6	T26	11156594
NA	CHEMICAL	GENE-N	3	8	Hence , the chemical paradox is not due to some function of gene , such as internalization of ligand-receptor complexes .	T7	T27	11156594
NA	CHEMICAL	GENE-Y	11	8	In neurones which possess Transport-P , transfection with gene cDNA resulted in over-expression of gene , but the chemical paradox was unaltered .	T8	T28	11156594
NA	CHEMICAL	GENE-Y	11	14	In neurones which possess Transport-P , transfection with gene cDNA resulted in over-expression of gene , but the chemical paradox was unaltered .	T8	T29	11156594
NA	CHEMICAL	GENE-N	16	17	In order to investigate the anti-inflammatory mechanism of AGT , we have detected the activities of chemical peroxidase ( gene ) and chemical reductase ( gene ) in the liver and the levels of chemical ( chemical ) and chemical in the edema paw .	T6	T18	17616291
NA	CHEMICAL	GENE-N	16	19	In order to investigate the anti-inflammatory mechanism of AGT , we have detected the activities of chemical peroxidase ( gene ) and chemical reductase ( gene ) in the liver and the levels of chemical ( chemical ) and chemical in the edema paw .	T6	T19	17616291
NA	CHEMICAL	GENE-Y	16	23	In order to investigate the anti-inflammatory mechanism of AGT , we have detected the activities of chemical peroxidase ( gene ) and chemical reductase ( gene ) in the liver and the levels of chemical ( chemical ) and chemical in the edema paw .	T6	T20	17616291
NA	CHEMICAL	GENE-Y	16	25	In order to investigate the anti-inflammatory mechanism of AGT , we have detected the activities of chemical peroxidase ( gene ) and chemical reductase ( gene ) in the liver and the levels of chemical ( chemical ) and chemical in the edema paw .	T6	T21	17616291
NA	CHEMICAL	GENE-N	22	17	In order to investigate the anti-inflammatory mechanism of AGT , we have detected the activities of chemical peroxidase ( gene ) and chemical reductase ( gene ) in the liver and the levels of chemical ( chemical ) and chemical in the edema paw .	T7	T18	17616291
NA	CHEMICAL	GENE-N	22	19	In order to investigate the anti-inflammatory mechanism of AGT , we have detected the activities of chemical peroxidase ( gene ) and chemical reductase ( gene ) in the liver and the levels of chemical ( chemical ) and chemical in the edema paw .	T7	T19	17616291
NA	CHEMICAL	GENE-Y	22	23	In order to investigate the anti-inflammatory mechanism of AGT , we have detected the activities of chemical peroxidase ( gene ) and chemical reductase ( gene ) in the liver and the levels of chemical ( chemical ) and chemical in the edema paw .	T7	T20	17616291
NA	CHEMICAL	GENE-Y	22	25	In order to investigate the anti-inflammatory mechanism of AGT , we have detected the activities of chemical peroxidase ( gene ) and chemical reductase ( gene ) in the liver and the levels of chemical ( chemical ) and chemical in the edema paw .	T7	T21	17616291
NA	CHEMICAL	GENE-N	34	17	In order to investigate the anti-inflammatory mechanism of AGT , we have detected the activities of chemical peroxidase ( gene ) and chemical reductase ( gene ) in the liver and the levels of chemical ( chemical ) and chemical in the edema paw .	T8	T18	17616291
NA	CHEMICAL	GENE-N	34	19	In order to investigate the anti-inflammatory mechanism of AGT , we have detected the activities of chemical peroxidase ( gene ) and chemical reductase ( gene ) in the liver and the levels of chemical ( chemical ) and chemical in the edema paw .	T8	T19	17616291
NA	CHEMICAL	GENE-Y	34	23	In order to investigate the anti-inflammatory mechanism of AGT , we have detected the activities of chemical peroxidase ( gene ) and chemical reductase ( gene ) in the liver and the levels of chemical ( chemical ) and chemical in the edema paw .	T8	T20	17616291
NA	CHEMICAL	GENE-Y	34	25	In order to investigate the anti-inflammatory mechanism of AGT , we have detected the activities of chemical peroxidase ( gene ) and chemical reductase ( gene ) in the liver and the levels of chemical ( chemical ) and chemical in the edema paw .	T8	T21	17616291
NA	CHEMICAL	GENE-N	36	17	In order to investigate the anti-inflammatory mechanism of AGT , we have detected the activities of chemical peroxidase ( gene ) and chemical reductase ( gene ) in the liver and the levels of chemical ( chemical ) and chemical in the edema paw .	T9	T18	17616291
NA	CHEMICAL	GENE-N	36	19	In order to investigate the anti-inflammatory mechanism of AGT , we have detected the activities of chemical peroxidase ( gene ) and chemical reductase ( gene ) in the liver and the levels of chemical ( chemical ) and chemical in the edema paw .	T9	T19	17616291
NA	CHEMICAL	GENE-Y	36	23	In order to investigate the anti-inflammatory mechanism of AGT , we have detected the activities of chemical peroxidase ( gene ) and chemical reductase ( gene ) in the liver and the levels of chemical ( chemical ) and chemical in the edema paw .	T9	T20	17616291
NA	CHEMICAL	GENE-Y	36	25	In order to investigate the anti-inflammatory mechanism of AGT , we have detected the activities of chemical peroxidase ( gene ) and chemical reductase ( gene ) in the liver and the levels of chemical ( chemical ) and chemical in the edema paw .	T9	T21	17616291
NA	CHEMICAL	GENE-N	39	17	In order to investigate the anti-inflammatory mechanism of AGT , we have detected the activities of chemical peroxidase ( gene ) and chemical reductase ( gene ) in the liver and the levels of chemical ( chemical ) and chemical in the edema paw .	T10	T18	17616291
NA	CHEMICAL	GENE-N	39	19	In order to investigate the anti-inflammatory mechanism of AGT , we have detected the activities of chemical peroxidase ( gene ) and chemical reductase ( gene ) in the liver and the levels of chemical ( chemical ) and chemical in the edema paw .	T10	T19	17616291
NA	CHEMICAL	GENE-Y	39	23	In order to investigate the anti-inflammatory mechanism of AGT , we have detected the activities of chemical peroxidase ( gene ) and chemical reductase ( gene ) in the liver and the levels of chemical ( chemical ) and chemical in the edema paw .	T10	T20	17616291
NA	CHEMICAL	GENE-Y	39	25	In order to investigate the anti-inflammatory mechanism of AGT , we have detected the activities of chemical peroxidase ( gene ) and chemical reductase ( gene ) in the liver and the levels of chemical ( chemical ) and chemical in the edema paw .	T10	T21	17616291
NA	CHEMICAL	GENE-N	47	35	In the anti-inflammatory test , AGT ( 0.5 and 1.0 g/kg ) decreased the paw edema at the third , fourth , fifth and sixth hour after lambda-carrageenan administration , and increased the activities of gene , gene and gene in the liver tissue and decreased the chemical level in the edema paw at the third hour after lambda-carrageenan injection .	T13	T22	17616291
NA	CHEMICAL	GENE-N	47	37	In the anti-inflammatory test , AGT ( 0.5 and 1.0 g/kg ) decreased the paw edema at the third , fourth , fifth and sixth hour after lambda-carrageenan administration , and increased the activities of gene , gene and gene in the liver tissue and decreased the chemical level in the edema paw at the third hour after lambda-carrageenan injection .	T13	T23	17616291
NA	CHEMICAL	GENE-Y	47	39	In the anti-inflammatory test , AGT ( 0.5 and 1.0 g/kg ) decreased the paw edema at the third , fourth , fifth and sixth hour after lambda-carrageenan administration , and increased the activities of gene , gene and gene in the liver tissue and decreased the chemical level in the edema paw at the third hour after lambda-carrageenan injection .	T13	T24	17616291
NA	CHEMICAL	GENE-N	0	1	chemical reductase is essential for Helicobacter pylori colonization of the mouse stomach .	T8	T21	11031122
NA	CHEMICAL	GENE-N	0	1	chemical reductase ( gene ) is the key enzyme in chemical respiration induced by anaerobic growth of bacteria .	T1	T9	11031122
NA	CHEMICAL	GENE-N	0	3	chemical reductase ( gene ) is the key enzyme in chemical respiration induced by anaerobic growth of bacteria .	T1	T15	11031122
CPR:9	CHEMICAL	GENE-N	10	1	chemical reductase ( gene ) is the key enzyme in chemical respiration induced by anaerobic growth of bacteria .	T5	T9	11031122
CPR:9	CHEMICAL	GENE-N	10	3	chemical reductase ( gene ) is the key enzyme in chemical respiration induced by anaerobic growth of bacteria .	T5	T15	11031122
NA	CHEMICAL	GENE-Y	20	1	The gene gene coding for gene , and two control genes , gene and gene associated with the export of chemical out of H. pylori , were inactivated by insertion of the chemical acetyltransferase cassette into these individual genes .	T6	T17	11031122
NA	CHEMICAL	GENE-Y	20	5	The gene gene coding for gene , and two control genes , gene and gene associated with the export of chemical out of H. pylori , were inactivated by insertion of the chemical acetyltransferase cassette into these individual genes .	T6	T18	11031122
CPR:9	CHEMICAL	GENE-Y	20	12	The gene gene coding for gene , and two control genes , gene and gene associated with the export of chemical out of H. pylori , were inactivated by insertion of the chemical acetyltransferase cassette into these individual genes .	T6	T19	11031122
CPR:9	CHEMICAL	GENE-Y	20	14	The gene gene coding for gene , and two control genes , gene and gene associated with the export of chemical out of H. pylori , were inactivated by insertion of the chemical acetyltransferase cassette into these individual genes .	T6	T20	11031122
NA	CHEMICAL	GENE-Y	32	1	The gene gene coding for gene , and two control genes , gene and gene associated with the export of chemical out of H. pylori , were inactivated by insertion of the chemical acetyltransferase cassette into these individual genes .	T7	T17	11031122
NA	CHEMICAL	GENE-Y	32	5	The gene gene coding for gene , and two control genes , gene and gene associated with the export of chemical out of H. pylori , were inactivated by insertion of the chemical acetyltransferase cassette into these individual genes .	T7	T18	11031122
NA	CHEMICAL	GENE-Y	32	12	The gene gene coding for gene , and two control genes , gene and gene associated with the export of chemical out of H. pylori , were inactivated by insertion of the chemical acetyltransferase cassette into these individual genes .	T7	T19	11031122
NA	CHEMICAL	GENE-Y	32	14	The gene gene coding for gene , and two control genes , gene and gene associated with the export of chemical out of H. pylori , were inactivated by insertion of the chemical acetyltransferase cassette into these individual genes .	T7	T20	11031122
CPR:3	CHEMICAL	GENE-N	2	11	Consumption of chemical for 8weeks induced severe liver damage with increases in prognostic indicators such as chemical transaminase , gene in serum whereas co-administration of CNF suppressed their increases .	T10	T23	23416143
CPR:3	CHEMICAL	GENE-N	2	11	Consumption of chemical for 8weeks induced severe liver damage with increases in prognostic indicators such as chemical transaminase , gene in serum whereas co-administration of CNF suppressed their increases .	T10	T24	23416143
NA	CHEMICAL	GENE-N	15	11	Consumption of chemical for 8weeks induced severe liver damage with increases in prognostic indicators such as chemical transaminase , gene in serum whereas co-administration of CNF suppressed their increases .	T11	T23	23416143
NA	CHEMICAL	GENE-N	15	11	Consumption of chemical for 8weeks induced severe liver damage with increases in prognostic indicators such as chemical transaminase , gene in serum whereas co-administration of CNF suppressed their increases .	T11	T24	23416143
NA	CHEMICAL	GENE-N	7	4	Co-administration of CNF maintained gene activity , chemical and chemical levels close to those of the normal diet group .	T14	T25	23416143
NA	CHEMICAL	GENE-N	9	4	Co-administration of CNF maintained gene activity , chemical and chemical levels close to those of the normal diet group .	T15	T25	23416143
CPR:3	CHEMICAL	GENE-N	3	13	Chronic consumption of chemical also stimulated abrupt increases in pro-inflammatory gene such as gene , gene and gene in liver otherwise co-administration of CNF effectively suppressed production of these cytokines dose-dependently .	T16	T18	23416143
CPR:3	CHEMICAL	GENE-Y	3	15	Chronic consumption of chemical also stimulated abrupt increases in pro-inflammatory gene such as gene , gene and gene in liver otherwise co-administration of CNF effectively suppressed production of these cytokines dose-dependently .	T16	T19	23416143
CPR:3	CHEMICAL	GENE-Y	3	17	Chronic consumption of chemical also stimulated abrupt increases in pro-inflammatory gene such as gene , gene and gene in liver otherwise co-administration of CNF effectively suppressed production of these cytokines dose-dependently .	T16	T20	23416143
NA	CHEMICAL	GENE-N	3	8	Chronic consumption of chemical also stimulated abrupt increases in pro-inflammatory gene such as gene , gene and gene in liver otherwise co-administration of CNF effectively suppressed production of these cytokines dose-dependently .	T16	T21	23416143
CPR:3	CHEMICAL	GENE-Y	13	27	At PND35 , the medial prefrontal cortex ( mPFC ) of rats given chemical showed 55 % greater immunoreactivity ( -ir ) for the chemical marker chemical hydroxylase ( gene ) , 60 % more Nissl-stained cells , and 40 % less chemical transporter ( gene ) -ir density .	T12	T22	17611273
CPR:3	CHEMICAL	GENE-Y	13	29	At PND35 , the medial prefrontal cortex ( mPFC ) of rats given chemical showed 55 % greater immunoreactivity ( -ir ) for the chemical marker chemical hydroxylase ( gene ) , 60 % more Nissl-stained cells , and 40 % less chemical transporter ( gene ) -ir density .	T12	T23	17611273
CPR:4	CHEMICAL	GENE-Y	13	43	At PND35 , the medial prefrontal cortex ( mPFC ) of rats given chemical showed 55 % greater immunoreactivity ( -ir ) for the chemical marker chemical hydroxylase ( gene ) , 60 % more Nissl-stained cells , and 40 % less chemical transporter ( gene ) -ir density .	T12	T24	17611273
CPR:4	CHEMICAL	GENE-Y	13	45	At PND35 , the medial prefrontal cortex ( mPFC ) of rats given chemical showed 55 % greater immunoreactivity ( -ir ) for the chemical marker chemical hydroxylase ( gene ) , 60 % more Nissl-stained cells , and 40 % less chemical transporter ( gene ) -ir density .	T12	T25	17611273
NA	CHEMICAL	GENE-Y	24	27	At PND35 , the medial prefrontal cortex ( mPFC ) of rats given chemical showed 55 % greater immunoreactivity ( -ir ) for the chemical marker chemical hydroxylase ( gene ) , 60 % more Nissl-stained cells , and 40 % less chemical transporter ( gene ) -ir density .	T13	T22	17611273
NA	CHEMICAL	GENE-Y	24	29	At PND35 , the medial prefrontal cortex ( mPFC ) of rats given chemical showed 55 % greater immunoreactivity ( -ir ) for the chemical marker chemical hydroxylase ( gene ) , 60 % more Nissl-stained cells , and 40 % less chemical transporter ( gene ) -ir density .	T13	T23	17611273
NA	CHEMICAL	GENE-Y	24	43	At PND35 , the medial prefrontal cortex ( mPFC ) of rats given chemical showed 55 % greater immunoreactivity ( -ir ) for the chemical marker chemical hydroxylase ( gene ) , 60 % more Nissl-stained cells , and 40 % less chemical transporter ( gene ) -ir density .	T13	T24	17611273
NA	CHEMICAL	GENE-Y	24	45	At PND35 , the medial prefrontal cortex ( mPFC ) of rats given chemical showed 55 % greater immunoreactivity ( -ir ) for the chemical marker chemical hydroxylase ( gene ) , 60 % more Nissl-stained cells , and 40 % less chemical transporter ( gene ) -ir density .	T13	T25	17611273
NA	CHEMICAL	GENE-Y	26	27	At PND35 , the medial prefrontal cortex ( mPFC ) of rats given chemical showed 55 % greater immunoreactivity ( -ir ) for the chemical marker chemical hydroxylase ( gene ) , 60 % more Nissl-stained cells , and 40 % less chemical transporter ( gene ) -ir density .	T14	T22	17611273
NA	CHEMICAL	GENE-Y	26	29	At PND35 , the medial prefrontal cortex ( mPFC ) of rats given chemical showed 55 % greater immunoreactivity ( -ir ) for the chemical marker chemical hydroxylase ( gene ) , 60 % more Nissl-stained cells , and 40 % less chemical transporter ( gene ) -ir density .	T14	T23	17611273
NA	CHEMICAL	GENE-Y	26	43	At PND35 , the medial prefrontal cortex ( mPFC ) of rats given chemical showed 55 % greater immunoreactivity ( -ir ) for the chemical marker chemical hydroxylase ( gene ) , 60 % more Nissl-stained cells , and 40 % less chemical transporter ( gene ) -ir density .	T14	T24	17611273
NA	CHEMICAL	GENE-Y	26	45	At PND35 , the medial prefrontal cortex ( mPFC ) of rats given chemical showed 55 % greater immunoreactivity ( -ir ) for the chemical marker chemical hydroxylase ( gene ) , 60 % more Nissl-stained cells , and 40 % less chemical transporter ( gene ) -ir density .	T14	T25	17611273
NA	CHEMICAL	GENE-Y	42	27	At PND35 , the medial prefrontal cortex ( mPFC ) of rats given chemical showed 55 % greater immunoreactivity ( -ir ) for the chemical marker chemical hydroxylase ( gene ) , 60 % more Nissl-stained cells , and 40 % less chemical transporter ( gene ) -ir density .	T15	T22	17611273
NA	CHEMICAL	GENE-Y	42	29	At PND35 , the medial prefrontal cortex ( mPFC ) of rats given chemical showed 55 % greater immunoreactivity ( -ir ) for the chemical marker chemical hydroxylase ( gene ) , 60 % more Nissl-stained cells , and 40 % less chemical transporter ( gene ) -ir density .	T15	T23	17611273
NA	CHEMICAL	GENE-Y	42	43	At PND35 , the medial prefrontal cortex ( mPFC ) of rats given chemical showed 55 % greater immunoreactivity ( -ir ) for the chemical marker chemical hydroxylase ( gene ) , 60 % more Nissl-stained cells , and 40 % less chemical transporter ( gene ) -ir density .	T15	T24	17611273
NA	CHEMICAL	GENE-Y	42	45	At PND35 , the medial prefrontal cortex ( mPFC ) of rats given chemical showed 55 % greater immunoreactivity ( -ir ) for the chemical marker chemical hydroxylase ( gene ) , 60 % more Nissl-stained cells , and 40 % less chemical transporter ( gene ) -ir density .	T15	T25	17611273
CPR:4	CHEMICAL	GENE-Y	5	13	In hippocampal dentate gyrus , chemical-receiving rats showed a 51 % decrease in gene-ir density and a 61 % expanded distribution of the new-cell marker PSA-gene ( polysialylated form of gene ) .	T16	T26	17611273
CPR:3	CHEMICAL	GENE-Y	5	25	In hippocampal dentate gyrus , chemical-receiving rats showed a 51 % decrease in gene-ir density and a 61 % expanded distribution of the new-cell marker PSA-gene ( polysialylated form of gene ) .	T16	T27	17611273
CPR:3	CHEMICAL	GENE-Y	5	30	In hippocampal dentate gyrus , chemical-receiving rats showed a 51 % decrease in gene-ir density and a 61 % expanded distribution of the new-cell marker PSA-gene ( polysialylated form of gene ) .	T16	T18	17611273
CPR:4	CHEMICAL	GENE-Y	4	4	In medial striatum , gene-ir decreased by 21 % , and in hypothalamus gene-ir increased by 10 % in chemical-exposed rats .	T1	T19	17611273
CPR:3	CHEMICAL	GENE-Y	4	13	In medial striatum , gene-ir decreased by 21 % , and in hypothalamus gene-ir increased by 10 % in chemical-exposed rats .	T1	T20	17611273
CPR:4	CHEMICAL	GENE-N	6	4	Although the inhibition of gene by chemical , which leads to its anti-inflammatory/analgesic properties , has been well studied , the mechanisms involved in its chemopreventive effects as well as some of its adverse effects are as yet ill-defined .	T9	T18	21475861
NA	CHEMICAL	GENE-N	11	9	Studies over the past decades suggest that , besides gene , chemical acetylates other cellular proteins .	T10	T19	21475861
NA	CHEMICAL	GENE-Y	7	22	In a recent study using protein-specific anti-acetyl chemical antibodies and immunological methods , we demonstrated the ability of chemical to acetylate the gene .	T15	T17	21475861
CPR:3	CHEMICAL	GENE-Y	1	22	In a recent study using protein-specific anti-acetyl chemical antibodies and immunological methods , we demonstrated the ability of chemical to acetylate the gene .	T2	T17	21475861
NA	CHEMICAL	GENE-Y	3	8	Swim training of chemical-obese mice improves the impaired gene chemical phosphorylation in pancreatic islets .	T15	T31	22983867
NA	CHEMICAL	GENE-Y	9	8	Swim training of chemical-obese mice improves the impaired gene chemical phosphorylation in pancreatic islets .	T16	T31	22983867
NA	CHEMICAL	GENE-Y	11	7	The goal of the present study was to investigate changes on chemical homoeostasis and of the gene ( gene ) and gene ( gene ) signalling in pancreatic islets from chemical-obese mice submitted to or not submitted to swim training .	T8	T30	22983867
NA	CHEMICAL	GENE-Y	11	18	The goal of the present study was to investigate changes on chemical homoeostasis and of the gene ( gene ) and gene ( gene ) signalling in pancreatic islets from chemical-obese mice submitted to or not submitted to swim training .	T8	T17	22983867
NA	CHEMICAL	GENE-Y	11	21	The goal of the present study was to investigate changes on chemical homoeostasis and of the gene ( gene ) and gene ( gene ) signalling in pancreatic islets from chemical-obese mice submitted to or not submitted to swim training .	T8	T20	22983867
NA	CHEMICAL	GENE-Y	11	23	The goal of the present study was to investigate changes on chemical homoeostasis and of the gene ( gene ) and gene ( gene ) signalling in pancreatic islets from chemical-obese mice submitted to or not submitted to swim training .	T8	T21	22983867
NA	CHEMICAL	GENE-Y	21	7	The goal of the present study was to investigate changes on chemical homoeostasis and of the gene ( gene ) and gene ( gene ) signalling in pancreatic islets from chemical-obese mice submitted to or not submitted to swim training .	T2	T30	22983867
NA	CHEMICAL	GENE-Y	21	18	The goal of the present study was to investigate changes on chemical homoeostasis and of the gene ( gene ) and gene ( gene ) signalling in pancreatic islets from chemical-obese mice submitted to or not submitted to swim training .	T2	T17	22983867
NA	CHEMICAL	GENE-Y	21	21	The goal of the present study was to investigate changes on chemical homoeostasis and of the gene ( gene ) and gene ( gene ) signalling in pancreatic islets from chemical-obese mice submitted to or not submitted to swim training .	T2	T20	22983867
NA	CHEMICAL	GENE-Y	21	23	The goal of the present study was to investigate changes on chemical homoeostasis and of the gene ( gene ) and gene ( gene ) signalling in pancreatic islets from chemical-obese mice submitted to or not submitted to swim training .	T2	T21	22983867
NA	CHEMICAL	GENE-Y	4	15	Swim training of 90-day-old chemical mice was used to evaluate whether signalling pathways of the gene and gene in islets are involved with the gene resistance and chemical intolerance observed in this obese animal model .	T3	T22	22983867
NA	CHEMICAL	GENE-Y	4	17	Swim training of 90-day-old chemical mice was used to evaluate whether signalling pathways of the gene and gene in islets are involved with the gene resistance and chemical intolerance observed in this obese animal model .	T3	T23	22983867
NA	CHEMICAL	GENE-N	4	18	Swim training of 90-day-old chemical mice was used to evaluate whether signalling pathways of the gene and gene in islets are involved with the gene resistance and chemical intolerance observed in this obese animal model .	T3	T24	22983867
NA	CHEMICAL	GENE-Y	27	15	Swim training of 90-day-old chemical mice was used to evaluate whether signalling pathways of the gene and gene in islets are involved with the gene resistance and chemical intolerance observed in this obese animal model .	T4	T22	22983867
NA	CHEMICAL	GENE-Y	27	17	Swim training of 90-day-old chemical mice was used to evaluate whether signalling pathways of the gene and gene in islets are involved with the gene resistance and chemical intolerance observed in this obese animal model .	T4	T23	22983867
NA	CHEMICAL	GENE-N	27	18	Swim training of 90-day-old chemical mice was used to evaluate whether signalling pathways of the gene and gene in islets are involved with the gene resistance and chemical intolerance observed in this obese animal model .	T4	T24	22983867
NA	CHEMICAL	GENE-Y	5	4	The results showed that gene chemical phosphorylation ( gene ) was reduced by 42 % in chemical-obese mice ( chemical , 6.7 ± 0.2 arbitrary units ( a.u .	T5	T25	22983867
NA	CHEMICAL	GENE-Y	5	8	The results showed that gene chemical phosphorylation ( gene ) was reduced by 42 % in chemical-obese mice ( chemical , 6.7 ± 0.2 arbitrary units ( a.u .	T5	T26	22983867
NA	CHEMICAL	GENE-Y	16	4	The results showed that gene chemical phosphorylation ( gene ) was reduced by 42 % in chemical-obese mice ( chemical , 6.7 ± 0.2 arbitrary units ( a.u .	T6	T25	22983867
CPR:4	CHEMICAL	GENE-Y	16	8	The results showed that gene chemical phosphorylation ( gene ) was reduced by 42 % in chemical-obese mice ( chemical , 6.7 ± 0.2 arbitrary units ( a.u .	T6	T26	22983867
NA	CHEMICAL	GENE-Y	19	4	The results showed that gene chemical phosphorylation ( gene ) was reduced by 42 % in chemical-obese mice ( chemical , 6.7 ± 0.2 arbitrary units ( a.u .	T7	T25	22983867
CPR:4	CHEMICAL	GENE-Y	19	8	The results showed that gene chemical phosphorylation ( gene ) was reduced by 42 % in chemical-obese mice ( chemical , 6.7 ± 0.2 arbitrary units ( a.u .	T7	T26	22983867
CPR:4	CHEMICAL	GENE-Y	15	10	) ; on the other hand , exercise training increased gene by 76 % in chemical mice without affecting control mice ( chemical , 11.8 ± 0.3 ; control , 12.8 ± 0.2 a.u . ) .	T9	T27	22983867
CPR:4	CHEMICAL	GENE-Y	22	10	) ; on the other hand , exercise training increased gene by 76 % in chemical mice without affecting control mice ( chemical , 11.8 ± 0.3 ; control , 12.8 ± 0.2 a.u . ) .	T10	T27	22983867
NA	CHEMICAL	GENE-Y	4	6	Although the treatment with chemical increased gene chemical phosphorylation ( gene ) by 96 % ( chemical , 17.02 ± 0.6 ; control , 8.7 ± 0.2 a.u .	T11	T28	22983867
CPR:3	CHEMICAL	GENE-Y	4	10	Although the treatment with chemical increased gene chemical phosphorylation ( gene ) by 96 % ( chemical , 17.02 ± 0.6 ; control , 8.7 ± 0.2 a.u .	T11	T29	22983867
NA	CHEMICAL	GENE-Y	7	6	Although the treatment with chemical increased gene chemical phosphorylation ( gene ) by 96 % ( chemical , 17.02 ± 0.6 ; control , 8.7 ± 0.2 a.u .	T12	T28	22983867
NA	CHEMICAL	GENE-Y	7	10	Although the treatment with chemical increased gene chemical phosphorylation ( gene ) by 96 % ( chemical , 17.02 ± 0.6 ; control , 8.7 ± 0.2 a.u .	T12	T29	22983867
NA	CHEMICAL	GENE-Y	16	6	Although the treatment with chemical increased gene chemical phosphorylation ( gene ) by 96 % ( chemical , 17.02 ± 0.6 ; control , 8.7 ± 0.2 a.u .	T13	T28	22983867
CPR:3	CHEMICAL	GENE-Y	16	10	Although the treatment with chemical increased gene chemical phosphorylation ( gene ) by 96 % ( chemical , 17.02 ± 0.6 ; control , 8.7 ± 0.2 a.u .	T13	T29	22983867
NA	CHEMICAL	GENE-Y	3	16	Antipsychotic profile of chemical : efficacy in rats and reduced sensitivity in mice deficient in the gene ( gene ) enzyme .	T14	T24	17333137
NA	CHEMICAL	GENE-Y	3	18	Antipsychotic profile of chemical : efficacy in rats and reduced sensitivity in mice deficient in the gene ( gene ) enzyme .	T14	T25	17333137
NA	CHEMICAL	GENE-Y	26	8	RATIONALE : Recent studies provide evidence for reduced gene ( gene ) as a genetic susceptibility factor as well as suggesting an association of several single chemical polymorphisms ( SNPs ) in gene that are associated with an increased incidence of schizophrenia .	T6	T21	17333137
NA	CHEMICAL	GENE-Y	26	10	RATIONALE : Recent studies provide evidence for reduced gene ( gene ) as a genetic susceptibility factor as well as suggesting an association of several single chemical polymorphisms ( SNPs ) in gene that are associated with an increased incidence of schizophrenia .	T6	T22	17333137
NA	CHEMICAL	GENE-Y	26	32	RATIONALE : Recent studies provide evidence for reduced gene ( gene ) as a genetic susceptibility factor as well as suggesting an association of several single chemical polymorphisms ( SNPs ) in gene that are associated with an increased incidence of schizophrenia .	T6	T18	17333137
CPR:4	CHEMICAL	GENE-N	14	18	OBJECTIVES : The aim of the current study was to assess the activity of chemical , a nonsubtype-selective gene inhibitor , in several animal models predictive of antipsychotic-like efficacy and side-effect liability and to use gene wild-type and knockout mice to begin to understand the subtypes involved in the activity of chemical .	T7	T19	17333137
NA	CHEMICAL	GENE-Y	14	35	OBJECTIVES : The aim of the current study was to assess the activity of chemical , a nonsubtype-selective gene inhibitor , in several animal models predictive of antipsychotic-like efficacy and side-effect liability and to use gene wild-type and knockout mice to begin to understand the subtypes involved in the activity of chemical .	T7	T20	17333137
NA	CHEMICAL	GENE-N	16	18	OBJECTIVES : The aim of the current study was to assess the activity of chemical , a nonsubtype-selective gene inhibitor , in several animal models predictive of antipsychotic-like efficacy and side-effect liability and to use gene wild-type and knockout mice to begin to understand the subtypes involved in the activity of chemical .	T8	T19	17333137
NA	CHEMICAL	GENE-Y	16	35	OBJECTIVES : The aim of the current study was to assess the activity of chemical , a nonsubtype-selective gene inhibitor , in several animal models predictive of antipsychotic-like efficacy and side-effect liability and to use gene wild-type and knockout mice to begin to understand the subtypes involved in the activity of chemical .	T8	T20	17333137
NA	CHEMICAL	GENE-Y	5	1	In gene wild-type mice , chemical dose-dependently suppressed CAR ( ED ( 50 ) = 2.4 mg/kg ) ; however , in knockout mice , their sensitivity to chemical at the higher doses ( 1.0 and 3.2 mg/kg ) was reduced , resulting in a threefold shift in the ED ( 50 ) ( 7.3 mg/kg ) , suggesting gene is involved , at least in part , with the activity of chemical .	T12	T23	17333137
NA	CHEMICAL	GENE-Y	5	59	In gene wild-type mice , chemical dose-dependently suppressed CAR ( ED ( 50 ) = 2.4 mg/kg ) ; however , in knockout mice , their sensitivity to chemical at the higher doses ( 1.0 and 3.2 mg/kg ) was reduced , resulting in a threefold shift in the ED ( 50 ) ( 7.3 mg/kg ) , suggesting gene is involved , at least in part , with the activity of chemical .	T12	T15	17333137
NA	CHEMICAL	GENE-Y	28	1	In gene wild-type mice , chemical dose-dependently suppressed CAR ( ED ( 50 ) = 2.4 mg/kg ) ; however , in knockout mice , their sensitivity to chemical at the higher doses ( 1.0 and 3.2 mg/kg ) was reduced , resulting in a threefold shift in the ED ( 50 ) ( 7.3 mg/kg ) , suggesting gene is involved , at least in part , with the activity of chemical .	T13	T23	17333137
NA	CHEMICAL	GENE-Y	28	59	In gene wild-type mice , chemical dose-dependently suppressed CAR ( ED ( 50 ) = 2.4 mg/kg ) ; however , in knockout mice , their sensitivity to chemical at the higher doses ( 1.0 and 3.2 mg/kg ) was reduced , resulting in a threefold shift in the ED ( 50 ) ( 7.3 mg/kg ) , suggesting gene is involved , at least in part , with the activity of chemical .	T13	T15	17333137
NA	CHEMICAL	GENE-Y	5	1	In gene wild-type mice , chemical dose-dependently suppressed CAR ( ED ( 50 ) = 2.4 mg/kg ) ; however , in knockout mice , their sensitivity to chemical at the higher doses ( 1.0 and 3.2 mg/kg ) was reduced , resulting in a threefold shift in the ED ( 50 ) ( 7.3 mg/kg ) , suggesting gene is involved , at least in part , with the activity of chemical .	T1	T23	17333137
NA	CHEMICAL	GENE-Y	5	59	In gene wild-type mice , chemical dose-dependently suppressed CAR ( ED ( 50 ) = 2.4 mg/kg ) ; however , in knockout mice , their sensitivity to chemical at the higher doses ( 1.0 and 3.2 mg/kg ) was reduced , resulting in a threefold shift in the ED ( 50 ) ( 7.3 mg/kg ) , suggesting gene is involved , at least in part , with the activity of chemical .	T1	T15	17333137
NA	CHEMICAL	GENE-Y	4	23	The effects of several chemical ( chemical ) -elevating agents on the proliferation of cultured rat microglia were investigated by immunocytochemical staining with an antibody against gene ( gene ) .	T1	T14	9509999
NA	CHEMICAL	GENE-Y	4	28	The effects of several chemical ( chemical ) -elevating agents on the proliferation of cultured rat microglia were investigated by immunocytochemical staining with an antibody against gene ( gene ) .	T1	T15	9509999
NA	CHEMICAL	GENE-Y	6	23	The effects of several chemical ( chemical ) -elevating agents on the proliferation of cultured rat microglia were investigated by immunocytochemical staining with an antibody against gene ( gene ) .	T10	T14	9509999
NA	CHEMICAL	GENE-Y	6	28	The effects of several chemical ( chemical ) -elevating agents on the proliferation of cultured rat microglia were investigated by immunocytochemical staining with an antibody against gene ( gene ) .	T10	T15	9509999
NA	CHEMICAL	GENE-N	0	8	chemical-induced autophagy mitigates cell apoptosis through modulation of gene/gene and gene and gene signaling pathways in human lung cancer cell lines .	T12	T24	23552851
NA	CHEMICAL	GENE-N	0	8	chemical-induced autophagy mitigates cell apoptosis through modulation of gene/gene and gene and gene signaling pathways in human lung cancer cell lines .	T12	T25	23552851
NA	CHEMICAL	GENE-N	0	10	chemical-induced autophagy mitigates cell apoptosis through modulation of gene/gene and gene and gene signaling pathways in human lung cancer cell lines .	T12	T26	23552851
NA	CHEMICAL	GENE-N	0	12	chemical-induced autophagy mitigates cell apoptosis through modulation of gene/gene and gene and gene signaling pathways in human lung cancer cell lines .	T12	T27	23552851
NA	CHEMICAL	GENE-Y	2	9	Results from chemical and annexin-V/PI double-staining assay showed that gene- and gene-dependent , and dose-dependent apoptoses were detected after a 24-h chemical treatment .	T6	T19	23552851
NA	CHEMICAL	GENE-Y	2	11	Results from chemical and annexin-V/PI double-staining assay showed that gene- and gene-dependent , and dose-dependent apoptoses were detected after a 24-h chemical treatment .	T6	T20	23552851
NA	CHEMICAL	GENE-Y	21	9	Results from chemical and annexin-V/PI double-staining assay showed that gene- and gene-dependent , and dose-dependent apoptoses were detected after a 24-h chemical treatment .	T7	T19	23552851
NA	CHEMICAL	GENE-Y	21	11	Results from chemical and annexin-V/PI double-staining assay showed that gene- and gene-dependent , and dose-dependent apoptoses were detected after a 24-h chemical treatment .	T7	T20	23552851
CPR:3	CHEMICAL	GENE-Y	15	24	Meanwhile , autophagy was detected as early as 12 h after an exposure to low-dose chemical , as indicated by an up-regulated expression of gene and gene proteins .	T8	T21	23552851
CPR:3	CHEMICAL	GENE-Y	15	26	Meanwhile , autophagy was detected as early as 12 h after an exposure to low-dose chemical , as indicated by an up-regulated expression of gene and gene proteins .	T8	T22	23552851
CPR:3	CHEMICAL	GENE-N	7	13	Treatment of A549 and H1299 cells with chemical caused a dose-dependent increase in gene and gene activity , accompanied with a decreased gene expression and decreased phosphorylation of gene and gene .	T11	T23	23552851
CPR:3	CHEMICAL	GENE-N	7	15	Treatment of A549 and H1299 cells with chemical caused a dose-dependent increase in gene and gene activity , accompanied with a decreased gene expression and decreased phosphorylation of gene and gene .	T11	T13	23552851
CPR:4	CHEMICAL	GENE-N	7	22	Treatment of A549 and H1299 cells with chemical caused a dose-dependent increase in gene and gene activity , accompanied with a decreased gene expression and decreased phosphorylation of gene and gene .	T11	T14	23552851
CPR:4	CHEMICAL	GENE-N	7	28	Treatment of A549 and H1299 cells with chemical caused a dose-dependent increase in gene and gene activity , accompanied with a decreased gene expression and decreased phosphorylation of gene and gene .	T11	T15	23552851
CPR:4	CHEMICAL	GENE-N	7	30	Treatment of A549 and H1299 cells with chemical caused a dose-dependent increase in gene and gene activity , accompanied with a decreased gene expression and decreased phosphorylation of gene and gene .	T11	T16	23552851
NA	CHEMICAL	GENE-N	3	6	Underexpression of the chemical-dependent neutral chemical transporter gene in the spontaneously hypertensive rat kidney .	T20	T31	17475673
NA	CHEMICAL	GENE-Y	3	7	Underexpression of the chemical-dependent neutral chemical transporter gene in the spontaneously hypertensive rat kidney .	T20	T32	17475673
NA	CHEMICAL	GENE-N	5	6	Underexpression of the chemical-dependent neutral chemical transporter gene in the spontaneously hypertensive rat kidney .	T21	T31	17475673
NA	CHEMICAL	GENE-Y	5	7	Underexpression of the chemical-dependent neutral chemical transporter gene in the spontaneously hypertensive rat kidney .	T21	T32	17475673
CPR:9	CHEMICAL	GENE-Y	7	10	This study examined the inward transport of chemical , an gene preferential substrate , in monolayers of immortalized renal proximal tubular epithelial ( PTE ) cells from Wistar-Kyoto ( WKY ) and spontaneously hypertensive ( SHR ) rats .	T9	T28	17475673
NA	CHEMICAL	GENE-Y	10	36	In the presence of the system L inhibitor BCH , chemical-dependent chemical uptake in WKY and SHR PTE cells was inhibited by chemical , chemical , and chemical , which is consistent with chemical transport through gene .	T10	T29	17475673
CPR:9	CHEMICAL	GENE-Y	11	36	In the presence of the system L inhibitor BCH , chemical-dependent chemical uptake in WKY and SHR PTE cells was inhibited by chemical , chemical , and chemical , which is consistent with chemical transport through gene .	T11	T29	17475673
CPR:4	CHEMICAL	GENE-Y	13	36	In the presence of the system L inhibitor BCH , chemical-dependent chemical uptake in WKY and SHR PTE cells was inhibited by chemical , chemical , and chemical , which is consistent with chemical transport through gene .	T12	T29	17475673
CPR:4	CHEMICAL	GENE-Y	13	36	In the presence of the system L inhibitor BCH , chemical-dependent chemical uptake in WKY and SHR PTE cells was inhibited by chemical , chemical , and chemical , which is consistent with chemical transport through gene .	T13	T29	17475673
CPR:4	CHEMICAL	GENE-Y	13	36	In the presence of the system L inhibitor BCH , chemical-dependent chemical uptake in WKY and SHR PTE cells was inhibited by chemical , chemical , and chemical , which is consistent with chemical transport through gene .	T14	T29	17475673
CPR:9	CHEMICAL	GENE-Y	33	36	In the presence of the system L inhibitor BCH , chemical-dependent chemical uptake in WKY and SHR PTE cells was inhibited by chemical , chemical , and chemical , which is consistent with chemical transport through gene .	T15	T29	17475673
NA	CHEMICAL	GENE-Y	4	8	Differences in magnitude of chemical-dependent chemical uptake through gene between WKY and SHR PTE cells correlated positively with differences in gene protein expression , this being more abundant in WKY PTE cells .	T18	T30	17475673
CPR:3	CHEMICAL	GENE-Y	4	20	Differences in magnitude of chemical-dependent chemical uptake through gene between WKY and SHR PTE cells correlated positively with differences in gene protein expression , this being more abundant in WKY PTE cells .	T18	T22	17475673
CPR:9	CHEMICAL	GENE-Y	1	8	Differences in magnitude of chemical-dependent chemical uptake through gene between WKY and SHR PTE cells correlated positively with differences in gene protein expression , this being more abundant in WKY PTE cells .	T19	T30	17475673
CPR:3	CHEMICAL	GENE-Y	1	20	Differences in magnitude of chemical-dependent chemical uptake through gene between WKY and SHR PTE cells correlated positively with differences in gene protein expression , this being more abundant in WKY PTE cells .	T19	T22	17475673
CPR:9	CHEMICAL	GENE-N	11	14	In conclusion , immortalized SHR and WKY PTE cells take up chemical mainly through a high-affinity chemical-dependent chemical transporter , with functional features of gene transport .	T1	T24	17475673
CPR:9	CHEMICAL	GENE-Y	11	24	In conclusion , immortalized SHR and WKY PTE cells take up chemical mainly through a high-affinity chemical-dependent chemical transporter , with functional features of gene transport .	T1	T25	17475673
NA	CHEMICAL	GENE-N	14	14	In conclusion , immortalized SHR and WKY PTE cells take up chemical mainly through a high-affinity chemical-dependent chemical transporter , with functional features of gene transport .	T2	T24	17475673
CPR:3	CHEMICAL	GENE-Y	14	24	In conclusion , immortalized SHR and WKY PTE cells take up chemical mainly through a high-affinity chemical-dependent chemical transporter , with functional features of gene transport .	T2	T25	17475673
NA	CHEMICAL	GENE-N	14	14	In conclusion , immortalized SHR and WKY PTE cells take up chemical mainly through a high-affinity chemical-dependent chemical transporter , with functional features of gene transport .	T3	T24	17475673
CPR:3	CHEMICAL	GENE-Y	14	24	In conclusion , immortalized SHR and WKY PTE cells take up chemical mainly through a high-affinity chemical-dependent chemical transporter , with functional features of gene transport .	T3	T25	17475673
CPR:4	CHEMICAL	GENE-Y	3	6	Discovery of novel chemical derivatives as gene inhibitors .	T4	T12	23414802
CPR:4	CHEMICAL	GENE-Y	4	16	In this study , a novel series of chemical derivatives were synthesized and evaluated for inhibiting gene chemical protease activity and suppressing cancer cell invasion .	T1	T7	23414802
CPR:4	CHEMICAL	GENE-N	4	4	In this study , a novel series of chemical derivatives were synthesized and evaluated for inhibiting gene chemical protease activity and suppressing cancer cell invasion .	T1	T8	23414802
NA	CHEMICAL	GENE-Y	17	16	In this study , a novel series of chemical derivatives were synthesized and evaluated for inhibiting gene chemical protease activity and suppressing cancer cell invasion .	T2	T7	23414802
NA	CHEMICAL	GENE-N	17	4	In this study , a novel series of chemical derivatives were synthesized and evaluated for inhibiting gene chemical protease activity and suppressing cancer cell invasion .	T2	T8	23414802
NA	CHEMICAL	GENE-N	5	9	No effects were observed when chemical was assessed for gene-dependent and gene-independent cytotoxicity to THLE cell lines , time-dependent inhibition of five major gene enzymes , inhibition of the biliary gene gene and gene or mitochondrial toxicity to THLE or HepG2 cells .	T3	T12	23609606
NA	CHEMICAL	GENE-N	5	11	No effects were observed when chemical was assessed for gene-dependent and gene-independent cytotoxicity to THLE cell lines , time-dependent inhibition of five major gene enzymes , inhibition of the biliary gene gene and gene or mitochondrial toxicity to THLE or HepG2 cells .	T3	T13	23609606
CPR:4	CHEMICAL	GENE-N	5	23	No effects were observed when chemical was assessed for gene-dependent and gene-independent cytotoxicity to THLE cell lines , time-dependent inhibition of five major gene enzymes , inhibition of the biliary gene gene and gene or mitochondrial toxicity to THLE or HepG2 cells .	T3	T14	23609606
CPR:4	CHEMICAL	GENE-N	5	30	No effects were observed when chemical was assessed for gene-dependent and gene-independent cytotoxicity to THLE cell lines , time-dependent inhibition of five major gene enzymes , inhibition of the biliary gene gene and gene or mitochondrial toxicity to THLE or HepG2 cells .	T3	T15	23609606
CPR:4	CHEMICAL	GENE-Y	5	31	No effects were observed when chemical was assessed for gene-dependent and gene-independent cytotoxicity to THLE cell lines , time-dependent inhibition of five major gene enzymes , inhibition of the biliary gene gene and gene or mitochondrial toxicity to THLE or HepG2 cells .	T3	T16	23609606
CPR:4	CHEMICAL	GENE-Y	5	33	No effects were observed when chemical was assessed for gene-dependent and gene-independent cytotoxicity to THLE cell lines , time-dependent inhibition of five major gene enzymes , inhibition of the biliary gene gene and gene or mitochondrial toxicity to THLE or HepG2 cells .	T3	T17	23609606
NA	CHEMICAL	GENE-Y	7	7	UNLABELLED : Therapeutic interventions that block the gene-chemical-chemical system ( RAAS ) have an important role in slowing the progression of cardiovascular risk actors to established cardiovascular diseases .	T9	T19	17588300
NA	CHEMICAL	GENE-Y	7	13	UNLABELLED : Therapeutic interventions that block the gene-chemical-chemical system ( RAAS ) have an important role in slowing the progression of cardiovascular risk actors to established cardiovascular diseases .	T9	T20	17588300
NA	CHEMICAL	GENE-Y	7	7	UNLABELLED : Therapeutic interventions that block the gene-chemical-chemical system ( RAAS ) have an important role in slowing the progression of cardiovascular risk actors to established cardiovascular diseases .	T10	T19	17588300
NA	CHEMICAL	GENE-Y	7	13	UNLABELLED : Therapeutic interventions that block the gene-chemical-chemical system ( RAAS ) have an important role in slowing the progression of cardiovascular risk actors to established cardiovascular diseases .	T10	T20	17588300
NA	CHEMICAL	GENE-N	4	5	In recent years , chemical receptor blockers ( ARBs ) have emerged as effective and well-tolerated alternatives to an chemical-converting enzyme inhibitor ( ACEi ) for RAAS blockade .	T6	T17	17588300
NA	CHEMICAL	GENE-Y	4	20	In recent years , chemical receptor blockers ( ARBs ) have emerged as effective and well-tolerated alternatives to an chemical-converting enzyme inhibitor ( ACEi ) for RAAS blockade .	T6	T18	17588300
NA	CHEMICAL	GENE-N	18	5	In recent years , chemical receptor blockers ( ARBs ) have emerged as effective and well-tolerated alternatives to an chemical-converting enzyme inhibitor ( ACEi ) for RAAS blockade .	T7	T17	17588300
NA	CHEMICAL	GENE-Y	18	20	In recent years , chemical receptor blockers ( ARBs ) have emerged as effective and well-tolerated alternatives to an chemical-converting enzyme inhibitor ( ACEi ) for RAAS blockade .	T7	T18	17588300
NA	CHEMICAL	GENE-Y	7	13	FINDINGS : Compared with other ARBs , chemical demonstrates the strongest binding affinity to the chemical type 1 receptor .	T12	T21	17588300
NA	CHEMICAL	GENE-Y	15	13	FINDINGS : Compared with other ARBs , chemical demonstrates the strongest binding affinity to the chemical type 1 receptor .	T13	T21	17588300
NA	CHEMICAL	GENE-N	5	15	Clinical trials have demonstrated that chemical is well tolerated in combination with diuretics or chemical channel blockers ( CCBs ) , making it a suitable treatment option for patients whose hypertension is not adequately controlled by monotherapy .	T14	T16	17588300
NA	CHEMICAL	GENE-N	5	15	Clinical trials have demonstrated that chemical is well tolerated in combination with diuretics or chemical channel blockers ( CCBs ) , making it a suitable treatment option for patients whose hypertension is not adequately controlled by monotherapy .	T1	T16	17588300
NA	CHEMICAL	GENE-Y	3	21	As predicted , chemical enhanced the production of both chemical precursors ( i.e. , chemical and chemical ) , and chemical oxidase was identified as the likely source of chemical-stimulated chemical production .	T29	T44	23318471
NA	CHEMICAL	GENE-Y	9	21	As predicted , chemical enhanced the production of both chemical precursors ( i.e. , chemical and chemical ) , and chemical oxidase was identified as the likely source of chemical-stimulated chemical production .	T30	T44	23318471
NA	CHEMICAL	GENE-Y	14	21	As predicted , chemical enhanced the production of both chemical precursors ( i.e. , chemical and chemical ) , and chemical oxidase was identified as the likely source of chemical-stimulated chemical production .	T31	T44	23318471
NA	CHEMICAL	GENE-Y	16	21	As predicted , chemical enhanced the production of both chemical precursors ( i.e. , chemical and chemical ) , and chemical oxidase was identified as the likely source of chemical-stimulated chemical production .	T32	T44	23318471
NA	CHEMICAL	GENE-Y	20	21	As predicted , chemical enhanced the production of both chemical precursors ( i.e. , chemical and chemical ) , and chemical oxidase was identified as the likely source of chemical-stimulated chemical production .	T33	T44	23318471
CPR:9	CHEMICAL	GENE-Y	29	21	As predicted , chemical enhanced the production of both chemical precursors ( i.e. , chemical and chemical ) , and chemical oxidase was identified as the likely source of chemical-stimulated chemical production .	T1	T44	23318471
CPR:9	CHEMICAL	GENE-Y	3	21	As predicted , chemical enhanced the production of both chemical precursors ( i.e. , chemical and chemical ) , and chemical oxidase was identified as the likely source of chemical-stimulated chemical production .	T2	T44	23318471
NA	CHEMICAL	GENE-N	6	31	Functional and biochemical studies indicated that chemical signaling involved activity of the chemical 3 ( PI3 ) kinase-gene ( gene ) cascade initiated by activation of the chemical receptor and culminated in enhanced production of chemical and microvascular vasodilation .	T3	T36	23318471
NA	CHEMICAL	GENE-Y	6	17	Functional and biochemical studies indicated that chemical signaling involved activity of the chemical 3 ( PI3 ) kinase-gene ( gene ) cascade initiated by activation of the chemical receptor and culminated in enhanced production of chemical and microvascular vasodilation .	T3	T37	23318471
NA	CHEMICAL	GENE-Y	6	19	Functional and biochemical studies indicated that chemical signaling involved activity of the chemical 3 ( PI3 ) kinase-gene ( gene ) cascade initiated by activation of the chemical receptor and culminated in enhanced production of chemical and microvascular vasodilation .	T3	T38	23318471
CPR:3	CHEMICAL	GENE-Y	6	28	Functional and biochemical studies indicated that chemical signaling involved activity of the chemical 3 ( PI3 ) kinase-gene ( gene ) cascade initiated by activation of the chemical receptor and culminated in enhanced production of chemical and microvascular vasodilation .	T3	T39	23318471
NA	CHEMICAL	GENE-N	12	31	Functional and biochemical studies indicated that chemical signaling involved activity of the chemical 3 ( PI3 ) kinase-gene ( gene ) cascade initiated by activation of the chemical receptor and culminated in enhanced production of chemical and microvascular vasodilation .	T4	T36	23318471
NA	CHEMICAL	GENE-Y	12	17	Functional and biochemical studies indicated that chemical signaling involved activity of the chemical 3 ( PI3 ) kinase-gene ( gene ) cascade initiated by activation of the chemical receptor and culminated in enhanced production of chemical and microvascular vasodilation .	T4	T37	23318471
NA	CHEMICAL	GENE-Y	12	19	Functional and biochemical studies indicated that chemical signaling involved activity of the chemical 3 ( PI3 ) kinase-gene ( gene ) cascade initiated by activation of the chemical receptor and culminated in enhanced production of chemical and microvascular vasodilation .	T4	T38	23318471
NA	CHEMICAL	GENE-Y	12	28	Functional and biochemical studies indicated that chemical signaling involved activity of the chemical 3 ( PI3 ) kinase-gene ( gene ) cascade initiated by activation of the chemical receptor and culminated in enhanced production of chemical and microvascular vasodilation .	T4	T39	23318471
NA	CHEMICAL	GENE-N	1	31	Functional and biochemical studies indicated that chemical signaling involved activity of the chemical 3 ( PI3 ) kinase-gene ( gene ) cascade initiated by activation of the chemical receptor and culminated in enhanced production of chemical and microvascular vasodilation .	T5	T36	23318471
NA	CHEMICAL	GENE-Y	1	17	Functional and biochemical studies indicated that chemical signaling involved activity of the chemical 3 ( PI3 ) kinase-gene ( gene ) cascade initiated by activation of the chemical receptor and culminated in enhanced production of chemical and microvascular vasodilation .	T5	T37	23318471
NA	CHEMICAL	GENE-Y	1	19	Functional and biochemical studies indicated that chemical signaling involved activity of the chemical 3 ( PI3 ) kinase-gene ( gene ) cascade initiated by activation of the chemical receptor and culminated in enhanced production of chemical and microvascular vasodilation .	T5	T38	23318471
NA	CHEMICAL	GENE-Y	1	28	Functional and biochemical studies indicated that chemical signaling involved activity of the chemical 3 ( PI3 ) kinase-gene ( gene ) cascade initiated by activation of the chemical receptor and culminated in enhanced production of chemical and microvascular vasodilation .	T5	T39	23318471
NA	CHEMICAL	GENE-N	35	31	Functional and biochemical studies indicated that chemical signaling involved activity of the chemical 3 ( PI3 ) kinase-gene ( gene ) cascade initiated by activation of the chemical receptor and culminated in enhanced production of chemical and microvascular vasodilation .	T6	T36	23318471
NA	CHEMICAL	GENE-Y	35	17	Functional and biochemical studies indicated that chemical signaling involved activity of the chemical 3 ( PI3 ) kinase-gene ( gene ) cascade initiated by activation of the chemical receptor and culminated in enhanced production of chemical and microvascular vasodilation .	T6	T37	23318471
NA	CHEMICAL	GENE-Y	35	19	Functional and biochemical studies indicated that chemical signaling involved activity of the chemical 3 ( PI3 ) kinase-gene ( gene ) cascade initiated by activation of the chemical receptor and culminated in enhanced production of chemical and microvascular vasodilation .	T6	T38	23318471
NA	CHEMICAL	GENE-Y	35	28	Functional and biochemical studies indicated that chemical signaling involved activity of the chemical 3 ( PI3 ) kinase-gene ( gene ) cascade initiated by activation of the chemical receptor and culminated in enhanced production of chemical and microvascular vasodilation .	T6	T39	23318471
NA	CHEMICAL	GENE-Y	5	5	These findings , derived from a variety of analytical and functional approaches , provide evidence for a novel nongenomic signaling mechanism for chemical action in the microvasculature : chemical-stimulated vasodilation mediated primarily by chemical formed from chemical oxidase-generated chemical and chemical .	T8	T40	23318471
NA	CHEMICAL	GENE-Y	28	5	These findings , derived from a variety of analytical and functional approaches , provide evidence for a novel nongenomic signaling mechanism for chemical action in the microvasculature : chemical-stimulated vasodilation mediated primarily by chemical formed from chemical oxidase-generated chemical and chemical .	T9	T40	23318471
CPR:9	CHEMICAL	GENE-Y	33	5	These findings , derived from a variety of analytical and functional approaches , provide evidence for a novel nongenomic signaling mechanism for chemical action in the microvasculature : chemical-stimulated vasodilation mediated primarily by chemical formed from chemical oxidase-generated chemical and chemical .	T10	T40	23318471
NA	CHEMICAL	GENE-Y	5	5	These findings , derived from a variety of analytical and functional approaches , provide evidence for a novel nongenomic signaling mechanism for chemical action in the microvasculature : chemical-stimulated vasodilation mediated primarily by chemical formed from chemical oxidase-generated chemical and chemical .	T11	T40	23318471
CPR:9	CHEMICAL	GENE-Y	38	5	These findings , derived from a variety of analytical and functional approaches , provide evidence for a novel nongenomic signaling mechanism for chemical action in the microvasculature : chemical-stimulated vasodilation mediated primarily by chemical formed from chemical oxidase-generated chemical and chemical .	T12	T40	23318471
CPR:9	CHEMICAL	GENE-Y	40	5	These findings , derived from a variety of analytical and functional approaches , provide evidence for a novel nongenomic signaling mechanism for chemical action in the microvasculature : chemical-stimulated vasodilation mediated primarily by chemical formed from chemical oxidase-generated chemical and chemical .	T13	T40	23318471
NA	CHEMICAL	GENE-N	16	8	This response was associated with activation of the gene-gene signaling cascade initiated by activation of the chemical receptor .	T14	T41	23318471
NA	CHEMICAL	GENE-Y	16	8	This response was associated with activation of the gene-gene signaling cascade initiated by activation of the chemical receptor .	T14	T42	23318471
NA	CHEMICAL	GENE-Y	16	17	This response was associated with activation of the gene-gene signaling cascade initiated by activation of the chemical receptor .	T14	T43	23318471
NA	CHEMICAL	GENE-Y	5	7	Mechanisms limiting distribution of the chemical-protein kinase B-RaF ( gene ) inhibitor chemical to the brain : implications for the treatment of melanoma brain metastases .	T14	T35	23249624
NA	CHEMICAL	GENE-N	5	9	Mechanisms limiting distribution of the chemical-protein kinase B-RaF ( gene ) inhibitor chemical to the brain : implications for the treatment of melanoma brain metastases .	T14	T36	23249624
CPR:4	CHEMICAL	GENE-Y	12	7	Mechanisms limiting distribution of the chemical-protein kinase B-RaF ( gene ) inhibitor chemical to the brain : implications for the treatment of melanoma brain metastases .	T15	T35	23249624
CPR:4	CHEMICAL	GENE-N	12	9	Mechanisms limiting distribution of the chemical-protein kinase B-RaF ( gene ) inhibitor chemical to the brain : implications for the treatment of melanoma brain metastases .	T15	T36	23249624
NA	CHEMICAL	GENE-Y	7	3	Dabrafenib is a gene ( gene encoding chemical/chemical-protein kinase B-Raf ) inhibitor that has been developed to selectively target the chemical 600 to chemical substitution ( gene ( gene ) ) , which is commonly found in metastatic melanoma .	T1	T34	23249624
NA	CHEMICAL	GENE-Y	7	2	Dabrafenib is a gene ( gene encoding chemical/chemical-protein kinase B-Raf ) inhibitor that has been developed to selectively target the chemical 600 to chemical substitution ( gene ( gene ) ) , which is commonly found in metastatic melanoma .	T1	T18	23249624
NA	CHEMICAL	GENE-N	7	2	Dabrafenib is a gene ( gene encoding chemical/chemical-protein kinase B-Raf ) inhibitor that has been developed to selectively target the chemical 600 to chemical substitution ( gene ( gene ) ) , which is commonly found in metastatic melanoma .	T1	T25	23249624
NA	CHEMICAL	GENE-Y	7	26	Dabrafenib is a gene ( gene encoding chemical/chemical-protein kinase B-Raf ) inhibitor that has been developed to selectively target the chemical 600 to chemical substitution ( gene ( gene ) ) , which is commonly found in metastatic melanoma .	T1	T26	23249624
NA	CHEMICAL	GENE-N	7	21	Dabrafenib is a gene ( gene encoding chemical/chemical-protein kinase B-Raf ) inhibitor that has been developed to selectively target the chemical 600 to chemical substitution ( gene ( gene ) ) , which is commonly found in metastatic melanoma .	T1	T27	23249624
NA	CHEMICAL	GENE-Y	3	3	Dabrafenib is a gene ( gene encoding chemical/chemical-protein kinase B-Raf ) inhibitor that has been developed to selectively target the chemical 600 to chemical substitution ( gene ( gene ) ) , which is commonly found in metastatic melanoma .	T3	T34	23249624
NA	CHEMICAL	GENE-Y	3	2	Dabrafenib is a gene ( gene encoding chemical/chemical-protein kinase B-Raf ) inhibitor that has been developed to selectively target the chemical 600 to chemical substitution ( gene ( gene ) ) , which is commonly found in metastatic melanoma .	T3	T18	23249624
NA	CHEMICAL	GENE-N	3	2	Dabrafenib is a gene ( gene encoding chemical/chemical-protein kinase B-Raf ) inhibitor that has been developed to selectively target the chemical 600 to chemical substitution ( gene ( gene ) ) , which is commonly found in metastatic melanoma .	T3	T25	23249624
NA	CHEMICAL	GENE-Y	3	26	Dabrafenib is a gene ( gene encoding chemical/chemical-protein kinase B-Raf ) inhibitor that has been developed to selectively target the chemical 600 to chemical substitution ( gene ( gene ) ) , which is commonly found in metastatic melanoma .	T3	T26	23249624
NA	CHEMICAL	GENE-N	3	21	Dabrafenib is a gene ( gene encoding chemical/chemical-protein kinase B-Raf ) inhibitor that has been developed to selectively target the chemical 600 to chemical substitution ( gene ( gene ) ) , which is commonly found in metastatic melanoma .	T3	T27	23249624
NA	CHEMICAL	GENE-Y	2	3	Dabrafenib is a gene ( gene encoding chemical/chemical-protein kinase B-Raf ) inhibitor that has been developed to selectively target the chemical 600 to chemical substitution ( gene ( gene ) ) , which is commonly found in metastatic melanoma .	T8	T34	23249624
NA	CHEMICAL	GENE-Y	2	2	Dabrafenib is a gene ( gene encoding chemical/chemical-protein kinase B-Raf ) inhibitor that has been developed to selectively target the chemical 600 to chemical substitution ( gene ( gene ) ) , which is commonly found in metastatic melanoma .	T8	T18	23249624
NA	CHEMICAL	GENE-N	2	2	Dabrafenib is a gene ( gene encoding chemical/chemical-protein kinase B-Raf ) inhibitor that has been developed to selectively target the chemical 600 to chemical substitution ( gene ( gene ) ) , which is commonly found in metastatic melanoma .	T8	T25	23249624
NA	CHEMICAL	GENE-Y	2	26	Dabrafenib is a gene ( gene encoding chemical/chemical-protein kinase B-Raf ) inhibitor that has been developed to selectively target the chemical 600 to chemical substitution ( gene ( gene ) ) , which is commonly found in metastatic melanoma .	T8	T26	23249624
NA	CHEMICAL	GENE-N	2	21	Dabrafenib is a gene ( gene encoding chemical/chemical-protein kinase B-Raf ) inhibitor that has been developed to selectively target the chemical 600 to chemical substitution ( gene ( gene ) ) , which is commonly found in metastatic melanoma .	T8	T27	23249624
NA	CHEMICAL	GENE-Y	2	3	Dabrafenib is a gene ( gene encoding chemical/chemical-protein kinase B-Raf ) inhibitor that has been developed to selectively target the chemical 600 to chemical substitution ( gene ( gene ) ) , which is commonly found in metastatic melanoma .	T9	T34	23249624
NA	CHEMICAL	GENE-Y	2	2	Dabrafenib is a gene ( gene encoding chemical/chemical-protein kinase B-Raf ) inhibitor that has been developed to selectively target the chemical 600 to chemical substitution ( gene ( gene ) ) , which is commonly found in metastatic melanoma .	T9	T18	23249624
NA	CHEMICAL	GENE-N	2	2	Dabrafenib is a gene ( gene encoding chemical/chemical-protein kinase B-Raf ) inhibitor that has been developed to selectively target the chemical 600 to chemical substitution ( gene ( gene ) ) , which is commonly found in metastatic melanoma .	T9	T25	23249624
NA	CHEMICAL	GENE-Y	2	26	Dabrafenib is a gene ( gene encoding chemical/chemical-protein kinase B-Raf ) inhibitor that has been developed to selectively target the chemical 600 to chemical substitution ( gene ( gene ) ) , which is commonly found in metastatic melanoma .	T9	T26	23249624
NA	CHEMICAL	GENE-N	2	21	Dabrafenib is a gene ( gene encoding chemical/chemical-protein kinase B-Raf ) inhibitor that has been developed to selectively target the chemical 600 to chemical substitution ( gene ( gene ) ) , which is commonly found in metastatic melanoma .	T9	T27	23249624
NA	CHEMICAL	GENE-N	15	16	Thus , the objective of the current study was to evaluate the brain distribution of chemical in mice , and to see whether active efflux by gene ( gene ) and gene ( gene ) restricts its delivery across the blood-brain barrier ( BBB ) .	T12	T28	23249624
NA	CHEMICAL	GENE-N	15	28	Thus , the objective of the current study was to evaluate the brain distribution of chemical in mice , and to see whether active efflux by gene ( gene ) and gene ( gene ) restricts its delivery across the blood-brain barrier ( BBB ) .	T12	T29	23249624
NA	CHEMICAL	GENE-Y	15	16	Thus , the objective of the current study was to evaluate the brain distribution of chemical in mice , and to see whether active efflux by gene ( gene ) and gene ( gene ) restricts its delivery across the blood-brain barrier ( BBB ) .	T12	T30	23249624
NA	CHEMICAL	GENE-Y	15	33	Thus , the objective of the current study was to evaluate the brain distribution of chemical in mice , and to see whether active efflux by gene ( gene ) and gene ( gene ) restricts its delivery across the blood-brain barrier ( BBB ) .	T12	T31	23249624
CPR:9	CHEMICAL	GENE-N	13	20	In vitro accumulation studies conducted in Madin-Darby canine kidney II cells indicate that chemical is an avid substrate for both gene and gene .	T13	T32	23249624
CPR:9	CHEMICAL	GENE-Y	13	22	In vitro accumulation studies conducted in Madin-Darby canine kidney II cells indicate that chemical is an avid substrate for both gene and gene .	T13	T33	23249624
NA	CHEMICAL	GENE-N	0	7	chemical plasma exposure was ∼2-fold greater in gene ( -/- ) gene ( -/- ) mice as compared with wild-type with an oral dose ( 25 mg/kg ) ; however , the brain distribution was increased by ~10-fold with a resulting K ( p ) of 0.25 .	T4	T21	23249624
NA	CHEMICAL	GENE-Y	0	11	chemical plasma exposure was ∼2-fold greater in gene ( -/- ) gene ( -/- ) mice as compared with wild-type with an oral dose ( 25 mg/kg ) ; however , the brain distribution was increased by ~10-fold with a resulting K ( p ) of 0.25 .	T4	T22	23249624
CPR:4	CHEMICAL	GENE-Y	4	7	Further , compared with chemical , another gene ( gene ) inhibitor , chemical showed greater brain penetration with a similar dose .	T5	T23	23249624
CPR:4	CHEMICAL	GENE-N	4	9	Further , compared with chemical , another gene ( gene ) inhibitor , chemical showed greater brain penetration with a similar dose .	T5	T24	23249624
NA	CHEMICAL	GENE-Y	13	7	Further , compared with chemical , another gene ( gene ) inhibitor , chemical showed greater brain penetration with a similar dose .	T6	T23	23249624
NA	CHEMICAL	GENE-N	13	9	Further , compared with chemical , another gene ( gene ) inhibitor , chemical showed greater brain penetration with a similar dose .	T6	T24	23249624
NA	CHEMICAL	GENE-Y	3	9	Individuals in whom chemical-associated breast cancer risk reduction appears to outweigh risk of serious side-effects include women with prior in situ or chemical receptor ( gene ) -positive invasive cancer , atypical hyperplasia , and/or women ages 35-49 with a calculated Gail 5-year risk of > or =1.7 % , hysterectomized women aged 50 and older with a 5-year Gail risk of > or =2.5 % , and nonhysterectomized women aged 50 and older with a 5-year Gail risk of > 5.0 % .	T12	T27	11906441
NA	CHEMICAL	GENE-Y	3	25	Individuals in whom chemical-associated breast cancer risk reduction appears to outweigh risk of serious side-effects include women with prior in situ or chemical receptor ( gene ) -positive invasive cancer , atypical hyperplasia , and/or women ages 35-49 with a calculated Gail 5-year risk of > or =1.7 % , hysterectomized women aged 50 and older with a 5-year Gail risk of > or =2.5 % , and nonhysterectomized women aged 50 and older with a 5-year Gail risk of > 5.0 % .	T12	T28	11906441
NA	CHEMICAL	GENE-Y	22	9	Individuals in whom chemical-associated breast cancer risk reduction appears to outweigh risk of serious side-effects include women with prior in situ or chemical receptor ( gene ) -positive invasive cancer , atypical hyperplasia , and/or women ages 35-49 with a calculated Gail 5-year risk of > or =1.7 % , hysterectomized women aged 50 and older with a 5-year Gail risk of > or =2.5 % , and nonhysterectomized women aged 50 and older with a 5-year Gail risk of > 5.0 % .	T13	T27	11906441
NA	CHEMICAL	GENE-Y	22	25	Individuals in whom chemical-associated breast cancer risk reduction appears to outweigh risk of serious side-effects include women with prior in situ or chemical receptor ( gene ) -positive invasive cancer , atypical hyperplasia , and/or women ages 35-49 with a calculated Gail 5-year risk of > or =1.7 % , hysterectomized women aged 50 and older with a 5-year Gail risk of > or =2.5 % , and nonhysterectomized women aged 50 and older with a 5-year Gail risk of > 5.0 % .	T13	T28	11906441
NA	CHEMICAL	GENE-Y	6	15	It is not yet clear whether chemical can reduce breast cancer incidence in women with gene and gene mutations , although preliminary evidence favors benefit for at least those with a gene mutation .	T1	T16	11906441
CPR:4	CHEMICAL	GENE-Y	6	17	It is not yet clear whether chemical can reduce breast cancer incidence in women with gene and gene mutations , although preliminary evidence favors benefit for at least those with a gene mutation .	T1	T17	11906441
CPR:4	CHEMICAL	GENE-Y	6	31	It is not yet clear whether chemical can reduce breast cancer incidence in women with gene and gene mutations , although preliminary evidence favors benefit for at least those with a gene mutation .	T1	T18	11906441
NA	CHEMICAL	GENE-Y	0	4	chemical is a selective gene modulator with less uterine chemical agonist activity than chemical , and it is hoped that it will result in fewer uterine cancers but will be equally efficacious in reducing the risk of breast cancer .	T2	T19	11906441
NA	CHEMICAL	GENE-Y	9	4	chemical is a selective gene modulator with less uterine chemical agonist activity than chemical , and it is hoped that it will result in fewer uterine cancers but will be equally efficacious in reducing the risk of breast cancer .	T3	T19	11906441
NA	CHEMICAL	GENE-Y	2	4	chemical is a selective gene modulator with less uterine chemical agonist activity than chemical , and it is hoped that it will result in fewer uterine cancers but will be equally efficacious in reducing the risk of breast cancer .	T4	T19	11906441
NA	CHEMICAL	GENE-Y	0	7	chemical does not reduce the incidence of gene-negative cancers , nor does it appear to be effective in preventing the appearance of one third of gene-positive cancers .	T7	T21	11906441
NA	CHEMICAL	GENE-Y	0	25	chemical does not reduce the incidence of gene-negative cancers , nor does it appear to be effective in preventing the appearance of one third of gene-positive cancers .	T7	T22	11906441
NA	CHEMICAL	GENE-Y	8	45	Priorities in prevention research are to develop ( a ) biomarkers to refine short-term risk assessments based on epidemiologic models , ( b ) biomarkers predictive of response to specific classes of preventive agents , ( c ) drugs with fewer side-effects and/or effective in gene-negative or gene-positive chemical-resistant precancerous disease , and ( d ) efficient clinical trial models to assess new agent efficacy .	T8	T23	11906441
NA	CHEMICAL	GENE-Y	8	47	Priorities in prevention research are to develop ( a ) biomarkers to refine short-term risk assessments based on epidemiologic models , ( b ) biomarkers predictive of response to specific classes of preventive agents , ( c ) drugs with fewer side-effects and/or effective in gene-negative or gene-positive chemical-resistant precancerous disease , and ( d ) efficient clinical trial models to assess new agent efficacy .	T8	T24	11906441
NA	CHEMICAL	GENE-Y	19	17	Here , we leveraged protein engineering to modify the PK characteristics of the native molecule by fusing gene to a gene and removing the intrinsic heparan chemical-binding activity of gene .	T1	T3	23249626
NA	CHEMICAL	GENE-N	19	20	Here , we leveraged protein engineering to modify the PK characteristics of the native molecule by fusing gene to a gene and removing the intrinsic heparan chemical-binding activity of gene .	T1	T4	23249626
NA	CHEMICAL	GENE-Y	19	19	Here , we leveraged protein engineering to modify the PK characteristics of the native molecule by fusing gene to a gene and removing the intrinsic heparan chemical-binding activity of gene .	T1	T5	23249626
CPR:6	CHEMICAL	GENE-Y	0	3	chemical is an gene antagonist that is metabolized primarily by glucuronidation but also undergoes oxidative metabolism by gene .	T1	T19	19389876
CPR:9	CHEMICAL	GENE-Y	0	17	chemical is an gene antagonist that is metabolized primarily by glucuronidation but also undergoes oxidative metabolism by gene .	T1	T18	19389876
CPR:4	CHEMICAL	GENE-Y	3	10	The potential for chemical , the archetypal strong inhibitor of gene , to alter the pharmacokinetic profile of chemical and its oxidative metabolite , chemical , was assessed in an open-label , nonrandomized , 2-period , single-sequence study in 16 healthy men .	T4	T20	19389876
NA	CHEMICAL	GENE-Y	18	10	The potential for chemical , the archetypal strong inhibitor of gene , to alter the pharmacokinetic profile of chemical and its oxidative metabolite , chemical , was assessed in an open-label , nonrandomized , 2-period , single-sequence study in 16 healthy men .	T5	T20	19389876
NA	CHEMICAL	GENE-Y	24	10	The potential for chemical , the archetypal strong inhibitor of gene , to alter the pharmacokinetic profile of chemical and its oxidative metabolite , chemical , was assessed in an open-label , nonrandomized , 2-period , single-sequence study in 16 healthy men .	T6	T20	19389876
NA	CHEMICAL	GENE-Y	2	2	Configuration of a scintillation proximity assay for the activity assessment of recombinant gene .	T11	T16	17199504
NA	CHEMICAL	GENE-Y	0	1	chemical phosphoribosyltransferase plays a role in chemical salvage by catalyzing the direct conversion of chemical to chemical .	T1	T12	17199504
NA	CHEMICAL	GENE-Y	5	1	chemical phosphoribosyltransferase plays a role in chemical salvage by catalyzing the direct conversion of chemical to chemical .	T9	T12	17199504
CPR:9	CHEMICAL	GENE-Y	3	1	chemical phosphoribosyltransferase plays a role in chemical salvage by catalyzing the direct conversion of chemical to chemical .	T2	T12	17199504
CPR:9	CHEMICAL	GENE-Y	3	1	chemical phosphoribosyltransferase plays a role in chemical salvage by catalyzing the direct conversion of chemical to chemical .	T3	T12	17199504
NA	CHEMICAL	GENE-Y	4	14	The involvement of the chemical salvage pathway in tumor proliferation and angiogenesis makes chemical phosphoribosyltransferase a potential target for oncology drug discovery .	T4	T13	17199504
NA	CHEMICAL	GENE-Y	7	14	The involvement of the chemical salvage pathway in tumor proliferation and angiogenesis makes chemical phosphoribosyltransferase a potential target for oncology drug discovery .	T5	T13	17199504
NA	CHEMICAL	GENE-Y	7	9	We have expressed and characterized recombinant , chemical-terminally chemical-tagged gene .	T6	T14	17199504
NA	CHEMICAL	GENE-Y	8	9	We have expressed and characterized recombinant , chemical-terminally chemical-tagged gene .	T7	T14	17199504
CPR:4	CHEMICAL	GENE-N	4	6	A new series of chemical analogues as gene inhibitors .	T4	T14	23466232
NA	CHEMICAL	GENE-N	3	3	Several members of a new family of non-chemical-type gene inhibitors , bearing a chemical moiety and various substituent at the N2 position , were synthesized and their activities were investigated .	T1	T9	23466232
CPR:4	CHEMICAL	GENE-N	3	3	Several members of a new family of non-chemical-type gene inhibitors , bearing a chemical moiety and various substituent at the N2 position , were synthesized and their activities were investigated .	T3	T9	23466232
NA	CHEMICAL	GENE-Y	2	2	The isolated gene protein underwent reduction in the presence of either chemical-cytochrome P450 reductase or chemical-putidaredoxin-putidaredoxin reductase but did not exhibit gene activity .	T1	T11	12699699
NA	CHEMICAL	GENE-Y	2	13	The isolated gene protein underwent reduction in the presence of either chemical-cytochrome P450 reductase or chemical-putidaredoxin-putidaredoxin reductase but did not exhibit gene activity .	T1	T12	12699699
NA	CHEMICAL	GENE-N	2	13	The isolated gene protein underwent reduction in the presence of either chemical-cytochrome P450 reductase or chemical-putidaredoxin-putidaredoxin reductase but did not exhibit gene activity .	T1	T14	12699699
NA	CHEMICAL	GENE-N	2	21	The isolated gene protein underwent reduction in the presence of either chemical-cytochrome P450 reductase or chemical-putidaredoxin-putidaredoxin reductase but did not exhibit gene activity .	T1	T15	12699699
NA	CHEMICAL	GENE-Y	15	2	The isolated gene protein underwent reduction in the presence of either chemical-cytochrome P450 reductase or chemical-putidaredoxin-putidaredoxin reductase but did not exhibit gene activity .	T2	T11	12699699
NA	CHEMICAL	GENE-Y	15	13	The isolated gene protein underwent reduction in the presence of either chemical-cytochrome P450 reductase or chemical-putidaredoxin-putidaredoxin reductase but did not exhibit gene activity .	T2	T12	12699699
NA	CHEMICAL	GENE-N	15	13	The isolated gene protein underwent reduction in the presence of either chemical-cytochrome P450 reductase or chemical-putidaredoxin-putidaredoxin reductase but did not exhibit gene activity .	T2	T14	12699699
NA	CHEMICAL	GENE-N	15	21	The isolated gene protein underwent reduction in the presence of either chemical-cytochrome P450 reductase or chemical-putidaredoxin-putidaredoxin reductase but did not exhibit gene activity .	T2	T15	12699699
CPR:3	CHEMICAL	GENE-N	4	5	The protein exhibited modest chemical-dependent gene activities with chemical , chemical , and chemical ( chemical ) .	T3	T16	12699699
CPR:9	CHEMICAL	GENE-N	8	5	The protein exhibited modest chemical-dependent gene activities with chemical , chemical , and chemical ( chemical ) .	T4	T16	12699699
CPR:9	CHEMICAL	GENE-N	10	5	The protein exhibited modest chemical-dependent gene activities with chemical , chemical , and chemical ( chemical ) .	T5	T16	12699699
CPR:9	CHEMICAL	GENE-N	13	5	The protein exhibited modest chemical-dependent gene activities with chemical , chemical , and chemical ( chemical ) .	T6	T16	12699699
CPR:9	CHEMICAL	GENE-N	15	5	The protein exhibited modest chemical-dependent gene activities with chemical , chemical , and chemical ( chemical ) .	T7	T16	12699699
NA	CHEMICAL	GENE-Y	6	8	Atypical neuroleptics have low affinity for chemical D2 receptors or are selective for gene .	T24	T38	9015795
NA	CHEMICAL	GENE-Y	6	8	Atypical neuroleptics have low affinity for chemical D2 receptors or are selective for gene .	T24	T39	9015795
NA	CHEMICAL	GENE-N	16	19	Such an examination requires consistent and accurate dissociation constants for the antipsychotic drugs at the relevant chemical and chemical receptors .	T20	T35	9015795
NA	CHEMICAL	GENE-N	18	19	Such an examination requires consistent and accurate dissociation constants for the antipsychotic drugs at the relevant chemical and chemical receptors .	T22	T35	9015795
NA	CHEMICAL	GENE-Y	13	21	It has long been known , however , that the dissociation constant of a given antipsychotic drug at the chemical D2 receptor varies between laboratories .	T23	T37	9015795
NA	CHEMICAL	GENE-N	6	10	These values are here given for chemical D2 and D4 receptors , as well as for chemical 5-HT2A receptors .	T1	T25	9015795
NA	CHEMICAL	GENE-Y	6	10	These values are here given for chemical D2 and D4 receptors , as well as for chemical 5-HT2A receptors .	T1	T26	9015795
NA	CHEMICAL	GENE-N	16	10	These values are here given for chemical D2 and D4 receptors , as well as for chemical 5-HT2A receptors .	T2	T25	9015795
NA	CHEMICAL	GENE-Y	16	10	These values are here given for chemical D2 and D4 receptors , as well as for chemical 5-HT2A receptors .	T2	T26	9015795
NA	CHEMICAL	GENE-Y	3	15	For example , chemical revealed a radioligand-independent value of 1.6 nM at the chemical gene receptor , agreeing with the value directly measured with chemical at D4 .	T3	T27	9015795
NA	CHEMICAL	GENE-Y	3	14	For example , chemical revealed a radioligand-independent value of 1.6 nM at the chemical gene receptor , agreeing with the value directly measured with chemical at D4 .	T3	T28	9015795
NA	CHEMICAL	GENE-Y	5	15	For example , chemical revealed a radioligand-independent value of 1.6 nM at the chemical gene receptor , agreeing with the value directly measured with chemical at D4 .	T4	T27	9015795
NA	CHEMICAL	GENE-Y	5	14	For example , chemical revealed a radioligand-independent value of 1.6 nM at the chemical gene receptor , agreeing with the value directly measured with chemical at D4 .	T4	T28	9015795
NA	CHEMICAL	GENE-Y	5	15	For example , chemical revealed a radioligand-independent value of 1.6 nM at the chemical gene receptor , agreeing with the value directly measured with chemical at D4 .	T5	T27	9015795
NA	CHEMICAL	GENE-Y	5	14	For example , chemical revealed a radioligand-independent value of 1.6 nM at the chemical gene receptor , agreeing with the value directly measured with chemical at D4 .	T5	T28	9015795
NA	CHEMICAL	GENE-Y	3	16	However , because chemical competes with endogenous chemical , the in vivo concentration of chemical ( to occupy chemical D4 receptors ) can be derived to be about 13 nM , agreeing with the value of 12 to 20 nM in the plasma water or spinal fluid observed in treated patients .	T6	T29	9015795
NA	CHEMICAL	GENE-Y	7	16	However , because chemical competes with endogenous chemical , the in vivo concentration of chemical ( to occupy chemical D4 receptors ) can be derived to be about 13 nM , agreeing with the value of 12 to 20 nM in the plasma water or spinal fluid observed in treated patients .	T7	T29	9015795
NA	CHEMICAL	GENE-Y	10	16	However , because chemical competes with endogenous chemical , the in vivo concentration of chemical ( to occupy chemical D4 receptors ) can be derived to be about 13 nM , agreeing with the value of 12 to 20 nM in the plasma water or spinal fluid observed in treated patients .	T8	T29	9015795
NA	CHEMICAL	GENE-Y	10	16	However , because chemical competes with endogenous chemical , the in vivo concentration of chemical ( to occupy chemical D4 receptors ) can be derived to be about 13 nM , agreeing with the value of 12 to 20 nM in the plasma water or spinal fluid observed in treated patients .	T9	T29	9015795
NA	CHEMICAL	GENE-Y	3	19	The atypical neuroleptics chemical , chemical , chemical , chemical , and chemical had low affinity for the chemical gene ( radioligand-independent dissociation constants of 30 to 90 nM ) .	T10	T30	9015795
NA	CHEMICAL	GENE-Y	5	19	The atypical neuroleptics chemical , chemical , chemical , chemical , and chemical had low affinity for the chemical gene ( radioligand-independent dissociation constants of 30 to 90 nM ) .	T11	T30	9015795
NA	CHEMICAL	GENE-Y	7	19	The atypical neuroleptics chemical , chemical , chemical , chemical , and chemical had low affinity for the chemical gene ( radioligand-independent dissociation constants of 30 to 90 nM ) .	T12	T30	9015795
NA	CHEMICAL	GENE-Y	9	19	The atypical neuroleptics chemical , chemical , chemical , chemical , and chemical had low affinity for the chemical gene ( radioligand-independent dissociation constants of 30 to 90 nM ) .	T13	T30	9015795
NA	CHEMICAL	GENE-Y	12	19	The atypical neuroleptics chemical , chemical , chemical , chemical , and chemical had low affinity for the chemical gene ( radioligand-independent dissociation constants of 30 to 90 nM ) .	T14	T30	9015795
NA	CHEMICAL	GENE-Y	18	19	The atypical neuroleptics chemical , chemical , chemical , chemical , and chemical had low affinity for the chemical gene ( radioligand-independent dissociation constants of 30 to 90 nM ) .	T15	T30	9015795
NA	CHEMICAL	GENE-Y	12	8	Most typical neuroleptics have radioligand-independent values of 0.3 to 5 nM at chemical D2 receptors , making them more resistant to displacement by endogenous chemical .	T17	T31	9015795
NA	CHEMICAL	GENE-Y	24	8	Most typical neuroleptics have radioligand-independent values of 0.3 to 5 nM at chemical D2 receptors , making them more resistant to displacement by endogenous chemical .	T18	T31	9015795
CPR:9	CHEMICAL	GENE-Y	0	5	chemical is principally metabolized by gene , and both are probable substrates of the gene gene .	T6	T16	15805193
CPR:9	CHEMICAL	GENE-N	0	14	chemical is principally metabolized by gene , and both are probable substrates of the gene gene .	T6	T17	15805193
CPR:9	CHEMICAL	GENE-N	0	15	chemical is principally metabolized by gene , and both are probable substrates of the gene gene .	T6	T18	15805193
NA	CHEMICAL	GENE-Y	7	8	We report that a known functional polymorphism in gene is highly associated with the maximum dose of chemical ( P = 0.0066 ) .	T9	T19	15805193
NA	CHEMICAL	GENE-Y	7	9	We also show that an intronic polymorphism in the gene gene shows significant association with maximum doses in regular usage of both chemical and chemical ( P = 0.0051 and P = 0.014 , respectively ) .	T10	T20	15805193
NA	CHEMICAL	GENE-Y	7	9	We also show that an intronic polymorphism in the gene gene shows significant association with maximum doses in regular usage of both chemical and chemical ( P = 0.0051 and P = 0.014 , respectively ) .	T11	T20	15805193
NA	CHEMICAL	GENE-Y	5	7	To confirm molecular recognition of chemical by gene , a surface acoustic wave-biosensor was applied .	T2	T8	19888514
NA	CHEMICAL	GENE-Y	22	0	A gene containing membrane preparation of MV3 cells was immobilised at the sensors to allow for detection of kinetic binding constants of chemical compared to gene .	T3	T9	19888514
NA	CHEMICAL	GENE-Y	22	0	A gene containing membrane preparation of MV3 cells was immobilised at the sensors to allow for detection of kinetic binding constants of chemical compared to gene .	T3	T10	19888514
NA	CHEMICAL	GENE-Y	0	3	chemical binds to gene with affinity in the low micromolar range ( 4.61 x 10 ( -6 ) M ) , which clearly indicates specific molecular recognition .	T4	T11	19888514
NA	CHEMICAL	GENE-Y	2	13	Furthermore , chemical displays a nearly identical k ( off ) compared to gene ( 5.13 x 10 ( -3 ) s ( -1 ) versus 3.44 x 10 ( -3 ) s ( -1 ) ) which is evident for interference with the ligand binding .	T5	T12	19888514
NA	CHEMICAL	GENE-Y	5	1	The gene/gene pathway is involved in chemical-induced apoptosis in cultured osteosarcoma cells .	T14	T33	23164673
NA	CHEMICAL	GENE-N	5	1	The gene/gene pathway is involved in chemical-induced apoptosis in cultured osteosarcoma cells .	T14	T32	23164673
CPR:4	CHEMICAL	GENE-Y	10	7	Furthermore , we validated the inhibition of gene/gene signaling following chemical treatment .	T12	T29	23164673
CPR:4	CHEMICAL	GENE-N	10	7	Furthermore , we validated the inhibition of gene/gene signaling following chemical treatment .	T12	T30	23164673
CPR:4	CHEMICAL	GENE-Y	3	7	Western blots showed a decrease in nuclear gene protein expression after exposure to different concentrations of chemical , while the phosphorylation of gene was simultaneously increased .	T13	T31	23164673
CPR:3	CHEMICAL	GENE-Y	3	22	Western blots showed a decrease in nuclear gene protein expression after exposure to different concentrations of chemical , while the phosphorylation of gene was simultaneously increased .	T13	T15	23164673
NA	CHEMICAL	GENE-Y	22	6	Transduction with constitutively active forms of gene could protect against the downregulation of gene and upregulation of cleaved-gene that are induced by chemical treatment .	T2	T16	23164673
CPR:4	CHEMICAL	GENE-Y	22	13	Transduction with constitutively active forms of gene could protect against the downregulation of gene and upregulation of cleaved-gene that are induced by chemical treatment .	T2	T17	23164673
CPR:3	CHEMICAL	GENE-N	22	17	Transduction with constitutively active forms of gene could protect against the downregulation of gene and upregulation of cleaved-gene that are induced by chemical treatment .	T2	T18	23164673
CPR:4	CHEMICAL	GENE-Y	5	14	However , combined treatment with chemical and chemical resulted in a significant reduction in gene and an increase in cleaved-gene in U2OS cells .	T3	T19	23164673
CPR:3	CHEMICAL	GENE-N	5	19	However , combined treatment with chemical and chemical resulted in a significant reduction in gene and an increase in cleaved-gene in U2OS cells .	T3	T20	23164673
CPR:4	CHEMICAL	GENE-Y	7	14	However , combined treatment with chemical and chemical resulted in a significant reduction in gene and an increase in cleaved-gene in U2OS cells .	T4	T19	23164673
CPR:3	CHEMICAL	GENE-N	7	19	However , combined treatment with chemical and chemical resulted in a significant reduction in gene and an increase in cleaved-gene in U2OS cells .	T4	T20	23164673
NA	CHEMICAL	GENE-Y	19	7	DATA SYNTHESIS : Albiglutide is a long-acting geneA that lowers gene ( gene ) and reduces weight by stimulating chemical-dependent gene secretion , suppressing gene secretion , delaying gastric emptying , and promoting satiety .	T4	T16	25136065
NA	CHEMICAL	GENE-Y	19	10	DATA SYNTHESIS : Albiglutide is a long-acting geneA that lowers gene ( gene ) and reduces weight by stimulating chemical-dependent gene secretion , suppressing gene secretion , delaying gastric emptying , and promoting satiety .	T4	T17	25136065
NA	CHEMICAL	GENE-Y	19	12	DATA SYNTHESIS : Albiglutide is a long-acting geneA that lowers gene ( gene ) and reduces weight by stimulating chemical-dependent gene secretion , suppressing gene secretion , delaying gastric emptying , and promoting satiety .	T4	T18	25136065
NA	CHEMICAL	GENE-Y	19	20	DATA SYNTHESIS : Albiglutide is a long-acting geneA that lowers gene ( gene ) and reduces weight by stimulating chemical-dependent gene secretion , suppressing gene secretion , delaying gastric emptying , and promoting satiety .	T4	T19	25136065
NA	CHEMICAL	GENE-Y	19	5	DATA SYNTHESIS : Albiglutide is a long-acting geneA that lowers gene ( gene ) and reduces weight by stimulating chemical-dependent gene secretion , suppressing gene secretion , delaying gastric emptying , and promoting satiety .	T4	T20	25136065
NA	CHEMICAL	GENE-Y	10	16	Albiglutide has been studied as monotherapy and add-on therapy to chemical , chemical , chemical , gene glargine , and varying combinations of these agents .	T5	T24	25136065
NA	CHEMICAL	GENE-Y	4	16	Albiglutide has been studied as monotherapy and add-on therapy to chemical , chemical , chemical , gene glargine , and varying combinations of these agents .	T6	T24	25136065
NA	CHEMICAL	GENE-Y	14	16	Albiglutide has been studied as monotherapy and add-on therapy to chemical , chemical , chemical , gene glargine , and varying combinations of these agents .	T7	T24	25136065
NA	CHEMICAL	GENE-Y	11	18	Clinical studies have shown albiglutide to be superior to placebo , chemical , and chemical and noninferior to gene glargine and gene lispro at reducing gene in T2D patients , with gene changes from baseline ranging from -0.55 % to -0.9 % .	T1	T8	25136065
NA	CHEMICAL	GENE-Y	11	21	Clinical studies have shown albiglutide to be superior to placebo , chemical , and chemical and noninferior to gene glargine and gene lispro at reducing gene in T2D patients , with gene changes from baseline ranging from -0.55 % to -0.9 % .	T1	T9	25136065
NA	CHEMICAL	GENE-Y	11	25	Clinical studies have shown albiglutide to be superior to placebo , chemical , and chemical and noninferior to gene glargine and gene lispro at reducing gene in T2D patients , with gene changes from baseline ranging from -0.55 % to -0.9 % .	T1	T10	25136065
NA	CHEMICAL	GENE-Y	11	31	Clinical studies have shown albiglutide to be superior to placebo , chemical , and chemical and noninferior to gene glargine and gene lispro at reducing gene in T2D patients , with gene changes from baseline ranging from -0.55 % to -0.9 % .	T1	T11	25136065
NA	CHEMICAL	GENE-Y	14	18	Clinical studies have shown albiglutide to be superior to placebo , chemical , and chemical and noninferior to gene glargine and gene lispro at reducing gene in T2D patients , with gene changes from baseline ranging from -0.55 % to -0.9 % .	T2	T8	25136065
NA	CHEMICAL	GENE-Y	14	21	Clinical studies have shown albiglutide to be superior to placebo , chemical , and chemical and noninferior to gene glargine and gene lispro at reducing gene in T2D patients , with gene changes from baseline ranging from -0.55 % to -0.9 % .	T2	T9	25136065
NA	CHEMICAL	GENE-Y	14	25	Clinical studies have shown albiglutide to be superior to placebo , chemical , and chemical and noninferior to gene glargine and gene lispro at reducing gene in T2D patients , with gene changes from baseline ranging from -0.55 % to -0.9 % .	T2	T10	25136065
NA	CHEMICAL	GENE-Y	14	31	Clinical studies have shown albiglutide to be superior to placebo , chemical , and chemical and noninferior to gene glargine and gene lispro at reducing gene in T2D patients , with gene changes from baseline ranging from -0.55 % to -0.9 % .	T2	T11	25136065
NA	CHEMICAL	GENE-Y	2	3	Alteration of chemical-associated protein ( gene ) expression in human breast epithelial cells during breast cancer development .	T10	T17	23411208
NA	CHEMICAL	GENE-Y	2	5	Alteration of chemical-associated protein ( gene ) expression in human breast epithelial cells during breast cancer development .	T10	T18	23411208
NA	CHEMICAL	GENE-Y	13	26	Over the last decade , many studies have demonstrated the anticancer activity of chemical , the main and most active form of natural chemical . chemical-associated protein ( gene ) was found to be one of the major chemical binding proteins in human serum and in liver , brain , and prostate tissues .	T1	T11	23411208
NA	CHEMICAL	GENE-Y	13	28	Over the last decade , many studies have demonstrated the anticancer activity of chemical , the main and most active form of natural chemical . chemical-associated protein ( gene ) was found to be one of the major chemical binding proteins in human serum and in liver , brain , and prostate tissues .	T1	T12	23411208
NA	CHEMICAL	GENE-N	13	26	Over the last decade , many studies have demonstrated the anticancer activity of chemical , the main and most active form of natural chemical . chemical-associated protein ( gene ) was found to be one of the major chemical binding proteins in human serum and in liver , brain , and prostate tissues .	T1	T13	23411208
NA	CHEMICAL	GENE-Y	23	26	Over the last decade , many studies have demonstrated the anticancer activity of chemical , the main and most active form of natural chemical . chemical-associated protein ( gene ) was found to be one of the major chemical binding proteins in human serum and in liver , brain , and prostate tissues .	T2	T11	23411208
NA	CHEMICAL	GENE-Y	23	28	Over the last decade , many studies have demonstrated the anticancer activity of chemical , the main and most active form of natural chemical . chemical-associated protein ( gene ) was found to be one of the major chemical binding proteins in human serum and in liver , brain , and prostate tissues .	T2	T12	23411208
NA	CHEMICAL	GENE-N	23	26	Over the last decade , many studies have demonstrated the anticancer activity of chemical , the main and most active form of natural chemical . chemical-associated protein ( gene ) was found to be one of the major chemical binding proteins in human serum and in liver , brain , and prostate tissues .	T2	T13	23411208
NA	CHEMICAL	GENE-Y	25	26	Over the last decade , many studies have demonstrated the anticancer activity of chemical , the main and most active form of natural chemical . chemical-associated protein ( gene ) was found to be one of the major chemical binding proteins in human serum and in liver , brain , and prostate tissues .	T3	T11	23411208
NA	CHEMICAL	GENE-Y	25	28	Over the last decade , many studies have demonstrated the anticancer activity of chemical , the main and most active form of natural chemical . chemical-associated protein ( gene ) was found to be one of the major chemical binding proteins in human serum and in liver , brain , and prostate tissues .	T3	T12	23411208
NA	CHEMICAL	GENE-N	25	26	Over the last decade , many studies have demonstrated the anticancer activity of chemical , the main and most active form of natural chemical . chemical-associated protein ( gene ) was found to be one of the major chemical binding proteins in human serum and in liver , brain , and prostate tissues .	T3	T13	23411208
NA	CHEMICAL	GENE-Y	32	26	Over the last decade , many studies have demonstrated the anticancer activity of chemical , the main and most active form of natural chemical . chemical-associated protein ( gene ) was found to be one of the major chemical binding proteins in human serum and in liver , brain , and prostate tissues .	T4	T11	23411208
NA	CHEMICAL	GENE-Y	32	28	Over the last decade , many studies have demonstrated the anticancer activity of chemical , the main and most active form of natural chemical . chemical-associated protein ( gene ) was found to be one of the major chemical binding proteins in human serum and in liver , brain , and prostate tissues .	T4	T12	23411208
NA	CHEMICAL	GENE-N	32	26	Over the last decade , many studies have demonstrated the anticancer activity of chemical , the main and most active form of natural chemical . chemical-associated protein ( gene ) was found to be one of the major chemical binding proteins in human serum and in liver , brain , and prostate tissues .	T4	T13	23411208
NA	CHEMICAL	GENE-N	11	11	The Turkish patient and her affected relatives all had a heterozygous gene ( gene ) of exon 10 of gene that results in a replacement of chemical by chemical .	T1	T12	16840830
NA	CHEMICAL	GENE-N	11	13	The Turkish patient and her affected relatives all had a heterozygous gene ( gene ) of exon 10 of gene that results in a replacement of chemical by chemical .	T1	T13	16840830
NA	CHEMICAL	GENE-Y	11	19	The Turkish patient and her affected relatives all had a heterozygous gene ( gene ) of exon 10 of gene that results in a replacement of chemical by chemical .	T1	T14	16840830
NA	CHEMICAL	GENE-N	9	11	The Turkish patient and her affected relatives all had a heterozygous gene ( gene ) of exon 10 of gene that results in a replacement of chemical by chemical .	T2	T12	16840830
NA	CHEMICAL	GENE-N	9	13	The Turkish patient and her affected relatives all had a heterozygous gene ( gene ) of exon 10 of gene that results in a replacement of chemical by chemical .	T2	T13	16840830
NA	CHEMICAL	GENE-Y	9	19	The Turkish patient and her affected relatives all had a heterozygous gene ( gene ) of exon 10 of gene that results in a replacement of chemical by chemical .	T2	T14	16840830
NA	CHEMICAL	GENE-N	10	20	The Chinese index patient and one of her siblings had a heterozygous mutation at codon 418 of exon 9 ( gene ) that results in a substitution of chemical by chemical .	T3	T5	16840830
NA	CHEMICAL	GENE-N	24	20	The Chinese index patient and one of her siblings had a heterozygous mutation at codon 418 of exon 9 ( gene ) that results in a substitution of chemical by chemical .	T4	T5	16840830
CPR:4	CHEMICAL	GENE-Y	0	17	chemical is a semisynthetic chemical that inhibit tumor growth by induction of microtubule stabilization and promotion of gene inactivation , which induce apoptosis .	T1	T11	15714982
CPR:4	CHEMICAL	GENE-Y	2	17	chemical is a semisynthetic chemical that inhibit tumor growth by induction of microtubule stabilization and promotion of gene inactivation , which induce apoptosis .	T2	T11	15714982
CPR:4	CHEMICAL	GENE-Y	2	2	Suppression of gene by the pharmacological inhibitor ( chemical ) markedly reduced gene release by HFL-1 in response to CSE and this effect was confirmed by gene siRNA .	T1	T12	23618901
CPR:4	CHEMICAL	GENE-Y	2	12	Suppression of gene by the pharmacological inhibitor ( chemical ) markedly reduced gene release by HFL-1 in response to CSE and this effect was confirmed by gene siRNA .	T1	T13	23618901
NA	CHEMICAL	GENE-Y	2	26	Suppression of gene by the pharmacological inhibitor ( chemical ) markedly reduced gene release by HFL-1 in response to CSE and this effect was confirmed by gene siRNA .	T1	T14	23618901
NA	CHEMICAL	GENE-Y	0	9	chemical does not account for the CSE stimulation of gene in HFL-1 .	T2	T19	23618901
NA	CHEMICAL	GENE-N	17	11	The objective of this study was to examine the effect of gene ( gene ) activation by chemical on protein synthesis and the gene ( gene ) signaling pathway in bovine mammary epithelial cells .	T2	T18	22972179
NA	CHEMICAL	GENE-N	17	13	The objective of this study was to examine the effect of gene ( gene ) activation by chemical on protein synthesis and the gene ( gene ) signaling pathway in bovine mammary epithelial cells .	T2	T19	22972179
NA	CHEMICAL	GENE-N	17	23	The objective of this study was to examine the effect of gene ( gene ) activation by chemical on protein synthesis and the gene ( gene ) signaling pathway in bovine mammary epithelial cells .	T2	T20	22972179
NA	CHEMICAL	GENE-N	17	25	The objective of this study was to examine the effect of gene ( gene ) activation by chemical on protein synthesis and the gene ( gene ) signaling pathway in bovine mammary epithelial cells .	T2	T21	22972179
NA	CHEMICAL	GENE-N	29	11	The objective of this study was to examine the effect of gene ( gene ) activation by chemical on protein synthesis and the gene ( gene ) signaling pathway in bovine mammary epithelial cells .	T3	T18	22972179
NA	CHEMICAL	GENE-N	29	13	The objective of this study was to examine the effect of gene ( gene ) activation by chemical on protein synthesis and the gene ( gene ) signaling pathway in bovine mammary epithelial cells .	T3	T19	22972179
NA	CHEMICAL	GENE-N	29	23	The objective of this study was to examine the effect of gene ( gene ) activation by chemical on protein synthesis and the gene ( gene ) signaling pathway in bovine mammary epithelial cells .	T3	T20	22972179
NA	CHEMICAL	GENE-N	29	25	The objective of this study was to examine the effect of gene ( gene ) activation by chemical on protein synthesis and the gene ( gene ) signaling pathway in bovine mammary epithelial cells .	T3	T21	22972179
NA	CHEMICAL	GENE-N	4	2	Phosphorylation of gene at chemical172 increased by 1.4-fold within 5 min , and remained elevated throughout a 30-min time course , in response to chemical .	T4	T22	22972179
CPR:3	CHEMICAL	GENE-N	24	2	Phosphorylation of gene at chemical172 increased by 1.4-fold within 5 min , and remained elevated throughout a 30-min time course , in response to chemical .	T5	T22	22972179
CPR:3	CHEMICAL	GENE-Y	14	4	Phosphorylation of ER-stress marker gene was also increased but only at 30 min of chemical exposure .	T6	T27	22972179
CPR:3	CHEMICAL	GENE-Y	0	4	chemical increased phosphorylation of gene ( gene ) on gene consensus sites but did not change the amount of gene bound to gene .	T7	T28	22972179
CPR:3	CHEMICAL	GENE-Y	0	6	chemical increased phosphorylation of gene ( gene ) on gene consensus sites but did not change the amount of gene bound to gene .	T7	T8	22972179
CPR:3	CHEMICAL	GENE-N	0	9	chemical increased phosphorylation of gene ( gene ) on gene consensus sites but did not change the amount of gene bound to gene .	T7	T9	22972179
NA	CHEMICAL	GENE-Y	0	19	chemical increased phosphorylation of gene ( gene ) on gene consensus sites but did not change the amount of gene bound to gene .	T7	T10	22972179
CPR:3	CHEMICAL	GENE-Y	0	22	chemical increased phosphorylation of gene ( gene ) on gene consensus sites but did not change the amount of gene bound to gene .	T7	T11	22972179
NA	CHEMICAL	GENE-N	4	4	The inhibitory effects of gene activation on gene signaling were associated with a marked increase in chemical792 phosphorylation on raptor .	T1	T14	22972179
NA	CHEMICAL	GENE-N	4	7	The inhibitory effects of gene activation on gene signaling were associated with a marked increase in chemical792 phosphorylation on raptor .	T1	T15	22972179
